Psyllid ID: psy2172

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-
Protein Sequence
MDYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDFNEQICKME
Secondary Structure (PSIPRED)
ccHHHHcHHHccccccccHHHccccEEcccccEEEEEEEEcccccccEEEEEccccccccHHHHHHHHHHHcccccccEEEEEEEEEccccEEEEEEccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHHHHHHHHccccccccccccEEEcccccccccEEEccccccccccccccccccccccEEEEEccccHHHccccccccHHHHHHHHHHHHHHHHcccccccccccccccccccHHHHHHHHHHccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccHHHHHHHHHcccHccHHHcEEEEEEcccccEEEEEEEcccccccEEEHHHHHcccccHHHHHHHHHHHHcccccEEEEEEEEEcccccEEEEEEEHHHHHHHHHHHHccHHHcccccccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccccccEEEccccccEEccHHHcEccccccccccHHHccHHHHccccccccHHHHHHHHHHHHHHHHcccccccccccccccccccHHHHHHHHHHHcccccccccccccccccccccccccHcccccc
Coil and Loop (DISEMBL)
mdyefkiktsnertkvedlfdyegckvgrgtygHVYKarrkdnsdtrDYALKQiegtglsmSACREIALLRelkhpnviNLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRaakankkpvmvpkGMVKSLLYQILDGIHYlhsnwvlhrdlkpanilVMGEGIERGRVKIADMGFarlfnnplkpladldpvvVTFWYRAPELLLGARHYTKAIDIWAIGCIFAelltsepifhcrqediktsnpyhhdqldrifsvmgfplekdwedirkmpehptllkDFNEQICKME
Flexible Loop (DISEMBL)
mdyefkiktsnertkvedlfdyegckvgrgtyghvykarrkdnsdtrDYALKqiegtglsmSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHraakankkpvmVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGFPLEKDWEDirkmpehptllkdfneqickme
Low Complexity Region (SEG)
MDYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANkkpvmvpkgmvkSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDFNEQICKME
Disordered region (IsUnstruct)
***************VEDLFDYEGCKVGRGTYGHVYKARR******RDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIR********************
Disordered Region (DISOPRED)
******************LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFH***********VPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDFNEQ*****
Disordered Region (DISEMBL)
MDYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDFNEQICKME
Disordered Region (DISPRO)
MDYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDFNEQ*****
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MDYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDFNEQICKME
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	291	2.2.26 [Sep-21-2011]
Q17IE8	501	Cyclin-dependent kinase 8	N/A	N/A	0.972	0.564	0.929	1e-157
Q6P3N6	464	Cyclin-dependent kinase 8	yes	N/A	0.972	0.609	0.890	1e-153
Q8BWD8	501	Cyclin-dependent kinase 1	yes	N/A	0.972	0.564	0.886	1e-152
Q9BWU1	502	Cyclin-dependent kinase 1	yes	N/A	0.972	0.563	0.886	1e-152
Q8JH47	464	Cyclin-dependent kinase 8	no	N/A	0.972	0.609	0.883	1e-152
Q9VT57	454	Cyclin-dependent kinase 8	yes	N/A	0.972	0.623	0.890	1e-149
Q8R3L8	464	Cyclin-dependent kinase 8	no	N/A	0.972	0.609	0.893	1e-149
P49336	464	Cyclin-dependent kinase 8	no	N/A	0.972	0.609	0.893	1e-148
Q66KH9	416	Cyclin-dependent kinase 8	N/A	N/A	0.807	0.564	0.731	1e-117
P0C661	612	Cyclin-dependent kinase 8	N/A	N/A	0.965	0.459	0.670	1e-112

>sp|Q17IE8|CDK8_AEDAE Cyclin-dependent kinase 8 OS=Aedes aegypti GN=Cdk8 PE=3 SV=2

 Score =  552 bits (1423), Expect = e-157,   Method: Compositional matrix adjust.
 Identities = 263/283 (92%), Positives = 271/283 (95%)

Query: 1   MDYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS 60
           MDYEFK+KT  ER KVEDLF+YEGCKVGRGTYGHVYKA RK+++DT+DYALKQIEGTGLS
Sbjct: 1   MDYEFKMKTQQERAKVEDLFEYEGCKVGRGTYGHVYKAHRKESNDTKDYALKQIEGTGLS 60

Query: 61  MSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKP 120
           MSACREIALLRELKHPNVINLI VFLSH DRKVWLLFDYAEHDLWHIIKFHRAAKA KKP
Sbjct: 61  MSACREIALLRELKHPNVINLIRVFLSHTDRKVWLLFDYAEHDLWHIIKFHRAAKATKKP 120

Query: 121 VMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
           VMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEG ERGRVKIADMGFARLF
Sbjct: 121 VMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGNERGRVKIADMGFARLF 180

Query: 181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
           N PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED
Sbjct: 181 NAPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240

Query: 241 IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF 283
           IKTSNPYHHDQLDRIF+VMGFP +KDWEDIRKMPEH TL KDF
Sbjct: 241 IKTSNPYHHDQLDRIFNVMGFPQDKDWEDIRKMPEHHTLTKDF 283

Component of the Mediator complex, a coactivator involved in regulated gene transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. Phosphorylates the CTD (C-terminal domain) of the large subunit of RNA polymerase II (RNAp II), which may inhibit the formation of a transcription initiation complex.
Aedes aegypti (taxid: 7159)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 3

>sp|Q6P3N6|CDK8_XENTR Cyclin-dependent kinase 8 OS=Xenopus tropicalis GN=cdk8 PE=2 SV=1

 Score =  541 bits (1394), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 252/283 (89%), Positives = 270/283 (95%)

Query: 1   MDYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS 60
           MDY+FK+K + ER +VEDLF+YEGCKVGRGTYGHVYKA+RKD  D RDYALKQIEGTG+S
Sbjct: 1   MDYDFKVKLTGERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGRDDRDYALKQIEGTGIS 60

Query: 61  MSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKP 120
           MSACREIALLRELKHPNVI+L  VFLSH DRKVWLLFD+AEHDLWHIIKFHRA+KANKKP
Sbjct: 61  MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDFAEHDLWHIIKFHRASKANKKP 120

Query: 121 VMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
           V +P+GMVKSLLYQILDGIHYLH+NWVLHRDLKPANILVMGEG ERGRVKIADMGFARLF
Sbjct: 121 VQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 180

Query: 181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
           N+PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED
Sbjct: 181 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240

Query: 241 IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF 283
           IKTSNPYHHDQLDRIF+VMGFP +KDWEDI+KMPEH TL+KDF
Sbjct: 241 IKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLIKDF 283

Component of the Mediator complex, a coactivator involved in regulated gene transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. Phosphorylates the CTD (C-terminal domain) of the large subunit of RNA polymerase II (RNAp II), which may inhibit the formation of a transcription initiation complex.

Xenopus tropicalis (taxid: 8364)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|Q8BWD8|CDK19_MOUSE Cyclin-dependent kinase 19 OS=Mus musculus GN=Cdk19 PE=2 SV=1

 Score =  538 bits (1386), Expect = e-152,   Method: Compositional matrix adjust.
 Identities = 251/283 (88%), Positives = 268/283 (94%)

Query: 1   MDYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS 60
           MDY+FK K + ER +VEDLF+YEGCKVGRGTYGHVYKARRKD  D ++YALKQIEGTG+S
Sbjct: 1   MDYDFKAKLAAERERVEDLFEYEGCKVGRGTYGHVYKARRKDGKDEKEYALKQIEGTGIS 60

Query: 61  MSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKP 120
           MSACREIALLRELKHPNVI L  VFLSH+DRKVWLLFDYAEHDLWHIIKFHRA+KANKKP
Sbjct: 61  MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKP 120

Query: 121 VMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
           + +P+ MVKSLLYQILDGIHYLH+NWVLHRDLKPANILVMGEG ERGRVKIADMGFARLF
Sbjct: 121 MQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 180

Query: 181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
           N+PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED
Sbjct: 181 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240

Query: 241 IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF 283
           IKTSNP+HHDQLDRIFSVMGFP +KDWEDIRKMPE+PTL KDF
Sbjct: 241 IKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDF 283

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|Q9BWU1|CDK19_HUMAN Cyclin-dependent kinase 19 OS=Homo sapiens GN=CDK19 PE=1 SV=1

 Score =  537 bits (1384), Expect = e-152,   Method: Compositional matrix adjust.
 Identities = 251/283 (88%), Positives = 268/283 (94%)

Query: 1   MDYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS 60
           MDY+FK K + ER +VEDLF+YEGCKVGRGTYGHVYKARRKD  D ++YALKQIEGTG+S
Sbjct: 1   MDYDFKAKLAAERERVEDLFEYEGCKVGRGTYGHVYKARRKDGKDEKEYALKQIEGTGIS 60

Query: 61  MSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKP 120
           MSACREIALLRELKHPNVI L  VFLSH+DRKVWLLFDYAEHDLWHIIKFHRA+KANKKP
Sbjct: 61  MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKP 120

Query: 121 VMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
           + +P+ MVKSLLYQILDGIHYLH+NWVLHRDLKPANILVMGEG ERGRVKIADMGFARLF
Sbjct: 121 MQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 180

Query: 181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
           N+PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED
Sbjct: 181 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240

Query: 241 IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF 283
           IKTSNP+HHDQLDRIFSVMGFP +KDWEDIRKMPE+PTL KDF
Sbjct: 241 IKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDF 283

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|Q8JH47|CDK8_DANRE Cyclin-dependent kinase 8 OS=Danio rerio GN=cdk8 PE=2 SV=1

 Score =  537 bits (1384), Expect = e-152,   Method: Compositional matrix adjust.
 Identities = 250/283 (88%), Positives = 268/283 (94%)

Query: 1   MDYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS 60
           M Y+FK+K + ER +VEDLF+YEGCKVGRGTYGHVYKA+RKD  D RDYALKQIEGTG+S
Sbjct: 1   MGYDFKVKLTGERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS 60

Query: 61  MSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKP 120
           MSACREIALLRELKHPNVI+L  VFLSH DRKVWLLFDYAEHDLWHIIKFHRA+KANKKP
Sbjct: 61  MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKP 120

Query: 121 VMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
           + +P+GMVKSLLYQILDGIHYLH+NWVLHRDLKPANILVMGEG ERGRVKIADMGFARL 
Sbjct: 121 LQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLS 180

Query: 181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
           N+PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED
Sbjct: 181 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240

Query: 241 IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF 283
           IKTSNPYHHDQLDRIF+VMGFP +KDWEDI+KMPEH TL+KDF
Sbjct: 241 IKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDF 283

Component of the Mediator complex, a coactivator involved in regulated gene transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. Phosphorylates the CTD (C-terminal domain) of the large subunit of RNA polymerase II (RNAp II), which may inhibit the formation of a transcription initiation complex.

Danio rerio (taxid: 7955)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|Q9VT57|CDK8_DROME Cyclin-dependent kinase 8 OS=Drosophila melanogaster GN=Cdk8 PE=1 SV=2

 Score =  529 bits (1362), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 252/283 (89%), Positives = 267/283 (94%)

Query: 1   MDYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS 60
           MDY+FK+KT  ERTKVEDLF+YEGCKVGRGTYGHVYKA+ K+ SD ++YALKQI+GTGLS
Sbjct: 1   MDYDFKMKTQIERTKVEDLFNYEGCKVGRGTYGHVYKAKWKETSDGKEYALKQIDGTGLS 60

Query: 61  MSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKP 120
           MSACREIALLRELKH NVI LI VFLSHNDRKV+LL DYAEHDLWHIIKFHRAAKA KK 
Sbjct: 61  MSACREIALLRELKHQNVITLIRVFLSHNDRKVFLLIDYAEHDLWHIIKFHRAAKATKKQ 120

Query: 121 VMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
           V+VP+GMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMG+G ERGRVKIADMGFARLF
Sbjct: 121 VVVPRGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGDGNERGRVKIADMGFARLF 180

Query: 181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
           N PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED
Sbjct: 181 NAPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240

Query: 241 IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF 283
           IKTSNPYHHDQLDRIF+VMGFP +KDWEDI+KMPEH TL KDF
Sbjct: 241 IKTSNPYHHDQLDRIFNVMGFPQDKDWEDIKKMPEHHTLTKDF 283

Component of the Mediator complex, a coactivator involved in regulated gene transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. May phosphorylate the CTD (C-terminal domain) of the large subunit of RNA polymerase II (RNAp II), which may inhibit the formation of a transcription initiation complex. Required for leg and eye development and macrochaete specification or differentiation.

Drosophila melanogaster (taxid: 7227)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|Q8R3L8|CDK8_MOUSE Cyclin-dependent kinase 8 OS=Mus musculus GN=Cdk8 PE=2 SV=3

 Score =  527 bits (1358), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 253/283 (89%), Positives = 272/283 (96%)

Query: 1   MDYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS 60
           MDY+FK+K S+ER +VEDLF+YEGCKVGRGTYGHVYKA+RKD  D +DYALKQIEGTG+S
Sbjct: 1   MDYDFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS 60

Query: 61  MSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKP 120
           MSACREIALLRELKHPNVI+L+ VFLSH DRKVWLLFDYAEHDLWHIIKFHRA+KANKKP
Sbjct: 61  MSACREIALLRELKHPNVISLLKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKP 120

Query: 121 VMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
           V +P+GMVKSLLYQILDGIHYLH+NWVLHRDLKPANILVMGEG ERGRVKIADMGFARLF
Sbjct: 121 VQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 180

Query: 181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
           N+PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED
Sbjct: 181 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240

Query: 241 IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF 283
           IKTSNPYHHDQLDRIF+VMGFP +KDWEDI+KMPEH TL+KDF
Sbjct: 241 IKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDF 283

Component of the Mediator complex, a coactivator involved in regulated gene transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. Phosphorylates the CTD (C-terminal domain) of the large subunit of RNA polymerase II (RNAp II), which may inhibit the formation of a transcription initiation complex. Phosphorylates CCNH leading to down-regulation of the TFIIH complex and transcriptional repression. Recruited through interaction with MAML1 to hyperphosphorylate the intracellular domain of NOTCH, leading to its degradation.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|P49336|CDK8_HUMAN Cyclin-dependent kinase 8 OS=Homo sapiens GN=CDK8 PE=1 SV=1

 Score =  525 bits (1353), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 253/283 (89%), Positives = 271/283 (95%)

Query: 1   MDYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS 60
           MDY+FK+K S+ER +VEDLF+YEGCKVGRGTYGHVYKA+RKD  D +DYALKQIEGTG+S
Sbjct: 1   MDYDFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS 60

Query: 61  MSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKP 120
           MSACREIALLRELKHPNVI+L  VFLSH DRKVWLLFDYAEHDLWHIIKFHRA+KANKKP
Sbjct: 61  MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKP 120

Query: 121 VMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
           V +P+GMVKSLLYQILDGIHYLH+NWVLHRDLKPANILVMGEG ERGRVKIADMGFARLF
Sbjct: 121 VQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 180

Query: 181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
           N+PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED
Sbjct: 181 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240

Query: 241 IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF 283
           IKTSNPYHHDQLDRIF+VMGFP +KDWEDI+KMPEH TL+KDF
Sbjct: 241 IKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDF 283

Component of the Mediator complex, a coactivator involved in regulated gene transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. Phosphorylates the CTD (C-terminal domain) of the large subunit of RNA polymerase II (RNAp II), which may inhibit the formation of a transcription initiation complex. Phosphorylates CCNH leading to down-regulation of the TFIIH complex and transcriptional repression. Recruited through interaction with MAML1 to hyperphosphorylate the intracellular domain of NOTCH, leading to its degradation.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|Q66KH9|CDK8_XENLA Cyclin-dependent kinase 8 OS=Xenopus laevis GN=cdk8 PE=2 SV=1

 Score =  421 bits (1082), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 207/283 (73%), Positives = 223/283 (78%), Gaps = 48/283 (16%)

Query: 1   MDYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS 60
           MDY+FK+K + ER +VEDLF+YEGCKVGRGTYGHVYKA+RKD  D RDYALKQIEGTG+S
Sbjct: 1   MDYDFKVKLTGERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS 60

Query: 61  MSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKP 120
           MSACREIALLRELKHPNVI+L  VFLSH DRKVWLLFD+AEHDLWHIIKFHRA+KANKKP
Sbjct: 61  MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDFAEHDLWHIIKFHRASKANKKP 120

Query: 121 VMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
           V +P+GMVKSLLYQILDGIHYLH+NWVLHRDLKPANILVMGEG ERGRVKIADMGFARLF
Sbjct: 121 VQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 180

Query: 181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
           N+PLKPLADLDPVVVTFWYRAPELLLGARHYTKAID                        
Sbjct: 181 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAID------------------------ 216

Query: 241 IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF 283
                                   KDWEDI+KMPEH TL+KDF
Sbjct: 217 ------------------------KDWEDIKKMPEHSTLIKDF 235

Component of the Mediator complex, a coactivator involved in regulated gene transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. Phosphorylates the CTD (C-terminal domain) of the large subunit of RNA polymerase II (RNAp II), which may inhibit the formation of a transcription initiation complex.

Xenopus laevis (taxid: 8355)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|P0C661|CDK8_CAEBR Cyclin-dependent kinase 8 OS=Caenorhabditis briggsae GN=cdk-8 PE=3 SV=2

 Score =  406 bits (1043), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 193/288 (67%), Positives = 236/288 (81%), Gaps = 7/288 (2%)

Query: 1   MDYEFKIKTSNERTKVEDLFDYEGCK-VGRGTYGHVYKARRKDNSD---TRDYALKQIEG 56
           +D  FK K +  R +VEDLF +E  K +GRGTYG VYKA  K ++     ++YALK IEG
Sbjct: 2   IDENFKKKLAVSRERVEDLFYFENSKEIGRGTYGLVYKAVPKHSNGRFPNKEYALKMIEG 61

Query: 57  TGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKA 116
            G SMSACREIAL REL+HPN+I L  VFL+ N++KVWLL DYAEHDLWH+IK HR AK 
Sbjct: 62  QGFSMSACREIALFRELRHPNLICLQRVFLT-NEKKVWLLLDYAEHDLWHVIKHHRTAKT 120

Query: 117 NKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIE--RGRVKIADM 174
            K P+MVP+ MVK++L+QIL G+HYLHSNWVLHRDLKPANIL+MG+G    RGRVKIAD+
Sbjct: 121 KKVPIMVPRNMVKNILFQILSGMHYLHSNWVLHRDLKPANILLMGDGGPDMRGRVKIADL 180

Query: 175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           GF+R+F NPLKP+A+LDPVVVTFWYRAPELLLGA+HYTKAID+WAIGCIFAELLT+EP+F
Sbjct: 181 GFSRIFANPLKPMAELDPVVVTFWYRAPELLLGAKHYTKAIDVWAIGCIFAELLTAEPLF 240

Query: 235 HCRQEDIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKD 282
            C++EDIK  NPYH+DQ+ RIF ++G+P + DW D++KMP+H  LL D
Sbjct: 241 FCKEEDIKAQNPYHYDQVKRIFHLLGYPSDTDWPDMKKMPDHQRLLND 288

Component of the Mediator complex, a coactivator involved in regulated gene transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. Phosphorylates the CTD (C-terminal domain) of the large subunit of RNA polymerase II (RNAp II), which may inhibit the formation of a transcription initiation complex.

Caenorhabditis briggsae (taxid: 6238)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	291
242012853	440	mitogen-activated protein kinase ERK-A,	0.979	0.647	0.940	1e-160
351734410	462	cyclin dependent kinase 8 [Bombyx mori]	1.0	0.629	0.928	1e-160
91076452	465	PREDICTED: similar to cdk8 [Tribolium ca	0.982	0.615	0.944	1e-160
357618680	446	putative mitogen-activated protein kinas	0.996	0.650	0.931	1e-159
328708686	558	PREDICTED: cyclin-dependent kinase 8-lik	0.972	0.507	0.932	1e-157
312370853	739	hypothetical protein AND_22964 [Anophele	0.972	0.382	0.925	1e-155
158298926	375	AGAP009936-PA [Anopheles gambiae str. PE	0.972	0.754	0.929	1e-155
157128583	507	cdk8 [Aedes aegypti] gi|108882204|gb|EAT	0.972	0.558	0.929	1e-155
166234055	501	RecName: Full=Cyclin-dependent kinase 8;	0.972	0.564	0.929	1e-155
383863591	455	PREDICTED: cyclin-dependent kinase 8-lik	0.982	0.628	0.888	1e-154

>gi|242012853|ref|XP_002427141.1| mitogen-activated protein kinase ERK-A, putative [Pediculus humanus corporis] gi|212511412|gb|EEB14403.1| mitogen-activated protein kinase ERK-A, putative [Pediculus humanus corporis]

 Score =  570 bits (1470), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 268/285 (94%), Positives = 276/285 (96%)

Query: 1   MDYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS 60
           MDY+FK KT+NER KVEDLFDYEGCKVGRGTYGHVYKARRKD SD +DYALKQIEGTGLS
Sbjct: 1   MDYDFKFKTANERAKVEDLFDYEGCKVGRGTYGHVYKARRKDGSDMKDYALKQIEGTGLS 60

Query: 61  MSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKP 120
           MSACREIALLRELKHPNVINLI VFLSHNDRKVWLLFD+AEHDLWHIIKFHRAAKANKKP
Sbjct: 61  MSACREIALLRELKHPNVINLIRVFLSHNDRKVWLLFDFAEHDLWHIIKFHRAAKANKKP 120

Query: 121 VMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
           VMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEG ERGRVKIADMGFARLF
Sbjct: 121 VMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 180

Query: 181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
           N PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED
Sbjct: 181 NAPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240

Query: 241 IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDFNE 285
           IKTSNPYHHDQLDRIF+VMGFPLEKDWEDIRKMPE+ TL+KDF +
Sbjct: 241 IKTSNPYHHDQLDRIFNVMGFPLEKDWEDIRKMPEYQTLVKDFKK 285

Source: Pediculus humanus corporis

Species: Pediculus humanus

Genus: Pediculus

Family: Pediculidae

Order: Phthiraptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|351734410|ref|NP_001162054.2| cyclin dependent kinase 8 [Bombyx mori] gi|351348882|gb|ACT83403.2| cyclin dependent kinase 8 [Bombyx mori]

 Score =  570 bits (1469), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 273/294 (92%), Positives = 279/294 (94%), Gaps = 3/294 (1%)

Query: 1   MDYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS 60
           MDY+FKIKT NER+KVEDLFDYEGCKVGRGTYGHVYKARRKD SDT+DYALKQIEGTGLS
Sbjct: 15  MDYDFKIKTQNERSKVEDLFDYEGCKVGRGTYGHVYKARRKDGSDTKDYALKQIEGTGLS 74

Query: 61  MSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKP 120
           MSACREIALLRELKHPNVINLI VFLSH DRKVWLLFDYAEHDLWHIIKFHRAAKANKK 
Sbjct: 75  MSACREIALLRELKHPNVINLIRVFLSHTDRKVWLLFDYAEHDLWHIIKFHRAAKANKKS 134

Query: 121 VMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
           VMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEG ERGRVKIADMGFARLF
Sbjct: 135 VMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 194

Query: 181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
           N PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED
Sbjct: 195 NAPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 254

Query: 241 IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF---NEQICKME 291
           IKTSNPYHHDQLDRIF+VMGFPLEKDWEDIRKMPEH TL+KDF   N Q C + 
Sbjct: 255 IKTSNPYHHDQLDRIFNVMGFPLEKDWEDIRKMPEHATLVKDFKRSNYQNCSLS 308

Source: Bombyx mori

Species: Bombyx mori

Genus: Bombyx

Family: Bombycidae

Order: Lepidoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|91076452|ref|XP_971782.1| PREDICTED: similar to cdk8 [Tribolium castaneum] gi|270002575|gb|EEZ99022.1| hypothetical protein TcasGA2_TC004891 [Tribolium castaneum]

 Score =  570 bits (1468), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 270/286 (94%), Positives = 276/286 (96%)

Query: 1   MDYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS 60
           MDYEFK+KT NER KVEDLFDYEGCKVGRGTYGHVYK RRKD SD RDYALKQIEGTGLS
Sbjct: 1   MDYEFKMKTQNERVKVEDLFDYEGCKVGRGTYGHVYKGRRKDGSDNRDYALKQIEGTGLS 60

Query: 61  MSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKP 120
           MSACREIALLRELKHPNVI LI VFLSHNDRKVWLLFD+AEHDLWHIIKFHRAAKANKKP
Sbjct: 61  MSACREIALLRELKHPNVITLIRVFLSHNDRKVWLLFDFAEHDLWHIIKFHRAAKANKKP 120

Query: 121 VMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
           VMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEG ERGRVKIADMGFARLF
Sbjct: 121 VMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 180

Query: 181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
           N PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED
Sbjct: 181 NAPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240

Query: 241 IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDFNEQ 286
           IKTSNPYHHDQLDRIF+VMGFPLEKDWEDI+KMPEHPTL+KDF +Q
Sbjct: 241 IKTSNPYHHDQLDRIFNVMGFPLEKDWEDIKKMPEHPTLVKDFKKQ 286

Source: Tribolium castaneum

Species: Tribolium castaneum

Genus: Tribolium

Family: Tenebrionidae

Order: Coleoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|357618680|gb|EHJ71569.1| putative mitogen-activated protein kinase ERK-A [Danaus plexippus]

 Score =  568 bits (1464), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 273/293 (93%), Positives = 278/293 (94%), Gaps = 3/293 (1%)

Query: 1   MDYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS 60
           MDYEFKIKT NER+KVEDLFDYEGCKVGRGTYGHVYKARRKD SDT+DYALKQIEGTGLS
Sbjct: 1   MDYEFKIKTQNERSKVEDLFDYEGCKVGRGTYGHVYKARRKDGSDTKDYALKQIEGTGLS 60

Query: 61  MSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKP 120
           MSACREIALLRELKHPNVINLI VFLSH DRKVWLLFDYAEHDLWHIIKFHRAAKANKK 
Sbjct: 61  MSACREIALLRELKHPNVINLIRVFLSHTDRKVWLLFDYAEHDLWHIIKFHRAAKANKKS 120

Query: 121 VMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
           VMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEG ERGRVKIADMGFARLF
Sbjct: 121 VMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 180

Query: 181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
           N PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED
Sbjct: 181 NAPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240

Query: 241 IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF---NEQICKM 290
           IKTSNPYHHDQLDRIF+VMGFP EKDWEDIRKMPEH TL+KDF   N Q C +
Sbjct: 241 IKTSNPYHHDQLDRIFNVMGFPQEKDWEDIRKMPEHATLVKDFKRSNYQNCSL 293

Source: Danaus plexippus

Species: Danaus plexippus

Genus: Danaus

Family: Nymphalidae

Order: Lepidoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|328708686|ref|XP_001950232.2| PREDICTED: cyclin-dependent kinase 8-like [Acyrthosiphon pisum]

 Score =  559 bits (1441), Expect = e-157,   Method: Compositional matrix adjust.
 Identities = 264/283 (93%), Positives = 274/283 (96%)

Query: 1   MDYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS 60
           MDYEFKIKT NER KVE+LF+YEGCKVGRGTYGHVYKARRKD  +++D+ALKQIEGTGLS
Sbjct: 1   MDYEFKIKTGNERAKVEELFEYEGCKVGRGTYGHVYKARRKDGDNSKDFALKQIEGTGLS 60

Query: 61  MSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKP 120
           MSACREIALLRELKHPNVINLI VFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKP
Sbjct: 61  MSACREIALLRELKHPNVINLIRVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKP 120

Query: 121 VMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
           VMVPKGMVKSLL+QILDGIHYLHSNWVLHRDLKPANILVMGEG ERGRVKIADMGFARLF
Sbjct: 121 VMVPKGMVKSLLFQILDGIHYLHSNWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 180

Query: 181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
           N PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED
Sbjct: 181 NAPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240

Query: 241 IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF 283
           IKTSNPYHHDQLDRIF+VMGFP EKDWEDI+KMPEH TL+KDF
Sbjct: 241 IKTSNPYHHDQLDRIFNVMGFPQEKDWEDIKKMPEHQTLMKDF 283

Source: Acyrthosiphon pisum

Species: Acyrthosiphon pisum

Genus: Acyrthosiphon

Family: Aphididae

Order: Hemiptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|312370853|gb|EFR19164.1| hypothetical protein AND_22964 [Anopheles darlingi]

 Score =  554 bits (1427), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 262/283 (92%), Positives = 269/283 (95%)

Query: 1   MDYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS 60
           MDYEFK+KT  ER KVEDLF+YEGCKVGRGTYGHVYKA RK+ +D +DYALKQIEGTGLS
Sbjct: 7   MDYEFKMKTQQERAKVEDLFEYEGCKVGRGTYGHVYKAHRKEGNDPKDYALKQIEGTGLS 66

Query: 61  MSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKP 120
           MSACREIALLRELKHPNVINLI VFLSH DRKVWLLFDYAEHDLWHIIKFHRAAKA KKP
Sbjct: 67  MSACREIALLRELKHPNVINLIRVFLSHTDRKVWLLFDYAEHDLWHIIKFHRAAKATKKP 126

Query: 121 VMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
           VMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEG ERGRVKIADMGFARLF
Sbjct: 127 VMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGNERGRVKIADMGFARLF 186

Query: 181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
           N PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED
Sbjct: 187 NAPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 246

Query: 241 IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF 283
           IKTSNPYHHDQLDRIF+VMGFP +KDWEDIRKMPEH TL KDF
Sbjct: 247 IKTSNPYHHDQLDRIFNVMGFPQDKDWEDIRKMPEHHTLTKDF 289

Source: Anopheles darlingi

Species: Anopheles darlingi

Genus: Anopheles

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|158298926|ref|XP_319061.3| AGAP009936-PA [Anopheles gambiae str. PEST] gi|157014122|gb|EAA13852.4| AGAP009936-PA [Anopheles gambiae str. PEST]

 Score =  553 bits (1425), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 263/283 (92%), Positives = 270/283 (95%)

Query: 1   MDYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS 60
           MDYEFK+KT  ER KVEDLF+YEGCKVGRGTYGHVYKARRK+ +D +DYALKQIEGTGLS
Sbjct: 7   MDYEFKMKTQQERAKVEDLFEYEGCKVGRGTYGHVYKARRKEGNDAKDYALKQIEGTGLS 66

Query: 61  MSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKP 120
           MSACREIALLRELKHPNVINLI VFLSH DRKVWLLFDYAEHDLWHIIKFHRAAKA KKP
Sbjct: 67  MSACREIALLRELKHPNVINLIRVFLSHTDRKVWLLFDYAEHDLWHIIKFHRAAKATKKP 126

Query: 121 VMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
           VMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEG ERGRVKIADMGFARLF
Sbjct: 127 VMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGNERGRVKIADMGFARLF 186

Query: 181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
           N PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED
Sbjct: 187 NAPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 246

Query: 241 IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF 283
           IKTSNPYHHDQLDRIF+VMGFP +KDWEDIRKMPEH TL KDF
Sbjct: 247 IKTSNPYHHDQLDRIFNVMGFPQDKDWEDIRKMPEHHTLTKDF 289

Source: Anopheles gambiae str. PEST

Species: Anopheles gambiae

Genus: Anopheles

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|157128583|ref|XP_001655140.1| cdk8 [Aedes aegypti] gi|108882204|gb|EAT46429.1| AAEL002395-PA [Aedes aegypti]

 Score =  553 bits (1425), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 263/283 (92%), Positives = 271/283 (95%)

Query: 1   MDYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS 60
           MDYEFK+KT  ER KVEDLF+YEGCKVGRGTYGHVYKA RK+++DT+DYALKQIEGTGLS
Sbjct: 7   MDYEFKMKTQQERAKVEDLFEYEGCKVGRGTYGHVYKAHRKESNDTKDYALKQIEGTGLS 66

Query: 61  MSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKP 120
           MSACREIALLRELKHPNVINLI VFLSH DRKVWLLFDYAEHDLWHIIKFHRAAKA KKP
Sbjct: 67  MSACREIALLRELKHPNVINLIRVFLSHTDRKVWLLFDYAEHDLWHIIKFHRAAKATKKP 126

Query: 121 VMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
           VMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEG ERGRVKIADMGFARLF
Sbjct: 127 VMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGNERGRVKIADMGFARLF 186

Query: 181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
           N PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED
Sbjct: 187 NAPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 246

Query: 241 IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF 283
           IKTSNPYHHDQLDRIF+VMGFP +KDWEDIRKMPEH TL KDF
Sbjct: 247 IKTSNPYHHDQLDRIFNVMGFPQDKDWEDIRKMPEHHTLTKDF 289

Source: Aedes aegypti

Species: Aedes aegypti

Genus: Aedes

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|166234055|sp|Q17IE8.2|CDK8_AEDAE RecName: Full=Cyclin-dependent kinase 8; AltName: Full=Cell division protein kinase 8; AltName: Full=Mediator complex subunit Cdk8; AltName: Full=Mediator of RNA polymerase II transcription subunit Cdk8

 Score =  552 bits (1423), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 263/283 (92%), Positives = 271/283 (95%)

Query: 1   MDYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS 60
           MDYEFK+KT  ER KVEDLF+YEGCKVGRGTYGHVYKA RK+++DT+DYALKQIEGTGLS
Sbjct: 1   MDYEFKMKTQQERAKVEDLFEYEGCKVGRGTYGHVYKAHRKESNDTKDYALKQIEGTGLS 60

Query: 61  MSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKP 120
           MSACREIALLRELKHPNVINLI VFLSH DRKVWLLFDYAEHDLWHIIKFHRAAKA KKP
Sbjct: 61  MSACREIALLRELKHPNVINLIRVFLSHTDRKVWLLFDYAEHDLWHIIKFHRAAKATKKP 120

Query: 121 VMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
           VMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEG ERGRVKIADMGFARLF
Sbjct: 121 VMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGNERGRVKIADMGFARLF 180

Query: 181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
           N PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED
Sbjct: 181 NAPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240

Query: 241 IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF 283
           IKTSNPYHHDQLDRIF+VMGFP +KDWEDIRKMPEH TL KDF
Sbjct: 241 IKTSNPYHHDQLDRIFNVMGFPQDKDWEDIRKMPEHHTLTKDF 283

Source: Aedes aegypti

Species: Aedes aegypti

Genus: Aedes

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|383863591|ref|XP_003707263.1| PREDICTED: cyclin-dependent kinase 8-like [Megachile rotundata]

 Score =  548 bits (1413), Expect = e-154,   Method: Compositional matrix adjust.
 Identities = 262/295 (88%), Positives = 274/295 (92%), Gaps = 9/295 (3%)

Query: 1   MDYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDN---------SDTRDYAL 51
           MDYEFK+KT  +RTKVEDLF++EGCKVGRGTYGHVYKARRK+           DT+D+ L
Sbjct: 2   MDYEFKMKTQKDRTKVEDLFEFEGCKVGRGTYGHVYKARRKEGVPDSELKSRPDTKDFGL 61

Query: 52  KQIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFH 111
           KQIEGTGLSMSACREIALLRELKH NVI LI VFLSHNDRKVWLLFD+AEHDLWHIIKFH
Sbjct: 62  KQIEGTGLSMSACREIALLRELKHVNVITLIRVFLSHNDRKVWLLFDFAEHDLWHIIKFH 121

Query: 112 RAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI 171
           RAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEG ERGRVKI
Sbjct: 122 RAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGNERGRVKI 181

Query: 172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 231
           ADMGFARLFN PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE
Sbjct: 182 ADMGFARLFNAPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 241

Query: 232 PIFHCRQEDIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDFNEQ 286
           PIFHCRQED+KTSNPYHHDQLDRIF+VMGFP+EKDWEDI+KMPEHPTLLKDF  Q
Sbjct: 242 PIFHCRQEDLKTSNPYHHDQLDRIFNVMGFPMEKDWEDIKKMPEHPTLLKDFKRQ 296

Source: Megachile rotundata

Species: Megachile rotundata

Genus: Megachile

Family: Megachilidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	291
UNIPROTKB|Q17IE8	501	Cdk8 "Cyclin-dependent kinase	0.972	0.564	0.886	1.7e-137
MGI|MGI:1196224	464	Cdk8 "cyclin-dependent kinase	0.972	0.609	0.862	4.1e-136
UNIPROTKB|E2RMV5	464	CDK8 "Uncharacterized protein"	0.972	0.609	0.862	1.4e-135
UNIPROTKB|P49336	464	CDK8 "Cyclin-dependent kinase	0.972	0.609	0.862	1.4e-135
UNIPROTKB|E1C2T0	467	CDK8 "Uncharacterized protein"	0.972	0.605	0.858	3.7e-135
ZFIN|ZDB-GENE-030903-2	465	cdk8 "cyclin-dependent kinase	0.972	0.608	0.858	3.7e-135
UNIPROTKB|Q9BWU1	502	CDK19 "Cyclin-dependent kinase	0.972	0.563	0.862	1.6e-134
MGI|MGI:1925584	501	Cdk19 "cyclin-dependent kinase	0.972	0.564	0.862	1.6e-134
ZFIN|ZDB-GENE-040724-19	484	cdk19 "cyclin-dependent kinase	0.972	0.584	0.858	4.2e-134
FB|FBgn0015618	454	Cdk8 "Cyclin-dependent kinase	0.972	0.623	0.858	2.7e-132

UNIPROTKB|Q17IE8 Cdk8 "Cyclin-dependent kinase 8" [Aedes aegypti (taxid:7159)]

 Score = 1346 (478.9 bits), Expect = 1.7e-137, P = 1.7e-137
 Identities = 251/283 (88%), Positives = 259/283 (91%)

Query:     1 MDYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS 60
             MDYEFK+KT  ER KVEDLF+YEGCKVGRGTYGHVYKA RK+++DT+DYALKQIEGTGLS
Sbjct:     1 MDYEFKMKTQQERAKVEDLFEYEGCKVGRGTYGHVYKAHRKESNDTKDYALKQIEGTGLS 60

Query:    61 MSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXX 120
             MSACREIALLRELKHPNVINLI VFLSH DRKVWLLFDYAEHDLWHIIKFHRAAKA    
Sbjct:    61 MSACREIALLRELKHPNVINLIRVFLSHTDRKVWLLFDYAEHDLWHIIKFHRAAKATKKP 120

Query:   121 XXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
                      SLLYQILDGIHYLHSNWVLHRDLKPANILVMGEG ERGRVKIADMGFARLF
Sbjct:   121 VMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGNERGRVKIADMGFARLF 180

Query:   181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
             N PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED
Sbjct:   181 NAPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240

Query:   241 IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF 283
             IKTSNPYHHDQLDRIF+VMGFP +KDWEDIRKMPEH TL KDF
Sbjct:   241 IKTSNPYHHDQLDRIFNVMGFPQDKDWEDIRKMPEHHTLTKDF 283

GO:0000082 "G1/S transition of mitotic cell cycle" evidence=ISS

GO:0005634 "nucleus" evidence=ISS

GO:0006468 "protein phosphorylation" evidence=ISS

MGI|MGI:1196224 Cdk8 "cyclin-dependent kinase 8" [Mus musculus (taxid:10090)]

 Score = 1333 (474.3 bits), Expect = 4.1e-136, P = 4.1e-136
 Identities = 244/283 (86%), Positives = 261/283 (92%)

Query:     1 MDYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS 60
             MDY+FK+K S+ER +VEDLF+YEGCKVGRGTYGHVYKA+RKD  D +DYALKQIEGTG+S
Sbjct:     1 MDYDFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS 60

Query:    61 MSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXX 120
             MSACREIALLRELKHPNVI+L+ VFLSH DRKVWLLFDYAEHDLWHIIKFHRA+KAN   
Sbjct:    61 MSACREIALLRELKHPNVISLLKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKP 120

Query:   121 XXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
                      SLLYQILDGIHYLH+NWVLHRDLKPANILVMGEG ERGRVKIADMGFARLF
Sbjct:   121 VQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 180

Query:   181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
             N+PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED
Sbjct:   181 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240

Query:   241 IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF 283
             IKTSNPYHHDQLDRIF+VMGFP +KDWEDI+KMPEH TL+KDF
Sbjct:   241 IKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDF 283

GO:0000166 "nucleotide binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISO

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0008353 "RNA polymerase II carboxy-terminal domain kinase activity" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016592 "mediator complex" evidence=ISO;IDA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

UNIPROTKB|E2RMV5 CDK8 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 1328 (472.5 bits), Expect = 1.4e-135, P = 1.4e-135
 Identities = 244/283 (86%), Positives = 260/283 (91%)

Query:     1 MDYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS 60
             MDY+FK+K S+ER +VEDLF+YEGCKVGRGTYGHVYKA+RKD  D +DYALKQIEGTG+S
Sbjct:     1 MDYDFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS 60

Query:    61 MSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXX 120
             MSACREIALLRELKHPNVI+L  VFLSH DRKVWLLFDYAEHDLWHIIKFHRA+KAN   
Sbjct:    61 MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKP 120

Query:   121 XXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
                      SLLYQILDGIHYLH+NWVLHRDLKPANILVMGEG ERGRVKIADMGFARLF
Sbjct:   121 VQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 180

Query:   181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
             N+PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED
Sbjct:   181 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240

Query:   241 IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF 283
             IKTSNPYHHDQLDRIF+VMGFP +KDWEDI+KMPEH TL+KDF
Sbjct:   241 IKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDF 283

GO:0016592 "mediator complex" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|P49336 CDK8 "Cyclin-dependent kinase 8" [Homo sapiens (taxid:9606)]

 Score = 1328 (472.5 bits), Expect = 1.4e-135, P = 1.4e-135
 Identities = 244/283 (86%), Positives = 260/283 (91%)

Query:     1 MDYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS 60
             MDY+FK+K S+ER +VEDLF+YEGCKVGRGTYGHVYKA+RKD  D +DYALKQIEGTG+S
Sbjct:     1 MDYDFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS 60

Query:    61 MSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXX 120
             MSACREIALLRELKHPNVI+L  VFLSH DRKVWLLFDYAEHDLWHIIKFHRA+KAN   
Sbjct:    61 MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKP 120

Query:   121 XXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
                      SLLYQILDGIHYLH+NWVLHRDLKPANILVMGEG ERGRVKIADMGFARLF
Sbjct:   121 VQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 180

Query:   181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
             N+PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED
Sbjct:   181 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240

Query:   241 IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF 283
             IKTSNPYHHDQLDRIF+VMGFP +KDWEDI+KMPEH TL+KDF
Sbjct:   241 IKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDF 283

GO:0005524 "ATP binding" evidence=IEA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IEA

GO:0008353 "RNA polymerase II carboxy-terminal domain kinase activity" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0004672 "protein kinase activity" evidence=TAS

GO:0005634 "nucleus" evidence=IDA

GO:0016592 "mediator complex" evidence=IDA

GO:0005654 "nucleoplasm" evidence=TAS

GO:0006351 "transcription, DNA-dependent" evidence=TAS

GO:0006367 "transcription initiation from RNA polymerase II promoter" evidence=TAS

GO:0007179 "transforming growth factor beta receptor signaling pathway" evidence=TAS

GO:0007219 "Notch signaling pathway" evidence=TAS

GO:0010467 "gene expression" evidence=TAS

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=TAS

UNIPROTKB|E1C2T0 CDK8 "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 1324 (471.1 bits), Expect = 3.7e-135, P = 3.7e-135
 Identities = 243/283 (85%), Positives = 259/283 (91%)

Query:     1 MDYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS 60
             MDY+FK+K + ER +VEDLF+YEGCKVGRGTYGHVYKA+RKD  D +DYALKQIEGTG+S
Sbjct:     1 MDYDFKVKLTGERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS 60

Query:    61 MSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXX 120
             MSACREIALLRELKHPNVI+L  VFLSH DRKVWLLFDYAEHDLWHIIKFHRA+KAN   
Sbjct:    61 MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKP 120

Query:   121 XXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
                      SLLYQILDGIHYLH+NWVLHRDLKPANILVMGEG ERGRVKIADMGFARLF
Sbjct:   121 VQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 180

Query:   181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
             N+PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED
Sbjct:   181 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240

Query:   241 IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF 283
             IKTSNPYHHDQLDRIF+VMGFP +KDWEDI+KMPEH TL+KDF
Sbjct:   241 IKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDF 283

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0016592 "mediator complex" evidence=IEA

ZFIN|ZDB-GENE-030903-2 cdk8 "cyclin-dependent kinase 8" [Danio rerio (taxid:7955)]

 Score = 1324 (471.1 bits), Expect = 3.7e-135, P = 3.7e-135
 Identities = 243/283 (85%), Positives = 259/283 (91%)

Query:     1 MDYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS 60
             MDY+FK+K + ER +VEDLF+YEGCKVGRGTYGHVYKA+RKD  D +DYALKQIEGTG+S
Sbjct:     1 MDYDFKVKLTGERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS 60

Query:    61 MSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXX 120
             MSACREIALLRELKHPNVI+L  VFLSH DRKVWLLFDYAEHDLWHIIKFHRA+KAN   
Sbjct:    61 MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKP 120

Query:   121 XXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
                      SLLYQILDGIHYLH+NWVLHRDLKPANILVMGEG ERGRVKIADMGFARLF
Sbjct:   121 LQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 180

Query:   181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
             N+PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED
Sbjct:   181 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240

Query:   241 IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF 283
             IKTSNPYHHDQLDRIF+VMGFP +KDWEDI+KMPEH TL+KDF
Sbjct:   241 IKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDF 283

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0008353 "RNA polymerase II carboxy-terminal domain kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

UNIPROTKB|Q9BWU1 CDK19 "Cyclin-dependent kinase 19" [Homo sapiens (taxid:9606)]

 Score = 1318 (469.0 bits), Expect = 1.6e-134, P = 1.6e-134
 Identities = 244/283 (86%), Positives = 258/283 (91%)

Query:     1 MDYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS 60
             MDY+FK K + ER +VEDLF+YEGCKVGRGTYGHVYKARRKD  D ++YALKQIEGTG+S
Sbjct:     1 MDYDFKAKLAAERERVEDLFEYEGCKVGRGTYGHVYKARRKDGKDEKEYALKQIEGTGIS 60

Query:    61 MSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXX 120
             MSACREIALLRELKHPNVI L  VFLSH+DRKVWLLFDYAEHDLWHIIKFHRA+KAN   
Sbjct:    61 MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKP 120

Query:   121 XXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
                      SLLYQILDGIHYLH+NWVLHRDLKPANILVMGEG ERGRVKIADMGFARLF
Sbjct:   121 MQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 180

Query:   181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
             N+PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED
Sbjct:   181 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240

Query:   241 IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF 283
             IKTSNP+HHDQLDRIFSVMGFP +KDWEDIRKMPE+PTL KDF
Sbjct:   241 IKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDF 283

GO:0005524 "ATP binding" evidence=IEA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IEA

MGI|MGI:1925584 Cdk19 "cyclin-dependent kinase 19" [Mus musculus (taxid:10090)]

 Score = 1318 (469.0 bits), Expect = 1.6e-134, P = 1.6e-134
 Identities = 244/283 (86%), Positives = 258/283 (91%)

Query:     1 MDYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS 60
             MDY+FK K + ER +VEDLF+YEGCKVGRGTYGHVYKARRKD  D ++YALKQIEGTG+S
Sbjct:     1 MDYDFKAKLAAERERVEDLFEYEGCKVGRGTYGHVYKARRKDGKDEKEYALKQIEGTGIS 60

Query:    61 MSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXX 120
             MSACREIALLRELKHPNVI L  VFLSH+DRKVWLLFDYAEHDLWHIIKFHRA+KAN   
Sbjct:    61 MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKP 120

Query:   121 XXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
                      SLLYQILDGIHYLH+NWVLHRDLKPANILVMGEG ERGRVKIADMGFARLF
Sbjct:   121 MQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 180

Query:   181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
             N+PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED
Sbjct:   181 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240

Query:   241 IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF 283
             IKTSNP+HHDQLDRIFSVMGFP +KDWEDIRKMPE+PTL KDF
Sbjct:   241 IKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDF 283

GO:0000166 "nucleotide binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0051301 "cell division" evidence=IEA

ZFIN|ZDB-GENE-040724-19 cdk19 "cyclin-dependent kinase 19" [Danio rerio (taxid:7955)]

 Score = 1314 (467.6 bits), Expect = 4.2e-134, P = 4.2e-134
 Identities = 243/283 (85%), Positives = 258/283 (91%)

Query:     1 MDYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS 60
             MDY+FK K + ER +VEDLF+YEGCKVGRGTYGHVYKA+RKD  D ++YALKQIEGTG+S
Sbjct:     1 MDYDFKTKLAAERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS 60

Query:    61 MSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXX 120
             MSACREIALLRELKHPNVI L  VFLSH+DRKVWLLFDYAEHDLWHIIKFHRA+KAN   
Sbjct:    61 MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKP 120

Query:   121 XXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
                      SLLYQILDGIHYLH+NWVLHRDLKPANILVMGEG ERGRVKIADMGFARLF
Sbjct:   121 MQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 180

Query:   181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
             N+PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED
Sbjct:   181 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240

Query:   241 IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF 283
             IKTSNP+HHDQLDRIFSVMGFP +KDWEDIRKMPE+PTL KDF
Sbjct:   241 IKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDF 283

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

FB|FBgn0015618 Cdk8 "Cyclin-dependent kinase 8" [Drosophila melanogaster (taxid:7227)]

 Score = 1297 (461.6 bits), Expect = 2.7e-132, P = 2.7e-132
 Identities = 243/283 (85%), Positives = 256/283 (90%)

Query:     1 MDYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS 60
             MDY+FK+KT  ERTKVEDLF+YEGCKVGRGTYGHVYKA+ K+ SD ++YALKQI+GTGLS
Sbjct:     1 MDYDFKMKTQIERTKVEDLFNYEGCKVGRGTYGHVYKAKWKETSDGKEYALKQIDGTGLS 60

Query:    61 MSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXX 120
             MSACREIALLRELKH NVI LI VFLSHNDRKV+LL DYAEHDLWHIIKFHRAAKA    
Sbjct:    61 MSACREIALLRELKHQNVITLIRVFLSHNDRKVFLLIDYAEHDLWHIIKFHRAAKATKKQ 120

Query:   121 XXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
                      SLLYQILDGIHYLHSNWVLHRDLKPANILVMG+G ERGRVKIADMGFARLF
Sbjct:   121 VVVPRGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGDGNERGRVKIADMGFARLF 180

Query:   181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
             N PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED
Sbjct:   181 NAPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240

Query:   241 IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF 283
             IKTSNPYHHDQLDRIF+VMGFP +KDWEDI+KMPEH TL KDF
Sbjct:   241 IKTSNPYHHDQLDRIFNVMGFPQDKDWEDIKKMPEHHTLTKDF 283

GO:0004674 "protein serine/threonine kinase activity" evidence=NAS

GO:0006468 "protein phosphorylation" evidence=NAS;IDA

GO:0005634 "nucleus" evidence=IDA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=ISS

GO:0001104 "RNA polymerase II transcription cofactor activity" evidence=ISS

GO:0006367 "transcription initiation from RNA polymerase II promoter" evidence=ISS

GO:0016592 "mediator complex" evidence=ISS;IDA;IPI

GO:0007049 "cell cycle" evidence=IMP

GO:0005524 "ATP binding" evidence=IEA

GO:0045498 "sex comb development" evidence=IMP

GO:0022416 "chaeta development" evidence=IMP

GO:0036011 "imaginal disc-derived leg segmentation" evidence=IMP

GO:0007411 "axon guidance" evidence=IMP

GO:0007095 "mitotic G2 DNA damage checkpoint" evidence=IGI

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q8BWD8	CDK19_MOUSE	2, ., 7, ., 1, 1, ., 2, 2	0.8869	0.9725	0.5648	yes	N/A
O13958	SSN3_SCHPO	2, ., 7, ., 1, 1, ., 2, 3	0.4318	0.8213	0.6476	yes	N/A
A2QU77	SSN3_ASPNC	2, ., 7, ., 1, 1, ., 2, 3	0.4571	0.8831	0.6018	yes	N/A
Q9BWU1	CDK19_HUMAN	2, ., 7, ., 1, 1, ., 2, 2	0.8869	0.9725	0.5637	yes	N/A
P90866	CDK8_CAEEL	2, ., 7, ., 1, 1, ., 2, 3	0.6666	0.9656	0.4778	yes	N/A
Q95YH0	CDK8_DICDI	2, ., 7, ., 1, 1, ., 2, 3	0.5054	0.8900	0.6815	yes	N/A
Q8JH47	CDK8_DANRE	2, ., 7, ., 1, 1, ., 2, 3	0.8833	0.9725	0.6099	no	N/A
Q9VT57	CDK8_DROME	2, ., 7, ., 1, 1, ., 2, 3	0.8904	0.9725	0.6233	yes	N/A
Q6CCB0	SSN3_YARLI	2, ., 7, ., 1, 1, ., 2, 3	0.4580	0.9072	0.6518	yes	N/A
P49336	CDK8_HUMAN	2, ., 7, ., 1, 1, ., 2, 3	0.8939	0.9725	0.6099	no	N/A
Q2UC58	SSN3_ASPOR	2, ., 7, ., 1, 1, ., 2, 3	0.45	0.8831	0.6222	yes	N/A
Q4WYR6	SSN3_ASPFU	2, ., 7, ., 1, 1, ., 2, 3	0.4607	0.8831	0.6032	yes	N/A
Q17IE8	CDK8_AEDAE	2, ., 7, ., 1, 1, ., 2, 3	0.9293	0.9725	0.5648	N/A	N/A
Q8R3L8	CDK8_MOUSE	2, ., 7, ., 1, 1, ., 2, 3	0.8939	0.9725	0.6099	no	N/A
Q84TI6	CDKE1_ARATH	2, ., 7, ., 1, 1, ., 2, 3	0.5098	0.8316	0.5148	yes	N/A
Q336M2	CDKE1_ORYSJ	2, ., 7, ., 1, 1, ., 2, 3	0.5190	0.8350	0.5115	yes	N/A
Q5BAE1	SSN3_EMENI	2, ., 7, ., 1, 1, ., 2, 3	0.4535	0.8831	0.6032	yes	N/A
Q6P3N6	CDK8_XENTR	2, ., 7, ., 1, 1, ., 2, 3	0.8904	0.9725	0.6099	yes	N/A

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.22	0.946
3rd Layer	2.7.11.23	0.946
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.963

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	291
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	0.0
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	0.0
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	0.0
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-107
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-82
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	6e-81
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-78
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-72
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	8e-72
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	6e-69
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-68
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	4e-68
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-67
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-65
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-64
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-64
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	4e-64
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-62
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	5e-61
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	5e-61
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	5e-61
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-60
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-58
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	4e-56
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-55
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-55
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-55
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-54
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-54
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-53
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	4e-52
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	8e-51
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	5e-50
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-47
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-46
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-44
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-44
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-43
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	4e-43
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-42
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-42
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-42
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-42
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-41
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	9e-41
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-39
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-39
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-37
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-36
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-36
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	8e-36
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-35
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-35
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	9e-35
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-34
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	5e-34
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-33
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-33
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-33
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-31
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	9e-31
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-30
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-29
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	9e-29
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	9e-29
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-28
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-27
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-26
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-26
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-26
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-26
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-25
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-25
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-25
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	4e-25
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-25
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-24
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-24
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-24
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	7e-24
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-23
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-23
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-23
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	5e-23
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	8e-23
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-22
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-22
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-22
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	4e-22
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-21
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-21
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-21
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-21
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-21
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	7e-21
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-20
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-20
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-19
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-19
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-19
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-19
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	9e-19
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-18
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-18
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-18
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-18
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-18
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-18
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-18
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	5e-18
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	7e-18
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-17
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-17
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-17
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-17
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-17
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	4e-17
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-16
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-16
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	3e-16
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-16
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-16
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	5e-16
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	9e-16
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-15
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-15
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-15
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	5e-15
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-14
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-14
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	5e-14
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	7e-14
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	7e-14
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	8e-14
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-13
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-13
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-13
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-13
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-13
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	5e-13
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	5e-13
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	5e-13
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	6e-13
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	7e-13
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	9e-13
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-12
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-12
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-12
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-12
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-12
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-12
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-12
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-12
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-12
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-12
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-12
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	7e-12
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	9e-12
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-11
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-11
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-11
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-11
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-11
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-11
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-11
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-11
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-11
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	4e-11
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	7e-11
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	8e-11
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	8e-11
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-10
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-10
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-10
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-10
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-10
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-10
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-10
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-10
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	5e-10
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	5e-10
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	5e-10
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	7e-10
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	7e-10
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	9e-10
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-09
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-09
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-09
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-09
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-09
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-09
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-09
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-09
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-09
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-09
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-09
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-09
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-09
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-09
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	4e-09
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	5e-09
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	5e-09
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	6e-09
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	7e-09
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	7e-09
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	7e-09
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	7e-09
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	7e-09
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	8e-09
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	9e-09
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	9e-09
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-08
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-08
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-08
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-08
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-08
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-08
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-08
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-08
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-08
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-08
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-08
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-08
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-08
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-08
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	4e-08
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-08
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	4e-08
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	4e-08
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	5e-08
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	5e-08
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	5e-08
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	7e-08
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	7e-08
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-07
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-07
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-07
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-07
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-07
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-07
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-07
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-07
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-07
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-07
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	4e-07
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-07
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	5e-07
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	5e-07
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	8e-07
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	8e-07
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	9e-07
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-06
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-06
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-06
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-06
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-06
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	2e-06
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-06
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-06
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-06
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-06
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	4e-06
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	4e-06
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	4e-06
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	6e-06
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	9e-06
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	9e-06
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-05
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-05
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-05
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-05
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	6e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	6e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	6e-05
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	7e-05
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	8e-05
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	8e-05
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	9e-05
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-04
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-04
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-04
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-04
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	5e-04
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	5e-04
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	8e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	0.001
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	0.002
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	0.003
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	0.004
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.004
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	0.004

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  520 bits (1341), Expect = 0.0
 Identities = 194/270 (71%), Positives = 222/270 (82%), Gaps = 10/270 (3%)

Query: 19  LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEG-----TGLSMSACREIALLREL 73
            ++ EGC +GRGTYG VYKA+RK+  D ++YA+K+ +G     TG+S SACREIALLREL
Sbjct: 1   KYEIEGC-IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL 59

Query: 74  KHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLY 133
           KH NV++L+ VFL H D+ V+LLFDYAEHDLW IIKFHR AK     V +P  MVKSLL+
Sbjct: 60  KHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKR----VSIPPSMVKSLLW 115

Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           QIL+G+HYLHSNWVLHRDLKPANILVMGEG ERG VKI D+G ARLFN PLKPLADLDPV
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175

Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 253
           VVT WYRAPELLLGARHYTKAIDIWAIGCIFAELLT EPIF  R+  IK SNP+  DQL+
Sbjct: 176 VVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235

Query: 254 RIFSVMGFPLEKDWEDIRKMPEHPTLLKDF 283
           RIF V+G P EKDW DI+KMPE+ TL+KDF
Sbjct: 236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDF 265

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score =  515 bits (1328), Expect = 0.0
 Identities = 242/265 (91%), Positives = 255/265 (96%)

Query: 19  LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNV 78
           LF+YEGCKVGRGTYGHVYKA+RKD  D RDYALKQIEGTG+SMSACREIALLRELKHPNV
Sbjct: 1   LFEYEGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNV 60

Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDG 138
           I+L  VFLSH DRKVWLLFDYAEHDLWHIIKFHRA+KANKKPV +P+GMVKSLLYQILDG
Sbjct: 61  ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120

Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           IHYLH+NWVLHRDLKPANILVMGEG ERGRVKIADMGFARLFN+PLKPLADLDPVVVTFW
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180

Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF+V
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 240

Query: 259 MGFPLEKDWEDIRKMPEHPTLLKDF 283
           MGFP +KDWEDI+KMPEH TL+KDF
Sbjct: 241 MGFPADKDWEDIKKMPEHSTLMKDF 265

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score =  514 bits (1324), Expect = 0.0
 Identities = 239/265 (90%), Positives = 254/265 (95%)

Query: 19  LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNV 78
           LF+YEGCKVGRGTYGHVYKA+RKD  D ++YALKQIEGTG+SMSACREIALLRELKHPNV
Sbjct: 1   LFEYEGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNV 60

Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDG 138
           I L  VFLSH+DRKVWLLFDYAEHDLWHIIKFHRA+KANKKP+ +P+ MVKSLLYQILDG
Sbjct: 61  IALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG 120

Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           IHYLH+NWVLHRDLKPANILVMGEG ERGRVKIADMGFARLFN+PLKPLADLDPVVVTFW
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180

Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP+HHDQLDRIFSV
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV 240

Query: 259 MGFPLEKDWEDIRKMPEHPTLLKDF 283
           MGFP +KDWEDIRKMPE+PTL KDF
Sbjct: 241 MGFPADKDWEDIRKMPEYPTLQKDF 265

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  313 bits (804), Expect = e-107
 Identities = 110/254 (43%), Positives = 161/254 (63%), Gaps = 32/254 (12%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG VYKAR K   +    ALK+I    E  G+  +A REI+LL+ELKHPN++ L
Sbjct: 6   KLGEGTYGVVYKARDKKTGEI--VALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKL 63

Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHY 141
           + V   H +RK++L+F+Y + DL   +         K+P  +   ++KS++YQ+L G+ Y
Sbjct: 64  LDVI--HTERKLYLVFEYCDMDLKKYLD--------KRPGPLSPNLIKSIMYQLLRGLAY 113

Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            HS+ +LHRDLKP NIL+  +G+    +K+AD G AR F  PL+        VVT WYRA
Sbjct: 114 CHSHRILHRDLKPQNILINRDGV----LKLADFGLARAFGIPLRTY---THEVVTLWYRA 166

Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           PE+LLG++HY+ A+DIW++GCIFAE++T +P+F    E          DQL +IF ++G 
Sbjct: 167 PEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE---------IDQLFKIFQILGT 217

Query: 262 PLEKDWEDIRKMPE 275
           P E+ W  + K+P+
Sbjct: 218 PTEESWPGVTKLPD 231

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  249 bits (638), Expect = 2e-82
 Identities = 94/254 (37%), Positives = 143/254 (56%), Gaps = 29/254 (11%)

Query: 25  CKVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVIN 80
            ++G GTYG VYKAR K   +    ALK+I    E  G  ++A REI LL++L+HPN++ 
Sbjct: 5   AQIGEGTYGQVYKARNKKTGEL--VALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVR 62

Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIH 140
           L  +  S     ++++F+Y +HDL  ++        +   V   +  +K  + Q+L+G+ 
Sbjct: 63  LKEIVTSKGKGSIYMVFEYMDHDLTGLL--------DSPEVKFTESQIKCYMKQLLEGLQ 114

Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YLHSN +LHRD+K +NIL+       G +K+AD G AR +        D    V+T WYR
Sbjct: 115 YLHSNGILHRDIKGSNILINN----DGVLKLADFGLARPYTKRNSA--DYTNRVITLWYR 168

Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
            PELLLGA  Y   +D+W++GCI AEL   +PIF    E          +QL++IF + G
Sbjct: 169 PPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE---------LEQLEKIFELCG 219

Query: 261 FPLEKDWEDIRKMP 274
            P +++W  + K+P
Sbjct: 220 SPTDENWPGVSKLP 233

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  246 bits (630), Expect = 6e-81
 Identities = 112/261 (42%), Positives = 151/261 (57%), Gaps = 36/261 (13%)

Query: 22  YE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQI-------EGTGLSMSACREIALLREL 73
           YE G K+G GTY  VYKAR  D    R  A+K+I          G++ +A REI LL+EL
Sbjct: 2   YEKGKKLGEGTYAVVYKAR--DKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL 59

Query: 74  KHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLY 133
           KHPN+I L+ VF       + L+F++ E DL  +IK       +K  V+ P   +KS + 
Sbjct: 60  KHPNIIGLLDVFGH--KSNINLVFEFMETDLEKVIK-------DKSIVLTP-ADIKSYML 109

Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
             L G+ YLHSNW+LHRDLKP N+L+  +G+    +K+AD G AR F +P + +      
Sbjct: 110 MTLRGLEYLHSNWILHRDLKPNNLLIASDGV----LKLADFGLARSFGSPNRKMT---HQ 162

Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 253
           VVT WYRAPELL GARHY   +D+W++GCIFAELL   P       DI        DQL 
Sbjct: 163 VVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLP-GDSDI--------DQLG 213

Query: 254 RIFSVMGFPLEKDWEDIRKMP 274
           +IF  +G P E++W  +  +P
Sbjct: 214 KIFEALGTPTEENWPGVTSLP 234

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  239 bits (611), Expect = 3e-78
 Identities = 104/253 (41%), Positives = 156/253 (61%), Gaps = 30/253 (11%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           ++  GTYG VY+AR  D       ALK++    E  G  +++ REI +L +L+HPN++ +
Sbjct: 12  RIEEGTYGVVYRAR--DKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTV 69

Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHY 141
             V +  N  K++++ +Y EHDL  +++        K+P +  +  VK L+ Q+L G+ +
Sbjct: 70  KEVVVGSNLDKIYMVMEYVEHDLKSLMETM------KQPFLQSE--VKCLMLQLLSGVAH 121

Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
           LH NW+LHRDLK +N+L+      RG +KI D G AR + +PLKP      +VVT WYRA
Sbjct: 122 LHDNWILHRDLKTSNLLLN----NRGILKICDFGLAREYGSPLKPYT---QLVVTLWYRA 174

Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           PELLLGA+ Y+ AID+W++GCIFAELLT +P+F  + E          DQL++IF ++G 
Sbjct: 175 PELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE---------IDQLNKIFKLLGT 225

Query: 262 PLEKDWEDIRKMP 274
           P EK W    ++P
Sbjct: 226 PTEKIWPGFSELP 238

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  224 bits (573), Expect = 1e-72
 Identities = 108/255 (42%), Positives = 150/255 (58%), Gaps = 33/255 (12%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG VYKAR  D       ALK+I    E  G+  +A REI+LL+EL HPN++ L
Sbjct: 6   KIGEGTYGVVYKAR--DKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRL 63

Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMV-PKGMVKSLLYQILDGIH 140
           + V   H++ K++L+F++ + DL   +        +  P+      ++KS LYQ+L GI 
Sbjct: 64  LDVV--HSENKLYLVFEFLDLDLKKYM--------DSSPLTGLDPPLIKSYLYQLLQGIA 113

Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           Y HS+ VLHRDLKP N+L+  EG     +K+AD G AR F  P++        VVT WYR
Sbjct: 114 YCHSHRVLHRDLKPQNLLIDREGA----LKLADFGLARAFGVPVRTYTH---EVVTLWYR 166

Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           APE+LLG+R Y+  +DIW+IGCIFAE++   P+F    E I        DQL RIF  +G
Sbjct: 167 APEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE-I--------DQLFRIFRTLG 217

Query: 261 FPLEKDWEDIRKMPE 275
            P E  W  +  +P+
Sbjct: 218 TPDEDVWPGVTSLPD 232

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  222 bits (568), Expect = 8e-72
 Identities = 104/249 (41%), Positives = 151/249 (60%), Gaps = 32/249 (12%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG VYKAR  D       A+K+I    E  G+  +A REI LL+EL HPN+I L
Sbjct: 6   KIGEGTYGVVYKAR--DKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKL 63

Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHY 141
           + VF   +   ++L+F++ + DL+ +IK        ++ +  P+ ++KS LYQ+L G+ +
Sbjct: 64  LDVF--RHKGDLYLVFEFMDTDLYKLIK------DRQRGL--PESLIKSYLYQLLQGLAF 113

Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            HS+ +LHRDLKP N+L+  EG+    +K+AD G AR F +P++P       VVT WYRA
Sbjct: 114 CHSHGILHRDLKPENLLINTEGV----LKLADFGLARSFGSPVRPYTHY---VVTRWYRA 166

Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           PELLLG + Y+  +DIW++GCIFAELL+  P+F  + E          DQL +IF  +G 
Sbjct: 167 PELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE---------IDQLFKIFRTLGT 217

Query: 262 PLEKDWEDI 270
           P  + W   
Sbjct: 218 PDPEVWPKF 226

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  215 bits (549), Expect = 6e-69
 Identities = 101/251 (40%), Positives = 145/251 (57%), Gaps = 37/251 (14%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELK---HPNVI 79
           +G G YG VYKAR  D +  R  ALK++       G+ +S  REIALL++L+   HPN++
Sbjct: 7   IGEGAYGTVYKAR--DLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64

Query: 80  NLISVFL-SHNDR--KVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQIL 136
            L+ V      DR  K+ L+F++ + DL   +          KP + P   +K L+ Q+L
Sbjct: 65  RLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKC------PKPGL-PPETIKDLMRQLL 117

Query: 137 DGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVT 196
            G+ +LHS+ ++HRDLKP NILV       G+VKIAD G AR+++  +     L  VVVT
Sbjct: 118 RGVDFLHSHRIVHRDLKPQNILVT----SDGQVKIADFGLARIYSFEMA----LTSVVVT 169

Query: 197 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 256
            WYRAPE+LL +  Y   +D+W++GCIFAEL    P+F     +         DQLD+IF
Sbjct: 170 LWYRAPEVLLQS-SYATPVDMWSVGCIFAELFRRRPLF-RGTSEA--------DQLDKIF 219

Query: 257 SVMGFPLEKDW 267
            V+G P E++W
Sbjct: 220 DVIGLPSEEEW 230

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  213 bits (545), Expect = 4e-68
 Identities = 100/253 (39%), Positives = 144/253 (56%), Gaps = 30/253 (11%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           ++G GTYG VY+AR   + +    ALK++    E  G+ +S+ REI LL  L+HPN++ L
Sbjct: 14  RIGEGTYGIVYRARDTTSGEI--VALKKVRMDNERDGIPISSLREITLLLNLRHPNIVEL 71

Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHY 141
             V +  +   ++L+ +Y E DL        A+  +  P    +  VK L+ Q+L G+ Y
Sbjct: 72  KEVVVGKHLDSIFLVMEYCEQDL--------ASLLDNMPTPFSESQVKCLMLQLLRGLQY 123

Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
           LH N+++HRDLK +N+L+  +G     +KIAD G AR +  P KP+    P VVT WYRA
Sbjct: 124 LHENFIIHRDLKVSNLLLTDKGC----LKIADFGLARTYGLPAKPMT---PKVVTLWYRA 176

Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           PELLLG   YT AID+WA+GCI AELL  +P+   + E          +QLD I  ++G 
Sbjct: 177 PELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE---------IEQLDLIIQLLGT 227

Query: 262 PLEKDWEDIRKMP 274
           P E  W     +P
Sbjct: 228 PNESIWPGFSDLP 240

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  212 bits (541), Expect = 4e-68
 Identities = 92/271 (33%), Positives = 131/271 (48%), Gaps = 44/271 (16%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQI---EGTGLSMSACREIALLRELKHPNVIN 80
             K+G G++G VY AR K     +  A+K I   +         REI +L++LKHPN++ 
Sbjct: 4   LEKLGEGSFGKVYLARDKKTG--KLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVR 61

Query: 81  LISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGI 139
           L  VF   ++ K++L+ +Y E  DL+ ++K             + +   +  L QIL  +
Sbjct: 62  LYDVF--EDEDKLYLVMEYCEGGDLFDLLKKRGR---------LSEDEARFYLRQILSAL 110

Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
            YLHS  ++HRDLKP NIL+     E G VK+AD G AR  +   K    L   V T  Y
Sbjct: 111 EYLHSKGIVHRDLKPENILLD----EDGHVKLADFGLARQLDPGEK----LTTFVGTPEY 162

Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVM 259
            APE+LLG + Y KA+DIW++G I  ELLT +P F               DQL  +F  +
Sbjct: 163 MAPEVLLG-KGYGKAVDIWSLGVILYELLTGKPPF------------PGDDQLLELFKKI 209

Query: 260 GFPLEKDWEDIRKMPEHPTLLKDFNEQICKM 290
           G P          +       KD    I K+
Sbjct: 210 GKPKPPFPPPEWDISPE---AKDL---IRKL 234

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  211 bits (538), Expect = 2e-67
 Identities = 106/257 (41%), Positives = 153/257 (59%), Gaps = 31/257 (12%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG VYKAR K   +    ALK+I    E  G+  +A REI+LL+EL HPN++ L
Sbjct: 7   KIGEGTYGVVYKARNKLTGEV--VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 64

Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHY 141
           + V   H + K++L+F++   DL    KF  A+  +     +P  ++KS L+Q+L G+ +
Sbjct: 65  LDVI--HTENKLYLVFEFLHQDL---KKFMDASPLSG----IPLPLIKSYLFQLLQGLAF 115

Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            HS+ VLHRDLKP N+L+  EG     +K+AD G AR F  P++        VVT WYRA
Sbjct: 116 CHSHRVLHRDLKPQNLLINTEG----AIKLADFGLARAFGVPVRTYTH---EVVTLWYRA 168

Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           PE+LLG ++Y+ A+DIW++GCIFAE++T   +F    E          DQL RIF  +G 
Sbjct: 169 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---------DQLFRIFRTLGT 219

Query: 262 PLEKDWEDIRKMPEHPT 278
           P E  W  +  +P++  
Sbjct: 220 PDEVVWPGVTSLPDYKP 236

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  207 bits (528), Expect = 1e-65
 Identities = 111/275 (40%), Positives = 152/275 (55%), Gaps = 42/275 (15%)

Query: 19  LFDYE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLREL 73
           L DYE   K+G GT+G VYKAR+      R  ALK+I    E  G  ++A REI +L++L
Sbjct: 7   LRDYEILGKLGEGTFGEVYKARQIKTG--RVVALKKILMHNEKDGFPITALREIKILKKL 64

Query: 74  KHPNVINLISVFLSHNDRK------VWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGM 127
           KHPNV+ LI + +   D+       V+++  Y +HDL  +++           V + +  
Sbjct: 65  KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPS--------VKLTESQ 116

Query: 128 VKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF-NNPLKP 186
           +K  + Q+L+GI+YLH N +LHRD+K ANIL+  +GI    +KIAD G AR +   P  P
Sbjct: 117 IKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGI----LKIADFGLARPYDGPPPNP 172

Query: 187 -------LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
                        +VVT WYR PELLLG R YT A+DIW IGC+FAE+ T  PI    + 
Sbjct: 173 KGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQ-GKS 231

Query: 240 DIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMP 274
           DI        DQL  IF + G P E+ W   R +P
Sbjct: 232 DI--------DQLHLIFKLCGTPTEETWPGWRSLP 258

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  202 bits (517), Expect = 2e-64
 Identities = 95/270 (35%), Positives = 129/270 (47%), Gaps = 40/270 (14%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMS----ACREIALLRELKHPNVINL 81
           K+G G++G VYKA+ K        A+K ++           A REI +LR L HPN++ L
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKI--VAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRL 63

Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIH 140
           I  F   +   ++L+ +Y E  DL+  +              + +   K +  QIL G+ 
Sbjct: 64  IDAF--EDKDHLYLVMEYCEGGDLFDYLSRGGP---------LSEDEAKKIALQILRGLE 112

Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YLHSN ++HRDLKP NIL+     E G VKIAD G A+      K  + L   V T WY 
Sbjct: 113 YLHSNGIIHRDLKPENILLD----ENGVVKIADFGLAKKLL---KSSSSLTTFVGTPWYM 165

Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           APE+LLG   Y   +D+W++G I  ELLT +P F         S     DQL  I  ++G
Sbjct: 166 APEVLLGGNGYGPKVDVWSLGVILYELLTGKPPF---------SGENILDQLQLIRRILG 216

Query: 261 FPLEKDWEDIRKMPEHPTLLKDFNEQICKM 290
            PLE D        E     KD    I K 
Sbjct: 217 PPLEFDEPKWSSGSE---EAKDL---IKKC 240

Length = 260

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  203 bits (517), Expect = 3e-64
 Identities = 105/256 (41%), Positives = 147/256 (57%), Gaps = 33/256 (12%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI-----EGTGLSMSACREIALLRELKHPNVIN 80
           K+G GTY  VYK R +   +    ALK+I     EGT    +A REI+L++ELKH N++ 
Sbjct: 7   KLGEGTYATVYKGRNRTTGEI--VALKEIHLDAEEGT--PSTAIREISLMKELKHENIVR 62

Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIH 140
           L  V   H + K+ L+F+Y + DL   +  H    A      +    VKS  YQ+L GI 
Sbjct: 63  LHDVI--HTENKLMLVFEYMDKDLKKYMDTHGVRGA------LDPNTVKSFTYQLLKGIA 114

Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           + H N VLHRDLKP N+L+      RG +K+AD G AR F  P+   ++    VVT WYR
Sbjct: 115 FCHENRVLHRDLKPQNLLINK----RGELKLADFGLARAFGIPVNTFSN---EVVTLWYR 167

Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           AP++LLG+R Y+ +IDIW++GCI AE++T  P+F     +         DQL +IF +MG
Sbjct: 168 APDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE---------DQLLKIFRIMG 218

Query: 261 FPLEKDWEDIRKMPEH 276
            P E  W  I ++PE+
Sbjct: 219 TPTESTWPGISQLPEY 234

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  202 bits (516), Expect = 4e-64
 Identities = 103/255 (40%), Positives = 149/255 (58%), Gaps = 30/255 (11%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG VYK R K        A+K+I    E  G+  +A REI+LL+EL+HPN++ L
Sbjct: 7   KIGEGTYGVVYKGRNKKTGQI--VAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCL 64

Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHY 141
             V +  +  +++L+F++   DL    K+  +    +    +   +VKS LYQIL GI +
Sbjct: 65  QDVLMQES--RLYLIFEFLSMDL---KKYLDSLPKGQ---YMDAELVKSYLYQILQGILF 116

Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            HS  VLHRDLKP N+L+  +G+    +K+AD G AR F  P++        VVT WYRA
Sbjct: 117 CHSRRVLHRDLKPQNLLIDNKGV----IKLADFGLARAFGIPVRVYTH---EVVTLWYRA 169

Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           PE+LLG+  Y+  +DIW+IG IFAE+ T +P+FH   E          DQL RIF ++G 
Sbjct: 170 PEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI---------DQLFRIFRILGT 220

Query: 262 PLEKDWEDIRKMPEH 276
           P E  W  +  +P++
Sbjct: 221 PTEDVWPGVTSLPDY 235

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  198 bits (506), Expect = 1e-62
 Identities = 92/253 (36%), Positives = 136/253 (53%), Gaps = 31/253 (12%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGT----GLSMSACREIALLRELKHPNVINL 81
           ++G G +G V+KA+ ++  +T   ALK++       G+   A REI  L+  +HP V+ L
Sbjct: 7   RIGEGAHGIVFKAKDRETGET--VALKKVALRRLEGGIPNQALREIKALQACQHPYVVKL 64

Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHY 141
           + VF   +     L+ +Y   DL  +++             +P+  VKS +  +L G+ Y
Sbjct: 65  LDVFP--HGSGFVLVMEYMPSDLSEVLRDEERP--------LPEAQVKSYMRMLLKGVAY 114

Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
           +H+N ++HRDLKPAN+L+       G +KIAD G ARLF+     L      V T WYRA
Sbjct: 115 MHANGIMHRDLKPANLLIS----ADGVLKIADFGLARLFSEEEPRL--YSHQVATRWYRA 168

Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           PELL GAR Y   +D+WA+GCIFAELL   P+F     DI        +QL  +F  +G 
Sbjct: 169 PELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGE-NDI--------EQLAIVFRTLGT 219

Query: 262 PLEKDWEDIRKMP 274
           P E+ W  +  +P
Sbjct: 220 PNEETWPGLTSLP 232

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  195 bits (496), Expect = 5e-61
 Identities = 106/259 (40%), Positives = 158/259 (61%), Gaps = 38/259 (14%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG VYKAR +  ++T   ALK+I    E  G+  +A REI+LL+E++H N++ L
Sbjct: 9   KIGEGTYGVVYKARDRVTNET--IALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66

Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFH--RAAKANKKPVMVPKGMVKSLLYQILDGI 139
             V   H++++++L+F+Y + DL    K H   +    K P ++     K+ LYQIL GI
Sbjct: 67  QDVV--HSEKRLYLVFEYLDLDL----KKHMDSSPDFAKNPRLI-----KTYLYQILRGI 115

Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGR--VKIADMGFARLFNNPLKPLADLDPVVVTF 197
            Y HS+ VLHRDLKP N+L     I+R    +K+AD G AR F  P++        VVT 
Sbjct: 116 AYCHSHRVLHRDLKPQNLL-----IDRRTNALKLADFGLARAFGIPVRTFTH---EVVTL 167

Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFS 257
           WYRAPE+LLG+RHY+  +DIW++GCIFAE++  +P+F    E          D+L +IF 
Sbjct: 168 WYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI---------DELFKIFR 218

Query: 258 VMGFPLEKDWEDIRKMPEH 276
           ++G P E+ W  +  +P++
Sbjct: 219 ILGTPNEETWPGVTSLPDY 237

Length = 294

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  194 bits (496), Expect = 5e-61
 Identities = 100/259 (38%), Positives = 152/259 (58%), Gaps = 33/259 (12%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG V+KA+ ++  +    ALK++    +  G+  SA REI LL+ELKH N++ L
Sbjct: 7   KIGEGTYGTVFKAKNRETHEI--VALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 64

Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHY 141
             V   H+D+K+ L+F+Y + DL    K+  +   +  P      +VKS ++Q+L G+ +
Sbjct: 65  YDVL--HSDKKLTLVFEYCDQDL---KKYFDSCNGDIDP-----EIVKSFMFQLLKGLAF 114

Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            HS+ VLHRDLKP N+L+       G +K+AD G AR F  P++  +     VVT WYR 
Sbjct: 115 CHSHNVLHRDLKPQNLLINK----NGELKLADFGLARAFGIPVRCYS---AEVVTLWYRP 167

Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           P++L GA+ Y+ +ID+W+ GCIFAEL  +  P+F     D         DQL RIF ++G
Sbjct: 168 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD---------DQLKRIFRLLG 218

Query: 261 FPLEKDWEDIRKMPEHPTL 279
            P E+ W  + K+P++   
Sbjct: 219 TPTEESWPGVSKLPDYKPY 237

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  196 bits (500), Expect = 5e-61
 Identities = 97/253 (38%), Positives = 131/253 (51%), Gaps = 31/253 (12%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC----REIALLRELKHPNVINLI 82
           +G G YG V  A   D    R  A+K+I      +       REI LLR L+H N+I L+
Sbjct: 8   IGSGAYGVVCSA--VDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLL 65

Query: 83  SVFL---SHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGI 139
            +       +   V+++ +  E DL  +IK       + +P+      ++  LYQIL G+
Sbjct: 66  DILRPPSPEDFNDVYIVTELMETDLHKVIK-------SPQPLTDDH--IQYFLYQILRGL 116

Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
            YLHS  V+HRDLKP+NILV         +KI D G AR  +        L   VVT WY
Sbjct: 117 KYLHSANVIHRDLKPSNILVN----SNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWY 172

Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVM 259
           RAPELLL +  YTKAIDIW++GCIFAELLT +P+F          +     QL+ I  V+
Sbjct: 173 RAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLF-------PGRDYID--QLNLIVEVL 223

Query: 260 GFPLEKDWEDIRK 272
           G P E+D + I  
Sbjct: 224 GTPSEEDLKFITS 236

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  192 bits (490), Expect = 4e-60
 Identities = 92/241 (38%), Positives = 127/241 (52%), Gaps = 33/241 (13%)

Query: 25  CKVGRGTYGHVYKARRKDNSDTRDYALK---QIEGTGLSM-SACREIALLRELKHPNVIN 80
             VG G YG V K R K        A+K   + E       +A RE+ +LR+L+H N++N
Sbjct: 7   GVVGEGAYGVVLKCRNKATG--EIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVN 64

Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIH 140
           L   F      +++L+F+Y E  L  +++          P  +P   V+S ++Q+L  I 
Sbjct: 65  LKEAFRR--KGRLYLVFEYVERTLLELLE--------ASPGGLPPDAVRSYIWQLLQAIA 114

Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPLKPLADLDPVVVTFWY 199
           Y HS+ ++HRD+KP NILV     E G +K+ D GFAR L   P  PL D    V T WY
Sbjct: 115 YCHSHNIIHRDIKPENILVS----ESGVLKLCDFGFARALRARPASPLTDY---VATRWY 167

Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVM 259
           RAPELL+G  +Y K +D+WAIGCI AELL  EP+F    +          DQL  I   +
Sbjct: 168 RAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD---------IDQLYLIQKCL 218

Query: 260 G 260
           G
Sbjct: 219 G 219

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  188 bits (479), Expect = 2e-58
 Identities = 96/265 (36%), Positives = 146/265 (55%), Gaps = 40/265 (15%)

Query: 25  CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC---REIALLRELK-HPNVIN 80
            ++G GT+G VY AR K+  +    A+K+++    S   C   RE+  LR+L  HPN++ 
Sbjct: 5   KQLGDGTFGSVYLARNKETGELV--AIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVK 62

Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIH 140
           L  VF  +++  ++ +F+Y E +L+ ++K       ++K     + +++S++YQIL G+ 
Sbjct: 63  LKEVFRENDE--LYFVFEYMEGNLYQLMK-------DRKGKPFSESVIRSIIYQILQGLA 113

Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPLKPLADLDPVVVTFWY 199
           ++H +   HRDLKP N+LV G  +    VKIAD G AR + + P  P  D    V T WY
Sbjct: 114 HIHKHGFFHRDLKPENLLVSGPEV----VKIADFGLAREIRSRP--PYTDY---VSTRWY 164

Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVM 259
           RAPE+LL +  Y+  +DIWA+GCI AEL T  P+F    E          DQL +I SV+
Sbjct: 165 RAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSE---------IDQLYKICSVL 215

Query: 260 GFPLEKDWEDIRKMPEHPTLLKDFN 284
           G P ++DW      PE   L     
Sbjct: 216 GTPTKQDW------PEGYKLASKLG 234

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  182 bits (465), Expect = 4e-56
 Identities = 86/219 (39%), Positives = 124/219 (56%), Gaps = 25/219 (11%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G+GT+G V+KAR K        ALK++    E  G  ++A REI +L+ LKH NV+NL
Sbjct: 19  KIGQGTFGEVFKARHKKTKQI--VALKKVLMENEKEGFPITALREIKILQLLKHENVVNL 76

Query: 82  ISVFLS-----HNDR-KVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQI 135
           I +  +     +  +   +L+F++ EHDL        A   + K V      +K ++  +
Sbjct: 77  IEICRTKATPYNRYKGSFYLVFEFCEHDL--------AGLLSNKNVKFTLSEIKKVMKML 128

Query: 136 LDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADL-DPVV 194
           L+G++Y+H N +LHRD+K ANIL+  +GI    +K+AD G AR F+       +     V
Sbjct: 129 LNGLYYIHRNKILHRDMKAANILITKDGI----LKLADFGLARAFSLSKNSKPNRYTNRV 184

Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI 233
           VT WYR PELLLG R Y   ID+W  GCI AE+ T  PI
Sbjct: 185 VTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPI 223

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  182 bits (465), Expect = 1e-55
 Identities = 99/262 (37%), Positives = 142/262 (54%), Gaps = 48/262 (18%)

Query: 25  CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-GLSMSA---CREIALLRELK-HPNVI 79
            K+G+G YG V+KA  +   +    ALK+I      +  A    REI  L+EL  HPN++
Sbjct: 13  QKLGKGAYGIVWKAIDRRTKEV--VALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIV 70

Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKAN------KKPVMVPKGMVKSLLY 133
            L++V  + ND+ ++L+F+Y E DL      H   +AN      K+ +M          Y
Sbjct: 71  KLLNVIKAENDKDIYLVFEYMETDL------HAVIRANILEDVHKRYIM----------Y 114

Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF----NNPLKPLAD 189
           Q+L  + Y+HS  V+HRDLKP+NIL+  +     RVK+AD G AR       NP  P   
Sbjct: 115 QLLKALKYIHSGNVIHRDLKPSNILLNSDC----RVKLADFGLARSLSELEENPENP--V 168

Query: 190 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 249
           L   V T WYRAPE+LLG+  YTK +D+W++GCI  E+L  +P+F        T N    
Sbjct: 169 LTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTS----TLN---- 220

Query: 250 DQLDRIFSVMGFPLEKDWEDIR 271
            QL++I  V+G P  +D E I+
Sbjct: 221 -QLEKIIEVIGPPSAEDIESIK 241

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  180 bits (458), Expect = 3e-55
 Identities = 96/270 (35%), Positives = 152/270 (56%), Gaps = 40/270 (14%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALK----QIEGTGLSMSACREIALLRELKH-PNVIN 80
           K+G GTYG VYKAR K+    +  ALK    +++  G+  +A REI+LL+ L     ++ 
Sbjct: 8   KIGEGTYGKVYKARDKNTG--KLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVR 65

Query: 81  LISVFLSHNDRK-----VWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQI 135
           L+ V   H + K     ++L+F+Y + DL   +  +           +P   +KS +YQ+
Sbjct: 66  LLDV--EHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRP----LPAKTIKSFMYQL 119

Query: 136 LDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVV 195
           L G+ + H + V+HRDLKP N+LV     ++G +KIAD+G  R F+ P+K        +V
Sbjct: 120 LKGVAHCHKHGVMHRDLKPQNLLV---DKQKGLLKIADLGLGRAFSIPVKSYTH---EIV 173

Query: 196 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 255
           T WYRAPE+LLG+ HY+  +DIW++GCIFAE+   +P+F     +++        QL  I
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLF-PGDSELQ--------QLLHI 224

Query: 256 FSVMGFPLEKDWEDIRKMPEHPTLLKDFNE 285
           F ++G P E+ W  + K       L+D++E
Sbjct: 225 FKLLGTPTEQVWPGVSK-------LRDWHE 247

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  179 bits (457), Expect = 4e-55
 Identities = 81/219 (36%), Positives = 125/219 (57%), Gaps = 35/219 (15%)

Query: 25  CKVGRGTYGHVYKARRKDNSDT----------RDYALKQIEGTGLSMSACREIALLRELK 74
            K+G G+YG V+K R ++               D  +K+I        A REI +L++LK
Sbjct: 7   SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKI--------ALREIRMLKQLK 58

Query: 75  HPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQ 134
           HPN++NLI VF     RK+ L+F+Y +H + + ++ +        P  VP+ ++K +++Q
Sbjct: 59  HPNLVNLIEVF--RRKRKLHLVFEYCDHTVLNELEKN--------PRGVPEHLIKKIIWQ 108

Query: 135 ILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVV 194
            L  +++ H +  +HRD+KP NIL+  +G     +K+ D GFAR+   P     D    V
Sbjct: 109 TLQAVNFCHKHNCIHRDVKPENILITKQGQ----IKLCDFGFARILTGPGDDYTDY---V 161

Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI 233
            T WYRAPELL+G   Y   +D+WAIGC+FAELLT +P+
Sbjct: 162 ATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPL 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  177 bits (451), Expect = 2e-54
 Identities = 101/261 (38%), Positives = 143/261 (54%), Gaps = 37/261 (14%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALK----QIEGTGLSMSACREIALLRELK---HPNV 78
           ++G G YG VYKAR   +      ALK    Q    GL +S  RE+ALL+ L+   HPN+
Sbjct: 7   EIGVGAYGTVYKARDPHSG--HFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNI 64

Query: 79  INLISVFLS-HNDR--KVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQI 135
           + L+ V  +   DR  KV L+F++ + DL       R       P  +P   +K L+ Q 
Sbjct: 65  VRLMDVCATSRTDRETKVTLVFEHVDQDL-------RTYLDKVPPPGLPAETIKDLMRQF 117

Query: 136 LDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVV 195
           L G+ +LH+N ++HRDLKP NILV       G+VK+AD G AR+++  +     L PVVV
Sbjct: 118 LRGLDFLHANCIVHRDLKPENILVT----SGGQVKLADFGLARIYSCQMA----LTPVVV 169

Query: 196 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 255
           T WYRAPE+LL +  Y   +D+W++GCIFAE+   +P+F    E          DQL +I
Sbjct: 170 TLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSE---------ADQLGKI 219

Query: 256 FSVMGFPLEKDWEDIRKMPEH 276
           F ++G P E DW     +P  
Sbjct: 220 FDLIGLPPEDDWPRDVTLPRG 240

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  178 bits (452), Expect = 3e-54
 Identities = 102/275 (37%), Positives = 147/275 (53%), Gaps = 40/275 (14%)

Query: 18  DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLREL 73
           D FD  G ++G GTYG VYKAR KD  +    ALK++    E  G  ++A REI +LR+L
Sbjct: 7   DKFDIIG-QIGEGTYGQVYKARDKDTGELV--ALKKVRLDNEKEGFPITAIREIKILRQL 63

Query: 74  KHPNVINLISVFLSHND--------RKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPK 125
            H N++NL  +     D           +L+F+Y +HDL  +++           V   +
Sbjct: 64  NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLE--------SGLVHFSE 115

Query: 126 GMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFN-NPL 184
             +KS + Q+L+G++Y H    LHRD+K +NIL+      +G++K+AD G ARL+N    
Sbjct: 116 DHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLN----NKGQIKLADFGLARLYNSEES 171

Query: 185 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS 244
           +P  +    V+T WYR PELLLG   Y  AID+W+ GCI  EL T +PIF   QE     
Sbjct: 172 RPYTNK---VITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE----- 223

Query: 245 NPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL 279
                 QL+ I  + G P    W D+ K+P   T+
Sbjct: 224 ----LAQLELISRLCGSPCPAVWPDVIKLPYFNTM 254

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  176 bits (448), Expect = 2e-53
 Identities = 95/291 (32%), Positives = 150/291 (51%), Gaps = 53/291 (18%)

Query: 11  NERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT------------- 57
           N    + + +  +G  +G GTYG V KA   D    +  A+K+++               
Sbjct: 1   NMSFSISERYIQKGAHLGEGTYGKVEKAY--DTLTGKIVAIKKVKIIEISNDVTKDRQLV 58

Query: 58  ---GLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAA 114
              G+  +  RE+ ++ E+KH N++ L+ V++  +   + L+ D    DL  ++      
Sbjct: 59  GMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD--FINLVMDIMASDLKKVV------ 110

Query: 115 KANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM 174
             ++K + + +  VK +L QIL+G++ LH  + +HRDL PANI +  +GI     KIAD 
Sbjct: 111 --DRK-IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGI----CKIADF 163

Query: 175 GFARLFNNPL-----------KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCI 223
           G AR +  P            +   ++   VVT WYRAPELL+GA  Y  A+D+W++GCI
Sbjct: 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCI 223

Query: 224 FAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMP 274
           FAELLT +P+F    E          DQL RIF ++G P E +W   +K+P
Sbjct: 224 FAELLTGKPLFPGENE---------IDQLGRIFELLGTPNEDNWPQAKKLP 265

Length = 335

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  172 bits (437), Expect = 4e-52
 Identities = 92/258 (35%), Positives = 137/258 (53%), Gaps = 38/258 (14%)

Query: 25  CKVGRGTYGHVYKARRKDNSDTRDYALKQI---EGTGLSMSACREIALLRELKHPNVINL 81
            K+G G+Y  VYK R K        ALK+I      G   +A RE +LL++LKH N++ L
Sbjct: 11  DKLGEGSYATVYKGRSKLTGQL--VALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTL 68

Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGM----VKSLLYQILD 137
             +   H  + + L+F+Y + DL   +                 G+    V+  L+Q+L 
Sbjct: 69  HDII--HTKKTLTLVFEYLDTDLKQYMDDC------------GGGLSMHNVRLFLFQLLR 114

Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF 197
           G+ Y H   VLHRDLKP N+L+     ERG +K+AD G AR  + P K  ++    VVT 
Sbjct: 115 GLAYCHQRRVLHRDLKPQNLLIS----ERGELKLADFGLARAKSVPSKTYSN---EVVTL 167

Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFS 257
           WYR P++LLG+  Y+ ++D+W +GCIF E+ T  P+F        +++    DQL +IF 
Sbjct: 168 WYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFP------GSTDVE--DQLHKIFR 219

Query: 258 VMGFPLEKDWEDIRKMPE 275
           V+G P E+ W  +   PE
Sbjct: 220 VLGTPTEETWPGVSSNPE 237

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  168 bits (427), Expect = 8e-51
 Identities = 101/261 (38%), Positives = 146/261 (55%), Gaps = 38/261 (14%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALK----QIEGTGLSMSACREIALLRELK---HPNV 78
           ++G G YG V+KAR   N   R  ALK    Q    G+ +S  RE+A+LR L+   HPNV
Sbjct: 8   EIGEGAYGKVFKARDLKNGG-RFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 66

Query: 79  INLISV-FLSHNDR--KVWLLFDYAEHDLWHIIKFHRAAKANKKP-VMVPKGMVKSLLYQ 134
           + L  V  +S  DR  K+ L+F++ + DL            +K P   VP   +K +++Q
Sbjct: 67  VRLFDVCTVSRTDRETKLTLVFEHVDQDL--------TTYLDKVPEPGVPTETIKDMMFQ 118

Query: 135 ILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVV 194
           +L G+ +LHS+ V+HRDLKP NILV       G++K+AD G AR+++        L  VV
Sbjct: 119 LLRGLDFLHSHRVVHRDLKPQNILVTSS----GQIKLADFGLARIYSFQ----MALTSVV 170

Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 254
           VT WYRAPE+LL +  Y   +D+W++GCIFAE+   +P+F     D+        DQL +
Sbjct: 171 VTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFR-GSSDV--------DQLGK 220

Query: 255 IFSVMGFPLEKDWEDIRKMPE 275
           I  V+G P E+DW     +P 
Sbjct: 221 ILDVIGLPGEEDWPRDVALPR 241

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  164 bits (417), Expect = 5e-50
 Identities = 73/205 (35%), Positives = 113/205 (55%), Gaps = 22/205 (10%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI---EGTGLSMSACREIALLRELKHPNVINLIS 83
           +G G +G VY AR K     +  A+K I   + + L     REI +L++L HPN++ L  
Sbjct: 1   LGEGGFGTVYLARDKKTG--KKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYG 58

Query: 84  VFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYL 142
           VF   N   ++L+ +Y E   L  ++K        +    + +  +  +L QIL+G+ YL
Sbjct: 59  VFEDENH--LYLVMEYCEGGSLKDLLK--------ENEGKLSEDEILRILLQILEGLEYL 108

Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAP 202
           HSN ++HRDLKP NIL+     + G+VK+AD G ++L  +       L  +V T  Y AP
Sbjct: 109 HSNGIIHRDLKPENILL---DSDNGKVKLADFGLSKLLTSDKSL---LKTIVGTPAYMAP 162

Query: 203 ELLLGARHYTKAIDIWAIGCIFAEL 227
           E+LLG  +Y++  DIW++G I  EL
Sbjct: 163 EVLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  159 bits (405), Expect = 2e-47
 Identities = 95/282 (33%), Positives = 153/282 (54%), Gaps = 35/282 (12%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQ-IEGTGLSMS---ACREIALLRELKHPNVINL 81
            VG G+YG V K + K+    +  A+K+ +E     M    A REI +L++L+H N++NL
Sbjct: 8   LVGEGSYGMVMKCKHKETG--QIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNL 65

Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHY 141
           I VF     ++++L+F++ +H +   ++        K P  + +  V+  L+QIL GI +
Sbjct: 66  IEVF--RRKKRLYLVFEFVDHTVLDDLE--------KYPNGLDESRVRKYLFQILRGIEF 115

Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            HS+ ++HRD+KP NILV   G+    VK+ D GFAR    P +   D    V T WYRA
Sbjct: 116 CHSHNIIHRDIKPENILVSQSGV----VKLCDFGFARTLAAPGEVYTDY---VATRWYRA 168

Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIF---------HCRQEDIKTSNPYHHDQL 252
           PELL+G   Y +A+DIWA+GC+  E+LT EP+F         +   + +    P H +  
Sbjct: 169 PELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF 228

Query: 253 DR--IFSVMGFPLEKDWEDIRK-MPEHPTLLKDFNEQICKME 291
            +  +F+ M  P  K+ E + K  P+   L+ D  +Q  +++
Sbjct: 229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRID 270

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  158 bits (402), Expect = 3e-46
 Identities = 96/277 (34%), Positives = 143/277 (51%), Gaps = 52/277 (18%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDY-ALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           VG G YG V  A    ++ T    A+K++    +    +    RE+ LL+ + H NVI L
Sbjct: 23  VGSGAYGQVCSAF---DTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGL 79

Query: 82  ISVFL--SHND--RKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILD 137
           + VF   S  +  + V+L+      DL +I+K  + +  +          ++ L+YQIL 
Sbjct: 80  LDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDH----------IQFLVYQILR 129

Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF 197
           G+ Y+HS  ++HRDLKP+NI V  E  E   +KI D G AR  +       ++   V T 
Sbjct: 130 GLKYIHSAGIIHRDLKPSNIAV-NEDCE---LKILDFGLARHTD------DEMTGYVATR 179

Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFS 257
           WYRAPE++L   HY + +DIW++GCI AELLT + +F     D       H DQL RI +
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLF--PGSD-------HIDQLKRIMN 230

Query: 258 VMGFP----LEK-DWED----IRKMPEHPTLLKDFNE 285
           ++G P    L+K   E     I+ +P+ P   KDF E
Sbjct: 231 LVGTPDEELLQKISSESARNYIQSLPQMPK--KDFKE 265

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  152 bits (384), Expect = 3e-44
 Identities = 93/255 (36%), Positives = 134/255 (52%), Gaps = 45/255 (17%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIE---GTGLSMSACREIALLRELKHPNVINLI 82
           K+G GTY  VYK R K   +    ALK+I      G   +A RE++LL++LKH N++ L 
Sbjct: 13  KLGEGTYATVYKGRSKLTDNL--VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70

Query: 83  SVFLSHNDRKVWLLFDYAEHDL-------WHIIKFHRAAKANKKPVMVPKGMVKSLLYQI 135
            +   H ++ + L+F+Y + DL        + I  H                VK  L+Q+
Sbjct: 71  DII--HTEKSLTLVFEYLDKDLKQYLDDCGNSINMHN---------------VKLFLFQL 113

Query: 136 LDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVV 195
           L G++Y H   VLHRDLKP N+L+     ERG +K+AD G AR  + P K  ++    VV
Sbjct: 114 LRGLNYCHRRKVLHRDLKPQNLLIN----ERGELKLADFGLARAKSIPTKTYSN---EVV 166

Query: 196 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 255
           T WYR P++LLG+  Y+  ID+W +GCIF E+ T  P+F               +QL  I
Sbjct: 167 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLF---------PGSTVEEQLHFI 217

Query: 256 FSVMGFPLEKDWEDI 270
           F ++G P E+ W  I
Sbjct: 218 FRILGTPTEETWPGI 232

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  152 bits (384), Expect = 3e-44
 Identities = 95/260 (36%), Positives = 135/260 (51%), Gaps = 45/260 (17%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIE---GTGLSMSACREIALLRELKHPNVINLI 82
           K+G GTY  V+K R K   +    ALK+I      G   +A RE++LL++LKH N++ L 
Sbjct: 13  KLGEGTYATVFKGRSKLTENL--VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70

Query: 83  SVFLSHNDRKVWLLFDYAEHDL-------WHIIKFHRAAKANKKPVMVPKGMVKSLLYQI 135
            +   H D+ + L+F+Y + DL        +I+  H                VK  LYQI
Sbjct: 71  DIV--HTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHN---------------VKIFLYQI 113

Query: 136 LDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVV 195
           L G+ Y H   VLHRDLKP N+L+     ERG +K+AD G AR  + P K  ++    VV
Sbjct: 114 LRGLAYCHRRKVLHRDLKPQNLLIN----ERGELKLADFGLARAKSVPTKTYSN---EVV 166

Query: 196 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 255
           T WYR P++LLG+  Y+  ID+W +GCIF E+ +  P+F               D+L  I
Sbjct: 167 TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLF---------PGSTVEDELHLI 217

Query: 256 FSVMGFPLEKDWEDIRKMPE 275
           F ++G P E+ W  I    E
Sbjct: 218 FRLLGTPTEETWPGISSNDE 237

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  150 bits (380), Expect = 3e-43
 Identities = 95/269 (35%), Positives = 137/269 (50%), Gaps = 39/269 (14%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELK-HPNVIN 80
           ++G+G YG V  AR  + S+    A+K+I        L+  A RE+ LLR  + H N+  
Sbjct: 7   ELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITC 66

Query: 81  LI--SVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDG 138
           L    +    N  +++L  +  E DL  II+             +     +S +YQIL G
Sbjct: 67  LYDMDIVFPGNFNELYLYEELMEADLHQIIR---------SGQPLTDAHFQSFIYQILCG 117

Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFN-NPLKPLADLDPVVVTF 197
           + Y+HS  VLHRDLKP N+LV  +      +KI D G AR F+ NP +    +   V T 
Sbjct: 118 LKYIHSANVLHRDLKPGNLLVNADC----ELKICDFGLARGFSENPGENAGFMTEYVATR 173

Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFS 257
           WYRAPE++L  + YTKAID+W++GCI AELL  +P+F  +          + DQL++I  
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD---------YVDQLNQILQ 224

Query: 258 VMGFPLE---------KDWEDIRKMPEHP 277
           V+G P E         K    IR +P  P
Sbjct: 225 VLGTPDEETLSRIGSPKAQNYIRSLPNIP 253

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  149 bits (379), Expect = 4e-43
 Identities = 88/247 (35%), Positives = 130/247 (52%), Gaps = 31/247 (12%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
            +G G YG V  A   D    +  A+K+I    +   L+    RE+ +LR  KH N+I +
Sbjct: 12  NIGSGAYGVVCSAI--DTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAI 69

Query: 82  ISVFLSHND--RKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGI 139
             +        + V+++ D  E DL HII        + +P+   +  ++  LYQ+L G+
Sbjct: 70  RDILRPPGADFKDVYVVMDLMESDLHHIIH-------SDQPLT--EEHIRYFLYQLLRGL 120

Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPLKPLADLDPVVVTFW 198
            Y+HS  V+HRDLKP+N+LV  +      ++I D G AR L ++P +    +   V T W
Sbjct: 121 KYIHSANVIHRDLKPSNLLVNEDC----ELRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176

Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPELLL    YT AID+W++GCIFAE+L    +F  +       N  H  QL  I SV
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGK-------NYVH--QLKLILSV 227

Query: 259 MGFPLEK 265
           +G P E+
Sbjct: 228 LGSPSEE 234

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  147 bits (372), Expect = 1e-42
 Identities = 89/253 (35%), Positives = 133/253 (52%), Gaps = 31/253 (12%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIE---GTGLSMSACREIALLRELKHPNVINLI 82
           K+G GTY  V+K R K   +    ALK+I      G   +A RE++LL+ LKH N++ L 
Sbjct: 12  KLGEGTYATVFKGRSKLTENL--VALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLH 69

Query: 83  SVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYL 142
            +   H +R + L+F+Y + DL   +        N   +M     VK  ++Q+L G+ Y 
Sbjct: 70  DII--HTERCLTLVFEYLDSDLKQYLD-------NCGNLMSMHN-VKIFMFQLLRGLSYC 119

Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAP 202
           H   +LHRDLKP N+L+     E+G +K+AD G AR  + P K  ++    VVT WYR P
Sbjct: 120 HKRKILHRDLKPQNLLIN----EKGELKLADFGLARAKSVPTKTYSN---EVVTLWYRPP 172

Query: 203 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGFP 262
           ++LLG+  Y+  ID+W +GCI  E+ T  P+F               ++L  IF ++G P
Sbjct: 173 DVLLGSTEYSTPIDMWGVGCILYEMATGRPMF---------PGSTVKEELHLIFRLLGTP 223

Query: 263 LEKDWEDIRKMPE 275
            E+ W  I    E
Sbjct: 224 TEETWPGITSNEE 236

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  146 bits (371), Expect = 1e-42
 Identities = 68/218 (31%), Positives = 110/218 (50%), Gaps = 24/218 (11%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG----LSMSACREIALLRELKHPNVI 79
           G  +GRG++G VY A  KD  +    A+K +E +G       +  REI +L  L+HPN++
Sbjct: 5   GELLGRGSFGSVYLALDKDTGEL--MAVKSVELSGDSEEELEALEREIRILSSLQHPNIV 62

Query: 80  NLISVFLSHNDRKVWLLF-DYA-EHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILD 137
                     ++    +F +Y     L  ++K           +  P+ +++    QIL+
Sbjct: 63  RYYGSERD-EEKNTLNIFLEYVSGGSLSSLLK-------KFGKL--PEPVIRKYTRQILE 112

Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF 197
           G+ YLHSN ++HRD+K ANILV  +    G VK+AD G A+   +          V  T 
Sbjct: 113 GLAYLHSNGIVHRDIKGANILVDSD----GVVKLADFGCAKRLGDIETGEGTG-SVRGTP 167

Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
           ++ APE++ G   Y +A DIW++GC   E+ T +P + 
Sbjct: 168 YWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPWS 204

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  148 bits (376), Expect = 1e-42
 Identities = 90/256 (35%), Positives = 131/256 (51%), Gaps = 35/256 (13%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI---EGTGLSMSACREIALLRELKHPNVINLI 82
            +G G YG V  A           A+K+I   E         REI +LR  KH N+I ++
Sbjct: 12  YIGEGAYGMVCSA--THKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGIL 69

Query: 83  SV-----FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILD 137
            +     F S ND  V+++ +  E DL+ +IK             +    ++  LYQIL 
Sbjct: 70  DIIRPPSFESFND--VYIVQELMETDLYKLIKTQ----------HLSNDHIQYFLYQILR 117

Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF 197
           G+ Y+HS  VLHRDLKP+N+L+         +KI D G AR+ +        L   V T 
Sbjct: 118 GLKYIHSANVLHRDLKPSNLLLN----TNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173

Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFS 257
           WYRAPE++L ++ YTKAIDIW++GCI AE+L++ P+F  +         Y H QL+ I  
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKD--------YLH-QLNLILG 224

Query: 258 VMGFPLEKDWEDIRKM 273
           V+G P ++D   I  +
Sbjct: 225 VLGTPSQEDLNCIISL 240

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  147 bits (371), Expect = 3e-42
 Identities = 91/252 (36%), Positives = 136/252 (53%), Gaps = 30/252 (11%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI---EGTGLSMSACREIALLRELKHPNVINLI 82
           K+G G+Y  VYK + K N   +  ALK I   E  G   +A RE +LL+ LKH N++ L 
Sbjct: 12  KLGEGSYATVYKGKSKVNG--KLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLH 69

Query: 83  SVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYL 142
            +   H    + L+F+Y   DL   +        +K P  +    VK  L+Q+L G+ Y+
Sbjct: 70  DII--HTKETLTLVFEYVHTDLCQYM--------DKHPGGLHPENVKLFLFQLLRGLSYI 119

Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAP 202
           H  ++LHRDLKP N+L+     + G +K+AD G AR  + P    ++    VVT WYR P
Sbjct: 120 HQRYILHRDLKPQNLLIS----DTGELKLADFGLARAKSVPSHTYSN---EVVTLWYRPP 172

Query: 203 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGFP 262
           ++LLG+  Y+  +D+W +GCIF E++     F    +DI+       DQL+RIF V+G P
Sbjct: 173 DVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFP-GMKDIQ-------DQLERIFLVLGTP 224

Query: 263 LEKDWEDIRKMP 274
            E  W  +  +P
Sbjct: 225 NEDTWPGVHSLP 236

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  145 bits (369), Expect = 1e-41
 Identities = 94/255 (36%), Positives = 134/255 (52%), Gaps = 40/255 (15%)

Query: 27  VGRGTYGHVYKARRKDNSDTRD-YALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           +GRG YG V  A+   NS+T +  A+K+I    +    +    REI LLR L H NVI +
Sbjct: 13  IGRGAYGIVCSAK---NSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAI 69

Query: 82  ISVFL-----SHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQIL 136
             +       + ND  V+++++  + DL  II+  +    +           +  LYQ+L
Sbjct: 70  KDIMPPPHREAFND--VYIVYELMDTDLHQIIRSSQTLSDDH---------CQYFLYQLL 118

Query: 137 DGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVT 196
            G+ Y+HS  VLHRDLKP+N+L+         +KI D G AR  +     + +    VVT
Sbjct: 119 RGLKYIHSANVLHRDLKPSNLLLN----ANCDLKICDFGLARTTSEKGDFMTEY---VVT 171

Query: 197 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 256
            WYRAPELLL    YT AID+W++GCIFAELL  +P+F  +         Y H QL  I 
Sbjct: 172 RWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKD--------YVH-QLKLIT 222

Query: 257 SVMGFPLEKDWEDIR 271
            ++G P E+D   IR
Sbjct: 223 ELLGSPSEEDLGFIR 237

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  142 bits (360), Expect = 9e-41
 Identities = 89/258 (34%), Positives = 135/258 (52%), Gaps = 38/258 (14%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIE---GTGLSMSACREIALLRELKHPNVINLI 82
           K+G G+Y  VYK   + N      ALK I      G+  +A RE +LL+ LKH N++ L 
Sbjct: 12  KLGEGSYATVYKGISRINGQL--VALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLH 69

Query: 83  SVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGM----VKSLLYQILDG 138
            +   H    +  +F+Y   DL   +  H            P G+    V+  ++Q+L G
Sbjct: 70  DII--HTKETLTFVFEYMHTDLAQYMIQH------------PGGLHPYNVRLFMFQLLRG 115

Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+H   +LHRDLKP N+L+       G +K+AD G AR  + P +  +     VVT W
Sbjct: 116 LAYIHGQHILHRDLKPQNLLIS----YLGELKLADFGLARAKSIPSQTYSS---EVVTLW 168

Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YR P++LLGA  Y+ A+DIW  GCIF E+L  +P F         S+ +  +QL++I++V
Sbjct: 169 YRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFP------GVSDVF--EQLEKIWTV 220

Query: 259 MGFPLEKDWEDIRKMPEH 276
           +G P E  W  + K+P +
Sbjct: 221 LGVPTEDTWPGVSKLPNY 238

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  141 bits (356), Expect = 2e-39
 Identities = 84/243 (34%), Positives = 129/243 (53%), Gaps = 33/243 (13%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC----REIALLRELKHPNVINLI 82
           +G G +G V+     D  D +  ALK++     ++ +C    RE+ +L   KH NV++ +
Sbjct: 8   IGYGAFGVVWSV--TDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSAL 65

Query: 83  SVFLS-HND--RKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGI 139
            +    H D   +++++ +  + DL  II   +   ++          VK  LYQIL G+
Sbjct: 66  DILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDH---------VKVFLYQILRGL 116

Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
            YLHS  +LHRD+KP N+LV    +    +KI D G AR+          +   VVT +Y
Sbjct: 117 KYLHSAGILHRDIKPGNLLVNSNCV----LKICDFGLARV--EEPDESKHMTQEVVTQYY 170

Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVM 259
           RAPE+L+G+RHYT A+DIW++GCIFAELL    +F       +  +P    QLD I  ++
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILF-------QAQSPI--QQLDLITDLL 221

Query: 260 GFP 262
           G P
Sbjct: 222 GTP 224

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  137 bits (348), Expect = 3e-39
 Identities = 69/214 (32%), Positives = 111/214 (51%), Gaps = 22/214 (10%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMS----ACREIALLRELKHPNVINL 81
           ++G+G++G VY  RRK +     Y LK+I+ + +S      A  E+ +L++L HPN+I  
Sbjct: 7   QIGKGSFGKVYLVRRKSDGKL--YVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKY 64

Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIH 140
              F      K+ ++ +YA+  DL   IK  +  K  K     P+  +     Q+   + 
Sbjct: 65  YESFE-EKG-KLCIVMEYADGGDLSQKIK--KQKKEGKPF---PEEQILDWFVQLCLALK 117

Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YLHS  +LHRD+KP NI +   G+    VK+ D G +++ ++ +  LA    VV T +Y 
Sbjct: 118 YLHSRKILHRDIKPQNIFLTSNGL----VKLGDFGISKVLSSTV-DLAKT--VVGTPYYL 170

Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           +PEL      Y    DIW++GC+  EL T +  F
Sbjct: 171 SPELCQNKP-YNYKSDIWSLGCVLYELCTLKHPF 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  133 bits (336), Expect = 3e-37
 Identities = 82/244 (33%), Positives = 128/244 (52%), Gaps = 36/244 (14%)

Query: 25  CKVGRGTYGHVYKAR-RKDNSDTRDYALKQIEGTGLSMS---ACREIALLRELK-HPNVI 79
            K+G GT+  V KA+ RK     + YA+K ++    S+      REI  LR L  HPN++
Sbjct: 5   GKIGEGTFSEVLKAQSRKTG---KYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNIL 61

Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGI 139
            LI V       ++ L+F+  + +L+ +IK  +     K+        VKS +YQ+L  +
Sbjct: 62  RLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKR--------VKSYMYQLLKSL 113

Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPLKPLADLDPVVVTFW 198
            ++H N + HRD+KP NIL+  +      +K+AD G  R +++ P  P  +    + T W
Sbjct: 114 DHMHRNGIFHRDIKPENILIKDD-----ILKLADFGSCRGIYSKP--PYTEY---ISTRW 163

Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE LL   +Y   +DIWA+GC+F E+L+  P+F    E          DQ+ +I  V
Sbjct: 164 YRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE---------LDQIAKIHDV 214

Query: 259 MGFP 262
           +G P
Sbjct: 215 LGTP 218

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  132 bits (333), Expect = 2e-36
 Identities = 89/245 (36%), Positives = 127/245 (51%), Gaps = 34/245 (13%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINLI 82
           +G+G+YG V  A   D       A+K+I    E    +    REI LLR L+HP+++ + 
Sbjct: 8   IGKGSYGVVCSA--IDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 65

Query: 83  SVFLSHNDRK---VWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGI 139
            + L  + R+   ++++F+  E DL      H+  KAN     +     +  LYQ+L  +
Sbjct: 66  HIMLPPSRREFKDIYVVFELMESDL------HQVIKANDD---LTPEHHQFFLYQLLRAL 116

Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
            Y+H+  V HRDLKP NIL   +     ++KI D G AR+  N           V T WY
Sbjct: 117 KYIHTANVFHRDLKPKNILANADC----KLKICDFGLARVAFNDTPTAIFWTDYVATRWY 172

Query: 200 RAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFS 257
           RAPEL  G+    YT AIDIW+IGCIFAE+LT +P+F  +       N  H  QLD I  
Sbjct: 173 RAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK-------NVVH--QLDLITD 222

Query: 258 VMGFP 262
           ++G P
Sbjct: 223 LLGTP 227

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  131 bits (332), Expect = 4e-36
 Identities = 87/286 (30%), Positives = 140/286 (48%), Gaps = 40/286 (13%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGT-GLSM-SACREIALLRELKHPNVINLISV 84
           +G G+ G V+ A   D+   +  A+K+I  T   S+  A REI ++R L H N++ +  V
Sbjct: 13  LGCGSNGLVFSA--VDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70

Query: 85  FLSHNDR------------KVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLL 132
                               V+++ +Y E DL ++++             + +   +  +
Sbjct: 71  LGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGP----------LSEEHARLFM 120

Query: 133 YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP 192
           YQ+L G+ Y+HS  VLHRDLKPAN+ +  E +    +KI D G AR+ +        L  
Sbjct: 121 YQLLRGLKYIHSANVLHRDLKPANVFINTEDL---VLKIGDFGLARIVDPHYSHKGYLSE 177

Query: 193 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE------DIKTSNP 246
            +VT WYR+P LLL   +YTKAID+WA GCIFAE+LT +P+F    E       +++   
Sbjct: 178 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237

Query: 247 YHHDQLDRIFSVMGFPLEKDWEDIRK-----MPEHPTLLKDFNEQI 287
              +  + + +V+   +  D  + R+     +P       DF EQI
Sbjct: 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQI 283

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  130 bits (329), Expect = 8e-36
 Identities = 83/246 (33%), Positives = 125/246 (50%), Gaps = 40/246 (16%)

Query: 25  CKVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVIN 80
            +VG G YG V  A  K   +    A+K++    +    +  A RE+ LL+ ++H NVI 
Sbjct: 21  KQVGSGAYGSVCSAIDKRTGEK--VAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIG 78

Query: 81  LISVFLS----HNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQIL 136
           L+ VF S       +  +L+  Y + DL  I+    +              V+ L+YQ+L
Sbjct: 79  LLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDK-----------VQYLVYQML 127

Query: 137 DGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVT 196
            G+ Y+HS  ++HRDLKP N+ V     E   +KI D G AR  +      A++   VVT
Sbjct: 128 CGLKYIHSAGIIHRDLKPGNLAVN----EDCELKILDFGLARHAD------AEMTGYVVT 177

Query: 197 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 256
            WYRAPE++L   HY + +DIW++GCI AE+LT + +F  +          + DQL +I 
Sbjct: 178 RWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD---------YLDQLTQIL 228

Query: 257 SVMGFP 262
            V G P
Sbjct: 229 KVTGVP 234

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  129 bits (325), Expect = 1e-35
 Identities = 85/244 (34%), Positives = 127/244 (52%), Gaps = 33/244 (13%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINLI 82
           VG G YG V K R K+  +    A+K+     E   +  +  RE+ +LR LK  N++ L 
Sbjct: 9   VGEGAYGVVLKCRHKETKEI--VAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELK 66

Query: 83  SVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYL 142
             F      K++L+F+Y E ++  +++          P  VP   V+S +YQ++  IH+ 
Sbjct: 67  EAFRRRG--KLYLVFEYVEKNMLELLEEM--------PNGVPPEKVRSYIYQLIKAIHWC 116

Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAP 202
           H N ++HRD+KP N+L+    +    +K+ D GFAR  N      A+    V T WYR+P
Sbjct: 117 HKNDIVHRDIKPENLLISHNDV----LKLCDFGFAR--NLSEGSNANYTEYVATRWYRSP 170

Query: 203 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG-F 261
           ELLLGA  Y KA+D+W++GCI  EL   +P+F    E          DQL  I  V+G  
Sbjct: 171 ELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEI---------DQLFTIQKVLGPL 220

Query: 262 PLEK 265
           P E+
Sbjct: 221 PAEQ 224

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  127 bits (322), Expect = 2e-35
 Identities = 77/218 (35%), Positives = 115/218 (52%), Gaps = 28/218 (12%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC----REIALLRELKHPNVI 79
           G  +GRG +G VYK    +  D    A+KQI    +   A     +EI LL+ LKHPN++
Sbjct: 5   GDLIGRGAFGVVYKGLNLETGDF--VAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIV 62

Query: 80  NLISVFLSHNDRKVWLLFDYAEH-DLWHIIK-FHRAAKANKKPVMVPKGMVKSLLYQILD 137
             I    + +   ++++ +YAE+  L  IIK F             P+ +V   +YQ+L 
Sbjct: 63  KYIGSIETSD--SLYIILEYAENGSLRQIIKKFGP----------FPESLVAVYVYQVLQ 110

Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF 197
           G+ YLH   V+HRD+K ANIL   +G+    VK+AD G A   N+  K  A    VV T 
Sbjct: 111 GLAYLHEQGVIHRDIKAANILTTKDGV----VKLADFGVATKLNDVSKDDAS---VVGTP 163

Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
           ++ APE++  +   T + DIW++GC   ELLT  P ++
Sbjct: 164 YWMAPEVIEMSGASTAS-DIWSLGCTVIELLTGNPPYY 200

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  129 bits (323), Expect = 9e-35
 Identities = 74/269 (27%), Positives = 112/269 (41%), Gaps = 32/269 (11%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS-----MSACREIALLRELKHP-NVI 79
           K+G G++G VY AR     D +  ALK +     S         REI +L  L HP N++
Sbjct: 7   KLGEGSFGEVYLAR-----DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIV 61

Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGI 139
            L   F   ++  ++L+ +Y +      +      K   +   + +     +L QIL  +
Sbjct: 62  KLYDFF--QDEGSLYLVMEYVDGGSLEDL-----LKKIGRKGPLSESEALFILAQILSAL 114

Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF---NNPLKPLADLDPVVVT 196
            YLHS  ++HRD+KP NIL+  +G     VK+ D G A+L     +     A     V T
Sbjct: 115 EYLHSKGIIHRDIKPENILLDRDG---RVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171

Query: 197 FWYRAPELLLG--ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 254
             Y APE+LLG    + + + DIW++G    ELLT  P F   +    T       Q  +
Sbjct: 172 PGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSAT------SQTLK 225

Query: 255 IFSVMGFPLEKDWEDIRKMPEHPTLLKDF 283
           I   +  P                   D 
Sbjct: 226 IILELPTPSLASPLSPSNPELISKAASDL 254

Length = 384

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  126 bits (319), Expect = 2e-34
 Identities = 81/243 (33%), Positives = 127/243 (52%), Gaps = 36/243 (14%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINLI 82
           VG G +G V  AR  D    ++ A+K+I        L+    RE+ LL+ L+H N+I+L 
Sbjct: 18  VGMGAFGLVCSAR--DQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLS 75

Query: 83  SVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYL 142
            +F+S  +  ++ + +    DL      HR   +  +P+   K  ++  LYQIL G+ Y+
Sbjct: 76  DIFISPLE-DIYFVTELLGTDL------HRLLTS--RPL--EKQFIQYFLYQILRGLKYV 124

Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAP 202
           HS  V+HRDLKP+NIL+     E   +KI D G AR+ +        +   V T +YRAP
Sbjct: 125 HSAGVVHRDLKPSNILIN----ENCDLKICDFGLARIQD------PQMTGYVSTRYYRAP 174

Query: 203 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGFP 262
           E++L  + Y   +DIW+ GCIFAE+L  +P+F  +          H +Q   I  ++G P
Sbjct: 175 EIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD---------HVNQFSIITDLLGTP 225

Query: 263 LEK 265
            + 
Sbjct: 226 PDD 228

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  126 bits (317), Expect = 5e-34
 Identities = 85/244 (34%), Positives = 127/244 (52%), Gaps = 39/244 (15%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++    +    +  A RE+ LL+ +KH NVI L+
Sbjct: 23  VGSGAYGTVCSAL--DRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLL 80

Query: 83  SVFLSHN--DR--KVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDG 138
            VF      DR    +L+  +   DL  ++K  + ++            ++ L+YQ+L G
Sbjct: 81  DVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDR----------IQFLVYQMLKG 130

Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+H+  ++HRDLKP N+ V     E   +KI D G AR  +      +++   VVT W
Sbjct: 131 LKYIHAAGIIHRDLKPGNLAVN----EDCELKILDFGLARQTD------SEMTGYVVTRW 180

Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HYT+ +DIW++GCI AE+LT +P+F       K  +  H DQL  I  V
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLF-------KGHD--HLDQLMEIMKV 231

Query: 259 MGFP 262
            G P
Sbjct: 232 TGTP 235

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  124 bits (313), Expect = 2e-33
 Identities = 85/244 (34%), Positives = 127/244 (52%), Gaps = 39/244 (15%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D    +  A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 23  VGSGAYGSVCSAY--DTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80

Query: 83  SVFLS----HNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDG 138
            VF       N  +V+L+ +    DL +I+K  + +  +          V+ L+YQ+L G
Sbjct: 81  DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEH----------VQFLIYQLLRG 130

Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   ++I D G AR  ++      ++   V T W
Sbjct: 131 LKYIHSAGIIHRDLKPSNVAVN----EDCELRILDFGLARQADD------EMTGYVATRW 180

Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELL  + +F          N Y  DQL RI  V
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF--------PGNDY-IDQLKRIMEV 231

Query: 259 MGFP 262
           +G P
Sbjct: 232 VGTP 235

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  122 bits (307), Expect = 2e-33
 Identities = 72/216 (33%), Positives = 113/216 (52%), Gaps = 22/216 (10%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIALLRELKHPNVINL 81
           K+G+G+YG VYK +R   SD + YALK+++   +S      A  EI +L  + HPN+I+ 
Sbjct: 7   KLGKGSYGSVYKVKR--LSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISY 64

Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHY 141
              FL  N  K+ ++ +YA      + K     K  +K +  P+  +  +  Q+L G+  
Sbjct: 65  KEAFLDGN--KLCIVMEYA--PFGDLSKAISKRKKKRKLI--PEQEIWRIFIQLLRGLQA 118

Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
           LH   +LHRDLK ANIL++   +    VKI D+G +++    +         + T  Y A
Sbjct: 119 LHEQKILHRDLKSANILLVANDL----VKIGDLGISKVLKKNM-----AKTQIGTPHYMA 169

Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 237
           PE+  G R Y+   DIW++GC+  E+ T  P F  R
Sbjct: 170 PEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEAR 204

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  122 bits (308), Expect = 4e-33
 Identities = 60/241 (24%), Positives = 107/241 (44%), Gaps = 43/241 (17%)

Query: 21  DYEGCKV-GRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-----SMSACRE-IALLREL 73
           D++  K+ G G++  V  A+ K+ +  ++YA+K ++   L           E   L R  
Sbjct: 2   DFKFGKIIGEGSFSTVVLAKEKETN--KEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN 59

Query: 74  KHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLL 132
            HP +I L   F   ++  ++ + +YA + +L   I+ + +         + +   +   
Sbjct: 60  GHPGIIKLYYTF--QDEENLYFVLEYAPNGELLQYIRKYGS---------LDEKCTRFYA 108

Query: 133 YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP 192
            +IL  + YLHS  ++HRDLKP NIL+     +   +KI D G A++ +    P ++   
Sbjct: 109 AEILLALEYLHSKGIIHRDLKPENILLD----KDMHIKITDFGTAKVLDPNSSPESNKGD 164

Query: 193 VVVTFW-----------------YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
                                  Y +PELL       K+ D+WA+GCI  ++LT +P F 
Sbjct: 165 ATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFR 223

Query: 236 C 236
            
Sbjct: 224 G 224

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  119 bits (299), Expect = 2e-31
 Identities = 86/258 (33%), Positives = 126/258 (48%), Gaps = 42/258 (16%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 25  VGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 82

Query: 83  SVFLSHNDRK----VWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDG 138
            VF      +    V+L+      DL +I+K  +    +          V+ L+YQIL G
Sbjct: 83  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH----------VQFLIYQILRG 132

Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 133 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDD------EMTGYVATRW 182

Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF---------PGTDHIDQLKLILRL 233

Query: 259 MGFPLEKDWEDIRKMPEH 276
           +G P     E ++K+   
Sbjct: 234 VGTP---GAELLKKISSE 248

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  115 bits (290), Expect = 9e-31
 Identities = 72/254 (28%), Positives = 120/254 (47%), Gaps = 35/254 (13%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACR----EIALLRELKHPNVINL 81
            +G+G++G V K RRK  SD +    K+I+   ++    +    E+ +LRELKHPN++  
Sbjct: 7   TIGKGSFGTVRKVRRK--SDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRY 64

Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIH 140
               +  +++ ++++ +Y E  DL  +I+  +  K  K    + +  +  +L Q+L  ++
Sbjct: 65  YDRIIDRSNQTLYIVMEYCEGGDLAQLIQ--KCKKERK---YIEEEFIWRILTQLLLALY 119

Query: 141 YLH-----SNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVV 195
             H      N VLHRDLKPANI +         VK+ D G A++  +           V 
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFL----DANNNVKLGDFGLAKILGHDSSFAKTY---VG 172

Query: 196 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR-----QEDIKTSN----P 246
           T +Y +PE L     Y +  DIW++GC+  EL    P F  R        IK       P
Sbjct: 173 TPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIP 231

Query: 247 YHH-DQLDRIFSVM 259
           Y +  +L+ +   M
Sbjct: 232 YRYSSELNEVIKSM 245

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  113 bits (286), Expect = 3e-30
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 28/220 (12%)

Query: 17  EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHP 76
           E++FD    K+G G+YG VYKA  K+       A+K +          +EI++L++   P
Sbjct: 2   EEVFDIL-EKLGEGSYGSVYKAIHKETGQV--VAIKVVPVEEDLQEIIKEISILKQCDSP 58

Query: 77  NVINLISVFLSHNDRKVWLLFDYAE----HDLWHIIKFHRAAKANKKPVMVPKGMVKSLL 132
            ++     +  + D  +W++ +Y       D+  I         NK    + +  + ++L
Sbjct: 59  YIVKYYGSYFKNTD--LWIVMEYCGAGSVSDIMKIT--------NKT---LTEEEIAAIL 105

Query: 133 YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP 192
           YQ L G+ YLHSN  +HRD+K  NIL+     E G+ K+AD G +    +    +A  + 
Sbjct: 106 YQTLKGLEYLHSNKKIHRDIKAGNILLN----EEGQAKLADFGVSGQLTD---TMAKRNT 158

Query: 193 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 232
           V+ T ++ APE++    +  KA DIW++G    E+   +P
Sbjct: 159 VIGTPFWMAPEVIQEIGYNNKA-DIWSLGITAIEMAEGKP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  112 bits (281), Expect = 2e-29
 Identities = 61/208 (29%), Positives = 110/208 (52%), Gaps = 23/208 (11%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACR-----EIALLRELKHPNVIN 80
           K+G+G +  VYKA    +   R  ALK+++   +  +  R     EI LL++L HPNVI 
Sbjct: 9   KIGKGQFSVVYKAICLLDG--RVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIK 66

Query: 81  LISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGI 139
            ++ F+ +N+  +  + + A+  DL  +IK        K+  ++P+  +     Q+   +
Sbjct: 67  YLASFIENNELNI--VLELADAGDLSRMIK-----HFKKQKRLIPERTIWKYFVQLCSAL 119

Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
            ++HS  ++HRD+KPAN+ +   G+    VK+ D+G  R F++       L   V T +Y
Sbjct: 120 EHMHSKRIMHRDIKPANVFITATGV----VKLGDLGLGRFFSSKTTAAHSL---VGTPYY 172

Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAEL 227
            +PE +    +  K+ DIW++GC+  E+
Sbjct: 173 MSPERIHENGYNFKS-DIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  109 bits (276), Expect = 9e-29
 Identities = 60/216 (27%), Positives = 106/216 (49%), Gaps = 30/216 (13%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA--CREIALLRELKHPNVINLIS 83
           K+G+G +G VYKAR K     ++ A+K I+            EI +L++ KHPN++    
Sbjct: 7   KIGKGGFGEVYKARHK--RTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYG 64

Query: 84  VFLSHNDRKVWLLFDYAE----HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGI 139
            +L  +  ++W++ ++       DL          K+  + +   +  +  +  ++L G+
Sbjct: 65  SYLKKD--ELWIVMEFCSGGSLKDL---------LKSTNQTL--TESQIAYVCKELLKGL 111

Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
            YLHSN ++HRD+K ANIL+       G VK+ D G +      L      + +V T ++
Sbjct: 112 EYLHSNGIIHRDIKAANILLT----SDGEVKLIDFGLS----AQLSDTKARNTMVGTPYW 163

Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
            APE++ G + Y    DIW++G    EL   +P + 
Sbjct: 164 MAPEVING-KPYDYKADIWSLGITAIELAEGKPPYS 198

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  112 bits (281), Expect = 9e-29
 Identities = 66/207 (31%), Positives = 103/207 (49%), Gaps = 39/207 (18%)

Query: 63  ACREIALLRELKHPNVINLISVFLSHND----RKVWLLFDYAEHDLWHIIKF---HRAAK 115
           A RE+ L++ + H N+I L++VF         + V+L+ +  + +L  +I+    H    
Sbjct: 62  AYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHER-- 119

Query: 116 ANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMG 175
                       +  LLYQ+L GI +LHS  ++HRDLKP+NI+V         +KI D G
Sbjct: 120 ------------MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKILDFG 163

Query: 176 FARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
            AR           + P VVT +YRAPE++LG   Y + +DIW++GCI  E++    +F 
Sbjct: 164 LARTAGTSFM----MTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGTVLFP 218

Query: 236 CRQEDIKTSNPYHHDQLDRIFSVMGFP 262
                       H DQ ++I   +G P
Sbjct: 219 GTD---------HIDQWNKIIEQLGTP 236

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  108 bits (272), Expect = 3e-28
 Identities = 58/217 (26%), Positives = 102/217 (47%), Gaps = 27/217 (12%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMS-----ACREIALLRELKHPNVINL 81
           +G+G++G V   R+KD    + YA+K ++   +           E  +L  + HP ++ L
Sbjct: 1   LGKGSFGKVLLVRKKDTG--KLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL 58

Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIH 140
              F    + K++L+ +YA   +L+  +                +   +    +I+  + 
Sbjct: 59  HYAF--QTEEKLYLVLEYAPGGELFSHLSKEG---------RFSEERARFYAAEIVLALE 107

Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YLHS  +++RDLKP NIL+       G +K+ D G A+         +  +    T  Y 
Sbjct: 108 YLHSLGIIYRDLKPENILLD----ADGHIKLTDFGLAKEL---SSEGSRTNTFCGTPEYL 160

Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 237
           APE+LLG   Y KA+D W++G +  E+LT +P F+  
Sbjct: 161 APEVLLGKG-YGKAVDWWSLGVLLYEMLTGKPPFYAE 196

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  106 bits (267), Expect = 2e-27
 Identities = 67/209 (32%), Positives = 109/209 (52%), Gaps = 24/209 (11%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINL 81
           K+G+G++G V+K  RK   D R YA+KQI+ + ++      A  E  +L +L    +I  
Sbjct: 7   KIGKGSFGVVFKVVRKA--DKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRY 64

Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIH 140
              FL  +  K+ ++ +YAE+ DL  ++K  R      +P+  P+  V     QIL G+ 
Sbjct: 65  YESFL--DKGKLNIVMEYAENGDLHKLLKMQR-----GRPL--PEDQVWRFFIQILLGLA 115

Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           +LHS  +LHRD+K  N+ +         VKI D+G A+L  +     A  + +V T +Y 
Sbjct: 116 HLHSKKILHRDIKSLNLFLD----AYDNVKIGDLGVAKLL-SDNTNFA--NTIVGTPYYL 168

Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT 229
           +PE L   + Y +  D+WA+G +  E  T
Sbjct: 169 SPE-LCEDKPYNEKSDVWALGVVLYECCT 196

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  104 bits (261), Expect = 2e-26
 Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 13/209 (6%)

Query: 26  KVGRGTYGHVYKARRKDNSD-TRDYALKQIEGTGLSMS---ACREIALLRELKHPNVINL 81
           K+G G +G VYK + K     T + A+K ++            +E  ++++L HPNV+ L
Sbjct: 2   KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61

Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIH 140
           + V     +  ++L+ +Y E  DL   ++  R    + +   +    + S   QI  G+ 
Sbjct: 62  LGV--CTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119

Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL S   +HRDL   N LV     E   VKI+D G +R   +           +   W  
Sbjct: 120 YLASKKFVHRDLAARNCLV----GEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM- 174

Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT 229
           APE L     +T   D+W+ G +  E+ T
Sbjct: 175 APESLKD-GIFTSKSDVWSFGVLLWEIFT 202

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  103 bits (260), Expect = 2e-26
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 32/215 (14%)

Query: 25  CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM---SACREIALLRELKHPNVINL 81
             +G+G+ G VYK R K       YALK+I   G         RE+  LR  + P V+  
Sbjct: 7   KVLGQGSSGVVYKVRHKPTGKI--YALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKC 64

Query: 82  ISVFLSHNDRKVWLLFDYAE----HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILD 137
              F  + + ++ ++ +Y +     DL             KK   +P+ ++  +  QIL 
Sbjct: 65  YGAF--YKEGEISIVLEYMDGGSLADLL------------KKVGKIPEPVLAYIARQILK 110

Query: 138 GIHYLHSNW-VLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVT 196
           G+ YLH+   ++HRD+KP+N+L+      +G VKIAD G +++  N L         V T
Sbjct: 111 GLDYLHTKRHIIHRDIKPSNLLIN----SKGEVKIADFGISKVLENTLDQCNTF---VGT 163

Query: 197 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 231
             Y +PE + G   Y+ A DIW++G    E    +
Sbjct: 164 VTYMSPERIQG-ESYSYAADIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  105 bits (264), Expect = 3e-26
 Identities = 67/204 (32%), Positives = 104/204 (50%), Gaps = 33/204 (16%)

Query: 63  ACREIALLRELKHPNVINLISVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANK 118
           A RE+ LL+ + H N+I+L++VF         + V+L+ +  + +L  +I          
Sbjct: 67  AYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHME------- 119

Query: 119 KPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR 178
               +    +  LLYQ+L GI +LHS  ++HRDLKP+NI+V  +      +KI D G AR
Sbjct: 120 ----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT----LKILDFGLAR 171

Query: 179 LFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 238
                      + P VVT +YRAPE++LG   Y + +DIW++GCI  EL+    IF    
Sbjct: 172 TACTNFM----MTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELVKGSVIFQGTD 226

Query: 239 EDIKTSNPYHHDQLDRIFSVMGFP 262
                    H DQ +++   +G P
Sbjct: 227 ---------HIDQWNKVIEQLGTP 241

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  103 bits (259), Expect = 4e-26
 Identities = 61/216 (28%), Positives = 107/216 (49%), Gaps = 36/216 (16%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC-REIALLRELKHPNVINLISV 84
           K+G G  G VYKA  +  +  ++ A+K++     +      EI ++++ KHPN+++    
Sbjct: 26  KIGEGASGEVYKATDR--ATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDS 83

Query: 85  FLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLH 143
           +L  ++  +W++ +Y +   L  II  +         V + +  +  +  ++L G+ YLH
Sbjct: 84  YLVGDE--LWVVMEYMDGGSLTDIITQN--------FVRMNEPQIAYVCREVLQGLEYLH 133

Query: 144 SNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP-------VVVT 196
           S  V+HRD+K  NIL+     + G VK+AD GFA          A L         VV T
Sbjct: 134 SQNVIHRDIKSDNILLS----KDGSVKLADFGFA----------AQLTKEKSKRNSVVGT 179

Query: 197 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 232
            ++ APE++     Y   +DIW++G +  E+   EP
Sbjct: 180 PYWMAPEVIKRKD-YGPKVDIWSLGIMCIEMAEGEP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  101 bits (253), Expect = 2e-25
 Identities = 74/260 (28%), Positives = 107/260 (41%), Gaps = 73/260 (28%)

Query: 1   MDYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL- 59
           ++YE++   + ER  +           G+GTYG VY AR          A+K+I      
Sbjct: 1   LEYEYEYDENGERVVL-----------GKGTYGIVYAARDLSTQ--VRIAIKEIPERDSR 47

Query: 60  -SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANK 118
                  EIAL   LKH N++  +     +   K+     + E                 
Sbjct: 48  YVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI-----FMEQ---------------- 86

Query: 119 KPVMVPKGMVKSLLY------------------QILDGIHYLHSNWVLHRDLKPANILVM 160
               VP G + +LL                   QIL+G+ YLH N ++HRD+K  N+LV 
Sbjct: 87  ----VPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLV- 141

Query: 161 GEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF----WYRAPELL-LGARHYTKAI 215
                 G VKI+D G +       K LA ++P   TF     Y APE++  G R Y    
Sbjct: 142 --NTYSGVVKISDFGTS-------KRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPA 192

Query: 216 DIWAIGCIFAELLTSEPIFH 235
           DIW++GC   E+ T +P F 
Sbjct: 193 DIWSLGCTIVEMATGKPPFI 212

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  101 bits (253), Expect = 2e-25
 Identities = 60/214 (28%), Positives = 94/214 (43%), Gaps = 27/214 (12%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDY-----ALKQIEGTGLSMSACREIALLRELKHPNV 78
           G K+G G +G VYK + K     +        LK+           RE  ++R+L HPNV
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 79  INLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILD 137
           + L+ V     +  ++++ +Y E  DL   ++ +R          +    + S   QI  
Sbjct: 64  VKLLGVCTE--EEPLYIVMEYMEGGDLLSYLRKNRPK--------LSLSDLLSFALQIAR 113

Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPLKPLADLD-PVVV 195
           G+ YL S   +HRDL   N LV     E   VKI+D G +R L+++          P+  
Sbjct: 114 GMEYLESKNFIHRDLAARNCLVG----ENLVVKISDFGLSRDLYDDDYYRKRGGKLPI-- 167

Query: 196 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
             W  APE L     +T   D+W+ G +  E+ T
Sbjct: 168 -RWM-APESLK-EGKFTSKSDVWSFGVLLWEIFT 198

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  101 bits (253), Expect = 2e-25
 Identities = 60/214 (28%), Positives = 95/214 (44%), Gaps = 26/214 (12%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDY-----ALKQIEGTGLSMSACREIALLRELKHPNV 78
           G K+G G +G VYK   K   D ++       LK+           RE  ++R+L HPN+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 79  INLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILD 137
           + L+ V     +  + ++ +Y    DL   ++ +R       P  +    + S   QI  
Sbjct: 64  VKLLGVCTE--EEPLMIVMEYMPGGDLLDYLRKNR-------PKELSLSDLLSFALQIAR 114

Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPLKPLADLD-PVVV 195
           G+ YL S   +HRDL   N LV     E   VKI+D G +R L+++    +     P+  
Sbjct: 115 GMEYLESKNFIHRDLAARNCLVG----ENLVVKISDFGLSRDLYDDDYYKVKGGKLPI-- 168

Query: 196 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
             W  APE L     +T   D+W+ G +  E+ T
Sbjct: 169 -RWM-APESLK-EGKFTSKSDVWSFGVLLWEIFT 199

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  103 bits (258), Expect = 4e-25
 Identities = 78/247 (31%), Positives = 126/247 (51%), Gaps = 31/247 (12%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLIS 83
           G  +G G++G VY+A   D S+    A+K++          RE+ +++ L H N+I L  
Sbjct: 71  GNIIGNGSFGVVYEAICIDTSE--KVAIKKVLQD--PQYKNRELLIMKNLNHINIIFLKD 126

Query: 84  VFLSH----NDRKVWL--LFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILD 137
            + +     N++ ++L  + ++    +   +K +  A+ N     +P  +VK   YQ+  
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHY--ARNNHA---LPLFLVKLYSYQLCR 181

Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF 197
            + Y+HS ++ HRDLKP N+L+         +K+ D G A+   N L     +  +   F
Sbjct: 182 ALAYIHSKFICHRDLKPQNLLI---DPNTHTLKLCDFGSAK---NLLAGQRSVSYICSRF 235

Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFS 257
            YRAPEL+LGA +YT  ID+W++GCI AE++   PIF         S     DQL RI  
Sbjct: 236 -YRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIF---------SGQSSVDQLVRIIQ 285

Query: 258 VMGFPLE 264
           V+G P E
Sbjct: 286 VLGTPTE 292

Length = 440

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  100 bits (252), Expect = 4e-25
 Identities = 61/220 (27%), Positives = 106/220 (48%), Gaps = 29/220 (13%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM-----SACREIALLRELKHPNVINL 81
           + +G YG V+ A++K   D   YA+K I+   +           E  +L + + P V+ L
Sbjct: 1   ISKGAYGRVFLAKKKSTGDI--YAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58

Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIH 140
              F     + ++L+ +Y    DL  +++   +         + + + +  + +I+  + 
Sbjct: 59  YYSFQG--KKNLYLVMEYLPGGDLASLLENVGS---------LDEDVARIYIAEIVLALE 107

Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIAD-----MGFARLFNNPLKPLADLDPVVV 195
           YLHSN ++HRDLKP NIL+   G     +K+ D     +G  R   N      +   +V 
Sbjct: 108 YLHSNGIIHRDLKPDNILIDSNGH----LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVG 163

Query: 196 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
           T  Y APE++LG + ++K +D W++GCI  E L   P FH
Sbjct: 164 TPDYIAPEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFH 202

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 98.7 bits (246), Expect = 2e-24
 Identities = 65/213 (30%), Positives = 107/213 (50%), Gaps = 24/213 (11%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMS----ACREIALLRELKHPNVINLI 82
           +G+G +G     RR    D      K++  T LS      A  EI +L  L+HPN+I   
Sbjct: 8   LGKGAFGEATLYRRT--EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65

Query: 83  SVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHY 141
           + F+  +D  + +  +YA    L+  I         +K  +  + MV   L+QI+  + Y
Sbjct: 66  NHFM--DDNTLLIEMEYANGGTLYDKI-------VRQKGQLFEEEMVLWYLFQIVSAVSY 116

Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
           +H   +LHRD+K  NI +   G+    +K+ D G +++  +    +A  + VV T +Y +
Sbjct: 117 IHKAGILHRDIKTLNIFLTKAGL----IKLGDFGISKILGSE-YSMA--ETVVGTPYYMS 169

Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           PEL  G ++  K+ DIWA+GC+  ELLT +  F
Sbjct: 170 PELCQGVKYNFKS-DIWALGCVLYELLTLKRTF 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 98.5 bits (246), Expect = 2e-24
 Identities = 62/222 (27%), Positives = 98/222 (44%), Gaps = 32/222 (14%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALK-----QIEGTGLSMSACREIALLRELKHPNVINL 81
           +G G +G V     K  S  R +ALK      I  TG       E  +L E  HP ++ L
Sbjct: 1   LGVGGFGRVELV--KVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL 58

Query: 82  ISVFLSHNDRKVWLLFDY-AEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLY--QILDG 138
              F   + + +++L +Y    +LW I+        ++           +  Y   ++  
Sbjct: 59  YRTF--KDKKYIYMLMEYCLGGELWTIL--RDRGLFDEY---------TARFYIACVVLA 105

Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
             YLH+  +++RDLKP N+L+       G VK+ D GFA+   +  K          T  
Sbjct: 106 FEYLHNRGIIYRDLKPENLLLD----SNGYVKLVDFGFAKKLKSGQKTWT----FCGTPE 157

Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
           Y APE++L  + Y  ++D W++G +  ELLT  P F    ED
Sbjct: 158 YVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDED 198

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 98.3 bits (245), Expect = 3e-24
 Identities = 61/216 (28%), Positives = 104/216 (48%), Gaps = 27/216 (12%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQ--IEGTGLSMSAC-----REIALLRELKHPNVI 79
           +G G++G VY+    D+ D   +A+K+  +   G +         +EIALL +L+HPN++
Sbjct: 8   LGSGSFGSVYEGLNLDDGDF--FAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGI 139
             +      ++  ++L            +     AK  KK    P+ +++    QIL G+
Sbjct: 66  QYLGTEREEDNLYIFLEL----------VPGGSLAKLLKKYGSFPEPVIRLYTRQILLGL 115

Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
            YLH    +HRD+K ANILV   G+    VK+AD G A+     +   +       + ++
Sbjct: 116 EYLHDRNTVHRDIKGANILVDTNGV----VKLADFGMAK----QVVEFSFAKSFKGSPYW 167

Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
            APE++     Y  A DIW++GC   E+ T +P + 
Sbjct: 168 MAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWS 203

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 99.0 bits (246), Expect = 7e-24
 Identities = 73/244 (29%), Positives = 123/244 (50%), Gaps = 39/244 (15%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINLI 82
           +G G  G V  A   D    R+ A+K++    +    +  A RE+ L++ + H N+I+L+
Sbjct: 25  IGSGAQGIVCAAY--DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82

Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDG 138
           +VF         + V+L+ +  + +L  +I+             +    +  LLYQ+L G
Sbjct: 83  NVFTPQKSLEEFQDVYLVMELMDANLCQVIQME-----------LDHERMSYLLYQMLCG 131

Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           I +LHS  ++HRDLKP+NI+V  +      +KI D G AR           + P VVT +
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCT----LKILDFGLARTAGTSFM----MTPYVVTRY 183

Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++LG   Y + +DIW++GCI  E++  + +F  R          + DQ +++   
Sbjct: 184 YRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRD---------YIDQWNKVIEQ 233

Query: 259 MGFP 262
           +G P
Sbjct: 234 LGTP 237

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 98.2 bits (244), Expect = 1e-23
 Identities = 63/204 (30%), Positives = 104/204 (50%), Gaps = 33/204 (16%)

Query: 63  ACREIALLRELKHPNVINLISVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANK 118
           A RE+ L++ + H N+I L++VF         + V+++ +  + +L  +I+         
Sbjct: 70  AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME------- 122

Query: 119 KPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR 178
               +    +  LLYQ+L GI +LHS  ++HRDLKP+NI+V  +      +KI D G AR
Sbjct: 123 ----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT----LKILDFGLAR 174

Query: 179 LFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 238
                      + P VVT +YRAPE++LG   Y + +DIW++GCI  E++    +F    
Sbjct: 175 TAGTSFM----MTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTD 229

Query: 239 EDIKTSNPYHHDQLDRIFSVMGFP 262
                    H DQ +++   +G P
Sbjct: 230 ---------HIDQWNKVIEQLGTP 244

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 96.4 bits (240), Expect = 2e-23
 Identities = 64/225 (28%), Positives = 104/225 (46%), Gaps = 39/225 (17%)

Query: 27  VGRGTYGHVYK----------ARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHP 76
           +GRG YG VY+          A +  N DT D  +  I+         RE+ALL +L+  
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQ---------REVALLSQLRQS 59

Query: 77  NVINLISVFLSH-NDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQI 135
              N+   + S+    ++W++ +YAE     +    +A    +K + V       ++ ++
Sbjct: 60  QPPNITKYYGSYLKGPRLWIIMEYAEGG--SVRTLMKAGPIAEKYISV-------IIREV 110

Query: 136 LDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFN-NPLKPLADLDPVV 194
           L  + Y+H   V+HRD+K ANILV       G VK+ D G A L N N  K        V
Sbjct: 111 LVALKYIHKVGVIHRDIKAANILVTNT----GNVKLCDFGVAALLNQNSSKRST----FV 162

Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
            T ++ APE++   ++Y    DIW++G    E+ T  P  +   +
Sbjct: 163 GTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPP-YSDVD 206

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 95.5 bits (237), Expect = 4e-23
 Identities = 65/215 (30%), Positives = 109/215 (50%), Gaps = 21/215 (9%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACR-----EIALLRELKHPNVIN 80
           K+GRG +  VY+A      D +  ALK+++   +  +  R     EI LL++L HPNVI 
Sbjct: 9   KIGRGQFSEVYRA--TCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIK 66

Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIH 140
            +  F+  N+  + L    A  DL  +IK+ +     K+  ++P+  V     Q+   + 
Sbjct: 67  YLDSFIEDNELNIVLELADA-GDLSQMIKYFK-----KQKRLIPERTVWKYFVQLCSAVE 120

Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           ++HS  V+HRD+KPAN+ +   G+    VK+ D+G  R F++       L   V T +Y 
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGV----VKLGDLGLGRFFSSKTTAAHSL---VGTPYYM 173

Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
           +PE  +    Y    DIW++GC+  E+   +  F+
Sbjct: 174 SPE-RIHENGYNFKSDIWSLGCLLYEMAALQSPFY 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 94.9 bits (236), Expect = 5e-23
 Identities = 68/219 (31%), Positives = 110/219 (50%), Gaps = 25/219 (11%)

Query: 22  YEGCKV-GRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIALLRELKHP 76
           YE  +V GRG +G V+  RRK   D +   +KQI    ++    ++A  E  +L+ L HP
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRKA--DQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHP 59

Query: 77  NVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQI 135
           N+I     FL   D+ + ++ +YA    L   I+    +       ++ +  +     QI
Sbjct: 60  NIIEYYENFLE--DKALMIVMEYAPGGTLAEYIQKRCNS-------LLDEDTILHFFVQI 110

Query: 136 LDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVV 195
           L  +H++H+  +LHRDLK  NIL+      +  VKI D G +++ ++  K       VV 
Sbjct: 111 LLALHHVHTKLILHRDLKTQNILL---DKHKMVVKIGDFGISKILSSKSKAYT----VVG 163

Query: 196 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           T  Y +PEL  G + Y +  DIWA+GC+  EL + +  F
Sbjct: 164 TPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAF 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 94.5 bits (235), Expect = 8e-23
 Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 32/217 (14%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACR-------EIALLRELKHPNVI 79
           +G+G +G VY     D    R+ A+KQ+     S    +       EI LL+ L+H  ++
Sbjct: 10  LGQGAFGRVYLCYDVDTG--RELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67

Query: 80  NLISVFLSHNDRKVWLLFDYAE----HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQI 135
                    +D  + +  +Y       D    +K + A             + +    QI
Sbjct: 68  QYYGCL--RDDETLSIFMEYMPGGSVKDQ---LKAYGALTET---------VTRKYTRQI 113

Query: 136 LDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVV 195
           L+G+ YLHSN ++HRD+K ANIL        G VK+ D G ++           +  V  
Sbjct: 114 LEGVEYLHSNMIVHRDIKGANILRD----SAGNVKLGDFGASKRLQTICSSGTGMKSVTG 169

Query: 196 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 232
           T ++ +PE++ G  +  KA D+W++GC   E+LT +P
Sbjct: 170 TPYWMSPEVISGEGYGRKA-DVWSVGCTVVEMLTEKP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 94.3 bits (235), Expect = 1e-22
 Identities = 64/221 (28%), Positives = 103/221 (46%), Gaps = 20/221 (9%)

Query: 21  DYE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQI--EGTGLSM-SACREIALLRELKHP 76
           DYE    +G G    VY A    N++    A+K+I  E    S+    +E+  + +  HP
Sbjct: 2   DYELIEVIGVGATAVVYAAICLPNNEK--VAIKRIDLEKCQTSVDELRKEVQAMSQCNHP 59

Query: 77  NVINLISVFLSHNDRKVWLLFDY-AEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQI 135
           NV+   + F+     ++WL+  Y +   L  I+K      +  +  +  + ++ ++L ++
Sbjct: 60  NVVKYYTSFVV--GDELWLVMPYLSGGSLLDIMKS-----SYPRGGL-DEAIIATVLKEV 111

Query: 136 LDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGF-ARLFNNPLKPLADLDPVV 194
           L G+ YLHSN  +HRD+K  NIL+     E G VKIAD G  A L +   +        V
Sbjct: 112 LKGLEYLHSNGQIHRDIKAGNILLG----EDGSVKIADFGVSASLADGGDRTRKVRKTFV 167

Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
            T  + APE++     Y    DIW+ G    EL T    + 
Sbjct: 168 GTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYS 208

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 94.9 bits (236), Expect = 2e-22
 Identities = 65/204 (31%), Positives = 93/204 (45%), Gaps = 32/204 (15%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGT---GLSMSACREIALLRELKHPNVINLI 82
           ++G G  G VYK   +     R YALK I G     +    CREI +LR++ HPNV+   
Sbjct: 81  RIGSGAGGTVYKVIHRPTG--RLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCH 138

Query: 83  SVFLSHNDRKVWLLF-DYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHY 141
            +F  + + +V L F D    +  HI      A                +  QIL GI Y
Sbjct: 139 DMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA---------------DVARQILSGIAY 183

Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
           LH   ++HRD+KP+N+L+         VKIAD G +R+    + P    +  V T  Y +
Sbjct: 184 LHRRHIVHRDIKPSNLLIN----SAKNVKIADFGVSRILAQTMDP---CNSSVGTIAYMS 236

Query: 202 PEL----LLGARHYTKAIDIWAIG 221
           PE     L    +   A DIW++G
Sbjct: 237 PERINTDLNHGAYDGYAGDIWSLG 260

Length = 353

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 93.0 bits (232), Expect = 2e-22
 Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 30/216 (13%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDY--ALKQI-EGTGLSMSA--CREIALLRELKHPNV 78
           G K+G G +G VYK   K + +  +   A+K + EG           E +++++L HPN+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNI 63

Query: 79  INLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILD 137
           + L+ V        ++++ +Y    DL   ++ H           +    +  +  QI  
Sbjct: 64  VRLLGVCTQ--GEPLYIVTEYMPGGDLLDFLRKHGEK--------LTLKDLLQMALQIAK 113

Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN----PLKPLADLDPV 193
           G+ YL S   +HRDL   N LV     E   VKI+D G +R          +    L P+
Sbjct: 114 GMEYLESKNFVHRDLAARNCLV----TENLVVKISDFGLSRDIYEDDYYRKRGGGKL-PI 168

Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
               W  APE L     +T   D+W+ G +  E+ T
Sbjct: 169 ---KWM-APESLK-DGKFTSKSDVWSFGVLLWEIFT 199

Length = 258

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 92.4 bits (230), Expect = 4e-22
 Identities = 66/220 (30%), Positives = 115/220 (52%), Gaps = 25/220 (11%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIA----LLRELKHPNVI 79
           G K+G GT+G VY A   D  +    A+K+I          +EIA    +L  LKHPN++
Sbjct: 5   GNKIGGGTFGKVYTAVNLDTGEL--MAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV 62

Query: 80  NLISVFLSHNDRKVWLLFDY-AEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDG 138
               V + H + KV++  +Y +   L  +++  R         ++ + +++    Q+L+G
Sbjct: 63  KYYGVEV-HRE-KVYIFMEYCSGGTLEELLEHGR---------ILDEHVIRVYTLQLLEG 111

Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA-RLFNNPLKPLADLDPVVVTF 197
           + YLHS+ ++HRD+KPANI +       G +K+ D G A +L NN      ++  +  T 
Sbjct: 112 LAYLHSHGIVHRDIKPANIFL----DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTP 167

Query: 198 WYRAPELLLGAR--HYTKAIDIWAIGCIFAELLTSEPIFH 235
            Y APE++ G +   + +A DIW++GC+  E+ T +  + 
Sbjct: 168 AYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWS 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 90.8 bits (226), Expect = 2e-21
 Identities = 63/217 (29%), Positives = 102/217 (47%), Gaps = 34/217 (15%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI---EGTGLSMSACREIALLRELKHPNVINLI 82
           ++G GTYG VYKAR     +    A+K I    G        +EI++L+E +HPN++   
Sbjct: 10  RIGSGTYGDVYKARDIATGEL--VAIKVIKLEPGDDFE-IIQQEISMLKECRHPNIVAYF 66

Query: 83  SVFLSHNDRKVWLLFDYAE----HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDG 138
             +L  +  K+W++ +Y       D++ + +             + +  +  +  + L G
Sbjct: 67  GSYLRRD--KLWIVMEYCGGGSLQDIYQVTRGP-----------LSELQIAYVCRETLKG 113

Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGF-ARLFNNPLKPLADLDPVVVTF 197
           + YLH    +HRD+K ANIL+     E G VK+AD G  A+L       +A     + T 
Sbjct: 114 LAYLHETGKIHRDIKGANILLT----EDGDVKLADFGVSAQLTAT----IAKRKSFIGTP 165

Query: 198 WYRAPELLLGARH--YTKAIDIWAIGCIFAELLTSEP 232
           ++ APE+    R   Y    DIWA+G    EL   +P
Sbjct: 166 YWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 90.9 bits (225), Expect = 2e-21
 Identities = 66/215 (30%), Positives = 107/215 (49%), Gaps = 21/215 (9%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACR-----EIALLRELKHPNVIN 80
           K+GRG +  VY+A      D    ALK+++   L  +  R     EI LL++L HPNVI 
Sbjct: 9   KIGRGQFSEVYRATCL--LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK 66

Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIH 140
             + F+  N+  + L    A  DL  +IK  +     K+  ++P+  V     Q+   + 
Sbjct: 67  YYASFIEDNELNIVLELADA-GDLSRMIKHFK-----KQKRLIPEKTVWKYFVQLCSALE 120

Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           ++HS  V+HRD+KPAN+ +   G+    VK+ D+G  R F++       L   V T +Y 
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGV----VKLGDLGLGRFFSSKTTAAHSL---VGTPYYM 173

Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
           +PE  +    Y    DIW++GC+  E+   +  F+
Sbjct: 174 SPE-RIHENGYNFKSDIWSLGCLLYEMAALQSPFY 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 90.7 bits (225), Expect = 2e-21
 Identities = 72/236 (30%), Positives = 116/236 (49%), Gaps = 42/236 (17%)

Query: 23  EGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC-----------REIALLR 71
           +G  +G G++G VY     + S     A+KQ+E   +S S+            REIALL+
Sbjct: 4   KGALIGSGSFGSVYLGM--NASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61

Query: 72  ELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSL 131
           EL+H N++  +   L  +   ++L +         +     AA  N       + +V++ 
Sbjct: 62  ELQHENIVQYLGSSLDADHLNIFLEY---------VPGGSVAALLNNYGAF-EETLVRNF 111

Query: 132 LYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF--------NNP 183
           + QIL G++YLH+  ++HRD+K ANILV      +G +KI+D G ++           N 
Sbjct: 112 VRQILKGLNYLHNRGIIHRDIKGANILVD----NKGGIKISDFGISKKLEANSLSTKTNG 167

Query: 184 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCRQ 238
            +P   L   V  FW  APE++    +  KA DIW++GC+  E+LT + P   C Q
Sbjct: 168 ARP--SLQGSV--FWM-APEVVKQTSYTRKA-DIWSLGCLVVEMLTGKHPFPDCTQ 217

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 90.4 bits (225), Expect = 2e-21
 Identities = 64/219 (29%), Positives = 101/219 (46%), Gaps = 42/219 (19%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA------CREIALLRELKHPNVI 79
            +G+G++G VYKA   D    +  A+K I+   L  +        +EI  L + + P + 
Sbjct: 8   CIGKGSFGEVYKAI--DKRTNQVVAIKVID---LEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 80  NLISVFLSHNDRKVWLLFDY----AEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQI 135
                FL     K+W++ +Y    +  DL    K               +  +  +L ++
Sbjct: 63  KYYGSFL--KGSKLWIIMEYCGGGSCLDLLKPGKL-------------DETYIAFILREV 107

Query: 136 LDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA-RLFNNPLKPLADLDPVV 194
           L G+ YLH    +HRD+K ANIL+     E G VK+AD G + +L +   K     +  V
Sbjct: 108 LLGLEYLHEEGKIHRDIKAANILLS----EEGDVKLADFGVSGQLTSTMSK----RNTFV 159

Query: 195 VT-FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 232
            T FW  APE++  + +  KA DIW++G    EL   EP
Sbjct: 160 GTPFWM-APEVIKQSGYDEKA-DIWSLGITAIELAKGEP 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 90.2 bits (224), Expect = 3e-21
 Identities = 57/215 (26%), Positives = 99/215 (46%), Gaps = 30/215 (13%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIE----------GTGLSM-SACR-EIALLRELK 74
           +G+GTYG VY A      +    A+KQ+E               M  A R EI  L++L 
Sbjct: 9   IGKGTYGRVYLALNVTTGEM--MAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66

Query: 75  HPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQ 134
           H N++  +    +     ++L +          +         +      + +V+    Q
Sbjct: 67  HLNIVQYLGFETTEEYLSIFLEY----------VPGGSIGSCLRTYGRFEEQLVRFFTEQ 116

Query: 135 ILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVV 194
           +L+G+ YLHS  +LHRDLK  N+LV  +GI     KI+D G ++  ++      ++    
Sbjct: 117 VLEGLAYLHSKGILHRDLKADNLLVDADGI----CKISDFGISKKSDDIYDNDQNMSMQG 172

Query: 195 VTFWYRAPELL-LGARHYTKAIDIWAIGCIFAELL 228
             FW  APE++   ++ Y+  +DIW++GC+  E+ 
Sbjct: 173 SVFWM-APEVIHSYSQGYSAKVDIWSLGCVVLEMF 206

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 89.1 bits (221), Expect = 7e-21
 Identities = 60/214 (28%), Positives = 109/214 (50%), Gaps = 24/214 (11%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIALLRELKHPNVINL 81
           K+G G++G     + K+  D + Y +K+I  + +S      + +E+A+L  +KHPN++  
Sbjct: 7   KIGEGSFGKAILVKSKE--DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64

Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIH 140
              F    +  ++++ DY E  DL+  I         ++ V+ P+  +     QI   + 
Sbjct: 65  QESF--EENGNLYIVMDYCEGGDLYKKIN-------AQRGVLFPEDQILDWFVQICLALK 115

Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           ++H   +LHRD+K  NI +  +G     +K+ D G AR+ N+ ++ LA     + T +Y 
Sbjct: 116 HVHDRKILHRDIKSQNIFLTKDGT----IKLGDFGIARVLNSTVE-LA--RTCIGTPYYL 168

Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           +PE+    R Y    DIWA+GC+  E+ T +  F
Sbjct: 169 SPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAF 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 88.1 bits (218), Expect = 1e-20
 Identities = 65/229 (28%), Positives = 113/229 (49%), Gaps = 31/229 (13%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINL 81
           K+G G++G +Y A  K  SD+    +K+I+ T + +    ++ +E+ LL ++KHPN++  
Sbjct: 7   KIGEGSFGKIYLA--KAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF 64

Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIH 140
            + F  +   +++++ +Y +  DL   I   R        V+  +  + S   QI  G+ 
Sbjct: 65  FASFQENG--RLFIVMEYCDGGDLMKRINRQRG-------VLFSEDQILSWFVQISLGLK 115

Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           ++H   +LHRD+K  NI +   G+     K+ D G AR  N+ ++ LA     V T +Y 
Sbjct: 116 HIHDRKILHRDIKSQNIFLSKNGMV---AKLGDFGIARQLNDSME-LA--YTCVGTPYYL 169

Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 249
           +PE+    R Y    DIW++GC+  EL T +  F          N  H 
Sbjct: 170 SPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFE--------GNNLHQ 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 87.4 bits (217), Expect = 2e-20
 Identities = 57/216 (26%), Positives = 99/216 (45%), Gaps = 30/216 (13%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEG-----TGLSMSACREIALLRELKHPNVINL 81
           +G+G +G V   +++D      +A+K +        G   +   E  +L+EL HP ++NL
Sbjct: 8   IGKGAFGKVCIVQKRDTKKM--FAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65

Query: 82  ISVFLSHNDRKVWLLFDY-AEHDL-WHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGI 139
              F   ++  ++L+ D     DL +H+ +  + ++            VK  + +I+  +
Sbjct: 66  WYSF--QDEENMYLVVDLLLGGDLRYHLSQKVKFSEE----------QVKFWICEIVLAL 113

Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
            YLHS  ++HRD+KP NIL+     E+G V I D   A        P         T  Y
Sbjct: 114 EYLHSKGIIHRDIKPDNILLD----EQGHVHITDFNIATKV----TPDTLTTSTSGTPGY 165

Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
            APE+L   + Y+ A+D W++G    E L  +  + 
Sbjct: 166 MAPEVLC-RQGYSVAVDWWSLGVTAYECLRGKRPYR 200

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 86.8 bits (215), Expect = 1e-19
 Identities = 61/214 (28%), Positives = 106/214 (49%), Gaps = 30/214 (14%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-----CREIALLRELKHPNVIN 80
           ++G G++G VY AR    ++    A+K++  +G   +       +E+  L++L+HPN I 
Sbjct: 22  EIGHGSFGAVYFARDVRTNEV--VAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIE 79

Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIH 140
               +L   +   WL+ +Y       I++ H      KKP+   +  + ++ +  L G+ 
Sbjct: 80  YKGCYL--REHTAWLVMEYCLGSASDILEVH------KKPLQ--EVEIAAICHGALQGLA 129

Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YLHS+  +HRD+K  NIL+     E G VK+AD G A L +         +  V T ++ 
Sbjct: 130 YLHSHERIHRDIKAGNILLT----EPGTVKLADFGSASLVSPA-------NSFVGTPYWM 178

Query: 201 APELLLGAR--HYTKAIDIWAIGCIFAELLTSEP 232
           APE++L      Y   +D+W++G    EL   +P
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 86.4 bits (215), Expect = 1e-19
 Identities = 65/222 (29%), Positives = 102/222 (45%), Gaps = 46/222 (20%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALK-----------QIEGTGLSMSACREIALLRELKH 75
           +G G++G V   R K +     YALK           Q+E          E  +L+ ++H
Sbjct: 9   LGTGSFGRVMLVRHKGSGKY--YALKILSKAKIVKLKQVEHV------LNEKRILQSIRH 60

Query: 76  PNVINLISVFLSHNDRKVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLY- 133
           P ++NL   F   +D  ++L+ +Y    +L     F    K+ + P  V +       Y 
Sbjct: 61  PFLVNLYGSF--QDDSNLYLVMEYVPGGEL-----FSHLRKSGRFPEPVAR------FYA 107

Query: 134 -QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP 192
            Q++  + YLHS  +++RDLKP N+L+       G +KI D GFA+        L     
Sbjct: 108 AQVVLALEYLHSLDIVYRDLKPENLLLD----SDGYIKITDFGFAKRVKGRTYTLCG--- 160

Query: 193 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
              T  Y APE++L  + Y KA+D WA+G +  E+L   P F
Sbjct: 161 ---TPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPF 198

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 85.8 bits (212), Expect = 1e-19
 Identities = 63/216 (29%), Positives = 107/216 (49%), Gaps = 23/216 (10%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIALLRELKHPNVINLI 82
           VG+G+YG V   R +  +D + Y +K++     S     +A +E  LL +LKHPN++   
Sbjct: 8   VGKGSYGEVSLVRHR--TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65

Query: 83  SVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHY 141
             +    D  ++++  + E  DL+H +K        +K  ++P+  V     QI   + Y
Sbjct: 66  ESW-EGEDGLLYIVMGFCEGGDLYHKLK-------EQKGKLLPENQVVEWFVQIAMALQY 117

Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
           LH   +LHRDLK  N+ +    I    +K+ D+G AR+  N     + L   + T +Y +
Sbjct: 118 LHEKHILHRDLKTQNVFLTRTNI----IKVGDLGIARVLENQCDMASTL---IGTPYYMS 170

Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 237
           PE L   + Y    D+WA+GC   E+ T +  F+ +
Sbjct: 171 PE-LFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 85.2 bits (211), Expect = 2e-19
 Identities = 65/227 (28%), Positives = 109/227 (48%), Gaps = 38/227 (16%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM------------SACREIALLRE-L 73
           +G G +G VYK R+K+N      ALK+I     +                 E+ +++E L
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNL-LALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 74  KHPNVINLISVFLSHNDRKVWLLFDYAE----HDLWHIIKFHRAAKANKKPVMVPKGMVK 129
           +HPN++     FL  NDR ++++ D  E     + ++ +K        +K     +  + 
Sbjct: 67  RHPNIVRYYKTFL-ENDR-LYIVMDLIEGAPLGEHFNSLK--------EKKQRFTEERIW 116

Query: 130 SLLYQILDGIHYLH-SNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLA 188
           ++  Q++  + YLH    ++HRDL P NI+ +GE     +V I D G A+       P +
Sbjct: 117 NIFVQMVLALRYLHKEKRIVHRDLTPNNIM-LGE---DDKVTITDFGLAKQKQ----PES 168

Query: 189 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
            L  VV T  Y  PE++    +  KA D+WA GCI  ++ T +P F+
Sbjct: 169 KLTSVVGTILYSCPEIVKNEPYGEKA-DVWAFGCILYQMCTLQPPFY 214

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 83.4 bits (206), Expect = 9e-19
 Identities = 61/222 (27%), Positives = 108/222 (48%), Gaps = 31/222 (13%)

Query: 23  EGCKVGRGTYGHVYKARRKDNSDTRDYALKQI--------EGTGLSMSACREIALLRELK 74
           +G ++G G +   Y+AR  D       A+KQ+        E   +  +  +EI L+  L 
Sbjct: 4   KGQQLGTGAFSSCYQAR--DVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN 61

Query: 75  HPNVINLI--SVFLSH-NDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSL 131
           HP++I ++  +   SH N    W+    A   + H++  + A K           ++ + 
Sbjct: 62  HPHIIRMLGATCEDSHFNLFVEWM----AGGSVSHLLSKYGAFKEA---------VIINY 108

Query: 132 LYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLD 191
             Q+L G+ YLH N ++HRD+K AN+L+   G    R++IAD G A           +  
Sbjct: 109 TEQLLRGLSYLHENQIIHRDVKGANLLIDSTG---QRLRIADFGAAARLAAKGTGAGEFQ 165

Query: 192 PVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 232
             ++ T  + APE+L G   Y ++ D+W++GC+  E+ T++P
Sbjct: 166 GQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 83.9 bits (207), Expect = 1e-18
 Identities = 66/236 (27%), Positives = 114/236 (48%), Gaps = 42/236 (17%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRD-YALKQIEGTGLSMSA-----CREIALLRELKHPNVI 79
           ++G G++G VY A    NS T +  A+K++  +G   +       +E+  L++LKHPN I
Sbjct: 28  EIGHGSFGAVYFA---TNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTI 84

Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGI 139
                +L   +   WL+ +Y       +++ H      KKP+   +  + ++ +  L G+
Sbjct: 85  EYKGCYL--KEHTAWLVMEYCLGSASDLLEVH------KKPLQEVE--IAAITHGALQGL 134

Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
            YLHS+ ++HRD+K  NIL+     E G+VK+AD G A          +  +  V T ++
Sbjct: 135 AYLHSHNMIHRDIKAGNILLT----EPGQVKLADFGSASK-------SSPANSFVGTPYW 183

Query: 200 RAPELLLGAR--HYTKAIDIWAIGCIFAELLTSEP----------IFHCRQEDIKT 243
            APE++L      Y   +D+W++G    EL   +P          ++H  Q D  T
Sbjct: 184 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPT 239

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 83.3 bits (206), Expect = 1e-18
 Identities = 62/218 (28%), Positives = 102/218 (46%), Gaps = 32/218 (14%)

Query: 28  GRGTYGHVYKARRKDNSDTRDYALKQIE-GTGLSMSA-CREIALLRELKHPNVINLISVF 85
           G G +G VYKA+ K+       A K I+  +   +     EI +L E KHPN++ L   +
Sbjct: 14  GDGAFGKVYKAQHKETG--LFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY 71

Query: 86  LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGM----VKSLLYQILDGIHY 141
                        + E+ LW +I+F      +   + + +G+    ++ +  Q+L+ +++
Sbjct: 72  -------------FYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNF 118

Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
           LHS+ V+HRDLK  NIL+  +    G VK+AD G +         L   D  + T ++ A
Sbjct: 119 LHSHKVIHRDLKAGNILLTLD----GDVKLADFGVSAKN---KSTLQKRDTFIGTPYWMA 171

Query: 202 PELLL----GARHYTKAIDIWAIGCIFAELLTSEPIFH 235
           PE++         Y    DIW++G    EL   EP  H
Sbjct: 172 PEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHH 209

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 82.1 bits (203), Expect = 3e-18
 Identities = 55/218 (25%), Positives = 98/218 (44%), Gaps = 36/218 (16%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELK--------HPNV 78
           + +G +G VY A+++   D   +A+K ++ +   M A  ++  ++  +         P V
Sbjct: 4   ISKGAFGSVYLAKKRSTGDY--FAIKVLKKS--DMIAKNQVTNVKAERAIMMIQGESPYV 59

Query: 79  INLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILD 137
             L   F S +   ++L+ +Y    D   +IK             +P+   K  + +++ 
Sbjct: 60  AKLYYSFQSKD--YLYLVMEYLNGGDCASLIK---------TLGGLPEDWAKQYIAEVVL 108

Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF 197
           G+  LH   ++HRD+KP N+L+     + G +K+ D G +R      K +   D      
Sbjct: 109 GVEDLHQRGIIHRDIKPENLLID----QTGHLKLTDFGLSRNGLENKKFVGTPD------ 158

Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
            Y APE +LG     K  D W++GC+  E L   P FH
Sbjct: 159 -YLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFH 194

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 81.9 bits (202), Expect = 3e-18
 Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 24/214 (11%)

Query: 21  DYEGCKV-GRGTYGHVYKARRKDNSDTRDYALKQI---EGTGLSMSACREIALLRELKHP 76
            Y   +V G G++G     +   NSD + YA+K+I   + +     + +E  LL ++KHP
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHV-NSDQK-YAMKEIRLPKSSSAVEDSRKEAVLLAKMKHP 58

Query: 77  NVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQI 135
           N++     F    D  ++++ +Y +  DL   IK  R         + P+  +     Q+
Sbjct: 59  NIVAFKESF--EADGHLYIVMEYCDGGDLMQKIKLQRGK-------LFPEDTILQWFVQM 109

Query: 136 LDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVV 195
             G+ ++H   VLHRD+K  NI +     + G+VK+ D G ARL  +   P A     V 
Sbjct: 110 CLGVQHIHEKRVLHRDIKSKNIFLT----QNGKVKLGDFGSARLLTS---PGAYACTYVG 162

Query: 196 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
           T +Y  PE+     +  K+ DIW++GCI  EL T
Sbjct: 163 TPYYVPPEIWENMPYNNKS-DIWSLGCILYELCT 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 82.0 bits (202), Expect = 3e-18
 Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 24/217 (11%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIE------GTGLSMSACR-EIALLRELKHP 76
           G  +G+G +G VY     D    R+ A KQ++       T   +SA   EI LL+ L+H 
Sbjct: 7   GKLLGQGAFGRVYLCYDVDTG--RELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHE 64

Query: 77  NVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPV-MVPKGMVKSLLYQI 135
            ++          ++ + +  +Y             + K   K    + + + +    QI
Sbjct: 65  RIVQYYGCLRDRAEKTLTIFMEYMPGG---------SVKDQLKAYGALTESVTRKYTRQI 115

Query: 136 LDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVV 195
           L+G+ YLHSN ++HRD+K ANIL        G VK+ D G ++           +  V  
Sbjct: 116 LEGMSYLHSNMIVHRDIKGANILRDSA----GNVKLGDFGASKRLQTICMSGTGIRSVTG 171

Query: 196 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 232
           T ++ +PE++ G  +  KA D+W++GC   E+LT +P
Sbjct: 172 TPYWMSPEVISGEGYGRKA-DVWSLGCTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 82.0 bits (202), Expect = 3e-18
 Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 24/214 (11%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI------EGTGLSMSACR-EIALLRELKHPNVI 79
           +GRG +G VY     D    R+ A+KQ+      + T   ++A   EI LL+ L+H  ++
Sbjct: 10  LGRGAFGEVYLCYDADTG--RELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67

Query: 80  NLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDG 138
                     ++K+ +  +Y     +   +K + A   N         + +    QIL G
Sbjct: 68  QYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTEN---------VTRRYTRQILQG 118

Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + YLHSN ++HRD+K ANIL        G VK+ D G ++           +  V  T +
Sbjct: 119 VSYLHSNMIVHRDIKGANILRDSA----GNVKLGDFGASKRIQTICMSGTGIKSVTGTPY 174

Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 232
           + +PE++ G  +  KA D+W++ C   E+LT +P
Sbjct: 175 WMSPEVISGEGYGRKA-DVWSVACTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 81.6 bits (201), Expect = 4e-18
 Identities = 56/213 (26%), Positives = 101/213 (47%), Gaps = 27/213 (12%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           ++G GTYG VYKAR  +  +     + ++E         +EI ++++ KH N++     +
Sbjct: 16  RIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY 75

Query: 86  LSHNDRKVWLLFDY----AEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHY 141
           L  +  K+W+  ++    +  D++H+               + +  +  +  + L G++Y
Sbjct: 76  LRRD--KLWICMEFCGGGSLQDIYHVTG------------PLSESQIAYVSRETLQGLYY 121

Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
           LHS   +HRD+K ANIL+     + G VK+AD G +         +A     + T ++ A
Sbjct: 122 LHSKGKMHRDIKGANILLT----DNGHVKLADFGVSAQIT---ATIAKRKSFIGTPYWMA 174

Query: 202 PELLLGARH--YTKAIDIWAIGCIFAELLTSEP 232
           PE+    R   Y +  DIWA+G    EL   +P
Sbjct: 175 PEVAAVERKGGYNQLCDIWAVGITAIELAELQP 207

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 81.2 bits (200), Expect = 5e-18
 Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 24/214 (11%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIE------GTGLSMSACR-EIALLRELKHPNVI 79
           +G+G +G VY     D    R+ A+KQ++       T   ++A   EI LL+ L H  ++
Sbjct: 10  LGQGAFGRVYLCYDADTG--RELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67

Query: 80  NLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDG 138
                     +R + +  ++     +   +K + A   N         + +    QIL+G
Sbjct: 68  QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTEN---------VTRKYTRQILEG 118

Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + YLHSN ++HRD+K ANIL        G VK+ D G ++           +  V  T +
Sbjct: 119 VSYLHSNMIVHRDIKGANILRDSV----GNVKLGDFGASKRLQTICLSGTGMKSVTGTPY 174

Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 232
           + +PE++ G  +  KA DIW++GC   E+LT +P
Sbjct: 175 WMSPEVISGEGYGRKA-DIWSVGCTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 81.3 bits (201), Expect = 7e-18
 Identities = 64/217 (29%), Positives = 93/217 (42%), Gaps = 33/217 (15%)

Query: 26  KVGRGTYGHVYKARRKDNSD--TRDYALKQI--EGTGLSMSAC-REIALLRELKHPNVIN 80
           ++G G +G V   R     D      A+K +   G     S   REI +LR L H N++ 
Sbjct: 11  QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVK 70

Query: 81  LISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLY--QILD 137
              V      R + L+ +Y     L   ++ HR     K+           LL+  QI  
Sbjct: 71  YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKR----------LLLFSSQICK 120

Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNP-----LKPLADLDP 192
           G+ YL S   +HRDL   NILV  E      VKI+D G A++         +K   +  P
Sbjct: 121 GMDYLGSQRYIHRDLAARNILVESE----DLVKISDFGLAKVLPEDKDYYYVKEPGES-P 175

Query: 193 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
           +   FWY APE L  ++  + + D+W+ G    EL T
Sbjct: 176 I---FWY-APECLRTSKFSSAS-DVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 79.7 bits (196), Expect = 2e-17
 Identities = 65/220 (29%), Positives = 106/220 (48%), Gaps = 30/220 (13%)

Query: 21  DYEGC-KVGRGTYGHVYKARRKDNSDTRDYALKQIE-GTGLSMSACREIALLRELKHPNV 78
           DYE   +VG GTYG VYKAR     +     + ++E G   S+   +EI +++E KH N+
Sbjct: 10  DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQ-QEIFMVKECKHCNI 68

Query: 79  INLISVFLSHNDRKVWLLFDY----AEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQ 134
           +     +LS    K+W+  +Y    +  D++H+               + +  +  +  +
Sbjct: 69  VAYFGSYLSR--EKLWICMEYCGGGSLQDIYHVTG------------PLSELQIAYVCRE 114

Query: 135 ILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVV 194
            L G+ YLHS   +HRD+K ANIL+     + G VK+AD G A         +A     +
Sbjct: 115 TLQGLAYLHSKGKMHRDIKGANILLT----DNGDVKLADFGVAAKIT---ATIAKRKSFI 167

Query: 195 VTFWYRAPELLLGARH--YTKAIDIWAIGCIFAELLTSEP 232
            T ++ APE+    ++  Y +  DIWA+G    EL   +P
Sbjct: 168 GTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQP 207

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 80.1 bits (197), Expect = 3e-17
 Identities = 59/214 (27%), Positives = 107/214 (50%), Gaps = 30/214 (14%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-----CREIALLRELKHPNVIN 80
           ++G G++G VY AR    ++    A+K++  +G   +       +E+  L+ +KHPN I 
Sbjct: 32  EIGHGSFGAVYFARDVRTNEV--VAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIE 89

Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIH 140
               +L   +   WL+ +Y       +++ H      KKP+   +  + ++ +  L G+ 
Sbjct: 90  YKGCYL--REHTAWLVMEYCLGSASDLLEVH------KKPLQEVE--IAAITHGALQGLA 139

Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YLHS+ ++HRD+K  NIL+     E G+VK+AD G A +        +  +  V T ++ 
Sbjct: 140 YLHSHNMIHRDIKAGNILLT----EPGQVKLADFGSASI-------ASPANSFVGTPYWM 188

Query: 201 APELLLGAR--HYTKAIDIWAIGCIFAELLTSEP 232
           APE++L      Y   +D+W++G    EL   +P
Sbjct: 189 APEVILAMDEGQYDGKVDVWSLGITCIELAERKP 222

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 79.2 bits (196), Expect = 3e-17
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 31/220 (14%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACR-EIALLREL-KHPNVINLISV 84
           +G GTYG VYKAR K     +  A+K ++         + E  +LR+   HPN+      
Sbjct: 14  IGEGTYGKVYKARHKKTG--QLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGA 71

Query: 85  FLSHNDR----KVWLLFDYAEH----DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQIL 136
           F+  N      ++WL+ +        DL             KK   + +  +  +L + L
Sbjct: 72  FIKKNPPGNDDQLWLVMELCGGGSVTDL--------VKGLRKKGKRLKEEWIAYILRETL 123

Query: 137 DGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVT 196
            G+ YLH N V+HRD+K  NIL+     +   VK+ D G +   +     L   +  + T
Sbjct: 124 RGLAYLHENKVIHRDIKGQNILLT----KNAEVKLVDFGVSAQLD---STLGRRNTFIGT 176

Query: 197 FWYRAPELLLG----ARHYTKAIDIWAIGCIFAELLTSEP 232
            ++ APE++         Y    D+W++G    EL   +P
Sbjct: 177 PYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKP 216

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 79.7 bits (196), Expect = 4e-17
 Identities = 61/214 (28%), Positives = 108/214 (50%), Gaps = 30/214 (14%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-----CREIALLRELKHPNVIN 80
           ++G G++G VY AR   NS+    A+K++  +G   +       +E+  L++L+HPN I 
Sbjct: 22  EIGHGSFGAVYFARDVRNSEV--VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79

Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIH 140
               +L   +   WL+ +Y       +++ H      KKP+   +  + ++ +  L G+ 
Sbjct: 80  YRGCYL--REHTAWLVMEYCLGSASDLLEVH------KKPLQEVE--IAAVTHGALQGLA 129

Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YLHS+ ++HRD+K  NIL+     E G VK+ D G A +       +A  +  V T ++ 
Sbjct: 130 YLHSHNMIHRDVKAGNILLS----EPGLVKLGDFGSASI-------MAPANXFVGTPYWM 178

Query: 201 APELLLGAR--HYTKAIDIWAIGCIFAELLTSEP 232
           APE++L      Y   +D+W++G    EL   +P
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 79.3 bits (195), Expect = 4e-17
 Identities = 59/229 (25%), Positives = 106/229 (46%), Gaps = 33/229 (14%)

Query: 17  EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHP 76
           E+ ++  G ++G G +G VYKA+ K+        +   +          EI +L    HP
Sbjct: 4   EEFWEIIG-ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHP 62

Query: 77  NVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKAN------KKPVMVPKGMVKS 130
           N++ L+  F             Y E++LW +I+F      +      ++P+  P+  ++ 
Sbjct: 63  NIVKLLDAF-------------YYENNLWILIEFCAGGAVDAVMLELERPLTEPQ--IRV 107

Query: 131 LLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADL 190
           +  Q L+ ++YLH N ++HRDLK  NIL   +    G +K+AD G +       + +   
Sbjct: 108 VCKQTLEALNYLHENKIIHRDLKAGNILFTLD----GDIKLADFGVSA---KNTRTIQRR 160

Query: 191 DPVVVTFWYRAPELLL----GARHYTKAIDIWAIGCIFAELLTSEPIFH 235
           D  + T ++ APE+++      R Y    D+W++G    E+   EP  H
Sbjct: 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHH 209

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 79.2 bits (195), Expect = 4e-17
 Identities = 62/220 (28%), Positives = 111/220 (50%), Gaps = 45/220 (20%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACRE-----IALLRELKHPNVIN 80
           K+G+G  G VY A   D +  ++ A+KQ+    L     +E     I ++RE KHPN++N
Sbjct: 26  KIGQGASGTVYTA--IDVATGQEVAIKQMN---LQQQPKKELIINEILVMRENKHPNIVN 80

Query: 81  LISVFLSHNDRKVWLLFDY-AEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGI 139
            +  +L  ++  +W++ +Y A   L  ++              + +G + ++  + L  +
Sbjct: 81  YLDSYLVGDE--LWVVMEYLAGGSLTDVVT----------ETCMDEGQIAAVCRECLQAL 128

Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP------- 192
            +LHSN V+HRD+K  NIL+   G++ G VK+ D GF           A + P       
Sbjct: 129 EFLHSNQVIHRDIKSDNILL---GMD-GSVKLTDFGFC----------AQITPEQSKRST 174

Query: 193 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 232
           +V T ++ APE++   + Y   +DIW++G +  E++  EP
Sbjct: 175 MVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMVEGEP 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 77.5 bits (190), Expect = 2e-16
 Identities = 57/212 (26%), Positives = 109/212 (51%), Gaps = 25/212 (11%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQ--IEGTGLSMSACREIALLRELKHPNVINLIS 83
           K+G+G  G VY A   D +  ++ A++Q  ++          EI ++RE K+PN++N + 
Sbjct: 27  KIGQGASGTVYTA--MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 84

Query: 84  VFLSHNDRKVWLLFDY-AEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYL 142
            +L  ++  +W++ +Y A   L  ++              + +G + ++  + L  + +L
Sbjct: 85  SYLVGDE--LWVVMEYLAGGSLTDVVT----------ETCMDEGQIAAVCRECLQALEFL 132

Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAP 202
           HSN V+HRD+K  NIL+   G++ G VK+ D GF           + +   V T ++ AP
Sbjct: 133 HSNQVIHRDIKSDNILL---GMD-GSVKLTDFGFCAQITPEQSKRSTM---VGTPYWMAP 185

Query: 203 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           E++   + Y   +DIW++G +  E++  EP +
Sbjct: 186 EVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPY 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 76.9 bits (189), Expect = 2e-16
 Identities = 63/223 (28%), Positives = 107/223 (47%), Gaps = 41/223 (18%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIE-GTGLSMSACR-------EIALLRELKHPNV 78
           +G+G YG VY       +  +  A+KQ+E  T   ++A +       E+ LL+ LKH N+
Sbjct: 8   LGKGAYGTVYCGL---TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64

Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDG 138
           +  +   L  N   +++ F          +     +    +   +P+ +      QILDG
Sbjct: 65  VQYLGTCLDDNTISIFMEF----------VPGGSISSILNRFGPLPEPVFCKYTKQILDG 114

Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF---------NNPLKPLAD 189
           + YLH+N V+HRD+K  N+++M  GI    +K+ D G AR           +N LK +  
Sbjct: 115 VAYLHNNCVVHRDIKGNNVMLMPNGI----IKLIDFGCARRLAWVGLHGTHSNMLKSMHG 170

Query: 190 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 232
                 T ++ APE++  + +  K+ DIW+IGC   E+ T +P
Sbjct: 171 ------TPYWMAPEVINESGYGRKS-DIWSIGCTVFEMATGKP 206

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 78.6 bits (193), Expect = 3e-16
 Identities = 70/237 (29%), Positives = 111/237 (46%), Gaps = 39/237 (16%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIALLRELKHPNVINL 81
           K+G G +G V+  + K   +   +  K I   GL          E+ ++RELKH N++  
Sbjct: 20  KIGNGRFGEVFLVKHKRTQEF--FCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRY 77

Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIH 140
           I  FL+  ++K+++L ++ +  DL   I+     K  K    + +  +  +  Q+L  + 
Sbjct: 78  IDRFLNKANQKLYILMEFCDAGDLSRNIQ-----KCYKMFGKIEEHAIVDITRQLLHALA 132

Query: 141 YLHS-------NWVLHRDLKPANILVMGEGIER------------GR--VKIADMGFARL 179
           Y H+         VLHRDLKP NI  +  GI              GR   KI D G ++ 
Sbjct: 133 YCHNLKDGPNGERVLHRDLKPQNIF-LSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK- 190

Query: 180 FNNPLKPLADLDPVVVTFWYRAPELLLG-ARHYTKAIDIWAIGCIFAELLTSEPIFH 235
            N  ++ +A     V T +Y +PELLL   + Y    D+WA+GCI  EL + +  FH
Sbjct: 191 -NIGIESMA--HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244

Length = 1021

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 76.2 bits (188), Expect = 3e-16
 Identities = 60/235 (25%), Positives = 102/235 (43%), Gaps = 31/235 (13%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG---LSMSACREIALLRELKHPNVINLI 82
           ++G G  G V K   +        A+K I       +     RE+ +L +   P ++   
Sbjct: 8   ELGAGNSGVVSKVLHRPTGKI--MAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFY 65

Query: 83  SVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYL 142
             F ++ D  + +  +Y   D   + K  +  +       +P+ ++  +   +L G+ YL
Sbjct: 66  GAFYNNGD--ISICMEYM--DGGSLDKILKEVQGR-----IPERILGKIAVAVLKGLTYL 116

Query: 143 HSNW-VLHRDLKPANILVMGEGIERGRVKIADMGFA-RLFNNPLKPLADLDPVVVTFWYR 200
           H    ++HRD+KP+NILV      RG++K+ D G + +L N+    LA     V T  Y 
Sbjct: 117 HEKHKIIHRDVKPSNILVN----SRGQIKLCDFGVSGQLVNS----LAKTF--VGTSSYM 166

Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 255
           APE + G   Y+   DIW++G    EL T    F    E+      +  + L  I
Sbjct: 167 APERIQGN-DYSVKSDIWSLGLSLIELATGR--FPYPPENDPPDGIF--ELLQYI 216

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 76.7 bits (189), Expect = 3e-16
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 30/216 (13%)

Query: 25  CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-LSMSACR----EIALLRELKHPNVI 79
             VG GT+G V+  R  D      YALK +     + +   +    E  +L+E+ HP +I
Sbjct: 7   KTVGTGTFGRVHLVR--DRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFII 64

Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGI 139
            L   +  H+ R +++L +Y       +  + R +                   +I+  +
Sbjct: 65  RLF--WTEHDQRFLYMLMEYVPGG--ELFSYLRNSGR------FSNSTGLFYASEIVCAL 114

Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVV-TFW 198
            YLHS  +++RDLKP NIL+  E    G +K+ D GFA       K L D    +  T  
Sbjct: 115 EYLHSKEIVYRDLKPENILLDKE----GHIKLTDFGFA-------KKLRDRTWTLCGTPE 163

Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           Y APE ++ ++ + KA+D WA+G +  E+L   P F
Sbjct: 164 YLAPE-VIQSKGHNKAVDWWALGILIYEMLVGYPPF 198

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 76.3 bits (187), Expect = 5e-16
 Identities = 58/212 (27%), Positives = 109/212 (51%), Gaps = 25/212 (11%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQ--IEGTGLSMSACREIALLRELKHPNVINLIS 83
           K+G+G  G VY A   D +  ++ A+KQ  ++          EI ++RE K+PN++N + 
Sbjct: 26  KIGQGASGTVYTAI--DIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 83

Query: 84  VFLSHNDRKVWLLFDY-AEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYL 142
            +L  ++  +W++ +Y A   L  ++              + +G + ++  + L  + +L
Sbjct: 84  SYLVGDE--LWVVMEYLAGGSLTDVVT----------ETCMDEGQIAAVCRECLQALDFL 131

Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAP 202
           HSN V+HRD+K  NIL+   G++ G VK+ D GF           + +   V T ++ AP
Sbjct: 132 HSNQVIHRDIKSDNILL---GMD-GSVKLTDFGFCAQITPEQSKRSTM---VGTPYWMAP 184

Query: 203 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           E++   + Y   +DIW++G +  E++  EP +
Sbjct: 185 EVVT-RKAYGPKVDIWSLGIMAIEMVEGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 75.0 bits (184), Expect = 9e-16
 Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 24/216 (11%)

Query: 26  KVGRGTYGHVYKAR-RKDNSDTRDYALKQIEGTGL----SMSACREIALLRELKHPNVIN 80
           ++G+G++G VY  + +K  ++ R   LK+I    L    ++ A +E  LL +L HP ++ 
Sbjct: 7   RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66

Query: 81  LISVFLSHNDRKVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGI 139
             + FL  +     ++ +Y E  DL    K        K    + +  V     Q+L G+
Sbjct: 67  FHASFLERDA--FCIITEYCEGRDL--DCKLEELKHTGKT---LSENQVCEWFIQLLLGV 119

Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVV-TFW 198
           HY+H   +LHRDLK  NI      ++   +KI D G +RL    L    DL      T +
Sbjct: 120 HYMHQRRILHRDLKAKNIF-----LKNNLLKIGDFGVSRL----LMGSCDLATTFTGTPY 170

Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           Y +PE L    + +K+ DIW++GCI  E+      F
Sbjct: 171 YMSPEALKHQGYDSKS-DIWSLGCILYEMCCLAHAF 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 75.1 bits (184), Expect = 1e-15
 Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 26/211 (12%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI---EGTGLSMSACREIALLRELKHPNVINLI 82
           K+G+G++G V+K    DN   +  A+K I   E         +EI +L +   P V    
Sbjct: 11  KIGKGSFGEVFKG--IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68

Query: 83  SVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYL 142
             +L   D K+W++ +Y             +A    +P  + +  + ++L +IL G+ YL
Sbjct: 69  GSYL--KDTKLWIIMEYLGGG---------SALDLLEPGPLDETQIATILREILKGLDYL 117

Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA-RLFNNPLKPLADLDPVVVTFWYRA 201
           HS   +HRD+K AN+L+     E G VK+AD G A +L +  +K     +  V T ++ A
Sbjct: 118 HSEKKIHRDIKAANVLLS----EHGEVKLADFGVAGQLTDTQIKR----NTFVGTPFWMA 169

Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEP 232
           PE++  + + +KA DIW++G    EL   EP
Sbjct: 170 PEVIKQSAYDSKA-DIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 75.1 bits (184), Expect = 1e-15
 Identities = 55/218 (25%), Positives = 99/218 (45%), Gaps = 28/218 (12%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           ++G G +G VYKA+ K+        + + +          EI +L    HP ++ L+  F
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 86  LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGM----VKSLLYQILDGIHY 141
                        Y +  LW +I+F      +   + + +G+    ++ +  Q+L+ + Y
Sbjct: 79  -------------YWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQY 125

Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
           LHS  ++HRDLK  N+L+  +    G +K+AD G +      +K L   D  + T ++ A
Sbjct: 126 LHSMKIIHRDLKAGNVLLTLD----GDIKLADFGVSA---KNVKTLQRRDSFIGTPYWMA 178

Query: 202 PELLLGARH----YTKAIDIWAIGCIFAELLTSEPIFH 235
           PE+++        Y    DIW++G    E+   EP  H
Sbjct: 179 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH 216

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 75.7 bits (186), Expect = 2e-15
 Identities = 65/218 (29%), Positives = 105/218 (48%), Gaps = 32/218 (14%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIALLRELKHPNVINLI 82
           +G G  G V  A+R   SD   +A+K ++  G+S      A  E+  L      +++   
Sbjct: 40  LGSGATGTVLCAKRV--SDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCH 97

Query: 83  SVFLSHNDRK------VWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQI 135
             F   + R       + L+ DYA   DL   IK    AK N+       G+   L  Q+
Sbjct: 98  EDFAKKDPRNPENVLMIALVLDYANAGDLRQEIK--SRAKTNRTFREHEAGL---LFIQV 152

Query: 136 LDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVV 195
           L  +H++HS  ++HRD+K ANIL+   G+    VK+ D GF++++   +      D V  
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGL----VKLGDFGFSKMYAATVS-----DDVGR 203

Query: 196 TF----WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
           TF    +Y APE+    + Y+K  D++++G +  ELLT
Sbjct: 204 TFCGTPYYVAPEIWR-RKPYSKKADMFSLGVLLYELLT 240

Length = 496

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 73.7 bits (181), Expect = 5e-15
 Identities = 66/227 (29%), Positives = 107/227 (47%), Gaps = 39/227 (17%)

Query: 19  LFDYE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-LSMSACREIA----LLRE 72
           L D+E G  +G G++G V  A+ K   +   YA+K ++    L M   + +A    +L E
Sbjct: 17  LSDFEMGETLGTGSFGRVRIAKHKGTGEY--YAIKCLKKREILKMKQVQHVAQEKSILME 74

Query: 73  LKHPNVINLISVFLSHNDRKVWLLFDY---AEHDLWHIIKFHRAAKANKKPVMVPKGMVK 129
           L HP ++N++  F   ++ +V+ L ++    E        F    KA + P  V K    
Sbjct: 75  LSHPFIVNMMCSFQ--DENRVYFLLEFVVGGE-------LFTHLRKAGRFPNDVAK---- 121

Query: 130 SLLY--QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPL 187
              Y  +++    YLHS  +++RDLKP N+L+  +    G VK+ D GFA+   +    L
Sbjct: 122 --FYHAELVLAFEYLHSKDIIYRDLKPENLLLDNK----GHVKVTDFGFAKKVPDRTFTL 175

Query: 188 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
                   T  Y APE++    H  KA+D W +G +  E +   P F
Sbjct: 176 CG------TPEYLAPEVIQSKGH-GKAVDWWTMGVLLYEFIAGYPPF 215

Length = 329

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 72.4 bits (177), Expect = 1e-14
 Identities = 63/211 (29%), Positives = 104/211 (49%), Gaps = 26/211 (12%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI---EGTGLSMSACREIALLRELKHPNVINLI 82
           ++G+G++G VYK    DN      A+K I   E         +EI +L +   P +    
Sbjct: 11  RIGKGSFGEVYKG--IDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYY 68

Query: 83  SVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYL 142
             +L     K+W++ +Y             +A    KP  + +  + ++L +IL G+ YL
Sbjct: 69  GSYLKGT--KLWIIMEYLGGG---------SALDLLKPGPLEETYIATILREILKGLDYL 117

Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA-RLFNNPLKPLADLDPVVVTFWYRA 201
           HS   +HRD+K AN+L+     E+G VK+AD G A +L +  +K     +  V T ++ A
Sbjct: 118 HSERKIHRDIKAANVLLS----EQGDVKLADFGVAGQLTDTQIKR----NTFVGTPFWMA 169

Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEP 232
           PE++  + +  KA DIW++G    EL   EP
Sbjct: 170 PEVIKQSAYDFKA-DIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 71.7 bits (175), Expect = 2e-14
 Identities = 55/212 (25%), Positives = 109/212 (51%), Gaps = 25/212 (11%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI--EGTGLSMSACREIALLRELKHPNVINLIS 83
           K+G+G  G V+ A   D +  ++ A+KQI  +          EI +++ELK+PN++N + 
Sbjct: 26  KIGQGASGTVFTA--IDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLD 83

Query: 84  VFLSHNDRKVWLLFDY-AEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYL 142
            FL  ++  ++++ +Y A   L  ++              + +  + ++  + L  + +L
Sbjct: 84  SFLVGDE--LFVVMEYLAGGSLTDVVT----------ETCMDEAQIAAVCRECLQALEFL 131

Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAP 202
           H+N V+HRD+K  N+L+   G++ G VK+ D GF           + +   V T ++ AP
Sbjct: 132 HANQVIHRDIKSDNVLL---GMD-GSVKLTDFGFCAQITPEQSKRSTM---VGTPYWMAP 184

Query: 203 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           E++   + Y   +DIW++G +  E++  EP +
Sbjct: 185 EVVT-RKAYGPKVDIWSLGIMAIEMVEGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 70.2 bits (172), Expect = 5e-14
 Identities = 55/208 (26%), Positives = 90/208 (43%), Gaps = 25/208 (12%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           K+G G +G V++   K+        LK  +         +E+  L+ L+H ++I+L +V 
Sbjct: 13  KLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQ-KEVQALKRLRHKHLISLFAVC 71

Query: 86  LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLY---QILDGIHYL 142
                  V+++ +  E        F R+ +    PV        SL+    Q+ +G+ YL
Sbjct: 72  SV--GEPVYIITELMEKGSLLA--FLRSPEGQVLPV-------ASLIDMACQVAEGMAYL 120

Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLD-PVVVTFWYRA 201
                +HRDL   NILV GE +     K+AD G ARL    +   +D   P   T    A
Sbjct: 121 EEQNSIHRDLAARNILV-GEDLV---CKVADFGLARLIKEDVYLSSDKKIPYKWT----A 172

Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
           PE       ++   D+W+ G +  E+ T
Sbjct: 173 PE-AASHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 70.4 bits (172), Expect = 7e-14
 Identities = 58/223 (26%), Positives = 98/223 (43%), Gaps = 55/223 (24%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKH----------- 75
           +G+GT+G VY+ R+KD    R YA+K +          +EI   +E+ H           
Sbjct: 1   IGKGTFGQVYQVRKKDTR--RIYAMKVLSK--------KEIVAKKEVAHTIGERNILVRT 50

Query: 76  -----PNVINLISVFLSHNDRKVWLLFDYAEHD--LWHIIKFHRAAKANKKPVMVPKGMV 128
                P ++ L   F + +D  ++L+ DY       WH+ K  R            +   
Sbjct: 51  LLDESPFIVGLKFSFQTDSD--LYLVTDYMSGGELFWHLQKEGR----------FSEDRA 98

Query: 129 KSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLA 188
           K  + +++  + +LH   +++RDLKP NIL+   G     + + D G +       K   
Sbjct: 99  KFYIAELVLALEHLHKYDIVYRDLKPENILLDATG----HIALCDFGLS-------KANL 147

Query: 189 DLDPVVVTFW----YRAPELLLGARHYTKAIDIWAIGCIFAEL 227
             +    TF     Y APE+LL  + YTK +D W++G +  E+
Sbjct: 148 TDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 69.6 bits (170), Expect = 7e-14
 Identities = 72/263 (27%), Positives = 119/263 (45%), Gaps = 41/263 (15%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLREL--------KHPNV 78
           +GRG +G VY  R+ D    + YA+K ++   + M     +AL   +          P +
Sbjct: 2   IGRGGFGEVYGCRKADTG--KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59

Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDG 138
           + +   F  H   K+  + D       H   +H +       V   K M +    +I+ G
Sbjct: 60  VCMTYAF--HTPDKLCFILDLMNGGDLH---YHLSQHG----VFSEKEM-RFYATEIILG 109

Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + ++H+ +V++RDLKPANIL+     E G V+I+D+G A  F+   KP A     V T  
Sbjct: 110 LEHMHNRFVVYRDLKPANILLD----EHGHVRISDLGLACDFSKK-KPHAS----VGTHG 160

Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           Y APE+L     Y  + D +++GC+  +LL     F  RQ   K  +     ++DR+   
Sbjct: 161 YMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF--RQHKTKDKH-----EIDRMTLT 213

Query: 259 MGFPLEKDWEDIRKMPEHPTLLK 281
           +   L   +      PE  +LL+
Sbjct: 214 VNVELPDSFS-----PELKSLLE 231

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 69.7 bits (170), Expect = 8e-14
 Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 26/211 (12%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI---EGTGLSMSACREIALLRELKHPNVINLI 82
           ++G+G++G V+K    DN   +  A+K I   E         +EI +L +   P V    
Sbjct: 11  RIGKGSFGEVFKG--IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68

Query: 83  SVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYL 142
             +L     K+W++ +Y        +   RA   ++         + ++L +IL G+ YL
Sbjct: 69  GSYLKGT--KLWIIMEYLGGG--SALDLLRAGPFDEF-------QIATMLKEILKGLDYL 117

Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA-RLFNNPLKPLADLDPVVVTFWYRA 201
           HS   +HRD+K AN+L+     E+G VK+AD G A +L +  +K     +  V T ++ A
Sbjct: 118 HSEKKIHRDIKAANVLLS----EQGDVKLADFGVAGQLTDTQIKR----NTFVGTPFWMA 169

Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEP 232
           PE++  + + +KA DIW++G    EL   EP
Sbjct: 170 PEVIQQSAYDSKA-DIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 69.0 bits (169), Expect = 1e-13
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 25/208 (12%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI---EGTGLSMSACREIALLRELKHPNVINLI 82
           ++G G  G V K R K+      +ALK I       L     RE+ + +  K P ++   
Sbjct: 8   RLGEGAGGSVTKCRLKNTG--MIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYY 65

Query: 83  SVFLSHNDRKVWLLFDYAE-HDLWHIIK--FHRAAKANKKPVMVPKGMVKSLLYQILDGI 139
             FL  +   + +  +Y E   L  I K    R  +  +K +    G +      +L G+
Sbjct: 66  GAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVL----GKIAE---SVLKGL 118

Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
            YLHS  ++HRD+KP+NIL+      +G+VK+ D G +    N L           T +Y
Sbjct: 119 SYLHSRKIIHRDIKPSNILLT----RKGQVKLCDFGVSGELVNSLA-----GTFTGTSFY 169

Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAEL 227
            APE + G + Y+   D+W++G    E+
Sbjct: 170 MAPERIQG-KPYSITSDVWSLGLTLLEV 196

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 68.9 bits (168), Expect = 2e-13
 Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 32/220 (14%)

Query: 27  VGRGTYGHVYK-ARRKDNSDTRDYALKQIEGTGLSMSACREIALLREL-KHPNVINLISV 84
           +G+GTYG VYK   +KD S      L  I      + A  E  +L+ L  HPNV+    +
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEA--EYNILQSLPNHPNVVKFYGM 87

Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKAN-------KKPVMVPKGMVKSLLYQILD 137
           F   +              LW +++                    + + M+  +LY  L 
Sbjct: 88  FYKADK--------LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALL 139

Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGF-ARLFNNPLKPLADLDPVVVT 196
           G+ +LH+N ++HRD+K  NIL+  E    G VK+ D G  A+L +  L+     +  V T
Sbjct: 140 GLQHLHNNRIIHRDVKGNNILLTTE----GGVKLVDFGVSAQLTSTRLRR----NTSVGT 191

Query: 197 FWYRAPELLLGARHYTKA----IDIWAIGCIFAELLTSEP 232
            ++ APE++   + Y  +     D+W++G    EL   +P
Sbjct: 192 PFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDP 231

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 68.7 bits (168), Expect = 2e-13
 Identities = 56/222 (25%), Positives = 97/222 (43%), Gaps = 26/222 (11%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIAL-----LRELKHPNVINL 81
           +G+G +G V   + K     + YA K+++   L      ++AL     L ++    +++L
Sbjct: 1   LGKGGFGEVCACQVKATG--KMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL 58

Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIH 140
              F       + L+       DL    K+H     N      P+        QI+ G+ 
Sbjct: 59  AYAF--ETKDDLCLVMTLMNGGDL----KYH---IYNVGEPGFPEARAIFYAAQIICGLE 109

Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           +LH   +++RDLKP N+L+     + G V+I+D+G A       K          T  Y 
Sbjct: 110 HLHQRRIVYRDLKPENVLLD----DHGNVRISDLGLAVELKGGKKIKGR----AGTPGYM 161

Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 242
           APE+L G   Y  ++D +A+GC   E++     F  R+E ++
Sbjct: 162 APEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 70.3 bits (172), Expect = 2e-13
 Identities = 54/177 (30%), Positives = 79/177 (44%), Gaps = 23/177 (12%)

Query: 65  REIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVP 124
           RE AL   L HPN++ L+    +     ++ +F+Y         +  R   A    +  P
Sbjct: 27  RETALCARLYHPNIVALLDSGEAPPGL-LFAVFEYVPG------RTLREVLAADGAL--P 77

Query: 125 KGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPL 184
            G    L+ Q+LD +   H+  ++HRDLKP NI+V   G+     K+ D G   L    L
Sbjct: 78  AGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRP-HAKVLDFGIGTL----L 132

Query: 185 KPLADLD--------PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI 233
             + D D         V+ T  Y APE L G    T   D++A G IF E LT + +
Sbjct: 133 PGVRDADVATLTRTTEVLGTPTYCAPEQLRG-EPVTPNSDLYAWGLIFLECLTGQRV 188

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 68.9 bits (168), Expect = 2e-13
 Identities = 57/213 (26%), Positives = 104/213 (48%), Gaps = 31/213 (14%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACRE-----IALLRELKHPNVIN 80
           K+G G+ G V  AR K +   R  A+K ++   L     RE     + ++R+ +H NV+ 
Sbjct: 28  KIGEGSTGIVCIAREKHSG--RQVAVKMMD---LRKQQRRELLFNEVVIMRDYQHQNVVE 82

Query: 81  LISVFLSHNDRKVWLLFDYAEHD-LWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGI 139
           +   +L     ++W+L ++ +   L  I+   R  +            + ++   +L  +
Sbjct: 83  MYKSYLV--GEELWVLMEFLQGGALTDIVSQTRLNEEQ----------IATVCESVLQAL 130

Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
            YLHS  V+HRD+K  +IL+  +    GRVK++D GF    +   K +     +V T ++
Sbjct: 131 CYLHSQGVIHRDIKSDSILLTLD----GRVKLSDFGFCAQIS---KDVPKRKSLVGTPYW 183

Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 232
            APE ++    Y   +DIW++G +  E++  EP
Sbjct: 184 MAPE-VISRTPYGTEVDIWSLGIMVIEMVDGEP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 67.8 bits (166), Expect = 5e-13
 Identities = 63/239 (26%), Positives = 101/239 (42%), Gaps = 59/239 (24%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDY----ALKQIEGTGLSMSAC-REIA-LLREL---- 73
           G  +G G +G V KA      D  +     A+K      L   A  ++++ L+ E+    
Sbjct: 17  GKPLGEGAFGQVVKAEAVG-LDNPNETSTVAVKM-----LKDDATEKDLSDLVSEMEMMK 70

Query: 74  ---KHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHR--AAKANKKPVMVPKGM 127
              KH N+INL+ V     +  ++++ +YA H +L   ++  R     A+      P+  
Sbjct: 71  MIGKHKNIINLLGV--CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEET 128

Query: 128 VK-----SLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN 182
           +      S  YQ+  G+ +L S   +HRDL   N+LV  E      +KIAD G AR  ++
Sbjct: 129 LTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV-TEDHV---MKIADFGLARDIHH 184

Query: 183 ------------PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                       P+K             + APE L   R YT   D+W+ G +  E+ T
Sbjct: 185 IDYYRKTTNGRLPVK-------------WMAPEALF-DRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 67.3 bits (164), Expect = 5e-13
 Identities = 71/271 (26%), Positives = 121/271 (44%), Gaps = 40/271 (14%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISV-- 84
           +GRG +G VY  R+ D    + YA+K ++   + M     +AL   +    +++L+S   
Sbjct: 2   IGRGGFGEVYGCRKADTG--KMYAMKCLDKKRIKMKQGETLALNERI----MLSLVSTGD 55

Query: 85  --------FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQIL 136
                   +  H   K+  + D       H   +H +       V     M +    +I+
Sbjct: 56  CPFIVCMSYAFHTPDKLSFILDLMNGGDLH---YHLSQHG----VFSEAEM-RFYAAEII 107

Query: 137 DGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVT 196
            G+ ++H+ +V++RDLKPANIL+     E G V+I+D+G A  F+   KP A     V T
Sbjct: 108 LGLEHMHNRFVVYRDLKPANILLD----EHGHVRISDLGLACDFSKK-KPHAS----VGT 158

Query: 197 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 256
             Y APE+L     Y  + D +++GC+  +LL     F  RQ   K  +     ++DR+ 
Sbjct: 159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF--RQHKTKDKH-----EIDRMT 211

Query: 257 SVMGFPLEKDWEDIRKMPEHPTLLKDFNEQI 287
             M   L   +    +      L +D N ++
Sbjct: 212 LTMAVELPDSFSPELRSLLEGLLQRDVNRRL 242

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 68.6 bits (168), Expect = 5e-13
 Identities = 73/228 (32%), Positives = 106/228 (46%), Gaps = 34/228 (14%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI-----EGTGLSMSACREIALLRELKHPNVIN 80
            +G+G  G VY A   D   +R  ALK+I     E   L     RE  +  +L HP ++ 
Sbjct: 9   LIGKGGMGEVYLAY--DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66

Query: 81  LISVFLSHNDRKVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLL---YQIL 136
           + S+  S  D  V+    Y E + L  ++K     ++  K  +  K  V + L   ++I 
Sbjct: 67  VYSIC-SDGD-PVYYTMPYIEGYTLKSLLKSVWQKESLSKE-LAEKTSVGAFLSIFHKIC 123

Query: 137 DGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLD----- 191
             I Y+HS  VLHRDLKP NIL+   G+  G V I D G A       + L D+D     
Sbjct: 124 ATIEYVHSKGVLHRDLKPDNILL---GL-FGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179

Query: 192 ----------PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                      +V T  Y APE LLG    +++ DI+A+G I  ++LT
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPA-SESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 67.2 bits (164), Expect = 6e-13
 Identities = 63/237 (26%), Positives = 98/237 (41%), Gaps = 33/237 (13%)

Query: 13  RTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDY---ALKQI-EGTGLSMSA--CRE 66
           R  +E    Y    +G+G +G V++AR         +   A+K + E     M A   RE
Sbjct: 4   RNNIE----YVR-DIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQRE 58

Query: 67  IALLRELKHPNVINLISV------------FLSHNDRKVWLLFD--YAEHDLWHIIKFHR 112
            AL+ E  HPN++ L+ V            ++++ D   +L      A+  L H     R
Sbjct: 59  AALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSAR 118

Query: 113 AAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA 172
               N  P+   + +  +   Q+  G+ YL     +HRDL   N LV     E   VKIA
Sbjct: 119 KCGLNPLPLSCTEQLCIAK--QVAAGMAYLSERKFVHRDLATRNCLVG----ENMVVKIA 172

Query: 173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
           D G +R   +     A  +  +   W   PE +   R YT   D+WA G +  E+ +
Sbjct: 173 DFGLSRNIYSADYYKASENDAIPIRWM-PPESIFYNR-YTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 67.5 bits (165), Expect = 7e-13
 Identities = 61/223 (27%), Positives = 108/223 (48%), Gaps = 41/223 (18%)

Query: 27  VGRGTYGHVYKARRKDNSDT-RDYALKQIEGTGLSMS--------ACREIALLRELKHPN 77
           +G+G YG V++ R+   +DT + +A+K ++   +  +        A R I  L  +KHP 
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNI--LEAVKHPF 61

Query: 78  VINLISVFLSHNDRKVWLLFDY-AEHDLW-HIIKFHRAAKANKKPVMVPKGMVKSLLYQI 135
           +++LI  F      K++L+ +Y +  +L+ H+          ++  +  +      L +I
Sbjct: 62  IVDLIYAF--QTGGKLYLILEYLSGGELFMHL----------EREGIFMEDTACFYLSEI 109

Query: 136 LDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVV 195
              + +LH   +++RDLKP NIL+  +    G VK+ D G         K       V  
Sbjct: 110 SLALEHLHQQGIIYRDLKPENILLDAQ----GHVKLTDFGLC-------KESIHEGTVTH 158

Query: 196 TFW----YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           TF     Y APE+L+ + H  KA+D W++G +  ++LT  P F
Sbjct: 159 TFCGTIEYMAPEILMRSGH-GKAVDWWSLGALMYDMLTGAPPF 200

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 66.6 bits (162), Expect = 9e-13
 Identities = 53/214 (24%), Positives = 107/214 (50%), Gaps = 29/214 (13%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACRE-----IALLRELKHPNVIN 80
           K+G G+ G V  A  K     +  A+K+++   L     RE     + ++R+  H NV++
Sbjct: 29  KIGEGSTGIVCIATEKHTG--KQVAVKKMD---LRKQQRRELLFNEVVIMRDYHHENVVD 83

Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIH 140
           + + +L  ++  +W++ ++ E      I  H   + N++        + ++   +L  + 
Sbjct: 84  MYNSYLVGDE--LWVVMEFLEGGALTDIVTH--TRMNEE-------QIATVCLSVLRALS 132

Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YLH+  V+HRD+K  +IL+  +    GR+K++D GF    +   K +     +V T ++ 
Sbjct: 133 YLHNQGVIHRDIKSDSILLTSD----GRIKLSDFGFCAQVS---KEVPKRKSLVGTPYWM 185

Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           APE ++    Y   +DIW++G +  E++  EP +
Sbjct: 186 APE-VISRLPYGTEVDIWSLGIMVIEMIDGEPPY 218

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 66.9 bits (163), Expect = 1e-12
 Identities = 64/217 (29%), Positives = 105/217 (48%), Gaps = 31/217 (14%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-SMS----ACREIALLRELKHPNVINL 81
           +G+G++G V + R++D    R YALK I    + S S       E  +L ++  P ++ L
Sbjct: 1   IGKGSFGKVMQVRKRDTQ--RIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL 58

Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLY--QILDG 138
              F S    K++L+  +    +L+H     R  + +         + ++  Y  ++L  
Sbjct: 59  KFSFQS--PEKLYLVLAFINGGELFH--HLQREGRFD---------LSRARFYTAELLCA 105

Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           +  LH   V++RDLKP NIL+      +G + + D G  +L    +K     +    T  
Sbjct: 106 LENLHKFNVIYRDLKPENILLD----YQGHIALCDFGLCKL---NMKDDDKTNTFCGTPE 158

Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
           Y APELLLG   YTKA+D W +G +  E+LT  P F+
Sbjct: 159 YLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFY 194

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 66.1 bits (161), Expect = 2e-12
 Identities = 62/215 (28%), Positives = 93/215 (43%), Gaps = 31/215 (14%)

Query: 27  VGRGTYGHVYKAR---RKDNSDTRDYALKQIE-GTGLSMSA--CREIALLRELKHPNVIN 80
           +G G +G V   R     DN+  +  A+K ++  +G +  A   +EI +LR L H N++ 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQ-VAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70

Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLL---YQILD 137
              +        + L+ ++              +     P    K  +K  L    QI  
Sbjct: 71  YKGICTEDGGNGIKLIMEF----------LPSGSLKEYLPRNKNKINLKQQLKYAVQICK 120

Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLA---DLDPVV 194
           G+ YL S   +HRDL   N+LV  E     +VKI D G  +      +      DLD  V
Sbjct: 121 GMDYLGSRQYVHRDLAARNVLVESE----HQVKIGDFGLTKAIETDKEYYTVKDDLDSPV 176

Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
             FWY APE L+ ++ Y  A D+W+ G    ELLT
Sbjct: 177 --FWY-APECLIQSKFY-IASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 65.9 bits (161), Expect = 2e-12
 Identities = 58/225 (25%), Positives = 112/225 (49%), Gaps = 35/225 (15%)

Query: 17  EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACRE-----IALLR 71
             L ++   K+G G+ G V  A  K  S  R  A+K+++   L     RE     + ++R
Sbjct: 19  SYLDNFV--KIGEGSTGIVCIATDK--STGRQVAVKKMD---LRKQQRRELLFNEVVIMR 71

Query: 72  ELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKS 130
           + +HPN++ + S +L     ++W++ ++ E   L  I+   R          + +  + +
Sbjct: 72  DYQHPNIVEMYSSYLV--GDELWVVMEFLEGGALTDIVTHTR----------MNEEQIAT 119

Query: 131 LLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADL 190
           +   +L  + +LH+  V+HRD+K  +IL+  +    GRVK++D GF    +  +     L
Sbjct: 120 VCLAVLKALSFLHAQGVIHRDIKSDSILLTSD----GRVKLSDFGFCAQVSKEVPRRKSL 175

Query: 191 DPVVVTFWYRAPELLLGARH-YTKAIDIWAIGCIFAELLTSEPIF 234
              V T ++ APE++  +R  Y   +DIW++G +  E++  EP +
Sbjct: 176 ---VGTPYWMAPEVI--SRLPYGTEVDIWSLGIMVIEMVDGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 66.0 bits (161), Expect = 2e-12
 Identities = 37/123 (30%), Positives = 60/123 (48%), Gaps = 21/123 (17%)

Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           +I+ G+ +LH   +++RDLK  N+L+  +    G +KIAD G  +   N        +  
Sbjct: 104 EIICGLQFLHKKGIIYRDLKLDNVLLDKD----GHIKIADFGMCKENMN-------GEGK 152

Query: 194 VVTFW----YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED-----IKTS 244
             TF     Y APE+L G + Y +++D W+ G +  E+L  +  FH   ED     I   
Sbjct: 153 ASTFCGTPDYIAPEILKGQK-YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND 211

Query: 245 NPY 247
            P+
Sbjct: 212 RPH 214

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 66.2 bits (161), Expect = 2e-12
 Identities = 73/275 (26%), Positives = 124/275 (45%), Gaps = 49/275 (17%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-------SMSACREIALLRELKHPNVI 79
           +G+G++G V  A+RK   D + YA+K ++   +        + A R + LL+ +KHP ++
Sbjct: 3   IGKGSFGKVLLAKRK--LDGKCYAVKVLQKKIVLNRKEQKHIMAERNV-LLKNVKHPFLV 59

Query: 80  NLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDG 138
            L   F      K++ + D+    +L+    FH      ++    P+   +    +I   
Sbjct: 60  GLHYSF--QTTEKLYFVLDFVNGGELF----FHL-----QRERSFPEPRARFYAAEIASA 108

Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVV--- 195
           + YLHS  +++RDLKP NIL+  +    G V + D G  +      + +A  D       
Sbjct: 109 LGYLHSINIVYRDLKPENILLDSQ----GHVVLTDFGLCK------EGIAQSDTTTTFCG 158

Query: 196 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR- 254
           T  Y APE++   + Y   +D W +G +  E+L   P F+CR       N  H   + R 
Sbjct: 159 TPEYLAPEVIR-KQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRP 217

Query: 255 -----IFSVMGFPLEKDW-------EDIRKMPEHP 277
                 +S++   LEKD        ED  ++ EHP
Sbjct: 218 GASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHP 252

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 65.3 bits (159), Expect = 2e-12
 Identities = 64/218 (29%), Positives = 97/218 (44%), Gaps = 27/218 (12%)

Query: 27  VGRGTYGHVYKARRKD----NSDTRDYALKQI-EGTGLSMSA--CREIALLRELKHPNVI 79
           +G G +G VY+    D     S     A+K + +G          +E  L+    HPN++
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 80  NLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILD- 137
            L+ V L   +   +++ +  E  DL     + R A+  +     P   +K LL   LD 
Sbjct: 63  KLLGVCL--LNEPQYIIMELMEGGDLLS---YLRDARVERFGP--PLLTLKELLDICLDV 115

Query: 138 --GIHYLHSNWVLHRDLKPANILVMGEGIERGR-VKIADMGFAR-LFNNPL--KPLADLD 191
             G  YL     +HRDL   N LV  +G +  R VKI D G AR ++ +    K    L 
Sbjct: 116 AKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175

Query: 192 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
           PV     + APE LL  + +T   D+W+ G +  E+LT
Sbjct: 176 PVR----WMAPESLLDGK-FTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 65.8 bits (160), Expect = 2e-12
 Identities = 62/219 (28%), Positives = 104/219 (47%), Gaps = 30/219 (13%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-------SMSACREIALLRELKHPNVI 79
           +G+G++G V  A+RK  SD   YA+K ++   +        + A R + LL+ LKHP ++
Sbjct: 3   IGKGSFGKVLLAKRK--SDGSFYAVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHPFLV 59

Query: 80  NLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDG 138
            L   F      K++ + DY    +L+    FH      ++  + P+    +   ++   
Sbjct: 60  GLHYSF--QTAEKLYFVLDYVNGGELF----FHLQ---RERCFLEPRARFYAA--EVASA 108

Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           I YLHS  +++RDLKP NIL+  +    G V + D G  +     ++P         T  
Sbjct: 109 IGYLHSLNIIYRDLKPENILLDSQ----GHVVLTDFGLCK---EGVEPEETTSTFCGTPE 161

Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 237
           Y APE +L    Y + +D W +G +  E+L   P F+ R
Sbjct: 162 YLAPE-VLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 41/103 (39%), Positives = 61/103 (59%), Gaps = 14/103 (13%)

Query: 131 LLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADL 190
           L YQI+  +  +HS  ++HRDLK ANI +M  GI    +K+ D GF++ +++ +     L
Sbjct: 174 LFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI----IKLGDFGFSKQYSDSVS----L 225

Query: 191 DPVVVTF----WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
           D V  +F    +Y APEL    R Y+K  D+W++G I  ELLT
Sbjct: 226 D-VASSFCGTPYYLAPELWERKR-YSKKADMWSLGVILYELLT 266

Length = 478

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 65.2 bits (159), Expect = 3e-12
 Identities = 59/221 (26%), Positives = 94/221 (42%), Gaps = 34/221 (15%)

Query: 27  VGRGTYGHVYK------ARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVIN 80
           +G G +G VYK        R   +      LK+     +     +E  L+ +L+HPN++ 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSL--------L 132
           L+ V     ++   +LF+Y  H   H      +  ++       + +  SL         
Sbjct: 73  LLGVCT--KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130

Query: 133 YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL------FNNPLKP 186
            QI  G+ YL S+  +HRDL   N LV GEG+    VKI+D G +R       +    K 
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLV-GEGLT---VKISDFGLSRDIYSADYYRVQSKS 186

Query: 187 LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 227
           L    PV     +  PE +L  + +T   DIW+ G +  E+
Sbjct: 187 LL---PVR----WMPPEAILYGK-FTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 65.4 bits (160), Expect = 3e-12
 Identities = 49/231 (21%), Positives = 91/231 (39%), Gaps = 44/231 (19%)

Query: 28  GRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMS-------ACREIALLRELKHPNVIN 80
           G+G  G V+  R K     + +ALK ++     M           E  +L  L HP +  
Sbjct: 10  GKGDVGRVFLVRLKGTG--KLFALKVLDKK--EMIKRNKVKRVLTEQEILATLDHPFLPT 65

Query: 81  LISVFLSHNDRKVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGI 139
           L + F +  +  + L+ DY    +L+ +++     +   K   + + + +    ++L  +
Sbjct: 66  LYASFQT--ETYLCLVMDYCPGGELFRLLQ-----RQPGK--CLSEEVARFYAAEVLLAL 116

Query: 140 HYLHSNWVLHRDLKPANILVMGEG-------------IERGRVKIADMGFARLFNNPLKP 186
            YLH   +++RDLKP NIL+   G                       +      ++    
Sbjct: 117 EYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176

Query: 187 LADL--DPV-------VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 228
            ++   +         V T  Y APE++ G  H   A+D W +G +  E+L
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEML 226

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 64.8 bits (158), Expect = 4e-12
 Identities = 57/175 (32%), Positives = 82/175 (46%), Gaps = 32/175 (18%)

Query: 65  REIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMV 123
           REI +L+ L+H N++    V  S   R + L+ +Y  +  L   ++ HR    ++K    
Sbjct: 54  REIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRK---- 109

Query: 124 PKGMVKSLLY--QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFN 181
                  LLY  QI  G+ YL S   +HRDL   NILV  E     RVKI D G  ++  
Sbjct: 110 ------LLLYASQICKGMEYLGSKRYVHRDLATRNILVESE----NRVKIGDFGLTKVL- 158

Query: 182 NPLKPLADLDPVVVT-------FWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
            P     D +   V        FWY APE L  ++ ++ A D+W+ G +  EL T
Sbjct: 159 -PQ----DKEYYKVREPGESPIFWY-APESLTESK-FSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 64.1 bits (156), Expect = 7e-12
 Identities = 35/112 (31%), Positives = 60/112 (53%), Gaps = 15/112 (13%)

Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           +I  G+  LH   +++RDLKP NIL+     + G ++I+D+G A         + + + +
Sbjct: 110 EITCGLEDLHRERIVYRDLKPENILLD----DYGHIRISDLGLA-------VEIPEGETI 158

Query: 194 ---VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 242
              V T  Y APE++   R YT + D W +GC+  E++  +  F  R+E +K
Sbjct: 159 RGRVGTVGYMAPEVVKNER-YTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK 209

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 63.9 bits (155), Expect = 9e-12
 Identities = 43/169 (25%), Positives = 88/169 (52%), Gaps = 19/169 (11%)

Query: 66  EIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPK 125
           E+ ++R+ +H NV+ + + +L  ++  +W++ ++ E      I  H   + N++      
Sbjct: 67  EVVIMRDYQHENVVEMYNSYLVGDE--LWVVMEFLEGGALTDIVTH--TRMNEE------ 116

Query: 126 GMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLK 185
             + ++   +L  +  LH+  V+HRD+K  +IL+  +    GRVK++D GF    +   K
Sbjct: 117 -QIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHD----GRVKLSDFGFCAQVS---K 168

Query: 186 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
            +     +V T ++ APE L+    Y   +DIW++G +  E++  EP +
Sbjct: 169 EVPRRKSLVGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIEMVDGEPPY 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 63.3 bits (154), Expect = 1e-11
 Identities = 58/219 (26%), Positives = 97/219 (44%), Gaps = 46/219 (21%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G G YG VY+   K  S T   A+K ++   + +    +E A+++E+KHPN++ L+ V
Sbjct: 13  KLGGGQYGEVYEGVWKKYSLT--VAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70

Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLY---QILDGIHY 141
                +   +++ ++  +   +++ + R     +   +V       LLY   QI   + Y
Sbjct: 71  --CTREPPFYIITEFMTYG--NLLDYLRECNRQEVNAVV-------LLYMATQISSAMEY 119

Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN-----------PLKPLADL 190
           L     +HRDL   N LV     E   VK+AD G +RL              P+K     
Sbjct: 120 LEKKNFIHRDLAARNCLVG----ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK----- 170

Query: 191 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                   + APE L   +   K+ D+WA G +  E+ T
Sbjct: 171 --------WTAPESLAYNKFSIKS-DVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 63.7 bits (155), Expect = 1e-11
 Identities = 62/219 (28%), Positives = 104/219 (47%), Gaps = 33/219 (15%)

Query: 27  VGRGTYGHVYKARRKDNSDTRD-YALKQIEGTGLS----MSACREIALLRELKHPNVINL 81
           +G+G++G V+  R+    D    YA+K ++   L     +    E  +L E+ HP ++ L
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63

Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIH 140
              F    + K++L+ D+    DL     F R +K     VM  +  VK  L ++   + 
Sbjct: 64  HYAF--QTEGKLYLILDFLRGGDL-----FTRLSKE----VMFTEEDVKFYLAELALALD 112

Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW-- 198
           +LHS  +++RDLKP NIL+     E G +K+ D G +       K   D +    +F   
Sbjct: 113 HLHSLGIIYRDLKPENILLD----EEGHIKLTDFGLS-------KESIDHEKKAYSFCGT 161

Query: 199 --YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
             Y APE ++  R +T++ D W+ G +  E+LT    F 
Sbjct: 162 VEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGSLPFQ 199

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 63.4 bits (154), Expect = 1e-11
 Identities = 42/142 (29%), Positives = 70/142 (49%), Gaps = 33/142 (23%)

Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR--LFNNPLKPLADLD 191
           +I+ G+ +LHS  +++RDLK  N+++  +    G +KIAD G  +  +F          D
Sbjct: 104 EIVCGLQFLHSKGIIYRDLKLDNVMLDRD----GHIKIADFGMCKENVFG---------D 150

Query: 192 PVVVTFW----YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED-----IK 242
               TF     Y APE+L G + YT ++D W+ G +  E+L  +  FH   ED     I+
Sbjct: 151 NRASTFCGTPDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR 209

Query: 243 TSNPYH--------HDQLDRIF 256
              P++         D L+++F
Sbjct: 210 VDTPHYPRWITKESKDILEKLF 231

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 63.7 bits (155), Expect = 1e-11
 Identities = 61/243 (25%), Positives = 105/243 (43%), Gaps = 31/243 (12%)

Query: 30  GTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFLSHN 89
           G+ G V+ A +    D     LK     G   +   E  LL+ + HP+VI +    +S  
Sbjct: 77  GSEGRVFVATKPGQPDP--VVLK----IGQKGTTLIEAMLLQNVNHPSVIRMKDTLVS-- 128

Query: 90  DRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLH 149
                ++  +   DL+  +          +P+ + + ++  +  QIL+G+ YLH+  ++H
Sbjct: 129 GAITCMVLPHYSSDLYTYLT------KRSRPLPIDQALI--IEKQILEGLRYLHAQRIIH 180

Query: 150 RDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGAR 209
           RD+K  NI +        +V I D+G A+    P+   A L  +  T    APE+L   +
Sbjct: 181 RDVKTENIFINDV----DQVCIGDLGAAQF---PVVAPAFLG-LAGTVETNAPEVLARDK 232

Query: 210 HYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG-----FPL 263
           + +KA DIW+ G +  E+L     IF       +      H  L +I S +      FP 
Sbjct: 233 YNSKA-DIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR 291

Query: 264 EKD 266
           +  
Sbjct: 292 DPG 294

Length = 357

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 63.2 bits (154), Expect = 2e-11
 Identities = 63/226 (27%), Positives = 103/226 (45%), Gaps = 38/226 (16%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALK--------QIEGTGLSMSACREIALLRELKHPNV 78
           +G+G++G V  A  K   +   YA+K        Q +    +M+  R +AL    KHP +
Sbjct: 3   LGKGSFGKVLLAELKGTDEL--YAVKVLKKDVILQDDDVECTMTEKRVLALAG--KHPFL 58

Query: 79  INLISVFLSHNDRKVWLLFDYAEH-DL-WHIIKFHRAAKANKKPVMVPKGMVKSLLY--Q 134
             L S F +  DR ++ + +Y    DL +HI +  R  +             ++  Y  +
Sbjct: 59  TQLHSCFQT-KDR-LFFVMEYVNGGDLMFHIQRSGRFDEP------------RARFYAAE 104

Query: 135 ILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVV 194
           I+ G+ +LH   +++RDLK  N+L+  E    G +KIAD G  +     +          
Sbjct: 105 IVLGLQFLHERGIIYRDLKLDNVLLDSE----GHIKIADFGMCK---EGILGGVTTSTFC 157

Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
            T  Y APE+L   + Y  A+D WA+G +  E+L  +  F    ED
Sbjct: 158 GTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDED 202

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 63.1 bits (153), Expect = 2e-11
 Identities = 64/242 (26%), Positives = 105/242 (43%), Gaps = 31/242 (12%)

Query: 6   KIKTSNERTKVEDLFDYEGCK----VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM 61
           K   S +  K ++   YE       +G G++G V  A  K N D    A+K+ E + +  
Sbjct: 13  KDSDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYK-NEDFPPVAIKRFEKSKIIK 71

Query: 62  S-----ACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKA 116
                    E  +L  + HP  +NL   F   ++  ++L+ ++         +F    + 
Sbjct: 72  QKQVDHVFSERKILNYINHPFCVNLYGSF--KDESYLYLVLEFVIGG-----EFFTFLRR 124

Query: 117 NKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGF 176
           NK+    P  +      QI+    YL S  +++RDLKP N+L+  +G     +K+ D GF
Sbjct: 125 NKR---FPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGF----IKMTDFGF 177

Query: 177 ARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 236
           A++ +     L        T  Y APE+LL   H  KA D W +G    E+L   P F+ 
Sbjct: 178 AKVVDTRTYTLCG------TPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYA 230

Query: 237 RQ 238
            +
Sbjct: 231 NE 232

Length = 340

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 62.5 bits (152), Expect = 3e-11
 Identities = 59/223 (26%), Positives = 103/223 (46%), Gaps = 38/223 (17%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-------SMSACREIALLRELKHPNVI 79
           +G+G++G V  A+ K  +D + YA+K ++   +        + A R + LL+ +KHP ++
Sbjct: 3   IGKGSFGKVLLAKHK--ADGKFYAVKVLQKKAILKKKEQKHIMAERNV-LLKNVKHPFLV 59

Query: 80  NLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDG 138
            L   F      K++ + DY    +L+  ++  R+          P+   +    +I   
Sbjct: 60  GLHYSF--QTADKLYFVLDYVNGGELFFHLQRERS---------FPEPRARFYAAEIASA 108

Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + YLHS  +++RDLKP NIL+      +G V + D G         K   +      TF 
Sbjct: 109 LGYLHSLNIIYRDLKPENILLD----SQGHVVLTDFGLC-------KEGIEHSKTTSTFC 157

Query: 199 ----YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 237
               Y APE+L   + Y + +D W +G +  E+L   P F+ R
Sbjct: 158 GTPEYLAPEVLR-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 61.7 bits (150), Expect = 4e-11
 Identities = 56/207 (27%), Positives = 90/207 (43%), Gaps = 21/207 (10%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           K+G+G +G VYK   K N++      +      L     +E  +L++  HPN++ LI V 
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV- 60

Query: 86  LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILD---GIHYL 142
                + ++++ +        ++ F R  K            VK LL   LD   G+ YL
Sbjct: 61  -CVQKQPIYIVMELVPGG--SLLTFLRKKKNRLT--------VKKLLQMSLDAAAGMEYL 109

Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAP 202
            S   +HRDL   N LV    +    +KI+D G +R     +  ++D    +   W  AP
Sbjct: 110 ESKNCIHRDLAARNCLVGENNV----LKISDFGMSREEEGGIYTVSDGLKQIPIKW-TAP 164

Query: 203 ELLLGARHYTKAIDIWAIGCIFAELLT 229
           E L   R YT   D+W+ G +  E  +
Sbjct: 165 EALNYGR-YTSESDVWSYGILLWETFS 190

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 62.4 bits (152), Expect = 4e-11
 Identities = 58/229 (25%), Positives = 101/229 (44%), Gaps = 58/229 (25%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-SMSACREIALLREL----KHPNVIN 80
           +VG+G YG V+ A++KD  +    ALK+++ + L  ++  R +   R++    K   ++ 
Sbjct: 8   QVGQGGYGQVFLAKKKDTGEI--VALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVK 65

Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLL-------- 132
           L+  F   +D  ++L  +Y                       VP G  ++LL        
Sbjct: 66  LLYAF--QDDEYLYLAMEY-----------------------VPGGDFRTLLNNLGVLSE 100

Query: 133 -----Y--QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLK 185
                Y  ++ + +  LH    +HRDLKP N L+       G +K+ D G ++       
Sbjct: 101 DHARFYMAEMFEAVDALHELGYIHRDLKPENFLID----ASGHIKLTDFGLSKGI----- 151

Query: 186 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
            +   + VV +  Y APE+L G + Y   +D W++GC+  E L   P F
Sbjct: 152 -VTYANSVVGSPDYMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPF 198

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 62.3 bits (151), Expect = 4e-11
 Identities = 56/218 (25%), Positives = 104/218 (47%), Gaps = 28/218 (12%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-LSMSACREI-----ALLRELKHPNVIN 80
           +G+G++G V  AR K  ++ + YA+K ++    L     + I      LL+ +KHP ++ 
Sbjct: 3   IGKGSFGKVLLARHK--AEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 81  LISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGI 139
           L   F + +  K++ + DY    +L++ ++  R         + P+    +   +I   +
Sbjct: 61  LHFSFQTAD--KLYFVLDYINGGELFYHLQRERC-------FLEPRARFYAA--EIASAL 109

Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
            YLHS  +++RDLKP NIL+  +    G + + D G  +     ++          T  Y
Sbjct: 110 GYLHSLNIVYRDLKPENILLDSQ----GHIVLTDFGLCK---ENIEHNGTTSTFCGTPEY 162

Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 237
            APE +L  + Y + +D W +G +  E+L   P F+ R
Sbjct: 163 LAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 61.5 bits (150), Expect = 7e-11
 Identities = 62/250 (24%), Positives = 101/250 (40%), Gaps = 57/250 (22%)

Query: 21  DYEGCKV-GRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELK----- 74
           D+E  KV GRG +G V+  R KD      YA+K +  + +      +IA +R  +     
Sbjct: 2   DFEVIKVIGRGAFGEVWLVRDKDTGQV--YAMKVLRKSDMIKR--NQIAHVRAERDILAD 57

Query: 75  --HPNVINLISVFLSHNDRKVWLLFDYAEH-DLW-HIIKFHRAAKANKKPVMVPKGMVKS 130
              P ++ L   F   ++  ++L+ +Y    DL   +I+              P+   + 
Sbjct: 58  ADSPWIVKLYYSF--QDEEHLYLVMEYMPGGDLMNLLIRKDV----------FPEETARF 105

Query: 131 LLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFN--------- 181
            + +++  +  +H    +HRD+KP NIL+       G +K+AD G  +  N         
Sbjct: 106 YIAELVLALDSVHKLGFIHRDIKPDNILID----ADGHIKLADFGLCKKMNKAKDREYYL 161

Query: 182 NPLKPLADLDPVVVTFW-----------------YRAPELLLGARHYTKAIDIWAIGCIF 224
           N    L   D V+V                    Y APE+L G   Y    D W++G I 
Sbjct: 162 NDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVIL 220

Query: 225 AELLTSEPIF 234
            E+L   P F
Sbjct: 221 YEMLYGFPPF 230

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 61.2 bits (148), Expect = 8e-11
 Identities = 59/218 (27%), Positives = 105/218 (48%), Gaps = 28/218 (12%)

Query: 27  VGRGTYGHVYKA-RRKDNSDTRDYALKQIEGTGLSMSACREIALLRELK-HPNVINLISV 84
           +G+GTYG V+K   +K+ S      L  I      + A  E  +L+ L  HPNV+    +
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEA--EYNILKALSDHPNVVKFYGM 83

Query: 85  FLSH---NDRKVWLLFDYAEH-DLWHIIK-FHRAAKANKKPVMVPKGMVKSLLYQILDGI 139
           +      N  ++WL+ +      +  ++K F +  +  ++P+      +  +L++ L G+
Sbjct: 84  YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI------IAYILHEALMGL 137

Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGF-ARLFNNPLKPLADLDPVVVTFW 198
            +LH N  +HRD+K  NIL+  E    G VK+ D G  A+L +  L+     +  V T +
Sbjct: 138 QHLHVNKTIHRDVKGNNILLTTE----GGVKLVDFGVSAQLTSTRLRR----NTSVGTPF 189

Query: 199 YRAPELLLGARH----YTKAIDIWAIGCIFAELLTSEP 232
           + APE++   +     Y    D+W++G    EL   +P
Sbjct: 190 WMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 60.5 bits (147), Expect = 8e-11
 Identities = 49/215 (22%), Positives = 89/215 (41%), Gaps = 42/215 (19%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI-EGTGLSMSACREIALLRELKHPNVINLISVF 85
           +G G +G V+  + +      D A+K I EG         E  ++ +L HPN++ L  V 
Sbjct: 12  LGSGQFGVVHLGKWRGK---IDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68

Query: 86  LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSN 145
                R ++++ +Y  +    ++ + R  K            +  +   + + + YL SN
Sbjct: 69  TKQ--RPIFIVTEYMANGC--LLNYLRERKGKLG-----TEWLLDMCSDVCEAMEYLESN 119

Query: 146 WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN-----------PLKPLADLDPVV 194
             +HRDL   N LV     E   VK++D G AR   +           P+K         
Sbjct: 120 GFIHRDLAARNCLVG----EDNVVKVSDFGLARYVLDDQYTSSQGTKFPVK--------- 166

Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
               +  PE+   +R  +K+ D+W+ G +  E+ +
Sbjct: 167 ----WAPPEVFDYSRFSSKS-DVWSFGVLMWEVFS 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 60.9 bits (147), Expect = 1e-10
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 27/217 (12%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACR-EIALLRELKH-PNVINLISV 84
           VG GTYG VYK R          A+K ++ TG      + EI +L++  H  N+      
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLA--AIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 71

Query: 85  FLSHN----DRKVWLLFDY-AEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGI 139
           F+  N    D ++WL+ ++     +  +IK       N K   + +  +  +  +IL G+
Sbjct: 72  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIK-------NTKGNTLKEEWIAYICREILRGL 124

Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
            +LH + V+HRD+K  N+L+     E   VK+ D G +   +   + +   +  + T ++
Sbjct: 125 SHLHQHKVIHRDIKGQNVLLT----ENAEVKLVDFGVSAQLD---RTVGRRNTFIGTPYW 177

Query: 200 RAPELLLGARH----YTKAIDIWAIGCIFAELLTSEP 232
            APE++    +    Y    D+W++G    E+    P
Sbjct: 178 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 214

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 60.8 bits (147), Expect = 1e-10
 Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 25/211 (11%)

Query: 21  DYEG-CKVGRGTYGHVYKARRKDNSDTRDYALKQIE-GTGLSMSACREIALLRELKHPNV 78
           D+E   ++G G  G V K + K +       L  +E    +     RE+ +L E   P +
Sbjct: 6   DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65

Query: 79  INLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILD 137
           +     F S  +  + +     EH D   + +  + AK       +P+ ++  +   +L 
Sbjct: 66  VGFYGAFYSDGEISICM-----EHMDGGSLDQVLKEAK------RIPEEILGKVSIAVLR 114

Query: 138 GIHYL-HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVT 196
           G+ YL   + ++HRD+KP+NILV      RG +K+ D G +    + +      +  V T
Sbjct: 115 GLAYLREKHQIMHRDVKPSNILVN----SRGEIKLCDFGVSGQLIDSMA-----NSFVGT 165

Query: 197 FWYRAPELLLGARHYTKAIDIWAIGCIFAEL 227
             Y +PE L G  HY+   DIW++G    EL
Sbjct: 166 RSYMSPERLQGT-HYSVQSDIWSMGLSLVEL 195

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 60.1 bits (146), Expect = 1e-10
 Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 29/215 (13%)

Query: 25  CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREI----ALLRELKHPNVIN 80
            ++GRG YG V K R          A+K+I  T  S    R +      +R +  P  + 
Sbjct: 7   EELGRGAYGVVDKMRHVPTGTI--MAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVT 64

Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIH 140
                    D  VW+  +  +  L    KF++  K   K + +P+ ++  +   I+  + 
Sbjct: 65  FYGALFREGD--VWICMEVMDTSLD---KFYK--KVYDKGLTIPEDILGKIAVSIVKALE 117

Query: 141 YLHSNW-VLHRDLKPANILVMGEGIERGRVKIADMGFA-RLFNNPLKPL-ADLDPVVVTF 197
           YLHS   V+HRD+KP+N+L+       G+VK+ D G +  L ++  K + A   P     
Sbjct: 118 YLHSKLSVIHRDVKPSNVLIN----RNGQVKLCDFGISGYLVDSVAKTIDAGCKP----- 168

Query: 198 WYRAPELL---LGARHYTKAIDIWAIGCIFAELLT 229
            Y APE +   L  + Y    D+W++G    EL T
Sbjct: 169 -YMAPERINPELNQKGYDVKSDVWSLGITMIELAT 202

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 69/281 (24%), Positives = 111/281 (39%), Gaps = 65/281 (23%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC-------REIALLRELKHPNVI 79
           VGRG +G V   R K   D   YA+K ++ + L            R+I  +     P + 
Sbjct: 9   VGRGHFGEVQVVREKATGDI--YAMKVMKKSVLLAQETVSFFEEERDILSIS--NSPWIP 64

Query: 80  NLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDG 138
            L   F   +   ++L+ +Y    DL  ++        N+      + M +  L +++  
Sbjct: 65  QLQYAF--QDKDNLYLVMEYQPGGDLLSLL--------NRYEDQFDEDMAQFYLAELVLA 114

Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIER-GRVKIADMGFARLFN-----NPLKPLADLDP 192
           IH +H    +HRD+KP N+L     I+R G +K+AD G A         N   P+   D 
Sbjct: 115 IHSVHQMGYVHRDIKPENVL-----IDRTGHIKLADFGSAARLTANKMVNSKLPVGTPD- 168

Query: 193 VVVTFWYRAPELLLGARHYTKAI-----DIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 247
                 Y APE+L       K       D W++G I  E+             I   +P+
Sbjct: 169 ------YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEM-------------IYGRSPF 209

Query: 248 HHDQLDRIFS-VMGFPLEKDWEDIRKMPEHPTLLKDFNEQI 287
           H     + ++ +M F      +   K PE P +  DF + I
Sbjct: 210 HEGTSAKTYNNIMNF------QRFLKFPEDPKVSSDFLDLI 244

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 43/126 (34%), Positives = 65/126 (51%), Gaps = 13/126 (10%)

Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           +I+ G+ +LHS  +++RDLK  NIL+  +    G +KIAD G  +   N L   A     
Sbjct: 104 EIICGLQFLHSKGIVYRDLKLDNILLDTD----GHIKIADFGMCK--ENMLGD-AKTCTF 156

Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED-----IKTSNPYH 248
             T  Y APE+LLG + Y  ++D W+ G +  E+L  +  FH   E+     I+  NP +
Sbjct: 157 CGTPDYIAPEILLGQK-YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCY 215

Query: 249 HDQLDR 254
              L R
Sbjct: 216 PRWLTR 221

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 59.5 bits (144), Expect = 3e-10
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 17/200 (8%)

Query: 65  REIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKP--V 121
           +EI ++  LK PN+I L++V ++     + ++ +Y E+ DL   +  H   +A +K   V
Sbjct: 68  KEIKIMSRLKDPNIIRLLAVCIT--SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVV 125

Query: 122 MVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LF 180
            +    +  +  QI  G+ YL S   +HRDL   N LV     +   +KIAD G +R L+
Sbjct: 126 TISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVG----KNYTIKIADFGMSRNLY 181

Query: 181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT---SEPIFHCR 237
           +     +     V+   W     +LLG   +T A D+WA G    E+LT    +P     
Sbjct: 182 SGDYYRIQG-RAVLPIRWMSWESILLG--KFTTASDVWAFGVTLWEILTLCKEQPYSQLS 238

Query: 238 QED-IKTSNPYHHDQLDRIF 256
            E  I+ +  +  DQ  +++
Sbjct: 239 DEQVIENTGEFFRDQGRQVY 258

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 59.2 bits (143), Expect = 3e-10
 Identities = 38/110 (34%), Positives = 58/110 (52%), Gaps = 11/110 (10%)

Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADL-DP 192
           +IL G+  LH    ++RDLKP NIL+     + G ++I+D+G A        P  +    
Sbjct: 110 EILCGLEDLHRENTVYRDLKPENILLD----DYGHIRISDLGLAVKI-----PEGESIRG 160

Query: 193 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 242
            V T  Y APE+L   R YT + D W +GC+  E++  +  F  R+E +K
Sbjct: 161 RVGTVGYMAPEVLNNQR-YTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK 209

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 58.9 bits (143), Expect = 4e-10
 Identities = 55/223 (24%), Positives = 86/223 (38%), Gaps = 22/223 (9%)

Query: 26  KVGRGTYGHVYKARRKD-NSDTRDYA---LKQIEGTGLSMSACREIALLRELKHPNVINL 81
           K+G G++G V +             A   LK  + + +     +E A++  L H N+I L
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 82  ISVFLSHNDRKVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIH 140
             V L+H    + ++ + A    L   ++                  +     QI +G+ 
Sbjct: 62  YGVVLTH---PLMMVTELAPLGSLLDRLRKDALG-------HFLISTLCDYAVQIANGMR 111

Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL S   +HRDL   NIL+        +VKI D G  R            + + V F + 
Sbjct: 112 YLESKRFIHRDLAARNILLA----SDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWC 167

Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT--SEPIFHCRQEDI 241
           APE  L  R ++ A D+W  G    E+ T   EP        I
Sbjct: 168 APE-SLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI 209

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 58.9 bits (143), Expect = 5e-10
 Identities = 65/232 (28%), Positives = 95/232 (40%), Gaps = 51/232 (21%)

Query: 28  GRGTYGHVYKARRKDNSDTRDYALK-----------QIEGTGLSMSACREIALLRELKHP 76
           GRG +G V  A  K   +   YA+K           ++E     M   R        +HP
Sbjct: 8   GRGHFGKVLLAEYKKTGEL--YAIKALKKGDIIARDEVESL---MCEKRIFETANSERHP 62

Query: 77  NVINLISVFLSHNDRKVWLLFDYAEH-DL-WHIIKFHRAAKANKKPVMVPKGMVKSLLY- 133
            ++NL + F    +  V  + +YA   DL  HI   H    +  + V           Y 
Sbjct: 63  FLVNLFACF--QTEDHVCFVMEYAAGGDLMMHI---HTDVFSEPRAV----------FYA 107

Query: 134 -QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP 192
             ++ G+ YLH N +++RDLK  N+L+  EG     VKIAD G         K       
Sbjct: 108 ACVVLGLQYLHENKIVYRDLKLDNLLLDTEG----FVKIADFGLC-------KEGMGFGD 156

Query: 193 VVVTFW----YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
              TF     + APE+L     YT+A+D W +G +  E+L  E  F    E+
Sbjct: 157 RTSTFCGTPEFLAPEVLTETS-YTRAVDWWGLGVLIYEMLVGESPFPGDDEE 207

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 58.8 bits (142), Expect = 5e-10
 Identities = 61/234 (26%), Positives = 91/234 (38%), Gaps = 45/234 (19%)

Query: 27  VGRGTYGHVYKARRKDNSDTRD-----YALKQIEGTGLSMSACREIALLRELKHPNVINL 81
           +G G +G V        +D          LK+  G   +    +EI +L+ L H N++  
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHY 141
                    + + L+ +Y    L  +  +    K N   +++          QI +G+ Y
Sbjct: 72  KGCCSEQGGKGLQLIMEYVP--LGSLRDYLPKHKLNLAQLLL-------FAQQICEGMAY 122

Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADL---------DP 192
           LHS   +HRDL   N+L+  + +    VKI D G A+       P              P
Sbjct: 123 LHSQHYIHRDLAARNVLLDNDRL----VKIGDFGLAKAV-----PEGHEYYRVREDGDSP 173

Query: 193 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 246
           V   FWY A E L   +    A D+W+ G    ELLT     HC   D K S P
Sbjct: 174 V---FWY-AVECLKENKFSY-ASDVWSFGVTLYELLT-----HC---DSKQSPP 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 58.6 bits (142), Expect = 5e-10
 Identities = 60/232 (25%), Positives = 99/232 (42%), Gaps = 38/232 (16%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDY------ALKQIEGTGLSMSACREIALLRELKHPNVIN 80
           +GRG +G V+ A+ K   +          AL++ +   L     RE+ + R+L H NV+ 
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72

Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKA----NKKPVMVPKGMVKSLLYQIL 136
           L+   L       +++ +Y   DL  + +F RA K+     K P +  K  V +L  QI 
Sbjct: 73  LLG--LCREAEPHYMILEYT--DLGDLKQFLRATKSKDEKLKPPPLSTKQKV-ALCTQIA 127

Query: 137 DGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR--------LFNNPLKPLA 188
            G+ +L +   +HRDL   N LV  +      VK++ +  ++           N L PL 
Sbjct: 128 LGMDHLSNARFVHRDLAARNCLVSSQ----REVKVSLLSLSKDVYNSEYYKLRNALIPLR 183

Query: 189 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
                    W  APE +      TK+ D+W+ G +  E+ T   +      D
Sbjct: 184 ---------WL-APEAVQEDDFSTKS-DVWSFGVLMWEVFTQGELPFYGLSD 224

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 58.1 bits (140), Expect = 7e-10
 Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 40/215 (18%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           K+G G +G V+      N+      LK   GT    S   E  ++++L+H  ++ L +V 
Sbjct: 13  KLGNGQFGEVWMGTWNGNTKVAVKTLK--PGTMSPESFLEEAQIMKKLRHDKLVQLYAVV 70

Query: 86  LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSN 145
              ++  ++++ +Y               +A K P +V       +  Q+  G+ Y+   
Sbjct: 71  ---SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLV------DMAAQVAAGMAYIERM 121

Query: 146 WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN-----------PLKPLADLDPVV 194
             +HRDL+ ANILV G+G+     KIAD G ARL  +           P+K         
Sbjct: 122 NYIHRDLRSANILV-GDGL---VCKIADFGLARLIEDNEYTARQGAKFPIK--------- 168

Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
               + APE  L  R   K+ D+W+ G +  EL+T
Sbjct: 169 ----WTAPEAALYGRFTIKS-DVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 58.1 bits (140), Expect = 7e-10
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 17/214 (7%)

Query: 25  CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISV 84
           C  G+   GH+Y              LK I          +E +L+ EL HPN++ L+ V
Sbjct: 16  CAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGV 75

Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLL---------YQI 135
                ++ V +LF+Y      H     R+  ++        G VKS L          QI
Sbjct: 76  VT--QEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQI 133

Query: 136 LDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVV 195
             G+ YL S++ +H+DL   NIL+ GE +    VKI+D+G +R   +          ++ 
Sbjct: 134 AAGMEYLSSHFFVHKDLAARNILI-GEQLH---VKISDLGLSREIYSADYYRVQPKSLLP 189

Query: 196 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
             W   PE ++  +  + + DIW+ G +  E+ +
Sbjct: 190 IRWM-PPEAIMYGKFSSDS-DIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 58.3 bits (141), Expect = 9e-10
 Identities = 66/230 (28%), Positives = 104/230 (45%), Gaps = 46/230 (20%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALK--------QIEGTGLSMSACREIALLRELKHPNV 78
           +G+G++G V  A RK   +   YA+K        Q +    +M   R +AL    K P +
Sbjct: 8   LGKGSFGKVMLAERKGTDEL--YAIKILKKDVIIQDDDVECTMVEKRVLALPG--KPPFL 63

Query: 79  INLISVFLSHNDRKVWLLFDYAEH-DL-WHIIKFHRAAKANKKPVMVPKGMVKSLLY--Q 134
             L S F +  DR ++ + +Y    DL +HI +  +     K+P  V         Y  +
Sbjct: 64  TQLHSCFQTM-DR-LYFVMEYVNGGDLMYHIQQVGKF----KEPHAV--------FYAAE 109

Query: 135 ILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVV 194
           I  G+ +LHS  +++RDLK  N+++  E    G +KIAD G  +                
Sbjct: 110 IAIGLFFLHSKGIIYRDLKLDNVMLDAE----GHIKIADFGMCKENIFG-------GKTT 158

Query: 195 VTFW----YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
            TF     Y APE++   + Y K++D WA G +  E+L  +P F    ED
Sbjct: 159 RTFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED 207

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 57.5 bits (139), Expect = 1e-09
 Identities = 35/112 (31%), Positives = 59/112 (52%), Gaps = 14/112 (12%)

Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA---RLFNNPLKPLADL 190
           QI+ G+ +LH   +++RDLKP N+L+  +    G V+I+D+G A   +   +  K  A  
Sbjct: 105 QIISGLEHLHQRRIIYRDLKPENVLLDND----GNVRISDLGLAVELKDGQSKTKGYAG- 159

Query: 191 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 242
                T  + APELL G   Y  ++D +A+G    E++ +   F  R E ++
Sbjct: 160 -----TPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 57.3 bits (138), Expect = 1e-09
 Identities = 61/234 (26%), Positives = 101/234 (43%), Gaps = 42/234 (17%)

Query: 24  GCKVGRGTYGHVYKA---RRKDNSDTRDYALKQI-EGTGLS--MSACREIALLRELKHPN 77
           G  +G G +G V KA   R K  +     A+K + E    S       E  LL+++ HP+
Sbjct: 5   GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPH 64

Query: 78  VINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKA-----------------NKK 119
           VI L        D  + L+ +YA++  L   ++  R                     +++
Sbjct: 65  VIKLYGACSQ--DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122

Query: 120 PVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL 179
            + +  G + S  +QI  G+ YL    ++HRDL   N+LV     E  ++KI+D G +R 
Sbjct: 123 ALTM--GDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVA----EGRKMKISDFGLSRD 176

Query: 180 F---NNPLKPLADLDPVVVTFWYRAPELLLGARH-YTKAIDIWAIGCIFAELLT 229
               ++ +K      PV     + A E L    H YT   D+W+ G +  E++T
Sbjct: 177 VYEEDSYVKRSKGRIPVK----WMAIESL--FDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 57.1 bits (138), Expect = 2e-09
 Identities = 65/237 (27%), Positives = 104/237 (43%), Gaps = 43/237 (18%)

Query: 20  FDYEGCK-VGRGTYGHVYKARRKDNSDTRD-YALKQIEGTGLSMS-------ACREIALL 70
            D+E  K +  G YG VY  R K+   TR  +A+K+I    L +          R+I   
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKE---TRQRFAMKKINKQNLILRNQIQQVFVERDILTF 57

Query: 71  RELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVK 129
            E  +P V+++   F     R + ++ +Y E  D   ++K       N   +  P  M +
Sbjct: 58  AE--NPFVVSMFCSF--ETKRHLCMVMEYVEGGDCATLLK-------NIGAL--PVDMAR 104

Query: 130 SLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-----LFNNPL 184
               + +  + YLH+  ++HRDLKP N+L+       G +K+ D G ++     L  N  
Sbjct: 105 MYFAETVLALEYLHNYGIVHRDLKPDNLLITS----MGHIKLTDFGLSKIGLMSLTTNLY 160

Query: 185 KPLADLDP-------VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           +   + D        V  T  Y APE++L  + Y K +D WA+G I  E L     F
Sbjct: 161 EGHIEKDTREFLDKQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPF 216

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 57.0 bits (137), Expect = 2e-09
 Identities = 36/109 (33%), Positives = 59/109 (54%), Gaps = 9/109 (8%)

Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           +I  G+  LH   +++RDLKP NIL+     + G ++I+D+G A      +     +   
Sbjct: 110 EICCGLEDLHQERIVYRDLKPENILLD----DHGHIRISDLGLAV----HVPEGQTIKGR 161

Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 242
           V T  Y APE++   R YT + D WA+GC+  E++  +  F  R++ IK
Sbjct: 162 VGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK 209

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 56.9 bits (137), Expect = 2e-09
 Identities = 53/206 (25%), Positives = 90/206 (43%), Gaps = 22/206 (10%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFL 86
           +G+G +G V+K   KD +       K+     L +    E  +L++  HPN++ LI V  
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 87  SHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILD---GIHYLH 143
               + ++++ +         + F R  K   K         K L+   LD   G+ YL 
Sbjct: 63  QR--QPIYIVMELVPGG--DFLSFLRKKKDELK--------TKQLVKFALDAAAGMAYLE 110

Query: 144 SNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPE 203
           S   +HRDL   N LV     E   +KI+D G +R  ++ +   + L  + +   + APE
Sbjct: 111 SKNCIHRDLAARNCLVG----ENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK--WTAPE 164

Query: 204 LLLGARHYTKAIDIWAIGCIFAELLT 229
            L   R Y+   D+W+ G +  E  +
Sbjct: 165 ALNYGR-YSSESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 57.2 bits (138), Expect = 2e-09
 Identities = 35/105 (33%), Positives = 55/105 (52%), Gaps = 10/105 (9%)

Query: 123 VPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN 182
           +P+ ++  +   ++ G+ YL S  +LHRD+KP+N+LV      RG+VK+ D G +    N
Sbjct: 92  IPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVN----TRGQVKLCDFGVSTQLVN 147

Query: 183 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 227
            +         V T  Y APE + G   Y    D+W++G  F EL
Sbjct: 148 SIA-----KTYVGTNAYMAPERISG-EQYGIHSDVWSLGISFMEL 186

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 57.0 bits (137), Expect = 2e-09
 Identities = 51/215 (23%), Positives = 89/215 (41%), Gaps = 18/215 (8%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA----CREIALLRELKHPNVI 79
           G  +G G +G V + +   +      A+K ++    + S       E   ++E  HPNV+
Sbjct: 4   GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVM 63

Query: 80  NLISVFLSHNDRKVW----LLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQI 135
            LI V L   + + +    ++  + +H   H   F   ++    P  +P  M+   +  I
Sbjct: 64  RLIGVCLQTVESEGYPSPVVILPFMKHGDLH--SFLLYSRLGDCPQYLPTQMLVKFMTDI 121

Query: 136 LDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA-RLFNNPLKPLADLDPVV 194
             G+ YL S   +HRDL   N ++     E   V +AD G + +++N        +  + 
Sbjct: 122 ASGMEYLSSKSFIHRDLAARNCMLN----ENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177

Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
           V  W       L  R YT   D+W+ G    E+ T
Sbjct: 178 VK-WIAIES--LADRVYTTKSDVWSFGVTMWEIAT 209

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 56.6 bits (136), Expect = 2e-09
 Identities = 48/205 (23%), Positives = 98/205 (47%), Gaps = 20/205 (9%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIA-LLRELKHPNVINLISV 84
           K+G G +G V+ A    ++     A+K ++   +S+ A    A +++ L+H  ++ L +V
Sbjct: 13  KLGAGQFGEVWMATYNKHTKV---AVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 69

Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHS 144
                   ++++ ++       ++ F ++ + +K+P+  PK  +     QI +G+ ++  
Sbjct: 70  V---TKEPIYIITEFMAKG--SLLDFLKSDEGSKQPL--PK--LIDFSAQIAEGMAFIEQ 120

Query: 145 NWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPEL 204
              +HRDL+ ANILV    +     KIAD G AR+  +        +       + APE 
Sbjct: 121 RNYIHRDLRAANILVSASLV----CKIADFGLARVIED--NEYTAREGAKFPIKWTAPE- 173

Query: 205 LLGARHYTKAIDIWAIGCIFAELLT 229
            +    +T   D+W+ G +  E++T
Sbjct: 174 AINFGSFTIKSDVWSFGILLMEIVT 198

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 56.6 bits (136), Expect = 2e-09
 Identities = 52/205 (25%), Positives = 90/205 (43%), Gaps = 22/205 (10%)

Query: 26  KVGRGTYGHVYKAR-RKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISV 84
           ++GRG +G V+  R R DN+     + ++     L     +E  +L++  HPN++ LI V
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILD---GIHY 141
                 + ++++ +  +      + F R      K        VK L+  + +   G+ Y
Sbjct: 62  --CTQKQPIYIVMELVQGG--DFLTFLRTEGPRLK--------VKELIQMVENAAAGMEY 109

Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
           L S   +HRDL   N LV     E+  +KI+D G +R   + +         +   W  A
Sbjct: 110 LESKHCIHRDLAARNCLVT----EKNVLKISDFGMSREEEDGVYASTGGMKQIPVKW-TA 164

Query: 202 PELLLGARHYTKAIDIWAIGCIFAE 226
           PE L   R Y+   D+W+ G +  E
Sbjct: 165 PEALNYGR-YSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 56.6 bits (137), Expect = 2e-09
 Identities = 53/183 (28%), Positives = 84/183 (45%), Gaps = 41/183 (22%)

Query: 65  REIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAA----KANKK 119
           +E+ +L  L  PN+  L+ V     D  + ++ +Y E+ DL   ++ H A       N K
Sbjct: 68  KEVKILSRLSDPNIARLLGVCT--VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125

Query: 120 PVMVPKGMVKSLLYQILDGIHYLHS-NWVLHRDLKPANILVMGEGIERGRVKIADMGFAR 178
              +    +  +  QI  G+ YL S N+V HRDL   N LV G+      +KIAD G +R
Sbjct: 126 --SLSFSTLLYMATQIASGMRYLESLNFV-HRDLATRNCLV-GKNY---TIKIADFGMSR 178

Query: 179 -LFNN-----------PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAE 226
            L+++           P++ +A         W    E +L  +  TK+ D+WA G    E
Sbjct: 179 NLYSSDYYRVQGRAPLPIRWMA---------W----ESVLLGKFTTKS-DVWAFGVTLWE 224

Query: 227 LLT 229
           +LT
Sbjct: 225 ILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 56.7 bits (137), Expect = 3e-09
 Identities = 38/142 (26%), Positives = 62/142 (43%), Gaps = 23/142 (16%)

Query: 118 KKPVMVPKGMVKSLLYQILDGIHYLHSNW-VLHRDLKPANILVMGEGIERGRVKIADMGF 176
           KK   +P+ ++  +   +L G+ YL     ++HRD+KP+NILV      RG +K+ D G 
Sbjct: 91  KKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVN----SRGEIKLCDFGV 146

Query: 177 ARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS------ 230
           +    + +      +  V T  Y +PE L G  HYT   DIW++G    E+         
Sbjct: 147 SGQLIDSMA-----NSFVGTRSYMSPERLQGT-HYTVQSDIWSLGLSLVEMAIGRYPIPP 200

Query: 231 ------EPIFHCRQEDIKTSNP 246
                 E +F     + +    
Sbjct: 201 PDAKELEAMFGRPVSEGEAKES 222

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 56.8 bits (137), Expect = 3e-09
 Identities = 62/241 (25%), Positives = 105/241 (43%), Gaps = 44/241 (18%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALK--------QIEGTGLSMSACREIALLRELKHPNV 78
           +G+G++G V  A  K   +   YA+K        Q +    +M+  R +AL    KHP +
Sbjct: 3   LGKGSFGKVMLAELKGTDEV--YAIKVLKKDVILQDDDVDCTMTEKRILALAA--KHPFL 58

Query: 79  INLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLY--QI 135
             L   F + +  +++ + +Y    DL  + +  R+ K ++          +S  Y  ++
Sbjct: 59  TALHCCFQTKD--RLFFVMEYVNGGDL--MFQIQRSRKFDEP---------RSRFYAAEV 105

Query: 136 LDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVV 195
              + +LH + V++RDLK  NIL+  E    G  K+AD G  +                 
Sbjct: 106 TLALMFLHRHGVIYRDLKLDNILLDAE----GHCKLADFGMCKEGILN-------GVTTT 154

Query: 196 TFW----YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 251
           TF     Y APE +L    Y  ++D WA+G +  E++  +P F    ED    +  H D 
Sbjct: 155 TFCGTPDYIAPE-ILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV 213

Query: 252 L 252
           L
Sbjct: 214 L 214

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 56.6 bits (136), Expect = 3e-09
 Identities = 64/254 (25%), Positives = 109/254 (42%), Gaps = 46/254 (18%)

Query: 21  DYEG-CKVGRGTYGHVYKARRKDNSDTRDYALKQIE-GTGLSMSACREIALLRELKHPNV 78
           D+E   ++G G  G V+K   K +       L  +E    +     RE+ +L E   P +
Sbjct: 6   DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65

Query: 79  INLISVFLSHNDRKVWLLFDYAEH----DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQ 134
           +     F S  +  + +     EH     L  ++K     KA +    +P+ ++  +   
Sbjct: 66  VGFYGAFYSDGEISICM-----EHMDGGSLDQVLK-----KAGR----IPEQILGKVSIA 111

Query: 135 ILDGIHYL-HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           ++ G+ YL   + ++HRD+KP+NILV      RG +K+ D G +    + +      +  
Sbjct: 112 VIKGLTYLREKHKIMHRDVKPSNILVN----SRGEIKLCDFGVSGQLIDSMA-----NSF 162

Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCRQEDIKTSNPYHHDQL 252
           V T  Y +PE L G  HY+   DIW++G    E+     PI            P    +L
Sbjct: 163 VGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAIGRYPI-----------PPPDAKEL 210

Query: 253 DRIFSVMGFPLEKD 266
           + +F   G P+E D
Sbjct: 211 ELMF---GCPVEGD 221

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 56.5 bits (136), Expect = 3e-09
 Identities = 62/233 (26%), Positives = 102/233 (43%), Gaps = 45/233 (19%)

Query: 24  GCKVGRGTYGHVYKAR-------RKDNSDTRDYALKQIEGTGLSMS-ACREIALLREL-K 74
           G  +G G +G V +A        R D + T    + +   T   ++    E+ L++ + K
Sbjct: 17  GKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGK 76

Query: 75  HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKP--VMVPKGMVK-- 129
           H N+INL+ V     +  ++++ +YA   +L   ++  R    +       VP+  +   
Sbjct: 77  HKNIINLLGV--CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFK 134

Query: 130 ---SLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKP 186
              S  YQ+  G+ YL S   +HRDL   N+LV  + +    +KIAD G AR        
Sbjct: 135 DLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNV----MKIADFGLAR-------G 183

Query: 187 LADLD----------PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
           + D+D          PV     + APE L   R YT   D+W+ G +  E+ T
Sbjct: 184 VHDIDYYKKTSNGRLPVK----WMAPEALFD-RVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 57.0 bits (137), Expect = 4e-09
 Identities = 46/202 (22%), Positives = 89/202 (44%), Gaps = 23/202 (11%)

Query: 56  GTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAK 115
           G+  ++    EI  L  L H N++ +  +  S  +   +++    + DL+  + +  A  
Sbjct: 203 GSRAAIQLENEILALGRLNHENILKIEEILRSEAN--TYMITQKYDFDLYSFM-YDEAFD 259

Query: 116 ANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMG 175
              +P++      ++++ Q+L  + Y+H   ++HRD+K  NI +  +    G++ + D G
Sbjct: 260 WKDRPLL---KQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD----GKIVLGDFG 312

Query: 176 FARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE--PI 233
            A  F    +        V T    +PE+L G   Y +  DIW+ G I  ++L+ +  PI
Sbjct: 313 TAMPFEKEREAFD--YGWVGTVATNSPEILAG-DGYCEITDIWSCGLILLDMLSHDFCPI 369

Query: 234 FHCRQEDIKTSNPYHHDQLDRI 255
                       P    QL +I
Sbjct: 370 ------GDGGGKP--GKQLLKI 383

Length = 501

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 56.2 bits (135), Expect = 5e-09
 Identities = 66/238 (27%), Positives = 109/238 (45%), Gaps = 33/238 (13%)

Query: 8   KTSNERTKVEDLFDYEGCKV-GRGTYGHVYKARRKDNSDTRDYALK---QIEGTGLSMSA 63
           K  + R K ED   YE  KV GRG +G V   R K  S  + YA+K   + E    S SA
Sbjct: 34  KIRDLRMKAED---YEVVKVIGRGAFGEVQLVRHK--STRKVYAMKLLSKFEMIKRSDSA 88

Query: 64  --CREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKP 120
               E  ++     P V+ L   F   +DR ++++ +Y    DL +++  +         
Sbjct: 89  FFWEERDIMAFANSPWVVQLFYAF--QDDRYLYMVMEYMPGGDLVNLMSNYD-------- 138

Query: 121 VMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
             VP+   +    +++  +  +HS   +HRD+KP N+L+     + G +K+AD G     
Sbjct: 139 --VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD----KSGHLKLADFGTCMKM 192

Query: 181 NNPLKPLADLDPVVVTFWYRAPELLL---GARHYTKAIDIWAIGCIFAELLTSEPIFH 235
           N   + +   D  V T  Y +PE+L    G  +Y +  D W++G    E+L  +  F+
Sbjct: 193 NK--EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 56.0 bits (135), Expect = 5e-09
 Identities = 58/225 (25%), Positives = 101/225 (44%), Gaps = 38/225 (16%)

Query: 21  DYEGCKV-GRGTYGHVYKARRKDNSDT-RDYALKQIEGTGLSMSA------CREIALLRE 72
           ++E  +V G G YG V+  R+    D  + YA+K ++   +   A        E  +L  
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 73  LKH-PNVINLISVFLSHNDRKVWLLFDYAE------HDLWHIIKFHRAAKANKKPVMVPK 125
           ++  P ++ L   F +  D K+ L+ DY        H L+    F  +            
Sbjct: 61  VRRCPFLVTLHYAFQT--DTKLHLILDYVNGGELFTH-LYQREHFTESE----------- 106

Query: 126 GMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLK 185
             V+  + +I+  + +LH   +++RD+K  NIL+  EG     V + D G ++ F    +
Sbjct: 107 --VRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEG----HVVLTDFGLSKEFLAEEE 160

Query: 186 PLADLDPVVVTFWYRAPELLL-GARHYTKAIDIWAIGCIFAELLT 229
             A       T  Y APE++  G+  + KA+D W++G +  ELLT
Sbjct: 161 ERAY--SFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLT 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 55.4 bits (134), Expect = 6e-09
 Identities = 62/231 (26%), Positives = 95/231 (41%), Gaps = 71/231 (30%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI-EGTGLSMSA---CREIALLRELKHPNVINL 81
           K+G G +G V+      N  T+  A+K +  GT   MS     +E  ++++L+H  ++ L
Sbjct: 13  KLGAGQFGEVWMG--TWNGTTK-VAVKTLKPGT---MSPEAFLQEAQIMKKLRHDKLVQL 66

Query: 82  ISV------------FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVK 129
            +V            ++S        L D+ +             K  + P +V   M  
Sbjct: 67  YAVCSEEEPIYIVTEYMSKGS-----LLDFLKSG---------EGKKLRLPQLV--DMAA 110

Query: 130 SLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN------- 182
               QI +G+ YL S   +HRDL   NILV GE +     KIAD G ARL  +       
Sbjct: 111 ----QIAEGMAYLESRNYIHRDLAARNILV-GENLV---CKIADFGLARLIEDDEYTARE 162

Query: 183 ----PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
               P+K            W  APE     R   K+ D+W+ G +  E++T
Sbjct: 163 GAKFPIK------------W-TAPEAANYGRFTIKS-DVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 55.4 bits (133), Expect = 7e-09
 Identities = 55/177 (31%), Positives = 83/177 (46%), Gaps = 28/177 (15%)

Query: 65  REIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIK----FHRAAKANKK 119
           +EI ++  LK+PN+I L+ V +S  D  + ++ +Y E+ DL   +           AN  
Sbjct: 66  KEIKIMSRLKNPNIIRLLGVCVS--DDPLCMITEYMENGDLNQFLSQREIESTFTHANN- 122

Query: 120 PVMVPKGMVKSLLY---QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGR---VKIAD 173
              +P   + +LLY   QI  G+ YL S   +HRDL   N LV       G    +KIAD
Sbjct: 123 ---IPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV-------GNHYTIKIAD 172

Query: 174 MGFAR-LFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
            G +R L++     +     V+   W     +LLG   +T A D+WA G    E+ T
Sbjct: 173 FGMSRNLYSGDYYRIQG-RAVLPIRWMAWESILLG--KFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 55.4 bits (134), Expect = 7e-09
 Identities = 56/225 (24%), Positives = 90/225 (40%), Gaps = 44/225 (19%)

Query: 27  VGRGTYGHVY----KARRKDNSDTRDYALKQIEGTGLSMSACREI----ALLRELKHPNV 78
           +G+G++G VY    K   K   +TR  A+K +     SM    E     ++++E    +V
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETR-VAIKTVNENA-SMRERIEFLNEASVMKEFNCHHV 71

Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLY--QIL 136
           + L+ V  +     V +    A+ DL   ++  R    N   +  P  + K +    +I 
Sbjct: 72  VRLLGVVSTGQPTLVVMEL-MAKGDLKSYLRSRRPEAENNPGLGPP-TLQKFIQMAAEIA 129

Query: 137 DGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVT 196
           DG+ YL +   +HRDL   N +V  +      VKI D G  R                 T
Sbjct: 130 DGMAYLAAKKFVHRDLAARNCMVAEDLT----VKIGDFGMTRDIYE-------------T 172

Query: 197 FWYR------------APELLLGARHYTKAIDIWAIGCIFAELLT 229
            +YR            APE L     +T   D+W+ G +  E+ T
Sbjct: 173 DYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 55.1 bits (133), Expect = 7e-09
 Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 39/215 (18%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIE-GTGLSMSACREIALLRELKHPNVINLISV 84
           K+G G +G V++      ++T   A+K ++ GT        E  ++++L+HP +I L +V
Sbjct: 13  KLGAGQFGEVWEGLW---NNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69

Query: 85  -------FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILD 137
                  ++     K   L +Y +           A +A K P ++       +  Q+  
Sbjct: 70  CTLEEPIYIVTELMKYGSLLEYLQGG---------AGRALKLPQLI------DMAAQVAS 114

Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPL---KPLADLDPVV 194
           G+ YL +   +HRDL   N+LV GE       K+AD G AR+    +   +  A   P+ 
Sbjct: 115 GMAYLEAQNYIHRDLAARNVLV-GEN---NICKVADFGLARVIKEDIYEAREGAKF-PIK 169

Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
            T    APE  L  R   K+ D+W+ G +  E++T
Sbjct: 170 WT----APEAALYNRFSIKS-DVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 55.0 bits (132), Expect = 7e-09
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 30/210 (14%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIA-LLRELKHPNVINLISV 84
           ++G G +G V+     +    R  A+K I    +S     E A ++ +L HP ++ L  V
Sbjct: 11  EIGSGQFGLVWLGYWLEK---RKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67

Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILD---GIHY 141
               +   + L+F++ EH    +  + RA +         K   ++LL   LD   G+ Y
Sbjct: 68  CTERS--PICLVFEFMEHGC--LSDYLRAQRG--------KFSQETLLGMCLDVCEGMAY 115

Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR--LFNNPLKPLADLDPVVVTFWY 199
           L S+ V+HRDL   N LV     E   VK++D G  R  L +          PV     +
Sbjct: 116 LESSNVIHRDLAARNCLVG----ENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK----W 167

Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLT 229
            +PE+   +++ +K+ D+W+ G +  E+ +
Sbjct: 168 SSPEVFSFSKYSSKS-DVWSFGVLMWEVFS 196

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 55.1 bits (132), Expect = 7e-09
 Identities = 54/206 (26%), Positives = 103/206 (50%), Gaps = 22/206 (10%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIE-GTGLSMSACREIALLRELKHPNVINLISV 84
           K+G+G +G V+       + T   A+K ++ GT +  +  +E  ++++L+H  ++ L +V
Sbjct: 13  KLGQGCFGEVWMGTW---NGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAV 69

Query: 85  FLSHNDRKVWLLFDY-AEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLH 143
               ++  ++++ ++  +  L   +K     + + K + +P+  +  +  QI DG+ Y+ 
Sbjct: 70  V---SEEPIYIVTEFMGKGSLLDFLK-----EGDGKYLKLPQ--LVDMAAQIADGMAYIE 119

Query: 144 SNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPE 203
               +HRDL+ ANILV G+ +     KIAD G ARL  +                + APE
Sbjct: 120 RMNYIHRDLRAANILV-GDNLV---CKIADFGLARLIED--NEYTARQGAKFPIKWTAPE 173

Query: 204 LLLGARHYTKAIDIWAIGCIFAELLT 229
             L  R   K+ D+W+ G +  EL+T
Sbjct: 174 AALYGRFTIKS-DVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 55.4 bits (133), Expect = 8e-09
 Identities = 52/166 (31%), Positives = 76/166 (45%), Gaps = 20/166 (12%)

Query: 74  KHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRA---------AKANKKPVMV 123
           KH N+INL+       D  ++++ +YA   +L   ++  R          A+   +  M 
Sbjct: 79  KHKNIINLLGA--CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQ-MT 135

Query: 124 PKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNP 183
            K +V S  YQ+  G+ YL S   +HRDL   N+LV     E   +KIAD G AR  NN 
Sbjct: 136 FKDLV-SCTYQVARGMEYLASQKCIHRDLAARNVLVT----ENNVMKIADFGLARDVNNI 190

Query: 184 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                  +  +   W  APE L   R YT   D+W+ G +  E+ T
Sbjct: 191 DYYKKTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 55.0 bits (132), Expect = 9e-09
 Identities = 53/217 (24%), Positives = 99/217 (45%), Gaps = 27/217 (12%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACR-EIALLRELKH-PNVINLISV 84
           VG GTYG VYK R          A+K ++ T       + EI +L++  H  N+      
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLA--AIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81

Query: 85  FLSH----NDRKVWLLFDY-AEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGI 139
           F+      +D ++WL+ ++     +  ++K       N K   + +  +  +  +IL G+
Sbjct: 82  FIKKSPPGHDDQLWLVMEFCGAGSVTDLVK-------NTKGNALKEDWIAYICREILRGL 134

Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
            +LH++ V+HRD+K  N+L+     E   VK+ D G +   +   + +   +  + T ++
Sbjct: 135 AHLHAHKVIHRDIKGQNVLLT----ENAEVKLVDFGVSAQLD---RTVGRRNTFIGTPYW 187

Query: 200 RAPELLLGARH----YTKAIDIWAIGCIFAELLTSEP 232
            APE++    +    Y    DIW++G    E+    P
Sbjct: 188 MAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 54.6 bits (131), Expect = 9e-09
 Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 26/207 (12%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLIS 83
           G  +G G +G V +         +  A+K I+    + +   E A++ +L H N++ L+ 
Sbjct: 11  GEIIGEGEFGAVLQGEYTG----QKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLG 66

Query: 84  VFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYL 142
           V L HN      L+   E     +++ F R     +   +V    +      + +G+ YL
Sbjct: 67  VIL-HNG-----LYIVMELMSKGNLVNFLRT----RGRALVSVIQLLQFSLDVAEGMEYL 116

Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAP 202
            S  ++HRDL   NILV  +G+     K++D G AR+    +       PV  T    AP
Sbjct: 117 ESKKLVHRDLAARNILVSEDGV----AKVSDFGLARV--GSMGVDNSKLPVKWT----AP 166

Query: 203 ELLLGARHYTKAIDIWAIGCIFAELLT 229
           E L   +  +K+ D+W+ G +  E+ +
Sbjct: 167 EALKHKKFSSKS-DVWSYGVLLWEVFS 192

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 54.8 bits (132), Expect = 1e-08
 Identities = 50/224 (22%), Positives = 89/224 (39%), Gaps = 41/224 (18%)

Query: 27  VGRGTYGHVYKAR-RKDNSDTRDYALKQIEGTGLSMSAC----REIALLRELKHPNVINL 81
           +G G +G V + +  +D+      A+K ++    + S       E A +++  HPNV+ L
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 82  ISVFLSHNDR----KVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILD 137
           I V    +      K  ++  + +H   H   F   ++    P  +P   +   +  I  
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLH--SFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124

Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN------------PLK 185
           G+ YL +   +HRDL   N ++     E   V +AD G ++   +            P+K
Sbjct: 125 GMEYLSNRNFIHRDLAARNCMLR----EDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 180

Query: 186 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
            +A ++              L  R YT   D+WA G    E+ T
Sbjct: 181 WIA-IES-------------LADRVYTSKSDVWAFGVTMWEIAT 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 54.4 bits (131), Expect = 1e-08
 Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 26/212 (12%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDY----ALKQIEGTGLSMSACREIALLRELKHPNVINLI 82
           +G+G +G VY     D+   + +    +L +I          +E  ++++  HPNV++L+
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 83  SVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLL---YQILDG 138
            + L  ++    ++  Y +H DL + I+          P       VK L+    Q+  G
Sbjct: 63  GICLP-SEGSPLVVLPYMKHGDLRNFIR-----SETHNPT------VKDLIGFGLQVAKG 110

Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPLKPLADLDPVVVTF 197
           + YL S   +HRDL   N ++     E   VK+AD G AR +++     + +     +  
Sbjct: 111 MEYLASKKFVHRDLAARNCMLD----ESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPV 166

Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
            + A E L   +  TK+ D+W+ G +  EL+T
Sbjct: 167 KWMALESLQTQKFTTKS-DVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 54.7 bits (131), Expect = 1e-08
 Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 22/206 (10%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G+G +G V+      N  TR  A+K ++   +S  A  +E  ++++L+H  ++ L +V
Sbjct: 13  KLGQGCFGEVWMGTW--NGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 69

Query: 85  FLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLH 143
               ++  ++++ +Y     L   +K     K  + P +V       +  QI  G+ Y+ 
Sbjct: 70  V---SEEPIYIVTEYMSKGSLLDFLK-GEMGKYLRLPQLV------DMAAQIASGMAYVE 119

Query: 144 SNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPE 203
               +HRDL+ ANILV GE +     K+AD G ARL  +                + APE
Sbjct: 120 RMNYVHRDLRAANILV-GENLV---CKVADFGLARLIED--NEYTARQGAKFPIKWTAPE 173

Query: 204 LLLGARHYTKAIDIWAIGCIFAELLT 229
             L  R   K+ D+W+ G +  EL T
Sbjct: 174 AALYGRFTIKS-DVWSFGILLTELTT 198

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 54.3 bits (131), Expect = 1e-08
 Identities = 57/215 (26%), Positives = 90/215 (41%), Gaps = 35/215 (16%)

Query: 27  VGRGTYGHVYKARRKDNSDTR-DYALKQIEGTGLSMSA----CREIALLRELKHPNVINL 81
           +G G +G V + R K       D A+K ++  G S         E +++ +  HPN+I L
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLK-AGSSDKQRLDFLTEASIMGQFDHPNIIRL 70

Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHY 141
             V      R V ++ +Y E+    + KF R              +V  +L  I  G+ Y
Sbjct: 71  EGVVTKS--RPVMIITEYMENG--SLDKFLR----ENDGKFTVGQLVG-MLRGIASGMKY 121

Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVT----- 196
           L     +HRDL   NILV    +     K++D G +R        L D +    T     
Sbjct: 122 LSEMNYVHRDLAARNILVNSNLV----CKVSDFGLSRR-------LEDSEATYTTKGGKI 170

Query: 197 --FWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
              W  APE  +  R +T A D+W+ G +  E+++
Sbjct: 171 PIRW-TAPE-AIAYRKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 54.6 bits (131), Expect = 1e-08
 Identities = 50/183 (27%), Positives = 81/183 (44%), Gaps = 33/183 (18%)

Query: 65  REIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKK-PVMV 123
            E+ L    +HPN++   +VF + +    WL         W I  F     AN       
Sbjct: 48  NEVVLSHFFRHPNIMTSWTVFTTGS----WL---------WVISPFMAYGSANSLLKTYF 94

Query: 124 PKGM----VKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL 179
           P+GM    + ++L+  L G++YLH N  +HR++K ++IL+ G+G+      ++  G + L
Sbjct: 95  PEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGL------VSLSGLSHL 148

Query: 180 F---NNPLKPLADLD----PVVVTFWYRAPELLLGARH-YTKAIDIWAIGCIFAELLTSE 231
           +    N  K     D       V  W  +PELL    + Y    DI+++G    EL T  
Sbjct: 149 YSLVRNGQKAKVVYDFPQFSTSVLPWL-SPELLRQDLYGYNVKSDIYSVGITACELATGR 207

Query: 232 PIF 234
             F
Sbjct: 208 VPF 210

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 54.1 bits (130), Expect = 2e-08
 Identities = 54/217 (24%), Positives = 96/217 (44%), Gaps = 44/217 (20%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G G +G V+      +      A+K ++   +S  A   E  L+++L+HP ++ L +V
Sbjct: 13  KLGAGQFGEVWMGYYNGH---TKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAV 69

Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHS 144
                   ++++ +Y E+    ++ F +  +  K  +     M      QI +G+ ++  
Sbjct: 70  V---TQEPIYIITEYMENG--SLVDFLKTPEGIKLTINKLIDMAA----QIAEGMAFIER 120

Query: 145 NWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN-----------PLKPLADLDPV 193
              +HRDL+ ANILV     E    KIAD G ARL  +           P+K        
Sbjct: 121 KNYIHRDLRAANILVS----ETLCCKIADFGLARLIEDNEYTAREGAKFPIK-------- 168

Query: 194 VVTFWYRAPELL-LGARHYTKAIDIWAIGCIFAELLT 229
                + APE +  G   +T   D+W+ G +  E++T
Sbjct: 169 -----WTAPEAINYGT--FTIKSDVWSFGILLTEIVT 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 54.3 bits (130), Expect = 2e-08
 Identities = 51/170 (30%), Positives = 78/170 (45%), Gaps = 22/170 (12%)

Query: 74  KHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAK---------ANKKP--VM 122
           KH N+INL+       D  +++L +YA     ++ ++ RA +           K P   +
Sbjct: 76  KHKNIINLLGA--CTQDGPLYVLVEYASKG--NLREYLRARRPPGMDYSFDTCKLPEEQL 131

Query: 123 VPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN 182
             K +V S  YQ+  G+ YL S   +HRDL   N+LV  + +    +KIAD G AR  +N
Sbjct: 132 TFKDLV-SCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNV----MKIADFGLARDVHN 186

Query: 183 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 232
                   +  +   W  APE L   R YT   D+W+ G +  E+ T   
Sbjct: 187 IDYYKKTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLLWEIFTLGG 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 53.9 bits (129), Expect = 2e-08
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 23/207 (11%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIA-LLRELKHPNVINLISV 84
           K+G G +G V+     +++     A+K ++   +S+ A  E A L++ L+H  ++ L +V
Sbjct: 13  KLGAGQFGEVWMGYYNNSTKV---AVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAV 69

Query: 85  FLSHNDRKVWLLFDY-AEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLH 143
                +  ++++ +Y A+  L   +K     K     V++PK +  S   QI +G+ Y+ 
Sbjct: 70  VT--KEEPIYIITEYMAKGSLLDFLKSDEGGK-----VLLPKLIDFSA--QIAEGMAYIE 120

Query: 144 SNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPE 203
               +HRDL+ AN+LV     E    KIAD G AR+  +        +       + APE
Sbjct: 121 RKNYIHRDLRAANVLVS----ESLMCKIADFGLARVIED--NEYTAREGAKFPIKWTAPE 174

Query: 204 LL-LGARHYTKAIDIWAIGCIFAELLT 229
            +  G+  +T   D+W+ G +  E++T
Sbjct: 175 AINFGS--FTIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 53.9 bits (129), Expect = 2e-08
 Identities = 48/164 (29%), Positives = 76/164 (46%), Gaps = 16/164 (9%)

Query: 74  KHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHR--AAKANKKPVMVPKGMVK- 129
           KH N+INL+       D  ++++ +YA   +L   ++  R    +    P  VP+  +  
Sbjct: 82  KHKNIINLLGA--CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSF 139

Query: 130 ----SLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLK 185
               S  YQ+  G+ YL S   +HRDL   N+LV  + +    +KIAD G AR  ++   
Sbjct: 140 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV----MKIADFGLARDIHHIDY 195

Query: 186 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                +  +   W  APE L   R YT   D+W+ G +  E+ T
Sbjct: 196 YKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 53.3 bits (128), Expect = 2e-08
 Identities = 48/170 (28%), Positives = 77/170 (45%), Gaps = 25/170 (14%)

Query: 76  PNVINLISVFLSHNDRKVWLLFDYAEH-DLW-HIIKFHRAAKANKKPVMVPKGMVKSLLY 133
           PN++ L    +S  +  V+L+  +AE   LW HI KF            +P+  VK    
Sbjct: 45  PNMVCLHKYIVS--EDSVFLVLQHAEGGKLWSHISKFLN----------IPEECVKRWAA 92

Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           +++  +  LH   ++ RDL P NIL+     +RG +++            ++   D +  
Sbjct: 93  EMVVALDALHREGIVCRDLNPNNILLD----DRGHIQLTYFSRWS----EVEDSCDGE-- 142

Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT 243
            V   Y APE + G    T+A D W++G I  ELLT + +  C    I T
Sbjct: 143 AVENMYCAPE-VGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINT 191

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 53.7 bits (129), Expect = 3e-08
 Identities = 52/214 (24%), Positives = 97/214 (45%), Gaps = 33/214 (15%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACR------EIALLRELKHPNVI 79
           ++G+G YG VYK   +    T   A+K+I    L +   +      E+ +L +   P ++
Sbjct: 8   ELGKGNYGSVYKVLHRPTGVT--MAMKEIR---LELDESKFNQIIMELDILHKAVSPYIV 62

Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGI 139
           +    F       V++  +Y   D   + K +    A +    +P+ +++ + Y ++ G+
Sbjct: 63  DFYGAFFIEG--AVYMCMEYM--DAGSLDKLYAGGVATEG---IPEDVLRRITYAVVKGL 115

Query: 140 HYLHSNW-VLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
            +L     ++HRD+KP N+LV G     G+VK+ D G +    N +  LA  +  +    
Sbjct: 116 KFLKEEHNIIHRDVKPTNVLVNG----NGQVKLCDFGVS---GNLVASLAKTN--IGCQS 166

Query: 199 YRAPELL-----LGARHYTKAIDIWAIGCIFAEL 227
           Y APE +          YT   D+W++G    E+
Sbjct: 167 YMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEM 200

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 53.9 bits (129), Expect = 3e-08
 Identities = 60/225 (26%), Positives = 104/225 (46%), Gaps = 30/225 (13%)

Query: 21  DYEGCKV-GRGTYGHVYKARRKDNSDTRDYALK---QIEGTGLSMSA--CREIALLRELK 74
           DY+  KV GRG +G V   R K  S  + YA+K   + E    S SA    E  ++    
Sbjct: 44  DYDVVKVIGRGAFGEVQLVRHK--SSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 101

Query: 75  HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLY 133
            P V+ L   F   +D+ ++++ +Y    DL +++  +           VP+   K    
Sbjct: 102 SPWVVQLFCAF--QDDKYLYMVMEYMPGGDLVNLMSNYD----------VPEKWAKFYTA 149

Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           +++  +  +HS  ++HRD+KP N+L+     + G +K+AD G     +     +   D  
Sbjct: 150 EVVLALDAIHSMGLIHRDVKPDNMLLD----KHGHLKLADFGTCMKMDE--TGMVRCDTA 203

Query: 194 VVTFWYRAPELLL---GARHYTKAIDIWAIGCIFAELLTSEPIFH 235
           V T  Y +PE+L    G  +Y +  D W++G    E+L  +  F+
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY 248

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 53.3 bits (128), Expect = 3e-08
 Identities = 41/169 (24%), Positives = 81/169 (47%), Gaps = 23/169 (13%)

Query: 65  REIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPV--M 122
           RE+ ++ E + P +++    FL+ N+  + +  ++   D   + + ++        +   
Sbjct: 52  RELQIMHECRSPYIVSFYGAFLNENN--ICMCMEFM--DCGSLDRIYKKGGPIPVEILGK 107

Query: 123 VPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN 182
           +   +V+ L Y     ++ +H   ++HRD+KP+NILV      RG++K+ D G +    N
Sbjct: 108 IAVAVVEGLTY-----LYNVHR--IMHRDIKPSNILVNS----RGQIKLCDFGVSGELIN 156

Query: 183 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 231
            +      D  V T  Y +PE + G + YT   D+W++G    EL   +
Sbjct: 157 SIA-----DTFVGTSTYMSPERIQGGK-YTVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 53.1 bits (127), Expect = 3e-08
 Identities = 35/117 (29%), Positives = 61/117 (52%), Gaps = 15/117 (12%)

Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF 197
           G+  L    +++RDLKP NIL+     +RG ++I+D+G A      +     +   V T 
Sbjct: 114 GLEDLQRERIVYRDLKPENILLD----DRGHIRISDLGLA----VQIPEGETVRGRVGTV 165

Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 254
            Y APE++   + YT + D W +GC+  E++  +  F  R+E +K       +++DR
Sbjct: 166 GYMAPEVINNEK-YTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK------REEVDR 215

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 53.2 bits (128), Expect = 4e-08
 Identities = 59/227 (25%), Positives = 85/227 (37%), Gaps = 44/227 (19%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDY------ALKQIEGTGLSMSACREIALLRELKHPNVIN 80
           +G G +G V+           D        LK+           RE  LL   +H N++ 
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 81  LISVFLSHNDRKVWLLFDYAEH-DLWHIIKFH-RAAKANKKPVMVPKGMVKSLLY----Q 134
              V    +     ++F+Y EH DL   ++ H   A   K P      +  S L     Q
Sbjct: 73  FYGVCTEGD--PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130

Query: 135 ILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVV 194
           I  G+ YL S   +HRDL   N LV G  +    VKI D G +R              V 
Sbjct: 131 IASGMVYLASQHFVHRDLATRNCLV-GYDL---VVKIGDFGMSR-------------DVY 173

Query: 195 VTFWYR------------APELLLGARHYTKAIDIWAIGCIFAELLT 229
            T +YR             PE ++  R +T   D+W+ G +  E+ T
Sbjct: 174 TTDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 52.9 bits (128), Expect = 4e-08
 Identities = 38/159 (23%), Positives = 71/159 (44%), Gaps = 23/159 (14%)

Query: 74  KHPNVINLISVFLSHNDRKVWLLFDY-AEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLL 132
            +PN I L         +   L+ DY  + DL+ ++K        +         VK ++
Sbjct: 67  DNPNFIKLYYSV--TTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAE---------VKKII 115

Query: 133 YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP 192
            Q+++ ++ LH + ++H D+K  N+L       + R+ + D G  ++   P       D 
Sbjct: 116 RQLVEALNDLHKHNIIHNDIKLENVLYDR---AKDRIYLCDYGLCKIIGTPSC----YDG 168

Query: 193 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 231
            +    Y +PE + G  +Y  + D WA+G +  ELLT +
Sbjct: 169 TLD---YFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGK 203

Length = 267

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 53.1 bits (127), Expect = 4e-08
 Identities = 61/233 (26%), Positives = 99/233 (42%), Gaps = 36/233 (15%)

Query: 12  ERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIA--- 68
           E  K ED+       +G G +G V +A  K +    + A+K ++    S +  R+ A   
Sbjct: 2   EDIKFEDV-------IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA-SENDHRDFAGEL 53

Query: 69  --LLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKA-NKKPVMVPK 125
             L +   HPN+INL+      N   +++  +YA +   +++ F R ++     P    +
Sbjct: 54  EVLCKLGHHPNIINLLGA--CENRGYLYIAIEYAPYG--NLLDFLRKSRVLETDPAFAKE 109

Query: 126 -GMVKSLLYQIL--------DGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGF 176
            G   +L  Q L         G+ YL     +HRDL   N+LV GE +     KIAD G 
Sbjct: 110 HGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV-GENLA---SKIADFGL 165

Query: 177 ARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
           +R     +K      PV    W     L      YT   D+W+ G +  E+++
Sbjct: 166 SRGEEVYVKKTMGRLPVR---WMAIESLNYSV--YTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 53.5 bits (128), Expect = 4e-08
 Identities = 63/265 (23%), Positives = 114/265 (43%), Gaps = 36/265 (13%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI------EGTGLSMSACREIALLRELKHPNVIN 80
           +GRG+Y  V   R K     R YA+K +      +   +      +    +   HP ++ 
Sbjct: 3   IGRGSYAKVLLVRLKKTE--RIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 81  LISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGI 139
           L S F    + +++ + +Y    DL   ++  R          +P+   +    +I   +
Sbjct: 61  LHSCF--QTESRLFFVIEYVNGGDLMFHMQRQRK---------LPEEHARFYSAEISLAL 109

Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
           +YLH   +++RDLK  N+L+  E    G +K+ D G  +     L+P         T  Y
Sbjct: 110 NYLHERGIIYRDLKLDNVLLDSE----GHIKLTDYGMCK---EGLRPGDTTSTFCGTPNY 162

Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVM 259
            APE+L G   Y  ++D WA+G +  E++     F    + + +S+    +  D +F V+
Sbjct: 163 IAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPF----DIVGSSDNPDQNTEDYLFQVI 217

Query: 260 GFPLEKDWEDIRKMP-EHPTLLKDF 283
              LEK     R +  +  ++LK F
Sbjct: 218 ---LEKQIRIPRSLSVKAASVLKSF 239

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 52.6 bits (126), Expect = 5e-08
 Identities = 58/227 (25%), Positives = 96/227 (42%), Gaps = 41/227 (18%)

Query: 24  GCKVGRGTYGHVYKARRK-DNSDTRDYALKQIEGTGLSMS----ACREIALLRELKHPNV 78
           G  +G+G +G V +A+ K ++   +  A+K ++    S S      RE A ++E  HPNV
Sbjct: 4   GRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNV 63

Query: 79  INLISVFLSHNDRK----VWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQ 134
           I LI V L    +       ++  + +H   H   F   ++  ++P  +P   +   +  
Sbjct: 64  IKLIGVSLRSRAKGRLPIPMVILPFMKHGDLH--TFLLMSRIGEEPFTLPLQTLVRFMID 121

Query: 135 ILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN------------ 182
           I  G+ YL S   +HRDL   N ++     E   V +AD G ++   +            
Sbjct: 122 IASGMEYLSSKNFIHRDLAARNCMLN----ENMTVCVADFGLSKKIYSGDYYRQGCASKL 177

Query: 183 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
           P+K LA L+              L    YT   D+WA G    E++T
Sbjct: 178 PVKWLA-LES-------------LADNVYTTHSDVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 52.6 bits (126), Expect = 5e-08
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 25/208 (12%)

Query: 65  REIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHR--AAKANKKPV 121
           +E+ +L  LK PN+I L+ V +   +  + ++ +Y E+ DL   +  H     + N    
Sbjct: 68  KEVKILSRLKDPNIIRLLGVCVD--EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDA 125

Query: 122 MVPKGMVKSLLY--------QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIAD 173
           + P   + ++ Y        QI  G+ YL S   +HRDL   N LV         +KIAD
Sbjct: 126 VPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGEN----LTIKIAD 181

Query: 174 MGFAR-LFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT--- 229
            G +R L+      +     V+   W     +L+G   +T A D+WA G    E+L    
Sbjct: 182 FGMSRNLYAGDYYRIQG-RAVLPIRWMAWECILMG--KFTTASDVWAFGVTLWEILMLCK 238

Query: 230 SEPIFHCRQED-IKTSNPYHHDQLDRIF 256
            +P      E  I+ +  +  DQ  +++
Sbjct: 239 EQPYGELTDEQVIENAGEFFRDQGRQVY 266

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 52.7 bits (126), Expect = 5e-08
 Identities = 53/228 (23%), Positives = 98/228 (42%), Gaps = 42/228 (18%)

Query: 26  KVGRGTYGHVYKAR---RKDNSDTRDYALKQIE--GTGLSMSACREIALLR-ELKHPNVI 79
           ++G   +G VYK           T+  A+K ++    G      +  A++R  L+HPN++
Sbjct: 12  ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71

Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANK---------KPVMVPKGMVKS 130
            L+ V     ++ + ++F Y  H   H     R+  ++          K  + P   V  
Sbjct: 72  CLLGVVT--KEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVH- 128

Query: 131 LLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR---------LFN 181
           ++ QI  G+ +L S+ V+H+DL   N+LV     ++  VKI+D+G  R         L  
Sbjct: 129 IVTQIAAGMEFLSSHHVVHKDLATRNVLVF----DKLNVKISDLGLFREVYAADYYKLMG 184

Query: 182 NPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
           N L P+  + P  + +             ++   DIW+ G +  E+ +
Sbjct: 185 NSLLPIRWMSPEAIMY-----------GKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 53.0 bits (127), Expect = 7e-08
 Identities = 64/217 (29%), Positives = 96/217 (44%), Gaps = 36/217 (16%)

Query: 48  DYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKV----WLLFDYAEHD 103
           DY  + +   G   S+  E  LLR L HP V+ L+ V      R V     L+      D
Sbjct: 192 DYPQRVVVKAGWYASSVHEARLLRRLSHPAVLALLDV------RVVGGLTCLVLPKYRSD 245

Query: 104 LWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMG-E 162
           L+  +       A  +P+ + +  V ++  Q+L  I Y+H   ++HRD+K  N+LV G E
Sbjct: 246 LYTYLG------ARLRPLGLAQ--VTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPE 297

Query: 163 GIERGRVKIADMG---FARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWA 219
            I  G     D G   FAR   +          +  T    APE+L G   YT ++DIW+
Sbjct: 298 DICLG-----DFGAACFARGSWSTPFHYG----IAGTVDTNAPEVLAG-DPYTPSVDIWS 347

Query: 220 IG-CIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 255
            G  IF   + +  +F   + D +   PY   Q+ RI
Sbjct: 348 AGLVIFEAAVHTASLFSASRGDER--RPY-DAQILRI 381

Length = 461

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 52.7 bits (126), Expect = 7e-08
 Identities = 52/177 (29%), Positives = 77/177 (43%), Gaps = 40/177 (22%)

Query: 66  EIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPK 125
           E  +LR + HP++I L   F ++N     +L  Y + DL+  +    AAK N     +  
Sbjct: 133 EAHILRAINHPSIIQLKGTF-TYNKFTCLILPRY-KTDLYCYL----AAKRN-----IAI 181

Query: 126 GMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLK 185
             + ++   +L  I YLH N ++HRD+K  NI +       G V + D G A        
Sbjct: 182 CDILAIERSVLRAIQYLHENRIIHRDIKAENIFIN----HPGDVCLGDFGAACF------ 231

Query: 186 PLADLDPVVV----------TFWYRAPELLLGARH-YTKAIDIWAIGCIFAELLTSE 231
                 PV +          T    APELL  AR  Y  A+DIW+ G +  E+ T  
Sbjct: 232 ------PVDINANKYYGWAGTIATNAPELL--ARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 51.9 bits (124), Expect = 1e-07
 Identities = 59/218 (27%), Positives = 92/218 (42%), Gaps = 29/218 (13%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIA-----LLRELKHPNVINL 81
           +G G +G V KAR K +    D A+K+++    S    R+ A     L +   HPN+INL
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINL 73

Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAK----------ANKKPVMVPKGMVKSL 131
           +      +   ++L  +YA H   +++ F R ++          AN     +    +   
Sbjct: 74  LGA--CEHRGYLYLAIEYAPHG--NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 129

Query: 132 LYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLD 191
              +  G+ YL     +HRDL   NILV GE       KIAD G +R     +K      
Sbjct: 130 AADVARGMDYLSQKQFIHRDLAARNILV-GENYV---AKIADFGLSRGQEVYVKKTMGRL 185

Query: 192 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
           PV    W     L      YT   D+W+ G +  E+++
Sbjct: 186 PVR---WMAIESLNYSV--YTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 51.6 bits (124), Expect = 1e-07
 Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 18/208 (8%)

Query: 30  GTYGHVYKA--RRKDNSDTRDYALKQI-EGTGLSMSAC--REIALLRELKHPNVINLISV 84
           GT+G ++      +      +  +K + +           +E  LL  L H N++ ++ V
Sbjct: 17  GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76

Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHS 144
            +   +    L       +L   ++  R  +AN    +  + +V  +  QI  G+ YLH 
Sbjct: 77  CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV-HMAIQIACGMSYLHK 135

Query: 145 NWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPLKPLADLD--PVVVTFWYRA 201
             V+H+D+   N ++     E  +VKI D   +R LF      L D +  PV    W  A
Sbjct: 136 RGVIHKDIAARNCVID----EELQVKITDNALSRDLFPMDYHCLGDNENRPVK---WM-A 187

Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
            E L+  + Y+ A D+W+ G +  EL+T
Sbjct: 188 LESLVN-KEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 51.6 bits (124), Expect = 1e-07
 Identities = 56/221 (25%), Positives = 93/221 (42%), Gaps = 48/221 (21%)

Query: 27  VGRGTYGHVYKA--RRKDNSDTRDYA---LKQIEGTGLSMSACREIALLRELKHPNVINL 81
           +G G +G V K     K   +  + A   LKQ           RE +++ +L HP ++ L
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEV-EVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL 61

Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHY 141
           I V        + L+ + A   L  ++K+ +     K+  + P   +K L +Q+  G+ Y
Sbjct: 62  IGVCKGE---PLMLVMELAP--LGPLLKYLK-----KRREI-PVSDLKELAHQVAMGMAY 110

Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN-------------PLKPLA 188
           L S   +HRDL   N+L+    + R + KI+D G +R                 PLK   
Sbjct: 111 LESKHFVHRDLAARNVLL----VNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLK--- 163

Query: 189 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                    WY APE +   +  +K+ D+W+ G    E  +
Sbjct: 164 ---------WY-APECINYGKFSSKS-DVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 52.0 bits (124), Expect = 1e-07
 Identities = 64/248 (25%), Positives = 109/248 (43%), Gaps = 41/248 (16%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKH--------PNV 78
           +GRG+Y  V   R K N     YA+K ++   +      +I  ++  KH        P +
Sbjct: 3   IGRGSYAKVLLVRLKKNDQI--YAMKVVKKELVHDD--EDIDWVQTEKHVFEQASSNPFL 58

Query: 79  INLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILD 137
           + L S F      +++L+ +Y    DL   ++  R          +P+   +    +I  
Sbjct: 59  VGLHSCF--QTTSRLFLVIEYVNGGDLMFHMQRQRK---------LPEEHARFYAAEICI 107

Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF 197
            +++LH   +++RDLK  N+L+  +    G +K+ D G  +     L P         T 
Sbjct: 108 ALNFLHERGIIYRDLKLDNVLLDAD----GHIKLTDYGMCK---EGLGPGDTTSTFCGTP 160

Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFS 257
            Y APE+L G   Y  ++D WA+G +  E++     F     DI T NP  + + D +F 
Sbjct: 161 NYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPF-----DIITDNPDMNTE-DYLFQ 213

Query: 258 VMGFPLEK 265
           V+   LEK
Sbjct: 214 VI---LEK 218

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 51.9 bits (124), Expect = 1e-07
 Identities = 60/226 (26%), Positives = 103/226 (45%), Gaps = 38/226 (16%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALK--------QIEGTGLSMSACREIALLRELKHPNV 78
           +G+G++G V  A RK   +   YA+K        Q +    +M   R +AL    K P +
Sbjct: 8   LGKGSFGKVMLAERKGTDEL--YAIKILKKDVVIQDDDVECTMVEKRVLAL--SGKPPFL 63

Query: 79  INLISVFLSHNDRKVWLLFDYAEHD--LWHIIKFHRAAKANKKPVMVPKGMVKSLLY--Q 134
             L S F + +  +++ + +Y      ++ I +  R     K+P         ++ Y  +
Sbjct: 64  TQLHSCFQTMD--RLYFVMEYVNGGDLMYQIQQVGRF----KEP--------HAVFYAAE 109

Query: 135 ILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVV 194
           I  G+ +LHS  +++RDLK  N+++  EG     +KIAD G  +   N    +       
Sbjct: 110 IAIGLFFLHSKGIIYRDLKLDNVMLDSEG----HIKIADFGMCK--ENMWDGVTT-KTFC 162

Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
            T  Y APE++   + Y K++D WA G +  E+L  +  F    ED
Sbjct: 163 GTPDYIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED 207

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 51.4 bits (123), Expect = 1e-07
 Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 24/211 (11%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDY-ALKQIEGTGLSMSACR----EIALLRELKHPNVINL 81
           +G G +G V + R K       + A+K ++  G +    R    E +++ +  HPN+I+L
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKS-GYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHY 141
             V      R V ++ ++ E+    +  F R        + +  GM++     I  G+ Y
Sbjct: 71  EGVVT--KSRPVMIITEFMENG--ALDSFLRQNDGQFTVIQL-VGMLRG----IAAGMKY 121

Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPLKP--LADLDPVVVTFW 198
           L     +HRDL   NILV    +     K++D G +R L ++   P   + L   +   W
Sbjct: 122 LSEMNYVHRDLAARNILVNSNLV----CKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW 177

Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
             APE  +  R +T A D+W+ G +  E+++
Sbjct: 178 -TAPE-AIAYRKFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 51.2 bits (123), Expect = 2e-07
 Identities = 39/176 (22%), Positives = 80/176 (45%), Gaps = 35/176 (19%)

Query: 66  EIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH----DLWHIIKFHRAAKANKKPV 121
           EI   R+L+HPN++  ++ F+  ++  ++++     +    DL   +K H          
Sbjct: 49  EIITSRQLQHPNILPYVTSFIVDSE--LYVVSPLMAYGSCEDL---LKTH---------- 93

Query: 122 MVPKGMVKSLLYQI----LDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA 177
             P+G+ +  +  I    L+ + Y+HS   +HR +K ++IL+ G+    G+V ++ + ++
Sbjct: 94  -FPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGD----GKVVLSGLRYS 148

Query: 178 RLFNNPLKPLADLD--PVVVTF---WYRAPELLLGARH-YTKAIDIWAIGCIFAEL 227
                  K    +   P        W  +PE+L      Y +  DI+++G    EL
Sbjct: 149 VSMIKHGKRQRVVHDFPKSSVKNLPWL-SPEVLQQNLQGYNEKSDIYSVGITACEL 203

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 50.7 bits (121), Expect = 3e-07
 Identities = 64/231 (27%), Positives = 100/231 (43%), Gaps = 48/231 (20%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALK--------QIEGTGLSMSACREIALLRELKHPNV 78
           +G+G++G V  AR K     R YA+K        Q +    +M+  R ++L R   HP +
Sbjct: 3   LGKGSFGKVMLARLK--ESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARN--HPFL 58

Query: 79  INLISVFLSHNDRKVWLLFDYAEHDL-WHIIKFHRAAKANKKPVMVPKGMVKSLLY--QI 135
             L   F +  DR  +++      DL +HI K  R  +A            ++  Y  +I
Sbjct: 59  TQLYCCFQT-PDRLFFVMEFVNGGDLMFHIQKSRRFDEA------------RARFYAAEI 105

Query: 136 LDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR--LFNNPLKPLADLDPV 193
              + +LH   +++RDLK  N+L+  E    G  K+AD G  +  +FN            
Sbjct: 106 TSALMFLHDKGIIYRDLKLDNVLLDHE----GHCKLADFGMCKEGIFNGKT--------- 152

Query: 194 VVTFW----YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
             TF     Y APE +L    Y  ++D WA+G +  E+L     F    ED
Sbjct: 153 TSTFCGTPDYIAPE-ILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED 202

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 50.7 bits (121), Expect = 3e-07
 Identities = 60/232 (25%), Positives = 100/232 (43%), Gaps = 43/232 (18%)

Query: 21  DYEGCKV-GRGTYGHVYKARRKDNSDT-RDYALKQIEGTGLSMSACR------EIALLRE 72
           ++E  KV G G YG V+  R+    DT + YA+K ++   L   A        E  +L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 73  LKH-PNVINLISVFLSHNDRKVWLLFDYAE-----HDLWHIIKFHRAAKANKKPVMVPKG 126
           ++  P ++ L   F    + K+ L+ DY         L+    F                
Sbjct: 61  VRQSPFLVTLHYAF--QTEAKLHLILDYVSGGEMFTHLYQRDNFSEDE------------ 106

Query: 127 MVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKP 186
            V+    +I+  + +LH   +++RD+K  NIL+  EG     V + D G ++ F      
Sbjct: 107 -VRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEG----HVVLTDFGLSKEF------ 155

Query: 187 LADLDPVVVTFW----YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           L++      +F     Y APE++ G   + KA+D W++G +  ELLT    F
Sbjct: 156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPF 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 50.5 bits (121), Expect = 3e-07
 Identities = 54/211 (25%), Positives = 83/211 (39%), Gaps = 29/211 (13%)

Query: 28  GRGTYGHVYKARRKDNSDTRDYA-----LKQIEGTGLSMSACREIALLRELKHPNVINLI 82
           G G +G VYK       +          L++      +     E  ++  + HP+V+ L+
Sbjct: 16  GSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLL 75

Query: 83  SVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLL---YQILDG 138
            + LS    +V L+        L   ++ H+    ++            LL    QI  G
Sbjct: 76  GICLS---SQVQLITQLMPLGCLLDYVRNHKDNIGSQ-----------YLLNWCVQIAKG 121

Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + YL    ++HRDL   N+LV         VKI D G A+L +   K        V   W
Sbjct: 122 MSYLEEKRLVHRDLAARNVLVK----TPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKW 177

Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
             A E +L  R YT   D+W+ G    EL+T
Sbjct: 178 M-ALESIL-HRIYTHKSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 50.5 bits (121), Expect = 3e-07
 Identities = 43/161 (26%), Positives = 64/161 (39%), Gaps = 16/161 (9%)

Query: 27  VGRGTYGHVYKA----RRKDNSD--TRDYALKQIEGTGLSMSACREIALLRELKHPNVIN 80
           +G G +G VY+     R  D  +       L +            E  ++ +  H N++ 
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73

Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILD--- 137
           LI V      R + LL   A  DL   ++ +R        + +     K LL+   D   
Sbjct: 74  LIGVSFERLPRFI-LLELMAGGDLKSFLRENRPRPERPSSLTM-----KDLLFCARDVAK 127

Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR 178
           G  YL  N  +HRD+   N L+  +G  R   KIAD G AR
Sbjct: 128 GCKYLEENHFIHRDIAARNCLLTCKGPGR-VAKIADFGMAR 167

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 50.6 bits (121), Expect = 4e-07
 Identities = 47/200 (23%), Positives = 84/200 (42%), Gaps = 22/200 (11%)

Query: 30  GTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFLSHN 89
           G+ G V+   +  +   +   +K + G     +  REI +L+ + H  +INLI  +    
Sbjct: 103 GSEGEVFVCTKHGDEQRKKVIVKAVTGGK---TPGREIDILKTISHRAIINLIHAY--RW 157

Query: 90  DRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLH 149
              V ++    + DL+  +           P+  P     ++  ++L+ + YLH   ++H
Sbjct: 158 KSTVCMVMPKYKCDLFTYVD-------RSGPL--PLEQAITIQRRLLEALAYLHGRGIIH 208

Query: 150 RDLKPANILVMGEGIERGRVKIADMGFA-RLFNNPLKPLADLDPVVVTFWYRAPELLLGA 208
           RD+K  NI +     E     + D G A +L  +P  P         T    +PELL   
Sbjct: 209 RDVKTENIFLD----EPENAVLGDFGAACKLDAHPDTP--QCYGWSGTLETNSPELLALD 262

Query: 209 RHYTKAIDIWAIGCIFAELL 228
            +  K  DIW+ G +  E+ 
Sbjct: 263 PYCAKT-DIWSAGLVLFEMS 281

Length = 392

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 50.0 bits (119), Expect = 4e-07
 Identities = 63/230 (27%), Positives = 95/230 (41%), Gaps = 48/230 (20%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDY------ALKQI-EGTGLSMSACREIALLRELKHPNV 78
           ++G G +G V+ A   +    +D       ALK+  E         RE  LL  L+H ++
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQ--REAELLTVLQHQHI 69

Query: 79  INLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRA-AKANKKPVMVPKGMVK-----SL 131
           +    V      R + ++F+Y  H DL   ++ H   AK       V  G +      ++
Sbjct: 70  VRFYGV--CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127

Query: 132 LYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLD 191
             QI  G+ YL S   +HRDL   N LV G+G+    VKI D G +R             
Sbjct: 128 ASQIASGMVYLASLHFVHRDLATRNCLV-GQGLV---VKIGDFGMSR------------- 170

Query: 192 PVVVTFWYRA------------PELLLGARHYTKAIDIWAIGCIFAELLT 229
            +  T +YR             PE +L  R +T   DIW+ G +  E+ T
Sbjct: 171 DIYSTDYYRVGGRTMLPIRWMPPESIL-YRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 49.5 bits (118), Expect = 5e-07
 Identities = 48/207 (23%), Positives = 94/207 (45%), Gaps = 24/207 (11%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI-EGTGLSMSACREIALLRELKHPNVINLISV 84
           ++G G +G V+  + +        A+K I EG         E  ++ +L HP ++ L  V
Sbjct: 11  ELGSGQFGVVHLGKWRA---QIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67

Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHS 144
                 + ++++ ++ E+    ++ + R  +       + K M+ S+   + +G+ YL  
Sbjct: 68  CTQQ--KPLYIVTEFMENGC--LLNYLRQRQGK-----LSKDMLLSMCQDVCEGMEYLER 118

Query: 145 NWVLHRDLKPANILVMGEGIERGRVKIADMGFAR--LFNNPLKPLADLDPVVVTFWYRAP 202
           N  +HRDL   N LV   G+    VK++D G  R  L +          PV     +  P
Sbjct: 119 NSFIHRDLAARNCLVSSTGV----VKVSDFGMTRYVLDDEYTSSSGAKFPVK----WSPP 170

Query: 203 ELLLGARHYTKAIDIWAIGCIFAELLT 229
           E+   +++ +K+ D+W+ G +  E+ T
Sbjct: 171 EVFNFSKYSSKS-DVWSFGVLMWEVFT 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 50.0 bits (119), Expect = 5e-07
 Identities = 62/231 (26%), Positives = 107/231 (46%), Gaps = 48/231 (20%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALK--------QIEGTGLSMSACREIALLRELKHPNV 78
           +G+G++G V  A RK   +   YA+K        Q +    +M   R +AL    K P +
Sbjct: 8   LGKGSFGKVMLAERKGTDEL--YAIKILKKDVVIQDDDVECTMVEKRVLALQD--KPPFL 63

Query: 79  INLISVFLSHNDRKVWLLFDYAEHD--LWHIIKFHRAAKANKKPVMVPKGMVKSLLY--Q 134
             L S F + +  +++ + +Y      ++HI +  +     K+P        +++ Y  +
Sbjct: 64  TQLHSCFQTVD--RLYFVMEYVNGGDLMYHIQQVGKF----KEP--------QAVFYAAE 109

Query: 135 ILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVV 194
           I  G+ +LH   +++RDLK  N+++  EG     +KIAD G  +           +D V 
Sbjct: 110 ISVGLFFLHRRGIIYRDLKLDNVMLDSEG----HIKIADFGMCKE--------HMVDGVT 157

Query: 195 V-TFW----YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
             TF     Y APE++   + Y K++D WA G +  E+L  +P F    ED
Sbjct: 158 TRTFCGTPDYIAPEII-AYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED 207

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 49.0 bits (117), Expect = 8e-07
 Identities = 47/219 (21%), Positives = 89/219 (40%), Gaps = 45/219 (20%)

Query: 26  KVGRGTYGHVYKARRKDNSDTR-DYALK--QIEGTG-LSMSACREIALLRELKHPNVINL 81
            +G G +G VY+       + +   A+K  +   +  +     +E  ++R+  HP+++ L
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIH 140
           I V     +  VW++ + A   +L   ++ ++ +        +    +    YQ+   + 
Sbjct: 73  IGVI---TENPVWIVMELAPLGELRSYLQVNKYS--------LDLASLILYSYQLSTALA 121

Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN-----------PLKPLAD 189
           YL S   +HRD+   N+LV         VK+ D G +R   +           P+K +A 
Sbjct: 122 YLESKRFVHRDIAARNVLVSSPDC----VKLGDFGLSRYLEDESYYKASKGKLPIKWMA- 176

Query: 190 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 228
             P  + F           R +T A D+W  G    E+L
Sbjct: 177 --PESINF-----------RRFTSASDVWMFGVCMWEIL 202

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 49.4 bits (118), Expect = 8e-07
 Identities = 56/246 (22%), Positives = 105/246 (42%), Gaps = 38/246 (15%)

Query: 3   YEFKIKTSNE-RTKVEDLFDYEGCKV-GRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS 60
           YE   +   + R K ED   ++  KV GRG +G V   R K +     YA+K +  +   
Sbjct: 28  YEKAAEKITKLRMKAED---FDVIKVIGRGAFGEVQLVRHKSSKQV--YAMKLL--SKFE 80

Query: 61  MSACREIALLRELKH-------PNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHR 112
           M    + A   E +          ++ L   F   +D+ ++++ +Y    DL +++  + 
Sbjct: 81  MIKRSDSAFFWEERDIMAHANSEWIVQLHYAF--QDDKYLYMVMEYMPGGDLVNLMSNYD 138

Query: 113 AAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA 172
                     +P+   +    +++  +  +HS   +HRD+KP N+L+     + G +K+A
Sbjct: 139 ----------IPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD----KSGHLKLA 184

Query: 173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARH---YTKAIDIWAIGCIFAELLT 229
           D G     +     +   D  V T  Y +PE+L        Y +  D W++G    E+L 
Sbjct: 185 DFGTCMKMDA--NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 242

Query: 230 SEPIFH 235
            +  F+
Sbjct: 243 GDTPFY 248

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 49.2 bits (117), Expect = 9e-07
 Identities = 58/226 (25%), Positives = 104/226 (46%), Gaps = 25/226 (11%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRD---YALKQIEGTGLSMSA--CREIALLRELKHPNVIN 80
           ++G G +G V+ A   + S T+D    A+K ++   L+      RE  LL  L+H +++ 
Sbjct: 12  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71

Query: 81  LISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAK---ANKKPVMVPKGM-VKSLLY-- 133
              V    +   + ++F+Y +H DL   ++ H        + +P      + +  +L+  
Sbjct: 72  FYGVCGDGD--PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129

Query: 134 -QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPLKPLADLD 191
            QI  G+ YL S   +HRDL   N LV G  +    VKI D G +R +++     +    
Sbjct: 130 SQIASGMVYLASQHFVHRDLATRNCLV-GANL---LVKIGDFGMSRDVYSTDYYRVG--G 183

Query: 192 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT--SEPIFH 235
             ++   +  PE ++  R +T   D+W+ G I  E+ T   +P F 
Sbjct: 184 HTMLPIRWMPPESIM-YRKFTTESDVWSFGVILWEIFTYGKQPWFQ 228

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 48.5 bits (115), Expect = 1e-06
 Identities = 62/218 (28%), Positives = 93/218 (42%), Gaps = 29/218 (13%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIA-----LLRELKHPNVINL 81
           +G G +G V KAR K +    D A+K+++    S    R+ A     L +   HPN+INL
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKA-NKKPVMVPKGMVKSLLY--QIL-- 136
           +      +   ++L  +YA H   +++ F R ++     P         S L   Q+L  
Sbjct: 62  LGA--CEHRGYLYLAIEYAPHG--NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 117

Query: 137 -----DGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLD 191
                 G+ YL     +HRDL   NILV GE       KIAD G +R     +K      
Sbjct: 118 AADVARGMDYLSQKQFIHRDLAARNILV-GENYVA---KIADFGLSRGQEVYVKKTMGRL 173

Query: 192 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
           PV    W     L      YT   D+W+ G +  E+++
Sbjct: 174 PVR---WMAIESLNYSV--YTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 48.0 bits (114), Expect = 2e-06
 Identities = 52/210 (24%), Positives = 96/210 (45%), Gaps = 30/210 (14%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI-EGTGLSMSA---CREIALLRELKHPNVINL 81
           ++G G +G V   + +   D    A+K I EG   SMS      E  ++ +L H  ++ L
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDV---AIKMIKEG---SMSEDEFIEEAKVMMKLSHEKLVQL 64

Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHY 141
             V      R ++++ +Y  +    ++ + R      +P  + +     +   + +G+ Y
Sbjct: 65  YGV--CTKQRPIYIVTEYMSNGC--LLNYLREHGKRFQPSQLLE-----MCKDVCEGMAY 115

Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR--LFNNPLKPLADLDPVVVTFWY 199
           L S   +HRDL   N LV  +G     VK++D G +R  L +     +    PV     +
Sbjct: 116 LESKQFIHRDLAARNCLVDDQGC----VKVSDFGLSRYVLDDEYTSSVGSKFPVR----W 167

Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLT 229
             PE+LL ++  +K+ D+WA G +  E+ +
Sbjct: 168 SPPEVLLYSKFSSKS-DVWAFGVLMWEVYS 196

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 48.1 bits (114), Expect = 2e-06
 Identities = 52/208 (25%), Positives = 86/208 (41%), Gaps = 21/208 (10%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYA-----LKQIEGTGLSMSACREIALLRELKHPNVINL 81
           +G G +G VYK       +T         L +  G   ++    E  ++  + HP+++ L
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHY 141
           + V LS   + V  L  +       ++ +    K N     +   ++ +   QI  G+ Y
Sbjct: 75  LGVCLSPTIQLVTQLMPHG-----CLLDYVHEHKDN-----IGSQLLLNWCVQIAKGMMY 124

Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
           L    ++HRDL   N+LV         VKI D G ARL     K   + D   +   + A
Sbjct: 125 LEERRLVHRDLAARNVLVKSP----NHVKITDFGLARLLEGDEKEY-NADGGKMPIKWMA 179

Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
            E  +  R +T   D+W+ G    EL+T
Sbjct: 180 LE-CIHYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 48.2 bits (115), Expect = 2e-06
 Identities = 65/233 (27%), Positives = 104/233 (44%), Gaps = 43/233 (18%)

Query: 21  DYEGCKV-GRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRE----LKH 75
           D+E  KV GRG +G V   + K+      YA+K +      M    E A  RE    L +
Sbjct: 2   DFEILKVIGRGAFGEVAVVKMKNTGQV--YAMKIL--NKWEMLKRAETACFREERDVLVN 57

Query: 76  PN---VINLISVFLSHNDRKVWLLFDY-AEHDLWHII-KFHRAAKANKKPVMVPKGMVKS 130
            +   + NL   F   ++  ++L+ DY    DL  ++ KF            +P+ M + 
Sbjct: 58  GDRRWITNLHYAF--QDENNLYLVMDYYVGGDLLTLLSKFEDR---------LPEDMARF 106

Query: 131 LLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLAD- 189
            L +++  I  +H    +HRD+KP N+L+     + G +++AD      F + L+ LAD 
Sbjct: 107 YLAEMVLAIDSVHQLGYVHRDIKPDNVLLD----KNGHIRLAD------FGSCLRLLADG 156

Query: 190 --LDPVVV-TFWYRAPELLL----GARHYTKAIDIWAIGCIFAELLTSEPIFH 235
                V V T  Y +PE+L     G   Y    D W++G    E+L  E  F+
Sbjct: 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY 209

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 47.7 bits (113), Expect = 2e-06
 Identities = 57/226 (25%), Positives = 99/226 (43%), Gaps = 30/226 (13%)

Query: 21  DYEGCKV-GRGTYGHVYKARRKDNSDT-RDYALKQIEGTGLSMSACR------EIALLRE 72
           ++E  KV G G YG V+  R+    D+ + YA+K ++   +   A        E  +L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 73  LKH-PNVINLISVFLSHNDRKVWLLFDYAEHD--LWHIIKFHRAAKANKKPVMVPKGMVK 129
           ++  P ++ L   F    D K+ L+ DY        H+ +  R  +            V+
Sbjct: 61  IRQSPFLVTLHYAF--QTDTKLHLILDYINGGELFTHLSQRERFKEQE----------VQ 108

Query: 130 SLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLAD 189
               +I+  + +LH   +++RD+K  NIL+   G     V + D G ++ F+      A 
Sbjct: 109 IYSGEIVLALEHLHKLGIIYRDIKLENILLDSNG----HVVLTDFGLSKEFHEDEVERAY 164

Query: 190 LDPVVVTFWYRAPELLLGARH-YTKAIDIWAIGCIFAELLTSEPIF 234
                 T  Y AP+++ G    + KA+D W++G +  ELLT    F
Sbjct: 165 --SFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 48.1 bits (114), Expect = 2e-06
 Identities = 53/217 (24%), Positives = 98/217 (45%), Gaps = 31/217 (14%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIA-------LLRELKHPNVI 79
           +G+GT+G V   R K  +  R YA+K +      + A  E+A       +L+  +HP + 
Sbjct: 3   LGKGTFGKVILVREK--ATGRYYAMKILRKE--VIIAKDEVAHTVTESRVLQNTRHPFLT 58

Query: 80  NLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDG 138
            L   F +H+  ++  + +YA   +L+  +   R     +          +    +I+  
Sbjct: 59  ALKYAFQTHD--RLCFVMEYANGGELFFHLSRERVFTEER---------ARFYGAEIVSA 107

Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + YLHS  V++RD+K  N+++  +    G +KI D G  +     +   A +     T  
Sbjct: 108 LEYLHSRDVVYRDIKLENLMLDKD----GHIKITDFGLCK---EGISDGATMKTFCGTPE 160

Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
           Y APE +L    Y +A+D W +G +  E++     F+
Sbjct: 161 YLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 196

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 48.1 bits (114), Expect = 2e-06
 Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 16/93 (17%)

Query: 127 MVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA-----RLFN 181
           ++K ++ Q+L G+  LH   ++HRD+KP N+LV  +    G+VKI D G A      +  
Sbjct: 310 VIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVD----GQVKIIDFGAAVDMCTGINF 365

Query: 182 NPLKPLADLDPVVVTFWYRAPELLLGARHYTKA 214
           NPL  +  LDP      Y  PE L+  +   +A
Sbjct: 366 NPLYGM--LDPR-----YSPPEELVMPQSCPRA 391

Length = 507

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 47.7 bits (113), Expect = 3e-06
 Identities = 59/226 (26%), Positives = 100/226 (44%), Gaps = 29/226 (12%)

Query: 21  DYEGCKV-GRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNV- 78
           D+E  KV GRG +G V   + K     R YA+K +    +   A  E A  RE ++  V 
Sbjct: 2   DFEIIKVIGRGAFGEVAVVKMK--HTERIYAMKILNKWEMLKRA--ETACFREERNVLVN 57

Query: 79  --INLISV--FLSHNDRKVWLLFDY-AEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLY 133
                I+   +   ++  ++L+ DY    DL  ++        +K    +P+ M +  + 
Sbjct: 58  GDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLL--------SKFEDRLPEDMARFYIA 109

Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           +++  IH +H    +HRD+KP N+L+       G +++AD G     N      + +   
Sbjct: 110 EMVLAIHSIHQLHYVHRDIKPDNVLLD----MNGHIRLADFGSCLKMNQDGTVQSSV--A 163

Query: 194 VVTFWYRAPELLL----GARHYTKAIDIWAIGCIFAELLTSEPIFH 235
           V T  Y +PE+L     G   Y    D W++G    E+L  E  F+
Sbjct: 164 VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY 209

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 47.3 bits (112), Expect = 3e-06
 Identities = 33/108 (30%), Positives = 56/108 (51%), Gaps = 9/108 (8%)

Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           QI  GI +LHS  +++RD+KP N+L+     ++G  +++D+G A      LK    +   
Sbjct: 103 QITCGILHLHSMDIVYRDMKPENVLLD----DQGNCRLSDLGLAV----ELKDGKTITQR 154

Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI 241
             T  Y APE+L     Y+  +D +A+GC   E++     F   +E +
Sbjct: 155 AGTNGYMAPEILK-EEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 47.0 bits (112), Expect = 4e-06
 Identities = 52/233 (22%), Positives = 90/233 (38%), Gaps = 51/233 (21%)

Query: 17  EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT--GLSMSACREIALLREL- 73
           EDL D    ++GRG +G V K   K +      A+K+I  T             LL +L 
Sbjct: 4   EDLKDLG--EIGRGAFGTVNKMLHKPSG--TIMAVKRIRSTVDEKEQ-----KRLLMDLD 54

Query: 74  ------KHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGM 127
                   P ++          D   W+  +  +  L    KF++      K  ++P+ +
Sbjct: 55  VVMRSSDCPYIVKFYGALFREGD--CWICMELMDISL---DKFYKYVYEVLK-SVIPEEI 108

Query: 128 VKSLLYQILDGIHYLHSNW-VLHRDLKPANILVMGEGIERGRVKIADMG--------FAR 178
           +  +    +  ++YL     ++HRD+KP+NIL+       G +K+ D G         A+
Sbjct: 109 LGKIAVATVKALNYLKEELKIIHRDVKPSNILLDR----NGNIKLCDFGISGQLVDSIAK 164

Query: 179 LFNNPLKPLADLDPVVVTFWYRAPELLL--GARHYTKAIDIWAIGCIFAELLT 229
             +   +P            Y APE +       Y    D+W++G    E+ T
Sbjct: 165 TRDAGCRP------------YMAPERIDPSARDGYDVRSDVWSLGITLYEVAT 205

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 47.1 bits (112), Expect = 4e-06
 Identities = 62/250 (24%), Positives = 110/250 (44%), Gaps = 43/250 (17%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKH--------PNV 78
           +GRG+Y  V     K     R YA+K I+   ++     +I  ++  KH        P +
Sbjct: 3   IGRGSYAKVLLVELKKTR--RIYAMKVIKKELVNDD--EDIDWVQTEKHVFETASNHPFL 58

Query: 79  INLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILD 137
           + L S F    + +++ + ++    DL     FH      ++   +P+   +    +I  
Sbjct: 59  VGLHSCF--QTESRLFFVIEFVSGGDL----MFHM-----QRQRKLPEEHARFYSAEISL 107

Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF 197
            +++LH   +++RDLK  N+L+  E    G +K+ D G  +     ++P         T 
Sbjct: 108 ALNFLHERGIIYRDLKLDNVLLDAE----GHIKLTDYGMCK---EGIRPGDTTSTFCGTP 160

Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ--LDRI 255
            Y APE+L G   Y  ++D WA+G +  E++     F     DI   +  + DQ   D +
Sbjct: 161 NYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPF-----DIVGMSD-NPDQNTEDYL 213

Query: 256 FSVMGFPLEK 265
           F V+   LEK
Sbjct: 214 FQVI---LEK 220

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 47.0 bits (111), Expect = 4e-06
 Identities = 51/216 (23%), Positives = 98/216 (45%), Gaps = 29/216 (13%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIA-------LLRELKHPNVI 79
           +G+GT+G V   R K  +  + YA+K ++     + A  E+A       +L+  +HP + 
Sbjct: 3   LGKGTFGKVILVREK--ASGKYYAMKILKKE--VIIAKDEVAHTLTESRVLKNTRHPFLT 58

Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGI 139
           +L   F +  DR  +++      +L+  +   R    ++          +    +I+  +
Sbjct: 59  SLKYSFQT-KDRLCFVMEYVNGGELFFHLSRERVFSEDR---------TRFYGAEIVSAL 108

Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
            YLHS  +++RDLK  N+++  +    G +KI D G  +     +   A +     T  Y
Sbjct: 109 DYLHSGKIVYRDLKLENLMLDKD----GHIKITDFGLCK---EGITDAATMKTFCGTPEY 161

Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
            APE +L    Y +A+D W +G +  E++     F+
Sbjct: 162 LAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 196

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 47.0 bits (111), Expect = 4e-06
 Identities = 57/216 (26%), Positives = 94/216 (43%), Gaps = 24/216 (11%)

Query: 26  KVGRGTYGHVY----KARRKDNSDTRDYALKQIEGTGL---SMSACREIALLRELKHPNV 78
           ++G+G++G VY    K   KD  +TR  A+K +         +    E ++++E    +V
Sbjct: 13  ELGQGSFGMVYEGIAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71

Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVK--SLLYQIL 136
           + L+ V +S     + ++      DL   ++  R  +    PV  P  + K   +  +I 
Sbjct: 72  VRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRP-EMENNPVQAPPSLKKMIQMAGEIA 129

Query: 137 DGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF---NNPLKPLADLDPV 193
           DG+ YL++N  +HRDL   N +V     E   VKI D G  R     +   K    L PV
Sbjct: 130 DGMAYLNANKFVHRDLAARNCMVA----EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185

Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
               W     L  G   +T   D+W+ G +  E+ T
Sbjct: 186 R---WMSPESLKDGV--FTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 47.5 bits (113), Expect = 4e-06
 Identities = 60/213 (28%), Positives = 86/213 (40%), Gaps = 54/213 (25%)

Query: 24  GCKVGRGTYGHVYKAR--RKDNSDTRDYALKQIEGTGLS--------MSACREIALLREL 73
           G K+G G +G VYKA    K +     Y LK+    G            AC         
Sbjct: 137 GKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRAC--------- 187

Query: 74  KHPNVI-NLISVFLSHNDRK----VWLLFDY-AEHDLWHIIK-----FHRAAKANKKPVM 122
             PN   + +  FL     K     WL++ Y  E  L  +++     ++       K   
Sbjct: 188 --PNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQD 245

Query: 123 VPKG------MVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGF 176
           +PKG      ++++++ QIL  +  LHS  ++HRD+KP NI+   EG   G  KI D+G 
Sbjct: 246 LPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNII-FSEG--SGSFKIIDLGA 302

Query: 177 ARLFNNPLKPLADLDPVVVTFWYRAPELLLGAR 209
           A          ADL    V   Y   E LL  R
Sbjct: 303 A----------ADLR---VGINYIPKEFLLDPR 322

Length = 566

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 46.4 bits (110), Expect = 6e-06
 Identities = 61/259 (23%), Positives = 101/259 (38%), Gaps = 34/259 (13%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLI 82
           ++G G +G V               +K++  +      +   +E+   REL HPNV+  +
Sbjct: 2   EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61

Query: 83  SVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHY 141
              +        L+ ++    DL + ++ +R   A      V + M      ++  G+ +
Sbjct: 62  GQCIESI--PYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMA----CEVASGLLW 115

Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
           LH    +H DL   N  +  +      VKI D G A L   P       D   V   + A
Sbjct: 116 LHQADFIHSDLALRNCQLTAD----LSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLA 170

Query: 202 PELL------LGARHYTKAIDIWAIGCIFAEL----------LTSEPIFH--CRQEDIKT 243
           PEL+      L  +  TK  +IW++G    EL          L+ E +     R++DIK 
Sbjct: 171 PELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKL 230

Query: 244 SNPYHHDQL-DRIFSVMGF 261
             P    +  DR + VM F
Sbjct: 231 PKPQLDLKYSDRWYEVMQF 249

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 46.1 bits (109), Expect = 9e-06
 Identities = 32/96 (33%), Positives = 42/96 (43%), Gaps = 6/96 (6%)

Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           QI  G++YL    ++HRDL   N+LV         VKI D G A+L     K        
Sbjct: 117 QIAKGMNYLEERRLVHRDLAARNVLVKTP----QHVKITDFGLAKLLGADEKEYHAEGGK 172

Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
           V   W     +L   R YT   D+W+ G    EL+T
Sbjct: 173 VPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 45.8 bits (109), Expect = 9e-06
 Identities = 67/276 (24%), Positives = 115/276 (41%), Gaps = 47/276 (17%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELK-----H--PNVI 79
           +G GT G VYK R K        A+KQ+  TG      R   +L +L      H  P ++
Sbjct: 23  IGSGTCGQVYKMRFKKTGHV--MAVKQMRRTGNKEENKR---ILMDLDVVLKSHDCPYIV 77

Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGI 139
                F++ +D  V++  +             +  K  + P+  P+ ++  +   I+  +
Sbjct: 78  KCYGYFITDSD--VFICMELMS------TCLDKLLKRIQGPI--PEDILGKMTVAIVKAL 127

Query: 140 HYL---HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA-RLFNNPLKPLADLDPVVV 195
           HYL   H   V+HRD+KP+NIL+       G VK+ D G + RL ++  K  +       
Sbjct: 128 HYLKEKHG--VIHRDVKPSNILLD----ASGNVKLCDFGISGRLVDSKAKTRSAGCAA-- 179

Query: 196 TFWYRAPELL---LGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 252
              Y APE +        Y    D+W++G    EL T +  +   + + +       ++ 
Sbjct: 180 ---YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP 236

Query: 253 DRIFSVMGF-PLEKDW------EDIRKMPEHPTLLK 281
             +    GF P    +      +D RK P++  LL+
Sbjct: 237 PSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ 272

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 45.5 bits (108), Expect = 1e-05
 Identities = 47/206 (22%), Positives = 92/206 (44%), Gaps = 32/206 (15%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISVF 85
           +G+G +G V     +     +  A+K ++    +  A   E +++  L+HPN++ L+ V 
Sbjct: 14  IGKGEFGDVMLGDYRG----QKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVV 69

Query: 86  LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSN 145
           L  N   ++++ +Y       ++ + R+     + V+     +      + +G+ YL   
Sbjct: 70  LQGNP--LYIVTEYMAKG--SLVDYLRS---RGRAVITLAQQLG-FALDVCEGMEYLEEK 121

Query: 146 WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLD----PVVVTFWYRA 201
             +HRDL   N+LV  + +     K++D G A+      +     D    PV  T    A
Sbjct: 122 NFVHRDLAARNVLVSEDLV----AKVSDFGLAK------EASQGQDSGKLPVKWT----A 167

Query: 202 PELLLGARHYTKAIDIWAIGCIFAEL 227
           PE L   +  TK+ D+W+ G +  E+
Sbjct: 168 PEALREKKFSTKS-DVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 46.0 bits (109), Expect = 1e-05
 Identities = 47/175 (26%), Positives = 77/175 (44%), Gaps = 55/175 (31%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-------SMSACREIALLRELKHPNVI 79
           + RG +G VY  R+K+NS  + YA+K ++   +        + A R+   L   K P ++
Sbjct: 12  ISRGAFGKVYLGRKKNNS--KLYAVKVVKKADMINKNMVHQVQAERDALALS--KSPFIV 67

Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLL--YQILD 137
           +L     S N   V+L+ +Y                      ++  G VKSLL  Y   D
Sbjct: 68  HLYYSLQSAN--NVYLVMEY----------------------LI-GGDVKSLLHIYGYFD 102

Query: 138 -------------GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL 179
                         + YLH + ++HRDLKP N+L+  E    G +K+ D G +++
Sbjct: 103 EEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNE----GHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 45.0 bits (106), Expect = 2e-05
 Identities = 54/218 (24%), Positives = 101/218 (46%), Gaps = 32/218 (14%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIA-------LLRELKHPNVI 79
           +G+GT+G V   + K  +  R YA+K ++     + A  E+A       +L+  +HP + 
Sbjct: 3   LGKGTFGKVILVKEK--ATGRYYAMKILKKE--VIVAKDEVAHTLTENRVLQNSRHPFLT 58

Query: 80  NLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDG 138
            L   F +H+  ++  + +YA   +L+  +   R    ++          +    +I+  
Sbjct: 59  ALKYSFQTHD--RLCFVMEYANGGELFFHLSRERVFSEDR---------ARFYGAEIVSA 107

Query: 139 IHYLHSNW-VLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF 197
           + YLHS   V++RDLK  N+++  +G     +KI D G  +     +K  A +     T 
Sbjct: 108 LDYLHSEKNVVYRDLKLENLMLDKDG----HIKITDFGLCK---EGIKDGATMKTFCGTP 160

Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
            Y APE+L     Y +A+D W +G +  E++     F+
Sbjct: 161 EYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFY 197

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 44.6 bits (105), Expect = 2e-05
 Identities = 43/201 (21%), Positives = 94/201 (46%), Gaps = 22/201 (10%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFL 86
           +G+G +G V     + N      A+K I+    + +   E +++ +L+H N++ L+ V +
Sbjct: 14  IGKGEFGDVMLGDYRGNK----VAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 69

Query: 87  SHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNW 146
                 ++++ +Y       ++ + R+     + V+    ++K  L  + + + YL +N 
Sbjct: 70  EEKG-GLYIVTEYMAKG--SLVDYLRS---RGRSVLGGDCLLKFSL-DVCEAMEYLEANN 122

Query: 147 VLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLL 206
            +HRDL   N+LV  + +     K++D G  +      +  +  D   +   + APE L 
Sbjct: 123 FVHRDLAARNVLVSEDNV----AKVSDFGLTK------EASSTQDTGKLPVKWTAPEALR 172

Query: 207 GARHYTKAIDIWAIGCIFAEL 227
             +  TK+ D+W+ G +  E+
Sbjct: 173 EKKFSTKS-DVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 45.0 bits (106), Expect = 2e-05
 Identities = 43/169 (25%), Positives = 71/169 (42%), Gaps = 24/169 (14%)

Query: 112 RAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI 171
           R    N+ P +    +V    YQ+ +G+ +L S   +HRDL   N+L+     E   VKI
Sbjct: 226 RDTLINESPALSYMDLV-GFSYQVANGMEFLASKNCVHRDLAARNVLI----CEGKLVKI 280

Query: 172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-- 229
            D G AR        ++     +   W  APE +     YT   D+W+ G +  E+ T  
Sbjct: 281 CDFGLARDIMRDSNYISKGSTFLPLKWM-APESIFNNL-YTTLSDVWSFGILLWEIFTLG 338

Query: 230 ---------SEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGFPLEKDWED 269
                    +E  ++  +   + + P H    D I+ +M    +K WE+
Sbjct: 339 GTPYPELPMNEQFYNAIKRGYRMAKPAHAS--DEIYEIM----QKCWEE 381

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 44.5 bits (105), Expect = 3e-05
 Identities = 52/210 (24%), Positives = 95/210 (45%), Gaps = 24/210 (11%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDY--ALKQIEGTGLSMSACR----EIALLRELKHPNVIN 80
           +G G +G V   R K     R+   A+K ++  G +    R    E +++ +  HPN+I+
Sbjct: 12  IGAGEFGEVCSGRLKLPG-KREIPVAIKTLKA-GYTEKQRRDFLSEASIMGQFDHPNIIH 69

Query: 81  LISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGI 139
           L  V      + V ++ +Y E+  L   ++ H      +  V+   GM++     I  G+
Sbjct: 70  LEGVVT--KSKPVMIVTEYMENGSLDAFLRKHDG----QFTVIQLVGMLRG----IASGM 119

Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
            YL     +HRDL   NILV    +     K++D G +R+  +  +         +   +
Sbjct: 120 KYLSDMGYVHRDLAARNILVNSNLV----CKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 175

Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLT 229
            APE  +  R +T A D+W+ G +  E+++
Sbjct: 176 TAPE-AIAYRKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 43.6 bits (103), Expect = 6e-05
 Identities = 59/244 (24%), Positives = 99/244 (40%), Gaps = 49/244 (20%)

Query: 68  ALLRELK-------HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKK 119
           AL+ ELK       H N++NL+          + ++ +Y  + DL + +   R     K+
Sbjct: 84  ALMSELKIMSHLGNHENIVNLLGACTIGG--PILVITEYCCYGDLLNFL--RR-----KR 134

Query: 120 PVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL 179
              +    + S  YQ+  G+ +L S   +HRDL   N+L+    I    VKI D G AR 
Sbjct: 135 ESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKI----VKICDFGLARD 190

Query: 180 F----NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT------ 229
                N  +K  A L PV     + APE +     YT   D+W+ G +  E+ +      
Sbjct: 191 IMNDSNYVVKGNARL-PVK----WMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPY 244

Query: 230 -----SEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGFPLEKDW-EDIRKMPEHPTLLKDF 283
                    +   +E  + + P H      I+ +M    +  W  D  K P    +++  
Sbjct: 245 PGMPVDSKFYKLIKEGYRMAQPEHAPA--EIYDIM----KTCWDADPLKRPTFKQIVQLI 298

Query: 284 NEQI 287
            +Q+
Sbjct: 299 GKQL 302

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 43.7 bits (103), Expect = 6e-05
 Identities = 39/110 (35%), Positives = 52/110 (47%), Gaps = 18/110 (16%)

Query: 130 SLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRV-KIADMGFARLFNNP----L 184
           S  YQ+  G+ +L S   +HRDL   NIL     +  GR+ KI D G AR   N     +
Sbjct: 218 SFSYQVAKGMSFLASKNCIHRDLAARNIL-----LTHGRITKICDFGLARDIRNDSNYVV 272

Query: 185 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL--LTSEP 232
           K  A L PV     + APE +     YT   D+W+ G +  E+  L S P
Sbjct: 273 KGNARL-PVK----WMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSP 316

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 43.5 bits (102), Expect = 6e-05
 Identities = 32/98 (32%), Positives = 49/98 (50%), Gaps = 8/98 (8%)

Query: 133 YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPLKPLADLD 191
           +Q+  G+ +L S   +HRDL   NIL+     E   VKI D G AR ++ +P   +   D
Sbjct: 186 FQVAKGMEFLASRKCIHRDLAARNILLS----ENNVVKICDFGLARDIYKDP-DYVRKGD 240

Query: 192 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
             +   W  APE +   R YT   D+W+ G +  E+ +
Sbjct: 241 ARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 43.1 bits (101), Expect = 7e-05
 Identities = 33/97 (34%), Positives = 46/97 (47%), Gaps = 8/97 (8%)

Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFN-NPLKPLADLDP 192
           QI  G+ YL    ++HRDL   N+LV         VKI D G ARL + +  +  AD   
Sbjct: 117 QIAKGMSYLEEVRLVHRDLAARNVLVKSP----NHVKITDFGLARLLDIDETEYHADGGK 172

Query: 193 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
           V +  W     +L   R +T   D+W+ G    EL+T
Sbjct: 173 VPIK-WMALESIL--HRRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 43.1 bits (101), Expect = 8e-05
 Identities = 61/231 (26%), Positives = 106/231 (45%), Gaps = 39/231 (16%)

Query: 21  DYEGCKV-GRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVI 79
           D+E  KV GRG +G V   + K N+D + +A+K +    +   A  E A  RE +   ++
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLK-NAD-KVFAMKILNKWEMLKRA--ETACFRE-ERDVLV 56

Query: 80  NLISVFLS------HNDRKVWLLFDY-AEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLL 132
           N  + +++       ++  ++L+ DY    DL  ++        +K    +P+ M +  L
Sbjct: 57  NGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLL--------SKFEDRLPEDMARFYL 108

Query: 133 YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLAD--- 189
            +++  I  +H    +HRD+KP NIL+       G +++AD      F + LK + D   
Sbjct: 109 AEMVIAIDSVHQLHYVHRDIKPDNILMD----MNGHIRLAD------FGSCLKLMEDGTV 158

Query: 190 -LDPVVVTFWYRAPELLL----GARHYTKAIDIWAIGCIFAELLTSEPIFH 235
                V T  Y +PE+L     G   Y    D W++G    E+L  E  F+
Sbjct: 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY 209

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 43.4 bits (102), Expect = 8e-05
 Identities = 32/116 (27%), Positives = 57/116 (49%), Gaps = 18/116 (15%)

Query: 131 LLYQILDGIHYLHSNW-VLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLK-PLA 188
           +++Q    + Y H+   ++H DLKP NIL     +E     +  +    L  +P +  + 
Sbjct: 236 IIFQTGVALDYFHTELHLMHTDLKPENIL-----METSDTVVDPVTNRALPPDPCRVRIC 290

Query: 189 DL----------DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           DL            +V T  YR+PE++LG   +  + D+W++GCI  EL T + ++
Sbjct: 291 DLGGCCDERHSRTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYELYTGKLLY 345

Length = 467

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 42.9 bits (101), Expect = 9e-05
 Identities = 31/107 (28%), Positives = 53/107 (49%), Gaps = 8/107 (7%)

Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           +I+  + YLHS  V++RDLK  N+++  +    G +KI D G   L    +   A +   
Sbjct: 103 EIVSALGYLHSCDVVYRDLKLENLMLDKD----GHIKITDFG---LCKEGISDGATMKTF 155

Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
             T  Y APE +L    Y +A+D W +G +  E++     F+ +  +
Sbjct: 156 CGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 201

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 42.9 bits (101), Expect = 1e-04
 Identities = 39/138 (28%), Positives = 52/138 (37%), Gaps = 47/138 (34%)

Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIER-GRVKIADMGFARLF----------------- 180
           I  +H    +HRD+KP NIL     I+R G +K+ D G    F                 
Sbjct: 114 IESVHKMGFIHRDIKPDNIL-----IDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQ 168

Query: 181 -------------NNPLKPLADLD----------PVVVTFWYRAPELLLGARHYTKAIDI 217
                           LKPL               +V T  Y APE+LL    YT+  D 
Sbjct: 169 DSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDW 227

Query: 218 WAIGCIFAELLTSEPIFH 235
           W++G I  E+L  +P F 
Sbjct: 228 WSVGVILYEMLVGQPPFL 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 41.5 bits (97), Expect = 2e-04
 Identities = 32/101 (31%), Positives = 49/101 (48%), Gaps = 14/101 (13%)

Query: 133 YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNP---LKPLA 188
           +Q+  G+ +L S   +HRDL   NIL+     E   VKI D G AR ++ +P    K  A
Sbjct: 181 FQVARGMEFLASRKCIHRDLAARNILLS----ENNVVKICDFGLARDIYKDPDYVRKGSA 236

Query: 189 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
            L        + APE +   + YT   D+W+ G +  E+ +
Sbjct: 237 RL-----PLKWMAPESIFD-KVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 41.5 bits (97), Expect = 2e-04
 Identities = 52/220 (23%), Positives = 85/220 (38%), Gaps = 44/220 (20%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYA---LKQIEGTGLSMSACREIALLRELKHPNVINLI 82
           ++G G +G V K   K      D A   LK      +     RE  ++ +L +P ++ +I
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 83  SVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYL 142
            V  +     + L+ + A     +  KF    K       +    V  L++Q+  G+ YL
Sbjct: 62  GVCEAEA---LMLVMEMASGGPLN--KFLSGKKDE-----ITVSNVVELMHQVSMGMKYL 111

Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGF------------ARLFNN-PLKPLAD 189
                +HRDL   N+L+    + +   KI+D G             AR     PLK    
Sbjct: 112 EGKNFVHRDLAARNVLL----VNQHYAKISDFGLSKALGADDSYYKARSAGKWPLK---- 163

Query: 190 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                   WY APE +   R ++   D+W+ G    E  +
Sbjct: 164 --------WY-APECIN-FRKFSSRSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 41.5 bits (97), Expect = 3e-04
 Identities = 32/103 (31%), Positives = 48/103 (46%), Gaps = 12/103 (11%)

Query: 130 SLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF---NNPLKP 186
           S  YQ+  G+ +L S   +HRDL   N+L+    I    VKI D G AR     +N +  
Sbjct: 241 SFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKI----VKICDFGLARDIMHDSNYVSK 296

Query: 187 LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
            +   PV     + APE +     YT   D+W+ G +  E+ +
Sbjct: 297 GSTFLPVK----WMAPESIFD-NLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 41.2 bits (97), Expect = 3e-04
 Identities = 33/131 (25%), Positives = 49/131 (37%), Gaps = 40/131 (30%)

Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMG------------FARLFNNPLKP 186
           I  +H    +HRD+KP N+L+      +G +K++D G            F R+ ++ L  
Sbjct: 114 IDSIHKLGYIHRDIKPDNLLLD----AKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPS 169

Query: 187 LADLDP-----------------------VVVTFWYRAPELLLGARHYTKAIDIWAIGCI 223
                                         V T  Y APE+ L    Y K  D W++G I
Sbjct: 170 NFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-QTGYNKECDWWSLGVI 228

Query: 224 FAELLTSEPIF 234
             E+L   P F
Sbjct: 229 MYEMLVGYPPF 239

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 40.6 bits (95), Expect = 5e-04
 Identities = 31/98 (31%), Positives = 49/98 (50%), Gaps = 8/98 (8%)

Query: 133 YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPLKPLADLD 191
           +Q+  G+ +L S   +HRDL   NIL+     E   VKI D G AR ++ +P   +   D
Sbjct: 180 FQVARGMEFLASRKCIHRDLAARNILLS----ENNVVKICDFGLARDIYKDP-DYVRKGD 234

Query: 192 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
             +   W  APE +   + YT   D+W+ G +  E+ +
Sbjct: 235 ARLPLKWM-APESIFD-KVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 40.3 bits (94), Expect = 5e-04
 Identities = 32/110 (29%), Positives = 51/110 (46%), Gaps = 8/110 (7%)

Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           QI  G++YL  + ++HR+L   NIL+  + I    V+IAD G A L     K     +  
Sbjct: 117 QIAKGMYYLEEHRMVHRNLAARNILLKSDSI----VQIADFGVADLLYPDDKKYFYSEHK 172

Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT--SEPIFHCRQEDI 241
               W     +L G   YT   D+W+ G    E+++  +EP    R  ++
Sbjct: 173 TPIKWMALESILFG--RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV 220

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 40.0 bits (93), Expect = 8e-04
 Identities = 38/164 (23%), Positives = 70/164 (42%), Gaps = 14/164 (8%)

Query: 66  EIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPK 125
           E +++ +  H N+I L  V          ++ +Y E+    + K+ R          +  
Sbjct: 56  EASIMGQFSHHNIIRLEGVVTKFKP--AMIITEYMENGA--LDKYLRDHDGEFSSYQL-V 110

Query: 126 GMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLK 185
           GM++     I  G+ YL     +HRDL   NILV          K++D G +R+  +  +
Sbjct: 111 GMLRG----IAAGMKYLSDMNYVHRDLAARNILVNSNLE----CKVSDFGLSRVLEDDPE 162

Query: 186 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                    +   + APE  +  R +T A D+W+ G +  E+++
Sbjct: 163 GTYTTSGGKIPIRWTAPE-AIAYRKFTSASDVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 39.5 bits (92), Expect = 0.001
 Identities = 19/57 (33%), Positives = 31/57 (54%), Gaps = 4/57 (7%)

Query: 124 PKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
            K ++K+++  +L  + Y+H + + H D+KP NI+V G      R  I D G A  F
Sbjct: 124 NKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDG----NNRGYIIDYGIASHF 176

Length = 294

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 39.1 bits (91), Expect = 0.002
 Identities = 19/36 (52%), Positives = 21/36 (58%), Gaps = 1/36 (2%)

Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           Y APELLLG  H   A+D WA+G    E LT  P F
Sbjct: 546 YLAPELLLGKPH-GPAVDWWALGVCLFEFLTGIPPF 580

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 38.5 bits (89), Expect = 0.003
 Identities = 59/253 (23%), Positives = 101/253 (39%), Gaps = 57/253 (22%)

Query: 21  DYEGCKV-GRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRE----LKH 75
           D+E  KV GRG +G V   ++KD      YA+K +      M    ++A +R     L  
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHI--YAMKILRKA--DMLEKEQVAHIRAERDILVE 57

Query: 76  PNVINLISVFLSHND-RKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLY 133
            +   ++ +F S  D R ++L+ ++    D+  ++              + + ++     
Sbjct: 58  ADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLA---- 113

Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMG-------------FARLF 180
             +D IH L     +HRD+KP N+L+      +G VK++D G             +  L 
Sbjct: 114 --IDAIHQLG---FIHRDIKPDNLLLDA----KGHVKLSDFGLCTGLKKAHRTEFYRNLT 164

Query: 181 NNPLKPLADLD-------------------PVVVTFWYRAPELLLGARHYTKAIDIWAIG 221
           +NP    +  +                     V T  Y APE+ +    Y K  D W++G
Sbjct: 165 HNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLG 223

Query: 222 CIFAELLTSEPIF 234
            I  E+L   P F
Sbjct: 224 VIMYEMLIGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 38.1 bits (88), Expect = 0.004
 Identities = 61/260 (23%), Positives = 102/260 (39%), Gaps = 71/260 (27%)

Query: 21  DYEGCKV-GRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRE----LKH 75
           D+E  KV GRG +G V   ++KD      YA+K +      M    ++  +R     L  
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHV--YAMKILRKA--DMLEKEQVGHIRAERDILVE 57

Query: 76  PNVINLISVFLSHNDR-KVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLY 133
            + + ++ +F S  D+  ++L+ ++    D+  ++         KK  +  +     +  
Sbjct: 58  ADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM--------KKDTLTEEETQFYIAE 109

Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMG------------FARLFN 181
            +L  I  +H    +HRD+KP N+L+      +G VK++D G            F R  N
Sbjct: 110 TVL-AIDSIHQLGFIHRDIKPDNLLLD----SKGHVKLSDFGLCTGLKKAHRTEFYRNLN 164

Query: 182 NPLKPLADLDPVVVTF-----------WYR----------------APELLLGARHYTKA 214
           + L       P   TF           W R                APE+ +    Y K 
Sbjct: 165 HSL-------PSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM-QTGYNKL 216

Query: 215 IDIWAIGCIFAELLTSEPIF 234
            D W++G I  E+L   P F
Sbjct: 217 CDWWSLGVIMYEMLIGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 38.1 bits (88), Expect = 0.004
 Identities = 40/156 (25%), Positives = 63/156 (40%), Gaps = 51/156 (32%)

Query: 124 PKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIER-GRVKIADMG------- 175
           P+ + +  + ++   +  +H    +HRD+KP NIL     I+R G +K+ D G       
Sbjct: 99  PEDLARFYIAELTCAVESVHKMGFIHRDIKPDNIL-----IDRDGHIKLTDFGLCTGFRW 153

Query: 176 -------------------FARLFNNP--------LKPLAD----------LDPVVVTFW 198
                              F+  + +P        LKPL               +V T  
Sbjct: 154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPN 213

Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           Y APE+LL    YT+  D W++G I  E+L  +P F
Sbjct: 214 YIAPEVLLRT-GYTQLCDWWSVGVILYEMLVGQPPF 248

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 37.6 bits (87), Expect = 0.004
 Identities = 54/216 (25%), Positives = 99/216 (45%), Gaps = 24/216 (11%)

Query: 26  KVGRGTYGHVYKARRKD----NSDTRDYALKQI-EGTGLS--MSACREIALLRELKHPNV 78
           ++G+G++G VY+   +D     ++TR  A+K + E   L   +    E ++++     +V
Sbjct: 13  ELGQGSFGMVYEGNARDIIKGEAETR-VAVKTVNESASLRERIEFLNEASVMKGFTCHHV 71

Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANK--KPVMVPKGMVKSLLYQIL 136
           + L+ V +S     + ++   A  DL   ++  R    N   +P    + M++ +  +I 
Sbjct: 72  VRLLGV-VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ-MAAEIA 129

Query: 137 DGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF---NNPLKPLADLDPV 193
           DG+ YL++   +HRDL   N +V         VKI D G  R     +   K    L PV
Sbjct: 130 DGMAYLNAKKFVHRDLAARNCMVA----HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185

Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                + APE L     +T + D+W+ G +  E+ +
Sbjct: 186 R----WMAPESLKDGV-FTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	291
KOG0666|consensus	438		100.0
KOG0600|consensus	560		100.0
KOG0659|consensus	318		100.0
KOG0615|consensus	475		100.0
KOG0663|consensus	419		100.0
KOG0575|consensus	592		100.0
KOG0581|consensus	364		100.0
KOG0595|consensus	429		100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
KOG0593|consensus	396		100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG0591|consensus	375		100.0
KOG0598|consensus	357		100.0
KOG0594|consensus	323		100.0
KOG0592|consensus	604		100.0
KOG0661|consensus	538		100.0
KOG0583|consensus	370		100.0
KOG0658|consensus	364		100.0
KOG0597|consensus	808		100.0
KOG0192|consensus	362		100.0
KOG0605|consensus	550		100.0
KOG0616|consensus	355		100.0
KOG0198|consensus	313		100.0
KOG0667|consensus	586		100.0
KOG0660|consensus	359		100.0
KOG0197|consensus	468		100.0
KOG0662|consensus	292		100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0585|consensus	576		100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0582|consensus	516		100.0
KOG0589|consensus	426		100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0578|consensus	550		100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0032|consensus	382		100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG0694|consensus	694		100.0
KOG0033|consensus	355		100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0588|consensus	786		100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
KOG0611|consensus	668		100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG0610|consensus	459		100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG0193|consensus	678		100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG0580|consensus	281		100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
KOG0201|consensus	467		100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
PTZ00284	467	protein kinase; Provisional	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
KOG1026|consensus	774		100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
KOG4717|consensus	864		100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
KOG4250|consensus	732		100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
KOG0574|consensus	502		100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
KOG0669|consensus	376		100.0
KOG1989|consensus	738		100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
KOG4721|consensus	904		100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG4236|consensus	888		100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
KOG1187|consensus	361		100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
KOG0607|consensus	463		100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
KOG0599|consensus	411		100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
KOG1095|consensus	1025		100.0
KOG0584|consensus	632		100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
KOG0604|consensus	400		100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG0586|consensus	596		100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG0596|consensus	677		100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
KOG0194|consensus	474		100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
KOG2345|consensus	302		100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
KOG0577|consensus	948		100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
KOG0199|consensus	1039		100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
KOG4257|consensus	974		100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG4279|consensus	1226		100.0
KOG0612|consensus	1317		100.0
KOG0986|consensus	591		100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG1035|consensus	1351		100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0984|consensus	282		100.0
KOG0983|consensus	391		100.0
KOG0603|consensus	612		100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG0671|consensus	415		100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG0196|consensus	996		100.0
KOG0690|consensus	516		100.0
KOG0579|consensus	1187		100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0614|consensus	732		100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG0696|consensus	683		100.0
KOG1006|consensus	361		100.0
KOG4278|consensus	1157		100.0
KOG4645|consensus	1509		100.0
KOG1151|consensus	775		100.0
KOG1152|consensus	772		100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG1094|consensus	807		100.0
KOG0608|consensus	1034		100.0
KOG1027|consensus	903		100.0
KOG0664|consensus	449		100.0
KOG2052|consensus	513		100.0
KOG0587|consensus	953		100.0
KOG0670|consensus	752		100.0
KOG1290|consensus	590		99.98
KOG3653|consensus	534		99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG0200|consensus	609		99.97
KOG1025|consensus	1177		99.97
KOG0668|consensus	338		99.97
KOG0695|consensus	593		99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG0665|consensus	369		99.97
KOG1163|consensus	341		99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG1024|consensus	563		99.96
KOG1167|consensus	418		99.96
KOG1345|consensus	378		99.96
KOG1165|consensus	449		99.96
KOG1164|consensus	322		99.95
KOG0576|consensus	829		99.94
PLN00181	793	protein SPA1-RELATED; Provisional	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.92
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.88
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.88
KOG1166|consensus	974		99.87
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.87
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.87
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.87
PRK12274	218	serine/threonine protein kinase; Provisional	99.86
KOG0590|consensus	601		99.86
PRK10345	210	hypothetical protein; Provisional	99.86
KOG4158|consensus	598		99.81
KOG1240|consensus	1431		99.81
KOG0603|consensus	612		99.8
smart00090	237	RIO RIO-like kinase.	99.79
KOG0195|consensus	448		99.78
PRK14879	211	serine/threonine protein kinase; Provisional	99.77
KOG0606|consensus	1205		99.76
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.74
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.74
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.74
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.72
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.67
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.67
KOG1033|consensus	516		99.64
KOG1023|consensus	484		99.64
KOG0590|consensus	601		99.56
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.52
KOG3087|consensus	229		99.49
KOG1243|consensus	690		99.47
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.45
KOG0601|consensus	524		99.41
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.41
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.41
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.38
COG4248	637	Uncharacterized protein with protein kinase and he	99.36
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.28
KOG0601|consensus	524		99.27
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.26
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.2
KOG3741|consensus	655		99.19
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.16
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.05
KOG1266|consensus	458		99.03
PRK09902	216	hypothetical protein; Provisional	99.02
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.85
KOG0606|consensus	1205		98.78
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.67
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.59
KOG2137|consensus	700		98.58
KOG1235|consensus	538		98.57
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.53
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.52
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.44
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.38
PF01636	239	APH: Phosphotransferase enzyme family This family	98.33
PLN02876	822	acyl-CoA dehydrogenase	98.31
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.26
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.11
KOG0576|consensus	829		98.1
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.02
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.93
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.79
PRK05231	319	homoserine kinase; Provisional	97.67
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.67
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.64
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.58
KOG2270|consensus	520		97.56
KOG2268|consensus	465		97.55
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.26
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.24
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	97.22
KOG1035|consensus	1351		97.11
PRK10593	297	hypothetical protein; Provisional	97.09
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.96
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.9
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.89
PLN02236	344	choline kinase	96.88
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.79
PTZ00384	383	choline kinase; Provisional	96.73
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.71
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.23
PRK11768	325	serine/threonine protein kinase; Provisional	96.21
PRK12396	409	5-methylribose kinase; Reviewed	96.17
PLN02756	418	S-methyl-5-thioribose kinase	96.1
COG2334	331	Putative homoserine kinase type II (protein kinase	95.66
KOG1826|consensus	2724		95.28
PF04655	253	APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r	95.26
PRK06148	1013	hypothetical protein; Provisional	95.07
PTZ00296	442	choline kinase; Provisional	94.62
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	94.6
KOG1236|consensus	565		94.57
PF03109	119	ABC1: ABC1 family; InterPro: IPR004147 This entry	94.56

>KOG0666|consensus

Probab=100.00  E-value=7.2e-52  Score=330.03  Aligned_cols=279  Identities=77%  Similarity=1.328  Sum_probs=253.7

Q ss_pred             CCcccceeeccccccccccccccc-ceeCcccceEEEEEEEccCCC--CceeEEEEeCCC----CCChhHHHHHHHHhcC
Q psy2172           1 MDYEFKIKTSNERTKVEDLFDYEG-CKVGRGTYGHVYKARRKDNSD--TRDYALKQIEGT----GLSMSACREIALLREL   73 (291)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~~~~~~-~~ig~G~~g~Vy~~~~~~~~~--~~~vaiK~~~~~----~~~~~~~~e~~~l~~l   73 (291)
                      ||+.|+-+-...+.++.+++.|++ ..||+|.||.||+|..+++..  .+.+|||.++.+    ..++.+.+|+.+++.+
T Consensus         5 ~~~~~~~~~~ser~rve~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl   84 (438)
T KOG0666|consen    5 MDYDFKSKLASERERVEDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLREL   84 (438)
T ss_pred             ccccchhhhhhhhhhHHHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHh
Confidence            688888888888888888888875 469999999999997666545  347999999866    6778999999999999


Q ss_pred             CCCCeeeEEEEEEeCCCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccC
Q psy2172          74 KHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLK  153 (291)
Q Consensus        74 ~h~~iv~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik  153 (291)
                      +|||++.+..+|+.. +..+++++||.+++|++.+..++.....    .++...++.+++||+.|++|||++-|+|||||
T Consensus        85 ~h~nvi~Lv~Vfl~~-d~~v~l~fdYAEhDL~~II~fHr~~~~~----~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLK  159 (438)
T KOG0666|consen   85 KHPNVISLVKVFLSH-DKKVWLLFDYAEHDLWHIIKFHRASKAK----QLPRSMVKSILWQILDGVHYLHSNWVLHRDLK  159 (438)
T ss_pred             cCCcchhHHHHHhcc-CceEEEEehhhhhhHHHHHHHhccchhc----cCCHHHHHHHHHHHHhhhHHHhhhheeeccCC
Confidence            999999999999764 7799999999999999999998876553    38999999999999999999999999999999


Q ss_pred             CCcEEeecCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCC
Q psy2172         154 PANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI  233 (291)
Q Consensus       154 ~~Nil~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p  233 (291)
                      |.||++..++..++.|||+|||+++.+.++..+........-|.+|+|||.+.|..+|+.+.|+||.||++.||++-.+.
T Consensus       160 PaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~Pl  239 (438)
T KOG0666|consen  160 PANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPL  239 (438)
T ss_pred             cceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcc
Confidence            99999998877889999999999999998877777777888899999999999999999999999999999999999999


Q ss_pred             CCCCcccccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhhhh
Q psy2172         234 FHCRQEDIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDFN  284 (291)
Q Consensus       234 f~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (291)
                      |.+...+....+|...+++.+|++.++.|..++||++..+|+|-.++++|.
T Consensus       240 F~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~  290 (438)
T KOG0666|consen  240 FKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFR  290 (438)
T ss_pred             ccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhH
Confidence            999999999999999999999999999999999999999999977777775

>KOG0600|consensus

Probab=100.00  E-value=1.3e-49  Score=335.08  Aligned_cols=232  Identities=42%  Similarity=0.769  Sum_probs=205.7

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT----GLSMSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      +.|+ .-++||+|.||.||+|++..  +++.||+|.++-+    .....+.+|+.||++|+||||+++.+...+.....+
T Consensus       117 ~~fe-ki~kIGeGTyg~VYkAr~~~--tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si  193 (560)
T KOG0600|consen  117 DSFE-KIEKIGEGTYGQVYKARDLE--TGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI  193 (560)
T ss_pred             HHHH-HHHHhcCcchhheeEeeecc--cCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence            3555 35699999999999999776  8899999998643    445568899999999999999999999987767899


Q ss_pred             EEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEee
Q psy2172          94 WLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIAD  173 (291)
Q Consensus        94 ~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~D  173 (291)
                      |+|+|||+++|..++....-        .|++.+++.++.||+.||+|+|.+||+|||||.+|||++    +++.+||+|
T Consensus       194 YlVFeYMdhDL~GLl~~p~v--------kft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLid----n~G~LKiaD  261 (560)
T KOG0600|consen  194 YLVFEYMDHDLSGLLSSPGV--------KFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILID----NNGVLKIAD  261 (560)
T ss_pred             EEEEecccchhhhhhcCCCc--------ccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEc----CCCCEEecc
Confidence            99999999999998876433        299999999999999999999999999999999999999    889999999


Q ss_pred             cccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccCCCCCcHHHHH
Q psy2172         174 MGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD  253 (291)
Q Consensus       174 fg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  253 (291)
                      ||+|+++.....  ...+...-|.+|+|||.+.|...|+.+.|+||.||+|.||+.|+++|.++.+         .+|+.
T Consensus       262 FGLAr~y~~~~~--~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE---------veQl~  330 (560)
T KOG0600|consen  262 FGLARFYTPSGS--APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE---------VEQLH  330 (560)
T ss_pred             ccceeeccCCCC--cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH---------HHHHH
Confidence            999998765432  2345667899999999999988899999999999999999999999999988         59999


Q ss_pred             HHHHhhCCCCcCChhhhhcCCCC
Q psy2172         254 RIFSVMGFPLEKDWEDIRKMPEH  276 (291)
Q Consensus       254 ~i~~~~~~~~~~~~~~~~~~~~~  276 (291)
                      .|++.|+.|.+..|| ..++|.+
T Consensus       331 kIfklcGSP~e~~W~-~~kLP~~  352 (560)
T KOG0600|consen  331 KIFKLCGSPTEDYWP-VSKLPHA  352 (560)
T ss_pred             HHHHHhCCCChhccc-cccCCcc
Confidence            999999999999999 6777643

>KOG0659|consensus

Probab=100.00  E-value=1.3e-49  Score=310.69  Aligned_cols=233  Identities=43%  Similarity=0.800  Sum_probs=208.3

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT----GLSMSACREIALLRELKHPNVINLISVFLSHNDRKVW   94 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (291)
                      +|.. -++||+|.||.||+|++..  +++.||||.++-.    .....+.+|++.|+.++|+||+.++++|  .....+-
T Consensus         3 rY~~-~~~lGEG~~gvVyka~d~~--t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F--~~~~~l~   77 (318)
T KOG0659|consen    3 RYEK-LEKLGEGTYGVVYKARDTE--TGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVF--PHKSNLS   77 (318)
T ss_pred             hhhh-hhhhcCcceEEEEEEEecC--CCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhc--cCCCceE
Confidence            4553 4699999999999999766  8899999999743    3456789999999999999999999999  7788999


Q ss_pred             EEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          95 LLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        95 iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      +|+||++.+|...++.....        ++...++.++.++++|++|+|++.|+||||||+|++++    .++.+||+||
T Consensus        78 lVfEfm~tdLe~vIkd~~i~--------l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis----~~g~lKiADF  145 (318)
T KOG0659|consen   78 LVFEFMPTDLEVVIKDKNII--------LSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLIS----SDGQLKIADF  145 (318)
T ss_pred             EEEEeccccHHHHhcccccc--------cCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEc----CCCcEEeecc
Confidence            99999999999999865432        89999999999999999999999999999999999999    7789999999


Q ss_pred             ccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccCCCCCcHHHHHH
Q psy2172         175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR  254 (291)
Q Consensus       175 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  254 (291)
                      |+++.+.++....   .....|.+|+|||.+.|.+.|+...|+||.||++.||+-|.+.|.|.++         .+|+..
T Consensus       146 GLAr~f~~p~~~~---~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD---------idQL~~  213 (318)
T KOG0659|consen  146 GLARFFGSPNRIQ---THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD---------IDQLSK  213 (318)
T ss_pred             cchhccCCCCccc---ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch---------HHHHHH
Confidence            9999887754432   2236799999999999999999999999999999999999999999887         599999


Q ss_pred             HHHhhCCCCcCChhhhhcCCCCcchh
Q psy2172         255 IFSVMGFPLEKDWEDIRKMPEHPTLL  280 (291)
Q Consensus       255 i~~~~~~~~~~~~~~~~~~~~~~~~~  280 (291)
                      |++.+++|.+..||++.++|+|..+.
T Consensus       214 If~~LGTP~~~~WP~~~~lpdY~~~~  239 (318)
T KOG0659|consen  214 IFRALGTPTPDQWPEMTSLPDYVKIQ  239 (318)
T ss_pred             HHHHcCCCCcccCccccccccHHHHh
Confidence            99999999999999999999886654

>KOG0615|consensus

Probab=100.00  E-value=1.5e-50  Score=333.16  Aligned_cols=252  Identities=25%  Similarity=0.412  Sum_probs=208.5

Q ss_pred             cccccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC---------CChhHHHHHHHHhcCCCCCeee
Q psy2172          10 SNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG---------LSMSACREIALLRELKHPNVIN   80 (291)
Q Consensus        10 ~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~e~~~l~~l~h~~iv~   80 (291)
                      +++.....+.|. .++.||+|+||.|-+|..+.  +++.||||++.+..         ......+|+++|++|+|||||+
T Consensus       164 ~~~pks~~d~yi-i~~~LGsGafg~Vkla~e~~--tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~  240 (475)
T KOG0615|consen  164 KVPPKSFNDYYI-ISKTLGSGAFGLVKLAYEKK--TGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVR  240 (475)
T ss_pred             cCccchhcceeE-eeeeecCCceeEEEEEEEcc--cCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEE
Confidence            334444555555 58999999999999999877  88999999996432         1224679999999999999999


Q ss_pred             EEEEEEeCCCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEe
Q psy2172          81 LISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILV  159 (291)
Q Consensus        81 ~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~  159 (291)
                      ++++|  +.....|+||||++| +|.+.+.....         +.+...+.+++||+.|+.|||+.||+||||||+|||+
T Consensus       241 ~~d~f--~~~ds~YmVlE~v~GGeLfd~vv~nk~---------l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl  309 (475)
T KOG0615|consen  241 IKDFF--EVPDSSYMVLEYVEGGELFDKVVANKY---------LREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILL  309 (475)
T ss_pred             Eeeee--ecCCceEEEEEEecCccHHHHHHhccc---------cccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEe
Confidence            99999  667788999999985 89988887654         7788889999999999999999999999999999999


Q ss_pred             ecCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCc--CCCCchhHHHHHHHHHHHHcCCCCCCCC
Q psy2172         160 MGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGAR--HYTKAIDIWAIGCIFAELLTSEPIFHCR  237 (291)
Q Consensus       160 ~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~~Dv~slG~~l~~l~~g~~pf~~~  237 (291)
                      +.+. .+..+||+|||+|+..+..    +-..+.+||+.|.|||++.+.+  .+..+.|+|||||+||-+++|.+||++.
T Consensus       310 ~~~~-e~~llKItDFGlAK~~g~~----sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~  384 (475)
T KOG0615|consen  310 SNDA-EDCLLKITDFGLAKVSGEG----SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEE  384 (475)
T ss_pred             ccCC-cceEEEecccchhhccccc----eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccc
Confidence            8654 4578999999999987642    4567789999999999997644  2445889999999999999999999987


Q ss_pred             cccccC--------------CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchh
Q psy2172         238 QEDIKT--------------SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLL  280 (291)
Q Consensus       238 ~~~~~~--------------~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  280 (291)
                      ..+...              .-..-.+...++++.|..-.|++||+..+...|||+.
T Consensus       385 ~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~  441 (475)
T KOG0615|consen  385 YTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFK  441 (475)
T ss_pred             cCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhh
Confidence            765411              1111145567888999999999999999999999986

>KOG0663|consensus

Probab=100.00  E-value=8.2e-49  Score=315.14  Aligned_cols=227  Identities=44%  Similarity=0.846  Sum_probs=206.5

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCC----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEec
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT----GLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDY   99 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~   99 (291)
                      ..+|++|.||+||+|+++.  +++.||+|.++-+    ...-...+|+.+|.+++|||||.+..+.+..+-+.+|+||||
T Consensus        81 lnrI~EGtyGiVYRakdk~--t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~  158 (419)
T KOG0663|consen   81 LNRIEEGTYGVVYRAKDKK--TDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEY  158 (419)
T ss_pred             HhhcccCcceeEEEeccCC--cceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHH
Confidence            5699999999999999877  8899999999744    445568899999999999999999999987778889999999


Q ss_pred             CCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeeccccee
Q psy2172         100 AEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL  179 (291)
Q Consensus       100 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~  179 (291)
                      |+++|.+++.....        ++....++.++.|+++|++|||.+.|+|||||++|+|++    +.+.+|++|||+|+.
T Consensus       159 ~EhDLksl~d~m~q--------~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~----~~G~lKiaDFGLAR~  226 (419)
T KOG0663|consen  159 VEHDLKSLMETMKQ--------PFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLS----HKGILKIADFGLARE  226 (419)
T ss_pred             HHhhHHHHHHhccC--------CCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeec----cCCcEEecccchhhh
Confidence            99999999987653        289999999999999999999999999999999999999    889999999999998


Q ss_pred             cCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccCCCCCcHHHHHHHHHhh
Q psy2172         180 FNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVM  259 (291)
Q Consensus       180 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~  259 (291)
                      +.++..   ..+...-|.+|+|||.+.|.+.|+.+.|+||+||++.||+.+.+.|.|..+         .+|+..|++.+
T Consensus       227 ygsp~k---~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE---------~dQl~~If~ll  294 (419)
T KOG0663|consen  227 YGSPLK---PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE---------IDQLDKIFKLL  294 (419)
T ss_pred             hcCCcc---cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch---------HHHHHHHHHHh
Confidence            887643   335567799999999999999999999999999999999999999999988         49999999999


Q ss_pred             CCCCcCChhhhhcCCCC
Q psy2172         260 GFPLEKDWEDIRKMPEH  276 (291)
Q Consensus       260 ~~~~~~~~~~~~~~~~~  276 (291)
                      +.|....||.+.++|..
T Consensus       295 GtPte~iwpg~~~lp~~  311 (419)
T KOG0663|consen  295 GTPSEAIWPGYSELPAV  311 (419)
T ss_pred             CCCccccCCCccccchh
Confidence            99999999999998743

>KOG0575|consensus

Probab=100.00  E-value=3e-48  Score=334.03  Aligned_cols=241  Identities=25%  Similarity=0.447  Sum_probs=206.4

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCC-----CCCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEG-----TGLSMSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      +|. .++.||+|||+.+|.+.+.+  +++.||+|++++     ....+.+.+|++|.+.|+|||||+++++|  ++..++
T Consensus        19 ~Y~-~g~~LGkGgFA~cYe~~~~~--tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F--EDs~nV   93 (592)
T KOG0575|consen   19 RYK-RGRFLGKGGFARCYEARDLD--TGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF--EDSNNV   93 (592)
T ss_pred             eee-eeeeeccCcceEEEEEEEcC--CCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe--ecCCce
Confidence            455 48999999999999999877  778899999975     34456789999999999999999999999  889999


Q ss_pred             EEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          94 WLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        94 ~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      |+|.|+|.. +|..+++....         ++|..++.+++||+.||.|||+++|+|||||..|+|++    ...+|||+
T Consensus        94 YivLELC~~~sL~el~Krrk~---------ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~----~~~~VKIg  160 (592)
T KOG0575|consen   94 YIVLELCHRGSLMELLKRRKP---------LTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLN----ENMNVKIG  160 (592)
T ss_pred             EEEEEecCCccHHHHHHhcCC---------CCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeec----CcCcEEec
Confidence            999999985 77776663222         99999999999999999999999999999999999999    77899999


Q ss_pred             ecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc---------C
Q psy2172         173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK---------T  243 (291)
Q Consensus       173 Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~---------~  243 (291)
                      |||+|.....+.   .+..+.+||+.|.|||++...+ .+..+||||+||+||-|+.|++||+...-...         .
T Consensus       161 DFGLAt~le~~~---Erk~TlCGTPNYIAPEVl~k~g-HsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~  236 (592)
T KOG0575|consen  161 DFGLATQLEYDG---ERKKTLCGTPNYIAPEVLNKSG-HSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYS  236 (592)
T ss_pred             ccceeeeecCcc---cccceecCCCcccChhHhccCC-CCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcc
Confidence            999999876432   3456789999999999998755 89999999999999999999999998743210         1


Q ss_pred             CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         244 SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       244 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                      .+...+....+++..+..+.|.+||+++++..|+.+.+
T Consensus       237 ~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~  274 (592)
T KOG0575|consen  237 MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKS  274 (592)
T ss_pred             cccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence            11233566788999999999999999999999988744

>KOG0581|consensus

Probab=100.00  E-value=4.9e-48  Score=315.42  Aligned_cols=238  Identities=26%  Similarity=0.412  Sum_probs=203.6

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCC---CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecC
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT---GLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYA  100 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~  100 (291)
                      ...||+|..|+||+|.++.  +++.+|+|.+...   ....++.+|+++++.++|||||++|+.|+.+.. .+.++||||
T Consensus        84 ~~~lG~G~gG~V~kv~Hk~--t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-~isI~mEYM  160 (364)
T KOG0581|consen   84 LGVLGSGNGGTVYKVRHKP--TGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-EISICMEYM  160 (364)
T ss_pred             hhhcccCCCcEEEEEEEcC--CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-eEEeehhhc
Confidence            4699999999999999987  7899999999432   334578999999999999999999999976554 799999999


Q ss_pred             CC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCeeeeccCCCcEEeecCCCCCCcEEEeecccce
Q psy2172         101 EH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHS-NWVLHRDLKPANILVMGEGIERGRVKIADMGFAR  178 (291)
Q Consensus       101 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~-~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~  178 (291)
                      ++ +|...+...+.         +++..+..++.++++||.|||+ ++|+||||||+|||++    ..++|||||||.+.
T Consensus       161 DgGSLd~~~k~~g~---------i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvN----skGeVKicDFGVS~  227 (364)
T KOG0581|consen  161 DGGSLDDILKRVGR---------IPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVN----SKGEVKICDFGVSG  227 (364)
T ss_pred             CCCCHHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeec----cCCCEEeccccccH
Confidence            96 66666654422         9999999999999999999995 9999999999999999    78899999999998


Q ss_pred             ecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc--------------ccC-
Q psy2172         179 LFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED--------------IKT-  243 (291)
Q Consensus       179 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~--------------~~~-  243 (291)
                      ...+.     ...+..||..|||||.+.+.. |+.++||||||++++|++.|+.||......              .+. 
T Consensus       228 ~lvnS-----~a~tfvGT~~YMsPERi~g~~-Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~  301 (364)
T KOG0581|consen  228 ILVNS-----IANTFVGTSAYMSPERISGES-YSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPR  301 (364)
T ss_pred             Hhhhh-----hcccccccccccChhhhcCCc-CCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCC
Confidence            76653     456789999999999999854 999999999999999999999999885221              111 


Q ss_pred             CCC-CcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhhh
Q psy2172         244 SNP-YHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF  283 (291)
Q Consensus       244 ~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (291)
                      ... .+++.+..++..+..-.|..||+..++..||++.+.-
T Consensus       302 lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~  342 (364)
T KOG0581|consen  302 LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE  342 (364)
T ss_pred             CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence            222 3678899999999999999999999999999987543

>KOG0595|consensus

Probab=100.00  E-value=8.4e-48  Score=316.95  Aligned_cols=202  Identities=31%  Similarity=0.602  Sum_probs=175.5

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC----hhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      +.|.+ .+.||.|+||+||+|+++.  ++..||||.+......    +-+..|+.+|+.++|||||.++++.  ...+++
T Consensus        10 ~~y~~-~~~iG~GsfavVykg~h~~--~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~--~~~~~i   84 (429)
T KOG0595|consen   10 GDYEL-SREIGSGSFAVVYKGRHKK--SGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI--EDDDFI   84 (429)
T ss_pred             cccee-hhhccCcceEEEEEeEecc--CCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE--ecCCeE
Confidence            45565 5579999999999999988  5688999999876532    3467899999999999999999999  567799


Q ss_pred             EEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCC--CcEE
Q psy2172          94 WLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIER--GRVK  170 (291)
Q Consensus        94 ~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~--~~~~  170 (291)
                      |+|||||. |+|..++...+.         +++..++.++.||+.||++||+++||||||||.|||++.....+  ..+|
T Consensus        85 ~lVMEyC~gGDLs~yi~~~~~---------l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LK  155 (429)
T KOG0595|consen   85 YLVMEYCNGGDLSDYIRRRGR---------LPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLK  155 (429)
T ss_pred             EEEEEeCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEE
Confidence            99999998 699999987653         99999999999999999999999999999999999999653233  6899


Q ss_pred             EeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCc
Q psy2172         171 IADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  238 (291)
Q Consensus       171 l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~  238 (291)
                      |+|||+|+.....    ....+.+|++.|||||++.. +.|+.|+|+||+|++||+|++|.+||...+
T Consensus       156 IADFGfAR~L~~~----~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t  218 (429)
T KOG0595|consen  156 IADFGFARFLQPG----SMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAET  218 (429)
T ss_pred             ecccchhhhCCch----hHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence            9999999987743    34567899999999999976 459999999999999999999999999544

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.5e-46  Score=319.34  Aligned_cols=262  Identities=91%  Similarity=1.512  Sum_probs=221.6

Q ss_pred             cccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEec
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDY   99 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~   99 (291)
                      |.+++++||+|+||.||+|.++...+++.+|+|.+........+.+|+.+++.++||||+++++++........|++|||
T Consensus         2 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07868           2 FEYEGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY   81 (317)
T ss_pred             ccccccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence            67789999999999999999876667788999999877667788999999999999999999999977677789999999


Q ss_pred             CCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeeccccee
Q psy2172         100 AEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL  179 (291)
Q Consensus       100 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~  179 (291)
                      +++++...+..............+++..++.++.|++.||.|||++||+|+||||+||++.......+.++|+|||++..
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07868          82 AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             cCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence            99999988876544333333345899999999999999999999999999999999999965433567899999999987


Q ss_pred             cCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccCCCCCcHHHHHHHHHhh
Q psy2172         180 FNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVM  259 (291)
Q Consensus       180 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~  259 (291)
                      ...............||..|+|||++.+...++.++|+||+||++|+|++|.+||.+...+.....+....++..++..+
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  241 (317)
T cd07868         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM  241 (317)
T ss_pred             cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence            65543333334456789999999999876668999999999999999999999999888877777777788999999999


Q ss_pred             CCCCcCChhhhhcCCCCcchhh
Q psy2172         260 GFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                      +.|....|+....++..+...+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~  263 (317)
T cd07868         242 GFPADKDWEDIKKMPEHSTLMK  263 (317)
T ss_pred             CCCChHHhHHHhhccchhhhhh
Confidence            9999999998887776554433

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG0593|consensus

Probab=100.00  E-value=7.8e-48  Score=305.86  Aligned_cols=217  Identities=45%  Similarity=0.783  Sum_probs=189.6

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC----hhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIALLRELKHPNVINLISVFLSHNDRKVW   94 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (291)
                      .|+..| ++|+|+||+||+|++++  +++.||||.+......    .-+.+|+++|++++|+|+|.++++|  .....++
T Consensus         3 kYE~Lg-kvGEGSYGvV~KCrnk~--TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF--rrkrklh   77 (396)
T KOG0593|consen    3 KYEKLG-KVGEGSYGVVMKCRNKD--TGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF--RRKRKLH   77 (396)
T ss_pred             HHhhhh-ccccCcceEEEEeccCC--cccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH--HhcceeE
Confidence            455445 99999999999999988  8899999999654432    3478999999999999999999999  7788999


Q ss_pred             EEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          95 LLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        95 iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      +|+|||+.++++.+.....+        ++.+.+..+++|++.|+.|.|+++++||||||+||+++    ..+.+|||||
T Consensus        78 LVFE~~dhTvL~eLe~~p~G--------~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit----~~gvvKLCDF  145 (396)
T KOG0593|consen   78 LVFEYCDHTVLHELERYPNG--------VPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILIT----QNGVVKLCDF  145 (396)
T ss_pred             EEeeecchHHHHHHHhccCC--------CCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEe----cCCcEEeccc
Confidence            99999999999988877665        89999999999999999999999999999999999999    8889999999


Q ss_pred             ccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccCCCCCcHHHHHH
Q psy2172         175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR  254 (291)
Q Consensus       175 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  254 (291)
                      |+|+....+..   ..+-...|.+|+|||.+.|...|+.+.||||+||++.||++|.+.|.|.++         .+++..
T Consensus       146 GFAR~L~~pgd---~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SD---------iDQLy~  213 (396)
T KOG0593|consen  146 GFARTLSAPGD---NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSD---------IDQLYL  213 (396)
T ss_pred             hhhHhhcCCcc---hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcch---------HHHHHH
Confidence            99987664322   233457799999999999977799999999999999999999999999887         477777


Q ss_pred             HHHhhCCCCc
Q psy2172         255 IFSVMGFPLE  264 (291)
Q Consensus       255 i~~~~~~~~~  264 (291)
                      |...++...|
T Consensus       214 I~ktLG~L~p  223 (396)
T KOG0593|consen  214 IRKTLGNLIP  223 (396)
T ss_pred             HHHHHcccCH
Confidence            7777765555

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.5e-45  Score=313.16  Aligned_cols=265  Identities=90%  Similarity=1.493  Sum_probs=222.5

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEe
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFD   98 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e   98 (291)
                      .|++++.+||+|+||.||+|.+++..++..||+|.+........+.+|+.+++.++||||+++++++...+....++++|
T Consensus         1 ~~~~~g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07867           1 LFEYEGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD   80 (317)
T ss_pred             CcceeceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence            36788999999999999999987766778899999987766678889999999999999999999997767788999999


Q ss_pred             cCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccce
Q psy2172          99 YAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR  178 (291)
Q Consensus        99 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~  178 (291)
                      |+++++.+.+..............+++..++.++.|++.||.|||+.|++|+||||+||++..+....+.++|+|||++.
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          81 YAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             eeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence            99999998887654433333334488999999999999999999999999999999999996544366799999999998


Q ss_pred             ecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccCCCCCcHHHHHHHHHh
Q psy2172         179 LFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV  258 (291)
Q Consensus       179 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~  258 (291)
                      ................++..|+|||.+.+...++.++|||||||++|+|++|.+||.....+.....+....++..++..
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~  240 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV  240 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence            76554333333445678999999999977556899999999999999999999999988887777777778899999999


Q ss_pred             hCCCCcCChhhhhcCCCCcchhhhh
Q psy2172         259 MGFPLEKDWEDIRKMPEHPTLLKDF  283 (291)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~  283 (291)
                      ++.|....|+.+.+.+.++...+.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~  265 (317)
T cd07867         241 MGFPADKDWEDIRKMPEYPTLQKDF  265 (317)
T ss_pred             cCCCChhhhhhhhhcccchhhhhhh
Confidence            9999999999888777665554443

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0591|consensus

Probab=100.00  E-value=5.5e-48  Score=303.92  Aligned_cols=235  Identities=26%  Similarity=0.434  Sum_probs=198.3

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT----GLSMSACREIALLRELKHPNVINLISVFLSHNDRKVW   94 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (291)
                      .|.+ -++||.|.||.||++.+..  ++..+|.|-+.-.    ...++...|+.+|++|+|||||+++++-+.++..-++
T Consensus        20 ~y~I-l~~IG~GsFg~vykv~~~~--~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln   96 (375)
T KOG0591|consen   20 DYQI-LKKIGRGSFGEVYKVQCLL--DGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN   96 (375)
T ss_pred             HHHH-HHHHcCCcchheEEeeecc--CcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence            3554 4699999999999999877  7788999998733    2345688999999999999999999965555666699


Q ss_pred             EEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhh--CC--eeeeccCCCcEEeecCCCCCCcE
Q psy2172          95 LLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHS--NW--VLHRDLKPANILVMGEGIERGRV  169 (291)
Q Consensus        95 iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~--~~--ivH~dik~~Nil~~~~~~~~~~~  169 (291)
                      +|||+|+ |+|.+.++........     +++..+|.++.|+++||.++|.  .+  |+||||||.||+++    ..+.+
T Consensus        97 ivmE~c~~GDLsqmIk~~K~qkr~-----ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~----~~gvv  167 (375)
T KOG0591|consen   97 IVMELCDAGDLSQMIKHFKKQKRL-----IPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLT----ANGVV  167 (375)
T ss_pred             HHHHhhcccCHHHHHHHHHhcccc-----CchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEc----CCCce
Confidence            9999998 6999888876655443     9999999999999999999998  45  99999999999999    77899


Q ss_pred             EEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcc----------
Q psy2172         170 KIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE----------  239 (291)
Q Consensus       170 ~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~----------  239 (291)
                      ||+|||+++.+.+..   .-.....||+.||+||.+.+.+ |+.++||||+||++|||+.-++||.+.+-          
T Consensus       168 KLGDfGL~r~l~s~~---tfA~S~VGTPyYMSPE~i~~~~-Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg  243 (375)
T KOG0591|consen  168 KLGDFGLGRFLSSKT---TFAHSLVGTPYYMSPERIHESG-YNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG  243 (375)
T ss_pred             eeccchhHhHhcchh---HHHHhhcCCCcccCHHHHhcCC-CCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC
Confidence            999999999876532   2234579999999999999866 99999999999999999999999998742          


Q ss_pred             ccc-CCCCCcHHHHHHHHHhhCCCCcCChhh
Q psy2172         240 DIK-TSNPYHHDQLDRIFSVMGFPLEKDWED  269 (291)
Q Consensus       240 ~~~-~~~~~~~~~~~~i~~~~~~~~~~~~~~  269 (291)
                      +.+ .....+++.+..++..|..+.+..+|+
T Consensus       244 d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~  274 (375)
T KOG0591|consen  244 DYPPLPDEHYSTDLRELINMCIAVDPEQRPD  274 (375)
T ss_pred             CCCCCcHHHhhhHHHHHHHHHccCCcccCCC
Confidence            222 222567889999999999999999997

>KOG0598|consensus

Probab=100.00  E-value=4e-46  Score=304.09  Aligned_cols=246  Identities=27%  Similarity=0.462  Sum_probs=198.8

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC-----ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-----SMSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      -|++ .++||+|+||.|++++.++  +++.||+|++++...     .....+|..+|..++||.||+++..|  ++...+
T Consensus        26 dF~~-lkviGkG~fGkV~~Vrk~d--t~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF--Qt~~kL  100 (357)
T KOG0598|consen   26 DFEI-LKVIGKGSFGKVFQVRKKD--TGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF--QTEEKL  100 (357)
T ss_pred             heee-eeeeeccCCceEEEEEEcc--cCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec--ccCCeE
Confidence            3553 5799999999999999886  889999999976533     34578899999999999999999999  899999


Q ss_pred             EEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          94 WLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        94 ~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      |+|+||+.| .|...+...+.         +++..++-++..|+.||.|||++|||||||||+|||++    ..++++|+
T Consensus       101 ylVld~~~GGeLf~hL~~eg~---------F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd----~~GHi~Lt  167 (357)
T KOG0598|consen  101 YLVLDYLNGGELFYHLQREGR---------FSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLD----EQGHIKLT  167 (357)
T ss_pred             EEEEeccCCccHHHHHHhcCC---------cchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeec----CCCcEEEe
Confidence            999999986 88877775443         99999999999999999999999999999999999999    88999999


Q ss_pred             ecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc----------c
Q psy2172         173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI----------K  242 (291)
Q Consensus       173 Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~----------~  242 (291)
                      |||+++..-..   .....+.+||+.|+|||++.+.+ ++.++|.||||+++|+|++|.+||.+.+...          .
T Consensus       168 DFgL~k~~~~~---~~~t~tfcGT~eYmAPEil~~~g-y~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~  243 (357)
T KOG0598|consen  168 DFGLCKEDLKD---GDATRTFCGTPEYMAPEILLGKG-YDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLP  243 (357)
T ss_pred             ccccchhcccC---CCccccccCCccccChHHHhcCC-CCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCC
Confidence            99999853322   12334579999999999999865 9999999999999999999999999877421          1


Q ss_pred             CCCCCcHHHHHHHHHhhCCCCcCCh----hhhhcCCCCcchhhhhhhc
Q psy2172         243 TSNPYHHDQLDRIFSVMGFPLEKDW----EDIRKMPEHPTLLKDFNEQ  286 (291)
Q Consensus       243 ~~~~~~~~~~~~i~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~  286 (291)
                      ...........++++.+..-.|..|    .+..++..||.+...-.+.
T Consensus       244 ~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~  291 (357)
T KOG0598|consen  244 LPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEK  291 (357)
T ss_pred             CCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHH
Confidence            2222234555666666665555554    4566666676665444443

>KOG0594|consensus

Probab=100.00  E-value=3.2e-45  Score=298.38  Aligned_cols=232  Identities=44%  Similarity=0.794  Sum_probs=202.9

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCC----CCChhHHHHHHHHhcCCCCC-eeeEEEEEEeCC----CceEE
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT----GLSMSACREIALLRELKHPN-VINLISVFLSHN----DRKVW   94 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~----~~~~~   94 (291)
                      .++||+|.||.||+|+.+.  +++.||+|.++-+    .......+|+.+++.++|+| |+++++++...+    ...++
T Consensus        16 ~eklGeGtyg~Vykar~~~--~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~   93 (323)
T KOG0594|consen   16 VEKLGEGTYGVVYKARSKR--TGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLY   93 (323)
T ss_pred             HHHhCCCCceEEEEEEEec--CCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEE
Confidence            5689999999999999887  6688999999633    34567899999999999999 999999995432    23899


Q ss_pred             EEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          95 LLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        95 iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      +|+||.+-+|..++.......     ..++...++.+++||+.||+|+|+++|+||||||.||+++    ..+.+||+||
T Consensus        94 lvfe~~d~DL~~ymd~~~~~~-----~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~----~~G~lKlaDF  164 (323)
T KOG0594|consen   94 LVFEFLDRDLKKYMDSLPKKP-----QGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLIS----SSGVLKLADF  164 (323)
T ss_pred             EEEEeecccHHHHHHhccccc-----cCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEEC----CCCcEeeecc
Confidence            999999999999998766432     1167789999999999999999999999999999999999    7889999999


Q ss_pred             ccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccCCCCCcHHHHHH
Q psy2172         175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR  254 (291)
Q Consensus       175 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  254 (291)
                      |+|+...-+..   ......+|.+|+|||++.+...|+...|+||+||++.||+++++.|.+..+         .+++..
T Consensus       165 GlAra~~ip~~---~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se---------~~ql~~  232 (323)
T KOG0594|consen  165 GLARAFSIPMR---TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE---------IDQLFR  232 (323)
T ss_pred             chHHHhcCCcc---cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH---------HHHHHH
Confidence            99996554332   245678899999999999988899999999999999999999999999888         499999


Q ss_pred             HHHhhCCCCcCChhhhhcCCCCcc
Q psy2172         255 IFSVMGFPLEKDWEDIRKMPEHPT  278 (291)
Q Consensus       255 i~~~~~~~~~~~~~~~~~~~~~~~  278 (291)
                      |++.++.|.+..||....+|++..
T Consensus       233 If~~lGtP~e~~Wp~v~~~~~~k~  256 (323)
T KOG0594|consen  233 IFRLLGTPNEKDWPGVSSLPDYKA  256 (323)
T ss_pred             HHHHcCCCCccCCCCccccccccc
Confidence            999999999999999999988853

>KOG0592|consensus

Probab=100.00  E-value=2.2e-45  Score=312.05  Aligned_cols=242  Identities=29%  Similarity=0.491  Sum_probs=206.1

Q ss_pred             cccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-----CChhHHHHHHHHhcC-CCCCeeeEEEEEEeCCCceE
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-----LSMSACREIALLREL-KHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~   93 (291)
                      |.+ |+.||.|+|++|++|..+.  +++.||||++.+..     ....+.+|-.+|.+| .||+|++++..|  ++...+
T Consensus        75 F~F-g~~lGeGSYStV~~A~~~~--t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF--QD~~sL  149 (604)
T KOG0592|consen   75 FKF-GKILGEGSYSTVVLAREKA--TGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF--QDEESL  149 (604)
T ss_pred             cch-hheeccccceeEEEeeecC--CCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe--ecccce
Confidence            444 8899999999999999887  88999999997543     334477888999999 899999999999  889999


Q ss_pred             EEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          94 WLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        94 ~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      |+|+||++ |+|++++...+.         +++.-++.++.+|+.||+|||++|||||||||+|||++    .+++++|+
T Consensus       150 YFvLe~A~nGdll~~i~K~Gs---------fde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd----~dmhikIT  216 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIKKYGS---------FDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLD----KDGHIKIT  216 (604)
T ss_pred             EEEEEecCCCcHHHHHHHhCc---------chHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEc----CCCcEEEe
Confidence            99999998 699999987654         99999999999999999999999999999999999999    78899999


Q ss_pred             ecccceecCCCCCC----------CCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc-
Q psy2172         173 DMGFARLFNNPLKP----------LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI-  241 (291)
Q Consensus       173 Dfg~~~~~~~~~~~----------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~-  241 (291)
                      |||.|+.+......          ..+.....||..|.+||++.... .+..+|+|+|||+||+|+.|.+||.+.++-+ 
T Consensus       217 DFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~-~~~~sDiWAlGCilyQmlaG~PPFra~Neyli  295 (604)
T KOG0592|consen  217 DFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSP-AGPSSDLWALGCILYQMLAGQPPFRAANEYLI  295 (604)
T ss_pred             eccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCC-CCcccchHHHHHHHHHHhcCCCCCccccHHHH
Confidence            99999988653211          12224579999999999998754 8999999999999999999999999987632 


Q ss_pred             --------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchh
Q psy2172         242 --------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLL  280 (291)
Q Consensus       242 --------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  280 (291)
                              -...+...+...++++.+..-.|.+|.+..++.+||.+-
T Consensus       296 FqkI~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~  342 (604)
T KOG0592|consen  296 FQKIQALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFE  342 (604)
T ss_pred             HHHHHHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccc
Confidence                    113334457788899999999999999999998887764

>KOG0661|consensus

Probab=100.00  E-value=3e-46  Score=312.74  Aligned_cols=229  Identities=34%  Similarity=0.643  Sum_probs=200.8

Q ss_pred             cccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChh---HHHHHHHHhcCC-CCCeeeEEEEEEeCC
Q psy2172          14 TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMS---ACREIALLRELK-HPNVINLISVFLSHN   89 (291)
Q Consensus        14 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~---~~~e~~~l~~l~-h~~iv~~~~~~~~~~   89 (291)
                      ..+.++|.+ .++||.|.||.||+|+.+.  ++..||||.+++.-..-+   -.||+..|++|+ ||||+++.+++.+.+
T Consensus         6 ~~~m~RY~~-i~klGDGTfGsV~la~~~~--~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~   82 (538)
T KOG0661|consen    6 VIFMDRYTV-IRKLGDGTFGSVYLAKSKE--TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDND   82 (538)
T ss_pred             hhHHHHHHH-HHHhcCCcceeEEEeeecC--CCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC
Confidence            345677875 5699999999999999877  778899999986544432   468999999998 999999999996543


Q ss_pred             CceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcE
Q psy2172          90 DRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRV  169 (291)
Q Consensus        90 ~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~  169 (291)
                      . .+|+|||||+.+|.++++..+.        ++++..++.|+.||++||+|+|++|+.|||+||+|||+.    ....+
T Consensus        83 ~-~L~fVfE~Md~NLYqLmK~R~r--------~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~----~~~~i  149 (538)
T KOG0661|consen   83 R-ILYFVFEFMDCNLYQLMKDRNR--------LFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILIS----GNDVI  149 (538)
T ss_pred             c-eEeeeHHhhhhhHHHHHhhcCC--------cCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEec----cccee
Confidence            3 9999999999999999987632        299999999999999999999999999999999999998    56789


Q ss_pred             EEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccCCCCCcH
Q psy2172         170 KIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH  249 (291)
Q Consensus       170 ~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  249 (291)
                      ||+|||+|+...+.    ...+....|.+|+|||++.....|+.+.|+||+||+++|+.+-++.|.|.++         .
T Consensus       150 KiaDFGLARev~Sk----pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE---------~  216 (538)
T KOG0661|consen  150 KIADFGLAREVRSK----PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE---------I  216 (538)
T ss_pred             EecccccccccccC----CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH---------H
Confidence            99999999977654    2334567799999999999888899999999999999999999999999988         4


Q ss_pred             HHHHHHHHhhCCCCcCChhhhh
Q psy2172         250 DQLDRIFSVMGFPLEKDWEDIR  271 (291)
Q Consensus       250 ~~~~~i~~~~~~~~~~~~~~~~  271 (291)
                      +++..|-..++.|....|+.-.
T Consensus       217 Dqi~KIc~VLGtP~~~~~~eg~  238 (538)
T KOG0661|consen  217 DQIYKICEVLGTPDKDSWPEGY  238 (538)
T ss_pred             HHHHHHHHHhCCCccccchhHH
Confidence            9999999999999999999843

>KOG0583|consensus

Probab=100.00  E-value=5.3e-44  Score=306.71  Aligned_cols=246  Identities=28%  Similarity=0.445  Sum_probs=208.2

Q ss_pred             ccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC-------CCChhHHHHHHHHhcCC-CCCeeeEEEEEE
Q psy2172          15 KVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-------GLSMSACREIALLRELK-HPNVINLISVFL   86 (291)
Q Consensus        15 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~   86 (291)
                      ...+.|.+ ++.||+|+||.|+.|.+..  ++..||+|++...       ...+.+.+|+.+++.++ ||||+++++++ 
T Consensus        14 ~~~g~y~~-~~~lG~GsfgkV~~a~~~~--t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~-   89 (370)
T KOG0583|consen   14 LSIGKYEL-GRTLGSGSFGKVKLAKHRL--TGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVF-   89 (370)
T ss_pred             cccCceee-eeeecCCCCeeEEEeeecc--CCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEE-
Confidence            55667774 8899999999999999877  6688999987653       23445678999999998 99999999999 


Q ss_pred             eCCCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCC
Q psy2172          87 SHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIE  165 (291)
Q Consensus        87 ~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~  165 (291)
                       .....+|+||||+.| +|.+.+.....         +.+..+..+++|+++|++|+|++||+||||||+||+++    .
T Consensus        90 -~t~~~~~ivmEy~~gGdL~~~i~~~g~---------l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld----~  155 (370)
T KOG0583|consen   90 -ATPTKIYIVMEYCSGGDLFDYIVNKGR---------LKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLD----G  155 (370)
T ss_pred             -ecCCeEEEEEEecCCccHHHHHHHcCC---------CChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEec----C
Confidence             666779999999986 99999887332         88999999999999999999999999999999999999    5


Q ss_pred             C-CcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCc-CCCCchhHHHHHHHHHHHHcCCCCCCCCccc---
Q psy2172         166 R-GRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGAR-HYTKAIDIWAIGCIFAELLTSEPIFHCRQED---  240 (291)
Q Consensus       166 ~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~---  240 (291)
                      . +.+||+|||++....   .........+|++.|+|||++.+.. ..+.++||||+|++||.|++|..||......   
T Consensus       156 ~~~~~Kl~DFG~s~~~~---~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~  232 (370)
T KOG0583|consen  156 NEGNLKLSDFGLSAISP---GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLY  232 (370)
T ss_pred             CCCCEEEeccccccccC---CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHH
Confidence            5 899999999998763   1123456789999999999999866 4568999999999999999999999985521   


Q ss_pred             ------ccCCCCCc-HHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         241 ------IKTSNPYH-HDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       241 ------~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                            ........ +.....++..|..+.|..++++.++..++|+.+
T Consensus       233 ~ki~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  233 RKIRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             HHHhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence                  12233333 677899999999999999999999999999987

>KOG0658|consensus

Probab=100.00  E-value=3.4e-45  Score=298.18  Aligned_cols=225  Identities=34%  Similarity=0.638  Sum_probs=190.3

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCc---eEEE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDR---KVWL   95 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~---~~~i   95 (291)
                      .|. ..+++|.|+||.||+|....  +++.||||..-.+  ...-.+|+++|+.++|||||++..+|....+.   +..+
T Consensus        25 ~~~-~~~liG~GsFg~Vyq~~~~e--~~~~vAIKKv~~d--~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   25 SYE-AVRLIGSGSFGVVYQAKLRE--TEEEVAIKKVLQD--KRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEE-eeEEEeecccceEEEEEEcC--CCceeEEEEecCC--CCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            455 47899999999999999887  5788999987543  22345789999999999999999999765444   6778


Q ss_pred             EEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecc
Q psy2172          96 LFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMG  175 (291)
Q Consensus        96 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg  175 (291)
                      ||||++.+|...++.......     .++.-.++-+.+||++||+|||+.||+||||||.|+|++.   ..+.+||||||
T Consensus       100 VleymP~tL~~~~r~~~~~~~-----~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~---~tg~LKicDFG  171 (364)
T KOG0658|consen  100 VLEYMPETLYRVIRHYTRANQ-----RMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDP---DTGVLKICDFG  171 (364)
T ss_pred             HHHhchHHHHHHHHHHhhcCC-----CCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcC---CCCeEEeccCC
Confidence            999999999999886322221     1788889999999999999999999999999999999995   56899999999


Q ss_pred             cceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccCCCCCcHHHHHHH
Q psy2172         176 FARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI  255 (291)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~i  255 (291)
                      +|+......    ......-|..|+|||.+.|...|+.+.||||.||++.||+-|++.|.|.+.         .+|+..|
T Consensus       172 SAK~L~~~e----pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~---------~dQL~eI  238 (364)
T KOG0658|consen  172 SAKVLVKGE----PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS---------VDQLVEI  238 (364)
T ss_pred             cceeeccCC----CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH---------HHHHHHH
Confidence            999876542    223455588899999999998899999999999999999999999999887         4999999


Q ss_pred             HHhhCCCCcCChhh
Q psy2172         256 FSVMGFPLEKDWED  269 (291)
Q Consensus       256 ~~~~~~~~~~~~~~  269 (291)
                      ++.++.|..++..+
T Consensus       239 ik~lG~Pt~e~I~~  252 (364)
T KOG0658|consen  239 IKVLGTPTREDIKS  252 (364)
T ss_pred             HHHhCCCCHHHHhh
Confidence            99999999876544

>KOG0597|consensus

Probab=100.00  E-value=4.4e-44  Score=305.34  Aligned_cols=238  Identities=30%  Similarity=0.552  Sum_probs=198.2

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCCh----hHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEec
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDY   99 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~   99 (291)
                      -+.||+|+||.||+|+.+.  +.+.||+|.+.+.....    .+.+|++|++.++||||+.++++|  ++..++|+|.||
T Consensus         7 ~e~iG~Gsfg~VYKgrrK~--t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf--Et~~~~~vVte~   82 (808)
T KOG0597|consen    7 YEMIGEGSFGRVYKGRRKY--TIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF--ETSAHLWVVTEY   82 (808)
T ss_pred             HHHhcCCccceeeeccccc--ceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh--cccceEEEEehh
Confidence            3589999999999999877  78999999997654332    478999999999999999999999  888999999999


Q ss_pred             CCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeeccccee
Q psy2172         100 AEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL  179 (291)
Q Consensus       100 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~  179 (291)
                      +.|+|..++.....         ++++.+..++.+++.||.|||+++|+|+|+||.||++.    ..+.+|+||||+++.
T Consensus        83 a~g~L~~il~~d~~---------lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~----~~~~~KlcdFg~Ar~  149 (808)
T KOG0597|consen   83 AVGDLFTILEQDGK---------LPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLE----KGGTLKLCDFGLARA  149 (808)
T ss_pred             hhhhHHHHHHhccC---------CCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeec----CCCceeechhhhhhh
Confidence            99999999887654         99999999999999999999999999999999999999    788999999999998


Q ss_pred             cCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcc---------cccCCCCCcHH
Q psy2172         180 FNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE---------DIKTSNPYHHD  250 (291)
Q Consensus       180 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~---------~~~~~~~~~~~  250 (291)
                      +....   .......||+-|||||...+. .|+..+|+|||||++||++.|++||-..+-         +.......-..
T Consensus       150 m~~~t---~vltsikGtPlYmAPElv~e~-pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~  225 (808)
T KOG0597|consen  150 MSTNT---SVLTSIKGTPLYMAPELVEEQ-PYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASS  225 (808)
T ss_pred             cccCc---eeeeeccCcccccCHHHHcCC-CccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccH
Confidence            76532   234557899999999999874 499999999999999999999999976542         22223333345


Q ss_pred             HHHHHHHhhCCCCcCChhhhhcCCCCcchhhh
Q psy2172         251 QLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKD  282 (291)
Q Consensus       251 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (291)
                      .+.++++.+..-.|..+-+|.++..||..-..
T Consensus       226 ~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  226 SFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK  257 (808)
T ss_pred             HHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence            66777777777777666666676666654433

>KOG0192|consensus

Probab=100.00  E-value=1.7e-42  Score=294.85  Aligned_cols=231  Identities=26%  Similarity=0.398  Sum_probs=188.3

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC----ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCc-eEEEEEe
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL----SMSACREIALLRELKHPNVINLISVFLSHNDR-KVWLLFD   98 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-~~~iv~e   98 (291)
                      .+.||+|+||+||++.|++.   ..||+|++.....    ...+.+|+.+|.+++|||||++++++.  +.. .+++|||
T Consensus        46 ~~~iG~G~~g~V~~~~~~g~---~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~--~~~~~~~iVtE  120 (362)
T KOG0192|consen   46 EEVLGSGSFGTVYKGKWRGT---DVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACT--SPPGSLCIVTE  120 (362)
T ss_pred             hhhcccCCceeEEEEEeCCc---eeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEc--CCCCceEEEEE
Confidence            56799999999999999752   2399999975422    347999999999999999999999994  343 6999999


Q ss_pred             cCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-eeeeccCCCcEEeecCCCCCC-cEEEeecc
Q psy2172          99 YAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNW-VLHRDLKPANILVMGEGIERG-RVKIADMG  175 (291)
Q Consensus        99 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~-ivH~dik~~Nil~~~~~~~~~-~~~l~Dfg  175 (291)
                      |+++ +|..++.....       ..++...+..++.||++|++|||+++ |||+||||+|||++    ... ++||+|||
T Consensus       121 y~~~GsL~~~l~~~~~-------~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~----~~~~~~KI~DFG  189 (362)
T KOG0192|consen  121 YMPGGSLSVLLHKKRK-------RKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVD----LKGKTLKIADFG  189 (362)
T ss_pred             eCCCCcHHHHHhhccc-------CCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEc----CCCCEEEECCCc
Confidence            9985 77777765311       12999999999999999999999999 99999999999999    665 99999999


Q ss_pred             cceecCCCCCCCCCCCCceecccccccccccCC-cCCCCchhHHHHHHHHHHHHcCCCCCCCCcc----------c-ccC
Q psy2172         176 FARLFNNPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQE----------D-IKT  243 (291)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~----------~-~~~  243 (291)
                      +++......   .......||..|||||++.+. ..++.++||||||+++|||++|..||.+...          . .+.
T Consensus       190 lsr~~~~~~---~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~  266 (362)
T KOG0192|consen  190 LSREKVISK---TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPP  266 (362)
T ss_pred             cceeecccc---ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence            998765432   222336889999999999852 4599999999999999999999999998763          1 122


Q ss_pred             CCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         244 SNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       244 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      ....+...+..++..+..+.|..||++.++
T Consensus       267 ~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei  296 (362)
T KOG0192|consen  267 IPKECPPHLSSLMERCWLVDPSRRPSFLEI  296 (362)
T ss_pred             CCccCCHHHHHHHHHhCCCCCCcCCCHHHH
Confidence            223356778888899999999999988764

>KOG0605|consensus

Probab=100.00  E-value=6.6e-43  Score=296.83  Aligned_cols=247  Identities=23%  Similarity=0.388  Sum_probs=192.0

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEe
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-----LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFD   98 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e   98 (291)
                      -..||+|+||.||+|+-++  ++..+|+|++++..     ....+..|-.+|...++|.||+++.+|  ++..++|+|||
T Consensus       146 Lk~IgkGAfGeVrLarKk~--Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF--QD~~~LYLiME  221 (550)
T KOG0605|consen  146 LKVIGKGAFGEVRLARKKD--TGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF--QDKEYLYLIME  221 (550)
T ss_pred             heeeccccceeEEEEEEcc--CCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe--cCCCeeEEEEE
Confidence            4699999999999999877  88999999998653     234578899999999999999999999  89999999999


Q ss_pred             cCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccc
Q psy2172          99 YAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA  177 (291)
Q Consensus        99 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~  177 (291)
                      |.+| ++..++.....         +++..++.++.+++.|++.||+.|++|+||||+|+|++    ..+++||+|||++
T Consensus       222 ylPGGD~mTLL~~~~~---------L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD----~~GHiKLSDFGLs  288 (550)
T KOG0605|consen  222 YLPGGDMMTLLMRKDT---------LTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLID----AKGHIKLSDFGLS  288 (550)
T ss_pred             ecCCccHHHHHHhcCc---------CchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeec----CCCCEeecccccc
Confidence            9985 88888876543         99999999999999999999999999999999999999    8899999999999


Q ss_pred             eecCCCCC---------------------CCC---CC--------------------CCceecccccccccccCCcCCCC
Q psy2172         178 RLFNNPLK---------------------PLA---DL--------------------DPVVVTFWYRAPELLLGARHYTK  213 (291)
Q Consensus       178 ~~~~~~~~---------------------~~~---~~--------------------~~~~g~~~y~aPE~~~~~~~~~~  213 (291)
                      ..+.....                     ...   ..                    ....|||.|+|||++.+.+ |+.
T Consensus       289 ~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~~  367 (550)
T KOG0605|consen  289 TGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YGK  367 (550)
T ss_pred             chhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CCc
Confidence            65432100                     000   00                    1248999999999999976 999


Q ss_pred             chhHHHHHHHHHHHHcCCCCCCCCccccc-------------CCCCCcHHHHHHHHHhhCCCCcCCh---hhhhcCCCCc
Q psy2172         214 AIDIWAIGCIFAELLTSEPIFHCRQEDIK-------------TSNPYHHDQLDRIFSVMGFPLEKDW---EDIRKMPEHP  277 (291)
Q Consensus       214 ~~Dv~slG~~l~~l~~g~~pf~~~~~~~~-------------~~~~~~~~~~~~i~~~~~~~~~~~~---~~~~~~~~~~  277 (291)
                      .+|.|||||++|||+.|-+||.+.....-             .......+...+++..+.+ .+..|   .++.++..||
T Consensus       368 ~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HP  446 (550)
T KOG0605|consen  368 ECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHP  446 (550)
T ss_pred             cccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCC
Confidence            99999999999999999999999876410             0111112333444444443 33322   3566777777


Q ss_pred             chhhhhhhcccc
Q psy2172         278 TLLKDFNEQICK  289 (291)
Q Consensus       278 ~~~~~~~~~~~~  289 (291)
                      ++..--.+.|.+
T Consensus       447 fF~~v~W~~l~~  458 (550)
T KOG0605|consen  447 FFKGVDWDHLRE  458 (550)
T ss_pred             ccccCCcchhhc
Confidence            766554444443

>KOG0616|consensus

Probab=100.00  E-value=4e-43  Score=278.16  Aligned_cols=235  Identities=23%  Similarity=0.405  Sum_probs=194.3

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC-----ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEe
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-----SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFD   98 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e   98 (291)
                      ...||.|+||.|.+++.+.  ++..+|+|+++++..     .++..+|..+|+.+.||.++++++.+  .+...+|+|||
T Consensus        49 ~~tlGtGSFGrV~LVr~k~--~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~--~d~~~lymvme  124 (355)
T KOG0616|consen   49 LKTLGTGSFGRVHLVREKH--SGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF--KDNSNLYMVME  124 (355)
T ss_pred             eeeeccCccceEEEEEEcc--CCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee--ccCCeEEEEEe
Confidence            4689999999999999887  678899999986543     24577899999999999999999999  67889999999


Q ss_pred             cCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccc
Q psy2172          99 YAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA  177 (291)
Q Consensus        99 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~  177 (291)
                      |.+| .|.++++..+.         +++..++-++.|++.||+|||+++|++||+||+|||++    ..+.+||+|||.|
T Consensus       125 yv~GGElFS~Lrk~~r---------F~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD----~~G~iKitDFGFA  191 (355)
T KOG0616|consen  125 YVPGGELFSYLRKSGR---------FSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLD----QNGHIKITDFGFA  191 (355)
T ss_pred             ccCCccHHHHHHhcCC---------CCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeec----cCCcEEEEeccce
Confidence            9985 88888876554         99999999999999999999999999999999999999    8899999999999


Q ss_pred             eecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---------cCCCCCc
Q psy2172         178 RLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---------KTSNPYH  248 (291)
Q Consensus       178 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---------~~~~~~~  248 (291)
                      +....      ...+.+||+.|+|||++...+ ++.++|.||||+++|||+.|.+||.+.+...         ...+...
T Consensus       192 K~v~~------rT~TlCGTPeYLAPEii~sk~-ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~f  264 (355)
T KOG0616|consen  192 KRVSG------RTWTLCGTPEYLAPEIIQSKG-YNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYF  264 (355)
T ss_pred             EEecC------cEEEecCCccccChHHhhcCC-CCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCccc
Confidence            87653      356789999999999998865 9999999999999999999999998877631         1133334


Q ss_pred             HHHHHHHHHhhCCCCcCCh-----hhhhcCCCCcchhhh
Q psy2172         249 HDQLDRIFSVMGFPLEKDW-----EDIRKMPEHPTLLKD  282 (291)
Q Consensus       249 ~~~~~~i~~~~~~~~~~~~-----~~~~~~~~~~~~~~~  282 (291)
                      +..+.++++.+..-....|     +...+++.|||+..-
T Consensus       265 s~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v  303 (355)
T KOG0616|consen  265 SSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGV  303 (355)
T ss_pred             CHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccc
Confidence            4555555555443333222     466778888887643

>KOG0198|consensus

Probab=100.00  E-value=4.8e-43  Score=289.98  Aligned_cols=247  Identities=30%  Similarity=0.441  Sum_probs=200.9

Q ss_pred             ccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC--ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecC
Q psy2172          23 EGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL--SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYA  100 (291)
Q Consensus        23 ~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~  100 (291)
                      .++.||+|+||.||++.+.+  ++..+|||.+.....  .+.+.+|+.+|++++|||||++++.........+++.|||+
T Consensus        21 ~~~~lG~Gs~G~V~l~~~~~--~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~   98 (313)
T KOG0198|consen   21 KGKLLGRGSFGSVYLATNKK--TGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYA   98 (313)
T ss_pred             hhccccCccceEEEEEEecC--CCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeecc
Confidence            48899999999999999877  578899999865411  34588999999999999999999974222224799999999


Q ss_pred             CC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCC-CCcEEEeecccce
Q psy2172         101 EH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIE-RGRVKIADMGFAR  178 (291)
Q Consensus       101 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~-~~~~~l~Dfg~~~  178 (291)
                      .+ +|.+++...+. .       +++..++.+.+|+++||+|||++|++|+||||+|||++    . .+.+||+|||.+.
T Consensus        99 ~~GsL~~~~~~~g~-~-------l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~----~~~~~~KlaDFG~a~  166 (313)
T KOG0198|consen   99 PGGSLSDLIKRYGG-K-------LPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLD----PSNGDVKLADFGLAK  166 (313)
T ss_pred             CCCcHHHHHHHcCC-C-------CCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEe----CCCCeEEeccCcccc
Confidence            85 88888876553 1       99999999999999999999999999999999999999    5 5799999999998


Q ss_pred             ecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCC------------cccccCCCC
Q psy2172         179 LFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR------------QEDIKTSNP  246 (291)
Q Consensus       179 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~------------~~~~~~~~~  246 (291)
                      ................||+.|+|||++........++|||||||++.||++|..||...            ....+....
T Consensus       167 ~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~  246 (313)
T KOG0198|consen  167 KLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPD  246 (313)
T ss_pred             ccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCc
Confidence            76642222223345789999999999985332445999999999999999999999873            112234455


Q ss_pred             CcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhhh
Q psy2172         247 YHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF  283 (291)
Q Consensus       247 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (291)
                      .......+++..+..-.|..||++.++..||.+...-
T Consensus       247 ~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  247 SLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             ccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence            5567889999999999999999999999998876543

>KOG0667|consensus

Probab=100.00  E-value=5.6e-43  Score=304.26  Aligned_cols=229  Identities=31%  Similarity=0.566  Sum_probs=195.7

Q ss_pred             cccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC-CCChhHHHHHHHHhcCC-C-----CCeeeEEEEEE
Q psy2172          14 TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-GLSMSACREIALLRELK-H-----PNVINLISVFL   86 (291)
Q Consensus        14 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l~-h-----~~iv~~~~~~~   86 (291)
                      ..+.-+|.+ .+.||+|+||+|.+|.+.+  +++.||||++++. ....+...|+.+|+.|+ |     -|+|+++++|.
T Consensus       182 d~i~~rY~V-~e~LGkGtFGQVvk~~d~~--T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~  258 (586)
T KOG0667|consen  182 DHIAYRYEV-LEVLGKGSFGQVVKAYDHK--TGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFY  258 (586)
T ss_pred             ceeEEEEEE-EEEecccccceeEEEEecC--CCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccc
Confidence            344446664 6799999999999999877  7899999999865 44567888999999996 3     39999999995


Q ss_pred             eCCCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCC
Q psy2172          87 SHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIER  166 (291)
Q Consensus        87 ~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~  166 (291)
                      .  .+++|||+|.++-+|.++++...-..       ++...++.++.||+.||.+||+.||||+||||+|||+...  .+
T Consensus       259 f--r~HlciVfELL~~NLYellK~n~f~G-------lsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~--~r  327 (586)
T KOG0667|consen  259 F--RNHLCIVFELLSTNLYELLKNNKFRG-------LSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDP--KR  327 (586)
T ss_pred             c--ccceeeeehhhhhhHHHHHHhcCCCC-------CCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccC--Cc
Confidence            4  67999999999999999998765432       8999999999999999999999999999999999999854  45


Q ss_pred             CcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccCCCC
Q psy2172         167 GRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP  246 (291)
Q Consensus       167 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~~~~  246 (291)
                      ..||++|||+|+.......      +..-+..|+|||++.|.+ |+.+.|+|||||++.||++|.+.|.|.++.      
T Consensus       328 ~~vKVIDFGSSc~~~q~vy------tYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~------  394 (586)
T KOG0667|consen  328 SRIKVIDFGSSCFESQRVY------TYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEY------  394 (586)
T ss_pred             CceeEEecccccccCCcce------eeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHH------
Confidence            6999999999987655322      445577899999999966 999999999999999999999999999884      


Q ss_pred             CcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         247 YHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       247 ~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                         +|+..|+..++.|.+........
T Consensus       395 ---DQl~~I~e~lG~Pp~~mL~~~~~  417 (586)
T KOG0667|consen  395 ---DQLARIIEVLGLPPPKMLDTAKK  417 (586)
T ss_pred             ---HHHHHHHHHhCCCCHHHHHhccc
Confidence               99999999999998865555443

>KOG0660|consensus

Probab=100.00  E-value=6.8e-43  Score=284.23  Aligned_cols=229  Identities=40%  Similarity=0.668  Sum_probs=196.6

Q ss_pred             cccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCC----CCCChhHHHHHHHHhcCCCCCeeeEEEEEEe
Q psy2172          12 ERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEG----TGLSMSACREIALLRELKHPNVINLISVFLS   87 (291)
Q Consensus        12 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   87 (291)
                      ....+..+|.. -+.||+|++|.|..|.++.  +++.||||.+.+    .....+..+|+++|+.++|+||+.+.+.+..
T Consensus        16 ~~~~i~~~y~~-~~~iG~GAyGvVcsA~~~~--t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p   92 (359)
T KOG0660|consen   16 ELFEIPRYYVL-IEPIGRGAYGVVCSAKDKR--TGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRP   92 (359)
T ss_pred             eEEeccceecc-cccccCcceeeEEEEEEcC--CCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccc
Confidence            34455555553 5799999999999999887  668899998863    3344678899999999999999999999965


Q ss_pred             ---CCCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCC
Q psy2172          88 ---HNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGI  164 (291)
Q Consensus        88 ---~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~  164 (291)
                         ++-..+|+|+|+++.+|.+.+.....         +++..+..+++|+++||+|+|+.+++|||+||+|++++    
T Consensus        93 ~~~~~f~DvYiV~elMetDL~~iik~~~~---------L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n----  159 (359)
T KOG0660|consen   93 PSRDKFNDVYLVFELMETDLHQIIKSQQD---------LTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLN----  159 (359)
T ss_pred             ccccccceeEEehhHHhhHHHHHHHcCcc---------ccHHHHHHHHHHHHHhcchhhcccccccccchhheeec----
Confidence               34567999999999999999886554         88999999999999999999999999999999999999    


Q ss_pred             CCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccCC
Q psy2172         165 ERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS  244 (291)
Q Consensus       165 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~~  244 (291)
                      .+..+||+|||+|+..... ......+....|.+|+|||.+.....|+.+.||||+||++.||++|++.|.|.+.     
T Consensus       160 ~~c~lKI~DFGLAR~~~~~-~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~-----  233 (359)
T KOG0660|consen  160 ADCDLKICDFGLARYLDKF-FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDY-----  233 (359)
T ss_pred             cCCCEEeccccceeecccc-CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCch-----
Confidence            6778999999999987654 2223345567799999999998877899999999999999999999999999887     


Q ss_pred             CCCcHHHHHHHHHhhCCCCcCC
Q psy2172         245 NPYHHDQLDRIFSVMGFPLEKD  266 (291)
Q Consensus       245 ~~~~~~~~~~i~~~~~~~~~~~  266 (291)
                          .+|+..|+..++.|.+..
T Consensus       234 ----v~Ql~lI~~~lGtP~~e~  251 (359)
T KOG0660|consen  234 ----VHQLQLILELLGTPSEED  251 (359)
T ss_pred             ----HHHHHHHHHhcCCCCHHH
Confidence                589999999999998764

>KOG0197|consensus

Probab=100.00  E-value=1.1e-42  Score=296.34  Aligned_cols=229  Identities=22%  Similarity=0.351  Sum_probs=191.3

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCC-CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecCC-
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-GLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAE-  101 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~~-  101 (291)
                      .+.||+|-||.||+|.+++   ...||+|.++.. ...+.+.+|+++|++|+|++||++++++  ..+..+||||||+. 
T Consensus       211 ~~~LG~G~FG~V~~g~~~~---~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~--~~~~piyIVtE~m~~  285 (468)
T KOG0197|consen  211 IRELGSGQFGEVWLGKWNG---STKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVC--TKQEPIYIVTEYMPK  285 (468)
T ss_pred             HHHhcCCccceEEEEEEcC---CCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEE--ecCCceEEEEEeccc
Confidence            6799999999999999975   345999999864 4457899999999999999999999999  44458999999998 


Q ss_pred             CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceecC
Q psy2172         102 HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFN  181 (291)
Q Consensus       102 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~~  181 (291)
                      |+|+++++......       ++....+.++.|||+|++||+++++|||||..+|||++    .+..+||+|||+++...
T Consensus       286 GsLl~yLr~~~~~~-------l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~----~~~~vKIsDFGLAr~~~  354 (468)
T KOG0197|consen  286 GSLLDYLRTREGGL-------LNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVD----EDLVVKISDFGLARLIG  354 (468)
T ss_pred             CcHHHHhhhcCCCc-------cchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeec----cCceEEEcccccccccC
Confidence            68999998733222       88899999999999999999999999999999999999    77899999999999544


Q ss_pred             CCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc----------ccCCCCCcHH
Q psy2172         182 NPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED----------IKTSNPYHHD  250 (291)
Q Consensus       182 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~----------~~~~~~~~~~  250 (291)
                      ..  .........-...|+|||++..+. ++.++||||||++||||++ |+.||.+....          -...+..+.+
T Consensus       355 d~--~Y~~~~~~kfPIkWtAPEa~~~~~-FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~  431 (468)
T KOG0197|consen  355 DD--EYTASEGGKFPIKWTAPEALNYGK-FSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPD  431 (468)
T ss_pred             CC--ceeecCCCCCCceecCHHHHhhCC-cccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCH
Confidence            32  112222334466799999998865 9999999999999999998 99999887643          2345556678


Q ss_pred             HHHHHHHhhCCCCcCChhhhh
Q psy2172         251 QLDRIFSVMGFPLEKDWEDIR  271 (291)
Q Consensus       251 ~~~~i~~~~~~~~~~~~~~~~  271 (291)
                      .+-+++..+....|.+||++.
T Consensus       432 ~vY~lM~~CW~~~P~~RPtF~  452 (468)
T KOG0197|consen  432 EVYELMKSCWHEDPEDRPTFE  452 (468)
T ss_pred             HHHHHHHHHhhCCcccCCCHH
Confidence            888899999999999999887

>KOG0662|consensus

Probab=100.00  E-value=1.3e-42  Score=257.34  Aligned_cols=226  Identities=43%  Similarity=0.812  Sum_probs=201.4

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCC----CCCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEec
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEG----TGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDY   99 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~   99 (291)
                      -++||+|.+|+||+|++++  +.+.||+|..+-    +.......+|+.+++.++|.|||+++++.  .+++.+.+|+||
T Consensus         7 mekigegtygtvfkarn~~--t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvl--hsdkkltlvfe~   82 (292)
T KOG0662|consen    7 MEKIGEGTYGTVFKARNRE--THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL--HSDKKLTLVFEF   82 (292)
T ss_pred             HHhhcCCcceeeEecccCC--ccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhh--ccCceeEEeHHH
Confidence            4799999999999999887  778899999863    34456799999999999999999999998  778899999999


Q ss_pred             CCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeeccccee
Q psy2172         100 AEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL  179 (291)
Q Consensus       100 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~  179 (291)
                      |..+|..++.+....        ++.+.++.++.|+++|+.+.|++++.|+|+||.|++++    .++++|++|||+++.
T Consensus        83 cdqdlkkyfdslng~--------~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin----~ngelkladfglara  150 (292)
T KOG0662|consen   83 CDQDLKKYFDSLNGD--------LDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLIN----RNGELKLADFGLARA  150 (292)
T ss_pred             hhHHHHHHHHhcCCc--------CCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEec----cCCcEEecccchhhh
Confidence            999999888765443        88999999999999999999999999999999999999    788999999999997


Q ss_pred             cCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccccCCCCCcHHHHHHHHHh
Q psy2172         180 FNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDIKTSNPYHHDQLDRIFSV  258 (291)
Q Consensus       180 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~i~~~  258 (291)
                      ++-+...   .....-|.+|.+|+++.|...|+...|+||.||++.|+.. |++.|.+.+.+         +++.+|+..
T Consensus       151 fgipvrc---ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvd---------dqlkrif~~  218 (292)
T KOG0662|consen  151 FGIPVRC---YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD---------DQLKRIFRL  218 (292)
T ss_pred             cCCceEe---eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHH---------HHHHHHHHH
Confidence            7654321   2334568899999999998889999999999999999985 89999999885         999999999


Q ss_pred             hCCCCcCChhhhhcCCCCc
Q psy2172         259 MGFPLEKDWEDIRKMPEHP  277 (291)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~  277 (291)
                      ++.|.+..||++.++|+|.
T Consensus       219 lg~p~ed~wps~t~lpdyk  237 (292)
T KOG0662|consen  219 LGTPTEDQWPSMTKLPDYK  237 (292)
T ss_pred             hCCCccccCCccccCCCCc
Confidence            9999999999999998873

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3e-41  Score=284.26  Aligned_cols=226  Identities=38%  Similarity=0.697  Sum_probs=188.1

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC---CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG---LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWL   95 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~i   95 (291)
                      .|.+ .++||+|+||.||+|.++.  ++..||+|.++...   ....+.+|+.++++++||||+++++++  .+....++
T Consensus         6 ~y~~-~~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~--~~~~~~~l   80 (288)
T cd07871           6 TYVK-LDKLGEGTYATVFKGRSKL--TENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII--HTERCLTL   80 (288)
T ss_pred             cceE-eeEEecCCCEEEEEEEECC--CCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEE--cCCCeEEE
Confidence            3554 5799999999999999876  67889999986432   334678999999999999999999999  56678999


Q ss_pred             EEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecc
Q psy2172          96 LFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMG  175 (291)
Q Consensus        96 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg  175 (291)
                      ||||++++|.+.+.....        .+++..+..++.|++.||++||++||+|+||||+||+++    .++.++|+|||
T Consensus        81 v~e~~~~~l~~~l~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~----~~~~~kl~DfG  148 (288)
T cd07871          81 VFEYLDSDLKQYLDNCGN--------LMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLIN----EKGELKLADFG  148 (288)
T ss_pred             EEeCCCcCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC----CCCCEEECcCc
Confidence            999999998887764322        278889999999999999999999999999999999998    67789999999


Q ss_pred             cceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccCCCCCcHHHHHHH
Q psy2172         176 FARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI  255 (291)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~i  255 (291)
                      ++........   ......++..|+|||.+.+...++.++|+||+||++|+|++|..||.+...         .+.+..+
T Consensus       149 ~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~---------~~~~~~~  216 (288)
T cd07871         149 LARAKSVPTK---TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTV---------KEELHLI  216 (288)
T ss_pred             ceeeccCCCc---cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH---------HHHHHHH
Confidence            9876443211   123356788999999987655589999999999999999999999988665         3778888


Q ss_pred             HHhhCCCCcCChhhhhcC
Q psy2172         256 FSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~  273 (291)
                      ...++.|.+..||.+...
T Consensus       217 ~~~~~~~~~~~~~~~~~~  234 (288)
T cd07871         217 FRLLGTPTEETWPGITSN  234 (288)
T ss_pred             HHHhCCCChHHhhccccc
Confidence            888999988888876543

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0585|consensus

Probab=100.00  E-value=2.3e-42  Score=289.45  Aligned_cols=255  Identities=27%  Similarity=0.398  Sum_probs=204.2

Q ss_pred             cccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC----------------CChhHHHHHHHHhcCCCCCee
Q psy2172          16 VEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG----------------LSMSACREIALLRELKHPNVI   79 (291)
Q Consensus        16 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~e~~~l~~l~h~~iv   79 (291)
                      .-+.|++ .+.||+|.||.|-+|++..  +++.||||++.+..                ..+...+|+.+|++|+|||||
T Consensus        95 ~lNqy~l-~~eiG~G~yGkVkLar~~~--~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV  171 (576)
T KOG0585|consen   95 QLNQYEL-IKEIGSGQYGKVKLARDEV--DGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV  171 (576)
T ss_pred             ehhheeh-hhhhcCCccceEEEEeecC--CCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence            3455664 6699999999999999766  78999999995321                114678999999999999999


Q ss_pred             eEEEEEEeCCCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCC-CCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcE
Q psy2172          80 NLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVM-VPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANI  157 (291)
Q Consensus        80 ~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~-~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Ni  157 (291)
                      +++++.-+.....+|+|+|||.. .+...          ....+ +++.+++.++++++.||+|||..||+||||||+|+
T Consensus       172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~----------p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNL  241 (576)
T KOG0585|consen  172 KLIEVLDDPESDKLYLVLEYCSKGEVKWC----------PPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNL  241 (576)
T ss_pred             EEEEeecCcccCceEEEEEeccCCccccC----------CCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhhe
Confidence            99999977778899999999984 32211          11222 88999999999999999999999999999999999


Q ss_pred             EeecCCCCCCcEEEeecccceecCCCCC--CCCCCCCceecccccccccccCC---cCCCCchhHHHHHHHHHHHHcCCC
Q psy2172         158 LVMGEGIERGRVKIADMGFARLFNNPLK--PLADLDPVVVTFWYRAPELLLGA---RHYTKAIDIWAIGCIFAELLTSEP  232 (291)
Q Consensus       158 l~~~~~~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~Dv~slG~~l~~l~~g~~  232 (291)
                      |++    .++++||+|||.+..+.....  .........||+.|+|||...+.   ...+.+.||||+||+||+|+.|+.
T Consensus       242 Ll~----~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~  317 (576)
T KOG0585|consen  242 LLS----SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQL  317 (576)
T ss_pred             EEc----CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccC
Confidence            999    678999999999987643211  11123347899999999998773   235778999999999999999999


Q ss_pred             CCCCCccc--------ccC---CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhhhhhcc
Q psy2172         233 IFHCRQED--------IKT---SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDFNEQI  287 (291)
Q Consensus       233 pf~~~~~~--------~~~---~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (291)
                      ||-+...-        .+.   ..+...+.+++++..|..-.|..|-++.++..|||....+...+
T Consensus       318 PF~~~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~~  383 (576)
T KOG0585|consen  318 PFFDDFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSPQ  383 (576)
T ss_pred             CcccchHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCCc
Confidence            99876532        112   22223577899999999999999999999999999988876544

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=8.6e-42  Score=292.70  Aligned_cols=256  Identities=23%  Similarity=0.397  Sum_probs=203.5

Q ss_pred             CCcccceeecccccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC-----CCChhHHHHHHHHhcCCC
Q psy2172           1 MDYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-----GLSMSACREIALLRELKH   75 (291)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h   75 (291)
                      |+.++.+........--+.|.+ .+.||+|+||.||+|.++.  +++.||+|++...     ...+.+.+|+.++++++|
T Consensus         1 ~~~~~~~~~~~~~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h   77 (329)
T PTZ00263          1 MKAAYMFTKPDTSSWKLSDFEM-GETLGTGSFGRVRIAKHKG--TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSH   77 (329)
T ss_pred             CCCCceeeccccCCCCchheEE-EEEEEecCCeEEEEEEECC--CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCC
Confidence            5555554433333333355664 6799999999999999876  6788999998643     223467899999999999


Q ss_pred             CCeeeEEEEEEeCCCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCC
Q psy2172          76 PNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKP  154 (291)
Q Consensus        76 ~~iv~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~  154 (291)
                      |||+++++++  .+....|++|||+.+ +|.+.+....         .+++..+..++.|++.||+|||++||+|+||||
T Consensus        78 p~iv~~~~~~--~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp  146 (329)
T PTZ00263         78 PFIVNMMCSF--QDENRVYFLLEFVVGGELFTHLRKAG---------RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKP  146 (329)
T ss_pred             CCCCcEEEEE--EcCCEEEEEEcCCCCChHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCH
Confidence            9999999999  567789999999975 7777765432         278899999999999999999999999999999


Q ss_pred             CcEEeecCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCC
Q psy2172         155 ANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF  234 (291)
Q Consensus       155 ~Nil~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf  234 (291)
                      +||+++    .++.++|+|||++......      .....|++.|+|||++.+.. ++.++|+|||||++|+|++|..||
T Consensus       147 ~NIll~----~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf  215 (329)
T PTZ00263        147 ENLLLD----NKGHVKVTDFGFAKKVPDR------TFTLCGTPEYLAPEVIQSKG-HGKAVDWWTMGVLLYEFIAGYPPF  215 (329)
T ss_pred             HHEEEC----CCCCEEEeeccCceEcCCC------cceecCChhhcCHHHHcCCC-CCCcceeechHHHHHHHHcCCCCC
Confidence            999998    6778999999998765432      12346899999999998754 789999999999999999999999


Q ss_pred             CCCcccc---------cCCCCCcHHHHHHHHHhhCCCCcCChhh-----hhcCCCCcchhh
Q psy2172         235 HCRQEDI---------KTSNPYHHDQLDRIFSVMGFPLEKDWED-----IRKMPEHPTLLK  281 (291)
Q Consensus       235 ~~~~~~~---------~~~~~~~~~~~~~i~~~~~~~~~~~~~~-----~~~~~~~~~~~~  281 (291)
                      .+.....         ..........+.+++..|..+.|..|++     +.++..||++.+
T Consensus       216 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~  276 (329)
T PTZ00263        216 FDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG  276 (329)
T ss_pred             CCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence            7654311         1122234567889999999999998875     688888888764

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=5.8e-41  Score=284.51  Aligned_cols=230  Identities=37%  Similarity=0.725  Sum_probs=188.2

Q ss_pred             ccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC---CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG---LSMSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      .+.|.+ .++||+|+||.||+|.++.  +++.||+|+++...   ....+.+|+.+++.++||||+++++++  .+....
T Consensus         4 ~~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~--~~~~~~   78 (303)
T cd07869           4 ADSYEK-LEKLGEGSYATVYKGKSKV--NGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII--HTKETL   78 (303)
T ss_pred             cccceE-eeeEEecCCEEEEEEEECC--CCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEE--ecCCeE
Confidence            356775 6799999999999999876  67889999986432   234577899999999999999999999  566789


Q ss_pred             EEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEee
Q psy2172          94 WLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIAD  173 (291)
Q Consensus        94 ~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~D  173 (291)
                      ++||||+++++.+.+.....        .+++..++.++.|++.||+|||++||+|+||||+||+++    ..+.++|+|
T Consensus        79 ~lv~e~~~~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~----~~~~~kl~D  146 (303)
T cd07869          79 TLVFEYVHTDLCQYMDKHPG--------GLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLIS----DTGELKLAD  146 (303)
T ss_pred             EEEEECCCcCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCCEEECC
Confidence            99999999998888764322        278889999999999999999999999999999999998    677899999


Q ss_pred             cccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccCCCCCcHHHHH
Q psy2172         174 MGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD  253 (291)
Q Consensus       174 fg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  253 (291)
                      ||++.......   .......++..|+|||++.+...++.++|+||+||++|+|++|..||.+....        .+.+.
T Consensus       147 fg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--------~~~~~  215 (303)
T cd07869         147 FGLARAKSVPS---HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI--------QDQLE  215 (303)
T ss_pred             CCcceeccCCC---ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH--------HHHHH
Confidence            99987543321   12233567889999999876555889999999999999999999999875432        46777


Q ss_pred             HHHHhhCCCCcCChhhhhcCC
Q psy2172         254 RIFSVMGFPLEKDWEDIRKMP  274 (291)
Q Consensus       254 ~i~~~~~~~~~~~~~~~~~~~  274 (291)
                      .+...++.|....||.....+
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~  236 (303)
T cd07869         216 RIFLVLGTPNEDTWPGVHSLP  236 (303)
T ss_pred             HHHHHhCCCChhhccchhhcc
Confidence            888888888887777665443

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.9e-41  Score=291.78  Aligned_cols=246  Identities=33%  Similarity=0.526  Sum_probs=194.8

Q ss_pred             cccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCC---ce
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT----GLSMSACREIALLRELKHPNVINLISVFLSHND---RK   92 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~~   92 (291)
                      |++ .++||+|+||.||+|.++.  ++..||+|.+...    .....+.+|+.+++.++||||+++++++...+.   ..
T Consensus         2 y~i-~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   78 (338)
T cd07859           2 YKI-QEVIGKGSYGVVCSAIDTH--TGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD   78 (338)
T ss_pred             eEE-EEEEeecCCeEEEEEEECC--CCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCce
Confidence            554 5799999999999999876  6788999998642    223457889999999999999999998854332   35


Q ss_pred             EEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          93 VWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        93 ~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      .|+||||++++|.+.+....         .+++..+..++.|++.||.|||++|++|+||||+||+++    .++.++|+
T Consensus        79 ~~lv~e~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~----~~~~~kL~  145 (338)
T cd07859          79 IYVVFELMESDLHQVIKAND---------DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILAN----ADCKLKIC  145 (338)
T ss_pred             EEEEEecCCCCHHHHHHhcc---------cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC----CCCcEEEc
Confidence            89999999999888776432         188999999999999999999999999999999999998    67899999


Q ss_pred             ecccceecCCCCCCCCCCCCceecccccccccccCC-cCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc---------
Q psy2172         173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK---------  242 (291)
Q Consensus       173 Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~---------  242 (291)
                      |||++.................|+..|+|||++.+. ..++.++|||||||++|+|++|++||.+......         
T Consensus       146 Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~  225 (338)
T cd07859         146 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLG  225 (338)
T ss_pred             cCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhC
Confidence            999997643322211222345689999999998652 3488999999999999999999999976432100         


Q ss_pred             -------------------------------CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         243 -------------------------------TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       243 -------------------------------~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                                                     ...+.....+.+++..|..+.|..||++.++..+||+..
T Consensus       226 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~  295 (338)
T cd07859         226 TPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKG  295 (338)
T ss_pred             CCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhh
Confidence                                           000112345678899999999999999999999998743

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-41  Score=284.67  Aligned_cols=238  Identities=24%  Similarity=0.327  Sum_probs=195.3

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-----LSMSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      .|.+ .+.||+|+||.||+|.++.  +++.||+|++....     ..+.+.+|+.+++.++||||+++++++  .+....
T Consensus         2 ~y~~-~~~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--~~~~~~   76 (291)
T cd05612           2 DLER-IKTVGTGTFGRVHLVRDRI--SEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE--HDQRFL   76 (291)
T ss_pred             Ccee-eeeeecCCCeEEEEEEEcC--CCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh--ccCCeE
Confidence            4554 5699999999999999876  67889999986432     234578899999999999999999988  567799


Q ss_pred             EEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          94 WLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        94 ~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      |+||||+.+ +|.+.+.....         +++..+..++.|++.||++||++|++|+||||+||+++    .++.++|+
T Consensus        77 ~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~----~~~~~kl~  143 (291)
T cd05612          77 YMLMEYVPGGELFSYLRNSGR---------FSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLD----KEGHIKLT  143 (291)
T ss_pred             EEEEeCCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC----CCCCEEEE
Confidence            999999975 78777764322         88999999999999999999999999999999999998    66789999


Q ss_pred             ecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---------cC
Q psy2172         173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---------KT  243 (291)
Q Consensus       173 Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---------~~  243 (291)
                      |||++......      .....|++.|+|||.+.+.. ++.++|||||||++|+|++|..||.+.....         ..
T Consensus       144 Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  216 (291)
T cd05612         144 DFGFAKKLRDR------TWTLCGTPEYLAPEVIQSKG-HNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLE  216 (291)
T ss_pred             ecCcchhccCC------cccccCChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcC
Confidence            99998765331      12346789999999998754 8899999999999999999999998765321         11


Q ss_pred             CCCCcHHHHHHHHHhhCCCCcCChhh-----hhcCCCCcchhh
Q psy2172         244 SNPYHHDQLDRIFSVMGFPLEKDWED-----IRKMPEHPTLLK  281 (291)
Q Consensus       244 ~~~~~~~~~~~i~~~~~~~~~~~~~~-----~~~~~~~~~~~~  281 (291)
                      ........+.++++.|....|..|++     +.++..|+|+..
T Consensus       217 ~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~  259 (291)
T cd05612         217 FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKS  259 (291)
T ss_pred             CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence            22233567889999999999999985     888999998754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.4e-41  Score=288.33  Aligned_cols=236  Identities=23%  Similarity=0.346  Sum_probs=192.2

Q ss_pred             ceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEec
Q psy2172          25 CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-----LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDY   99 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~   99 (291)
                      +.||+|+||.||+|.++.  +++.||+|+++...     ....+.+|+.+++.++||||+++++++  .+....|+||||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~--~~~~~~~lv~e~   76 (323)
T cd05571           1 KLLGKGTFGKVILVREKA--TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF--QTHDRLCFVMEY   76 (323)
T ss_pred             CeeeeCCCeEEEEEEECC--CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE--EcCCEEEEEEeC
Confidence            479999999999999876  67889999987432     223567899999999999999999998  567799999999


Q ss_pred             CCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccce
Q psy2172         100 AEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR  178 (291)
Q Consensus       100 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~  178 (291)
                      +.+ +|...+....         .+++..+..++.|++.||+|||++||+|+||||+||+++    .++.++|+|||++.
T Consensus        77 ~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~----~~~~~kl~DfG~a~  143 (323)
T cd05571          77 ANGGELFFHLSRER---------VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLD----KDGHIKITDFGLCK  143 (323)
T ss_pred             CCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEEC----CCCCEEEeeCCCCc
Confidence            986 6766665322         288999999999999999999999999999999999998    67789999999987


Q ss_pred             ecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---------cCCCCCcH
Q psy2172         179 LFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---------KTSNPYHH  249 (291)
Q Consensus       179 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---------~~~~~~~~  249 (291)
                      ......   .......|++.|+|||++.+.. ++.++|||||||++|+|++|..||.+.....         ........
T Consensus       144 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~  219 (323)
T cd05571         144 EGISDG---ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLS  219 (323)
T ss_pred             ccccCC---CcccceecCccccChhhhcCCC-CCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence            432211   1223457899999999998754 8999999999999999999999997654321         11223345


Q ss_pred             HHHHHHHHhhCCCCcCChh-----hhhcCCCCcchhh
Q psy2172         250 DQLDRIFSVMGFPLEKDWE-----DIRKMPEHPTLLK  281 (291)
Q Consensus       250 ~~~~~i~~~~~~~~~~~~~-----~~~~~~~~~~~~~  281 (291)
                      ..+.+++..|....|..|+     ++.++..|+|+..
T Consensus       220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~  256 (323)
T cd05571         220 PEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFAS  256 (323)
T ss_pred             HHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence            6788999999999999999     7888888888754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=8.8e-41  Score=281.24  Aligned_cols=241  Identities=33%  Similarity=0.580  Sum_probs=193.6

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG----LSMSACREIALLRELKHPNVINLISVFLSHNDRKVW   94 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (291)
                      +|.+ .+.||+|+||.||+|.++.  +++.+|+|.+....    ....+.+|+.+++.++||||+++++++  .+....|
T Consensus         2 ~y~~-~~~lg~g~~~~v~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~~~   76 (287)
T cd07848           2 KFEV-LGVVGEGAYGVVLKCRHKE--TKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF--RRRGKLY   76 (287)
T ss_pred             CceE-EEEecccCCEEEEEEEECC--CCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE--ecCCEEE
Confidence            4664 6699999999999999876  67889999986432    234678899999999999999999998  5677899


Q ss_pred             EEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          95 LLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        95 iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      +||||+++++...+.....        .+++..++.++.|++.||.+||+.|++|+||||+||+++    .++.++|+||
T Consensus        77 lv~e~~~~~~l~~~~~~~~--------~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~----~~~~~kl~Df  144 (287)
T cd07848          77 LVFEYVEKNMLELLEEMPN--------GVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLIS----HNDVLKLCDF  144 (287)
T ss_pred             EEEecCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc----CCCcEEEeec
Confidence            9999999887766543221        288999999999999999999999999999999999998    6678999999


Q ss_pred             ccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc------------
Q psy2172         175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK------------  242 (291)
Q Consensus       175 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~------------  242 (291)
                      |.+........  .......|+..|+|||++.+.. ++.++|+|||||++|+|++|++||.+......            
T Consensus       145 g~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  221 (287)
T cd07848         145 GFARNLSEGSN--ANYTEYVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLP  221 (287)
T ss_pred             cCccccccccc--ccccccccccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCC
Confidence            99876543211  1223346788999999998755 88999999999999999999999986432100            


Q ss_pred             -------------------C----------CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         243 -------------------T----------SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       243 -------------------~----------~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                                         .          ........+.+++..|..+.|..||+++++..|||+
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         222 AEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             HHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence                               0          000123457889999999999999999998888874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.3e-40  Score=295.18  Aligned_cols=248  Identities=25%  Similarity=0.419  Sum_probs=195.1

Q ss_pred             ccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCCCCeeeEEEEEEeC------CC
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFLSH------ND   90 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~   90 (291)
                      .+.|.+ +++||+|+||.||+|.+..  +++.||||.+...  .....+|+.+++.++||||+++++++...      ..
T Consensus        65 ~~~y~~-~~~LG~G~fg~Vy~~~~~~--~~~~vAiK~i~~~--~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         65 NKSYKL-GNIIGNGSFGVVYEAICID--TSEKVAIKKVLQD--PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             CCeEEE-eEEEEeCCCEEEEEEEECC--CCCEEEEEEEecC--cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            456774 7899999999999999876  6788999988643  33456799999999999999999987432      22


Q ss_pred             ceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEE
Q psy2172          91 RKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVK  170 (291)
Q Consensus        91 ~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~  170 (291)
                      .++++||||+++++...+.......     ..+++..++.++.|++.||+|||++||+||||||+||+++.   ....++
T Consensus       140 ~~l~lvmE~~~~~l~~~~~~~~~~~-----~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~---~~~~vk  211 (440)
T PTZ00036        140 IFLNVVMEFIPQTVHKYMKHYARNN-----HALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDP---NTHTLK  211 (440)
T ss_pred             eEEEEEEecCCccHHHHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcC---CCCcee
Confidence            3678999999999887776543221     22889999999999999999999999999999999999973   234799


Q ss_pred             EeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---------
Q psy2172         171 IADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---------  241 (291)
Q Consensus       171 l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---------  241 (291)
                      |+|||+++......    ......|++.|+|||++.+...++.++|||||||++|+|++|.+||.+.....         
T Consensus       212 L~DFGla~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~  287 (440)
T PTZ00036        212 LCDFGSAKNLLAGQ----RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVL  287 (440)
T ss_pred             eeccccchhccCCC----CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence            99999998654321    12234678899999998775568999999999999999999999998754210         


Q ss_pred             --------------------cCC---------CCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         242 --------------------KTS---------NPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       242 --------------------~~~---------~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                                          +..         .......+.+++..|....|..|+++.++..||++..
T Consensus       288 ~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~  356 (440)
T PTZ00036        288 GTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD  356 (440)
T ss_pred             CCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHh
Confidence                                000         0012345778889999999999999999999988754

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.2e-40  Score=287.45  Aligned_cols=246  Identities=30%  Similarity=0.478  Sum_probs=197.9

Q ss_pred             ccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeC
Q psy2172          13 RTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT----GLSMSACREIALLRELKHPNVINLISVFLSH   88 (291)
Q Consensus        13 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   88 (291)
                      ...+.++|++ .+.||+|+||.||+|.+..  +++.||+|.+...    .....+.+|+.+++.++||||+++++++...
T Consensus        16 ~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   92 (359)
T cd07876          16 TFTVLKRYQQ-LKPIGSGAQGIVCAAFDTV--LGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQ   92 (359)
T ss_pred             hhhhhhceEE-EEEeecCCCEEEEEEEEcC--CCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccC
Confidence            3456778885 6799999999999999776  6788999998643    2234577899999999999999999998433


Q ss_pred             C----CceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCC
Q psy2172          89 N----DRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGI  164 (291)
Q Consensus        89 ~----~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~  164 (291)
                      +    ....|++|||+++++...+..           .+++..+..++.|++.||.|||++||+|+||||+||+++    
T Consensus        93 ~~~~~~~~~~lv~e~~~~~l~~~~~~-----------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~----  157 (359)
T cd07876          93 KSLEEFQDVYLVMELMDANLCQVIHM-----------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----  157 (359)
T ss_pred             CCccccceeEEEEeCCCcCHHHHHhc-----------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC----
Confidence            2    235899999999988776532           178888999999999999999999999999999999998    


Q ss_pred             CCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc--
Q psy2172         165 ERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK--  242 (291)
Q Consensus       165 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~--  242 (291)
                      .++.++|+|||++......    .......|+..|+|||.+.+.. ++.++|+|||||++|+|++|..||.+.+....  
T Consensus       158 ~~~~~kl~Dfg~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~  232 (359)
T cd07876         158 SDCTLKILDFGLARTACTN----FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWN  232 (359)
T ss_pred             CCCCEEEecCCCccccccC----ccCCCCcccCCCCCchhccCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            6789999999998754322    1223457788999999998754 88999999999999999999999986542100  


Q ss_pred             -----------------------------C--------------------CCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         243 -----------------------------T--------------------SNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       243 -----------------------------~--------------------~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                                                   .                    ......+.+.+++..|..+.|..||++.++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~  312 (359)
T cd07876         233 KVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEA  312 (359)
T ss_pred             HHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHH
Confidence                                         0                    000113457889999999999999999999


Q ss_pred             CCCcchhh
Q psy2172         274 PEHPTLLK  281 (291)
Q Consensus       274 ~~~~~~~~  281 (291)
                      ..+||+..
T Consensus       313 l~hp~~~~  320 (359)
T cd07876         313 LRHPYITV  320 (359)
T ss_pred             hcCchhhh
Confidence            99998764

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.6e-40  Score=279.35  Aligned_cols=239  Identities=22%  Similarity=0.331  Sum_probs=192.7

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEe
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-----LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFD   98 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e   98 (291)
                      .+.||+|+||.||+|.+..  +++.||+|.+....     ....+.+|+.+++.++|++|+++++++  .+....+++||
T Consensus         5 ~~~lg~G~~g~V~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~--~~~~~~~lv~e   80 (285)
T cd05631           5 YRVLGKGGFGEVCACQVRA--TGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY--ETKDALCLVLT   80 (285)
T ss_pred             EEEEecCCCEEEEEEEEec--CCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE--ccCCeEEEEEE
Confidence            5689999999999999877  67889999986432     123467899999999999999999998  55678999999


Q ss_pred             cCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccc
Q psy2172          99 YAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA  177 (291)
Q Consensus        99 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~  177 (291)
                      |+.+ +|...+.....       ..+++..+..++.|++.||+|||++|++|+||||+||+++    .++.++|+|||++
T Consensus        81 ~~~~g~L~~~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~----~~~~~kl~Dfg~~  149 (285)
T cd05631          81 IMNGGDLKFHIYNMGN-------PGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLD----DRGHIRISDLGLA  149 (285)
T ss_pred             ecCCCcHHHHHHhhCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC----CCCCEEEeeCCCc
Confidence            9985 66655543221       1288999999999999999999999999999999999998    6678999999998


Q ss_pred             eecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc-------------cCC
Q psy2172         178 RLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI-------------KTS  244 (291)
Q Consensus       178 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~-------------~~~  244 (291)
                      .......    ......|+..|+|||++.+.. ++.++|||||||++|+|++|+.||.+.....             ...
T Consensus       150 ~~~~~~~----~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  224 (285)
T cd05631         150 VQIPEGE----TVRGRVGTVGYMAPEVINNEK-YTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEY  224 (285)
T ss_pred             EEcCCCC----eecCCCCCCCccCHhhhcCCC-CCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccC
Confidence            7653321    112346789999999998754 8999999999999999999999998754321             112


Q ss_pred             CCCcHHHHHHHHHhhCCCCcCChhh-----hhcCCCCcchhhh
Q psy2172         245 NPYHHDQLDRIFSVMGFPLEKDWED-----IRKMPEHPTLLKD  282 (291)
Q Consensus       245 ~~~~~~~~~~i~~~~~~~~~~~~~~-----~~~~~~~~~~~~~  282 (291)
                      .......+.++++.|..+.|..|++     +.++..+|++...
T Consensus       225 ~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~  267 (285)
T cd05631         225 SEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNI  267 (285)
T ss_pred             CccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence            2234567889999999999999986     7788888887643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0582|consensus

Probab=100.00  E-value=1.1e-40  Score=277.57  Aligned_cols=246  Identities=23%  Similarity=0.352  Sum_probs=199.9

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHNDRKVWL   95 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~i   95 (291)
                      -|++ .+.||.|..++||+|++..  .+..||||++.-+..   ...+.+|+..|+.++||||++++.+|..  +..+|+
T Consensus        27 ~YeL-~e~IG~G~sa~V~~A~c~p--~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv--~~~LWv  101 (516)
T KOG0582|consen   27 DYEL-QEVIGVGASAVVYLARCIP--TNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV--DSELWV  101 (516)
T ss_pred             ceeE-EEEEeccceeEeeeeeecc--cCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe--cceeEE
Confidence            3443 5799999999999999987  568899999974433   3568899999999999999999999954  668999


Q ss_pred             EEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          96 LFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        96 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      ||++|. |++.+++...-...       +++..+..+++++++||.|||.+|.+|||||+.|||++    .++.|+|+||
T Consensus       102 VmpfMa~GS~ldIik~~~~~G-------l~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~----~dG~VkLadF  170 (516)
T KOG0582|consen  102 VMPFMAGGSLLDIIKTYYPDG-------LEEASIATILREVLKALDYLHQNGHIHRDVKAGNILID----SDGTVKLADF  170 (516)
T ss_pred             eehhhcCCcHHHHHHHHcccc-------ccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEc----CCCcEEEcCc
Confidence            999998 58888887654321       89999999999999999999999999999999999999    7789999999


Q ss_pred             ccceecCCCCC-CCCCCCCceeccccccccccc-CCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc------------
Q psy2172         175 GFARLFNNPLK-PLADLDPVVVTFWYRAPELLL-GARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED------------  240 (291)
Q Consensus       175 g~~~~~~~~~~-~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~------------  240 (291)
                      |.+..+..... .........|+++|+|||++. ....|+.++||||||++..|+++|..||.....-            
T Consensus       171 gvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp  250 (516)
T KOG0582|consen  171 GVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPP  250 (516)
T ss_pred             eeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCC
Confidence            99876655321 111224568999999999953 3345999999999999999999999999876521            


Q ss_pred             -------ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchh
Q psy2172         241 -------IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLL  280 (291)
Q Consensus       241 -------~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  280 (291)
                             .......+...+..++..+..-.|..||+.+++..|+++-
T Consensus       251 ~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk  297 (516)
T KOG0582|consen  251 TLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFK  297 (516)
T ss_pred             CcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHh
Confidence                   0112223344677889999999999999999998887764

>KOG0589|consensus

Probab=100.00  E-value=1.4e-41  Score=288.32  Aligned_cols=246  Identities=30%  Similarity=0.495  Sum_probs=209.7

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT----GLSMSACREIALLRELKHPNVINLISVFLSHNDRKVW   94 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (291)
                      .|.+ .+++|+|+||.+++++++.  ....+|+|.+.-.    .....+.+|+.++++++|||||.+.+.|+. ++..++
T Consensus         5 ~Ye~-~~~iG~GafG~a~lvrhk~--~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~-~~~~l~   80 (426)
T KOG0589|consen    5 NYEV-LRQVGRGAFGSALLVRHKS--DDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEE-DGQLLC   80 (426)
T ss_pred             hhhh-hhhcCccccchhhhhhhcc--CCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhc-CCceEE
Confidence            4553 7899999999999999876  7778999998633    334468899999999999999999999953 444599


Q ss_pred             EEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEee
Q psy2172          95 LLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIAD  173 (291)
Q Consensus        95 iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~D  173 (291)
                      |||+||+| ++.+.+...+..       .++++.++.++.|++.|+.|||+++|+|||||+.|||++    .+..|+|+|
T Consensus        81 Ivm~Y~eGg~l~~~i~~~k~~-------~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Niflt----k~~~VkLgD  149 (426)
T KOG0589|consen   81 IVMEYCEGGDLAQLIKEQKGV-------LFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLT----KDKKVKLGD  149 (426)
T ss_pred             EEEeecCCCCHHHHHHHHhhc-------cccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcc----ccCceeecc
Confidence            99999986 777777765522       399999999999999999999999999999999999999    777899999


Q ss_pred             cccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc----------ccC
Q psy2172         174 MGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED----------IKT  243 (291)
Q Consensus       174 fg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~----------~~~  243 (291)
                      ||+|+..+...   .......||+.|++||.+.+.+ |+.++|+|||||++|||++-+++|.+.+-.          ...
T Consensus       150 fGlaK~l~~~~---~~a~tvvGTp~YmcPEil~d~p-Yn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~P  225 (426)
T KOG0589|consen  150 FGLAKILNPED---SLASTVVGTPYYMCPEILSDIP-YNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSP  225 (426)
T ss_pred             hhhhhhcCCch---hhhheecCCCcccCHHHhCCCC-CCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCC
Confidence            99999887643   2445679999999999999866 999999999999999999999999987643          234


Q ss_pred             CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhhh
Q psy2172         244 SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF  283 (291)
Q Consensus       244 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (291)
                      ....+...+..+++.+....|..+|++.++...|.+....
T Consensus       226 lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~~  265 (426)
T KOG0589|consen  226 LPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRYL  265 (426)
T ss_pred             CCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhHH
Confidence            5556678899999999999999999999998887777655

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.7e-40  Score=287.18  Aligned_cols=244  Identities=20%  Similarity=0.317  Sum_probs=186.8

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-----LSMSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      .|++ .+.||+|+||.||+|.++.  +++.||+|+++...     ....+.+|+.++..++|++|+++++.+  .+....
T Consensus         2 ~y~~-~~~LG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~--~~~~~~   76 (363)
T cd05628           2 DFES-LKVIGRGAFGEVRLVQKKD--TGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF--QDKLNL   76 (363)
T ss_pred             CceE-eEEEEeCCCEEEEEEEECC--CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE--ecCCeE
Confidence            3553 6799999999999999876  67889999986432     224577899999999999999999999  567799


Q ss_pred             EEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          94 WLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        94 ~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      |+||||+++ +|.+.+....         .+++..++.++.|++.||+|||++||+||||||+||+++    .++.++|+
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~----~~~~vkL~  143 (363)
T cd05628          77 YLIMEFLPGGDMMTLLMKKD---------TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLD----SKGHVKLS  143 (363)
T ss_pred             EEEEcCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC----CCCCEEEe
Confidence            999999975 7777775432         289999999999999999999999999999999999998    66789999


Q ss_pred             ecccceecCCCCCC--------------------------------CCCCCCceecccccccccccCCcCCCCchhHHHH
Q psy2172         173 DMGFARLFNNPLKP--------------------------------LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAI  220 (291)
Q Consensus       173 Dfg~~~~~~~~~~~--------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~sl  220 (291)
                      |||++.........                                ........||+.|+|||++.+.. ++.++|+|||
T Consensus       144 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DvwSl  222 (363)
T cd05628         144 DFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG-YNKLCDWWSL  222 (363)
T ss_pred             eccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCC-CCCchhhhhh
Confidence            99998754321100                                00012347899999999998754 8899999999


Q ss_pred             HHHHHHHHcCCCCCCCCccccc-----------CCC--CCcHHHHHHHHHhhCCCCc--CChhhhhcCCCCcchhh
Q psy2172         221 GCIFAELLTSEPIFHCRQEDIK-----------TSN--PYHHDQLDRIFSVMGFPLE--KDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       221 G~~l~~l~~g~~pf~~~~~~~~-----------~~~--~~~~~~~~~i~~~~~~~~~--~~~~~~~~~~~~~~~~~  281 (291)
                      ||++|+|++|..||.+......           ...  ....+...+++..+.....  ..+|++.++..|||+..
T Consensus       223 Gvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~  298 (363)
T cd05628         223 GVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEG  298 (363)
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCC
Confidence            9999999999999987553210           000  1123455565555443211  24578889999988753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.4e-41  Score=286.89  Aligned_cols=238  Identities=24%  Similarity=0.414  Sum_probs=194.4

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-----LSMSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      .|.+ .+.||+|+||.||+|.+..  +++.||+|+++...     ....+.+|+.++..++||||+++++++  .+....
T Consensus         2 ~y~~-~~~ig~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~--~~~~~~   76 (333)
T cd05600           2 DFQI-LTQVGQGGYGQVFLAKKKD--TGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF--QDDEYL   76 (333)
T ss_pred             CcEE-EEEEeecCCeEEEEEEECC--CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE--EcCCEE
Confidence            3554 6799999999999999876  66889999986432     234577899999999999999999998  567799


Q ss_pred             EEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          94 WLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        94 ~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      |+||||+++ +|.+.+....         .+++..++.++.|++.||.+||++|++|+||||+||+++    ..+.++|+
T Consensus        77 ~lv~e~~~g~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~----~~~~~kL~  143 (333)
T cd05600          77 YLAMEYVPGGDFRTLLNNLG---------VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLID----ASGHIKLT  143 (333)
T ss_pred             EEEEeCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC----CCCCEEEE
Confidence            999999975 8887775432         288999999999999999999999999999999999998    67789999


Q ss_pred             ecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc----------
Q psy2172         173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK----------  242 (291)
Q Consensus       173 Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~----------  242 (291)
                      |||++.....      ......|++.|+|||++.+. .++.++|||||||++|+|++|..||.+......          
T Consensus       144 Dfg~a~~~~~------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  216 (333)
T cd05600         144 DFGLSKGIVT------YANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET  216 (333)
T ss_pred             eCcCCccccc------ccCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccc
Confidence            9999875433      22345689999999999875 489999999999999999999999986543210          


Q ss_pred             -CCC------CCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         243 -TSN------PYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       243 -~~~------~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                       ...      ....+.+.+++..|....+..+|++.++..+|++.+
T Consensus       217 ~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~  262 (333)
T cd05600         217 LQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKE  262 (333)
T ss_pred             ccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence             000      122466778888888888889999999998888764

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0578|consensus

Probab=100.00  E-value=5e-41  Score=287.25  Aligned_cols=234  Identities=26%  Similarity=0.495  Sum_probs=197.3

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCC--CCCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecCC
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEG--TGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAE  101 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~~  101 (291)
                      -++||+|+.|.||.|....  +++.||||.+..  ....+-+.+|+.+|+..+|+|||.+++.|+.  ++.+|+||||++
T Consensus       278 ~~kigqgaSG~vy~A~~~~--~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv--~deLWVVMEym~  353 (550)
T KOG0578|consen  278 FKKIGQGATGGVYVARKIS--TKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLV--GDELWVVMEYME  353 (550)
T ss_pred             hhhhccccccceeeeeecc--CCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcc--cceeEEEEeecC
Confidence            5699999999999999766  778899999863  3344568899999999999999999999964  468999999998


Q ss_pred             C-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceec
Q psy2172         102 H-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF  180 (291)
Q Consensus       102 ~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~  180 (291)
                      | +|.+.+....          +++.++..|.++++.||+|||.+||+|+|||.+||+++    .++.+||+|||++..+
T Consensus       354 ggsLTDvVt~~~----------~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~----~~g~vKltDFGFcaqi  419 (550)
T KOG0578|consen  354 GGSLTDVVTKTR----------MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLT----MDGSVKLTDFGFCAQI  419 (550)
T ss_pred             CCchhhhhhccc----------ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEec----cCCcEEEeeeeeeecc
Confidence            6 6666665443          89999999999999999999999999999999999999    6778999999999876


Q ss_pred             CCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc------------ccCCCCCc
Q psy2172         181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED------------IKTSNPYH  248 (291)
Q Consensus       181 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~------------~~~~~~~~  248 (291)
                      ....   .......||+.|||||+..... |+++.||||||++++||+.|.+||=....-            ........
T Consensus       420 ~~~~---~KR~TmVGTPYWMAPEVvtrk~-YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~kl  495 (550)
T KOG0578|consen  420 SEEQ---SKRSTMVGTPYWMAPEVVTRKP-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKL  495 (550)
T ss_pred             cccc---CccccccCCCCccchhhhhhcc-cCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCcccc
Confidence            5432   2456789999999999998755 999999999999999999999999753321            01122233


Q ss_pred             HHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         249 HDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       249 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                      +..+.+++..|..-.+..|+++.+|.+||.+
T Consensus       496 S~~~kdFL~~cL~~dv~~RasA~eLL~HpFl  526 (550)
T KOG0578|consen  496 SPELKDFLDRCLVVDVEQRASAKELLEHPFL  526 (550)
T ss_pred             CHHHHHHHHHHhhcchhcCCCHHHHhcChhh
Confidence            6778999999999999999999999999876

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.3e-40  Score=282.21  Aligned_cols=236  Identities=23%  Similarity=0.359  Sum_probs=189.2

Q ss_pred             ceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEec
Q psy2172          25 CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-----LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDY   99 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~   99 (291)
                      +.||+|+||.||++.++.  ++..||+|.++...     ....+.+|+.+++.++||||+++++++  ......|+||||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~--~~~~~~~lv~E~   76 (323)
T cd05595           1 KLLGKGTFGKVILVREKA--TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF--QTHDRLCFVMEY   76 (323)
T ss_pred             CeeeeCCCEEEEEEEECC--CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEE--ecCCEEEEEEeC
Confidence            479999999999999876  67889999986431     223567899999999999999999999  556789999999


Q ss_pred             CCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccce
Q psy2172         100 AEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR  178 (291)
Q Consensus       100 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~  178 (291)
                      +++ +|...+....         .+++..++.++.|++.||+|||++|++|+||||+||+++    .++.++|+|||++.
T Consensus        77 ~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~----~~~~~kL~Dfg~~~  143 (323)
T cd05595          77 ANGGELFFHLSRER---------VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD----KDGHIKITDFGLCK  143 (323)
T ss_pred             CCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEc----CCCCEEecccHHhc
Confidence            986 6655554322         288999999999999999999999999999999999998    67789999999986


Q ss_pred             ecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---------cCCCCCcH
Q psy2172         179 LFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---------KTSNPYHH  249 (291)
Q Consensus       179 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---------~~~~~~~~  249 (291)
                      ......   .......|+..|+|||.+.+.. ++.++|+|||||++|+|++|..||.......         ........
T Consensus       144 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~  219 (323)
T cd05595         144 EGISDG---ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLS  219 (323)
T ss_pred             cccCCC---CccccccCCcCcCCcccccCCC-CCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Confidence            432211   1223456899999999997754 8999999999999999999999997654321         11223345


Q ss_pred             HHHHHHHHhhCCCCcCChh-----hhhcCCCCcchhh
Q psy2172         250 DQLDRIFSVMGFPLEKDWE-----DIRKMPEHPTLLK  281 (291)
Q Consensus       250 ~~~~~i~~~~~~~~~~~~~-----~~~~~~~~~~~~~  281 (291)
                      ..+.+++..|....|..|+     ++.++..++|+.+
T Consensus       220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~  256 (323)
T cd05595         220 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS  256 (323)
T ss_pred             HHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCC
Confidence            6788999999999999887     7777777777653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.5e-40  Score=284.49  Aligned_cols=240  Identities=24%  Similarity=0.380  Sum_probs=193.7

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC-----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCce
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-----GLSMSACREIALLRELKHPNVINLISVFLSHNDRK   92 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (291)
                      +.|.+ .+.||+|+||.||+|.++.. ....||+|.+...     .....+.+|+.+++.++||||+++++++  .+...
T Consensus        30 ~~y~~-~~~ig~G~~g~Vy~a~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~--~~~~~  105 (340)
T PTZ00426         30 EDFNF-IRTLGTGSFGRVILATYKNE-DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF--KDESY  105 (340)
T ss_pred             hhcEE-EEEEeecCCeEEEEEEEECC-CCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE--EeCCE
Confidence            34554 57999999999999987652 3367999988532     2334677899999999999999999999  55678


Q ss_pred             EEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEE
Q psy2172          93 VWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI  171 (291)
Q Consensus        93 ~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l  171 (291)
                      .|+||||+.+ +|.+.+....         .+++..+..++.|++.||.|||++|++|+||||+||+++    .++.++|
T Consensus       106 ~~lv~Ey~~~g~L~~~i~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~----~~~~ikL  172 (340)
T PTZ00426        106 LYLVLEFVIGGEFFTFLRRNK---------RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLD----KDGFIKM  172 (340)
T ss_pred             EEEEEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEEC----CCCCEEE
Confidence            9999999974 7877776432         288999999999999999999999999999999999998    6789999


Q ss_pred             eecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---------c
Q psy2172         172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---------K  242 (291)
Q Consensus       172 ~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---------~  242 (291)
                      +|||++......      .....||+.|+|||++.+.. ++.++|+|||||++|+|++|..||.+.....         .
T Consensus       173 ~DFG~a~~~~~~------~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~  245 (340)
T PTZ00426        173 TDFGFAKVVDTR------TYTLCGTPEYIAPEILLNVG-HGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII  245 (340)
T ss_pred             ecCCCCeecCCC------cceecCChhhcCHHHHhCCC-CCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC
Confidence            999999765431      23456899999999998754 8899999999999999999999998765421         1


Q ss_pred             CCCCCcHHHHHHHHHhhCCCCcCCh-----hhhhcCCCCcchhh
Q psy2172         243 TSNPYHHDQLDRIFSVMGFPLEKDW-----EDIRKMPEHPTLLK  281 (291)
Q Consensus       243 ~~~~~~~~~~~~i~~~~~~~~~~~~-----~~~~~~~~~~~~~~  281 (291)
                      ...........++++.|....|..|     ++++++..|||+..
T Consensus       246 ~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~  289 (340)
T PTZ00426        246 YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN  289 (340)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence            1223335667888998888888777     47888888888753

>KOG0032|consensus

Probab=100.00  E-value=7.7e-40  Score=280.90  Aligned_cols=250  Identities=29%  Similarity=0.469  Sum_probs=211.9

Q ss_pred             cccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC-----ChhHHHHHHHHhcCC-CCCeeeEEEEE
Q psy2172          12 ERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-----SMSACREIALLRELK-HPNVINLISVF   85 (291)
Q Consensus        12 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~-h~~iv~~~~~~   85 (291)
                      ....+.+.|.+ ++.||+|.||.||+|..+.  +++.+|+|.+.+...     ...+.+|+.+|++++ ||||+.++++|
T Consensus        29 ~~~~~~~~Y~l-~~~lG~G~Fg~v~~~~~~~--tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~  105 (382)
T KOG0032|consen   29 FSEDIKEKYEL-GRELGRGQFGVVYLCREKS--TGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF  105 (382)
T ss_pred             ccccccccEEe-hhhhCCCCceEEEEEEecC--CCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            34556667775 7899999999999999887  688999999975433     247899999999998 99999999999


Q ss_pred             EeCCCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCC
Q psy2172          86 LSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGI  164 (291)
Q Consensus        86 ~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~  164 (291)
                        ++...+++|||++.| .|.+.+...          .+++..+..++.|++.+++|+|+.|++|+||||+|+++.....
T Consensus       106 --e~~~~~~lvmEL~~GGeLfd~i~~~----------~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~  173 (382)
T KOG0032|consen  106 --EDPDSVYLVMELCEGGELFDRIVKK----------HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDE  173 (382)
T ss_pred             --EcCCeEEEEEEecCCchHHHHHHHc----------cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccC
Confidence              677799999999985 888887765          1899999999999999999999999999999999999987654


Q ss_pred             CCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---
Q psy2172         165 ERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---  241 (291)
Q Consensus       165 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---  241 (291)
                      ....++++|||++......    ......+||+.|+|||++...+ |+..+|+||+|+++|.|++|.+||.+.....   
T Consensus       174 ~~~~ik~~DFGla~~~~~~----~~~~~~~Gtp~y~APEvl~~~~-y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~  248 (382)
T KOG0032|consen  174 GSGRIKLIDFGLAKFIKPG----ERLHTIVGTPEYVAPEVLGGRP-YGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL  248 (382)
T ss_pred             CCCcEEEeeCCCceEccCC----ceEeeecCCccccCchhhcCCC-CCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH
Confidence            4568999999999987652    3445679999999999998644 9999999999999999999999999987431   


Q ss_pred             ----------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         242 ----------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       242 ----------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                                ...-+...+...+++..+....|..|.++.+...|||+..
T Consensus       249 ~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~  298 (382)
T KOG0032|consen  249 AILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKS  298 (382)
T ss_pred             HHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccC
Confidence                      1122233677888999999999999999999999999765

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.9e-40  Score=285.47  Aligned_cols=254  Identities=30%  Similarity=0.471  Sum_probs=202.4

Q ss_pred             ceeecccccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC----CChhHHHHHHHHhcCCCCCeeeE
Q psy2172           6 KIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG----LSMSACREIALLRELKHPNVINL   81 (291)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~   81 (291)
                      .+..+.....+.++|.+ .+.||+|+||.||+|.+..  .++.+|+|.+....    ....+.+|+.+++.++||||+++
T Consensus         5 ~~~~~~~~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   81 (355)
T cd07874           5 SVEVGDSTFTVLKRYQN-LKPIGSGAQGIVCAAYDAV--LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL   81 (355)
T ss_pred             eeccCchhhhhhhceeE-EEEeeecCCEEEEEEEecC--CCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhce
Confidence            44445555667788885 6799999999999999765  67889999987532    22457789999999999999999


Q ss_pred             EEEEEeC----CCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcE
Q psy2172          82 ISVFLSH----NDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANI  157 (291)
Q Consensus        82 ~~~~~~~----~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Ni  157 (291)
                      ++++...    .....|++|||+++++.+.+..           .++...+..++.|++.||+|||++|++|+||||+||
T Consensus        82 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-----------~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Ni  150 (355)
T cd07874          82 LNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM-----------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI  150 (355)
T ss_pred             eeeeeccccccccceeEEEhhhhcccHHHHHhh-----------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHE
Confidence            9988532    2246899999999988776642           178889999999999999999999999999999999


Q ss_pred             EeecCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q psy2172         158 LVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  237 (291)
Q Consensus       158 l~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~  237 (291)
                      +++    .++.++|+|||++......    .......|+..|+|||++.+.. ++.++|+|||||++|+|++|..||.+.
T Consensus       151 ll~----~~~~~kl~Dfg~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~  221 (355)
T cd07874         151 VVK----SDCTLKILDFGLARTAGTS----FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGR  221 (355)
T ss_pred             EEC----CCCCEEEeeCcccccCCCc----cccCCccccCCccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            998    6678999999999765432    1223457789999999998754 889999999999999999999999765


Q ss_pred             cccc---------------------------------------------------cCCCCCcHHHHHHHHHhhCCCCcCC
Q psy2172         238 QEDI---------------------------------------------------KTSNPYHHDQLDRIFSVMGFPLEKD  266 (291)
Q Consensus       238 ~~~~---------------------------------------------------~~~~~~~~~~~~~i~~~~~~~~~~~  266 (291)
                      ....                                                   ..........+.+++..|..+.|..
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~  301 (355)
T cd07874         222 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK  301 (355)
T ss_pred             CHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchh
Confidence            4100                                                   0000112345678999999999999


Q ss_pred             hhhhhcCCCCcchhhh
Q psy2172         267 WEDIRKMPEHPTLLKD  282 (291)
Q Consensus       267 ~~~~~~~~~~~~~~~~  282 (291)
                      ||++.++..+||+..-
T Consensus       302 Rps~~ell~hp~~~~~  317 (355)
T cd07874         302 RISVDEALQHPYINVW  317 (355)
T ss_pred             cCCHHHHhcCcchhcc
Confidence            9999999999988643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0694|consensus

Probab=100.00  E-value=1.1e-40  Score=290.64  Aligned_cols=241  Identities=24%  Similarity=0.355  Sum_probs=191.2

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC-----ChhHHHHHHHHhcC-CCCCeeeEEEEEEeCCCc
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-----SMSACREIALLREL-KHPNVINLISVFLSHNDR   91 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~   91 (291)
                      +.|.+ -++||+|+||.|+++..+.  +++.+|||.+++...     .+....|.+|+... +||.++++++.|  +...
T Consensus       368 ~~F~~-l~vLGkGsFGkV~lae~k~--~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f--QT~~  442 (694)
T KOG0694|consen  368 DDFRL-LAVLGRGSFGKVLLAELKG--TNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF--QTKE  442 (694)
T ss_pred             cceEE-EEEeccCcCceEEEEEEcC--CCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc--ccCC
Confidence            34554 4599999999999999888  778999999987643     33467788888888 599999999999  8899


Q ss_pred             eEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEE
Q psy2172          92 KVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI  171 (291)
Q Consensus        92 ~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l  171 (291)
                      ++|.||||..|+-...+...+         .+++..+.-++..++.||.|||++||++||||.+|||++    ..+.+||
T Consensus       443 ~l~fvmey~~Ggdm~~~~~~~---------~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD----~eGh~ki  509 (694)
T KOG0694|consen  443 HLFFVMEYVAGGDLMHHIHTD---------VFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLD----TEGHVKI  509 (694)
T ss_pred             eEEEEEEecCCCcEEEEEecc---------cccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEc----ccCcEEe
Confidence            999999999874322222111         199999999999999999999999999999999999999    7899999


Q ss_pred             eecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc---------cc
Q psy2172         172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED---------IK  242 (291)
Q Consensus       172 ~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~---------~~  242 (291)
                      +|||+++..-.   ......+.+||+.|+|||++.+.. |+.+.|.|||||+||+|+.|..||.+.+++         ..
T Consensus       510 ADFGlcKe~m~---~g~~TsTfCGTpey~aPEil~e~~-Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~  585 (694)
T KOG0694|consen  510 ADFGLCKEGMG---QGDRTSTFCGTPEFLAPEVLTEQS-YTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEV  585 (694)
T ss_pred             cccccccccCC---CCCccccccCChhhcChhhhccCc-ccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC
Confidence            99999985321   224567889999999999999855 999999999999999999999999988864         23


Q ss_pred             CCCCCcHHHHHHHHHhhCCCCcCChhh-----hhcCCCCcchh
Q psy2172         243 TSNPYHHDQLDRIFSVMGFPLEKDWED-----IRKMPEHPTLL  280 (291)
Q Consensus       243 ~~~~~~~~~~~~i~~~~~~~~~~~~~~-----~~~~~~~~~~~  280 (291)
                      .++...+.....|++.+..-.|+.|=.     ..++..+|.+.
T Consensus       586 ~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr  628 (694)
T KOG0694|consen  586 RYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFR  628 (694)
T ss_pred             CCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccc
Confidence            344444555666666666666654422     34455555544

>KOG0033|consensus

Probab=100.00  E-value=8.2e-42  Score=264.35  Aligned_cols=249  Identities=27%  Similarity=0.388  Sum_probs=204.4

Q ss_pred             ccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCC----CCCChhHHHHHHHHhcCCCCCeeeEEEEEEeC
Q psy2172          13 RTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEG----TGLSMSACREIALLRELKHPNVINLISVFLSH   88 (291)
Q Consensus        13 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   88 (291)
                      ....++.|++ -+.||+|+|+.||+|.++.  +++.+++|++..    ....+++.+|+.|-+.|+||||+++.+.+  .
T Consensus         6 ~~~f~d~y~l-~e~igkG~FSvVrRc~~~~--tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti--~   80 (355)
T KOG0033|consen    6 STKFSDNYDV-KEELGKGAFSVVRRCVHKT--TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI--Q   80 (355)
T ss_pred             ccccchhhhH-HHHHccCchHHHHHHHhcc--chHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh--c
Confidence            3456677775 5699999999999999776  788899999863    34567899999999999999999999999  7


Q ss_pred             CCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCC
Q psy2172          89 NDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERG  167 (291)
Q Consensus        89 ~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~  167 (291)
                      +..+.|+|+|++.| +|..-+....-         +++..+-..++||+.||.|.|.+||||||+||+|+++.+.. ...
T Consensus        81 ~~~~~ylvFe~m~G~dl~~eIV~R~~---------ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~-~~A  150 (355)
T KOG0033|consen   81 EESFHYLVFDLVTGGELFEDIVAREF---------YSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKA-KGA  150 (355)
T ss_pred             ccceeEEEEecccchHHHHHHHHHHH---------HHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeecc-CCC
Confidence            78899999999987 66666554422         88999999999999999999999999999999999998764 567


Q ss_pred             cEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc-c-----
Q psy2172         168 RVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED-I-----  241 (291)
Q Consensus       168 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~-~-----  241 (291)
                      -+||+|||++......    .......||+.|+|||++...+ ++..+|||+.|++||-++.|.+||.+.+.. +     
T Consensus       151 ~vKL~~FGvAi~l~~g----~~~~G~~GtP~fmaPEvvrkdp-y~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~  225 (355)
T KOG0033|consen  151 AVKLADFGLAIEVNDG----EAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIK  225 (355)
T ss_pred             ceeecccceEEEeCCc----cccccccCCCcccCHHHhhcCC-CCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHh
Confidence            8999999999977632    3345678999999999998755 999999999999999999999999984331 1     


Q ss_pred             -------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         242 -------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       242 -------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                             ...-+.-.+...++++.|..-.|..+-+..+-..|||+.+
T Consensus       226 ~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~  272 (355)
T KOG0033|consen  226 AGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN  272 (355)
T ss_pred             ccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence                   0011222455677888888888888888888888888764

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.6e-39  Score=276.41  Aligned_cols=226  Identities=40%  Similarity=0.728  Sum_probs=186.0

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC---CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG---LSMSACREIALLRELKHPNVINLISVFLSHNDRKVW   94 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (291)
                      +.|.+ .++||+|+||.||+|.++.  +++.+|+|.++...   ....+.+|+.++++++||||+++++++  .+....+
T Consensus         6 ~~y~~-~~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~~~   80 (309)
T cd07872           6 ETYIK-LEKLGEGTYATVFKGRSKL--TENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV--HTDKSLT   80 (309)
T ss_pred             CceEE-EEEecccCCEEEEEEEecC--CCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEE--eeCCeEE
Confidence            34553 6799999999999999876  66789999986432   234577899999999999999999998  4567899


Q ss_pred             EEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          95 LLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        95 iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      +||||+++++.+.+.....        .++...+..++.|++.||++||++||+|+||||+||+++    .++.++|+||
T Consensus        81 lv~e~~~~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~----~~~~~kl~Df  148 (309)
T cd07872          81 LVFEYLDKDLKQYMDDCGN--------IMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLIN----ERGELKLADF  148 (309)
T ss_pred             EEEeCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCCEEECcc
Confidence            9999999988877754322        278889999999999999999999999999999999998    6678999999


Q ss_pred             ccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccCCCCCcHHHHHH
Q psy2172         175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR  254 (291)
Q Consensus       175 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  254 (291)
                      |.+........   ......++..|+|||.+.+...++.++|+||||+++|+|++|+.||.+....         +.+..
T Consensus       149 g~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~---------~~~~~  216 (309)
T cd07872         149 GLARAKSVPTK---TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE---------DELHL  216 (309)
T ss_pred             ccceecCCCcc---ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH---------HHHHH
Confidence            99875433211   1223456889999999876556889999999999999999999999877653         67788


Q ss_pred             HHHhhCCCCcCChhhhhc
Q psy2172         255 IFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       255 i~~~~~~~~~~~~~~~~~  272 (291)
                      +.+.++.|.+..||.+..
T Consensus       217 ~~~~~~~~~~~~~~~~~~  234 (309)
T cd07872         217 IFRLLGTPTEETWPGISS  234 (309)
T ss_pred             HHHHhCCCCHHHHhhhcc
Confidence            888888888888877643

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0588|consensus

Probab=100.00  E-value=1.5e-40  Score=288.44  Aligned_cols=241  Identities=26%  Similarity=0.403  Sum_probs=205.7

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC-----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-----GLSMSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      -|+ .|+-||.|+.|.|-+|++..  +|+..|||++.+.     .....+.+|+-+|+.+.|||++++|+++  ++..++
T Consensus        13 pwk-LgkTLG~Gstg~vrlakh~~--TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw--e~~~~l   87 (786)
T KOG0588|consen   13 PWK-LGKTLGKGSTGCVRLAKHAE--TGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW--ENKQHL   87 (786)
T ss_pred             cee-ccccccCCCCceehhhhccc--ccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee--ccCceE
Confidence            355 38899999999999999877  8899999999765     2345689999999999999999999999  788899


Q ss_pred             EEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          94 WLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        94 ~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      |+|.||++ |.|.+++...+.         +++..+..+++||+.|+.|.|..+|+|+|+||+|++++    ..+.+||+
T Consensus        88 ylvlEyv~gGELFdylv~kG~---------l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd----~~~nIKIA  154 (786)
T KOG0588|consen   88 YLVLEYVPGGELFDYLVRKGP---------LPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLD----VKNNIKIA  154 (786)
T ss_pred             EEEEEecCCchhHHHHHhhCC---------CCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhh----cccCEeee
Confidence            99999997 588888886554         89999999999999999999999999999999999999    66679999


Q ss_pred             ecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---------cC
Q psy2172         173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---------KT  243 (291)
Q Consensus       173 Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---------~~  243 (291)
                      |||+|......    ....+.+|++.|.|||++.|.++.+.++||||.|++||.|++|..||.+.+...         ..
T Consensus       155 DFGMAsLe~~g----klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~  230 (786)
T KOG0588|consen  155 DFGMASLEVPG----KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFE  230 (786)
T ss_pred             ccceeecccCC----ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCccc
Confidence            99999875543    334667999999999999998878899999999999999999999999765431         11


Q ss_pred             CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         244 SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       244 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                      ..-.-....++++..|..-.|..+-+.+++..|||+.+
T Consensus       231 MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g  268 (786)
T KOG0588|consen  231 MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSG  268 (786)
T ss_pred             CCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhc
Confidence            12223466788999999899999988888888888764

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-39  Score=275.89  Aligned_cols=254  Identities=74%  Similarity=1.251  Sum_probs=207.0

Q ss_pred             cccccceeCcccceEEEEEEEccCCCCceeEEEEeCC-----CCCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEE
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEG-----TGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVW   94 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (291)
                      |.+ .+.||+|++|.||+|.++....+..||+|.+..     ......+.+|+.+++.++||||+++++++...+....+
T Consensus         2 y~~-~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           2 YEI-EGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             ceE-EEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            454 458999999999999987644678899999976     34456788899999999999999999999655457899


Q ss_pred             EEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          95 LLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        95 iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      +||||+++++.+.+........    ..+++..++.++.|++.||+|||+++++|+||+|+||+++.++...+.++|+||
T Consensus        81 lv~e~~~~~l~~~~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEHDLWQIIKFHRQAKR----VSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCcCHHHHHHhhccCCC----cCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            9999999998888765543221    238999999999999999999999999999999999999854334789999999


Q ss_pred             ccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccCCCCCcHHHHHH
Q psy2172         175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR  254 (291)
Q Consensus       175 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  254 (291)
                      |++.................++..|+|||.+.+...++.++|+||||+++++|++|++||.+.........+.....+..
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99987654332222233456788899999987755588999999999999999999999998877654555566678899


Q ss_pred             HHHhhCCCCcCChhhhhcCCCCcc
Q psy2172         255 IFSVMGFPLEKDWEDIRKMPEHPT  278 (291)
Q Consensus       255 i~~~~~~~~~~~~~~~~~~~~~~~  278 (291)
                      ++..++.+.+..|+...+++++..
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~  260 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDT  260 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchh
Confidence            999999999988888777776654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-40  Score=287.83  Aligned_cols=242  Identities=22%  Similarity=0.375  Sum_probs=187.9

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC-----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-----GLSMSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      .|++ .+.||+|+||.||+|.+..  +++.||||++...     .....+.+|+.++..++||||+++++++  .+....
T Consensus         2 ~y~~-~~~lG~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~--~~~~~~   76 (364)
T cd05599           2 DFES-IKVIGRGAFGEVRLVQKKD--TGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF--QDENYL   76 (364)
T ss_pred             CceE-EEEEEecCCEEEEEEEECC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE--EcCCeE
Confidence            3554 5799999999999999876  6788999999643     1223467899999999999999999999  567799


Q ss_pred             EEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          94 WLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        94 ~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      |+||||+.+ +|.+.+....         .+++..++.++.|++.||+|||++||+|+||||+||+++    .++.++|+
T Consensus        77 ~lv~E~~~~g~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~----~~~~~kl~  143 (364)
T cd05599          77 YLIMEYLPGGDMMTLLMKKD---------TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLD----AKGHIKLS  143 (364)
T ss_pred             EEEECCCCCcHHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC----CCCCEEEe
Confidence            999999975 7777665422         289999999999999999999999999999999999998    67899999


Q ss_pred             ecccceecCCCCCCC-----------------------------------CCCCCceecccccccccccCCcCCCCchhH
Q psy2172         173 DMGFARLFNNPLKPL-----------------------------------ADLDPVVVTFWYRAPELLLGARHYTKAIDI  217 (291)
Q Consensus       173 Dfg~~~~~~~~~~~~-----------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv  217 (291)
                      |||++..........                                   .......||+.|+|||++.+.. ++.++|+
T Consensus       144 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di  222 (364)
T cd05599         144 DFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDW  222 (364)
T ss_pred             ecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCC-CCCeeee
Confidence            999987543211000                                   0011235899999999997754 8999999


Q ss_pred             HHHHHHHHHHHcCCCCCCCCcccc------------c-CCCCCcHHHHHHHHHhhCCCCcCChhh---hhcCCCCcchh
Q psy2172         218 WAIGCIFAELLTSEPIFHCRQEDI------------K-TSNPYHHDQLDRIFSVMGFPLEKDWED---IRKMPEHPTLL  280 (291)
Q Consensus       218 ~slG~~l~~l~~g~~pf~~~~~~~------------~-~~~~~~~~~~~~i~~~~~~~~~~~~~~---~~~~~~~~~~~  280 (291)
                      |||||++|+|++|..||.+.....            . .......+...+++..|.. .|..+++   +.++..+||+.
T Consensus       223 wSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~  300 (364)
T cd05599         223 WSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFK  300 (364)
T ss_pred             ecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcC
Confidence            999999999999999998654210            0 0111224566777777665 5666665   88888888864

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-40  Score=280.47  Aligned_cols=234  Identities=26%  Similarity=0.402  Sum_probs=188.7

Q ss_pred             eCcccceEEEEEEEccCCCCceeEEEEeCCC-----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecCC
Q psy2172          27 VGRGTYGHVYKARRKDNSDTRDYALKQIEGT-----GLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAE  101 (291)
Q Consensus        27 ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~~  101 (291)
                      ||+|+||.||+|.+..  +++.||+|.++..     .....+.+|+.++++++||||+++++++  .+....|+||||+.
T Consensus         1 lg~G~~g~Vy~~~~~~--~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~~~lv~e~~~   76 (312)
T cd05585           1 IGKGSFGKVMQVRKRD--TQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF--QSPEKLYLVLAFIN   76 (312)
T ss_pred             CCcCCCeEEEEEEECC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE--ecCCeEEEEEcCCC
Confidence            6999999999999876  6788999998642     2224567899999999999999999998  56778999999998


Q ss_pred             C-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceec
Q psy2172         102 H-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF  180 (291)
Q Consensus       102 ~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~  180 (291)
                      + +|.+.+....         .+++..+..++.|++.||.|||++||+|+||||+||+++    .++.++|+|||++...
T Consensus        77 ~g~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~----~~~~~kl~Dfg~~~~~  143 (312)
T cd05585          77 GGELFHHLQREG---------RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLD----YQGHIALCDFGLCKLN  143 (312)
T ss_pred             CCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEEC----CCCcEEEEECcccccC
Confidence            5 7777765422         288999999999999999999999999999999999998    6778999999998753


Q ss_pred             CCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---------cCCCCCcHHH
Q psy2172         181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---------KTSNPYHHDQ  251 (291)
Q Consensus       181 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---------~~~~~~~~~~  251 (291)
                      ....   .......|++.|+|||.+.+.. ++.++|||||||++|+|++|..||.+.....         ..........
T Consensus       144 ~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  219 (312)
T cd05585         144 MKDD---DKTNTFCGTPEYLAPELLLGHG-YTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRD  219 (312)
T ss_pred             ccCC---CccccccCCcccCCHHHHcCCC-CCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHH
Confidence            2211   1223456899999999998754 8999999999999999999999997654321         1122334567


Q ss_pred             HHHHHHhhCCCCcCChhh---hhcCCCCcchhh
Q psy2172         252 LDRIFSVMGFPLEKDWED---IRKMPEHPTLLK  281 (291)
Q Consensus       252 ~~~i~~~~~~~~~~~~~~---~~~~~~~~~~~~  281 (291)
                      +.+++..|..+.|..|++   +.++..||++.+
T Consensus       220 ~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~  252 (312)
T cd05585         220 AKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQ  252 (312)
T ss_pred             HHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCC
Confidence            889999999999999964   566777777654

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=5e-40  Score=281.60  Aligned_cols=236  Identities=22%  Similarity=0.357  Sum_probs=189.8

Q ss_pred             ceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEec
Q psy2172          25 CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-----LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDY   99 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~   99 (291)
                      +.||+|+||.||+|.++.  +++.||+|++....     ....+.+|+.+++.++||||+++++++  .+....|+||||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--~~~~~~~lv~Ey   76 (328)
T cd05593           1 KLLGKGTFGKVILVREKA--SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF--QTKDRLCFVMEY   76 (328)
T ss_pred             CeeeeCCCEEEEEEEECC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE--EcCCEEEEEEeC
Confidence            379999999999999876  67889999986432     224577899999999999999999998  567789999999


Q ss_pred             CCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccce
Q psy2172         100 AEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR  178 (291)
Q Consensus       100 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~  178 (291)
                      +++ +|...+....         .+++..+..++.|++.||+|||++||+|+||||+||+++    .++.++|+|||++.
T Consensus        77 ~~~g~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~----~~~~~kL~DfG~~~  143 (328)
T cd05593          77 VNGGELFFHLSRER---------VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLD----KDGHIKITDFGLCK  143 (328)
T ss_pred             CCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEEC----CCCcEEEecCcCCc
Confidence            986 6665554322         288999999999999999999999999999999999998    67789999999987


Q ss_pred             ecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---------cCCCCCcH
Q psy2172         179 LFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---------KTSNPYHH  249 (291)
Q Consensus       179 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---------~~~~~~~~  249 (291)
                      ......   .......|++.|+|||.+.+.. ++.++|+|||||++|+|++|..||.......         ........
T Consensus       144 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~  219 (328)
T cd05593         144 EGITDA---ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLS  219 (328)
T ss_pred             cCCCcc---cccccccCCcCccChhhhcCCC-CCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCC
Confidence            532211   1223456899999999997754 8899999999999999999999997654321         11222345


Q ss_pred             HHHHHHHHhhCCCCcCChh-----hhhcCCCCcchhh
Q psy2172         250 DQLDRIFSVMGFPLEKDWE-----DIRKMPEHPTLLK  281 (291)
Q Consensus       250 ~~~~~i~~~~~~~~~~~~~-----~~~~~~~~~~~~~  281 (291)
                      ..+.+++..|....|..|+     ++.++..++|+..
T Consensus       220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~  256 (328)
T cd05593         220 ADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTG  256 (328)
T ss_pred             HHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence            6788899999999999886     7888888887643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2.8e-39  Score=272.52  Aligned_cols=225  Identities=41%  Similarity=0.791  Sum_probs=181.7

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC----CChhHHHHHHHHhcC---CCCCeeeEEEEEEe---C
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG----LSMSACREIALLREL---KHPNVINLISVFLS---H   88 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~---~   88 (291)
                      .|++ .+.||+|+||.||+|.+... +++.||+|.++...    ....+.+|+.+++.+   +||||+++++++..   .
T Consensus         2 ~Y~~-~~~lg~G~~g~Vy~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~   79 (290)
T cd07862           2 QYEC-VAEIGEGAYGKVFKARDLKN-GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   79 (290)
T ss_pred             Ccce-eeEeccCCCeEEEEEEEcCC-CCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence            4664 56999999999999997542 45779999886432    223566787777766   69999999998742   2


Q ss_pred             CCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCc
Q psy2172          89 NDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGR  168 (291)
Q Consensus        89 ~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~  168 (291)
                      .....+++|||++++|.+.+......       .+++..++.++.|++.||.|||++|++|+||||+||+++    .++.
T Consensus        80 ~~~~~~lv~e~~~~~l~~~~~~~~~~-------~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~----~~~~  148 (290)
T cd07862          80 RETKLTLVFEHVDQDLTTYLDKVPEP-------GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT----SSGQ  148 (290)
T ss_pred             CCCcEEEEEccCCCCHHHHHHhCCCC-------CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEc----CCCC
Confidence            34579999999999988887643221       278999999999999999999999999999999999998    6678


Q ss_pred             EEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccCCCCCc
Q psy2172         169 VKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH  248 (291)
Q Consensus       169 ~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  248 (291)
                      ++|+|||.+......    .......|+..|+|||.+.+.. ++.++|+|||||++|+|++|.+||.+...         
T Consensus       149 ~kl~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~~f~~~~~---------  214 (290)
T cd07862         149 IKLADFGLARIYSFQ----MALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSD---------  214 (290)
T ss_pred             EEEccccceEeccCC----cccccccccccccChHHHhCCC-CCCccchHHHHHHHHHHHcCCCCcCCCCH---------
Confidence            999999999765432    2223456789999999997744 88999999999999999999999998765         


Q ss_pred             HHHHHHHHHhhCCCCcCChhhh
Q psy2172         249 HDQLDRIFSVMGFPLEKDWEDI  270 (291)
Q Consensus       249 ~~~~~~i~~~~~~~~~~~~~~~  270 (291)
                      .+.+..++..++.|.+..||..
T Consensus       215 ~~~~~~i~~~~~~~~~~~~~~~  236 (290)
T cd07862         215 VDQLGKILDVIGLPGEEDWPRD  236 (290)
T ss_pred             HHHHHHHHHHhCCCChhhchhh
Confidence            3778888888888888887753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=9.8e-40  Score=278.47  Aligned_cols=235  Identities=23%  Similarity=0.380  Sum_probs=186.0

Q ss_pred             ceeCcccceEEEEEEEccCCCCceeEEEEeCCC-----CCChhHHHHHHHHhcC-CCCCeeeEEEEEEeCCCceEEEEEe
Q psy2172          25 CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-----GLSMSACREIALLREL-KHPNVINLISVFLSHNDRKVWLLFD   98 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~iv~e   98 (291)
                      +.||+|+||.||+|.+..  +++.||+|.++..     ........|..++..+ +||||+++++++  ......|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~--~~~~~~~lv~e   76 (316)
T cd05592           1 KVLGKGSFGKVMLAELKG--TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF--QTKEHLFFVME   76 (316)
T ss_pred             CeeeeCCCeEEEEEEECC--CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE--EcCCEEEEEEc
Confidence            479999999999999876  6788999998643     1223455666676654 899999999998  56778999999


Q ss_pred             cCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccc
Q psy2172          99 YAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA  177 (291)
Q Consensus        99 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~  177 (291)
                      |+++ +|...+....         .+++..+..++.|++.||.|||++||+|+||||+||+++    .++.++|+|||++
T Consensus        77 ~~~gg~L~~~~~~~~---------~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~----~~~~~kL~Dfg~a  143 (316)
T cd05592          77 YLNGGDLMFHIQSSG---------RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLD----KDGHIKIADFGMC  143 (316)
T ss_pred             CCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEEC----CCCCEEEccCcCC
Confidence            9975 7766665322         288999999999999999999999999999999999998    6778999999998


Q ss_pred             eecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc---------ccCCCCCc
Q psy2172         178 RLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED---------IKTSNPYH  248 (291)
Q Consensus       178 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~---------~~~~~~~~  248 (291)
                      .......   .......|+..|+|||.+.+.. ++.++|+|||||++|+|++|..||.+....         ........
T Consensus       144 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~  219 (316)
T cd05592         144 KENMNGE---GKASTFCGTPDYIAPEILKGQK-YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWI  219 (316)
T ss_pred             eECCCCC---CccccccCCccccCHHHHcCCC-CCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence            7543221   1223456899999999998754 889999999999999999999999876532         11223334


Q ss_pred             HHHHHHHHHhhCCCCcCChhhhh-cCCCCcchh
Q psy2172         249 HDQLDRIFSVMGFPLEKDWEDIR-KMPEHPTLL  280 (291)
Q Consensus       249 ~~~~~~i~~~~~~~~~~~~~~~~-~~~~~~~~~  280 (291)
                      ...+.+++..|....|..|++.. ++..++++.
T Consensus       220 ~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~  252 (316)
T cd05592         220 SKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFR  252 (316)
T ss_pred             CHHHHHHHHHHccCCHHHcCCChHHHHcCcccC
Confidence            56678899999999999998764 666776654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-39  Score=285.01  Aligned_cols=239  Identities=21%  Similarity=0.298  Sum_probs=190.5

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLF   97 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~   97 (291)
                      +.|.+ .++||+|+||.||+|.+..  +++.||+|...    ...+.+|+.++++++||||+++++++  ......++++
T Consensus        92 ~~y~~-~~~lg~G~~g~V~~~~d~~--~~~~vaiK~~~----~~~~~~E~~il~~l~HpnIv~~~~~~--~~~~~~~lv~  162 (391)
T PHA03212         92 AGFSI-LETFTPGAEGFAFACIDNK--TCEHVVIKAGQ----RGGTATEAHILRAINHPSIIQLKGTF--TYNKFTCLIL  162 (391)
T ss_pred             CCcEE-EEEEcCCCCeEEEEEEECC--CCCEEEEechh----hhhhHHHHHHHHhCCCCCCCCEeEEE--EECCeeEEEE
Confidence            45664 6799999999999999876  77889999754    33578899999999999999999999  4566899999


Q ss_pred             ecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccc
Q psy2172          98 DYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA  177 (291)
Q Consensus        98 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~  177 (291)
                      |++.++|...+.....         +++..++.++.|++.||.|||++||+|+||||+||+++    ..+.++|+|||++
T Consensus       163 e~~~~~L~~~l~~~~~---------l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~----~~~~vkL~DFG~a  229 (391)
T PHA03212        163 PRYKTDLYCYLAAKRN---------IAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFIN----HPGDVCLGDFGAA  229 (391)
T ss_pred             ecCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEc----CCCCEEEEeCCcc
Confidence            9999988877754321         78899999999999999999999999999999999998    6678999999998


Q ss_pred             eecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc-----------------
Q psy2172         178 RLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED-----------------  240 (291)
Q Consensus       178 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~-----------------  240 (291)
                      .......  ........||+.|+|||++.+.. ++.++|+|||||++|+|++|..||-.....                 
T Consensus       230 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~  306 (391)
T PHA03212        230 CFPVDIN--ANKYYGWAGTIATNAPELLARDP-YGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRS  306 (391)
T ss_pred             ccccccc--ccccccccCccCCCChhhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHh
Confidence            6533211  11223457899999999998754 899999999999999999998776432110                 


Q ss_pred             ------cc------------------C----CCC------CcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         241 ------IK------------------T----SNP------YHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       241 ------~~------------------~----~~~------~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                            ..                  .    ..+      .....+.+++..|....|..||++.++..+||+..
T Consensus       307 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~  381 (391)
T PHA03212        307 GTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD  381 (391)
T ss_pred             cCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence                  00                  0    000      01234677888899999999999999999998754

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.7e-39  Score=282.36  Aligned_cols=246  Identities=30%  Similarity=0.482  Sum_probs=197.3

Q ss_pred             ccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC----CChhHHHHHHHHhcCCCCCeeeEEEEEEeC
Q psy2172          13 RTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG----LSMSACREIALLRELKHPNVINLISVFLSH   88 (291)
Q Consensus        13 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   88 (291)
                      ...+.++|.+ .+.||+|+||.||+|.+..  .++.||||.+....    ....+.+|+.+++.++||||+++++++...
T Consensus        19 ~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~   95 (364)
T cd07875          19 TFTVLKRYQN-LKPIGSGAQGIVCAAYDAI--LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQ   95 (364)
T ss_pred             hhchhcceeE-EEEeecCCCeEEEEEEECC--CCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccc
Confidence            3456778885 6799999999999999766  67889999986432    234577899999999999999999987432


Q ss_pred             ----CCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCC
Q psy2172          89 ----NDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGI  164 (291)
Q Consensus        89 ----~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~  164 (291)
                          .....|+||||+++++...+...           ++...+..++.|++.||++||++||+|+||||+||+++    
T Consensus        96 ~~~~~~~~~~lv~e~~~~~l~~~~~~~-----------~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~----  160 (364)
T cd07875          96 KSLEEFQDVYIVMELMDANLCQVIQME-----------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----  160 (364)
T ss_pred             ccccccCeEEEEEeCCCCCHHHHHHhc-----------CCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEEC----
Confidence                22468999999999888776421           78888999999999999999999999999999999998    


Q ss_pred             CCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---
Q psy2172         165 ERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---  241 (291)
Q Consensus       165 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---  241 (291)
                      .++.++|+|||++......    .......++..|+|||++.+.. ++.++|||||||++|+|++|..||.+.....   
T Consensus       161 ~~~~~kL~DfG~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~  235 (364)
T cd07875         161 SDCTLKILDFGLARTAGTS----FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWN  235 (364)
T ss_pred             CCCcEEEEeCCCccccCCC----CcccCCcccCCcCCHHHHhCCC-CCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            6778999999999765432    1223456789999999998754 8999999999999999999999997643210   


Q ss_pred             ----------------------------c--------------------CCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         242 ----------------------------K--------------------TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       242 ----------------------------~--------------------~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                                                  +                    .........+.+++..|....|..||++.++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~  315 (364)
T cd07875         236 KVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA  315 (364)
T ss_pred             HHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHH
Confidence                                        0                    0000113457789999999999999999999


Q ss_pred             CCCcchhh
Q psy2172         274 PEHPTLLK  281 (291)
Q Consensus       274 ~~~~~~~~  281 (291)
                      ..|||+..
T Consensus       316 L~hp~~~~  323 (364)
T cd07875         316 LQHPYINV  323 (364)
T ss_pred             hcCccccc
Confidence            99998753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0611|consensus

Probab=100.00  E-value=5.9e-41  Score=276.45  Aligned_cols=242  Identities=26%  Similarity=0.471  Sum_probs=196.4

Q ss_pred             ccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC-----hhHHHHHHHHhcCCCCCeeeEEEEEEe
Q psy2172          13 RTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS-----MSACREIALLRELKHPNVINLISVFLS   87 (291)
Q Consensus        13 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~   87 (291)
                      .-.+.-+|++ .+.||+|.||.|-+|....  .++.||||.++++...     ..+.+|++||..|+||||+++|.+|  
T Consensus        48 khnlkHRyE~-~etLGkGTYGKVk~A~e~~--sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF--  122 (668)
T KOG0611|consen   48 KHNLKHRYEI-TETLGKGTYGKVKLAYEHK--SGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF--  122 (668)
T ss_pred             ccchhhHHHH-HHHhcCCcccceeehhhcc--CCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh--
Confidence            3445567775 6799999999999999655  8899999999866443     3578999999999999999999999  


Q ss_pred             CCCceEEEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCC
Q psy2172          88 HNDRKVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIER  166 (291)
Q Consensus        88 ~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~  166 (291)
                      ++.+.+.+||||.. |.|.+++...+.         +++..++.+++||++|+.|.|+++++|+|||.+|||++    .+
T Consensus       123 ENkdKIvivMEYaS~GeLYDYiSer~~---------LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD----~N  189 (668)
T KOG0611|consen  123 ENKDKIVIVMEYASGGELYDYISERGS---------LSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLD----QN  189 (668)
T ss_pred             cCCceEEEEEEecCCccHHHHHHHhcc---------ccHHHHHHHHHHHHHHHHHHhhccceecccchhheeec----CC
Confidence            88999999999997 599999987665         99999999999999999999999999999999999999    78


Q ss_pred             CcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc----
Q psy2172         167 GRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK----  242 (291)
Q Consensus       167 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~----  242 (291)
                      +.+||+|||++-.+...    .-..+.+|++.|.+||+..|.+.-++..|-||||++||-+..|.+||.|.+....    
T Consensus       190 ~NiKIADFGLSNly~~~----kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQI  265 (668)
T KOG0611|consen  190 NNIKIADFGLSNLYADK----KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQI  265 (668)
T ss_pred             CCeeeeccchhhhhccc----cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHh
Confidence            89999999999776543    2235679999999999999988778999999999999999999999999876421    


Q ss_pred             ----CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCC
Q psy2172         243 ----TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEH  276 (291)
Q Consensus       243 ----~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  276 (291)
                          +..|.......-+++-|..-+|..+.+++++..|
T Consensus       266 s~GaYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  266 SRGAYREPETPSDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             hcccccCCCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence                1122222223334444455555555555555443

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=8.1e-40  Score=285.88  Aligned_cols=243  Identities=23%  Similarity=0.344  Sum_probs=186.6

Q ss_pred             cccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEE
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-----LSMSACREIALLRELKHPNVINLISVFLSHNDRKVW   94 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (291)
                      |+ ..+.||+|+||.||+|.++.  +++.||+|++....     ....+.+|+.+++.++||||+++++++  .+....|
T Consensus         3 f~-~~~~LG~G~~g~Vy~~~~~~--~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~--~~~~~~~   77 (381)
T cd05626           3 FV-KIKTLGIGAFGEVCLACKVD--THALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSF--QDKDNLY   77 (381)
T ss_pred             ce-EEEEEeecCCEEEEEEEECC--CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEE--ecCCEEE
Confidence            44 36799999999999999876  67889999996432     223578899999999999999999999  5677899


Q ss_pred             EEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEee
Q psy2172          95 LLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIAD  173 (291)
Q Consensus        95 iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~D  173 (291)
                      +||||+++ +|.+.+....         .+++..++.++.|++.||.|||+.||+|+||||+||+++    ..+.++|+|
T Consensus        78 lv~E~~~gg~L~~~l~~~~---------~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~----~~~~~kL~D  144 (381)
T cd05626          78 FVMDYIPGGDMMSLLIRME---------VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILID----LDGHIKLTD  144 (381)
T ss_pred             EEEecCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEEC----CCCCEEEee
Confidence            99999975 7777765432         288999999999999999999999999999999999998    667999999


Q ss_pred             cccceecCCCCC--------------------------------------------CCCCCCCceecccccccccccCCc
Q psy2172         174 MGFARLFNNPLK--------------------------------------------PLADLDPVVVTFWYRAPELLLGAR  209 (291)
Q Consensus       174 fg~~~~~~~~~~--------------------------------------------~~~~~~~~~g~~~y~aPE~~~~~~  209 (291)
                      ||++........                                            .........||..|+|||.+.+..
T Consensus       145 FGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~  224 (381)
T cd05626         145 FGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG  224 (381)
T ss_pred             CcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCC
Confidence            998754321000                                            000012346899999999998744


Q ss_pred             CCCCchhHHHHHHHHHHHHcCCCCCCCCcccc-----------cCCC--CCcHHHHHHHHHhhCC--CCcCChhhhhcCC
Q psy2172         210 HYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI-----------KTSN--PYHHDQLDRIFSVMGF--PLEKDWEDIRKMP  274 (291)
Q Consensus       210 ~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~-----------~~~~--~~~~~~~~~i~~~~~~--~~~~~~~~~~~~~  274 (291)
                       ++.++|||||||++|+|++|..||.......           ....  ........+++..+..  +.+..++++.++.
T Consensus       225 -~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l  303 (381)
T cd05626         225 -YTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIK  303 (381)
T ss_pred             -CCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence             8899999999999999999999997655321           0011  1124556666666443  3333488999999


Q ss_pred             CCcchhh
Q psy2172         275 EHPTLLK  281 (291)
Q Consensus       275 ~~~~~~~  281 (291)
                      .||++..
T Consensus       304 ~hp~f~~  310 (381)
T cd05626         304 AHPFFSE  310 (381)
T ss_pred             cCcccCC
Confidence            9988754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.3e-39  Score=274.49  Aligned_cols=242  Identities=36%  Similarity=0.606  Sum_probs=195.2

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC---CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT---GLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWL   95 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~i   95 (291)
                      .|.+ .++||+|+||.||+|.++.  +++.||+|.++..   .....+.+|+.+++.++||||+++++++  ......++
T Consensus         7 ~y~~-~~~lg~g~~g~vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~--~~~~~~~l   81 (301)
T cd07873           7 TYIK-LDKLGEGTYATVYKGRSKL--TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII--HTEKSLTL   81 (301)
T ss_pred             ceEE-eeEeccCcCEEEEEEEEcC--CCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEE--ecCCeEEE
Confidence            4554 5699999999999999776  6788999998633   2234677899999999999999999999  55678999


Q ss_pred             EEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecc
Q psy2172          96 LFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMG  175 (291)
Q Consensus        96 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg  175 (291)
                      ||||++++|.+.+.....        .+++..+..++.|++.||++||++|++|+||||+||+++    .++.++|+|||
T Consensus        82 v~e~~~~~l~~~l~~~~~--------~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~----~~~~~kl~dfg  149 (301)
T cd07873          82 VFEYLDKDLKQYLDDCGN--------SINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLIN----ERGELKLADFG  149 (301)
T ss_pred             EEeccccCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEEC----CCCcEEECcCc
Confidence            999999988877764322        278899999999999999999999999999999999998    66789999999


Q ss_pred             cceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc--------------
Q psy2172         176 FARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI--------------  241 (291)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~--------------  241 (291)
                      .+........   ......++..|+|||.+.+...++.++||||||+++|+|++|.+||.+.+...              
T Consensus       150 ~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~  226 (301)
T cd07873         150 LARAKSIPTK---TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTE  226 (301)
T ss_pred             chhccCCCCC---cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence            9875433211   12234568889999998765558889999999999999999999997654210              


Q ss_pred             -----------------cC--------CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchh
Q psy2172         242 -----------------KT--------SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLL  280 (291)
Q Consensus       242 -----------------~~--------~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  280 (291)
                                       +.        ..+.....+.+++..|..+.|..||++.++..++|+.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~  290 (301)
T cd07873         227 ETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFH  290 (301)
T ss_pred             hhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence                             00        0112245577899999999999999999999999984

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.6e-39  Score=277.60  Aligned_cols=242  Identities=24%  Similarity=0.376  Sum_probs=196.4

Q ss_pred             ccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC---CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG---LSMSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      .+.|++ .+.||+|+||.||++.+..  ++..+|+|.+....   ....+.+|+++++.++||||+++++++.  +....
T Consensus         4 ~~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~   78 (331)
T cd06649           4 DDDFER-ISELGAGNGGVVTKVQHKP--SGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY--SDGEI   78 (331)
T ss_pred             cccceE-EEeecCCCCEEEEEEEECC--CCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE--ECCEE
Confidence            356664 6799999999999999876  67889999987542   2346889999999999999999999984  46689


Q ss_pred             EEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CeeeeccCCCcEEeecCCCCCCcEEE
Q psy2172          94 WLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSN-WVLHRDLKPANILVMGEGIERGRVKI  171 (291)
Q Consensus        94 ~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~-~ivH~dik~~Nil~~~~~~~~~~~~l  171 (291)
                      ++||||+++ +|.+.+....         .+++..+..++.|++.||.|||++ +++|+||||+||+++    .++.++|
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~----~~~~~kl  145 (331)
T cd06649          79 SICMEHMDGGSLDQVLKEAK---------RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVN----SRGEIKL  145 (331)
T ss_pred             EEEeecCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEc----CCCcEEE
Confidence            999999986 7877765432         188999999999999999999986 699999999999998    6678999


Q ss_pred             eecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc----------
Q psy2172         172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI----------  241 (291)
Q Consensus       172 ~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~----------  241 (291)
                      +|||++......     ......|+..|+|||.+.+.. ++.++|+|||||++|+|++|+.||.......          
T Consensus       146 ~Dfg~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~  219 (331)
T cd06649         146 CDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVV  219 (331)
T ss_pred             ccCccccccccc-----ccccCCCCcCcCCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccccc
Confidence            999998755332     123346789999999998754 8999999999999999999999996532100          


Q ss_pred             -----------------------------------------------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCC
Q psy2172         242 -----------------------------------------------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMP  274 (291)
Q Consensus       242 -----------------------------------------------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  274 (291)
                                                                     ..........+.+++..|....|.+||++.++.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell  299 (331)
T cd06649         220 DGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLM  299 (331)
T ss_pred             ccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHh
Confidence                                                           000112346688999999999999999999999


Q ss_pred             CCcchhhh
Q psy2172         275 EHPTLLKD  282 (291)
Q Consensus       275 ~~~~~~~~  282 (291)
                      .++|+.+.
T Consensus       300 ~h~~~~~~  307 (331)
T cd06649         300 NHTFIKRS  307 (331)
T ss_pred             cChHHhhc
Confidence            99987654

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.5e-39  Score=271.46  Aligned_cols=238  Identities=23%  Similarity=0.326  Sum_probs=189.7

Q ss_pred             eCcccceEEEEEEEccCCCCceeEEEEeCCCCC-----ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecCC
Q psy2172          27 VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-----SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAE  101 (291)
Q Consensus        27 ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~~  101 (291)
                      ||+|+||.||+|.++.  +++.+|+|.+.....     ...+..|+.+++.++|+||+++.+++  ......|++|||++
T Consensus         1 lg~G~~g~Vy~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~--~~~~~~~lv~e~~~   76 (280)
T cd05608           1 LGKGGFGEVSACQMRA--TGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF--QTKTDLCLVMTIMN   76 (280)
T ss_pred             CCCCCceeEEEEEEcc--CCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE--cCCCeEEEEEeCCC
Confidence            6999999999999876  678899999864321     23567899999999999999999998  56678999999997


Q ss_pred             C-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceec
Q psy2172         102 H-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF  180 (291)
Q Consensus       102 ~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~  180 (291)
                      + +|...+......     ...+++..++.++.|++.||.|||++|++|+||||+||+++    .++.++|+|||.+...
T Consensus        77 ~g~L~~~~~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~----~~~~~~l~dfg~~~~~  147 (280)
T cd05608          77 GGDLRYHIYNVDEE-----NPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLD----NDGNVRISDLGLAVEL  147 (280)
T ss_pred             CCCHHHHHHhcccc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEEeeCccceec
Confidence            5 666655432211     12389999999999999999999999999999999999998    6678999999998765


Q ss_pred             CCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc-------------cCCCCC
Q psy2172         181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI-------------KTSNPY  247 (291)
Q Consensus       181 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~-------------~~~~~~  247 (291)
                      .....   ......|+..|+|||.+.+.. ++.++|+||||+++|+|++|..||.......             ......
T Consensus       148 ~~~~~---~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (280)
T cd05608         148 KDGQS---KTKGYAGTPGFMAPELLQGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDK  223 (280)
T ss_pred             CCCCc---cccccCCCcCccCHHHhcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCccc
Confidence            43211   123346788999999998754 8899999999999999999999998653211             111223


Q ss_pred             cHHHHHHHHHhhCCCCcCChh-----hhhcCCCCcchhh
Q psy2172         248 HHDQLDRIFSVMGFPLEKDWE-----DIRKMPEHPTLLK  281 (291)
Q Consensus       248 ~~~~~~~i~~~~~~~~~~~~~-----~~~~~~~~~~~~~  281 (291)
                      ....+.+++..|....|..|+     +++++..+||+..
T Consensus       224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~  262 (280)
T cd05608         224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRD  262 (280)
T ss_pred             CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhc
Confidence            456788999999999999999     5677888888754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.7e-39  Score=277.46  Aligned_cols=235  Identities=23%  Similarity=0.334  Sum_probs=188.2

Q ss_pred             ceeCcccceEEEEEEEccCCCCceeEEEEeCCC-----CCChhHHHHHHHHhcC-CCCCeeeEEEEEEeCCCceEEEEEe
Q psy2172          25 CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-----GLSMSACREIALLREL-KHPNVINLISVFLSHNDRKVWLLFD   98 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~iv~e   98 (291)
                      +.||+|+||.||+|.++.  +++.||+|+++..     .....+..|..++..+ +||||+++++++  .+....|+|||
T Consensus         1 ~~lg~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~--~~~~~~~iv~E   76 (320)
T cd05590           1 RVLGKGSFGKVMLARLKE--SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF--QTPDRLFFVME   76 (320)
T ss_pred             CeeeeCCCeEEEEEEEcC--CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE--EcCCEEEEEEc
Confidence            479999999999999876  6788999998643     2234566788888876 699999999999  56778999999


Q ss_pred             cCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccc
Q psy2172          99 YAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA  177 (291)
Q Consensus        99 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~  177 (291)
                      |+++ +|...+....         .+++..++.++.|++.||+|||++|++|+||||+||+++    .++.++|+|||++
T Consensus        77 y~~~g~L~~~i~~~~---------~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~----~~~~~kL~DfG~~  143 (320)
T cd05590          77 FVNGGDLMFHIQKSR---------RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLD----HEGHCKLADFGMC  143 (320)
T ss_pred             CCCCchHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEEC----CCCcEEEeeCCCC
Confidence            9985 7766654332         188999999999999999999999999999999999998    6678999999998


Q ss_pred             eecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---------cCCCCCc
Q psy2172         178 RLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---------KTSNPYH  248 (291)
Q Consensus       178 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---------~~~~~~~  248 (291)
                      .......   .......|++.|+|||.+.+.. ++.++|+|||||++|+|++|..||.+.....         .......
T Consensus       144 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  219 (320)
T cd05590         144 KEGIFNG---KTTSTFCGTPDYIAPEILQEML-YGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWL  219 (320)
T ss_pred             eecCcCC---CcccccccCccccCHHHHcCCC-CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Confidence            7532211   1223456899999999998744 8899999999999999999999998765321         1122234


Q ss_pred             HHHHHHHHHhhCCCCcCChhhh------hcCCCCcchh
Q psy2172         249 HDQLDRIFSVMGFPLEKDWEDI------RKMPEHPTLL  280 (291)
Q Consensus       249 ~~~~~~i~~~~~~~~~~~~~~~------~~~~~~~~~~  280 (291)
                      ...+.++++.|....|..|++.      +++..|||+.
T Consensus       220 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~  257 (320)
T cd05590         220 SQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFK  257 (320)
T ss_pred             CHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcC
Confidence            5678889999999999999887      6667777764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.6e-39  Score=277.11  Aligned_cols=236  Identities=22%  Similarity=0.329  Sum_probs=188.1

Q ss_pred             ceeCcccceEEEEEEEccCCCCceeEEEEeCCC-----CCChhHHHHHHHHhcC-CCCCeeeEEEEEEeCCCceEEEEEe
Q psy2172          25 CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-----GLSMSACREIALLREL-KHPNVINLISVFLSHNDRKVWLLFD   98 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~iv~e   98 (291)
                      +.||+|+||.||+|.++.  +++.||+|.++..     ........|..++... +||+|+++++++  .+....|+|||
T Consensus         1 ~~lg~G~~g~V~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~--~~~~~~~lv~E   76 (316)
T cd05620           1 KVLGKGSFGKVLLAELKG--KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF--QTKEHLFFVME   76 (316)
T ss_pred             CeeeeCCCeEEEEEEECC--CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE--EeCCEEEEEEC
Confidence            479999999999999876  6788999998643     2233466777787755 899999999999  56779999999


Q ss_pred             cCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccc
Q psy2172          99 YAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA  177 (291)
Q Consensus        99 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~  177 (291)
                      |+.+ +|...+....         .+++..+..++.|++.||+|||++|++|+||||+||+++    .++.++|+|||++
T Consensus        77 ~~~~g~L~~~i~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~----~~~~~kl~Dfg~~  143 (316)
T cd05620          77 FLNGGDLMFHIQDKG---------RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLD----RDGHIKIADFGMC  143 (316)
T ss_pred             CCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC----CCCCEEeCccCCC
Confidence            9985 7776665322         288999999999999999999999999999999999998    6678999999998


Q ss_pred             eecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---------cCCCCCc
Q psy2172         178 RLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---------KTSNPYH  248 (291)
Q Consensus       178 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---------~~~~~~~  248 (291)
                      .......   .......|+..|+|||++.+.. ++.++|+|||||++|+|++|..||.+.....         .......
T Consensus       144 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  219 (316)
T cd05620         144 KENVFGD---NRASTFCGTPDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWI  219 (316)
T ss_pred             eecccCC---CceeccCCCcCccCHHHHcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCC
Confidence            6432111   1223456899999999998754 8999999999999999999999998765321         1222334


Q ss_pred             HHHHHHHHHhhCCCCcCChhhh-hcCCCCcchhh
Q psy2172         249 HDQLDRIFSVMGFPLEKDWEDI-RKMPEHPTLLK  281 (291)
Q Consensus       249 ~~~~~~i~~~~~~~~~~~~~~~-~~~~~~~~~~~  281 (291)
                      ...+.+++..|....|..|+++ .++..||++..
T Consensus       220 ~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~  253 (316)
T cd05620         220 TKESKDILEKLFERDPTRRLGVVGNIRGHPFFKT  253 (316)
T ss_pred             CHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCC
Confidence            5678889999999999999987 46777777644

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.2e-39  Score=278.65  Aligned_cols=235  Identities=23%  Similarity=0.328  Sum_probs=188.0

Q ss_pred             ceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-----CChhHHHHHHHHhcC-CCCCeeeEEEEEEeCCCceEEEEEe
Q psy2172          25 CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-----LSMSACREIALLREL-KHPNVINLISVFLSHNDRKVWLLFD   98 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~iv~e   98 (291)
                      ++||+|+||.||+|.++.  +++.||+|+++...     ....+..|..++..+ +||||+++++++  .+....|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~--~~~~~~~lv~E   76 (321)
T cd05591           1 KVLGKGSFGKVMLAELKG--TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF--QTKDRLFFVME   76 (321)
T ss_pred             CccccCCCeEEEEEEECC--CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEE--EcCCeEEEEEe
Confidence            469999999999999876  67889999987432     223466788888866 799999999999  56678999999


Q ss_pred             cCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccc
Q psy2172          99 YAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA  177 (291)
Q Consensus        99 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~  177 (291)
                      |+++ +|...+....         .+++..+..++.|++.||+|||++|++|+||||+||+++    .++.++|+|||++
T Consensus        77 ~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~----~~~~~kL~Dfg~~  143 (321)
T cd05591          77 YVNGGDLMFQIQRSR---------KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLD----AEGHCKLADFGMC  143 (321)
T ss_pred             CCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC----CCCCEEEeecccc
Confidence            9985 7766665332         188899999999999999999999999999999999998    6779999999998


Q ss_pred             eecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---------cCCCCCc
Q psy2172         178 RLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---------KTSNPYH  248 (291)
Q Consensus       178 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---------~~~~~~~  248 (291)
                      .......   .......|+..|+|||++.+.. ++.++|+|||||++|+|++|..||.+.....         .......
T Consensus       144 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~  219 (321)
T cd05591         144 KEGILNG---VTTTTFCGTPDYIAPEILQELE-YGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWL  219 (321)
T ss_pred             eecccCC---ccccccccCccccCHHHHcCCC-CCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence            7533221   1223456899999999997744 8899999999999999999999998765321         1122223


Q ss_pred             HHHHHHHHHhhCCCCcCChh-------hhhcCCCCcchh
Q psy2172         249 HDQLDRIFSVMGFPLEKDWE-------DIRKMPEHPTLL  280 (291)
Q Consensus       249 ~~~~~~i~~~~~~~~~~~~~-------~~~~~~~~~~~~  280 (291)
                      ...+.+++..|..+.|..|+       ++.++..+|++.
T Consensus       220 ~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~  258 (321)
T cd05591         220 SKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFK  258 (321)
T ss_pred             CHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccC
Confidence            56788899999999999998       677777887764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.9e-39  Score=277.59  Aligned_cols=237  Identities=24%  Similarity=0.414  Sum_probs=190.0

Q ss_pred             ceeCcccceEEEEEEEcc-CCCCceeEEEEeCCC------CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEE
Q psy2172          25 CKVGRGTYGHVYKARRKD-NSDTRDYALKQIEGT------GLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLF   97 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~-~~~~~~vaiK~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~   97 (291)
                      ++||+|+||.||+|.+.. ...++.||+|+++..      .....+.+|+.+++.++||||+++++++  ......|++|
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~--~~~~~~~lv~   79 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAF--QTGGKLYLIL   79 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEE--ecCCeEEEEE
Confidence            589999999999998743 346788999998642      1223567899999999999999999998  4567899999


Q ss_pred             ecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeeccc
Q psy2172          98 DYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGF  176 (291)
Q Consensus        98 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~  176 (291)
                      ||+.+ +|.+.+....         .+++..+..++.|++.||+|||++|++|+||||+||+++    .++.++|+|||+
T Consensus        80 e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~----~~~~~kl~Dfg~  146 (323)
T cd05584          80 EYLSGGELFMHLEREG---------IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLD----AQGHVKLTDFGL  146 (323)
T ss_pred             eCCCCchHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC----CCCCEEEeeCcC
Confidence            99986 7766664322         278888999999999999999999999999999999998    677999999999


Q ss_pred             ceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc---------ccCCCCC
Q psy2172         177 ARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED---------IKTSNPY  247 (291)
Q Consensus       177 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~---------~~~~~~~  247 (291)
                      +.......   .......|+..|+|||++.+.. ++.++||||||+++|+|++|..||.+....         .....+.
T Consensus       147 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~  222 (323)
T cd05584         147 CKESIHEG---TVTHTFCGTIEYMAPEILMRSG-HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPY  222 (323)
T ss_pred             CeecccCC---CcccccCCCccccChhhccCCC-CCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            87432211   1223356899999999998754 789999999999999999999999875431         1122333


Q ss_pred             cHHHHHHHHHhhCCCCcCChh-----hhhcCCCCcchh
Q psy2172         248 HHDQLDRIFSVMGFPLEKDWE-----DIRKMPEHPTLL  280 (291)
Q Consensus       248 ~~~~~~~i~~~~~~~~~~~~~-----~~~~~~~~~~~~  280 (291)
                      ....+.+++..|..+.|..|+     ++.++..+|++.
T Consensus       223 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~  260 (323)
T cd05584         223 LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFR  260 (323)
T ss_pred             CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcC
Confidence            456788999999999999998     788888888764

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.6e-39  Score=283.28  Aligned_cols=241  Identities=32%  Similarity=0.521  Sum_probs=192.9

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCC----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCC---ceEEEE
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG----LSMSACREIALLRELKHPNVINLISVFLSHND---RKVWLL   96 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~~~~iv   96 (291)
                      .+.||+|+||.||+|.+..  +++.||+|.+....    ....+.+|+.+++.++|+||+++++++...+.   ...|+|
T Consensus         5 ~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv   82 (372)
T cd07853           5 DRPIGYGAFGVVWSVTDPR--DGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVV   82 (372)
T ss_pred             cceeeeCCCEEEEEEEECC--CCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEE
Confidence            6799999999999999766  67889999986432    22467889999999999999999999843221   278999


Q ss_pred             EecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeeccc
Q psy2172          97 FDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGF  176 (291)
Q Consensus        97 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~  176 (291)
                      +||+.++|...+....         .+++..++.++.|++.||+|||++|++|+||||+||+++    .++.++|+|||+
T Consensus        83 ~e~~~~~l~~~~~~~~---------~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~----~~~~~kL~Dfg~  149 (372)
T cd07853          83 TELMQSDLHKIIVSPQ---------PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVN----SNCVLKICDFGL  149 (372)
T ss_pred             eeccccCHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEEC----CCCCEEeccccc
Confidence            9999998887765322         288999999999999999999999999999999999998    677999999999


Q ss_pred             ceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---------------
Q psy2172         177 ARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---------------  241 (291)
Q Consensus       177 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---------------  241 (291)
                      +........  .......++..|+|||.+.+...++.++||||+||++|+|++|+.||.+.....               
T Consensus       150 a~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~  227 (372)
T cd07853         150 ARVEEPDES--KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLE  227 (372)
T ss_pred             eeecccCcc--ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence            976543211  122334568889999999876668899999999999999999999997654210               


Q ss_pred             ----------------c----------CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         242 ----------------K----------TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       242 ----------------~----------~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                                      .          .......+.+.+++..|....|..||++.++..+||+..
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  293 (372)
T cd07853         228 AMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE  293 (372)
T ss_pred             HHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence                            0          001112345678888999999999999999999988764

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-40  Score=284.65  Aligned_cols=243  Identities=24%  Similarity=0.403  Sum_probs=194.8

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC-----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-----GLSMSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      .|.+ .+.||+|+||.||+|.+..  +++.||+|+++..     .....+.+|+.++..++||||+++++++  .+....
T Consensus         2 ~y~~-~~~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~--~~~~~~   76 (350)
T cd05573           2 DFEV-IKVIGRGAFGEVWLVRDKD--TGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF--QDEEHL   76 (350)
T ss_pred             CceE-EEEEEeCCcEEEEEEEECC--CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe--ecCCeE
Confidence            4554 6799999999999999876  6788999998643     2234578899999999999999999998  567799


Q ss_pred             EEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          94 WLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        94 ~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      |+||||+.+ +|.+.+....         .+++..++.++.|++.||++||++|++|+||||+||+++    .++.++|+
T Consensus        77 ~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~----~~~~~kL~  143 (350)
T cd05573          77 YLVMEYMPGGDLMNLLIRKD---------VFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILID----ADGHIKLA  143 (350)
T ss_pred             EEEEcCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC----CCCCEEee
Confidence            999999975 8877776441         289999999999999999999999999999999999998    67899999


Q ss_pred             ecccceecCCCCC--------------------------CCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHH
Q psy2172         173 DMGFARLFNNPLK--------------------------PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAE  226 (291)
Q Consensus       173 Dfg~~~~~~~~~~--------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~  226 (291)
                      |||++........                          .........|+..|+|||++.+. .++.++|||||||++|+
T Consensus       144 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~e  222 (350)
T cd05573         144 DFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYE  222 (350)
T ss_pred             cCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhh
Confidence            9999876544320                          01122345789999999999875 48999999999999999


Q ss_pred             HHcCCCCCCCCcccc-------------cCCCCCcHHHHHHHHHhhCCCCcCChhh-hhcCCCCcchhh
Q psy2172         227 LLTSEPIFHCRQEDI-------------KTSNPYHHDQLDRIFSVMGFPLEKDWED-IRKMPEHPTLLK  281 (291)
Q Consensus       227 l~~g~~pf~~~~~~~-------------~~~~~~~~~~~~~i~~~~~~~~~~~~~~-~~~~~~~~~~~~  281 (291)
                      |++|+.||.......             ..........+.+++..|.. .|..|++ +.++..+|++.+
T Consensus       223 ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~  290 (350)
T cd05573         223 MLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG  290 (350)
T ss_pred             hccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence            999999998765311             01111125667788887776 7788888 999999988753

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.1e-39  Score=283.48  Aligned_cols=244  Identities=23%  Similarity=0.374  Sum_probs=189.4

Q ss_pred             ccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC-----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCc
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-----GLSMSACREIALLRELKHPNVINLISVFLSHNDR   91 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (291)
                      .+.|++ .+.||+|+||.||+|.++.  +++.+|+|++...     .....+.+|+.+++.++||||+++++++  .+..
T Consensus        42 ~~~y~~-~~~lG~G~fg~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~--~~~~  116 (370)
T cd05621          42 AEDYDV-VKVIGRGAFGEVQLVRHKS--SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF--QDDK  116 (370)
T ss_pred             HHHCeE-EEEEEecCCeEEEEEEECC--CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE--EcCC
Confidence            355664 5699999999999999876  6788999998632     1233477899999999999999999999  5677


Q ss_pred             eEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEE
Q psy2172          92 KVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVK  170 (291)
Q Consensus        92 ~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~  170 (291)
                      ..|+||||+++ +|.+++....          +++..+..++.|++.||++||++||+|+||||+||+++    .++.++
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~~~~----------~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~----~~~~~k  182 (370)
T cd05621         117 YLYMVMEYMPGGDLVNLMSNYD----------VPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLD----KHGHLK  182 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC----CCCCEE
Confidence            99999999975 8887775321          78899999999999999999999999999999999998    678999


Q ss_pred             EeecccceecCCCCCCCCCCCCceecccccccccccCCc---CCCCchhHHHHHHHHHHHHcCCCCCCCCccc-------
Q psy2172         171 IADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGAR---HYTKAIDIWAIGCIFAELLTSEPIFHCRQED-------  240 (291)
Q Consensus       171 l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~-------  240 (291)
                      |+|||++........  .......||+.|+|||++.+.+   .++.++|+||+||++|+|++|..||.+....       
T Consensus       183 L~DFG~a~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~  260 (370)
T cd05621         183 LADFGTCMKMDETGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM  260 (370)
T ss_pred             EEecccceecccCCc--eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            999999986543211  1223457899999999986532   3788999999999999999999999865421       


Q ss_pred             -----cc-CCCCCcHHHHHHHHHhhCCCCc--CChhhhhcCCCCcchhh
Q psy2172         241 -----IK-TSNPYHHDQLDRIFSVMGFPLE--KDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       241 -----~~-~~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~~~~~~~~~~  281 (291)
                           .. ...........+++..+....+  ..++++.++..|||+..
T Consensus       261 ~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~  309 (370)
T cd05621         261 DHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN  309 (370)
T ss_pred             hCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence                 00 0111224456666666654333  23778888888888754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.7e-39  Score=282.55  Aligned_cols=243  Identities=22%  Similarity=0.352  Sum_probs=192.0

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC-----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCce
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-----GLSMSACREIALLRELKHPNVINLISVFLSHNDRK   92 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (291)
                      +.|.+ .++||+|+||.||+|.++.  +++.||+|+++..     .....+.+|+.+++.++||||+++++++  .+...
T Consensus        43 ~~y~~-~~~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~--~~~~~  117 (370)
T cd05596          43 EDFDV-IKVIGRGAFGEVQLVRHKS--SKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF--QDDKY  117 (370)
T ss_pred             HHcEE-EEEEeeCCCEEEEEEEECC--CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE--ecCCE
Confidence            44554 5799999999999999876  6788999998632     2223467899999999999999999998  56779


Q ss_pred             EEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEE
Q psy2172          93 VWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI  171 (291)
Q Consensus        93 ~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l  171 (291)
                      .|+||||+++ +|.+++....          +++..+..++.|++.||+|||++||+|+||||+||+++    .++.++|
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~~~----------l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~----~~~~~kL  183 (370)
T cd05596         118 LYMVMEYMPGGDLVNLMSNYD----------IPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD----KSGHLKL  183 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEc----CCCCEEE
Confidence            9999999975 7777664321          78889999999999999999999999999999999998    6789999


Q ss_pred             eecccceecCCCCCCCCCCCCceecccccccccccCCc---CCCCchhHHHHHHHHHHHHcCCCCCCCCccc--------
Q psy2172         172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGAR---HYTKAIDIWAIGCIFAELLTSEPIFHCRQED--------  240 (291)
Q Consensus       172 ~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~--------  240 (291)
                      +|||.+........  .......|++.|+|||.+.+..   .++.++|+|||||++|+|++|..||.+....        
T Consensus       184 ~DfG~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  261 (370)
T cd05596         184 ADFGTCMKMDANGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMD  261 (370)
T ss_pred             EeccceeeccCCCc--ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHc
Confidence            99999876543211  1223457899999999986532   3788999999999999999999999875431        


Q ss_pred             ----cc-CCCCCcHHHHHHHHHhhCCCCcCC--hhhhhcCCCCcchhh
Q psy2172         241 ----IK-TSNPYHHDQLDRIFSVMGFPLEKD--WEDIRKMPEHPTLLK  281 (291)
Q Consensus       241 ----~~-~~~~~~~~~~~~i~~~~~~~~~~~--~~~~~~~~~~~~~~~  281 (291)
                          .. ......+..+.+++..|....|..  ++++.++..||++..
T Consensus       262 ~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~  309 (370)
T cd05596         262 HKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN  309 (370)
T ss_pred             CCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence                00 111123566777888777666655  889999999988754

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-40  Score=286.21  Aligned_cols=243  Identities=22%  Similarity=0.326  Sum_probs=184.7

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-----LSMSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      .|.+ .++||+|+||.||+|.++.  +++.||+|.+....     ....+.+|+.+++.++||||+++++++  .+....
T Consensus         2 ~y~~-~~~lG~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~--~~~~~~   76 (377)
T cd05629           2 DFHT-VKVIGKGAFGEVRLVQKKD--TGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF--QDAQYL   76 (377)
T ss_pred             CceE-eEEEeecCCEEEEEEEECC--CCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE--EcCCee
Confidence            3553 5799999999999999876  67889999985421     224577899999999999999999999  567799


Q ss_pred             EEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          94 WLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        94 ~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      |+||||+++ +|.+.+....         .+++..++.++.|++.||+|||++||+|+||||+||+++    .++.++|+
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~----~~~~~kl~  143 (377)
T cd05629          77 YLIMEFLPGGDLMTMLIKYD---------TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILID----RGGHIKLS  143 (377)
T ss_pred             EEEEeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEC----CCCCEEEe
Confidence            999999974 7877765432         288999999999999999999999999999999999998    67789999


Q ss_pred             ecccceecCCCCCC------------C--------------------------------CCCCCceecccccccccccCC
Q psy2172         173 DMGFARLFNNPLKP------------L--------------------------------ADLDPVVVTFWYRAPELLLGA  208 (291)
Q Consensus       173 Dfg~~~~~~~~~~~------------~--------------------------------~~~~~~~g~~~y~aPE~~~~~  208 (291)
                      |||++.........            .                                .......||+.|+|||++.+.
T Consensus       144 DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  223 (377)
T cd05629         144 DFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ  223 (377)
T ss_pred             ecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC
Confidence            99998633210000            0                                000124689999999999774


Q ss_pred             cCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc-----------cCCC--CCcHHHHHHHHHhhCCCCcCC--hhhhhcC
Q psy2172         209 RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI-----------KTSN--PYHHDQLDRIFSVMGFPLEKD--WEDIRKM  273 (291)
Q Consensus       209 ~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~-----------~~~~--~~~~~~~~~i~~~~~~~~~~~--~~~~~~~  273 (291)
                      . ++.++|+|||||++|+|++|..||.+.....           ....  ......+.+++..|....+..  ++++.++
T Consensus       224 ~-~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~~~~~r~~r~~~~~~  302 (377)
T cd05629         224 G-YGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEI  302 (377)
T ss_pred             C-CCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHH
Confidence            4 8999999999999999999999997654321           0000  112345667777665422222  5688888


Q ss_pred             CCCcchh
Q psy2172         274 PEHPTLL  280 (291)
Q Consensus       274 ~~~~~~~  280 (291)
                      ..+||+.
T Consensus       303 l~hp~~~  309 (377)
T cd05629         303 KSHPFFR  309 (377)
T ss_pred             hcCCCcC
Confidence            8888765

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0610|consensus

Probab=100.00  E-value=3.4e-39  Score=266.40  Aligned_cols=242  Identities=23%  Similarity=0.323  Sum_probs=188.8

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC-----ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEe
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-----SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFD   98 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e   98 (291)
                      -+.||+|.-|.||+|+.++  ++..+|+|++.+...     ..+++.|.+||..++||.++.+|+.|  +...+.|++||
T Consensus        82 lk~LG~GdiG~VyL~~l~~--t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f--et~~~~cl~me  157 (459)
T KOG0610|consen   82 LKRLGCGDIGTVYLVELRG--TNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF--ETDKYSCLVME  157 (459)
T ss_pred             HHHcCCCCceeEEEEEecC--CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee--eccceeEEEEe
Confidence            4699999999999999887  668999999976532     34678899999999999999999999  78889999999


Q ss_pred             cCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccc
Q psy2172          99 YAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA  177 (291)
Q Consensus        99 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~  177 (291)
                      ||+| +|..+.+.....       .+++..++-++..++.||+|||-.|||+|||||+|||+.    .++++.|+||.++
T Consensus       158 yCpGGdL~~LrqkQp~~-------~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvr----edGHIMLsDFDLS  226 (459)
T KOG0610|consen  158 YCPGGDLHSLRQKQPGK-------RFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVR----EDGHIMLSDFDLS  226 (459)
T ss_pred             cCCCccHHHHHhhCCCC-------ccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEe----cCCcEEeeecccc
Confidence            9986 777666654433       299999999999999999999999999999999999999    7899999999998


Q ss_pred             eecCCC-------C--------------------C---C-C----------------------CCCCCceeccccccccc
Q psy2172         178 RLFNNP-------L--------------------K---P-L----------------------ADLDPVVVTFWYRAPEL  204 (291)
Q Consensus       178 ~~~~~~-------~--------------------~---~-~----------------------~~~~~~~g~~~y~aPE~  204 (291)
                      ......       .                    .   . .                      .......||-+|.|||+
T Consensus       227 ~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEv  306 (459)
T KOG0610|consen  227 LRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEV  306 (459)
T ss_pred             ccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccccee
Confidence            654210       0                    0   0 0                      00112478999999999


Q ss_pred             ccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc-----------cCCCCCcHHHHHHHHHhhCCCCcCChhh----
Q psy2172         205 LLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI-----------KTSNPYHHDQLDRIFSVMGFPLEKDWED----  269 (291)
Q Consensus       205 ~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~-----------~~~~~~~~~~~~~i~~~~~~~~~~~~~~----  269 (291)
                      +.|.+ .+.++|.|+||+++|||+.|..||.|.+.+.           ....+..+....++++.+..-.|..|=.    
T Consensus       307 I~G~G-HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rG  385 (459)
T KOG0610|consen  307 IRGEG-HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRG  385 (459)
T ss_pred             eecCC-CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccc
Confidence            99976 8899999999999999999999999988751           0111122345566666665555554433    


Q ss_pred             hhcCCCCcchhh
Q psy2172         270 IRKMPEHPTLLK  281 (291)
Q Consensus       270 ~~~~~~~~~~~~  281 (291)
                      ..++..||.+-.
T Consensus       386 A~eIK~HpFF~g  397 (459)
T KOG0610|consen  386 AAEIKRHPFFEG  397 (459)
T ss_pred             hHHhhcCccccC
Confidence            555566655443

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.3e-39  Score=281.73  Aligned_cols=243  Identities=22%  Similarity=0.355  Sum_probs=188.8

Q ss_pred             ccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC-----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCc
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-----GLSMSACREIALLRELKHPNVINLISVFLSHNDR   91 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (291)
                      .+.|++ .+.||+|+||.||+|.++.  +++.+|+|++...     .....+.+|+.+++.++||||+++++++  .+..
T Consensus        42 ~~~y~i-~~~lG~G~fg~Vy~~~~~~--~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~--~~~~  116 (371)
T cd05622          42 AEDYEV-VKVIGRGAFGEVQLVRHKS--TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF--QDDR  116 (371)
T ss_pred             hhhcEE-EEEEeecCCeEEEEEEECC--CCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE--EcCC
Confidence            356775 6799999999999999877  7788999998632     1223467899999999999999999999  5677


Q ss_pred             eEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEE
Q psy2172          92 KVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVK  170 (291)
Q Consensus        92 ~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~  170 (291)
                      ..|+||||+++ +|.+++....          +++..+..++.|++.||+|||++||+|+||||+||+++    .++.++
T Consensus       117 ~~~lv~Ey~~gg~L~~~~~~~~----------~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~----~~~~ik  182 (371)
T cd05622         117 YLYMVMEYMPGGDLVNLMSNYD----------VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD----KSGHLK  182 (371)
T ss_pred             EEEEEEcCCCCCcHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEC----CCCCEE
Confidence            99999999975 7777665321          78889999999999999999999999999999999998    678999


Q ss_pred             EeecccceecCCCCCCCCCCCCceecccccccccccCCc---CCCCchhHHHHHHHHHHHHcCCCCCCCCccc-------
Q psy2172         171 IADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGAR---HYTKAIDIWAIGCIFAELLTSEPIFHCRQED-------  240 (291)
Q Consensus       171 l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~-------  240 (291)
                      |+|||++........  .......||+.|+|||++.+..   .++.++|+|||||++|+|++|..||.+....       
T Consensus       183 L~DfG~a~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~  260 (371)
T cd05622         183 LADFGTCMKMNKEGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM  260 (371)
T ss_pred             EEeCCceeEcCcCCc--ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            999999986543211  1223457899999999986532   3788999999999999999999999875531       


Q ss_pred             -----cc-CCCCCcHHHHHHHHHhhCCCCcC--ChhhhhcCCCCcchh
Q psy2172         241 -----IK-TSNPYHHDQLDRIFSVMGFPLEK--DWEDIRKMPEHPTLL  280 (291)
Q Consensus       241 -----~~-~~~~~~~~~~~~i~~~~~~~~~~--~~~~~~~~~~~~~~~  280 (291)
                           .. ...+.......+++..+....+.  .++++.++..++++.
T Consensus       261 ~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~  308 (371)
T cd05622         261 NHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFK  308 (371)
T ss_pred             cCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccC
Confidence                 00 11122345667777776653332  367788888877764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=9.3e-40  Score=285.20  Aligned_cols=242  Identities=23%  Similarity=0.366  Sum_probs=187.4

Q ss_pred             cccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC-----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEE
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-----GLSMSACREIALLRELKHPNVINLISVFLSHNDRKVW   94 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (291)
                      |++ .+.||+|+||.||+|+++.  +++.||+|++...     .....+.+|+.+++.++||||+++++.+  .+...+|
T Consensus         3 y~~-~~~lG~G~~g~V~~a~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~--~~~~~~~   77 (376)
T cd05598           3 FVK-IKTIGIGAFGEVCLVRKVD--TNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF--QDKDNLY   77 (376)
T ss_pred             ceE-EEEEEeCCCeEEEEEEECC--CCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE--EcCCEEE
Confidence            454 5699999999999999876  6788999998642     2234577899999999999999999999  5677999


Q ss_pred             EEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEee
Q psy2172          95 LLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIAD  173 (291)
Q Consensus        95 iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~D  173 (291)
                      +||||+++ +|.+++....         .+++..++.++.|++.||+|||++||+|+||||+||+++    .++.++|+|
T Consensus        78 lv~E~~~~g~L~~~i~~~~---------~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~----~~~~ikL~D  144 (376)
T cd05598          78 FVMDYIPGGDMMSLLIRLG---------IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILID----RDGHIKLTD  144 (376)
T ss_pred             EEEeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEEC----CCCCEEEEe
Confidence            99999975 7888775432         278899999999999999999999999999999999998    677899999


Q ss_pred             cccceecCCCCC----------------------------------------CCCCCCCceecccccccccccCCcCCCC
Q psy2172         174 MGFARLFNNPLK----------------------------------------PLADLDPVVVTFWYRAPELLLGARHYTK  213 (291)
Q Consensus       174 fg~~~~~~~~~~----------------------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~  213 (291)
                      ||++..+.....                                        .........||+.|+|||++.+.. ++.
T Consensus       145 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~  223 (376)
T cd05598         145 FGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQ  223 (376)
T ss_pred             CCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCC-CCc
Confidence            999753311000                                        000011346899999999998754 889


Q ss_pred             chhHHHHHHHHHHHHcCCCCCCCCcccc------------c-CCCCCcHHHHHHHHHhhCCCCcCChh---hhhcCCCCc
Q psy2172         214 AIDIWAIGCIFAELLTSEPIFHCRQEDI------------K-TSNPYHHDQLDRIFSVMGFPLEKDWE---DIRKMPEHP  277 (291)
Q Consensus       214 ~~Dv~slG~~l~~l~~g~~pf~~~~~~~------------~-~~~~~~~~~~~~i~~~~~~~~~~~~~---~~~~~~~~~  277 (291)
                      ++|||||||++|+|++|..||.+.....            . ...........+++..|. ..|..++   ++.++..+|
T Consensus       224 ~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~  302 (376)
T cd05598         224 LCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHP  302 (376)
T ss_pred             ceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCC
Confidence            9999999999999999999998765321            0 011122345556666654 4677777   788888888


Q ss_pred             chhh
Q psy2172         278 TLLK  281 (291)
Q Consensus       278 ~~~~  281 (291)
                      |+..
T Consensus       303 ~~~~  306 (376)
T cd05598         303 FFKG  306 (376)
T ss_pred             CcCC
Confidence            8653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.9e-39  Score=275.51  Aligned_cols=236  Identities=24%  Similarity=0.385  Sum_probs=187.3

Q ss_pred             ceeCcccceEEEEEEEccCCCCceeEEEEeCCC-----CCChhHHHHHHHHhcC-CCCCeeeEEEEEEeCCCceEEEEEe
Q psy2172          25 CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-----GLSMSACREIALLREL-KHPNVINLISVFLSHNDRKVWLLFD   98 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~iv~e   98 (291)
                      +.||+|+||.||+|.++.  +++.||+|+++..     ........|..++... +||||+++++++  .+....++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~--~~~~~~~lv~e   76 (316)
T cd05619           1 KMLGKGSFGKVFLAELKG--TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTF--QTKENLFFVME   76 (316)
T ss_pred             CeeeeCCCEEEEEEEECC--CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEE--EeCCEEEEEEe
Confidence            479999999999999876  6788999998643     2233456677777764 899999999999  55678999999


Q ss_pred             cCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccc
Q psy2172          99 YAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA  177 (291)
Q Consensus        99 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~  177 (291)
                      |+++ +|...+....         .+++..+..++.|++.||+|||++|++|+||||+||+++    .++.++|+|||++
T Consensus        77 y~~~g~L~~~l~~~~---------~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~----~~~~~kl~Dfg~~  143 (316)
T cd05619          77 YLNGGDLMFHIQSCH---------KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLD----TDGHIKIADFGMC  143 (316)
T ss_pred             CCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEEC----CCCCEEEccCCcc
Confidence            9975 7777765422         178889999999999999999999999999999999998    6678999999998


Q ss_pred             eecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---------cCCCCCc
Q psy2172         178 RLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---------KTSNPYH  248 (291)
Q Consensus       178 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---------~~~~~~~  248 (291)
                      .......   .......|+..|+|||++.+.. ++.++|+||+||++|+|++|..||.+.....         .......
T Consensus       144 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~  219 (316)
T cd05619         144 KENMLGD---AKTCTFCGTPDYIAPEILLGQK-YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWL  219 (316)
T ss_pred             eECCCCC---CceeeecCCccccCHHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccC
Confidence            7532211   1223346789999999998754 8999999999999999999999998765321         1122234


Q ss_pred             HHHHHHHHHhhCCCCcCChhhhh-cCCCCcchhh
Q psy2172         249 HDQLDRIFSVMGFPLEKDWEDIR-KMPEHPTLLK  281 (291)
Q Consensus       249 ~~~~~~i~~~~~~~~~~~~~~~~-~~~~~~~~~~  281 (291)
                      ...+.+++..|....|..|+++. ++..+|++..
T Consensus       220 ~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~  253 (316)
T cd05619         220 TREAKDILVKLFVREPERRLGVKGDIRQHPFFRE  253 (316)
T ss_pred             CHHHHHHHHHHhccCHhhcCCChHHHHcCcccCC
Confidence            56678889999999999998886 6777777644

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=5e-39  Score=270.65  Aligned_cols=241  Identities=37%  Similarity=0.655  Sum_probs=186.3

Q ss_pred             cccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC----CChhHHHHHHHHhcC---CCCCeeeEEEEEEeC---C
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG----LSMSACREIALLREL---KHPNVINLISVFLSH---N   89 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~---~   89 (291)
                      |++ .+.||+|+||.||+|.++.  +++.||+|.++...    ....+.+|+.+++.+   +||||+++++++...   .
T Consensus         2 y~~-~~~lg~g~~g~v~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~   78 (288)
T cd07863           2 YEP-VAEIGVGAYGTVYKARDPH--SGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDR   78 (288)
T ss_pred             ceE-eeEEeecCCeEEEEEEECC--CCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCC
Confidence            454 5689999999999999877  67889999986432    233566788777766   699999999987432   2


Q ss_pred             CceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcE
Q psy2172          90 DRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRV  169 (291)
Q Consensus        90 ~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~  169 (291)
                      ....+++||++.+++.+.+.....       ..+++..++.++.|++.||.|||++|++|+||||+||+++    .++.+
T Consensus        79 ~~~~~lv~e~~~~~l~~~~~~~~~-------~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~----~~~~~  147 (288)
T cd07863          79 ETKVTLVFEHVDQDLRTYLDKVPP-------PGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT----SGGQV  147 (288)
T ss_pred             CceEEEEEcccccCHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC----CCCCE
Confidence            456899999999988887764321       1288999999999999999999999999999999999998    66789


Q ss_pred             EEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc-------
Q psy2172         170 KIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK-------  242 (291)
Q Consensus       170 ~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~-------  242 (291)
                      +|+|||.+......    .......++..|+|||.+.+.. ++.++|+||+||++|+|++|.+||.+......       
T Consensus       148 kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~  222 (288)
T cd07863         148 KLADFGLARIYSCQ----MALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL  222 (288)
T ss_pred             EECccCccccccCc----ccCCCccccccccCchHhhCCC-CCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHH
Confidence            99999998765432    1123346788999999997754 89999999999999999999999976533100       


Q ss_pred             -----------------------------CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         243 -----------------------------TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       243 -----------------------------~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                                                   ...+...+.+.+++..|..+.|..||++.++..+||+
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         223 IGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             hCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                                         0001123445677777777888888888877777764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-39  Score=270.60  Aligned_cols=238  Identities=23%  Similarity=0.318  Sum_probs=192.9

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEe
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-----LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFD   98 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e   98 (291)
                      .++||+|+||.||++.+..  +++.||+|.+....     ....+.+|+.+++.++||||+++++.+  .+....+++||
T Consensus         5 ~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~~~lv~e   80 (285)
T cd05605           5 YRVLGKGGFGEVCACQVRA--TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY--ETKDALCLVLT   80 (285)
T ss_pred             EEEEecCCCeEEEEEEEcC--CCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee--cCCCeEEEEEe
Confidence            5689999999999999765  67889999986432     123467899999999999999999998  55678999999


Q ss_pred             cCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccc
Q psy2172          99 YAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA  177 (291)
Q Consensus        99 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~  177 (291)
                      |+.+ +|...+.....       ..+++..+..++.|++.||.+||+.|++|+||+|+||+++    ..+.++|+|||++
T Consensus        81 ~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~----~~~~~~l~Dfg~~  149 (285)
T cd05605          81 LMNGGDLKFHIYNMGN-------PGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLD----DYGHIRISDLGLA  149 (285)
T ss_pred             ccCCCcHHHHHHhcCc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEEC----CCCCEEEeeCCCc
Confidence            9985 66655543211       1288999999999999999999999999999999999998    6678999999998


Q ss_pred             eecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc-------------cCC
Q psy2172         178 RLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI-------------KTS  244 (291)
Q Consensus       178 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~-------------~~~  244 (291)
                      .......    ......|+..|+|||.+.+.. ++.++|+||+|+++|+|++|..||.+.....             ...
T Consensus       150 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~-~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  224 (285)
T cd05605         150 VEIPEGE----TIRGRVGTVGYMAPEVVKNER-YTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEY  224 (285)
T ss_pred             eecCCCC----ccccccCCCCccCcHHhcCCC-CCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhccccc
Confidence            7653321    112346788999999997744 8899999999999999999999998754321             112


Q ss_pred             CCCcHHHHHHHHHhhCCCCcCChh-----hhhcCCCCcchhh
Q psy2172         245 NPYHHDQLDRIFSVMGFPLEKDWE-----DIRKMPEHPTLLK  281 (291)
Q Consensus       245 ~~~~~~~~~~i~~~~~~~~~~~~~-----~~~~~~~~~~~~~  281 (291)
                      .......+.+++..|....|..||     ++.++..++|+.+
T Consensus       225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~  266 (285)
T cd05605         225 SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT  266 (285)
T ss_pred             CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence            223456788999999999999999     7888989988774

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.4e-39  Score=282.87  Aligned_cols=245  Identities=20%  Similarity=0.304  Sum_probs=196.5

Q ss_pred             cccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEE
Q psy2172          16 VEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWL   95 (291)
Q Consensus        16 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~i   95 (291)
                      +...|.+ .+.||+|+||.||+|...+...++.|++|.+...   ....+|+.++++++||||+++++++  ......|+
T Consensus        90 ~~~~y~i-~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~---~~~~~E~~il~~l~h~~iv~~~~~~--~~~~~~~l  163 (392)
T PHA03207         90 VRMQYNI-LSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---KTPGREIDILKTISHRAIINLIHAY--RWKSTVCM  163 (392)
T ss_pred             ccCceEE-EEeecCCCCeEEEEEEEcCCccceeEEEEecccc---ccHHHHHHHHHhcCCCCccceeeeE--eeCCEEEE
Confidence            3445775 6799999999999998776667788999988653   3456899999999999999999998  55678999


Q ss_pred             EEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecc
Q psy2172          96 LFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMG  175 (291)
Q Consensus        96 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg  175 (291)
                      +||++.++|...+....         .+++..++.++.|++.||.|||++||+|+||||+||+++    ..+.++|+|||
T Consensus       164 v~e~~~~~l~~~l~~~~---------~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~----~~~~~~l~DfG  230 (392)
T PHA03207        164 VMPKYKCDLFTYVDRSG---------PLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLD----EPENAVLGDFG  230 (392)
T ss_pred             EehhcCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc----CCCCEEEccCc
Confidence            99999999888773221         289999999999999999999999999999999999998    67899999999


Q ss_pred             cceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc--------------
Q psy2172         176 FARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI--------------  241 (291)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~--------------  241 (291)
                      ++........ ........||..|+|||++.+.. ++.++|||||||++|+|++|..||.+.....              
T Consensus       231 ~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~  308 (392)
T PHA03207        231 AACKLDAHPD-TPQCYGWSGTLETNSPELLALDP-YCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQV  308 (392)
T ss_pred             cccccCcccc-cccccccccccCccCHhHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhcc
Confidence            9876543211 11223457899999999998754 8899999999999999999999997653210              


Q ss_pred             -----cC---------------------------CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         242 -----KT---------------------------SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       242 -----~~---------------------------~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                           ..                           ........+.+++..|....|..||++.++..+|++.+
T Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~  380 (392)
T PHA03207        309 HPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK  380 (392)
T ss_pred             CccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence                 00                           00011234667788888899999999999999998764

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.5e-39  Score=284.38  Aligned_cols=243  Identities=23%  Similarity=0.379  Sum_probs=184.7

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-----LSMSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      +|+ ..++||+|+||.||+|.++.  +++.||+|++....     ....+.+|+.++++++||||+++++.+  .+....
T Consensus         2 ~f~-~~~~LG~G~~g~Vy~a~~~~--~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~--~~~~~~   76 (382)
T cd05625           2 MFV-KIKTLGIGAFGEVCLARKVD--TKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSF--QDKDNL   76 (382)
T ss_pred             CcE-EEEEEEeCCCEEEEEEEECC--CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEE--EeCCEE
Confidence            355 36799999999999999876  67889999986432     234578899999999999999999999  567799


Q ss_pred             EEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          94 WLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        94 ~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      |+||||+++ +|.+.+....         .+++..++.++.|++.||+|||++||+|+||||+||+++    .++.++|+
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~---------~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~----~~g~~kL~  143 (382)
T cd05625          77 YFVMDYIPGGDMMSLLIRMG---------IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILID----RDGHIKLT  143 (382)
T ss_pred             EEEEeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC----CCCCEEEe
Confidence            999999975 7777765432         278999999999999999999999999999999999998    67799999


Q ss_pred             ecccceecCCCCC--------------------------------------------CCCCCCCceecccccccccccCC
Q psy2172         173 DMGFARLFNNPLK--------------------------------------------PLADLDPVVVTFWYRAPELLLGA  208 (291)
Q Consensus       173 Dfg~~~~~~~~~~--------------------------------------------~~~~~~~~~g~~~y~aPE~~~~~  208 (291)
                      |||++........                                            .........||+.|+|||++.+.
T Consensus       144 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~  223 (382)
T cd05625         144 DFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT  223 (382)
T ss_pred             ECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC
Confidence            9999753321000                                            00001234689999999999875


Q ss_pred             cCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc------------c-CCCCCcHHHHHHHHHhhCCCCcCChhh---hhc
Q psy2172         209 RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI------------K-TSNPYHHDQLDRIFSVMGFPLEKDWED---IRK  272 (291)
Q Consensus       209 ~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~------------~-~~~~~~~~~~~~i~~~~~~~~~~~~~~---~~~  272 (291)
                      . ++.++|+|||||++|+|++|..||.+.....            . ...........+++..+. ..|..+++   +.+
T Consensus       224 ~-~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~e  301 (382)
T cd05625         224 G-YTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADE  301 (382)
T ss_pred             C-CCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHH
Confidence            5 8899999999999999999999998754310            0 011122344555555554 35566654   777


Q ss_pred             CCCCcchhh
Q psy2172         273 MPEHPTLLK  281 (291)
Q Consensus       273 ~~~~~~~~~  281 (291)
                      +..||++..
T Consensus       302 i~~hp~f~~  310 (382)
T cd05625         302 IKAHPFFKT  310 (382)
T ss_pred             HhcCCCcCC
Confidence            788887643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.5e-39  Score=277.50  Aligned_cols=235  Identities=23%  Similarity=0.336  Sum_probs=186.8

Q ss_pred             ceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-----CChhHHHHHHHHhcC-CCCCeeeEEEEEEeCCCceEEEEEe
Q psy2172          25 CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-----LSMSACREIALLREL-KHPNVINLISVFLSHNDRKVWLLFD   98 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~iv~e   98 (291)
                      +.||+|+||.||+|.++.  +++.||+|+++...     ....+.+|..+++.+ +||||+++++++  .+....|+|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~--~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~--~~~~~~~lv~e   76 (329)
T cd05588           1 RVIGRGSYAKVLLVELKK--TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF--QTESRLFFVIE   76 (329)
T ss_pred             CeEeeCCCeEEEEEEECC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE--EcCCEEEEEEe
Confidence            479999999999999876  67889999997432     123467899999988 799999999999  56778999999


Q ss_pred             cCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccc
Q psy2172          99 YAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA  177 (291)
Q Consensus        99 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~  177 (291)
                      |+++ +|...+....         .+++..++.++.|++.||.|||++|++|+||||+||+++    .++.++|+|||++
T Consensus        77 ~~~~g~L~~~~~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~----~~~~~kL~Dfg~~  143 (329)
T cd05588          77 FVSGGDLMFHMQRQR---------KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLD----AEGHIKLTDYGMC  143 (329)
T ss_pred             CCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC----CCCCEEECcCccc
Confidence            9986 7766554322         289999999999999999999999999999999999998    6778999999998


Q ss_pred             eecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc----------------
Q psy2172         178 RLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI----------------  241 (291)
Q Consensus       178 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~----------------  241 (291)
                      ......   ........|+..|+|||++.+.. ++.++|+|||||++|+|++|+.||.......                
T Consensus       144 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  219 (329)
T cd05588         144 KEGIRP---GDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE  219 (329)
T ss_pred             cccccC---CCccccccCCccccCHHHHcCCC-CCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc
Confidence            642221   11223457899999999998744 8899999999999999999999996422110                


Q ss_pred             --cCCCCCcHHHHHHHHHhhCCCCcCChhh------hhcCCCCcchh
Q psy2172         242 --KTSNPYHHDQLDRIFSVMGFPLEKDWED------IRKMPEHPTLL  280 (291)
Q Consensus       242 --~~~~~~~~~~~~~i~~~~~~~~~~~~~~------~~~~~~~~~~~  280 (291)
                        ..........+.+++..|....|..|++      +.++..|||+.
T Consensus       220 ~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~  266 (329)
T cd05588         220 KQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFR  266 (329)
T ss_pred             CCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCC
Confidence              0112233456788999999999999986      56777777764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3e-39  Score=277.45  Aligned_cols=244  Identities=23%  Similarity=0.349  Sum_probs=192.4

Q ss_pred             cccccceeCcccceEEEEEEEcc-CCCCceeEEEEeCCC------CCChhHHHHHHHHhcC-CCCCeeeEEEEEEeCCCc
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKD-NSDTRDYALKQIEGT------GLSMSACREIALLREL-KHPNVINLISVFLSHNDR   91 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~~~~vaiK~~~~~------~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~   91 (291)
                      |++ .++||+|+||.||+|++.. ..+++.||+|++...      .....+..|+.+++.+ +|++|+++++++  ....
T Consensus         2 y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~--~~~~   78 (332)
T cd05614           2 FEL-LKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF--QTEA   78 (332)
T ss_pred             ceE-EEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE--ecCC
Confidence            443 6799999999999998743 236788999998642      1223577899999999 589999999998  5677


Q ss_pred             eEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEE
Q psy2172          92 KVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVK  170 (291)
Q Consensus        92 ~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~  170 (291)
                      ..+++|||+.+ +|.+.+....         .+++..++.++.|++.||.|||++|++|+||||+||+++    .++.++
T Consensus        79 ~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~----~~~~~k  145 (332)
T cd05614          79 KLHLILDYVSGGEMFTHLYQRD---------NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLD----SEGHVV  145 (332)
T ss_pred             EEEEEEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEEC----CCCCEE
Confidence            89999999985 7777765422         288999999999999999999999999999999999998    667899


Q ss_pred             EeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---------
Q psy2172         171 IADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---------  241 (291)
Q Consensus       171 l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---------  241 (291)
                      |+|||++........  .......|+..|+|||.+.+...++.++|||||||++|+|++|..||.......         
T Consensus       146 l~DfG~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~  223 (332)
T cd05614         146 LTDFGLSKEFLSEEK--ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI  223 (332)
T ss_pred             EeeCcCCccccccCC--CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHH
Confidence            999999875433211  112235689999999999875557889999999999999999999997533210         


Q ss_pred             ----cCCCCCcHHHHHHHHHhhCCCCcCChh-----hhhcCCCCcchhh
Q psy2172         242 ----KTSNPYHHDQLDRIFSVMGFPLEKDWE-----DIRKMPEHPTLLK  281 (291)
Q Consensus       242 ----~~~~~~~~~~~~~i~~~~~~~~~~~~~-----~~~~~~~~~~~~~  281 (291)
                          ..........+.+++..|....|..|+     ++.++..+||+..
T Consensus       224 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~  272 (332)
T cd05614         224 LKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG  272 (332)
T ss_pred             hcCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence                112223456688999999999999999     6778888887653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=8.2e-40  Score=280.10  Aligned_cols=236  Identities=23%  Similarity=0.349  Sum_probs=188.9

Q ss_pred             ceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEec
Q psy2172          25 CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-----LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDY   99 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~   99 (291)
                      +.||+|+||.||+|.++.  +++.||+|+++...     ....+.+|+.++..++||||+++++++  ......|+||||
T Consensus         1 ~~lG~G~~g~V~~~~~~~--~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~--~~~~~~~lv~E~   76 (325)
T cd05594           1 KLLGKGTFGKVILVKEKA--TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF--QTHDRLCFVMEY   76 (325)
T ss_pred             CeeeeCCCEEEEEEEECC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE--EcCCEEEEEEeC
Confidence            479999999999999876  67889999987432     224567899999999999999999998  566789999999


Q ss_pred             CCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCeeeeccCCCcEEeecCCCCCCcEEEeecccc
Q psy2172         100 AEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHS-NWVLHRDLKPANILVMGEGIERGRVKIADMGFA  177 (291)
Q Consensus       100 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~-~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~  177 (291)
                      +++ +|...+....         .+++..++.++.|++.||+|||+ +|++|+||||+||+++    .++.++|+|||++
T Consensus        77 ~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~----~~~~~kL~Dfg~~  143 (325)
T cd05594          77 ANGGELFFHLSRER---------VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD----KDGHIKITDFGLC  143 (325)
T ss_pred             CCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEEC----CCCCEEEecCCCC
Confidence            986 6655554322         28899999999999999999997 7999999999999998    6778999999998


Q ss_pred             eecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---------cCCCCCc
Q psy2172         178 RLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---------KTSNPYH  248 (291)
Q Consensus       178 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---------~~~~~~~  248 (291)
                      .......   .......|+..|+|||++.+.. ++.++|+|||||++|+|++|..||.+...+.         .......
T Consensus       144 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~  219 (325)
T cd05594         144 KEGIKDG---ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTL  219 (325)
T ss_pred             eecCCCC---cccccccCCcccCCHHHHccCC-CCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Confidence            7533211   1223456899999999997754 8999999999999999999999997765321         1122234


Q ss_pred             HHHHHHHHHhhCCCCcCChh-----hhhcCCCCcchhh
Q psy2172         249 HDQLDRIFSVMGFPLEKDWE-----DIRKMPEHPTLLK  281 (291)
Q Consensus       249 ~~~~~~i~~~~~~~~~~~~~-----~~~~~~~~~~~~~  281 (291)
                      ...+.+++..|....|..|+     ++.++..|+|+..
T Consensus       220 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~  257 (325)
T cd05594         220 SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAG  257 (325)
T ss_pred             CHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCC
Confidence            56788899999999998885     7888888877653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-39  Score=275.82  Aligned_cols=244  Identities=22%  Similarity=0.332  Sum_probs=188.4

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC-----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-----GLSMSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      .|.+ .+.||+|+||.||++.++.  +++.||+|++...     .....+.+|..++..++|+||+++++++  .+....
T Consensus         2 ~y~~-~~~lG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~--~~~~~~   76 (331)
T cd05597           2 DFEI-LKVIGRGAFGEVAVVKMKN--TGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF--QDENNL   76 (331)
T ss_pred             CceE-EEEEEecCCeEEEEEEECC--CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE--ecCCeE
Confidence            3554 6799999999999999876  6788999998632     1223477899999999999999999999  567799


Q ss_pred             EEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          94 WLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        94 ~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      |+||||+.+ +|.+.+.....        .+++..+..++.|++.||+|||++|++|+||||+||+++    .++.++|+
T Consensus        77 ~lv~e~~~g~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~----~~~~~kl~  144 (331)
T cd05597          77 YLVMDYYVGGDLLTLLSKFED--------RLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLD----KNGHIRLA  144 (331)
T ss_pred             EEEEecCCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEEC----CCCCEEEE
Confidence            999999964 88877754221        288999999999999999999999999999999999998    67789999


Q ss_pred             ecccceecCCCCCCCCCCCCceecccccccccccC----CcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc--------
Q psy2172         173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLG----ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED--------  240 (291)
Q Consensus       173 Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~--------  240 (291)
                      |||++........  .......|++.|+|||++.+    ...++.++|+||+||++|+|++|..||.+....        
T Consensus       145 Dfg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~  222 (331)
T cd05597         145 DFGSCLRLLADGT--VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN  222 (331)
T ss_pred             ECCceeecCCCCC--ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHc
Confidence            9999876543211  11223468999999999863    234788999999999999999999999765321        


Q ss_pred             ------ccCCCCCcHHHHHHHHHhhCCCCcC--ChhhhhcCCCCcchhh
Q psy2172         241 ------IKTSNPYHHDQLDRIFSVMGFPLEK--DWEDIRKMPEHPTLLK  281 (291)
Q Consensus       241 ------~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~~~~~~~~~~~~~  281 (291)
                            .....+...+.+.+++..|....+.  .++++.++..|||+..
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~  271 (331)
T cd05597         223 HKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEG  271 (331)
T ss_pred             CCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence                  0111122345677777776654333  3678888888888743

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0193|consensus

Probab=100.00  E-value=7.3e-40  Score=281.67  Aligned_cols=231  Identities=23%  Similarity=0.369  Sum_probs=187.8

Q ss_pred             ccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC----ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEe
Q psy2172          23 EGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL----SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFD   98 (291)
Q Consensus        23 ~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e   98 (291)
                      .++.||+|.||+||+|+|.+     .||||.+.-+..    .+.|.+|+.++++-+|.||+-+.|++  -+... .||+.
T Consensus       396 l~~rIGsGsFGtV~Rg~whG-----dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~--~~p~~-AIiTq  467 (678)
T KOG0193|consen  396 LGERIGSGSFGTVYRGRWHG-----DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGAC--MNPPL-AIITQ  467 (678)
T ss_pred             ccceeccccccceeeccccc-----ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhh--cCCce-eeeeh
Confidence            48999999999999999875     499999964432    34688999999999999999999999  33434 99999


Q ss_pred             cCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccc
Q psy2172          99 YAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA  177 (291)
Q Consensus        99 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~  177 (291)
                      +|+| +|...+.-.+..        +.......|+.|+++|+.|||.++|+|+|||..|||+.    +++.|+|+|||++
T Consensus       468 wCeGsSLY~hlHv~etk--------fdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~----~~~kVkIgDFGLa  535 (678)
T KOG0193|consen  468 WCEGSSLYTHLHVQETK--------FDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLH----EDLKVKIGDFGLA  535 (678)
T ss_pred             hccCchhhhhccchhhh--------hhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEc----cCCcEEEecccce
Confidence            9998 777777655543        88889999999999999999999999999999999998    6689999999999


Q ss_pred             eecCCCCCCCCCCCCceecccccccccccCC--cCCCCchhHHHHHHHHHHHHcCCCCCCCCccc--------------c
Q psy2172         178 RLFNNPLKPLADLDPVVVTFWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQED--------------I  241 (291)
Q Consensus       178 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~--------------~  241 (291)
                      .....- ..........|...|+|||++...  ..|++.+||||||+++|||++|..||.+...+              .
T Consensus       536 tvk~~w-~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~  614 (678)
T KOG0193|consen  536 TVKTRW-SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDL  614 (678)
T ss_pred             eeeeee-ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccc
Confidence            865433 222344556778899999998532  24899999999999999999999999965543              2


Q ss_pred             cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCC
Q psy2172         242 KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMP  274 (291)
Q Consensus       242 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  274 (291)
                      ..........+.+++..+....+++||.+.++.
T Consensus       615 s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il  647 (678)
T KOG0193|consen  615 SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLL  647 (678)
T ss_pred             hhhhccCHHHHHHHHHHHHhcCcccCccHHHHH
Confidence            223444556788888888888888888777643

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=5.1e-39  Score=278.19  Aligned_cols=236  Identities=27%  Similarity=0.438  Sum_probs=190.0

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecC
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYA  100 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~  100 (291)
                      .++||+|+||.||+|.+..  +++.||+|++.....   ...+.+|+++++.++|+||+++++++  ......+++|||+
T Consensus        79 ~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~~~lv~e~~  154 (353)
T PLN00034         79 VNRIGSGAGGTVYKVIHRP--TGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF--DHNGEIQVLLEFM  154 (353)
T ss_pred             hhhccCCCCeEEEEEEECC--CCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe--ccCCeEEEEEecC
Confidence            5799999999999999876  678899999864322   24578999999999999999999998  5677899999999


Q ss_pred             CC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeeccccee
Q psy2172         101 EH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL  179 (291)
Q Consensus       101 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~  179 (291)
                      .+ +|.+..             ..++..+..++.|++.||+|||++|++|+||||+||+++    .++.++|+|||++..
T Consensus       155 ~~~~L~~~~-------------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~----~~~~~kL~DfG~~~~  217 (353)
T PLN00034        155 DGGSLEGTH-------------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLIN----SAKNVKIADFGVSRI  217 (353)
T ss_pred             CCCcccccc-------------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc----CCCCEEEccccccee
Confidence            86 443211             156778889999999999999999999999999999998    677999999999986


Q ss_pred             cCCCCCCCCCCCCceecccccccccccCC----cCCCCchhHHHHHHHHHHHHcCCCCCCCCccc-------------cc
Q psy2172         180 FNNPLKPLADLDPVVVTFWYRAPELLLGA----RHYTKAIDIWAIGCIFAELLTSEPIFHCRQED-------------IK  242 (291)
Q Consensus       180 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~-------------~~  242 (291)
                      ......   ......|+..|+|||.+...    ...+.++|||||||++|+|++|+.||......             ..
T Consensus       218 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  294 (353)
T PLN00034        218 LAQTMD---PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPP  294 (353)
T ss_pred             cccccc---cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCC
Confidence            543211   12345689999999987431    23456899999999999999999999743221             01


Q ss_pred             CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhhh
Q psy2172         243 TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF  283 (291)
Q Consensus       243 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (291)
                      .........+.+++..|....|..||++.++..|+|+.+..
T Consensus       295 ~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~  335 (353)
T PLN00034        295 EAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ  335 (353)
T ss_pred             CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence            12233456789999999999999999999999999988764

>KOG0580|consensus

Probab=100.00  E-value=2.4e-40  Score=255.11  Aligned_cols=242  Identities=26%  Similarity=0.463  Sum_probs=198.3

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC-----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCce
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-----GLSMSACREIALLRELKHPNVINLISVFLSHNDRK   92 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (291)
                      +.|++ |+.||+|-||.||+|+.+.  +.-.||+|++.++     ....++.+|++|-..|+||||.++|++|  .+...
T Consensus        22 ~dfei-gr~LgkgkFG~vYlarekk--s~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f--hd~~r   96 (281)
T KOG0580|consen   22 DDFEI-GRPLGKGKFGNVYLAREKK--SLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF--HDSKR   96 (281)
T ss_pred             hhccc-cccccCCccccEeEeeecc--CCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe--eccce
Confidence            44664 8999999999999999877  6778999998643     3456788999999999999999999999  67889


Q ss_pred             EEEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEE
Q psy2172          93 VWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI  171 (291)
Q Consensus        93 ~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l  171 (291)
                      .|+++||.+ |.+...+...+..+       +++...+.++.|++.|+.|+|.++++||||||+|+|++    ..+.+++
T Consensus        97 iyLilEya~~gel~k~L~~~~~~~-------f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg----~~~~lki  165 (281)
T KOG0580|consen   97 IYLILEYAPRGELYKDLQEGRMKR-------FDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLG----SAGELKI  165 (281)
T ss_pred             eEEEEEecCCchHHHHHHhccccc-------ccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccC----CCCCeec
Confidence            999999997 68888887655443       88999999999999999999999999999999999999    7789999


Q ss_pred             eecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc---------
Q psy2172         172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK---------  242 (291)
Q Consensus       172 ~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~---------  242 (291)
                      +|||.+.....     ....+.+||..|.|||+..+.. .+...|+|++|++.||++.|.+||+....+..         
T Consensus       166 AdfGwsV~~p~-----~kR~tlcgt~dyl~pEmv~~~~-hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~  239 (281)
T KOG0580|consen  166 ADFGWSVHAPS-----NKRKTLCGTLDYLPPEMVEGRG-HDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDL  239 (281)
T ss_pred             cCCCceeecCC-----CCceeeecccccCCHhhcCCCC-ccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccc
Confidence            99999987543     3446789999999999998855 88999999999999999999999998775310         


Q ss_pred             CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         243 TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       243 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                      ..+..-.....+++..+..-.|..+-...+..+|||+..
T Consensus       240 ~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  240 KFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             cCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence            111222344555666666666666666777777777643

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=7.8e-39  Score=275.55  Aligned_cols=247  Identities=21%  Similarity=0.319  Sum_probs=186.8

Q ss_pred             cccccccceeCcccceEEEEEEEcc---CCCCceeEEEEeCCCCC---ChhHHHHHHHHhcC-CCCCeeeEEEEEEeCCC
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKD---NSDTRDYALKQIEGTGL---SMSACREIALLREL-KHPNVINLISVFLSHND   90 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~---~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~   90 (291)
                      ++|.+ +++||+|+||.||+|.+..   ..++..||+|.++....   ...+.+|+.++..+ +||||+++++++.. ..
T Consensus         7 ~~~~~-~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-~~   84 (338)
T cd05102           7 DRLRL-GKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK-PN   84 (338)
T ss_pred             hHcee-eeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC-CC
Confidence            45664 7899999999999998632   22456799999875432   23578899999999 89999999998843 34


Q ss_pred             ceEEEEEecCCC-CHHHHHHHhhhhhh-----------------------------------------------------
Q psy2172          91 RKVWLLFDYAEH-DLWHIIKFHRAAKA-----------------------------------------------------  116 (291)
Q Consensus        91 ~~~~iv~e~~~~-~l~~~~~~~~~~~~-----------------------------------------------------  116 (291)
                      ..++++|||+++ +|.+.+........                                                     
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            568999999985 88877765321100                                                     


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceecCCCCCCCCCCCCceec
Q psy2172         117 NKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVT  196 (291)
Q Consensus       117 ~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~  196 (291)
                      ......++...+..++.|++.||+|||++||+|+||||+||+++    .++.++|+|||++........ ........++
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~----~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~~~  239 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLS----ENNVVKICDFGLARDIYKDPD-YVRKGSARLP  239 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEc----CCCcEEEeecccccccccCcc-hhcccCCCCC
Confidence            00012377888999999999999999999999999999999998    667899999999976533211 1112233456


Q ss_pred             ccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc-----------cCCCCCcHHHHHHHHHhhCCCCc
Q psy2172         197 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI-----------KTSNPYHHDQLDRIFSVMGFPLE  264 (291)
Q Consensus       197 ~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~-----------~~~~~~~~~~~~~i~~~~~~~~~  264 (291)
                      ..|+|||++.+.. ++.++||||||+++|+|++ |..||.+.....           ..........+.+++..|..+.|
T Consensus       240 ~~y~aPE~~~~~~-~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp  318 (338)
T cd05102         240 LKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDP  318 (338)
T ss_pred             ccccCcHHhhcCC-CCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCCh
Confidence            7899999997744 8999999999999999996 999998754321           11122334668889999999999


Q ss_pred             CChhhhhc
Q psy2172         265 KDWEDIRK  272 (291)
Q Consensus       265 ~~~~~~~~  272 (291)
                      ..||++.+
T Consensus       319 ~~RPs~~e  326 (338)
T cd05102         319 KERPTFSA  326 (338)
T ss_pred             hhCcCHHH
Confidence            99998875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=6.8e-39  Score=274.31  Aligned_cols=236  Identities=24%  Similarity=0.308  Sum_probs=186.2

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCC-----CCChhHHHHHHHHhcCCC-CCeeeEEEEEEeCCCceEEEEE
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-----GLSMSACREIALLRELKH-PNVINLISVFLSHNDRKVWLLF   97 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~~iv~   97 (291)
                      .+.||+|+||.||+|.+++  +++.||+|++...     .....+..|..++..++| ++|+++++++  .+....|+||
T Consensus         5 ~~~lg~G~~g~Vy~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~--~~~~~~~lv~   80 (324)
T cd05587           5 LMVLGKGSFGKVMLAERKG--TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF--QTMDRLYFVM   80 (324)
T ss_pred             EEEEeeccCeEEEEEEECC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEE--EcCCEEEEEE
Confidence            5699999999999999876  6788999998643     223457788999999976 5688888888  4567899999


Q ss_pred             ecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeeccc
Q psy2172          98 DYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGF  176 (291)
Q Consensus        98 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~  176 (291)
                      ||+++ +|...+....         .+++..+..++.|++.||+|||++||+|+||||+||+++    .++.++|+|||+
T Consensus        81 E~~~~g~L~~~~~~~~---------~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~----~~~~~kL~Dfg~  147 (324)
T cd05587          81 EYVNGGDLMYHIQQVG---------KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD----AEGHIKIADFGM  147 (324)
T ss_pred             cCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEc----CCCCEEEeecCc
Confidence            99975 7776665332         278899999999999999999999999999999999998    667899999999


Q ss_pred             ceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---------cCCCCC
Q psy2172         177 ARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---------KTSNPY  247 (291)
Q Consensus       177 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---------~~~~~~  247 (291)
                      +.......   .......|+..|+|||++.+.. ++.++|+||+||++|+|++|+.||.+.....         ......
T Consensus       148 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~  223 (324)
T cd05587         148 CKENIFGG---KTTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKS  223 (324)
T ss_pred             ceecCCCC---CceeeecCCccccChhhhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            86432211   1123456899999999998754 8899999999999999999999998765321         112223


Q ss_pred             cHHHHHHHHHhhCCCCcCChhhh-----hcCCCCcchh
Q psy2172         248 HHDQLDRIFSVMGFPLEKDWEDI-----RKMPEHPTLL  280 (291)
Q Consensus       248 ~~~~~~~i~~~~~~~~~~~~~~~-----~~~~~~~~~~  280 (291)
                      ....+.+++..|..+.|..|++.     +++.++|++.
T Consensus       224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~  261 (324)
T cd05587         224 LSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFR  261 (324)
T ss_pred             CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcC
Confidence            35667788899999999888765     5677777654

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.5e-38  Score=266.39  Aligned_cols=234  Identities=24%  Similarity=0.335  Sum_probs=186.3

Q ss_pred             eCcccceEEEEEEEccCCCCceeEEEEeCCCC-----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecCC
Q psy2172          27 VGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-----LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAE  101 (291)
Q Consensus        27 ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~~  101 (291)
                      ||+|+||.||++.++.  +++.||+|.+....     ....+..|++++++++||||+++++++  .+....+++|||+.
T Consensus         1 lg~G~~g~Vy~~~~~~--~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~--~~~~~~~lv~e~~~   76 (277)
T cd05607           1 LGKGGFGEVCAVQVKN--TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF--ESKTHLCLVMSLMN   76 (277)
T ss_pred             CCCCCceEEEEEEEcc--CCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE--ecCCeEEEEEecCC
Confidence            7999999999999876  67889999986422     123456799999999999999999998  56778999999997


Q ss_pred             C-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceec
Q psy2172         102 H-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF  180 (291)
Q Consensus       102 ~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~  180 (291)
                      + +|...+.....       ..+++..+..++.|++.||++||++|++|+||||+||+++    .++.++|+|||.+...
T Consensus        77 g~~L~~~~~~~~~-------~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~----~~~~~~l~Dfg~~~~~  145 (277)
T cd05607          77 GGDLKYHIYNVGE-------RGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLD----DQGNCRLSDLGLAVEL  145 (277)
T ss_pred             CCCHHHHHHhccc-------cCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEc----CCCCEEEeeceeeeec
Confidence            5 77666643221       1278888999999999999999999999999999999998    6778999999998765


Q ss_pred             CCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc--------------cCCCC
Q psy2172         181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI--------------KTSNP  246 (291)
Q Consensus       181 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~--------------~~~~~  246 (291)
                      ....    ......|+..|+|||++.+.. ++.++|+||+||++|+|++|..||.......              .....
T Consensus       146 ~~~~----~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  220 (277)
T cd05607         146 KDGK----TITQRAGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQ  220 (277)
T ss_pred             CCCc----eeeccCCCCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccc
Confidence            4321    112346788999999998755 8999999999999999999999997643210              11112


Q ss_pred             CcHHHHHHHHHhhCCCCcCChhhhh----cCCCCcchh
Q psy2172         247 YHHDQLDRIFSVMGFPLEKDWEDIR----KMPEHPTLL  280 (291)
Q Consensus       247 ~~~~~~~~i~~~~~~~~~~~~~~~~----~~~~~~~~~  280 (291)
                      .....+.+++..|..+.|..||++.    +...|+|+.
T Consensus       221 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~  258 (277)
T cd05607         221 NFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFK  258 (277)
T ss_pred             cCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhc
Confidence            3456789999999999999999984    455666663

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.1e-39  Score=278.55  Aligned_cols=244  Identities=32%  Similarity=0.511  Sum_probs=195.4

Q ss_pred             ccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC----CChhHHHHHHHHhcCCCCCeeeEEEEEEeC--
Q psy2172          15 KVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG----LSMSACREIALLRELKHPNVINLISVFLSH--   88 (291)
Q Consensus        15 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--   88 (291)
                      .+.++|.+ .+.||+|+||.||+|.+..  +++.||+|.+....    ....+.+|+.+++.++||||+++++++...  
T Consensus        12 ~~~~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07878          12 EVPERYQN-LTPVGSGAYGSVCSAYDTR--LRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATS   88 (343)
T ss_pred             hhhhhhhh-heecccCCCeEEEEEEECC--CCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence            45677885 5699999999999999766  67889999987532    224567899999999999999999987422  


Q ss_pred             --CCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCC
Q psy2172          89 --NDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIER  166 (291)
Q Consensus        89 --~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~  166 (291)
                        .....|+++++++++|...+...          .+++..++.++.|++.||.|||++||+|+||||+||+++    .+
T Consensus        89 ~~~~~~~~~~~~~~~~~l~~~~~~~----------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~----~~  154 (343)
T cd07878          89 IENFNEVYLVTNLMGADLNNIVKCQ----------KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVN----ED  154 (343)
T ss_pred             ccccCcEEEEeecCCCCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEEC----CC
Confidence              12457999999988887766422          189999999999999999999999999999999999998    67


Q ss_pred             CcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc-----
Q psy2172         167 GRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI-----  241 (291)
Q Consensus       167 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~-----  241 (291)
                      +.++|+|||++......      .....|+..|+|||.+.+...++.++|||||||++|+|++|..||.+.....     
T Consensus       155 ~~~kl~Dfg~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~  228 (343)
T cd07878         155 CELRILDFGLARQADDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRI  228 (343)
T ss_pred             CCEEEcCCccceecCCC------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            88999999998765432      2334678899999999875568899999999999999999999997643110     


Q ss_pred             ---------------------------cCCC--------CCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         242 ---------------------------KTSN--------PYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       242 ---------------------------~~~~--------~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                                                 ....        ......+.+++..|..+.|..||++.++..|||+.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~  303 (343)
T cd07878         229 MEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ  303 (343)
T ss_pred             HHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhc
Confidence                                       0000        001233568888999999999999999999999865

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=6.4e-39  Score=273.72  Aligned_cols=236  Identities=24%  Similarity=0.343  Sum_probs=189.7

Q ss_pred             ceeCcccceEEEEEEEccCCCCceeEEEEeCCC-----CCChhHHHHHHHHhcC-CCCCeeeEEEEEEeCCCceEEEEEe
Q psy2172          25 CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-----GLSMSACREIALLREL-KHPNVINLISVFLSHNDRKVWLLFD   98 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~iv~e   98 (291)
                      +.||+|+||.||+|.++.  +++.||+|+++..     .....+.+|..+++.+ +||||+++++++  .+....|+|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~--~~~~~~~lv~e   76 (318)
T cd05570           1 KVLGKGSFGKVLLAELKG--TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF--QTKDRLFFVME   76 (318)
T ss_pred             CeeeeCCCeEEEEEEECC--CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEE--EcCCEEEEEEc
Confidence            479999999999999876  6788999998743     2233466788888888 799999999998  56778999999


Q ss_pred             cCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccc
Q psy2172          99 YAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA  177 (291)
Q Consensus        99 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~  177 (291)
                      |+.+ +|...+....         .+++..+..++.|++.||.|||++|++|+||||+||+++    .++.++|+|||++
T Consensus        77 ~~~~~~L~~~~~~~~---------~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~----~~~~~kl~Dfg~~  143 (318)
T cd05570          77 YVNGGDLMFHIQRSG---------RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLD----SEGHIKIADFGMC  143 (318)
T ss_pred             CCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEEC----CCCcEEecccCCC
Confidence            9975 7766554332         289999999999999999999999999999999999998    6778999999998


Q ss_pred             eecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---------cCCCCCc
Q psy2172         178 RLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---------KTSNPYH  248 (291)
Q Consensus       178 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---------~~~~~~~  248 (291)
                      .......   .......|+..|+|||.+.+.. ++.++|+|||||++|+|++|..||.+.....         .......
T Consensus       144 ~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~  219 (318)
T cd05570         144 KEGILGG---VTTSTFCGTPDYIAPEILSYQP-YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWL  219 (318)
T ss_pred             eecCcCC---CcccceecCccccCHHHhcCCC-CCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcC
Confidence            6432211   1223346889999999998754 8899999999999999999999998654321         1122234


Q ss_pred             HHHHHHHHHhhCCCCcCChhhh-----hcCCCCcchhh
Q psy2172         249 HDQLDRIFSVMGFPLEKDWEDI-----RKMPEHPTLLK  281 (291)
Q Consensus       249 ~~~~~~i~~~~~~~~~~~~~~~-----~~~~~~~~~~~  281 (291)
                      ...+.++++.|....|..||+.     .++..+||+..
T Consensus       220 ~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~  257 (318)
T cd05570         220 SKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFRE  257 (318)
T ss_pred             CHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence            5678899999999999999998     88888877643

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.3e-39  Score=279.40  Aligned_cols=243  Identities=25%  Similarity=0.336  Sum_probs=193.5

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-----LSMSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      .|.+ .+.||+|+||.||+|.++.  +++.||+|+++...     ....+.+|+.+++.++|+||+++++++  .+....
T Consensus         2 ~y~~-~~~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~--~~~~~~   76 (330)
T cd05601           2 DFDV-KSLVGRGHFGEVQVVREKA--TGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF--QDKDNL   76 (330)
T ss_pred             CceE-EEEEEeccCEEEEEEEECC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE--ecCCeE
Confidence            3554 5699999999999999876  67889999987432     234577899999999999999999998  567789


Q ss_pred             EEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          94 WLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        94 ~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      |+||||+++ +|.+++.....        .+++..+..++.|++.||++||++||+|+||||+||+++    ..+.++|+
T Consensus        77 ~lv~e~~~~~~L~~~l~~~~~--------~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~----~~~~~kL~  144 (330)
T cd05601          77 YLVMEYQPGGDLLSLLNRYED--------QFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLID----RTGHIKLA  144 (330)
T ss_pred             EEEECCCCCCCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEEC----CCCCEEec
Confidence            999999974 88877765421        289999999999999999999999999999999999998    67899999


Q ss_pred             ecccceecCCCCCCCCCCCCceecccccccccccC-----CcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc------
Q psy2172         173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLG-----ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI------  241 (291)
Q Consensus       173 Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~------  241 (291)
                      |||++.........  ......|+..|+|||++..     ...++.++|||||||++|+|++|..||.......      
T Consensus       145 Dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~  222 (330)
T cd05601         145 DFGSAARLTANKMV--NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM  222 (330)
T ss_pred             cCCCCeECCCCCce--eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHH
Confidence            99999865432211  1223467899999999863     2347889999999999999999999997644210      


Q ss_pred             -----c--CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         242 -----K--TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       242 -----~--~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                           .  ...+.....+.+++..|.. .|..|+++.++..+|++.+
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~  268 (330)
T cd05601         223 NFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSK  268 (330)
T ss_pred             cCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence                 0  1112235667788888876 8899999999999988764

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.9e-38  Score=284.71  Aligned_cols=253  Identities=25%  Similarity=0.355  Sum_probs=200.5

Q ss_pred             ccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC----hhHHHHHHHHhcCCCCCeeeEEEEEEeC
Q psy2172          13 RTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIALLRELKHPNVINLISVFLSH   88 (291)
Q Consensus        13 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~   88 (291)
                      .....++|.+ .+.||+|+||.||+|.+..  +++.||+|.+......    ..+.+|+.++..++|+|+++++..+...
T Consensus        27 ~~~~~~rY~i-~~~LG~G~fG~Vy~a~~~~--~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~  103 (496)
T PTZ00283         27 AKEQAKKYWI-SRVLGSGATGTVLCAKRVS--DGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKK  103 (496)
T ss_pred             ccccCCCEEE-EEEEecCCCEEEEEEEEcC--CCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence            3445578886 6799999999999999776  6788999998654322    3567899999999999999998877432


Q ss_pred             CC------ceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeec
Q psy2172          89 ND------RKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMG  161 (291)
Q Consensus        89 ~~------~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~  161 (291)
                      +.      ..+++||||+.+ +|.+.+......     ...+++..+..++.|++.||.|||++||+|+||||+||+++ 
T Consensus       104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~-----~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~-  177 (496)
T PTZ00283        104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKT-----NRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLC-  177 (496)
T ss_pred             cccCcccceEEEEEEeCCCCCcHHHHHHHhhcc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEe-
Confidence            21      247899999984 888877643321     12389999999999999999999999999999999999998 


Q ss_pred             CCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc-
Q psy2172         162 EGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED-  240 (291)
Q Consensus       162 ~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~-  240 (291)
                         .++.++|+|||+++........ .......||+.|+|||.+.+.. ++.++||||||+++|+|++|..||.+.... 
T Consensus       178 ---~~~~vkL~DFGls~~~~~~~~~-~~~~~~~Gt~~Y~aPE~~~~~~-~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~  252 (496)
T PTZ00283        178 ---SNGLVKLGDFGFSKMYAATVSD-DVGRTFCGTPYYVAPEIWRRKP-YSKKADMFSLGVLLYELLTLKRPFDGENMEE  252 (496)
T ss_pred             ---CCCCEEEEecccCeeccccccc-cccccccCCcceeCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence               6778999999998765432111 1223457899999999998754 899999999999999999999999865431 


Q ss_pred             ---------ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         241 ---------IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       241 ---------~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                               .....+.....+.+++..|..+.|..||++.++..+|+.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~  300 (496)
T PTZ00283        253 VMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPIC  300 (496)
T ss_pred             HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHH
Confidence                     112233445778999999999999999999998877653

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=7.7e-39  Score=273.96  Aligned_cols=235  Identities=26%  Similarity=0.349  Sum_probs=184.8

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-----CChhHHHHHHHH---hcCCCCCeeeEEEEEEeCCCceEEE
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-----LSMSACREIALL---RELKHPNVINLISVFLSHNDRKVWL   95 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l---~~l~h~~iv~~~~~~~~~~~~~~~i   95 (291)
                      .+.||+|+||.||+|.++.  +++.||+|+++...     ....+.+|+.++   +.++||||+++++++  .+....|+
T Consensus         4 ~~~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~--~~~~~~~l   79 (324)
T cd05589           4 LAVLGRGHFGKVLLAEYKK--TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF--QTEDHVCF   79 (324)
T ss_pred             EEEEeecCCEEEEEEEECC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE--EcCCEEEE
Confidence            5699999999999999876  67889999986431     223456666655   456799999999999  56779999


Q ss_pred             EEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          96 LFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        96 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      ||||+.+ +|...+...          .+++..++.++.|++.||+|||++|++|+||||+||+++    .++.++|+||
T Consensus        80 v~E~~~~~~L~~~~~~~----------~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~----~~~~~kL~Df  145 (324)
T cd05589          80 VMEYAAGGDLMMHIHTD----------VFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLD----TEGFVKIADF  145 (324)
T ss_pred             EEcCCCCCcHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC----CCCcEEeCcc
Confidence            9999986 665544321          289999999999999999999999999999999999998    6789999999


Q ss_pred             ccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---------cCCC
Q psy2172         175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---------KTSN  245 (291)
Q Consensus       175 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---------~~~~  245 (291)
                      |++......   ........|+..|+|||.+.+.. ++.++|+|||||++|+|++|..||.+.....         ....
T Consensus       146 g~~~~~~~~---~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p  221 (324)
T cd05589         146 GLCKEGMGF---GDRTSTFCGTPEFLAPEVLTETS-YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYP  221 (324)
T ss_pred             cCCccCCCC---CCcccccccCccccCHhHhcCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence            988643221   11223457899999999998744 8899999999999999999999998765321         1122


Q ss_pred             CCcHHHHHHHHHhhCCCCcCChh-----hhhcCCCCcchh
Q psy2172         246 PYHHDQLDRIFSVMGFPLEKDWE-----DIRKMPEHPTLL  280 (291)
Q Consensus       246 ~~~~~~~~~i~~~~~~~~~~~~~-----~~~~~~~~~~~~  280 (291)
                      ......+.+++..|....|..||     ++.++..++++.
T Consensus       222 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~  261 (324)
T cd05589         222 RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFR  261 (324)
T ss_pred             CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcC
Confidence            23456678899999999999988     466667777654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=5.1e-39  Score=275.47  Aligned_cols=235  Identities=23%  Similarity=0.351  Sum_probs=184.7

Q ss_pred             ceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-----CChhHHHHHHHHhcC-CCCCeeeEEEEEEeCCCceEEEEEe
Q psy2172          25 CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-----LSMSACREIALLREL-KHPNVINLISVFLSHNDRKVWLLFD   98 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~iv~e   98 (291)
                      +.||+|+||.||+|.++.  +++.||+|+++...     ....+.+|+.++.++ +||||+++++++  ......|+|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~--~~~~~~~lv~E   76 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKK--TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF--QTESRLFFVIE   76 (329)
T ss_pred             CeeeeCCCeEEEEEEECC--CCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEE--EeCCEEEEEEe
Confidence            479999999999999876  67889999987532     123466788888776 899999999998  55678999999


Q ss_pred             cCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccc
Q psy2172          99 YAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA  177 (291)
Q Consensus        99 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~  177 (291)
                      |+.+ +|...+....         .+++..++.++.|++.||+|||++|++|+||||+||+++    .++.++|+|||++
T Consensus        77 ~~~~~~L~~~~~~~~---------~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~----~~~~~kL~DfG~~  143 (329)
T cd05618          77 YVNGGDLMFHMQRQR---------KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD----SEGHIKLTDYGMC  143 (329)
T ss_pred             CCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEC----CCCCEEEeeCCcc
Confidence            9985 6665554321         289999999999999999999999999999999999998    6778999999998


Q ss_pred             eecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc-----------------
Q psy2172         178 RLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED-----------------  240 (291)
Q Consensus       178 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~-----------------  240 (291)
                      .......   .......|+..|+|||++.+.. ++.++|+|||||++|+|++|..||......                 
T Consensus       144 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~  219 (329)
T cd05618         144 KEGLRPG---DTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE  219 (329)
T ss_pred             ccccCCC---CccccccCCccccCHHHHcCCC-CCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc
Confidence            7432211   1223457899999999998754 889999999999999999999999532110                 


Q ss_pred             -ccCCCCCcHHHHHHHHHhhCCCCcCChhh------hhcCCCCcchh
Q psy2172         241 -IKTSNPYHHDQLDRIFSVMGFPLEKDWED------IRKMPEHPTLL  280 (291)
Q Consensus       241 -~~~~~~~~~~~~~~i~~~~~~~~~~~~~~------~~~~~~~~~~~  280 (291)
                       ...........+.++++.|....|..|++      +.++..||++.
T Consensus       220 ~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~  266 (329)
T cd05618         220 KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR  266 (329)
T ss_pred             CCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCC
Confidence             00112233466778899999999999987      45777777764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=5.3e-39  Score=274.85  Aligned_cols=235  Identities=25%  Similarity=0.390  Sum_probs=184.0

Q ss_pred             ceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-----CChhHHHHHH-HHhcCCCCCeeeEEEEEEeCCCceEEEEEe
Q psy2172          25 CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-----LSMSACREIA-LLRELKHPNVINLISVFLSHNDRKVWLLFD   98 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e   98 (291)
                      +.||+|+||.||+|.++.  +++.||+|++....     ....+..|.. +++.++||||+++++.+  .+....|+|||
T Consensus         1 ~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~--~~~~~~~lv~e   76 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKA--DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSF--QTADKLYFVLD   76 (323)
T ss_pred             CeeeeCCCeEEEEEEECC--CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEE--EeCCEEEEEEc
Confidence            479999999999999876  67889999986432     1223444544 56788999999999998  55778999999


Q ss_pred             cCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccc
Q psy2172          99 YAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA  177 (291)
Q Consensus        99 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~  177 (291)
                      |+.+ +|...+....         .+++..+..++.|++.||+|||++|++|+||||+||+++    .++.++|+|||++
T Consensus        77 ~~~~g~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~----~~~~~kl~Dfg~~  143 (323)
T cd05575          77 YVNGGELFFHLQRER---------SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLD----SQGHVVLTDFGLC  143 (323)
T ss_pred             CCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEEC----CCCcEEEeccCCC
Confidence            9986 7766665322         288999999999999999999999999999999999998    6779999999998


Q ss_pred             eecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc---------ccCCCCCc
Q psy2172         178 RLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED---------IKTSNPYH  248 (291)
Q Consensus       178 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~---------~~~~~~~~  248 (291)
                      .......   .......|++.|+|||.+.+.. ++.++|+|||||++|+|++|..||.+....         .....+..
T Consensus       144 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  219 (323)
T cd05575         144 KEGIEHS---KTTSTFCGTPEYLAPEVLRKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNI  219 (323)
T ss_pred             cccccCC---CccccccCChhhcChhhhcCCC-CCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence            6432211   1223456899999999998754 889999999999999999999999875432         11223334


Q ss_pred             HHHHHHHHHhhCCCCcCChhhh----hcCCCCcchh
Q psy2172         249 HDQLDRIFSVMGFPLEKDWEDI----RKMPEHPTLL  280 (291)
Q Consensus       249 ~~~~~~i~~~~~~~~~~~~~~~----~~~~~~~~~~  280 (291)
                      ...+.+++..|....|..||+.    .++..+|++.
T Consensus       220 ~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~  255 (323)
T cd05575         220 SVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFS  255 (323)
T ss_pred             CHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcC
Confidence            5678888898888888888776    4566666654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.1e-38  Score=266.41  Aligned_cols=239  Identities=39%  Similarity=0.647  Sum_probs=190.4

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCC----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEec
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG----LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDY   99 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~   99 (291)
                      .+.||+|++|.||+|.++.  ++..|++|.++...    ....+.+|+.+++.++||||+++++++  .++...|+||||
T Consensus         5 ~~~l~~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~~v~e~   80 (285)
T cd07861           5 IEKIGEGTYGVVYKGRNKK--TGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVL--MQESRLYLIFEF   80 (285)
T ss_pred             eeEecccCceEEEEEEECC--CCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEE--eeCCeEEEEEec
Confidence            5689999999999999876  66889999986432    234678899999999999999999999  456789999999


Q ss_pred             CCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeeccccee
Q psy2172         100 AEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL  179 (291)
Q Consensus       100 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~  179 (291)
                      +.+++.+.+.....      ...+++..++.++.|++.||++||++|++|+||+|+||+++    .++.++|+|||++..
T Consensus        81 ~~~~l~~~~~~~~~------~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~----~~~~~~l~dfg~~~~  150 (285)
T cd07861          81 LSMDLKKYLDSLPK------GQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLID----NKGVIKLADFGLARA  150 (285)
T ss_pred             CCCCHHHHHhcCCC------CCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEc----CCCcEEECcccceee
Confidence            99988877754322      12288999999999999999999999999999999999998    677899999999876


Q ss_pred             cCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc-----------------
Q psy2172         180 FNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK-----------------  242 (291)
Q Consensus       180 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~-----------------  242 (291)
                      ......   ......++..|+|||.+.+...++.++|+||||+++|+|++|++||.+......                 
T Consensus       151 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (285)
T cd07861         151 FGIPVR---VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWP  227 (285)
T ss_pred             cCCCcc---cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Confidence            543211   112335678899999987655578999999999999999999999986532100                 


Q ss_pred             ---------------------CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         243 ---------------------TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       243 ---------------------~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                                           .........+.+++..|..+.|..||++.++..+||+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         228 GVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             cchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence                                 0011123455678888888999999999988888874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG0201|consensus

Probab=100.00  E-value=1.7e-40  Score=275.95  Aligned_cols=240  Identities=25%  Similarity=0.401  Sum_probs=201.5

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC---CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG---LSMSACREIALLRELKHPNVINLISVFLSHNDRKVW   94 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (291)
                      ..|+. -+.||+|+||.||+|.+..  +++.||+|++.-+.   ...++++|+.++.+++++||.++|+.|+.  +..++
T Consensus        13 ~~~~~-~~~IgrGsfG~Vyk~~d~~--t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~--g~~Lw   87 (467)
T KOG0201|consen   13 LLYTK-LELIGRGSFGEVYKAIDNK--TKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLK--GTKLW   87 (467)
T ss_pred             ccccc-chhccccccceeeeeeecc--ccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheee--cccHH
Confidence            35553 4799999999999999876  78899999997443   33568899999999999999999999965  66899


Q ss_pred             EEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEee
Q psy2172          95 LLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIAD  173 (291)
Q Consensus        95 iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~D  173 (291)
                      ++||||+| ++.+++.....         +.+..+.-++++++.|+.|||..+.+|+|||+.||++.    ..+.++++|
T Consensus        88 iiMey~~gGsv~~lL~~~~~---------~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s----~~g~vkl~D  154 (467)
T KOG0201|consen   88 IIMEYCGGGSVLDLLKSGNI---------LDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLS----ESGDVKLAD  154 (467)
T ss_pred             HHHHHhcCcchhhhhccCCC---------CccceeeeehHHHHHHhhhhhhcceecccccccceeEe----ccCcEEEEe
Confidence            99999986 77777664432         47888888999999999999999999999999999999    668999999


Q ss_pred             cccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc----------ccC
Q psy2172         174 MGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED----------IKT  243 (291)
Q Consensus       174 fg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~----------~~~  243 (291)
                      ||.+.......   ....+..||+.|||||++.+.+ |+.++||||||++.+||++|.+|+.....-          .+.
T Consensus       155 fgVa~ql~~~~---~rr~tfvGTPfwMAPEVI~~~~-Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~  230 (467)
T KOG0201|consen  155 FGVAGQLTNTV---KRRKTFVGTPFWMAPEVIKQSG-YDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPR  230 (467)
T ss_pred             cceeeeeechh---hccccccccccccchhhhcccc-ccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCc
Confidence            99998766532   2336789999999999999644 999999999999999999999999876542          233


Q ss_pred             CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         244 SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       244 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                      ..-.+...+.+++..+..-.|+.||+..++..|..+
T Consensus       231 L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FI  266 (467)
T KOG0201|consen  231 LDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFI  266 (467)
T ss_pred             cccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHH
Confidence            334667889999999999999999999998776443

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-38  Score=261.19  Aligned_cols=242  Identities=24%  Similarity=0.396  Sum_probs=194.0

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC-------ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCc
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-------SMSACREIALLRELKHPNVINLISVFLSHNDR   91 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (291)
                      .|.+ ++.||+|++|.||.|.+..  +++.+++|.+.....       ...+.+|+.++++++||||+++++++  .+..
T Consensus         3 ~~~~-~~~lg~g~~~~vy~~~~~~--~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~   77 (263)
T cd06625           3 NWRR-GKLLGQGAFGRVYLCYDVD--TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCL--RDDE   77 (263)
T ss_pred             cccc-cceecCCCceEEEEEEEcC--CCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE--ccCC
Confidence            4664 7899999999999999765  678899998864321       23577899999999999999999999  5566


Q ss_pred             eEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEE
Q psy2172          92 KVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVK  170 (291)
Q Consensus        92 ~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~  170 (291)
                      ..++++||+++ +|.+.+....         .+++..+..++.|++.||.+||+.|++|+||+|+||+++    .++.++
T Consensus        78 ~~~~v~e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~----~~~~~~  144 (263)
T cd06625          78 TLSIFMEYMPGGSVKDQLKAYG---------ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRD----SAGNVK  144 (263)
T ss_pred             eEEEEEEECCCCcHHHHHHHhC---------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc----CCCCEE
Confidence            99999999975 7777665432         278899999999999999999999999999999999998    667899


Q ss_pred             EeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc----------
Q psy2172         171 IADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED----------  240 (291)
Q Consensus       171 l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~----------  240 (291)
                      |+|||.+.................++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||......          
T Consensus       145 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~  223 (263)
T cd06625         145 LGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP  223 (263)
T ss_pred             EeecccceeccccccccccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccC
Confidence            999999876543221111112345678899999998755 889999999999999999999999764321          


Q ss_pred             -ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         241 -IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       241 -~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                       ...........+.+++..|....|..||++.++..++|+
T Consensus       224 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         224 TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence             111223445678899999999999999999998888774

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=8e-39  Score=274.10  Aligned_cols=236  Identities=22%  Similarity=0.341  Sum_probs=186.1

Q ss_pred             ceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-----CChhHHHHHHHHhcC-CCCCeeeEEEEEEeCCCceEEEEEe
Q psy2172          25 CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-----LSMSACREIALLREL-KHPNVINLISVFLSHNDRKVWLLFD   98 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~iv~e   98 (291)
                      +.||+|+||.||+|.++.  +++.||+|+++...     ....+.+|+.++.++ +||+|+++++++  .+....|+|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~--~~~~~~~lv~e   76 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKK--NDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF--QTTSRLFLVIE   76 (327)
T ss_pred             CeeeeCCCeEEEEEEECC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE--EeCCEEEEEEe
Confidence            479999999999999876  67889999997532     223467889999888 699999999998  55678999999


Q ss_pred             cCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccc
Q psy2172          99 YAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA  177 (291)
Q Consensus        99 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~  177 (291)
                      |+.+ +|...+....         .+++..++.++.|++.||+|||++|++|+||||+||+++    .++.++|+|||++
T Consensus        77 ~~~~~~L~~~~~~~~---------~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~----~~~~~kl~Dfg~~  143 (327)
T cd05617          77 YVNGGDLMFHMQRQR---------KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD----ADGHIKLTDYGMC  143 (327)
T ss_pred             CCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEe----CCCCEEEeccccc
Confidence            9975 7766554322         289999999999999999999999999999999999998    6778999999998


Q ss_pred             eecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc----------------
Q psy2172         178 RLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI----------------  241 (291)
Q Consensus       178 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~----------------  241 (291)
                      .......   .......|++.|+|||.+.+.. ++.++|+|||||++|+|++|..||.....+.                
T Consensus       144 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  219 (327)
T cd05617         144 KEGLGPG---DTTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP  219 (327)
T ss_pred             eeccCCC---CceecccCCcccCCHHHHCCCC-CCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC
Confidence            7432211   1223456899999999998754 8899999999999999999999997533211                


Q ss_pred             cCCCCCcHHHHHHHHHhhCCCCcCChhhh------hcCCCCcchhh
Q psy2172         242 KTSNPYHHDQLDRIFSVMGFPLEKDWEDI------RKMPEHPTLLK  281 (291)
Q Consensus       242 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~------~~~~~~~~~~~  281 (291)
                      ..........+.+++..|....|..|+++      +++..|+++..
T Consensus       220 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~  265 (327)
T cd05617         220 IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRS  265 (327)
T ss_pred             CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCC
Confidence            01122234567888888888999888764      56777776654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=4.1e-39  Score=279.48  Aligned_cols=242  Identities=21%  Similarity=0.347  Sum_probs=185.4

Q ss_pred             cccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC-----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEE
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-----GLSMSACREIALLRELKHPNVINLISVFLSHNDRKVW   94 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (291)
                      |++ .+.||+|+||.||+|.++.  +++.||+|+++..     .....+.+|+.++..++||+|+++++.+  .+....|
T Consensus         3 f~~-~~~lG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~--~~~~~~~   77 (360)
T cd05627           3 FES-LKVIGRGAFGEVRLVQKKD--TGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF--QDKRNLY   77 (360)
T ss_pred             ceE-EEEEeeCCCEEEEEEEECC--CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE--EcCCEEE
Confidence            443 5699999999999999876  6788999998632     2234577899999999999999999999  6677999


Q ss_pred             EEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEee
Q psy2172          95 LLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIAD  173 (291)
Q Consensus        95 iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~D  173 (291)
                      +||||++| +|.+.+....         .+++..++.++.|++.||++||++||+|+||||+||+++    .++.++|+|
T Consensus        78 lv~E~~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~----~~~~vkL~D  144 (360)
T cd05627          78 LIMEFLPGGDMMTLLMKKD---------TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLD----AKGHVKLSD  144 (360)
T ss_pred             EEEeCCCCccHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEEC----CCCCEEEee
Confidence            99999975 7777775432         288999999999999999999999999999999999998    678999999


Q ss_pred             cccceecCCCCCC--------------------------------CCCCCCceecccccccccccCCcCCCCchhHHHHH
Q psy2172         174 MGFARLFNNPLKP--------------------------------LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIG  221 (291)
Q Consensus       174 fg~~~~~~~~~~~--------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG  221 (291)
                      ||++.........                                ........||+.|+|||++.+.. ++.++|+||||
T Consensus       145 fG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlG  223 (360)
T cd05627         145 FGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDWWSLG  223 (360)
T ss_pred             ccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCC-CCCcceecccc
Confidence            9998754321100                                00011346899999999998755 88999999999


Q ss_pred             HHHHHHHcCCCCCCCCccccc-----------CCC--CCcHHHHHHHHHhhCCCCcCChh---hhhcCCCCcchhh
Q psy2172         222 CIFAELLTSEPIFHCRQEDIK-----------TSN--PYHHDQLDRIFSVMGFPLEKDWE---DIRKMPEHPTLLK  281 (291)
Q Consensus       222 ~~l~~l~~g~~pf~~~~~~~~-----------~~~--~~~~~~~~~i~~~~~~~~~~~~~---~~~~~~~~~~~~~  281 (291)
                      |++|+|++|..||.+......           ...  ....+...+++..+.. .|..++   +++++..|||+..
T Consensus       224 vilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~  298 (360)
T cd05627         224 VIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEG  298 (360)
T ss_pred             ceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCC
Confidence            999999999999987653210           001  1123455666655543 455554   4677788887653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.5e-38  Score=283.59  Aligned_cols=246  Identities=24%  Similarity=0.340  Sum_probs=193.7

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC--ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL--SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLL   96 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv   96 (291)
                      .|.+ .+.||+|++|.||+|..... .+..||+|.+.....  ...+.+|+.+++.++||||+++++++  ......|+|
T Consensus        68 ~y~~-~~~lg~G~~g~vy~a~~~~~-~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~--~~~~~~~lv  143 (478)
T PTZ00267         68 MYVL-TTLVGRNPTTAAFVATRGSD-PKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDF--KSDDKLLLI  143 (478)
T ss_pred             eEEE-EEEEEeCCCcEEEEEEEcCC-CCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEE--EECCEEEEE
Confidence            3554 67999999999999987552 256788887653322  23467899999999999999999999  456789999


Q ss_pred             EecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecc
Q psy2172          97 FDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMG  175 (291)
Q Consensus        97 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg  175 (291)
                      |||+.+ +|.+.+......     ..++++..+..++.|++.||.|||++||+||||||+||+++    ..+.++|+|||
T Consensus       144 ~E~~~gg~L~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~----~~~~~kL~DFg  214 (478)
T PTZ00267        144 MEYGSGGDLNKQIKQRLKE-----HLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLM----PTGIIKLGDFG  214 (478)
T ss_pred             EECCCCCCHHHHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEEC----CCCcEEEEeCc
Confidence            999975 887776543221     12388999999999999999999999999999999999998    67799999999


Q ss_pred             cceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc----------ccCCC
Q psy2172         176 FARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED----------IKTSN  245 (291)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~----------~~~~~  245 (291)
                      ++........ ........||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+....          .....
T Consensus       215 la~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~  292 (478)
T PTZ00267        215 FSKQYSDSVS-LDVASSFCGTPYYLAPELWERKR-YSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFP  292 (478)
T ss_pred             CceecCCccc-cccccccCCCccccCHhHhCCCC-CCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence            9987643211 11223456899999999998754 899999999999999999999999865431          11122


Q ss_pred             CCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         246 PYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       246 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                      ......+.+++..|..+.|..||+..++..++++
T Consensus       293 ~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~  326 (478)
T PTZ00267        293 CPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFL  326 (478)
T ss_pred             ccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHH
Confidence            2345678899999999999999999988766554

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2e-38  Score=272.20  Aligned_cols=244  Identities=22%  Similarity=0.349  Sum_probs=195.9

Q ss_pred             ccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      .+.|++ .++||+|+||.||+|.+..  ++..+++|++.....   ...+.+|+++++.++||||+++++++.  +....
T Consensus         4 ~~~y~~-~~~lg~g~~g~V~~~~~~~--~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~   78 (333)
T cd06650           4 DDDFEK-ISELGAGNGGVVFKVSHKP--SGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY--SDGEI   78 (333)
T ss_pred             hhhhhe-eccccCCCCEEEEEEEECC--CCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEE--ECCEE
Confidence            456775 6799999999999999876  667899998865422   245889999999999999999999994  46689


Q ss_pred             EEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CeeeeccCCCcEEeecCCCCCCcEEE
Q psy2172          94 WLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSN-WVLHRDLKPANILVMGEGIERGRVKI  171 (291)
Q Consensus        94 ~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~-~ivH~dik~~Nil~~~~~~~~~~~~l  171 (291)
                      ++||||+.+ +|.+.+....         .+++..+..++.|++.||.|||++ +++|+||||+||+++    .++.++|
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~----~~~~~kL  145 (333)
T cd06650          79 SICMEHMDGGSLDQVLKKAG---------RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN----SRGEIKL  145 (333)
T ss_pred             EEEEecCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEc----CCCCEEE
Confidence            999999975 8887775432         178899999999999999999975 799999999999998    6678999


Q ss_pred             eecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc---------
Q psy2172         172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK---------  242 (291)
Q Consensus       172 ~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~---------  242 (291)
                      +|||++......     ......|+..|+|||.+.+.. ++.++|+|||||++|+|++|..||........         
T Consensus       146 ~Dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  219 (333)
T cd06650         146 CDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVE  219 (333)
T ss_pred             eeCCcchhhhhh-----ccccCCCCccccCHHHhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCccc
Confidence            999998754332     112346788999999998744 88999999999999999999999975332100         


Q ss_pred             ----------------------------------------------CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCC
Q psy2172         243 ----------------------------------------------TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEH  276 (291)
Q Consensus       243 ----------------------------------------------~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  276 (291)
                                                                    .........+.+++..|....|..||++.++..+
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h  299 (333)
T cd06650         220 GDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH  299 (333)
T ss_pred             CCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence                                                          0000123567899999999999999999999999


Q ss_pred             cchhhhhh
Q psy2172         277 PTLLKDFN  284 (291)
Q Consensus       277 ~~~~~~~~  284 (291)
                      +++.....
T Consensus       300 ~~~~~~~~  307 (333)
T cd06650         300 AFIKRSEA  307 (333)
T ss_pred             HHHhcCcc
Confidence            98865543

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.4e-38  Score=283.45  Aligned_cols=249  Identities=23%  Similarity=0.369  Sum_probs=193.4

Q ss_pred             ccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC-CCChhHHHHHHHHhcCCC------CCeeeEEEEEEeCC
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-GLSMSACREIALLRELKH------PNVINLISVFLSHN   89 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l~h------~~iv~~~~~~~~~~   89 (291)
                      .++|.+ .++||+|+||.||+|.+..  .++.||||+++.. ........|+.+++.++|      ++++++++++.. +
T Consensus       128 ~~~y~i-~~~lG~G~fg~V~~a~~~~--~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~-~  203 (467)
T PTZ00284        128 TQRFKI-LSLLGEGTFGKVVEAWDRK--RKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN-E  203 (467)
T ss_pred             CCcEEE-EEEEEeccCEEEEEEEEcC--CCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc-C
Confidence            456775 6699999999999999876  6788999999643 233456678888887754      458888888843 4


Q ss_pred             CceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCeeeeccCCCcEEeecCCC----
Q psy2172          90 DRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHS-NWVLHRDLKPANILVMGEGI----  164 (291)
Q Consensus        90 ~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~-~~ivH~dik~~Nil~~~~~~----  164 (291)
                      ...+|+||++++++|.+.+....         .+++..+..++.|++.||.|||+ .||+|+||||+||+++.++.    
T Consensus       204 ~~~~~iv~~~~g~~l~~~l~~~~---------~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~  274 (467)
T PTZ00284        204 TGHMCIVMPKYGPCLLDWIMKHG---------PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDP  274 (467)
T ss_pred             CceEEEEEeccCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccc
Confidence            46899999999999888776432         28899999999999999999997 59999999999999985321    


Q ss_pred             --------CCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCC
Q psy2172         165 --------ERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  236 (291)
Q Consensus       165 --------~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~  236 (291)
                              ....++|+|||.+.....      ......||..|+|||++.+.. ++.++|||||||++|+|++|+.||.+
T Consensus       275 ~~~~~~~~~~~~vkl~DfG~~~~~~~------~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvil~elltG~~pf~~  347 (467)
T PTZ00284        275 VTNRALPPDPCRVRICDLGGCCDERH------SRTAIVSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDT  347 (467)
T ss_pred             ccccccCCCCceEEECCCCccccCcc------ccccccCCccccCcHHhhcCC-CCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence                    123599999998754322      223457899999999998755 89999999999999999999999976


Q ss_pred             Cccccc------------------------------------CC---------------CCCcHHHHHHHHHhhCCCCcC
Q psy2172         237 RQEDIK------------------------------------TS---------------NPYHHDQLDRIFSVMGFPLEK  265 (291)
Q Consensus       237 ~~~~~~------------------------------------~~---------------~~~~~~~~~~i~~~~~~~~~~  265 (291)
                      ......                                    ..               .......+.+++..|....|.
T Consensus       348 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~  427 (467)
T PTZ00284        348 HDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQ  427 (467)
T ss_pred             CChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChh
Confidence            542100                                    00               001124456889999999999


Q ss_pred             ChhhhhcCCCCcchhhhhhh
Q psy2172         266 DWEDIRKMPEHPTLLKDFNE  285 (291)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~  285 (291)
                      .|+++.++..|||+.+.+.+
T Consensus       428 ~R~ta~e~L~Hp~~~~~~~~  447 (467)
T PTZ00284        428 KRLNARQMTTHPYVLKYYPE  447 (467)
T ss_pred             hCCCHHHHhcCccccccCCc
Confidence            99999999999999876543

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1e-38  Score=264.58  Aligned_cols=236  Identities=31%  Similarity=0.555  Sum_probs=194.4

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChh----HHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEec
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMS----ACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDY   99 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~----~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~   99 (291)
                      ++.||+|+||.||+|.+..  +++.+|+|++........    ..+|+.+++.++||||+++++++.  +....+++||+
T Consensus         4 ~~~lg~G~~g~v~~~~~~~--~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~--~~~~~~~v~~~   79 (260)
T PF00069_consen    4 VKKLGSGGFGTVYKAKNKK--NGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQ--DDNYLYIVMEY   79 (260)
T ss_dssp             EEEEEEESSEEEEEEEETT--TTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEE--ESSEEEEEEEE
T ss_pred             eEEEEeCCCEEEEEEEECC--CCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccc--ccccccccccc
Confidence            6799999999999999877  677899999986644332    345899999999999999999994  47789999999


Q ss_pred             CCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccce
Q psy2172         100 AEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR  178 (291)
Q Consensus       100 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~  178 (291)
                      +.+ +|.+.+.....         ++...++.++.|++.||++||++|++|+||||+||+++    .++.++|+|||.+.
T Consensus        80 ~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~----~~~~~~l~Dfg~~~  146 (260)
T PF00069_consen   80 CPGGSLQDYLQKNKP---------LSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLD----ENGEVKLIDFGSSV  146 (260)
T ss_dssp             ETTEBHHHHHHHHSS---------BBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEES----TTSEEEESSGTTTE
T ss_pred             ccccccccccccccc---------cccccccccccccccccccccccccccccccccccccc----cccccccccccccc
Confidence            998 88888872221         89999999999999999999999999999999999999    67899999999998


Q ss_pred             ecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---------------cC
Q psy2172         179 LFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---------------KT  243 (291)
Q Consensus       179 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---------------~~  243 (291)
                      ....   .........++..|+|||.+.....++.++|+||||+++|+|++|..||.......               ..
T Consensus       147 ~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  223 (260)
T PF00069_consen  147 KLSE---NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS  223 (260)
T ss_dssp             ESTS---TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT
T ss_pred             cccc---cccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccc
Confidence            6421   11233455678899999999833458999999999999999999999999872110               00


Q ss_pred             -CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         244 -SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       244 -~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                       ........+.+++..|..+.|..||++.++..+||+
T Consensus       224 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  224 QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             cccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence             111113789999999999999999999999998885

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG1026|consensus

Probab=100.00  E-value=2e-39  Score=289.41  Aligned_cols=242  Identities=22%  Similarity=0.358  Sum_probs=197.2

Q ss_pred             cceeCcccceEEEEEEEccC---CCCceeEEEEeCCCCCC---hhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEE
Q psy2172          24 GCKVGRGTYGHVYKARRKDN---SDTRDYALKQIEGTGLS---MSACREIALLRELKHPNVINLISVFLSHNDRKVWLLF   97 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~---~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~   97 (291)
                      .+.||+|+||.||+|+..+.   +....||||.++.....   ++|++|++++..++|||||+++|++  ..++.+|+|+
T Consensus       491 ~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC--~~~~P~~MvF  568 (774)
T KOG1026|consen  491 KEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVC--REGDPLCMVF  568 (774)
T ss_pred             hhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE--ccCCeeEEEE
Confidence            56899999999999987553   24456999999876544   5799999999999999999999999  6788999999


Q ss_pred             ecCC-CCHHHHHHHhhhhhhCC-----CCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEE
Q psy2172          98 DYAE-HDLWHIIKFHRAAKANK-----KPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI  171 (291)
Q Consensus        98 e~~~-~~l~~~~~~~~~~~~~~-----~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l  171 (291)
                      ||+. |+|.+++..........     .+.+++..+.+.|+.|||.|+.||-++.+||+||..+|+|++    ....|||
T Consensus       569 EYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVg----e~l~VKI  644 (774)
T KOG1026|consen  569 EYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVG----ENLVVKI  644 (774)
T ss_pred             EecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceec----cceEEEe
Confidence            9998 69999998765433221     245589999999999999999999999999999999999999    7889999


Q ss_pred             eecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc----------
Q psy2172         172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED----------  240 (291)
Q Consensus       172 ~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~----------  240 (291)
                      +|||+++...+..... ......-..+|||||.+...+ ++.++||||+||+|||+++ |.-||.+..++          
T Consensus       645 sDfGLsRdiYssDYYk-~~~~t~lPIRWMppEsIly~k-FTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~  722 (774)
T KOG1026|consen  645 SDFGLSRDIYSSDYYK-VRGNTLLPIRWMPPESILYGK-FTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQ  722 (774)
T ss_pred             cccccchhhhhhhhhc-ccCCceeeeecCCHHHhhcCc-ccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCC
Confidence            9999999877643321 122345578899999998855 9999999999999999997 99999987764          


Q ss_pred             ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         241 IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       241 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      +....-.+...+.+++..+..-.|.+||+++++
T Consensus       723 lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI  755 (774)
T KOG1026|consen  723 LLSCPENCPTEVYSLMLECWNENPKRRPSFKEI  755 (774)
T ss_pred             cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            222333445667777777777777777777764

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.3e-39  Score=275.60  Aligned_cols=238  Identities=23%  Similarity=0.371  Sum_probs=189.9

Q ss_pred             ceeCcccceEEEEEEEcc-CCCCceeEEEEeCCCC----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEec
Q psy2172          25 CKVGRGTYGHVYKARRKD-NSDTRDYALKQIEGTG----LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDY   99 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~-~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~   99 (291)
                      +.||+|+||.||++.+.. ..+++.+|+|++....    ....+.+|++++++++||||+++++++  .+....|+||||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~--~~~~~~~lv~e~   79 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAF--QTEGKLYLILDF   79 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEE--EcCCEEEEEEcC
Confidence            479999999999998642 2367889999987432    233567899999999999999999999  556789999999


Q ss_pred             CCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccce
Q psy2172         100 AEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR  178 (291)
Q Consensus       100 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~  178 (291)
                      +.+ +|.+.+....         .+++..++.++.|++.||+|||++|++|+||||+||+++    .++.++|+|||++.
T Consensus        80 ~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~----~~~~~kL~Dfg~~~  146 (318)
T cd05582          80 LRGGDLFTRLSKEV---------MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD----EEGHIKLTDFGLSK  146 (318)
T ss_pred             CCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEEC----CCCcEEEeeccCCc
Confidence            974 7776664321         289999999999999999999999999999999999998    66789999999987


Q ss_pred             ecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc---------ccCCCCCcH
Q psy2172         179 LFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED---------IKTSNPYHH  249 (291)
Q Consensus       179 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~---------~~~~~~~~~  249 (291)
                      ......   .......|+..|+|||.+.+.. ++.++|+|||||++|+|++|..||.+....         .........
T Consensus       147 ~~~~~~---~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~  222 (318)
T cd05582         147 ESIDHE---KKAYSFCGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLS  222 (318)
T ss_pred             ccCCCC---CceecccCChhhcCHHHHcCCC-CCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence            543321   1223456889999999998744 789999999999999999999999875532         111223345


Q ss_pred             HHHHHHHHhhCCCCcCChhh-----hhcCCCCcchhh
Q psy2172         250 DQLDRIFSVMGFPLEKDWED-----IRKMPEHPTLLK  281 (291)
Q Consensus       250 ~~~~~i~~~~~~~~~~~~~~-----~~~~~~~~~~~~  281 (291)
                      ..+.+++..|..+.|..||+     +.++..++++..
T Consensus       223 ~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~  259 (318)
T cd05582         223 PEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFST  259 (318)
T ss_pred             HHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCC
Confidence            67889999999999999998     556777777643

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.5e-38  Score=271.87  Aligned_cols=234  Identities=25%  Similarity=0.382  Sum_probs=180.7

Q ss_pred             ceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-----CChhHHHHHH-HHhcCCCCCeeeEEEEEEeCCCceEEEEEe
Q psy2172          25 CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-----LSMSACREIA-LLRELKHPNVINLISVFLSHNDRKVWLLFD   98 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e   98 (291)
                      +.||+|+||.||+|.+..  +++.||+|++....     ....+..|.. +++.++||||+++++++  .+....|+|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~--~~~~~~~lv~e   76 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKS--DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF--QTAEKLYFVLD   76 (321)
T ss_pred             CeeeeCCCEEEEEEEECC--CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE--EcCCEEEEEEc
Confidence            479999999999999876  67889999986432     1223444544 67888999999999998  56778999999


Q ss_pred             cCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccc
Q psy2172          99 YAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA  177 (291)
Q Consensus        99 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~  177 (291)
                      |+++ +|...+....         .+++..+..++.|++.||.|||++||+|+||||+||+++    .++.++|+|||++
T Consensus        77 ~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~----~~~~~kl~Dfg~~  143 (321)
T cd05603          77 YVNGGELFFHLQRER---------CFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLD----SQGHVVLTDFGLC  143 (321)
T ss_pred             CCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC----CCCCEEEccCCCC
Confidence            9986 6665554321         278899999999999999999999999999999999998    6779999999998


Q ss_pred             eecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc---------ccCCCCCc
Q psy2172         178 RLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED---------IKTSNPYH  248 (291)
Q Consensus       178 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~---------~~~~~~~~  248 (291)
                      .......   .......|++.|+|||.+.+.. ++.++|+|||||++|+|++|..||.+.+..         .....+..
T Consensus       144 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  219 (321)
T cd05603         144 KEGVEPE---ETTSTFCGTPEYLAPEVLRKEP-YDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGK  219 (321)
T ss_pred             ccCCCCC---CccccccCCcccCCHHHhcCCC-CCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Confidence            6432211   1223456899999999997744 889999999999999999999999876531         11122234


Q ss_pred             HHHHHHHHHhhCCCCcCChhhh----hcCCCCcch
Q psy2172         249 HDQLDRIFSVMGFPLEKDWEDI----RKMPEHPTL  279 (291)
Q Consensus       249 ~~~~~~i~~~~~~~~~~~~~~~----~~~~~~~~~  279 (291)
                      ...+.+++..|....|..|++.    .++..++++
T Consensus       220 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~  254 (321)
T cd05603         220 TVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFF  254 (321)
T ss_pred             CHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCc
Confidence            5567788888888888888654    355555554

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2.7e-38  Score=270.44  Aligned_cols=236  Identities=24%  Similarity=0.300  Sum_probs=184.5

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-----CChhHHHHHHHHhcC-CCCCeeeEEEEEEeCCCceEEEEE
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-----LSMSACREIALLREL-KHPNVINLISVFLSHNDRKVWLLF   97 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~iv~   97 (291)
                      .+.||+|+||.||+|.++.  +++.||+|+++...     .......|..++..+ +|++|+++++++  .+....|+||
T Consensus         5 ~~~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~--~~~~~~~lv~   80 (323)
T cd05616           5 LMVLGKGSFGKVMLAERKG--TDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF--QTMDRLYFVM   80 (323)
T ss_pred             EEEEeeCCCeEEEEEEECC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE--ecCCEEEEEE
Confidence            5699999999999999876  67889999987432     122456677888777 589999999998  5567899999


Q ss_pred             ecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeeccc
Q psy2172          98 DYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGF  176 (291)
Q Consensus        98 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~  176 (291)
                      ||+++ +|...+....         .+++..+..++.|++.||+|||++|++|+||||+||+++    .++.++|+|||+
T Consensus        81 E~~~~g~L~~~~~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~----~~~~~kL~DfG~  147 (323)
T cd05616          81 EYVNGGDLMYQIQQVG---------RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD----SEGHIKIADFGM  147 (323)
T ss_pred             cCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEEC----CCCcEEEccCCC
Confidence            99975 7776665332         288999999999999999999999999999999999998    677899999999


Q ss_pred             ceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---------cCCCCC
Q psy2172         177 ARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---------KTSNPY  247 (291)
Q Consensus       177 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---------~~~~~~  247 (291)
                      +.......   .......|++.|+|||++.+.. ++.++|+|||||++|+|++|..||.+.....         ......
T Consensus       148 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~  223 (323)
T cd05616         148 CKENMWDG---VTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS  223 (323)
T ss_pred             ceecCCCC---CccccCCCChhhcCHHHhcCCC-CCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence            87543211   1223456899999999998754 8999999999999999999999998765321         111223


Q ss_pred             cHHHHHHHHHhhCCCCcCChhhh-----hcCCCCcchh
Q psy2172         248 HHDQLDRIFSVMGFPLEKDWEDI-----RKMPEHPTLL  280 (291)
Q Consensus       248 ~~~~~~~i~~~~~~~~~~~~~~~-----~~~~~~~~~~  280 (291)
                      ....+.+++..|....|..|++.     .++..++++.
T Consensus       224 ~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~  261 (323)
T cd05616         224 MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR  261 (323)
T ss_pred             CCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcC
Confidence            34667788888888888887764     4555665543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.3e-38  Score=272.62  Aligned_cols=234  Identities=24%  Similarity=0.393  Sum_probs=181.3

Q ss_pred             ceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-----CChhHHHHH-HHHhcCCCCCeeeEEEEEEeCCCceEEEEEe
Q psy2172          25 CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-----LSMSACREI-ALLRELKHPNVINLISVFLSHNDRKVWLLFD   98 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e   98 (291)
                      +.||+|+||.||+|.++.  +++.||+|++....     ....+..|. .+++.++||||+++++++  .+....|+|||
T Consensus         1 ~~lg~G~fg~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~--~~~~~~~lv~e   76 (325)
T cd05602           1 KVIGKGSFGKVLLARHKA--EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF--QTADKLYFVLD   76 (325)
T ss_pred             CeeeeCCCeEEEEEEECC--CCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEE--EcCCeEEEEEe
Confidence            479999999999999876  67889999986421     122344444 356778999999999998  55678999999


Q ss_pred             cCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccc
Q psy2172          99 YAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA  177 (291)
Q Consensus        99 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~  177 (291)
                      |+.+ +|...+....         .+++..+..++.|++.||.|||++||+|+||||+||+++    .++.++|+|||++
T Consensus        77 ~~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~----~~~~~kl~DfG~a  143 (325)
T cd05602          77 YINGGELFYHLQRER---------CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD----SQGHIVLTDFGLC  143 (325)
T ss_pred             CCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC----CCCCEEEccCCCC
Confidence            9986 7766665322         178889999999999999999999999999999999998    6678999999998


Q ss_pred             eecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---------cCCCCCc
Q psy2172         178 RLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---------KTSNPYH  248 (291)
Q Consensus       178 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---------~~~~~~~  248 (291)
                      .......   .......|++.|+|||++.+.. ++.++|||||||++|+|++|..||.+.....         ....+..
T Consensus       144 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  219 (325)
T cd05602         144 KENIEHN---GTTSTFCGTPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNI  219 (325)
T ss_pred             cccccCC---CCcccccCCccccCHHHHcCCC-CCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCC
Confidence            7432211   1223456899999999998754 8899999999999999999999998754321         1223344


Q ss_pred             HHHHHHHHHhhCCCCcCChhhhh----cCCCCcch
Q psy2172         249 HDQLDRIFSVMGFPLEKDWEDIR----KMPEHPTL  279 (291)
Q Consensus       249 ~~~~~~i~~~~~~~~~~~~~~~~----~~~~~~~~  279 (291)
                      ...+.+++..|....|..|++..    ++..++++
T Consensus       220 ~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~  254 (325)
T cd05602         220 TNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFF  254 (325)
T ss_pred             CHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCccc
Confidence            56788888888888888887654    44445443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG4717|consensus

Probab=100.00  E-value=6.3e-39  Score=271.45  Aligned_cols=250  Identities=27%  Similarity=0.445  Sum_probs=212.4

Q ss_pred             ccccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC----ChhHHHHHHHHhcCCCCCeeeEEEEEE
Q psy2172          11 NERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL----SMSACREIALLRELKHPNVINLISVFL   86 (291)
Q Consensus        11 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~   86 (291)
                      .-..+|.++|.. .+-||+|-|+.|-+|++.-  +++.||||++.+...    ..++..|+..|+.++|||||++|++. 
T Consensus        11 i~DgkIAGLYDL-ekTlG~GHFAVVKLArHVF--TGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi-   86 (864)
T KOG4717|consen   11 IYDGKIAGLYDL-EKTLGRGHFAVVKLARHVF--TGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-   86 (864)
T ss_pred             ccccceeeeehh-hhhhcCCceehhhhhhhhc--ccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh-
Confidence            356789999996 5699999999999998665  889999999986543    34688999999999999999999999 


Q ss_pred             eCCCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCC
Q psy2172          87 SHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIE  165 (291)
Q Consensus        87 ~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~  165 (291)
                       +....+|+|.|.-++ +|.+++..+..+        +++..+.+++.||+.|+.|.|+..+||+||||+|+++..   +
T Consensus        87 -DTQTKlyLiLELGD~GDl~DyImKHe~G--------l~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFE---K  154 (864)
T KOG4717|consen   87 -DTQTKLYLILELGDGGDLFDYIMKHEEG--------LNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFE---K  154 (864)
T ss_pred             -cccceEEEEEEecCCchHHHHHHhhhcc--------ccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEee---e
Confidence             778899999999985 999999887766        899999999999999999999999999999999998874   5


Q ss_pred             CCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccC--
Q psy2172         166 RGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT--  243 (291)
Q Consensus       166 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~--  243 (291)
                      -+.|||+|||++-.+...    ....+.+|+..|.|||++.|..+..++.|||||||+||-+.+|++||+..++..-.  
T Consensus       155 lGlVKLTDFGFSNkf~PG----~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTm  230 (864)
T KOG4717|consen  155 LGLVKLTDFGFSNKFQPG----KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTM  230 (864)
T ss_pred             cCceEeeeccccccCCCc----chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhh
Confidence            689999999998766543    44567899999999999999876778999999999999999999999877653211  


Q ss_pred             -------CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchh
Q psy2172         244 -------SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLL  280 (291)
Q Consensus       244 -------~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  280 (291)
                             ........-.+++..|..-.|+.+.+++++...+|+.
T Consensus       231 ImDCKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq  274 (864)
T KOG4717|consen  231 IMDCKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQ  274 (864)
T ss_pred             hhcccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcccccc
Confidence                   1112244567788888888899999999988888865

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=7.2e-39  Score=274.25  Aligned_cols=235  Identities=26%  Similarity=0.404  Sum_probs=182.0

Q ss_pred             ceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-----CChhHHHHHH-HHhcCCCCCeeeEEEEEEeCCCceEEEEEe
Q psy2172          25 CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-----LSMSACREIA-LLRELKHPNVINLISVFLSHNDRKVWLLFD   98 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e   98 (291)
                      +.||+|+||.||+|.++.  +++.+|+|++....     ....+..|.. +++.++||||+++++++  ......|+|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~--~~~~~~~lv~e   76 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKL--DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF--QTTEKLYFVLD   76 (325)
T ss_pred             CceeeCCCeEEEEEEECC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE--ecCCEEEEEEc
Confidence            469999999999999876  67889999986431     1223445544 56778999999999998  56778999999


Q ss_pred             cCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccc
Q psy2172          99 YAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA  177 (291)
Q Consensus        99 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~  177 (291)
                      |+.+ +|...+....         .+++..+..++.|++.||+|||++|++|+||||+||+++    .++.++|+|||++
T Consensus        77 ~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~----~~~~~kL~DfG~~  143 (325)
T cd05604          77 FVNGGELFFHLQRER---------SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLD----SQGHVVLTDFGLC  143 (325)
T ss_pred             CCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC----CCCCEEEeecCCc
Confidence            9986 6665554322         288999999999999999999999999999999999998    6779999999998


Q ss_pred             eecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---------cCCCCCc
Q psy2172         178 RLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---------KTSNPYH  248 (291)
Q Consensus       178 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---------~~~~~~~  248 (291)
                      .......   .......|+..|+|||++.+.. ++.++|||||||++|+|++|..||.+.....         ....+..
T Consensus       144 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~  219 (325)
T cd05604         144 KEGIAQS---DTTTTFCGTPEYLAPEVIRKQP-YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGA  219 (325)
T ss_pred             ccCCCCC---CCcccccCChhhCCHHHHcCCC-CCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCC
Confidence            6432211   1223456899999999998754 8899999999999999999999998764321         1122334


Q ss_pred             HHHHHHHHHhhCCCCcCChhhhh----cCCCCcchh
Q psy2172         249 HDQLDRIFSVMGFPLEKDWEDIR----KMPEHPTLL  280 (291)
Q Consensus       249 ~~~~~~i~~~~~~~~~~~~~~~~----~~~~~~~~~  280 (291)
                      ...+.+++..|....|..||+..    ++..+|++.
T Consensus       220 ~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~  255 (325)
T cd05604         220 SLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFE  255 (325)
T ss_pred             CHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcC
Confidence            55677888888888888887653    566666654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=8.9e-38  Score=268.66  Aligned_cols=238  Identities=39%  Similarity=0.717  Sum_probs=193.9

Q ss_pred             ccccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC----------------hhHHHHHHHHhcCC
Q psy2172          11 NERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----------------MSACREIALLRELK   74 (291)
Q Consensus        11 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----------------~~~~~e~~~l~~l~   74 (291)
                      |+...+.++|....+.||+|+||.||+|.+..  .++.||+|.++.....                ..+.+|+++++.++
T Consensus         1 ~~~~~~~~ry~~~~~~ig~G~~g~vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~   78 (335)
T PTZ00024          1 NMSFSISERYIQKGAHLGEGTYGKVEKAYDTL--TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK   78 (335)
T ss_pred             CCccccccchhhhhhcccCCCceeEEEEEECC--CCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC
Confidence            45667888998778899999999999999876  6788999988643222                14678999999999


Q ss_pred             CCCeeeEEEEEEeCCCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCC
Q psy2172          75 HPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKP  154 (291)
Q Consensus        75 h~~iv~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~  154 (291)
                      |+||+++++++  ......+++|||++++|.+.+....         .+++..+..++.|++.||++||++|++|+||+|
T Consensus        79 h~~iv~~~~~~--~~~~~~~lv~e~~~~~l~~~l~~~~---------~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~  147 (335)
T PTZ00024         79 HENIMGLVDVY--VEGDFINLVMDIMASDLKKVVDRKI---------RLTESQVKCILLQILNGLNVLHKWYFMHRDLSP  147 (335)
T ss_pred             CcceeeeeEEE--ecCCcEEEEEeccccCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCeecccccH
Confidence            99999999999  4567899999999999888875422         188999999999999999999999999999999


Q ss_pred             CcEEeecCCCCCCcEEEeecccceecCCCCC-----------CCCCCCCceecccccccccccCCcCCCCchhHHHHHHH
Q psy2172         155 ANILVMGEGIERGRVKIADMGFARLFNNPLK-----------PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCI  223 (291)
Q Consensus       155 ~Nil~~~~~~~~~~~~l~Dfg~~~~~~~~~~-----------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~  223 (291)
                      +||+++    ..+.++|+|||.+........           .........++..|+|||.+.+...++.++|+||||++
T Consensus       148 ~nill~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~  223 (335)
T PTZ00024        148 ANIFIN----SKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCI  223 (335)
T ss_pred             HHeEEC----CCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHH
Confidence            999998    667899999999876542110           01111233457789999999775557899999999999


Q ss_pred             HHHHHcCCCCCCCCcccccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCC
Q psy2172         224 FAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMP  274 (291)
Q Consensus       224 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  274 (291)
                      +|+|++|..||.+...         .+.+..+...++.|.+..||....++
T Consensus       224 l~el~tg~~p~~~~~~---------~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (335)
T PTZ00024        224 FAELLTGKPLFPGENE---------IDQLGRIFELLGTPNEDNWPQAKKLP  265 (335)
T ss_pred             HHHHHhCCCCCCCCCH---------HHHHHHHHHHhCCCchhhCcchhhcc
Confidence            9999999999987765         36778888888888887787665444

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=5.6e-38  Score=263.94  Aligned_cols=238  Identities=24%  Similarity=0.388  Sum_probs=192.2

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC-----ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEe
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-----SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFD   98 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e   98 (291)
                      .+.||+|+||.||+|.+..  +++.||+|.+.....     ...+.+|+.++++++|++++.+++.+  .+....+++||
T Consensus         5 ~~~ig~G~~g~v~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~--~~~~~~~lv~e   80 (285)
T cd05630           5 YRVLGKGGFGEVCACQVRA--TGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAY--ETKDALCLVLT   80 (285)
T ss_pred             eEEeecCCCeEEEEEEEcC--CCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEE--ecCCEEEEEEE
Confidence            5689999999999999877  678999998864321     23466899999999999999999998  45678999999


Q ss_pred             cCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccc
Q psy2172          99 YAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA  177 (291)
Q Consensus        99 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~  177 (291)
                      |+.+ +|...+.....       ..+++..+..++.|++.||.+||+.|++|+||||+||+++    .++.++|+|||++
T Consensus        81 ~~~g~~L~~~l~~~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~----~~~~~~l~Dfg~~  149 (285)
T cd05630          81 LMNGGDLKFHIYHMGE-------AGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLD----DHGHIRISDLGLA  149 (285)
T ss_pred             ecCCCcHHHHHHHhcc-------cCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC----CCCCEEEeeccce
Confidence            9975 77766643221       1288999999999999999999999999999999999998    6678999999998


Q ss_pred             eecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc-------------cCC
Q psy2172         178 RLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI-------------KTS  244 (291)
Q Consensus       178 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~-------------~~~  244 (291)
                      .......    ......|+..|+|||++.+.. ++.++|+||+|+++|+|++|..||.......             ...
T Consensus       150 ~~~~~~~----~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  224 (285)
T cd05630         150 VHVPEGQ----TIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEY  224 (285)
T ss_pred             eecCCCc----cccCCCCCccccChHHHcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhc
Confidence            7543221    112346789999999998754 8999999999999999999999998643211             011


Q ss_pred             CCCcHHHHHHHHHhhCCCCcCChhh-----hhcCCCCcchhh
Q psy2172         245 NPYHHDQLDRIFSVMGFPLEKDWED-----IRKMPEHPTLLK  281 (291)
Q Consensus       245 ~~~~~~~~~~i~~~~~~~~~~~~~~-----~~~~~~~~~~~~  281 (291)
                      .......+.+++..+....|..|++     ++++..+||+.+
T Consensus       225 ~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~  266 (285)
T cd05630         225 SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ  266 (285)
T ss_pred             CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence            2234566889999999999999998     788999998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=7.6e-38  Score=265.55  Aligned_cols=248  Identities=23%  Similarity=0.298  Sum_probs=186.2

Q ss_pred             ccccccccceeCcccceEEEEEEEccC--------------CCCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCee
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDN--------------SDTRDYALKQIEGTGL---SMSACREIALLRELKHPNVI   79 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~--------------~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv   79 (291)
                      .++|++ .++||+|+||.||+|.+...              ..+..||+|.+.....   ..++.+|+.++.+++||||+
T Consensus         4 ~~~~~~-~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv   82 (304)
T cd05096           4 RGHLLF-KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNII   82 (304)
T ss_pred             hhhCee-eeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCee
Confidence            346665 66999999999999986432              2345799999875432   23588999999999999999


Q ss_pred             eEEEEEEeCCCceEEEEEecCCC-CHHHHHHHhhhhhh----------CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCee
Q psy2172          80 NLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKA----------NKKPVMVPKGMVKSLLYQILDGIHYLHSNWVL  148 (291)
Q Consensus        80 ~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~----------~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~iv  148 (291)
                      ++++++.  +....+++|||+.+ +|.+.+........          ......++...++.++.|++.||.|||++|++
T Consensus        83 ~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv  160 (304)
T cd05096          83 RLLGVCV--DEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV  160 (304)
T ss_pred             EEEEEEe--cCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            9999994  45678999999975 88877755322111          01112377888999999999999999999999


Q ss_pred             eeccCCCcEEeecCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHH
Q psy2172         149 HRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL  228 (291)
Q Consensus       149 H~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~  228 (291)
                      |+||||+||+++    .++.++|+|||++........ ........++..|+|||.+.+.. ++.++||||||+++|+|+
T Consensus       161 H~dlkp~Nill~----~~~~~kl~DfG~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~  234 (304)
T cd05096         161 HRDLATRNCLVG----ENLTIKIADFGMSRNLYAGDY-YRIQGRAVLPIRWMAWECILMGK-FTTASDVWAFGVTLWEIL  234 (304)
T ss_pred             ccCcchhheEEc----CCccEEECCCccceecccCce-eEecCcCCCCccccCHHHHhcCC-CCchhhhHHHHHHHHHHH
Confidence            999999999998    667899999999876543211 11122334567899999987644 899999999999999998


Q ss_pred             c--CCCCCCCCcccc-----------------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         229 T--SEPIFHCRQEDI-----------------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       229 ~--g~~pf~~~~~~~-----------------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      +  +..||.......                 ....+.....+.+++..|....|..||++.++
T Consensus       235 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i  298 (304)
T cd05096         235 MLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDI  298 (304)
T ss_pred             HccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHH
Confidence            6  567887543210                 01122334668888999999999999988764

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.6e-38  Score=265.79  Aligned_cols=240  Identities=36%  Similarity=0.636  Sum_probs=185.0

Q ss_pred             cccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEE
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG----LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWL   95 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~i   95 (291)
                      |++ .+.||+|+||.||+|.++.  ++..+++|.++...    ....+.+|+.++++++||||+++++++  .+....++
T Consensus         2 y~~-~~~l~~g~~~~vy~~~~~~--~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~--~~~~~~~l   76 (284)
T cd07839           2 YEK-LEKIGEGTYGTVFKAKNRE--THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVL--HSDKKLTL   76 (284)
T ss_pred             cee-EEEecccCCeEEEEEEECC--CCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHh--ccCCceEE
Confidence            453 5689999999999999876  66789999986432    234577899999999999999999999  56778999


Q ss_pred             EEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecc
Q psy2172          96 LFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMG  175 (291)
Q Consensus        96 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg  175 (291)
                      ++||+++++.+.+.....        .+++..++.++.|++.||.+||++|++|+||+|+||+++    .++.++|+|||
T Consensus        77 v~e~~~~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~----~~~~~~l~dfg  144 (284)
T cd07839          77 VFEYCDQDLKKYFDSCNG--------DIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLIN----KNGELKLADFG  144 (284)
T ss_pred             EEecCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEc----CCCcEEECccc
Confidence            999999988877654321        289999999999999999999999999999999999998    66789999999


Q ss_pred             cceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCC-CCCcccc-------------
Q psy2172         176 FARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF-HCRQEDI-------------  241 (291)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf-~~~~~~~-------------  241 (291)
                      .+........   ......++..|+|||.+.+...++.++|+|||||++|+|++|..|| .+.....             
T Consensus       145 ~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~  221 (284)
T cd07839         145 LARAFGIPVR---CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT  221 (284)
T ss_pred             hhhccCCCCC---CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCC
Confidence            9875543211   1223456788999999877555789999999999999999988775 3322100             


Q ss_pred             ----------------c---------CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         242 ----------------K---------TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       242 ----------------~---------~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                                      .         ...+.....+.+++..|....|..||++.++..+||+
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         222 EESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             hHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence                            0         0001123445567777777777777777777666653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.7e-38  Score=292.46  Aligned_cols=255  Identities=25%  Similarity=0.387  Sum_probs=200.4

Q ss_pred             cccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC----ChhHHHHHHHHhcCCCCCeeeEEEEEEeCC
Q psy2172          14 TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL----SMSACREIALLRELKHPNVINLISVFLSHN   89 (291)
Q Consensus        14 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   89 (291)
                      ....+.|.+ .++||+|+||.||+|.+..  ++..+++|.+.....    ...+..|+.+++.++||||++++++|....
T Consensus         9 e~~l~~YeI-l~kLG~GgFGtVYLAkdk~--tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~   85 (1021)
T PTZ00266          9 ESRLNEYEV-IKKIGNGRFGEVFLVKHKR--TQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA   85 (1021)
T ss_pred             ccccCCEEE-EEEEecCCCeEEEEEEECC--CCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence            344456775 6799999999999999876  678899999874322    345788999999999999999999997766


Q ss_pred             CceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-------CeeeeccCCCcEEeec
Q psy2172          90 DRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSN-------WVLHRDLKPANILVMG  161 (291)
Q Consensus        90 ~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~-------~ivH~dik~~Nil~~~  161 (291)
                      ...+|+||||+++ +|...+.......     ..+++..++.++.||+.||.|||+.       +|+|+||||+|||++.
T Consensus        86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~-----g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s  160 (1021)
T PTZ00266         86 NQKLYILMEFCDAGDLSRNIQKCYKMF-----GKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLST  160 (1021)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeec
Confidence            7789999999985 8888876543221     1289999999999999999999984       4999999999999974


Q ss_pred             CC-------------CCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCC-cCCCCchhHHHHHHHHHHH
Q psy2172         162 EG-------------IERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAEL  227 (291)
Q Consensus       162 ~~-------------~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l  227 (291)
                      ..             .....++|+|||++.......    ......|++.|+|||++.+. ..++.++|||||||+||+|
T Consensus       161 ~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s----~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYEL  236 (1021)
T PTZ00266        161 GIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES----MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL  236 (1021)
T ss_pred             CccccccccccccccCCCCceEEccCCccccccccc----cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHH
Confidence            21             123468999999997654321    12345689999999998642 3478999999999999999


Q ss_pred             HcCCCCCCCCccc----------ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchh
Q psy2172         228 LTSEPIFHCRQED----------IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLL  280 (291)
Q Consensus       228 ~~g~~pf~~~~~~----------~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  280 (291)
                      ++|..||......          ...........+.+++..|....|..+|++.++..++++.
T Consensus       237 LTGk~PF~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik  299 (1021)
T PTZ00266        237 CSGKTPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIK  299 (1021)
T ss_pred             HHCCCCCCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHh
Confidence            9999999764421          0111122356788999999999999999999988887664

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.1e-37  Score=271.68  Aligned_cols=246  Identities=21%  Similarity=0.317  Sum_probs=186.9

Q ss_pred             ccccccceeCcccceEEEEEEEc---cCCCCceeEEEEeCCCCC---ChhHHHHHHHHhcC-CCCCeeeEEEEEEeCCCc
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRK---DNSDTRDYALKQIEGTGL---SMSACREIALLREL-KHPNVINLISVFLSHNDR   91 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~---~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~   91 (291)
                      .|++ +++||+|+||.||+|.+.   ...++..||+|+++....   .+.+.+|+.++..+ +||||+++++++  .+..
T Consensus        36 ~~~~-~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~--~~~~  112 (375)
T cd05104          36 RLSF-GKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC--TVGG  112 (375)
T ss_pred             Heeh-hheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee--ccCC
Confidence            4664 789999999999999753   223556799999874332   24578899999999 899999999999  5567


Q ss_pred             eEEEEEecCCC-CHHHHHHHhhhhh-------------------------------------------------------
Q psy2172          92 KVWLLFDYAEH-DLWHIIKFHRAAK-------------------------------------------------------  115 (291)
Q Consensus        92 ~~~iv~e~~~~-~l~~~~~~~~~~~-------------------------------------------------------  115 (291)
                      ..++||||+++ +|.+.+.......                                                       
T Consensus       113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (375)
T cd05104         113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG  192 (375)
T ss_pred             cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence            89999999984 8888876432100                                                       


Q ss_pred             -----------hCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceecCCCC
Q psy2172         116 -----------ANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPL  184 (291)
Q Consensus       116 -----------~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~~~~~  184 (291)
                                 .......+++..+..++.|++.||+|||++|++|+||||+||+++    ....++|+|||++.......
T Consensus       193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~----~~~~~kl~DfG~a~~~~~~~  268 (375)
T cd05104         193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLT----HGRITKICDFGLARDIRNDS  268 (375)
T ss_pred             eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEE----CCCcEEEecCccceeccCcc
Confidence                       000112478889999999999999999999999999999999998    66789999999998654322


Q ss_pred             CCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc-----------cCCCCCcHHHH
Q psy2172         185 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI-----------KTSNPYHHDQL  252 (291)
Q Consensus       185 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~-----------~~~~~~~~~~~  252 (291)
                      .. .......++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||.+...+.           ..........+
T Consensus       269 ~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  346 (375)
T cd05104         269 NY-VVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEM  346 (375)
T ss_pred             cc-cccCCCCCCcceeChhHhcCCC-CCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHH
Confidence            11 1112233456799999998754 8999999999999999997 899997654221           11112234568


Q ss_pred             HHHHHhhCCCCcCChhhhhcC
Q psy2172         253 DRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       253 ~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      .+++..|..+.|..||++.++
T Consensus       347 ~~li~~cl~~dP~~RPs~~ei  367 (375)
T cd05104         347 YDIMKSCWDADPLKRPTFKQI  367 (375)
T ss_pred             HHHHHHHccCChhHCcCHHHH
Confidence            899999999999999888763

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.1e-37  Score=258.36  Aligned_cols=231  Identities=17%  Similarity=0.292  Sum_probs=183.3

Q ss_pred             eeCcccceEEEEEEEccCCCCceeEEEEeCCCCC----ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecCC
Q psy2172          26 KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL----SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAE  101 (291)
Q Consensus        26 ~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~~  101 (291)
                      .||+|+||.||+|.++...++..+|+|+++....    ...+.+|+.+++.++||||+++++++  . ....+++|||++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~-~~~~~lv~e~~~   78 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGIC--E-AESWMLVMELAE   78 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEE--c-CCCcEEEEecCC
Confidence            6899999999999876666778899999875432    24678899999999999999999987  3 346789999998


Q ss_pred             C-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceec
Q psy2172         102 H-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF  180 (291)
Q Consensus       102 ~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~  180 (291)
                      + +|.+.+....         .+++..+..++.|++.||++||++|++|+||||.||+++    .+..++|+|||.+...
T Consensus        79 ~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~----~~~~~kl~Dfg~~~~~  145 (257)
T cd05116          79 LGPLNKFLQKNK---------HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLV----TQHYAKISDFGLSKAL  145 (257)
T ss_pred             CCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEc----CCCeEEECCCcccccc
Confidence            5 7777765322         288999999999999999999999999999999999998    6678999999999766


Q ss_pred             CCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc----------ccCCCCCcH
Q psy2172         181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED----------IKTSNPYHH  249 (291)
Q Consensus       181 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~----------~~~~~~~~~  249 (291)
                      ..............++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||......          .........
T Consensus       146 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~  224 (257)
T cd05116         146 GADENYYKAKTHGKWPVKWYAPECMNYYK-FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCP  224 (257)
T ss_pred             CCCCCeeeecCCCCCCccccCHhHhccCC-cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
Confidence            44322111122233457899999987644 8889999999999999997 99999865321          112233445


Q ss_pred             HHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         250 DQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       250 ~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      ..+.+++..|..+.|.+||++..+
T Consensus       225 ~~l~~li~~~~~~~p~~Rp~~~~i  248 (257)
T cd05116         225 PEMYDLMKLCWTYGVDERPGFAVV  248 (257)
T ss_pred             HHHHHHHHHHhccCchhCcCHHHH
Confidence            778899999999999999988753

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=8.3e-38  Score=262.94  Aligned_cols=238  Identities=24%  Similarity=0.357  Sum_probs=191.0

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC-----ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEe
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-----SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFD   98 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e   98 (291)
                      .+.||+|+||.||+|.+..  +++.+|+|.+.....     ...+.+|+.+++.++|++++++++.+  ..+...+++||
T Consensus         5 ~~~lg~G~~g~vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~--~~~~~~~lv~e   80 (285)
T cd05632           5 YRVLGKGGFGEVCACQVRA--TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY--ETKDALCLVLT   80 (285)
T ss_pred             EEEEecCCCeEEEEEEECC--CCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEE--ecCCEEEEEEE
Confidence            4689999999999999876  678899999864321     23467899999999999999999998  55678999999


Q ss_pred             cCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccc
Q psy2172          99 YAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA  177 (291)
Q Consensus        99 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~  177 (291)
                      |+.+ +|...+.....       ..+++..+..++.|++.||.|||++||+|+||+|+||+++    ..+.++|+|||++
T Consensus        81 ~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~----~~~~~kl~Dfg~~  149 (285)
T cd05632          81 IMNGGDLKFHIYNMGN-------PGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLD----DYGHIRISDLGLA  149 (285)
T ss_pred             eccCccHHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEC----CCCCEEEecCCcc
Confidence            9986 66655543221       1289999999999999999999999999999999999998    6678999999998


Q ss_pred             eecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc-------------ccCC
Q psy2172         178 RLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED-------------IKTS  244 (291)
Q Consensus       178 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~-------------~~~~  244 (291)
                      ......    .......|+..|+|||.+.+.. ++.++|+||||+++|+|++|..||.+....             ....
T Consensus       150 ~~~~~~----~~~~~~~g~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~  224 (285)
T cd05632         150 VKIPEG----ESIRGRVGTVGYMAPEVLNNQR-YTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVY  224 (285)
T ss_pred             eecCCC----CcccCCCCCcCccChHHhcCCC-CCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcccccc
Confidence            754322    1123346789999999997754 889999999999999999999999875432             1122


Q ss_pred             CCCcHHHHHHHHHhhCCCCcCChhh-----hhcCCCCcchhh
Q psy2172         245 NPYHHDQLDRIFSVMGFPLEKDWED-----IRKMPEHPTLLK  281 (291)
Q Consensus       245 ~~~~~~~~~~i~~~~~~~~~~~~~~-----~~~~~~~~~~~~  281 (291)
                      .+.....+.+++..+..+.|..||+     +.++..++++..
T Consensus       225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~  266 (285)
T cd05632         225 SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRN  266 (285)
T ss_pred             CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhc
Confidence            2334566888999999999999998     667788877754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-38  Score=263.51  Aligned_cols=201  Identities=39%  Similarity=0.713  Sum_probs=165.2

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC---CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG---LSMSACREIALLRELKHPNVINLISVFLSHNDRKVW   94 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (291)
                      +.|++ .+.||+|++|.||+|.++.  +++.|++|.+....   ....+.+|+.++++++|+||+++++++  .+....+
T Consensus         5 ~~y~~-~~~lg~g~~~~vy~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~~~   79 (291)
T cd07844           5 ETYKK-LDKLGEGSYATVYKGRSKL--TGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII--HTKKTLT   79 (291)
T ss_pred             cceeE-EEEEeecCCeEEEEEEEcC--CCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEE--ecCCeEE
Confidence            45664 6799999999999999865  66789999986432   234567899999999999999999998  5677999


Q ss_pred             EEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          95 LLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        95 iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      +||||++++|.+.+.....        .+++..++.++.|++.||.+||++|++|+||+|+||+++    .++.++|+||
T Consensus        80 lv~e~~~~~L~~~~~~~~~--------~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~----~~~~~kl~df  147 (291)
T cd07844          80 LVFEYLDTDLKQYMDDCGG--------GLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLIS----ERGELKLADF  147 (291)
T ss_pred             EEEecCCCCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEc----CCCCEEECcc
Confidence            9999999988877654322        278999999999999999999999999999999999998    6678999999


Q ss_pred             ccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCc
Q psy2172         175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  238 (291)
Q Consensus       175 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~  238 (291)
                      |.+.........   .....++..|+|||.+.+...++.++|+||+|+++|+|++|..||.+..
T Consensus       148 g~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~  208 (291)
T cd07844         148 GLARAKSVPSKT---YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST  208 (291)
T ss_pred             ccccccCCCCcc---ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence            998654322111   1122457789999998765557899999999999999999999997654

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG4250|consensus

Probab=100.00  E-value=1.7e-39  Score=284.06  Aligned_cols=205  Identities=28%  Similarity=0.461  Sum_probs=174.3

Q ss_pred             ccceeCcccceEEEEEEEccCCCCceeEEEEeCCC---CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCC----CceEEE
Q psy2172          23 EGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT---GLSMSACREIALLRELKHPNVINLISVFLSHN----DRKVWL   95 (291)
Q Consensus        23 ~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~~~i   95 (291)
                      -.+.||+||||.||+++++.  +|+.||||.++..   ...+...+|+++|++++|+|||++.++-....    .+.-.+
T Consensus        17 ~~e~LG~Ga~g~V~rgrnke--tG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   17 MDERLGKGAFGNVYRGRNKE--TGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             ehhhhcCCccceeeeecccc--cccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            36899999999999999877  8899999999863   44556889999999999999999999863333    446789


Q ss_pred             EEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          96 LFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        96 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      +||||.| +|...+....+...      +++..++.++.+++.||.|||++||+||||||.||++-.........||+||
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~G------LpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDf  168 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYG------LPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDF  168 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccC------CCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecc
Confidence            9999985 88877776554433      9999999999999999999999999999999999999866545567899999


Q ss_pred             ccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcc
Q psy2172         175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE  239 (291)
Q Consensus       175 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~  239 (291)
                      |.|+.....    +......||..|.+||.....+.|+..+|.|||||++|+++||..||.-...
T Consensus       169 G~Arel~d~----s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~  229 (732)
T KOG4250|consen  169 GAARELDDN----SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG  229 (732)
T ss_pred             cccccCCCC----CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence            999977654    3566789999999999998656699999999999999999999999975544

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.3e-37  Score=270.92  Aligned_cols=246  Identities=19%  Similarity=0.311  Sum_probs=185.9

Q ss_pred             cccccccceeCcccceEEEEEEEccC---CCCceeEEEEeCCCCCC---hhHHHHHHHHhcC-CCCCeeeEEEEEEeCCC
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDN---SDTRDYALKQIEGTGLS---MSACREIALLREL-KHPNVINLISVFLSHND   90 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~---~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~   90 (291)
                      +.|.+ ++.||+|+||.||+|.+...   .+...||+|.++.....   ..+.+|+.+++.+ +|+||+++++++  ...
T Consensus        38 ~~~~~-~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~--~~~  114 (374)
T cd05106          38 DNLQF-GKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC--THG  114 (374)
T ss_pred             HHcee-hheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe--cCC
Confidence            34554 78999999999999987542   23457999999754322   3577899999999 899999999998  556


Q ss_pred             ceEEEEEecCCC-CHHHHHHHhhhhh------------------------------------------------------
Q psy2172          91 RKVWLLFDYAEH-DLWHIIKFHRAAK------------------------------------------------------  115 (291)
Q Consensus        91 ~~~~iv~e~~~~-~l~~~~~~~~~~~------------------------------------------------------  115 (291)
                      ...+++|||+.+ +|.+.+.......                                                      
T Consensus       115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (374)
T cd05106         115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS  194 (374)
T ss_pred             CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence            789999999974 8888776432110                                                      


Q ss_pred             -------hCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceecCCCCCCCC
Q psy2172         116 -------ANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLA  188 (291)
Q Consensus       116 -------~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~  188 (291)
                             .......+++..++.++.|++.||.|||++|++|+||||+||+++    .+..++|+|||++......... .
T Consensus       195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~----~~~~~kL~DfGla~~~~~~~~~-~  269 (374)
T cd05106         195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLT----DGRVAKICDFGLARDIMNDSNY-V  269 (374)
T ss_pred             ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEe----CCCeEEEeeceeeeeccCCcce-e
Confidence                   001122378889999999999999999999999999999999998    6678999999998765432111 1


Q ss_pred             CCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc-----------cCCCCCcHHHHHHHH
Q psy2172         189 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI-----------KTSNPYHHDQLDRIF  256 (291)
Q Consensus       189 ~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~-----------~~~~~~~~~~~~~i~  256 (291)
                      ......++..|+|||++.+.. ++.++||||||+++|+|++ |..||.....+.           ..........+.+++
T Consensus       270 ~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  348 (374)
T cd05106         270 VKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIM  348 (374)
T ss_pred             eccCCCCccceeCHHHhcCCC-CCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHH
Confidence            112223456799999997644 8999999999999999997 999997654321           011112246688888


Q ss_pred             HhhCCCCcCChhhhhc
Q psy2172         257 SVMGFPLEKDWEDIRK  272 (291)
Q Consensus       257 ~~~~~~~~~~~~~~~~  272 (291)
                      ..+..+.|..||++.+
T Consensus       349 ~~cl~~dp~~RPs~~~  364 (374)
T cd05106         349 KMCWNLEPTERPTFSQ  364 (374)
T ss_pred             HHHcCCChhhCcCHHH
Confidence            8888888888888775

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=5e-38  Score=269.77  Aligned_cols=244  Identities=22%  Similarity=0.328  Sum_probs=186.6

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC-----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-----GLSMSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      .|.+ .++||+|+||.||++.++.  +++.+|+|++.+.     .....+.+|+.++..++|++|+++++.+  .+....
T Consensus         2 ~y~~-~~~lG~G~fg~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~--~~~~~~   76 (332)
T cd05623           2 DFEI-LKVIGRGAFGEVAVVKLKN--ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF--QDENNL   76 (332)
T ss_pred             CceE-EEEEEeCCCeEEEEEEECC--CCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE--ecCCEE
Confidence            3453 5699999999999999876  6788999998632     1223467889999999999999999998  567789


Q ss_pred             EEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          94 WLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        94 ~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      |+||||+. |+|.+.+.....        .+++..++.++.|++.||.+||++|++|+||||+||+++    .++.++|+
T Consensus        77 ~lv~ey~~~g~L~~~l~~~~~--------~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~----~~~~~kL~  144 (332)
T cd05623          77 YLVMDYYVGGDLLTLLSKFED--------RLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD----MNGHIRLA  144 (332)
T ss_pred             EEEEeccCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC----CCCCEEEe
Confidence            99999997 588877764321        188999999999999999999999999999999999998    67789999


Q ss_pred             ecccceecCCCCCCCCCCCCceecccccccccccC----CcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc--------
Q psy2172         173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLG----ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED--------  240 (291)
Q Consensus       173 Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~--------  240 (291)
                      |||++........  .......||+.|+|||++.+    ...++.++|+|||||++|+|++|..||......        
T Consensus       145 DfG~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~  222 (332)
T cd05623         145 DFGSCLKLMEDGT--VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN  222 (332)
T ss_pred             ecchheecccCCc--ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Confidence            9999875433211  11223568999999999862    234788999999999999999999999865421        


Q ss_pred             ------ccCCCCCcHHHHHHHHHhhCCCCcCC--hhhhhcCCCCcchhh
Q psy2172         241 ------IKTSNPYHHDQLDRIFSVMGFPLEKD--WEDIRKMPEHPTLLK  281 (291)
Q Consensus       241 ------~~~~~~~~~~~~~~i~~~~~~~~~~~--~~~~~~~~~~~~~~~  281 (291)
                            .+.........+.+++..|....+..  ++++.++..||++..
T Consensus       223 ~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~  271 (332)
T cd05623         223 HKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG  271 (332)
T ss_pred             CCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence                  01111123456677777766443332  467888888887653

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8e-39  Score=274.58  Aligned_cols=235  Identities=24%  Similarity=0.403  Sum_probs=184.9

Q ss_pred             eCcccceEEEEEEEccCCCCceeEEEEeCCCCC-----ChhHHHHHHHHhcC---CCCCeeeEEEEEEeCCCceEEEEEe
Q psy2172          27 VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-----SMSACREIALLREL---KHPNVINLISVFLSHNDRKVWLLFD   98 (291)
Q Consensus        27 ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~~~iv~e   98 (291)
                      ||+|+||.||+|.++.  +++.||+|++.....     ......|..++..+   +||+|+++++++  .+....|+|||
T Consensus         1 lG~G~~g~Vy~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~--~~~~~~~lv~e   76 (330)
T cd05586           1 IGKGTFGQVYQVRKKD--TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF--QTDSDLYLVTD   76 (330)
T ss_pred             CCCCCceEEEEEEECC--CCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE--ecCCeEEEEEc
Confidence            7999999999999876  678899999864321     12344566666655   699999999999  56778999999


Q ss_pred             cCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccc
Q psy2172          99 YAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA  177 (291)
Q Consensus        99 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~  177 (291)
                      |+.+ +|...+....         .+++..++.++.|++.||+|||++||+|+||||+||+++    .++.++|+|||++
T Consensus        77 ~~~~g~L~~~l~~~~---------~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~----~~~~~kl~Dfg~a  143 (330)
T cd05586          77 YMSGGELFWHLQKEG---------RFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLD----ATGHIALCDFGLS  143 (330)
T ss_pred             CCCCChHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC----CCCCEEEecCCcC
Confidence            9975 7766654322         289999999999999999999999999999999999998    6678999999998


Q ss_pred             eecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc----------cCCCCC
Q psy2172         178 RLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI----------KTSNPY  247 (291)
Q Consensus       178 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~----------~~~~~~  247 (291)
                      .......   .......|+..|+|||++.+...++.++|||||||++|+|++|..||.+.....          ......
T Consensus       144 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~  220 (330)
T cd05586         144 KANLTDN---KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNV  220 (330)
T ss_pred             cCCCCCC---CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence            6533211   122345689999999999765558899999999999999999999998754321          111122


Q ss_pred             cHHHHHHHHHhhCCCCcCChh----hhhcCCCCcchhh
Q psy2172         248 HHDQLDRIFSVMGFPLEKDWE----DIRKMPEHPTLLK  281 (291)
Q Consensus       248 ~~~~~~~i~~~~~~~~~~~~~----~~~~~~~~~~~~~  281 (291)
                      ..+.+.++++.|..+.|..|+    ++.++..+||+..
T Consensus       221 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~  258 (330)
T cd05586         221 LSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFAD  258 (330)
T ss_pred             CCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccC
Confidence            356778899999999999887    5777888888753

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3.1e-38  Score=270.94  Aligned_cols=243  Identities=22%  Similarity=0.327  Sum_probs=184.8

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC-----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-----GLSMSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      .|.+ .+.||+|+||.||++.++.  +++.||+|++...     .....+.+|..++..++|++|+++++++  .+....
T Consensus         2 ~y~i-~~~lG~G~fg~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~--~~~~~~   76 (331)
T cd05624           2 DFEI-IKVIGRGAFGEVAVVKMKH--TERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF--QDENYL   76 (331)
T ss_pred             CceE-EEEEeeCCCeEEEEEEECC--CCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE--EcCCEE
Confidence            4554 6799999999999999876  6788999998642     1223467789999999999999999999  567799


Q ss_pred             EEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          94 WLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        94 ~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      |+||||+.| +|.+.+.....        .+++..+..++.|++.||++||++||+|+||||+||+++    ..+.++|+
T Consensus        77 ~lv~Ey~~gg~L~~~l~~~~~--------~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~----~~~~~kl~  144 (331)
T cd05624          77 YLVMDYYVGGDLLTLLSKFED--------RLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLD----MNGHIRLA  144 (331)
T ss_pred             EEEEeCCCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEc----CCCCEEEE
Confidence            999999975 88877764321        288999999999999999999999999999999999998    66789999


Q ss_pred             ecccceecCCCCCCCCCCCCceecccccccccccCC----cCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc-------
Q psy2172         173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGA----RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI-------  241 (291)
Q Consensus       173 Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~-------  241 (291)
                      |||++........  .......|+..|+|||++.+.    ..++.++|+||||+++|+|++|..||.+.....       
T Consensus       145 DfG~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~  222 (331)
T cd05624         145 DFGSCLKMNQDGT--VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN  222 (331)
T ss_pred             eccceeeccCCCc--eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHc
Confidence            9999876543211  112235689999999998642    247889999999999999999999997654210       


Q ss_pred             -------cCCCCCcHHHHHHHHHhhCCCCcCC--hhhhhcCCCCcchh
Q psy2172         242 -------KTSNPYHHDQLDRIFSVMGFPLEKD--WEDIRKMPEHPTLL  280 (291)
Q Consensus       242 -------~~~~~~~~~~~~~i~~~~~~~~~~~--~~~~~~~~~~~~~~  280 (291)
                             +.......+...+++..|....+..  +++++++..++++.
T Consensus       223 ~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~  270 (331)
T cd05624         223 HEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFE  270 (331)
T ss_pred             CCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcC
Confidence                   0011112456677777666544332  34667777777653

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=5.1e-38  Score=268.68  Aligned_cols=236  Identities=24%  Similarity=0.309  Sum_probs=183.3

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-----CChhHHHHHHHHhcCC-CCCeeeEEEEEEeCCCceEEEEE
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-----LSMSACREIALLRELK-HPNVINLISVFLSHNDRKVWLLF   97 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~iv~   97 (291)
                      .+.||+|+||.||+|.++.  +++.||+|+++...     ....+..|..++..+. |++|+++++++  .+....|+||
T Consensus         5 ~~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~--~~~~~~~lv~   80 (323)
T cd05615           5 LMVLGKGSFGKVMLAERKG--TDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF--QTVDRLYFVM   80 (323)
T ss_pred             EEEEEecCCeEEEEEEECC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE--ecCCEEEEEE
Confidence            4689999999999999876  67889999986431     2234667888888885 57788899888  5567899999


Q ss_pred             ecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeeccc
Q psy2172          98 DYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGF  176 (291)
Q Consensus        98 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~  176 (291)
                      ||+++ +|...+....         .+++..+..++.|++.||+|||++|++|+||||+||+++    .++.++|+|||+
T Consensus        81 Ey~~~g~L~~~i~~~~---------~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~----~~~~ikL~Dfg~  147 (323)
T cd05615          81 EYVNGGDLMYHIQQVG---------KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLD----SEGHIKIADFGM  147 (323)
T ss_pred             cCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC----CCCCEEEecccc
Confidence            99975 7776664322         288999999999999999999999999999999999998    667899999999


Q ss_pred             ceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---------cCCCCC
Q psy2172         177 ARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---------KTSNPY  247 (291)
Q Consensus       177 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---------~~~~~~  247 (291)
                      +.......   .......|+..|+|||++.+.. ++.++|+||+||++|+|++|..||.+.....         ......
T Consensus       148 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~  223 (323)
T cd05615         148 CKEHMVDG---VTTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKS  223 (323)
T ss_pred             ccccCCCC---ccccCccCCccccCHHHHcCCC-CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc
Confidence            87533211   1123346899999999998744 8899999999999999999999998765421         111223


Q ss_pred             cHHHHHHHHHhhCCCCcCChhhh-----hcCCCCcchh
Q psy2172         248 HHDQLDRIFSVMGFPLEKDWEDI-----RKMPEHPTLL  280 (291)
Q Consensus       248 ~~~~~~~i~~~~~~~~~~~~~~~-----~~~~~~~~~~  280 (291)
                      ....+.+++..|....|..|++.     .++..|+++.
T Consensus       224 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~  261 (323)
T cd05615         224 LSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFR  261 (323)
T ss_pred             CCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccC
Confidence            34567778888888888887753     4455665544

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>KOG0574|consensus

Probab=100.00  E-value=8.1e-41  Score=266.17  Aligned_cols=254  Identities=23%  Similarity=0.414  Sum_probs=212.0

Q ss_pred             ccceeecccccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCCCCeeeEEE
Q psy2172           4 EFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLIS   83 (291)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   83 (291)
                      +|+++..-......+.|++ .++||+|+||.||+|.++.  ++..+|||.++-+...+++..|+.+|+++++|++|++|+
T Consensus        19 ~~KLd~~sL~K~PEEVFDi-~~KLGEGSYGSV~KAIH~E--sG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYG   95 (502)
T KOG0574|consen   19 GFKLDSSALNKPPEEVFDI-VGKLGEGSYGSVHKAIHRE--SGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYG   95 (502)
T ss_pred             ccccChhhhcCChHHHHHH-HHHhcCCcchHHHHHHHhc--cCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhh
Confidence            4667777777788888987 5599999999999999888  889999999998888999999999999999999999999


Q ss_pred             EEEeCCCceEEEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecC
Q psy2172          84 VFLSHNDRKVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGE  162 (291)
Q Consensus        84 ~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~  162 (291)
                      .|+-  ...+|+|||||+ |+..+.++..+.        ++++..+..+++..++||+|||...-+|||||..|||++  
T Consensus        96 SYFK--~sDLWIVMEYCGAGSiSDI~R~R~K--------~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLN--  163 (502)
T KOG0574|consen   96 SYFK--HSDLWIVMEYCGAGSISDIMRARRK--------PLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLN--  163 (502)
T ss_pred             hhcc--CCceEeehhhcCCCcHHHHHHHhcC--------CccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEc--
Confidence            9854  457999999998 576666665433        299999999999999999999999999999999999999  


Q ss_pred             CCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc--
Q psy2172         163 GIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED--  240 (291)
Q Consensus       163 ~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~--  240 (291)
                        .++..||+|||.+-.+..   +.....+..||+.|+|||++..-+ |+..+||||||++..+|+.|++||....+-  
T Consensus       164 --T~G~AKLADFGVAGQLTD---TMAKRNTVIGTPFWMAPEVI~EIG-Y~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA  237 (502)
T KOG0574|consen  164 --TDGIAKLADFGVAGQLTD---TMAKRNTVIGTPFWMAPEVIEEIG-YDTKADIWSLGITAIEMAEGRPPYSDIHPMRA  237 (502)
T ss_pred             --ccchhhhhhccccchhhh---hHHhhCccccCcccccHHHHHHhc-cchhhhHhhhcchhhhhhcCCCCcccccccce
Confidence              678999999999876543   223345678999999999998766 899999999999999999999999875431  


Q ss_pred             -------c-cC--CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcc
Q psy2172         241 -------I-KT--SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPT  278 (291)
Q Consensus       241 -------~-~~--~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  278 (291)
                             . +.  ....-++.+.++++.+..-.|+.+.+..++-+|+.
T Consensus       238 IFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~F  285 (502)
T KOG0574|consen  238 IFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTF  285 (502)
T ss_pred             eEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhh
Confidence                   0 11  11112567888889888888888888888777754

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-38  Score=271.26  Aligned_cols=252  Identities=33%  Similarity=0.536  Sum_probs=198.6

Q ss_pred             ccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC---CCChhHHHHHHHHhcCCCCCeeeEEEEEEeC---
Q psy2172          15 KVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT---GLSMSACREIALLRELKHPNVINLISVFLSH---   88 (291)
Q Consensus        15 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---   88 (291)
                      .+.+.|.+ .++||+|+||.||+|.+..  +++.||+|.+...   .....+.+|+.++++++|+||+++++++...   
T Consensus         2 ~~~~~y~i-~~~lg~G~~g~vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   78 (336)
T cd07849           2 DVGPRYQN-LSYIGEGAYGMVCSATHKP--TGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFE   78 (336)
T ss_pred             ccccceEE-EEEEEecCCeEEEEEEEcC--CCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeeccccc
Confidence            35577885 6799999999999999876  6788999998632   2334577899999999999999999887432   


Q ss_pred             CCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCc
Q psy2172          89 NDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGR  168 (291)
Q Consensus        89 ~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~  168 (291)
                      .....|+++||+++++...+...          .+++..++.++.|++.||++||++|++|+||||+||+++    ..+.
T Consensus        79 ~~~~~~lv~e~~~~~l~~~~~~~----------~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~----~~~~  144 (336)
T cd07849          79 SFNDVYIVQELMETDLYKLIKTQ----------HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN----TNCD  144 (336)
T ss_pred             ccceEEEEehhcccCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEC----CCCC
Confidence            22468999999999887766432          289999999999999999999999999999999999998    6788


Q ss_pred             EEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc-------
Q psy2172         169 VKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI-------  241 (291)
Q Consensus       169 ~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~-------  241 (291)
                      ++|+|||++.................|+..|+|||.+.+...++.++|+||+|+++|+|++|+.||.+.....       
T Consensus       145 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~  224 (336)
T cd07849         145 LKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILG  224 (336)
T ss_pred             EEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            9999999987654432222222335678899999987654558899999999999999999999997542100       


Q ss_pred             -------------------------cC--------CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhhh
Q psy2172         242 -------------------------KT--------SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF  283 (291)
Q Consensus       242 -------------------------~~--------~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (291)
                                               ..        ..+.....+.+++..|..+.|..||++.++..+|++.+-+
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~  299 (336)
T cd07849         225 VLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH  299 (336)
T ss_pred             HcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence                                     00        0012235577899999999999999999999998876544

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.8e-38  Score=272.33  Aligned_cols=237  Identities=21%  Similarity=0.294  Sum_probs=185.5

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEe
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFD   98 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e   98 (291)
                      .|.+ .+.||+|+||.||+|.+..  ++..||+|+....    ....|+.++++++||||+++++++.  .....++|+|
T Consensus        67 ~y~~-~~~lg~G~~g~Vy~~~~~~--~~~~valK~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e  137 (357)
T PHA03209         67 GYTV-IKTLTPGSEGRVFVATKPG--QPDPVVLKIGQKG----TTLIEAMLLQNVNHPSVIRMKDTLV--SGAITCMVLP  137 (357)
T ss_pred             CcEE-EEEecCCCCeEEEEEEECC--CCceEEEEeCCcc----ccHHHHHHHHhCCCCCCcChhheEE--eCCeeEEEEE
Confidence            4564 6799999999999999876  6678999985433    3456899999999999999999994  4668899999


Q ss_pred             cCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccce
Q psy2172          99 YAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR  178 (291)
Q Consensus        99 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~  178 (291)
                      ++.++|.+.+.....        .+++..++.++.|++.||.|||++||+|+||||+||+++    ..+.++|+|||.+.
T Consensus       138 ~~~~~l~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~----~~~~~kl~DfG~a~  205 (357)
T PHA03209        138 HYSSDLYTYLTKRSR--------PLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIN----DVDQVCIGDLGAAQ  205 (357)
T ss_pred             ccCCcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCCEEEecCcccc
Confidence            999998887754321        288999999999999999999999999999999999998    67789999999987


Q ss_pred             ecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcC-CCCCCCCccc-----------------
Q psy2172         179 LFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQED-----------------  240 (291)
Q Consensus       179 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g-~~pf~~~~~~-----------------  240 (291)
                      .....    .......|+..|+|||++.+.. ++.++|+|||||++|+|+++ ..+|......                 
T Consensus       206 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~  280 (357)
T PHA03209        206 FPVVA----PAFLGLAGTVETNAPEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIIS  280 (357)
T ss_pred             ccccC----cccccccccccccCCeecCCCC-CCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHH
Confidence            43321    1122356789999999998754 89999999999999999975 4444432211                 


Q ss_pred             --------ccC---------------------------CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         241 --------IKT---------------------------SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       241 --------~~~---------------------------~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                              ...                           ...........++..|....|..||++.++..|||+.+
T Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        281 TLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             HhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence                    000                           00011223345788889999999999999999998764

>KOG0669|consensus

Probab=100.00  E-value=1.6e-40  Score=258.26  Aligned_cols=232  Identities=38%  Similarity=0.715  Sum_probs=197.8

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEe----CCCCCChhHHHHHHHHhcCCCCCeeeEEEEEE------eCCCceE
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINLISVFL------SHNDRKV   93 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~~~~~~   93 (291)
                      ..+||+|.||.||+|+.++  +++.|++|.+    .+........+|+.+|..|+|+|++.+++.+.      ..+...+
T Consensus        22 ~~kigqGtfgeVFkAr~~n--~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~   99 (376)
T KOG0669|consen   22 LAKIGQGTFGEVFKARSKN--TGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATF   99 (376)
T ss_pred             HHhcCCchHHHHHHHhhcC--ccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccccee
Confidence            4699999999999999877  6677888865    25567788999999999999999999987652      1344579


Q ss_pred             EEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEee
Q psy2172          94 WLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIAD  173 (291)
Q Consensus        94 ~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~D  173 (291)
                      |+||++|+++|..++.+....        ++...+..++.++..||.|+|.+.|+|||+|+.|++++    .++.++|+|
T Consensus       100 ylVf~~cehDLaGlLsn~~vr--------~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt----~dgilklAD  167 (376)
T KOG0669|consen  100 YLVFDFCEHDLAGLLSNRKVR--------FSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLIT----KDGILKLAD  167 (376)
T ss_pred             eeeHHHhhhhHHHHhcCcccc--------ccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEc----CCceEEeec
Confidence            999999999999888654322        89999999999999999999999999999999999999    778999999


Q ss_pred             cccceecCCCCCC-CCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccCCCCCcHHHH
Q psy2172         174 MGFARLFNNPLKP-LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL  252 (291)
Q Consensus       174 fg~~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  252 (291)
                      ||+++.+..+... ........-|.+|.+||.+.|.+.++++.|+|+.||++.+|+++.+.+++..+         ..++
T Consensus       168 FGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnte---------qqql  238 (376)
T KOG0669|consen  168 FGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE---------QQQL  238 (376)
T ss_pred             cccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChH---------HHHH
Confidence            9999776543222 12223456699999999999988899999999999999999999999999988         4889


Q ss_pred             HHHHHhhCCCCcCChhhhhcCCCCcc
Q psy2172         253 DRIFSVMGFPLEKDWEDIRKMPEHPT  278 (291)
Q Consensus       253 ~~i~~~~~~~~~~~~~~~~~~~~~~~  278 (291)
                      .-|...++.-+++.||....+|.+..
T Consensus       239 ~~Is~LcGs~tkevWP~~d~lpL~~s  264 (376)
T KOG0669|consen  239 HLISQLCGSITKEVWPNVDNLPLYQS  264 (376)
T ss_pred             HHHHHHhccCCcccCCCcccchHHHh
Confidence            99999999999999999998876543

>KOG1989|consensus

Probab=100.00  E-value=2.9e-38  Score=282.98  Aligned_cols=237  Identities=23%  Similarity=0.348  Sum_probs=188.6

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCC--CCChhHHHHHHHHhcCC-CCCeeeEEEE-EEe---CC-CceEEE
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT--GLSMSACREIALLRELK-HPNVINLISV-FLS---HN-DRKVWL   95 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~-~~~---~~-~~~~~i   95 (291)
                      .+.|.+|||+.||+|.+..  .+..||+|++-..  .....+.+|+.+|++|+ |+|||.+++. ...   .+ ...+++
T Consensus        42 ~~vLAEGGFa~VYla~~~~--~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evll  119 (738)
T KOG1989|consen   42 EKVLAEGGFAQVYLAQDVK--GGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLL  119 (738)
T ss_pred             EEEEccCCcEEEEEEEecC--CCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEe
Confidence            5699999999999999876  4478999987533  33446889999999996 9999999993 322   22 356889


Q ss_pred             EEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          96 LFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNW--VLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        96 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      .||||. |+|.+++.......       |++..+++|+.|+++|+++||...  |+|||||-+|||++    .++.+|||
T Consensus       120 LmEyC~gg~Lvd~mn~Rlq~~-------lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls----~~g~~KLC  188 (738)
T KOG1989|consen  120 LMEYCKGGSLVDFMNTRLQTR-------LTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS----ADGNYKLC  188 (738)
T ss_pred             ehhhccCCcHHHHHHHHHhcc-------CChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEc----CCCCEEeC
Confidence            999999 69999998655433       999999999999999999999987  99999999999999    77899999


Q ss_pred             ecccceecCCCCCCCCC------CCCceecccccccccccC--CcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc----
Q psy2172         173 DMGFARLFNNPLKPLAD------LDPVVVTFWYRAPELLLG--ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED----  240 (291)
Q Consensus       173 Dfg~~~~~~~~~~~~~~------~~~~~g~~~y~aPE~~~~--~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~----  240 (291)
                      |||.++-.-........      .-....|+.|+|||++.-  +...+.|+|||+|||+||.|+....||+....-    
T Consensus       189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIln  268 (738)
T KOG1989|consen  189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILN  268 (738)
T ss_pred             cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEe
Confidence            99998743322110000      011355889999999742  234899999999999999999999999987321    


Q ss_pred             --c-cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         241 --I-KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       241 --~-~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                        + ....+.+.+.+.+++..|..+.|..||++-+.
T Consensus       269 g~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv  304 (738)
T KOG1989|consen  269 GNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQV  304 (738)
T ss_pred             ccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHH
Confidence              1 12335678899999999999999999998764

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.9e-37  Score=259.92  Aligned_cols=233  Identities=24%  Similarity=0.362  Sum_probs=188.7

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecC
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYA  100 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~  100 (291)
                      .++||+|+||.||+|.+..  +++.||+|.+.....   ...+.+|+.++++++||||+++++.+.  .....+++|||+
T Consensus         6 ~~~lg~g~~~~v~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~   81 (279)
T cd06619           6 QEILGHGNGGTVYKAYHLL--TRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFF--VENRISICTEFM   81 (279)
T ss_pred             eeeeccCCCeEEEEEEEcC--CCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEE--ECCEEEEEEecC
Confidence            4689999999999999776  678899999864422   245778999999999999999999994  466889999999


Q ss_pred             CCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceec
Q psy2172         101 EHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF  180 (291)
Q Consensus       101 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~  180 (291)
                      ++..+....            .+++..+..++.|++.||.+||+.|++|+||||+||+++    .++.++|+|||++...
T Consensus        82 ~~~~l~~~~------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~----~~~~~~l~dfg~~~~~  145 (279)
T cd06619          82 DGGSLDVYR------------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVN----TRGQVKLCDFGVSTQL  145 (279)
T ss_pred             CCCChHHhh------------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEEC----CCCCEEEeeCCcceec
Confidence            975443221            178888999999999999999999999999999999998    6789999999998765


Q ss_pred             CCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc------------------c
Q psy2172         181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI------------------K  242 (291)
Q Consensus       181 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~------------------~  242 (291)
                      ...     ......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||.......                  .
T Consensus       146 ~~~-----~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  219 (279)
T cd06619         146 VNS-----IAKTYVGTNAYMAPERISGEQ-YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPV  219 (279)
T ss_pred             ccc-----cccCCCCChhhcCceeecCCC-CCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCC
Confidence            432     223356788999999998754 8899999999999999999999996532110                  0


Q ss_pred             CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhh
Q psy2172         243 TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKD  282 (291)
Q Consensus       243 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (291)
                      .........+.+++..+..+.|..||+++++..++|+...
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~  259 (279)
T cd06619         220 LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY  259 (279)
T ss_pred             CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence            0111234567889999999999999999999999987643

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.2e-37  Score=261.94  Aligned_cols=242  Identities=34%  Similarity=0.668  Sum_probs=191.6

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG----LSMSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      ++|++ .+.||+|++|.||+|.++.  +++.|++|.+....    ..+.+.+|+.++++++|||++++++.+  ......
T Consensus         1 ~~y~~-~~~l~~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~--~~~~~~   75 (286)
T cd07847           1 EKYEK-LSKIGEGSYGVVFKCRNRE--TGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVF--RRKRKL   75 (286)
T ss_pred             Cceee-eeeecccCCeEEEEEEECC--CCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEE--eeCCEE
Confidence            35665 4689999999999999876  67889999885332    234578899999999999999999999  556789


Q ss_pred             EEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEee
Q psy2172          94 WLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIAD  173 (291)
Q Consensus        94 ~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~D  173 (291)
                      +++|||++++++..+.....        .+++..++.++.|++.||++||+.|++|+||+|+||+++    .++.++|+|
T Consensus        76 ~~v~e~~~~~~l~~~~~~~~--------~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~----~~~~~~l~d  143 (286)
T cd07847          76 HLVFEYCDHTVLNELEKNPR--------GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILIT----KQGQIKLCD  143 (286)
T ss_pred             EEEEeccCccHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEc----CCCcEEECc
Confidence            99999999876655432211        288999999999999999999999999999999999998    667899999


Q ss_pred             cccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc-----------
Q psy2172         174 MGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK-----------  242 (291)
Q Consensus       174 fg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~-----------  242 (291)
                      ||.+........   ......++..|+|||.+.+...++.++|+||||+++|+|++|..||.+......           
T Consensus       144 fg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  220 (286)
T cd07847         144 FGFARILTGPGD---DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDL  220 (286)
T ss_pred             cccceecCCCcc---cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            999987654321   112335678899999987655578999999999999999999999976542100           


Q ss_pred             ------------------CC-----------CCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         243 ------------------TS-----------NPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       243 ------------------~~-----------~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                                        ..           .+.....+.+++..+..+.|..||++.++..++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         221 IPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             ChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence                              00           01123456788888999999999999998888764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.5e-37  Score=259.73  Aligned_cols=241  Identities=20%  Similarity=0.265  Sum_probs=185.2

Q ss_pred             cccccccceeCcccceEEEEEEEc--cCCCCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCce
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRK--DNSDTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHNDRK   92 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~--~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (291)
                      ++|....+.||+|+||.||++...  ....+..+|+|.++....   ...+.+|+.+++.++||||+++++++...+...
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG   82 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence            455324679999999999987643  223567899999875432   346788999999999999999999886555668


Q ss_pred             EEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEE
Q psy2172          93 VWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI  171 (291)
Q Consensus        93 ~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l  171 (291)
                      .+++|||+.+ +|.+.+....          +++..++.++.|++.||.+||++|++|+||||+||+++    .++.++|
T Consensus        83 ~~lv~e~~~~~~l~~~~~~~~----------l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~----~~~~~~l  148 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPKHK----------LNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLD----NDRLVKI  148 (283)
T ss_pred             EEEEecCCCCCCHHHHHHHcC----------CCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEc----CCCcEEE
Confidence            9999999985 7777665321          89999999999999999999999999999999999998    6678999


Q ss_pred             eecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc---------
Q psy2172         172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK---------  242 (291)
Q Consensus       172 ~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~---------  242 (291)
                      +|||++.................++..|+|||.+.+.. ++.++|+||||+++|+|++|..||........         
T Consensus       149 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~  227 (283)
T cd05080         149 GDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENK-FSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQ  227 (283)
T ss_pred             eecccccccCCcchhhccCCCCCCCceeeCHhHhcccC-CCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccc
Confidence            99999886544222111112233456799999987644 88999999999999999999999865332100         


Q ss_pred             ----------------CCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         243 ----------------TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       243 ----------------~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                                      .........+.+++..|..+.|..||++.++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i  274 (283)
T cd05080         228 MTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSL  274 (283)
T ss_pred             cchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHH
Confidence                            0112234678888999999999888888753

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3.2e-37  Score=260.13  Aligned_cols=242  Identities=33%  Similarity=0.569  Sum_probs=188.2

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC---CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG---LSMSACREIALLRELKHPNVINLISVFLSHNDRKVW   94 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (291)
                      +.|.+ .+.||+|+||.||+|.++.  ++..+++|.++...   ....+.+|+.+++.++|+||+++++++  .+....|
T Consensus         5 ~~y~~-~~~ig~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~--~~~~~~~   79 (291)
T cd07870           5 TSYLN-LEKLGEGSYATVYKGISRI--NGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII--HTKETLT   79 (291)
T ss_pred             ceeEE-EEEEEecCCEEEEEEEEcC--CCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEE--ecCCeEE
Confidence            45664 6799999999999999876  56789999986432   223577899999999999999999998  4567899


Q ss_pred             EEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          95 LLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        95 iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      +++||+++++.+.+.....        .+++..+..++.|++.||.+||++|++|+||||+||+++    .++.++|+||
T Consensus        80 lv~e~~~~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~----~~~~~~l~Df  147 (291)
T cd07870          80 FVFEYMHTDLAQYMIQHPG--------GLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLIS----YLGELKLADF  147 (291)
T ss_pred             EEEecccCCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEc----CCCcEEEecc
Confidence            9999999888776653221        167788899999999999999999999999999999998    6778999999


Q ss_pred             ccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc-------------
Q psy2172         175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI-------------  241 (291)
Q Consensus       175 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~-------------  241 (291)
                      |.+........   ......++..|+|||.+.+...++.++|+||||+++|+|++|..||.+.....             
T Consensus       148 g~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~  224 (291)
T cd07870         148 GLARAKSIPSQ---TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVP  224 (291)
T ss_pred             ccccccCCCCC---CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCC
Confidence            99875433211   11233568889999998765457889999999999999999999997543210             


Q ss_pred             -----------cC------------------CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         242 -----------KT------------------SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       242 -----------~~------------------~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                                 +.                  ........+.+++..|....|..||++.++..+|++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         225 TEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             ChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence                       00                  000113456677888888888888888887777764

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.6e-37  Score=255.29  Aligned_cols=232  Identities=19%  Similarity=0.284  Sum_probs=180.6

Q ss_pred             eeCcccceEEEEEEEccCCCCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecCCC
Q psy2172          26 KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH  102 (291)
Q Consensus        26 ~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~~~  102 (291)
                      .||+|+||.||+|.++....+..||+|++.....   .+.+.+|+.++++++||||+++++++  + ....++||||+++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~--~-~~~~~lv~e~~~~   78 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC--E-AEALMLVMEMASG   78 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEE--c-CCCeEEEEEeCCC
Confidence            4899999999999886544566799999875432   24578999999999999999999987  3 3468999999975


Q ss_pred             -CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceecC
Q psy2172         103 -DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFN  181 (291)
Q Consensus       103 -~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~~  181 (291)
                       +|.+.+.....        .+++..++.++.|++.||++||++|++|+||||+||+++    .+..++|+|||.+....
T Consensus        79 ~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~----~~~~~kl~dfg~~~~~~  146 (257)
T cd05115          79 GPLNKFLSGKKD--------EITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLV----NQHYAKISDFGLSKALG  146 (257)
T ss_pred             CCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEc----CCCcEEeccCCcccccc
Confidence             77766653221        289999999999999999999999999999999999998    67789999999987554


Q ss_pred             CCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc----------ccCCCCCcHH
Q psy2172         182 NPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED----------IKTSNPYHHD  250 (291)
Q Consensus       182 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~----------~~~~~~~~~~  250 (291)
                      .............++..|+|||.+.+.. ++.++|+||||+++|++++ |..||.+....          .....+....
T Consensus       147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (257)
T cd05115         147 ADDSYYKARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPP  225 (257)
T ss_pred             CCccceeccCCCCCCcccCCHHHHccCC-CCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCH
Confidence            3222111112223356799999987644 8899999999999999996 99999764421          1122234457


Q ss_pred             HHHHHHHhhCCCCcCChhhhhcC
Q psy2172         251 QLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       251 ~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      .+.+++..+....+.+||++.++
T Consensus       226 ~l~~li~~c~~~~~~~Rp~~~~i  248 (257)
T cd05115         226 EMYALMKDCWIYKWEDRPNFAKV  248 (257)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHH
Confidence            78889999999889888887753

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=4.3e-37  Score=255.84  Aligned_cols=243  Identities=25%  Similarity=0.398  Sum_probs=185.9

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC---C----ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCc
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG---L----SMSACREIALLRELKHPNVINLISVFLSHNDR   91 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (291)
                      .|++ ++.||+|+||.||.+.+..  ++..|++|.+....   .    ...+.+|+.++++++||||+++++++.+....
T Consensus         3 ~~~~-~~~l~~g~~g~v~~~~~~~--~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   79 (265)
T cd06652           3 NWRL-GKLLGQGAFGRVYLCYDAD--TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMER   79 (265)
T ss_pred             cceE-eeEEecCCceEEEEEEEcC--CCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCc
Confidence            4554 7899999999999999876  67889999875321   1    13567899999999999999999988544456


Q ss_pred             eEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEE
Q psy2172          92 KVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVK  170 (291)
Q Consensus        92 ~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~  170 (291)
                      .++++|||+++ +|.+.+....         .+++..+..++.|++.||++||+++++|+||+|+||+++    .++.++
T Consensus        80 ~~~~v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~----~~~~~~  146 (265)
T cd06652          80 TLSIFMEHMPGGSIKDQLKSYG---------ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRD----SVGNVK  146 (265)
T ss_pred             eEEEEEEecCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEec----CCCCEE
Confidence            78999999975 7777665332         178888999999999999999999999999999999998    677899


Q ss_pred             EeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---------
Q psy2172         171 IADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---------  241 (291)
Q Consensus       171 l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---------  241 (291)
                      |+|||.+.................++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||.......         
T Consensus       147 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~  225 (265)
T cd06652         147 LGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEG-YGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP  225 (265)
T ss_pred             ECcCccccccccccccccccccCCCCccccChhhhcCCC-CCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCC
Confidence            999999876543211111223345788899999998744 8899999999999999999999997543210         


Q ss_pred             --cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         242 --KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       242 --~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                        ..........+.+++..+.. .|..+|+++++..++++
T Consensus       226 ~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~  264 (265)
T cd06652         226 TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFV  264 (265)
T ss_pred             CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCccc
Confidence              11112223445566666553 67788888888877764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG4721|consensus

Probab=100.00  E-value=4e-39  Score=275.31  Aligned_cols=226  Identities=23%  Similarity=0.384  Sum_probs=190.7

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecCC-C
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAE-H  102 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~~-~  102 (291)
                      -+.||+|+.|.||+|+.++    +.||||.++.     .-..+++-|++|+||||+.+.+++  ....++|||||||. |
T Consensus       129 LeWlGSGaQGAVF~Grl~n----etVAVKKV~e-----lkETdIKHLRkLkH~NII~FkGVC--tqsPcyCIiMEfCa~G  197 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLHN----ETVAVKKVRE-----LKETDIKHLRKLKHPNIITFKGVC--TQSPCYCIIMEFCAQG  197 (904)
T ss_pred             hhhhccCcccceeeeeccC----ceehhHHHhh-----hhhhhHHHHHhccCcceeeEeeee--cCCceeEEeeeccccc
Confidence            5789999999999999754    6799998653     223568899999999999999999  66789999999998 6


Q ss_pred             CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceecCC
Q psy2172         103 DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN  182 (291)
Q Consensus       103 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~~~  182 (291)
                      .|...++..+.         +....+..+..+|+.|++|||.+.|+|||||.-|||++    .+..|||+|||.++....
T Consensus       198 qL~~VLka~~~---------itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs----~~d~VKIsDFGTS~e~~~  264 (904)
T KOG4721|consen  198 QLYEVLKAGRP---------ITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILIS----YDDVVKISDFGTSKELSD  264 (904)
T ss_pred             cHHHHHhccCc---------cCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEee----ccceEEeccccchHhhhh
Confidence            89988887654         77888999999999999999999999999999999999    667899999999876543


Q ss_pred             CCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc-----------cCCCCCcHHH
Q psy2172         183 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI-----------KTSNPYHHDQ  251 (291)
Q Consensus       183 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~-----------~~~~~~~~~~  251 (291)
                      .    +.+-...||..|||||++.+.+ .+.++|||||||+||||++|..||.......           ......+.+.
T Consensus       265 ~----STkMSFaGTVaWMAPEvIrneP-csEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~G  339 (904)
T KOG4721|consen  265 K----STKMSFAGTVAWMAPEVIRNEP-CSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDG  339 (904)
T ss_pred             h----hhhhhhhhhHhhhCHHHhhcCC-cccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchH
Confidence            2    2234578999999999999855 9999999999999999999999998755421           2233455678


Q ss_pred             HHHHHHhhCCCCcCChhhhhcCCCCcc
Q psy2172         252 LDRIFSVMGFPLEKDWEDIRKMPEHPT  278 (291)
Q Consensus       252 ~~~i~~~~~~~~~~~~~~~~~~~~~~~  278 (291)
                      +.-+++.+..-.|.++|+++++..|-.
T Consensus       340 fklL~Kqcw~sKpRNRPSFrqil~Hld  366 (904)
T KOG4721|consen  340 FKLLLKQCWNSKPRNRPSFRQILLHLD  366 (904)
T ss_pred             HHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence            999999999999999999998766533

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-37  Score=274.98  Aligned_cols=195  Identities=25%  Similarity=0.343  Sum_probs=160.5

Q ss_pred             ccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEE
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLL   96 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv   96 (291)
                      ...|.+ .+.||+|+||.||+|.+..  .++.||+|...    ...+.+|+.++++++|+||+++++++.  .....+++
T Consensus       168 ~~gy~i-~~~Lg~G~~G~Vy~a~~~~--~~~~vavK~~~----~~~~~~E~~iL~~L~HpnIv~l~~~~~--~~~~~~lv  238 (461)
T PHA03211        168 GLGFAI-HRALTPGSEGCVFESSHPD--YPQRVVVKAGW----YASSVHEARLLRRLSHPAVLALLDVRV--VGGLTCLV  238 (461)
T ss_pred             cCCeEE-EEEEccCCCeEEEEEEECC--CCCEEEEeccc----ccCHHHHHHHHHHCCCCCCCcEEEEEE--ECCEEEEE
Confidence            345675 5699999999999999876  66789999643    335678999999999999999999984  46688999


Q ss_pred             EecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeeccc
Q psy2172          97 FDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGF  176 (291)
Q Consensus        97 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~  176 (291)
                      |+++.++|...+.....        .+++..++.++.|++.||.|||++||+|+||||+||+++    ..+.++|+|||+
T Consensus       239 ~e~~~~~L~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~----~~~~vkL~DFGl  306 (461)
T PHA03211        239 LPKYRSDLYTYLGARLR--------PLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVN----GPEDICLGDFGA  306 (461)
T ss_pred             EEccCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEEC----CCCCEEEcccCC
Confidence            99999998887754321        289999999999999999999999999999999999998    667899999999


Q ss_pred             ceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCC
Q psy2172         177 ARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF  234 (291)
Q Consensus       177 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf  234 (291)
                      ++........ .......||..|+|||++.+.. ++.++|||||||++|+|++|..|+
T Consensus       307 a~~~~~~~~~-~~~~~~~GT~~Y~APE~~~~~~-~~~~sDvwSlGviL~El~~g~~~l  362 (461)
T PHA03211        307 ACFARGSWST-PFHYGIAGTVDTNAPEVLAGDP-YTPSVDIWSAGLVIFEAAVHTASL  362 (461)
T ss_pred             ceeccccccc-ccccccCCCcCCcCHHHHcCCC-CCchHHHHHHHHHHHHHHHcCCCc
Confidence            9765432111 1112356899999999998754 899999999999999999876543

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.8e-37  Score=258.37  Aligned_cols=237  Identities=15%  Similarity=0.200  Sum_probs=181.2

Q ss_pred             ccccccceeCcccceEEEEEEEcc-CCCCceeEEEEeCCCCCC---hhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKD-NSDTRDYALKQIEGTGLS---MSACREIALLRELKHPNVINLISVFLSHNDRKVW   94 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (291)
                      .|.+ .+.||+|+||.||+|.++. ...+..||+|.++.....   ..+.+|+.++++++||||+++++++  ......+
T Consensus         6 ~~~~-~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~~~~~~~   82 (266)
T cd05064           6 SIKI-ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVI--TRGNTMM   82 (266)
T ss_pred             HeEE-eeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEE--ecCCCcE
Confidence            3554 6799999999999998653 234568999998764322   3578899999999999999999998  4567899


Q ss_pred             EEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEee
Q psy2172          95 LLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIAD  173 (291)
Q Consensus        95 iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~D  173 (291)
                      +||||+++ +|.+.+....        ..+++..++.++.|++.||++||++|++|+||||+||+++    .++.++++|
T Consensus        83 lv~e~~~~~~L~~~l~~~~--------~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~----~~~~~~l~d  150 (266)
T cd05064          83 IVTEYMSNGALDSFLRKHE--------GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVN----SDLVCKISG  150 (266)
T ss_pred             EEEEeCCCCcHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEc----CCCcEEECC
Confidence            99999986 6665654322        1288999999999999999999999999999999999998    677999999


Q ss_pred             cccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc----------cc
Q psy2172         174 MGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED----------IK  242 (291)
Q Consensus       174 fg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~----------~~  242 (291)
                      ||.+........  .......++..|+|||.+.+.. ++.++|||||||++|++++ |..||......          ..
T Consensus       151 fg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~  227 (266)
T cd05064         151 FRRLQEDKSEAI--YTTMSGKSPVLWAAPEAIQYHH-FSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL  227 (266)
T ss_pred             Ccccccccccch--hcccCCCCceeecCHHHHhhCC-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC
Confidence            998764322111  1111223456799999987744 8999999999999999775 99999765432          11


Q ss_pred             CCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         243 TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       243 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      .........+.+++..+..+.|..||++.++
T Consensus       228 ~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i  258 (266)
T cd05064         228 PAPRNCPNLLHQLMLDCWQKERGERPRFSQI  258 (266)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCchhCCCHHHH
Confidence            1223334667788888888888888887653

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG4236|consensus

Probab=100.00  E-value=3.6e-39  Score=273.56  Aligned_cols=209  Identities=29%  Similarity=0.531  Sum_probs=181.6

Q ss_pred             cccccccccc-ccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC----ChhHHHHHHHHhcCCCCCeeeEEEEEEe
Q psy2172          13 RTKVEDLFDY-EGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL----SMSACREIALLRELKHPNVINLISVFLS   87 (291)
Q Consensus        13 ~~~~~~~~~~-~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~   87 (291)
                      ...+...|.+ -.+.||+|-||+||-|.+++  +++.||||++.+-..    ...+.+|+.||+++.||+||.+...|  
T Consensus       557 ~vd~stvYQif~devLGSGQFG~VYgg~hRk--tGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~--  632 (888)
T KOG4236|consen  557 NVDISTVYQIFADEVLGSGQFGTVYGGKHRK--TGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF--  632 (888)
T ss_pred             hhhHHHHHHhhhHhhccCCcceeeecceecc--cCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee--
Confidence            3344445552 36899999999999999888  889999999975432    35688999999999999999999999  


Q ss_pred             CCCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCC
Q psy2172          88 HNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERG  167 (291)
Q Consensus        88 ~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~  167 (291)
                      +..+.+++|||-+.|+.++.+.....++       +++..-+.++.||+.||.|||.++|+|+||||+|||+.+.. .-.
T Consensus       633 ET~ervFVVMEKl~GDMLEMILSsEkgR-------L~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~-~FP  704 (888)
T KOG4236|consen  633 ETPERVFVVMEKLHGDMLEMILSSEKGR-------LPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASAS-PFP  704 (888)
T ss_pred             cCCceEEEEehhhcchHHHHHHHhhccc-------chHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCC-CCC
Confidence            7888999999999999999998876654       89999999999999999999999999999999999998764 667


Q ss_pred             cEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCc
Q psy2172         168 RVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  238 (291)
Q Consensus       168 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~  238 (291)
                      ++||||||.++.++..    +-.....||+.|.|||++.+.+ |+..-|+||.|+++|.-++|..||.-..
T Consensus       705 QvKlCDFGfARiIgEk----sFRrsVVGTPAYLaPEVLrnkG-yNrSLDMWSVGVIiYVsLSGTFPFNEdE  770 (888)
T KOG4236|consen  705 QVKLCDFGFARIIGEK----SFRRSVVGTPAYLAPEVLRNKG-YNRSLDMWSVGVIIYVSLSGTFPFNEDE  770 (888)
T ss_pred             ceeeccccceeecchh----hhhhhhcCCccccCHHHHhhcc-ccccccceeeeEEEEEEecccccCCCcc
Confidence            9999999999988764    2234578999999999999866 9999999999999999999999997544

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=4.2e-37  Score=261.59  Aligned_cols=230  Identities=42%  Similarity=0.777  Sum_probs=188.6

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC----ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL----SMSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      +.|.+ .+.||+|+||.||+|.++.  +++.||+|.++....    .....+|+.++++++|+|++++++++........
T Consensus         7 ~~y~~-~~~ig~g~~~~v~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (309)
T cd07845           7 TEFEK-LNRIGEGTYGIVYRARDTT--SGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI   83 (309)
T ss_pred             cceeE-eeeeeecCCEEEEEEEECC--CCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence            44664 6699999999999999876  678899999863322    2346689999999999999999999865555678


Q ss_pred             EEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEee
Q psy2172          94 WLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIAD  173 (291)
Q Consensus        94 ~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~D  173 (291)
                      ++||||++++|.+++....        ..+++..++.++.|++.||++||++|++|+||+|+||+++    ..+.++|+|
T Consensus        84 ~lv~e~~~~~l~~~l~~~~--------~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~----~~~~~kL~d  151 (309)
T cd07845          84 FLVMEYCEQDLASLLDNMP--------TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLT----DKGCLKIAD  151 (309)
T ss_pred             EEEEecCCCCHHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC----CCCCEEECc
Confidence            9999999998888876533        1289999999999999999999999999999999999998    667899999


Q ss_pred             cccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccCCCCCcHHHHH
Q psy2172         174 MGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD  253 (291)
Q Consensus       174 fg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  253 (291)
                      ||.+........   ......++..|+|||.+.+...++.++|+||||+++|+|++|.+||.+.+.         .+.+.
T Consensus       152 fg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~---------~~~~~  219 (309)
T cd07845         152 FGLARTYGLPAK---PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE---------IEQLD  219 (309)
T ss_pred             cceeeecCCccC---CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH---------HHHHH
Confidence            999987654321   112234577899999987655588999999999999999999999987665         37788


Q ss_pred             HHHHhhCCCCcCChhhhhcCC
Q psy2172         254 RIFSVMGFPLEKDWEDIRKMP  274 (291)
Q Consensus       254 ~i~~~~~~~~~~~~~~~~~~~  274 (291)
                      .+...++.+....||.+..++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~  240 (309)
T cd07845         220 LIIQLLGTPNESIWPGFSDLP  240 (309)
T ss_pred             HHHHhcCCCChhhchhhhccc
Confidence            888888888888887766554

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2e-37  Score=260.52  Aligned_cols=241  Identities=34%  Similarity=0.584  Sum_probs=191.6

Q ss_pred             cccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEE
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG----LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWL   95 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~i   95 (291)
                      |.+ .+.||+|++|.||+|.+..  ++..|++|.+....    ....+.+|+.++++++|||++++++++  ......++
T Consensus         2 y~~-~~~l~~g~~~~v~~~~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~--~~~~~~~~   76 (286)
T cd07832           2 YKI-LGRIGEGAHGIVFKAKDRE--TGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVF--PHGSGFVL   76 (286)
T ss_pred             ceE-EeecccCCCcEEEEEEECC--CCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEE--ecCCeeEE
Confidence            443 5689999999999999876  57789999986543    235688999999999999999999999  55778999


Q ss_pred             EEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecc
Q psy2172          96 LFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMG  175 (291)
Q Consensus        96 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg  175 (291)
                      |+||++++|.+.+.....        .+++..++.++.|++.||++||+.|++|+||+|+||+++    ..+.++|+|||
T Consensus        77 v~e~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~----~~~~~~l~dfg  144 (286)
T cd07832          77 VMEYMPSDLSEVLRDEER--------PLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLIS----ADGVLKIADFG  144 (286)
T ss_pred             EecccCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEc----CCCcEEEeeee
Confidence            999997799888765431        289999999999999999999999999999999999998    67789999999


Q ss_pred             cceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc--------------
Q psy2172         176 FARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI--------------  241 (291)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~--------------  241 (291)
                      .+........  .......++..|+|||.+.+...++.++||||+|+++++|++|.+||.+.....              
T Consensus       145 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~  222 (286)
T cd07832         145 LARLFSEEEP--RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNE  222 (286)
T ss_pred             ecccccCCCC--CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCCh
Confidence            9886654321  112334678889999998776667899999999999999999999887654210              


Q ss_pred             -----------------c--------CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         242 -----------------K--------TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       242 -----------------~--------~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                                       .        ...+.....+.+++..|..+.|..||+++++..||++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~  285 (286)
T cd07832         223 ETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF  285 (286)
T ss_pred             HHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCc
Confidence                             0        0001123556677777777888888888887777765

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG1187|consensus

Probab=100.00  E-value=5.3e-38  Score=269.03  Aligned_cols=204  Identities=25%  Similarity=0.408  Sum_probs=167.4

Q ss_pred             cccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC--ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCc
Q psy2172          14 TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL--SMSACREIALLRELKHPNVINLISVFLSHNDR   91 (291)
Q Consensus        14 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (291)
                      ..-++.|. +..+||+|+||.||+|...+   +..||||.+.....  ..+|.+|+.++.+++|||+|+++|++.+.+. 
T Consensus        71 ~~AT~~Fs-~~~~ig~Ggfg~VYkG~l~~---~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~-  145 (361)
T KOG1187|consen   71 RKATNNFS-ESNLIGEGGFGTVYKGVLSD---GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGE-  145 (361)
T ss_pred             HHHHhCCc-hhcceecCCCeEEEEEEECC---CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCc-
Confidence            34456777 46799999999999999764   37899998876554  4679999999999999999999999954332 


Q ss_pred             eEEEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeeccCCCcEEeecCCCCCC
Q psy2172          92 KVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSN---WVLHRDLKPANILVMGEGIERG  167 (291)
Q Consensus        92 ~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~dik~~Nil~~~~~~~~~  167 (291)
                      ..++|+||+. |+|.+.+......       ++++..+.+|+.++|+||+|||+.   .|+|||||++|||++    .+.
T Consensus       146 ~~~LVYEym~nGsL~d~L~~~~~~-------~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD----~~~  214 (361)
T KOG1187|consen  146 HRLLVYEYMPNGSLEDHLHGKKGE-------PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD----EDF  214 (361)
T ss_pred             eEEEEEEccCCCCHHHHhCCCCCC-------CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC----CCC
Confidence            6999999998 5877777653321       389999999999999999999985   399999999999999    788


Q ss_pred             cEEEeecccceecCCCCCCCCCCCCc-eecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q psy2172         168 RVKIADMGFARLFNNPLKPLADLDPV-VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  237 (291)
Q Consensus       168 ~~~l~Dfg~~~~~~~~~~~~~~~~~~-~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~  237 (291)
                      +.||+|||+++.....   ....... .||.+|+|||+... +..+.++||||||++|.|+++|+.+....
T Consensus       215 ~aKlsDFGLa~~~~~~---~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~  281 (361)
T KOG1187|consen  215 NAKLSDFGLAKLGPEG---DTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQS  281 (361)
T ss_pred             CEEccCccCcccCCcc---ccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCC
Confidence            9999999999654321   1111112 78999999999987 44899999999999999999999888754

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=5.8e-37  Score=258.78  Aligned_cols=230  Identities=43%  Similarity=0.816  Sum_probs=189.8

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC----ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL----SMSACREIALLRELKHPNVINLISVFLSHNDRKVW   94 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (291)
                      .|++ .+.||+|+||.||+|.++.  +++.+++|.++....    ...+.+|+.++++++||||+++++++...+....|
T Consensus         6 ~y~~-~~~lg~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (293)
T cd07843           6 EYEK-LNRIEEGTYGVVYRARDKK--TGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY   82 (293)
T ss_pred             hhhh-hhhhcCCCCeEEEEEEECC--CCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence            4554 5799999999999999876  667899999864322    23467899999999999999999998665558999


Q ss_pred             EEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          95 LLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        95 iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      +++||++++|.+.+.....        .+++..++.++.|++.||++||++|++|+||+|+||+++    ..+.++|+||
T Consensus        83 lv~e~~~~~L~~~~~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~----~~~~~~l~d~  150 (293)
T cd07843          83 MVMEYVEHDLKSLMETMKQ--------PFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLN----NRGILKICDF  150 (293)
T ss_pred             EEehhcCcCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEEC----CCCcEEEeec
Confidence            9999999988887765332        289999999999999999999999999999999999998    6688999999


Q ss_pred             ccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccCCCCCcHHHHHH
Q psy2172         175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR  254 (291)
Q Consensus       175 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  254 (291)
                      |.+........   ......++..|+|||.+.+...++.++|+||||+++|+|++|.+||.....         .+.+..
T Consensus       151 g~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~---------~~~~~~  218 (293)
T cd07843         151 GLAREYGSPLK---PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE---------IDQLNK  218 (293)
T ss_pred             CceeeccCCcc---ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHH
Confidence            99886654321   122345678899999987755578999999999999999999999987665         367788


Q ss_pred             HHHhhCCCCcCChhhhhcCCC
Q psy2172         255 IFSVMGFPLEKDWEDIRKMPE  275 (291)
Q Consensus       255 i~~~~~~~~~~~~~~~~~~~~  275 (291)
                      ++..++.|.+..|+.+..++.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~  239 (293)
T cd07843         219 IFKLLGTPTEKIWPGFSELPG  239 (293)
T ss_pred             HHHHhCCCchHHHHHhhccch
Confidence            888888888888887766543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=4.7e-37  Score=254.12  Aligned_cols=237  Identities=30%  Similarity=0.474  Sum_probs=192.5

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCC----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEec
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT----GLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDY   99 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~   99 (291)
                      .+.||+|++|.||+|.++.  +++.|++|.+...    .....+.+|+.+++.++|||++++++++  .+....+++|||
T Consensus         5 ~~~l~~g~~~~v~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~lv~e~   80 (256)
T cd08529           5 LNKIGKGSFGVVFKVVRKA--DKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESF--LDKGKLNIVMEY   80 (256)
T ss_pred             eEEecCCCCeEEEEEEEcC--CCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeee--ccCCEEEEEEEe
Confidence            4689999999999999876  6788999988643    2334678899999999999999999998  456789999999


Q ss_pred             CCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccce
Q psy2172         100 AEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR  178 (291)
Q Consensus       100 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~  178 (291)
                      +.+ +|.+.+......       .++...++.++.|++.||.+||++|++|+||+|+||+++    .++.++|+|||.+.
T Consensus        81 ~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~----~~~~~~l~df~~~~  149 (256)
T cd08529          81 AENGDLHKLLKMQRGR-------PLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLD----AYDNVKIGDLGVAK  149 (256)
T ss_pred             CCCCcHHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEe----CCCCEEEcccccce
Confidence            975 888777653211       288999999999999999999999999999999999998    66789999999988


Q ss_pred             ecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc----------ccCCCCCc
Q psy2172         179 LFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED----------IKTSNPYH  248 (291)
Q Consensus       179 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~----------~~~~~~~~  248 (291)
                      .......   ......|+..|+|||++.+.. ++.++|+||||+++|+|++|..||......          ........
T Consensus       150 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  225 (256)
T cd08529         150 LLSDNTN---FANTIVGTPYYLSPELCEDKP-YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMY  225 (256)
T ss_pred             eccCccc---hhhccccCccccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccc
Confidence            6654321   112345788899999998754 889999999999999999999999866531          11112233


Q ss_pred             HHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         249 HDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       249 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                      ...+.+++..|..+.|..||++.++..++++
T Consensus       226 ~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         226 SQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             CHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence            5678889999999999999999988887764

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=4.2e-37  Score=259.79  Aligned_cols=248  Identities=35%  Similarity=0.584  Sum_probs=192.4

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC----CChhHHHHHHHHhcCC-CCCeeeEEEEEEeCC---C
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG----LSMSACREIALLRELK-HPNVINLISVFLSHN---D   90 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~---~   90 (291)
                      +|++ .+.||+|+||.||+|.+..  +++.||+|..+...    ....+.+|+.+++.++ ||||+++++++...+   .
T Consensus         2 ~y~~-~~~lg~g~~g~vy~~~~~~--~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~   78 (295)
T cd07837           2 AYEK-LEKIGEGTYGKVYKARDKN--TGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGK   78 (295)
T ss_pred             CceE-eeEecccCCeEEEEEEECC--CCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCC
Confidence            4564 6799999999999999876  67889999876432    2346788999999995 699999999885422   2


Q ss_pred             ceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEE
Q psy2172          91 RKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVK  170 (291)
Q Consensus        91 ~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~  170 (291)
                      ...|++|||+++++.+.+.......    ...+++..++.++.|++.||.|||++|++|+||+|+||+++.   .++.++
T Consensus        79 ~~~~lv~e~~~~~l~~~~~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~---~~~~~k  151 (295)
T cd07837          79 PSLYLVFEYLDSDLKKFMDSNGRGP----GRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDK---QKGLLK  151 (295)
T ss_pred             ceEEEEeeccCcCHHHHHHHhcccC----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEec---CCCeEE
Confidence            2489999999999888876543221    123899999999999999999999999999999999999983   267899


Q ss_pred             EeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---------
Q psy2172         171 IADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---------  241 (291)
Q Consensus       171 l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---------  241 (291)
                      |+|||.+........   ......+++.|+|||.+.+...++.++|+||||+++|+|++|..||.+.....         
T Consensus       152 l~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~  228 (295)
T cd07837         152 IADLGLGRAFSIPVK---SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLL  228 (295)
T ss_pred             EeecccceecCCCcc---ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            999999876543211   11223557789999998765557899999999999999999999997643210         


Q ss_pred             ----------------------------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         242 ----------------------------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       242 ----------------------------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                                                  ....+.....+.+++..|..+.|..||++.++..+||+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~  294 (295)
T cd07837         229 GTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF  294 (295)
T ss_pred             CCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCc
Confidence                                        00012234567788888889999999999998888875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=9.6e-37  Score=253.92  Aligned_cols=243  Identities=23%  Similarity=0.413  Sum_probs=189.3

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC-------ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCc
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-------SMSACREIALLRELKHPNVINLISVFLSHNDR   91 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (291)
                      .|.+ ++.||+|+||.||+|.+..  ++..|++|.+.....       ...+.+|+.++++++||||+++++.+......
T Consensus         3 ~~~~-~~~lg~g~~g~vy~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   79 (266)
T cd06651           3 NWRR-GKLLGQGAFGRVYLCYDVD--TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEK   79 (266)
T ss_pred             Cccc-cceecCCCCEEEEEEEEcC--CCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCC
Confidence            3553 7799999999999999776  677899998864321       13477899999999999999999988655567


Q ss_pred             eEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEE
Q psy2172          92 KVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVK  170 (291)
Q Consensus        92 ~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~  170 (291)
                      ..++++||+++ +|.+.+....         .++....+.++.|++.||++||+++++|+||+|+||+++    .++.++
T Consensus        80 ~~~l~~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~----~~~~~~  146 (266)
T cd06651          80 TLTIFMEYMPGGSVKDQLKAYG---------ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRD----SAGNVK  146 (266)
T ss_pred             EEEEEEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC----CCCCEE
Confidence            88999999975 7777775432         178888999999999999999999999999999999998    667899


Q ss_pred             EeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---------
Q psy2172         171 IADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---------  241 (291)
Q Consensus       171 l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---------  241 (291)
                      |+|||++.................++..|+|||.+.+.. ++.++|+||+|+++|+|++|+.||.......         
T Consensus       147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~  225 (266)
T cd06651         147 LGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEG-YGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQP  225 (266)
T ss_pred             EccCCCccccccccccCCccccCCccccccCHHHhCCCC-CCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCC
Confidence            999999876543221112222345788899999998744 8899999999999999999999997553211         


Q ss_pred             --cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         242 --KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       242 --~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                        +.......+.+..+++.+. ..|..||++.++..+|++
T Consensus       226 ~~~~~~~~~~~~~~~li~~~~-~~p~~Rp~~~eil~hp~~  264 (266)
T cd06651         226 TNPQLPSHISEHARDFLGCIF-VEARHRPSAEELLRHPFA  264 (266)
T ss_pred             CCCCCchhcCHHHHHHHHHhc-CChhhCcCHHHHhcCccc
Confidence              1112223455677776554 588999999999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=7.2e-37  Score=254.69  Aligned_cols=238  Identities=26%  Similarity=0.440  Sum_probs=190.8

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC-----------hhHHHHHHHHhcCCCCCeeeEEEEEEeCCCce
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS-----------MSACREIALLRELKHPNVINLISVFLSHNDRK   92 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (291)
                      +..||+|++|.||+|.+..  .+..+++|.+......           ..+.+|+.++++++||||+++++++  .+...
T Consensus         5 ~~~ig~g~~~~v~~a~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~   80 (267)
T cd06628           5 GALIGSGSFGSVYLGMNAS--SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSS--LDADH   80 (267)
T ss_pred             cceeecCCCeEEEEEEecC--CCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEE--EeCCc
Confidence            6799999999999999765  5678999988643221           3477899999999999999999998  45668


Q ss_pred             EEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEE
Q psy2172          93 VWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI  171 (291)
Q Consensus        93 ~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l  171 (291)
                      .++++||+++ +|.+.+.....         +++..+..++.|++.||++||++|++|+||+|+||+++    .++.++|
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~---------l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~----~~~~~~l  147 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGA---------FEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVD----NKGGIKI  147 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccC---------ccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEc----CCCCEEe
Confidence            8999999976 77777754321         78889999999999999999999999999999999998    6778999


Q ss_pred             eecccceecCCCCCCC---CCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc--------
Q psy2172         172 ADMGFARLFNNPLKPL---ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED--------  240 (291)
Q Consensus       172 ~Dfg~~~~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~--------  240 (291)
                      +|||.+..........   .......|+..|+|||.+.+.. ++.++|+||||+++|+|++|..||......        
T Consensus       148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  226 (267)
T cd06628         148 SDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTS-YTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE  226 (267)
T ss_pred             cccCCCcccccccccCCccccccccCCCcCccChhHhccCC-CCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc
Confidence            9999988665321111   1112235778899999997754 788999999999999999999999764321        


Q ss_pred             --ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         241 --IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       241 --~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                        ...........+.++++.|..+.|..||++.++..++++
T Consensus       227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         227 NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence              111222345778899999999999999999998888764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=4e-37  Score=258.21  Aligned_cols=237  Identities=31%  Similarity=0.528  Sum_probs=190.0

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCC---CChhHHHHHHHHhcCC-CCCeeeEEEEEEeCCCceEEEEEec
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG---LSMSACREIALLRELK-HPNVINLISVFLSHNDRKVWLLFDY   99 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~iv~e~   99 (291)
                      .++||+|+||.||+|.++.  +++.+|+|.++...   ......+|+.+++++. |+|++++++++.+......++||||
T Consensus         4 ~~~lg~g~~~~v~~~~~~~--~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~   81 (282)
T cd07831           4 LGKIGEGTFSEVLKAQSRK--TGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL   81 (282)
T ss_pred             EeeccccccceEEEEEEcC--CCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence            5689999999999999876  66889999987532   2234457888999885 9999999999965544789999999


Q ss_pred             CCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeeccccee
Q psy2172         100 AEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL  179 (291)
Q Consensus       100 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~  179 (291)
                      +++++.+.+.....        .+++..+..++.|++.||++||++|++|+||+|+||+++    . +.++|+|||.+..
T Consensus        82 ~~~~l~~~l~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~----~-~~~kl~dfg~~~~  148 (282)
T cd07831          82 MDMNLYELIKGRKR--------PLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIK----D-DILKLADFGSCRG  148 (282)
T ss_pred             CCccHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEc----C-CCeEEEecccccc
Confidence            99988887764321        289999999999999999999999999999999999998    5 8999999999876


Q ss_pred             cCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc------------------
Q psy2172         180 FNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI------------------  241 (291)
Q Consensus       180 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~------------------  241 (291)
                      ......    .....++..|+|||.+.....++.++|+|||||++|+|++|..||.+.+...                  
T Consensus       149 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (282)
T cd07831         149 IYSKPP----YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLK  224 (282)
T ss_pred             cccCCC----cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence            543211    1224567889999987654557889999999999999999999997653210                  


Q ss_pred             --------------------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         242 --------------------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       242 --------------------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                                          ....+.....+.+++..|..+.|..||++.++..+||+
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         225 KFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             hhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence                                00012234678889999999999999999999888874

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=5.3e-37  Score=256.16  Aligned_cols=247  Identities=23%  Similarity=0.415  Sum_probs=195.7

Q ss_pred             cccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-CChhHHHHHHHHhcC-CCCCeeeEEEEEEeCC----
Q psy2172          16 VEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-LSMSACREIALLREL-KHPNVINLISVFLSHN----   89 (291)
Q Consensus        16 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~----   89 (291)
                      .++.|++ .+.||+|+||.||+|.++.  +++.+|+|.+.... ....+.+|+.+++++ +|+||+++++++...+    
T Consensus         4 ~~~~y~~-~~~lg~g~~g~vy~~~~~~--~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (272)
T cd06637           4 PAGIFEL-VELVGNGTYGQVYKGRHVK--TGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   80 (272)
T ss_pred             hhhhhhH-HHheeecCCeEEEEEEEcC--CCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence            4567775 5689999999999999876  67889999986543 334678899999998 6999999999986432    


Q ss_pred             CceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCc
Q psy2172          90 DRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGR  168 (291)
Q Consensus        90 ~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~  168 (291)
                      ....|++|||+++ +|.+.+.....       ..+++..+..++.|++.|++|||+++++|+||+|+||+++    .++.
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~~-------~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~----~~~~  149 (272)
T cd06637          81 DDQLWLVMEFCGAGSVTDLIKNTKG-------NTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT----ENAE  149 (272)
T ss_pred             CcEEEEEEEcCCCCcHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEEC----CCCC
Confidence            3578999999985 77777764321       1288999999999999999999999999999999999998    6678


Q ss_pred             EEEeecccceecCCCCCCCCCCCCceecccccccccccCC----cCCCCchhHHHHHHHHHHHHcCCCCCCCCccc----
Q psy2172         169 VKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGA----RHYTKAIDIWAIGCIFAELLTSEPIFHCRQED----  240 (291)
Q Consensus       169 ~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~----  240 (291)
                      ++|+|||++.......   .......|+..|+|||++.+.    ..++.++|+||+||++|+|++|..||......    
T Consensus       150 ~~l~Dfg~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~  226 (272)
T cd06637         150 VKLVDFGVSAQLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF  226 (272)
T ss_pred             EEEccCCCceeccccc---ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH
Confidence            9999999987654321   122345678899999998531    24788999999999999999999999653311    


Q ss_pred             -------ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         241 -------IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       241 -------~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                             ...........+.+++..|....|..||++.++..+||+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         227 LIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             HHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence                   011112234678899999999999999999999998875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4.6e-37  Score=258.03  Aligned_cols=227  Identities=15%  Similarity=0.187  Sum_probs=183.5

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC-----ChhHHHHHHHHhcCCCCCeeeEEEEEEe--CCCceEEEE
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-----SMSACREIALLRELKHPNVINLISVFLS--HNDRKVWLL   96 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~~~iv   96 (291)
                      ...||+|++|.||+|.+    +++.||+|.++....     .+.+.+|+.+|++++||||+++++++.+  ++....+++
T Consensus        25 ~~~i~~g~~~~v~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv  100 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF----NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLI  100 (283)
T ss_pred             CeEEeeCCceEEEEEEE----CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEE
Confidence            35899999999999987    457899999875432     2456699999999999999999999865  445689999


Q ss_pred             EecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          97 FDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSN-WVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        97 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~-~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      |||+.+ +|.+.+....         .++......++.|++.|+.+||+. +++|+||||+||+++    .++.++|+||
T Consensus       101 ~Ey~~~g~L~~~l~~~~---------~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~----~~~~~kl~df  167 (283)
T PHA02988        101 LEYCTRGYLREVLDKEK---------DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVT----ENYKLKIICH  167 (283)
T ss_pred             EEeCCCCcHHHHHhhCC---------CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEEC----CCCcEEEccc
Confidence            999986 7877776432         178888999999999999999984 999999999999998    6789999999


Q ss_pred             ccceecCCCCCCCCCCCCceecccccccccccCC-cCCCCchhHHHHHHHHHHHHcCCCCCCCCccc-----------cc
Q psy2172         175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQED-----------IK  242 (291)
Q Consensus       175 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~-----------~~  242 (291)
                      |++......      .....++..|+|||.+.+. ..++.++||||||+++|+|++|..||.+....           ..
T Consensus       168 g~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~  241 (283)
T PHA02988        168 GLEKILSSP------PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL  241 (283)
T ss_pred             chHhhhccc------cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC
Confidence            998754332      1234567889999998752 34899999999999999999999999876432           11


Q ss_pred             CCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         243 TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       243 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      .........+.+++..+....|..||++.++
T Consensus       242 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~el  272 (283)
T PHA02988        242 KLPLDCPLEIKCIVEACTSHDSIKRPNIKEI  272 (283)
T ss_pred             CCCCcCcHHHHHHHHHHhcCCcccCcCHHHH
Confidence            1222456778999999999999999988764

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=3.1e-37  Score=259.22  Aligned_cols=238  Identities=39%  Similarity=0.691  Sum_probs=187.8

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCC----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEec
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG----LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDY   99 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~   99 (291)
                      .+.||.|++|.||+|++..  +++.|++|.++...    ....+.+|++++++++||||+++++++  .+....+++|||
T Consensus         5 ~~~l~~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~~~~v~e~   80 (284)
T cd07860           5 VEKIGEGTYGVVYKARNKL--TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI--HTENKLYLVFEF   80 (284)
T ss_pred             eeeecCCCceEEEEEEECC--CCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc--ccCCcEEEEeec
Confidence            5689999999999999876  66789999886432    224688899999999999999999998  567789999999


Q ss_pred             CCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeeccccee
Q psy2172         100 AEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL  179 (291)
Q Consensus       100 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~  179 (291)
                      +.++|.+.+......       .+++..++.++.|++.||+|||++|++|+||+|+||+++    .++.++|+|||.+..
T Consensus        81 ~~~~l~~~~~~~~~~-------~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~----~~~~~~l~dfg~~~~  149 (284)
T cd07860          81 LHQDLKKFMDASPLS-------GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN----TEGAIKLADFGLARA  149 (284)
T ss_pred             cccCHHHHHHhCCCC-------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCCEEEeeccchhh
Confidence            988888777643221       288999999999999999999999999999999999998    667899999999875


Q ss_pred             cCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc-----------------
Q psy2172         180 FNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK-----------------  242 (291)
Q Consensus       180 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~-----------------  242 (291)
                      ......   ......++..|+|||.+.+...++.++|+||||+++|+|++|..||.+......                 
T Consensus       150 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (284)
T cd07860         150 FGVPVR---TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP  226 (284)
T ss_pred             cccCcc---ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Confidence            543211   112334577899999987756578899999999999999999999976543100                 


Q ss_pred             ---------------------CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         243 ---------------------TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       243 ---------------------~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                                           ...+.....+.+++..|....|..||++.++..+||+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         227 GVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             hhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence                                 0001122345567777888888888888888777764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.9e-37  Score=253.14  Aligned_cols=232  Identities=22%  Similarity=0.326  Sum_probs=182.9

Q ss_pred             ceeCcccceEEEEEEEccCC-CCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecC
Q psy2172          25 CKVGRGTYGHVYKARRKDNS-DTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYA  100 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~~-~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~  100 (291)
                      ++||+|+||.||+|.+.... ....+++|.+.....   ...+.+|+.+++.++||||+++++++  . ....+++|||+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~-~~~~~~v~e~~   77 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVC--K-GEPLMLVMELA   77 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEE--c-CCceEEEEEeC
Confidence            47999999999999876533 447899999875543   34678899999999999999999987  2 44679999998


Q ss_pred             CC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeeccccee
Q psy2172         101 EH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL  179 (291)
Q Consensus       101 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~  179 (291)
                      .+ +|.+.+....         .+++..+..++.|++.|+++||+++++|+||+|+||+++    .++.++|+|||.+..
T Consensus        78 ~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~----~~~~~kl~df~~~~~  144 (257)
T cd05060          78 PLGPLLKYLKKRR---------EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLV----NRHQAKISDFGMSRA  144 (257)
T ss_pred             CCCcHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEc----CCCcEEeccccccce
Confidence            74 8888776443         288999999999999999999999999999999999998    677899999999886


Q ss_pred             cCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc----------ccCCCCCc
Q psy2172         180 FNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED----------IKTSNPYH  248 (291)
Q Consensus       180 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~----------~~~~~~~~  248 (291)
                      ...............++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||......          ........
T Consensus       145 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  223 (257)
T cd05060         145 LGAGSDYYRATTAGRWPLKWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEEC  223 (257)
T ss_pred             eecCCcccccccCccccccccCHHHhcCCC-CCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCC
Confidence            644322211122223346799999987654 8999999999999999997 99999764431          11122233


Q ss_pred             HHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         249 HDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       249 ~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      ...+.+++..+..+.|..||++.++
T Consensus       224 ~~~l~~li~~cl~~~p~~Rp~~~~l  248 (257)
T cd05060         224 PQEIYSIMLSCWKYRPEDRPTFSEL  248 (257)
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHH
Confidence            4678889999999999999987753

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=7.2e-37  Score=258.59  Aligned_cols=248  Identities=23%  Similarity=0.376  Sum_probs=197.6

Q ss_pred             ccccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC--CChhHHHHHHHHhcCCCCCeeeEEEEEEeC
Q psy2172          11 NERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG--LSMSACREIALLRELKHPNVINLISVFLSH   88 (291)
Q Consensus        11 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   88 (291)
                      ........+|++ .+.||+|++|.||+|.+..  +++.+++|.+....  ....+.+|+.+++.++|+|++++++.+.  
T Consensus        13 ~~~~~~~~~y~~-~~~lg~g~~~~v~~~~~~~--~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~--   87 (296)
T cd06654          13 VSVGDPKKKYTR-FEKIGQGASGTVYTAMDVA--TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL--   87 (296)
T ss_pred             cccCCcccceee-EEEecCCCCeEEEEEEECC--CCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEE--
Confidence            344455567775 6789999999999999766  67889999886433  2356788999999999999999999984  


Q ss_pred             CCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCC
Q psy2172          89 NDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERG  167 (291)
Q Consensus        89 ~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~  167 (291)
                      .....|+||||+.+ +|.+.+...          .++...+..++.|++.||.+||+.|++|+||+|+||+++    .++
T Consensus        88 ~~~~~~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~----~~~  153 (296)
T cd06654          88 VGDELWVVMEYLAGGSLTDVVTET----------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG----MDG  153 (296)
T ss_pred             eCCEEEEeecccCCCCHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc----CCC
Confidence            46689999999975 777766432          178889999999999999999999999999999999998    667


Q ss_pred             cEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc-----
Q psy2172         168 RVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK-----  242 (291)
Q Consensus       168 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~-----  242 (291)
                      .++|+|||.+.......   .......++..|+|||.+.+.. ++.++|+|||||++|+|++|..||........     
T Consensus       154 ~~kl~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~  229 (296)
T cd06654         154 SVKLTDFGFCAQITPEQ---SKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA  229 (296)
T ss_pred             CEEECccccchhccccc---cccCcccCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHh
Confidence            89999999887543321   1122346788899999987744 78999999999999999999999976543110     


Q ss_pred             -------CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         243 -------TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       243 -------~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                             .........+.+++..|..+.|..||++.++..++++..
T Consensus       230 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~  275 (296)
T cd06654         230 TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (296)
T ss_pred             cCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhc
Confidence                   011223456888999999999999999999999888653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=8.6e-37  Score=257.85  Aligned_cols=244  Identities=39%  Similarity=0.654  Sum_probs=189.7

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG----LSMSACREIALLRELKHPNVINLISVFLSHNDRKVW   94 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (291)
                      .|.+ .+.||+|++|.||+|.++.  +++.|++|.+....    ....+.+|+.++++++||||+++++++  .+....|
T Consensus         3 ~y~~-~~~l~~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~   77 (294)
T PLN00009          3 QYEK-VEKIGEGTYGVVYKARDRV--TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVV--HSEKRLY   77 (294)
T ss_pred             ceEE-EEEecCCCCEEEEEEEecC--CCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEE--ecCCeEE
Confidence            4564 5699999999999999876  67889999886432    234678899999999999999999999  5567999


Q ss_pred             EEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          95 LLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        95 iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      +||||+++++.+.+.....       ..+++..++.++.|++.||++||++|++|+||+|+||+++.   ....++|+||
T Consensus        78 lv~e~~~~~l~~~~~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~---~~~~~kl~df  147 (294)
T PLN00009         78 LVFEYLDLDLKKHMDSSPD-------FAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDR---RTNALKLADF  147 (294)
T ss_pred             EEEecccccHHHHHHhCCC-------CCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEEC---CCCEEEEccc
Confidence            9999999888777654322       12678889999999999999999999999999999999973   2357999999


Q ss_pred             ccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc-------------
Q psy2172         175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI-------------  241 (291)
Q Consensus       175 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~-------------  241 (291)
                      |.+........   ......++..|+|||.+.+...++.++|+||+|+++|+|++|..||.......             
T Consensus       148 g~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~  224 (294)
T PLN00009        148 GLARAFGIPVR---TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPN  224 (294)
T ss_pred             ccccccCCCcc---ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            99875543211   11233567889999998765558899999999999999999999997543200             


Q ss_pred             -------------------------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchh
Q psy2172         242 -------------------------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLL  280 (291)
Q Consensus       242 -------------------------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  280 (291)
                                               ....+.....+.+++..|....|..||+..++..++++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~  288 (294)
T PLN00009        225 EETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK  288 (294)
T ss_pred             hhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHh
Confidence                                     000112234566777888888888888888888877764

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.1e-36  Score=257.51  Aligned_cols=245  Identities=23%  Similarity=0.384  Sum_probs=197.0

Q ss_pred             ccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC--CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCC
Q psy2172          13 RTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG--LSMSACREIALLRELKHPNVINLISVFLSHND   90 (291)
Q Consensus        13 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   90 (291)
                      ......+|.+ .+.||+|++|.||+|.+..  +++.|++|.+....  ....+.+|+.+++.++|+||+++++++  ...
T Consensus        14 ~~~~~~~y~~-~~~lg~g~~g~v~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~--~~~   88 (297)
T cd06656          14 VGDPKKKYTR-FEKIGQGASGTVYTAIDIA--TGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY--LVG   88 (297)
T ss_pred             cCChhhhcee-eeeeccCCCeEEEEEEECC--CCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEE--ecC
Confidence            3455567775 6799999999999999766  67889999986432  234578899999999999999999999  456


Q ss_pred             ceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcE
Q psy2172          91 RKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRV  169 (291)
Q Consensus        91 ~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~  169 (291)
                      ...++||||+++ +|.+.+...          .+++..+..++.|++.||.+||+.|++|+||+|+||+++    .++.+
T Consensus        89 ~~~~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~----~~~~~  154 (297)
T cd06656          89 DELWVVMEYLAGGSLTDVVTET----------CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLG----MDGSV  154 (297)
T ss_pred             CEEEEeecccCCCCHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCE
Confidence            789999999975 777666432          178889999999999999999999999999999999998    67789


Q ss_pred             EEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc-------
Q psy2172         170 KIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK-------  242 (291)
Q Consensus       170 ~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~-------  242 (291)
                      +|+|||.+........   ......++..|+|||.+.+.. ++.++|+||||+++|++++|..||.+......       
T Consensus       155 ~l~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~  230 (297)
T cd06656         155 KLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN  230 (297)
T ss_pred             EECcCccceEccCCcc---CcCcccCCccccCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccC
Confidence            9999999876543211   122346788899999998744 88999999999999999999999976543110       


Q ss_pred             -----CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchh
Q psy2172         243 -----TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLL  280 (291)
Q Consensus       243 -----~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  280 (291)
                           .........+.+++..|....|..||++.++..+||+.
T Consensus       231 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~  273 (297)
T cd06656         231 GTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLK  273 (297)
T ss_pred             CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhc
Confidence                 01122345678899999999999999999999998864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3.9e-37  Score=254.61  Aligned_cols=241  Identities=24%  Similarity=0.473  Sum_probs=196.1

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLF   97 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~   97 (291)
                      +.|++ .+.||+|+||.||+|.++.  +++.+++|.++.....+.+.+|+.++++++||||+++++.+  .+....|+++
T Consensus         3 ~~y~~-~~~i~~g~~~~v~~~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~--~~~~~~~l~~   77 (256)
T cd06612           3 EVFDI-LEKLGEGSYGSVYKAIHKE--TGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSY--FKNTDLWIVM   77 (256)
T ss_pred             ccchh-hhhhcCCCCeEEEEEEEcC--CCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeee--ecCCcEEEEE
Confidence            45664 6689999999999999876  56889999987655567889999999999999999999999  4567899999


Q ss_pred             ecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeeccc
Q psy2172          98 DYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGF  176 (291)
Q Consensus        98 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~  176 (291)
                      ||+++ +|.+.+.....        .+++..++.++.|++.|+.+||+.+++|+||+|+||+++    .++.++|+|||.
T Consensus        78 e~~~~~~L~~~l~~~~~--------~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~----~~~~~~l~dfg~  145 (256)
T cd06612          78 EYCGAGSVSDIMKITNK--------TLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLN----EEGQAKLADFGV  145 (256)
T ss_pred             ecCCCCcHHHHHHhCcc--------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEC----CCCcEEEccccc
Confidence            99986 77777654221        288999999999999999999999999999999999998    667899999999


Q ss_pred             ceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc------------CC
Q psy2172         177 ARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK------------TS  244 (291)
Q Consensus       177 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~------------~~  244 (291)
                      +........   ......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||........            ..
T Consensus       146 ~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  221 (256)
T cd06612         146 SGQLTDTMA---KRNTVIGTPFWMAPEVIQEIG-YNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSD  221 (256)
T ss_pred             chhcccCcc---ccccccCCccccCHHHHhcCC-CCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCc
Confidence            886544221   122344678899999997754 88999999999999999999999976443210            01


Q ss_pred             CCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         245 NPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       245 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                      .......+.+++..|..+.|..||++.++..++|+
T Consensus       222 ~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         222 PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             hhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence            11223567889999999999999999998888874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=7.7e-37  Score=252.43  Aligned_cols=231  Identities=21%  Similarity=0.352  Sum_probs=180.2

Q ss_pred             ceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecCC
Q psy2172          25 CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAE  101 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~~  101 (291)
                      ++||+|+||.||+|.++.  +++.+|+|.+.....   ...+.+|++++++++||||+++++++  ......++||||+.
T Consensus         1 ~~lg~g~~g~vy~~~~~~--~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~lv~e~~~   76 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRA--DNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC--TQKQPIYIVMELVQ   76 (252)
T ss_pred             CccCcccCccEEEEEEec--CCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE--cCCCCeEEEEeecc
Confidence            479999999999999876  677899998764322   24688999999999999999999998  55678999999997


Q ss_pred             C-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceec
Q psy2172         102 H-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF  180 (291)
Q Consensus       102 ~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~  180 (291)
                      + +|.+.+....        ..+++..++.++.|++.||.|||++|++|+||+|+||+++    .++.++|+|||.+...
T Consensus        77 ~~~L~~~~~~~~--------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~----~~~~~kl~dfg~~~~~  144 (252)
T cd05084          77 GGDFLTFLRTEG--------PRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVT----EKNVLKISDFGMSREE  144 (252)
T ss_pred             CCcHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEc----CCCcEEECccccCccc
Confidence            5 7777665322        1278899999999999999999999999999999999998    6678999999998754


Q ss_pred             CCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc----------ccCCCCCcH
Q psy2172         181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED----------IKTSNPYHH  249 (291)
Q Consensus       181 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~----------~~~~~~~~~  249 (291)
                      ...... ........+..|+|||.+.+.. ++.++|+||||+++|+|++ |..||......          .........
T Consensus       145 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (252)
T cd05084         145 EDGVYA-STGGMKQIPVKWTAPEALNYGR-YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCP  222 (252)
T ss_pred             cccccc-ccCCCCCCceeecCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCC
Confidence            322111 1111122345699999987744 8899999999999999997 89999654421          111222334


Q ss_pred             HHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         250 DQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       250 ~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      ..+.+++..|..+.|..||++.++
T Consensus       223 ~~~~~li~~~l~~~p~~Rps~~~~  246 (252)
T cd05084         223 DAVYRLMERCWEYDPGQRPSFSTV  246 (252)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHH
Confidence            678889999999999999988764

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=6.2e-37  Score=255.15  Aligned_cols=240  Identities=25%  Similarity=0.405  Sum_probs=190.3

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC--CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG--LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWL   95 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~i   95 (291)
                      +.|.+ .+.||+|+||.||+|.+..  +++.|++|.++...  ....+.+|+.+++.++||||+++++.+  .+....++
T Consensus         9 ~~~~~-~~~lg~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~--~~~~~~~l   83 (267)
T cd06645           9 EDFEL-IQRIGSGTYGDVYKARNVN--TGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY--LRRDKLWI   83 (267)
T ss_pred             HHHHH-HHHhCCCCCeEEEEEEEcC--CCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEE--EeCCEEEE
Confidence            45664 5699999999999999766  67889999986542  223577899999999999999999998  45678999


Q ss_pred             EEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          96 LFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        96 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      +|||+++ +|.+++....         .+++..++.++.|++.|+++||+.|++|+||+|+||+++    .++.++|+||
T Consensus        84 v~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~----~~~~~~l~df  150 (267)
T cd06645          84 CMEFCGGGSLQDIYHVTG---------PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLT----DNGHVKLADF  150 (267)
T ss_pred             EEeccCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCCEEECcc
Confidence            9999985 7777765332         289999999999999999999999999999999999998    6678999999


Q ss_pred             ccceecCCCCCCCCCCCCceecccccccccccC--CcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc----------c
Q psy2172         175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLG--ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI----------K  242 (291)
Q Consensus       175 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~----------~  242 (291)
                      |.+.......   .......|+..|+|||.+..  ...++.++|+|||||++|+|++|..||.......          .
T Consensus       151 g~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~  227 (267)
T cd06645         151 GVSAQITATI---AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQ  227 (267)
T ss_pred             eeeeEccCcc---cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCC
Confidence            9987654321   12233467889999999742  2347889999999999999999999986433210          0


Q ss_pred             C----CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcc
Q psy2172         243 T----SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPT  278 (291)
Q Consensus       243 ~----~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  278 (291)
                      .    ........+.+++..+....|..||++.++..+||
T Consensus       228 ~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         228 PPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             CCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            0    01122356788999999999999999998888775

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.7e-36  Score=255.80  Aligned_cols=248  Identities=24%  Similarity=0.387  Sum_probs=194.3

Q ss_pred             cccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC--CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCc
Q psy2172          14 TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG--LSMSACREIALLRELKHPNVINLISVFLSHNDR   91 (291)
Q Consensus        14 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (291)
                      ....+.|++ .++||+|+||.||+|.+..  ++..+++|.+....  ..+.+.+|+.+++.++||||+++++.+.  ...
T Consensus         8 ~~~~~~y~i-~~~lg~g~~g~vy~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~   82 (292)
T cd06644           8 LDPNEVWEI-IGELGDGAFGKVYKAKNKE--TGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY--WDG   82 (292)
T ss_pred             cCcchhhhh-hheecCCCCeEEEEEEECC--CCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEE--eCC
Confidence            345677886 6699999999999999776  67889999987543  2345778999999999999999999984  456


Q ss_pred             eEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEE
Q psy2172          92 KVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVK  170 (291)
Q Consensus        92 ~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~  170 (291)
                      ..++||||+++ ++...+.....        .+++..+..++.|++.++.+||++|++|+||+|+||+++    .++.++
T Consensus        83 ~~~lv~e~~~~~~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~----~~~~~k  150 (292)
T cd06644          83 KLWIMIEFCPGGAVDAIMLELDR--------GLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLT----LDGDIK  150 (292)
T ss_pred             eEEEEEecCCCCcHHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEc----CCCCEE
Confidence            89999999987 55444433221        288999999999999999999999999999999999998    667899


Q ss_pred             EeecccceecCCCCCCCCCCCCceecccccccccccC----CcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc-----
Q psy2172         171 IADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLG----ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI-----  241 (291)
Q Consensus       171 l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~-----  241 (291)
                      |+|||.+.......   .......++..|+|||.+.+    ...++.++|+|||||++|+|++|..||.......     
T Consensus       151 l~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~  227 (292)
T cd06644         151 LADFGVSAKNVKTL---QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI  227 (292)
T ss_pred             EccCccceeccccc---cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHH
Confidence            99999886543221   11223456788999999853    2236789999999999999999999997654210     


Q ss_pred             -------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         242 -------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       242 -------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                             ..........+.+++..+....|..||++.++..+|++..
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  274 (292)
T cd06644         228 AKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS  274 (292)
T ss_pred             hcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence                   0111222356788999999999999999999999888653

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=7.4e-37  Score=264.73  Aligned_cols=252  Identities=29%  Similarity=0.482  Sum_probs=200.3

Q ss_pred             ecccccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC----CChhHHHHHHHHhcCCCCCeeeEEEE
Q psy2172           9 TSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG----LSMSACREIALLRELKHPNVINLISV   84 (291)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~   84 (291)
                      .+.....+.++|++ .+.||+|+||.||+|.+..  +++.||+|.+....    ....+.+|+.++++++||||++++++
T Consensus         7 ~~~~~~~~~~~y~~-~~~lg~g~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   83 (353)
T cd07850           7 VGDSTFTVLKRYQN-LKPIGSGAQGIVCAAYDTV--TGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNV   83 (353)
T ss_pred             ccchhhhhhcceEE-EEEeccCCCEEEEEEEECC--CCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeee
Confidence            33444567888986 6799999999999999876  67889999986432    22456789999999999999999998


Q ss_pred             EEeC----CCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEee
Q psy2172          85 FLSH----NDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVM  160 (291)
Q Consensus        85 ~~~~----~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~  160 (291)
                      +...    +....|+||||+++++.+.+...           ++...+..++.|++.||++||++|++|+||||+||+++
T Consensus        84 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-----------l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~  152 (353)
T cd07850          84 FTPQKSLEEFQDVYLVMELMDANLCQVIQMD-----------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK  152 (353)
T ss_pred             eccCCCccccCcEEEEEeccCCCHHHHHhhc-----------CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC
Confidence            8532    22468999999999888776421           78888999999999999999999999999999999998


Q ss_pred             cCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc
Q psy2172         161 GEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED  240 (291)
Q Consensus       161 ~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~  240 (291)
                          .++.++|+|||.+.......    ......++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+..
T Consensus       153 ----~~~~~kL~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~~  223 (353)
T cd07850         153 ----SDCTLKILDFGLARTAGTSF----MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHI  223 (353)
T ss_pred             ----CCCCEEEccCccceeCCCCC----CCCCCcccccccCHHHHhCCC-CCCchhhHhHHHHHHHHHHCCCCCCCCCHH
Confidence                66789999999998654321    123345788899999998754 899999999999999999999999754310


Q ss_pred             c-------------------------------cCC---------------------CCCcHHHHHHHHHhhCCCCcCChh
Q psy2172         241 I-------------------------------KTS---------------------NPYHHDQLDRIFSVMGFPLEKDWE  268 (291)
Q Consensus       241 ~-------------------------------~~~---------------------~~~~~~~~~~i~~~~~~~~~~~~~  268 (291)
                      .                               ...                     .....+.+.+++..|..+.|..||
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  303 (353)
T cd07850         224 DQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRI  303 (353)
T ss_pred             HHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCc
Confidence            0                               000                     011234567899999999999999


Q ss_pred             hhhcCCCCcchhhhh
Q psy2172         269 DIRKMPEHPTLLKDF  283 (291)
Q Consensus       269 ~~~~~~~~~~~~~~~  283 (291)
                      ++.++..+||+..-+
T Consensus       304 t~~eiL~~~~~~~~~  318 (353)
T cd07850         304 SVDDALQHPYINVWY  318 (353)
T ss_pred             CHHHHhcChhHhhcc
Confidence            999999999876433

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.6e-36  Score=251.10  Aligned_cols=241  Identities=26%  Similarity=0.505  Sum_probs=193.5

Q ss_pred             cccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC----ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEE
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL----SMSACREIALLRELKHPNVINLISVFLSHNDRKVWL   95 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~i   95 (291)
                      |++ .+.||.|++|.||++.++.  +++.+++|.+.....    ...+.+|+.++++++|+|++++++.+. ......|+
T Consensus         2 y~~-~~~lg~g~~~~v~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~~l   77 (257)
T cd08223           2 YCF-VRVVGKGSYGEVSLVRHRT--DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE-GEDGLLYI   77 (257)
T ss_pred             ceE-EEEecCCCCeEEEEEEEcC--CCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec-CCCCEEEE
Confidence            443 5699999999999999876  567899999864322    235788999999999999999999873 23457899


Q ss_pred             EEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          96 LFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        96 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      ++||+++ +|.+.+.....       ..+++..++.++.|++.|+++||++|++|+||+|+||+++    .++.++|+||
T Consensus        78 v~e~~~~~~l~~~l~~~~~-------~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~----~~~~~~l~df  146 (257)
T cd08223          78 VMGFCEGGDLYHKLKEQKG-------KLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLT----RTNIIKVGDL  146 (257)
T ss_pred             EecccCCCcHHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEe----cCCcEEEecc
Confidence            9999975 77776654221       1288999999999999999999999999999999999998    6789999999


Q ss_pred             ccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc----------ccCC
Q psy2172         175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED----------IKTS  244 (291)
Q Consensus       175 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~----------~~~~  244 (291)
                      |.+........   ......+++.|+|||.+.+.. ++.++|+||||+++++|++|+.||......          ....
T Consensus       147 ~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~  222 (257)
T cd08223         147 GIARVLENQCD---MASTLIGTPYYMSPELFSNKP-YNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPM  222 (257)
T ss_pred             cceEEecccCC---ccccccCCcCccChhHhcCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence            99986643221   223346788899999988754 888999999999999999999999765421          1122


Q ss_pred             CCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         245 NPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       245 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                      .......+.+++..|..+.|..||++.++..+|++
T Consensus       223 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         223 PKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             ccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            23345778999999999999999999999888875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=6.8e-37  Score=258.92  Aligned_cols=242  Identities=42%  Similarity=0.706  Sum_probs=192.7

Q ss_pred             cccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC-------hhHHHHHHHHhcCCCCCeeeEEEEEEeCCCce
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS-------MSACREIALLRELKHPNVINLISVFLSHNDRK   92 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (291)
                      |.+ .+.||+|++|.||+|.+..  +++.|++|.++.....       ..+..|++++++++|+||+++++++  .+...
T Consensus         2 y~~-~~~lg~g~~~~vy~~~~~~--~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~--~~~~~   76 (298)
T cd07841           2 YEK-GKKLGEGTYAVVYKARDKE--TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF--GHKSN   76 (298)
T ss_pred             cee-eeeeeeccccEEEEEEECC--CCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhhee--ecCCE
Confidence            453 4689999999999999876  5778999998754322       3467899999999999999999999  45678


Q ss_pred             EEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          93 VWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        93 ~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      .++||||++++|.+.+....        ..+++..++.++.|+++||.+||++|++|+||+|+||+++    .++.++|+
T Consensus        77 ~~lv~e~~~~~L~~~i~~~~--------~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~----~~~~~~l~  144 (298)
T cd07841          77 INLVFEFMETDLEKVIKDKS--------IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIA----SDGVLKLA  144 (298)
T ss_pred             EEEEEcccCCCHHHHHhccC--------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEc----CCCCEEEc
Confidence            99999999878888876432        1288999999999999999999999999999999999998    66789999


Q ss_pred             ecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc-----------
Q psy2172         173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI-----------  241 (291)
Q Consensus       173 Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~-----------  241 (291)
                      |||++........   ......++..|.|||.+.+...++.++|+|||||++|+|++|.+||.+.....           
T Consensus       145 dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~  221 (298)
T cd07841         145 DFGLARSFGSPNR---KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGT  221 (298)
T ss_pred             cceeeeeccCCCc---cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCC
Confidence            9999987654321   11233457789999998765558899999999999999999988887544210           


Q ss_pred             --------------------------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         242 --------------------------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       242 --------------------------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                                                ..........+.+++..|..+.|..||++.++..++|+..
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~  287 (298)
T cd07841         222 PTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSN  287 (298)
T ss_pred             CchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccC
Confidence                                      0000112355677888888899999999999888888764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2e-36  Score=251.84  Aligned_cols=237  Identities=25%  Similarity=0.389  Sum_probs=189.2

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC--------ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEE
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL--------SMSACREIALLRELKHPNVINLISVFLSHNDRKVWL   95 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~i   95 (291)
                      ++.||+|+||.||+|.+.   +++.+|+|.++....        ...+.+|+.+++.++|+||+++++++  .+....++
T Consensus         5 ~~~ig~g~~~~v~~~~~~---~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~l   79 (265)
T cd06631           5 GEVLGKGAYGTVYCGLTN---QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTC--LDDNTISI   79 (265)
T ss_pred             cceEeccCCeEEEEEEEc---CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEe--ecCCeEEE
Confidence            679999999999999853   567899998864321        13477899999999999999999999  45679999


Q ss_pred             EEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          96 LFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        96 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      ++||+.+ +|.+.+....         .+++..+..++.|++.||++||+.+++|+||+|+||+++    .++.++|+||
T Consensus        80 v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~----~~~~~~l~df  146 (265)
T cd06631          80 FMEFVPGGSISSILNRFG---------PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLM----PNGIIKLIDF  146 (265)
T ss_pred             EEecCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEEC----CCCeEEeccc
Confidence            9999976 7777765432         178899999999999999999999999999999999998    6678999999


Q ss_pred             ccceecCCCCC---CCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc-----------
Q psy2172         175 GFARLFNNPLK---PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED-----------  240 (291)
Q Consensus       175 g~~~~~~~~~~---~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~-----------  240 (291)
                      |.+........   .........++..|+|||.+.+.. ++.++|+||||+++|+|++|..||......           
T Consensus       147 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~  225 (265)
T cd06631         147 GCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESG-YGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRG  225 (265)
T ss_pred             hhhHhhhhccccccccccccccCCCccccChhhhcCCC-CcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccC
Confidence            99875432111   111122345788899999997744 789999999999999999999999764321           


Q ss_pred             -ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         241 -IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       241 -~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                       ...........+.+++..+..+.|..||++.++..+|++
T Consensus       226 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         226 LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence             112223345678889999999999999999999888874

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=9.1e-37  Score=256.21  Aligned_cols=249  Identities=21%  Similarity=0.351  Sum_probs=194.5

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC---hhHHHHHHH-HhcCCCCCeeeEEEEEEeCCCceEE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS---MSACREIAL-LRELKHPNVINLISVFLSHNDRKVW   94 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~~~   94 (291)
                      .|++ .+.||+|+||.||+|.++.  +++.||+|.++.....   ..+..|+.+ ++.++||||+++++++.  .....|
T Consensus         2 ~~~~-~~~ig~g~~g~v~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~--~~~~~~   76 (283)
T cd06617           2 DLEV-IEELGRGAYGVVDKMRHVP--TGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALF--REGDVW   76 (283)
T ss_pred             CceE-EEEecccCCeEEEEEEEcC--CCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEe--cCCcEE
Confidence            3454 4689999999999999876  6789999998754322   245556554 56678999999999994  566799


Q ss_pred             EEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CeeeeccCCCcEEeecCCCCCCcEEEee
Q psy2172          95 LLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSN-WVLHRDLKPANILVMGEGIERGRVKIAD  173 (291)
Q Consensus        95 iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~-~ivH~dik~~Nil~~~~~~~~~~~~l~D  173 (291)
                      ++|||++++|.+++.......     ..+++..++.++.|++.||++||++ +++|+||||+||+++    .++.++|+|
T Consensus        77 lv~e~~~~~l~~~l~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~----~~~~~kl~d  147 (283)
T cd06617          77 ICMEVMDTSLDKFYKKVYDKG-----LTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLIN----RNGQVKLCD  147 (283)
T ss_pred             EEhhhhcccHHHHHHHhccCC-----CCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEEC----CCCCEEEee
Confidence            999999999888876543221     2389999999999999999999997 999999999999998    677999999


Q ss_pred             cccceecCCCCCCCCCCCCceecccccccccccCC---cCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---------
Q psy2172         174 MGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGA---RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---------  241 (291)
Q Consensus       174 fg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---------  241 (291)
                      ||.+.......    ......++..|+|||.+.+.   ..++.++|+||||+++|+|++|..||.......         
T Consensus       148 fg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  223 (283)
T cd06617         148 FGISGYLVDSV----AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE  223 (283)
T ss_pred             ccccccccccc----ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc
Confidence            99987553321    11224567889999988652   236889999999999999999999997532210         


Q ss_pred             --c-CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhhhhh
Q psy2172         242 --K-TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDFNE  285 (291)
Q Consensus       242 --~-~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (291)
                        . .........+.+++..|....|..||++.++..++++.+...+
T Consensus       224 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  270 (283)
T cd06617         224 PSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSK  270 (283)
T ss_pred             CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcccc
Confidence              0 1111234678899999999999999999999999998876544

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-36  Score=252.12  Aligned_cols=242  Identities=25%  Similarity=0.414  Sum_probs=184.8

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-------CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCc
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-------LSMSACREIALLRELKHPNVINLISVFLSHNDR   91 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (291)
                      .|++ ++.||+|+||.||+|.+..  ++..+++|.+....       ....+.+|+.++++++|+||+++++.+...+..
T Consensus         3 ~~~~-~~~lg~g~~g~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   79 (264)
T cd06653           3 NWRL-GKLLGRGAFGEVYLCYDAD--TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEK   79 (264)
T ss_pred             ceee-eeeEccCCCeEEEEEEEcC--CCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCC
Confidence            4554 7899999999999999876  67889999874321       123577899999999999999999998665567


Q ss_pred             eEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEE
Q psy2172          92 KVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVK  170 (291)
Q Consensus        92 ~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~  170 (291)
                      ..++++||+++ +|.+.+....         .+++..++.++.|++.||.+||++|++|+||+|+||+++    .++.++
T Consensus        80 ~~~~v~e~~~~~~L~~~~~~~~---------~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~----~~~~~~  146 (264)
T cd06653          80 KLSIFVEYMPGGSIKDQLKAYG---------ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRD----SAGNVK  146 (264)
T ss_pred             EEEEEEEeCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc----CCCCEE
Confidence            88999999975 7777765332         178888999999999999999999999999999999998    667899


Q ss_pred             EeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc----------
Q psy2172         171 IADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED----------  240 (291)
Q Consensus       171 l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~----------  240 (291)
                      |+|||.+.................++..|+|||.+.+.. ++.++|+||||+++|++++|+.||......          
T Consensus       147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  225 (264)
T cd06653         147 LGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEG-YGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQP  225 (264)
T ss_pred             ECccccccccccccccCccccccCCcccccCHhhhcCCC-CCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCC
Confidence            999999976543211111122345788899999998754 889999999999999999999999764321          


Q ss_pred             -ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcc
Q psy2172         241 -IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPT  278 (291)
Q Consensus       241 -~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  278 (291)
                       .........+.+.+++..+... +..+|+..++..||.
T Consensus       226 ~~~~~p~~~~~~~~~~i~~~l~~-~~~r~~~~~~~~~~~  263 (264)
T cd06653         226 TKPMLPDGVSDACRDFLKQIFVE-EKRRPTAEFLLRHPF  263 (264)
T ss_pred             CCCCCCcccCHHHHHHHHHHhcC-cccCccHHHHhcCCC
Confidence             0111222345566666666653 466777777666654

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.2e-36  Score=254.52  Aligned_cols=249  Identities=24%  Similarity=0.359  Sum_probs=198.2

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHNDRKVWL   95 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~i   95 (291)
                      .|+. .++||.|++|.||+|.+..  +++.+++|.+.....   ...+.+|++++++++||||+++++++........++
T Consensus         2 ~~~~-~~~lg~g~~~~v~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   78 (287)
T cd06621           2 KIVE-LSRLGEGAGGSVTKCRLKN--TGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI   78 (287)
T ss_pred             ceEE-EEEeccCCceEEEEEEECC--CCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence            3453 5699999999999999876  678899999875432   346889999999999999999999987666778999


Q ss_pred             EEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          96 LFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        96 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      +|||+++ +|.+++......     ...+++..+..++.|++.||.|||+.|++|+||+|+||+++    ..+.++|+||
T Consensus        79 v~e~~~~~~L~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~----~~~~~~l~df  149 (287)
T cd06621          79 AMEYCEGGSLDSIYKKVKKR-----GGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLT----RKGQVKLCDF  149 (287)
T ss_pred             EEEecCCCCHHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEe----cCCeEEEeec
Confidence            9999975 777766543321     12278899999999999999999999999999999999998    5678999999


Q ss_pred             ccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc--------------
Q psy2172         175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED--------------  240 (291)
Q Consensus       175 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~--------------  240 (291)
                      |++.......     .....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||......              
T Consensus       150 g~~~~~~~~~-----~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  223 (287)
T cd06621         150 GVSGELVNSL-----AGTFTGTSFYMAPERIQGKP-YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM  223 (287)
T ss_pred             cccccccccc-----cccccCCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC
Confidence            9986543321     12334677899999987644 889999999999999999999999876220              


Q ss_pred             -ccC---C---CCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhhhhh
Q psy2172         241 -IKT---S---NPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDFNE  285 (291)
Q Consensus       241 -~~~---~---~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (291)
                       ...   .   .....+.+.+++..+..+.|..||++.++..++|+.+...+
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~  275 (287)
T cd06621         224 PNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKK  275 (287)
T ss_pred             CchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccc
Confidence             000   0   01124567899999999999999999999999998655444

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.1e-36  Score=258.86  Aligned_cols=247  Identities=34%  Similarity=0.577  Sum_probs=191.2

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCC----
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG----LSMSACREIALLRELKHPNVINLISVFLSHN----   89 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----   89 (291)
                      +.|++ .++||+|+||.||+|.++.  +++.||+|.+....    ....+.+|+.++++++||||+++++++....    
T Consensus        12 ~~y~~-~~~lg~g~~~~v~~~~~~~--~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (310)
T cd07865          12 SKYEK-LAKIGQGTFGEVFKARHKK--TKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN   88 (310)
T ss_pred             hheEE-EEEeecCCCEEEEEEEECC--CCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence            34664 6699999999999999876  67889999885432    2234568999999999999999999875322    


Q ss_pred             --CceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCC
Q psy2172          90 --DRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERG  167 (291)
Q Consensus        90 --~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~  167 (291)
                        ....++||||+++++.+.+.....        .+++..++.++.|++.||++||++|++|+||+|+||+++    ..+
T Consensus        89 ~~~~~~~lv~e~~~~~l~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~----~~~  156 (310)
T cd07865          89 RYKGSFYLVFEFCEHDLAGLLSNKNV--------KFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILIT----KDG  156 (310)
T ss_pred             CCCceEEEEEcCCCcCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEC----CCC
Confidence              246799999999988877754321        289999999999999999999999999999999999998    677


Q ss_pred             cEEEeecccceecCCCCCCC-CCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc----
Q psy2172         168 RVKIADMGFARLFNNPLKPL-ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK----  242 (291)
Q Consensus       168 ~~~l~Dfg~~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~----  242 (291)
                      .++|+|||.+.......... .......++..|+|||.+.+...++.++|+||||+++|+|++|..||.+......    
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~  236 (310)
T cd07865         157 ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLI  236 (310)
T ss_pred             cEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99999999997654432211 1122345678899999987755578899999999999999999999976542100    


Q ss_pred             ---------------------------C----------CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         243 ---------------------------T----------SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       243 ---------------------------~----------~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                                                 .          ........+.+++..|..+.|..||++.++..+||+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         237 SQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             HHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence                                       0          000112345678888888999999999988888874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-37  Score=256.90  Aligned_cols=245  Identities=27%  Similarity=0.421  Sum_probs=195.7

Q ss_pred             ccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC--CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEE
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG--LSMSACREIALLRELKHPNVINLISVFLSHNDRKVW   94 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (291)
                      .++|.+ .+.||+|++|.||++.+..  ++..+++|.+....  ....+.+|+.++++++||||+++++.+  ......|
T Consensus         4 ~~~~~i-~~~l~~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~   78 (280)
T cd06611           4 NDIWEI-IGELGDGAFGKVYKAQHKE--TGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY--FYENKLW   78 (280)
T ss_pred             hhHHHH-HHHhcCCCCceEEEEEEcC--CCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEE--ecCCeEE
Confidence            356775 5689999999999999876  67889999986432  234678899999999999999999999  4567899


Q ss_pred             EEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEee
Q psy2172          95 LLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIAD  173 (291)
Q Consensus        95 iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~D  173 (291)
                      +||||+++ +|.+.+.....        .+++..++.++.|++.||.+||++|++|+||+|+||+++    .++.++|+|
T Consensus        79 lv~e~~~~~~L~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~----~~~~~~l~d  146 (280)
T cd06611          79 ILIEFCDGGALDSIMLELER--------GLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLT----LDGDVKLAD  146 (280)
T ss_pred             EEeeccCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEC----CCCCEEEcc
Confidence            99999986 66666654321        289999999999999999999999999999999999998    678999999


Q ss_pred             cccceecCCCCCCCCCCCCceecccccccccccC----CcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc--------
Q psy2172         174 MGFARLFNNPLKPLADLDPVVVTFWYRAPELLLG----ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI--------  241 (291)
Q Consensus       174 fg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~--------  241 (291)
                      ||.+........   ......++..|+|||.+..    ...++.++|+||||+++|+|++|..||.......        
T Consensus       147 ~g~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  223 (280)
T cd06611         147 FGVSAKNKSTLQ---KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS  223 (280)
T ss_pred             Cccchhhccccc---ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcC
Confidence            998765433211   1223467888999999752    2336789999999999999999999998654211        


Q ss_pred             ----cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         242 ----KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       242 ----~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                          ..........+.+++..|..+.|..||++.++..++|+.+
T Consensus       224 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~  267 (280)
T cd06611         224 EPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSD  267 (280)
T ss_pred             CCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcc
Confidence                0112233467889999999999999999999999988764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>KOG0607|consensus

Probab=100.00  E-value=1.1e-37  Score=249.97  Aligned_cols=214  Identities=25%  Similarity=0.410  Sum_probs=177.9

Q ss_pred             ccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC--CChhHHHHHHHHhcCC-CCCeeeEEEEEEeCC
Q psy2172          13 RTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG--LSMSACREIALLRELK-HPNVINLISVFLSHN   89 (291)
Q Consensus        13 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~   89 (291)
                      -.+..+.|...++.||+|+++.|-.|....  ++..||||++.+..  ...++.+|++++.+++ |+||++++++|  ++
T Consensus        72 ~g~F~d~YkLt~e~LGeGAyasVqtcv~i~--t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefF--Ed  147 (463)
T KOG0607|consen   72 SGKFEDMYKLTSELLGEGAYASVQTCVSIQ--TGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFF--ED  147 (463)
T ss_pred             cchHHHHHHhHHHHhcCccceeeeeeeeec--cchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHh--cc
Confidence            345677888889999999999999999776  78889999998653  3457899999999995 99999999999  77


Q ss_pred             CceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCc
Q psy2172          90 DRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGR  168 (291)
Q Consensus        90 ~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~  168 (291)
                      +...|+|||-+.| .|++.+....-         +++..+.++..+|+.||.+||++||.|+|+||+|||-...+ .-..
T Consensus       148 d~~FYLVfEKm~GGplLshI~~~~~---------F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn-~vsP  217 (463)
T KOG0607|consen  148 DTRFYLVFEKMRGGPLLSHIQKRKH---------FNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPN-KVSP  217 (463)
T ss_pred             cceEEEEEecccCchHHHHHHHhhh---------ccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCC-CcCc
Confidence            8899999999975 88888776543         99999999999999999999999999999999999997533 4457


Q ss_pred             EEEeecccceecCCCCCC----CCCCCCceeccccccccccc----CCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc
Q psy2172         169 VKIADMGFARLFNNPLKP----LADLDPVVVTFWYRAPELLL----GARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED  240 (291)
Q Consensus       169 ~~l~Dfg~~~~~~~~~~~----~~~~~~~~g~~~y~aPE~~~----~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~  240 (291)
                      +|||||.+..-+......    .....+..|+..|||||+..    ....|+.++|+||||++||-|++|-+||.|....
T Consensus       218 vKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~  297 (463)
T KOG0607|consen  218 VKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGA  297 (463)
T ss_pred             eeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCC
Confidence            899999887654432221    12233568888999999853    2346899999999999999999999999987753

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=9.8e-37  Score=257.04  Aligned_cols=237  Identities=26%  Similarity=0.434  Sum_probs=192.7

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-----LSMSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      .|.+ .+.||+|++|.||++.+..  .++.+++|.+....     ....+.+|++++++++||||+++++++  .+....
T Consensus         2 ~y~~-~~~ig~g~~~~vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~   76 (290)
T cd05580           2 DFEF-IKTLGTGSFGRVMLVRHKG--SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSF--QDDSNL   76 (290)
T ss_pred             ceEE-EEEeecCCCeEEEEEEEcC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEE--EcCCeE
Confidence            4554 4699999999999999876  67889999986432     234578899999999999999999999  556789


Q ss_pred             EEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          94 WLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        94 ~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      +++|||++ ++|.+.+....         .+++..+..++.|++.||.+||++|++|+||+|+||+++    .++.++|+
T Consensus        77 ~~v~e~~~~~~L~~~~~~~~---------~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~----~~~~~kl~  143 (290)
T cd05580          77 YLVMEYVPGGELFSHLRKSG---------RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLD----SDGYIKIT  143 (290)
T ss_pred             EEEEecCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC----CCCCEEEe
Confidence            99999995 68877776442         288999999999999999999999999999999999998    66789999


Q ss_pred             ecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc---------ccC
Q psy2172         173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED---------IKT  243 (291)
Q Consensus       173 Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~---------~~~  243 (291)
                      |||++......      .....+++.|+|||.+.+.. .+.++|+||||+++|+|++|..||......         ...
T Consensus       144 dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  216 (290)
T cd05580         144 DFGFAKRVKGR------TYTLCGTPEYLAPEIILSKG-YGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVR  216 (290)
T ss_pred             eCCCccccCCC------CCCCCCCccccChhhhcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcc
Confidence            99998765432      23345788899999987754 788999999999999999999999765421         111


Q ss_pred             CCCCcHHHHHHHHHhhCCCCcCChh-----hhhcCCCCcchh
Q psy2172         244 SNPYHHDQLDRIFSVMGFPLEKDWE-----DIRKMPEHPTLL  280 (291)
Q Consensus       244 ~~~~~~~~~~~i~~~~~~~~~~~~~-----~~~~~~~~~~~~  280 (291)
                      ........+.+++..|..+.|..|+     ++.++..+|++.
T Consensus       217 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~  258 (290)
T cd05580         217 FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFA  258 (290)
T ss_pred             CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccc
Confidence            2233356788899999999998887     777777777753

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1e-36  Score=282.47  Aligned_cols=242  Identities=27%  Similarity=0.291  Sum_probs=185.1

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC-----ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCce
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-----SMSACREIALLRELKHPNVINLISVFLSHNDRK   92 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (291)
                      ++|++ .++||+|+||.||+|.+..  +++.||+|.++....     ..++.+|++++++++||||+++++++  .+...
T Consensus         2 grYeI-i~~LGkGgfG~VYlA~d~~--tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~--~d~~~   76 (932)
T PRK13184          2 QRYDI-IRLIGKGGMGEVYLAYDPV--CSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSIC--SDGDP   76 (932)
T ss_pred             CCeEE-EEEEecCCCEEEEEEEECC--CCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEE--eeCCE
Confidence            45664 6799999999999999876  678899999874322     24578899999999999999999998  55678


Q ss_pred             EEEEEecCCC-CHHHHHHHhhhhhhC--CCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcE
Q psy2172          93 VWLLFDYAEH-DLWHIIKFHRAAKAN--KKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRV  169 (291)
Q Consensus        93 ~~iv~e~~~~-~l~~~~~~~~~~~~~--~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~  169 (291)
                      .|++|||++| +|.+.+.........  ......+...+..++.|++.||++||++||+||||||+||+++    ..+.+
T Consensus        77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd----~dg~v  152 (932)
T PRK13184         77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLG----LFGEV  152 (932)
T ss_pred             EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEc----CCCCE
Confidence            9999999985 888877653322111  0112256778899999999999999999999999999999998    66789


Q ss_pred             EEeecccceecCCCCC---------------CCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCC
Q psy2172         170 KIADMGFARLFNNPLK---------------PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF  234 (291)
Q Consensus       170 ~l~Dfg~~~~~~~~~~---------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf  234 (291)
                      +|+|||++........               .........||+.|+|||.+.+.. ++.++|+|||||++|+|++|..||
T Consensus       153 KLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~-~S~kSDIWSLGVILyELLTG~~PF  231 (932)
T PRK13184        153 VILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP-ASESTDIYALGVILYQMLTLSFPY  231 (932)
T ss_pred             EEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC-CCcHhHHHHHHHHHHHHHHCCCCC
Confidence            9999999986622110               011122346899999999998754 899999999999999999999999


Q ss_pred             CCCcccccC------------CCCCcHHHHHHHHHhhCCCCcCChhh
Q psy2172         235 HCRQEDIKT------------SNPYHHDQLDRIFSVMGFPLEKDWED  269 (291)
Q Consensus       235 ~~~~~~~~~------------~~~~~~~~~~~i~~~~~~~~~~~~~~  269 (291)
                      .........            ........+.+++..|..+.|..|++
T Consensus       232 ~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~s  278 (932)
T PRK13184        232 RRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYS  278 (932)
T ss_pred             CCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcC
Confidence            764432100            00112355778888888888888753

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.3e-36  Score=251.77  Aligned_cols=238  Identities=26%  Similarity=0.410  Sum_probs=192.4

Q ss_pred             cccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-------CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCce
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-------LSMSACREIALLRELKHPNVINLISVFLSHNDRK   92 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (291)
                      |+ .++.||+|++|.||+|.+..  ++..|++|.+....       ....+.+|+.+++.++|+||+++++++  .+...
T Consensus         2 ~~-~~~~ig~g~~~~vy~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~--~~~~~   76 (258)
T cd06632           2 WR-KGELLGSGSFGSVYEGLNLD--DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE--REEDN   76 (258)
T ss_pred             cc-ccceeeecCCceEEEEEEcC--CCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE--ecCCe
Confidence            45 36799999999999999865  66789999885432       224578899999999999999999988  56678


Q ss_pred             EEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEE
Q psy2172          93 VWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI  171 (291)
Q Consensus        93 ~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l  171 (291)
                      .++++||+++ +|.+.+....         .+++..+..++.|++.|+++||+.|++|+||+|+||+++    .++.++|
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~----~~~~~kl  143 (258)
T cd06632          77 LYIFLELVPGGSLAKLLKKYG---------SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVD----TNGVVKL  143 (258)
T ss_pred             EEEEEEecCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEE
Confidence            9999999986 7777765432         178889999999999999999999999999999999998    6779999


Q ss_pred             eecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc-----------
Q psy2172         172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED-----------  240 (291)
Q Consensus       172 ~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~-----------  240 (291)
                      +|||.+.......    ......++..|+|||.+.....++.++|+||||+++|+|++|+.||......           
T Consensus       144 ~d~~~~~~~~~~~----~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  219 (258)
T cd06632         144 ADFGMAKQVVEFS----FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE  219 (258)
T ss_pred             ccCccceeccccc----cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhccc
Confidence            9999987654322    2234567888999999866434789999999999999999999999664421           


Q ss_pred             ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         241 IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       241 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                      .....+.....+.+++..+....|..||++.++..+|++
T Consensus       220 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         220 LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence            112223345668888999999999999999998888764

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.5e-37  Score=265.13  Aligned_cols=248  Identities=34%  Similarity=0.552  Sum_probs=196.7

Q ss_pred             ccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCC-
Q psy2172          15 KVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT----GLSMSACREIALLRELKHPNVINLISVFLSHN-   89 (291)
Q Consensus        15 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-   89 (291)
                      .+.++|.+ .+.||+|+||.||+|.+..  +++.||+|.+...    .....+.+|+.+++.++|+||+++++++.... 
T Consensus         2 ~~~~~y~~-~~~lg~G~~~~vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~   78 (337)
T cd07858           2 EVDTKYVP-IKPIGRGAYGIVCSAKNSE--TNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHR   78 (337)
T ss_pred             ccccceeE-EEEeccCCCeEEEEEEecC--CCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccc
Confidence            35667886 5599999999999999765  7788999988642    22345778999999999999999999874322 


Q ss_pred             --CceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCC
Q psy2172          90 --DRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERG  167 (291)
Q Consensus        90 --~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~  167 (291)
                        ....|+++||++++|.+.+....         .+++..+..++.|++.||.+||+++++|+||+|+||+++    .++
T Consensus        79 ~~~~~~~lv~e~~~~~L~~~~~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~----~~~  145 (337)
T cd07858          79 EAFNDVYIVYELMDTDLHQIIRSSQ---------TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN----ANC  145 (337)
T ss_pred             cccCcEEEEEeCCCCCHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc----CCC
Confidence              24589999999998887775432         289999999999999999999999999999999999998    667


Q ss_pred             cEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc-------
Q psy2172         168 RVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED-------  240 (291)
Q Consensus       168 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~-------  240 (291)
                      .++|+|||++.......   .......++..|+|||.+.+...++.++|+||||+++|+|++|..||.+.+..       
T Consensus       146 ~~kL~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~  222 (337)
T cd07858         146 DLKICDFGLARTTSEKG---DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLIT  222 (337)
T ss_pred             CEEECcCccccccCCCc---ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Confidence            89999999987654321   11223456888999999876445889999999999999999999999764310       


Q ss_pred             ----------c-----------------------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         241 ----------I-----------------------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       241 ----------~-----------------------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                                .                       ....+.....+.+++..|..+.|..||++.++..+||+..
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~  296 (337)
T cd07858         223 ELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS  296 (337)
T ss_pred             HHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence                      0                       0001123455678999999999999999999999988753

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2e-36  Score=257.22  Aligned_cols=244  Identities=27%  Similarity=0.474  Sum_probs=195.3

Q ss_pred             cccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC-----ChhHHHHHHHHhcCCCCCeeeEEEEEEeC
Q psy2172          14 TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-----SMSACREIALLRELKHPNVINLISVFLSH   88 (291)
Q Consensus        14 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   88 (291)
                      .....+|.. .+.||+|+||.||+|.+..  +++.|++|.+.....     ...+.+|+.+++.++|||++++++++.  
T Consensus        11 ~~~~~~y~~-~~~lg~g~~g~vy~~~~~~--~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~--   85 (307)
T cd06607          11 DDPEKLFTD-LREIGHGSFGAVYFARDVR--TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL--   85 (307)
T ss_pred             CCcchhhhh-heeecCCCCeEEEEEEEcC--CCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE--
Confidence            445566774 5799999999999999876  678899998864321     135778999999999999999999994  


Q ss_pred             CCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCc
Q psy2172          89 NDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGR  168 (291)
Q Consensus        89 ~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~  168 (291)
                      +....++|+||+.+++.+.+.....        .+++..+..++.|++.||.|||+.|++|+||+|+||+++    .++.
T Consensus        86 ~~~~~~lv~e~~~g~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~----~~~~  153 (307)
T cd06607          86 REHTAWLVMEYCLGSASDILEVHKK--------PLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLT----EPGT  153 (307)
T ss_pred             eCCeEEEEHHhhCCCHHHHHHHccc--------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEC----CCCC
Confidence            4667899999999988877754321        288999999999999999999999999999999999998    6678


Q ss_pred             EEEeecccceecCCCCCCCCCCCCceecccccccccccC--CcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc------
Q psy2172         169 VKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLG--ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED------  240 (291)
Q Consensus       169 ~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~------  240 (291)
                      ++|+|||++......       ....++..|+|||.+.+  ...++.++||||||+++|+|++|..||.+....      
T Consensus       154 ~kL~dfg~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~  226 (307)
T cd06607         154 VKLADFGSASLVSPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI  226 (307)
T ss_pred             EEEeecCcceecCCC-------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHH
Confidence            999999988654321       22356778999998742  234788999999999999999999999764321      


Q ss_pred             ----ccC-CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         241 ----IKT-SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       241 ----~~~-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                          ... ........+.+++..|..+.|..||++.++..++++.+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  272 (307)
T cd06607         227 AQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR  272 (307)
T ss_pred             hcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence                011 11123456889999999999999999999988887654

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=5.3e-37  Score=258.04  Aligned_cols=241  Identities=34%  Similarity=0.585  Sum_probs=190.6

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG----LSMSACREIALLRELKHPNVINLISVFLSHNDRKVW   94 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (291)
                      .|.+ .++||+|+||.||+|.+++  +++.||+|.+....    ....+.+|+++++.++||||+++++++  .+....+
T Consensus         2 ~y~~-~~~lg~g~~~~vy~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~   76 (286)
T cd07846           2 KYEN-LGLVGEGSYGMVMKCKHKE--TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF--RRKKRLY   76 (286)
T ss_pred             ceeE-eeeeccCCCeEEEEEEECC--CCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc--ccCCeEE
Confidence            4553 5799999999999999876  57889999875432    234577899999999999999999999  5677999


Q ss_pred             EEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          95 LLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        95 iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      +++||+++++...+....        ..+++..++.++.|++.||.|||+.|++|+||+|+||+++    .++.++|+||
T Consensus        77 lv~e~~~~~~l~~~~~~~--------~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~----~~~~~~l~df  144 (286)
T cd07846          77 LVFEFVDHTVLDDLEKYP--------NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVS----QSGVVKLCDF  144 (286)
T ss_pred             EEEecCCccHHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC----CCCcEEEEee
Confidence            999999986555443221        1178999999999999999999999999999999999998    6779999999


Q ss_pred             ccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc-------------
Q psy2172         175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI-------------  241 (291)
Q Consensus       175 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~-------------  241 (291)
                      |++........   ......++..|+|||.+.+...++.++|+||||+++|+|++|.+||.+.....             
T Consensus       145 g~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~  221 (286)
T cd07846         145 GFARTLAAPGE---VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLI  221 (286)
T ss_pred             eeeeeccCCcc---ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCc
Confidence            99876543221   12234568889999998765557889999999999999999999997544210             


Q ss_pred             ------------------c---------CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         242 ------------------K---------TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       242 ------------------~---------~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                                        +         ...+.....+.+++..+..+.|..||++.++..++|+
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         222 PRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             hhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence                              0         0011224557888999999999999999988888764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=6.8e-37  Score=263.37  Aligned_cols=251  Identities=34%  Similarity=0.593  Sum_probs=198.3

Q ss_pred             cccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC----CCChhHHHHHHHHhcC-CCCCeeeEEEEEEeC
Q psy2172          14 TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT----GLSMSACREIALLREL-KHPNVINLISVFLSH   88 (291)
Q Consensus        14 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~   88 (291)
                      ..+.++|++ .+.||+|+||.||+|.+..  +++.+++|.+...    .....+.+|+.+++++ +||||+++++++...
T Consensus         3 ~~~~~~y~~-~~~lg~g~~~~v~~~~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~   79 (337)
T cd07852           3 KHILRKYEI-LQKLGKGAYGIVWKAIDRR--TKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE   79 (337)
T ss_pred             chhhhHHHH-hHhhcCCCCeeEEEEEEcC--CCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccC
Confidence            356778885 6799999999999999865  6678999987432    2234577899999999 999999999998655


Q ss_pred             CCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCc
Q psy2172          89 NDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGR  168 (291)
Q Consensus        89 ~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~  168 (291)
                      +....|+||||++++|...+...          .+++..++.++.|++.||++||++|++|+||+|+||+++    .++.
T Consensus        80 ~~~~~~lv~e~~~~~L~~~~~~~----------~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~----~~~~  145 (337)
T cd07852          80 NDKDIYLVFEYMETDLHAVIRAN----------ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLN----SDCR  145 (337)
T ss_pred             CCceEEEEecccccCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc----CCCc
Confidence            66689999999999887776532          178888999999999999999999999999999999998    7789


Q ss_pred             EEEeecccceecCCCCCC--CCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc-----
Q psy2172         169 VKIADMGFARLFNNPLKP--LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI-----  241 (291)
Q Consensus       169 ~~l~Dfg~~~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~-----  241 (291)
                      ++|+|||.+.........  ........|+..|+|||.+.+...++.++|+||||+++|+|++|+.||.+.....     
T Consensus       146 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~  225 (337)
T cd07852         146 VKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKI  225 (337)
T ss_pred             EEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            999999998765433211  1122234678899999998765558899999999999999999999997543210     


Q ss_pred             -----------------------------------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         242 -----------------------------------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       242 -----------------------------------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                                                         ....+.....+.+++..|..+.|..||++.++..++++.+
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~  300 (337)
T cd07852         226 IEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ  300 (337)
T ss_pred             HHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhh
Confidence                                               0001112455778888888899999999999888877654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.5e-36  Score=258.07  Aligned_cols=239  Identities=23%  Similarity=0.362  Sum_probs=191.9

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHNDRKVWL   95 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~i   95 (291)
                      .|.+ .+.||+|+||.||++.+..  ++..+++|.+.....   ...+.+|++++++++||||+++++.+  .+....++
T Consensus         2 ~~~~-~~~lg~G~~g~v~~~~~~~--~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~~~l   76 (308)
T cd06615           2 DFEK-LGELGAGNGGVVTKVLHRP--SGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAF--YSDGEISI   76 (308)
T ss_pred             CceE-EeeccCCCCeEEEEEEEcC--CCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE--eeCCEEEE
Confidence            3553 6689999999999999876  667899999864322   23577899999999999999999999  45678999


Q ss_pred             EEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCeeeeccCCCcEEeecCCCCCCcEEEee
Q psy2172          96 LFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHS-NWVLHRDLKPANILVMGEGIERGRVKIAD  173 (291)
Q Consensus        96 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~-~~ivH~dik~~Nil~~~~~~~~~~~~l~D  173 (291)
                      +|||+++ +|.+.+....         .+++..+..++.|++.||.|||+ .+++|+||+|+||+++    .++.++|+|
T Consensus        77 v~ey~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~----~~~~~~l~d  143 (308)
T cd06615          77 CMEHMDGGSLDQVLKKAG---------RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVN----SRGEIKLCD  143 (308)
T ss_pred             EeeccCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEe----cCCcEEEcc
Confidence            9999985 7877775432         28899999999999999999997 5999999999999998    667899999


Q ss_pred             cccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccC----------
Q psy2172         174 MGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT----------  243 (291)
Q Consensus       174 fg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~----------  243 (291)
                      ||.+......     ......++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||.........          
T Consensus       144 fg~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  217 (308)
T cd06615         144 FGVSGQLIDS-----MANSFVGTRSYMSPERLQGTH-YTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEG  217 (308)
T ss_pred             CCCccccccc-----ccccCCCCcCccChhHhcCCC-CCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccc
Confidence            9988654322     123346788999999987744 889999999999999999999998643211000          


Q ss_pred             -----------------------------------C--CCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         244 -----------------------------------S--NPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       244 -----------------------------------~--~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                                                         .  .......+.+++..|....|..||++.++..+||+.+
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~  292 (308)
T cd06615         218 EAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR  292 (308)
T ss_pred             cccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence                                               0  0012345789999999999999999999999999865

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>KOG0599|consensus

Probab=100.00  E-value=6.4e-38  Score=246.39  Aligned_cols=242  Identities=27%  Similarity=0.441  Sum_probs=195.9

Q ss_pred             ccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC------CC----hhHHHHHHHHhcC-CCCCeeeEEEEEEeCCCc
Q psy2172          23 EGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG------LS----MSACREIALLREL-KHPNVINLISVFLSHNDR   91 (291)
Q Consensus        23 ~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~------~~----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~   91 (291)
                      ..+.||.|..+.|-+|.++.  ++..+++|++.-..      ..    +.-.+|+.||+++ .||+|+++.++|  ++..
T Consensus        21 pkeilgrgvss~vrRci~k~--t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y--es~s   96 (411)
T KOG0599|consen   21 PKEILGRGVSSVVRRCIHKE--TGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY--ESDA   96 (411)
T ss_pred             hHHHhcccchhhhhhhhhcc--cccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec--cCcc
Confidence            47899999999999999877  67789999884211      11    2345799999999 699999999999  7888


Q ss_pred             eEEEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEE
Q psy2172          92 KVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVK  170 (291)
Q Consensus        92 ~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~  170 (291)
                      .+++|+|.|+ |.|.+++.+.-.         +++...+.+++|++.|++|||.++|||+||||+||+++    ++.+++
T Consensus        97 F~FlVFdl~prGELFDyLts~Vt---------lSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILld----dn~~i~  163 (411)
T KOG0599|consen   97 FVFLVFDLMPRGELFDYLTSKVT---------LSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLD----DNMNIK  163 (411)
T ss_pred             hhhhhhhhcccchHHHHhhhhee---------ecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeec----cccceE
Confidence            9999999998 788888876543         89999999999999999999999999999999999999    778999


Q ss_pred             EeecccceecCCCCCCCCCCCCceecccccccccccC-----CcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc----
Q psy2172         171 IADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLG-----ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI----  241 (291)
Q Consensus       171 l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~----  241 (291)
                      |+|||.++.+...    ......+||++|.|||.+.+     .+.|+...|.||+|+++|-++.|.+||.-+..-.    
T Consensus       164 isDFGFa~~l~~G----ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~  239 (411)
T KOG0599|consen  164 ISDFGFACQLEPG----EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRM  239 (411)
T ss_pred             EeccceeeccCCc----hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHH
Confidence            9999999977653    34456799999999999753     3458999999999999999999999996443211    


Q ss_pred             ---------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhhhhh
Q psy2172         242 ---------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDFNE  285 (291)
Q Consensus       242 ---------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (291)
                               ...=....+...++++.+..-.|..+-+.++-.+||++.+...+
T Consensus       240 ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~  292 (411)
T KOG0599|consen  240 IMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQ  292 (411)
T ss_pred             HHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHh
Confidence                     00111224567777787777888888888888888888665544

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.3e-36  Score=253.93  Aligned_cols=242  Identities=23%  Similarity=0.365  Sum_probs=184.5

Q ss_pred             cccccccceeCcccceEEEEEEEc--cCCCCceeEEEEeCCCCC--ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRK--DNSDTRDYALKQIEGTGL--SMSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~--~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      ..|++ .+.||+|+||.||+|...  +..++..|++|.+.....  ...+.+|++++++++||||+++++++...+....
T Consensus         4 ~~~~~-~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           4 RHLKF-IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             cccee-eeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            34554 569999999999999854  233677899999865432  2467899999999999999999998866666789


Q ss_pred             EEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          94 WLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        94 ~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      ++++||++ ++|.+.+.....        .+++..++.++.|++.||++||++|++|+||||+||+++    .++.++|+
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~--------~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~----~~~~~~l~  150 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKHRE--------RLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVE----SENRVKIG  150 (284)
T ss_pred             EEEEEecCCCCHHHHHHhcCc--------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEEC----CCCeEEEC
Confidence            99999997 588887754321        278899999999999999999999999999999999998    66789999


Q ss_pred             ecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc----------
Q psy2172         173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK----------  242 (291)
Q Consensus       173 Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~----------  242 (291)
                      |||++.................++..|+|||.+.+.. ++.++|+||||+++++|++|..|+........          
T Consensus       151 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd05081         151 DFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQ  229 (284)
T ss_pred             CCcccccccCCCcceeecCCCCCceEeeCHHHhccCC-cChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccc
Confidence            9999986543322111112223345699999997744 88999999999999999998776644322110          


Q ss_pred             ----------------CCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         243 ----------------TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       243 ----------------~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                                      .........+.+++..+..+.|..||++.++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei  276 (284)
T cd05081         230 MIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSEL  276 (284)
T ss_pred             cchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence                            0111223568888888888888888887753

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-36  Score=258.52  Aligned_cols=246  Identities=22%  Similarity=0.348  Sum_probs=195.7

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC-----hhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS-----MSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      .|.. .+.||+|++|.||+|.+..  +++.+++|.+......     ..+.+|+++++.++|+||+++++.+  .+....
T Consensus         2 ~y~~-~~~ig~g~~g~vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~   76 (316)
T cd05574           2 HFKK-IKLLGKGDVGRVFLVRLKG--TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF--QTETYL   76 (316)
T ss_pred             ceEE-eeeecCCccEEEEEEEEcC--CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee--ecCCEE
Confidence            3453 5689999999999999876  6788999998754322     3578899999999999999999998  557789


Q ss_pred             EEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          94 WLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        94 ~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      |++|||+.+ +|.+.+.....       ..+++..++.++.|++.||+|||+.|++|+||||+||+++    .++.++|+
T Consensus        77 ~lv~e~~~~~~L~~~~~~~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~----~~~~~~l~  145 (316)
T cd05574          77 CLVMDYCPGGELFRLLQRQPG-------KCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLH----ESGHIMLS  145 (316)
T ss_pred             EEEEEecCCCCHHHHHHhCCC-------CccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEc----CCCCEEEe
Confidence            999999975 87777653221       1288999999999999999999999999999999999998    66789999


Q ss_pred             ecccceecCCCCCCC--------------------------CCCCCceecccccccccccCCcCCCCchhHHHHHHHHHH
Q psy2172         173 DMGFARLFNNPLKPL--------------------------ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAE  226 (291)
Q Consensus       173 Dfg~~~~~~~~~~~~--------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~  226 (291)
                      |||++..........                          .......|+..|+|||.+.+.. ++.++|+||||+++|+
T Consensus       146 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~ll~~  224 (316)
T cd05574         146 DFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYE  224 (316)
T ss_pred             ecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCC-CCchHHHHHHHHHHHH
Confidence            999987553321100                          0111235788899999998754 7899999999999999


Q ss_pred             HHcCCCCCCCCcccc---------cCCCC--CcHHHHHHHHHhhCCCCcCChhh----hhcCCCCcchhh
Q psy2172         227 LLTSEPIFHCRQEDI---------KTSNP--YHHDQLDRIFSVMGFPLEKDWED----IRKMPEHPTLLK  281 (291)
Q Consensus       227 l~~g~~pf~~~~~~~---------~~~~~--~~~~~~~~i~~~~~~~~~~~~~~----~~~~~~~~~~~~  281 (291)
                      |++|..||.+.....         .....  .....+.+++..|....|..||+    +.++..++|+..
T Consensus       225 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~  294 (316)
T cd05574         225 MLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG  294 (316)
T ss_pred             HhhCCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhc
Confidence            999999997665321         01111  13567899999999999999999    999999888754

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.7e-36  Score=252.48  Aligned_cols=242  Identities=24%  Similarity=0.410  Sum_probs=191.4

Q ss_pred             cccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC--------CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCc
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG--------LSMSACREIALLRELKHPNVINLISVFLSHNDR   91 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (291)
                      |+. ++.||+|++|.||++.+..  +++.+++|.+....        ....+.+|+.++++++|+|++++++++  .+..
T Consensus         2 ~~~-~~~lg~g~~~~v~~~~~~~--~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~~~~   76 (268)
T cd06630           2 WLK-GQQLGTGAFSSCYQARDVK--TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT--CEDS   76 (268)
T ss_pred             ccc-cceecCcCceEEEEEEEcC--CCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee--ccCC
Confidence            443 6799999999999999765  67889999986432        124678899999999999999999999  5677


Q ss_pred             eEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEE
Q psy2172          92 KVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVK  170 (291)
Q Consensus        92 ~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~  170 (291)
                      ..++++||+.+ +|.+.+....         ++++..++.++.|++.||++||++|++|+||+|+||+++.   ....++
T Consensus        77 ~~~~v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~---~~~~~~  144 (268)
T cd06630          77 HFNLFVEWMAGGSVSHLLSKYG---------AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDS---TGQRLR  144 (268)
T ss_pred             eEEEEEeccCCCcHHHHHHHhC---------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC---CCCEEE
Confidence            89999999986 7777665322         2788999999999999999999999999999999999973   224699


Q ss_pred             EeecccceecCCCCCCC-CCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc--------
Q psy2172         171 IADMGFARLFNNPLKPL-ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI--------  241 (291)
Q Consensus       171 l~Dfg~~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~--------  241 (291)
                      |+|||.+.......... .......++..|+|||.+.+.. ++.++|+||+|+++++|++|..||.......        
T Consensus       145 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  223 (268)
T cd06630         145 IADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ-YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKI  223 (268)
T ss_pred             EcccccccccccccccCCccccccccccceeCHhHhccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHH
Confidence            99999987665431111 1122346788999999987644 8899999999999999999999997543210        


Q ss_pred             ------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         242 ------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       242 ------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                            ..........+.+++..+..+.|..||+..++..+|++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~  267 (268)
T cd06630         224 ASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVF  267 (268)
T ss_pred             hccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCccc
Confidence                  11112234567788888999999999999999888875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.4e-36  Score=252.26  Aligned_cols=233  Identities=25%  Similarity=0.426  Sum_probs=191.6

Q ss_pred             eCcccceEEEEEEEccCCCCceeEEEEeCCCC-----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecCC
Q psy2172          27 VGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-----LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAE  101 (291)
Q Consensus        27 ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~~  101 (291)
                      ||.|++|.||+|.+..  +++.+++|.+....     ....+.+|+.+++.++||||+++++.+  .++...++++||++
T Consensus         1 lg~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~lv~e~~~   76 (262)
T cd05572           1 LGVGGFGRVELVKVKS--KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTF--KDKKYIYMLMEYCL   76 (262)
T ss_pred             CCCCCceEEEEEEECC--CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeE--EcCCccEEEEecCC
Confidence            6899999999999876  67889999986432     224688899999999999999999998  55678999999987


Q ss_pred             C-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceec
Q psy2172         102 H-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF  180 (291)
Q Consensus       102 ~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~  180 (291)
                      + +|.+.+.....         +++..+..++.|++.||++||++|++|+||+|+||+++    .++.++|+|||.+...
T Consensus        77 ~~~L~~~l~~~~~---------l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~----~~~~~~l~df~~~~~~  143 (262)
T cd05572          77 GGELWTILRDRGL---------FDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLD----SNGYVKLVDFGFAKKL  143 (262)
T ss_pred             CCcHHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEc----CCCCEEEeeCCccccc
Confidence            4 88777754321         78899999999999999999999999999999999998    6678999999998766


Q ss_pred             CCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcc-------------cccCCCCC
Q psy2172         181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE-------------DIKTSNPY  247 (291)
Q Consensus       181 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~-------------~~~~~~~~  247 (291)
                      ....    ......++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||.....             ........
T Consensus       144 ~~~~----~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  218 (262)
T cd05572         144 KSGQ----KTWTFCGTPEYVAPEIILNKG-YDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNY  218 (262)
T ss_pred             Cccc----ccccccCCcCccChhHhcCCC-CCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcc
Confidence            4421    122345678899999987644 88999999999999999999999987762             11122223


Q ss_pred             cHHHHHHHHHhhCCCCcCChhh-----hhcCCCCcchhh
Q psy2172         248 HHDQLDRIFSVMGFPLEKDWED-----IRKMPEHPTLLK  281 (291)
Q Consensus       248 ~~~~~~~i~~~~~~~~~~~~~~-----~~~~~~~~~~~~  281 (291)
                      ..+.+.+++..|..+.|..|++     +.++.++||+..
T Consensus       219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~  257 (262)
T cd05572         219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNG  257 (262)
T ss_pred             cCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhC
Confidence            3567889999999999999999     899999998763

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.7e-36  Score=251.69  Aligned_cols=235  Identities=21%  Similarity=0.327  Sum_probs=184.9

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLL   96 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv   96 (291)
                      +.|++ .++||+|+||.||+|.+.   .+..+++|.+.... ..+.+.+|+.+++.++|+||+++++.+  .+....+++
T Consensus         6 ~~~~~-~~~lg~g~~g~v~~~~~~---~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~lv   79 (261)
T cd05072           6 ESIKL-VKKLGAGQFGEVWMGYYN---NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV--TKEEPIYII   79 (261)
T ss_pred             HHeEE-eeecCCcCCceEEEEEec---CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEE--cCCCCcEEE
Confidence            34554 679999999999999865   34569999886533 345788999999999999999999998  566788999


Q ss_pred             EecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecc
Q psy2172          97 FDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMG  175 (291)
Q Consensus        97 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg  175 (291)
                      |||+. ++|.+.+......       .++...+..++.|++.||++||+++++|+||+|+||+++    .++.++|+|||
T Consensus        80 ~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~----~~~~~~l~dfg  148 (261)
T cd05072          80 TEYMAKGSLLDFLKSDEGG-------KVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVS----ESLMCKIADFG  148 (261)
T ss_pred             EecCCCCcHHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEec----CCCcEEECCCc
Confidence            99997 5888877643221       278888999999999999999999999999999999998    67789999999


Q ss_pred             cceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc----------cCC
Q psy2172         176 FARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI----------KTS  244 (291)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~----------~~~  244 (291)
                      .+........  .......++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||.......          ...
T Consensus       149 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~  225 (261)
T cd05072         149 LARVIEDNEY--TAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPR  225 (261)
T ss_pred             cceecCCCce--eccCCCccceecCCHHHhccCC-CChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            9987543221  1112234566799999987644 8889999999999999998 999997654310          111


Q ss_pred             CCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         245 NPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       245 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      .......+.+++..|..+.|..||++++
T Consensus       226 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~  253 (261)
T cd05072         226 MENCPDELYDIMKTCWKEKAEERPTFDY  253 (261)
T ss_pred             CCCCCHHHHHHHHHHccCCcccCcCHHH
Confidence            1223467888899999999999998875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.4e-36  Score=260.30  Aligned_cols=243  Identities=18%  Similarity=0.228  Sum_probs=187.5

Q ss_pred             cceeCcc--cceEEEEEEEccCCCCceeEEEEeCCCCCC----hhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEE
Q psy2172          24 GCKVGRG--TYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIALLRELKHPNVINLISVFLSHNDRKVWLLF   97 (291)
Q Consensus        24 ~~~ig~G--~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~   97 (291)
                      .++||+|  +|++||++.++.  +++.||+|.++.....    ..+.+|+.+++.++||||+++++++.  .....++||
T Consensus         3 ~~~ig~G~~~~~~v~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~--~~~~~~lv~   78 (327)
T cd08227           3 LTVIGRGFEDLMTVNLARYKP--TGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFI--ADNELWVVT   78 (327)
T ss_pred             hhhccccccceEEEEEEeecc--cCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE--ECCEEEEEE
Confidence            4589999  789999999876  7788999999754322    34677999999999999999999994  456899999


Q ss_pred             ecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeeccc
Q psy2172          98 DYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGF  176 (291)
Q Consensus        98 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~  176 (291)
                      ||+++ ++.+++......       .+++..++.++.|++.||+|||++|++|+||||+||+++    .++.++++||+.
T Consensus        79 e~~~~~~l~~~~~~~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~----~~~~~~l~~~~~  147 (327)
T cd08227          79 SFMAYGSAKDLICTHFMD-------GMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS----VDGKVYLSGLRS  147 (327)
T ss_pred             eccCCCcHHHHHHhhccC-------CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEe----cCCcEEEcccch
Confidence            99985 777777543211       178899999999999999999999999999999999998    667899999986


Q ss_pred             ceecCCCCCCC----CCCCCceecccccccccccCC-cCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc----------
Q psy2172         177 ARLFNNPLKPL----ADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI----------  241 (291)
Q Consensus       177 ~~~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~----------  241 (291)
                      ...........    .......++..|+|||++.+. ..++.++|+|||||++|+|++|..||.......          
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  227 (327)
T cd08227         148 NLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV  227 (327)
T ss_pred             hhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCc
Confidence            54332111100    011223456779999998753 348899999999999999999999997432100          


Q ss_pred             c---------------------------------------------CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCC
Q psy2172         242 K---------------------------------------------TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEH  276 (291)
Q Consensus       242 ~---------------------------------------------~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  276 (291)
                      +                                             .........+.+++..|..+.|..||++.++..+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         228 PCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             cccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence            0                                             0011123467889999999999999999999999


Q ss_pred             cchhh
Q psy2172         277 PTLLK  281 (291)
Q Consensus       277 ~~~~~  281 (291)
                      |++.+
T Consensus       308 p~f~~  312 (327)
T cd08227         308 SFFKQ  312 (327)
T ss_pred             hhhhh
Confidence            98754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>KOG1095|consensus

Probab=100.00  E-value=3.6e-37  Score=284.05  Aligned_cols=242  Identities=24%  Similarity=0.379  Sum_probs=199.0

Q ss_pred             cceeCcccceEEEEEEEccCCC---CceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEE
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSD---TRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLF   97 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~---~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~   97 (291)
                      +..||+|+||.||.|...+...   ...||+|.++....   ..+|.+|+.+|+.++|||||+++|+.++  ....+|++
T Consensus       697 ~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~--~~~~~i~l  774 (1025)
T KOG1095|consen  697 LRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD--SGPPLILL  774 (1025)
T ss_pred             eeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC--CCCcEEEe
Confidence            6799999999999999876433   34489998875433   3468999999999999999999999965  66789999


Q ss_pred             ecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeeccc
Q psy2172          98 DYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGF  176 (291)
Q Consensus        98 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~  176 (291)
                      |||. |+|+.+++..+.....  +..++...++.++.|+|+|++||+++++|||||..+|+|++    .+..+||+|||+
T Consensus       775 eyM~gGDL~sflr~~r~~~~~--~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~----~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  775 EYMEGGDLLSFLRESRPAPFQ--PSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLD----ERRVVKIADFGL  848 (1025)
T ss_pred             hhcccCcHHHHHHhcccccCC--CCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeec----ccCcEEEcccch
Confidence            9998 5999999987543322  33488999999999999999999999999999999999999    668999999999


Q ss_pred             ceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc----------ccCCC
Q psy2172         177 ARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED----------IKTSN  245 (291)
Q Consensus       177 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~----------~~~~~  245 (291)
                      |+.+....... ......-...|||||++.. +.++.++|||||||++||+++ |..||.+....          .....
T Consensus       849 ArDiy~~~yyr-~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P  926 (1025)
T KOG1095|consen  849 ARDIYDKDYYR-KHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPP  926 (1025)
T ss_pred             hHhhhhchhee-ccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCC
Confidence            99665432211 1112234568999999987 459999999999999999998 89999987753          23456


Q ss_pred             CCcHHHHHHHHHhhCCCCcCChhhhhcCCC
Q psy2172         246 PYHHDQLDRIFSVMGFPLEKDWEDIRKMPE  275 (291)
Q Consensus       246 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  275 (291)
                      .++.+.+.+++..+..+.|.+||++..+.+
T Consensus       927 ~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  927 SYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             CCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            677888889999999999999999887654

>KOG0584|consensus

Probab=100.00  E-value=4.7e-38  Score=271.82  Aligned_cols=248  Identities=26%  Similarity=0.393  Sum_probs=204.0

Q ss_pred             ccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEe------CCCCCChhHHHHHHHHhcCCCCCeeeEEEEEE
Q psy2172          13 RTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQI------EGTGLSMSACREIALLRELKHPNVINLISVFL   86 (291)
Q Consensus        13 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   86 (291)
                      ...-+++|---.++||+|+|-+||+|.+..  ++..||--.+      +.+...+++..|+.+|+.|+||||+++++++.
T Consensus        34 e~~p~gRy~k~~evLGrGafKtVYka~De~--~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~  111 (632)
T KOG0584|consen   34 EKDPTGRYLKFDEVLGRGAFKTVYKAFDEE--EGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWV  111 (632)
T ss_pred             ccCCCCceeehhhhcccccceeeeeccccc--cchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeehee
Confidence            334455555447799999999999999865  6666664433      23444578999999999999999999999998


Q ss_pred             eCCCceEEEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhC--CeeeeccCCCcEEeecCC
Q psy2172          87 SHNDRKVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSN--WVLHRDLKPANILVMGEG  163 (291)
Q Consensus        87 ~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~--~ivH~dik~~Nil~~~~~  163 (291)
                      +....++-+|+|.+. |+|..+.+..+.         ++...++.|++||++||.|||++  .|+|||||++|||+++  
T Consensus       112 d~~n~~in~iTEL~TSGtLr~Y~kk~~~---------vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG--  180 (632)
T KOG0584|consen  112 DTDNKTINFITELFTSGTLREYRKKHRR---------VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNG--  180 (632)
T ss_pred             cCCCceeeeeeecccCCcHHHHHHHhcc---------CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcC--
Confidence            877788999999997 699999887765         77889999999999999999987  5999999999999986  


Q ss_pred             CCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc--
Q psy2172         164 IERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI--  241 (291)
Q Consensus       164 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~--  241 (291)
                       +.+.|||+|+|+|.....+     ......||+.|||||+...  .|+...||||||+++.||+|+..||+-.....  
T Consensus       181 -~~G~VKIGDLGLAtl~r~s-----~aksvIGTPEFMAPEmYEE--~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQI  252 (632)
T KOG0584|consen  181 -NLGEVKIGDLGLATLLRKS-----HAKSVIGTPEFMAPEMYEE--NYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQI  252 (632)
T ss_pred             -CcCceeecchhHHHHhhcc-----ccceeccCccccChHHHhh--hcchhhhhhhhhHHHHHHHhccCChhhhCCHHHH
Confidence             6789999999999987763     2344789999999999985  59999999999999999999999998655421  


Q ss_pred             ----------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhh
Q psy2172         242 ----------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKD  282 (291)
Q Consensus       242 ----------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (291)
                                ..........+++++..+..+ ...|+++.++..++.+..+
T Consensus       253 YKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  253 YKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             HHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence                      112223357788899988888 8899999999888777654

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.9e-36  Score=253.21  Aligned_cols=245  Identities=21%  Similarity=0.347  Sum_probs=188.0

Q ss_pred             cccccceeCcccceEEEEEEEccCC---CCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKDNS---DTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~~~---~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      |++ .+.||+|+||.||+|.+....   ....+++|.+.....   ...+.+|+.++..++||||+++++++  .+....
T Consensus         7 ~~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~--~~~~~~   83 (283)
T cd05048           7 VRF-LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVC--TKEQPT   83 (283)
T ss_pred             cch-hhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEE--cCCCce
Confidence            443 569999999999999876532   236799999864432   24578899999999999999999998  456688


Q ss_pred             EEEEecCCC-CHHHHHHHhhhhhh-------CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCC
Q psy2172          94 WLLFDYAEH-DLWHIIKFHRAAKA-------NKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIE  165 (291)
Q Consensus        94 ~iv~e~~~~-~l~~~~~~~~~~~~-------~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~  165 (291)
                      +++|||+++ +|.+.+........       ......++...++.++.|++.||++||++|++|+||||+||+++    .
T Consensus        84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~----~  159 (283)
T cd05048          84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG----E  159 (283)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEc----C
Confidence            999999974 88887765432111       01113378899999999999999999999999999999999998    6


Q ss_pred             CCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc----
Q psy2172         166 RGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED----  240 (291)
Q Consensus       166 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~----  240 (291)
                      ++.++|+|||++........ ........++..|+|||.+.+.. ++.++|+|||||++|+|++ |..||.+....    
T Consensus       160 ~~~~~L~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~  237 (283)
T cd05048         160 GLTVKISDFGLSRDIYSADY-YRVQSKSLLPVRWMPPEAILYGK-FTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE  237 (283)
T ss_pred             CCcEEECCCcceeecccccc-ccccCCCcccccccCHHHhccCc-CchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            67899999999876543211 11122345577899999987754 8999999999999999997 99999764431    


Q ss_pred             ------ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         241 ------IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       241 ------~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                            ...........+.+++..|..+.|..||++.++
T Consensus       238 ~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i  276 (283)
T cd05048         238 MIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDI  276 (283)
T ss_pred             HHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence                  112223445778899999999999999988753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-36  Score=254.99  Aligned_cols=238  Identities=41%  Similarity=0.688  Sum_probs=189.8

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCC----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEec
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG----LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDY   99 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~   99 (291)
                      .+.||.|++|.||+|.++.  ++..|++|.+....    ....+.+|+.+++.++|||++++++++  .+....|+++||
T Consensus         4 ~~~l~~g~~~~vy~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~--~~~~~~~iv~e~   79 (283)
T cd07835           4 VEKIGEGTYGVVYKARDKL--TGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVV--HSENKLYLVFEF   79 (283)
T ss_pred             heEecCCCCeEEEEEEEcC--CCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhhee--ccCCeEEEEEec
Confidence            5689999999999999876  67889999986432    234678899999999999999999998  556799999999


Q ss_pred             CCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeeccccee
Q psy2172         100 AEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL  179 (291)
Q Consensus       100 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~  179 (291)
                      ++++|.+.+.....       ..+++..++.++.|++.||++||+++++|+||+|+||+++    .++.++|+|||.+..
T Consensus        80 ~~~~l~~~~~~~~~-------~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~----~~~~~~l~df~~~~~  148 (283)
T cd07835          80 LDLDLKKYMDSSPL-------TGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLID----REGALKLADFGLARA  148 (283)
T ss_pred             cCcCHHHHHhhCCC-------CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc----CCCcEEEeecccccc
Confidence            98888887765432       1288999999999999999999999999999999999998    677899999999875


Q ss_pred             cCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc------------------
Q psy2172         180 FNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI------------------  241 (291)
Q Consensus       180 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~------------------  241 (291)
                      ......   ......++..|+|||.+.+...++.++|+||||+++|+|++|..||.......                  
T Consensus       149 ~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  225 (283)
T cd07835         149 FGVPVR---TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWP  225 (283)
T ss_pred             cCCCcc---ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhh
Confidence            543211   11223457889999988765557899999999999999999999997553210                  


Q ss_pred             --------------------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         242 --------------------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       242 --------------------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                                          ....+.....+.+++..|..+.|..||++.++..++|+
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         226 GVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence                                00112223556778888888888888888888877764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=5.1e-37  Score=264.59  Aligned_cols=249  Identities=33%  Similarity=0.496  Sum_probs=194.3

Q ss_pred             cccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC--CChhHHHHHHHHhcCCCCCeeeEEEEEEeCC----
Q psy2172          16 VEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG--LSMSACREIALLRELKHPNVINLISVFLSHN----   89 (291)
Q Consensus        16 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----   89 (291)
                      +.++|.+ .+.||.|+||.||+|.++.  +++.|++|.+....  ....+.+|+.++++++||||+++++++....    
T Consensus         3 ~~~~y~~-~~~Lg~g~~g~vy~~~~~~--~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (342)
T cd07854           3 LGSRYMD-LRPLGCGSNGLVFSAVDSD--CDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT   79 (342)
T ss_pred             cCcceEE-EEEecCCCCEEEEEEEECC--CCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence            4577885 6799999999999999876  67889999886433  2345788999999999999999998764322    


Q ss_pred             --------CceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeec
Q psy2172          90 --------DRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMG  161 (291)
Q Consensus        90 --------~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~  161 (291)
                              ....|+++||++++|.+.+...          .+++..++.++.|++.||.+||+.|++|+||||+||+++.
T Consensus        80 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~----------~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~  149 (342)
T cd07854          80 EDVGSLTELNSVYIVQEYMETDLANVLEQG----------PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINT  149 (342)
T ss_pred             cccccccccceEEEEeecccccHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcC
Confidence                    1357999999998877666422          1889999999999999999999999999999999999973


Q ss_pred             CCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc
Q psy2172         162 EGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI  241 (291)
Q Consensus       162 ~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~  241 (291)
                         .+..++++|||.+.................++..|+|||.+.+...++.++|+|||||++|+|++|+.||.+.....
T Consensus       150 ---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~  226 (342)
T cd07854         150 ---EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE  226 (342)
T ss_pred             ---CCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence               34578999999987654322211122234568889999987654558889999999999999999999997543100


Q ss_pred             ---------------------------------cC------CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchh
Q psy2172         242 ---------------------------------KT------SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLL  280 (291)
Q Consensus       242 ---------------------------------~~------~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  280 (291)
                                                       ..      ..+.....+.+++..|..+.|..||++.++..++|+.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~  304 (342)
T cd07854         227 QMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMS  304 (342)
T ss_pred             HHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccc
Confidence                                             00      0112235567899999999999999999999998884

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=5.6e-37  Score=254.36  Aligned_cols=234  Identities=25%  Similarity=0.422  Sum_probs=181.9

Q ss_pred             cceeCcccceEEEEEEEc--cCCCCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEe
Q psy2172          24 GCKVGRGTYGHVYKARRK--DNSDTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFD   98 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~--~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e   98 (291)
                      .+.||.|+||.||+|.+.  ....+..|+||.++....   ...+.+|++.+++++||||+++++++.  .....++|+|
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~--~~~~~~lv~e   81 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCI--ENEPLFLVME   81 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEE--SSSSEEEEEE
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccc--cccccccccc
Confidence            468999999999999998  444667899999965433   357889999999999999999999996  4455999999


Q ss_pred             cCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccc
Q psy2172          99 YAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA  177 (291)
Q Consensus        99 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~  177 (291)
                      |+. |+|.+.+......       .++...+..++.|++.||.|||+++++|++|+++||+++    .++.+||+|||++
T Consensus        82 ~~~~g~L~~~L~~~~~~-------~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~----~~~~~Kl~~f~~~  150 (259)
T PF07714_consen   82 YCPGGSLDDYLKSKNKE-------PLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLD----SNGQVKLSDFGLS  150 (259)
T ss_dssp             --TTEBHHHHHHHTCTT-------TSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEE----TTTEEEEESTTTG
T ss_pred             ccccccccccccccccc-------ccccccccccccccccccccccccccccccccccccccc----ccccccccccccc
Confidence            998 5899888876111       288999999999999999999999999999999999999    6789999999999


Q ss_pred             eecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc----------cCCCC
Q psy2172         178 RLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI----------KTSNP  246 (291)
Q Consensus       178 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~----------~~~~~  246 (291)
                      ......... ...........|+|||.+.+.. ++.++||||||+++|++++ |..||.......          .....
T Consensus       151 ~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  228 (259)
T PF07714_consen  151 RPISEKSKY-KNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPD  228 (259)
T ss_dssp             EETTTSSSE-EESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBT
T ss_pred             ccccccccc-cccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccceecc
Confidence            876332111 2223345677899999997755 8999999999999999999 789997754321          12223


Q ss_pred             CcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         247 YHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       247 ~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      .....+.+++..+....|..||++.+
T Consensus       229 ~~~~~~~~li~~C~~~~p~~RPs~~~  254 (259)
T PF07714_consen  229 NCPKDIYSLIQQCWSHDPEKRPSFQE  254 (259)
T ss_dssp             TSBHHHHHHHHHHT-SSGGGS--HHH
T ss_pred             chhHHHHHHHHHHcCCChhhCcCHHH
Confidence            34567888999999999999998875

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=3.6e-37  Score=264.79  Aligned_cols=250  Identities=33%  Similarity=0.536  Sum_probs=197.7

Q ss_pred             ccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC----CChhHHHHHHHHhcCCCCCeeeEEEEEEeC--
Q psy2172          15 KVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG----LSMSACREIALLRELKHPNVINLISVFLSH--   88 (291)
Q Consensus        15 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--   88 (291)
                      .+.+.|.+ .+.||+|++|.||+|.+..  +++.|++|.+....    ....+.+|+.++++++||||+++++++...  
T Consensus         2 ~~~~~y~~-~~~lg~g~~g~v~~~~~~~--~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   78 (334)
T cd07855           2 DVGSRYKP-IENIGSGAYGVVCSAIDTR--SGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGA   78 (334)
T ss_pred             chhhceee-eeeeecCCCeEEEEEEEcC--CCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCC
Confidence            35567775 5699999999999999876  67889999986532    234577899999999999999999987432  


Q ss_pred             CCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCc
Q psy2172          89 NDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGR  168 (291)
Q Consensus        89 ~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~  168 (291)
                      .....++||||++++|.+.+....         .+++..++.++.|++.||++||++|++|+||||+||+++    .++.
T Consensus        79 ~~~~~~lv~e~~~~~l~~~~~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~----~~~~  145 (334)
T cd07855          79 DFKDVYVVMDLMESDLHHIIHSDQ---------PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVN----EDCE  145 (334)
T ss_pred             CCceEEEEEehhhhhHHHHhccCC---------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc----CCCc
Confidence            345789999999988777664322         289999999999999999999999999999999999998    6789


Q ss_pred             EEEeecccceecCCCCCC-CCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc-------
Q psy2172         169 VKIADMGFARLFNNPLKP-LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED-------  240 (291)
Q Consensus       169 ~~l~Dfg~~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~-------  240 (291)
                      ++|+|||.+......... ........++..|+|||.+.+...++.++|+||||+++|+|++|+.||.+....       
T Consensus       146 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~  225 (334)
T cd07855         146 LRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLIL  225 (334)
T ss_pred             EEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHH
Confidence            999999998765432211 111123467888999999876455889999999999999999999999764310       


Q ss_pred             -------------------------ccC--------CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchh
Q psy2172         241 -------------------------IKT--------SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLL  280 (291)
Q Consensus       241 -------------------------~~~--------~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  280 (291)
                                               ...        ..+.....+.+++..|....|..||++.++..+||+.
T Consensus       226 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~  298 (334)
T cd07855         226 SVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLA  298 (334)
T ss_pred             HHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhh
Confidence                                     000        0012346688899999999999999999988888875

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-36  Score=250.96  Aligned_cols=239  Identities=21%  Similarity=0.332  Sum_probs=185.2

Q ss_pred             cccccccceeCcccceEEEEEEEccC-CCCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDN-SDTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~-~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      +.|++ .+.||+|+||.||+|.++.. .....+++|.++....   ..++.+|+.++++++||||+++++++  .+....
T Consensus         4 ~~~~~-~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~   80 (266)
T cd05033           4 SYVTI-EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVV--TKSRPV   80 (266)
T ss_pred             HHcee-eeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEE--ecCCce
Confidence            34664 67999999999999998653 2346799999875432   23578899999999999999999998  456689


Q ss_pred             EEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          94 WLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        94 ~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      +++|||+.+ +|.+.+.....        .++...+..++.|++.|+++||+++++|+||+|+||+++    .++.++|+
T Consensus        81 ~iv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~----~~~~~~l~  148 (266)
T cd05033          81 MIITEYMENGSLDKFLRENDG--------KFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVN----SNLVCKVS  148 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc----CCCCEEEC
Confidence            999999975 77777654322        288999999999999999999999999999999999998    67789999


Q ss_pred             ecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc----------c
Q psy2172         173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED----------I  241 (291)
Q Consensus       173 Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~----------~  241 (291)
                      |||.+......... .......++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||......          .
T Consensus       149 dfg~~~~~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~  226 (266)
T cd05033         149 DFGLSRRLEDSEAT-YTTKGGKIPIRWTAPEAIAYRK-FTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYR  226 (266)
T ss_pred             ccchhhcccccccc-eeccCCCCCccccChhhhccCC-CccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC
Confidence            99999876521111 1111223456799999987744 8899999999999999997 99999654321          0


Q ss_pred             cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         242 KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       242 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      ..........+.+++..+....|..+|++.++
T Consensus       227 ~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei  258 (266)
T cd05033         227 LPPPMDCPSALYQLMLDCWQKDRNERPTFSQI  258 (266)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence            11122334678888888888888888887753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.3e-36  Score=253.18  Aligned_cols=238  Identities=29%  Similarity=0.534  Sum_probs=187.3

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-----LSMSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      .|.+ .+.||+|+||.||+|.+..  +++.||+|.+....     ....+.+|+.+++.++||||+++++++.  +....
T Consensus         3 ~~~i-~~~l~~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~   77 (267)
T cd08228           3 NFQI-EKKIGRGQFSEVYRATCLL--DRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI--EDNEL   77 (267)
T ss_pred             ceee-eeeeccCCCeeEEEEEEeC--CCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE--ECCeE
Confidence            4664 6699999999999999876  67889999875321     1235788999999999999999999984  45688


Q ss_pred             EEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          94 WLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        94 ~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      ++++||+++ +|.+++.......     ..+++..+..++.|++.||.|||++|++|+||+|+||+++    .++.++|+
T Consensus        78 ~~v~e~~~~~~L~~~~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~----~~~~~~l~  148 (267)
T cd08228          78 NIVLELADAGDLSQMIKYFKKQK-----RLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFIT----ATGVVKLG  148 (267)
T ss_pred             EEEEEecCCCcHHHHHHHhhhcc-----CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEc----CCCCEEEC
Confidence            999999985 7777776543221     1278999999999999999999999999999999999998    66789999


Q ss_pred             ecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc-----------
Q psy2172         173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI-----------  241 (291)
Q Consensus       173 Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~-----------  241 (291)
                      |||.+........   ......++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||.....+.           
T Consensus       149 d~g~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~  224 (267)
T cd08228         149 DLGLGRFFSSKTT---AAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD  224 (267)
T ss_pred             ccccceeccchhH---HHhcCCCCccccChhhhccCC-CCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCC
Confidence            9999876543211   112345678899999997744 8889999999999999999999996543221           


Q ss_pred             -cC-CCCCcHHHHHHHHHhhCCCCcCChhhhhcCC
Q psy2172         242 -KT-SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMP  274 (291)
Q Consensus       242 -~~-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  274 (291)
                       +. ........+.+++..|....|..||++.++.
T Consensus       225 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl  259 (267)
T cd08228         225 YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVH  259 (267)
T ss_pred             CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHH
Confidence             01 1112346688999999999999999988643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.5e-36  Score=255.10  Aligned_cols=199  Identities=44%  Similarity=0.800  Sum_probs=165.1

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCC---CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecC
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG---LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYA  100 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~  100 (291)
                      .++||+|++|.||+|.+..  ++..||+|.++...   ....+.+|+.++++++|+||+++++++  .+....+++|||+
T Consensus         5 ~~~l~~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~~~lv~e~~   80 (284)
T cd07836           5 LEKLGEGTYATVYKGRNRT--TGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI--HTENKLMLVFEYM   80 (284)
T ss_pred             eeeeccCCceEEEEEEECC--CCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeE--eeCCcEEEEEecC
Confidence            5699999999999999876  67889999986432   234677899999999999999999999  4566889999999


Q ss_pred             CCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceec
Q psy2172         101 EHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF  180 (291)
Q Consensus       101 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~  180 (291)
                      +++|.+.+.....      ...+++..+..++.|++.||++||+.|++|+||+|+||+++    .++.++|+|||.+...
T Consensus        81 ~~~l~~~~~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~----~~~~~~l~d~g~~~~~  150 (284)
T cd07836          81 DKDLKKYMDTHGV------RGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLIN----KRGELKLADFGLARAF  150 (284)
T ss_pred             CccHHHHHHhcCC------CCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEC----CCCcEEEeecchhhhh
Confidence            9988887764332      12389999999999999999999999999999999999998    6678999999998754


Q ss_pred             CCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcc
Q psy2172         181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE  239 (291)
Q Consensus       181 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~  239 (291)
                      .....   ......++..|+|||.+.+...++.++|+||||+++|+|++|..||.+...
T Consensus       151 ~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~  206 (284)
T cd07836         151 GIPVN---TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN  206 (284)
T ss_pred             cCCcc---ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence            33211   112345678899999987755578999999999999999999999987653

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-36  Score=250.33  Aligned_cols=241  Identities=27%  Similarity=0.403  Sum_probs=191.6

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC--CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG--LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWL   95 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~i   95 (291)
                      +.|.+ .+.||+|+||.||+|.+..  +++.+++|.+....  ....+.+|+.++++++||||+++++.+  .+....|+
T Consensus         3 ~~~~~-~~~l~~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~--~~~~~~~l   77 (262)
T cd06613           3 EDYEL-IQRIGSGTYGDVYKARDIA--TGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY--LRRDKLWI   77 (262)
T ss_pred             cceEE-EEEecCCCceEEEEeEecC--CCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEE--EeCCEEEE
Confidence            45664 5699999999999999876  56789999987432  345688999999999999999999998  45678999


Q ss_pred             EEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          96 LFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        96 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      +|||+++ +|.+.+.....        .+++..++.++.|++.||.+||++|++|+||+|+||+++    .++.++|+||
T Consensus        78 ~~e~~~~~~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~----~~~~~~l~d~  145 (262)
T cd06613          78 VMEYCGGGSLQDIYQVTRG--------PLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLT----EDGDVKLADF  145 (262)
T ss_pred             EEeCCCCCcHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEEC----CCCCEEECcc
Confidence            9999986 76666654321        288999999999999999999999999999999999998    6678999999


Q ss_pred             ccceecCCCCCCCCCCCCceecccccccccccCC--cCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc----------c
Q psy2172         175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI----------K  242 (291)
Q Consensus       175 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~----------~  242 (291)
                      |.+.......   .......++..|+|||.+.+.  +.++.++|+||||+++|+|++|..||.......          .
T Consensus       146 g~~~~~~~~~---~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~  222 (262)
T cd06613         146 GVSAQLTATI---AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFP  222 (262)
T ss_pred             ccchhhhhhh---hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC
Confidence            9987654321   111234567789999998764  247889999999999999999999997654210          0


Q ss_pred             ----CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcc
Q psy2172         243 ----TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPT  278 (291)
Q Consensus       243 ----~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  278 (291)
                          .........+.+++..|..+.|..||++.++..++|
T Consensus       223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         223 PPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             CccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence                011122356789999999999999999998877764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.2e-36  Score=253.92  Aligned_cols=244  Identities=23%  Similarity=0.395  Sum_probs=192.3

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC--CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG--LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWL   95 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~i   95 (291)
                      +.|++ .+.||+|+||.||++.+..  ++..+++|.+....  ....+.+|+.+++.++|||++++++.+.  .....++
T Consensus         5 ~~~~i-~~~lg~g~~g~v~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~--~~~~~~~   79 (282)
T cd06643           5 EFWEI-IGELGDGAFGKVYKAQNKE--TGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY--YENNLWI   79 (282)
T ss_pred             HHHHH-HhhcccCCCeEEEEEEECC--CCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEe--eCCEEEE
Confidence            34554 4589999999999999876  66789999986433  2345778999999999999999999984  4668999


Q ss_pred             EEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          96 LFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        96 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      ++||+++ ++...+....        .++++..+..++.|++.||.+||+.|++|+||+|+||+++    .++.++++||
T Consensus        80 v~e~~~~~~l~~~~~~~~--------~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~----~~~~~kl~df  147 (282)
T cd06643          80 LIEFCAGGAVDAVMLELE--------RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFT----LDGDIKLADF  147 (282)
T ss_pred             EEEecCCCcHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEc----cCCCEEEccc
Confidence            9999986 5544443211        1288999999999999999999999999999999999998    6678999999


Q ss_pred             ccceecCCCCCCCCCCCCceecccccccccccC----CcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---------
Q psy2172         175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLG----ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---------  241 (291)
Q Consensus       175 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---------  241 (291)
                      |++.......   .......++..|+|||.+..    ...++.++|+||+||++|+|++|..||.......         
T Consensus       148 g~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~  224 (282)
T cd06643         148 GVSAKNTRTI---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE  224 (282)
T ss_pred             cccccccccc---cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcC
Confidence            9986543221   11223457888999999842    2347789999999999999999999998654210         


Q ss_pred             ---cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         242 ---KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       242 ---~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                         ..........+.+++..|..+.|..||++.++..+|++..
T Consensus       225 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  267 (282)
T cd06643         225 PPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTV  267 (282)
T ss_pred             CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEec
Confidence               0112234567899999999999999999999999988664

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-36  Score=255.53  Aligned_cols=242  Identities=35%  Similarity=0.596  Sum_probs=193.3

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT----GLSMSACREIALLRELKHPNVINLISVFLSHNDRKVW   94 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (291)
                      +|++ .+.||+|++|.||+|.++.  +++.|++|.++..    .....+.+|++++++++|+||+++++.+.  +....+
T Consensus         2 ~y~~-~~~i~~g~~~~v~~~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~   76 (288)
T cd07833           2 KYEV-LGVVGEGAYGVVLKCRNKA--TGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFR--RKGRLY   76 (288)
T ss_pred             ceeE-EEEecccCCeeEEEEEeCC--CCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEE--ECCEEE
Confidence            4664 6699999999999999876  5688999988642    23456889999999999999999999994  467899


Q ss_pred             EEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          95 LLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        95 iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      +++||+++++...+.....        .+++..++.++.|++.|+++||++|++|+||+|+||+++    .++.++|+||
T Consensus        77 iv~e~~~~~~l~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~----~~~~~kl~d~  144 (288)
T cd07833          77 LVFEYVERTLLELLEASPG--------GLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVS----ESGVLKLCDF  144 (288)
T ss_pred             EEEecCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC----CCCCEEEEee
Confidence            9999999877765543221        278999999999999999999999999999999999998    6789999999


Q ss_pred             ccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc-------------
Q psy2172         175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI-------------  241 (291)
Q Consensus       175 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~-------------  241 (291)
                      |.+........  .......++..|+|||++.+...++.++|+||||+++|+|++|.+||.+.....             
T Consensus       145 g~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~  222 (288)
T cd07833         145 GFARALRARPA--SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLP  222 (288)
T ss_pred             ecccccCCCcc--ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            99876654322  122234567889999999876458899999999999999999999997542110             


Q ss_pred             ------------------c----------CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         242 ------------------K----------TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       242 ------------------~----------~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                                        .          .........+.+++..+..+.|..||+++++..++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         223 PSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             HHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence                              0          0011124567888899999999999999988888764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=4.2e-36  Score=250.76  Aligned_cols=240  Identities=23%  Similarity=0.327  Sum_probs=184.1

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCC----CChhHHHHHHHHhcCCCCCeeeEEEEEEeC----CCceEEE
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG----LSMSACREIALLRELKHPNVINLISVFLSH----NDRKVWL   95 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~~~~~i   95 (291)
                      +++||+|+||.||+|.+........+|+|.++...    ....+.+|+.+++.++|+||+++++.+...    .....++
T Consensus         4 ~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~   83 (272)
T cd05075           4 GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVV   83 (272)
T ss_pred             ccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEE
Confidence            67999999999999998765444579999886532    224577899999999999999999986432    1235789


Q ss_pred             EEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          96 LFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        96 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      +|||+. ++|.+.+...+...   ....+++..+..++.|++.||+|||++|++|+||||+||+++    .++.++|+||
T Consensus        84 v~e~~~~~~l~~~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~----~~~~~kl~Df  156 (272)
T cd05075          84 ILPFMKHGDLHSFLLYSRLGD---CPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLN----ENMNVCVADF  156 (272)
T ss_pred             EEEeCCCCcHHHHHHHhcccC---CcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEc----CCCCEEECCC
Confidence            999998 47777665433221   122388999999999999999999999999999999999998    6778999999


Q ss_pred             ccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc----------ccC
Q psy2172         175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED----------IKT  243 (291)
Q Consensus       175 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~----------~~~  243 (291)
                      |++......... .......++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||.+....          ...
T Consensus       157 g~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  234 (272)
T cd05075         157 GLSKKIYNGDYY-RQGRIAKMPVKWIAIESLADRV-YTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLK  234 (272)
T ss_pred             CcccccCcccce-ecCCcccCCcccCCHHHccCCC-cChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            998865432211 1112234466799999987744 8999999999999999998 89999764331          111


Q ss_pred             CCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         244 SNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       244 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      ..+...+.+.+++..+..+.|..||++.+
T Consensus       235 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~  263 (272)
T cd05075         235 QPPDCLDGLYSLMSSCWLLNPKDRPSFET  263 (272)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence            22334567889999999999999998775

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.2e-36  Score=252.13  Aligned_cols=202  Identities=23%  Similarity=0.349  Sum_probs=157.5

Q ss_pred             eeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC---hhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecCCC
Q psy2172          26 KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS---MSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH  102 (291)
Q Consensus        26 ~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~~~  102 (291)
                      .||+|+||.||+|..........+++|.+......   ..+.+|+.+++.++||||+++++.+  ......+++|||+++
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~--~~~~~~~lv~e~~~~   79 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQC--IESIPYLLVLEFCPL   79 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEE--CCCCceEEEEEeCCC
Confidence            68999999999998655445667899987644322   3567899999999999999999998  556789999999985


Q ss_pred             -CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceecC
Q psy2172         103 -DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFN  181 (291)
Q Consensus       103 -~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~~  181 (291)
                       +|.+.+........    ...++..+..++.|++.||+|||++|++|+||||+||+++    .++.++|+|||.+....
T Consensus        80 g~L~~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~----~~~~~kl~dfg~~~~~~  151 (269)
T cd05042          80 GDLKNYLRSNRGMVA----QMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLT----ADLSVKIGDYGLALEQY  151 (269)
T ss_pred             CcHHHHHHhcccccc----ccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEec----CCCcEEEeccccccccc
Confidence             88887765442211    1156778899999999999999999999999999999998    67789999999986433


Q ss_pred             CCCCCCCCCCCceecccccccccccC------CcCCCCchhHHHHHHHHHHHHc-CCCCCCCCc
Q psy2172         182 NPLKPLADLDPVVVTFWYRAPELLLG------ARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQ  238 (291)
Q Consensus       182 ~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~  238 (291)
                      ..... .......++..|+|||++..      ...++.++|+||||+++|+|++ |..||....
T Consensus       152 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~  214 (269)
T cd05042         152 PEDYY-ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS  214 (269)
T ss_pred             cchhe-eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC
Confidence            22111 11123345677999998743      2246889999999999999998 889997654

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-36  Score=250.52  Aligned_cols=235  Identities=20%  Similarity=0.317  Sum_probs=183.5

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLL   96 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv   96 (291)
                      +.|++ .+.||+|++|.||+|.+..   ++.||+|.++... ....+.+|+.++++++||||+++++++  ......+++
T Consensus         6 ~~~~~-~~~lg~g~~~~v~~~~~~~---~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~lv   79 (261)
T cd05068           6 TSIQL-LRKLGAGQFGEVWEGLWNN---TTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC--TLEEPIYIV   79 (261)
T ss_pred             hheee-EEEecccCCccEEEEEecC---CeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEE--ecCCCeeee
Confidence            34664 5799999999999998653   4679999987543 345688999999999999999999988  456678999


Q ss_pred             EecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecc
Q psy2172          97 FDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMG  175 (291)
Q Consensus        97 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg  175 (291)
                      |||+. ++|.+.+....       ...++...+..++.|++.|+.+||++|++|+||+|+||+++    .++.++|+|||
T Consensus        80 ~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~----~~~~~~l~dfg  148 (261)
T cd05068          80 TELMKYGSLLEYLQGGA-------GRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVG----ENNICKVADFG  148 (261)
T ss_pred             eecccCCcHHHHHhccC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEc----CCCCEEECCcc
Confidence            99995 68888776432       11288999999999999999999999999999999999998    66789999999


Q ss_pred             cceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc----------cCC
Q psy2172         176 FARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI----------KTS  244 (291)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~----------~~~  244 (291)
                      ++........  ........+..|+|||.+.+.. ++.++|+||||+++|+|++ |+.||.+.....          ...
T Consensus       149 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~  225 (261)
T cd05068         149 LARVIKEDIY--EAREGAKFPIKWTAPEAALYNR-FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPC  225 (261)
T ss_pred             eEEEccCCcc--cccCCCcCceeccCccccccCC-CCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            9987653211  1111122245799999987644 8899999999999999998 999997754320          112


Q ss_pred             CCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         245 NPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       245 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      .......+.+++..|....|.+||++.+
T Consensus       226 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~  253 (261)
T cd05068         226 PPGCPKELYDIMLDCWKEDPDDRPTFET  253 (261)
T ss_pred             CCcCCHHHHHHHHHHhhcCcccCCCHHH
Confidence            2233566778888888888888887764

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=6.3e-37  Score=253.81  Aligned_cols=234  Identities=24%  Similarity=0.349  Sum_probs=192.3

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEe
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-----LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFD   98 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e   98 (291)
                      .+.||+|+||.||+|.+..  ++..+++|.+....     ....+.+|++++++++||||+++++.+  .+....++++|
T Consensus         5 ~~~i~~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~lv~e   80 (258)
T cd05578           5 LRVIGKGAFGKVCIVQKRD--TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF--QDEENMYLVVD   80 (258)
T ss_pred             EEEeccCCCceEEEEEEcc--CCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh--cCCCeEEEEEe
Confidence            5699999999999999876  67889999986432     235688899999999999999999998  67789999999


Q ss_pred             cCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccc
Q psy2172          99 YAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA  177 (291)
Q Consensus        99 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~  177 (291)
                      |+.+ +|...+....         ++++..+..++.|++.||.+||++|++|+||+|+||+++    .++.++|+|||.+
T Consensus        81 ~~~~~~L~~~l~~~~---------~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~----~~~~~~l~d~~~~  147 (258)
T cd05578          81 LLLGGDLRYHLSQKV---------KFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLD----EQGHVHITDFNIA  147 (258)
T ss_pred             CCCCCCHHHHHHhcC---------CcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEc----CCCCEEEeecccc
Confidence            9976 7776665431         288999999999999999999999999999999999998    6778999999998


Q ss_pred             eecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcc------------cccCCC
Q psy2172         178 RLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE------------DIKTSN  245 (291)
Q Consensus       178 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~------------~~~~~~  245 (291)
                      .......    ......|+..|.|||.+.+.. ++.++|+||||+++|+|++|..||.....            ......
T Consensus       148 ~~~~~~~----~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  222 (258)
T cd05578         148 TKVTPDT----LTTSTSGTPGYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYP  222 (258)
T ss_pred             cccCCCc----cccccCCChhhcCHHHHcccC-CCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCc
Confidence            7654421    223345778899999997754 88999999999999999999999987663            112222


Q ss_pred             CCcHHHHHHHHHhhCCCCcCChhhh--hcCCCCcch
Q psy2172         246 PYHHDQLDRIFSVMGFPLEKDWEDI--RKMPEHPTL  279 (291)
Q Consensus       246 ~~~~~~~~~i~~~~~~~~~~~~~~~--~~~~~~~~~  279 (291)
                      +.....+.+++..|....|..||+.  .++..+|++
T Consensus       223 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         223 ATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             ccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence            2334678888899999999999998  888887764

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=3.2e-36  Score=250.82  Aligned_cols=240  Identities=26%  Similarity=0.384  Sum_probs=187.7

Q ss_pred             ccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC--CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEE
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG--LSMSACREIALLRELKHPNVINLISVFLSHNDRKVW   94 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (291)
                      .+.|++ .+.||+|+||.||+|.+..  +++.+++|++....  ....+.+|+.++++++||||+++++++.  .....+
T Consensus         8 ~~~y~~-~~~lg~g~~g~vy~~~~~~--~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~--~~~~~~   82 (267)
T cd06646           8 QHDYEL-IQRVGSGTYGDVYKARNLH--TGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL--SREKLW   82 (267)
T ss_pred             hhhcch-hheeecCCCeEEEEEEECC--CCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEE--eCCEEE
Confidence            345664 6799999999999999866  67889999986432  2345778999999999999999999984  466899


Q ss_pred             EEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEee
Q psy2172          95 LLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIAD  173 (291)
Q Consensus        95 iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~D  173 (291)
                      +||||+++ +|.+.+....         .+++..+..++.|++.|+.+||++|++|+||+|+||+++    .++.++|+|
T Consensus        83 iv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~----~~~~~~l~d  149 (267)
T cd06646          83 ICMEYCGGGSLQDIYHVTG---------PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLT----DNGDVKLAD  149 (267)
T ss_pred             EEEeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC----CCCCEEECc
Confidence            99999985 7776664321         278999999999999999999999999999999999998    667899999


Q ss_pred             cccceecCCCCCCCCCCCCceecccccccccccC--CcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc----------
Q psy2172         174 MGFARLFNNPLKPLADLDPVVVTFWYRAPELLLG--ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI----------  241 (291)
Q Consensus       174 fg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~----------  241 (291)
                      ||++.......   .......++..|+|||.+.+  ...++.++|+||+|+++|+|++|..||.......          
T Consensus       150 fg~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~  226 (267)
T cd06646         150 FGVAAKITATI---AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNF  226 (267)
T ss_pred             Cccceeecccc---cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCC
Confidence            99987654321   11223467788999998753  2337789999999999999999999986433211          


Q ss_pred             cC----CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCc
Q psy2172         242 KT----SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHP  277 (291)
Q Consensus       242 ~~----~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  277 (291)
                      ..    ........+.++++.+....|..||+++++..++
T Consensus       227 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         227 QPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            00    0012245688899999999999999988766554

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3.4e-36  Score=249.21  Aligned_cols=234  Identities=22%  Similarity=0.310  Sum_probs=184.4

Q ss_pred             ceeCcccceEEEEEEEcc-CCCCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecC
Q psy2172          25 CKVGRGTYGHVYKARRKD-NSDTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYA  100 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~-~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~  100 (291)
                      ++||+|++|.||+|.+.. .+....+++|.++....   ...+.+|+.++++++||||+++++.+.  + ...++++||+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~-~~~~~v~e~~   77 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVL--T-HPLMMVTELA   77 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEc--C-CeEEEEEEec
Confidence            478999999999999865 33334699999986544   346888999999999999999999984  3 7899999999


Q ss_pred             C-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeeccccee
Q psy2172         101 E-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL  179 (291)
Q Consensus       101 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~  179 (291)
                      . ++|.+.+.....       ..+++..++.++.|++.||++||++|++|+||+|+||+++    .++.++|+|||.+..
T Consensus        78 ~~~~L~~~l~~~~~-------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~----~~~~~kl~dfg~~~~  146 (257)
T cd05040          78 PLGSLLDRLRKDAL-------GHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLA----SDDKVKIGDFGLMRA  146 (257)
T ss_pred             CCCcHHHHHHhccc-------ccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEe----cCCEEEecccccccc
Confidence            6 588887765431       1288999999999999999999999999999999999999    668999999999987


Q ss_pred             cCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc-----------cCCCCC
Q psy2172         180 FNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI-----------KTSNPY  247 (291)
Q Consensus       180 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~-----------~~~~~~  247 (291)
                      ...............++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||.......           ......
T Consensus       147 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  225 (257)
T cd05040         147 LPQNEDHYVMEEHLKVPFAWCAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEA  225 (257)
T ss_pred             ccccccceecccCCCCCceecCHHHhcccC-cCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCcc
Confidence            654322222222345567899999987644 8899999999999999998 999996543211           111122


Q ss_pred             cHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         248 HHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       248 ~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      ....+.+++..|....|..||++.++
T Consensus       226 ~~~~~~~li~~~l~~~p~~Rps~~~~  251 (257)
T cd05040         226 CPQDIYNVMLQCWAHNPADRPTFAAL  251 (257)
T ss_pred             CCHHHHHHHHHHCCCCcccCCCHHHH
Confidence            34678888888888999888887753

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>KOG0604|consensus

Probab=100.00  E-value=9.2e-38  Score=248.21  Aligned_cols=252  Identities=25%  Similarity=0.392  Sum_probs=204.5

Q ss_pred             cccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcC-CCCCeeeEEEEEEe--C
Q psy2172          12 ERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLREL-KHPNVINLISVFLS--H   88 (291)
Q Consensus        12 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~   88 (291)
                      ....|++-|++..++||-|-.|.|..|.++.  +++.+|+|++..   .+.+.+|+++-=.. .|||||.++++|..  +
T Consensus        55 k~~~itedY~is~qvLG~GinGkV~~C~~k~--T~ekfALKvL~D---s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~  129 (400)
T KOG0604|consen   55 KEYSITEDYSISWQVLGAGINGKVVQCVHKR--TQEKFALKVLLD---SPKARREVELHWMASGHPHIVSIIDVYENSYQ  129 (400)
T ss_pred             hcccchhhheehhhhhccccCCceEEEEecc--chhhhHHHHHhc---CHHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence            3456888899889999999999999999887  778899999864   56777888776555 69999999999832  4


Q ss_pred             CCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCC
Q psy2172          89 NDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERG  167 (291)
Q Consensus        89 ~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~  167 (291)
                      +..++.+|||.++| .|.+.+...+...       +++..+.+|+.||+.|+.|||+.+|.||||||+|+|+.... .+.
T Consensus       130 ~rkcLLiVmE~meGGeLfsriq~~g~~a-------fTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~-~na  201 (400)
T KOG0604|consen  130 GRKCLLIVMECMEGGELFSRIQDRGDQA-------FTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTS-PNA  201 (400)
T ss_pred             CceeeEeeeecccchHHHHHHHHccccc-------chHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCC-CCc
Confidence            56789999999986 8888887655432       99999999999999999999999999999999999998765 567


Q ss_pred             cEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccC----
Q psy2172         168 RVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT----  243 (291)
Q Consensus       168 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~----  243 (291)
                      .+||+|||+++....+    ....+.+-|+.|.|||++...+ |+..+|+||+||++|-|+.|-+||-+.......    
T Consensus       202 ~lKLtDfGFAK~t~~~----~~L~TPc~TPyYvaPevlg~eK-ydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk  276 (400)
T KOG0604|consen  202 PLKLTDFGFAKETQEP----GDLMTPCFTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK  276 (400)
T ss_pred             ceEecccccccccCCC----ccccCCcccccccCHHHhCchh-cCCCCCccchhHHHHHhhcCCCcccccCCccCChhHH
Confidence            8999999999865542    2334556799999999997644 999999999999999999999999876652111    


Q ss_pred             --------CCC-----CcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         244 --------SNP-----YHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       244 --------~~~-----~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                              .-|     .-++...++++.+..-.|.++=++.++.++||+.+
T Consensus       277 ~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~  327 (400)
T KOG0604|consen  277 RRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQ  327 (400)
T ss_pred             hHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcc
Confidence                    000     11455677778888888888888888888888754

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=3.1e-36  Score=250.46  Aligned_cols=232  Identities=22%  Similarity=0.329  Sum_probs=183.0

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC-ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecCC-
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAE-  101 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~~-  101 (291)
                      .+.||+|++|.||+|.+++  .++.+++|.+..... ...+.+|+.+++.++|+||+++++++  ......+++|||++ 
T Consensus        11 ~~~ig~g~~~~v~~~~~~~--~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~lv~e~~~~   86 (263)
T cd05052          11 KHKLGGGQYGEVYEGVWKK--YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC--TREPPFYIITEFMTY   86 (263)
T ss_pred             eeecCCcccceEEEEEEec--CCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEE--cCCCCcEEEEEeCCC
Confidence            4689999999999999876  667899999875432 34688899999999999999999998  55668899999997 


Q ss_pred             CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceecC
Q psy2172         102 HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFN  181 (291)
Q Consensus       102 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~~  181 (291)
                      ++|.+.+.....       ..++...++.++.|++.||++||++|++|+||||+||+++    .++.++|+|||.+....
T Consensus        87 ~~L~~~~~~~~~-------~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~----~~~~~kl~df~~~~~~~  155 (263)
T cd05052          87 GNLLDYLRECNR-------QEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG----ENHLVKVADFGLSRLMT  155 (263)
T ss_pred             CcHHHHHHhCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc----CCCcEEeCCCccccccc
Confidence            478777754321       1278889999999999999999999999999999999998    67889999999987654


Q ss_pred             CCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc----------cCCCCCcHH
Q psy2172         182 NPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI----------KTSNPYHHD  250 (291)
Q Consensus       182 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~----------~~~~~~~~~  250 (291)
                      ....  .......++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||.+...+.          .........
T Consensus       156 ~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (263)
T cd05052         156 GDTY--TAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPP  232 (263)
T ss_pred             ccee--eccCCCCCccccCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCH
Confidence            3211  1111223356799999987644 8899999999999999998 999997644321          111222346


Q ss_pred             HHHHHHHhhCCCCcCChhhhhcC
Q psy2172         251 QLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       251 ~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      .+.+++..+..+.|..||++.++
T Consensus       233 ~~~~li~~cl~~~p~~Rp~~~~l  255 (263)
T cd05052         233 KVYELMRACWQWNPSDRPSFAEI  255 (263)
T ss_pred             HHHHHHHHHccCCcccCCCHHHH
Confidence            78888888888888888887753

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=4.5e-36  Score=249.71  Aligned_cols=246  Identities=24%  Similarity=0.336  Sum_probs=196.1

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC---CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG---LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWL   95 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~i   95 (291)
                      .|++ ++.||.|+||+||+|.+..  ++..+++|.+....   ....+.+|+.+++.++|+|++++++.+  ......++
T Consensus         2 ~y~~-~~~lg~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~i   76 (267)
T cd06610           2 DYEL-IEVIGVGATAVVYAAICLP--NNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF--VVGDELWL   76 (267)
T ss_pred             ccee-eeeecCCCCeEEEEEEEcC--CCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEE--eeCCEEEE
Confidence            4554 7799999999999999876  66789999986433   234688999999999999999999988  45678999


Q ss_pred             EEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          96 LFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        96 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      ++|++.+ +|.+.+......      ..+++..+..++.|++.||++||+.|++|+||+|+||+++    .++.++|+||
T Consensus        77 v~e~~~~~~l~~~~~~~~~~------~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~----~~~~~~l~df  146 (267)
T cd06610          77 VMPYLSGGSLLDIMKSSYPR------GGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLG----EDGSVKIADF  146 (267)
T ss_pred             EEeccCCCcHHHHHHHhccc------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc----CCCCEEEccc
Confidence            9999975 777777643220      1288999999999999999999999999999999999998    6678999999


Q ss_pred             ccceecCCCCCCC-CCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc------------
Q psy2172         175 GFARLFNNPLKPL-ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI------------  241 (291)
Q Consensus       175 g~~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~------------  241 (291)
                      |.+.......... .......|+..|+|||.+.....++.++|+||||+++|+|++|..||.......            
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  226 (267)
T cd06610         147 GVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPS  226 (267)
T ss_pred             chHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCC
Confidence            9987665432221 112334678899999998775458899999999999999999999997654210            


Q ss_pred             -cCCC--CCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         242 -KTSN--PYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       242 -~~~~--~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                       ....  ......+.+++..|....|..||++.++..+|++
T Consensus       227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         227 LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             cCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence             0000  1234667899999999999999999999888874

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3.2e-36  Score=252.46  Aligned_cols=245  Identities=21%  Similarity=0.289  Sum_probs=188.7

Q ss_pred             ccccccceeCcccceEEEEEEEccC---CCCceeEEEEeCCCCCC---hhHHHHHHHHhcCCCCCeeeEEEEEEeCCCce
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDN---SDTRDYALKQIEGTGLS---MSACREIALLRELKHPNVINLISVFLSHNDRK   92 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~---~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (291)
                      .|.+ .+.||+|+||.||+|.+.+.   .....|++|.++.....   +.+.+|+++++.++|+||+++++++  .+...
T Consensus         6 ~~~~-~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~   82 (280)
T cd05049           6 TIVL-KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVC--TEGDP   82 (280)
T ss_pred             HhhH-HhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEE--ecCCC
Confidence            3554 46899999999999987553   34578999998754333   5688999999999999999999999  44578


Q ss_pred             EEEEEecCCC-CHHHHHHHhhhhhh-----CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCC
Q psy2172          93 VWLLFDYAEH-DLWHIIKFHRAAKA-----NKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIER  166 (291)
Q Consensus        93 ~~iv~e~~~~-~l~~~~~~~~~~~~-----~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~  166 (291)
                      .+++|||+.+ +|.+.+........     ......+++..+..++.|++.|+.+||++|++|+||||+||+++    .+
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~----~~  158 (280)
T cd05049          83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVG----YD  158 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEc----CC
Confidence            9999999975 88888765432100     11122378899999999999999999999999999999999998    67


Q ss_pred             CcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc----
Q psy2172         167 GRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI----  241 (291)
Q Consensus       167 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~----  241 (291)
                      +.++|+|||.+......... .......++..|+|||++.+.. ++.++||||||+++|+|++ |..||.+.....    
T Consensus       159 ~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~  236 (280)
T cd05049         159 LVVKIGDFGMSRDVYTTDYY-RVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC  236 (280)
T ss_pred             CeEEECCcccceecccCcce-ecCCCCcccceecChhhhccCC-cchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            89999999998754332111 1112334567899999998754 8999999999999999998 999997644321    


Q ss_pred             ------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         242 ------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       242 ------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                            ..........+.+++..|..+.|..||++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e  273 (280)
T cd05049         237 ITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKD  273 (280)
T ss_pred             HHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHH
Confidence                  1112234567888999998888988888765

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2.9e-36  Score=256.42  Aligned_cols=235  Identities=43%  Similarity=0.765  Sum_probs=187.7

Q ss_pred             ccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCC---
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG----LSMSACREIALLRELKHPNVINLISVFLSHN---   89 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---   89 (291)
                      .+.|.+ .++||+|++|.||+|.++.  +++.+++|.+....    ....+.+|+++++.++||||+++++.+....   
T Consensus         7 ~~~y~~-~~~lg~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (311)
T cd07866           7 LRDYEI-LGKLGEGTFGEVYKARQIK--TGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKS   83 (311)
T ss_pred             cccEEE-EEEeccCCCEEEEEEEECC--CCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence            467775 6699999999999999876  66789999885322    2345788999999999999999999875432   


Q ss_pred             ---CceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCC
Q psy2172          90 ---DRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIER  166 (291)
Q Consensus        90 ---~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~  166 (291)
                         ...++++++|+++++...+....        ..+++..+..++.|+++||.+||++|++|+||+|+||+++    .+
T Consensus        84 ~~~~~~~~lv~~~~~~~l~~~~~~~~--------~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~----~~  151 (311)
T cd07866          84 KRKRGSVYMVTPYMDHDLSGLLENPS--------VKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILID----NQ  151 (311)
T ss_pred             cccCceEEEEEecCCcCHHHHHhccc--------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC----CC
Confidence               34689999999998877665422        1289999999999999999999999999999999999998    67


Q ss_pred             CcEEEeecccceecCCCCCCCC--------CCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCc
Q psy2172         167 GRVKIADMGFARLFNNPLKPLA--------DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  238 (291)
Q Consensus       167 ~~~~l~Dfg~~~~~~~~~~~~~--------~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~  238 (291)
                      +.++|+|||++...........        ......++..|+|||.+.+...++.++|+||||+++|+|++|.+||.+..
T Consensus       152 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~  231 (311)
T cd07866         152 GILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKS  231 (311)
T ss_pred             CCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCC
Confidence            8999999999876543221111        11223567889999998765558899999999999999999999998766


Q ss_pred             ccccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCC
Q psy2172         239 EDIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPE  275 (291)
Q Consensus       239 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  275 (291)
                      .         ......+....+.+.+..||.+..++.
T Consensus       232 ~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (311)
T cd07866         232 D---------IDQLHLIFKLCGTPTEETWPGWRSLPG  259 (311)
T ss_pred             H---------HHHHHHHHHHhCCCChhhchhhhhccc
Confidence            5         366778888888888877777665554

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.4e-36  Score=253.87  Aligned_cols=237  Identities=20%  Similarity=0.294  Sum_probs=182.3

Q ss_pred             ccceeCcccceEEEEEEEc--cCCCCceeEEEEeCCCC---CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEE
Q psy2172          23 EGCKVGRGTYGHVYKARRK--DNSDTRDYALKQIEGTG---LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLF   97 (291)
Q Consensus        23 ~~~~ig~G~~g~Vy~~~~~--~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~   97 (291)
                      ..+.||+|+||.||+|.+.  +..++..|++|.++...   ....+.+|+.++++++|||++++++++...+....+++|
T Consensus         8 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~   87 (284)
T cd05079           8 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIM   87 (284)
T ss_pred             hceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEE
Confidence            4678999999999999853  23367789999987443   234688899999999999999999998655557899999


Q ss_pred             ecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeeccc
Q psy2172          98 DYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGF  176 (291)
Q Consensus        98 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~  176 (291)
                      ||+++ +|.+.+.....        .+++..+..++.|++.||++||++|++|+||||+||+++    .++.++|+|||.
T Consensus        88 e~~~g~~L~~~l~~~~~--------~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~----~~~~~~l~dfg~  155 (284)
T cd05079          88 EFLPSGSLKEYLPRNKN--------KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE----SEHQVKIGDFGL  155 (284)
T ss_pred             EccCCCCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEc----CCCCEEECCCcc
Confidence            99975 77777643221        278899999999999999999999999999999999998    667899999999


Q ss_pred             ceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc----------------
Q psy2172         177 ARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED----------------  240 (291)
Q Consensus       177 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~----------------  240 (291)
                      +.................++..|+|||.+.+.. ++.++|+||||+++|+|+++..|+......                
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd05079         156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK-FYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTR  234 (284)
T ss_pred             ccccccCccceeecCCCCCCccccCHHHhccCC-CCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHH
Confidence            886654322111222345567799999987744 889999999999999999987654321110                


Q ss_pred             ---------ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         241 ---------IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       241 ---------~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                               ...........+.+++..|..+.|.+||++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~  275 (284)
T cd05079         235 LVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQN  275 (284)
T ss_pred             HHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHH
Confidence                     01112233567888899999889988888775

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.7e-36  Score=254.20  Aligned_cols=241  Identities=22%  Similarity=0.382  Sum_probs=194.2

Q ss_pred             ccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC--CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEE
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG--LSMSACREIALLRELKHPNVINLISVFLSHNDRKVW   94 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (291)
                      ..+|++ .+.||.|++|.||+|.+..  +++.|++|.+....  ....+.+|+.+++.++|||++++++++  ......+
T Consensus        18 ~~~y~~-~~~lg~g~~g~vy~~~~~~--~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~~~~~~~   92 (296)
T cd06655          18 KKKYTR-YEKIGQGASGTVFTAIDVA--TGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF--LVGDELF   92 (296)
T ss_pred             cceEEE-EEEEecCCCeEEEEEEEcC--CCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeE--ecCceEE
Confidence            345664 6799999999999999766  67889999886432  234678899999999999999999998  4567899


Q ss_pred             EEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEee
Q psy2172          95 LLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIAD  173 (291)
Q Consensus        95 iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~D  173 (291)
                      +++||+.+ +|...+...          .+++..+..++.|++.|+++||++|++|+||+|+||+++    .++.++|+|
T Consensus        93 lv~e~~~~~~L~~~~~~~----------~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~----~~~~~kl~d  158 (296)
T cd06655          93 VVMEYLAGGSLTDVVTET----------CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLG----MDGSVKLTD  158 (296)
T ss_pred             EEEEecCCCcHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEEcc
Confidence            99999986 666655421          178999999999999999999999999999999999998    677899999


Q ss_pred             cccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc------------
Q psy2172         174 MGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI------------  241 (291)
Q Consensus       174 fg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~------------  241 (291)
                      ||++........   ......++..|+|||.+.+.. ++.++|+|||||++|+|++|..||.+.....            
T Consensus       159 fg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~  234 (296)
T cd06655         159 FGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPE  234 (296)
T ss_pred             Cccchhcccccc---cCCCcCCCccccCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcc
Confidence            998875443211   112345788899999987744 8899999999999999999999998754310            


Q ss_pred             cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchh
Q psy2172         242 KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLL  280 (291)
Q Consensus       242 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  280 (291)
                      ..........+.+++..|....|..||++.++..++|+.
T Consensus       235 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~  273 (296)
T cd06655         235 LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLK  273 (296)
T ss_pred             cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhh
Confidence            011122346688899999999999999999999998875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.2e-36  Score=253.26  Aligned_cols=235  Identities=23%  Similarity=0.346  Sum_probs=188.6

Q ss_pred             eCcccceEEEEEEEccCCCCceeEEEEeCCCC-----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecCC
Q psy2172          27 VGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-----LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAE  101 (291)
Q Consensus        27 ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~~  101 (291)
                      ||+|+||.||+|.++.  +++.|++|.+....     ....+.+|+.++++++||||+++++++  ......|++|||++
T Consensus         1 lg~g~~g~vy~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~lv~e~~~   76 (277)
T cd05577           1 LGKGGFGEVCACQVKA--TGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF--ETKDDLCLVMTLMN   76 (277)
T ss_pred             CCCCCceeEEEEEEcC--CCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE--ecCCeEEEEEecCC
Confidence            6899999999999776  67889999986422     233467899999999999999999998  55678999999998


Q ss_pred             C-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceec
Q psy2172         102 H-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF  180 (291)
Q Consensus       102 ~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~  180 (291)
                      + +|.+.+.....       ..+++..+..++.|++.||.+||++|++|+||+|+||+++    .++.++|+|||.+...
T Consensus        77 ~~~L~~~l~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~----~~~~~~l~dfg~~~~~  145 (277)
T cd05577          77 GGDLKYHIYNVGE-------PGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLD----DHGNVRISDLGLAVEL  145 (277)
T ss_pred             CCcHHHHHHHcCc-------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC----CCCCEEEccCcchhhh
Confidence            5 77777654332       1289999999999999999999999999999999999998    6678999999988754


Q ss_pred             CCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc-------------ccCCCCC
Q psy2172         181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED-------------IKTSNPY  247 (291)
Q Consensus       181 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~-------------~~~~~~~  247 (291)
                      ...    .......++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||......             .......
T Consensus       146 ~~~----~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  220 (277)
T cd05577         146 KGG----KKIKGRAGTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDK  220 (277)
T ss_pred             ccC----CccccccCCCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCcc
Confidence            331    1122345677899999988755 889999999999999999999999765431             1112223


Q ss_pred             cHHHHHHHHHhhCCCCcCChh-----hhhcCCCCcchhh
Q psy2172         248 HHDQLDRIFSVMGFPLEKDWE-----DIRKMPEHPTLLK  281 (291)
Q Consensus       248 ~~~~~~~i~~~~~~~~~~~~~-----~~~~~~~~~~~~~  281 (291)
                      ....+.+++..|....|..||     ++.++..+||+.+
T Consensus       221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~  259 (277)
T cd05577         221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKD  259 (277)
T ss_pred             CCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhc
Confidence            456788999999999999999     6666888888753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=5.6e-36  Score=249.72  Aligned_cols=237  Identities=19%  Similarity=0.257  Sum_probs=176.9

Q ss_pred             ceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC---hhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecCC
Q psy2172          25 CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS---MSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAE  101 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~~  101 (291)
                      +.||+|+||.||+|.+.+..+...+++|.++.....   ..+.+|+.++++++||||+++++++  .+....++||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~~~lv~e~~~   78 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQC--TEVTPYLLVMEFCP   78 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEE--cCCCCcEEEEECCC
Confidence            368999999999998776556678999988754322   3577899999999999999999998  55667899999998


Q ss_pred             -CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceec
Q psy2172         102 -HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF  180 (291)
Q Consensus       102 -~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~  180 (291)
                       ++|.+.+........    ...+...+..++.|++.|++|||++|++|+||||+||+++    ....++|+|||.+...
T Consensus        79 ~g~L~~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~----~~~~~kL~dfg~~~~~  150 (269)
T cd05087          79 LGDLKGYLRSCRKAEL----MTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLT----ADLTVKIGDYGLSHNK  150 (269)
T ss_pred             CCcHHHHHHHhhhccc----ccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEc----CCCcEEECCccccccc
Confidence             588777765432211    1256778889999999999999999999999999999998    6678999999998654


Q ss_pred             CCCCCCCCCCCCceecccccccccccCCc------CCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc-----------c
Q psy2172         181 NNPLKPLADLDPVVVTFWYRAPELLLGAR------HYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI-----------K  242 (291)
Q Consensus       181 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~------~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~-----------~  242 (291)
                      ..... ........++..|+|||++.+..      .++.++|+||||+++|+|++ |..||.......           .
T Consensus       151 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  229 (269)
T cd05087         151 YKEDY-YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLK  229 (269)
T ss_pred             cCcce-eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCC
Confidence            32211 11122345677899999986421      25789999999999999996 999997543221           0


Q ss_pred             ----CCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         243 ----TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       243 ----~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                          .......+.+.++++.+. ..|..||++.++
T Consensus       230 ~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l  263 (269)
T cd05087         230 LPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEV  263 (269)
T ss_pred             CCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHH
Confidence                011122345667777765 457778877754

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG0586|consensus

Probab=100.00  E-value=5.3e-37  Score=264.84  Aligned_cols=247  Identities=24%  Similarity=0.385  Sum_probs=207.4

Q ss_pred             ccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC----hhHHHHHHHHhcCCCCCeeeEEEEEEeCCCce
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIALLRELKHPNVINLISVFLSHNDRK   92 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (291)
                      .+.|.+ ...||+|.|+.|.+|.+..  ++..||||++.+....    +.+.+|+.+|+.++|||||+++.+.  +....
T Consensus        55 vg~y~i-~~tig~g~f~~V~La~~~~--t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~--~t~~~  129 (596)
T KOG0586|consen   55 VGLYVI-IKTIGKGNFAKVKLARHIL--TGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVI--ETEAT  129 (596)
T ss_pred             ccceee-eeeeccceeEEEEeeEecC--CCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeee--eecce
Confidence            356665 4599999999999999877  6778999999865443    3478999999999999999999999  66889


Q ss_pred             EEEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEE
Q psy2172          93 VWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI  171 (291)
Q Consensus        93 ~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l  171 (291)
                      +|+||||+. |.+.+++.....         ..+..+..++.|+++|++|+|+++|||+|||++||+++    .+..++|
T Consensus       130 lylV~eya~~ge~~~yl~~~gr---------~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~----~~mnikI  196 (596)
T KOG0586|consen  130 LYLVMEYASGGELFDYLVKHGR---------MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLD----ENMNIKI  196 (596)
T ss_pred             eEEEEEeccCchhHHHHHhccc---------chhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccc----cccceee
Confidence            999999997 588888887765         55688999999999999999999999999999999998    6677999


Q ss_pred             eecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccC--------
Q psy2172         172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT--------  243 (291)
Q Consensus       172 ~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~--------  243 (291)
                      +|||++..+...    ......+|++.|.|||++.+....++.+|+||+|+++|-|+.|..||.+..-....        
T Consensus       197 aDfgfS~~~~~~----~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~  272 (596)
T KOG0586|consen  197 ADFGFSTFFDYG----LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKY  272 (596)
T ss_pred             eccccceeeccc----ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeee
Confidence            999999887643    34567899999999999999887889999999999999999999999987643211        


Q ss_pred             -CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhhhhh
Q psy2172         244 -SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDFNE  285 (291)
Q Consensus       244 -~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (291)
                       ..-.-...-+++++.+..+.|..+..++.+..++|+-..+.+
T Consensus       273 rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  273 RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             cccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence             111113446788888889999999999999999887665554

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=6.9e-36  Score=261.49  Aligned_cols=246  Identities=20%  Similarity=0.296  Sum_probs=185.0

Q ss_pred             cccccccceeCcccceEEEEEEEccCC---CCceeEEEEeCCCCC---ChhHHHHHHHHhcCC-CCCeeeEEEEEEeCCC
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNS---DTRDYALKQIEGTGL---SMSACREIALLRELK-HPNVINLISVFLSHND   90 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~---~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~   90 (291)
                      +.|++ +++||+|+||.||+|.+....   ....||+|.++....   .+.+.+|+.+++++. ||||+++++++  .+.
T Consensus        37 ~~~~~-~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~--~~~  113 (400)
T cd05105          37 DGLVL-GRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC--TKS  113 (400)
T ss_pred             cceeh-hheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE--ccC
Confidence            44553 789999999999999875422   234699999975332   346889999999996 99999999999  567


Q ss_pred             ceEEEEEecCC-CCHHHHHHHhhhhhh-----------------------------------------------------
Q psy2172          91 RKVWLLFDYAE-HDLWHIIKFHRAAKA-----------------------------------------------------  116 (291)
Q Consensus        91 ~~~~iv~e~~~-~~l~~~~~~~~~~~~-----------------------------------------------------  116 (291)
                      ...|+||||+. |+|.+.+........                                                     
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (400)
T cd05105         114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE  193 (400)
T ss_pred             CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence            78999999997 488877764321100                                                     


Q ss_pred             ----------------------------------CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecC
Q psy2172         117 ----------------------------------NKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGE  162 (291)
Q Consensus       117 ----------------------------------~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~  162 (291)
                                                        ......+++..+..++.|++.||+|||+++++|+||||+||+++  
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~--  271 (400)
T cd05105         194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA--  271 (400)
T ss_pred             hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe--
Confidence                                              00112377888999999999999999999999999999999998  


Q ss_pred             CCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc
Q psy2172         163 GIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI  241 (291)
Q Consensus       163 ~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~  241 (291)
                        .+..++|+|||++......... .......++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.....+.
T Consensus       272 --~~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~  347 (400)
T cd05105         272 --QGKIVKICDFGLARDIMHDSNY-VSKGSTFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS  347 (400)
T ss_pred             --CCCEEEEEeCCcceeccccccc-cccCCcCCCcceEChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence              6678999999998765432111 1122335567899999987744 8899999999999999996 999997643211


Q ss_pred             -----------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         242 -----------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       242 -----------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                                 ..........+.+++..+....|..||++.+
T Consensus       348 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~  389 (400)
T cd05105         348 TFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLH  389 (400)
T ss_pred             HHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHH
Confidence                       1111223456788888888888888887664

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.5e-36  Score=255.41  Aligned_cols=243  Identities=21%  Similarity=0.342  Sum_probs=191.9

Q ss_pred             cccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEE
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLL   96 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv   96 (291)
                      |.+ .+.||+|+||.||+|.+..  ++..+|+|.++....   ...+.+|+.++++++||||+++++.+  ......+++
T Consensus         3 ~~~-~~~ig~g~~g~v~~~~~~~--~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~--~~~~~~~lv   77 (286)
T cd06622           3 IEV-LDELGKGNYGSVYKVLHRP--TGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF--FIEGAVYMC   77 (286)
T ss_pred             hhh-hhhhcccCCeEEEEEEEcC--CCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhe--ecCCeEEEE
Confidence            443 5699999999999999876  678899998864322   24678899999999999999999998  456789999


Q ss_pred             EecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          97 FDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHS-NWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        97 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~-~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      |||+++ +|..++.....      ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++    .++.++|+||
T Consensus        78 ~e~~~~~~l~~~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~----~~~~~~l~df  147 (286)
T cd06622          78 MEYMDAGSLDKLYAGGVA------TEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVN----GNGQVKLCDF  147 (286)
T ss_pred             EeecCCCCHHHHHHhccc------cCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEEC----CCCCEEEeec
Confidence            999986 66666553211      1128999999999999999999997 5999999999999998    6678999999


Q ss_pred             ccceecCCCCCCCCCCCCceecccccccccccCCc-----CCCCchhHHHHHHHHHHHHcCCCCCCCCccc---------
Q psy2172         175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGAR-----HYTKAIDIWAIGCIFAELLTSEPIFHCRQED---------  240 (291)
Q Consensus       175 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-----~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~---------  240 (291)
                      |.+......     ......++..|+|||.+.+..     .++.++|+|||||++|+|++|..||......         
T Consensus       148 g~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~  222 (286)
T cd06622         148 GVSGNLVAS-----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAI  222 (286)
T ss_pred             CCcccccCC-----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHH
Confidence            998755332     112345677899999985432     2578999999999999999999999653321         


Q ss_pred             ----ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhh
Q psy2172         241 ----IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKD  282 (291)
Q Consensus       241 ----~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (291)
                          .....+.....+.+++..|....|..+|++.++..++|+.+.
T Consensus       223 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~  268 (286)
T cd06622         223 VDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY  268 (286)
T ss_pred             hhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence                111222345678889999999999999999999999887543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=4.5e-36  Score=252.13  Aligned_cols=244  Identities=20%  Similarity=0.343  Sum_probs=184.9

Q ss_pred             cccccceeCcccceEEEEEEEcc--CCCCceeEEEEeCCCCCC---hhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEE
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKD--NSDTRDYALKQIEGTGLS---MSACREIALLRELKHPNVINLISVFLSHNDRKVW   94 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~--~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (291)
                      |++ .+.||+|+||.||+|.+..  ...+..+++|.+......   ..+.+|+.+++.++||||+++++++  ......|
T Consensus         7 ~~~-~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~--~~~~~~~   83 (283)
T cd05090           7 VRF-MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVV--TQEQPVC   83 (283)
T ss_pred             cee-eeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEE--ecCCceE
Confidence            443 4699999999999998642  235578999998754332   3578899999999999999999998  5566899


Q ss_pred             EEEecCCC-CHHHHHHHhhhhh--------hCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCC
Q psy2172          95 LLFDYAEH-DLWHIIKFHRAAK--------ANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIE  165 (291)
Q Consensus        95 iv~e~~~~-~l~~~~~~~~~~~--------~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~  165 (291)
                      ++|||+++ +|.+.+.......        .......+++..+..++.|++.||+|||++|++|+||||+||+++    .
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~----~  159 (283)
T cd05090          84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG----E  159 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEc----C
Confidence            99999985 8877775332100        001122378889999999999999999999999999999999998    6


Q ss_pred             CCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc----
Q psy2172         166 RGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED----  240 (291)
Q Consensus       166 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~----  240 (291)
                      +..++|+|||++......... .......++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||.+....    
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~  237 (283)
T cd05090         160 QLHVKISDLGLSREIYSADYY-RVQPKSLLPIRWMPPEAIMYGK-FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE  237 (283)
T ss_pred             CCcEEeccccccccccCCcce-ecccCCCccceecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            678999999999765432211 1112234466799999997644 8999999999999999998 99999764421    


Q ss_pred             ------ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         241 ------IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       241 ------~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                            ...........+.+++..|..+.|..||++.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~  275 (283)
T cd05090         238 MVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKD  275 (283)
T ss_pred             HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHH
Confidence                  11122233567888888999999989888775

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=7.1e-36  Score=251.90  Aligned_cols=254  Identities=24%  Similarity=0.396  Sum_probs=197.8

Q ss_pred             ccccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-CChhHHHHHHHHhcC-CCCCeeeEEEEEEeC
Q psy2172          11 NERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-LSMSACREIALLREL-KHPNVINLISVFLSH   88 (291)
Q Consensus        11 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~   88 (291)
                      .......+.|.+ .+.||+|+||.||+|.+..  +++.+++|.+.... ....+.+|+.+++++ +|||++++++++...
T Consensus        15 ~~~~~~~~~y~~-~~~l~~g~~~~vy~~~~~~--~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   91 (291)
T cd06639          15 ESLGDPTDTWEI-IETIGKGTYGKVYKVTNKK--DGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA   91 (291)
T ss_pred             ccCCCCCCCeEE-EEEeecCCCeEEEEEEECC--CCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence            344456778886 5699999999999999876  67889999987543 335677899999999 799999999998643


Q ss_pred             C---CceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCC
Q psy2172          89 N---DRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGI  164 (291)
Q Consensus        89 ~---~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~  164 (291)
                      +   ....++|+||+++ +|.+++.......     ..+++..++.++.|++.||++||++|++|+||+|+||+++    
T Consensus        92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~----  162 (291)
T cd06639          92 DKLVGGQLWLVLELCNGGSVTELVKGLLICG-----QRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLT----  162 (291)
T ss_pred             cccCCCeeEEEEEECCCCcHHHHHHHhhhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEc----
Confidence            3   2478999999975 7777765432211     1288999999999999999999999999999999999998    


Q ss_pred             CCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCc----CCCCchhHHHHHHHHHHHHcCCCCCCCCccc
Q psy2172         165 ERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGAR----HYTKAIDIWAIGCIFAELLTSEPIFHCRQED  240 (291)
Q Consensus       165 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~  240 (291)
                      .++.++|+|||.+........   ......++..|+|||.+....    .++.++|+|||||++|+|++|+.||......
T Consensus       163 ~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~  239 (291)
T cd06639         163 TEGGVKLVDFGVSAQLTSTRL---RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV  239 (291)
T ss_pred             CCCCEEEeecccchhcccccc---cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH
Confidence            667899999999876543211   112345688899999976432    2678999999999999999999999765421


Q ss_pred             c----------c--CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         241 I----------K--TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       241 ~----------~--~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                      .          .  .........+.+++..|....|..+|++.++..+|++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  290 (291)
T cd06639         240 KTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFI  290 (291)
T ss_pred             HHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCccc
Confidence            0          0  0111223567889999999999999999999999886

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-36  Score=251.60  Aligned_cols=241  Identities=26%  Similarity=0.426  Sum_probs=195.8

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHNDRKVWL   95 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~i   95 (291)
                      +|.+ .+.||.|++|.||+|.+..  ++..+++|.+.....   ...+.+|+.+++.++|+|++++++++.  +....|+
T Consensus         2 ~y~~-~~~lg~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~   76 (274)
T cd06609           2 LFTL-LECIGKGSFGEVYKAIDKR--TNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFL--KGSKLWI   76 (274)
T ss_pred             hhhh-hhhhcCCCCeEEEEEEECC--CCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEE--ECCeEEE
Confidence            4554 5689999999999999876  678899999865432   245788999999999999999999984  4578999


Q ss_pred             EEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          96 LFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        96 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      ++||+++ +|.+.+...          ++++..++.++.|++.|+.+||+.+++|+||+|+||+++    .++.++|+||
T Consensus        77 v~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~----~~~~~~l~d~  142 (274)
T cd06609          77 IMEYCGGGSCLDLLKPG----------KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLS----EEGDVKLADF  142 (274)
T ss_pred             EEEeeCCCcHHHHHhhc----------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC----CCCCEEEccc
Confidence            9999986 777776543          289999999999999999999999999999999999998    6778999999


Q ss_pred             ccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc----------cCC
Q psy2172         175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI----------KTS  244 (291)
Q Consensus       175 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~----------~~~  244 (291)
                      |.+.......   .......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||.......          ...
T Consensus       143 g~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~  218 (274)
T cd06609         143 GVSGQLTSTM---SKRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSL  218 (274)
T ss_pred             ccceeecccc---cccccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCC
Confidence            9998765432   1223345678899999998755 8999999999999999999999997643211          011


Q ss_pred             CCC-cHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhh
Q psy2172         245 NPY-HHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKD  282 (291)
Q Consensus       245 ~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (291)
                      ... ....+.+++..+..+.|..||+++++..++++.+.
T Consensus       219 ~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~  257 (274)
T cd06609         219 EGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA  257 (274)
T ss_pred             cccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence            111 34568889999999999999999999999887653

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG0596|consensus

Probab=100.00  E-value=3.5e-37  Score=262.57  Aligned_cols=248  Identities=26%  Similarity=0.362  Sum_probs=194.6

Q ss_pred             ccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCC----CCCChhHHHHHHHHhcCC-CCCeeeEEEEEEe
Q psy2172          13 RTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEG----TGLSMSACREIALLRELK-HPNVINLISVFLS   87 (291)
Q Consensus        13 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~   87 (291)
                      ..++.++-+-..++||+||.+.||++..-+   ...||+|.+.-    ......+.+|+..|.+|+ |.+|++++++-+ 
T Consensus       355 ~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~---~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv-  430 (677)
T KOG0596|consen  355 IIKVKGREYEILKQIGSGGSSKVFKVLNSD---KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEV-  430 (677)
T ss_pred             eEEECcchhhHHHhhcCCCcceeeeeecCC---CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeec-
Confidence            344555544346799999999999998543   34566665542    223345889999999995 899999999985 


Q ss_pred             CCCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCC
Q psy2172          88 HNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERG  167 (291)
Q Consensus        88 ~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~  167 (291)
                       .+.++|+||||-+.+|...+......        .+...++.+..||+.|++++|+.||||.||||.|+++.     ++
T Consensus       431 -~d~~lYmvmE~Gd~DL~kiL~k~~~~--------~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-----kG  496 (677)
T KOG0596|consen  431 -TDGYLYMVMECGDIDLNKILKKKKSI--------DPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-----KG  496 (677)
T ss_pred             -cCceEEEEeecccccHHHHHHhccCC--------CchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-----ee
Confidence             46799999999999999888765543        44458899999999999999999999999999999995     57


Q ss_pred             cEEEeecccceecCCCCCCCCCCCCceecccccccccccCCc----------CCCCchhHHHHHHHHHHHHcCCCCCCCC
Q psy2172         168 RVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGAR----------HYTKAIDIWAIGCIFAELLTSEPIFHCR  237 (291)
Q Consensus       168 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----------~~~~~~Dv~slG~~l~~l~~g~~pf~~~  237 (291)
                      .+||+|||+|..+... ..........||..|||||++....          ..+.++|||||||+||+|+.|++||...
T Consensus       497 ~LKLIDFGIA~aI~~D-TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~  575 (677)
T KOG0596|consen  497 RLKLIDFGIANAIQPD-TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI  575 (677)
T ss_pred             eEEeeeechhcccCcc-ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH
Confidence            9999999999987653 3334456789999999999984211          2678899999999999999999999764


Q ss_pred             cc---------------cccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         238 QE---------------DIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       238 ~~---------------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                      ..               +++.....  ..+.++++.|..-.|+.|++++++..||.+..
T Consensus       576 ~n~~aKl~aI~~P~~~Iefp~~~~~--~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  576 INQIAKLHAITDPNHEIEFPDIPEN--DELIDVMKCCLARDPKKRWSIPELLQHPFLQI  632 (677)
T ss_pred             HHHHHHHHhhcCCCccccccCCCCc--hHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence            42               11222222  23788889999999999999999999987654

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=7.9e-36  Score=247.01  Aligned_cols=233  Identities=19%  Similarity=0.345  Sum_probs=181.6

Q ss_pred             cccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC-ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEe
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFD   98 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e   98 (291)
                      |++ .+.||+|+||.||++.++.   ...+++|.+..... ...+.+|+.++++++||||+++++++  .+....+++||
T Consensus         6 ~~~-~~~lg~G~~~~vy~~~~~~---~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~iv~e   79 (256)
T cd05114           6 LTF-MKELGSGQFGVVHLGKWRA---QIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC--TQQKPLYIVTE   79 (256)
T ss_pred             cEE-eeEecCCcCceEEEEEecc---CceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEE--ccCCCEEEEEE
Confidence            554 5689999999999998753   35699998875433 45788999999999999999999998  55678999999


Q ss_pred             cCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccc
Q psy2172          99 YAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA  177 (291)
Q Consensus        99 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~  177 (291)
                      |++ ++|.+.+.....        .+++..+..++.|++.||++||++|++|+||+|+||+++    .++.++++|||.+
T Consensus        80 ~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~----~~~~~kl~d~g~~  147 (256)
T cd05114          80 FMENGCLLNYLRQRQG--------KLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVS----STGVVKVSDFGMT  147 (256)
T ss_pred             cCCCCcHHHHHHhCcc--------CCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEc----CCCeEEECCCCCc
Confidence            997 477776653221        278899999999999999999999999999999999998    6678999999988


Q ss_pred             eecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc----------cCCCC
Q psy2172         178 RLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI----------KTSNP  246 (291)
Q Consensus       178 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~----------~~~~~  246 (291)
                      ........  .......++..|+|||.+.+.. ++.++|+||||+++|+|++ |+.||.......          .....
T Consensus       148 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~  224 (256)
T cd05114         148 RYVLDDEY--TSSSGAKFPVKWSPPEVFNFSK-YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPK  224 (256)
T ss_pred             cccCCCce--eccCCCCCchhhCChhhcccCc-cchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCC
Confidence            75432211  1111223456799999987644 8899999999999999999 899997654321          11122


Q ss_pred             CcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         247 YHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       247 ~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      .....+.+++..+..+.|..||++.++
T Consensus       225 ~~~~~~~~li~~c~~~~p~~Rps~~~l  251 (256)
T cd05114         225 LASMTVYEVMYSCWHEKPEGRPTFAEL  251 (256)
T ss_pred             CCCHHHHHHHHHHccCCcccCcCHHHH
Confidence            234567788888888888888887753

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=8e-36  Score=248.61  Aligned_cols=239  Identities=26%  Similarity=0.365  Sum_probs=188.8

Q ss_pred             ceeCcccceEEEEEEEccCCCCceeEEEEeCCCC--CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecCCC
Q psy2172          25 CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG--LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH  102 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~~~  102 (291)
                      ..||+|+||.||+|.+..  ++..|++|.+....  ..+.+.+|+.+++.++|+||+++++++  ......++++||+.+
T Consensus        14 ~~lg~g~~g~v~~~~~~~--~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~~~~~~~lv~e~~~~   89 (268)
T cd06624          14 VVLGKGTYGIVYAARDLS--TQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD--SENGFFKIFMEQVPG   89 (268)
T ss_pred             EEEecCCceEEEEeEecC--CCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeee--ccCCEEEEEEecCCC
Confidence            489999999999999876  66789999886543  234688999999999999999999998  556789999999975


Q ss_pred             -CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceecC
Q psy2172         103 -DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFN  181 (291)
Q Consensus       103 -~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~~  181 (291)
                       +|.+.+......      ...+...+..++.|++.|+++||++|++|+||+|+||+++.   ..+.++|+|||.+....
T Consensus        90 ~~L~~~l~~~~~~------~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~---~~~~~~l~dfg~~~~~~  160 (268)
T cd06624          90 GSLSALLRSKWGP------LKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNT---YSGVVKISDFGTSKRLA  160 (268)
T ss_pred             CCHHHHHHHhccc------CCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC---CCCeEEEecchhheecc
Confidence             787777643211      00277888999999999999999999999999999999973   24689999999987654


Q ss_pred             CCCCCCCCCCCceecccccccccccCC-cCCCCchhHHHHHHHHHHHHcCCCCCCCCccc------------ccCCCCCc
Q psy2172         182 NPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQED------------IKTSNPYH  248 (291)
Q Consensus       182 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~------------~~~~~~~~  248 (291)
                      ....   ......++..|+|||.+.+. ..++.++|+||+|+++|+|++|..||......            .+......
T Consensus       161 ~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (268)
T cd06624         161 GINP---CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESL  237 (268)
T ss_pred             cCCC---ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCccc
Confidence            3211   12234568889999998653 24788999999999999999999999754321            11122234


Q ss_pred             HHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         249 HDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       249 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                      .+.+.+++..+..+.|..||++.++..+||+
T Consensus       238 ~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         238 SAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             CHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence            5678889999999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.2e-36  Score=250.17  Aligned_cols=234  Identities=27%  Similarity=0.474  Sum_probs=186.4

Q ss_pred             cccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC---CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEE
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT---GLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLL   96 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv   96 (291)
                      |.+ .++||+|+||.||++.+..  +++.+++|.++..   ...+.+.+|+.+++.++|+||+++++.+  .+....|++
T Consensus         2 y~~-~~~lg~g~~g~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~lv   76 (255)
T cd08219           2 YNV-LRVVGEGSFGRALLVQHVN--SDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF--EADGHLYIV   76 (255)
T ss_pred             ceE-EEEeeccCCeEEEEEEEcC--CCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEE--EECCEEEEE
Confidence            443 5799999999999999876  6788999988533   2335678899999999999999999999  556799999


Q ss_pred             EecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecc
Q psy2172          97 FDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMG  175 (291)
Q Consensus        97 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg  175 (291)
                      |||+++ ++.+.+.....       ..+++..++.++.|++.||.+||++|++|+||+|+||+++    .++.++++|||
T Consensus        77 ~e~~~~~~l~~~~~~~~~-------~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~----~~~~~~l~dfg  145 (255)
T cd08219          77 MEYCDGGDLMQKIKLQRG-------KLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLT----QNGKVKLGDFG  145 (255)
T ss_pred             EeeCCCCcHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEC----CCCcEEEcccC
Confidence            999975 77776654221       1278999999999999999999999999999999999998    67789999999


Q ss_pred             cceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc----------ccCCC
Q psy2172         176 FARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED----------IKTSN  245 (291)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~----------~~~~~  245 (291)
                      .+........   ......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||......          .....
T Consensus       146 ~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  221 (255)
T cd08219         146 SARLLTSPGA---YACTYVGTPYYVPPEIWENMP-YNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLP  221 (255)
T ss_pred             cceeeccccc---ccccccCCccccCHHHHccCC-cCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCC
Confidence            9876543211   112345788899999997754 889999999999999999999999865421          11122


Q ss_pred             CCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         246 PYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       246 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      ......+.+++..|....|..||++.++
T Consensus       222 ~~~~~~~~~li~~~l~~~P~~Rp~~~~i  249 (255)
T cd08219         222 SHYSYELRSLIKQMFKRNPRSRPSATTI  249 (255)
T ss_pred             cccCHHHHHHHHHHHhCCcccCCCHHHH
Confidence            2334567888888888899999887764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=8.6e-36  Score=247.53  Aligned_cols=241  Identities=27%  Similarity=0.471  Sum_probs=195.5

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC----ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEec
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL----SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDY   99 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~   99 (291)
                      .+.||.|+||.||+|.+..  ++..+++|.+.....    ...+.+|+.+++.++||||+++++.+........+++|||
T Consensus         5 ~~~lg~g~~~~v~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~   82 (265)
T cd08217           5 LETIGKGSFGTVRKVRRKS--DGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEY   82 (265)
T ss_pred             eeeeccCCCeEEEEeeecC--CCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehh
Confidence            4589999999999999876  667899999864332    2357789999999999999999998876667789999999


Q ss_pred             CCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHh-----hCCeeeeccCCCcEEeecCCCCCCcEEEee
Q psy2172         100 AEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLH-----SNWVLHRDLKPANILVMGEGIERGRVKIAD  173 (291)
Q Consensus       100 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH-----~~~ivH~dik~~Nil~~~~~~~~~~~~l~D  173 (291)
                      +++ +|.+.+......     ...+++..++.++.|++.||.+||     +.+++|+||+|+||+++    ..+.++|+|
T Consensus        83 ~~~~~L~~~l~~~~~~-----~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~----~~~~~kl~d  153 (265)
T cd08217          83 CEGGDLAQLIQKCKKE-----RKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLD----ANNNVKLGD  153 (265)
T ss_pred             ccCCCHHHHHHHHhhc-----ccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEe----cCCCEEEec
Confidence            975 888887654322     123889999999999999999999     89999999999999998    678999999


Q ss_pred             cccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc----------ccC
Q psy2172         174 MGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED----------IKT  243 (291)
Q Consensus       174 fg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~----------~~~  243 (291)
                      ||.+........   ......++..|+|||.+.+.. ++.++|+||||+++++|++|..||......          ...
T Consensus       154 ~g~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  229 (265)
T cd08217         154 FGLAKILGHDSS---FAKTYVGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRR  229 (265)
T ss_pred             ccccccccCCcc---cccccccCCCccChhhhcCCC-CCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCC
Confidence            999887654321   122346788899999998754 889999999999999999999999876321          112


Q ss_pred             CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         244 SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       244 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                      ........+.+++..|....|..||++.++.++|++
T Consensus       230 ~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         230 IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             CccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            223345678899999999999999999998888764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3.9e-36  Score=252.32  Aligned_cols=247  Identities=22%  Similarity=0.387  Sum_probs=195.2

Q ss_pred             cccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-CChhHHHHHHHHhcC-CCCCeeeEEEEEEeC----C
Q psy2172          16 VEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-LSMSACREIALLREL-KHPNVINLISVFLSH----N   89 (291)
Q Consensus        16 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~----~   89 (291)
                      -.+.|++ .+.||+|+||.||+|.+..  +++.+++|+..... ...++..|+.+++++ +|+||+++++++...    .
T Consensus        14 ~~~~~~~-~~~lg~g~~~~v~~~~~~~--~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   90 (282)
T cd06636          14 PAGIFEL-VEVVGNGTYGQVYKGRHVK--TGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH   90 (282)
T ss_pred             hhhhhhh-heeeccCCCeEEEEEEEcC--CCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence            3467776 5699999999999999876  66889999986542 334678899999998 699999999998532    3


Q ss_pred             CceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCc
Q psy2172          90 DRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGR  168 (291)
Q Consensus        90 ~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~  168 (291)
                      ....|++|||+++ +|.+++......       .+++..++.++.|++.|+.|||++|++|+||+|+||+++    .++.
T Consensus        91 ~~~~~iv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~----~~~~  159 (282)
T cd06636          91 DDQLWLVMEFCGAGSVTDLVKNTKGN-------ALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLT----ENAE  159 (282)
T ss_pred             CCEEEEEEEeCCCCcHHHHHHHccCC-------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCC
Confidence            5689999999986 777777643321       278888999999999999999999999999999999998    6678


Q ss_pred             EEEeecccceecCCCCCCCCCCCCceecccccccccccC----CcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc----
Q psy2172         169 VKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLG----ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED----  240 (291)
Q Consensus       169 ~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~----  240 (291)
                      ++|+|||.+.......   .......|+..|+|||.+..    ...++.++|+|||||++|+|++|..||......    
T Consensus       160 ~~l~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~  236 (282)
T cd06636         160 VKLVDFGVSAQLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF  236 (282)
T ss_pred             EEEeeCcchhhhhccc---cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh
Confidence            9999999987543221   12233567888999998753    234788999999999999999999999654321    


Q ss_pred             -------ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         241 -------IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       241 -------~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                             ...........+.+++..|..+.|..||++.++..+||+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         237 LIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             hHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence                   011112345678899999999999999999999998875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=6.1e-36  Score=253.54  Aligned_cols=235  Identities=41%  Similarity=0.755  Sum_probs=188.1

Q ss_pred             ccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCC-
Q psy2172          15 KVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT----GLSMSACREIALLRELKHPNVINLISVFLSHN-   89 (291)
Q Consensus        15 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-   89 (291)
                      ...+.|++ .+.||+|+||.||+|.++.  +++.|++|.++..    .....+.+|++++++++|||++++++++...+ 
T Consensus         4 ~~~~~~~~-~~~lg~g~~g~v~~~~~~~--~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~   80 (302)
T cd07864           4 RCVDKFDI-IGQIGEGTYGQVYKARDKD--TGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQD   80 (302)
T ss_pred             hhhhhhhe-eeeecccCCEEEEEEEECC--CCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcch
Confidence            34566775 5699999999999999876  5678999998643    22345778999999999999999999884432 


Q ss_pred             -------CceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecC
Q psy2172          90 -------DRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGE  162 (291)
Q Consensus        90 -------~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~  162 (291)
                             ....++++||+++++...+....        ..+++..++.++.|++.||++||+.|++|+||+|+||+++  
T Consensus        81 ~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~--  150 (302)
T cd07864          81 ALDFKKDKGAFYLVFEYMDHDLMGLLESGL--------VHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLN--  150 (302)
T ss_pred             hhhccccCCcEEEEEcccCccHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC--
Confidence                   23799999999998877665421        1289999999999999999999999999999999999998  


Q ss_pred             CCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc
Q psy2172         163 GIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK  242 (291)
Q Consensus       163 ~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~  242 (291)
                        ..+.++|+|||.+........  .......++..|+|||.+.+...++.++|+|||||++++|++|++||.....   
T Consensus       151 --~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~---  223 (302)
T cd07864         151 --NKGQIKLADFGLARLYNSEES--RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE---  223 (302)
T ss_pred             --CCCcEEeCcccccccccCCcc--cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---
Confidence              678999999999876544321  1112234567899999887655578899999999999999999999986554   


Q ss_pred             CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCC
Q psy2172         243 TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPE  275 (291)
Q Consensus       243 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  275 (291)
                            .+.+..+.+.++.+.+..||.+.+.+.
T Consensus       224 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (302)
T cd07864         224 ------LAQLELISRLCGSPCPAVWPDVIKLPY  250 (302)
T ss_pred             ------HHHHHHHHHHhCCCChhhccccccccc
Confidence                  367788888888888888887766543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=8.1e-36  Score=250.85  Aligned_cols=250  Identities=21%  Similarity=0.366  Sum_probs=194.2

Q ss_pred             ccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-CChhHHHHHHHHhcC-CCCCeeeEEEEEEe---CC
Q psy2172          15 KVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-LSMSACREIALLREL-KHPNVINLISVFLS---HN   89 (291)
Q Consensus        15 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~---~~   89 (291)
                      ...+.|++ .+.||+|+||.||+|.+..  +++.+++|.+.... ....+.+|+.+++.+ +||||+++++++..   .+
T Consensus        15 ~~~~~~~~-~~~lg~g~~~~vy~~~~~~--~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   91 (286)
T cd06638          15 DPSDTWEI-IETIGKGTYGKVFKVLNKK--NGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN   91 (286)
T ss_pred             Ccccceee-eeeeccCCCcEEEEEEECC--CCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence            45667775 5699999999999999876  66789999886533 235678899999999 69999999998753   24


Q ss_pred             CceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCc
Q psy2172          90 DRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGR  168 (291)
Q Consensus        90 ~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~  168 (291)
                      +...+++|||+++ +|.+.+......     ...+++..++.++.|++.||.+||+.+++|+||+|+||+++    .++.
T Consensus        92 ~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~----~~~~  162 (286)
T cd06638          92 GDQLWLVLELCNGGSVTDLVKGFLKR-----GERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLT----TEGG  162 (286)
T ss_pred             CCeEEEEEeecCCCCHHHHHHHhhcc-----CccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEEC----CCCC
Confidence            5679999999975 777766532211     11278899999999999999999999999999999999998    6678


Q ss_pred             EEEeecccceecCCCCCCCCCCCCceecccccccccccCC----cCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc--
Q psy2172         169 VKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGA----RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK--  242 (291)
Q Consensus       169 ~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~--  242 (291)
                      ++|+|||.+.......   .......|+..|+|||++.+.    ..++.++|+||+||++|+|++|..||........  
T Consensus       163 ~kl~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~  239 (286)
T cd06638         163 VKLVDFGVSAQLTSTR---LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF  239 (286)
T ss_pred             EEEccCCceeecccCC---CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh
Confidence            9999999987654321   112334678899999997532    3378899999999999999999999976542110  


Q ss_pred             ---------C-CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         243 ---------T-SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       243 ---------~-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                               . ........+.+++..|....|..||++.++.+++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         240 KIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             hccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence                     0 111224568889999999999999999998887764

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=8e-36  Score=249.83  Aligned_cols=248  Identities=20%  Similarity=0.285  Sum_probs=186.5

Q ss_pred             cccccccccceeCcccceEEEEEEEccC---CCCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCC
Q psy2172          16 VEDLFDYEGCKVGRGTYGHVYKARRKDN---SDTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHN   89 (291)
Q Consensus        16 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~---~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   89 (291)
                      .+++|++ .+.||+|+||.||+|.+++.   ..+..||+|.+.....   ..++.+|+.+++.++||||+++++++  ..
T Consensus         4 ~~~~~~~-~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~--~~   80 (277)
T cd05062           4 AREKITM-SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV--SQ   80 (277)
T ss_pred             cHHHcee-eeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE--cC
Confidence            4566776 56999999999999987532   2456799998864322   23578899999999999999999998  56


Q ss_pred             CceEEEEEecCCC-CHHHHHHHhhhhhh-CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCC
Q psy2172          90 DRKVWLLFDYAEH-DLWHIIKFHRAAKA-NKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERG  167 (291)
Q Consensus        90 ~~~~~iv~e~~~~-~l~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~  167 (291)
                      ....+++|||+++ +|.+++........ ......++...+..++.|++.||.+||++|++|+||||+||+++    .++
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~----~~~  156 (277)
T cd05062          81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA----EDF  156 (277)
T ss_pred             CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEc----CCC
Confidence            6789999999985 88877765332111 11122367788999999999999999999999999999999998    667


Q ss_pred             cEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc-----
Q psy2172         168 RVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI-----  241 (291)
Q Consensus       168 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~-----  241 (291)
                      .++|+|||++......... .......++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||.+.....     
T Consensus       157 ~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~  234 (277)
T cd05062         157 TVKIGDFGMTRDIYETDYY-RKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV  234 (277)
T ss_pred             CEEECCCCCccccCCccee-ecCCCCccCHhhcChhHhhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            8999999998755432111 1112234467899999997744 8999999999999999998 789997654321     


Q ss_pred             -----cCCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         242 -----KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       242 -----~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                           ..........+.+++..|....|.+||++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e  270 (277)
T cd05062         235 MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLE  270 (277)
T ss_pred             HcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence                 1122233456788888888888888887665

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=8e-36  Score=247.79  Aligned_cols=239  Identities=28%  Similarity=0.458  Sum_probs=198.2

Q ss_pred             cccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEE
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLL   96 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv   96 (291)
                      |.+ .+.||+|++|.||+|.+..  +++.+++|.+.....   ...+.+|+..+..++|+|++++++.+  ......+++
T Consensus         3 ~~~-~~~i~~g~~~~v~~~~~~~--~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~lv   77 (264)
T cd06623           3 LER-VKVLGQGSSGVVYKVRHKP--TGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF--YKEGEISIV   77 (264)
T ss_pred             cee-eeeeeecCCeEEEEEEEcC--CCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEE--ccCCeEEEE
Confidence            443 5799999999999999876  678899999876543   45788999999999999999999999  456789999


Q ss_pred             EecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          97 FDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHS-NWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        97 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~-~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      +||++ ++|.+.+....         .+++..++.++.|++.|+.+||+ .|++|+||+|+||+++    .++.++|+||
T Consensus        78 ~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~----~~~~~~l~df  144 (264)
T cd06623          78 LEYMDGGSLADLLKKVG---------KIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLIN----SKGEVKIADF  144 (264)
T ss_pred             EEecCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEEC----CCCCEEEccC
Confidence            99999 58887776541         28999999999999999999999 9999999999999998    6789999999


Q ss_pred             ccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcc-------------cc
Q psy2172         175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE-------------DI  241 (291)
Q Consensus       175 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~-------------~~  241 (291)
                      |.+.........   .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||.....             ..
T Consensus       145 ~~~~~~~~~~~~---~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~  220 (264)
T cd06623         145 GISKVLENTLDQ---CNTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP  220 (264)
T ss_pred             ccceecccCCCc---ccceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCC
Confidence            998866443221   1234678889999998775 488999999999999999999999987741             11


Q ss_pred             cCCCCC-cHHHHHHHHHhhCCCCcCChhhhhcCCCCcchh
Q psy2172         242 KTSNPY-HHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLL  280 (291)
Q Consensus       242 ~~~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  280 (291)
                      ...... ....+.+++..|..+.|..||++.++.++|++.
T Consensus       221 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~  260 (264)
T cd06623         221 PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIK  260 (264)
T ss_pred             CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHH
Confidence            112222 456799999999999999999999999998874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-36  Score=250.55  Aligned_cols=249  Identities=25%  Similarity=0.426  Sum_probs=196.2

Q ss_pred             cccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC-ChhHHHHHHHHhcC-CCCCeeeEEEEEEeCC----
Q psy2172          16 VEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-SMSACREIALLREL-KHPNVINLISVFLSHN----   89 (291)
Q Consensus        16 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~----   89 (291)
                      -.++|.+ .+.||+|++|.||+|.++.  +++.+++|.+..... ...+.+|+.+++++ +|+||+++++++....    
T Consensus         4 ~~~~y~~-~~~l~~g~~~~v~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (275)
T cd06608           4 PTGIFEL-VEVIGEGTYGKVYKARHKK--TGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN   80 (275)
T ss_pred             chhheeh-eeeecCCCCeEEEEEEECC--CCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence            3577886 5799999999999999876  567899999875433 35688999999999 6999999999986533    


Q ss_pred             CceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCc
Q psy2172          90 DRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGR  168 (291)
Q Consensus        90 ~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~  168 (291)
                      ....+++|||+++ +|.+.+.......     ..+++..++.++.|++.||.+||++|++|+||+|+||+++    .++.
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~-----~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~----~~~~  151 (275)
T cd06608          81 DDQLWLVMELCGGGSVTDLVKGLRKKG-----KRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLT----KNAE  151 (275)
T ss_pred             ceEEEEEEEcCCCCcHHHHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEc----cCCe
Confidence            4578999999986 7777765433111     1288999999999999999999999999999999999998    6678


Q ss_pred             EEEeecccceecCCCCCCCCCCCCceecccccccccccCC----cCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---
Q psy2172         169 VKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGA----RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---  241 (291)
Q Consensus       169 ~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---  241 (291)
                      ++|+|||.+.......   .......++..|+|||.+...    ..++.++|+||||+++|+|++|..||.......   
T Consensus       152 ~~l~d~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~  228 (275)
T cd06608         152 VKLVDFGVSAQLDSTL---GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF  228 (275)
T ss_pred             EEECCCccceecccch---hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHH
Confidence            9999999987654321   112334578889999987532    346788999999999999999999997543210   


Q ss_pred             ------c---CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         242 ------K---TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       242 ------~---~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                            .   .........+.+++..|..+.|..||++.++..+||+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         229 KIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             HhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence                  0   0111134568899999999999999999999988875

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=6.1e-36  Score=248.56  Aligned_cols=234  Identities=21%  Similarity=0.350  Sum_probs=183.4

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC-ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLL   96 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv   96 (291)
                      ++|++ .++||+|+||.||+|.+.+  + ..+++|.++.... ...+.+|+.++++++||||+++++.+  . ....+++
T Consensus         6 ~~~~~-~~~lg~g~~~~v~~~~~~~--~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~--~-~~~~~lv   78 (262)
T cd05071           6 ESLRL-EVKLGQGCFGEVWMGTWNG--T-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV--S-EEPIYIV   78 (262)
T ss_pred             HHeeE-eeecCCCCCCcEEEEEecC--C-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEE--C-CCCcEEE
Confidence            45675 5699999999999998754  3 4599999976433 35688999999999999999999987  3 3457999


Q ss_pred             EecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecc
Q psy2172          97 FDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMG  175 (291)
Q Consensus        97 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg  175 (291)
                      |||+++ +|.+.+.....       ..+++..+..++.|++.||++||+++++|+||+|+||+++    .++.++|+|||
T Consensus        79 ~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~----~~~~~~L~dfg  147 (262)
T cd05071          79 TEYMSKGSLLDFLKGEMG-------KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG----ENLVCKVADFG  147 (262)
T ss_pred             EEcCCCCcHHHHHhhccc-------cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEc----CCCcEEeccCC
Confidence            999985 88877764321       1278899999999999999999999999999999999998    66789999999


Q ss_pred             cceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc----------cCC
Q psy2172         176 FARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI----------KTS  244 (291)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~----------~~~  244 (291)
                      .+........  .......++..|+|||...+.. ++.++|+||||+++|+|++ |..||.+.....          ...
T Consensus       148 ~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~  224 (262)
T cd05071         148 LARLIEDNEY--TARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC  224 (262)
T ss_pred             ceeecccccc--ccccCCcccceecCHhHhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCC
Confidence            9976543221  1112334567799999987654 8999999999999999999 889997654321          111


Q ss_pred             CCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         245 NPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       245 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      .......+.+++..|..+.|..||++.+
T Consensus       225 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~  252 (262)
T cd05071         225 PPECPESLHDLMCQCWRKEPEERPTFEY  252 (262)
T ss_pred             ccccCHHHHHHHHHHccCCcccCCCHHH
Confidence            2233466788889999899988888775

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=5.6e-36  Score=249.46  Aligned_cols=239  Identities=20%  Similarity=0.294  Sum_probs=182.8

Q ss_pred             cccccccceeCcccceEEEEEEEccCC-CCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNS-DTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~-~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      ++|.+ ++.||+|+||.||+|.++..+ ....+++|.++....   ...+.+|+.++++++||||+++++++  .+....
T Consensus         4 ~~~~~-~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~   80 (267)
T cd05066           4 SCIKI-EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV--TKSKPV   80 (267)
T ss_pred             HHeEe-eeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE--ecCCcc
Confidence            35564 679999999999999876432 345799999865432   23678899999999999999999998  456689


Q ss_pred             EEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          94 WLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        94 ~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      +++|||+++ +|.+.+....        ..++...+..++.|++.|+.+||++|++|+||||+||+++    .++.++++
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~----~~~~~~l~  148 (267)
T cd05066          81 MIVTEYMENGSLDAFLRKHD--------GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVN----SNLVCKVS  148 (267)
T ss_pred             EEEEEcCCCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEEC----CCCeEEeC
Confidence            999999975 7777765322        1278899999999999999999999999999999999998    66789999


Q ss_pred             ecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc----------
Q psy2172         173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI----------  241 (291)
Q Consensus       173 Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~----------  241 (291)
                      |||.+.................++..|+|||.+.+.. ++.++|+||||+++|++++ |..||.......          
T Consensus       149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~  227 (267)
T cd05066         149 DFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR  227 (267)
T ss_pred             CCCcccccccccceeeecCCCccceeecCHhHhccCc-cCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc
Confidence            9999886544221111111222345799999998744 8999999999999999886 999997654310          


Q ss_pred             cCCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         242 KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       242 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      ..........+.+++..+..+.|..+|++.+
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~  258 (267)
T cd05066         228 LPAPMDCPAALHQLMLDCWQKDRNERPKFEQ  258 (267)
T ss_pred             CCCCCCCCHHHHHHHHHHcccCchhCCCHHH
Confidence            1111223456788888888888888887764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-35  Score=247.55  Aligned_cols=240  Identities=22%  Similarity=0.309  Sum_probs=183.5

Q ss_pred             cceeCcccceEEEEEEEccCC-CCceeEEEEeCCCCCC----hhHHHHHHHHhcCCCCCeeeEEEEEEeCCC----ceEE
Q psy2172          24 GCKVGRGTYGHVYKARRKDNS-DTRDYALKQIEGTGLS----MSACREIALLRELKHPNVINLISVFLSHND----RKVW   94 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~-~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----~~~~   94 (291)
                      ++.||+|+||.||.|.+.... ....+|+|.++.....    ..+.+|+.+++.++||||+++++.+...+.    ...+
T Consensus         4 ~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   83 (273)
T cd05035           4 GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPM   83 (273)
T ss_pred             ccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccE
Confidence            679999999999999876432 4577999998754332    357889999999999999999998754322    3589


Q ss_pred             EEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEee
Q psy2172          95 LLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIAD  173 (291)
Q Consensus        95 iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~D  173 (291)
                      +++||+.+ +|...+.......   ....+++..+..++.|++.||.|||+++++|+||||+||+++    .++.++|+|
T Consensus        84 ~v~e~~~~~~l~~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~----~~~~~kl~d  156 (273)
T cd05035          84 VILPFMKHGDLHSFLLYSRLGG---LPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLR----EDMTVCVAD  156 (273)
T ss_pred             EEEeccCCCCHHHHHHHhhccC---CcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEEC----CCCeEEECC
Confidence            99999985 7777775543221   112389999999999999999999999999999999999998    677999999


Q ss_pred             cccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc----------cc
Q psy2172         174 MGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED----------IK  242 (291)
Q Consensus       174 fg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~----------~~  242 (291)
                      ||.+......... .......++..|+|||.+.+. .++.++||||||+++|+|++ |..||.+....          ..
T Consensus       157 fg~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~  234 (273)
T cd05035         157 FGLSKKIYSGDYY-RQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRL  234 (273)
T ss_pred             ccceeeccccccc-cccccccCCccccCHhhcccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence            9998865432211 111122345679999998764 48899999999999999998 89999765431          11


Q ss_pred             CCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         243 TSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       243 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      .........+.+++..|..+.|..||++.+
T Consensus       235 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e  264 (273)
T cd05035         235 KQPEDCLDELYDLMYSCWRADPKDRPTFTK  264 (273)
T ss_pred             CCCcCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            122334567788888888888988888765

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.2e-35  Score=248.78  Aligned_cols=248  Identities=19%  Similarity=0.296  Sum_probs=186.6

Q ss_pred             cccccccceeCcccceEEEEEEEccCC---CCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCc
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNS---DTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHNDR   91 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~---~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (291)
                      +.|.+ .+.||+|++|.||+|.+....   ....|++|.......   ...+.+|+.+++.++|+||+++++++.  +..
T Consensus         6 ~~~~~-~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~   82 (277)
T cd05036           6 DSITL-LRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSF--ERL   82 (277)
T ss_pred             HHcEe-eeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc--cCC
Confidence            44554 569999999999999986522   457799998864332   235788999999999999999999884  456


Q ss_pred             eEEEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEE
Q psy2172          92 KVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVK  170 (291)
Q Consensus        92 ~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~  170 (291)
                      ..+++|||+. ++|.+++...+....  ....+++..+..++.|++.|+++||+++++|+||+|+||+++.++ ....++
T Consensus        83 ~~~lv~e~~~g~~L~~~i~~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~-~~~~~k  159 (277)
T cd05036          83 PRFILLELMAGGDLKSFLRENRPRPE--RPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKG-PGRVAK  159 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHHhCCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccC-CCcceE
Confidence            7899999996 588888765542211  122388999999999999999999999999999999999998432 245799


Q ss_pred             EeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc--------
Q psy2172         171 IADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI--------  241 (291)
Q Consensus       171 l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~--------  241 (291)
                      |+|||.+......... ........+..|+|||++.+.. ++.++|||||||++|+|++ |..||.+.....        
T Consensus       160 l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~  237 (277)
T cd05036         160 IADFGMARDIYRASYY-RKGGRAMLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG  237 (277)
T ss_pred             eccCccccccCCccce-ecCCCCCccHhhCCHHHHhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            9999998765332111 1111223356799999997754 8999999999999999996 999998654211        


Q ss_pred             --cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         242 --KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       242 --~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                        ..........+.+++..|..+.|..||++.++
T Consensus       238 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~v  271 (277)
T cd05036         238 GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATI  271 (277)
T ss_pred             CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence              11122334567888888888889888887763

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=8.8e-36  Score=246.98  Aligned_cols=241  Identities=25%  Similarity=0.385  Sum_probs=188.9

Q ss_pred             ceeCcccceEEEEEEEccC-CCCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecC
Q psy2172          25 CKVGRGTYGHVYKARRKDN-SDTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYA  100 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~-~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~  100 (291)
                      +.||+|+||.||+|.+... ..+..+++|.+.....   ...+.+|+.+++.++|+|++++++++  .+....+++|||+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~--~~~~~~~lv~e~~   78 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVC--TEEEPLYLVLEYM   78 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeee--cCCCceEEEEEec
Confidence            4799999999999998752 2377899999976544   35788999999999999999999998  4577899999999


Q ss_pred             C-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeeccccee
Q psy2172         101 E-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL  179 (291)
Q Consensus       101 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~  179 (291)
                      . ++|.+.+..............+++..++.++.|++.||++||++|++|+||+|+||+++    .++.++|+|||.+..
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~----~~~~~~l~dfg~~~~  154 (262)
T cd00192          79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVG----EDLVVKISDFGLSRD  154 (262)
T ss_pred             cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEEC----CCCcEEEcccccccc
Confidence            5 68888877642111000112389999999999999999999999999999999999998    668999999999987


Q ss_pred             cCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc----------ccCCCCCc
Q psy2172         180 FNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED----------IKTSNPYH  248 (291)
Q Consensus       180 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~----------~~~~~~~~  248 (291)
                      ...... ........++..|+|||.+.+. .++.++|+||||+++|+|++ |..||......          ........
T Consensus       155 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  232 (262)
T cd00192         155 VYDDDY-YRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYC  232 (262)
T ss_pred             cccccc-cccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccC
Confidence            654321 1122344567889999998875 48999999999999999998 69999876432          11122233


Q ss_pred             HHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         249 HDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       249 ~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      ...+.+++..|..+.|..||++.++
T Consensus       233 ~~~~~~li~~~l~~~p~~Rps~~~l  257 (262)
T cd00192         233 PDELYELMLSCWQLDPEDRPTFSEL  257 (262)
T ss_pred             ChHHHHHHHHHccCCcccCcCHHHH
Confidence            5678888888888889888887754

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=5.8e-36  Score=250.68  Aligned_cols=241  Identities=24%  Similarity=0.390  Sum_probs=193.3

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHNDRKVW   94 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (291)
                      ..|.. .++||+|+||.||+|.+..  ++..+|+|.+.....   ...+.+|+.+++.++||||+++++.+  .+....+
T Consensus         4 ~~y~~-~~~lg~g~~~~vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~   78 (277)
T cd06640           4 ELFTK-LERIGKGSFGEVFKGIDNR--TQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY--LKGTKLW   78 (277)
T ss_pred             Hhhhh-hhhcccCCCeEEEEEEEcc--CCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEE--EECCEEE
Confidence            44553 5689999999999999876  667899999874332   24678899999999999999999999  4567899


Q ss_pred             EEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEee
Q psy2172          95 LLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIAD  173 (291)
Q Consensus        95 iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~D  173 (291)
                      +||||+++ +|.+.+...          ++++..+..++.|++.|+++||+++++|+||+|+||+++    .++.++++|
T Consensus        79 lv~e~~~~~~L~~~i~~~----------~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~----~~~~~~l~d  144 (277)
T cd06640          79 IIMEYLGGGSALDLLRAG----------PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLS----EQGDVKLAD  144 (277)
T ss_pred             EEEecCCCCcHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEc----CCCCEEEcc
Confidence            99999986 777666421          178889999999999999999999999999999999998    667899999


Q ss_pred             cccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc----------ccC
Q psy2172         174 MGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED----------IKT  243 (291)
Q Consensus       174 fg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~----------~~~  243 (291)
                      ||.+........   ......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||......          .+.
T Consensus       145 fg~~~~~~~~~~---~~~~~~~~~~y~apE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~  220 (277)
T cd06640         145 FGVAGQLTDTQI---KRNTFVGTPFWMAPEVIQQSA-YDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPT  220 (277)
T ss_pred             cccceeccCCcc---ccccccCcccccCHhHhccCC-CccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCC
Confidence            999876543211   122345677899999987654 889999999999999999999999754322          111


Q ss_pred             CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         244 SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       244 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                      ........+.+++..|....|..||++.++..++++..
T Consensus       221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  258 (277)
T cd06640         221 LTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVK  258 (277)
T ss_pred             CchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhh
Confidence            11223466889999999999999999999988877653

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.5e-36  Score=247.55  Aligned_cols=230  Identities=20%  Similarity=0.328  Sum_probs=181.2

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecCCC
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH  102 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~~~  102 (291)
                      .+.||+|+||.||++.++   ....+++|.+.... ....+.+|+.++++++||||+++++++  ......+++|||+++
T Consensus         9 ~~~lg~G~~~~v~~~~~~---~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~lv~e~~~~   83 (256)
T cd05059           9 LKELGSGQFGVVHLGKWR---GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC--TKQRPIFIVTEYMAN   83 (256)
T ss_pred             hhhhccCCCceEEEeEec---CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEE--cCCCceEEEEecCCC
Confidence            678999999999999875   34579999987543 345688899999999999999999998  556789999999975


Q ss_pred             -CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceecC
Q psy2172         103 -DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFN  181 (291)
Q Consensus       103 -~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~~  181 (291)
                       +|.+.+.....        .+++..++.++.|++.|+++||++|++|+||+|+||+++    .++.++|+|||.+....
T Consensus        84 ~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~----~~~~~kl~dfg~~~~~~  151 (256)
T cd05059          84 GCLLNYLRERKG--------KLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVG----EDNVVKVSDFGLARYVL  151 (256)
T ss_pred             CCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEEC----CCCcEEECCcccceecc
Confidence             77777654321        288999999999999999999999999999999999998    67789999999987654


Q ss_pred             CCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc----------cCCCCCcHH
Q psy2172         182 NPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI----------KTSNPYHHD  250 (291)
Q Consensus       182 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~----------~~~~~~~~~  250 (291)
                      .....  ......++..|+|||.+.+.. ++.++|+||||+++|++++ |..||.......          .........
T Consensus       152 ~~~~~--~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (256)
T cd05059         152 DDQYT--SSQGTKFPVKWAPPEVFDYSR-FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPT  228 (256)
T ss_pred             ccccc--ccCCCCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCH
Confidence            32111  111122345799999998744 8899999999999999998 899997654221          112233456


Q ss_pred             HHHHHHHhhCCCCcCChhhhhcC
Q psy2172         251 QLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       251 ~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      .+.+++..|..+.|..||++.++
T Consensus       229 ~~~~li~~cl~~~p~~Rpt~~~~  251 (256)
T cd05059         229 EVYTIMYSCWHEKPEDRPAFKKL  251 (256)
T ss_pred             HHHHHHHHHhcCChhhCcCHHHH
Confidence            78888888888888888887753

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.2e-36  Score=249.33  Aligned_cols=247  Identities=20%  Similarity=0.277  Sum_probs=188.9

Q ss_pred             cccccccceeCcccceEEEEEEEccCC---CCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCc
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNS---DTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHNDR   91 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~---~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (291)
                      +.|.+ .+.||+|+||.||+|.++...   ....|++|.+.....   ...+.+|+.+++.++||||+++++++  .+..
T Consensus         6 ~~~~~-~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~--~~~~   82 (277)
T cd05032           6 EKITL-IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVV--STGQ   82 (277)
T ss_pred             HHeeE-EeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEE--cCCC
Confidence            45564 569999999999999986532   447799999865432   23577899999999999999999998  5567


Q ss_pred             eEEEEEecCC-CCHHHHHHHhhhhhhC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcE
Q psy2172          92 KVWLLFDYAE-HDLWHIIKFHRAAKAN-KKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRV  169 (291)
Q Consensus        92 ~~~iv~e~~~-~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~  169 (291)
                      ..+++|||++ ++|.+.+......... .....+++..+..++.|++.||.|||+++++|+||+|+||+++    .++.+
T Consensus        83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~----~~~~~  158 (277)
T cd05032          83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVA----EDLTV  158 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEc----CCCCE
Confidence            8999999997 5888887654322111 1122377889999999999999999999999999999999998    67889


Q ss_pred             EEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc--------
Q psy2172         170 KIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED--------  240 (291)
Q Consensus       170 ~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~--------  240 (291)
                      +|+|||.+........ ........++..|+|||.+.+.. ++.++|+||||+++|++++ |..||.+....        
T Consensus       159 kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~  236 (277)
T cd05032         159 KIGDFGMTRDIYETDY-YRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID  236 (277)
T ss_pred             EECCcccchhhccCcc-cccCCCCCccccccCHHHHhcCC-CCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc
Confidence            9999999876543211 11123344577899999987644 8899999999999999998 99999765421        


Q ss_pred             --ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         241 --IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       241 --~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                        ...........+.+++..+..+.|..||++.++
T Consensus       237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l  271 (277)
T cd05032         237 GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEI  271 (277)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence              111222335678888888888888888887753

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=8.2e-36  Score=246.98  Aligned_cols=233  Identities=19%  Similarity=0.346  Sum_probs=182.5

Q ss_pred             cccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC-ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEe
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFD   98 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e   98 (291)
                      |++ .+.||+|+||.||.|.+.+   ...+|+|.++.... ...+.+|+.++++++||||+++++++  ......+++||
T Consensus         6 ~~~-~~~lg~G~~~~vy~~~~~~---~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~lv~e   79 (256)
T cd05113           6 LTF-LKELGTGQFGVVKYGKWRG---QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC--TKQRPIYIVTE   79 (256)
T ss_pred             eEE-eeEecCcccceEEEEEecC---CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEE--ccCCCcEEEEE
Confidence            444 4689999999999998754   34599998875433 35688999999999999999999998  55667899999


Q ss_pred             cCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccc
Q psy2172          99 YAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA  177 (291)
Q Consensus        99 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~  177 (291)
                      |+.+ +|.+.+.....        .+++..++.++.|++.||++||++|++|+||+|+||+++    .++.++|+|||.+
T Consensus        80 ~~~~~~l~~~i~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~----~~~~~kl~d~g~~  147 (256)
T cd05113          80 YMSNGCLLNYLREHGK--------RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVD----DQGCVKVSDFGLS  147 (256)
T ss_pred             cCCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc----CCCCEEECCCccc
Confidence            9975 77777654321        288999999999999999999999999999999999998    6678999999998


Q ss_pred             eecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc----------ccCCCC
Q psy2172         178 RLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED----------IKTSNP  246 (291)
Q Consensus       178 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~----------~~~~~~  246 (291)
                      ........  .......++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||......          ......
T Consensus       148 ~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  224 (256)
T cd05113         148 RYVLDDEY--TSSVGSKFPVRWSPPEVLLYSK-FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPH  224 (256)
T ss_pred             eecCCCce--eecCCCccChhhCCHHHHhcCc-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCC
Confidence            76543211  1111223456799999997654 8899999999999999998 99999764431          011122


Q ss_pred             CcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         247 YHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       247 ~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      .....+.+++..|..+.|..||++.++
T Consensus       225 ~~~~~~~~li~~cl~~~p~~Rp~~~~l  251 (256)
T cd05113         225 LASEKVYAIMYSCWHEKAEERPTFQQL  251 (256)
T ss_pred             CCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence            234678888888888999888887754

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=7.6e-36  Score=246.89  Aligned_cols=237  Identities=28%  Similarity=0.431  Sum_probs=191.2

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC----ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEec
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL----SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDY   99 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~   99 (291)
                      .+.||+|++|.||+|.+..  ++..+++|.+.....    ...+.+|+.++++++|||++++++.+  ......++||||
T Consensus         5 ~~~lg~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~--~~~~~~~lv~e~   80 (256)
T cd08220           5 IRVVGRGAFGIVHLCRRKA--DQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENF--LEDKALMIVMEY   80 (256)
T ss_pred             EEEecccCceEEEEEEEcC--CCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeE--ecCCEEEEEEec
Confidence            5699999999999999876  678899999865432    34578899999999999999999998  456789999999


Q ss_pred             CCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccce
Q psy2172         100 AEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR  178 (291)
Q Consensus       100 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~  178 (291)
                      +++ +|.+.+.....       ..+++..+..++.|++.++++||++|++|+||+|+||+++.   ....++|+|||.+.
T Consensus        81 ~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~---~~~~~~l~d~~~~~  150 (256)
T cd08220          81 APGGTLAEYIQKRCN-------SLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDK---HKMVVKIGDFGISK  150 (256)
T ss_pred             CCCCCHHHHHHHhcc-------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC---CCCEEEEccCCCce
Confidence            975 88877765321       12788999999999999999999999999999999999973   23468999999998


Q ss_pred             ecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc----------ccCCCCCc
Q psy2172         179 LFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED----------IKTSNPYH  248 (291)
Q Consensus       179 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~----------~~~~~~~~  248 (291)
                      ......    ......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||......          ........
T Consensus       151 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (256)
T cd08220         151 ILSSKS----KAYTVVGTPCYISPELCEGKP-YNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRY  225 (256)
T ss_pred             ecCCCc----cccccccCCcccCchhccCCC-CCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCc
Confidence            665431    122345788899999997644 788999999999999999999999765421          11112223


Q ss_pred             HHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         249 HDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       249 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                      ...+.+++..|..+.|..||++.++..+|++
T Consensus       226 ~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         226 SPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence            5678899999999999999999998888764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.2e-35  Score=245.79  Aligned_cols=239  Identities=26%  Similarity=0.441  Sum_probs=190.9

Q ss_pred             cccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEE
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG----LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWL   95 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~i   95 (291)
                      |+. .+.||.|+||.||.+.+..  +++.+++|.+....    ...++.+|+.++++++|+||+++++++  .+....++
T Consensus         2 y~~-~~~ig~g~~g~v~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~--~~~~~~~~   76 (256)
T cd08221           2 YIP-IRVLGKGAFGEATLYRRTE--DDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHF--MDDNTLLI   76 (256)
T ss_pred             ceE-eeEecccCCceEEEEEEcC--CCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEE--ecCCeEEE
Confidence            443 5699999999999999766  67889999876432    234678999999999999999999999  45678999


Q ss_pred             EEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          96 LFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        96 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      +|||+++ +|.+.+.....       ..+++..+..++.|++.++.+||+.|++|+||+|+||+++    .++.++|+||
T Consensus        77 ~~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~----~~~~~kl~d~  145 (256)
T cd08221          77 EMEYANGGTLYDKIVRQKG-------QLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLT----KAGLIKLGDF  145 (256)
T ss_pred             EEEecCCCcHHHHHHhccc-------cCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEe----CCCCEEECcC
Confidence            9999975 88877664321       1288999999999999999999999999999999999998    6678999999


Q ss_pred             ccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc----------cCC
Q psy2172         175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI----------KTS  244 (291)
Q Consensus       175 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~----------~~~  244 (291)
                      |.+........   ......++..|.|||.+.+.. ++.++|+||||+++|+|++|..||.......          ...
T Consensus       146 ~~~~~~~~~~~---~~~~~~~~~~y~ape~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~  221 (256)
T cd08221         146 GISKILGSEYS---MAETVVGTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPV  221 (256)
T ss_pred             cceEEcccccc---cccccCCCccccCHhhcCCCC-CCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            99886644321   223346788999999998754 7889999999999999999999997654311          111


Q ss_pred             CCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcc
Q psy2172         245 NPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPT  278 (291)
Q Consensus       245 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  278 (291)
                      .......+.+++..+..+.|..||++.++..+++
T Consensus       222 ~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~  255 (256)
T cd08221         222 VSVYSSELISLVHSLLQQDPEKRPTADEVLDQPL  255 (256)
T ss_pred             ccccCHHHHHHHHHHcccCcccCCCHHHHhhCcC
Confidence            2233466788888888888989998888766654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG0194|consensus

Probab=100.00  E-value=4e-37  Score=265.95  Aligned_cols=232  Identities=22%  Similarity=0.356  Sum_probs=184.3

Q ss_pred             cceeCcccceEEEEEEEccCCC--CceeEEEEeCCCC-----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEE
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSD--TRDYALKQIEGTG-----LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLL   96 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~--~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv   96 (291)
                      +++||+|+||.||+|..+....  ...||+|..+...     ...++.+|+++|++++|||||++||+.  -....+++|
T Consensus       162 ~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa--~~~~Pl~iv  239 (474)
T KOG0194|consen  162 GKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA--VLEEPLMLV  239 (474)
T ss_pred             cceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE--cCCCccEEE
Confidence            5799999999999999876433  2238999987522     224688999999999999999999998  456789999


Q ss_pred             EecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecc
Q psy2172          97 FDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMG  175 (291)
Q Consensus        97 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg  175 (291)
                      ||+|.| +|.++++.....        ++......++.+.+.||+|||+++++||||..+|+|++    ....+||+|||
T Consensus       240 mEl~~gGsL~~~L~k~~~~--------v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~----~~~~vKISDFG  307 (474)
T KOG0194|consen  240 MELCNGGSLDDYLKKNKKS--------LPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYS----KKGVVKISDFG  307 (474)
T ss_pred             EEecCCCcHHHHHHhCCCC--------CCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheec----CCCeEEeCccc
Confidence            999985 888888866542        88999999999999999999999999999999999998    66678999999


Q ss_pred             cceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc-----------ccC
Q psy2172         176 FARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED-----------IKT  243 (291)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~-----------~~~  243 (291)
                      ++.....-   ........-...|+|||.+... .++.++||||||+++||+++ |..||.+....           ...
T Consensus       308 Ls~~~~~~---~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~  383 (474)
T KOG0194|consen  308 LSRAGSQY---VMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMP  383 (474)
T ss_pred             cccCCcce---eeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCC
Confidence            98754310   0111112346789999999875 69999999999999999998 88899987631           122


Q ss_pred             CCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         244 SNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       244 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      ........+..++..+....|.+||++.++
T Consensus       384 ~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i  413 (474)
T KOG0194|consen  384 IPSKTPKELAKVMKQCWKKDPEDRPTMSTI  413 (474)
T ss_pred             CCCCCHHHHHHHHHHhccCChhhccCHHHH
Confidence            333445667777778888888888877654

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.1e-35  Score=247.61  Aligned_cols=235  Identities=22%  Similarity=0.320  Sum_probs=183.2

Q ss_pred             cccccccc-eeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcC-CCCCeeeEEEEEEeCCCceEEE
Q psy2172          18 DLFDYEGC-KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLREL-KHPNVINLISVFLSHNDRKVWL   95 (291)
Q Consensus        18 ~~~~~~~~-~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~i   95 (291)
                      +.|++... +||+|+||.||++..+.  +++.+++|.+.......   .|+.....+ +|||++++++.+.  .....|+
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~--~~~~~~~k~~~~~~~~~---~e~~~~~~~~~h~~iv~~~~~~~--~~~~~~i   86 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKP--TQKLFVQKIIKAKNFNA---IEPMVHQLMKDNPNFIKLYYSVT--TLKGHVL   86 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcC--CCcEEEEEEEehhhcch---hhHHHHHHhhcCCCEEEEEEEEe--cCCeeEE
Confidence            34454332 36999999999999876  67889999987543222   123233323 7999999999994  4568999


Q ss_pred             EEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCC-cEEEee
Q psy2172          96 LFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERG-RVKIAD  173 (291)
Q Consensus        96 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~-~~~l~D  173 (291)
                      ||||++ ++|.+.+....         .+++..++.++.|+++||.+||+.|++|+||+|+||+++    ..+ .++|+|
T Consensus        87 v~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~----~~~~~~~l~d  153 (267)
T PHA03390         87 IMDYIKDGDLFDLLKKEG---------KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD----RAKDRIYLCD  153 (267)
T ss_pred             EEEcCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEe----CCCCeEEEec
Confidence            999997 58888876442         289999999999999999999999999999999999998    445 899999


Q ss_pred             cccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc-----------
Q psy2172         174 MGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK-----------  242 (291)
Q Consensus       174 fg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~-----------  242 (291)
                      ||.+......       ....++..|+|||++.+.. ++.++|+||+|+++|+|++|..||.....+..           
T Consensus       154 fg~~~~~~~~-------~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  225 (267)
T PHA03390        154 YGLCKIIGTP-------SCYDGTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK  225 (267)
T ss_pred             CccceecCCC-------ccCCCCCcccChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcc
Confidence            9998765432       2235688899999998754 88999999999999999999999985543211           


Q ss_pred             --CCCCCcHHHHHHHHHhhCCCCcCChhh-hhcCCCCcchh
Q psy2172         243 --TSNPYHHDQLDRIFSVMGFPLEKDWED-IRKMPEHPTLL  280 (291)
Q Consensus       243 --~~~~~~~~~~~~i~~~~~~~~~~~~~~-~~~~~~~~~~~  280 (291)
                        ...+.....+.+++..|..+.|..|++ ++++..+||+.
T Consensus       226 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~  266 (267)
T PHA03390        226 KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK  266 (267)
T ss_pred             cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence              111234567888999999999999984 79999998863

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.2e-37  Score=275.64  Aligned_cols=255  Identities=18%  Similarity=0.251  Sum_probs=184.5

Q ss_pred             ccccccccccceeCcccceEEEEEEEccCCCCceeEEE------------------EeC-CCCCChhHHHHHHHHhcCCC
Q psy2172          15 KVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALK------------------QIE-GTGLSMSACREIALLRELKH   75 (291)
Q Consensus        15 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK------------------~~~-~~~~~~~~~~e~~~l~~l~h   75 (291)
                      .+.+.|++ .++||+|+||.||+|.++... +...++|                  ... .......+.+|+.++++++|
T Consensus       145 ~~~~~Y~i-i~~LG~G~fG~Vyl~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~H  222 (501)
T PHA03210        145 EFLAHFRV-IDDLPAGAFGKIFICALRAST-EEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNH  222 (501)
T ss_pred             hhhhccEE-EeEecCCCCcceEEEEEeccc-hhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCC
Confidence            34567775 569999999999999765421 1111211                  111 11123457889999999999


Q ss_pred             CCeeeEEEEEEeCCCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCC
Q psy2172          76 PNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPA  155 (291)
Q Consensus        76 ~~iv~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~  155 (291)
                      |||+++++++  ......|++++++.+++...+........    .......+..++.|++.||+|||++||+|+||||+
T Consensus       223 pnIv~l~~~~--~~~~~~~lv~e~~~~~l~~~l~~~~~~~~----~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~  296 (501)
T PHA03210        223 ENILKIEEIL--RSEANTYMITQKYDFDLYSFMYDEAFDWK----DRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLE  296 (501)
T ss_pred             CCcCcEeEEE--EECCeeEEEEeccccCHHHHHhhcccccc----ccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence            9999999999  45668899999999988887754322111    11345678889999999999999999999999999


Q ss_pred             cEEeecCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCC-CC
Q psy2172         156 NILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP-IF  234 (291)
Q Consensus       156 Nil~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~-pf  234 (291)
                      ||+++    .++.++|+|||++........  .......|+..|+|||++.+.. ++.++|||||||++|+|++|.. ||
T Consensus       297 NILl~----~~~~vkL~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~~~~~p~  369 (501)
T PHA03210        297 NIFLN----CDGKIVLGDFGTAMPFEKERE--AFDYGWVGTVATNSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPI  369 (501)
T ss_pred             HEEEC----CCCCEEEEeCCCceecCcccc--cccccccCCcCCCCchhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCc
Confidence            99998    677899999999986654221  1122357899999999998754 8999999999999999999874 44


Q ss_pred             CCCccc------------------ccC----------------C---------CCCcHHHHHHHHHhhCCCCcCChhhhh
Q psy2172         235 HCRQED------------------IKT----------------S---------NPYHHDQLDRIFSVMGFPLEKDWEDIR  271 (291)
Q Consensus       235 ~~~~~~------------------~~~----------------~---------~~~~~~~~~~i~~~~~~~~~~~~~~~~  271 (291)
                      ......                  .+.                .         .......+.+++..|....|..||++.
T Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~  449 (501)
T PHA03210        370 GDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAA  449 (501)
T ss_pred             cCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHH
Confidence            332211                  000                0         000112344556778889999999999


Q ss_pred             cCCCCcchhhhhh
Q psy2172         272 KMPEHPTLLKDFN  284 (291)
Q Consensus       272 ~~~~~~~~~~~~~  284 (291)
                      ++..+|++.....
T Consensus       450 elL~hp~f~~~~~  462 (501)
T PHA03210        450 ELLALPLFSAEEE  462 (501)
T ss_pred             HHhhChhhhcCCc
Confidence            9999999865433

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=5.5e-36  Score=247.86  Aligned_cols=240  Identities=25%  Similarity=0.483  Sum_probs=192.4

Q ss_pred             cccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEE
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT----GLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWL   95 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~i   95 (291)
                      |++ .++||+|+||.||.+.+..  +++.|++|.+...    ....++.+|+.++++++||||+++++++  .+....++
T Consensus         2 y~~-~~~lg~g~~g~~~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~l   76 (256)
T cd08218           2 YVK-VKKIGEGSFGKAILVKSKE--DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF--EENGNLYI   76 (256)
T ss_pred             ceE-EEEeccCCceEEEEEEEcC--CCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee--cCCCeEEE
Confidence            453 6799999999999999876  6788999988632    2234688899999999999999999998  56779999


Q ss_pred             EEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          96 LFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        96 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      ++||+.+ +|.+.+......       .+++..+..++.|++.|+.+||++|++|+||+|+||+++    .+..++++||
T Consensus        77 v~e~~~~~~l~~~~~~~~~~-------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~----~~~~~~l~d~  145 (256)
T cd08218          77 VMDYCEGGDLYKKINAQRGV-------LFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT----KDGTIKLGDF  145 (256)
T ss_pred             EEecCCCCcHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc----CCCCEEEeec
Confidence            9999975 787777643211       278889999999999999999999999999999999998    6678999999


Q ss_pred             ccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc----------ccCC
Q psy2172         175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED----------IKTS  244 (291)
Q Consensus       175 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~----------~~~~  244 (291)
                      |.+........   ......|+..|+|||.+.+.. .+.++|+||||+++++|++|..||......          ....
T Consensus       146 ~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~  221 (256)
T cd08218         146 GIARVLNSTVE---LARTCIGTPYYLSPEICENRP-YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPV  221 (256)
T ss_pred             cceeecCcchh---hhhhccCCccccCHHHhCCCC-CCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCC
Confidence            99876544211   112335678899999987744 888999999999999999999999754321          1112


Q ss_pred             CCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         245 NPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       245 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                      .......+.+++..|..+.|..||++.++..++|+
T Consensus       222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         222 SSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             cccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence            22334668889999999999999999998888774

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>KOG2345|consensus

Probab=100.00  E-value=1.3e-37  Score=241.20  Aligned_cols=245  Identities=24%  Similarity=0.333  Sum_probs=192.1

Q ss_pred             ccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC--CChhHHHHHHHHhcCCCCCeeeEEEEEEeC---CCc
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG--LSMSACREIALLRELKHPNVINLISVFLSH---NDR   91 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~   91 (291)
                      +++|++ .+.||.|||+-||++....  ++..||+|.+....  ......+|+...++++|||+++++++.+.+   ...
T Consensus        20 ~~Ryri-~~~LgeGGfsfv~LV~~~s--~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~   96 (302)
T KOG2345|consen   20 NKRYRI-QRLLGEGGFSFVDLVKGLS--TGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH   96 (302)
T ss_pred             CceEEE-eeeecCCCceeeeeecccC--cccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence            457775 6799999999999999544  77889999986543  345688999999999999999999876432   345


Q ss_pred             eEEEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeeccCCCcEEeecCCCCCCc
Q psy2172          92 KVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNW--VLHRDLKPANILVMGEGIERGR  168 (291)
Q Consensus        92 ~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~dik~~Nil~~~~~~~~~~  168 (291)
                      ..|++++|+. |+|++.+........     .+++.+++.++.++++||++||+..  +.|+||||.||+++    ..+.
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~-----~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls----~~~~  167 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERLKIKGN-----FVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLS----DSGL  167 (302)
T ss_pred             eEEEEeehhccccHHHHHHHHhhcCC-----ccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEec----CCCc
Confidence            7999999997 689999887665432     2999999999999999999999998  99999999999998    6789


Q ss_pred             EEEeecccceecCCCCCCCCCC------CCceecccccccccccCC--cCCCCchhHHHHHHHHHHHHcCCCCCCCCccc
Q psy2172         169 VKIADMGFARLFNNPLKPLADL------DPVVVTFWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQED  240 (291)
Q Consensus       169 ~~l~Dfg~~~~~~~~~~~~~~~------~~~~g~~~y~aPE~~~~~--~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~  240 (291)
                      +++.|||++....-.-......      ....-|..|+|||.+.-.  ...+.++|||||||+||.|+.|..||+..-..
T Consensus       168 ~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~  247 (302)
T KOG2345|consen  168 PVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ  247 (302)
T ss_pred             eEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc
Confidence            9999999987653221111110      011337779999998542  24788999999999999999999999743221


Q ss_pred             ------------c-cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         241 ------------I-KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       241 ------------~-~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                                  . .....-+++.+-++++.|..+.|..||.++++
T Consensus       248 GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~l  293 (302)
T KOG2345|consen  248 GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPEL  293 (302)
T ss_pred             CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHH
Confidence                        0 11222357889999999999999999998864

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.5e-36  Score=254.24  Aligned_cols=240  Identities=24%  Similarity=0.390  Sum_probs=191.4

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHNDRKVW   94 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (291)
                      +.|+. .+.||+|+||.||+|.+..  ++..||+|.++....   ...+.+|+.++++++||||+++++.+  ......+
T Consensus         4 ~~y~~-~~~l~~g~~~~vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~   78 (277)
T cd06642           4 ELFTK-LERIGKGSFGEVYKGIDNR--TKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY--LKGTKLW   78 (277)
T ss_pred             HHHHH-HHHhcCCCCeeEEEEEEcC--CCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccc--ccCCceE
Confidence            44553 5689999999999999765  667899999874332   23578899999999999999999999  4567899


Q ss_pred             EEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEee
Q psy2172          95 LLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIAD  173 (291)
Q Consensus        95 iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~D  173 (291)
                      +|+||+++ +|.+.+...          .+++..+..++.|++.|+.+||++|++|+||+|+||+++    .++.++++|
T Consensus        79 lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~----~~~~~~l~d  144 (277)
T cd06642          79 IIMEYLGGGSALDLLKPG----------PLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLS----EQGDVKLAD  144 (277)
T ss_pred             EEEEccCCCcHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEe----CCCCEEEcc
Confidence            99999986 666655321          278899999999999999999999999999999999998    667899999


Q ss_pred             cccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc----------cC
Q psy2172         174 MGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI----------KT  243 (291)
Q Consensus       174 fg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~----------~~  243 (291)
                      ||++........   ......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||.......          ..
T Consensus       145 fg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~  220 (277)
T cd06642         145 FGVAGQLTDTQI---KRNTFVGTPFWMAPEVIKQSA-YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPT  220 (277)
T ss_pred             ccccccccCcch---hhhcccCcccccCHHHhCcCC-CchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCC
Confidence            999875543211   112235678899999998754 8899999999999999999999997543211          11


Q ss_pred             CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchh
Q psy2172         244 SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLL  280 (291)
Q Consensus       244 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  280 (291)
                      ........+.+++..|....|..||++.++..++++.
T Consensus       221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~  257 (277)
T cd06642         221 LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFIT  257 (277)
T ss_pred             CCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHH
Confidence            1112345688899999999999999999998888765

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=6.1e-36  Score=255.21  Aligned_cols=238  Identities=22%  Similarity=0.310  Sum_probs=181.4

Q ss_pred             ccccccceeCcccceEEEEEEEccCCC--CceeEEEEeCCCC---CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSD--TRDYALKQIEGTG---LSMSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~--~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      .|++ .+.||+|+||.||+|.+...+.  ...||+|.++...   ..+++.+|+.+++.++||||+++++++..   ...
T Consensus         8 ~f~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~---~~~   83 (316)
T cd05108           8 EFKK-IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT---STV   83 (316)
T ss_pred             hcee-eeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC---CCc
Confidence            3553 5699999999999999765322  2348999986432   23568889999999999999999999843   246


Q ss_pred             EEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          94 WLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        94 ~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      +++++|+. |+|.+.+.....        .++...++.++.|++.||+|||++|++|+||||+||+++    .++.++|+
T Consensus        84 ~~v~e~~~~g~l~~~l~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~----~~~~~kl~  151 (316)
T cd05108          84 QLITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVK----TPQHVKIT  151 (316)
T ss_pred             eeeeecCCCCCHHHHHHhccc--------cCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEec----CCCcEEEc
Confidence            78888887 578777764321        278889999999999999999999999999999999998    66789999


Q ss_pred             ecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc----------c
Q psy2172         173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED----------I  241 (291)
Q Consensus       173 Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~----------~  241 (291)
                      |||++.......... ......++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+....          .
T Consensus       152 DfG~a~~~~~~~~~~-~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~  229 (316)
T cd05108         152 DFGLAKLLGADEKEY-HAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER  229 (316)
T ss_pred             cccccccccCCCcce-eccCCccceeecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCC
Confidence            999998665322111 111223356799999997744 8999999999999999987 99999865421          1


Q ss_pred             cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCC
Q psy2172         242 KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMP  274 (291)
Q Consensus       242 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  274 (291)
                      ....+.....+.+++..+....|..||++.++.
T Consensus       230 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~  262 (316)
T cd05108         230 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELI  262 (316)
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            112233445677888888888888888877643

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-36  Score=249.85  Aligned_cols=240  Identities=25%  Similarity=0.412  Sum_probs=193.1

Q ss_pred             cccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC---CChhHHHHHHHHhcCC---CCCeeeEEEEEEeCCCceE
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG---LSMSACREIALLRELK---HPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~~   93 (291)
                      |.+ .+.||+|+||.||+|.+..  +++.+++|.++...   ...++.+|+.++++++   |||++++++++  .+....
T Consensus         3 y~~-~~~l~~g~~g~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~--~~~~~~   77 (277)
T cd06917           3 YQR-LELIGRGAYGAVYRGKHVP--TGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSY--LKGPRL   77 (277)
T ss_pred             hhh-hhheeccCCceEEEEEEcC--CCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeee--eeCCEE
Confidence            443 5689999999999999866  67889999986432   2346788999999996   99999999998  456789


Q ss_pred             EEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          94 WLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        94 ~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      +++|||+.+ +|.+++...          .+++..++.++.|++.||.+||+.|++|+||+|+||+++    ..+.++|+
T Consensus        78 ~lv~e~~~~~~L~~~~~~~----------~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~----~~~~~~l~  143 (277)
T cd06917          78 WIIMEYAEGGSVRTLMKAG----------PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVT----NTGNVKLC  143 (277)
T ss_pred             EEEEecCCCCcHHHHHHcc----------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEc----CCCCEEEc
Confidence            999999976 776665432          288999999999999999999999999999999999998    67789999


Q ss_pred             ecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc----------c
Q psy2172         173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI----------K  242 (291)
Q Consensus       173 Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~----------~  242 (291)
                      |||.+........   ......|+..|+|||.+.+...++.++|+||||+++|+|++|..||.......          +
T Consensus       144 dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~  220 (277)
T cd06917         144 DFGVAALLNQNSS---KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPP  220 (277)
T ss_pred             cCCceeecCCCcc---ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCC
Confidence            9999887654321   12234578889999998765557899999999999999999999997654321          0


Q ss_pred             CCCC-CcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         243 TSNP-YHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       243 ~~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                      .... .....+.+++..|..+.|..||++.++..++|+..
T Consensus       221 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~  260 (277)
T cd06917         221 RLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKA  260 (277)
T ss_pred             CCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhc
Confidence            1111 13457889999999999999999999988888743

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=4.8e-36  Score=257.78  Aligned_cols=248  Identities=22%  Similarity=0.342  Sum_probs=185.5

Q ss_pred             cccccccceeCcccceEEEEEEEccC---CCCceeEEEEeCCCCCC---hhHHHHHHHHhcC-CCCCeeeEEEEEEeCCC
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDN---SDTRDYALKQIEGTGLS---MSACREIALLREL-KHPNVINLISVFLSHND   90 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~---~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~   90 (291)
                      ++|.+ .+.||+|+||.||+|.+.+.   .+++.||+|.++.....   ..+..|+.++.++ +|+||+++++++.. .+
T Consensus         7 ~~~~i-~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~-~~   84 (337)
T cd05054           7 DRLKL-GKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK-PG   84 (337)
T ss_pred             HHhhh-hcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec-CC
Confidence            46775 67999999999999976442   24578999998754332   3467899999999 79999999998753 45


Q ss_pred             ceEEEEEecCCC-CHHHHHHHhhhhh----------------------------------------------------hC
Q psy2172          91 RKVWLLFDYAEH-DLWHIIKFHRAAK----------------------------------------------------AN  117 (291)
Q Consensus        91 ~~~~iv~e~~~~-~l~~~~~~~~~~~----------------------------------------------------~~  117 (291)
                      ..+++++||+.+ +|.+.+.......                                                    ..
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            678999999985 7877775432110                                                    00


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceecCCCCCCCCCCCCceecc
Q psy2172         118 KKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF  197 (291)
Q Consensus       118 ~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~  197 (291)
                      .....++...+..++.|++.||+|||++||+|+||||+||+++    .++.++|+|||++......... .......++.
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~----~~~~vkL~DfG~a~~~~~~~~~-~~~~~~~~~~  239 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLS----ENNVVKICDFGLARDIYKDPDY-VRKGDARLPL  239 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEe----CCCcEEEeccccchhcccCcch-hhccCCCCCc
Confidence            0012478899999999999999999999999999999999998    6678999999999865432111 1122334567


Q ss_pred             cccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc-----------cCCCCCcHHHHHHHHHhhCCCCcC
Q psy2172         198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI-----------KTSNPYHHDQLDRIFSVMGFPLEK  265 (291)
Q Consensus       198 ~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~-----------~~~~~~~~~~~~~i~~~~~~~~~~  265 (291)
                      .|+|||++.+.. ++.++|||||||++|+|++ |..||.+...+.           ..........+.+++..+....|.
T Consensus       240 ~y~aPE~~~~~~-~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~  318 (337)
T cd05054         240 KWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPE  318 (337)
T ss_pred             cccCcHHhcCCC-CCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChh
Confidence            799999998754 8999999999999999997 999997644221           011122235567778888888888


Q ss_pred             ChhhhhcC
Q psy2172         266 DWEDIRKM  273 (291)
Q Consensus       266 ~~~~~~~~  273 (291)
                      +||++.++
T Consensus       319 ~RPs~~el  326 (337)
T cd05054         319 DRPTFSEL  326 (337)
T ss_pred             hCcCHHHH
Confidence            88887763

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1e-35  Score=250.62  Aligned_cols=242  Identities=21%  Similarity=0.332  Sum_probs=187.0

Q ss_pred             cceeCcccceEEEEEEEcc---CCCCceeEEEEeCCCC--CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEe
Q psy2172          24 GCKVGRGTYGHVYKARRKD---NSDTRDYALKQIEGTG--LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFD   98 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~---~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e   98 (291)
                      .+.||+|+||.||++.+..   ......+++|.+....  ....+.+|+.++++++||||+++++++  ......+++||
T Consensus        10 ~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~lv~e   87 (288)
T cd05093          10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVC--VEGDPLIMVFE   87 (288)
T ss_pred             ccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEE--ecCCccEEEEE
Confidence            6699999999999998643   2244568999887543  234688999999999999999999998  45678999999


Q ss_pred             cCC-CCHHHHHHHhhhhh----hCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEee
Q psy2172          99 YAE-HDLWHIIKFHRAAK----ANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIAD  173 (291)
Q Consensus        99 ~~~-~~l~~~~~~~~~~~----~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~D  173 (291)
                      |+. ++|.+++.......    .......+++..++.++.|++.||++||++|++|+||||+||+++    .++.++|+|
T Consensus        88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~----~~~~~kl~d  163 (288)
T cd05093          88 YMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG----ENLLVKIGD  163 (288)
T ss_pred             cCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc----cCCcEEecc
Confidence            997 48888876543210    111222389999999999999999999999999999999999998    677899999


Q ss_pred             cccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc----------cc
Q psy2172         174 MGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED----------IK  242 (291)
Q Consensus       174 fg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~----------~~  242 (291)
                      ||.+........ ........++..|+|||.+.+. .++.++|+||||+++|+|++ |..||......          ..
T Consensus       164 fg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~  241 (288)
T cd05093         164 FGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL  241 (288)
T ss_pred             CCccccccCCce-eecCCCCCccccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcC
Confidence            999875543211 1112233456789999998774 48899999999999999998 99999765432          11


Q ss_pred             CCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         243 TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       243 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      .........+.+++..|..+.|..||++.++
T Consensus       242 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v  272 (288)
T cd05093         242 QRPRTCPKEVYDLMLGCWQREPHMRLNIKEI  272 (288)
T ss_pred             CCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence            1122334678999999999999999998864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=5.2e-36  Score=252.32  Aligned_cols=243  Identities=18%  Similarity=0.315  Sum_probs=191.8

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC---ChhHHHHHHHHhcCC-CCCeeeEEEEEEeCCCceEEEEEec
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL---SMSACREIALLRELK-HPNVINLISVFLSHNDRKVWLLFDY   99 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~iv~e~   99 (291)
                      .+.||+|+||.||++.+..  +++.+|+|.+.....   ...+.+|+.++.++. |+||+++++++.  .....+++|||
T Consensus         9 ~~~lg~G~~g~vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~--~~~~~~~~~e~   84 (288)
T cd06616           9 LGEIGRGAFGTVNKMLHKP--SGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALF--REGDCWICMEL   84 (288)
T ss_pred             HHHhCCCCceEEEEEEECC--CCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEe--cCCcEEEEEec
Confidence            4689999999999999876  678899999864332   235778999999996 999999999884  45678999999


Q ss_pred             CCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CeeeeccCCCcEEeecCCCCCCcEEEeecccce
Q psy2172         100 AEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSN-WVLHRDLKPANILVMGEGIERGRVKIADMGFAR  178 (291)
Q Consensus       100 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~-~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~  178 (291)
                      ++.++.++........    ...+++..+..++.|++.||+|||+. +++|+||||+||+++    .++.++|+|||++.
T Consensus        85 ~~~~l~~l~~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~----~~~~~kl~dfg~~~  156 (288)
T cd06616          85 MDISLDKFYKYVYEVL----KSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLD----RNGNIKLCDFGISG  156 (288)
T ss_pred             ccCCHHHHHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEc----cCCcEEEeecchhH
Confidence            9987766654322211    12289999999999999999999974 999999999999998    66789999999987


Q ss_pred             ecCCCCCCCCCCCCceecccccccccccCC--cCCCCchhHHHHHHHHHHHHcCCCCCCCCccc-----------ccC--
Q psy2172         179 LFNNPLKPLADLDPVVVTFWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQED-----------IKT--  243 (291)
Q Consensus       179 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~-----------~~~--  243 (291)
                      ......    ......|+..|+|||.+.+.  ..++.++|+||+|+++|+|++|..||......           .+.  
T Consensus       157 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd06616         157 QLVDSI----AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILS  232 (288)
T ss_pred             HhccCC----ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCC
Confidence            544321    11233567889999998765  35889999999999999999999999754321           000  


Q ss_pred             --CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhh
Q psy2172         244 --SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKD  282 (291)
Q Consensus       244 --~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (291)
                        ........+.+++..|..+.|..||++.++..++++.+.
T Consensus       233 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~  273 (288)
T cd06616         233 NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY  273 (288)
T ss_pred             CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence              111235678899999999999999999999999998653

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.3e-35  Score=251.54  Aligned_cols=239  Identities=21%  Similarity=0.331  Sum_probs=184.6

Q ss_pred             cccccccceeCcccceEEEEEEEcc---CCCCceeEEEEeCCCCC---ChhHHHHHHHHhcC-CCCCeeeEEEEEEeCCC
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKD---NSDTRDYALKQIEGTGL---SMSACREIALLREL-KHPNVINLISVFLSHND   90 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~---~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~   90 (291)
                      +.|.+ ++.||+|+||.||+|.+..   ......+|+|.++....   .+.+.+|+.+++++ +||||+++++++  ...
T Consensus        35 ~~~~~-~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~--~~~  111 (302)
T cd05055          35 NNLSF-GKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC--TIG  111 (302)
T ss_pred             HHeEE-cceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEE--ecC
Confidence            35554 6799999999999998632   22455799998875432   23578899999999 799999999998  456


Q ss_pred             ceEEEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcE
Q psy2172          91 RKVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRV  169 (291)
Q Consensus        91 ~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~  169 (291)
                      ...+++|||+. ++|.+.+.....       ..+++..+..++.|++.||+|||+++++|+||||+||+++    ....+
T Consensus       112 ~~~~lv~e~~~~~~L~~~i~~~~~-------~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~----~~~~~  180 (302)
T cd05055         112 GPILVITEYCCYGDLLNFLRRKRE-------SFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLT----HGKIV  180 (302)
T ss_pred             CceEEEEEcCCCCcHHHHHHhCCC-------CCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEc----CCCeE
Confidence            68999999997 588877754221       1178999999999999999999999999999999999998    66789


Q ss_pred             EEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc-------
Q psy2172         170 KIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI-------  241 (291)
Q Consensus       170 ~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~-------  241 (291)
                      +++|||.+......... .......++..|+|||.+.+.. ++.++||||+|+++|+|++ |..||.+.....       
T Consensus       181 ~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~  258 (302)
T cd05055         181 KICDFGLARDIMNDSNY-VVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK  258 (302)
T ss_pred             EECCCcccccccCCCce-eecCCCCcccccCCHhhhccCC-CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHH
Confidence            99999998765432111 1112234567899999987754 8899999999999999998 999997644321       


Q ss_pred             ----cCCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         242 ----KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       242 ----~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                          ..........+.+++..|..+.|..||++.+
T Consensus       259 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~e  293 (302)
T cd05055         259 EGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQ  293 (302)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence                0111223467888999999888988888775

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-36  Score=259.89  Aligned_cols=246  Identities=38%  Similarity=0.561  Sum_probs=196.4

Q ss_pred             cccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCC---Cce
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG----LSMSACREIALLRELKHPNVINLISVFLSHN---DRK   92 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---~~~   92 (291)
                      |.+ .+.||+|++|.||+|.+..  ++..|++|.+....    ....+.+|+.+++.++|+||+++++++...+   ...
T Consensus         2 y~i-~~~ig~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~   78 (330)
T cd07834           2 YEL-LKPIGSGAYGVVCSAVDKR--TGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFND   78 (330)
T ss_pred             cee-eeeecCCCCeEEEEEEeCC--CCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccc
Confidence            554 5799999999999999765  67889999887532    3456889999999999999999999984432   247


Q ss_pred             EEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          93 VWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        93 ~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      .|++|+|++++|.+.+....         .+++..++.++.|++.||++||++|++|+||||+||+++    .++.++|+
T Consensus        79 ~~lv~e~~~~~l~~~l~~~~---------~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~----~~~~~~L~  145 (330)
T cd07834          79 VYIVTELMETDLHKVIKSPQ---------PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVN----SNCDLKIC  145 (330)
T ss_pred             eEEEecchhhhHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc----CCCCEEEc
Confidence            89999999988777765322         289999999999999999999999999999999999998    66899999


Q ss_pred             ecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc-----------
Q psy2172         173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI-----------  241 (291)
Q Consensus       173 Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~-----------  241 (291)
                      |||.+.................++..|+|||.+.+...++.++|+||||+++|+|++|.+||.+.....           
T Consensus       146 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  225 (330)
T cd07834         146 DFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGT  225 (330)
T ss_pred             ccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCC
Confidence            999998765532211122334668889999999876458999999999999999999999997654210           


Q ss_pred             -----------------------------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         242 -----------------------------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       242 -----------------------------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                                                   ....+.....+.+++..|....|..||++.++..+||+..
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~  294 (330)
T cd07834         226 PSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ  294 (330)
T ss_pred             CChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHh
Confidence                                         0001112355778999999999999999999999888753

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=7.7e-36  Score=256.29  Aligned_cols=244  Identities=35%  Similarity=0.544  Sum_probs=192.3

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCC----CChhHHHHHHHHhcC-CCCCeeeEEEEEEe--CCCceEEEE
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG----LSMSACREIALLREL-KHPNVINLISVFLS--HNDRKVWLL   96 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~~~~iv   96 (291)
                      .+.||+|+||.||++.+.....+..||+|.++...    ..+.+.+|+.+++++ +||||+++++....  ......+++
T Consensus         5 ~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~   84 (332)
T cd07857           5 IKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLY   84 (332)
T ss_pred             EEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEE
Confidence            56899999999999998764337889999986432    234577899999999 59999999987532  233568999


Q ss_pred             EecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeeccc
Q psy2172          97 FDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGF  176 (291)
Q Consensus        97 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~  176 (291)
                      +++++++|...+....         .+++..++.++.|++.||++||++|++|+||||+||+++    .++.++|+|||.
T Consensus        85 ~e~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~----~~~~~kl~Dfg~  151 (332)
T cd07857          85 EELMEADLHQIIRSGQ---------PLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVN----ADCELKICDFGL  151 (332)
T ss_pred             EecccCCHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEc----CCCCEEeCcCCC
Confidence            9999998887775322         288999999999999999999999999999999999998    667899999999


Q ss_pred             ceecCCCCCC-CCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc---------------
Q psy2172         177 ARLFNNPLKP-LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED---------------  240 (291)
Q Consensus       177 ~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~---------------  240 (291)
                      +......... ........|+..|+|||.+.+...++.++|+||+|+++|+|++|.+||......               
T Consensus       152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  231 (332)
T cd07857         152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE  231 (332)
T ss_pred             ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCH
Confidence            9865432211 111233467889999998876455889999999999999999999999764310               


Q ss_pred             -------------------------ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchh
Q psy2172         241 -------------------------IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLL  280 (291)
Q Consensus       241 -------------------------~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  280 (291)
                                               .....+.....+.+++..|..+.|..||++.++..+||+.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~  296 (332)
T cd07857         232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLA  296 (332)
T ss_pred             HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhh
Confidence                                     0001112245688899999999999999999999999874

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=3.8e-36  Score=249.52  Aligned_cols=233  Identities=22%  Similarity=0.374  Sum_probs=185.6

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC--ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL--SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLL   96 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv   96 (291)
                      .|.+ .++||.|+||.||+|.+.+   +..+++|.+.....  ...+.+|+.+++.++|+||+++++++  .+....+++
T Consensus         7 ~y~~-~~~ig~g~~~~vy~~~~~~---~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~lv   80 (261)
T cd05148           7 EFTL-ERKLGSGYFGEVWEGLWKN---RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC--SVGEPVYII   80 (261)
T ss_pred             HHHH-hhhhccCCCccEEEeEecC---CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeE--ecCCCeEEE
Confidence            4554 6799999999999999864   56799999875533  45788999999999999999999998  556789999


Q ss_pred             EecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecc
Q psy2172          97 FDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMG  175 (291)
Q Consensus        97 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg  175 (291)
                      |||+++ +|.+++.....       ..++...+..++.|++.|+++||++|++|+||+|+||+++    .++.++|+|||
T Consensus        81 ~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~----~~~~~kl~d~g  149 (261)
T cd05148          81 TELMEKGSLLAFLRSPEG-------QVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVG----EDLVCKVADFG  149 (261)
T ss_pred             EeecccCCHHHHHhcCCC-------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEc----CCceEEEcccc
Confidence            999985 88888865322       1278899999999999999999999999999999999998    67789999999


Q ss_pred             cceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc----------cCC
Q psy2172         176 FARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI----------KTS  244 (291)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~----------~~~  244 (291)
                      .+........   ......++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||.......          ...
T Consensus       150 ~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~-~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~  225 (261)
T cd05148         150 LARLIKEDVY---LSSDKKIPYKWTAPEAASHGT-FSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPC  225 (261)
T ss_pred             chhhcCCccc---cccCCCCceEecCHHHHccCC-CCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCC
Confidence            9876543211   111334466799999987644 8899999999999999998 899997654321          112


Q ss_pred             CCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         245 NPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       245 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      .....+.+.+++..|....|..||++.+
T Consensus       226 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~  253 (261)
T cd05148         226 PAKCPQEIYKIMLECWAAEPEDRPSFKA  253 (261)
T ss_pred             CCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence            2334466788888888888888888775

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.6e-35  Score=245.97  Aligned_cols=242  Identities=26%  Similarity=0.459  Sum_probs=192.9

Q ss_pred             cccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC----ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEE
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL----SMSACREIALLRELKHPNVINLISVFLSHNDRKVWL   95 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~i   95 (291)
                      |.+ .+.||+|+||.||+|.+..  +++.+++|.++....    ...+.+|+.+++.++|+||+++++.+  .+....++
T Consensus         2 y~~-~~~lg~G~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~--~~~~~~~l   76 (264)
T cd06626           2 WQR-GNKIGGGTFGKVYTAVNLD--TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE--VHREKVYI   76 (264)
T ss_pred             cee-eeEeecCCCcEEEEEEECC--CCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE--ecCCEEEE
Confidence            453 5799999999999999765  678899999875433    34678999999999999999999988  56778999


Q ss_pred             EEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          96 LFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        96 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      ++||+++ +|.+.+....         .+++..+..++.|++.|+.+||++|++|+||+|+||+++    ..+.++|+||
T Consensus        77 v~e~~~~~~L~~~~~~~~---------~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~----~~~~~kl~d~  143 (264)
T cd06626          77 FMEYCSGGTLEELLEHGR---------ILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLD----HNGVIKLGDF  143 (264)
T ss_pred             EEecCCCCcHHHHHhhcC---------CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEEccc
Confidence            9999985 7777665422         178888999999999999999999999999999999998    6778999999


Q ss_pred             ccceecCCCCCCCCC-CCCceecccccccccccCCc--CCCCchhHHHHHHHHHHHHcCCCCCCCCccc-----------
Q psy2172         175 GFARLFNNPLKPLAD-LDPVVVTFWYRAPELLLGAR--HYTKAIDIWAIGCIFAELLTSEPIFHCRQED-----------  240 (291)
Q Consensus       175 g~~~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~--~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~-----------  240 (291)
                      |.+............ .....++..|+|||++.+..  ..+.++|+||||+++|++++|..||......           
T Consensus       144 g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  223 (264)
T cd06626         144 GCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGH  223 (264)
T ss_pred             ccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCC
Confidence            998876543222111 22345678899999987633  3788999999999999999999999754221           


Q ss_pred             ccCCCC--CcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         241 IKTSNP--YHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       241 ~~~~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                      ......  .....+.+++..+..+.|..||++.++..+||+
T Consensus       224 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         224 KPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             CCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            011111  125667889999999999999999999888874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.3e-35  Score=247.03  Aligned_cols=237  Identities=27%  Similarity=0.487  Sum_probs=187.8

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC-----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCce
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-----GLSMSACREIALLRELKHPNVINLISVFLSHNDRK   92 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (291)
                      +.|.+ .+.||+|++|.||+|.+..  +++.|++|.++..     .....+.+|++++++++|++++++++.+.  +...
T Consensus         2 ~~y~~-~~~lg~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~--~~~~   76 (267)
T cd08224           2 GNFKI-EKKIGKGQFSVVYKAICLL--DGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI--ENNE   76 (267)
T ss_pred             Cceee-eeeeccCCceEEEEEEEcC--CCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee--cCCe
Confidence            45665 6699999999999999875  6788999988532     12346789999999999999999999994  4568


Q ss_pred             EEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEE
Q psy2172          93 VWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI  171 (291)
Q Consensus        93 ~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l  171 (291)
                      .+++|||+++ +|..++......     ...+++..++.++.|++.|+.+||+.|++|+||+|+||+++    .++.++|
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~----~~~~~~l  147 (267)
T cd08224          77 LNIVLELADAGDLSRMIKHFKKQ-----KRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFIT----ATGVVKL  147 (267)
T ss_pred             EEEEEecCCCCCHHHHHHHhccc-----CCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEEC----CCCcEEE
Confidence            9999999985 888777653221     12278999999999999999999999999999999999998    6678999


Q ss_pred             eecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc----------
Q psy2172         172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI----------  241 (291)
Q Consensus       172 ~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~----------  241 (291)
                      +|||.+........   ......++..|.|||.+.+.. ++.++|+||||+++|+|++|..||.......          
T Consensus       148 ~d~~~~~~~~~~~~---~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  223 (267)
T cd08224         148 GDLGLGRFFSSKTT---AAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC  223 (267)
T ss_pred             eccceeeeccCCCc---ccceecCCccccCHHHhccCC-CCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcC
Confidence            99999876543211   112345678899999987644 8899999999999999999999996654221          


Q ss_pred             --c-CCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         242 --K-TSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       242 --~-~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                        . .........+.+++..|..+.|..||++.+
T Consensus       224 ~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~  257 (267)
T cd08224         224 DYPPLPADHYSEELRDLVSRCINPDPEKRPDISY  257 (267)
T ss_pred             CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHH
Confidence              0 111134457888999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=8e-36  Score=255.62  Aligned_cols=243  Identities=31%  Similarity=0.526  Sum_probs=195.1

Q ss_pred             cccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCC
Q psy2172          14 TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT----GLSMSACREIALLRELKHPNVINLISVFLSHN   89 (291)
Q Consensus        14 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   89 (291)
                      ..++++|.+ .+.||.|+||.||+|.+..  +++.+++|.+...    .....+.+|+.+++.++||||+++++++.. .
T Consensus         6 ~~~~~~y~~-~~~ig~g~~g~v~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~   81 (328)
T cd07856           6 FEITNRYVD-LQPVGMGAFGLVCSARDQL--TGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFIS-P   81 (328)
T ss_pred             eccccceEE-EEeecccCCeEEEEEEECC--CCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEec-C
Confidence            457888886 6799999999999999776  6788999987532    234567889999999999999999998853 3


Q ss_pred             CceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcE
Q psy2172          90 DRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRV  169 (291)
Q Consensus        90 ~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~  169 (291)
                      ....++++||++++|...+...          ++++..+..++.|++.||.+||++|++|+||+|+||+++    .++.+
T Consensus        82 ~~~~~lv~e~~~~~L~~~~~~~----------~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~----~~~~~  147 (328)
T cd07856          82 LEDIYFVTELLGTDLHRLLTSR----------PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILIN----ENCDL  147 (328)
T ss_pred             CCcEEEEeehhccCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeEC----CCCCE
Confidence            4578999999988887766422          178888999999999999999999999999999999998    67789


Q ss_pred             EEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc---------
Q psy2172         170 KIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED---------  240 (291)
Q Consensus       170 ~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~---------  240 (291)
                      +|+|||.+......      .....++..|+|||.+.+...++.++|+||||+++|+|++|..||.+....         
T Consensus       148 ~l~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~  221 (328)
T cd07856         148 KICDFGLARIQDPQ------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDL  221 (328)
T ss_pred             EeCccccccccCCC------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            99999998754321      123355778999998866455899999999999999999999999764320         


Q ss_pred             -----------------------ccC--------CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchh
Q psy2172         241 -----------------------IKT--------SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLL  280 (291)
Q Consensus       241 -----------------------~~~--------~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  280 (291)
                                             ...        ..+.....+.+++..|..+.|..||++.++..++++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~  292 (328)
T cd07856         222 LGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLA  292 (328)
T ss_pred             hCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccc
Confidence                                   000        0012245688899999999999999999998888763

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.3e-35  Score=246.30  Aligned_cols=236  Identities=21%  Similarity=0.363  Sum_probs=184.3

Q ss_pred             ccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC-ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEE
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-SMSACREIALLRELKHPNVINLISVFLSHNDRKVWL   95 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~i   95 (291)
                      .+.|.+ .++||+|+||.||+|..+   +++.+++|.+..... ...+.+|+.++++++|+|++++++++  . ....++
T Consensus         5 ~~~~~~-~~~ig~G~~g~v~~~~~~---~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~-~~~~~~   77 (260)
T cd05067           5 RETLKL-VKKLGAGQFGEVWMGYYN---GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVV--T-QEPIYI   77 (260)
T ss_pred             hHHcee-eeeeccCccceEEeeecC---CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEE--c-cCCcEE
Confidence            455665 579999999999999865   456799999875433 45788999999999999999999987  2 346899


Q ss_pred             EEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          96 LFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        96 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      +|||+. ++|.+.+.....       ..++...+..++.|++.||++||+.|++|+||+|+||+++    .++.++|+||
T Consensus        78 v~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~----~~~~~~l~df  146 (260)
T cd05067          78 ITEYMENGSLVDFLKTPEG-------IKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVS----ETLCCKIADF  146 (260)
T ss_pred             EEEcCCCCCHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEc----CCCCEEEccC
Confidence            999997 488877654321       1278899999999999999999999999999999999998    6778999999


Q ss_pred             ccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc----------cC
Q psy2172         175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI----------KT  243 (291)
Q Consensus       175 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~----------~~  243 (291)
                      |.+........  .......++..|+|||.+.+.. ++.++|+||||+++|++++ |+.||.+.....          ..
T Consensus       147 g~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  223 (260)
T cd05067         147 GLARLIEDNEY--TAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP  223 (260)
T ss_pred             cceeecCCCCc--ccccCCcccccccCHHHhccCC-cCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC
Confidence            99876542211  1112234466899999987644 8899999999999999998 999997654311          01


Q ss_pred             CCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         244 SNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       244 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      ........+.+++..|..+.|..||+++++
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l  253 (260)
T cd05067         224 RPDNCPEELYELMRLCWKEKPEERPTFEYL  253 (260)
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence            112234578889999998999888887753

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.1e-35  Score=251.40  Aligned_cols=243  Identities=20%  Similarity=0.291  Sum_probs=184.3

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC---CChhHHHHHHHHhcC-CCCCeeeEEEEEEeCCCceEE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG---LSMSACREIALLREL-KHPNVINLISVFLSHNDRKVW   94 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~   94 (291)
                      .|.+ .+.||+|+||.||+|.+++.+....+++|.++...   ..+.+.+|+.++.++ +||||+++++++  .+....+
T Consensus         3 ~~~~-~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~--~~~~~~~   79 (297)
T cd05089           3 DIKF-EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGAC--ENRGYLY   79 (297)
T ss_pred             ccee-eeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEE--ccCCcce
Confidence            4554 55999999999999998765444557888876422   234678899999999 799999999998  5566899


Q ss_pred             EEEecCC-CCHHHHHHHhhhhh-------hCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCC
Q psy2172          95 LLFDYAE-HDLWHIIKFHRAAK-------ANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIER  166 (291)
Q Consensus        95 iv~e~~~-~~l~~~~~~~~~~~-------~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~  166 (291)
                      +++||++ ++|.+.+.......       .......+++..++.++.|++.||++||++|++|+||||+||+++    .+
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~----~~  155 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVG----EN  155 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEEC----CC
Confidence            9999997 58888876533211       011223488999999999999999999999999999999999998    66


Q ss_pred             CcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc----
Q psy2172         167 GRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI----  241 (291)
Q Consensus       167 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~----  241 (291)
                      ..++|+|||++......    ........+..|+|||...+.. ++.++|||||||++|+|++ |..||.......    
T Consensus       156 ~~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~  230 (297)
T cd05089         156 LASKIADFGLSRGEEVY----VKKTMGRLPVRWMAIESLNYSV-YTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK  230 (297)
T ss_pred             CeEEECCcCCCccccce----eccCCCCcCccccCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            78999999998633211    0111112245699999987644 8899999999999999997 999997654321    


Q ss_pred             ------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         242 ------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       242 ------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                            ..........+.+++..|....|..||++.++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i  268 (297)
T cd05089         231 LPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQI  268 (297)
T ss_pred             HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence                  11122344678889999999999999988764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.5e-36  Score=254.78  Aligned_cols=244  Identities=22%  Similarity=0.429  Sum_probs=192.7

Q ss_pred             cccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC--CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCc
Q psy2172          14 TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG--LSMSACREIALLRELKHPNVINLISVFLSHNDR   91 (291)
Q Consensus        14 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (291)
                      ....+.|.. ...||+|+||.||++.+..  ++..|+||.+....  ....+.+|+.+++.++|+|++++++.+  ....
T Consensus        18 ~~~~~~~~~-~~~lg~g~~g~v~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~--~~~~   92 (292)
T cd06658          18 GDPREYLDS-FIKIGEGSTGIVCIATEKH--TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY--LVGD   92 (292)
T ss_pred             CchHHHHhh-hhcccCCCCeEEEEEEECC--CCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhe--ecCC
Confidence            334444553 5689999999999999765  66789999886432  234578899999999999999999998  4567


Q ss_pred             eEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEE
Q psy2172          92 KVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVK  170 (291)
Q Consensus        92 ~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~  170 (291)
                      ..+++|||+++ +|.+.+...          .+++..++.++.|++.||.+||++|++|+||+|+||+++    .++.++
T Consensus        93 ~~~lv~e~~~~~~L~~~~~~~----------~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~----~~~~~k  158 (292)
T cd06658          93 ELWVVMEFLEGGALTDIVTHT----------RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLT----SDGRIK  158 (292)
T ss_pred             eEEEEEeCCCCCcHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc----CCCCEE
Confidence            89999999986 555544321          178899999999999999999999999999999999998    667899


Q ss_pred             EeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---------
Q psy2172         171 IADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---------  241 (291)
Q Consensus       171 l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---------  241 (291)
                      |+|||++.......   .......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||.+.....         
T Consensus       159 L~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~  234 (292)
T cd06658         159 LSDFGFCAQVSKEV---PKRKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNL  234 (292)
T ss_pred             EccCcchhhccccc---ccCceeecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC
Confidence            99999986543221   1223356788999999987644 8899999999999999999999997644210         


Q ss_pred             ---cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchh
Q psy2172         242 ---KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLL  280 (291)
Q Consensus       242 ---~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  280 (291)
                         ..........+.+++..|..+.|..+|++.++..++++.
T Consensus       235 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~  276 (292)
T cd06658         235 PPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLK  276 (292)
T ss_pred             CCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhh
Confidence               011112356688899999999999999999998887765

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.4e-35  Score=246.05  Aligned_cols=235  Identities=21%  Similarity=0.316  Sum_probs=182.6

Q ss_pred             ccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEE
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWL   95 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~i   95 (291)
                      .+.|++ .++||+|+||.||+|.+.   .+..+++|.+.... ..+.+.+|+.++++++|++++++++++  . ....++
T Consensus         5 ~~~~~~-~~~ig~g~~~~v~~~~~~---~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~--~-~~~~~l   77 (260)
T cd05070           5 RESLQL-IKKLGNGQFGEVWMGTWN---GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVV--S-EEPIYI   77 (260)
T ss_pred             hHHhhh-hheeccccCceEEEEEec---CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEE--C-CCCcEE
Confidence            345665 569999999999999865   34569999887543 345788999999999999999999987  3 345789


Q ss_pred             EEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          96 LFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        96 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      +|||+.+ +|.+.+.....       ..+++..++.++.|++.||++||++|++|+||+|+||+++    .++.++|+||
T Consensus        78 v~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~----~~~~~~l~df  146 (260)
T cd05070          78 VTEYMSKGSLLDFLKDGEG-------RALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVG----DGLVCKIADF  146 (260)
T ss_pred             EEEecCCCcHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEe----CCceEEeCCc
Confidence            9999975 88877764321       1278999999999999999999999999999999999998    6678999999


Q ss_pred             ccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc----------ccC
Q psy2172         175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED----------IKT  243 (291)
Q Consensus       175 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~----------~~~  243 (291)
                      |.+........  .......++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||.+....          ...
T Consensus       147 g~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~  223 (260)
T cd05070         147 GLARLIEDNEY--TARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMP  223 (260)
T ss_pred             eeeeeccCccc--ccccCCCCCccccChHHHhcCC-CcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            99976543211  1111223456799999987644 8899999999999999998 89999764421          011


Q ss_pred             CCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         244 SNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       244 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      ........+.+++..+..+.|..||++.+
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~  252 (260)
T cd05070         224 CPQDCPISLHELMLQCWKKDPEERPTFEY  252 (260)
T ss_pred             CCCcCCHHHHHHHHHHcccCcccCcCHHH
Confidence            12233467888889988889988888774

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.9e-35  Score=252.35  Aligned_cols=248  Identities=25%  Similarity=0.442  Sum_probs=195.7

Q ss_pred             cccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC-----ChhHHHHHHHHhcCCCCCeeeEEEEEE
Q psy2172          12 ERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-----SMSACREIALLRELKHPNVINLISVFL   86 (291)
Q Consensus        12 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~   86 (291)
                      ........|.. .+.||+|+||.||++.+..  ++..+++|.+.....     ...+.+|+.+++.++|||++++++++ 
T Consensus        19 ~~~~~~~~f~~-~~~lg~G~~~~v~~~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-   94 (317)
T cd06635          19 FKEDPEKLFTD-LREIGHGSFGAVYFARDVR--TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCY-   94 (317)
T ss_pred             cCCCchhhhhh-hheeccCCCeEEEEEEEcC--CCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence            34445555663 6689999999999999876  667899999864321     23577899999999999999999998 


Q ss_pred             eCCCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCC
Q psy2172          87 SHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIER  166 (291)
Q Consensus        87 ~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~  166 (291)
                       .+....++||||+.|++.+.+.....        ++++..+..++.|++.|+.+||++|++|+||+|+||+++    .+
T Consensus        95 -~~~~~~~lv~e~~~g~l~~~~~~~~~--------~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~----~~  161 (317)
T cd06635          95 -LREHTAWLVMEYCLGSASDLLEVHKK--------PLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT----EP  161 (317)
T ss_pred             -eeCCeEEEEEeCCCCCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEEC----CC
Confidence             45668899999999988877654321        278899999999999999999999999999999999998    66


Q ss_pred             CcEEEeecccceecCCCCCCCCCCCCceecccccccccccC--CcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc----
Q psy2172         167 GRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLG--ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED----  240 (291)
Q Consensus       167 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~----  240 (291)
                      +.++|+|||++.....       .....++..|+|||.+..  ...++.++|+|||||++|+|++|..||......    
T Consensus       162 ~~~kl~dfg~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~  234 (317)
T cd06635         162 GQVKLADFGSASIASP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY  234 (317)
T ss_pred             CCEEEecCCCccccCC-------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH
Confidence            7899999998764332       123456788999999742  234788999999999999999999998764321    


Q ss_pred             -------ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhhh
Q psy2172         241 -------IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF  283 (291)
Q Consensus       241 -------~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (291)
                             ...........+.+++..|....|..||++.++..++++....
T Consensus       235 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  284 (317)
T cd06635         235 HIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER  284 (317)
T ss_pred             HHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence                   1111223356688999999999999999999988887655433

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=4.3e-36  Score=253.94  Aligned_cols=237  Identities=24%  Similarity=0.445  Sum_probs=190.3

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCC--CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecCC
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT--GLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAE  101 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~~  101 (291)
                      ...||+|+||.||+|.+..  ++..|++|.+...  .....+.+|+.+++.++|||++++++.+  ......++++||++
T Consensus        26 ~~~ig~g~~g~v~~~~~~~--~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~--~~~~~~~iv~e~~~  101 (297)
T cd06659          26 YIKIGEGSTGIVCIAREKH--SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY--LVGEELWVLMEFLQ  101 (297)
T ss_pred             hhhcCCCCceeEEEEEEcC--CCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhe--eeCCeEEEEEecCC
Confidence            4589999999999999765  6678999998532  2334678899999999999999999998  45678999999998


Q ss_pred             C-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceec
Q psy2172         102 H-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF  180 (291)
Q Consensus       102 ~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~  180 (291)
                      + +|...+...          .+++..++.++.|++.||++||++|++|+||+|+||+++    .++.++|+|||++...
T Consensus       102 ~~~L~~~~~~~----------~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~----~~~~~kL~dfg~~~~~  167 (297)
T cd06659         102 GGALTDIVSQT----------RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLT----LDGRVKLSDFGFCAQI  167 (297)
T ss_pred             CCCHHHHHhhc----------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEc----cCCcEEEeechhHhhc
Confidence            6 665544321          178999999999999999999999999999999999998    6789999999998654


Q ss_pred             CCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc------------cCCCCCc
Q psy2172         181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI------------KTSNPYH  248 (291)
Q Consensus       181 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~------------~~~~~~~  248 (291)
                      ....   .......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||.......            .......
T Consensus       168 ~~~~---~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (297)
T cd06659         168 SKDV---PKRKSLVGTPYWMAPEVISRTP-YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKI  243 (297)
T ss_pred             cccc---ccccceecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCC
Confidence            3321   1123356788999999997754 8899999999999999999999997543210            0111223


Q ss_pred             HHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhh
Q psy2172         249 HDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKD  282 (291)
Q Consensus       249 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (291)
                      ...+.+++..|....|..+|++.++..++++.+.
T Consensus       244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~  277 (297)
T cd06659         244 SPVLRDFLERMLTREPQERATAQELLDHPFLLQT  277 (297)
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHhhChhhccC
Confidence            4568889999999999999999999998877644

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=6.6e-36  Score=253.51  Aligned_cols=243  Identities=22%  Similarity=0.315  Sum_probs=183.3

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC---CChhHHHHHHHHhcC-CCCCeeeEEEEEEeCCCceEE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG---LSMSACREIALLREL-KHPNVINLISVFLSHNDRKVW   94 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~   94 (291)
                      .|.+ .+.||+|+||.||+|.++.++....+++|.++...   ....+.+|+.++.++ +||||+++++++  ......|
T Consensus         8 ~~~~-~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~--~~~~~~~   84 (303)
T cd05088           8 DIKF-QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC--EHRGYLY   84 (303)
T ss_pred             hcee-eeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE--CCCCCce
Confidence            3454 46899999999999998764444556888776422   223577899999999 899999999998  5667899


Q ss_pred             EEEecCC-CCHHHHHHHhhhhhh-------CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCC
Q psy2172          95 LLFDYAE-HDLWHIIKFHRAAKA-------NKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIER  166 (291)
Q Consensus        95 iv~e~~~-~~l~~~~~~~~~~~~-------~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~  166 (291)
                      ++|||++ ++|.+++........       ......+++..++.++.|++.|+++||++|++|+||||+||+++    .+
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~----~~  160 (303)
T cd05088          85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG----EN  160 (303)
T ss_pred             EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEec----CC
Confidence            9999997 488888765432110       01122488999999999999999999999999999999999998    66


Q ss_pred             CcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc----
Q psy2172         167 GRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI----  241 (291)
Q Consensus       167 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~----  241 (291)
                      +.++|+|||++......    .......++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.......    
T Consensus       161 ~~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~  235 (303)
T cd05088         161 YVAKIADFGLSRGQEVY----VKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK  235 (303)
T ss_pred             CcEEeCccccCcccchh----hhcccCCCcccccCHHHHhccC-CcccccchhhhhHHHHHHhcCCCCcccCChHHHHHH
Confidence            78999999998632211    1111122356799999987644 8899999999999999998 999997643221    


Q ss_pred             -----c-CCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         242 -----K-TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       242 -----~-~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                           . .........+.+++..|....|..||++.++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i  273 (303)
T cd05088         236 LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI  273 (303)
T ss_pred             HhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence                 0 0111234667889999999999999988764

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.5e-36  Score=247.12  Aligned_cols=236  Identities=22%  Similarity=0.340  Sum_probs=184.0

Q ss_pred             ccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEE
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWL   95 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~i   95 (291)
                      .+.|.+ .++||+|+||.||+|.+.+   .+.+++|.+.... ...++.+|+.++++++|+|++++++++  .+....++
T Consensus         5 ~~~~~i-~~~ig~g~~~~v~~~~~~~---~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~~   78 (261)
T cd05034           5 RESLKL-ERKLGAGQFGEVWMGTWNG---TTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC--SEEEPIYI   78 (261)
T ss_pred             hhheee-eeeeccCcceEEEEEEEcC---CceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeee--ecCCceEE
Confidence            456775 5699999999999998653   4669999987543 345788999999999999999999998  55678999


Q ss_pred             EEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          96 LFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        96 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      +|||+.+ +|.+.+.....       ..++...+..++.|++.|+.+||++|++|+||+|+||+++    .++.++|+||
T Consensus        79 v~e~~~~~~L~~~i~~~~~-------~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~----~~~~~~l~d~  147 (261)
T cd05034          79 VTEYMSKGSLLDFLKSGEG-------KKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVG----ENLVCKIADF  147 (261)
T ss_pred             EEeccCCCCHHHHHhcccc-------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEc----CCCCEEECcc
Confidence            9999975 88877764321       1288899999999999999999999999999999999998    6689999999


Q ss_pred             ccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc----------cC
Q psy2172         175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI----------KT  243 (291)
Q Consensus       175 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~----------~~  243 (291)
                      |.+........  .......++..|+|||.+.+.. ++.++|+||+|++++++++ |+.||.+.....          ..
T Consensus       148 g~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~  224 (261)
T cd05034         148 GLARLIEDDEY--TAREGAKFPIKWTAPEAANYGR-FTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMP  224 (261)
T ss_pred             ccceeccchhh--hhhhccCCCccccCHHHhccCC-cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            99876543211  1111223356799999998644 8899999999999999998 999997755321          01


Q ss_pred             CCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         244 SNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       244 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      ........+.+++..|..+.|..||++.+
T Consensus       225 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~  253 (261)
T cd05034         225 RPPNCPEELYDLMLQCWDKDPEERPTFEY  253 (261)
T ss_pred             CCCCCCHHHHHHHHHHcccCcccCCCHHH
Confidence            11222456777888888888888887664

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.1e-35  Score=249.22  Aligned_cols=234  Identities=26%  Similarity=0.403  Sum_probs=181.3

Q ss_pred             eeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC-----hhHHHHHHHHhc---CCCCCeeeEEEEEEeCCCceEEEEE
Q psy2172          26 KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS-----MSACREIALLRE---LKHPNVINLISVFLSHNDRKVWLLF   97 (291)
Q Consensus        26 ~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~e~~~l~~---l~h~~iv~~~~~~~~~~~~~~~iv~   97 (291)
                      .||+|+||.||++.+..  +++.+|+|.+......     ....+|..+++.   .+||+++.+++.+  ...+..++||
T Consensus         1 ~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~--~~~~~~~lv~   76 (279)
T cd05633           1 IIGRGGFGEVYGCRKAD--TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAF--HTPDKLCFIL   76 (279)
T ss_pred             CcccCCCeEEEEEEECC--CCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEE--ecCCeEEEEE
Confidence            48999999999999866  6788999988643221     223444443333   4799999999998  4566899999


Q ss_pred             ecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeeccc
Q psy2172          98 DYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGF  176 (291)
Q Consensus        98 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~  176 (291)
                      ||+.+ +|...+....         .+++..+..++.|++.||.+||++|++|+||||+||+++    .++.++|+|||+
T Consensus        77 e~~~~~~L~~~i~~~~---------~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~----~~~~~~l~dfg~  143 (279)
T cd05633          77 DLMNGGDLHYHLSQHG---------VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLD----EHGHVRISDLGL  143 (279)
T ss_pred             ecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEEC----CCCCEEEccCCc
Confidence            99985 7766554322         289999999999999999999999999999999999998    667899999999


Q ss_pred             ceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc------------cCC
Q psy2172         177 ARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI------------KTS  244 (291)
Q Consensus       177 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~------------~~~  244 (291)
                      +......     ......|+..|+|||.+.+...++.++|+||+||++|+|++|..||.......            ...
T Consensus       144 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  218 (279)
T cd05633         144 ACDFSKK-----KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVEL  218 (279)
T ss_pred             ceecccc-----CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCC
Confidence            8654332     11234678899999998654458899999999999999999999997543211            011


Q ss_pred             CCCcHHHHHHHHHhhCCCCcCChh-----hhhcCCCCcchhh
Q psy2172         245 NPYHHDQLDRIFSVMGFPLEKDWE-----DIRKMPEHPTLLK  281 (291)
Q Consensus       245 ~~~~~~~~~~i~~~~~~~~~~~~~-----~~~~~~~~~~~~~  281 (291)
                      .......+.+++..|....|..|+     ++.++.+||++..
T Consensus       219 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~  260 (279)
T cd05633         219 PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG  260 (279)
T ss_pred             ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccC
Confidence            223356678889999999999998     5888888888765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.2e-35  Score=248.83  Aligned_cols=237  Identities=26%  Similarity=0.391  Sum_probs=182.4

Q ss_pred             eeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC-----hhHHHHHH---HHhcCCCCCeeeEEEEEEeCCCceEEEEE
Q psy2172          26 KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS-----MSACREIA---LLRELKHPNVINLISVFLSHNDRKVWLLF   97 (291)
Q Consensus        26 ~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~e~~---~l~~l~h~~iv~~~~~~~~~~~~~~~iv~   97 (291)
                      .||+|+||.||+|.+..  +++.||+|.+......     ..+..|..   +++...||+|+++++.+  .+....++||
T Consensus         1 ~ig~g~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~--~~~~~~~~v~   76 (278)
T cd05606           1 IIGRGGFGEVYGCRKAD--TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF--HTPDKLSFIL   76 (278)
T ss_pred             CcccCCCeEEEEEEEec--CCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee--ecCCEEEEEE
Confidence            48999999999999765  6788999998653221     12333433   44445799999999999  5567899999


Q ss_pred             ecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeeccc
Q psy2172          98 DYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGF  176 (291)
Q Consensus        98 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~  176 (291)
                      ||+.| +|...+....         .+++..++.++.|++.|++|||+++++|+||+|+||+++    .++.++|+|||.
T Consensus        77 e~~~g~~L~~~l~~~~---------~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~----~~~~~kl~dfg~  143 (278)
T cd05606          77 DLMNGGDLHYHLSQHG---------VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD----EHGHVRISDLGL  143 (278)
T ss_pred             ecCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEEC----CCCCEEEccCcC
Confidence            99986 6655553221         289999999999999999999999999999999999998    667899999999


Q ss_pred             ceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc------------cCC
Q psy2172         177 ARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI------------KTS  244 (291)
Q Consensus       177 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~------------~~~  244 (291)
                      +......     ......|+..|+|||.+.+...++.++|+||+|+++|+|++|..||.......            ...
T Consensus       144 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  218 (278)
T cd05606         144 ACDFSKK-----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL  218 (278)
T ss_pred             ccccCcc-----CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCC
Confidence            8754332     11234678899999998764458899999999999999999999997652110            111


Q ss_pred             CCCcHHHHHHHHHhhCCCCcCChh-----hhhcCCCCcchhhhhh
Q psy2172         245 NPYHHDQLDRIFSVMGFPLEKDWE-----DIRKMPEHPTLLKDFN  284 (291)
Q Consensus       245 ~~~~~~~~~~i~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~  284 (291)
                      .......+.+++..+....|..++     ++.++.++||+.+-..
T Consensus       219 ~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~  263 (278)
T cd05606         219 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDW  263 (278)
T ss_pred             CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCc
Confidence            122356788888888888898998     7888888888765433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.6e-35  Score=245.21  Aligned_cols=230  Identities=17%  Similarity=0.306  Sum_probs=181.9

Q ss_pred             cccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEec
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDY   99 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~   99 (291)
                      |.+ .+.||+|+||.||++...    +..+++|.++.....+.+.+|+.++++++|+|++++++++.. .....++++||
T Consensus         8 ~~~-~~~lg~g~~~~v~~~~~~----~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~lv~e~   81 (256)
T cd05082           8 LKL-LQTIGKGEFGDVMLGDYR----GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE-EKGGLYIVTEY   81 (256)
T ss_pred             Cee-eeeecccCCCeEEEEEEc----CCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEc-CCCceEEEEEC
Confidence            443 579999999999999764    456999999876666678999999999999999999998653 45678999999


Q ss_pred             CCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccce
Q psy2172         100 AEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR  178 (291)
Q Consensus       100 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~  178 (291)
                      +++ +|.+.+.....       ..+++..++.++.|++.||++||++|++|+||||+||+++    .++.++|+|||++.
T Consensus        82 ~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~----~~~~~kl~dfg~~~  150 (256)
T cd05082          82 MAKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVS----EDNVAKVSDFGLTK  150 (256)
T ss_pred             CCCCcHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEc----CCCcEEecCCccce
Confidence            985 88877764322       1278899999999999999999999999999999999998    67899999999987


Q ss_pred             ecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc----------cCCCCC
Q psy2172         179 LFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI----------KTSNPY  247 (291)
Q Consensus       179 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~----------~~~~~~  247 (291)
                      ......      ....++..|+|||++.+.. ++.++|+||||+++|+|++ |+.||.......          ......
T Consensus       151 ~~~~~~------~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  223 (256)
T cd05082         151 EASSTQ------DTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG  223 (256)
T ss_pred             eccccC------CCCccceeecCHHHHccCC-CCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Confidence            543321      1223356799999987644 8899999999999999997 999997643210          111122


Q ss_pred             cHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         248 HHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       248 ~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      ....+.+++..+....|..||++.++
T Consensus       224 ~~~~~~~li~~~l~~~p~~Rpt~~~l  249 (256)
T cd05082         224 CPPVVYDVMKQCWHLDAATRPSFLQL  249 (256)
T ss_pred             CCHHHHHHHHHHhcCChhhCcCHHHH
Confidence            34567888888888888888887753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.5e-36  Score=257.77  Aligned_cols=245  Identities=32%  Similarity=0.546  Sum_probs=194.4

Q ss_pred             cccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC----ChhHHHHHHHHhcCCCCCeeeEEEEEEeCC
Q psy2172          14 TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL----SMSACREIALLRELKHPNVINLISVFLSHN   89 (291)
Q Consensus        14 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   89 (291)
                      ..+.++|.+ .+.||+|+||.||+|.+..  ++..||+|.+.....    ...+.+|+.+++.++||||+++++++....
T Consensus        11 ~~~~~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   87 (343)
T cd07880          11 WEVPDRYRD-LKQVGSGAYGTVCSALDRR--TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDL   87 (343)
T ss_pred             hccccceEE-EEEeeecCCeEEEEEEECC--CCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence            346778885 6799999999999999766  678899999864322    235778999999999999999999984322


Q ss_pred             C----ceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCC
Q psy2172          90 D----RKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIE  165 (291)
Q Consensus        90 ~----~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~  165 (291)
                      .    ...++||+++++++...+...          .+++..++.++.|++.||++||+.|++|+||+|+||+++    .
T Consensus        88 ~~~~~~~~~lv~e~~~~~l~~~~~~~----------~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~----~  153 (343)
T cd07880          88 SLDRFHDFYLVMPFMGTDLGKLMKHE----------KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN----E  153 (343)
T ss_pred             cccccceEEEEEecCCCCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc----C
Confidence            1    256999999988887776532          188999999999999999999999999999999999998    6


Q ss_pred             CCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc----
Q psy2172         166 RGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI----  241 (291)
Q Consensus       166 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~----  241 (291)
                      ++.++++|||.+......      .....++..|+|||.+.+...++.++|+||||+++|++++|..||.+.....    
T Consensus       154 ~~~~kl~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~  227 (343)
T cd07880         154 DCELKILDFGLARQTDSE------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLME  227 (343)
T ss_pred             CCCEEEeecccccccccC------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            678999999998754331      1233567889999998764458899999999999999999999997653210    


Q ss_pred             ------------------------------------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         242 ------------------------------------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       242 ------------------------------------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                                                          ....+.....+.+++..|....|..||++.++..++++..
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~  303 (343)
T cd07880         228 IMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEE  303 (343)
T ss_pred             HHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhh
Confidence                                                0001122345678888899999999999999888888764

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.1e-35  Score=248.96  Aligned_cols=241  Identities=22%  Similarity=0.326  Sum_probs=182.5

Q ss_pred             cceeCcccceEEEEEEEccC---CCCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEE
Q psy2172          24 GCKVGRGTYGHVYKARRKDN---SDTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLF   97 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~---~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~   97 (291)
                      .+.||+|+||.||+|.+...   .....+++|.+.....   ...+.+|+.+++.++||||+++++.+  ......++++
T Consensus         5 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~~~lv~   82 (290)
T cd05045           5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGAC--SQDGPLLLIV   82 (290)
T ss_pred             cccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEE--ecCCCcEEEE
Confidence            57999999999999987532   1335689998875433   24578899999999999999999998  4566789999


Q ss_pred             ecCCC-CHHHHHHHhhhhh---------------hCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeec
Q psy2172          98 DYAEH-DLWHIIKFHRAAK---------------ANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMG  161 (291)
Q Consensus        98 e~~~~-~l~~~~~~~~~~~---------------~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~  161 (291)
                      ||+.+ +|.+++.......               .......++...++.++.|++.||++||+++++|+||+|+||+++ 
T Consensus        83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~-  161 (290)
T cd05045          83 EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVA-  161 (290)
T ss_pred             EecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEc-
Confidence            99984 7877766432110               011223488999999999999999999999999999999999998 


Q ss_pred             CCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc
Q psy2172         162 EGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED  240 (291)
Q Consensus       162 ~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~  240 (291)
                         .++.++|+|||++......... .......++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+....
T Consensus       162 ---~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~  236 (290)
T cd05045         162 ---EGRKMKISDFGLSRDVYEEDSY-VKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE  236 (290)
T ss_pred             ---CCCcEEeccccccccccCccch-hcccCCCCCccccCHHHHccCC-cchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence               6678999999998755332111 1112234466799999987644 8899999999999999998 99999765432


Q ss_pred             c----------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         241 I----------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       241 ~----------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      .          ..........+.+++..|..+.|..||++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~  278 (290)
T cd05045         237 RLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFAD  278 (290)
T ss_pred             HHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence            1          0112223456788888888888888888775

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.6e-35  Score=247.97  Aligned_cols=241  Identities=25%  Similarity=0.412  Sum_probs=192.6

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHNDRKVW   94 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (291)
                      +.|+ ..+.||+|+||.||+|.+..  ++..+|+|.+.....   ...+.+|+.++++++||||+++++++  .+....+
T Consensus         4 ~~~~-~~~~ig~G~~~~vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~~~~~~~   78 (277)
T cd06641           4 ELFT-KLEKIGKGSFGEVFKGIDNR--TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY--LKDTKLW   78 (277)
T ss_pred             Hhhh-hheeEeecCCeEEEEEEECC--CCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEE--EeCCeEE
Confidence            4555 36689999999999998766  668899998864332   24577899999999999999999999  4567899


Q ss_pred             EEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEee
Q psy2172          95 LLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIAD  173 (291)
Q Consensus        95 iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~D  173 (291)
                      +||||+++ +|...+...          .++...+..++.|++.++.+||++|++|+||+|+||+++    .++.++++|
T Consensus        79 lv~e~~~~~~l~~~i~~~----------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~----~~~~~~l~d  144 (277)
T cd06641          79 IIMEYLGGGSALDLLEPG----------PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS----EHGEVKLAD  144 (277)
T ss_pred             EEEEeCCCCcHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEEC----CCCCEEEee
Confidence            99999986 666665421          278999999999999999999999999999999999998    667899999


Q ss_pred             cccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc----------ccC
Q psy2172         174 MGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED----------IKT  243 (291)
Q Consensus       174 fg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~----------~~~  243 (291)
                      ||.+........   ......++..|+|||.+.+.. ++.++|+|||||++|+|++|..||......          ...
T Consensus       145 fg~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  220 (277)
T cd06641         145 FGVAGQLTDTQI---KRNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPT  220 (277)
T ss_pred             cccceecccchh---hhccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCC
Confidence            999876543211   112345678899999987644 788999999999999999999999764422          111


Q ss_pred             CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         244 SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       244 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                      ........+.+++..+....|..+|++.++..++++.+
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~  258 (277)
T cd06641         221 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVR  258 (277)
T ss_pred             CCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhh
Confidence            22233456888999999999999999999988877753

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=3.8e-36  Score=250.02  Aligned_cols=238  Identities=25%  Similarity=0.417  Sum_probs=193.3

Q ss_pred             cccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEE
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLL   96 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv   96 (291)
                      |++ .+.||+|++|.||+|.++.  +++.+++|.+.....   ...+.+|+++++.++||||+++++.+  ......+++
T Consensus         3 ~~~-~~~ig~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~--~~~~~~~lv   77 (265)
T cd06605           3 LEY-LGELGAGNSGVVSKVLHRP--TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF--YNNGDISIC   77 (265)
T ss_pred             chH-HHHhcCCCCeEEEEEEEcC--CCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheee--ecCCEEEEE
Confidence            443 5689999999999999876  678899999875432   24578899999999999999999998  445789999


Q ss_pred             EecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          97 FDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHS-NWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        97 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~-~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      +||++ ++|.+++....        ..+++..+..++.|++.|+++||+ .|++|+||+|+||+++    .++.++|+||
T Consensus        78 ~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~----~~~~~~l~d~  145 (265)
T cd06605          78 MEYMDGGSLDKILKEVQ--------GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN----SRGQIKLCDF  145 (265)
T ss_pred             EEecCCCcHHHHHHHcc--------CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEEC----CCCCEEEeec
Confidence            99999 58887776542        128899999999999999999999 9999999999999998    6778999999


Q ss_pred             ccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc--------------
Q psy2172         175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED--------------  240 (291)
Q Consensus       175 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~--------------  240 (291)
                      |.+........     ....++..|+|||.+.+. .++.++|+||||+++|+|++|..||......              
T Consensus       146 g~~~~~~~~~~-----~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  219 (265)
T cd06605         146 GVSGQLVNSLA-----KTFVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE  219 (265)
T ss_pred             ccchhhHHHHh-----hcccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC
Confidence            99865533211     115667889999999775 4889999999999999999999999754210              


Q ss_pred             -ccCCCC-CcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchh
Q psy2172         241 -IKTSNP-YHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLL  280 (291)
Q Consensus       241 -~~~~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  280 (291)
                       ...... .....+.+++..|..+.|..||++.++..+||+.
T Consensus       220 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~  261 (265)
T cd06605         220 PPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIK  261 (265)
T ss_pred             CCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhh
Confidence             001111 1356788999999999999999999999999884

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.3e-35  Score=251.90  Aligned_cols=242  Identities=24%  Similarity=0.379  Sum_probs=189.7

Q ss_pred             cccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEE
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-----LSMSACREIALLRELKHPNVINLISVFLSHNDRKVW   94 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (291)
                      |.+ .+.||+|+||.||++.+..  .++.|++|.+....     ....+.+|+.+++.++||||+++++.+  ......+
T Consensus         3 y~~-~~~l~~g~~~~v~~~~~~~--~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~--~~~~~~~   77 (305)
T cd05609           3 FET-IKLISNGAYGAVYLVRHKE--TRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF--ETKRHLC   77 (305)
T ss_pred             ceE-eeEeecCCCeeEEEEEECC--CCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE--ecCCEEE
Confidence            443 4699999999999999876  67889999986532     123567899999999999999999998  5567899


Q ss_pred             EEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEee
Q psy2172          95 LLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIAD  173 (291)
Q Consensus        95 iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~D  173 (291)
                      ++|||++| +|.+.+....         .+++..+..++.|++.|+++||++|++|+||+|+||+++    ..+.++|+|
T Consensus        78 lv~e~~~g~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~----~~~~~~l~d  144 (305)
T cd05609          78 MVMEYVEGGDCATLLKNIG---------ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLIT----SMGHIKLTD  144 (305)
T ss_pred             EEEecCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEEC----CCCCEEEee
Confidence            99999986 7777775432         278999999999999999999999999999999999998    678999999


Q ss_pred             cccceecCCCCCC------------CCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc
Q psy2172         174 MGFARLFNNPLKP------------LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI  241 (291)
Q Consensus       174 fg~~~~~~~~~~~------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~  241 (291)
                      ||.+.........            ........++..|+|||.+.+.. ++.++|+||||+++|+|++|..||.+.....
T Consensus       145 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~vl~el~~g~~pf~~~~~~~  223 (305)
T cd05609         145 FGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEE  223 (305)
T ss_pred             CCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            9988642111000            00111235677899999987744 8999999999999999999999998654321


Q ss_pred             ------------cCCCCCcHHHHHHHHHhhCCCCcCChhh---hhcCCCCcchh
Q psy2172         242 ------------KTSNPYHHDQLDRIFSVMGFPLEKDWED---IRKMPEHPTLL  280 (291)
Q Consensus       242 ------------~~~~~~~~~~~~~i~~~~~~~~~~~~~~---~~~~~~~~~~~  280 (291)
                                  +.........+.+++..|..+.|..||+   +.++.++|++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~  277 (305)
T cd05609         224 LFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL  277 (305)
T ss_pred             HHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCcccc
Confidence                        1111133566899999999999999997   56667777753

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=3.2e-35  Score=243.07  Aligned_cols=239  Identities=30%  Similarity=0.465  Sum_probs=196.2

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC----ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEec
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL----SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDY   99 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~   99 (291)
                      .+.||+|++|.||+|.+..  +++.+++|.+.....    .+.+.+|+.++++++||||+++++.+........++++|+
T Consensus         5 ~~~i~~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~   82 (260)
T cd06606           5 GELLGRGSFGSVYLALDKD--TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEY   82 (260)
T ss_pred             eeEeeecCceEEEEEEECC--CCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEe
Confidence            5799999999999999876  678899999875543    4568899999999999999999999954333789999999


Q ss_pred             CC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccce
Q psy2172         100 AE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR  178 (291)
Q Consensus       100 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~  178 (291)
                      ++ ++|.+.+....         .+++..++.++.|++.||++||+.|++|+||+|+||+++    ..+.++|+|||.+.
T Consensus        83 ~~~~~L~~~~~~~~---------~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~----~~~~~~l~d~~~~~  149 (260)
T cd06606          83 VSGGSLSSLLKKFG---------KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVD----SDGVVKLADFGCAK  149 (260)
T ss_pred             cCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc----CCCCEEEcccccEE
Confidence            95 57777776443         289999999999999999999999999999999999998    67899999999998


Q ss_pred             ecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcc------------cccCCCC
Q psy2172         179 LFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE------------DIKTSNP  246 (291)
Q Consensus       179 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~------------~~~~~~~  246 (291)
                      ........ .......++..|.|||.+.+.. .+.++|+||||+++++|++|..||.....            .......
T Consensus       150 ~~~~~~~~-~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  227 (260)
T cd06606         150 RLGDIETG-EGTGSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPE  227 (260)
T ss_pred             eccccccc-ccccCCCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCc
Confidence            76653221 0123456788899999997754 88999999999999999999999987651            1122223


Q ss_pred             CcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         247 YHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       247 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                      .....+.+++..|..+.|..||++.++..+||+
T Consensus       228 ~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         228 HLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             ccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence            335678999999999999999999999888875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.4e-35  Score=246.46  Aligned_cols=232  Identities=17%  Similarity=0.219  Sum_probs=173.2

Q ss_pred             ceeCcccceEEEEEEEccC----------CCCceeEEEEeCCCC--CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCce
Q psy2172          25 CKVGRGTYGHVYKARRKDN----------SDTRDYALKQIEGTG--LSMSACREIALLRELKHPNVINLISVFLSHNDRK   92 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~----------~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (291)
                      +.||+|+||.||+|.....          .....+++|.+....  ....+.+|+.+++.++||||+++++++.  +...
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~--~~~~   78 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCV--RDVE   78 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEe--cCCC
Confidence            4789999999999985421          123358889876432  2335778899999999999999999984  4557


Q ss_pred             EEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCC---CCCc
Q psy2172          93 VWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGI---ERGR  168 (291)
Q Consensus        93 ~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~---~~~~  168 (291)
                      .+++|||+++ +|..++....        ..+++..++.++.|++.||+|||++|++|+||||+||+++.+..   ....
T Consensus        79 ~~lv~e~~~~~~l~~~~~~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~  150 (262)
T cd05077          79 NIMVEEFVEFGPLDLFMHRKS--------DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPF  150 (262)
T ss_pred             CEEEEecccCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCce
Confidence            7999999986 4444433211        12889999999999999999999999999999999999974321   1124


Q ss_pred             EEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHH-cCCCCCCCCcccc------
Q psy2172         169 VKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDI------  241 (291)
Q Consensus       169 ~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~-~g~~pf~~~~~~~------  241 (291)
                      ++++|||.+......       ....++..|+|||.+.+...++.++||||||+++|+|+ .|..||.......      
T Consensus       151 ~~l~d~g~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~  223 (262)
T cd05077         151 IKLSDPGIPITVLSR-------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYE  223 (262)
T ss_pred             eEeCCCCCCccccCc-------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHh
Confidence            899999988654321       22346778999999875456889999999999999997 6889987644211      


Q ss_pred             --cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         242 --KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       242 --~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                        ........+.+.+++..|....|.+||++.++
T Consensus       224 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~i  257 (262)
T cd05077         224 GQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAI  257 (262)
T ss_pred             cCccCCCCChHHHHHHHHHHcCCChhhCcCHHHH
Confidence              01111124567889999999999999887754

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.8e-35  Score=249.74  Aligned_cols=244  Identities=16%  Similarity=0.148  Sum_probs=171.8

Q ss_pred             cccccccccccceeCcccceEEEEEEEccCCC-CceeEEEEeCCCCCC--h-----------hHHHHHHHHhcCCCCCee
Q psy2172          14 TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSD-TRDYALKQIEGTGLS--M-----------SACREIALLRELKHPNVI   79 (291)
Q Consensus        14 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~-~~~vaiK~~~~~~~~--~-----------~~~~e~~~l~~l~h~~iv   79 (291)
                      ....+.|.+ +++||+|+||.||+|.+.+... ...+++|........  .           ....+...+..++|++++
T Consensus         8 ~i~~~~y~i-~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~   86 (294)
T PHA02882          8 DITGKEWKI-DKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP   86 (294)
T ss_pred             ccCCCceEE-eeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence            344567775 7799999999999999866311 455777764322211  0           112233445567899999


Q ss_pred             eEEEEEEeCCC--ceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcE
Q psy2172          80 NLISVFLSHND--RKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANI  157 (291)
Q Consensus        80 ~~~~~~~~~~~--~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Ni  157 (291)
                      ++++.......  ...+++++++..++.+.+.....         .++..++.++.|++.||++||+++++||||||+||
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Ni  157 (294)
T PHA02882         87 KYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKC---------KNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENI  157 (294)
T ss_pred             cEEEeeeEecCCceEEEEEEehhccCHHHHHHhhcc---------CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence            99987643322  25678888887777666553221         56788999999999999999999999999999999


Q ss_pred             EeecCCCCCCcEEEeecccceecCCCCCC----CCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCC
Q psy2172         158 LVMGEGIERGRVKIADMGFARLFNNPLKP----LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI  233 (291)
Q Consensus       158 l~~~~~~~~~~~~l~Dfg~~~~~~~~~~~----~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p  233 (291)
                      +++    .++.++|+|||+++........    ........||+.|+|||++.+.. ++.++|||||||++++|++|..|
T Consensus       158 ll~----~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~-~~~~~DiwSlG~~l~el~~g~~P  232 (294)
T PHA02882        158 MVD----GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGAC-VTRRGDLESLGYCMLKWAGIKLP  232 (294)
T ss_pred             EEc----CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHhCCCC
Confidence            998    6678999999999865432111    11122346899999999998755 89999999999999999999999


Q ss_pred             CCCCccccc-----------------CCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         234 FHCRQEDIK-----------------TSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       234 f~~~~~~~~-----------------~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      |.+......                 ...+.....+.++++.+....+.++|++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~  288 (294)
T PHA02882        233 WKGFGHNGNLIHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDA  288 (294)
T ss_pred             CCccccchHHHHHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHH
Confidence            987643110                 011122344666666666666666666554

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.4e-35  Score=243.23  Aligned_cols=229  Identities=20%  Similarity=0.346  Sum_probs=178.3

Q ss_pred             ceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecCC
Q psy2172          25 CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAE  101 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~~  101 (291)
                      ++||+|+||.||+|...   ++..+|+|.+.....   ...+.+|+.+++.++||||+++++++  .+....+++|||++
T Consensus         1 ~~ig~g~~g~vy~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~lv~e~~~   75 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK---DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC--TQRQPIYIVMELVP   75 (250)
T ss_pred             CccCCCCCceEEEEEec---CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEE--ecCCccEEEEECCC
Confidence            47999999999999854   456799999875432   23578899999999999999999998  45668899999997


Q ss_pred             C-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceec
Q psy2172         102 H-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF  180 (291)
Q Consensus       102 ~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~  180 (291)
                      + +|.+.+.....        .+++..+..++.|++.+|.++|++|++|+||+|+||+++    .++.++|+|||++...
T Consensus        76 ~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~----~~~~~~l~d~g~~~~~  143 (250)
T cd05085          76 GGDFLSFLRKKKD--------ELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVG----ENNVLKISDFGMSRQE  143 (250)
T ss_pred             CCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEc----CCCeEEECCCccceec
Confidence            5 77766643221        278899999999999999999999999999999999998    6678999999998754


Q ss_pred             CCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc----------cCCCCCcH
Q psy2172         181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI----------KTSNPYHH  249 (291)
Q Consensus       181 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~----------~~~~~~~~  249 (291)
                      .....  .......++..|+|||++.+.. ++.++|+||||+++|++++ |..||.......          ........
T Consensus       144 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  220 (250)
T cd05085         144 DDGIY--SSSGLKQIPIKWTAPEALNYGR-YSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCP  220 (250)
T ss_pred             ccccc--ccCCCCCCcccccCHHHhccCC-CCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence            32211  1112223356799999987644 8899999999999999998 999997654321          11122334


Q ss_pred             HHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         250 DQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       250 ~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      ..+.+++..+....|.+||++.++
T Consensus       221 ~~~~~li~~~l~~~p~~Rp~~~~l  244 (250)
T cd05085         221 DDVYKVMQRCWDYKPENRPKFSEL  244 (250)
T ss_pred             HHHHHHHHHHcccCcccCCCHHHH
Confidence            678888888888888888887753

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=3.5e-35  Score=250.19  Aligned_cols=243  Identities=24%  Similarity=0.431  Sum_probs=193.2

Q ss_pred             cccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC-----ChhHHHHHHHHhcCCCCCeeeEEEEEEeC
Q psy2172          14 TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-----SMSACREIALLRELKHPNVINLISVFLSH   88 (291)
Q Consensus        14 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   88 (291)
                      ..+.+.|.. .++||+|+||.||+|.+..  ++..+++|.+.....     ...+.+|+.+++.++|||++++++++  .
T Consensus        17 ~~~~~~~~~-~~~lg~g~~g~v~~~~~~~--~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~   91 (313)
T cd06633          17 DDPEEIFVG-LHEIGHGSFGAVYFATNSH--TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCY--L   91 (313)
T ss_pred             CCHHHHhhc-ceeeccCCCeEEEEEEECC--CCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEE--E
Confidence            334444553 4589999999999999765  678899999864322     13577899999999999999999999  4


Q ss_pred             CCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCc
Q psy2172          89 NDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGR  168 (291)
Q Consensus        89 ~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~  168 (291)
                      +....|++|||+.+++.+.+.....        ++++..+..++.|++.|+.+||++|++|+||+|+||+++    .++.
T Consensus        92 ~~~~~~lv~e~~~~~l~~~l~~~~~--------~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~----~~~~  159 (313)
T cd06633          92 KEHTAWLVMEYCLGSASDLLEVHKK--------PLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT----EPGQ  159 (313)
T ss_pred             eCCEEEEEEecCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEEC----CCCC
Confidence            5678999999999988877654321        278899999999999999999999999999999999998    6678


Q ss_pred             EEEeecccceecCCCCCCCCCCCCceecccccccccccC--CcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc------
Q psy2172         169 VKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLG--ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED------  240 (291)
Q Consensus       169 ~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~------  240 (291)
                      ++|+|||.+.....       .....|+..|+|||.+..  ...++.++|+||||+++|+|++|..||......      
T Consensus       160 ~kL~dfg~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~  232 (313)
T cd06633         160 VKLADFGSASKSSP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI  232 (313)
T ss_pred             EEEeecCCCcccCC-------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            99999998753221       123467888999999842  234788999999999999999999999764421      


Q ss_pred             ----c-cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchh
Q psy2172         241 ----I-KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLL  280 (291)
Q Consensus       241 ----~-~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  280 (291)
                          . ..........+.+++..|..+.|..||++.++..++++.
T Consensus       233 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~  277 (313)
T cd06633         233 AQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVR  277 (313)
T ss_pred             HhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccC
Confidence                1 111122345688999999999999999999999888874

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-35  Score=247.94  Aligned_cols=225  Identities=41%  Similarity=0.796  Sum_probs=185.7

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCC----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEec
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG----LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDY   99 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~   99 (291)
                      .+.||+|++|.||+|.+.+  +++.+++|.+....    ....+.+|+.+++.++|+|++++++++........++++||
T Consensus         4 ~~~l~~g~~~~vy~~~~~~--~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~   81 (287)
T cd07840           4 IAQIGEGTYGQVYKARNKK--TGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY   81 (287)
T ss_pred             eEEeccCCCeEEEEEEECC--CCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence            5689999999999999876  66889999997542    33467889999999999999999999954323789999999


Q ss_pred             CCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeeccccee
Q psy2172         100 AEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL  179 (291)
Q Consensus       100 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~  179 (291)
                      +++++.+.+....        ..+++..++.++.|++.||++||+.|++|+||+|+||+++    .++.++|+|||.+..
T Consensus        82 ~~~~l~~~~~~~~--------~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~----~~~~~~l~d~g~~~~  149 (287)
T cd07840          82 MDHDLTGLLDSPE--------VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILIN----NDGVLKLADFGLARP  149 (287)
T ss_pred             ccccHHHHHhccC--------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEc----CCCCEEEccccceee
Confidence            9988887775432        1289999999999999999999999999999999999998    678999999999986


Q ss_pred             cCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccCCCCCcHHHHHHHHHhh
Q psy2172         180 FNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVM  259 (291)
Q Consensus       180 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~  259 (291)
                      ......  .......++..|+|||.+.+...++.++|+||||+++|+|++|..||.....         ...+..+.+.+
T Consensus       150 ~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~---------~~~~~~~~~~~  218 (287)
T cd07840         150 YTKRNS--ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE---------LEQLEKIFELC  218 (287)
T ss_pred             ccCCCc--ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHHh
Confidence            654321  1122335577899999887655578999999999999999999999987665         36778888888


Q ss_pred             CCCCcCChhhhhcC
Q psy2172         260 GFPLEKDWEDIRKM  273 (291)
Q Consensus       260 ~~~~~~~~~~~~~~  273 (291)
                      ..+.+..|+.+..+
T Consensus       219 ~~~~~~~~~~~~~~  232 (287)
T cd07840         219 GSPTDENWPGVSKL  232 (287)
T ss_pred             CCCchhhccccccc
Confidence            88888888876654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.1e-35  Score=249.97  Aligned_cols=240  Identities=22%  Similarity=0.373  Sum_probs=191.6

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC---CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG---LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWL   95 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~i   95 (291)
                      .|++ .+.||+|+||.||++.+..  ++..+++|++....   ....+.+|+++++.++||||+++++.+  ......++
T Consensus         6 ~~~~-~~~ig~g~~g~v~~~~~~~--~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~~~l   80 (284)
T cd06620           6 DLET-ISDLGAGNGGSVSKVKHIP--TGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF--LNENNICM   80 (284)
T ss_pred             HHHH-HHHcCCCCCeEEEEEEEcC--CCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeE--ecCCEEEE
Confidence            3453 5699999999999999876  66789999876432   234688999999999999999999999  45678999


Q ss_pred             EEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCeeeeccCCCcEEeecCCCCCCcEEEee
Q psy2172          96 LFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHS-NWVLHRDLKPANILVMGEGIERGRVKIAD  173 (291)
Q Consensus        96 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~-~~ivH~dik~~Nil~~~~~~~~~~~~l~D  173 (291)
                      ||||+++ +|...+....         .++...+..++.+++.+|.|||+ .+++|+||+|+||+++    .++.++|+|
T Consensus        81 v~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~----~~~~~~l~d  147 (284)
T cd06620          81 CMEFMDCGSLDRIYKKGG---------PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVN----SRGQIKLCD  147 (284)
T ss_pred             EEecCCCCCHHHHHHhcc---------CCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEEC----CCCcEEEcc
Confidence            9999986 6666554322         27899999999999999999997 5999999999999998    677899999


Q ss_pred             cccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc-------------
Q psy2172         174 MGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED-------------  240 (291)
Q Consensus       174 fg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~-------------  240 (291)
                      ||++......     ......|+..|+|||++.+. .++.++|+|||||++|++++|..||......             
T Consensus       148 ~gl~~~~~~~-----~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~  221 (284)
T cd06620         148 FGVSGELINS-----IADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL  221 (284)
T ss_pred             CCcccchhhh-----ccCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHH
Confidence            9987654321     11234678899999998764 4889999999999999999999999865431             


Q ss_pred             --------ccCC-CCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhh
Q psy2172         241 --------IKTS-NPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKD  282 (291)
Q Consensus       241 --------~~~~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (291)
                              .... .......+.+++..|..+.|..||++.++..++++.+.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         222 LQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             HHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence                    0000 01123467889999999999999999999888877654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-35  Score=256.09  Aligned_cols=245  Identities=32%  Similarity=0.495  Sum_probs=193.8

Q ss_pred             cccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC----ChhHHHHHHHHhcCCCCCeeeEEEEEEeC-
Q psy2172          14 TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL----SMSACREIALLRELKHPNVINLISVFLSH-   88 (291)
Q Consensus        14 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-   88 (291)
                      ..+.++|.+ .+.||+|+||.||+|.+..  +++.||+|.+.....    ...+.+|+.++++++||||+++++++... 
T Consensus        13 ~~~~~~y~~-~~~lg~G~~g~v~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~   89 (345)
T cd07877          13 WEVPERYQN-LSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   89 (345)
T ss_pred             hhccCceEE-EEEeeecCCeEEEEEEEcC--CCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence            446678885 6799999999999999765  678899999865321    24577899999999999999999987432 


Q ss_pred             ---CCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCC
Q psy2172          89 ---NDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIE  165 (291)
Q Consensus        89 ---~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~  165 (291)
                         .....|+++++++++|.+.+...          .+++..++.++.|++.||++||++|++|+||+|+||+++    .
T Consensus        90 ~~~~~~~~~lv~~~~~~~L~~~~~~~----------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~----~  155 (345)
T cd07877          90 SLEEFNDVYLVTHLMGADLNNIVKCQ----------KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN----E  155 (345)
T ss_pred             cccccccEEEEehhcccCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEc----C
Confidence               22457899999988887766422          188999999999999999999999999999999999998    6


Q ss_pred             CCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc---
Q psy2172         166 RGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK---  242 (291)
Q Consensus       166 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~---  242 (291)
                      ++.++|+|||++.....      ......++..|+|||.+.+...++.++|+|||||++|+|++|..||........   
T Consensus       156 ~~~~kl~dfg~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~  229 (345)
T cd07877         156 DCELKILDFGLARHTDD------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL  229 (345)
T ss_pred             CCCEEEecccccccccc------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            67899999999875432      122345678899999987644588899999999999999999999975432100   


Q ss_pred             -----------------------------CC--------CCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         243 -----------------------------TS--------NPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       243 -----------------------------~~--------~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                                                   ..        .......+.+++..|..+.|..|+++.++..++++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~  305 (345)
T cd07877         230 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ  305 (345)
T ss_pred             HHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhh
Confidence                                         00        0012345678888999999999999999999988764

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.9e-35  Score=244.25  Aligned_cols=234  Identities=21%  Similarity=0.354  Sum_probs=181.9

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLL   96 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv   96 (291)
                      +.|.+ .++||+|++|.||+|.+..   ...+++|.+.... ..+.+.+|+.++++++|+|++++++++  . ....+++
T Consensus         6 ~~~~~-~~~ig~g~~~~v~~~~~~~---~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~-~~~~~~v   78 (260)
T cd05069           6 ESLRL-DVKLGQGCFGEVWMGTWNG---TTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV--S-EEPIYIV   78 (260)
T ss_pred             HHeee-eeeecCcCCCeEEEEEEcC---CceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEE--c-CCCcEEE
Confidence            45665 5699999999999998754   2458999886543 335688999999999999999999887  3 3457899


Q ss_pred             EecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecc
Q psy2172          97 FDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMG  175 (291)
Q Consensus        97 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg  175 (291)
                      |||+.+ +|.+.+.....       ..++...+..++.|++.||.+||++|++|+||+|+||+++    .++.++|+|||
T Consensus        79 ~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~----~~~~~~l~dfg  147 (260)
T cd05069          79 TEFMGKGSLLDFLKEGDG-------KYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVG----DNLVCKIADFG  147 (260)
T ss_pred             EEcCCCCCHHHHHhhCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc----CCCeEEECCCc
Confidence            999985 88887764321       1278889999999999999999999999999999999998    67789999999


Q ss_pred             cceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc----------cCC
Q psy2172         176 FARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI----------KTS  244 (291)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~----------~~~  244 (291)
                      .+........  .......++..|+|||...+.. ++.++|+||||+++|+|++ |..||.+.....          ...
T Consensus       148 ~~~~~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~  224 (260)
T cd05069         148 LARLIEDNEY--TARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPC  224 (260)
T ss_pred             cceEccCCcc--cccCCCccchhhCCHHHhccCC-cChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            9976543211  1112234466799999887644 8899999999999999998 999998754321          111


Q ss_pred             CCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         245 NPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       245 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      .......+.+++..+..+.|..||++.+
T Consensus       225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~  252 (260)
T cd05069         225 PQGCPESLHELMKLCWKKDPDERPTFEY  252 (260)
T ss_pred             CcccCHHHHHHHHHHccCCcccCcCHHH
Confidence            2233466888888888888888887764

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.9e-35  Score=248.24  Aligned_cols=245  Identities=21%  Similarity=0.309  Sum_probs=187.3

Q ss_pred             cccccceeCcccceEEEEEEEcc---CCCCceeEEEEeCCCCCC--hhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEE
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKD---NSDTRDYALKQIEGTGLS--MSACREIALLRELKHPNVINLISVFLSHNDRKVW   94 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~---~~~~~~vaiK~~~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (291)
                      |.+ .+.||+|+||.||+|.+..   ..+...+++|.+......  ..+.+|+.++++++|+||+++++++  .+....+
T Consensus         7 ~~~-~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~   83 (291)
T cd05094           7 IVL-KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVC--GDGDPLI   83 (291)
T ss_pred             eEE-eeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEE--ccCCceE
Confidence            443 4699999999999998653   224456899998754332  4688999999999999999999998  5667899


Q ss_pred             EEEecCC-CCHHHHHHHhhhhh-------hCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCC
Q psy2172          95 LLFDYAE-HDLWHIIKFHRAAK-------ANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIER  166 (291)
Q Consensus        95 iv~e~~~-~~l~~~~~~~~~~~-------~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~  166 (291)
                      +||||++ ++|.+.+.......       .......+++..++.++.|++.|+++||++|++|+||||+||+++    .+
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~----~~  159 (291)
T cd05094          84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG----AN  159 (291)
T ss_pred             EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc----cC
Confidence            9999997 58888876543210       001112378999999999999999999999999999999999998    67


Q ss_pred             CcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc-----
Q psy2172         167 GRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED-----  240 (291)
Q Consensus       167 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~-----  240 (291)
                      +.++|+|||.+......... .......++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||......     
T Consensus       160 ~~~~l~dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  237 (291)
T cd05094         160 LLVKIGDFGMSRDVYSTDYY-RVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC  237 (291)
T ss_pred             CcEEECCCCcccccCCCcee-ecCCCCCcceeecChHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            79999999998755432111 1122344577899999987744 8899999999999999998 99998654431     


Q ss_pred             -----ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         241 -----IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       241 -----~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                           ...........+.+++..|..+.|..||++.++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v  275 (291)
T cd05094         238 ITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEI  275 (291)
T ss_pred             HhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHH
Confidence                 111222334668889999999999999987763

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.4e-35  Score=250.26  Aligned_cols=247  Identities=23%  Similarity=0.359  Sum_probs=186.1

Q ss_pred             ccccccccceeCcccceEEEEEEEcc-----CCCCceeEEEEeCCCCC---ChhHHHHHHHHhcC-CCCCeeeEEEEEEe
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKD-----NSDTRDYALKQIEGTGL---SMSACREIALLREL-KHPNVINLISVFLS   87 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l-~h~~iv~~~~~~~~   87 (291)
                      .+.|.+ ++.||+|+||.||+|.+..     ......+++|.......   ..++.+|+.+++.+ +||||+++++.+  
T Consensus        14 ~~~~~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~--   90 (304)
T cd05101          14 RDKLTL-GKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC--   90 (304)
T ss_pred             HHHeee-cceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE--
Confidence            445554 6899999999999998632     12345799998875322   24688999999999 899999999998  


Q ss_pred             CCCceEEEEEecCCC-CHHHHHHHhhhhhh-------CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEe
Q psy2172          88 HNDRKVWLLFDYAEH-DLWHIIKFHRAAKA-------NKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILV  159 (291)
Q Consensus        88 ~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~-------~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~  159 (291)
                      ......+++|||+.+ +|.+++........       ......++...+..++.|++.||.|||++|++|+||||+||++
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili  170 (304)
T cd05101          91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV  170 (304)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEE
Confidence            556788999999975 88888775432110       0011237888899999999999999999999999999999999


Q ss_pred             ecCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCc
Q psy2172         160 MGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQ  238 (291)
Q Consensus       160 ~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~  238 (291)
                      +    .++.++|+|||.+......... .......++..|+|||++.+.. ++.++|+||||+++|+|++ |..||.+..
T Consensus       171 ~----~~~~~kl~D~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~  244 (304)
T cd05101         171 T----ENNVMKIADFGLARDVNNIDYY-KKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIP  244 (304)
T ss_pred             c----CCCcEEECCCccceeccccccc-ccccCCCCCceeeCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence            8    6678999999999866432211 1112234466799999997744 8899999999999999998 788887654


Q ss_pred             ccc----------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         239 EDI----------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       239 ~~~----------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      ...          ..........+..++..+..+.|..||++.+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e  288 (304)
T cd05101         245 VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQ  288 (304)
T ss_pred             HHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHH
Confidence            321          1112233467888889998899988887765

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2e-35  Score=248.13  Aligned_cols=242  Identities=19%  Similarity=0.336  Sum_probs=183.3

Q ss_pred             cceeCcccceEEEEEEEccC---CCCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEE
Q psy2172          24 GCKVGRGTYGHVYKARRKDN---SDTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLF   97 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~---~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~   97 (291)
                      .+.||+|+||.||+|.+..+   ..+..||+|.++....   ...+.+|+.++..++||||+++++++  ......++++
T Consensus        10 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~--~~~~~~~~~~   87 (283)
T cd05091          10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVV--TKEQPLSMIF   87 (283)
T ss_pred             HHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEE--cCCCceEEEE
Confidence            56899999999999987542   2356799999975432   24577899999999999999999998  5566789999


Q ss_pred             ecCCC-CHHHHHHHhhhhh-------hCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcE
Q psy2172          98 DYAEH-DLWHIIKFHRAAK-------ANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRV  169 (291)
Q Consensus        98 e~~~~-~l~~~~~~~~~~~-------~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~  169 (291)
                      +|+.+ +|.+++.......       .......++...++.++.|++.||.+||++|++|+||||+||+++    .+..+
T Consensus        88 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~----~~~~~  163 (283)
T cd05091          88 SYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF----DKLNV  163 (283)
T ss_pred             EcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEec----CCCce
Confidence            99975 7777765321100       001122378888999999999999999999999999999999998    66789


Q ss_pred             EEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc--------
Q psy2172         170 KIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED--------  240 (291)
Q Consensus       170 ~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~--------  240 (291)
                      +|+|||++........ ........+++.|+|||.+.+.. ++.++|+||||+++|+|++ |..||.+....        
T Consensus       164 kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~  241 (283)
T cd05091         164 KISDLGLFREVYAADY-YKLMGNSLLPIRWMSPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN  241 (283)
T ss_pred             Eecccccccccccchh-eeeccCccCCccccCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            9999999875533211 11122334567899999987644 8899999999999999998 88899775432        


Q ss_pred             --ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         241 --IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       241 --~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                        .........+.+.+++..+....|..||++.++
T Consensus       242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i  276 (283)
T cd05091         242 RQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDI  276 (283)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHH
Confidence              111223345667888888888888888887753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.6e-36  Score=256.68  Aligned_cols=243  Identities=33%  Similarity=0.534  Sum_probs=191.3

Q ss_pred             ccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCC-
Q psy2172          15 KVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG----LSMSACREIALLRELKHPNVINLISVFLSHN-   89 (291)
Q Consensus        15 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-   89 (291)
                      .+.++|.+ .+.||+|+||.||+|.+..  ++..||+|.+....    ....+.+|+.+++.++||||+++++++.... 
T Consensus        12 ~~~~~y~~-~~~ig~g~~g~v~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~   88 (342)
T cd07879          12 ELPERYTS-LKQVGSGAYGSVCSAIDKR--TGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVS   88 (342)
T ss_pred             ccccceEE-EEEeeecCCeEEEEEEeCC--CCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheeccccc
Confidence            34567775 6799999999999999866  67889999986432    2345788999999999999999999984322 


Q ss_pred             ---CceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCC
Q psy2172          90 ---DRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIER  166 (291)
Q Consensus        90 ---~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~  166 (291)
                         ....+++++|+..++.....           ..+++..+..++.|++.||++||++|++|+||+|+||+++    .+
T Consensus        89 ~~~~~~~~lv~e~~~~~l~~~~~-----------~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~----~~  153 (342)
T cd07879          89 GDEFQDFYLVMPYMQTDLQKIMG-----------HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVN----ED  153 (342)
T ss_pred             CCCCceEEEEecccccCHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CC
Confidence               23579999999876654431           0188899999999999999999999999999999999998    67


Q ss_pred             CcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc-----
Q psy2172         167 GRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI-----  241 (291)
Q Consensus       167 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~-----  241 (291)
                      +.++|+|||++.....      ......++..|+|||.+.+...++.++|+||||+++|+|++|+.||.+.....     
T Consensus       154 ~~~kL~dfg~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~  227 (342)
T cd07879         154 CELKILDFGLARHADA------EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI  227 (342)
T ss_pred             CCEEEeeCCCCcCCCC------CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            8999999999875432      11234668889999998764458899999999999999999999998654100     


Q ss_pred             ---------------------------cCC--------CCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         242 ---------------------------KTS--------NPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       242 ---------------------------~~~--------~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                                                 ...        .+.....+.+++..|..+.|..||++.++..++++.+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~  302 (342)
T cd07879         228 LKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDS  302 (342)
T ss_pred             HHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhh
Confidence                                       000        0112344678999999999999999999999988754

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.5e-35  Score=250.50  Aligned_cols=248  Identities=22%  Similarity=0.351  Sum_probs=185.2

Q ss_pred             ccccccccceeCcccceEEEEEEEccCC-----CCceeEEEEeCCCCCC---hhHHHHHHHHhcC-CCCCeeeEEEEEEe
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDNS-----DTRDYALKQIEGTGLS---MSACREIALLREL-KHPNVINLISVFLS   87 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~-----~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l-~h~~iv~~~~~~~~   87 (291)
                      .+.|.+ ++.||+|+||.||+|.+.+..     ....+|+|.+......   .++.+|+.+++.+ +||||+++++++  
T Consensus        17 ~~~~~i-~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~--   93 (307)
T cd05098          17 RDRLVL-GKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC--   93 (307)
T ss_pred             hHHeEE-eeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE--
Confidence            355664 789999999999999875422     2346999998754322   3577899999999 799999999998  


Q ss_pred             CCCceEEEEEecCCC-CHHHHHHHhhhhhh-------CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEe
Q psy2172          88 HNDRKVWLLFDYAEH-DLWHIIKFHRAAKA-------NKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILV  159 (291)
Q Consensus        88 ~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~-------~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~  159 (291)
                      ......|++|||+++ +|.+.+........       ......++...++.++.|++.||++||++|++|+||||+||++
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill  173 (307)
T cd05098          94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV  173 (307)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEE
Confidence            456689999999985 88888865432110       0011237888999999999999999999999999999999999


Q ss_pred             ecCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCc
Q psy2172         160 MGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQ  238 (291)
Q Consensus       160 ~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~  238 (291)
                      +    .++.++|+|||.+......... .......++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||.+..
T Consensus       174 ~----~~~~~kL~dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~~~g~~p~~~~~  247 (307)
T cd05098         174 T----EDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVP  247 (307)
T ss_pred             c----CCCcEEECCCcccccccccchh-hccccCCCccceeChHHhccCC-CCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence            8    6678999999998755321110 1111122346799999997744 8899999999999999998 889997654


Q ss_pred             ccc----------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         239 EDI----------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       239 ~~~----------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      .+.          ..........+.+++..+....|..||++.++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ev  292 (307)
T cd05098         248 VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL  292 (307)
T ss_pred             HHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHH
Confidence            321          11122334677788888888888888877753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=4.1e-35  Score=256.53  Aligned_cols=241  Identities=22%  Similarity=0.339  Sum_probs=183.8

Q ss_pred             cceeCcccceEEEEEEEcc---CCCCceeEEEEeCCCCCC---hhHHHHHHHHhcCC-CCCeeeEEEEEEeCCCceEEEE
Q psy2172          24 GCKVGRGTYGHVYKARRKD---NSDTRDYALKQIEGTGLS---MSACREIALLRELK-HPNVINLISVFLSHNDRKVWLL   96 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~---~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~iv   96 (291)
                      +++||+|+||.||+|.+++   ......||+|+++.....   +.+.+|+.++.++. ||||+++++++  ......++|
T Consensus        42 ~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~--~~~~~~~iv  119 (401)
T cd05107          42 GRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC--TKGGPIYII  119 (401)
T ss_pred             hhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE--ccCCCcEEE
Confidence            7899999999999999753   224567999999754322   35788999999997 99999999998  455689999


Q ss_pred             EecCCC-CHHHHHHHhhhhh------------------------------------------------------------
Q psy2172          97 FDYAEH-DLWHIIKFHRAAK------------------------------------------------------------  115 (291)
Q Consensus        97 ~e~~~~-~l~~~~~~~~~~~------------------------------------------------------------  115 (291)
                      +||+.+ +|.+.+.......                                                            
T Consensus       120 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  199 (401)
T cd05107         120 TEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTV  199 (401)
T ss_pred             EeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhh
Confidence            999984 8888876432100                                                            


Q ss_pred             -----------------------------hCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCC
Q psy2172         116 -----------------------------ANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIER  166 (291)
Q Consensus       116 -----------------------------~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~  166 (291)
                                                   .......++...++.++.|++.||+|||+++++|+||||+||+++    ..
T Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~----~~  275 (401)
T cd05107         200 KYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC----EG  275 (401)
T ss_pred             hhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEe----CC
Confidence                                         000112367788899999999999999999999999999999998    66


Q ss_pred             CcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc----
Q psy2172         167 GRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI----  241 (291)
Q Consensus       167 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~----  241 (291)
                      ..++|+|||++......... .......++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||.......    
T Consensus       276 ~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~  353 (401)
T cd05107         276 KLVKICDFGLARDIMRDSNY-ISKGSTFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYN  353 (401)
T ss_pred             CEEEEEecCcceeccccccc-ccCCCcCCCCceeChHHhcCCC-CCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHH
Confidence            78999999999765332111 1122335677899999997754 8899999999999999998 899997643211    


Q ss_pred             -------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         242 -------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       242 -------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                             ..........+.+++..+..+.|..+|++.+
T Consensus       354 ~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~e  391 (401)
T cd05107         354 AIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQ  391 (401)
T ss_pred             HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHH
Confidence                   1112233567888999998888888888775

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=8.6e-36  Score=248.22  Aligned_cols=236  Identities=28%  Similarity=0.499  Sum_probs=185.6

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-----LSMSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      .|.+ .+.||+|++|.||+|.+..  ++..+++|.+....     ...++.+|+.+++.++||||+++++++.  +....
T Consensus         3 ~y~~-~~~ig~g~~g~v~~~~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~   77 (267)
T cd08229           3 NFRI-EKKIGRGQFSEVYRATCLL--DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI--EDNEL   77 (267)
T ss_pred             hhhh-hhhhcccCCeEEEEEeecC--CCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE--eCCeE
Confidence            4554 5689999999999999766  66889999875422     2246778999999999999999999994  45688


Q ss_pred             EEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          94 WLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        94 ~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      +++|||+.+ +|.+.+......     ...+++..++.++.|++.||.+||++|++|+||+|+||+++    .++.++++
T Consensus        78 ~~v~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~----~~~~~~l~  148 (267)
T cd08229          78 NIVLELADAGDLSRMIKHFKKQ-----KRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT----ATGVVKLG  148 (267)
T ss_pred             EEEEEecCCCCHHHHHHHhhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc----CCCCEEEC
Confidence            999999985 787777643221     12288999999999999999999999999999999999998    66789999


Q ss_pred             ecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc-----------
Q psy2172         173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI-----------  241 (291)
Q Consensus       173 Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~-----------  241 (291)
                      |||.+........   ......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||.+...+.           
T Consensus       149 dfg~~~~~~~~~~---~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  224 (267)
T cd08229         149 DLGLGRFFSSKTT---AAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD  224 (267)
T ss_pred             cchhhhccccCCc---ccccccCCcCccCHHHhcCCC-ccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCC
Confidence            9999876543211   112345788899999997744 8889999999999999999999997644321           


Q ss_pred             -c-CCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         242 -K-TSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       242 -~-~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                       . .........+.+++..|....|..||++.+
T Consensus       225 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~  257 (267)
T cd08229         225 YPPLPSDHYSEELRQLVNMCINPDPEKRPDITY  257 (267)
T ss_pred             CCCCCcccccHHHHHHHHHhcCCCcccCCCHHH
Confidence             0 111224567888899888889988888774

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.1e-35  Score=245.51  Aligned_cols=239  Identities=23%  Similarity=0.387  Sum_probs=188.5

Q ss_pred             ccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC------------ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCC
Q psy2172          23 EGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL------------SMSACREIALLRELKHPNVINLISVFLSHND   90 (291)
Q Consensus        23 ~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~------------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   90 (291)
                      .++.||+|++|.||+|.+..  +++.+|+|.++....            .+.+.+|+.+++.++|||++++++++  ...
T Consensus         5 ~~~~lg~g~~~~vy~~~~~~--~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~   80 (272)
T cd06629           5 KGELIGKGTYGRVYLALNVT--TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFE--TTE   80 (272)
T ss_pred             ecceecccCceEEEEEeecC--CCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEe--ccC
Confidence            36799999999999999766  667899998753210            12467899999999999999999998  556


Q ss_pred             ceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcE
Q psy2172          91 RKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRV  169 (291)
Q Consensus        91 ~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~  169 (291)
                      ...++||||+.+ +|.+.+....         .++...+..++.|++.||.+||++|++|+||+|+||+++    .++.+
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~----~~~~~  147 (272)
T cd06629          81 EYLSIFLEYVPGGSIGSCLRTYG---------RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVD----ADGIC  147 (272)
T ss_pred             CceEEEEecCCCCcHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEc----CCCeE
Confidence            789999999975 7777765431         288889999999999999999999999999999999998    67899


Q ss_pred             EEeecccceecCCCCCCCCCCCCceecccccccccccCCc-CCCCchhHHHHHHHHHHHHcCCCCCCCCcccc-------
Q psy2172         170 KIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGAR-HYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI-------  241 (291)
Q Consensus       170 ~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~-------  241 (291)
                      +++|||.+......... .......++..|+|||.+.... .++.++|+||||+++|++++|..||.......       
T Consensus       148 ~l~d~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~  226 (272)
T cd06629         148 KISDFGISKKSDDIYDN-DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGN  226 (272)
T ss_pred             EEeeccccccccccccc-cccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhc
Confidence            99999998754332111 1122345688899999987543 47889999999999999999999996533210       


Q ss_pred             ----c----CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         242 ----K----TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       242 ----~----~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                          .    ...+.....+.+++..|..+.|..||++.++..+|++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         227 KRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             cccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence                0    0111234678889999999999999999998888874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-36  Score=261.36  Aligned_cols=250  Identities=32%  Similarity=0.515  Sum_probs=199.4

Q ss_pred             cccccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC----CChhHHHHHHHHhcCCCCCeeeEEEEE
Q psy2172          10 SNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG----LSMSACREIALLRELKHPNVINLISVF   85 (291)
Q Consensus        10 ~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~   85 (291)
                      .+....+.++|.+ .+.||+|++|.||+|.+..  ++..|++|.+....    ....+.+|+.++++++|||++++++++
T Consensus         7 ~~~~~~~~~~y~~-~~~ig~g~~g~vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   83 (343)
T cd07851           7 NKTVWEVPDRYQN-LSPVGSGAYGQVCSAFDTK--TGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVF   83 (343)
T ss_pred             ccceecccCceEE-EEEeccCCceEEEEEEECC--CCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHh
Confidence            3345567888885 6799999999999999876  67889999986432    224567899999999999999999887


Q ss_pred             EeCCC----ceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeec
Q psy2172          86 LSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMG  161 (291)
Q Consensus        86 ~~~~~----~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~  161 (291)
                      ...+.    ...++|+||++++|.+.+...          .+++..++.++.|++.||++||+.|++|+||+|+||+++ 
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~----------~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~-  152 (343)
T cd07851          84 TPASSLEDFQDVYLVTHLMGADLNNIVKCQ----------KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN-  152 (343)
T ss_pred             hccccccccccEEEEEecCCCCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC-
Confidence            43221    358999999998888877641          289999999999999999999999999999999999998 


Q ss_pred             CCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc
Q psy2172         162 EGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI  241 (291)
Q Consensus       162 ~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~  241 (291)
                         .++.++|+|||.+......      .....++..|+|||.+.+...++.++|+||||+++|++++|+.||.+.....
T Consensus       153 ---~~~~~kL~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~  223 (343)
T cd07851         153 ---EDCELKILDFGLARHTDDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID  223 (343)
T ss_pred             ---CCCCEEEcccccccccccc------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH
Confidence               6678999999998765432      2234567889999998764457899999999999999999999997543210


Q ss_pred             c----------------------------------------CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         242 K----------------------------------------TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       242 ~----------------------------------------~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                      .                                        .........+.+++..|..+.|..||++.++..+||+.+
T Consensus       224 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~  303 (343)
T cd07851         224 QLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE  303 (343)
T ss_pred             HHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccc
Confidence            0                                        000112456778999999999999999999999998865


Q ss_pred             h
Q psy2172         282 D  282 (291)
Q Consensus       282 ~  282 (291)
                      -
T Consensus       304 ~  304 (343)
T cd07851         304 Y  304 (343)
T ss_pred             c
Confidence            4

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=4e-35  Score=241.54  Aligned_cols=234  Identities=26%  Similarity=0.468  Sum_probs=192.3

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCC--CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecCC
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG--LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAE  101 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~~  101 (291)
                      .+.||+|++|.||++.+..  ++..+++|.+....  ....+.+|+.++++++|++++++++.+  ......++++||++
T Consensus         5 ~~~l~~g~~~~v~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~l~~e~~~   80 (253)
T cd05122           5 LEKIGKGGFGEVYKARHKR--TGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY--LKKDELWIVMEFCS   80 (253)
T ss_pred             eeeeccCCceEEEEEEECC--CCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEE--ecCCeEEEEEecCC
Confidence            5799999999999999876  66889999997654  446788999999999999999999998  44578999999999


Q ss_pred             -CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceec
Q psy2172         102 -HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF  180 (291)
Q Consensus       102 -~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~  180 (291)
                       ++|.+.+....        ..+++..+..++.|++.|+++||++|++|+||+|+||+++    .++.++|+|||.+...
T Consensus        81 ~~~L~~~~~~~~--------~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~----~~~~~~l~d~~~~~~~  148 (253)
T cd05122          81 GGSLKDLLKSTN--------QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLT----SDGEVKLIDFGLSAQL  148 (253)
T ss_pred             CCcHHHHHhhcC--------CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEc----cCCeEEEeeccccccc
Confidence             47777765432        1289999999999999999999999999999999999998    6789999999998766


Q ss_pred             CCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc-----------cC-CCCCc
Q psy2172         181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI-----------KT-SNPYH  248 (291)
Q Consensus       181 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~-----------~~-~~~~~  248 (291)
                      .....    .....++..|+|||.+.+.. ++.++|+||||+++++|++|..||.......           .. .....
T Consensus       149 ~~~~~----~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (253)
T cd05122         149 SDTKA----RNTMVGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKW  223 (253)
T ss_pred             ccccc----ccceecCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCccccc
Confidence            54321    23456788899999998754 8899999999999999999999998662110           01 11111


Q ss_pred             HHHHHHHHHhhCCCCcCChhhhhcCCCCcc
Q psy2172         249 HDQLDRIFSVMGFPLEKDWEDIRKMPEHPT  278 (291)
Q Consensus       249 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  278 (291)
                      ...+.+++..|..+.|..+|++.++..+||
T Consensus       224 ~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         224 SDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence            467889999999999999999998887775

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3.7e-35  Score=246.07  Aligned_cols=237  Identities=22%  Similarity=0.279  Sum_probs=181.1

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCC--ceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDT--RDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~--~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      .|.+ .++||+|+||+||+|.+..++..  ..||+|.++....   ...+.+|+.+++.++||||+++++++..   ...
T Consensus         8 ~~~~-~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~~   83 (279)
T cd05109           8 ELKK-VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT---STV   83 (279)
T ss_pred             heee-eeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC---CCc
Confidence            4443 57999999999999997653322  2489999864432   3467789999999999999999998842   346


Q ss_pred             EEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          94 WLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        94 ~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      +++++|++ |+|.+.+.....        .+++..+..++.|++.||+|||++|++|+||||+||+++    ..+.++|+
T Consensus        84 ~l~~~~~~~g~l~~~l~~~~~--------~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~----~~~~~kL~  151 (279)
T cd05109          84 QLVTQLMPYGCLLDYVRENKD--------RIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVK----SPNHVKIT  151 (279)
T ss_pred             EEEEEcCCCCCHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc----CCCcEEEC
Confidence            78999987 588777654221        288999999999999999999999999999999999998    56789999


Q ss_pred             ecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc----------c
Q psy2172         173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED----------I  241 (291)
Q Consensus       173 Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~----------~  241 (291)
                      |||++......... .......++..|+|||...+.. ++.++|+|||||++|+|++ |..||......          .
T Consensus       152 dfG~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~  229 (279)
T cd05109         152 DFGLARLLDIDETE-YHADGGKVPIKWMALESILHRR-FTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGER  229 (279)
T ss_pred             CCCceeecccccce-eecCCCccchhhCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCc
Confidence            99999866432111 1112233456799999997754 8899999999999999998 99999764321          1


Q ss_pred             cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         242 KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       242 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      ..........+.+++..+....|..||++.++
T Consensus       230 ~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l  261 (279)
T cd05109         230 LPQPPICTIDVYMIMVKCWMIDSECRPRFREL  261 (279)
T ss_pred             CCCCccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            11223345667888888888888888887764

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG0577|consensus

Probab=100.00  E-value=5.1e-37  Score=263.51  Aligned_cols=234  Identities=26%  Similarity=0.476  Sum_probs=194.3

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC-----hhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEe
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS-----MSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFD   98 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e   98 (291)
                      -+-||.|+||.||.|++..  +.+.||||.+.-....     +++..|+.+|++++|||++.+.++|+.  ....|+|||
T Consensus        31 LrEIGHGSFGAVYfArd~~--n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr--e~TaWLVME  106 (948)
T KOG0577|consen   31 LREIGHGSFGAVYFARDVR--NSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR--EHTAWLVME  106 (948)
T ss_pred             HHHhcCCccceeEEeeccC--ccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec--cchHHHHHH
Confidence            4679999999999999876  7789999998643322     468999999999999999999999964  557899999


Q ss_pred             cCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccce
Q psy2172          99 YAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR  178 (291)
Q Consensus        99 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~  178 (291)
                      ||-|+-.+++.-....        +.+-.+..|..+.+.||+|||+.+.+|+|||..|||++    ..+.|||+|||++.
T Consensus       107 YClGSAsDlleVhkKp--------lqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLs----e~g~VKLaDFGSAs  174 (948)
T KOG0577|consen  107 YCLGSASDLLEVHKKP--------LQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLS----EPGLVKLADFGSAS  174 (948)
T ss_pred             HHhccHHHHHHHHhcc--------chHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEec----CCCeeeeccccchh
Confidence            9999888888766543        88889999999999999999999999999999999999    78899999999987


Q ss_pred             ecCCCCCCCCCCCCceeccccccccccc--CCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcc-----------cccCCC
Q psy2172         179 LFNNPLKPLADLDPVVVTFWYRAPELLL--GARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE-----------DIKTSN  245 (291)
Q Consensus       179 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~-----------~~~~~~  245 (291)
                      ....       .....||+.|||||++.  ..+.|+-++||||||++..+++..++|+-.-+.           ......
T Consensus       175 i~~P-------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs  247 (948)
T KOG0577|consen  175 IMAP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQS  247 (948)
T ss_pred             hcCc-------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCC
Confidence            6543       35678999999999974  234699999999999999999999988754321           112223


Q ss_pred             CCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchh
Q psy2172         246 PYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLL  280 (291)
Q Consensus       246 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  280 (291)
                      ..-++.+.+++..|..-.|.++|+..++..|+.+.
T Consensus       248 ~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~  282 (948)
T KOG0577|consen  248 NEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVL  282 (948)
T ss_pred             chhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhc
Confidence            33367789999999988999999988887765443

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.6e-35  Score=249.95  Aligned_cols=245  Identities=24%  Similarity=0.388  Sum_probs=195.0

Q ss_pred             ccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC--CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCC
Q psy2172          13 RTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT--GLSMSACREIALLRELKHPNVINLISVFLSHND   90 (291)
Q Consensus        13 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   90 (291)
                      -....++|.+ .+.||+|+||.||++.+..  ++..+++|.+...  ...+.+.+|+.+++.++|||++++++.+  ...
T Consensus        14 ~~~~~~~~~~-~~~lg~g~~g~v~~~~~~~--~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~--~~~   88 (293)
T cd06647          14 VGDPKKKYTR-FEKIGQGASGTVYTAIDVA--TGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY--LVG   88 (293)
T ss_pred             ccCchhhcee-eeEecCCCCeEEEEEEEcC--CCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhhee--eeC
Confidence            3444567775 6799999999999998765  5678999998643  2334678899999999999999999998  446


Q ss_pred             ceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcE
Q psy2172          91 RKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRV  169 (291)
Q Consensus        91 ~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~  169 (291)
                      ...|+|+||+.+ +|.+.+....          ++...+..++.|++.|+.+||++|++|+||+|+||+++    .++.+
T Consensus        89 ~~~~lv~e~~~~~~L~~~~~~~~----------l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~----~~~~~  154 (293)
T cd06647          89 DELWVVMEYLAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG----MDGSV  154 (293)
T ss_pred             CcEEEEEecCCCCcHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEc----CCCCE
Confidence            689999999975 7777665321          78888999999999999999999999999999999998    66789


Q ss_pred             EEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccC------
Q psy2172         170 KIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT------  243 (291)
Q Consensus       170 ~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~------  243 (291)
                      +|+|||.+........   ......++..|+|||.+.+.. ++.++|+||||+++|++++|..||.........      
T Consensus       155 kL~dfg~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~  230 (293)
T cd06647         155 KLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN  230 (293)
T ss_pred             EEccCcceeccccccc---ccccccCChhhcCchhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcC
Confidence            9999998865443211   122345788899999987744 889999999999999999999999765432110      


Q ss_pred             ------CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchh
Q psy2172         244 ------SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLL  280 (291)
Q Consensus       244 ------~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  280 (291)
                            ........+.+++..|....|..||+++++..++++.
T Consensus       231 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~  273 (293)
T cd06647         231 GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLK  273 (293)
T ss_pred             CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHh
Confidence                  0011234588899999999999999999999988765

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3e-35  Score=245.29  Aligned_cols=234  Identities=20%  Similarity=0.300  Sum_probs=179.0

Q ss_pred             cceeCcccceEEEEEEEccCCC-CceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEec
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSD-TRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDY   99 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~-~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~   99 (291)
                      ++.||+|+||.||+|.++..+. ...|++|.+.....   ...+..|+.+++.++||||+++++++  .+....+++|||
T Consensus         9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~--~~~~~~~lv~e~   86 (269)
T cd05065           9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV--TKSRPVMIITEF   86 (269)
T ss_pred             EeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEE--CCCCceEEEEec
Confidence            6799999999999999876332 34699999875422   34688899999999999999999998  567789999999


Q ss_pred             CCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccce
Q psy2172         100 AEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR  178 (291)
Q Consensus       100 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~  178 (291)
                      +++ +|.+++.....        .++...++.++.|++.||.+||++|++|+||+|+||+++    .+..++|+|||.+.
T Consensus        87 ~~~~~L~~~l~~~~~--------~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~----~~~~~kl~dfg~~~  154 (269)
T cd05065          87 MENGALDSFLRQNDG--------QFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVN----SNLVCKVSDFGLSR  154 (269)
T ss_pred             CCCCcHHHHHhhCCC--------CCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEc----CCCcEEECCCcccc
Confidence            986 67666654321        278899999999999999999999999999999999998    66789999999987


Q ss_pred             ecCCCCCCCCCCCCc--eecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc----------cCCC
Q psy2172         179 LFNNPLKPLADLDPV--VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI----------KTSN  245 (291)
Q Consensus       179 ~~~~~~~~~~~~~~~--~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~----------~~~~  245 (291)
                      ...............  ..+..|+|||.+.+.. ++.++||||||+++|++++ |..||.......          ....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  233 (269)
T cd05065         155 FLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPP  233 (269)
T ss_pred             ccccCccccccccccCCCcceeecCHhHhccCc-ccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCc
Confidence            654322111111111  1235799999997754 8899999999999999886 999997654210          1111


Q ss_pred             CCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         246 PYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       246 ~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      ......+.+++..+..+.|.++|++.+
T Consensus       234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~  260 (269)
T cd05065         234 MDCPTALHQLMLDCWQKDRNARPKFGQ  260 (269)
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            223456777888888888888887764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG0199|consensus

Probab=100.00  E-value=2.2e-36  Score=263.77  Aligned_cols=236  Identities=22%  Similarity=0.325  Sum_probs=196.3

Q ss_pred             cceeCcccceEEEEEEEccC-CCCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEec
Q psy2172          24 GCKVGRGTYGHVYKARRKDN-SDTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDY   99 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~-~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~   99 (291)
                      .++||+|+||.|++|.|... +....||||+++....   ..+|.+|+.+|.+|+|+|++++|++.++   ..+.+|||.
T Consensus       115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~---qp~mMV~EL  191 (1039)
T KOG0199|consen  115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD---QPAMMVFEL  191 (1039)
T ss_pred             HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc---chhhHHhhh
Confidence            57999999999999999763 2335589999986543   3579999999999999999999999953   567899999


Q ss_pred             CC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccce
Q psy2172         100 AE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR  178 (291)
Q Consensus       100 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~  178 (291)
                      +. |+|++.+.....       ..+....+..++.||+.|+.||..+++|||||..+|+++.    ....|||+|||+++
T Consensus       192 aplGSLldrLrka~~-------~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNllla----sprtVKI~DFGLmR  260 (1039)
T KOG0199|consen  192 APLGSLLDRLRKAKK-------AILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLA----SPRTVKICDFGLMR  260 (1039)
T ss_pred             cccchHHHHHhhccc-------cceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheec----ccceeeeeccccee
Confidence            98 588888876221       2288899999999999999999999999999999999998    56789999999999


Q ss_pred             ecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcc----------cccCCCCC
Q psy2172         179 LFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQE----------DIKTSNPY  247 (291)
Q Consensus       179 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~----------~~~~~~~~  247 (291)
                      .+..+...........-...|+|||.+... .++.++|||++||++|||++ |..||.|...          +.....+.
T Consensus       261 aLg~ned~Yvm~p~rkvPfAWCaPEsLrh~-kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~  339 (1039)
T KOG0199|consen  261 ALGENEDMYVMAPQRKVPFAWCAPESLRHR-KFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKY  339 (1039)
T ss_pred             ccCCCCcceEecCCCcCcccccCHhHhccc-cccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCC
Confidence            887654433333333446679999999874 49999999999999999997 7999998664          23446667


Q ss_pred             cHHHHHHHHHhhCCCCcCChhhhhcCC
Q psy2172         248 HHDQLDRIFSVMGFPLEKDWEDIRKMP  274 (291)
Q Consensus       248 ~~~~~~~i~~~~~~~~~~~~~~~~~~~  274 (291)
                      +.+.+.+|+..++.+.+.++|++..+.
T Consensus       340 csedIY~imk~cWah~paDRptFsair  366 (1039)
T KOG0199|consen  340 CSEDIYQIMKNCWAHNPADRPTFSAIR  366 (1039)
T ss_pred             ChHHHHHHHHHhccCCccccccHHHHH
Confidence            788899999999999999999998764

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3.8e-35  Score=243.64  Aligned_cols=234  Identities=23%  Similarity=0.347  Sum_probs=175.2

Q ss_pred             ceeCcccceEEEEEEEccC-CCCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecC
Q psy2172          25 CKVGRGTYGHVYKARRKDN-SDTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYA  100 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~-~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~  100 (291)
                      +.||+|+||.||+|.+.+. .....+|+|.+.....   ...+.+|+.+++.++||||+++++++.. .....++++||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~~lv~e~~   79 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLP-SEGSPLVVLPYM   79 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeec-CCCCcEEEEecC
Confidence            4689999999999987542 2446799998864322   2467789999999999999999997753 344678999999


Q ss_pred             CC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeeccccee
Q psy2172         101 EH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL  179 (291)
Q Consensus       101 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~  179 (291)
                      .+ +|.+.+.....        ..+...+..++.|++.||++||+.+++|+||||+||+++    .++.++|+|||++..
T Consensus        80 ~~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~----~~~~~kl~dfg~~~~  147 (262)
T cd05058          80 KHGDLRNFIRSETH--------NPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLD----ESFTVKVADFGLARD  147 (262)
T ss_pred             CCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc----CCCcEEECCcccccc
Confidence            74 87777653221        156777888999999999999999999999999999998    667899999999875


Q ss_pred             cCCCCC-CCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc----------ccCCCCC
Q psy2172         180 FNNPLK-PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED----------IKTSNPY  247 (291)
Q Consensus       180 ~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~----------~~~~~~~  247 (291)
                      ...... .........++..|+|||.+.+.. ++.++||||||+++|+|++ |.+||......          .......
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (262)
T cd05058         148 IYDKEYYSVHNHTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEY  226 (262)
T ss_pred             ccCCcceeecccccCcCCccccChhHhccCc-cchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCc
Confidence            433211 111112234466899999987754 8899999999999999999 56777653321          1111122


Q ss_pred             cHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         248 HHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       248 ~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      ....+.+++..+..+.|..||++.+
T Consensus       227 ~~~~~~~li~~cl~~~p~~Rp~~~~  251 (262)
T cd05058         227 CPDPLYEVMLSCWHPKPEMRPTFSE  251 (262)
T ss_pred             CCHHHHHHHHHHcCCChhhCCCHHH
Confidence            2456888888898889988887765

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=5e-35  Score=244.67  Aligned_cols=245  Identities=21%  Similarity=0.325  Sum_probs=188.2

Q ss_pred             cccccccceeCcccceEEEEEEEccC---CCCceeEEEEeCCCCCC---hhHHHHHHHHhcCCCCCeeeEEEEEEeCCCc
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDN---SDTRDYALKQIEGTGLS---MSACREIALLRELKHPNVINLISVFLSHNDR   91 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~---~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (291)
                      +.|++ ...||+|+||.||+|.++..   ...+.+++|.+......   ..+.+|+.++++++|+||+++++++  .+..
T Consensus         5 ~~~~~-~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~   81 (275)
T cd05046           5 SNLQE-ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLC--REAE   81 (275)
T ss_pred             Hhcee-eeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEE--CCCC
Confidence            34553 56899999999999997642   24567999988654333   4688999999999999999999998  5667


Q ss_pred             eEEEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEE
Q psy2172          92 KVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVK  170 (291)
Q Consensus        92 ~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~  170 (291)
                      ..+++|||++ ++|.+.+..............+++..+..++.|++.||+|||++|++|+||||+||+++    .++.++
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~----~~~~~~  157 (275)
T cd05046          82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVS----SQREVK  157 (275)
T ss_pred             cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEe----CCCcEE
Confidence            8999999998 58888876554222111122389999999999999999999999999999999999998    677899


Q ss_pred             EeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc--------
Q psy2172         171 IADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI--------  241 (291)
Q Consensus       171 l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~--------  241 (291)
                      ++|||.+.......  ........++..|+|||.+.+.. .+.++|+||||+++|++++ |..||.......        
T Consensus       158 l~~~~~~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~  234 (275)
T cd05046         158 VSLLSLSKDVYNSE--YYKLRNALIPLRWLAPEAVQEDD-FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG  234 (275)
T ss_pred             EcccccccccCccc--ccccCCceeEEeecChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcC
Confidence            99999986543221  12223345677899999987644 7889999999999999998 888996543211        


Q ss_pred             ---cCCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         242 ---KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       242 ---~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                         ..........+.+++..+..+.|..||++.+
T Consensus       235 ~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~  268 (275)
T cd05046         235 KLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSE  268 (275)
T ss_pred             CcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHH
Confidence               0112233467888888888888888888775

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.1e-35  Score=247.87  Aligned_cols=236  Identities=25%  Similarity=0.374  Sum_probs=185.4

Q ss_pred             cceeCcccceEEEEEEEcc--CCCCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEe
Q psy2172          24 GCKVGRGTYGHVYKARRKD--NSDTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFD   98 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~--~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e   98 (291)
                      .+.||+|+||.||+|.+..  ..++..+|+|.++....   ...+.+|+++++.++|+||+++++++...+....+++||
T Consensus         9 ~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   88 (284)
T cd05038           9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIME   88 (284)
T ss_pred             heeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEe
Confidence            4699999999999998753  23567899999976544   457889999999999999999999886555778999999


Q ss_pred             cCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccc
Q psy2172          99 YAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA  177 (291)
Q Consensus        99 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~  177 (291)
                      |+.+ +|.+.+.....        .++...+..++.|++.||++||++|++|+||+|+||+++    .++.++|+|||.+
T Consensus        89 ~~~~~~l~~~l~~~~~--------~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~----~~~~~~l~dfg~~  156 (284)
T cd05038          89 YLPSGSLRDYLQRHRD--------QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVE----SEDLVKISDFGLA  156 (284)
T ss_pred             cCCCCCHHHHHHhCcc--------ccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc----CCCCEEEcccccc
Confidence            9974 88877765432        288899999999999999999999999999999999998    6689999999999


Q ss_pred             eecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc---------------
Q psy2172         178 RLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK---------------  242 (291)
Q Consensus       178 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~---------------  242 (291)
                      .................++..|+|||.+.+.. ++.++|+||||+++++|++|..||........               
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd05038         157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSK-FSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL  235 (284)
T ss_pred             cccccCCcceeccCCCCCcccccCcHHHccCC-CCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHH
Confidence            87653322211122234456699999987754 88999999999999999999999876433210               


Q ss_pred             ----------CCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         243 ----------TSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       243 ----------~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                                .........+.+++..|..+.|..||++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~e  275 (284)
T cd05038         236 LELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFAD  275 (284)
T ss_pred             HHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHH
Confidence                      001122356778888888888888888765

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=4.2e-35  Score=244.23  Aligned_cols=238  Identities=18%  Similarity=0.258  Sum_probs=178.6

Q ss_pred             ccccccceeCcccceEEEEEEEccCC-CCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNS-DTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHNDRKVW   94 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~-~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (291)
                      .|+. .+.||+|+||.||+|.+...+ ....+++|.++....   .+.+.+|+++++.++|||++++.+++  .+....+
T Consensus         6 ~~~~-~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~   82 (268)
T cd05063           6 HITK-QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVV--TKFKPAM   82 (268)
T ss_pred             HceE-eeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEE--ccCCCcE
Confidence            4553 679999999999999986532 234799999865422   34578899999999999999999999  5567889


Q ss_pred             EEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEee
Q psy2172          95 LLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIAD  173 (291)
Q Consensus        95 iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~D  173 (291)
                      ++|||+++ +|...+....        ..+++..+..++.|++.|+++||+.|++|+||||+||+++    .+..++++|
T Consensus        83 lv~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~----~~~~~kl~d  150 (268)
T cd05063          83 IITEYMENGALDKYLRDHD--------GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVN----SNLECKVSD  150 (268)
T ss_pred             EEEEcCCCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEc----CCCcEEECC
Confidence            99999986 7766665322        1278899999999999999999999999999999999998    667899999


Q ss_pred             cccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc----------c
Q psy2172         174 MGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI----------K  242 (291)
Q Consensus       174 fg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~----------~  242 (291)
                      ||.+..................+..|+|||.+.+.. ++.++|+||||+++|+|++ |..||.......          .
T Consensus       151 fg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~  229 (268)
T cd05063         151 FGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK-FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRL  229 (268)
T ss_pred             CccceecccccccceeccCCCcCceecCHHHhhcCC-cChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCC
Confidence            999876543211111111122245699999987744 8899999999999999987 999997544310          0


Q ss_pred             CCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         243 TSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       243 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      .........+.+++..+....|.+||++.+
T Consensus       230 ~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~  259 (268)
T cd05063         230 PAPMDCPSAVYQLMLQCWQQDRARRPRFVD  259 (268)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence            011112345667777777777777777664

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=7.1e-35  Score=245.46  Aligned_cols=248  Identities=18%  Similarity=0.274  Sum_probs=186.7

Q ss_pred             ccccccccceeCcccceEEEEEEEccC---CCCceeEEEEeCCCCCC---hhHHHHHHHHhcCCCCCeeeEEEEEEeCCC
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDN---SDTRDYALKQIEGTGLS---MSACREIALLRELKHPNVINLISVFLSHND   90 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~---~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   90 (291)
                      .++|.+ .++||+|+||.||+|.+++.   .....||+|.+......   ..+.+|+.+++.++||||+++++++  .+.
T Consensus         5 ~~~~~i-~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~   81 (288)
T cd05061           5 REKITL-LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVV--SKG   81 (288)
T ss_pred             HHHcee-eeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE--cCC
Confidence            456775 57999999999999987542   23457999988644322   3467899999999999999999998  456


Q ss_pred             ceEEEEEecCC-CCHHHHHHHhhhhhh-CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCc
Q psy2172          91 RKVWLLFDYAE-HDLWHIIKFHRAAKA-NKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGR  168 (291)
Q Consensus        91 ~~~~iv~e~~~-~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~  168 (291)
                      ...+++|||+. ++|.+.+........ .......+...+..++.|++.||.|||+++++|+||||+||+++    .++.
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~----~~~~  157 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVA----HDFT  157 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEc----CCCc
Confidence            68899999997 588888865432111 11122356778899999999999999999999999999999998    6678


Q ss_pred             EEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc------
Q psy2172         169 VKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI------  241 (291)
Q Consensus       169 ~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~------  241 (291)
                      ++|+|||++......... .......++..|+|||.+.+.. ++.++|+|||||++|+|++ |..||.+.....      
T Consensus       158 ~~L~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~~pE~~~~~~-~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~  235 (288)
T cd05061         158 VKIGDFGMTRDIYETDYY-RKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM  235 (288)
T ss_pred             EEECcCCccccccccccc-cccCCCcccccccCHHHhccCC-CChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            999999998754332111 1112233466799999987644 8899999999999999998 788997644211      


Q ss_pred             ----cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         242 ----KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       242 ----~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                          ..........+.+++..|..+.|..||++.++
T Consensus       236 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l  271 (288)
T cd05061         236 DGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEI  271 (288)
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence                11122234678899999999999999887764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=4.1e-35  Score=246.59  Aligned_cols=236  Identities=24%  Similarity=0.447  Sum_probs=190.2

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCC--CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecCC
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG--LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAE  101 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~~  101 (291)
                      -++||+|++|.||++.+..  ++..+++|.+....  ....+.+|+.+++.++|||++++++++  ......++++||+.
T Consensus        24 ~~~lg~g~~g~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~--~~~~~~~~v~e~~~   99 (285)
T cd06648          24 FVKIGEGSTGIVCIATDKS--TGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY--LVGDELWVVMEFLE   99 (285)
T ss_pred             ceEeccCCCeEEEEEEECC--CCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEE--EcCCeEEEEEeccC
Confidence            4599999999999999766  66789999885332  234578899999999999999999998  45678899999997


Q ss_pred             C-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceec
Q psy2172         102 H-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF  180 (291)
Q Consensus       102 ~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~  180 (291)
                      + +|.+.+...          .++...+..++.|++.|+++||++|++|+||+|+||+++    .++.++|+|||.+...
T Consensus       100 ~~~L~~~~~~~----------~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~----~~~~~~l~d~g~~~~~  165 (285)
T cd06648         100 GGALTDIVTHT----------RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLT----SDGRVKLSDFGFCAQV  165 (285)
T ss_pred             CCCHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEc----CCCcEEEcccccchhh
Confidence            5 777666541          178899999999999999999999999999999999998    6779999999987654


Q ss_pred             CCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc---------c-cC--CCCCc
Q psy2172         181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED---------I-KT--SNPYH  248 (291)
Q Consensus       181 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~---------~-~~--~~~~~  248 (291)
                      ....   .......|+..|+|||.+.+.. ++.++|+||+|+++|+|++|..||......         . ..  .....
T Consensus       166 ~~~~---~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (285)
T cd06648         166 SKEV---PRRKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKV  241 (285)
T ss_pred             ccCC---cccccccCCccccCHHHhcCCC-CCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccC
Confidence            3321   1122345788899999987744 889999999999999999999999764321         0 01  11123


Q ss_pred             HHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         249 HDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       249 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                      ...+.+++..|..+.|..||++.++..++++.+
T Consensus       242 ~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  274 (285)
T cd06648         242 SPRLRSFLDRMLVRDPAQRATAAELLNHPFLAK  274 (285)
T ss_pred             CHHHHHHHHHHcccChhhCcCHHHHccCccccc
Confidence            467899999999999999999999999988754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-35  Score=248.90  Aligned_cols=237  Identities=41%  Similarity=0.703  Sum_probs=190.3

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC----ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEec
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL----SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDY   99 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~   99 (291)
                      .+.||+|++|.||+|.+..  +++.+++|.+.....    ...+.+|+.++++++|+||+++++++  .+....++++||
T Consensus         4 ~~~i~~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~~v~e~   79 (283)
T cd05118           4 LGKIGEGTYGVVYKARDKL--TGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVF--RHKGDLYLVFEF   79 (283)
T ss_pred             ceeeecCCCceEEEEEcCC--CCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhh--ccCCCEEEEEec
Confidence            4689999999999999765  678899999865432    34678899999999999999999998  456789999999


Q ss_pred             CCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeeccccee
Q psy2172         100 AEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL  179 (291)
Q Consensus       100 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~  179 (291)
                      +++++.+.+.....        .+++..+..++.|++.||.+||+.+++|+||+|+||+++    .++.++|+|||.+..
T Consensus        80 ~~~~l~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~----~~~~~~l~df~~~~~  147 (283)
T cd05118          80 MDTDLYKLIKDRQR--------GLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLIN----TEGVLKLADFGLARS  147 (283)
T ss_pred             cCCCHHHHHHhhcc--------cCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEEC----CCCcEEEeeeeeeEe
Confidence            99988887765321        288999999999999999999999999999999999998    667899999999987


Q ss_pred             cCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc-----------------
Q psy2172         180 FNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK-----------------  242 (291)
Q Consensus       180 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~-----------------  242 (291)
                      ......   ......++..|+|||.+.+...++.++|+||||+++|+|++|+.||.+.+....                 
T Consensus       148 ~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (283)
T cd05118         148 FGSPVR---PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWP  224 (283)
T ss_pred             cCCCcc---cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcc
Confidence            654321   112235677899999998754589999999999999999999999976543100                 


Q ss_pred             ----------------------CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         243 ----------------------TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       243 ----------------------~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                                            ...+.....+.+++..|..+.|..||++.++..+||+
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         225 KFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             cchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence                                  0011123557778888888888888888888777764

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.9e-35  Score=244.71  Aligned_cols=234  Identities=21%  Similarity=0.348  Sum_probs=181.9

Q ss_pred             cccccceeCcccceEEEEEEEccC-CCCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEE
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKDN-SDTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHNDRKVWL   95 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~~-~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~i   95 (291)
                      |.+ .++||+|+||.||+|.+... .....+++|.......   .+.+.+|+.++++++||||+++++++.  + ...++
T Consensus         8 ~~~-~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~-~~~~l   83 (270)
T cd05056           8 ITL-GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVIT--E-NPVWI   83 (270)
T ss_pred             cee-eeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEc--C-CCcEE
Confidence            554 57999999999999987653 2345689998875432   346888999999999999999999883  2 45689


Q ss_pred             EEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          96 LFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        96 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      +|||+.+ +|.+.+.....        .++...++.++.|++.||++||++|++|+||+|+||+++    ..+.++|+||
T Consensus        84 v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~----~~~~~~l~d~  151 (270)
T cd05056          84 VMELAPLGELRSYLQVNKY--------SLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVS----SPDCVKLGDF  151 (270)
T ss_pred             EEEcCCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEe----cCCCeEEccC
Confidence            9999974 88877754321        278999999999999999999999999999999999998    6678999999


Q ss_pred             ccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc----------ccC
Q psy2172         175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED----------IKT  243 (291)
Q Consensus       175 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~----------~~~  243 (291)
                      |++........  .......++..|+|||.+.+.. ++.++|+||||+++|++++ |..||.+....          ...
T Consensus       152 g~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~  228 (270)
T cd05056         152 GLSRYLEDESY--YKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLP  228 (270)
T ss_pred             ceeeecccccc--eecCCCCccccccChhhhccCC-CCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCC
Confidence            99876543311  1111223456799999987644 8899999999999999885 99999765432          111


Q ss_pred             CCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         244 SNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       244 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      ........+.+++..+..+.|..||++.+
T Consensus       229 ~~~~~~~~~~~li~~~l~~~P~~Rpt~~~  257 (270)
T cd05056         229 MPPNCPPTLYSLMTKCWAYDPSKRPRFTE  257 (270)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            22334567888999999999988887765

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-35  Score=245.90  Aligned_cols=237  Identities=23%  Similarity=0.311  Sum_probs=178.9

Q ss_pred             ceeCcccceEEEEEEEccCCCCceeEEEEeCCCC---CChhHHHHHHHHhcC-CCCCeeeEEEEEEeCCCceEEEEEecC
Q psy2172          25 CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG---LSMSACREIALLREL-KHPNVINLISVFLSHNDRKVWLLFDYA  100 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~iv~e~~  100 (291)
                      +.||+|+||.||+|.+.+++....+++|.++...   ..+.+.+|+.++.++ +||||+++++++  ......+++|||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~--~~~~~~~lv~e~~   78 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC--EHRGYLYLAIEYA   78 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEE--ecCCCceEEEEeC
Confidence            3689999999999998774444567888887432   234678899999999 799999999998  4566789999999


Q ss_pred             C-CCHHHHHHHhhhhhh-------CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172         101 E-HDLWHIIKFHRAAKA-------NKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus       101 ~-~~l~~~~~~~~~~~~-------~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      . ++|.+++........       ......++...++.++.|++.|+++||++|++|+||||+||+++    .++.++++
T Consensus        79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~----~~~~~kl~  154 (270)
T cd05047          79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG----ENYVAKIA  154 (270)
T ss_pred             CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEc----CCCeEEEC
Confidence            7 588888765432110       01122378999999999999999999999999999999999998    67889999


Q ss_pred             ecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc----------
Q psy2172         173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI----------  241 (291)
Q Consensus       173 Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~----------  241 (291)
                      |||++......    ........+..|+|||.+.+.. ++.++|+||||+++|+|++ |..||.+.....          
T Consensus       155 dfgl~~~~~~~----~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~  229 (270)
T cd05047         155 DFGLSRGQEVY----VKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  229 (270)
T ss_pred             CCCCccccchh----hhccCCCCccccCChHHHccCC-CCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCC
Confidence            99987532211    1111122355699999987644 8899999999999999996 999997643210          


Q ss_pred             cCCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         242 KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       242 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      ..........+.+++..|....|..||++.+
T Consensus       230 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  260 (270)
T cd05047         230 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQ  260 (270)
T ss_pred             CCCCCcCCHHHHHHHHHHcccChhhCCCHHH
Confidence            0111122456788888888888888888775

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.1e-35  Score=246.94  Aligned_cols=230  Identities=18%  Similarity=0.264  Sum_probs=171.9

Q ss_pred             eeCcccceEEEEEEEcc----------------------CCCCceeEEEEeCCCCC--ChhHHHHHHHHhcCCCCCeeeE
Q psy2172          26 KVGRGTYGHVYKARRKD----------------------NSDTRDYALKQIEGTGL--SMSACREIALLRELKHPNVINL   81 (291)
Q Consensus        26 ~ig~G~~g~Vy~~~~~~----------------------~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~   81 (291)
                      .||+|+||.||+|....                      ......|++|.+.....  ...+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999997532                      11224588898864322  2457788999999999999999


Q ss_pred             EEEEEeCCCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEee
Q psy2172          82 ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVM  160 (291)
Q Consensus        82 ~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~  160 (291)
                      ++++.  +....++||||+++ +|...+.....        .+++..+..++.|++.||+|||++|++|+||||+||+++
T Consensus        82 ~~~~~--~~~~~~lv~ey~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~  151 (274)
T cd05076          82 HGVCV--RGSENIMVEEFVEHGPLDVCLRKEKG--------RVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLA  151 (274)
T ss_pred             EEEEE--eCCceEEEEecCCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEe
Confidence            99984  45678999999986 55555433211        278899999999999999999999999999999999997


Q ss_pred             cCCC---CCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHH-HcCCCCCCC
Q psy2172         161 GEGI---ERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL-LTSEPIFHC  236 (291)
Q Consensus       161 ~~~~---~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l-~~g~~pf~~  236 (291)
                      ..+.   ....++++|||.+......       ....++..|+|||.+.+...++.++|+||||+++|++ ++|..||..
T Consensus       152 ~~~~~~~~~~~~kl~d~g~~~~~~~~-------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~  224 (274)
T cd05076         152 RLGLAEGTSPFIKLSDPGVSFTALSR-------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE  224 (274)
T ss_pred             ccCcccCccceeeecCCccccccccc-------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccc
Confidence            4321   2335899999987543221       1234567799999987655589999999999999998 479999976


Q ss_pred             Ccccc--------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         237 RQEDI--------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       237 ~~~~~--------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      .....        ..........+.+++..+....|..||++.+
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~  268 (274)
T cd05076         225 RTPSEKERFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRT  268 (274)
T ss_pred             cChHHHHHHHHhccCCCCCCChHHHHHHHHHcccChhhCcCHHH
Confidence            54321        0111112245778888888888888888765

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.6e-35  Score=248.64  Aligned_cols=246  Identities=23%  Similarity=0.391  Sum_probs=186.6

Q ss_pred             cccccccceeCcccceEEEEEEEccC---CCCceeEEEEeCCCCCC---hhHHHHHHHHhcC-CCCCeeeEEEEEEeCCC
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDN---SDTRDYALKQIEGTGLS---MSACREIALLREL-KHPNVINLISVFLSHND   90 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~---~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~   90 (291)
                      +.|.+ .+.||+|+||.||++.+...   .....+++|.+......   .++.+|+.+++++ +|+||+++++++  ...
T Consensus        12 ~~~~~-~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~--~~~   88 (293)
T cd05053          12 DRLTL-GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC--TQE   88 (293)
T ss_pred             hHeEE-eeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE--cCC
Confidence            34554 57999999999999997643   24467999998754332   3577899999999 799999999998  556


Q ss_pred             ceEEEEEecCCC-CHHHHHHHhhhhh-------hCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecC
Q psy2172          91 RKVWLLFDYAEH-DLWHIIKFHRAAK-------ANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGE  162 (291)
Q Consensus        91 ~~~~iv~e~~~~-~l~~~~~~~~~~~-------~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~  162 (291)
                      ...+++|||+.+ +|...+.......       .......+++..+..++.|++.||+|||++|++|+||||+||+++  
T Consensus        89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~--  166 (293)
T cd05053          89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT--  166 (293)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc--
Confidence            689999999974 8887776432100       001223488999999999999999999999999999999999998  


Q ss_pred             CCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc
Q psy2172         163 GIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI  241 (291)
Q Consensus       163 ~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~  241 (291)
                        .++.++|+|||.+........ ........++..|+|||.+.+.. ++.++|+|||||++|++++ |..||.+.....
T Consensus       167 --~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  242 (293)
T cd05053         167 --EDHVMKIADFGLARDIHHIDY-YRKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE  242 (293)
T ss_pred             --CCCeEEeCccccccccccccc-eeccCCCCCCccccCHHHhccCC-cCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence              678999999999986543211 11112223456799999987644 8899999999999999997 999997654311


Q ss_pred             ----------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         242 ----------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       242 ----------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                                ..........+.+++..+..+.|..||++.+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e  283 (293)
T cd05053         243 LFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQ  283 (293)
T ss_pred             HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHH
Confidence                      1122233467888999999999999888775

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=6.3e-35  Score=244.68  Aligned_cols=233  Identities=20%  Similarity=0.248  Sum_probs=177.1

Q ss_pred             cceeCcccceEEEEEEEccCCCC--ceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEe
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDT--RDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFD   98 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~--~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e   98 (291)
                      .+.||+|+||.||+|.+..++..  ..+++|.+.....   ..++..|+.+++.++||||+++++++  . ....++++|
T Consensus        12 ~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~--~-~~~~~~i~e   88 (279)
T cd05111          12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGIC--P-GASLQLVTQ   88 (279)
T ss_pred             ccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEE--C-CCccEEEEE
Confidence            56999999999999998653221  2478888764322   23566788889999999999999987  3 335678889


Q ss_pred             cCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccc
Q psy2172          99 YAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA  177 (291)
Q Consensus        99 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~  177 (291)
                      |+. ++|.+.+.....        .+++..+..++.|++.||+|||++|++|+||||+||+++    .++.++|+|||.+
T Consensus        89 ~~~~gsL~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~----~~~~~kl~Dfg~~  156 (279)
T cd05111          89 LSPLGSLLDHVRQHRD--------SLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLK----SDSIVQIADFGVA  156 (279)
T ss_pred             eCCCCcHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEc----CCCcEEEcCCccc
Confidence            987 588888764322        288999999999999999999999999999999999998    6778999999999


Q ss_pred             eecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc----------cCCCC
Q psy2172         178 RLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI----------KTSNP  246 (291)
Q Consensus       178 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~----------~~~~~  246 (291)
                      ......... .......++..|+|||.+.+.. ++.++|+||||+++|++++ |..||.+.....          .....
T Consensus       157 ~~~~~~~~~-~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~  234 (279)
T cd05111         157 DLLYPDDKK-YFYSEHKTPIKWMALESILFGR-YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQ  234 (279)
T ss_pred             eeccCCCcc-cccCCCCCcccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCC
Confidence            765432111 1122344567899999997644 8999999999999999998 999998754321          11112


Q ss_pred             CcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         247 YHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       247 ~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      .....+..++..+....|..||++.++
T Consensus       235 ~~~~~~~~li~~c~~~~p~~Rps~~el  261 (279)
T cd05111         235 ICTIDVYMVMVKCWMIDENVRPTFKEL  261 (279)
T ss_pred             CCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence            233456677778888888888888764

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=6.8e-35  Score=241.10  Aligned_cols=242  Identities=29%  Similarity=0.495  Sum_probs=196.9

Q ss_pred             cccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEE
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG----LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWL   95 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~i   95 (291)
                      |.+ .+.||.|++|.||++.+..  ++..+++|.+....    ....+.+|+++++.++|||++++++.+.  .....++
T Consensus         2 y~~-~~~l~~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~--~~~~~~l   76 (258)
T cd08215           2 YEI-IKQIGKGSFGKVYLVRRKS--DGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFE--EKGKLCI   76 (258)
T ss_pred             ceE-EeeeccCCCeEEEEEEEcC--CCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEe--cCCEEEE
Confidence            443 4689999999999999876  67889999987543    3346788999999999999999999984  4578999


Q ss_pred             EEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          96 LFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        96 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      ++|++++ +|.+.+......     ...+++..+..++.+++.||.+||+.|++|+||+|+||+++    .++.++|+||
T Consensus        77 v~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~----~~~~~~l~d~  147 (258)
T cd08215          77 VMEYADGGDLSQKIKKQKKE-----GKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLT----SNGLVKLGDF  147 (258)
T ss_pred             EEEecCCCcHHHHHHHhhcc-----CCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEc----CCCcEEECCc
Confidence            9999986 888777654321     12289999999999999999999999999999999999998    6678999999


Q ss_pred             ccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc----------ccCC
Q psy2172         175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED----------IKTS  244 (291)
Q Consensus       175 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~----------~~~~  244 (291)
                      |.+.......   .......|+..|+|||.+.+.. ++.++|+||+|+++++|++|..||......          ....
T Consensus       148 ~~~~~~~~~~---~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  223 (258)
T cd08215         148 GISKVLSSTV---DLAKTVVGTPYYLSPELCQNKP-YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPI  223 (258)
T ss_pred             cceeecccCc---ceecceeeeecccChhHhccCC-CCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCC
Confidence            9987655432   1223346788899999987744 889999999999999999999999765321          1112


Q ss_pred             CCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         245 NPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       245 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                      .......+.+++..|....|..||++.++..+|++
T Consensus       224 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         224 PSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            22445778999999999999999999999888874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.5e-36  Score=248.27  Aligned_cols=231  Identities=15%  Similarity=0.237  Sum_probs=176.0

Q ss_pred             ceeCcccceEEEEEEEccCCC-----CceeEEEEeCCCC--CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEE
Q psy2172          25 CKVGRGTYGHVYKARRKDNSD-----TRDYALKQIEGTG--LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLF   97 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~~~-----~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~   97 (291)
                      +.||+|+||.||+|.++..+.     ...+++|......  ..+.+.+|+.+++.++|||++++++++.  .....++||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~--~~~~~~lv~   78 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCV--CGDESIMVQ   78 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEE--eCCCcEEEE
Confidence            479999999999999765322     2348888876432  2346788999999999999999999994  455789999


Q ss_pred             ecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCC----CCCcEEEe
Q psy2172          98 DYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGI----ERGRVKIA  172 (291)
Q Consensus        98 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~----~~~~~~l~  172 (291)
                      ||+++ +|...+.....        .+++..+..++.|++.||+|||++|++|+||||+||+++.++.    ....++++
T Consensus        79 e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~  150 (258)
T cd05078          79 EYVKFGSLDTYLKKNKN--------LINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLS  150 (258)
T ss_pred             ecCCCCcHHHHHhcCCC--------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEec
Confidence            99985 77777654332        2788899999999999999999999999999999999985421    12347999


Q ss_pred             ecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcC-CCCCCCCcccc--------cC
Q psy2172         173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQEDI--------KT  243 (291)
Q Consensus       173 Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g-~~pf~~~~~~~--------~~  243 (291)
                      |||.+.....       .....++..|+|||.+.+...++.++|+||||+++|+|++| ..||.......        ..
T Consensus       151 d~g~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~  223 (258)
T cd05078         151 DPGISITVLP-------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQ  223 (258)
T ss_pred             ccccccccCC-------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHcccc
Confidence            9998864432       12245677899999998755588999999999999999998 57776544321        11


Q ss_pred             CCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         244 SNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       244 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      ........+.+++..|..+.|..||++++
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~  252 (258)
T cd05078         224 LPAPKWTELANLINQCMDYEPDFRPSFRA  252 (258)
T ss_pred             CCCCCcHHHHHHHHHHhccChhhCCCHHH
Confidence            12223356788888888888888888775

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.6e-35  Score=246.93  Aligned_cols=247  Identities=23%  Similarity=0.311  Sum_probs=184.7

Q ss_pred             cccccccceeCcccceEEEEEEEccC------------CCCceeEEEEeCCCCCC---hhHHHHHHHHhcCCCCCeeeEE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDN------------SDTRDYALKQIEGTGLS---MSACREIALLRELKHPNVINLI   82 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~------------~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~   82 (291)
                      ++|++ .++||+|+||.||+|.+.+.            +....||+|.++.....   ..+.+|++++++++|+|+++++
T Consensus         5 ~~~~~-~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           5 QQLRL-KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             HhCee-hhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            45665 57999999999999987542            12345899998754322   3578899999999999999999


Q ss_pred             EEEEeCCCceEEEEEecCCC-CHHHHHHHhhhhh---hCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEE
Q psy2172          83 SVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAK---ANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANIL  158 (291)
Q Consensus        83 ~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~---~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil  158 (291)
                      +++  ......+++|||+.+ +|.+.+.......   .......++...+..++.|++.||+|||++|++|+||||+||+
T Consensus        84 ~~~--~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil  161 (295)
T cd05097          84 GVC--VSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL  161 (295)
T ss_pred             EEE--cCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence            999  556789999999985 7877775432110   0111123678899999999999999999999999999999999


Q ss_pred             eecCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc--CCCCCCC
Q psy2172         159 VMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT--SEPIFHC  236 (291)
Q Consensus       159 ~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~--g~~pf~~  236 (291)
                      ++    .++.++|+|||++........ ........++..|+|||.+.+.. ++.++|+||||+++++|++  |..||..
T Consensus       162 l~----~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~~l~el~~~~~~~p~~~  235 (295)
T cd05097         162 VG----NHYTIKIADFGMSRNLYSGDY-YRIQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEMFTLCKEQPYSL  235 (295)
T ss_pred             Ec----CCCcEEecccccccccccCcc-eeccCcCcCceeecChhhhccCC-cCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence            98    567899999999875433211 11112234467899999987754 8999999999999999987  6778875


Q ss_pred             Ccccc-----------------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         237 RQEDI-----------------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       237 ~~~~~-----------------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      .....                 ....+.....+.+++..|....|..||+++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i  289 (295)
T cd05097         236 LSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKI  289 (295)
T ss_pred             cChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence            43210                 11122334678889999999999999988753

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=7.6e-35  Score=241.71  Aligned_cols=235  Identities=20%  Similarity=0.320  Sum_probs=182.9

Q ss_pred             ccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC-ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEE
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-SMSACREIALLRELKHPNVINLISVFLSHNDRKVWL   95 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~i   95 (291)
                      .+.|.+ .++||+|+||.||++.+..   +..+++|.+..... ...+.+|+.++++++|+||+++++.+.  + ...++
T Consensus         5 ~~~~~~-~~~lg~g~~~~vy~~~~~~---~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~-~~~~~   77 (260)
T cd05073           5 RESLKL-EKKLGAGQFGEVWMATYNK---HTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT--K-EPIYI   77 (260)
T ss_pred             ccceeE-EeEecCccceEEEEEEecC---CccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEc--C-CCeEE
Confidence            456664 6799999999999998643   34699998875432 356888999999999999999999983  3 57899


Q ss_pred             EEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          96 LFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        96 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      +|||++ ++|.+.+......       .++...+..++.|++.||.+||++|++|+||+|+||+++    ..+.++|+||
T Consensus        78 v~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~----~~~~~~l~d~  146 (260)
T cd05073          78 ITEFMAKGSLLDFLKSDEGS-------KQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS----ASLVCKIADF  146 (260)
T ss_pred             EEEeCCCCcHHHHHHhCCcc-------ccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc----CCCcEEECCC
Confidence            999997 4888887653211       277888999999999999999999999999999999998    6789999999


Q ss_pred             ccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc----------cC
Q psy2172         175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI----------KT  243 (291)
Q Consensus       175 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~----------~~  243 (291)
                      |.+........  .......++..|+|||.+.... ++.++|+||||+++|++++ |..||.+.....          ..
T Consensus       147 ~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~  223 (260)
T cd05073         147 GLARVIEDNEY--TAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP  223 (260)
T ss_pred             cceeeccCCCc--ccccCCcccccccCHhHhccCC-cCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCC
Confidence            99876543211  1112234456799999997644 8889999999999999998 999998654321          01


Q ss_pred             CCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         244 SNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       244 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      ........+.+++..+..+.|..||++.+
T Consensus       224 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~  252 (260)
T cd05073         224 RPENCPEELYNIMMRCWKNRPEERPTFEY  252 (260)
T ss_pred             CcccCCHHHHHHHHHHcccCcccCcCHHH
Confidence            12223456888888899899988888764

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=5.4e-35  Score=247.13  Aligned_cols=246  Identities=24%  Similarity=0.331  Sum_probs=184.5

Q ss_pred             cccccccceeCcccceEEEEEEEcc--------------CCCCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeee
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKD--------------NSDTRDYALKQIEGTGL---SMSACREIALLRELKHPNVIN   80 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~--------------~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~   80 (291)
                      ++|++ .++||+|+||.||++.+.+              ..+...+|+|.+.....   ..++.+|+.+++.++|+||++
T Consensus         5 ~~~~~-~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           5 KRLTF-KEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhcee-eeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            45665 6699999999999986543              12345689999875432   246889999999999999999


Q ss_pred             EEEEEEeCCCceEEEEEecCCC-CHHHHHHHhhhhhh--CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcE
Q psy2172          81 LISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKA--NKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANI  157 (291)
Q Consensus        81 ~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~--~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Ni  157 (291)
                      +++++  ......+++|||+.+ +|.+.+........  ......+++..+..++.|++.||++||++|++|+||||+||
T Consensus        84 ~~~~~--~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni  161 (296)
T cd05095          84 LLAVC--ITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC  161 (296)
T ss_pred             EEEEE--ecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence            99998  456678999999974 88887765432111  11122377889999999999999999999999999999999


Q ss_pred             EeecCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc--CCCCCC
Q psy2172         158 LVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT--SEPIFH  235 (291)
Q Consensus       158 l~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~--g~~pf~  235 (291)
                      +++    .++.++|+|||.+......... .......++..|+|||...+.. ++.++|+|||||++|+|++  |..||.
T Consensus       162 li~----~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~-~~~~~DiwSlG~~l~el~~~~~~~p~~  235 (296)
T cd05095         162 LVG----KNYTIKIADFGMSRNLYSGDYY-RIQGRAVLPIRWMSWESILLGK-FTTASDVWAFGVTLWEILTLCKEQPYS  235 (296)
T ss_pred             EEc----CCCCEEeccCcccccccCCcce-eccCcCcCccccCCHHHHhcCC-ccchhhhhHHHHHHHHHHHhCCCCCcc
Confidence            998    6678999999998765432111 1112233456799999877644 8999999999999999997  778886


Q ss_pred             CCcccc-----------------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         236 CRQEDI-----------------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       236 ~~~~~~-----------------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      ......                 ..........+.+++..+..+.|..||++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~  289 (296)
T cd05095         236 QLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQE  289 (296)
T ss_pred             ccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHH
Confidence            543211                 0112233467888999999999999888775

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.2e-35  Score=244.21  Aligned_cols=238  Identities=27%  Similarity=0.496  Sum_probs=190.4

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCC----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEec
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT----GLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDY   99 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~   99 (291)
                      .+.||+|+||.||++.++.  ++..+++|.+...    .....+.+|+.+++.++|+||+++++.+  .+....++++||
T Consensus         5 ~~~l~~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~--~~~~~~~lv~e~   80 (257)
T cd08225           5 IKKIGEGSFGKIYLAKAKS--DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF--QENGRLFIVMEY   80 (257)
T ss_pred             EEEecCCCcceEEEEEEcC--CCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee--ccCCeEEEEEec
Confidence            6789999999999999876  6678999998643    2334678899999999999999999998  567789999999


Q ss_pred             CCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccce
Q psy2172         100 AEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR  178 (291)
Q Consensus       100 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~  178 (291)
                      +.+ +|.+.+.....       ..+++..+..++.|++.||.+||+++++|+||+|+||+++.   ....++++|||.+.
T Consensus        81 ~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~---~~~~~~l~d~~~~~  150 (257)
T cd08225          81 CDGGDLMKRINRQRG-------VLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSK---NGMVAKLGDFGIAR  150 (257)
T ss_pred             CCCCcHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcC---CCCeEEecccccch
Confidence            975 87777754321       12789999999999999999999999999999999999983   22457999999987


Q ss_pred             ecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc----------ccCCCCCc
Q psy2172         179 LFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED----------IKTSNPYH  248 (291)
Q Consensus       179 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~----------~~~~~~~~  248 (291)
                      .......   ......|+..|+|||.+.+.. ++.++|+||||+++++|++|..||......          .....+..
T Consensus       151 ~~~~~~~---~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  226 (257)
T cd08225         151 QLNDSME---LAYTCVGTPYYLSPEICQNRP-YNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNF  226 (257)
T ss_pred             hccCCcc---cccccCCCccccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCC
Confidence            6543221   112235788899999987644 889999999999999999999999764321          11122233


Q ss_pred             HHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         249 HDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       249 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                      ...+.+++..|....|..||++.++..+||+
T Consensus       227 ~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         227 SRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence            5678888999999999999999999888874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG4257|consensus

Probab=100.00  E-value=1.1e-35  Score=256.61  Aligned_cols=234  Identities=24%  Similarity=0.369  Sum_probs=195.3

Q ss_pred             ccceeCcccceEEEEEEEccCCCC--ceeEEEEeCCCC---CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEE
Q psy2172          23 EGCKVGRGTYGHVYKARRKDNSDT--RDYALKQIEGTG---LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLF   97 (291)
Q Consensus        23 ~~~~ig~G~~g~Vy~~~~~~~~~~--~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~   97 (291)
                      .+++||.|-||.||.|.+.....+  -.||||.++.+.   ..+.|..|+.+|++++||||++++|++   .....|+||
T Consensus       393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~---~e~P~Wivm  469 (974)
T KOG4257|consen  393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVC---VEQPMWIVM  469 (974)
T ss_pred             HHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeee---eccceeEEE
Confidence            378999999999999998664333  348999998643   345799999999999999999999998   355799999


Q ss_pred             ecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeeccc
Q psy2172          98 DYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGF  176 (291)
Q Consensus        98 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~  176 (291)
                      |.++ |.|.+++......        ++...+..+..||+.||+|||+.++|||||..+||++.    ....|||+|||+
T Consensus       470 EL~~~GELr~yLq~nk~s--------L~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVs----Sp~CVKLaDFGL  537 (974)
T KOG4257|consen  470 ELAPLGELREYLQQNKDS--------LPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVS----SPQCVKLADFGL  537 (974)
T ss_pred             ecccchhHHHHHHhcccc--------chHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeec----Ccceeeecccch
Confidence            9998 7899888866543        88889999999999999999999999999999999998    567899999999


Q ss_pred             ceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc----------ccCCC
Q psy2172         177 ARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED----------IKTSN  245 (291)
Q Consensus       177 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~----------~~~~~  245 (291)
                      ++.......  .......-...|+|||.+.-.+ ++.++|||.|||++||++. |..||.+....          .....
T Consensus       538 SR~~ed~~y--YkaS~~kLPIKWmaPESINfRr-FTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P  614 (974)
T KOG4257|consen  538 SRYLEDDAY--YKASRGKLPIKWMAPESINFRR-FTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCP  614 (974)
T ss_pred             hhhccccch--hhccccccceeecCccccchhc-ccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCC
Confidence            998766432  2223344467899999997644 9999999999999999875 99999986653          34567


Q ss_pred             CCcHHHHHHHHHhhCCCCcCChhhhhcCC
Q psy2172         246 PYHHDQLDRIFSVMGFPLEKDWEDIRKMP  274 (291)
Q Consensus       246 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  274 (291)
                      +.+...+..++..+....|..+|.+.++.
T Consensus       615 ~nCPp~LYslmskcWayeP~kRPrftei~  643 (974)
T KOG4257|consen  615 PNCPPALYSLMSKCWAYEPSKRPRFTEIK  643 (974)
T ss_pred             CCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence            77888899999999999999999888653

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=4.5e-35  Score=246.38  Aligned_cols=254  Identities=26%  Similarity=0.458  Sum_probs=202.7

Q ss_pred             eeecccccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC-ChhHHHHHHHHhcCCCCCeeeEEEEE
Q psy2172           7 IKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-SMSACREIALLRELKHPNVINLISVF   85 (291)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~   85 (291)
                      +++........+.|+. .+.||+|++|.||+|.+..  .+..+++|.+..... ...+.+|+++++.++|+|++++++.+
T Consensus         8 ~~~~~~~~~~~~~~~~-~~~l~~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~   84 (286)
T cd06614           8 LKDIVSEGDPRELYKN-LEKIGEGASGEVYKATDRA--TGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSY   84 (286)
T ss_pred             HhhhcCCCCccccchH-hHhccCCCCeEEEEEEEcc--CCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEE
Confidence            3344444566777775 5799999999999999875  567899999875433 45688899999999999999999999


Q ss_pred             EeCCCceEEEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCC
Q psy2172          86 LSHNDRKVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGI  164 (291)
Q Consensus        86 ~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~  164 (291)
                      .  .....|+++||++ ++|.+.+....        ..++...+..++.|++.||++||+.|++|+||+|+||+++    
T Consensus        85 ~--~~~~~~lv~e~~~~~~L~~~l~~~~--------~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~----  150 (286)
T cd06614          85 L--VGDELWVVMEYMDGGSLTDIITQNF--------VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLS----  150 (286)
T ss_pred             E--ECCEEEEEEeccCCCcHHHHHHHhc--------cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEc----
Confidence            4  4578999999999 58888877543        1288999999999999999999999999999999999998    


Q ss_pred             CCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc----
Q psy2172         165 ERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED----  240 (291)
Q Consensus       165 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~----  240 (291)
                      .++.++|+|||.+........   ......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||......    
T Consensus       151 ~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~  226 (286)
T cd06614         151 KDGSVKLADFGFAAQLTKEKS---KRNSVVGTPYWMAPEVIKRKD-YGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF  226 (286)
T ss_pred             CCCCEEECccchhhhhccchh---hhccccCCcccCCHhHhcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            667899999998865443211   112334677899999987644 889999999999999999999999865431    


Q ss_pred             ------ccC--CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         241 ------IKT--SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       241 ------~~~--~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                            ...  ........+.+++..|..+.|..||++.++..++++.+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  275 (286)
T cd06614         227 LITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK  275 (286)
T ss_pred             HHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence                  000  11113466889999999999999999999988887765

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.6e-35  Score=243.55  Aligned_cols=236  Identities=22%  Similarity=0.308  Sum_probs=180.8

Q ss_pred             ccccccceeCcccceEEEEEEEccCCC--CceeEEEEeCCCCCC---hhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSD--TRDYALKQIEGTGLS---MSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~--~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      .|.+ .+.||+|+||.||+|.++.++.  ...+++|.+......   ..+.+|+.++++++||||+++++++..   ...
T Consensus         8 ~~~~-~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~   83 (279)
T cd05057           8 ELEK-IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS---SQV   83 (279)
T ss_pred             HcEE-cceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec---Cce
Confidence            4443 5799999999999999876432  235899988755432   457789999999999999999999843   578


Q ss_pred             EEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          94 WLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        94 ~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      ++++||+. ++|.+.+.....        .+++..+..++.|++.||++||++|++|+||+|+||+++    .++.++|+
T Consensus        84 ~~v~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~----~~~~~kL~  151 (279)
T cd05057          84 QLITQLMPLGCLLDYVRNHKD--------NIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVK----TPQHVKIT  151 (279)
T ss_pred             EEEEecCCCCcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEc----CCCeEEEC
Confidence            99999997 488777654322        188999999999999999999999999999999999998    66789999


Q ss_pred             ecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc----------
Q psy2172         173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI----------  241 (291)
Q Consensus       173 Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~----------  241 (291)
                      |||.+.......... ......++..|+|||.+.... ++.++|+||||+++|++++ |..||.+.....          
T Consensus       152 dfg~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~  229 (279)
T cd05057         152 DFGLAKLLDVDEKEY-HAEGGKVPIKWMALESILHRI-YTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGER  229 (279)
T ss_pred             CCcccccccCcccce-ecCCCcccccccCHHHhhcCC-cCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC
Confidence            999998655322111 111222356799999987644 8899999999999999998 999998755321          


Q ss_pred             cCCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         242 KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       242 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      ..........+.+++..+....|..+|++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~  260 (279)
T cd05057         230 LPQPPICTIDVYMVLVKCWMIDAESRPTFKE  260 (279)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence            1122223456677777787788888877665

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.7e-35  Score=241.05  Aligned_cols=229  Identities=18%  Similarity=0.331  Sum_probs=182.9

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC-ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLF   97 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~   97 (291)
                      .|.+ .+.||+|+||.||+|...    ++.+++|.++.... ..++.+|+.+++.++|+||+++++++  .+....+++|
T Consensus         7 ~~~~-~~~ig~g~~g~v~~~~~~----~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~~v~   79 (256)
T cd05039           7 ELKL-GATIGKGEFGDVMLGDYR----GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVV--LQGNPLYIVT   79 (256)
T ss_pred             hccc-eeeeecCCCceEEEEEec----CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEE--cCCCCeEEEE
Confidence            4454 569999999999999864    46799999986544 45788999999999999999999998  4467899999


Q ss_pred             ecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeeccc
Q psy2172          98 DYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGF  176 (291)
Q Consensus        98 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~  176 (291)
                      ||+++ +|.+.+......       .+++..++.++.|++.||.+||++|++|+||+|+||+++    .++.++|+|||.
T Consensus        80 e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~----~~~~~~l~d~g~  148 (256)
T cd05039          80 EYMAKGSLVDYLRSRGRA-------VITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVS----EDLVAKVSDFGL  148 (256)
T ss_pred             EecCCCcHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEe----CCCCEEEccccc
Confidence            99984 888777643321       288999999999999999999999999999999999998    677899999999


Q ss_pred             ceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc----------cCCC
Q psy2172         177 ARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI----------KTSN  245 (291)
Q Consensus       177 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~----------~~~~  245 (291)
                      +.......      .....+..|+|||.+.+.. ++.++|+||||+++|++++ |..||.......          ....
T Consensus       149 ~~~~~~~~------~~~~~~~~~~ape~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  221 (256)
T cd05039         149 AKEASQGQ------DSGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAP  221 (256)
T ss_pred             cccccccc------ccCCCcccccCchhhcCCc-CCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCc
Confidence            87653211      1223356799999987644 8889999999999999997 999997654321          1112


Q ss_pred             CCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         246 PYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       246 ~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      ....+.+.+++..|..+.|..||++.+
T Consensus       222 ~~~~~~~~~li~~~l~~~p~~Rp~~~~  248 (256)
T cd05039         222 EGCPPEVYKVMKDCWELDPAKRPTFKQ  248 (256)
T ss_pred             cCCCHHHHHHHHHHhccChhhCcCHHH
Confidence            223467888888888888888888764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=5.3e-35  Score=247.08  Aligned_cols=247  Identities=23%  Similarity=0.308  Sum_probs=185.4

Q ss_pred             cccccccceeCcccceEEEEEEEccCC--------------CCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeee
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNS--------------DTRDYALKQIEGTGL---SMSACREIALLRELKHPNVIN   80 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~--------------~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~   80 (291)
                      +.|++ .+.||+|+||.||+|.+....              ....+++|.+.....   ...+.+|+.++++++||||++
T Consensus         5 ~~~~~-~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           5 QPLNF-VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhCcc-cccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            35664 679999999999999875432              234589999875432   346778999999999999999


Q ss_pred             EEEEEEeCCCceEEEEEecCCC-CHHHHHHHhhhhhhC--CCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcE
Q psy2172          81 LISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKAN--KKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANI  157 (291)
Q Consensus        81 ~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~--~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Ni  157 (291)
                      +++++  .+....+++||++.+ +|.+++.........  .....+++..++.++.|++.||++||++|++|+||||+||
T Consensus        84 ~~~~~--~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni  161 (296)
T cd05051          84 LLGVC--TVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC  161 (296)
T ss_pred             EEEEE--ecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence            99998  455789999999975 888777654321100  1112388999999999999999999999999999999999


Q ss_pred             EeecCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc--CCCCCC
Q psy2172         158 LVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT--SEPIFH  235 (291)
Q Consensus       158 l~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~--g~~pf~  235 (291)
                      +++    ..+.++|+|||.+......... .......++..|+|||.+.+.. ++.++||||||+++|+|++  |..||.
T Consensus       162 li~----~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~~~~~p~~  235 (296)
T cd05051         162 LVG----KNYTIKIADFGMSRNLYSSDYY-RVQGRAPLPIRWMAWESVLLGK-FTTKSDVWAFGVTLWEILTLCREQPYE  235 (296)
T ss_pred             eec----CCCceEEccccceeecccCcce-eecCcCCCCceecCHHHhhcCC-CCccchhhhhHHHHHHHHhcCCCCCCC
Confidence            998    6689999999998765432111 1122334567899999987744 8999999999999999987  678886


Q ss_pred             CCcccc-----------------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         236 CRQEDI-----------------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       236 ~~~~~~-----------------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      ......                 ..........+.+++..|..+.|..||++.++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el  290 (296)
T cd05051         236 HLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREI  290 (296)
T ss_pred             CcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHH
Confidence            543211                 00112223568888888888888888887754

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-35  Score=245.18  Aligned_cols=238  Identities=37%  Similarity=0.631  Sum_probs=185.7

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC----ChhHHHHHHHHhcC---CCCCeeeEEEEEEeCCC---ceE
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL----SMSACREIALLREL---KHPNVINLISVFLSHND---RKV   93 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~---~~~   93 (291)
                      .+.||+|+||.||+|.++.  +++.+++|.++....    ...+.+|+.+++++   +|+|++++++.+...+.   ...
T Consensus         4 ~~~l~~g~~~~v~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~   81 (287)
T cd07838           4 LAEIGEGAYGTVYKARDLN--TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL   81 (287)
T ss_pred             EEEecccCceEEEEEEECC--CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence            5689999999999999876  678899999864322    23466787777666   59999999999854322   249


Q ss_pred             EEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEee
Q psy2172          94 WLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIAD  173 (291)
Q Consensus        94 ~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~D  173 (291)
                      +++|||+++++.+.+......       .+++..++.++.|++.||.+||+.+++|+||+|+||+++    .++.++|+|
T Consensus        82 ~l~~e~~~~~l~~~l~~~~~~-------~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~----~~~~~~l~d  150 (287)
T cd07838          82 TLVFEHVDQDLATYLSKCPKP-------GLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVT----SDGQVKIAD  150 (287)
T ss_pred             EEEehhcccCHHHHHHHccCC-------CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEc----cCCCEEEec
Confidence            999999998888776543221       288999999999999999999999999999999999998    668999999


Q ss_pred             cccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc-----------
Q psy2172         174 MGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK-----------  242 (291)
Q Consensus       174 fg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~-----------  242 (291)
                      ||.+.......    ......++..|+|||.+.+.. ++.++|+||||+++|+|++|.+||.+......           
T Consensus       151 fg~~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (287)
T cd07838         151 FGLARIYSFEM----ALTSVVVTLWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLP  225 (287)
T ss_pred             cCcceeccCCc----ccccccccccccChHHhccCC-CCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCC
Confidence            99987654331    112234678899999998754 88999999999999999999999986542100           


Q ss_pred             -----------------C--------CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         243 -----------------T--------SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       243 -----------------~--------~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                                       .        ..+.....+.+++..|..+.|..||++.++..++|+
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         226 SEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             ChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                             0        000113456678888888999999999988888764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3e-35  Score=247.02  Aligned_cols=237  Identities=34%  Similarity=0.575  Sum_probs=186.6

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC---ChhHHHHHHHHhcCC-CCCeeeEEEEEEeCCCceEEEEEec
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL---SMSACREIALLRELK-HPNVINLISVFLSHNDRKVWLLFDY   99 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~iv~e~   99 (291)
                      .+.||+|++|.||+|.+.+  +++.+++|.+.....   .....+|+..+++++ |+|++++++++  .+....++||||
T Consensus         4 ~~~ig~g~~g~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~--~~~~~~~lv~e~   79 (283)
T cd07830           4 IKQLGDGTFGSVYLARNKE--TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVF--RENDELYFVFEY   79 (283)
T ss_pred             heeeccCCceEEEEEEECC--CCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHh--hcCCcEEEEEec
Confidence            5689999999999999866  667899999865422   123457899999998 99999999998  457789999999


Q ss_pred             CCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeeccccee
Q psy2172         100 AEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL  179 (291)
Q Consensus       100 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~  179 (291)
                      +++++.+.+.....       ..+++..+..++.|++.+|.+||++|++|+||+|+||+++    .++.++|+|||.+..
T Consensus        80 ~~~~l~~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~----~~~~~~l~d~~~~~~  148 (283)
T cd07830          80 MEGNLYQLMKDRKG-------KPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVS----GPEVVKIADFGLARE  148 (283)
T ss_pred             CCCCHHHHHHhccc-------ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEc----CCCCEEEeeccccee
Confidence            98898887765431       1288999999999999999999999999999999999998    678999999999876


Q ss_pred             cCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc-----------------
Q psy2172         180 FNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK-----------------  242 (291)
Q Consensus       180 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~-----------------  242 (291)
                      .....    ......++..|+|||.+.....++.++|+||||+++++|++|.+||.+......                 
T Consensus       149 ~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (283)
T cd07830         149 IRSRP----PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWP  224 (283)
T ss_pred             ccCCC----CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhh
Confidence            54321    112345678899999886655588999999999999999999999976543100                 


Q ss_pred             ----------------------CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         243 ----------------------TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       243 ----------------------~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                                            ...+.....+.+++..|....|..||++.++..+|++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         225 EGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             hHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence                                  0000112456677777777888888888877777653

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=7.7e-35  Score=251.09  Aligned_cols=248  Identities=20%  Similarity=0.336  Sum_probs=183.0

Q ss_pred             cccccccceeCcccceEEEEEEEcc---CCCCceeEEEEeCCCCCC---hhHHHHHHHHhcC-CCCCeeeEEEEEEeCCC
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKD---NSDTRDYALKQIEGTGLS---MSACREIALLREL-KHPNVINLISVFLSHND   90 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~---~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~   90 (291)
                      ++|++ ++.||+|+||.||+|.+.+   ..+++.||||.++.....   ..+.+|+.++.++ +||||+++++++.. ..
T Consensus         7 ~~~~~-~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-~~   84 (343)
T cd05103           7 DRLKL-GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK-PG   84 (343)
T ss_pred             hHhcc-cccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec-CC
Confidence            46775 6799999999999998643   235678999999754322   3577899999999 68999999998753 34


Q ss_pred             ceEEEEEecCCC-CHHHHHHHhhhhh------------------------------------------------------
Q psy2172          91 RKVWLLFDYAEH-DLWHIIKFHRAAK------------------------------------------------------  115 (291)
Q Consensus        91 ~~~~iv~e~~~~-~l~~~~~~~~~~~------------------------------------------------------  115 (291)
                      ...+++|||+++ +|.+.+.......                                                      
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            578999999985 8877776432100                                                      


Q ss_pred             ----hCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceecCCCCCCCCCCC
Q psy2172         116 ----ANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLD  191 (291)
Q Consensus       116 ----~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  191 (291)
                          .......++...+..++.|++.||+|||++|++|+||||+||+++    .++.++|+|||++........ .....
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~----~~~~~kl~dfg~~~~~~~~~~-~~~~~  239 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLS----ENNVVKICDFGLARDIYKDPD-YVRKG  239 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEc----CCCcEEEEecccccccccCcc-hhhcC
Confidence                000012367888899999999999999999999999999999998    667899999999876432211 11112


Q ss_pred             CceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc-----------cCCCCCcHHHHHHHHHhh
Q psy2172         192 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI-----------KTSNPYHHDQLDRIFSVM  259 (291)
Q Consensus       192 ~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~-----------~~~~~~~~~~~~~i~~~~  259 (291)
                      ...++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||.......           ..........+.+++..+
T Consensus       240 ~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~c  318 (343)
T cd05103         240 DARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC  318 (343)
T ss_pred             CCCCCcceECcHHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHH
Confidence            234466799999987644 8899999999999999996 999997643210           011112234567777788


Q ss_pred             CCCCcCChhhhhcC
Q psy2172         260 GFPLEKDWEDIRKM  273 (291)
Q Consensus       260 ~~~~~~~~~~~~~~  273 (291)
                      ..+.|..||++.++
T Consensus       319 l~~~p~~Rps~~ei  332 (343)
T cd05103         319 WHGEPSQRPTFSEL  332 (343)
T ss_pred             ccCChhhCcCHHHH
Confidence            88888888887764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=9.4e-35  Score=243.77  Aligned_cols=242  Identities=23%  Similarity=0.335  Sum_probs=183.9

Q ss_pred             cceeCcccceEEEEEEEcc---CCCCceeEEEEeCCCC--CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEe
Q psy2172          24 GCKVGRGTYGHVYKARRKD---NSDTRDYALKQIEGTG--LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFD   98 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~---~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e   98 (291)
                      .++||+|+||.||++...+   ...+..+++|.+....  ....+.+|+++++.++|+||+++++++  .+....+++||
T Consensus        10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~lv~e   87 (280)
T cd05092          10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVC--TEGRPLLMVFE   87 (280)
T ss_pred             ccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEE--ecCCceEEEEe
Confidence            5699999999999997643   2345678999876432  234688999999999999999999998  45667899999


Q ss_pred             cCCC-CHHHHHHHhhhhh------hCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEE
Q psy2172          99 YAEH-DLWHIIKFHRAAK------ANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI  171 (291)
Q Consensus        99 ~~~~-~l~~~~~~~~~~~------~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l  171 (291)
                      |+++ +|.+++.......      .......+++..+..++.|++.|++|||++|++|+||||+||+++    .+..++|
T Consensus        88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~----~~~~~kL  163 (280)
T cd05092          88 YMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG----QGLVVKI  163 (280)
T ss_pred             cCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEc----CCCCEEE
Confidence            9974 8888876543210      011122378899999999999999999999999999999999998    6778999


Q ss_pred             eecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc----------
Q psy2172         172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED----------  240 (291)
Q Consensus       172 ~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~----------  240 (291)
                      +|||++........ ........++..|+|||.+.+.. ++.++|+|||||++|+|++ |..||......          
T Consensus       164 ~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~  241 (280)
T cd05092         164 GDFGMSRDIYSTDY-YRVGGRTMLPIRWMPPESILYRK-FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR  241 (280)
T ss_pred             CCCCceeEcCCCce-eecCCCccccccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc
Confidence            99999875533211 11112234467899999988754 8999999999999999998 99999654321          


Q ss_pred             ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         241 IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       241 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      ...........+.+++..|....|.+||++.++
T Consensus       242 ~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l  274 (280)
T cd05092         242 ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDI  274 (280)
T ss_pred             cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence            111122334668889999999999888887753

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.3e-35  Score=244.99  Aligned_cols=236  Identities=27%  Similarity=0.455  Sum_probs=189.5

Q ss_pred             eCcccceEEEEEEEccCCCCceeEEEEeCCCC-----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecCC
Q psy2172          27 VGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-----LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAE  101 (291)
Q Consensus        27 ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~~  101 (291)
                      ||+|+||.||+|.+..  +++.+++|.+....     ....+.+|+.++++++||||+++++.+  ......|+++||+.
T Consensus         1 lg~g~~~~vy~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~--~~~~~~~lv~e~~~   76 (265)
T cd05579           1 ISKGAYGRVFLAKKKS--TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF--QGKKNLYLVMEYLP   76 (265)
T ss_pred             CCCCCceEEEEEEECC--CCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe--ecCcEEEEEEecCC
Confidence            6899999999999876  67889999986542     234678899999999999999999988  56778999999997


Q ss_pred             C-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceec
Q psy2172         102 H-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF  180 (291)
Q Consensus       102 ~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~  180 (291)
                      + +|.+.+....         .+++..++.++.|++.||.+||++|++|+||+|+||+++    .++.++|+|||++...
T Consensus        77 ~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~----~~~~~~l~dfg~~~~~  143 (265)
T cd05579          77 GGDLASLLENVG---------SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILID----SNGHLKLTDFGLSKVG  143 (265)
T ss_pred             CCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEc----CCCCEEEEecccchhc
Confidence            5 8877776433         289999999999999999999999999999999999998    6779999999998754


Q ss_pred             CCCCCC-----CCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---------cCCCC
Q psy2172         181 NNPLKP-----LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---------KTSNP  246 (291)
Q Consensus       181 ~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---------~~~~~  246 (291)
                      ......     ........++..|+|||...+.. .+.++|+||||+++|++++|..||.......         .....
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  222 (265)
T cd05579         144 LVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPE  222 (265)
T ss_pred             ccCcccccccccccccCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCc
Confidence            332110     11122345677899999987755 8889999999999999999999997554321         01111


Q ss_pred             C--cHHHHHHHHHhhCCCCcCChhhh---hcCCCCcchh
Q psy2172         247 Y--HHDQLDRIFSVMGFPLEKDWEDI---RKMPEHPTLL  280 (291)
Q Consensus       247 ~--~~~~~~~i~~~~~~~~~~~~~~~---~~~~~~~~~~  280 (291)
                      .  ....+.+++..|..+.|..||++   .++..+||+.
T Consensus       223 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~  261 (265)
T cd05579         223 DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFK  261 (265)
T ss_pred             cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCcccc
Confidence            1  15678899999999999999999   8888888875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.2e-34  Score=244.07  Aligned_cols=246  Identities=24%  Similarity=0.368  Sum_probs=185.7

Q ss_pred             cccccccceeCcccceEEEEEEEcc---CCCCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCc
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKD---NSDTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHNDR   91 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~---~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (291)
                      +.|++ .+.||+|+||.||+|.+..   ..+...+++|.+.....   ...+.+|+.+++.++||||+++++++  .+..
T Consensus         5 ~~~~~-~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~--~~~~   81 (288)
T cd05050           5 NNIEY-VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVC--AVGK   81 (288)
T ss_pred             Hhcee-cccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEE--cCCC
Confidence            34564 4599999999999998754   23567899999875432   24578899999999999999999988  5566


Q ss_pred             eEEEEEecCCC-CHHHHHHHhhhhh-------------hCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcE
Q psy2172          92 KVWLLFDYAEH-DLWHIIKFHRAAK-------------ANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANI  157 (291)
Q Consensus        92 ~~~iv~e~~~~-~l~~~~~~~~~~~-------------~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Ni  157 (291)
                      ..++++||+++ +|.+.+.......             .......+++..++.++.|++.||.+||+++++|+||+|+||
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni  161 (288)
T cd05050          82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC  161 (288)
T ss_pred             ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence            88999999985 8888876432110             001122378889999999999999999999999999999999


Q ss_pred             EeecCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q psy2172         158 LVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHC  236 (291)
Q Consensus       158 l~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~  236 (291)
                      +++    .++.++|+|||.+......... ........+..|+|||.+.+.. ++.++|+||||+++|+|++ |..||.+
T Consensus       162 l~~----~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~~~~p~~~  235 (288)
T cd05050         162 LVG----ENMVVKIADFGLSRNIYSADYY-KASENDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGMQPYYG  235 (288)
T ss_pred             Eec----CCCceEECccccceecccCccc-cccCCCccChhhcCHHHHhcCC-CCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            998    6778999999998754332111 1111223356799999987754 8999999999999999997 8888865


Q ss_pred             Cccc----------ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         237 RQED----------IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       237 ~~~~----------~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      ....          ...........+.+++..|..+.|..||++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~e  281 (288)
T cd05050         236 MAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFAS  281 (288)
T ss_pred             CCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHH
Confidence            4321          11112233467888888888888988888775

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=4.2e-35  Score=249.16  Aligned_cols=243  Identities=25%  Similarity=0.458  Sum_probs=193.1

Q ss_pred             ccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCC
Q psy2172          15 KVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-----LSMSACREIALLRELKHPNVINLISVFLSHN   89 (291)
Q Consensus        15 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   89 (291)
                      ...+.|.. .+.||+|++|.||+|.++.  ++..+++|.+....     ...++.+|+.+++.++|+|++++++++.  +
T Consensus        12 ~~~~~~~~-~~~lg~g~~g~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~   86 (308)
T cd06634          12 DPEKLFSD-LREIGHGSFGAVYFARDVR--NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL--R   86 (308)
T ss_pred             CcHHHHHH-HHheeeCCCEEEEEEEEcC--CCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEE--c
Confidence            34445553 5689999999999999876  66789999886321     1235678999999999999999999984  4


Q ss_pred             CceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcE
Q psy2172          90 DRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRV  169 (291)
Q Consensus        90 ~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~  169 (291)
                      ....++|+||+.+++.+.+.....        .+++..+..++.|++.|+.+||+++++|+||+|+||+++    ..+.+
T Consensus        87 ~~~~~lv~e~~~~~l~~~~~~~~~--------~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~----~~~~~  154 (308)
T cd06634          87 EHTAWLVMEYCLGSASDLLEVHKK--------PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS----EPGLV  154 (308)
T ss_pred             CCeeEEEEEccCCCHHHHHHHcCC--------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEEC----CCCcE
Confidence            568899999999988777653321        278899999999999999999999999999999999998    66789


Q ss_pred             EEeecccceecCCCCCCCCCCCCceecccccccccccC--CcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc-------
Q psy2172         170 KIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLG--ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED-------  240 (291)
Q Consensus       170 ~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~-------  240 (291)
                      +|+|||++......       ....++..|+|||.+.+  ...++.++|||||||++|+|++|..||......       
T Consensus       155 kl~dfg~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~  227 (308)
T cd06634         155 KLGDFGSASIMAPA-------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA  227 (308)
T ss_pred             EECCcccceeecCc-------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHh
Confidence            99999998754331       23456788999999752  234788999999999999999999998654321       


Q ss_pred             ----ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         241 ----IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       241 ----~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                          ...........+.++++.|..+.|..||++.++..++++..
T Consensus       228 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~  272 (308)
T cd06634         228 QNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (308)
T ss_pred             hcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence                01112234566889999999999999999999988888654

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.3e-34  Score=246.81  Aligned_cols=248  Identities=23%  Similarity=0.367  Sum_probs=185.9

Q ss_pred             cccccccceeCcccceEEEEEEEcc-----CCCCceeEEEEeCCCCCC---hhHHHHHHHHhcC-CCCCeeeEEEEEEeC
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKD-----NSDTRDYALKQIEGTGLS---MSACREIALLREL-KHPNVINLISVFLSH   88 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l-~h~~iv~~~~~~~~~   88 (291)
                      ++|.+ +++||+|+||.||+|.+.+     ......+|+|.++.....   .++.+|+.+++++ +||||+++++++  .
T Consensus        12 ~~~~~-~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~--~   88 (314)
T cd05099          12 DRLVL-GKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC--T   88 (314)
T ss_pred             HHeee-eeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE--c
Confidence            45664 6799999999999998643     123456999998754332   3577899999999 699999999998  4


Q ss_pred             CCceEEEEEecCCC-CHHHHHHHhhhhh-------hCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEee
Q psy2172          89 NDRKVWLLFDYAEH-DLWHIIKFHRAAK-------ANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVM  160 (291)
Q Consensus        89 ~~~~~~iv~e~~~~-~l~~~~~~~~~~~-------~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~  160 (291)
                      +....+++|||+.+ +|.+++.......       .......++...+..++.|++.||.|||++|++|+||||+||+++
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~  168 (314)
T cd05099          89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT  168 (314)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc
Confidence            56689999999974 8888886543210       001112378889999999999999999999999999999999998


Q ss_pred             cCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcc
Q psy2172         161 GEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQE  239 (291)
Q Consensus       161 ~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~  239 (291)
                          .++.++|+|||.++........ .......++..|+|||.+.+. .++.++|+||||+++|+|++ |..||.+...
T Consensus       169 ----~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~~g~~p~~~~~~  242 (314)
T cd05099         169 ----EDNVMKIADFGLARGVHDIDYY-KKTSNGRLPVKWMAPEALFDR-VYTHQSDVWSFGILMWEIFTLGGSPYPGIPV  242 (314)
T ss_pred             ----CCCcEEEccccccccccccccc-cccccCCCCccccCHHHHccC-CcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence                6678999999999765432110 111112234579999998774 48899999999999999998 8999976542


Q ss_pred             cc----------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCC
Q psy2172         240 DI----------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMP  274 (291)
Q Consensus       240 ~~----------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  274 (291)
                      ..          ..........+.+++..|..+.|..||++.++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll  287 (314)
T cd05099         243 EELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLV  287 (314)
T ss_pred             HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHH
Confidence            10          111223345688899999999999999877643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=5.6e-35  Score=241.61  Aligned_cols=228  Identities=21%  Similarity=0.358  Sum_probs=178.8

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEe
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFD   98 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e   98 (291)
                      .|++ ++.||+|+||.||++..    .++.+++|.++.......+.+|+.+++.++|||++++++++..   ...+++||
T Consensus         7 ~~~~-~~~lg~g~~g~v~~~~~----~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~~~~v~e   78 (254)
T cd05083           7 KLTL-GEIIGEGEFGAVLQGEY----TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH---NGLYIVME   78 (254)
T ss_pred             Hcee-eeeeccCCCCceEeccc----CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcC---CCcEEEEE
Confidence            3554 67999999999999864    4567999999776566778999999999999999999999842   24699999


Q ss_pred             cCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccc
Q psy2172          99 YAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA  177 (291)
Q Consensus        99 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~  177 (291)
                      |+.+ +|.+.+.....       ..+++..++.++.|++.|+.+||++|++|+||+|+||+++    .++.++|+|||.+
T Consensus        79 ~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~----~~~~~kl~Dfg~~  147 (254)
T cd05083          79 LMSKGNLVNFLRTRGR-------ALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVS----EDGVAKVSDFGLA  147 (254)
T ss_pred             CCCCCCHHHHHHhcCc-------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc----CCCcEEECCCccc
Confidence            9974 88888764321       1278889999999999999999999999999999999998    6678999999998


Q ss_pred             eecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc----------cCCCC
Q psy2172         178 RLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI----------KTSNP  246 (291)
Q Consensus       178 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~----------~~~~~  246 (291)
                      .......      .....+..|+|||.+.+.. ++.++|+||||+++|+|++ |+.||.......          .....
T Consensus       148 ~~~~~~~------~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  220 (254)
T cd05083         148 RVGSMGV------DNSKLPVKWTAPEALKHKK-FSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPE  220 (254)
T ss_pred             eeccccC------CCCCCCceecCHHHhccCC-cCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCC
Confidence            7543211      1122356799999987644 8899999999999999997 999997654310          01112


Q ss_pred             CcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         247 YHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       247 ~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      .....+.+++..+..+.|..||++.+
T Consensus       221 ~~~~~~~~li~~~l~~~p~~Rp~~~~  246 (254)
T cd05083         221 GCPADVYVLMTSCWETEPKKRPSFHK  246 (254)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            23456778888888888888877664

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=7.6e-35  Score=242.78  Aligned_cols=241  Identities=21%  Similarity=0.349  Sum_probs=181.8

Q ss_pred             eeCcccceEEEEEEEccCC----CCceeEEEEeCCCC---CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEe
Q psy2172          26 KVGRGTYGHVYKARRKDNS----DTRDYALKQIEGTG---LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFD   98 (291)
Q Consensus        26 ~ig~G~~g~Vy~~~~~~~~----~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e   98 (291)
                      .||+|+||.||+|.+.+..    +++.+++|.+....   ....+.+|+.+++.++||||+++++++  ......+++||
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~~v~e   79 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVC--LLNEPQYIIME   79 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeee--cCCCCeEEEEe
Confidence            6899999999999876422    33679999876432   344688899999999999999999998  45667999999


Q ss_pred             cCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCC-CCCCcEEEeeccc
Q psy2172          99 YAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEG-IERGRVKIADMGF  176 (291)
Q Consensus        99 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~-~~~~~~~l~Dfg~  176 (291)
                      |++ ++|.+.+........  ....+++..+..++.|++.|++|||+++++|+||+|+||+++.+. .....++++|||+
T Consensus        80 ~~~~~~L~~~l~~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          80 LMEGGDLLSYLRDARVERF--GPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             ccCCCcHHHHHHHhhhccc--CCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            997 488888765432211  122378889999999999999999999999999999999998432 1123899999999


Q ss_pred             ceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc----------ccCCC
Q psy2172         177 ARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED----------IKTSN  245 (291)
Q Consensus       177 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~----------~~~~~  245 (291)
                      +........ ........++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||......          .....
T Consensus       158 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~  235 (269)
T cd05044         158 ARDIYKSDY-YRKEGEGLLPVRWMAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKP  235 (269)
T ss_pred             ccccccccc-cccCcccCCCccccCHHHHccCC-cccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCc
Confidence            875533211 11112334467899999998754 8999999999999999997 99999754321          11122


Q ss_pred             CCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         246 PYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       246 ~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      ......+.+++..|..+.|..||++.+
T Consensus       236 ~~~~~~~~~li~~~l~~~p~~Rp~~~~  262 (269)
T cd05044         236 ENCPDKIYQLMTNCWAQDPSERPTFDR  262 (269)
T ss_pred             ccchHHHHHHHHHHcCCCcccCCCHHH
Confidence            233466788889999899989888775

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG4279|consensus

Probab=100.00  E-value=3.7e-36  Score=262.46  Aligned_cols=238  Identities=27%  Similarity=0.403  Sum_probs=191.6

Q ss_pred             ceeCcccceEEEEEEEccCCCCceeEEEEeCC--CCCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecCCC
Q psy2172          25 CKVGRGTYGHVYKARRKDNSDTRDYALKQIEG--TGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH  102 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~~~  102 (291)
                      -+||+|.||+||-|++.+  +...+|||.++.  ....+-+..|+.+-+.|+|.|||+++|.+  ...+++-|.||..+|
T Consensus       581 vVLGKGTYG~VYA~RD~~--tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~--senGf~kIFMEqVPG  656 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMD--TQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV--SENGFFKIFMEQVPG  656 (1226)
T ss_pred             EEeecCceeEEEeecccc--ceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc--CCCCeEEEEeecCCC
Confidence            379999999999999887  778899999864  34556788999999999999999999998  667799999999986


Q ss_pred             -CHHHHHHHhhhhhhCCCCCCC--CHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeeccccee
Q psy2172         103 -DLWHIIKFHRAAKANKKPVMV--PKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL  179 (291)
Q Consensus       103 -~l~~~~~~~~~~~~~~~~~~~--~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~  179 (291)
                       +|.++++..-        +++  ++.++..+.+||+.||.|||++.|||||||.+|++++.   ..+.+||+|||.++.
T Consensus       657 GSLSsLLrskW--------GPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNT---ySGvlKISDFGTsKR  725 (1226)
T KOG4279|consen  657 GSLSSLLRSKW--------GPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNT---YSGVLKISDFGTSKR  725 (1226)
T ss_pred             CcHHHHHHhcc--------CCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEee---ccceEEecccccchh
Confidence             6666665422        224  78889999999999999999999999999999999985   568999999999986


Q ss_pred             cCCCCCCCCCCCCceecccccccccccC-CcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc---------ccCCCC---
Q psy2172         180 FNNPLKPLADLDPVVVTFWYRAPELLLG-ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED---------IKTSNP---  246 (291)
Q Consensus       180 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~---------~~~~~~---  246 (291)
                      ...-   .....+..||..|||||++.. .+.|+.++|||||||++.||++|++||.--...         ++..++   
T Consensus       726 LAgi---nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPe  802 (1226)
T KOG4279|consen  726 LAGI---NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPE  802 (1226)
T ss_pred             hccC---CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcH
Confidence            5432   123456789999999999964 346999999999999999999999999754432         112222   


Q ss_pred             CcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchh
Q psy2172         247 YHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLL  280 (291)
Q Consensus       247 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  280 (291)
                      .-...-++++-.+-.|.|.++|+..++..-|.+.
T Consensus       803 elsaeak~FilrcFepd~~~R~sA~~LL~DpFlq  836 (1226)
T KOG4279|consen  803 ELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQ  836 (1226)
T ss_pred             HHHHHHHHHHHHHcCCCcccCccHHHhccCcccc
Confidence            2345566777788889999999998876555443

>KOG0612|consensus

Probab=100.00  E-value=8.2e-37  Score=278.41  Aligned_cols=245  Identities=22%  Similarity=0.341  Sum_probs=197.8

Q ss_pred             cccccceeCcccceEEEEEEEccCCCCceeEEEEeCC-----CCCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEE
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEG-----TGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVW   94 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (291)
                      |.+ .++||+|+||.|..++++.  +++.||+|++.+     ......|..|-.+|...+.+=|+.++-.|  ++..++|
T Consensus        77 fei-lKvIGrGaFGEV~lVr~k~--t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF--QD~~~LY  151 (1317)
T KOG0612|consen   77 FEI-LKVIGRGAFGEVALVRHKS--TEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF--QDERYLY  151 (1317)
T ss_pred             hHH-HHHhcccccceeEEEEeec--cccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh--cCccceE
Confidence            443 5799999999999999887  788999999975     34455688899999999999999999999  8999999


Q ss_pred             EEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEee
Q psy2172          95 LLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIAD  173 (291)
Q Consensus        95 iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~D  173 (291)
                      +||||++| +|..++.....         +|+.+++.++..|+.||..||+.|+|||||||+|||++    ..|+++|+|
T Consensus       152 lVMdY~pGGDlltLlSk~~~---------~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld----~~GHikLAD  218 (1317)
T KOG0612|consen  152 LVMDYMPGGDLLTLLSKFDR---------LPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLD----KSGHIKLAD  218 (1317)
T ss_pred             EEEecccCchHHHHHhhcCC---------ChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEec----ccCcEeecc
Confidence            99999975 88888876542         99999999999999999999999999999999999999    789999999


Q ss_pred             cccceecCCCCCCCCCCCCceecccccccccccC---C-cCCCCchhHHHHHHHHHHHHcCCCCCCCCcc----------
Q psy2172         174 MGFARLFNNPLKPLADLDPVVVTFWYRAPELLLG---A-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQE----------  239 (291)
Q Consensus       174 fg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~-~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~----------  239 (291)
                      ||.+-.+....  ........|||.|.|||++..   + +.|+..+|.||+||++|||+.|..||...+-          
T Consensus       219 FGsClkm~~dG--~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h  296 (1317)
T KOG0612|consen  219 FGSCLKMDADG--TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH  296 (1317)
T ss_pred             chhHHhcCCCC--cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch
Confidence            99998776432  234456799999999999842   2 3589999999999999999999999976432          


Q ss_pred             ----cccCCCCCcHHHHHHHHHhhCCCCcCC--hhhhhcCCCCcchhhhhhh
Q psy2172         240 ----DIKTSNPYHHDQLDRIFSVMGFPLEKD--WEDIRKMPEHPTLLKDFNE  285 (291)
Q Consensus       240 ----~~~~~~~~~~~~~~~i~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  285 (291)
                          .++ ....-+....+++..+.++.+..  +.+++++..||++...=.+
T Consensus       297 k~~l~FP-~~~~VSeeakdLI~~ll~~~e~RLgrngiedik~HpFF~g~~W~  347 (1317)
T KOG0612|consen  297 KESLSFP-DETDVSEEAKDLIEALLCDREVRLGRNGIEDIKNHPFFEGIDWD  347 (1317)
T ss_pred             hhhcCCC-cccccCHHHHHHHHHHhcChhhhcccccHHHHHhCccccCCChh
Confidence                011 11223566777777776555543  4567788888776644333

>KOG0986|consensus

Probab=100.00  E-value=1.6e-36  Score=253.19  Aligned_cols=198  Identities=26%  Similarity=0.405  Sum_probs=170.0

Q ss_pred             ccceeCcccceEEEEEEEccCCCCceeEEEEeCCC-----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEE
Q psy2172          23 EGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-----GLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLF   97 (291)
Q Consensus        23 ~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~   97 (291)
                      .-++||+|+||.|+-|+.+.  ++++||+|.+.+.     ....-..+|-.+|.+++.+.||.+--.|  +..+.+|+|+
T Consensus       189 ~~RvlGkGGFGEV~acqvra--TGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf--eTkd~LClVL  264 (591)
T KOG0986|consen  189 VYRVLGKGGFGEVCACQVRA--TGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF--ETKDALCLVL  264 (591)
T ss_pred             eeEEEecccccceeEEEEec--chhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee--cCCCceEEEE
Confidence            46799999999999999887  8899999987543     3344578999999999999999998888  7888999999


Q ss_pred             ecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeeccc
Q psy2172          98 DYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGF  176 (291)
Q Consensus        98 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~  176 (291)
                      ..|+| +|.-.+-+...       +-++++.++-++.+|+.||++||+.+||+||+||+|||++    +.+++.|+|+|+
T Consensus       265 tlMNGGDLkfHiyn~g~-------~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLD----d~GhvRISDLGL  333 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGN-------PGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLD----DHGHVRISDLGL  333 (591)
T ss_pred             EeecCCceeEEeeccCC-------CCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeec----cCCCeEeeccce
Confidence            99986 65544443332       1299999999999999999999999999999999999999    889999999999


Q ss_pred             ceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc
Q psy2172         177 ARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED  240 (291)
Q Consensus       177 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~  240 (291)
                      |..+...    .......||.+|||||++.+.. |+...|.|||||++|+|+.|+.||....+.
T Consensus       334 Avei~~g----~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK  392 (591)
T KOG0986|consen  334 AVEIPEG----KPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEK  392 (591)
T ss_pred             EEecCCC----CccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhh
Confidence            9977653    2233458999999999999866 999999999999999999999999887653

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-35  Score=241.70  Aligned_cols=231  Identities=24%  Similarity=0.419  Sum_probs=182.0

Q ss_pred             ceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC-----hhHHHHHHHH-hcCCCCCeeeEEEEEEeCCCceEEEEEe
Q psy2172          25 CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS-----MSACREIALL-RELKHPNVINLISVFLSHNDRKVWLLFD   98 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~e~~~l-~~l~h~~iv~~~~~~~~~~~~~~~iv~e   98 (291)
                      +.||+|+||.||+|.+..  .++.||+|.++.....     ..+..|..++ ...+|+|++++++++  .+....|+++|
T Consensus         2 ~~l~~g~~~~v~~a~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~--~~~~~~~lv~e   77 (260)
T cd05611           2 KPISKGAFGSVYLAKKRS--TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF--QSKDYLYLVME   77 (260)
T ss_pred             ccCCcCCCeeEEEEEecC--CCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeE--EcCCeEEEEEe
Confidence            478999999999999866  6678999998653211     1234454444 445899999999999  55678999999


Q ss_pred             cCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccc
Q psy2172          99 YAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA  177 (291)
Q Consensus        99 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~  177 (291)
                      |+++ +|.+++....         .+++..+..++.|++.||.+||+.+++|+||+|+||+++    .++.++|+|||.+
T Consensus        78 ~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~----~~~~~~l~dfg~~  144 (260)
T cd05611          78 YLNGGDCASLIKTLG---------GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLID----QTGHLKLTDFGLS  144 (260)
T ss_pred             ccCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC----CCCcEEEeecccc
Confidence            9975 7777765432         288999999999999999999999999999999999998    6678999999988


Q ss_pred             eecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc-------------CC
Q psy2172         178 RLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK-------------TS  244 (291)
Q Consensus       178 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~-------------~~  244 (291)
                      .....       .....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||........             ..
T Consensus       145 ~~~~~-------~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  216 (260)
T cd05611         145 RNGLE-------NKKFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEV  216 (260)
T ss_pred             eeccc-------cccCCCCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence            75332       12345677899999998755 88999999999999999999999976543210             01


Q ss_pred             CCCcHHHHHHHHHhhCCCCcCChhh---hhcCCCCcchh
Q psy2172         245 NPYHHDQLDRIFSVMGFPLEKDWED---IRKMPEHPTLL  280 (291)
Q Consensus       245 ~~~~~~~~~~i~~~~~~~~~~~~~~---~~~~~~~~~~~  280 (291)
                      .......+.+++..|..+.|..||+   +.++..+|++.
T Consensus       217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~  255 (260)
T cd05611         217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFK  255 (260)
T ss_pred             cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhh
Confidence            1133567889999999999999995   46777788764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.4e-35  Score=247.03  Aligned_cols=242  Identities=27%  Similarity=0.476  Sum_probs=194.3

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-----CChhHHHHHHHHhcCC-CCCeeeEEEEEEeCCCce
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-----LSMSACREIALLRELK-HPNVINLISVFLSHNDRK   92 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~   92 (291)
                      .|.+ .+.||+|++|.||+|.++.  +++.+++|++....     ....+.+|+.++++++ ||||+++++++  .+...
T Consensus         2 ~y~~-~~~lg~g~~~~vy~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~--~~~~~   76 (280)
T cd05581           2 DFKF-GKIIGEGSFSTVVLAKEKE--TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF--QDEEN   76 (280)
T ss_pred             CceE-eeeecCCCceEEEEEEEcC--CCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh--cCCce
Confidence            3453 5689999999999999876  67889999986532     2345788999999998 99999999998  56778


Q ss_pred             EEEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEE
Q psy2172          93 VWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI  171 (291)
Q Consensus        93 ~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l  171 (291)
                      .+++||++. ++|.+.+....         .++...++.++.|++.||.+||++|++|+||+|+||+++    .++.+++
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~----~~~~~~l  143 (280)
T cd05581          77 LYFVLEYAPNGELLQYIRKYG---------SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLD----KDMHIKI  143 (280)
T ss_pred             EEEEEcCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC----CCCCEEe
Confidence            999999995 68888776543         289999999999999999999999999999999999998    6678999


Q ss_pred             eecccceecCCCCCC-----------------CCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCC
Q psy2172         172 ADMGFARLFNNPLKP-----------------LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF  234 (291)
Q Consensus       172 ~Dfg~~~~~~~~~~~-----------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf  234 (291)
                      +|||.+.........                 ........++..|+|||...+.. ++.++|+||||++++++++|+.||
T Consensus       144 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~  222 (280)
T cd05581         144 TDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP-AGKSSDLWALGCIIYQMLTGKPPF  222 (280)
T ss_pred             cCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCC-CChhhhHHHHHHHHHHHHhCCCCC
Confidence            999998866543221                 01223345678899999987744 888999999999999999999999


Q ss_pred             CCCcccc---------cCCCCCcHHHHHHHHHhhCCCCcCChhhh----hcCCCCcch
Q psy2172         235 HCRQEDI---------KTSNPYHHDQLDRIFSVMGFPLEKDWEDI----RKMPEHPTL  279 (291)
Q Consensus       235 ~~~~~~~---------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~----~~~~~~~~~  279 (291)
                      .......         ..........+.+++..|..+.|..+|++    .++..+|++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         223 RGSNEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             CCccHHHHHHHHHhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            8764310         11222234668889999999999999999    888887764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-35  Score=240.41  Aligned_cols=232  Identities=26%  Similarity=0.460  Sum_probs=189.2

Q ss_pred             eCcccceEEEEEEEccCCCCceeEEEEeCCCCC-----ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecCC
Q psy2172          27 VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-----SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAE  101 (291)
Q Consensus        27 ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~~  101 (291)
                      ||+|+||.||++.+..  +++.+++|.++....     ...+..|+.++++++|+|++++++.+  .+....+++|||+.
T Consensus         1 lg~G~~~~v~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~~v~e~~~   76 (250)
T cd05123           1 LGKGSFGKVLLVRKKD--TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF--QTEEKLYLVLEYAP   76 (250)
T ss_pred             CCCCCceEEEEEEECC--CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe--ecCCeeEEEEecCC
Confidence            6899999999999866  678899999875432     23678899999999999999999998  66789999999994


Q ss_pred             -CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceec
Q psy2172         102 -HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF  180 (291)
Q Consensus       102 -~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~  180 (291)
                       ++|.+.+....         .+++..+..++.|++.|+.+||+.+++|+||+|+||+++    ..+.++|+|||.+...
T Consensus        77 ~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~----~~~~~~l~d~~~~~~~  143 (250)
T cd05123          77 GGELFSHLSKEG---------RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLD----ADGHIKLTDFGLAKEL  143 (250)
T ss_pred             CCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEc----CCCcEEEeecCcceec
Confidence             68887776543         278999999999999999999999999999999999998    6678999999998765


Q ss_pred             CCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---------cCCCCCcHHH
Q psy2172         181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---------KTSNPYHHDQ  251 (291)
Q Consensus       181 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---------~~~~~~~~~~  251 (291)
                      ....   .......++..|+|||...+.. .+.++|+||||+++|++++|..||.......         ..........
T Consensus       144 ~~~~---~~~~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  219 (250)
T cd05123         144 SSEG---SRTNTFCGTPEYLAPEVLLGKG-YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPE  219 (250)
T ss_pred             ccCC---CcccCCcCCccccChHHhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHH
Confidence            4421   1223456688899999987744 7889999999999999999999997665211         1122233567


Q ss_pred             HHHHHHhhCCCCcCChhhh---hcCCCCcch
Q psy2172         252 LDRIFSVMGFPLEKDWEDI---RKMPEHPTL  279 (291)
Q Consensus       252 ~~~i~~~~~~~~~~~~~~~---~~~~~~~~~  279 (291)
                      +.++++.|....|..||++   .++..+||+
T Consensus       220 l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         220 ARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             HHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence            8889999999999999998   777777764

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-34  Score=238.45  Aligned_cols=229  Identities=21%  Similarity=0.353  Sum_probs=178.3

Q ss_pred             ceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecCC
Q psy2172          25 CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAE  101 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~~  101 (291)
                      ++||+|+||.||+|.+.+   ++.|++|.++....   ...+.+|+.++++++|+||+++++++  .+....+++|||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~---~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~~v~e~~~   75 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG---NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC--VQKQPIYIVMELVP   75 (251)
T ss_pred             CccccCCCceEEEEEEeC---CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEE--ecCCCeEEEEEcCC
Confidence            479999999999999753   57799999875433   24688899999999999999999998  55678999999997


Q ss_pred             C-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceec
Q psy2172         102 H-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF  180 (291)
Q Consensus       102 ~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~  180 (291)
                      + +|.+.+.....        .++...+..++.+++.++++||+++++|+||+|+||+++    .++.++|+|||.+...
T Consensus        76 ~~~l~~~l~~~~~--------~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~----~~~~~~l~d~g~~~~~  143 (251)
T cd05041          76 GGSLLTFLRKKKN--------RLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVG----ENNVLKISDFGMSREE  143 (251)
T ss_pred             CCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEc----CCCcEEEeeccccccc
Confidence            5 77777654321        278889999999999999999999999999999999998    6779999999998755


Q ss_pred             CCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc----------cCCCCCcH
Q psy2172         181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI----------KTSNPYHH  249 (291)
Q Consensus       181 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~----------~~~~~~~~  249 (291)
                      ...... .......++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||.......          ........
T Consensus       144 ~~~~~~-~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  221 (251)
T cd05041         144 EGGIYT-VSDGLKQIPIKWTAPEALNYGR-YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCP  221 (251)
T ss_pred             cCCcce-eccccCcceeccCChHhhccCC-CCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCC
Confidence            421111 1111223356699999987644 8899999999999999998 889997654211          11112234


Q ss_pred             HHHHHHHHhhCCCCcCChhhhhc
Q psy2172         250 DQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       250 ~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      ..+.+++..+....|..||++.+
T Consensus       222 ~~~~~li~~~l~~~p~~Rp~~~e  244 (251)
T cd05041         222 EEIYRLMLQCWAYDPENRPSFSE  244 (251)
T ss_pred             HHHHHHHHHHhccChhhCcCHHH
Confidence            67888888888888888887764

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=8.8e-35  Score=240.92  Aligned_cols=230  Identities=20%  Similarity=0.238  Sum_probs=175.3

Q ss_pred             ceeCcccceEEEEEEEccCCC--------CceeEEEEeCCCCC-ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEE
Q psy2172          25 CKVGRGTYGHVYKARRKDNSD--------TRDYALKQIEGTGL-SMSACREIALLRELKHPNVINLISVFLSHNDRKVWL   95 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~~~--------~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~i   95 (291)
                      +.||+|+||.||+|.+.....        ...+++|.+..... ...+.+|+.+++.++||||+++++++..   ...++
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~l   77 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR---DENIM   77 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec---CCcEE
Confidence            479999999999999876321        13578887765433 5678899999999999999999998854   46799


Q ss_pred             EEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCC---CCCCcEEE
Q psy2172          96 LFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEG---IERGRVKI  171 (291)
Q Consensus        96 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~---~~~~~~~l  171 (291)
                      +|||+++ +|.+.+.....        .++...+..++.|++.||+|||++|++|+||||+||+++.+.   .....++|
T Consensus        78 v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl  149 (259)
T cd05037          78 VEEYVKFGPLDVFLHREKN--------NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKL  149 (259)
T ss_pred             EEEcCCCCcHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEe
Confidence            9999985 67666654332        288899999999999999999999999999999999998432   01127999


Q ss_pred             eecccceecCCCCCCCCCCCCceecccccccccccCC-cCCCCchhHHHHHHHHHHHHc-CCCCCCCCccccc-------
Q psy2172         172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDIK-------  242 (291)
Q Consensus       172 ~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~~-------  242 (291)
                      +|||.+.....       .....++..|+|||++.+. ..++.++|+||||+++|+|++ |..||........       
T Consensus       150 ~Dfg~a~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~  222 (259)
T cd05037         150 SDPGIPITVLS-------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQ  222 (259)
T ss_pred             CCCCccccccc-------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcC
Confidence            99999876443       1223456679999998765 358899999999999999998 6888876532110       


Q ss_pred             -CCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         243 -TSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       243 -~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                       .........+.+++..+....|..||++.+
T Consensus       223 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~  253 (259)
T cd05037         223 HRLPMPDCAELANLINQCWTYDPTKRPSFRA  253 (259)
T ss_pred             CCCCCCCchHHHHHHHHHhccChhhCCCHHH
Confidence             001111257778888888888888887664

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.9e-34  Score=238.63  Aligned_cols=234  Identities=25%  Similarity=0.388  Sum_probs=184.7

Q ss_pred             cceeCcccceEEEEEEEccCC--CCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEe
Q psy2172          24 GCKVGRGTYGHVYKARRKDNS--DTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFD   98 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~--~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e   98 (291)
                      .+.||.|+||.||+|.+....  ....+++|.+.....   ...+..|+.+++.++|+||+++++++  .+....+++||
T Consensus         4 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~~i~e   81 (258)
T smart00219        4 GKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVC--TEEEPLMIVME   81 (258)
T ss_pred             cceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEE--cCCCeeEEEEe
Confidence            568999999999999987632  237899999976543   34688899999999999999999999  44578999999


Q ss_pred             cCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccc
Q psy2172          99 YAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA  177 (291)
Q Consensus        99 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~  177 (291)
                      ++.+ +|.+.+.......       +++..+..++.|++.|+++||+.|++|+||+|+||+++    ..+.++|+|||.+
T Consensus        82 ~~~~~~l~~~~~~~~~~~-------~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~----~~~~~~l~dfg~~  150 (258)
T smart00219       82 YMEGGDLLDYLRKNRPKE-------LSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVG----ENLVVKISDFGLS  150 (258)
T ss_pred             ccCCCCHHHHHHhhhhcc-------CCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEc----cCCeEEEcccCCc
Confidence            9975 8877776543211       78999999999999999999999999999999999998    6679999999999


Q ss_pred             eecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc----------cCCCC
Q psy2172         178 RLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI----------KTSNP  246 (291)
Q Consensus       178 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~----------~~~~~  246 (291)
                      ..........  .....++..|+|||.+.+ ..++.++|+||||+++++|++ |..||.......          .....
T Consensus       151 ~~~~~~~~~~--~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  227 (258)
T smart00219      151 RDLYDDDYYK--KKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPE  227 (258)
T ss_pred             eecccccccc--cccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCC
Confidence            8765431111  112236778999999865 448999999999999999998 889997644321          11122


Q ss_pred             CcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         247 YHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       247 ~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      .....+.+++..|..+.|..||++.++
T Consensus       228 ~~~~~~~~~i~~~l~~~p~~Rpt~~~l  254 (258)
T smart00219      228 NCPPEIYKLMLQCWAEDPEDRPTFSEL  254 (258)
T ss_pred             cCCHHHHHHHHHHCcCChhhCcCHHHH
Confidence            235667888888988899888887753

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=6.5e-35  Score=246.12  Aligned_cols=238  Identities=23%  Similarity=0.406  Sum_probs=189.5

Q ss_pred             ceeCcccceEEEEEEEccCCCCceeEEEEeCCCC--CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecCCC
Q psy2172          25 CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG--LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH  102 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~~~  102 (291)
                      .+||+|+||.||++.++.  ++..||+|.+....  ....+.+|+.+++.++|+|++++++.+  ......+++|||+++
T Consensus        26 ~~lg~g~~g~v~~~~~~~--~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~~~~~~~lv~e~~~~  101 (292)
T cd06657          26 IKIGEGSTGIVCIATVKS--SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY--LVGDELWVVMEFLEG  101 (292)
T ss_pred             HHcCCCCCeEEEEEEEcC--CCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEE--EeCCEEEEEEecCCC
Confidence            579999999999999876  67889999875432  233578899999999999999999999  456789999999986


Q ss_pred             -CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceecC
Q psy2172         103 -DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFN  181 (291)
Q Consensus       103 -~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~~  181 (291)
                       +|.+.+...          .+++..+..++.|++.|+++||+.|++|+||+|+||+++    .++.++|+|||.+....
T Consensus       102 ~~L~~~~~~~----------~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~----~~~~~~l~dfg~~~~~~  167 (292)
T cd06657         102 GALTDIVTHT----------RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLT----HDGRVKLSDFGFCAQVS  167 (292)
T ss_pred             CcHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCCEEEcccccceecc
Confidence             555544321          178889999999999999999999999999999999998    66789999999886543


Q ss_pred             CCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc---------ccC---CCCCcH
Q psy2172         182 NPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED---------IKT---SNPYHH  249 (291)
Q Consensus       182 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~---------~~~---~~~~~~  249 (291)
                      ...   .......++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||.+....         ...   ......
T Consensus       168 ~~~---~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (292)
T cd06657         168 KEV---PRRKSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVS  243 (292)
T ss_pred             ccc---ccccccccCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCC
Confidence            321   1122345788899999987644 789999999999999999999999765321         110   111234


Q ss_pred             HHHHHHHHhhCCCCcCChhhhhcCCCCcchhhhhh
Q psy2172         250 DQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDFN  284 (291)
Q Consensus       250 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (291)
                      ..+.+++..|..+.|..+|++.++..++++.+...
T Consensus       244 ~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~  278 (292)
T cd06657         244 PSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP  278 (292)
T ss_pred             HHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence            56788899999999999999999999988776543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-35  Score=246.23  Aligned_cols=196  Identities=48%  Similarity=0.899  Sum_probs=165.1

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCC----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEec
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT----GLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDY   99 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~   99 (291)
                      .+.||+|++|.||+|.+..  +++.+++|.+...    .....+..|+.++++++|+|++++++++  .+....++++|+
T Consensus         4 ~~~ig~g~~~~vy~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~--~~~~~~~~v~e~   79 (282)
T cd07829           4 LEKLGEGTYGVVYKARDKK--TGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVI--HTERKLYLVFEY   79 (282)
T ss_pred             ehcccccCcceEEEeeecC--CCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhh--hcCCceEEEecC
Confidence            4689999999999999876  6788999998753    2345678899999999999999999998  456789999999


Q ss_pred             CCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeeccccee
Q psy2172         100 AEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL  179 (291)
Q Consensus       100 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~  179 (291)
                      ++++|.+.+.....        .+++..+..++.|++.||++||++|++|+||+|+||+++    .++.++|+|||.+..
T Consensus        80 ~~~~l~~~i~~~~~--------~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~----~~~~~~l~d~g~~~~  147 (282)
T cd07829          80 CDMDLKKYLDKRPG--------PLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILIN----RDGVLKLADFGLARA  147 (282)
T ss_pred             cCcCHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEc----CCCCEEEecCCcccc
Confidence            99999888875431        289999999999999999999999999999999999998    678899999999876


Q ss_pred             cCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCc
Q psy2172         180 FNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  238 (291)
Q Consensus       180 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~  238 (291)
                      ......   ......++..|+|||.+.+...++.++|+||||++++++++|..||.+..
T Consensus       148 ~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~  203 (282)
T cd07829         148 FGIPLR---TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS  203 (282)
T ss_pred             cCCCcc---ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence            543221   11223446779999998775458899999999999999999999997754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.7e-34  Score=237.73  Aligned_cols=233  Identities=20%  Similarity=0.366  Sum_probs=181.3

Q ss_pred             cccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC-ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEe
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFD   98 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e   98 (291)
                      |++ .+.||+|+||.||++.+.   .+..+++|.+..... ...+.+|++++++++||+++++++++  ......++++|
T Consensus         6 ~~~-~~~ig~g~~g~v~~~~~~---~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~~v~e   79 (256)
T cd05112           6 LTL-VQEIGSGQFGLVWLGYWL---EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC--TERSPICLVFE   79 (256)
T ss_pred             eEE-EeeecCcccceEEEEEEe---CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEE--ccCCceEEEEE
Confidence            443 468999999999999875   345799998875433 45788999999999999999999998  55668899999


Q ss_pred             cCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccc
Q psy2172          99 YAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA  177 (291)
Q Consensus        99 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~  177 (291)
                      |+.+ +|.+.+.....        .+++..++.++.|++.++++||+++++|+||+|+||+++    .++.++|+|||.+
T Consensus        80 ~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~----~~~~~~l~d~g~~  147 (256)
T cd05112          80 FMEHGCLSDYLRAQRG--------KFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVG----ENQVVKVSDFGMT  147 (256)
T ss_pred             cCCCCcHHHHHHhCcc--------CCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEc----CCCeEEECCCcce
Confidence            9986 66666543221        278899999999999999999999999999999999998    6678999999998


Q ss_pred             eecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc----------cCCCC
Q psy2172         178 RLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI----------KTSNP  246 (291)
Q Consensus       178 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~----------~~~~~  246 (291)
                      ........  .......++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||.......          .....
T Consensus       148 ~~~~~~~~--~~~~~~~~~~~~~aPe~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  224 (256)
T cd05112         148 RFVLDDQY--TSSTGTKFPVKWSSPEVFSFSK-YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPR  224 (256)
T ss_pred             eecccCcc--cccCCCccchhhcCHhHhccCC-cChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCC
Confidence            76543211  1111223456799999997644 8899999999999999998 999997554221          11122


Q ss_pred             CcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         247 YHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       247 ~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      ...+.+.+++..+..+.|..||++.++
T Consensus       225 ~~~~~~~~l~~~~l~~~p~~Rp~~~~~  251 (256)
T cd05112         225 LASQSVYELMQHCWKERPEDRPSFSLL  251 (256)
T ss_pred             CCCHHHHHHHHHHcccChhhCCCHHHH
Confidence            235668888888888888888887753

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.3e-34  Score=244.86  Aligned_cols=242  Identities=22%  Similarity=0.359  Sum_probs=190.2

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC---ChhHHHHHHHHhcC-CCCCeeeEEEEEEeCCCceEE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL---SMSACREIALLREL-KHPNVINLISVFLSHNDRKVW   94 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~   94 (291)
                      .|.+ .+.||+|++|.||+|.++.  +++.+|+|.++....   ...+..|+.++.++ .||||+++++++  .+....|
T Consensus        16 ~~~~-~~~lg~g~~~~v~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~--~~~~~~~   90 (296)
T cd06618          16 DLEN-LGEIGSGTCGQVYKMRFKK--TGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYF--ITDSDVF   90 (296)
T ss_pred             hhee-eeEeeccCCeEEEEEEECC--CCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheee--ecCCeEE
Confidence            3443 6799999999999999876  578899999875432   23466677767666 499999999999  5567899


Q ss_pred             EEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCeeeeccCCCcEEeecCCCCCCcEEEee
Q psy2172          95 LLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHS-NWVLHRDLKPANILVMGEGIERGRVKIAD  173 (291)
Q Consensus        95 iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~-~~ivH~dik~~Nil~~~~~~~~~~~~l~D  173 (291)
                      ++|||+++.+.++......        .+++..+..++.|++.|++|||+ .|++|+||+|+||+++    .++.++|+|
T Consensus        91 ~v~e~~~~~l~~l~~~~~~--------~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~----~~~~~kL~d  158 (296)
T cd06618          91 ICMELMSTCLDKLLKRIQG--------PIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLD----ASGNVKLCD  158 (296)
T ss_pred             EEeeccCcCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEc----CCCCEEECc
Confidence            9999999887777655322        28899999999999999999997 5999999999999998    677999999


Q ss_pred             cccceecCCCCCCCCCCCCceecccccccccccCC---cCCCCchhHHHHHHHHHHHHcCCCCCCCCccc----------
Q psy2172         174 MGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGA---RHYTKAIDIWAIGCIFAELLTSEPIFHCRQED----------  240 (291)
Q Consensus       174 fg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~----------  240 (291)
                      ||.+........    .....++..|+|||.+.+.   +.++.++|+||||+++|+|++|..||.....+          
T Consensus       159 fg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~  234 (296)
T cd06618         159 FGISGRLVDSKA----KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE  234 (296)
T ss_pred             cccchhccCCCc----ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcC
Confidence            999875533211    1223467789999998653   23788999999999999999999999763221          


Q ss_pred             -ccC--CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         241 -IKT--SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       241 -~~~--~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                       ...  ........+.+++..|..+.|..||++.++..++|+..
T Consensus       235 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~  278 (296)
T cd06618         235 EPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR  278 (296)
T ss_pred             CCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence             011  11123567899999999999999999999999988664

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.6e-34  Score=239.53  Aligned_cols=234  Identities=18%  Similarity=0.243  Sum_probs=170.2

Q ss_pred             eeCcccceEEEEEEEccCCCCceeEEEEeCCCC---CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecCCC
Q psy2172          26 KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG---LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH  102 (291)
Q Consensus        26 ~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~~~  102 (291)
                      .||+|+||.||++..........+++|.+....   ....+.+|+.+++.++||||+++++.+  .+....|++|||+.+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~--~~~~~~~lv~e~~~~   79 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQC--VEAIPYLLVFEYCEL   79 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEe--cCCCccEEEEecCCC
Confidence            699999999999986554455567788776432   234688899999999999999999998  456788999999985


Q ss_pred             -CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceecC
Q psy2172         103 -DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFN  181 (291)
Q Consensus       103 -~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~~  181 (291)
                       +|.+.+.......     ...+...++.++.|++.||+|||+++++|+||||+||+++    .++.++|+|||++....
T Consensus        80 ~~L~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~----~~~~~~l~Dfg~~~~~~  150 (268)
T cd05086          80 GDLKSYLSQEQWHR-----RNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLT----SDLTVKVGDYGIGPSRY  150 (268)
T ss_pred             CcHHHHHHhhhccc-----ccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEc----CCccEEecccccccccC
Confidence             8887776543211     1266778889999999999999999999999999999998    67789999999875432


Q ss_pred             CCCCCCCCCCCceecccccccccccCC------cCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc--------------
Q psy2172         182 NPLKPLADLDPVVVTFWYRAPELLLGA------RHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED--------------  240 (291)
Q Consensus       182 ~~~~~~~~~~~~~g~~~y~aPE~~~~~------~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~--------------  240 (291)
                      .... ........++..|+|||++...      ..++.++|+||||+++|+|++ |..||......              
T Consensus       151 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~  229 (268)
T cd05086         151 KEDY-IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKL  229 (268)
T ss_pred             cchh-hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhccccc
Confidence            2111 1112234567889999987431      125778999999999999986 57788654321              


Q ss_pred             -ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         241 -IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       241 -~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                       .+.......+.+.+++..+. ..|..||++.+
T Consensus       230 ~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~  261 (268)
T cd05086         230 FKPQLELPYSERWYEVLQFCW-LSPEKRATAEE  261 (268)
T ss_pred             CCCccCCCCcHHHHHHHHHHh-hCcccCCCHHH
Confidence             01111223445556666555 33666666654

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.3e-34  Score=240.36  Aligned_cols=246  Identities=20%  Similarity=0.274  Sum_probs=186.3

Q ss_pred             cccccccceeCcccceEEEEEEEccCC--CCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCce
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNS--DTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHNDRK   92 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~--~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (291)
                      ++|.+ .+.||+|+||.||+|.+....  ....|++|.+.....   ...+.+|+.++++++||||+++++++.. +...
T Consensus         6 ~~~~~-~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~   83 (280)
T cd05043           6 DRVTL-SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIE-DGEP   83 (280)
T ss_pred             hheEE-eeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CCCC
Confidence            45664 579999999999999986522  357799998874322   2457789999999999999999998754 3567


Q ss_pred             EEEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEE
Q psy2172          93 VWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI  171 (291)
Q Consensus        93 ~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l  171 (291)
                      .+++++|++ ++|...+........ .....+++..++.++.|++.||+|||+++++|+||+|+||+++    .+..+++
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~----~~~~~kl  158 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEA-NNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVID----EELQVKI  158 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhcccccc-ccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEc----CCCcEEE
Confidence            889999987 588777765432210 1123388999999999999999999999999999999999998    6689999


Q ss_pred             eecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc---------c
Q psy2172         172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED---------I  241 (291)
Q Consensus       172 ~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~---------~  241 (291)
                      +|||+++........ .......++..|+|||.+.+.. ++.++||||||+++|++++ |+.||......         .
T Consensus       159 ~d~g~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~  236 (280)
T cd05043         159 TDNALSRDLFPMDYH-CLGDNENRPVKWMALESLVNKE-YSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY  236 (280)
T ss_pred             CCCCCcccccCCceE-EeCCCCCcchhccCHHHHhcCC-CCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC
Confidence            999998755332111 1111234466799999997754 8899999999999999998 99999764321         0


Q ss_pred             -cCCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         242 -KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       242 -~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                       ........+.+.+++..+..+.|..||++.+
T Consensus       237 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  268 (280)
T cd05043         237 RLAQPINCPDELFAVMACCWALDPEERPSFSQ  268 (280)
T ss_pred             CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHH
Confidence             1112223466888999999999988888775

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-34  Score=237.95  Aligned_cols=238  Identities=32%  Similarity=0.498  Sum_probs=192.9

Q ss_pred             cccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC----ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEE
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL----SMSACREIALLRELKHPNVINLISVFLSHNDRKVWL   95 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~i   95 (291)
                      |++ .+.||+|++|.||++.+..  .++.+++|.+.....    ...+.+|++++.+++|+|++++++++  .+....++
T Consensus         2 y~~-~~~l~~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~~   76 (254)
T cd06627           2 YQL-GDLIGRGAFGVVYKGLNLE--TGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSI--ETSDSLYI   76 (254)
T ss_pred             cee-eeEEcccCCeEEEEEEEcC--CCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEE--EeCCEEEE
Confidence            443 6799999999999999766  667899999876543    34578999999999999999999998  45678999


Q ss_pred             EEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          96 LFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        96 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      ++|++++ +|.+.+....         .+++..++.++.|++.|+.+||++|++|+||+|+||+++    .++.++|+||
T Consensus        77 v~e~~~~~~L~~~~~~~~---------~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~----~~~~~~l~d~  143 (254)
T cd06627          77 ILEYAENGSLRQIIKKFG---------PFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTT----KDGVVKLADF  143 (254)
T ss_pred             EEecCCCCcHHHHHHhcc---------CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEC----CCCCEEEecc
Confidence            9999986 7777765432         289999999999999999999999999999999999998    5678999999


Q ss_pred             ccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc----------ccCC
Q psy2172         175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED----------IKTS  244 (291)
Q Consensus       175 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~----------~~~~  244 (291)
                      |.+.........   .....++..|+|||...+.. ++.++|+||+|+++++|++|..||......          ....
T Consensus       144 ~~~~~~~~~~~~---~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  219 (254)
T cd06627         144 GVATKLNDVSKD---DASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPL  219 (254)
T ss_pred             ccceecCCCccc---ccccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCC
Confidence            999876543221   23346688899999987754 889999999999999999999999754321          1112


Q ss_pred             CCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         245 NPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       245 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                      .....+.+.+++..+..+.|+.||++.++..++++
T Consensus       220 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         220 PEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             CCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence            22335678888999999999999999888777653

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.8e-34  Score=238.64  Aligned_cols=239  Identities=31%  Similarity=0.531  Sum_probs=192.2

Q ss_pred             cccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEE
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG----LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWL   95 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~i   95 (291)
                      |++ .++||+|++|.||++.++.  +++.+++|.+....    ....+.+|+.+++.++|+||+++++.+.  +....++
T Consensus         2 y~~-~~~i~~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~~   76 (256)
T cd08530           2 FKV-LKKLGKGSYGSVYKVKRLS--DNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFL--DGNKLCI   76 (256)
T ss_pred             ceE-eeeecCCCceeEEEEEECC--CCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhc--cCCEEEE
Confidence            443 5689999999999999776  66889999986432    2335778999999999999999999984  4578999


Q ss_pred             EEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          96 LFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        96 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      ++||+++ +|.+.+.......     ..+++..++.++.|++.||++||+.|++|+||+|+||+++    .++.++|+||
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~-----~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~----~~~~~kl~d~  147 (256)
T cd08530          77 VMEYAPFGDLSKAISKRKKKR-----KLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLV----ANDLVKIGDL  147 (256)
T ss_pred             EehhcCCCCHHHHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEe----cCCcEEEeec
Confidence            9999975 7877776533211     1288999999999999999999999999999999999999    6678999999


Q ss_pred             ccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc----------cCC
Q psy2172         175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI----------KTS  244 (291)
Q Consensus       175 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~----------~~~  244 (291)
                      |.+......     ......++..|+|||.+.+.. ++.++|+||||+++++|++|..||.......          ...
T Consensus       148 g~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  221 (256)
T cd08530         148 GISKVLKKN-----MAKTQIGTPHYMAPEVWKGRP-YSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPI  221 (256)
T ss_pred             cchhhhccC-----CcccccCCccccCHHHHCCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence            998766543     112245678899999997744 8889999999999999999999998765421          111


Q ss_pred             CCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcc
Q psy2172         245 NPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPT  278 (291)
Q Consensus       245 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  278 (291)
                      .......+.+++..|..+.|..||++.++..+|.
T Consensus       222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~  255 (256)
T cd08530         222 PPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPA  255 (256)
T ss_pred             chhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCC
Confidence            1233466889999999999999999999888775

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.3e-34  Score=248.19  Aligned_cols=244  Identities=18%  Similarity=0.265  Sum_probs=186.7

Q ss_pred             eeCcc--cceEEEEEEEccCCCCceeEEEEeCCCCCC----hhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEec
Q psy2172          26 KVGRG--TYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDY   99 (291)
Q Consensus        26 ~ig~G--~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~   99 (291)
                      .||+|  +||+||+|.+..  +++.||+|+.......    +.+.+|+.+++.++||||+++++++  ..+...++++||
T Consensus         5 ~ig~g~~~~~~v~~a~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~--~~~~~~~~v~e~   80 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTP--TGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVF--TTGSWLWVISPF   80 (328)
T ss_pred             HhCCcccCceeEEEEEEcC--CCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeE--ecCCceEEEEec
Confidence            56666  999999999766  6788999998754322    4577899999999999999999999  556789999999


Q ss_pred             CCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccce
Q psy2172         100 AEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR  178 (291)
Q Consensus       100 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~  178 (291)
                      +.+ ++.+++......       .+++..+..++.|++.||+|||++|++|+||||+||+++    .++.++++||+.+.
T Consensus        81 ~~~~~l~~~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~----~~~~~~~~~~~~~~  149 (328)
T cd08226          81 MAYGSANSLLKTYFPE-------GMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILIS----GDGLVSLSGLSHLY  149 (328)
T ss_pred             ccCCCHHHHHHhhccc-------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEe----CCCcEEEechHHHh
Confidence            985 777776654321       288999999999999999999999999999999999998    66789999998654


Q ss_pred             ecCCCCCC----CCCCCCceecccccccccccCC-cCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc-----------
Q psy2172         179 LFNNPLKP----LADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK-----------  242 (291)
Q Consensus       179 ~~~~~~~~----~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~-----------  242 (291)
                      ........    ........++..|+|||++.+. ..++.++|+||+||++|+|++|..||........           
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  229 (328)
T cd08226         150 SLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYS  229 (328)
T ss_pred             hhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCC
Confidence            32211110    0001112345679999998763 2378999999999999999999999975431100           


Q ss_pred             ---------------------------------------------CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCc
Q psy2172         243 ---------------------------------------------TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHP  277 (291)
Q Consensus       243 ---------------------------------------------~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  277 (291)
                                                                   .........+.+++..|....|..||++.++..++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~  309 (328)
T cd08226         230 PLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA  309 (328)
T ss_pred             CccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence                                                         00112345678899999999999999999999999


Q ss_pred             chhhhhh
Q psy2172         278 TLLKDFN  284 (291)
Q Consensus       278 ~~~~~~~  284 (291)
                      |+...-+
T Consensus       310 ~~~~~~~  316 (328)
T cd08226         310 FFKQVKE  316 (328)
T ss_pred             HHHHHHH
Confidence            8765443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=5.4e-34  Score=245.06  Aligned_cols=246  Identities=23%  Similarity=0.352  Sum_probs=184.6

Q ss_pred             ccccccceeCcccceEEEEEEEccCC-----CCceeEEEEeCCCCC---ChhHHHHHHHHhcC-CCCCeeeEEEEEEeCC
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNS-----DTRDYALKQIEGTGL---SMSACREIALLREL-KHPNVINLISVFLSHN   89 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~-----~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~   89 (291)
                      +|.+ ++.||+|+||.||+|.+....     ....+++|.+.....   ...+.+|+.+++++ +||||+++++++  ..
T Consensus        13 ~~~i-~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~--~~   89 (334)
T cd05100          13 RLTL-GKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC--TQ   89 (334)
T ss_pred             Heee-cceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE--cc
Confidence            4664 779999999999999864321     223689998875322   24678899999999 799999999998  45


Q ss_pred             CceEEEEEecCCC-CHHHHHHHhhhhh-------hCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeec
Q psy2172          90 DRKVWLLFDYAEH-DLWHIIKFHRAAK-------ANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMG  161 (291)
Q Consensus        90 ~~~~~iv~e~~~~-~l~~~~~~~~~~~-------~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~  161 (291)
                      ....++++||+++ +|.+.+.......       .......++...+..++.|++.||.+||++|++|+||||+||+++ 
T Consensus        90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~-  168 (334)
T cd05100          90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT-  168 (334)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc-
Confidence            6689999999975 8888776532100       001122377888999999999999999999999999999999998 


Q ss_pred             CCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc
Q psy2172         162 EGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED  240 (291)
Q Consensus       162 ~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~  240 (291)
                         .++.++|+|||.++........ .......++..|+|||++.+.. ++.++|+||||+++|+|++ |..||.+...+
T Consensus       169 ---~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~  243 (334)
T cd05100         169 ---EDNVMKIADFGLARDVHNIDYY-KKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE  243 (334)
T ss_pred             ---CCCcEEECCcccceeccccccc-ccccCCCcCceEcCHHHhccCC-cCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence               6678999999998765432111 1112223356799999997744 8899999999999999998 88999765422


Q ss_pred             c----------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         241 I----------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       241 ~----------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      .          ..........+.+++..|..+.|..||++.++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~el  286 (334)
T cd05100         244 ELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQL  286 (334)
T ss_pred             HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHH
Confidence            1          11122334567888899999999999887764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.8e-34  Score=242.76  Aligned_cols=233  Identities=22%  Similarity=0.322  Sum_probs=177.6

Q ss_pred             cceeCcccceEEEEEEEccCCCC--ceeEEEEeCCCCCC---hhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEe
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDT--RDYALKQIEGTGLS---MSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFD   98 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~--~~vaiK~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e   98 (291)
                      .+.||+|+||.||+|.+...+..  ..+++|.+......   .++.+|+.+++.++||||+++++++..   ...+++++
T Consensus        12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~---~~~~~v~e   88 (303)
T cd05110          12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS---PTIQLVTQ   88 (303)
T ss_pred             ccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC---CCceeeeh
Confidence            56899999999999998653322  35799988754332   257789999999999999999998842   24578899


Q ss_pred             cCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccc
Q psy2172          99 YAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA  177 (291)
Q Consensus        99 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~  177 (291)
                      |++ |+|.+.+.....        .+++..++.++.|++.||.|||++|++|+||||+||+++    .++.++|+|||++
T Consensus        89 ~~~~g~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~----~~~~~kL~Dfg~~  156 (303)
T cd05110          89 LMPHGCLLDYVHEHKD--------NIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVK----SPNHVKITDFGLA  156 (303)
T ss_pred             hcCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeec----CCCceEEcccccc
Confidence            997 577777654321        278889999999999999999999999999999999998    5678999999999


Q ss_pred             eecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc----------ccCCCC
Q psy2172         178 RLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED----------IKTSNP  246 (291)
Q Consensus       178 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~----------~~~~~~  246 (291)
                      ......... .......++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+....          .....+
T Consensus       157 ~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~-~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~  234 (303)
T cd05110         157 RLLEGDEKE-YNADGGKMPIKWMALECIHYRK-FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPP  234 (303)
T ss_pred             ccccCcccc-cccCCCccccccCCHHHhccCC-CChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCC
Confidence            865432111 1122234467899999987644 8999999999999999987 89999764321          011122


Q ss_pred             CcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         247 YHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       247 ~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      .....+.+++..+....|..+|++.++
T Consensus       235 ~~~~~~~~li~~c~~~~p~~Rp~~~~l  261 (303)
T cd05110         235 ICTIDVYMVMVKCWMIDADSRPKFKEL  261 (303)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            334567778888888888888887764

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=6.9e-34  Score=237.48  Aligned_cols=240  Identities=24%  Similarity=0.358  Sum_probs=180.3

Q ss_pred             cceeCcccceEEEEEEEcc-CCCCceeEEEEeCCCCC----ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCC----ceEE
Q psy2172          24 GCKVGRGTYGHVYKARRKD-NSDTRDYALKQIEGTGL----SMSACREIALLRELKHPNVINLISVFLSHND----RKVW   94 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~-~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----~~~~   94 (291)
                      ++.||+|+||.||+|.++. .++++.+|+|++.....    ..++.+|+.++++++||||+++++++...+.    ...+
T Consensus         4 ~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   83 (273)
T cd05074           4 GRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPM   83 (273)
T ss_pred             hhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceE
Confidence            5689999999999998754 33568899999875432    2357789999999999999999998854322    2347


Q ss_pred             EEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEee
Q psy2172          95 LLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIAD  173 (291)
Q Consensus        95 iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~D  173 (291)
                      ++++|+.+ ++...+.......   ....++...++.++.|++.|++|||++|++|+||||+||+++    ....++++|
T Consensus        84 ~~~~~~~~~~l~~~~~~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~----~~~~~kl~d  156 (273)
T cd05074          84 VILPFMKHGDLHTFLLMSRIGE---EPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLN----ENMTVCVAD  156 (273)
T ss_pred             EEEecCCCCcHHHHHHHhcccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEc----CCCCEEECc
Confidence            88899874 6666654332111   112378899999999999999999999999999999999998    667899999


Q ss_pred             cccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc----------cc
Q psy2172         174 MGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED----------IK  242 (291)
Q Consensus       174 fg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~----------~~  242 (291)
                      ||.+......... .......++..|++||.+.+.. ++.++||||||+++|+|++ |.+||.+....          ..
T Consensus       157 fg~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~-~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~  234 (273)
T cd05074         157 FGLSKKIYSGDYY-RQGCASKLPVKWLALESLADNV-YTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRL  234 (273)
T ss_pred             ccccccccCCcce-ecCCCccCchhhcCHhHHhcCc-cchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcC
Confidence            9998765432111 1112233456799999987644 7889999999999999998 89999765431          11


Q ss_pred             CCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         243 TSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       243 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      ...+.....+.+++..+..+.|..||++.+
T Consensus       235 ~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~  264 (273)
T cd05074         235 KQPPDCLEDVYELMCQCWSPEPKCRPSFQH  264 (273)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            122234467888888899899988888775

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG1035|consensus

Probab=100.00  E-value=2.4e-35  Score=270.67  Aligned_cols=243  Identities=29%  Similarity=0.423  Sum_probs=183.7

Q ss_pred             cccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC---CChhHHHHHHHHhcCCCCCeeeEEEEEE----
Q psy2172          14 TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG---LSMSACREIALLRELKHPNVINLISVFL----   86 (291)
Q Consensus        14 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~----   86 (291)
                      +++..-|+ |-+.||+||||.||+++++-  +++.||||.|+-..   ....+.+|+.++.+|+|||||+++..++    
T Consensus       475 SRY~~DFE-EL~lLGkGGFG~VvkVRNKl--DGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~  551 (1351)
T KOG1035|consen  475 SRYLNDFE-ELELLGKGGFGSVVKVRNKL--DGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTA  551 (1351)
T ss_pred             hhHhhhhH-HHHHhcCCCCceEEEEeecc--cchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCC
Confidence            34555556 46799999999999999877  88999999997543   3346889999999999999999985411    


Q ss_pred             ----------------------------------------------------e--------------------C------
Q psy2172          87 ----------------------------------------------------S--------------------H------   88 (291)
Q Consensus        87 ----------------------------------------------------~--------------------~------   88 (291)
                                                                          .                    +      
T Consensus       552 ~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S  631 (1351)
T KOG1035|consen  552 ELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLS  631 (1351)
T ss_pred             ccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccc
Confidence                                                                0                    0      


Q ss_pred             ----------------------------C-------CceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHH
Q psy2172          89 ----------------------------N-------DRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLY  133 (291)
Q Consensus        89 ----------------------------~-------~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  133 (291)
                                                  +       ...+||-||||+.+++..+.......       -....+|++++
T Consensus       632 ~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-------~~~d~~wrLFr  704 (1351)
T KOG1035|consen  632 NTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-------SQRDEAWRLFR  704 (1351)
T ss_pred             cccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-------hhhHHHHHHHH
Confidence                                        0       04689999999986666555433210       13677999999


Q ss_pred             HHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceecC----C-----------CCCCCCCCCCceeccc
Q psy2172         134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFN----N-----------PLKPLADLDPVVVTFW  198 (291)
Q Consensus       134 ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~~----~-----------~~~~~~~~~~~~g~~~  198 (291)
                      +|+.||.|+|+.|||||||||.|||++    .++.|||+|||+++...    .           ........+...||.-
T Consensus       705 eIlEGLaYIH~~giIHRDLKP~NIFLd----~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTal  780 (1351)
T KOG1035|consen  705 EILEGLAYIHDQGIIHRDLKPRNIFLD----SRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTAL  780 (1351)
T ss_pred             HHHHHHHHHHhCceeeccCCcceeEEc----CCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceee
Confidence            999999999999999999999999999    77899999999998721    0           0111123356789999


Q ss_pred             ccccccccCCc--CCCCchhHHHHHHHHHHHHc-----------------CCCCCCCCcccccCCCCCcHHHHHHHHHhh
Q psy2172         199 YRAPELLLGAR--HYTKAIDIWAIGCIFAELLT-----------------SEPIFHCRQEDIKTSNPYHHDQLDRIFSVM  259 (291)
Q Consensus       199 y~aPE~~~~~~--~~~~~~Dv~slG~~l~~l~~-----------------g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~  259 (291)
                      |+|||.+.+..  .|+.++|+||||++++||+.                 |..|+..   ++   .-.....-..+++.|
T Consensus       781 YvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~yPF~TsMERa~iL~~LR~g~iP~~~---~f---~~~~~~~e~slI~~L  854 (1351)
T KOG1035|consen  781 YVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLYPFGTSMERASILTNLRKGSIPEPA---DF---FDPEHPEEASLIRWL  854 (1351)
T ss_pred             eecHHHhcccccccccchhhhHHHHHHHHHHhccCCchHHHHHHHHhcccCCCCCCc---cc---ccccchHHHHHHHHH
Confidence            99999998765  69999999999999999985                 3333330   00   011124456778888


Q ss_pred             CCCCcCChhhhhcCCCC
Q psy2172         260 GFPLEKDWEDIRKMPEH  276 (291)
Q Consensus       260 ~~~~~~~~~~~~~~~~~  276 (291)
                      ....|..||++.++...
T Consensus       855 l~hdP~kRPtA~eLL~s  871 (1351)
T KOG1035|consen  855 LSHDPSKRPTATELLNS  871 (1351)
T ss_pred             hcCCCccCCCHHHHhhc
Confidence            89999999999987554

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=5e-34  Score=240.51  Aligned_cols=240  Identities=23%  Similarity=0.357  Sum_probs=186.0

Q ss_pred             cceeCcccceEEEEEEEcc-CCCCceeEEEEeCCCC------CChhHHHHHHHHhcC-CCCCeeeEEEEEEeCCCceEEE
Q psy2172          24 GCKVGRGTYGHVYKARRKD-NSDTRDYALKQIEGTG------LSMSACREIALLREL-KHPNVINLISVFLSHNDRKVWL   95 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~-~~~~~~vaiK~~~~~~------~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~i   95 (291)
                      .+.||+|+||.||.|.+.. ..++..||+|+++...      ....+.+|+.+++++ +|++|+++++.+  ......|+
T Consensus         5 ~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~--~~~~~~~l   82 (290)
T cd05613           5 LKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF--QTDTKLHL   82 (290)
T ss_pred             eeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe--ecCCeEEE
Confidence            5699999999999998753 2356789999986421      234577899999999 589999999998  55678999


Q ss_pred             EEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          96 LFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        96 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      |+||+++ +|.+.+....         .+++..+..++.|++.||.+||+.|++|+||+|+||+++    .++.++|+||
T Consensus        83 v~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~----~~~~~kl~df  149 (290)
T cd05613          83 ILDYINGGELFTHLSQRE---------RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLD----SNGHVVLTDF  149 (290)
T ss_pred             EEecCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEC----CCCCEEEeeC
Confidence            9999985 7777665422         278889999999999999999999999999999999998    6679999999


Q ss_pred             ccceecCCCCCCCCCCCCceecccccccccccCC-cCCCCchhHHHHHHHHHHHHcCCCCCCCCccc-------------
Q psy2172         175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQED-------------  240 (291)
Q Consensus       175 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~-------------  240 (291)
                      |++........  .......|+..|+|||.+.+. ..++.++|+||||+++|+|++|..||......             
T Consensus       150 g~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~  227 (290)
T cd05613         150 GLSKEFHEDEV--ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS  227 (290)
T ss_pred             ccceecccccc--cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc
Confidence            99876543211  112234578889999998653 23678899999999999999999999643211             


Q ss_pred             ccCCCCCcHHHHHHHHHhhCCCCcCChh-----hhhcCCCCcchh
Q psy2172         241 IKTSNPYHHDQLDRIFSVMGFPLEKDWE-----DIRKMPEHPTLL  280 (291)
Q Consensus       241 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~-----~~~~~~~~~~~~  280 (291)
                      ...........+.+++..|....|..|+     ++.++..+|++.
T Consensus       228 ~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~  272 (290)
T cd05613         228 EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQ  272 (290)
T ss_pred             CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccc
Confidence            1112223456678888888888888885     677777777654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.5e-34  Score=239.78  Aligned_cols=241  Identities=25%  Similarity=0.403  Sum_probs=185.4

Q ss_pred             cccccceeCcccceEEEEEEEccCCCCceeEEEEeCC-------CCCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCce
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEG-------TGLSMSACREIALLRELKHPNVINLISVFLSHNDRK   92 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (291)
                      |.+ .++||+|+||.||++.+..  .+..+++|+.+.       ......+..|+.+++.++||||+++++++  .+...
T Consensus         2 y~i-~~~ig~g~~g~v~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~   76 (260)
T cd08222           2 YIL-QQRLGKGSFGTVYLVKDKK--AVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF--LERDA   76 (260)
T ss_pred             cee-eeeecCCCCceEEEEEecC--CCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH--hcCCc
Confidence            554 5699999999999999876  334455555432       11233567789999999999999999998  45667


Q ss_pred             EEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEE
Q psy2172          93 VWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI  171 (291)
Q Consensus        93 ~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l  171 (291)
                      .++++||+.+ +|.+.+.......     ..+++..++.++.|++.|+.+||++|++|+||+|+||+++    . +.++|
T Consensus        77 ~~lv~e~~~~~~l~~~~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~----~-~~~~l  146 (260)
T cd08222          77 FCIITEYCEGRDLDCKLEELKHTG-----KTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK----N-NLLKI  146 (260)
T ss_pred             eEEEEEeCCCCCHHHHHHHHhhcc-----cccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee----c-CCEee
Confidence            8999999986 7776665432211     1289999999999999999999999999999999999996    2 46999


Q ss_pred             eecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc----------c
Q psy2172         172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED----------I  241 (291)
Q Consensus       172 ~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~----------~  241 (291)
                      +|||.+........   ......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||......          .
T Consensus       147 ~d~g~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  222 (260)
T cd08222         147 GDFGVSRLLMGSCD---LATTFTGTPYYMSPEALKHQG-YDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPT  222 (260)
T ss_pred             cccCceeecCCCcc---cccCCCCCcCccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCC
Confidence            99999876543211   122345678899999987644 788999999999999999999999754321          1


Q ss_pred             cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         242 KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       242 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                      ..........+.+++..|....|..||++.++..+||+
T Consensus       223 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         223 PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            11222334678889999999999999999999988874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0984|consensus

Probab=100.00  E-value=6.6e-35  Score=220.66  Aligned_cols=200  Identities=23%  Similarity=0.389  Sum_probs=163.0

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCCh---hHHHHHHHHhcC-CCCCeeeEEEEEEeCCCceEEEEEec
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM---SACREIALLREL-KHPNVINLISVFLSHNDRKVWLLFDY   99 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~---~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~iv~e~   99 (291)
                      ++.||+|++|+|-+.++..  ++...|+|.++..-..+   +..+|+.+..+. ..|.+|.+++..+  +....++.||.
T Consensus        51 i~elGrGayG~vekmrh~~--sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~--regdvwIcME~  126 (282)
T KOG0984|consen   51 IEELGRGAYGVVEKMRHIQ--SGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALF--REGDVWICMEL  126 (282)
T ss_pred             hhhhcCCccchhhheeecc--CCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhh--ccccEEEeHHH
Confidence            6789999999999888777  78899999997554433   466777766665 6899999999884  45679999999


Q ss_pred             CCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CeeeeccCCCcEEeecCCCCCCcEEEeecccce
Q psy2172         100 AEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSN-WVLHRDLKPANILVMGEGIERGRVKIADMGFAR  178 (291)
Q Consensus       100 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~-~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~  178 (291)
                      +..+|..+...--.     ....+++..+.+|+-.++.||.|||++ .++|||+||+|||++    ..+++|+||||.+-
T Consensus       127 M~tSldkfy~~v~~-----~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn----~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  127 MDTSLDKFYRKVLK-----KGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILIN----YDGQVKICDFGISG  197 (282)
T ss_pred             hhhhHHHHHHHHHh-----cCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEc----cCCcEEEcccccce
Confidence            99887766654332     233499999999999999999999986 899999999999999    78999999999998


Q ss_pred             ecCCCCCCCCCCCCceecccccccccccCC---cCCCCchhHHHHHHHHHHHHcCCCCCCCCccc
Q psy2172         179 LFNNPLKPLADLDPVVVTFWYRAPELLLGA---RHYTKAIDIWAIGCIFAELLTSEPIFHCRQED  240 (291)
Q Consensus       179 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~  240 (291)
                      .+.++..    .+...|-..|+|||.+...   ..|+.++||||||++++||++++.||......
T Consensus       198 ~L~dSiA----kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tp  258 (282)
T KOG0984|consen  198 YLVDSIA----KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTP  258 (282)
T ss_pred             eehhhhH----HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCH
Confidence            7765321    1224556679999998542   24899999999999999999999999987653

>KOG0983|consensus

Probab=100.00  E-value=5.8e-35  Score=229.75  Aligned_cols=235  Identities=22%  Similarity=0.359  Sum_probs=183.5

Q ss_pred             ceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCCh---hHHHHHHHHhcCC-CCCeeeEEEEEEeCCCceEEEEEecC
Q psy2172          25 CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM---SACREIALLRELK-HPNVINLISVFLSHNDRKVWLLFDYA  100 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~---~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~iv~e~~  100 (291)
                      ..||.|.-|+||++..+.  ++...|||..+.....+   +++..+.++.+.. .|+||+++++|..  ...+++.||.+
T Consensus        98 ~dlGsGtcG~V~k~~~rs--~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~--n~dV~IcMelM  173 (391)
T KOG0983|consen   98 GDLGSGTCGQVWKMRFRS--TGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT--NTDVFICMELM  173 (391)
T ss_pred             HhhcCCCccceEEEEEcc--cceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee--CchHHHHHHHH
Confidence            489999999999999887  77889999998766554   4555666666654 8999999999965  34578888888


Q ss_pred             CCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CeeeeccCCCcEEeecCCCCCCcEEEeeccccee
Q psy2172         101 EHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSN-WVLHRDLKPANILVMGEGIERGRVKIADMGFARL  179 (291)
Q Consensus       101 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~-~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~  179 (291)
                      ..=+..++....        .++|+.-+..+...+++||.||.++ ||+|||+||+|||++    ..+.+||||||++-.
T Consensus       174 s~C~ekLlkrik--------~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlD----e~GniKlCDFGIsGr  241 (391)
T KOG0983|consen  174 STCAEKLLKRIK--------GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD----ERGNIKLCDFGISGR  241 (391)
T ss_pred             HHHHHHHHHHhc--------CCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEc----cCCCEEeecccccce
Confidence            754444443322        2389999999999999999999975 899999999999999    889999999999976


Q ss_pred             cCCCCCCCCCCCCceecccccccccccCC--cCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc----------cC---C
Q psy2172         180 FNNPLKPLADLDPVVVTFWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI----------KT---S  244 (291)
Q Consensus       180 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~----------~~---~  244 (291)
                      +..+.    ......|-+.|||||.+...  +.|+.++||||||++|+|+++|+.||.+.+.+.          +.   .
T Consensus       242 lvdSk----AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~  317 (391)
T KOG0983|consen  242 LVDSK----AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPG  317 (391)
T ss_pred             eeccc----ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCc
Confidence            65432    22345677889999998643  458999999999999999999999999976542          11   1


Q ss_pred             CCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         245 NPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       245 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                      ..-++..+.+++..+..-....+|..+++.+||.+
T Consensus       318 ~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi  352 (391)
T KOG0983|consen  318 HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFI  352 (391)
T ss_pred             ccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcce
Confidence            11246677788888877777788888877777654

>KOG0603|consensus

Probab=100.00  E-value=1e-34  Score=252.03  Aligned_cols=235  Identities=23%  Similarity=0.413  Sum_probs=191.1

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcC-CCCCeeeEEEEEEeCCCceEEEE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLREL-KHPNVINLISVFLSHNDRKVWLL   96 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~iv   96 (291)
                      +.|+... .+|.|+|+.|-.|.+..  +++..++|++.+.  ..+..+|+.++... +||||+++.+.+  .+....|+|
T Consensus       322 ~~y~~~~-~~~~gs~s~~~~~~~~~--t~~~~~vkii~~~--~~~~~~e~~~~~~~~~h~niv~~~~v~--~~~~~~~~v  394 (612)
T KOG0603|consen  322 ESYEFRE-ELGEGSFSAVKYCESSP--TDQEPAVKIISKR--ADDNQDEIPISLLVRDHPNIVKSHDVY--EDGKEIYLV  394 (612)
T ss_pred             hhhcccc-ccCCCCccceeeeeccc--cccchhheecccc--ccccccccchhhhhcCCCcceeeccee--cCCceeeee
Confidence            4455434 69999999999999776  7788999999865  44556677666666 799999999999  788999999


Q ss_pred             EecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecc
Q psy2172          97 FDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMG  175 (291)
Q Consensus        97 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg  175 (291)
                      ||.+.| .+.+.+...+          .....+..|+.+|+.|+.|||++|+||||+||+|||+..   ..++++|+|||
T Consensus       395 ~e~l~g~ell~ri~~~~----------~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~---~~g~lrltyFG  461 (612)
T KOG0603|consen  395 MELLDGGELLRRIRSKP----------EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDG---SAGHLRLTYFG  461 (612)
T ss_pred             ehhccccHHHHHHHhcc----------hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecC---CCCcEEEEEec
Confidence            999987 4444444322          222567789999999999999999999999999999951   66789999999


Q ss_pred             cceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc--------CCCCC
Q psy2172         176 FARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK--------TSNPY  247 (291)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~--------~~~~~  247 (291)
                      .++.....      ....+-|..|.|||++...+ ++.++|+||||++||+|++|..||.....+..        .....
T Consensus       462 ~a~~~~~~------~~tp~~t~~y~APEvl~~~~-yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s~~  534 (612)
T KOG0603|consen  462 FWSELERS------CDTPALTLQYVAPEVLAIQE-YTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFSEC  534 (612)
T ss_pred             hhhhCchh------hcccchhhcccChhhhccCC-CCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccccc
Confidence            99865543      22345578899999998644 99999999999999999999999998776621        11233


Q ss_pred             cHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         248 HHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       248 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                      -++...++++.|..+.|..|++..++..++|+
T Consensus       535 vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  535 VSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             cCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence            46778999999999999999999999999998

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=5.9e-34  Score=242.74  Aligned_cols=242  Identities=18%  Similarity=0.231  Sum_probs=182.7

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCC----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEec
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG----LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDY   99 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~   99 (291)
                      ++.+|.|++  ||.+....  +++.||+|.+....    ....+.+|+.+++.++|+||+++++++  .+....+++|||
T Consensus         7 ~~~~~~~~~--v~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~--~~~~~~~~~~e~   80 (314)
T cd08216           7 GKCFEDLMI--VHLAKHKP--TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF--IVDSELYVVSPL   80 (314)
T ss_pred             hHhhcCCce--EEEEEecC--CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhhee--ecCCeEEEEEec
Confidence            444455544  55555444  67889999986542    224688999999999999999999998  456689999999


Q ss_pred             CCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccce
Q psy2172         100 AEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR  178 (291)
Q Consensus       100 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~  178 (291)
                      +++ ++.+++......       .+++..+..++.|++.||+|||+++|+|+||+|+||+++    .++.++++|||.+.
T Consensus        81 ~~~~~l~~~l~~~~~~-------~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~----~~~~~kl~d~~~~~  149 (314)
T cd08216          81 MAYGSCEDLLKTHFPE-------GLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLS----GDGKVVLSGLRYSV  149 (314)
T ss_pred             cCCCCHHHHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEe----cCCceEEecCccce
Confidence            985 777776643221       178899999999999999999999999999999999998    66789999999887


Q ss_pred             ecCCCCC----CCCCCCCceecccccccccccCC-cCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc-----------
Q psy2172         179 LFNNPLK----PLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK-----------  242 (291)
Q Consensus       179 ~~~~~~~----~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~-----------  242 (291)
                      .......    .........++..|+|||.+.+. ..++.++|+||+|+++|+|++|..||........           
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  229 (314)
T cd08216         150 SMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPC  229 (314)
T ss_pred             eeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCcc
Confidence            5533211    11111234567789999998653 2478899999999999999999999975421100           


Q ss_pred             --------------------------------CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhh
Q psy2172         243 --------------------------------TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKD  282 (291)
Q Consensus       243 --------------------------------~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (291)
                                                      .........+.+++..|....|..||++.++.++|++...
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~  301 (314)
T cd08216         230 LLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC  301 (314)
T ss_pred             ccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence                                            0011113456778899999999999999999999997644

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG0671|consensus

Probab=100.00  E-value=9.5e-36  Score=243.76  Aligned_cols=223  Identities=26%  Similarity=0.517  Sum_probs=182.6

Q ss_pred             cccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC-hhHHHHHHHHhcCC-C-C----CeeeEEEEEE
Q psy2172          14 TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS-MSACREIALLRELK-H-P----NVINLISVFL   86 (291)
Q Consensus        14 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~e~~~l~~l~-h-~----~iv~~~~~~~   86 (291)
                      ..+.++|.+ ...+|+|.||.|-.|.++.  .+..||||++++-... +...-|++++.++. + |    -++++.+|| 
T Consensus        85 D~l~~Ry~i-~~~lGeGtFGkV~ec~D~~--~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF-  160 (415)
T KOG0671|consen   85 DILTNRYEI-VDLLGEGTFGKVVECWDRE--TKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF-  160 (415)
T ss_pred             cccccceeh-hhhhcCCcccceEEEeecC--CCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh-
Confidence            345778886 5699999999999999887  4788999999875433 45667999999993 2 2    477888888 


Q ss_pred             eCCCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCC---
Q psy2172          87 SHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEG---  163 (291)
Q Consensus        87 ~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~---  163 (291)
                       +-.++.|+|+|.++-++.+++......       +++...++.|++|++.++++||+.+++|.||||+||++.+..   
T Consensus       161 -dyrghiCivfellG~S~~dFlk~N~y~-------~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~  232 (415)
T KOG0671|consen  161 -DYRGHICIVFELLGLSTFDFLKENNYI-------PFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFK  232 (415)
T ss_pred             -hccCceEEEEeccChhHHHHhccCCcc-------ccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEE
Confidence             667899999999999999998865432       389999999999999999999999999999999999996531   


Q ss_pred             -------------CCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcC
Q psy2172         164 -------------IERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS  230 (291)
Q Consensus       164 -------------~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g  230 (291)
                                   .....|+++|||.|.......      .....|..|+|||++.+-+ ++.++||||+||+|+|+.+|
T Consensus       233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h------s~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~ElytG  305 (415)
T KOG0671|consen  233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH------STIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYTG  305 (415)
T ss_pred             EeccCCccceeccCCCcceEEEecCCcceeccCc------ceeeeccccCCchheeccC-cCCccCceeeeeEEEEeecc
Confidence                         224578999999998765432      4557799999999999976 99999999999999999999


Q ss_pred             CCCCCCCcccccCCCCCcHHHHHHHHHhhCCCCcC
Q psy2172         231 EPIFHCRQEDIKTSNPYHHDQLDRIFSVMGFPLEK  265 (291)
Q Consensus       231 ~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  265 (291)
                      ...|...++         .+.+..+-..++ |.|.
T Consensus       306 ~~LFqtHen---------~EHLaMMerIlG-p~P~  330 (415)
T KOG0671|consen  306 ETLFQTHEN---------LEHLAMMERILG-PIPS  330 (415)
T ss_pred             ceecccCCc---------HHHHHHHHHhhC-CCcH
Confidence            999998875         366755555555 6654

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.3e-33  Score=235.41  Aligned_cols=233  Identities=26%  Similarity=0.469  Sum_probs=182.2

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCC------------CChhHHHHHHHHhc-CCCCCeeeEEEEEEeCCC
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG------------LSMSACREIALLRE-LKHPNVINLISVFLSHND   90 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~------------~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~   90 (291)
                      .+.||+|+||.||+|.+..+ +++.+++|.+....            ...++.+|+.++.+ ++||||+++++++  ...
T Consensus         5 ~~~ig~G~~~~v~~~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~--~~~   81 (269)
T cd08528           5 LEHLGSGAFGCVYKVRKKNN-GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF--LEN   81 (269)
T ss_pred             hhhhcCCCCceEEEEEEcCC-CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeE--ccC
Confidence            56899999999999998653 45789999875221            11346678887765 6999999999998  556


Q ss_pred             ceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCeeeeccCCCcEEeecCCCCCCc
Q psy2172          91 RKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHS-NWVLHRDLKPANILVMGEGIERGR  168 (291)
Q Consensus        91 ~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~-~~ivH~dik~~Nil~~~~~~~~~~  168 (291)
                      ...+++|||+.+ +|.+.+.......     ..+++..++.++.|++.+|.+||+ .+++|+||+|+||+++    .++.
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~----~~~~  152 (269)
T cd08528          82 DRLYIVMDLIEGAPLGEHFNSLKEKK-----QRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLG----EDDK  152 (269)
T ss_pred             CeEEEEEecCCCCcHHHHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEEC----CCCc
Confidence            789999999985 7777775433221     228899999999999999999996 7899999999999998    6779


Q ss_pred             EEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc--------
Q psy2172         169 VKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED--------  240 (291)
Q Consensus       169 ~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~--------  240 (291)
                      ++|+|||.+.......    ......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||......        
T Consensus       153 ~~l~dfg~~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~  227 (269)
T cd08528         153 VTITDFGLAKQKQPES----KLTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVE  227 (269)
T ss_pred             EEEecccceeeccccc----ccccccCcccCcChhhhcCCC-CchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhh
Confidence            9999999997654432    223456788899999998754 899999999999999999999999764321        


Q ss_pred             --cc-CCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         241 --IK-TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       241 --~~-~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                        .. .........+.+++..+....|..||++.++
T Consensus       228 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~  263 (269)
T cd08528         228 AVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQV  263 (269)
T ss_pred             ccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHH
Confidence              00 1111335678889999999999999987764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG0196|consensus

Probab=100.00  E-value=1.5e-35  Score=261.39  Aligned_cols=231  Identities=22%  Similarity=0.337  Sum_probs=187.9

Q ss_pred             ccccccccccceeCcccceEEEEEEEccCC-CCceeEEEEeCCC---CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCC
Q psy2172          15 KVEDLFDYEGCKVGRGTYGHVYKARRKDNS-DTRDYALKQIEGT---GLSMSACREIALLRELKHPNVINLISVFLSHND   90 (291)
Q Consensus        15 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~-~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   90 (291)
                      .|+-.+....++||.|.||.|++|+.+..+ ....||||.++..   ....+|+.|+.||-+++||||+++.++.  ...
T Consensus       625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVV--Tks  702 (996)
T KOG0196|consen  625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVV--TKS  702 (996)
T ss_pred             hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEE--ecC
Confidence            344444445679999999999999987632 3356999999854   3345799999999999999999999999  667


Q ss_pred             ceEEEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcE
Q psy2172          91 RKVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRV  169 (291)
Q Consensus        91 ~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~  169 (291)
                      +.+.||.|||+ |.|..+++.....        +...++..|++.|+.|++||-+.|+|||||..+|||++    .+..+
T Consensus       703 ~PvMIiTEyMENGsLDsFLR~~DGq--------ftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVN----snLvC  770 (996)
T KOG0196|consen  703 KPVMIITEYMENGSLDSFLRQNDGQ--------FTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVN----SNLVC  770 (996)
T ss_pred             ceeEEEhhhhhCCcHHHHHhhcCCc--------eEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeec----cceEE
Confidence            88999999998 5777777655422        88889999999999999999999999999999999999    67899


Q ss_pred             EEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccccCCCCCc
Q psy2172         170 KIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDIKTSNPYH  248 (291)
Q Consensus       170 ~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~  248 (291)
                      |++|||+++.+....+.........-..+|.|||++.. +.++.++||||+|++|||.++ |..||..-++         
T Consensus       771 KVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN---------  840 (996)
T KOG0196|consen  771 KVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---------  840 (996)
T ss_pred             EeccccceeecccCCCccccccCCccceeecChhHhhh-cccCchhhccccceEEEEecccCCCcccccch---------
Confidence            99999999988765433322222333678999999987 459999999999999999765 9999987666         


Q ss_pred             HHHHHHHHHhhCCCCcCChhh
Q psy2172         249 HDQLDRIFSVMGFPLEKDWED  269 (291)
Q Consensus       249 ~~~~~~i~~~~~~~~~~~~~~  269 (291)
                      ++.+..|.....-|.|-+.|.
T Consensus       841 QdVIkaIe~gyRLPpPmDCP~  861 (996)
T KOG0196|consen  841 QDVIKAIEQGYRLPPPMDCPA  861 (996)
T ss_pred             HHHHHHHHhccCCCCCCCCcH
Confidence            478888888888888876654

>KOG0690|consensus

Probab=100.00  E-value=3.4e-35  Score=236.33  Aligned_cols=201  Identities=25%  Similarity=0.435  Sum_probs=169.7

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC-----hhHHHHHHHHhcCCCCCeeeEEEEEEeCCCce
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS-----MSACREIALLRELKHPNVINLISVFLSHNDRK   92 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (291)
                      +.|++ -++||+|.||.|-+|+-+.  +++.||+|+++++-..     .+-..|-++|+..+||.+..+.-.|  +....
T Consensus       168 ~dFdf-LKvLGkGTFGKVIL~rEKa--t~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF--Qt~dr  242 (516)
T KOG0690|consen  168 EDFDF-LKVLGKGTFGKVILCREKA--TGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF--QTQDR  242 (516)
T ss_pred             chhhH-HHHhcCCccceEEEEeecc--cCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh--ccCce
Confidence            34555 4699999999999999776  8899999999876432     3456788999999999999998888  77889


Q ss_pred             EEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEE
Q psy2172          93 VWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI  171 (291)
Q Consensus        93 ~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l  171 (291)
                      +|.||||..| .|.-.+...+.         +++...+-+...|+.||.|||+++||++|+|.+|++++    .++++||
T Consensus       243 lCFVMeyanGGeLf~HLsrer~---------FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLD----kDGHIKi  309 (516)
T KOG0690|consen  243 LCFVMEYANGGELFFHLSRERV---------FSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLD----KDGHIKI  309 (516)
T ss_pred             EEEEEEEccCceEeeehhhhhc---------ccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheec----cCCceEe
Confidence            9999999986 55444433222         89999999999999999999999999999999999999    8899999


Q ss_pred             eecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc
Q psy2172         172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED  240 (291)
Q Consensus       172 ~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~  240 (291)
                      +|||+++..-.   ......+.+||+.|.|||++.... |+.+.|.|.+||++|+|++|+.||...+.+
T Consensus       310 tDFGLCKE~I~---~g~t~kTFCGTPEYLAPEVleDnD-YgraVDWWG~GVVMYEMmCGRLPFyn~dh~  374 (516)
T KOG0690|consen  310 TDFGLCKEEIK---YGDTTKTFCGTPEYLAPEVLEDND-YGRAVDWWGVGVVMYEMMCGRLPFYNKDHE  374 (516)
T ss_pred             eecccchhccc---ccceeccccCChhhcCchhhcccc-ccceeehhhhhHHHHHHHhccCcccccchh
Confidence            99999974222   223456789999999999998754 999999999999999999999999988764

>KOG0579|consensus

Probab=100.00  E-value=1.2e-35  Score=256.97  Aligned_cols=245  Identities=26%  Similarity=0.445  Sum_probs=195.9

Q ss_pred             cccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC--CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          16 VEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT--GLSMSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        16 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      ..+.+.|.| -||.|+||.||+|.++.  ++...|-|.+...  ....++.-|+.||..++||+||++++.|+.  .+.+
T Consensus        30 P~d~WeIiG-ELGDGAFGKVyKA~nke--t~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~--enkL  104 (1187)
T KOG0579|consen   30 PRDHWEIIG-ELGDGAFGKVYKAVNKE--TKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYF--ENKL  104 (1187)
T ss_pred             HHHHHHHHh-hhcCccchhhhhhhccc--chhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhc--cCce
Confidence            345677766 89999999999999886  5566777887643  334578889999999999999999998865  4478


Q ss_pred             EEEEecCCCC-HHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          94 WLLFDYAEHD-LWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        94 ~iv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      |++.|||+|+ ....+......        +.+.++..+.+|++.||.|||+++|+|+|||..|||++    -++.++|+
T Consensus       105 wiliEFC~GGAVDaimlEL~r~--------LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~T----ldGdirLA  172 (1187)
T KOG0579|consen  105 WILIEFCGGGAVDAIMLELGRV--------LTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLT----LDGDIRLA  172 (1187)
T ss_pred             EEEEeecCCchHhHHHHHhccc--------cchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEE----ecCcEeee
Confidence            9999999975 44444444332        89999999999999999999999999999999999999    77899999


Q ss_pred             ecccceecCCCCCCCCCCCCceecccccccccccC----CcCCCCchhHHHHHHHHHHHHcCCCCCCCCcc---------
Q psy2172         173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLG----ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE---------  239 (291)
Q Consensus       173 Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~---------  239 (291)
                      |||.+.....   .........||+.|||||+..+    ..+|+.++||||||++|.+|+.+.+|-..-+.         
T Consensus       173 DFGVSAKn~~---t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaK  249 (1187)
T KOG0579|consen  173 DFGVSAKNKS---TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK  249 (1187)
T ss_pred             cccccccchh---HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhh
Confidence            9999865332   2234456899999999999754    24589999999999999999999999875442         


Q ss_pred             -cccC-CCC-CcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchh
Q psy2172         240 -DIKT-SNP-YHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLL  280 (291)
Q Consensus       240 -~~~~-~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  280 (291)
                       +.+. ..| .-...+.++++.+..-+|..+|...++..||++.
T Consensus       250 SePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~  293 (1187)
T KOG0579|consen  250 SEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQ  293 (1187)
T ss_pred             cCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccc
Confidence             1111 111 2245688889998889999999999999998876

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.2e-33  Score=231.35  Aligned_cols=223  Identities=22%  Similarity=0.342  Sum_probs=175.7

Q ss_pred             ccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecCCC-CHHHHH
Q psy2172          30 GTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHII  108 (291)
Q Consensus        30 G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~  108 (291)
                      |.+|.||+|.++.  +++.||+|.++...   ...+|...+....||||+++++++  .+....+++|||+++ +|.+.+
T Consensus         4 g~~~~v~~~~~~~--~~~~~~~K~i~~~~---~~~~~~~~~~~~~~~~i~~~~~~~--~~~~~~~lv~e~~~~~~L~~~l   76 (237)
T cd05576           4 GVIDKVLLVMDTR--TQQTFILKGLRKSS---EYSRERLTIIPHCVPNMVCLHKYI--VSEDSVFLVLQHAEGGKLWSHI   76 (237)
T ss_pred             cccceEEEEEEcc--CCcEEEEEeecchh---hhhhHHHHHHhcCCCceeehhhhe--ecCCeEEEEEecCCCCCHHHHH
Confidence            8999999999877  67889999997643   233455555566799999999998  556789999999985 787777


Q ss_pred             HHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceecCCCCCCCC
Q psy2172         109 KFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLA  188 (291)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~  188 (291)
                      .....         +++..+..++.|++.||++||++|++|+||||+||+++    .++.++++|||.+.......    
T Consensus        77 ~~~~~---------l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~----~~~~~~l~df~~~~~~~~~~----  139 (237)
T cd05576          77 SKFLN---------IPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD----DRGHIQLTYFSRWSEVEDSC----  139 (237)
T ss_pred             HHhcC---------CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEc----CCCCEEEecccchhcccccc----
Confidence            54321         88999999999999999999999999999999999998    66789999999876543321    


Q ss_pred             CCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc-----CCCCCcHHHHHHHHHhhCCCC
Q psy2172         189 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK-----TSNPYHHDQLDRIFSVMGFPL  263 (291)
Q Consensus       189 ~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~-----~~~~~~~~~~~~i~~~~~~~~  263 (291)
                        ....++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||........     .........+.+++..|....
T Consensus       140 --~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  216 (237)
T cd05576         140 --DGEAVENMYCAPEVGGISE-ETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFN  216 (237)
T ss_pred             --ccCCcCccccCCcccCCCC-CCchhhHHHHHHHHHHHHHCcchhhcCchhcccccccCCcccCCHHHHHHHHHHccCC
Confidence              1223466799999987644 78899999999999999999988765433211     122334567889999999999


Q ss_pred             cCChhhh-----hcCCCCcch
Q psy2172         264 EKDWEDI-----RKMPEHPTL  279 (291)
Q Consensus       264 ~~~~~~~-----~~~~~~~~~  279 (291)
                      |..|++.     +++..|||+
T Consensus       217 p~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         217 PTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             HHHhcCCCccchHHHHcCCCC
Confidence            9999875     666677663

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0614|consensus

Probab=100.00  E-value=6.9e-36  Score=252.44  Aligned_cols=193  Identities=26%  Similarity=0.480  Sum_probs=170.0

Q ss_pred             ceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC-----ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEec
Q psy2172          25 CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-----SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDY   99 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~   99 (291)
                      .-||-|+||.|-++..+.  ....+|+|++++...     .+++..|-.+|..+++|.||++|-.|  .+.+++|+.||-
T Consensus       426 aTLGvGgFGRVELV~~~~--~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf--rd~kyvYmLmEa  501 (732)
T KOG0614|consen  426 ATLGVGGFGRVELVKVNS--QKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF--RDSKYVYMLMEA  501 (732)
T ss_pred             hhcccCccceEEEEEecc--cchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh--ccchhhhhhHHh
Confidence            479999999999998765  334699999875433     34577899999999999999999999  788899999998


Q ss_pred             C-CCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccce
Q psy2172         100 A-EHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR  178 (291)
Q Consensus       100 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~  178 (291)
                      | +|.++..+...+.         +++...+-++..++.|++|||.+|||+|||||+|++++    .++-+||.|||+++
T Consensus       502 ClGGElWTiLrdRg~---------Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd----~~Gy~KLVDFGFAK  568 (732)
T KOG0614|consen  502 CLGGELWTILRDRGS---------FDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLD----NRGYLKLVDFGFAK  568 (732)
T ss_pred             hcCchhhhhhhhcCC---------cccchhhhhHHHHHHHHHHHHhcCceeccCChhheeec----cCCceEEeehhhHH
Confidence            8 4688888876554         88889999999999999999999999999999999999    78899999999999


Q ss_pred             ecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcc
Q psy2172         179 LFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE  239 (291)
Q Consensus       179 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~  239 (291)
                      .+.+.    ....+.+||+.|.|||++.+.+ .+.++|.||||+++||+++|++||++.+.
T Consensus       569 ki~~g----~KTwTFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~~dp  624 (732)
T KOG0614|consen  569 KIGSG----RKTWTFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFSGVDP  624 (732)
T ss_pred             HhccC----CceeeecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCCCch
Confidence            88765    4567889999999999999866 78999999999999999999999998765

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.9e-33  Score=236.80  Aligned_cols=241  Identities=23%  Similarity=0.344  Sum_probs=185.8

Q ss_pred             cceeCcccceEEEEEEEccC-CCCceeEEEEeCCC------CCChhHHHHHHHHhcC-CCCCeeeEEEEEEeCCCceEEE
Q psy2172          24 GCKVGRGTYGHVYKARRKDN-SDTRDYALKQIEGT------GLSMSACREIALLREL-KHPNVINLISVFLSHNDRKVWL   95 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~-~~~~~vaiK~~~~~------~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~i   95 (291)
                      .+.||+|++|.||++.+... ..+..|++|.++..      .....+.+|+.++.++ +||+|+++++.+  ......++
T Consensus         5 ~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~--~~~~~~~l   82 (288)
T cd05583           5 LRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF--QTDTKLHL   82 (288)
T ss_pred             EEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee--ecCCEEEE
Confidence            56899999999999987542 25577999998642      2234577899999999 599999999998  56678999


Q ss_pred             EEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          96 LFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        96 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      ||||+.+ +|...+....         .+++..++.++.|++.+|.+||+.|++|+||+|+||+++    .++.++|+||
T Consensus        83 v~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~----~~~~~~l~df  149 (288)
T cd05583          83 ILDYVNGGELFTHLYQRE---------HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLD----SEGHVVLTDF  149 (288)
T ss_pred             EEecCCCCcHHHHHhhcC---------CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC----CCCCEEEEEC
Confidence            9999985 7766664321         278889999999999999999999999999999999998    6678999999


Q ss_pred             ccceecCCCCCCCCCCCCceecccccccccccCCc-CCCCchhHHHHHHHHHHHHcCCCCCCCCccc-------------
Q psy2172         175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGAR-HYTKAIDIWAIGCIFAELLTSEPIFHCRQED-------------  240 (291)
Q Consensus       175 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~-------------  240 (291)
                      |++........  .......|+..|+|||.+.+.. ..+.++|+||||+++|+|++|..||......             
T Consensus       150 g~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~  227 (288)
T cd05583         150 GLSKEFLAEEE--ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS  227 (288)
T ss_pred             ccccccccccc--cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc
Confidence            99876543211  1112345788899999986532 3678999999999999999999999643211             


Q ss_pred             ccCCCCCcHHHHHHHHHhhCCCCcCChhhh---hcCCCCcchhh
Q psy2172         241 IKTSNPYHHDQLDRIFSVMGFPLEKDWEDI---RKMPEHPTLLK  281 (291)
Q Consensus       241 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~---~~~~~~~~~~~  281 (291)
                      ...........+.+++..|..+.|..||++   .++..++++..
T Consensus       228 ~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~  271 (288)
T cd05583         228 KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQG  271 (288)
T ss_pred             CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCccccc
Confidence            011222234667888899999999999874   55677777644

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0696|consensus

Probab=100.00  E-value=1.6e-34  Score=239.10  Aligned_cols=221  Identities=25%  Similarity=0.338  Sum_probs=175.4

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCCh-----hHHHHHHHHhcC-CCCCeeeEEEEEEeCCCceEEEEE
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM-----SACREIALLREL-KHPNVINLISVFLSHNDRKVWLLF   97 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~iv~   97 (291)
                      ..+||+|+||.|.+|..++  +.+.+|||+++++-..+     --..|-++|... +-|.+++++..|  +..+.+|.||
T Consensus       354 l~VlGKGSFGKVlLaerkg--tdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF--QTmDRLyFVM  429 (683)
T KOG0696|consen  354 LMVLGKGSFGKVLLAERKG--TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF--QTMDRLYFVM  429 (683)
T ss_pred             EEEeccCccceeeeecccC--cchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh--hhhhheeeEE
Confidence            3589999999999999776  77889999998764333     234566777766 578999999999  8888999999


Q ss_pred             ecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeeccc
Q psy2172          98 DYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGF  176 (291)
Q Consensus        98 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~  176 (291)
                      ||+.| +|.-.++.-+.         +.+..+.-++..|+-||-+||++||++||||.+||+++    ..+++||+|||+
T Consensus       430 EyvnGGDLMyhiQQ~Gk---------FKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd----~eGHiKi~DFGm  496 (683)
T KOG0696|consen  430 EYVNGGDLMYHIQQVGK---------FKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD----SEGHIKIADFGM  496 (683)
T ss_pred             EEecCchhhhHHHHhcc---------cCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEec----cCCceEeeeccc
Confidence            99985 77666654443         78888999999999999999999999999999999999    778999999999


Q ss_pred             ceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---------cCCCCC
Q psy2172         177 ARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---------KTSNPY  247 (291)
Q Consensus       177 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---------~~~~~~  247 (291)
                      ++.--..   .....+.+||+.|+|||++.-.+ |+..+|.||+|++||||+.|++||.+.+++.         ..+.+.
T Consensus       497 cKEni~~---~~TTkTFCGTPdYiAPEIi~YqP-YgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKs  572 (683)
T KOG0696|consen  497 CKENIFD---GVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKS  572 (683)
T ss_pred             ccccccC---CcceeeecCCCcccccceEEecc-cccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCccc
Confidence            8742221   12345679999999999998744 9999999999999999999999999988752         123333


Q ss_pred             cHHHHHHHHHhhCCCCcC
Q psy2172         248 HHDQLDRIFSVMGFPLEK  265 (291)
Q Consensus       248 ~~~~~~~i~~~~~~~~~~  265 (291)
                      .+.....|.+.+..-.|.
T Consensus       573 lSkEAv~ickg~ltK~P~  590 (683)
T KOG0696|consen  573 LSKEAVAICKGLLTKHPG  590 (683)
T ss_pred             ccHHHHHHHHHHhhcCCc
Confidence            344444555555444443

>KOG1006|consensus

Probab=100.00  E-value=8.9e-36  Score=233.34  Aligned_cols=239  Identities=19%  Similarity=0.330  Sum_probs=185.4

Q ss_pred             ceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC---ChhHHHHHHHHhcC-CCCCeeeEEEEEEeCCCceEEEEEecC
Q psy2172          25 CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL---SMSACREIALLREL-KHPNVINLISVFLSHNDRKVWLLFDYA  100 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~iv~e~~  100 (291)
                      ..||.|+||+|++..++.  +++..|||.++....   ..++..|.....+- +.||||++|+..+.  +...|+.||.+
T Consensus        70 g~iG~G~fG~V~KM~hk~--sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~--EGdcWiCMELM  145 (361)
T KOG1006|consen   70 GEIGNGAFGTVNKMLHKP--SGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS--EGDCWICMELM  145 (361)
T ss_pred             HHhcCCcchhhhhhhcCc--cCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc--CCceeeeHHHH
Confidence            489999999999999887  889999999986544   33566676655444 68999999999864  45679999999


Q ss_pred             CCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CeeeeccCCCcEEeecCCCCCCcEEEeeccccee
Q psy2172         101 EHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSN-WVLHRDLKPANILVMGEGIERGRVKIADMGFARL  179 (291)
Q Consensus       101 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~-~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~  179 (291)
                      +-++..+...-...+...    +++.-+..|.-..+.||.||-+. .|+|||+||+|||++    ..+.+||||||.+-.
T Consensus       146 d~SlDklYk~vy~vq~~~----ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILld----r~G~vKLCDFGIcGq  217 (361)
T KOG1006|consen  146 DISLDKLYKRVYSVQKSR----IPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLD----RHGDVKLCDFGICGQ  217 (361)
T ss_pred             hhhHHHHHHHHHHHHhcc----CcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEe----cCCCEeeecccchHh
Confidence            988887777655544433    89999999999999999999964 899999999999999    788999999999876


Q ss_pred             cCCCCCCCCCCCCceecccccccccccCCcC-CCCchhHHHHHHHHHHHHcCCCCCCCCcccc-----------cC--CC
Q psy2172         180 FNNPLKPLADLDPVVVTFWYRAPELLLGARH-YTKAIDIWAIGCIFAELLTSEPIFHCRQEDI-----------KT--SN  245 (291)
Q Consensus       180 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~-----------~~--~~  245 (291)
                      ...+    ...+.-.|-..|+|||.+..... |+.++|+||||++|+|+++|+.||.+...-.           +.  ..
T Consensus       218 Lv~S----iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~  293 (361)
T KOG1006|consen  218 LVDS----IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFD  293 (361)
T ss_pred             HHHH----HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCc
Confidence            5543    22234466677999999976544 8999999999999999999999998865421           10  11


Q ss_pred             ---CCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         246 ---PYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       246 ---~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                         -.+...+.+.+..+..-....+|...++..++..
T Consensus       294 ~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fy  330 (361)
T KOG1006|consen  294 KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFY  330 (361)
T ss_pred             ccccccCHHHHHHHHHHhhcccccCcchhhhhcCchh
Confidence               1134456667777777777777877777666543

>KOG4278|consensus

Probab=100.00  E-value=3.2e-34  Score=247.79  Aligned_cols=232  Identities=22%  Similarity=0.332  Sum_probs=190.6

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCC-CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecCC-
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-GLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAE-  101 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~~-  101 (291)
                      ..+||.|-||.||.+.|++  -...||||.++.+ ....+|+.|+.+|+.++|||+|++++++  ..+...|||+|||. 
T Consensus       272 khKLGGGQYGeVYeGvWKk--yslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVC--T~EpPFYIiTEfM~y  347 (1157)
T KOG4278|consen  272 KHKLGGGQYGEVYEGVWKK--YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC--THEPPFYIITEFMCY  347 (1157)
T ss_pred             eeccCCCcccceeeeeeec--cceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhh--ccCCCeEEEEecccC
Confidence            4699999999999999998  5677999999865 3456899999999999999999999999  55678999999997 


Q ss_pred             CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceecC
Q psy2172         102 HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFN  181 (291)
Q Consensus       102 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~~  181 (291)
                      |+|+++++......       ++.-.++.|+.||.+|++||..++++||||..+|.|++    .+..||++|||+++.+.
T Consensus       348 GNLLdYLRecnr~e-------v~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVg----EnhiVKvADFGLsRlMt  416 (1157)
T KOG4278|consen  348 GNLLDYLRECNRSE-------VPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG----ENHIVKVADFGLSRLMT  416 (1157)
T ss_pred             ccHHHHHHHhchhh-------cchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccc----ccceEEeeccchhhhhc
Confidence            79999998766544       67778899999999999999999999999999999998    77899999999999876


Q ss_pred             CCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc----------ccCCCCCcHH
Q psy2172         182 NPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED----------IKTSNPYHHD  250 (291)
Q Consensus       182 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~----------~~~~~~~~~~  250 (291)
                      ....  ...-.......|.|||.+.-.. ++.++|||+|||+|||+++ |-.||.+.+-.          .+....-+..
T Consensus       417 gDTY--TAHAGAKFPIKWTAPEsLAyNt-FSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPp  493 (1157)
T KOG4278|consen  417 GDTY--TAHAGAKFPIKWTAPESLAYNT-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPP  493 (1157)
T ss_pred             CCce--ecccCccCcccccCcccccccc-cccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCH
Confidence            5322  1111222356799999997644 9999999999999999987 89999987632          1223334456


Q ss_pred             HHHHHHHhhCCCCcCChhhhhcC
Q psy2172         251 QLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       251 ~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      .+.+++..+..=.|.++|++.++
T Consensus       494 kVYeLMraCW~WsPsDRPsFaei  516 (1157)
T KOG4278|consen  494 KVYELMRACWNWSPSDRPSFAEI  516 (1157)
T ss_pred             HHHHHHHHHhcCCcccCccHHHH
Confidence            67778888887788888887764

>KOG4645|consensus

Probab=100.00  E-value=4.8e-35  Score=270.08  Aligned_cols=208  Identities=30%  Similarity=0.498  Sum_probs=170.2

Q ss_pred             ccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCC
Q psy2172          15 KVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT----GLSMSACREIALLRELKHPNVINLISVFLSHND   90 (291)
Q Consensus        15 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   90 (291)
                      .++-++- .+.+||+|.||.||.|.+.+  +++-.|+|-++-.    .....+.+|..++..++|||+|+++++-.+  .
T Consensus      1232 nV~~rWq-rg~~Ig~G~fG~VYtavN~~--tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH--R 1306 (1509)
T KOG4645|consen 1232 NVTFRWQ-RGNFIGGGTFGKVYTAVNLD--TGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH--R 1306 (1509)
T ss_pred             cceeeec-cccccCCcceeeeEEeecCC--ccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeec--H
Confidence            3444555 37899999999999999877  6777999988532    334567899999999999999999999865  4


Q ss_pred             ceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcE
Q psy2172          91 RKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRV  169 (291)
Q Consensus        91 ~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~  169 (291)
                      ...+|.||||.+ +|.+++...+.         .++.....+..|++.|++|||+.||||+||||.||+++    .++.+
T Consensus      1307 ekv~IFMEyC~~GsLa~ll~~gri---------~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld----~~g~i 1373 (1509)
T KOG4645|consen 1307 EKVYIFMEYCEGGSLASLLEHGRI---------EDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLD----FNGLI 1373 (1509)
T ss_pred             HHHHHHHHHhccCcHHHHHHhcch---------hhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeee----cCCcE
Confidence            478999999985 77777765543         56777788889999999999999999999999999999    67799


Q ss_pred             EEeecccceecCCCCCC-CCCCCCceecccccccccccCCc--CCCCchhHHHHHHHHHHHHcCCCCCCCCccc
Q psy2172         170 KIADMGFARLFNNPLKP-LADLDPVVVTFWYRAPELLLGAR--HYTKAIDIWAIGCIFAELLTSEPIFHCRQED  240 (291)
Q Consensus       170 ~l~Dfg~~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~--~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~  240 (291)
                      |++|||.|..+...... ........||+.|||||++.+..  ....++|||||||++.||++|+.||..-+.+
T Consensus      1374 K~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne 1447 (1509)
T KOG4645|consen 1374 KYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE 1447 (1509)
T ss_pred             EeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch
Confidence            99999999987664211 11223568999999999997643  2567899999999999999999999877664

>KOG1151|consensus

Probab=100.00  E-value=2.6e-34  Score=239.76  Aligned_cols=254  Identities=25%  Similarity=0.447  Sum_probs=194.5

Q ss_pred             cccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeC---------CCCCChhHHHHHHHHhcCCCCCeeeEEEE
Q psy2172          14 TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIE---------GTGLSMSACREIALLRELKHPNVINLISV   84 (291)
Q Consensus        14 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~---------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   84 (291)
                      -.++++|.. -.+||+|||+.||+|.+..  ..+.||+|+-.         +......+.+|..|-+.|+||.||++|++
T Consensus       459 ptLn~RYLl-LhLLGrGGFSEVyKAFDl~--EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDy  535 (775)
T KOG1151|consen  459 PTLNDRYLL-LHLLGRGGFSEVYKAFDLT--EQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDY  535 (775)
T ss_pred             cchHHHHHH-HHHhccccHHHHHHhcccc--hhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeee
Confidence            356777875 4599999999999999776  77889999852         22233568899999999999999999999


Q ss_pred             EEeCCCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhC--CeeeeccCCCcEEeec
Q psy2172          85 FLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSN--WVLHRDLKPANILVMG  161 (291)
Q Consensus        85 ~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~--~ivH~dik~~Nil~~~  161 (291)
                      |.- +...+|-|+|||+| +|.-+++..+.         +++..++.|+.||+.||.||.+.  .|+|-||||.|||+..
T Consensus       536 fsl-DtdsFCTVLEYceGNDLDFYLKQhkl---------mSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~  605 (775)
T KOG1151|consen  536 FSL-DTDSFCTVLEYCEGNDLDFYLKQHKL---------MSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVN  605 (775)
T ss_pred             eee-ccccceeeeeecCCCchhHHHHhhhh---------hhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEec
Confidence            954 45678999999998 55555554443         89999999999999999999976  5999999999999975


Q ss_pred             CCCCCCcEEEeecccceecCCCCCC----CCCCCCceecccccccccccC---CcCCCCchhHHHHHHHHHHHHcCCCCC
Q psy2172         162 EGIERGRVKIADMGFARLFNNPLKP----LADLDPVVVTFWYRAPELLLG---ARHYTKAIDIWAIGCIFAELLTSEPIF  234 (291)
Q Consensus       162 ~~~~~~~~~l~Dfg~~~~~~~~~~~----~~~~~~~~g~~~y~aPE~~~~---~~~~~~~~Dv~slG~~l~~l~~g~~pf  234 (291)
                      .. .-+.+||+|||+++.+......    ........||.+|.|||.+.-   .+..+.+.||||+||++|.++.|+.||
T Consensus       606 Gt-acGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPF  684 (775)
T KOG1151|consen  606 GT-ACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPF  684 (775)
T ss_pred             Cc-ccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCC
Confidence            43 5679999999999988764332    122345688999999998753   345789999999999999999999999


Q ss_pred             CCCccc---------------ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         235 HCRQED---------------IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       235 ~~~~~~---------------~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                      ......               -...+|........+++.+....-.++-++.++...|-+++
T Consensus       685 GhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  685 GHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             CCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence            765432               01233444445556666665555566666666666555554

>KOG1152|consensus

Probab=100.00  E-value=3.1e-34  Score=245.68  Aligned_cols=190  Identities=30%  Similarity=0.477  Sum_probs=167.8

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC----------hhHHHHHHHHhcCC---CCCeeeEEEEEEeCCC
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----------MSACREIALLRELK---HPNVINLISVFLSHND   90 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----------~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~   90 (291)
                      -..+|.|+||.|++|.++.  +...|+||.+.+++..          ..+-.|++||..++   |+||++++++|  ++.
T Consensus       566 lq~lG~GAyGkV~lai~K~--n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF--Edd  641 (772)
T KOG1152|consen  566 LQPLGEGAYGKVNLAIHKE--NNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF--EDD  641 (772)
T ss_pred             eeeccccccceEEEeeecc--cceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee--ecC
Confidence            4689999999999999987  5778999998765432          23557999999996   99999999999  888


Q ss_pred             ceEEEEEecCCC--CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCc
Q psy2172          91 RKVWLLFDYAEH--DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGR  168 (291)
Q Consensus        91 ~~~~iv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~  168 (291)
                      +++|++||..+.  +|.+++.....         +++..+..|++|++.|+++||+.||||||||-+|++++    .++-
T Consensus       642 d~yyl~te~hg~gIDLFd~IE~kp~---------m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd----~~g~  708 (772)
T KOG1152|consen  642 DYYYLETEVHGEGIDLFDFIEFKPR---------MDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVD----SNGF  708 (772)
T ss_pred             CeeEEEecCCCCCcchhhhhhccCc---------cchHHHHHHHHHHHhccccccccCceecccccccEEEe----cCCe
Confidence            899999999874  78888876554         89999999999999999999999999999999999999    7789


Q ss_pred             EEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCC
Q psy2172         169 VKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH  235 (291)
Q Consensus       169 ~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~  235 (291)
                      ++|+|||.+....+     .......||..|.|||++.|.+..+..-|||++|++||-+.....||-
T Consensus       709 ~klidfgsaa~~ks-----gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  709 VKLIDFGSAAYTKS-----GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             EEEeeccchhhhcC-----CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            99999999976655     456778999999999999998877889999999999999999998885

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=2.4e-32  Score=253.19  Aligned_cols=143  Identities=25%  Similarity=0.504  Sum_probs=121.9

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC-----ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCce
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-----SMSACREIALLRELKHPNVINLISVFLSHNDRK   92 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (291)
                      +.|.+ .++||+|+||.||+|.+..  +++.||+|+++....     ...+..|+.+++.++||||+++++++  .....
T Consensus         4 ~~y~i-~~~LG~G~fg~Vy~a~~~~--~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~--~~~~~   78 (669)
T cd05610           4 EEFVI-VKPISRGAFGKVYLGRKKN--NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL--QSANN   78 (669)
T ss_pred             CCEEE-EEEEecCCCeEEEEEEECC--CCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE--EECCE
Confidence            34564 5799999999999999876  678899999975322     24678899999999999999999988  55678


Q ss_pred             EEEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEE
Q psy2172          93 VWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI  171 (291)
Q Consensus        93 ~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l  171 (291)
                      .|+||||+. ++|..++....         .+++..++.++.||+.||.|||++||+|+||||+|||++    .++.++|
T Consensus        79 ~~lVmEy~~g~~L~~li~~~~---------~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~----~~g~vkL  145 (669)
T cd05610          79 VYLVMEYLIGGDVKSLLHIYG---------YFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLIS----NEGHIKL  145 (669)
T ss_pred             EEEEEeCCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEc----CCCCEEE
Confidence            999999996 48887775432         178889999999999999999999999999999999998    6678999


Q ss_pred             eecccce
Q psy2172         172 ADMGFAR  178 (291)
Q Consensus       172 ~Dfg~~~  178 (291)
                      +|||+++
T Consensus       146 ~DFGls~  152 (669)
T cd05610         146 TDFGLSK  152 (669)
T ss_pred             EeCCCCc
Confidence            9999876

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1094|consensus

Probab=100.00  E-value=1.8e-33  Score=241.30  Aligned_cols=233  Identities=24%  Similarity=0.333  Sum_probs=182.1

Q ss_pred             ccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEec
Q psy2172          23 EGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDY   99 (291)
Q Consensus        23 ~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~   99 (291)
                      .+++||+|-||.|.+|.-.   ....||+|.++....   ..+|.+|+++|.+|+||||+.+++++..  ++.+++++||
T Consensus       542 ~~ekiGeGqFGEVhLCeve---g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~--DePicmI~EY  616 (807)
T KOG1094|consen  542 FKEKIGEGQFGEVHLCEVE---GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQ--DDPLCMITEY  616 (807)
T ss_pred             hhhhhcCcccceeEEEEec---CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeec--CCchHHHHHH
Confidence            4889999999999999854   357799999986543   3579999999999999999999999964  5578999999


Q ss_pred             CC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccce
Q psy2172         100 AE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR  178 (291)
Q Consensus       100 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~  178 (291)
                      ++ |+|.+++..+....       .......+|+.||++|++||.+.++||||+.++|+|++    ...++||+|||+++
T Consensus       617 mEnGDLnqFl~aheapt-------~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~----~e~~iKiadfgmsR  685 (807)
T KOG1094|consen  617 MENGDLNQFLSAHELPT-------AETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVD----GEFTIKIADFGMSR  685 (807)
T ss_pred             HhcCcHHHHHHhccCcc-------cccchhHHHHHHHHHHHHHHHhhchhhccccccceeec----CcccEEecCccccc
Confidence            98 69999888764322       34556778999999999999999999999999999999    77899999999998


Q ss_pred             ecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc--CCCCCCCCccc----------------
Q psy2172         179 LFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT--SEPIFHCRQED----------------  240 (291)
Q Consensus       179 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~--g~~pf~~~~~~----------------  240 (291)
                      -....... ...+......+|+|+|.+..++ ++.++|+|+||+++||+++  ..-||+.-..+                
T Consensus       686 ~lysg~yy-~vqgr~vlpiRwmawEsillgk-FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~  763 (807)
T KOG1094|consen  686 NLYSGDYY-RVQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQ  763 (807)
T ss_pred             ccccCCce-eeecceeeeeeehhHHHHHhcc-ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcc
Confidence            66553221 1223445578899999988755 9999999999999999865  77899865543                


Q ss_pred             -ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         241 -IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       241 -~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                       .....+.+...+.+++-.+..-...++|+++++
T Consensus       764 ~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~l  797 (807)
T KOG1094|consen  764 VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQL  797 (807)
T ss_pred             eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHH
Confidence             122334444445555555555555667776653

>KOG0608|consensus

Probab=100.00  E-value=2.8e-33  Score=242.26  Aligned_cols=240  Identities=23%  Similarity=0.366  Sum_probs=187.7

Q ss_pred             ccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC-----ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEE
Q psy2172          23 EGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-----SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLF   97 (291)
Q Consensus        23 ~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~   97 (291)
                      ..+-||-|+||.|-++.-.+  +...||.|.+++...     ......|-.||..-+++-||++|-.|  ++++.+|+||
T Consensus       633 kik~iGvGAFGeV~Lv~KvD--T~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF--QDkdnLYFVM  708 (1034)
T KOG0608|consen  633 KIKTIGVGAFGEVCLVRKVD--TRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF--QDKDNLYFVM  708 (1034)
T ss_pred             EEeeecccccceeEEEeecc--hhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe--ccCCceEEEE
Confidence            45689999999999998666  678899999975432     23467788999999999999999999  8899999999


Q ss_pred             ecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeeccc
Q psy2172          98 DYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGF  176 (291)
Q Consensus        98 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~  176 (291)
                      +|.+| ++..++-..+-         |++..++.++..+..|+++.|+.|++||||||+||||+    .++++||+|||+
T Consensus       709 dYIPGGDmMSLLIrmgI---------FeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILID----rdGHIKLTDFGL  775 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIRMGI---------FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILID----RDGHIKLTDFGL  775 (1034)
T ss_pred             eccCCccHHHHHHHhcc---------CHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEc----cCCceeeeeccc
Confidence            99985 88888876554         88999999999999999999999999999999999999    788999999999


Q ss_pred             ceecCCCCCC---------------------------------------CCCCCCceecccccccccccCCcCCCCchhH
Q psy2172         177 ARLFNNPLKP---------------------------------------LADLDPVVVTFWYRAPELLLGARHYTKAIDI  217 (291)
Q Consensus       177 ~~~~~~~~~~---------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv  217 (291)
                      +.-+......                                       ........||+.|+|||++...+ ++..+|.
T Consensus       776 CTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g-~~q~cdw  854 (1034)
T KOG0608|consen  776 CTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG-YTQLCDW  854 (1034)
T ss_pred             cccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC-ccccchh
Confidence            9765432110                                       00001247899999999998866 9999999


Q ss_pred             HHHHHHHHHHHcCCCCCCCCcccc--------------cCCCCCcHHHHHHHHHhhCCCCcC-ChhhhhcCCCCcchh
Q psy2172         218 WAIGCIFAELLTSEPIFHCRQEDI--------------KTSNPYHHDQLDRIFSVMGFPLEK-DWEDIRKMPEHPTLL  280 (291)
Q Consensus       218 ~slG~~l~~l~~g~~pf~~~~~~~--------------~~~~~~~~~~~~~i~~~~~~~~~~-~~~~~~~~~~~~~~~  280 (291)
                      ||.||+||+|+.|++||.......              ...-....+.+..|.+.+..+... -....+++..||++.
T Consensus       855 ws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~sad~RLGkng~d~vKaHpfFk  932 (1034)
T KOG0608|consen  855 WSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCCSADSRLGKNGADQVKAHPFFK  932 (1034)
T ss_pred             hHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhcChhhhhcccchhhhhcCcccc
Confidence            999999999999999998766531              222223355555555555433321 124445677777764

>KOG1027|consensus

Probab=100.00  E-value=9.4e-34  Score=251.78  Aligned_cols=251  Identities=27%  Similarity=0.342  Sum_probs=201.1

Q ss_pred             ccccccceeCcccce-EEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcC-CCCCeeeEEEEEEeCCCceEEEE
Q psy2172          19 LFDYEGCKVGRGTYG-HVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLREL-KHPNVINLISVFLSHNDRKVWLL   96 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g-~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~iv   96 (291)
                      .+....+.+|.|+.| .||+|..    .++.||||++-.+ ....+.+|+..|+.- +||||+++++.-  .+..++||.
T Consensus       509 ~~~~~~eilG~Gs~Gt~Vf~G~y----e~R~VAVKrll~e-~~~~A~rEi~lL~eSD~H~NviRyyc~E--~d~qF~YIa  581 (903)
T KOG1027|consen  509 LFFSPKEILGYGSNGTVVFRGVY----EGREVAVKRLLEE-FFDFAQREIQLLQESDEHPNVIRYYCSE--QDRQFLYIA  581 (903)
T ss_pred             eeeccHHHcccCCCCcEEEEEee----CCceehHHHHhhH-hHHHHHHHHHHHHhccCCCceEEEEeec--cCCceEEEE
Confidence            334456789999997 5699987    4578999998643 455688999999998 599999999987  788899999


Q ss_pred             EecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCC-CCCcEEEeecc
Q psy2172          97 FDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGI-ERGRVKIADMG  175 (291)
Q Consensus        97 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~-~~~~~~l~Dfg  175 (291)
                      .|.|..+|.+++.........     ......+.++.|+++||+|||+.+||||||||.|||++..+. ...+++|+|||
T Consensus       582 lELC~~sL~dlie~~~~d~~~-----~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfg  656 (903)
T KOG1027|consen  582 LELCACSLQDLIESSGLDVEM-----QSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFG  656 (903)
T ss_pred             ehHhhhhHHHHHhccccchhh-----cccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccc
Confidence            999999999999875111100     122456788999999999999999999999999999986432 33689999999


Q ss_pred             cceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcC-CCCCCCCcccc----------cCC
Q psy2172         176 FARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQEDI----------KTS  244 (291)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g-~~pf~~~~~~~----------~~~  244 (291)
                      +++................||.+|+|||++.+.. .+.++|+|||||++|+.++| .+||.+.....          ...
T Consensus       657 lsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L  735 (903)
T KOG1027|consen  657 LSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHL  735 (903)
T ss_pred             cccccCCCcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeee
Confidence            9999887766666677789999999999998865 67799999999999998875 99998765431          112


Q ss_pred             CCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhh
Q psy2172         245 NPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKD  282 (291)
Q Consensus       245 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (291)
                      .+.......+++..|..|.|..||+++++..||.+...
T Consensus       736 ~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~  773 (903)
T KOG1027|consen  736 EPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS  773 (903)
T ss_pred             ccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence            22222267899999999999999999999999887643

>KOG0664|consensus

Probab=100.00  E-value=1.9e-35  Score=232.77  Aligned_cols=219  Identities=37%  Similarity=0.663  Sum_probs=181.4

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCC----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCc---eEEEE
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT----GLSMSACREIALLRELKHPNVINLISVFLSHNDR---KVWLL   96 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~---~~~iv   96 (291)
                      ++.||-|+||.||.+.+..  +++.|++|.+.+-    ....++.+|+++|.-++|.|+...++..-...-+   .+|++
T Consensus        58 DRPIGYGAFGVVWsVTDPR--dgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   58 DRPIGYGAFGVVWSVTDPR--SGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCcccccceeEEEeccCCC--CccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            6799999999999999766  8899999988643    2245688999999999999999988876222211   36778


Q ss_pred             EecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeeccc
Q psy2172          97 FDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGF  176 (291)
Q Consensus        97 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~  176 (291)
                      +|.+..+|...+.+         +..++...++-+++||++||+|||+.+|.||||||.|++++    .+..+||||||+
T Consensus       136 TELmQSDLHKIIVS---------PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVN----SNCvLKICDFGL  202 (449)
T KOG0664|consen  136 TELMQSDLHKIIVS---------PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVN----SNCILKICDFGL  202 (449)
T ss_pred             HHHHHhhhhheecc---------CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEec----cCceEEeccccc
Confidence            88887777766654         33488899999999999999999999999999999999998    677899999999


Q ss_pred             ceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccCCCCCcHHHHHHHH
Q psy2172         177 ARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF  256 (291)
Q Consensus       177 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~i~  256 (291)
                      ++..+...  ........-|..|+|||++.|.+.|+.+.||||.||++.|++..+..|...+.         .++++-|.
T Consensus       203 ARvee~d~--~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P---------iqQL~lIt  271 (449)
T KOG0664|consen  203 ARTWDQRD--RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP---------IEQLQMII  271 (449)
T ss_pred             ccccchhh--hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh---------HHHHHHHH
Confidence            98765421  12233445688899999999999999999999999999999999999998776         58999999


Q ss_pred             HhhCCCCcCChh
Q psy2172         257 SVMGFPLEKDWE  268 (291)
Q Consensus       257 ~~~~~~~~~~~~  268 (291)
                      ..++.|..+.+.
T Consensus       272 dLLGTPs~EaMr  283 (449)
T KOG0664|consen  272 DLLGTPSQEAMK  283 (449)
T ss_pred             HHhCCCcHHHHH
Confidence            999999886543

>KOG2052|consensus

Probab=100.00  E-value=9.4e-33  Score=230.16  Aligned_cols=198  Identities=28%  Similarity=0.403  Sum_probs=160.2

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcC--CCCCeeeEEEEEEeCC--CceEEEEEec
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLREL--KHPNVINLISVFLSHN--DRKVWLLFDY   99 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l--~h~~iv~~~~~~~~~~--~~~~~iv~e~   99 (291)
                      .+.||+|.||.||+|.|++    +.||||++.. .......+|.+|++..  +|+||+.+++.=.-++  -..+|+|++|
T Consensus       216 ~e~IGkGRyGEVwrG~wrG----e~VAVKiF~s-rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdY  290 (513)
T KOG2052|consen  216 QEIIGKGRFGEVWRGRWRG----EDVAVKIFSS-RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDY  290 (513)
T ss_pred             EEEecCccccceeeccccC----CceEEEEecc-cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeec
Confidence            5699999999999999976    5699999975 3466788899988875  9999999998753222  2369999999


Q ss_pred             CC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhh--------CCeeeeccCCCcEEeecCCCCCCcEE
Q psy2172         100 AE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHS--------NWVLHRDLKPANILVMGEGIERGRVK  170 (291)
Q Consensus       100 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~--------~~ivH~dik~~Nil~~~~~~~~~~~~  170 (291)
                      .+ |+|.+++....          ++.+.+.+++..++.||+|||.        -.|.|||||+.||++.    +++.+.
T Consensus       291 He~GSL~DyL~r~t----------v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK----kn~~C~  356 (513)
T KOG2052|consen  291 HEHGSLYDYLNRNT----------VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK----KNGTCC  356 (513)
T ss_pred             ccCCcHHHHHhhcc----------CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc----cCCcEE
Confidence            98 69999988643          8899999999999999999994        2499999999999998    788999


Q ss_pred             EeecccceecCCC-CCCCCCCCCceecccccccccccCCcC---C--CCchhHHHHHHHHHHHHc-----C-----CCCC
Q psy2172         171 IADMGFARLFNNP-LKPLADLDPVVVTFWYRAPELLLGARH---Y--TKAIDIWAIGCIFAELLT-----S-----EPIF  234 (291)
Q Consensus       171 l~Dfg~~~~~~~~-~~~~~~~~~~~g~~~y~aPE~~~~~~~---~--~~~~Dv~slG~~l~~l~~-----g-----~~pf  234 (291)
                      |+|+|+|...... ..-........||.+|||||++.+.-.   +  -..+||||||.++||++.     |     .+||
T Consensus       357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py  436 (513)
T KOG2052|consen  357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY  436 (513)
T ss_pred             EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence            9999999876654 223334567899999999999976421   1  145999999999999874     2     3777


Q ss_pred             CCCccc
Q psy2172         235 HCRQED  240 (291)
Q Consensus       235 ~~~~~~  240 (291)
                      .+..+.
T Consensus       437 yd~Vp~  442 (513)
T KOG2052|consen  437 YDVVPS  442 (513)
T ss_pred             ccCCCC
Confidence            765554

>KOG0587|consensus

Probab=100.00  E-value=8.5e-32  Score=240.48  Aligned_cols=248  Identities=24%  Similarity=0.428  Sum_probs=196.8

Q ss_pred             cccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC-CCChhHHHHHHHHhcC-CCCCeeeEEEEEEe---CCC
Q psy2172          16 VEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-GLSMSACREIALLREL-KHPNVINLISVFLS---HND   90 (291)
Q Consensus        16 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~---~~~   90 (291)
                      -++.|.+ -+.||+|-+|.||++..++  +++-.|+|+.... ...+++..|.++++.. .|||++.++++|.-   ..+
T Consensus        17 p~d~~ei-~evig~Gtygkv~k~k~~~--~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~   93 (953)
T KOG0587|consen   17 PADIFEI-IEVIGNGTYGKVYKGRHVK--TGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG   93 (953)
T ss_pred             CCCccEE-EEEEeeccceeEEEEeeee--cCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence            3456665 5699999999999999888  5566888887654 3455788899999988 69999999999853   466


Q ss_pred             ceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcE
Q psy2172          91 RKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRV  169 (291)
Q Consensus        91 ~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~  169 (291)
                      +.+|+|||||+| +..++++.....       .+.++.+..|++.++.|+.|||.+.++|+|||-.||+++    ..+.|
T Consensus        94 DqLWLVMEfC~gGSVTDLVKn~~g~-------rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT----~e~~V  162 (953)
T KOG0587|consen   94 DQLWLVMEFCGGGSVTDLVKNTKGN-------RLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLT----ENAEV  162 (953)
T ss_pred             CeEEEEeeccCCccHHHHHhhhccc-------chhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEe----ccCcE
Confidence            789999999985 777777765521       289999999999999999999999999999999999999    77899


Q ss_pred             EEeecccceecCCCCCCCCCCCCceecccccccccccCCc----CCCCchhHHHHHHHHHHHHcCCCCCCCCccc-----
Q psy2172         170 KIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGAR----HYTKAIDIWAIGCIFAELLTSEPIFHCRQED-----  240 (291)
Q Consensus       170 ~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~-----  240 (291)
                      ||+|||.+......   ..+..+..||+.|||||++.+.+    .|+.++|+||||++..||..|.+|+..--.-     
T Consensus       163 KLvDFGvSaQldsT---~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~  239 (953)
T KOG0587|consen  163 KLVDFGVSAQLDST---VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL  239 (953)
T ss_pred             EEeeeeeeeeeecc---cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc
Confidence            99999999876653   23445678999999999997643    4778999999999999999999999764321     


Q ss_pred             ------ccCCCC-CcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchh
Q psy2172         241 ------IKTSNP-YHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLL  280 (291)
Q Consensus       241 ------~~~~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  280 (291)
                            +....+ .-...+.+.+..+..-.-..+|...+++.||.+.
T Consensus       240 IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~  286 (953)
T KOG0587|consen  240 IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFIT  286 (953)
T ss_pred             CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence                  111111 1245566666666666667889999998888765

>KOG0670|consensus

Probab=100.00  E-value=1.2e-33  Score=239.42  Aligned_cols=209  Identities=27%  Similarity=0.505  Sum_probs=176.4

Q ss_pred             cccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-CChhHHHHHHHHhcCC------CCCeeeEEEE
Q psy2172          12 ERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-LSMSACREIALLRELK------HPNVINLISV   84 (291)
Q Consensus        12 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~------h~~iv~~~~~   84 (291)
                      ..+.++.+|.+.+ ..|+|-|++|..|.+..  .+..||||+|++.. ....=+.|++||++|+      -.|+++++..
T Consensus       426 igE~LD~RY~V~~-~~GkGvFs~Vvra~D~~--r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~  502 (752)
T KOG0670|consen  426 IGELLDSRYEVQG-YTGKGVFSTVVRARDQA--RGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRH  502 (752)
T ss_pred             hhhhhcceeEEEe-ccccceeeeeeeccccC--CCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHH
Confidence            4556778888766 89999999999999876  55689999998643 3345678999999995      2488899988


Q ss_pred             EEeCCCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCC
Q psy2172          85 FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGI  164 (291)
Q Consensus        85 ~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~  164 (291)
                      |.  -..++|+|+|-+.-+|.+++...+..-.      +....+..++.|++.||.+|-..||+|.||||+|||++.   
T Consensus       503 F~--hknHLClVFE~LslNLRevLKKyG~nvG------L~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE---  571 (752)
T KOG0670|consen  503 FK--HKNHLCLVFEPLSLNLREVLKKYGRNVG------LHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNE---  571 (752)
T ss_pred             hh--hcceeEEEehhhhchHHHHHHHhCcccc------eeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEecc---
Confidence            84  4679999999999999999987654322      777889999999999999999999999999999999985   


Q ss_pred             CCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc
Q psy2172         165 ERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED  240 (291)
Q Consensus       165 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~  240 (291)
                      ....+||||||.|.....+     ...+..-+..|.|||++.|.+ |+...|+||.||+|||+.+|...|.|...+
T Consensus       572 ~k~iLKLCDfGSA~~~~en-----eitPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN  641 (752)
T KOG0670|consen  572 SKNILKLCDFGSASFASEN-----EITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNN  641 (752)
T ss_pred             CcceeeeccCccccccccc-----cccHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcH
Confidence            5678999999999876553     334556677899999999966 999999999999999999999999999884

>KOG1290|consensus

Probab=99.98  E-value=3.3e-31  Score=223.17  Aligned_cols=133  Identities=29%  Similarity=0.517  Sum_probs=113.6

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-CChhHHHHHHHHhcCC-----C---CCeeeEEEEEEe-
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-LSMSACREIALLRELK-----H---PNVINLISVFLS-   87 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~-----h---~~iv~~~~~~~~-   87 (291)
                      ++|-+ .++||.|-|++||+|.+..  ..+.||+|+.+... ..+....|+++|++++     |   .+||++++.|.. 
T Consensus        78 gRY~v-~rKLGWGHFSTVWLawDtq--~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs  154 (590)
T KOG1290|consen   78 GRYHV-QRKLGWGHFSTVWLAWDTQ--NKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS  154 (590)
T ss_pred             ceEEE-EEeccccccceeEEEeecc--CCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence            45554 6799999999999999766  77899999998653 4456889999999983     2   379999999954 


Q ss_pred             -CCCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCeeeeccCCCcEEee
Q psy2172          88 -HNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHS-NWVLHRDLKPANILVM  160 (291)
Q Consensus        88 -~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~-~~ivH~dik~~Nil~~  160 (291)
                       .++.++|+|+|+++.+|+.++....-..       ++...+++|++|++.||.|||. .||+|.||||+|||+.
T Consensus       155 GpNG~HVCMVfEvLGdnLLklI~~s~YrG-------lpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  155 GPNGQHVCMVFEVLGDNLLKLIKYSNYRG-------LPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC  222 (590)
T ss_pred             CCCCcEEEEEehhhhhHHHHHHHHhCCCC-------CcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence             4677999999999999999998765432       8999999999999999999996 5999999999999994

>KOG3653|consensus

Probab=99.97  E-value=1.4e-31  Score=224.78  Aligned_cols=191  Identities=28%  Similarity=0.365  Sum_probs=157.8

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcC--CCCCeeeEEEEEEeC--CCceEEEEEec
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLREL--KHPNVINLISVFLSH--NDRKVWLLFDY   99 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l--~h~~iv~~~~~~~~~--~~~~~~iv~e~   99 (291)
                      .++||+|.||.||+|...+    +.||||+++.. ..+.+++|-.|++..  +|+||+++++.-...  +...+++|++|
T Consensus       215 ~eli~~Grfg~V~KaqL~~----~~VAVKifp~~-~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f  289 (534)
T KOG3653|consen  215 LELIGRGRFGCVWKAQLDN----RLVAVKIFPEQ-EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF  289 (534)
T ss_pred             HHHhhcCccceeehhhccC----ceeEEEecCHH-HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence            4689999999999998743    78999999753 466788888888876  799999999986322  24479999999


Q ss_pred             CC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhh---------CCeeeeccCCCcEEeecCCCCCCcE
Q psy2172         100 AE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHS---------NWVLHRDLKPANILVMGEGIERGRV  169 (291)
Q Consensus       100 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~---------~~ivH~dik~~Nil~~~~~~~~~~~  169 (291)
                      .+ |+|.+++..+.          ++.....+++..|++||+|||+         ..|+|||||+.|||+.    .+.+.
T Consensus       290 h~kGsL~dyL~~nt----------isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK----~DlTc  355 (534)
T KOG3653|consen  290 HPKGSLCDYLKANT----------ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVK----NDLTC  355 (534)
T ss_pred             ccCCcHHHHHHhcc----------ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEc----cCCcE
Confidence            97 79999998765          8999999999999999999996         3599999999999998    77899


Q ss_pred             EEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCC-----CchhHHHHHHHHHHHHcCCCCC
Q psy2172         170 KIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYT-----KAIDIWAIGCIFAELLTSEPIF  234 (291)
Q Consensus       170 ~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~-----~~~Dv~slG~~l~~l~~g~~pf  234 (291)
                      .|+|||+|..+... ..........||.+|||||++.+.-.+.     .+.||||+|.+||||++...-+
T Consensus       356 cIaDFGLAl~~~p~-~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~  424 (534)
T KOG3653|consen  356 CIADFGLALRLEPG-KPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA  424 (534)
T ss_pred             EeeccceeEEecCC-CCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence            99999999887743 3333444579999999999998753333     4689999999999999865444

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=5.9e-31  Score=215.25  Aligned_cols=227  Identities=35%  Similarity=0.555  Sum_probs=184.8

Q ss_pred             cceEEEEEEEccCCCCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecCCC-CHHH
Q psy2172          31 TYGHVYKARRKDNSDTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWH  106 (291)
Q Consensus        31 ~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~~~-~l~~  106 (291)
                      +||.||+|.+.+  +++.+++|++.....   ...+.+|++.+++++|+|++++++.+.  .....++++|++++ +|.+
T Consensus         1 ~~g~v~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~--~~~~~~l~~e~~~~~~L~~   76 (244)
T smart00220        1 SFGKVYLARDKK--TGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFE--DEDKLYLVMEYCDGGDLFD   76 (244)
T ss_pred             CceEEEEEEECC--CCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhhee--eCCEEEEEEeCCCCCCHHH
Confidence            589999999876  678899999976543   467889999999999999999999984  45789999999997 8887


Q ss_pred             HHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceecCCCCCC
Q psy2172         107 IIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKP  186 (291)
Q Consensus       107 ~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~~~~~~~  186 (291)
                      .+.....         ++...++.++.+++.++.+||+.+++|+||+|+||+++    ..+.++++|||.+.......  
T Consensus        77 ~~~~~~~---------~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~----~~~~~~l~d~~~~~~~~~~~--  141 (244)
T smart00220       77 LLKKRGR---------LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLD----EDGHVKLADFGLARQLDPGG--  141 (244)
T ss_pred             HHHhccC---------CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEEC----CCCcEEEccccceeeecccc--
Confidence            7764322         78889999999999999999999999999999999998    56799999999998765431  


Q ss_pred             CCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCC-ccc---------ccCCCCC---cHHHHH
Q psy2172         187 LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR-QED---------IKTSNPY---HHDQLD  253 (291)
Q Consensus       187 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~-~~~---------~~~~~~~---~~~~~~  253 (291)
                        ......++..|+|||.+.+.. ++.++|+||+|++++++++|..||... ...         .......   ....+.
T Consensus       142 --~~~~~~~~~~~~~pE~~~~~~-~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  218 (244)
T smart00220      142 --LLTTFVGTPEYMAPEVLLGKG-YGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAK  218 (244)
T ss_pred             --ccccccCCcCCCCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHH
Confidence              223455677899999997644 788999999999999999999999772 211         0001111   346788


Q ss_pred             HHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         254 RIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       254 ~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                      +++..+....|..||++.++..++++
T Consensus       219 ~~i~~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      219 DLIRKLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             HHHHHHccCCchhccCHHHHhhCCCC
Confidence            89999999999999999988877764

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.97  E-value=7.4e-31  Score=254.40  Aligned_cols=182  Identities=23%  Similarity=0.401  Sum_probs=146.0

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecCCC-
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-  102 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~~~-  102 (291)
                      ...||+|+||.||+|.++.  ++..||+|.+.....  ....|++.+++++||||+++++++.  +....++||||+++ 
T Consensus       695 ~~~ig~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~--~~~~~~~~l~~l~HpnIv~~~~~~~--~~~~~~lv~Ey~~~g  768 (968)
T PLN00113        695 ENVISRGKKGASYKGKSIK--NGMQFVVKEINDVNS--IPSSEIADMGKLQHPNIVKLIGLCR--SEKGAYLIHEYIEGK  768 (968)
T ss_pred             ccEEccCCCeeEEEEEECC--CCcEEEEEEccCCcc--ccHHHHHHHhhCCCCCcceEEEEEE--cCCCCEEEEeCCCCC
Confidence            4689999999999999866  668899999864322  2345688999999999999999994  45678999999984 


Q ss_pred             CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeeccCCCcEEeecCCCCCCcEEEeeccccee
Q psy2172         103 DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLH---SNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL  179 (291)
Q Consensus       103 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~  179 (291)
                      +|.+.+..            +++..+..++.|++.|++|||   +.+++|+||||+||+++    .....++. |+....
T Consensus       769 ~L~~~l~~------------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~----~~~~~~~~-~~~~~~  831 (968)
T PLN00113        769 NLSEVLRN------------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID----GKDEPHLR-LSLPGL  831 (968)
T ss_pred             cHHHHHhc------------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEEC----CCCceEEE-eccccc
Confidence            77777641            778889999999999999999   67999999999999998    34444443 444322


Q ss_pred             cCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCC
Q psy2172         180 FNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  236 (291)
Q Consensus       180 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~  236 (291)
                      ...       .....++..|+|||++.+.. ++.++|||||||++|||++|+.||..
T Consensus       832 ~~~-------~~~~~~t~~y~aPE~~~~~~-~~~~sDv~S~Gvvl~el~tg~~p~~~  880 (968)
T PLN00113        832 LCT-------DTKCFISSAYVAPETRETKD-ITEKSDIYGFGLILIELLTGKSPADA  880 (968)
T ss_pred             ccc-------CCCccccccccCcccccCCC-CCcccchhhHHHHHHHHHhCCCCCCc
Confidence            111       12235688999999988744 89999999999999999999999853

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=1e-31  Score=243.51  Aligned_cols=258  Identities=22%  Similarity=0.299  Sum_probs=166.5

Q ss_pred             cccccccceeCcccceEEEEEEEccC--CCCceeEEEEeCCCCCChhHHHHHHHHhcCCCCCeeeEEEEEE----eCCCc
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDN--SDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFL----SHNDR   91 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~--~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~~~~   91 (291)
                      +.|.+ .++||+|+||.||+|.+..+  ..+..||+|.+......+....+  .++...+.++..+...+.    .....
T Consensus       132 ~~y~l-~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~  208 (566)
T PLN03225        132 DDFVL-GKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKED  208 (566)
T ss_pred             CCeEE-eEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHH--HHHhhchhhHHHHHHhhhcccccccCC
Confidence            34553 67999999999999998762  11678999988654322222221  112222222222222211    14566


Q ss_pred             eEEEEEecCCC-CHHHHHHHhhhhh-----------hCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEe
Q psy2172          92 KVWLLFDYAEH-DLWHIIKFHRAAK-----------ANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILV  159 (291)
Q Consensus        92 ~~~iv~e~~~~-~l~~~~~~~~~~~-----------~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~  159 (291)
                      ..++|+||+++ +|.+++.......           ............+..++.|++.||+|||+++|+|+||||+|||+
T Consensus       209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl  288 (566)
T PLN03225        209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIF  288 (566)
T ss_pred             ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEE
Confidence            89999999985 7777765432100           00000012344577899999999999999999999999999999


Q ss_pred             ecCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCc---------------------CCCCchhHH
Q psy2172         160 MGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGAR---------------------HYTKAIDIW  218 (291)
Q Consensus       160 ~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---------------------~~~~~~Dv~  218 (291)
                      +.   ..+.++|+|||++........  .......+++.|+|||.+....                     .++.++|||
T Consensus       289 ~~---~~~~~KL~DFGlA~~l~~~~~--~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw  363 (566)
T PLN03225        289 SE---GSGSFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY  363 (566)
T ss_pred             eC---CCCcEEEEeCCCccccccccc--cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence            83   246899999999976543211  2223457788999999764321                     123456999


Q ss_pred             HHHHHHHHHHcCCCCCCCCcccc-----------c----CCCCCc--------------HHHHHHHHHhhCCCCcCChhh
Q psy2172         219 AIGCIFAELLTSEPIFHCRQEDI-----------K----TSNPYH--------------HDQLDRIFSVMGFPLEKDWED  269 (291)
Q Consensus       219 slG~~l~~l~~g~~pf~~~~~~~-----------~----~~~~~~--------------~~~~~~i~~~~~~~~~~~~~~  269 (291)
                      ||||+||+|+++..++.......           .    ...+..              .....+++..|....|..||+
T Consensus       364 SlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~t  443 (566)
T PLN03225        364 SAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRIS  443 (566)
T ss_pred             HHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCC
Confidence            99999999999876654321000           0    000000              011226899999999999999


Q ss_pred             hhcCCCCcchhhhh
Q psy2172         270 IRKMPEHPTLLKDF  283 (291)
Q Consensus       270 ~~~~~~~~~~~~~~  283 (291)
                      +.++..||++...-
T Consensus       444 a~e~L~Hpff~~~~  457 (566)
T PLN03225        444 AKAALAHPYFDREG  457 (566)
T ss_pred             HHHHhCCcCcCCCC
Confidence            99999999987543

>KOG0200|consensus

Probab=99.97  E-value=9.3e-31  Score=239.44  Aligned_cols=244  Identities=26%  Similarity=0.377  Sum_probs=189.5

Q ss_pred             cceeCcccceEEEEEEEccCCC-----CceeEEEEeCCCCCC---hhHHHHHHHHhcC-CCCCeeeEEEEEEeCCCceEE
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSD-----TRDYALKQIEGTGLS---MSACREIALLREL-KHPNVINLISVFLSHNDRKVW   94 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~-----~~~vaiK~~~~~~~~---~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~   94 (291)
                      ++.||.|+||.|++|.......     ...||||..+.....   ..+..|+++|+.+ +|+||+.+++++.  .....+
T Consensus       301 ~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t--~~~~~~  378 (609)
T KOG0200|consen  301 GKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACT--QDGPLY  378 (609)
T ss_pred             cceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeec--cCCceE
Confidence            5599999999999997553222     456999998765443   5688999999999 6999999999994  477899


Q ss_pred             EEEecCC-CCHHHHHHHhhhhhhCCCC-------CCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCC
Q psy2172          95 LLFDYAE-HDLWHIIKFHRAAKANKKP-------VMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIER  166 (291)
Q Consensus        95 iv~e~~~-~~l~~~~~~~~~~~~~~~~-------~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~  166 (291)
                      +|+||+. |+|.+++...+........       ..++...++.++.||+.|++||+++++|||||..+||++.    .+
T Consensus       379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~----~~  454 (609)
T KOG0200|consen  379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT----KN  454 (609)
T ss_pred             EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec----CC
Confidence            9999998 6999999887711111111       1388899999999999999999999999999999999998    67


Q ss_pred             CcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCc-------
Q psy2172         167 GRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQ-------  238 (291)
Q Consensus       167 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~-------  238 (291)
                      ..+||+|||+++................-...|+|||.+.. ..++.++||||+|++|||+++ |..||.+..       
T Consensus       455 ~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~  533 (609)
T KOG0200|consen  455 KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLE  533 (609)
T ss_pred             CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHH
Confidence            79999999999865543222211111113556999999988 559999999999999999998 899999733       


Q ss_pred             ---ccc-cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCC
Q psy2172         239 ---EDI-KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMP  274 (291)
Q Consensus       239 ---~~~-~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  274 (291)
                         ... ...+..+.+.+..++..++.-.|..||++.++.
T Consensus       534 ~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~  573 (609)
T KOG0200|consen  534 FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECV  573 (609)
T ss_pred             HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHH
Confidence               111 223334467788899999988998999887643

>KOG1025|consensus

Probab=99.97  E-value=1.3e-31  Score=237.82  Aligned_cols=233  Identities=23%  Similarity=0.314  Sum_probs=180.7

Q ss_pred             ccceeCcccceEEEEEEEccCC--CCceeEEEEeCCC---CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEE
Q psy2172          23 EGCKVGRGTYGHVYKARRKDNS--DTRDYALKQIEGT---GLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLF   97 (291)
Q Consensus        23 ~~~~ig~G~~g~Vy~~~~~~~~--~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~   97 (291)
                      .+++||+|+||+||+|.|.-.+  -.-+||+|++...   ....++..|+-+|..++|||+++++++...   +.+.+|+
T Consensus       700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~---s~~qlvt  776 (1177)
T KOG1025|consen  700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCML---STLQLVT  776 (1177)
T ss_pred             hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhccc---chHHHHH
Confidence            4789999999999999986432  2345889988643   345689999999999999999999999843   2378999


Q ss_pred             ecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeeccc
Q psy2172          98 DYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGF  176 (291)
Q Consensus        98 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~  176 (291)
                      +|++ |.|+++++.++..        +-.+..+.|..||++|+.|||++++|||||..+|+|+.    .-..+|+.|||+
T Consensus       777 q~mP~G~LlDyvr~hr~~--------igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVk----sP~hvkitdfgl  844 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREHRDN--------IGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVK----SPNHVKITDFGL  844 (1177)
T ss_pred             HhcccchHHHHHHHhhcc--------ccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeec----CCCeEEEEecch
Confidence            9998 6999999986653        78889999999999999999999999999999999998    667999999999


Q ss_pred             ceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc----------ccCCC
Q psy2172         177 ARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED----------IKTSN  245 (291)
Q Consensus       177 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~----------~~~~~  245 (291)
                      ++......... ......-.+.|+|-|.+... .++.++||||+||++||++| |..||.+...+          .....
T Consensus       845 a~ll~~d~~ey-~~~~gK~pikwmale~i~~~-~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqP  922 (1177)
T KOG1025|consen  845 AKLLAPDEKEY-SAPGGKVPIKWMALESIRIR-KYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQP  922 (1177)
T ss_pred             hhccCcccccc-cccccccCcHHHHHHHhhcc-CCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCC
Confidence            99876543322 22223336679999988774 49999999999999999987 99999887653          12233


Q ss_pred             CCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         246 PYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       246 ~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      +.+.-.+-.++-.+....+..+|.+++
T Consensus       923 piCtiDVy~~mvkCwmid~~~rp~fke  949 (1177)
T KOG1025|consen  923 PICTIDVYMVMVKCWMIDADSRPTFKE  949 (1177)
T ss_pred             CCccHHHHHHHHHHhccCcccCccHHH
Confidence            444444444444555555556666554

>KOG0668|consensus

Probab=99.97  E-value=1.4e-31  Score=205.84  Aligned_cols=214  Identities=26%  Similarity=0.556  Sum_probs=175.3

Q ss_pred             cccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCC-CCCeeeEEEEEEeCCCceEE
Q psy2172          16 VEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELK-HPNVINLISVFLSHNDRKVW   94 (291)
Q Consensus        16 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~   94 (291)
                      ..+.|.+ .+++|+|-++.||.|.+..  +.+.++||++++. ....+.+|+.||+.|. ||||+++++...++......
T Consensus        36 ~~ddYei-vrk~GRGKYSEVFeg~~~~--~~eK~ViKiLKPV-kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa  111 (338)
T KOG0668|consen   36 NQDDYEI-VRKVGRGKYSEVFEGINIT--NNEKCVIKILKPV-KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS  111 (338)
T ss_pred             ccchHHH-HHHHcCccHhhHhcccccC--CCceEEEeeechH-HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence            4455664 6799999999999999766  6788999998753 3567899999999996 99999999999888888899


Q ss_pred             EEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEee
Q psy2172          95 LLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIAD  173 (291)
Q Consensus        95 iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~D  173 (291)
                      +++||..+ +...+...            ++...++..+.++++||.|.|+.||.|+|+||.|++++.   ....++|+|
T Consensus       112 LiFE~v~n~Dfk~ly~t------------l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh---~~rkLrlID  176 (338)
T KOG0668|consen  112 LIFEYVNNTDFKQLYPT------------LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDH---ELRKLRLID  176 (338)
T ss_pred             hHhhhhccccHHHHhhh------------hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeech---hhceeeeee
Confidence            99999987 44443332            677789999999999999999999999999999999995   456899999


Q ss_pred             cccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCC-CCCcccccCCCCCcHHHH
Q psy2172         174 MGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF-HCRQEDIKTSNPYHHDQL  252 (291)
Q Consensus       174 fg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf-~~~~~~~~~~~~~~~~~~  252 (291)
                      +|+|.+......    -.....+..|--||.+...+.|+..-|+|||||++..|+..+.|| .|.+.         .+|+
T Consensus       177 WGLAEFYHp~~e----YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN---------~DQL  243 (338)
T KOG0668|consen  177 WGLAEFYHPGKE----YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN---------YDQL  243 (338)
T ss_pred             cchHhhcCCCce----eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCC---------HHHH
Confidence            999987765422    233455677899999988778999999999999999999876555 55554         4777


Q ss_pred             HHHHHhhCC
Q psy2172         253 DRIFSVMGF  261 (291)
Q Consensus       253 ~~i~~~~~~  261 (291)
                      ..|.+.++.
T Consensus       244 VkIakVLGt  252 (338)
T KOG0668|consen  244 VKIAKVLGT  252 (338)
T ss_pred             HHHHHHhCh
Confidence            777777753

>KOG0695|consensus

Probab=99.97  E-value=3.2e-31  Score=214.49  Aligned_cols=195  Identities=25%  Similarity=0.422  Sum_probs=164.9

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCCh-----hHHHHHHHHhcC-CCCCeeeEEEEEEeCCCceEEEEE
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM-----SACREIALLREL-KHPNVINLISVFLSHNDRKVWLLF   97 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~iv~   97 (291)
                      -.+||+|+|+.|.+++.+.  +.+.||+|+++++....     =.+.|-.+..+. +||.+|-++..|  +.+..++.|.
T Consensus       255 l~vigrgsyakvl~~~~~~--t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf--qtesrlffvi  330 (593)
T KOG0695|consen  255 LRVIGRGSYAKVLLVRLKK--TDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF--QTESRLFFVI  330 (593)
T ss_pred             eeeecCcchhhhhheehcc--cceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh--cccceEEEEE
Confidence            4599999999999999877  77899999997654332     256677777777 699999999999  7888999999


Q ss_pred             ecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeeccc
Q psy2172          98 DYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGF  176 (291)
Q Consensus        98 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~  176 (291)
                      ||.+| +|.-.++..+.         +|++.++.+...|+.||.|||++||+++|+|.+|++++    ..+++||+|+|+
T Consensus       331 eyv~ggdlmfhmqrqrk---------lpeeharfys~ei~lal~flh~rgiiyrdlkldnvlld----aeghikltdygm  397 (593)
T KOG0695|consen  331 EYVNGGDLMFHMQRQRK---------LPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLD----AEGHIKLTDYGM  397 (593)
T ss_pred             EEecCcceeeehhhhhc---------CcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEc----cCCceeecccch
Confidence            99986 66544443332         99999999999999999999999999999999999999    778999999999


Q ss_pred             ceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcc
Q psy2172         177 ARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE  239 (291)
Q Consensus       177 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~  239 (291)
                      ++.--.   ......+.+||+.|.|||++.+.. |....|.|+||++++||+.|+.||.....
T Consensus       398 cke~l~---~gd~tstfcgtpnyiapeilrgee-ygfsvdwwalgvlmfemmagrspfdivgm  456 (593)
T KOG0695|consen  398 CKEGLG---PGDTTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIVGM  456 (593)
T ss_pred             hhcCCC---CCcccccccCCCcccchhhhcccc-cCceehHHHHHHHHHHHHcCCCCcceecC
Confidence            874322   223446789999999999999865 99999999999999999999999986553

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=1.2e-29  Score=225.12  Aligned_cols=260  Identities=19%  Similarity=0.262  Sum_probs=172.7

Q ss_pred             ccccccccceeCcccceEEEEEEEccC--------------CCCceeEEEEeCCCCC----------------ChhHHHH
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDN--------------SDTRDYALKQIEGTGL----------------SMSACRE   66 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~--------------~~~~~vaiK~~~~~~~----------------~~~~~~e   66 (291)
                      .+.|++ .++||+|+||.||+|.+...              ..++.||||.+.....                .+....|
T Consensus       144 ~d~F~i-~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        144 SDDFQL-RDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             ccCceE-eeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            456774 67999999999999975221              2345799999864221                1223346


Q ss_pred             HHHHhcCCCCCe-----eeEEEEEEeC------CCceEEEEEecCCC-CHHHHHHHhhhh---------------hhCCC
Q psy2172          67 IALLRELKHPNV-----INLISVFLSH------NDRKVWLLFDYAEH-DLWHIIKFHRAA---------------KANKK  119 (291)
Q Consensus        67 ~~~l~~l~h~~i-----v~~~~~~~~~------~~~~~~iv~e~~~~-~l~~~~~~~~~~---------------~~~~~  119 (291)
                      +.++.+++|.++     +++++++...      .....++|+||+++ +|.+.+......               .....
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            667777766543     5666665321      23468999999985 787777542110               00001


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccc
Q psy2172         120 PVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY  199 (291)
Q Consensus       120 ~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y  199 (291)
                      ...++...++.++.|++.+|.+||+.+++|+||||+||+++    .+..++|+|||++........  .......+++.|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~----~~~~~kL~DFGla~~~~~~~~--~~~~~g~~tp~Y  376 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVT----VDGQVKIIDFGAAVDMCTGIN--FNPLYGMLDPRY  376 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEEC----CCCcEEEEeCcCccccccCCc--cCccccCCCcce
Confidence            11256778999999999999999999999999999999998    667899999999875443211  111223347889


Q ss_pred             cccccccCCcC---------------------CCCchhHHHHHHHHHHHHcCCC-CCCCCccc---c-------------
Q psy2172         200 RAPELLLGARH---------------------YTKAIDIWAIGCIFAELLTSEP-IFHCRQED---I-------------  241 (291)
Q Consensus       200 ~aPE~~~~~~~---------------------~~~~~Dv~slG~~l~~l~~g~~-pf~~~~~~---~-------------  241 (291)
                      +|||.+.....                     ...+.|+||+||++++|++|.. ||......   .             
T Consensus       377 ~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~  456 (507)
T PLN03224        377 SPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY  456 (507)
T ss_pred             eChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh
Confidence            99998753210                     1124799999999999999875 77532100   0             


Q ss_pred             ------cCCCCCcHHHHHHHHHhhCCCC---cCChhhhhcCCCCcchhhhh
Q psy2172         242 ------KTSNPYHHDQLDRIFSVMGFPL---EKDWEDIRKMPEHPTLLKDF  283 (291)
Q Consensus       242 ------~~~~~~~~~~~~~i~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  283 (291)
                            ........+...+++..+....   +..|.++.+...|||+..+|
T Consensus       457 ~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~~~  507 (507)
T PLN03224        457 KGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLPEF  507 (507)
T ss_pred             cccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCCCC
Confidence                  0001112344555666655543   36799999999999998775

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=3.1e-29  Score=203.04  Aligned_cols=195  Identities=39%  Similarity=0.653  Sum_probs=162.3

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCC---CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecC
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG---LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYA  100 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~  100 (291)
                      ++.||+|++|.||++.+.+  ++..+++|.+....   ....+.+|++.++.++|+|++++++.+  ......++++|++
T Consensus         4 ~~~i~~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~--~~~~~~~~v~e~~   79 (225)
T smart00221        4 GKKLGEGAFGKVYLARDKG--TGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVF--EDPEPLYLVMEYC   79 (225)
T ss_pred             eeEeecCCCeEEEEEEEcC--CCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeee--ecCCceEEEEecc
Confidence            5789999999999999865  56789999997653   345788899999999999999999998  4456889999999


Q ss_pred             CC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeeccccee
Q psy2172         101 EH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL  179 (291)
Q Consensus       101 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~  179 (291)
                      ++ +|.+.+......        +++..+..++.+++.++.+||+.+++|+|++|.||+++    ....++|+|||.+..
T Consensus        80 ~~~~L~~~~~~~~~~--------~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~----~~~~~~l~d~g~~~~  147 (225)
T smart00221       80 EGGDLFDYLRKKGGK--------LSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLG----MDGLVKLADFGLARF  147 (225)
T ss_pred             CCCCHHHHHHhcccC--------CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc----CCCCEEEeeCceeeE
Confidence            97 888777653321        67888999999999999999999999999999999998    568999999999987


Q ss_pred             cCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCC
Q psy2172         180 FNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  236 (291)
Q Consensus       180 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~  236 (291)
                      ......  .......++..|++||.+.....++.++|+|+||+++++|++|+.||..
T Consensus       148 ~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      148 IHRDLA--ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ecCccc--ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            654321  1223456677899999984323477899999999999999999999966

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0665|consensus

Probab=99.97  E-value=1e-30  Score=209.87  Aligned_cols=222  Identities=32%  Similarity=0.550  Sum_probs=183.0

Q ss_pred             ccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeC
Q psy2172          13 RTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT----GLSMSACREIALLRELKHPNVINLISVFLSH   88 (291)
Q Consensus        13 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   88 (291)
                      .+++..+|. .-..+|.|+- .|-.|.+.-  .+++||+|....+    ....++.+|..++..++|+||++++.+|..+
T Consensus        12 ~ftv~~Ry~-nL~p~~~g~~-~v~~a~D~v--~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~   87 (369)
T KOG0665|consen   12 TFTVPKRYV-NLKPIGSGAQ-IVVAAFDQV--LGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQ   87 (369)
T ss_pred             ceeeeeeee-eecccCCCCc-eEEecchhh--ccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCcc
Confidence            344555555 3568888888 777777544  7788999987543    2345688999999999999999999998532


Q ss_pred             ----CCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCC
Q psy2172          89 ----NDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGI  164 (291)
Q Consensus        89 ----~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~  164 (291)
                          .....|+|||++..+|.+.+...           ++-..+..++.|++.|++|||+.||+||||||+||++.    
T Consensus        88 ~~l~~~~e~y~v~e~m~~nl~~vi~~e-----------lDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~----  152 (369)
T KOG0665|consen   88 KTLEEFQEVYLVMELMDANLCQVILME-----------LDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVN----  152 (369)
T ss_pred             ccHHHHHhHHHHHHhhhhHHHHHHHHh-----------cchHHHHHHHHHHHHHHHHHHhcceeecccCcccceec----
Confidence                22468999999999999988822           67788999999999999999999999999999999998    


Q ss_pred             CCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccCC
Q psy2172         165 ERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS  244 (291)
Q Consensus       165 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~~  244 (291)
                      .+..+|+.|||++......    -..+....+..|.|||++.+-+ +...+||||+||++.||+.|...|.|...     
T Consensus       153 ~~~~lKi~dfg~ar~e~~~----~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~-----  222 (369)
T KOG0665|consen  153 SDCTLKILDFGLARTEDTD----FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDH-----  222 (369)
T ss_pred             chhheeeccchhhcccCcc----cccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchH-----
Confidence            6789999999999865442    2445677788999999999876 99999999999999999999999998766     


Q ss_pred             CCCcHHHHHHHHHhhCCCCcCCh
Q psy2172         245 NPYHHDQLDRIFSVMGFPLEKDW  267 (291)
Q Consensus       245 ~~~~~~~~~~i~~~~~~~~~~~~  267 (291)
                          .++...+++.++.|.+.-+
T Consensus       223 ----idQ~~ki~~~lgtpd~~F~  241 (369)
T KOG0665|consen  223 ----IDQWNKIIEQLGTPDPSFM  241 (369)
T ss_pred             ----HHHHHHHHHHhcCCCHHHH
Confidence                4788888888888887533

>KOG1163|consensus

Probab=99.96  E-value=9.2e-30  Score=197.16  Aligned_cols=216  Identities=19%  Similarity=0.234  Sum_probs=184.0

Q ss_pred             cccccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCC-CCeeeEEEEEEeC
Q psy2172          10 SNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKH-PNVINLISVFLSH   88 (291)
Q Consensus        10 ~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~   88 (291)
                      ......+.+.|.+ .++||+|+||.+|+|....  ++..||||.-++.....++..|..+++.|++ .+|+.+..++  .
T Consensus         7 s~~~~iv~gky~l-vrkiGsGSFGdIy~~~~i~--~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~--~   81 (341)
T KOG1163|consen    7 SLEELIVGGKYKL-VRKIGSGSFGDIYLGISIT--SGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYG--T   81 (341)
T ss_pred             chhhheeccceEE-EEeecCCchhheeeeeecc--CCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhc--c
Confidence            3445566677775 7899999999999999877  7889999999887778889999999999975 7888888887  6


Q ss_pred             CCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCc
Q psy2172          89 NDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGR  168 (291)
Q Consensus        89 ~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~  168 (291)
                      +..+-.+||+..+.+|.+++......        ++..+++-++-|++.-++|+|.++++|+||||+|++.+-+. ....
T Consensus        82 e~~ynvlVMdLLGPsLEdLfnfC~R~--------ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgr-h~~k  152 (341)
T KOG1163|consen   82 EKDYNVLVMDLLGPSLEDLFNFCSRR--------FTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGR-HCNK  152 (341)
T ss_pred             ccccceeeeeccCccHHHHHHHHhhh--------hhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeecccc-ccce
Confidence            67789999999999999999887654        88889999999999999999999999999999999998654 5678


Q ss_pred             EEEeecccceecCCC----CCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc
Q psy2172         169 VKIADMGFARLFNNP----LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED  240 (291)
Q Consensus       169 ~~l~Dfg~~~~~~~~----~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~  240 (291)
                      +.++|||+|+...+.    ..+........||..|.+-.++.+.. .+.+.|+-|+|.+|.++-.|..||.+-...
T Consensus       153 l~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglka~  227 (341)
T KOG1163|consen  153 LYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLKAA  227 (341)
T ss_pred             EEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccchh
Confidence            999999999987543    22233345568999999999888755 788999999999999999999999987654

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=3e-28  Score=194.69  Aligned_cols=208  Identities=36%  Similarity=0.624  Sum_probs=173.5

Q ss_pred             eCcccceEEEEEEEccCCCCceeEEEEeCCCCCC---hhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecCC-C
Q psy2172          27 VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS---MSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAE-H  102 (291)
Q Consensus        27 ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~~-~  102 (291)
                      ||+|++|.||++....  +++.+++|........   ..+.+|+..++.++|++++++++++  ......++++|+++ +
T Consensus         1 l~~g~~~~v~~~~~~~--~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~--~~~~~~~~~~e~~~~~   76 (215)
T cd00180           1 LGEGGFGTVYLARDKK--TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF--EDENHLYLVMEYCEGG   76 (215)
T ss_pred             CCcCCceEEEEEEecC--CCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeee--ecCCeEEEEEecCCCC
Confidence            6899999999999765  5788999999876553   6799999999999999999999999  44578999999999 5


Q ss_pred             CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCC-CCcEEEeecccceecC
Q psy2172         103 DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIE-RGRVKIADMGFARLFN  181 (291)
Q Consensus       103 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~-~~~~~l~Dfg~~~~~~  181 (291)
                      +|.+.+....        ..++...++.++.++++++++||+.|++|+||+|.||+++    . ...++|+|||.+....
T Consensus        77 ~l~~~~~~~~--------~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~----~~~~~~~l~d~~~~~~~~  144 (215)
T cd00180          77 SLKDLLKENE--------GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLD----SDNGKVKLADFGLSKLLT  144 (215)
T ss_pred             cHHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEe----CCCCcEEEecCCceEEcc
Confidence            8888776542        1278899999999999999999999999999999999998    5 6799999999998665


Q ss_pred             CCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccCCCCCcHHHHHHHHHhhCC
Q psy2172         182 NPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF  261 (291)
Q Consensus       182 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~  261 (291)
                      ....   ......+...|.+||........+.+.|+|++|++++++                      ..+.+++..+..
T Consensus       145 ~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------~~~~~~l~~~l~  199 (215)
T cd00180         145 SDKS---LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------PELKDLIRKMLQ  199 (215)
T ss_pred             CCcc---hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------HHHHHHHHHHhh
Confidence            4321   122345677899999987753578999999999999999                      457888888888


Q ss_pred             CCcCChhhhhcCCC
Q psy2172         262 PLEKDWEDIRKMPE  275 (291)
Q Consensus       262 ~~~~~~~~~~~~~~  275 (291)
                      +.|..+|++.++..
T Consensus       200 ~~p~~R~~~~~l~~  213 (215)
T cd00180         200 KDPEKRPSAKEILE  213 (215)
T ss_pred             CCcccCcCHHHHhh
Confidence            99999998776543

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1024|consensus

Probab=99.96  E-value=1.5e-29  Score=208.24  Aligned_cols=258  Identities=17%  Similarity=0.259  Sum_probs=198.8

Q ss_pred             ccccccceeCcccceEEEEEEEccCCC---CceeEEEEeCCCCCC---hhHHHHHHHHhcCCCCCeeeEEEEEEeCCCce
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSD---TRDYALKQIEGTGLS---MSACREIALLRELKHPNVINLISVFLSHNDRK   92 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~---~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (291)
                      +++. ..++-+|.||.||.|.|++..+   .+.+.+|.++.....   ..+..|...+..+.|||+..+.++..+ +...
T Consensus       285 Rv~l-~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie-~~~~  362 (563)
T KOG1024|consen  285 RVRL-SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE-DYAT  362 (563)
T ss_pred             heec-hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEee-ccCc
Confidence            4442 4578899999999998876322   234666766543322   247789999999999999999999874 5667


Q ss_pred             EEEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEE
Q psy2172          93 VWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI  171 (291)
Q Consensus        93 ~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l  171 (291)
                      .++++.+.+ |+|..++...+ +...+....++..++..++.|++.|++|||++|+||.||..+|.+++    +..++||
T Consensus       363 P~V~y~~~~~gNLK~FL~~Cr-~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvId----d~LqVkl  437 (563)
T KOG1024|consen  363 PFVLYPATGVGNLKSFLQICR-GDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVID----DQLQVKL  437 (563)
T ss_pred             ceEEEeccCcchHHHHHHHhc-cCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceeh----hheeEEe
Confidence            788889888 79998888766 44555666688999999999999999999999999999999999999    7789999


Q ss_pred             eecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc---------
Q psy2172         172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI---------  241 (291)
Q Consensus       172 ~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~---------  241 (291)
                      +|=.+++....... .+--........|++||.+.+.. |+.++|+||||++||||++ |..||...++..         
T Consensus       438 tDsaLSRDLFP~DY-hcLGDnEnRPvkWMslEal~n~~-yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGy  515 (563)
T KOG1024|consen  438 TDSALSRDLFPGDY-HCLGDNENRPVKWMSLEALQNSH-YSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGY  515 (563)
T ss_pred             ccchhccccCcccc-cccCCCCCCcccccCHHHHhhhh-hcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccc
Confidence            99999987654321 12222233466799999999855 9999999999999999987 899998766532         


Q ss_pred             -cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhhhhhccc
Q psy2172         242 -KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDFNEQIC  288 (291)
Q Consensus       242 -~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (291)
                       ...+-++.+++..++..+..-.|+++|++.++   ..-+.+|..+|.
T Consensus       516 RlaQP~NCPDeLf~vMacCWallpeeRPsf~Ql---v~cLseF~~qlt  560 (563)
T KOG1024|consen  516 RLAQPFNCPDELFTVMACCWALLPEERPSFSQL---VICLSEFHTQLT  560 (563)
T ss_pred             eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHH---HHHHHHHHHHHh
Confidence             12344567889999999999999999988763   223345555544

>KOG1167|consensus

Probab=99.96  E-value=1.4e-29  Score=210.13  Aligned_cols=208  Identities=28%  Similarity=0.453  Sum_probs=171.0

Q ss_pred             ccccccccccceeCcccceEEEEEEEcc-CCCCceeEEEEeCCCCCChhHHHHHHHHhcC-CCCCeeeEEEEEEeCCCce
Q psy2172          15 KVEDLFDYEGCKVGRGTYGHVYKARRKD-NSDTRDYALKQIEGTGLSMSACREIALLREL-KHPNVINLISVFLSHNDRK   92 (291)
Q Consensus        15 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~   92 (291)
                      .+.+.|.. .++||.|.|++||++.+.. ....+.||+|.+........+.+|+++|..+ .+.||+++.+.+  ...+.
T Consensus        33 ~~~~~~~~-v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~--rnnd~  109 (418)
T KOG1167|consen   33 FISNAYKV-VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCF--RNNDQ  109 (418)
T ss_pred             hhhhhhhh-hccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhh--ccCCe
Confidence            35556664 6799999999999998765 2356779999999888899999999999999 589999999999  77889


Q ss_pred             EEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEE
Q psy2172          93 VWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI  171 (291)
Q Consensus        93 ~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l  171 (291)
                      .++|+||+++ .-.++...            ++...+..+++.++.||+++|.+||||+||||+|++++.   ..+.-.|
T Consensus       110 v~ivlp~~~H~~f~~l~~~------------l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~---~t~rg~L  174 (418)
T KOG1167|consen  110 VAIVLPYFEHDRFRDLYRS------------LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNR---RTQRGVL  174 (418)
T ss_pred             eEEEecccCccCHHHHHhc------------CCHHHHHHHHHHHHHHhhhhhccCccccCCCcccccccc---ccCCceE
Confidence            9999999998 44444432            778889999999999999999999999999999999985   5678899


Q ss_pred             eecccceecCC-C------C-----CC-----------------------------CCCCCCceecccccccccccCCcC
Q psy2172         172 ADMGFARLFNN-P------L-----KP-----------------------------LADLDPVVVTFWYRAPELLLGARH  210 (291)
Q Consensus       172 ~Dfg~~~~~~~-~------~-----~~-----------------------------~~~~~~~~g~~~y~aPE~~~~~~~  210 (291)
                      +|||++..... .      .     ..                             ....-...||++|.|||++...+.
T Consensus       175 vDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~  254 (418)
T KOG1167|consen  175 VDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPR  254 (418)
T ss_pred             EechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccC
Confidence            99999982110 0      0     00                             000012478999999999998887


Q ss_pred             CCCchhHHHHHHHHHHHHcCCCCCCCCccc
Q psy2172         211 YTKAIDIWAIGCIFAELLTSEPIFHCRQED  240 (291)
Q Consensus       211 ~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~  240 (291)
                      .+.+.|+||.|+++..+++++.||-....+
T Consensus       255 QttaiDiws~GVI~Lslls~~~PFf~a~dd  284 (418)
T KOG1167|consen  255 QTTAIDIWSAGVILLSLLSRRYPFFKAKDD  284 (418)
T ss_pred             cCCccceeeccceeehhhccccccccCccc
Confidence            899999999999999999999999776665

>KOG1345|consensus

Probab=99.96  E-value=7.4e-30  Score=200.78  Aligned_cols=206  Identities=25%  Similarity=0.392  Sum_probs=164.1

Q ss_pred             cccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC-hhHHHHHHHHhcC-CCCCeeeEEEEEEeCC
Q psy2172          12 ERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS-MSACREIALLREL-KHPNVINLISVFLSHN   89 (291)
Q Consensus        12 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~   89 (291)
                      +..++.+.|.+ .+.+|.|.||.+-+|.++.  +...+|+|.+..+... .+|.+|...---| .|.||+.-|++.+ +.
T Consensus        18 ~kv~l~d~y~I-~k~lgeG~FgkIlL~eHr~--s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaF-qt   93 (378)
T KOG1345|consen   18 KKVDLEDVYTI-NKQLGEGRFGKILLAEHRQ--SKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAF-QT   93 (378)
T ss_pred             cccchhhhhhH-HHHhcccceeeEEeeeccC--CceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHh-hc
Confidence            34566778886 5699999999999999887  7788999999876544 5788887765556 5899999988765 45


Q ss_pred             CceEEEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCc
Q psy2172          90 DRKVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGR  168 (291)
Q Consensus        90 ~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~  168 (291)
                      .+.++.++||++ |+|.+-+...+          +-+.....++.|+++|+.|+|++++||||||.+|||+...  +..+
T Consensus        94 ~d~YvF~qE~aP~gdL~snv~~~G----------igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~--df~r  161 (378)
T KOG1345|consen   94 SDAYVFVQEFAPRGDLRSNVEAAG----------IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDA--DFYR  161 (378)
T ss_pred             CceEEEeeccCccchhhhhcCccc----------ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecC--CccE
Confidence            668899999998 68877666543          7788899999999999999999999999999999999765  3459


Q ss_pred             EEEeecccceecCCCCCCCCCCCCceecccccccccccCC----cCCCCchhHHHHHHHHHHHHcCCCCCCCCcc
Q psy2172         169 VKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGA----RHYTKAIDIWAIGCIFAELLTSEPIFHCRQE  239 (291)
Q Consensus       169 ~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~  239 (291)
                      +||||||.+...+....      ...-+..|.+||.....    -...+.+|+|.||++++.+++|.+||.....
T Consensus       162 vKlcDFG~t~k~g~tV~------~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~  230 (378)
T KOG1345|consen  162 VKLCDFGLTRKVGTTVK------YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI  230 (378)
T ss_pred             EEeeecccccccCceeh------hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc
Confidence            99999999876554221      12224558999986432    1356789999999999999999999986544

>KOG1165|consensus

Probab=99.96  E-value=6.5e-28  Score=194.88  Aligned_cols=209  Identities=19%  Similarity=0.294  Sum_probs=181.4

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCC-CCCeeeEEEEEEeCCCceEEEE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELK-HPNVINLISVFLSHNDRKVWLL   96 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~iv   96 (291)
                      -.|++ |++||.|+||.++.|.+.-  +++.||||..+......++.-|...++.|. .++|+.+|-+.  +.+.+-.+|
T Consensus        28 ~hyrV-GkKIGeGsFG~lf~G~Nl~--nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFG--qeG~~NiLV  102 (449)
T KOG1165|consen   28 PHYRV-GKKIGEGSFGVLFLGKNLY--NNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFG--QEGKYNILV  102 (449)
T ss_pred             cccee-ccccccCcceeeecccccc--cCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeec--cccchhhhh
Confidence            36674 9999999999999999766  789999999988888888999999999995 68999998777  778888999


Q ss_pred             EecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCC-CCCcEEEeecc
Q psy2172          97 FDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGI-ERGRVKIADMG  175 (291)
Q Consensus        97 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~-~~~~~~l~Dfg  175 (291)
                      +|..+.+|.+++..+...        |+..++..++.||+.-++++|++.+|.|||||+|+||+..+. ....+.++|||
T Consensus       103 idLLGPSLEDLFD~CgR~--------FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFG  174 (449)
T KOG1165|consen  103 IDLLGPSLEDLFDLCGRR--------FSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFG  174 (449)
T ss_pred             hhhhCcCHHHHHHHhcCc--------ccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEecc
Confidence            999999999999887654        999999999999999999999999999999999999985432 33578999999


Q ss_pred             cceecCCC----CCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc
Q psy2172         176 FARLFNNP----LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED  240 (291)
Q Consensus       176 ~~~~~~~~----~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~  240 (291)
                      +++....+    ..+........||.+||+...+.|.. .+.+.|+-|||-++.+.+.|..||.|-..+
T Consensus       175 mAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLKA~  242 (449)
T KOG1165|consen  175 MAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAD  242 (449)
T ss_pred             chhhhcCccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence            99987654    23344455678999999999998865 889999999999999999999999997764

>KOG1164|consensus

Probab=99.95  E-value=1.2e-26  Score=197.87  Aligned_cols=210  Identities=22%  Similarity=0.282  Sum_probs=167.6

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC--hhHHHHHHHHhcCC----CCCeeeEEEEEEeCCCce
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS--MSACREIALLRELK----HPNVINLISVFLSHNDRK   92 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~e~~~l~~l~----h~~iv~~~~~~~~~~~~~   92 (291)
                      .|.+ .++||+|+||.||.|.+.... ...+|+|........  ..+..|..++..+.    .++++.+++.+. ....+
T Consensus        19 ~~~i-~~~iG~G~fG~V~~v~~~~~~-~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~   95 (322)
T KOG1164|consen   19 RYKL-GKKIGEGGFGAVYLVSDKSEK-NKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDF   95 (322)
T ss_pred             ceEE-eeeccccCCceEEEEEecCCC-CeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCce
Confidence            6775 679999999999999987643 467999988654322  26888899999886    268999999884 35668


Q ss_pred             EEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCC-CCCCcEEE
Q psy2172          93 VWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEG-IERGRVKI  171 (291)
Q Consensus        93 ~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~-~~~~~~~l  171 (291)
                      .|+||+.++.+|.++.......       .++..++..++.|++.+|++||+.|++||||||.|+.++... .....+.+
T Consensus        96 ~~iVM~l~G~sL~dl~~~~~~~-------~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~l  168 (322)
T KOG1164|consen   96 NFIVMSLLGPSLEDLRKRNPPG-------RFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYL  168 (322)
T ss_pred             eEEEEeccCccHHHHHHhCCCC-------CcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEE
Confidence            9999999999999987655411       299999999999999999999999999999999999998543 12357999


Q ss_pred             eecccceecC--CCCC----CCCC-CCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcc
Q psy2172         172 ADMGFARLFN--NPLK----PLAD-LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE  239 (291)
Q Consensus       172 ~Dfg~~~~~~--~~~~----~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~  239 (291)
                      .|||+++...  ....    .... .....||..|+|+.++.+.. .+.+.|+||+++++.++..|..||.+...
T Consensus       169 lDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e-~~r~DDles~~Y~l~el~~g~LPW~~~~~  242 (322)
T KOG1164|consen  169 LDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE-QGRRDDLESLFYMLLELLKGSLPWEALEM  242 (322)
T ss_pred             EecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc-cCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence            9999998322  2111    1111 23456999999999998865 89999999999999999999999977653

>KOG0576|consensus

Probab=99.94  E-value=1.5e-27  Score=207.88  Aligned_cols=249  Identities=26%  Similarity=0.401  Sum_probs=192.7

Q ss_pred             ccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCC--CCCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCce
Q psy2172          15 KVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEG--TGLSMSACREIALLRELKHPNVINLISVFLSHNDRK   92 (291)
Q Consensus        15 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (291)
                      .-.+.|+. ..++|+|.+|.||+|+++.  +++..|+|.++-  .....-++.|+-+++.++|||||.+++.+.  ....
T Consensus        12 nP~ddyel-lqrvgsgTygdvyKaRd~~--s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsyl--r~dk   86 (829)
T KOG0576|consen   12 NPQDDYEL-LQRVGSGTYGDVYKARDKR--SGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYL--RRDK   86 (829)
T ss_pred             CCccchhh-eeeecCCcccchhhhcccc--cCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhh--hhcC
Confidence            34445553 5689999999999999877  778889998863  344556788999999999999999999994  4557


Q ss_pred             EEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          93 VWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        93 ~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      .|++||||+|+.++.+-.        ...++++.++..+.+..+++++|||+.|-+|||||-.||+++    +.+.+++.
T Consensus        87 lwicMEycgggslQdiy~--------~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanillt----d~gDvkla  154 (829)
T KOG0576|consen   87 LWICMEYCGGGSLQDIYH--------VTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLT----DEGDVKLA  154 (829)
T ss_pred             cEEEEEecCCCcccceee--------ecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeec----ccCceeec
Confidence            899999999754433322        222388999999999999999999999999999999999999    77899999


Q ss_pred             ecccceecCCCCCCCCCCCCceeccccccccccc--CCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcc----------c
Q psy2172         173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLL--GARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE----------D  240 (291)
Q Consensus       173 Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~----------~  240 (291)
                      |||.+-.+...   ..+.....||+.|+|||+..  ....|...+|+|++|.+..|+..-++|.-..-.          .
T Consensus       155 Dfgvsaqitat---i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~  231 (829)
T KOG0576|consen  155 DFGVSAQITAT---IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSG  231 (829)
T ss_pred             ccCchhhhhhh---hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccC
Confidence            99998765432   23345578999999999863  223489999999999999998877665432111          0


Q ss_pred             c---cCCCC-CcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhhh
Q psy2172         241 I---KTSNP-YHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF  283 (291)
Q Consensus       241 ~---~~~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (291)
                      +   ....+ .-.+.+-++++....-.|+.||+.+++..|+.....+
T Consensus       232 ~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~l  278 (829)
T KOG0576|consen  232 FQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQTL  278 (829)
T ss_pred             CCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccch
Confidence            0   00111 1246688899999999999999999998887766553

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.93  E-value=2.5e-26  Score=217.76  Aligned_cols=201  Identities=13%  Similarity=0.128  Sum_probs=141.6

Q ss_pred             cCCC-CCeeeEEEEEEe-----CCCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhC
Q psy2172          72 ELKH-PNVINLISVFLS-----HNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSN  145 (291)
Q Consensus        72 ~l~h-~~iv~~~~~~~~-----~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~  145 (291)
                      .++| +||++++++|-.     .....++.++|+++++|.+.+....        ..+++..++.++.||+.||.|||++
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~al~~lH~~   99 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPD--------RSVDAFECFHVFRQIVEIVNAAHSQ   99 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhccc--------ccccHHHHHHHHHHHHHHHHHHHhC
Confidence            3445 577777776611     1224678889999999998886321        1289999999999999999999999


Q ss_pred             CeeeeccCCCcEEeecCC---------------CCCCcEEEeecccceecCCCCC-------------CCCCCCCceecc
Q psy2172         146 WVLHRDLKPANILVMGEG---------------IERGRVKIADMGFARLFNNPLK-------------PLADLDPVVVTF  197 (291)
Q Consensus       146 ~ivH~dik~~Nil~~~~~---------------~~~~~~~l~Dfg~~~~~~~~~~-------------~~~~~~~~~g~~  197 (291)
                      ||+||||||+|||++..+               .....++++|||+++.......             .........||+
T Consensus       100 gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  179 (793)
T PLN00181        100 GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS  179 (793)
T ss_pred             CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence            999999999999996310               1344667777777754221000             000111245788


Q ss_pred             cccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc--------cCCCCCcHHHHHHHHHhhCCCCcCChhh
Q psy2172         198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI--------KTSNPYHHDQLDRIFSVMGFPLEKDWED  269 (291)
Q Consensus       198 ~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~--------~~~~~~~~~~~~~i~~~~~~~~~~~~~~  269 (291)
                      .|+|||++.+.. ++.++|||||||+||||++|.+|+.......        +............+...|..+.|..||+
T Consensus       180 ~Y~APE~~~~~~-~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps  258 (793)
T PLN00181        180 WYTSPEEDNGSS-SNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPS  258 (793)
T ss_pred             ceEChhhhccCC-CCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcC
Confidence            899999998755 8999999999999999999999987532110        0000011223445666778899999999


Q ss_pred             hhcCCCCcchhh
Q psy2172         270 IRKMPEHPTLLK  281 (291)
Q Consensus       270 ~~~~~~~~~~~~  281 (291)
                      +.++..+|++.+
T Consensus       259 ~~eil~h~~~~~  270 (793)
T PLN00181        259 MSELLQSEFINE  270 (793)
T ss_pred             hHHHhhchhhhh
Confidence            999999998754

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=8.1e-25  Score=186.72  Aligned_cols=169  Identities=19%  Similarity=0.184  Sum_probs=123.0

Q ss_pred             ccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-------CChhHHHHHHHHhcCCCCCeeeEEEEE
Q psy2172          13 RTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-------LSMSACREIALLRELKHPNVINLISVF   85 (291)
Q Consensus        13 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~   85 (291)
                      ...+.+.|++ ++.||+|+||.||+|.++.. +++.+|||.+....       ....+.+|+++|++++|+|++..+..+
T Consensus        13 ~~~~~~~Y~~-~~~IG~G~fg~Vy~a~~~~~-~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~   90 (365)
T PRK09188         13 IPALSARFVE-TAVLKRDVFSTVERGYFAGD-PGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT   90 (365)
T ss_pred             cccccCCceE-ccEEeecCcEEEEEEEEcCC-CCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc
Confidence            3456677885 77999999999999987642 34568999865321       123588999999999999988533222


Q ss_pred             EeCCCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeecc-CCCcEEeecCCC
Q psy2172          86 LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDL-KPANILVMGEGI  164 (291)
Q Consensus        86 ~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~di-k~~Nil~~~~~~  164 (291)
                           ...|+||||++|..+....  .          ..   ...++.|++.+|.+||++||+|+|| ||+||+++    
T Consensus        91 -----~~~~LVmE~~~G~~L~~~~--~----------~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~----  146 (365)
T PRK09188         91 -----GKDGLVRGWTEGVPLHLAR--P----------HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMG----  146 (365)
T ss_pred             -----CCcEEEEEccCCCCHHHhC--c----------cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEc----
Confidence                 2469999999874333211  0          11   1457889999999999999999999 99999997    


Q ss_pred             CCCcEEEeecccceecCCCCCCCC-----CCCCceecccccccccccC
Q psy2172         165 ERGRVKIADMGFARLFNNPLKPLA-----DLDPVVVTFWYRAPELLLG  207 (291)
Q Consensus       165 ~~~~~~l~Dfg~~~~~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~  207 (291)
                      .++.++|+|||+++..........     ......++..|.|||.+..
T Consensus       147 ~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        147 PDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             CCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            557899999999997755321111     1134566778999998754

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=1.7e-23  Score=166.68  Aligned_cols=172  Identities=17%  Similarity=0.166  Sum_probs=126.0

Q ss_pred             ccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCCh-h----------HHHHHHHHhcCCCCCeeeE
Q psy2172          13 RTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM-S----------ACREIALLRELKHPNVINL   81 (291)
Q Consensus        13 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~-~----------~~~e~~~l~~l~h~~iv~~   81 (291)
                      ..-++++|+. .+++|.|+||.||++..    ++..+|+|.+....... .          +.+|+..+.++.|++|+.+
T Consensus        26 ~~~l~~~y~~-~~~l~~~~f~~v~l~~~----~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~  100 (232)
T PRK10359         26 DDFLSYNIKT-IKVFRNIDDTKVSLIDT----DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASL  100 (232)
T ss_pred             HHHhhCceEE-EEEecCCCceEEEEEec----CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcc
Confidence            3456788885 67999999999999754    24469999997442221 1          5789999999999999999


Q ss_pred             EEEEEeCC------CceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCC
Q psy2172          82 ISVFLSHN------DRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKP  154 (291)
Q Consensus        82 ~~~~~~~~------~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~  154 (291)
                      .+++....      ....+++|||++| +|.+...             +++    ....+++.++..+|+.|++|+|++|
T Consensus       101 ~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp  163 (232)
T PRK10359        101 NDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-------------ISE----DVKAKIKASIESLHQHGMVSGDPHK  163 (232)
T ss_pred             eEeeeecccccccccCCeEEEEEEECCccHHHhhh-------------ccH----HHHHHHHHHHHHHHHcCCccCCCCh
Confidence            99875432      2358999999998 6654421             333    2456899999999999999999999


Q ss_pred             CcEEeecCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccc-cccCCcCCCCchhHHHHHHHHHHHH
Q psy2172         155 ANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPE-LLLGARHYTKAIDIWAIGCIFAELL  228 (291)
Q Consensus       155 ~Nil~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE-~~~~~~~~~~~~Dv~slG~~l~~l~  228 (291)
                      +||+++    +++ ++++|||.........                |-+ .... ..+..++|+||||+++....
T Consensus       164 ~Nili~----~~g-i~liDfg~~~~~~e~~----------------a~d~~vle-r~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        164 GNFIVS----KNG-LRIIDLSGKRCTAQRK----------------AKDRIDLE-RHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             HHEEEe----CCC-EEEEECCCcccccchh----------------hHHHHHHH-hHhcccccccceeEeehHHH
Confidence            999998    455 9999999876432210                111 1222 33668899999999876543

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.88  E-value=1.2e-22  Score=159.87  Aligned_cols=135  Identities=19%  Similarity=0.283  Sum_probs=101.6

Q ss_pred             ceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC-----------hh-----------------HHHHHHHHhcCCCC
Q psy2172          25 CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS-----------MS-----------------ACREIALLRELKHP   76 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----------~~-----------------~~~e~~~l~~l~h~   76 (291)
                      +.||+|++|.||+|.+.   +++.||+|+++.....           ..                 ..+|++++.++.++
T Consensus         3 ~~ig~G~~~~Vy~a~~~---~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05147           3 GCISTGKEANVYHATTA---NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTA   79 (190)
T ss_pred             CccccccceEEEEEECC---CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHC
Confidence            48999999999999874   5788999998643210           11                 23489999999877


Q ss_pred             CeeeEEEEEEeCCCceEEEEEecCCCCHH-HHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHH-hhCCeeeeccCC
Q psy2172          77 NVINLISVFLSHNDRKVWLLFDYAEHDLW-HIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYL-HSNWVLHRDLKP  154 (291)
Q Consensus        77 ~iv~~~~~~~~~~~~~~~iv~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~L-H~~~ivH~dik~  154 (291)
                      ++........  ..  .++||||++|+.. .......         .++...+..++.|++.+|.++ |+.||+|+||||
T Consensus        80 ~v~~p~~~~~--~~--~~iVmE~i~g~~l~~~~~~~~---------~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP  146 (190)
T cd05147          80 GIPCPEPILL--KS--HVLVMEFIGDDGWAAPRLKDA---------PLSESKARELYLQVIQIMRILYQDCRLVHADLSE  146 (190)
T ss_pred             CCCCCcEEEe--cC--CEEEEEEeCCCCCcchhhhcC---------CCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCH
Confidence            7644433321  11  2899999997432 2221111         288899999999999999999 799999999999


Q ss_pred             CcEEeecCCCCCCcEEEeecccceec
Q psy2172         155 ANILVMGEGIERGRVKIADMGFARLF  180 (291)
Q Consensus       155 ~Nil~~~~~~~~~~~~l~Dfg~~~~~  180 (291)
                      +||+++    . +.++|+|||++...
T Consensus       147 ~NIli~----~-~~v~LiDFG~a~~~  167 (190)
T cd05147         147 YNLLYH----D-GKLYIIDVSQSVEH  167 (190)
T ss_pred             HHEEEE----C-CcEEEEEccccccC
Confidence            999997    2 57999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.88  E-value=7.4e-21  Score=162.19  Aligned_cols=199  Identities=34%  Similarity=0.536  Sum_probs=159.7

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC-----ChhHHHHHHHHhcCCCC-CeeeEEEEEEeCCCceEEEEE
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-----SMSACREIALLRELKHP-NVINLISVFLSHNDRKVWLLF   97 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~~~iv~   97 (291)
                      .+.||.|+||.||.+.+.     ..+++|.+.....     ...+.+|+.+++.+.|+ +++++.+.+  ......++++
T Consensus         5 ~~~l~~g~~~~v~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~   77 (384)
T COG0515           5 LRKLGEGSFGEVYLARDR-----KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF--QDEGSLYLVM   77 (384)
T ss_pred             EEeecCCCCeEEEEEEec-----cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEE--ecCCEEEEEE
Confidence            568999999999999975     5689998865432     44688999999999988 799999999  4455589999


Q ss_pred             ecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCC-cEEEeecc
Q psy2172          98 DYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERG-RVKIADMG  175 (291)
Q Consensus        98 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~-~~~l~Dfg  175 (291)
                      +++.+ .+.+.+......      ..++......++.|++.++.++|+.+++|+|+||+||+++    ... .++++|||
T Consensus        78 ~~~~~~~l~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~----~~~~~~~l~dfg  147 (384)
T COG0515          78 EYVDGGSLEDLLKKIGRK------GPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLD----RDGRVVKLIDFG  147 (384)
T ss_pred             ecCCCCcHHHHHHhcccc------cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec----CCCCeEEEeccC
Confidence            99986 555343332211      1288899999999999999999999999999999999998    445 79999999


Q ss_pred             cceecCCCCCCCC---CCCCceecccccccccccCC--cCCCCchhHHHHHHHHHHHHcCCCCCCCCcc
Q psy2172         176 FARLFNNPLKPLA---DLDPVVVTFWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQE  239 (291)
Q Consensus       176 ~~~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~--~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~  239 (291)
                      .+...........   ......|+..|+|||.+.+.  ...+...|+||+|+++++++.|..||.....
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~  216 (384)
T COG0515         148 LAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN  216 (384)
T ss_pred             cceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCc
Confidence            9985544322211   34567889999999999873  3588999999999999999999999877653

>KOG1166|consensus

Probab=99.87  E-value=3.4e-22  Score=185.38  Aligned_cols=245  Identities=20%  Similarity=0.286  Sum_probs=172.9

Q ss_pred             ccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCC---CCCeeeEEEEEEeCCCceE
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELK---HPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~~   93 (291)
                      .+.|.| .+.||+|+||.||.|...+   ++.||+|+-+.. ..-++.-..+++.+|+   -+.|..+...++-.+.  -
T Consensus       697 ~~~~~I-~~e~G~g~y~~vy~a~~~~---~~~~alK~e~P~-~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~--S  769 (974)
T KOG1166|consen  697 GEKFCI-SKEIGEGSYGSVYVATHSN---GKLVALKVEKPP-NPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNA--S  769 (974)
T ss_pred             ceeEEE-EeeeccccceEEEEeecCC---CcEEEEEeecCC-CceeeeehHHHHHhhchhhhcchHHHHHHHccCCc--c
Confidence            345554 5699999999999999754   788999987653 4555555567777777   2344444444433443  4


Q ss_pred             EEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecC---CCCCCcE
Q psy2172          94 WLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGE---GIERGRV  169 (291)
Q Consensus        94 ~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~---~~~~~~~  169 (291)
                      ++|++|.+ |+|++++.....         +++..+..++.||+..+++||..+||||||||+|+++...   +....-+
T Consensus       770 ~lv~ey~~~Gtlld~~N~~~~---------m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l  840 (974)
T KOG1166|consen  770 VLVSEYSPYGTLLDLINTNKV---------MDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGL  840 (974)
T ss_pred             eeeeeccccccHHHhhccCCC---------CCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccce
Confidence            88999998 799999883222         7888899999999999999999999999999999999742   2234578


Q ss_pred             EEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCC--CCCcccccC--CC
Q psy2172         170 KIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF--HCRQEDIKT--SN  245 (291)
Q Consensus       170 ~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf--~~~~~~~~~--~~  245 (291)
                      +|+|||.+..+.--.. .......++|..+-.+|+..|.+ ++...|.|.++.+++.|+.|+..=  .+.......  .+
T Consensus       841 ~lIDfG~siDm~lfp~-~~~F~~~~~td~f~C~EM~~grp-WtYq~DyfGlAa~~h~mLFG~y~q~~~g~~~~~~~~~~R  918 (974)
T KOG1166|consen  841 YLIDFGRSIDMKLFPD-GTKFKAVWHTDLFDCIEMREGRP-WTYQIDYFGLAATVHVMLFGKYMEVKNGSSWMVKTNFPR  918 (974)
T ss_pred             EEEecccceeeeEcCC-CcEEeeeeccccchhHHHhcCCC-CchhhhhHHHHHHHHHHHHHHHHHhcCCcceeccccchh
Confidence            9999999987653211 23445667889999999999855 999999999999999999997332  121111111  22


Q ss_pred             CCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhhhhh
Q psy2172         246 PYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDFNE  285 (291)
Q Consensus       246 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (291)
                      ....+.=.+++..+..      |+.+.+|....+...|++
T Consensus       919 y~~~~~W~~~F~~lLN------~~~~~~p~l~~lr~~~~~  952 (974)
T KOG1166|consen  919 YWKRDMWNKFFDLLLN------PDCDTLPNLQELRTELEE  952 (974)
T ss_pred             hhhHHHHHHHHHHHhC------cCcccchhHHHHHHHHHH
Confidence            2234555667777665      334444444445555444

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.87  E-value=9.5e-22  Score=153.46  Aligned_cols=150  Identities=21%  Similarity=0.247  Sum_probs=114.3

Q ss_pred             CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceecC
Q psy2172         102 HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFN  181 (291)
Q Consensus       102 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~~  181 (291)
                      |+|.+.+.....        .+++..++.++.|++.||+|||+++      ||+||+++    .++.+++  ||.+....
T Consensus         1 GsL~~~l~~~~~--------~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~----~~~~~~~--fG~~~~~~   60 (176)
T smart00750        1 VSLADILEVRGR--------PLNEEEIWAVCLQCLRALRELHRQA------KSGNILLT----WDGLLKL--DGSVAFKT   60 (176)
T ss_pred             CcHHHHHHHhCC--------CCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEc----Cccceee--ccceEeec
Confidence            466776654321        2899999999999999999999998      99999998    6678888  99987654


Q ss_pred             CCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc----------cCC-------
Q psy2172         182 NPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI----------KTS-------  244 (291)
Q Consensus       182 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~----------~~~-------  244 (291)
                      ..        ...|++.|+|||++.+.. ++.++|||||||++|+|++|..||.......          ...       
T Consensus        61 ~~--------~~~g~~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  131 (176)
T smart00750       61 PE--------QSRVDPYFMAPEVIQGQS-YTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSN  131 (176)
T ss_pred             cc--------cCCCcccccChHHhcCCC-CcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCcccccc
Confidence            32        125789999999998755 8899999999999999999999997543210          000       


Q ss_pred             CCCcHH--HHHHHHHhhCCCCcCChhhhhcCCCCcchh
Q psy2172         245 NPYHHD--QLDRIFSVMGFPLEKDWEDIRKMPEHPTLL  280 (291)
Q Consensus       245 ~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  280 (291)
                      .....+  .+.+++..+....|..||++.++..+++..
T Consensus       132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            000111  477788888888888899888877666544

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.87  E-value=2.6e-21  Score=158.70  Aligned_cols=229  Identities=18%  Similarity=0.214  Sum_probs=142.2

Q ss_pred             ccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC-----ChhHHHHHHHHhcCC----------CCCeeeEEEEEE-
Q psy2172          23 EGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-----SMSACREIALLRELK----------HPNVINLISVFL-   86 (291)
Q Consensus        23 ~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~----------h~~iv~~~~~~~-   86 (291)
                      .++.||.|+++.||.+.+..  +++.+++|+......     ...+.+|.-....+.          |-.++..++... 
T Consensus        16 ~~~~i~~g~~~~v~~v~d~~--t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   16 RGRIIGKGGFSIVFEVTDVE--TGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEETTEEEEEEEETT--TTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EccccccCCceEEEEEEEcc--CCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            48899999999999999877  789999998853321     123444443333322          112333333221 


Q ss_pred             -------e--CCCc-----eEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeecc
Q psy2172          87 -------S--HNDR-----KVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDL  152 (291)
Q Consensus        87 -------~--~~~~-----~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~di  152 (291)
                             .  .+..     ..+++|+-+.++|..++.........  ...+.......+..|+++.+++||..|+||+||
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~--~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi  171 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQT--HSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI  171 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTT--SHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred             cCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccc--cchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence                   0  1111     24678888889998887765544322  111334455666789999999999999999999


Q ss_pred             CCCcEEeecCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCC-------cCCCCchhHHHHHHHHH
Q psy2172         153 KPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGA-------RHYTKAIDIWAIGCIFA  225 (291)
Q Consensus       153 k~~Nil~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-------~~~~~~~Dv~slG~~l~  225 (291)
                      +|+|++++    .++.+.|+||+.....+.....      ...+..|.|||.....       -.++.+.|.|+||+++|
T Consensus       172 ~~~nfll~----~~G~v~Lg~F~~~~r~g~~~~~------~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly  241 (288)
T PF14531_consen  172 KPENFLLD----QDGGVFLGDFSSLVRAGTRYRC------SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLY  241 (288)
T ss_dssp             SGGGEEE-----TTS-EEE--GGGEEETTEEEEG------GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHH
T ss_pred             ceeeEEEc----CCCCEEEcChHHHeecCceeec------cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHH
Confidence            99999999    7899999999988765542111      2234668999976432       13788999999999999


Q ss_pred             HHHcCCCCCCCCccc------ccCCCCCcHHHHHHHHHhhCCCCcCC
Q psy2172         226 ELLTSEPIFHCRQED------IKTSNPYHHDQLDRIFSVMGFPLEKD  266 (291)
Q Consensus       226 ~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~i~~~~~~~~~~~  266 (291)
                      .|++|+.||......      ..... ...+.++.++..+..+.+.+
T Consensus       242 ~lWC~~lPf~~~~~~~~~~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~  287 (288)
T PF14531_consen  242 SLWCGRLPFGLSSPEADPEWDFSRCR-DMPEPVQFLIRGLLQRNPED  287 (288)
T ss_dssp             HHHHSS-STCCCGGGSTSGGGGTTSS----HHHHHHHHHHT-SSGGG
T ss_pred             HHHHccCCCCCCCccccccccchhcC-CcCHHHHHHHHHHccCCccc
Confidence            999999999865543      22233 33556666777666655543

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.87  E-value=3.3e-21  Score=152.10  Aligned_cols=137  Identities=23%  Similarity=0.230  Sum_probs=104.5

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC----------------------------hhHHHHHHHHhcCCC
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----------------------------MSACREIALLRELKH   75 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----------------------------~~~~~e~~~l~~l~h   75 (291)
                      ...||+|++|.||+|.+.   +++.||||+++.....                            .....|...+.++.+
T Consensus         2 ~~~ig~G~~~~Vy~a~~~---~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~   78 (190)
T cd05145           2 NGCISTGKEANVYHARTG---DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYE   78 (190)
T ss_pred             CceeecCCCcEEEEEEcC---CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHh
Confidence            358999999999999864   5788999998754210                            113578899999999


Q ss_pred             CCeeeEEEEEEeCCCceEEEEEecCCCC-HHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCeeeeccC
Q psy2172          76 PNVINLISVFLSHNDRKVWLLFDYAEHD-LWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHS-NWVLHRDLK  153 (291)
Q Consensus        76 ~~iv~~~~~~~~~~~~~~~iv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~-~~ivH~dik  153 (291)
                      +++.....+...  .  .++||||++|. +........         .++...+..++.|++.++.++|+ .||+|+|||
T Consensus        79 ~~i~~p~~~~~~--~--~~lVmE~~~g~~~~~~~l~~~---------~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlk  145 (190)
T cd05145          79 AGVPVPEPILLK--K--NVLVMEFIGDDGSPAPRLKDV---------PLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLS  145 (190)
T ss_pred             CCCCCceEEEec--C--CEEEEEEecCCCchhhhhhhc---------cCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCC
Confidence            887555544422  2  38999999975 322211111         17788899999999999999999 999999999


Q ss_pred             CCcEEeecCCCCCCcEEEeecccceecC
Q psy2172         154 PANILVMGEGIERGRVKIADMGFARLFN  181 (291)
Q Consensus       154 ~~Nil~~~~~~~~~~~~l~Dfg~~~~~~  181 (291)
                      |+||+++     ++.++|+|||++....
T Consensus       146 P~NIll~-----~~~~~liDFG~a~~~~  168 (190)
T cd05145         146 EYNILYH-----DGKPYIIDVSQAVELD  168 (190)
T ss_pred             hhhEEEE-----CCCEEEEEcccceecC
Confidence            9999997     2579999999997544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.86  E-value=3.1e-21  Score=150.66  Aligned_cols=188  Identities=20%  Similarity=0.128  Sum_probs=132.1

Q ss_pred             ccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC-Ch-----hHHHHHHHHhcCC-CCCeeeEEEEEEeCCCceEEE
Q psy2172          23 EGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-SM-----SACREIALLRELK-HPNVINLISVFLSHNDRKVWL   95 (291)
Q Consensus        23 ~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~-----~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~i   95 (291)
                      .+..|++|+||+||.+..    .+..++.+.+..... ..     .+.+|+++|++|+ ++++++++++.      ..++
T Consensus         6 ~~~~l~~~~f~~v~~~~~----~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~------~~~l   75 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG----GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD------GRHL   75 (218)
T ss_pred             cceeecCCCcceEEEeec----CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc------CEEE
Confidence            467999999999997753    456788777654322 12     4788999999995 58899998863      3599


Q ss_pred             EEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeecc-CCCcEEeecCCCCCCcEEEeec
Q psy2172          96 LFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDL-KPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        96 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~di-k~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      +|+|+.|..+...              .+.. ...++.|++.+|.++|++||+|+|| ||+||+++    .++.++|+||
T Consensus        76 vmeyI~G~~L~~~--------------~~~~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~----~~g~i~LIDF  136 (218)
T PRK12274         76 DRSYLAGAAMYQR--------------PPRG-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQ----EDGSPAVIDF  136 (218)
T ss_pred             EEeeecCccHHhh--------------hhhh-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEc----CCCCEEEEEC
Confidence            9999988433211              1111 1346789999999999999999999 79999998    5678999999


Q ss_pred             ccceecCCCCCC----C-CC-----CCCceecccccccccccCCcCCC-CchhHHHHHHHHHHHHcCCCCCCCCcc
Q psy2172         175 GFARLFNNPLKP----L-AD-----LDPVVVTFWYRAPELLLGARHYT-KAIDIWAIGCIFAELLTSEPIFHCRQE  239 (291)
Q Consensus       175 g~~~~~~~~~~~----~-~~-----~~~~~g~~~y~aPE~~~~~~~~~-~~~Dv~slG~~l~~l~~g~~pf~~~~~  239 (291)
                      |++.........    . ..     ......++.+.+|+...--...+ .+.+.++.|+-+|.++|++.|+-+..+
T Consensus       137 G~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~  212 (218)
T PRK12274        137 QLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE  212 (218)
T ss_pred             CCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence            999854432110    0 00     00112355566665433211133 567889999999999999988876654

>KOG0590|consensus

Probab=99.86  E-value=3.3e-22  Score=181.42  Aligned_cols=247  Identities=24%  Similarity=0.377  Sum_probs=181.0

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeC----CCCCCh----hHHHHHHHHhcCCCCCeeeEEEEEEeCC
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIE----GTGLSM----SACREIALLRELKHPNVINLISVFLSHN   89 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~----~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~   89 (291)
                      +.|--.+.++|.|++|.|+.+....  ....++.|..+    ......    .+..|..+-..+.|||++.....+.  +
T Consensus       317 ~~y~~~~~~~g~ga~g~~~~~~~~~--~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~--~  392 (601)
T KOG0590|consen  317 EKYGKPGRVLGSGAYGSVRIAKRRS--DLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQ--E  392 (601)
T ss_pred             cccCCccceeeecccCceEEEEecC--CCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHh--h
Confidence            3343457799999999888777554  23334444332    111111    1455666777789999977776663  2


Q ss_pred             CceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcE
Q psy2172          90 DRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRV  169 (291)
Q Consensus        90 ~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~  169 (291)
                      .....-.||||+++|..++.....         +....+-.++.|++.|++|+|+.|+.|+|+|++|+++.    ..+.+
T Consensus       393 ~~~~~~~mE~~~~Dlf~~~~~~~~---------~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~----~~g~l  459 (601)
T KOG0590|consen  393 IDGILQSMEYCPYDLFSLVMSNGK---------LTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVT----ENGIL  459 (601)
T ss_pred             cccchhhhhcccHHHHHHHhcccc---------cchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEe----cCCce
Confidence            333344499999988888876521         77788999999999999999999999999999999999    77799


Q ss_pred             EEeecccceecCCCCCC-CCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccCC--C-
Q psy2172         170 KIADMGFARLFNNPLKP-LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS--N-  245 (291)
Q Consensus       170 ~l~Dfg~~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~~--~-  245 (291)
                      +|+|||.+.....+.+. ........|+..|.|||.+.+........||||.|++++.|.+|+.||..........  . 
T Consensus       460 ki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~  539 (601)
T KOG0590|consen  460 KIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNN  539 (601)
T ss_pred             EEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhc
Confidence            99999999887665443 2234567889999999999987756677999999999999999999998766543210  0 


Q ss_pred             ---------------CCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         246 ---------------PYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       246 ---------------~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                                     -.....-+.++..|..+.|..|-++.++..-+|+..
T Consensus       540 ~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~  590 (601)
T KOG0590|consen  540 YSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRS  590 (601)
T ss_pred             cccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhh
Confidence                           011334556777888888888888888777777653

>PRK10345 hypothetical protein; Provisional

Probab=99.86  E-value=1.6e-20  Score=149.09  Aligned_cols=138  Identities=20%  Similarity=0.282  Sum_probs=102.7

Q ss_pred             ccceeCcccceEEEEEEEccCCCCceeEEEEeCCC--CCChhHHHHHHHHhcC-----CCCCeeeEEEEEEeCCC-ceEE
Q psy2172          23 EGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT--GLSMSACREIALLREL-----KHPNVINLISVFLSHND-RKVW   94 (291)
Q Consensus        23 ~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~-~~~~   94 (291)
                      ..+.||+|+||.||.  +..  ... .+||++...  .....+.+|+.+++.+     +||||+++++++....+ ..++
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~--~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPE--DAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             CcceecCCCceEEEE--CCC--CcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            357999999999995  443  333 468887643  2345689999999999     57999999999954322 3434


Q ss_pred             -EEEecCC---CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHH-HHHhhCCeeeeccCCCcEEeecCCCCCCcE
Q psy2172          95 -LLFDYAE---HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGI-HYLHSNWVLHRDLKPANILVMGEGIERGRV  169 (291)
Q Consensus        95 -iv~e~~~---~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l-~~LH~~~ivH~dik~~Nil~~~~~~~~~~~  169 (291)
                       +|+||.+   ++|.+++....          +++.  ..++.|++.++ +|||+++|+|+||||+||+++.......++
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~~~----------~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~  148 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQCR----------YEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIP  148 (210)
T ss_pred             EEEecCCCCcchhHHHHHHccc----------ccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcE
Confidence             7899955   58888885421          5554  35677888777 999999999999999999998543344589


Q ss_pred             EEee-cccc
Q psy2172         170 KIAD-MGFA  177 (291)
Q Consensus       170 ~l~D-fg~~  177 (291)
                      +|+| ||..
T Consensus       149 ~LiDg~G~~  157 (210)
T PRK10345        149 VVCDNIGES  157 (210)
T ss_pred             EEEECCCCc
Confidence            9999 5543

>KOG4158|consensus

Probab=99.81  E-value=4.4e-19  Score=147.33  Aligned_cols=187  Identities=21%  Similarity=0.223  Sum_probs=140.3

Q ss_pred             CCCCeeeEEEEEEe-------------------------CCCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHH
Q psy2172          74 KHPNVINLISVFLS-------------------------HNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMV  128 (291)
Q Consensus        74 ~h~~iv~~~~~~~~-------------------------~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  128 (291)
                      +|||||++...|.+                         .....+|+||..+..+|.+++....          .+....
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~----------~s~r~~  343 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRH----------RSYRTG  343 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCC----------CchHHH
Confidence            59999999887631                         2456799999999999999987654          566778


Q ss_pred             HHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceecCC---CCCCCCCCCCceecccccccccc
Q psy2172         129 KSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN---PLKPLADLDPVVVTFWYRAPELL  205 (291)
Q Consensus       129 ~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~~~---~~~~~~~~~~~~g~~~y~aPE~~  205 (291)
                      .-++.|+++|+.|||++|+.|+|+|++||++..+++.-..+.++|||.+-....   .....+..-...|....+|||+.
T Consensus       344 ~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~  423 (598)
T KOG4158|consen  344 RVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA  423 (598)
T ss_pred             HHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence            889999999999999999999999999999987765667889999998754332   11122222234567788999987


Q ss_pred             cCCcC-----CCCchhHHHHHHHHHHHHcCCCCCCCCccc-----------ccCCCCCcHHHHHHHHHhhCCCCcCChhh
Q psy2172         206 LGARH-----YTKAIDIWAIGCIFAELLTSEPIFHCRQED-----------IKTSNPYHHDQLDRIFSVMGFPLEKDWED  269 (291)
Q Consensus       206 ~~~~~-----~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~-----------~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  269 (291)
                      ...+.     .-.++|.|+.|.+.||+++...||-+..+-           ++.........+++++-.+..+.|+.+++
T Consensus       424 ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvs  503 (598)
T KOG4158|consen  424 TAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVS  503 (598)
T ss_pred             hcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCC
Confidence            53221     235799999999999999999999885432           22222233455777888888888887766


Q ss_pred             h
Q psy2172         270 I  270 (291)
Q Consensus       270 ~  270 (291)
                      .
T Consensus       504 p  504 (598)
T KOG4158|consen  504 P  504 (598)
T ss_pred             c
Confidence            3

>KOG1240|consensus

Probab=99.81  E-value=8.7e-21  Score=174.21  Aligned_cols=230  Identities=22%  Similarity=0.281  Sum_probs=162.7

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC------hhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEE
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS------MSACREIALLRELKHPNVINLISVFLSHNDRKVWLLF   97 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~   97 (291)
                      .+.||++.|=.|.+|++++   |. |+||++-+....      .+...|++ ....++||++.+..+.  ...+..|+|-
T Consensus        28 ~~~LGstRFlKv~r~k~~e---G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~--~t~kAAylvR  100 (1431)
T KOG1240|consen   28 VENLGSTRFLKVARAKDRE---GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL--VTDKAAYLVR  100 (1431)
T ss_pred             ecccCchhhhhhhhccCCC---ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH--HhhHHHHHHH
Confidence            5789999999999998753   33 899988544311      22334444 5556899999998876  5567789999


Q ss_pred             ecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccc
Q psy2172          98 DYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA  177 (291)
Q Consensus        98 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~  177 (291)
                      +|..++|.+.+.-.+-         +.....+.|+.|++.||...|+.||+|||||.+|||++    ..+-+.|+||..-
T Consensus       101 qyvkhnLyDRlSTRPF---------L~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiT----SWNW~~LtDFAsF  167 (1431)
T KOG1240|consen  101 QYVKHNLYDRLSTRPF---------LVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILIT----SWNWLYLTDFASF  167 (1431)
T ss_pred             HHHhhhhhhhhccchH---------HHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEe----eechhhhhccccc
Confidence            9999999887764432         66677888999999999999999999999999999999    6778899999876


Q ss_pred             eecCCCCCCCCCCCC----ceecccccccccccCC----------cCCCCchhHHHHHHHHHHHHc-CCCCCCCCc----
Q psy2172         178 RLFNNPLKPLADLDP----VVVTFWYRAPELLLGA----------RHYTKAIDIWAIGCIFAELLT-SEPIFHCRQ----  238 (291)
Q Consensus       178 ~~~~~~~~~~~~~~~----~~g~~~y~aPE~~~~~----------~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~----  238 (291)
                      +...-+.........    ...-.+|.|||.+...          +..+++.||||+||++.|++. |++||.-..    
T Consensus       168 KPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aY  247 (1431)
T KOG1240|consen  168 KPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAY  247 (1431)
T ss_pred             CCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhH
Confidence            554333222222222    2224479999987431          126788999999999999875 899996321    


Q ss_pred             -----cc-ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         239 -----ED-IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       239 -----~~-~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                           .+ .+.........+++++..|..-.|..|-+.++.
T Consensus       248 r~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedy  288 (1431)
T KOG1240|consen  248 RSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDY  288 (1431)
T ss_pred             hccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHH
Confidence                 00 011122223346667777766666666665553

>KOG0603|consensus

Probab=99.80  E-value=1.4e-20  Score=164.45  Aligned_cols=186  Identities=27%  Similarity=0.433  Sum_probs=148.0

Q ss_pred             eeCcccceEEEEEEEc-cCCCCceeEEEEeCCCCC----ChhHHHHHHHHhcCC-CCCeeeEEEEEEeCCCceEEEEEec
Q psy2172          26 KVGRGTYGHVYKARRK-DNSDTRDYALKQIEGTGL----SMSACREIALLRELK-HPNVINLISVFLSHNDRKVWLLFDY   99 (291)
Q Consensus        26 ~ig~G~~g~Vy~~~~~-~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~iv~e~   99 (291)
                      .+|+|+||.|+++.-. +...+.-+++|...+...    ......|..++..++ ||.+++++..+  +.....++++++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyaf--qt~~kl~l~ld~   78 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAF--QTDGKLYLILDF   78 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeee--ccccchhHhhhh
Confidence            3789999999987532 233556688888764322    224456778888886 99999999999  677788999999


Q ss_pred             CCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccce
Q psy2172         100 AEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR  178 (291)
Q Consensus       100 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~  178 (291)
                      ..| .+...+....         .+.+.........++-++.++|+.+++|+|+|++||+++    ..+++++.|||.++
T Consensus        79 ~rgg~lft~l~~~~---------~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld----~~Ghi~~tdfglsk  145 (612)
T KOG0603|consen   79 LRGGDLFTRLSKEV---------MFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLL----LEGHIKLTDFGLSK  145 (612)
T ss_pred             cccchhhhccccCC---------chHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeec----ccCccccCCchhhh
Confidence            886 5443333222         267777888889999999999999999999999999999    77899999999998


Q ss_pred             ecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCC
Q psy2172         179 LFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  236 (291)
Q Consensus       179 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~  236 (291)
                      ..-...       ..+||..|+|||++.+   ...++|.||+|+++++|++|..||.+
T Consensus       146 e~v~~~-------~~cgt~eymApEI~~g---h~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  146 EAVKEK-------IACGTYEYRAPEIING---HLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             HhHhhh-------hcccchhhhhhHhhhc---cCCcccchhhhhhHHHHhhCCCCCch
Confidence            654321       1288999999999984   67889999999999999999999987

>smart00090 RIO RIO-like kinase

Probab=99.79  E-value=4.9e-19  Score=143.91  Aligned_cols=136  Identities=24%  Similarity=0.222  Sum_probs=101.1

Q ss_pred             cceeCcccceEEEEEE-EccCCCCceeEEEEeCCCCC--------------------------ChhHHHHHHHHhcCCC-
Q psy2172          24 GCKVGRGTYGHVYKAR-RKDNSDTRDYALKQIEGTGL--------------------------SMSACREIALLRELKH-   75 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~-~~~~~~~~~vaiK~~~~~~~--------------------------~~~~~~e~~~l~~l~h-   75 (291)
                      .+.||+|++|.||+|. +..  +++.||+|+++....                          ...+.+|+.++.++.+ 
T Consensus        33 ~~~Lg~G~~g~Vy~a~~~~~--~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~  110 (237)
T smart00090       33 GGCISTGKEANVYHALDFDG--SGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEA  110 (237)
T ss_pred             CCeeccCcceeEEEEEecCC--CCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhc
Confidence            6799999999999998 433  678899999864321                          0124679999999975 


Q ss_pred             -CCeeeEEEEEEeCCCceEEEEEecCCCC-HHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-eeeecc
Q psy2172          76 -PNVINLISVFLSHNDRKVWLLFDYAEHD-LWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNW-VLHRDL  152 (291)
Q Consensus        76 -~~iv~~~~~~~~~~~~~~~iv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~-ivH~di  152 (291)
                       ..++++++..      ..++||||++|. +.......         ..+....+..++.|++.++++||+.| ++|+||
T Consensus       111 ~i~~p~~~~~~------~~~lV~E~~~g~~L~~~~~~~---------~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Di  175 (237)
T smart00090      111 GVPVPKPIAWR------RNVLVMEFIGGDGLPAPRLKD---------VEPEEEEEFELYDDILEEMRKLYKEGELVHGDL  175 (237)
T ss_pred             CCCCCeeeEec------CceEEEEEecCCccccccccc---------CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCC
Confidence             3345555431      248999999984 33322111         11556667899999999999999999 999999


Q ss_pred             CCCcEEeecCCCCCCcEEEeecccceecC
Q psy2172         153 KPANILVMGEGIERGRVKIADMGFARLFN  181 (291)
Q Consensus       153 k~~Nil~~~~~~~~~~~~l~Dfg~~~~~~  181 (291)
                      ||+||+++     .+.++|+|||.+....
T Consensus       176 kp~NIli~-----~~~i~LiDFg~a~~~~  199 (237)
T smart00090      176 SEYNILVH-----DGKVVIIDVSQSVELD  199 (237)
T ss_pred             ChhhEEEE-----CCCEEEEEChhhhccC
Confidence            99999997     3579999999886433

>KOG0195|consensus

Probab=99.78  E-value=4e-19  Score=140.78  Aligned_cols=223  Identities=17%  Similarity=0.251  Sum_probs=166.4

Q ss_pred             ceeCcccceEEEEEEEccCCCCceeEEEEeC----CCCCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecC
Q psy2172          25 CKVGRGTYGHVYKARRKDNSDTRDYALKQIE----GTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYA  100 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~  100 (291)
                      .+|.....|..|+++|.+    ..++.|++.    ....+.+|..|.-.|+.+.||||..+++.+  .+.....++..|+
T Consensus       196 tkl~e~hsgelwrgrwqg----ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgac--nsppnlv~isq~m  269 (448)
T KOG0195|consen  196 TKLAESHSGELWRGRWQG----NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGAC--NSPPNLVIISQYM  269 (448)
T ss_pred             hhhccCCCcccccccccC----cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhc--cCCCCceEeeeec
Confidence            478889999999999976    337777764    335567889999999999999999999999  7778999999999


Q ss_pred             C-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeeccCCCcEEeecCCCCCCcEEEeecccc
Q psy2172         101 E-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNW--VLHRDLKPANILVMGEGIERGRVKIADMGFA  177 (291)
Q Consensus       101 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~  177 (291)
                      + |+|.+++.....-       -++..++.+++.++++|++|||+..  |.---+.+..++++.+  -..++..+|--++
T Consensus       270 p~gslynvlhe~t~v-------vvd~sqav~faldiargmaflhslep~ipr~~lns~hvmided--ltarismad~kfs  340 (448)
T KOG0195|consen  270 PFGSLYNVLHEQTSV-------VVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDED--LTARISMADTKFS  340 (448)
T ss_pred             cchHHHHHHhcCccE-------EEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecch--hhhheecccceee
Confidence            8 6888887754432       1667789999999999999999863  3344588889999833  1223333444333


Q ss_pred             eecCCCCCCCCCCCCceecccccccccccCCcC--CCCchhHHHHHHHHHHHHcCCCCCCCCccc-----------ccCC
Q psy2172         178 RLFNNPLKPLADLDPVVVTFWYRAPELLLGARH--YTKAIDIWAIGCIFAELLTSEPIFHCRQED-----------IKTS  244 (291)
Q Consensus       178 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~--~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~-----------~~~~  244 (291)
                      ...          ......+.|++||.++..+.  .-.++|+|||++++||+.+...||..-.+-           ....
T Consensus       341 fqe----------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~i  410 (448)
T KOG0195|consen  341 FQE----------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHI  410 (448)
T ss_pred             eec----------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccC
Confidence            211          12234678999999986542  235799999999999999999999865531           1234


Q ss_pred             CCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         245 NPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       245 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      .|--...+..+++.+....|..+|.++.
T Consensus       411 ppgis~hm~klm~icmnedpgkrpkfdm  438 (448)
T KOG0195|consen  411 PPGISRHMNKLMNICMNEDPGKRPKFDM  438 (448)
T ss_pred             CCCccHHHHHHHHHHhcCCCCcCCCcce
Confidence            5555677888888888888888776653

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.77  E-value=7.6e-18  Score=135.33  Aligned_cols=131  Identities=19%  Similarity=0.240  Sum_probs=103.1

Q ss_pred             ceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC----------hhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEE
Q psy2172          25 CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----------MSACREIALLRELKHPNVINLISVFLSHNDRKVW   94 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (291)
                      +.||+|++|.||+|.+    .+..+++|........          ..+.+|+.++..+.|++++....++..  ....+
T Consensus         2 ~~l~~G~~~~vy~~~~----~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~   75 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF----LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD--PENFI   75 (211)
T ss_pred             cccccCceEEEEEEee----CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe--CCCCE
Confidence            4799999999999986    3456888876543211          246789999999999888777666633  44678


Q ss_pred             EEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEee
Q psy2172          95 LLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIAD  173 (291)
Q Consensus        95 iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~D  173 (291)
                      ++|||++| +|.+.+...            .. ....++.+++.+|.++|+.|++|+|++|.||+++     .+.++++|
T Consensus        76 lv~e~~~G~~L~~~~~~~------------~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-----~~~~~liD  137 (211)
T PRK14879         76 IVMEYIEGEPLKDLINSN------------GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-----GGKIYLID  137 (211)
T ss_pred             EEEEEeCCcCHHHHHHhc------------cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-----CCCEEEEE
Confidence            99999987 776665421            12 6788999999999999999999999999999997     35789999


Q ss_pred             ccccee
Q psy2172         174 MGFARL  179 (291)
Q Consensus       174 fg~~~~  179 (291)
                      ||.+..
T Consensus       138 f~~a~~  143 (211)
T PRK14879        138 FGLAEF  143 (211)
T ss_pred             CCcccC
Confidence            998864

>KOG0606|consensus

Probab=99.76  E-value=6.5e-19  Score=161.66  Aligned_cols=165  Identities=31%  Similarity=0.453  Sum_probs=119.2

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecCCCC
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHD  103 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~~~~  103 (291)
                      .+.|..|++|.||.++++.  +.+++|+|+-+..    .+.+.  ++....+|.+|                      |+
T Consensus        88 IklisngAygavylvrh~~--trqrfa~kiNkq~----lilRn--ilt~a~npfvv----------------------gD  137 (1205)
T KOG0606|consen   88 IKLISNGAYGAVYLVRHKE--TRQRFAMKINKQN----LILRN--ILTFAGNPFVV----------------------GD  137 (1205)
T ss_pred             eEeeccCCCCceeeeeccc--cccchhhcccccc----hhhhc--cccccCCccee----------------------ch
Confidence            5689999999999999887  6678999653322    11111  22222344443                      33


Q ss_pred             HHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceecCCC
Q psy2172         104 LWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNP  183 (291)
Q Consensus       104 l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~~~~  183 (291)
                      -..+++..         .+++...        +.+++|||+.||+|+|+||+|.++.    ..+++|++|||+++.....
T Consensus       138 c~tllk~~---------g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT----~mGhiKlTDfgLsk~GLms  196 (1205)
T KOG0606|consen  138 CATLLKNI---------GPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLIT----SMGHIKLTDFGLSKKGLMS  196 (1205)
T ss_pred             hhhhcccC---------CCCcchh--------hHHhHhhccCCeecCCCCCCcceee----ecccccccchhhhhhhhhh
Confidence            22222221         1244433        7789999999999999999999999    7889999999998865321


Q ss_pred             CCC------------CCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc
Q psy2172         184 LKP------------LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED  240 (291)
Q Consensus       184 ~~~------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~  240 (291)
                      ...            .-.....+||+.|.|||++.-.+ |...+|.|++|+++|+.+-|..||-+...+
T Consensus       197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqg-ygkpvdwwamGiIlyeFLVgcvpffGdtpe  264 (1205)
T KOG0606|consen  197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPE  264 (1205)
T ss_pred             ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhc-cCCCccHHHHHHHHHHHheeeeeccCCCHH
Confidence            111            01123458999999999998755 999999999999999999999999998764

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.74  E-value=3.7e-17  Score=148.71  Aligned_cols=129  Identities=19%  Similarity=0.274  Sum_probs=98.9

Q ss_pred             ccceeCcccceEEEEEEEccCCCCceeEEEEe-CCC-C--------CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCce
Q psy2172          23 EGCKVGRGTYGHVYKARRKDNSDTRDYALKQI-EGT-G--------LSMSACREIALLRELKHPNVINLISVFLSHNDRK   92 (291)
Q Consensus        23 ~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~-~~~-~--------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (291)
                      ..++||+|+||.||++.+.+  .  .+++|.. .+. .        ....+.+|+++++.++|++++....+...  ...
T Consensus       337 ~~~~iG~G~~g~Vy~~~~~~--~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~  410 (535)
T PRK09605        337 PDHLIGKGAEADIKKGEYLG--R--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD--PEE  410 (535)
T ss_pred             ccceeccCCcEEEEEEeecC--c--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe--CCC
Confidence            46899999999999998754  2  2333332 111 1        11357789999999999999887766643  345


Q ss_pred             EEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEE
Q psy2172          93 VWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI  171 (291)
Q Consensus        93 ~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l  171 (291)
                      .++||||++| +|.+.+.                 ....++.+++.+|.+||+.|++|+||||+||+++     .+.++|
T Consensus       411 ~~lv~E~~~g~~L~~~l~-----------------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-----~~~~~l  468 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE-----------------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-----DDRLYL  468 (535)
T ss_pred             CEEEEEecCCCcHHHHHH-----------------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-----CCcEEE
Confidence            6899999986 6665543                 2456889999999999999999999999999994     357999


Q ss_pred             eeccccee
Q psy2172         172 ADMGFARL  179 (291)
Q Consensus       172 ~Dfg~~~~  179 (291)
                      +|||+++.
T Consensus       469 iDFGla~~  476 (535)
T PRK09605        469 IDFGLGKY  476 (535)
T ss_pred             EeCccccc
Confidence            99999865

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.74  E-value=1.8e-17  Score=131.83  Aligned_cols=133  Identities=24%  Similarity=0.252  Sum_probs=99.3

Q ss_pred             cccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC------------------------ChhHHHHHHHHhcCCC
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL------------------------SMSACREIALLRELKH   75 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~------------------------~~~~~~e~~~l~~l~h   75 (291)
                      |. .++.||+|+||.||++.+.   +++.++||+++....                        ......|..++..+.+
T Consensus        17 ~~-~~~~i~~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~   92 (198)
T cd05144          17 ES-LGNQIGVGKESDVYLALDP---DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYE   92 (198)
T ss_pred             hh-cCCccccCcceEEEEEEcC---CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHH
Confidence            44 3679999999999999864   578899998753220                        0125678888888877


Q ss_pred             C--CeeeEEEEEEeCCCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeecc
Q psy2172          76 P--NVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDL  152 (291)
Q Consensus        76 ~--~iv~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~di  152 (291)
                      +  .++..++.      ...+++|||++| ++.....               ......++.+++.++.++|+.|++|+||
T Consensus        93 ~~i~v~~~~~~------~~~~lv~e~~~g~~L~~~~~---------------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl  151 (198)
T cd05144          93 EGFPVPKPIDW------NRHAVVMEYIDGVELYRVRV---------------LEDPEEVLDEILEEIVKAYKHGIIHGDL  151 (198)
T ss_pred             cCCCCCceeec------CCceEEEEEeCCcchhhccc---------------cccHHHHHHHHHHHHHHHHHCCCCcCCC
Confidence            6  45555442      234899999997 4432211               0235678899999999999999999999


Q ss_pred             CCCcEEeecCCCCCCcEEEeecccceecC
Q psy2172         153 KPANILVMGEGIERGRVKIADMGFARLFN  181 (291)
Q Consensus       153 k~~Nil~~~~~~~~~~~~l~Dfg~~~~~~  181 (291)
                      +|+||+++    .++.++|+|||.+....
T Consensus       152 ~p~Nill~----~~~~~~liDfg~~~~~~  176 (198)
T cd05144         152 SEFNILVD----DDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             CcccEEEc----CCCcEEEEECCccccCC
Confidence            99999998    67799999999986443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.74  E-value=3.5e-17  Score=130.29  Aligned_cols=127  Identities=19%  Similarity=0.237  Sum_probs=95.0

Q ss_pred             eeCcccceEEEEEEEccCCCCceeEEEEeCCCCC----------ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEE
Q psy2172          26 KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL----------SMSACREIALLRELKHPNVINLISVFLSHNDRKVWL   95 (291)
Q Consensus        26 ~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~i   95 (291)
                      .||+|++|.||++.+    .+..+++|.......          ..++.+|++++..++|+++.....++..  ....++
T Consensus         1 ~ig~G~~~~vy~~~~----~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~l   74 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF----LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD--PDNKTI   74 (199)
T ss_pred             CCCCCceEEEEEeec----CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE--CCCCEE
Confidence            489999999999985    346689998643211          1345689999999988765444444432  334689


Q ss_pred             EEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          96 LFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        96 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      +|||++| ++.+.+....          .      .++.+++.+|.+||+.|++|+|++|.||+++     .+.++++||
T Consensus        75 v~e~~~g~~l~~~~~~~~----------~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-----~~~~~liDf  133 (199)
T TIGR03724        75 VMEYIEGKPLKDVIEEGN----------D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-----DDKLYLIDF  133 (199)
T ss_pred             EEEEECCccHHHHHhhcH----------H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-----CCcEEEEEC
Confidence            9999986 6655543211          0      7889999999999999999999999999997     357999999


Q ss_pred             cccee
Q psy2172         175 GFARL  179 (291)
Q Consensus       175 g~~~~  179 (291)
                      |.+..
T Consensus       134 g~a~~  138 (199)
T TIGR03724       134 GLGKY  138 (199)
T ss_pred             CCCcC
Confidence            98764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.72  E-value=9.1e-17  Score=130.88  Aligned_cols=139  Identities=20%  Similarity=0.245  Sum_probs=102.5

Q ss_pred             ccccccceeC-cccceEEEEEEEccCCCCceeEEEEeCCCC---------------CChhHHHHHHHHhcCCCCCe--ee
Q psy2172          19 LFDYEGCKVG-RGTYGHVYKARRKDNSDTRDYALKQIEGTG---------------LSMSACREIALLRELKHPNV--IN   80 (291)
Q Consensus        19 ~~~~~~~~ig-~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---------------~~~~~~~e~~~l~~l~h~~i--v~   80 (291)
                      .+...+..|| .|+.|+||.+...    +..++||......               ....+.+|+.++..++|+++  +.
T Consensus        31 ~~~~~~~~lg~~~g~gtv~~v~~~----~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~  106 (239)
T PRK01723         31 FWQQQARVVGSAKGRGTTWFVQTP----GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPR  106 (239)
T ss_pred             HHhhcCceeecCCCCccEEEEEeC----CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCce
Confidence            4444577898 8999999999853    4678998874321               12357789999999988774  67


Q ss_pred             EEEEEEeCCCc--eEEEEEecCCC--CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCc
Q psy2172          81 LISVFLSHNDR--KVWLLFDYAEH--DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPAN  156 (291)
Q Consensus        81 ~~~~~~~~~~~--~~~iv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~N  156 (291)
                      .+++.......  ..++|||+++|  +|.+.+...          .+++.    .+.+++.++.+||++||+|+||||.|
T Consensus       107 pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~----------~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~N  172 (239)
T PRK01723        107 PIAARVVRHGLFYRADILIERIEGARDLVALLQEA----------PLSEE----QWQAIGQLIARFHDAGVYHADLNAHN  172 (239)
T ss_pred             eEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC----------CCCHH----HHHHHHHHHHHHHHCCCCCCCCCchh
Confidence            77765332222  23599999986  666665421          14443    35689999999999999999999999


Q ss_pred             EEeecCCCCCCcEEEeeccccee
Q psy2172         157 ILVMGEGIERGRVKIADMGFARL  179 (291)
Q Consensus       157 il~~~~~~~~~~~~l~Dfg~~~~  179 (291)
                      |+++    .++.++|+|||.+..
T Consensus       173 ILv~----~~~~v~LIDfg~~~~  191 (239)
T PRK01723        173 ILLD----PDGKFWLIDFDRGEL  191 (239)
T ss_pred             EEEc----CCCCEEEEECCCccc
Confidence            9998    456899999998764

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.67  E-value=1e-15  Score=115.98  Aligned_cols=130  Identities=26%  Similarity=0.296  Sum_probs=104.8

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCC--CCeeeEEEEEEeCCCceEEEEEecCC
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKH--PNVINLISVFLSHNDRKVWLLFDYAE  101 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~~~iv~e~~~  101 (291)
                      .+.||+|.++.||++...+    ..+++|..........+.+|+.+++.+++  .++++++.+.  ......++++||+.
T Consensus         3 ~~~i~~g~~~~v~~~~~~~----~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~--~~~~~~~~v~e~~~   76 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD----EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASG--ESDGWSYLLMEWIE   76 (155)
T ss_pred             ceecccccccceEEEEecC----CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEc--CCCCccEEEEEecC
Confidence            4689999999999999643    56999998765434578899999999976  5899998887  45568999999998


Q ss_pred             CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeeccCCCcEEeecCCCCCCcEEEeecccce
Q psy2172         102 HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSN---WVLHRDLKPANILVMGEGIERGRVKIADMGFAR  178 (291)
Q Consensus       102 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~  178 (291)
                      +.....               ++......++.+++.+++.+|..   +++|+|++|+||+++    ..+.++++|||.+.
T Consensus        77 g~~~~~---------------~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~----~~~~~~l~Df~~~~  137 (155)
T cd05120          77 GETLDE---------------VSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD----DGKILGIIDWEYAG  137 (155)
T ss_pred             Ceeccc---------------CCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE----CCcEEEEEeccccc
Confidence            742211               12345667788999999999984   799999999999998    56789999999875

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.67  E-value=6.1e-16  Score=121.85  Aligned_cols=132  Identities=28%  Similarity=0.261  Sum_probs=93.0

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC----hh----------------------HHHHHHHHhcCCCC-
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MS----------------------ACREIALLRELKHP-   76 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~----------------------~~~e~~~l~~l~h~-   76 (291)
                      ++.||+|+||.||+|.+.   +++.||+|+++.....    ..                      ...|...+..+.+. 
T Consensus         2 ~~~lg~G~~g~Vy~a~~~---~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~   78 (187)
T cd05119           2 GGPIGTGKEADVYLALDG---DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAG   78 (187)
T ss_pred             CcccccccceeEEEEECC---CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcC
Confidence            468999999999999864   5678999988643211    00                      12455556565433 


Q ss_pred             -CeeeEEEEEEeCCCceEEEEEecCCCC-HH-HHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCeeeecc
Q psy2172          77 -NVINLISVFLSHNDRKVWLLFDYAEHD-LW-HIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHS-NWVLHRDL  152 (291)
Q Consensus        77 -~iv~~~~~~~~~~~~~~~iv~e~~~~~-l~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~-~~ivH~di  152 (291)
                       .++++++..      ..+++|||++++ +. ..+....          .. ..+..++.+++.++.++|. .|++|+||
T Consensus        79 ~~~~~~~~~~------~~~lv~e~~~g~~~~~~~l~~~~----------~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl  141 (187)
T cd05119          79 VPVPKPIDLN------RHVLVMEFIGGDGIPAPRLKDVR----------LL-EDPEELYDQILELMRKLYREAGLVHGDL  141 (187)
T ss_pred             CCCCceEecC------CCEEEEEEeCCCCccChhhhhhh----------hc-ccHHHHHHHHHHHHHHHhhccCcCcCCC
Confidence             355555432      248999999972 11 1111110          11 4578899999999999999 99999999


Q ss_pred             CCCcEEeecCCCCCCcEEEeecccceec
Q psy2172         153 KPANILVMGEGIERGRVKIADMGFARLF  180 (291)
Q Consensus       153 k~~Nil~~~~~~~~~~~~l~Dfg~~~~~  180 (291)
                      +|+||+++     ++.++++|||.+...
T Consensus       142 ~p~Nili~-----~~~~~liDfg~a~~~  164 (187)
T cd05119         142 SEYNILVD-----DGKVYIIDVPQAVEI  164 (187)
T ss_pred             ChhhEEEE-----CCcEEEEECcccccc
Confidence            99999997     357999999998643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG1033|consensus

Probab=99.64  E-value=4.8e-17  Score=139.84  Aligned_cols=170  Identities=22%  Similarity=0.355  Sum_probs=122.1

Q ss_pred             ceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcE
Q psy2172          91 RKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRV  169 (291)
Q Consensus        91 ~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~  169 (291)
                      .++|+.|++|.. +|.+.+...+....      .+...++.++.|++.++.|   +|.+|+|+||.||++.    .+.++
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~------~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~----~d~q~  395 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEE------RSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFS----DDDQL  395 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccc------cchhHHHHHHHhhccchhh---ccchhhhccccccccc----cchhh
Confidence            368999999985 77777664443332      5667789999999999999   9999999999999998    55689


Q ss_pred             EEeecccceecCCCC---CCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCC------Ccc
Q psy2172         170 KIADMGFARLFNNPL---KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHC------RQE  239 (291)
Q Consensus       170 ~l~Dfg~~~~~~~~~---~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~------~~~  239 (291)
                      +|.|||+........   ..........||..|++||.+.+.. |+.++||||||++|+|++. =...|..      ...
T Consensus       396 kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~-y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~d~r~  474 (516)
T KOG1033|consen  396 KIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ-YSEKVDIYALGLILAELLIQFSTQFERIATLTDIRD  474 (516)
T ss_pred             hhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhh-hhhhcchhhHHHHHHHHHHHhccHHHHHHhhhhhhc
Confidence            999999988665432   1223455678999999999999854 9999999999999999987 1112211      100


Q ss_pred             -cccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCC
Q psy2172         240 -DIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMP  274 (291)
Q Consensus       240 -~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  274 (291)
                       .++.........-..++..+..|.|..+|.+-...
T Consensus       475 g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~  510 (516)
T KOG1033|consen  475 GIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVA  510 (516)
T ss_pred             CCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHh
Confidence             11101111123345788888899999998554433

>KOG1023|consensus

Probab=99.64  E-value=8.7e-16  Score=134.12  Aligned_cols=154  Identities=28%  Similarity=0.449  Sum_probs=122.1

Q ss_pred             HhcCCCCCeeeEEEEEEeCCCceEEEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCe-
Q psy2172          70 LRELKHPNVINLISVFLSHNDRKVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWV-  147 (291)
Q Consensus        70 l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~i-  147 (291)
                      |+.+.|.|+.++++..+.+  ...++|.+||. |+|.+.+......        ++.-+...++++++.||+|||+..| 
T Consensus         1 l~~l~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~~~--------~d~~F~~s~~rdi~~Gl~ylh~s~i~   70 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNEDIK--------LDYFFILSFIRDISKGLAYLHNSPIG   70 (484)
T ss_pred             CcccchhhhhhheeeEecC--CceEEEEeeecCccHHhHHhccccC--------ccHHHHHHHHHHHHHHHHHHhcCcce
Confidence            4678999999999999754  78999999998 6888888763322        7888899999999999999998866 


Q ss_pred             eeeccCCCcEEeecCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCc------CCCCchhHHHHH
Q psy2172         148 LHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGAR------HYTKAIDIWAIG  221 (291)
Q Consensus       148 vH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~------~~~~~~Dv~slG  221 (291)
                      .|+.+++.|.+++    .++.+|++|||+......... ........-..-|.|||.+.+..      ..+.++|+||+|
T Consensus        71 ~hg~l~s~nClvd----~~w~lklt~~Gl~~~~~~~~~-~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~  145 (484)
T KOG1023|consen   71 YHGALKSSNCLVD----SRWVLKLTDFGLNSLLEETAE-PEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFG  145 (484)
T ss_pred             eeeeeccccceee----eeEEEEechhhhccccccccc-ccccchhHHHHhccCHHHhcccccccccccccccCCeehHH
Confidence            9999999999999    889999999999876542100 01111122345699999987631      146789999999


Q ss_pred             HHHHHHHcCCCCCCCCc
Q psy2172         222 CIFAELLTSEPIFHCRQ  238 (291)
Q Consensus       222 ~~l~~l~~g~~pf~~~~  238 (291)
                      ++++|+++...||....
T Consensus       146 ii~~ei~~r~~~~~~~~  162 (484)
T KOG1023|consen  146 IIMYEILFRSGPFDLRN  162 (484)
T ss_pred             HHHHHHHhccCcccccc
Confidence            99999999999998744

>KOG0590|consensus

Probab=99.56  E-value=2.2e-16  Score=143.65  Aligned_cols=243  Identities=24%  Similarity=0.323  Sum_probs=175.8

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCC----CChhHHHHHHHHhcCC-CCCeeeEEEEEEeCCCceEEEEEe
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG----LSMSACREIALLRELK-HPNVINLISVFLSHNDRKVWLLFD   98 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~iv~e   98 (291)
                      .+.||+|+|+.|-.+..... ....++.|.+....    .......|..+-+.+. |+|++.+++..  .+....+++.+
T Consensus        25 ~~~ig~gs~~~~~~~~~~~~-~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~--~~~~~~~~~~~  101 (601)
T KOG0590|consen   25 SRSIGKGSFSSSALASNSRD-PESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS--SSPRSYLLSLS  101 (601)
T ss_pred             cccccccccchhhhhhhcCC-CcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc--CCCcccccccC
Confidence            45799999999998876442 33446677665432    1223445677777776 99999999998  66778899999


Q ss_pred             cCCC-CHHHHHH-HhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHh-hCCeeeeccCCCcEEeecCCCCCC-cEEEeec
Q psy2172          99 YAEH-DLWHIIK-FHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLH-SNWVLHRDLKPANILVMGEGIERG-RVKIADM  174 (291)
Q Consensus        99 ~~~~-~l~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH-~~~ivH~dik~~Nil~~~~~~~~~-~~~l~Df  174 (291)
                      +..| ++...+. ....        ..+...+...+.|+..++.|+| ..+++|+|++|+|.+++    ..+ .+++.||
T Consensus       102 ~s~g~~~f~~i~~~~~~--------~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~----~s~~~l~~~df  169 (601)
T KOG0590|consen  102 YSDGGSLFSKISHPDST--------GTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLD----ESGSALKIADF  169 (601)
T ss_pred             cccccccccccccCCcc--------CCCCcchhhhhhhhccCccccCcccccccCCCCCccchhc----cCCCcccCCCc
Confidence            9775 5444442 1110        1566678889999999999999 99999999999999998    555 8999999


Q ss_pred             ccceecCCCCCCCCCCCCcee-cccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccC----------
Q psy2172         175 GFARLFNNPLKPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT----------  243 (291)
Q Consensus       175 g~~~~~~~~~~~~~~~~~~~g-~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~----------  243 (291)
                      |+|.................| ++.|.|||...+.....+..|+||.|+++.-+++|..|+.........          
T Consensus       170 ~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~  249 (601)
T KOG0590|consen  170 GLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGR  249 (601)
T ss_pred             hhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccc
Confidence            999877663333334445567 999999999988556788899999999999999999999765543211          


Q ss_pred             --CCC--CcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         244 --SNP--YHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       244 --~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                        ..+  ........+...+..+.+..+.+++++...+|...
T Consensus       250 ~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  250 FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             cccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence              000  11233344444444467777888888877777665

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.52  E-value=1e-13  Score=122.52  Aligned_cols=148  Identities=22%  Similarity=0.327  Sum_probs=96.9

Q ss_pred             ccccccc-cccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCCh--------------------------------
Q psy2172          15 KVEDLFD-YEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM--------------------------------   61 (291)
Q Consensus        15 ~~~~~~~-~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~--------------------------------   61 (291)
                      .+.+.|. ++.+.||.|++|+||+|..+   +++.||||+.+... ..                                
T Consensus       112 ~~~~~F~~fd~~plasaSigQVh~A~l~---~G~~VaVKv~rp~i-~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~  187 (437)
T TIGR01982       112 PLEELFAEFEEKPLAAASIAQVHRARLV---DGKEVAVKVLRPGI-EKTIAADIALLYRLARIVERLSPDSRRLRPTEVV  187 (437)
T ss_pred             CHHHHHhhCCCcceeeeehhheEEEEec---CCCEEEEEeeCCCc-HHHHHHHHHHHHHHHHHHHHhCccccccCHHHHH
Confidence            4455555 34578999999999999975   56889999975321 11                                


Q ss_pred             -----------hHHHHHHHHhcC----CCCCeeeEEEEEEeCCCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCH
Q psy2172          62 -----------SACREIALLREL----KHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPK  125 (291)
Q Consensus        62 -----------~~~~e~~~l~~l----~h~~iv~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~  125 (291)
                                 ++.+|+..+.++    ++.+-+.+-..+. +-....++||||++| ++.+........        .+ 
T Consensus       188 ~e~~~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~-~~~~~~vLvmE~i~G~~L~~~~~~~~~~--------~~-  257 (437)
T TIGR01982       188 KEFEKTLRRELDLRREAANASELGENFKNDPGVYVPEVYW-DRTSERVLTMEWIDGIPLSDIAALDEAG--------LD-  257 (437)
T ss_pred             HHHHHHHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEeh-hhcCCceEEEEeECCcccccHHHHHhcC--------CC-
Confidence                       133455555554    2322233333332 112346999999987 555544321110        21 


Q ss_pred             HHHHHHHHHHHH-HHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceecCC
Q psy2172         126 GMVKSLLYQILD-GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN  182 (291)
Q Consensus       126 ~~~~~i~~ql~~-~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~~~  182 (291)
                        ...++.+++. .+..+|..|++|+|++|.||++.    .+++++++|||++.....
T Consensus       258 --~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~----~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       258 --RKALAENLARSFLNQVLRDGFFHADLHPGNIFVL----KDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             --HHHHHHHHHHHHHHHHHhCCceeCCCCcccEEEC----CCCcEEEEeCCCeeECCH
Confidence              2345555655 47889999999999999999997    667899999999976543

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG3087|consensus

Probab=99.49  E-value=6.8e-13  Score=100.13  Aligned_cols=143  Identities=16%  Similarity=0.168  Sum_probs=104.1

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCC-----CC-----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEG-----TG-----LSMSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~-----~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      -+.|-||+-+.|+++.+.    ++.++||.=..     +.     ...+..+|++++.++.--+|.-..-+|.+  ...-
T Consensus        12 l~likQGAEArv~~~~~~----Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D--~~~~   85 (229)
T KOG3087|consen   12 LELIKQGAEARVPRGSFS----GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFID--TYGG   85 (229)
T ss_pred             ceeeeccceeeEeeeccC----CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEe--cCCC
Confidence            358999999999999874    46677774221     11     22356789999999875555444444433  3344


Q ss_pred             EEEEecCCC--CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEE
Q psy2172          94 WLLFDYAEH--DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI  171 (291)
Q Consensus        94 ~iv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l  171 (291)
                      .++|||.+|  ++.+++.......       ...+....++.++-+.+.-||.++++||||..+||++.+++ ....+.+
T Consensus        86 ~i~ME~~~g~~~vk~~i~~~~~~~-------~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~-~~~~~~l  157 (229)
T KOG3087|consen   86 QIYMEFIDGASTVKDFILSTMEDE-------SEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDG-NQITPIL  157 (229)
T ss_pred             eEEEEeccchhHHHHHHHHHccCc-------ccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCC-CcCceEE
Confidence            789999998  8888877654432       23334478889999999999999999999999999998654 4556799


Q ss_pred             eecccceec
Q psy2172         172 ADMGFARLF  180 (291)
Q Consensus       172 ~Dfg~~~~~  180 (291)
                      +|||++..-
T Consensus       158 Idfgls~~s  166 (229)
T KOG3087|consen  158 IDFGLSSVS  166 (229)
T ss_pred             Eeecchhcc
Confidence            999998753

>KOG1243|consensus

Probab=99.47  E-value=1.1e-12  Score=116.49  Aligned_cols=161  Identities=20%  Similarity=0.334  Sum_probs=118.9

Q ss_pred             CCceeEEEEeCCCCC--ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCC
Q psy2172          45 DTRDYALKQIEGTGL--SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVM  122 (291)
Q Consensus        45 ~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~  122 (291)
                      .+.+|.|...+....  ...+.+-++.|+.++||+|+++++.+  +.....|+|+|.+.. |...+..            
T Consensus        36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~--e~~~~~ylvTErV~P-l~~~lk~------------  100 (690)
T KOG1243|consen   36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTT--EEEGTLYLVTERVRP-LETVLKE------------  100 (690)
T ss_pred             cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhh--cccCceEEEeecccc-HHHHHHH------------
Confidence            556677777665444  34577888999999999999999999  566799999998863 3333333            


Q ss_pred             CCHHHHHHHHHHHHHHHHHHh-hCCeeeeccCCCcEEeecCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccc
Q psy2172         123 VPKGMVKSLLYQILDGIHYLH-SNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA  201 (291)
Q Consensus       123 ~~~~~~~~i~~ql~~~l~~LH-~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~a  201 (291)
                      +....+...+.||+.||.+|| +.+++|++|.-..|+++    ..+.++|++|..++.......   .......-..|..
T Consensus       101 l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn----~~GeWkLggle~v~~~~~~~~---~~~~~~~~~s~~~  173 (690)
T KOG1243|consen  101 LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVN----ESGEWKLGGLELVSKASGFNA---PAKSLYLIESFDD  173 (690)
T ss_pred             hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEc----CCCcEEEeeeEEEeccccCCc---ccccchhhhcccC
Confidence            334456778899999999998 57899999999999999    778999999999875433211   1111222233666


Q ss_pred             cccccCCcCCCCchhHHHHHHHHHHHHcC
Q psy2172         202 PELLLGARHYTKAIDIWAIGCIFAELLTS  230 (291)
Q Consensus       202 PE~~~~~~~~~~~~Dv~slG~~l~~l~~g  230 (291)
                      |+.+....   -..|.|.||+++++++.|
T Consensus       174 P~~~~~s~---~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  174 PEEIDPSE---WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             hhhcCccc---cchhhhhHHHHHHHHhCc
Confidence            66554322   347999999999999999

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.45  E-value=1.8e-12  Score=101.32  Aligned_cols=136  Identities=20%  Similarity=0.190  Sum_probs=97.3

Q ss_pred             ceeCcccceEEEEEEEccC----CCCceeEEEEeCCC---------------C--------CCh-h----HHHHHHHHhc
Q psy2172          25 CKVGRGTYGHVYKARRKDN----SDTRDYALKQIEGT---------------G--------LSM-S----ACREIALLRE   72 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~----~~~~~vaiK~~~~~---------------~--------~~~-~----~~~e~~~l~~   72 (291)
                      ..||.|--+.||.|...+.    ..+..+|||+.+..               .        ... .    ..+|...|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            4899999999999985431    13467999986310               0        001 1    2379999999


Q ss_pred             CC--CCCeeeEEEEEEeCCCceEEEEEecCCCC-HHH-HHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHH-hhCCe
Q psy2172          73 LK--HPNVINLISVFLSHNDRKVWLLFDYAEHD-LWH-IIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYL-HSNWV  147 (291)
Q Consensus        73 l~--h~~iv~~~~~~~~~~~~~~~iv~e~~~~~-l~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~L-H~~~i  147 (291)
                      +.  .-++++++++.      .-++||||++++ +.. .+...          .++...+..+..+++.++..+ |+.|+
T Consensus        83 l~~~Gv~vP~pi~~~------~~~lvME~Ig~~~~~~~~Lkd~----------~~~~~~~~~i~~~i~~~l~~l~H~~gl  146 (197)
T cd05146          83 MQKAGIPCPEVVVLK------KHVLVMSFIGDDQVPAPKLKDA----------KLNDEEMKNAYYQVLSMMKQLYKECNL  146 (197)
T ss_pred             HHHcCCCCCeEEEec------CCEEEEEEcCCCCccchhhhcc----------ccCHHHHHHHHHHHHHHHHHHHHhCCe
Confidence            95  35677777653      348999999864 211 11110          155566778889999999988 89999


Q ss_pred             eeeccCCCcEEeecCCCCCCcEEEeecccceecC
Q psy2172         148 LHRDLKPANILVMGEGIERGRVKIADMGFARLFN  181 (291)
Q Consensus       148 vH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~~  181 (291)
                      +|||+++.||++.     .+.++++|||.+....
T Consensus       147 VHGDLs~~NIL~~-----~~~v~iIDF~qav~~~  175 (197)
T cd05146         147 VHADLSEYNMLWH-----DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             ecCCCCHHHEEEE-----CCcEEEEECCCceeCC
Confidence            9999999999996     3579999999887544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601|consensus

Probab=99.41  E-value=2.9e-13  Score=118.66  Aligned_cols=198  Identities=22%  Similarity=0.289  Sum_probs=152.1

Q ss_pred             cceeCc--ccceEEEEEEEccCCCCceeEEEEeCC----CCCChhHHHHHHHHhcC-CCCCeeeEEEEEEeCCCceEEEE
Q psy2172          24 GCKVGR--GTYGHVYKARRKDNSDTRDYALKQIEG----TGLSMSACREIALLREL-KHPNVINLISVFLSHNDRKVWLL   96 (291)
Q Consensus        24 ~~~ig~--G~~g~Vy~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~iv   96 (291)
                      ...+|.  |.+|.||.+.+........+|+|.-+.    +.....-.+|+...+++ .|++.++.+..+  ++.+..++-
T Consensus       119 ~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~--e~~~~lfiq  196 (524)
T KOG0601|consen  119 SSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW--EGSGILFIQ  196 (524)
T ss_pred             ccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc--ccCCcceee
Confidence            457888  999999999983334677788887432    22333445666666666 489999988888  678899999


Q ss_pred             EecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHH----HHHHHhhCCeeeeccCCCcEEeecCCCCC-CcEEE
Q psy2172          97 FDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILD----GIHYLHSNWVLHRDLKPANILVMGEGIER-GRVKI  171 (291)
Q Consensus        97 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~----~l~~LH~~~ivH~dik~~Nil~~~~~~~~-~~~~l  171 (291)
                      +|.|+.++..........        ++...++..+.+...    ||.++|..+++|.|++|.||+..    .+ ...++
T Consensus       197 tE~~~~sl~~~~~~~~~~--------~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~----~~~~s~~~  264 (524)
T KOG0601|consen  197 TELCGESLQSYCHTPCNF--------LPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTT----SDWTSCKL  264 (524)
T ss_pred             eccccchhHHhhhccccc--------CCchhhhhHHhhhhhcccccccccCCCcccccccchhheecc----cccceeec
Confidence            999997777666543332        778889999999998    99999999999999999999998    44 68899


Q ss_pred             eecccceecCCCCCCC-CC-CCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q psy2172         172 ADMGFARLFNNPLKPL-AD-LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  237 (291)
Q Consensus       172 ~Dfg~~~~~~~~~~~~-~~-~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~  237 (291)
                      +|||....+....-.. .. .....|...|++||...+  .++...|+|++|-+..+...+..+....
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g  330 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVG  330 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCC
Confidence            9999998877643111 11 122256777999999976  4789999999999999988876655544

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.41  E-value=3.4e-13  Score=120.76  Aligned_cols=148  Identities=18%  Similarity=0.248  Sum_probs=91.3

Q ss_pred             cccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC-----------------------------------------
Q psy2172          22 YEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS-----------------------------------------   60 (291)
Q Consensus        22 ~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----------------------------------------   60 (291)
                      ++.+.||+|++|+||+|..++  +++.||||+.++....                                         
T Consensus       122 fd~~PlasaSiaQVh~A~l~~--~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        122 FDIKPLASASIAQVHFARLKD--NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             cChhhhcCCCccEEEEEEECC--CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            345799999999999999876  5788999998643100                                         


Q ss_pred             -hhHHHHHHHHhcCC----CCCeeeEEEEEEeCCCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHH
Q psy2172          61 -MSACREIALLRELK----HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQ  134 (291)
Q Consensus        61 -~~~~~e~~~l~~l~----h~~iv~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~q  134 (291)
                       -++.+|+..+.++.    +...+.+-.++.+ -....++||||+.| .+.+.......+.   ....+.+..+..++. 
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d-~st~~VLvmE~i~G~~l~d~~~l~~~g~---d~~~la~~~v~~~~~-  274 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWD-YCSETVMVMERMYGIPVSDVAALRAAGT---DMKLLAERGVEVFFT-  274 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeecc-cCCCceEEEeeecCccHHhHHHHHhcCC---CHHHHHHHHHHHHHH-
Confidence             12344555555542    3333343333321 13356899999998 5544321111100   000022333333333 


Q ss_pred             HHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceecCC
Q psy2172         135 ILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN  182 (291)
Q Consensus       135 l~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~~~  182 (291)
                            .+...|++|+|++|.||+++.++...++++++|||++.....
T Consensus       275 ------Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        275 ------QVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             ------HHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                  445699999999999999985443445999999999987644

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.41  E-value=1.7e-12  Score=100.45  Aligned_cols=125  Identities=19%  Similarity=0.187  Sum_probs=91.3

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-CChhHHHHHHHHhcCCCCC-eeeEEEEEEeCCCceEEEEEecCC
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-LSMSACREIALLRELKHPN-VINLISVFLSHNDRKVWLLFDYAE  101 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~~~iv~e~~~  101 (291)
                      .+.|+.|.++.||++...    +..+++|+..... ....+..|+.+++.+.+.+ +++++...  .+  ..++||||++
T Consensus         3 ~~~l~~G~~~~vy~~~~~----~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~--~~~lv~e~i~   74 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA----NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PE--TGVLITEFIE   74 (170)
T ss_pred             eeecCCcccCceEEEEEC----CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CC--CCeEEEEecC
Confidence            457899999999999853    4679999976543 2345788999999986444 45565544  22  3479999999


Q ss_pred             CC-HHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCe-----eeeccCCCcEEeecCCCCCCcEEEeecc
Q psy2172         102 HD-LWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWV-----LHRDLKPANILVMGEGIERGRVKIADMG  175 (291)
Q Consensus       102 ~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~i-----vH~dik~~Nil~~~~~~~~~~~~l~Dfg  175 (291)
                      |. +...    .          ..   ....+.+++.+++.||..++     +|+|++|.||+++     .+.++++||+
T Consensus        75 G~~l~~~----~----------~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-----~~~~~liDf~  132 (170)
T cd05151          75 GSELLTE----D----------FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-----DGRLWLIDWE  132 (170)
T ss_pred             CCccccc----c----------cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-----CCeEEEEecc
Confidence            83 2211    0          11   12356789999999999885     9999999999997     2468999999


Q ss_pred             cce
Q psy2172         176 FAR  178 (291)
Q Consensus       176 ~~~  178 (291)
                      .+.
T Consensus       133 ~a~  135 (170)
T cd05151         133 YAG  135 (170)
T ss_pred             ccc
Confidence            875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.38  E-value=7.2e-12  Score=94.99  Aligned_cols=128  Identities=20%  Similarity=0.280  Sum_probs=89.7

Q ss_pred             ceeCcccceEEEEEEEccCCCCceeEEEEe-CCC----CCC-----hhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEE
Q psy2172          25 CKVGRGTYGHVYKARRKDNSDTRDYALKQI-EGT----GLS-----MSACREIALLRELKHPNVINLISVFLSHNDRKVW   94 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~-~~~----~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (291)
                      ..+++|+-+.+|.+.+.+    ..+++|.= ++.    ...     .+..+|+.++.++.-.+|...+-+.++  .....
T Consensus         2 ~~i~~GAEa~i~~~~~~g----~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD--~~~~~   75 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLG----LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD--PDNGL   75 (204)
T ss_pred             chhhCCcceeEEeeeccC----cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc--CCCCE
Confidence            368899999999997743    23666642 211    111     235679999999865554444444432  44568


Q ss_pred             EEEecCCCCHH-HHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEee
Q psy2172          95 LLFDYAEHDLW-HIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIAD  173 (291)
Q Consensus        95 iv~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~D  173 (291)
                      ++|||.+|.+. +.+...                ...++..+-.-+.-||..||+|||++++||++++     ..+.++|
T Consensus        76 I~me~I~G~~lkd~l~~~----------------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~-----~~i~~ID  134 (204)
T COG3642          76 IVMEYIEGELLKDALEEA----------------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSG-----GRIYFID  134 (204)
T ss_pred             EEEEEeCChhHHHHHHhc----------------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeC-----CcEEEEE
Confidence            99999999544 354432                1345666777788899999999999999999973     3499999


Q ss_pred             ccccee
Q psy2172         174 MGFARL  179 (291)
Q Consensus       174 fg~~~~  179 (291)
                      ||++..
T Consensus       135 fGLg~~  140 (204)
T COG3642         135 FGLGEF  140 (204)
T ss_pred             CCcccc
Confidence            999874

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.36  E-value=1.2e-11  Score=104.54  Aligned_cols=199  Identities=15%  Similarity=0.131  Sum_probs=133.6

Q ss_pred             ccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcC-CCCCeeeEEE----EEEeCCC-ceEEEE
Q psy2172          23 EGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLREL-KHPNVINLIS----VFLSHND-RKVWLL   96 (291)
Q Consensus        23 ~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~----~~~~~~~-~~~~iv   96 (291)
                      .|..||+|+.+.+|..-     +....+-|+...+.-...... +..|... .||-+-.-+.    ..+..+. ....+.
T Consensus        15 ~gr~LgqGgea~ly~l~-----e~~d~VAKIYh~Pppa~~aqk-~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          15 PGRPLGQGGEADLYTLG-----EVRDQVAKIYHAPPPAAQAQK-VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCccccCCccceeeecc-----hhhchhheeecCCCchHHHHH-HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            37889999999999654     334466677654433333332 3333333 5664333121    1122233 347888


Q ss_pred             EecCCC--CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          97 FDYAEH--DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        97 ~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      |+...|  .+..+....   ..+.......+..+++.++.++.+.+.||+.|.+-||+.++|++++    ++..+.|+|=
T Consensus        89 mP~v~g~~pI~~~y~p~---tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVs----d~~~V~LVds  161 (637)
T COG4248          89 MPKVSGKEPIHMIYSPA---TRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVS----DDSKVVLVDS  161 (637)
T ss_pred             cccCCCccchhhhcCch---hhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeee----cCceEEEEcc
Confidence            888876  444333322   2222334478889999999999999999999999999999999999    7778999886


Q ss_pred             ccceecCCCCCCCCCCCCceeccccccccccc-----CCcCCCCchhHHHHHHHHHHHHcC-CCCCCCCcc
Q psy2172         175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLL-----GARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQE  239 (291)
Q Consensus       175 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~~Dv~slG~~l~~l~~g-~~pf~~~~~  239 (291)
                      ..-....+    .....+..|...|.+||.-.     +.. -+...|.|.||+++++++.| ++||++...
T Consensus       162 Dsfqi~~n----g~~~~cpVg~~eftPPElQ~~~sf~g~~-r~~~hD~FGLavLiF~lL~ggrHPysGI~~  227 (637)
T COG4248         162 DSFQINAN----GTLHLCPVGVSEFTPPELQTLPSFVGFE-RTANHDNFGLAVLIFHLLFGGRHPYSGIPL  227 (637)
T ss_pred             cceeeccC----CceEecccCccccCCHHHhccccccccC-CCccccchhHHHHHHHHHhcCCCCCCcccc
Confidence            54332221    13334567899999999753     211 46779999999999998775 999998653

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.28  E-value=7.5e-11  Score=91.92  Aligned_cols=124  Identities=27%  Similarity=0.236  Sum_probs=78.8

Q ss_pred             EEEEEEEccCCCCceeEEEEeCCC---------------C--------CC-----hhHHHHHHHHhcCCCC--CeeeEEE
Q psy2172          34 HVYKARRKDNSDTRDYALKQIEGT---------------G--------LS-----MSACREIALLRELKHP--NVINLIS   83 (291)
Q Consensus        34 ~Vy~~~~~~~~~~~~vaiK~~~~~---------------~--------~~-----~~~~~e~~~l~~l~h~--~iv~~~~   83 (291)
                      .||.|...   .+..+|+|+-+..               .        ..     ....+|.+.|.++...  ++++++.
T Consensus         1 ~Vy~~~~~---~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~   77 (188)
T PF01163_consen    1 DVYHAIDP---DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYD   77 (188)
T ss_dssp             EEEEEEEC---TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEE
T ss_pred             CEEEEECC---CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEE
Confidence            38888864   4568999986311               0        00     1256899999999765  6788876


Q ss_pred             EEEeCCCceEEEEEecCC--CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHH-HHhhCCeeeeccCCCcEEee
Q psy2172          84 VFLSHNDRKVWLLFDYAE--HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIH-YLHSNWVLHRDLKPANILVM  160 (291)
Q Consensus        84 ~~~~~~~~~~~iv~e~~~--~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~-~LH~~~ivH~dik~~Nil~~  160 (291)
                      +.  .+    ++||||++  |.....+....          ++......++.+++..+. .+|+.|++|||+++.||+++
T Consensus        78 ~~--~~----~ivME~I~~~G~~~~~l~~~~----------~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~  141 (188)
T PF01163_consen   78 YN--RN----VIVMEYIGEDGVPLPRLKDVD----------LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVD  141 (188)
T ss_dssp             EE--TT----EEEEE--EETTEEGGCHHHCG----------GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEE
T ss_pred             Ee--CC----EEEEEecCCCccchhhHHhcc----------ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEee
Confidence            64  33    79999999  73333333222          112335666777777444 46899999999999999997


Q ss_pred             cCCCCCCcEEEeecccceecC
Q psy2172         161 GEGIERGRVKIADMGFARLFN  181 (291)
Q Consensus       161 ~~~~~~~~~~l~Dfg~~~~~~  181 (291)
                          .+ .+.++|||.+....
T Consensus       142 ----~~-~~~iIDf~qav~~~  157 (188)
T PF01163_consen  142 ----DG-KVYIIDFGQAVDSS  157 (188)
T ss_dssp             ----TT-CEEE--GTTEEETT
T ss_pred             ----cc-eEEEEecCcceecC
Confidence                33 89999999887543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0601|consensus

Probab=99.27  E-value=7e-12  Score=110.10  Aligned_cols=245  Identities=20%  Similarity=0.209  Sum_probs=168.1

Q ss_pred             ccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC--h--hHHHHHHHHhcC-CCCCeeeEEEEEEe
Q psy2172          13 RTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS--M--SACREIALLREL-KHPNVINLISVFLS   87 (291)
Q Consensus        13 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~--~--~~~~e~~~l~~l-~h~~iv~~~~~~~~   87 (291)
                      .......|- +...||.|.|+.|+.+. +...++..|++|...+....  .  .-..|+.+...+ .|.+++..+..+. 
T Consensus       260 ~s~~~~df~-~v~~i~~~~~~~~~~~~-~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~-  336 (524)
T KOG0601|consen  260 TSCKLTDFG-LVSKISDGNFSSVFKVS-KRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWS-  336 (524)
T ss_pred             ceeecCCcc-eeEEccCCccccceeee-ecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcc-
Confidence            333444455 46799999999999988 44457788999987654221  1  234566666666 4778888777763 


Q ss_pred             CCCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCC
Q psy2172          88 HNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERG  167 (291)
Q Consensus        88 ~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~  167 (291)
                       .-...|+-.|||.+....+.......        +.+...+.+..|++.++.++|+..++|.|++|+||++..+   .+
T Consensus       337 -~~r~~~ip~e~~~~~s~~l~~~~~~~--------~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~---~~  404 (524)
T KOG0601|consen  337 -QLRQGYIPLEFCEGGSSSLRSVTSQM--------LDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISND---GF  404 (524)
T ss_pred             -ccccccCchhhhcCcchhhhhHHHHh--------cCcchhhhhHHHHHhccccccchhhhcccccccceeeccc---hh
Confidence             34456799999986444443322222        7788899999999999999999999999999999999842   26


Q ss_pred             cEEEeecccceecCCCCCCCCCCCCceeccccc-ccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCC-Cc------c
Q psy2172         168 RVKIADMGFARLFNNPLKPLADLDPVVVTFWYR-APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC-RQ------E  239 (291)
Q Consensus       168 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~-aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~-~~------~  239 (291)
                      ..++.||+........     . .......++. .+|++.....+..+.|++|||..+.+..++...-.. ..      .
T Consensus       405 ~~~~~~~~~~t~~~~~-----~-~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i~~~  478 (524)
T KOG0601|consen  405 FSKLGDFGCWTRLAFS-----S-GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTIRSG  478 (524)
T ss_pred             hhhcccccccccccee-----c-ccccccccccccchhhccccccccccccccccccccccccCcccCcccccceeeecc
Confidence            7788999987632211     0 1112233344 366665555588899999999999999887633322 11      1


Q ss_pred             cccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         240 DIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       240 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                      ..+..... ..+++.+.+.+..+.+..||.+.++..+..+
T Consensus       479 ~~p~~~~~-~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  479 DTPNLPGL-KLQLQVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             cccCCCch-HHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence            22222223 3788899999999999999998877666543

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.26  E-value=1.3e-10  Score=95.83  Aligned_cols=151  Identities=15%  Similarity=0.135  Sum_probs=103.1

Q ss_pred             ccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC------------C-hhHHHHHHHHhcCCCCC--eeeE
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL------------S-MSACREIALLRELKHPN--VINL   81 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~------------~-~~~~~e~~~l~~l~h~~--iv~~   81 (291)
                      +..+..+++.+-.-....|++...    .++.|.||.......            + ..+.+|...+.+|...+  .+.+
T Consensus        20 ~~~~~~~~e~v~~~~~rrvvr~~~----~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~p   95 (268)
T PRK15123         20 EEVKTLQGEVFRELEGRRTLRFEL----AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTG   95 (268)
T ss_pred             HHHHhcCCcEEecCCCceEEEEEE----CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCe
Confidence            344455666777666666777654    345788886643221            1 14778999888885333  3344


Q ss_pred             EEEEEeCC---CceEEEEEecCCC--CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCc
Q psy2172          82 ISVFLSHN---DRKVWLLFDYAEH--DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPAN  156 (291)
Q Consensus        82 ~~~~~~~~---~~~~~iv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~N  156 (291)
                      +.+.....   ....++|+|++++  +|.+++......       ..+......++.+++..+..||+.||+|+|++++|
T Consensus        96 Va~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~-------~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~N  168 (268)
T PRK15123         96 VAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATN-------PPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICH  168 (268)
T ss_pred             eEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhccc-------CCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhh
Confidence            44442211   2357899999997  677776533211       15566778999999999999999999999999999


Q ss_pred             EEeecC---CCCCCcEEEeecccce
Q psy2172         157 ILVMGE---GIERGRVKIADMGFAR  178 (291)
Q Consensus       157 il~~~~---~~~~~~~~l~Dfg~~~  178 (291)
                      |+++.+   ......+.++||+.+.
T Consensus       169 iLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        169 FLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             EEEeccccCCCCCceEEEEECCccc
Confidence            999842   1135689999999875

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.20  E-value=1.9e-10  Score=92.89  Aligned_cols=76  Identities=13%  Similarity=0.149  Sum_probs=55.8

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCC---CChhHHHHHHHHhcCCC--CCeeeEEEEEEeCC-CceEEEEE
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG---LSMSACREIALLRELKH--PNVINLISVFLSHN-DRKVWLLF   97 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~-~~~~~iv~   97 (291)
                      .+.|+.|..+.||++...   +++.+++|......   ....+.+|+++++.+.+  ..+++++.+..... ....+++|
T Consensus         3 ~~~l~~G~~n~~~~v~~~---~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~   79 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAG---GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM   79 (223)
T ss_pred             ceecCCCccceEEEEEec---CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence            457899999999999863   24679999986543   35678999999999975  34677777652111 12568999


Q ss_pred             ecCCC
Q psy2172          98 DYAEH  102 (291)
Q Consensus        98 e~~~~  102 (291)
                      |+++|
T Consensus        80 e~i~G   84 (223)
T cd05154          80 ERVDG   84 (223)
T ss_pred             EEeCC
Confidence            99987

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3741|consensus

Probab=99.19  E-value=5.5e-10  Score=96.86  Aligned_cols=174  Identities=22%  Similarity=0.322  Sum_probs=129.8

Q ss_pred             cceEEEEEEEccCCCCceeEEEEeCCCC--CChhHHHHHHHHhcCCCCCeeeEEEEEEe--CCCceEEEEEecCCC--CH
Q psy2172          31 TYGHVYKARRKDNSDTRDYALKQIEGTG--LSMSACREIALLRELKHPNVINLISVFLS--HNDRKVWLLFDYAEH--DL  104 (291)
Q Consensus        31 ~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~~~iv~e~~~~--~l  104 (291)
                      -..+.|+|..+-  +|..|++|++...+  .......-+++++++.|+|||++.++|..  -....+++|++|+++  +|
T Consensus       288 ~~~Ttyk~~s~~--DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL  365 (655)
T KOG3741|consen  288 FSITTYKATSNV--DGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL  365 (655)
T ss_pred             ccceeEeeeecc--CCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence            345789998765  77889999994221  12234456789999999999999999842  244579999999985  77


Q ss_pred             HHHHHHhhhhh------hCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccce
Q psy2172         105 WHIIKFHRAAK------ANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR  178 (291)
Q Consensus       105 ~~~~~~~~~~~------~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~  178 (291)
                      .++.-......      ....+...++..+|.++.|+..||.++|+.|+.-+-|.|.+|+++    .+.+++|...|..-
T Consensus       366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~----G~~RIriS~C~i~D  441 (655)
T KOG3741|consen  366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVT----GKMRIRISGCGIMD  441 (655)
T ss_pred             HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEee----CcceEEEeccccee
Confidence            77665443222      112334488999999999999999999999999999999999999    55689999988877


Q ss_pred             ecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCC
Q psy2172         179 LFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE  231 (291)
Q Consensus       179 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~  231 (291)
                      .......                 +-+.    --.+-|.=.||.++..|.+|.
T Consensus       442 vl~~d~~-----------------~~le----~~Qq~D~~~lG~ll~aLAt~~  473 (655)
T KOG3741|consen  442 VLQEDPT-----------------EPLE----SQQQNDLRDLGLLLLALATGT  473 (655)
T ss_pred             eecCCCC-----------------cchh----HHhhhhHHHHHHHHHHHhhcc
Confidence            6554320                 1111    124579999999999999995

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.16  E-value=1.4e-09  Score=86.89  Aligned_cols=146  Identities=20%  Similarity=0.184  Sum_probs=98.2

Q ss_pred             cceeCcc-cceEEEEEEEcc-CCCCceeEEEEeCCC---------CCChhHHHHHHHHhcCCCC--CeeeEEEEEEeCCC
Q psy2172          24 GCKVGRG-TYGHVYKARRKD-NSDTRDYALKQIEGT---------GLSMSACREIALLRELKHP--NVINLISVFLSHND   90 (291)
Q Consensus        24 ~~~ig~G-~~g~Vy~~~~~~-~~~~~~vaiK~~~~~---------~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~~~   90 (291)
                      ++..+.+ +-+.+|.+.... ....+.+.+|.....         .......+|...+..|...  .+++.+++......
T Consensus         8 ~~~~~~~~~R~~~~~~~~~~~~~~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~   87 (206)
T PF06293_consen    8 GEWVEEPNGRRGGWFGVQRVVDLVGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKG   87 (206)
T ss_pred             CcEEecCCCCceEEEEEEccccccceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCC
Confidence            3444443 344555555443 334556666653211         2344678888888888532  34555555533221


Q ss_pred             --ceEEEEEecCCC--CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCC
Q psy2172          91 --RKVWLLFDYAEH--DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIER  166 (291)
Q Consensus        91 --~~~~iv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~  166 (291)
                        ...++|+|++++  +|.+++.....         .+......++.+++..+.-||++|++|+|+++.|||+..++ ..
T Consensus        88 ~~~~s~lite~l~~~~~L~~~~~~~~~---------~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~-~~  157 (206)
T PF06293_consen   88 GGYRSYLITEALPGAQDLRDLLQQWEQ---------LDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDD-GQ  157 (206)
T ss_pred             CceeEEEEEEeCCCcccHHHHHHhhcc---------cchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCC-Cc
Confidence              346899999987  67777765332         45556788999999999999999999999999999998543 34


Q ss_pred             CcEEEeeccccee
Q psy2172         167 GRVKIADMGFARL  179 (291)
Q Consensus       167 ~~~~l~Dfg~~~~  179 (291)
                      ..+.++||+.+..
T Consensus       158 ~~~~lIDld~~~~  170 (206)
T PF06293_consen  158 YRFYLIDLDRMRF  170 (206)
T ss_pred             eeEEEEcchhcee
Confidence            5899999998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.05  E-value=1.3e-09  Score=87.72  Aligned_cols=131  Identities=25%  Similarity=0.243  Sum_probs=97.1

Q ss_pred             ccceeCcccceEEEEEEEccCCCCceeEEEEeCCC------------------CC------ChhHHHHHHHHhcCCCC--
Q psy2172          23 EGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT------------------GL------SMSACREIALLRELKHP--   76 (291)
Q Consensus        23 ~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~------------------~~------~~~~~~e~~~l~~l~h~--   76 (291)
                      .|.+||-|--+.||.|.+.   .+..+++|.=+-.                  ..      ...+.+|.++|.+|...  
T Consensus        95 iG~~IGvGKEsdVY~~~~~---~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          95 IGTKIGVGKESDVYVAIDP---KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             hccccccCccceEEEEECC---CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            5889999999999999865   5788999974210                  01      12367899999999755  


Q ss_pred             CeeeEEEEEEeCCCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCc
Q psy2172          77 NVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPAN  156 (291)
Q Consensus        77 ~iv~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~N  156 (291)
                      .+++.+++-      ..++|||+.+|..+.-+.             +.....-.++..|+.-+..+-..|+||||+++-|
T Consensus       172 ~VP~P~~~n------RHaVvMe~ieG~eL~~~r-------------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefN  232 (304)
T COG0478         172 KVPKPIAWN------RHAVVMEYIEGVELYRLR-------------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFN  232 (304)
T ss_pred             CCCCccccc------cceeeeehcccceeeccc-------------CcccCHHHHHHHHHHHHHHHHHcCccccCCchhe
Confidence            888888864      458999999983221111             1233344556666666666678999999999999


Q ss_pred             EEeecCCCCCCcEEEeeccccee
Q psy2172         157 ILVMGEGIERGRVKIADMGFARL  179 (291)
Q Consensus       157 il~~~~~~~~~~~~l~Dfg~~~~  179 (291)
                      |+++    .++.+.++||--+..
T Consensus       233 IlV~----~dg~~~vIDwPQ~v~  251 (304)
T COG0478         233 ILVT----EDGDIVVIDWPQAVP  251 (304)
T ss_pred             EEEe----cCCCEEEEeCccccc
Confidence            9999    677999999986654

>KOG1266|consensus

Probab=99.03  E-value=2.3e-10  Score=93.82  Aligned_cols=200  Identities=19%  Similarity=0.172  Sum_probs=128.9

Q ss_pred             hcCCCCCeeeEEEEEEe---CCCceEEEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-
Q psy2172          71 RELKHPNVINLISVFLS---HNDRKVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSN-  145 (291)
Q Consensus        71 ~~l~h~~iv~~~~~~~~---~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~-  145 (291)
                      -++-|.|+|+++.++-+   ++.....++.+|+. |++.++++........     ++.....++..||+.||.|||+. 
T Consensus       122 lqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a-----~~~~~wkkw~tqIlsal~yLhs~~  196 (458)
T KOG1266|consen  122 LQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKA-----LFQKAWKKWCTQILSALSYLHSCD  196 (458)
T ss_pred             HHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhh-----hhHHHHHHHHHHHHhhhhhhhccC
Confidence            33468999999998832   24456788899997 6888888876655443     78889999999999999999986 


Q ss_pred             -CeeeeccCCCcEEeecCCCCCCcEEEeecccceecCCC-CCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHH
Q psy2172         146 -WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNP-LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCI  223 (291)
Q Consensus       146 -~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~  223 (291)
                       -|+|+++..+.|++.    .++-+++.--.....-... ...........+.++|.+||.=... ..+.++|||++|..
T Consensus       197 PpiihgnlTc~tifiq----~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~t-n~~~a~dIy~fgmc  271 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQ----HNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTT-NTTGASDIYKFGMC  271 (458)
T ss_pred             CccccCCcchhheeec----CCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccc-ccccchhhhhhhHH
Confidence             599999999999998    5566665432222111110 0011122334567788999864432 36778999999999


Q ss_pred             HHHHHcCCCCCCCCcccccC------CCCCc-HHHHHHHHHhhCCCCcCChhhhhcCCCCcchh
Q psy2172         224 FAELLTSEPIFHCRQEDIKT------SNPYH-HDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLL  280 (291)
Q Consensus       224 l~~l~~g~~pf~~~~~~~~~------~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  280 (291)
                      ..+|.-+..--.........      .-... ...-......+..+.|..+|+.+.+.-||.+.
T Consensus       272 AlemailEiq~tnseS~~~~ee~ia~~i~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllf  335 (458)
T KOG1266|consen  272 ALEMAILEIQSTNSESKVEVEENIANVIIGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLF  335 (458)
T ss_pred             HHHHHHheeccCCCcceeehhhhhhhheeeccCccccCcCcccccCCCCCCcchhhhhcCceee
Confidence            99998776432211111000      00000 01112234455667777888888877776654

>PRK09902 hypothetical protein; Provisional

Probab=99.02  E-value=1.4e-08  Score=79.87  Aligned_cols=141  Identities=15%  Similarity=0.117  Sum_probs=100.5

Q ss_pred             eeCcccceEEEEEEEccCCCCceeEEEEeCC--------CCCChhHHHHHHHHhcCCCC--CeeeEEEEE--EeCCCceE
Q psy2172          26 KVGRGTYGHVYKARRKDNSDTRDYALKQIEG--------TGLSMSACREIALLRELKHP--NVINLISVF--LSHNDRKV   93 (291)
Q Consensus        26 ~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~--------~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~--~~~~~~~~   93 (291)
                      --|.||.+.|+.....+    +.+-+|.-.+        +.....+.+|...+.+|...  .++++...-  .....-..
T Consensus        25 N~~rgG~SgV~r~~~~g----~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA  100 (216)
T PRK09902         25 NYRRNGMSGVQCVERNG----KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRA  100 (216)
T ss_pred             CcCCCCcceEEEEEeCC----cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEE
Confidence            34669999999877543    3588887541        33456799999999999532  244444211  11223357


Q ss_pred             EEEEecCCC--CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEE
Q psy2172          94 WLLFDYAEH--DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI  171 (291)
Q Consensus        94 ~iv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l  171 (291)
                      ++|+|-++|  +|.+.+......       +.+......++.+++.++.-||+.|+.|+|+.+.||+++.+  ....+.+
T Consensus       101 ~LVTe~L~g~~~L~~~l~~~~~~-------~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~--g~~~v~l  171 (216)
T PRK09902        101 LLVTEDMAGFISIADWYAQHAVS-------PYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTE--GKAEAGF  171 (216)
T ss_pred             EEEEEeCCCCccHHHHHhcCCcC-------CcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCC--CCeeEEE
Confidence            899998885  777666443221       15777788999999999999999999999999999999743  2346999


Q ss_pred             eeccccee
Q psy2172         172 ADMGFARL  179 (291)
Q Consensus       172 ~Dfg~~~~  179 (291)
                      +||..++.
T Consensus       172 IDlEk~r~  179 (216)
T PRK09902        172 LDLEKSRR  179 (216)
T ss_pred             EEhhccch
Confidence            99997653

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.85  E-value=6.8e-08  Score=78.12  Aligned_cols=71  Identities=15%  Similarity=0.203  Sum_probs=53.7

Q ss_pred             ceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCCC--CeeeEEEEEEeCCCceEEEEEecCCC
Q psy2172          25 CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHP--NVINLISVFLSHNDRKVWLLFDYAEH  102 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~~~~~~~iv~e~~~~  102 (291)
                      ..||+|..+.||+..      +..+++|+...........+|.++++.+..-  .+++++++.  ++.....++|++++|
T Consensus         7 ~~i~~G~t~~~y~~~------~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~--~~~~~~glv~e~i~G   78 (226)
T TIGR02172         7 TQTGEGGNGESYTHK------TGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLV--EDGGRLGLIYELIVG   78 (226)
T ss_pred             eeecCCCCcceeEec------CCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEE--ecCCeeeeeeeecCC
Confidence            479999999999842      3358899987655566789999999998643  346677766  445567889999998


Q ss_pred             C
Q psy2172         103 D  103 (291)
Q Consensus       103 ~  103 (291)
                      .
T Consensus        79 ~   79 (226)
T TIGR02172        79 K   79 (226)
T ss_pred             c
Confidence            3

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG0606|consensus

Probab=98.78  E-value=2.2e-09  Score=100.10  Aligned_cols=197  Identities=24%  Similarity=0.260  Sum_probs=133.0

Q ss_pred             ceeCcccceEEEEEEEccCCCCceeEEEEeCCC-----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEec
Q psy2172          25 CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-----GLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDY   99 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~   99 (291)
                      +-+.+|+++.++.+.-..  ++-..+.|.....     ...+...++-.++....+|-++...-.+  ......+++++|
T Consensus       810 ~p~qS~sp~ss~p~~pa~--sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~--~~rsP~~L~~~~  885 (1205)
T KOG0606|consen  810 KPSQSGSPSSSFPASPAG--SGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF--PCRSPLPLVGHY  885 (1205)
T ss_pred             ccccCCCCcccccCCccc--cccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC--CCCCCcchhhHH
Confidence            477889999998887444  3333333332211     1122222333333333455555554444  345678999999


Q ss_pred             CCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccce
Q psy2172         100 AEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR  178 (291)
Q Consensus       100 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~  178 (291)
                      .++ ++...+....         +.+.+..+..+..+..+.++||...+.|+|++|.|++..    ..+...+.||+...
T Consensus       886 ~~~~~~~Skl~~~~---------~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~----~~gh~~l~~~~t~~  952 (1205)
T KOG0606|consen  886 LNGGDLPSKLHNSG---------CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIA----YDGHRPLTDFGTLS  952 (1205)
T ss_pred             hccCCchhhhhcCC---------CcccccccchhHHHHhhhhccccchhhcccccccchhhc----ccCCcccCcccccc
Confidence            975 7776666544         155556677777888999999999999999999999998    67788899987333


Q ss_pred             ecCCC-----C------------------C-----CCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcC
Q psy2172         179 LFNNP-----L------------------K-----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS  230 (291)
Q Consensus       179 ~~~~~-----~------------------~-----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g  230 (291)
                      ...-.     .                  .     .........+|+.|.+||...+.. ....+|.|+.|+++++.++|
T Consensus       953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l~g 1031 (1205)
T KOG0606|consen  953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVLTG 1031 (1205)
T ss_pred             ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhhcC
Confidence            22110     0                  0     001122347799999999998865 67789999999999999999


Q ss_pred             CCCCCCCcc
Q psy2172         231 EPIFHCRQE  239 (291)
Q Consensus       231 ~~pf~~~~~  239 (291)
                      .+||.....
T Consensus      1032 ~pp~na~tp 1040 (1205)
T KOG0606|consen 1032 IPPFNAETP 1040 (1205)
T ss_pred             CCCCCCcch
Confidence            999998766

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.67  E-value=1.2e-07  Score=84.93  Aligned_cols=148  Identities=22%  Similarity=0.336  Sum_probs=95.3

Q ss_pred             ccccccccc-cccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC---------------------------CC----
Q psy2172          13 RTKVEDLFD-YEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG---------------------------LS----   60 (291)
Q Consensus        13 ~~~~~~~~~-~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---------------------------~~----   60 (291)
                      ...+.+.|. ++.+.|+.++-|+||.|..+   +|+.||||+.++.-                           ..    
T Consensus       118 G~~iee~F~eF~~~PiAsASIaQVH~A~L~---sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~v  194 (517)
T COG0661         118 GRPIEELFSEFEPEPIASASIAQVHRAVLK---SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEV  194 (517)
T ss_pred             CCCHHHHHHHcCCCchhhhhHhhheeEEec---CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHH
Confidence            345666666 45689999999999999987   47899999873210                           00    


Q ss_pred             -----------hhHHHHHHHHhcCC-----CC--CeeeEEEEEEeCCCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCC
Q psy2172          61 -----------MSACREIALLRELK-----HP--NVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPV  121 (291)
Q Consensus        61 -----------~~~~~e~~~l~~l~-----h~--~iv~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~  121 (291)
                                 -++.+|+..+.+++     .+  .|++++.-+    .....++|||++| .+.+.......+       
T Consensus       195 v~e~~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~----t~~~VLtmE~i~Gi~i~d~~~l~~~g-------  263 (517)
T COG0661         195 VDEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEY----TTRRVLTMEWIDGIKISDIAALKSAG-------  263 (517)
T ss_pred             HHHHHHHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhc----cCCcEEEEEeeCCEecccHHHHHhcC-------
Confidence                       11345666666652     23  233443322    3356899999998 333332221111       


Q ss_pred             CCCHHHHHHHHHHHHHH-HHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceecCC
Q psy2172         122 MVPKGMVKSLLYQILDG-IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN  182 (291)
Q Consensus       122 ~~~~~~~~~i~~ql~~~-l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~~~  182 (291)
                       ++.   ..++..++.+ +..+-..|+.|+|..|.||++.    .++++.+.|||+...+..
T Consensus       264 -~d~---k~ia~~~~~~f~~q~~~dgffHaDpHpGNi~v~----~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         264 -IDR---KELAELLVRAFLRQLLRDGFFHADPHPGNILVR----SDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             -CCH---HHHHHHHHHHHHHHHHhcCccccCCCccceEEe----cCCcEEEEcCcceecCCH
Confidence             332   2233333322 4455568999999999999999    668999999999876654

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.59  E-value=6.8e-07  Score=67.75  Aligned_cols=126  Identities=18%  Similarity=0.191  Sum_probs=90.1

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCCCCe-eeEEEEEEeCCCceEEEEEecCCC
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNV-INLISVFLSHNDRKVWLLFDYAEH  102 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~~iv~e~~~~  102 (291)
                      .+.|++|.+|.||++.|++    ..+|+|+=+.+.....+..|+++|+.++..++ ++++.+-  .+    .+.|||..|
T Consensus        27 ~~~L~KG~~s~Vyl~~~~~----~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg--~~----~i~me~i~G   96 (201)
T COG2112          27 EKELAKGTTSVVYLGEWRG----GEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYG--ED----FIRMEYIDG   96 (201)
T ss_pred             hhhhhcccccEEEEeeccC----ceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEec--hh----hhhhhhhcC
Confidence            3689999999999999865    46999998888888889999999999976544 4555554  22    455999998


Q ss_pred             -CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccC-CCcEEeecCCCCCCcEEEeeccccee
Q psy2172         103 -DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLK-PANILVMGEGIERGRVKIADMGFARL  179 (291)
Q Consensus       103 -~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik-~~Nil~~~~~~~~~~~~l~Dfg~~~~  179 (291)
                       .|.......            .    .+-+..++.+-.-|-..||-|+.|. |...++.    ++..+.|+||..|+.
T Consensus        97 ~~L~~~~~~~------------~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv----~~~~~~iIDFd~At~  155 (201)
T COG2112          97 RPLGKLEIGG------------D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLV----NDRDVYIIDFDSATF  155 (201)
T ss_pred             cchhhhhhcc------------c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEe----cCCcEEEEEccchhh
Confidence             555443321            1    1223345555555667899999987 5545554    455899999999874

>KOG2137|consensus

Probab=98.58  E-value=2.2e-08  Score=89.93  Aligned_cols=138  Identities=20%  Similarity=0.255  Sum_probs=91.1

Q ss_pred             HHHHHHHHHHHhhC-CeeeeccCCCcEEeecCCCCCCcEEEeecccceecCCCCCCCC------CCCCceeccccccccc
Q psy2172         132 LYQILDGIHYLHSN-WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLA------DLDPVVVTFWYRAPEL  204 (291)
Q Consensus       132 ~~ql~~~l~~LH~~-~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~------~~~~~~g~~~y~aPE~  204 (291)
                      +.+.+.|+.++|.. ++||++|.|++|+++    ..+.+||+.|+++.....+.....      ......-...|.|||+
T Consensus       105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~n----a~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~  180 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVN----ANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEY  180 (700)
T ss_pred             hhcccchhhhhccCcceeecccchhheeec----cCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchh
Confidence            34556899999964 899999999999999    778999999999876554221100      0111233557999999


Q ss_pred             ccCCcCCCCchhHHHHHHHHHHHH-cCCCCCCCCcccccC-------------CCCCcHHHHHHHHHhhCCCCcCChhhh
Q psy2172         205 LLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKT-------------SNPYHHDQLDRIFSVMGFPLEKDWEDI  270 (291)
Q Consensus       205 ~~~~~~~~~~~Dv~slG~~l~~l~-~g~~pf~~~~~~~~~-------------~~~~~~~~~~~i~~~~~~~~~~~~~~~  270 (291)
                      +.+ ...+.++|+||+|+++|-+. .|...+......+..             +...-...+.+=+..+....+..+|.+
T Consensus       181 ~~~-~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~  259 (700)
T KOG2137|consen  181 LLG-TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTL  259 (700)
T ss_pred             hcc-ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcch
Confidence            987 45889999999999999988 556655554332111             111112334444455555666666655


Q ss_pred             hcCC
Q psy2172         271 RKMP  274 (291)
Q Consensus       271 ~~~~  274 (291)
                      ..+.
T Consensus       260 ~~l~  263 (700)
T KOG2137|consen  260 DLLL  263 (700)
T ss_pred             hhhh
Confidence            4443

>KOG1235|consensus

Probab=98.57  E-value=3.7e-07  Score=81.60  Aligned_cols=151  Identities=19%  Similarity=0.259  Sum_probs=98.5

Q ss_pred             cccccccccc-cccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC--------------------------------
Q psy2172          12 ERTKVEDLFD-YEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG--------------------------------   58 (291)
Q Consensus        12 ~~~~~~~~~~-~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--------------------------------   58 (291)
                      ....+.+.|. +.-+.||..+.|+|++|+.++   ++.||||+-++.-                                
T Consensus       153 lG~~ie~if~~f~~~piaaASlaQVhrA~L~~---G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvd  229 (538)
T KOG1235|consen  153 LGAPIEDIFSEFDEEPIAAASLAQVHRARLKN---GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVD  229 (538)
T ss_pred             hCCCHHHHHHhcCcchhhhcchhheEEEEecC---CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHH
Confidence            4455666666 445799999999999999774   7889999843210                                


Q ss_pred             -----CCh--hHHHHHHHHhcC----CCCC------eeeEEEEEEeCCCceEEEEEecCCC---CHHHHHHHhhhhhhCC
Q psy2172          59 -----LSM--SACREIALLREL----KHPN------VINLISVFLSHNDRKVWLLFDYAEH---DLWHIIKFHRAAKANK  118 (291)
Q Consensus        59 -----~~~--~~~~e~~~l~~l----~h~~------iv~~~~~~~~~~~~~~~iv~e~~~~---~l~~~~~~~~~~~~~~  118 (291)
                           ..+  ++.+|++-.+++    .|-+      |++++..+    .....++|||++|   +-.+.+...+      
T Consensus       230 E~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~----st~RVLtME~~~G~~i~Dl~~i~~~g------  299 (538)
T KOG1235|consen  230 EIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDL----STKRVLTMEYVDGIKINDLDAIDKRG------  299 (538)
T ss_pred             HHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhc----CcceEEEEEecCCccCCCHHHHHHcC------
Confidence                 001  244555544443    3444      66666655    4467999999998   2223333222      


Q ss_pred             CCCCCCHHHHHHHHHHHHHH-HHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceecCC
Q psy2172         119 KPVMVPKGMVKSLLYQILDG-IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN  182 (291)
Q Consensus       119 ~~~~~~~~~~~~i~~ql~~~-l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~~~  182 (291)
                          ++...+   +..+.++ .+.|-..|++|+|=.|.||++..+...+.++.+.|||+...+..
T Consensus       300 ----i~~~~i---~~~l~~~~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  300 ----ISPHDI---LNKLVEAYLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             ----CCHHHH---HHHHHHHHHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence                554433   3333333 34455689999999999999996544577999999999876543

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.53  E-value=3e-06  Score=66.75  Aligned_cols=134  Identities=16%  Similarity=0.239  Sum_probs=94.1

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCC------------------CChhHHHHHHHHhcCC------CCCee
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG------------------LSMSACREIALLRELK------HPNVI   79 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~------------------~~~~~~~e~~~l~~l~------h~~iv   79 (291)
                      ...||+|+.-.||.--     .+...+||+.....                  ...+..+|+.-...+.      +.+|+
T Consensus         6 ~~~i~~G~~R~cy~HP-----~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~   80 (199)
T PF10707_consen    6 SDLIAQGGERDCYQHP-----DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIP   80 (199)
T ss_pred             CcccccCCCceEEECC-----CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccc
Confidence            4589999999999653     44568999887554                  2345667777666665      78999


Q ss_pred             eEEEEEEeCCCceEEEEEecCC---C----CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeecc
Q psy2172          80 NLISVFLSHNDRKVWLLFDYAE---H----DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDL  152 (291)
Q Consensus        80 ~~~~~~~~~~~~~~~iv~e~~~---~----~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~di  152 (291)
                      +++|+.  +......+|+|...   |    +|.+++....          ++. .+.+   .+-....+|-+.+|+.+|+
T Consensus        81 r~~G~v--eT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----------~~~-~~~~---~L~~f~~~l~~~~Iv~~dl  144 (199)
T PF10707_consen   81 RFYGFV--ETNLGLGLVVELIRDADGNISPTLEDYLKEGG----------LTE-ELRQ---ALDEFKRYLLDHHIVIRDL  144 (199)
T ss_pred             cEeEEE--ecCCceEEEEEEEECCCCCcCccHHHHHHcCC----------ccH-HHHH---HHHHHHHHHHHcCCeecCC
Confidence            999999  55666788888763   3    5666664322          444 3333   3344556778899999999


Q ss_pred             CCCcEEeecCCCCCCcEEEee-cccce
Q psy2172         153 KPANILVMGEGIERGRVKIAD-MGFAR  178 (291)
Q Consensus       153 k~~Nil~~~~~~~~~~~~l~D-fg~~~  178 (291)
                      +|.||++.........+.++| ||...
T Consensus       145 ~~~NIv~~~~~~~~~~lvlIDG~G~~~  171 (199)
T PF10707_consen  145 NPHNIVVQRRDSGEFRLVLIDGLGEKE  171 (199)
T ss_pred             CcccEEEEecCCCceEEEEEeCCCCcc
Confidence            999999987654444788888 56443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.52  E-value=2.1e-06  Score=68.84  Aligned_cols=136  Identities=24%  Similarity=0.237  Sum_probs=94.2

Q ss_pred             ceeCcccceEEEEEEEccCCCCceeEEEEeCCCC--------------------CC-hh-----HHHHHHHHhcCC--CC
Q psy2172          25 CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG--------------------LS-MS-----ACREIALLRELK--HP   76 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--------------------~~-~~-----~~~e~~~l~~l~--h~   76 (291)
                      ..|++|--+.||+|..   +.+..+|+|+.+...                    .. ..     ...|..-|.++.  +=
T Consensus        54 g~istGKEA~Vy~a~~---~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV  130 (268)
T COG1718          54 GCISTGKEANVYLAET---GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV  130 (268)
T ss_pred             eeecCCcceEEEeecc---CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence            4788899999999974   356889999974221                    01 11     235777788773  45


Q ss_pred             CeeeEEEEEEeCCCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCeeeeccCCC
Q psy2172          77 NVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHS-NWVLHRDLKPA  155 (291)
Q Consensus        77 ~iv~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~-~~ivH~dik~~  155 (291)
                      .+++.+.+.  .+    .++||+.+..-   ......     ....+.......+..++++.+.-|-. .++||+||+.=
T Consensus       131 rvP~Pi~~~--~n----VLvMEfIg~~g---~pAP~L-----kDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEy  196 (268)
T COG1718         131 RVPEPIAFR--NN----VLVMEFIGDDG---LPAPRL-----KDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEY  196 (268)
T ss_pred             CCCCceeec--CC----eEEEEeccCCC---CCCCCc-----ccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhh
Confidence            677778877  33    79999998531   000000     11113333577777888888888887 89999999999


Q ss_pred             cEEeecCCCCCCcEEEeecccceecCC
Q psy2172         156 NILVMGEGIERGRVKIADMGFARLFNN  182 (291)
Q Consensus       156 Nil~~~~~~~~~~~~l~Dfg~~~~~~~  182 (291)
                      |||+.     .+.+.++||+-+.....
T Consensus       197 NiL~~-----~~~p~iID~~QaV~~~h  218 (268)
T COG1718         197 NILVH-----DGEPYIIDVSQAVTIDH  218 (268)
T ss_pred             heEEE-----CCeEEEEECccccccCC
Confidence            99996     46899999998875543

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.44  E-value=2.5e-06  Score=67.57  Aligned_cols=66  Identities=30%  Similarity=0.434  Sum_probs=49.2

Q ss_pred             ceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcE
Q psy2172          91 RKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRV  169 (291)
Q Consensus        91 ~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~  169 (291)
                      ...+++|||++| .+.+...             +++    .++..+..++..||+.|++|||..|.|++++     .+.+
T Consensus       116 ~~~~ll~EYIeG~~l~d~~~-------------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~-----~~~i  173 (229)
T PF06176_consen  116 SSYVLLMEYIEGVELNDIED-------------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVS-----NNGI  173 (229)
T ss_pred             eEEEEEEEEecCeecccchh-------------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEE-----CCcE
Confidence            356789999998 4433322             332    2345577789999999999999999999997     3459


Q ss_pred             EEeecccce
Q psy2172         170 KIADMGFAR  178 (291)
Q Consensus       170 ~l~Dfg~~~  178 (291)
                      +++||+...
T Consensus       174 ~iID~~~k~  182 (229)
T PF06176_consen  174 RIIDTQGKR  182 (229)
T ss_pred             EEEECcccc
Confidence            999998654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.38  E-value=9.1e-06  Score=66.68  Aligned_cols=71  Identities=25%  Similarity=0.264  Sum_probs=50.0

Q ss_pred             eeCcccc-eEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCC-CCCeeeEEEEEEeCCCceEEEEEecCCCC
Q psy2172          26 KVGRGTY-GHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELK-HPNVINLISVFLSHNDRKVWLLFDYAEHD  103 (291)
Q Consensus        26 ~ig~G~~-g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~iv~e~~~~~  103 (291)
                      .|..|.. ..||+....    +..+++|+..... ..+..+|+.+++.+. +--+++++++.  ......++||++.+|.
T Consensus         5 ~~~~g~~~~~v~~~~~~----~~~~~vk~~~~~~-~~~~~~E~~~l~~l~~~~~vP~v~~~~--~~~~~~~lv~e~i~G~   77 (244)
T cd05150           5 RVTEGQSGATVYRLDGK----NPGLYLKIAPSGP-TYELEREAERLRWLAGKLPVPEVIDYG--SDDGRAWLLTSAVPGV   77 (244)
T ss_pred             ecCCCCCcCeEEEEcCC----CCcEEEEecCCCc-ccchHHHHHHHHHHHhcCCCCeEEEEE--ecCCccEEEEEeeCCc
Confidence            4555655 788998642    2568999886543 456778999998884 44567777766  3335678999999883

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.33  E-value=8e-06  Score=66.25  Aligned_cols=79  Identities=24%  Similarity=0.258  Sum_probs=54.7

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCCC--CeeeEEEEEEeC-CCceEEEEEecC
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHP--NVINLISVFLSH-NDRKVWLLFDYA  100 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~-~~~~~~iv~e~~  100 (291)
                      .+.|+.|..+.||.+...+    ..+++|..........+.+|+.+++.+...  .+++++...... .....+++|++.
T Consensus         2 i~~l~~G~~n~~~~v~~~~----~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i   77 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD----GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT----SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC----cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence            3578999999999998643    479999987653445788899999888432  467777644222 233579999999


Q ss_pred             CC-CHHH
Q psy2172         101 EH-DLWH  106 (291)
Q Consensus       101 ~~-~l~~  106 (291)
                      +| .+..
T Consensus        78 ~g~~~~~   84 (239)
T PF01636_consen   78 PGRPLDD   84 (239)
T ss_dssp             SSEEHHH
T ss_pred             ccccccc
Confidence            98 4433

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PLN02876 acyl-CoA dehydrogenase

Probab=98.31  E-value=8e-06  Score=78.52  Aligned_cols=81  Identities=16%  Similarity=0.282  Sum_probs=55.5

Q ss_pred             ccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC---CChhHHHHHHHHhcCC-CCCe--eeEEEEEEeCC-CceEEE
Q psy2172          23 EGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG---LSMSACREIALLRELK-HPNV--INLISVFLSHN-DRKVWL   95 (291)
Q Consensus        23 ~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~-h~~i--v~~~~~~~~~~-~~~~~i   95 (291)
                      ..+.++.|.+..+|+...........+++|+.....   ....+.+|+.+|+.+. |.++  ++++.++.+.+ ....|+
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl  121 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY  121 (822)
T ss_pred             eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence            356889999999999876542222468888765432   2246889999999995 6654  77777662211 135789


Q ss_pred             EEecCCCC
Q psy2172          96 LFDYAEHD  103 (291)
Q Consensus        96 v~e~~~~~  103 (291)
                      ||||++|.
T Consensus       122 VME~v~G~  129 (822)
T PLN02876        122 IMEYLEGR  129 (822)
T ss_pred             EEEecCCc
Confidence            99999874

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.26  E-value=3.6e-05  Score=60.29  Aligned_cols=103  Identities=19%  Similarity=0.263  Sum_probs=77.2

Q ss_pred             HHHHHHHhcCCC-CCeeeEEEEEEeCCCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHH
Q psy2172          64 CREIALLRELKH-PNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHY  141 (291)
Q Consensus        64 ~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~  141 (291)
                      ..|.-+++.+++ +++++++|++  ..    +++.||.+. .+.+......      .....++..+..++.+++..+.+
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C--G~----~~v~E~~~~~~~~~~~~~l~------~~~~~~w~~R~~iA~~lL~~l~~   74 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC--GR----FYVVEYVGAGSLYGIYRPLS------QFLQSPWEQRAKIALQLLELLEE   74 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC--CC----EEEEEeecCccccccccccc------cccccCHHHHHHHHHHHHHHHHH
Confidence            357788888865 6999999998  32    678899884 3332100000      00116788999999999999999


Q ss_pred             Hhh---CCeeeeccCCCcEEeecCCCCCCcEEEeecccceecCC
Q psy2172         142 LHS---NWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN  182 (291)
Q Consensus       142 LH~---~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~~~  182 (291)
                      |+.   ..+.-+|++++|+.++    .+++++++|...+.....
T Consensus        75 l~~~~~~~~~lcDv~~~nfgv~----~~~~lk~iDld~v~~~~~  114 (188)
T PF12260_consen   75 LDHGPLGFFYLCDVSPDNFGVN----DDGRLKLIDLDDVFVEDK  114 (188)
T ss_pred             HhcCCCCcEEEeecchHHeEEe----CCCcEEEEechhcchhHH
Confidence            997   4588899999999999    667899999998876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.11  E-value=2.6e-05  Score=63.66  Aligned_cols=71  Identities=14%  Similarity=0.166  Sum_probs=45.5

Q ss_pred             ceeCcccce-EEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCCC---CeeeEEEEEEeCCC-ceEEEEEec
Q psy2172          25 CKVGRGTYG-HVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHP---NVINLISVFLSHND-RKVWLLFDY   99 (291)
Q Consensus        25 ~~ig~G~~g-~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~~~~~-~~~~iv~e~   99 (291)
                      +.|+.|+.. .||+..       ..+++|+.+.......+.+|+++++.+...   .++++++.....+. ...+++|++
T Consensus         3 ~~~~~gG~~n~vy~~~-------~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           3 EPVDSGGTDNATFRLG-------DDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             eeccCCCcccceEEcC-------CceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            467777776 589762       247888876544455788999999888532   45555554311111 245889999


Q ss_pred             CCC
Q psy2172         100 AEH  102 (291)
Q Consensus       100 ~~~  102 (291)
                      ++|
T Consensus        76 i~G   78 (235)
T cd05155          76 LEG   78 (235)
T ss_pred             ecC
Confidence            887

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG0576|consensus

Probab=98.10  E-value=4.9e-07  Score=80.90  Aligned_cols=202  Identities=18%  Similarity=0.217  Sum_probs=135.6

Q ss_pred             cccceeecccccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCCCC-eeeE
Q psy2172           3 YEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPN-VINL   81 (291)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~   81 (291)
                      ++|+..+.+...+-...|-    -+++|+.+.+++.+...  + +....+.+...   ....-++++|.+++||| .+..
T Consensus       230 S~~qpp~lkDk~kws~~fh----~fvK~altknpKkRpta--e-klL~h~fvs~~---l~~rl~~eLLdK~n~P~~~v~~  299 (829)
T KOG0576|consen  230 SGFQPPTLKDKTKWSEFFH----NFVKGALTKNPKKRPTA--E-KLLQHPFVSQT---LSRRLAIELLDKVNNPNPVVRY  299 (829)
T ss_pred             cCCCCCcccCCccchHHHH----HHHHHHhcCCCccCCCh--h-hheeceeeccc---hhhHHHHHHHHHccCCCCcccc
Confidence            4555555555554444333    56789999999987543  2 23445554433   34445788999999999 5555


Q ss_pred             EEEEEeCCCceEEEEEecCCCC--HHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEe
Q psy2172          82 ISVFLSHNDRKVWLLFDYAEHD--LWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILV  159 (291)
Q Consensus        82 ~~~~~~~~~~~~~iv~e~~~~~--l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~  159 (291)
                      ++.+  +.+.+.++.++++++.  ..........        .+...+...+.+.-+++++++|+..-+|+|    ||+.
T Consensus       300 ~~d~--~~E~~~~i~~~i~s~~rs~~~~~~~se~--------~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~  365 (829)
T KOG0576|consen  300 LEDY--DGEDYLWIPMRICSTGRSSALEMTVSEI--------ALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILG  365 (829)
T ss_pred             cccC--CcccccchhhhhhcCCccccccCChhhH--------hhhhhhhhhhhhhhcccccccccccccCcc----cccc
Confidence            5555  5677899999999854  1111111100        033344555666677889999988778888    7776


Q ss_pred             ecCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCc
Q psy2172         160 MGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  238 (291)
Q Consensus       160 ~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~  238 (291)
                      +     ....+..||+....+....    ......+++.++|||+..+.. +....|+|++|.-..++.-|-+|-....
T Consensus       366 s-----~~~~~~~~~~v~~~L~~~~----~~~t~~~~~~~~~pev~~~~~-~~~~p~~~~~~~~~~~~ap~~pPr~~P~  434 (829)
T KOG0576|consen  366 S-----EEEVKLLDFAVPPQLTRTM----KPRTAIGTPEPLAPEVIQENT-IDGCPDSGSLAVSAIQMAPGLPPRSSPP  434 (829)
T ss_pred             c-----ccccccccccCCcccCccc----ccccCCCCCCCCCchhhcccc-cccCCCccCCCcchhhcCCCCCCCCCCc
Confidence            4     3578899999876554432    234567899999999887755 8888999999988888888888876643

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.02  E-value=0.00016  Score=56.72  Aligned_cols=120  Identities=23%  Similarity=0.206  Sum_probs=84.2

Q ss_pred             cceeCcccc-eEEEEEEEccCCCCceeEEEEeCC-----C------------------CCChhHHHHHHHHhcCC---CC
Q psy2172          24 GCKVGRGTY-GHVYKARRKDNSDTRDYALKQIEG-----T------------------GLSMSACREIALLRELK---HP   76 (291)
Q Consensus        24 ~~~ig~G~~-g~Vy~~~~~~~~~~~~vaiK~~~~-----~------------------~~~~~~~~e~~~l~~l~---h~   76 (291)
                      -+.||.|.- |.||++...    ++.||+|+++.     .                  ....-|.+|.++..+|+   +.
T Consensus        42 lefLg~g~~~~~V~kv~I~----g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e  117 (207)
T PF13095_consen   42 LEFLGHGSHDGYVFKVEID----GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGRE  117 (207)
T ss_pred             eeecCCCCceeEEEEEEEC----CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcccc
Confidence            468999999 999999864    46899999421     0                  01123678888888885   34


Q ss_pred             Ce--eeEEEEEEeC----------------CCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHH
Q psy2172          77 NV--INLISVFLSH----------------NDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDG  138 (291)
Q Consensus        77 ~i--v~~~~~~~~~----------------~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~  138 (291)
                      ++  |++++|..-.                ......||.||....-                 .+...    -+.+|.+-
T Consensus       118 ~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------------~~~~~----~~~~~~~d  176 (207)
T PF13095_consen  118 GLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------------PLQIR----DIPQMLRD  176 (207)
T ss_pred             CceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------------ccchh----HHHHHHHH
Confidence            55  9999998432                1123567888776532                 02222    34567777


Q ss_pred             HHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccc
Q psy2172         139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA  177 (291)
Q Consensus       139 l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~  177 (291)
                      +..+|..||+-+|+++.|..=         -+|+|||.+
T Consensus       177 l~~~~k~gI~~~Dv~~~ny~~---------G~lvDfs~~  206 (207)
T PF13095_consen  177 LKILHKLGIVPRDVKPRNYRG---------GKLVDFSSS  206 (207)
T ss_pred             HHHHHHCCeeeccCccccccC---------CEEEecccC
Confidence            888999999999999999852         389999965

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.93  E-value=0.00042  Score=56.39  Aligned_cols=72  Identities=14%  Similarity=0.206  Sum_probs=46.4

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC-ChhHHHHHHHHhcCCC-CCeeeEEEEEEeCCCceEEEEEecCC
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-SMSACREIALLRELKH-PNVINLISVFLSHNDRKVWLLFDYAE  101 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~~iv~e~~~  101 (291)
                      .+.|..|-...+|++...+. .++.|++|+...... .....+|+.+++.+.. .-.++++...  .+    .++|||++
T Consensus         3 i~~l~gG~tN~~~~v~~~~~-~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~--~~----~~l~e~i~   75 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKED-NQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATF--QN----GLIYEFIP   75 (235)
T ss_pred             EEEcCCcccceEEEEEcCCC-CCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEe--CC----cEEEEeeC
Confidence            45788898999999974310 245788997654321 1344578889988843 3345555443  22    37999998


Q ss_pred             C
Q psy2172         102 H  102 (291)
Q Consensus       102 ~  102 (291)
                      |
T Consensus        76 G   76 (235)
T cd05157          76 G   76 (235)
T ss_pred             C
Confidence            7

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.79  E-value=0.00022  Score=58.91  Aligned_cols=139  Identities=17%  Similarity=0.250  Sum_probs=76.3

Q ss_pred             eeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC--hhHHHHHHHHhcCCCCC-eeeEEEEEEeCCCceEEEEEecCCC
Q psy2172          26 KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS--MSACREIALLRELKHPN-VINLISVFLSHNDRKVWLLFDYAEH  102 (291)
Q Consensus        26 ~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~~~iv~e~~~~  102 (291)
                      .+..|-...+|+...    ++..+++|........  ....+|..+++.+...+ .++++...  ++    ++|++|++|
T Consensus         3 ~~~~G~tn~~y~~~~----~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~~----~~v~e~i~G   72 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH----PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--EH----WLLVEWLEG   72 (256)
T ss_pred             cCCCcCcCCeEEEEe----CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--CC----EEEEEeccC
Confidence            456688889998862    3457889986543222  25678999999986433 34555443  22    689999987


Q ss_pred             CHH------------HHHHHhhhhhhCCC-CCCCCHH-HHHHHHHHH---------HHHHHHHhh--------CCeeeec
Q psy2172         103 DLW------------HIIKFHRAAKANKK-PVMVPKG-MVKSLLYQI---------LDGIHYLHS--------NWVLHRD  151 (291)
Q Consensus       103 ~l~------------~~~~~~~~~~~~~~-~~~~~~~-~~~~i~~ql---------~~~l~~LH~--------~~ivH~d  151 (291)
                      ...            .+......-+.... ..+++.. .+.....++         ...+..+-.        ..++|+|
T Consensus        73 ~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D  152 (256)
T TIGR02721        73 EVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMD  152 (256)
T ss_pred             cccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence            221            11111111111111 1112211 111111111         111222211        2489999


Q ss_pred             cCCCcEEeecCCCCCCcEEEeeccccee
Q psy2172         152 LKPANILVMGEGIERGRVKIADMGFARL  179 (291)
Q Consensus       152 ik~~Nil~~~~~~~~~~~~l~Dfg~~~~  179 (291)
                      +.|.||+++    +++ +.++||+.+..
T Consensus       153 l~~~Nil~~----~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       153 VHAYNLVVT----PQG-LKLIDWEYASD  175 (256)
T ss_pred             CCcCcEEEe----CCC-CEEEeccccCc
Confidence            999999998    333 78999998764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK05231 homoserine kinase; Provisional

Probab=97.67  E-value=0.002  Score=55.10  Aligned_cols=74  Identities=14%  Similarity=0.085  Sum_probs=44.9

Q ss_pred             ceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCC--CCeeeEEEE----EEeCCCceEEEEEe
Q psy2172          25 CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKH--PNVINLISV----FLSHNDRKVWLLFD   98 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~----~~~~~~~~~~iv~e   98 (291)
                      +.|+.|....+|.....   . ..+++|+.. ......+..|+.+++.|..  -.+++++..    .+..-....+++++
T Consensus        28 ~~l~~G~~n~~y~v~t~---~-g~~vLK~~~-~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~  102 (319)
T PRK05231         28 KGIAEGIENSNFFLTTT---Q-GEYVLTLFE-RLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT  102 (319)
T ss_pred             chhccccccceEEEEeC---C-CcEEEEEec-cCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence            45677877899998743   2 358999876 3334455566777776632  224444432    11112345789999


Q ss_pred             cCCCC
Q psy2172          99 YAEHD  103 (291)
Q Consensus        99 ~~~~~  103 (291)
                      |.+|.
T Consensus       103 ~l~G~  107 (319)
T PRK05231        103 FLEGK  107 (319)
T ss_pred             ecCCC
Confidence            99873

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.67  E-value=0.00089  Score=56.56  Aligned_cols=146  Identities=18%  Similarity=0.074  Sum_probs=81.0

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCCC--CeeeEEEEE----EeCCCceEEEEE
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHP--NVINLISVF----LSHNDRKVWLLF   97 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~----~~~~~~~~~iv~   97 (291)
                      .+.|..|....+|+....    +..+++|+... .....+..|+.++..+.+.  .+++++...    .....+..++++
T Consensus        19 i~~i~~G~~n~~y~v~~~----~~~~vLr~~~~-~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~   93 (296)
T cd05153          19 FEGISAGIENTNYFVTTD----SGRYVLTLFEK-VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV   93 (296)
T ss_pred             eecccCccccceEEEEeC----CCcEEEEEcCC-CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence            457888888899998642    24699998875 4455677888888888433  245554421    111223568999


Q ss_pred             ecCCCCHHH---------HHHHhhhhhh---C-CCC--CCCCHHHHHH------------HHHHHHHHHHHHhh------
Q psy2172          98 DYAEHDLWH---------IIKFHRAAKA---N-KKP--VMVPKGMVKS------------LLYQILDGIHYLHS------  144 (291)
Q Consensus        98 e~~~~~l~~---------~~~~~~~~~~---~-~~~--~~~~~~~~~~------------i~~ql~~~l~~LH~------  144 (291)
                      ++.+|....         ........+.   . ...  ..........            ....+..++..+.+      
T Consensus        94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~  173 (296)
T cd05153          94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL  173 (296)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            999872210         1111111110   0 000  0000000000            11112233344432      


Q ss_pred             -CCeeeeccCCCcEEeecCCCCCCcEEEeecccce
Q psy2172         145 -NWVLHRDLKPANILVMGEGIERGRVKIADMGFAR  178 (291)
Q Consensus       145 -~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~  178 (291)
                       .+++|+|+.|.|++++    .+..+.|+||+.+.
T Consensus       174 ~~~l~HgD~~~~Nil~~----~~~~~~iIDfe~a~  204 (296)
T cd05153         174 PRGVIHADLFRDNVLFD----GDELSGVIDFYFAC  204 (296)
T ss_pred             CCcCCccCcCcccEEEe----CCceEEEeehhhhc
Confidence             4799999999999998    44556899999775

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.64  E-value=0.0016  Score=55.41  Aligned_cols=146  Identities=18%  Similarity=0.081  Sum_probs=79.8

Q ss_pred             ceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCCCC--eeeEEEEE----EeCCCceEEEEEe
Q psy2172          25 CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPN--VINLISVF----LSHNDRKVWLLFD   98 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~----~~~~~~~~~iv~e   98 (291)
                      ..++.|....+|++...    +..+++|+.........+..|++++..|...+  +++++...    .....+..+++++
T Consensus        28 ~~~~~G~~n~~y~v~t~----~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        28 KGIAEGVENSNYLLTTD----VGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             cccCCccccceEEEEeC----CCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            45677777899988632    23588998765434556777888888874322  44554421    1122345789999


Q ss_pred             cCCCCH-----HHHHHHh----hhhhhC--C--CCC----CCCH---HHHH----------HHHHHHHHHHHHHh-----
Q psy2172          99 YAEHDL-----WHIIKFH----RAAKAN--K--KPV----MVPK---GMVK----------SLLYQILDGIHYLH-----  143 (291)
Q Consensus        99 ~~~~~l-----~~~~~~~----~~~~~~--~--~~~----~~~~---~~~~----------~i~~ql~~~l~~LH-----  143 (291)
                      |++|..     .......    ...+..  .  .+.    ..+.   ....          .....+...++++.     
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            988721     1111111    000100  0  000    0000   0000          00112233444443     


Q ss_pred             --hCCeeeeccCCCcEEeecCCCCCCcEEEeecccce
Q psy2172         144 --SNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR  178 (291)
Q Consensus       144 --~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~  178 (291)
                        ..+++|+|+.+.|++++    .+..+.++||+.+.
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~----~~~~~~vIDfd~~~  216 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFD----GDSVKGVIDFYFAC  216 (307)
T ss_pred             cCCCccCCCCCCcCcEEEE----CCceEEEeeccccc
Confidence              26899999999999998    44456899999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.58  E-value=0.002  Score=56.43  Aligned_cols=74  Identities=12%  Similarity=0.062  Sum_probs=52.9

Q ss_pred             ccceeCcccceEEEEEEEccCCCCceeEEEEeCC---------CCCChhHHHHHHHHhcCC---CCCeeeEEEEEEeCCC
Q psy2172          23 EGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEG---------TGLSMSACREIALLRELK---HPNVINLISVFLSHND   90 (291)
Q Consensus        23 ~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~---------~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~   90 (291)
                      ..+.||.|.+..||++...+  .++.++||.-..         +....+...|++.|+.+.   ..++++++.+-    .
T Consensus        30 ~~~elggGn~N~VyrV~~~~--g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D----~  103 (401)
T PRK09550         30 TAREIGDGNLNLVFRVSDTE--GGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD----E  103 (401)
T ss_pred             eeeEcCCCceEEEEEEEeCC--CCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC----C
Confidence            34689999999999999753  324799998531         123345777888888873   34678888764    3


Q ss_pred             ceEEEEEecCCC
Q psy2172          91 RKVWLLFDYAEH  102 (291)
Q Consensus        91 ~~~~iv~e~~~~  102 (291)
                      ...++|||++++
T Consensus       104 ~~~~lVME~L~~  115 (401)
T PRK09550        104 ELAVTVMEDLSD  115 (401)
T ss_pred             CCCEEEEecCCC
Confidence            457899999875

>KOG2270|consensus

Probab=97.56  E-value=0.00086  Score=57.18  Aligned_cols=138  Identities=20%  Similarity=0.305  Sum_probs=93.0

Q ss_pred             ceeCcccceEEEEEEEccCCCCceeEEEEeCCC-----------------------CCChh-----HHHHHHHHhcCCCC
Q psy2172          25 CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-----------------------GLSMS-----ACREIALLRELKHP   76 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-----------------------~~~~~-----~~~e~~~l~~l~h~   76 (291)
                      ..|..|--+-||.|...   +|..+|||+.+..                       ..+..     +..|+.-|+++...
T Consensus       150 GCiSTGKEANVYHat~~---dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  150 GCISTGKEANVYHATEE---DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             cccccCccceeEeeecC---CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            47889999999999854   5566999987311                       11221     45678888888766


Q ss_pred             CeeeEEEEEEeCCCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHh-hCCeeeeccCCC
Q psy2172          77 NVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLH-SNWVLHRDLKPA  155 (291)
Q Consensus        77 ~iv~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH-~~~ivH~dik~~  155 (291)
                      +|+-.--..+    ....+||++++.+-+-.        +.-....++...+..+-.|++.-+.-|. ..++||.||+-=
T Consensus       227 GIP~PePIlL----k~hVLVM~FlGrdgw~a--------PkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEf  294 (520)
T KOG2270|consen  227 GIPCPEPILL----KNHVLVMEFLGRDGWAA--------PKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEF  294 (520)
T ss_pred             CCCCCCceee----ecceEeeeeccCCCCcC--------cccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhh
Confidence            6544333332    13479999998531111        0111122666667777777777777665 469999999999


Q ss_pred             cEEeecCCCCCCcEEEeecccceecCC
Q psy2172         156 NILVMGEGIERGRVKIADMGFARLFNN  182 (291)
Q Consensus       156 Nil~~~~~~~~~~~~l~Dfg~~~~~~~  182 (291)
                      |+|+     ..+.+.++|.+-+.....
T Consensus       295 N~Ly-----hdG~lyiIDVSQSVE~DH  316 (520)
T KOG2270|consen  295 NLLY-----HDGKLYIIDVSQSVEHDH  316 (520)
T ss_pred             hheE-----ECCEEEEEEccccccCCC
Confidence            9999     568999999998875443

>KOG2268|consensus

Probab=97.55  E-value=7.6e-05  Score=62.35  Aligned_cols=129  Identities=17%  Similarity=0.247  Sum_probs=89.6

Q ss_pred             ccceeCcccceEEEEEEEccCCCCceeEEEEeC----------CCC--------------CChhHHHHHHHHhcCCC--C
Q psy2172          23 EGCKVGRGTYGHVYKARRKDNSDTRDYALKQIE----------GTG--------------LSMSACREIALLRELKH--P   76 (291)
Q Consensus        23 ~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~----------~~~--------------~~~~~~~e~~~l~~l~h--~   76 (291)
                      -|..||-|--+.||.+-+.   .+++.++|+=+          ...              ..-.+.+|...|+.|..  -
T Consensus        96 vGnqIGVGKESDIY~v~d~---~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   96 VGNQIGVGKESDIYVVADE---EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hccccccccccceEEEecC---CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            3899999999999999865   56778888531          000              01135678999999953  4


Q ss_pred             CeeeEEEEEEeCCCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCC
Q psy2172          77 NVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPA  155 (291)
Q Consensus        77 ~iv~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~  155 (291)
                      -+++.+++.      ..++|||+..| .|...-.-            -+   ...+...+...+--|..+|+||||..-=
T Consensus       173 pVPkpiD~~------RH~Vvmelv~g~Pl~~v~~v------------~d---~~~ly~~lm~~Iv~la~~GlIHgDFNEF  231 (465)
T KOG2268|consen  173 PVPKPIDHN------RHCVVMELVDGYPLRQVRHV------------ED---PPTLYDDLMGLIVRLANHGLIHGDFNEF  231 (465)
T ss_pred             CCCCccccc------ceeeHHHhhcccceeeeeec------------CC---hHHHHHHHHHHHHHHHHcCceecccchh
Confidence            566666654      56899999887 44432211            11   2233344555566778899999999999


Q ss_pred             cEEeecCCCCCCcEEEeeccccee
Q psy2172         156 NILVMGEGIERGRVKIADMGFARL  179 (291)
Q Consensus       156 Nil~~~~~~~~~~~~l~Dfg~~~~  179 (291)
                      ||++.    .+..++++||--...
T Consensus       232 Nimv~----dd~~i~vIDFPQmvS  251 (465)
T KOG2268|consen  232 NIMVK----DDDKIVVIDFPQMVS  251 (465)
T ss_pred             eeEEe----cCCCEEEeechHhhc
Confidence            99998    667899999976543

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.26  E-value=0.0096  Score=50.43  Aligned_cols=73  Identities=21%  Similarity=0.261  Sum_probs=47.2

Q ss_pred             cceeCcccceEEEEEEEcc----CCCCceeEEEEeCCCC-CChhHHHHHHHHhcCCCC-CeeeEEEEEEeCCCceEEEEE
Q psy2172          24 GCKVGRGTYGHVYKARRKD----NSDTRDYALKQIEGTG-LSMSACREIALLRELKHP-NVINLISVFLSHNDRKVWLLF   97 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~----~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~~~iv~   97 (291)
                      .+.+..|-...+|++...+    ...++.+++|+..... ......+|..+++.+... -.++++..+  .+    ..|+
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~--~~----~~v~   76 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIF--PN----GRIE   76 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEe--CC----Cchh
Confidence            3467778888999987432    1124679999976532 234677888888888532 244556555  32    3578


Q ss_pred             ecCCC
Q psy2172          98 DYAEH  102 (291)
Q Consensus        98 e~~~~  102 (291)
                      +|++|
T Consensus        77 e~i~G   81 (302)
T cd05156          77 EFIPS   81 (302)
T ss_pred             heeCC
Confidence            88876

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.24  E-value=0.0069  Score=50.62  Aligned_cols=48  Identities=19%  Similarity=0.181  Sum_probs=31.1

Q ss_pred             cceeCcccce---EEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCC
Q psy2172          24 GCKVGRGTYG---HVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELK   74 (291)
Q Consensus        24 ~~~ig~G~~g---~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~   74 (291)
                      +..++.|..|   .|+.+..   ..+..+++|.-+.......+.+|+++|+.+.
T Consensus        13 ~~~~~~~~~g~~~~v~~i~~---~~g~~~VlR~p~~~~~~~~l~rE~~vL~~L~   63 (276)
T cd05152          13 PETLSLNESGLDFQVVFAKD---TDGVPWVLRIPRRPDVSERAAAEKRVLALVR   63 (276)
T ss_pred             CCcceecCCcceeEEEEEEc---CCCCeEEEEecCCHHHHHHHHHHHHHHHHHH
Confidence            3344444444   4555432   1456799998875555567899999999985

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=97.22  E-value=0.0057  Score=52.05  Aligned_cols=29  Identities=17%  Similarity=0.113  Sum_probs=25.6

Q ss_pred             CeeeeccCCCcEEeecCCCCCCcEEEeecccce
Q psy2172         146 WVLHRDLKPANILVMGEGIERGRVKIADMGFAR  178 (291)
Q Consensus       146 ~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~  178 (291)
                      +++|+|+.++|++++    +++.+.++||..+.
T Consensus       197 ~lcHgD~~~~Nvl~~----~~~~~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLYD----ETRGGYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEEc----CCCCEEEEEhhhcc
Confidence            799999999999998    55678999999775

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>KOG1035|consensus

Probab=97.11  E-value=0.0024  Score=61.81  Aligned_cols=157  Identities=20%  Similarity=0.240  Sum_probs=97.2

Q ss_pred             HHHHHHHHhcCCCCCeeeEEEEEEeCCCc--eEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHH
Q psy2172          63 ACREIALLRELKHPNVINLISVFLSHNDR--KVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGI  139 (291)
Q Consensus        63 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~--~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l  139 (291)
                      ...|...+.++.|+|++.++.+.+.....  ...+..+++.. ++...+..-..         ++....+.+..++..|+
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~---------i~~~~~r~~~~~~~~GL  299 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS---------IPLETLRILHQKLLEGL  299 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc---------cCHHHHHHHHHHHhhhH
Confidence            44577788888999999999988643222  12233455654 55555443332         78889999999999999


Q ss_pred             HHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe--ecccceecCCCCCCCCCCCCceecccccccccccCCc-CCCCchh
Q psy2172         140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIA--DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGAR-HYTKAID  216 (291)
Q Consensus       140 ~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~--Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~~D  216 (291)
                      .++|+....|.-+..+...-... ...+.+...  ||+.+.........    ....-+..+.++|...... ..+...|
T Consensus       300 ~~~h~~~l~~v~L~~s~~~~~~~-~~e~~~~~sl~~~~ss~~l~d~~~~----~~~~~~~~~~~~e~~~~~~~~~~r~~d  374 (1351)
T KOG1035|consen  300 AYLHSLSLEHVVLSASSSKESTV-DGEGVVAISLSDFDSSKPLPDNEKS----FSDLLAEIRNADEDLKENTAKKSRLTD  374 (1351)
T ss_pred             HHHHHhccceeEEeccccccccc-CccceeecchhhhcccccCCCcccc----hhhcCccccccccccccccchhhhhhH
Confidence            99999865555444431111111 123344444  88877655443221    1122244467777765532 1334479


Q ss_pred             HHHHHHHHHHHHcCCCC
Q psy2172         217 IWAIGCIFAELLTSEPI  233 (291)
Q Consensus       217 v~slG~~l~~l~~g~~p  233 (291)
                      +|.+|..+..+..|..+
T Consensus       375 L~~lgll~~~~~~~~~i  391 (1351)
T KOG1035|consen  375 LWCLGLLLLQLSQGEDI  391 (1351)
T ss_pred             HHHHHHHHhhhhhcCcc
Confidence            99999999999887644

>PRK10593 hypothetical protein; Provisional

Probab=97.09  E-value=0.0047  Score=52.24  Aligned_cols=75  Identities=11%  Similarity=-0.001  Sum_probs=55.2

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCC---CCeeeEEEEEEeC-CCceEEEEEec
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKH---PNVINLISVFLSH-NDRKVWLLFDY   99 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h---~~iv~~~~~~~~~-~~~~~~iv~e~   99 (291)
                      .+.||.|..+.||.....+    ..+++|..+.......+.+|+..|+.+..   -.++++++++... .....++|||+
T Consensus        19 ~~~i~~G~~~~vy~~~~~~----~~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~   94 (297)
T PRK10593         19 VECISEQPYAALWALYDSQ----GNPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER   94 (297)
T ss_pred             eeecCCccceeEEEEEcCC----CCEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence            5689999999999986432    24777875442345688999999999853   4688888876322 23558999999


Q ss_pred             CCC
Q psy2172         100 AEH  102 (291)
Q Consensus       100 ~~~  102 (291)
                      .+|
T Consensus        95 i~G   97 (297)
T PRK10593         95 LRG   97 (297)
T ss_pred             cCC
Confidence            987

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.96  E-value=0.031  Score=47.47  Aligned_cols=29  Identities=24%  Similarity=0.391  Sum_probs=24.6

Q ss_pred             CCeeeeccCCCcEEeecCCCCCCcEEEeecccce
Q psy2172         145 NWVLHRDLKPANILVMGEGIERGRVKIADMGFAR  178 (291)
Q Consensus       145 ~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~  178 (291)
                      .+++|||+.+.||+++    . +.+.++||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~----~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLK----D-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEe----C-CcEEEEECcccc
Confidence            5789999999999997    3 468999999654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.90  E-value=0.024  Score=48.90  Aligned_cols=71  Identities=20%  Similarity=0.194  Sum_probs=47.5

Q ss_pred             eeCcccceEEEEEEEccCCCCceeEEEEeC------C---CCCChhHHHHHHHHhcCC--CC-CeeeEEEEEEeCCCceE
Q psy2172          26 KVGRGTYGHVYKARRKDNSDTRDYALKQIE------G---TGLSMSACREIALLRELK--HP-NVINLISVFLSHNDRKV   93 (291)
Q Consensus        26 ~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~------~---~~~~~~~~~e~~~l~~l~--h~-~iv~~~~~~~~~~~~~~   93 (291)
                      .||.|-...||++...+  .++.++||.-.      .   +....+...|..+|+...  -| .+++++.+    +....
T Consensus         2 EigdGnlN~VfrV~~~~--g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~----D~e~~   75 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQE--GDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF----DTEMA   75 (370)
T ss_pred             cCCCCceEEEEEEEcCC--CCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE----ccccc
Confidence            46889999999999642  33569999753      1   223345667888887763  23 56666654    35566


Q ss_pred             EEEEecCCC
Q psy2172          94 WLLFDYAEH  102 (291)
Q Consensus        94 ~iv~e~~~~  102 (291)
                      .++||+++.
T Consensus        76 ~~vMEdL~~   84 (370)
T TIGR01767        76 VTVMEDLSH   84 (370)
T ss_pred             eehHhhCcc
Confidence            799999864

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.89  E-value=0.0088  Score=50.17  Aligned_cols=72  Identities=21%  Similarity=0.158  Sum_probs=46.7

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCC---CCCeeeEEEEEEeCCCceEEEEEecC
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELK---HPNVINLISVFLSHNDRKVWLLFDYA  100 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~~~iv~e~~  100 (291)
                      .+.++.|....+|+..  .  +++.+.+|+-. ......+..|+.-|+.|.   .-.+++++++...  ....++++||.
T Consensus        22 ~~~v~GG~i~~a~~~~--~--~~~~~FvK~~~-~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~--~~~~fLlle~l   94 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD--T--DGGSYFVKVNS-ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEY--DDDAFLLLEFL   94 (288)
T ss_dssp             EEEE--SSSSEEEEEE--T--TS-EEEEEEEE-GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE---SSCCEEEEE--
T ss_pred             eEecCCCChhheEEEE--C--CCccEEEEecC-hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEee--cCCceEEEEee
Confidence            4678889999999987  3  56779999876 444567888888888883   4568899988743  33449999998


Q ss_pred             CC
Q psy2172         101 EH  102 (291)
Q Consensus       101 ~~  102 (291)
                      +.
T Consensus        95 ~~   96 (288)
T PF03881_consen   95 EM   96 (288)
T ss_dssp             --
T ss_pred             cC
Confidence            64

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02236 choline kinase

Probab=96.88  E-value=0.035  Score=48.00  Aligned_cols=148  Identities=17%  Similarity=0.157  Sum_probs=80.1

Q ss_pred             ccceeCcccceEEEEEEEccC--CCCceeEEEEeCCCC-CChhHHHHHHHHhcCCCC-CeeeEEEEEEeCCCceEEEEEe
Q psy2172          23 EGCKVGRGTYGHVYKARRKDN--SDTRDYALKQIEGTG-LSMSACREIALLRELKHP-NVINLISVFLSHNDRKVWLLFD   98 (291)
Q Consensus        23 ~~~~ig~G~~g~Vy~~~~~~~--~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~~~iv~e   98 (291)
                      ....+..|-.-.+|++...+.  ...+.|++|+..... ..-...+|..+++.+... --+++++.+  .++    .+.+
T Consensus        40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~--~~g----~v~e  113 (344)
T PLN02236         40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRF--PNG----RVEE  113 (344)
T ss_pred             EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEE--CCc----eEEE
Confidence            345777799999999875432  123678999875432 222346788898888533 334556665  333    4677


Q ss_pred             cCCC-CHH-----------HHHHHhhhhhhCCCCC---CCCHHHHHHHHHHH-----------------HHHHHHH----
Q psy2172          99 YAEH-DLW-----------HIIKFHRAAKANKKPV---MVPKGMVKSLLYQI-----------------LDGIHYL----  142 (291)
Q Consensus        99 ~~~~-~l~-----------~~~~~~~~~~~~~~~~---~~~~~~~~~i~~ql-----------------~~~l~~L----  142 (291)
                      |+++ ++.           ........-+....+.   ......+..++.++                 ...+..|    
T Consensus       114 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~  193 (344)
T PLN02236        114 FIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKEL  193 (344)
T ss_pred             eeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHh
Confidence            8775 221           1111111111111110   01112222222111                 1111111    


Q ss_pred             h----hCCeeeeccCCCcEEeecCCCCCCcEEEeeccccee
Q psy2172         143 H----SNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL  179 (291)
Q Consensus       143 H----~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~  179 (291)
                      .    ...++|+|+++.||+++.   .+..+.++||..+..
T Consensus       194 ~~~~~~~~~cH~Dl~~~Nil~~~---~~~~~~lID~Eya~~  231 (344)
T PLN02236        194 SGDDQEIGFCHNDLQYGNIMIDE---ETRAITIIDYEYASY  231 (344)
T ss_pred             cccCCCceEEeCCCCcCcEEEeC---CCCcEEEEeehhccc
Confidence            1    235899999999999973   235799999998753

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.79  E-value=0.012  Score=49.94  Aligned_cols=32  Identities=22%  Similarity=0.381  Sum_probs=26.5

Q ss_pred             CeeeeccCCCcEEeecCCCCCCcEEEeecccceecC
Q psy2172         146 WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFN  181 (291)
Q Consensus       146 ~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~~  181 (291)
                      .++|||+.+.|++++    +...+-++||+.+..-.
T Consensus       199 ~lvHGD~~~gNlii~----~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         199 VLVHGDYRPGNLIID----PGRPTGVLDWELATLGD  230 (321)
T ss_pred             eeeeCCcccCCEEEe----CCCeeEEEeccccccCC
Confidence            389999999999999    44458999999987544

>PTZ00384 choline kinase; Provisional

Probab=96.73  E-value=0.036  Score=48.58  Aligned_cols=75  Identities=17%  Similarity=0.230  Sum_probs=46.2

Q ss_pred             cccceeCcccceEEEEEEEccCCCC----ceeEEEEeC-CCCCChhHHHHHHHHhcCC-CCCeeeEEEEEEeCCCceEEE
Q psy2172          22 YEGCKVGRGTYGHVYKARRKDNSDT----RDYALKQIE-GTGLSMSACREIALLRELK-HPNVINLISVFLSHNDRKVWL   95 (291)
Q Consensus        22 ~~~~~ig~G~~g~Vy~~~~~~~~~~----~~vaiK~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~i   95 (291)
                      ++.+.|..|-...+|++...+....    +.|.++... .....-+..+|..+++.+. +-.-+++++.+  .+    ++
T Consensus        53 i~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f--~~----g~  126 (383)
T PTZ00384         53 IEIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRF--GD----FT  126 (383)
T ss_pred             EEEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEec--CC----EE
Confidence            3456777799999999975432111    123444321 1122234567899999995 44556777777  33    68


Q ss_pred             EEecCCC
Q psy2172          96 LFDYAEH  102 (291)
Q Consensus        96 v~e~~~~  102 (291)
                      +.||++|
T Consensus       127 l~efIeG  133 (383)
T PTZ00384        127 IQEWVEG  133 (383)
T ss_pred             EEEEecc
Confidence            9999987

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.71  E-value=0.088  Score=45.27  Aligned_cols=75  Identities=13%  Similarity=0.272  Sum_probs=47.6

Q ss_pred             cccceeCcccceEEEEEEEccC-CCCceeEEEEeCCCC-CChhHHHHHHHHhcCCCCCe-eeEEEEEEeCCCceEEEEEe
Q psy2172          22 YEGCKVGRGTYGHVYKARRKDN-SDTRDYALKQIEGTG-LSMSACREIALLRELKHPNV-INLISVFLSHNDRKVWLLFD   98 (291)
Q Consensus        22 ~~~~~ig~G~~g~Vy~~~~~~~-~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~~iv~e   98 (291)
                      +..+.|..|-...+|++...+. .+...|++|+..... ..-...+|..+++.+...++ +++++++  .++    ++.+
T Consensus        17 i~i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~--~~G----~i~~   90 (330)
T PLN02421         17 FSVERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVF--GNG----MIQS   90 (330)
T ss_pred             eEEEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEe--CCc----Eeeh
Confidence            3456777788899999875432 123478999875432 22345678889988864444 4556555  332    4788


Q ss_pred             cCCC
Q psy2172          99 YAEH  102 (291)
Q Consensus        99 ~~~~  102 (291)
                      |++|
T Consensus        91 fi~g   94 (330)
T PLN02421         91 FINA   94 (330)
T ss_pred             hhcC
Confidence            8775

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.23  E-value=0.026  Score=48.35  Aligned_cols=75  Identities=21%  Similarity=0.255  Sum_probs=57.8

Q ss_pred             CCCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CeeeeccCCCcEEeecCCCCC
Q psy2172          88 HNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSN-WVLHRDLKPANILVMGEGIER  166 (291)
Q Consensus        88 ~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~-~ivH~dik~~Nil~~~~~~~~  166 (291)
                      .+..+.|++|++.++++...-.             -..+++..++++.+..+.-+..+ .+-|+++...||+++     .
T Consensus       296 de~~y~yl~~kdhgt~is~ik~-------------~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-----~  357 (488)
T COG5072         296 DETLYLYLHFKDHGTPISIIKA-------------DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-----E  357 (488)
T ss_pred             CCceEEEEEEecCCceeeeeec-------------ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-----c
Confidence            3556889999998876442211             34567888899988887777754 689999999999996     5


Q ss_pred             CcEEEeecccceec
Q psy2172         167 GRVKIADMGFARLF  180 (291)
Q Consensus       167 ~~~~l~Dfg~~~~~  180 (291)
                      ++|.|+||.+++.-
T Consensus       358 GnvtLIDfklsRl~  371 (488)
T COG5072         358 GNVTLIDFKLSRLS  371 (488)
T ss_pred             CceEEEEeeeeecc
Confidence            78999999999843

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.21  E-value=0.11  Score=44.61  Aligned_cols=70  Identities=19%  Similarity=0.141  Sum_probs=41.4

Q ss_pred             ccceEEEEEEEccCCCCceeEEEEeCCCC-CChhHHHHHHHHhcCCCCC--eeeEE---EEEEeCCCceEEEEEecCCC
Q psy2172          30 GTYGHVYKARRKDNSDTRDYALKQIEGTG-LSMSACREIALLRELKHPN--VINLI---SVFLSHNDRKVWLLFDYAEH  102 (291)
Q Consensus        30 G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~--iv~~~---~~~~~~~~~~~~iv~e~~~~  102 (291)
                      +.-..||+....   ++..+++|+.+... ....+..|+.++..|....  ++...   +-.+..-+...+.++++.+|
T Consensus        36 s~eN~vy~v~~~---~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G  111 (325)
T PRK11768         36 SYENRVYQFGDE---DGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGG  111 (325)
T ss_pred             cccceEEEEecC---CCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCC
Confidence            455678888643   44569999886443 3456778888888774221  22221   11111123467889999876

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.17  E-value=0.058  Score=47.16  Aligned_cols=73  Identities=12%  Similarity=0.093  Sum_probs=50.4

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeC-----C---CCCChhHHHHHHHHhcCC--CC-CeeeEEEEEEeCCCce
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIE-----G---TGLSMSACREIALLRELK--HP-NVINLISVFLSHNDRK   92 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~-----~---~~~~~~~~~e~~~l~~l~--h~-~iv~~~~~~~~~~~~~   92 (291)
                      .+.||.|--.-||++.+..  .++.++||.-.     .   +....+...|.++|+...  -| ++++++.+    +...
T Consensus        34 ~~eigdGnlN~VfrV~~~~--~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~----D~e~  107 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQ--KNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF----DSVM  107 (409)
T ss_pred             eeEcCCCceEEEEEEeeCC--CCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE----CcHH
Confidence            5689999999999998742  23568998752     1   123356677888888773  23 56666664    4556


Q ss_pred             EEEEEecCCC
Q psy2172          93 VWLLFDYAEH  102 (291)
Q Consensus        93 ~~iv~e~~~~  102 (291)
                      ..+|||+++.
T Consensus       108 ~~~vMEdL~~  117 (409)
T PRK12396        108 NCCVMEDLSD  117 (409)
T ss_pred             hhHHHHhCcc
Confidence            7889999864

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.10  E-value=0.13  Score=45.17  Aligned_cols=72  Identities=21%  Similarity=0.169  Sum_probs=50.3

Q ss_pred             ccceeCcccceEEEEEEEccCCCCceeEEEEeCC-----C----CCChhHHHHHHHHhcCC---CCCeeeEEEEEEeCCC
Q psy2172          23 EGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEG-----T----GLSMSACREIALLRELK---HPNVINLISVFLSHND   90 (291)
Q Consensus        23 ~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~-----~----~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~   90 (291)
                      ..+.||.|-...||+..+.    +..++||.-..     .    ....+...|++.|+.+.   ...+++++.+.  +  
T Consensus        36 ~~~eiggGn~N~VyrV~~~----~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d--e--  107 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS----SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD--R--  107 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC----CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC--C--
Confidence            4568899999999998852    24589998651     1    13345566777777664   24788888876  3  


Q ss_pred             ceEEEEEecCCC
Q psy2172          91 RKVWLLFDYAEH  102 (291)
Q Consensus        91 ~~~~iv~e~~~~  102 (291)
                      ...+++||++++
T Consensus       108 d~~vlvME~L~~  119 (418)
T PLN02756        108 TMALIGMRYLEP  119 (418)
T ss_pred             CCCEEEEeecCC
Confidence            345788999965

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.66  E-value=0.26  Score=42.29  Aligned_cols=74  Identities=20%  Similarity=0.214  Sum_probs=45.9

Q ss_pred             eeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCC-C--CC---eeeEEEEEEeCCC--ceEEEEE
Q psy2172          26 KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELK-H--PN---VINLISVFLSHND--RKVWLLF   97 (291)
Q Consensus        26 ~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~-h--~~---iv~~~~~~~~~~~--~~~~iv~   97 (291)
                      .|.+ .-..+|+....+    ..+++|+.+......++..|..+|..|. +  +-   ++..=+-.+..-.  .+.+.++
T Consensus        33 ~l~s-~eN~~f~~~~~~----g~~iLki~~~~~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf  107 (331)
T COG2334          33 GLNS-EENSNFRVQTED----GRYILKIYRPGWTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALF  107 (331)
T ss_pred             cccc-ccCceEEEEecC----CCeEEEEecCCCCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEE
Confidence            3444 556788887543    3459999887656677888899988883 1  11   2222222221112  4788899


Q ss_pred             ecCCCCH
Q psy2172          98 DYAEHDL  104 (291)
Q Consensus        98 e~~~~~l  104 (291)
                      +|++|..
T Consensus       108 ~~l~G~~  114 (331)
T COG2334         108 EYLPGRP  114 (331)
T ss_pred             EecCCcC
Confidence            9998843

>KOG1826|consensus

Probab=95.28  E-value=0.003  Score=63.03  Aligned_cols=158  Identities=16%  Similarity=0.053  Sum_probs=107.7

Q ss_pred             HHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHh
Q psy2172          65 REIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLH  143 (291)
Q Consensus        65 ~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH  143 (291)
                      .|..-++...|+++.....-.........+..++++. |.+.+.+........     +.....+.....+.+.+..-.|
T Consensus      1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~-----~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESP-----DLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred             hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCC-----cchhchHHHHHHHHHhccchhh
Confidence            3444455567888877776665455566788888886 577777665443321     1444444444445466666666


Q ss_pred             hC-C----eeeeccCCCcEEeecCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHH
Q psy2172         144 SN-W----VLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIW  218 (291)
Q Consensus       144 ~~-~----ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~  218 (291)
                      .. +    -+|.++++.|.++.    ....+++.++|+.+.....   ..-.+...+++-|++|+....-. ++.++|+|
T Consensus      1353 s~tnlg~T~v~~~Lkf~lpmIV----tny~v~~gk~gLdKIknp~---~sf~Gl~l~sp~~v~qli~N~ik-~t~rsdil 1424 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIV----TNYNVKLGKGGLDKIKNPV---LSFFGLELCSPIYVLQLIKNEIK-FTKRSDIL 1424 (2724)
T ss_pred             hcccCCccchhhhhhhhcccee----cCCcccccccccccccCch---HhhhhhhhCCHHHHHHHHHHHHh-hhhHHHHH
Confidence            43 1    68999999999998    6678999999998833221   12234456677788888776533 77789999


Q ss_pred             HHHHHHHHHHcCCCCCC
Q psy2172         219 AIGCIFAELLTSEPIFH  235 (291)
Q Consensus       219 slG~~l~~l~~g~~pf~  235 (291)
                      ..|+.+|....|..+|.
T Consensus      1425 r~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1425 RRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred             HHHHHHHHHhcccHHHH
Confidence            99999999998887773

>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []

Probab=95.26  E-value=0.25  Score=40.63  Aligned_cols=76  Identities=20%  Similarity=0.136  Sum_probs=52.5

Q ss_pred             eeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecC-CC-C
Q psy2172          26 KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYA-EH-D  103 (291)
Q Consensus        26 ~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~-~~-~  103 (291)
                      .+..|..+.|+.+...   ++.+.++|+................|+..+-.+.|++++.-    ...-.+++|.+ ++ +
T Consensus         9 ~~~~g~~s~V~pv~~~---dG~~avLKl~~p~~~~~~E~~g~~~L~~w~G~GaVrll~~d----~~~~AlLLErl~~g~~   81 (253)
T PF04655_consen    9 PPAHGSSSLVVPVRRA---DGTPAVLKLAPPHAEAEHEARGEAALRWWNGRGAVRLLAAD----PERGALLLERLDPGRS   81 (253)
T ss_pred             CCCCCcceEEEEEEcC---CCCeEEEEecCCcccchhhhhHHhHhheeCCCCceeeeccc----cccchhhhhhccCCCc
Confidence            5667999999999843   56789999987544333222233568888888899999854    44557888888 44 5


Q ss_pred             HHHHH
Q psy2172         104 LWHII  108 (291)
Q Consensus       104 l~~~~  108 (291)
                      |.+..
T Consensus        82 L~~~~   86 (253)
T PF04655_consen   82 LASLP   86 (253)
T ss_pred             hhhcc
Confidence            55444

Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process

>PRK06148 hypothetical protein; Provisional

Probab=95.07  E-value=0.44  Score=47.41  Aligned_cols=75  Identities=19%  Similarity=0.271  Sum_probs=43.7

Q ss_pred             ceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCC--CCC--eeeEEEE----E---Ee--CCCc
Q psy2172          25 CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELK--HPN--VINLISV----F---LS--HNDR   91 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~--h~~--iv~~~~~----~---~~--~~~~   91 (291)
                      +.|+ |..-.+|+....   ++..+++|+.+..........|..+|..|.  .+.  +++++-.    .   ..  ....
T Consensus        31 ~~L~-s~~d~nf~v~~~---~g~~yVLKi~~~~~~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~  106 (1013)
T PRK06148         31 TPLD-GERDLNFRLTTD---DGADYILKIVNPSEPRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEP  106 (1013)
T ss_pred             eecC-CcCCceEEEEeC---CCCeEEEEEcCCccchhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCce
Confidence            4554 445777887642   455799999986554555566666776552  222  3343321    1   11  1222


Q ss_pred             eEEEEEecCCCC
Q psy2172          92 KVWLLFDYAEHD  103 (291)
Q Consensus        92 ~~~iv~e~~~~~  103 (291)
                      ..+.+++|.+|.
T Consensus       107 ~~vrLl~~l~G~  118 (1013)
T PRK06148        107 RLLRLLSWLPGT  118 (1013)
T ss_pred             EEEEEEeccCCC
Confidence            577889999984

>PTZ00296 choline kinase; Provisional

Probab=94.62  E-value=1.4  Score=39.45  Aligned_cols=75  Identities=8%  Similarity=0.105  Sum_probs=46.4

Q ss_pred             cccceeCcccceEEEEEEEccCC------CCceeEEEEeCCCC-CChhHHHHHHHHhcCCCCCe-eeEEEEEEeCCCceE
Q psy2172          22 YEGCKVGRGTYGHVYKARRKDNS------DTRDYALKQIEGTG-LSMSACREIALLRELKHPNV-INLISVFLSHNDRKV   93 (291)
Q Consensus        22 ~~~~~ig~G~~g~Vy~~~~~~~~------~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~   93 (291)
                      +..+.|..|-.-.+|++...+..      .++.|++++..... ......+|..+++.+...++ +++++.+  .+    
T Consensus       108 I~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f--~g----  181 (442)
T PTZ00296        108 VRVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTF--SG----  181 (442)
T ss_pred             EEEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEe--CC----
Confidence            34567888989999999764311      13578888874321 22245668888888753333 3556665  33    


Q ss_pred             EEEEecCCC
Q psy2172          94 WLLFDYAEH  102 (291)
Q Consensus        94 ~iv~e~~~~  102 (291)
                      +.+.+|.+|
T Consensus       182 g~I~efi~g  190 (442)
T PTZ00296        182 GRIEEWLYG  190 (442)
T ss_pred             CEEEEeeCC
Confidence            356788775

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=94.60  E-value=0.3  Score=39.23  Aligned_cols=84  Identities=17%  Similarity=0.218  Sum_probs=57.0

Q ss_pred             hHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHH
Q psy2172          62 SACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHY  141 (291)
Q Consensus        62 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~  141 (291)
                      -+.++..+++++.  +|+++..    ++.-.+.++.|+|-..-.                 .+.    .++..=+.+|..
T Consensus       104 ~y~nky~v~Armh--GilrL~N----Dn~~~yGvIlE~Cy~~~i-----------------~~~----N~i~agi~~L~~  156 (308)
T PF07387_consen  104 LYFNKYRVFARMH--GILRLKN----DNNYKYGVILERCYKIKI-----------------NFS----NFITAGIKDLMD  156 (308)
T ss_pred             hhhhhhhHHHHhh--heeEeec----CCCceeEEEEeeccCccc-----------------chh----HHHHHhHHHHHH
Confidence            3566777777653  5777763    456678899998864211                 111    111111456778


Q ss_pred             Hhh--CCeeeeccCCCcEEeecCCCCCCcEEEeeccc
Q psy2172         142 LHS--NWVLHRDLKPANILVMGEGIERGRVKIADMGF  176 (291)
Q Consensus       142 LH~--~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~  176 (291)
                      +|+  .+.+|||-.|+||+-+    ..+.+||.|=+.
T Consensus       157 fH~~~~~~lHGD~np~NiM~D----~~G~lKlVDP~~  189 (308)
T PF07387_consen  157 FHSENQHCLHGDCNPDNIMCD----KFGYLKLVDPVC  189 (308)
T ss_pred             hhccCCCeecCCCChhheeec----CCCCEEecChhh
Confidence            884  4799999999999999    778999999764

The function of this family is unknown.

>KOG1236|consensus

Probab=94.57  E-value=0.15  Score=44.67  Aligned_cols=60  Identities=22%  Similarity=0.381  Sum_probs=39.1

Q ss_pred             EEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHH-HHhhCCeeeeccCCCcEEeecC
Q psy2172          93 VWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIH-YLHSNWVLHRDLKPANILVMGE  162 (291)
Q Consensus        93 ~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~-~LH~~~ivH~dik~~Nil~~~~  162 (291)
                      ..++-+|..| ++..++....          .+++....++.-.+.|+- .|---+++|.|+.|.||++...
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~~~----------~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~  381 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKWKS----------QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN  381 (565)
T ss_pred             ceeeeeccccccHHhhhhccc----------ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence            4556666666 5555554332          455566666666666643 3334689999999999999753

>PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli []

Probab=94.56  E-value=0.01  Score=42.71  Aligned_cols=57  Identities=23%  Similarity=0.433  Sum_probs=41.5

Q ss_pred             ccccccccc-cccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcC
Q psy2172          13 RTKVEDLFD-YEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLREL   73 (291)
Q Consensus        13 ~~~~~~~~~-~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l   73 (291)
                      +..+++.|+ ++.+.||.|+.|+||+|..+   +++.||||+.++ .....+...+.+|+.+
T Consensus         4 G~~~~~~F~~fd~~PlasASiaQVh~a~l~---~g~~VaVKV~rP-~i~~~i~~Dl~~l~~~   61 (119)
T PF03109_consen    4 GKPIDEIFDEFDPEPLASASIAQVHRARLK---DGEEVAVKVQRP-GIEEQIEADLRILRRL   61 (119)
T ss_pred             CCCHHHHHHHCCcchhhheehhhheeeeec---ccchhhhhhcch-HHHHHHHHHHHHHHHH
Confidence            344556664 56789999999999999976   478899998764 3455666666666644

These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	291
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		1e-141
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-46
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-46
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-45
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-45
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-45
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-45
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-45
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-45
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-45
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-45
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-45
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-45
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-45
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-45
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-45
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-45
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-45
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-45
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-45
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-45
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-45
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		4e-45
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-45
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-45
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-45
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-45
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-45
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-45
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-45
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-45
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		9e-45
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-44
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-44
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-44
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-44
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-44
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-44
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-43
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-43
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-43
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-42
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-41
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-40
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-40
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		7e-40
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-39
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-38
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-38
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-37
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-37
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		6e-37
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		6e-37
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		6e-37
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-36
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		6e-34
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		9e-34
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		9e-34
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		9e-34
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-33
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-31
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-31
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-30
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-30
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-30
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-30
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-30
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-30
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-30
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-30
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-30
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-30
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-30
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-30
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-30
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-30
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-30
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-30
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-30
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-30
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-30
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-30
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-30
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		5e-30
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		4e-29
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		8e-29
4exu_A	371	Mapk13, Inactive Form Length = 371		8e-29
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-28
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-27
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-27
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-27
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-27
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-27
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-27
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		5e-27
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-26
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-26
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-26
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-26
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-26
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-26
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-26
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-26
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-26
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-26
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-26
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-26
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-26
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-26
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		4e-26
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		4e-26
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-26
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-26
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-26
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-26
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-26
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		4e-26
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-26
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-26
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-26
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-26
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-26
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-26
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-26
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-26
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-26
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-26
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-26
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-26
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		4e-26
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-26
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		5e-26
2oza_B	366	Structure Of P38alpha Complex Length = 366		5e-26
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		5e-26
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		5e-26
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		5e-26
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-26
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-26
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		5e-26
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-26
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-26
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		5e-26
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		5e-26
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-26
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		6e-26
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-26
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		6e-26
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-26
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		7e-26
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-26
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		7e-26
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		8e-26
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		8e-26
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		9e-26
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-25
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-25
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		6e-25
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		7e-25
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		8e-25
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		8e-25
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		9e-25
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-24
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-24
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-24
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-24
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		4e-24
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		4e-24
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-24
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		4e-24
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-24
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		4e-24
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		4e-24
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		4e-24
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		4e-24
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-24
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		4e-24
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		5e-24
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		5e-24
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		5e-24
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		5e-24
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		5e-24
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-23
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		7e-23
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		7e-23
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		7e-23
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		8e-23
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		9e-23
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		9e-23
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-22
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-22
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-22
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-22
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-22
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-22
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-22
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-22
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-22
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-22
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-22
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-22
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-22
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-22
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-22
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-22
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		3e-22
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-22
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		4e-22
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-22
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		5e-22
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		5e-22
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		5e-22
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		9e-22
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-21
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		3e-21
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		9e-21
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-19
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-19
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-19
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-19
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		6e-19
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		7e-19
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		7e-19
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		8e-19
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		9e-19
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-18
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-18
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-18
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		4e-18
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		5e-18
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		5e-18
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-18
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		6e-18
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		6e-18
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		6e-18
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-18
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		8e-18
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		8e-18
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		9e-18
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-17
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-17
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-17
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-17
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-17
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-17
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-17
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-17
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-17
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-17
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-17
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-17
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-17
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-17
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-17
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-17
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-17
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-17
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-17
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-17
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-17
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-17
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-17
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-17
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-17
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-17
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-17
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		7e-17
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		7e-17
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		9e-17
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		9e-17
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-16
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-16
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-16
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-16
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-16
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-16
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-16
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		5e-16
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		5e-16
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		5e-16
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		5e-16
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		6e-16
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		6e-16
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-16
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		6e-16
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		6e-16
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		6e-16
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		7e-16
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		7e-16
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		7e-16
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		7e-16
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		7e-16
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		7e-16
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		7e-16
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		7e-16
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		8e-16
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		8e-16
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		8e-16
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		9e-16
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		9e-16
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-15
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-15
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-15
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-15
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-15
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-15
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		3e-15
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-15
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-15
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		4e-15
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-15
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		5e-15
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		5e-15
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		5e-15
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		5e-15
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		5e-15
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		5e-15
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		5e-15
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		5e-15
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		6e-15
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-15
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		6e-15
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		6e-15
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		6e-15
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		6e-15
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		6e-15
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		7e-15
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-15
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-15
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		7e-15
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		7e-15
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		8e-15
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		8e-15
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		8e-15
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		8e-15
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-15
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		8e-15
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		8e-15
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-15
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		9e-15
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		9e-15
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		9e-15
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		9e-15
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		9e-15
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		9e-15
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-14
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-14
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-14
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-14
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-14
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-14
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-14
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-14
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-14
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-14
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-14
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-14
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-14
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-14
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		3e-14
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-14
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-14
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-14
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-14
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		4e-14
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		4e-14
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-14
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-14
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		5e-14
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		5e-14
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		5e-14
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		5e-14
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		5e-14
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		5e-14
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		5e-14
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		5e-14
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		5e-14
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		5e-14
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		5e-14
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-14
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		6e-14
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		6e-14
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		6e-14
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		7e-14
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-13
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-13
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-13
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-13
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-13
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-13
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-13
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-13
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		3e-13
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		3e-13
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-13
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-13
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		5e-13
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		6e-13
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		6e-13
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		7e-13
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		7e-13
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-13
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		7e-13
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		7e-13
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-13
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-12
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-12
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		1e-12
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-12
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		2e-12
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		2e-12
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-12
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-12
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-12
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		3e-12
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-12
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-12
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-12
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-12
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-12
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		4e-12
3kk9_A	282	Camkii Substrate Complex B Length = 282		5e-12
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		6e-12
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		6e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		7e-12
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		8e-12
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		8e-12
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		9e-12
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		9e-12
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-11
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-11
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-11
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-11
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-11
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-11
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-11
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-11
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-11
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-11
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		4e-11
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-11
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-11
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		5e-11
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		7e-11
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		7e-11
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		7e-11
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		7e-11
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		7e-11
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-11
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		7e-11
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		8e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		8e-11
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		8e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		8e-11
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		8e-11
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		8e-11
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		8e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		8e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		8e-11
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		9e-11
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		9e-11
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		9e-11
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-10
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-10
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-10
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-10
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-10
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-10
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-10
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-10
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-10
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-10
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-10
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-10
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-10
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-10
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-10
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-10
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-10
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-10
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-10
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-10
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-10
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-10
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-10
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-10
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		3e-10
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		3e-10
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-10
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		3e-10
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-10
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-10
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-10
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-10
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-10
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-10
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-10
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-10
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-10
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-10
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-10
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-10
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-10
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		4e-10
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-10
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-10
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-10
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-10
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		4e-10
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-10
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		4e-10
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-10
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		4e-10
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		4e-10
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-10
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-10
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		4e-10
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		5e-10
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-10
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-10
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		5e-10
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		5e-10
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		5e-10
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		6e-10
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		6e-10
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		6e-10
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		6e-10
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		6e-10
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		6e-10
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		6e-10
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		6e-10
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		6e-10
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		6e-10
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		7e-10
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		7e-10
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		7e-10
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		7e-10
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		7e-10
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		8e-10
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		8e-10
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		8e-10
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		8e-10
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		9e-10
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		9e-10
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		9e-10
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-09
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-09
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-09
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-09
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-09
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-09
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-09
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-09
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-09
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-09
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-09
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-09
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-09
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-09
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-09
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-09
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-09
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-09
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-09
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-09
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-09
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-09
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-09
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-09
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-09
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-09
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-09
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-09
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-09
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-09
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-09
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-09
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-09
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-09
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-09
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-09
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-09
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-09
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-09
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-09
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-09
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-09
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-09
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-09
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		3e-09
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-09
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-09
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		4e-09
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		4e-09
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-09
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-09
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		4e-09
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-09
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-09
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-09
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-09
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		4e-09
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-09
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-09
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		4e-09
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		4e-09
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-09
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		4e-09
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-09
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		5e-09
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		5e-09
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-09
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		5e-09
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		5e-09
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		5e-09
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		5e-09
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		5e-09
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		5e-09
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		6e-09
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		6e-09
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		6e-09
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		6e-09
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		6e-09
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		7e-09
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-09
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		7e-09
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		7e-09
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		7e-09
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		8e-09
2oza_A	356	Structure Of P38alpha Complex Length = 356		8e-09
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		8e-09
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		8e-09
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		8e-09
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		8e-09
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		8e-09
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		8e-09
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		8e-09
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		8e-09
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		8e-09
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		8e-09
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		9e-09
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		9e-09
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		9e-09
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		9e-09
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		9e-09
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		9e-09
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-08
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-08
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-08
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-08
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-08
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-08
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-08
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-08
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-08
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-08
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-08
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-08
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-08
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-08
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-08
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-08
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-08
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-08
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-08
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-08
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-08
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-08
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-08
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-08
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-08
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-08
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-08
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-08
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-08
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-08
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-08
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-08
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-08
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-08
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-08
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-08
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-08
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-08
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-08
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-08
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-08
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-08
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-08
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		2e-08
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-08
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-08
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-08
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-08
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-08
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-08
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-08
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-08
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-08
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-08
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-08
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-08
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-08
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-08
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-08
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-08
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-08
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-08
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-08
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-08
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-08
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-08
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-08
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-08
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-08
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-08
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-08
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		3e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-08
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-08
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		4e-08
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-08
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-08
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-08
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-08
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		6e-08
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		6e-08
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		6e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		6e-08
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		6e-08
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		7e-08
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-08
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-08
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		7e-08
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-08
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		7e-08
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		7e-08
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		7e-08
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		7e-08
2pl0_A	289	Lck Bound To Imatinib Length = 289		7e-08
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		8e-08
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		8e-08
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		8e-08
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-08
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		8e-08
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		9e-08
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		9e-08
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-07
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-07
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-07
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		1e-07
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-07
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		1e-07
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-07
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-07
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-07
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-07
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-07
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-07
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-07
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-07
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-07
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-07
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-07
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-07
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-07
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-07
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-07
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-07
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-07
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		2e-07
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-07
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-07
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-07
3soa_A	444	Full-Length Human Camkii Length = 444		2e-07
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-07
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		2e-07
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-07
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-07
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-07
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-07
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-07
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-07
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		2e-07
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-07
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-07
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-07
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-07
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-07
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-07
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-07
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-07
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-07
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-07
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-07
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-07
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-07
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-07
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-07
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		4e-07
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-07
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		5e-07
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-07
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		5e-07
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		6e-07
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		6e-07
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		6e-07
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		6e-07
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		6e-07
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		7e-07
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		7e-07
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		7e-07
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		7e-07
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		7e-07
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		7e-07
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-07
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		8e-07
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		8e-07
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		8e-07
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		8e-07
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		9e-07
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		9e-07
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		9e-07
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		9e-07
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		9e-07
4h58_A	275	Braf In Complex With Compound 3 Length = 275		9e-07
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-06
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-06
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-06
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-06
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-06
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-06
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-06
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-06
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-06
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		1e-06
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-06
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-06
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-06
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-06
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-06
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-06
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-06
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-06
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-06
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-06
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-06
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-06
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-06
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-06
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-06
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-06
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-06
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-06
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-06
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-06
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-06
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-06
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-06
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-06
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-06
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		3e-06
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		3e-06
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-06
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-06
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-06
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-06
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-06
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-06
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-06
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		4e-06
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-06
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-06
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-06
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		4e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-06
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-06
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-06
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-06
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-06
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-06
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-06
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-06
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		5e-06
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		5e-06
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		5e-06
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-06
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		5e-06
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		5e-06
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		5e-06
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-06
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		6e-06
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		6e-06
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		6e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		6e-06
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		7e-06
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		8e-06
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		8e-06
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		8e-06
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		8e-06
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		8e-06
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		8e-06
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		9e-06
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-06
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		9e-06
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		9e-06
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-06
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-05
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-05
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-05
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-05
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		1e-05
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-05
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-05
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-05
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		1e-05
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-05
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-05
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-05
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-05
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-05
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-05
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-05
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-05
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-05
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-05
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-05
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-05
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-05
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-05
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-05
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-05
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-05
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-05
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-05
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-05
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-05
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-05
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-05
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-05
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-05
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-05
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-05
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-05
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-05
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-05
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-05
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-05
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-05
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-05
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-05
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-05
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-05
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-05
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-05
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-05
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		3e-05
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-05
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-05
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		4e-05
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-05
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		4e-05
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-05
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-05
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-05
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		4e-05
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-05
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-05
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-05
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-05
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		4e-05
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		4e-05
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-05
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		4e-05
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		4e-05
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-05
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-05
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-05
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		5e-05
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		5e-05
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-05
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		5e-05
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		5e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		7e-05
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		7e-05
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		7e-05
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		8e-05
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		8e-05
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		8e-05

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score =  498 bits (1281), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 244/283 (86%), Positives = 260/283 (91%)
Query: 1   MDYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS 60
           MDY+FK+K S+ER +VEDLF+YEGCKVGRGTYGHVYKA+RKD  D +DYALKQIEGTG+S
Sbjct: 3   MDYDFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS 62
Query: 61  MSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXX 120
           MSACREIALLRELKHPNVI+L  VFLSH DRKVWLLFDYAEHDLWHIIKFHRA+KAN   
Sbjct: 63  MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKP 122
Query: 121 XXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
                    SLLYQILDGIHYLH+NWVLHRDLKPANILVMGEG ERGRVKIADMGFARLF
Sbjct: 123 VQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182
Query: 181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
           N+PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED
Sbjct: 183 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 242
Query: 241 IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF 283
           IKTSNPYHHDQLDRIF+VMGFP +KDWEDI+KMPEH TL+KDF
Sbjct: 243 IKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDF 285

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  181 bits (460), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 99/253 (39%), Positives = 155/253 (61%), Gaps = 33/253 (13%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           KVG GTYG VYKA+   +S  R  ALK+I    E  G+  +A REI+LL+EL HPN+++L
Sbjct: 28  KVGEGTYGVVYKAK---DSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSL 84
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
           I V   H++R + L+F++ E DL  ++  ++    +              LYQ+L G+ +
Sbjct: 85  IDVI--HSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIY--------LYQLLRGVAH 134
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            H + +LHRDLKP N+L+  +G     +K+AD G AR F  P++        VVT WYRA
Sbjct: 135 CHQHRILHRDLKPQNLLINSDGA----LKLADFGLARAFGIPVRSYTH---EVVTLWYRA 187
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           P++L+G++ Y+ ++DIW+IGCIFAE++T +P+F    +D         DQL +IFS++G 
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD---------DQLPKIFSILGT 238
Query: 262 PLEKDWEDIRKMP 274
           P  ++W  ++++P
Sbjct: 239 PNPREWPQVQELP 251

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  181 bits (460), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 99/253 (39%), Positives = 155/253 (61%), Gaps = 33/253 (13%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           KVG GTYG VYKA+   +S  R  ALK+I    E  G+  +A REI+LL+EL HPN+++L
Sbjct: 28  KVGEGTYGVVYKAK---DSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSL 84
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
           I V   H++R + L+F++ E DL  ++  ++    +              LYQ+L G+ +
Sbjct: 85  IDVI--HSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIY--------LYQLLRGVAH 134
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            H + +LHRDLKP N+L+  +G     +K+AD G AR F  P++        VVT WYRA
Sbjct: 135 CHQHRILHRDLKPQNLLINSDGA----LKLADFGLARAFGIPVRSYTH---EVVTLWYRA 187
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           P++L+G++ Y+ ++DIW+IGCIFAE++T +P+F    +D         DQL +IFS++G 
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD---------DQLPKIFSILGT 238
Query: 262 PLEKDWEDIRKMP 274
           P  ++W  ++++P
Sbjct: 239 PNPREWPQVQELP 251

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  179 bits (453), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 109/275 (39%), Positives = 158/275 (57%), Gaps = 36/275 (13%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG VYKAR K   +    ALK+I    E  G+  +A REI+LL+EL HPN++ L
Sbjct: 13  KIGEGTYGVVYKARNKLTGEV--VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
           + V   H + K++L+F++ + DL    KF  A+               S L+Q+L G+ +
Sbjct: 71  LDVI--HTENKLYLVFEHVDQDLK---KFMDASALTGIPLPLIK----SYLFQLLQGLAF 121
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            HS+ VLHRDLKP N+L+  EG     +K+AD G AR F  P++        VVT WYRA
Sbjct: 122 CHSHRVLHRDLKPQNLLINTEG----AIKLADFGLARAFGVPVRTYXH---EVVTLWYRA 174
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           PE+LLG ++Y+ A+DIW++GCIFAE++T   +F    E          DQL RIF  +G 
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---------DQLFRIFRTLGT 225
Query: 262 PLEKDWEDIRKMPEH-PTLLK----DFNEQICKME 291
           P E  W  +  MP++ P+  K    DF++ +  ++
Sbjct: 226 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 260

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  179 bits (453), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 105/255 (41%), Positives = 147/255 (57%), Gaps = 31/255 (12%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG VYKAR K   +    ALK+I    E  G+  +A REI+LL+EL HPN++ L
Sbjct: 10  KIGEGTYGVVYKARNKLTGEV--VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
           + V   H + K++L+F++   DL    KF  A+               S L+Q+L G+ +
Sbjct: 68  LDVI--HTENKLYLVFEFLHQDLK---KFMDASALTGIPLPLIK----SYLFQLLQGLSF 118
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            HS+ VLHRDLKP N+L+  EG     +K+AD G AR F  P++        VVT WYRA
Sbjct: 119 CHSHRVLHRDLKPQNLLINTEG----AIKLADFGLARAFGVPVRTYTH---EVVTLWYRA 171
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           PE+LLG ++Y+ A+DIW++GCIFAE++T   +F    E          DQL RIF  +G 
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---------DQLFRIFRTLGT 222
Query: 262 PLEKDWEDIRKMPEH 276
           P E  W  +  MP++
Sbjct: 223 PDEVVWPGVTSMPDY 237

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  179 bits (453), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 109/275 (39%), Positives = 157/275 (57%), Gaps = 36/275 (13%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG VYKAR K   +    ALK+I    E  G+  +A REI+LL+EL HPN++ L
Sbjct: 10  KIGEGTYGVVYKARNKLTGEV--VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
           + V   H + K++L+F++   DL    KF  A+               S L+Q+L G+ +
Sbjct: 68  LDVI--HTENKLYLVFEFLHQDLK---KFMDASALTGIPLPLIK----SYLFQLLQGLAF 118
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            HS+ VLHRDLKP N+L+  EG     +K+AD G AR F  P++        VVT WYRA
Sbjct: 119 CHSHRVLHRDLKPQNLLINTEG----AIKLADFGLARAFGVPVRTYTH---EVVTLWYRA 171
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           PE+LLG ++Y+ A+DIW++GCIFAE++T   +F    E          DQL RIF  +G 
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---------DQLFRIFRTLGT 222
Query: 262 PLEKDWEDIRKMPEH-PTLLK----DFNEQICKME 291
           P E  W  +  MP++ P+  K    DF++ +  ++
Sbjct: 223 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 257

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  178 bits (452), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 105/255 (41%), Positives = 147/255 (57%), Gaps = 31/255 (12%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG VYKAR K   +    ALK+I    E  G+  +A REI+LL+EL HPN++ L
Sbjct: 10  KIGEGTYGVVYKARNKLTGEV--VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
           + V   H + K++L+F++   DL    KF  A+               S L+Q+L G+ +
Sbjct: 68  LDVI--HTENKLYLVFEFLHQDLK---KFMDASALTGIPLPLIK----SYLFQLLQGLAF 118
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            HS+ VLHRDLKP N+L+  EG     +K+AD G AR F  P++        VVT WYRA
Sbjct: 119 CHSHRVLHRDLKPQNLLINTEG----AIKLADFGLARAFGVPVRTYTH---EVVTLWYRA 171
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           PE+LLG ++Y+ A+DIW++GCIFAE++T   +F    E          DQL RIF  +G 
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---------DQLFRIFRTLGT 222
Query: 262 PLEKDWEDIRKMPEH 276
           P E  W  +  MP++
Sbjct: 223 PDEVVWPGVTSMPDY 237

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  178 bits (452), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 105/255 (41%), Positives = 147/255 (57%), Gaps = 31/255 (12%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG VYKAR K   +    ALK+I    E  G+  +A REI+LL+EL HPN++ L
Sbjct: 11  KIGEGTYGVVYKARNKLTGEV--VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
           + V   H + K++L+F++   DL    KF  A+               S L+Q+L G+ +
Sbjct: 69  LDVI--HTENKLYLVFEFLHQDLK---KFMDASALTGIPLPLIK----SYLFQLLQGLAF 119
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            HS+ VLHRDLKP N+L+  EG     +K+AD G AR F  P++        VVT WYRA
Sbjct: 120 CHSHRVLHRDLKPQNLLINTEGA----IKLADFGLARAFGVPVRTYTH---EVVTLWYRA 172
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           PE+LLG ++Y+ A+DIW++GCIFAE++T   +F    E          DQL RIF  +G 
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---------DQLFRIFRTLGT 223
Query: 262 PLEKDWEDIRKMPEH 276
           P E  W  +  MP++
Sbjct: 224 PDEVVWPGVTSMPDY 238

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  178 bits (452), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 105/255 (41%), Positives = 147/255 (57%), Gaps = 31/255 (12%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG VYKAR K   +    ALK+I    E  G+  +A REI+LL+EL HPN++ L
Sbjct: 9   KIGEGTYGVVYKARNKLTGEV--VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
           + V   H + K++L+F++   DL    KF  A+               S L+Q+L G+ +
Sbjct: 67  LDVI--HTENKLYLVFEFLHQDLK---KFMDASALTGIPLPLIK----SYLFQLLQGLAF 117
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            HS+ VLHRDLKP N+L+  EG     +K+AD G AR F  P++        VVT WYRA
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEG----AIKLADFGLARAFGVPVRTYTH---EVVTLWYRA 170
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           PE+LLG ++Y+ A+DIW++GCIFAE++T   +F    E          DQL RIF  +G 
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---------DQLFRIFRTLGT 221
Query: 262 PLEKDWEDIRKMPEH 276
           P E  W  +  MP++
Sbjct: 222 PDEVVWPGVTSMPDY 236

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  178 bits (452), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 109/275 (39%), Positives = 157/275 (57%), Gaps = 36/275 (13%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG VYKAR K   +    ALK+I    E  G+  +A REI+LL+EL HPN++ L
Sbjct: 10  KIGEGTYGVVYKARNKLTGEV--VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
           + V   H + K++L+F++   DL    KF  A+               S L+Q+L G+ +
Sbjct: 68  LDVI--HTENKLYLVFEFLHQDLK---KFMDASALTGIPLPLIK----SYLFQLLQGLAF 118
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            HS+ VLHRDLKP N+L+  EG     +K+AD G AR F  P++        VVT WYRA
Sbjct: 119 CHSHRVLHRDLKPQNLLINTEGA----IKLADFGLARAFGVPVRTYTH---EVVTLWYRA 171
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           PE+LLG ++Y+ A+DIW++GCIFAE++T   +F    E          DQL RIF  +G 
Sbjct: 172 PEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---------DQLFRIFRTLGT 222
Query: 262 PLEKDWEDIRKMPEH-PTLLK----DFNEQICKME 291
           P E  W  +  MP++ P+  K    DF++ +  ++
Sbjct: 223 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 257

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  178 bits (452), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 109/275 (39%), Positives = 157/275 (57%), Gaps = 36/275 (13%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG VYKAR K   +    ALK+I    E  G+  +A REI+LL+EL HPN++ L
Sbjct: 9   KIGEGTYGVVYKARNKLTGEV--VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
           + V   H + K++L+F++   DL    KF  A+               S L+Q+L G+ +
Sbjct: 67  LDVI--HTENKLYLVFEFLHQDLK---KFMDASALTGIPLPLIK----SYLFQLLQGLAF 117
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            HS+ VLHRDLKP N+L+  EG     +K+AD G AR F  P++        VVT WYRA
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEG----AIKLADFGLARAFGVPVRTYTH---EVVTLWYRA 170
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           PE+LLG ++Y+ A+DIW++GCIFAE++T   +F    E          DQL RIF  +G 
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---------DQLFRIFRTLGT 221
Query: 262 PLEKDWEDIRKMPEH-PTLLK----DFNEQICKME 291
           P E  W  +  MP++ P+  K    DF++ +  ++
Sbjct: 222 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 256

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  178 bits (452), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 109/275 (39%), Positives = 157/275 (57%), Gaps = 36/275 (13%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG VYKAR K   +    ALK+I    E  G+  +A REI+LL+EL HPN++ L
Sbjct: 17  KIGEGTYGVVYKARNKLTGEV--VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 74
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
           + V   H + K++L+F++   DL    KF  A+               S L+Q+L G+ +
Sbjct: 75  LDVI--HTENKLYLVFEFLHQDLK---KFMDASALTGIPLPLIK----SYLFQLLQGLAF 125
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            HS+ VLHRDLKP N+L+  EG     +K+AD G AR F  P++        VVT WYRA
Sbjct: 126 CHSHRVLHRDLKPQNLLINTEG----AIKLADFGLARAFGVPVRTYTH---EVVTLWYRA 178
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           PE+LLG ++Y+ A+DIW++GCIFAE++T   +F    E          DQL RIF  +G 
Sbjct: 179 PEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---------DQLFRIFRTLGT 229
Query: 262 PLEKDWEDIRKMPEH-PTLLK----DFNEQICKME 291
           P E  W  +  MP++ P+  K    DF++ +  ++
Sbjct: 230 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 264

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  178 bits (452), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 109/275 (39%), Positives = 157/275 (57%), Gaps = 36/275 (13%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG VYKAR K   +    ALK+I    E  G+  +A REI+LL+EL HPN++ L
Sbjct: 17  KIGEGTYGVVYKARNKLTGEV--VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 74
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
           + V   H + K++L+F++   DL    KF  A+               S L+Q+L G+ +
Sbjct: 75  LDVI--HTENKLYLVFEFLHQDLK---KFMDASALTGIPLPLIK----SYLFQLLQGLAF 125
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            HS+ VLHRDLKP N+L+  EG     +K+AD G AR F  P++        VVT WYRA
Sbjct: 126 CHSHRVLHRDLKPQNLLINTEG----AIKLADFGLARAFGVPVRTYTH---EVVTLWYRA 178
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           PE+LLG ++Y+ A+DIW++GCIFAE++T   +F    E          DQL RIF  +G 
Sbjct: 179 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---------DQLFRIFRTLGT 229
Query: 262 PLEKDWEDIRKMPEH-PTLLK----DFNEQICKME 291
           P E  W  +  MP++ P+  K    DF++ +  ++
Sbjct: 230 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 264

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  178 bits (452), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 109/275 (39%), Positives = 157/275 (57%), Gaps = 36/275 (13%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG VYKAR K   +    ALK+I    E  G+  +A REI+LL+EL HPN++ L
Sbjct: 14  KIGEGTYGVVYKARNKLTGEV--VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 71
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
           + V   H + K++L+F++   DL    KF  A+               S L+Q+L G+ +
Sbjct: 72  LDVI--HTENKLYLVFEFLHQDLK---KFMDASALTGIPLPLIK----SYLFQLLQGLAF 122
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            HS+ VLHRDLKP N+L+  EG     +K+AD G AR F  P++        VVT WYRA
Sbjct: 123 CHSHRVLHRDLKPQNLLINTEGA----IKLADFGLARAFGVPVRTYTH---EVVTLWYRA 175
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           PE+LLG ++Y+ A+DIW++GCIFAE++T   +F    E          DQL RIF  +G 
Sbjct: 176 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---------DQLFRIFRTLGT 226
Query: 262 PLEKDWEDIRKMPEH-PTLLK----DFNEQICKME 291
           P E  W  +  MP++ P+  K    DF++ +  ++
Sbjct: 227 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 261

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  178 bits (451), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 109/275 (39%), Positives = 157/275 (57%), Gaps = 36/275 (13%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG VYKAR K   +    ALK+I    E  G+  +A REI+LL+EL HPN++ L
Sbjct: 12  KIGEGTYGVVYKARNKLTGEV--VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 69
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
           + V   H + K++L+F++   DL    KF  A+               S L+Q+L G+ +
Sbjct: 70  LDVI--HTENKLYLVFEFLHQDLK---KFMDASALTGIPLPLIK----SYLFQLLQGLAF 120
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            HS+ VLHRDLKP N+L+  EG     +K+AD G AR F  P++        VVT WYRA
Sbjct: 121 CHSHRVLHRDLKPQNLLINTEGA----IKLADFGLARAFGVPVRTYXH---EVVTLWYRA 173
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           PE+LLG ++Y+ A+DIW++GCIFAE++T   +F    E          DQL RIF  +G 
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---------DQLFRIFRTLGT 224
Query: 262 PLEKDWEDIRKMPEH-PTLLK----DFNEQICKME 291
           P E  W  +  MP++ P+  K    DF++ +  ++
Sbjct: 225 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 259

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  178 bits (451), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 109/275 (39%), Positives = 157/275 (57%), Gaps = 36/275 (13%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG VYKAR K   +    ALK+I    E  G+  +A REI+LL+EL HPN++ L
Sbjct: 13  KIGEGTYGVVYKARNKLTGEV--VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
           + V   H + K++L+F++   DL    KF  A+               S L+Q+L G+ +
Sbjct: 71  LDVI--HTENKLYLVFEFLHQDLK---KFMDASALTGIPLPLIK----SYLFQLLQGLAF 121
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            HS+ VLHRDLKP N+L+  EG     +K+AD G AR F  P++        VVT WYRA
Sbjct: 122 CHSHRVLHRDLKPQNLLINTEGA----IKLADFGLARAFGVPVRTYXH---EVVTLWYRA 174
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           PE+LLG ++Y+ A+DIW++GCIFAE++T   +F    E          DQL RIF  +G 
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---------DQLFRIFRTLGT 225
Query: 262 PLEKDWEDIRKMPEH-PTLLK----DFNEQICKME 291
           P E  W  +  MP++ P+  K    DF++ +  ++
Sbjct: 226 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 260

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  178 bits (451), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 109/275 (39%), Positives = 157/275 (57%), Gaps = 36/275 (13%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG VYKAR K   +    ALK+I    E  G+  +A REI+LL+EL HPN++ L
Sbjct: 12  KIGEGTYGVVYKARNKLTGEV--VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 69
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
           + V   H + K++L+F++   DL    KF  A+               S L+Q+L G+ +
Sbjct: 70  LDVI--HTENKLYLVFEFLHQDLK---KFMDASALTGIPLPLIK----SYLFQLLQGLAF 120
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            HS+ VLHRDLKP N+L+  EG     +K+AD G AR F  P++        VVT WYRA
Sbjct: 121 CHSHRVLHRDLKPQNLLINTEGA----IKLADFGLARAFGVPVRTYXH---EVVTLWYRA 173
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           PE+LLG ++Y+ A+DIW++GCIFAE++T   +F    E          DQL RIF  +G 
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---------DQLFRIFRTLGT 224
Query: 262 PLEKDWEDIRKMPEH-PTLLK----DFNEQICKME 291
           P E  W  +  MP++ P+  K    DF++ +  ++
Sbjct: 225 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 259

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  178 bits (451), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 105/255 (41%), Positives = 147/255 (57%), Gaps = 31/255 (12%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG VYKAR K   +    ALK+I    E  G+  +A REI+LL+EL HPN++ L
Sbjct: 10  KIGEGTYGVVYKARNKLTGEV--VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
           + V   H + K++L+F++   DL    KF  A+               S L+Q+L G+ +
Sbjct: 68  LDVI--HTENKLYLVFEFLHQDLK---KFMDASALTGIPLPLIK----SYLFQLLQGLAF 118
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            HS+ VLHRDLKP N+L+  EG     +K+AD G AR F  P++        VVT WYRA
Sbjct: 119 CHSHRVLHRDLKPQNLLINTEG----AIKLADFGLARAFGVPVRTYXH---EVVTLWYRA 171
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           PE+LLG ++Y+ A+DIW++GCIFAE++T   +F    E          DQL RIF  +G 
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---------DQLFRIFRTLGT 222
Query: 262 PLEKDWEDIRKMPEH 276
           P E  W  +  MP++
Sbjct: 223 PDEVVWPGVTSMPDY 237

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  178 bits (451), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 109/275 (39%), Positives = 157/275 (57%), Gaps = 36/275 (13%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG VYKAR K   +    ALK+I    E  G+  +A REI+LL+EL HPN++ L
Sbjct: 14  KIGEGTYGVVYKARNKLTGEV--VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 71
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
           + V   H + K++L+F++   DL    KF  A+               S L+Q+L G+ +
Sbjct: 72  LDVI--HTENKLYLVFEFLHQDLK---KFMDASALTGIPLPLIK----SYLFQLLQGLAF 122
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            HS+ VLHRDLKP N+L+  EG     +K+AD G AR F  P++        VVT WYRA
Sbjct: 123 CHSHRVLHRDLKPQNLLINTEG----AIKLADFGLARAFGVPVRTYXH---EVVTLWYRA 175
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           PE+LLG ++Y+ A+DIW++GCIFAE++T   +F    E          DQL RIF  +G 
Sbjct: 176 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---------DQLFRIFRTLGT 226
Query: 262 PLEKDWEDIRKMPEH-PTLLK----DFNEQICKME 291
           P E  W  +  MP++ P+  K    DF++ +  ++
Sbjct: 227 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 261

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  178 bits (451), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 109/275 (39%), Positives = 157/275 (57%), Gaps = 36/275 (13%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG VYKAR K   +    ALK+I    E  G+  +A REI+LL+EL HPN++ L
Sbjct: 11  KIGEGTYGVVYKARNKLTGEV--VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
           + V   H + K++L+F++   DL    KF  A+               S L+Q+L G+ +
Sbjct: 69  LDVI--HTENKLYLVFEFLHQDLK---KFMDASALTGIPLPLIK----SYLFQLLQGLAF 119
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            HS+ VLHRDLKP N+L+  EG     +K+AD G AR F  P++        VVT WYRA
Sbjct: 120 CHSHRVLHRDLKPQNLLINTEGA----IKLADFGLARAFGVPVRTYXH---EVVTLWYRA 172
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           PE+LLG ++Y+ A+DIW++GCIFAE++T   +F    E          DQL RIF  +G 
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---------DQLFRIFRTLGT 223
Query: 262 PLEKDWEDIRKMPEH-PTLLK----DFNEQICKME 291
           P E  W  +  MP++ P+  K    DF++ +  ++
Sbjct: 224 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 258

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  178 bits (451), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 109/275 (39%), Positives = 157/275 (57%), Gaps = 36/275 (13%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG VYKAR K   +    ALK+I    E  G+  +A REI+LL+EL HPN++ L
Sbjct: 9   KIGEGTYGVVYKARNKLTGEV--VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
           + V   H + K++L+F++   DL    KF  A+               S L+Q+L G+ +
Sbjct: 67  LDVI--HTENKLYLVFEFLHQDLK---KFMDASALTGIPLPLIK----SYLFQLLQGLAF 117
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            HS+ VLHRDLKP N+L+  EG     +K+AD G AR F  P++        VVT WYRA
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEG----AIKLADFGLARAFGVPVRTYXH---EVVTLWYRA 170
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           PE+LLG ++Y+ A+DIW++GCIFAE++T   +F    E          DQL RIF  +G 
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---------DQLFRIFRTLGT 221
Query: 262 PLEKDWEDIRKMPEH-PTLLK----DFNEQICKME 291
           P E  W  +  MP++ P+  K    DF++ +  ++
Sbjct: 222 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 256

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  178 bits (451), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 109/275 (39%), Positives = 157/275 (57%), Gaps = 36/275 (13%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG VYKAR K   +    ALK+I    E  G+  +A REI+LL+EL HPN++ L
Sbjct: 10  KIGEGTYGVVYKARNKLTGEV--VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
           + V   H + K++L+F++   DL    KF  A+               S L+Q+L G+ +
Sbjct: 68  LDVI--HTENKLYLVFEFLHQDLK---KFMDASALTGIPLPLIK----SYLFQLLQGLAF 118
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            HS+ VLHRDLKP N+L+  EG     +K+AD G AR F  P++        VVT WYRA
Sbjct: 119 CHSHRVLHRDLKPQNLLINTEG----AIKLADFGLARAFGVPVRTYXH---EVVTLWYRA 171
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           PE+LLG ++Y+ A+DIW++GCIFAE++T   +F    E          DQL RIF  +G 
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---------DQLFRIFRTLGT 222
Query: 262 PLEKDWEDIRKMPEH-PTLLK----DFNEQICKME 291
           P E  W  +  MP++ P+  K    DF++ +  ++
Sbjct: 223 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 257

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  178 bits (451), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 109/275 (39%), Positives = 157/275 (57%), Gaps = 36/275 (13%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG VYKAR K   +    ALK+I    E  G+  +A REI+LL+EL HPN++ L
Sbjct: 13  KIGEGTYGVVYKARNKLTGEV--VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
           + V   H + K++L+F++   DL    KF  A+               S L+Q+L G+ +
Sbjct: 71  LDVI--HTENKLYLVFEFLHQDLK---KFMDASALTGIPLPLIK----SYLFQLLQGLAF 121
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            HS+ VLHRDLKP N+L+  EG     +K+AD G AR F  P++        VVT WYRA
Sbjct: 122 CHSHRVLHRDLKPQNLLINTEG----AIKLADFGLARAFGVPVRTYXH---EVVTLWYRA 174
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           PE+LLG ++Y+ A+DIW++GCIFAE++T   +F    E          DQL RIF  +G 
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---------DQLFRIFRTLGT 225
Query: 262 PLEKDWEDIRKMPEH-PTLLK----DFNEQICKME 291
           P E  W  +  MP++ P+  K    DF++ +  ++
Sbjct: 226 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 260

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  178 bits (451), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 109/275 (39%), Positives = 157/275 (57%), Gaps = 36/275 (13%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG VYKAR K   +    ALK+I    E  G+  +A REI+LL+EL HPN++ L
Sbjct: 10  KIGEGTYGVVYKARNKLTGEV--VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
           + V   H + K++L+F++   DL    KF  A+               S L+Q+L G+ +
Sbjct: 68  LDVI--HTENKLYLVFEFLHQDLK---KFMDASALTGIPLPLIK----SYLFQLLQGLAF 118
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            HS+ VLHRDLKP N+L+  EG     +K+AD G AR F  P++        VVT WYRA
Sbjct: 119 CHSHRVLHRDLKPQNLLINTEGA----IKLADFGLARAFGVPVRTYXH---EVVTLWYRA 171
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           PE+LLG ++Y+ A+DIW++GCIFAE++T   +F    E          DQL RIF  +G 
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---------DQLFRIFRTLGT 222
Query: 262 PLEKDWEDIRKMPEH-PTLLK----DFNEQICKME 291
           P E  W  +  MP++ P+  K    DF++ +  ++
Sbjct: 223 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 257

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  178 bits (451), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 105/255 (41%), Positives = 147/255 (57%), Gaps = 31/255 (12%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG VYKAR K   +    ALK+I    E  G+  +A REI+LL+EL HPN++ L
Sbjct: 10  KIGEGTYGVVYKARNKLTGEV--VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
           + V   H + K++L+F++   DL    KF  A+               S L+Q+L G+ +
Sbjct: 68  LDVI--HTENKLYLVFEFLHQDLK---KFMDASALTGIPLPLIK----SYLFQLLQGLAF 118
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            HS+ VLHRDLKP N+L+  EG     +K+AD G AR F  P++        VVT WYRA
Sbjct: 119 CHSHRVLHRDLKPQNLLINTEG----AIKLADFGLARAFGVPVRTYXH---EVVTLWYRA 171
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           PE+LLG ++Y+ A+DIW++GCIFAE++T   +F    E          DQL RIF  +G 
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---------DQLFRIFRTLGT 222
Query: 262 PLEKDWEDIRKMPEH 276
           P E  W  +  MP++
Sbjct: 223 PDEVVWPGVTSMPDY 237

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  178 bits (451), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 109/275 (39%), Positives = 157/275 (57%), Gaps = 36/275 (13%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG VYKAR K   +    ALK+I    E  G+  +A REI+LL+EL HPN++ L
Sbjct: 12  KIGEGTYGVVYKARNKLTGEV--VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 69
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
           + V   H + K++L+F++   DL    KF  A+               S L+Q+L G+ +
Sbjct: 70  LDVI--HTENKLYLVFEFLHQDLK---KFMDASALTGIPLPLIK----SYLFQLLQGLAF 120
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            HS+ VLHRDLKP N+L+  EG     +K+AD G AR F  P++        VVT WYRA
Sbjct: 121 CHSHRVLHRDLKPENLLINTEGA----IKLADFGLARAFGVPVRTYXH---EVVTLWYRA 173
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           PE+LLG ++Y+ A+DIW++GCIFAE++T   +F    E          DQL RIF  +G 
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---------DQLFRIFRTLGT 224
Query: 262 PLEKDWEDIRKMPEH-PTLLK----DFNEQICKME 291
           P E  W  +  MP++ P+  K    DF++ +  ++
Sbjct: 225 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 259

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  178 bits (451), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 109/275 (39%), Positives = 157/275 (57%), Gaps = 36/275 (13%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG VYKAR K   +    ALK+I    E  G+  +A REI+LL+EL HPN++ L
Sbjct: 13  KIGEGTYGVVYKARNKLTGEV--VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
           + V   H + K++L+F++   DL    KF  A+               S L+Q+L G+ +
Sbjct: 71  LDVI--HTENKLYLVFEFLSMDLK---KFMDASALTGIPLPLIK----SYLFQLLQGLAF 121
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            HS+ VLHRDLKP N+L+  EG     +K+AD G AR F  P++        VVT WYRA
Sbjct: 122 CHSHRVLHRDLKPENLLINTEG----AIKLADFGLARAFGVPVRTYXH---EVVTLWYRA 174
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           PE+LLG ++Y+ A+DIW++GCIFAE++T   +F    E          DQL RIF  +G 
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---------DQLFRIFRTLGT 225
Query: 262 PLEKDWEDIRKMPEH-PTLLK----DFNEQICKME 291
           P E  W  +  MP++ P+  K    DF++ +  ++
Sbjct: 226 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 260

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  178 bits (451), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 105/255 (41%), Positives = 147/255 (57%), Gaps = 31/255 (12%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG VYKAR K   +    ALK+I    E  G+  +A REI+LL+EL HPN++ L
Sbjct: 9   KIGEGTYGVVYKARNKLTGEV--VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
           + V   H + K++L+F++   DL    KF  A+               S L+Q+L G+ +
Sbjct: 67  LDVI--HTENKLYLVFEFLHQDLK---KFMDASALTGIPLPLIK----SYLFQLLQGLAF 117
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            HS+ VLHRDLKP N+L+  EG     +K+AD G AR F  P++        VVT WYRA
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEG----AIKLADFGLARAFGVPVRTYXH---EVVTLWYRA 170
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           PE+LLG ++Y+ A+DIW++GCIFAE++T   +F    E          DQL RIF  +G 
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---------DQLFRIFRTLGT 221
Query: 262 PLEKDWEDIRKMPEH 276
           P E  W  +  MP++
Sbjct: 222 PDEVVWPGVTSMPDY 236

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  177 bits (450), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 109/275 (39%), Positives = 157/275 (57%), Gaps = 36/275 (13%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG VYKAR K   +    ALK+I    E  G+  +A REI+LL+EL HPN++ L
Sbjct: 11  KIGEGTYGVVYKARNKLTGEV--VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
           + V   H + K++L+F++   DL    KF  A+               S L+Q+L G+ +
Sbjct: 69  LDVI--HTENKLYLVFEFLHQDLK---KFMDASALTGIPLPLIK----SYLFQLLQGLAF 119
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            HS+ VLHRDLKP N+L+  EG     +K+AD G AR F  P++        VVT WYRA
Sbjct: 120 CHSHRVLHRDLKPENLLINTEGA----IKLADFGLARAFGVPVRTYXH---EVVTLWYRA 172
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           PE+LLG ++Y+ A+DIW++GCIFAE++T   +F    E          DQL RIF  +G 
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---------DQLFRIFRTLGT 223
Query: 262 PLEKDWEDIRKMPEH-PTLLK----DFNEQICKME 291
           P E  W  +  MP++ P+  K    DF++ +  ++
Sbjct: 224 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 258

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  177 bits (450), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 109/275 (39%), Positives = 157/275 (57%), Gaps = 36/275 (13%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG VYKAR K   +    ALK+I    E  G+  +A REI+LL+EL HPN++ L
Sbjct: 11  KIGEGTYGVVYKARNKLTGEV--VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
           + V   H + K++L+F++   DL    KF  A+               S L+Q+L G+ +
Sbjct: 69  LDVI--HTENKLYLVFEFLSMDLK---KFMDASALTGIPLPLIK----SYLFQLLQGLAF 119
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            HS+ VLHRDLKP N+L+  EG     +K+AD G AR F  P++        VVT WYRA
Sbjct: 120 CHSHRVLHRDLKPENLLINTEG----AIKLADFGLARAFGVPVRTYXH---EVVTLWYRA 172
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           PE+LLG ++Y+ A+DIW++GCIFAE++T   +F    E          DQL RIF  +G 
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---------DQLFRIFRTLGT 223
Query: 262 PLEKDWEDIRKMPEH-PTLLK----DFNEQICKME 291
           P E  W  +  MP++ P+  K    DF++ +  ++
Sbjct: 224 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 258

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  177 bits (450), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 109/275 (39%), Positives = 157/275 (57%), Gaps = 36/275 (13%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG VYKAR K   +    ALK+I    E  G+  +A REI+LL+EL HPN++ L
Sbjct: 11  KIGEGTYGVVYKARNKLTGEV--VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
           + V   H + K++L+F++   DL    KF  A+               S L+Q+L G+ +
Sbjct: 69  LDVI--HTENKLYLVFEFLHQDLK---KFMDASALTGIPLPLIK----SYLFQLLQGLAF 119
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            HS+ VLHRDLKP N+L+  EG     +K+AD G AR F  P++        VVT WYRA
Sbjct: 120 CHSHRVLHRDLKPQNLLINTEG----AIKLADFGLARAFGVPVRTYXH---EVVTLWYRA 172
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           PE+LLG ++Y+ A+DIW++GCIFAE++T   +F    E          DQL RIF  +G 
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---------DQLFRIFRTLGT 223
Query: 262 PLEKDWEDIRKMPEH-PTLLK----DFNEQICKME 291
           P E  W  +  MP++ P+  K    DF++ +  ++
Sbjct: 224 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 258

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  176 bits (447), Expect = 9e-45,   Method: Compositional matrix adjust.
 Identities = 109/275 (39%), Positives = 156/275 (56%), Gaps = 36/275 (13%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG VYKAR K   +    ALK+I    E  G+  +A REI+LL+EL HPN++ L
Sbjct: 9   KIGEGTYGVVYKARNKLTGEV--VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
           + V   H + K++L+F++   DL    K    A A             S L+Q+L G+ +
Sbjct: 67  LDVI--HTENKLYLVFEHVHQDL----KTFMDASA---LTGIPLPLIKSYLFQLLQGLAF 117
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            HS+ VLHRDLKP N+L+  EG     +K+AD G AR F  P++        VVT WYRA
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEG----AIKLADFGLARAFGVPVRTYTH---EVVTLWYRA 170
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           PE+LLG ++Y+ A+DIW++GCIFAE++T   +F    E          DQL RIF  +G 
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---------DQLFRIFRTLGT 221
Query: 262 PLEKDWEDIRKMPEH-PTLLK----DFNEQICKME 291
           P E  W  +  MP++ P+  K    DF++ +  ++
Sbjct: 222 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 256

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  176 bits (447), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 109/275 (39%), Positives = 156/275 (56%), Gaps = 36/275 (13%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG VYKAR K   +    ALK+I    E  G+  +A REI+LL+EL HPN++ L
Sbjct: 13  KIGEGTYGVVYKARNKLTGEV--VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
           + V   H + K++L+F++   DL    K    A A             S L+Q+L G+ +
Sbjct: 71  LDVI--HTENKLYLVFEFLHQDL----KTFMDASA---LTGIPLPLIKSYLFQLLQGLAF 121
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            HS+ VLHRDLKP N+L+  EG     +K+AD G AR F  P++        VVT WYRA
Sbjct: 122 CHSHRVLHRDLKPQNLLINTEG----AIKLADFGLARAFGVPVRTYXH---EVVTLWYRA 174
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           PE+LLG ++Y+ A+DIW++GCIFAE++T   +F    E          DQL RIF  +G 
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---------DQLFRIFRTLGT 225
Query: 262 PLEKDWEDIRKMPEH-PTLLK----DFNEQICKME 291
           P E  W  +  MP++ P+  K    DF++ +  ++
Sbjct: 226 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 260

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  176 bits (447), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 108/275 (39%), Positives = 156/275 (56%), Gaps = 36/275 (13%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG VYKAR K   +    AL +I    E  G+  +A REI+LL+EL HPN++ L
Sbjct: 10  KIGEGTYGVVYKARNKLTGEV--VALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
           + V   H + K++L+F++   DL    KF  A+               S L+Q+L G+ +
Sbjct: 68  LDVI--HTENKLYLVFEFLHQDLK---KFMDASALTGIPLPLIK----SYLFQLLQGLAF 118
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            HS+ VLHRDLKP N+L+  EG     +K+AD G AR F  P++        VVT WYRA
Sbjct: 119 CHSHRVLHRDLKPQNLLINTEG----AIKLADFGLARAFGVPVRTYTH---EVVTLWYRA 171
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           PE+LLG ++Y+ A+DIW++GCIFAE++T   +F    E          DQL RIF  +G 
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---------DQLFRIFRTLGT 222
Query: 262 PLEKDWEDIRKMPEH-PTLLK----DFNEQICKME 291
           P E  W  +  MP++ P+  K    DF++ +  ++
Sbjct: 223 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 257

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  176 bits (447), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 108/275 (39%), Positives = 156/275 (56%), Gaps = 36/275 (13%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG VYKAR K   +    AL +I    E  G+  +A REI+LL+EL HPN++ L
Sbjct: 9   KIGEGTYGVVYKARNKLTGEV--VALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
           + V   H + K++L+F++   DL    KF  A+               S L+Q+L G+ +
Sbjct: 67  LDVI--HTENKLYLVFEFLHQDLK---KFMDASALTGIPLPLIK----SYLFQLLQGLAF 117
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            HS+ VLHRDLKP N+L+  EG     +K+AD G AR F  P++        VVT WYRA
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEG----AIKLADFGLARAFGVPVRTYTH---EVVTLWYRA 170
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           PE+LLG ++Y+ A+DIW++GCIFAE++T   +F    E          DQL RIF  +G 
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---------DQLFRIFRTLGT 221
Query: 262 PLEKDWEDIRKMPEH-PTLLK----DFNEQICKME 291
           P E  W  +  MP++ P+  K    DF++ +  ++
Sbjct: 222 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 256

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  176 bits (445), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 108/275 (39%), Positives = 156/275 (56%), Gaps = 36/275 (13%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG VYKAR K   +    ALK+I    E  G+  +A REI+LL+EL HPN++ L
Sbjct: 10  KIGEGTYGVVYKARNKLTGEV--VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
           + V   H + K++L+F++   DL     F  A+               S L+Q+L G+ +
Sbjct: 68  LDVI--HTENKLYLVFEFLHQDLK---DFMDASALTGIPLPLIK----SYLFQLLQGLAF 118
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            HS+ VLHRDLKP N+L+  EG     +K+AD G AR F  P++        VVT WYRA
Sbjct: 119 CHSHRVLHRDLKPENLLINTEG----AIKLADFGLARAFGVPVRTYXH---EVVTLWYRA 171
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           PE+LLG ++Y+ A+DIW++GCIFAE++T   +F    E          DQL RIF  +G 
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---------DQLFRIFRTLGT 222
Query: 262 PLEKDWEDIRKMPEH-PTLLK----DFNEQICKME 291
           P E  W  +  MP++ P+  K    DF++ +  ++
Sbjct: 223 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 257

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  176 bits (445), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 108/275 (39%), Positives = 156/275 (56%), Gaps = 36/275 (13%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG VYKAR K   +    ALK+I    E  G+  +A REI+LL+EL HPN++ L
Sbjct: 12  KIGEGTYGVVYKARNKLTGEV--VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 69
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
           + V   H + K++L+F++   DL     F  A+               S L+Q+L G+ +
Sbjct: 70  LDVI--HTENKLYLVFEFLSMDLK---DFMDASALTGIPLPLIK----SYLFQLLQGLAF 120
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            HS+ VLHRDLKP N+L+  EG     +K+AD G AR F  P++        VVT WYRA
Sbjct: 121 CHSHRVLHRDLKPQNLLINTEG----AIKLADFGLARAFGVPVRTYXH---EVVTLWYRA 173
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           PE+LLG ++Y+ A+DIW++GCIFAE++T   +F    E          DQL RIF  +G 
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---------DQLFRIFRTLGT 224
Query: 262 PLEKDWEDIRKMPEH-PTLLK----DFNEQICKME 291
           P E  W  +  MP++ P+  K    DF++ +  ++
Sbjct: 225 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 259

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  176 bits (445), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 108/275 (39%), Positives = 156/275 (56%), Gaps = 36/275 (13%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG VYKAR K   +    ALK+I    E  G+  +A REI+LL+EL HPN++ L
Sbjct: 13  KIGEGTYGVVYKARNKLTGEV--VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
           + V   H + K++L+F++   DL     F  A+               S L+Q+L G+ +
Sbjct: 71  LDVI--HTENKLYLVFEFLSMDLK---DFMDASALTGIPLPLIK----SYLFQLLQGLAF 121
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            HS+ VLHRDLKP N+L+  EG     +K+AD G AR F  P++        VVT WYRA
Sbjct: 122 CHSHRVLHRDLKPQNLLINTEG----AIKLADFGLARAFGVPVRTYXH---EVVTLWYRA 174
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           PE+LLG ++Y+ A+DIW++GCIFAE++T   +F    E          DQL RIF  +G 
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---------DQLFRIFRTLGT 225
Query: 262 PLEKDWEDIRKMPEH-PTLLK----DFNEQICKME 291
           P E  W  +  MP++ P+  K    DF++ +  ++
Sbjct: 226 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 260

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  173 bits (438), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 97/255 (38%), Positives = 145/255 (56%), Gaps = 33/255 (12%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG VYKA+   N+    +ALK+I    E  G+  +  REI++L+ELKH N++ L
Sbjct: 9   KIGEGTYGVVYKAQ---NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
             V   H  +++ L+F++ + DL  ++                     S L Q+L+GI Y
Sbjct: 66  YDVI--HTKKRLVLVFEHLDQDLKKLLDVCEGG--------LESVTAKSFLLQLLNGIAY 115
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            H   VLHRDLKP N+L+  EG     +KIAD G AR F  P++        VVT WYRA
Sbjct: 116 CHDRRVLHRDLKPQNLLINREG----ELKIADFGLARAFGIPVRKYTH---EVVTLWYRA 168
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           P++L+G++ Y+  IDIW++GCIFAE++   P+F    E          DQL RIF ++G 
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE---------ADQLMRIFRILGT 219
Query: 262 PLEKDWEDIRKMPEH 276
           P  K+W ++ ++P++
Sbjct: 220 PNSKNWPNVTELPKY 234

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  173 bits (438), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 97/255 (38%), Positives = 145/255 (56%), Gaps = 33/255 (12%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG VYKA+   N+    +ALK+I    E  G+  +  REI++L+ELKH N++ L
Sbjct: 9   KIGEGTYGVVYKAQ---NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
             V   H  +++ L+F++ + DL  ++                     S L Q+L+GI Y
Sbjct: 66  YDVI--HTKKRLVLVFEHLDQDLKKLLDVCEGG--------LESVTAKSFLLQLLNGIAY 115
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            H   VLHRDLKP N+L+  EG     +KIAD G AR F  P++        VVT WYRA
Sbjct: 116 CHDRRVLHRDLKPQNLLINREG----ELKIADFGLARAFGIPVRKYTH---EVVTLWYRA 168
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           P++L+G++ Y+  IDIW++GCIFAE++   P+F    E          DQL RIF ++G 
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSE---------ADQLMRIFRILGT 219
Query: 262 PLEKDWEDIRKMPEH 276
           P  K+W ++ ++P++
Sbjct: 220 PNSKNWPNVTELPKY 234

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  172 bits (436), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 96/255 (37%), Positives = 145/255 (56%), Gaps = 33/255 (12%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG VYKA+   N+    +ALK+I    E  G+  +  REI++L+ELKH N++ L
Sbjct: 9   KIGEGTYGVVYKAQ---NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
             V   H  +++ L+F++ + DL  ++                     S L Q+L+GI Y
Sbjct: 66  YDVI--HTKKRLVLVFEHLDQDLKKLLDVCEGG--------LESVTAKSFLLQLLNGIAY 115
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            H   VLHRDLKP N+L+  EG     +KIAD G AR F  P++        +VT WYRA
Sbjct: 116 CHDRRVLHRDLKPQNLLINREG----ELKIADFGLARAFGIPVRKYTH---EIVTLWYRA 168
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           P++L+G++ Y+  IDIW++GCIFAE++   P+F    E          DQL RIF ++G 
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE---------ADQLMRIFRILGT 219
Query: 262 PLEKDWEDIRKMPEH 276
           P  K+W ++ ++P++
Sbjct: 220 PNSKNWPNVTELPKY 234

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  169 bits (427), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 97/256 (37%), Positives = 144/256 (56%), Gaps = 30/256 (11%)
Query: 25  CKVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVIN 80
            K+G GTYG VYKA   D       A+K+I    E  G+  +A RE++LL+EL+H N+I 
Sbjct: 40  TKLGEGTYGEVYKA--IDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIE 97
Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           L SV   H++ ++ L+F+YAE+DL          K              S LYQ+++G++
Sbjct: 98  LKSVI--HHNHRLHLIFEYAENDL---------KKYMDKNPDVSMRVIKSFLYQLINGVN 146
Query: 141 YLHSNWVLHRDLKPANILV-MGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
           + HS   LHRDLKP N+L+ + +  E   +KI D G AR F  P++        ++T WY
Sbjct: 147 FCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH---EIITLWY 203
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVM 259
           R PE+LLG+RHY+ ++DIW+I CI+AE+L   P+F    E          DQL +IF V+
Sbjct: 204 RPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI---------DQLFKIFEVL 254
Query: 260 GFPLEKDWEDIRKMPE 275
           G P +  W  +  +P+
Sbjct: 255 GLPDDTTWPGVTALPD 270

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  165 bits (417), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 97/256 (37%), Positives = 147/256 (57%), Gaps = 33/256 (12%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG V+KA+ ++  +    ALK++    +  G+  SA REI LL+ELKH N++ L
Sbjct: 9   KIGEGTYGTVFKAKNRETHEI--VALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 66
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
             V   H+D+K+ L+F++ + DL    K+  +   +            S L+Q+L G+ +
Sbjct: 67  HDVL--HSDKKLTLVFEFCDQDLK---KYFDSCNGDLDPEIVK-----SFLFQLLKGLGF 116
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            HS  VLHRDLKP N+L+       G +K+AD G AR F  P++  +     VVT WYR 
Sbjct: 117 CHSRNVLHRDLKPQNLLIN----RNGELKLADFGLARAFGIPVRCYS---AEVVTLWYRP 169
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           P++L GA+ Y+ +ID+W+ GCIFAEL   + P+F     D         DQL RIF ++G
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAARPLFPGNDVD---------DQLKRIFRLLG 220
Query: 261 FPLEKDWEDIRKMPEH 276
            P E+ W  + K+P++
Sbjct: 221 TPTEEQWPSMTKLPDY 236

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  163 bits (412), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 96/256 (37%), Positives = 147/256 (57%), Gaps = 33/256 (12%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG V+KA+ ++  +    ALK++    +  G+  SA REI LL+ELKH N++ L
Sbjct: 9   KIGEGTYGTVFKAKNRETHEI--VALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 66
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
             V   H+D+K+ L+F++ + DL    K+  +   +            S L+Q+L G+ +
Sbjct: 67  HDVL--HSDKKLTLVFEFCDQDLK---KYFDSCNGDLDPEIVK-----SFLFQLLKGLGF 116
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            HS  VLHRDLKP N+L+       G +K+A+ G AR F  P++  +     VVT WYR 
Sbjct: 117 CHSRNVLHRDLKPQNLLIN----RNGELKLANFGLARAFGIPVRCYS---AEVVTLWYRP 169
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           P++L GA+ Y+ +ID+W+ GCIFAEL  +  P+F     D         DQL RIF ++G
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD---------DQLKRIFRLLG 220
Query: 261 FPLEKDWEDIRKMPEH 276
            P E+ W  + K+P++
Sbjct: 221 TPTEEQWPSMTKLPDY 236

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  161 bits (407), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 90/254 (35%), Positives = 140/254 (55%), Gaps = 26/254 (10%)
Query: 26  KVGRGTYGHVYKARRKDNS---DTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLI 82
           K+G GTY  VYK   K        ++  L   EGT    +A REI+L++ELKH N++ L 
Sbjct: 12  KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT--PSTAIREISLMKELKHENIVRLY 69
Query: 83  SVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
            V   H + K+ L+F++ ++DL    K+  +                   +Q+L G+ + 
Sbjct: 70  DVI--HTENKLTLVFEFMDNDL---KKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAP 202
           H N +LHRDLKP N+L+     +RG++K+ D G AR F  P+   +     VVT WYRAP
Sbjct: 125 HENKILHRDLKPQNLLIN----KRGQLKLGDFGLARAFGIPVNTFSS---EVVTLWYRAP 177
Query: 203 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGFP 262
           ++L+G+R Y+ +IDIW+ GCI AE++T +P+F    ++         +QL  IF +MG P
Sbjct: 178 DVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE---------EQLKLIFDIMGTP 228
Query: 263 LEKDWEDIRKMPEH 276
            E  W  + K+P++
Sbjct: 229 NESLWPSVTKLPKY 242

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  160 bits (406), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 100/260 (38%), Positives = 140/260 (53%), Gaps = 35/260 (13%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIE-------GTGLSMSACREIALLRELKHPNVI 79
           +G G +  VYKAR K+ +     A+K+I+         G++ +A REI LL+EL HPN+I
Sbjct: 18  LGEGQFATVYKARDKNTNQI--VAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGI 139
            L+  F   +   + L+FD+ E DL  IIK +                  + +   L G+
Sbjct: 76  GLLDAF--GHKSNISLVFDFMETDLEVIIKDNSLV--------LTPSHIKAYMLMTLQGL 125
Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
            YLH +W+LHRDLKP N+L+     E G +K+AD G A+ F +P +        VVT WY
Sbjct: 126 EYLHQHWILHRDLKPNNLLL----DENGVLKLADFGLAKSFGSPNRAYXH---QVVTRWY 178
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVM 259
           RAPELL GAR Y   +D+WA+GCI AELL   P F     D+        DQL RIF  +
Sbjct: 179 RAPELLFGARMYGVGVDMWAVGCILAELLLRVP-FLPGDSDL--------DQLTRIFETL 229
Query: 260 GFPLEKDWEDIRKMPEHPTL 279
           G P E+ W D+  +P++ T 
Sbjct: 230 GTPTEEQWPDMCSLPDYVTF 249

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  157 bits (398), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 102/260 (39%), Positives = 138/260 (53%), Gaps = 37/260 (14%)
Query: 25  CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT----GLSMSACREIALLRELK---HPN 77
            ++G G YG VYKAR  D       ALK +       GL +S  RE+ALLR L+   HPN
Sbjct: 10  AEIGVGAYGTVYKAR--DPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPN 67
Query: 78  VINLISV-FLSHNDR--KVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQ 134
           V+ L+ V   S  DR  KV L+F++ + DL       R                  L+ Q
Sbjct: 68  VVRLMDVCATSRTDREIKVTLVFEHVDQDL-------RTYLDKAPPPGLPAETIKDLMRQ 120
Query: 135 ILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVV 194
            L G+ +LH+N ++HRDLKP NILV   G     VK+AD G AR+++  +     LDPVV
Sbjct: 121 FLRGLDFLHANCIVHRDLKPENILVTSGGT----VKLADFGLARIYSYQMA----LDPVV 172
Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 254
           VT WYRAPE+LL +  Y   +D+W++GCIFAE+   +P+F    E          DQL +
Sbjct: 173 VTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSE---------ADQLGK 222
Query: 255 IFSVMGFPLEKDWEDIRKMP 274
           IF ++G P E DW     +P
Sbjct: 223 IFDLIGLPPEDDWPRDVSLP 242

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  155 bits (391), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 101/260 (38%), Positives = 137/260 (52%), Gaps = 37/260 (14%)
Query: 25  CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT----GLSMSACREIALLRELK---HPN 77
            ++G G YG VYKAR  D       ALK +       GL +S  RE+ALLR L+   HPN
Sbjct: 10  AEIGVGAYGTVYKAR--DPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPN 67
Query: 78  VINLISV-FLSHNDR--KVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQ 134
           V+ L+ V   S  DR  KV L+F++ + DL       R                  L+ Q
Sbjct: 68  VVRLMDVCATSRTDREIKVTLVFEHVDQDL-------RTYLDKAPPPGLPAETIKDLMRQ 120
Query: 135 ILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVV 194
            L G+ +LH+N ++HRDLKP NILV   G     VK+AD G AR+++  +     L PVV
Sbjct: 121 FLRGLDFLHANCIVHRDLKPENILVTSGGT----VKLADFGLARIYSYQMA----LAPVV 172
Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 254
           VT WYRAPE+LL +  Y   +D+W++GCIFAE+   +P+F    E          DQL +
Sbjct: 173 VTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSE---------ADQLGK 222
Query: 255 IFSVMGFPLEKDWEDIRKMP 274
           IF ++G P E DW     +P
Sbjct: 223 IFDLIGLPPEDDWPRDVSLP 242

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  154 bits (389), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 101/260 (38%), Positives = 137/260 (52%), Gaps = 37/260 (14%)
Query: 25  CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT----GLSMSACREIALLRELK---HPN 77
            ++G G YG VYKAR  D       ALK +       GL +S  RE+ALLR L+   HPN
Sbjct: 10  AEIGVGAYGTVYKAR--DPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPN 67
Query: 78  VINLISV-FLSHNDR--KVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQ 134
           V+ L+ V   S  DR  KV L+F++ + DL       R                  L+ Q
Sbjct: 68  VVRLMDVCATSRTDREIKVTLVFEHVDQDL-------RTYLDKAPPPGLPAETIKDLMRQ 120
Query: 135 ILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVV 194
            L G+ +LH+N ++HRDLKP NILV   G     VK+AD G AR+++  +     L PVV
Sbjct: 121 FLRGLDFLHANCIVHRDLKPENILVTSGGT----VKLADFGLARIYSYQMA----LFPVV 172
Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 254
           VT WYRAPE+LL +  Y   +D+W++GCIFAE+   +P+F    E          DQL +
Sbjct: 173 VTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSE---------ADQLGK 222
Query: 255 IFSVMGFPLEKDWEDIRKMP 274
           IF ++G P E DW     +P
Sbjct: 223 IFDLIGLPPEDDWPRDVSLP 242

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  153 bits (386), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 102/285 (35%), Positives = 152/285 (53%), Gaps = 49/285 (17%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELK-HPNVIN 80
           K+G+G YG V+K+  +   +    A+K+I    + +  +    REI +L EL  H N++N
Sbjct: 16  KLGKGAYGIVWKSIDRRTGEV--VAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVN 73
Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           L++V  + NDR V+L+FDY E DL      H   +AN             ++YQ++  I 
Sbjct: 74  LLNVLRADNDRDVYLVFDYMETDL------HAVIRANILEPVHKQY----VVYQLIKVIK 123
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLK-----PLA------- 188
           YLHS  +LHRD+KP+NIL+  E      VK+AD G +R F N  +     PL+       
Sbjct: 124 YLHSGGLLHRDMKPSNILLNAEC----HVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179
Query: 189 --DLDPV----VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 242
             D  P+    V T WYRAPE+LLG+  YTK ID+W++GCI  E+L  +PIF        
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF-------- 231
Query: 243 TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDFNEQI 287
                  +QL+RI  V+ FP  +D E I+  P   T+++   E++
Sbjct: 232 -PGSSTMNQLERIIGVIDFPSNEDVESIQS-PFAKTMIESLKEKV 274

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  151 bits (382), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 102/263 (38%), Positives = 138/263 (52%), Gaps = 40/263 (15%)
Query: 25  CKVGRGTYGHVYKARRKDNSDTRDYALKQIE-------GTGLSMSACREIALLRELK--- 74
            ++G G YG VYKAR  D       ALK +        G GL +S  RE+ALLR L+   
Sbjct: 15  AEIGVGAYGTVYKAR--DPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFE 72
Query: 75  HPNVINLISV-FLSHNDR--KVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSL 131
           HPNV+ L+ V   S  DR  KV L+F++ + DL       R                  L
Sbjct: 73  HPNVVRLMDVCATSRTDREIKVTLVFEHVDQDL-------RTYLDKAPPPGLPAETIKDL 125
Query: 132 LYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLD 191
           + Q L G+ +LH+N ++HRDLKP NILV   G     VK+AD G AR+++  +     L 
Sbjct: 126 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGT----VKLADFGLARIYSYQMA----LT 177
Query: 192 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 251
           PVVVT WYRAPE+LL +  Y   +D+W++GCIFAE+   +P+F    E          DQ
Sbjct: 178 PVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSE---------ADQ 227
Query: 252 LDRIFSVMGFPLEKDWEDIRKMP 274
           L +IF ++G P E DW     +P
Sbjct: 228 LGKIFDLIGLPPEDDWPRDVSLP 250

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  150 bits (380), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 94/262 (35%), Positives = 141/262 (53%), Gaps = 36/262 (13%)
Query: 25  CKVGRGTYGHVYKARRKDNSDTRDYALKQIE----GTGLSMSACREIALLRELK---HPN 77
            ++G G YG V+KAR   N   R  ALK++       G+ +S  RE+A+LR L+   HPN
Sbjct: 17  AEIGEGAYGKVFKARDLKNGG-RFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 75
Query: 78  VINLISV-FLSHNDR--KVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQ 134
           V+ L  V  +S  DR  K+ L+F++ + DL   +                      +++Q
Sbjct: 76  VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLD-------KVPEPGVPTETIKDMMFQ 128
Query: 135 ILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVV 194
           +L G+ +LHS+ V+HRDLKP NILV       G++K+AD G AR+++  +     L  VV
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSS----GQIKLADFGLARIYSFQMA----LTSVV 180
Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 254
           VT WYRAPE+LL +  Y   +D+W++GCIFAE+   +P+F    +          DQL +
Sbjct: 181 VTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSD---------VDQLGK 230
Query: 255 IFSVMGFPLEKDWEDIRKMPEH 276
           I  V+G P E+DW     +P  
Sbjct: 231 ILDVIGLPGEEDWPRDVALPRQ 252

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  150 bits (380), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 94/262 (35%), Positives = 141/262 (53%), Gaps = 36/262 (13%)
Query: 25  CKVGRGTYGHVYKARRKDNSDTRDYALKQIE----GTGLSMSACREIALLRELK---HPN 77
            ++G G YG V+KAR   N   R  ALK++       G+ +S  RE+A+LR L+   HPN
Sbjct: 17  AEIGEGAYGKVFKARDLKNGG-RFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 75
Query: 78  VINLISV-FLSHNDR--KVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQ 134
           V+ L  V  +S  DR  K+ L+F++ + DL   +                      +++Q
Sbjct: 76  VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLD-------KVPEPGVPTETIKDMMFQ 128
Query: 135 ILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVV 194
           +L G+ +LHS+ V+HRDLKP NILV       G++K+AD G AR+++  +     L  VV
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSS----GQIKLADFGLARIYSFQMA----LTSVV 180
Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 254
           VT WYRAPE+LL +  Y   +D+W++GCIFAE+   +P+F    +          DQL +
Sbjct: 181 VTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSD---------VDQLGK 230
Query: 255 IFSVMGFPLEKDWEDIRKMPEH 276
           I  V+G P E+DW     +P  
Sbjct: 231 ILDVIGLPGEEDWPRDVALPRQ 252

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  150 bits (380), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 94/262 (35%), Positives = 141/262 (53%), Gaps = 36/262 (13%)
Query: 25  CKVGRGTYGHVYKARRKDNSDTRDYALKQIE----GTGLSMSACREIALLRELK---HPN 77
            ++G G YG V+KAR   N   R  ALK++       G+ +S  RE+A+LR L+   HPN
Sbjct: 17  AEIGEGAYGKVFKARDLKNGG-RFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 75
Query: 78  VINLISV-FLSHNDR--KVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQ 134
           V+ L  V  +S  DR  K+ L+F++ + DL   +                      +++Q
Sbjct: 76  VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLD-------KVPEPGVPTETIKDMMFQ 128
Query: 135 ILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVV 194
           +L G+ +LHS+ V+HRDLKP NILV       G++K+AD G AR+++  +     L  VV
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSS----GQIKLADFGLARIYSFQMA----LTSVV 180
Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 254
           VT WYRAPE+LL +  Y   +D+W++GCIFAE+   +P+F    +          DQL +
Sbjct: 181 VTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSD---------VDQLGK 230
Query: 255 IFSVMGFPLEKDWEDIRKMPEH 276
           I  V+G P E+DW     +P  
Sbjct: 231 ILDVIGLPGEEDWPRDVALPRQ 252

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  148 bits (374), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 94/263 (35%), Positives = 134/263 (50%), Gaps = 45/263 (17%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIE---GTGLSMSACREIALLRELKHPNVINLI 82
           K+G GTY  VYK + K   +    ALK+I      G   +A RE++LL++LKH N++ L 
Sbjct: 9   KLGEGTYATVYKGKSKLTDNL--VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 66
Query: 83  SVFLSHNDRKVWLLFDYAEHDL-------WHIIKFHRAAKANXXXXXXXXXXXXSLLYQI 135
            +   H ++ + L+F+Y + DL        +II  H                    L+Q+
Sbjct: 67  DII--HTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVK---------------LFLFQL 109
Query: 136 LDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVV 195
           L G+ Y H   VLHRDLKP N+L+     ERG +K+AD G AR  + P K     D  VV
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLIN----ERGELKLADFGLARAKSIPTK---TYDNEVV 162
Query: 196 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 255
           T WYR P++LLG+  Y+  ID+W +GCIF E+ T  P+F     +         +QL  I
Sbjct: 163 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE---------EQLHFI 213
Query: 256 FSVMGFPLEKDWEDIRKMPEHPT 278
           F ++G P E+ W  I    E  T
Sbjct: 214 FRILGTPTEETWPGILSNEEFKT 236

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  140 bits (354), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 84/226 (37%), Positives = 124/226 (54%), Gaps = 25/226 (11%)
Query: 25  CKVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVIN 80
            K+G+GT+G V+KAR +     +  ALK++    E  G  ++A REI +L+ LKH NV+N
Sbjct: 24  AKIGQGTFGEVFKARHRKTG--QKVALKKVLMENEKEGFPITALREIKILQLLKHENVVN 81
Query: 81  LISVFLS----HNDRK--VWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQ 134
           LI +  +    +N  K  ++L+FD+ EHDL        A   +             ++  
Sbjct: 82  LIEICRTKASPYNRCKGSIYLVFDFCEHDL--------AGLLSNVLVKFTLSEIKRVMQM 133
Query: 135 ILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLAD-LDPV 193
           +L+G++Y+H N +LHRD+K AN+L+  +G+    +K+AD G AR F+       +     
Sbjct: 134 LLNGLYYIHRNKILHRDMKAANVLITRDGV----LKLADFGLARAFSLAKNSQPNRYXNR 189
Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
           VVT WYR PELLLG R Y   ID+W  GCI AE+ T  PI     E
Sbjct: 190 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 235

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  140 bits (353), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 88/240 (36%), Positives = 130/240 (54%), Gaps = 30/240 (12%)
Query: 11  NERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACRE 66
           +E +K E L      K+G+GT+G V+KAR +     +  ALK++    E  G  ++A RE
Sbjct: 14  DEVSKYEKL-----AKIGQGTFGEVFKARHRKTG--QKVALKKVLMENEKEGFPITALRE 66
Query: 67  IALLRELKHPNVINLISVFLS----HNDRK--VWLLFDYAEHDLWHIIKFHRAAKANXXX 120
           I +L+ LKH NV+NLI +  +    +N  K  ++L+FD+ EHDL        A   +   
Sbjct: 67  IKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDL--------AGLLSNVL 118
Query: 121 XXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
                     ++  +L+G++Y+H N +LHRD+K AN+L+  +G+    +K+AD G AR F
Sbjct: 119 VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV----LKLADFGLARAF 174
Query: 181 NNPLKPLAD-LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
           +       +     VVT WYR PELLLG R Y   ID+W  GCI AE+ T  PI     E
Sbjct: 175 SLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 234

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  140 bits (352), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 82/225 (36%), Positives = 121/225 (53%), Gaps = 25/225 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G+GT+G V+KAR +     +  ALK++    E  G  ++A REI +L+ LKH NV+NL
Sbjct: 25  KIGQGTFGEVFKARHRKTG--QKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNL 82
Query: 82  ISVFLSHND------RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQI 135
           I +  +           ++L+FD+ EHDL        A   +             ++  +
Sbjct: 83  IEICRTKASPYNRCKASIYLVFDFCEHDL--------AGLLSNVLVKFTLSEIKRVMQML 134
Query: 136 LDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLAD-LDPVV 194
           L+G++Y+H N +LHRD+K AN+L+  +G+    +K+AD G AR F+       +     V
Sbjct: 135 LNGLYYIHRNKILHRDMKAANVLITRDGV----LKLADFGLARAFSLAKNSQPNRYXNRV 190
Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
           VT WYR PELLLG R Y   ID+W  GCI AE+ T  PI     E
Sbjct: 191 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 235

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  140 bits (352), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 88/240 (36%), Positives = 130/240 (54%), Gaps = 30/240 (12%)
Query: 11  NERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACRE 66
           +E +K E L      K+G+GT+G V+KAR +     +  ALK++    E  G  ++A RE
Sbjct: 15  DEVSKYEKL-----AKIGQGTFGEVFKARHRKTG--QKVALKKVLMENEKEGFPITALRE 67
Query: 67  IALLRELKHPNVINLISVFLS----HNDRK--VWLLFDYAEHDLWHIIKFHRAAKANXXX 120
           I +L+ LKH NV+NLI +  +    +N  K  ++L+FD+ EHDL        A   +   
Sbjct: 68  IKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDL--------AGLLSNVL 119
Query: 121 XXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
                     ++  +L+G++Y+H N +LHRD+K AN+L+  +G+    +K+AD G AR F
Sbjct: 120 VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV----LKLADFGLARAF 175
Query: 181 NNPLKPLAD-LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
           +       +     VVT WYR PELLLG R Y   ID+W  GCI AE+ T  PI     E
Sbjct: 176 SLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 235

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  137 bits (346), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 77/215 (35%), Positives = 122/215 (56%), Gaps = 27/215 (12%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G G+YG V+K R +D       A+K+     +   +   A REI +L++LKHPN++NL
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQI--VAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNL 67
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHII-KFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           + VF     R++ L+F+Y +H + H + ++ R    +            S+ +Q L  ++
Sbjct: 68  LEVF--RRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVK---------SITWQTLQAVN 116
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADL-DPVVVTFWY 199
           + H +  +HRD+KP NIL+    +    +K+ D GFARL   P    +D  D  V T WY
Sbjct: 117 FCHKHNCIHRDVKPENILITKHSV----IKLCDFGFARLLTGP----SDYYDDEVATRWY 168
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           R+PELL+G   Y   +D+WAIGC+FAELL+  P++
Sbjct: 169 RSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLW 203

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  133 bits (334), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 78/212 (36%), Positives = 116/212 (54%), Gaps = 23/212 (10%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINLI 82
           VG G+YG V K R KD    R  A+K+     +   +   A REI LL++L+H N++NL+
Sbjct: 33  VGEGSYGMVMKCRNKDTG--RIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90
Query: 83  SVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
            V      ++ +L+F++ +H +   ++                      L+QI++GI + 
Sbjct: 91  EV--CKKKKRWYLVFEFVDHTILDDLELFPNG--------LDYQVVQKYLFQIINGIGFC 140
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAP 202
           HS+ ++HRD+KP NILV   G+    VK+ D GFAR    P +     D  V T WYRAP
Sbjct: 141 HSHNIIHRDIKPENILVSQSGV----VKLCDFGFARTLAAPGEVY---DDEVATRWYRAP 193
Query: 203 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           ELL+G   Y KA+D+WAIGC+  E+   EP+F
Sbjct: 194 ELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLF 225

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  132 bits (331), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 86/253 (33%), Positives = 130/253 (51%), Gaps = 31/253 (12%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI---EGTGLSMSACREIALLRELKHPNVINLIS 83
           +G G YG V  A   D+      A+K+I   E         REI +L   +H NVI +  
Sbjct: 51  IGEGAYGMVSSAY--DHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRD 108
Query: 84  VFLSHN---DRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           +  +      R V+++ D  E DL+ ++K  + +  +              LYQIL G+ 
Sbjct: 109 ILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICY----------FLYQILRGLK 158
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           Y+HS  VLHRDLKP+N+L+         +KI D G AR+ +        L   V T WYR
Sbjct: 159 YIHSANVLHRDLKPSNLLIN----TTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYR 214
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           APE++L ++ YTK+IDIW++GCI AE+L++ PIF  +         ++ DQL+ I  ++G
Sbjct: 215 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK---------HYLDQLNHILGILG 265
Query: 261 FPLEKDWEDIRKM 273
            P ++D   I  M
Sbjct: 266 SPSQEDLNCIINM 278

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  130 bits (326), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 84/250 (33%), Positives = 129/250 (51%), Gaps = 31/250 (12%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI---EGTGLSMSACREIALLRELKHPNVINLIS 83
           +G G YG V  A   DN +    A+K+I   E         REI +L   +H N+I +  
Sbjct: 31  IGEGAYGMVCSAY--DNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 84  VFLS---HNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           +  +      + V+++ D  E DL+ ++K    +  +              LYQIL G+ 
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY----------FLYQILRGLK 138
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           Y+HS  VLHRDLKP+N+L+         +KI D G AR+ +        L   V T WYR
Sbjct: 139 YIHSANVLHRDLKPSNLLLNTTX----DLKICDFGLARVADPDHDHTGFLTEYVATRWYR 194
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           APE++L ++ YTK+IDIW++GCI AE+L++ PIF  +         ++ DQL+ I  ++G
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK---------HYLDQLNHILGILG 245
Query: 261 FPLEKDWEDI 270
            P ++D   I
Sbjct: 246 SPSQEDLNXI 255

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  129 bits (325), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 84/250 (33%), Positives = 129/250 (51%), Gaps = 31/250 (12%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI---EGTGLSMSACREIALLRELKHPNVINLIS 83
           +G G YG V  A   DN +    A+K+I   E         REI +L   +H N+I +  
Sbjct: 31  IGEGAYGMVCSAY--DNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 84  VFLS---HNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           +  +      + V+++ D  E DL+ ++K    +  +              LYQIL G+ 
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY----------FLYQILRGLK 138
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           Y+HS  VLHRDLKP+N+L+         +KI D G AR+ +        L   V T WYR
Sbjct: 139 YIHSANVLHRDLKPSNLLLNTTX----DLKIXDFGLARVADPDHDHTGFLTEYVATRWYR 194
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           APE++L ++ YTK+IDIW++GCI AE+L++ PIF  +         ++ DQL+ I  ++G
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK---------HYLDQLNHILGILG 245
Query: 261 FPLEKDWEDI 270
            P ++D   I
Sbjct: 246 SPSQEDLNXI 255

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  129 bits (325), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 83/246 (33%), Positives = 128/246 (52%), Gaps = 31/246 (12%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI---EGTGLSMSACREIALLRELKHPNVINLIS 83
           +G G YG V  A   DN +    A+K+I   E         REI +L   +H N+I +  
Sbjct: 33  IGEGAYGMVCSAY--DNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGIND 90
Query: 84  VFLS---HNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           +  +      + V+++ D  E DL+ ++K    +  +              LYQIL G+ 
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY----------FLYQILRGLK 140
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           Y+HS  VLHRDLKP+N+L+         +KI D G AR+ +        L   V T WYR
Sbjct: 141 YIHSANVLHRDLKPSNLLLN----TTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 196
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           APE++L ++ YTK+IDIW++GCI AE+L++ PIF  +         ++ DQL+ I  ++G
Sbjct: 197 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK---------HYLDQLNHILGILG 247
Query: 261 FPLEKD 266
            P ++D
Sbjct: 248 SPSQED 253

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 83/246 (33%), Positives = 128/246 (52%), Gaps = 31/246 (12%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI---EGTGLSMSACREIALLRELKHPNVINLIS 83
           +G G YG V  A   DN +    A+K+I   E         REI +L   +H N+I +  
Sbjct: 39  IGEGAYGMVCSAY--DNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 96
Query: 84  VFLS---HNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           +  +      + V+++ D  E DL+ ++K    +  +              LYQIL G+ 
Sbjct: 97  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY----------FLYQILRGLK 146
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           Y+HS  VLHRDLKP+N+L+         +KI D G AR+ +        L   V T WYR
Sbjct: 147 YIHSANVLHRDLKPSNLLLN----TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 202
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           APE++L ++ YTK+IDIW++GCI AE+L++ PIF  +         ++ DQL+ I  ++G
Sbjct: 203 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK---------HYLDQLNHILGILG 253
Query: 261 FPLEKD 266
            P ++D
Sbjct: 254 SPSQED 259

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 83/246 (33%), Positives = 128/246 (52%), Gaps = 31/246 (12%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI---EGTGLSMSACREIALLRELKHPNVINLIS 83
           +G G YG V  A   DN +    A+K+I   E         REI +L   +H N+I +  
Sbjct: 31  IGEGAYGMVCSAY--DNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 84  VFLS---HNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           +  +      + V+++ D  E DL+ ++K    +  +              LYQIL G+ 
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY----------FLYQILRGLK 138
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           Y+HS  VLHRDLKP+N+L+         +KI D G AR+ +        L   V T WYR
Sbjct: 139 YIHSANVLHRDLKPSNLLLN----TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 194
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           APE++L ++ YTK+IDIW++GCI AE+L++ PIF  +         ++ DQL+ I  ++G
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK---------HYLDQLNHILGILG 245
Query: 261 FPLEKD 266
            P ++D
Sbjct: 246 SPSQED 251

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  129 bits (324), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 84/250 (33%), Positives = 129/250 (51%), Gaps = 31/250 (12%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI---EGTGLSMSACREIALLRELKHPNVINLIS 83
           +G G YG V  A   DN +    A+K+I   E         REI +L   +H N+I +  
Sbjct: 33  IGEGAYGMVCSAY--DNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 90
Query: 84  VFLS---HNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           +  +      + V+++ D  E DL+ ++K    +  +              LYQIL G+ 
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY----------FLYQILRGLK 140
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           Y+HS  VLHRDLKP+N+L+         +KI D G AR+ +        L   V T WYR
Sbjct: 141 YIHSANVLHRDLKPSNLLLNTTC----DLKICDFGLARVADPDHDHTGFLTEYVATRWYR 196
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           APE++L ++ YTK+IDIW++GCI AE+L++ PIF  +         ++ DQL+ I  ++G
Sbjct: 197 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK---------HYLDQLNHILGILG 247
Query: 261 FPLEKDWEDI 270
            P ++D   I
Sbjct: 248 SPSQEDLNCI 257

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  129 bits (324), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 84/250 (33%), Positives = 129/250 (51%), Gaps = 31/250 (12%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI---EGTGLSMSACREIALLRELKHPNVINLIS 83
           +G G YG V  A   DN +    A+K+I   E         REI +L   +H N+I +  
Sbjct: 51  IGEGAYGMVCSAY--DNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 108
Query: 84  VFLS---HNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           +  +      + V+++ D  E DL+ ++K    +  +              LYQIL G+ 
Sbjct: 109 IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY----------FLYQILRGLK 158
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           Y+HS  VLHRDLKP+N+L+         +KI D G AR+ +        L   V T WYR
Sbjct: 159 YIHSANVLHRDLKPSNLLLN----TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 214
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           APE++L ++ YTK+IDIW++GCI AE+L++ PIF  +         ++ DQL+ I  ++G
Sbjct: 215 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK---------HYLDQLNHILGILG 265
Query: 261 FPLEKDWEDI 270
            P ++D   I
Sbjct: 266 SPSQEDLNCI 275

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  129 bits (324), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 84/250 (33%), Positives = 129/250 (51%), Gaps = 31/250 (12%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI---EGTGLSMSACREIALLRELKHPNVINLIS 83
           +G G YG V  A   DN +    A+K+I   E         REI +L   +H N+I +  
Sbjct: 31  IGEGAYGMVCSAY--DNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 84  VFLS---HNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           +  +      + V+++ D  E DL+ ++K    +  +              LYQIL G+ 
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY----------FLYQILRGLK 138
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           Y+HS  VLHRDLKP+N+L+         +KI D G AR+ +        L   V T WYR
Sbjct: 139 YIHSANVLHRDLKPSNLLLNTTC----DLKICDFGLARVADPDHDHTGFLTEYVATRWYR 194
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           APE++L ++ YTK+IDIW++GCI AE+L++ PIF  +         ++ DQL+ I  ++G
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK---------HYLDQLNHILGILG 245
Query: 261 FPLEKDWEDI 270
            P ++D   I
Sbjct: 246 SPSQEDLNCI 255

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  129 bits (324), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 83/246 (33%), Positives = 128/246 (52%), Gaps = 31/246 (12%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI---EGTGLSMSACREIALLRELKHPNVINLIS 83
           +G G YG V  A   DN +    A+K+I   E         REI +L   +H N+I +  
Sbjct: 31  IGEGAYGMVCSAY--DNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 84  VFLS---HNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           +  +      + V+++ D  E DL+ ++K    +  +              LYQIL G+ 
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY----------FLYQILRGLK 138
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           Y+HS  VLHRDLKP+N+L+         +KI D G AR+ +        L   V T WYR
Sbjct: 139 YIHSANVLHRDLKPSNLLLNTTX----DLKICDFGLARVADPDHDHTGFLTEYVATRWYR 194
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           APE++L ++ YTK+IDIW++GCI AE+L++ PIF  +         ++ DQL+ I  ++G
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK---------HYLDQLNHILGILG 245
Query: 261 FPLEKD 266
            P ++D
Sbjct: 246 SPSQED 251

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  129 bits (323), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 84/250 (33%), Positives = 129/250 (51%), Gaps = 31/250 (12%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI---EGTGLSMSACREIALLRELKHPNVINLIS 83
           +G G YG V  A   DN +    A+K+I   E         REI +L   +H N+I +  
Sbjct: 33  IGEGAYGMVCSAY--DNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGIND 90
Query: 84  VFLS---HNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           +  +      + V+++ D  E DL+ ++K    +  +              LYQIL G+ 
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY----------FLYQILRGLK 140
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           Y+HS  VLHRDLKP+N+L+         +KI D G AR+ +        L   V T WYR
Sbjct: 141 YIHSANVLHRDLKPSNLLLNTTC----DLKICDFGLARVADPDHDHTGFLTEYVATRWYR 196
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           APE++L ++ YTK+IDIW++GCI AE+L++ PIF  +         ++ DQL+ I  ++G
Sbjct: 197 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK---------HYLDQLNHILGILG 247
Query: 261 FPLEKDWEDI 270
            P ++D   I
Sbjct: 248 SPSQEDLNCI 257

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  129 bits (323), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 84/250 (33%), Positives = 129/250 (51%), Gaps = 31/250 (12%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI---EGTGLSMSACREIALLRELKHPNVINLIS 83
           +G G YG V  A   DN +    A+K+I   E         REI +L   +H N+I +  
Sbjct: 29  IGEGAYGMVCSAY--DNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 86
Query: 84  VFLS---HNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           +  +      + V+++ D  E DL+ ++K    +  +              LYQIL G+ 
Sbjct: 87  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY----------FLYQILRGLK 136
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           Y+HS  VLHRDLKP+N+L+         +KI D G AR+ +        L   V T WYR
Sbjct: 137 YIHSANVLHRDLKPSNLLLNTTC----DLKICDFGLARVADPDHDHTGFLTEYVATRWYR 192
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           APE++L ++ YTK+IDIW++GCI AE+L++ PIF  +         ++ DQL+ I  ++G
Sbjct: 193 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK---------HYLDQLNHILGILG 243
Query: 261 FPLEKDWEDI 270
            P ++D   I
Sbjct: 244 SPSQEDLNCI 253

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 84/250 (33%), Positives = 129/250 (51%), Gaps = 31/250 (12%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI---EGTGLSMSACREIALLRELKHPNVINLIS 83
           +G G YG V  A   DN +    A+K+I   E         REI +L   +H N+I +  
Sbjct: 36  IGEGAYGMVCSAY--DNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 93
Query: 84  VFLS---HNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           +  +      + V+++ D  E DL+ ++K    +  +              LYQIL G+ 
Sbjct: 94  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY----------FLYQILRGLK 143
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           Y+HS  VLHRDLKP+N+L+         +KI D G AR+ +        L   V T WYR
Sbjct: 144 YIHSANVLHRDLKPSNLLLNTTC----DLKICDFGLARVADPDHDHTGFLTEYVATRWYR 199
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           APE++L ++ YTK+IDIW++GCI AE+L++ PIF  +         ++ DQL+ I  ++G
Sbjct: 200 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK---------HYLDQLNHILGILG 250
Query: 261 FPLEKDWEDI 270
            P ++D   I
Sbjct: 251 SPSQEDLNCI 260

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 84/250 (33%), Positives = 129/250 (51%), Gaps = 31/250 (12%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI---EGTGLSMSACREIALLRELKHPNVINLIS 83
           +G G YG V  A   DN +    A+K+I   E         REI +L   +H N+I +  
Sbjct: 37  IGEGAYGMVCSAY--DNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 94
Query: 84  VFLS---HNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           +  +      + V+++ D  E DL+ ++K    +  +              LYQIL G+ 
Sbjct: 95  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY----------FLYQILRGLK 144
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           Y+HS  VLHRDLKP+N+L+         +KI D G AR+ +        L   V T WYR
Sbjct: 145 YIHSANVLHRDLKPSNLLLNTTC----DLKICDFGLARVADPDHDHTGFLTEYVATRWYR 200
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           APE++L ++ YTK+IDIW++GCI AE+L++ PIF  +         ++ DQL+ I  ++G
Sbjct: 201 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK---------HYLDQLNHILGILG 251
Query: 261 FPLEKDWEDI 270
            P ++D   I
Sbjct: 252 SPSQEDLNCI 261

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 84/250 (33%), Positives = 129/250 (51%), Gaps = 31/250 (12%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI---EGTGLSMSACREIALLRELKHPNVINLIS 83
           +G G YG V  A   DN +    A+K+I   E         REI +L   +H N+I +  
Sbjct: 28  IGEGAYGMVCSAY--DNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 85
Query: 84  VFLS---HNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           +  +      + V+++ D  E DL+ ++K    +  +              LYQIL G+ 
Sbjct: 86  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY----------FLYQILRGLK 135
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           Y+HS  VLHRDLKP+N+L+         +KI D G AR+ +        L   V T WYR
Sbjct: 136 YIHSANVLHRDLKPSNLLLNTTC----DLKICDFGLARVADPDHDHTGFLTEYVATRWYR 191
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           APE++L ++ YTK+IDIW++GCI AE+L++ PIF  +         ++ DQL+ I  ++G
Sbjct: 192 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK---------HYLDQLNHILGILG 242
Query: 261 FPLEKDWEDI 270
            P ++D   I
Sbjct: 243 SPSQEDLNCI 252

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 84/250 (33%), Positives = 129/250 (51%), Gaps = 31/250 (12%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI---EGTGLSMSACREIALLRELKHPNVINLIS 83
           +G G YG V  A   DN +    A+K+I   E         REI +L   +H N+I +  
Sbjct: 35  IGEGAYGMVCSAY--DNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 84  VFLS---HNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           +  +      + V+++ D  E DL+ ++K    +  +              LYQIL G+ 
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY----------FLYQILRGLK 142
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           Y+HS  VLHRDLKP+N+L+         +KI D G AR+ +        L   V T WYR
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTC----DLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           APE++L ++ YTK+IDIW++GCI AE+L++ PIF  +         ++ DQL+ I  ++G
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK---------HYLDQLNHILGILG 249
Query: 261 FPLEKDWEDI 270
            P ++D   I
Sbjct: 250 SPSQEDLNCI 259

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 83/246 (33%), Positives = 128/246 (52%), Gaps = 31/246 (12%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI---EGTGLSMSACREIALLRELKHPNVINLIS 83
           +G G YG V  A   DN +    A+K+I   E         REI +L   +H N+I +  
Sbjct: 35  IGEGAYGMVCSAY--DNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 84  VFLS---HNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           +  +      + V+++ D  E DL+ ++K    +  +              LYQIL G+ 
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY----------FLYQILRGLK 142
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           Y+HS  VLHRDLKP+N+L+         +KI D G AR+ +        L   V T WYR
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTX----DLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           APE++L ++ YTK+IDIW++GCI AE+L++ PIF  +         ++ DQL+ I  ++G
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK---------HYLDQLNHILGILG 249
Query: 261 FPLEKD 266
            P ++D
Sbjct: 250 SPSQED 255

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 84/250 (33%), Positives = 129/250 (51%), Gaps = 31/250 (12%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI---EGTGLSMSACREIALLRELKHPNVINLIS 83
           +G G YG V  A   DN +    A+K+I   E         REI +L   +H N+I +  
Sbjct: 35  IGEGAYGMVCSAY--DNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 84  VFLS---HNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           +  +      + V+++ D  E DL+ ++K    +  +              LYQIL G+ 
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICY----------FLYQILRGLK 142
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           Y+HS  VLHRDLKP+N+L+         +KI D G AR+ +        L   V T WYR
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTC----DLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           APE++L ++ YTK+IDIW++GCI AE+L++ PIF  +         ++ DQL+ I  ++G
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK---------HYLDQLNHILGILG 249
Query: 261 FPLEKDWEDI 270
            P ++D   I
Sbjct: 250 SPSQEDLNCI 259

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 84/250 (33%), Positives = 129/250 (51%), Gaps = 31/250 (12%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI---EGTGLSMSACREIALLRELKHPNVINLIS 83
           +G G YG V  A   DN +    A+K+I   E         REI +L   +H N+I +  
Sbjct: 35  IGEGAYGMVCSAY--DNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 84  VFLS---HNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           +  +      + V+++ D  E DL+ ++K    +  +              LYQIL G+ 
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY----------FLYQILRGLK 142
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           Y+HS  VLHRDLKP+N+L+         +KI D G AR+ +        L   V T WYR
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTC----DLKICDFGLARVADPDHDHTGFLXEXVATRWYR 198
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           APE++L ++ YTK+IDIW++GCI AE+L++ PIF  +         ++ DQL+ I  ++G
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK---------HYLDQLNHILGILG 249
Query: 261 FPLEKDWEDI 270
            P ++D   I
Sbjct: 250 SPSQEDLNCI 259

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 84/250 (33%), Positives = 129/250 (51%), Gaps = 31/250 (12%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI---EGTGLSMSACREIALLRELKHPNVINLIS 83
           +G G YG V  A   DN +    A+K+I   E         REI +L   +H N+I +  
Sbjct: 36  IGEGAYGMVCSAY--DNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 93
Query: 84  VFLS---HNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           +  +      + V+++ D  E DL+ ++K    +  +              LYQIL G+ 
Sbjct: 94  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY----------FLYQILRGLK 143
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           Y+HS  VLHRDLKP+N+L+         +KI D G AR+ +        L   V T WYR
Sbjct: 144 YIHSANVLHRDLKPSNLLLNTTC----DLKICDFGLARVADPDHDHTGFLXEXVATRWYR 199
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           APE++L ++ YTK+IDIW++GCI AE+L++ PIF  +         ++ DQL+ I  ++G
Sbjct: 200 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK---------HYLDQLNHILGILG 250
Query: 261 FPLEKDWEDI 270
            P ++D   I
Sbjct: 251 SPSQEDLNCI 260

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  128 bits (322), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 83/246 (33%), Positives = 128/246 (52%), Gaps = 31/246 (12%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI---EGTGLSMSACREIALLRELKHPNVINLIS 83
           +G G YG V  A   DN +    A+K+I   E         REI +L   +H N+I +  
Sbjct: 35  IGEGAYGMVCSAY--DNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGIND 92
Query: 84  VFLS---HNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           +  +      + V+++ D  E DL+ ++K    +  +              LYQIL G+ 
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY----------FLYQILRGLK 142
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           Y+HS  VLHRDLKP+N+L+         +KI D G AR+ +        L   V T WYR
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTX----DLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           APE++L ++ YTK+IDIW++GCI AE+L++ PIF  +         ++ DQL+ I  ++G
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK---------HYLDQLNHILGILG 249
Query: 261 FPLEKD 266
            P ++D
Sbjct: 250 SPSQED 255

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  128 bits (322), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 84/250 (33%), Positives = 129/250 (51%), Gaps = 31/250 (12%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI---EGTGLSMSACREIALLRELKHPNVINLIS 83
           +G G YG V  A   DN +    A+K+I   E         REI +L   +H N+I +  
Sbjct: 29  IGEGAYGMVCSAY--DNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 86
Query: 84  VFLS---HNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           +  +      + V+++ D  E DL+ ++K    +  +              LYQIL G+ 
Sbjct: 87  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY----------FLYQILRGLK 136
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           Y+HS  VLHRDLKP+N+L+         +KI D G AR+ +        L   V T WYR
Sbjct: 137 YIHSANVLHRDLKPSNLLLNTTC----DLKICDFGLARVADPDHDHTGFLTEYVATRWYR 192
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           APE++L ++ YTK+IDIW++GCI AE+L++ PIF  +         ++ DQL+ I  ++G
Sbjct: 193 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK---------HYLDQLNHILGILG 243
Query: 261 FPLEKDWEDI 270
            P ++D   I
Sbjct: 244 SPEQEDLNCI 253

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  127 bits (320), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 83/250 (33%), Positives = 129/250 (51%), Gaps = 31/250 (12%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI---EGTGLSMSACREIALLRELKHPNVINLIS 83
           +G G YG V  A   DN +    A+++I   E         REI +L   +H N+I +  
Sbjct: 35  IGEGAYGMVCSAY--DNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 84  VFLS---HNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           +  +      + V+++ D  E DL+ ++K    +  +              LYQIL G+ 
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY----------FLYQILRGLK 142
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           Y+HS  VLHRDLKP+N+L+         +KI D G AR+ +        L   V T WYR
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTC----DLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           APE++L ++ YTK+IDIW++GCI AE+L++ PIF  +         ++ DQL+ I  ++G
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK---------HYLDQLNHILGILG 249
Query: 261 FPLEKDWEDI 270
            P ++D   I
Sbjct: 250 SPSQEDLNCI 259

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  124 bits (312), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 83/250 (33%), Positives = 127/250 (50%), Gaps = 31/250 (12%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI---EGTGLSMSACREIALLRELKHPNVINLIS 83
           +G G YG V  A   DN +    A+K+I   E         REI +L   +H N+I +  
Sbjct: 51  IGEGAYGMVCSAY--DNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 108
Query: 84  VFLS---HNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           +  +      + V+L+      DL+ ++K    +  +              LYQIL G+ 
Sbjct: 109 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICY----------FLYQILRGLK 158
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           Y+HS  VLHRDLKP+N+L+         +KI D G AR+ +        L   V T WYR
Sbjct: 159 YIHSANVLHRDLKPSNLLLN----TTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 214
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           APE++L ++ YTK+IDIW++GCI AE+L++ PIF  +         ++ DQL+ I  ++G
Sbjct: 215 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK---------HYLDQLNHILGILG 265
Query: 261 FPLEKDWEDI 270
            P ++D   I
Sbjct: 266 SPSQEDLNCI 275

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  124 bits (310), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 79/240 (32%), Positives = 121/240 (50%), Gaps = 32/240 (13%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINLI 82
           VG G YG V  A  K + +    A+K++    +    +  A RE+ LL+ ++H NVI L+
Sbjct: 32  VGSGAYGSVCSAIDKRSGE--KVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89
Query: 83  SVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
            VF   +  + +       +D + ++ F +                  L+YQ+L G+ Y+
Sbjct: 90  DVFTPASSLRNF-------YDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYI 142
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAP 202
           HS  V+HRDLKP N+ V     E   +KI D G AR  +      A++   VVT WYRAP
Sbjct: 143 HSAGVVHRDLKPGNLAVN----EDCELKILDFGLARHAD------AEMTGYVVTRWYRAP 192
Query: 203 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGFP 262
           E++L   HY + +DIW++GCI AE+LT + +F  +          + DQL +I  V G P
Sbjct: 193 EVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD---------YLDQLTQILKVTGVP 243

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  124 bits (310), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 79/240 (32%), Positives = 121/240 (50%), Gaps = 32/240 (13%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINLI 82
           VG G YG V  A  K + +    A+K++    +    +  A RE+ LL+ ++H NVI L+
Sbjct: 50  VGSGAYGSVCSAIDKRSGE--KVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 107
Query: 83  SVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
            VF   +  + +       +D + ++ F +                  L+YQ+L G+ Y+
Sbjct: 108 DVFTPASSLRNF-------YDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYI 160
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAP 202
           HS  V+HRDLKP N+ V     E   +KI D G AR  +      A++   VVT WYRAP
Sbjct: 161 HSAGVVHRDLKPGNLAVN----EDCELKILDFGLARHAD------AEMTGYVVTRWYRAP 210
Query: 203 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGFP 262
           E++L   HY + +DIW++GCI AE+LT + +F  +          + DQL +I  V G P
Sbjct: 211 EVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD---------YLDQLTQILKVTGVP 261

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 95/299 (31%), Positives = 141/299 (47%), Gaps = 68/299 (22%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC----REIALLRELKHPNVINLI 82
           +G G+YGHV +A   D  + R  A+K+I      +  C    REIA+L  L H +V+ ++
Sbjct: 61  IGTGSYGHVCEAY--DKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVL 118
Query: 83  SVFLSHNDRK---VWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGI 139
            + +  +  K   ++++ + A+ D   + +                    +LLY +L G+
Sbjct: 119 DIVIPKDVEKFDELYVVLEIADSDFKKLFR---------TPVYLTELHIKTLLYNLLVGV 169
Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNP--------LKPLAD-- 189
            Y+HS  +LHRDLKPAN LV  +      VK+ D G AR  + P        + P  D  
Sbjct: 170 KYVHSAGILHRDLKPANCLVNQDC----SVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 190 --------------LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT------ 229
                         L   VVT WYRAPEL+L   +YT+AID+W+IGCIFAELL       
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285
Query: 230 -----SEPIFHCR-----QEDIKTSNPY------HHDQLDRIFSVMGFPLEKDWEDIRK 272
                  P+F          D K  N +      + DQL+ IF+++G P E+D E + K
Sbjct: 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEK 344

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  119 bits (298), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 83/245 (33%), Positives = 122/245 (49%), Gaps = 33/245 (13%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGT----GLSMSACREIALLRELKHPNVINLI 82
           +G G YG V  ARR+     +  A+K+I         +    RE+ +L+  KH N+I + 
Sbjct: 62  IGNGAYGVVSSARRRLTG--QQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIK 119
Query: 83  SVF---LSHND-RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            +    + + + + V+++ D  E DL  II   +                   LYQ+L G
Sbjct: 120 DILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRY---------FLYQLLRG 170
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPLKPLADLDPVVVTF 197
           + Y+HS  V+HRDLKP+N+LV     E   +KI D G AR L  +P +    +   V T 
Sbjct: 171 LKYMHSAQVIHRDLKPSNLLVN----ENCELKIGDFGMARGLCTSPAEHQYFMTEYVATR 226
Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFS 257
           WYRAPEL+L    YT+AID+W++GCIF E+L    +F  +         Y H QL  I  
Sbjct: 227 WYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN--------YVH-QLQLIMM 277
Query: 258 VMGFP 262
           V+G P
Sbjct: 278 VLGTP 282

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  119 bits (298), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 80/243 (32%), Positives = 119/243 (48%), Gaps = 37/243 (15%)
Query: 27  VGRGTYGHV---YKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLIS 83
           VG G YG V   Y AR +     +  + +  +    +    RE+ LL+ LKH NVI L+ 
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLS-RPFQSLIHARRTYRELRLLKHLKHENVIGLLD 94
Query: 84  VFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGI 139
           VF          +V+L+      DL +I+K    +  +             L+YQ+L G+
Sbjct: 95  VFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQF----------LVYQLLRGL 144
Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
            Y+HS  ++HRDLKP+N+ V     E   ++I D G AR  +       ++   V T WY
Sbjct: 145 KYIHSAGIIHRDLKPSNVAVN----EDSELRILDFGLARQADE------EMTGYVATRWY 194
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVM 259
           RAPE++L   HY + +DIW++GCI AELL  + +F             + DQL RI  V+
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSD---------YIDQLKRIMEVV 245
Query: 260 GFP 262
           G P
Sbjct: 246 GTP 248

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  119 bits (298), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 80/243 (32%), Positives = 119/243 (48%), Gaps = 37/243 (15%)
Query: 27  VGRGTYGHV---YKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLIS 83
           VG G YG V   Y AR +     +  + +  +    +    RE+ LL+ LKH NVI L+ 
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLS-RPFQSLIHARRTYRELRLLKHLKHENVIGLLD 94
Query: 84  VFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGI 139
           VF          +V+L+      DL +I+K    +  +             L+YQ+L G+
Sbjct: 95  VFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF----------LVYQLLRGL 144
Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
            Y+HS  ++HRDLKP+N+ V     E   ++I D G AR  +       ++   V T WY
Sbjct: 145 KYIHSAGIIHRDLKPSNVAVN----EDSELRILDFGLARQADE------EMTGYVATRWY 194
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVM 259
           RAPE++L   HY + +DIW++GCI AELL  + +F             + DQL RI  V+
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSD---------YIDQLKRIMEVV 245
Query: 260 GFP 262
           G P
Sbjct: 246 GTP 248

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  119 bits (297), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 83/245 (33%), Positives = 122/245 (49%), Gaps = 33/245 (13%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGT----GLSMSACREIALLRELKHPNVINLI 82
           +G G YG V  ARR+     +  A+K+I         +    RE+ +L+  KH N+I + 
Sbjct: 63  IGNGAYGVVSSARRRLTG--QQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIK 120
Query: 83  SVF---LSHND-RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            +    + + + + V+++ D  E DL  II   +                   LYQ+L G
Sbjct: 121 DILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRY---------FLYQLLRG 171
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPLKPLADLDPVVVTF 197
           + Y+HS  V+HRDLKP+N+LV     E   +KI D G AR L  +P +    +   V T 
Sbjct: 172 LKYMHSAQVIHRDLKPSNLLVN----ENCELKIGDFGMARGLCTSPAEHQYFMTEYVATR 227
Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFS 257
           WYRAPEL+L    YT+AID+W++GCIF E+L    +F  +         Y H QL  I  
Sbjct: 228 WYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN--------YVH-QLQLIMM 278
Query: 258 VMGFP 262
           V+G P
Sbjct: 279 VLGTP 283

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  118 bits (295), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 84/244 (34%), Positives = 119/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 30  VGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 137
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDD------EMTGYVATRW 187
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L A HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 188 YRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 238
Query: 259 MGFP 262
           +G P
Sbjct: 239 VGTP 242

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  118 bits (295), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 80/244 (32%), Positives = 121/244 (49%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++    +    +  A RE+ LL+ ++H NVI L+
Sbjct: 33  VGSGAYGAVCSA--VDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF            +L+  +   DL  ++K  +  +               L+YQ+L G
Sbjct: 91  DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQF----------LVYQMLKG 140
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+H+  ++HRDLKP N+ V     E   +KI D G AR  +      +++   VVT W
Sbjct: 141 LRYIHAAGIIHRDLKPGNLAVN----EDCELKILDFGLARQAD------SEMXGXVVTRW 190
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L    YT+ +DIW++GCI AE++T + +F       K S+  H DQL  I  V
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF-------KGSD--HLDQLKEIMKV 241
Query: 259 MGFP 262
            G P
Sbjct: 242 TGTP 245

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  118 bits (295), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 80/243 (32%), Positives = 119/243 (48%), Gaps = 37/243 (15%)
Query: 27  VGRGTYGHV---YKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLIS 83
           VG G YG V   Y AR +     +  + +  +    +    RE+ LL+ LKH NVI L+ 
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLS-RPFQSLIHARRTYRELRLLKHLKHENVIGLLD 86
Query: 84  VFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGI 139
           VF          +V+L+      DL +I+K    +  +             L+YQ+L G+
Sbjct: 87  VFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF----------LVYQLLRGL 136
Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
            Y+HS  ++HRDLKP+N+ V     E   ++I D G AR  +       ++   V T WY
Sbjct: 137 KYIHSAGIIHRDLKPSNVAVN----EDCELRILDFGLARQADE------EMTGYVATRWY 186
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVM 259
           RAPE++L   HY + +DIW++GCI AELL  + +F             + DQL RI  V+
Sbjct: 187 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSD---------YIDQLKRIMEVV 237
Query: 260 GFP 262
           G P
Sbjct: 238 GTP 240

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  115 bits (289), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 36  VGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 93
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 94  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 143
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 144 LKYIHSADIIHRDLKPSNLAVN----EDSELKILDFGLARHTDD------EMTGYVATRW 193
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 244
Query: 259 MGFP 262
           +G P
Sbjct: 245 VGTP 248

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  115 bits (289), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 32  VGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 89
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 90  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 139
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 140 LKYIHSADIIHRDLKPSNLAVN----EDSELKILDFGLARHTDD------EMTGYVATRW 189
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 190 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 240
Query: 259 MGFP 262
           +G P
Sbjct: 241 VGTP 244

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  115 bits (288), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 30  VGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQF----------LIYQILRG 137
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVN----EDXELKILDFGLARHTDD------EMTGYVATRW 187
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 238
Query: 259 MGFP 262
           +G P
Sbjct: 239 VGTP 242

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  115 bits (288), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 42  VGSGAYGSVCAAF--DTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLL 99
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 100 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 149
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 150 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDD------EMTGYVATRW 199
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 200 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 250
Query: 259 MGFP 262
           +G P
Sbjct: 251 VGTP 254

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  115 bits (288), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 41  VGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 98
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 99  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 148
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 149 LKYIHSADIIHRDLKPSNLAVN----EDXELKILDFGLARHTDD------EMTGYVATRW 198
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 199 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 249
Query: 259 MGFP 262
           +G P
Sbjct: 250 VGTP 253

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  115 bits (288), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 40  VGSGAYGSVCAAF--DTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 97
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 98  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 147
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 148 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDD------EMTGYVATRW 197
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 198 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 248
Query: 259 MGFP 262
           +G P
Sbjct: 249 VGTP 252

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score =  115 bits (288), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 92/294 (31%), Positives = 141/294 (47%), Gaps = 61/294 (20%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC----REIALLRELKHPNVINLI 82
           +GRG+YG+VY A   D +  ++ A+K++      +  C    REI +L  LK   +I L 
Sbjct: 34  IGRGSYGYVYLAY--DKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLY 91
Query: 83  SVFLSHNDRK---VWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGI 139
            + +  +  K   ++++ + A+ DL  + K                    ++LY +L G 
Sbjct: 92  DLIIPDDLLKFDELYIVLEIADSDLKKLFK---------TPIFLTEEHIKTILYNLLLGE 142
Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFN-----NPLKPLAD----- 189
           +++H + ++HRDLKPAN L+  +      VK+ D G AR  N     N +  L +     
Sbjct: 143 NFIHESGIIHRDLKPANCLLNQDC----SVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198
Query: 190 ---------LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL-----------T 229
                    L   VVT WYRAPEL+L   +YTK+IDIW+ GCIFAELL            
Sbjct: 199 PHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258
Query: 230 SEPIF---HC-----RQEDIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPE 275
             P+F    C      +   K     + DQL+ IF+++G P E D ++I K PE
Sbjct: 259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINK-PE 311

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  115 bits (288), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 49  VGSGAYGSVCAAF--DTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 106
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 107 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 156
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 157 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDD------EMTGYVATRW 206
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 207 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 257
Query: 259 MGFP 262
           +G P
Sbjct: 258 VGTP 261

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  115 bits (288), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 50  VGSGAYGSVCAAF--DTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 107
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 108 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 157
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 158 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDD------EMXGXVATRW 207
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 208 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 258
Query: 259 MGFP 262
           +G P
Sbjct: 259 VGTP 262

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  115 bits (287), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 137/277 (49%), Gaps = 40/277 (14%)
Query: 5   FKIKTSNERTKVEDLFDYEGCKV-GRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA 63
            K+  S+ +T  +    Y  CKV G G++G V++A+  ++ +    A+K++         
Sbjct: 25  IKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEV---AIKKVLQD--KRFK 79
Query: 64  CREIALLRELKHPNVINLISVFLSHNDRK----VWLLFDYAEHDLWHIIKFHRAAKANXX 119
            RE+ ++R +KHPNV++L + F S+ D+K    + L+ +Y    ++   + +   K    
Sbjct: 80  NRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMP 139
Query: 120 XXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL 179
                       +YQ+L  + Y+HS  + HRD+KP N+L+       G +K+ D G A++
Sbjct: 140 MLLIKLY-----MYQLLRSLAYIHSIGICHRDIKPQNLLL---DPPSGVLKLIDFGSAKI 191
Query: 180 FNNPLKPLADLDP---VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 236
                  L   +P    + + +YRAPEL+ GA +YT  IDIW+ GC+ AEL+  +P+F  
Sbjct: 192 -------LIAGEPNVSXICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPG 244
Query: 237 RQEDIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM 273
                        DQL  I  V+G P     E I+ M
Sbjct: 245 ES---------GIDQLVEIIKVLGTP---SREQIKTM 269

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  115 bits (287), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 30  VGSGAYGSVCAAF--DTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 137
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDD------EMTGYVATRW 187
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 238
Query: 259 MGFP 262
           +G P
Sbjct: 239 VGTP 242

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  115 bits (287), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 50  VGSGAYGSVCAAF--DTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 107
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 108 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 157
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 158 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDD------EMTGYVATRW 207
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 208 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 258
Query: 259 MGFP 262
           +G P
Sbjct: 259 VGTP 262

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  115 bits (287), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 30  VGSGAYGSVCAAF--DTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 137
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDD------EMAGFVATRW 187
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 238
Query: 259 MGFP 262
           +G P
Sbjct: 239 VGTP 242

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 30  VGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQF----------LIYQILRG 137
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDD------EMTGYVATRW 187
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 238
Query: 259 MGFP 262
           +G P
Sbjct: 239 VGTP 242

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 35  VGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 92
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 93  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 142
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 143 LKYIHSADIIHRDLKPSNLAVN----EDXELKILDFGLARHTDD------EMTGYVATRW 192
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 193 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 243
Query: 259 MGFP 262
           +G P
Sbjct: 244 VGTP 247

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 30  VGSGAYGSVCAAF--DTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 137
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDD------EMAGFVATRW 187
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 238
Query: 259 MGFP 262
           +G P
Sbjct: 239 VGTP 242

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 42  VGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 99
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 100 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 149
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 150 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDD------EMTGYVATRW 199
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 200 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 250
Query: 259 MGFP 262
           +G P
Sbjct: 251 VGTP 254

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 42  VGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 99
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 100 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 149
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 150 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDD------EMTGYVATRW 199
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 200 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 250
Query: 259 MGFP 262
           +G P
Sbjct: 251 VGTP 254

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 30  VGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 137
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDD------EMTGYVATRW 187
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 238
Query: 259 MGFP 262
           +G P
Sbjct: 239 VGTP 242

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 41  VGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 98
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 99  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 148
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 149 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDD------EMTGYVATRW 198
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 199 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 249
Query: 259 MGFP 262
           +G P
Sbjct: 250 VGTP 253

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 30  VGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 137
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDD------EMTGYVATRW 187
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 238
Query: 259 MGFP 262
           +G P
Sbjct: 239 VGTP 242

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 32  VGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 89
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 90  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 139
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 140 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDD------EMTGYVATRW 189
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 190 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 240
Query: 259 MGFP 262
           +G P
Sbjct: 241 VGTP 244

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 30  VGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 137
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDD------EMTGYVATRW 187
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 238
Query: 259 MGFP 262
           +G P
Sbjct: 239 VGTP 242

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 30  VGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 137
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDD------EMTGYVATRW 187
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 238
Query: 259 MGFP 262
           +G P
Sbjct: 239 VGTP 242

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 50  VGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 107
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 108 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 157
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 158 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDD------EMTGYVATRW 207
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 208 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 258
Query: 259 MGFP 262
           +G P
Sbjct: 259 VGTP 262

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 32  VGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 89
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 90  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 139
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 140 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDD------EMTGYVATRW 189
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 190 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 240
Query: 259 MGFP 262
           +G P
Sbjct: 241 VGTP 244

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 35  VGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 92
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 93  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 142
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 143 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDD------EMTGYVATRW 192
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 193 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 243
Query: 259 MGFP 262
           +G P
Sbjct: 244 VGTP 247

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 29  VGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 86
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 87  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 136
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 137 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDD------EMTGYVATRW 186
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 187 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 237
Query: 259 MGFP 262
           +G P
Sbjct: 238 VGTP 241

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 30  VGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 137
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDD------EMTGYVATRW 187
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 238
Query: 259 MGFP 262
           +G P
Sbjct: 239 VGTP 242

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 30  VGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 137
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDD------EMTGYVATRW 187
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 238
Query: 259 MGFP 262
           +G P
Sbjct: 239 VGTP 242

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  114 bits (286), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 30  VGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 137
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDD------EMTGXVATRW 187
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 238
Query: 259 MGFP 262
           +G P
Sbjct: 239 VGTP 242

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  114 bits (286), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 36  VGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 93
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 94  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 143
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 144 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDD------EMTGYVATRW 193
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 244
Query: 259 MGFP 262
           +G P
Sbjct: 245 VGTP 248

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  114 bits (286), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 53  VGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 110
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 111 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 160
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 161 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDD------EMTGYVATRW 210
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 211 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 261
Query: 259 MGFP 262
           +G P
Sbjct: 262 VGTP 265

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  114 bits (286), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 49  VGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 106
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 107 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 156
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 157 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDD------EMTGYVATRW 206
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 207 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 257
Query: 259 MGFP 262
           +G P
Sbjct: 258 VGTP 261

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  114 bits (286), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 32  VGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 89
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 90  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 139
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 140 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDD------EMTGYVATRW 189
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 190 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 240
Query: 259 MGFP 262
           +G P
Sbjct: 241 VGTP 244

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  114 bits (286), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 37  VGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 144
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDD------EMTGYVATRW 194
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 245
Query: 259 MGFP 262
           +G P
Sbjct: 246 VGTP 249

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  114 bits (286), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 85/258 (32%), Positives = 122/258 (47%), Gaps = 42/258 (16%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  +   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 59  VGSGAYGSVCSSY--DVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 116
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 117 DVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 166
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 167 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDD------EMTGYVATRW 216
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY   +DIW++GCI AELLT   +F             H +QL +I  +
Sbjct: 217 YRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTD---------HINQLQQIMRL 267
Query: 259 MGFPLEKDWEDIRKMPEH 276
            G P       I +MP H
Sbjct: 268 TGTP---PASVISRMPSH 282

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  114 bits (286), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 36  VGSGAYGSVCAAF--DTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 93
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 94  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 143
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 144 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDD------EMTGYVATRW 193
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF---------PGTDHIDQLKLILRL 244
Query: 259 MGFP 262
           +G P
Sbjct: 245 VGTP 248

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  114 bits (286), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 26  VGSGAYGSVCAAF--DTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 133
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 134 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDD------EMAGFVATRW 183
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 234
Query: 259 MGFP 262
           +G P
Sbjct: 235 VGTP 238

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  114 bits (286), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 26  VGSGAYGSVCAAF--DTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 133
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 134 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDD------EMTGYVATRW 183
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 234
Query: 259 MGFP 262
           +G P
Sbjct: 235 VGTP 238

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  114 bits (286), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 30  VGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 137
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDAGLARHTDD------EMTGYVATRW 187
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 238
Query: 259 MGFP 262
           +G P
Sbjct: 239 VGTP 242

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  114 bits (286), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 27  VGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 84
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 85  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 134
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 135 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDD------EMTGYVATRW 184
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 185 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 235
Query: 259 MGFP 262
           +G P
Sbjct: 236 VGTP 239

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  114 bits (286), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 30  VGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 137
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDD------EMTGYVATRW 187
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 238
Query: 259 MGFP 262
           +G P
Sbjct: 239 VGTP 242

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  114 bits (286), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 53  VGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 110
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 111 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 160
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 161 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDD------EMXGYVATRW 210
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 211 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 261
Query: 259 MGFP 262
           +G P
Sbjct: 262 VGTP 265

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  114 bits (286), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 28  VGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 85
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 86  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 135
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 136 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDD------EMTGYVATRW 185
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 186 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 236
Query: 259 MGFP 262
           +G P
Sbjct: 237 VGTP 240

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  114 bits (286), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 35  VGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 92
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 93  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 142
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 143 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDD------EMTGYVATRW 192
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 193 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 243
Query: 259 MGFP 262
           +G P
Sbjct: 244 VGTP 247

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  114 bits (286), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 27  VGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 84
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 85  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 134
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 135 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDD------EMTGYVATRW 184
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 185 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 235
Query: 259 MGFP 262
           +G P
Sbjct: 236 VGTP 239

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  114 bits (286), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 82/244 (33%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           +G G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 35  IGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 92
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 93  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 142
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 143 LKYIHSADIIHRDLKPSNLAVN----EDXELKILDFGLARHTDD------EMTGYVATRW 192
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 193 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 243
Query: 259 MGFP 262
           +G P
Sbjct: 244 VGTP 247

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  114 bits (286), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 26  VGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 133
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 134 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDD------EMTGYVATRW 183
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 234
Query: 259 MGFP 262
           +G P
Sbjct: 235 VGTP 238

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  114 bits (285), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 76/227 (33%), Positives = 115/227 (50%), Gaps = 29/227 (12%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMS--ACREIALLRELKHPNVINLISV 84
           +G G  G V+ A   DN   +  A+K+I  T       A REI ++R L H N++ +  +
Sbjct: 19  LGCGGNGLVFSA--VDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEI 76
Query: 85  FLSHNDR------------KVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLL 132
                 +             V+++ +Y E DL ++++     + +              +
Sbjct: 77  LGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARL----------FM 126
Query: 133 YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP 192
           YQ+L G+ Y+HS  VLHRDLKPAN+ +  E +    +KI D G AR+ +        L  
Sbjct: 127 YQLLRGLKYIHSANVLHRDLKPANLFINTEDL---VLKIGDFGLARIMDPHYSHKGHLSE 183
Query: 193 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
            +VT WYR+P LLL   +YTKAID+WA GCIFAE+LT + +F    E
Sbjct: 184 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE 230

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  114 bits (285), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 30  VGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 137
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDYGLARHTDD------EMTGYVATRW 187
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 238
Query: 259 MGFP 262
           +G P
Sbjct: 239 VGTP 242

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  114 bits (285), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 36  VGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 93
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 94  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 143
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 144 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDD------EMTGYVATRW 193
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF---------PGTDHIDQLKLILRL 244
Query: 259 MGFP 262
           +G P
Sbjct: 245 VGTP 248

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  114 bits (285), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 30  VGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 137
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDRGLARHTDD------EMTGYVATRW 187
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 238
Query: 259 MGFP 262
           +G P
Sbjct: 239 VGTP 242

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  114 bits (285), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 82/244 (33%), Positives = 117/244 (47%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 30  VGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQF----------LIYQILRG 137
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G  R  ++      ++   V T W
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVN----EDSELKILDFGLCRHTDD------EMTGYVATRW 187
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 238
Query: 259 MGFP 262
           +G P
Sbjct: 239 VGTP 242

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  114 bits (285), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 30  VGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 137
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDGGLARHTDD------EMTGYVATRW 187
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 238
Query: 259 MGFP 262
           +G P
Sbjct: 239 VGTP 242

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  114 bits (284), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 117/244 (47%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 37  VGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 144
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR   +      ++   V T W
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTAD------EMTGYVATRW 194
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 245
Query: 259 MGFP 262
           +G P
Sbjct: 246 VGTP 249

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  114 bits (284), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 117/244 (47%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 37  VGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 144
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR   +      ++   V T W
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTAD------EMTGYVATRW 194
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 245
Query: 259 MGFP 262
           +G P
Sbjct: 246 VGTP 249

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  114 bits (284), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 117/244 (47%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 37  VGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 144
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR   +      ++   V T W
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTAD------EMTGYVATRW 194
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 245
Query: 259 MGFP 262
           +G P
Sbjct: 246 VGTP 249

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  114 bits (284), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 26  VGSGAYGSVCAAF--DTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQF----------LIYQILRG 133
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++      ++   V T W
Sbjct: 134 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDD------EMTGYVATRW 183
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 234
Query: 259 MGFP 262
           +G P
Sbjct: 235 VGTP 238

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 82/244 (33%), Positives = 117/244 (47%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 30  VGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 137
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI   G AR  ++      ++   V T W
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVN----EDCELKILGFGLARHTDD------EMTGYVATRW 187
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 238
Query: 259 MGFP 262
           +G P
Sbjct: 239 VGTP 242

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  111 bits (278), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 82/244 (33%), Positives = 117/244 (47%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++     S+       RE+ LL+ +KH NVI L+
Sbjct: 30  VGSGAYGSVCAAF--DTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +             L+YQIL G
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------LIYQILRG 137
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D   AR  ++      ++   V T W
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDFYLARHTDD------EMTGYVATRW 187
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 238
Query: 259 MGFP 262
           +G P
Sbjct: 239 VGTP 242

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  111 bits (277), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 75/249 (30%), Positives = 119/249 (47%), Gaps = 38/249 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTG---LSMSACREIALLRELKHPNVINLIS 83
           +G G YG V  A  K   +    A+K+IE       ++   REI +L+  KH N+I + +
Sbjct: 19  LGEGAYGVVCSATHKPTGEI--VAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFN 76
Query: 84  VFLS---HNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           +       N  +V+++ +  + DL  +I     +  +              +YQ L  + 
Sbjct: 77  IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY----------FIYQTLRAVK 126
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN-------PLKPLADLDPV 193
            LH + V+HRDLKP+N+L+         +K+ D G AR+ +        P    + +   
Sbjct: 127 VLHGSNVIHRDLKPSNLLINSNC----DLKVCDFGLARIIDESAADNSEPTGQQSGMTEX 182
Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 253
           V T WYRAPE++L +  Y++A+D+W+ GCI AEL    PIF  R         Y H QL 
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD--------YRH-QLL 233
Query: 254 RIFSVMGFP 262
            IF ++G P
Sbjct: 234 LIFGIIGTP 242

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  110 bits (276), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 75/249 (30%), Positives = 119/249 (47%), Gaps = 38/249 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTG---LSMSACREIALLRELKHPNVINLIS 83
           +G G YG V  A  K   +    A+K+IE       ++   REI +L+  KH N+I + +
Sbjct: 19  LGEGAYGVVCSATHKPTGEI--VAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFN 76
Query: 84  VFLS---HNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           +       N  +V+++ +  + DL  +I     +  +              +YQ L  + 
Sbjct: 77  IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY----------FIYQTLRAVK 126
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN-------PLKPLADLDPV 193
            LH + V+HRDLKP+N+L+         +K+ D G AR+ +        P    + +   
Sbjct: 127 VLHGSNVIHRDLKPSNLLINSNC----DLKVCDFGLARIIDESAADNSEPTGQQSGMTEY 182
Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 253
           V T WYRAPE++L +  Y++A+D+W+ GCI AEL    PIF  R         Y H QL 
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD--------YRH-QLL 233
Query: 254 RIFSVMGFP 262
            IF ++G P
Sbjct: 234 LIFGIIGTP 242

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  110 bits (275), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 77/255 (30%), Positives = 126/255 (49%), Gaps = 40/255 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI-EGTGLSMSACREIALLRELKHPNVINLISVF 85
           +G G++G VY+A+  D+ +    A+K++ +G        RE+ ++R+L H N++ L   F
Sbjct: 28  IGNGSFGVVYQAKLCDSGEL--VAIKKVLQGKAFKN---RELQIMRKLDHCNIVRLRYFF 82
Query: 86  LSHNDRK----VWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
            S  ++K    + L+ DY    ++ + + +  AK                +YQ+   + Y
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY-----MYQLFRSLAY 137
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP---VVVTFW 198
           +HS  + HRD+KP N+L+     +   +K+ D G A       K L   +P    + + +
Sbjct: 138 IHSFGICHRDIKPQNLLL---DPDTAVLKLCDFGSA-------KQLVRGEPNVSYICSRY 187
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPEL+ GA  YT +ID+W+ GC+ AELL  +PIF               DQL  I  V
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF---------PGDSGVDQLVEIIKV 238
Query: 259 MGFPLEKDWEDIRKM 273
           +G P     E IR+M
Sbjct: 239 LGTPTR---EQIREM 250

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  110 bits (275), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 77/255 (30%), Positives = 126/255 (49%), Gaps = 40/255 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI-EGTGLSMSACREIALLRELKHPNVINLISVF 85
           +G G++G VY+A+  D+ +    A+K++ +G        RE+ ++R+L H N++ L   F
Sbjct: 28  IGNGSFGVVYQAKLCDSGEL--VAIKKVLQGKAFKN---RELQIMRKLDHCNIVRLRYFF 82
Query: 86  LSHNDRK----VWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
            S  ++K    + L+ DY    ++ + + +  AK                +YQ+   + Y
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY-----MYQLFRSLAY 137
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP---VVVTFW 198
           +HS  + HRD+KP N+L+     +   +K+ D G A       K L   +P    + + +
Sbjct: 138 IHSFGICHRDIKPQNLLL---DPDTAVLKLCDFGSA-------KQLVRGEPNVSYICSRY 187
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPEL+ GA  YT +ID+W+ GC+ AELL  +PIF               DQL  I  V
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF---------PGDSGVDQLVEIIKV 238
Query: 259 MGFPLEKDWEDIRKM 273
           +G P     E IR+M
Sbjct: 239 LGTPTR---EQIREM 250

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  110 bits (275), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 77/255 (30%), Positives = 126/255 (49%), Gaps = 40/255 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI-EGTGLSMSACREIALLRELKHPNVINLISVF 85
           +G G++G VY+A+  D+ +    A+K++ +G        RE+ ++R+L H N++ L   F
Sbjct: 28  IGNGSFGVVYQAKLCDSGEL--VAIKKVLQGKAFKN---RELQIMRKLDHCNIVRLRYFF 82
Query: 86  LSHNDRK----VWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
            S  ++K    + L+ DY    ++ + + +  AK                +YQ+   + Y
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLY-----MYQLFRSLAY 137
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP---VVVTFW 198
           +HS  + HRD+KP N+L+     +   +K+ D G A       K L   +P    + + +
Sbjct: 138 IHSFGICHRDIKPQNLLL---DPDTAVLKLCDFGSA-------KQLVRGEPNVSXICSRY 187
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPEL+ GA  YT +ID+W+ GC+ AELL  +PIF               DQL  I  V
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF---------PGDSGVDQLVEIIKV 238
Query: 259 MGFPLEKDWEDIRKM 273
           +G P     E IR+M
Sbjct: 239 LGTPTR---EQIREM 250

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 75/249 (30%), Positives = 119/249 (47%), Gaps = 38/249 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTG---LSMSACREIALLRELKHPNVINLIS 83
           +G G YG V  A  K   +    A+K+IE       ++   REI +L+  KH N+I + +
Sbjct: 19  LGEGAYGVVCSATHKPTGEI--VAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFN 76
Query: 84  VFLS---HNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           +       N  +V+++ +  + DL  +I     +  +              +YQ L  + 
Sbjct: 77  IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY----------FIYQTLRAVK 126
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN-------PLKPLADLDPV 193
            LH + V+HRDLKP+N+L+         +K+ D G AR+ +        P    + +   
Sbjct: 127 VLHGSNVIHRDLKPSNLLINSNC----DLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 253
           V T WYRAPE++L +  Y++A+D+W+ GCI AEL    PIF  R         Y H QL 
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD--------YRH-QLL 233
Query: 254 RIFSVMGFP 262
            IF ++G P
Sbjct: 234 LIFGIIGTP 242

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 91/294 (30%), Positives = 135/294 (45%), Gaps = 63/294 (21%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC----REIALLRELKHPNVINLI 82
           +GRG+YG+VY A   D +  ++ A+K++      +  C    REI +L  LK   +I L 
Sbjct: 36  IGRGSYGYVYLAY--DKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLH 93
Query: 83  SVFLSHNDRK---VWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGI 139
            + +  +  K   ++++ + A+ DL  + K                    ++LY +L G 
Sbjct: 94  DLIIPEDLLKFDELYIVLEIADSDLKKLFK---------TPIFLTEQHVKTILYNLLLGE 144
Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFN--------NPLKPL---- 187
            ++H + ++HRDLKPAN L+  +      VKI D G AR  N        N L+      
Sbjct: 145 KFIHESGIIHRDLKPANCLLNQDC----SVKICDFGLARTINSDKDIHIVNDLEEKEENE 200
Query: 188 ----------ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE------ 231
                       L   VVT WYRAPEL+L   +YT +IDIW+ GCIFAELL         
Sbjct: 201 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHINN 260
Query: 232 -----PIF---HC-----RQEDIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRK 272
                P+F    C          K     + DQL+ IF+V+G P E+D + I K
Sbjct: 261 PTNRFPLFPGSSCFPLSPDHNSKKVHEKSNRDQLNIIFNVIGTPPEEDLKCITK 314

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  108 bits (270), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 125/254 (49%), Gaps = 38/254 (14%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFL 86
           +G G++G VY+A+  D+ +    A+K++       +  RE+ ++R+L H N++ L   F 
Sbjct: 62  IGNGSFGVVYQAKLCDSGEL--VAIKKVLQDKRFKN--RELQIMRKLDHCNIVRLRYFFY 117
Query: 87  SHNDRK----VWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
           S  ++K    + L+ DY    ++ + + +  AK                +YQ+   + Y+
Sbjct: 118 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-----YMYQLFRSLAYI 172
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP---VVVTFWY 199
           HS  + HRD+KP N+L+     +   +K+ D G A       K L   +P    + + +Y
Sbjct: 173 HSFGICHRDIKPQNLLL---DPDTAVLKLCDFGSA-------KQLVRGEPNVSXICSRYY 222
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVM 259
           RAPEL+ GA  YT +ID+W+ GC+ AELL  +PIF               DQL  I  V+
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF---------PGDSGVDQLVEIIKVL 273
Query: 260 GFPLEKDWEDIRKM 273
           G P     E IR+M
Sbjct: 274 GTPTR---EQIREM 284

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  108 bits (270), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 125/254 (49%), Gaps = 38/254 (14%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFL 86
           +G G++G VY+A+  D+ +    A+K++       +  RE+ ++R+L H N++ L   F 
Sbjct: 47  IGNGSFGVVYQAKLCDSGEL--VAIKKVLQDKRFKN--RELQIMRKLDHCNIVRLRYFFY 102
Query: 87  SHNDRK----VWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
           S  ++K    + L+ DY    ++ + + +  AK                +YQ+   + Y+
Sbjct: 103 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-----YMYQLFRSLAYI 157
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP---VVVTFWY 199
           HS  + HRD+KP N+L+     +   +K+ D G A       K L   +P    + + +Y
Sbjct: 158 HSFGICHRDIKPQNLLL---DPDTAVLKLCDFGSA-------KQLVRGEPNVSXICSRYY 207
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVM 259
           RAPEL+ GA  YT +ID+W+ GC+ AELL  +PIF               DQL  I  V+
Sbjct: 208 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF---------PGDSGVDQLVEIIKVL 258
Query: 260 GFPLEKDWEDIRKM 273
           G P     E IR+M
Sbjct: 259 GTPTR---EQIREM 269

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 125/254 (49%), Gaps = 38/254 (14%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFL 86
           +G G++G VY+A+  D+ +    A+K++       +  RE+ ++R+L H N++ L   F 
Sbjct: 40  IGNGSFGVVYQAKLCDSGEL--VAIKKVLQDKRFKN--RELQIMRKLDHCNIVRLRYFFY 95
Query: 87  SHNDRK----VWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
           S  ++K    + L+ DY    ++ + + +  AK                +YQ+   + Y+
Sbjct: 96  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-----YMYQLFRSLAYI 150
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP---VVVTFWY 199
           HS  + HRD+KP N+L+     +   +K+ D G A       K L   +P    + + +Y
Sbjct: 151 HSFGICHRDIKPQNLLL---DPDTAVLKLCDFGSA-------KQLVRGEPNVSXICSRYY 200
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVM 259
           RAPEL+ GA  YT +ID+W+ GC+ AELL  +PIF               DQL  I  V+
Sbjct: 201 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF---------PGDSGVDQLVEIIKVL 251
Query: 260 GFPLEKDWEDIRKM 273
           G P     E IR+M
Sbjct: 252 GTPTR---EQIREM 262

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 125/254 (49%), Gaps = 38/254 (14%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFL 86
           +G G++G VY+A+  D+ +    A+K++       +  RE+ ++R+L H N++ L   F 
Sbjct: 29  IGNGSFGVVYQAKLCDSGEL--VAIKKVLQDKRFKN--RELQIMRKLDHCNIVRLRYFFY 84
Query: 87  SHNDRK----VWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
           S  ++K    + L+ DY    ++ + + +  AK                +YQ+   + Y+
Sbjct: 85  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY-----MYQLFRSLAYI 139
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP---VVVTFWY 199
           HS  + HRD+KP N+L+     +   +K+ D G A       K L   +P    + + +Y
Sbjct: 140 HSFGICHRDIKPQNLLL---DPDTAVLKLCDFGSA-------KQLVRGEPNVSXICSRYY 189
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVM 259
           RAPEL+ GA  YT +ID+W+ GC+ AELL  +PIF               DQL  I  V+
Sbjct: 190 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF---------PGDSGVDQLVEIIKVL 240
Query: 260 GFPLEKDWEDIRKM 273
           G P     E IR+M
Sbjct: 241 GTPTR---EQIREM 251

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 125/254 (49%), Gaps = 38/254 (14%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFL 86
           +G G++G VY+A+  D+ +    A+K++       +  RE+ ++R+L H N++ L   F 
Sbjct: 56  IGNGSFGVVYQAKLCDSGEL--VAIKKVLQDKRFKN--RELQIMRKLDHCNIVRLRYFFY 111
Query: 87  SHNDRK----VWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
           S  ++K    + L+ DY    ++ + + +  AK                +YQ+   + Y+
Sbjct: 112 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-----YMYQLFRSLAYI 166
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVV---VTFWY 199
           HS  + HRD+KP N+L+     +   +K+ D G A       K L   +P V    + +Y
Sbjct: 167 HSFGICHRDIKPQNLLL---DPDTAVLKLCDFGSA-------KQLVRGEPNVSYICSRYY 216
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVM 259
           RAPEL+ GA  YT +ID+W+ GC+ AELL  +PIF               DQL  I  V+
Sbjct: 217 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF---------PGDSGVDQLVEIIKVL 267
Query: 260 GFPLEKDWEDIRKM 273
           G P     E IR+M
Sbjct: 268 GTPTR---EQIREM 278

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 125/254 (49%), Gaps = 38/254 (14%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFL 86
           +G G++G VY+A+  D+ +    A+K++       +  RE+ ++R+L H N++ L   F 
Sbjct: 36  IGNGSFGVVYQAKLCDSGEL--VAIKKVLQDKRFKN--RELQIMRKLDHCNIVRLRYFFY 91
Query: 87  SHNDRK----VWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
           S  ++K    + L+ DY    ++ + + +  AK                +YQ+   + Y+
Sbjct: 92  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-----YMYQLFRSLAYI 146
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP---VVVTFWY 199
           HS  + HRD+KP N+L+     +   +K+ D G A       K L   +P    + + +Y
Sbjct: 147 HSFGICHRDIKPQNLLL---DPDTAVLKLCDFGSA-------KQLVRGEPNVSXICSRYY 196
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVM 259
           RAPEL+ GA  YT +ID+W+ GC+ AELL  +PIF               DQL  I  V+
Sbjct: 197 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF---------PGDSGVDQLVEIIKVL 247
Query: 260 GFPLEKDWEDIRKM 273
           G P     E IR+M
Sbjct: 248 GTPTR---EQIREM 258

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 125/254 (49%), Gaps = 38/254 (14%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFL 86
           +G G++G VY+A+  D+ +    A+K++       +  RE+ ++R+L H N++ L   F 
Sbjct: 28  IGNGSFGVVYQAKLCDSGEL--VAIKKVLQDKRFKN--RELQIMRKLDHCNIVRLRYFFY 83
Query: 87  SHNDRK----VWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
           S  ++K    + L+ DY    ++ + + +  AK                +YQ+   + Y+
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY-----MYQLFRSLAYI 138
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP---VVVTFWY 199
           HS  + HRD+KP N+L+     +   +K+ D G A       K L   +P    + + +Y
Sbjct: 139 HSFGICHRDIKPQNLLL---DPDTAVLKLCDFGSA-------KQLVRGEPNVSXICSRYY 188
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVM 259
           RAPEL+ GA  YT +ID+W+ GC+ AELL  +PIF               DQL  I  V+
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF---------PGDSGVDQLVEIIKVL 239
Query: 260 GFPLEKDWEDIRKM 273
           G P     E IR+M
Sbjct: 240 GTPTR---EQIREM 250

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  108 bits (269), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 125/254 (49%), Gaps = 38/254 (14%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFL 86
           +G G++G VY+A+  D+ +    A+K++       +  RE+ ++R+L H N++ L   F 
Sbjct: 40  IGNGSFGVVYQAKLCDSGEL--VAIKKVLQDKRFKN--RELQIMRKLDHCNIVRLRYFFY 95
Query: 87  SHNDRK----VWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
           S  ++K    + L+ DY    ++ + + +  AK                +YQ+   + Y+
Sbjct: 96  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-----YMYQLFRSLAYI 150
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP---VVVTFWY 199
           HS  + HRD+KP N+L+     +   +K+ D G A       K L   +P    + + +Y
Sbjct: 151 HSFGICHRDIKPQNLLL---DPDTAVLKLCDFGSA-------KQLVRGEPNVSXICSRYY 200
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVM 259
           RAPEL+ GA  YT +ID+W+ GC+ AELL  +PIF               DQL  I  V+
Sbjct: 201 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF---------PGDSGVDQLVEIIKVL 251
Query: 260 GFPLEKDWEDIRKM 273
           G P     E IR+M
Sbjct: 252 GTPTR---EQIREM 262

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  108 bits (269), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 125/254 (49%), Gaps = 38/254 (14%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFL 86
           +G G++G VY+A+  D+ +    A+K++       +  RE+ ++R+L H N++ L   F 
Sbjct: 32  IGNGSFGVVYQAKLCDSGEL--VAIKKVLQDKRFKN--RELQIMRKLDHCNIVRLRYFFY 87
Query: 87  SHNDRK----VWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
           S  ++K    + L+ DY    ++ + + +  AK                +YQ+   + Y+
Sbjct: 88  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY-----MYQLFRSLAYI 142
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP---VVVTFWY 199
           HS  + HRD+KP N+L+     +   +K+ D G A       K L   +P    + + +Y
Sbjct: 143 HSFGICHRDIKPQNLLL---DPDTAVLKLCDFGSA-------KQLVRGEPNVSXICSRYY 192
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVM 259
           RAPEL+ GA  YT +ID+W+ GC+ AELL  +PIF               DQL  I  V+
Sbjct: 193 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF---------PGDSGVDQLVEIIKVL 243
Query: 260 GFPLEKDWEDIRKM 273
           G P     E IR+M
Sbjct: 244 GTPTR---EQIREM 254

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  108 bits (269), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 125/254 (49%), Gaps = 38/254 (14%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFL 86
           +G G++G VY+A+  D+ +    A+K++       +  RE+ ++R+L H N++ L   F 
Sbjct: 28  IGNGSFGVVYQAKLCDSGEL--VAIKKVLQDKRFKN--RELQIMRKLDHCNIVRLRYFFY 83
Query: 87  SHNDRK----VWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
           S  ++K    + L+ DY    ++ + + +  AK                +YQ+   + Y+
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY-----MYQLFRSLAYI 138
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP---VVVTFWY 199
           HS  + HRD+KP N+L+     +   +K+ D G A       K L   +P    + + +Y
Sbjct: 139 HSFGICHRDIKPQNLLL---DPDTAVLKLCDFGSA-------KQLVRGEPNVSXICSRYY 188
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVM 259
           RAPEL+ GA  YT +ID+W+ GC+ AELL  +PIF               DQL  I  V+
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF---------PGDSGVDQLVEIIKVL 239
Query: 260 GFPLEKDWEDIRKM 273
           G P     E IR+M
Sbjct: 240 GTPTR---EQIREM 250

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  108 bits (269), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 125/254 (49%), Gaps = 38/254 (14%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFL 86
           +G G++G VY+A+  D+ +    A+K++       +  RE+ ++R+L H N++ L   F 
Sbjct: 28  IGNGSFGVVYQAKLCDSGEL--VAIKKVLQDKRFKN--RELQIMRKLDHCNIVRLRYFFY 83
Query: 87  SHNDRK----VWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
           S  ++K    + L+ DY    ++ + + +  AK                +YQ+   + Y+
Sbjct: 84  SSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY-----MYQLFRSLAYI 138
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP---VVVTFWY 199
           HS  + HRD+KP N+L+     +   +K+ D G A       K L   +P    + + +Y
Sbjct: 139 HSFGICHRDIKPQNLLL---DPDTAVLKLCDFGSA-------KQLVRGEPNVSXICSRYY 188
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVM 259
           RAPEL+ GA  YT +ID+W+ GC+ AELL  +PIF               DQL  I  V+
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF---------PGDSGVDQLVEIIKVL 239
Query: 260 GFPLEKDWEDIRKM 273
           G P     E IR+M
Sbjct: 240 GTPTR---EQIREM 250

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  108 bits (269), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 125/254 (49%), Gaps = 38/254 (14%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFL 86
           +G G++G VY+A+  D+ +    A+K++       +  RE+ ++R+L H N++ L   F 
Sbjct: 62  IGNGSFGVVYQAKLCDSGEL--VAIKKVLQDKRFKN--RELQIMRKLDHCNIVRLRYFFY 117
Query: 87  SHNDRK----VWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
           S  ++K    + L+ DY    ++ + + +  AK                +YQ+   + Y+
Sbjct: 118 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-----YMYQLFRSLAYI 172
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVV---VTFWY 199
           HS  + HRD+KP N+L+     +   +K+ D G A       K L   +P V    + +Y
Sbjct: 173 HSFGICHRDIKPQNLLL---DPDTAVLKLCDFGSA-------KQLVRGEPNVSYICSRYY 222
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVM 259
           RAPEL+ GA  YT +ID+W+ GC+ AELL  +PIF               DQL  I  V+
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF---------PGDSGVDQLVEIIKVL 273
Query: 260 GFPLEKDWEDIRKM 273
           G P     E IR+M
Sbjct: 274 GTPTR---EQIREM 284

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  108 bits (269), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 125/254 (49%), Gaps = 38/254 (14%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFL 86
           +G G++G VY+A+  D+ +    A+K++       +  RE+ ++R+L H N++ L   F 
Sbjct: 107 IGNGSFGVVYQAKLCDSGEL--VAIKKVLQDKRFKN--RELQIMRKLDHCNIVRLRYFFY 162
Query: 87  SHNDRK----VWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
           S  ++K    + L+ DY    ++ + + +  AK                +YQ+   + Y+
Sbjct: 163 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-----YMYQLFRSLAYI 217
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVV---VTFWY 199
           HS  + HRD+KP N+L+     +   +K+ D G A       K L   +P V    + +Y
Sbjct: 218 HSFGICHRDIKPQNLLL---DPDTAVLKLCDFGSA-------KQLVRGEPNVSYICSRYY 267
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVM 259
           RAPEL+ GA  YT +ID+W+ GC+ AELL  +PIF               DQL  I  V+
Sbjct: 268 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF---------PGDSGVDQLVEIIKVL 318
Query: 260 GFPLEKDWEDIRKM 273
           G P     E IR+M
Sbjct: 319 GTPTR---EQIREM 329

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  108 bits (269), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 125/254 (49%), Gaps = 38/254 (14%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFL 86
           +G G++G VY+A+  D+ +    A+K++       +  RE+ ++R+L H N++ L   F 
Sbjct: 28  IGNGSFGVVYQAKLCDSGEL--VAIKKVLQDKRFKN--RELQIMRKLDHCNIVRLRYFFY 83
Query: 87  SHNDRK----VWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
           S  ++K    + L+ DY    ++ + + +  AK                +YQ+   + Y+
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY-----MYQLFRSLAYI 138
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP---VVVTFWY 199
           HS  + HRD+KP N+L+     +   +K+ D G A       K L   +P    + + +Y
Sbjct: 139 HSFGICHRDIKPQNLLL---DPDTAVLKLCDFGSA-------KQLVRGEPNVSYICSRYY 188
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVM 259
           RAPEL+ GA  YT +ID+W+ GC+ AELL  +PIF               DQL  I  V+
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF---------PGDSGVDQLVEIIKVL 239
Query: 260 GFPLEKDWEDIRKM 273
           G P     E IR+M
Sbjct: 240 GTPTR---EQIREM 250

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  108 bits (269), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 125/254 (49%), Gaps = 38/254 (14%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFL 86
           +G G++G VY+A+  D+ +    A+K++       +  RE+ ++R+L H N++ L   F 
Sbjct: 64  IGNGSFGVVYQAKLCDSGEL--VAIKKVLQDKRFKN--RELQIMRKLDHCNIVRLRYFFY 119
Query: 87  SHNDRK----VWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
           S  ++K    + L+ DY    ++ + + +  AK                +YQ+   + Y+
Sbjct: 120 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-----YMYQLFRSLAYI 174
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVV---VTFWY 199
           HS  + HRD+KP N+L+     +   +K+ D G A       K L   +P V    + +Y
Sbjct: 175 HSFGICHRDIKPQNLLL---DPDTAVLKLCDFGSA-------KQLVRGEPNVSYICSRYY 224
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVM 259
           RAPEL+ GA  YT +ID+W+ GC+ AELL  +PIF               DQL  I  V+
Sbjct: 225 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF---------PGDSGVDQLVEIIKVL 275
Query: 260 GFPLEKDWEDIRKM 273
           G P     E IR+M
Sbjct: 276 GTPTR---EQIREM 286

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  108 bits (269), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 125/254 (49%), Gaps = 38/254 (14%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFL 86
           +G G++G VY+A+  D+ +    A+K++       +  RE+ ++R+L H N++ L   F 
Sbjct: 33  IGNGSFGVVYQAKLCDSGEL--VAIKKVLQDKRFKN--RELQIMRKLDHCNIVRLRYFFY 88
Query: 87  SHNDRK----VWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
           S  ++K    + L+ DY    ++ + + +  AK                +YQ+   + Y+
Sbjct: 89  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-----YMYQLFRSLAYI 143
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVV---VTFWY 199
           HS  + HRD+KP N+L+     +   +K+ D G A       K L   +P V    + +Y
Sbjct: 144 HSFGICHRDIKPQNLLL---DPDTAVLKLCDFGSA-------KQLVRGEPNVSYICSRYY 193
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVM 259
           RAPEL+ GA  YT +ID+W+ GC+ AELL  +PIF               DQL  I  V+
Sbjct: 194 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF---------PGDSGVDQLVEIIKVL 244
Query: 260 GFPLEKDWEDIRKM 273
           G P     E IR+M
Sbjct: 245 GTPTR---EQIREM 255

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  108 bits (269), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 125/254 (49%), Gaps = 38/254 (14%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFL 86
           +G G++G VY+A+  D+ +    A+K++       +  RE+ ++R+L H N++ L   F 
Sbjct: 66  IGNGSFGVVYQAKLCDSGEL--VAIKKVLQDKRFKN--RELQIMRKLDHCNIVRLRYFFY 121
Query: 87  SHNDRK----VWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
           S  ++K    + L+ DY    ++ + + +  AK                +YQ+   + Y+
Sbjct: 122 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-----YMYQLFRSLAYI 176
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVV---VTFWY 199
           HS  + HRD+KP N+L+     +   +K+ D G A       K L   +P V    + +Y
Sbjct: 177 HSFGICHRDIKPQNLLL---DPDTAVLKLCDFGSA-------KQLVRGEPNVSYICSRYY 226
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVM 259
           RAPEL+ GA  YT +ID+W+ GC+ AELL  +PIF               DQL  I  V+
Sbjct: 227 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF---------PGDSGVDQLVEIIKVL 277
Query: 260 GFPLEKDWEDIRKM 273
           G P     E IR+M
Sbjct: 278 GTPTR---EQIREM 288

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  107 bits (268), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 125/254 (49%), Gaps = 38/254 (14%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFL 86
           +G G++G VY+A+  D+ +    A+K++       +  RE+ ++R+L H N++ L   F 
Sbjct: 41  IGNGSFGVVYQAKLCDSGEL--VAIKKVLQDKRFKN--RELQIMRKLDHCNIVRLRYFFY 96
Query: 87  SHNDRK----VWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
           S  ++K    + L+ DY    ++ + + +  AK                +YQ+   + Y+
Sbjct: 97  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-----YMYQLFRSLAYI 151
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP---VVVTFWY 199
           HS  + HRD+KP N+L+     +   +K+ D G A       K L   +P    + + +Y
Sbjct: 152 HSFGICHRDIKPQNLLL---DPDTAVLKLCDFGSA-------KQLVRGEPNVSYICSRYY 201
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVM 259
           RAPEL+ GA  YT +ID+W+ GC+ AELL  +PIF               DQL  I  V+
Sbjct: 202 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF---------PGDSGVDQLVEIIKVL 252
Query: 260 GFPLEKDWEDIRKM 273
           G P     E IR+M
Sbjct: 253 GTPTR---EQIREM 263

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score =  105 bits (262), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 75/250 (30%), Positives = 124/250 (49%), Gaps = 40/250 (16%)
Query: 22  YEGCK-VGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHP 76
           Y+  K +G G  G V  A   D    R+ A+K++    +    +  A RE+ L++ + H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAY--DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHK 83
Query: 77  NVINLISVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLL 132
           N+I+L++VF         + V+L+ +  + +L  +I+                     LL
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQME-----------LDHERMSYLL 132
Query: 133 YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP 192
           YQ+L GI +LHS  ++HRDLKP+NI+V  +      +KI D G AR           + P
Sbjct: 133 YQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXT----LKILDFGLARTAGTSFM----MTP 184
Query: 193 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 252
            VVT +YRAPE++LG   Y + +DIW++GCI  E++  + +F  R          + DQ 
Sbjct: 185 YVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRD---------YIDQW 234
Query: 253 DRIFSVMGFP 262
           +++   +G P
Sbjct: 235 NKVIEQLGTP 244

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score =  104 bits (259), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 75/250 (30%), Positives = 124/250 (49%), Gaps = 40/250 (16%)
Query: 22  YEGCK-VGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHP 76
           Y+  K +G G  G V  A   D    R+ A+K++    +    +  A RE+ L++ + H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAY--DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHK 83
Query: 77  NVINLISVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLL 132
           N+I+L++VF         + V+L+ +  + +L  +I+                     LL
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQME-----------LDHERMSYLL 132
Query: 133 YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP 192
           YQ+L GI +LHS  ++HRDLKP+NI+V  +      +KI D G AR           + P
Sbjct: 133 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXT----LKILDFGLARTAGTSFM----MTP 184
Query: 193 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 252
            VVT +YRAPE++LG   Y + +DIW++GCI  E++  + +F  R          + DQ 
Sbjct: 185 YVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRD---------YIDQW 234
Query: 253 DRIFSVMGFP 262
           +++   +G P
Sbjct: 235 NKVIEQLGTP 244

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score =  104 bits (259), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 75/250 (30%), Positives = 124/250 (49%), Gaps = 40/250 (16%)
Query: 22  YEGCK-VGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHP 76
           Y+  K +G G  G V  A   D    R+ A+K++    +    +  A RE+ L++ + H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAY--DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHK 83
Query: 77  NVINLISVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLL 132
           N+I+L++VF         + V+L+ +  + +L  +I+                     LL
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME-----------LDHERMSYLL 132
Query: 133 YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP 192
           YQ+L GI +LHS  ++HRDLKP+NI+V  +      +KI D G AR           + P
Sbjct: 133 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXT----LKILDFGLARTAGTSFM----MTP 184
Query: 193 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 252
            VVT +YRAPE++LG   Y + +DIW++GCI  E++  + +F  R          + DQ 
Sbjct: 185 YVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRD---------YIDQW 234
Query: 253 DRIFSVMGFP 262
           +++   +G P
Sbjct: 235 NKVIEQLGTP 244

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  104 bits (259), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 73/246 (29%), Positives = 119/246 (48%), Gaps = 32/246 (13%)
Query: 22  YEGCK-VGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHP 76
           Y+  K +G G  G V  A   D    R+ A+K++    +    +  A RE+ L++ + H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAY--DAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 77  NVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQIL 136
           N+I L++VF      + +        D++ +++   A  +              LLYQ+L
Sbjct: 84  NIIGLLNVFTPQKSLEEF-------QDVYIVMELMDANLSQVIQMELDHERMSYLLYQML 136
Query: 137 DGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVT 196
            GI +LHS  ++HRDLKP+NI+V  +      +KI D G AR           + P VVT
Sbjct: 137 VGIKHLHSAGIIHRDLKPSNIVVKSDAT----LKILDFGLARTAGTSFM----MTPYVVT 188
Query: 197 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 256
            +YRAPE++LG   Y + +DIW++GCI  E++    +F             H DQ +++ 
Sbjct: 189 RYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTD---------HIDQWNKVI 238
Query: 257 SVMGFP 262
             +G P
Sbjct: 239 EQLGTP 244

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score =  103 bits (258), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 75/250 (30%), Positives = 124/250 (49%), Gaps = 40/250 (16%)
Query: 22  YEGCK-VGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHP 76
           Y+  K +G G  G V  A   D    R+ A+K++    +    +  A RE+ L++ + H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAY--DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 77  NVINLISVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLL 132
           N+I+L++VF         + V+L+ +  + +L  +I+                     LL
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQME-----------LDHERMSYLL 132
Query: 133 YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP 192
           YQ+L GI +LHS  ++HRDLKP+NI+V  +      +KI D G AR           + P
Sbjct: 133 YQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXT----LKILDFGLARTAGTSFM----MTP 184
Query: 193 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 252
            VVT +YRAPE++LG   Y + +DIW++GCI  E++  + +F  R          + DQ 
Sbjct: 185 YVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRD---------YIDQW 234
Query: 253 DRIFSVMGFP 262
           +++   +G P
Sbjct: 235 NKVIEQLGTP 244

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score =  103 bits (258), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 75/250 (30%), Positives = 124/250 (49%), Gaps = 40/250 (16%)
Query: 22  YEGCK-VGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHP 76
           Y+  K +G G  G V  A   D    R+ A+K++    +    +  A RE+ L++ + H 
Sbjct: 19  YQNLKPIGSGAQGIVCAAY--DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 77  NVINLISVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLL 132
           N+I+L++VF         + V+L+ +  + +L  +I+                     LL
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQME-----------LDHERMSYLL 125
Query: 133 YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP 192
           YQ+L GI +LHS  ++HRDLKP+NI+V  +      +KI D G AR           + P
Sbjct: 126 YQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXT----LKILDFGLARTAGTSFM----MTP 177
Query: 193 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 252
            VVT +YRAPE++LG   Y + +DIW++GCI  E++  + +F  R          + DQ 
Sbjct: 178 YVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRD---------YIDQW 227
Query: 253 DRIFSVMGFP 262
           +++   +G P
Sbjct: 228 NKVIEQLGTP 237

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  103 bits (258), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 73/246 (29%), Positives = 119/246 (48%), Gaps = 32/246 (13%)
Query: 22  YEGCK-VGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHP 76
           Y+  K +G G  G V  A   D    R+ A+K++    +    +  A RE+ L++ + H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAY--DAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 77  NVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQIL 136
           N+I L++VF      + +        D++ +++   A  +              LLYQ+L
Sbjct: 84  NIIGLLNVFTPQKSLEEF-------QDVYIVMELMDANLSQVIQMELDHERMSYLLYQML 136
Query: 137 DGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVT 196
            GI +LHS  ++HRDLKP+NI+V  +      +KI D G AR           + P VVT
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDAT----LKILDFGLARTAGTSFM----MTPYVVT 188
Query: 197 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 256
            +YRAPE++LG   Y + +DIW++GCI  E++    +F             H DQ +++ 
Sbjct: 189 RYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTD---------HIDQWNKVI 238
Query: 257 SVMGFP 262
             +G P
Sbjct: 239 EQLGTP 244

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/244 (29%), Positives = 121/244 (49%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINLI 82
           +G G  G V  A   D    R+ A+K++    +    +  A RE+ L++ + H N+I+L+
Sbjct: 70  IGSGAQGIVCAAY--DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           +VF         + V+L+ +  + +L  +I+                     LLYQ+L G
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQME-----------LDHERMSYLLYQMLCG 176
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           I +LHS  ++HRDLKP+NI+V  +      +KI D G AR           + P VVT +
Sbjct: 177 IKHLHSAGIIHRDLKPSNIVVKSDCT----LKILDFGLARTAGTSFM----MTPYVVTRY 228
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++LG   Y + +DIW++GCI  E++  + +F  R          + DQ +++   
Sbjct: 229 YRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRD---------YIDQWNKVIEQ 278
Query: 259 MGFP 262
           +G P
Sbjct: 279 LGTP 282

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score =  103 bits (256), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/244 (29%), Positives = 121/244 (49%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINLI 82
           +G G  G V  A   D    R+ A+K++    +    +  A RE+ L++ + H N+I+L+
Sbjct: 33  IGSGAQGIVCAAY--DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 90
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           +VF         + V+L+ +  + +L  +I+                     LLYQ+L G
Sbjct: 91  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQME-----------LDHERMSYLLYQMLCG 139
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           I +LHS  ++HRDLKP+NI+V  +      +KI D G AR           + P VVT +
Sbjct: 140 IKHLHSAGIIHRDLKPSNIVVKSDCT----LKILDFGLARTAGTSFM----MTPYVVTRY 191
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++LG   Y + +DIW++GCI  E++  + +F  R          + DQ +++   
Sbjct: 192 YRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRD---------YIDQWNKVIEQ 241
Query: 259 MGFP 262
           +G P
Sbjct: 242 LGTP 245

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  103 bits (256), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/246 (29%), Positives = 119/246 (48%), Gaps = 32/246 (13%)
Query: 22  YEGCK-VGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHP 76
           Y+  K +G G  G V  A   D    R+ A+K++    +    +  A RE+ L++ + H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAY--DAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 77  NVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQIL 136
           N+I L++VF      + +        D++ +++   A  +              LLYQ+L
Sbjct: 84  NIIGLLNVFTPQKSLEEF-------QDVYIVMELMDANLSQVIQMELDHERMSYLLYQML 136
Query: 137 DGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVT 196
            GI +LHS  ++HRDLKP+NI+V  +      +KI D G AR           + P VVT
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDAT----LKILDFGLARTAGTSFM----MTPYVVT 188
Query: 197 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 256
            +YRAPE++LG   Y + +DIW++GCI  E++    +F             H DQ +++ 
Sbjct: 189 RYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTD---------HIDQWNKVI 238
Query: 257 SVMGFP 262
             +G P
Sbjct: 239 EQLGTP 244

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score =  103 bits (256), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 72/244 (29%), Positives = 121/244 (49%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINLI 82
           +G G  G V  A   D    R+ A+K++    +    +  A RE+ L++ + H N+I L+
Sbjct: 32  IGSGAQGIVCAAY--DAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           +VF         + V+++ +  + +L  +I+                     LLYQ+L G
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQME-----------LDHERMSYLLYQMLCG 138
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           I +LHS  ++HRDLKP+NI+V  +      +KI D G AR           ++P VVT +
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCT----LKILDFGLARTAGTSFM----MEPEVVTRY 190
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++LG   Y + +DIW++GCI  E++  + +F  R          + DQ +++   
Sbjct: 191 YRAPEVILGM-GYKENVDIWSVGCIMGEMVCHKILFPGRD---------YIDQWNKVIEQ 240
Query: 259 MGFP 262
           +G P
Sbjct: 241 LGTP 244

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score =  103 bits (256), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 75/250 (30%), Positives = 124/250 (49%), Gaps = 40/250 (16%)
Query: 22  YEGCK-VGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHP 76
           Y+  K +G G  G V  A   D    R+ A+K++    +    +  A RE+ L++ + H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAY--DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 77  NVINLISVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLL 132
           N+I+L++VF         + V+L+ +  + +L  +I+                     LL
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME-----------LDHERMSYLL 132
Query: 133 YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP 192
           YQ+L GI +LHS  ++HRDLKP+NI+V  +      +KI D G AR           + P
Sbjct: 133 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT----LKILDFGLARTAGTSFM----MTP 184
Query: 193 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 252
            VVT +YRAPE++LG   Y + +DIW++GCI  E++  + +F  R          + DQ 
Sbjct: 185 YVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRD---------YIDQW 234
Query: 253 DRIFSVMGFP 262
           +++   +G P
Sbjct: 235 NKVIEQLGTP 244

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/244 (29%), Positives = 121/244 (49%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINLI 82
           +G G  G V  A   D    R+ A+K++    +    +  A RE+ L++ + H N+I+L+
Sbjct: 70  IGSGAQGIVCAAY--DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           +VF         + V+L+ +  + +L  +I+                     LLYQ+L G
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQME-----------LDHERMSYLLYQMLCG 176
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           I +LHS  ++HRDLKP+NI+V  +      +KI D G AR           + P VVT +
Sbjct: 177 IKHLHSAGIIHRDLKPSNIVVKSDCT----LKILDFGLARTAGTSFM----MTPYVVTRY 228
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++LG   Y + +DIW++GCI  E++  + +F  R          + DQ +++   
Sbjct: 229 YRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRD---------YIDQWNKVIEQ 278
Query: 259 MGFP 262
           +G P
Sbjct: 279 LGTP 282

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/250 (30%), Positives = 124/250 (49%), Gaps = 40/250 (16%)
Query: 22  YEGCK-VGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHP 76
           Y+  K +G G  G V  A   D    R+ A+K++    +    +  A RE+ L++ + H 
Sbjct: 27  YQNLKPIGSGAQGIVCAAY--DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 77  NVINLISVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLL 132
           N+I+L++VF         + V+L+ +  + +L  +I+                     LL
Sbjct: 85  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME-----------LDHERMSYLL 133
Query: 133 YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP 192
           YQ+L GI +LHS  ++HRDLKP+NI+V  +      +KI D G AR           + P
Sbjct: 134 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT----LKILDFGLARTAGTSFM----MTP 185
Query: 193 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 252
            VVT +YRAPE++LG   Y + +DIW++GCI  E++  + +F  R          + DQ 
Sbjct: 186 YVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRD---------YIDQW 235
Query: 253 DRIFSVMGFP 262
           +++   +G P
Sbjct: 236 NKVIEQLGTP 245

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/244 (29%), Positives = 121/244 (49%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINLI 82
           +G G  G V  A   D    R+ A+K++    +    +  A RE+ L++ + H N+I+L+
Sbjct: 32  IGSGAQGIVCAAY--DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 89
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           +VF         + V+L+ +  + +L  +I+                     LLYQ+L G
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQME-----------LDHERMSYLLYQMLCG 138
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           I +LHS  ++HRDLKP+NI+V  +      +KI D G AR           + P VVT +
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCT----LKILDFGLARTAGTSFM----MTPYVVTRY 190
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++LG   Y + +DIW++GCI  E++  + +F  R          + DQ +++   
Sbjct: 191 YRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRD---------YIDQWNKVIEQ 240
Query: 259 MGFP 262
           +G P
Sbjct: 241 LGTP 244

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/244 (29%), Positives = 121/244 (49%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINLI 82
           +G G  G V  A   D    R+ A+K++    +    +  A RE+ L++ + H N+I+L+
Sbjct: 26  IGSGAQGIVCAAY--DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 83
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           +VF         + V+L+ +  + +L  +I+                     LLYQ+L G
Sbjct: 84  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQME-----------LDHERMSYLLYQMLCG 132
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           I +LHS  ++HRDLKP+NI+V  +      +KI D G AR           + P VVT +
Sbjct: 133 IKHLHSAGIIHRDLKPSNIVVKSDCT----LKILDFGLARTAGTSFM----MTPYVVTRY 184
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++LG   Y + +DIW++GCI  E++  + +F  R          + DQ +++   
Sbjct: 185 YRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRD---------YIDQWNKVIEQ 234
Query: 259 MGFP 262
           +G P
Sbjct: 235 LGTP 238

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/250 (30%), Positives = 124/250 (49%), Gaps = 40/250 (16%)
Query: 22  YEGCK-VGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHP 76
           Y+  K +G G  G V  A   D    R+ A+K++    +    +  A RE+ L++ + H 
Sbjct: 20  YQNLKPIGSGAQGIVCAAY--DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 77
Query: 77  NVINLISVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLL 132
           N+I+L++VF         + V+L+ +  + +L  +I+                     LL
Sbjct: 78  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME-----------LDHERMSYLL 126
Query: 133 YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP 192
           YQ+L GI +LHS  ++HRDLKP+NI+V  +      +KI D G AR           + P
Sbjct: 127 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT----LKILDFGLARTAGTSFM----MTP 178
Query: 193 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 252
            VVT +YRAPE++LG   Y + +DIW++GCI  E++  + +F  R          + DQ 
Sbjct: 179 YVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRD---------YIDQW 228
Query: 253 DRIFSVMGFP 262
           +++   +G P
Sbjct: 229 NKVIEQLGTP 238

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/244 (29%), Positives = 121/244 (49%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINLI 82
           +G G  G V  A   D    R+ A+K++    +    +  A RE+ L++ + H N+I+L+
Sbjct: 25  IGSGAQGIVCAAY--DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           +VF         + V+L+ +  + +L  +I+                     LLYQ+L G
Sbjct: 83  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQME-----------LDHERMSYLLYQMLCG 131
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           I +LHS  ++HRDLKP+NI+V  +      +KI D G AR           + P VVT +
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCT----LKILDFGLARTAGTSFM----MTPYVVTRY 183
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++LG   Y + +DIW++GCI  E++  + +F  R          + DQ +++   
Sbjct: 184 YRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRD---------YIDQWNKVIEQ 233
Query: 259 MGFP 262
           +G P
Sbjct: 234 LGTP 237

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/244 (29%), Positives = 121/244 (49%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINLI 82
           +G G  G V  A   D    R+ A+K++    +    +  A RE+ L++ + H N+I+L+
Sbjct: 31  IGSGAQGIVCAAY--DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 88
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           +VF         + V+L+ +  + +L  +I+                     LLYQ+L G
Sbjct: 89  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQME-----------LDHERMSYLLYQMLCG 137
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           I +LHS  ++HRDLKP+NI+V  +      +KI D G AR           + P VVT +
Sbjct: 138 IKHLHSAGIIHRDLKPSNIVVKSDCT----LKILDFGLARTAGTSFM----MTPYVVTRY 189
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++LG   Y + +DIW++GCI  E++  + +F  R          + DQ +++   
Sbjct: 190 YRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRD---------YIDQWNKVIEQ 239
Query: 259 MGFP 262
           +G P
Sbjct: 240 LGTP 243

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  102 bits (254), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 103/204 (50%), Gaps = 33/204 (16%)
Query: 63  ACREIALLRELKHPNVINLISVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANX 118
           A RE+ LL+ + H N+I+L++VF         + V+L+ +  + +L  +I          
Sbjct: 68  AYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHME------- 120
Query: 119 XXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR 178
                       LLYQ+L GI +LHS  ++HRDLKP+NI+V  +      +KI D G AR
Sbjct: 121 ----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT----LKILDFGLAR 172
Query: 179 LFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 238
             +        + P VVT +YRAPE++LG   Y + +DIW++GCI  EL+    IF    
Sbjct: 173 TASTNFM----MTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELVKGSVIFQGTD 227
Query: 239 EDIKTSNPYHHDQLDRIFSVMGFP 262
                    H DQ +++   +G P
Sbjct: 228 ---------HIDQWNKVIEQLGTP 242

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 72/244 (29%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINLI 82
           +G G  G V  A   D    R+ A+K++    +    +  A RE+ L++ + H N+I L+
Sbjct: 33  IGSGAQGIVCAAY--DAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 90
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           +VF         + V+++ +  + +L  +I+                     LLYQ+L G
Sbjct: 91  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQME-----------LDHERMSYLLYQMLCG 139
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           I +LHS  ++HRDLKP+NI+V  +      +KI D G AR           + P VVT +
Sbjct: 140 IKHLHSAGIIHRDLKPSNIVVKSDCT----LKILDFGLARTAGTSFM----MTPYVVTRY 191
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++LG   Y + +DIW++GCI  E++    +F             H DQ +++   
Sbjct: 192 YRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTD---------HIDQWNKVIEQ 241
Query: 259 MGFP 262
           +G P
Sbjct: 242 LGTP 245

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score =  102 bits (253), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 72/244 (29%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINLI 82
           +G G  G V  A   D    R+ A+K++    +    +  A RE+ L++ + H N+I L+
Sbjct: 32  IGSGAQGIVCAAY--DAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           +VF         + V+++ +  + +L  +I+                     LLYQ+L G
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQME-----------LDHERMSYLLYQMLCG 138
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           I +LHS  ++HRDLKP+NI+V  +      +KI D G AR           + P VVT +
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCT----LKILDFGLARTAGTSFM----MTPYVVTRY 190
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++LG   Y + +DIW++GCI  E++    +F             H DQ +++   
Sbjct: 191 YRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLF---------PGTDHIDQWNKVIEQ 240
Query: 259 MGFP 262
           +G P
Sbjct: 241 LGTP 244

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  102 bits (253), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 72/244 (29%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINLI 82
           +G G  G V  A   D    R+ A+K++    +    +  A RE+ L++ + H N+I L+
Sbjct: 32  IGSGAQGIVCAAY--DAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           +VF         + V+++ +  + +L  +I+                     LLYQ+L G
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQME-----------LDHERMSYLLYQMLCG 138
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           I +LHS  ++HRDLKP+NI+V  +      +KI D G AR           + P VVT +
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCT----LKILDFGLARTAGTSFM----MTPYVVTRY 190
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++LG   Y + +DIW++GCI  E++    +F             H DQ +++   
Sbjct: 191 YRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTD---------HIDQWNKVIEQ 240
Query: 259 MGFP 262
           +G P
Sbjct: 241 LGTP 244

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score =  102 bits (253), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 121/244 (49%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINLI 82
           +G G  G V  A   D    R+ A+K++    +    +  A RE+ L++ + H N+I L+
Sbjct: 32  IGSGAQGIVCAAY--DAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           +VF         + V+++ +  + +L  +I+                     LLYQ+L G
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQME-----------LDHERMSYLLYQMLCG 138
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           I +LHS  ++HRDLKP+NI+V  +      +KI D G AR           ++P VVT +
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCT----LKILDFGLARTAGTSFM----MEPEVVTRY 190
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++LG   Y + +D+W++GCI  E++  + +F  R          + DQ +++   
Sbjct: 191 YRAPEVILGM-GYKENVDLWSVGCIMGEMVCHKILFPGRD---------YIDQWNKVIEQ 240
Query: 259 MGFP 262
           +G P
Sbjct: 241 LGTP 244

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  102 bits (253), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 73/246 (29%), Positives = 119/246 (48%), Gaps = 32/246 (13%)
Query: 22  YEGCK-VGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHP 76
           Y+  K +G G  G V  A   D    R+ A+K++    +    +  A RE+ L++ + H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAY--DAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 77  NVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQIL 136
           N+I L++VF      + +        D++ +++   A  +              LLYQ+L
Sbjct: 84  NIIGLLNVFTPQKSLEEF-------QDVYIVMELMDANLSQVIQMELDHERMSYLLYQML 136
Query: 137 DGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVT 196
            GI +LHS  ++HRDLKP+NI+V  +      +KI D G AR           + P VVT
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCT----LKILDFGLARTAGTSFM----MTPYVVT 188
Query: 197 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 256
            +YRAPE++LG   Y + +DIW++GCI  E++    +F             H DQ +++ 
Sbjct: 189 RYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTD---------HIDQWNKVI 238
Query: 257 SVMGFP 262
             +G P
Sbjct: 239 EQLGTP 244

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 72/244 (29%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINLI 82
           +G G  G V  A   D    R+ A+K++    +    +  A RE+ L++ + H N+I L+
Sbjct: 34  IGSGAQGIVCAAY--DAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 91
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           +VF         + V+++ +  + +L  +I+                     LLYQ+L G
Sbjct: 92  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQME-----------LDHERMSYLLYQMLCG 140
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           I +LHS  ++HRDLKP+NI+V  +      +KI D G AR           + P VVT +
Sbjct: 141 IKHLHSAGIIHRDLKPSNIVVKSDCT----LKILDFGLARTAGTSFM----MVPFVVTRY 192
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++LG   Y + +DIW++GCI  E++    +F             H DQ +++   
Sbjct: 193 YRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTD---------HIDQWNKVIEQ 242
Query: 259 MGFP 262
           +G P
Sbjct: 243 LGTP 246

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score =  101 bits (252), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 72/244 (29%), Positives = 118/244 (48%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINLI 82
           +G G  G V  A   D    R+ A+K++    +    +  A RE+ L++ + H N+I L+
Sbjct: 32  IGSGAQGIVCAAY--DAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           +VF         + V+++ +  + +L  +I+                     LLYQ+L G
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQME-----------LDHERMSYLLYQMLCG 138
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           I +LHS  ++HRDLKP+NI+V  +      +KI D G AR           + P VVT +
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCT----LKILDFGLARTAGTSFM----MTPEVVTRY 190
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++LG   Y + +DIW++GCI  E++    +F             H DQ +++   
Sbjct: 191 YRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTD---------HIDQWNKVIEQ 240
Query: 259 MGFP 262
           +G P
Sbjct: 241 LGTP 244

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 72/246 (29%), Positives = 118/246 (47%), Gaps = 32/246 (13%)
Query: 22  YEGCK-VGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHP 76
           Y+  K +G G  G V  A   D    R+ A+K++    +    +  A RE+ L++ + H 
Sbjct: 26  YQNLKPIGSGAQGIVVAAY--DAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 77  NVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQIL 136
           N+I L++VF      + +        D++ +++   A  +              LLYQ+L
Sbjct: 84  NIIGLLNVFTPQKSLEEF-------QDVYIVMELMDANLSQVIQMELDHERMSYLLYQML 136
Query: 137 DGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVT 196
            GI +LHS  ++HRDLKP+NI+V  +      +KI D G AR           + P VVT
Sbjct: 137 VGIKHLHSAGIIHRDLKPSNIVVKSDAT----LKILDFGLARTAGTSFM----MTPYVVT 188
Query: 197 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 256
            +YRAPE++LG   Y + +DIW++G I  E++    +F             H DQ +++ 
Sbjct: 189 RYYRAPEVILGM-GYKENVDIWSVGVIMGEMIKGGVLFPGTD---------HIDQWNKVI 238
Query: 257 SVMGFP 262
             +G P
Sbjct: 239 EQLGTP 244

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score =  101 bits (251), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 120/244 (49%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINLI 82
           +G G  G V  A   D    R+ A+K++    +    +  A RE+ L++ + H N+I L+
Sbjct: 37  IGSGAQGIVCAAY--DAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 94
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           +VF         + V+++ +  + +L  +I+                     LLYQ+L G
Sbjct: 95  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQME-----------LDHERMSYLLYQMLCG 143
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           I +LHS  ++HRDLKP+NI+V  +      +KI D G AR           + P VVT +
Sbjct: 144 IKHLHSAGIIHRDLKPSNIVVKSDCT----LKILDFGLARTAGTSFM----MTPYVVTRY 195
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++LG   Y + +D+W++GCI  E++  + +F  R          + DQ +++   
Sbjct: 196 YRAPEVILGM-GYKENVDLWSVGCIMGEMVCHKILFPGRD---------YIDQWNKVIEQ 245
Query: 259 MGFP 262
           +G P
Sbjct: 246 LGTP 249

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score =  101 bits (251), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 120/244 (49%), Gaps = 39/244 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINLI 82
           +G G  G V  A   D    R+ A+K++    +    +  A RE+ L++ + H N+I L+
Sbjct: 26  IGSGAQGIVCAAY--DAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 83
Query: 83  SVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           +VF         + V+++ +  + +L  +I+                     LLYQ+L G
Sbjct: 84  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQME-----------LDHERMSYLLYQMLCG 132
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           I +LHS  ++HRDLKP+NI+V  +      +KI D G AR           + P VVT +
Sbjct: 133 IKHLHSAGIIHRDLKPSNIVVKSDCT----LKILDFGLARTAGTSFM----MTPYVVTRY 184
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++LG   Y + +D+W++GCI  E++  + +F  R          + DQ +++   
Sbjct: 185 YRAPEVILGM-GYKENVDLWSVGCIMGEMVCHKILFPGRD---------YIDQWNKVIEQ 234
Query: 259 MGFP 262
           +G P
Sbjct: 235 LGTP 238

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  100 bits (249), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 72/246 (29%), Positives = 118/246 (47%), Gaps = 32/246 (13%)
Query: 22  YEGCK-VGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHP 76
           Y+  K +G G  G V  A   D    R+ A+K++    +    +  A RE+ L++ + H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAY--DAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 77  NVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQIL 136
           N+I L++VF      + +        D++ +++   A  +              LLYQ+L
Sbjct: 84  NIIGLLNVFTPQKSLEEF-------QDVYIVMELMDANLSQVIQMELDHERMSYLLYQML 136
Query: 137 DGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVT 196
            GI +LHS  ++HRDLKP+NI+V  +      +KI D G AR           + P VVT
Sbjct: 137 VGIKHLHSAGIIHRDLKPSNIVVKSDAT----LKILDFGLARTAGTSFM----MTPYVVT 188
Query: 197 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 256
            +YRAPE++LG   Y + +DIW++G I  E++    +F             H DQ +++ 
Sbjct: 189 RYYRAPEVILGM-GYKENVDIWSVGVIMGEMIKGGVLFPGTD---------HIDQWNKVI 238
Query: 257 SVMGFP 262
             +G P
Sbjct: 239 EQLGTP 244

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 101/204 (49%), Gaps = 33/204 (16%)
Query: 63  ACREIALLRELKHPNVINLISVFLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANX 118
           A RE+ LL+ + H N+I+L++VF         + V+L+ +  + +L  +I          
Sbjct: 70  AYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHME------- 122
Query: 119 XXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR 178
                       LLYQ+L GI +LHS  ++HRDLKP+NI+V  +      +KI D G AR
Sbjct: 123 ----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT----LKILDFGLAR 174
Query: 179 LFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 238
                      + P VVT +YRAPE++LG   Y   +DIW++GCI  EL+    IF    
Sbjct: 175 TACTNFM----MTPYVVTRYYRAPEVILGM-GYAANVDIWSVGCIMGELVKGCVIFQGTD 229
Query: 239 EDIKTSNPYHHDQLDRIFSVMGFP 262
                    H DQ +++   +G P
Sbjct: 230 ---------HIDQWNKVIEQLGTP 244

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 98.6 bits (244), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 88/281 (31%), Positives = 135/281 (48%), Gaps = 43/281 (15%)
Query: 9   TSNERTKVE-DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREI 67
            ++ER++ E D F  E    G+GT+G V   + K  S     A+K++       +  RE+
Sbjct: 13  AADERSRKEMDRFQVER-MAGQGTFGTVQLGKEK--STGMSVAIKKVIQDPRFRN--REL 67
Query: 68  ALLRELK---HPNVINLISVF--LSHNDRK---VWLLFDYAEHDLWHIIK-FHRAAKANX 118
            ++++L    HPN++ L S F  L   DR+   + ++ +Y    L    + ++R   A  
Sbjct: 68  QIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPP 127
Query: 119 XXXXXXXXXXXSLLYQILDGIHYLH--SNWVLHRDLKPANILVMGEGIERGRVKIADMGF 176
                        L+Q++  I  LH  S  V HRD+KP N+LV       G +K+ D G 
Sbjct: 128 PILIKV------FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLV---NEADGTLKLCDFGS 178
Query: 177 ARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 236
           A+     L P       + + +YRAPEL+ G +HYT A+DIW++GCIFAE++  EPIF  
Sbjct: 179 AK----KLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRG 234
Query: 237 RQEDIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM-PEH 276
                         QL  I  V+G P     E +RK+ P H
Sbjct: 235 DNS---------AGQLHEIVRVLGCP---SREVLRKLNPSH 263

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 97.1 bits (240), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 84/320 (26%), Positives = 139/320 (43%), Gaps = 74/320 (23%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLIS 83
           G  +G G++G V +    D    + +ALK++          RE+ +++ L H N+I L+ 
Sbjct: 12  GKTLGTGSFGIVCEVF--DIESGKRFALKKVLQD--PRYKNRELDIMKVLDHVNIIKLVD 67
Query: 84  VFLSHNDRKV------------------------WLLFDYAEHDLWHII------KFHRA 113
            F +  D +                          ++ + +++   ++I        H+ 
Sbjct: 68  YFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKV 127
Query: 114 AKANXXXXXXXXXXXXSL-LYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA 172
            K+             S+ +YQ+   + ++HS  + HRD+KP N+LV  +      +K+ 
Sbjct: 128 LKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKD---NTLKLC 184
Query: 173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 232
           D G A+     L P       + + +YRAPEL+LGA  YT +ID+W+IGC+F EL+  +P
Sbjct: 185 DFGSAK----KLIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP 240
Query: 233 IFHCRQEDIKTSNPYHHDQLDRIFSVMGFPLE--------------------KDWEDIRK 272
           +F         S     DQL RI  +MG P +                    KDW  I  
Sbjct: 241 LF---------SGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKI-- 289
Query: 273 MPE-HPTLLKDFNEQICKME 291
           +PE  P+L  D  EQI + E
Sbjct: 290 LPEGTPSLAIDLLEQILRYE 309

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 113/250 (45%), Gaps = 32/250 (12%)
Query: 22  YEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINL 81
           Y     G  + G     +R  N+ +    +  +  + L     REI LL    HPN++ L
Sbjct: 35  YGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGL 94
Query: 82  ISVFLSHND---RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
             +F+   +    K++L+ +    DL  +I   R   +               +Y IL G
Sbjct: 95  RDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQY--------FMYHILLG 146
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV--VVT 196
           +H LH   V+HRDL P NIL+     +   + I D   AR      +  AD +    V  
Sbjct: 147 LHVLHEAGVVHRDLHPGNILLA----DNNDITICDFNLAR------EDTADANKTHYVTH 196
Query: 197 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 256
            WYRAPEL++  + +TK +D+W+ GC+ AE+   + +F       + S  Y  +QL++I 
Sbjct: 197 RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF-------RGSTFY--NQLNKIV 247
Query: 257 SVMGFPLEKD 266
            V+G P  +D
Sbjct: 248 EVVGTPKIED 257

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 113/250 (45%), Gaps = 32/250 (12%)
Query: 22  YEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINL 81
           Y     G  + G     +R  N+ +    +  +  + L     REI LL    HPN++ L
Sbjct: 35  YGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGL 94
Query: 82  ISVFLSHND---RKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
             +F+   +    K++L+ +    DL  +I   R   +               +Y IL G
Sbjct: 95  RDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQY--------FMYHILLG 146
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV--VVT 196
           +H LH   V+HRDL P NIL+     +   + I D   AR      +  AD +    V  
Sbjct: 147 LHVLHEAGVVHRDLHPGNILLA----DNNDITICDFNLAR------EDTADANKTHYVTH 196
Query: 197 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 256
            WYRAPEL++  + +TK +D+W+ GC+ AE+   + +F       + S  Y  +QL++I 
Sbjct: 197 RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF-------RGSTFY--NQLNKIV 247
Query: 257 SVMGFPLEKD 266
            V+G P  +D
Sbjct: 248 EVVGTPKIED 257

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/246 (29%), Positives = 117/246 (47%), Gaps = 40/246 (16%)
Query: 4   EFKIKTSNERTKVED--LFDYE-GCKVGRGTYGHVYKARRKDNSDTRDYALK-----QIE 55
           E   K  NE +K     L D+E G  +G+G +G+VY AR K +      ALK     Q+E
Sbjct: 16  ELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFI--LALKVLFKAQLE 73
Query: 56  GTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAE-----HDLWHIIKF 110
             G+     RE+ +   L+HPN++ L   F  H+  +V+L+ +YA       +L  + KF
Sbjct: 74  KAGVEHQLRREVEIQSHLRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKF 131
Query: 111 HRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVK 170
                A             + + ++ + + Y HS  V+HRD+KP N+L+       G +K
Sbjct: 132 DEQRTA-------------TYITELANALSYCHSKRVIHRDIKPENLLLGSA----GELK 174
Query: 171 IADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 230
           IAD G++        P +  D +  T  Y  PE++ G  H  K +D+W++G +  E L  
Sbjct: 175 IADFGWSV-----HAPSSRRDDLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVG 228
Query: 231 EPIFHC 236
           +P F  
Sbjct: 229 KPPFEA 234

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 112/222 (50%), Gaps = 29/222 (13%)
Query: 25  CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL----SMSACREIALLRELKHPNVIN 80
           C +G+G++G V K   KD    ++YA+K I         + +  RE+ LL++L HPN++ 
Sbjct: 28  CMLGKGSFGEVLKC--KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 81  LISVFLSHNDRKVWLLFD-YAEHDLW-HIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           L  +    +    +++ + Y   +L+  IIK  R ++ +             ++ Q+  G
Sbjct: 86  LFEIL--EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR----------IIKQVFSG 133
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERG-RVKIADMGFARLFNNPLKPLADLDPVVVTF 197
           I Y+H + ++HRDLKP NIL+  E  E+   +KI D G +  F    K    +   + T 
Sbjct: 134 ITYMHKHNIVHRDLKPENILL--ESKEKDCDIKIIDFGLSTCFQQNTK----MKDRIGTA 187
Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
           +Y APE+L G   Y +  D+W+ G I   LL+  P F+ + E
Sbjct: 188 YYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNE 227

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 91.3 bits (225), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 112/222 (50%), Gaps = 29/222 (13%)
Query: 25  CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL----SMSACREIALLRELKHPNVIN 80
           C +G+G++G V K   KD    ++YA+K I         + +  RE+ LL++L HPN++ 
Sbjct: 28  CMLGKGSFGEVLKC--KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 81  LISVFLSHNDRKVWLLFD-YAEHDLW-HIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           L  +    +    +++ + Y   +L+  IIK  R ++ +             ++ Q+  G
Sbjct: 86  LFEIL--EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA----------RIIKQVFSG 133
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERG-RVKIADMGFARLFNNPLKPLADLDPVVVTF 197
           I Y+H + ++HRDLKP NIL+  E  E+   +KI D G +  F    K    +   + T 
Sbjct: 134 ITYMHKHNIVHRDLKPENILL--ESKEKDCDIKIIDFGLSTCFQQNTK----MKDRIGTA 187
Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
           +Y APE+L G   Y +  D+W+ G I   LL+  P F+ + E
Sbjct: 188 YYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNE 227

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 90.9 bits (224), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 109/225 (48%), Gaps = 28/225 (12%)
Query: 20  FDYEGCKV--GRGTYGHVYKARRKDNSDTRDYALKQI--EGTGLSMSACREIALLRELKH 75
           +D  G +V  G+GTYG VY  R  D S+    A+K+I    +  S     EIAL + LKH
Sbjct: 21  YDENGDRVVLGKGTYGIVYAGR--DLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKH 78
Query: 76  PNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQI 135
            N++  +  F  +   K+++        L  +++       +                QI
Sbjct: 79  KNIVQYLGSFSENGFIKIFME-QVPGGSLSALLRSKWGPLKDNEQTIGFYTK------QI 131
Query: 136 LDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVV 195
           L+G+ YLH N ++HRD+K  N+L+       G +KI+D G +       K LA ++P   
Sbjct: 132 LEGLKYLHDNQIVHRDIKGDNVLI---NTYSGVLKISDFGTS-------KRLAGINPCTE 181
Query: 196 TF----WYRAPELL-LGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
           TF     Y APE++  G R Y KA DIW++GC   E+ T +P F+
Sbjct: 182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFY 226

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 90.9 bits (224), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 112/222 (50%), Gaps = 29/222 (13%)
Query: 25  CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL----SMSACREIALLRELKHPNVIN 80
           C +G+G++G V K   KD    ++YA+K I         + +  RE+ LL++L HPN++ 
Sbjct: 28  CMLGKGSFGEVLKC--KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 81  LISVFLSHNDRKVWLLFD-YAEHDLW-HIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           L  +    +    +++ + Y   +L+  IIK  R ++ +             ++ Q+  G
Sbjct: 86  LFEIL--EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA----------RIIKQVFSG 133
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERG-RVKIADMGFARLFNNPLKPLADLDPVVVTF 197
           I Y+H + ++HRDLKP NIL+  E  E+   +KI D G +  F    K    +   + T 
Sbjct: 134 ITYMHKHNIVHRDLKPENILL--ESKEKDCDIKIIDFGLSTCFQQNTK----MKDRIGTA 187
Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
           +Y APE+L G   Y +  D+W+ G I   LL+  P F+ + E
Sbjct: 188 YYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNE 227

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 90.9 bits (224), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 72/246 (29%), Positives = 116/246 (47%), Gaps = 40/246 (16%)
Query: 4   EFKIKTSNERTKVED--LFDYE-GCKVGRGTYGHVYKARRKDNSDTRDYALK-----QIE 55
           E   K  NE +K     L D+E G  +G+G +G+VY AR K +      ALK     Q+E
Sbjct: 16  ELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFI--LALKVLFKAQLE 73
Query: 56  GTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAE-----HDLWHIIKF 110
             G+     RE+ +   L+HPN++ L   F  H+  +V+L+ +YA       +L  + KF
Sbjct: 74  KAGVEHQLRREVEIQSHLRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKF 131
Query: 111 HRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVK 170
                A             + + ++ + + Y HS  V+HRD+KP N+L+       G +K
Sbjct: 132 DEQRTA-------------TYITELANALSYCHSKRVIHRDIKPENLLLGSA----GELK 174
Query: 171 IADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 230
           IAD G++        P +    +  T  Y  PE++ G  H  K +D+W++G +  E L  
Sbjct: 175 IADFGWSV-----HAPSSRRTTLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVG 228
Query: 231 EPIFHC 236
           +P F  
Sbjct: 229 KPPFEA 234

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 90.5 bits (223), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 72/246 (29%), Positives = 116/246 (47%), Gaps = 40/246 (16%)
Query: 4   EFKIKTSNERTKVED--LFDYE-GCKVGRGTYGHVYKARRKDNSDTRDYALK-----QIE 55
           E   K  NE +K     L D+E G  +G+G +G+VY AR K +      ALK     Q+E
Sbjct: 7   ELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFI--LALKVLFKAQLE 64
Query: 56  GTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAE-----HDLWHIIKF 110
             G+     RE+ +   L+HPN++ L   F  H+  +V+L+ +YA       +L  + KF
Sbjct: 65  KAGVEHQLRREVEIQSHLRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKF 122
Query: 111 HRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVK 170
                A             + + ++ + + Y HS  V+HRD+KP N+L+       G +K
Sbjct: 123 DEQRTA-------------TYITELANALSYCHSKRVIHRDIKPENLLLGSA----GELK 165
Query: 171 IADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 230
           IAD G++        P +    +  T  Y  PE++ G  H  K +D+W++G +  E L  
Sbjct: 166 IADFGWS-----VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVG 219
Query: 231 EPIFHC 236
           +P F  
Sbjct: 220 KPPFEA 225

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/219 (32%), Positives = 109/219 (49%), Gaps = 35/219 (15%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA----CREIALLRELKHPNVINL 81
           K+G G YG V   R K     R  A+K I  T +S S+      E+A+L+ L HPN++ L
Sbjct: 44  KLGSGAYGEVLLCRDKVTHVER--AIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL 101
Query: 82  ISVFLSHNDRKVWLLFD-YAEHDLW----HIIKFHRAAKANXXXXXXXXXXXXSLLYQIL 136
              F   + R  +L+ + Y   +L+    H +KF+    A              ++ Q+L
Sbjct: 102 YDFF--EDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAA-------------VIIKQVL 146
Query: 137 DGIHYLHSNWVLHRDLKPANILVMGEGIER-GRVKIADMGFARLFNNPLKPLADLDPVVV 195
            G+ YLH + ++HRDLKP N+L+  E  E+   +KI D G + +F N  K    +   + 
Sbjct: 147 SGVTYLHKHNIVHRDLKPENLLL--ESKEKDALIKIVDFGLSAVFENQKK----MKERLG 200
Query: 196 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           T +Y APE+L   + Y +  D+W+IG I   LL   P F
Sbjct: 201 TAYYIAPEVL--RKKYDEKCDVWSIGVILFILLAGYPPF 237

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 109/225 (48%), Gaps = 28/225 (12%)
Query: 20  FDYEGCKV--GRGTYGHVYKARRKDNSDTRDYALKQI--EGTGLSMSACREIALLRELKH 75
           +D  G +V  G+GTYG VY  R  D S+    A+K+I    +  S     EIAL + LKH
Sbjct: 7   YDENGDRVVLGKGTYGIVYAGR--DLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKH 64
Query: 76  PNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQI 135
            N++  +  F  +   K+++        L  +++       +                QI
Sbjct: 65  KNIVQYLGSFSENGFIKIFME-QVPGGSLSALLRSKWGPLKDNEQTIGFYTK------QI 117
Query: 136 LDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVV 195
           L+G+ YLH N ++HRD+K  N+L+       G +KI+D G +       K LA ++P   
Sbjct: 118 LEGLKYLHDNQIVHRDIKGDNVLI---NTYSGVLKISDFGTS-------KRLAGINPCTE 167
Query: 196 TF----WYRAPELL-LGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
           TF     Y APE++  G R Y KA DIW++GC   E+ T +P F+
Sbjct: 168 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFY 212

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 111/229 (48%), Gaps = 38/229 (16%)
Query: 19  LFDYE-GCKVGRGTYGHVYKARRKDNSDTRDYALK-----QIEGTGLSMSACREIALLRE 72
           L D+E G  +G+G +G+VY AR K +      ALK     Q+E  G+     RE+ +   
Sbjct: 8   LEDFEIGRPLGKGKFGNVYLAREKQSKFI--LALKVLFKAQLEKAGVEHQLRREVEIQSH 65
Query: 73  LKHPNVINLISVFLSHNDRKVWLLFDYAE-----HDLWHIIKFHRAAKANXXXXXXXXXX 127
           L+HPN++ L   F  H+  +V+L+ +YA       +L  + KF     A           
Sbjct: 66  LRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA----------- 112
Query: 128 XXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPL 187
             + + ++ + + Y HS  V+HRD+KP N+L+       G +KIAD G++        P 
Sbjct: 113 --TYITELANALSYCHSKRVIHRDIKPENLLLGSA----GELKIADFGWS-----VHAPS 161
Query: 188 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 236
           +  D +  T  Y  PE++ G  H  K +D+W++G +  E L  +P F  
Sbjct: 162 SRRDTLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEA 209

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 88.2 bits (217), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 111/229 (48%), Gaps = 38/229 (16%)
Query: 19  LFDYE-GCKVGRGTYGHVYKARRKDNSDTRDYALK-----QIEGTGLSMSACREIALLRE 72
           L D+E G  +G+G +G+VY AR K +      ALK     Q+E  G+     RE+ +   
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFI--LALKVLFKAQLEKAGVEHQLRREVEIQSH 67
Query: 73  LKHPNVINLISVFLSHNDRKVWLLFDYAE-----HDLWHIIKFHRAAKANXXXXXXXXXX 127
           L+HPN++ L   F  H+  +V+L+ +YA       +L  + KF     A           
Sbjct: 68  LRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA----------- 114
Query: 128 XXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPL 187
             + + ++ + + Y HS  V+HRD+KP N+L+       G +KIAD G++        P 
Sbjct: 115 --TYITELANALSYCHSKRVIHRDIKPENLLLGSA----GELKIADFGWSV-----HAPS 163
Query: 188 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 236
           +  D +  T  Y  PE++ G  H  K +D+W++G +  E L  +P F  
Sbjct: 164 SRRDDLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEA 211

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 120/252 (47%), Gaps = 40/252 (15%)
Query: 18  DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALK-----QIEGTGLSMSACREIALLRE 72
           D FD  G  +G+G +G+VY AR K N      ALK     Q+E  G+     REI +   
Sbjct: 15  DDFDI-GRPLGKGKFGNVYLAREKQNKFI--MALKVLFKSQLEKEGVEHQLRREIEIQSH 71
Query: 73  LKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSL 131
           L+HPN++ + + F  H+ ++++L+ ++A   +L+  ++ H                  + 
Sbjct: 72  LRHPNILRMYNYF--HDRKRIYLMLEFAPRGELYKELQKH---------GRFDEQRSATF 120
Query: 132 LYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLD 191
           + ++ D +HY H   V+HRD+KP N+L MG    +G +KIAD G++        P     
Sbjct: 121 MEELADALHYCHERKVIHRDIKPENLL-MG---YKGELKIADFGWSV-----HAPSLRRR 171
Query: 192 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 251
            +  T  Y  PE++ G  H  K +D+W  G +  E L   P F          +P H + 
Sbjct: 172 XMCGTLDYLPPEMIEGKTHDEK-VDLWCAGVLCYEFLVGMPPF---------DSPSHTET 221
Query: 252 LDRIFSV-MGFP 262
             RI +V + FP
Sbjct: 222 HRRIVNVDLKFP 233

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 111/229 (48%), Gaps = 38/229 (16%)
Query: 19  LFDYE-GCKVGRGTYGHVYKARRKDNSDTRDYALK-----QIEGTGLSMSACREIALLRE 72
           L D+E G  +G+G +G+VY AR K +      ALK     Q+E  G+     RE+ +   
Sbjct: 12  LEDFEIGRPLGKGKFGNVYLAREKQSKFI--LALKVLFKAQLEKAGVEHQLRREVEIQSH 69
Query: 73  LKHPNVINLISVFLSHNDRKVWLLFDYAE-----HDLWHIIKFHRAAKANXXXXXXXXXX 127
           L+HPN++ L   F  H+  +V+L+ +YA       +L  + KF     A           
Sbjct: 70  LRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA----------- 116
Query: 128 XXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPL 187
             + + ++ + + Y HS  V+HRD+KP N+L+       G +KIAD G++   + P    
Sbjct: 117 --TYITELANALSYCHSKRVIHRDIKPENLLLGSA----GELKIADFGWS--VHAPSSRR 168
Query: 188 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 236
            DL     T  Y  PE++ G  H  K +D+W++G +  E L  +P F  
Sbjct: 169 TDL---CGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEA 213

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 112/229 (48%), Gaps = 38/229 (16%)
Query: 19  LFDYE-GCKVGRGTYGHVYKARRKDNSDTRDYALK-----QIEGTGLSMSACREIALLRE 72
           L D+E G  +G+G +G+VY AR K +      ALK     Q+E  G+     RE+ +   
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFI--LALKVLFKAQLEKAGVEHQLRREVEIQSH 64
Query: 73  LKHPNVINLISVFLSHNDRKVWLLFDYAE-----HDLWHIIKFHRAAKANXXXXXXXXXX 127
           L+HPN++ L   F  H+  +V+L+ +YA       +L  + KF     A           
Sbjct: 65  LRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA----------- 111
Query: 128 XXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPL 187
             + + ++ + + Y HS  V+HRD+KP N+L +G     G +KIAD G++   + P    
Sbjct: 112 --TYITELANALSYCHSKRVIHRDIKPENLL-LGSA---GELKIADFGWS--VHAPSSRR 163
Query: 188 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 236
            DL     T  Y  PE++ G  H  K +D+W++G +  E L  +P F  
Sbjct: 164 TDL---CGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEA 208

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 76/259 (29%), Positives = 120/259 (46%), Gaps = 47/259 (18%)
Query: 20  FDYEGCKV-GRGTYGHVYKARRKDNSDTRDYALKQIEGTG-LSMSACREIALLRELKHP- 76
           + YE  KV G+G++G V KA   D+   +  ALK +         A  EI +L  L+   
Sbjct: 97  YRYEVLKVIGKGSFGQVVKAY--DHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQD 154
Query: 77  -----NVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSL 131
                NVI+++  F   N   + + F+    +L+ +IK ++                   
Sbjct: 155 KDNTMNVIHMLENFTFRNH--ICMTFELLSMNLYELIKKNK-------FQGFSLPLVRKF 205
Query: 132 LYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA-----RLFNNPLKP 186
            + IL  +  LH N ++H DLKP NIL+  +G  R  +K+ D G +     R++      
Sbjct: 206 AHSILQCLDALHKNRIIHCDLKPENILLKQQG--RSGIKVIDFGSSCYEHQRVYT----- 258
Query: 187 LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 246
                  + + +YRAPE++LGAR Y   ID+W++GCI AELLT  P+     E       
Sbjct: 259 ------XIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEG------ 305
Query: 247 YHHDQLDRIFSVMGFPLEK 265
              DQL  +  ++G P +K
Sbjct: 306 ---DQLACMIELLGMPSQK 321

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 111/229 (48%), Gaps = 38/229 (16%)
Query: 19  LFDYE-GCKVGRGTYGHVYKARRKDNSDTRDYALK-----QIEGTGLSMSACREIALLRE 72
           L D+E G  +G+G +G+VY AR K +      ALK     Q+E  G+     RE+ +   
Sbjct: 8   LEDFEIGRPLGKGKFGNVYLAREKQSKFI--LALKVLFKAQLEKAGVEHQLRREVEIQSH 65
Query: 73  LKHPNVINLISVFLSHNDRKVWLLFDYAE-----HDLWHIIKFHRAAKANXXXXXXXXXX 127
           L+HPN++ L   F  H+  +V+L+ +YA       +L  + KF     A           
Sbjct: 66  LRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA----------- 112
Query: 128 XXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPL 187
             + + ++ + + Y HS  V+HRD+KP N+L+       G +KIAD G++   + P    
Sbjct: 113 --TYITELANALSYCHSKRVIHRDIKPENLLLGSA----GELKIADFGWS--VHAPSSRR 164
Query: 188 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 236
            DL     T  Y  PE++ G  H  K +D+W++G +  E L  +P F  
Sbjct: 165 TDL---CGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEA 209

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 111/229 (48%), Gaps = 38/229 (16%)
Query: 19  LFDYE-GCKVGRGTYGHVYKARRKDNSDTRDYALK-----QIEGTGLSMSACREIALLRE 72
           L D+E G  +G+G +G+VY AR K +      ALK     Q+E  G+     RE+ +   
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFI--LALKVLFKAQLEKAGVEHQLRREVEIQSH 64
Query: 73  LKHPNVINLISVFLSHNDRKVWLLFDYAE-----HDLWHIIKFHRAAKANXXXXXXXXXX 127
           L+HPN++ L   F  H+  +V+L+ +YA       +L  + KF     A           
Sbjct: 65  LRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA----------- 111
Query: 128 XXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPL 187
             + + ++ + + Y HS  V+HRD+KP N+L+       G +KIAD G++   + P    
Sbjct: 112 --TYITELANALSYCHSKRVIHRDIKPENLLLGSA----GELKIADFGWS--VHAPSSRR 163
Query: 188 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 236
            DL     T  Y  PE++ G  H  K +D+W++G +  E L  +P F  
Sbjct: 164 TDL---CGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEA 208

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 87.4 bits (215), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 76/259 (29%), Positives = 120/259 (46%), Gaps = 47/259 (18%)
Query: 20  FDYEGCKV-GRGTYGHVYKARRKDNSDTRDYALKQIEGTG-LSMSACREIALLRELKHP- 76
           + YE  KV G+G++G V KA   D+   +  ALK +         A  EI +L  L+   
Sbjct: 97  YRYEVLKVIGKGSFGQVVKAY--DHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQD 154
Query: 77  -----NVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSL 131
                NVI+++  F   N   + + F+    +L+ +IK ++                   
Sbjct: 155 KDNTMNVIHMLENFTFRNH--ICMTFELLSMNLYELIKKNK-------FQGFSLPLVRKF 205
Query: 132 LYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA-----RLFNNPLKP 186
            + IL  +  LH N ++H DLKP NIL+  +G  R  +K+ D G +     R++      
Sbjct: 206 AHSILQCLDALHKNRIIHCDLKPENILLKQQG--RSGIKVIDFGSSCYEHQRVYT----- 258
Query: 187 LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 246
                  + + +YRAPE++LGAR Y   ID+W++GCI AELLT  P+     E       
Sbjct: 259 ------XIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEG------ 305
Query: 247 YHHDQLDRIFSVMGFPLEK 265
              DQL  +  ++G P +K
Sbjct: 306 ---DQLACMIELLGMPSQK 321

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 87.4 bits (215), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 110/229 (48%), Gaps = 38/229 (16%)
Query: 19  LFDYE-GCKVGRGTYGHVYKARRKDNSDTRDYALK-----QIEGTGLSMSACREIALLRE 72
           L D+E G  +G+G +G+VY AR K +      ALK     Q+E  G+     RE+ +   
Sbjct: 12  LEDFEIGRPLGKGKFGNVYLAREKQSKFI--LALKVLFKAQLEKAGVEHQLRREVEIQSH 69
Query: 73  LKHPNVINLISVFLSHNDRKVWLLFDYAEH-----DLWHIIKFHRAAKANXXXXXXXXXX 127
           L+HPN++ L   F  H+  +V+L+ +YA       +L  + KF     A           
Sbjct: 70  LRHPNILRLYGYF--HDATRVYLILEYAPRGEVYKELQKLSKFDEQRTA----------- 116
Query: 128 XXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPL 187
             + + ++ + + Y HS  V+HRD+KP N+L+       G +KIAD G++        P 
Sbjct: 117 --TYITELANALSYCHSKRVIHRDIKPENLLLGSA----GELKIADFGWS-----VHAPS 165
Query: 188 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 236
           +    +  T  Y  PE++ G  H  K +D+W++G +  E L  +P F  
Sbjct: 166 SRRTTLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEA 213

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 74/256 (28%), Positives = 123/256 (48%), Gaps = 36/256 (14%)
Query: 16  VEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMS--------ACREI 67
           VED ++  G ++G G +  V K R+K     ++YA K I+   LS S          RE+
Sbjct: 10  VEDHYEM-GEELGSGQFAIVRKCRQKGTG--KEYAAKFIKKRRLSSSRRGVSREEIEREV 66
Query: 68  ALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXX 127
            +LRE++HPN+I L  +F +  D  V +L   +  +L+  +    +   +          
Sbjct: 67  NILREIRHPNIITLHDIFENKTD-VVLILELVSGGELFDFLAEKESLTEDEAT------- 118
Query: 128 XXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPL 187
               L QILDG+HYLHS  + H DLKP NI+++ + +   R+K+ D G A    + ++  
Sbjct: 119 --QFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA----HKIEAG 172
Query: 188 ADLDPVVVTFWYRAPELL----LGARHYTKAIDIWAIGCIFAELLTSEPIF--HCRQEDI 241
            +   +  T  + APE++    LG        D+W+IG I   LL+    F    +QE +
Sbjct: 173 NEFKNIFGTPEFVAPEIVNYEPLGLE-----ADMWSIGVITYILLSGASPFLGETKQETL 227
Query: 242 KTSNPYHHDQLDRIFS 257
              +  ++D  +  FS
Sbjct: 228 TNISAVNYDFDEEYFS 243

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 110/229 (48%), Gaps = 38/229 (16%)
Query: 19  LFDYE-GCKVGRGTYGHVYKARRKDNSDTRDYALK-----QIEGTGLSMSACREIALLRE 72
           L D+E G  +G+G +G+VY AR K +      ALK     Q+E  G+     RE+ +   
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFI--LALKVLFKAQLEKAGVEHQLRREVEIQSH 67
Query: 73  LKHPNVINLISVFLSHNDRKVWLLFDYAE-----HDLWHIIKFHRAAKANXXXXXXXXXX 127
           L+HPN++ L   F  H+  +V+L+ +YA       +L  + KF     A           
Sbjct: 68  LRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA----------- 114
Query: 128 XXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPL 187
             + + ++ + + Y HS  V+HRD+KP N+L+       G +KIAD G++        P 
Sbjct: 115 --TYITELANALSYCHSKRVIHRDIKPENLLLGSA----GELKIADFGWS-----VHAPS 163
Query: 188 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 236
           +    +  T  Y  PE++ G  H  K +D+W++G +  E L  +P F  
Sbjct: 164 SRRTTLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEA 211

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/258 (28%), Positives = 124/258 (48%), Gaps = 36/258 (13%)
Query: 14  TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMS--------ACR 65
           + VED ++  G ++G G +  V K R+K     ++YA K I+   LS S          R
Sbjct: 1   SMVEDHYEM-GEELGSGQFAIVRKCRQKGTG--KEYAAKFIKKRRLSSSRRGVSREEIER 57
Query: 66  EIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXX 125
           E+ +LRE++HPN+I L  +F +  D  V +L   +  +L+  +    +   +        
Sbjct: 58  EVNILREIRHPNIITLHDIFENKTD-VVLILELVSGGELFDFLAEKESLTEDEAT----- 111
Query: 126 XXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLK 185
                 L QILDG+HYLHS  + H DLKP NI+++ + +   R+K+ D G A    + ++
Sbjct: 112 ----QFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA----HKIE 163
Query: 186 PLADLDPVVVTFWYRAPELL----LGARHYTKAIDIWAIGCIFAELLTSEPIF--HCRQE 239
              +   +  T  + APE++    LG        D+W+IG I   LL+    F    +QE
Sbjct: 164 AGNEFKNIFGTPEFVAPEIVNYEPLGLE-----ADMWSIGVITYILLSGASPFLGETKQE 218
Query: 240 DIKTSNPYHHDQLDRIFS 257
            +   +  ++D  +  FS
Sbjct: 219 TLTNISAVNYDFDEEYFS 236

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 110/229 (48%), Gaps = 38/229 (16%)
Query: 19  LFDYE-GCKVGRGTYGHVYKARRKDNSDTRDYALK-----QIEGTGLSMSACREIALLRE 72
           L D+E G  +G+G +G+VY AR K +      ALK     Q+E  G+     RE+ +   
Sbjct: 12  LEDFEIGRPLGKGKFGNVYLAREKQSKFI--LALKVLFKAQLEKAGVEHQLRREVEIQSH 69
Query: 73  LKHPNVINLISVFLSHNDRKVWLLFDYAE-----HDLWHIIKFHRAAKANXXXXXXXXXX 127
           L+HPN++ L   F  H+  +V+L+ +YA       +L  + KF     A           
Sbjct: 70  LRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA----------- 116
Query: 128 XXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPL 187
             + + ++ + + Y HS  V+HRD+KP N+L+       G +KIAD G++        P 
Sbjct: 117 --TYITELANALSYCHSKRVIHRDIKPENLLLGSA----GELKIADFGWS-----VHAPS 165
Query: 188 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 236
           +    +  T  Y  PE++ G  H  K +D+W++G +  E L  +P F  
Sbjct: 166 SRRTTLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEA 213

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 113/229 (49%), Gaps = 38/229 (16%)
Query: 19  LFDYE-GCKVGRGTYGHVYKARRKDNSDTRDYALK-----QIEGTGLSMSACREIALLRE 72
           L D+E G  +G+G +G+VY AR K++      ALK     Q+E  G+     RE+ +   
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKNSKFI--LALKVLFKAQLEKAGVEHQLRREVEIQSH 64
Query: 73  LKHPNVINLISVFLSHNDRKVWLLFDYAE-----HDLWHIIKFHRAAKANXXXXXXXXXX 127
           L+HPN++ L   F  H+  +V+L+ +YA       +L  + KF     A           
Sbjct: 65  LRHPNILRLYGYF--HDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTA----------- 111
Query: 128 XXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPL 187
             + + ++ + + Y HS  V+HRD+KP N+L +G     G +KIAD G++   + P    
Sbjct: 112 --TYITELANALSYCHSKKVIHRDIKPENLL-LGSA---GELKIADFGWS--VHAPSSRR 163
Query: 188 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 236
           A L     T  Y  PE++ G  H  K +D+W++G +  E L  +P F  
Sbjct: 164 AAL---CGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEA 208

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 110/229 (48%), Gaps = 38/229 (16%)
Query: 19  LFDYE-GCKVGRGTYGHVYKARRKDNSDTRDYALK-----QIEGTGLSMSACREIALLRE 72
           L D+E G  +G+G +G+VY AR K +      ALK     Q+E  G+     RE+ +   
Sbjct: 8   LEDFEIGRPLGKGKFGNVYLAREKQSKFI--LALKVLFKAQLEKAGVEHQLRREVEIQSH 65
Query: 73  LKHPNVINLISVFLSHNDRKVWLLFDYAE-----HDLWHIIKFHRAAKANXXXXXXXXXX 127
           L+HPN++ L   F  H+  +V+L+ +YA       +L  + KF     A           
Sbjct: 66  LRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA----------- 112
Query: 128 XXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPL 187
             + + ++ + + Y HS  V+HRD+KP N+L+       G +KIAD G++        P 
Sbjct: 113 --TYITELANALSYCHSKRVIHRDIKPENLLLGSA----GELKIADFGWS-----CHAPS 161
Query: 188 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 236
           +    +  T  Y  PE++ G  H  K +D+W++G +  E L  +P F  
Sbjct: 162 SRRTTLSGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEA 209

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 110/229 (48%), Gaps = 38/229 (16%)
Query: 19  LFDYE-GCKVGRGTYGHVYKARRKDNSDTRDYALK-----QIEGTGLSMSACREIALLRE 72
           L D+E G  +G+G +G+VY AR K +      ALK     Q+E  G+     RE+ +   
Sbjct: 12  LEDFEIGRPLGKGKFGNVYLAREKQSKFI--LALKVLFKAQLEKAGVEHQLRREVEIQSH 69
Query: 73  LKHPNVINLISVFLSHNDRKVWLLFDYAEH-----DLWHIIKFHRAAKANXXXXXXXXXX 127
           L+HPN++ L   F  H+  +V+L+ +YA       +L  + KF     A           
Sbjct: 70  LRHPNILRLYGYF--HDATRVYLILEYAPRGEVYKELQKLSKFDEQRTA----------- 116
Query: 128 XXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPL 187
             + + ++ + + Y HS  V+HRD+KP N+L+       G +KIAD G++        P 
Sbjct: 117 --TYITELANALSYCHSKRVIHRDIKPENLLLGSA----GELKIADFGWS-----VHAPS 165
Query: 188 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 236
           +    +  T  Y  PE++ G  H  K +D+W++G +  E L  +P F  
Sbjct: 166 SRRXXLXGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEA 213

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/259 (29%), Positives = 119/259 (45%), Gaps = 47/259 (18%)
Query: 20  FDYEGCKV-GRGTYGHVYKARRKDNSDTRDYALKQIEGTG-LSMSACREIALLRELKHP- 76
           + YE  KV G+G +G V KA   D+   +  ALK +         A  EI +L  L+   
Sbjct: 97  YRYEVLKVIGKGXFGQVVKAY--DHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQD 154
Query: 77  -----NVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSL 131
                NVI+++  F   N   + + F+    +L+ +IK ++                   
Sbjct: 155 KDNTMNVIHMLENFTFRNH--ICMTFELLSMNLYELIKKNK-------FQGFSLPLVRKF 205
Query: 132 LYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA-----RLFNNPLKP 186
            + IL  +  LH N ++H DLKP NIL+  +G  R  +K+ D G +     R++      
Sbjct: 206 AHSILQCLDALHKNRIIHCDLKPENILLKQQG--RSGIKVIDFGSSCYEHQRVYX----- 258
Query: 187 LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 246
                  + + +YRAPE++LGAR Y   ID+W++GCI AELLT  P+     E       
Sbjct: 259 ------XIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEG------ 305
Query: 247 YHHDQLDRIFSVMGFPLEK 265
              DQL  +  ++G P +K
Sbjct: 306 ---DQLACMIELLGMPXQK 321

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 110/229 (48%), Gaps = 38/229 (16%)
Query: 19  LFDYE-GCKVGRGTYGHVYKARRKDNSDTRDYALK-----QIEGTGLSMSACREIALLRE 72
           L D+E G  +G+G +G+VY AR K +      ALK     Q+E  G+     RE+ +   
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFI--LALKVLFKAQLEKAGVEHQLRREVEIQSH 64
Query: 73  LKHPNVINLISVFLSHNDRKVWLLFDYAE-----HDLWHIIKFHRAAKANXXXXXXXXXX 127
           L+HPN++ L   F  H+  +V+L+ +YA       +L  + KF     A           
Sbjct: 65  LRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA----------- 111
Query: 128 XXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPL 187
             + + ++ + + Y HS  V+HRD+KP N+L+       G +KIAD G++        P 
Sbjct: 112 --TYITELANALSYCHSKRVIHRDIKPENLLLGSA----GELKIADFGWS-----VHAPS 160
Query: 188 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 236
           +    +  T  Y  PE++ G  H  K +D+W++G +  E L  +P F  
Sbjct: 161 SRRTTLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEA 208

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 110/229 (48%), Gaps = 38/229 (16%)
Query: 19  LFDYE-GCKVGRGTYGHVYKARRKDNSDTRDYALK-----QIEGTGLSMSACREIALLRE 72
           L D+E G  +G+G +G+VY AR K +      ALK     Q+E  G+     RE+ +   
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFI--LALKVLFKAQLEKAGVEHQLRREVEIQSH 64
Query: 73  LKHPNVINLISVFLSHNDRKVWLLFDYAE-----HDLWHIIKFHRAAKANXXXXXXXXXX 127
           L+HPN++ L   F  H+  +V+L+ +YA       +L  + KF     A           
Sbjct: 65  LRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA----------- 111
Query: 128 XXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPL 187
             + + ++ + + Y HS  V+HRD+KP N+L+       G +KIAD G++        P 
Sbjct: 112 --TYITELANALSYCHSKRVIHRDIKPENLLLGSA----GELKIADFGWS-----VHAPS 160
Query: 188 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 236
           +    +  T  Y  PE++ G  H  K +D+W++G +  E L  +P F  
Sbjct: 161 SRRTELCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEA 208

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 116/243 (47%), Gaps = 39/243 (16%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALK-----QIEGTGLSMSACREIALLRELKHPNVINL 81
           +G+G +G+VY AR K N      ALK     Q+E  G+     REI +   L+HPN++ +
Sbjct: 22  LGKGKFGNVYLAREKQNKFI--MALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
            + F  H+ ++++L+ ++A   +L+  ++ H                  + + ++ D +H
Sbjct: 80  YNYF--HDRKRIYLMLEFAPRGELYKELQKH---------GRFDEQRSATFMEELADALH 128
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           Y H   V+HRD+KP N+L MG    +G +KIAD G++        P      +  T  Y 
Sbjct: 129 YCHERKVIHRDIKPENLL-MG---YKGELKIADFGWSV-----HAPSLRRRXMCGTLDYL 179
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV-M 259
            PE++ G  H  K +D+W  G +  E L   P F          +P H +   RI +V +
Sbjct: 180 PPEMIEGKTHDEK-VDLWCAGVLCYEFLVGMPPF---------DSPSHTETHRRIVNVDL 229
Query: 260 GFP 262
            FP
Sbjct: 230 KFP 232

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 111/229 (48%), Gaps = 38/229 (16%)
Query: 19  LFDYE-GCKVGRGTYGHVYKARRKDNSDTRDYALK-----QIEGTGLSMSACREIALLRE 72
           L D+E G  +G+G +G+VY AR K +      ALK     Q+E  G+     RE+ +   
Sbjct: 9   LEDFEIGRPLGKGKFGNVYLAREKQSKFI--LALKVLFKAQLEKAGVEHQLRREVEIQSH 66
Query: 73  LKHPNVINLISVFLSHNDRKVWLLFDYAE-----HDLWHIIKFHRAAKANXXXXXXXXXX 127
           L+HPN++ L   F  H+  +V+L+ +YA       +L  + KF     A           
Sbjct: 67  LRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA----------- 113
Query: 128 XXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPL 187
             + + ++ + + Y HS  V+HRD+KP N+L +G     G +KIAD G++        P 
Sbjct: 114 --TYITELANALSYCHSKRVIHRDIKPENLL-LGSA---GELKIADFGWS-----VHAPS 162
Query: 188 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 236
           +    +  T  Y  PE++ G  H  K +D+W++G +  E L  +P F  
Sbjct: 163 SRRXXLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEA 210

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 111/229 (48%), Gaps = 38/229 (16%)
Query: 19  LFDYE-GCKVGRGTYGHVYKARRKDNSDTRDYALK-----QIEGTGLSMSACREIALLRE 72
           L D+E G  +G+G +G+VY AR K +      ALK     Q+E  G+     RE+ +   
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFI--LALKVLFKAQLEKAGVEHQLRREVEIQSH 67
Query: 73  LKHPNVINLISVFLSHNDRKVWLLFDYAE-----HDLWHIIKFHRAAKANXXXXXXXXXX 127
           L+HPN++ L   F  H+  +V+L+ +YA       +L  + KF     A           
Sbjct: 68  LRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA----------- 114
Query: 128 XXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPL 187
             + + ++ + + Y HS  V+HRD+KP N+L +G     G +KIAD G++        P 
Sbjct: 115 --TYITELANALSYCHSKRVIHRDIKPENLL-LGSA---GELKIADFGWS-----VHAPS 163
Query: 188 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 236
           +    +  T  Y  PE++ G  H  K +D+W++G +  E L  +P F  
Sbjct: 164 SRRTTLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEA 211

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 21/215 (9%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACR-----EIALLRELKHPNVIN 80
           K+GRG +  VY+A      D    ALK+++   L  +  R     EI LL++L HPNVI 
Sbjct: 39  KIGRGQFSEVYRAACL--LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK 96
Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
             + F+  N+  + L    A  DL  +IK  +  K                  Q+   + 
Sbjct: 97  YYASFIEDNELNIVLELADA-GDLSRMIKHFKKQK-----RLIPERTVWKYFVQLCSALE 150
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           ++HS  V+HRD+KPAN+ +   G+    VK+ D+G  R F++       L   V T +Y 
Sbjct: 151 HMHSRRVMHRDIKPANVFITATGV----VKLGDLGLGRFFSSKTTAAHSL---VGTPYYM 203
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
           +PE  +    Y    DIW++GC+  E+   +  F+
Sbjct: 204 SPE-RIHENGYNFKSDIWSLGCLLYEMAALQSPFY 237

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 111/229 (48%), Gaps = 38/229 (16%)
Query: 19  LFDYE-GCKVGRGTYGHVYKARRKDNSDTRDYALK-----QIEGTGLSMSACREIALLRE 72
           L D+E G  +G+G +G+VY AR K +      ALK     Q+E  G+     RE+ +   
Sbjct: 6   LEDFEIGRPLGKGKFGNVYLAREKQSKFI--LALKVLFKAQLEKAGVEHQLRREVEIQSH 63
Query: 73  LKHPNVINLISVFLSHNDRKVWLLFDYAE-----HDLWHIIKFHRAAKANXXXXXXXXXX 127
           L+HPN++ L   F  H+  +V+L+ +YA       +L  + KF     A           
Sbjct: 64  LRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA----------- 110
Query: 128 XXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPL 187
             + + ++ + + Y HS  V+HRD+KP N+L +G     G +KIAD G++        P 
Sbjct: 111 --TYITELANALSYCHSKRVIHRDIKPENLL-LGSA---GELKIADFGWS-----VHAPS 159
Query: 188 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 236
           +    +  T  Y  PE++ G  H  K +D+W++G +  E L  +P F  
Sbjct: 160 SRRTTLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEA 207

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 110/229 (48%), Gaps = 38/229 (16%)
Query: 19  LFDYE-GCKVGRGTYGHVYKARRKDNSDTRDYALK-----QIEGTGLSMSACREIALLRE 72
           L D+E G  +G+G +G+VY AR K +      ALK     Q+E  G+     RE+ +   
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFI--LALKVLFKAQLEKAGVEHQLRREVEIQSH 67
Query: 73  LKHPNVINLISVFLSHNDRKVWLLFDYAE-----HDLWHIIKFHRAAKANXXXXXXXXXX 127
           L+HPN++ L   F  H+  +V+L+ +YA       +L  + KF     A           
Sbjct: 68  LRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA----------- 114
Query: 128 XXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPL 187
             + + ++ + + Y HS  V+HRD+KP N+L+       G +KIAD G++        P 
Sbjct: 115 --TYITELANALSYCHSKRVIHRDIKPENLLLGSA----GELKIADFGWS-----VHAPS 163
Query: 188 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 236
           +    +  T  Y  PE++ G  H  K +D+W++G +  E L  +P F  
Sbjct: 164 SRRAALCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEA 211

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 110/229 (48%), Gaps = 38/229 (16%)
Query: 19  LFDYE-GCKVGRGTYGHVYKARRKDNSDTRDYALK-----QIEGTGLSMSACREIALLRE 72
           L D+E G  +G+G +G+VY AR K +      ALK     Q+E  G+     RE+ +   
Sbjct: 11  LEDFEIGRPLGKGKFGNVYLAREKQSKFI--LALKVLFKAQLEKAGVEHQLRREVEIQSH 68
Query: 73  LKHPNVINLISVFLSHNDRKVWLLFDYAE-----HDLWHIIKFHRAAKANXXXXXXXXXX 127
           L+HPN++ L   F  H+  +V+L+ +YA       +L  + KF     A           
Sbjct: 69  LRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA----------- 115
Query: 128 XXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPL 187
             + + ++ + + Y HS  V+HRD+KP N+L+       G +KIAD G++        P 
Sbjct: 116 --TYITELANALSYCHSKRVIHRDIKPENLLLGSA----GELKIADFGWS-----VHAPS 164
Query: 188 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 236
           +    +  T  Y  PE++ G  H  K +D+W++G +  E L  +P F  
Sbjct: 165 SRRTTLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEA 212

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 112/229 (48%), Gaps = 38/229 (16%)
Query: 19  LFDYE-GCKVGRGTYGHVYKARRKDNSDTRDYALK-----QIEGTGLSMSACREIALLRE 72
           L D+E G  +G+G +G+VY AR K +      ALK     Q+E  G+     RE+ +   
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFI--LALKVLFKAQLEKAGVEHQLRREVEIQSH 64
Query: 73  LKHPNVINLISVFLSHNDRKVWLLFDYAE-----HDLWHIIKFHRAAKANXXXXXXXXXX 127
           L+HPN++ L   F  H+  +V+L+ +YA       +L  + KF     A           
Sbjct: 65  LRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA----------- 111
Query: 128 XXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPL 187
             + + ++ + + Y HS  V+HRD+KP N+L +G     G +KIAD G++   + P    
Sbjct: 112 --TYITELANALSYCHSKRVIHRDIKPENLL-LGSA---GELKIADFGWS--VHAPSSRR 163
Query: 188 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 236
           A L     T  Y  PE++ G  H  K +D+W++G +  E L  +P F  
Sbjct: 164 AAL---CGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEA 208

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 110/229 (48%), Gaps = 38/229 (16%)
Query: 19  LFDYE-GCKVGRGTYGHVYKARRKDNSDTRDYALK-----QIEGTGLSMSACREIALLRE 72
           L D+E G  +G+G +G+VY AR K +      ALK     Q+E  G+     RE+ +   
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFI--LALKVLFKAQLEKAGVEHQLRREVEIQSH 67
Query: 73  LKHPNVINLISVFLSHNDRKVWLLFDYAE-----HDLWHIIKFHRAAKANXXXXXXXXXX 127
           L+HPN++ L   F  H+  +V+L+ +YA       +L  + KF     A           
Sbjct: 68  LRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA----------- 114
Query: 128 XXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPL 187
             + + ++ + + Y HS  V+HRD+KP N+L+       G +KIAD G++        P 
Sbjct: 115 --TYITELANALSYCHSKRVIHRDIKPENLLLGSA----GELKIADFGWS-----VHAPS 163
Query: 188 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 236
           +    +  T  Y  PE++ G  H  K +D+W++G +  E L  +P F  
Sbjct: 164 SRRXXLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEA 211

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 110/229 (48%), Gaps = 38/229 (16%)
Query: 19  LFDYE-GCKVGRGTYGHVYKARRKDNSDTRDYALK-----QIEGTGLSMSACREIALLRE 72
           L D+E G  +G+G +G+VY AR K +      ALK     Q+E  G+     RE+ +   
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFI--LALKVLFKAQLEKAGVEHQLRREVEIQSH 64
Query: 73  LKHPNVINLISVFLSHNDRKVWLLFDYAE-----HDLWHIIKFHRAAKANXXXXXXXXXX 127
           L+HPN++ L   F  H+  +V+L+ +YA       +L  + KF     A           
Sbjct: 65  LRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA----------- 111
Query: 128 XXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPL 187
             + + ++ + + Y HS  V+HRD+KP N+L+       G +KIAD G++        P 
Sbjct: 112 --TYITELANALSYCHSKRVIHRDIKPENLLLGSA----GELKIADFGWS-----VHAPS 160
Query: 188 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 236
           +    +  T  Y  PE++ G  H  K +D+W++G +  E L  +P F  
Sbjct: 161 SRRTXLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEA 208

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 109/229 (47%), Gaps = 38/229 (16%)
Query: 19  LFDYE-GCKVGRGTYGHVYKARRKDNSDTRDYALK-----QIEGTGLSMSACREIALLRE 72
           L D+E G  +G+G +G+VY AR K +      ALK     Q+E  G+     RE+ +   
Sbjct: 12  LEDFEIGRPLGKGKFGNVYLAREKQSKFI--LALKVLFKAQLEKAGVEHQLRREVEIQSH 69
Query: 73  LKHPNVINLISVFLSHNDRKVWLLFDYAE-----HDLWHIIKFHRAAKANXXXXXXXXXX 127
           L+HPN++ L   F  H+  +V+L+ +YA       +L  + KF     A           
Sbjct: 70  LRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA----------- 116
Query: 128 XXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPL 187
             + + ++ + + Y HS  V+HRD+KP N+L+       G +KIAD G++        P 
Sbjct: 117 --TYITELANALSYCHSKRVIHRDIKPENLLLGSA----GELKIADFGWS-----VHAPS 165
Query: 188 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 236
           +    +  T  Y  PE + G  H  K +D+W++G +  E L  +P F  
Sbjct: 166 SRRTTLCGTLDYLPPEXIEGRXHDEK-VDLWSLGVLCYEFLVGKPPFEA 213

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 110/231 (47%), Gaps = 39/231 (16%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALK-----QIEGTGLSMSACREIALLRELKHPNV 78
           G  +G+G +G+VY AR + +      ALK     Q+E  G+     RE+ +   L+HPN+
Sbjct: 17  GRPLGKGKFGNVYLARERQSKFI--LALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNI 74
Query: 79  INLISVFLSHNDRKVWLLFDYAE-----HDLWHIIKFHRAAKANXXXXXXXXXXXXSLLY 133
           + L   F  H+  +V+L+ +YA       +L  + +F     A             + + 
Sbjct: 75  LRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSRFDEQRTA-------------TYIT 119
Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           ++ + + Y HS  V+HRD+KP N+L+       G +KIAD G++        P +  D +
Sbjct: 120 ELANALSYCHSKRVIHRDIKPENLLLGSN----GELKIADFGWS-----VHAPSSRRDTL 170
Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF--HCRQEDIK 242
             T  Y  PE++ G  H  K +D+W++G +  E L   P F  H  QE  +
Sbjct: 171 CGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGMPPFEAHTYQETYR 220

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 110/229 (48%), Gaps = 38/229 (16%)
Query: 19  LFDYE-GCKVGRGTYGHVYKARRKDNSDTRDYALK-----QIEGTGLSMSACREIALLRE 72
           L D+E G  +G+G +G+VY AR K +      ALK     Q+E  G+     RE+ +   
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFI--LALKVLFKAQLEKAGVEHQLRREVEIQSH 64
Query: 73  LKHPNVINLISVFLSHNDRKVWLLFDYAE-----HDLWHIIKFHRAAKANXXXXXXXXXX 127
           L+HPN++ L   F  H+  +V+L+ +YA       +L  + KF     A           
Sbjct: 65  LRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA----------- 111
Query: 128 XXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPL 187
             + + ++ + + Y HS  V+HRD+KP N+L+       G +KIAD G++        P 
Sbjct: 112 --TYITELANALSYCHSKRVIHRDIKPENLLLGSA----GELKIADFGWS-----VHAPS 160
Query: 188 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 236
           +    +  T  Y  PE++ G  H  K +D+W++G +  E L  +P F  
Sbjct: 161 SRRXXLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEA 208

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 110/229 (48%), Gaps = 38/229 (16%)
Query: 19  LFDYE-GCKVGRGTYGHVYKARRKDNSDTRDYALK-----QIEGTGLSMSACREIALLRE 72
           L D+E G  +G+G +G+VY AR K        ALK     Q+E  G+     RE+ +   
Sbjct: 4   LEDFEIGRPLGKGKFGNVYLAREKQRKFI--LALKVLFKAQLEKAGVEHQLRREVEIQSH 61
Query: 73  LKHPNVINLISVFLSHNDRKVWLLFDYAE-----HDLWHIIKFHRAAKANXXXXXXXXXX 127
           L+HPN++ L   F  H+  +V+L+ +YA       +L  + KF     A           
Sbjct: 62  LRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA----------- 108
Query: 128 XXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPL 187
             + + ++ + + Y HS  V+HRD+KP N+L +G     G +KIAD G++        P 
Sbjct: 109 --TYITELANALSYCHSKRVIHRDIKPENLL-LGSA---GELKIADFGWS-----VHAPS 157
Query: 188 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 236
           +    +  T  Y  PE++ G  H  K +D+W++G +  E L  +P F  
Sbjct: 158 SRRTTLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEA 205

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 111/229 (48%), Gaps = 38/229 (16%)
Query: 19  LFDYE-GCKVGRGTYGHVYKARRKDNSDTRDYALK-----QIEGTGLSMSACREIALLRE 72
           L D+E G  +G+G +G+VY AR K +      ALK     Q+E  G+     RE+ +   
Sbjct: 9   LEDFEIGRPLGKGKFGNVYLAREKQSKFI--LALKVLFKAQLEKAGVEHQLRREVEIQSH 66
Query: 73  LKHPNVINLISVFLSHNDRKVWLLFDYAE-----HDLWHIIKFHRAAKANXXXXXXXXXX 127
           L+HPN++ L   F  H+  +V+L+ +YA       +L  + KF     A           
Sbjct: 67  LRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA----------- 113
Query: 128 XXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPL 187
             + + ++ + + Y HS  V+HRD+KP N+L +G     G +KIA+ G++        P 
Sbjct: 114 --TYITELANALSYCHSKRVIHRDIKPENLL-LGSA---GELKIANFGWS-----VHAPS 162
Query: 188 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 236
           +    +  T  Y  PE++ G  H  K +D+W++G +  E L  +P F  
Sbjct: 163 SRRTTLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEA 210

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 124/259 (47%), Gaps = 36/259 (13%)
Query: 13  RTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMS--------AC 64
           ++ VED ++  G ++G G +  V K R+K     ++YA K I+   L  S          
Sbjct: 21  QSMVEDHYEM-GEELGSGQFAIVRKCRQKGTG--KEYAAKFIKKRRLXSSRRGVSREEIE 77
Query: 65  REIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXX 124
           RE+ +LRE++HPN+I L  +F +  D  V +L   +  +L+  +    +   +       
Sbjct: 78  REVNILREIRHPNIITLHDIFENKTD-VVLILELVSGGELFDFLAEKESLTEDEAT---- 132
Query: 125 XXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPL 184
                  L QILDG+HYLHS  + H DLKP NI+++ + +   R+K+ D G A    + +
Sbjct: 133 -----QFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA----HKI 183
Query: 185 KPLADLDPVVVTFWYRAPELL----LGARHYTKAIDIWAIGCIFAELLTSEPIF--HCRQ 238
           +   +   +  T  + APE++    LG        D+W+IG I   LL+    F    +Q
Sbjct: 184 EAGNEFKNIFGTPEFVAPEIVNYEPLGLE-----ADMWSIGVITYILLSGASPFLGETKQ 238
Query: 239 EDIKTSNPYHHDQLDRIFS 257
           E +   +  ++D  +  FS
Sbjct: 239 ETLTNISAVNYDFDEEYFS 257

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 111/229 (48%), Gaps = 38/229 (16%)
Query: 19  LFDYE-GCKVGRGTYGHVYKARRKDNSDTRDYALK-----QIEGTGLSMSACREIALLRE 72
           L D+E G  +G+G +G+VY AR K +      ALK     Q+E  G+     RE+ +   
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFI--LALKVLFKAQLEKAGVEHQLRREVEIQSH 67
Query: 73  LKHPNVINLISVFLSHNDRKVWLLFDYAE-----HDLWHIIKFHRAAKANXXXXXXXXXX 127
           L+HPN++ L   F  H+  +V+L+ +YA       +L  + KF     A           
Sbjct: 68  LRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA----------- 114
Query: 128 XXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPL 187
             + + ++ + + Y HS  V+HRD+KP N+L +G     G +KIA+ G++        P 
Sbjct: 115 --TYITELANALSYCHSKRVIHRDIKPENLL-LGSA---GELKIANFGWS-----VHAPS 163
Query: 188 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 236
           +    +  T  Y  PE++ G  H  K +D+W++G +  E L  +P F  
Sbjct: 164 SRRTTLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEA 211

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 111/227 (48%), Gaps = 31/227 (13%)
Query: 22  YEGCKV-GRGTYGHVYKARRKDNSDTRDYALK-----QIEGTGLSMSACREIALLRELKH 75
           Y+G +V G+G++G V     KD    ++ A+K     Q++      S  RE+ LL++L H
Sbjct: 28  YKGQRVLGKGSFGEVILC--KDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 76  PNVINLISVFLSHNDRKVWLLFD--YAEHDLW-HIIKFHRAAKANXXXXXXXXXXXXSLL 132
           PN++ L   F    D+  + L    Y   +L+  II   R ++ +             ++
Sbjct: 86  PNIMKLYEFF---EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR----------II 132
Query: 133 YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP 192
            Q+L GI Y+H N ++HRDLKP N+L+  +  +   ++I D G +  F    K    +  
Sbjct: 133 RQVLSGITYMHKNKIVHRDLKPENLLLESKS-KDANIRIIDFGLSTHFEASKK----MKD 187
Query: 193 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
            + T +Y APE+L G   Y +  D+W+ G I   LL+  P F+   E
Sbjct: 188 KIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANE 232

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 104/225 (46%), Gaps = 26/225 (11%)
Query: 21  DYEGC-KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA----CREIALLRELKH 75
           DYE    +G G+YG   K RRK  SD +    K+++   ++ +       E+ LLRELKH
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRK--SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64
Query: 76  PNVINLISVFLSHNDRKVWLLFDYAE-HDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQ 134
           PN++      +   +  ++++ +Y E  DL  +I      K               ++ Q
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI-----TKGTKERQYLDEEFVLRVMTQ 119
Query: 135 ILDGIHYLH-----SNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLAD 189
           +   +   H      + VLHRDLKPAN+ + G    +  VK+ D G AR+ N+     + 
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDG----KQNVKLGDFGLARILNH---DTSF 172
Query: 190 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
               V T +Y +PE  +    Y +  DIW++GC+  EL    P F
Sbjct: 173 AKTFVGTPYYMSPE-QMNRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 104/225 (46%), Gaps = 26/225 (11%)
Query: 21  DYEGC-KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA----CREIALLRELKH 75
           DYE    +G G+YG   K RRK  SD +    K+++   ++ +       E+ LLRELKH
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRK--SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64
Query: 76  PNVINLISVFLSHNDRKVWLLFDYAE-HDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQ 134
           PN++      +   +  ++++ +Y E  DL  +I      K               ++ Q
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI-----TKGTKERQYLDEEFVLRVMTQ 119
Query: 135 ILDGIHYLH-----SNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLAD 189
           +   +   H      + VLHRDLKPAN+ + G    +  VK+ D G AR+ N+     + 
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDG----KQNVKLGDFGLARILNH---DTSF 172
Query: 190 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
               V T +Y +PE  +    Y +  DIW++GC+  EL    P F
Sbjct: 173 AKAFVGTPYYMSPE-QMNRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 111/227 (48%), Gaps = 31/227 (13%)
Query: 22  YEGCKV-GRGTYGHVYKARRKDNSDTRDYALK-----QIEGTGLSMSACREIALLRELKH 75
           Y+G +V G+G++G V     KD    ++ A+K     Q++      S  RE+ LL++L H
Sbjct: 51  YKGQRVLGKGSFGEVILC--KDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 108
Query: 76  PNVINLISVFLSHNDRKVWLLFD--YAEHDLW-HIIKFHRAAKANXXXXXXXXXXXXSLL 132
           PN++ L   F    D+  + L    Y   +L+  II   R ++ +             ++
Sbjct: 109 PNIMKLYEFF---EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR----------II 155
Query: 133 YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP 192
            Q+L GI Y+H N ++HRDLKP N+L+  +  +   ++I D G +  F    K    +  
Sbjct: 156 RQVLSGITYMHKNKIVHRDLKPENLLLESKS-KDANIRIIDFGLSTHFEASKK----MKD 210
Query: 193 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
            + T +Y APE+L G   Y +  D+W+ G I   LL+  P F+   E
Sbjct: 211 KIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANE 255

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 104/225 (46%), Gaps = 26/225 (11%)
Query: 21  DYEGC-KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA----CREIALLRELKH 75
           DYE    +G G+YG   K RRK  SD +    K+++   ++ +       E+ LLRELKH
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRK--SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64
Query: 76  PNVINLISVFLSHNDRKVWLLFDYAE-HDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQ 134
           PN++      +   +  ++++ +Y E  DL  +I      K               ++ Q
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI-----TKGTKERQYLDEEFVLRVMTQ 119
Query: 135 ILDGIHYLH-----SNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLAD 189
           +   +   H      + VLHRDLKPAN+ + G    +  VK+ D G AR+ N+      +
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDG----KQNVKLGDFGLARILNHDEDFAKE 175
Query: 190 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
               V T +Y +PE  +    Y +  DIW++GC+  EL    P F
Sbjct: 176 F---VGTPYYMSPE-QMNRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 111/227 (48%), Gaps = 31/227 (13%)
Query: 22  YEGCKV-GRGTYGHVYKARRKDNSDTRDYALK-----QIEGTGLSMSACREIALLRELKH 75
           Y+G +V G+G++G V     KD    ++ A+K     Q++      S  RE+ LL++L H
Sbjct: 52  YKGQRVLGKGSFGEVILC--KDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 109
Query: 76  PNVINLISVFLSHNDRKVWLLFD--YAEHDLW-HIIKFHRAAKANXXXXXXXXXXXXSLL 132
           PN++ L   F    D+  + L    Y   +L+  II   R ++ +             ++
Sbjct: 110 PNIMKLYEFF---EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR----------II 156
Query: 133 YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP 192
            Q+L GI Y+H N ++HRDLKP N+L+  +  +   ++I D G +  F    K    +  
Sbjct: 157 RQVLSGITYMHKNKIVHRDLKPENLLLESKS-KDANIRIIDFGLSTHFEASKK----MKD 211
Query: 193 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
            + T +Y APE+L G   Y +  D+W+ G I   LL+  P F+   E
Sbjct: 212 KIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANE 256

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 111/227 (48%), Gaps = 31/227 (13%)
Query: 22  YEGCKV-GRGTYGHVYKARRKDNSDTRDYALK-----QIEGTGLSMSACREIALLRELKH 75
           Y+G +V G+G++G V     KD    ++ A+K     Q++      S  RE+ LL++L H
Sbjct: 34  YKGQRVLGKGSFGEVILC--KDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 91
Query: 76  PNVINLISVFLSHNDRKVWLLFD--YAEHDLW-HIIKFHRAAKANXXXXXXXXXXXXSLL 132
           PN++ L   F    D+  + L    Y   +L+  II   R ++ +             ++
Sbjct: 92  PNIMKLYEFF---EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA----------RII 138
Query: 133 YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP 192
            Q+L GI Y+H N ++HRDLKP N+L+  +  +   ++I D G +  F    K    +  
Sbjct: 139 RQVLSGITYMHKNKIVHRDLKPENLLLESKS-KDANIRIIDFGLSTHFEASKK----MKD 193
Query: 193 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
            + T +Y APE+L G   Y +  D+W+ G I   LL+  P F+   E
Sbjct: 194 KIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANE 238

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 109/231 (47%), Gaps = 39/231 (16%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALK-----QIEGTGLSMSACREIALLRELKHPNV 78
           G  +G+G +G+VY AR + +      ALK     Q+E  G+     RE+ +   L+HPN+
Sbjct: 17  GRPLGKGKFGNVYLARERQSKFI--LALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNI 74
Query: 79  INLISVFLSHNDRKVWLLFDYAE-----HDLWHIIKFHRAAKANXXXXXXXXXXXXSLLY 133
           + L   F  H+  +V+L+ +YA       +L  + +F     A             + + 
Sbjct: 75  LRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSRFDEQRTA-------------TYIT 119
Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           ++ + + Y HS  V+HRD+KP N+L+       G +KIAD G++        P +    +
Sbjct: 120 ELANALSYCHSKRVIHRDIKPENLLLGSN----GELKIADFGWS-----VHAPSSRRTTL 170
Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF--HCRQEDIK 242
             T  Y  PE++ G  H  K +D+W++G +  E L   P F  H  QE  +
Sbjct: 171 CGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGMPPFEAHTYQETYR 220

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 109/243 (44%), Gaps = 48/243 (19%)
Query: 10  SNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIAL 69
            + R  + D F+ E  ++GRG    VY+ ++K     + YALK ++ T        EI +
Sbjct: 45  GSNRDALSDFFEVES-ELGRGATSIVYRCKQKGTQ--KPYALKVLKKTVDKKIVRTEIGV 101
Query: 70  LRELKHPNVINLISVFLSHNDRKVWL-------LFD-------YAEHDLWHIIKFHRAAK 115
           L  L HPN+I L  +F +  +  + L       LFD       Y+E D    +K      
Sbjct: 102 LLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVK------ 155
Query: 116 ANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMG 175
                             QIL+ + YLH N ++HRDLKP N+L      +   +KIAD G
Sbjct: 156 ------------------QILEAVAYLHENGIVHRDLKPENLLYATPAPD-APLKIADFG 196
Query: 176 FARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIF 234
            +++  + +     +  V  T  Y APE+L G   Y   +D+W++G I   LL   EP +
Sbjct: 197 LSKIVEHQVL----MKTVCGTPGYCAPEILRGC-AYGPEVDMWSVGIITYILLCGFEPFY 251
Query: 235 HCR 237
             R
Sbjct: 252 DER 254

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 102/230 (44%), Gaps = 46/230 (20%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMS---------------ACREIALL 70
           K+G G YG V   + K+    +  A+K I+ +                       EI+LL
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEK--AIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100
Query: 71  RELKHPNVINLISVFLSHNDRKVWLLFD--YAEHDLWHII----KFHRAAKANXXXXXXX 124
           + L HPN+I L  VF    D+K + L    Y   +L+  I    KF     AN       
Sbjct: 101 KSLDHPNIIKLFDVF---EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAAN------- 150
Query: 125 XXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPL 184
                 ++ QIL GI YLH + ++HRD+KP NIL+  +      +KI D G +  F+   
Sbjct: 151 ------IMKQILSGICYLHKHNIVHRDIKPENILLENKN-SLLNIKIVDFGLSSFFSKDY 203
Query: 185 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           K    L   + T +Y APE+L   + Y +  D+W+ G I   LL   P F
Sbjct: 204 K----LRDRLGTAYYIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPPF 247

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 107/236 (45%), Gaps = 45/236 (19%)
Query: 21  DYEGCKV-GRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC-REIALLRELKHPNV 78
           D+E   V G+G +G V KAR  +  D+R YA+K+I  T   +S    E+ LL  L H  V
Sbjct: 7   DFEEIAVLGQGAFGQVVKAR--NALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 79  INLISVFLSHND-----------RKVWLLFDYAE----HDLWHIIKFHRAAKANXXXXXX 123
           +   + +L   +             +++  +Y E    +DL H    ++           
Sbjct: 65  VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQ---------- 114
Query: 124 XXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNP 183
                  L  QIL+ + Y+HS  ++HRDLKP NI +     E   VKI D G A+  +  
Sbjct: 115 -RDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFID----ESRNVKIGDFGLAKNVHRS 169
Query: 184 LKPLA-----------DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 228
           L  L            +L   + T  Y A E+L G  HY + ID++++G IF E++
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 107/236 (45%), Gaps = 45/236 (19%)
Query: 21  DYEGCKV-GRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC-REIALLRELKHPNV 78
           D+E   V G+G +G V KAR  +  D+R YA+K+I  T   +S    E+ LL  L H  V
Sbjct: 7   DFEEIAVLGQGAFGQVVKAR--NALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 79  INLISVFLSHND-----------RKVWLLFDYAE----HDLWHIIKFHRAAKANXXXXXX 123
           +   + +L   +             +++  +Y E    +DL H    ++           
Sbjct: 65  VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDE------- 117
Query: 124 XXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNP 183
                  L  QIL+ + Y+HS  ++HRDLKP NI +     E   VKI D G A+  +  
Sbjct: 118 ----YWRLFRQILEALSYIHSQGIIHRDLKPMNIFID----ESRNVKIGDFGLAKNVHRS 169
Query: 184 LKPLA-----------DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 228
           L  L            +L   + T  Y A E+L G  HY + ID++++G IF E++
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 24/209 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMS----ACREIALLRELKHPNVINL 81
           K+G G++G       K   D R Y +K+I  + +S      + RE+A+L  +KHPN++  
Sbjct: 31  KIGEGSFGKAILV--KSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQY 88
Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
              F    +  ++++ DY E  DL+  I   +                     QI   + 
Sbjct: 89  RESF--EENGSLYIVMDYCEGGDLFKRINAQKGV-------LFQEDQILDWFVQICLALK 139
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           ++H   +LHRD+K  NI +  +G     V++ D G AR+ N+ ++ LA     + T +Y 
Sbjct: 140 HVHDRKILHRDIKSQNIFLTKDGT----VQLGDFGIARVLNSTVE-LAR--ACIGTPYYL 192
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT 229
           +PE+    + Y    DIWA+GC+  EL T
Sbjct: 193 SPEICEN-KPYNNKSDIWALGCVLYELCT 220

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 26/213 (12%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC----REIALLRELKHPNVINLI 82
           +G+G +  V  AR       R+ A+K I+ T L+ ++     RE+ +++ L HPN++ L 
Sbjct: 23  IGKGNFAKVKLARHVLTG--REVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 83  SVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
            V     ++ ++L+ +YA   +++  +  H   K              +   QI+  + Y
Sbjct: 81  EVI--ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEAR---------AKFRQIVSAVQY 129
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            H  +++HRDLK  N+L+ G+      +KIAD GF+  F    K    LD    +  Y A
Sbjct: 130 CHQKYIVHRDLKAENLLLDGD----MNIKIADFGFSNEFTVGNK----LDTFCGSPPYAA 181
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           PEL  G ++    +D+W++G I   L++    F
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 214

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 103/214 (48%), Gaps = 30/214 (14%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-----CREIALLRELKHPNVIN 80
           ++G G++G VY AR   NS+    A+K++  +G   +       +E+  L++L+HPN I 
Sbjct: 61  EIGHGSFGAVYFARDVRNSEV--VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 118
Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
               +L   +   WL+ +Y       +++ H+                 ++ +  L G+ 
Sbjct: 119 YRGCYL--REHTAWLVMEYCLGSASDLLEVHKKP--------LQEVEIAAVTHGALQGLA 168
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YLHS+ ++HRD+K  NIL+     E G VK+ D G A +       +A  +  V T ++ 
Sbjct: 169 YLHSHNMIHRDVKAGNILLS----EPGLVKLGDFGSASI-------MAPANXFVGTPYWM 217
Query: 201 APELLLGA--RHYTKAIDIWAIGCIFAELLTSEP 232
           APE++L      Y   +D+W++G    EL   +P
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELAERKP 251

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 83/274 (30%), Positives = 130/274 (47%), Gaps = 43/274 (15%)
Query: 16  VEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-------GLSMSAC-REI 67
           V+D +D  G ++G G +  V K R K  S    YA K I+         G+S     RE+
Sbjct: 9   VDDYYD-TGEELGSGQFAVVKKCREK--STGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 68  ALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXX 127
           ++L+E++HPNVI L  V+ +  D  + +L   A  +L+  +    A K +          
Sbjct: 66  SILKEIQHPNVITLHEVYENKTDV-ILILELVAGGELFDFL----AEKESLTEEEAT--- 117
Query: 128 XXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL--FNNPLK 185
               L QIL+G++YLHS  + H DLKP NI+++   + + R+KI D G A    F N  K
Sbjct: 118 --EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 186 PLADLDPVVVTFWYRAPELL----LGARHYTKAIDIWAIGCIFAELLTSEPIF--HCRQE 239
                  +  T  + APE++    LG        D+W+IG I   LL+    F    +QE
Sbjct: 176 ------NIFGTPEFVAPEIVNYEPLGLEA-----DMWSIGVITYILLSGASPFLGDTKQE 224
Query: 240 DIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM 273
            +   +  +++  D  FS     L KD+  IR++
Sbjct: 225 TLANVSAVNYEFEDEYFSNTS-ALAKDF--IRRL 255

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 83/274 (30%), Positives = 130/274 (47%), Gaps = 43/274 (15%)
Query: 16  VEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-------GLSMSAC-REI 67
           V+D +D  G ++G G +  V K R K  S    YA K I+         G+S     RE+
Sbjct: 9   VDDYYD-TGEELGSGVFAVVKKCREK--STGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 68  ALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXX 127
           ++L+E++HPNVI L  V+ +  D  + +L   A  +L+  +    A K +          
Sbjct: 66  SILKEIQHPNVITLHEVYENKTDV-ILILELVAGGELFDFL----AEKESLTEEEAT--- 117
Query: 128 XXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL--FNNPLK 185
               L QIL+G++YLHS  + H DLKP NI+++   + + R+KI D G A    F N  K
Sbjct: 118 --EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 186 PLADLDPVVVTFWYRAPELL----LGARHYTKAIDIWAIGCIFAELLTSEPIF--HCRQE 239
                  +  T  + APE++    LG        D+W+IG I   LL+    F    +QE
Sbjct: 176 ------NIFGTPEFVAPEIVNYEPLGLE-----ADMWSIGVITYILLSGASPFLGDTKQE 224
Query: 240 DIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM 273
            +   +  +++  D  FS     L KD+  IR++
Sbjct: 225 TLANVSAVNYEFEDEYFSNTS-ALAKDF--IRRL 255

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 83/274 (30%), Positives = 130/274 (47%), Gaps = 43/274 (15%)
Query: 16  VEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-------GLSMSAC-REI 67
           V+D +D  G ++G G +  V K R K  S    YA K I+         G+S     RE+
Sbjct: 9   VDDYYD-TGEELGSGQFAVVKKCREK--STGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 68  ALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXX 127
           ++L+E++HPNVI L  V+ +  D  + +L   A  +L+  +    A K +          
Sbjct: 66  SILKEIQHPNVITLHEVYENKTDV-ILILELVAGGELFDFL----AEKESLTEEEAT--- 117
Query: 128 XXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL--FNNPLK 185
               L QIL+G++YLHS  + H DLKP NI+++   + + R+KI D G A    F N  K
Sbjct: 118 --EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 186 PLADLDPVVVTFWYRAPELL----LGARHYTKAIDIWAIGCIFAELLTSEPIF--HCRQE 239
                  +  T  + APE++    LG        D+W+IG I   LL+    F    +QE
Sbjct: 176 ------NIFGTPEFVAPEIVNYEPLGLEA-----DMWSIGVITYILLSGASPFLGDTKQE 224
Query: 240 DIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM 273
            +   +  +++  D  FS     L KD+  IR++
Sbjct: 225 TLANVSAVNYEFEDEYFSNTS-ALAKDF--IRRL 255

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 29/227 (12%)
Query: 17  EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHP 76
           ED ++  G ++G G +G VYKA+ K+ S      +   +          EI +L    HP
Sbjct: 36  EDFWEIIG-ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHP 94
Query: 77  NVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLY--- 133
           N++ L+  F             Y E++LW +I+F      +            S +    
Sbjct: 95  NIVKLLDAF-------------YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVC 141
Query: 134 -QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP 192
            Q LD ++YLH N ++HRDLK  NIL   +    G +K+AD G +       + +   D 
Sbjct: 142 KQTLDALNYLHDNKIIHRDLKAGNILFTLD----GDIKLADFGVSA---KNTRTIQRRDS 194
Query: 193 VVVTFWYRAPELLLGA----RHYTKAIDIWAIGCIFAELLTSEPIFH 235
            + T ++ APE+++      R Y    D+W++G    E+   EP  H
Sbjct: 195 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH 241

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 83/274 (30%), Positives = 130/274 (47%), Gaps = 43/274 (15%)
Query: 16  VEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-------GLSMSAC-REI 67
           V+D +D  G ++G G +  V K R K  S    YA K I+         G+S     RE+
Sbjct: 9   VDDYYD-TGEELGSGQFAVVKKCREK--STGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 68  ALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXX 127
           ++L+E++HPNVI L  V+ +  D  + +L   A  +L+  +    A K +          
Sbjct: 66  SILKEIQHPNVITLHEVYENKTDV-ILILELVAGGELFDFL----AEKESLTEEEAT--- 117
Query: 128 XXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL--FNNPLK 185
               L QIL+G++YLHS  + H DLKP NI+++   + + R+KI D G A    F N  K
Sbjct: 118 --EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 186 PLADLDPVVVTFWYRAPELL----LGARHYTKAIDIWAIGCIFAELLTSEPIF--HCRQE 239
                  +  T  + APE++    LG        D+W+IG I   LL+    F    +QE
Sbjct: 176 ------NIFGTPEFVAPEIVNYEPLGLEA-----DMWSIGVITYILLSGASPFLGDTKQE 224
Query: 240 DIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM 273
            +   +  +++  D  FS     L KD+  IR++
Sbjct: 225 TLANVSAVNYEFEDEYFSNTS-ALAKDF--IRRL 255

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 103/214 (48%), Gaps = 30/214 (14%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-----CREIALLRELKHPNVIN 80
           ++G G++G VY AR   NS+    A+K++  +G   +       +E+  L++L+HPN I 
Sbjct: 22  EIGHGSFGAVYFARDVRNSEV--VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
               +L   +   WL+ +Y       +++ H+                 ++ +  L G+ 
Sbjct: 80  YRGCYL--REHTAWLVMEYCLGSASDLLEVHKKP--------LQEVEIAAVTHGALQGLA 129
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YLHS+ ++HRD+K  NIL+     E G VK+ D G A +       +A  +  V T ++ 
Sbjct: 130 YLHSHNMIHRDVKAGNILLS----EPGLVKLGDFGSASI-------MAPANXFVGTPYWM 178
Query: 201 APELLLGA--RHYTKAIDIWAIGCIFAELLTSEP 232
           APE++L      Y   +D+W++G    EL   +P
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKP 212

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 83/274 (30%), Positives = 130/274 (47%), Gaps = 43/274 (15%)
Query: 16  VEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-------GLSMSAC-REI 67
           V+D +D  G ++G G +  V K R K  S    YA K I+         G+S     RE+
Sbjct: 9   VDDYYD-TGEELGSGQFAVVKKCREK--STGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 68  ALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXX 127
           ++L+E++HPNVI L  V+ +  D  + +L   A  +L+  +    A K +          
Sbjct: 66  SILKEIQHPNVITLHEVYENKTDV-ILILELVAGGELFDFL----AEKESLTEEEAT--- 117
Query: 128 XXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL--FNNPLK 185
               L QIL+G++YLHS  + H DLKP NI+++   + + R+KI D G A    F N  K
Sbjct: 118 --EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 186 PLADLDPVVVTFWYRAPELL----LGARHYTKAIDIWAIGCIFAELLTSEPIF--HCRQE 239
                  +  T  + APE++    LG        D+W+IG I   LL+    F    +QE
Sbjct: 176 ------NIFGTPEFVAPEIVNYEPLGLEA-----DMWSIGVITYILLSGASPFLGDTKQE 224
Query: 240 DIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM 273
            +   +  +++  D  FS     L KD+  IR++
Sbjct: 225 TLANVSAVNYEFEDEYFSNTS-ALAKDF--IRRL 255

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 83/274 (30%), Positives = 130/274 (47%), Gaps = 43/274 (15%)
Query: 16  VEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-------GLSMSAC-REI 67
           V+D +D  G ++G G +  V K R K  S    YA K I+         G+S     RE+
Sbjct: 9   VDDYYD-TGEELGSGQFAVVKKCREK--STGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 68  ALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXX 127
           ++L+E++HPNVI L  V+ +  D  + +L   A  +L+  +    A K +          
Sbjct: 66  SILKEIQHPNVITLHEVYENKTD-VILILELVAGGELFDFL----AEKESLTEEEAT--- 117
Query: 128 XXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL--FNNPLK 185
               L QIL+G++YLHS  + H DLKP NI+++   + + R+KI D G A    F N  K
Sbjct: 118 --EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 186 PLADLDPVVVTFWYRAPELL----LGARHYTKAIDIWAIGCIFAELLTSEPIF--HCRQE 239
                  +  T  + APE++    LG        D+W+IG I   LL+    F    +QE
Sbjct: 176 ------NIFGTPEFVAPEIVNYEPLGLEA-----DMWSIGVITYILLSGASPFLGDTKQE 224
Query: 240 DIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM 273
            +   +  +++  D  FS     L KD+  IR++
Sbjct: 225 TLANVSAVNYEFEDEYFSNTS-ALAKDF--IRRL 255

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 83/274 (30%), Positives = 130/274 (47%), Gaps = 43/274 (15%)
Query: 16  VEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-------GLSMSAC-REI 67
           V+D +D  G ++G G +  V K R K  S    YA K I+         G+S     RE+
Sbjct: 9   VDDYYD-TGEELGSGQFAVVKKCREK--STGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 68  ALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXX 127
           ++L+E++HPNVI L  V+ +  D  + +L   A  +L+  +    A K +          
Sbjct: 66  SILKEIQHPNVITLHEVYENKTDV-ILILELVAGGELFDFL----AEKESLTEEEAT--- 117
Query: 128 XXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL--FNNPLK 185
               L QIL+G++YLHS  + H DLKP NI+++   + + R+KI D G A    F N  K
Sbjct: 118 --EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 186 PLADLDPVVVTFWYRAPELL----LGARHYTKAIDIWAIGCIFAELLTSEPIF--HCRQE 239
                  +  T  + APE++    LG        D+W+IG I   LL+    F    +QE
Sbjct: 176 ------NIFGTPEFVAPEIVNYEPLGLE-----ADMWSIGVITYILLSGASPFLGDTKQE 224
Query: 240 DIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM 273
            +   +  +++  D  FS     L KD+  IR++
Sbjct: 225 TLANVSAVNYEFEDEYFSNTS-ALAKDF--IRRL 255

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 83/274 (30%), Positives = 130/274 (47%), Gaps = 43/274 (15%)
Query: 16  VEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-------GLSMSAC-REI 67
           V+D +D  G ++G G +  V K R K  S    YA K I+         G+S     RE+
Sbjct: 8   VDDYYD-TGEELGSGQFAVVKKCREK--STGLQYAAKFIKKRRTKSSRRGVSREDIEREV 64
Query: 68  ALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXX 127
           ++L+E++HPNVI L  V+ +  D  + +L   A  +L+  +    A K +          
Sbjct: 65  SILKEIQHPNVITLHEVYENKTDV-ILILELVAGGELFDFL----AEKESLTEEEAT--- 116
Query: 128 XXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL--FNNPLK 185
               L QIL+G++YLHS  + H DLKP NI+++   + + R+KI D G A    F N  K
Sbjct: 117 --EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 174
Query: 186 PLADLDPVVVTFWYRAPELL----LGARHYTKAIDIWAIGCIFAELLTSEPIF--HCRQE 239
                  +  T  + APE++    LG        D+W+IG I   LL+    F    +QE
Sbjct: 175 ------NIFGTPEFVAPEIVNYEPLGLE-----ADMWSIGVITYILLSGASPFLGDTKQE 223
Query: 240 DIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM 273
            +   +  +++  D  FS     L KD+  IR++
Sbjct: 224 TLANVSAVNYEFEDEYFSNTS-ALAKDF--IRRL 254

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 107/225 (47%), Gaps = 26/225 (11%)
Query: 16  VEDLFDYEGCKVGRGTYGHVYKARRKDNSD---TRDYALKQIEGTGLSMSACREIALLRE 72
           + D++D+    +G G +  V  A  K        +  A K +EG   SM    EIA+L +
Sbjct: 16  IRDIYDFRDV-LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSME--NEIAVLHK 72
Query: 73  LKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIK--FHRAAKANXXXXXXXXXXXXS 130
           +KHPN++ L  ++ S     + +           I++  F+    A+             
Sbjct: 73  IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS------------R 120
Query: 131 LLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADL 190
           L++Q+LD + YLH   ++HRDLKP N+L      E  ++ I+D G +++ +    P + L
Sbjct: 121 LIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLD-EDSKIMISDFGLSKMED----PGSVL 175
Query: 191 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
                T  Y APE +L  + Y+KA+D W+IG I   LL   P F+
Sbjct: 176 STACGTPGYVAPE-VLAQKPYSKAVDCWSIGVIAYILLCGYPPFY 219

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 83/274 (30%), Positives = 130/274 (47%), Gaps = 43/274 (15%)
Query: 16  VEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-------GLSMSAC-REI 67
           V+D +D  G ++G G +  V K R K  S    YA K I+         G+S     RE+
Sbjct: 9   VDDYYD-TGEELGSGKFAVVKKCREK--STGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 68  ALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXX 127
           ++L+E++HPNVI L  V+ +  D  + +L   A  +L+  +    A K +          
Sbjct: 66  SILKEIQHPNVITLHEVYENKTDV-ILILELVAGGELFDFL----AEKESLTEEEAT--- 117
Query: 128 XXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL--FNNPLK 185
               L QIL+G++YLHS  + H DLKP NI+++   + + R+KI D G A    F N  K
Sbjct: 118 --EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 186 PLADLDPVVVTFWYRAPELL----LGARHYTKAIDIWAIGCIFAELLTSEPIF--HCRQE 239
                  +  T  + APE++    LG        D+W+IG I   LL+    F    +QE
Sbjct: 176 ------NIFGTPEFVAPEIVNYEPLGLE-----ADMWSIGVITYILLSGASPFLGDTKQE 224
Query: 240 DIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM 273
            +   +  +++  D  FS     L KD+  IR++
Sbjct: 225 TLANVSAVNYEFEDEYFSNTS-ALAKDF--IRRL 255

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 83/274 (30%), Positives = 130/274 (47%), Gaps = 43/274 (15%)
Query: 16  VEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-------GLSMSAC-REI 67
           V+D +D  G ++G G +  V K R K  S    YA K I+         G+S     RE+
Sbjct: 8   VDDYYD-TGEELGSGQFAVVKKCREK--STGLQYAAKFIKKRRTKSSRRGVSREDIEREV 64
Query: 68  ALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXX 127
           ++L+E++HPNVI L  V+ +  D  + +L   A  +L+  +    A K +          
Sbjct: 65  SILKEIQHPNVITLHEVYENKTDV-ILILELVAGGELFDFL----AEKESLTEEEAT--- 116
Query: 128 XXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL--FNNPLK 185
               L QIL+G++YLHS  + H DLKP NI+++   + + R+KI D G A    F N  K
Sbjct: 117 --EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 174
Query: 186 PLADLDPVVVTFWYRAPELL----LGARHYTKAIDIWAIGCIFAELLTSEPIF--HCRQE 239
                  +  T  + APE++    LG        D+W+IG I   LL+    F    +QE
Sbjct: 175 ------NIFGTPEFVAPEIVNYEPLGLE-----ADMWSIGVITYILLSGASPFLGDTKQE 223
Query: 240 DIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM 273
            +   +  +++  D  FS     L KD+  IR++
Sbjct: 224 TLANVSAVNYEFEDEYFSNTS-ALAKDF--IRRL 254

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 83/274 (30%), Positives = 130/274 (47%), Gaps = 43/274 (15%)
Query: 16  VEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-------GLSMSAC-REI 67
           V+D +D  G ++G G +  V K R K  S    YA K I+         G+S     RE+
Sbjct: 9   VDDYYD-TGEELGSGQFAVVKKCREK--STGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 68  ALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXX 127
           ++L+E++HPNVI L  V+ +  D  + +L   A  +L+  +    A K +          
Sbjct: 66  SILKEIQHPNVITLHEVYENKTD-VILILELVAGGELFDFL----AEKESLTEEEAT--- 117
Query: 128 XXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL--FNNPLK 185
               L QIL+G++YLHS  + H DLKP NI+++   + + R+KI D G A    F N  K
Sbjct: 118 --EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 186 PLADLDPVVVTFWYRAPELL----LGARHYTKAIDIWAIGCIFAELLTSEPIF--HCRQE 239
                  +  T  + APE++    LG        D+W+IG I   LL+    F    +QE
Sbjct: 176 ------NIFGTPAFVAPEIVNYEPLGLEA-----DMWSIGVITYILLSGASPFLGDTKQE 224
Query: 240 DIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM 273
            +   +  +++  D  FS     L KD+  IR++
Sbjct: 225 TLANVSAVNYEFEDEYFSNTS-ALAKDF--IRRL 255

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 29/227 (12%)
Query: 17  EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHP 76
           ED ++  G ++G G +G VYKA+ K+ S      +   +          EI +L    HP
Sbjct: 36  EDFWEIIG-ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHP 94
Query: 77  NVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLY--- 133
           N++ L+  F             Y E++LW +I+F      +            S +    
Sbjct: 95  NIVKLLDAF-------------YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVC 141
Query: 134 -QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP 192
            Q LD ++YLH N ++HRDLK  NIL   +    G +K+AD G +       + +   D 
Sbjct: 142 KQTLDALNYLHDNKIIHRDLKAGNILFTLD----GDIKLADFGVSA---KNTRXIQRRDS 194
Query: 193 VVVTFWYRAPELLLGA----RHYTKAIDIWAIGCIFAELLTSEPIFH 235
            + T ++ APE+++      R Y    D+W++G    E+   EP  H
Sbjct: 195 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH 241

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 83/274 (30%), Positives = 130/274 (47%), Gaps = 43/274 (15%)
Query: 16  VEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-------GLSMSAC-REI 67
           V+D +D  G ++G G +  V K R K  S    YA K I+         G+S     RE+
Sbjct: 9   VDDYYD-TGEELGSGQFAVVKKCREK--STGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 68  ALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXX 127
           ++L+E++HPNVI L  V+ +  D  + +L   A  +L+  +    A K +          
Sbjct: 66  SILKEIQHPNVITLHEVYENKTDV-ILILELVAGGELFDFL----AEKESLTEEEAT--- 117
Query: 128 XXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL--FNNPLK 185
               L QIL+G++YLHS  + H DLKP NI+++   + + R+KI D G A    F N  K
Sbjct: 118 --EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 186 PLADLDPVVVTFWYRAPELL----LGARHYTKAIDIWAIGCIFAELLTSEPIF--HCRQE 239
                  +  T  + APE++    LG        D+W+IG I   LL+    F    +QE
Sbjct: 176 ------NIFGTPEFVAPEIVNYEPLGLEA-----DMWSIGVITYILLSGASPFLGDTKQE 224
Query: 240 DIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM 273
            +   +  +++  D  FS     L KD+  IR++
Sbjct: 225 TLANVSAVNYEFEDEYFSNTS-ALAKDF--IRRL 255

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 83/274 (30%), Positives = 130/274 (47%), Gaps = 43/274 (15%)
Query: 16  VEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-------GLSMSAC-REI 67
           V+D +D  G ++G G +  V K R K  S    YA K I+         G+S     RE+
Sbjct: 9   VDDYYDT-GEELGSGQFAVVKKCREK--STGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 68  ALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXX 127
           ++L+E++HPNVI L  V+ +  D  + +L   A  +L+  +    A K +          
Sbjct: 66  SILKEIQHPNVITLHEVYENKTDV-ILILELVAGGELFDFL----AEKESLTEEEAT--- 117
Query: 128 XXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL--FNNPLK 185
               L QIL+G++YLHS  + H DLKP NI+++   + + R+KI D G A    F N  K
Sbjct: 118 --EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 186 PLADLDPVVVTFWYRAPELL----LGARHYTKAIDIWAIGCIFAELLTSEPIF--HCRQE 239
                  +  T  + APE++    LG        D+W+IG I   LL+    F    +QE
Sbjct: 176 ------NIFGTPEFVAPEIVNYEPLGLE-----ADMWSIGVITYILLSGASPFLGDTKQE 224
Query: 240 DIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM 273
            +   +  +++  D  FS     L KD+  IR++
Sbjct: 225 TLANVSAVNYEFEDEYFSNTS-ALAKDF--IRRL 255

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 29/227 (12%)
Query: 17  EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHP 76
           ED ++  G ++G G +G VYKA+ K+ S      +   +          EI +L    HP
Sbjct: 36  EDFWEIIG-ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHP 94
Query: 77  NVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLY--- 133
           N++ L+  F             Y E++LW +I+F      +            S +    
Sbjct: 95  NIVKLLDAF-------------YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVC 141
Query: 134 -QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP 192
            Q LD ++YLH N ++HRDLK  NIL   +    G +K+AD G +       + +   D 
Sbjct: 142 KQTLDALNYLHDNKIIHRDLKAGNILFTLD----GDIKLADFGVSA---KNTRXIQRRDX 194
Query: 193 VVVTFWYRAPELLLGA----RHYTKAIDIWAIGCIFAELLTSEPIFH 235
            + T ++ APE+++      R Y    D+W++G    E+   EP  H
Sbjct: 195 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH 241

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 108/227 (47%), Gaps = 31/227 (13%)
Query: 22  YEGCKV-GRGTYGHVYKARRKDNSDTRDYALK-----QIEGTGLSMSACREIALLRELKH 75
           Y+G +V G+G++G V     KD    ++ A+K     Q++      S  RE+ LL++L H
Sbjct: 28  YKGQRVLGKGSFGEVILC--KDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 76  PNVINLISVFLSHNDRKVWLLFD--YAEHDLW-HIIKFHRAAKANXXXXXXXXXXXXSLL 132
           PN+  L   F    D+  + L    Y   +L+  II   R ++ +             ++
Sbjct: 86  PNIXKLYEFF---EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR----------II 132
Query: 133 YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP 192
            Q+L GI Y H N ++HRDLKP N+L+  +  +   ++I D G +  F    K       
Sbjct: 133 RQVLSGITYXHKNKIVHRDLKPENLLLESKS-KDANIRIIDFGLSTHFEASKK----XKD 187
Query: 193 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
            + T +Y APE+L G   Y +  D+W+ G I   LL+  P F+   E
Sbjct: 188 KIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANE 232

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 80.5 bits (197), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 131/276 (47%), Gaps = 39/276 (14%)
Query: 12  ERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYA---LKQIEGTGLSMSACRE-- 66
           ++ KVED +D  G ++G G +  V K R K  S   +YA   +K+ +        CRE  
Sbjct: 6   KQQKVEDFYDI-GEELGSGQFAIVKKCREK--STGLEYAAKFIKKRQSRASRRGVCREEI 62
Query: 67  ---IALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXX 123
              +++LR++ HPN+I L  V+ +  D  V +L   +  +L+  +    A K +      
Sbjct: 63  EREVSILRQVLHPNIITLHDVYENRTD-VVLILELVSGGELFDFL----AQKESLSEEEA 117
Query: 124 XXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNP 183
                 S + QILDG++YLH+  + H DLKP NI+++ + I    +K+ D G A    + 
Sbjct: 118 T-----SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA----HE 168
Query: 184 LKPLADLDPVVVTFWYRAPELL----LGARHYTKAIDIWAIGCIFAELLTSEPIF--HCR 237
           ++   +   +  T  + APE++    LG        D+W+IG I   LL+    F    +
Sbjct: 169 IEDGVEFKNIFGTPEFVAPEIVNYEPLGLE-----ADMWSIGVITYILLSGASPFLGDTK 223
Query: 238 QEDIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM 273
           QE +       +D  +  FS     L KD+  IRK+
Sbjct: 224 QETLANITAVSYDFDEEFFSQTS-ELAKDF--IRKL 256

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 110/238 (46%), Gaps = 34/238 (14%)
Query: 26  KVGRGTYGHVYKARR-KDNSDTRDYALKQIEGTGLSMSACREIALLRELKH-PNVINLIS 83
           K+GRG Y  V++A    +N       LK ++   +     REI +L  L+  PN+I L  
Sbjct: 44  KLGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIK----REIKILENLRGGPNIITLAD 99
Query: 84  VFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLH 143
           +      R   L+F++  +                             +Y+IL  + Y H
Sbjct: 100 IVKDPVSRTPALVFEHVNN-----------TDFKQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 144 SNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPE 203
           S  ++HRD+KP N+++     E  ++++ D G A  ++    P  + +  V + +++ PE
Sbjct: 149 SMGIMHRDVKPHNVMI---DHEHRKLRLIDWGLAEFYH----PGQEYNVRVASRYFKGPE 201
Query: 204 LLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           LL+  + Y  ++D+W++GC+ A ++   EP FH            ++DQL RI  V+G
Sbjct: 202 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD---------NYDQLVRIAKVLG 250

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 107/225 (47%), Gaps = 26/225 (11%)
Query: 16  VEDLFDYEGCKVGRGTYGHVYKARRKDNSD---TRDYALKQIEGTGLSMSACREIALLRE 72
           + D++D+    +G G +  V  A  K        +  A + +EG   SM    EIA+L +
Sbjct: 16  IRDIYDFRDV-LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSME--NEIAVLHK 72
Query: 73  LKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIK--FHRAAKANXXXXXXXXXXXXS 130
           +KHPN++ L  ++ S     + +           I++  F+    A+             
Sbjct: 73  IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS------------R 120
Query: 131 LLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADL 190
           L++Q+LD + YLH   ++HRDLKP N+L      E  ++ I+D G +++ +    P + L
Sbjct: 121 LIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLD-EDSKIMISDFGLSKMED----PGSVL 175
Query: 191 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
                T  Y APE +L  + Y+KA+D W+IG I   LL   P F+
Sbjct: 176 STACGTPGYVAPE-VLAQKPYSKAVDCWSIGVIAYILLCGYPPFY 219

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 84/275 (30%), Positives = 131/275 (47%), Gaps = 45/275 (16%)
Query: 16  VEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-------GLSMSAC-REI 67
           V+D +D  G ++G G +  V K R K  S    YA K I+         G+S     RE+
Sbjct: 9   VDDYYD-TGEELGSGQFAVVKKCREK--STGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 68  ALLRELKHPNVINLISVFLSHNDRKVWLLFD-YAEHDLWHIIKFHRAAKANXXXXXXXXX 126
           ++L+E++HPNVI L  V+ +  D  V L+ +  A  +L+  +    A K +         
Sbjct: 66  SILKEIQHPNVITLHEVYENKTD--VILIGELVAGGELFDFL----AEKESLTEEEAT-- 117
Query: 127 XXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL--FNNPL 184
                L QIL+G++YLHS  + H DLKP NI+++   + + R+KI D G A    F N  
Sbjct: 118 ---EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 185 KPLADLDPVVVTFWYRAPELL----LGARHYTKAIDIWAIGCIFAELLTSEPIF--HCRQ 238
           K       +  T  + APE++    LG        D+W+IG I   LL+    F    +Q
Sbjct: 175 K------NIFGTPEFVAPEIVNYEPLGLE-----ADMWSIGVITYILLSGASPFLGDTKQ 223
Query: 239 EDIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM 273
           E +   +  +++  D  FS     L KD+  IR++
Sbjct: 224 ETLANVSAVNYEFEDEYFSNTS-ALAKDF--IRRL 255

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 107/225 (47%), Gaps = 26/225 (11%)
Query: 16  VEDLFDYEGCKVGRGTYGHVYKARRKDNSD---TRDYALKQIEGTGLSMSACREIALLRE 72
           + D++D+    +G G +  V  A  K        +  A + +EG   SM    EIA+L +
Sbjct: 16  IRDIYDFRDV-LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSME--NEIAVLHK 72
Query: 73  LKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIK--FHRAAKANXXXXXXXXXXXXS 130
           +KHPN++ L  ++ S     + +           I++  F+    A+             
Sbjct: 73  IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS------------R 120
Query: 131 LLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADL 190
           L++Q+LD + YLH   ++HRDLKP N+L      E  ++ I+D G +++ +    P + L
Sbjct: 121 LIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLD-EDSKIMISDFGLSKMED----PGSVL 175
Query: 191 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
                T  Y APE +L  + Y+KA+D W+IG I   LL   P F+
Sbjct: 176 STACGTPGYVAPE-VLAQKPYSKAVDCWSIGVIAYILLCGYPPFY 219

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 107/225 (47%), Gaps = 26/225 (11%)
Query: 16  VEDLFDYEGCKVGRGTYGHVYKARRKDNSD---TRDYALKQIEGTGLSMSACREIALLRE 72
           + D++D+    +G G +  V  A  K        +  A + +EG   SM    EIA+L +
Sbjct: 16  IRDIYDFRDV-LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSME--NEIAVLHK 72
Query: 73  LKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIK--FHRAAKANXXXXXXXXXXXXS 130
           +KHPN++ L  ++ S     + +           I++  F+    A+             
Sbjct: 73  IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS------------R 120
Query: 131 LLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADL 190
           L++Q+LD + YLH   ++HRDLKP N+L      E  ++ I+D G +++ +    P + L
Sbjct: 121 LIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLD-EDSKIMISDFGLSKMED----PGSVL 175
Query: 191 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
                T  Y APE +L  + Y+KA+D W+IG I   LL   P F+
Sbjct: 176 STACGTPGYVAPE-VLAQKPYSKAVDCWSIGVIAYILLCGYPPFY 219

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 30/215 (13%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC----REIALLRELKHPNVINLI 82
           +G+G +  V  AR       ++ A+K I+ T L+ S+     RE+ +++ L HPN++ L 
Sbjct: 22  IGKGNFAKVKLARHILTG--KEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 83  SVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
            V     ++ ++L+ +YA   +++  +  H   K              +   QI+  + Y
Sbjct: 80  EVI--ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEAR---------AKFRQIVSAVQY 128
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR--LFNNPLKPLADLDPVVVTFWY 199
            H  +++HRDLK  N+L+  +      +KIAD GF+    F N L       P      Y
Sbjct: 129 CHQKFIVHRDLKAENLLLDAD----MNIKIADFGFSNEFTFGNKLDAFCGAPP------Y 178
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
            APEL  G ++    +D+W++G I   L++    F
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/242 (23%), Positives = 114/242 (47%), Gaps = 31/242 (12%)
Query: 21  DYEGC-KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVI 79
           DYE   KVGRG Y  V++    +N++     + +           + +  L  +  PN++
Sbjct: 32  DYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNL--MGGPNIV 89
Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGI 139
            L+ +    + +   L+F+Y  +  + ++                       +Y++L  +
Sbjct: 90  KLLDIVRDQHSKTPSLIFEYVNNTDFKVL-----------YPTLTDYDIRYYIYELLKAL 138
Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
            Y HS  ++HRD+KP N+++     E  ++++ D G A  ++    P  + +  V + ++
Sbjct: 139 DYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYH----PGKEYNVRVASRYF 191
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           + PELL+  + Y  ++D+W++GC+FA ++   EP F+            +HDQL +I  V
Sbjct: 192 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD---------NHDQLVKIAKV 242
Query: 259 MG 260
           +G
Sbjct: 243 LG 244

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 30/215 (13%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC----REIALLRELKHPNVINLI 82
           +G+G +  V  AR       ++ A+K I+ T L+ S+     RE+ +++ L HPN++ L 
Sbjct: 22  IGKGNFAKVKLARHILTG--KEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 83  SVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
            V     ++ ++L+ +YA   +++  +  H   K              +   QI+  + Y
Sbjct: 80  EVI--ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEAR---------AKFRQIVSAVQY 128
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR--LFNNPLKPLADLDPVVVTFWY 199
            H  +++HRDLK  N+L+  +      +KIAD GF+    F N L       P      Y
Sbjct: 129 CHQKFIVHRDLKAENLLLDAD----MNIKIADFGFSNEFTFGNKLDTFCGSPP------Y 178
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
            APEL  G ++    +D+W++G I   L++    F
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 101/213 (47%), Gaps = 26/213 (12%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC----REIALLRELKHPNVINLI 82
           +G+G +  V  AR       R+ A+K I+ T L+ ++     RE+ +++ L HPN++ L 
Sbjct: 20  IGKGNFAKVKLARHILTG--REVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 77
Query: 83  SVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
            V     ++ ++L+ +YA   +++  +  H   K              S   QI+  + Y
Sbjct: 78  EVI--ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEAR---------SKFRQIVSAVQY 126
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            H   ++HRDLK  N+L+  +      +KIAD GF+  F    K    LD    +  Y A
Sbjct: 127 CHQKRIVHRDLKAENLLLDAD----MNIKIADFGFSNEFTVGGK----LDTFCGSPPYAA 178
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           PEL  G ++    +D+W++G I   L++    F
Sbjct: 179 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 211

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 30/215 (13%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC----REIALLRELKHPNVINLI 82
           +G+G +  V  AR       ++ A+K I+ T L+ S+     RE+ +++ L HPN++ L 
Sbjct: 22  IGKGNFAKVKLARHILTG--KEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 83  SVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
            V     ++ ++L+ +YA   +++  +  H   K              +   QI+  + Y
Sbjct: 80  EVI--ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEAR---------AKFRQIVSAVQY 128
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR--LFNNPLKPLADLDPVVVTFWY 199
            H  +++HRDLK  N+L+  +      +KIAD GF+    F N L       P      Y
Sbjct: 129 CHQKFIVHRDLKAENLLLDAD----MNIKIADFGFSNEFTFGNKLDTFCGSPP------Y 178
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
            APEL  G ++    +D+W++G I   L++    F
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 104/221 (47%), Gaps = 23/221 (10%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMS-----ACREIALLRELKHPNV 78
           G  +G G++  V  AR  + + +R+YA+K +E   +          RE  ++  L HP  
Sbjct: 37  GKILGEGSFSTVVLAR--ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           + L   F   +D K++    YA++    ++K+ R   +                 +I+  
Sbjct: 95  VKLYFTF--QDDEKLYFGLSYAKNGC--LLKYIRKIGSFDETCTRFYTA------EIVSA 144
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + YLH   ++HRDLKP NIL+     E   ++I D G A++  +P    A  +  V T  
Sbjct: 145 LEYLHGKGIIHRDLKPENILLN----EDMHIQITDFGTAKVL-SPESKQARANSFVGTAQ 199
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
           Y +PELL   +  +K+ D+WA+GCI  +L+   P F    E
Sbjct: 200 YVSPELLT-EKSASKSSDLWALGCIIYQLVAGLPPFRAGNE 239

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/242 (23%), Positives = 113/242 (46%), Gaps = 31/242 (12%)
Query: 21  DYEGC-KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVI 79
           DYE   KVGRG Y  V++    +N++     + +           + +  L     PN++
Sbjct: 33  DYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLX--GGPNIV 90
Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGI 139
            L+ +    + +   L+F+Y  +  + ++                       +Y++L  +
Sbjct: 91  KLLDIVRDQHSKTPSLIFEYVNNTDFKVL-----------YPTLTDYDIRYYIYELLKAL 139
Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
            Y HS  ++HRD+KP N+++     E  ++++ D G A  ++    P  + +  V + ++
Sbjct: 140 DYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYH----PGKEYNVRVASRYF 192
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           + PELL+  + Y  ++D+W++GC+FA ++   EP F+            +HDQL +I  V
Sbjct: 193 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD---------NHDQLVKIAKV 243
Query: 259 MG 260
           +G
Sbjct: 244 LG 245

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/242 (23%), Positives = 113/242 (46%), Gaps = 31/242 (12%)
Query: 21  DYEGC-KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVI 79
           DYE   KVGRG Y  V++    +N++     + +           + +  L     PN++
Sbjct: 32  DYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLX--GGPNIV 89
Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGI 139
            L+ +    + +   L+F+Y  +  + ++                       +Y++L  +
Sbjct: 90  KLLDIVRDQHSKTPSLIFEYVNNTDFKVL-----------YPTLTDYDIRYYIYELLKAL 138
Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
            Y HS  ++HRD+KP N+++     E  ++++ D G A  ++    P  + +  V + ++
Sbjct: 139 DYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYH----PGKEYNVRVASRYF 191
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           + PELL+  + Y  ++D+W++GC+FA ++   EP F+            +HDQL +I  V
Sbjct: 192 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD---------NHDQLVKIAKV 242
Query: 259 MG 260
           +G
Sbjct: 243 LG 244

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/242 (23%), Positives = 113/242 (46%), Gaps = 31/242 (12%)
Query: 21  DYEGC-KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVI 79
           DYE   KVGRG Y  V++    +N++     + +           + +  L     PN++
Sbjct: 32  DYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLX--GGPNIV 89
Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGI 139
            L+ +    + +   L+F+Y  +  + ++                       +Y++L  +
Sbjct: 90  KLLDIVRDQHSKTPSLIFEYVNNTDFKVL-----------YPTLTDYDIRYYIYELLKAL 138
Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
            Y HS  ++HRD+KP N+++     E  ++++ D G A  ++    P  + +  V + ++
Sbjct: 139 DYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYH----PGKEYNVRVASRYF 191
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           + PELL+  + Y  ++D+W++GC+FA ++   EP F+            +HDQL +I  V
Sbjct: 192 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD---------NHDQLVKIAKV 242
Query: 259 MG 260
           +G
Sbjct: 243 LG 244

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/242 (23%), Positives = 113/242 (46%), Gaps = 31/242 (12%)
Query: 21  DYEGC-KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVI 79
           DYE   KVGRG Y  V++    +N++     + +           + +  L     PN++
Sbjct: 34  DYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNL--CGGPNIV 91
Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGI 139
            L+ +    + +   L+F+Y  +  + ++                       +Y++L  +
Sbjct: 92  KLLDIVRDQHSKTPSLIFEYVNNTDFKVL-----------YPTLTDYDIRYYIYELLKAL 140
Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
            Y HS  ++HRD+KP N+++     E  ++++ D G A  ++    P  + +  V + ++
Sbjct: 141 DYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYH----PGKEYNVRVASRYF 193
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           + PELL+  + Y  ++D+W++GC+FA ++   EP F+            +HDQL +I  V
Sbjct: 194 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD---------NHDQLVKIAKV 244
Query: 259 MG 260
           +G
Sbjct: 245 LG 246

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/242 (23%), Positives = 113/242 (46%), Gaps = 31/242 (12%)
Query: 21  DYEGC-KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVI 79
           DYE   KVGRG Y  V++    +N++     + +           + +  L     PN++
Sbjct: 32  DYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLX--GGPNIV 89
Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGI 139
            L+ +    + +   L+F+Y  +  + ++                       +Y++L  +
Sbjct: 90  KLLDIVRDQHSKTPSLIFEYVNNTDFKVL-----------YPTLTDYDIRYYIYELLKAL 138
Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
            Y HS  ++HRD+KP N+++     E  ++++ D G A  ++    P  + +  V + ++
Sbjct: 139 DYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYH----PGKEYNVRVASRYF 191
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           + PELL+  + Y  ++D+W++GC+FA ++   EP F+            +HDQL +I  V
Sbjct: 192 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD---------NHDQLVKIAKV 242
Query: 259 MG 260
           +G
Sbjct: 243 LG 244

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/242 (23%), Positives = 113/242 (46%), Gaps = 31/242 (12%)
Query: 21  DYEGC-KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVI 79
           DYE   KVGRG Y  V++    +N++     + +           + +  L     PN++
Sbjct: 33  DYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNL--CGGPNIV 90
Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGI 139
            L+ +    + +   L+F+Y  +  + ++                       +Y++L  +
Sbjct: 91  KLLDIVRDQHSKTPSLIFEYVNNTDFKVL-----------YPTLTDYDIRYYIYELLKAL 139
Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
            Y HS  ++HRD+KP N+++     E  ++++ D G A  ++    P  + +  V + ++
Sbjct: 140 DYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYH----PGKEYNVRVASRYF 192
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           + PELL+  + Y  ++D+W++GC+FA ++   EP F+            +HDQL +I  V
Sbjct: 193 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD---------NHDQLVKIAKV 243
Query: 259 MG 260
           +G
Sbjct: 244 LG 245

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/242 (23%), Positives = 113/242 (46%), Gaps = 31/242 (12%)
Query: 21  DYEGC-KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVI 79
           DYE   KVGRG Y  V++    +N++     + +           + +  L     PN++
Sbjct: 32  DYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNL--CGGPNIV 89
Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGI 139
            L+ +    + +   L+F+Y  +  + ++                       +Y++L  +
Sbjct: 90  KLLDIVRDQHSKTPSLIFEYVNNTDFKVL-----------YPTLTDYDIRYYIYELLKAL 138
Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
            Y HS  ++HRD+KP N+++     E  ++++ D G A  ++    P  + +  V + ++
Sbjct: 139 DYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYH----PGKEYNVRVASRYF 191
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           + PELL+  + Y  ++D+W++GC+FA ++   EP F+            +HDQL +I  V
Sbjct: 192 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD---------NHDQLVKIAKV 242
Query: 259 MG 260
           +G
Sbjct: 243 LG 244

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/242 (23%), Positives = 113/242 (46%), Gaps = 31/242 (12%)
Query: 21  DYEGC-KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVI 79
           DYE   KVGRG Y  V++    +N++     + +           + +  L     PN++
Sbjct: 32  DYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNL--CGGPNIV 89
Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGI 139
            L+ +    + +   L+F+Y  +  + ++                       +Y++L  +
Sbjct: 90  KLLDIVRDQHSKTPSLIFEYVNNTDFKVL-----------YPTLTDYDIRYYIYELLKAL 138
Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
            Y HS  ++HRD+KP N+++     E  ++++ D G A  ++    P  + +  V + ++
Sbjct: 139 DYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYH----PGKEYNVRVASRYF 191
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           + PELL+  + Y  ++D+W++GC+FA ++   EP F+            +HDQL +I  V
Sbjct: 192 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD---------NHDQLVKIAKV 242
Query: 259 MG 260
           +G
Sbjct: 243 LG 244

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 71/236 (30%), Positives = 106/236 (44%), Gaps = 45/236 (19%)
Query: 21  DYEGCKV-GRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC-REIALLRELKHPNV 78
           D+E   V G+G +G V KAR  +  D+R YA+K+I  T   +S    E+ LL  L H  V
Sbjct: 7   DFEEIAVLGQGAFGQVVKAR--NALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQYV 64
Query: 79  INLISVFLSHND--------RKVWLLF---DYAE----HDLWHIIKFHRAAKANXXXXXX 123
           +   + +L   +        +K   LF   +Y E    +DL H    ++           
Sbjct: 65  VRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQ---------- 114
Query: 124 XXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNP 183
                  L  QIL+ + Y+HS  ++HR+LKP NI +     E   VKI D G A+  +  
Sbjct: 115 -RDEYWRLFRQILEALSYIHSQGIIHRNLKPXNIFID----ESRNVKIGDFGLAKNVHRS 169
Query: 184 LKPLA-----------DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 228
           L  L            +L   + T  Y A E+L G  HY + ID +++G IF E +
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/242 (23%), Positives = 113/242 (46%), Gaps = 31/242 (12%)
Query: 21  DYEGC-KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVI 79
           DYE   KVGRG Y  V++    +N++     + +           + +  L     PN++
Sbjct: 53  DYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLX--GGPNIV 110
Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGI 139
            L+ +    + +   L+F+Y  +  + ++                       +Y++L  +
Sbjct: 111 KLLDIVRDQHSKTPSLIFEYVNNTDFKVL-----------YPTLTDYDIRYYIYELLKAL 159
Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
            Y HS  ++HRD+KP N+++     E  ++++ D G A  ++    P  + +  V + ++
Sbjct: 160 DYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYH----PGKEYNVRVASRYF 212
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           + PELL+  + Y  ++D+W++GC+FA ++   EP F+            +HDQL +I  V
Sbjct: 213 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD---------NHDQLVKIAKV 263
Query: 259 MG 260
           +G
Sbjct: 264 LG 265

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 26/213 (12%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC----REIALLRELKHPNVINLI 82
           +G+G +  V  AR       R+ A+K I+ T L+ ++     RE+ +++ L HPN++ L 
Sbjct: 23  IGKGNFAKVKLARHILTG--REVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 83  SVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
            V     ++ ++L+ +YA   +++  +  H   K              S   QI+  + Y
Sbjct: 81  EVI--ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEAR---------SKFRQIVSAVQY 129
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            H   ++HRDLK  N+L+  +      +KIAD GF+  F    K    LD       Y A
Sbjct: 130 CHQKRIVHRDLKAENLLLDAD----MNIKIADFGFSNEFTVGGK----LDAFCGAPPYAA 181
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           PEL  G ++    +D+W++G I   L++    F
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 214

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 23/221 (10%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMS-----ACREIALLRELKHPNV 78
           G  +G G++  V  AR  + + +R+YA+K +E   +          RE  ++  L HP  
Sbjct: 35  GKILGEGSFSTVVLAR--ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           + L   F   +D K++    YA++    ++K+ R   +                 +I+  
Sbjct: 93  VKLYFTF--QDDEKLYFGLSYAKNG--ELLKYIRKIGSFDETCTRFYTA------EIVSA 142
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + YLH   ++HRDLKP NIL+     E   ++I D G A++  +P    A  +  V T  
Sbjct: 143 LEYLHGKGIIHRDLKPENILLN----EDMHIQITDFGTAKVL-SPESKQARANAFVGTAQ 197
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
           Y +PELL   +   K+ D+WA+GCI  +L+   P F    E
Sbjct: 198 YVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 237

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 104/223 (46%), Gaps = 23/223 (10%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMS-----ACREIALLRELKHPNV 78
           G  +G G++  V  AR  + + +R+YA+K +E   +          RE  ++  L HP  
Sbjct: 37  GKILGEGSFSTVVLAR--ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           + L   F   +D K++    YA++    ++K+ R   +                 +I+  
Sbjct: 95  VKLYFTF--QDDEKLYFGLSYAKNG--ELLKYIRKIGSFDETCTRFYTA------EIVSA 144
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + YLH   ++HRDLKP NIL+     E   ++I D G A++  +P    A  +  V T  
Sbjct: 145 LEYLHGKGIIHRDLKPENILLN----EDMHIQITDFGTAKVL-SPESKQARANXFVGTAQ 199
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI 241
           Y +PELL   +   K+ D+WA+GCI  +L+   P F    E +
Sbjct: 200 YVSPELLT-EKSAXKSSDLWALGCIIYQLVAGLPPFRAGNEGL 241

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 23/221 (10%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMS-----ACREIALLRELKHPNV 78
           G  +G G++  V  AR  + + +R+YA+K +E   +          RE  ++  L HP  
Sbjct: 34  GKILGEGSFSTVVLAR--ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 91
Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           + L   F   +D K++    YA++    ++K+ R   +                 +I+  
Sbjct: 92  VKLYFTF--QDDEKLYFGLSYAKNG--ELLKYIRKIGSFDETCTRFYTA------EIVSA 141
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + YLH   ++HRDLKP NIL+     E   ++I D G A++  +P    A  +  V T  
Sbjct: 142 LEYLHGKGIIHRDLKPENILLN----EDMHIQITDFGTAKVL-SPESKQARANSFVGTAQ 196
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
           Y +PELL   +   K+ D+WA+GCI  +L+   P F    E
Sbjct: 197 YVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 236

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 104/223 (46%), Gaps = 23/223 (10%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMS-----ACREIALLRELKHPNV 78
           G  +G G++  V  AR  + + +R+YA+K +E   +          RE  ++  L HP  
Sbjct: 37  GKILGEGSFSTVVLAR--ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           + L   F   +D K++    YA++    ++K+ R   +                 +I+  
Sbjct: 95  VKLYFTF--QDDEKLYFGLSYAKNG--ELLKYIRKIGSFDETCTRFYTA------EIVSA 144
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + YLH   ++HRDLKP NIL+     E   ++I D G A++  +P    A  +  V T  
Sbjct: 145 LEYLHGKGIIHRDLKPENILLN----EDMHIQITDFGTAKVL-SPESKQARANXFVGTAQ 199
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI 241
           Y +PELL   +   K+ D+WA+GCI  +L+   P F    E +
Sbjct: 200 YVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL 241

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 101/215 (46%), Gaps = 30/215 (13%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC----REIALLRELKHPNVINLI 82
           +G+G +  V  AR       ++ A++ I+ T L+ S+     RE+ +++ L HPN++ L 
Sbjct: 22  IGKGNFAKVKLARHILTG--KEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 83  SVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
            V     ++ ++L+ +YA   +++  +  H   K              +   QI+  + Y
Sbjct: 80  EVI--ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEAR---------AKFRQIVSAVQY 128
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR--LFNNPLKPLADLDPVVVTFWY 199
            H  +++HRDLK  N+L+  +      +KIAD GF+    F N L       P      Y
Sbjct: 129 CHQKFIVHRDLKAENLLLDAD----MNIKIADFGFSNEFTFGNKLDTFCGSPP------Y 178
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
            APEL  G ++    +D+W++G I   L++    F
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 30/215 (13%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC----REIALLRELKHPNVINLI 82
           +G+G +  V  AR       ++ A+K I+ T L+ S+     RE+ + + L HPN++ L 
Sbjct: 22  IGKGNFAKVKLARHILTG--KEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLF 79
Query: 83  SVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
            V     ++ ++L+ +YA   +++  +  H   K              +   QI+  + Y
Sbjct: 80  EVI--ETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEAR---------AKFRQIVSAVQY 128
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR--LFNNPLKPLADLDPVVVTFWY 199
            H  +++HRDLK  N+L+  +      +KIAD GF+    F N L       P      Y
Sbjct: 129 CHQKFIVHRDLKAENLLLDAD----XNIKIADFGFSNEFTFGNKLDAFCGAPP------Y 178
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
            APEL  G ++    +D+W++G I   L++    F
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 23/221 (10%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMS-----ACREIALLRELKHPNV 78
           G  +G G++  V  AR  + + +R+YA+K +E   +          RE  ++  L HP  
Sbjct: 38  GKILGEGSFSTVVLAR--ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 95
Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           + L   F   +D K++    YA++    ++K+ R   +                 +I+  
Sbjct: 96  VKLYFTF--QDDEKLYFGLSYAKNG--ELLKYIRKIGSFDETCTRFYTA------EIVSA 145
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + YLH   ++HRDLKP NIL+     E   ++I D G A++  +P    A  +  V T  
Sbjct: 146 LEYLHGKGIIHRDLKPENILLN----EDMHIQITDFGTAKVL-SPESKQARANSFVGTAQ 200
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
           Y +PELL   +   K+ D+WA+GCI  +L+   P F    E
Sbjct: 201 YVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 240

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 101/215 (46%), Gaps = 30/215 (13%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC----REIALLRELKHPNVINLI 82
           +G+G +  V  AR       ++ A++ I+ T L+ S+     RE+ +++ L HPN++ L 
Sbjct: 22  IGKGNFAKVKLARHILTG--KEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 83  SVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
            V     ++ ++L+ +YA   +++  +  H   K              +   QI+  + Y
Sbjct: 80  EVI--ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEAR---------AKFRQIVSAVQY 128
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR--LFNNPLKPLADLDPVVVTFWY 199
            H  +++HRDLK  N+L+  +      +KIAD GF+    F N L       P      Y
Sbjct: 129 CHQKFIVHRDLKAENLLLDAD----MNIKIADFGFSNEFTFGNKLDEFCGSPP------Y 178
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
            APEL  G ++    +D+W++G I   L++    F
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 23/221 (10%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMS-----ACREIALLRELKHPNV 78
           G  +G G++  V  AR  + + +R+YA+K +E   +          RE  ++  L HP  
Sbjct: 14  GKILGEGSFSTVVLAR--ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 71
Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           + L   F   +D K++    YA++    ++K+ R   +                 +I+  
Sbjct: 72  VKLYFTF--QDDEKLYFGLSYAKNG--ELLKYIRKIGSFDETCTRFYTA------EIVSA 121
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + YLH   ++HRDLKP NIL+     E   ++I D G A++  +P    A  +  V T  
Sbjct: 122 LEYLHGKGIIHRDLKPENILLN----EDMHIQITDFGTAKVL-SPESKQARANXFVGTAQ 176
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
           Y +PELL   +   K+ D+WA+GCI  +L+   P F    E
Sbjct: 177 YVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 216

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 23/221 (10%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMS-----ACREIALLRELKHPNV 78
           G  +G G++  V  AR  + + +R+YA+K +E   +          RE  ++  L HP  
Sbjct: 13  GKILGEGSFSTVVLAR--ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 70
Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           + L   F   +D K++    YA++    ++K+ R   +                 +I+  
Sbjct: 71  VKLYFTF--QDDEKLYFGLSYAKNG--ELLKYIRKIGSFDETCTRFYTA------EIVSA 120
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + YLH   ++HRDLKP NIL+     E   ++I D G A++  +P    A  +  V T  
Sbjct: 121 LEYLHGKGIIHRDLKPENILLN----EDMHIQITDFGTAKVL-SPESKQARANXFVGTAQ 175
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
           Y +PELL   +   K+ D+WA+GCI  +L+   P F    E
Sbjct: 176 YVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 215

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 30/215 (13%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC----REIALLRELKHPNVINLI 82
           +G+G +  V  AR       ++ A+K I+ T L+ S+     RE+ +++ L HPN++ L 
Sbjct: 15  IGKGNFAKVKLARHILTG--KEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 72
Query: 83  SVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
            V     ++ ++L+ +YA   +++  +  H   K              +   QI+  + Y
Sbjct: 73  EVI--ETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEAR---------AKFRQIVSAVQY 121
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR--LFNNPLKPLADLDPVVVTFWY 199
            H  +++HRDLK  N+L+  +      +KIAD GF+    F N L       P      Y
Sbjct: 122 CHQKFIVHRDLKAENLLLDAD----MNIKIADFGFSNEFTFGNKLDTFCGSPP------Y 171
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
            APEL  G ++    +D+W++G I   L++    F
Sbjct: 172 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 206

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 23/221 (10%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMS-----ACREIALLRELKHPNV 78
           G  +G G++  V  AR  + + +R+YA+K +E   +          RE  ++  L HP  
Sbjct: 12  GKILGEGSFSTVVLAR--ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 69
Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           + L   F   +D K++    YA++    ++K+ R   +                 +I+  
Sbjct: 70  VKLYFTF--QDDEKLYFGLSYAKNG--ELLKYIRKIGSFDETCTRFYTA------EIVSA 119
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + YLH   ++HRDLKP NIL+     E   ++I D G A++  +P    A  +  V T  
Sbjct: 120 LEYLHGKGIIHRDLKPENILLN----EDMHIQITDFGTAKVL-SPESKQARANXFVGTAQ 174
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
           Y +PELL   +   K+ D+WA+GCI  +L+   P F    E
Sbjct: 175 YVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 214

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 131/276 (47%), Gaps = 39/276 (14%)
Query: 12  ERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-------GLSMSAC 64
           ++ KVED +D  G ++G G +  V K R K  S   +YA K I+         G+S    
Sbjct: 6   KQQKVEDFYDI-GEELGSGQFAIVKKCREK--STGLEYAAKFIKKRQSRASRRGVSREEI 62
Query: 65  -REIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXX 123
            RE+++LR++ H NVI L  V+ +  D  V +L   +  +L+  +    A K +      
Sbjct: 63  EREVSILRQVLHHNVITLHDVYENRTD-VVLILELVSGGELFDFL----AQKESLSEEEA 117
Query: 124 XXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNP 183
                 S + QILDG++YLH+  + H DLKP NI+++ + I    +K+ D G A    + 
Sbjct: 118 T-----SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA----HE 168
Query: 184 LKPLADLDPVVVTFWYRAPELL----LGARHYTKAIDIWAIGCIFAELLTSEPIF--HCR 237
           ++   +   +  T  + APE++    LG        D+W+IG I   LL+    F    +
Sbjct: 169 IEDGVEFKNIFGTPEFVAPEIVNYEPLGLE-----ADMWSIGVITYILLSGASPFLGDTK 223
Query: 238 QEDIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM 273
           QE +       +D  +  FS     L KD+  IRK+
Sbjct: 224 QETLANITAVSYDFDEEFFSQTS-ELAKDF--IRKL 256

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 23/221 (10%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMS-----ACREIALLRELKHPNV 78
           G  +G G++  V  AR  + + +R+YA+K +E   +          RE  ++  L HP  
Sbjct: 37  GKILGEGSFSTVVLAR--ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           + L   F   +D K++    YA++    ++K+ R   +                 +I+  
Sbjct: 95  VKLYFTF--QDDEKLYFGLSYAKNG--ELLKYIRKIGSFDETCTRFYTA------EIVSA 144
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + YLH   ++HRDLKP NIL+     E   ++I D G A++  +P    A  +  V T  
Sbjct: 145 LEYLHGKGIIHRDLKPENILLN----EDMHIQITDFGTAKVL-SPESKQARANXFVGTAQ 199
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
           Y +PELL   +   K+ D+WA+GCI  +L+   P F    E
Sbjct: 200 YVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 239

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 23/221 (10%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMS-----ACREIALLRELKHPNV 78
           G  +G G++  V  AR  + + +R+YA+K +E   +          RE  ++  L HP  
Sbjct: 15  GKILGEGSFSTVVLAR--ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 72
Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           + L   F   +D K++    YA++    ++K+ R   +                 +I+  
Sbjct: 73  VKLYFTF--QDDEKLYFGLSYAKNG--ELLKYIRKIGSFDETCTRFYTA------EIVSA 122
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + YLH   ++HRDLKP NIL+     E   ++I D G A++  +P    A  +  V T  
Sbjct: 123 LEYLHGKGIIHRDLKPENILLN----EDMHIQITDFGTAKVL-SPESKQARANXFVGTAQ 177
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
           Y +PELL   +   K+ D+WA+GCI  +L+   P F    E
Sbjct: 178 YVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 217

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 23/221 (10%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMS-----ACREIALLRELKHPNV 78
           G  +G G++  V  AR  + + +R+YA+K +E   +          RE  ++  L HP  
Sbjct: 35  GKILGEGSFSTVVLAR--ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           + L   F   +D K++    YA++    ++K+ R   +                 +I+  
Sbjct: 93  VKLYFTF--QDDEKLYFGLSYAKNG--ELLKYIRKIGSFDETCTRFYTA------EIVSA 142
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + YLH   ++HRDLKP NIL+     E   ++I D G A++  +P    A  +  V T  
Sbjct: 143 LEYLHGKGIIHRDLKPENILLN----EDMHIQITDFGTAKVL-SPESKQARANXFVGTAQ 197
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
           Y +PELL   +   K+ D+WA+GCI  +L+   P F    E
Sbjct: 198 YVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 237

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 23/221 (10%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMS-----ACREIALLRELKHPNV 78
           G  +G G++  V  AR  + + +R+YA+K +E   +          RE  ++  L HP  
Sbjct: 34  GKILGEGSFSTVVLAR--ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 91
Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           + L   F   +D K++    YA++    ++K+ R   +                 +I+  
Sbjct: 92  VKLYFTF--QDDEKLYFGLSYAKNG--ELLKYIRKIGSFDETCTRFYTA------EIVSA 141
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + YLH   ++HRDLKP NIL+     E   ++I D G A++  +P    A  +  V T  
Sbjct: 142 LEYLHGKGIIHRDLKPENILLN----EDMHIQITDFGTAKVL-SPESKQARANXFVGTAQ 196
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
           Y +PELL   +   K+ D+WA+GCI  +L+   P F    E
Sbjct: 197 YVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 236

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 23/221 (10%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMS-----ACREIALLRELKHPNV 78
           G  +G G++  V  AR  + + +R+YA+K +E   +          RE  ++  L HP  
Sbjct: 19  GKILGEGSFSTVVLAR--ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 76
Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           + L   F   +D K++    YA++    ++K+ R   +                 +I+  
Sbjct: 77  VKLYFTF--QDDEKLYFGLSYAKNG--ELLKYIRKIGSFDETCTRFYTA------EIVSA 126
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + YLH   ++HRDLKP NIL+     E   ++I D G A++  +P    A  +  V T  
Sbjct: 127 LEYLHGKGIIHRDLKPENILLN----EDMHIQITDFGTAKVL-SPESKQARANXFVGTAQ 181
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
           Y +PELL   +   K+ D+WA+GCI  +L+   P F    E
Sbjct: 182 YVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 221

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 23/221 (10%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMS-----ACREIALLRELKHPNV 78
           G  +G G++  V  AR  + + +R+YA+K +E   +          RE  ++  L HP  
Sbjct: 37  GKILGEGSFSTVVLAR--ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           + L   F   +D K++    YA++    ++K+ R   +                 +I+  
Sbjct: 95  VKLYFTF--QDDEKLYFGLSYAKNG--ELLKYIRKIGSFDETCTRFYTA------EIVSA 144
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + YLH   ++HRDLKP NIL+     E   ++I D G A++  +P    A  +  V T  
Sbjct: 145 LEYLHGKGIIHRDLKPENILLN----EDMHIQITDFGTAKVL-SPESKQARANXFVGTAQ 199
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
           Y +PELL   +   K+ D+WA+GCI  +L+   P F    E
Sbjct: 200 YVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 239

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 23/221 (10%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMS-----ACREIALLRELKHPNV 78
           G  +G G++  V  AR  + + +R+YA+K +E   +          RE  ++  L HP  
Sbjct: 35  GKILGEGSFSTVVLAR--ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           + L   F   +D K++    YA++    ++K+ R   +                 +I+  
Sbjct: 93  VKLYFTF--QDDEKLYFGLSYAKNG--ELLKYIRKIGSFDETCTRFYTA------EIVSA 142
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + YLH   ++HRDLKP NIL+     E   ++I D G A++  +P    A  +  V T  
Sbjct: 143 LEYLHGKGIIHRDLKPENILLN----EDMHIQITDFGTAKVL-SPESKQARANXFVGTAQ 197
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
           Y +PELL   +   K+ D+WA+GCI  +L+   P F    E
Sbjct: 198 YVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 237

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 23/221 (10%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMS-----ACREIALLRELKHPNV 78
           G  +G G++  V  AR  + + +R+YA+K +E   +          RE  ++  L HP  
Sbjct: 38  GKILGEGSFSTVVLAR--ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 95
Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           + L   F   +D K++    YA++    ++K+ R   +                 +I+  
Sbjct: 96  VKLYFTF--QDDEKLYFGLSYAKNG--ELLKYIRKIGSFDETCTRFYTA------EIVSA 145
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + YLH   ++HRDLKP NIL+     E   ++I D G A++  +P    A  +  V T  
Sbjct: 146 LEYLHGKGIIHRDLKPENILLN----EDMHIQITDFGTAKVL-SPESKQARANXFVGTAQ 200
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
           Y +PELL   +   K+ D+WA+GCI  +L+   P F    E
Sbjct: 201 YVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 240

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 110/226 (48%), Gaps = 28/226 (12%)
Query: 16  VEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL---SMSACREIALLRE 72
           ++ +F+++   +G G +  V  A  K  +  + +A+K I    L     S   EIA+LR+
Sbjct: 20  IKKIFEFKET-LGTGAFSEVVLAEEK--ATGKLFAVKCIPKKALKGKESSIENEIAVLRK 76
Query: 73  LKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIK--FHRAAKANXXXXXXXXXXXXS 130
           +KH N++ L  ++ S N   + +           I++  F+    A+            +
Sbjct: 77  IKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDAS------------T 124
Query: 131 LLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLAD- 189
           L+ Q+LD ++YLH   ++HRDLKP N+L   +  E  ++ I+D G +++         D 
Sbjct: 125 LIRQVLDAVYYLHRMGIVHRDLKPENLLYYSQD-EESKIMISDFGLSKMEGK-----GDV 178
Query: 190 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
           +     T  Y APE +L  + Y+KA+D W+IG I   LL   P F+
Sbjct: 179 MSTACGTPGYVAPE-VLAQKPYSKAVDCWSIGVIAYILLCGYPPFY 223

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 23/221 (10%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMS-----ACREIALLRELKHPNV 78
           G  +G G++  V  AR  + + +R+YA+K +E   +          RE  ++  L HP  
Sbjct: 37  GKILGEGSFSTVVLAR--ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           + L   F   +D K++    YA++    ++K+ R   +                 +I+  
Sbjct: 95  VKLYFTF--QDDEKLYFGLSYAKNG--ELLKYIRKIGSFDETCTRFYTA------EIVSA 144
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + YLH   ++HRDLKP NIL+     E   ++I D G A++  +P    A  +  V T  
Sbjct: 145 LEYLHGKGIIHRDLKPENILLN----EDMHIQITDFGTAKVL-SPESKQARANXFVGTAQ 199
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
           Y +PELL   +   K+ D+WA+GCI  +L+   P F    E
Sbjct: 200 YVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 239

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 23/221 (10%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMS-----ACREIALLRELKHPNV 78
           G  +G G++  V  AR  + + +R+YA+K +E   +          RE  ++  L HP  
Sbjct: 40  GKILGEGSFSTVVLAR--ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 97
Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           + L   F   +D K++    YA++    ++K+ R   +                 +I+  
Sbjct: 98  VKLYFTF--QDDEKLYFGLSYAKNG--ELLKYIRKIGSFDETCTRFYTA------EIVSA 147
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + YLH   ++HRDLKP NIL+     E   ++I D G A++  +P    A  +  V T  
Sbjct: 148 LEYLHGKGIIHRDLKPENILLN----EDMHIQITDFGTAKVL-SPESKQARANXFVGTAQ 202
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
           Y +PELL   +   K+ D+WA+GCI  +L+   P F    E
Sbjct: 203 YVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 242

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 103/230 (44%), Gaps = 49/230 (21%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL--SMSACREIALLRELKHPNVINLISV 84
           +G G +  V+  +++     + +ALK I+ +      S   EIA+L+++KH N++ L  +
Sbjct: 17  LGSGAFSEVFLVKQRLTG--KLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 85  FLSHNDRKVWL-------LFD-------YAEHDLWHIIKFHRAAKANXXXXXXXXXXXXS 130
           + S     + +       LFD       Y E D   +I+                     
Sbjct: 75  YESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQ--------------------- 113
Query: 131 LLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADL 190
              Q+L  + YLH N ++HRDLKP N+L +    E  ++ I D G +++  N +   A  
Sbjct: 114 ---QVLSAVKYLHENGIVHRDLKPENLLYLTPE-ENSKIMITDFGLSKMEQNGIMSTACG 169
Query: 191 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
            P      Y APE +L  + Y+KA+D W+IG I   LL   P F+   E 
Sbjct: 170 TP-----GYVAPE-VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES 213

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 23/221 (10%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMS-----ACREIALLRELKHPNV 78
           G  +G G++  V  AR  + + +R+YA+K +E   +          RE  ++  L HP  
Sbjct: 42  GKILGEGSFSTVVLAR--ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 99
Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           + L   F   +D K++    YA++    ++K+ R   +                 +I+  
Sbjct: 100 VKLYFCF--QDDEKLYFGLSYAKNG--ELLKYIRKIGSFDETCTRFYTA------EIVSA 149
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + YLH   ++HRDLKP NIL+     E   ++I D G A++  +P    A  +  V T  
Sbjct: 150 LEYLHGKGIIHRDLKPENILLN----EDMHIQITDFGTAKVL-SPESKQARANXFVGTAQ 204
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
           Y +PELL   +   K+ D+WA+GCI  +L+   P F    E
Sbjct: 205 YVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 244

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 131/276 (47%), Gaps = 39/276 (14%)
Query: 12  ERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-------GLSMSAC 64
           ++ KVED +D  G ++G G +  V K R K  S   +YA K I+         G+S    
Sbjct: 6   KQQKVEDFYDI-GEELGSGQFAIVKKCREK--STGLEYAAKFIKKRQSRASRRGVSREEI 62
Query: 65  -REIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXX 123
            RE+++LR++ H NVI L  V+ +  D  V +L   +  +L+  +    A K +      
Sbjct: 63  EREVSILRQVLHHNVITLHDVYENRTD-VVLILELVSGGELFDFL----AQKESLSEEEA 117
Query: 124 XXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNP 183
                 S + QILDG++YLH+  + H DLKP NI+++ + I    +K+ D G A    + 
Sbjct: 118 T-----SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA----HE 168
Query: 184 LKPLADLDPVVVTFWYRAPELL----LGARHYTKAIDIWAIGCIFAELLTSEPIF--HCR 237
           ++   +   +  T  + APE++    LG        D+W+IG I   LL+    F    +
Sbjct: 169 IEDGVEFKNIFGTPEFVAPEIVNYEPLGLE-----ADMWSIGVITYILLSGASPFLGDTK 223
Query: 238 QEDIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM 273
           QE +       +D  +  FS     L KD+  IRK+
Sbjct: 224 QETLANITAVSYDFDEEFFSQTS-ELAKDF--IRKL 256

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 131/276 (47%), Gaps = 39/276 (14%)
Query: 12  ERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-------GLSMSAC 64
           ++ KVED +D  G ++G G +  V K R K  S   +YA K I+         G+S    
Sbjct: 6   KQQKVEDFYDI-GEELGSGQFAIVKKCREK--STGLEYAAKFIKKRQSRASRRGVSREEI 62
Query: 65  -REIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXX 123
            RE+++LR++ H NVI L  V+ +  D  V +L   +  +L+  +    A K +      
Sbjct: 63  EREVSILRQVLHHNVITLHDVYENRTD-VVLILELVSGGELFDFL----AQKESLSEEEA 117
Query: 124 XXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNP 183
                 S + QILDG++YLH+  + H DLKP NI+++ + I    +K+ D G A    + 
Sbjct: 118 T-----SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA----HE 168
Query: 184 LKPLADLDPVVVTFWYRAPELL----LGARHYTKAIDIWAIGCIFAELLTSEPIF--HCR 237
           ++   +   +  T  + APE++    LG        D+W+IG I   LL+    F    +
Sbjct: 169 IEDGVEFKNIFGTPEFVAPEIVNYEPLGLE-----ADMWSIGVITYILLSGASPFLGDTK 223
Query: 238 QEDIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM 273
           QE +       +D  +  FS     L KD+  IRK+
Sbjct: 224 QETLANITSVSYDFDEEFFSHTS-ELAKDF--IRKL 256

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 131/276 (47%), Gaps = 39/276 (14%)
Query: 12  ERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-------GLSMSAC 64
           ++ KVED +D  G ++G G +  V K R K  S   +YA K I+         G+S    
Sbjct: 6   KQQKVEDFYDI-GEELGSGQFAIVKKCREK--STGLEYAAKFIKKRQSRASRRGVSREEI 62
Query: 65  -REIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXX 123
            RE+++LR++ H NVI L  V+ +  D  V +L   +  +L+  +    A K +      
Sbjct: 63  EREVSILRQVLHHNVITLHDVYENRTD-VVLILELVSGGELFDFL----AQKESLSEEEA 117
Query: 124 XXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNP 183
                 S + QILDG++YLH+  + H DLKP NI+++ + I    +K+ D G A    + 
Sbjct: 118 T-----SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA----HE 168
Query: 184 LKPLADLDPVVVTFWYRAPELL----LGARHYTKAIDIWAIGCIFAELLTSEPIF--HCR 237
           ++   +   +  T  + APE++    LG        D+W+IG I   LL+    F    +
Sbjct: 169 IEDGVEFKNIFGTPEFVAPEIVNYEPLGLE-----ADMWSIGVITYILLSGASPFLGDTK 223
Query: 238 QEDIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM 273
           QE +       +D  +  FS     L KD+  IRK+
Sbjct: 224 QETLANITSVSYDFDEEFFSHTS-ELAKDF--IRKL 256

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 106/212 (50%), Gaps = 25/212 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQ--IEGTGLSMSACREIALLRELKHPNVINLIS 83
           K+G+G  G VY A   D +  ++ A++Q  ++          EI ++RE K+PN++N + 
Sbjct: 27  KIGQGASGTVYTAM--DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 84  VFLSHNDRKVWLLFDY-AEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
            +L  ++  +W++ +Y A   L  ++                     ++  + L  + +L
Sbjct: 85  SYLVGDE--LWVVMEYLAGGSLTDVV----------TETCMDEGQIAAVCRECLQALEFL 132
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAP 202
           HSN V+HRD+K  NIL+   G++ G VK+ D GF           +++   V T ++ AP
Sbjct: 133 HSNQVIHRDIKSDNILL---GMD-GSVKLTDFGFCAQITPEQSKRSEM---VGTPYWMAP 185
Query: 203 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           E++   + Y   +DIW++G +  E++  EP +
Sbjct: 186 EVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 106/216 (49%), Gaps = 28/216 (12%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-----CREIALLRELKHPNVIN 80
           K+G G YG V   + K     R  A+K I+ + ++ ++       E+A+L++L HPN++ 
Sbjct: 11  KLGSGAYGEVLLCKDKLTGAER--AIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMK 68
Query: 81  LISVFLSHNDRKVWLLFD-YAEHDLW-HIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           L   F   + R  +L+ + Y   +L+  II   + ++ +             ++ Q+L G
Sbjct: 69  LYEFF--EDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV----------IMKQVLSG 116
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
             YLH + ++HRDLKP N+L+  +  +   +KI D G +  F    K    +   + T +
Sbjct: 117 TTYLHKHNIVHRDLKPENLLLESKSRD-ALIKIVDFGLSAHFEVGGK----MKERLGTAY 171
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           Y APE+L   + Y +  D+W+ G I   LL   P F
Sbjct: 172 YIAPEVL--RKKYDEKCDVWSCGVILYILLCGYPPF 205

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 131/276 (47%), Gaps = 39/276 (14%)
Query: 12  ERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-------GLSMSAC 64
           ++ KVED +D  G ++G G +  V K R K  S   +YA K I+         G+S    
Sbjct: 6   KQQKVEDFYDI-GEELGSGQFAIVKKCREK--STGLEYAAKFIKKRQSRASRRGVSREEI 62
Query: 65  -REIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXX 123
            RE+++LR++ H NVI L  V+ +  D  V +L   +  +L+  +    A K +      
Sbjct: 63  EREVSILRQVLHHNVITLHDVYENRTD-VVLILELVSGGELFDFL----AQKESLSEEEA 117
Query: 124 XXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNP 183
                 S + QILDG++YLH+  + H DLKP NI+++ + I    +K+ D G A    + 
Sbjct: 118 T-----SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA----HE 168
Query: 184 LKPLADLDPVVVTFWYRAPELL----LGARHYTKAIDIWAIGCIFAELLTSEPIF--HCR 237
           ++   +   +  T  + APE++    LG        D+W+IG I   LL+    F    +
Sbjct: 169 IEDGVEFKNIFGTPEFVAPEIVNYEPLGLE-----ADMWSIGVITYILLSGASPFLGDTK 223
Query: 238 QEDIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM 273
           QE +       +D  +  FS     L KD+  IRK+
Sbjct: 224 QETLANITSVSYDFDEEFFSHTS-ELAKDF--IRKL 256

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMS-----ACREIALLRELKHPNV 78
           G  +G G++     AR  + + +R+YA+K +E   +          RE  ++  L HP  
Sbjct: 35  GKILGEGSFSTTVLAR--ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           + L   F   +D K++    YA++    ++K+ R   +                 +I+  
Sbjct: 93  VKLYFTF--QDDEKLYFGLSYAKNG--ELLKYIRKIGSFDETCTRFYTA------EIVSA 142
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + YLH   ++HRDLKP NIL+     E   ++I D G A++  +P    A  +  V T  
Sbjct: 143 LEYLHGKGIIHRDLKPENILLN----EDMHIQITDFGTAKVL-SPESKQARANXFVGTAQ 197
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
           Y +PELL   +   K+ D+WA+GCI  +L+   P F    E
Sbjct: 198 YVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 237

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 103/221 (46%), Gaps = 26/221 (11%)
Query: 17  EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHP 76
           E++FD    K+G G+YG VYKA  K+       A+KQ+          +EI+++++   P
Sbjct: 28  EEVFDVLE-KLGEGSYGSVYKAIHKETGQI--VAIKQVPVESDLQEIIKEISIMQQCDSP 84
Query: 77  NVINLISVFLSHNDRKVWLLFDY-AEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQI 135
           +V+     +  + D  +W++ +Y     +  II+                    ++L   
Sbjct: 85  HVVKYYGSYFKNTD--LWIVMEYCGAGSVSDIIRLRNKT--------LTEDEIATILQST 134
Query: 136 LDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVV 195
           L G+ YLH    +HRD+K  NIL+  E    G  K+AD G A    +    +A  + V+ 
Sbjct: 135 LKGLEYLHFMRKIHRDIKAGNILLNTE----GHAKLADFGVAGQLTD---XMAKRNXVIG 187
Query: 196 TFWYRAPELL--LGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           T ++ APE++  +G   Y    DIW++G    E+   +P +
Sbjct: 188 TPFWMAPEVIQEIG---YNCVADIWSLGITAIEMAEGKPPY 225

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 105/212 (49%), Gaps = 25/212 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQ--IEGTGLSMSACREIALLRELKHPNVINLIS 83
           K+G+G  G VY A   D +  ++ A++Q  ++          EI ++RE K+PN++N + 
Sbjct: 27  KIGQGASGTVYTAM--DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 84  VFLSHNDRKVWLLFDY-AEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
            +L  ++  +W++ +Y A   L  ++                     ++  + L  + +L
Sbjct: 85  SYLVGDE--LWVVMEYLAGGSLTDVV----------TETCMDEGQIAAVCRECLQALEFL 132
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAP 202
           HSN V+HRD+K  NIL+   G++ G VK+ D GF           +    +V T ++ AP
Sbjct: 133 HSNQVIHRDIKSDNILL---GMD-GSVKLTDFGFCAQIT---PEQSKRSTMVGTPYWMAP 185
Query: 203 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           E++   + Y   +DIW++G +  E++  EP +
Sbjct: 186 EVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 34/215 (15%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIE---GTGLSMSACREIALLRELKHPNVINLI 82
           K+G+G++G V+K    DN   +  A+K I+            +EI +L +   P V    
Sbjct: 34  KIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 91
Query: 83  SVFLSHNDRKVWLLFDY----AEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
             +L   D K+W++ +Y    +  DL           A             ++L +IL G
Sbjct: 92  GSYL--KDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-------------TILREILKG 136
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA-RLFNNPLKPLADLDPVVVTF 197
           + YLHS   +HRD+K AN+L+     E G VK+AD G A +L +  +K     +  V T 
Sbjct: 137 LDYLHSEKKIHRDIKAANVLLS----EHGEVKLADFGVAGQLTDTQIK----RNTFVGTP 188
Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 232
           ++ APE++  + + +KA DIW++G    EL   EP
Sbjct: 189 FWMAPEVIKQSAYDSKA-DIWSLGITAIELARGEP 222

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 108/236 (45%), Gaps = 30/236 (12%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           K+GRG Y  V++A    N++     + +           + +  LR    PN+I L  + 
Sbjct: 44  KLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNIITLADIV 101
Query: 86  LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSN 145
                R   L+F++  +  +  ++                      +Y+IL  + Y HS 
Sbjct: 102 KDPVSRTPALVFEHVNNTDFKQLR-----------QTLTDYDIRFYMYEILKALDYCHSM 150
Query: 146 WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELL 205
            ++HRD+KP N+++     E  ++++ D G A  ++    P  + +  V + +++ PELL
Sbjct: 151 GIMHRDVKPHNVMI---DHEHRKLRLIDWGLAEFYH----PGQEYNVRVASRYFKGPELL 203
Query: 206 LGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           +  + Y  ++D+W++GC+ A ++   EP FH            ++DQL RI  V+G
Sbjct: 204 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD---------NYDQLVRIAKVLG 250

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 106/216 (49%), Gaps = 28/216 (12%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACR-----EIALLRELKHPNVIN 80
           K+G G YG V   + K     R  A+K I+ + ++ ++       E+A+L++L HPN++ 
Sbjct: 28  KLGSGAYGEVLLCKDKLTGAER--AIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMK 85
Query: 81  LISVFLSHNDRKVWLLFD-YAEHDLW-HIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           L   F   + R  +L+ + Y   +L+  II   + ++ +             ++ Q+L G
Sbjct: 86  LYEFF--EDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV----------IMKQVLSG 133
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
             YLH + ++HRDLKP N+L+  +  +   +KI D G +  F    K    +   + T +
Sbjct: 134 TTYLHKHNIVHRDLKPENLLLESKSRD-ALIKIVDFGLSAHFEVGGK----MKERLGTAY 188
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           Y APE+L   + Y +  D+W+ G I   LL   P F
Sbjct: 189 YIAPEVL--RKKYDEKCDVWSCGVILYILLCGYPPF 222

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 105/212 (49%), Gaps = 25/212 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQ--IEGTGLSMSACREIALLRELKHPNVINLIS 83
           K+G+G  G VY A   D +  ++ A++Q  ++          EI ++RE K+PN++N + 
Sbjct: 27  KIGQGASGTVYTAM--DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 84  VFLSHNDRKVWLLFDY-AEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
            +L  ++  +W++ +Y A   L  ++                     ++  + L  + +L
Sbjct: 85  SYLVGDE--LWVVMEYLAGGSLTDVV----------TETCMDEGQIAAVCRECLQALEFL 132
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAP 202
           HSN V+HRD+K  NIL+   G++ G VK+ D GF           + +   V T ++ AP
Sbjct: 133 HSNQVIHRDIKSDNILL---GMD-GSVKLTDFGFCAQITPEQSKRSXM---VGTPYWMAP 185
Query: 203 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           E++   + Y   +DIW++G +  E++  EP +
Sbjct: 186 EVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 105/212 (49%), Gaps = 25/212 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQ--IEGTGLSMSACREIALLRELKHPNVINLIS 83
           K+G+G  G VY A   D +  ++ A++Q  ++          EI ++RE K+PN++N + 
Sbjct: 28  KIGQGASGTVYTAM--DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 85
Query: 84  VFLSHNDRKVWLLFDY-AEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
            +L  ++  +W++ +Y A   L  ++                     ++  + L  + +L
Sbjct: 86  SYLVGDE--LWVVMEYLAGGSLTDVV----------TETCMDEGQIAAVCRECLQALEFL 133
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAP 202
           HSN V+HRD+K  NIL+   G++ G VK+ D GF           + +   V T ++ AP
Sbjct: 134 HSNQVIHRDIKSDNILL---GMD-GSVKLTDFGFCAQITPEQSKRSXM---VGTPYWMAP 186
Query: 203 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           E++   + Y   +DIW++G +  E++  EP +
Sbjct: 187 EVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPY 217

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 34/215 (15%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIE---GTGLSMSACREIALLRELKHPNVINLI 82
           K+G+G++G V+K    DN   +  A+K I+            +EI +L +   P V    
Sbjct: 14  KIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 71
Query: 83  SVFLSHNDRKVWLLFDY----AEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
             +L   D K+W++ +Y    +  DL           A             ++L +IL G
Sbjct: 72  GSYL--KDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-------------TILREILKG 116
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA-RLFNNPLKPLADLDPVVVTF 197
           + YLHS   +HRD+K AN+L+     E G VK+AD G A +L +  +K     +  V T 
Sbjct: 117 LDYLHSEKKIHRDIKAANVLLS----EHGEVKLADFGVAGQLTDTQIK----RNTFVGTP 168
Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 232
           ++ APE++  + + +KA DIW++G    EL   EP
Sbjct: 169 FWMAPEVIKQSAYDSKA-DIWSLGITAIELARGEP 202

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 105/236 (44%), Gaps = 30/236 (12%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           K+GRG Y  V++A    N++     + +           + +  LR    PN+I L  + 
Sbjct: 44  KLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNIITLADIV 101
Query: 86  LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSN 145
                R   L+F++  +                             +Y+IL  + Y HS 
Sbjct: 102 KDPVSRTPALVFEHVNN-----------TDFKQLYQTLTDYDIRFYMYEILKALDYCHSM 150
Query: 146 WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELL 205
            ++HRD+KP N+++     E  ++++ D G A  ++    P  + +  V + +++ PELL
Sbjct: 151 GIMHRDVKPHNVMI---DHEHRKLRLIDWGLAEFYH----PGQEYNVRVASRYFKGPELL 203
Query: 206 LGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           +  + Y  ++D+W++GC+ A ++   EP FH            ++DQL RI  V+G
Sbjct: 204 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD---------NYDQLVRIAKVLG 250

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 105/236 (44%), Gaps = 30/236 (12%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           K+GRG Y  V++A    N++     + +           + +  LR    PN+I L  + 
Sbjct: 43  KLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNIITLADIV 100
Query: 86  LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSN 145
                R   L+F++  +                             +Y+IL  + Y HS 
Sbjct: 101 KDPVSRTPALVFEHVNN-----------TDFKQLYQTLTDYDIRFYMYEILKALDYCHSM 149
Query: 146 WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELL 205
            ++HRD+KP N+++     E  ++++ D G A  ++    P  + +  V + +++ PELL
Sbjct: 150 GIMHRDVKPHNVMI---DHEHRKLRLIDWGLAEFYH----PGQEYNVRVASRYFKGPELL 202
Query: 206 LGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           +  + Y  ++D+W++GC+ A ++   EP FH            ++DQL RI  V+G
Sbjct: 203 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD---------NYDQLVRIAKVLG 249

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 34/215 (15%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIE---GTGLSMSACREIALLRELKHPNVINLI 82
           K+G+G++G V+K    DN   +  A+K I+            +EI +L +   P V    
Sbjct: 29  KIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 86
Query: 83  SVFLSHNDRKVWLLFDY----AEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
             +L   D K+W++ +Y    +  DL           A             ++L +IL G
Sbjct: 87  GSYL--KDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-------------TILREILKG 131
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA-RLFNNPLKPLADLDPVVVTF 197
           + YLHS   +HRD+K AN+L+     E G VK+AD G A +L +  +K     +  V T 
Sbjct: 132 LDYLHSEKKIHRDIKAANVLLS----EHGEVKLADFGVAGQLTDTQIK----RNXFVGTP 183
Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 232
           ++ APE++  + + +KA DIW++G    EL   EP
Sbjct: 184 FWMAPEVIKQSAYDSKA-DIWSLGITAIELARGEP 217

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 111/263 (42%), Gaps = 53/263 (20%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-----------------C---- 64
           ++G+G+YG V K    +N +T  YA+K +    L   A                 C    
Sbjct: 20  EIGKGSYG-VVKLAYNENDNTY-YAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77
Query: 65  -------REIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKAN 117
                  +EIA+L++L HPNV+ L+ V    N+  ++++F+         +   +    +
Sbjct: 78  GPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSED 137
Query: 118 XXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA 177
                            ++ GI YLH   ++HRD+KP+N+LV     E G +KIAD G +
Sbjct: 138 QARFY---------FQDLIKGIEYLHYQKIIHRDIKPSNLLVG----EDGHIKIADFGVS 184
Query: 178 RLFNNPLKPLADLDPVVVTFWYRAPELLLGARHY--TKAIDIWAIGC-----IFAELLTS 230
             F      L++    V T  + APE L   R     KA+D+WA+G      +F +    
Sbjct: 185 NEFKGSDALLSN---TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241
Query: 231 EPIFHCRQEDIKTSNPYHHDQLD 253
           +    C    IK+      DQ D
Sbjct: 242 DERIMCLHSKIKSQALEFPDQPD 264

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 105/236 (44%), Gaps = 30/236 (12%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           K+GRG Y  V++A    N++     + +           + +  LR    PN+I L  + 
Sbjct: 44  KLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNIITLADIV 101
Query: 86  LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSN 145
                R   L+F++  +                             +Y+IL  + Y HS 
Sbjct: 102 KDPVSRTPALVFEHVNN-----------TDFKQLYQTLTDYDIRFYMYEILKALDYCHSM 150
Query: 146 WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELL 205
            ++HRD+KP N+++     E  ++++ D G A  ++    P  + +  V + +++ PELL
Sbjct: 151 GIMHRDVKPHNVMI---DHEHRKLRLIDWGLAEFYH----PGQEYNVRVASRYFKGPELL 203
Query: 206 LGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           +  + Y  ++D+W++GC+ A ++   EP FH            ++DQL RI  V+G
Sbjct: 204 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD---------NYDQLVRIAKVLG 250

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 105/236 (44%), Gaps = 30/236 (12%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           K+GRG Y  V++A    N++     + +           + +  LR    PN+I L  + 
Sbjct: 44  KLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNIITLADIV 101
Query: 86  LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSN 145
                R   L+F++  +                             +Y+IL  + Y HS 
Sbjct: 102 KDPVSRTPALVFEHVNN-----------TDFKQLYQTLTDYDIRFYMYEILKALDYCHSM 150
Query: 146 WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELL 205
            ++HRD+KP N+++     E  ++++ D G A  ++    P  + +  V + +++ PELL
Sbjct: 151 GIMHRDVKPHNVMI---DHEHRKLRLIDWGLAEFYH----PGQEYNVRVASRYFKGPELL 203
Query: 206 LGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           +  + Y  ++D+W++GC+ A ++   EP FH            ++DQL RI  V+G
Sbjct: 204 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD---------NYDQLVRIAKVLG 250

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 105/236 (44%), Gaps = 30/236 (12%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           K+GRG Y  V++A    N++     + +           + +  LR    PN+I L  + 
Sbjct: 44  KLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNIITLADIV 101
Query: 86  LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSN 145
                R   L+F++  +                             +Y+IL  + Y HS 
Sbjct: 102 KDPVSRTPALVFEHVNN-----------TDFKQLYQTLTDYDIRFYMYEILKALDYCHSM 150
Query: 146 WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELL 205
            ++HRD+KP N+++     E  ++++ D G A  ++    P  + +  V + +++ PELL
Sbjct: 151 GIMHRDVKPHNVMI---DHEHRKLRLIDWGLAEFYH----PGQEYNVRVASRYFKGPELL 203
Query: 206 LGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           +  + Y  ++D+W++GC+ A ++   EP FH            ++DQL RI  V+G
Sbjct: 204 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD---------NYDQLVRIAKVLG 250

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 95/225 (42%), Gaps = 33/225 (14%)
Query: 16  VEDLFDYEGCKVGRGTYGHVYKARRKD----------NSDTRDYALKQIEGTGLSMSACR 65
           ++DLF ++  K+G G +G V+    +           N D     ++QIE          
Sbjct: 20  IDDLFIFKR-KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEA--------- 69
Query: 66  EIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXX 125
           EI +L+ L HPN+I +  VF  +++  ++++ +  E          R   A         
Sbjct: 70  EIEVLKSLDHPNIIKIFEVFEDYHN--MYIVMETCEGGEL----LERIVSAQARGKALSE 123
Query: 126 XXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLK 185
                L+ Q+++ + Y HS  V+H+DLKP NIL          +KI D G A LF    K
Sbjct: 124 GYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTS-PHSPIKIIDFGLAELF----K 178
Query: 186 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 230
                     T  Y APE+    R  T   DIW+ G +   LLT 
Sbjct: 179 SDEHSTNAAGTALYMAPEVF--KRDVTFKCDIWSAGVVMYFLLTG 221

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 105/236 (44%), Gaps = 30/236 (12%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           K+GRG Y  V++A    N++     + +           + +  LR    PN+I L  + 
Sbjct: 44  KLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNIITLADIV 101
Query: 86  LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSN 145
                R   L+F++  +                             +Y+IL  + Y HS 
Sbjct: 102 KDPVSRTPALVFEHVNN-----------TDFKQLYQTLTDYDIRFYMYEILKALDYCHSM 150
Query: 146 WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELL 205
            ++HRD+KP N+++     E  ++++ D G A  ++    P  + +  V + +++ PELL
Sbjct: 151 GIMHRDVKPHNVMI---DHEHRKLRLIDWGLAEFYH----PGQEYNVRVASRYFKGPELL 203
Query: 206 LGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           +  + Y  ++D+W++GC+ A ++   EP FH            ++DQL RI  V+G
Sbjct: 204 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD---------NYDQLVRIAKVLG 250

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 105/236 (44%), Gaps = 30/236 (12%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           K+GRG Y  V++A    N++     + +           + +  LR    PN+I L  + 
Sbjct: 42  KLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNIITLADIV 99
Query: 86  LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSN 145
                R   L+F++  +                             +Y+IL  + Y HS 
Sbjct: 100 KDPVSRTPALVFEHVNN-----------TDFKQLYQTLTDYDIRFYMYEILKALDYCHSM 148
Query: 146 WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELL 205
            ++HRD+KP N+++     E  ++++ D G A  ++    P  + +  V + +++ PELL
Sbjct: 149 GIMHRDVKPHNVMI---DHEHRKLRLIDWGLAEFYH----PGQEYNVRVASRYFKGPELL 201
Query: 206 LGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           +  + Y  ++D+W++GC+ A ++   EP FH            ++DQL RI  V+G
Sbjct: 202 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD---------NYDQLVRIAKVLG 248

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 105/236 (44%), Gaps = 30/236 (12%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           K+GRG Y  V++A    N++     + +           + +  LR    PN+I L  + 
Sbjct: 44  KLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNIITLADIV 101
Query: 86  LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSN 145
                R   L+F++  +                             +Y+IL  + Y HS 
Sbjct: 102 KDPVSRTPALVFEHVNN-----------TDFKQLYQTLTDYDIRFYMYEILKALDYCHSM 150
Query: 146 WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELL 205
            ++HRD+KP N+++     E  ++++ D G A  ++    P  + +  V + +++ PELL
Sbjct: 151 GIMHRDVKPHNVMI---DHEHRKLRLIDWGLAEFYH----PGQEYNVRVASRYFKGPELL 203
Query: 206 LGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           +  + Y  ++D+W++GC+ A ++   EP FH            ++DQL RI  V+G
Sbjct: 204 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD---------NYDQLVRIAKVLG 250

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 105/236 (44%), Gaps = 30/236 (12%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           K+GRG Y  V++A    N++     + +           + +  LR    PN+I L  + 
Sbjct: 44  KLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNIITLADIV 101
Query: 86  LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSN 145
                R   L+F++  +                             +Y+IL  + Y HS 
Sbjct: 102 KDPVSRTPALVFEHVNN-----------TDFKQLYQTLTDYDIRFYMYEILKALDYCHSM 150
Query: 146 WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELL 205
            ++HRD+KP N+++     E  ++++ D G A  ++    P  + +  V + +++ PELL
Sbjct: 151 GIMHRDVKPHNVMI---DHEHRKLRLIDWGLAEFYH----PGQEYNVRVASRYFKGPELL 203
Query: 206 LGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           +  + Y  ++D+W++GC+ A ++   EP FH            ++DQL RI  V+G
Sbjct: 204 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD---------NYDQLVRIAKVLG 250

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 105/236 (44%), Gaps = 30/236 (12%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           K+GRG Y  V++A    N++     + +           + +  LR    PN+I L  + 
Sbjct: 44  KLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNIITLADIV 101
Query: 86  LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSN 145
                R   L+F++  +                             +Y+IL  + Y HS 
Sbjct: 102 KDPVSRTPALVFEHVNN-----------TDFKQLYQTLTDYDIRFYMYEILKALDYCHSM 150
Query: 146 WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELL 205
            ++HRD+KP N+++     E  ++++ D G A  ++    P  + +  V + +++ PELL
Sbjct: 151 GIMHRDVKPHNVMI---DHEHRKLRLIDWGLAEFYH----PGQEYNVRVASRYFKGPELL 203
Query: 206 LGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           +  + Y  ++D+W++GC+ A ++   EP FH            ++DQL RI  V+G
Sbjct: 204 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD---------NYDQLVRIAKVLG 250

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 105/236 (44%), Gaps = 30/236 (12%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           K+GRG Y  V++A    N++     + +           + +  LR    PN+I L  + 
Sbjct: 43  KLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNIITLADIV 100
Query: 86  LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSN 145
                R   L+F++  +                             +Y+IL  + Y HS 
Sbjct: 101 KDPVSRTPALVFEHVNN-----------TDFKQLYQTLTDYDIRFYMYEILKALDYCHSM 149
Query: 146 WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELL 205
            ++HRD+KP N+++     E  ++++ D G A  ++    P  + +  V + +++ PELL
Sbjct: 150 GIMHRDVKPHNVMI---DHEHRKLRLIDWGLAEFYH----PGQEYNVRVASRYFKGPELL 202
Query: 206 LGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           +  + Y  ++D+W++GC+ A ++   EP FH            ++DQL RI  V+G
Sbjct: 203 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD---------NYDQLVRIAKVLG 249

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 105/236 (44%), Gaps = 30/236 (12%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           K+GRG Y  V++A    N++     + +           + +  LR    PN+I L  + 
Sbjct: 49  KLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNIITLADIV 106
Query: 86  LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSN 145
                R   L+F++  +                             +Y+IL  + Y HS 
Sbjct: 107 KDPVSRTPALVFEHVNN-----------TDFKQLYQTLTDYDIRFYMYEILKALDYCHSM 155
Query: 146 WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELL 205
            ++HRD+KP N+++     E  ++++ D G A  ++    P  + +  V + +++ PELL
Sbjct: 156 GIMHRDVKPHNVMI---DHEHRKLRLIDWGLAEFYH----PGQEYNVRVASRYFKGPELL 208
Query: 206 LGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           +  + Y  ++D+W++GC+ A ++   EP FH            ++DQL RI  V+G
Sbjct: 209 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD---------NYDQLVRIAKVLG 255

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 34/215 (15%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIE---GTGLSMSACREIALLRELKHPNVINLI 82
           K+G+G++G V+K    DN   +  A+K I+            +EI +L +   P V    
Sbjct: 14  KIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 71
Query: 83  SVFLSHNDRKVWLLFDY----AEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
             +L   D K+W++ +Y    +  DL           A             ++L +IL G
Sbjct: 72  GSYL--KDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-------------TILREILKG 116
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA-RLFNNPLKPLADLDPVVVTF 197
           + YLHS   +HRD+K AN+L+     E G VK+AD G A +L +  +K     +  V T 
Sbjct: 117 LDYLHSEKKIHRDIKAANVLLS----EHGEVKLADFGVAGQLTDTQIK----RNXFVGTP 168
Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 232
           ++ APE++  + + +KA DIW++G    EL   EP
Sbjct: 169 FWMAPEVIKQSAYDSKA-DIWSLGITAIELARGEP 202

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 105/236 (44%), Gaps = 30/236 (12%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           K+GRG Y  V++A    N++     + +           + +  LR    PN+I L  + 
Sbjct: 44  KLGRGKYSEVFEAINITNNEKVAVKILKPVKKKKIKREIKILENLR--GGPNIITLADIV 101
Query: 86  LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSN 145
                R   L+F++  +                             +Y+IL  + Y HS 
Sbjct: 102 KDPVSRTPALVFEHVNN-----------TDFKQLYQTLTDYDIRFYMYEILKALDYCHSM 150
Query: 146 WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELL 205
            ++HRD+KP N+L+     E  ++++ D G A  ++    P  + +  V + +++ PELL
Sbjct: 151 GIMHRDVKPHNVLI---DHEHRKLRLIDWGLAEFYH----PGQEYNVRVASRYFKGPELL 203
Query: 206 LGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           +  + Y  ++D+W++GC+ A ++   EP FH            ++DQL RI  V+G
Sbjct: 204 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD---------NYDQLVRIAKVLG 250

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 105/220 (47%), Gaps = 28/220 (12%)
Query: 21  DYE-GCKVGRGTYGHVYKARRKDNSDTRDYALK-----QIEGTGLSMSACREIALLRELK 74
           D+E G  +G+G +G+VY AR K +      ALK     QIE  G+     REI +   L 
Sbjct: 24  DFEIGRPLGKGKFGNVYLAREKKSHFI--VALKVLFKSQIEKEGVEHQLRREIEIQAHLH 81
Query: 75  HPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQ 134
           HPN++ L + F  ++ R+++L+ +YA     +        K              +++ +
Sbjct: 82  HPNILRLYNYF--YDRRRIYLILEYAPRGELY--------KELQKSCTFDEQRTATIMEE 131
Query: 135 ILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVV 194
           + D + Y H   V+HRD+KP N+L+      +G +KIAD G++        P      + 
Sbjct: 132 LADALMYCHGKKVIHRDIKPENLLLG----LKGELKIADFGWSV-----HAPSLRRKTMC 182
Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
            T  Y  PE++ G  H  K +D+W IG +  ELL   P F
Sbjct: 183 GTLDYLPPEMIEGRMHNEK-VDLWCIGVLCYELLVGNPPF 221

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 113/245 (46%), Gaps = 48/245 (19%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           K+GRG Y  V++A    N++     + +           + +  LR     N+I LI   
Sbjct: 45  KLGRGKYSEVFEAINITNNERVVVKILKPVKKKKIKREVKILENLR--GGTNIIKLIDTV 102
Query: 86  LSHNDRKVWLLFDYAEH----DLWHI-----IKFHRAAKANXXXXXXXXXXXXSLLYQIL 136
                +   L+F+Y  +     L+ I     I+F+                    +Y++L
Sbjct: 103 KDPVSKTPALVFEYINNTDFKQLYQILTDFDIRFY--------------------MYELL 142
Query: 137 DGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVT 196
             + Y HS  ++HRD+KP N+++     ++ ++++ D G A  ++    P  + +  V +
Sbjct: 143 KALDYCHSKGIMHRDVKPHNVMI---DHQQKKLRLIDWGLAEFYH----PAQEYNVRVAS 195
Query: 197 FWYRAPELLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPYHHDQLDRI 255
            +++ PELL+  + Y  ++D+W++GC+ A ++   EP FH +          ++DQL RI
Sbjct: 196 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQD---------NYDQLVRI 246
Query: 256 FSVMG 260
             V+G
Sbjct: 247 AKVLG 251

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 113/245 (46%), Gaps = 48/245 (19%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           K+GRG Y  V++A    N++     + +           + +  LR     N+I LI   
Sbjct: 50  KLGRGKYSEVFEAINITNNERVVVKILKPVKKKKIKREVKILENLR--GGTNIIKLIDTV 107
Query: 86  LSHNDRKVWLLFDYAEH----DLWHI-----IKFHRAAKANXXXXXXXXXXXXSLLYQIL 136
                +   L+F+Y  +     L+ I     I+F+                    +Y++L
Sbjct: 108 KDPVSKTPALVFEYINNTDFKQLYQILTDFDIRFY--------------------MYELL 147
Query: 137 DGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVT 196
             + Y HS  ++HRD+KP N+++     ++ ++++ D G A  ++    P  + +  V +
Sbjct: 148 KALDYCHSKGIMHRDVKPHNVMI---DHQQKKLRLIDWGLAEFYH----PAQEYNVRVAS 200
Query: 197 FWYRAPELLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPYHHDQLDRI 255
            +++ PELL+  + Y  ++D+W++GC+ A ++   EP FH +          ++DQL RI
Sbjct: 201 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQD---------NYDQLVRI 251
Query: 256 FSVMG 260
             V+G
Sbjct: 252 AKVLG 256

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 105/212 (49%), Gaps = 25/212 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQ--IEGTGLSMSACREIALLRELKHPNVINLIS 83
           K+G+G  G VY A   D +  ++ A++Q  ++          EI ++RE K+PN++N + 
Sbjct: 28  KIGQGASGTVYTAM--DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 85
Query: 84  VFLSHNDRKVWLLFDY-AEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
            +L  ++  +W++ +Y A   L  ++                     ++  + L  + +L
Sbjct: 86  SYLVGDE--LWVVMEYLAGGSLTDVV----------TETCMDEGQIAAVCRECLQALEFL 133
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAP 202
           HSN V+HR++K  NIL+   G++ G VK+ D GF           +    +V T ++ AP
Sbjct: 134 HSNQVIHRNIKSDNILL---GMD-GSVKLTDFGFCAQIT---PEQSKRSTMVGTPYWMAP 186
Query: 203 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           E++   + Y   +DIW++G +  E++  EP +
Sbjct: 187 EVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPY 217

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 108/246 (43%), Gaps = 34/246 (13%)
Query: 19  LFDYEGCK-VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMS---ACREIALLRELK 74
           L D+E  + +GRG +G V++A  K+  D  +YA+K+I      ++     RE+  L +L+
Sbjct: 4   LTDFEPIQCLGRGGFGVVFEA--KNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 75  HPNVINLISVFLSHNDR--------KVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXX 126
           HP ++   + +L  N          KV+L   Y +  L                      
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYL---YIQMQLCRKENLKDWMNGRCTIEERERS 118
Query: 127 XXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKP 186
               +  QI + + +LHS  ++HRDLKP+NI    + +    VK+ D G     +   + 
Sbjct: 119 VCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV----VKVGDFGLVTAMDQDEEE 174
Query: 187 LADLDPV---------VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 237
              L P+         V T  Y +PE + G   Y+  +DI+++G I  ELL     F  +
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLYP---FSTQ 230
Query: 238 QEDIKT 243
            E ++T
Sbjct: 231 MERVRT 236

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 122/268 (45%), Gaps = 34/268 (12%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFL 86
           +GRG +G VY  R+ D      YA+K ++   + M     +AL   +    +++L+S   
Sbjct: 196 IGRGGFGEVYGCRKADTGKM--YAMKCLDKKRIKMKQGETLALNERI----MLSLVST-- 247
Query: 87  SHNDRKVWLLFDYAEH---DLWHIIKFHRAAKANXXXXXXXXXXXXSLLY---QILDGIH 140
              D    +   YA H    L  I+        +             + +   +I+ G+ 
Sbjct: 248 --GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 305
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           ++H+ +V++RDLKPANIL+     E G V+I+D+G A  F+   KP A     V T  Y 
Sbjct: 306 HMHNRFVVYRDLKPANILL----DEHGHVRISDLGLACDFSKK-KPHAS----VGTHGYM 356
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           APE+L     Y  + D +++GC+  +LL     F  RQ   K  +     ++DR+   M 
Sbjct: 357 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF--RQHKTKDKH-----EIDRMTLTMA 409
Query: 261 FPLEKDWE-DIRKMPEHPTLLKDFNEQI 287
             L   +  ++R + E   L +D N ++
Sbjct: 410 VELPDSFSPELRSLLEG-LLQRDVNRRL 436

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 122/268 (45%), Gaps = 34/268 (12%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFL 86
           +GRG +G VY  R+ D      YA+K ++   + M     +AL   +    +++L+S   
Sbjct: 197 IGRGGFGEVYGCRKADTGKM--YAMKCLDKKRIKMKQGETLALNERI----MLSLVST-- 248
Query: 87  SHNDRKVWLLFDYAEH---DLWHIIKFHRAAKANXXXXXXXXXXXXSLLY---QILDGIH 140
              D    +   YA H    L  I+        +             + +   +I+ G+ 
Sbjct: 249 --GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 306
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           ++H+ +V++RDLKPANIL+     E G V+I+D+G A  F+   KP A     V T  Y 
Sbjct: 307 HMHNRFVVYRDLKPANILL----DEHGHVRISDLGLACDFSKK-KPHAS----VGTHGYM 357
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           APE+L     Y  + D +++GC+  +LL     F  RQ   K  +     ++DR+   M 
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF--RQHKTKDKH-----EIDRMTLTMA 410
Query: 261 FPLEKDWE-DIRKMPEHPTLLKDFNEQI 287
             L   +  ++R + E   L +D N ++
Sbjct: 411 VELPDSFSPELRSLLEG-LLQRDVNRRL 437

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 122/268 (45%), Gaps = 34/268 (12%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFL 86
           +GRG +G VY  R+ D      YA+K ++   + M     +AL   +    +++L+S   
Sbjct: 197 IGRGGFGEVYGCRKADTGKM--YAMKCLDKKRIKMKQGETLALNERI----MLSLVST-- 248
Query: 87  SHNDRKVWLLFDYAEH---DLWHIIKFHRAAKANXXXXXXXXXXXXSLLY---QILDGIH 140
              D    +   YA H    L  I+        +             + +   +I+ G+ 
Sbjct: 249 --GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 306
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           ++H+ +V++RDLKPANIL+     E G V+I+D+G A  F+   KP A     V T  Y 
Sbjct: 307 HMHNRFVVYRDLKPANILL----DEHGHVRISDLGLACDFSKK-KPHAS----VGTHGYM 357
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           APE+L     Y  + D +++GC+  +LL     F  RQ   K  +     ++DR+   M 
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF--RQHKTKDKH-----EIDRMTLTMA 410
Query: 261 FPLEKDWE-DIRKMPEHPTLLKDFNEQI 287
             L   +  ++R + E   L +D N ++
Sbjct: 411 VELPDSFSPELRSLLEG-LLQRDVNRRL 437

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 122/268 (45%), Gaps = 34/268 (12%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFL 86
           +GRG +G VY  R+ D      YA+K ++   + M     +AL   +    +++L+S   
Sbjct: 197 IGRGGFGEVYGCRKADTGKM--YAMKCLDKKRIKMKQGETLALNERI----MLSLVST-- 248
Query: 87  SHNDRKVWLLFDYAEH---DLWHIIKFHRAAKANXXXXXXXXXXXXSLLY---QILDGIH 140
              D    +   YA H    L  I+        +             + +   +I+ G+ 
Sbjct: 249 --GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 306
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           ++H+ +V++RDLKPANIL+     E G V+I+D+G A  F+   KP A     V T  Y 
Sbjct: 307 HMHNRFVVYRDLKPANILL----DEHGHVRISDLGLACDFSKK-KPHAS----VGTHGYM 357
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           APE+L     Y  + D +++GC+  +LL     F  RQ   K  +     ++DR+   M 
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF--RQHKTKDKH-----EIDRMTLTMA 410
Query: 261 FPLEKDWE-DIRKMPEHPTLLKDFNEQI 287
             L   +  ++R + E   L +D N ++
Sbjct: 411 VELPDSFSPELRSLLEG-LLQRDVNRRL 437

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           ++G G +G VYKA+ K+        + + +          EI +L    HP ++ L+  +
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 86  LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSN 145
             ++D K+W++ ++        I                      +  Q+L+ +++LHS 
Sbjct: 86  --YHDGKLWIMIEFCPGGAVDAIMLE-------LDRGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 146 WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELL 205
            ++HRDLK  N+L+  E    G +++AD G +      LK L   D  + T ++ APE++
Sbjct: 137 RIIHRDLKAGNVLMTLE----GDIRLADFGVS---AKNLKTLQKRDSFIGTPYWMAPEVV 189
Query: 206 LGARH----YTKAIDIWAIGCIFAELLTSEPIFH 235
           +        Y    DIW++G    E+   EP  H
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH 223

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           ++G G +G VYKA+ K+        + + +          EI +L    HP ++ L+  +
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 86  LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSN 145
             ++D K+W++ ++        I                      +  Q+L+ +++LHS 
Sbjct: 78  --YHDGKLWIMIEFCPGGAVDAIMLE-------LDRGLTEPQIQVVCRQMLEALNFLHSK 128
Query: 146 WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELL 205
            ++HRDLK  N+L+  E    G +++AD G +      LK L   D  + T ++ APE++
Sbjct: 129 RIIHRDLKAGNVLMTLE----GDIRLADFGVS---AKNLKTLQKRDSFIGTPYWMAPEVV 181
Query: 206 LGARH----YTKAIDIWAIGCIFAELLTSEPIFH 235
           +        Y    DIW++G    E+   EP  H
Sbjct: 182 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH 215

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 83/178 (46%), Gaps = 18/178 (10%)
Query: 65  REIALLRELKHPNVINLISVFLSHNDRKVWLLFDY-AEHDLWHIIKFHRAAKANXXXXXX 123
           +EI  + +  HPN+++  + F+  ++  +WL+    +   +  IIK H  AK        
Sbjct: 62  KEIQAMSQCHHPNIVSYYTSFVVKDE--LWLVMKLLSGGSVLDIIK-HIVAKGEHKSGVL 118
Query: 124 XXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNP 183
                 ++L ++L+G+ YLH N  +HRD+K  NIL+     E G V+IAD G +      
Sbjct: 119 DESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLG----EDGSVQIADFGVSAF---- 170
Query: 184 LKPLADL------DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
           L    D+         V T  + APE++   R Y    DIW+ G    EL T    +H
Sbjct: 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYH 228

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/180 (31%), Positives = 87/180 (48%), Gaps = 17/180 (9%)
Query: 63  ACREIALLRELK-HPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXX 121
           A  EI LL E   HPNVI          DR +++  +    +L  +++    +  N    
Sbjct: 73  ALMEIKLLTESDDHPNVIRYYCS--ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQ 130
Query: 122 XXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGE---------GIERGRVKIA 172
                   SLL QI  G+ +LHS  ++HRDLKP NILV            G E  R+ I+
Sbjct: 131 KEYNPI--SLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 188
Query: 173 DMGFARLFNNPLKPL-ADLDPVVVTFWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLT 229
           D G  +  ++       +L+    T  +RAPELL  +  R  T++IDI+++GC+F  +L+
Sbjct: 189 DFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILS 248

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/180 (31%), Positives = 87/180 (48%), Gaps = 17/180 (9%)
Query: 63  ACREIALLRELK-HPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXX 121
           A  EI LL E   HPNVI          DR +++  +    +L  +++    +  N    
Sbjct: 73  ALMEIKLLTESDDHPNVIRYYCS--ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQ 130
Query: 122 XXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGE---------GIERGRVKIA 172
                   SLL QI  G+ +LHS  ++HRDLKP NILV            G E  R+ I+
Sbjct: 131 KEYNPI--SLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 188
Query: 173 DMGFARLFNNPLKPL-ADLDPVVVTFWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLT 229
           D G  +  ++       +L+    T  +RAPELL  +  R  T++IDI+++GC+F  +L+
Sbjct: 189 DFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILS 248

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 97/209 (46%), Gaps = 21/209 (10%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIE----GTGLSMSACREIALLRELKH-PNVIN 80
           ++GRG +  V +   K  S  ++YA K ++    G         EIA+L   K  P VIN
Sbjct: 36  ELGRGKFAVVRQCISK--STGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVIN 93
Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           L  V+   N  ++ L+ +YA       +     A+               L+ QIL+G++
Sbjct: 94  LHEVY--ENTSEIILILEYAAGGEIFSLCLPELAE------MVSENDVIRLIKQILEGVY 145
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YLH N ++H DLKP NIL +      G +KI D G +R   +      +L  ++ T  Y 
Sbjct: 146 YLHQNNIVHLDLKPQNIL-LSSIYPLGDIKIVDFGMSRKIGHA----CELREIMGTPEYL 200
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT 229
           APE +L     T A D+W IG I   LLT
Sbjct: 201 APE-ILNYDPITTATDMWNIGIIAYMLLT 228

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 83/178 (46%), Gaps = 18/178 (10%)
Query: 65  REIALLRELKHPNVINLISVFLSHNDRKVWLLFDY-AEHDLWHIIKFHRAAKANXXXXXX 123
           +EI  + +  HPN+++  + F+  ++  +WL+    +   +  IIK H  AK        
Sbjct: 57  KEIQAMSQCHHPNIVSYYTSFVVKDE--LWLVMKLLSGGSVLDIIK-HIVAKGEHKSGVL 113
Query: 124 XXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNP 183
                 ++L ++L+G+ YLH N  +HRD+K  NIL+     E G V+IAD G +      
Sbjct: 114 DESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLG----EDGSVQIADFGVSAF---- 165
Query: 184 LKPLADL------DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
           L    D+         V T  + APE++   R Y    DIW+ G    EL T    +H
Sbjct: 166 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYH 223

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 87/184 (47%), Gaps = 21/184 (11%)
Query: 63  ACREIALLRELK-HPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXX 121
           A  EI LL E   HPNVI          DR +++  +    +L  +++    +  N    
Sbjct: 55  ALMEIKLLTESDDHPNVIRYYCS--ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQ 112
Query: 122 XXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGE---------GIERGRVKIA 172
                   SLL QI  G+ +LHS  ++HRDLKP NILV            G E  R+ I+
Sbjct: 113 KEYNPI--SLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170
Query: 173 DMGFARLFNNPLKPL-ADLDPVVVTFWYRAPELLLGA------RHYTKAIDIWAIGCIFA 225
           D G  +  ++       +L+    T  +RAPELL  +      R  T++IDI+++GC+F 
Sbjct: 171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY 230
Query: 226 ELLT 229
            +L+
Sbjct: 231 YILS 234

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 34/215 (15%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIE---GTGLSMSACREIALLRELKHPNVINLI 82
           ++G+G++G V+K    DN   +  A+K I+            +EI +L +     V    
Sbjct: 30  RIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYY 87
Query: 83  SVFLSHNDRKVWLLFDY----AEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
             +L  +  K+W++ +Y    +  DL     F     A             ++L +IL G
Sbjct: 88  GSYLKGS--KLWIIMEYLGGGSALDLLRAGPFDEFQIA-------------TMLKEILKG 132
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA-RLFNNPLKPLADLDPVVVTF 197
           + YLHS   +HRD+K AN+L+     E+G VK+AD G A +L +  +K     +  V T 
Sbjct: 133 LDYLHSEKKIHRDIKAANVLLS----EQGDVKLADFGVAGQLTDTQIK----RNTFVGTP 184
Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 232
           ++ APE++  + + +KA DIW++G    EL   EP
Sbjct: 185 FWMAPEVIQQSAYDSKA-DIWSLGITAIELAKGEP 218

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 104/237 (43%), Gaps = 31/237 (13%)
Query: 27  VGRGTYGHVYKARRKDNS--------DTRDYALKQIEGTGLSMSACREIALLRELKHPNV 78
           +G G  G V  A  +             R +A+        +++   EI +L++L HP +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           I + + F + +   V  L +  E     ++   R  +A                YQ+L  
Sbjct: 78  IKIKNFFDAEDYYIVLELMEGGEL-FDKVVGNKRLKEATCKLY----------FYQMLLA 126
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + YLH N ++HRDLKP N+L+  +  E   +KI D G +++        + +  +  T  
Sbjct: 127 VQYLHENGIIHRDLKPENVLLSSQE-EDCLIKITDFGHSKILGE----TSLMRTLCGTPT 181
Query: 199 YRAPELL--LGARHYTKAIDIWAIGCIFAELLTSEPIF--HCRQEDIK---TSNPYH 248
           Y APE+L  +G   Y +A+D W++G I    L+  P F  H  Q  +K   TS  Y+
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 238

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 104/237 (43%), Gaps = 31/237 (13%)
Query: 27  VGRGTYGHVYKARRKDNS--------DTRDYALKQIEGTGLSMSACREIALLRELKHPNV 78
           +G G  G V  A  +             R +A+        +++   EI +L++L HP +
Sbjct: 24  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 83
Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           I + + F + +   V  L +  E     ++   R  +A                YQ+L  
Sbjct: 84  IKIKNFFDAEDYYIVLELMEGGEL-FDKVVGNKRLKEATCKLY----------FYQMLLA 132
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + YLH N ++HRDLKP N+L+  +  E   +KI D G +++        + +  +  T  
Sbjct: 133 VQYLHENGIIHRDLKPENVLLSSQE-EDCLIKITDFGHSKILGE----TSLMRTLCGTPT 187
Query: 199 YRAPELL--LGARHYTKAIDIWAIGCIFAELLTSEPIF--HCRQEDIK---TSNPYH 248
           Y APE+L  +G   Y +A+D W++G I    L+  P F  H  Q  +K   TS  Y+
Sbjct: 188 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 244

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 111/257 (43%), Gaps = 26/257 (10%)
Query: 27  VGRGTYGHVYKARRKDNS--------DTRDYALKQIEGTGLSMSACREIALLRELKHPNV 78
           +G G  G V  A  +             R +A+        +++   EI +L++L HP +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           I + + F + +   V  L +  E     ++   R  +A                YQ+L  
Sbjct: 203 IKIKNFFDAEDYYIVLELMEGGEL-FDKVVGNKRLKEATCKL----------YFYQMLLA 251
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + YLH N ++HRDLKP N+L+  +  E   +KI D G +++    L   + +  +  T  
Sbjct: 252 VQYLHENGIIHRDLKPENVLLSSQE-EDCLIKITDFGHSKI----LGETSLMRTLCGTPT 306
Query: 199 YRAPELL--LGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 256
           Y APE+L  +G   Y +A+D W++G I    L+  P F   +  +   +     + + I 
Sbjct: 307 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 366
Query: 257 SVMGFPLEKDWEDIRKM 273
            V     EK  + ++K+
Sbjct: 367 EVWAEVSEKALDLVKKL 383

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 104/237 (43%), Gaps = 31/237 (13%)
Query: 27  VGRGTYGHVYKARRKDNS--------DTRDYALKQIEGTGLSMSACREIALLRELKHPNV 78
           +G G  G V  A  +             R +A+        +++   EI +L++L HP +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           I + + F + +   V  L +  E     ++   R  +A                YQ+L  
Sbjct: 78  IKIKNFFDAEDYYIVLELMEGGEL-FDKVVGNKRLKEATCKLY----------FYQMLLA 126
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + YLH N ++HRDLKP N+L+  +  E   +KI D G +++        + +  +  T  
Sbjct: 127 VQYLHENGIIHRDLKPENVLLSSQE-EDCLIKITDFGHSKILGE----TSLMRTLCGTPT 181
Query: 199 YRAPELL--LGARHYTKAIDIWAIGCIFAELLTSEPIF--HCRQEDIK---TSNPYH 248
           Y APE+L  +G   Y +A+D W++G I    L+  P F  H  Q  +K   TS  Y+
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 238

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 111/257 (43%), Gaps = 26/257 (10%)
Query: 27  VGRGTYGHVYKARRKDNS--------DTRDYALKQIEGTGLSMSACREIALLRELKHPNV 78
           +G G  G V  A  +             R +A+        +++   EI +L++L HP +
Sbjct: 157 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 216
Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           I + + F + +   V  L +  E     ++   R  +A                YQ+L  
Sbjct: 217 IKIKNFFDAEDYYIVLELMEGGEL-FDKVVGNKRLKEATCKLY----------FYQMLLA 265
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + YLH N ++HRDLKP N+L+  +  E   +KI D G +++    L   + +  +  T  
Sbjct: 266 VQYLHENGIIHRDLKPENVLLSSQE-EDCLIKITDFGHSKI----LGETSLMRTLCGTPT 320
Query: 199 YRAPELL--LGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 256
           Y APE+L  +G   Y +A+D W++G I    L+  P F   +  +   +     + + I 
Sbjct: 321 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 380
Query: 257 SVMGFPLEKDWEDIRKM 273
            V     EK  + ++K+
Sbjct: 381 EVWAEVSEKALDLVKKL 397

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 104/237 (43%), Gaps = 31/237 (13%)
Query: 27  VGRGTYGHVYKARRKDNS--------DTRDYALKQIEGTGLSMSACREIALLRELKHPNV 78
           +G G  G V  A  +             R +A+        +++   EI +L++L HP +
Sbjct: 17  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 76
Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           I + + F + +   V  L +  E     ++   R  +A                YQ+L  
Sbjct: 77  IKIKNFFDAEDYYIVLELMEGGEL-FDKVVGNKRLKEATCKLY----------FYQMLLA 125
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + YLH N ++HRDLKP N+L+  +  E   +KI D G +++        + +  +  T  
Sbjct: 126 VQYLHENGIIHRDLKPENVLLSSQE-EDCLIKITDFGHSKILGE----TSLMRTLCGTPT 180
Query: 199 YRAPELL--LGARHYTKAIDIWAIGCIFAELLTSEPIF--HCRQEDIK---TSNPYH 248
           Y APE+L  +G   Y +A+D W++G I    L+  P F  H  Q  +K   TS  Y+
Sbjct: 181 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 237

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 104/237 (43%), Gaps = 31/237 (13%)
Query: 27  VGRGTYGHVYKARRKDNS--------DTRDYALKQIEGTGLSMSACREIALLRELKHPNV 78
           +G G  G V  A  +             R +A+        +++   EI +L++L HP +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           I + + F + +   V  L +  E     ++   R  +A                YQ+L  
Sbjct: 78  IKIKNFFDAEDYYIVLELMEGGEL-FDKVVGNKRLKEATCKLY----------FYQMLLA 126
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + YLH N ++HRDLKP N+L+  +  E   +KI D G +++        + +  +  T  
Sbjct: 127 VQYLHENGIIHRDLKPENVLLSSQE-EDCLIKITDFGHSKILGE----TSLMRTLCGTPT 181
Query: 199 YRAPELL--LGARHYTKAIDIWAIGCIFAELLTSEPIF--HCRQEDIK---TSNPYH 248
           Y APE+L  +G   Y +A+D W++G I    L+  P F  H  Q  +K   TS  Y+
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 238

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/232 (29%), Positives = 107/232 (46%), Gaps = 31/232 (13%)
Query: 11  NERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACRE 66
           N  TK  D +D +  ++G+G +  V +   K  +   ++A K I    LS        RE
Sbjct: 22  NASTKFSDNYDVKE-ELGKGAFSVVRRCVHK--TTGLEFAAKIINTKKLSARDFQKLERE 78
Query: 67  IALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHII---KFHRAAKANXXXXX 122
             + R+L+HPN++ L        +   +L+FD     +L+  I   +F+  A A+     
Sbjct: 79  ARICRKLQHPNIVRLHDSI--QEESFHYLVFDLVTGGELFEDIVAREFYSEADASH---- 132
Query: 123 XXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN 182
                    + QIL+ I Y HSN ++HR+LKP N+L+  +  +   VK+AD G A   N+
Sbjct: 133 --------CIQQILESIAYCHSNGIVHRNLKPENLLLASKA-KGAAVKLADFGLAIEVND 183
Query: 183 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
                        T  Y +PE +L    Y+K +DIWA G I   LL   P F
Sbjct: 184 S----EAWHGFAGTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPF 230

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 112/233 (48%), Gaps = 37/233 (15%)
Query: 10  SNERTKV--EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIE---GTGLSMSAC 64
           +N+ ++V  E+LF  +  ++G+G++G VYK    DN      A+K I+            
Sbjct: 9   ANQHSRVDPEELFT-KLDRIGKGSFGEVYKGI--DNHTKEVVAIKIIDLEEAEDEIEDIQ 65
Query: 65  REIALLRELKHPNVINLISVFLSHNDRKVWLLFDY----AEHDLWHIIKFHRAAKANXXX 120
           +EI +L +   P +      +L     K+W++ +Y    +  DL           A    
Sbjct: 66  QEITVLSQCDSPYITRYFGSYLKST--KLWIIMEYLGGGSALDLLKPGPLEETYIA---- 119
Query: 121 XXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA-RL 179
                    ++L +IL G+ YLHS   +HRD+K AN+L+     E+G VK+AD G A +L
Sbjct: 120 ---------TILREILKGLDYLHSERKIHRDIKAANVLLS----EQGDVKLADFGVAGQL 166
Query: 180 FNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 232
            +  +K     +  V T ++ APE++  + +  KA DIW++G    EL   EP
Sbjct: 167 TDTQIK----RNXFVGTPFWMAPEVIKQSAYDFKA-DIWSLGITAIELAKGEP 214

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 87/184 (47%), Gaps = 21/184 (11%)
Query: 63  ACREIALLRELK-HPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXX 121
           A  EI LL E   HPNVI          DR +++  +    +L  +++    +  N    
Sbjct: 55  ALMEIKLLTESDDHPNVIRYYCS--ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQ 112
Query: 122 XXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGE---------GIERGRVKIA 172
                   SLL QI  G+ +LHS  ++HRDLKP NILV            G E  R+ I+
Sbjct: 113 KEYNPI--SLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170
Query: 173 DMGFARLFNNPLKPL-ADLDPVVVTFWYRAPELLLGA------RHYTKAIDIWAIGCIFA 225
           D G  +  ++       +L+    T  +RAPELL  +      R  T++IDI+++GC+F 
Sbjct: 171 DFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY 230
Query: 226 ELLT 229
            +L+
Sbjct: 231 YILS 234

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 105/225 (46%), Gaps = 26/225 (11%)
Query: 15  KVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEG-----TGLSMSACREIAL 69
           K+ED     G  +G+G++  VY+A         + A+K I+       G+      E+ +
Sbjct: 9   KIEDF--KVGNLLGKGSFAGVYRAESIHTG--LEVAIKMIDKKAMYKAGMVQRVQNEVKI 64
Query: 70  LRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXX 129
             +LKHP+++ L + F   N   V+L+ +     + H  + +R  K              
Sbjct: 65  HCQLKHPSILELYNYFEDSN--YVYLVLE-----MCHNGEMNRYLK--NRVKPFSENEAR 115
Query: 130 SLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLAD 189
             ++QI+ G+ YLHS+ +LHRDL  +N+L+         +KIAD G A     P +    
Sbjct: 116 HFMHQIITGMLYLHSHGILHRDLTLSNLLL----TRNMNIKIADFGLATQLKMPHEKHYT 171
Query: 190 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           L     T  Y +PE+   + H  ++ D+W++GC+F  LL   P F
Sbjct: 172 L---CGTPNYISPEIATRSAHGLES-DVWSLGCMFYTLLIGRPPF 212

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 114/245 (46%), Gaps = 38/245 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACR-EIALLREL-KHPN-----VI 79
           +G+G++G V KA   D  +    A+K I+     ++  + E+ LL  + KH       ++
Sbjct: 62  IGKGSFGQVVKAY--DRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIV 119
Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGI 139
           +L   F+  N   + L+F+   ++L+ +++       N                Q+   +
Sbjct: 120 HLKRHFMFRNH--LCLVFEMLSYNLYDLLR-------NTNFRGVSLNLTRKFAQQMCTAL 170
Query: 140 HYLHSN--WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF 197
            +L +    ++H DLKP NIL+     +R  +KI D G +      +         + + 
Sbjct: 171 LFLATPELSIIHCDLKPENILLCNP--KRSAIKIVDFGSSCQLGQRIYQ------XIQSR 222
Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFS 257
           +YR+PE+LLG   Y  AID+W++GCI  E+ T EP+F         S     DQ+++I  
Sbjct: 223 FYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLF---------SGANEVDQMNKIVE 272
Query: 258 VMGFP 262
           V+G P
Sbjct: 273 VLGIP 277

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 114/245 (46%), Gaps = 38/245 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACR-EIALLREL-KHPN-----VI 79
           +G+G++G V KA   D  +    A+K I+     ++  + E+ LL  + KH       ++
Sbjct: 43  IGKGSFGQVVKAY--DRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIV 100
Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGI 139
           +L   F+  N   + L+F+   ++L+ +++       N                Q+   +
Sbjct: 101 HLKRHFMFRNH--LCLVFEMLSYNLYDLLR-------NTNFRGVSLNLTRKFAQQMCTAL 151
Query: 140 HYLHSN--WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF 197
            +L +    ++H DLKP NIL+     +R  +KI D G +      +         + + 
Sbjct: 152 LFLATPELSIIHCDLKPENILLCNP--KRSAIKIVDFGSSCQLGQRIYQ------XIQSR 203
Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFS 257
           +YR+PE+LLG   Y  AID+W++GCI  E+ T EP+F         S     DQ+++I  
Sbjct: 204 FYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLF---------SGANEVDQMNKIVE 253
Query: 258 VMGFP 262
           V+G P
Sbjct: 254 VLGIP 258

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 103/217 (47%), Gaps = 30/217 (13%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA----CREIALLRELKHPNVINL 81
           ++G G +G+V +   +D  +    A+KQ     LS       C EI ++++L HPNV++ 
Sbjct: 21  RLGTGGFGYVLRWIHQDTGE--QVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSA 77
Query: 82  ISV-----FLSHNDRKVWLLFDYAEH-DLW-HIIKFHRAAKANXXXXXXXXXXXXSLLYQ 134
             V      L+ ND  + L  +Y E  DL  ++ +F                   +LL  
Sbjct: 78  REVPDGLQKLAPNDLPL-LAMEYCEGGDLRKYLNQFENCCGLKEGPIR-------TLLSD 129
Query: 135 ILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADL-DPV 193
           I   + YLH N ++HRDLKP NI V+  G +R   KI D+G+A+  +       +L    
Sbjct: 130 ISSALRYLHENRIIHRDLKPENI-VLQPGPQRLIHKIIDLGYAKELDQ-----GELCTEF 183
Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 230
           V T  Y APE LL  + YT  +D W+ G +  E +T 
Sbjct: 184 VGTLQYLAPE-LLEQKKYTVTVDYWSFGTLAFECITG 219

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 103/217 (47%), Gaps = 30/217 (13%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA----CREIALLRELKHPNVINL 81
           ++G G +G+V +   +D  +    A+KQ     LS       C EI ++++L HPNV++ 
Sbjct: 22  RLGTGGFGYVLRWIHQDTGE--QVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSA 78
Query: 82  ISV-----FLSHNDRKVWLLFDYAEH-DLW-HIIKFHRAAKANXXXXXXXXXXXXSLLYQ 134
             V      L+ ND  + L  +Y E  DL  ++ +F                   +LL  
Sbjct: 79  REVPDGLQKLAPNDLPL-LAMEYCEGGDLRKYLNQFENCCGLKEGPIR-------TLLSD 130
Query: 135 ILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADL-DPV 193
           I   + YLH N ++HRDLKP NI V+  G +R   KI D+G+A+  +       +L    
Sbjct: 131 ISSALRYLHENRIIHRDLKPENI-VLQPGPQRLIHKIIDLGYAKELDQ-----GELCTEF 184
Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 230
           V T  Y APE LL  + YT  +D W+ G +  E +T 
Sbjct: 185 VGTLQYLAPE-LLEQKKYTVTVDYWSFGTLAFECITG 220

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 101/210 (48%), Gaps = 32/210 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC-----REIALLRELKHPNVINL 81
           +G G++G V  A     +  +  ALK I    L+ S       REI+ LR L+HP++I L
Sbjct: 12  LGEGSFGKVKLAYH--TTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 69
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLW-HIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
             V  S ++  + ++ +YA ++L+ +I++  + ++                  QI+  + 
Sbjct: 70  YDVIKSKDE--IIMVIEYAGNELFDYIVQRDKMSEQEAR----------RFFQQIISAVE 117
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFN--NPLKPLADLDPVVVTFW 198
           Y H + ++HRDLKP N+L+     E   VKIAD G + +    N LK          +  
Sbjct: 118 YCHRHKIVHRDLKPENLLLD----EHLNVKIADFGLSNIMTDGNFLKTSCG------SPN 167
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELL 228
           Y APE++ G  +    +D+W+ G I   +L
Sbjct: 168 YAAPEVISGKLYAGPEVDVWSCGVILYVML 197

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 114/245 (46%), Gaps = 38/245 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACR-EIALLREL-KHPN-----VI 79
           +G+G++G V KA   D  +    A+K I+     ++  + E+ LL  + KH       ++
Sbjct: 62  IGKGSFGQVVKAY--DRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIV 119
Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGI 139
           +L   F+  N   + L+F+   ++L+ +++       N                Q+   +
Sbjct: 120 HLKRHFMFRNH--LCLVFEMLSYNLYDLLR-------NTNFRGVSLNLTRKFAQQMCTAL 170
Query: 140 HYLHSN--WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF 197
            +L +    ++H DLKP NIL+     +R  +KI D G +      +         + + 
Sbjct: 171 LFLATPELSIIHCDLKPENILLCNP--KRXAIKIVDFGSSCQLGQRIYQ------XIQSR 222
Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFS 257
           +YR+PE+LLG   Y  AID+W++GCI  E+ T EP+F         S     DQ+++I  
Sbjct: 223 FYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLF---------SGANEVDQMNKIVE 272
Query: 258 VMGFP 262
           V+G P
Sbjct: 273 VLGIP 277

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 101/210 (48%), Gaps = 32/210 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC-----REIALLRELKHPNVINL 81
           +G G++G V  A     +  +  ALK I    L+ S       REI+ LR L+HP++I L
Sbjct: 22  LGEGSFGKVKLAYH--TTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 79
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLW-HIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
             V  S ++  + ++ +YA ++L+ +I++  + ++                  QI+  + 
Sbjct: 80  YDVIKSKDE--IIMVIEYAGNELFDYIVQRDKMSEQEAR----------RFFQQIISAVE 127
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFN--NPLKPLADLDPVVVTFW 198
           Y H + ++HRDLKP N+L+     E   VKIAD G + +    N LK          +  
Sbjct: 128 YCHRHKIVHRDLKPENLLLD----EHLNVKIADFGLSNIMTDGNFLKTSCG------SPN 177
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELL 228
           Y APE++ G  +    +D+W+ G I   +L
Sbjct: 178 YAAPEVISGKLYAGPEVDVWSCGVILYVML 207

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 108/229 (47%), Gaps = 37/229 (16%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMS----------ACREIALLRELK-H 75
           +GRG    V +   +  +   ++A+K +E T   +S            RE  +LR++  H
Sbjct: 102 IGRGVSSVVRRCVHR--ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159
Query: 76  PNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQI 135
           P++I LI  + S +   ++L+FD             + A +             S++  +
Sbjct: 160 PHIITLIDSYESSS--FMFLVFDLMRKGELFDYLTEKVALSEKETR--------SIMRSL 209
Query: 136 LDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVV 195
           L+ + +LH+N ++HRDLKP NIL+     +  +++++D GF+      L+P   L  +  
Sbjct: 210 LEAVSFLHANNIVHRDLKPENILL----DDNMQIRLSDFGFS----CHLEPGEKLRELCG 261
Query: 196 TFWYRAPELL---LGARH--YTKAIDIWAIGCIFAELLTSEPIF-HCRQ 238
           T  Y APE+L   +   H  Y K +D+WA G I   LL   P F H RQ
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ 310

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 101/210 (48%), Gaps = 32/210 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC-----REIALLRELKHPNVINL 81
           +G G++G V  A     +  +  ALK I    L+ S       REI+ LR L+HP++I L
Sbjct: 16  LGEGSFGKVKLAYH--TTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 73
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLW-HIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
             V  S ++  + ++ +YA ++L+ +I++  + ++                  QI+  + 
Sbjct: 74  YDVIKSKDE--IIMVIEYAGNELFDYIVQRDKMSEQEAR----------RFFQQIISAVE 121
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFN--NPLKPLADLDPVVVTFW 198
           Y H + ++HRDLKP N+L+     E   VKIAD G + +    N LK          +  
Sbjct: 122 YCHRHKIVHRDLKPENLLLD----EHLNVKIADFGLSNIMTDGNFLKTSCG------SPN 171
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELL 228
           Y APE++ G  +    +D+W+ G I   +L
Sbjct: 172 YAAPEVISGKLYAGPEVDVWSCGVILYVML 201

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 101/210 (48%), Gaps = 32/210 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC-----REIALLRELKHPNVINL 81
           +G G++G V  A     +  +  ALK I    L+ S       REI+ LR L+HP++I L
Sbjct: 21  LGEGSFGKVKLAYH--TTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 78
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLW-HIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
             V  S ++  + ++ +YA ++L+ +I++  + ++                  QI+  + 
Sbjct: 79  YDVIKSKDE--IIMVIEYAGNELFDYIVQRDKMSEQEAR----------RFFQQIISAVE 126
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFN--NPLKPLADLDPVVVTFW 198
           Y H + ++HRDLKP N+L+     E   VKIAD G + +    N LK          +  
Sbjct: 127 YCHRHKIVHRDLKPENLLLD----EHLNVKIADFGLSNIMTDGNFLKTSCG------SPN 176
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELL 228
           Y APE++ G  +    +D+W+ G I   +L
Sbjct: 177 YAAPEVISGKLYAGPEVDVWSCGVILYVML 206

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 105/229 (45%), Gaps = 31/229 (13%)
Query: 14  TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIAL 69
           TK  D +D +  ++G+G +  V +   K      ++A K I    LS        RE  +
Sbjct: 2   TKFSDNYDVKE-ELGKGAFSVVRRCVHKTTG--LEFAAKIINTKKLSARDFQKLEREARI 58
Query: 70  LRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHII---KFHRAAKANXXXXXXXX 125
            R+L+HPN++ L        +   +L+FD     +L+  I   +F+  A A+        
Sbjct: 59  CRKLQHPNIVRLHDSI--QEESFHYLVFDLVTGGELFEDIVAREFYSEADASH------- 109
Query: 126 XXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLK 185
                 + QIL+ I Y HSN ++HR+LKP N+L+  +  +   VK+AD G A   N+   
Sbjct: 110 -----CIQQILESIAYCHSNGIVHRNLKPENLLLASKA-KGAAVKLADFGLAIEVNDS-- 161
Query: 186 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
                     T  Y +PE +L    Y+K +DIWA G I   LL   P F
Sbjct: 162 --EAWHGFAGTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPF 207

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 106/229 (46%), Gaps = 31/229 (13%)
Query: 14  TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIAL 69
           TK  D +D +  ++G+G +  V +   K  +   ++A K I    LS        RE  +
Sbjct: 2   TKFSDNYDVKE-ELGKGAFSVVRRCVHK--TTGLEFAAKIINTKKLSARDFQKLEREARI 58
Query: 70  LRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHII---KFHRAAKANXXXXXXXX 125
            R+L+HPN++ L        +   +L+FD     +L+  I   +F+  A A+        
Sbjct: 59  CRKLQHPNIVRLHDSI--QEESFHYLVFDLVTGGELFEDIVAREFYSEADASH------- 109
Query: 126 XXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLK 185
                 + QIL+ I Y HSN ++HR+LKP N+L+  +  +   VK+AD G A   N+   
Sbjct: 110 -----CIQQILESIAYCHSNGIVHRNLKPENLLLASKA-KGAAVKLADFGLAIEVNDS-- 161
Query: 186 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
                     T  Y +PE +L    Y+K +DIWA G I   LL   P F
Sbjct: 162 --EAWHGFAGTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPF 207

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 106/229 (46%), Gaps = 31/229 (13%)
Query: 14  TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIAL 69
           TK  D +D +  ++G+G +  V +   K  +   ++A K I    LS        RE  +
Sbjct: 1   TKFSDNYDVKE-ELGKGAFSVVRRCVHK--TTGLEFAAKIINTKKLSARDFQKLEREARI 57
Query: 70  LRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHII---KFHRAAKANXXXXXXXX 125
            R+L+HPN++ L       +    +L+FD     +L+  I   +F+  A A+        
Sbjct: 58  CRKLQHPNIVRLHDSIQEESFH--YLVFDLVTGGELFEDIVAREFYSEADASH------- 108
Query: 126 XXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLK 185
                 + QIL+ I Y HSN ++HR+LKP N+L+  +  +   VK+AD G A   N+   
Sbjct: 109 -----CIQQILESIAYCHSNGIVHRNLKPENLLLASKA-KGAAVKLADFGLAIEVNDS-- 160
Query: 186 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
                     T  Y +PE +L    Y+K +DIWA G I   LL   P F
Sbjct: 161 --EAWHGFAGTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPF 206

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 105/216 (48%), Gaps = 27/216 (12%)
Query: 27  VGRGTYGHVYKARRKDNSDT-RDYALKQIEGTGLSMSAC------REIALLRELKHPNVI 79
           +G+G YG V++ R+   ++T + +A+K ++   +  +A        E  +L E+KHP ++
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 80  NLISVFLSHNDRKVWLLFDY-AEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           +LI  F      K++L+ +Y +  +L+  ++  R                   L +I   
Sbjct: 85  DLIYAF--QTGGKLYLILEYLSGGELF--MQLEREG-------IFMEDTACFYLAEISMA 133
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + +LH   +++RDLKP NI++      +G VK+ D G  +     +           T  
Sbjct: 134 LGHLHQKGIIYRDLKPENIMLN----HQGHVKLTDFGLCK---ESIHDGTVTHTFCGTIE 186
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           Y APE+L+ + H  +A+D W++G +  ++LT  P F
Sbjct: 187 YMAPEILMRSGH-NRAVDWWSLGALMYDMLTGAPPF 221

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 105/216 (48%), Gaps = 27/216 (12%)
Query: 27  VGRGTYGHVYKARRKDNSDT-RDYALKQIEGTGLSMSAC------REIALLRELKHPNVI 79
           +G+G YG V++ R+   ++T + +A+K ++   +  +A        E  +L E+KHP ++
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 80  NLISVFLSHNDRKVWLLFDY-AEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           +LI  F      K++L+ +Y +  +L+  ++  R                   L +I   
Sbjct: 85  DLIYAF--QTGGKLYLILEYLSGGELF--MQLEREG-------IFMEDTACFYLAEISMA 133
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + +LH   +++RDLKP NI++      +G VK+ D G  +     +           T  
Sbjct: 134 LGHLHQKGIIYRDLKPENIMLN----HQGHVKLTDFGLCK---ESIHDGTVTHXFCGTIE 186
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           Y APE+L+ + H  +A+D W++G +  ++LT  P F
Sbjct: 187 YMAPEILMRSGH-NRAVDWWSLGALMYDMLTGAPPF 221

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 39/219 (17%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF- 85
           +G G +G V+KA+ +   D + Y +K+++    +  A RE+  L +L H N+++    + 
Sbjct: 19  IGSGGFGQVFKAKHR--IDGKTYVIKRVKYN--NEKAEREVKALAKLDHVNIVHYNGCWD 74
Query: 86  ----------LSHNDRKVWLLF------DYAEHDLWHIIKFHRAAKANXXXXXXXXXXXX 129
                      + +  K   LF      D    + W  I+  R  K +            
Sbjct: 75  GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQW--IEKRRGEKLDKVLAL------- 125
Query: 130 SLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLAD 189
            L  QI  G+ Y+HS  +++RDLKP+NI +    ++  +VKI D G      N  K    
Sbjct: 126 ELFEQITKGVDYIHSKKLINRDLKPSNIFL----VDTKQVKIGDFGLVTSLKNDGKRXRS 181
Query: 190 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 228
                 T  Y +PE  + ++ Y K +D++A+G I AELL
Sbjct: 182 KG----TLRYMSPE-QISSQDYGKEVDLYALGLILAELL 215

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 97/223 (43%), Gaps = 26/223 (11%)
Query: 22  YEGCK-VGRGTYGHVYKARRKDNSDTRDYALKQIE-GTGLSMSACREIALLRELKHPNVI 79
           YE  K +G G +G     R K +++    A+K IE G  ++ +  REI   R L+HPN++
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNEL--VAVKYIERGEKIAANVKREIINHRSLRHPNIV 78
Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGI 139
               V L+     + ++ +YA         F R   A                 Q++ G+
Sbjct: 79  RFKEVILTPT--HLAIVMEYASGGEL----FERICNAGRFSEDEARF----FFQQLISGV 128
Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR---LFNNPLKPLADLDPVVVT 196
            Y H+  V HRDLK  N L+  +G    R+KI D G+++   L + P          V T
Sbjct: 129 SYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKS-------TVGT 179
Query: 197 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
             Y APE+LL   +  K  D+W+ G     +L     F   +E
Sbjct: 180 PAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEE 222

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 99/213 (46%), Gaps = 27/213 (12%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           K+G G+ G V  AR K +       +  +           E+ ++R+ +H NV+ +   +
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 86  LSHNDRKVWLLFDY----AEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
           L   +  +W+L ++    A  D+   ++ +    A             ++   +L  + Y
Sbjct: 112 LVGEE--LWVLMEFLQGGALTDIVSQVRLNEEQIA-------------TVCEAVLQALAY 156
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
           LH+  V+HRD+K  +IL+  +    GRVK++D GF    +   K +     +V T ++ A
Sbjct: 157 LHAQGVIHRDIKSDSILLTLD----GRVKLSDFGFCAQIS---KDVPKRKXLVGTPYWMA 209
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           PE ++    Y   +DIW++G +  E++  EP +
Sbjct: 210 PE-VISRSLYATEVDIWSLGIMVIEMVDGEPPY 241

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 72/254 (28%), Positives = 105/254 (41%), Gaps = 36/254 (14%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIE-GTGLSMSACREIALLRELKHPNVINLISVF 85
           +G G +G     R K   +    A+K IE G  +  +  REI   R L+HPN++    V 
Sbjct: 28  IGSGNFGVARLMRDKLTKEL--VAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 86  LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSN 145
           L+     + ++ +YA         + R   A                 Q+L G+ Y HS 
Sbjct: 86  LTPT--HLAIIMEYASGGEL----YERICNAGRFSEDEARF----FFQQLLSGVSYCHSM 135
Query: 146 WVLHRDLKPANILVMGEGIERGRVKIADMGFAR---LFNNPLKPLADLDPVVVTFWYRAP 202
            + HRDLK  N L+  +G    R+KI D G+++   L + P          V T  Y AP
Sbjct: 136 QICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKS-------TVGTPAYIAP 186
Query: 203 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV-MGF 261
           E+LL   +  K  D+W+ G     +L     F    ED +    Y    + RI SV    
Sbjct: 187 EVLLRQEYDGKIADVWSCGVTLYVMLVGAYPF----EDPEEPRDYRK-TIQRILSVKYSI 241
Query: 262 PLEKDWEDIRKMPE 275
           P     +DIR  PE
Sbjct: 242 P-----DDIRISPE 250

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 79/170 (46%), Gaps = 19/170 (11%)
Query: 65  REIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXX 124
           +EI LLR L+H NVI L+ V  +   +K++++ +Y    +  ++        +       
Sbjct: 55  KEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLD-------SVPEKRFP 107
Query: 125 XXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPL 184
                    Q++DG+ YLHS  ++H+D+KP N+L+       G +KI+ +G A      L
Sbjct: 108 VCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLL----TTGGTLKISALGVAEA----L 159
Query: 185 KPLADLDPVVVTFW---YRAPELLLGARHYTK-AIDIWAIGCIFAELLTS 230
            P A  D    +     ++ PE+  G   ++   +DIW+ G     + T 
Sbjct: 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 121/255 (47%), Gaps = 37/255 (14%)
Query: 13  RTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRE 72
           + K+ED   ++   +G+G++G V+ A  K  +    +A+K ++   + M    E  ++ +
Sbjct: 13  KLKIEDFILHK--MLGKGSFGKVFLAEFKKTNQF--FAIKALKKDVVLMDDDVECTMVEK 68
Query: 73  ------LKHPNVINLISVFLSHNDRKVWLLFDYAEHD--LWHIIKFHRAAKANXXXXXXX 124
                  +HP + ++   F +  +  ++ + +Y      ++HI   H+   +        
Sbjct: 69  RVLSLAWEHPFLTHMFCTFQTKEN--LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAA- 125
Query: 125 XXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPL 184
                    +I+ G+ +LHS  +++RDLK  NIL+  +    G +KIAD G  +   N L
Sbjct: 126 ---------EIILGLQFLHSKGIVYRDLKLDNILLDKD----GHIKIADFGMCK--ENML 170
Query: 185 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED---- 240
              A  +    T  Y APE+LLG + Y  ++D W+ G +  E+L  +  FH + E+    
Sbjct: 171 GD-AKTNXFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 228
Query: 241 -IKTSNPYHHDQLDR 254
            I+  NP++   L++
Sbjct: 229 SIRMDNPFYPRWLEK 243

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 96/220 (43%), Gaps = 20/220 (9%)
Query: 22  YEGCK-VGRGTYGHVYKARRKDNSDTRDYALKQIE-GTGLSMSACREIALLRELKHPNVI 79
           YE  K +G G +G     R K  ++    A+K IE G  +  +  REI   R L+HPN++
Sbjct: 21  YELVKDIGAGNFGVARLMRDKQANEL--VAVKYIERGEKIDENVKREIINHRSLRHPNIV 78
Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGI 139
               V L+     + ++ +YA         F R   A                 Q++ G+
Sbjct: 79  RFKEVILTPT--HLAIVMEYASGGEL----FERICNAGRFSEDEARF----FFQQLISGV 128
Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
            Y H+  V HRDLK  N L+  +G    R+KIAD G+++      +P +     V T  Y
Sbjct: 129 SYAHAMQVAHRDLKLENTLL--DGSPAPRLKIADFGYSKASVLHSQPKS----AVGTPAY 182
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
            APE+LL   +  K  D+W+ G     +L     F   +E
Sbjct: 183 IAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEE 222

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 102/214 (47%), Gaps = 29/214 (13%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACRE-----IALLRELKHPNVIN 80
           K+G G+ G V  A  K     +  A+K+++   L     RE     + ++R+  H NV++
Sbjct: 52  KIGEGSTGIVCIATEKHTG--KQVAVKKMD---LRKQQRRELLFNEVVIMRDYHHDNVVD 106
Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           + S +L  ++  +W++ ++ E      I  H                  ++   +L  + 
Sbjct: 107 MYSSYLVGDE--LWVVMEFLEGGALTDIVTHTRMNEEQIA---------TVCLSVLRALS 155
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YLH+  V+HRD+K  +IL+  +    GR+K++D GF    +   K +     +V T ++ 
Sbjct: 156 YLHNQGVIHRDIKSDSILLTSD----GRIKLSDFGFCAQVS---KEVPKRKXLVGTPYWM 208
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           APE ++    Y   +DIW++G +  E++  EP +
Sbjct: 209 APE-VISRLPYGTEVDIWSLGIMVIEMIDGEPPY 241

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 114/241 (47%), Gaps = 35/241 (14%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRE------LKHPNVIN 80
           +G+G++G V+ A  K  +    +A+K ++   + M    E  ++ +       +HP + +
Sbjct: 26  LGKGSFGKVFLAEFKKTNQF--FAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 83
Query: 81  LISVFLSHNDRKVWLLFDYAEHD--LWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           +   F +  +  ++ + +Y      ++HI   H+   +                 +I+ G
Sbjct: 84  MFCTFQTKEN--LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAA----------EIILG 131
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + +LHS  +++RDLK  NIL+  +    G +KIAD G  +   N L   A  +    T  
Sbjct: 132 LQFLHSKGIVYRDLKLDNILLDKD----GHIKIADFGMCK--ENMLGD-AKTNEFCGTPD 184
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED-----IKTSNPYHHDQLD 253
           Y APE+LLG + Y  ++D W+ G +  E+L  +  FH + E+     I+  NP++   L+
Sbjct: 185 YIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLE 243
Query: 254 R 254
           +
Sbjct: 244 K 244

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 103/223 (46%), Gaps = 50/223 (22%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFL 86
           VGRG +G V KA+ +     +D A+KQIE      +   E+  L  + HPN++ L    L
Sbjct: 17  VGRGAFGVVCKAKWR----AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL 72
Query: 87  SHNDRKVWLLFDYAE-HDLWHI------IKFHRAAKANXXXXXXXXXXXXSLLYQILDGI 139
           +     V L+ +YAE   L+++      + ++ AA A             S   Q   G+
Sbjct: 73  N----PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHA------------MSWCLQCSQGV 116
Query: 140 HYLHS---NWVLHRDLKPANILVMGEGIERGRVKIADMGFA-----RLFNNPLKPLADLD 191
            YLHS     ++HRDLKP N+L++  G     +KI D G A      + NN         
Sbjct: 117 AYLHSMQPKALIHRDLKPPNLLLVAGGT---VLKICDFGTACDIQTHMTNNK-------- 165
Query: 192 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
               +  + APE+  G+ +Y++  D+++ G I  E++T    F
Sbjct: 166 ---GSAAWMAPEVFEGS-NYSEKCDVFSWGIILWEVITRRKPF 204

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 103/223 (46%), Gaps = 50/223 (22%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFL 86
           VGRG +G V KA+ +     +D A+KQIE      +   E+  L  + HPN++ L    L
Sbjct: 16  VGRGAFGVVCKAKWR----AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL 71
Query: 87  SHNDRKVWLLFDYAE-HDLWHI------IKFHRAAKANXXXXXXXXXXXXSLLYQILDGI 139
           +     V L+ +YAE   L+++      + ++ AA A             S   Q   G+
Sbjct: 72  N----PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHA------------MSWCLQCSQGV 115
Query: 140 HYLHS---NWVLHRDLKPANILVMGEGIERGRVKIADMGFA-----RLFNNPLKPLADLD 191
            YLHS     ++HRDLKP N+L++  G     +KI D G A      + NN         
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGT---VLKICDFGTACDIQTHMTNNK-------- 164
Query: 192 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
               +  + APE+  G+ +Y++  D+++ G I  E++T    F
Sbjct: 165 ---GSAAWMAPEVFEGS-NYSEKCDVFSWGIILWEVITRRKPF 203

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 101/212 (47%), Gaps = 32/212 (15%)
Query: 27  VGRGTYGHV-----YKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINL 81
           +G G++G V     YK ++K     +  + + ++ + + M   REI+ L+ L+HP++I L
Sbjct: 17  LGEGSFGKVKLATHYKTQQK--VALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLW-HIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
             V  +  D  + ++ +YA  +L+ +I++  R  +                  QI+  I 
Sbjct: 75  YDVITTPTD--IVMVIEYAGGELFDYIVEKKRMTEDEGR----------RFFQQIICAIE 122
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFN--NPLKPLADLDPVVVTFW 198
           Y H + ++HRDLKP N+L+     +   VKIAD G + +    N LK          +  
Sbjct: 123 YCHRHKIVHRDLKPENLLLD----DNLNVKIADFGLSNIMTDGNFLKTSCG------SPN 172
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTS 230
           Y APE++ G  +    +D+W+ G +   +L  
Sbjct: 173 YAAPEVINGKLYAGPEVDVWSCGIVLYVMLVG 204

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 96/220 (43%), Gaps = 20/220 (9%)
Query: 22  YEGCK-VGRGTYGHVYKARRKDNSDTRDYALKQIE-GTGLSMSACREIALLRELKHPNVI 79
           YE  K +G G +G     R K +++    A+K IE G  +  +  REI   R L+HPN++
Sbjct: 20  YELVKDIGSGNFGVARLMRDKQSNEL--VAVKYIERGEKIDENVKREIINHRSLRHPNIV 77
Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGI 139
               V L+     + ++ +YA         F R   A                 Q++ G+
Sbjct: 78  RFKEVILTPT--HLAIVMEYASGGEL----FERICNAGRFSEDEARF----FFQQLISGV 127
Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
            Y H+  V HRDLK  N L+  +G    R+KI D G+++      +P +     V T  Y
Sbjct: 128 SYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKS----TVGTPAY 181
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
            APE+LL   +  K  D+W+ G     +L     F   +E
Sbjct: 182 IAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEE 221

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 100/232 (43%), Gaps = 52/232 (22%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF- 85
           +G G +G V+KA+ +   D + Y +++++    +  A RE+  L +L H N+++    + 
Sbjct: 20  IGSGGFGQVFKAKHR--IDGKTYVIRRVKYN--NEKAEREVKALAKLDHVNIVHYNGCWD 75
Query: 86  ------------LSHND-----------RKVWLLF------DYAEHDLWHIIKFHRAAKA 116
                       L  +D            K   LF      D    + W  I+  R  K 
Sbjct: 76  GFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQW--IEKRRGEKL 133
Query: 117 NXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGF 176
           +             L  QI  G+ Y+HS  ++HRDLKP+NI +    ++  +VKI D G 
Sbjct: 134 DKVLAL-------ELFEQITKGVDYIHSKKLIHRDLKPSNIFL----VDTKQVKIGDFGL 182
Query: 177 ARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 228
                N  K          T  Y +PE  + ++ Y K +D++A+G I AELL
Sbjct: 183 VTSLKNDGKRTRSKG----TLRYMSPE-QISSQDYGKEVDLYALGLILAELL 229

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 79/172 (45%), Gaps = 19/172 (11%)
Query: 65  REIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXX 123
           RE+    +L H N++++I V     D   +L+ +Y E   L   I+ H     +      
Sbjct: 60  REVHNSSQLSHQNIVSMIDV--DEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAI--- 114
Query: 124 XXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNP 183
                 +   QILDGI + H   ++HRD+KP NIL+         +KI D G A+  +  
Sbjct: 115 ------NFTNQILDGIKHAHDMRIVHRDIKPQNILIDS----NKTLKIFDFGIAKALSE- 163
Query: 184 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
              L   + V+ T  Y +PE   G     +  DI++IG +  E+L  EP F+
Sbjct: 164 -TSLTQTNHVLGTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPPFN 213

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 104/236 (44%), Gaps = 28/236 (11%)
Query: 15  KVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEG-TGLSMSAC-REIALLRE 72
           K ED++      +G G Y  V  A    N   ++YA+K IE   G S S   RE+  L +
Sbjct: 9   KFEDMYKLTSELLGEGAYAKVQGAVSLQNG--KEYAVKIIEKQAGHSRSRVFREVETLYQ 66
Query: 73  LK-HPNVINLISVFLSHNDRKVWLLFDYAEHD--LWHIIKFHRAAKANXXXXXXXXXXXX 129
            + + N++ LI  F   +D + +L+F+  +    L HI K                    
Sbjct: 67  CQGNKNILELIEFF--EDDTRFYLVFEKLQGGSILAHIQK----------QKHFNEREAS 114
Query: 130 SLLYQILDGIHYLHSNWVLHRDLKPANILVMG-EGIERGRVKIADMGFARLFNNPLKPLA 188
            ++  +   + +LH+  + HRDLKP NIL    E +   ++   D+G     NN   P+ 
Sbjct: 115 RVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPIT 174
Query: 189 --DLDPVVVTFWYRAPELLL----GARHYTKAIDIWAIGCIFAELLTSEPIF--HC 236
             +L     +  Y APE++      A  Y K  D+W++G +   +L+  P F  HC
Sbjct: 175 TPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHC 230

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 38/118 (32%), Positives = 59/118 (50%), Gaps = 8/118 (6%)
Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF 197
            +++ H N ++HRD+KPANIL+         VK+ D G AR   +    +     V+ T 
Sbjct: 128 ALNFSHQNGIIHRDVKPANILISATNA----VKVVDFGIARAIADSGNSVXQTAAVIGTA 183
Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 255
            Y +PE   G     ++ D++++GC+  E+LT EP F     D   S  Y H + D I
Sbjct: 184 QYLSPEQARGDSVDARS-DVYSLGCVLYEVLTGEPPF---TGDSPVSVAYQHVREDPI 237

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 99/223 (44%), Gaps = 25/223 (11%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELK-HPNVINLISVF 85
           +G G++    K   K ++    +A+K I    +  +  +EI  L+  + HPN++ L  VF
Sbjct: 19  LGEGSFSICRKCVHKKSNQA--FAVKIISKR-MEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 86  LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSN 145
             H+    +L+ +           F R  K               ++ +++  + ++H  
Sbjct: 76  --HDQLHTFLVMELLNGGEL----FERIKKKKHFSETEASY----IMRKLVSAVSHMHDV 125
Query: 146 WVLHRDLKPANILVMGEGIERGRVKIADMGFARLF---NNPLKPLADLDPVVVTFWYRAP 202
            V+HRDLKP N+L   E  +   +KI D GFARL    N PLK          T  Y AP
Sbjct: 126 GVVHRDLKPENLLFTDEN-DNLEIKIIDFGFARLKPPDNQPLK------TPCFTLHYAAP 178
Query: 203 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN 245
           E LL    Y ++ D+W++G I   +L+ +  F      +  ++
Sbjct: 179 E-LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTS 220

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 111/230 (48%), Gaps = 29/230 (12%)
Query: 22  YEGCKV-GRGTYGHVYKARRKDNSDT-RDYALKQIE------GTGLSMSAC-REIALLRE 72
           YE C+V G+G +  V   RR  N +T + +A+K ++        GLS     RE ++   
Sbjct: 26  YELCEVIGKGAFSVV---RRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 73  LKHPNVINLISVFLSHNDRKVWLLFDYAE-HDL-WHIIKFHRAAKANXXXXXXXXXXXXS 130
           LKHP+++ L+  + S  D  ++++F++ +  DL + I+K   A                 
Sbjct: 83  LKHPHIVELLETYSS--DGMLYMVFEFMDGADLCFEIVKRADAG------FVYSEAVASH 134
Query: 131 LLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA-RLFNNPLKPLAD 189
            + QIL+ + Y H N ++HRD+KP N+L+  +      VK+ D G A +L  + L     
Sbjct: 135 YMRQILEALRYCHDNNIIHRDVKPENVLLASKE-NSAPVKLGDFGVAIQLGESGLVAGGR 193
Query: 190 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
               V T  + APE ++    Y K +D+W  G I   LL+    F+  +E
Sbjct: 194 ----VGTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE 238

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 110/246 (44%), Gaps = 37/246 (15%)
Query: 2   DYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSD---------TRDYALK 52
           D+  K +T ++ T   D FD     +G G++G V   + K++ +          +   LK
Sbjct: 25  DFLKKWETPSQNTAQLDQFDRIKT-LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK 83
Query: 53  QIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHR 112
           QIE T        E  +L+ +  P ++ L   F  +++  + + +        H+ +  R
Sbjct: 84  QIEHT------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR 137
Query: 113 AAKANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA 172
            ++ +                QI+    YLHS  +++RDLKP N+L+     ++G +++ 
Sbjct: 138 FSEPHARFYAA----------QIVLTFEYLHSLDLIYRDLKPENLLI----DQQGYIQVT 183
Query: 173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 232
           D GFA+        LA       T  Y APE++L ++ Y KA+D WA+G +  E+    P
Sbjct: 184 DFGFAKRVKGRTWXLAG------TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYP 236
Query: 233 IFHCRQ 238
            F   Q
Sbjct: 237 PFFADQ 242

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 100/217 (46%), Gaps = 29/217 (13%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIALLRELKHPNVINL 81
           ++G+G +  V +  +K  + T++YA K I    LS        RE  + R LKHPN++ L
Sbjct: 38  ELGKGAFSVVRRCVKK--TPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRL 95
Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHII---KFHRAAKANXXXXXXXXXXXXSLLYQILD 137
                       +L+FD     +L+  I   +++  A A+              ++QIL+
Sbjct: 96  HDSISEEGFH--YLVFDLVTGGELFEDIVAREYYSEADAS------------HCIHQILE 141
Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF 197
            ++++H + ++HRDLKP N+L +    +   VK+AD G A       +          T 
Sbjct: 142 SVNHIHQHDIVHRDLKPENLL-LASKCKGAAVKLADFGLAIEVQGEQQAWFGF---AGTP 197
Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
            Y +PE+L     Y K +DIWA G I   LL   P F
Sbjct: 198 GYLSPEVLR-KDPYGKPVDIWACGVILYILLVGYPPF 233

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 18/209 (8%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRD--YALKQIEGTGLS--MSACREIALLRELKHPNVINL 81
           ++G+G +G V   R     D      A+K+++ +         REI +L+ L+H N++  
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
             V  S   R + L+ +Y  +  L   ++ H+                     QI  G+ 
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE--------RIDHIKLLQYTSQICKGME 131
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL +   +HRDL   NILV  E     RVKI D G  ++     +     +P     ++ 
Sbjct: 132 YLGTKRYIHRDLATRNILVENE----NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 187
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT 229
           APE L  ++ ++ A D+W+ G +  EL T
Sbjct: 188 APESLTESK-FSVASDVWSFGVVLYELFT 215

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 18/209 (8%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRD--YALKQIEGTGLS--MSACREIALLRELKHPNVINL 81
           ++G+G +G V   R     D      A+K+++ +         REI +L+ L+H N++  
Sbjct: 48  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
             V  S   R + L+ +Y  +  L   ++ H+                     QI  G+ 
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE--------RIDHIKLLQYTSQICKGME 159
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL +   +HRDL   NILV  E     RVKI D G  ++     +     +P     ++ 
Sbjct: 160 YLGTKRYIHRDLATRNILVENE----NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 215
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT 229
           APE L  ++ ++ A D+W+ G +  EL T
Sbjct: 216 APESLTESK-FSVASDVWSFGVVLYELFT 243

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 92/209 (44%), Gaps = 18/209 (8%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRD--YALKQIEGTGLS--MSACREIALLRELKHPNVINL 81
           ++G+G +G V   R     D      A+K+++ +         REI +L+ L+H N++  
Sbjct: 15  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 74
Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
             V  S   R + L+ +Y  +  L   ++ H+    +                QI  G+ 
Sbjct: 75  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS--------QICKGME 126
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL +   +HRDL   NILV  E     RVKI D G  ++     +     +P     ++ 
Sbjct: 127 YLGTKRYIHRDLATRNILVENE----NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 182
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT 229
           APE L  ++ ++ A D+W+ G +  EL T
Sbjct: 183 APESLTESK-FSVASDVWSFGVVLYELFT 210

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 101/222 (45%), Gaps = 31/222 (13%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-------SMSACREIALLRELKHPNVI 79
           +G+G +   Y+    D  +   +A K +  + L        MS   EIA+ + L +P+V+
Sbjct: 34  LGKGGFAKCYEITDMDTKEV--FAGKVVPKSMLLKPHQKEKMST--EIAIHKSLDNPHVV 89
Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGI 139
                F   +D  V+++ +        +++ H+  KA               + Q + G+
Sbjct: 90  GFHGFF--EDDDFVYVVLEICRR--RSLLELHKRRKA------VTEPEARYFMRQTIQGV 139
Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
            YLH+N V+HRDLK  N L + + ++   VKI D G A       +   DL     T  Y
Sbjct: 140 QYLHNNRVIHRDLKLGN-LFLNDDMD---VKIGDFGLATKIEFDGERKKDL---CGTPNY 192
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH--CRQE 239
            APE+L    H +  +DIW++GCI   LL  +P F   C +E
Sbjct: 193 IAPEVLCKKGH-SFEVDIWSLGCILYTLLVGKPPFETSCLKE 233

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 18/209 (8%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRD--YALKQIEGTGLS--MSACREIALLRELKHPNVINL 81
           ++G+G +G V   R     D      A+K+++ +         REI +L+ L+H N++  
Sbjct: 23  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 82
Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
             V  S   R + L+ +Y  +  L   ++ H+                     QI  G+ 
Sbjct: 83  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE--------RIDHIKLLQYTSQICKGME 134
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL +   +HRDL   NILV  E     RVKI D G  ++     +     +P     ++ 
Sbjct: 135 YLGTKRYIHRDLATRNILVENE----NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 190
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT 229
           APE L  ++ ++ A D+W+ G +  EL T
Sbjct: 191 APESLTESK-FSVASDVWSFGVVLYELFT 218

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 18/209 (8%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRD--YALKQIEGTGLS--MSACREIALLRELKHPNVINL 81
           ++G+G +G V   R     D      A+K+++ +         REI +L+ L+H N++  
Sbjct: 24  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 83
Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
             V  S   R + L+ +Y  +  L   ++ H+                     QI  G+ 
Sbjct: 84  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE--------RIDHIKLLQYTSQICKGME 135
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL +   +HRDL   NILV  E     RVKI D G  ++     +     +P     ++ 
Sbjct: 136 YLGTKRYIHRDLATRNILVENE----NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 191
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT 229
           APE L  ++ ++ A D+W+ G +  EL T
Sbjct: 192 APESLTESK-FSVASDVWSFGVVLYELFT 219

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 37/118 (31%), Positives = 59/118 (50%), Gaps = 8/118 (6%)
Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF 197
            +++ H N ++HRD+KPANI++         VK+ D G AR   +    +     V+ T 
Sbjct: 128 ALNFSHQNGIIHRDVKPANIMISATNA----VKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 255
            Y +PE   G     ++ D++++GC+  E+LT EP F     D   S  Y H + D I
Sbjct: 184 QYLSPEQARGDSVDARS-DVYSLGCVLYEVLTGEPPF---TGDSPVSVAYQHVREDPI 237

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 37/118 (31%), Positives = 59/118 (50%), Gaps = 8/118 (6%)
Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF 197
            +++ H N ++HRD+KPANI++         VK+ D G AR   +    +     V+ T 
Sbjct: 128 ALNFSHQNGIIHRDVKPANIMISATNA----VKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 255
            Y +PE   G     ++ D++++GC+  E+LT EP F     D   S  Y H + D I
Sbjct: 184 QYLSPEQARGDSVDARS-DVYSLGCVLYEVLTGEPPF---TGDSPVSVAYQHVREDPI 237

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 37/118 (31%), Positives = 59/118 (50%), Gaps = 8/118 (6%)
Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF 197
            +++ H N ++HRD+KPANI++         VK+ D G AR   +    +     V+ T 
Sbjct: 128 ALNFSHQNGIIHRDVKPANIMISATNA----VKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 255
            Y +PE   G     ++ D++++GC+  E+LT EP F     D   S  Y H + D I
Sbjct: 184 QYLSPEQARGDSVDARS-DVYSLGCVLYEVLTGEPPF---TGDSPVSVAYQHVREDPI 237

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 18/209 (8%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRD--YALKQIEGTGLS--MSACREIALLRELKHPNVINL 81
           ++G+G +G V   R     D      A+K+++ +         REI +L+ L+H N++  
Sbjct: 16  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 75
Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
             V  S   R + L+ +Y  +  L   ++ H+                     QI  G+ 
Sbjct: 76  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE--------RIDHIKLLQYTSQICKGME 127
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL +   +HRDL   NILV  E     RVKI D G  ++     +     +P     ++ 
Sbjct: 128 YLGTKRYIHRDLATRNILVENE----NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 183
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT 229
           APE L  ++ ++ A D+W+ G +  EL T
Sbjct: 184 APESLTESK-FSVASDVWSFGVVLYELFT 211

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 18/209 (8%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRD--YALKQIEGTGLS--MSACREIALLRELKHPNVINL 81
           ++G+G +G V   R     D      A+K+++ +         REI +L+ L+H N++  
Sbjct: 22  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 81
Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
             V  S   R + L+ +Y  +  L   ++ H+                     QI  G+ 
Sbjct: 82  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE--------RIDHIKLLQYTSQICKGME 133
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL +   +HRDL   NILV  E     RVKI D G  ++     +     +P     ++ 
Sbjct: 134 YLGTKRYIHRDLATRNILVENE----NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 189
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT 229
           APE L  ++ ++ A D+W+ G +  EL T
Sbjct: 190 APESLTESK-FSVASDVWSFGVVLYELFT 217

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 92/209 (44%), Gaps = 18/209 (8%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRD--YALKQIEGTGLS--MSACREIALLRELKHPNVINL 81
           ++G+G +G V   R     D      A+K+++ +         REI +L+ L+H N++  
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
             V  S   R + L+ +Y  +  L   ++ H+    +                QI  G+ 
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS--------QICKGME 128
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL +   +HRDL   NILV  E     RVKI D G  ++     +     +P     ++ 
Sbjct: 129 YLGTKRYIHRDLATRNILVENE----NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 184
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT 229
           APE L  ++ ++ A D+W+ G +  EL T
Sbjct: 185 APESLTESK-FSVASDVWSFGVVLYELFT 212

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 37/118 (31%), Positives = 59/118 (50%), Gaps = 8/118 (6%)
Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF 197
            +++ H N ++HRD+KPANI++         VK+ D G AR   +    +     V+ T 
Sbjct: 128 ALNFSHQNGIIHRDVKPANIMISATNA----VKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 255
            Y +PE   G     ++ D++++GC+  E+LT EP F     D   S  Y H + D I
Sbjct: 184 QYLSPEQARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPD---SVAYQHVREDPI 237

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 37/118 (31%), Positives = 59/118 (50%), Gaps = 8/118 (6%)
Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF 197
            +++ H N ++HRD+KPANI++         VK+ D G AR   +    +     V+ T 
Sbjct: 145 ALNFSHQNGIIHRDVKPANIMISATNA----VKVMDFGIARAIADSGNSVTQTAAVIGTA 200
Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 255
            Y +PE   G     ++ D++++GC+  E+LT EP F     D   S  Y H + D I
Sbjct: 201 QYLSPEQARGDSVDARS-DVYSLGCVLYEVLTGEPPF---TGDSPVSVAYQHVREDPI 254

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 92/209 (44%), Gaps = 18/209 (8%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRD--YALKQIEGTGLS--MSACREIALLRELKHPNVINL 81
           ++G+G +G V   R     D      A+K+++ +         REI +L+ L+H N++  
Sbjct: 21  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 80
Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
             V  S   R + L+ +Y  +  L   ++ H+    +                QI  G+ 
Sbjct: 81  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS--------QICKGME 132
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL +   +HRDL   NILV  E     RVKI D G  ++     +     +P     ++ 
Sbjct: 133 YLGTKRYIHRDLATRNILVENE----NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 188
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT 229
           APE L  ++ ++ A D+W+ G +  EL T
Sbjct: 189 APESLTESK-FSVASDVWSFGVVLYELFT 216

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 18/209 (8%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRD--YALKQIEGTGLS--MSACREIALLRELKHPNVINL 81
           ++G+G +G V   R     D      A+K+++ +         REI +L+ L+H N++  
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
             V  S   R + L+ +Y  +  L   ++ H+                     QI  G+ 
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE--------RIDHIKLLQYTSQICKGME 128
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL +   +HRDL   NILV  E     RVKI D G  ++     +     +P     ++ 
Sbjct: 129 YLGTKRYIHRDLATRNILVENE----NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 184
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT 229
           APE L  ++ ++ A D+W+ G +  EL T
Sbjct: 185 APESLTESK-FSVASDVWSFGVVLYELFT 212

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 25/218 (11%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFL 86
           +G G+Y    +   K  +   ++A+K I+ +    +   EI LLR  +HPN+I L  V+ 
Sbjct: 30  IGVGSYSVCKRCIHK--ATNMEFAVKIIDKSKRDPTEEIEI-LLRYGQHPNIITLKDVY- 85
Query: 87  SHNDRKVWLLFDYAEH-DLWHII---KFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
             + + V+++ +  +  +L   I   KF    +A+            ++L+ I   + YL
Sbjct: 86  -DDGKYVYVVTELMKGGELLDKILRQKFFSEREAS------------AVLFTITKTVEYL 132
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAP 202
           H+  V+HRDLKP+NIL + E      ++I D GFA+        L  + P   T  + AP
Sbjct: 133 HAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL--MTP-CYTANFVAP 189
Query: 203 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
           E +L  + Y  A DIW++G +   +LT    F    +D
Sbjct: 190 E-VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD 226

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 92/209 (44%), Gaps = 18/209 (8%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRD--YALKQIEGTGLS--MSACREIALLRELKHPNVINL 81
           ++G+G +G V   R     D      A+K+++ +         REI +L+ L+H N++  
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
             V  S   R + L+ +Y  +  L   ++ H+    +                QI  G+ 
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS--------QICKGME 146
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL +   +HRDL   NILV  E     RVKI D G  ++     +     +P     ++ 
Sbjct: 147 YLGTKRYIHRDLATRNILVENE----NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 202
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT 229
           APE L  ++ ++ A D+W+ G +  EL T
Sbjct: 203 APESLTESK-FSVASDVWSFGVVLYELFT 230

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 18/209 (8%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRD--YALKQIEGTGLS--MSACREIALLRELKHPNVINL 81
           ++G+G +G V   R     D      A+K+++ +         REI +L+ L+H N++  
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
             V  S   R + L+ +Y  +  L   ++ H A + +                QI  G+ 
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQAH-AERIDHIKLLQYTS-------QICKGME 131
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL +   +HRDL   NILV  E     RVKI D G  ++     +     +P     ++ 
Sbjct: 132 YLGTKRYIHRDLATRNILVENE----NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 187
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT 229
           APE L  ++ ++ A D+W+ G +  EL T
Sbjct: 188 APESLTESK-FSVASDVWSFGVVLYELFT 215

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 92/209 (44%), Gaps = 18/209 (8%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRD--YALKQIEGTGLS--MSACREIALLRELKHPNVINL 81
           ++G+G +G V   R     D      A+K+++ +         REI +L+ L+H N++  
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
             V  S   R + L+ +Y  +  L   ++ H+    +                QI  G+ 
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS--------QICKGME 128
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL +   +HRDL   NILV  E     RVKI D G  ++     +     +P     ++ 
Sbjct: 129 YLGTKRYIHRDLATRNILVENE----NRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY 184
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT 229
           APE L  ++ ++ A D+W+ G +  EL T
Sbjct: 185 APESLTESK-FSVASDVWSFGVVLYELFT 212

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 109/246 (44%), Gaps = 37/246 (15%)
Query: 2   DYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSD---------TRDYALK 52
           D+  K +T ++ T   D FD     +G G++G V   + K++ +          +   LK
Sbjct: 46  DFLKKWETPSQNTAQLDQFDRIKT-LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK 104
Query: 53  QIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHR 112
           QIE T        E  +L+ +  P ++ L   F  +++  + + +        H+ +  R
Sbjct: 105 QIEHT------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR 158
Query: 113 AAKANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA 172
            ++ +                QI+    YLHS  +++RDLKP N+L+     ++G +++ 
Sbjct: 159 FSEPHARFYAA----------QIVLTFEYLHSLDLIYRDLKPENLLI----DQQGYIQVT 204
Query: 173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 232
           D GFA+        L        T  Y APE++L ++ Y KA+D WA+G +  E+    P
Sbjct: 205 DFGFAKRVKGATWTLCG------TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYP 257
Query: 233 IFHCRQ 238
            F   Q
Sbjct: 258 PFFADQ 263

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 92/209 (44%), Gaps = 18/209 (8%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRD--YALKQIEGTGLS--MSACREIALLRELKHPNVINL 81
           ++G+G +G V   R     D      A+K+++ +         REI +L+ L+H N++  
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
             V  S   R + L+ +Y  +  L   ++ H+    +                QI  G+ 
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS--------QICKGME 146
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL +   +HRDL   NILV  E     RVKI D G  ++     +     +P     ++ 
Sbjct: 147 YLGTKRYIHRDLATRNILVENE----NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 202
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT 229
           APE L  ++ ++ A D+W+ G +  EL T
Sbjct: 203 APESLTESK-FSVASDVWSFGVVLYELFT 230

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 25/212 (11%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFL 86
           +G G+Y    +   K  +   +YA+K I+ +    S   EI LLR  +HPN+I L  V+ 
Sbjct: 35  IGVGSYSECKRCVHK--ATNMEYAVKVIDKSKRDPSEEIEI-LLRYGQHPNIITLKDVY- 90
Query: 87  SHNDRKVWLLFDYAEH-DLWHII---KFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
             + + V+L+ +     +L   I   KF    +A+             +L+ I   + YL
Sbjct: 91  -DDGKHVYLVTELMRGGELLDKILRQKFFSEREASF------------VLHTIGKTVEYL 137
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAP 202
           HS  V+HRDLKP+NIL + E      ++I D GFA+        L  + P   T  + AP
Sbjct: 138 HSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLL--MTP-CYTANFVAP 194
Query: 203 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           E +L  + Y +  DIW++G +   +L     F
Sbjct: 195 E-VLKRQGYDEGCDIWSLGILLYTMLAGYTPF 225

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 109/246 (44%), Gaps = 37/246 (15%)
Query: 2   DYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSD---------TRDYALK 52
           D+  K +T ++ T   D FD     +G G++G V   + K++ +          +   LK
Sbjct: 12  DFLKKWETPSQNTAQLDQFDRIKT-LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK 70
Query: 53  QIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHR 112
           QIE T        E  +L+ +  P ++ L   F  +++  + + +        H+ +  R
Sbjct: 71  QIEHT------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR 124
Query: 113 AAKANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA 172
            ++ +                QI+    YLHS  +++RDLKP N+L+     E+G +++ 
Sbjct: 125 FSEPHARFYAA----------QIVLTFEYLHSLDLIYRDLKPENLLID----EQGYIQVT 170
Query: 173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 232
           D GFA+        L        T  Y APE++L ++ Y KA+D WA+G +  E+    P
Sbjct: 171 DFGFAKRVKGRTWXLCG------TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYP 223
Query: 233 IFHCRQ 238
            F   Q
Sbjct: 224 PFFADQ 229

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 109/246 (44%), Gaps = 37/246 (15%)
Query: 2   DYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSD---------TRDYALK 52
           D+  K +T ++ T   D FD     +G G++G V   + K++ +          +   LK
Sbjct: 25  DFLKKWETPSQNTAQLDQFDRIKT-LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK 83
Query: 53  QIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHR 112
           QIE T        E  +L+ +  P ++ L   F  +++  + + +        H+ +  R
Sbjct: 84  QIEHT------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR 137
Query: 113 AAKANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA 172
            A+ +                QI+    YLHS  +++RDLKP N+L+     ++G +++ 
Sbjct: 138 FAEPHARFYAA----------QIVLTFEYLHSLDLIYRDLKPENLLID----QQGYIQVT 183
Query: 173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 232
           D GFA+        L        T  Y APE++L ++ Y KA+D WA+G +  E+    P
Sbjct: 184 DFGFAKRVKGRTWXLCG------TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYP 236
Query: 233 IFHCRQ 238
            F   Q
Sbjct: 237 PFFADQ 242

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 101/222 (45%), Gaps = 31/222 (13%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-------SMSACREIALLRELKHPNVI 79
           +G+G +   Y+    D  +   +A K +  + L        MS   EIA+ + L +P+V+
Sbjct: 50  LGKGGFAKCYEITDMDTKEV--FAGKVVPKSMLLKPHQKEKMST--EIAIHKSLDNPHVV 105
Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGI 139
                F   +D  V+++ +        +++ H+  KA               + Q + G+
Sbjct: 106 GFHGFF--EDDDFVYVVLEICRR--RSLLELHKRRKA------VTEPEARYFMRQTIQGV 155
Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
            YLH+N V+HRDLK  N L + + ++   VKI D G A       +   DL     T  Y
Sbjct: 156 QYLHNNRVIHRDLKLGN-LFLNDDMD---VKIGDFGLATKIEFDGERKKDL---CGTPNY 208
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH--CRQE 239
            APE+L    H +  +DIW++GCI   LL  +P F   C +E
Sbjct: 209 IAPEVLCKKGH-SFEVDIWSLGCILYTLLVGKPPFETSCLKE 249

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 95/220 (43%), Gaps = 20/220 (9%)
Query: 22  YEGCK-VGRGTYGHVYKARRKDNSDTRDYALKQIE-GTGLSMSACREIALLRELKHPNVI 79
           YE  K +G G +G     R K +++    A+K IE G  +  +  REI   R L+HPN++
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNEL--VAVKYIERGEKIDENVKREIINHRSLRHPNIV 78
Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGI 139
               V L+     + ++ +YA         F R   A                 Q++ G+
Sbjct: 79  RFKEVILTPT--HLAIVMEYASGGEL----FERICNAGRFSEDEARF----FFQQLISGV 128
Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
            Y H+  V HRDLK  N L+  +G    R+KI   G+++      +P +     V T  Y
Sbjct: 129 SYCHAMQVCHRDLKLENTLL--DGSPAPRLKICAFGYSKSSVLHSQPKS----TVGTPAY 182
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
            APE+LL   +  K  D+W+ G     +L     F   +E
Sbjct: 183 IAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEE 222

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 29/220 (13%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFL 86
           +G G+Y    +   K  +   ++A+K I+ +    +   EI LLR  +HPN+I L  V+ 
Sbjct: 30  IGVGSYSVCKRCIHK--ATNXEFAVKIIDKSKRDPTEEIEI-LLRYGQHPNIITLKDVY- 85
Query: 87  SHNDRKVWLLFDYAEH-DLWHII---KFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
             + + V+++ +  +  +L   I   KF    +A+            ++L+ I   + YL
Sbjct: 86  -DDGKYVYVVTELXKGGELLDKILRQKFFSEREAS------------AVLFTITKTVEYL 132
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF--NNPLKPLADLDPVVVTFWYR 200
           H+  V+HRDLKP+NIL + E      ++I D GFA+     N L     L     T  + 
Sbjct: 133 HAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL-----LXTPCYTANFV 187
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
           APE +L  + Y  A DIW++G +    LT    F    +D
Sbjct: 188 APE-VLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDD 226

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 91/209 (43%), Gaps = 18/209 (8%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRD--YALKQIEGTGLS--MSACREIALLRELKHPNVINL 81
           ++G+G +G V   R     D      A+K+++ +         REI +L+ L+H N++  
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
             V  S   R + L+ ++  +  L   ++ H+                     QI  G+ 
Sbjct: 80  KGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKE--------RIDHIKLLQYTSQICKGME 131
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL +   +HRDL   NILV  E     RVKI D G  ++     +     +P     ++ 
Sbjct: 132 YLGTKRYIHRDLATRNILVENE----NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 187
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT 229
           APE L  ++ ++ A D+W+ G +  EL T
Sbjct: 188 APESLTESK-FSVASDVWSFGVVLYELFT 215

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS--MSACREIALLRELKHPNVINLISV 84
           +G G +G V+K   ++ +     A K I+  G+        EI+++ +L H N+I L   
Sbjct: 97  LGGGRFGQVHKC--EETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA 154
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHS 144
           F S ND  + L+ +Y +        F R    +              + QI +GI ++H 
Sbjct: 155 FESKND--IVLVMEYVDGGEL----FDRIIDESYNLTELDTIL---FMKQICEGIRHMHQ 205
Query: 145 NWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPEL 204
            ++LH DLKP NIL +    +  ++KI D G AR +    KP   L     T  + APE 
Sbjct: 206 MYILHLDLKPENILCVNR--DAKQIKIIDFGLARRY----KPREKLKVNFGTPEFLAPE- 258
Query: 205 LLGARHYTKAIDIWAIGCIFAELLT 229
           ++     +   D+W++G I   LL+
Sbjct: 259 VVNYDFVSFPTDMWSVGVIAYMLLS 283

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 105/227 (46%), Gaps = 26/227 (11%)
Query: 18  DLFDYEGCKV-GRGTYGHVYKARRKDNSDTRD-YALKQIEGTGLSMS----ACREIALLR 71
           D   +E  KV G+G++G V+  ++   SD R  YA+K ++   L +        E  +L 
Sbjct: 22  DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV 81
Query: 72  ELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXS 130
           E+ HP ++ L   F    + K++L+ D+    DL     F R +K               
Sbjct: 82  EVNHPFIVKLHYAF--QTEGKLYLILDFLRGGDL-----FTRLSKE----VMFTEEDVKF 130
Query: 131 LLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADL 190
            L ++   + +LHS  +++RDLKP NIL+     E G +K+ D G ++   +  K     
Sbjct: 131 YLAELALALDHLHSLGIIYRDLKPENILL----DEEGHIKLTDFGLSKESIDHEKKAYSF 186
Query: 191 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 237
                T  Y APE ++  R +T++ D W+ G +  E+LT    F  +
Sbjct: 187 ---CGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK 229

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 25/212 (11%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFL 86
           +G G+Y    +   K  +   +YA+K I+ +    S   EI LLR  +HPN+I L  V+ 
Sbjct: 35  IGVGSYSECKRCVHK--ATNMEYAVKVIDKSKRDPSEEIEI-LLRYGQHPNIITLKDVY- 90
Query: 87  SHNDRKVWLLFDYAEH-DLWHII---KFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
             + + V+L+ +     +L   I   KF    +A+             +L+ I   + YL
Sbjct: 91  -DDGKHVYLVTELMRGGELLDKILRQKFFSEREASF------------VLHTIGKTVEYL 137
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAP 202
           HS  V+HRDLKP+NIL + E      ++I D GFA+        L  + P   T  + AP
Sbjct: 138 HSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLL--MTP-CYTANFVAP 194
Query: 203 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           E +L  + Y +  DIW++G +   +L     F
Sbjct: 195 E-VLKRQGYDEGCDIWSLGILLYTMLAGYTPF 225

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 114/259 (44%), Gaps = 36/259 (13%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM--SACREIALLRELKHPNVINLISV 84
           +GRG++G V  A +K     R  A K+I    +       +EI +++ L HPN+I L   
Sbjct: 34  IGRGSWGEVKIAVQKGTRIRR--AAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 91
Query: 85  FLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLH 143
           F  + D  ++L+ +     +L+  +   R  + +             ++  +L  + Y H
Sbjct: 92  FEDNTD--IYLVMELCTGGELFERVVHKRVFRESDAA---------RIMKDVLSAVAYCH 140
Query: 144 SNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPE 203
              V HRDLKP N L + +  +   +K+ D G A  F    KP   +   V T +Y +P+
Sbjct: 141 KLNVAHRDLKPENFLFLTDSPD-SPLKLIDFGLAARF----KPGKMMRTKVGTPYYVSPQ 195
Query: 204 LLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF-SVMGFP 262
           +L G   Y    D W+ G +   LL   P F         S P   + + +I      FP
Sbjct: 196 VLEGL--YGPECDEWSAGVMMYVLLCGYPPF---------SAPTDXEVMLKIREGTFTFP 244
Query: 263 LEKDWEDIRKMPEHPTLLK 281
            EKDW ++   P+  +L++
Sbjct: 245 -EKDWLNVS--PQAESLIR 260

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 95/223 (42%), Gaps = 26/223 (11%)
Query: 22  YEGCK-VGRGTYGHVYKARRKDNSDTRDYALKQIE-GTGLSMSACREIALLRELKHPNVI 79
           YE  K +G G +G     R K +++    A+K IE G  +  +  REI   R L+HPN++
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNEL--VAVKYIERGEKIDENVKREIINHRSLRHPNIV 78
Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGI 139
               V L+     + ++ +YA         F R   A                 Q++ G+
Sbjct: 79  RFKEVILTPT--HLAIVMEYASGGEL----FERICNAGRFSEDEARF----FFQQLISGV 128
Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR---LFNNPLKPLADLDPVVVT 196
            Y H+  V HRDLK  N L+  +G    R+KI   G+++   L + P          V T
Sbjct: 129 SYCHAMQVCHRDLKLENTLL--DGSPAPRLKICAFGYSKSSVLHSQPKD-------TVGT 179
Query: 197 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
             Y APE+LL   +  K  D+W+ G     +L     F   +E
Sbjct: 180 PAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEE 222

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/169 (24%), Positives = 83/169 (49%), Gaps = 19/169 (11%)
Query: 66  EIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXX 125
           E+ ++R+ +H NV+ + + +L  ++  +W++ ++ E      I  H              
Sbjct: 198 EVVIMRDYQHENVVEMYNSYLVGDE--LWVVMEFLEGGALTDIVTH---------TRMNE 246
Query: 126 XXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLK 185
               ++   +L  +  LH+  V+HRD+K  +IL+  +    GRVK++D GF    +   K
Sbjct: 247 EQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHD----GRVKLSDFGFCAQVS---K 299
Query: 186 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
            +     +V T ++ APE L+    Y   +DIW++G +  E++  EP +
Sbjct: 300 EVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIEMVDGEPPY 347

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 114/259 (44%), Gaps = 36/259 (13%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM--SACREIALLRELKHPNVINLISV 84
           +GRG++G V  A +K     R  A K+I    +       +EI +++ L HPN+I L   
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRR--AAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 74
Query: 85  FLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLH 143
           F  + D  ++L+ +     +L+  +   R  + +             ++  +L  + Y H
Sbjct: 75  FEDNTD--IYLVMELCTGGELFERVVHKRVFRESDAA---------RIMKDVLSAVAYCH 123
Query: 144 SNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPE 203
              V HRDLKP N L + +  +   +K+ D G A  F    KP   +   V T +Y +P+
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPD-SPLKLIDFGLAARF----KPGKMMRTKVGTPYYVSPQ 178
Query: 204 LLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF-SVMGFP 262
           +L G   Y    D W+ G +   LL   P F         S P   + + +I      FP
Sbjct: 179 VLEGL--YGPECDEWSAGVMMYVLLCGYPPF---------SAPTDXEVMLKIREGTFTFP 227
Query: 263 LEKDWEDIRKMPEHPTLLK 281
            EKDW ++   P+  +L++
Sbjct: 228 -EKDWLNVS--PQAESLIR 243

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 110/238 (46%), Gaps = 29/238 (12%)
Query: 7   IKTSNERTKVEDLFDYEGCKV-GRGTYGHVYKARRKDNSDTRD-YALKQIEGTGLSMS-- 62
           +K  +E+    D   +E  KV G+G++G V+  ++   SD R  YA+K ++   L +   
Sbjct: 14  VKEGHEKA---DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR 70
Query: 63  --ACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXX 119
                E  +L E+ HP ++ L   F    + K++L+ D+    DL     F R +K    
Sbjct: 71  VRTKMERDILVEVNHPFIVKLHYAF--QTEGKLYLILDFLRGGDL-----FTRLSKE--- 120
Query: 120 XXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL 179
                       L ++   + +LHS  +++RDLKP NIL+     E G +K+ D G ++ 
Sbjct: 121 -VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL----DEEGHIKLTDFGLSKE 175
Query: 180 FNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 237
             +  K          T  Y APE ++  R +T++ D W+ G +  E+LT    F  +
Sbjct: 176 SIDHEKKAYSF---CGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK 229

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 99/228 (43%), Gaps = 34/228 (14%)
Query: 20  FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACR----EIALLRELKH 75
           FD E   +GRG++  VYK    D   T + A  +++   L+ S  +    E   L+ L+H
Sbjct: 30  FDIE---IGRGSFKTVYKGL--DTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQH 84
Query: 76  PNVINLISVFLSH-NDRKVWLLFD--YAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLL 132
           PN++     + S    +K  +L         L   +K  +  K              S  
Sbjct: 85  PNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLR---------SWC 135
Query: 133 YQILDGIHYLHSNW--VLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADL 190
            QIL G+ +LH+    ++HRDLK  NI + G     G VKI D+G A      LK  +  
Sbjct: 136 RQILKGLQFLHTRTPPIIHRDLKCDNIFITG---PTGSVKIGDLGLA-----TLKRASFA 187
Query: 191 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCR 237
             V+ T  + APE       Y +++D++A G    E  TSE P   C+
Sbjct: 188 KAVIGTPEFXAPEXY--EEKYDESVDVYAFGXCXLEXATSEYPYSECQ 233

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 110/238 (46%), Gaps = 29/238 (12%)
Query: 7   IKTSNERTKVEDLFDYEGCKV-GRGTYGHVYKARRKDNSDTRD-YALKQIEGTGLSMS-- 62
           +K  +E+    D   +E  KV G+G++G V+  ++   SD R  YA+K ++   L +   
Sbjct: 15  VKEGHEKA---DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR 71
Query: 63  --ACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXX 119
                E  +L E+ HP ++ L   F    + K++L+ D+    DL     F R +K    
Sbjct: 72  VRTKMERDILVEVNHPFIVKLHYAF--QTEGKLYLILDFLRGGDL-----FTRLSKE--- 121
Query: 120 XXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL 179
                       L ++   + +LHS  +++RDLKP NIL+     E G +K+ D G ++ 
Sbjct: 122 -VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL----DEEGHIKLTDFGLSKE 176
Query: 180 FNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 237
             +  K          T  Y APE ++  R +T++ D W+ G +  E+LT    F  +
Sbjct: 177 SIDHEKKAYSF---CGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK 230

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 22/210 (10%)
Query: 24  GCKVGRGTYGHVYKAR-RKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLI 82
           G ++GRG +G V+  R R DN+     + ++     L     +E  +L++  HPN++ LI
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 83  SVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILD---GI 139
            V      + ++++ +  +      + F R   A             +LL  + D   G+
Sbjct: 179 GV--CTQKQPIYIVMELVQGG--DFLTFLRTEGAR--------LRVKTLLQMVGDAAAGM 226
Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
            YL S   +HRDL   N LV     E+  +KI+D G +R   + +   +     V   W 
Sbjct: 227 EYLESKCCIHRDLAARNCLV----TEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWT 282
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLT 229
            APE L   R Y+   D+W+ G +  E  +
Sbjct: 283 -APEALNYGR-YSSESDVWSFGILLWETFS 310

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 109/246 (44%), Gaps = 37/246 (15%)
Query: 2   DYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSD---------TRDYALK 52
           D+  K +T ++ T   D FD     +G G++G V   + K++ +          +   LK
Sbjct: 25  DFLKKWETPSQNTAQLDQFDRIKT-LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK 83
Query: 53  QIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHR 112
           QIE T        E  +L+ +  P ++ L   F  +++  + + +        H+ +  R
Sbjct: 84  QIEHT------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR 137
Query: 113 AAKANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA 172
            ++ +                QI+    YLHS  +++RDLKP N+L+     ++G +++ 
Sbjct: 138 FSEPHARFYAA----------QIVLTFEYLHSLDLIYRDLKPENLLID----QQGYIQVT 183
Query: 173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 232
           D GFA+        L        T  Y APE++L ++ Y KA+D WA+G +  E+    P
Sbjct: 184 DFGFAKRVKGRTWXLCG------TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYP 236
Query: 233 IFHCRQ 238
            F   Q
Sbjct: 237 PFFADQ 242

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 109/246 (44%), Gaps = 37/246 (15%)
Query: 2   DYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSD---------TRDYALK 52
           D+  K +T ++ T   D FD     +G G++G V   + K++ +          +   LK
Sbjct: 26  DFLKKWETPSQNTAQLDQFDRIKT-LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK 84
Query: 53  QIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHR 112
           QIE T        E  +L+ +  P ++ L   F  +++  + + +        H+ +  R
Sbjct: 85  QIEHT------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR 138
Query: 113 AAKANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA 172
            ++ +                QI+    YLHS  +++RDLKP N+L+     ++G +++ 
Sbjct: 139 FSEPHARFYAA----------QIVLTFEYLHSLDLIYRDLKPENLLI----DQQGYIQVT 184
Query: 173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 232
           D GFA+        L        T  Y APE++L ++ Y KA+D WA+G +  E+    P
Sbjct: 185 DFGFAKRVKGRTWXLCG------TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYP 237
Query: 233 IFHCRQ 238
            F   Q
Sbjct: 238 PFFADQ 243

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 109/246 (44%), Gaps = 37/246 (15%)
Query: 2   DYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSD---------TRDYALK 52
           D+  K +T ++ T   D FD     +G G++G V   + K++ +          +   LK
Sbjct: 25  DFLKKWETPSQNTAQLDQFDRIKT-LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK 83
Query: 53  QIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHR 112
           QIE T        E  +L+ +  P ++ L   F  +++  + + +        H+ +  R
Sbjct: 84  QIEHT------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR 137
Query: 113 AAKANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA 172
            ++ +                QI+    YLHS  +++RDLKP N+L+     ++G +++ 
Sbjct: 138 FSEPHARFYAA----------QIVLTFEYLHSLDLIYRDLKPENLLID----QQGYIQVT 183
Query: 173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 232
           D GFA+        L        T  Y APE++L ++ Y KA+D WA+G +  E+    P
Sbjct: 184 DFGFAKRVKGRTWXLCG------TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYP 236
Query: 233 IFHCRQ 238
            F   Q
Sbjct: 237 PFFADQ 242

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 109/246 (44%), Gaps = 37/246 (15%)
Query: 2   DYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSD---------TRDYALK 52
           D+  K +T ++ T   D FD     +G G++G V   + K++ +          +   LK
Sbjct: 25  DFLKKWETPSQNTAQLDQFDRIKT-LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK 83
Query: 53  QIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHR 112
           QIE T        E  +L+ +  P ++ L   F  +++  + + +        H+ +  R
Sbjct: 84  QIEHT------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR 137
Query: 113 AAKANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA 172
            ++ +                QI+    YLHS  +++RDLKP N+L+     ++G +++ 
Sbjct: 138 FSEPHARFYAA----------QIVLTFEYLHSLDLIYRDLKPENLLI----DQQGYIQVT 183
Query: 173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 232
           D GFA+        L        T  Y APE++L ++ Y KA+D WA+G +  E+    P
Sbjct: 184 DFGFAKRVKGRTWXLXG------TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYP 236
Query: 233 IFHCRQ 238
            F   Q
Sbjct: 237 PFFADQ 242

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 109/246 (44%), Gaps = 37/246 (15%)
Query: 2   DYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSD---------TRDYALK 52
           D+  K +T ++ T   D FD     +G G++G V   + K++ +          +   LK
Sbjct: 25  DFLKKWETPSQNTAQLDQFDRIKT-LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK 83
Query: 53  QIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHR 112
           QIE T        E  +L+ +  P ++ L   F  +++  + + +        H+ +  R
Sbjct: 84  QIEHT------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR 137
Query: 113 AAKANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA 172
            ++ +                QI+    YLHS  +++RDLKP N+L+     ++G +++ 
Sbjct: 138 FSEPHARFYAA----------QIVLTFEYLHSLDLIYRDLKPENLLID----QQGYIQVT 183
Query: 173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 232
           D GFA+        L        T  Y APE++L ++ Y KA+D WA+G +  E+    P
Sbjct: 184 DFGFAKRVKGRTWXLCG------TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYP 236
Query: 233 IFHCRQ 238
            F   Q
Sbjct: 237 PFFADQ 242

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 102/214 (47%), Gaps = 29/214 (13%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACRE-----IALLRELKHPNVIN 80
           K+G G+ G V  A  +  S  +  A+K+++   L     RE     + ++R+ +H NV+ 
Sbjct: 81  KIGEGSTGIVCIATVR--SSGKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVE 135
Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           + + +L  ++  +W++ ++ E      I  H                  ++   +L  + 
Sbjct: 136 MYNSYLVGDE--LWVVMEFLEGGALTDIVTH---------TRMNEEQIAAVCLAVLQALS 184
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
            LH+  V+HRD+K  +IL+  +    GRVK++D GF    +   K +     +V T ++ 
Sbjct: 185 VLHAQGVIHRDIKSDSILLTHD----GRVKLSDFGFCAQVS---KEVPRRKXLVGTPYWM 237
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           APE L+    Y   +DIW++G +  E++  EP +
Sbjct: 238 APE-LISRLPYGPEVDIWSLGIMVIEMVDGEPPY 270

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 109/246 (44%), Gaps = 37/246 (15%)
Query: 2   DYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSD---------TRDYALK 52
           D+  K +T ++ T   D FD     +G G++G V   + K++ +          +   LK
Sbjct: 25  DFLKKWETPSQNTAQLDQFDRIKT-LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK 83
Query: 53  QIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHR 112
           QIE T        E  +L+ +  P ++ L   F  +++  + + +        H+ +  R
Sbjct: 84  QIEHT------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR 137
Query: 113 AAKANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA 172
            ++ +                QI+    YLHS  +++RDLKP N+L+     ++G +++ 
Sbjct: 138 FSEPHARFYAA----------QIVLTFEYLHSLDLIYRDLKPENLLID----QQGYIQVT 183
Query: 173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 232
           D GFA+        L        T  Y APE++L ++ Y KA+D WA+G +  E+    P
Sbjct: 184 DFGFAKRVKGRTWXLCG------TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYP 236
Query: 233 IFHCRQ 238
            F   Q
Sbjct: 237 PFFADQ 242

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 97/237 (40%), Gaps = 51/237 (21%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELK------------ 74
           +GRG    V +   K     ++YA+K I+ TG    +  E+  LRE              
Sbjct: 25  LGRGVSSVVRRCIHKPTC--KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82
Query: 75  HPNVINLISV-------FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXX 127
           HPN+I L          FL  +  K   LFDY    +    K  R               
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR--------------- 127
Query: 128 XXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPL 187
              ++  +L+ I  LH   ++HRDLKP NIL+  +      +K+ D GF+      L P 
Sbjct: 128 --KIMRALLEVICALHKLNIVHRDLKPENILLDDD----MNIKLTDFGFS----CQLDPG 177
Query: 188 ADLDPVVVTFWYRAPELLLGARH-----YTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
             L  V  T  Y APE++  + +     Y K +D+W+ G I   LL   P F  R++
Sbjct: 178 EKLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ 234

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 35/224 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-------SMSACREIALLRELKHPNVI 79
           +G+G +   Y+    D  +   +A K +  + L        MS   EIA+ + L +P+V+
Sbjct: 50  LGKGGFAKCYEITDMDTKEV--FAGKVVPKSMLLKPHQKEKMST--EIAIHKSLDNPHVV 105
Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGI 139
                F   +D  V+++ +        +++ H+  KA               + Q + G+
Sbjct: 106 GFHGFF--EDDDFVYVVLEICRR--RSLLELHKRRKA------VTEPEARYFMRQTIQGV 155
Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL--FNNPLKPLADLDPVVVTF 197
            YLH+N V+HRDLK  N L + + ++   VKI D G A    F+   K       +  T 
Sbjct: 156 QYLHNNRVIHRDLKLGN-LFLNDDMD---VKIGDFGLATKIEFDGERK-----KTLCGTP 206
Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH--CRQE 239
            Y APE+L    H +  +DIW++GCI   LL  +P F   C +E
Sbjct: 207 NYIAPEVLCKKGH-SFEVDIWSLGCILYTLLVGKPPFETSCLKE 249

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 97/237 (40%), Gaps = 51/237 (21%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELK------------ 74
           +GRG    V +   K     ++YA+K I+ TG    +  E+  LRE              
Sbjct: 12  LGRGVSSVVRRCIHKPTC--KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 69
Query: 75  HPNVINLISV-------FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXX 127
           HPN+I L          FL  +  K   LFDY    +    K  R               
Sbjct: 70  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR--------------- 114
Query: 128 XXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPL 187
              ++  +L+ I  LH   ++HRDLKP NIL+  +      +K+ D GF+      L P 
Sbjct: 115 --KIMRALLEVICALHKLNIVHRDLKPENILLDDD----MNIKLTDFGFS----CQLDPG 164
Query: 188 ADLDPVVVTFWYRAPELLLGARH-----YTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
             L  V  T  Y APE++  + +     Y K +D+W+ G I   LL   P F  R++
Sbjct: 165 EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ 221

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 100/211 (47%), Gaps = 23/211 (10%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC--REIALLRELKHPNVINLIS 83
           K+G G+ G V  A  +  S  +  A+K+++            E+ ++R+ +H NV+ + +
Sbjct: 36  KIGEGSTGIVCIATVR--SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 93
Query: 84  VFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLH 143
            +L  ++  +W++ ++ E      I  H                  ++   +L  +  LH
Sbjct: 94  SYLVGDE--LWVVMEFLEGGALTDIVTH---------TRMNEEQIAAVCLAVLQALSVLH 142
Query: 144 SNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPE 203
           +  V+HRD+K  +IL+  +    GRVK++D GF    +   K +     +V T ++ APE
Sbjct: 143 AQGVIHRDIKSDSILLTHD----GRVKLSDFGFCAQVS---KEVPRRKXLVGTPYWMAPE 195
Query: 204 LLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
            L+    Y   +DIW++G +  E++  EP +
Sbjct: 196 -LISRLPYGPEVDIWSLGIMVIEMVDGEPPY 225

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 102/214 (47%), Gaps = 29/214 (13%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACRE-----IALLRELKHPNVIN 80
           K+G G+ G V  A  +  S  +  A+K+++   L     RE     + ++R+ +H NV+ 
Sbjct: 38  KIGEGSTGIVCIATVR--SSGKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVE 92
Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           + + +L  ++  +W++ ++ E      I  H                  ++   +L  + 
Sbjct: 93  MYNSYLVGDE--LWVVMEFLEGGALTDIVTH---------TRMNEEQIAAVCLAVLQALS 141
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
            LH+  V+HRD+K  +IL+  +    GRVK++D GF    +   K +     +V T ++ 
Sbjct: 142 VLHAQGVIHRDIKSDSILLTHD----GRVKLSDFGFCAQVS---KEVPRRKXLVGTPYWM 194
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           APE L+    Y   +DIW++G +  E++  EP +
Sbjct: 195 APE-LISRLPYGPEVDIWSLGIMVIEMVDGEPPY 227

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 97/237 (40%), Gaps = 51/237 (21%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELK------------ 74
           +GRG    V +   K     ++YA+K I+ TG    +  E+  LRE              
Sbjct: 25  LGRGVSSVVRRCIHKPTC--KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82
Query: 75  HPNVINLISV-------FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXX 127
           HPN+I L          FL  +  K   LFDY    +    K  R               
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR--------------- 127
Query: 128 XXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPL 187
              ++  +L+ I  LH   ++HRDLKP NIL+  +      +K+ D GF+      L P 
Sbjct: 128 --KIMRALLEVICALHKLNIVHRDLKPENILLDDD----MNIKLTDFGFS----CQLDPG 177
Query: 188 ADLDPVVVTFWYRAPELLLGARH-----YTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
             L  V  T  Y APE++  + +     Y K +D+W+ G I   LL   P F  R++
Sbjct: 178 EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ 234

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 35/224 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-------SMSACREIALLRELKHPNVI 79
           +G+G +   Y+    D  +   +A K +  + L        MS   EIA+ + L +P+V+
Sbjct: 50  LGKGGFAKCYEITDMDTKEV--FAGKVVPKSMLLKPHQKEKMST--EIAIHKSLDNPHVV 105
Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGI 139
                F   +D  V+++ +        +++ H+  KA               + Q + G+
Sbjct: 106 GFHGFF--EDDDFVYVVLEICRR--RSLLELHKRRKA------VTEPEARYFMRQTIQGV 155
Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL--FNNPLKPLADLDPVVVTF 197
            YLH+N V+HRDLK  N L + + ++   VKI D G A    F+   K       +  T 
Sbjct: 156 QYLHNNRVIHRDLKLGN-LFLNDDMD---VKIGDFGLATKIEFDGERK-----KXLCGTP 206
Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH--CRQE 239
            Y APE+L    H +  +DIW++GCI   LL  +P F   C +E
Sbjct: 207 NYIAPEVLCKKGH-SFEVDIWSLGCILYTLLVGKPPFETSCLKE 249

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 100/211 (47%), Gaps = 23/211 (10%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC--REIALLRELKHPNVINLIS 83
           K+G G+ G V  A  +  S  +  A+K+++            E+ ++R+ +H NV+ + +
Sbjct: 31  KIGEGSTGIVCIATVR--SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 88
Query: 84  VFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLH 143
            +L  ++  +W++ ++ E      I  H                  ++   +L  +  LH
Sbjct: 89  SYLVGDE--LWVVMEFLEGGALTDIVTH---------TRMNEEQIAAVCLAVLQALSVLH 137
Query: 144 SNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPE 203
           +  V+HRD+K  +IL+  +    GRVK++D GF    +   K +     +V T ++ APE
Sbjct: 138 AQGVIHRDIKSDSILLTHD----GRVKLSDFGFCAQVS---KEVPRRKXLVGTPYWMAPE 190
Query: 204 LLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
            L+    Y   +DIW++G +  E++  EP +
Sbjct: 191 -LISRLPYGPEVDIWSLGIMVIEMVDGEPPY 220

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 40/223 (17%)
Query: 27  VGRGTYGHVYKARRKDNSD---------TRDYALKQIEGTGLSMSACREIALLRELKHPN 77
           +G G++G V   + K+  +          +   LKQIE T        E  +L+ +  P 
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT------LNEKRILQAVNFPF 103
Query: 78  VINLISVFLSHNDRKVWLLFDYAEHD--LWHIIKFHRAAKANXXXXXXXXXXXXSLLYQI 135
           ++ L   F   ++  ++++ +YA       H+ +  R ++ +                QI
Sbjct: 104 LVKLEFSF--KDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAA----------QI 151
Query: 136 LDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVV 195
           +    YLHS  +++RDLKP N+++     ++G +K+ D GFA+        L        
Sbjct: 152 VLTFEYLHSLDLIYRDLKPENLMI----DQQGYIKVTDFGFAKRVKGRTWXLCG------ 201
Query: 196 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 238
           T  Y APE++L ++ Y KA+D WA+G +  E+    P F   Q
Sbjct: 202 TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 243

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 22/210 (10%)
Query: 24  GCKVGRGTYGHVYKAR-RKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLI 82
           G ++GRG +G V+  R R DN+     + ++     L     +E  +L++  HPN++ LI
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 83  SVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILD---GI 139
            V      + ++++ +  +      + F R   A             +LL  + D   G+
Sbjct: 179 GV--CTQKQPIYIVMELVQGG--DFLTFLRTEGAR--------LRVKTLLQMVGDAAAGM 226
Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
            YL S   +HRDL   N LV     E+  +KI+D G +R   + +   +     V   W 
Sbjct: 227 EYLESKCCIHRDLAARNCLV----TEKNVLKISDFGMSREEADGVYAASGGLRQVPVKW- 281
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLT 229
            APE L   R Y+   D+W+ G +  E  +
Sbjct: 282 TAPEALNYGR-YSSESDVWSFGILLWETFS 310

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 100/211 (47%), Gaps = 23/211 (10%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC--REIALLRELKHPNVINLIS 83
           K+G G+ G V  A  +  S  +  A+K+++            E+ ++R+ +H NV+ + +
Sbjct: 27  KIGEGSTGIVCIATVR--SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 84  VFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLH 143
            +L  ++  +W++ ++ E      I  H                  ++   +L  +  LH
Sbjct: 85  SYLVGDE--LWVVMEFLEGGALTDIVTH---------TRMNEEQIAAVCLAVLQALSVLH 133
Query: 144 SNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPE 203
           +  V+HRD+K  +IL+  +    GRVK++D GF    +   K +     +V T ++ APE
Sbjct: 134 AQGVIHRDIKSDSILLTHD----GRVKLSDFGFCAQVS---KEVPRRKXLVGTPYWMAPE 186
Query: 204 LLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
            L+    Y   +DIW++G +  E++  EP +
Sbjct: 187 -LISRLPYGPEVDIWSLGIMVIEMVDGEPPY 216

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 97/229 (42%), Gaps = 50/229 (21%)
Query: 27  VGRGTYGHVY-----------KARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKH 75
           +G G +G VY           KA R D  +     ++ +          +E  L   LKH
Sbjct: 15  IGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVR---------QEAKLFAMLKH 65
Query: 76  PNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXX--XXXSLLY 133
           PN+I L  V L              E +L  +++F R    N              +   
Sbjct: 66  PNIIALRGVCLK-------------EPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAV 112
Query: 134 QILDGIHYLHSNWV---LHRDLKPANILVMGEGIERGRV-----KIADMGFARLFNNPLK 185
           QI  G++YLH   +   +HRDLK +NIL++ + +E G +     KI D G AR ++   K
Sbjct: 113 QIARGMNYLHDEAIVPIIHRDLKSSNILIL-QKVENGDLSNKILKITDFGLAREWHRTTK 171
Query: 186 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
             A        + + APE++  A  ++K  D+W+ G +  ELLT E  F
Sbjct: 172 MSA-----AGAYAWMAPEVIR-ASMFSKGSDVWSYGVLLWELLTGEVPF 214

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 94/218 (43%), Gaps = 36/218 (16%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRD--YALKQIEGTGLSMSA--CREIALLRELKHPNVINL 81
           ++G+G +G V   R     D      A+KQ++ +G        REI +L+ L    ++  
Sbjct: 17  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 76
Query: 82  ISVFLSHNDRKVWLLFDYAEHD-LWHIIKFHRAAKANXXXXXXXXXXXXSLLY--QILDG 138
             V      + + L+ +Y     L   ++ HRA                 LLY  QI  G
Sbjct: 77  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA----------RLDASRLLLYSSQICKG 126
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVV--- 195
           + YL S   +HRDL   NILV  E      VKIAD G A+L   PL    D D  VV   
Sbjct: 127 MEYLGSRRCVHRDLAARNILVESE----AHVKIADFGLAKLL--PL----DKDYYVVREP 176
Query: 196 ----TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                FWY APE  L    +++  D+W+ G +  EL T
Sbjct: 177 GQSPIFWY-APE-SLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 108/246 (43%), Gaps = 37/246 (15%)
Query: 2   DYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSD---------TRDYALK 52
           D+  K +T ++ T   D FD     +G G++G V   + K++ +          +   LK
Sbjct: 46  DFLKKWETPSQNTAQLDQFDRIKT-LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK 104
Query: 53  QIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHR 112
           QIE T        E  +L+ +  P ++ L   F  +++  + + +        H+ +  R
Sbjct: 105 QIEHT------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR 158
Query: 113 AAKANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA 172
             + +                QI+    YLHS  +++RDLKP N+L+     ++G +++ 
Sbjct: 159 FXEPHARFYAA----------QIVLTFEYLHSLDLIYRDLKPENLLI----DQQGYIQVT 204
Query: 173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 232
           D GFA+        L        T  Y APE++L ++ Y KA+D WA+G +  E+    P
Sbjct: 205 DFGFAKRVKGRTWXLCG------TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYP 257
Query: 233 IFHCRQ 238
            F   Q
Sbjct: 258 PFFADQ 263

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 94/218 (43%), Gaps = 36/218 (16%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRD--YALKQIEGTGLSMSA--CREIALLRELKHPNVINL 81
           ++G+G +G V   R     D      A+KQ++ +G        REI +L+ L    ++  
Sbjct: 14  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 73
Query: 82  ISVFLSHNDRKVWLLFDYAEHD-LWHIIKFHRAAKANXXXXXXXXXXXXSLLY--QILDG 138
             V       ++ L+ +Y     L   ++ HRA                 LLY  QI  G
Sbjct: 74  RGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRA----------RLDASRLLLYSSQICKG 123
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVV--- 195
           + YL S   +HRDL   NILV  E      VKIAD G A+L   PL    D D  VV   
Sbjct: 124 MEYLGSRRCVHRDLAARNILVESE----AHVKIADFGLAKLL--PL----DKDXXVVREP 173
Query: 196 ----TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                FWY APE  L    +++  D+W+ G +  EL T
Sbjct: 174 GQSPIFWY-APE-SLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 18/209 (8%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRD--YALKQIEGTGLS--MSACREIALLRELKHPNVINL 81
           ++G+G +G V   R     D      A+K+++ +         REI +L+ L+H N++  
Sbjct: 18  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 77
Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
             V  S   R + L+ +Y  +  L   ++ H+    +                QI  G+ 
Sbjct: 78  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS--------QICKGME 129
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL +   +HR+L   NILV  E     RVKI D G  ++     +     +P     ++ 
Sbjct: 130 YLGTKRYIHRNLATRNILVENE----NRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY 185
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT 229
           APE L  ++ ++ A D+W+ G +  EL T
Sbjct: 186 APESLTESK-FSVASDVWSFGVVLYELFT 213

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 96/220 (43%), Gaps = 40/220 (18%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYA-----------LKQIEGTGLSMSACREIALLRELKH 75
           +G G++G V+  R + N   R YA           LKQ+E T        E  +L  + H
Sbjct: 14  LGTGSFGRVHLIRSRHNG--RYYAMKVLKKEIVVRLKQVEHTN------DERLMLSIVTH 65
Query: 76  PNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQI 135
           P +I +   F   + ++++++ DY E     +    R ++               L    
Sbjct: 66  PFIIRMWGTF--QDAQQIFMIMDYIEGG--ELFSLLRKSQRFPNPVAKFYAAEVCL---- 117
Query: 136 LDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVV 195
              + YLHS  +++RDLKP NIL+     + G +KI D GFA+   +    L        
Sbjct: 118 --ALEYLHSKDIIYRDLKPENILLD----KNGHIKITDFGFAKYVPDVTYXLCG------ 165
Query: 196 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
           T  Y APE ++  + Y K+ID W+ G +  E+L     F+
Sbjct: 166 TPDYIAPE-VVSTKPYNKSIDWWSFGILIYEMLAGYTPFY 204

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 94/218 (43%), Gaps = 36/218 (16%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRD--YALKQIEGTGLSMSA--CREIALLRELKHPNVINL 81
           ++G+G +G V   R     D      A+KQ++ +G        REI +L+ L    ++  
Sbjct: 30  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 82  ISVFLSHNDRKVWLLFDYAEHD-LWHIIKFHRAAKANXXXXXXXXXXXXSLLY--QILDG 138
             V      + + L+ +Y     L   ++ HRA                 LLY  QI  G
Sbjct: 90  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA----------RLDASRLLLYSSQICKG 139
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVV--- 195
           + YL S   +HRDL   NILV  E      VKIAD G A+L   PL    D D  VV   
Sbjct: 140 MEYLGSRRCVHRDLAARNILVESE----AHVKIADFGLAKLL--PL----DKDYYVVREP 189
Query: 196 ----TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                FWY APE  L    +++  D+W+ G +  EL T
Sbjct: 190 GQSPIFWY-APE-SLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 100/223 (44%), Gaps = 40/223 (17%)
Query: 27  VGRGTYGHVYKARRKDNSD---------TRDYALKQIEGTGLSMSACREIALLRELKHPN 77
           +G G++G V   + K+  +          +   LKQIE T        E  + + +  P 
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT------LNEKRIQQAVNFPF 103
Query: 78  VINLISVFLSHNDRKVWLLFDYAEHD--LWHIIKFHRAAKANXXXXXXXXXXXXSLLYQI 135
           ++ L   F   ++  ++++ +YA       H+ +  R ++ +                QI
Sbjct: 104 LVKLEFSF--KDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAA----------QI 151
Query: 136 LDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVV 195
           +    YLHS  +++RDLKP N+L+     ++G +K+AD GFA+        L        
Sbjct: 152 VLTFEYLHSLDLIYRDLKPENLLI----DQQGYIKVADFGFAKRVKGRTWXLCG------ 201
Query: 196 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 238
           T  Y APE++L ++ Y KA+D WA+G +  E+    P F   Q
Sbjct: 202 TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 243

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 108/246 (43%), Gaps = 37/246 (15%)
Query: 2   DYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSD---------TRDYALK 52
           D+  K +T ++ T   D FD     +G G++G V   + K++ +          +   LK
Sbjct: 25  DFLKKWETPSQNTAQLDQFDRIKT-LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK 83
Query: 53  QIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHR 112
           QIE T        E  +L+ +  P ++ L   F  +++  + + +        H+ +  R
Sbjct: 84  QIEHT------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR 137
Query: 113 AAKANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA 172
             + +                QI+    YLHS  +++RDLKP N+L+     ++G +++ 
Sbjct: 138 FXEPHARFYAA----------QIVLTFEYLHSLDLIYRDLKPENLLID----QQGYIQVT 183
Query: 173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 232
           D GFA+        L        T  Y APE++L ++ Y KA+D WA+G +  E+    P
Sbjct: 184 DFGFAKRVKGRTWXLCG------TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYP 236
Query: 233 IFHCRQ 238
            F   Q
Sbjct: 237 PFFADQ 242

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 35/221 (15%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVI 79
           G  +G+G +G   K   ++  +     +K++    E T    +  +E+ ++R L+HPNV+
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEV--MVMKELIRFDEET--QRTFLKEVKVMRCLEHPNVL 70
Query: 80  NLISVFLSHNDRKVWLLFDYAEHD-LWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
             I V   + D+++  + +Y +   L  IIK                    S    I  G
Sbjct: 71  KFIGVL--YKDKRLNFITEYIKGGTLRGIIK--------SMDSQYPWSQRVSFAKDIASG 120
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF----NNP--LKPLADLD- 191
           + YLHS  ++HRDL   N LV     E   V +AD G ARL       P  L+ L   D 
Sbjct: 121 MAYLHSMNIIHRDLNSHNCLVR----ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDR 176
Query: 192 ----PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 228
                VV   ++ APE++ G R Y + +D+++ G +  E++
Sbjct: 177 KKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEII 216

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 108/246 (43%), Gaps = 37/246 (15%)
Query: 2   DYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSD---------TRDYALK 52
           D+  K +T ++ T   D FD     +G G++G V   + K++ +          +   LK
Sbjct: 25  DFLKKWETPSQNTAQLDQFDRIKT-LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK 83
Query: 53  QIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHR 112
           QIE T        E  +L+ +  P ++ L   F  +++  + + +        H+ +  R
Sbjct: 84  QIEHT------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR 137
Query: 113 AAKANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA 172
             + +                QI+    YLHS  +++RDLKP N+L+     ++G +++ 
Sbjct: 138 FXEPHARFYAA----------QIVLTFEYLHSLDLIYRDLKPENLLID----QQGYIQVT 183
Query: 173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 232
           D GFA+        L        T  Y APE++L ++ Y KA+D WA+G +  E+    P
Sbjct: 184 DFGFAKRVKGRTWXLCG------TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYP 236
Query: 233 IFHCRQ 238
            F   Q
Sbjct: 237 PFFADQ 242

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 108/246 (43%), Gaps = 37/246 (15%)
Query: 2   DYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSD---------TRDYALK 52
           D+  K +T ++ T   D FD     +G G++G V   + K++ +          +   LK
Sbjct: 20  DFLKKWETPSQNTAQLDQFDRIKT-LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK 78
Query: 53  QIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHR 112
           QIE T        E  +L+ +  P ++ L   F  +++  + + +        H+ +  R
Sbjct: 79  QIEHT------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR 132
Query: 113 AAKANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA 172
             + +                QI+    YLHS  +++RDLKP N+L+     ++G +++ 
Sbjct: 133 FXEPHARFYAA----------QIVLTFEYLHSLDLIYRDLKPENLLID----QQGYIQVT 178
Query: 173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 232
           D GFA+        L        T  Y APE++L ++ Y KA+D WA+G +  E+    P
Sbjct: 179 DFGFAKRVKGRTWXLCG------TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYP 231
Query: 233 IFHCRQ 238
            F   Q
Sbjct: 232 PFFADQ 237

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 94/218 (43%), Gaps = 36/218 (16%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRD--YALKQIEGTGLSMSA--CREIALLRELKHPNVINL 81
           ++G+G +G V   R     D      A+KQ++ +G        REI +L+ L    ++  
Sbjct: 18  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 77
Query: 82  ISVFLSHNDRKVWLLFDYAEHD-LWHIIKFHRAAKANXXXXXXXXXXXXSLLY--QILDG 138
             V      + + L+ +Y     L   ++ HRA                 LLY  QI  G
Sbjct: 78  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA----------RLDASRLLLYSSQICKG 127
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVV--- 195
           + YL S   +HRDL   NILV  E      VKIAD G A+L   PL    D D  VV   
Sbjct: 128 MEYLGSRRCVHRDLAARNILVESE----AHVKIADFGLAKLL--PL----DKDYYVVREP 177
Query: 196 ----TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                FWY APE  L    +++  D+W+ G +  EL T
Sbjct: 178 GQSPIFWY-APE-SLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 25/210 (11%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYAL---KQIEGTGLSMSACREIALLRELKHPNVIN 80
           G  +G GT+G V   + +         +   ++I    +     REI  L+  +HP++I 
Sbjct: 21  GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIK 80
Query: 81  LISVFLSHNDRKVWLLFDYAEH-DLW-HIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           L  V  + +D  ++++ +Y    +L+ +I K  R  +               L  QIL G
Sbjct: 81  LYQVISTPSD--IFMVMEYVSGGELFDYICKNGRLDEKESR----------RLFQQILSG 128
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y H + V+HRDLKP N+L+          KIAD G + + ++       L     +  
Sbjct: 129 VDYCHRHMVVHRDLKPENVLLDAH----MNAKIADFGLSNMMSDG----EFLRXSCGSPN 180
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELL 228
           Y APE++ G  +    +DIW+ G I   LL
Sbjct: 181 YAAPEVISGRLYAGPEVDIWSSGVILYALL 210

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 108/246 (43%), Gaps = 37/246 (15%)
Query: 2   DYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSD---------TRDYALK 52
           D+  K +T ++ T   D FD     +G G++G V   + K++ +          +   LK
Sbjct: 25  DFLKKWETPSQNTAQLDQFDRIKT-LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK 83
Query: 53  QIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHR 112
           QIE T        E  +L+ +  P ++ L   F  +++  + + +        H+ +  R
Sbjct: 84  QIEHT------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR 137
Query: 113 AAKANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA 172
             + +                QI+    YLHS  +++RDLKP N+L+     ++G +++ 
Sbjct: 138 FXEPHARFYAA----------QIVLTFEYLHSLDLIYRDLKPENLLID----QQGYIQVT 183
Query: 173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 232
           D GFA+        L        T  Y APE++L ++ Y KA+D WA+G +  E+    P
Sbjct: 184 DFGFAKRVKGRTWXLCG------TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYP 236
Query: 233 IFHCRQ 238
            F   Q
Sbjct: 237 PFFADQ 242

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 57/105 (54%), Gaps = 11/105 (10%)
Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           QI+    YLHS  +++RDLKP N+L+     ++G +K+AD GFA+        L      
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLI----DQQGYIKVADFGFAKRVKGRTWXLCG---- 200
Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 238
             T  Y APE++L ++ Y KA+D WA+G +  E+    P F   Q
Sbjct: 201 --TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 57/105 (54%), Gaps = 11/105 (10%)
Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           QI+    YLHS  +++RDLKP N+L+     ++G +K+AD GFA+        L      
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLI----DQQGYIKVADFGFAKRVKGRTWXLCG---- 200
Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 238
             T  Y APE++L ++ Y KA+D WA+G +  E+    P F   Q
Sbjct: 201 --TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 57/105 (54%), Gaps = 11/105 (10%)
Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           QI+    YLHS  +++RDLKP N+L+     ++G +K+AD GFA+        L      
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLID----QQGYIKVADFGFAKRVKGRTWXLCG---- 200
Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 238
             T  Y APE++L ++ Y KA+D WA+G +  E+    P F   Q
Sbjct: 201 --TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/185 (30%), Positives = 85/185 (45%), Gaps = 17/185 (9%)
Query: 45  DTRDYALKQIEGTGLSMSACREIALLREL-KHPNVINLISVFLSHNDRKV-WLLFDYAEH 102
           D RD A+K+I     S  A RE+ LLRE  +HPNVI     F +  DR+  ++  +    
Sbjct: 47  DNRDVAVKRILPECFSF-ADREVQLLRESDEHPNVIRY---FCTEKDRQFQYIAIELCAA 102
Query: 103 DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILV-MG 161
            L   ++    A               +LL Q   G+ +LHS  ++HRDLKP NIL+ M 
Sbjct: 103 TLQEYVEQKDFAHLGLEPI--------TLLQQTTSGLAHLHSLNIVHRDLKPHNILISMP 154
Query: 162 EGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLL--GARHYTKAIDIWA 219
               + +  I+D G  +         +    V  T  + APE+L      + T  +DI++
Sbjct: 155 NAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFS 214
Query: 220 IGCIF 224
            GC+F
Sbjct: 215 AGCVF 219

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 109/246 (44%), Gaps = 37/246 (15%)
Query: 2   DYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSD---------TRDYALK 52
           D+  K +T ++ T   D FD     +G G++G V   + K++ +          +   LK
Sbjct: 25  DFLKKWETPSQNTAQLDQFDRIKT-LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK 83
Query: 53  QIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHR 112
           QIE T        E  +L+ +  P ++ L   F  +++  + + +        H+ +  R
Sbjct: 84  QIEHT------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR 137
Query: 113 AAKANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA 172
            ++ +                QI+    YLHS  +++RDLKP N+L+     ++G +++ 
Sbjct: 138 FSEPHARFYAA----------QIVLTFEYLHSLDLIYRDLKPENLLI----DQQGYIQVT 183
Query: 173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 232
           D GFA+        L        T  Y APE++L ++ Y KA+D WA+G +  ++    P
Sbjct: 184 DFGFAKRVKGRTWXLCG------TPEYLAPEIIL-SKGYNKAVDWWALGVLIYQMAAGYP 236
Query: 233 IFHCRQ 238
            F   Q
Sbjct: 237 PFFADQ 242

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 38/217 (17%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIE---GTGLSMSACREIALLRELKHPNVINLIS 83
           +G G YG V  A  +   +    A+K ++         +  +EI + + L H NV+    
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 84  VFLSHNDRKVWL-------LFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQIL 136
                N + ++L       LFD  E D+                            +Q++
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDI-----------------GMPEPDAQRFFHQLM 114
Query: 137 DGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF--NNPLKPLADLDPVV 194
            G+ YLH   + HRD+KP N+L+     ER  +KI+D G A +F  NN  +    L+ + 
Sbjct: 115 AGVVYLHGIGITHRDIKPENLLLD----ERDNLKISDFGLATVFRYNNRERL---LNKMC 167
Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 231
            T  Y APELL     + + +D+W+ G +   +L  E
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 38/217 (17%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIE---GTGLSMSACREIALLRELKHPNVINLIS 83
           +G G YG V  A  +   +    A+K ++         +  +EI + + L H NV+    
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 84  VFLSHNDRKVWL-------LFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQIL 136
                N + ++L       LFD  E D+                            +Q++
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDI-----------------GMPEPDAQRFFHQLM 115
Query: 137 DGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF--NNPLKPLADLDPVV 194
            G+ YLH   + HRD+KP N+L+     ER  +KI+D G A +F  NN  +    L+ + 
Sbjct: 116 AGVVYLHGIGITHRDIKPENLLLD----ERDNLKISDFGLATVFRYNNRERL---LNKMC 168
Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 231
            T  Y APELL     + + +D+W+ G +   +L  E
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 38/217 (17%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIE---GTGLSMSACREIALLRELKHPNVINLIS 83
           +G G YG V  A  +   +    A+K ++         +  +EI + + L H NV+    
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 84  VFLSHNDRKVWL-------LFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQIL 136
                N + ++L       LFD  E D+                            +Q++
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDI-----------------GMPEPDAQRFFHQLM 115
Query: 137 DGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF--NNPLKPLADLDPVV 194
            G+ YLH   + HRD+KP N+L+     ER  +KI+D G A +F  NN  +    L+ + 
Sbjct: 116 AGVVYLHGIGITHRDIKPENLLLD----ERDNLKISDFGLATVFRYNNRERL---LNKMC 168
Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 231
            T  Y APELL     + + +D+W+ G +   +L  E
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 38/217 (17%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIE---GTGLSMSACREIALLRELKHPNVINLIS 83
           +G G YG V  A  +   +    A+K ++         +  +EI + + L H NV+    
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 84  VFLSHNDRKVWL-------LFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQIL 136
                N + ++L       LFD  E D+                            +Q++
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDI-----------------GMPEPDAQRFFHQLM 115
Query: 137 DGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF--NNPLKPLADLDPVV 194
            G+ YLH   + HRD+KP N+L+     ER  +KI+D G A +F  NN  +    L+ + 
Sbjct: 116 AGVVYLHGIGITHRDIKPENLLLD----ERDNLKISDFGLATVFRYNNRERL---LNKMC 168
Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 231
            T  Y APELL     + + +D+W+ G +   +L  E
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 38/217 (17%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIE---GTGLSMSACREIALLRELKHPNVINLIS 83
           +G G YG V  A  +   +    A+K ++         +  +EI + + L H NV+    
Sbjct: 13  LGEGAYGEVQLAVNRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 84  VFLSHNDRKVWL-------LFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQIL 136
                N + ++L       LFD  E D+                            +Q++
Sbjct: 71  HRREGNIQYLFLEYCSGGELFDRIEPDI-----------------GMPEPDAQRFFHQLM 113
Query: 137 DGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF--NNPLKPLADLDPVV 194
            G+ YLH   + HRD+KP N+L+     ER  +KI+D G A +F  NN  +    L+ + 
Sbjct: 114 AGVVYLHGIGITHRDIKPENLLLD----ERDNLKISDFGLATVFRYNNRERL---LNKMC 166
Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 231
            T  Y APELL     + + +D+W+ G +   +L  E
Sbjct: 167 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 203

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 38/217 (17%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIE---GTGLSMSACREIALLRELKHPNVINLIS 83
           +G G YG V  A  +   +    A+K ++         +  +EI + + L H NV+    
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 84  VFLSHNDRKVWL-------LFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQIL 136
                N + ++L       LFD  E D+                            +Q++
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDI-----------------GMPEPDAQRFFHQLM 114
Query: 137 DGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF--NNPLKPLADLDPVV 194
            G+ YLH   + HRD+KP N+L+     ER  +KI+D G A +F  NN  +    L+ + 
Sbjct: 115 AGVVYLHGIGITHRDIKPENLLLD----ERDNLKISDFGLATVFRYNNRERL---LNKMC 167
Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 231
            T  Y APELL     + + +D+W+ G +   +L  E
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 38/217 (17%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIE---GTGLSMSACREIALLRELKHPNVINLIS 83
           +G G YG V  A  +   +    A+K ++         +  +EI + + L H NV+    
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 84  VFLSHNDRKVWL-------LFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQIL 136
                N + ++L       LFD  E D+                            +Q++
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDI-----------------GMPEPDAQRFFHQLM 115
Query: 137 DGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF--NNPLKPLADLDPVV 194
            G+ YLH   + HRD+KP N+L+     ER  +KI+D G A +F  NN  +    L+ + 
Sbjct: 116 AGVVYLHGIGITHRDIKPENLLL----DERDNLKISDFGLATVFRYNNRERL---LNKMC 168
Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 231
            T  Y APELL     + + +D+W+ G +   +L  E
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 38/217 (17%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIE---GTGLSMSACREIALLRELKHPNVINLIS 83
           +G G YG V  A  +   +    A+K ++         +  +EI + + L H NV+    
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 84  VFLSHNDRKVWL-------LFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQIL 136
                N + ++L       LFD  E D+                            +Q++
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDI-----------------GMPEPDAQRFFHQLM 114
Query: 137 DGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF--NNPLKPLADLDPVV 194
            G+ YLH   + HRD+KP N+L+     ER  +KI+D G A +F  NN  +    L+ + 
Sbjct: 115 AGVVYLHGIGITHRDIKPENLLLD----ERDNLKISDFGLATVFRYNNRERL---LNKMC 167
Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 231
            T  Y APELL     + + +D+W+ G +   +L  E
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 38/217 (17%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIE---GTGLSMSACREIALLRELKHPNVINLIS 83
           +G G YG V  A  +   +    A+K ++         +  +EI + + L H NV+    
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 84  VFLSHNDRKVWL-------LFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQIL 136
                N + ++L       LFD  E D+                            +Q++
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDI-----------------GMPEPDAQRFFHQLM 114
Query: 137 DGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF--NNPLKPLADLDPVV 194
            G+ YLH   + HRD+KP N+L+     ER  +KI+D G A +F  NN  +    L+ + 
Sbjct: 115 AGVVYLHGIGITHRDIKPENLLLD----ERDNLKISDFGLATVFRYNNRERL---LNKMC 167
Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 231
            T  Y APELL     + + +D+W+ G +   +L  E
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 38/217 (17%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIE---GTGLSMSACREIALLRELKHPNVINLIS 83
           +G G YG V  A  +   +    A+K ++         +  +EI + + L H NV+    
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 84  VFLSHNDRKVWL-------LFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQIL 136
                N + ++L       LFD  E D+                            +Q++
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDI-----------------GMPEPDAQRFFHQLM 114
Query: 137 DGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF--NNPLKPLADLDPVV 194
            G+ YLH   + HRD+KP N+L+     ER  +KI+D G A +F  NN  +    L+ + 
Sbjct: 115 AGVVYLHGIGITHRDIKPENLLLD----ERDNLKISDFGLATVFRYNNRERL---LNKMC 167
Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 231
            T  Y APELL     + + +D+W+ G +   +L  E
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 94/216 (43%), Gaps = 25/216 (11%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACR-EIALLRELKH-PNVINLISV 84
           VG GTYG VYK R          A+K ++ TG      + EI +L++  H  N+      
Sbjct: 32  VGNGTYGQVYKGRHVKTGQL--AAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 89
Query: 85  FLSHN----DRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           F+  N    D ++WL+ ++       +    +  K N             +  +IL G+ 
Sbjct: 90  FIKKNPPGMDDQLWLVMEFC--GAGSVTDLIKNTKGNTLKEEWIAY----ICREILRGLS 143
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           +LH + V+HRD+K  N+L+     E   VK+ D G +   +   + +   +  + T ++ 
Sbjct: 144 HLHQHKVIHRDIKGQNVLL----TENAEVKLVDFGVSAQLD---RTVGRRNTFIGTPYWM 196
Query: 201 APELLLGARH----YTKAIDIWAIGCIFAELLTSEP 232
           APE++    +    Y    D+W++G    E+    P
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 38/217 (17%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIE---GTGLSMSACREIALLRELKHPNVINLIS 83
           +G G YG V  A  +   +    A+K ++         +  +EI + + L H NV+    
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 84  VFLSHNDRKVWL-------LFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQIL 136
                N + ++L       LFD  E D+                            +Q++
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDI-----------------GMPEPDAQRFFHQLM 115
Query: 137 DGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF--NNPLKPLADLDPVV 194
            G+ YLH   + HRD+KP N+L+     ER  +KI+D G A +F  NN  +    L+ + 
Sbjct: 116 AGVVYLHGIGITHRDIKPENLLLD----ERDNLKISDFGLATVFRYNNRERL---LNKMC 168
Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 231
            T  Y APELL     + + +D+W+ G +   +L  E
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 92/216 (42%), Gaps = 36/216 (16%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIE---GTGLSMSACREIALLRELKHPNVINLIS 83
           +G G YG V  A  +   +    A+K ++         +  +EI + + L H NV+    
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 84  VFLSHNDRKVWL-------LFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQIL 136
                N + ++L       LFD  E D+                            +Q++
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDI-----------------GMPEPDAQRFFHQLM 115
Query: 137 DGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFN-NPLKPLADLDPVVV 195
            G+ YLH   + HRD+KP N+L+     ER  +KI+D G A +F  N  + L  L+ +  
Sbjct: 116 AGVVYLHGIGITHRDIKPENLLL----DERDNLKISDFGLATVFRYNNRERL--LNKMCG 169
Query: 196 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 231
           T  Y APELL     + + +D+W+ G +   +L  E
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 92/216 (42%), Gaps = 36/216 (16%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIE---GTGLSMSACREIALLRELKHPNVINLIS 83
           +G G YG V  A  +   +    A+K ++         +  +EI + + L H NV+    
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 84  VFLSHNDRKVWL-------LFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQIL 136
                N + ++L       LFD  E D+                            +Q++
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDI-----------------GMPEPDAQRFFHQLM 114
Query: 137 DGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFN-NPLKPLADLDPVVV 195
            G+ YLH   + HRD+KP N+L+     ER  +KI+D G A +F  N  + L  L+ +  
Sbjct: 115 AGVVYLHGIGITHRDIKPENLLLD----ERDNLKISDFGLATVFRYNNRERL--LNKMCG 168
Query: 196 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 231
           T  Y APELL     + + +D+W+ G +   +L  E
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/244 (24%), Positives = 108/244 (44%), Gaps = 37/244 (15%)
Query: 2   DYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSD---------TRDYALK 52
           D+  K +T ++ T   D FD     +G G++G V   + K++ +          +   LK
Sbjct: 25  DFLKKWETPSQNTAQLDQFDRIKT-LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK 83
Query: 53  QIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHR 112
           QIE T        E  +L+ +  P ++ L   F  +++  + + +        H+ +  R
Sbjct: 84  QIEHT------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR 137
Query: 113 AAKANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA 172
            ++ +                QI+    YLHS  +++RDLKP N+L+     ++G +++ 
Sbjct: 138 FSEPHARFYAA----------QIVLTFEYLHSLDLIYRDLKPENLLID----QQGYIQVT 183
Query: 173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 232
           D GFA+        L        T  Y APE++L ++ Y KA+D WA+G +  E+    P
Sbjct: 184 DFGFAKRVKGRTWXLCG------TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYP 236
Query: 233 IFHC 236
            F  
Sbjct: 237 PFFA 240

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 38/217 (17%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIE---GTGLSMSACREIALLRELKHPNVINLIS 83
           +G G YG V  A  +   +    A+K ++         +  +EI + + L H NV+    
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 84  VFLSHNDRKVWL-------LFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQIL 136
                N + ++L       LFD  E D+                            +Q++
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDI-----------------GMPEPDAQRFFHQLM 114
Query: 137 DGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF--NNPLKPLADLDPVV 194
            G+ YLH   + HRD+KP N+L+     ER  +KI+D G A +F  NN  +    L+ + 
Sbjct: 115 AGVVYLHGIGITHRDIKPENLLLD----ERDNLKISDFGLATVFRYNNRERL---LNKMX 167
Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 231
            T  Y APELL     + + +D+W+ G +   +L  E
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 38/217 (17%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIE---GTGLSMSACREIALLRELKHPNVINLIS 83
           +G G YG V  A  +   +    A+K ++         +  +EI + + L H NV+    
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA--VAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 71
Query: 84  VFLSHNDRKVWL-------LFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQIL 136
                N + ++L       LFD  E D+                            +Q++
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDI-----------------GMPEPDAQRFFHQLM 114
Query: 137 DGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF--NNPLKPLADLDPVV 194
            G+ YLH   + HRD+KP N+L+     ER  +KI+D G A +F  NN  +    L+ + 
Sbjct: 115 AGVVYLHGIGITHRDIKPENLLLD----ERDNLKISDFGLATVFRYNNRERL---LNKMC 167
Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 231
            T  Y APELL     + + +D+W+ G +   +L  E
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 38/217 (17%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIE---GTGLSMSACREIALLRELKHPNVINLIS 83
           +G G YG V  A  +   +    A+K ++         +  +EI + + L H NV+    
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA--VAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 72
Query: 84  VFLSHNDRKVWL-------LFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQIL 136
                N + ++L       LFD  E D+                            +Q++
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDI-----------------GMPEPDAQRFFHQLM 115
Query: 137 DGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF--NNPLKPLADLDPVV 194
            G+ YLH   + HRD+KP N+L+     ER  +KI+D G A +F  NN  +    L+ + 
Sbjct: 116 AGVVYLHGIGITHRDIKPENLLL----DERDNLKISDFGLATVFRYNNRERL---LNKMX 168
Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 231
            T  Y APELL     + + +D+W+ G +   +L  E
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 38/217 (17%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIE---GTGLSMSACREIALLRELKHPNVINLIS 83
           +G G YG V  A  +   +    A+K ++         +  +EI + + L H NV+    
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 84  VFLSHNDRKVWL-------LFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQIL 136
                N + ++L       LFD  E D+                            +Q++
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDI-----------------GMPEPDAQRFFHQLM 114
Query: 137 DGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF--NNPLKPLADLDPVV 194
            G+ YLH   + HRD+KP N+L+     ER  +KI+D G A +F  NN  +    L+ + 
Sbjct: 115 AGVVYLHGIGITHRDIKPENLLLD----ERDNLKISDFGLATVFRYNNRERL---LNKMX 167
Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 231
            T  Y APELL     + + +D+W+ G +   +L  E
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 38/217 (17%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIE---GTGLSMSACREIALLRELKHPNVINLIS 83
           +G G YG V  A  +   +    A+K ++         +  +EI + + L H NV+    
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 84  VFLSHNDRKVWL-------LFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQIL 136
                N + ++L       LFD  E D+                            +Q++
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDI-----------------GMPEPDAQRFFHQLM 114
Query: 137 DGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF--NNPLKPLADLDPVV 194
            G+ YLH   + HRD+KP N+L+     ER  +KI+D G A +F  NN  +    L+ + 
Sbjct: 115 AGVVYLHGIGITHRDIKPENLLLD----ERDNLKISDFGLATVFRYNNRERL---LNKMX 167
Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 231
            T  Y APELL     + + +D+W+ G +   +L  E
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 108/246 (43%), Gaps = 37/246 (15%)
Query: 2   DYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSD---------TRDYALK 52
           D+  K +T ++ T   D FD     +G G++G V   + K++ +          +   LK
Sbjct: 25  DFLKKWETPSQNTAQLDQFDRIKT-LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK 83
Query: 53  QIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHR 112
           QIE T        E  +L+ +  P ++ L   F  +++  + + +        H+ +  R
Sbjct: 84  QIEHT------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR 137
Query: 113 AAKANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA 172
            ++ +                QI+    YLHS  +++RDLKP N+L+     ++G +++ 
Sbjct: 138 FSEPHARFYAA----------QIVLTFEYLHSLDLIYRDLKPENLLID----QQGYIQVT 183
Query: 173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 232
           D GFA+        L      +      APE++L ++ Y KA+D WA+G +  E+    P
Sbjct: 184 DFGFAKRVKGRTWXLCGTPEAL------APEIIL-SKGYNKAVDWWALGVLIYEMAAGYP 236
Query: 233 IFHCRQ 238
            F   Q
Sbjct: 237 PFFADQ 242

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 109/246 (44%), Gaps = 37/246 (15%)
Query: 2   DYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSD---------TRDYALK 52
           D+  K +T ++ T   D FD     +G G++G V   + K++ +          +   LK
Sbjct: 25  DFLKKWETPSQNTAQLDQFDRIKT-LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK 83
Query: 53  QIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHR 112
           QIE T        E  +L+ +  P ++ L   F  +++  + + +        H+ +  R
Sbjct: 84  QIEHT------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR 137
Query: 113 AAKANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA 172
            ++ +                QI+    YLHS  +++RDLKP N+++     ++G +++ 
Sbjct: 138 FSEPHARFYAA----------QIVLTFEYLHSLDLIYRDLKPENLIID----QQGYIQVT 183
Query: 173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 232
           D GFA+        L        T  Y APE+++ ++ Y KA+D WA+G +  E+    P
Sbjct: 184 DFGFAKRVKGRTWXLCG------TPEYLAPEIII-SKGYNKAVDWWALGVLIYEMAAGYP 236
Query: 233 IFHCRQ 238
            F   Q
Sbjct: 237 PFFADQ 242

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 38/217 (17%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIE---GTGLSMSACREIALLRELKHPNVINLIS 83
           +G G YG V  A  +   +    A+K ++         +  +EI + + L H NV+    
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA--VAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 71
Query: 84  VFLSHNDRKVWL-------LFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQIL 136
                N + ++L       LFD  E D+                            +Q++
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDI-----------------GMPEPDAQRFFHQLM 114
Query: 137 DGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF--NNPLKPLADLDPVV 194
            G+ YLH   + HRD+KP N+L+     ER  +KI+D G A +F  NN  +    L+ + 
Sbjct: 115 AGVVYLHGIGITHRDIKPENLLLD----ERDNLKISDFGLATVFRYNNRERL---LNKMX 167
Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 231
            T  Y APELL     + + +D+W+ G +   +L  E
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 56/103 (54%), Gaps = 9/103 (8%)
Query: 131 LLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF--NNPLKPLA 188
             +Q++ G+ YLH   + HRD+KP N+L+     ER  +KI+D G A +F  NN  +   
Sbjct: 109 FFHQLMAGVVYLHGIGITHRDIKPENLLLD----ERDNLKISDFGLATVFRYNNRERL-- 162
Query: 189 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 231
            L+ +  T  Y APELL     + + +D+W+ G +   +L  E
Sbjct: 163 -LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 108/246 (43%), Gaps = 37/246 (15%)
Query: 2   DYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSD---------TRDYALK 52
           D+  K +T ++ T   D FD     +G G++G V   + K++ +          +   LK
Sbjct: 25  DFLKKWETPSQNTAQLDQFDRIKT-LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK 83
Query: 53  QIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHR 112
           QIE T        E  +L+ +  P ++ L   F  +++  + + +        H+ +  R
Sbjct: 84  QIEHT------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR 137
Query: 113 AAKANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA 172
            ++ +                QI+    YLHS  +++RDLKP N+L+     ++G +++ 
Sbjct: 138 FSEPHARFYAA----------QIVLTFEYLHSLDLIYRDLKPENLLID----QQGYIQVT 183
Query: 173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 232
           D GFA+        L        T  Y AP ++L ++ Y KA+D WA+G +  E+    P
Sbjct: 184 DFGFAKRVKGRTWXLCG------TPEYLAPAIIL-SKGYNKAVDWWALGVLIYEMAAGYP 236
Query: 233 IFHCRQ 238
            F   Q
Sbjct: 237 PFFADQ 242

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 56/103 (54%), Gaps = 9/103 (8%)
Query: 131 LLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF--NNPLKPLA 188
             +Q++ G+ YLH   + HRD+KP N+L+     ER  +KI+D G A +F  NN  +   
Sbjct: 110 FFHQLMAGVVYLHGIGITHRDIKPENLLL----DERDNLKISDFGLATVFRYNNRERL-- 163
Query: 189 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 231
            L+ +  T  Y APELL     + + +D+W+ G +   +L  E
Sbjct: 164 -LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 101/224 (45%), Gaps = 35/224 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDT-------RDYALKQIEGTGLSMSACREIALLRELKHPNVI 79
           +G+G +   ++    D  +        +   LK  +   +SM    EI++ R L H +V+
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM----EISIHRSLAHQHVV 102
Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGI 139
                F   ND  V+++ +        +++ H+  KA               L QI+ G 
Sbjct: 103 GFHG-FFEDNDF-VFVVLELCRR--RSLLELHKRRKA------LTEPEARYYLRQIVLGC 152
Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL--FNNPLKPLADLDPVVVTF 197
            YLH N V+HRDLK  N L + E +E   VKI D G A    ++   K +     +  T 
Sbjct: 153 QYLHRNRVIHRDLKLGN-LFLNEDLE---VKIGDFGLATKVEYDGERKKV-----LCGTP 203
Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH--CRQE 239
            Y APE +L  + ++  +D+W+IGCI   LL  +P F   C +E
Sbjct: 204 NYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE 246

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 100/224 (44%), Gaps = 35/224 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDT-------RDYALKQIEGTGLSMSACREIALLRELKHPNVI 79
           +G+G +   ++    D  +        +   LK  +   +SM    EI++ R L H +V+
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM----EISIHRSLAHQHVV 78
Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGI 139
                F   ND  V+++ +        +++ H+  KA               L QI+ G 
Sbjct: 79  GFHG-FFEDNDF-VFVVLELCRR--RSLLELHKRRKA------LTEPEARYYLRQIVLGC 128
Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL--FNNPLKPLADLDPVVVTF 197
            YLH N V+HRDLK  N L + E +E   VKI D G A    ++   K +    P     
Sbjct: 129 QYLHRNRVIHRDLKLGN-LFLNEDLE---VKIGDFGLATKVEYDGERKKVLCGTP----- 179
Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH--CRQE 239
            Y APE +L  + ++  +D+W+IGCI   LL  +P F   C +E
Sbjct: 180 NYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE 222

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 99/223 (44%), Gaps = 40/223 (17%)
Query: 27  VGRGTYGHVYKARRKDNSD---------TRDYALKQIEGTGLSMSACREIALLRELKHPN 77
           +G G++G V   + K+  +          +   LKQIE T        E  +L+ +  P 
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT------LNEKRILQAVNFPF 95
Query: 78  VINLISVFLSHNDRKVWLLFDYAEHD--LWHIIKFHRAAKANXXXXXXXXXXXXSLLYQI 135
           ++ L   F   ++  ++++ +Y        H+ +  R ++ +                QI
Sbjct: 96  LVKLEFSF--KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA----------QI 143
Query: 136 LDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVV 195
           +    YLHS  +++RDLKP N+L+     ++G +++ D GFA+        L        
Sbjct: 144 VLTFEYLHSLDLIYRDLKPENLLI----DQQGYIQVTDFGFAKRVKGRTWXLCG------ 193
Query: 196 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 238
           T  Y APE++L ++ Y KA+D WA+G +  E+    P F   Q
Sbjct: 194 TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 235

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 101/224 (45%), Gaps = 35/224 (15%)
Query: 27  VGRGTYGHVYKARRKDNSDT-------RDYALKQIEGTGLSMSACREIALLRELKHPNVI 79
           +G+G +   ++    D  +        +   LK  +   +SM    EI++ R L H +V+
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM----EISIHRSLAHQHVV 104
Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGI 139
                F   ND  V+++ +        +++ H+  KA               L QI+ G 
Sbjct: 105 GFHG-FFEDNDF-VFVVLELCRR--RSLLELHKRRKA------LTEPEARYYLRQIVLGC 154
Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL--FNNPLKPLADLDPVVVTF 197
            YLH N V+HRDLK  N L + E +E   VKI D G A    ++   K +     +  T 
Sbjct: 155 QYLHRNRVIHRDLKLGN-LFLNEDLE---VKIGDFGLATKVEYDGERKKV-----LCGTP 205
Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH--CRQE 239
            Y APE +L  + ++  +D+W+IGCI   LL  +P F   C +E
Sbjct: 206 NYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE 248

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 107/251 (42%), Gaps = 38/251 (15%)
Query: 6   KIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIE---------- 55
           K+    E+  +E  +   G  +G G +G VY   R   SD    A+K +E          
Sbjct: 31  KLAPGKEKEPLESQYQV-GPLLGSGGFGSVYSGIRV--SDNLPVAIKHVEKDRISDWGEL 87
Query: 56  --GTGLSMSACREIALLRELKH--PNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFH 111
             GT + M    E+ LL+++      VI L+  F   +   + L       DL+  I   
Sbjct: 88  PNGTRVPM----EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER 143
Query: 112 RAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI 171
            A +              S  +Q+L+ + + H+  VLHRD+K  NIL+    + RG +K+
Sbjct: 144 GALQEELAR---------SFFWQVLEAVRHCHNCGVLHRDIKDENILI---DLNRGELKL 191
Query: 172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 231
            D G   L  + +    D D   V   Y  PE +   R++ ++  +W++G +  +++  +
Sbjct: 192 IDFGSGALLKDTV--YTDFDGTRV---YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246
Query: 232 PIFHCRQEDIK 242
             F   +E I+
Sbjct: 247 IPFEHDEEIIR 257

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 107/251 (42%), Gaps = 38/251 (15%)
Query: 6   KIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIE---------- 55
           K+    E+  +E  +   G  +G G +G VY   R   SD    A+K +E          
Sbjct: 11  KLAPGKEKEPLESQYQV-GPLLGSGGFGSVYSGIRV--SDNLPVAIKHVEKDRISDWGEL 67
Query: 56  --GTGLSMSACREIALLRELKH--PNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFH 111
             GT + M    E+ LL+++      VI L+  F   +   + L       DL+  I   
Sbjct: 68  PNGTRVPM----EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER 123
Query: 112 RAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI 171
            A +              S  +Q+L+ + + H+  VLHRD+K  NIL+    + RG +K+
Sbjct: 124 GALQEELAR---------SFFWQVLEAVRHCHNCGVLHRDIKDENILI---DLNRGELKL 171
Query: 172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 231
            D G   L  + +    D D   V   Y  PE +   R++ ++  +W++G +  +++  +
Sbjct: 172 IDFGSGALLKDTV--YTDFDGTRV---YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 226
Query: 232 PIFHCRQEDIK 242
             F   +E I+
Sbjct: 227 IPFEHDEEIIR 237

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 99/223 (44%), Gaps = 40/223 (17%)
Query: 27  VGRGTYGHVYKARRKDNSD---------TRDYALKQIEGTGLSMSACREIALLRELKHPN 77
           +G G++G V   + K+  +          +   LKQIE T        E  +L+ +  P 
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHT------LNEKRILQAVNFPF 102
Query: 78  VINLISVFLSHNDRKVWLLFDYAEHD--LWHIIKFHRAAKANXXXXXXXXXXXXSLLYQI 135
           ++ L   F   ++  ++++ +Y        H+ +  R ++ +                QI
Sbjct: 103 LVKLEYSF--KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA----------QI 150
Query: 136 LDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVV 195
           +    YLHS  +++RDLKP N+L+     ++G +++ D GFA+        L        
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLID----QQGYIQVTDFGFAKRVKGRTWXLCG------ 200
Query: 196 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 238
           T  Y APE++L ++ Y KA+D WA+G +  E+    P F   Q
Sbjct: 201 TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 98/222 (44%), Gaps = 31/222 (13%)
Query: 27  VGRGTYGHVYKARRKDNSDT-------RDYALKQIEGTGLSMSACREIALLRELKHPNVI 79
           +G+G +   ++    D  +        +   LK  +   +SM    EI++ R L H +V+
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM----EISIHRSLAHQHVV 80
Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGI 139
                F   ND  V+++ +        +++ H+  KA               L QI+ G 
Sbjct: 81  GFHG-FFEDNDF-VFVVLELCRR--RSLLELHKRRKA------LTEPEARYYLRQIVLGC 130
Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
            YLH N V+HRDLK  N L + E +E   VKI D G A       +    L     T  Y
Sbjct: 131 QYLHRNRVIHRDLKLGN-LFLNEDLE---VKIGDFGLATKVEYDGERKKTL---CGTPNY 183
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH--CRQE 239
            APE +L  + ++  +D+W+IGCI   LL  +P F   C +E
Sbjct: 184 IAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE 224

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 99/223 (44%), Gaps = 40/223 (17%)
Query: 27  VGRGTYGHVYKARRKDNSD---------TRDYALKQIEGTGLSMSACREIALLRELKHPN 77
           +G G++G V   + K+  +          +   LKQIE T        E  +L+ +  P 
Sbjct: 70  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT------LNEKRILQAVNFPF 123
Query: 78  VINLISVFLSHNDRKVWLLFDYAEHD--LWHIIKFHRAAKANXXXXXXXXXXXXSLLYQI 135
           ++ L   F   ++  ++++ +Y        H+ +  R ++ +                QI
Sbjct: 124 LVKLEFSF--KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA----------QI 171
Query: 136 LDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVV 195
           +    YLHS  +++RDLKP N+L+     ++G +++ D GFA+        L        
Sbjct: 172 VLTFEYLHSLDLIYRDLKPENLLI----DQQGYIQVTDFGFAKRVKGRTWXLCG------ 221
Query: 196 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 238
           T  Y APE++L ++ Y KA+D WA+G +  E+    P F   Q
Sbjct: 222 TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 263

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 99/223 (44%), Gaps = 40/223 (17%)
Query: 27  VGRGTYGHVYKARRKDNSD---------TRDYALKQIEGTGLSMSACREIALLRELKHPN 77
           +G G++G V   + K+  +          +   LKQIE T        E  +L+ +  P 
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHT------LNEKRILQAVNFPF 102
Query: 78  VINLISVFLSHNDRKVWLLFDYAEHD--LWHIIKFHRAAKANXXXXXXXXXXXXSLLYQI 135
           ++ L   F   ++  ++++ +Y        H+ +  R ++ +                QI
Sbjct: 103 LVKLEYSF--KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA----------QI 150
Query: 136 LDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVV 195
           +    YLHS  +++RDLKP N+L+     ++G +++ D GFA+        L        
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLID----QQGYIQVTDFGFAKRVKGRTWXLCG------ 200
Query: 196 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 238
           T  Y APE++L ++ Y KA+D WA+G +  E+    P F   Q
Sbjct: 201 TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 98/222 (44%), Gaps = 31/222 (13%)
Query: 27  VGRGTYGHVYKARRKDNSDT-------RDYALKQIEGTGLSMSACREIALLRELKHPNVI 79
           +G+G +   ++    D  +        +   LK  +   +SM    EI++ R L H +V+
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM----EISIHRSLAHQHVV 80
Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGI 139
                F   ND  V+++ +        +++ H+  KA               L QI+ G 
Sbjct: 81  GFHG-FFEDNDF-VFVVLELCRR--RSLLELHKRRKA------LTEPEARYYLRQIVLGC 130
Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
            YLH N V+HRDLK  N L + E +E   VKI D G A       +    L     T  Y
Sbjct: 131 QYLHRNRVIHRDLKLGN-LFLNEDLE---VKIGDFGLATKVEYDGERKKTL---CGTPNY 183
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH--CRQE 239
            APE +L  + ++  +D+W+IGCI   LL  +P F   C +E
Sbjct: 184 IAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE 224

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 107/251 (42%), Gaps = 38/251 (15%)
Query: 6   KIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIE---------- 55
           K+    E+  +E  +   G  +G G +G VY   R   SD    A+K +E          
Sbjct: 12  KLAPGKEKEPLESQYQV-GPLLGSGGFGSVYSGIRV--SDNLPVAIKHVEKDRISDWGEL 68
Query: 56  --GTGLSMSACREIALLRELKH--PNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFH 111
             GT + M    E+ LL+++      VI L+  F   +   + L       DL+  I   
Sbjct: 69  PNGTRVPM----EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER 124
Query: 112 RAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI 171
            A +              S  +Q+L+ + + H+  VLHRD+K  NIL+    + RG +K+
Sbjct: 125 GALQEELAR---------SFFWQVLEAVRHCHNCGVLHRDIKDENILI---DLNRGELKL 172
Query: 172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 231
            D G   L  + +    D D   V   Y  PE +   R++ ++  +W++G +  +++  +
Sbjct: 173 IDFGSGALLKDTV--YTDFDGTRV---YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 227
Query: 232 PIFHCRQEDIK 242
             F   +E I+
Sbjct: 228 IPFEHDEEIIR 238

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 107/251 (42%), Gaps = 38/251 (15%)
Query: 6   KIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIE---------- 55
           K+    E+  +E  +   G  +G G +G VY   R   SD    A+K +E          
Sbjct: 11  KLAPGKEKEPLESQYQV-GPLLGSGGFGSVYSGIRV--SDNLPVAIKHVEKDRISDWGEL 67
Query: 56  --GTGLSMSACREIALLRELKH--PNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFH 111
             GT + M    E+ LL+++      VI L+  F   +   + L       DL+  I   
Sbjct: 68  PNGTRVPM----EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER 123
Query: 112 RAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI 171
            A +              S  +Q+L+ + + H+  VLHRD+K  NIL+    + RG +K+
Sbjct: 124 GALQEELAR---------SFFWQVLEAVRHCHNCGVLHRDIKDENILI---DLNRGELKL 171
Query: 172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 231
            D G   L  + +    D D   V   Y  PE +   R++ ++  +W++G +  +++  +
Sbjct: 172 IDFGSGALLKDTV--YTDFDGTRV---YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 226
Query: 232 PIFHCRQEDIK 242
             F   +E I+
Sbjct: 227 IPFEHDEEIIR 237

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 99/223 (44%), Gaps = 40/223 (17%)
Query: 27  VGRGTYGHVYKARRKDNSD---------TRDYALKQIEGTGLSMSACREIALLRELKHPN 77
           +G G++G V   + K+  +          +   LKQIE T        E  +L+ +  P 
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHT------LNEKRILQAVNFPF 102
Query: 78  VINLISVFLSHNDRKVWLLFDYAEHD--LWHIIKFHRAAKANXXXXXXXXXXXXSLLYQI 135
           ++ L   F   ++  ++++ +Y        H+ +  R ++ +                QI
Sbjct: 103 LVKLEYSF--KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA----------QI 150
Query: 136 LDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVV 195
           +    YLHS  +++RDLKP N+L+     ++G +++ D GFA+        L        
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLID----QQGYIQVTDFGFAKRVKGRTWXLCG------ 200
Query: 196 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 238
           T  Y APE++L ++ Y KA+D WA+G +  E+    P F   Q
Sbjct: 201 TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 99/223 (44%), Gaps = 40/223 (17%)
Query: 27  VGRGTYGHVYKARRKDNSD---------TRDYALKQIEGTGLSMSACREIALLRELKHPN 77
           +G G++G V   + K+  +          +   LKQIE T        E  +L+ +  P 
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT------LNEKRILQAVNFPF 103
Query: 78  VINLISVFLSHNDRKVWLLFDYAEHD--LWHIIKFHRAAKANXXXXXXXXXXXXSLLYQI 135
           ++ L   F   ++  ++++ +Y        H+ +  R ++ +                QI
Sbjct: 104 LVKLEFSF--KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA----------QI 151
Query: 136 LDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVV 195
           +    YLHS  +++RDLKP N+L+     ++G +++ D GFA+        L        
Sbjct: 152 VLTFEYLHSLDLIYRDLKPENLLI----DQQGYIQVTDFGFAKRVKGRTWXLCG------ 201
Query: 196 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 238
           T  Y APE++L ++ Y KA+D WA+G +  E+    P F   Q
Sbjct: 202 TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 243

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 99/223 (44%), Gaps = 40/223 (17%)
Query: 27  VGRGTYGHVYKARRKDNSD---------TRDYALKQIEGTGLSMSACREIALLRELKHPN 77
           +G G++G V   + K+  +          +   LKQIE T        E  +L+ +  P 
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT------LNEKRILQAVNFPF 103
Query: 78  VINLISVFLSHNDRKVWLLFDYAEHD--LWHIIKFHRAAKANXXXXXXXXXXXXSLLYQI 135
           ++ L   F   ++  ++++ +Y        H+ +  R ++ +                QI
Sbjct: 104 LVKLEFSF--KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA----------QI 151
Query: 136 LDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVV 195
           +    YLHS  +++RDLKP N+L+     ++G +++ D GFA+        L        
Sbjct: 152 VLTFEYLHSLDLIYRDLKPENLLI----DQQGYIQVTDFGFAKRVKGRTWXLCG------ 201
Query: 196 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 238
           T  Y APE++L ++ Y KA+D WA+G +  E+    P F   Q
Sbjct: 202 TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 243

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 107/251 (42%), Gaps = 38/251 (15%)
Query: 6   KIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIE---------- 55
           K+    E+  +E  +   G  +G G +G VY   R   SD    A+K +E          
Sbjct: 12  KLAPGKEKEPLESQYQV-GPLLGSGGFGSVYSGIRV--SDNLPVAIKHVEKDRISDWGEL 68
Query: 56  --GTGLSMSACREIALLRELKH--PNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFH 111
             GT + M    E+ LL+++      VI L+  F   +   + L       DL+  I   
Sbjct: 69  PNGTRVPM----EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER 124
Query: 112 RAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI 171
            A +              S  +Q+L+ + + H+  VLHRD+K  NIL+    + RG +K+
Sbjct: 125 GALQEELAR---------SFFWQVLEAVRHCHNCGVLHRDIKDENILI---DLNRGELKL 172
Query: 172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 231
            D G   L  + +    D D   V   Y  PE +   R++ ++  +W++G +  +++  +
Sbjct: 173 IDFGSGALLKDTV--YTDFDGTRV---YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 227
Query: 232 PIFHCRQEDIK 242
             F   +E I+
Sbjct: 228 IPFEHDEEIIR 238

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 99/223 (44%), Gaps = 40/223 (17%)
Query: 27  VGRGTYGHVYKARRKDNSD---------TRDYALKQIEGTGLSMSACREIALLRELKHPN 77
           +G G++G V   + K+  +          +   LKQIE T        E  +L+ +  P 
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT------LNEKRILQAVNFPF 103
Query: 78  VINLISVFLSHNDRKVWLLFDYAEHD--LWHIIKFHRAAKANXXXXXXXXXXXXSLLYQI 135
           ++ L   F   ++  ++++ +Y        H+ +  R ++ +                QI
Sbjct: 104 LVKLEFSF--KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA----------QI 151
Query: 136 LDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVV 195
           +    YLHS  +++RDLKP N+L+     ++G +++ D GFA+        L        
Sbjct: 152 VLTFEYLHSLDLIYRDLKPENLLI----DQQGYIQVTDFGFAKRVKGRTWXLCG------ 201
Query: 196 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 238
           T  Y APE++L ++ Y KA+D WA+G +  E+    P F   Q
Sbjct: 202 TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 243

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 94/210 (44%), Gaps = 28/210 (13%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G G YG VY+   K  S T   A+K ++   + +    +E A+++E+KHPN++ L+ V
Sbjct: 21  KLGGGQYGEVYEGVWKKYSLT--VAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLY---QILDGIHY 141
                +   +++ ++  +   +++ + R                  LLY   QI   + Y
Sbjct: 79  --CTREPPFYIITEFMTYG--NLLDYLRECNRQEVNAVV-------LLYMATQISSAMEY 127
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNP--LKPLADLDPVVVTFWY 199
           L     +HRDL   N LV     E   VK+AD G +RL        P     P+  T   
Sbjct: 128 LEKKNFIHRDLAARNCLVG----ENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWT--- 180
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLT 229
            APE L   +   K+ D+WA G +  E+ T
Sbjct: 181 -APESLAYNKFSIKS-DVWAFGVLLWEIAT 208

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 107/251 (42%), Gaps = 38/251 (15%)
Query: 6   KIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIE---------- 55
           K+    E+  +E  +   G  +G G +G VY   R   SD    A+K +E          
Sbjct: 12  KLAPGKEKEPLESQYQV-GPLLGSGGFGSVYSGIRV--SDNLPVAIKHVEKDRISDWGEL 68
Query: 56  --GTGLSMSACREIALLRELKH--PNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFH 111
             GT + M    E+ LL+++      VI L+  F   +   + L       DL+  I   
Sbjct: 69  PNGTRVPM----EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER 124
Query: 112 RAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI 171
            A +              S  +Q+L+ + + H+  VLHRD+K  NIL+    + RG +K+
Sbjct: 125 GALQEELAR---------SFFWQVLEAVRHCHNCGVLHRDIKDENILI---DLNRGELKL 172
Query: 172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 231
            D G   L  + +    D D   V   Y  PE +   R++ ++  +W++G +  +++  +
Sbjct: 173 IDFGSGALLKDTV--YTDFDGTRV---YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 227
Query: 232 PIFHCRQEDIK 242
             F   +E I+
Sbjct: 228 IPFEHDEEIIR 238

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 107/251 (42%), Gaps = 38/251 (15%)
Query: 6   KIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIE---------- 55
           K+    E+  +E  +   G  +G G +G VY   R   SD    A+K +E          
Sbjct: 39  KLAPGKEKEPLESQYQV-GPLLGSGGFGSVYSGIRV--SDNLPVAIKHVEKDRISDWGEL 95
Query: 56  --GTGLSMSACREIALLRELKH--PNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFH 111
             GT + M    E+ LL+++      VI L+  F   +   + L       DL+  I   
Sbjct: 96  PNGTRVPM----EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER 151
Query: 112 RAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI 171
            A +              S  +Q+L+ + + H+  VLHRD+K  NIL+    + RG +K+
Sbjct: 152 GALQEELAR---------SFFWQVLEAVRHCHNCGVLHRDIKDENILI---DLNRGELKL 199
Query: 172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 231
            D G   L  + +    D D   V   Y  PE +   R++ ++  +W++G +  +++  +
Sbjct: 200 IDFGSGALLKDTV--YTDFDGTRV---YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 254
Query: 232 PIFHCRQEDIK 242
             F   +E I+
Sbjct: 255 IPFEHDEEIIR 265

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 94/210 (44%), Gaps = 28/210 (13%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G G YG VY+   K  S T   A+K ++   + +    +E A+++E+KHPN++ L+ V
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLT--VAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLY---QILDGIHY 141
                +   +++ ++  +   +++ + R                  LLY   QI   + Y
Sbjct: 80  --CTREPPFYIITEFMTYG--NLLDYLRECNRQEVNAVV-------LLYMATQISSAMEY 128
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNP--LKPLADLDPVVVTFWY 199
           L     +HRDL   N LV     E   VK+AD G +RL        P     P+  T   
Sbjct: 129 LEKKNFIHRDLAARNCLVG----ENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWT--- 181
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLT 229
            APE L   +   K+ D+WA G +  E+ T
Sbjct: 182 -APESLAYNKFSIKS-DVWAFGVLLWEIAT 209

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 107/251 (42%), Gaps = 38/251 (15%)
Query: 6   KIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIE---------- 55
           K+    E+  +E  +   G  +G G +G VY   R   SD    A+K +E          
Sbjct: 24  KLAPGKEKEPLESQYQV-GPLLGSGGFGSVYSGIRV--SDNLPVAIKHVEKDRISDWGEL 80
Query: 56  --GTGLSMSACREIALLRELKH--PNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFH 111
             GT + M    E+ LL+++      VI L+  F   +   + L       DL+  I   
Sbjct: 81  PNGTRVPM----EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER 136
Query: 112 RAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI 171
            A +              S  +Q+L+ + + H+  VLHRD+K  NIL+    + RG +K+
Sbjct: 137 GALQEELAR---------SFFWQVLEAVRHCHNCGVLHRDIKDENILI---DLNRGELKL 184
Query: 172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 231
            D G   L  + +    D D   V   Y  PE +   R++ ++  +W++G +  +++  +
Sbjct: 185 IDFGSGALLKDTV--YTDFDGTRV---YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 239
Query: 232 PIFHCRQEDIK 242
             F   +E I+
Sbjct: 240 IPFEHDEEIIR 250

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 107/251 (42%), Gaps = 38/251 (15%)
Query: 6   KIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIE---------- 55
           K+    E+  +E  +   G  +G G +G VY   R   SD    A+K +E          
Sbjct: 39  KLAPGKEKEPLESQYQV-GPLLGSGGFGSVYSGIRV--SDNLPVAIKHVEKDRISDWGEL 95
Query: 56  --GTGLSMSACREIALLRELKH--PNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFH 111
             GT + M    E+ LL+++      VI L+  F   +   + L       DL+  I   
Sbjct: 96  PNGTRVPM----EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER 151
Query: 112 RAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI 171
            A +              S  +Q+L+ + + H+  VLHRD+K  NIL+    + RG +K+
Sbjct: 152 GALQEELAR---------SFFWQVLEAVRHCHNCGVLHRDIKDENILI---DLNRGELKL 199
Query: 172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 231
            D G   L  + +    D D   V   Y  PE +   R++ ++  +W++G +  +++  +
Sbjct: 200 IDFGSGALLKDTV--YTDFDGTRV---YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 254
Query: 232 PIFHCRQEDIK 242
             F   +E I+
Sbjct: 255 IPFEHDEEIIR 265

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 99/223 (44%), Gaps = 40/223 (17%)
Query: 27  VGRGTYGHVYKARRKDNSD---------TRDYALKQIEGTGLSMSACREIALLRELKHPN 77
           +G G++G V   +  +  +          +   LKQIE T        E  +L+ +  P 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT------LNEKRILQAVNFPF 102
Query: 78  VINLISVFLSHNDRKVWLLFDYAEHD--LWHIIKFHRAAKANXXXXXXXXXXXXSLLYQI 135
           ++ L   F   ++  ++++ +YA       H+ +  R ++ +                QI
Sbjct: 103 LVKLEFSF--KDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAA----------QI 150
Query: 136 LDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVV 195
           +    YLHS  +++RDLKP N+++     ++G +K+ D GFA+        L        
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLMI----DQQGYIKVTDFGFAKRVKGRTWXLCG------ 200
Query: 196 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 238
           T  Y APE++L ++ Y KA+D WA+G +  E+    P F   Q
Sbjct: 201 TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 98/222 (44%), Gaps = 31/222 (13%)
Query: 27  VGRGTYGHVYKARRKDNSDT-------RDYALKQIEGTGLSMSACREIALLRELKHPNVI 79
           +G+G +   ++    D  +        +   LK  +   +SM    EI++ R L H +V+
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM----EISIHRSLAHQHVV 84
Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGI 139
                F   ND  V+++ +        +++ H+  KA               L QI+ G 
Sbjct: 85  GFHG-FFEDNDF-VFVVLELCRR--RSLLELHKRRKA------LTEPEARYYLRQIVLGC 134
Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
            YLH N V+HRDLK  N L + E +E   VKI D G A       +    L     T  Y
Sbjct: 135 QYLHRNRVIHRDLKLGN-LFLNEDLE---VKIGDFGLATKVEYDGERKKTL---CGTPNY 187
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH--CRQE 239
            APE +L  + ++  +D+W+IGCI   LL  +P F   C +E
Sbjct: 188 IAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE 228

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 107/251 (42%), Gaps = 38/251 (15%)
Query: 6   KIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIE---------- 55
           K+    E+  +E  +   G  +G G +G VY   R   SD    A+K +E          
Sbjct: 44  KLAPGKEKEPLESQYQV-GPLLGSGGFGSVYSGIRV--SDNLPVAIKHVEKDRISDWGEL 100
Query: 56  --GTGLSMSACREIALLRELKH--PNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFH 111
             GT + M    E+ LL+++      VI L+  F   +   + L       DL+  I   
Sbjct: 101 PNGTRVPM----EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER 156
Query: 112 RAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI 171
            A +              S  +Q+L+ + + H+  VLHRD+K  NIL+    + RG +K+
Sbjct: 157 GALQEELAR---------SFFWQVLEAVRHCHNCGVLHRDIKDENILI---DLNRGELKL 204
Query: 172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 231
            D G   L  + +    D D   V   Y  PE +   R++ ++  +W++G +  +++  +
Sbjct: 205 IDFGSGALLKDTV--YTDFDGTRV---YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 259
Query: 232 PIFHCRQEDIK 242
             F   +E I+
Sbjct: 260 IPFEHDEEIIR 270

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 89/204 (43%), Gaps = 18/204 (8%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           ++G G +G V+      N+      LK   GT    S   E  ++++LKH  ++ L +V 
Sbjct: 16  RLGNGQFGEVWMGTWNGNTKVAIKTLKP--GTMSPESFLEEAQIMKKLKHDKLVQLYAVV 73
Query: 86  LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSN 145
              ++  ++++ +Y       ++ F +  +               +  Q+  G+ Y+   
Sbjct: 74  ---SEEPIYIVTEYMNKG--SLLDFLKDGEGRALKLPNLV----DMAAQVAAGMAYIERM 124
Query: 146 WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELL 205
             +HRDL+ ANILV G G+     KIAD G ARL  +                + APE  
Sbjct: 125 NYIHRDLRSANILV-GNGL---ICKIADFGLARLIED--NEXTARQGAKFPIKWTAPEAA 178
Query: 206 LGARHYTKAIDIWAIGCIFAELLT 229
           L  R   K+ D+W+ G +  EL+T
Sbjct: 179 LYGRFTIKS-DVWSFGILLTELVT 201

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 56/105 (53%), Gaps = 11/105 (10%)
Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           QI+    YLHS  +++RDLKP N+++     ++G +K+ D GFA+        L      
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLMI----DQQGYIKVTDFGFAKRVKGRTWXLCG---- 201
Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 238
             T  Y APE++L ++ Y KA+D WA+G +  E+    P F   Q
Sbjct: 202 --TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 243

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 56/105 (53%), Gaps = 11/105 (10%)
Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           QI+    YLHS  +++RDLKP N+++     ++G +K+ D GFA+        L      
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLMI----DQQGYIKVTDFGFAKRVKGRTWXLCG---- 200
Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 238
             T  Y APE++L ++ Y KA+D WA+G +  E+    P F   Q
Sbjct: 201 --TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 56/105 (53%), Gaps = 11/105 (10%)
Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           QI+    YLHS  +++RDLKP N+++     ++G +K+ D GFA+        L      
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLMI----DQQGYIKVTDFGFAKRVKGRTWXLCG---- 201
Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 238
             T  Y APE++L ++ Y KA+D WA+G +  E+    P F   Q
Sbjct: 202 --TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 243

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 56/105 (53%), Gaps = 11/105 (10%)
Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           QI+    YLHS  +++RDLKP N+++     ++G +K+ D GFA+        L      
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLMI----DQQGYIKVTDFGFAKRVKGRTWXLCG---- 201
Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 238
             T  Y APE++L ++ Y KA+D WA+G +  E+    P F   Q
Sbjct: 202 --TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 243

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 56/105 (53%), Gaps = 11/105 (10%)
Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           QI+    YLHS  +++RDLKP N+L+     ++G +++ D GFA+        L      
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLI----DQQGYIQVTDFGFAKRVKGRTWTLCG---- 201
Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 238
             T  Y APE++L ++ Y KA+D WA+G +  E+    P F   Q
Sbjct: 202 --TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 243

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 56/105 (53%), Gaps = 11/105 (10%)
Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           QI+    YLHS  +++RDLKP N+L+     ++G +++ D GFA+        L      
Sbjct: 135 QIVLTFEYLHSLDLIYRDLKPENLLI----DQQGYIQVTDFGFAKRVKGRTWTLCG---- 186
Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 238
             T  Y APE++L ++ Y KA+D WA+G +  E+    P F   Q
Sbjct: 187 --TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 228

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 99/220 (45%), Gaps = 35/220 (15%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIALLRELKHPNVINL 81
           ++G+G +  V +  +      ++YA K I    LS        RE  + R LKHPN++ L
Sbjct: 11  ELGKGAFSVVRRCMKIPTG--QEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRL 68
Query: 82  ---ISVFLSHNDRKVWLLFDYAEH-DLWHII---KFHRAAKANXXXXXXXXXXXXSLLYQ 134
              IS    H     +L+FD     +L+  I   +++  A A+              + Q
Sbjct: 69  HDSISEEGFH-----YLVFDLVTGGELFEDIVAREYYSEADASH------------CIQQ 111
Query: 135 ILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVV 194
           IL+ +++ H N ++HRDLKP N+L+  +  +   VK+AD G A       +         
Sbjct: 112 ILESVNHCHLNGIVHRDLKPENLLLASKS-KGAAVKLADFGLAIEVQGDQQAWFGF---A 167
Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
            T  Y +PE+L     Y K +D+WA G I   LL   P F
Sbjct: 168 GTPGYLSPEVLR-KDPYGKPVDMWACGVILYILLVGYPPF 206

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 56/105 (53%), Gaps = 11/105 (10%)
Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           QI+    YLHS  +++RDLKP N+L+     ++G +++ D GFA+        L      
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLI----DQQGYIQVTDFGFAKRVKGRTWXLCG---- 200
Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 238
             T  Y APE++L ++ Y KA+D WA+G +  E+    P F   Q
Sbjct: 201 --TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 98/223 (43%), Gaps = 40/223 (17%)
Query: 27  VGRGTYGHVYKARRKDNSD---------TRDYALKQIEGTGLSMSACREIALLRELKHPN 77
           +G G++G V   + K+  +          +   LKQIE T        E  +L+ +  P 
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT------LNEKRILQAVNFPF 95
Query: 78  VINLISVFLSHNDRKVWLLFDYAEHD--LWHIIKFHRAAKANXXXXXXXXXXXXSLLYQI 135
           ++ L   F   ++  ++++ +Y        H+ +  R  + +                QI
Sbjct: 96  LVKLEFSF--KDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAA----------QI 143
Query: 136 LDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVV 195
           +    YLHS  +++RDLKP N+L+     ++G +++ D GFA+        L        
Sbjct: 144 VLTFEYLHSLDLIYRDLKPENLLI----DQQGYIQVTDFGFAKRVKGRTWXLCG------ 193
Query: 196 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 238
           T  Y APE++L ++ Y KA+D WA+G +  E+    P F   Q
Sbjct: 194 TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 235

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 85/210 (40%), Gaps = 21/210 (10%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYAL---KQIEGTGLSMSACREIALLRELKHPNVIN 80
           G  +G GT+G V     +         +   ++I    +     REI  L+  +HP++I 
Sbjct: 16  GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           L  V  +  D  + + +        +I K  R  +               L  QIL  + 
Sbjct: 76  LYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR----------RLFQQILSAVD 125
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           Y H + V+HRDLKP N+L+          KIAD G + + ++       L     +  Y 
Sbjct: 126 YCHRHMVVHRDLKPENVLLDAH----MNAKIADFGLSNMMSDG----EFLRTSCGSPNYA 177
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTS 230
           APE++ G  +    +DIW+ G I   LL  
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 56/105 (53%), Gaps = 11/105 (10%)
Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           QI+    YLHS  +++RDLKP N+L+     ++G +++ D GFA+        L      
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLI----DQQGYIQVTDFGFAKRVKGRTWXLCG---- 200
Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 238
             T  Y APE++L ++ Y KA+D WA+G +  E+    P F   Q
Sbjct: 201 --TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 56/105 (53%), Gaps = 11/105 (10%)
Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           QI+    YLHS  +++RDLKP N+L+     ++G +++ D GFA+        L      
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLI----DQQGYIQVTDFGFAKRVKGRTWXLCG---- 201
Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 238
             T  Y APE++L ++ Y KA+D WA+G +  E+    P F   Q
Sbjct: 202 --TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 243

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 106/250 (42%), Gaps = 38/250 (15%)
Query: 6   KIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIE---------- 55
           K+    E+  +E  +   G  +G G +G VY   R   SD    A+K +E          
Sbjct: 24  KLAPGKEKEPLESQYQV-GPLLGSGGFGSVYSGIRV--SDNLPVAIKHVEKDRISDWGEL 80
Query: 56  --GTGLSMSACREIALLRELKH--PNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFH 111
             GT + M    E+ LL+++      VI L+  F   +   + L       DL+  I   
Sbjct: 81  PNGTRVPM----EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER 136
Query: 112 RAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI 171
            A +              S  +Q+L+ + + H+  VLHRD+K  NIL+    + RG +K+
Sbjct: 137 GALQEELAR---------SFFWQVLEAVRHCHNCGVLHRDIKDENILI---DLNRGELKL 184
Query: 172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 231
            D G   L  + +    D D   V   Y  PE +   R++ ++  +W++G +  +++  +
Sbjct: 185 IDFGSGALLKDTV--YTDFDGTRV---YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 239
Query: 232 PIFHCRQEDI 241
             F   +E I
Sbjct: 240 IPFEHDEEII 249

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 106/250 (42%), Gaps = 38/250 (15%)
Query: 6   KIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIE---------- 55
           K+    E+  +E  +   G  +G G +G VY   R   SD    A+K +E          
Sbjct: 25  KLAPGKEKEPLESQYQV-GPLLGSGGFGSVYSGIRV--SDNLPVAIKHVEKDRISDWGEL 81
Query: 56  --GTGLSMSACREIALLRELKH--PNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFH 111
             GT + M    E+ LL+++      VI L+  F   +   + L       DL+  I   
Sbjct: 82  PNGTRVPM----EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER 137
Query: 112 RAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI 171
            A +              S  +Q+L+ + + H+  VLHRD+K  NIL+    + RG +K+
Sbjct: 138 GALQEELAR---------SFFWQVLEAVRHCHNCGVLHRDIKDENILI---DLNRGELKL 185
Query: 172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 231
            D G   L  + +    D D   V   Y  PE +   R++ ++  +W++G +  +++  +
Sbjct: 186 IDFGSGALLKDTV--YTDFDGTRV---YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 240
Query: 232 PIFHCRQEDI 241
             F   +E I
Sbjct: 241 IPFEHDEEII 250

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 106/250 (42%), Gaps = 38/250 (15%)
Query: 6   KIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIE---------- 55
           K+    E+  +E  +   G  +G G +G VY   R   SD    A+K +E          
Sbjct: 25  KLAPGKEKEPLESQYQV-GPLLGSGGFGSVYSGIRV--SDNLPVAIKHVEKDRISDWGEL 81
Query: 56  --GTGLSMSACREIALLRELKH--PNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFH 111
             GT + M    E+ LL+++      VI L+  F   +   + L       DL+  I   
Sbjct: 82  PNGTRVPM----EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER 137
Query: 112 RAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI 171
            A +              S  +Q+L+ + + H+  VLHRD+K  NIL+    + RG +K+
Sbjct: 138 GALQEELAR---------SFFWQVLEAVRHCHNCGVLHRDIKDENILI---DLNRGELKL 185
Query: 172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 231
            D G   L  + +    D D   V   Y  PE +   R++ ++  +W++G +  +++  +
Sbjct: 186 IDFGSGALLKDTV--YTDFDGTRV---YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 240
Query: 232 PIFHCRQEDI 241
             F   +E I
Sbjct: 241 IPFEHDEEII 250

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 106/250 (42%), Gaps = 38/250 (15%)
Query: 6   KIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIE---------- 55
           K+    E+  +E  +   G  +G G +G VY   R   SD    A+K +E          
Sbjct: 24  KLAPGKEKEPLESQYQV-GPLLGSGGFGSVYSGIRV--SDNLPVAIKHVEKDRISDWGEL 80
Query: 56  --GTGLSMSACREIALLRELKH--PNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFH 111
             GT + M    E+ LL+++      VI L+  F   +   + L       DL+  I   
Sbjct: 81  PNGTRVPM----EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER 136
Query: 112 RAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI 171
            A +              S  +Q+L+ + + H+  VLHRD+K  NIL+    + RG +K+
Sbjct: 137 GALQEELAR---------SFFWQVLEAVRHCHNCGVLHRDIKDENILI---DLNRGELKL 184
Query: 172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 231
            D G   L  + +    D D   V   Y  PE +   R++ ++  +W++G +  +++  +
Sbjct: 185 IDFGSGALLKDTV--YTDFDGTRV---YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 239
Query: 232 PIFHCRQEDI 241
             F   +E I
Sbjct: 240 IPFEHDEEII 249

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 96/217 (44%), Gaps = 29/217 (13%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIALLRELKHPNVINL 81
           ++G+G +  V +  +      ++YA K I    LS        RE  + R LKHPN++ L
Sbjct: 11  ELGKGAFSVVRRCMKIPTG--QEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRL 68
Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHII---KFHRAAKANXXXXXXXXXXXXSLLYQILD 137
                       +L+FD     +L+  I   +++  A A+              + QIL+
Sbjct: 69  HDSISEEGFH--YLVFDLVTGGELFEDIVAREYYSEADAS------------HCIQQILE 114
Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF 197
            +++ H N ++HRDLKP N+L+  +  +   VK+AD G A       +          T 
Sbjct: 115 SVNHCHLNGIVHRDLKPENLLLASKS-KGAAVKLADFGLAIEVQGDQQAWFGF---AGTP 170
Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
            Y +PE+L     Y K +D+WA G I   LL   P F
Sbjct: 171 GYLSPEVLR-KDPYGKPVDMWACGVILYILLVGYPPF 206

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 56/105 (53%), Gaps = 11/105 (10%)
Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           QI+    YLHS  +++RDLKP N+L+     ++G +++ D GFA+        L      
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLI----DQQGYIQVTDFGFAKRVKGRTWXLCG---- 201
Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 238
             T  Y APE++L ++ Y KA+D WA+G +  E+    P F   Q
Sbjct: 202 --TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 243

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 56/105 (53%), Gaps = 11/105 (10%)
Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           QI+    YLHS  +++RDLKP N+L+     ++G +++ D GFA+        L      
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLI----DQQGYIQVTDFGFAKRVKGRTWXLCG---- 200
Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 238
             T  Y APE++L ++ Y KA+D WA+G +  E+    P F   Q
Sbjct: 201 --TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 56/105 (53%), Gaps = 11/105 (10%)
Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           QI+    YLHS  +++RDLKP N+L+     ++G +++ D GFA+        L      
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLI----DQQGYIQVTDFGFAKRVKGRTWXLCG---- 200
Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 238
             T  Y APE++L ++ Y KA+D WA+G +  E+    P F   Q
Sbjct: 201 --TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 98/227 (43%), Gaps = 40/227 (17%)
Query: 26  KVGRGTYGHVYKAR---RKDNSDTRDYALKQIE--GTGLSMSACREIALLR-ELKHPNVI 79
           ++G   +G VYK           T+  A+K ++    G      R  A+LR  L+HPNV+
Sbjct: 33  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 92
Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSL-------- 131
            L+ V     D+ + ++F Y  H   H     R+  ++            +L        
Sbjct: 93  CLLGVVT--KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 150
Query: 132 LYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR---------LFNN 182
           + QI  G+ YL S+ V+H+DL   N+LV     ++  VKI+D+G  R         L  N
Sbjct: 151 VAQIAAGMEYLSSHHVVHKDLATRNVLVY----DKLNVKISDLGLFREVYAADYYKLLGN 206
Query: 183 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
            L P+           + APE ++  + ++   DIW+ G +  E+ +
Sbjct: 207 SLLPIR----------WMAPEAIMYGK-FSIDSDIWSYGVVLWEVFS 242

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 106/250 (42%), Gaps = 38/250 (15%)
Query: 6   KIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIE---------- 55
           K+    E+  +E  +   G  +G G +G VY   R   SD    A+K +E          
Sbjct: 25  KLAPGKEKEPLESQYQV-GPLLGSGGFGSVYSGIRV--SDNLPVAIKHVEKDRISDWGEL 81
Query: 56  --GTGLSMSACREIALLRELKH--PNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFH 111
             GT + M    E+ LL+++      VI L+  F   +   + L       DL+  I   
Sbjct: 82  PNGTRVPM----EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER 137
Query: 112 RAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI 171
            A +              S  +Q+L+ + + H+  VLHRD+K  NIL+    + RG +K+
Sbjct: 138 GALQEELAR---------SFFWQVLEAVRHCHNCGVLHRDIKDENILI---DLNRGELKL 185
Query: 172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 231
            D G   L  + +    D D   V   Y  PE +   R++ ++  +W++G +  +++  +
Sbjct: 186 IDFGSGALLKDTV--YTDFDGTRV---YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 240
Query: 232 PIFHCRQEDI 241
             F   +E I
Sbjct: 241 IPFEHDEEII 250

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 56/105 (53%), Gaps = 11/105 (10%)
Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           QI+    YLHS  +++RDLKP N+L+     ++G +++ D GFA+        L      
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLI----DQQGYIQVTDFGFAKRVKGRTWXLCG---- 200
Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 238
             T  Y APE++L ++ Y KA+D WA+G +  E+    P F   Q
Sbjct: 201 --TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 106/250 (42%), Gaps = 38/250 (15%)
Query: 6   KIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIE---------- 55
           K+    E+  +E  +   G  +G G +G VY   R   SD    A+K +E          
Sbjct: 25  KLAPGKEKEPLESQYQV-GPLLGSGGFGSVYSGIRV--SDNLPVAIKHVEKDRISDWGEL 81
Query: 56  --GTGLSMSACREIALLRELKH--PNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFH 111
             GT + M    E+ LL+++      VI L+  F   +   + L       DL+  I   
Sbjct: 82  PNGTRVPM----EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER 137
Query: 112 RAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI 171
            A +              S  +Q+L+ + + H+  VLHRD+K  NIL+    + RG +K+
Sbjct: 138 GALQEELAR---------SFFWQVLEAVRHCHNCGVLHRDIKDENILI---DLNRGELKL 185
Query: 172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 231
            D G   L  + +    D D   V   Y  PE +   R++ ++  +W++G +  +++  +
Sbjct: 186 IDFGSGALLKDTV--YTDFDGTRV---YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 240
Query: 232 PIFHCRQEDI 241
             F   +E I
Sbjct: 241 IPFEHDEEII 250

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 106/250 (42%), Gaps = 38/250 (15%)
Query: 6   KIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIE---------- 55
           K+    E+  +E  +   G  +G G +G VY   R   SD    A+K +E          
Sbjct: 24  KLAPGKEKEPLESQYQV-GPLLGSGGFGSVYSGIRV--SDNLPVAIKHVEKDRISDWGEL 80
Query: 56  --GTGLSMSACREIALLRELKH--PNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFH 111
             GT + M    E+ LL+++      VI L+  F   +   + L       DL+  I   
Sbjct: 81  PNGTRVPM----EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER 136
Query: 112 RAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI 171
            A +              S  +Q+L+ + + H+  VLHRD+K  NIL+    + RG +K+
Sbjct: 137 GALQEELAR---------SFFWQVLEAVRHCHNCGVLHRDIKDENILI---DLNRGELKL 184
Query: 172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 231
            D G   L  + +    D D   V   Y  PE +   R++ ++  +W++G +  +++  +
Sbjct: 185 IDFGSGALLKDTV--YTDFDGTRV---YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 239
Query: 232 PIFHCRQEDI 241
             F   +E I
Sbjct: 240 IPFEHDEEII 249

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 56/105 (53%), Gaps = 11/105 (10%)
Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           QI+    YLHS  +++RDLKP N+L+     ++G +++ D GFA+        L      
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLI----DQQGYIQVTDFGFAKRVKGRTWXLCG---- 200
Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 238
             T  Y APE++L ++ Y KA+D WA+G +  E+    P F   Q
Sbjct: 201 --TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/220 (23%), Positives = 95/220 (43%), Gaps = 31/220 (14%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS-----MSACREIALLRELKHPNVINL 81
           +G+G++G V   ++ D    + YA+K +            +  +E+ +++ L+HP ++NL
Sbjct: 23  IGKGSFGKVCIVQKNDTK--KMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
              F    D     +F   +  L   +++H     +              + +++  + Y
Sbjct: 81  WYSFQDEED-----MFMVVDLLLGGDLRYHLQQNVHFKEETVKL-----FICELVMALDY 130
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF--NNPLKPLADLDPVVVTFWY 199
           L +  ++HRD+KP NIL+     E G V I D   A +      +  +A   P      Y
Sbjct: 131 LQNQRIIHRDMKPDNILL----DEHGHVHITDFNIAAMLPRETQITTMAGTKP------Y 180
Query: 200 RAPELLLGAR--HYTKAIDIWAIGCIFAELLTSEPIFHCR 237
            APE+    +   Y+ A+D W++G    ELL     +H R
Sbjct: 181 MAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIR 220

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 98/227 (43%), Gaps = 40/227 (17%)
Query: 26  KVGRGTYGHVYKAR---RKDNSDTRDYALKQIE--GTGLSMSACREIALLR-ELKHPNVI 79
           ++G   +G VYK           T+  A+K ++    G      R  A+LR  L+HPNV+
Sbjct: 16  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSL-------- 131
            L+ V     D+ + ++F Y  H   H     R+  ++            +L        
Sbjct: 76  CLLGVVT--KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 132 LYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR---------LFNN 182
           + QI  G+ YL S+ V+H+DL   N+LV     ++  VKI+D+G  R         L  N
Sbjct: 134 VAQIAAGMEYLSSHHVVHKDLATRNVLVY----DKLNVKISDLGLFREVYAADYYKLLGN 189
Query: 183 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
            L P+           + APE ++  + ++   DIW+ G +  E+ +
Sbjct: 190 SLLPIR----------WMAPEAIMYGK-FSIDSDIWSYGVVLWEVFS 225

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 94/223 (42%), Gaps = 25/223 (11%)
Query: 24  GCKVGRGTYGHVYKAR-----RKDNSDTRDYALKQI--EGTGLSMS-ACREIALLREL-K 74
           G  +G G +G V  A      +    +    A+K +  + T   +S    E+ +++ + K
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 75  HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXX-------XXXXXXX 126
           H N+INL+       D  ++++ +YA   +L   ++  R                     
Sbjct: 100 HKNIINLLGA--CTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFK 157
Query: 127 XXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKP 186
              S  YQ+  G+ YL S   +HRDL   N+LV     E   +KIAD G AR  NN    
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLV----TENNVMKIADFGLARDINNIDXX 213
Query: 187 LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
               +  +   W  APE L   R YT   D+W+ G +  E+ T
Sbjct: 214 KKTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLMWEIFT 254

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 80/211 (37%), Gaps = 23/211 (10%)
Query: 27  VGRGTYGHVYKARRKDNSDTRD-----YALKQIEGTGLSMSACREIALLRELKHPNVINL 81
           +G G +G V   R     D         +LK   G        +EI +LR L H N++  
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
             +        + L+ ++               K N                QI  G+ Y
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQL-------KYAVQICKGMDY 141
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLA---DLDPVVVTFW 198
           L S   +HRDL   N+LV  E     +VKI D G  +      +      D D  V  FW
Sbjct: 142 LGSRQYVHRDLAARNVLVESE----HQVKIGDFGLTKAIETDKEXXTVKDDRDSPV--FW 195
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
           Y APE L+ ++ Y  A D+W+ G    ELLT
Sbjct: 196 Y-APECLMQSKFYI-ASDVWSFGVTLHELLT 224

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 85/210 (40%), Gaps = 21/210 (10%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYAL---KQIEGTGLSMSACREIALLRELKHPNVIN 80
           G  +G GT+G V     +         +   ++I    +     REI  L+  +HP++I 
Sbjct: 16  GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           L  V  +  D  + + +        +I K  R  +               L  QIL  + 
Sbjct: 76  LYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR----------RLFQQILSAVD 125
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           Y H + V+HRDLKP N+L+          KIAD G + + ++       L     +  Y 
Sbjct: 126 YCHRHMVVHRDLKPENVLLDAH----MNAKIADFGLSNMMSDG----EFLRDSCGSPNYA 177
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTS 230
           APE++ G  +    +DIW+ G I   LL  
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 80/211 (37%), Gaps = 23/211 (10%)
Query: 27  VGRGTYGHVYKARRKDNSDTRD-----YALKQIEGTGLSMSACREIALLRELKHPNVINL 81
           +G G +G V   R     D         +LK   G        +EI +LR L H N++  
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
             +        + L+ ++               K N                QI  G+ Y
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAV-------QICKGMDY 129
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLA---DLDPVVVTFW 198
           L S   +HRDL   N+LV  E     +VKI D G  +      +      D D  V  FW
Sbjct: 130 LGSRQYVHRDLAARNVLVESE----HQVKIGDFGLTKAIETDKEXXTVKDDRDSPV--FW 183
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
           Y APE L+ ++ Y  A D+W+ G    ELLT
Sbjct: 184 Y-APECLMQSKFYI-ASDVWSFGVTLHELLT 212

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 93/223 (41%), Gaps = 25/223 (11%)
Query: 24  GCKVGRGTYGHVYKAR-----RKDNSDTRDYALKQI--EGTGLSMS-ACREIALLREL-K 74
           G  +G G +G V  A      +    +    A+K +  + T   +S    E+ +++ + K
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 75  HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXX-------XXXXXXX 126
           H N+INL+       D  ++++ +YA   +L   ++  R                     
Sbjct: 100 HKNIINLLGA--CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 127 XXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKP 186
              S  YQ+  G+ YL S   +HRDL   N+LV     E   +KIAD G AR  NN    
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLV----TENNVMKIADFGLARDINNIDXX 213
Query: 187 LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
               +  +   W  APE L   R YT   D+W+ G +  E+ T
Sbjct: 214 KKTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLMWEIFT 254

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 98/229 (42%), Gaps = 29/229 (12%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS--------MSACREIALLRELKH 75
           G  +G G +G VY   R   SD    A+K +E   +S             E+ LL+++  
Sbjct: 13  GPLLGSGGFGSVYSGIRV--SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 70
Query: 76  --PNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLY 133
               VI L+  F   +   + L       DL+  I    A +              S  +
Sbjct: 71  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------SFFW 121
Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           Q+L+ + + H+  VLHRD+K  NIL+    + RG +K+ D G   L  + +    D D  
Sbjct: 122 QVLEAVRHCHNCGVLHRDIKDENILI---DLNRGELKLIDFGSGALLKDTV--YTDFDGT 176
Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 242
            V   Y  PE +   R++ ++  +W++G +  +++  +  F   +E I+
Sbjct: 177 RV---YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 222

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 99/223 (44%), Gaps = 40/223 (17%)
Query: 27  VGRGTYGHVYKARRKDNSD---------TRDYALKQIEGTGLSMSACREIALLRELKHPN 77
           +G G++G V   +  +  +          +   LKQIE T        E  +L+ +  P 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT------LNEKRILQAVNFPF 102
Query: 78  VINLISVFLSHNDRKVWLLFDYAEHD--LWHIIKFHRAAKANXXXXXXXXXXXXSLLYQI 135
           ++ L   F   ++  ++++ +YA       H+ +  R ++ +                QI
Sbjct: 103 LVKLEFSF--KDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAA----------QI 150
Query: 136 LDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVV 195
           +    YLHS  +++RDLKP N+++     ++G +++ D GFA+        L        
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLMI----DQQGYIQVTDFGFAKRVKGRTWXLCG------ 200
Query: 196 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 238
           T  Y APE++L ++ Y KA+D WA+G +  E+    P F   Q
Sbjct: 201 TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 98/229 (42%), Gaps = 29/229 (12%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS--------MSACREIALLRELKH 75
           G  +G G +G VY   R   SD    A+K +E   +S             E+ LL+++  
Sbjct: 9   GPLLGSGGFGSVYSGIRV--SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 76  --PNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLY 133
               VI L+  F   +   + L       DL+  I    A +              S  +
Sbjct: 67  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------SFFW 117
Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           Q+L+ + + H+  VLHRD+K  NIL+    + RG +K+ D G   L  + +    D D  
Sbjct: 118 QVLEAVRHCHNXGVLHRDIKDENILI---DLNRGELKLIDFGSGALLKDTV--YTDFDGT 172
Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 242
            V   Y  PE +   R++ ++  +W++G +  +++  +  F   +E I+
Sbjct: 173 RV---YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 218

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 100/233 (42%), Gaps = 37/233 (15%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIE------------GTGLSMSACREIALLR 71
           G  +G G +G VY   R   SD    A+K +E            GT + M    E+ LL+
Sbjct: 14  GPLLGSGGFGSVYSGIRV--SDNLPVAIKHVEKDRISDWGELPNGTRVPM----EVVLLK 67
Query: 72  ELKH--PNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXX 129
           ++      VI L+  F   +   + L       DL+  I    A +              
Sbjct: 68  KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR--------- 118
Query: 130 SLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLAD 189
           S  +Q+L+ + + H+  VLHRD+K  NIL+    + RG +K+ D G   L  + +    D
Sbjct: 119 SFFWQVLEAVRHCHNCGVLHRDIKDENILI---DLNRGELKLIDFGSGALLKDTV--YTD 173
Query: 190 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 242
            D   V   Y  PE +   R++ ++  +W++G +  +++  +  F   +E I+
Sbjct: 174 FDGTRV---YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 223

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 109/230 (47%), Gaps = 29/230 (12%)
Query: 22  YEGCKV-GRGTYGHVYKARRKDNSDT-RDYALKQIE------GTGLSMSAC-REIALLRE 72
           YE C+V G+G +  V   RR  N +T + +A+K ++        GLS     RE ++   
Sbjct: 26  YELCEVIGKGPFSVV---RRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 73  LKHPNVINLISVFLSHNDRKVWLLFDYAE-HDL-WHIIKFHRAAKANXXXXXXXXXXXXS 130
           LKHP+++ L+  + S  D  ++++F++ +  DL + I+K   A                 
Sbjct: 83  LKHPHIVELLETYSS--DGMLYMVFEFMDGADLCFEIVKRADAG------FVYSEAVASH 134
Query: 131 LLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA-RLFNNPLKPLAD 189
            + QIL+ + Y H N ++HRD+KP  +L+  +      VK+   G A +L  + L     
Sbjct: 135 YMRQILEALRYCHDNNIIHRDVKPHCVLLASKE-NSAPVKLGGFGVAIQLGESGLVAGGR 193
Query: 190 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
               V T  + APE ++    Y K +D+W  G I   LL+    F+  +E
Sbjct: 194 ----VGTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE 238

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 100/233 (42%), Gaps = 37/233 (15%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIE------------GTGLSMSACREIALLR 71
           G  +G G +G VY   R   SD    A+K +E            GT + M    E+ LL+
Sbjct: 14  GPLLGSGGFGSVYSGIRV--SDNLPVAIKHVEKDRISDWGELPNGTRVPM----EVVLLK 67
Query: 72  ELKH--PNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXX 129
           ++      VI L+  F   +   + L       DL+  I    A +              
Sbjct: 68  KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR--------- 118
Query: 130 SLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLAD 189
           S  +Q+L+ + + H+  VLHRD+K  NIL+    + RG +K+ D G   L  + +    D
Sbjct: 119 SFFWQVLEAVRHCHNCGVLHRDIKDENILI---DLNRGELKLIDFGSGALLKDTV--YTD 173
Query: 190 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 242
            D   V   Y  PE +   R++ ++  +W++G +  +++  +  F   +E I+
Sbjct: 174 FDGTRV---YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 223

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 96/239 (40%), Gaps = 32/239 (13%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYA------LKQIEGTGLSMSACREIALLRELKHPNVIN 80
           +G G +G V++AR         +       LK+     +     RE AL+ E  +PN++ 
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 81  LISVFLSHNDRKVWLLFDYAEH----------------DLWHIIKFHRAAKANXXXXXXX 124
           L+ V      + + LLF+Y  +                 L H     RA  ++       
Sbjct: 115 LLGV--CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 125 XXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPL 184
                 +  Q+  G+ YL     +HRDL   N LV GE +    VKIAD G +R   +  
Sbjct: 173 CAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV-GENMV---VKIADFGLSRNIYSAD 228
Query: 185 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS--EPIFHCRQEDI 241
              AD +  +   W   PE +   R YT   D+WA G +  E+ +   +P +    E++
Sbjct: 229 YYKADGNDAIPIRWM-PPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 285

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 100/233 (42%), Gaps = 37/233 (15%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIE------------GTGLSMSACREIALLR 71
           G  +G G +G VY   R   SD    A+K +E            GT + M    E+ LL+
Sbjct: 36  GPLLGSGGFGSVYSGIRV--SDNLPVAIKHVEKDRISDWGELPNGTRVPM----EVVLLK 89
Query: 72  ELKH--PNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXX 129
           ++      VI L+  F   +   + L       DL+  I    A +              
Sbjct: 90  KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR--------- 140
Query: 130 SLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLAD 189
           S  +Q+L+ + + H+  VLHRD+K  NIL+    + RG +K+ D G   L  + +    D
Sbjct: 141 SFFWQVLEAVRHCHNCGVLHRDIKDENILI---DLNRGELKLIDFGSGALLKDTV--YTD 195
Query: 190 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 242
            D   V   Y  PE +   R++ ++  +W++G +  +++  +  F   +E I+
Sbjct: 196 FDGTRV---YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 245

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 100/233 (42%), Gaps = 37/233 (15%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIE------------GTGLSMSACREIALLR 71
           G  +G G +G VY   R   SD    A+K +E            GT + M    E+ LL+
Sbjct: 14  GPLLGSGGFGSVYSGIRV--SDNLPVAIKHVEKDRISDWGELPNGTRVPM----EVVLLK 67
Query: 72  ELKH--PNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXX 129
           ++      VI L+  F   +   + L       DL+  I    A +              
Sbjct: 68  KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR--------- 118
Query: 130 SLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLAD 189
           S  +Q+L+ + + H+  VLHRD+K  NIL+    + RG +K+ D G   L  + +    D
Sbjct: 119 SFFWQVLEAVRHCHNCGVLHRDIKDENILI---DLNRGELKLIDFGSGALLKDTV--YTD 173
Query: 190 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 242
            D   V   Y  PE +   R++ ++  +W++G +  +++  +  F   +E I+
Sbjct: 174 FDGTRV---YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 223

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 98/229 (42%), Gaps = 29/229 (12%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS--------MSACREIALLRELKH 75
           G  +G G +G VY   R   SD    A+K +E   +S             E+ LL+++  
Sbjct: 12  GPLLGSGGFGSVYSGIRV--SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 69
Query: 76  --PNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLY 133
               VI L+  F   +   + L       DL+  I    A +              S  +
Sbjct: 70  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------SFFW 120
Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           Q+L+ + + H+  VLHRD+K  NIL+    + RG +K+ D G   L  + +    D D  
Sbjct: 121 QVLEAVRHCHNCGVLHRDIKDENILI---DLNRGELKLIDFGSGALLKDTV--YTDFDGT 175
Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 242
            V   Y  PE +   R++ ++  +W++G +  +++  +  F   +E I+
Sbjct: 176 RV---YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 221

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 88/208 (42%), Gaps = 18/208 (8%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDY----ALKQIEGTGLSMSACREIALLRELKHPNVINLI 82
           +G+G +G VY     D +  R      +L +I       +  RE  L+R L HPNV+ LI
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 83  SVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
            + L        LL      DL   ++F R+ + N            S   Q+  G+ YL
Sbjct: 89  GIMLPPEGLPHVLLPYMCHGDL---LQFIRSPQRN-----PTVKDLISFGLQVARGMEYL 140
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPLKPLADLDPVVVTFWYRA 201
                +HRDL   N ++     E   VK+AD G AR + +     +       +   + A
Sbjct: 141 AEQKFVHRDLAARNCML----DESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTA 196
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
            E L   R  TK+ D+W+ G +  ELLT
Sbjct: 197 LESLQTYRFTTKS-DVWSFGVLLWELLT 223

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 98/229 (42%), Gaps = 29/229 (12%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS--------MSACREIALLRELKH 75
           G  +G G +G VY   R   SD    A+K +E   +S             E+ LL+++  
Sbjct: 9   GPLLGSGGFGSVYSGIRV--SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 76  --PNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLY 133
               VI L+  F   +   + L       DL+  I    A +              S  +
Sbjct: 67  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------SFFW 117
Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           Q+L+ + + H+  VLHRD+K  NIL+    + RG +K+ D G   L  + +    D D  
Sbjct: 118 QVLEAVRHCHNCGVLHRDIKDENILI---DLNRGELKLIDFGSGALLKDTV--YTDFDGT 172
Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 242
            V   Y  PE +   R++ ++  +W++G +  +++  +  F   +E I+
Sbjct: 173 RV---YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 218

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 109/230 (47%), Gaps = 29/230 (12%)
Query: 22  YEGCKV-GRGTYGHVYKARRKDNSDT-RDYALKQIE------GTGLSMSAC-REIALLRE 72
           YE C+V G+G +  V   RR  N +T + +A+K ++        GLS     RE ++   
Sbjct: 28  YELCEVIGKGPFSVV---RRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 84
Query: 73  LKHPNVINLISVFLSHNDRKVWLLFDYAE-HDL-WHIIKFHRAAKANXXXXXXXXXXXXS 130
           LKHP+++ L+  + S  D  ++++F++ +  DL + I+K   A                 
Sbjct: 85  LKHPHIVELLETYSS--DGMLYMVFEFMDGADLCFEIVKRADAG------FVYSEAVASH 136
Query: 131 LLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA-RLFNNPLKPLAD 189
            + QIL+ + Y H N ++HRD+KP  +L+  +      VK+   G A +L  + L     
Sbjct: 137 YMRQILEALRYCHDNNIIHRDVKPHCVLLASKE-NSAPVKLGGFGVAIQLGESGLVAGGR 195
Query: 190 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
               V T  + APE ++    Y K +D+W  G I   LL+    F+  +E
Sbjct: 196 ----VGTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE 240

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G+G +G V+      N  TR  A+K ++   +S  A  +E  ++++L+H  ++ L +V
Sbjct: 25  KLGQGCFGEVWMGTW--NGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHS 144
               ++  ++++ +Y       ++ F +                  +  QI  G+ Y+  
Sbjct: 82  V---SEEPIYIVIEYMSKG--SLLDFLKGEMGKYLRLPQLV----DMAAQIASGMAYVER 132
Query: 145 NWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPEL 204
              +HRDL+ ANILV GE +     K+AD G ARL  +                + APE 
Sbjct: 133 MNYVHRDLRAANILV-GENL---VCKVADFGLARLIED--NEXTARQGAKFPIKWTAPEA 186
Query: 205 LLGARHYTKAIDIWAIGCIFAELLT 229
            L  R   K+ D+W+ G +  EL T
Sbjct: 187 ALYGRFTIKS-DVWSFGILLTELTT 210

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 24/208 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G G YG VY+   K  S T   A+K ++   + +    +E A+++E+KHPN++ L+ V
Sbjct: 18  KLGGGQYGEVYEGVWKKYSLT--VAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLY---QILDGIHY 141
                +   +++ ++  +   +++ + R                  LLY   QI   + Y
Sbjct: 76  --CTREPPFYIIIEFMTYG--NLLDYLRECNRQEVSAVV-------LLYMATQISSAMEY 124
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
           L     +HRDL   N LV     E   VK+AD G +RL               +   + A
Sbjct: 125 LEKKNFIHRDLAARNCLVG----ENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK--WTA 178
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
           PE L   +   K+ D+WA G +  E+ T
Sbjct: 179 PESLAYNKFSIKS-DVWAFGVLLWEIAT 205

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 54/105 (51%), Gaps = 6/105 (5%)
Query: 131 LLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADL 190
           ++  I + I YLHS  + HRD+KP N+L   +      +K+ D GFA+   +       L
Sbjct: 166 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR-PNAILKLTDFGFAKETTSH----NSL 220
Query: 191 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
                T +Y APE +LG   Y K+ D+W++G I   LL   P F+
Sbjct: 221 TTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 264

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 54/105 (51%), Gaps = 6/105 (5%)
Query: 131 LLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADL 190
           ++  I + I YLHS  + HRD+KP N+L   +      +K+ D GFA+   +       L
Sbjct: 172 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR-PNAILKLTDFGFAKETTSH----NSL 226
Query: 191 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
                T +Y APE +LG   Y K+ D+W++G I   LL   P F+
Sbjct: 227 TTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 270

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 104/231 (45%), Gaps = 48/231 (20%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALK--------QIEGTGLSMSACREIALLRELKHPNV 78
           +G+G++G V  A RK   +   YA+K        Q +    +M   R +ALL   K P +
Sbjct: 27  LGKGSFGKVMLADRKGTEEL--YAIKILKKDVVIQDDDVECTMVEKRVLALLD--KPPFL 82
Query: 79  INLISVFLSHNDRKVWLLFDYAEHD--LWHIIKFHRAAKANXXXXXXXXXXXXSLLY--Q 134
             L S F + +  +++ + +Y      ++HI +  +  +              ++ Y  +
Sbjct: 83  TQLHSCFQTVD--RLYFVMEYVNGGDLMYHIQQVGKFKEPQ------------AVFYAAE 128
Query: 135 ILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVV 194
           I  G+ +LH   +++RDLK  N+++  EG     +KIAD G  +           +D V 
Sbjct: 129 ISIGLFFLHKRGIIYRDLKLDNVMLDSEG----HIKIADFGMCKEHM--------MDGVT 176
Query: 195 V-----TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
                 T  Y APE++   + Y K++D WA G +  E+L  +P F    ED
Sbjct: 177 TREFCGTPDYIAPEII-AYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED 226

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 54/105 (51%), Gaps = 6/105 (5%)
Query: 131 LLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADL 190
           ++  I + I YLHS  + HRD+KP N+L   +      +K+ D GFA+   +       L
Sbjct: 128 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR-PNAILKLTDFGFAKETTS----HNSL 182
Query: 191 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
                T +Y APE +LG   Y K+ D+W++G I   LL   P F+
Sbjct: 183 TTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 226

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 54/105 (51%), Gaps = 6/105 (5%)
Query: 131 LLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADL 190
           ++  I + I YLHS  + HRD+KP N+L   +      +K+ D GFA+   +       L
Sbjct: 122 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR-PNAILKLTDFGFAKETTS----HNSL 176
Query: 191 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
                T +Y APE +LG   Y K+ D+W++G I   LL   P F+
Sbjct: 177 TTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 220

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 93/222 (41%), Gaps = 30/222 (13%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALK--------QIEGTGLSMSACREIALLRELKHPNV 78
           +G+G++G V  AR K+  D   YA+K        Q +    +M+  R ++L R   HP +
Sbjct: 31  LGKGSFGKVMLARVKETGDL--YAVKVLKKDVILQDDDVECTMTEKRILSLAR--NHPFL 86
Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
             L   F + +     + F      ++HI K  R  +A                 +I+  
Sbjct: 87  TQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAA----------EIISA 136
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + +LH   +++RDLK  N+L+  E    G  K+AD G  +     +           T  
Sbjct: 137 LMFLHDKGIIYRDLKLDNVLLDHE----GHCKLADFGMCK---EGICNGVTTATFCGTPD 189
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
           Y APE +L    Y  A+D WA+G +  E+L     F    ED
Sbjct: 190 YIAPE-ILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED 230

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 54/105 (51%), Gaps = 6/105 (5%)
Query: 131 LLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADL 190
           ++  I + I YLHS  + HRD+KP N+L   +      +K+ D GFA+   +       L
Sbjct: 127 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR-PNAILKLTDFGFAKETTS----HNSL 181
Query: 191 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
                T +Y APE +LG   Y K+ D+W++G I   LL   P F+
Sbjct: 182 TTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 225

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 54/105 (51%), Gaps = 6/105 (5%)
Query: 131 LLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADL 190
           ++  I + I YLHS  + HRD+KP N+L   +      +K+ D GFA+   +       L
Sbjct: 126 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR-PNAILKLTDFGFAKETTS----HNSL 180
Query: 191 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
                T +Y APE +LG   Y K+ D+W++G I   LL   P F+
Sbjct: 181 TTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 224

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 24/208 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G G YG VY+   K  S T   A+K ++   + +    +E A+++E+KHPN++ L+ V
Sbjct: 21  KLGGGQYGEVYEGVWKKYSLT--VAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLY---QILDGIHY 141
                +   +++ ++  +   +++ + R                  LLY   QI   + Y
Sbjct: 79  --CTREPPFYIIIEFMTYG--NLLDYLRECNRQEVNAVV-------LLYMATQISSAMEY 127
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
           L     +HRDL   N LV     E   VK+AD G +RL        A         W  A
Sbjct: 128 LEKKNFIHRDLAARNCLVG----ENHLVKVADFGLSRLMTGDTX-TAHAGAKFPIKW-TA 181
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
           PE L   +   K+ D+WA G +  E+ T
Sbjct: 182 PESLAYNKFSIKS-DVWAFGVLLWEIAT 208

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 54/105 (51%), Gaps = 6/105 (5%)
Query: 131 LLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADL 190
           ++  I + I YLHS  + HRD+KP N+L   +      +K+ D GFA+   +       L
Sbjct: 122 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR-PNAILKLTDFGFAKETTS----HNSL 176
Query: 191 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
                T +Y APE +LG   Y K+ D+W++G I   LL   P F+
Sbjct: 177 TTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 220

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G+G +G V+      N  TR  A+K ++   +S  A  +E  ++++L+H  ++ L +V
Sbjct: 25  KLGQGCFGEVWMGTW--NGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHS 144
               ++  ++++ +Y       ++ F +                  +  QI  G+ Y+  
Sbjct: 82  V---SEEPIYIVIEYMSKG--SLLDFLKGEMGKYLRLPQLV----DMAAQIASGMAYVER 132
Query: 145 NWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPEL 204
              +HRDL+ ANILV GE +     K+AD G ARL  +                + APE 
Sbjct: 133 MNYVHRDLRAANILV-GENL---VCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEA 186
Query: 205 LLGARHYTKAIDIWAIGCIFAELLT 229
            L  R   K+ D+W+ G +  EL T
Sbjct: 187 ALYGRFTIKS-DVWSFGILLTELTT 210

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 54/105 (51%), Gaps = 6/105 (5%)
Query: 131 LLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADL 190
           ++  I + I YLHS  + HRD+KP N+L   +      +K+ D GFA+   +       L
Sbjct: 120 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR-PNAILKLTDFGFAKETTS----HNSL 174
Query: 191 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
                T +Y APE +LG   Y K+ D+W++G I   LL   P F+
Sbjct: 175 TTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 218

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 101/244 (41%), Gaps = 43/244 (17%)
Query: 3   YEFKIKTSN--ERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDT--RDYALKQIEGTG 58
           YE K  T+N  ER          G K+G G +G VYK    + +    +  A+  I    
Sbjct: 18  YELKNVTNNFDERP-----ISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEE 72
Query: 59  LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH----------DLWHII 108
           L     +EI ++ + +H N++ L+    S +   + L++ Y  +          D    +
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLG--FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 130
Query: 109 KFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGR 168
            +H   K               +     +GI++LH N  +HRD+K ANIL+     E   
Sbjct: 131 SWHMRCK---------------IAQGAANGINFLHENHHIHRDIKSANILL----DEAFT 171
Query: 169 VKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 228
            KI+D G AR  +           +V T  Y APE L G    T   DI++ G +  E++
Sbjct: 172 AKISDFGLARA-SEKFAQTVMXSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEII 228
Query: 229 TSEP 232
           T  P
Sbjct: 229 TGLP 232

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDY----ALKQIEGTGLSMSACREIALLRELKHPNVINLI 82
           +GRG +G VY     DN   + +    +L +I   G       E  ++++  HPNV++L+
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 83  SVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
            + L      + +L      DL + I+                        Q+  G+ YL
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGMKYL 148
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPLKPLADLDPVVVTFWYRA 201
            S   +HRDL   N ++     E+  VK+AD G AR +++     + +     +   + A
Sbjct: 149 ASKKFVHRDLAARNCML----DEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMA 204
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
            E L   +  TK+ D+W+ G +  EL+T
Sbjct: 205 LESLQTQKFTTKS-DVWSFGVLLWELMT 231

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G+G +G V+      N  TR  A+K ++   +S  A  +E  ++++L+H  ++ L +V
Sbjct: 25  KLGQGCFGEVWMGTW--NGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHS 144
               ++  ++++ +Y       ++ F +                  +  QI  G+ Y+  
Sbjct: 82  V---SEEPIYIVMEYMSKGC--LLDFLKGEMGKYLRLPQLV----DMAAQIASGMAYVER 132
Query: 145 NWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPEL 204
              +HRDL+ ANILV GE +     K+AD G ARL  +                + APE 
Sbjct: 133 MNYVHRDLRAANILV-GENL---VCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEA 186
Query: 205 LLGARHYTKAIDIWAIGCIFAELLT 229
            L  R   K+ D+W+ G +  EL T
Sbjct: 187 ALYGRFTIKS-DVWSFGILLTELTT 210

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 54/105 (51%), Gaps = 6/105 (5%)
Query: 131 LLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADL 190
           ++  I + I YLHS  + HRD+KP N+L   +      +K+ D GFA+   +       L
Sbjct: 121 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR-PNAILKLTDFGFAKETTS----HNSL 175
Query: 191 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
                T +Y APE +LG   Y K+ D+W++G I   LL   P F+
Sbjct: 176 TTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 219

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 24/208 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G G YG VY+   K  S T   A+K ++   + +    +E A+++E+KHPN++ L+ V
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLT--VAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLY---QILDGIHY 141
                +   +++ ++  +   +++ + R                  LLY   QI   + Y
Sbjct: 78  --CTREPPFYIIIEFMTYG--NLLDYLRECNRQEVSAVV-------LLYMATQISSAMEY 126
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
           L     +HRDL   N LV     E   VK+AD G +RL        A         W  A
Sbjct: 127 LEKKNFIHRDLAARNCLVG----ENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKW-TA 180
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
           PE L   +   K+ D+WA G +  E+ T
Sbjct: 181 PESLAYNKFSIKS-DVWAFGVLLWEIAT 207

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 54/105 (51%), Gaps = 6/105 (5%)
Query: 131 LLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADL 190
           ++  I + I YLHS  + HRD+KP N+L   +      +K+ D GFA+   +       L
Sbjct: 136 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR-PNAILKLTDFGFAKETTS----HNSL 190
Query: 191 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
                T +Y APE +LG   Y K+ D+W++G I   LL   P F+
Sbjct: 191 TTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 234

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 100/233 (42%), Gaps = 37/233 (15%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIE------------GTGLSMSACREIALLR 71
           G  +G G +G VY   R   SD    A+K +E            GT + M    E+ LL+
Sbjct: 13  GPLLGSGGFGSVYSGIRV--SDNLPVAIKHVEKDRISDWGELPNGTRVPM----EVVLLK 66
Query: 72  ELKH--PNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXX 129
           ++      VI L+  F   +   + L       DL+  I    A +              
Sbjct: 67  KVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELAR--------- 117
Query: 130 SLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLAD 189
           S  +Q+L+ + + H+  VLHRD+K  NIL+    + RG +K+ D G   L  + +    D
Sbjct: 118 SFFWQVLEAVRHCHNCGVLHRDIKDENILI---DLNRGELKLIDFGSGALLKDTV--YTD 172
Query: 190 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 242
            D   V   Y  PE +   R++ ++  +W++G +  +++  +  F   +E I+
Sbjct: 173 FDGTRV---YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 222

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 54/105 (51%), Gaps = 6/105 (5%)
Query: 131 LLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADL 190
           ++  I + I YLHS  + HRD+KP N+L   +      +K+ D GFA+   +       L
Sbjct: 120 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR-PNAILKLTDFGFAKETTS----HNSL 174
Query: 191 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
                T +Y APE +LG   Y K+ D+W++G I   LL   P F+
Sbjct: 175 TEPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 218

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 24/208 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G G YG VY+   K  S T   A+K ++   + +    +E A+++E+KHPN++ L+ V
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLT--VAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLY---QILDGIHY 141
                +   +++ ++  +   +++ + R                  LLY   QI   + Y
Sbjct: 78  --CTREPPFYIIIEFMTYG--NLLDYLRECNRQEVSAVV-------LLYMATQISSAMEY 126
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
           L     +HRDL   N LV     E   VK+AD G +RL        A         W  A
Sbjct: 127 LEKKNFIHRDLAARNCLVG----ENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKW-TA 180
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
           PE L   +   K+ D+WA G +  E+ T
Sbjct: 181 PESLAYNKFSIKS-DVWAFGVLLWEIAT 207

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G+G +G V+      N  TR  A+K ++   +S  A  +E  ++++L+H  ++ L +V
Sbjct: 18  KLGQGCFGEVWMGTW--NGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 74
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHS 144
               ++  ++++ +Y       ++ F +                  +  QI  G+ Y+  
Sbjct: 75  V---SEEPIYIVTEYMSKG--SLLDFLKGETGKYLRLPQLV----DMAAQIASGMAYVER 125
Query: 145 NWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPEL 204
              +HRDL+ ANILV GE +     K+AD G ARL  +                + APE 
Sbjct: 126 MNYVHRDLRAANILV-GENL---VCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEA 179
Query: 205 LLGARHYTKAIDIWAIGCIFAELLT 229
            L  R   K+ D+W+ G +  EL T
Sbjct: 180 ALYGRFTIKS-DVWSFGILLTELTT 203

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 24/208 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G G YG VY+   K  S T   A+K ++   + +    +E A+++E+KHPN++ L+ V
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLT--VAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLY---QILDGIHY 141
                +   +++ ++  +   +++ + R                  LLY   QI   + Y
Sbjct: 83  --CTREPPFYIIIEFMTYG--NLLDYLRECNRQEVNAVV-------LLYMATQISSAMEY 131
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
           L     +HRDL   N LV     E   VK+AD G +RL        A         W  A
Sbjct: 132 LEKKNFIHRDLAARNCLVG----ENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKW-TA 185
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
           PE L   +   K+ D+WA G +  E+ T
Sbjct: 186 PESLAYNKFSIKS-DVWAFGVLLWEIAT 212

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G+G +G V+      N  TR  A+K ++   +S  A  +E  ++++L+H  ++ L +V
Sbjct: 191 KLGQGCFGEVWMGTW--NGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHS 144
               ++  ++++ +Y       ++ F +                  +  QI  G+ Y+  
Sbjct: 248 V---SEEPIYIVTEYMSKG--SLLDFLKGETGKYLRLPQLV----DMAAQIASGMAYVER 298
Query: 145 NWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPEL 204
              +HRDL+ ANILV GE +     K+AD G ARL  +                + APE 
Sbjct: 299 MNYVHRDLRAANILV-GENL---VCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEA 352
Query: 205 LLGARHYTKAIDIWAIGCIFAELLT 229
            L  R   K+ D+W+ G +  EL T
Sbjct: 353 ALYGRFTIKS-DVWSFGILLTELTT 376

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G+G +G V+      N  TR  A+K ++   +S  A  +E  ++++L+H  ++ L +V
Sbjct: 191 KLGQGCFGEVWMGTW--NGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHS 144
               ++  ++++ +Y       ++ F +                  +  QI  G+ Y+  
Sbjct: 248 V---SEEPIYIVTEYMSKG--SLLDFLKGETGKYLRLPQLV----DMAAQIASGMAYVER 298
Query: 145 NWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPEL 204
              +HRDL+ ANILV GE +     K+AD G ARL  +                + APE 
Sbjct: 299 MNYVHRDLRAANILV-GENL---VCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEA 352
Query: 205 LLGARHYTKAIDIWAIGCIFAELLT 229
            L  R   K+ D+W+ G +  EL T
Sbjct: 353 ALYGRFTIKS-DVWSFGILLTELTT 376

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/109 (33%), Positives = 58/109 (53%), Gaps = 9/109 (8%)
Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           +I  G+  LH   +++RDLKP NIL+     + G ++I+D+G A            +   
Sbjct: 294 EICCGLEDLHRERIVYRDLKPENILL----DDHGHIRISDLGLAVHVPEG----QTIKGR 345
Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 242
           V T  Y APE++   R YT + D WA+GC+  E++  +  F  R++ IK
Sbjct: 346 VGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK 393

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 97/228 (42%), Gaps = 29/228 (12%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS--------MSACREIALLRELKH 75
           G  +G G +G VY   R   SD    A+K +E   +S             E+ LL+++  
Sbjct: 9   GPLLGSGGFGSVYSGIRV--SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 76  --PNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLY 133
               VI L+  F   +   + L       DL+  I    A +              S  +
Sbjct: 67  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------SFFW 117
Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           Q+L+ + + H+  VLHRD+K  NIL+    + RG +K+ D G   L  + +    D D  
Sbjct: 118 QVLEAVRHCHNCGVLHRDIKDENILI---DLNRGELKLIDFGSGALLKDTV--YTDFDGT 172
Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI 241
            V   Y  PE +   R++ ++  +W++G +  +++  +  F   +E I
Sbjct: 173 RV---YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 217

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDY----ALKQIEGTGLSMSACREIALLRELKHPNVINLI 82
           +GRG +G VY     DN   + +    +L +I   G       E  ++++  HPNV++L+
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 83  SVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
            + L      + +L      DL + I+                        Q+  G+ YL
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGMKYL 147
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPLKPLADLDPVVVTFWYRA 201
            S   +HRDL   N ++     E+  VK+AD G AR +++     + +     +   + A
Sbjct: 148 ASKKFVHRDLAARNCML----DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 203
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
            E L   +  TK+ D+W+ G +  EL+T
Sbjct: 204 LESLQTQKFTTKS-DVWSFGVLLWELMT 230

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 101/244 (41%), Gaps = 43/244 (17%)
Query: 3   YEFKIKTSN--ERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDT--RDYALKQIEGTG 58
           YE K  T+N  ER          G K+G G +G VYK    + +    +  A+  I    
Sbjct: 18  YELKNVTNNFDERP-----ISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEE 72
Query: 59  LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH----------DLWHII 108
           L     +EI ++ + +H N++ L+    S +   + L++ Y  +          D    +
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLG--FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 130
Query: 109 KFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGR 168
            +H   K               +     +GI++LH N  +HRD+K ANIL+     E   
Sbjct: 131 SWHMRCK---------------IAQGAANGINFLHENHHIHRDIKSANILL----DEAFT 171
Query: 169 VKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 228
            KI+D G AR  +           +V T  Y APE L G    T   DI++ G +  E++
Sbjct: 172 AKISDFGLARA-SEKFAQTVMXXRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEII 228
Query: 229 TSEP 232
           T  P
Sbjct: 229 TGLP 232

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 55/105 (52%), Gaps = 11/105 (10%)
Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           QI+    YLHS  +++RDLKP N+++     ++G +K+ D G A+        L      
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLMI----DQQGYIKVTDFGLAKRVKGRTWXLCG---- 200
Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 238
             T  Y APE++L ++ Y KA+D WA+G +  E+    P F   Q
Sbjct: 201 --TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G+G +G V+      N  TR  A+K ++   +S  A  +E  ++++L+H  ++ L +V
Sbjct: 25  KLGQGCFGEVWMGTW--NGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHS 144
               ++  ++++ +Y       ++ F +                  +  QI  G+ Y+  
Sbjct: 82  V---SEEPIYIVTEYMSKG--SLLDFLKGEMGKYLRLPQLV----DMAAQIASGMAYVER 132
Query: 145 NWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPEL 204
              +HRDL+ ANILV GE +     K+AD G ARL  +                + APE 
Sbjct: 133 MNYVHRDLRAANILV-GENL---VCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEA 186
Query: 205 LLGARHYTKAIDIWAIGCIFAELLT 229
            L  R   K+ D+W+ G +  EL T
Sbjct: 187 ALYGRFTIKS-DVWSFGILLTELTT 210

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 24/208 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G G YG VY+   K  S T   A+K ++   + +    +E A+++E+KHPN++ L+ V
Sbjct: 18  KLGGGQYGEVYEGVWKKYSLT--VAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLY---QILDGIHY 141
                +   +++ ++  +   +++ + R                  LLY   QI   + Y
Sbjct: 76  --CTREPPFYIITEFMTYG--NLLDYLRECNRQEVSAVV-------LLYMATQISSAMEY 124
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
           L     +HRDL   N LV     E   VK+AD G +RL                   + A
Sbjct: 125 LEKKNFIHRDLAARNCLVG----ENHLVKVADFGLSRLMTG--DTFTAHAGAKFPIKWTA 178
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
           PE L   +   K+ D+WA G +  E+ T
Sbjct: 179 PESLAYNKFSIKS-DVWAFGVLLWEIAT 205

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/109 (33%), Positives = 58/109 (53%), Gaps = 9/109 (8%)
Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           +I  G+  LH   +++RDLKP NIL+     + G ++I+D+G A            +   
Sbjct: 294 EICCGLEDLHRERIVYRDLKPENILL----DDHGHIRISDLGLAVHVPEG----QTIKGR 345
Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 242
           V T  Y APE++   R YT + D WA+GC+  E++  +  F  R++ IK
Sbjct: 346 VGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK 393

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 101/244 (41%), Gaps = 43/244 (17%)
Query: 3   YEFKIKTSN--ERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDT--RDYALKQIEGTG 58
           YE K  T+N  ER          G K+G G +G VYK    + +    +  A+  I    
Sbjct: 12  YELKNVTNNFDERP-----ISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEE 66
Query: 59  LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH----------DLWHII 108
           L     +EI ++ + +H N++ L+    S +   + L++ Y  +          D    +
Sbjct: 67  LKQQFDQEIKVMAKCQHENLVELLG--FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 124
Query: 109 KFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGR 168
            +H   K               +     +GI++LH N  +HRD+K ANIL+     E   
Sbjct: 125 SWHMRCK---------------IAQGAANGINFLHENHHIHRDIKSANILL----DEAFT 165
Query: 169 VKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 228
            KI+D G AR  +           +V T  Y APE L G    T   DI++ G +  E++
Sbjct: 166 AKISDFGLARA-SEKFAQXVMXXRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEII 222
Query: 229 TSEP 232
           T  P
Sbjct: 223 TGLP 226

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G+G +G V+      N  TR  A+K ++   +S  A  +E  ++++L+H  ++ L +V
Sbjct: 16  KLGQGCFGEVWMGTW--NGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 72
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHS 144
               ++  ++++ +Y       ++ F +                  +  QI  G+ Y+  
Sbjct: 73  V---SEEPIYIVTEYMSKG--SLLDFLKGEMGKYLRLPQLV----DMAAQIASGMAYVER 123
Query: 145 NWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPEL 204
              +HRDL+ ANILV GE +     K+AD G ARL  +                + APE 
Sbjct: 124 MNYVHRDLRAANILV-GENL---VCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEA 177
Query: 205 LLGARHYTKAIDIWAIGCIFAELLT 229
            L  R   K+ D+W+ G +  EL T
Sbjct: 178 ALYGRFTIKS-DVWSFGILLTELTT 201

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G+G +G V+      N  TR  A+K ++   +S  A  +E  ++++L+H  ++ L +V
Sbjct: 25  KLGQGCFGEVWMGTW--NGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHS 144
               ++  ++++ +Y       ++ F +                  +  QI  G+ Y+  
Sbjct: 82  V---SEEPIYIVCEYMSKG--SLLDFLKGEMGKYLRLPQLV----DMAAQIASGMAYVER 132
Query: 145 NWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPEL 204
              +HRDL+ ANILV GE +     K+AD G ARL  +                + APE 
Sbjct: 133 MNYVHRDLRAANILV-GENL---VCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEA 186
Query: 205 LLGARHYTKAIDIWAIGCIFAELLT 229
            L  R   K+ D+W+ G +  EL T
Sbjct: 187 ALYGRFTIKS-DVWSFGILLTELTT 210

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 68/239 (28%), Positives = 106/239 (44%), Gaps = 33/239 (13%)
Query: 8   KTSNERTKVEDLFDYEGCKV-GRGTYGHVYKARRKDNSDTRDYALK---QIEGTGLSMSA 63
           K  + R K ED   YE  KV GRG +G V   R K  S  + YA+K   + E    S SA
Sbjct: 65  KIRDLRMKAED---YEVVKVIGRGAFGEVQLVRHK--STRKVYAMKLLSKFEMIKRSDSA 119
Query: 64  C--REIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXX 120
               E  ++     P V+ L   F   +DR ++++ +Y    DL +++       +N   
Sbjct: 120 FFWEERDIMAFANSPWVVQLFYAF--QDDRYLYMVMEYMPGGDLVNLM-------SNYDV 170
Query: 121 XXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
                    + +   LD IH   S   +HRD+KP N+L+     + G +K+AD G     
Sbjct: 171 PEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLL----DKSGHLKLADFGTCMKM 223
Query: 181 NNPLKPLADLDPVVVTFWYRAPELLL---GARHYTKAIDIWAIGCIFAELLTSEPIFHC 236
           N   + +   D  V T  Y +PE+L    G  +Y +  D W++G    E+L  +  F+ 
Sbjct: 224 NK--EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 280

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDY----ALKQIEGTGLSMSACREIALLRELKHPNVINLI 82
           +GRG +G VY     DN   + +    +L +I   G       E  ++++  HPNV++L+
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 83  SVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
            + L      + +L      DL + I+                        Q+  G+ YL
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGMKYL 144
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPLKPLADLDPVVVTFWYRA 201
            S   +HRDL   N ++     E+  VK+AD G AR +++     + +     +   + A
Sbjct: 145 ASKKFVHRDLAARNCML----DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 200
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
            E L   +  TK+ D+W+ G +  EL+T
Sbjct: 201 LESLQTQKFTTKS-DVWSFGVLLWELMT 227

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 68/239 (28%), Positives = 106/239 (44%), Gaps = 33/239 (13%)
Query: 8   KTSNERTKVEDLFDYEGCKV-GRGTYGHVYKARRKDNSDTRDYALK---QIEGTGLSMSA 63
           K  + R K ED   YE  KV GRG +G V   R K  S  + YA+K   + E    S SA
Sbjct: 60  KIRDLRMKAED---YEVVKVIGRGAFGEVQLVRHK--STRKVYAMKLLSKFEMIKRSDSA 114
Query: 64  C--REIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXX 120
               E  ++     P V+ L   F   +DR ++++ +Y    DL +++       +N   
Sbjct: 115 FFWEERDIMAFANSPWVVQLFYAF--QDDRYLYMVMEYMPGGDLVNLM-------SNYDV 165
Query: 121 XXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
                    + +   LD IH   S   +HRD+KP N+L+     + G +K+AD G     
Sbjct: 166 PEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLL----DKSGHLKLADFGTCMKM 218
Query: 181 NNPLKPLADLDPVVVTFWYRAPELLL---GARHYTKAIDIWAIGCIFAELLTSEPIFHC 236
           N   + +   D  V T  Y +PE+L    G  +Y +  D W++G    E+L  +  F+ 
Sbjct: 219 NK--EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 275

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G+G +G V+      N  TR  A+K ++   +S  A  +E  ++++L+H  ++ L +V
Sbjct: 22  KLGQGCFGEVWMGTW--NGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 78
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHS 144
               ++  ++++ +Y       ++ F +                  +  QI  G+ Y+  
Sbjct: 79  V---SEEPIYIVTEYMNKG--SLLDFLKGETGKYLRLPQLV----DMSAQIASGMAYVER 129
Query: 145 NWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPEL 204
              +HRDL+ ANILV GE +     K+AD G ARL  +                + APE 
Sbjct: 130 MNYVHRDLRAANILV-GENL---VCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEA 183
Query: 205 LLGARHYTKAIDIWAIGCIFAELLT 229
            L  R   K+ D+W+ G +  EL T
Sbjct: 184 ALYGRFTIKS-DVWSFGILLTELTT 207

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 68/239 (28%), Positives = 106/239 (44%), Gaps = 33/239 (13%)
Query: 8   KTSNERTKVEDLFDYEGCKV-GRGTYGHVYKARRKDNSDTRDYALK---QIEGTGLSMSA 63
           K  + R K ED   YE  KV GRG +G V   R K  S  + YA+K   + E    S SA
Sbjct: 65  KIRDLRMKAED---YEVVKVIGRGAFGEVQLVRHK--STRKVYAMKLLSKFEMIKRSDSA 119
Query: 64  C--REIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXX 120
               E  ++     P V+ L   F   +DR ++++ +Y    DL +++       +N   
Sbjct: 120 FFWEERDIMAFANSPWVVQLFYAF--QDDRYLYMVMEYMPGGDLVNLM-------SNYDV 170
Query: 121 XXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
                    + +   LD IH   S   +HRD+KP N+L+     + G +K+AD G     
Sbjct: 171 PEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLL----DKSGHLKLADFGTCMKM 223
Query: 181 NNPLKPLADLDPVVVTFWYRAPELLL---GARHYTKAIDIWAIGCIFAELLTSEPIFHC 236
           N   + +   D  V T  Y +PE+L    G  +Y +  D W++G    E+L  +  F+ 
Sbjct: 224 NK--EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 280

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 24/208 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G G YG VY+   K  S T   A+K ++   + +    +E A+++E+KHPN++ L+ V
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLT--VAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLY---QILDGIHY 141
                +   +++ ++  +   +++ + R                  LLY   QI   + Y
Sbjct: 83  --CTREPPFYIITEFMTYG--NLLDYLRECNRQEVNAVV-------LLYMATQISSAMEY 131
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
           L     +HRDL   N LV     E   VK+AD G +RL        A         W  A
Sbjct: 132 LEKKNFIHRDLAARNCLVG----ENHLVKVADFGLSRLMTGDTX-TAHAGAKFPIKW-TA 185
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
           PE L   +   K+ D+WA G +  E+ T
Sbjct: 186 PESLAYNKFSIKS-DVWAFGVLLWEIAT 212

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDY----ALKQIEGTGLSMSACREIALLRELKHPNVINLI 82
           +GRG +G VY     DN   + +    +L +I   G       E  ++++  HPNV++L+
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 83  SVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
            + L      + +L      DL + I+                        Q+  G+ YL
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGMKYL 149
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPLKPLADLDPVVVTFWYRA 201
            S   +HRDL   N ++     E+  VK+AD G AR +++     + +     +   + A
Sbjct: 150 ASKKFVHRDLAARNCML----DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 205
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
            E L   +  TK+ D+W+ G +  EL+T
Sbjct: 206 LESLQTQKFTTKS-DVWSFGVLLWELMT 232

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDY----ALKQIEGTGLSMSACREIALLRELKHPNVINLI 82
           +GRG +G VY     DN   + +    +L +I   G       E  ++++  HPNV++L+
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 83  SVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
            + L      + +L      DL + I+                        Q+  G+ YL
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGMKYL 149
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPLKPLADLDPVVVTFWYRA 201
            S   +HRDL   N ++     E+  VK+AD G AR +++     + +     +   + A
Sbjct: 150 ASKKFVHRDLAARNCML----DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 205
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
            E L   +  TK+ D+W+ G +  EL+T
Sbjct: 206 LESLQTQKFTTKS-DVWSFGVLLWELMT 232

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G+G +G V+      N  TR  A+K ++   +S  A  +E  ++++L+H  ++ L +V
Sbjct: 191 KLGQGCFGEVWMGTW--NGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHS 144
               ++  ++++ +Y       ++ F +                  +  QI  G+ Y+  
Sbjct: 248 V---SEEPIYIVGEYMSKG--SLLDFLKGETGKYLRLPQLV----DMAAQIASGMAYVER 298
Query: 145 NWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPEL 204
              +HRDL+ ANILV GE +     K+AD G ARL  +                + APE 
Sbjct: 299 MNYVHRDLRAANILV-GENL---VCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEA 352
Query: 205 LLGARHYTKAIDIWAIGCIFAELLT 229
            L  R   K+ D+W+ G +  EL T
Sbjct: 353 ALYGRFTIKS-DVWSFGILLTELTT 376

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G+G +G V+      N  TR  A+K ++   +S  A  +E  ++++L+H  ++ L +V
Sbjct: 14  KLGQGCFGEVWMGTW--NGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 70
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHS 144
               ++  ++++ +Y       ++ F +                  +  QI  G+ Y+  
Sbjct: 71  V---SEEPIYIVTEYMSKG--SLLDFLKGEMGKYLRLPQLV----DMAAQIASGMAYVER 121
Query: 145 NWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPEL 204
              +HRDL+ ANILV GE +     K+AD G ARL  +                + APE 
Sbjct: 122 MNYVHRDLRAANILV-GENL---VCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEA 175
Query: 205 LLGARHYTKAIDIWAIGCIFAELLT 229
            L  R   K+ D+W+ G +  EL T
Sbjct: 176 ALYGRFTIKS-DVWSFGILLTELTT 199

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 81/186 (43%), Gaps = 26/186 (13%)
Query: 50  ALKQIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAE-HDLWHII 108
           ALK+  G  L     REI +LR L H +++          ++ V L+ +Y     L   +
Sbjct: 44  ALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL 103
Query: 109 KFHRAAKANXXXXXXXXXXXXSLLY--QILDGIHYLHSNWVLHRDLKPANILVMGEGIER 166
             H    A              LL+  QI +G+ YLH+   +HR L   N+L+  + +  
Sbjct: 104 PRHCVGLAQL------------LLFAQQICEGMAYLHAQHYIHRALAARNVLLDNDRL-- 149
Query: 167 GRVKIADMGFARLF---NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCI 223
             VKI D G A+     +   +   D D  V  FWY APE L   + Y  A D+W+ G  
Sbjct: 150 --VKIGDFGLAKAVPEGHEYYRVREDGDSPV--FWY-APECLKECKFYY-ASDVWSFGVT 203
Query: 224 FAELLT 229
             ELLT
Sbjct: 204 LYELLT 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 81/186 (43%), Gaps = 26/186 (13%)
Query: 50  ALKQIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAE-HDLWHII 108
           ALK+  G  L     REI +LR L H +++          ++ V L+ +Y     L   +
Sbjct: 45  ALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL 104
Query: 109 KFHRAAKANXXXXXXXXXXXXSLLY--QILDGIHYLHSNWVLHRDLKPANILVMGEGIER 166
             H    A              LL+  QI +G+ YLH+   +HR L   N+L+  + +  
Sbjct: 105 PRHCVGLAQL------------LLFAQQICEGMAYLHAQHYIHRALAARNVLLDNDRL-- 150
Query: 167 GRVKIADMGFARLF---NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCI 223
             VKI D G A+     +   +   D D  V  FWY APE L   + Y  A D+W+ G  
Sbjct: 151 --VKIGDFGLAKAVPEGHEYYRVREDGDSPV--FWY-APECLKECKFYY-ASDVWSFGVT 204
Query: 224 FAELLT 229
             ELLT
Sbjct: 205 LYELLT 210

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 109/238 (45%), Gaps = 29/238 (12%)
Query: 7   IKTSNERTKVEDLFDYEGCKV-GRGTYGHVYKARRKDNSDTRD-YALKQIEGTGLSMS-- 62
           +K  +E+    D   +E  KV G+G++G V+  R+    D+   YA+K ++   L +   
Sbjct: 18  VKAGSEKA---DPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDR 74
Query: 63  --ACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXX 119
                E  +L ++ HP V+ L   F    + K++L+ D+    DL     F R +K    
Sbjct: 75  VRTKMERDILADVNHPFVVKLHYAF--QTEGKLYLILDFLRGGDL-----FTRLSKE--- 124
Query: 120 XXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL 179
                       L ++  G+ +LHS  +++RDLKP NIL+     E G +K+ D G ++ 
Sbjct: 125 -VMFTEEDVKFYLAELALGLDHLHSLGIIYRDLKPENILL----DEEGHIKLTDFGLSKE 179
Query: 180 FNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 237
             +  K          T  Y APE ++  + ++ + D W+ G +  E+LT    F  +
Sbjct: 180 AIDHEKKAYSF---CGTVEYMAPE-VVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGK 233

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 25/223 (11%)
Query: 24  GCKVGRGTYGHVYKAR-----RKDNSDTRDYALKQI--EGTGLSMS-ACREIALLREL-K 74
           G  +G G +G V  A      +    +    A+K +  + T   +S    E+ +++ + K
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 75  HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXX-------XXXXXXX 126
           H N+INL+       D  ++++ +YA   +L   ++  R                     
Sbjct: 100 HKNIINLLGA--CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 127 XXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKP 186
              S  YQ+  G+ YL S   +HRDL   N+LV     E   +KIAD G AR  NN +  
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLV----TENNVMKIADFGLARDINN-IDY 212
Query: 187 LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
             +     +   + APE L   R YT   D+W+ G +  E+ T
Sbjct: 213 YKNTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFT 254

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 24/208 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G G YG VY+   K  S T   A+K ++   + +    +E A+++E+KHPN++ L+ V
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLT--VAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLY---QILDGIHY 141
                +   +++ ++  +   +++ + R                  LLY   QI   + Y
Sbjct: 78  --CTREPPFYIITEFMTYG--NLLDYLRECNRQEVSAVV-------LLYMATQISSAMEY 126
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
           L     +HRDL   N LV     E   VK+AD G +RL        A         W  A
Sbjct: 127 LEKKNFIHRDLAARNCLVG----ENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKW-TA 180
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
           PE L   +   K+ D+WA G +  E+ T
Sbjct: 181 PESLAYNKFSIKS-DVWAFGVLLWEIAT 207

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 24/208 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G G YG VY+   K  S T   A+K ++   + +    +E A+++E+KHPN++ L+ V
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLT--VAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLY---QILDGIHY 141
                +   +++ ++  +   +++ + R                  LLY   QI   + Y
Sbjct: 78  --CTREPPFYIITEFMTYG--NLLDYLRECNRQEVSAVV-------LLYMATQISSAMEY 126
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
           L     +HRDL   N LV     E   VK+AD G +RL        A         W  A
Sbjct: 127 LEKKNFIHRDLAARNCLVG----ENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKW-TA 180
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
           PE L   +   K+ D+WA G +  E+ T
Sbjct: 181 PESLAYNKFSIKS-DVWAFGVLLWEIAT 207

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 93/223 (41%), Gaps = 25/223 (11%)
Query: 24  GCKVGRGTYGHVYKAR-----RKDNSDTRDYALKQI--EGTGLSMS-ACREIALLREL-K 74
           G  +G G +G V  A      +    +    A+K +  + T   +S    E+ +++ + K
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGK 99
Query: 75  HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXX-------XXXXXXX 126
           H N+INL+       D  ++++ +YA   +L   ++  R                     
Sbjct: 100 HKNIINLLGA--CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 127 XXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKP 186
              S  YQ+  G+ YL S   +HRDL   N+LV     E   +KIAD G AR  NN    
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLV----TENNVMKIADFGLARDINNIDYY 213
Query: 187 LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
               +  +   W  APE L   R YT   D+W+ G +  E+ T
Sbjct: 214 KKTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLMWEIFT 254

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 24/208 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G G YG VY+   K  S T   A+K ++   + +    +E A+++E+KHPN++ L+ V
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLT--VAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLY---QILDGIHY 141
                +   +++ ++  +   +++ + R                  LLY   QI   + Y
Sbjct: 83  --CTREPPFYIITEFMTYG--NLLDYLRECNRQEVSAVV-------LLYMATQISSAMEY 131
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
           L     +HRDL   N LV     E   VK+AD G +RL        A         W  A
Sbjct: 132 LEKKNFIHRDLAARNCLVG----ENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKW-TA 185
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
           PE L   +   K+ D+WA G +  E+ T
Sbjct: 186 PESLAYNKFSIKS-DVWAFGVLLWEIAT 212

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDY----ALKQIEGTGLSMSACREIALLRELKHPNVINLI 82
           +GRG +G VY     DN   + +    +L +I   G       E  ++++  HPNV++L+
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 83  SVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
            + L      + +L      DL + I+                        Q+  G+ YL
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGMKYL 148
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPLKPLADLDPVVVTFWYRA 201
            S   +HRDL   N ++     E+  VK+AD G AR +++     + +     +   + A
Sbjct: 149 ASKKFVHRDLAARNCML----DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 204
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
            E L   +  TK+ D+W+ G +  EL+T
Sbjct: 205 LESLQTQKFTTKS-DVWSFGVLLWELMT 231

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 99/244 (40%), Gaps = 43/244 (17%)
Query: 3   YEFKIKTSN--ERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDT--RDYALKQIEGTG 58
           YE K  T+N  ER          G K G G +G VYK    + +    +  A+  I    
Sbjct: 9   YELKNVTNNFDERP-----ISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEE 63
Query: 59  LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH----------DLWHII 108
           L     +EI +  + +H N++ L+    S +   + L++ Y  +          D    +
Sbjct: 64  LKQQFDQEIKVXAKCQHENLVELLG--FSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPL 121
Query: 109 KFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGR 168
            +H   K               +     +GI++LH N  +HRD+K ANIL+     E   
Sbjct: 122 SWHXRCK---------------IAQGAANGINFLHENHHIHRDIKSANILLD----EAFT 162
Query: 169 VKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 228
            KI+D G AR  +           +V T  Y APE L G    T   DI++ G +  E++
Sbjct: 163 AKISDFGLARA-SEKFAQXVXXSRIVGTTAYXAPEALRG--EITPKSDIYSFGVVLLEII 219
Query: 229 TSEP 232
           T  P
Sbjct: 220 TGLP 223

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDY----ALKQIEGTGLSMSACREIALLRELKHPNVINLI 82
           +GRG +G VY     DN   + +    +L +I   G       E  ++++  HPNV++L+
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 83  SVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
            + L      + +L      DL + I+                        Q+  G+ YL
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGMKYL 167
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPLKPLADLDPVVVTFWYRA 201
            S   +HRDL   N ++     E+  VK+AD G AR +++     + +     +   + A
Sbjct: 168 ASKKFVHRDLAARNCML----DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 223
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
            E L   +  TK+ D+W+ G +  EL+T
Sbjct: 224 LESLQTQKFTTKS-DVWSFGVLLWELMT 250

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G+G +G V+      N  TR  A+K ++   +S  A  +E  ++++L+H  ++ L +V
Sbjct: 22  KLGQGCFGEVWMGTW--NGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 78
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHS 144
               ++  ++++ +Y       ++ F +                  +  QI  G+ Y+  
Sbjct: 79  V---SEEPIYIVTEYMNKG--SLLDFLKGETGKYLRLPQLV----DMSAQIASGMAYVER 129
Query: 145 NWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPEL 204
              +HRDL+ ANILV GE +     K+AD G ARL  +                + APE 
Sbjct: 130 MNYVHRDLRAANILV-GENL---VCKVADFGLARLIED--NEWTARQGAKFPIKWTAPEA 183
Query: 205 LLGARHYTKAIDIWAIGCIFAELLT 229
            L  R   K+ D+W+ G +  EL T
Sbjct: 184 ALYGRFTIKS-DVWSFGILLTELTT 207

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G+G +G V+      N  TR  A+K ++   +S  A  +E  ++++L+H  ++ L +V
Sbjct: 25  KLGQGCFGEVWMGTW--NGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHS 144
               ++  ++++ +Y       ++ F +                  +  QI  G+ Y+  
Sbjct: 82  V---SEEPIYIVTEYMSKGC--LLDFLKGEMGKYLRLPQLV----DMAAQIASGMAYVER 132
Query: 145 NWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPEL 204
              +HRDL+ ANILV GE +     K+AD G ARL  +                + APE 
Sbjct: 133 MNYVHRDLRAANILV-GENL---VCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEA 186
Query: 205 LLGARHYTKAIDIWAIGCIFAELLT 229
            L  R   K+ D+W+ G +  EL T
Sbjct: 187 ALYGRFTIKS-DVWSFGILLTELTT 210

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDY----ALKQIEGTGLSMSACREIALLRELKHPNVINLI 82
           +GRG +G VY     DN   + +    +L +I   G       E  ++++  HPNV++L+
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 83  SVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
            + L      + +L      DL + I+                        Q+  G+ +L
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGMKFL 150
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPLKPLADLDPVVVTFWYRA 201
            S   +HRDL   N ++     E+  VK+AD G AR +++     + +     +   + A
Sbjct: 151 ASKKFVHRDLAARNCML----DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 206
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
            E L   +  TK+ D+W+ G +  EL+T
Sbjct: 207 LESLQTQKFTTKS-DVWSFGVLLWELMT 233

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDY----ALKQIEGTGLSMSACREIALLRELKHPNVINLI 82
           +GRG +G VY     DN   + +    +L +I   G       E  ++++  HPNV++L+
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 83  SVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
            + L      + +L      DL + I+                        Q+  G+ YL
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGMKYL 146
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPLKPLADLDPVVVTFWYRA 201
            S   +HRDL   N ++     E+  VK+AD G AR +++     + +     +   + A
Sbjct: 147 ASKKFVHRDLAARNCML----DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 202
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
            E L   +  TK+ D+W+ G +  EL+T
Sbjct: 203 LESLQTQKFTTKS-DVWSFGVLLWELMT 229

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDY----ALKQIEGTGLSMSACREIALLRELKHPNVINLI 82
           +GRG +G VY     DN   + +    +L +I   G       E  ++++  HPNV++L+
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 83  SVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
            + L      + +L      DL + I+                        Q+  G+ +L
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGMKFL 149
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPLKPLADLDPVVVTFWYRA 201
            S   +HRDL   N ++     E+  VK+AD G AR +++     + +     +   + A
Sbjct: 150 ASKKFVHRDLAARNCMLD----EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 205
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
            E L   +  TK+ D+W+ G +  EL+T
Sbjct: 206 LESLQTQKFTTKS-DVWSFGVLLWELMT 232

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 24/208 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G G YG VY+   K  S T   A+K ++   + +    +E A+++E+KHPN++ L+ V
Sbjct: 33  KLGGGQYGEVYEGVWKKYSLT--VAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 90
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLY---QILDGIHY 141
                +   +++ ++  +   +++ + R                  LLY   QI   + Y
Sbjct: 91  --CTREPPFYIITEFMTYG--NLLDYLRECNRQEVNAVV-------LLYMATQISSAMEY 139
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
           L     +HRDL   N LV     E   VK+AD G +RL        A         W  A
Sbjct: 140 LEKKNFIHRDLAARNCLVG----ENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKW-TA 193
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
           PE L   +   K+ D+WA G +  E+ T
Sbjct: 194 PESLAYNKFSIKS-DVWAFGVLLWEIAT 220

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDY----ALKQIEGTGLSMSACREIALLRELKHPNVINLI 82
           +GRG +G VY     DN   + +    +L +I   G       E  ++++  HPNV++L+
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 83  SVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
            + L      + +L      DL + I+                        Q+  G+ YL
Sbjct: 90  GICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGMKYL 141
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPLKPLADLDPVVVTFWYRA 201
            S   +HRDL   N ++     E+  VK+AD G AR +++     + +     +   + A
Sbjct: 142 ASKKFVHRDLAARNCML----DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 197
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
            E L   +  TK+ D+W+ G +  EL+T
Sbjct: 198 LESLQTQKFTTKS-DVWSFGVLLWELMT 224

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDY----ALKQIEGTGLSMSACREIALLRELKHPNVINLI 82
           +GRG +G VY     DN   + +    +L +I   G       E  ++++  HPNV++L+
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 83  SVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
            + L      + +L      DL + I+                        Q+  G+ +L
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGMKFL 149
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPLKPLADLDPVVVTFWYRA 201
            S   +HRDL   N ++     E+  VK+AD G AR +++     + +     +   + A
Sbjct: 150 ASKKFVHRDLAARNCML----DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 205
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
            E L   +  TK+ D+W+ G +  EL+T
Sbjct: 206 LESLQTQKFTTKS-DVWSFGVLLWELMT 232

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 24/208 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G G YG VY+   K  S T   A+K ++   + +    +E A+++E+KHPN++ L+ V
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLT--VAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLY---QILDGIHY 141
                +   +++ ++  +   +++ + R                  LLY   QI   + Y
Sbjct: 83  --CTREPPFYIITEFMTYG--NLLDYLRECNRQEVNAVV-------LLYMATQISSAMEY 131
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
           L     +HRDL   N LV     E   VK+AD G +RL        A         W  A
Sbjct: 132 LEKKNFIHRDLAARNCLVG----ENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKW-TA 185
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
           PE L   +   K+ D+WA G +  E+ T
Sbjct: 186 PESLAYNKFSIKS-DVWAFGVLLWEIAT 212

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 56/115 (48%), Gaps = 14/115 (12%)
Query: 131 LLYQILDGIHYLHSNWVLHRDLKPANIL-VMGEGIERGRVKIADMGFARLFNNPLKPLAD 189
           + YQI   +++LHSN + H DLKP NIL V  +  E    KI      R   NP   + D
Sbjct: 123 MAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD--ERTLINPDIKVVD 180
Query: 190 L----------DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
                        +V T  YRAPE++L A  +++  D+W+IGCI  E      +F
Sbjct: 181 FGSATYDDEHHSTLVSTRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVF 234

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 24/208 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G G YG VY+   K  S T   A+K ++   + +    +E A+++E+KHPN++ L+ V
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLT--VAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLY---QILDGIHY 141
                +   +++ ++  +   +++ + R                  LLY   QI   + Y
Sbjct: 83  --CTREPPFYIITEFMTYG--NLLDYLRECNRQEVNAVV-------LLYMATQISSAMEY 131
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
           L     +HRDL   N LV     E   VK+AD G +RL        A         W  A
Sbjct: 132 LEKKNFIHRDLAARNCLVG----ENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKW-TA 185
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
           PE L   +   K+ D+WA G +  E+ T
Sbjct: 186 PESLAYNKFSIKS-DVWAFGVLLWEIAT 212

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 93/223 (41%), Gaps = 25/223 (11%)
Query: 24  GCKVGRGTYGHVYKAR-----RKDNSDTRDYALKQI--EGTGLSMS-ACREIALLREL-K 74
           G  +G G +G V  A      +    +    A+K +  + T   +S    E+ +++ + K
Sbjct: 27  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 86
Query: 75  HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXX-------XXXXXXX 126
           H N+INL+       D  ++++ +YA   +L   ++  R                     
Sbjct: 87  HKNIINLLGA--CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 144
Query: 127 XXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKP 186
              S  YQ+  G+ YL S   +HRDL   N+LV     E   +KIAD G AR  NN    
Sbjct: 145 DLVSCTYQLARGMEYLASQKCIHRDLTARNVLV----TENNVMKIADFGLARDINNIDYY 200
Query: 187 LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
               +  +   W  APE L   R YT   D+W+ G +  E+ T
Sbjct: 201 KKTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLMWEIFT 241

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 93/223 (41%), Gaps = 25/223 (11%)
Query: 24  GCKVGRGTYGHVYKAR-----RKDNSDTRDYALKQI--EGTGLSMS-ACREIALLREL-K 74
           G  +G G +G V  A      +    +    A+K +  + T   +S    E+ +++ + K
Sbjct: 29  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 88
Query: 75  HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXX-------XXXXXXX 126
           H N+INL+       D  ++++ +YA   +L   ++  R                     
Sbjct: 89  HKNIINLLGA--CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 146
Query: 127 XXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKP 186
              S  YQ+  G+ YL S   +HRDL   N+LV     E   +KIAD G AR  NN    
Sbjct: 147 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLV----TENNVMKIADFGLARDINNIDYY 202
Query: 187 LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
               +  +   W  APE L   R YT   D+W+ G +  E+ T
Sbjct: 203 KKTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLMWEIFT 243

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDY----ALKQIEGTGLSMSACREIALLRELKHPNVINLI 82
           +GRG +G VY     DN   + +    +L +I   G       E  ++++  HPNV++L+
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 83  SVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
            + L      + +L      DL + I+                        Q+  G+ YL
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGMKYL 168
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPLKPLADLDPVVVTFWYRA 201
            S   +HRDL   N ++     E+  VK+AD G AR +++     + +     +   + A
Sbjct: 169 ASKKFVHRDLAARNCML----DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 224
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
            E L   +  TK+ D+W+ G +  EL+T
Sbjct: 225 LESLQTQKFTTKS-DVWSFGVLLWELMT 251

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 93/223 (41%), Gaps = 25/223 (11%)
Query: 24  GCKVGRGTYGHVYKAR-----RKDNSDTRDYALKQI--EGTGLSMS-ACREIALLREL-K 74
           G  +G G +G V  A      +    +    A+K +  + T   +S    E+ +++ + K
Sbjct: 32  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 91
Query: 75  HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXX-------XXXXXXX 126
           H N+INL+       D  ++++ +YA   +L   ++  R                     
Sbjct: 92  HKNIINLLGA--CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 149
Query: 127 XXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKP 186
              S  YQ+  G+ YL S   +HRDL   N+LV     E   +KIAD G AR  NN    
Sbjct: 150 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLV----TENNVMKIADFGLARDINNIDYY 205
Query: 187 LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
               +  +   W  APE L   R YT   D+W+ G +  E+ T
Sbjct: 206 KKTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLMWEIFT 246

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDY----ALKQIEGTGLSMSACREIALLRELKHPNVINLI 82
           +GRG +G VY     DN   + +    +L +I   G       E  ++++  HPNV++L+
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 83  SVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
            + L      + +L      DL + I+                        Q+  G+ +L
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGMKFL 147
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPLKPLADLDPVVVTFWYRA 201
            S   +HRDL   N ++     E+  VK+AD G AR +++     + +     +   + A
Sbjct: 148 ASKKFVHRDLAARNCML----DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 203
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
            E L   +  TK+ D+W+ G +  EL+T
Sbjct: 204 LESLQTQKFTTKS-DVWSFGVLLWELMT 230

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDY----ALKQIEGTGLSMSACREIALLRELKHPNVINLI 82
           +GRG +G VY     DN   + +    +L +I   G       E  ++++  HPNV++L+
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 83  SVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
            + L      + +L      DL + I+                        Q+  G+ +L
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGMKFL 154
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPLKPLADLDPVVVTFWYRA 201
            S   +HRDL   N ++     E+  VK+AD G AR +++     + +     +   + A
Sbjct: 155 ASKKFVHRDLAARNCML----DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 210
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
            E L   +  TK+ D+W+ G +  EL+T
Sbjct: 211 LESLQTQKFTTKS-DVWSFGVLLWELMT 237

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G+G +G V+      N  TR  A+K ++   +S  A  +E  ++++L+H  ++ L +V
Sbjct: 274 KLGQGCFGEVWMGTW--NGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHS 144
               ++  ++++ +Y       ++ F +                  +  QI  G+ Y+  
Sbjct: 331 V---SEEPIYIVTEYMSKG--SLLDFLKGETGKYLRLPQLV----DMAAQIASGMAYVER 381
Query: 145 NWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPEL 204
              +HRDL+ ANILV GE +     K+AD G ARL  +                + APE 
Sbjct: 382 MNYVHRDLRAANILV-GENL---VCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEA 435
Query: 205 LLGARHYTKAIDIWAIGCIFAELLT 229
            L  R   K+ D+W+ G +  EL T
Sbjct: 436 ALYGRFTIKS-DVWSFGILLTELTT 459

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 102/220 (46%), Gaps = 30/220 (13%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-------SMSACREIALLRELKHPNVI 79
           +G+G++G V  AR K  ++   YA+K ++   +        + + R + LL+ +KHP ++
Sbjct: 46  IGKGSFGKVLLARHK--AEEVFYAVKVLQKKAILKKKEEKHIMSERNV-LLKNVKHPFLV 102
Query: 80  NLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            L   F + +  K++ + DY    +L++ ++  R                     +I   
Sbjct: 103 GLHFSFQTAD--KLYFVLDYINGGELFYHLQRERCFLEPRARFYAA---------EIASA 151
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + YLHS  +++RDLKP NIL+  +    G + + D G  +     ++  +       T  
Sbjct: 152 LGYLHSLNIVYRDLKPENILLDSQ----GHIVLTDFGLCK---ENIEHNSTTSTFCGTPE 204
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 238
           Y APE +L  + Y + +D W +G +  E+L   P F+ R 
Sbjct: 205 YLAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 243

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 24/208 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G G YG VY+   K  S T   A+K ++   + +    +E A+++E+KHPN++ L+ V
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLT--VAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLY---QILDGIHY 141
                +   +++ ++  +   +++ + R                  LLY   QI   + Y
Sbjct: 80  --CTREPPFYIITEFMTYG--NLLDYLRECNRQEVNAVV-------LLYMATQISSAMEY 128
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
           L     +HRDL   N LV     E   VK+AD G +RL        A         W  A
Sbjct: 129 LEKKNFIHRDLAARNCLVG----ENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKW-TA 182
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
           PE L   +   K+ D+WA G +  E+ T
Sbjct: 183 PESLAYNKFSIKS-DVWAFGVLLWEIAT 209

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 24/208 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G G YG VY+   K  S T   A+K ++   + +    +E A+++E+KHPN++ L+ V
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLT--VAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLY---QILDGIHY 141
                +   +++ ++  +   +++ + R                  LLY   QI   + Y
Sbjct: 80  --CTREPPFYIITEFMTYG--NLLDYLRECNRQEVNAVV-------LLYMATQISSAMEY 128
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
           L     +HRDL   N LV     E   VK+AD G +RL        A         W  A
Sbjct: 129 LEKKNFIHRDLAARNCLVG----ENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKW-TA 182
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
           PE L   +   K+ D+WA G +  E+ T
Sbjct: 183 PESLAYNKFSIKS-DVWAFGVLLWEIAT 209

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 24/208 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G G YG VY+   K  S T   A+K ++   + +    +E A+++E+KHPN++ L+ V
Sbjct: 24  KLGGGQYGEVYEGVWKKYSLT--VAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLY---QILDGIHY 141
                +   +++ ++  +   +++ + R                  LLY   QI   + Y
Sbjct: 82  --CTREPPFYIITEFMTYG--NLLDYLRECNRQEVNAVV-------LLYMATQISSAMEY 130
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
           L     +HRDL   N LV     E   VK+AD G +RL        A         W  A
Sbjct: 131 LEKKNFIHRDLAARNCLVG----ENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKW-TA 184
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
           PE L   +   K+ D+WA G +  E+ T
Sbjct: 185 PESLAYNKFSIKS-DVWAFGVLLWEIAT 211

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 97/227 (42%), Gaps = 35/227 (15%)
Query: 25  CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACR-EIALLRELKHPNVINLIS 83
            ++G G++G VYK   K + D     LK ++ T     A R E+A+LR+ +H N++    
Sbjct: 42  TRIGSGSFGTVYKG--KWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNIL---- 95
Query: 84  VFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILD------ 137
                      L   Y   D   I+   +  + +              ++Q++D      
Sbjct: 96  -----------LFMGYMTKDNLAIVT--QWCEGSSLYKHLHVQETKFQMFQLIDIARQTA 142
Query: 138 -GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVT 196
            G+ YLH+  ++HRD+K  NI  + EG+    VKI D G A + +          P    
Sbjct: 143 QGMDYLHAKNIIHRDMKSNNIF-LHEGLT---VKIGDFGLATVKSRWSGSQQVEQPTGSV 198
Query: 197 FWYRAPELLLGARH--YTKAIDIWAIGCIFAELLTSE-PIFHCRQED 240
            W  APE++    +  ++   D+++ G +  EL+T E P  H    D
Sbjct: 199 LWM-APEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD 244

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 24/208 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G G YG VY+   K  S T   A+K ++   + +    +E A+++E+KHPN++ L+ V
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLT--VAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLY---QILDGIHY 141
                +   +++ ++  +   +++ + R                  LLY   QI   + Y
Sbjct: 78  --CTREPPFYIITEFMTYG--NLLDYLRECNRQEVNAVV-------LLYMATQISSAMEY 126
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
           L     +HRDL   N LV     E   VK+AD G +RL        A         W  A
Sbjct: 127 LEKKNFIHRDLAARNCLVG----ENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKW-TA 180
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
           PE L   +   K+ D+WA G +  E+ T
Sbjct: 181 PESLAYNKFSIKS-DVWAFGVLLWEIAT 207

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDY----ALKQIEGTGLSMSACREIALLRELKHPNVINLI 82
           +GRG +G VY     DN   + +    +L +I   G       E  ++++  HPNV++L+
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 83  SVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
            + L      + +L      DL + I+                        Q+  G+ +L
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGMKFL 208
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPLKPLADLDPVVVTFWYRA 201
            S   +HRDL   N ++     E+  VK+AD G AR +++     + +     +   + A
Sbjct: 209 ASKKFVHRDLAARNCML----DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 264
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
            E L   +  TK+ D+W+ G +  EL+T
Sbjct: 265 LESLQTQKFTTKS-DVWSFGVLLWELMT 291

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 93/223 (41%), Gaps = 25/223 (11%)
Query: 24  GCKVGRGTYGHVYKAR-----RKDNSDTRDYALKQI--EGTGLSMS-ACREIALLREL-K 74
           G  +G G +G V  A      +    +    A+K +  + T   +S    E+ +++ + K
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 75  HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXX-------XXXXXXX 126
           H N+INL+       D  ++++ +YA   +L   ++  R                     
Sbjct: 146 HKNIINLLGA--CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203
Query: 127 XXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKP 186
              S  YQ+  G+ YL S   +HRDL   N+LV     E   +KIAD G AR  NN    
Sbjct: 204 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLV----TENNVMKIADFGLARDINNIDYY 259
Query: 187 LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
               +  +   W  APE L   R YT   D+W+ G +  E+ T
Sbjct: 260 KKTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLMWEIFT 300

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 90/216 (41%), Gaps = 18/216 (8%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI--EGTGLSMSACREIALLRELKHPNVINLIS 83
           K+G G + +V     +   D   YALK+I          A RE  + R   HPN++ L++
Sbjct: 36  KLGEGGFSYVDLV--EGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVA 93
Query: 84  VFLSHNDRK--VWLLFDYAEHD-LWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
             L     K   WLL  + +   LW+ I+     +               LL  I  G+ 
Sbjct: 94  YCLRERGAKHEAWLLLPFFKRGTLWNEIE-----RLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF---NNPLKPLADLDPVVVTF 197
            +H+    HRDLKP NIL+  EG +   + +  M  A +    +     L D      T 
Sbjct: 149 AIHAKGYAHRDLKPTNILLGDEG-QPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 198 WYRAPELLLGARHYT--KAIDIWAIGCIFAELLTSE 231
            YRAPEL     H    +  D+W++GC+   ++  E
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 24/208 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G G YG VY+   K  S T   A+K ++   + +    +E A+++E+KHPN++ L+ V
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLT--VAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLY---QILDGIHY 141
                +   +++ ++  +   +++ + R                  LLY   QI   + Y
Sbjct: 78  --CTREPPFYIITEFMTYG--NLLDYLRECNRQEVNAVV-------LLYMATQISSAMEY 126
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
           L     +HRDL   N LV     E   VK+AD G +RL               +   + A
Sbjct: 127 LEKKNFIHRDLAARNCLVG----ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTA 180
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
           PE L   +   K+ D+WA G +  E+ T
Sbjct: 181 PESLAYNKFSIKS-DVWAFGVLLWEIAT 207

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 54/105 (51%), Gaps = 7/105 (6%)
Query: 131 LLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADL 190
           ++  I   I +LHS+ + HRD+KP N+L   +  +   +K+ D GFA+           L
Sbjct: 114 IMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKE-KDAVLKLTDFGFAKETTQ-----NAL 167
Query: 191 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
                T +Y APE +LG   Y K+ D+W++G I   LL   P F+
Sbjct: 168 QTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPFY 211

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 55/106 (51%), Gaps = 9/106 (8%)
Query: 131 LLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRV-KIADMGFARLFNNPLKPLAD 189
           ++  I   I +LHS+ + HRD+KP N+L   +  E+  V K+ D GFA+           
Sbjct: 133 IMRDIGTAIQFLHSHNIAHRDVKPENLLYTSK--EKDAVLKLTDFGFAKETTQ-----NA 185
Query: 190 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
           L     T +Y APE +LG   Y K+ D+W++G I   LL   P F+
Sbjct: 186 LQTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPFY 230

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G+G +G V+      N  TR  A+K ++   +S  A  +E  ++++++H  ++ L +V
Sbjct: 25  KLGQGCFGEVWMGTW--NGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKIRHEKLVQLYAV 81
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHS 144
               ++  ++++ +Y       ++ F +                  +  QI  G+ Y+  
Sbjct: 82  V---SEEPIYIVTEYMSKG--SLLDFLKGEMGKYLRLPQLV----DMAAQIASGMAYVER 132
Query: 145 NWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPEL 204
              +HRDL+ ANILV GE +     K+AD G ARL  +                + APE 
Sbjct: 133 MNYVHRDLRAANILV-GENL---VCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEA 186
Query: 205 LLGARHYTKAIDIWAIGCIFAELLT 229
            L  R   K+ D+W+ G +  EL T
Sbjct: 187 ALYGRFTIKS-DVWSFGILLTELTT 210

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 20/205 (9%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G+G +G V+      N  TR  A+K ++   +S  A  +E  ++++L+H  ++ L +V
Sbjct: 25  KLGQGCFGEVWMGTW--NGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHS 144
               ++  ++++ +Y       ++ F +                  +  QI  G+ Y+  
Sbjct: 82  V---SEEPIYIVTEYMSKG--SLLDFLKGEMGKYLRLPQLV----DMAAQIASGMAYVER 132
Query: 145 NWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPEL 204
              +HRDL  ANILV GE +     K+AD G ARL  +                + APE 
Sbjct: 133 MNYVHRDLAAANILV-GENL---VCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEA 186
Query: 205 LLGARHYTKAIDIWAIGCIFAELLT 229
            L  R   K+ D+W+ G +  EL T
Sbjct: 187 ALYGRFTIKS-DVWSFGILLTELTT 210

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 24/208 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G G +G VY+   K  S T   A+K ++   + +    +E A+++E+KHPN++ L+ V
Sbjct: 18  KLGGGQFGEVYEGVWKKYSLT--VAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLY---QILDGIHY 141
                +   +++ ++  +   +++ + R                  LLY   QI   + Y
Sbjct: 76  --CTREPPFYIITEFMTYG--NLLDYLRECNRQEVSAVV-------LLYMATQISSAMEY 124
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
           L     +HRDL   N LV     E   VK+AD G +RL               +   + A
Sbjct: 125 LEKKNFIHRDLAARNCLVG----ENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK--WTA 178
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
           PE L   +   K+ D+WA G +  E+ T
Sbjct: 179 PESLAYNKFSIKS-DVWAFGVLLWEIAT 205

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 20/205 (9%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G+G +G V+      N  TR  A+K ++   +S  A  +E  ++++L+H  ++ L +V
Sbjct: 15  KLGQGCFGEVWMGTW--NGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 71
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHS 144
               ++  + ++ +Y       ++ F +                  +  QI  G+ Y+  
Sbjct: 72  V---SEEPIXIVTEYMSKG--SLLDFLKGETGKYLRLPQLV----DMAAQIASGMAYVER 122
Query: 145 NWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPEL 204
              +HRDL+ ANILV GE +     K+AD G ARL  +                + APE 
Sbjct: 123 MNYVHRDLRAANILV-GENL---VCKVADFGLARLIED--NEXTARQGAKFPIKWTAPEA 176
Query: 205 LLGARHYTKAIDIWAIGCIFAELLT 229
            L  R   K+ D+W+ G +  EL T
Sbjct: 177 ALYGRFTIKS-DVWSFGILLTELTT 200

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 94/217 (43%), Gaps = 29/217 (13%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIALLRELKHPNVINL 81
           ++G+G +  V +  +      ++YA K I    LS        RE  + R LKHPN++ L
Sbjct: 29  ELGKGAFSVVRRCVKVLAG--QEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRL 86
Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHII---KFHRAAKANXXXXXXXXXXXXSLLYQILD 137
                       +L+FD     +L+  I   +++  A A+              + QIL+
Sbjct: 87  HDSISEEGHH--YLIFDLVTGGELFEDIVAREYYSEADAS------------HCIQQILE 132
Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF 197
            + + H   V+HRDLKP N+L +   ++   VK+AD G A       +          T 
Sbjct: 133 AVLHCHQMGVVHRDLKPENLL-LASKLKGAAVKLADFGLAIEVEGEQQAWFGF---AGTP 188
Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
            Y +PE+L     Y K +D+WA G I   LL   P F
Sbjct: 189 GYLSPEVLR-KDPYGKPVDLWACGVILYILLVGYPPF 224

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 55/105 (52%), Gaps = 11/105 (10%)
Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           QI+    YLHS  +++RDLKP N+++     ++G +++ D G A+        L      
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLMI----DQQGYIQVTDFGLAKRVKGRTWXLCG---- 200
Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 238
             T  Y APE++L ++ Y KA+D WA+G +  E+    P F   Q
Sbjct: 201 --TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 93/223 (41%), Gaps = 25/223 (11%)
Query: 24  GCKVGRGTYGHVYKAR-----RKDNSDTRDYALKQI--EGTGLSMS-ACREIALLREL-K 74
           G  +G G +G V  A      +    +    A+K +  + T   +S    E+ +++ + K
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 75  HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXX-------XXXXXXX 126
           H N+INL+       D  ++++ +YA   +L   ++  R                     
Sbjct: 100 HKNIINLLGA--CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 127 XXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKP 186
              S  YQ+  G+ YL S   +HRDL   N+LV     E   ++IAD G AR  NN    
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLV----TENNVMRIADFGLARDINNIDYY 213
Query: 187 LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
               +  +   W  APE L   R YT   D+W+ G +  E+ T
Sbjct: 214 KKTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 92/223 (41%), Gaps = 25/223 (11%)
Query: 24  GCKVGRGTYGHVYKAR-----RKDNSDTRDYALKQI--EGTGLSMS-ACREIALLREL-K 74
           G  +G G +G V  A      +    +    A+K +  + T   +S    E+ +++ + K
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 75  HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXX-------XXXXXXX 126
           H N+INL+       D  ++++  YA   +L   ++  R                     
Sbjct: 100 HKNIINLLGA--CTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 127 XXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKP 186
              S  YQ+  G+ YL S   +HRDL   N+LV     E   +KIAD G AR  NN    
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLV----TENNVMKIADFGLARDINNIDYY 213
Query: 187 LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
               +  +   W  APE L   R YT   D+W+ G +  E+ T
Sbjct: 214 KKTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLMWEIFT 254

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/112 (32%), Positives = 59/112 (52%), Gaps = 14/112 (12%)
Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA---RLFNNPLKPLADL 190
           QI+ G+ +LH   +++RDLKP N+L+     + G V+I+D+G A   +      K  A  
Sbjct: 297 QIVSGLEHLHQRNIIYRDLKPENVLL----DDDGNVRISDLGLAVELKAGQTKTKGYAG- 351
Query: 191 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 242
                T  + APELLLG   Y  ++D +A+G    E++ +   F  R E ++
Sbjct: 352 -----TPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE 397

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 18/208 (8%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDY----ALKQIEGTGLSMSACREIALLRELKHPNVINLI 82
           +GRG +G VY     DN   + +    +L +I   G       E  ++++  HPNV++L+
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 83  SVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
            + L      + +L      DL + I+                        Q+  G+ +L
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGMKFL 150
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPLKPLADLDPVVVTFWYRA 201
            S   +HRDL   N ++     E+  VK+AD G AR + +     + +     +   + A
Sbjct: 151 ASKKFVHRDLAARNCML----DEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMA 206
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
            E L   +  TK+ D+W+ G +  EL+T
Sbjct: 207 LESLQTQKFTTKS-DVWSFGVLLWELMT 233

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 51/101 (50%), Gaps = 6/101 (5%)
Query: 135 ILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVV 194
           I + I YLHS  + HRD+KP N+L   +      +K+ D GFA+   +       L    
Sbjct: 170 IGEAIQYLHSINIAHRDVKPENLLYTSKR-PNAILKLTDFGFAKETTS----HNSLTTPC 224
Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
            T +Y APE +LG   Y K+ D W++G I   LL   P F+
Sbjct: 225 YTPYYVAPE-VLGPEKYDKSCDXWSLGVIXYILLCGYPPFY 264

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/112 (32%), Positives = 59/112 (52%), Gaps = 14/112 (12%)
Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA---RLFNNPLKPLADL 190
           QI+ G+ +LH   +++RDLKP N+L+     + G V+I+D+G A   +      K  A  
Sbjct: 297 QIVSGLEHLHQRNIIYRDLKPENVLL----DDDGNVRISDLGLAVELKAGQTKTKGYAG- 351
Query: 191 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 242
                T  + APELLLG   Y  ++D +A+G    E++ +   F  R E ++
Sbjct: 352 -----TPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE 397

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/112 (32%), Positives = 59/112 (52%), Gaps = 14/112 (12%)
Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA---RLFNNPLKPLADL 190
           QI+ G+ +LH   +++RDLKP N+L+     + G V+I+D+G A   +      K  A  
Sbjct: 297 QIVSGLEHLHQRNIIYRDLKPENVLL----DDDGNVRISDLGLAVELKAGQTKTKGYAG- 351
Query: 191 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 242
                T  + APELLLG   Y  ++D +A+G    E++ +   F  R E ++
Sbjct: 352 -----TPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE 397

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/112 (32%), Positives = 59/112 (52%), Gaps = 14/112 (12%)
Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA---RLFNNPLKPLADL 190
           QI+ G+ +LH   +++RDLKP N+L+     + G V+I+D+G A   +      K  A  
Sbjct: 297 QIVSGLEHLHQRNIIYRDLKPENVLL----DDDGNVRISDLGLAVELKAGQTKTKGYAG- 351
Query: 191 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 242
                T  + APELLLG   Y  ++D +A+G    E++ +   F  R E ++
Sbjct: 352 -----TPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE 397

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 92/223 (41%), Gaps = 25/223 (11%)
Query: 24  GCKVGRGTYGHVYKAR-----RKDNSDTRDYALKQI--EGTGLSMS-ACREIALLREL-K 74
           G  +G G +G V  A      +    +    A+K +  + T   +S    E+ +++ + K
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 75  HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXX-------XXXXXXX 126
           H N+INL+       D  ++++  YA   +L   ++  R                     
Sbjct: 100 HKNIINLLGA--CTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 127 XXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKP 186
              S  YQ+  G+ YL S   +HRDL   N+LV     E   +KIAD G AR  NN    
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLV----TENNVMKIADFGLARDINNIDYY 213
Query: 187 LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
               +  +   W  APE L   R YT   D+W+ G +  E+ T
Sbjct: 214 KKTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 20/205 (9%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G+G +G V+      N  TR  A+K ++   +S  A  +E  ++++L+H  ++ L +V
Sbjct: 192 KLGQGCFGEVWMGTW--NGTTR-VAIKTLKPGNMSPEAFLQEAQVMKKLRHEKLVQLYAV 248
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHS 144
               ++  ++++ +Y       ++ F +                  +  QI  G+ Y+  
Sbjct: 249 V---SEEPIYIVTEYMSKG--SLLDFLKGEMGKYLRLPQLV----DMAAQIASGMAYVER 299
Query: 145 NWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPEL 204
              +HRDL+ ANILV GE +     K+AD G  RL  +                + APE 
Sbjct: 300 MNYVHRDLRAANILV-GENL---VCKVADFGLGRLIED--NEYTARQGAKFPIKWTAPEA 353
Query: 205 LLGARHYTKAIDIWAIGCIFAELLT 229
            L  R   K+ D+W+ G +  EL T
Sbjct: 354 ALYGRFTIKS-DVWSFGILLTELTT 377

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 91/225 (40%), Gaps = 29/225 (12%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIA-----LLRELKHPNVINL 81
           +G G +G V KAR K +    D A+K+++    S    R+ A     L +   HPN+INL
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAK----------ANXXXXXXXXXXXXSL 131
           +      +   ++L  +YA H   +++ F R ++          AN              
Sbjct: 92  LGA--CEHRGYLYLAIEYAPHG--NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147
Query: 132 LYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLD 191
              +  G+ YL     +HRDL   NILV     E    KIAD G +R     +K      
Sbjct: 148 AADVARGMDYLSQKQFIHRDLAARNILVG----ENYVAKIADFGLSRGQEVYVKKTMGRL 203
Query: 192 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 236
           PV    W     L      YT   D+W+ G +  E+++     +C
Sbjct: 204 PVR---WMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYC 243

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 91/225 (40%), Gaps = 29/225 (12%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIA-----LLRELKHPNVINL 81
           +G G +G V KAR K +    D A+K+++    S    R+ A     L +   HPN+INL
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINL 81
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAK----------ANXXXXXXXXXXXXSL 131
           +      +   ++L  +YA H   +++ F R ++          AN              
Sbjct: 82  LGA--CEHRGYLYLAIEYAPHG--NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 137
Query: 132 LYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLD 191
              +  G+ YL     +HRDL   NILV     E    KIAD G +R     +K      
Sbjct: 138 AADVARGMDYLSQKQFIHRDLAARNILVG----ENYVAKIADFGLSRGQEVYVKKTMGRL 193
Query: 192 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 236
           PV    W     L      YT   D+W+ G +  E+++     +C
Sbjct: 194 PVR---WMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYC 233

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 87/205 (42%), Gaps = 24/205 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIE-GTGLSMSACREIALLRELKHPNVINLISV 84
           ++G G  G V K + + +       L  +E    +     RE+ +L E   P ++     
Sbjct: 23  ELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 82
Query: 85  FLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL- 142
           F S  +  + +     EH D   + +  + AK               +   +L G+ YL 
Sbjct: 83  FYSDGEISICM-----EHMDGGSLDQVLKEAK------RIPEEILGKVSIAVLRGLAYLR 131
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAP 202
             + ++HRD+KP+NILV      RG +K+ D G +    + +      +  V T  Y AP
Sbjct: 132 EKHQIMHRDVKPSNILVN----SRGEIKLCDFGVSGQLIDSMA-----NSFVGTRSYMAP 182
Query: 203 ELLLGARHYTKAIDIWAIGCIFAEL 227
           E L G  HY+   DIW++G    EL
Sbjct: 183 ERLQGT-HYSVQSDIWSMGLSLVEL 206

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 94/224 (41%), Gaps = 27/224 (12%)
Query: 24  GCKVGRGTYGHVYKA------RRKDNSDTRDYALKQIEGTGLSMSACREIALLRELK--- 74
           G  +G G +G V  A      + K N  T+  A+K ++           I+ +  +K   
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTK-VAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 75  -HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAA-------KANXXXXXXXX 125
            H N+INL+       D  ++++ +YA   +L   ++  R          ++        
Sbjct: 92  KHKNIINLLGA--CTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSS 149
Query: 126 XXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLK 185
               S  YQ+  G+ YL S   +HRDL   N+LV  + +    +KIAD G AR  ++   
Sbjct: 150 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV----MKIADFGLARDIHHIDX 205
Query: 186 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                +  +   W  APE L   R YT   D+W+ G +  E+ T
Sbjct: 206 XKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFGVLLWEIFT 247

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/234 (22%), Positives = 100/234 (42%), Gaps = 23/234 (9%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           ++G G +G V+      ++     +LKQ  G+    +   E  L+++L+H  ++ L +V 
Sbjct: 26  RLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 83
Query: 86  LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSN 145
                  ++++ +Y E+    ++ F +                  +  QI +G+ ++   
Sbjct: 84  ---TQEPIYIITEYMENG--SLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEER 134
Query: 146 WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELL 205
             +HRDL+ ANILV     +    KIAD G ARL  +        +       + APE  
Sbjct: 135 NYIHRDLRAANILVS----DTLSCKIADFGLARLIED--NEXTAREGAKFPIKWTAPE-A 187
Query: 206 LGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVM 259
           +    +T   D+W+ G +  E++T     H R      +NP     L+R + ++
Sbjct: 188 INYGTFTIKSDVWSFGILLTEIVT-----HGRIPYPGMTNPEVIQNLERGYRMV 236

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/234 (22%), Positives = 100/234 (42%), Gaps = 23/234 (9%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           ++G G +G V+      ++     +LKQ  G+    +   E  L+++L+H  ++ L +V 
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 86  LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSN 145
                  ++++ +Y E+    ++ F +                  +  QI +G+ ++   
Sbjct: 78  ---TQEPIYIITEYMENG--SLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEER 128
Query: 146 WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELL 205
             +HRDL+ ANILV     +    KIAD G ARL  +        +       + APE  
Sbjct: 129 NYIHRDLRAANILVS----DTLSCKIADFGLARLIED--NEXTAREGAKFPIKWTAPE-A 181
Query: 206 LGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVM 259
           +    +T   D+W+ G +  E++T     H R      +NP     L+R + ++
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVT-----HGRIPYPGMTNPEVIQNLERGYRMV 230

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 90/208 (43%), Gaps = 19/208 (9%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDY--ALKQIEGTGLS---MSACREIALLRELKHPNVINL 81
           +G G +G VYK   K +S  ++   A+K ++        +    E  ++ +  H N+I L
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
             V   +  + + ++ +Y E+    + KF R                  +L  I  G+ Y
Sbjct: 112 EGVISKY--KPMMIITEYMENG--ALDKFLREKDGEFSVLQLV-----GMLRGIAAGMKY 162
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
           L +   +HRDL   NILV    +     K++D G +R+  +  +         +   + A
Sbjct: 163 LANMNYVHRDLAARNILVNSNLV----CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 218
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
           PE  +  R +T A D+W+ G +  E++T
Sbjct: 219 PE-AISYRKFTSASDVWSFGIVMWEVMT 245

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 54/109 (49%), Gaps = 14/109 (12%)
Query: 131 LLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFN--------- 181
           +  QI + + +LHS  ++HRDLKP+NI    + +    VK+ D G     +         
Sbjct: 169 IFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV----VKVGDFGLVTAMDQDEEEQTVL 224
Query: 182 NPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 230
            P+   A     V T  Y +PE + G  +Y+  +DI+++G I  ELL S
Sbjct: 225 TPMPAYATHXGQVGTKLYMSPEQIHG-NNYSHKVDIFSLGLILFELLYS 272

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/234 (22%), Positives = 100/234 (42%), Gaps = 23/234 (9%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           ++G G +G V+      ++     +LKQ  G+    +   E  L+++L+H  ++ L +V 
Sbjct: 29  RLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 86
Query: 86  LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSN 145
                  ++++ +Y E+    ++ F +                  +  QI +G+ ++   
Sbjct: 87  ---TQEPIYIITEYMENG--SLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEER 137
Query: 146 WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELL 205
             +HRDL+ ANILV     +    KIAD G ARL  +        +       + APE  
Sbjct: 138 NYIHRDLRAANILVS----DTLSCKIADFGLARLIED--NEXTAREGAKFPIKWTAPE-A 190
Query: 206 LGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVM 259
           +    +T   D+W+ G +  E++T     H R      +NP     L+R + ++
Sbjct: 191 INYGTFTIKSDVWSFGILLTEIVT-----HGRIPYPGMTNPEVIQNLERGYRMV 239

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/234 (22%), Positives = 100/234 (42%), Gaps = 23/234 (9%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           ++G G +G V+      ++     +LKQ  G+    +   E  L+++L+H  ++ L +V 
Sbjct: 28  RLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 85
Query: 86  LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSN 145
                  ++++ +Y E+    ++ F +                  +  QI +G+ ++   
Sbjct: 86  ---TQEPIYIITEYMENG--SLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEER 136
Query: 146 WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELL 205
             +HRDL+ ANILV     +    KIAD G ARL  +        +       + APE  
Sbjct: 137 NYIHRDLRAANILVS----DTLSCKIADFGLARLIED--NEXTAREGAKFPIKWTAPE-A 189
Query: 206 LGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVM 259
           +    +T   D+W+ G +  E++T     H R      +NP     L+R + ++
Sbjct: 190 INYGTFTIKSDVWSFGILLTEIVT-----HGRIPYPGMTNPEVIQNLERGYRMV 238

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 92/223 (41%), Gaps = 25/223 (11%)
Query: 24  GCKVGRGTYGHVYKAR-----RKDNSDTRDYALKQI--EGTGLSMS-ACREIALLREL-K 74
           G  +G G +G V  A      +    +    A+K +  + T   +S    E+ +++ + K
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 75  HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXX-------XXXXXXX 126
           H N+I L+       D  ++++ +YA   +L   ++  R                     
Sbjct: 100 HKNIITLLGA--CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 127 XXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKP 186
              S  YQ+  G+ YL S   +HRDL   N+LV     E   +KIAD G AR  NN    
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLV----TENNVMKIADFGLARDINNIDYY 213
Query: 187 LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
               +  +   W  APE L   R YT   D+W+ G +  E+ T
Sbjct: 214 KKTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLMWEIFT 254

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 94/223 (42%), Gaps = 24/223 (10%)
Query: 27  VGRGTYGHVYKARRKDNSDTR-DYALKQIEGTGLSMSACR----EIALLRELKHPNVINL 81
           VG G +G V   R K  S      A+K ++  G +    R    E +++ +  HPN+I L
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
             V      + V ++ +Y E+  L   ++ H A                 +L  I  G+ 
Sbjct: 112 EGVVT--KSKPVMIVTEYMENGSLDSFLRKHDA--------QFTVIQLVGMLRGIASGMK 161
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL     +HRDL   NIL+    +     K++D G AR+  +  +         +   + 
Sbjct: 162 YLSDMGYVHRDLAARNILINSNLV----CKVSDFGLARVLEDDPEAAYTTRGGKIPIRWT 217
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT--SEPIFHCRQEDI 241
           +PE  +  R +T A D+W+ G +  E+++    P +    +D+
Sbjct: 218 SPE-AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 259

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 99/223 (44%), Gaps = 27/223 (12%)
Query: 11  NERTKVEDLFDYEGCKV---GRGTYGHVYKARRKDNSDTRDYALKQIE-GTGLSMSACRE 66
            ++ KV +L D +  K+   G G  G V+K   K +       L  +E    +     RE
Sbjct: 57  TQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRE 116
Query: 67  IALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXX 125
           + +L E   P ++     F  ++D ++ +  ++ +   L  ++K  +A +          
Sbjct: 117 LQVLHECNSPYIVGFYGAF--YSDGEISICMEHMDGGSLDQVLK--KAGR-------IPE 165
Query: 126 XXXXSLLYQILDGIHYL-HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPL 184
                +   ++ G+ YL   + ++HRD+KP+NILV      RG +K+ D G +    + +
Sbjct: 166 QILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN----SRGEIKLCDFGVSGQLIDSM 221
Query: 185 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 227
                 +  V T  Y +PE L G  HY+   DIW++G    E+
Sbjct: 222 A-----NSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEM 258

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 98/223 (43%), Gaps = 27/223 (12%)
Query: 11  NERTKVEDLFDYEGCKV---GRGTYGHVYKARRKDNSDTRDYALKQIE-GTGLSMSACRE 66
            ++ KV +L D +  K+   G G  G V+K   K +       L  +E    +     RE
Sbjct: 22  TQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRE 81
Query: 67  IALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXX 125
           + +L E   P ++     F  ++D ++ +  ++ +   L  ++K     KA         
Sbjct: 82  LQVLHECNSPYIVGFYGAF--YSDGEISICMEHMDGGSLDQVLK-----KAGRIPEQILG 134
Query: 126 XXXXSLLYQILDGIHYL-HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPL 184
               +    ++ G+ YL   + ++HRD+KP+NILV      RG +K+ D G +    + +
Sbjct: 135 KVSIA----VIKGLTYLREKHKIMHRDVKPSNILVN----SRGEIKLCDFGVSGQLIDSM 186
Query: 185 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 227
                 +  V T  Y +PE L G  HY+   DIW++G    E+
Sbjct: 187 A-----NSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEM 223

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/234 (22%), Positives = 100/234 (42%), Gaps = 23/234 (9%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           ++G G +G V+      ++     +LKQ  G+    +   E  L+++L+H  ++ L +V 
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 86  LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSN 145
                  ++++ +Y E+    ++ F +                  +  QI +G+ ++   
Sbjct: 78  ---TQEPIYIITEYMENG--SLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEER 128
Query: 146 WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELL 205
             +HRDL+ ANILV     +    KIAD G ARL  +        +       + APE  
Sbjct: 129 NYIHRDLRAANILVS----DTLSCKIADFGLARLIED--NEXTAREGAKFPIKWTAPE-A 181
Query: 206 LGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVM 259
           +    +T   D+W+ G +  E++T     H R      +NP     L+R + ++
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVT-----HGRIPYPGMTNPEVIQNLERGYRMV 230

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/234 (22%), Positives = 100/234 (42%), Gaps = 23/234 (9%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           ++G G +G V+      ++     +LKQ  G+    +   E  L+++L+H  ++ L +V 
Sbjct: 22  RLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 79
Query: 86  LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSN 145
                  ++++ +Y E+    ++ F +                  +  QI +G+ ++   
Sbjct: 80  ---TQEPIYIITEYMENG--SLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEER 130
Query: 146 WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELL 205
             +HRDL+ ANILV     +    KIAD G ARL  +        +       + APE  
Sbjct: 131 NYIHRDLRAANILVS----DTLSCKIADFGLARLIED--NEXTAREGAKFPIKWTAPE-A 183
Query: 206 LGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVM 259
           +    +T   D+W+ G +  E++T     H R      +NP     L+R + ++
Sbjct: 184 INYGTFTIKSDVWSFGILLTEIVT-----HGRIPYPGMTNPEVIQNLERGYRMV 232

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/234 (22%), Positives = 100/234 (42%), Gaps = 23/234 (9%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           ++G G +G V+      ++     +LKQ  G+    +   E  L+++L+H  ++ L +V 
Sbjct: 25  RLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 82
Query: 86  LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSN 145
                  ++++ +Y E+    ++ F +                  +  QI +G+ ++   
Sbjct: 83  ---TQEPIYIITEYMENG--SLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEER 133
Query: 146 WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELL 205
             +HRDL+ ANILV     +    KIAD G ARL  +        +       + APE  
Sbjct: 134 NYIHRDLRAANILVS----DTLSCKIADFGLARLIED--NEYTAREGAKFPIKWTAPE-A 186
Query: 206 LGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVM 259
           +    +T   D+W+ G +  E++T     H R      +NP     L+R + ++
Sbjct: 187 INYGTFTIKSDVWSFGILLTEIVT-----HGRIPYPGMTNPEVIQNLERGYRMV 235

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/234 (22%), Positives = 100/234 (42%), Gaps = 23/234 (9%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           ++G G +G V+      ++     +LKQ  G+    +   E  L+++L+H  ++ L +V 
Sbjct: 21  RLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 78
Query: 86  LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSN 145
                  ++++ +Y E+    ++ F +                  +  QI +G+ ++   
Sbjct: 79  ---TQEPIYIITEYMENG--SLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEER 129
Query: 146 WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELL 205
             +HRDL+ ANILV     +    KIAD G ARL  +        +       + APE  
Sbjct: 130 NYIHRDLRAANILVS----DTLSCKIADFGLARLIED--NEXTAREGAKFPIKWTAPE-A 182
Query: 206 LGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVM 259
           +    +T   D+W+ G +  E++T     H R      +NP     L+R + ++
Sbjct: 183 INYGTFTIKSDVWSFGILLTEIVT-----HGRIPYPGMTNPEVIQNLERGYRMV 231

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/234 (22%), Positives = 100/234 (42%), Gaps = 23/234 (9%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           ++G G +G V+      ++     +LKQ  G+    +   E  L+++L+H  ++ L +V 
Sbjct: 30  RLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 87
Query: 86  LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSN 145
                  ++++ +Y E+    ++ F +                  +  QI +G+ ++   
Sbjct: 88  ---TQEPIYIITEYMENG--SLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEER 138
Query: 146 WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELL 205
             +HRDL+ ANILV     +    KIAD G ARL  +        +       + APE  
Sbjct: 139 NYIHRDLRAANILVS----DTLSCKIADFGLARLIED--NEYTAREGAKFPIKWTAPE-A 191
Query: 206 LGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVM 259
           +    +T   D+W+ G +  E++T     H R      +NP     L+R + ++
Sbjct: 192 INYGTFTIKSDVWSFGILLTEIVT-----HGRIPYPGMTNPEVIQNLERGYRMV 240

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/234 (22%), Positives = 100/234 (42%), Gaps = 23/234 (9%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           ++G G +G V+      ++     +LKQ  G+    +   E  L+++L+H  ++ L +V 
Sbjct: 26  RLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 83
Query: 86  LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSN 145
                  ++++ +Y E+    ++ F +                  +  QI +G+ ++   
Sbjct: 84  ---TQEPIYIITEYMENG--SLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEER 134
Query: 146 WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELL 205
             +HRDL+ ANILV     +    KIAD G ARL  +        +       + APE  
Sbjct: 135 NYIHRDLRAANILVS----DTLSCKIADFGLARLIED--NEYTAREGAKFPIKWTAPE-A 187
Query: 206 LGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVM 259
           +    +T   D+W+ G +  E++T     H R      +NP     L+R + ++
Sbjct: 188 INYGTFTIKSDVWSFGILLTEIVT-----HGRIPYPGMTNPEVIQNLERGYRMV 236

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 55/115 (47%), Gaps = 14/115 (12%)
Query: 131 LLYQILDGIHYLHSNWVLHRDLKPANIL-VMGEGIERGRVKIADMGFARLFNNPLKPLAD 189
           + YQI   +++LHSN + H DLKP NIL V  +  E    KI      R   NP   + D
Sbjct: 123 MAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD--ERTLINPDIKVVD 180
Query: 190 L----------DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
                        +V    YRAPE++L A  +++  D+W+IGCI  E      +F
Sbjct: 181 FGSATYDDEHHSTLVXXRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVF 234

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/234 (22%), Positives = 100/234 (42%), Gaps = 23/234 (9%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           ++G G +G V+      ++     +LKQ  G+    +   E  L+++L+H  ++ L +V 
Sbjct: 15  RLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 72
Query: 86  LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSN 145
                  ++++ +Y E+    ++ F +                  +  QI +G+ ++   
Sbjct: 73  ---TQEPIYIITEYMENG--SLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEER 123
Query: 146 WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELL 205
             +HRDL+ ANILV     +    KIAD G ARL  +        +       + APE  
Sbjct: 124 NYIHRDLRAANILVS----DTLSCKIADFGLARLIED--NEYTAREGAKFPIKWTAPE-A 176
Query: 206 LGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVM 259
           +    +T   D+W+ G +  E++T     H R      +NP     L+R + ++
Sbjct: 177 INYGTFTIKSDVWSFGILLTEIVT-----HGRIPYPGMTNPEVIQNLERGYRMV 225

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 93/223 (41%), Gaps = 25/223 (11%)
Query: 24  GCKVGRGTYGHVYKAR-----RKDNSDTRDYALKQI--EGTGLSMS-ACREIALLREL-K 74
           G  +G G +G V  A      +    +    A+K +  + T   +S    E+ +++ + K
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 75  HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXX-------XXXXXXX 126
           H N+I+L+       D  ++++ +YA   +L   ++  R                     
Sbjct: 100 HKNIIHLLGA--CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 127 XXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKP 186
              S  YQ+  G+ YL S   +HRDL   N+LV     E   +KIAD G AR  NN    
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLV----TENNVMKIADFGLARDINNIDYY 213
Query: 187 LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
               +  +   W  APE L   R YT   D+W+ G +  E+ T
Sbjct: 214 KKTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLMWEIFT 254

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/234 (22%), Positives = 100/234 (42%), Gaps = 23/234 (9%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           ++G G +G V+      ++     +LKQ  G+    +   E  L+++L+H  ++ L +V 
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 86  LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSN 145
                  ++++ +Y E+    ++ F +                  +  QI +G+ ++   
Sbjct: 78  ---TQEPIYIITEYMENG--SLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEER 128
Query: 146 WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELL 205
             +HRDL+ ANILV     +    KIAD G ARL  +        +       + APE  
Sbjct: 129 NYIHRDLRAANILVS----DTLSCKIADFGLARLIED--NEYTAREGAKFPIKWTAPE-A 181
Query: 206 LGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVM 259
           +    +T   D+W+ G +  E++T     H R      +NP     L+R + ++
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVT-----HGRIPYPGMTNPEVIQNLERGYRMV 230

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 96/206 (46%), Gaps = 23/206 (11%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFL 86
           +GRG +G V++     +  T      +++GT   +   +EI++L   +H N+++L   F 
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL-VKKEISILNIARHRNILHLHESFE 71
Query: 87  SHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSN 145
           S  +  + ++F++    D++         + N            S ++Q+ + + +LHS+
Sbjct: 72  SMEE--LVMIFEFISGLDIFE--------RINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 146 WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELL 205
            + H D++P NI+          +KI + G AR     LKP  +   +     Y APE+ 
Sbjct: 122 NIGHFDIRPENIIYQTR--RSSTIKIIEFGQAR----QLKPGDNFRLLFTAPEYYAPEV- 174
Query: 206 LGARH--YTKAIDIWAIGCIFAELLT 229
              +H   + A D+W++G +   LL+
Sbjct: 175 --HQHDVVSTATDMWSLGTLVYVLLS 198

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 98/223 (43%), Gaps = 27/223 (12%)
Query: 11  NERTKVEDLFDYEGCKV---GRGTYGHVYKARRKDNSDTRDYALKQIE-GTGLSMSACRE 66
            ++ KV +L D +  K+   G G  G V+K   K +       L  +E    +     RE
Sbjct: 14  TQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRE 73
Query: 67  IALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXX 125
           + +L E   P ++     F  ++D ++ +  ++ +   L  ++K     KA         
Sbjct: 74  LQVLHECNSPYIVGFYGAF--YSDGEISICMEHMDGGSLDQVLK-----KAGRIPEQILG 126
Query: 126 XXXXSLLYQILDGIHYL-HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPL 184
               +    ++ G+ YL   + ++HRD+KP+NILV      RG +K+ D G +    + +
Sbjct: 127 KVSIA----VIKGLTYLREKHKIMHRDVKPSNILVN----SRGEIKLCDFGVSGQLIDSM 178
Query: 185 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 227
                 +  V T  Y +PE L G  HY+   DIW++G    E+
Sbjct: 179 A-----NSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEM 215

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 94/228 (41%), Gaps = 31/228 (13%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL--------SMSACREIALLRELK- 74
           G  +G+G +G V+   R   +D    A+K I    +        S++   E+ALL ++  
Sbjct: 36  GPLLGKGGFGTVFAGHRL--TDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGA 93
Query: 75  ---HPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSL 131
              HP VI L+  F +     + L       DL+  I                       
Sbjct: 94  GGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSR---------CF 144
Query: 132 LYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLD 191
             Q++  I + HS  V+HRD+K  NIL+    + RG  K+ D G   L ++  +P  D D
Sbjct: 145 FGQVVAAIQHCHSRGVVHRDIKDENILI---DLRRGCAKLIDFGSGALLHD--EPYTDFD 199
Query: 192 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
              V   Y  PE +   +++     +W++G +  +++  +  F   QE
Sbjct: 200 GTRV---YSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE 244

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 24/208 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G G YG VY    K  S T   A+K ++   + +    +E A+++E+KHPN++ L+ V
Sbjct: 39  KLGGGQYGEVYVGVWKKYSLT--VAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 96
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLY---QILDGIHY 141
                +   +++ +Y  +   +++ + R                  LLY   QI   + Y
Sbjct: 97  --CTLEPPFYIVTEYMPYG--NLLDYLRECNREEVTAVV-------LLYMATQISSAMEY 145
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
           L     +HRDL   N LV     E   VK+AD G +RL        A         W  A
Sbjct: 146 LEKKNFIHRDLAARNCLVG----ENHVVKVADFGLSRLMTGDTY-TAHAGAKFPIKW-TA 199
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
           PE  L    ++   D+WA G +  E+ T
Sbjct: 200 PE-SLAYNTFSIKSDVWAFGVLLWEIAT 226

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 24/208 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G G YG VY+   K  S T   A+K ++   + +    +E A+++E+KHPN++ L+ V
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLT--VAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLY---QILDGIHY 141
                +   +++ ++  +   +++ + R                  LLY   QI   + Y
Sbjct: 285 --CTREPPFYIITEFMTYG--NLLDYLRECNRQEVSAVV-------LLYMATQISSAMEY 333
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
           L     +HR+L   N LV     E   VK+AD G +RL        A         W  A
Sbjct: 334 LEKKNFIHRNLAARNCLVG----ENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKW-TA 387
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
           PE L   +   K+ D+WA G +  E+ T
Sbjct: 388 PESLAYNKFSIKS-DVWAFGVLLWEIAT 414

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 34/206 (16%)
Query: 60  SMSACREIALLRELKH--PNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKAN 117
           SM A   + LL    H  PN ++++ VF    +  + L+  Y EH    +I   + +K  
Sbjct: 82  SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKY-EHRGIPLIYVKQISK-- 138
Query: 118 XXXXXXXXXXXXSLLYQILDGIHYLHSN-WVLHRDLKPANIL--VMGEGIERGRVKIADM 174
                           Q+L G+ Y+H    ++H D+KP N+L  ++       ++KIAD+
Sbjct: 139 ----------------QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADL 182
Query: 175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           G A  ++            + T  YR+PE+LLGA  +    DIW+  C+  EL+T + +F
Sbjct: 183 GNACWYDE------HYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLF 235
Query: 235 HCRQEDIKTSNPYHHDQLDRIFSVMG 260
              + D   S     D + +I  ++G
Sbjct: 236 ---EPDEGHSYTKDDDHIAQIIELLG 258

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 94/223 (42%), Gaps = 24/223 (10%)
Query: 27  VGRGTYGHVYKARRKDNSDTR-DYALKQIEGTGLSMSACR----EIALLRELKHPNVINL 81
           VG G +G V   R K  S      A+K ++  G +    R    E +++ +  HPN+I L
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
             V      + V ++ +Y E+  L   ++ H A                 +L  I  G+ 
Sbjct: 112 EGVVT--KSKPVMIVTEYMENGSLDSFLRKHDA--------QFTVIQLVGMLRGIASGMK 161
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL     +HRDL   NIL+    +     K++D G +R+  +  +         +   + 
Sbjct: 162 YLSDMGFVHRDLAARNILINSNLV----CKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT--SEPIFHCRQEDI 241
           +PE  +  R +T A D+W+ G +  E+++    P +    +D+
Sbjct: 218 SPE-AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 259

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 34/206 (16%)
Query: 60  SMSACREIALLRELKH--PNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKAN 117
           SM A   + LL    H  PN ++++ VF    +  + L+  Y EH    +I   + +K  
Sbjct: 82  SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKY-EHRGIPLIYVKQISK-- 138
Query: 118 XXXXXXXXXXXXSLLYQILDGIHYLHSN-WVLHRDLKPANIL--VMGEGIERGRVKIADM 174
                           Q+L G+ Y+H    ++H D+KP N+L  ++       ++KIAD+
Sbjct: 139 ----------------QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADL 182
Query: 175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           G A  ++            + T  YR+PE+LLGA  +    DIW+  C+  EL+T + +F
Sbjct: 183 GNACWYDE------HYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLF 235
Query: 235 HCRQEDIKTSNPYHHDQLDRIFSVMG 260
              + D   S     D + +I  ++G
Sbjct: 236 ---EPDEGHSYTKDDDHIAQIIELLG 258

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 91/205 (44%), Gaps = 24/205 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIE-GTGLSMSACREIALLRELKHPNVINLISV 84
           ++G G  G V+K   K +       L  +E    +     RE+ +L E   P ++     
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 85  FLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL- 142
           F  ++D ++ +  ++ +   L  ++K  +A +               +   ++ G+ YL 
Sbjct: 73  F--YSDGEISICMEHMDGGSLDQVLK--KAGR-------IPEQILGKVSIAVIKGLTYLR 121
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAP 202
             + ++HRD+KP+NILV      RG +K+ D G +    + +      +  V T  Y +P
Sbjct: 122 EKHKIMHRDVKPSNILVN----SRGEIKLCDFGVSGQLIDSMA-----NSFVGTRSYMSP 172
Query: 203 ELLLGARHYTKAIDIWAIGCIFAEL 227
           E L G  HY+   DIW++G    E+
Sbjct: 173 ERLQGT-HYSVQSDIWSMGLSLVEM 196

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 90/216 (41%), Gaps = 29/216 (13%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIALLRELKHPNVINLI 82
           +G+G +  V +  +       +YA K I    LS        RE  + R LKH N++ L 
Sbjct: 12  IGKGAFSVVRRCVKL--CTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLH 69
Query: 83  SVFLSHNDRKVWLLFDYAEH-DLWHII---KFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
                      +L+FD     +L+  I   +++  A A+              + QIL+ 
Sbjct: 70  DSISEEGFH--YLVFDLVTGGELFEDIVAREYYSEADAS------------HCIQQILEA 115
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + + H   V+HRDLKP N+L +    +   VK+AD G A       +          T  
Sbjct: 116 VLHCHQMGVVHRDLKPENLL-LASKCKGAAVKLADFGLAIEVQGDQQAWFGF---AGTPG 171
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           Y +PE+L     Y K +DIWA G I   LL   P F
Sbjct: 172 YLSPEVLR-KEAYGKPVDIWACGVILYILLVGYPPF 206

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 91/205 (44%), Gaps = 24/205 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIE-GTGLSMSACREIALLRELKHPNVINLISV 84
           ++G G  G V+K   K +       L  +E    +     RE+ +L E   P ++     
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 85  FLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL- 142
           F  ++D ++ +  ++ +   L  ++K  +A +               +   ++ G+ YL 
Sbjct: 73  F--YSDGEISICMEHMDGGSLDQVLK--KAGR-------IPEQILGKVSIAVIKGLTYLR 121
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAP 202
             + ++HRD+KP+NILV      RG +K+ D G +    + +      +  V T  Y +P
Sbjct: 122 EKHKIMHRDVKPSNILVN----SRGEIKLCDFGVSGQLIDSMA-----NSFVGTRSYMSP 172
Query: 203 ELLLGARHYTKAIDIWAIGCIFAEL 227
           E L G  HY+   DIW++G    E+
Sbjct: 173 ERLQGT-HYSVQSDIWSMGLSLVEM 196

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 91/205 (44%), Gaps = 24/205 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIE-GTGLSMSACREIALLRELKHPNVINLISV 84
           ++G G  G V+K   K +       L  +E    +     RE+ +L E   P ++     
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 85  FLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL- 142
           F  ++D ++ +  ++ +   L  ++K  +A +               +   ++ G+ YL 
Sbjct: 73  F--YSDGEISICMEHMDGGSLDQVLK--KAGR-------IPEQILGKVSIAVIKGLTYLR 121
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAP 202
             + ++HRD+KP+NILV      RG +K+ D G +    + +      +  V T  Y +P
Sbjct: 122 EKHKIMHRDVKPSNILVN----SRGEIKLCDFGVSGQLIDSMA-----NSFVGTRSYMSP 172
Query: 203 ELLLGARHYTKAIDIWAIGCIFAEL 227
           E L G  HY+   DIW++G    E+
Sbjct: 173 ERLQGT-HYSVQSDIWSMGLSLVEM 196

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 94/223 (42%), Gaps = 24/223 (10%)
Query: 27  VGRGTYGHVYKARRKDNSDTR-DYALKQIEGTGLSMSACR----EIALLRELKHPNVINL 81
           VG G +G V   R K  S      A+K ++  G +    R    E +++ +  HPN+I L
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
             V      + V ++ +Y E+  L   ++ H A                 +L  I  G+ 
Sbjct: 112 EGVVT--KSKPVMIVTEYMENGSLDSFLRKHDA--------QFTVIQLVGMLRGIASGMK 161
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL     +HRDL   NIL+    +     K++D G +R+  +  +         +   + 
Sbjct: 162 YLSDMGYVHRDLAARNILINSNLV----CKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT--SEPIFHCRQEDI 241
           +PE  +  R +T A D+W+ G +  E+++    P +    +D+
Sbjct: 218 SPE-AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 259

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 104/248 (41%), Gaps = 25/248 (10%)
Query: 3   YEFKIKTSNERTKVEDLFDYEGCKV-GRGTYGHVYKARRKDNSDTR-DYALKQIEGTGLS 60
           YE   +T +E  K  D  +    KV G G +G V   R K  S      A+K ++  G +
Sbjct: 28  YEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYT 86
Query: 61  MSACR----EIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAK 115
               R    E +++ +  HPN+I L  V      + V ++ +Y E+  L   ++ H A  
Sbjct: 87  EKQRRDFLGEASIMGQFDHPNIIRLEGVVT--KSKPVMIVTEYMENGSLDSFLRKHDA-- 142
Query: 116 ANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMG 175
                          +L  I  G+ YL     +HRDL   NIL+    +     K++D G
Sbjct: 143 ------QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLV----CKVSDFG 192
Query: 176 FARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT--SEPI 233
            +R+  +  +         +   + +PE  +  R +T A D+W+ G +  E+++    P 
Sbjct: 193 LSRVLEDDPEAAYTTRGGKIPIRWTSPE-AIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251
Query: 234 FHCRQEDI 241
           +    +D+
Sbjct: 252 WEMSNQDV 259

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 94/223 (42%), Gaps = 24/223 (10%)
Query: 27  VGRGTYGHVYKARRKDNSDTR-DYALKQIEGTGLSMSACR----EIALLRELKHPNVINL 81
           VG G +G V   R K  S      A+K ++  G +    R    E +++ +  HPN+I L
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
             V      + V ++ +Y E+  L   ++ H A                 +L  I  G+ 
Sbjct: 112 EGVVT--KSKPVMIVTEYMENGSLDSFLRKHDA--------QFTVIQLVGMLRGIASGMK 161
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL     +HRDL   NIL+    +     K++D G +R+  +  +         +   + 
Sbjct: 162 YLSDMGYVHRDLAARNILINSNLV----CKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT--SEPIFHCRQEDI 241
           +PE  +  R +T A D+W+ G +  E+++    P +    +D+
Sbjct: 218 SPE-AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 259

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 24/208 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G G YG VY+   K  S T   A+K ++   + +    +E A+++E+KHPN++ L+ V
Sbjct: 266 KLGGGQYGEVYEGVWKKYSLT--VAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 323
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLY---QILDGIHY 141
                +   +++ ++  +   +++ + R                  LLY   QI   + Y
Sbjct: 324 CT--REPPFYIITEFMTYG--NLLDYLRECNRQEVNAVV-------LLYMATQISSAMEY 372
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
           L     +HR+L   N LV     E   VK+AD G +RL        A         W  A
Sbjct: 373 LEKKNFIHRNLAARNCLVG----ENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKW-TA 426
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
           PE L   +   K+ D+WA G +  E+ T
Sbjct: 427 PESLAYNKFSIKS-DVWAFGVLLWEIAT 453

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 104/248 (41%), Gaps = 25/248 (10%)
Query: 3   YEFKIKTSNERTKVEDLFDYEGCKV-GRGTYGHVYKARRKDNSDTR-DYALKQIEGTGLS 60
           YE   +T +E  K  D  +    KV G G +G V   R K  S      A+K ++  G +
Sbjct: 28  YEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYT 86
Query: 61  MSACR----EIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAK 115
               R    E +++ +  HPN+I L  V      + V ++ +Y E+  L   ++ H A  
Sbjct: 87  EKQRRDFLGEASIMGQFDHPNIIRLEGVVT--KSKPVMIVTEYMENGSLDSFLRKHDA-- 142
Query: 116 ANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMG 175
                          +L  I  G+ YL     +HRDL   NIL+    +     K++D G
Sbjct: 143 ------QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLV----CKVSDFG 192
Query: 176 FARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT--SEPI 233
            +R+  +  +         +   + +PE  +  R +T A D+W+ G +  E+++    P 
Sbjct: 193 LSRVLEDDPEAAYTTRGGKIPIRWTSPE-AIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251
Query: 234 FHCRQEDI 241
           +    +D+
Sbjct: 252 WEMSNQDV 259

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 91/225 (40%), Gaps = 29/225 (12%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIA-----LLRELKHPNVINL 81
           +G G +G V KAR K +    D A+K+++    S    R+ A     L +   HPN+INL
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINL 88
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAK----------ANXXXXXXXXXXXXSL 131
           +      +   ++L  +YA H   +++ F R ++          AN              
Sbjct: 89  LGA--CEHRGYLYLAIEYAPHG--NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 144
Query: 132 LYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLD 191
              +  G+ YL     +HR+L   NILV     E    KIAD G +R     +K      
Sbjct: 145 AADVARGMDYLSQKQFIHRNLAARNILVG----ENYVAKIADFGLSRGQEVYVKKTMGRL 200
Query: 192 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 236
           PV    W     L      YT   D+W+ G +  E+++     +C
Sbjct: 201 PVR---WMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYC 240

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 94/224 (41%), Gaps = 27/224 (12%)
Query: 24  GCKVGRGTYGHVYKA------RRKDNSDTRDYALKQIEGTGLSMSACREIALLRELK--- 74
           G  +G G +G V  A      + K N  T+  A+K ++           I+ +  +K   
Sbjct: 22  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTK-VAVKMLKSDATEKDLSDLISEMEMMKMIG 80
Query: 75  -HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAA-------KANXXXXXXXX 125
            H N+INL+       D  ++++ +YA   +L   ++  R          ++        
Sbjct: 81  KHKNIINLLGA--CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 138
Query: 126 XXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLK 185
               S  YQ+  G+ YL S   +HRDL   N+LV  + +    +KIAD G AR  ++   
Sbjct: 139 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV----MKIADFGLARDIHHIDY 194
Query: 186 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                +  +   W  APE L   R YT   D+W+ G +  E+ T
Sbjct: 195 YKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFGVLLWEIFT 236

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 91/205 (44%), Gaps = 24/205 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIE-GTGLSMSACREIALLRELKHPNVINLISV 84
           ++G G  G V+K   K +       L  +E    +     RE+ +L E   P ++     
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 85  FLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL- 142
           F  ++D ++ +  ++ +   L  ++K  +A +               +   ++ G+ YL 
Sbjct: 73  F--YSDGEISICMEHMDGGSLDQVLK--KAGR-------IPEQILGKVSIAVIKGLTYLR 121
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAP 202
             + ++HRD+KP+NILV      RG +K+ D G +    + +      +  V T  Y +P
Sbjct: 122 EKHKIMHRDVKPSNILVN----SRGEIKLCDFGVSGQLIDSMA-----NSFVGTRSYMSP 172
Query: 203 ELLLGARHYTKAIDIWAIGCIFAEL 227
           E L G  HY+   DIW++G    E+
Sbjct: 173 ERLQGT-HYSVQSDIWSMGLSLVEM 196

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 91/205 (44%), Gaps = 24/205 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIE-GTGLSMSACREIALLRELKHPNVINLISV 84
           ++G G  G V+K   K +       L  +E    +     RE+ +L E   P ++     
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 85  FLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL- 142
           F  ++D ++ +  ++ +   L  ++K  +A +               +   ++ G+ YL 
Sbjct: 73  F--YSDGEISICMEHMDGGSLDQVLK--KAGR-------IPEQILGKVSIAVIKGLTYLR 121
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAP 202
             + ++HRD+KP+NILV      RG +K+ D G +    + +      +  V T  Y +P
Sbjct: 122 EKHKIMHRDVKPSNILVN----SRGEIKLCDFGVSGQLIDSMA-----NSFVGTRSYMSP 172
Query: 203 ELLLGARHYTKAIDIWAIGCIFAEL 227
           E L G  HY+   DIW++G    E+
Sbjct: 173 ERLQGT-HYSVQSDIWSMGLSLVEM 196

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/216 (22%), Positives = 98/216 (45%), Gaps = 30/216 (13%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACR----EIALLRELKHPNVI 79
           G ++G G++G VYK +        D A+K +  T  +    +    E+ +LR+ +H N++
Sbjct: 17  GQRIGSGSFGTVYKGKWHG-----DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 71
Query: 80  NLISVFLSHNDR-KVWLLFDYAE-HDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILD 137
               +F+ ++ + ++ ++  + E   L+H +        +             +  Q   
Sbjct: 72  ----LFMGYSTKPQLAIVTQWCEGSSLYHHL--------HASETKFEMKKLIDIARQTAR 119
Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF 197
           G+ YLH+  ++HRDLK  NI +     E   VKI D G A +  +        + +  + 
Sbjct: 120 GMDYLHAKSIIHRDLKSNNIFLH----EDNTVKIGDFGLATV-KSRWSGSHQFEQLSGSI 174
Query: 198 WYRAPEL--LLGARHYTKAIDIWAIGCIFAELLTSE 231
            + APE+  +  +  Y+   D++A G +  EL+T +
Sbjct: 175 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 210

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 101/226 (44%), Gaps = 38/226 (16%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALK--------QIEGTGLSMSACREIALLRELKHPNV 78
           +G+G++G V  + RK   +   YA+K        Q +    +M   R +AL    K P +
Sbjct: 28  LGKGSFGKVMLSERKGTDEL--YAVKILKKDVVIQDDDVECTMVEKRVLALPG--KPPFL 83
Query: 79  INLISVFLSHNDRKVWLLFDYAEHD--LWHIIKFHRAAKANXXXXXXXXXXXXSLLY--Q 134
             L S F + +  +++ + +Y      ++HI +  R  + +            ++ Y  +
Sbjct: 84  TQLHSCFQTMD--RLYFVMEYVNGGDLMYHIQQVGRFKEPH------------AVFYAAE 129
Query: 135 ILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVV 194
           I  G+ +L S  +++RDLK  N+++  EG     +KIAD G  +     +          
Sbjct: 130 IAIGLFFLQSKGIIYRDLKLDNVMLDSEG----HIKIADFGMCK---ENIWDGVTTKXFC 182
Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
            T  Y APE++   + Y K++D WA G +  E+L  +  F    ED
Sbjct: 183 GTPDYIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED 227

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 94/224 (41%), Gaps = 27/224 (12%)
Query: 24  GCKVGRGTYGHVYKA------RRKDNSDTRDYALKQIEGTGLSMSACREIALLRELK--- 74
           G  +G G +G V  A      + K N  T+  A+K ++           I+ +  +K   
Sbjct: 18  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTK-VAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 75  -HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAA-------KANXXXXXXXX 125
            H N+INL+       D  ++++ +YA   +L   ++  R          ++        
Sbjct: 77  KHKNIINLLGA--CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSS 134
Query: 126 XXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLK 185
               S  YQ+  G+ YL S   +HRDL   N+LV  + +    +KIAD G AR  ++   
Sbjct: 135 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV----MKIADFGLARDIHHIDY 190
Query: 186 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                +  +   W  APE L   R YT   D+W+ G +  E+ T
Sbjct: 191 YKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFGVLLWEIFT 232

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 93/235 (39%), Gaps = 41/235 (17%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACR-EIALLRELKHPNVIN-LISV 84
           +G GT+G V +        ++  ALK I   G    A R EI +L+++K  +  N  + V
Sbjct: 27  LGEGTFGKVVECLDHARGKSQ-VALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCV 85
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSL------LYQILDG 138
            +S      W  F++  H     I F    K               L       YQ+   
Sbjct: 86  LMSD-----W--FNFHGH---MCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHA 135
Query: 139 IHYLHSNWVLHRDLKPANILVMG---------------EGIERGRVKIADMGFARLFNNP 183
           + +LH N + H DLKP NIL +                + ++   +++AD G A   +  
Sbjct: 136 LRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE- 194
Query: 184 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 238
                    +V T  YR PE++L    + +  D+W+IGCI  E      +F   +
Sbjct: 195 -----HHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHE 243

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 94/223 (42%), Gaps = 24/223 (10%)
Query: 27  VGRGTYGHVYKARRKDNSDTR-DYALKQIEGTGLSMSACR----EIALLRELKHPNVINL 81
           VG G +G V   R K  S      A+K ++  G +    R    E +++ +  HPN+I L
Sbjct: 51  VGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYTEKQRRDFLGEASIMGQFDHPNIIRL 109
Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
             V      + V ++ +Y E+  L   ++ H A                 +L  I  G+ 
Sbjct: 110 EGVVT--KSKPVMIVTEYMENGSLDSFLRKHDA--------QFTVIQLVGMLRGIASGMK 159
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL     +HRDL   NIL+    +     K++D G +R+  +  +         +   + 
Sbjct: 160 YLSDMGYVHRDLAARNILINSNLV----CKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 215
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT--SEPIFHCRQEDI 241
           +PE  +  R +T A D+W+ G +  E+++    P +    +D+
Sbjct: 216 SPE-AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 257

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 94/223 (42%), Gaps = 24/223 (10%)
Query: 27  VGRGTYGHVYKARRKDNSDTR-DYALKQIEGTGLSMSACR----EIALLRELKHPNVINL 81
           VG G +G V   R K  S      A+K ++  G +    R    E +++ +  HPN+I L
Sbjct: 41  VGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYTEKQRRDFLGEASIMGQFDHPNIIRL 99
Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
             V      + V ++ +Y E+  L   ++ H A                 +L  I  G+ 
Sbjct: 100 EGVV--TKSKPVMIVTEYMENGSLDSFLRKHDA--------QFTVIQLVGMLRGIASGMK 149
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL     +HRDL   NIL+    +     K++D G +R+  +  +         +   + 
Sbjct: 150 YLSDMGYVHRDLAARNILINSNLV----CKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 205
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT--SEPIFHCRQEDI 241
           +PE  +  R +T A D+W+ G +  E+++    P +    +D+
Sbjct: 206 SPE-AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 247

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 96/224 (42%), Gaps = 27/224 (12%)
Query: 24  GCKVGRGTYGHVYKA------RRKDNSDTRDYALKQIEGTGLSMSAC---REIALLREL- 73
           G  +G G +G V  A      + K N  T+  A+K ++             E+ +++ + 
Sbjct: 26  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTK-VAVKMLKSDATEKDLSDLISEMEMMKMIG 84
Query: 74  KHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAA-------KANXXXXXXXX 125
           KH N+INL+       D  ++++ +YA   +L   ++  R          ++        
Sbjct: 85  KHKNIINLLGA--CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 142
Query: 126 XXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLK 185
               S  YQ+  G+ YL S   +HRDL   N+LV  + +    +KIAD G AR  ++   
Sbjct: 143 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV----MKIADFGLARDIHHIDY 198
Query: 186 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                +  +   W  APE L   R YT   D+W+ G +  E+ T
Sbjct: 199 YKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFGVLLWEIFT 240

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 77/174 (44%), Gaps = 23/174 (13%)
Query: 65  REIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHII---KFHRAAKANXXX 120
           RE  + R LKHPN++ L            +L+FD     +L+  I   +++  A A+   
Sbjct: 59  REARICRLLKHPNIVRLHDSISEEGHH--YLIFDLVTGGELFEDIVAREYYSEADAS--- 113
Query: 121 XXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
                      + QIL+ + + H   V+HR+LKP N+L +   ++   VK+AD G A   
Sbjct: 114 ---------HCIQQILEAVLHCHQMGVVHRNLKPENLL-LASKLKGAAVKLADFGLAIEV 163
Query: 181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
               +          T  Y +PE+L     Y K +D+WA G I   LL   P F
Sbjct: 164 EGEQQAWFGF---AGTPGYLSPEVLR-KDPYGKPVDLWACGVILYILLVGYPPF 213

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 94/224 (41%), Gaps = 27/224 (12%)
Query: 24  GCKVGRGTYGHVYKA------RRKDNSDTRDYALKQIEGTGLSMSACREIALLRELK--- 74
           G  +G G +G V  A      + K N  T+  A+K ++           I+ +  +K   
Sbjct: 25  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTK-VAVKMLKSDATEKDLSDLISEMEMMKMIG 83
Query: 75  -HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAA-------KANXXXXXXXX 125
            H N+INL+       D  ++++ +YA   +L   ++  R          ++        
Sbjct: 84  KHKNIINLLGA--CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 141
Query: 126 XXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLK 185
               S  YQ+  G+ YL S   +HRDL   N+LV  + +    +KIAD G AR  ++   
Sbjct: 142 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV----MKIADFGLARDIHHIDY 197
Query: 186 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                +  +   W  APE L   R YT   D+W+ G +  E+ T
Sbjct: 198 YKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFGVLLWEIFT 239

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 93/235 (39%), Gaps = 41/235 (17%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACR-EIALLRELKHPNVIN-LISV 84
           +G GT+G V +        ++  ALK I   G    A R EI +L+++K  +  N  + V
Sbjct: 36  LGEGTFGKVVECLDHARGKSQ-VALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCV 94
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSL------LYQILDG 138
            +S      W  F++  H     I F    K               L       YQ+   
Sbjct: 95  LMSD-----W--FNFHGH---MCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHA 144
Query: 139 IHYLHSNWVLHRDLKPANILVMG---------------EGIERGRVKIADMGFARLFNNP 183
           + +LH N + H DLKP NIL +                + ++   +++AD G A   +  
Sbjct: 145 LRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE- 203
Query: 184 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 238
                    +V T  YR PE++L    + +  D+W+IGCI  E      +F   +
Sbjct: 204 -----HHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHE 252

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 94/224 (41%), Gaps = 27/224 (12%)
Query: 24  GCKVGRGTYGHVYKA------RRKDNSDTRDYALKQIEGTGLSMSACREIALLRELK--- 74
           G  +G G +G V  A      + K N  T+  A+K ++           I+ +  +K   
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTK-VAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 75  -HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAA-------KANXXXXXXXX 125
            H N+INL+       D  ++++ +YA   +L   ++  R          ++        
Sbjct: 92  KHKNIINLLGA--CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 149
Query: 126 XXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLK 185
               S  YQ+  G+ YL S   +HRDL   N+LV  + +    +KIAD G AR  ++   
Sbjct: 150 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV----MKIADFGLARDIHHIDY 205
Query: 186 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                +  +   W  APE L   R YT   D+W+ G +  E+ T
Sbjct: 206 YKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFGVLLWEIFT 247

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 93/223 (41%), Gaps = 24/223 (10%)
Query: 27  VGRGTYGHVYKARRKDNSDTR-DYALKQIEGTGLSMSACR----EIALLRELKHPNVINL 81
           VG G +G V   R K  S      A+K ++  G +    R    E +++ +  HPN+I L
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
             V      + V ++ +Y E+  L   ++ H A                 +L  I  G+ 
Sbjct: 112 EGVVT--KSKPVMIVTEYMENGSLDSFLRKHDA--------QFTVIQLVGMLRGIASGMK 161
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL     +HRDL   NIL+    +     K++D G  R+  +  +         +   + 
Sbjct: 162 YLSDMGYVHRDLAARNILINSNLV----CKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT--SEPIFHCRQEDI 241
           +PE  +  R +T A D+W+ G +  E+++    P +    +D+
Sbjct: 218 SPE-AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 259

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 94/224 (41%), Gaps = 27/224 (12%)
Query: 24  GCKVGRGTYGHVYKA------RRKDNSDTRDYALKQIEGTGLSMSACREIALLRELK--- 74
           G  +G G +G V  A      + K N  T+  A+K ++           I+ +  +K   
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTK-VAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 75  -HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAA-------KANXXXXXXXX 125
            H N+INL+       D  ++++ +YA   +L   ++  R          ++        
Sbjct: 92  KHKNIINLLGA--CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSS 149
Query: 126 XXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLK 185
               S  YQ+  G+ YL S   +HRDL   N+LV  + +    +KIAD G AR  ++   
Sbjct: 150 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV----MKIADFGLARDIHHIDY 205
Query: 186 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                +  +   W  APE L   R YT   D+W+ G +  E+ T
Sbjct: 206 YKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFGVLLWEIFT 247

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/266 (22%), Positives = 112/266 (42%), Gaps = 38/266 (14%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI------EGTGLSMSACREIALLRELKHPNVIN 80
           +GRG+Y  V   R K     R YA+K +      +   +      +    +   HP ++ 
Sbjct: 28  IGRGSYAKVLLVRLKKTD--RIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 85
Query: 81  LISVFLSHNDRKVWLLFDYAEHD--LWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           L S F    + +++ + +Y      ++H+ +  +  + +                +I   
Sbjct: 86  LHSCF--QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA----------EISLA 133
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           ++YLH   +++RDLK  N+L+  E    G +K+ D G  +     L+P         T  
Sbjct: 134 LNYLHERGIIYRDLKLDNVLLDSE----GHIKLTDYGMCK---EGLRPGDTTSXFCGTPN 186
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           Y APE+L G   Y  ++D WA+G +  E++     F      + +S+    +  D +F V
Sbjct: 187 YIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDI----VGSSDNPDQNTEDYLFQV 241
Query: 259 MGFPLEKDWEDIRKMP-EHPTLLKDF 283
           +   LEK     R M  +  ++LK F
Sbjct: 242 I---LEKQIRIPRSMSVKAASVLKSF 264

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 94/223 (42%), Gaps = 24/223 (10%)
Query: 27  VGRGTYGHVYKARRKDNSDTR-DYALKQIEGTGLSMSACR----EIALLRELKHPNVINL 81
           VG G +G V   R K  S      A+K ++  G +    R    E +++ +  HPN+I L
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYTEKQRRDFLGEASIMGQFDHPNIIRL 82
Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
             V      + V ++ +Y E+  L   ++ H A                 +L  I  G+ 
Sbjct: 83  EGVVT--KSKPVMIVTEYMENGSLDSFLRKHDA--------QFTVIQLVGMLRGIASGMK 132
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL     +HRDL   NIL+    +     K++D G +R+  +  +         +   + 
Sbjct: 133 YLSDMGYVHRDLAARNILINSNLV----CKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 188
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT--SEPIFHCRQEDI 241
           +PE  +  R +T A D+W+ G +  E+++    P +    +D+
Sbjct: 189 SPE-AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 230

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 96/222 (43%), Gaps = 28/222 (12%)
Query: 20  FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMS-----ACREIALLRELK 74
           FDY    +G+GT+G V   R K  +  R YA+K +    +           E  +L+  +
Sbjct: 7   FDYLKL-LGKGTFGKVILVREK--ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 75  HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLY 133
           HP +  L   F +H+  ++  + +YA   +L+  +   R                     
Sbjct: 64  HPFLTALKYAFQTHD--RLCFVMEYANGGELFFHLSRERVFTEERARFYGA--------- 112
Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           +I+  + YLHS  V++RD+K  N+++  +    G +KI D G  +     +   A +   
Sbjct: 113 EIVSALEYLHSRDVVYRDIKLENLMLDKD----GHIKITDFGLCK---EGISDGATMKXF 165
Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
             T  Y APE +L    Y +A+D W +G +  E++     F+
Sbjct: 166 CGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 206

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 93/235 (39%), Gaps = 41/235 (17%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACR-EIALLRELKHPNVIN-LISV 84
           +G GT+G V +        ++  ALK I   G    A R EI +L+++K  +  N  + V
Sbjct: 59  LGEGTFGKVVECLDHARGKSQ-VALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCV 117
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSL------LYQILDG 138
            +S      W  F++  H     I F    K               L       YQ+   
Sbjct: 118 LMSD-----W--FNFHGH---MCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHA 167
Query: 139 IHYLHSNWVLHRDLKPANILVMG---------------EGIERGRVKIADMGFARLFNNP 183
           + +LH N + H DLKP NIL +                + ++   +++AD G A   +  
Sbjct: 168 LRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE- 226
Query: 184 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 238
                    +V T  YR PE++L    + +  D+W+IGCI  E      +F   +
Sbjct: 227 -----HHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHE 275

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 89/205 (43%), Gaps = 24/205 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIE-GTGLSMSACREIALLRELKHPNVINLISV 84
           ++G G  G V+K   K +       L  +E    +     RE+ +L E   P ++     
Sbjct: 16  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 75
Query: 85  FLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL- 142
           F S  D ++ +  ++ +   L  ++K     KA             +    ++ G+ YL 
Sbjct: 76  FYS--DGEISICMEHMDGGSLDQVLK-----KAGRIPEQILGKVSIA----VIKGLTYLR 124
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAP 202
             + ++HRD+KP+NILV      RG +K+ D G +    + +      +  V T  Y +P
Sbjct: 125 EKHKIMHRDVKPSNILVN----SRGEIKLCDFGVSGQLIDEMA-----NEFVGTRSYMSP 175
Query: 203 ELLLGARHYTKAIDIWAIGCIFAEL 227
           E L G  HY+   DIW++G    E+
Sbjct: 176 ERLQGT-HYSVQSDIWSMGLSLVEM 199

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 96/222 (43%), Gaps = 28/222 (12%)
Query: 20  FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMS-----ACREIALLRELK 74
           FDY    +G+GT+G V   R K  +  R YA+K +    +           E  +L+  +
Sbjct: 7   FDYLKL-LGKGTFGKVILVREK--ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 75  HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLY 133
           HP +  L   F +H+  ++  + +YA   +L+  +   R                     
Sbjct: 64  HPFLTALKYAFQTHD--RLCFVMEYANGGELFFHLSRERVFTEERARFYGA--------- 112
Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           +I+  + YLHS  V++RD+K  N+++  +    G +KI D G  +     +   A +   
Sbjct: 113 EIVSALEYLHSRDVVYRDIKLENLMLDKD----GHIKITDFGLCK---EGISDGATMKTF 165
Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
             T  Y APE +L    Y +A+D W +G +  E++     F+
Sbjct: 166 CGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 206

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 96/222 (43%), Gaps = 28/222 (12%)
Query: 20  FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMS-----ACREIALLRELK 74
           FDY    +G+GT+G V   R K  +  R YA+K +    +           E  +L+  +
Sbjct: 7   FDYLKL-LGKGTFGKVILVREK--ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 75  HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLY 133
           HP +  L   F +H+  ++  + +YA   +L+  +   R                     
Sbjct: 64  HPFLTALKYAFQTHD--RLCFVMEYANGGELFFHLSRERVFTEERARFYGA--------- 112
Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           +I+  + YLHS  V++RD+K  N+++  +    G +KI D G  +     +   A +   
Sbjct: 113 EIVSALEYLHSRDVVYRDIKLENLMLDKD----GHIKITDFGLCK---EGISDGATMKTF 165
Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
             T  Y APE +L    Y +A+D W +G +  E++     F+
Sbjct: 166 CGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 206

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 94/225 (41%), Gaps = 26/225 (11%)
Query: 27  VGRGTYGHVYKARRKDNSDTRD-YALKQIEGTGLSMSACREI----ALLRELKHPNVINL 81
           +G G +G V + R K         A+K ++G G +    RE     +++ + +HPN+I L
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKG-GYTERQRREFLSEASIMGQFEHPNIIRL 80
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
             V    N   V +L ++ E+    +  F R                  +L  I  G+ Y
Sbjct: 81  EGVV--TNSMPVMILTEFMENG--ALDSFLRLNDGQFTVIQLV-----GMLRGIASGMRY 131
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF-NNPLKP--LADLDPVVVTFW 198
           L     +HRDL   NILV    +     K++D G +R    N   P   + L   +   W
Sbjct: 132 LAEMSYVHRDLAARNILVNSNLV----CKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRW 187
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLT--SEPIFHCRQEDI 241
             APE  +  R +T A D W+ G +  E+++    P +    +D+
Sbjct: 188 T-APE-AIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDV 230

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 94/224 (41%), Gaps = 27/224 (12%)
Query: 24  GCKVGRGTYGHVYKA------RRKDNSDTRDYALKQIEGTGLSMSACREIALLRELK--- 74
           G  +G G +G V  A      + K N  T+  A+K ++           I+ +  +K   
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTK-VAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 75  -HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAA-------KANXXXXXXXX 125
            H N+INL+       D  ++++ +YA   +L   ++  R          ++        
Sbjct: 133 KHKNIINLLGA--CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 190
Query: 126 XXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLK 185
               S  YQ+  G+ YL S   +HRDL   N+LV  + +    +KIAD G AR  ++   
Sbjct: 191 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV----MKIADFGLARDIHHIDY 246
Query: 186 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                +  +   W  APE L   R YT   D+W+ G +  E+ T
Sbjct: 247 YKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFGVLLWEIFT 288

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 96/222 (43%), Gaps = 28/222 (12%)
Query: 20  FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMS-----ACREIALLRELK 74
           FDY    +G+GT+G V   R K  +  R YA+K +    +           E  +L+  +
Sbjct: 7   FDYLKL-LGKGTFGKVILVREK--ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 75  HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLY 133
           HP +  L   F +H+  ++  + +YA   +L+  +   R                     
Sbjct: 64  HPFLTALKYAFQTHD--RLCFVMEYANGGELFFHLSRERVFTEERARFYGA--------- 112
Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           +I+  + YLHS  V++RD+K  N+++  +    G +KI D G  +     +   A +   
Sbjct: 113 EIVSALEYLHSRDVVYRDIKLENLMLDKD----GHIKITDFGLCK---EGISDGATMKXF 165
Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
             T  Y APE +L    Y +A+D W +G +  E++     F+
Sbjct: 166 CGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 206

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 24/211 (11%)
Query: 27  VGRGTYGHVYKARRKDNSDTRD-YALKQIEGTGLSMSACREI----ALLRELKHPNVINL 81
           +G G +G V + R K         A+K ++G G +    RE     +++ + +HPN+I L
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKG-GYTERQRREFLSEASIMGQFEHPNIIRL 82
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
             V    N   V +L ++ E+    +  F R                  +L  I  G+ Y
Sbjct: 83  EGVVT--NSMPVMILTEFMENG--ALDSFLRLNDGQFTVIQLV-----GMLRGIASGMRY 133
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF-NNPLKP--LADLDPVVVTFW 198
           L     +HRDL   NILV    +     K++D G +R    N   P   + L   +   W
Sbjct: 134 LAEMSYVHRDLAARNILVNSNLV----CKVSDFGLSRFLEENSSDPTETSSLGGKIPIRW 189
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
             APE  +  R +T A D W+ G +  E+++
Sbjct: 190 T-APE-AIAFRKFTSASDAWSYGIVMWEVMS 218

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 96/222 (43%), Gaps = 28/222 (12%)
Query: 20  FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMS-----ACREIALLRELK 74
           FDY    +G+GT+G V   R K  +  R YA+K +    +           E  +L+  +
Sbjct: 12  FDYLKL-LGKGTFGKVILVREK--ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 68
Query: 75  HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLY 133
           HP +  L   F +H+  ++  + +YA   +L+  +   R                     
Sbjct: 69  HPFLTALKYAFQTHD--RLCFVMEYANGGELFFHLSRERVFTEERARFYGA--------- 117
Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           +I+  + YLHS  V++RD+K  N+++  +    G +KI D G  +     +   A +   
Sbjct: 118 EIVSALEYLHSRDVVYRDIKLENLMLDKD----GHIKITDFGLCK---EGISDGATMKXF 170
Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
             T  Y APE +L    Y +A+D W +G +  E++     F+
Sbjct: 171 CGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 211

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 96/222 (43%), Gaps = 28/222 (12%)
Query: 20  FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMS-----ACREIALLRELK 74
           FDY    +G+GT+G V   R K  +  R YA+K +    +           E  +L+  +
Sbjct: 10  FDYLKL-LGKGTFGKVILVREK--ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 66
Query: 75  HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLY 133
           HP +  L   F +H+  ++  + +YA   +L+  +   R                     
Sbjct: 67  HPFLTALKYAFQTHD--RLCFVMEYANGGELFFHLSRERVFTEERARFYGA--------- 115
Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           +I+  + YLHS  V++RD+K  N+++  +    G +KI D G  +     +   A +   
Sbjct: 116 EIVSALEYLHSRDVVYRDIKLENLMLDKD----GHIKITDFGLCK---EGISDGATMKTF 168
Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
             T  Y APE +L    Y +A+D W +G +  E++     F+
Sbjct: 169 CGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 209

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 101/226 (44%), Gaps = 38/226 (16%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALK--------QIEGTGLSMSACREIALLRELKHPNV 78
           +G+G++G V  + RK   +   YA+K        Q +    +M   R +AL    K P +
Sbjct: 349 LGKGSFGKVMLSERKGTDEL--YAVKILKKDVVIQDDDVECTMVEKRVLAL--PGKPPFL 404
Query: 79  INLISVFLSHNDRKVWLLFDYAEHD--LWHIIKFHRAAKANXXXXXXXXXXXXSLLY--Q 134
             L S F + +  +++ + +Y      ++HI +  R  + +            ++ Y  +
Sbjct: 405 TQLHSCFQTMD--RLYFVMEYVNGGDLMYHIQQVGRFKEPH------------AVFYAAE 450
Query: 135 ILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVV 194
           I  G+ +L S  +++RDLK  N+++  EG     +KIAD G  +     +          
Sbjct: 451 IAIGLFFLQSKGIIYRDLKLDNVMLDSEG----HIKIADFGMCK---ENIWDGVTTKXFC 503
Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
            T  Y APE++   + Y K++D WA G +  E+L  +  F    ED
Sbjct: 504 GTPDYIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED 548

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/234 (21%), Positives = 100/234 (42%), Gaps = 23/234 (9%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           ++G G +G V+      ++     +LKQ  G+    +   E  L+++L+H  ++ L +V 
Sbjct: 16  RLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 73
Query: 86  LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSN 145
                  ++++ +Y E+    ++ F +                  +  QI +G+ ++   
Sbjct: 74  ---TQEPIYIITEYMENG--SLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEER 124
Query: 146 WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELL 205
             +HR+L+ ANILV     +    KIAD G ARL  +        +       + APE  
Sbjct: 125 NYIHRNLRAANILVS----DTLSCKIADFGLARLIED--NEYTAREGAKFPIKWTAPE-A 177
Query: 206 LGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVM 259
           +    +T   D+W+ G +  E++T     H R      +NP     L+R + ++
Sbjct: 178 INYGTFTIKSDVWSFGILLTEIVT-----HGRIPYPGMTNPEVIQNLERGYRMV 226

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 96/222 (43%), Gaps = 28/222 (12%)
Query: 20  FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMS-----ACREIALLRELK 74
           FDY    +G+GT+G V   R K  +  R YA+K +    +           E  +L+  +
Sbjct: 7   FDYLKL-LGKGTFGKVILVREK--ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 75  HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLY 133
           HP +  L   F +H+  ++  + +YA   +L+  +   R                     
Sbjct: 64  HPFLTALKYAFQTHD--RLCFVMEYANGGELFFHLSRERVFTEERARFYGA--------- 112
Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           +I+  + YLHS  V++RD+K  N+++  +    G +KI D G  +     +   A +   
Sbjct: 113 EIVSALEYLHSRDVVYRDIKLENLMLDKD----GHIKITDFGLCK---EGISDGATMKXF 165
Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
             T  Y APE +L    Y +A+D W +G +  E++     F+
Sbjct: 166 CGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 206

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 104/237 (43%), Gaps = 40/237 (16%)
Query: 10  SNERTKVEDLFDYEGCKVGRGTYGHVYKAR-RKDNSDTRDYALKQIEGTGLSMSACREIA 68
           S +RT   D+   E C VG+G YG V++   + +N   + ++ +         S  RE  
Sbjct: 1   SMQRTVARDITLLE-C-VGKGRYGEVWRGSWQGENVAVKIFSSRD------EKSWFRETE 52
Query: 69  LLRE--LKHPNVINLISVFLS--HNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXX 124
           L     L+H N++  I+  ++  H+  ++WL+  Y  H++  +  + +    +       
Sbjct: 53  LYNTVMLRHENILGFIASDMTSRHSSTQLWLITHY--HEMGSLYDYLQLTTLDTVSCLR- 109
Query: 125 XXXXXSLLYQILDGIHYLH--------SNWVLHRDLKPANILVMGEGIERGRVKIADMGF 176
                 ++  I  G+ +LH           + HRDLK  NILV     + G+  IAD+G 
Sbjct: 110 ------IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK----KNGQCCIADLGL 159
Query: 177 ARLFNNPLKPL-ADLDPVVVTFWYRAPELL-----LGARHYTKAIDIWAIGCIFAEL 227
           A + +     L    +P V T  Y APE+L     +      K +DIWA G +  E+
Sbjct: 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/234 (22%), Positives = 100/234 (42%), Gaps = 23/234 (9%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           ++G G  G V+      ++     +LKQ  G+    +   E  L+++L+H  ++ L +V 
Sbjct: 20  RLGAGQAGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 86  LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSN 145
                  ++++ +Y E+    ++ F +                  +  QI +G+ ++   
Sbjct: 78  ---TQEPIYIITEYMENG--SLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEER 128
Query: 146 WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELL 205
             +HRDL+ ANILV     +    KIAD G ARL  +      +     +   + APE  
Sbjct: 129 NYIHRDLRAANILVS----DTLSCKIADFGLARLIEDAEXTAREGAKFPIK--WTAPE-A 181
Query: 206 LGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVM 259
           +    +T   D+W+ G +  E++T     H R      +NP     L+R + ++
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVT-----HGRIPYPGMTNPEVIQNLERGYRMV 230

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/113 (27%), Positives = 59/113 (52%), Gaps = 8/113 (7%)
Query: 130 SLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLAD 189
           S  +Q+L+ + + H+  VLHRD+K  NIL+    + RG +K+ D G   L  + +    D
Sbjct: 161 SFFWQVLEAVRHCHNCGVLHRDIKDENILI---DLNRGELKLIDFGSGALLKDTV--YTD 215
Query: 190 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 242
            D   V   Y  PE +   R++ ++  +W++G +  +++  +  F   +E I+
Sbjct: 216 FDGTRV---YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 265

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 93/207 (44%), Gaps = 23/207 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIA-LLRELKHPNVINLISV 84
           ++G G +G V+     +++     A+K ++   +S+ A  E A L++ L+H  ++ L +V
Sbjct: 20  RLGAGQFGEVWMGYYNNSTKV---AVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAV 76
Query: 85  FLSHNDRKVWLLFDY-AEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLH 143
                +  ++++ +Y A+  L   +K     K                  QI +G+ Y+ 
Sbjct: 77  V--TREEPIYIITEYMAKGSLLDFLKSDEGGKV-------LLPKLIDFSAQIAEGMAYIE 127
Query: 144 SNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPE 203
               +HRDL+ AN+LV     E    KIAD G AR+  +        +       + APE
Sbjct: 128 RKNYIHRDLRAANVLVS----ESLMCKIADFGLARVIED--NEYTAREGAKFPIKWTAPE 181
Query: 204 LL-LGARHYTKAIDIWAIGCIFAELLT 229
            +  G   +T   D+W+ G +  E++T
Sbjct: 182 AINFGC--FTIKSDVWSFGILLYEIVT 206

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 76/171 (44%), Gaps = 26/171 (15%)
Query: 65  REIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAE-HDLWHIIKFHRAAKANXXXXXX 123
           +EI +LR L H ++I          ++ + L+ +Y     L   +  H    A       
Sbjct: 65  QEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQL----- 119
Query: 124 XXXXXXSLLY--QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF- 180
                  LL+  QI +G+ YLHS   +HR+L   N+L+  + +    VKI D G A+   
Sbjct: 120 -------LLFAQQICEGMAYLHSQHYIHRNLAARNVLLDNDRL----VKIGDFGLAKAVP 168
Query: 181 --NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
             +   +   D D  V  FWY APE L   + Y  A D+W+ G    ELLT
Sbjct: 169 EGHEYYRVREDGDSPV--FWY-APECLKEYKFYY-ASDVWSFGVTLYELLT 215

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 89/206 (43%), Gaps = 17/206 (8%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           K+G G++G V++A    +       ++Q           RE+A+++ L+HPN++  +   
Sbjct: 44  KIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 86  LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSN 145
               +  +  + +Y           +R    +            S+ Y +  G++YLH+ 
Sbjct: 104 TQPPNLSI--VTEYLSRG-----SLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 146 --WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPE 203
              ++HRDLK  N+LV     ++  VK+ D G +RL  +    L          W  APE
Sbjct: 157 NPPIVHRDLKSPNLLV----DKKYTVKVCDFGLSRLKASXF--LXSKXAAGTPEWM-APE 209
Query: 204 LLLGARHYTKAIDIWAIGCIFAELLT 229
           +L       K+ D+++ G I  EL T
Sbjct: 210 VLRDEPSNEKS-DVYSFGVILWELAT 234

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/216 (22%), Positives = 97/216 (44%), Gaps = 30/216 (13%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACR----EIALLRELKHPNVI 79
           G ++G G++G VYK +        D A+K +  T  +    +    E+ +LR+ +H N++
Sbjct: 29  GQRIGSGSFGTVYKGKWHG-----DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 80  NLISVFLSHNDR-KVWLLFDYAE-HDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILD 137
               +F+ ++ + ++ ++  + E   L+H +        +             +  Q   
Sbjct: 84  ----LFMGYSTKPQLAIVTQWCEGSSLYHHL--------HASETKFEMKKLIDIARQTAR 131
Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF 197
           G+ YLH+  ++HRDLK  NI +     E   VKI D G A    +        + +  + 
Sbjct: 132 GMDYLHAKSIIHRDLKSNNIFLH----EDNTVKIGDFGLA-TEKSRWSGSHQFEQLSGSI 186
Query: 198 WYRAPEL--LLGARHYTKAIDIWAIGCIFAELLTSE 231
            + APE+  +  +  Y+   D++A G +  EL+T +
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 30/226 (13%)
Query: 21  DYEGCKV-GRGTYGHVYKARRKDNSDTRDYALK---QIEGTGLSMSAC--REIALLRELK 74
           DY+  KV GRG +G V   R K  +  + YA+K   + E    S SA    E  ++    
Sbjct: 76  DYDVVKVIGRGAFGEVQLVRHK--ASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 133
Query: 75  HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLY 133
            P V+ L   F   +D+ ++++ +Y    DL +++       +N            + + 
Sbjct: 134 SPWVVQLFCAF--QDDKYLYMVMEYMPGGDLVNLM-------SNYDVPEKWAKFYTAEVV 184
Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
             LD IH   S  ++HRD+KP N+L+     + G +K+AD G     +     +   D  
Sbjct: 185 LALDAIH---SMGLIHRDVKPDNMLL----DKHGHLKLADFGTCMKMDE--TGMVHCDTA 235
Query: 194 VVTFWYRAPELLL---GARHYTKAIDIWAIGCIFAELLTSEPIFHC 236
           V T  Y +PE+L    G  +Y +  D W++G    E+L  +  F+ 
Sbjct: 236 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA 281

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 90/206 (43%), Gaps = 17/206 (8%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           K+G G++G V++A    +       ++Q           RE+A+++ L+HPN++  +   
Sbjct: 44  KIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 86  LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSN 145
               +  +  + +Y           +R    +            S+ Y +  G++YLH+ 
Sbjct: 104 TQPPNLSI--VTEYLSRG-----SLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 146 --WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPE 203
              ++HR+LK  N+LV     ++  VK+ D G +RL  +    L+         W  APE
Sbjct: 157 NPPIVHRNLKSPNLLV----DKKYTVKVCDFGLSRLKASTF--LSSKSAAGTPEWM-APE 209
Query: 204 LLLGARHYTKAIDIWAIGCIFAELLT 229
           +L       K+ D+++ G I  EL T
Sbjct: 210 VLRDEPSNEKS-DVYSFGVILWELAT 234

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/241 (21%), Positives = 101/241 (41%), Gaps = 34/241 (14%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI------EGTGLSMSACREIALLRELKHPNVIN 80
           +GRG+Y  V   R K     R YA+K +      +   +      +    +   HP ++ 
Sbjct: 13  IGRGSYAKVLLVRLKKTD--RIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 70
Query: 81  LISVFLSHNDRKVWLLFDYAEHD--LWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           L S F    + +++ + +Y      ++H+ +  +  + +                +I   
Sbjct: 71  LHSCF--QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA----------EISLA 118
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           ++YLH   +++RDLK  N+L+  E    G +K+ D G  +     L+P         T  
Sbjct: 119 LNYLHERGIIYRDLKLDNVLLDSE----GHIKLTDYGMCK---EGLRPGDTTSXFCGTPN 171
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           Y APE+L G   Y  ++D WA+G +  E++     F      + +S+    +  D +F V
Sbjct: 172 YIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDI----VGSSDNPDQNTEDYLFQV 226
Query: 259 M 259
           +
Sbjct: 227 I 227

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 38/220 (17%)
Query: 27  VGRGTYGHVYKAR-RKDNSDTRDYALKQIEGTGLSMSACREIALLRE--LKHPNVINLIS 83
           VG+G YG V++   + +N   + ++ +         S  RE  L     L+H N++  I+
Sbjct: 45  VGKGRYGEVWRGSWQGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIA 98
Query: 84  VFLS--HNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
             ++  H+  ++WL+  Y  H++  +  + +    +             ++  I  G+ +
Sbjct: 99  SDMTSRHSSTQLWLITHY--HEMGSLYDYLQLTTLDTVSCLR-------IVLSIASGLAH 149
Query: 142 LH--------SNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPL-ADLDP 192
           LH           + HRDLK  NILV     + G+  IAD+G A + +     L    +P
Sbjct: 150 LHIEIFGTQGKPAIAHRDLKSKNILVK----KNGQCCIADLGLAVMHSQSTNQLDVGNNP 205
Query: 193 VVVTFWYRAPELL-----LGARHYTKAIDIWAIGCIFAEL 227
            V T  Y APE+L     +      K +DIWA G +  E+
Sbjct: 206 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 38/220 (17%)
Query: 27  VGRGTYGHVYKAR-RKDNSDTRDYALKQIEGTGLSMSACREIALLRE--LKHPNVINLIS 83
           VG+G YG V++   + +N   + ++ +         S  RE  L     L+H N++  I+
Sbjct: 16  VGKGRYGEVWRGSWQGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIA 69
Query: 84  VFLS--HNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
             ++  H+  ++WL+  Y  H++  +  + +    +             ++  I  G+ +
Sbjct: 70  SDMTSRHSSTQLWLITHY--HEMGSLYDYLQLTTLDTVSCLR-------IVLSIASGLAH 120
Query: 142 LH--------SNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPL-ADLDP 192
           LH           + HRDLK  NILV     + G+  IAD+G A + +     L    +P
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVK----KNGQCCIADLGLAVMHSQSTNQLDVGNNP 176
Query: 193 VVVTFWYRAPELL-----LGARHYTKAIDIWAIGCIFAEL 227
            V T  Y APE+L     +      K +DIWA G +  E+
Sbjct: 177 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 87/208 (41%), Gaps = 23/208 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           +VGRG++G V+  R KD       A+K++    L +    E+     L  P ++ L    
Sbjct: 81  RVGRGSFGEVH--RMKDKQTGFQCAVKKVR---LEVFRVEELVACAGLSSPRIVPLYGAV 135
Query: 86  LSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHS 144
                  V +  +  E   L  +IK       +              L Q L+G+ YLH+
Sbjct: 136 --REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYY---------LGQALEGLEYLHT 184
Query: 145 NWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF--NNPLKPLADLDPVVVTFWYRAP 202
             +LH D+K  N+L+  +G    R  + D G A     +   K L   D +  T  + AP
Sbjct: 185 RRILHGDVKADNVLLSSDG---SRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 241
Query: 203 ELLLGARHYTKAIDIWAIGCIFAELLTS 230
           E+++G     K +DIW+  C+   +L  
Sbjct: 242 EVVMGKPCDAK-VDIWSSCCMMLHMLNG 268

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 34/120 (28%), Positives = 55/120 (45%), Gaps = 22/120 (18%)
Query: 131 LLYQILDGIHYLHSNWVLHRDLKPANILVMGE------GIERGR---------VKIADMG 175
           + +Q+   + +LH N + H DLKP NIL +         +E+ R         V++ D G
Sbjct: 142 MAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFG 201
Query: 176 FARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
            A   +           +V T  YRAPE++L    +++  D+W+IGCI  E      +F 
Sbjct: 202 SATFDHE------HHSTIVSTRHYRAPEVILEL-GWSQPCDVWSIGCIIFEYYVGFTLFQ 254

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 87/208 (41%), Gaps = 23/208 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           +VGRG++G V+  R KD       A+K++    L +    E+     L  P ++ L    
Sbjct: 65  RVGRGSFGEVH--RMKDKQTGFQCAVKKVR---LEVFRVEELVACAGLSSPRIVPLYGAV 119
Query: 86  LSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHS 144
                  V +  +  E   L  +IK       +              L Q L+G+ YLH+
Sbjct: 120 --REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALY---------YLGQALEGLEYLHT 168
Query: 145 NWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF--NNPLKPLADLDPVVVTFWYRAP 202
             +LH D+K  N+L+  +G    R  + D G A     +   K L   D +  T  + AP
Sbjct: 169 RRILHGDVKADNVLLSSDG---SRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225
Query: 203 ELLLGARHYTKAIDIWAIGCIFAELLTS 230
           E+++G     K +DIW+  C+   +L  
Sbjct: 226 EVVMGKPCDAK-VDIWSSCCMMLHMLNG 252

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 92/229 (40%), Gaps = 27/229 (11%)
Query: 7   IKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACRE 66
           I   N   K +DL      ++GRG YG V K R   +      A+K+I  T  S    R 
Sbjct: 41  IGNQNFEVKADDLEPI--MELGRGAYGVVEKMRHVPSGQI--MAVKRIRATVNSQEQKRL 96
Query: 67  IALL----RELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXX 122
           +  L    R +  P  +          D  VW+  +  +  L    KF++  +       
Sbjct: 97  LMDLDISMRTVDCPFTVTFYGALFREGD--VWICMELMDTSL---DKFYK--QVIDKGQT 149
Query: 123 XXXXXXXSLLYQILDGIHYLHSNW-VLHRDLKPANILVMGEGIERGRVKIADMGFARLFN 181
                   +   I+  + +LHS   V+HRD+KP+N+L+       G+VK+ D G +    
Sbjct: 150 IPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINA----LGQVKMCDFGISGYLV 205
Query: 182 NPLKPLADLDPVVVTFWYRAPELL---LGARHYTKAIDIWAIGCIFAEL 227
           + +    D         Y APE +   L  + Y+   DIW++G    EL
Sbjct: 206 DSVAKTIDAG----CKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 250

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/241 (21%), Positives = 101/241 (41%), Gaps = 34/241 (14%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI------EGTGLSMSACREIALLRELKHPNVIN 80
           +GRG+Y  V   R K     R YA+K +      +   +      +    +   HP ++ 
Sbjct: 17  IGRGSYAKVLLVRLKKTD--RIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 81  LISVFLSHNDRKVWLLFDYAEHD--LWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           L S F    + +++ + +Y      ++H+ +  +  + +                +I   
Sbjct: 75  LHSCF--QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA----------EISLA 122
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           ++YLH   +++RDLK  N+L+  E    G +K+ D G  +     L+P         T  
Sbjct: 123 LNYLHERGIIYRDLKLDNVLLDSE----GHIKLTDYGMCK---EGLRPGDTTSXFCGTPN 175
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           Y APE+L G   Y  ++D WA+G +  E++     F      + +S+    +  D +F V
Sbjct: 176 YIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDI----VGSSDNPDQNTEDYLFQV 230
Query: 259 M 259
           +
Sbjct: 231 I 231

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 111/256 (43%), Gaps = 41/256 (16%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACR----EIALLRELKHPNVI 79
           G ++G G++G VYK +        D A+K +  T  +    +    E+ +LR+ +H N++
Sbjct: 41  GQRIGSGSFGTVYKGKWHG-----DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 95
Query: 80  NLISVFLSHNDR-KVWLLFDYAE-HDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILD 137
               +F+ ++ + ++ ++  + E   L+H +        +             +  Q   
Sbjct: 96  ----LFMGYSTKPQLAIVTQWCEGSSLYHHL--------HIIETKFEMIKLIDIARQTAQ 143
Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF 197
           G+ YLH+  ++HRDLK  NI +     E   VKI D G A +  +        + +  + 
Sbjct: 144 GMDYLHAKSIIHRDLKSNNIFLH----EDLTVKIGDFGLATV-KSRWSGSHQFEQLSGSI 198
Query: 198 WYRAPEL--LLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 255
            + APE+  +     Y+   D++A G +  EL+T +         +  SN  + DQ+  I
Sbjct: 199 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ---------LPYSNINNRDQI--I 247
Query: 256 FSVMGFPLEKDWEDIR 271
           F V    L  D   +R
Sbjct: 248 FMVGRGYLSPDLSKVR 263

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 111/256 (43%), Gaps = 41/256 (16%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACR----EIALLRELKHPNVI 79
           G ++G G++G VYK +        D A+K +  T  +    +    E+ +LR+ +H N++
Sbjct: 40  GQRIGSGSFGTVYKGKWHG-----DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 94
Query: 80  NLISVFLSHNDR-KVWLLFDYAE-HDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILD 137
               +F+ ++ + ++ ++  + E   L+H +        +             +  Q   
Sbjct: 95  ----LFMGYSTKPQLAIVTQWCEGSSLYHHL--------HIIETKFEMIKLIDIARQTAQ 142
Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF 197
           G+ YLH+  ++HRDLK  NI +     E   VKI D G A +  +        + +  + 
Sbjct: 143 GMDYLHAKSIIHRDLKSNNIFLH----EDLTVKIGDFGLATV-KSRWSGSHQFEQLSGSI 197
Query: 198 WYRAPEL--LLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 255
            + APE+  +     Y+   D++A G +  EL+T +         +  SN  + DQ+  I
Sbjct: 198 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ---------LPYSNINNRDQI--I 246
Query: 256 FSVMGFPLEKDWEDIR 271
           F V    L  D   +R
Sbjct: 247 FMVGRGYLSPDLSKVR 262

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 93/223 (41%), Gaps = 24/223 (10%)
Query: 27  VGRGTYGHVYKARRKDNSDTR-DYALKQIEGTGLSMSACR----EIALLRELKHPNVINL 81
           VG G +G V   R K  S      A+K ++  G +    R    E +++ +  HPN+I L
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
             V      + V ++ +  E+  L   ++ H A                 +L  I  G+ 
Sbjct: 112 EGVVT--KSKPVMIVTEXMENGSLDSFLRKHDA--------QFTVIQLVGMLRGIASGMK 161
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL     +HRDL   NIL+    +     K++D G +R+  +  +         +   + 
Sbjct: 162 YLSDMGAVHRDLAARNILINSNLV----CKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT--SEPIFHCRQEDI 241
           +PE  +  R +T A D+W+ G +  E+++    P +    +D+
Sbjct: 218 SPE-AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 259

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 111/256 (43%), Gaps = 41/256 (16%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACR----EIALLRELKHPNVI 79
           G ++G G++G VYK +        D A+K +  T  +    +    E+ +LR+ +H N++
Sbjct: 18  GQRIGSGSFGTVYKGKWHG-----DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 72
Query: 80  NLISVFLSHNDR-KVWLLFDYAE-HDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILD 137
               +F+ ++ + ++ ++  + E   L+H +        +             +  Q   
Sbjct: 73  ----LFMGYSTKPQLAIVTQWCEGSSLYHHL--------HIIETKFEMIKLIDIARQTAQ 120
Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF 197
           G+ YLH+  ++HRDLK  NI +     E   VKI D G A +  +        + +  + 
Sbjct: 121 GMDYLHAKSIIHRDLKSNNIFLH----EDLTVKIGDFGLATV-KSRWSGSHQFEQLSGSI 175
Query: 198 WYRAPEL--LLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 255
            + APE+  +     Y+   D++A G +  EL+T +         +  SN  + DQ+  I
Sbjct: 176 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ---------LPYSNINNRDQI--I 224
Query: 256 FSVMGFPLEKDWEDIR 271
           F V    L  D   +R
Sbjct: 225 FMVGRGYLSPDLSKVR 240

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 93/224 (41%), Gaps = 27/224 (12%)
Query: 24  GCKVGRGTYGHVYKA------RRKDNSDTRDYALKQIEGTGLSMSACREIALLRELK--- 74
           G  +G G +G V  A      + K N  T+  A+K ++           I+ +  +K   
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTK-VAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 75  -HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAA-------KANXXXXXXXX 125
            H N+INL+       D  ++++ +YA   +L   ++             ++        
Sbjct: 92  KHKNIINLLGA--CTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSS 149
Query: 126 XXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLK 185
               S  YQ+  G+ YL S   +HRDL   N+LV  + +    +KIAD G AR  ++   
Sbjct: 150 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV----MKIADFGLARDIHHIDY 205
Query: 186 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                +  +   W  APE L   R YT   D+W+ G +  E+ T
Sbjct: 206 YKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFGVLLWEIFT 247

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 96/232 (41%), Gaps = 25/232 (10%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC-----REIALLRELKHPNVIN 80
           ++G G +G V+ A   + S T+D  L  ++       A      RE  LL  L+H +++ 
Sbjct: 22  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 81
Query: 81  LISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRA-------AKANXXXXXXXXXXXXSLL 132
              V    +   + ++F+Y +H DL   ++ H          +               + 
Sbjct: 82  FYGV--CGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 133 YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPLKPLADLD 191
            QI  G+ YL S   +HRDL   N LV    +    VKI D G +R +++     +    
Sbjct: 140 SQIASGMVYLASQHFVHRDLATRNCLVGANLL----VKIGDFGMSRDVYSTDYYRVG--G 193
Query: 192 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT--SEPIFHCRQEDI 241
             ++   +  PE ++  R +T   D+W+ G I  E+ T   +P F     ++
Sbjct: 194 HTMLPIRWMPPESIM-YRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV 244

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 93/220 (42%), Gaps = 25/220 (11%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA---CREIALLRELKHPNVINLIS 83
           +G+G   +V++ R K   D   +A+K               RE  +L++L H N++ L +
Sbjct: 17  LGQGATANVFRGRHKKTGDL--FAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 84  VFLSHNDRKVWLLFDYAE-HDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
           +      R   L+ ++     L+ +++    A                +L  ++ G+++L
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG------LPESEFLIVLRDVVGGMNHL 128
Query: 143 HSNWVLHRDLKPANIL-VMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
             N ++HR++KP NI+ V+GE   +   K+ D G AR     L+       +  T  Y  
Sbjct: 129 RENGIVHRNIKPGNIMRVIGED-GQSVYKLTDFGAAR----ELEDDEQFVSLYGTEEYLH 183
Query: 202 PELLLGA-------RHYTKAIDIWAIGCIFAELLTSEPIF 234
           P++   A       + Y   +D+W+IG  F    T    F
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 94/223 (42%), Gaps = 31/223 (13%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA---CREIALLRELKHPNVINLIS 83
           +G+G   +V++ R K   D   +A+K               RE  +L++L H N++ L +
Sbjct: 17  LGQGATANVFRGRHKKTGDL--FAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 84  VFLSHNDRKVWLLFDYAE-HDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
           +      R   L+ ++     L+ +++    A                +L  ++ G+++L
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG------LPESEFLIVLRDVVGGMNHL 128
Query: 143 HSNWVLHRDLKPANIL-VMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW--- 198
             N ++HR++KP NI+ V+GE   +   K+ D G AR        L D +  V  +    
Sbjct: 129 RENGIVHRNIKPGNIMRVIGED-GQSVYKLTDFGAAR-------ELEDDEQFVXLYGTEE 180
Query: 199 YRAPELLLGA-------RHYTKAIDIWAIGCIFAELLTSEPIF 234
           Y  P++   A       + Y   +D+W+IG  F    T    F
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 94/208 (45%), Gaps = 36/208 (17%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G G +G V+ A    ++     A+K ++   +S+ A   E  +++ L+H  ++ L +V
Sbjct: 189 KLGAGQFGEVWMATYNKHTKV---AVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 245
Query: 85  FLSHNDRKVWLLFDY-AEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLH 143
                   ++++ ++ A+  L   +K    +K                  QI +G+ ++ 
Sbjct: 246 V---TKEPIYIITEFMAKGSLLDFLKSDEGSK-------QPLPKLIDFSAQIAEGMAFIE 295
Query: 144 SNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN-PLKPLADLDPVVVTFWYRAP 202
               +HRDL+ ANILV    +     KIAD G AR+    P+K             + AP
Sbjct: 296 QRNYIHRDLRAANILVSASLV----CKIADFGLARVGAKFPIK-------------WTAP 338
Query: 203 ELL-LGARHYTKAIDIWAIGCIFAELLT 229
           E +  G+  +T   D+W+ G +  E++T
Sbjct: 339 EAINFGS--FTIKSDVWSFGILLMEIVT 364

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 59/266 (22%), Positives = 112/266 (42%), Gaps = 38/266 (14%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI------EGTGLSMSACREIALLRELKHPNVIN 80
           +GRG+Y  V   R K     R YA++ +      +   +      +    +   HP ++ 
Sbjct: 60  IGRGSYAKVLLVRLKKTD--RIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117
Query: 81  LISVFLSHNDRKVWLLFDYAEHD--LWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
           L S F    + +++ + +Y      ++H+ +  +  + +                +I   
Sbjct: 118 LHSCF--QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA----------EISLA 165
Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           ++YLH   +++RDLK  N+L+  E    G +K+ D G  +     L+P         T  
Sbjct: 166 LNYLHERGIIYRDLKLDNVLLDSE----GHIKLTDYGMCK---EGLRPGDTTSTFCGTPN 218
Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           Y APE+L G   Y  ++D WA+G +  E++     F      + +S+    +  D +F V
Sbjct: 219 YIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDI----VGSSDNPDQNTEDYLFQV 273
Query: 259 MGFPLEKDWEDIRKMP-EHPTLLKDF 283
           +   LEK     R +  +  ++LK F
Sbjct: 274 I---LEKQIRIPRSLSVKAASVLKSF 296

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 60/253 (23%), Positives = 110/253 (43%), Gaps = 35/253 (13%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACR-EIALLRELKHPNVINLI 82
           G ++G G++G VYK   K + D     L     T   + A + E+ +LR+ +H N++   
Sbjct: 15  GQRIGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL--- 69
Query: 83  SVFLSHNDR-KVWLLFDYAE-HDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
            +F+ ++ + ++ ++  + E   L+H +        +             +  Q   G+ 
Sbjct: 70  -LFMGYSTKPQLAIVTQWCEGSSLYHHL--------HIIETKFEMIKLIDIARQTAQGMD 120
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YLH+  ++HRDLK  NI +     E   VKI D G A +  +        + +  +  + 
Sbjct: 121 YLHAKSIIHRDLKSNNIFLH----EDLTVKIGDFGLATV-KSRWSGSHQFEQLSGSILWM 175
Query: 201 APEL--LLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           APE+  +     Y+   D++A G +  EL+T +         +  SN  + DQ+  IF V
Sbjct: 176 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ---------LPYSNINNRDQI--IFMV 224
Query: 259 MGFPLEKDWEDIR 271
               L  D   +R
Sbjct: 225 GRGYLSPDLSKVR 237

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 76/171 (44%), Gaps = 26/171 (15%)
Query: 65  REIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAE-HDLWHIIKFHRAAKANXXXXXX 123
           +EI +LR L H ++I          ++ + L+ +Y     L   +  H    A       
Sbjct: 65  QEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQL----- 119
Query: 124 XXXXXXSLLY--QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF- 180
                  LL+  QI +G+ YLH+   +HR+L   N+L+  + +    VKI D G A+   
Sbjct: 120 -------LLFAQQICEGMAYLHAQHYIHRNLAARNVLLDNDRL----VKIGDFGLAKAVP 168
Query: 181 --NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
             +   +   D D  V  FWY APE L   + Y  A D+W+ G    ELLT
Sbjct: 169 EGHEYYRVREDGDSPV--FWY-APECLKEYKFYY-ASDVWSFGVTLYELLT 215

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 60/253 (23%), Positives = 110/253 (43%), Gaps = 35/253 (13%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACR-EIALLRELKHPNVINLI 82
           G ++G G++G VYK   K + D     L     T   + A + E+ +LR+ +H N++   
Sbjct: 13  GQRIGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL--- 67
Query: 83  SVFLSHNDR-KVWLLFDYAE-HDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
            +F+ ++ + ++ ++  + E   L+H +        +             +  Q   G+ 
Sbjct: 68  -LFMGYSTKPQLAIVTQWCEGSSLYHHL--------HIIETKFEMIKLIDIARQTAQGMD 118
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YLH+  ++HRDLK  NI +     E   VKI D G A +  +        + +  +  + 
Sbjct: 119 YLHAKSIIHRDLKSNNIFLH----EDLTVKIGDFGLATV-KSRWSGSHQFEQLSGSILWM 173
Query: 201 APEL--LLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           APE+  +     Y+   D++A G +  EL+T +         +  SN  + DQ+  IF V
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ---------LPYSNINNRDQI--IFMV 222
Query: 259 MGFPLEKDWEDIR 271
               L  D   +R
Sbjct: 223 GRGYLSPDLSKVR 235

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 111/256 (43%), Gaps = 41/256 (16%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACR----EIALLRELKHPNVI 79
           G ++G G++G VYK +        D A+K +  T  +    +    E+ +LR+ +H N++
Sbjct: 18  GQRIGSGSFGTVYKGKWHG-----DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 72
Query: 80  NLISVFLSHNDR-KVWLLFDYAE-HDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILD 137
               +F+ ++ + ++ ++  + E   L+H +        +             +  Q   
Sbjct: 73  ----LFMGYSTKPQLAIVTQWCEGSSLYHHL--------HIIETKFEMIKLIDIARQTAQ 120
Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF 197
           G+ YLH+  ++HRDLK  NI +     E   VKI D G A +  +        + +  + 
Sbjct: 121 GMDYLHAKSIIHRDLKSNNIFLH----EDLTVKIGDFGLATV-KSRWSGSHQFEQLSGSI 175
Query: 198 WYRAPEL--LLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 255
            + APE+  +     Y+   D++A G +  EL+T +         +  SN  + DQ+  I
Sbjct: 176 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ---------LPYSNINNRDQI--I 224
Query: 256 FSVMGFPLEKDWEDIR 271
           F V    L  D   +R
Sbjct: 225 FMVGRGYLSPDLSKVR 240

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/216 (22%), Positives = 96/216 (44%), Gaps = 30/216 (13%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACR----EIALLRELKHPNVI 79
           G ++G G++G VYK +        D A+K +  T  +    +    E+ +LR+ +H N++
Sbjct: 29  GQRIGSGSFGTVYKGKWHG-----DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 80  NLISVFLSHNDR-KVWLLFDYAE-HDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILD 137
               +F+ ++   ++ ++  + E   L+H +        +             +  Q   
Sbjct: 84  ----LFMGYSTAPQLAIVTQWCEGSSLYHHL--------HASETKFEMKKLIDIARQTAR 131
Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF 197
           G+ YLH+  ++HRDLK  NI +     E   VKI D G A    +        + +  + 
Sbjct: 132 GMDYLHAKSIIHRDLKSNNIFLH----EDNTVKIGDFGLA-TEKSRWSGSHQFEQLSGSI 186
Query: 198 WYRAPEL--LLGARHYTKAIDIWAIGCIFAELLTSE 231
            + APE+  +  +  Y+   D++A G +  EL+T +
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 93/207 (44%), Gaps = 24/207 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G G +G V+ A    ++     A+K ++   +S+ A   E  +++ L+H  ++ L +V
Sbjct: 195 KLGAGQFGEVWMATYNKHTKV---AVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 85  FLSHNDRKVWLLFDY-AEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLH 143
                   ++++ ++ A+  L   +K    +K                  QI +G+ ++ 
Sbjct: 252 V---TKEPIYIITEFMAKGSLLDFLKSDEGSK-------QPLPKLIDFSAQIAEGMAFIE 301
Query: 144 SNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPE 203
               +HRDL+ ANILV    +     KIAD G AR+  +        +       + APE
Sbjct: 302 QRNYIHRDLRAANILVSASLV----CKIADFGLARVIED--NEYTAREGAKFPIKWTAPE 355
Query: 204 LL-LGARHYTKAIDIWAIGCIFAELLT 229
            +  G+  +T   D+W+ G +  E++T
Sbjct: 356 AINFGS--FTIKSDVWSFGILLMEIVT 380

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 90/212 (42%), Gaps = 29/212 (13%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALL----RELKHPNVINL 81
           ++GRG YG V K R   +      A+K+I  T  S    R +  L    R +  P  +  
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQI--MAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTF 71
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
                   D  VW+  +  +  L    KF++  +               +   I+  + +
Sbjct: 72  YGALFREGD--VWICMELMDTSL---DKFYK--QVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 142 LHSNW-VLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPLKPL-ADLDPVVVTFW 198
           LHS   V+HRD+KP+N+L+       G+VK+ D G +  L ++  K + A   P      
Sbjct: 125 LHSKLSVIHRDVKPSNVLINA----LGQVKMCDFGISGYLVDDVAKDIDAGCKP------ 174
Query: 199 YRAPELL---LGARHYTKAIDIWAIGCIFAEL 227
           Y APE +   L  + Y+   DIW++G    EL
Sbjct: 175 YMAPERINPELNQKGYSVKSDIWSLGITMIEL 206

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 103/248 (41%), Gaps = 25/248 (10%)
Query: 3   YEFKIKTSNERTKVEDLFDYEGCKV-GRGTYGHVYKARRKDNSDTR-DYALKQIEGTGLS 60
           YE   +T +E  K  D  +    KV G G +G V   R K  S      A+K ++  G +
Sbjct: 28  YEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYT 86
Query: 61  MSACR----EIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAK 115
               R    E +++ +  HPN+I L  V      + V ++ +  E+  L   ++ H A  
Sbjct: 87  EKQRRDFLGEASIMGQFDHPNIIRLEGVVT--KSKPVMIVTEXMENGSLDSFLRKHDA-- 142
Query: 116 ANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMG 175
                          +L  I  G+ YL     +HRDL   NIL+    +     K++D G
Sbjct: 143 ------QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLV----CKVSDFG 192
Query: 176 FARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT--SEPI 233
            +R+  +  +         +   + +PE  +  R +T A D+W+ G +  E+++    P 
Sbjct: 193 LSRVLEDDPEAAYTTRGGKIPIRWTSPE-AIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251
Query: 234 FHCRQEDI 241
           +    +D+
Sbjct: 252 WEMSNQDV 259

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 22/215 (10%)
Query: 26  KVGRGTYGHVY----KARRKDNSDTRDYALKQI-EGTGLS--MSACREIALLRELKHPNV 78
           ++G+G++G VY    K   KD  +TR  A+K + E   +   +    E ++++E    +V
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXX-XXXXXXSLLYQILD 137
           + L+ V +S     + ++      DL   ++  R A AN              +  +I D
Sbjct: 91  VRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPL--KPLADLDPVV 194
           G+ YL++N  +HRDL   N +V     E   VKI D G  R ++      K    L PV 
Sbjct: 150 GMAYLNANKFVHRDLAARNCMV----AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
              W     L  G   +T   D+W+ G +  E+ T
Sbjct: 206 ---WMSPESLKDGV--FTTYSDVWSFGVVLWEIAT 235

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 93/207 (44%), Gaps = 23/207 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIA-LLRELKHPNVINLISV 84
           K+G G +G V+     +++     A+K ++   +S+ A  E A L++ L+H  ++ L +V
Sbjct: 19  KLGAGQFGEVWMGYYNNSTKV---AVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAV 75
Query: 85  FLSHNDRKVWLLFDY-AEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLH 143
                +  ++++ ++ A+  L   +K     K                  QI +G+ Y+ 
Sbjct: 76  V--TKEEPIYIITEFMAKGSLLDFLKSDEGGKV-------LLPKLIDFSAQIAEGMAYIE 126
Query: 144 SNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPE 203
               +HRDL+ AN+LV     E    KIAD G AR+  +        +       + APE
Sbjct: 127 RKNYIHRDLRAANVLVS----ESLMCKIADFGLARVIED--NEYTAREGAKFPIKWTAPE 180
Query: 204 LL-LGARHYTKAIDIWAIGCIFAELLT 229
            +  G   +T   ++W+ G +  E++T
Sbjct: 181 AINFGC--FTIKSNVWSFGILLYEIVT 205

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 96/222 (43%), Gaps = 40/222 (18%)
Query: 28  GRGTYGHVYKAR-RKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFL 86
            RG +G V+KA+   D    + + L+  +    S  + REI     +KH N++  I+   
Sbjct: 24  ARGRFGCVWKAQLMNDFVAVKIFPLQDKQ----SWQSEREIFSTPGMKHENLLQFIAAEK 79
Query: 87  SHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILD----GIHYL 142
             ++ +V         +LW I  FH   K +            + L  + +    G+ YL
Sbjct: 80  RGSNLEV---------ELWLITAFHD--KGSLTDYLKGNIITWNELCHVAETMSRGLSYL 128
Query: 143 HSN--W---------VLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLD 191
           H +  W         + HRD K  N+L+  +        +AD G A  F  P KP  D  
Sbjct: 129 HEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLT----AVLADFGLAVRF-EPGKPPGDTH 183
Query: 192 PVVVTFWYRAPELLLGARHYTK----AIDIWAIGCIFAELLT 229
             V T  Y APE+L GA ++ +     ID++A+G +  EL++
Sbjct: 184 GQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 22/215 (10%)
Query: 26  KVGRGTYGHVY----KARRKDNSDTRDYALKQI-EGTGLS--MSACREIALLRELKHPNV 78
           ++G+G++G VY    K   KD  +TR  A+K + E   +   +    E ++++E    +V
Sbjct: 22  ELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 80
Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXX-XXXXXXSLLYQILD 137
           + L+ V +S     + ++      DL   ++  R A AN              +  +I D
Sbjct: 81  VRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 139
Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPL--KPLADLDPVV 194
           G+ YL++N  +HRDL   N +V     E   VKI D G  R ++      K    L PV 
Sbjct: 140 GMAYLNANKFVHRDLAARNCMV----AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 195
Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
              W     L  G   +T   D+W+ G +  E+ T
Sbjct: 196 ---WMSPESLKDGV--FTTYSDVWSFGVVLWEIAT 225

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 117/273 (42%), Gaps = 62/273 (22%)
Query: 14  TKVEDLFD---YEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-LSMSACREIAL 69
            K+ DLF+   +   K+G G +  V+     D    R  A+K ++     + +A  EI L
Sbjct: 23  VKIGDLFNGRYHVIRKLGWGHFSTVWLCW--DMQGKRFVAMKVVKSAQHYTETALDEIKL 80
Query: 70  LRELKH-----PN---VINLISVF--LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXX 119
           L+ ++      PN   V+ LI  F     N   V ++F+   H   H++K+    K+N  
Sbjct: 81  LKCVRESDPSDPNKDMVVQLIDDFKISGMNGIHVCMVFEVLGH---HLLKW--IIKSNYQ 135
Query: 120 XXXXXXXXXXSLLYQILDGIHYLHSNW-VLHRDLKPANIL----------VMGEGIERGR 168
                     S++ Q+L G+ YLHS   ++H D+KP NIL          +  E  E  +
Sbjct: 136 GLPVRCVK--SIIRQVLQGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMAAEATEWQK 193
Query: 169 V--------KIADMGFARLFNNPLKP---------LADLDPV----------VVTFWYRA 201
                     ++    A L  NPL P         +ADL             + T  YR+
Sbjct: 194 AGAPPPSGSAVSTAPAADLLVNPLDPRNADKIRVKIADLGNACWVHKHFTEDIQTRQYRS 253
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
            E+L+GA + T A DIW+  C+  EL T + +F
Sbjct: 254 IEVLIGAGYSTPA-DIWSTACMAFELATGDYLF 285

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 93/223 (41%), Gaps = 24/223 (10%)
Query: 27  VGRGTYGHVYKARRKDNSDTR-DYALKQIEGTGLSMSACR----EIALLRELKHPNVINL 81
           VG G +G V   R K  S      A+K ++  G +    R    E +++ +  HPN+I L
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYTEKQRRDFLGEASIMGQFDHPNIIRL 82
Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
             V      + V ++ +  E+  L   ++ H A                 +L  I  G+ 
Sbjct: 83  EGVV--TKSKPVMIVTEXMENGSLDSFLRKHDA--------QFTVIQLVGMLRGIASGMK 132
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL     +HRDL   NIL+    +     K++D G +R+  +  +         +   + 
Sbjct: 133 YLSDMGYVHRDLAARNILINSNLV----CKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 188
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT--SEPIFHCRQEDI 241
           +PE  +  R +T A D+W+ G +  E+++    P +    +D+
Sbjct: 189 SPE-AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 230

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 88/210 (41%), Gaps = 22/210 (10%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI-EGTGLSMSACREIALLRELKHPNVINLISV 84
           ++G G +G V+     +       A+K I EG         E  ++ +L HP ++ L  V
Sbjct: 12  EIGSGQFGLVHLGYWLNKDKV---AIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 68
Query: 85  FLSHNDRKVWLLFDYAEHD-LWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLH 143
            L      + L+F++ EH  L   ++  R   A              +   + +G+ YL 
Sbjct: 69  CLEQA--PICLVFEFMEHGCLSDYLRTQRGLFA--------AETLLGMCLDVCEGMAYLE 118
Query: 144 SNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPE 203
              V+HRDL   N LV     E   +K++D G  R   +     +      V   + +PE
Sbjct: 119 EACVIHRDLAARNCLVG----ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK--WASPE 172
Query: 204 LLLGARHYTKAIDIWAIGCIFAELLTSEPI 233
           +   +R+ +K+ D+W+ G +  E+ +   I
Sbjct: 173 VFSFSRYSSKS-DVWSFGVLMWEVFSEGKI 201

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 93/207 (44%), Gaps = 24/207 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G G +G V+ A    ++     A+K ++   +S+ A   E  +++ L+H  ++ L +V
Sbjct: 22  KLGAGQFGEVWMATYNKHTKV---AVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 78
Query: 85  FLSHNDRKVWLLFDY-AEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLH 143
                   ++++ ++ A+  L   +K    +K                  QI +G+ ++ 
Sbjct: 79  V---TKEPIYIITEFMAKGSLLDFLKSDEGSK-------QPLPKLIDFSAQIAEGMAFIE 128
Query: 144 SNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPE 203
               +HRDL+ ANILV    +     KIAD G AR+  +        +       + APE
Sbjct: 129 QRNYIHRDLRAANILVSASLV----CKIADFGLARVIED--NEYTAREGAKFPIKWTAPE 182
Query: 204 LL-LGARHYTKAIDIWAIGCIFAELLT 229
            +  G+  +T   D+W+ G +  E++T
Sbjct: 183 AINFGS--FTIKSDVWSFGILLMEIVT 207

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 84/208 (40%), Gaps = 21/208 (10%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYA-----LKQIEGTGLSMSACREIALLRELKHPNVINL 81
           +G G +G VYK       +T         L +  G   ++    E  ++  + HP+++ L
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
           + V LS   + V  L  +       ++++    K N            +   QI  G+ Y
Sbjct: 83  LGVCLSPTIQLVTQLMPHG-----CLLEYVHEHKDNIGSQLLL-----NWCVQIAKGMMY 132
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
           L    ++HRDL   N+LV         VKI D G ARL     K   + D   +   + A
Sbjct: 133 LEERRLVHRDLAARNVLVKSP----NHVKITDFGLARLLEGDEKEY-NADGGKMPIKWMA 187
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
            E  +  R +T   D+W+ G    EL+T
Sbjct: 188 LE-CIHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 87/208 (41%), Gaps = 23/208 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           ++GRG++G V+  R KD       A+K++    L +    E+     L  P ++ L    
Sbjct: 79  RLGRGSFGEVH--RMKDKQTGFQCAVKKVR---LEVFRVEELVACAGLSSPRIVPLYGAV 133
Query: 86  LSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHS 144
                  V +  +  E   L  +IK       +              L Q L+G+ YLH+
Sbjct: 134 --REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYY---------LGQALEGLEYLHT 182
Query: 145 NWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF--NNPLKPLADLDPVVVTFWYRAP 202
             +LH D+K  N+L+  +G    R  + D G A     +   K L   D +  T  + AP
Sbjct: 183 RRILHGDVKADNVLLSSDG---SRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 239
Query: 203 ELLLGARHYTKAIDIWAIGCIFAELLTS 230
           E+++G     K +DIW+  C+   +L  
Sbjct: 240 EVVMGKPCDAK-VDIWSSCCMMLHMLNG 266

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/116 (36%), Positives = 56/116 (48%), Gaps = 19/116 (16%)
Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF---NNPLKPLADL 190
           QI +G+ YLH+   +HRDL   N+L+  + +    VKI D G A+     +   +   D 
Sbjct: 142 QICEGMAYLHAQHYIHRDLAARNVLLDNDRL----VKIGDFGLAKAVPEGHEXYRVREDG 197
Query: 191 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 246
           D  V  FWY APE L   + Y  A D+W+ G    ELLT     HC   D   S P
Sbjct: 198 DSPV--FWY-APECLKEYKFYY-ASDVWSFGVTLYELLT-----HC---DSSQSPP 241

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 89/212 (41%), Gaps = 26/212 (12%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI-EGTGLSMSACREIALLRELKHPNVINLISV 84
           ++G G +G V+     +       A+K I EG         E  ++ +L HP ++ L  V
Sbjct: 14  EIGSGQFGLVHLGYWLNKDKV---AIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 85  FLSHNDRKVWLLFDYAEHD-LWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLH 143
            L      + L+F++ EH  L   ++  R   A              +   + +G+ YL 
Sbjct: 71  CLEQA--PICLVFEFMEHGCLSDYLRTQRGLFA--------AETLLGMCLDVCEGMAYLE 120
Query: 144 SNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR--LFNNPLKPLADLDPVVVTFWYRA 201
              V+HRDL   N LV     E   +K++D G  R  L +          PV     + +
Sbjct: 121 EACVIHRDLAARNCLVG----ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK----WAS 172
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPI 233
           PE+   +R+ +K+ D+W+ G +  E+ +   I
Sbjct: 173 PEVFSFSRYSSKS-DVWSFGVLMWEVFSEGKI 203

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 89/212 (41%), Gaps = 26/212 (12%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI-EGTGLSMSACREIALLRELKHPNVINLISV 84
           ++G G +G V+     +       A+K I EG         E  ++ +L HP ++ L  V
Sbjct: 17  EIGSGQFGLVHLGYWLNKDKV---AIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 73
Query: 85  FLSHNDRKVWLLFDYAEHD-LWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLH 143
            L      + L+F++ EH  L   ++  R   A              +   + +G+ YL 
Sbjct: 74  CLEQA--PICLVFEFMEHGCLSDYLRTQRGLFA--------AETLLGMCLDVCEGMAYLE 123
Query: 144 SNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR--LFNNPLKPLADLDPVVVTFWYRA 201
              V+HRDL   N LV     E   +K++D G  R  L +          PV     + +
Sbjct: 124 EACVIHRDLAARNCLVG----ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK----WAS 175
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPI 233
           PE+   +R+ +K+ D+W+ G +  E+ +   I
Sbjct: 176 PEVFSFSRYSSKS-DVWSFGVLMWEVFSEGKI 206

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/206 (22%), Positives = 78/206 (37%), Gaps = 21/206 (10%)
Query: 27  VGRGTYGHV----YKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLI 82
           +G G +G V    Y +             K      +     +E   +R+  HP+++ LI
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 83  SVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
            V     +  VW++ +     L  +  F +  K +               YQ+   + YL
Sbjct: 78  GVI---TENPVWIIMELC--TLGELRSFLQVRKFSLDLASLILYA-----YQLSTALAYL 127
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAP 202
            S   +HRD+   N+LV         VK+ D G +R   +     A    + +   + AP
Sbjct: 128 ESKRFVHRDIAARNVLVSSNDC----VKLGDFGLSRYMEDSTXXKASKGKLPIK--WMAP 181
Query: 203 ELLLGARHYTKAIDIWAIGCIFAELL 228
           E  +  R +T A D+W  G    E+L
Sbjct: 182 E-SINFRRFTSASDVWMFGVCMWEIL 206

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 110/256 (42%), Gaps = 41/256 (16%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACR----EIALLRELKHPNVI 79
           G ++G G++G VYK +        D A+K +  T  +    +    E+ +LR+ +H N++
Sbjct: 41  GQRIGSGSFGTVYKGKWHG-----DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 95
Query: 80  NLISVFLSHNDR-KVWLLFDYAE-HDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILD 137
               +F+ ++ + ++ ++  + E   L+H +        +             +  Q   
Sbjct: 96  ----LFMGYSTKPQLAIVTQWCEGSSLYHHL--------HIIETKFEMIKLIDIARQTAQ 143
Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF 197
           G+ YLH+  ++HRDLK  NI +     E   VKI D G A    +        + +  + 
Sbjct: 144 GMDYLHAKSIIHRDLKSNNIFLH----EDLTVKIGDFGLA-TEKSRWSGSHQFEQLSGSI 198
Query: 198 WYRAPEL--LLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 255
            + APE+  +     Y+   D++A G +  EL+T +         +  SN  + DQ+  I
Sbjct: 199 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ---------LPYSNINNRDQI--I 247
Query: 256 FSVMGFPLEKDWEDIR 271
           F V    L  D   +R
Sbjct: 248 FMVGRGYLSPDLSKVR 263

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 96/222 (43%), Gaps = 41/222 (18%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACR----------EIALLREL-K 74
           ++G G+YG V+K R K+  D R YA+K+      SMS  R          E+    ++ +
Sbjct: 64  RLGHGSYGEVFKVRSKE--DGRLYAVKR------SMSPFRGPKDRARKLAEVGSHEKVGQ 115
Query: 75  HPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQ 134
           HP  + L   +      +  +L+   E     + +   A  A+            +LL  
Sbjct: 116 HPCCVRLEQAW-----EEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLL-- 168
Query: 135 ILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMG-FARLFNNPLKPLADLDPV 193
               + +LHS  ++H D+KPANI +      RGR K+ D G    L       + + DP 
Sbjct: 169 ---ALAHLHSQGLVHLDVKPANIFLG----PRGRCKLGDFGLLVELGTAGAGEVQEGDPR 221
Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
                Y APELL G+  Y  A D++++G    E+  +  + H
Sbjct: 222 -----YMAPELLQGS--YGTAADVFSLGLTILEVACNMELPH 256

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 98/223 (43%), Gaps = 27/223 (12%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM---SACREIALLRELKHPNVINLI 82
           ++G G +G V++   K  +  R +  K I  T   +   +   EI+++ +L HP +INL 
Sbjct: 58  ELGSGAFGVVHRCVEK--ATGRVFVAKFI-NTPYPLDKYTVKNEISIMNQLHHPKLINLH 114
Query: 83  SVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
             F    +  + L F      L     F R A  +            + + Q  +G+ ++
Sbjct: 115 DAFEDKYEMVLILEF------LSGGELFDRIAAEDYKMSEAEVI---NYMRQACEGLKHM 165
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAP 202
           H + ++H D+KP NI  M E  +   VKI D G A   N    P   +     T  + AP
Sbjct: 166 HEHSIVHLDIKPENI--MCETKKASSVKIIDFGLATKLN----PDEIVKVTTATAEFAAP 219
Query: 203 ELL--LGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT 243
           E++       YT   D+WAIG +   LL+    F   ++D++T
Sbjct: 220 EIVDREPVGFYT---DMWAIGVLGYVLLSGLSPF-AGEDDLET 258

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 94/223 (42%), Gaps = 24/223 (10%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALK-QIEGTGLSMSACR----EIALLRELKHPNVINL 81
           +G G +G V   R K     RD A+  +    G +    R    E +++ +  HPNV++L
Sbjct: 51  IGAGEFGEVCSGRLK-LPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHL 109
Query: 82  ISVFLSHNDRKVWLLFDYAEHD-LWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
             V      + V ++ ++ E+  L   ++ H                   +L  I  G+ 
Sbjct: 110 EGVVT--RGKPVMIVIEFMENGALDAFLRKHDG--------QFTVIQLVGMLRGIAAGMR 159
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL     +HRDL   NILV    +     K++D G +R+  +  + +       +   + 
Sbjct: 160 YLADMGYVHRDLAARNILVNSNLV----CKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWT 215
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT--SEPIFHCRQEDI 241
           APE +   R +T A D+W+ G +  E+++    P +    +D+
Sbjct: 216 APEAIQ-YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV 257

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 89/210 (42%), Gaps = 22/210 (10%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI-EGTGLSMSACREIALLRELKHPNVINLISV 84
           ++G G +G V+     +       A+K I EG+        E  ++ +L HP ++ L  V
Sbjct: 34  EIGSGQFGLVHLGYWLNKDKV---AIKTIKEGSMSEDDFIEEAEVMMKLSHPKLVQLYGV 90
Query: 85  FLSHNDRKVWLLFDYAEHD-LWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLH 143
            L      + L+F++ EH  L   ++  R   A              +   + +G+ YL 
Sbjct: 91  CLEQA--PICLVFEFMEHGCLSDYLRTQRGLFA--------AETLLGMCLDVCEGMAYLE 140
Query: 144 SNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPE 203
              V+HRDL   N LV     E   +K++D G  R   +     +      V   + +PE
Sbjct: 141 EACVIHRDLAARNCLVG----ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK--WASPE 194
Query: 204 LLLGARHYTKAIDIWAIGCIFAELLTSEPI 233
           +   +R+ +K+ D+W+ G +  E+ +   I
Sbjct: 195 VFSFSRYSSKS-DVWSFGVLMWEVFSEGKI 223

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 103/253 (40%), Gaps = 35/253 (13%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACR-EIALLRELKHPNVINLI 82
           G ++G G++G VYK   K + D     L     T   + A + E+ +LR+ +H N++  +
Sbjct: 13  GQRIGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 83  SVFLSHNDRKV--WLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
               +     V  W       H L HII+                     +  Q   G+ 
Sbjct: 71  GYSTAPQLAIVTQWCEGSSLYHHL-HIIE-----------TKFEMIKLIDIARQTAQGMD 118
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YLH+  ++HRDLK  NI +     E   VKI D G A +  +        + +  +  + 
Sbjct: 119 YLHAKSIIHRDLKSNNIFLH----EDLTVKIGDFGLATV-KSRWSGSHQFEQLSGSILWM 173
Query: 201 APEL--LLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           APE+  +     Y+   D++A G +  EL+T +         +  SN  + DQ+  IF V
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ---------LPYSNINNRDQI--IFMV 222
Query: 259 MGFPLEKDWEDIR 271
               L  D   +R
Sbjct: 223 GRGYLSPDLSKVR 235

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 99/218 (45%), Gaps = 32/218 (14%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIA-------LLRELKHPNVI 79
           +G+GT+G V   + K  +  R YA+K ++     + A  E+A       +L+  +HP + 
Sbjct: 16  LGKGTFGKVILVKEK--ATGRYYAMKILKKE--VIVAKDEVAHTLTENRVLQNSRHPFLT 71
Query: 80  NLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            L   F +H+  ++  + +YA   +L+  +   R    +                +I+  
Sbjct: 72  ALKYSFQTHD--RLCFVMEYANGGELFFHLSRERVFSEDRARFYGA---------EIVSA 120
Query: 139 IHYLHSNW-VLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF 197
           + YLHS   V++RDLK  N+++  +G     +KI D G  +     +K  A +     T 
Sbjct: 121 LDYLHSEKNVVYRDLKLENLMLDKDG----HIKITDFGLCK---EGIKDGATMKXFCGTP 173
Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
            Y APE+L     Y +A+D W +G +  E++     F+
Sbjct: 174 EYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFY 210

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/253 (23%), Positives = 109/253 (43%), Gaps = 35/253 (13%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACR-EIALLRELKHPNVINLI 82
           G ++G G++G VYK   K + D     L     T   + A + E+ +LR+ +H N++   
Sbjct: 33  GQRIGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL--- 87
Query: 83  SVFLSHNDR-KVWLLFDYAE-HDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
            +F+ ++ + ++ ++  + E   L+H +        +             +  Q   G+ 
Sbjct: 88  -LFMGYSTKPQLAIVTQWCEGSSLYHHL--------HIIETKFEMIKLIDIARQTAQGMD 138
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YLH+  ++HRDLK  NI +     E   VKI D G A    +        + +  +  + 
Sbjct: 139 YLHAKSIIHRDLKSNNIFLH----EDLTVKIGDFGLA-TEKSRWSGSHQFEQLSGSILWM 193
Query: 201 APEL--LLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           APE+  +     Y+   D++A G +  EL+T +         +  SN  + DQ+  IF V
Sbjct: 194 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ---------LPYSNINNRDQI--IFMV 242
Query: 259 MGFPLEKDWEDIR 271
               L  D   +R
Sbjct: 243 GRGYLSPDLSKVR 255

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 84/208 (40%), Gaps = 21/208 (10%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYA-----LKQIEGTGLSMSACREIALLRELKHPNVINL 81
           +G G +G VYK       +T         L +  G   ++    E  ++  + HP+++ L
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
           + V LS   + V  L  +       ++++    K N            +   QI  G+ Y
Sbjct: 106 LGVCLSPTIQLVTQLMPHG-----CLLEYVHEHKDNIGSQLLL-----NWCVQIAKGMMY 155
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
           L    ++HRDL   N+LV         VKI D G ARL     K   + D   +   + A
Sbjct: 156 LEERRLVHRDLAARNVLVKSP----NHVKITDFGLARLLEGDEKEY-NADGGKMPIKWMA 210
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
            E  +  R +T   D+W+ G    EL+T
Sbjct: 211 LE-CIHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/253 (23%), Positives = 109/253 (43%), Gaps = 35/253 (13%)
Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACR-EIALLRELKHPNVINLI 82
           G ++G G++G VYK   K + D     L     T   + A + E+ +LR+ +H N++   
Sbjct: 13  GQRIGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL--- 67
Query: 83  SVFLSHNDR-KVWLLFDYAE-HDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
            +F+ ++ + ++ ++  + E   L+H +        +             +  Q   G+ 
Sbjct: 68  -LFMGYSTKPQLAIVTQWCEGSSLYHHL--------HIIETKFEMIKLIDIARQTAQGMD 118
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YLH+  ++HRDLK  NI +     E   VKI D G A    +        + +  +  + 
Sbjct: 119 YLHAKSIIHRDLKSNNIFLH----EDLTVKIGDFGLATE-KSRWSGSHQFEQLSGSILWM 173
Query: 201 APEL--LLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           APE+  +     Y+   D++A G +  EL+T +         +  SN  + DQ+  IF V
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ---------LPYSNINNRDQI--IFMV 222
Query: 259 MGFPLEKDWEDIR 271
               L  D   +R
Sbjct: 223 GRGYLSPDLSKVR 235

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 99/218 (45%), Gaps = 32/218 (14%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIA-------LLRELKHPNVI 79
           +G+GT+G V   + K  +  R YA+K ++     + A  E+A       +L+  +HP + 
Sbjct: 18  LGKGTFGKVILVKEK--ATGRYYAMKILKKE--VIVAKDEVAHTLTENRVLQNSRHPFLT 73
Query: 80  NLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            L   F +H+  ++  + +YA   +L+  +   R    +                +I+  
Sbjct: 74  ALKYSFQTHD--RLCFVMEYANGGELFFHLSRERVFSEDRARFYGA---------EIVSA 122
Query: 139 IHYLHSNW-VLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF 197
           + YLHS   V++RDLK  N+++  +G     +KI D G  +     +K  A +     T 
Sbjct: 123 LDYLHSEKNVVYRDLKLENLMLDKDG----HIKITDFGLCK---EGIKDGATMKXFCGTP 175
Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
            Y APE+L     Y +A+D W +G +  E++     F+
Sbjct: 176 EYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFY 212

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/207 (22%), Positives = 83/207 (40%), Gaps = 18/207 (8%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACR----EIALLRELKHPNVINLI 82
           +G G +G V   R K           +    G +    R    E +++ +  HPN+I+L 
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 96
Query: 83  SVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
            V      + V ++ +Y E+    +  F R                  +L  I  G+ YL
Sbjct: 97  GVVTKC--KPVMIITEYMENG--SLDAFLRKNDGRFTVIQLV-----GMLRGIGSGMKYL 147
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAP 202
                +HRDL   NILV    +     K++D G +R+  +  +         +   + AP
Sbjct: 148 SDMSAVHRDLAARNILVNSNLV----CKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAP 203
Query: 203 ELLLGARHYTKAIDIWAIGCIFAELLT 229
           E  +  R +T A D+W+ G +  E+++
Sbjct: 204 E-AIAYRKFTSASDVWSYGIVMWEVMS 229

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 99/218 (45%), Gaps = 32/218 (14%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIA-------LLRELKHPNVI 79
           +G+GT+G V     K+ +  R YA+K ++     + A  E+A       +L+  +HP + 
Sbjct: 159 LGKGTFGKVILV--KEKATGRYYAMKILKKE--VIVAKDEVAHTLTENRVLQNSRHPFLT 214
Query: 80  NLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            L   F +H+  ++  + +YA   +L+  +   R    +                +I+  
Sbjct: 215 ALKYSFQTHD--RLCFVMEYANGGELFFHLSRERVFSEDRARFYGA---------EIVSA 263
Query: 139 IHYLHSNW-VLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF 197
           + YLHS   V++RDLK  N+++  +G     +KI D G  +     +K  A +     T 
Sbjct: 264 LDYLHSEKNVVYRDLKLENLMLDKDG----HIKITDFGLCK---EGIKDGATMKTFCGTP 316
Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
            Y APE+L     Y +A+D W +G +  E++     F+
Sbjct: 317 EYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFY 353

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 99/218 (45%), Gaps = 32/218 (14%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIA-------LLRELKHPNVI 79
           +G+GT+G V   + K  +  R YA+K ++     + A  E+A       +L+  +HP + 
Sbjct: 17  LGKGTFGKVILVKEK--ATGRYYAMKILKKE--VIVAKDEVAHTLTENRVLQNSRHPFLT 72
Query: 80  NLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            L   F +H+  ++  + +YA   +L+  +   R    +                +I+  
Sbjct: 73  ALKYSFQTHD--RLCFVMEYANGGELFFHLSRERVFSEDRARFYGA---------EIVSA 121
Query: 139 IHYLHSNW-VLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF 197
           + YLHS   V++RDLK  N+++  +G     +KI D G  +     +K  A +     T 
Sbjct: 122 LDYLHSEKNVVYRDLKLENLMLDKDG----HIKITDFGLCK---EGIKDGATMKXFCGTP 174
Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
            Y APE+L     Y +A+D W +G +  E++     F+
Sbjct: 175 EYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFY 211

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 90/207 (43%), Gaps = 24/207 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI-EGTGLSMSACREIALLRELKHPNVINLISV 84
           ++G G +G V   + +   D    A+K I EG+        E  ++  L H  ++ L  V
Sbjct: 31  ELGTGQFGVVKYGKWRGQYDV---AIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHS 144
                 R ++++ +Y  +    ++ + R  +               +   + + + YL S
Sbjct: 88  --CTKQRPIFIITEYMANGC--LLNYLREMRHRFQTQQLL-----EMCKDVCEAMEYLES 138
Query: 145 NWVLHRDLKPANILVMGEGIERGRVKIADMGFAR--LFNNPLKPLADLDPVVVTFWYRAP 202
              LHRDL   N LV  +G+    VK++D G +R  L +     +    PV     +  P
Sbjct: 139 KQFLHRDLAARNCLVNDQGV----VKVSDFGLSRYVLDDEETSSVGSKFPVR----WSPP 190
Query: 203 ELLLGARHYTKAIDIWAIGCIFAELLT 229
           E+L+ ++  +K+ DIWA G +  E+ +
Sbjct: 191 EVLMYSKFSSKS-DIWAFGVLMWEIYS 216

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 90/207 (43%), Gaps = 24/207 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI-EGTGLSMSACREIALLRELKHPNVINLISV 84
           ++G G +G V   + +   D    A+K I EG+        E  ++  L H  ++ L  V
Sbjct: 15  ELGTGQFGVVKYGKWRGQYDV---AIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 71
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHS 144
                 R ++++ +Y  +    ++ + R  +               +   + + + YL S
Sbjct: 72  --CTKQRPIFIITEYMANGC--LLNYLREMRHRFQTQQLL-----EMCKDVCEAMEYLES 122
Query: 145 NWVLHRDLKPANILVMGEGIERGRVKIADMGFAR--LFNNPLKPLADLDPVVVTFWYRAP 202
              LHRDL   N LV  +G+    VK++D G +R  L +     +    PV     +  P
Sbjct: 123 KQFLHRDLAARNCLVNDQGV----VKVSDFGLSRYVLDDEYTSSVGSKFPVR----WSPP 174
Query: 203 ELLLGARHYTKAIDIWAIGCIFAELLT 229
           E+L+ ++  +K+ DIWA G +  E+ +
Sbjct: 175 EVLMYSKFSSKS-DIWAFGVLMWEIYS 200

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 90/207 (43%), Gaps = 24/207 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI-EGTGLSMSACREIALLRELKHPNVINLISV 84
           ++G G +G V   + +   D    A+K I EG+        E  ++  L H  ++ L  V
Sbjct: 16  ELGTGQFGVVKYGKWRGQYDV---AIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 72
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHS 144
                 R ++++ +Y  +    ++ + R  +               +   + + + YL S
Sbjct: 73  --CTKQRPIFIITEYMANGC--LLNYLREMRHRFQTQQLL-----EMCKDVCEAMEYLES 123
Query: 145 NWVLHRDLKPANILVMGEGIERGRVKIADMGFAR--LFNNPLKPLADLDPVVVTFWYRAP 202
              LHRDL   N LV  +G+    VK++D G +R  L +     +    PV     +  P
Sbjct: 124 KQFLHRDLAARNCLVNDQGV----VKVSDFGLSRYVLDDEYTSSVGSKFPVR----WSPP 175
Query: 203 ELLLGARHYTKAIDIWAIGCIFAELLT 229
           E+L+ ++  +K+ DIWA G +  E+ +
Sbjct: 176 EVLMYSKFSSKS-DIWAFGVLMWEIYS 201

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/254 (22%), Positives = 100/254 (39%), Gaps = 44/254 (17%)
Query: 15  KVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRD-YALKQIEGTGLSMSACREIALLREL 73
           ++ ++F  E  K+G GT+  VY A  +      +  ALK +  T   +    E+  L   
Sbjct: 18  QLSNVFKIED-KIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVA 76
Query: 74  KHPNVINLISVFLSHNDRKVWLLFDYAEH----DLWHIIKFHRAAKANXXXXXXXXXXXX 129
              + +  +      ND  V +   Y EH    D+ + + F    +              
Sbjct: 77  GGQDNVMGVKYCFRKNDH-VVIAMPYLEHESFLDILNSLSFQEVRE-------------- 121
Query: 130 SLLYQILDGIHYLHSNWVLHRDLKPANIL---------VMGEGIERGR--VKIADMGFA- 177
             +  +   +  +H   ++HRD+KP+N L         ++  G+ +G    KI  + F  
Sbjct: 122 -YMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQ 180
Query: 178 ------RLFNNP----LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 227
                 R   N     L     + P   T  +RAPE+L    + T AID+W+ G IF  L
Sbjct: 181 SEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSL 240
Query: 228 LTSEPIFHCRQEDI 241
           L+    F+   +D+
Sbjct: 241 LSGRYPFYKASDDL 254

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 88/212 (41%), Gaps = 18/212 (8%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFL 86
           +GRG +G VYK R  D +      LK+    G  +    E+ ++    H N++ L    +
Sbjct: 46  LGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCM 105
Query: 87  SHNDRKVWLLFDY-AEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSN 145
           +  +R   L++ Y A   +   ++    ++              S       G+ YLH +
Sbjct: 106 TPTER--LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSA-----RGLAYLHDH 158
Query: 146 W---VLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAP 202
               ++HRD+K ANIL+     E     + D G A+L +   K       V  T  + AP
Sbjct: 159 CDPKIIHRDVKAANILL----DEEFEAVVGDFGLAKLMD--YKDXHVXXAVRGTIGHIAP 212
Query: 203 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           E L   +   K  D++  G +  EL+T +  F
Sbjct: 213 EYLSTGKSSEKT-DVFGYGVMLLELITGQRAF 243

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 94/225 (41%), Gaps = 31/225 (13%)
Query: 24  GCKVGRGTYGHVYKARR---KDNSDTRDYALKQIEGTGLSMSACREIALLRELK------ 74
           G  +GRG +G V +A        +  R  A+K ++  G + S  R  AL+ ELK      
Sbjct: 33  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHR--ALMSELKILIHIG 89
Query: 75  -HPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLL- 132
            H NV+NL+    +     + ++ ++ +    ++  + R+ +                L 
Sbjct: 90  HHLNVVNLLGA-CTKPGGPLMVIVEFCK--FGNLSTYLRSKRNEFVPYKTPEDLYKDFLT 146
Query: 133 --------YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPL 184
                   +Q+  G+ +L S   +HRDL   NIL+     E+  VKI D G AR      
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS----EKNVVKICDFGLARDIXKDP 202
Query: 185 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
             +   D  +   W  APE +   R YT   D+W+ G +  E+ +
Sbjct: 203 DXVRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 245

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 90/207 (43%), Gaps = 24/207 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI-EGTGLSMSACREIALLRELKHPNVINLISV 84
           ++G G +G V   + +   D    A+K I EG+        E  ++  L H  ++ L  V
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDV---AIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 67
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHS 144
                 R ++++ +Y  +    ++ + R  +               +   + + + YL S
Sbjct: 68  --CTKQRPIFIITEYMANGC--LLNYLREMRHRFQTQQLL-----EMCKDVCEAMEYLES 118
Query: 145 NWVLHRDLKPANILVMGEGIERGRVKIADMGFAR--LFNNPLKPLADLDPVVVTFWYRAP 202
              LHRDL   N LV  +G+    VK++D G +R  L +     +    PV     +  P
Sbjct: 119 KQFLHRDLAARNCLVNDQGV----VKVSDFGLSRYVLDDEYTSSVGSKFPVR----WSPP 170
Query: 203 ELLLGARHYTKAIDIWAIGCIFAELLT 229
           E+L+ ++  +K+ DIWA G +  E+ +
Sbjct: 171 EVLMYSKFSSKS-DIWAFGVLMWEIYS 196

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 99/218 (45%), Gaps = 32/218 (14%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIA-------LLRELKHPNVI 79
           +G+GT+G V     K+ +  R YA+K ++     + A  E+A       +L+  +HP + 
Sbjct: 156 LGKGTFGKVILV--KEKATGRYYAMKILKKE--VIVAKDEVAHTLTENRVLQNSRHPFLT 211
Query: 80  NLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
            L   F +H+  ++  + +YA   +L+  +   R    +                +I+  
Sbjct: 212 ALKYSFQTHD--RLCFVMEYANGGELFFHLSRERVFSEDRARFYGA---------EIVSA 260
Query: 139 IHYLHSNW-VLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF 197
           + YLHS   V++RDLK  N+++  +G     +KI D G  +     +K  A +     T 
Sbjct: 261 LDYLHSEKNVVYRDLKLENLMLDKDG----HIKITDFGLCK---EGIKDGATMKTFCGTP 313
Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
            Y APE+L     Y +A+D W +G +  E++     F+
Sbjct: 314 EYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFY 350

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 94/231 (40%), Gaps = 27/231 (11%)
Query: 5   FKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC 64
           F+    N   K +DL      ++GRG YG V K R   +      A+K+I  T  S    
Sbjct: 22  FQGAXENFEVKADDLEPIX--ELGRGAYGVVEKXRHVPSGQIX--AVKRIRATVNSQEQK 77
Query: 65  REIALL----RELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXX 120
           R +  L    R +  P  +          D  VW+  +  +  L    KF++  +     
Sbjct: 78  RLLXDLDISXRTVDCPFTVTFYGALFREGD--VWICXELXDTSL---DKFYK--QVIDKG 130
Query: 121 XXXXXXXXXSLLYQILDGIHYLHSNW-VLHRDLKPANILVMGEGIERGRVKIADMGFARL 179
                     +   I+  + +LHS   V+HRD+KP+N+L+       G+VK  D G +  
Sbjct: 131 QTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINA----LGQVKXCDFGISGY 186
Query: 180 FNNPLKPLADLDPVVVTFWYRAPELL---LGARHYTKAIDIWAIGCIFAEL 227
             + +    D+D       Y APE +   L  + Y+   DIW++G    EL
Sbjct: 187 LVDDVA--KDIDAGCKP--YXAPERINPELNQKGYSVKSDIWSLGITXIEL 233

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 89/212 (41%), Gaps = 26/212 (12%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI-EGTGLSMSACREIALLRELKHPNVINLISV 84
           ++G G +G V+     +       A+K I EG         E  ++ +L HP ++ L  V
Sbjct: 14  EIGSGQFGLVHLGYWLNKDKV---AIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 85  FLSHNDRKVWLLFDYAEHD-LWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLH 143
            L      + L+F++ EH  L   ++  R   A              +   + +G+ YL 
Sbjct: 71  CLEQA--PICLVFEFMEHGCLSDYLRTQRGLFA--------AETLLGMCLDVCEGMAYLE 120
Query: 144 SNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR--LFNNPLKPLADLDPVVVTFWYRA 201
              V+HRDL   N LV     E   +K++D G  R  L +          PV     + +
Sbjct: 121 EASVIHRDLAARNCLVG----ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK----WAS 172
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPI 233
           PE+   +R+ +K+ D+W+ G +  E+ +   I
Sbjct: 173 PEVFSFSRYSSKS-DVWSFGVLMWEVFSEGKI 203

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 68/164 (41%), Gaps = 17/164 (10%)
Query: 65  REIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXX 124
           +E   +R+  HP+++ LI V     +  VW++ +     L  +  F +  K +       
Sbjct: 63  QEALTMRQFDHPHIVKLIGVI---TENPVWIIMELC--TLGELRSFLQVRKYSLDLASLI 117
Query: 125 XXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPL 184
                   YQ+   + YL S   +HRD+   N+LV         VK+ D G +R   +  
Sbjct: 118 LYA-----YQLSTALAYLESKRFVHRDIAARNVLVSSNDC----VKLGDFGLSRYMEDST 168
Query: 185 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 228
              A    + +   + APE  +  R +T A D+W  G    E+L
Sbjct: 169 YYKASKGKLPIK--WMAPE-SINFRRFTSASDVWMFGVCMWEIL 209

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 90/207 (43%), Gaps = 24/207 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI-EGTGLSMSACREIALLRELKHPNVINLISV 84
           ++G G +G V   + +   D    A+K I EG+        E  ++  L H  ++ L  V
Sbjct: 22  ELGTGQFGVVKYGKWRGQYDV---AIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 78
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHS 144
                 R ++++ +Y  +    ++ + R  +               +   + + + YL S
Sbjct: 79  --CTKQRPIFIITEYMANGC--LLNYLREMRHRFQTQQLL-----EMCKDVCEAMEYLES 129
Query: 145 NWVLHRDLKPANILVMGEGIERGRVKIADMGFAR--LFNNPLKPLADLDPVVVTFWYRAP 202
              LHRDL   N LV  +G+    VK++D G +R  L +     +    PV     +  P
Sbjct: 130 KQFLHRDLAARNCLVNDQGV----VKVSDFGLSRYVLDDEYTSSVGSKFPVR----WSPP 181
Query: 203 ELLLGARHYTKAIDIWAIGCIFAELLT 229
           E+L+ ++  +K+ DIWA G +  E+ +
Sbjct: 182 EVLMYSKFSSKS-DIWAFGVLMWEIYS 207

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 99/232 (42%), Gaps = 34/232 (14%)
Query: 16  VEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG---LSMSACREIALLRE 72
           V   ++ +GC +  G  G +Y A  + N + R   LK +  +G       A  E   L E
Sbjct: 78  VAGQYEVKGC-IAHGGLGWIYLALDR-NVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAE 135
Query: 73  LKHPNVINLISVFLSHNDRKV----WLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXX 128
           + HP+++ + + F+ H DR      +++ +Y         K  +   A            
Sbjct: 136 VVHPSIVQIFN-FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAI--------- 185
Query: 129 XSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLA 188
            + L +IL  + YLHS  +++ DLKP NI++  E     ++K+ D+G     N+      
Sbjct: 186 -AYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-----QLKLIDLGAVSRINS------ 233
Query: 189 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
               +  T  ++APE++      T A DI+ +G   A L    P  + R  D
Sbjct: 234 -FGYLYGTPGFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRYVD 282

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 79/209 (37%), Gaps = 21/209 (10%)
Query: 24  GCKVGRGTYGHV----YKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVI 79
           G  +G G +G V    Y +             K      +     +E   +R+  HP+++
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGI 139
            LI V     +  VW++ +     L  +  F +  K +               YQ+   +
Sbjct: 455 KLIGVI---TENPVWIIMELC--TLGELRSFLQVRKFSLDLASLILYA-----YQLSTAL 504
Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
            YL S   +HRD+   N+LV         VK+ D G +R   +     A    + +   +
Sbjct: 505 AYLESKRFVHRDIAARNVLVSATDC----VKLGDFGLSRYMEDSTYYKASKGKLPIK--W 558
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELL 228
            APE  +  R +T A D+W  G    E+L
Sbjct: 559 MAPE-SINFRRFTSASDVWMFGVCMWEIL 586

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 68/164 (41%), Gaps = 17/164 (10%)
Query: 65  REIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXX 124
           +E   +R+  HP+++ LI V     +  VW++ +     L  +  F +  K +       
Sbjct: 62  QEALTMRQFDHPHIVKLIGVI---TENPVWIIMELC--TLGELRSFLQVRKYSLDLASLI 116
Query: 125 XXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPL 184
                   YQ+   + YL S   +HRD+   N+LV         VK+ D G +R   +  
Sbjct: 117 LYA-----YQLSTALAYLESKRFVHRDIAARNVLVSSNDC----VKLGDFGLSRYMEDST 167
Query: 185 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 228
              A    + +   + APE  +  R +T A D+W  G    E+L
Sbjct: 168 YYKASKGKLPIK--WMAPE-SINFRRFTSASDVWMFGVCMWEIL 208

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 68/164 (41%), Gaps = 17/164 (10%)
Query: 65  REIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXX 124
           +E   +R+  HP+++ LI V     +  VW++ +     L  +  F +  K +       
Sbjct: 60  QEALTMRQFDHPHIVKLIGVI---TENPVWIIMELC--TLGELRSFLQVRKYSLDLASLI 114
Query: 125 XXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPL 184
                   YQ+   + YL S   +HRD+   N+LV         VK+ D G +R   +  
Sbjct: 115 LYA-----YQLSTALAYLESKRFVHRDIAARNVLVSSNDC----VKLGDFGLSRYMEDST 165
Query: 185 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 228
              A    + +   + APE  +  R +T A D+W  G    E+L
Sbjct: 166 YYKASKGKLPIK--WMAPE-SINFRRFTSASDVWMFGVCMWEIL 206

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 88/224 (39%), Gaps = 28/224 (12%)
Query: 24  GCKVGRGTYGHVYKARR---KDNSDTRDYALKQIEGTGLSMSACREIALLRELK------ 74
           G  +GRG +G V +A        +  R  A+K ++  G + S  R  AL+ ELK      
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHR--ALMSELKILIHIG 88
Query: 75  -HPNVINLISVFLSHNDR--------KVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXX 125
            H NV+NL+                 K   L  Y        + + + A  +        
Sbjct: 89  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY-KVAPEDLYKDFLTL 147
Query: 126 XXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLK 185
                  +Q+  G+ +L S   +HRDL   NIL+     E+  VKI D G AR       
Sbjct: 148 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS----EKNVVKICDFGLARDIXKDPD 203
Query: 186 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
            +   D  +   W  APE +   R YT   D+W+ G +  E+ +
Sbjct: 204 XVRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 245

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 86/208 (41%), Gaps = 23/208 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           ++GRG++G V+  R +D       A+K++    L +    E+     L  P ++ L    
Sbjct: 100 RLGRGSFGEVH--RMEDKQTGFQCAVKKVR---LEVFRAEELMACAGLTSPRIVPLYGAV 154
Query: 86  LSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHS 144
                  V +  +  E   L  ++K       +              L Q L+G+ YLHS
Sbjct: 155 --REGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALY---------YLGQALEGLEYLHS 203
Query: 145 NWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF--NNPLKPLADLDPVVVTFWYRAP 202
             +LH D+K  N+L+  +G       + D G A     +   K L   D +  T  + AP
Sbjct: 204 RRILHGDVKADNVLLSSDG---SHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAP 260
Query: 203 ELLLGARHYTKAIDIWAIGCIFAELLTS 230
           E++LG R     +D+W+  C+   +L  
Sbjct: 261 EVVLG-RSCDAKVDVWSSCCMMLHMLNG 287

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 68/164 (41%), Gaps = 17/164 (10%)
Query: 65  REIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXX 124
           +E   +R+  HP+++ LI V     +  VW++ +     L  +  F +  K +       
Sbjct: 440 QEALTMRQFDHPHIVKLIGVI---TENPVWIIMELC--TLGELRSFLQVRKFSLDLASLI 494
Query: 125 XXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPL 184
                   YQ+   + YL S   +HRD+   N+LV         VK+ D G +R   +  
Sbjct: 495 LYA-----YQLSTALAYLESKRFVHRDIAARNVLVSSNDC----VKLGDFGLSRYMEDST 545
Query: 185 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 228
              A    + +   + APE  +  R +T A D+W  G    E+L
Sbjct: 546 YYKASKGKLPIK--WMAPE-SINFRRFTSASDVWMFGVCMWEIL 586

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 68/164 (41%), Gaps = 17/164 (10%)
Query: 65  REIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXX 124
           +E   +R+  HP+++ LI V     +  VW++ +     L  +  F +  K +       
Sbjct: 60  QEALTMRQFDHPHIVKLIGVI---TENPVWIIMELC--TLGELRSFLQVRKYSLDLASLI 114
Query: 125 XXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPL 184
                   YQ+   + YL S   +HRD+   N+LV         VK+ D G +R   +  
Sbjct: 115 LYA-----YQLSTALAYLESKRFVHRDIAARNVLVSSNDC----VKLGDFGLSRYMEDST 165
Query: 185 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 228
              A    + +   + APE  +  R +T A D+W  G    E+L
Sbjct: 166 YYKASKGKLPIK--WMAPE-SINFRRFTSASDVWMFGVCMWEIL 206

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 68/164 (41%), Gaps = 17/164 (10%)
Query: 65  REIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXX 124
           +E   +R+  HP+++ LI V     +  VW++ +     L  +  F +  K +       
Sbjct: 88  QEALTMRQFDHPHIVKLIGVI---TENPVWIIMELC--TLGELRSFLQVRKYSLDLASLI 142
Query: 125 XXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPL 184
                   YQ+   + YL S   +HRD+   N+LV         VK+ D G +R   +  
Sbjct: 143 LYA-----YQLSTALAYLESKRFVHRDIAARNVLVSSNDC----VKLGDFGLSRYMEDST 193
Query: 185 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 228
              A    + +   + APE  +  R +T A D+W  G    E+L
Sbjct: 194 YYKASKGKLPIK--WMAPE-SINFRRFTSASDVWMFGVCMWEIL 234

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 68/164 (41%), Gaps = 17/164 (10%)
Query: 65  REIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXX 124
           +E   +R+  HP+++ LI V     +  VW++ +     L  +  F +  K +       
Sbjct: 57  QEALTMRQFDHPHIVKLIGVI---TENPVWIIMELC--TLGELRSFLQVRKYSLDLASLI 111
Query: 125 XXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPL 184
                   YQ+   + YL S   +HRD+   N+LV         VK+ D G +R   +  
Sbjct: 112 LYA-----YQLSTALAYLESKRFVHRDIAARNVLVSSNDC----VKLGDFGLSRYMEDST 162
Query: 185 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 228
              A    + +   + APE  +  R +T A D+W  G    E+L
Sbjct: 163 YYKASKGKLPIK--WMAPE-SINFRRFTSASDVWMFGVCMWEIL 203

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 88/224 (39%), Gaps = 28/224 (12%)
Query: 24  GCKVGRGTYGHVYKARR---KDNSDTRDYALKQIEGTGLSMSACREIALLRELK------ 74
           G  +GRG +G V +A        +  R  A+K ++  G + S  R  AL+ ELK      
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHR--ALMSELKILIHIG 79
Query: 75  -HPNVINLISVFLSHNDR--------KVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXX 125
            H NV+NL+                 K   L  Y        + + + A  +        
Sbjct: 80  HHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPY-KVAPEDLYKDFLTL 138
Query: 126 XXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLK 185
                  +Q+  G+ +L S   +HRDL   NIL+     E+  VKI D G AR       
Sbjct: 139 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS----EKNVVKICDFGLARDIXKDPD 194
Query: 186 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
            +   D  +   W  APE +   R YT   D+W+ G +  E+ +
Sbjct: 195 XVRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 236

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 68/164 (41%), Gaps = 17/164 (10%)
Query: 65  REIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXX 124
           +E   +R+  HP+++ LI V     +  VW++ +     L  +  F +  K +       
Sbjct: 65  QEALTMRQFDHPHIVKLIGVI---TENPVWIIMELC--TLGELRSFLQVRKYSLDLASLI 119
Query: 125 XXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPL 184
                   YQ+   + YL S   +HRD+   N+LV         VK+ D G +R   +  
Sbjct: 120 LYA-----YQLSTALAYLESKRFVHRDIAARNVLVSSNDC----VKLGDFGLSRYMEDST 170
Query: 185 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 228
              A    + +   + APE  +  R +T A D+W  G    E+L
Sbjct: 171 YYKASKGKLPIK--WMAPE-SINFRRFTSASDVWMFGVCMWEIL 211

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 68/164 (41%), Gaps = 17/164 (10%)
Query: 65  REIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXX 124
           +E   +R+  HP+++ LI V     +  VW++ +     L  +  F +  K +       
Sbjct: 60  QEALTMRQFDHPHIVKLIGVI---TENPVWIIMELC--TLGELRSFLQVRKFSLDLASLI 114
Query: 125 XXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPL 184
                   YQ+   + YL S   +HRD+   N+LV         VK+ D G +R   +  
Sbjct: 115 LYA-----YQLSTALAYLESKRFVHRDIAARNVLVSATDC----VKLGDFGLSRYMEDST 165
Query: 185 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 228
              A    + +   + APE  +  R +T A D+W  G    E+L
Sbjct: 166 YYKASKGKLPIK--WMAPE-SINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/178 (23%), Positives = 76/178 (42%), Gaps = 16/178 (8%)
Query: 66  EIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXX 125
           E +++ +  HPN+I+L  V      + V ++ +Y E+    +  F R             
Sbjct: 65  EASIMGQFDHPNIIHLEGVVTKC--KPVMIITEYMENG--SLDAFLRKNDGRFTVIQLV- 119
Query: 126 XXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLK 185
                +L  I  G+ YL     +HRDL   NILV    +     K++D G +R+  +  +
Sbjct: 120 ----GMLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLV----CKVSDFGMSRVLEDDPE 171
Query: 186 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT--SEPIFHCRQEDI 241
                    +   + APE  +  R +T A D+W+ G +  E+++    P +    +D+
Sbjct: 172 AAYTTRGGKIPIRWTAPE-AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV 228

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 44/104 (42%), Gaps = 20/104 (19%)
Query: 149 HRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGA 208
           HRD+KP NILV  +        + D G A    +  + L  L   V T +Y APE     
Sbjct: 157 HRDVKPENILVSADDF----AYLVDFGIASATTD--EKLTQLGNTVGTLYYXAPE-RFSE 209
Query: 209 RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 252
            H T   DI+A+ C+  E LT  P             PY  DQL
Sbjct: 210 SHATYRADIYALTCVLYECLTGSP-------------PYQGDQL 240

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 89/212 (41%), Gaps = 16/212 (7%)
Query: 26  KVGRGTYGHVY----KARRKDNSDTRDYALKQI-EGTGLS--MSACREIALLRELKHPNV 78
           ++G+G++G VY    K   KD  +TR  A+K + E   +   +    E ++++E    +V
Sbjct: 17  ELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 75
Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRA-AKANXXXXXXXXXXXXSLLYQILD 137
           + L+ V +S     + ++      DL   ++  R   + N             +  +I D
Sbjct: 76  VRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 134
Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF 197
           G+ YL++N  +HRDL   N +V     E   VKI D G  R              ++   
Sbjct: 135 GMAYLNANKFVHRDLAARNCMV----AEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 190
Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
           W     L  G   +T   D+W+ G +  E+ T
Sbjct: 191 WMSPESLKDGV--FTTYSDVWSFGVVLWEIAT 220

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/225 (23%), Positives = 96/225 (42%), Gaps = 32/225 (14%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREI----ALLRELKHPNVINL 81
           ++G GT G V+K R +        A+KQ+  +G      R +     +L+    P ++  
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHV--IAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQC 89
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
              F+++ D  V++  +        + K  +                  +   I+  ++Y
Sbjct: 90  FGTFITNTD--VFIAMELMGTCAEKLKKRMQGP--------IPERILGKMTVAIVKALYY 139
Query: 142 L-HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA-RLFNNPLKPLADLDPVVVTFWY 199
           L   + V+HRD+KP+NIL+     ERG++K+ D G + RL ++  K     D       Y
Sbjct: 140 LKEKHGVIHRDVKPSNILL----DERGQIKLCDFGISGRLVDDKAK-----DRSAGCAAY 190
Query: 200 RAPELL----LGARHYTKAIDIWAIGCIFAELLTSE-PIFHCRQE 239
            APE +         Y    D+W++G    EL T + P  +C+ +
Sbjct: 191 MAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD 235

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 88/224 (39%), Gaps = 28/224 (12%)
Query: 24  GCKVGRGTYGHVYKARR---KDNSDTRDYALKQIEGTGLSMSACREIALLRELK------ 74
           G  +GRG +G V +A        +  R  A+K ++  G + S  R  AL+ ELK      
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHR--ALMSELKILIHIG 79
Query: 75  -HPNVINLISVFLSHNDR--------KVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXX 125
            H NV+NL+                 K   L  Y        + + + A  +        
Sbjct: 80  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY-KVAPEDLYKDFLTL 138
Query: 126 XXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLK 185
                  +Q+  G+ +L S   +HRDL   NIL+     E+  VKI D G AR       
Sbjct: 139 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS----EKNVVKICDFGLARDIXKDPD 194
Query: 186 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
            +   D  +   W  APE +   R YT   D+W+ G +  E+ +
Sbjct: 195 XVRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 236

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 90/207 (43%), Gaps = 24/207 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI-EGTGLSMSACREIALLRELKHPNVINLISV 84
           ++G G +G V   + +   D    A+K I EG+        E  ++  L H  ++ L  V
Sbjct: 31  ELGTGQFGVVKYGKWRGQYDV---AIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHS 144
                 R ++++ +Y  +    ++ + R  +               +   + + + YL S
Sbjct: 88  --CTKQRPIFIITEYMANGC--LLNYLREMRHRFQTQQLL-----EMCKDVCEAMEYLES 138
Query: 145 NWVLHRDLKPANILVMGEGIERGRVKIADMGFAR--LFNNPLKPLADLDPVVVTFWYRAP 202
              LHRDL   N LV  +G+    VK++D G +R  L +     +    PV     +  P
Sbjct: 139 KQFLHRDLAARNCLVNDQGV----VKVSDFGLSRYVLDDEYTSSVGSKFPVR----WSPP 190
Query: 203 ELLLGARHYTKAIDIWAIGCIFAELLT 229
           E+L+ ++  +K+ DIWA G +  E+ +
Sbjct: 191 EVLMYSKFSSKS-DIWAFGVLMWEIYS 216

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/178 (23%), Positives = 76/178 (42%), Gaps = 16/178 (8%)
Query: 66  EIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXX 125
           E +++ +  HPN+I+L  V      + V ++ +Y E+    +  F R             
Sbjct: 59  EASIMGQFDHPNIIHLEGVVTKC--KPVMIITEYMENG--SLDAFLRKNDGRFTVIQLV- 113
Query: 126 XXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLK 185
                +L  I  G+ YL     +HRDL   NILV    +     K++D G +R+  +  +
Sbjct: 114 ----GMLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLV----CKVSDFGMSRVLEDDPE 165
Query: 186 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT--SEPIFHCRQEDI 241
                    +   + APE  +  R +T A D+W+ G +  E+++    P +    +D+
Sbjct: 166 AAYTTRGGKIPIRWTAPE-AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV 222

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 89/212 (41%), Gaps = 16/212 (7%)
Query: 26  KVGRGTYGHVY----KARRKDNSDTRDYALKQI-EGTGLS--MSACREIALLRELKHPNV 78
           ++G+G++G VY    K   KD  +TR  A+K + E   +   +    E ++++E    +V
Sbjct: 26  ELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 84
Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRA-AKANXXXXXXXXXXXXSLLYQILD 137
           + L+ V +S     + ++      DL   ++  R   + N             +  +I D
Sbjct: 85  VRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 143
Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF 197
           G+ YL++N  +HRDL   N +V     E   VKI D G  R              ++   
Sbjct: 144 GMAYLNANKFVHRDLAARNCMV----AEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 199
Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
           W     L  G   +T   D+W+ G +  E+ T
Sbjct: 200 WMSPESLKDGV--FTTYSDVWSFGVVLWEIAT 229

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/222 (22%), Positives = 91/222 (40%), Gaps = 22/222 (9%)
Query: 27  VGRGTYGHVYKARRK-DNSDTRDYALKQIEGTGLSMSACR----EIALLRELKHPNVINL 81
           +G G +G V   R K         A+K ++  G +    R    E +++ +  HPN+I+L
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLK-VGYTEKQRRDFLGEASIMGQFDHPNIIHL 88
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
             V      + V ++ +Y E+            K N             +L  I  G+ Y
Sbjct: 89  EGVVT--KSKPVMIVTEYMENG-----SLDTFLKKNDGQFTVIQLV--GMLRGISAGMKY 139
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
           L     +HRDL   NIL+    +     K++D G +R+  +  +         +   + A
Sbjct: 140 LSDMGYVHRDLAARNILINSNLV----CKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTA 195
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT--SEPIFHCRQEDI 241
           PE  +  R +T A D+W+ G +  E+++    P +    +D+
Sbjct: 196 PE-AIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDV 236

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 94/225 (41%), Gaps = 32/225 (14%)
Query: 24  GCKVGRGTYGHVYKARR---KDNSDTRDYALKQIEGTGLSMSACREIALLRELK------ 74
           G  +GRG +G V +A        +  R  A+K ++  G + S  R  AL+ ELK      
Sbjct: 34  GKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLK-EGATHSEHR--ALMSELKILIHIG 90
Query: 75  -HPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLL- 132
            H NV+NL+    +     + ++ ++ +   +  +  +  +K N              L 
Sbjct: 91  HHLNVVNLLGA-CTKPGGPLMVIVEFCK---FGNLSTYLRSKRNEFVPYKPEDLYKDFLT 146
Query: 133 --------YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPL 184
                   +Q+  G+ +L S   +HRDL   NIL+     E+  VKI D G AR      
Sbjct: 147 LEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLS----EKNVVKICDFGLARDIXKDP 202
Query: 185 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
             +   D  +   W  APE +   R YT   D+W+ G +  E+ +
Sbjct: 203 DXVRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 245

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 92/225 (40%), Gaps = 30/225 (13%)
Query: 24  GCKVGRGTYGHVYKARR---KDNSDTRDYALKQIEGTGLSMSACREIALLRELK------ 74
           G  +GRG +G V +A        +  R  A+K ++  G + S  R  AL+ ELK      
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHR--ALMSELKILIHIG 88
Query: 75  -HPNVINLISVFLSHNDR--------KVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXX 125
            H NV+NL+                 K   L  Y        + + + A  +        
Sbjct: 89  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY-KVAPEDLYKDFLTL 147
Query: 126 XXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPL 184
                  +Q+  G+ +L S   +HRDL   NIL+     E+  VKI D G AR ++ +P 
Sbjct: 148 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS----EKNVVKICDFGLARDIYKDP- 202
Query: 185 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
             +   D  +   W  APE +   R YT   D+W+ G +  E+ +
Sbjct: 203 DXVRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 245

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/217 (20%), Positives = 88/217 (40%), Gaps = 20/217 (9%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           ++G G +G V++   +   +                +  +EI  +  L+HP ++NL   F
Sbjct: 58  ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 117
Query: 86  LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSN 145
              +D ++ +++++          F + A  +              + Q+  G+ ++H N
Sbjct: 118 --EDDNEMVMIYEFMSGGEL----FEKVADEHNKMSEDEAV---EYMRQVCKGLCHMHEN 168
Query: 146 WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELL 205
             +H DLKP NI+   +      +K+ D G        L P   +     T  + APE+ 
Sbjct: 169 NYVHLDLKPENIMFTTK--RSNELKLIDFGLTAH----LDPKQSVKVTTGTAEFAAPEVA 222
Query: 206 LG--ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
            G    +YT   D+W++G +   LL+    F    +D
Sbjct: 223 EGKPVGYYT---DMWSVGVLSYILLSGLSPFGGENDD 256

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 86/208 (41%), Gaps = 23/208 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           ++GRG++G V+  R +D       A+K++    L +    E+     L  P ++ L    
Sbjct: 81  RLGRGSFGEVH--RMEDKQTGFQCAVKKVR---LEVFRAEELMACAGLTSPRIVPLYGAV 135
Query: 86  LSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHS 144
                  V +  +  E   L  ++K       +              L Q L+G+ YLHS
Sbjct: 136 --REGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALY---------YLGQALEGLEYLHS 184
Query: 145 NWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF--NNPLKPLADLDPVVVTFWYRAP 202
             +LH D+K  N+L+  +G       + D G A     +   K L   D +  T  + AP
Sbjct: 185 RRILHGDVKADNVLLSSDG---SHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAP 241
Query: 203 ELLLGARHYTKAIDIWAIGCIFAELLTS 230
           E++LG R     +D+W+  C+   +L  
Sbjct: 242 EVVLG-RSCDAKVDVWSSCCMMLHMLNG 268

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/217 (20%), Positives = 88/217 (40%), Gaps = 20/217 (9%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           ++G G +G V++   +   +                +  +EI  +  L+HP ++NL   F
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 86  LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSN 145
              +D ++ +++++          F + A  +              + Q+  G+ ++H N
Sbjct: 224 --EDDNEMVMIYEFMSGGEL----FEKVADEHNKMSEDEAV---EYMRQVCKGLCHMHEN 274
Query: 146 WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELL 205
             +H DLKP NI+   +      +K+ D G        L P   +     T  + APE+ 
Sbjct: 275 NYVHLDLKPENIMFTTK--RSNELKLIDFGLTAH----LDPKQSVKVTTGTAEFAAPEVA 328
Query: 206 LG--ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
            G    +YT   D+W++G +   LL+    F    +D
Sbjct: 329 EGKPVGYYT---DMWSVGVLSYILLSGLSPFGGENDD 362

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 89/207 (42%), Gaps = 24/207 (11%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI-EGTGLSMSACREIALLRELKHPNVINLISV 84
           ++G G +G V   + +   D    A+K I EG+        E  ++  L H  ++ L  V
Sbjct: 16  ELGTGQFGVVKYGKWRGQYDV---AIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 72
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHS 144
                 R ++++ +Y  +    ++ + R  +               +   + + + YL S
Sbjct: 73  --CTKQRPIFIITEYMANGC--LLNYLREMRHRFQTQQLL-----EMCKDVCEAMEYLES 123
Query: 145 NWVLHRDLKPANILVMGEGIERGRVKIADMGFAR--LFNNPLKPLADLDPVVVTFWYRAP 202
              LHRDL   N LV  +G+    VK++D G +R  L +          PV     +  P
Sbjct: 124 KQFLHRDLAARNCLVNDQGV----VKVSDFGLSRYVLDDEYTSSRGSKFPVR----WSPP 175
Query: 203 ELLLGARHYTKAIDIWAIGCIFAELLT 229
           E+L+ ++  +K+ DIWA G +  E+ +
Sbjct: 176 EVLMYSKFSSKS-DIWAFGVLMWEIYS 201

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 34/112 (30%), Positives = 52/112 (46%), Gaps = 9/112 (8%)
Query: 131 LLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR--LFNNPLKPLA 188
           ++  +   + +LH+  + HRDLKP NIL      +   VKI D G       N    P++
Sbjct: 116 VVQDVASALDFLHNKGIAHRDLKPENILCEHPN-QVSPVKICDFGLGSGIKLNGDCSPIS 174
Query: 189 --DLDPVVVTFWYRAPELLLG----ARHYTKAIDIWAIGCIFAELLTSEPIF 234
             +L     +  Y APE++      A  Y K  D+W++G I   LL+  P F
Sbjct: 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 30/223 (13%)
Query: 24  GCKVGRGTYGHVYKARR---KDNSDTRDYALKQIEGTGLSMSACREIALLRELK------ 74
           G  +GRG +G V +A        +  R  A+K ++  G + S  R  AL+ ELK      
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLK-EGATHSEHR--ALMSELKILIHIG 88
Query: 75  -HPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSL-- 131
            H NV+NL+    +     + ++ ++ +    ++  + R+ +              +L  
Sbjct: 89  HHLNVVNLLGA-CTKPGGPLMVIVEFCK--FGNLSTYLRSKRNEFVPYKDLYKDFLTLEH 145
Query: 132 ----LYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPLKP 186
                +Q+  G+ +L S   +HRDL   NIL+     E+  VKI D G AR ++ +P   
Sbjct: 146 LICYSFQVAKGMEFLASRKXIHRDLAARNILLS----EKNVVKICDFGLARDIYKDP-DY 200
Query: 187 LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
           +   D  +   W  APE +   R YT   D+W+ G +  E+ +
Sbjct: 201 VRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 241

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 30/223 (13%)
Query: 24  GCKVGRGTYGHVYKARR---KDNSDTRDYALKQIEGTGLSMSACREIALLRELK------ 74
           G  +GRG +G V +A        +  R  A+K ++  G + S  R  AL+ ELK      
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLK-EGATHSEHR--ALMSELKILIHIG 88
Query: 75  -HPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSL-- 131
            H NV+NL+    +     + ++ ++ +    ++  + R+ +              +L  
Sbjct: 89  HHLNVVNLLGA-CTKPGGPLMVIVEFCK--FGNLSTYLRSKRNEFVPYKDLYKDFLTLEH 145
Query: 132 ----LYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPLKP 186
                +Q+  G+ +L S   +HRDL   NIL+     E+  VKI D G AR ++ +P   
Sbjct: 146 LIXYSFQVAKGMEFLASRKXIHRDLAARNILLS----EKNVVKIXDFGLARDIYKDP-DY 200
Query: 187 LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
           +   D  +   W  APE +   R YT   D+W+ G +  E+ +
Sbjct: 201 VRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 241

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 71/324 (21%), Positives = 116/324 (35%), Gaps = 53/324 (16%)
Query: 2   DYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM 61
           +YE+ +K    R  +E      G  +G G +G V  A     S T       ++      
Sbjct: 33  EYEYDLKWEFPRENLEF-----GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA 87
Query: 62  SACREIALLRELK-------HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRA 113
            +    AL+ ELK       H N++NL+          ++L+F+Y  + DL + ++  R 
Sbjct: 88  DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG--PIYLIFEYCCYGDLLNYLRSKRE 145
Query: 114 A--------------KANXXXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILV 159
                          +                 YQ+  G+ +L     +HRDL   N+LV
Sbjct: 146 KFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV 205
Query: 160 MGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWA 219
               +    VKI D G AR   +    +   +  +   W  APE L     YT   D+W+
Sbjct: 206 THGKV----VKICDFGLARDIMSDSNYVVRGNARLPVKW-MAPESLFEG-IYTIKSDVWS 259
Query: 220 IGCIFAELLT-----------SEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGFPLEKDWE 268
            G +  E+ +               +   Q   K   P++  +   I+ +M    +  W 
Sbjct: 260 YGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATE--EIYIIM----QSCWA 313
Query: 269 -DIRKMPEHPTLLKDFNEQICKME 291
            D RK P  P L      Q+   E
Sbjct: 314 FDSRKRPSFPNLTSFLGCQLADAE 337

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 104/236 (44%), Gaps = 37/236 (15%)
Query: 14  TKVEDLFDYEGCKVGRGTYGHVYKARR-KDNS--DTRDYALKQIEGTGLSMSAC----RE 66
           T  ++  +YE  ++G+G +G V+K R  KD S    +   L   EG    +       RE
Sbjct: 15  TLADNEIEYEK-QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQRE 73
Query: 67  IALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHII--KFHRAAKANXXXXXXX 124
           + ++  L HPN++ L    L HN  ++ + F     DL+H +  K H    +        
Sbjct: 74  VFIMSNLNHPNIVKLYG--LMHNPPRMVMEF-VPCGDLYHRLLDKAHPIKWS-------- 122
Query: 125 XXXXXSLLYQILDGIHYLHSN--WVLHRDLKPANILVMGEGIERGRV--KIADMGFARLF 180
                 L+  I  GI Y+ +    ++HRDL+  NI +     E   V  K+AD G ++  
Sbjct: 123 --VKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLD-ENAPVCAKVADFGLSQ-- 177
Query: 181 NNPLKPLADLDPVVVTFWYRAPELLLGARH--YTKAIDIWAIGCIFAELLTSEPIF 234
               + +  +  ++  F + APE  +GA    YT+  D ++   I   +LT E  F
Sbjct: 178 ----QSVHSVSGLLGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 92/225 (40%), Gaps = 30/225 (13%)
Query: 24  GCKVGRGTYGHVYKARR---KDNSDTRDYALKQIEGTGLSMSACREIALLRELK------ 74
           G  +GRG +G V +A        +  R  A+K ++  G + S  R  AL+ ELK      
Sbjct: 69  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHR--ALMSELKILIHIG 125
Query: 75  -HPNVINLISVFLSHNDR--------KVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXX 125
            H NV+NL+                 K   L  Y        + + + A  +        
Sbjct: 126 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY-KVAPEDLYKDFLTL 184
Query: 126 XXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPL 184
                  +Q+  G+ +L S   +HRDL   NIL+     E+  VKI D G AR ++ +P 
Sbjct: 185 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS----EKNVVKICDFGLARDIYKDP- 239
Query: 185 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
             +   D  +   W  APE +   R YT   D+W+ G +  E+ +
Sbjct: 240 DYVRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 282

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 92/225 (40%), Gaps = 30/225 (13%)
Query: 24  GCKVGRGTYGHVYKARR---KDNSDTRDYALKQIEGTGLSMSACREIALLRELK------ 74
           G  +GRG +G V +A        +  R  A+K ++  G + S  R  AL+ ELK      
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHR--ALMSELKILIHIG 79
Query: 75  -HPNVINLISVFLSHNDR--------KVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXX 125
            H NV+NL+                 K   L  Y        + + + A  +        
Sbjct: 80  HHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPY-KVAPEDLYKDFLTL 138
Query: 126 XXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPL 184
                  +Q+  G+ +L S   +HRDL   NIL+     E+  VKI D G AR ++ +P 
Sbjct: 139 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS----EKNVVKICDFGLARDIYKDP- 193
Query: 185 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
             +   D  +   W  APE +   R YT   D+W+ G +  E+ +
Sbjct: 194 DYVRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 236

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 103/234 (44%), Gaps = 33/234 (14%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-LSMSACREIALLRELKHPNVINLISV 84
           K+G GT+G V   +  DN   + YA+K +      + SA  E  +L+++++ ++ N   V
Sbjct: 42  KMGDGTFGRVLLCQHIDNK--KYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIV 99
Query: 85  -----FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGI 139
                F+ ++   + L+F+     L+ II      + N             +  +IL  +
Sbjct: 100 KYHGKFMYYDH--MCLIFEPLGPSLYEII-----TRNNYNGFHIEDIKLYCI--EILKAL 150
Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRV---KIADMGFARLFNNPLKPLADLDPVVVT 196
           +YL    + H DLKP NIL+     E+  +   ++ D    +++      +  +D    T
Sbjct: 151 NYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCAT 210
Query: 197 F------------WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 238
           F             YRAPE++L    +  + D+W+ GC+ AEL T   +F   +
Sbjct: 211 FKSDYHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRTHE 263

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 92/225 (40%), Gaps = 30/225 (13%)
Query: 24  GCKVGRGTYGHVYKARR---KDNSDTRDYALKQIEGTGLSMSACREIALLRELK------ 74
           G  +GRG +G V +A        +  R  A+K ++  G + S  R  AL+ ELK      
Sbjct: 34  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHR--ALMSELKILIHIG 90
Query: 75  -HPNVINLISVFLSHNDR--------KVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXX 125
            H NV+NL+                 K   L  Y        + + + A  +        
Sbjct: 91  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY-KEAPEDLYKDFLTL 149
Query: 126 XXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPL 184
                  +Q+  G+ +L S   +HRDL   NIL+     E+  VKI D G AR ++ +P 
Sbjct: 150 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS----EKNVVKICDFGLARDIYKDP- 204
Query: 185 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
             +   D  +   W  APE +   R YT   D+W+ G +  E+ +
Sbjct: 205 DYVRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 247

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 92/225 (40%), Gaps = 30/225 (13%)
Query: 24  GCKVGRGTYGHVYKARR---KDNSDTRDYALKQIEGTGLSMSACREIALLRELK------ 74
           G  +GRG +G V +A        +  R  A+K ++  G + S  R  AL+ ELK      
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHR--ALMSELKILIHIG 79
Query: 75  -HPNVINLISVFLSHNDR--------KVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXX 125
            H NV+NL+                 K   L  Y        + + + A  +        
Sbjct: 80  HHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPY-KVAPEDLYKDFLTL 138
Query: 126 XXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPL 184
                  +Q+  G+ +L S   +HRDL   NIL+     E+  VKI D G AR ++ +P 
Sbjct: 139 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS----EKNVVKICDFGLARDIYKDP- 193
Query: 185 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
             +   D  +   W  APE +   R YT   D+W+ G +  E+ +
Sbjct: 194 DYVRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 236

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 92/225 (40%), Gaps = 30/225 (13%)
Query: 24  GCKVGRGTYGHVYKARR---KDNSDTRDYALKQIEGTGLSMSACREIALLRELK------ 74
           G  +GRG +G V +A        +  R  A+K ++  G + S  R  AL+ ELK      
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHR--ALMSELKILIHIG 88
Query: 75  -HPNVINLISVFLSHNDR--------KVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXX 125
            H NV+NL+                 K   L  Y        + + + A  +        
Sbjct: 89  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY-KVAPEDLYKDFLTL 147
Query: 126 XXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPL 184
                  +Q+  G+ +L S   +HRDL   NIL+     E+  VKI D G AR ++ +P 
Sbjct: 148 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS----EKNVVKICDFGLARDIYKDP- 202
Query: 185 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
             +   D  +   W  APE +   R YT   D+W+ G +  E+ +
Sbjct: 203 DYVRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 245

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/276 (21%), Positives = 113/276 (40%), Gaps = 42/276 (15%)
Query: 27  VGRGTYGHVYKA--RRKDNSDTRDYALKQ-------IEGTGLSMSACREIALLRELKHPN 77
           +G G +G V+ A  + K+      +  K+       IE   L      EIA+L  ++H N
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLG-KVTLEIAILSRVEHAN 90
Query: 78  VINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILD 137
           +I ++ +F +    ++ +    +  DL+  I  H                   +  Q++ 
Sbjct: 91  IIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRH---------PRLDEPLASYIFRQLVS 141
Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA------RLFNNPLKPLADLD 191
            + YL    ++HRD+K  NI++     E   +K+ D G A      +LF           
Sbjct: 142 AVGYLRLKDIIHRDIKDENIVIA----EDFTIKLIDFGSAAYLERGKLFYT--------- 188
Query: 192 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS--NPYH- 248
               T  Y APE+L+G  +    +++W++G     L+  E  F   +E ++ +   PY  
Sbjct: 189 -FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLV 247
Query: 249 HDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDFN 284
             +L  + S +  P+ +    + K+   P + +  N
Sbjct: 248 SKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVN 283

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/259 (23%), Positives = 98/259 (37%), Gaps = 44/259 (16%)
Query: 24  GCKVGRGTYGHVYKARR---KDNSDTRDYALKQIEGTGLSMSACR----EIALLRELKHP 76
           G  +G G +G V KA     K  +     A+K ++    S S  R    E  +L+++ HP
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHP 86
Query: 77  NVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXX---------------X 120
           +VI L        D  + L+ +YA++  L   ++  R                       
Sbjct: 87  HVIKLYGA--CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 121 XXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
                    S  +QI  G+ YL    ++HRDL   NILV     E  ++KI+D G +R  
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVA----EGRKMKISDFGLSRDV 200
Query: 181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
                 +      +   W     L      YT   D+W+ G +  E++T           
Sbjct: 201 YEEDSXVKRSQGRIPVKWMAIESLF--DHIYTTQSDVWSFGVLLWEIVTL---------- 248
Query: 241 IKTSNPYHHDQLDRIFSVM 259
               NPY     +R+F+++
Sbjct: 249 --GGNPYPGIPPERLFNLL 265

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/259 (23%), Positives = 98/259 (37%), Gaps = 44/259 (16%)
Query: 24  GCKVGRGTYGHVYKARR---KDNSDTRDYALKQIEGTGLSMSACR----EIALLRELKHP 76
           G  +G G +G V KA     K  +     A+K ++    S S  R    E  +L+++ HP
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHP 86
Query: 77  NVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXX---------------X 120
           +VI L        D  + L+ +YA++  L   ++  R                       
Sbjct: 87  HVIKLYGA--CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 121 XXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
                    S  +QI  G+ YL    ++HRDL   NILV     E  ++KI+D G +R  
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA----EGRKMKISDFGLSRDV 200
Query: 181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
                 +      +   W     L      YT   D+W+ G +  E++T           
Sbjct: 201 YEEDSXVKRSQGRIPVKWMAIESLF--DHIYTTQSDVWSFGVLLWEIVTL---------- 248
Query: 241 IKTSNPYHHDQLDRIFSVM 259
               NPY     +R+F+++
Sbjct: 249 --GGNPYPGIPPERLFNLL 265

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 62/144 (43%), Gaps = 41/144 (28%)
Query: 131 LLYQILDGIHYLHSNW-VLHRDLKPANIL----------VMGEGIERGR----------V 169
           ++ Q+L G+ YLH+   ++H D+KP NIL          +  E  E  R          V
Sbjct: 151 IIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAV 210
Query: 170 KIADMGFARLFNNPLKP---------LADLDPV----------VVTFWYRAPELLLGARH 210
             A         NPL+P         +ADL             + T  YR+ E+L+G+ +
Sbjct: 211 STAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGY 270
Query: 211 YTKAIDIWAIGCIFAELLTSEPIF 234
            T A DIW+  C+  EL T + +F
Sbjct: 271 NTPA-DIWSTACMAFELATGDYLF 293

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 93/231 (40%), Gaps = 22/231 (9%)
Query: 13  RTKVEDLFDYE-----GCKVGRGTYGHVYKAR-RKDNSDTRDYALKQIEGTGLSMSAC-- 64
           + K+ED+   E     G  +G+G +G V +A+ ++++      A+K ++   ++ S    
Sbjct: 12  KEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEE 71
Query: 65  --REIALLRELKHPNVINLISVFLSHNDRK----VWLLFDYAEHDLWHIIKFHRAAKANX 118
             RE A ++E  HP+V  L+ V L    +       ++  + +H   H   F  A++   
Sbjct: 72  FLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLH--AFLLASRIGE 129
Query: 119 XXXXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR 178
                        +  I  G+ YL S   +HRDL   N ++     E   V +AD G +R
Sbjct: 130 NPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML----AEDMTVCVADFGLSR 185
Query: 179 LFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
              +           +   W       L    YT   D+WA G    E++T
Sbjct: 186 KIYSGDYYRQGCASKLPVKWLALES--LADNLYTVHSDVWAFGVTMWEIMT 234

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/231 (22%), Positives = 92/231 (39%), Gaps = 43/231 (18%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACR-------------EIALLREL 73
           +G G +G VY+           Y   + E   +++  C+             E  +++ L
Sbjct: 16  LGEGFFGEVYEGV---------YTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL 66
Query: 74  KHPNVINLISVFLSHNDRKVWLLFD-YAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLL 132
            HP+++ LI +     +   W++ + Y   +L H +      + N            SL 
Sbjct: 67  DHPHIVKLIGII---EEEPTWIIMELYPYGELGHYL------ERNKNSLKVLTLVLYSL- 116
Query: 133 YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP 192
            QI   + YL S   +HRD+   NILV         VK+ D G +R   +     A +  
Sbjct: 117 -QICKAMAYLESINCVHRDIAVRNILVASPEC----VKLGDFGLSRYIEDEDYYKASVTR 171
Query: 193 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT--SEPIFHCRQEDI 241
           + +   + +PE  +  R +T A D+W       E+L+   +P F    +D+
Sbjct: 172 LPIK--WMSPE-SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV 219

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/231 (22%), Positives = 92/231 (39%), Gaps = 43/231 (18%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACR-------------EIALLREL 73
           +G G +G VY+           Y   + E   +++  C+             E  +++ L
Sbjct: 20  LGEGFFGEVYEGV---------YTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL 70
Query: 74  KHPNVINLISVFLSHNDRKVWLLFD-YAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLL 132
            HP+++ LI +     +   W++ + Y   +L H +      + N            SL 
Sbjct: 71  DHPHIVKLIGII---EEEPTWIIMELYPYGELGHYL------ERNKNSLKVLTLVLYSL- 120
Query: 133 YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP 192
            QI   + YL S   +HRD+   NILV         VK+ D G +R   +     A +  
Sbjct: 121 -QICKAMAYLESINCVHRDIAVRNILVASPEC----VKLGDFGLSRYIEDEDYYKASVTR 175
Query: 193 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT--SEPIFHCRQEDI 241
           + +   + +PE  +  R +T A D+W       E+L+   +P F    +D+
Sbjct: 176 LPIK--WMSPE-SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV 223

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 62/144 (43%), Gaps = 41/144 (28%)
Query: 131 LLYQILDGIHYLHSNW-VLHRDLKPANIL----------VMGEGIERGR----------V 169
           ++ Q+L G+ YLH+   ++H D+KP NIL          +  E  E  R          V
Sbjct: 135 IIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAV 194
Query: 170 KIADMGFARLFNNPLKP---------LADLDPV----------VVTFWYRAPELLLGARH 210
             A         NPL+P         +ADL             + T  YR+ E+L+G+ +
Sbjct: 195 STAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGY 254
Query: 211 YTKAIDIWAIGCIFAELLTSEPIF 234
            T A DIW+  C+  EL T + +F
Sbjct: 255 NTPA-DIWSTACMAFELATGDYLF 277

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/210 (22%), Positives = 87/210 (41%), Gaps = 22/210 (10%)
Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI-EGTGLSMSACREIALLRELKHPNVINLISV 84
           ++G G +G V+     +       A+K I EG         E  ++ +L HP ++ L  V
Sbjct: 15  EIGSGQFGLVHLGYWLNKDKV---AIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 85  FLSHNDRKVWLLFDYAEHD-LWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLH 143
            L      + L+ ++ EH  L   ++  R   A              +   + +G+ YL 
Sbjct: 72  CLEQA--PICLVTEFMEHGCLSDYLRTQRGLFA--------AETLLGMCLDVCEGMAYLE 121
Query: 144 SNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPE 203
              V+HRDL   N LV     E   +K++D G  R   +     +      V   + +PE
Sbjct: 122 EACVIHRDLAARNCLVG----ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK--WASPE 175
Query: 204 LLLGARHYTKAIDIWAIGCIFAELLTSEPI 233
           +   +R+ +K+ D+W+ G +  E+ +   I
Sbjct: 176 VFSFSRYSSKS-DVWSFGVLMWEVFSEGKI 204

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 22/215 (10%)
Query: 26  KVGRGTYGHVY----KARRKDNSDTRDYALKQI-EGTGLS--MSACREIALLRELKHPNV 78
           ++G+G++G VY    K   KD  +TR  A+K + E   +   +    E ++++E    +V
Sbjct: 19  ELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 77
Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRA-AKANXXXXXXXXXXXXSLLYQILD 137
           + L+ V +S     + ++      DL   ++  R   + N             +  +I D
Sbjct: 78  VRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 136
Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPL--KPLADLDPVV 194
           G+ YL++N  +HRDL   N +V     E   VKI D G  R ++      K    L PV 
Sbjct: 137 GMAYLNANKFVHRDLAARNCMV----AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 192
Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
              W     L  G   +T   D+W+ G +  E+ T
Sbjct: 193 ---WMSPESLKDGV--FTTYSDVWSFGVVLWEIAT 222

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 22/215 (10%)
Query: 26  KVGRGTYGHVY----KARRKDNSDTRDYALKQI-EGTGLS--MSACREIALLRELKHPNV 78
           ++G+G++G VY    K   KD  +TR  A+K + E   +   +    E ++++E    +V
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAA-KANXXXXXXXXXXXXSLLYQILD 137
           + L+ V +S     + ++      DL   ++  R   + N             +  +I D
Sbjct: 91  VRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 149
Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPL--KPLADLDPVV 194
           G+ YL++N  +HRDL   N +V     E   VKI D G  R ++      K    L PV 
Sbjct: 150 GMAYLNANKFVHRDLAARNCMV----AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
              W     L  G   +T   D+W+ G +  E+ T
Sbjct: 206 ---WMSPESLKDGV--FTTYSDVWSFGVVLWEIAT 235

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 22/215 (10%)
Query: 26  KVGRGTYGHVY----KARRKDNSDTRDYALKQI-EGTGLS--MSACREIALLRELKHPNV 78
           ++G+G++G VY    K   KD  +TR  A+K + E   +   +    E ++++E    +V
Sbjct: 23  ELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 81
Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRA-AKANXXXXXXXXXXXXSLLYQILD 137
           + L+ V +S     + ++      DL   ++  R   + N             +  +I D
Sbjct: 82  VRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 140
Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPL--KPLADLDPVV 194
           G+ YL++N  +HRDL   N +V     E   VKI D G  R ++      K    L PV 
Sbjct: 141 GMAYLNANKFVHRDLAARNCMV----AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 196
Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
              W     L  G   +T   D+W+ G +  E+ T
Sbjct: 197 ---WMSPESLKDGV--FTTYSDVWSFGVVLWEIAT 226

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/231 (22%), Positives = 92/231 (39%), Gaps = 43/231 (18%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACR-------------EIALLREL 73
           +G G +G VY+           Y   + E   +++  C+             E  +++ L
Sbjct: 32  LGEGFFGEVYEGV---------YTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL 82
Query: 74  KHPNVINLISVFLSHNDRKVWLLFD-YAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLL 132
            HP+++ LI +     +   W++ + Y   +L H +      + N            SL 
Sbjct: 83  DHPHIVKLIGII---EEEPTWIIMELYPYGELGHYL------ERNKNSLKVLTLVLYSL- 132
Query: 133 YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP 192
            QI   + YL S   +HRD+   NILV         VK+ D G +R   +     A +  
Sbjct: 133 -QICKAMAYLESINCVHRDIAVRNILVASPEC----VKLGDFGLSRYIEDEDYYKASVTR 187
Query: 193 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT--SEPIFHCRQEDI 241
           + +   + +PE  +  R +T A D+W       E+L+   +P F    +D+
Sbjct: 188 LPIK--WMSPE-SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV 235

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 22/212 (10%)
Query: 27  VGRGTYGHVYKAR-RKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           +G+G +G V++ + R +    + ++ ++ E +    +   +  +LR   H N++  I+  
Sbjct: 50  IGKGRFGEVWRGKWRGEEVAVKIFSSRE-ERSWFREAEIYQTVMLR---HENILGFIAAD 105
Query: 86  LSHNDR--KVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
              N    ++WL+ DY EH  L+  +  +                  + L+  + G    
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 165
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP--VVVTFWYR 200
            +  + HRDLK  NILV     + G   IAD+G A   ++    + D+ P   V T  Y 
Sbjct: 166 PA--IAHRDLKSKNILVK----KNGTCCIADLGLAVRHDSATDTI-DIAPNHRVGTKRYM 218
Query: 201 APELL---LGARHYT--KAIDIWAIGCIFAEL 227
           APE+L   +  +H+   K  DI+A+G +F E+
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 104/236 (44%), Gaps = 37/236 (15%)
Query: 14  TKVEDLFDYEGCKVGRGTYGHVYKARR-KDNS--DTRDYALKQIEGTGLSMSAC----RE 66
           T  ++  +YE  ++G+G +G V+K R  KD S    +   L   EG    +       RE
Sbjct: 15  TLADNEIEYEK-QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQRE 73
Query: 67  IALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHII--KFHRAAKANXXXXXXX 124
           + ++  L HPN++ L    L HN  ++ + F     DL+H +  K H    +        
Sbjct: 74  VFIMSNLNHPNIVKLYG--LMHNPPRMVMEF-VPCGDLYHRLLDKAHPIKWS-------- 122
Query: 125 XXXXXSLLYQILDGIHYLHSN--WVLHRDLKPANILVMGEGIERGRV--KIADMGFARLF 180
                 L+  I  GI Y+ +    ++HRDL+  NI +     E   V  K+AD G ++  
Sbjct: 123 --VKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLD-ENAPVCAKVADFGTSQ-- 177
Query: 181 NNPLKPLADLDPVVVTFWYRAPELLLGARH--YTKAIDIWAIGCIFAELLTSEPIF 234
               + +  +  ++  F + APE  +GA    YT+  D ++   I   +LT E  F
Sbjct: 178 ----QSVHSVSGLLGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 22/215 (10%)
Query: 26  KVGRGTYGHVY----KARRKDNSDTRDYALKQI-EGTGLS--MSACREIALLRELKHPNV 78
           ++G+G++G VY    K   KD  +TR  A+K + E   +   +    E ++++E    +V
Sbjct: 25  ELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 83
Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRA-AKANXXXXXXXXXXXXSLLYQILD 137
           + L+ V +S     + ++      DL   ++  R   + N             +  +I D
Sbjct: 84  VRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 142
Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPL--KPLADLDPVV 194
           G+ YL++N  +HRDL   N +V     E   VKI D G  R ++      K    L PV 
Sbjct: 143 GMAYLNANKFVHRDLAARNCMV----AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 198
Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
              W     L  G   +T   D+W+ G +  E+ T
Sbjct: 199 ---WMSPESLKDGV--FTTYSDVWSFGVVLWEIAT 228

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/112 (30%), Positives = 53/112 (47%), Gaps = 9/112 (8%)
Query: 131 LLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA--DMGFARLFNNPLKPLA 188
           ++  +   + +LH+  + HRDLKP NIL      +   VKI   D+G     N    P++
Sbjct: 116 VVQDVASALDFLHNKGIAHRDLKPENILCEHPN-QVSPVKICDFDLGSGIKLNGDCSPIS 174
Query: 189 --DLDPVVVTFWYRAPELLLG----ARHYTKAIDIWAIGCIFAELLTSEPIF 234
             +L     +  Y APE++      A  Y K  D+W++G I   LL+  P F
Sbjct: 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 22/212 (10%)
Query: 27  VGRGTYGHVYKAR-RKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           +G+G +G V++ + R +    + ++ ++ E +    +   +  +LR   H N++  I+  
Sbjct: 12  IGKGRFGEVWRGKWRGEEVAVKIFSSRE-ERSWFREAEIYQTVMLR---HENILGFIAAD 67
Query: 86  LSHNDR--KVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
              N    ++WL+ DY EH  L+  +  +                  + L+  + G    
Sbjct: 68  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 127
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP--VVVTFWYR 200
            +  + HRDLK  NILV     + G   IAD+G A   ++    + D+ P   V T  Y 
Sbjct: 128 PA--IAHRDLKSKNILVK----KNGTCCIADLGLAVRHDSATDTI-DIAPNHRVGTKRYM 180
Query: 201 APELL---LGARHYT--KAIDIWAIGCIFAEL 227
           APE+L   +  +H+   K  DI+A+G +F E+
Sbjct: 181 APEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 22/215 (10%)
Query: 26  KVGRGTYGHVY----KARRKDNSDTRDYALKQI-EGTGLS--MSACREIALLRELKHPNV 78
           ++G+G++G VY    K   KD  +TR  A+K + E   +   +    E ++++E    +V
Sbjct: 25  ELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 83
Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRA-AKANXXXXXXXXXXXXSLLYQILD 137
           + L+ V +S     + ++      DL   ++  R   + N             +  +I D
Sbjct: 84  VRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 142
Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPL--KPLADLDPVV 194
           G+ YL++N  +HRDL   N +V     E   VKI D G  R ++      K    L PV 
Sbjct: 143 GMAYLNANKFVHRDLAARNCMV----AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV- 197
Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
              W     L  G   +T   D+W+ G +  E+ T
Sbjct: 198 --RWMSPESLKDGV--FTTYSDVWSFGVVLWEIAT 228

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 22/212 (10%)
Query: 27  VGRGTYGHVYKAR-RKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           +G+G +G V++ + R +    + ++ ++ E +    +   +  +LR   H N++  I+  
Sbjct: 14  IGKGRFGEVWRGKWRGEEVAVKIFSSRE-ERSWFREAEIYQTVMLR---HENILGFIAAD 69
Query: 86  LSHNDR--KVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
              N    ++WL+ DY EH  L+  +  +                  + L+  + G    
Sbjct: 70  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 129
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP--VVVTFWYR 200
            +  + HRDLK  NILV     + G   IAD+G A   ++    + D+ P   V T  Y 
Sbjct: 130 PA--IAHRDLKSKNILVK----KNGTCCIADLGLAVRHDSATDTI-DIAPNHRVGTKRYM 182
Query: 201 APELL---LGARHYT--KAIDIWAIGCIFAEL 227
           APE+L   +  +H+   K  DI+A+G +F E+
Sbjct: 183 APEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 81/210 (38%), Gaps = 21/210 (10%)
Query: 26  KVGRGTYGHVYKAR-RKDNSDTRDYALKQIEGTGLSMSAC-----REIALLRELKHPNVI 79
           K+G G++G V +      +  T   A+K ++   LS         RE+  +  L H N+I
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGI 139
            L  V L+   + V  L       L   ++ H+                     Q+ +G+
Sbjct: 85  RLYGVVLTPPMKMVTELAPLGS--LLDRLRKHQG--------HFLLGTLSRYAVQVAEGM 134
Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
            YL S   +HRDL   N+L+      R  VKI D G  R            +   V F +
Sbjct: 135 GYLESKRFIHRDLAARNLLL----ATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAW 190
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLT 229
            APE  L  R ++ A D W  G    E+ T
Sbjct: 191 CAPE-SLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/264 (23%), Positives = 101/264 (38%), Gaps = 54/264 (20%)
Query: 24  GCKVGRGTYGHVYKARR---KDNSDTRDYALKQIEGTGLSMSACR----EIALLRELKHP 76
           G  +G G +G V KA     K  +     A+K ++    S S  R    E  +L+++ HP
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHP 86
Query: 77  NVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXX---------------X 120
           +VI L        D  + L+ +YA++  L   ++  R                       
Sbjct: 87  HVIKLYGA--CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 121 XXXXXXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
                    S  +QI  G+ YL    ++HRDL   NILV     E  ++KI+D G +R  
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA----EGRKMKISDFGLSR-- 198
Query: 181 NNPLKPLADLDPVVVTFWYRAPELLLGARH-----YTKAIDIWAIGCIFAELLTSEPIFH 235
                 + + D  V     R P   +         YT   D+W+ G +  E++T      
Sbjct: 199 -----DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL----- 248
Query: 236 CRQEDIKTSNPYHHDQLDRIFSVM 259
                    NPY     +R+F+++
Sbjct: 249 -------GGNPYPGIPPERLFNLL 265

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 22/215 (10%)
Query: 26  KVGRGTYGHVY----KARRKDNSDTRDYALKQI-EGTGLS--MSACREIALLRELKHPNV 78
           ++G+G++G VY    K   KD  +TR  A+K + E   +   +    E ++++E    +V
Sbjct: 26  ELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 84
Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRA-AKANXXXXXXXXXXXXSLLYQILD 137
           + L+ V +S     + ++      DL   ++  R   + N             +  +I D
Sbjct: 85  VRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 143
Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPL--KPLADLDPVV 194
           G+ YL++N  +HRDL   N +V     E   VKI D G  R ++      K    L PV 
Sbjct: 144 GMAYLNANKFVHRDLAARNCMV----AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 199
Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
              W     L  G   +T   D+W+ G +  E+ T
Sbjct: 200 ---WMSPESLKDGV--FTTYSDVWSFGVVLWEIAT 229

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 22/212 (10%)
Query: 27  VGRGTYGHVYKAR-RKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           +G+G +G V++ + R +    + ++ ++ E +    +   +  +LR   H N++  I+  
Sbjct: 11  IGKGRFGEVWRGKWRGEEVAVKIFSSRE-ERSWFREAEIYQTVMLR---HENILGFIAAD 66
Query: 86  LSHNDR--KVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
              N    ++WL+ DY EH  L+  +  +                  + L+  + G    
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP--VVVTFWYR 200
            +  + HRDLK  NILV     + G   IAD+G A   ++    + D+ P   V T  Y 
Sbjct: 127 PA--IAHRDLKSKNILVK----KNGTCCIADLGLAVRHDSATDTI-DIAPNHRVGTKRYM 179
Query: 201 APELL---LGARHYT--KAIDIWAIGCIFAEL 227
           APE+L   +  +H+   K  DI+A+G +F E+
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 81/210 (38%), Gaps = 21/210 (10%)
Query: 26  KVGRGTYGHVYKAR-RKDNSDTRDYALKQIEGTGLSMSAC-----REIALLRELKHPNVI 79
           K+G G++G V +      +  T   A+K ++   LS         RE+  +  L H N+I
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGI 139
            L  V L+   + V  L       L   ++ H+                     Q+ +G+
Sbjct: 85  RLYGVVLTPPMKMVTELAPLGS--LLDRLRKHQG--------HFLLGTLSRYAVQVAEGM 134
Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
            YL S   +HRDL   N+L+      R  VKI D G  R            +   V F +
Sbjct: 135 GYLESKRFIHRDLAARNLLL----ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 190
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLT 229
            APE  L  R ++ A D W  G    E+ T
Sbjct: 191 CAPE-SLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 22/212 (10%)
Query: 27  VGRGTYGHVYKAR-RKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           +G+G +G V++ + R +    + ++ ++ E +    +   +  +LR   H N++  I+  
Sbjct: 17  IGKGRFGEVWRGKWRGEEVAVKIFSSRE-ERSWFREAEIYQTVMLR---HENILGFIAAD 72
Query: 86  LSHNDR--KVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
              N    ++WL+ DY EH  L+  +  +                  + L+  + G    
Sbjct: 73  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 132
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP--VVVTFWYR 200
            +  + HRDLK  NILV     + G   IAD+G A   ++    + D+ P   V T  Y 
Sbjct: 133 PA--IAHRDLKSKNILVK----KNGTCCIADLGLAVRHDSATDTI-DIAPNHRVGTKRYM 185
Query: 201 APELL---LGARHYT--KAIDIWAIGCIFAEL 227
           APE+L   +  +H+   K  DI+A+G +F E+
Sbjct: 186 APEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/182 (21%), Positives = 75/182 (41%), Gaps = 18/182 (9%)
Query: 66  EIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXX 124
           E +++ +  HPN+I L  V      R   ++ +Y E+  L   ++ H             
Sbjct: 100 EASIMGQFDHPNIIRLEGVVT--RGRLAMIVTEYMENGSLDTFLRTHDG--------QFT 149
Query: 125 XXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPL 184
                 +L  +  G+ YL     +HRDL   N+LV    +     K++D G +R+  +  
Sbjct: 150 IMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLV----CKVSDFGLSRVLEDDP 205
Query: 185 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT--SEPIFHCRQEDIK 242
                     +   + APE  +  R ++ A D+W+ G +  E+L     P ++    D+ 
Sbjct: 206 DAAXTTTGGKIPIRWTAPE-AIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVI 264
Query: 243 TS 244
           +S
Sbjct: 265 SS 266

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 81/210 (38%), Gaps = 21/210 (10%)
Query: 26  KVGRGTYGHVYKAR-RKDNSDTRDYALKQIEGTGLSMSAC-----REIALLRELKHPNVI 79
           K+G G++G V +      +  T   A+K ++   LS         RE+  +  L H N+I
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGI 139
            L  V L+   + V  L       L   ++ H+                     Q+ +G+
Sbjct: 79  RLYGVVLTPPMKMVTELAPLGS--LLDRLRKHQG--------HFLLGTLSRYAVQVAEGM 128
Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
            YL S   +HRDL   N+L+      R  VKI D G  R            +   V F +
Sbjct: 129 GYLESKRFIHRDLAARNLLL----ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 184
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLT 229
            APE  L  R ++ A D W  G    E+ T
Sbjct: 185 CAPE-SLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 81/210 (38%), Gaps = 21/210 (10%)
Query: 26  KVGRGTYGHVYKAR-RKDNSDTRDYALKQIEGTGLSMSAC-----REIALLRELKHPNVI 79
           K+G G++G V +      +  T   A+K ++   LS         RE+  +  L H N+I
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGI 139
            L  V L+   + V  L       L   ++ H+                     Q+ +G+
Sbjct: 75  RLYGVVLTPPMKMVTELAPLGS--LLDRLRKHQG--------HFLLGTLSRYAVQVAEGM 124
Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
            YL S   +HRDL   N+L+      R  VKI D G  R            +   V F +
Sbjct: 125 GYLESKRFIHRDLAARNLLL----ATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAW 180
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLT 229
            APE  L  R ++ A D W  G    E+ T
Sbjct: 181 CAPE-SLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/203 (20%), Positives = 88/203 (43%), Gaps = 22/203 (10%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFL 86
           +G+G +G V     + N      A+K I+    + +   E +++ +L+H N++ L+ V +
Sbjct: 20  IGKGEFGDVMLGDYRGNK----VAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 75
Query: 87  SHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSNW 146
                 ++++ +Y       ++ + R+   +                 + + + YL  N 
Sbjct: 76  EEKG-GLYIVTEYMAKG--SLVDYLRSRGRSVLGGDCLL----KFSLDVCEAMEYLEGNN 128
Query: 147 VLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLL 206
            +HRDL   N+LV  + +     K++D G  +      +  +  D   +   + APE L 
Sbjct: 129 FVHRDLAARNVLVSEDNV----AKVSDFGLTK------EASSTQDTGKLPVKWTAPEALR 178
Query: 207 GARHYTKAIDIWAIGCIFAELLT 229
            A   TK+ D+W+ G +  E+ +
Sbjct: 179 EAAFSTKS-DVWSFGILLWEIYS 200

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 22/212 (10%)
Query: 27  VGRGTYGHVYKAR-RKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           +G+G +G V++ + R +    + ++ ++ E +    +   +  +LR   H N++  I+  
Sbjct: 37  IGKGRFGEVWRGKWRGEEVAVKIFSSRE-ERSWFREAEIYQTVMLR---HENILGFIAAD 92
Query: 86  LSHNDR--KVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
              N    ++WL+ DY EH  L+  +  +                  + L+  + G    
Sbjct: 93  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 152
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP--VVVTFWYR 200
            +  + HRDLK  NILV     + G   IAD+G A   ++    + D+ P   V T  Y 
Sbjct: 153 PA--IAHRDLKSKNILVK----KNGTCCIADLGLAVRHDSATDTI-DIAPNHRVGTKRYM 205
Query: 201 APELL---LGARHYT--KAIDIWAIGCIFAEL 227
           APE+L   +  +H+   K  DI+A+G +F E+
Sbjct: 206 APEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/203 (19%), Positives = 88/203 (43%), Gaps = 22/203 (10%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFL 86
           +G+G +G V     + N      A+K I+    + +   E +++ +L+H N++ L+ V +
Sbjct: 201 IGKGEFGDVMLGDYRGNK----VAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 256
Query: 87  SHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSNW 146
                 ++++ +Y       ++ + R+   +                 + + + YL  N 
Sbjct: 257 EEKG-GLYIVTEYMAKG--SLVDYLRSRGRSVLGGDCLL----KFSLDVCEAMEYLEGNN 309
Query: 147 VLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLL 206
            +HRDL   N+LV  + +     K++D G  +      +  +  D   +   + APE L 
Sbjct: 310 FVHRDLAARNVLVSEDNV----AKVSDFGLTK------EASSTQDTGKLPVKWTAPEALR 359
Query: 207 GARHYTKAIDIWAIGCIFAELLT 229
             +  TK+ D+W+ G +  E+ +
Sbjct: 360 EKKFSTKS-DVWSFGILLWEIYS 381

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 89/206 (43%), Gaps = 17/206 (8%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQ--IEGTGLSMSACREIALLRELKHPNVINLISV 84
           +G G +G VYK   +D +     ALK+   E +        EI  L   +HP++++LI  
Sbjct: 47  IGHGVFGKVYKGVLRDGAKV---ALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGF 103
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHS 144
               N+  + L++ Y E+     +K H    ++             +      G+HYLH+
Sbjct: 104 CDERNE--MILIYKYMENG---NLKRHLYG-SDLPTMSMSWEQRLEICIGAARGLHYLHT 157
Query: 145 NWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPEL 204
             ++HRD+K  NIL+     E    KI D G ++     L        V  T  Y  PE 
Sbjct: 158 RAIIHRDVKSINILLD----ENFVPKITDFGISKK-GTELDQTHLXXVVKGTLGYIDPEY 212
Query: 205 LLGARHYTKAIDIWAIGCIFAELLTS 230
            +  R  T+  D+++ G +  E+L +
Sbjct: 213 FIKGR-LTEKSDVYSFGVVLFEVLCA 237

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 81/210 (38%), Gaps = 21/210 (10%)
Query: 26  KVGRGTYGHVYKAR-RKDNSDTRDYALKQIEGTGLSMSAC-----REIALLRELKHPNVI 79
           K+G G++G V +      +  T   A+K ++   LS         RE+  +  L H N+I
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGI 139
            L  V L+   + V  L       L   ++ H+                     Q+ +G+
Sbjct: 75  RLYGVVLTPPMKMVTELAPLGS--LLDRLRKHQG--------HFLLGTLSRYAVQVAEGM 124
Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
            YL S   +HRDL   N+L+      R  VKI D G  R            +   V F +
Sbjct: 125 GYLESKRFIHRDLAARNLLL----ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLT 229
            APE  L  R ++ A D W  G    E+ T
Sbjct: 181 CAPE-SLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 81/210 (38%), Gaps = 21/210 (10%)
Query: 26  KVGRGTYGHVYKAR-RKDNSDTRDYALKQIEGTGLSMSAC-----REIALLRELKHPNVI 79
           K+G G++G V +      +  T   A+K ++   LS         RE+  +  L H N+I
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGI 139
            L  V L+   + V  L       L   ++ H+                     Q+ +G+
Sbjct: 79  RLYGVVLTPPMKMVTELAPLGS--LLDRLRKHQG--------HFLLGTLSRYAVQVAEGM 128
Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
            YL S   +HRDL   N+L+      R  VKI D G  R            +   V F +
Sbjct: 129 GYLESKRFIHRDLAARNLLL----ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 184
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLT 229
            APE  L  R ++ A D W  G    E+ T
Sbjct: 185 CAPE-SLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 89/206 (43%), Gaps = 17/206 (8%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQ--IEGTGLSMSACREIALLRELKHPNVINLISV 84
           +G G +G VYK   +D +     ALK+   E +        EI  L   +HP++++LI  
Sbjct: 47  IGHGVFGKVYKGVLRDGAKV---ALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGF 103
Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHS 144
               N+  + L++ Y E+     +K H    ++             +      G+HYLH+
Sbjct: 104 CDERNE--MILIYKYMENG---NLKRHLYG-SDLPTMSMSWEQRLEICIGAARGLHYLHT 157
Query: 145 NWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPEL 204
             ++HRD+K  NIL+     E    KI D G ++     L        V  T  Y  PE 
Sbjct: 158 RAIIHRDVKSINILLD----ENFVPKITDFGISKK-GTELGQTHLXXVVKGTLGYIDPEY 212
Query: 205 LLGARHYTKAIDIWAIGCIFAELLTS 230
            +  R  T+  D+++ G +  E+L +
Sbjct: 213 FIKGR-LTEKSDVYSFGVVLFEVLCA 237

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 81/210 (38%), Gaps = 21/210 (10%)
Query: 26  KVGRGTYGHVYKAR-RKDNSDTRDYALKQIEGTGLSMSAC-----REIALLRELKHPNVI 79
           K+G G++G V +      +  T   A+K ++   LS         RE+  +  L H N+I
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGI 139
            L  V L+   + V  L       L   ++ H+                     Q+ +G+
Sbjct: 75  RLYGVVLTPPMKMVTELAPLGS--LLDRLRKHQG--------HFLLGTLSRYAVQVAEGM 124
Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
            YL S   +HRDL   N+L+      R  VKI D G  R            +   V F +
Sbjct: 125 GYLESKRFIHRDLAARNLLL----ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLT 229
            APE  L  R ++ A D W  G    E+ T
Sbjct: 181 CAPE-SLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 100/235 (42%), Gaps = 38/235 (16%)
Query: 21  DYEGCKV-GRGTYGHVYKARRKDNSDT-RDYALKQIEGTGLSMSACR------EIALLRE 72
           ++E  KV G G YG V+  R+    DT + YA+K ++   +   A        E  +L  
Sbjct: 55  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 114
Query: 73  LKH-PNVINLISVFLSHNDRKVWLLFDYAEHD--LWHIIKFHRAAKANXXXXXXXXXXXX 129
           ++  P ++ L   F    + K+ L+ DY        H+ +  R  +              
Sbjct: 115 IRQSPFLVTLHYAF--QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY-------- 164
Query: 130 SLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLAD 189
             + +I+  + +LH   +++RD+K  NIL+       G V + D G ++ F      +AD
Sbjct: 165 --VGEIVLALEHLHKLGIIYRDIKLENILLD----SNGHVVLTDFGLSKEF------VAD 212
Query: 190 LDPVVVTFW----YRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
                  F     Y AP+++ G    + KA+D W++G +  ELLT    F    E
Sbjct: 213 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE 267

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 85/209 (40%), Gaps = 23/209 (11%)
Query: 27  VGRGTYGHVYKARRKDNSDTRD--YALKQIEGTGLSMSACREIA----LLRELKHPNVIN 80
           +G G +G VYK       +      A+K++     S  A +EI     ++  + +P+V  
Sbjct: 20  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 78
Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           L+ + L+   + +  L  +       ++ + R  K N            +   QI +G++
Sbjct: 79  LLGICLTSTVQLITQLMPFG-----CLLDYVREHKDNIGSQYLL-----NWCVQIAEGMN 128
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL    ++HRDL   N+LV         VKI D G A+L     K        V   W  
Sbjct: 129 YLEDRRLVHRDLAARNVLVKTP----QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 184
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT 229
              +L   R YT   D+W+ G    EL+T
Sbjct: 185 LESIL--HRIYTHQSDVWSYGVTVWELMT 211

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 22/215 (10%)
Query: 26  KVGRGTYGHVY----KARRKDNSDTRDYALKQI-EGTGLS--MSACREIALLRELKHPNV 78
           ++G+G++G VY    K   KD  +TR  A+K + E   +   +    E ++++E    +V
Sbjct: 54  ELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 112
Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRA-AKANXXXXXXXXXXXXSLLYQILD 137
           + L+ V +S     + ++      DL   ++  R   + N             +  +I D
Sbjct: 113 VRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 171
Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPL--KPLADLDPVV 194
           G+ YL++N  +HRDL   N +V     E   VKI D G  R ++      K    L PV 
Sbjct: 172 GMAYLNANKFVHRDLAARNCMV----AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 227
Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
              W     L  G   +T   D+W+ G +  E+ T
Sbjct: 228 ---WMSPESLKDGV--FTTYSDVWSFGVVLWEIAT 257

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/203 (19%), Positives = 88/203 (43%), Gaps = 22/203 (10%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFL 86
           +G+G +G V     + N      A+K I+    + +   E +++ +L+H N++ L+ V +
Sbjct: 29  IGKGEFGDVMLGDYRGNK----VAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 87  SHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSNW 146
                 ++++ +Y       ++ + R+   +                 + + + YL  N 
Sbjct: 85  EEKG-GLYIVTEYMAKG--SLVDYLRSRGRSVLGGDCLL----KFSLDVCEAMEYLEGNN 137
Query: 147 VLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLL 206
            +HRDL   N+LV  + +     K++D G  +      +  +  D   +   + APE L 
Sbjct: 138 FVHRDLAARNVLVSEDNV----AKVSDFGLTK------EASSTQDTGKLPVKWTAPEALR 187
Query: 207 GARHYTKAIDIWAIGCIFAELLT 229
             +  TK+ D+W+ G +  E+ +
Sbjct: 188 EKKFSTKS-DVWSFGILLWEIYS 209

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 86/212 (40%), Gaps = 18/212 (8%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFL 86
           +GRG +G VYK R  D        LK+    G  +    E+ ++    H N++ L    +
Sbjct: 38  LGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97
Query: 87  SHNDRKVWLLFDY-AEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSN 145
           +  +R   L++ Y A   +   ++    ++              S       G+ YLH +
Sbjct: 98  TPTER--LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSA-----RGLAYLHDH 150
Query: 146 W---VLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAP 202
               ++HRD+K ANIL+     E     + D G A+L +   K       V     + AP
Sbjct: 151 CDPKIIHRDVKAANILL----DEEFEAVVGDFGLAKLMD--YKDXHVXXAVRGXIGHIAP 204
Query: 203 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           E L   +   K  D++  G +  EL+T +  F
Sbjct: 205 EYLSTGKSSEKT-DVFGYGVMLLELITGQRAF 235

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/203 (19%), Positives = 88/203 (43%), Gaps = 22/203 (10%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFL 86
           +G+G +G V     + N      A+K I+    + +   E +++ +L+H N++ L+ V +
Sbjct: 14  IGKGEFGDVMLGDYRGNK----VAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 69
Query: 87  SHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYLHSNW 146
                 ++++ +Y       ++ + R+   +                 + + + YL  N 
Sbjct: 70  EEKG-GLYIVTEYMAKG--SLVDYLRSRGRSVLGGDCLL----KFSLDVCEAMEYLEGNN 122
Query: 147 VLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLL 206
            +HRDL   N+LV  + +     K++D G  +      +  +  D   +   + APE L 
Sbjct: 123 FVHRDLAARNVLVSEDNV----AKVSDFGLTK------EASSTQDTGKLPVKWTAPEALR 172
Query: 207 GARHYTKAIDIWAIGCIFAELLT 229
             +  TK+ D+W+ G +  E+ +
Sbjct: 173 EKKFSTKS-DVWSFGILLWEIYS 194

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 84/209 (40%), Gaps = 23/209 (11%)
Query: 27  VGRGTYGHVYKARRKDNSDTRD--YALKQIEGTGLSMSACREIA----LLRELKHPNVIN 80
           +G G +G VYK       +      A+K++     S  A +EI     ++  + +P+V  
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 82
Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           L+ + L+   + +  L  +       ++ + R  K N            +   QI  G++
Sbjct: 83  LLGICLTSTVQLIMQLMPFG-----XLLDYVREHKDNIGSQYLL-----NWCVQIAKGMN 132
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL    ++HRDL   N+LV         VKI D G A+L     K        V   W  
Sbjct: 133 YLEDRRLVHRDLAARNVLVKTP----QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 188
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT 229
              +L   R YT   D+W+ G    EL+T
Sbjct: 189 LESIL--HRIYTHQSDVWSYGVTVWELMT 215

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 84/209 (40%), Gaps = 23/209 (11%)
Query: 27  VGRGTYGHVYKARRKDNSDTRD--YALKQIEGTGLSMSACREIA----LLRELKHPNVIN 80
           +G G +G VYK       +      A+K++     S  A +EI     ++  + +P+V  
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           L+ + L+   + +  L  +       ++ + R  K N            +   QI  G++
Sbjct: 82  LLGICLTSTVQLITQLMPFG-----XLLDYVREHKDNIGSQYLL-----NWCVQIAKGMN 131
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL    ++HRDL   N+LV         VKI D G A+L     K        V   W  
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTP----QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT 229
              +L   R YT   D+W+ G    EL+T
Sbjct: 188 LESIL--HRIYTHQSDVWSYGVTVWELMT 214

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/182 (21%), Positives = 75/182 (41%), Gaps = 18/182 (9%)
Query: 66  EIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXX 124
           E +++ +  HPN+I L  V      R   ++ +Y E+  L   ++ H             
Sbjct: 100 EASIMGQFDHPNIIRLEGVVT--RGRLAMIVTEYMENGSLDTFLRTHDG--------QFT 149
Query: 125 XXXXXSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPL 184
                 +L  +  G+ YL     +HRDL   N+LV    +     K++D G +R+  +  
Sbjct: 150 IMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLV----CKVSDFGLSRVLEDDP 205
Query: 185 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT--SEPIFHCRQEDIK 242
                     +   + APE  +  R ++ A D+W+ G +  E+L     P ++    D+ 
Sbjct: 206 DAAYTTTGGKIPIRWTAPE-AIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVI 264
Query: 243 TS 244
           +S
Sbjct: 265 SS 266

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/173 (21%), Positives = 82/173 (47%), Gaps = 20/173 (11%)
Query: 66  EIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKF--HRAAKANXXXXXX 123
           E+ ++ ++K+   +    +  ++++  V+++++Y E+D   I+KF  +            
Sbjct: 93  ELQIITDIKNEYCLTCEGIITNYDE--VYIIYEYMEND--SILKFDEYFFVLDKNYTCFI 148
Query: 124 XXXXXXSLLYQILDGIHYLHSNW-VLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFN 181
                  ++  +L+   Y+H+   + HRD+KP+NIL+     + GRVK++D G +  + +
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD----KNGRVKLSDFGESEYMVD 204
Query: 182 NPLKPLADLDPVVVTFWYRAPELLLGARHYTKA-IDIWAIG-CIFAELLTSEP 232
             +K          T+ +  PE       Y  A +DIW++G C++       P
Sbjct: 205 KKIKGSRG------TYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 84/209 (40%), Gaps = 23/209 (11%)
Query: 27  VGRGTYGHVYKARRKDNSDTRD--YALKQIEGTGLSMSACREIA----LLRELKHPNVIN 80
           +G G +G VYK       +      A+K++     S  A +EI     ++  + +P+V  
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 85
Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           L+ + L+   + +  L  +       ++ + R  K N            +   QI  G++
Sbjct: 86  LLGICLTSTVQLIMQLMPFG-----CLLDYVREHKDNIGSQYLL-----NWCVQIAKGMN 135
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL    ++HRDL   N+LV         VKI D G A+L     K        V   W  
Sbjct: 136 YLEDRRLVHRDLAARNVLVKTP----QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 191
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT 229
              +L   R YT   D+W+ G    EL+T
Sbjct: 192 LESIL--HRIYTHQSDVWSYGVTVWELMT 218

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/109 (28%), Positives = 49/109 (44%), Gaps = 8/109 (7%)
Query: 130 SLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF---NNPLKP 186
           +++ QI   +HYLH+  + HRD+KP N L      +   +K+ D G ++ F   NN    
Sbjct: 172 NIMRQIFSALHYLHNQGICHRDIKPENFLFSTN--KSFEIKLVDFGLSKEFYKLNN--GE 227
Query: 187 LADLDPVVVTFWYRAPELL-LGARHYTKAIDIWAIGCIFAELLTSEPIF 234
              +     T ++ APE+L      Y    D W+ G +   LL     F
Sbjct: 228 YYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPF 276

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 84/209 (40%), Gaps = 23/209 (11%)
Query: 27  VGRGTYGHVYKARRKDNSDTRD--YALKQIEGTGLSMSACREIA----LLRELKHPNVIN 80
           +G G +G VYK       +      A+K++     S  A +EI     ++  + +P+V  
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           L+ + L+   + +  L  +       ++ + R  K N            +   QI  G++
Sbjct: 85  LLGICLTSTVQLIMQLMPFG-----CLLDYVREHKDNIGSQYLL-----NWCVQIAKGMN 134
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL    ++HRDL   N+LV         VKI D G A+L     K        V   W  
Sbjct: 135 YLEDRRLVHRDLAARNVLVKTP----QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT 229
              +L   R YT   D+W+ G    EL+T
Sbjct: 191 LESIL--HRIYTHQSDVWSYGVTVWELMT 217

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 84/209 (40%), Gaps = 23/209 (11%)
Query: 27  VGRGTYGHVYKARRKDNSDTRD--YALKQIEGTGLSMSACREIA----LLRELKHPNVIN 80
           +G G +G VYK       +      A+K++     S  A +EI     ++  + +P+V  
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           L+ + L+   + +  L  +       ++ + R  K N            +   QI  G++
Sbjct: 82  LLGICLTSTVQLIMQLMPFG-----CLLDYVREHKDNIGSQYLL-----NWCVQIAKGMN 131
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL    ++HRDL   N+LV         VKI D G A+L     K        V   W  
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTP----QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT 229
              +L   R YT   D+W+ G    EL+T
Sbjct: 188 LESIL--HRIYTHQSDVWSYGVTVWELMT 214

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 84/209 (40%), Gaps = 23/209 (11%)
Query: 27  VGRGTYGHVYKARRKDNSDTRD--YALKQIEGTGLSMSACREIA----LLRELKHPNVIN 80
           +G G +G VYK       +      A+K++     S  A +EI     ++  + +P+V  
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           L+ + L+   + +  L  +       ++ + R  K N            +   QI  G++
Sbjct: 84  LLGICLTSTVQLIMQLMPFG-----CLLDYVREHKDNIGSQYLL-----NWCVQIAKGMN 133
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL    ++HRDL   N+LV         VKI D G A+L     K        V   W  
Sbjct: 134 YLEDRRLVHRDLAARNVLVKTP----QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT 229
              +L   R YT   D+W+ G    EL+T
Sbjct: 190 LESIL--HRIYTHQSDVWSYGVTVWELMT 216

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 84/209 (40%), Gaps = 23/209 (11%)
Query: 27  VGRGTYGHVYKARRKDNSDTRD--YALKQIEGTGLSMSACREIA----LLRELKHPNVIN 80
           +G G +G VYK       +      A+K++     S  A +EI     ++  + +P+V  
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 82
Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           L+ + L+   + +  L  +       ++ + R  K N            +   QI  G++
Sbjct: 83  LLGICLTSTVQLIMQLMPFG-----CLLDYVREHKDNIGSQYLL-----NWCVQIAKGMN 132
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL    ++HRDL   N+LV         VKI D G A+L     K        V   W  
Sbjct: 133 YLEDRRLVHRDLAARNVLVKTP----QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 188
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT 229
              +L   R YT   D+W+ G    EL+T
Sbjct: 189 LESIL--HRIYTHQSDVWSYGVTVWELMT 215

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 84/209 (40%), Gaps = 23/209 (11%)
Query: 27  VGRGTYGHVYKARRKDNSDTRD--YALKQIEGTGLSMSACREIA----LLRELKHPNVIN 80
           +G G +G VYK       +      A+K++     S  A +EI     ++  + +P+V  
Sbjct: 33  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 91
Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           L+ + L+   + +  L  +       ++ + R  K N            +   QI  G++
Sbjct: 92  LLGICLTSTVQLITQLMPFG-----CLLDYVREHKDNIGSQYLL-----NWCVQIAKGMN 141
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL    ++HRDL   N+LV         VKI D G A+L     K        V   W  
Sbjct: 142 YLEDRRLVHRDLAARNVLVKTP----QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 197
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT 229
              +L   R YT   D+W+ G    EL+T
Sbjct: 198 LESIL--HRIYTHQSDVWSYGVTVWELMT 224

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 84/209 (40%), Gaps = 23/209 (11%)
Query: 27  VGRGTYGHVYKARRKDNSDTRD--YALKQIEGTGLSMSACREIA----LLRELKHPNVIN 80
           +G G +G VYK       +      A+K++     S  A +EI     ++  + +P+V  
Sbjct: 48  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 106
Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           L+ + L+   + +  L  +       ++ + R  K N            +   QI  G++
Sbjct: 107 LLGICLTSTVQLITQLMPFG-----CLLDYVREHKDNIGSQYLL-----NWCVQIAKGMN 156
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL    ++HRDL   N+LV         VKI D G A+L     K        V   W  
Sbjct: 157 YLEDRRLVHRDLAARNVLVKTP----QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 212
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT 229
              +L   R YT   D+W+ G    EL+T
Sbjct: 213 LESIL--HRIYTHQSDVWSYGVTVWELMT 239

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 84/209 (40%), Gaps = 23/209 (11%)
Query: 27  VGRGTYGHVYKARRKDNSDTRD--YALKQIEGTGLSMSACREIA----LLRELKHPNVIN 80
           +G G +G VYK       +      A+K++     S  A +EI     ++  + +P+V  
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           L+ + L+   + +  L  +       ++ + R  K N            +   QI  G++
Sbjct: 85  LLGICLTSTVQLITQLMPFG-----CLLDYVREHKDNIGSQYLL-----NWCVQIAKGMN 134
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL    ++HRDL   N+LV         VKI D G A+L     K        V   W  
Sbjct: 135 YLEDRRLVHRDLAARNVLVKTP----QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT 229
              +L   R YT   D+W+ G    EL+T
Sbjct: 191 LESIL--HRIYTHQSDVWSYGVTVWELMT 217

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 84/209 (40%), Gaps = 23/209 (11%)
Query: 27  VGRGTYGHVYKARRKDNSDTRD--YALKQIEGTGLSMSACREIA----LLRELKHPNVIN 80
           +G G +G VYK       +      A+K++     S  A +EI     ++  + +P+V  
Sbjct: 17  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 75
Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           L+ + L+   + +  L  +       ++ + R  K N            +   QI  G++
Sbjct: 76  LLGICLTSTVQLITQLMPFG-----CLLDYVREHKDNIGSQYLL-----NWCVQIAKGMN 125
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL    ++HRDL   N+LV         VKI D G A+L     K        V   W  
Sbjct: 126 YLEDRRLVHRDLAARNVLVKTP----QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT 229
              +L   R YT   D+W+ G    EL+T
Sbjct: 182 LESIL--HRIYTHQSDVWSYGVTVWELMT 208

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 8/101 (7%)
Query: 130 SLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPLKPLA 188
           S  +Q+  G+ +L S   +HRDL   NIL+     E   VKI D G AR ++ NP   + 
Sbjct: 203 SYSFQVARGMEFLSSRKCIHRDLAARNILLS----ENNVVKICDFGLARDIYKNP-DYVR 257
Query: 189 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
             D  +   W  APE +    + TK+ D+W+ G +  E+ +
Sbjct: 258 KGDTRLPLKWM-APESIFDKIYSTKS-DVWSYGVLLWEIFS 296

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 84/209 (40%), Gaps = 23/209 (11%)
Query: 27  VGRGTYGHVYKARRKDNSDTRD--YALKQIEGTGLSMSACREIA----LLRELKHPNVIN 80
           +G G +G VYK       +      A+K++     S  A +EI     ++  + +P+V  
Sbjct: 29  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 87
Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           L+ + L+   + +  L  +       ++ + R  K N            +   QI  G++
Sbjct: 88  LLGICLTSTVQLITQLMPFG-----CLLDYVREHKDNIGSQYLL-----NWCVQIAKGMN 137
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL    ++HRDL   N+LV         VKI D G A+L     K        V   W  
Sbjct: 138 YLEDRRLVHRDLAARNVLVKTP----QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 193
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT 229
              +L   R YT   D+W+ G    EL+T
Sbjct: 194 LESIL--HRIYTHQSDVWSYGVTVWELMT 220

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 84/209 (40%), Gaps = 23/209 (11%)
Query: 27  VGRGTYGHVYKARRKDNSDTRD--YALKQIEGTGLSMSACREIA----LLRELKHPNVIN 80
           +G G +G VYK       +      A+K++     S  A +EI     ++  + +P+V  
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           L+ + L+   + +  L  +       ++ + R  K N            +   QI  G++
Sbjct: 85  LLGICLTSTVQLITQLMPFG-----CLLDYVREHKDNIGSQYLL-----NWCVQIAKGMN 134
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL    ++HRDL   N+LV         VKI D G A+L     K        V   W  
Sbjct: 135 YLEDRRLVHRDLAARNVLVKTP----QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT 229
              +L   R YT   D+W+ G    EL+T
Sbjct: 191 LESIL--HRIYTHQSDVWSYGVTVWELMT 217

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 84/209 (40%), Gaps = 23/209 (11%)
Query: 27  VGRGTYGHVYKARRKDNSDTRD--YALKQIEGTGLSMSACREIA----LLRELKHPNVIN 80
           +G G +G VYK       +      A+K++     S  A +EI     ++  + +P+V  
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           L+ + L+   + +  L  +       ++ + R  K N            +   QI  G++
Sbjct: 89  LLGICLTSTVQLITQLMPFG-----CLLDYVREHKDNIGSQYLL-----NWCVQIAKGMN 138
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL    ++HRDL   N+LV         VKI D G A+L     K        V   W  
Sbjct: 139 YLEDRRLVHRDLAARNVLVKTP----QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT 229
              +L   R YT   D+W+ G    EL+T
Sbjct: 195 LESIL--HRIYTHQSDVWSYGVTVWELMT 221

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 84/209 (40%), Gaps = 23/209 (11%)
Query: 27  VGRGTYGHVYKARRKDNSDTRD--YALKQIEGTGLSMSACREIA----LLRELKHPNVIN 80
           +G G +G VYK       +      A+K++     S  A +EI     ++  + +P+V  
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           L+ + L+   + +  L  +       ++ + R  K N            +   QI  G++
Sbjct: 82  LLGICLTSTVQLITQLMPFG-----CLLDYVREHKDNIGSQYLL-----NWCVQIAKGMN 131
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL    ++HRDL   N+LV         VKI D G A+L     K        V   W  
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTP----QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT 229
              +L   R YT   D+W+ G    EL+T
Sbjct: 188 LESIL--HRIYTHQSDVWSYGVTVWELMT 214

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 44/100 (44%), Gaps = 16/100 (16%)
Query: 135 ILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVV 194
           +L+ +H +H + ++H DLKPAN L++      G +K+ D G A     P       D  V
Sbjct: 164 MLEAVHTIHQHGIVHSDLKPANFLIVD-----GMLKLIDFGIANQM-QPDTTSVVKDSQV 217
Query: 195 VTFWYRAPELL----------LGARHYTKAIDIWAIGCIF 224
            T  Y  PE +                +   D+W++GCI 
Sbjct: 218 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 257

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 84/209 (40%), Gaps = 23/209 (11%)
Query: 27  VGRGTYGHVYKARRKDNSDTRD--YALKQIEGTGLSMSACREIA----LLRELKHPNVIN 80
           +G G +G VYK       +      A+K++     S  A +EI     ++  + +P+V  
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           L+ + L+   + +  L  +       ++ + R  K N            +   QI  G++
Sbjct: 85  LLGICLTSTVQLITQLMPFG-----CLLDYVREHKDNIGSQYLL-----NWCVQIAKGMN 134
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL    ++HRDL   N+LV         VKI D G A+L     K        V   W  
Sbjct: 135 YLEDRRLVHRDLAARNVLVKTP----QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT 229
              +L   R YT   D+W+ G    EL+T
Sbjct: 191 LESIL--HRIYTHQSDVWSYGVTVWELMT 217

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 84/209 (40%), Gaps = 23/209 (11%)
Query: 27  VGRGTYGHVYKARRKDNSDTRD--YALKQIEGTGLSMSACREIA----LLRELKHPNVIN 80
           +G G +G VYK       +      A+K++     S  A +EI     ++  + +P+V  
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           L+ + L+   + +  L  +       ++ + R  K N            +   QI  G++
Sbjct: 84  LLGICLTSTVQLITQLMPFG-----CLLDYVREHKDNIGSQYLL-----NWCVQIAKGMN 133
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL    ++HRDL   N+LV         VKI D G A+L     K        V   W  
Sbjct: 134 YLEDRRLVHRDLAARNVLVKTP----QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT 229
              +L   R YT   D+W+ G    EL+T
Sbjct: 190 LESIL--HRIYTHQSDVWSYGVTVWELMT 216

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 8/98 (8%)
Query: 133 YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPLKPLADLD 191
           +Q+  G+ +L S   +HRDL   NIL+     E+  VKI D G AR ++ +P   +   D
Sbjct: 205 FQVAKGMEFLASRKCIHRDLAARNILLS----EKNVVKICDFGLARDIYKDP-DYVRKGD 259
Query: 192 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
             +   W  APE +   R YT   D+W+ G +  E+ +
Sbjct: 260 ARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 295

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 92/215 (42%), Gaps = 22/215 (10%)
Query: 26  KVGRGTYGHVY----KARRKDNSDTRDYALKQI-EGTGLS--MSACREIALLRELKHPNV 78
           ++G+G++G VY    K   KD  +TR  A+K + E   +   +    E ++++E    +V
Sbjct: 19  ELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 77
Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRA-AKANXXXXXXXXXXXXSLLYQILD 137
           + L+ V +S     + ++      DL   ++  R   + N             +  +I D
Sbjct: 78  VRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 136
Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPL--KPLADLDPVV 194
           G+ YL++N  +HRDL   N  V     E   VKI D G  R ++      K    L PV 
Sbjct: 137 GMAYLNANKFVHRDLAARNCXV----AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV- 191
Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
              W     L  G   +T   D+W+ G +  E+ T
Sbjct: 192 --RWMSPESLKDGV--FTTYSDVWSFGVVLWEIAT 222

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 84/209 (40%), Gaps = 23/209 (11%)
Query: 27  VGRGTYGHVYKARRKDNSDTRD--YALKQIEGTGLSMSACREIA----LLRELKHPNVIN 80
           +G G +G VYK       +      A+K++     S  A +EI     ++  + +P+V  
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           L+ + L+   + +  L  +       ++ + R  K N            +   QI  G++
Sbjct: 82  LLGICLTSTVQLITQLMPFG-----CLLDYVREHKDNIGSQYLL-----NWCVQIAKGMN 131
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL    ++HRDL   N+LV         VKI D G A+L     K        V   W  
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTP----QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT 229
              +L   R YT   D+W+ G    EL+T
Sbjct: 188 LESIL--HRIYTHQSDVWSYGVTVWELMT 214

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 8/98 (8%)
Query: 133 YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPLKPLADLD 191
           +Q+  G+ +L S   +HRDL   NIL+     E+  VKI D G AR ++ +P   +   D
Sbjct: 207 FQVAKGMEFLASRKCIHRDLAARNILLS----EKNVVKICDFGLARDIYKDP-DYVRKGD 261
Query: 192 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
             +   W  APE +   R YT   D+W+ G +  E+ +
Sbjct: 262 ARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 297

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 8/98 (8%)
Query: 133 YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPLKPLADLD 191
           +Q+  G+ +L S   +HRDL   NIL+     E+  VKI D G AR ++ +P   +   D
Sbjct: 198 FQVAKGMEFLASRKCIHRDLAARNILLS----EKNVVKICDFGLARDIYKDP-DYVRKGD 252
Query: 192 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
             +   W  APE +   R YT   D+W+ G +  E+ +
Sbjct: 253 ARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 288

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 103/236 (43%), Gaps = 37/236 (15%)
Query: 14  TKVEDLFDYEGCKVGRGTYGHVYKARR-KDNS--DTRDYALKQIEGTGLSMSAC----RE 66
           T  ++  +YE  ++G+G +G V+K R  KD S    +   L   EG    +       RE
Sbjct: 15  TLADNEIEYEK-QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQRE 73
Query: 67  IALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHII--KFHRAAKANXXXXXXX 124
           + ++  L HPN++ L    L HN  ++ + F     DL+H +  K H    +        
Sbjct: 74  VFIMSNLNHPNIVKLYG--LMHNPPRMVMEF-VPCGDLYHRLLDKAHPIKWS-------- 122
Query: 125 XXXXXSLLYQILDGIHYLHSN--WVLHRDLKPANILVMGEGIERGRV--KIADMGFARLF 180
                 L+  I  GI Y+ +    ++HRDL+  NI +     E   V  K+AD   ++  
Sbjct: 123 --VKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLD-ENAPVCAKVADFSLSQ-- 177
Query: 181 NNPLKPLADLDPVVVTFWYRAPELLLGARH--YTKAIDIWAIGCIFAELLTSEPIF 234
               + +  +  ++  F + APE  +GA    YT+  D ++   I   +LT E  F
Sbjct: 178 ----QSVHSVSGLLGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 85/220 (38%), Gaps = 44/220 (20%)
Query: 26  KVGRGTYGHVYKA---RRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLI 82
           ++G G +G V +     RK   D     LKQ      +    RE  ++ +L +P ++ LI
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 83  SVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
            V  +     + L+ + A     H  KF    +               LL+Q+  G+ YL
Sbjct: 77  GVCQAE---ALMLVMEMAGGGPLH--KFLVGKREEIPVSNVA-----ELLHQVSMGMKYL 126
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN-------------PLKPLAD 189
                +HRDL   N+L+    + R   KI+D G ++                 PLK    
Sbjct: 127 EEKNFVHRDLAARNVLL----VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK---- 178
Query: 190 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                   WY APE  +  R ++   D+W+ G    E L+
Sbjct: 179 --------WY-APE-CINFRKFSSRSDVWSYGVTMWEALS 208

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 8/98 (8%)
Query: 133 YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR-LFNNPLKPLADLD 191
           +Q+  G+ +L S   +HRDL   NIL+     E+  VKI D G AR ++ +P   +   D
Sbjct: 200 FQVAKGMEFLASRKCIHRDLAARNILLS----EKNVVKICDFGLARDIYKDP-DYVRKGD 254
Query: 192 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
             +   W  APE +   R YT   D+W+ G +  E+ +
Sbjct: 255 ARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 290

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 82/208 (39%), Gaps = 21/208 (10%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIE-GTGLSMSACREIA----LLRELKHPNVINL 81
           +G G +G VYK       +     +  +E     S  A +EI     ++  + +P+V  L
Sbjct: 57  LGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRL 116
Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHY 141
           + + L+   + +  L  +       ++ + R  K N            +   QI  G++Y
Sbjct: 117 LGICLTSTVQLITQLMPFG-----CLLDYVREHKDNIGSQYLL-----NWCVQIAKGMNY 166
Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
           L    ++HRDL   N+LV         VKI D G A+L     K        V   W   
Sbjct: 167 LEDRRLVHRDLAARNVLVKTP----QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 222
Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
             +L   R YT   D+W+ G    EL+T
Sbjct: 223 ESIL--HRIYTHQSDVWSYGVTVWELMT 248

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 44/100 (44%), Gaps = 16/100 (16%)
Query: 135 ILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVV 194
           +L+ +H +H + ++H DLKPAN L++      G +K+ D G A     P       D  V
Sbjct: 117 MLEAVHTIHQHGIVHSDLKPANFLIVD-----GMLKLIDFGIANQM-QPDTTSVVKDSQV 170
Query: 195 VTFWYRAPELL----------LGARHYTKAIDIWAIGCIF 224
            T  Y  PE +                +   D+W++GCI 
Sbjct: 171 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 210

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 44/100 (44%), Gaps = 16/100 (16%)
Query: 135 ILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVV 194
           +L+ +H +H + ++H DLKPAN L++      G +K+ D G A     P       D  V
Sbjct: 164 MLEAVHTIHQHGIVHSDLKPANFLIVD-----GMLKLIDFGIANQM-QPDTTSVVKDSQV 217
Query: 195 VTFWYRAPELL----------LGARHYTKAIDIWAIGCIF 224
            T  Y  PE +                +   D+W++GCI 
Sbjct: 218 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 257

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 44/100 (44%), Gaps = 16/100 (16%)
Query: 135 ILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVV 194
           +L+ +H +H + ++H DLKPAN L++      G +K+ D G A     P       D  V
Sbjct: 136 MLEAVHTIHQHGIVHSDLKPANFLIVD-----GMLKLIDFGIANQM-QPDTTSVVKDSQV 189
Query: 195 VTFWYRAPELL----------LGARHYTKAIDIWAIGCIF 224
            T  Y  PE +                +   D+W++GCI 
Sbjct: 190 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 229

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 48/214 (22%), Positives = 83/214 (38%), Gaps = 30/214 (14%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACR----EIALLRELKHPNVINLI 82
           +G G +G V     K       +   +   +G +    R    E +++ +  HPNVI+L 
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 100
Query: 83  SVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIHYL 142
            V        V ++ ++ E+    +  F R                  +L  I  G+ YL
Sbjct: 101 GVVTKST--PVMIITEFMENG--SLDSFLRQNDGQFTVIQLV-----GMLRGIAAGMKYL 151
Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVV-------V 195
                +HRDL   NILV    +     K++D G +R   +        DP         +
Sbjct: 152 ADMNYVHRDLAARNILVNSNLV----CKVSDFGLSRFLEDDTS-----DPTYTSALGGKI 202
Query: 196 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
              + APE  +  R +T A D+W+ G +  E+++
Sbjct: 203 PIRWTAPE-AIQYRKFTSASDVWSYGIVMWEVMS 235

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 50/224 (22%), Positives = 96/224 (42%), Gaps = 42/224 (18%)
Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIEGTG--LSMSACREIALLRELK-HPNVINLIS 83
           +  G +  VY+A  +D    R+YALK++       + +  +E+  +++L  HPN++   S
Sbjct: 36  LAEGGFAFVYEA--QDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 84  VFL-----SHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDG 138
                   S   +  +LL    E     +++F +  ++              + YQ    
Sbjct: 94  AASIGKEESDTGQAEFLLL--TELCKGQLVEFLKKMESRGPLSCDTVL---KIFYQTCRA 148
Query: 139 IHYLHSNW--VLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN------PLKPLADL 190
           + ++H     ++HRDLK  N+L+  +G     +K+ D G A   ++        +  A +
Sbjct: 149 VQHMHRQKPPIIHRDLKVENLLLSNQGT----IKLCDFGSATTISHYPDYSWSAQRRALV 204
Query: 191 DPVV---VTFWYRAPELL-------LGARHYTKAIDIWAIGCIF 224
           +  +    T  YR PE++       +G +      DIWA+GCI 
Sbjct: 205 EEEITRNTTPMYRTPEIIDLYSNFPIGEKQ-----DIWALGCIL 243

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 44/100 (44%), Gaps = 16/100 (16%)
Query: 135 ILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVV 194
           +L+ +H +H + ++H DLKPAN L++      G +K+ D G A     P       D  V
Sbjct: 136 MLEAVHTIHQHGIVHSDLKPANFLIVD-----GMLKLIDFGIANQM-QPDXXXVVKDSQV 189
Query: 195 VTFWYRAPELL----------LGARHYTKAIDIWAIGCIF 224
            T  Y  PE +                +   D+W++GCI 
Sbjct: 190 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 229

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 84/209 (40%), Gaps = 23/209 (11%)
Query: 27  VGRGTYGHVYKARRKDNSDTRD--YALKQIEGTGLSMSACREIA----LLRELKHPNVIN 80
           +G G +G VYK       +      A+K++     S  A +EI     ++  + +P+V  
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANXXXXXXXXXXXXSLLYQILDGIH 140
           L+ + L+   + +  L  +       ++ + R  K N            +   QI  G++
Sbjct: 84  LLGICLTSTVQLIMQLMPFG-----CLLDYVREHKDNIGSQYLL-----NWCVQIAKGMN 133
Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL    ++HRDL   N+LV         VKI D G A+L     K        V   W  
Sbjct: 134 YLEDRRLVHRDLAARNVLVKTP----QHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT 229
              +L   R YT   D+W+ G    EL+T
Sbjct: 190 LESIL--HRIYTHQSDVWSYGVTVWELMT 216

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 99/221 (44%), Gaps = 29/221 (13%)
Query: 24  GCKVGRGTYGHVYKARR----KDNSDTRDYALKQIEGTGLSMSACREIALLRELK----- 74
           G  +G G +G V +A      K+++  +  A+K ++ T     A  + AL+ ELK     
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLK-VAVKMLKSTA---HADEKEALMSELKIMSHL 106
Query: 75  --HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANXXXXXXXXXXXXSL 131
             H N++NL+    +H    V ++ +Y  + DL + ++  R A+A+             L
Sbjct: 107 GQHENIVNLLGA-CTHGG-PVLVITEYCCYGDLLNFLR--RKAEADLDKEDGRPLELRDL 162
Query: 132 LY---QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLA 188
           L+   Q+  G+ +L S   +HRD+   N+L+    +     KI D G AR   N    + 
Sbjct: 163 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV----AKIGDFGLARDIMNDSNYIV 218
Query: 189 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
             +  +   W  APE +     YT   D+W+ G +  E+ +
Sbjct: 219 KGNARLPVKWM-APESIFDCV-YTVQSDVWSYGILLWEIFS 257
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	291
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-163
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	9e-97
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	5e-96
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	6e-96
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-95
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-95
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-95
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-94
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-93
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-93
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-91
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-90
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-88
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-88
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-73
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-72
3rp9_A	458	Mitogen-activated protein kinase; structural genom	4e-70
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	8e-65
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-64
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-64
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	7e-64
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	8e-64
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	4e-63
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-62
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-62
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	6e-62
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	7e-62
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	9e-62
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-60
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-58
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	7e-57
2a19_B	284	Interferon-induced, double-stranded RNA-activated	8e-50
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	5e-49
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	6e-49
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-48
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-47
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-46
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-45
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-45
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-45
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	5e-45
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	7e-44
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	9e-44
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-42
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-42
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-42
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-41
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	6e-41
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	8e-39
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-38
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-37
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-36
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	4e-36
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	6e-36
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-35
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-35
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-35
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-35
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-35
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-35
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	6e-35
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	7e-35
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	8e-35
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	9e-35
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-34
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-34
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-34
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-34
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-34
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-34
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	6e-34
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	6e-34
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	7e-34
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	8e-34
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-33
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-33
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-33
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-33
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-33
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-33
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-33
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-33
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-33
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	4e-33
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	7e-33
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-32
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	4e-32
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	5e-32
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	7e-32
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	7e-32
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-31
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-31
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-31
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	4e-31
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	5e-31
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	6e-31
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-30
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-30
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-29
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-29
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-29
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-29
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-29
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-29
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	7e-29
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	8e-29
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	9e-29
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-28
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-28
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-28
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-28
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	5e-28
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	6e-28
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	7e-28
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-27
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-27
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-27
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-27
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	6e-27
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	7e-27
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-26
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-26
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-26
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-26
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-26
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-26
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-25
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-25
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-25
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-25
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-24
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-24
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-24
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	5e-24
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-23
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-23
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-22
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-22
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-22
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-22
3fme_A	290	Dual specificity mitogen-activated protein kinase;	4e-22
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-22
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	4e-22
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	5e-22
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	6e-22
3an0_A	340	Dual specificity mitogen-activated protein kinase;	6e-22
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-21
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	4e-21
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	5e-21
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	5e-21
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	8e-21
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	9e-21
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-20
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-20
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-20
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-20
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-20
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-20
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-20
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	5e-20
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-19
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-19
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-19
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-19
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-19
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-19
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-19
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-19
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	6e-19
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	8e-19
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-18
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	4e-18
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-18
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-18
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	6e-18
3ork_A	311	Serine/threonine protein kinase; structural genomi	9e-18
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	6e-17
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-16
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-16
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-16
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-16
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-16
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	5e-16
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	6e-16
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	6e-16
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	9e-16
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	9e-16
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	9e-16
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-15
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-15
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-15
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-15
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-15
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-15
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-15
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-15
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-15
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-15
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	4e-15
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	6e-15
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-15
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	7e-15
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-14
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-14
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-14
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-14
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-14
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-14
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-14
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-14
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-14
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-14
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-14
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-14
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-14
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-14
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-14
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	5e-14
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-13
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-13
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-13
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-13
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-13
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	6e-13
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	8e-13
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-11
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-11
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-10
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	3e-10
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-09
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-09
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	4e-09
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	6e-09
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	8e-09
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-08
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	4e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-06

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  459 bits (1183), Expect = e-163
 Identities = 253/286 (88%), Positives = 271/286 (94%)

Query: 1   MDYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS 60
           MDY+FK+K S+ER +VEDLF+YEGCKVGRGTYGHVYKA+RKD  D +DYALKQIEGTG+S
Sbjct: 3   MDYDFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS 62

Query: 61  MSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKP 120
           MSACREIALLRELKHPNVI+L  VFLSH DRKVWLLFDYAEHDLWHIIKFHRA+KANKKP
Sbjct: 63  MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKP 122

Query: 121 VMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
           V +P+GMVKSLLYQILDGIHYLH+NWVLHRDLKPANILVMGEG ERGRVKIADMGFARLF
Sbjct: 123 VQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182

Query: 181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
           N+PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED
Sbjct: 183 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 242

Query: 241 IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDFNEQ 286
           IKTSNPYHHDQLDRIF+VMGFP +KDWEDI+KMPEH TL+KDF   
Sbjct: 243 IKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRN 288

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  286 bits (734), Expect = 9e-97
 Identities = 84/254 (33%), Positives = 134/254 (52%), Gaps = 32/254 (12%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G G+YG V+K R +D       A+K+     +   +   A REI +L++LKHPN++NL
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQI--VAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNL 67

Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHY 141
           + VF     R++ L+F+Y +H + H +         +    VP+ +VKS+ +Q L  +++
Sbjct: 68  LEVF--RRKRRLHLVFEYCDHTVLHELD--------RYQRGVPEHLVKSITWQTLQAVNF 117

Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            H +  +HRD+KP NIL+    +    +K+ D GFARL   P     D    V T WYR+
Sbjct: 118 CHKHNCIHRDVKPENILITKHSV----IKLCDFGFARLLTGPSDYYDDE---VATRWYRS 170

Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           PELL+G   Y   +D+WAIGC+FAELL+  P++  + +          DQL  I   +G 
Sbjct: 171 PELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDV---------DQLYLIRKTLGD 221

Query: 262 PLEKDWEDIRKMPE 275
            + +  +       
Sbjct: 222 LIPRHQQVFSTNQY 235

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  285 bits (731), Expect = 5e-96
 Identities = 87/254 (34%), Positives = 132/254 (51%), Gaps = 32/254 (12%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
            VG G+YG V K R KD       A+K+     +   +   A REI LL++L+H N++NL
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRI--VAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNL 89

Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHY 141
           + V      ++ +L+F++ +H +   ++          P  +   +V+  L+QI++GI +
Sbjct: 90  LEVC--KKKKRWYLVFEFVDHTILDDLE--------LFPNGLDYQVVQKYLFQIINGIGF 139

Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            HS+ ++HRD+KP NILV   G+    VK+ D GFAR    P +   D    V T WYRA
Sbjct: 140 CHSHNIIHRDIKPENILVSQSGV----VKLCDFGFARTLAAPGEVYDDE---VATRWYRA 192

Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           PELL+G   Y KA+D+WAIGC+  E+   EP+F    +          DQL  I   +G 
Sbjct: 193 PELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI---------DQLYHIMMCLGN 243

Query: 262 PLEKDWEDIRKMPE 275
            + +  E   K P 
Sbjct: 244 LIPRHQELFNKNPV 257

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  282 bits (724), Expect = 1e-95
 Identities = 95/254 (37%), Positives = 143/254 (56%), Gaps = 33/254 (12%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG VYKA+         +ALK+I    E  G+  +  REI++L+ELKH N++ L
Sbjct: 9   KIGEGTYGVVYKAQNNYG---ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL 65

Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHY 141
             V   H  +++ L+F++ + DL  ++              +     KS L Q+L+GI Y
Sbjct: 66  YDVI--HTKKRLVLVFEHLDQDLKKLLD--------VCEGGLESVTAKSFLLQLLNGIAY 115

Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            H   VLHRDLKP N+L+       G +KIAD G AR F  P++        +VT WYRA
Sbjct: 116 CHDRRVLHRDLKPQNLLIN----REGELKIADFGLARAFGIPVRKYT---HEIVTLWYRA 168

Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           P++L+G++ Y+  IDIW++GCIFAE++   P+F    E          DQL RIF ++G 
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA---------DQLMRIFRILGT 219

Query: 262 PLEKDWEDIRKMPE 275
           P  K+W ++ ++P+
Sbjct: 220 PNSKNWPNVTELPK 233

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  283 bits (727), Expect = 2e-95
 Identities = 99/255 (38%), Positives = 153/255 (60%), Gaps = 30/255 (11%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG VYKA     ++T   A+K+I    E  G+  +A RE++LL+EL+H N+I L
Sbjct: 41  KLGEGTYGEVYKAIDTVTNET--VAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIEL 98

Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHY 141
            SV   H++ ++ L+F+YAE+DL   +        +K P +    ++KS LYQ+++G+++
Sbjct: 99  KSVI--HHNHRLHLIFEYAENDLKKYM--------DKNPDVSM-RVIKSFLYQLINGVNF 147

Query: 142 LHSNWVLHRDLKPANILV-MGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
            HS   LHRDLKP N+L+ + +  E   +KI D G AR F  P++        ++T WYR
Sbjct: 148 CHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFT---HEIITLWYR 204

Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
            PE+LLG+RHY+ ++DIW+I CI+AE+L   P+F    E          DQL +IF V+G
Sbjct: 205 PPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI---------DQLFKIFEVLG 255

Query: 261 FPLEKDWEDIRKMPE 275
            P +  W  +  +P+
Sbjct: 256 LPDDTTWPGVTALPD 270

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  282 bits (724), Expect = 3e-95
 Identities = 99/254 (38%), Positives = 153/254 (60%), Gaps = 33/254 (12%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           KVG GTYG VYKA+       R  ALK+I    E  G+  +A REI+LL+EL HPN+++L
Sbjct: 28  KVGEGTYGVVYKAKDSQG---RIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSL 84

Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHY 141
           I V   H++R + L+F++ E DL  ++         +    +    +K  LYQ+L G+ +
Sbjct: 85  IDVI--HSERCLTLVFEFMEKDLKKVLD--------ENKTGLQDSQIKIYLYQLLRGVAH 134

Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            H + +LHRDLKP N+L+       G +K+AD G AR F  P++        VVT WYRA
Sbjct: 135 CHQHRILHRDLKPQNLLIN----SDGALKLADFGLARAFGIPVRSYT---HEVVTLWYRA 187

Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           P++L+G++ Y+ ++DIW+IGCIFAE++T +P+F    +D         DQL +IFS++G 
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD---------DQLPKIFSILGT 238

Query: 262 PLEKDWEDIRKMPE 275
           P  ++W  ++++P 
Sbjct: 239 PNPREWPQVQELPL 252

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  281 bits (722), Expect = 2e-94
 Identities = 99/261 (37%), Positives = 141/261 (54%), Gaps = 35/261 (13%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI-------EGTGLSMSACREIALLRELKHPNV 78
            +G G +  VYKAR K+ +     A+K+I          G++ +A REI LL+EL HPN+
Sbjct: 17  FLGEGQFATVYKARDKNTNQI--VAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI 74

Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDG 138
           I L+  F   +   + L+FD+ E DL  IIK           +++    +K+ +   L G
Sbjct: 75  IGLLDAF--GHKSNISLVFDFMETDLEVIIK--------DNSLVLTPSHIKAYMLMTLQG 124

Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + YLH +W+LHRDLKP N+L+     E G +K+AD G A+ F +P +        VVT W
Sbjct: 125 LEYLHQHWILHRDLKPNNLLLD----ENGVLKLADFGLAKSFGSPNRAYT---HQVVTRW 177

Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPELL GAR Y   +D+WA+GCI AELL   P      +          DQL RIF  
Sbjct: 178 YRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL---------DQLTRIFET 228

Query: 259 MGFPLEKDWEDIRKMPEHPTL 279
           +G P E+ W D+  +P++ T 
Sbjct: 229 LGTPTEEQWPDMCSLPDYVTF 249

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  278 bits (714), Expect = 1e-93
 Identities = 92/253 (36%), Positives = 142/253 (56%), Gaps = 26/253 (10%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI---EGTGLSMSACREIALLRELKHPNVINLI 82
           K+G GTY  VYK   K        ALK++      G   +A REI+L++ELKH N++ L 
Sbjct: 12  KLGNGTYATVYKGLNKTTGVY--VALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLY 69

Query: 83  SVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYL 142
            V   H + K+ L+F++ ++DL   +           P  +   +VK   +Q+L G+ + 
Sbjct: 70  DVI--HTENKLTLVFEFMDNDLKKYMDSRTVGN---TPRGLELNLVKYFQWQLLQGLAFC 124

Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAP 202
           H N +LHRDLKP N+L+     +RG++K+ D G AR F  P+   +     VVT WYRAP
Sbjct: 125 HENKILHRDLKPQNLLIN----KRGQLKLGDFGLARAFGIPVNTFS---SEVVTLWYRAP 177

Query: 203 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGFP 262
           ++L+G+R Y+ +IDIW+ GCI AE++T +P+F    ++         +QL  IF +MG P
Sbjct: 178 DVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE---------EQLKLIFDIMGTP 228

Query: 263 LEKDWEDIRKMPE 275
            E  W  + K+P+
Sbjct: 229 NESLWPSVTKLPK 241

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  277 bits (711), Expect = 1e-93
 Identities = 97/255 (38%), Positives = 146/255 (57%), Gaps = 33/255 (12%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG V+KA+ ++  +    ALK++    +  G+  SA REI LL+ELKH N++ L
Sbjct: 9   KIGEGTYGTVFKAKNRETHEI--VALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 66

Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHY 141
             V   H+D+K+ L+F++ + DL                  +   +VKS L+Q+L G+ +
Sbjct: 67  HDVL--HSDKKLTLVFEFCDQDLKKYFD--------SCNGDLDPEIVKSFLFQLLKGLGF 116

Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            HS  VLHRDLKP N+L+       G +K+A+ G AR F  P++  +     VVT WYR 
Sbjct: 117 CHSRNVLHRDLKPQNLLIN----RNGELKLANFGLARAFGIPVRCYS---AEVVTLWYRP 169

Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           P++L GA+ Y+ +ID+W+ GCIFAEL  +  P+F     D         DQL RIF ++G
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD---------DQLKRIFRLLG 220

Query: 261 FPLEKDWEDIRKMPE 275
            P E+ W  + K+P+
Sbjct: 221 TPTEEQWPSMTKLPD 235

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  274 bits (702), Expect = 1e-91
 Identities = 91/253 (35%), Positives = 133/253 (52%), Gaps = 31/253 (12%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI---EGTGLSMSACREIALLRELKHPNVINLI 82
           K+G GTY  VYK + K   +    ALK+I      G   +A RE++LL++LKH N++ L 
Sbjct: 9   KLGEGTYATVYKGKSKLTDNL--VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 66

Query: 83  SVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYL 142
            +   H ++ + L+F+Y + DL   +             ++    VK  L+Q+L G+ Y 
Sbjct: 67  DII--HTEKSLTLVFEYLDKDLKQYLD--------DCGNIINMHNVKLFLFQLLRGLAYC 116

Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAP 202
           H   VLHRDLKP N+L+     ERG +K+AD G AR  + P K        VVT WYR P
Sbjct: 117 HRQKVLHRDLKPQNLLIN----ERGELKLADFGLARAKSIPTKTYD---NEVVTLWYRPP 169

Query: 203 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGFP 262
           ++LLG+  Y+  ID+W +GCIF E+ T  P+F     +         +QL  IF ++G P
Sbjct: 170 DILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE---------EQLHFIFRILGTP 220

Query: 263 LEKDWEDIRKMPE 275
            E+ W  I    E
Sbjct: 221 TEETWPGILSNEE 233

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  271 bits (696), Expect = 2e-90
 Identities = 89/260 (34%), Positives = 131/260 (50%), Gaps = 34/260 (13%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G+GT+G V+KAR +        ALK++    E  G  ++A REI +L+ LKH NV+NL
Sbjct: 24  KIGQGTFGEVFKARHRKTGQK--VALKKVLMENEKEGFPITALREIKILQLLKHENVVNL 81

Query: 82  ISVFLSHNDR------KVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQI 135
           I +  +           ++L+FD+ EHDL        A   +   V      +K ++  +
Sbjct: 82  IEICRTKASPYNRCKGSIYLVFDFCEHDL--------AGLLSNVLVKFTLSEIKRVMQML 133

Query: 136 LDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLK-PLADLDPVV 194
           L+G++Y+H N +LHRD+K AN+L+  +G+    +K+AD G AR F+             V
Sbjct: 134 LNGLYYIHRNKILHRDMKAANVLITRDGV----LKLADFGLARAFSLAKNSQPNRYTNRV 189

Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 254
           VT WYR PELLLG R Y   ID+W  GCI AE+ T  PI     E           QL  
Sbjct: 190 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ---------HQLAL 240

Query: 255 IFSVMGFPLEKDWEDIRKMP 274
           I  + G    + W ++    
Sbjct: 241 ISQLCGSITPEVWPNVDNYE 260

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  265 bits (681), Expect = 1e-88
 Identities = 93/262 (35%), Positives = 143/262 (54%), Gaps = 38/262 (14%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDY-ALKQI----EGTGLSMSACREIALLRELK---HPN 77
           ++G G YG V+KAR  D  +   + ALK++       G+ +S  RE+A+LR L+   HPN
Sbjct: 18  EIGEGAYGKVFKAR--DLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 75

Query: 78  VINLISVFLSHN---DRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQ 134
           V+ L  V        + K+ L+F++ + DL   +              VP   +K +++Q
Sbjct: 76  VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLD-------KVPEPGVPTETIKDMMFQ 128

Query: 135 ILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVV 194
           +L G+ +LHS+ V+HRDLKP NILV       G++K+AD G AR+++  +     L  VV
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVT----SSGQIKLADFGLARIYSFQMA----LTSVV 180

Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 254
           VT WYRAPE+LL +  Y   +D+W++GCIFAE+   +P+F    +          DQL +
Sbjct: 181 VTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDV---------DQLGK 230

Query: 255 IFSVMGFPLEKDWEDIRKMPEH 276
           I  V+G P E+DW     +P  
Sbjct: 231 ILDVIGLPGEEDWPRDVALPRQ 252

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  264 bits (678), Expect = 3e-88
 Identities = 100/264 (37%), Positives = 142/264 (53%), Gaps = 40/264 (15%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI------EGT-GLSMSACREIALLRELK---H 75
           ++G G YG VYKAR   +      ALK +       G  GL +S  RE+ALLR L+   H
Sbjct: 16  EIGVGAYGTVYKARDPHSGHF--VALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEH 73

Query: 76  PNVINLISVFLSHN---DRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLL 132
           PNV+ L+ V  +     + KV L+F++ + DL   +           P  +P   +K L+
Sbjct: 74  PNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLD-------KAPPPGLPAETIKDLM 126

Query: 133 YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP 192
            Q L G+ +LH+N ++HRDLKP NILV       G VK+AD G AR+++  +     L P
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVT----SGGTVKLADFGLARIYSYQMA----LTP 178

Query: 193 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 252
           VVVT WYRAPE+LL +  Y   +D+W++GCIFAE+   +P+F    E          DQL
Sbjct: 179 VVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEA---------DQL 228

Query: 253 DRIFSVMGFPLEKDWEDIRKMPEH 276
            +IF ++G P E DW     +P  
Sbjct: 229 GKIFDLIGLPPEDDWPRDVSLPRG 252

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  229 bits (587), Expect = 2e-73
 Identities = 78/275 (28%), Positives = 140/275 (50%), Gaps = 39/275 (14%)

Query: 6   KIKTSNERTKVEDLFDYEGCK-VGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLS 60
           K+  S+ +T  +    Y  CK +G G++G V++A+     ++ + A+K++          
Sbjct: 26  KVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAK---LVESDEVAIKKVLQDKRFKN-- 80

Query: 61  MSACREIALLRELKHPNVINLISVFLSHNDRK----VWLLFDYAEHDLWHIIKFHRAAKA 116
               RE+ ++R +KHPNV++L + F S+ D+K    + L+ +Y    ++   + +   K 
Sbjct: 81  ----RELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQ 136

Query: 117 NKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGF 176
                 +P  ++K  +YQ+L  + Y+HS  + HRD+KP N+L+       G +K+ D G 
Sbjct: 137 T-----MPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPP---SGVLKLIDFGS 188

Query: 177 ARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 236
           A++     +P       + + +YRAPEL+ GA +YT  IDIW+ GC+ AEL+  +P+F  
Sbjct: 189 AKILI-AGEPNVSY---ICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPG 244

Query: 237 RQEDIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIR 271
                        DQL  I  V+G P  +  + + 
Sbjct: 245 ESG---------IDQLVEIIKVLGTPSREQIKTMN 270

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  226 bits (579), Expect = 4e-72
 Identities = 76/269 (28%), Positives = 130/269 (48%), Gaps = 30/269 (11%)

Query: 7   IKTSNERTKVEDLFDYEGCK-VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACR 65
           + T  +         Y   K +G G++G VY+A+  D+ +    A+K++          R
Sbjct: 41  VATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGEL--VAIKKVLQD--KRFKNR 96

Query: 66  EIALLRELKHPNVINLISVFLSHNDRK----VWLLFDYAEHDLWHIIKFHRAAKANKKPV 121
           E+ ++R+L H N++ L   F S  ++K    + L+ DY    ++ + + +  AK      
Sbjct: 97  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT---- 152

Query: 122 MVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFN 181
            +P   VK  +YQ+   + Y+HS  + HRD+KP N+L+     +   +K+ D G A+   
Sbjct: 153 -LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL---DPDTAVLKLCDFGSAKQLV 208

Query: 182 NPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI 241
              +P       + + +YRAPEL+ GA  YT +ID+W+ GC+ AELL  +PIF       
Sbjct: 209 -RGEPNVSY---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-- 262

Query: 242 KTSNPYHHDQLDRIFSVMGFPLEKDWEDI 270
                   DQL  I  V+G P  +   ++
Sbjct: 263 -------VDQLVEIIKVLGTPTREQIREM 284

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  223 bits (569), Expect = 4e-70
 Identities = 94/300 (31%), Positives = 141/300 (47%), Gaps = 68/300 (22%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
            +G G+YGHV +A   D  + R  A+K+I    E         REIA+L  L H +V+ +
Sbjct: 60  LIGTGSYGHVCEA--YDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKV 117

Query: 82  ISVFLS---HNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDG 138
           + + +        +++++ + A+ D   + +          PV + +  +K+LLY +L G
Sbjct: 118 LDIVIPKDVEKFDELYVVLEIADSDFKKLFR---------TPVYLTELHIKTLLYNLLVG 168

Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV----- 193
           + Y+HS  +LHRDLKPAN LV     +   VK+ D G AR  + P    + L        
Sbjct: 169 VKYVHSAGILHRDLKPANCLVN----QDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224

Query: 194 -------------------VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE--- 231
                              VVT WYRAPEL+L   +YT+AID+W+IGCIFAELL      
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284

Query: 232 --------PIF-----------HCRQEDIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRK 272
                   P+F                D K     + DQL+ IF+++G P E+D E + K
Sbjct: 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEK 344

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  206 bits (526), Expect = 8e-65
 Identities = 75/276 (27%), Positives = 129/276 (46%), Gaps = 36/276 (13%)

Query: 7   IKTSNERTKVEDLFDYEGCK-VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACR 65
              + +    +++  ++  +  G+GT+G V     K+ S     A+K++          R
Sbjct: 10  AAAAADERSRKEMDRFQVERMAGQGTFGTVQLG--KEKSTGMSVAIKKVIQD--PRFRNR 65

Query: 66  EIALLRELK---HPNVINLISVFLSH-----NDRKVWLLFDYAEHDLWHIIKFHRAAKAN 117
           E+ ++++L    HPN++ L S F +       D  + ++ +Y    L    + +   +  
Sbjct: 66  ELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVA 125

Query: 118 KKPVMVPKGMVKSLLYQILDGIHYLH--SNWVLHRDLKPANILVMGEGIERGRVKIADMG 175
                 P  ++K  L+Q++  I  LH  S  V HRD+KP N+LV       G +K+ D G
Sbjct: 126 -----PPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLV---NEADGTLKLCDFG 177

Query: 176 FARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
            A+  + P +P       + + +YRAPEL+ G +HYT A+DIW++GCIFAE++  EPIF 
Sbjct: 178 SAKKLS-PSEPNVAY---ICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFR 233

Query: 236 CRQEDIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIR 271
                          QL  I  V+G P  +    + 
Sbjct: 234 GDN---------SAGQLHEIVRVLGCPSREVLRKLN 260

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  204 bits (522), Expect = 1e-64
 Identities = 78/260 (30%), Positives = 125/260 (48%), Gaps = 38/260 (14%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI--EGTGLSMSACREIALLRELKHPNVINLIS 83
            +G G  G V+ A   DN   +  A+K+I          A REI ++R L H N++ +  
Sbjct: 18  PLGCGGNGLVFSA--VDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFE 75

Query: 84  VFLSHNDRK------------VWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSL 131
           +      +             V+++ +Y E DL ++++     + +           +  
Sbjct: 76  ILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEH----------ARLF 125

Query: 132 LYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLD 191
           +YQ+L G+ Y+HS  VLHRDLKPAN+ +  E +    +KI D G AR+ +        L 
Sbjct: 126 MYQLLRGLKYIHSANVLHRDLKPANLFINTEDLV---LKIGDFGLARIMDPHYSHKGHLS 182

Query: 192 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 251
             +VT WYR+P LLL   +YTKAID+WA GCIFAE+LT + +F               +Q
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH---------ELEQ 233

Query: 252 LDRIFSVMGFPLEKDWEDIR 271
           +  I   +    E+D +++ 
Sbjct: 234 MQLILESIPVVHEEDRQELL 253

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  205 bits (525), Expect = 1e-64
 Identities = 84/251 (33%), Positives = 129/251 (51%), Gaps = 31/251 (12%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI---EGTGLSMSACREIALLRELKHPNVINLIS 83
           +G G YG V  A   DN +    A+K+I   E         REI +L   +H N+I +  
Sbjct: 35  IGEGAYGMVCSA--YDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 92

Query: 84  VFLS---HNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIH 140
           +  +      + V+++ D  E DL+ ++K    +  +          +   LYQIL G+ 
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH----------ICYFLYQILRGLK 142

Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           Y+HS  VLHRDLKP+N+L+         +KI D G AR+ +        L   V T WYR
Sbjct: 143 YIHSANVLHRDLKPSNLLLN----TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198

Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           APE++L ++ YTK+IDIW++GCI AE+L++ PIF  +          + DQL+ I  ++G
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH---------YLDQLNHILGILG 249

Query: 261 FPLEKDWEDIR 271
            P ++D   I 
Sbjct: 250 SPSQEDLNCII 260

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  203 bits (519), Expect = 7e-64
 Identities = 73/266 (27%), Positives = 119/266 (44%), Gaps = 51/266 (19%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI---EGTGLSMSACREIALLRELKHPNVINLI 82
            +G G YG V  A           A+K+I   +    ++   REI +L+  KH N+I + 
Sbjct: 18  LLGEGAYGVVCSA--THKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIF 75

Query: 83  SVFLS---HNDRKVWLLFDYAEHDLWHIIK------FHRAAKANKKPVMVPKGMVKSLLY 133
           ++       N  +V+++ +  + DL  +I        H                ++  +Y
Sbjct: 76  NIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDH----------------IQYFIY 119

Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           Q L  +  LH + V+HRDLKP+N+L+         +K+ D G AR+ +      ++    
Sbjct: 120 QTLRAVKVLHGSNVIHRDLKPSNLLIN----SNCDLKVCDFGLARIIDESAADNSEPTGQ 175

Query: 194 -------VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 246
                  V T WYRAPE++L +  Y++A+D+W+ GCI AEL    PIF  R         
Sbjct: 176 QSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD-------- 227

Query: 247 YHHDQLDRIFSVMGFPL-EKDWEDIR 271
            +  QL  IF ++G P  + D   I 
Sbjct: 228 -YRHQLLLIFGIIGTPHSDNDLRCIE 252

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  203 bits (519), Expect = 8e-64
 Identities = 69/262 (26%), Positives = 113/262 (43%), Gaps = 44/262 (16%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC-------------REIALLRE 72
            +  G+YG V       +S+    A+K++  T                    REI LL  
Sbjct: 29  FISSGSYGAVCAGV---DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNH 85

Query: 73  LKHPNVINLISVFL---SHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVK 129
             HPN++ L  +F+        K++L+ +    DL  +I   R   + +         ++
Sbjct: 86  FHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQH--------IQ 137

Query: 130 SLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLAD 189
             +Y IL G+H LH   V+HRDL P NIL+     +   + I D   AR         A+
Sbjct: 138 YFMYHILLGLHVLHEAGVVHRDLHPGNILLA----DNNDITICDFNLAREDTAD----AN 189

Query: 190 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 249
               V   WYRAPEL++  + +TK +D+W+ GC+ AE+   + +F              +
Sbjct: 190 KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST---------FY 240

Query: 250 DQLDRIFSVMGFPLEKDWEDIR 271
           +QL++I  V+G P  +D     
Sbjct: 241 NQLNKIVEVVGTPKIEDVVMFS 262

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  202 bits (516), Expect = 4e-63
 Identities = 95/275 (34%), Positives = 140/275 (50%), Gaps = 60/275 (21%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC----REIALLRELK-HPNVIN 80
           K+G+G YG V+K+   D       A+K+I     + +      REI +L EL  H N++N
Sbjct: 16  KLGKGAYGIVWKS--IDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVN 73

Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIK------FHRAAKANKKPVMVPKGMVKSLLYQ 134
           L++V  + NDR V+L+FDY E DL  +I+       H                 + ++YQ
Sbjct: 74  LLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVH----------------KQYVVYQ 117

Query: 135 ILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV- 193
           ++  I YLHS  +LHRD+KP+NIL+         VK+AD G +R F N  +   ++    
Sbjct: 118 LIKVIKYLHSGGLLHRDMKPSNILLN----AECHVKVADFGLSRSFVNIRRVTNNIPLSI 173

Query: 194 -----------------VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 236
                            V T WYRAPE+LLG+  YTK ID+W++GCI  E+L  +PIF  
Sbjct: 174 NENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF-- 231

Query: 237 RQEDIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIR 271
                  S+    +QL+RI  V+ FP  +D E I+
Sbjct: 232 -----PGSS--TMNQLERIIGVIDFPSNEDVESIQ 259

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  199 bits (508), Expect = 3e-62
 Identities = 81/259 (31%), Positives = 123/259 (47%), Gaps = 50/259 (19%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
            VG G YG V  A   D       A+K++    +    +  A RE+ LL+ ++H NVI L
Sbjct: 31  HVGSGAYGSVCSAI--DKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGL 88

Query: 82  ISVFLS----HNDRKVWLLFDYAEHDLWHIIK-----FHRAAKANKKPVMVPKGMVKSLL 132
           + VF       N    +L+  + + DL  I+                        ++ L+
Sbjct: 89  LDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEK----------------IQYLV 132

Query: 133 YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP 192
           YQ+L G+ Y+HS  V+HRDLKP N+ V     E   +KI D G AR  +       ++  
Sbjct: 133 YQMLKGLKYIHSAGVVHRDLKPGNLAVN----EDCELKILDFGLARHADA------EMTG 182

Query: 193 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 252
            VVT WYRAPE++L   HY + +DIW++GCI AE+LT + +F  +          + DQL
Sbjct: 183 YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD---------YLDQL 233

Query: 253 DRIFSVMGFPLEKDWEDIR 271
            +I  V G P  +  + + 
Sbjct: 234 TQILKVTGVPGTEFVQKLN 252

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  201 bits (513), Expect = 4e-62
 Identities = 88/292 (30%), Positives = 140/292 (47%), Gaps = 60/292 (20%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC----REIALLRELKHPNVINL 81
            +GRG+YG+VY A   D +  ++ A+K++      +  C    REI +L  LK   +I L
Sbjct: 33  LIGRGSYGYVYLA--YDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRL 90

Query: 82  ISVFLS---HNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDG 138
             + +        +++++ + A+ DL  + K          P+ + +  +K++LY +L G
Sbjct: 91  YDLIIPDDLLKFDELYIVLEIADSDLKKLFK---------TPIFLTEEHIKTILYNLLLG 141

Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV----- 193
            +++H + ++HRDLKPAN L+     +   VK+ D G AR  N+        D       
Sbjct: 142 ENFIHESGIIHRDLKPANCLLN----QDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197

Query: 194 --------------VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS--------- 230
                         VVT WYRAPEL+L   +YTK+IDIW+ GCIFAELL           
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257

Query: 231 --EPIF--------HCRQEDIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRK 272
              P+F           +   K     + DQL+ IF+++G P E D ++I K
Sbjct: 258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINK 309

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  199 bits (507), Expect = 6e-62
 Identities = 78/253 (30%), Positives = 124/253 (49%), Gaps = 39/253 (15%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++    +    +  A RE+ LL+ ++H NVI L+
Sbjct: 33  VGSGAYGAVCSAV--DGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90

Query: 83  SVFLSHNDRK----VWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDG 138
            VF            +L+  +   DL  ++K  +  +            ++ L+YQ+L G
Sbjct: 91  DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDR----------IQFLVYQMLKG 140

Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+H+  ++HRDLKP N+ V     E   +KI D G AR  ++      ++   VVT W
Sbjct: 141 LRYIHAAGIIHRDLKPGNLAVN----EDCELKILDFGLARQADS------EMTGYVVTRW 190

Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L    YT+ +DIW++GCI AE++T + +F             H DQL  I  V
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD---------HLDQLKEIMKV 241

Query: 259 MGFPLEKDWEDIR 271
            G P  +  + ++
Sbjct: 242 TGTPPAEFVQRLQ 254

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  199 bits (508), Expect = 7e-62
 Identities = 70/282 (24%), Positives = 125/282 (44%), Gaps = 61/282 (21%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
            +G G++G V +    D    + +ALK++          RE+ +++ L H N+I L+  F
Sbjct: 14  TLGTGSFGIVCEV--FDIESGKRFALKKV--LQDPRYKNRELDIMKVLDHVNIIKLVDYF 69

Query: 86  LSHNDRK------------------------------------VWLLFDYAEHDLWHIIK 109
            +  D +                                    + ++ +Y    L  ++K
Sbjct: 70  YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLK 129

Query: 110 FHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRV 169
               +  +     +P  ++   +YQ+   + ++HS  + HRD+KP N+LV     +   +
Sbjct: 130 SFIRSGRS-----IPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLV---NSKDNTL 181

Query: 170 KIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
           K+ D G A+    P +P       + + +YRAPEL+LGA  YT +ID+W+IGC+F EL+ 
Sbjct: 182 KLCDFGSAKKLI-PSEPSVAY---ICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237

Query: 230 SEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIR 271
            +P+F    E          DQL RI  +MG P ++    + 
Sbjct: 238 GKPLF--SGET-------SIDQLVRIIQIMGTPTKEQMIRMN 270

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  198 bits (506), Expect = 9e-62
 Identities = 84/253 (33%), Positives = 122/253 (48%), Gaps = 39/253 (15%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINLI 82
           VG G YG V  A   D       A+K++    +    +    RE+ LL+ +KH NVI L+
Sbjct: 37  VGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94

Query: 83  SVFLS----HNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDG 138
            VF           V+L+      DL +I+K  +    +          V+ L+YQIL G
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH----------VQFLIYQILRG 144

Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + Y+HS  ++HRDLKP+N+ V     E   +KI D G AR   +      ++   V T W
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTAD------EMTGYVATRW 194

Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  +
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILRL 245

Query: 259 MGFPLEKDWEDIR 271
           +G P  +  + I 
Sbjct: 246 VGTPGAELLKKIS 258

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  194 bits (495), Expect = 2e-60
 Identities = 69/286 (24%), Positives = 130/286 (45%), Gaps = 41/286 (14%)

Query: 2   DYEFKIKTSNERTKVEDLFDYEGC-KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS 60
           DYE      +   +  +  DY+   K+GRG Y  V++A    N++     +K ++     
Sbjct: 24  DYE------SHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK--VVVKILKPV-KK 74

Query: 61  MSACREIALLRELK-HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANK 118
               REI +L  L+  PN+I L  +      R   L+F++  + D   + +         
Sbjct: 75  KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ--------- 125

Query: 119 KPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR 178
               +    ++  +Y+IL  + Y HS  ++HRD+KP N+++     E  ++++ D G A 
Sbjct: 126 ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI---DHEHRKLRLIDWGLAE 179

Query: 179 LFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCR 237
            ++    P  + +  V + +++ PELL+  + Y  ++D+W++GC+ A ++   EP FH  
Sbjct: 180 FYH----PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 235

Query: 238 QEDIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF 283
                     ++DQL RI  V+G     D+ D   +   P      
Sbjct: 236 D---------NYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDIL 272

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  193 bits (491), Expect = 2e-58
 Identities = 75/275 (27%), Positives = 130/275 (47%), Gaps = 49/275 (17%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINLI 82
           +G G  G V  A   D    R+ A+K++    +    +  A RE+ L++ + H N+I+L+
Sbjct: 70  IGSGAQGIVCAA--YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127

Query: 83  SVFLSHNDRK----VWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDG 138
           +VF      +    V+L+ +  + +L  +I+           +      +  LLYQ+L G
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---------MELD--HERMSYLLYQMLCG 176

Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           I +LHS  ++HRDLKP+NI+V         +KI D G AR           + P VVT +
Sbjct: 177 IKHLHSAGIIHRDLKPSNIVVK----SDCTLKILDFGLARTAGTS----FMMTPYVVTRY 228

Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++LG   Y + +DIW++GCI  E++  + +F  R          + DQ +++   
Sbjct: 229 YRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRD---------YIDQWNKVIEQ 278

Query: 259 MGFPLEKDWEDI--------RKMPEHPTLLKDFNE 285
           +G P  +  + +           P++      F +
Sbjct: 279 LGTPCPEFMKKLQPTVRNYVENRPKYAG--LTFPK 311

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  186 bits (474), Expect = 7e-57
 Identities = 74/275 (26%), Positives = 127/275 (46%), Gaps = 49/275 (17%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINLI 82
           +G G  G V  A   D    R+ A+K++    +    +  A RE+ L++ + H N+I L+
Sbjct: 33  IGSGAQGIVCAA--YDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 90

Query: 83  SVFLSHNDRK----VWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDG 138
           +VF      +    V+++ +  + +L  +I+     +            +  LLYQ+L G
Sbjct: 91  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE-----------RMSYLLYQMLCG 139

Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           I +LHS  ++HRDLKP+NI+V         +KI D G AR           + P VVT +
Sbjct: 140 IKHLHSAGIIHRDLKPSNIVVK----SDCTLKILDFGLAR----TAGTSFMMTPYVVTRY 191

Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPE++LG   Y + +DIW++GCI  E++    +F             H DQ +++   
Sbjct: 192 YRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTD---------HIDQWNKVIEQ 241

Query: 259 MGFPLEKDWEDI--------RKMPEHPTLLKDFNE 285
           +G P  +  + +           P++      F +
Sbjct: 242 LGTPCPEFMKKLQPTVRTYVENRPKYAG--YSFEK 274

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  165 bits (419), Expect = 8e-50
 Identities = 54/239 (22%), Positives = 102/239 (42%), Gaps = 36/239 (15%)

Query: 21  DYE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVI 79
           D++    +G G +G V+KA+ +   D + Y +K+++    +  A RE+  L +L H N++
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHR--IDGKTYVIKRVKYN--NEKAEREVKALAKLDHVNIV 67

Query: 80  NLISVFLSHN--------------DRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVP 124
           +    +   +               + +++  ++ +   L   I+        ++   + 
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE-------KRRGEKLD 120

Query: 125 KGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPL 184
           K +   L  QI  G+ Y+HS  +++RDLKP+NI ++        VKI D G      N  
Sbjct: 121 KVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ----VKIGDFGLVTSLKND- 175

Query: 185 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT 243
                      T  Y +PE +   + Y K +D++A+G I AELL          +    
Sbjct: 176 ---GKRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFETSKFFTD 230

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  164 bits (416), Expect = 5e-49
 Identities = 63/229 (27%), Positives = 114/229 (49%), Gaps = 24/229 (10%)

Query: 21  DYE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS-----MSACREIALLRELK 74
           ++    K+GRG +  VY+A      D    ALK+++   L          +EI LL++L 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACL--LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 90

Query: 75  HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLY 133
           HPNVI   + F+  N  ++ ++ + A+  DL  +IK  +     K+  ++P+  V     
Sbjct: 91  HPNVIKYYASFIEDN--ELNIVLELADAGDLSRMIKHFK-----KQKRLIPERTVWKYFV 143

Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           Q+   + ++HS  V+HRD+KPAN+ +   G+    VK+ D+G  R F++          +
Sbjct: 144 QLCSALEHMHSRRVMHRDIKPANVFITATGV----VKLGDLGLGRFFSSKTTAAHS---L 196

Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 242
           V T +Y +PE +     Y    DIW++GC+  E+   +  F+  + ++ 
Sbjct: 197 VGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY 244

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  164 bits (418), Expect = 6e-49
 Identities = 61/236 (25%), Positives = 108/236 (45%), Gaps = 25/236 (10%)

Query: 6   KIKTSNERTKVEDLFDYE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS---- 60
            +    E    + +  Y    K+G G++G     +     D R Y +K+I  + +S    
Sbjct: 10  GVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKST--EDGRQYVIKEINISRMSSKER 67

Query: 61  MSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKK 119
             + RE+A+L  +KHPN++     F  +    ++++ DY E  DL+  I         +K
Sbjct: 68  EESRREVAVLANMKHPNIVQYRESFEENG--SLYIVMDYCEGGDLFKRIN-------AQK 118

Query: 120 PVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL 179
            V+  +  +     QI   + ++H   +LHRD+K  NI +  +G     V++ D G AR+
Sbjct: 119 GVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT----VQLGDFGIARV 174

Query: 180 FNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
            N+    +      + T +Y +PE+    + Y    DIWA+GC+  EL T +  F 
Sbjct: 175 LNS---TVELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFE 226

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  161 bits (409), Expect = 3e-48
 Identities = 67/225 (29%), Positives = 107/225 (47%), Gaps = 26/225 (11%)

Query: 21  DYE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIALLRELKH 75
           DYE    +G G+YG   K RRK  SD +    K+++   ++         E+ LLRELKH
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRK--SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64

Query: 76  PNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQ 134
           PN++      +   +  ++++ +Y E  DL  +I         K+   + +  V  ++ Q
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGT-----KERQYLDEEFVLRVMTQ 119

Query: 135 ILDGIHYLHS-----NWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLAD 189
           +   +   H      + VLHRDLKPAN+ + G+      VK+ D G AR+ N+     A 
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN----VKLGDFGLARILNHDTS-FA- 173

Query: 190 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
               V T +Y +PE +     Y +  DIW++GC+  EL    P F
Sbjct: 174 -KTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPF 216

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  160 bits (406), Expect = 1e-47
 Identities = 54/290 (18%), Positives = 105/290 (36%), Gaps = 62/290 (21%)

Query: 21  DYE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA----CREIALLRELKH 75
            Y    ++G G    V++   +     + YA+K +               EIA L +L+ 
Sbjct: 29  IYSILKQIGSGGSSKVFQVLNEKK---QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 85

Query: 76  PN--VINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLY 133
            +  +I L        D+ ++++ +    DL   +K  ++         +     KS   
Sbjct: 86  HSDKIIRLYDYE--ITDQYIYMVMECGNIDLNSWLKKKKS---------IDPWERKSYWK 134

Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
            +L+ +H +H + ++H DLKPAN L     I  G +K+ D G A         +   D  
Sbjct: 135 NMLEAVHTIHQHGIVHSDLKPANFL-----IVDGMLKLIDFGIANQMQPDTTSVV-KDSQ 188

Query: 194 VVTFWYRAPELLLGARH----------YTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT 243
           V T  Y  PE +                +   D+W++GCI   +   +            
Sbjct: 189 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT----------- 237

Query: 244 SNPYHH--DQLDRIFSVMGFPLEKDWEDIRKMPEH-PTLLKDFNEQICKM 290
             P+    +Q+ ++ +++      D     + P+     L+D    +   
Sbjct: 238 --PFQQIINQISKLHAII------DPNHEIEFPDIPEKDLQDV---LKCC 276

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  156 bits (397), Expect = 6e-46
 Identities = 51/242 (21%), Positives = 92/242 (38%), Gaps = 38/242 (15%)

Query: 11  NERTKVEDLFDYE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA----CR 65
           NE   V+    Y    ++G G    V++   +     + YA+K +               
Sbjct: 1   NECISVKG-RIYSILKQIGSGGSSKVFQVLNEKK---QIYAIKYVNLEEADNQTLDSYRN 56

Query: 66  EIALLRELKHPN--VINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMV 123
           EIA L +L+  +  +I L    ++     ++++ +    DL   +K  ++         +
Sbjct: 57  EIAYLNKLQQHSDKIIRLYDYEITDQ--YIYMVMECGNIDLNSWLKKKKS---------I 105

Query: 124 PKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNP 183
                KS    +L+ +H +H + ++H DLKPAN L     I  G +K+ D G A      
Sbjct: 106 DPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFL-----IVDGMLKLIDFGIANQMQPD 160

Query: 184 LKPLADLDPVVVTFWYRAPELLLGARH----------YTKAIDIWAIGCIFAELLTSEPI 233
              +   D  V T  Y  PE +                +   D+W++GCI   +   +  
Sbjct: 161 TTSVV-KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219

Query: 234 FH 235
           F 
Sbjct: 220 FQ 221

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  154 bits (392), Expect = 2e-45
 Identities = 67/234 (28%), Positives = 105/234 (44%), Gaps = 39/234 (16%)

Query: 21  DYEGCKV-GRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC-REIALLRELKHPNV 78
           D+E   V G+G +G V KAR     D+R YA+K+I  T   +S    E+ LL  L H  V
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNA--LDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64

Query: 79  INLISVFLSHNDR-----------KVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKG 126
           +   + +L   +             +++  +Y E   L+ +I          + +   + 
Sbjct: 65  VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH--------SENLNQQRD 116

Query: 127 MVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKP 186
               L  QIL+ + Y+HS  ++HRDLKP NI +     E   VKI D G A+  +  L  
Sbjct: 117 EYWRLFRQILEALSYIHSQGIIHRDLKPMNIFID----ESRNVKIGDFGLAKNVHRSLDI 172

Query: 187 LADLDPVVV-----------TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
           L      +            T  Y A E+L G  HY + ID++++G IF E++ 
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  154 bits (391), Expect = 2e-45
 Identities = 56/233 (24%), Positives = 98/233 (42%), Gaps = 37/233 (15%)

Query: 21  DYE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS---MSACREIALLRELKHP 76
           D+E    +GRG +G V++A+ K   D  +YA+K+I             RE+  L +L+HP
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNK--VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 63

Query: 77  NVINLISVFL----------SHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPK 125
            ++   + +L          S     +++        +L   +                +
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMN------GRCTIEERER 117

Query: 126 GMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN--- 182
            +   +  QI + + +LHS  ++HRDLKP+NI    + +    VK+ D G     +    
Sbjct: 118 SVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV----VKVGDFGLVTAMDQDEE 173

Query: 183 ------PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                 P+   A     V T  Y +PE + G   Y+  +DI+++G I  ELL 
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY 225

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  158 bits (400), Expect = 2e-45
 Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 19/219 (8%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLREL-KHPNVINLISV 84
            +G G  G +      DN   RD A+K+I     S  A RE+ LLRE  +HPNVI     
Sbjct: 31  VLGHGAEGTIVYRGMFDN---RDVAVKRILPECFSF-ADREVQLLRESDEHPNVIRYFCT 86

Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHS 144
               + +  ++  +     L   ++    A    +P         +LL Q   G+ +LHS
Sbjct: 87  E--KDRQFQYIAIELCAATLQEYVEQKDFAHLGLEP--------ITLLQQTTSGLAHLHS 136

Query: 145 NWVLHRDLKPANILVMGEGIERG-RVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPE 203
             ++HRDLKP NIL+         +  I+D G  +         +    V  T  + APE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196

Query: 204 LLLGA--RHYTKAIDIWAIGCIFAELLTS-EPIFHCRQE 239
           +L      + T  +DI++ GC+F  +++     F    +
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ 235

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  153 bits (389), Expect = 5e-45
 Identities = 53/231 (22%), Positives = 89/231 (38%), Gaps = 28/231 (12%)

Query: 10  SNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACR 65
           S   +  +  F     ++G G+YG V+K R K+  D R YA+K+                
Sbjct: 49  SRPESFFQQSFQ-RLSRLGHGSYGEVFKVRSKE--DGRLYAVKRSMSPFRGPKDRARKLA 105

Query: 66  EIALLREL-KHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVP 124
           E+    ++ +HP  + L   +       ++L  +     L    +             +P
Sbjct: 106 EVGSHEKVGQHPCCVRLEQAWE--EGGILYLQTELCGPSLQQHCE--------AWGASLP 155

Query: 125 KGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPL 184
           +  V   L   L  + +LHS  ++H D+KPANI +       GR K+ D G         
Sbjct: 156 EAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPR----GRCKLGDFGLLVELGTAG 211

Query: 185 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
                         Y APELL G+  Y  A D++++G    E+  +  + H
Sbjct: 212 AGEV----QEGDPRYMAPELLQGS--YGTAADVFSLGLTILEVACNMELPH 256

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  152 bits (386), Expect = 7e-44
 Identities = 52/253 (20%), Positives = 95/253 (37%), Gaps = 38/253 (15%)

Query: 8   KTSNERTKVEDLFDYE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA--- 63
            ++NE   V+    Y    ++G G    V++   +     + YA+K +            
Sbjct: 45  SSANECISVKG-RIYSILKQIGSGGSSKVFQVLNEKK---QIYAIKYVNLEEADNQTLDS 100

Query: 64  -CREIALLRELKHPN--VINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKP 120
              EIA L +L+  +  +I L    +   D+ ++++ +    DL   +K  ++       
Sbjct: 101 YRNEIAYLNKLQQHSDKIIRLYDYEI--TDQYIYMVMECGNIDLNSWLKKKKS------- 151

Query: 121 VMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
             +     KS    +L+ +H +H + ++H DLKPAN L     I  G +K+ D G A   
Sbjct: 152 --IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFL-----IVDGMLKLIDFGIANQM 204

Query: 181 NNPLKPLADLDPVVVTFWYRAPELLLGA----------RHYTKAIDIWAIGCIFAELLTS 230
                 +   D  V    Y  PE +                +   D+W++GCI   +   
Sbjct: 205 QPDTTSVV-KDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 263

Query: 231 EPIFHCRQEDIKT 243
           +  F      I  
Sbjct: 264 KTPFQQIINQISK 276

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  150 bits (381), Expect = 9e-44
 Identities = 59/222 (26%), Positives = 94/222 (42%), Gaps = 24/222 (10%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM--SACREIALLRELKHPNVINLIS 83
           K+G G + +V         D   YALK+I          A RE  + R   HPN++ L++
Sbjct: 36  KLGEGGFSYVDLVEGL--HDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVA 93

Query: 84  VFLSHNDRK--VWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIH 140
             L     K   WLL  + +   LW+ I+     +   K   + +  +  LL  I  G+ 
Sbjct: 94  YCLRERGAKHEAWLLLPFFKRGTLWNEIE-----RLKDKGNFLTEDQILWLLLGICRGLE 148

Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLK------PLADLDPVV 194
            +H+    HRDLKP NIL+     + G+  + D+G        ++       L D     
Sbjct: 149 AIHAKGYAHRDLKPTNILLG----DEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204

Query: 195 VTFWYRAPELLLGARH--YTKAIDIWAIGCIFAELLTSEPIF 234
            T  YRAPEL     H    +  D+W++GC+   ++  E  +
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY 246

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  146 bits (370), Expect = 2e-42
 Identities = 52/252 (20%), Positives = 96/252 (38%), Gaps = 40/252 (15%)

Query: 10  SNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACR 65
              +++    F  E  K+G G +G V+K  ++   D   YA+K+ +          +A R
Sbjct: 3   MGMKSRYTTEFH-ELEKIGSGEFGSVFKCVKRL--DGCIYAIKRSKKPLAGSVDEQNALR 59

Query: 66  EIALLREL-KHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMV 123
           E+     L +H +V+   S +    D  + +  +Y     L   I      +  +     
Sbjct: 60  EVYAHAVLGQHSHVVRYFSAWA--EDDHMLIQNEYCNGGSLADAIS-----ENYRIMSYF 112

Query: 124 PKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGI---------------ERGR 168
            +  +K LL Q+  G+ Y+HS  ++H D+KP+NI +    I                +  
Sbjct: 113 KEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVM 172

Query: 169 VKIADMGFARLFNNPLKPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 227
            KI D+G     ++P         V      + A E+L     +    DI+A+       
Sbjct: 173 FKIGDLGHVTRISSP--------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCA 224

Query: 228 LTSEPIFHCRQE 239
             +EP+     +
Sbjct: 225 AGAEPLPRNGDQ 236

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  149 bits (378), Expect = 3e-42
 Identities = 72/285 (25%), Positives = 123/285 (43%), Gaps = 33/285 (11%)

Query: 10  SNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIAL 69
            N    +++L       +G G+ G V           R  A+K++      + A  EI L
Sbjct: 7   PNFEQSLKNLVV-SEKILGYGSSGTVVFQGSFQG---RPVAVKRMLIDFCDI-ALMEIKL 61

Query: 70  LRELK-HPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMV 128
           L E   HPNVI          DR +++  +    +L  +++      +++   +  +   
Sbjct: 62  LTESDDHPNVIRYYCSE--TTDRFLYIALELCNLNLQDLVESKN--VSDENLKLQKEYNP 117

Query: 129 KSLLYQILDGIHYLHSNWVLHRDLKPANILV---------MGEGIERGRVKIADMGFARL 179
            SLL QI  G+ +LHS  ++HRDLKP NILV            G E  R+ I+D G  + 
Sbjct: 118 ISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177

Query: 180 F-NNPLKPLADLDPVVVTFWYRAPELLLGA------RHYTKAIDIWAIGCIFAELLTS-E 231
             +       +L+    T  +RAPELL  +      R  T++IDI+++GC+F  +L+  +
Sbjct: 178 LDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237

Query: 232 PIF---HCRQEDIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM 273
             F   + R+ +I     +  D++  +          D   I +M
Sbjct: 238 HPFGDKYSRESNII-RGIFSLDEMKCLHDRSLIAEATDL--ISQM 279

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  146 bits (371), Expect = 3e-42
 Identities = 51/294 (17%), Positives = 110/294 (37%), Gaps = 27/294 (9%)

Query: 11  NERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA---CREI 67
             ++    L+      +G+G   +V++ R K   D   +A+K               RE 
Sbjct: 2   GSQSTSNHLWLL-SDILGQGATANVFRGRHKKTGDL--FAIKVFNNISFLRPVDVQMREF 58

Query: 68  ALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKG 126
            +L++L H N++ L ++      R   L+ ++     L+ +++             +P+ 
Sbjct: 59  EVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLE------EPSNAYGLPES 112

Query: 127 MVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKP 186
               +L  ++ G+++L  N ++HR++KP NI+ +     +   K+ D G AR   +  + 
Sbjct: 113 EFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ- 171

Query: 187 LADLDPVVVTFWYRAPELLLGA-------RHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
                 +  T  Y  P++   A       + Y   +D+W+IG  F    T    F   + 
Sbjct: 172 ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228

Query: 240 DIKTSNPYHH---DQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDFNEQICKM 290
             +     +     +     S +        +    MP   +L +     +  +
Sbjct: 229 PRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPV 282

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  145 bits (368), Expect = 4e-41
 Identities = 48/240 (20%), Positives = 96/240 (40%), Gaps = 32/240 (13%)

Query: 11  NERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA---CREI 67
             ++    L+      +G+G   +V++ R K   D   +A+K               RE 
Sbjct: 2   GSQSTSNHLWLL-SDILGQGATANVFRGRHKKTGDL--FAIKVFNNISFLRPVDVQMREF 58

Query: 68  ALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKG 126
            +L++L H N++ L ++      R   L+ ++     L+ +++             +P+ 
Sbjct: 59  EVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLE------EPSNAYGLPES 112

Query: 127 MVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKP 186
               +L  ++ G+++L  N ++HR++KP NI+ +     +   K+ D G AR   +    
Sbjct: 113 EFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED---- 168

Query: 187 LADLDPVVVTF----WYRAPELLLGA-------RHYTKAIDIWAIGCIFAELLTSEPIFH 235
               D   V+      Y  P++   A       + Y   +D+W+IG  F    T    F 
Sbjct: 169 ----DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  144 bits (365), Expect = 6e-41
 Identities = 39/297 (13%), Positives = 70/297 (23%), Gaps = 57/297 (19%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC-----REIALLRELKHPN- 77
              +  G    V+  R  +     D+ALK       +  +              L   + 
Sbjct: 67  VEPLRVGDRSVVFLVRDVERL--EDFALKVFTMGAENSRSELERLHEATFAAARLLGESP 124

Query: 78  -----------------------VINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAA 114
                                     L      +      LL   A  DL  +       
Sbjct: 125 EEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFV 184

Query: 115 KANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM 174
              +         +  L  Q++     L S  ++H    P N+ +M      GR+ + D+
Sbjct: 185 YVFRGD--EGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIM----PDGRLMLGDV 238

Query: 175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLG-ARHYTKAIDIWAIGCIFAELLTSEPI 233
                               V   Y   E L      +T A++ W +G     +      
Sbjct: 239 SALWKVGTRGP------ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292

Query: 234 FHCRQEDIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDFNEQICKM 290
           F           P       R    +       +     +P+    +K     I + 
Sbjct: 293 FG-------LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDF---VKTL---IGRF 336

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  137 bits (348), Expect = 8e-39
 Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 29/215 (13%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLIS 83
             +VGRG++G V++ + K        A+K++    L +    E+     L  P ++ L  
Sbjct: 63  QPRVGRGSFGEVHRMKDKQTGFQ--CAVKKVR---LEVFRVEELVACAGLSSPRIVPLYG 117

Query: 84  VFLSHNDRKVWLLFDYAE----HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGI 139
                    V +  +  E      L   IK             +P+      L Q L+G+
Sbjct: 118 AVRE--GPWVNIFMELLEGGSLGQL---IKQMGC---------LPEDRALYYLGQALEGL 163

Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA-RLFNNPLKPLADLDPVVV-TF 197
            YLH+  +LH D+K  N+L+  +G    R  + D G A  L  + L         +  T 
Sbjct: 164 EYLHTRRILHGDVKADNVLLSSDGS---RAALCDFGHALCLQPDGLGKSLLTGDYIPGTE 220

Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 232
            + APE+++G       +DIW+  C+   +L    
Sbjct: 221 THMAPEVVMGKP-CDAKVDIWSSCCMMLHMLNGCH 254

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  135 bits (342), Expect = 3e-38
 Identities = 56/218 (25%), Positives = 98/218 (44%), Gaps = 30/218 (13%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACR----EIALLRELKHPNVI 79
             ++GRG++  VYK    D   T + A  +++   L+ S  +    E  +L+ L+HPN++
Sbjct: 31  DIEIGRGSFKTVYKG--LDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIV 88

Query: 80  NLISVFL--SHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQIL 136
                +       + + L+ +      L   +K  +          +   +++S   QIL
Sbjct: 89  RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---------MKIKVLRSWCRQIL 139

Query: 137 DGIHYLHSN--WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVV 194
            G+ +LH+    ++HRDLK  NI + G     G VKI D+G A L             V+
Sbjct: 140 KGLQFLHTRTPPIIHRDLKCDNIFITGP---TGSVKIGDLGLATLKRASFAK-----AVI 191

Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 232
            T  + APE+      Y +++D++A G    E+ TSE 
Sbjct: 192 GTPEFMAPEM--YEEKYDESVDVYAFGMCMLEMATSEY 227

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  132 bits (335), Expect = 3e-37
 Identities = 68/249 (27%), Positives = 112/249 (44%), Gaps = 44/249 (17%)

Query: 7   IKTSNERTKVEDLFDYE--------GCKVGRGTYGHVYKARRKDNSDTRDY-ALKQIEGT 57
           ++++ E     DL +Y+           +G+GTYG VY  R   +   +   A+K+I   
Sbjct: 2   MRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGR---DLSNQVRIAIKEIPER 58

Query: 58  GLSMSAC--REIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAE----HDLWHIIKFH 111
               S     EIAL + LKH N++  +  F    +  + +  +         L       
Sbjct: 59  DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE--NGFIKIFMEQVPGGSLSAL------- 109

Query: 112 RAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI 171
              ++   P+   +  +     QIL+G+ YLH N ++HRD+K  N+L+       G +KI
Sbjct: 110 --LRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYS---GVLKI 164

Query: 172 ADMGFARLFNNPLKPLADLDPVVVTF----WYRAPELLLGARH-YTKAIDIWAIGCIFAE 226
           +D G +       K LA ++P   TF     Y APE++      Y KA DIW++GC   E
Sbjct: 165 SDFGTS-------KRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIE 217

Query: 227 LLTSEPIFH 235
           + T +P F+
Sbjct: 218 MATGKPPFY 226

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  130 bits (329), Expect = 2e-36
 Identities = 69/236 (29%), Positives = 106/236 (44%), Gaps = 38/236 (16%)

Query: 14  TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC--------R 65
           + VED ++  G ++G G +  V K R+K     ++YA K I+   LS S          R
Sbjct: 1   SMVEDHYEM-GEELGSGQFAIVRKCRQK--GTGKEYAAKFIKKRRLSSSRRGVSREEIER 57

Query: 66  EIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVP 124
           E+ +LRE++HPN+I L  +F   N   V L+ +     +L     F           +  
Sbjct: 58  EVNILREIRHPNIITLHDIF--ENKTDVVLILELVSGGEL-----FDF---------LAE 101

Query: 125 KGM-----VKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL 179
           K           L QILDG+HYLHS  + H DLKP NI+++ + +   R+K+ D G A  
Sbjct: 102 KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161

Query: 180 FNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
                    +   +  T  + APE++          D+W+IG I   LL+    F 
Sbjct: 162 I-EAGNEFKN---IFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL 212

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  131 bits (331), Expect = 4e-36
 Identities = 51/243 (20%), Positives = 107/243 (44%), Gaps = 23/243 (9%)

Query: 7   IKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC-- 64
           +  +++    ED+++     +G+G +  V +   ++    + +A+K ++    + S    
Sbjct: 13  LDMADDDVLFEDVYEL-CEVIGKGPFSVVRRCINRETG--QQFAVKIVDVAKFTSSPGLS 69

Query: 65  -----REIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANK 118
                RE ++   LKHP+++ L+  +   +D  ++++F++ +  DL          K   
Sbjct: 70  TEDLKREASICHMLKHPHIVELLETY--SSDGMLYMVFEFMDGADL-----CFEIVKRAD 122

Query: 119 KPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR 178
              +  + +    + QIL+ + Y H N ++HRD+KP  +L+  +      VK+   G A 
Sbjct: 123 AGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKE-NSAPVKLGGFGVAI 181

Query: 179 LFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 238
                          V T  + APE++     Y K +D+W  G I   LL+    F+  +
Sbjct: 182 QLGESGLVAGG---RVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGTK 237

Query: 239 EDI 241
           E +
Sbjct: 238 ERL 240

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  130 bits (329), Expect = 6e-36
 Identities = 69/280 (24%), Positives = 110/280 (39%), Gaps = 68/280 (24%)

Query: 21  DYE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIA-LLRELKHPNV 78
            YE    +G G+Y    +   K  +   ++A+K I+ +    +   EI  LLR  +HPN+
Sbjct: 23  GYEVKEDIGVGSYSVCKRCIHKATN--MEFAVKIIDKSKRDPT--EEIEILLRYGQHPNI 78

Query: 79  INLISVFLSHNDRKVWL---------LFD-------YAEHDLWHIIKFHRAAKANKKPVM 122
           I L  V+   + + V++         L D       ++E +         A+        
Sbjct: 79  ITLKDVY--DDGKYVYVVTELMKGGELLDKILRQKFFSERE---------ASA------- 120

Query: 123 VPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN 182
                   +L+ I   + YLH+  V+HRDLKP+NIL + E      ++I D GFA+    
Sbjct: 121 --------VLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172

Query: 183 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 242
               L        T  + APE+L   + Y  A DIW++G +   +LT    F    +D  
Sbjct: 173 ENGLLMT---PCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT- 227

Query: 243 TSNPYHHDQLDRIFS-VMGFPLEKDWED--------IRKM 273
                  + L RI S          W          + KM
Sbjct: 228 -----PEEILARIGSGKFSLS-GGYWNSVSDTAKDLVSKM 261

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  134 bits (338), Expect = 1e-35
 Identities = 64/289 (22%), Positives = 115/289 (39%), Gaps = 40/289 (13%)

Query: 8   KTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIE---GTGLSMSAC 64
           ++ +  T+    ++    ++G G +G+V +   +D  +    A+KQ             C
Sbjct: 4   RSPSLPTQTCGPWEM-KERLGTGGFGYVLRWIHQDTGEQ--VAIKQCRQELSPKNRERWC 60

Query: 65  REIALLRELKHPNVINLISVFLSHN----DRKVWLLFDYAEH-DLWHIIKFHRAAKANKK 119
            EI ++++L HPNV++   V         +    L  +Y E  DL   +         + 
Sbjct: 61  LEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLN------QFEN 114

Query: 120 PVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL 179
              + +G +++LL  I   + YLH N ++HRDLKP NI++     +R   KI D+G+A+ 
Sbjct: 115 CCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGP-QRLIHKIIDLGYAKE 173

Query: 180 FNNPLKPLADLDPVVVTF----WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
            +           +   F     Y APELL   + YT  +D W+ G +  E +T    F 
Sbjct: 174 LDQ--------GELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFL 224

Query: 236 CRQEDIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDFN 284
                          Q               ++D+    +  ++L   N
Sbjct: 225 PNW---------QPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPN 264

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  131 bits (331), Expect = 1e-35
 Identities = 57/250 (22%), Positives = 108/250 (43%), Gaps = 35/250 (14%)

Query: 2   DYEFKIKTSNERTKVEDLF--DYE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG 58
            + F   T ++++        +Y     +G G  G V  A  +     +  A++ I    
Sbjct: 115 VFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFER--KTCKKVAIRIISKRK 172

Query: 59  LSMSAC----------REIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHI 107
            ++ +            EI +L++L HP +I + + F   +    +++ +  E  +L   
Sbjct: 173 FAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF---DAEDYYIVLELMEGGEL--- 226

Query: 108 IKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERG 167
             F +     +    + +   K   YQ+L  + YLH N ++HRDLKP N+L+  +  E  
Sbjct: 227 --FDKVVGNKR----LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE-EDC 279

Query: 168 RVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARH--YTKAIDIWAIGCIFA 225
            +KI D G +++        + +  +  T  Y APE+L+      Y +A+D W++G I  
Sbjct: 280 LIKITDFGHSKIL----GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 335

Query: 226 ELLTSEPIFH 235
             L+  P F 
Sbjct: 336 ICLSGYPPFS 345

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  130 bits (327), Expect = 2e-35
 Identities = 50/306 (16%), Positives = 100/306 (32%), Gaps = 40/306 (13%)

Query: 6   KIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRD---YALKQIEGTGLSMS 62
            IK   E      L       +G G +  VY+A + D +D ++   + LK  +       
Sbjct: 53  AIKPKTEFQLGSKLVY-VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEF 111

Query: 63  --ACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKK 119
               + +  L+       +   S  L  N     L+ +   +  L + I  ++       
Sbjct: 112 YIGTQLMERLKPSMQHMFMKFYSAHLFQN--GSVLVGELYSYGTLLNAINLYKNTPEKV- 168

Query: 120 PVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVM-------GEGIERGRVKIA 172
              +P+G+V S   ++L  I  +H   ++H D+KP N ++         E      + + 
Sbjct: 169 ---MPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALI 225

Query: 173 DMGFARLFNNPLKPLADLDPVVVTFW----YRAPELLLGARHYTKAIDIWAIGCIFAELL 228
           D+G +       K       +         ++  E+L   + +   ID + +      +L
Sbjct: 226 DLGQSIDMKLFPK-----GTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCML 279

Query: 229 TSEPIFHCRQEDI-----KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF 283
               +    +              H D  +  F VM   L     D   +P    L +  
Sbjct: 280 FGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVM---LNIP--DCHHLPSLDLLRQKL 334

Query: 284 NEQICK 289
            +   +
Sbjct: 335 KKVFQQ 340

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  127 bits (321), Expect = 3e-35
 Identities = 62/222 (27%), Positives = 109/222 (49%), Gaps = 30/222 (13%)

Query: 21  DYE-GCKVGRGTYGHVYKARRKDNSDTRDYALK-----QIEGTGLSMSACREIALLRELK 74
           D+E G  +G+G +G+VY AR K +      ALK     Q+E  G+     RE+ +   L+
Sbjct: 10  DFEIGRPLGKGKFGNVYLAREKQSK--FILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67

Query: 75  HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLY 133
           HPN++ L   F  H+  +V+L+ +YA    +     +    K +K      +    + + 
Sbjct: 68  HPNILRLYGYF--HDATRVYLILEYAPLGTV-----YRELQKLSK----FDEQRTATYIT 116

Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           ++ + + Y HS  V+HRD+KP N+L+       G +KIAD G++    +          +
Sbjct: 117 ELANALSYCHSKRVIHRDIKPENLLLG----SAGELKIADFGWSVHAPSSR-----RTDL 167

Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
             T  Y  PE++ G R + + +D+W++G +  E L  +P F 
Sbjct: 168 CGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  129 bits (325), Expect = 3e-35
 Identities = 66/241 (27%), Positives = 106/241 (43%), Gaps = 38/241 (15%)

Query: 9   TSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC---- 64
            + ++ KVED +D  G ++G G +  V K R K  S   +YA K I+      S      
Sbjct: 3   ETFKQQKVEDFYDI-GEELGSGQFAIVKKCREK--STGLEYAAKFIKKRQSRASRRGVCR 59

Query: 65  ----REIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKK 119
               RE+++LR++ HPN+I L  V+   N   V L+ +     +L+  +           
Sbjct: 60  EEIEREVSILRQVLHPNIITLHDVY--ENRTDVVLILELVSGGELFDFL----------- 106

Query: 120 PVMVPKGM-----VKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM 174
                K         S + QILDG++YLH+  + H DLKP NI+++ + I    +K+ D 
Sbjct: 107 ---AQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163

Query: 175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           G A           +   +  T  + APE++          D+W+IG I   LL+    F
Sbjct: 164 GLAHEI-EDGVEFKN---IFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPF 218

Query: 235 H 235
            
Sbjct: 219 L 219

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  128 bits (323), Expect = 4e-35
 Identities = 68/241 (28%), Positives = 105/241 (43%), Gaps = 38/241 (15%)

Query: 9   TSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC---- 64
           T   +  V+D +D  G ++G G +  V K R K  S    YA K I+      S      
Sbjct: 2   TVFRQENVDDYYDT-GEELGSGQFAVVKKCREK--STGLQYAAKFIKKRRTKSSRRGVSR 58

Query: 65  ----REIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAE-HDLWHIIKFHRAAKANKK 119
               RE+++L+E++HPNVI L  V+   N   V L+ +     +L     F         
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVY--ENKTDVILILELVAGGEL-----FDF------- 104

Query: 120 PVMVPKGM-----VKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM 174
             +  K           L QIL+G++YLHS  + H DLKP NI+++   + + R+KI D 
Sbjct: 105 --LAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162

Query: 175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           G A    +      +   +  T  + APE++          D+W+IG I   LL+    F
Sbjct: 163 GLAHKI-DFGNEFKN---IFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPF 217

Query: 235 H 235
            
Sbjct: 218 L 218

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  130 bits (330), Expect = 6e-35
 Identities = 65/240 (27%), Positives = 111/240 (46%), Gaps = 37/240 (15%)

Query: 13  RTKVEDLFD-YE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC----RE 66
            +K   L + Y+   K+G G YG V   R K        A+K I  T +S S+      E
Sbjct: 29  TSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVE--RAIKIIRKTSVSTSSNSKLLEE 86

Query: 67  IALLRELKHPNVINLISVFLSHNDRKVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPK 125
           +A+L+ L HPN++ L   F   + R  +L+ +  +  +L     F           ++ +
Sbjct: 87  VAVLKLLDHPNIMKLYDFF--EDKRNYYLVMECYKGGEL-----FDE---------IIHR 130

Query: 126 G-----MVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
                     ++ Q+L G+ YLH + ++HRDLKP N+L+  +  +   +KI D G + +F
Sbjct: 131 MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKE-KDALIKIVDFGLSAVF 189

Query: 181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
               +    +   + T +Y APE+L   + Y +  D+W+IG I   LL   P F  + + 
Sbjct: 190 ----ENQKKMKERLGTAYYIAPEVL--RKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ 243

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  126 bits (320), Expect = 7e-35
 Identities = 63/244 (25%), Positives = 109/244 (44%), Gaps = 54/244 (22%)

Query: 10  SNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC--REI 67
           S + T +   F +    +G G +  V+  +++     + +ALK I+ +     +    EI
Sbjct: 1   SMQTTNIRKTFIF-MEVLGSGAFSEVFLVKQR--LTGKLFALKCIKKSPAFRDSSLENEI 57

Query: 68  ALLRELKHPNVINLISVFLSHNDRKVWL---------LFD-------YAEHDLWHIIKFH 111
           A+L+++KH N++ L  ++   +    +L         LFD       Y E D        
Sbjct: 58  AVLKKIKHENIVTLEDIY--ESTTHYYLVMQLVSGGELFDRILERGVYTEKD-------- 107

Query: 112 RAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI 171
            A+                ++ Q+L  + YLH N ++HRDLKP N+L +    E  ++ I
Sbjct: 108 -ASL---------------VIQQVLSAVKYLHENGIVHRDLKPENLLYLTPE-ENSKIMI 150

Query: 172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 231
            D G +++  N +     +     T  Y APE+L   + Y+KA+D W+IG I   LL   
Sbjct: 151 TDFGLSKMEQNGI-----MSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGY 204

Query: 232 PIFH 235
           P F+
Sbjct: 205 PPFY 208

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  126 bits (320), Expect = 8e-35
 Identities = 66/235 (28%), Positives = 102/235 (43%), Gaps = 38/235 (16%)

Query: 15  KVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC--------RE 66
           KVED +D  G ++G G +  V K R K  S   +YA K I+      S          RE
Sbjct: 9   KVEDFYDI-GEELGSGQFAIVKKCREK--STGLEYAAKFIKKRQSRASRRGVSREEIERE 65

Query: 67  IALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPK 125
           +++LR++ H NVI L  V+   N   V L+ +     +L+  +                K
Sbjct: 66  VSILRQVLHHNVITLHDVY--ENRTDVVLILELVSGGELFDFL--------------AQK 109

Query: 126 GM-----VKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
                    S + QILDG++YLH+  + H DLKP NI+++ + I    +K+ D G A   
Sbjct: 110 ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169

Query: 181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
                   +   +  T  + APE++          D+W+IG I   LL+    F 
Sbjct: 170 -EDGVEFKN---IFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL 219

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  127 bits (322), Expect = 9e-35
 Identities = 66/229 (28%), Positives = 100/229 (43%), Gaps = 51/229 (22%)

Query: 11  NERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALL 70
           + R  + D F+    ++GRG    VY+ ++K     + YALK ++ T        EI +L
Sbjct: 46  SNRDALSDFFEV-ESELGRGATSIVYRCKQK--GTQKPYALKVLKKTVDKKIVRTEIGVL 102

Query: 71  RELKHPNVINLISVFLSHNDRKVWL---------LFD-------YAEHDLWHIIKFHRAA 114
             L HPN+I L  +F      ++ L         LFD       Y+E D         AA
Sbjct: 103 LRLSHPNIIKLKEIF--ETPTEISLVLELVTGGELFDRIVEKGYYSERD---------AA 151

Query: 115 KANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM 174
                            + QIL+ + YLH N ++HRDLKP N+L          +KIAD 
Sbjct: 152 D---------------AVKQILEAVAYLHENGIVHRDLKPENLLYATPA-PDAPLKIADF 195

Query: 175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCI 223
           G +++  +    +     V  T  Y APE+L G   Y   +D+W++G I
Sbjct: 196 GLSKIVEHQ-VLMKT---VCGTPGYCAPEILRG-CAYGPEVDMWSVGII 239

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  129 bits (326), Expect = 2e-34
 Identities = 58/241 (24%), Positives = 105/241 (43%), Gaps = 38/241 (15%)

Query: 13  RTKVEDLFD-YE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC-----R 65
           +       D Y+    +G+G++G V   + K     ++ A+K I    +          R
Sbjct: 18  QHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITG--QECAVKVISKRQVKQKTDKESLLR 75

Query: 66  EIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVP 124
           E+ LL++L HPN++ L   F   +    +L+ +     +L     F           ++ 
Sbjct: 76  EVQLLKQLDHPNIMKLYEFF--EDKGYFYLVGEVYTGGEL-----FDE---------IIS 119

Query: 125 KG-----MVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL 179
           +          ++ Q+L GI Y+H N ++HRDLKP N+L+  +  +   ++I D G +  
Sbjct: 120 RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKS-KDANIRIIDFGLSTH 178

Query: 180 FNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
           F    +    +   + T +Y APE+L     Y +  D+W+ G I   LL+  P F+   E
Sbjct: 179 F----EASKKMKDKIGTAYYIAPEVL--HGTYDEKCDVWSTGVILYILLSGCPPFNGANE 232

Query: 240 D 240
            
Sbjct: 233 Y 233

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  126 bits (319), Expect = 2e-34
 Identities = 51/272 (18%), Positives = 95/272 (34%), Gaps = 49/272 (18%)

Query: 12  ERTKVEDLFD-YE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC----- 64
           +   + +L   Y     +G+G+YG V  A           A+K +    +          
Sbjct: 17  QGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTR--AIRAIKIMNKNKIRQINPKDVER 74

Query: 65  --REIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAE-HDL-WHIIKFHRAAKANKKP 120
              E+ L+++L HPN+  L  V+   +++ + L+ +      L   +  F   +      
Sbjct: 75  IKTEVRLMKKLHHPNIARLYEVY--EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAM 132

Query: 121 VMVPKGMV------------------------------KSLLYQILDGIHYLHSNWVLHR 150
            +V   +                                +++ QI   +HYLH+  + HR
Sbjct: 133 DVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHR 192

Query: 151 DLKPANILVMGEGIERGRVKIADMGFARLFNNP-LKPLADLDPVVVTFWYRAPELLLGA- 208
           D+KP N L      +   +K+ D G ++ F          +     T ++ APE+L    
Sbjct: 193 DIKPENFLFSTN--KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTN 250

Query: 209 RHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
             Y    D W+ G +   LL     F    + 
Sbjct: 251 ESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDA 282

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  128 bits (324), Expect = 2e-34
 Identities = 54/220 (24%), Positives = 90/220 (40%), Gaps = 34/220 (15%)

Query: 14  TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC----REIAL 69
           T+  + +     ++G+G +  V +  +      ++YA   I    LS        RE  +
Sbjct: 7   TRFTEEYQL-FEELGKGAFSVVRRCVKV--LAGQEYAAMIINTKKLSARDHQKLEREARI 63

Query: 70  LRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKG-- 126
            R LKHPN++ L        +   +L+FD     +L     F           +V +   
Sbjct: 64  CRLLKHPNIVRLHDSI--SEEGHHYLIFDLVTGGEL-----FED---------IVAREYY 107

Query: 127 ---MVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNP 183
                   + QIL+ + + H   V+HR+LKP N+L+  +  +   VK+AD G A      
Sbjct: 108 SEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKL-KGAAVKLADFGLAIEVEGE 166

Query: 184 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCI 223
            +          T  Y +PE+L     Y K +D+WA G I
Sbjct: 167 QQAWFG---FAGTPGYLSPEVLRK-DPYGKPVDLWACGVI 202

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  125 bits (315), Expect = 4e-34
 Identities = 63/285 (22%), Positives = 100/285 (35%), Gaps = 70/285 (24%)

Query: 21  DYE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQI---EGTGLSMSACREIALLRELKHP 76
           D+E    +GRG +G V++A+ K   D  +YA+K+I             RE+  L +L+HP
Sbjct: 7   DFEPIQCMGRGGFGVVFEAKNK--VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 64

Query: 77  NVINLISVFLSHNDRKVW----------------LLFDYAEHDLWHIIKFHRAAKANKKP 120
            ++   + +L     K                  L            I+           
Sbjct: 65  GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124

Query: 121 VMVPKGMVKSLLY----------------------------------QILDGIHYLHSNW 146
             +     K  LY                                  QI + + +LHS  
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184

Query: 147 VLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN---------PLKPLADLDPVVVTF 197
           ++HRDLKP+NI    + +    VK+ D G     +          P+   A     V T 
Sbjct: 185 LMHRDLKPSNIFFTMDDV----VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240

Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 242
            Y +PE + G  +Y+  +DI+++G I  ELL S      R   I 
Sbjct: 241 LYMSPEQIHG-NNYSHKVDIFSLGLILFELLYSFSTQMERVRIIT 284

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  125 bits (316), Expect = 5e-34
 Identities = 50/231 (21%), Positives = 89/231 (38%), Gaps = 34/231 (14%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM--SACREIALLRELK-HPNVINLI 82
            +  G +  VY+A+       R+YALK++         +  +E+  +++L  HPN++   
Sbjct: 35  VLAEGGFAFVYEAQDV--GSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92

Query: 83  SVF------LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQIL 136
           S              +  LL +  +  L   +K   +         +    V  + YQ  
Sbjct: 93  SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP------LSCDTVLKIFYQTC 146

Query: 137 DGIHYLHSN--WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVV 194
             + ++H     ++HRDLK  N+L+      +G +K+ D G A   ++            
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLS----NQGTIKLCDFGSATTISHYPDYSWSAQRRA 202

Query: 195 V---------TFWYRAPEL--LLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           +         T  YR PE+  L       +  DIWA+GCI   L   +  F
Sbjct: 203 LVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF 253

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  125 bits (315), Expect = 5e-34
 Identities = 69/233 (29%), Positives = 103/233 (44%), Gaps = 23/233 (9%)

Query: 9   TSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSAC 64
                    + +     ++GRG +  V +   K  S  ++YA K ++             
Sbjct: 19  YFQSMENFNNFYILTSKELGRGKFAVVRQCISK--STGQEYAAKFLKKRRRGQDCRAEIL 76

Query: 65  REIALLRELKH-PNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVM 122
            EIA+L   K  P VINL  V+   N  ++ L+ +YA   ++     F       +   M
Sbjct: 77  HEIAVLELAKSCPRVINLHEVY--ENTSEIILILEYAAGGEI-----FSLCLP--ELAEM 127

Query: 123 VPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN 182
           V +  V  L+ QIL+G++YLH N ++H DLKP NIL+       G +KI D G +R    
Sbjct: 128 VSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIY-PLGDIKIVDFGMSRKI-G 185

Query: 183 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
               L +   ++ T  Y APE+L      T A D+W IG I   LLT    F 
Sbjct: 186 HACELRE---IMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFV 234

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  125 bits (315), Expect = 6e-34
 Identities = 64/295 (21%), Positives = 121/295 (41%), Gaps = 69/295 (23%)

Query: 7   IKTSNERTKVEDLFDYEGCK--VGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC 64
           +K S         +D +     +G G++    K   K ++  + +A+K I     + +  
Sbjct: 1   MKDSP----FYQHYDLDLKDKPLGEGSFSICRKCVHKKSN--QAFAVKIISKRMEANTQ- 53

Query: 65  REIALLRELK-HPNVINLISVFLSHNDRKVWL---------LFD-------YAEHDLWHI 107
           +EI  L+  + HPN++ L  VF  H+    +L         LF+       ++E +    
Sbjct: 54  KEITALKLCEGHPNIVKLHEVF--HDQLHTFLVMELLNGGELFERIKKKKHFSETE---- 107

Query: 108 IKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERG 167
                A+                ++ +++  + ++H   V+HRDLKP N+L   E  +  
Sbjct: 108 -----ASY---------------IMRKLVSAVSHMHDVGVVHRDLKPENLLFTDEN-DNL 146

Query: 168 RVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 227
            +KI D GFARL     +PL        T  Y APE LL    Y ++ D+W++G I   +
Sbjct: 147 EIKIIDFGFARLKPPDNQPLKT---PCFTLHYAAPE-LLNQNGYDESCDLWSLGVILYTM 202

Query: 228 LTSEPIFHCRQEDIKTSNPYHHDQLDRIFS-VMGFPLEKDWED--------IRKM 273
           L+ +  F      +  ++    + + +I      F   + W++        I+ +
Sbjct: 203 LSGQVPFQSHDRSLTCTSA--VEIMKKIKKGDFSFE-GEAWKNVSQEAKDLIQGL 254

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  128 bits (323), Expect = 6e-34
 Identities = 66/251 (26%), Positives = 108/251 (43%), Gaps = 48/251 (19%)

Query: 13  RTKVEDLFD-YE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC------ 64
           R K   + + Y    K+G G YG V   + K+     + A+K I+ +             
Sbjct: 28  RKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGH--SEKAIKVIKKSQFDKGRYSDDNKN 85

Query: 65  ---------REIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAE-HDLWHIIKFHRAA 114
                     EI+LL+ L HPN+I L  VF   + +  +L+ ++ E  +L     F +  
Sbjct: 86  IEKFHEEIYNEISLLKSLDHPNIIKLFDVF--EDKKYFYLVTEFYEGGEL-----FEQ-- 136

Query: 115 KANKKPVMVPKG-----MVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRV 169
                  ++ +         +++ QIL GI YLH + ++HRD+KP NIL+  +      +
Sbjct: 137 -------IINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKN-SLLNI 188

Query: 170 KIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
           KI D G +  F         L   + T +Y APE+L     Y +  D+W+ G I   LL 
Sbjct: 189 KIVDFGLSSFF----SKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLC 242

Query: 230 SEPIFHCRQED 240
             P F  + + 
Sbjct: 243 GYPPFGGQNDQ 253

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  123 bits (312), Expect = 7e-34
 Identities = 61/222 (27%), Positives = 109/222 (49%), Gaps = 30/222 (13%)

Query: 21  DYE-GCKVGRGTYGHVYKARRKDNSDTRDYALK-----QIEGTGLSMSACREIALLRELK 74
           D++ G  +G+G +G+VY AR K N      ALK     Q+E  G+     REI +   L+
Sbjct: 15  DFDIGRPLGKGKFGNVYLAREKQNK--FIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 72

Query: 75  HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLY 133
           HPN++ + + F  H+ ++++L+ ++A   +L     +    K  +      +    + + 
Sbjct: 73  HPNILRMYNYF--HDRKRIYLMLEFAPRGEL-----YKELQKHGR----FDEQRSATFME 121

Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           ++ D +HY H   V+HRD+KP N+L+      +G +KIAD G++        P      +
Sbjct: 122 ELADALHYCHERKVIHRDIKPENLLMG----YKGELKIADFGWSV-----HAPSLRRRTM 172

Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
             T  Y  PE++ G + + + +D+W  G +  E L   P F 
Sbjct: 173 CGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  125 bits (317), Expect = 8e-34
 Identities = 56/245 (22%), Positives = 102/245 (41%), Gaps = 36/245 (14%)

Query: 2   DYEFKIKTSNERTKVEDLFD-YE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL 59
           D   K        K   ++D Y+   ++G G +G V++   K  +  R +  K I     
Sbjct: 32  DIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEK--ATGRVFVAKFINTPYP 89

Query: 60  S--MSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKA 116
               +   EI+++ +L HP +INL   F   +  ++ L+ ++    +L     F R    
Sbjct: 90  LDKYTVKNEISIMNQLHHPKLINLHDAF--EDKYEMVLILEFLSGGEL-----FDR---- 138

Query: 117 NKKPVMVPKGM------VKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVK 170
                +  +        V + + Q  +G+ ++H + ++H D+KP NI+   +  +   VK
Sbjct: 139 -----IAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK--KASSVK 191

Query: 171 IADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 230
           I D G A    NP + +        T  + APE++          D+WAIG +   LL+ 
Sbjct: 192 IIDFGLATKL-NPDEIVKV---TTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSG 246

Query: 231 EPIFH 235
              F 
Sbjct: 247 LSPFA 251

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  124 bits (313), Expect = 1e-33
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 44/227 (19%)

Query: 17  EDLFD-YE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC---------- 64
           + L D Y     +G G  G V  A  +     +  A+K I     ++ +           
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFER--KTCKKVAIKIISKRKFAIGSAREADPALNVE 63

Query: 65  REIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMV 123
            EI +L++L HP +I + + F   +    +++ +  E  +L     F +         +V
Sbjct: 64  TEIEILKKLNHPCIIKIKNFF---DAEDYYIVLELMEGGEL-----FDK---------VV 106

Query: 124 PKGMV-----KSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR 178
               +     K   YQ+L  + YLH N ++HRDLKP N+L+  +  E   +KI D G ++
Sbjct: 107 GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE-EDCLIKITDFGHSK 165

Query: 179 LFNNPLKPLADLDPVVVTFWYRAPELLLGA--RHYTKAIDIWAIGCI 223
           +       +  L     T  Y APE+L+      Y +A+D W++G I
Sbjct: 166 IL-GETSLMRTL---CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 208

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  123 bits (310), Expect = 1e-33
 Identities = 57/225 (25%), Positives = 102/225 (45%), Gaps = 36/225 (16%)

Query: 22  YE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC----REIALLRELKHP 76
           Y   C +G+G++G V K + +     ++YA+K I              RE+ LL++L HP
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDR--ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81

Query: 77  NVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKG-----MVKS 130
           N++ L  +    +    +++ +     +L     F           ++ +          
Sbjct: 82  NIMKLFEIL--EDSSSFYIVGELYTGGEL-----FDE---------IIKRKRFSEHDAAR 125

Query: 131 LLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADL 190
           ++ Q+  GI Y+H + ++HRDLKP NIL+  +  +   +KI D G +  F      + D 
Sbjct: 126 IIKQVFSGITYMHKHNIVHRDLKPENILLESKE-KDCDIKIIDFGLSTCF-QQNTKMKD- 182

Query: 191 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
              + T +Y APE+L     Y +  D+W+ G I   LL+  P F+
Sbjct: 183 --RIGTAYYIAPEVL--RGTYDEKCDVWSAGVILYILLSGTPPFY 223

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  123 bits (312), Expect = 1e-33
 Identities = 46/217 (21%), Positives = 94/217 (43%), Gaps = 35/217 (16%)

Query: 17  EDLFD-YE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC-REIALLREL 73
           ++L++ Y     +GRG +G V++      S  + Y  K ++  G       +EI++L   
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVET--SSKKTYMAKFVKVKGTDQVLVKKEISILNIA 58

Query: 74  KHPNVINLISVFLSHNDRKVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGM----- 127
           +H N+++L   F   +  ++ ++F++    D+     F R         +          
Sbjct: 59  RHRNILHLHESF--ESMEELVMIFEFISGLDI-----FER---------INTSAFELNER 102

Query: 128 -VKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKP 186
            + S ++Q+ + + +LHS+ + H D++P NI+          +KI + G AR    P   
Sbjct: 103 EIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR--RSSTIKIIEFGQARQL-KPGDN 159

Query: 187 LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCI 223
                 +     Y APE+       + A D+W++G +
Sbjct: 160 FRL---LFTAPEYYAPEVHQH-DVVSTATDMWSLGTL 192

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  124 bits (313), Expect = 1e-33
 Identities = 55/239 (23%), Positives = 91/239 (38%), Gaps = 36/239 (15%)

Query: 8   KTSNERTKVEDLFDYE-GCKVGRGTYGHVYKARRKDNSDTRDYALK-----QIEGTGLSM 61
           +             Y  G  +G+G +   ++    D      +A K      +       
Sbjct: 29  EIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTK--EVFAGKIVPKSLLLKPHQRE 86

Query: 62  SACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKP 120
               EI++ R L H +V+     F   ++  V+++ +      L  + K  +A       
Sbjct: 87  KMSMEISIHRSLAHQHVVGFHGFF--EDNDFVFVVLELCRRRSLLELHKRRKA------- 137

Query: 121 VMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
             + +   +  L QI+ G  YLH N V+HRDLK  N+ +     E   VKI D G A   
Sbjct: 138 --LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN----EDLEVKIGDFGLATKV 191

Query: 181 NNPLKPLADLDPVVVTF----WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
               +                 Y APE+L   + ++  +D+W+IGCI   LL  +P F 
Sbjct: 192 EYDGERKK-------VLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFE 242

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  123 bits (310), Expect = 1e-33
 Identities = 64/230 (27%), Positives = 97/230 (42%), Gaps = 55/230 (23%)

Query: 14  TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC----REIAL 69
           TK  D +D    ++G+G +  V +   K  +   ++A K I    LS        RE  +
Sbjct: 2   TKFSDNYDV-KEELGKGAFSVVRRCVHK--TTGLEFAAKIINTKKLSARDFQKLEREARI 58

Query: 70  LRELKHPNVINLISVFLSHNDRKVWL---------LFD-------YAEHDLWHIIKFHRA 113
            R+L+HPN++ L        +   +L         LF+       Y+E D  H I+    
Sbjct: 59  CRKLQHPNIVRLHDSI--QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ---- 112

Query: 114 AKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIAD 173
                               QIL+ I Y HSN ++HR+LKP N+L+  +  +   VK+AD
Sbjct: 113 --------------------QILESIAYCHSNGIVHRNLKPENLLLASKA-KGAAVKLAD 151

Query: 174 MGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCI 223
            G A    N  +          T  Y +PE+L     Y+K +DIWA G I
Sbjct: 152 FGLAIEV-NDSEAWHG---FAGTPGYLSPEVLKK-DPYSKPVDIWACGVI 196

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  122 bits (309), Expect = 1e-33
 Identities = 59/232 (25%), Positives = 95/232 (40%), Gaps = 35/232 (15%)

Query: 14  TKVEDLFD-YE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC--REIAL 69
           +   D+   Y     +GRG++G V  A +K        A K+I    +       +EI +
Sbjct: 2   STKGDINQYYTLENTIGRGSWGEVKIAVQKGTR--IRRAAKKIPKYFVEDVDRFKQEIEI 59

Query: 70  LRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKG-- 126
           ++ L HPN+I L   F   ++  ++L+ +     +L     F R         +V K   
Sbjct: 60  MKSLDHPNIIRLYETF--EDNTDIYLVMELCTGGEL-----FER---------VVHKRVF 103

Query: 127 ---MVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNP 183
                  ++  +L  + Y H   V HRDLKP N L + +      +K+ D G A  F  P
Sbjct: 104 RESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDS-PDSPLKLIDFGLAARF-KP 161

Query: 184 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
            K +      V T +Y +P++L     Y    D W+ G +   LL   P F 
Sbjct: 162 GKMMRT---KVGTPYYVSPQVL--EGLYGPECDEWSAGVMMYVLLCGYPPFS 208

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  122 bits (308), Expect = 2e-33
 Identities = 54/226 (23%), Positives = 101/226 (44%), Gaps = 35/226 (15%)

Query: 21  DYE-GCKVGRGTYGHVYKARRKDNSDTRDYALK-----QIEGTGLSMSACREIALLRELK 74
           D++ G  +G+G++  VY+A         + A+K      +   G+      E+ +  +LK
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTG--LEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69

Query: 75  HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLY 133
           HP+++ L + F   +   V+L+ +   + ++   +K         +     +   +  ++
Sbjct: 70  HPSILELYNYF--EDSNYVYLVLEMCHNGEMNRYLK--------NRVKPFSENEARHFMH 119

Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           QI+ G+ YLHS+ +LHRDL  +N+L+         +KIAD G A     P +        
Sbjct: 120 QIITGMLYLHSHGILHRDLTLSNLLLT----RNMNIKIADFGLATQLKMPHEKHY----- 170

Query: 194 VVTF----WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
             T      Y +PE+      +    D+W++GC+F  LL   P F 
Sbjct: 171 --TLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFD 213

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  123 bits (310), Expect = 2e-33
 Identities = 66/307 (21%), Positives = 112/307 (36%), Gaps = 72/307 (23%)

Query: 9   TSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC--RE 66
           T +   + ED++  +   +G G +  V        S  ++YA+K IE     + +   RE
Sbjct: 3   TDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITS--QEYAVKIIEKQPGHIRSRVFRE 60

Query: 67  IALLRELK-HPNVINLISVFLSHNDRKVWL---------LFD-------YAEHDLWHIIK 109
           + +L + + H NV+ LI  F    + + +L         +         + E +      
Sbjct: 61  VEMLYQCQGHRNVLELIEFF--EEEDRFYLVFEKMRGGSILSHIHKRRHFNELE------ 112

Query: 110 FHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRV 169
              A+                ++  +   + +LH+  + HRDLKP NIL      +   V
Sbjct: 113 ---ASV---------------VVQDVASALDFLHNKGIAHRDLKPENILCEHPN-QVSPV 153

Query: 170 KIADMGFARLFNNPLKPLADLDPVVVTF----WYRAPELLLG----ARHYTKAIDIWAIG 221
           KI D                  P ++T      Y APE++      A  Y K  D+W++G
Sbjct: 154 KICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLG 213

Query: 222 CIFAELLTSEPIFH--CRQEDIKTSNPYHHDQLDRIF-SVMG----FPLEKDWED----- 269
            I   LL+  P F   C  +             + +F S+      FP +KDW       
Sbjct: 214 VILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFP-DKDWAHISCAA 272

Query: 270 ---IRKM 273
              I K+
Sbjct: 273 KDLISKL 279

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  126 bits (318), Expect = 3e-33
 Identities = 57/243 (23%), Positives = 105/243 (43%), Gaps = 36/243 (14%)

Query: 8   KTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC--- 64
           +    +    + ++   C +G+G++G V K + +       YA+K I             
Sbjct: 12  ENLYFQGTFAERYNI-VCMLGKGSFGEVLKCKDRITQQE--YAVKVINKASAKNKDTSTI 68

Query: 65  -REIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAE-HDLWHIIKFH-----RAAKAN 117
            RE+ LL++L HPN++ L  +    +    +++ +     +L+  I          A   
Sbjct: 69  LREVELLKKLDHPNIMKLFEIL--EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA-- 124

Query: 118 KKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA 177
                        ++ Q+  GI Y+H + ++HRDLKP NIL+  +  +   +KI D G +
Sbjct: 125 ------------RIIKQVFSGITYMHKHNIVHRDLKPENILLESKE-KDCDIKIIDFGLS 171

Query: 178 RLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 237
             F    +    +   + T +Y APE+L     Y +  D+W+ G I   LL+  P F+ +
Sbjct: 172 TCF----QQNTKMKDRIGTAYYIAPEVLR--GTYDEKCDVWSAGVILYILLSGTPPFYGK 225

Query: 238 QED 240
            E 
Sbjct: 226 NEY 228

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  121 bits (307), Expect = 4e-33
 Identities = 55/226 (24%), Positives = 90/226 (39%), Gaps = 36/226 (15%)

Query: 21  DYE-GCKVGRGTYGHVYKARRKDNSDTRDYALK-----QIEGTGLSMSACREIALLRELK 74
            Y  G  +G+G +   ++    D      +A K      +           EI++ R L 
Sbjct: 16  RYVRGRFLGKGGFAKCFEISDADTK--EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 73

Query: 75  HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLY 133
           H +V+     F   ++  V+++ +      L  + K  +A         + +   +  L 
Sbjct: 74  HQHVVGFHGFF--EDNDFVFVVLELCRRRSLLELHKRRKA---------LTEPEARYYLR 122

Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           QI+ G  YLH N V+HRDLK  N+ +     E   VKI D G A       +        
Sbjct: 123 QIVLGCQYLHRNRVIHRDLKLGNLFLN----EDLEVKIGDFGLATKVEYDGERKK----- 173

Query: 194 VVTF----WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
                    Y APE+L   + ++  +D+W+IGCI   LL  +P F 
Sbjct: 174 --VLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFE 216

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  122 bits (309), Expect = 7e-33
 Identities = 63/223 (28%), Positives = 98/223 (43%), Gaps = 35/223 (15%)

Query: 11  NERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC----RE 66
           N  TK  D +D    ++G+G +  V +   K  +   ++A K I    LS        RE
Sbjct: 22  NASTKFSDNYDV-KEELGKGAFSVVRRCVHK--TTGLEFAAKIINTKKLSARDFQKLERE 78

Query: 67  IALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPK 125
             + R+L+HPN++ L        +   +L+FD     +L     F           +V +
Sbjct: 79  ARICRKLQHPNIVRLHDSI--QEESFHYLVFDLVTGGEL-----FED---------IVAR 122

Query: 126 G-----MVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
                      + QIL+ I Y HSN ++HR+LKP N+L+  +  +   VK+AD G A   
Sbjct: 123 EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA-KGAAVKLADFGLAIEV 181

Query: 181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCI 223
            N  +          T  Y +PE+L     Y+K +DIWA G I
Sbjct: 182 -NDSEAWHG---FAGTPGYLSPEVLKK-DPYSKPVDIWACGVI 219

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  120 bits (302), Expect = 2e-32
 Identities = 63/226 (27%), Positives = 99/226 (43%), Gaps = 21/226 (9%)

Query: 14  TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC---REIALL 70
             ++DLF +   K+G G +G V+    + +    +  +K I      +       EI +L
Sbjct: 18  GTIDDLFIF-KRKLGSGAFGDVHLVEERSSG--LERVIKTINKDRSQVPMEQIEAEIEVL 74

Query: 71  RELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVK 129
           + L HPN+I +  VF   +   ++++ +  E  +L       R   A  +   + +G V 
Sbjct: 75  KSLDHPNIIKIFEVF--EDYHNMYIVMETCEGGEL-----LERIVSAQARGKALSEGYVA 127

Query: 130 SLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLAD 189
            L+ Q+++ + Y HS  V+H+DLKP NIL          +KI D G A LF    K    
Sbjct: 128 ELMKQMMNALAYFHSQHVVHKDLKPENILFQDTS-PHSPIKIIDFGLAELF----KSDEH 182

Query: 190 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
                 T  Y APE+    R  T   DIW+ G +   LLT    F 
Sbjct: 183 STNAAGTALYMAPEVF--KRDVTFKCDIWSAGVVMYFLLTGCLPFT 226

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  120 bits (304), Expect = 4e-32
 Identities = 59/233 (25%), Positives = 101/233 (43%), Gaps = 35/233 (15%)

Query: 13  RTKVEDLFDYEGCKV-GRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS--MSACREIAL 69
           +  V   +     ++ G G +G V+K      +     A K I+  G+        EI++
Sbjct: 82  QGAVNSFYTVSKTEILGGGRFGQVHKCEET--ATGLKLAAKIIKTRGMKDKEEVKNEISV 139

Query: 70  LRELKHPNVINLISVFLSHNDRKVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKG-- 126
           + +L H N+I L   F S ND  + L+ +Y +  +L     F R         ++ +   
Sbjct: 140 MNQLDHANLIQLYDAFESKND--IVLVMEYVDGGEL-----FDR---------IIDESYN 183

Query: 127 ----MVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN 182
                    + QI +GI ++H  ++LH DLKP NIL +    +  ++KI D G AR +  
Sbjct: 184 LTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNR--DAKQIKIIDFGLARRY-K 240

Query: 183 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
           P + L        T  + APE++      +   D+W++G I   LL+    F 
Sbjct: 241 PREKLKV---NFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFL 289

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  120 bits (303), Expect = 5e-32
 Identities = 48/252 (19%), Positives = 101/252 (40%), Gaps = 41/252 (16%)

Query: 8   KTSNERTKVEDLFDYE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC-- 64
                + K + + DY     + +G +  +    + +    + YALK+ E + L       
Sbjct: 19  LNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEKDN----KFYALKKYEKSLLEKKRDFT 74

Query: 65  -----------------REIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHD--LW 105
                             E+ ++ ++K+   +    +    N  +V+++++Y E+D  L 
Sbjct: 75  KSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGII--TNYDEVYIIYEYMENDSILK 132

Query: 106 HIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHS-NWVLHRDLKPANILVMGEGI 164
               F    K       +P  ++K ++  +L+   Y+H+   + HRD+KP+NIL+     
Sbjct: 133 FDEYFFVLDKNYTCF--IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD---- 186

Query: 165 ERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHY-TKAIDIWAIGCI 223
           + GRVK++D G +    +       +     T+ +  PE       Y    +DIW++G  
Sbjct: 187 KNGRVKLSDFGESEYMVDKK-----IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGIC 241

Query: 224 FAELLTSEPIFH 235
              +  +   F 
Sbjct: 242 LYVMFYNVVPFS 253

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  123 bits (309), Expect = 7e-32
 Identities = 48/231 (20%), Positives = 95/231 (41%), Gaps = 33/231 (14%)

Query: 13  RTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS--MSACREIALL 70
              V D +D    ++G G +G V++   +  +   ++A K +     S   +  +EI  +
Sbjct: 152 HDHVLDHYDI-HEELGTGAFGVVHRVTER--ATGNNFAAKFVMTPHESDKETVRKEIQTM 208

Query: 71  RELKHPNVINLISVFLSHNDRKVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGM-- 127
             L+HP ++NL   F    D ++ +++++    +L     F +        V        
Sbjct: 209 SVLRHPTLVNLHDAFED--DNEMVMIYEFMSGGEL-----FEK--------VADEHNKMS 253

Query: 128 ---VKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPL 184
                  + Q+  G+ ++H N  +H DLKP NI+   +      +K+ D G      +P 
Sbjct: 254 EDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK--RSNELKLIDFGLTAHL-DPK 310

Query: 185 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
           + +        T  + APE+  G +      D+W++G +   LL+    F 
Sbjct: 311 QSVKVT---TGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFG 357

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  118 bits (299), Expect = 7e-32
 Identities = 66/223 (29%), Positives = 102/223 (45%), Gaps = 18/223 (8%)

Query: 21  DYE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQI--EGTGLSMSAC-REIALLRELKHP 76
           DYE    +G G    V  A      +    A+K+I  E    SM    +EI  + +  HP
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEK--VAIKRINLEKCQTSMDELLKEIQAMSQCHHP 73

Query: 77  NVINLISVFLSHNDRKVWLLFDY-AEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQI 135
           N+++  + F+     ++WL+    +   +  IIK   A   +K  V+  +  + ++L ++
Sbjct: 74  NIVSYYTSFV--VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVL-DESTIATILREV 130

Query: 136 LDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGF-ARLFNNPLKPLADL-DPV 193
           L+G+ YLH N  +HRD+K  NIL+     E G V+IAD G  A L          +    
Sbjct: 131 LEGLEYLHKNGQIHRDVKAGNILLG----EDGSVQIADFGVSAFLATGGDITRNKVRKTF 186

Query: 194 VVT-FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
           V T  W  APE++   R Y    DIW+ G    EL T    +H
Sbjct: 187 VGTPCWM-APEVMEQVRGYDFKADIWSFGITAIELATGAAPYH 228

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  118 bits (299), Expect = 1e-31
 Identities = 54/235 (22%), Positives = 100/235 (42%), Gaps = 37/235 (15%)

Query: 12  ERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALL- 70
           ++  V D +      +G G  G V +   +     +  ALK +  +  +    +E+    
Sbjct: 22  KKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTG--QKCALKLLYDSPKAR---QEVDHHW 76

Query: 71  RELKHPNVINLISVF--LSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGM 127
           +    P+++ ++ V+  + H  R + ++ +  E  +L     F R         +  +G 
Sbjct: 77  QASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGEL-----FSR---------IQERGD 122

Query: 128 VK-------SLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
                     ++  I   I +LHS+ + HRD+KP N+L   +  +   +K+ D GFA+  
Sbjct: 123 QAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKE-KDAVLKLTDFGFAKET 181

Query: 181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
                    L     T +Y APE +LG   Y K+ D+W++G I   LL   P F+
Sbjct: 182 TQNA-----LQTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPFY 230

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  119 bits (299), Expect = 3e-31
 Identities = 33/246 (13%), Positives = 74/246 (30%), Gaps = 44/246 (17%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACRE--------IALLRELKH 75
           G  +G+       +A  ++      + +     T    S   +        + LLR +K+
Sbjct: 83  GTVLGQEDPYAYLEATDQETG--ESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKN 140

Query: 76  PNVINLISVFLSHND----------------------RKVWLLFDYAEHDLWHIIKFHRA 113
                +   F+   D                         + L+   + +L    +   +
Sbjct: 141 QKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS 200

Query: 114 AKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIAD 173
             +  K +         L  Q++  +  LH   ++H  L+P +I++     +RG V +  
Sbjct: 201 HSSTHKSL--VHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD----QRGGVFLTG 254

Query: 174 MGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARH----YTKAIDIWAIGCIFAELLT 229
                        ++ +          A  +L   +H     T A D W +G     +  
Sbjct: 255 FEHLVRDGASA--VSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312

Query: 230 SEPIFH 235
           ++    
Sbjct: 313 ADLPNT 318

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  118 bits (297), Expect = 4e-31
 Identities = 55/235 (23%), Positives = 99/235 (42%), Gaps = 69/235 (29%)

Query: 22  YE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC----------REIALL 70
           Y+    +GRG    V +   +      ++A+K +E T   +S            RE  +L
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATG--HEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153

Query: 71  RELK-HPNVINLISVFLSHNDRKVWL---------LFD-------YAEHDLWHIIKFHRA 113
           R++  HP++I LI  +   +   ++L         LFD        +E +          
Sbjct: 154 RQVAGHPHIITLIDSY--ESSSFMFLVFDLMRKGELFDYLTEKVALSEKE---------T 202

Query: 114 AKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIAD 173
                            ++  +L+ + +LH+N ++HRDLKP NIL+     +  +++++D
Sbjct: 203 RS---------------IMRSLLEAVSFLHANNIVHRDLKPENILLD----DNMQIRLSD 243

Query: 174 MGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGA-----RHYTKAIDIWAIGCI 223
            GF+     P + L +   +  T  Y APE+L  +       Y K +D+WA G I
Sbjct: 244 FGFSCHL-EPGEKLRE---LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVI 294

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  118 bits (297), Expect = 4e-31
 Identities = 63/257 (24%), Positives = 113/257 (43%), Gaps = 37/257 (14%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM-SACREIALLRELK---------- 74
           K+G G +  V+ A+  D  +    A+K + G  +   +A  EI LL+ +           
Sbjct: 26  KLGWGHFSTVWLAK--DMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83

Query: 75  -HPNVINLISVFLSHNDRK--VWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSL 131
              +++ L+  F         V ++F+    +L  +IK +           +P   VK +
Sbjct: 84  GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE-------HRGIPLIYVKQI 136

Query: 132 LYQILDGIHYLHSNW-VLHRDLKPANILVMGEGIERGR--VKIADMGFARLFNNPLKPLA 188
             Q+L G+ Y+H    ++H D+KP N+L+           +KIAD+G A  ++       
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN-- 194

Query: 189 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 248
                + T  YR+PE+LLGA  +    DIW+  C+  EL+T + +F   +    T +   
Sbjct: 195 ----SIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD--- 246

Query: 249 HDQLDRIFSVMG-FPLE 264
            D + +I  ++G  P  
Sbjct: 247 DDHIAQIIELLGELPSY 263

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  117 bits (294), Expect = 5e-31
 Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 28/212 (13%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLIS 83
              VGRG +G V KA+ +     +D A+KQIE      +   E+  L  + HPN++ L  
Sbjct: 13  EEVVGRGAFGVVCKAKWRA----KDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYG 68

Query: 84  VFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYL 142
             L      V L+ +YAE   L++++         +           S   Q   G+ YL
Sbjct: 69  ACL----NPVCLVMEYAEGGSLYNVLH------GAEPLPYYTAAHAMSWCLQCSQGVAYL 118

Query: 143 HS---NWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
           HS     ++HRDLKP N+L++  G     +KI D G A      +           +  +
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGG---TVLKICDFGTACDIQTHMTNNKG------SAAW 169

Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSE 231
            APE+  G  +Y++  D+++ G I  E++T  
Sbjct: 170 MAPEVFEG-SNYSEKCDVFSWGIILWEVITRR 200

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  118 bits (298), Expect = 6e-31
 Identities = 56/243 (23%), Positives = 98/243 (40%), Gaps = 58/243 (23%)

Query: 4   EFKIKTSNERTKVEDLFDYE--GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM 61
           +F +K+  +  K   + DY+     +G G  G V +   K       +ALK ++      
Sbjct: 45  QFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQ--EKFALKMLQD---CP 99

Query: 62  SACREIALLREL-KHPNVINLISVF--LSHNDRKVWL---------LFD---------YA 100
            A RE+ L     + P+++ ++ V+  L    + + +         LF          + 
Sbjct: 100 KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT 159

Query: 101 EHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVM 160
           E +         A++               ++  I + I YLHS  + HRD+KP N+L  
Sbjct: 160 ERE---------ASE---------------IMKSIGEAIQYLHSINIAHRDVKPENLLYT 195

Query: 161 GEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAI 220
            +      +K+ D GFA+        L        T +Y APE +LG   Y K+ D+W++
Sbjct: 196 SKR-PNAILKLTDFGFAKET-TSHNSLTT---PCYTPYYVAPE-VLGPEKYDKSCDMWSL 249

Query: 221 GCI 223
           G I
Sbjct: 250 GVI 252

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  115 bits (290), Expect = 1e-30
 Identities = 58/234 (24%), Positives = 102/234 (43%), Gaps = 51/234 (21%)

Query: 15  KVEDLFD-YE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC-------- 64
                ++ YE    +GRG    V +   K     ++YA+K I+ TG    +         
Sbjct: 11  STHGFYENYEPKEILGRGVSSVVRRCIHKPTC--KEYAVKIIDVTGGGSFSAEEVQELRE 68

Query: 65  ---REIALLRELK-HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKK 119
              +E+ +LR++  HPN+I L   +    +   +L+FD  +  +L     F         
Sbjct: 69  ATLKEVDILRKVSGHPNIIQLKDTY--ETNTFFFLVFDLMKKGEL-----FDY------- 114

Query: 120 PVMVPKGMV-----KSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM 174
             +  K  +     + ++  +L+ I  LH   ++HRDLKP NIL+     +   +K+ D 
Sbjct: 115 --LTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD----DDMNIKLTDF 168

Query: 175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGA-----RHYTKAIDIWAIGCI 223
           GF+    +P + L +   V  T  Y APE++  +       Y K +D+W+ G I
Sbjct: 169 GFSCQL-DPGEKLRE---VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 218

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  113 bits (286), Expect = 5e-30
 Identities = 59/238 (24%), Positives = 98/238 (41%), Gaps = 38/238 (15%)

Query: 10  SNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-SMSACREIA 68
           S +RT   D+   E   VG+G YG V++   +      + A+K        S     E+ 
Sbjct: 1   SMQRTVARDITLLE--CVGKGRYGEVWRGSWQG----ENVAVKIFSSRDEKSWFRETELY 54

Query: 69  LLRELKHPNVINLI--SVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPK 125
               L+H N++  I   +   H+  ++WL+  Y E   L+  ++            +   
Sbjct: 55  NTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ---------LTTLDTV 105

Query: 126 GMVKSLLYQILDGIHYLHSNW--------VLHRDLKPANILVMGEGIERGRVKIADMGFA 177
             ++ ++  I  G+ +LH           + HRDLK  NILV     + G+  IAD+G A
Sbjct: 106 SCLR-IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK----KNGQCCIADLGLA 160

Query: 178 RLF-NNPLKPLADLDPVVVTFWYRAPELLLGA-----RHYTKAIDIWAIGCIFAELLT 229
            +   +  +     +P V T  Y APE+L            K +DIWA G +  E+  
Sbjct: 161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR 218

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  113 bits (285), Expect = 2e-29
 Identities = 59/237 (24%), Positives = 97/237 (40%), Gaps = 38/237 (16%)

Query: 11  NERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC-REIAL 69
            +RT    +   E   +G+G +G V++ + +      + A+K              EI  
Sbjct: 36  VQRTIARTIVLQE--SIGKGRFGEVWRGKWRG----EEVAVKIFSSREERSWFREAEIYQ 89

Query: 70  LRELKHPNVINLISVFLSHNDR--KVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKG 126
              L+H N++  I+     N    ++WL+ DY EH  L+  +          +  +  +G
Sbjct: 90  TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN---------RYTVTVEG 140

Query: 127 MVKSLLYQILDGIHYLHSNW--------VLHRDLKPANILVMGEGIERGRVKIADMGFAR 178
           M+K L      G+ +LH           + HRDLK  NILV     + G   IAD+G A 
Sbjct: 141 MIK-LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK----KNGTCCIADLGLAV 195

Query: 179 LFNNPLKPLADLDPVVV-TFWYRAPELLLGA-----RHYTKAIDIWAIGCIFAELLT 229
             ++    +       V T  Y APE+L  +         K  DI+A+G +F E+  
Sbjct: 196 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 252

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  114 bits (286), Expect = 2e-29
 Identities = 68/275 (24%), Positives = 121/275 (44%), Gaps = 38/275 (13%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIE-GTGLSMSACREIALLRELKHP------NV 78
            +G+G++G V KA   D  +    A+K I+        A  E+ LL  +          +
Sbjct: 61  LIGKGSFGQVVKAY--DRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYI 118

Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDG 138
           ++L   F+  N   + L+F+   ++L+ +++       N + V     + +    Q+   
Sbjct: 119 VHLKRHFMFRN--HLCLVFEMLSYNLYDLLR-----NTNFRGV--SLNLTRKFAQQMCTA 169

Query: 139 IHYLHSNW--VLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVT 196
           + +L +    ++H DLKP NIL+      R  +KI D G +            +   + +
Sbjct: 170 LLFLATPELSIIHCDLKPENILLCNPK--RSAIKIVDFGSSCQLGQ------RIYQYIQS 221

Query: 197 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 256
            +YR+PE+LLG   Y  AID+W++GCI  E+ T EP+F    E          DQ+++I 
Sbjct: 222 RFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANE---------VDQMNKIV 271

Query: 257 SVMGFPLEKDWEDIRKMPEHPTLLKDFNEQICKME 291
            V+G P     +   K  +    L D    + K +
Sbjct: 272 EVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTK 306

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  112 bits (281), Expect = 2e-29
 Identities = 46/222 (20%), Positives = 86/222 (38%), Gaps = 34/222 (15%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA---------CREIALLRELK 74
             ++G+G +G V+K R   +      A+K +                   RE+ ++  L 
Sbjct: 24  EKQIGKGGFGLVHKGRLVKD--KSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81

Query: 75  HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLY 133
           HPN++ L  +          ++ ++    DL+H +          K   +   +   L+ 
Sbjct: 82  HPNIVKLYGLMH----NPPRMVMEFVPCGDLYHRL--------LDKAHPIKWSVKLRLML 129

Query: 134 QILDGIHYLHSN--WVLHRDLKPANILVMGEGIERG-RVKIADMGFARLFNNPLKPLADL 190
            I  GI Y+ +    ++HRDL+  NI +           K+AD G ++   + +  L   
Sbjct: 130 DIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLG- 188

Query: 191 DPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSE 231
                 F + APE +      YT+  D ++   I   +LT E
Sbjct: 189 -----NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  114 bits (286), Expect = 3e-29
 Identities = 72/243 (29%), Positives = 116/243 (47%), Gaps = 36/243 (14%)

Query: 27  VGRGTYGHVYKARRKDNSDTRDYALKQIE-GTGLSMSACREIALLRELKH------PNVI 79
           +G+G++G V KA   D+   +  ALK +         A  EI +L  L+        NVI
Sbjct: 105 IGKGSFGQVVKAY--DHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162

Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGI 139
           +++  F   N   + + F+    +L+ +IK     K   +       +V+   + IL  +
Sbjct: 163 HMLENFTFRN--HICMTFELLSMNLYELIK-----KNKFQGF--SLPLVRKFAHSILQCL 213

Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
             LH N ++H DLKP NIL+  +G  R  +K+ D G +   +  +         + + +Y
Sbjct: 214 DALHKNRIIHCDLKPENILLKQQG--RSGIKVIDFGSSCYEHQRVY------TYIQSRFY 265

Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVM 259
           RAPE++LGAR Y   ID+W++GCI AELLT  P+     E          DQL  +  ++
Sbjct: 266 RAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDE---------GDQLACMIELL 315

Query: 260 GFP 262
           G P
Sbjct: 316 GMP 318

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  113 bits (284), Expect = 4e-29
 Identities = 43/229 (18%), Positives = 89/229 (38%), Gaps = 30/229 (13%)

Query: 21  DYE-GCKVGRG--TYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC----REIALLREL 73
            YE    +G+G      V  AR K   +     +++I     S         E+ + +  
Sbjct: 26  CYELLTVIGKGFEDLMTVNLARYKPTGEY--VTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 74  KHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLL 132
            HPN++   + F++  D ++W++  +  +     +I  H           + +  +  +L
Sbjct: 84  NHPNIVPYRATFIA--DNELWVVTSFMAYGSAKDLICTH-------FMDGMNELAIAYIL 134

Query: 133 YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGF-ARLFNNPLK----PL 187
             +L  + Y+H    +HR +K ++IL+       G+V ++ +     + ++  +      
Sbjct: 135 QGVLKALDYIHHMGYVHRSVKASHILIS----VDGKVYLSGLRSNLSMISHGQRQRVVHD 190

Query: 188 ADLDPVVVTFWYRAPELLLGARH-YTKAIDIWAIGCIFAELLTSEPIFH 235
                V V  W  +PE+L      Y    DI+++G    EL      F 
Sbjct: 191 FPKYSVKVLPWL-SPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 238

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  112 bits (281), Expect = 7e-29
 Identities = 36/288 (12%), Positives = 78/288 (27%), Gaps = 75/288 (26%)

Query: 28  GRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC-----REIALLRELK-------- 74
           G+       +A  ++      + +     T    S        E+  LR L+        
Sbjct: 82  GQEDPYAYLEATDQETG--ESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 75  -----------------HPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKAN 117
                               +I +            + L+   + +L    +   +  + 
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 118 KKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA 177
            K +         L  Q++  +  LH   ++H  L+P +I++     +RG V +      
Sbjct: 200 HKSL--VHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD----QRGGVFLTGFEHL 253

Query: 178 RLFNNPLKPLADLDPVVVTFWYRAPELL----------LGARHYTKAIDIWAIGCIFAEL 227
                 +          V+  +  PEL                 T + D WA+G +   +
Sbjct: 254 VRDGARVVS-------SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306

Query: 228 LTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPE 275
             ++              P   D             E  +   + +P+
Sbjct: 307 WCADL-------------PITKDAALGGS-------EWIFRSCKNIPQ 334

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  111 bits (279), Expect = 8e-29
 Identities = 44/223 (19%), Positives = 92/223 (41%), Gaps = 35/223 (15%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA----CREIALLRELKHPNVI 79
           G  +G+G +G VY  R        + A++ I+    +        RE+   R+ +H NV+
Sbjct: 38  GELIGKGRFGQVYHGRWHG-----EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVV 92

Query: 80  NLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDG 138
             +   +  +   + ++    +   L+ +++           +++     + +  +I+ G
Sbjct: 93  LFMGACM--SPPHLAIITSLCKGRTLYSVVR--------DAKIVLDVNKTRQIAQEIVKG 142

Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + YLH+  +LH+DLK  N+       + G+V I D G   +         +    +   W
Sbjct: 143 MGYLHAKGILHKDLKSKNVFY-----DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGW 197

Query: 199 YR--APELLLGAR--------HYTKAIDIWAIGCIFAELLTSE 231
               APE++             ++K  D++A+G I+ EL   E
Sbjct: 198 LCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  110 bits (277), Expect = 9e-29
 Identities = 64/222 (28%), Positives = 106/222 (47%), Gaps = 31/222 (13%)

Query: 17  EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA---CREIALLREL 73
           E+LF     K+G+G++G V+K            A+K I+            +EI +L + 
Sbjct: 21  EELFTKL-EKIGKGSFGEVFKGIDNRTQKV--VAIKIIDLEEAEDEIEDIQQEITVLSQC 77

Query: 74  KHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLL 132
             P V      +L   D K+W++ +Y        +++          P  + +  + ++L
Sbjct: 78  DSPYVTKYYGSYL--KDTKLWIIMEYLGGGSALDLLE----------PGPLDETQIATIL 125

Query: 133 YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGF-ARLFNNPLKPLADLD 191
            +IL G+ YLHS   +HRD+K AN+L+     E G VK+AD G   +L +  +K     +
Sbjct: 126 REILKGLDYLHSEKKIHRDIKAANVLLS----EHGEVKLADFGVAGQLTDTQIKR----N 177

Query: 192 PVVVT-FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 232
             V T FW  APE++  + + +KA DIW++G    EL   EP
Sbjct: 178 TFVGTPFWM-APEVIKQSAYDSKA-DIWSLGITAIELARGEP 217

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  111 bits (279), Expect = 1e-28
 Identities = 63/228 (27%), Positives = 108/228 (47%), Gaps = 41/228 (17%)

Query: 17  EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-----CREIALLR 71
           E LF     ++G G++G VY AR   NS+    A+K++  +G   +       +E+  L+
Sbjct: 53  EKLFSDL-REIGHGSFGAVYFARDVRNSEV--VAIKKMSYSGKQSNEKWQDIIKEVRFLQ 109

Query: 72  ELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSL 131
           +L+HPN I     +L   +   WL+ +Y       +++ H           + +  + ++
Sbjct: 110 KLRHPNTIQYRGCYL--REHTAWLVMEYCLGSASDLLEVH--------KKPLQEVEIAAV 159

Query: 132 LYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLD 191
            +  L G+ YLHS+ ++HRD+K  NIL+     E G VK+ D G A          + + 
Sbjct: 160 THGALQGLAYLHSHNMIHRDVKAGNILLS----EPGLVKLGDFGSA----------SIMA 205

Query: 192 P---VVVT-FWYRAPELLLGAR--HYTKAIDIWAIGCIFA-ELLTSEP 232
           P    V T +W  APE++L      Y   +D+W++G I   EL   +P
Sbjct: 206 PANSFVGTPYWM-APEVILAMDEGQYDGKVDVWSLG-ITCIELAERKP 251

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  111 bits (279), Expect = 1e-28
 Identities = 56/252 (22%), Positives = 98/252 (38%), Gaps = 48/252 (19%)

Query: 11  NERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNS------DTRDYALKQIEGTGLSMSAC 64
            +RT  + +   +  ++G+G YG V+  + +          T + A    E         
Sbjct: 31  VQRTIAKQIQMVK--QIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRE--------- 79

Query: 65  REIALLRELKHPNVINLISVFLSHNDR--KVWLLFDYAEH-DLWHIIKFHRAAKANKKPV 121
            EI     ++H N++  I+  +       +++L+ DY E+  L+  +K            
Sbjct: 80  TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK---------STT 130

Query: 122 MVPKGMVKSLLYQILDGIHYLHSNW--------VLHRDLKPANILVMGEGIERGRVKIAD 173
           +  K M+K L Y  + G+ +LH+          + HRDLK  NILV     + G   IAD
Sbjct: 131 LDAKSMLK-LAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK----KNGTCCIAD 185

Query: 174 MGFARLFNNPLKPLADLDPVVV-TFWYRAPELLLGA-----RHYTKAIDIWAIGCIFAEL 227
           +G A  F +    +       V T  Y  PE+L  +            D+++ G I  E+
Sbjct: 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

Query: 228 LTSEPIFHCRQE 239
                     +E
Sbjct: 246 ARRCVSGGIVEE 257

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  109 bits (274), Expect = 1e-28
 Identities = 37/217 (17%), Positives = 77/217 (35%), Gaps = 32/217 (14%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA----CREIALLRELKHPNVI 79
             K+     G ++K R + N    D  +K ++    S         E   LR   HPNV+
Sbjct: 15  LTKLNENHSGELWKGRWQGN----DIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70

Query: 80  NLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDG 138
            ++    S       L+  +  +  L++++             +V +         +  G
Sbjct: 71  PVLGACQSPPAPHPTLITHWMPYGSLYNVLH-------EGTNFVVDQSQAVKFALDMARG 123

Query: 139 IHYLHS--NWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVT 196
           + +LH+    +    L   ++++     E    +I+       F +P +        +  
Sbjct: 124 MAFLHTLEPLIPRHALNSRSVMID----EDMTARISMADVKFSFQSPGR--------MYA 171

Query: 197 FWYRAPELLLGAR--HYTKAIDIWAIGCIFAELLTSE 231
             + APE L         ++ D+W+   +  EL+T E
Sbjct: 172 PAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTRE 208

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  109 bits (275), Expect = 2e-28
 Identities = 49/215 (22%), Positives = 97/215 (45%), Gaps = 27/215 (12%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA----CREIALLRELKHPNVI 79
             K+G G++G V++A         D A+K +              RE+A+++ L+HPN++
Sbjct: 42  KEKIGAGSFGTVHRAEWHG----SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97

Query: 80  NLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDG 138
             +          + ++ +Y     L+ ++  H++    +    + +    S+ Y +  G
Sbjct: 98  LFMGAVTQPP--NLSIVTEYLSRGSLYRLL--HKSGAREQ----LDERRRLSMAYDVAKG 149

Query: 139 IHYLHSN--WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVT 196
           ++YLH+    ++HR+LK  N+LV     ++  VK+ D G +RL  +             T
Sbjct: 150 MNYLHNRNPPIVHRNLKSPNLLVD----KKYTVKVCDFGLSRLKASTFL---SSKSAAGT 202

Query: 197 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 231
             + APE+L       +  D+++ G I  EL T +
Sbjct: 203 PEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQ 236

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  108 bits (273), Expect = 5e-28
 Identities = 55/220 (25%), Positives = 92/220 (41%), Gaps = 31/220 (14%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA--CREIALLRELKHPNVINL 81
           G  +G+G +G   K   ++        +K++            +E+ ++R L+HPNV+  
Sbjct: 15  GEVLGKGCFGQAIKVTHRET--GEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKF 72

Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIH 140
           I V     D+++  + +Y +   L  IIK              P     S    I  G+ 
Sbjct: 73  IGVLY--KDKRLNFITEYIKGGTLRGIIK--------SMDSQYPWSQRVSFAKDIASGMA 122

Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN-----------PLKPLAD 189
           YLHS  ++HRDL   N LV     E   V +AD G ARL  +                  
Sbjct: 123 YLHSMNIIHRDLNSHNCLVR----ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK 178

Query: 190 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
              VV   ++ APE++ G R Y + +D+++ G +  E++ 
Sbjct: 179 RYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIG 217

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  108 bits (272), Expect = 6e-28
 Identities = 59/234 (25%), Positives = 107/234 (45%), Gaps = 34/234 (14%)

Query: 6   KIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACR 65
           K+   +   + E++FD     +G G+YG VYKA  K+       A+KQ+          +
Sbjct: 17  KLDEDSLTKQPEEVFDVLEK-LGEGSYGSVYKAIHKETGQI--VAIKQVPVESDLQEIIK 73

Query: 66  EIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAE----HDLWHIIKFHRAAKANKKPV 121
           EI+++++   P+V+     +    +  +W++ +Y       D+  +           +  
Sbjct: 74  EISIMQQCDSPHVVKYYGSYF--KNTDLWIVMEYCGAGSVSDIIRL-----------RNK 120

Query: 122 MVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGF-ARLF 180
            + +  + ++L   L G+ YLH    +HRD+K  NIL+       G  K+AD G   +L 
Sbjct: 121 TLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLN----TEGHAKLADFGVAGQLT 176

Query: 181 NNPLKPLADLDPVVVT-FWYRAPELLLGARHYTKAIDIWAIGCIFA-ELLTSEP 232
           +   K     + V+ T FW  APE++    +   A DIW++G I A E+   +P
Sbjct: 177 DTMAKR----NTVIGTPFWM-APEVIQEIGYNCVA-DIWSLG-ITAIEMAEGKP 223

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  108 bits (271), Expect = 7e-28
 Identities = 58/231 (25%), Positives = 98/231 (42%), Gaps = 58/231 (25%)

Query: 28  GRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC----------------------- 64
           G+G+YG V  A   + +D   YA+K +    L   A                        
Sbjct: 22  GKGSYGVVKLAY--NENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79

Query: 65  -----REIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANK 118
                +EIA+L++L HPNV+ L+ V    N+  ++++F+      +  +           
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP------ 133

Query: 119 KPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR 178
               + +   +     ++ GI YLH   ++HRD+KP+N+LV     E G +KIAD G + 
Sbjct: 134 ----LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG----EDGHIKIADFGVSN 185

Query: 179 LFNNPLKPLADLDPVVVTF----WYRAPELLLGARH-YT-KAIDIWAIGCI 223
            F          D ++        + APE L   R  ++ KA+D+WA+G  
Sbjct: 186 EFKGS-------DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVT 229

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  107 bits (269), Expect = 1e-27
 Identities = 57/213 (26%), Positives = 102/213 (47%), Gaps = 29/213 (13%)

Query: 25  CKVGRGTYGHVYKARRKDNSDTRDYALKQI--EGTGLSMSACREIALLRELKHPNVINLI 82
            K+G+G  G VY A           A++Q+  +          EI ++RE K+PN++N +
Sbjct: 26  EKIGQGASGTVYTAMDVATGQE--VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYL 83

Query: 83  SVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHY 141
             +L  +  ++W++ +Y     L  ++              + +G + ++  + L  + +
Sbjct: 84  DSYLVGD--ELWVVMEYLAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEF 131

Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGF-ARLFNNPLKPLADLDPVVVT-FWY 199
           LHSN V+HRD+K  NIL+       G VK+ D GF A++     K       +V T +W 
Sbjct: 132 LHSNQVIHRDIKSDNILLG----MDGSVKLTDFGFCAQITPEQSKR----STMVGTPYWM 183

Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 232
            APE++    +  K  DIW++G +  E++  EP
Sbjct: 184 -APEVVTRKAYGPKV-DIWSLGIMAIEMIEGEP 214

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  107 bits (270), Expect = 2e-27
 Identities = 56/213 (26%), Positives = 104/213 (48%), Gaps = 29/213 (13%)

Query: 25  CKVGRGTYGHVYKARRKDNSDTRDYALKQI--EGTGLSMSACREIALLRELKHPNVINLI 82
            K+G G+ G V  AR K +   R  A+K +             E+ ++R+ +H NV+ + 
Sbjct: 51  VKIGEGSTGIVCLAREKHSG--RQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMY 108

Query: 83  SVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHY 141
             +L     ++W+L ++ +   L  I+            V + +  + ++   +L  + Y
Sbjct: 109 KSYLVGE--ELWVLMEFLQGGALTDIVS----------QVRLNEEQIATVCEAVLQALAY 156

Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGF-ARLFNNPLKPLADLDPVVVT-FWY 199
           LH+  V+HRD+K  +IL+       GRVK++D GF A++  +  K       +V T +W 
Sbjct: 157 LHAQGVIHRDIKSDSILLT----LDGRVKLSDFGFCAQISKDVPKR----KSLVGTPYWM 208

Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 232
            APE++  +  Y   +DIW++G +  E++  EP
Sbjct: 209 -APEVISRSL-YATEVDIWSLGIMVIEMVDGEP 239

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  107 bits (268), Expect = 2e-27
 Identities = 54/229 (23%), Positives = 103/229 (44%), Gaps = 39/229 (17%)

Query: 17  EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQI--EGTGLSMSACREIALLRELK 74
            ++++  G ++G G +G VYKA+ K+       A K I  +          EI +L    
Sbjct: 18  NEVWEIVG-ELGDGAFGKVYKAKNKETGAL--AAAKVIETKSEEELEDYIVEIEILATCD 74

Query: 75  HPNVINLISVFLSHNDRKVWLLFDYAE----HDLWHIIKFHRAAKANKKPVMVPKGMVKS 130
           HP ++ L+  +   +D K+W++ ++        +              + +   +  ++ 
Sbjct: 75  HPYIVKLLGAYY--HDGKLWIMIEFCPGGAVDAI---------MLELDRGL--TEPQIQV 121

Query: 131 LLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGF-ARLFNNPLKPLAD 189
           +  Q+L+ +++LHS  ++HRDLK  N+L+       G +++AD G  A+      K    
Sbjct: 122 VCRQMLEALNFLHSKRIIHRDLKAGNVLMT----LEGDIRLADFGVSAKNLKTLQK---- 173

Query: 190 LDPVVVT-FWYRAPELLLGAR----HYTKAIDIWAIGCIFA-ELLTSEP 232
            D  + T +W  APE+++        Y    DIW++G I   E+   EP
Sbjct: 174 RDSFIGTPYWM-APEVVMCETMKDTPYDYKADIWSLG-ITLIEMAQIEP 220

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  107 bits (269), Expect = 2e-27
 Identities = 64/257 (24%), Positives = 99/257 (38%), Gaps = 65/257 (25%)

Query: 9   TSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALK-----------QIEGT 57
               + + ED F + G  +G G++  V  AR    S  R+YA+K           ++   
Sbjct: 22  PQPRKKRPED-FKF-GKILGEGSFSTVVLARELATS--REYAIKILEKRHIIKENKVPYV 77

Query: 58  GLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAE--HDLWHIIKFHR--- 112
                  RE  ++  L HP  + L   F   +D K++    YA+    L +I K      
Sbjct: 78  ------TRERDVMSRLDHPFFVKLYFTF--QDDEKLYFGLSYAKNGELLKYIRKIGSFDE 129

Query: 113 -AAKANKKPVMVPKGMVKSLLY--QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRV 169
              +                 Y  +I+  + YLH   ++HRDLKP NIL+  +      +
Sbjct: 130 TCTR----------------FYTAEIVSALEYLHGKGIIHRDLKPENILLNED----MHI 169

Query: 170 KIADMGFARLFNNPLKPLADLDPVVVTFW------YRAPELLLGARHYTKAIDIWAIGCI 223
           +I D G A       K L+                Y +PELL       K+ D+WA+GCI
Sbjct: 170 QITDFGTA-------KVLSPESKQARANSFVGTAQYVSPELLTEKSA-CKSSDLWALGCI 221

Query: 224 FAELLTSEPIFHCRQED 240
             +L+   P F    E 
Sbjct: 222 IYQLVAGLPPFRAGNEY 238

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  105 bits (263), Expect = 6e-27
 Identities = 57/229 (24%), Positives = 96/229 (41%), Gaps = 38/229 (16%)

Query: 17  EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA------CREIALL 70
            +L   E   +G G +G VY+A         + A+K          +       +E  L 
Sbjct: 7   AELTLEE--IIGIGGFGKVYRAFWIG----DEVAVKAARHDPDEDISQTIENVRQEAKLF 60

Query: 71  RELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVK 129
             LKHPN+I L  V     +  + L+ ++A    L  ++   R          +P  ++ 
Sbjct: 61  AMLKHPNIIALRGV--CLKEPNLCLVMEFARGGPLNRVLSGKR----------IPPDILV 108

Query: 130 SLLYQILDGIHYLHSN---WVLHRDLKPANILV----MGEGIERGRVKIADMGFARLFNN 182
           +   QI  G++YLH      ++HRDLK +NIL+        +    +KI D G AR ++ 
Sbjct: 109 NWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR 168

Query: 183 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 231
                         + + APE++     ++K  D+W+ G +  ELLT E
Sbjct: 169 -----TTKMSAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGE 211

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  105 bits (265), Expect = 7e-27
 Identities = 54/217 (24%), Positives = 95/217 (43%), Gaps = 37/217 (17%)

Query: 28  GRGTYGHVYKARRKDNSDT-RDYALKQIEGTGLSMSAC------REIALLRELKHPNVIN 80
           G G+YG V +     +S+T    A+K ++   L           +EI LLR L+H NVI 
Sbjct: 14  GEGSYGKVKEVL---DSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70

Query: 81  LISVFLSHNDRKVWLLFDYAE---HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILD 137
           L+ V  +   +K++++ +Y      ++   +   R           P         Q++D
Sbjct: 71  LVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR----------FPVCQAHGYFCQLID 120

Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF 197
           G+ YLHS  ++H+D+KP N+L+       G +KI+ +G A   +         D    T 
Sbjct: 121 GLEYLHSQGIVHKDIKPGNLLLT----TGGTLKISALGVAEALHPFAA-----DDTCRTS 171

Query: 198 ----WYRAPELLLGARHYT-KAIDIWAIGCIFAELLT 229
                ++ PE+  G   ++   +DIW+ G     + T
Sbjct: 172 QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITT 208

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  104 bits (262), Expect = 1e-26
 Identities = 52/253 (20%), Positives = 91/253 (35%), Gaps = 79/253 (31%)

Query: 6   KIKTSNERTKVEDLFDYE--GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA 63
            +K+  +  K   + DY+     +G G  G V +   K       +ALK ++       A
Sbjct: 3   HVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNK--RTQEKFALKMLQD---CPKA 57

Query: 64  CREIALLREL-KHPNVINLISVF--LSHNDRKVWL---------LFD---------YAEH 102
            RE+ L     + P+++ ++ V+  L    + + +         LF          + E 
Sbjct: 58  RREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 117

Query: 103 DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGE 162
           +         A++               ++  I + I YLHS  + HRD+KP N+L   +
Sbjct: 118 E---------ASE---------------IMKSIGEAIQYLHSINIAHRDVKPENLLYTSK 153

Query: 163 GIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGC 222
                 +K+ D GF                        A E       Y K+ D+W++G 
Sbjct: 154 R-PNAILKLTDFGF------------------------AKETT--GEKYDKSCDMWSLGV 186

Query: 223 IFAELLTSEPIFH 235
           I   LL   P F+
Sbjct: 187 IMYILLCGYPPFY 199

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  105 bits (263), Expect = 1e-26
 Identities = 57/232 (24%), Positives = 100/232 (43%), Gaps = 38/232 (16%)

Query: 17  EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLREL-K 74
             +F+     VG GTYG VYK R          A+K ++ TG       +EI +L++   
Sbjct: 23  AGIFELV-ELVGNGTYGQVYKGRHVKTGQL--AAIKVMDVTGDEEEEIKQEINMLKKYSH 79

Query: 75  HPNVINLISVFL----SHNDRKVWLLFDYAE----HDLWHIIKFHRAAKANKKPVMVPKG 126
           H N+      F+       D ++WL+ ++       DL    K +           + + 
Sbjct: 80  HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT----------LKEE 129

Query: 127 MVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKP 186
            +  +  +IL G+ +LH + V+HRD+K  N+L+     E   VK+ D G +   +     
Sbjct: 130 WIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT----ENAEVKLVDFGVSAQLDR---T 182

Query: 187 LADLDPVVVT-FWYRAPELLLGARH----YTKAIDIWAIGCIFA-ELLTSEP 232
           +   +  + T +W  APE++    +    Y    D+W++G I A E+    P
Sbjct: 183 VGRRNTFIGTPYWM-APEVIACDENPDATYDFKSDLWSLG-ITAIEMAEGAP 232

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  103 bits (260), Expect = 2e-26
 Identities = 48/217 (22%), Positives = 88/217 (40%), Gaps = 32/217 (14%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA----CREIALLRELKHPNVI 79
           G ++G G++G VYK +        D A+K +  T  +         E+ +LR+ +H N++
Sbjct: 29  GQRIGSGSFGTVYKGKWHG-----DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83

Query: 80  NLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDG 138
             +    +     + ++  + E   L+H +                   +  +  Q   G
Sbjct: 84  LFMGYSTAPQ---LAIVTQWCEGSSLYHHLH--------ASETKFEMKKLIDIARQTARG 132

Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + YLH+  ++HRDLK  NI +     E   VKI D G A   +              +  
Sbjct: 133 MDYLHAKSIIHRDLKSNNIFLH----EDNTVKIGDFGLATEKSRWSGSHQFEQL---SGS 185

Query: 199 YR--APELLLG--ARHYTKAIDIWAIGCIFAELLTSE 231
               APE++    +  Y+   D++A G +  EL+T +
Sbjct: 186 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  104 bits (262), Expect = 2e-26
 Identities = 56/222 (25%), Positives = 86/222 (38%), Gaps = 37/222 (16%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-SMSACREIALLRELKHPNVINLI-- 82
              RG +G V+KA+  +       A+K        S     E+  L  +KH N++  I  
Sbjct: 31  VKARGRFGCVWKAQLLN----EYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGA 86

Query: 83  SVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHY 141
               +  D  +WL+  + E   L   +K +           V    +  +   +  G+ Y
Sbjct: 87  EKRGTSVDVDLWLITAFHEKGSLSDFLKANV----------VSWNELCHIAETMARGLAY 136

Query: 142 LHSNW----------VLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLD 191
           LH +           + HRD+K  N+L+           IAD G A  F    K   D  
Sbjct: 137 LHEDIPGLKDGHKPAISHRDIKSKNVLLK----NNLTACIADFGLALKF-EAGKSAGDTH 191

Query: 192 PVVVTFWYRAPELLLGA----RHYTKAIDIWAIGCIFAELLT 229
             V T  Y APE+L GA    R     ID++A+G +  EL +
Sbjct: 192 GQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  104 bits (260), Expect = 4e-26
 Identities = 50/240 (20%), Positives = 94/240 (39%), Gaps = 50/240 (20%)

Query: 21  DYE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC----------REIAL 69
            Y     +G G +G V+ A  K+ +  ++  +K I+   +                EIA+
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKN--KEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82

Query: 70  LRELKHPNVINLISVFLSHNDRKVWL----------LFDYAEHDLWHIIKFHRAAKANKK 119
           L  ++H N+I ++ +F   N     L          LF + +                + 
Sbjct: 83  LSRVEHANIIKVLDIF--ENQGFFQLVMEKHGSGLDLFAFID----------------RH 124

Query: 120 PVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL 179
           P +    +   +  Q++  + YL    ++HRD+K  NI++     E   +K+ D G A  
Sbjct: 125 PRLDEP-LASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIA----EDFTIKLIDFGSA-- 177

Query: 180 FNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
               L+          T  Y APE+L+G  +    +++W++G     L+  E  F   +E
Sbjct: 178 --AYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE 235

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  103 bits (258), Expect = 1e-25
 Identities = 54/274 (19%), Positives = 101/274 (36%), Gaps = 35/274 (12%)

Query: 25  CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMS---ACREIALLRELKHPNVINL 81
            ++G G  G V+K   K +      A K I             RE+ +L E   P ++  
Sbjct: 39  SELGAGNGGVVFKVSHKPSGLV--MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGF 96

Query: 82  ISVFLSHNDRKVWLLFDYAE----HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILD 137
              F S  +  + +  ++ +      +             KK   +P+ ++  +   ++ 
Sbjct: 97  YGAFYSDGE--ISICMEHMDGGSLDQVL------------KKAGRIPEQILGKVSIAVIK 142

Query: 138 GIHYLHSNW-VLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVT 196
           G+ YL     ++HRD+KP+NILV      RG +K+ D G +    + +      +  V T
Sbjct: 143 GLTYLREKHKIMHRDVKPSNILVN----SRGEIKLCDFGVSGQLIDSMA-----NSFVGT 193

Query: 197 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCRQEDIKTSNPYHHDQLDRI 255
             Y +PE L G  HY+   DIW++G    E+     PI     ++++       +     
Sbjct: 194 RSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 252

Query: 256 FSVMGFPLEKDWEDIRKMPEHPTLLKDFNEQICK 289
                    +           P  + +  + I  
Sbjct: 253 TPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVN 286

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  101 bits (254), Expect = 2e-25
 Identities = 51/223 (22%), Positives = 86/223 (38%), Gaps = 46/223 (20%)

Query: 21  DYE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC--------REIALLR 71
           +Y  G  +G+G +G V+   R   +D    A+K I    +   +          E+ALL 
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRL--TDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLW 89

Query: 72  EL----KHPNVINLISVFLSHNDRKVWLLFDYAEH--DLWHIIKFHRAAKANKKPVMVPK 125
           ++     HP VI L+  F         L+ +      DL+  I              + +
Sbjct: 90  KVGAGGGHPGVIRLLDWF--ETQEGFMLVLERPLPAQDLFDYITEKGP---------LGE 138

Query: 126 GMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF-NNPL 184
           G  +    Q++  I + HS  V+HRD+K  NIL+      RG  K+ D G   L  + P 
Sbjct: 139 GPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDL---RRGCAKLIDFGSGALLHDEPY 195

Query: 185 KPLADLDPVVVTF----WYRAPELLLGARHYTKAIDIWAIGCI 223
                       F     Y  PE +   +++     +W++G +
Sbjct: 196 T----------DFDGTRVYSPPEWISRHQYHALPATVWSLGIL 228

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  101 bits (254), Expect = 3e-25
 Identities = 53/221 (23%), Positives = 92/221 (41%), Gaps = 44/221 (19%)

Query: 21  DYE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC--------REIALLR 71
            Y+ G  +G G +G VY   R   SD    A+K +E   +S             E+ LL+
Sbjct: 44  QYQVGPLLGSGGFGSVYSGIRV--SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 101

Query: 72  ELKH--PNVINLISVFLSHNDRKVWLLFDYAEH--DLWHIIKFHRAAKANKKPVMVPKGM 127
           ++      VI L+  F         L+ +  E   DL+  I    A         + + +
Sbjct: 102 KVSSGFSGVIRLLDWF--ERPDSFVLILERPEPVQDLFDFITERGA---------LQEEL 150

Query: 128 VKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF-NNPLKP 186
            +S  +Q+L+ + + H+  VLHRD+K  NIL+    + RG +K+ D G   L  +     
Sbjct: 151 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILI---DLNRGELKLIDFGSGALLKDTVYT- 206

Query: 187 LADLDPVVVTF----WYRAPELLLGARHYTKAIDIWAIGCI 223
                     F     Y  PE +   R++ ++  +W++G +
Sbjct: 207 ---------DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGIL 238

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  101 bits (254), Expect = 4e-25
 Identities = 59/255 (23%), Positives = 106/255 (41%), Gaps = 40/255 (15%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDY-ALKQIEGTG-LSMSACREIALLRELKHP------N 77
            +G GT+G V +    D++  +   ALK I   G    +A  EI +L+++K         
Sbjct: 26  NLGEGTFGKVVECL--DHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFL 83

Query: 78  VINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILD 137
            + +   F  H    + + F+    + +  +K +     N +P   P   V+ + YQ+  
Sbjct: 84  CVLMSDWFNFHG--HMCIAFELLGKNTFEFLKEN-----NFQPY--PLPHVRHMAYQLCH 134

Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLAD-------- 189
            + +LH N + H DLKP NIL +    E    +        + N  ++ +AD        
Sbjct: 135 ALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIR-VADFGSATFDH 193

Query: 190 --LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 247
                +V T  YR PE++L    + +  D+W+IGCI  E      +F       +T    
Sbjct: 194 EHHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLF-------QTHE-- 243

Query: 248 HHDQLDRIFSVMGFP 262
           + + L  +  ++G  
Sbjct: 244 NREHLVMMEKILGPI 258

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 98.9 bits (247), Expect = 3e-24
 Identities = 56/209 (26%), Positives = 102/209 (48%), Gaps = 30/209 (14%)

Query: 28  GRGTYGHVYKARRKDNSDT-RDYALKQIEGTGLSMSAC----REIALLRELKHPNVINLI 82
           G+G +  V  AR   +  T R+ A+K I+ T L+ ++     RE+ +++ L HPN++ L 
Sbjct: 24  GKGNFAKVKLAR---HILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80

Query: 83  SVFLSHNDRKVWLLFDYAEH-DLW-HIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIH 140
            V     ++ ++L+ +YA   +++ +++   R          + +   +S   QI+  + 
Sbjct: 81  EVI--ETEKTLYLIMEYASGGEVFDYLVAHGR----------MKEKEARSKFRQIVSAVQ 128

Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           Y H   ++HRDLK  N+L+         +KIAD GF+  F         LD       Y 
Sbjct: 129 YCHQKRIVHRDLKAENLLLD----ADMNIKIADFGFSNEF----TVGGKLDAFCGAPPYA 180

Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLT 229
           APEL  G ++    +D+W++G I   L++
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVS 209

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 98.9 bits (247), Expect = 4e-24
 Identities = 57/255 (22%), Positives = 98/255 (38%), Gaps = 40/255 (15%)

Query: 26  KVGRGTYGHVYKAR-RKDNSDTRDYALKQIEGTG-LSMSACREIALLRELKHP------N 77
            +G G +G V +    K     R  A+K ++       +A  EI +L  L          
Sbjct: 21  TLGEGAFGKVVECIDHKAGG--RHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFR 78

Query: 78  VINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILD 137
            + ++  F  H    + ++F+      +  IK +        P       ++ + YQI  
Sbjct: 79  CVQMLEWFEHHG--HICIVFELLGLSTYDFIKEN-----GFLPF--RLDHIRKMAYQICK 129

Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLAD-------- 189
            +++LHSN + H DLKP NIL +                  L N  +K + D        
Sbjct: 130 SVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIK-VVDFGSATYDD 188

Query: 190 --LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 247
                +V T  YRAPE++L    +++  D+W+IGCI  E      +F        T +  
Sbjct: 189 EHHSTLVSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYLGFTVF-------PTHD-- 238

Query: 248 HHDQLDRIFSVMGFP 262
             + L  +  ++G  
Sbjct: 239 SKEHLAMMERILGPL 253

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 98.8 bits (246), Expect = 4e-24
 Identities = 50/229 (21%), Positives = 81/229 (35%), Gaps = 43/229 (18%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI-EGTGLSMSACREIALLRELKHPNVINLI-- 82
            +GRG YG VYK    +    R  A+K        +    + I  +  ++H N+   I  
Sbjct: 20  LIGRGRYGAVYKGSLDE----RPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVG 75

Query: 83  -SVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIH 140
                +    +  L+ +Y  +  L   +  H                   L + +  G+ 
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----------SDWVSSCRLAHSVTRGLA 125

Query: 141 YLHSNW---------VLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLD 191
           YLH+           + HRDL   N+LV       G   I+D G +             +
Sbjct: 126 YLHTELPRGDHYKPAISHRDLNSRNVLVK----NDGTCVISDFGLSMRLTGNRLVRPGEE 181

Query: 192 -----PVVVTFWYRAPELLLGA------RHYTKAIDIWAIGCIFAELLT 229
                  V T  Y APE+L GA          K +D++A+G I+ E+  
Sbjct: 182 DNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 99.0 bits (247), Expect = 5e-24
 Identities = 61/227 (26%), Positives = 97/227 (42%), Gaps = 24/227 (10%)

Query: 1   MDYEFKIKTSNERTKVEDLFDYE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQIE-GTG 58
           MD         +   + D   Y+    +G G +G     R K   +    A+K IE G  
Sbjct: 1   MDRAPVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKEL--VAVKYIERGAA 58

Query: 59  LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKAN 117
           +  +  REI   R L+HPN++    V L+     + ++ +YA   +L     + R   A 
Sbjct: 59  IDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIIMEYASGGEL-----YERICNAG 111

Query: 118 KKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA 177
           +      +   +    Q+L G+ Y HS  + HRDLK  N L+  +G    R+KI D G++
Sbjct: 112 R----FSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLL--DGSPAPRLKICDFGYS 165

Query: 178 RLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYT-KAIDIWAIGCI 223
           +         +     V T  Y APE+LL  + Y  K  D+W+ G  
Sbjct: 166 KSS----VLHSQPKSTVGTPAYIAPEVLLR-QEYDGKIADVWSCGVT 207

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 98.2 bits (245), Expect = 1e-23
 Identities = 57/258 (22%), Positives = 103/258 (39%), Gaps = 42/258 (16%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-GLSMSACREIALLRELKH-----PNVI 79
           K+G GT+G V   +     + + YA+K +      + SA  E  +L+++++      N++
Sbjct: 42  KMGDGTFGRVLLCQ--HIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIV 99

Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGI 139
                F+ ++   + L+F+     L+ II  +     N          +K    +IL  +
Sbjct: 100 KYHGKFMYYD--HMCLIFEPLGPSLYEIITRN-----NYNGF--HIEDIKLYCIEILKAL 150

Query: 140 HYLHSNWVLHRDLKPANILV-----MGEGIERGRVKIADMGFARLFNNPLKPLADL---- 190
           +YL    + H DLKP NIL+         I   RV            +    L D     
Sbjct: 151 NYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCAT 210

Query: 191 ------DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS 244
                   ++ T  YRAPE++L    +  + D+W+ GC+ AEL T   +F   +      
Sbjct: 211 FKSDYHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRTHEH----- 264

Query: 245 NPYHHDQLDRIFSVMGFP 262
                + L  + S++   
Sbjct: 265 ----MEHLAMMESIIQPI 278

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 99.5 bits (248), Expect = 1e-23
 Identities = 56/268 (20%), Positives = 94/268 (35%), Gaps = 67/268 (25%)

Query: 26  KVGRGTYGHVYKARRKDNS-DTRDYALKQIEGTGLSMS--------ACREIALLRELKHP 76
            +  G  G +Y A   D + + R   LK     GL  S        A  E   L E+ HP
Sbjct: 87  CIAHGGLGWIYLAL--DRNVNGRPVVLK-----GLVHSGDAEAQAMAMAERQFLAEVVHP 139

Query: 77  NVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFH------------RAAKANKKPVMVP 124
           +++ +               F++ EH   H                 + +K  K PV   
Sbjct: 140 SIVQI---------------FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPV--- 181

Query: 125 KGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPL 184
                + L +IL  + YLHS  +++ DLKP NI+     +   ++K+ D+G         
Sbjct: 182 -AEAIAYLLEILPALSYLHSIGLVYNDLKPENIM-----LTEEQLKLIDLGAVS------ 229

Query: 185 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF---HCRQEDI 241
             +     +  T  ++APE++      T A DI+ +G   A L    P     +      
Sbjct: 230 -RINSFGYLYGTPGFQAPEIVRT--GPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPE 286

Query: 242 KTSNPYHHDQLDRIFSVMGFPLEKDWED 269
                  +D   R+       ++ D   
Sbjct: 287 DDPVLKTYDSYGRLLRRA---IDPDPRQ 311

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 95.7 bits (238), Expect = 1e-22
 Identities = 66/297 (22%), Positives = 112/297 (37%), Gaps = 77/297 (25%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALK-QIEGTGLSMSACREIALLRELK-----HPN-- 77
           K+G G +  V+ +   D    +  A+K        + +A  EI LL+ ++      PN  
Sbjct: 44  KLGWGHFSTVWLSW--DIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNRE 101

Query: 78  -VINLISVFLSH--NDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQ 134
            V+ L+  F     N   + ++F+   H L   I              +P   VK ++ Q
Sbjct: 102 MVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKS-------NYQGLPLPCVKKIIQQ 154

Query: 135 ILDGIHYLHS-NWVLHRDLKPANILVMGE------------------------------- 162
           +L G+ YLH+   ++H D+KP NIL+                                  
Sbjct: 155 VLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 214

Query: 163 --------------GIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGA 208
                           E+ +VKIAD+G A   +            + T  YR+ E+L+G+
Sbjct: 215 ATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTED------IQTRQYRSLEVLIGS 268

Query: 209 RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMG-FPLE 264
             Y    DIW+  C+  EL T + +F     +  T +  H   +  I  ++G  P +
Sbjct: 269 -GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDH---IALIIELLGKVPRK 321

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 96.4 bits (240), Expect = 1e-22
 Identities = 57/249 (22%), Positives = 103/249 (41%), Gaps = 45/249 (18%)

Query: 12  ERTKVEDLFDYEGCKV-GRGTYGHVYKARRKDNSDTRDYALKQIE--------GTGLSMS 62
           E   +     +   +V GRG +G V+  + K     + YA K++         G   +M 
Sbjct: 178 EAQPM-GEDWFLDFRVLGRGGFGEVFACQMKATG--KLYACKKLNKKRLKKRKGYQGAMV 234

Query: 63  ACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DL-WHIIKFHRAAKANKKP 120
              E  +L ++    +++L   F       + L+       D+ +HI          ++P
Sbjct: 235 ---EKKILAKVHSRFIVSLAYAF--ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP 289

Query: 121 VMVPKGMVKSLLY--QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR 178
             +         Y  QI+ G+ +LH   +++RDLKP N+L+  +    G V+I+D+G A 
Sbjct: 290 RAI--------FYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDD----GNVRISDLGLA- 336

Query: 179 LFNNPLKPLADLDPVVVTF----WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
                   L         +     + APELLLG   Y  ++D +A+G    E++ +   F
Sbjct: 337 ------VELKAGQTKTKGYAGTPGFMAPELLLGEE-YDFSVDYFALGVTLYEMIAARGPF 389

Query: 235 HCRQEDIKT 243
             R E ++ 
Sbjct: 390 RARGEKVEN 398

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 92.3 bits (230), Expect = 3e-22
 Identities = 54/218 (24%), Positives = 88/218 (40%), Gaps = 46/218 (21%)

Query: 28  GRGTYGHVYKARRKDNSDTRDY-ALKQIEGT---GLSMSACREIALLRELKHPNVINLIS 83
           G G YG V  A    N  T +  A+K ++         +  +EI + + L H NV+    
Sbjct: 16  GEGAYGEVQLAV---NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72

Query: 84  VFLSHNDRKVWL-------LFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVK-----SL 131
                N + ++L       LFD                       + P   +        
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDR----------------------IEPDIGMPEPDAQRF 110

Query: 132 LYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLD 191
            +Q++ G+ YLH   + HRD+KP N+L+     ER  +KI+D G A +F         L+
Sbjct: 111 FHQLMAGVVYLHGIGITHRDIKPENLLLD----ERDNLKISDFGLATVF-RYNNRERLLN 165

Query: 192 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
            +  T  Y APELL     + + +D+W+ G +   +L 
Sbjct: 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 203

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 92.3 bits (230), Expect = 4e-22
 Identities = 51/216 (23%), Positives = 87/216 (40%), Gaps = 25/216 (11%)

Query: 25  CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA---CREIA-LLRELKHPNVIN 80
            ++GRG YG V K R   +      A+K+I  T  S        ++   +R +  P  + 
Sbjct: 13  MELGRGAYGVVEKMRHVPSGQI--MAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVT 70

Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIH 140
                    D  VW+  +  +  L    K     +   K   +P+ ++  +   I+  + 
Sbjct: 71  FYGALFREGD--VWICMELMDTSLDKFYK-----QVIDKGQTIPEDILGKIAVSIVKALE 123

Query: 141 YLHSNW-VLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
           +LHS   V+HRD+KP+N+L+       G+VK+ D G +    + +      D       Y
Sbjct: 124 HLHSKLSVIHRDVKPSNVLI----NALGQVKMCDFGISGYLVDDVA----KDIDAGCKPY 175

Query: 200 RAPELLLGAR---HYTKAIDIWAIGCIFAELLTSEP 232
            APE +        Y+   DIW++G    EL     
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILRF 211

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 92.3 bits (230), Expect = 4e-22
 Identities = 58/216 (26%), Positives = 89/216 (41%), Gaps = 43/216 (19%)

Query: 28  GRGTYGHVYKARRKDNSDTRDY-ALK-----QIEGTGLSMSACREIALLRELKHPNVINL 81
           G GT+G V       +  T    A+K     +I    +     REI  L+  +HP++I L
Sbjct: 20  GVGTFGKVKIGE---HQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76

Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLW-HIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGI 139
             V         +++ +Y    +L+ +I K  R          V +   + L  QIL  +
Sbjct: 77  YQVI--STPTDFFMVMEYVSGGELFDYICKHGR----------VEEMEARRLFQQILSAV 124

Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF--NNPLKPLADLDPVVVTF 197
            Y H + V+HRDLKP N+L+          KIAD G + +      L+          T 
Sbjct: 125 DYCHRHMVVHRDLKPENVLLD----AHMNAKIADFGLSNMMSDGEFLR----------TS 170

Query: 198 ----WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                Y APE++ G  +    +DIW+ G I   LL 
Sbjct: 171 CGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLC 206

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 93.1 bits (232), Expect = 4e-22
 Identities = 57/215 (26%), Positives = 99/215 (46%), Gaps = 42/215 (19%)

Query: 28  GRGTYGHVYKARRKDNSDTRDY-ALK-----QIEGTGLSMSACREIALLRELKHPNVINL 81
           G G++G V  A    +  T+   ALK      ++ + + M   REI+ L+ L+HP++I L
Sbjct: 18  GEGSFGKVKLAT---HYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74

Query: 82  ISVFLSHNDRKVWLLFDYAEHDLW-HIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIH 140
             V        + ++ +YA  +L+ +I++  R          + +   +    QI+  I 
Sbjct: 75  YDVI--TTPTDIVMVIEYAGGELFDYIVEKKR----------MTEDEGRRFFQQIICAIE 122

Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF--NNPLKPLADLDPVVVTF- 197
           Y H + ++HRDLKP N+L+     +   VKIAD G + +    N LK          T  
Sbjct: 123 YCHRHKIVHRDLKPENLLLD----DNLNVKIADFGLSNIMTDGNFLK----------TSC 168

Query: 198 ---WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
               Y APE++ G  +    +D+W+ G +   +L 
Sbjct: 169 GSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLV 203

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 93.1 bits (232), Expect = 5e-22
 Identities = 57/256 (22%), Positives = 106/256 (41%), Gaps = 55/256 (21%)

Query: 4   EFKIKTSNERTKVEDLFDYEGCKV-GRGTYGHVYKARRKDNSDTRDYALK---------- 52
           +F  K          L  ++  K  G G++G V   + K++     YA+K          
Sbjct: 25  DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESG--NHYAMKILDKQKVVKL 82

Query: 53  -QIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAE-HDLWHIIKF 110
            QIE T   ++   E  +L+ +  P ++ L   F   ++  ++++ +Y    +++  ++ 
Sbjct: 83  KQIEHT---LN---EKRILQAVNFPFLVKLEFSF--KDNSNLYMVMEYVAGGEMFSHLR- 133

Query: 111 HRAAKANKKPVMVPKGMVKSLLY--QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGR 168
               +  +      +       Y  QI+    YLHS  +++RDLKP N+L+  +    G 
Sbjct: 134 ----RIGRFSEPHAR------FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ----GY 179

Query: 169 VKIADMGFARLFNNPLKPLADLDPVVVTF----WYRAPELLLGARHYTKAIDIWAIGCIF 224
           +++ D GFA+                 T        APE++L  + Y KA+D WA+G + 
Sbjct: 180 IQVTDFGFAKRVKGRTW----------TLCGTPEALAPEIILS-KGYNKAVDWWALGVLI 228

Query: 225 AELLTSEPIFHCRQED 240
            E+    P F   Q  
Sbjct: 229 YEMAAGYPPFFADQPI 244

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 93.2 bits (232), Expect = 6e-22
 Identities = 57/248 (22%), Positives = 107/248 (43%), Gaps = 49/248 (19%)

Query: 11  NERTKVEDLFDYEGCKV-GRGTYGHVYKARRKDNSDTRDYALK-----------QIEGTG 58
           +E   V +   +E  +  G+G++G V   ++ D      YA+K           ++    
Sbjct: 7   DENEDV-NFDHFEILRAIGKGSFGKVCIVQKNDTKKM--YAMKYMNKQKCVERNEVRNV- 62

Query: 59  LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DL-WHIIKFHRAAKA 116
                 +E+ +++ L+HP ++NL   F   ++  ++++ D     DL +H+         
Sbjct: 63  -----FKELQIMQGLEHPFLVNLWYSF--QDEEDMFMVVDLLLGGDLRYHL--------- 106

Query: 117 NKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGF 176
            ++ V   +  VK  + +++  + YL +  ++HRD+KP NIL+     E G V I D   
Sbjct: 107 -QQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLD----EHGHVHITDFNI 161

Query: 177 ARLF--NNPLKPLADLDPVVVTFWYRAPELLL--GARHYTKAIDIWAIGCIFAELLTSEP 232
           A +      +  +A       T  Y APE+        Y+ A+D W++G    ELL    
Sbjct: 162 AAMLPRETQITTMAG------TKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

Query: 233 IFHCRQED 240
            +H R   
Sbjct: 216 PYHIRSST 223

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 91.2 bits (227), Expect = 2e-21
 Identities = 54/218 (24%), Positives = 87/218 (39%), Gaps = 46/218 (21%)

Query: 28  GRGTYGHVYKARRKDNSDTRDY-ALKQIEGTGLSMSAC---REIALLRELKHPNVINLIS 83
           G G YG V  A    N  T +  A+K ++            +EI + + L H NV+    
Sbjct: 16  GEGAYGEVQLAV---NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72

Query: 84  VFLSHNDRKVWL-------LFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVK-----SL 131
                N + ++L       LFD                       + P   +        
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDR----------------------IEPDIGMPEPDAQRF 110

Query: 132 LYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLD 191
            +Q++ G+ YLH   + HRD+KP N+L+     ER  +KI+D G A +F         L+
Sbjct: 111 FHQLMAGVVYLHGIGITHRDIKPENLLLD----ERDNLKISDFGLATVF-RYNNRERLLN 165

Query: 192 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
            +  T  Y APELL     + + +D+W+ G +   +L 
Sbjct: 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 203

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 91.3 bits (227), Expect = 4e-21
 Identities = 66/249 (26%), Positives = 107/249 (42%), Gaps = 37/249 (14%)

Query: 4   EFKIKTSNERTKVEDLFDYEGCKV-GRGTYGHVYKARRKDNSDTRDYALKQI---EGTGL 59
           +   K  + R K ED   YE  KV GRG +G V   R K     + YA+K +   E    
Sbjct: 56  DTINKIRDLRMKAED---YEVVKVIGRGAFGEVQLVRHKSTR--KVYAMKLLSKFEMIKR 110

Query: 60  SMSAC----REIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAE-HDLWHIIKFHRAA 114
           S SA     R+I  +     P V+ L   F   +DR ++++ +Y    DL +++  +   
Sbjct: 111 SDSAFFWEERDI--MAFANSPWVVQLFYAF--QDDRYLYMVMEYMPGGDLVNLMSNYD-- 164

Query: 115 KANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM 174
                   VP+   +    +++  +  +HS   +HRD+KP N+L+       G +K+AD 
Sbjct: 165 --------VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS----GHLKLADF 212

Query: 175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLL---GARHYTKAIDIWAIGCIFAELLTSE 231
           G     N       D    V T  Y +PE+L    G  +Y +  D W++G    E+L  +
Sbjct: 213 GTCMKMNKEGMVRCDT--AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270

Query: 232 PIFHCRQED 240
             F+     
Sbjct: 271 TPFYADSLV 279

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 91.9 bits (228), Expect = 5e-21
 Identities = 58/244 (23%), Positives = 109/244 (44%), Gaps = 35/244 (14%)

Query: 8   KTSNERTKVEDLFDYEGCKV-GRGTYGHVYKARRKDNSDTRDYALKQIE--------GTG 58
           K       +  + D+   ++ GRG +G VY  R+ D    + YA+K ++        G  
Sbjct: 178 KNVELNIHL-TMNDFSVHRIIGRGGFGEVYGCRKADTG--KMYAMKCLDKKRIKMKQGET 234

Query: 59  LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DL-WHIIKFHRAAKA 116
           L+++    ++L+     P ++ +   F  H   K+  + D     DL +H+         
Sbjct: 235 LALNERIMLSLVSTGDCPFIVCMSYAF--HTPDKLSFILDLMNGGDLHYHL--------- 283

Query: 117 NKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGF 176
             +  +  +  ++    +I+ G+ ++H+ +V++RDLKPANIL+   G     V+I+D+G 
Sbjct: 284 -SQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG----HVRISDLGL 338

Query: 177 ARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 236
           A  F+            V T  Y APE+L     Y  + D +++GC+  +LL     F  
Sbjct: 339 ACDFSK-----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 393

Query: 237 RQED 240
            +  
Sbjct: 394 HKTK 397

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 91.8 bits (228), Expect = 5e-21
 Identities = 60/245 (24%), Positives = 107/245 (43%), Gaps = 42/245 (17%)

Query: 12  ERTKVEDLFDYEGCKV-GRGTYGHVYKARRKDNSDTRDYALKQIE--------GTGLSMS 62
           ER  V     +   +V G+G +G V   + +     + YA K++E        G  ++++
Sbjct: 177 ERQPV-TKNTFRQYRVLGKGGFGEVCACQVRATG--KMYACKKLEKKRIKKRKGEAMALN 233

Query: 63  ACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DL-WHIIKFHRAAKANKKP 120
              E  +L ++    V++L   +       + L+       DL +HI    +A       
Sbjct: 234 ---EKQILEKVNSRFVVSLAYAY--ETKDALCLVLTLMNGGDLKFHIYHMGQA------- 281

Query: 121 VMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
              P+        +I  G+  LH   +++RDLKP NIL+       G ++I+D+G A   
Sbjct: 282 -GFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDH----GHIRISDLGLA--- 333

Query: 181 NNPLKPLADLDPV---VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 237
                 + +   +   V T  Y APE++   R YT + D WA+GC+  E++  +  F  R
Sbjct: 334 ----VHVPEGQTIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQR 388

Query: 238 QEDIK 242
           ++ IK
Sbjct: 389 KKKIK 393

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 90.6 bits (225), Expect = 8e-21
 Identities = 63/255 (24%), Positives = 100/255 (39%), Gaps = 46/255 (18%)

Query: 4   EFKIKTSNERTKVEDLFDYEGCKV-GRGTYGHVYKARRKDNSDTRDYALKQI---EGTGL 59
            F  K    R   ED F+    KV GRG +G V   + K+      +A+K +   E    
Sbjct: 61  PFTSKVKQMRLHRED-FEI--LKVIGRGAFGEVAVVKLKNADKV--FAMKILNKWEMLKR 115

Query: 60  SMSAC----REIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAE--HDLWHIIKFHRA 113
           + +AC    R++  L       +  L   F   +D  ++L+ DY      L  + KF   
Sbjct: 116 AETACFREERDV--LVNGDSKWITTLHYAF--QDDNNLYLVMDYYVGGDLLTLLSKFED- 170

Query: 114 AKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIAD 173
                    +P+ M +  L +++  I  +H    +HRD+KP NIL+       G +++AD
Sbjct: 171 --------RLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMN----GHIRLAD 218

Query: 174 MGFARLFNNPLKPLADLDPVVVTFW----YRAPELLL----GARHYTKAIDIWAIGCIFA 225
            G        LK + D             Y +PE+L     G   Y    D W++G    
Sbjct: 219 FGSC------LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMY 272

Query: 226 ELLTSEPIFHCRQED 240
           E+L  E  F+     
Sbjct: 273 EMLYGETPFYAESLV 287

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 90.6 bits (225), Expect = 9e-21
 Identities = 60/223 (26%), Positives = 89/223 (39%), Gaps = 57/223 (25%)

Query: 28  GRGTYGHVYKARRKDNSDTRDY-ALK-----QIEGTGLSMSACREIALLRELKHPNVINL 81
           G GT+G V   +   +  T    A+K     +I    +     REI  L+  +HP++I L
Sbjct: 25  GVGTFGKVKVGK---HELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81

Query: 82  ISVFLSHNDRKVWL---------LFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLL 132
             V        +++         LFDY       I K  R          + +   + L 
Sbjct: 82  YQVI--STPSDIFMVMEYVSGGELFDY-------ICKNGR----------LDEKESRRLF 122

Query: 133 YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF--NNPLKPLADL 190
            QIL G+ Y H + V+HRDLKP N+L+          KIAD G + +      L+     
Sbjct: 123 QQILSGVDYCHRHMVVHRDLKPENVLLD----AHMNAKIADFGLSNMMSDGEFLR----- 173

Query: 191 DPVVVTF----WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                T      Y APE++ G  +    +DIW+ G I   LL 
Sbjct: 174 -----TSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLC 211

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 89.0 bits (221), Expect = 1e-20
 Identities = 55/238 (23%), Positives = 99/238 (41%), Gaps = 38/238 (15%)

Query: 9   TSNERTKVEDLFDYEG-CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREI 67
           T   +    ++ D E   ++G GT G V+K R +        A+KQ+     S +     
Sbjct: 14  TIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHV--IAVKQMR---RSGNKEENK 68

Query: 68  ALLRELK-------HPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKP 120
            +L +L         P ++     F+++ D  V++  +        + K        +  
Sbjct: 69  RILMDLDVVLKSHDCPYIVQCFGTFITNTD--VFIAMELMGTCAEKLKK--------RMQ 118

Query: 121 VMVPKGMVKSLLYQILDGIHYLHSNW-VLHRDLKPANILVMGEGIERGRVKIADMGF-AR 178
             +P+ ++  +   I+  ++YL     V+HRD+KP+NIL+     ERG++K+ D G   R
Sbjct: 119 GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD----ERGQIKLCDFGISGR 174

Query: 179 LFNNPLKPLADLDPVVVTFWYRAPELLLGAR----HYTKAIDIWAIGCIFAELLTSEP 232
           L ++  K     D       Y APE +         Y    D+W++G    EL T + 
Sbjct: 175 LVDDKAK-----DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQF 227

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 89.2 bits (222), Expect = 1e-20
 Identities = 63/255 (24%), Positives = 109/255 (42%), Gaps = 52/255 (20%)

Query: 4   EFKIKTSNERTKVEDLFDYEGCKV-GRGTYGHVYKARRKDNSDTRDYALK---------- 52
             +  +   + K+ED F     K+ G+G++G V+ A  K  +  + +A+K          
Sbjct: 4   NKERPSLQIKLKIED-FIL--HKMLGKGSFGKVFLAEFKKTN--QFFAIKALKKDVVLMD 58

Query: 53  -QIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DL-WHIIK 109
             +E T   M   + + L    +HP + ++   F       ++ + +Y    DL +HI  
Sbjct: 59  DDVECT---MVE-KRV-LSLAWEHPFLTHMFCTF--QTKENLFFVMEYLNGGDLMYHI-- 109

Query: 110 FHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRV 169
                   +               +I+ G+ +LHS  +++RDLK  NIL+  +    G +
Sbjct: 110 --------QSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD----GHI 157

Query: 170 KIADMGFARLFNNPLKPLADLDPVVVTF----WYRAPELLLGARHYTKAIDIWAIGCIFA 225
           KIAD G         K     D    TF     Y APE+LLG + Y  ++D W+ G +  
Sbjct: 158 KIADFGMC-------KENMLGDAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLY 209

Query: 226 ELLTSEPIFHCRQED 240
           E+L  +  FH + E+
Sbjct: 210 EMLIGQSPFHGQDEE 224

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 88.9 bits (221), Expect = 1e-20
 Identities = 49/237 (20%), Positives = 93/237 (39%), Gaps = 27/237 (11%)

Query: 6   KIKTSNERTKVEDLFDYEG-CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC 64
           K+K S E+       D +   ++GRG YG V K   K +      A+K+I  T +     
Sbjct: 8   KLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQI--MAVKRIRST-VDEKEQ 64

Query: 65  REI-----ALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKK 119
           +++      ++R    P ++          D   W+  +          K       +  
Sbjct: 65  KQLLMDLDVVMRSSDCPYIVQFYGALFREGD--CWICMELMSTSFDKFYK----YVYSVL 118

Query: 120 PVMVPKGMVKSLLYQILDGIHYLHSNW-VLHRDLKPANILVMGEGIERGRVKIADMGFAR 178
             ++P+ ++  +    +  +++L  N  ++HRD+KP+NIL+       G +K+ D G + 
Sbjct: 119 DDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLD----RSGNIKLCDFGISG 174

Query: 179 LFNNPLKPLADLDPVVVTFWYRAPELLLGARH---YTKAIDIWAIGCIFAELLTSEP 232
              + +    D         Y APE +  +     Y    D+W++G    EL T   
Sbjct: 175 QLVDSIAKTRD----AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRF 227

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 88.4 bits (220), Expect = 2e-20
 Identities = 60/238 (25%), Positives = 101/238 (42%), Gaps = 53/238 (22%)

Query: 21  DYEGCKV-GRGTYGHVYKARRKDNSDTRDYALK-----------QIEGTGLSMSACREIA 68
           D++  +  G G++G V+  R + N   R YA+K           Q+E T        E  
Sbjct: 7   DFQILRTLGTGSFGRVHLIRSRHNG--RYYAMKVLKKEIVVRLKQVEHT---ND---ERL 58

Query: 69  LLRELKHPNVINLISVFLSHNDRKVWLLFDYAE-HDL-WHIIKFHRAAKANKKPVMVPKG 126
           +L  + HP +I +   F   + ++++++ DY E  +L   + K  R           P  
Sbjct: 59  MLSIVTHPFIIRMWGTF--QDAQQIFMIMDYIEGGELFSLLRKSQR----------FPNP 106

Query: 127 MVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKP 186
           + K    ++   + YLHS  +++RDLKP NIL+       G +KI D GFA+   +    
Sbjct: 107 VAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKN----GHIKITDFGFAKYVPDVTY- 161

Query: 187 LADLDPVVVTFW----YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
                    T      Y APE++    +  K+ID W+ G +  E+L     F+     
Sbjct: 162 ---------TLCGTPDYIAPEVVSTKPY-NKSIDWWSFGILIYEMLAGYTPFYDSNTM 209

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 88.2 bits (219), Expect = 2e-20
 Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 32/216 (14%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDY--ALKQI-EGTGLSMSA-CREIALLRELKHPNVINL 81
           ++G+G +G V   R     D      A+K++   T   +    REI +L+ L+H N++  
Sbjct: 48  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107

Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIH 140
             V  S   R + L+ +Y  +  L   ++ H+          +    +     QI  G+ 
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--------IDHIKLLQYTSQICKGME 159

Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVT---- 196
           YL +   +HRDL   NILV        RVKI D G  ++         D +   V     
Sbjct: 160 YLGTKRYIHRDLATRNILVE----NENRVKIGDFGLTKVLPQ------DKEYYKVKEPGE 209

Query: 197 ---FWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
              FWY APE L     ++ A D+W+ G +  EL T
Sbjct: 210 SPIFWY-APESLT-ESKFSVASDVWSFGVVLYELFT 243

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 87.7 bits (218), Expect = 2e-20
 Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 32/216 (14%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDY--ALKQI-EGTGLSMSA-CREIALLRELKHPNVINL 81
           ++G+G +G V   R     D      A+K++   T   +    REI +L+ L+H N++  
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76

Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIH 140
             V  S   R + L+ +Y  +  L   ++ H+          +    +     QI  G+ 
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--------IDHIKLLQYTSQICKGME 128

Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVT---- 196
           YL +   +HRDL   NILV        RVKI D G  ++         D +   V     
Sbjct: 129 YLGTKRYIHRDLATRNILVE----NENRVKIGDFGLTKVLPQ------DKEFFKVKEPGE 178

Query: 197 ---FWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
              FWY APE L     ++ A D+W+ G +  EL T
Sbjct: 179 SPIFWY-APESLT-ESKFSVASDVWSFGVVLYELFT 212

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 87.3 bits (217), Expect = 4e-20
 Identities = 56/218 (25%), Positives = 83/218 (38%), Gaps = 30/218 (13%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC------REIALLRELKHPNVI 79
            VGRG  G VY+A   D    R  ALK +    LS          RE      L+ P+V+
Sbjct: 41  LVGRGGMGDVYEAE--DTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97

Query: 80  NLISVF-LSHNDRKVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILD 137
               +      D ++++        DL  +++             +      +++ QI  
Sbjct: 98  P---IHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP---------LAPPRAVAIVRQIGS 145

Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF 197
            +   H+    HRD+KP NILV           + D G A    +    L  L   V T 
Sbjct: 146 ALDAAHAAGATHRDVKPENILVS----ADDFAYLVDFGIASATTDE--KLTQLGNTVGTL 199

Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
           +Y APE      H T   DI+A+ C+  E LT  P + 
Sbjct: 200 YYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQ 236

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 88.2 bits (219), Expect = 5e-20
 Identities = 54/253 (21%), Positives = 94/253 (37%), Gaps = 40/253 (15%)

Query: 4   EFKIKTSNERTKVEDLFDYEGCKV-GRGTYGHVYKARRKDNSDTRDYALKQI---EGTGL 59
              ++    R + +D F+    KV GRG +  V   + K       YA+K +   +    
Sbjct: 48  PIVVRLKEVRLQRDD-FEI--LKVIGRGAFSEVAVVKMKQTGQV--YAMKIMNKWDMLKR 102

Query: 60  SMSAC----REIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAE--HDLWHIIKFHRA 113
              +C    R++  L       +  L   F   ++  ++L+ +Y      L  + KF   
Sbjct: 103 GEVSCFREERDV--LVNGDRRWITQLHFAF--QDENYLYLVMEYYVGGDLLTLLSKFGE- 157

Query: 114 AKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIAD 173
                    +P  M +  L +I+  I  +H    +HRD+KP NIL+       G +++AD
Sbjct: 158 --------RIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRC----GHIRLAD 205

Query: 174 MGFARLFNNPLKPLADLDPVVVTFWYRAPELLLG------ARHYTKAIDIWAIGCIFAEL 227
            G            + +   V T  Y +PE+L           Y    D WA+G    E+
Sbjct: 206 FGSCLKLRADGTVRSLV--AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEM 263

Query: 228 LTSEPIFHCRQED 240
              +  F+     
Sbjct: 264 FYGQTPFYADSTA 276

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 86.1 bits (214), Expect = 1e-19
 Identities = 60/252 (23%), Positives = 115/252 (45%), Gaps = 43/252 (17%)

Query: 4   EFKIKTSNERTKVEDLFDYEGCKV-GRGTYGHVYKARRKDNSDTRD-YALKQIEGTGLSM 61
           E  +    E+ + E  F+    +V G+G YG V++ R+   ++T   +A+K ++   + +
Sbjct: 4   ETSVNRGPEKIRPEC-FEL--LRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMI-V 59

Query: 62  SACREIA-------LLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DL-WHIIKFHR 112
              ++ A       +L E+KHP +++LI  F +    K++L+ +Y    +L   +     
Sbjct: 60  RNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG--KLYLILEYLSGGELFMQL----- 112

Query: 113 AAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA 172
                ++  +  +      L +I   + +LH   +++RDLKP NI++  +    G VK+ 
Sbjct: 113 -----EREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQ----GHVKLT 163

Query: 173 DMGFARLFNNPLKPLADLDPVVVTFW----YRAPELLLGARHYTKAIDIWAIGCIFAELL 228
           D G         K       V  TF     Y APE+L+    + +A+D W++G +  ++L
Sbjct: 164 DFGLC-------KESIHDGTVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDML 215

Query: 229 TSEPIFHCRQED 240
           T  P F      
Sbjct: 216 TGAPPFTGENRK 227

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 86.2 bits (214), Expect = 2e-19
 Identities = 63/251 (25%), Positives = 107/251 (42%), Gaps = 52/251 (20%)

Query: 8   KTSNERTKVEDLFDYEGCKV-GRGTYGHVYKARRKDNSDTRDYALK-----------QIE 55
            +SN   K  D F +   KV G+G++G V  AR K       YA+K           + +
Sbjct: 29  PSSNPHAKPSD-FHF--LKVIGKGSFGKVLLARHKAEE--VFYAVKVLQKKAILKKKEEK 83

Query: 56  GTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DL-WHIIKFHRA 113
                + + R + LL+ +KHP ++ L   F      K++ + DY    +L +H+      
Sbjct: 84  ----HIMSERNV-LLKNVKHPFLVGLHFSF--QTADKLYFVLDYINGGELFYHL------ 130

Query: 114 AKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIAD 173
               ++     +   +    +I   + YLHS  +++RDLKP NIL+  +    G + + D
Sbjct: 131 ----QRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ----GHIVLTD 182

Query: 174 MGFARLFNNPLKPLADLDPVVVTF----WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
            G         K   + +    TF     Y APE+L   + Y + +D W +G +  E+L 
Sbjct: 183 FGLC-------KENIEHNSTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLY 234

Query: 230 SEPIFHCRQED 240
             P F+ R   
Sbjct: 235 GLPPFYSRNTA 245

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 85.4 bits (212), Expect = 2e-19
 Identities = 54/237 (22%), Positives = 82/237 (34%), Gaps = 35/237 (14%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDY-----ALKQIEGTGLSMSACREIALLRELKHPNVIN 80
            +G G +G V   R     D         +LK   G        +EI +LR L H N++ 
Sbjct: 28  DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87

Query: 81  LISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGI 139
              +        + L+ ++     L   +  ++     K+ +            QI  G+
Sbjct: 88  YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQL--------KYAVQICKGM 139

Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVT--- 196
            YL S   +HRDL   N+LV        +VKI D G  +          D +   V    
Sbjct: 140 DYLGSRQYVHRDLAARNVLVE----SEHQVKIGDFGLTKAIET------DKEYYTVKDDR 189

Query: 197 ----FWYRAPELLLGARHYTKAIDIWAIGCIFAELLT--SEPIFHCRQEDIKTSNPY 247
               FWY APE L+    +  A D+W+ G    ELLT                   +
Sbjct: 190 DSPVFWY-APECLM-QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTH 244

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 85.9 bits (213), Expect = 2e-19
 Identities = 61/216 (28%), Positives = 90/216 (41%), Gaps = 32/216 (14%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDY--ALKQIEGTGLSMSA--CREIALLRELKHPNVINL 81
           ++G+G +G V   R     D      A+KQ++ +G        REI +L+ L    ++  
Sbjct: 30  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89

Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIH 140
             V      + + L+ +Y     L   ++ HRA         +    +     QI  G+ 
Sbjct: 90  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR--------LDASRLLLYSSQICKGME 141

Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVT---- 196
           YL S   +HRDL   NILV         VKIAD G A+L         D D  VV     
Sbjct: 142 YLGSRRCVHRDLAARNILVE----SEAHVKIADFGLAKLLP------LDKDYYVVREPGQ 191

Query: 197 ---FWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
              FWY APE L     +++  D+W+ G +  EL T
Sbjct: 192 SPIFWY-APESLS-DNIFSRQSDVWSFGVVLYELFT 225

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 87.0 bits (215), Expect = 2e-19
 Identities = 61/255 (23%), Positives = 103/255 (40%), Gaps = 52/255 (20%)

Query: 4   EFKIKTSNERTKVEDLFDYEGCKV-GRGTYGHVYKARRKDNSDTRDYALK---------- 52
           +F    + +R K+ D F++    V G+G++G V  + RK       YA+K          
Sbjct: 328 KFDNNGNRDRMKLTD-FNF--LMVLGKGSFGKVMLSERKGTD--ELYAVKILKKDVVIQD 382

Query: 53  -QIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DL-WHIIK 109
             +E         + + L    K P +  L S F      +++ + +Y    DL +HI  
Sbjct: 383 DDVE----CTMVEKRV-LALPGKPPFLTQLHSCF--QTMDRLYFVMEYVNGGDLMYHI-- 433

Query: 110 FHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRV 169
                   ++     +        +I  G+ +L S  +++RDLK  N+++  E    G +
Sbjct: 434 --------QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE----GHI 481

Query: 170 KIADMGFARLFNNPLKPLADLDPVVVTFW----YRAPELLLGARHYTKAIDIWAIGCIFA 225
           KIAD G         K          TF     Y APE++   + Y K++D WA G +  
Sbjct: 482 KIADFGMC-------KENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLY 533

Query: 226 ELLTSEPIFHCRQED 240
           E+L  +  F    ED
Sbjct: 534 EMLAGQAPFEGEDED 548

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 85.3 bits (212), Expect = 2e-19
 Identities = 65/254 (25%), Positives = 112/254 (44%), Gaps = 43/254 (16%)

Query: 1   MDYEFKIKTSNERTKVEDLFDYEGCKV-GRGTYGHVYKARRKDNSDT-RDYALKQ----- 53
           +     +K  +E+      F+    KV G+G++G V+  ++   SD  + YA+K      
Sbjct: 8   IAITHHVKEGHEKADPSQ-FEL--LKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKAT 64

Query: 54  -IEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DL-WHIIKF 110
                 +     R+I  L E+ HP ++ L   F +    K++L+ D+    DL   +   
Sbjct: 65  LKVRDRVRTKMERDI--LVEVNHPFIVKLHYAFQTEG--KLYLILDFLRGGDLFTRL--- 117

Query: 111 HRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVK 170
                   K VM  +  VK  L ++   + +LHS  +++RDLKP NIL+  E    G +K
Sbjct: 118 -------SKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE----GHIK 166

Query: 171 IADMGFARLFNNPLKPLADLDPVVVTF----WYRAPELLLGARHYTKAIDIWAIGCIFAE 226
           + D G +       K   D +    +F     Y APE++   R +T++ D W+ G +  E
Sbjct: 167 LTDFGLS-------KESIDHEKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFE 218

Query: 227 LLTSEPIFHCRQED 240
           +LT    F  +   
Sbjct: 219 MLTGTLPFQGKDRK 232

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 85.7 bits (213), Expect = 2e-19
 Identities = 55/238 (23%), Positives = 103/238 (43%), Gaps = 50/238 (21%)

Query: 21  DYEGCKV-GRGTYGHVYKARRKDNSDTRDYALK-----------QIEGTGLSMSACREIA 68
           D++  K+ G+GT+G V   R K     R YA+K           ++  T   ++   E  
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATG--RYYAMKILRKEVIIAKDEVAHT---VT---ESR 57

Query: 69  LLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DL-WHIIKFHRAAKANKKPVMVPKG 126
           +L+  +HP +  L   F +H+  ++  + +YA   +L +H+ +               + 
Sbjct: 58  VLQNTRHPFLTALKYAFQTHD--RLCFVMEYANGGELFFHLSRERV----------FTEE 105

Query: 127 MVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKP 186
             +    +I+  + YLHS  V++RD+K  N+++  +    G +KI D G         K 
Sbjct: 106 RARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD----GHIKITDFGLC-------KE 154

Query: 187 LADLDPVVVTF----WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
                  + TF     Y APE+L     Y +A+D W +G +  E++     F+ +  +
Sbjct: 155 GISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 211

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 84.7 bits (210), Expect = 4e-19
 Identities = 54/237 (22%), Positives = 79/237 (33%), Gaps = 37/237 (15%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDY-----ALKQIEGTGLSMSACREIALLRELKHPNVIN 80
            +G G +G V        +D         ALK   G        +EI +LR L H ++I 
Sbjct: 38  DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97

Query: 81  LISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGI 139
                       + L+ +Y     L   +  H           +    +     QI +G+
Sbjct: 98  YKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS----------IGLAQLLLFAQQICEGM 147

Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVT--- 196
            YLH+   +HRDL   N+L+         VKI D G A+            +   V    
Sbjct: 148 AYLHAQHYIHRDLAARNVLLD----NDRLVKIGDFGLAKAVPE------GHEYYRVREDG 197

Query: 197 ----FWYRAPELLLGARHYTKAIDIWAIGCIFAELLT--SEPIFHCRQEDIKTSNPY 247
               FWY APE L     +  A D+W+ G    ELLT          +         
Sbjct: 198 DSPVFWY-APECLK-EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ 252

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 84.6 bits (210), Expect = 6e-19
 Identities = 61/255 (23%), Positives = 103/255 (40%), Gaps = 52/255 (20%)

Query: 4   EFKIKTSNERTKVEDLFDYEGCKV-GRGTYGHVYKARRKDNSDTRDYALK---------- 52
           +F    + +R K+ D F++    V G+G++G V  + RK       YA+K          
Sbjct: 7   KFDNNGNRDRMKLTD-FNF--LMVLGKGSFGKVMLSERKGTD--ELYAVKILKKDVVIQD 61

Query: 53  -QIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DL-WHIIK 109
             +E         + + L    K P +  L S F      +++ + +Y    DL +HI  
Sbjct: 62  DDVE----CTMVEKRV-LALPGKPPFLTQLHSCF--QTMDRLYFVMEYVNGGDLMYHI-- 112

Query: 110 FHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRV 169
                   ++     +        +I  G+ +L S  +++RDLK  N+++  E    G +
Sbjct: 113 --------QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE----GHI 160

Query: 170 KIADMGFARLFNNPLKPLADLDPVVVTFW----YRAPELLLGARHYTKAIDIWAIGCIFA 225
           KIAD G         K          TF     Y APE++   + Y K++D WA G +  
Sbjct: 161 KIADFGMC-------KENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLY 212

Query: 226 ELLTSEPIFHCRQED 240
           E+L  +  F    ED
Sbjct: 213 EMLAGQAPFEGEDED 227

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 84.2 bits (209), Expect = 8e-19
 Identities = 59/250 (23%), Positives = 100/250 (40%), Gaps = 52/250 (20%)

Query: 9   TSNERTKVEDLFDYEGCKV-GRGTYGHVYKARRKDNSDTRDYALK-----------QIEG 56
            S+ R  +++ F++   +V G+G++G V  AR K+      YA+K            +E 
Sbjct: 15  NSSNRLGIDN-FEF--IRVLGKGSFGKVMLARVKETG--DLYAVKVLKKDVILQDDDVE- 68

Query: 57  TGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DL-WHIIKFHRAA 114
                   + I L     HP +  L   F      +++ + ++    DL +HI       
Sbjct: 69  ---CTMTEKRI-LSLARNHPFLTQLFCCF--QTPDRLFFVMEFVNGGDLMFHI------- 115

Query: 115 KANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM 174
              +K     +   +    +I+  + +LH   +++RDLK  N+L+  E    G  K+AD 
Sbjct: 116 ---QKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHE----GHCKLADF 168

Query: 175 GFARLFNNPLKPLADLDPVVVTF----WYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 230
           G  +                 TF     Y APE+L     Y  A+D WA+G +  E+L  
Sbjct: 169 GMCKEGICN-------GVTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCG 220

Query: 231 EPIFHCRQED 240
              F    ED
Sbjct: 221 HAPFEAENED 230

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 83.9 bits (208), Expect = 1e-18
 Identities = 59/257 (22%), Positives = 108/257 (42%), Gaps = 40/257 (15%)

Query: 1   MDYEFKIKTSNERTKVEDLFDYEGCKV-GRGTYGHVYKARRKDNSDT-RDYALKQIEGTG 58
           + +E +        +   + ++E  KV G G YG V+  R+    DT + YA+K ++   
Sbjct: 35  VKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKAT 94

Query: 59  L--------SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DL-WHII 108
           +             R++ L    + P ++ L   F +    K+ L+ DY    +L  H+ 
Sbjct: 95  IVQKAKTTEHTRTERQV-LEHIRQSPFLVTLHYAFQTET--KLHLILDYINGGELFTHL- 150

Query: 109 KFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGR 168
                     +     +  V+  + +I+  + +LH   +++RD+K  NIL+       G 
Sbjct: 151 ---------SQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN----GH 197

Query: 169 VKIADMGFARLFNNPLKPLADLDPVVVTFW----YRAPELLLGARH-YTKAIDIWAIGCI 223
           V + D G ++ F      +AD       F     Y AP+++ G    + KA+D W++G +
Sbjct: 198 VVLTDFGLSKEF------VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVL 251

Query: 224 FAELLTSEPIFHCRQED 240
             ELLT    F    E 
Sbjct: 252 MYELLTGASPFTVDGEK 268

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 81.5 bits (202), Expect = 4e-18
 Identities = 60/216 (27%), Positives = 90/216 (41%), Gaps = 28/216 (12%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC------REIALLRELKHPNVI 79
           K+G G    VY A   D       A+K I                RE+    +L H N++
Sbjct: 18  KLGGGGMSTVYLAE--DTILNIKVAIKAIF-IPPREKEETLKRFEREVHNSSQLSHQNIV 74

Query: 80  NLISVFLSHNDRKVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDG 138
           ++I V     D   +L+ +Y E   L   I+ H           +      +   QILDG
Sbjct: 75  SMIDV--DEEDDCYYLVMEYIEGPTLSEYIESHGP---------LSVDTAINFTNQILDG 123

Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           I + H   ++HRD+KP NIL+         +KI D G A+  +     L   + V+ T  
Sbjct: 124 IKHAHDMRIVHRDIKPQNILID----SNKTLKIFDFGIAKALSET--SLTQTNHVLGTVQ 177

Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           Y +PE   G     +  DI++IG +  E+L  EP F
Sbjct: 178 YFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPPF 212

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 82.9 bits (205), Expect = 4e-18
 Identities = 58/256 (22%), Positives = 109/256 (42%), Gaps = 54/256 (21%)

Query: 4   EFKIKTSNERTKVEDLFDYEGCKV-GRGTYGHVYKARRKDNSDTRDYALK---------- 52
           E  +     R  + + F+Y   K+ G+GT+G V   + K     R YA+K          
Sbjct: 135 EVSLAKPKHRVTMNE-FEY--LKLLGKGTFGKVILVKEKATG--RYYAMKILKKEVIVAK 189

Query: 53  -QIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DL-WHIIK 109
            ++  T   ++   E  +L+  +HP +  L   F +H+  ++  + +YA   +L +H+  
Sbjct: 190 DEVAHT---LT---ENRVLQNSRHPFLTALKYSFQTHD--RLCFVMEYANGGELFFHL-- 239

Query: 110 FHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHS-NWVLHRDLKPANILVMGEGIERGR 168
                    +  +  +   +    +I+  + YLHS   V++RDLK  N+++  +G     
Sbjct: 240 --------SRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG----H 287

Query: 169 VKIADMGFARLFNNPLKPLADLDPVVVTFW----YRAPELLLGARHYTKAIDIWAIGCIF 224
           +KI D G         K        + TF     Y APE+L     Y +A+D W +G + 
Sbjct: 288 IKITDFGLC-------KEGIKDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVM 339

Query: 225 AELLTSEPIFHCRQED 240
            E++     F+ +  +
Sbjct: 340 YEMMCGRLPFYNQDHE 355

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 81.9 bits (203), Expect = 4e-18
 Identities = 58/264 (21%), Positives = 103/264 (39%), Gaps = 52/264 (19%)

Query: 10  SNERTKVEDLFDYEGCKV-GRGTYGHVYKARRKDNSDTRDYALK-----------QIEGT 57
           + +   ++D FD    +V GRG+Y  V   R K     R YA+K            I+  
Sbjct: 2   AMDPLGLQD-FDL--LRVIGRGSYAKVLLVRLKKTD--RIYAMKVVKKELVNDDEDID-- 54

Query: 58  GLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DL-WHIIKFHRAAK 115
              +   + +   +   HP ++ L S F    + +++ + +Y    DL +H+        
Sbjct: 55  --WVQTEKHV-FEQASNHPFLVGLHSCF--QTESRLFFVIEYVNGGDLMFHM-------- 101

Query: 116 ANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMG 175
             ++   +P+   +    +I   ++YLH   +++RDLK  N+L+  E    G +K+ D G
Sbjct: 102 --QRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE----GHIKLTDYG 155

Query: 176 FARLFNNPLKPLADLDPVVVTF----WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 231
             +    P            TF     Y APE+L G   Y  ++D WA+G +  E++   
Sbjct: 156 MCKEGLRP-------GDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGR 207

Query: 232 PIFHCRQEDIKTSNPYHHDQLDRI 255
             F                    I
Sbjct: 208 SPFDIVGSSDNPDQNTEDYLFQVI 231

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 82.0 bits (203), Expect = 6e-18
 Identities = 57/266 (21%), Positives = 103/266 (38%), Gaps = 52/266 (19%)

Query: 8   KTSNERTKVEDLFDYEGCKV-GRGTYGHVYKARRKDNSDTRDYALK-----------QIE 55
             ++    ++D FD    +V GRG+Y  V   R K     R YA++            I+
Sbjct: 43  GKASSSLGLQD-FDL--LRVIGRGSYAKVLLVRLKKTD--RIYAMRVVKKELVNDDEDID 97

Query: 56  GTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DL-WHIIKFHRA 113
                +   + +   +   HP ++ L S F    + +++ + +Y    DL +H+      
Sbjct: 98  ----WVQTEKHV-FEQASNHPFLVGLHSCF--QTESRLFFVIEYVNGGDLMFHM------ 144

Query: 114 AKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIAD 173
               ++   +P+   +    +I   ++YLH   +++RDLK  N+L+  E    G +K+ D
Sbjct: 145 ----QRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE----GHIKLTD 196

Query: 174 MGFARLFNNPLKPLADLDPVVVTF----WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
            G  +    P            TF     Y APE+L G   Y  ++D WA+G +  E++ 
Sbjct: 197 YGMCKEGLRP-------GDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMA 248

Query: 230 SEPIFHCRQEDIKTSNPYHHDQLDRI 255
               F                    I
Sbjct: 249 GRSPFDIVGSSDNPDQNTEDYLFQVI 274

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 80.8 bits (200), Expect = 9e-18
 Identities = 55/226 (24%), Positives = 92/226 (40%), Gaps = 33/226 (14%)

Query: 22  YE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC------REIALLRELK 74
           YE G  +G G    V+ AR  D  D RD A+K +    L+          RE      L 
Sbjct: 14  YELGEILGFGGMSEVHLAR--DLRDHRDVAVK-VLRADLARDPSFYLRFRREAQNAAALN 70

Query: 75  HPNVINLISVF-----LSHNDRKVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMV 128
           HP ++    V+      +      +++ +Y +   L  I+              +     
Sbjct: 71  HPAIVA---VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---------MTPKRA 118

Query: 129 KSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLA 188
             ++      +++ H N ++HRD+KPANI++         VK+ D G AR   +    + 
Sbjct: 119 IEVIADACQALNFSHQNGIIHRDVKPANIMIS----ATNAVKVMDFGIARAIADSGNSVT 174

Query: 189 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
               V+ T  Y +PE   G        D++++GC+  E+LT EP F
Sbjct: 175 QTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPF 219

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 79.5 bits (196), Expect = 6e-17
 Identities = 52/208 (25%), Positives = 89/208 (42%), Gaps = 26/208 (12%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI-EGTGLSMSACREIALLRELKHPNVINLISV 84
           K+G+G +G V+       +     A+K +  GT    +  +E  ++++L+H  ++ L +V
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRV---AIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330

Query: 85  FLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLH 143
                +  ++++ +Y     L   + F +        +     M      QI  G+ Y+ 
Sbjct: 331 VS---EEPIYIVTEYMSKGSL---LDFLKGETGKYLRLPQLVDM----AAQIASGMAYVE 380

Query: 144 SNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNP--LKPLADLDPVVVTFWYRA 201
               +HRDL+ ANILV     E    K+AD G ARL  +           P+    W  A
Sbjct: 381 RMNYVHRDLRAANILVG----ENLVCKVADFGLARLIEDNEYTARQGAKFPI---KWT-A 432

Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
           PE  L    +T   D+W+ G +  EL T
Sbjct: 433 PEAAL-YGRFTIKSDVWSFGILLTELTT 459

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 76.9 bits (190), Expect = 2e-16
 Identities = 35/222 (15%), Positives = 84/222 (37%), Gaps = 41/222 (18%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDY-----ALKQIEGTGLSMSA--CREIALLRELKHPNV 78
            +G+GT+  ++K  R++  D          LK ++    + S       +++ +L H ++
Sbjct: 15  SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74

Query: 79  INLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILD 137
           +    V +     +  L+ ++ +   L     + +      K  +     ++ +  Q+  
Sbjct: 75  VLNYGVCV--CGDENILVQEFVKFGSL---DTYLK----KNKNCINILWKLE-VAKQLAA 124

Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGI----ERGRVKIADMGFARLFNN------PLKPL 187
            +H+L  N ++H ++   NIL++ E          +K++D G +            +   
Sbjct: 125 AMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP-- 182

Query: 188 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                     W   PE +   ++   A D W+ G    E+ +
Sbjct: 183 ----------WV-PPECIENPKNLNLATDKWSFGTTLWEICS 213

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 77.3 bits (191), Expect = 2e-16
 Identities = 53/224 (23%), Positives = 86/224 (38%), Gaps = 47/224 (20%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDY--ALKQI-EGTGLSMSA--CREIALLRELKHPNV 78
              +G G +G VYK       +      A+K++ E T    +     E  ++  + +P+V
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 79  INLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILD 137
             L+ + L+     V L+        L   ++ H+          +    + +   QI  
Sbjct: 80  CRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDN--------IGSQYLLNWCVQIAK 128

Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN------------PLK 185
           G++YL    ++HRDL   N+LV         VKI D G A+L               P+K
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVK----TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184

Query: 186 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                       W  A E +L  R YT   D+W+ G    EL+T
Sbjct: 185 ------------WM-ALESIL-HRIYTHQSDVWSYGVTVWELMT 214

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 77.0 bits (190), Expect = 2e-16
 Identities = 55/228 (24%), Positives = 95/228 (41%), Gaps = 43/228 (18%)

Query: 24  GCKVGRGTYGHVYKAR-RKDNSDTRDYALKQIEGTGLSMSAC----REIALLRELKHPNV 78
           G  +G+G +G V +A+ ++++      A+K ++   ++ S      RE A ++E  HP+V
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 79  INLISVFL----SHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLY 133
             L+ V L            ++  + +H DL     F  A++  + P  +P   +   + 
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDL---HAFLLASRIGENPFNLPLQTLVRFMV 144

Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN----------- 182
            I  G+ YL S   +HRDL   N ++  +      V +AD G +R   +           
Sbjct: 145 DIACGMEYLSSRNFIHRDLAARNCMLAEDMT----VCVADFGLSRKIYSGDYYRQGCASK 200

Query: 183 -PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
            P+K            W  A E L     YT   D+WA G    E++T
Sbjct: 201 LPVK------------WL-ALESLA-DNLYTVHSDVWAFGVTMWEIMT 234

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 76.6 bits (189), Expect = 3e-16
 Identities = 47/224 (20%), Positives = 84/224 (37%), Gaps = 47/224 (20%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDY--ALKQIEGTGLSMSAC---REIALLRELKHPNV 78
              +G G +G V+K       ++      +K IE      S       +  +  L H ++
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 79  INLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILD 137
           + L+ +        + L+  Y     L   ++ HR A        +   ++ +   QI  
Sbjct: 78  VRLLGLCP---GSSLQLVTQYLPLGSLLDHVRQHRGA--------LGPQLLLNWGVQIAK 126

Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN------------PLK 185
           G++YL  + ++HR+L   N+L+        +V++AD G A L               P+K
Sbjct: 127 GMYYLEEHGMVHRNLAARNVLLK----SPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK 182

Query: 186 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                       W  A E +     YT   D+W+ G    EL+T
Sbjct: 183 ------------WM-ALESIH-FGKYTHQSDVWSYGVTVWELMT 212

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 76.2 bits (188), Expect = 4e-16
 Identities = 54/230 (23%), Positives = 92/230 (40%), Gaps = 48/230 (20%)

Query: 24  GCKVGRGTYGHVYKAR-RKDNSDTRDYALKQIEGTGLSMSAC----REIALLRELKHPNV 78
           G  +G G +G V +   ++++  +   A+K ++    S         E A +++  HPNV
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 79  INLISVFL---SHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLL-- 132
           I L+ V +   S    K  ++  + ++ DL   + + R     K   +      ++LL  
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPL------QTLLKF 152

Query: 133 -YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN--------- 182
              I  G+ YL +   LHRDL   N ++  +      V +AD G ++   +         
Sbjct: 153 MVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT----VCVADFGLSKKIYSGDYYRQGRI 208

Query: 183 ---PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
              P+K            W  A E L   R YT   D+WA G    E+ T
Sbjct: 209 AKMPVK------------WI-AIESLA-DRVYTSKSDVWAFGVTMWEIAT 244

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 75.8 bits (187), Expect = 5e-16
 Identities = 60/212 (28%), Positives = 89/212 (41%), Gaps = 27/212 (12%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQI-EGTGLSMSA--CREIALLREL-KHPNVI 79
              +G G +G V KAR K +    D A+K++ E            E+ +L +L  HPN+I
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 80  NLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGM----VKSLL-- 132
           NL+      +   ++L  +YA H +L   ++  R  + +    +          + LL  
Sbjct: 90  NLLGA--CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147

Query: 133 -YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLD 191
              +  G+ YL     +HRDL   NILV GE       KIAD G +R     +K      
Sbjct: 148 AADVARGMDYLSQKQFIHRDLAARNILV-GENYV---AKIADFGLSRGQEVYVKKTMGRL 203

Query: 192 PVVVTFWYR--APELLLGARHYTKAIDIWAIG 221
           PV      R  A E L     YT   D+W+ G
Sbjct: 204 PV------RWMAIESLN-YSVYTTNSDVWSYG 228

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 76.8 bits (189), Expect = 6e-16
 Identities = 50/211 (23%), Positives = 86/211 (40%), Gaps = 27/211 (12%)

Query: 26  KVGRGTYGHVYKAR-RKDNSDTRDYALKQI-EGTGLSMSA--CREIALLRELKHPNVINL 81
            +G G +G V++       +     A+K     T  S+     +E   +R+  HP+++ L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456

Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIH 140
           I V   +    VW++ +     +L     F +     +K  +    ++    YQ+   + 
Sbjct: 457 IGVITENP---VWIIMELCTLGEL---RSFLQ----VRKFSLDLASLI-LYAYQLSTALA 505

Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPL--KPLADLDPVVVTFW 198
           YL S   +HRD+   N+LV         VK+ D G +R   +    K      P+    W
Sbjct: 506 YLESKRFVHRDIAARNVLVS----SNDCVKLGDFGLSRYMEDSTYYKASKGKLPI---KW 558

Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
             APE +   R +T A D+W  G    E+L 
Sbjct: 559 M-APESIN-FRRFTSASDVWMFGVCMWEILM 587

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 75.4 bits (186), Expect = 6e-16
 Identities = 46/228 (20%), Positives = 88/228 (38%), Gaps = 54/228 (23%)

Query: 23  EGCKVGRGTYGHVYKARRKDNSDTRDYALKQI-EGTGLSMSACREIALLRE------LKH 75
           E  ++G G +G V K   +     +  A+K +            +  LL E      L +
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA---NDPALKDELLAEANVMQQLDN 77

Query: 76  PNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQ 134
           P ++ +I +  +       L+ + AE   L    K+ +  +  K   ++       L++Q
Sbjct: 78  PYIVRMIGICEAE---SWMLVMEMAELGPL---NKYLQQNRHVKDKNII------ELVHQ 125

Query: 135 ILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN------------ 182
           +  G+ YL  +  +HRDL   N+L++     +   KI+D G ++                
Sbjct: 126 VSMGMKYLEESNFVHRDLAARNVLLV----TQHYAKISDFGLSKALRADENYYKAQTHGK 181

Query: 183 -PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
            P+K            WY APE +     ++   D+W+ G +  E  +
Sbjct: 182 WPVK------------WY-APECIN-YYKFSSKSDVWSFGVLMWEAFS 215

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 75.9 bits (187), Expect = 9e-16
 Identities = 52/208 (25%), Positives = 89/208 (42%), Gaps = 26/208 (12%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI-EGTGLSMSACREIALLRELKHPNVINLISV 84
           K+G+G +G V+       +     A+K +  GT    +  +E  ++++L+H  ++ L +V
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRV---AIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247

Query: 85  FLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLH 143
                +  ++++ +Y     L   + F +        +     M      QI  G+ Y+ 
Sbjct: 248 VS---EEPIYIVTEYMSKGSL---LDFLKGETGKYLRLPQLVDM----AAQIASGMAYVE 297

Query: 144 SNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNP--LKPLADLDPVVVTFWYRA 201
               +HRDL+ ANILV     E    K+AD G ARL  +           P+    W  A
Sbjct: 298 RMNYVHRDLRAANILVG----ENLVCKVADFGLARLIEDNEYTARQGAKFPI---KWT-A 349

Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
           PE  L    +T   D+W+ G +  EL T
Sbjct: 350 PEAAL-YGRFTIKSDVWSFGILLTELTT 376

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 75.0 bits (185), Expect = 9e-16
 Identities = 55/235 (23%), Positives = 86/235 (36%), Gaps = 49/235 (20%)

Query: 24  GCKVGRGTYGHVYKARRKD---NSDTRDYALKQI-EGTGLSMSA--CREIALLREL-KHP 76
           G  +G G +G V +A       +      A+K +     L+       E+ +L  L  H 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 77  NVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLL--- 132
           N++NL+            ++ +Y  + DL + ++  R +    K         +  L   
Sbjct: 88  NIVNLLGA--CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145

Query: 133 ------YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN---- 182
                 YQ+  G+ +L S   +HRDL   NIL+   G      KI D G AR   N    
Sbjct: 146 DLLSFSYQVAKGMAFLASKNCIHRDLAARNILL-THG---RITKICDFGLARDIKNDSNY 201

Query: 183 --------PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                   P+K            W  APE +     YT   D+W+ G    EL +
Sbjct: 202 VVKGNARLPVK------------WM-APESIFN-CVYTFESDVWSYGIFLWELFS 242

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 76.0 bits (187), Expect = 9e-16
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 24/210 (11%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLI 82
             K+G G YG VY+   K    +   A+K ++   + +    +E A+++E+KHPN++ L+
Sbjct: 225 KHKLGGGQYGEVYEGVWKKY--SLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 282

Query: 83  SVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHY 141
            V     +   +++ ++  + +L   + + R     +   +V   M      QI   + Y
Sbjct: 283 GVCT--REPPFYIITEFMTYGNL---LDYLRECNRQEVSAVVLLYM----ATQISSAMEY 333

Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPL--KPLADLDPVVVTFWY 199
           L     +HR+L   N LV     E   VK+AD G +RL              P+    W 
Sbjct: 334 LEKKNFIHRNLAARNCLVG----ENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWT 386

Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLT 229
            APE L     ++   D+WA G +  E+ T
Sbjct: 387 -APESLA-YNKFSIKSDVWAFGVLLWEIAT 414

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 74.6 bits (184), Expect = 1e-15
 Identities = 42/214 (19%), Positives = 92/214 (42%), Gaps = 38/214 (17%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLIS 83
              +G+G +G V     + N      A+K I+    + +   E +++ +L+H N++ L+ 
Sbjct: 26  LQTIGKGEFGDVMLGDYRGN----KVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLG 81

Query: 84  VFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYL 142
           V +      ++++ +Y     L   + + R+     + V+    ++      + + + YL
Sbjct: 82  V-IVEEKGGLYIVTEYMAKGSL---VDYLRS---RGRSVLGGDCLL-KFSLDVCEAMEYL 133

Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN-------PLKPLADLDPVVV 195
             N  +HRDL   N+LV  + +     K++D G  +  ++       P+K          
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNV----AKVSDFGLTKEASSTQDTGKLPVK---------- 179

Query: 196 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
             W  APE L   + ++   D+W+ G +  E+ +
Sbjct: 180 --WT-APEALR-EKKFSTKSDVWSFGILLWEIYS 209

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 74.2 bits (183), Expect = 1e-15
 Identities = 49/215 (22%), Positives = 90/215 (41%), Gaps = 30/215 (13%)

Query: 26  KVGRGTYGHVYKAR-RKDNSDTRDYALKQI-EGTGLSMSA--CREIALLRELKHPNVINL 81
            +GRG +G VY      ++      A+K +   T +   +    E  ++++  HPNV++L
Sbjct: 32  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91

Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIH 140
           + +    ++    ++  Y +H DL + I+               K ++     Q+  G+ 
Sbjct: 92  LGI-CLRSEGSPLVVLPYMKHGDLRNFIRNET-------HNPTVKDLI-GFGLQVAKGMK 142

Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YL S   +HRDL   N ++  +      VK+AD G AR   +      +   V      +
Sbjct: 143 YLASKKFVHRDLAARNCMLDEKFT----VKVADFGLARDMYD-----KEYYSVHNKTGAK 193

Query: 201 ------APELLLGARHYTKAIDIWAIGCIFAELLT 229
                 A E L   + +T   D+W+ G +  EL+T
Sbjct: 194 LPVKWMALESLQ-TQKFTTKSDVWSFGVLLWELMT 227

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 74.6 bits (184), Expect = 1e-15
 Identities = 57/233 (24%), Positives = 93/233 (39%), Gaps = 46/233 (19%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDY---ALKQI-EGTGLSMSA--CREIALLREL-KHP 76
           G  +GRG +G V +A       T      A+K + EG   S       E+ +L  +  H 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91

Query: 77  NVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGM----VKSL 131
           NV+NL+    +     + ++ ++ +  +L   ++  R      K            ++ L
Sbjct: 92  NVVNLLGA-CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150

Query: 132 L---YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN------ 182
           +   +Q+  G+ +L S   +HRDL   NIL+     E+  VKI D G AR          
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILLS----EKNVVKICDFGLARDIYKDPDYVR 206

Query: 183 ------PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                 PLK            W  APE +   R YT   D+W+ G +  E+ +
Sbjct: 207 KGDARLPLK------------WM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 245

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 74.2 bits (183), Expect = 2e-15
 Identities = 58/217 (26%), Positives = 86/217 (39%), Gaps = 34/217 (15%)

Query: 26  KVGRGTYGHVYKAR-RKDNSDTRDYALKQI-EGTGLSMSA--CREIALLRELKHPNVINL 81
            +G+G +G VY         +    A+K +   T +       RE  L+R L HPNV+ L
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87

Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLL---YQILD 137
           I + +   +    +L  Y  H DL   I+  +               VK L+    Q+  
Sbjct: 88  IGI-MLPPEGLPHVLLPYMCHGDLLQFIRSPQ-----------RNPTVKDLISFGLQVAR 135

Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN-----PLKPLADLDP 192
           G+ YL     +HRDL   N ++         VK+AD G AR   +       +      P
Sbjct: 136 GMEYLAEQKFVHRDLAARNCMLDESFT----VKVADFGLARDILDREYYSVQQHRHARLP 191

Query: 193 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
           V    W  A E L     +T   D+W+ G +  ELLT
Sbjct: 192 VK---WT-ALESLQ-TYRFTTKSDVWSFGVLLWELLT 223

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 74.2 bits (183), Expect = 2e-15
 Identities = 55/219 (25%), Positives = 91/219 (41%), Gaps = 42/219 (19%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQI-EGTGLSMSACREIALLRELKHPNVINLI 82
             K+G G YG VY+        +   A+K + E T       +E A+++E+KHPN++ L+
Sbjct: 18  KHKLGGGQYGEVYEG--VWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75

Query: 83  SVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHY 141
            V     +   +++ ++  + +L   + + R     +   +V   M      QI   + Y
Sbjct: 76  GVCT--REPPFYIITEFMTYGNL---LDYLRECNRQEVSAVVLLYM----ATQISSAMEY 126

Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN-----------PLKPLADL 190
           L     +HRDL   N LV    +    VK+AD G +RL              P+K     
Sbjct: 127 LEKKNFIHRDLAARNCLVGENHL----VKVADFGLSRLMTGDTYTAHAGAKFPIK----- 177

Query: 191 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                  W  APE L     ++   D+WA G +  E+ T
Sbjct: 178 -------WT-APESLA-YNKFSIKSDVWAFGVLLWEIAT 207

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 75.4 bits (185), Expect = 2e-15
 Identities = 50/223 (22%), Positives = 87/223 (39%), Gaps = 46/223 (20%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC---REIALLRELKHPNVIN 80
             ++G G +G V +   +      D A+K ++            RE  ++ +L +P ++ 
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400

Query: 81  LISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGI 139
           LI V  +     + L+ + A    L   +   R          +P   V  LL+Q+  G+
Sbjct: 401 LIGVCQAEA---LMLVMEMAGGGPLHKFLVGKREE--------IPVSNVAELLHQVSMGM 449

Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN-------------PLKP 186
            YL     +HR+L   N+L+    + R   KI+D G ++                 PLK 
Sbjct: 450 KYLEEKNFVHRNLAARNVLL----VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK- 504

Query: 187 LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                      WY APE +   R ++   D+W+ G    E L+
Sbjct: 505 -----------WY-APECIN-FRKFSSRSDVWSYGVTMWEALS 534

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 73.8 bits (182), Expect = 2e-15
 Identities = 51/222 (22%), Positives = 87/222 (39%), Gaps = 46/222 (20%)

Query: 25  CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC---REIALLRELKHPNVINL 81
            ++G G +G V +   +      D A+K ++            RE  ++ +L +P ++ L
Sbjct: 16  IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75

Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIH 140
           I V  +     + L+ + A    L   +   R          +P   V  LL+Q+  G+ 
Sbjct: 76  IGVCQAE---ALMLVMEMAGGGPLHKFLVGKREE--------IPVSNVAELLHQVSMGMK 124

Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN-------------PLKPL 187
           YL     +HRDL   N+L++     R   KI+D G ++                 PLK  
Sbjct: 125 YLEEKNFVHRDLAARNVLLV----NRHYAKISDFGLSKALGADDSYYTARSAGKWPLK-- 178

Query: 188 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                     WY APE +   R ++   D+W+ G    E L+
Sbjct: 179 ----------WY-APECIN-FRKFSSRSDVWSYGVTMWEALS 208

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 74.4 bits (183), Expect = 2e-15
 Identities = 50/215 (23%), Positives = 91/215 (42%), Gaps = 30/215 (13%)

Query: 26  KVGRGTYGHVYKARRKD-NSDTRDYALKQI-EGTGLSMSA--CREIALLRELKHPNVINL 81
            +GRG +G VY     D +      A+K +   T +   +    E  ++++  HPNV++L
Sbjct: 96  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155

Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIH 140
           + +    ++    ++  Y +H DL + I+               K ++     Q+  G+ 
Sbjct: 156 LGI-CLRSEGSPLVVLPYMKHGDLRNFIRNET-------HNPTVKDLI-GFGLQVAKGMK 206

Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           +L S   +HRDL   N ++  +      VK+AD G AR   +      + D V      +
Sbjct: 207 FLASKKFVHRDLAARNCMLDEKFT----VKVADFGLARDMYD-----KEFDSVHNKTGAK 257

Query: 201 ------APELLLGARHYTKAIDIWAIGCIFAELLT 229
                 A E L   + +T   D+W+ G +  EL+T
Sbjct: 258 LPVKWMALESLQ-TQKFTTKSDVWSFGVLLWELMT 291

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 73.9 bits (182), Expect = 3e-15
 Identities = 57/222 (25%), Positives = 96/222 (43%), Gaps = 32/222 (14%)

Query: 24  GCKVGRGTYGHVYKAR----RKDNSDTRDYALKQI-EGTGLSMSA--CREIALLRELKHP 76
             ++G+G++G VY+       KD  +TR  A+K + E   +        E ++++E    
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASVMKEFNCH 88

Query: 77  NVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLL--- 132
           +V+ L+ V      +   ++ +     DL   ++  R A AN   +  P   +  ++   
Sbjct: 89  HVVRLLGV--VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS--LSKMIQMA 144

Query: 133 YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNP---LKPLAD 189
            +I DG+ YL++N  +HRDL   N +V  E      VKI D G  R         K    
Sbjct: 145 GEIADGMAYLNANKFVHRDLAARNCMV-AEDFT---VKIGDFGMTRDIYETDYYRKGGKG 200

Query: 190 LDPVVVTFWYR--APELLLGARHYTKAIDIWAIGCIFAELLT 229
           L PV      R  +PE L     +T   D+W+ G +  E+ T
Sbjct: 201 LLPV------RWMSPESLK-DGVFTTYSDVWSFGVVLWEIAT 235

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 73.5 bits (181), Expect = 4e-15
 Identities = 53/222 (23%), Positives = 86/222 (38%), Gaps = 47/222 (21%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDY--ALKQI-EGTGLSMSA--CREIALLRELKHPNVIN 80
            +G G +G VYK       +      A+K++ E T    +     E  ++  + +P+V  
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81

Query: 81  LISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGI 139
           L+ + L+     V L+        L   ++ H+          +    + +   QI  G+
Sbjct: 82  LLGICLTS---TVQLITQLMPFGCLLDYVREHKDN--------IGSQYLLNWCVQIAKGM 130

Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN------------PLKPL 187
           +YL    ++HRDL   N+LV         VKI D G A+L               P+K  
Sbjct: 131 NYLEDRRLVHRDLAARNVLVK----TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK-- 184

Query: 188 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                     W  A E +L  R YT   D+W+ G    EL+T
Sbjct: 185 ----------WM-ALESIL-HRIYTHQSDVWSYGVTVWELMT 214

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 73.9 bits (182), Expect = 4e-15
 Identities = 42/214 (19%), Positives = 90/214 (42%), Gaps = 38/214 (17%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLIS 83
              +G+G +G V     + N      A+K I+    + +   E +++ +L+H N++ L+ 
Sbjct: 198 LQTIGKGEFGDVMLGDYRGN----KVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLG 253

Query: 84  VFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYL 142
           V +      ++++ +Y     L   + + R    ++   ++    +      + + + YL
Sbjct: 254 V-IVEEKGGLYIVTEYMAKGSL---VDYLR----SRGRSVLGGDCLLKFSLDVCEAMEYL 305

Query: 143 HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN-------PLKPLADLDPVVV 195
             N  +HRDL   N+LV     E    K++D G  +  ++       P+K          
Sbjct: 306 EGNNFVHRDLAARNVLVS----EDNVAKVSDFGLTKEASSTQDTGKLPVK---------- 351

Query: 196 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
             W  APE L   + ++   D+W+ G +  E+ +
Sbjct: 352 --WT-APEALR-EKKFSTKSDVWSFGILLWEIYS 381

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 72.3 bits (178), Expect = 6e-15
 Identities = 48/220 (21%), Positives = 85/220 (38%), Gaps = 45/220 (20%)

Query: 26  KVGRGTYGHVYKAR-RKDNSDTRDYALKQI-EGTGLSMSA--CREIALLRELKHPNVINL 81
            +G G +G V++       +     A+K     T  S+     +E   +R+  HP+++ L
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIH 140
           I V   +    VW++ +     +L   ++  +         +    ++    YQ+   + 
Sbjct: 82  IGVITEN---PVWIIMELCTLGELRSFLQVRK-------YSLDLASLI-LYAYQLSTALA 130

Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN-----------PLKPLAD 189
           YL S   +HRD+   N+LV         VK+ D G +R   +           P+K    
Sbjct: 131 YLESKRFVHRDIAARNVLVSSNDC----VKLGDFGLSRYMEDSTYYKASKGKLPIK---- 182

Query: 190 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                   W  APE +   R +T A D+W  G    E+L 
Sbjct: 183 --------WM-APESIN-FRRFTSASDVWMFGVCMWEILM 212

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 73.2 bits (180), Expect = 6e-15
 Identities = 52/216 (24%), Positives = 88/216 (40%), Gaps = 34/216 (15%)

Query: 26  KVGRGTYGHVYKAR-RKDNSDTRDYALKQI-EGTGLSMSAC--REIALLRELKHPNVINL 81
            VG G +G V   R +  +      A+K +  G           E +++ +  HPN+I L
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111

Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIH 140
             V      + V ++ +Y E+  L   ++ H          +V  GM    L  I  G+ 
Sbjct: 112 EGVVT--KSKPVMIVTEYMENGSLDSFLRKHD--AQFTVIQLV--GM----LRGIASGMK 161

Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF--- 197
           YL     +HRDL   NIL+    +     K++D G  R+  +      D +    T    
Sbjct: 162 YLSDMGYVHRDLAARNILINSNLV----CKVSDFGLGRVLED------DPEAAYTTRGGK 211

Query: 198 ----WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
               W  +PE +   R +T A D+W+ G +  E+++
Sbjct: 212 IPIRWT-SPEAIA-YRKFTSASDVWSYGIVLWEVMS 245

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 72.3 bits (178), Expect = 7e-15
 Identities = 53/224 (23%), Positives = 81/224 (36%), Gaps = 49/224 (21%)

Query: 26  KVGRGTYGHVYKAR-RKDNSDTRDYALKQI-EGTGLSMSAC----REIALLRELKHPNVI 79
           K+G G++G V +      +  T   A+K +         A     RE+  +  L H N+I
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 80  NLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDG 138
            L  V L+     + ++ + A    L   ++ H+             G +     Q+ +G
Sbjct: 85  RLYGVVLTP---PMKMVTELAPLGSLLDRLRKHQG--------HFLLGTLSRYAVQVAEG 133

Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN-------------PLK 185
           + YL S   +HRDL   N+L+      R  VKI D G  R                 P  
Sbjct: 134 MGYLESKRFIHRDLAARNLLLA----TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 189

Query: 186 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                       W  APE L   R ++ A D W  G    E+ T
Sbjct: 190 ------------WC-APESLK-TRTFSHASDTWMFGVTLWEMFT 219

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 71.5 bits (176), Expect = 1e-14
 Identities = 48/223 (21%), Positives = 86/223 (38%), Gaps = 51/223 (22%)

Query: 26  KVGRGTYGHVYKAR-RKDNSDTRDYALKQI-EGTGLSMSA--CREIALLRELKHPNVINL 81
            +G G +G VY+        +  + A+K   +   L        E  +++ L HP+++ L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78

Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLL---YQILD 137
           I +         W++ +   + +L H ++ ++               V +L+    QI  
Sbjct: 79  IGIIEEEP---TWIIMELYPYGELGHYLERNK-----------NSLKVLTLVLYSLQICK 124

Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN-----------PLKP 186
            + YL S   +HRD+   NILV         VK+ D G +R   +           P+K 
Sbjct: 125 AMAYLESINCVHRDIAVRNILVA----SPECVKLGDFGLSRYIEDEDYYKASVTRLPIK- 179

Query: 187 LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                      W  +PE +   R +T A D+W       E+L+
Sbjct: 180 -----------WM-SPESIN-FRRFTTASDVWMFAVCMWEILS 209

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 71.9 bits (177), Expect = 1e-14
 Identities = 51/216 (23%), Positives = 84/216 (38%), Gaps = 34/216 (15%)

Query: 26  KVGRGTYGHVYKAR-RKDNSDTRDYALKQI-EGTGLSMSAC--REIALLRELKHPNVINL 81
            +G G  G V   R R         A+K +  G           E +++ +  HPN+I L
Sbjct: 56  IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115

Query: 82  ISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIH 140
             V      R   ++ +Y E+  L   ++ H          +V       +L  +  G+ 
Sbjct: 116 EGVVT--RGRLAMIVTEYMENGSLDTFLRTHD--GQFTIMQLV------GMLRGVGAGMR 165

Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF--- 197
           YL     +HRDL   N+LV    +     K++D G +R+  +      D D    T    
Sbjct: 166 YLSDLGYVHRDLAARNVLVDSNLV----CKVSDFGLSRVLED------DPDAAYTTTGGK 215

Query: 198 ----WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
               W  APE +   R ++ A D+W+ G +  E+L 
Sbjct: 216 IPIRWT-APEAIA-FRTFSSASDVWSFGVVMWEVLA 249

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 72.0 bits (177), Expect = 1e-14
 Identities = 44/223 (19%), Positives = 79/223 (35%), Gaps = 38/223 (17%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDY---ALKQI-EGTGLSMSA--CREIALLRELKHPNVI 79
            +G G +G VY+ +     +       A+K + E            E  ++ +  H N++
Sbjct: 37  GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96

Query: 80  NLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDG 138
             I V  S      ++L +     DL   ++  R  + ++   +    ++  +   I  G
Sbjct: 97  RCIGV--SLQSLPRFILMELMAGGDLKSFLRETRP-RPSQPSSLAMLDLL-HVARDIACG 152

Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
             YL  N  +HRD+   N L+   G      KI D G AR        +          +
Sbjct: 153 CQYLEENHFIHRDIAARNCLLTCPG-PGRVAKIGDFGMAR-------DIYRAS------Y 198

Query: 199 YR------------APELLLGARHYTKAIDIWAIGCIFAELLT 229
           YR             PE  +    +T   D W+ G +  E+ +
Sbjct: 199 YRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFS 240

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 71.1 bits (175), Expect = 1e-14
 Identities = 48/219 (21%), Positives = 90/219 (41%), Gaps = 44/219 (20%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQI-EGTGLSMSACREIALLRELKHPNVINLI 82
             ++G G +G V   + K   D    A+K I EG+       +E   + +L HP ++   
Sbjct: 13  LKELGSGQFGVVKLGKWKGQYDV---AVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFY 69

Query: 83  SVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHY 141
            V     +  ++++ +Y  +  L + ++ H   K  +   ++       + Y + +G+ +
Sbjct: 70  GVCS--KEYPIYIVTEYISNGCLLNYLRSHG--KGLEPSQLL------EMCYDVCEGMAF 119

Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN-----------PLKPLADL 190
           L S+  +HRDL   N LV  +      VK++D G  R   +           P+K     
Sbjct: 120 LESHQFIHRDLAARNCLVDRDLC----VKVSDFGMTRYVLDDQYVSSVGTKFPVK----- 170

Query: 191 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                  W  APE+      Y+   D+WA G +  E+ +
Sbjct: 171 -------WS-APEVFH-YFKYSSKSDVWAFGILMWEVFS 200

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 71.6 bits (176), Expect = 2e-14
 Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 35/217 (16%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDY--ALKQI-EGTGLSMSAC--REIALLRELKHPNVIN 80
            +G G +G VYK   K +S  ++   A+K +  G           E  ++ +  H N+I 
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110

Query: 81  LISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGI 139
           L  V      + + ++ +Y E+  L    KF R     K        +V  +L  I  G+
Sbjct: 111 LEGVISK--YKPMMIITEYMENGAL---DKFLR----EKDGEFSVLQLV-GMLRGIAAGM 160

Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF-- 197
            YL +   +HRDL   NILV    +     K++D G +R+  +      D +    T   
Sbjct: 161 KYLANMNYVHRDLAARNILVNSNLV----CKVSDFGLSRVLED------DPEATYTTSGG 210

Query: 198 -----WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                W  APE +   R +T A D+W+ G +  E++T
Sbjct: 211 KIPIRWT-APEAIS-YRKFTSASDVWSFGIVMWEVMT 245

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 70.9 bits (174), Expect = 2e-14
 Identities = 29/240 (12%), Positives = 54/240 (22%), Gaps = 72/240 (30%)

Query: 26  KVGRGTYGHVYKARRKDNSDT---RDYALKQIEGTGLSMSACREIALLRE------LKHP 76
             G       ++A      DT   R  AL  ++     +        L        +  P
Sbjct: 38  FHGGVPPLQFWQAL-----DTALDRQVALTFVD-PQGVLPDDVLQETLSRTLRLSRIDKP 91

Query: 77  NVINLISVFLSHNDRKVWLLFDYAE-HDLWHIIKF----HRAAKANKKPVMVPKGMVKSL 131
            V  ++ V +        ++ ++     L  +         A +A               
Sbjct: 92  GVARVLDV-VHTRAG-GLVVAEWIRGGSLQEVADTSPSPVGAIRA--------------- 134

Query: 132 LYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLD 191
           +  +       H   V      P+ + V  +    G V +A              + D +
Sbjct: 135 MQSLAAAADAAHRAGVALSIDHPSRVRVSID----GDVVLAYPAT----------MPDAN 180

Query: 192 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 251
           P                       DI  IG     LL +             +       
Sbjct: 181 P---------------------QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTA 219

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 70.7 bits (174), Expect = 2e-14
 Identities = 51/219 (23%), Positives = 93/219 (42%), Gaps = 44/219 (20%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQI-EGTGLSMSACREIALLRELKHPNVINLI 82
             ++G G +G V+      ++     A+K + +G+    +   E  L+++L+H  ++ L 
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKV---AVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 74

Query: 83  SVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHY 141
           +V        ++++ +Y E+  L   + F +     K  +     M      QI +G+ +
Sbjct: 75  AVVT---QEPIYIITEYMENGSL---VDFLKTPSGIKLTINKLLDM----AAQIAEGMAF 124

Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN-----------PLKPLADL 190
           +     +HRDL+ ANILV          KIAD G ARL  +           P+K     
Sbjct: 125 IEERNYIHRDLRAANILVSDTLS----CKIADFGLARLIEDNEYTAREGAKFPIK----- 175

Query: 191 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                  W  APE +     +T   D+W+ G +  E++T
Sbjct: 176 -------WT-APEAIN-YGTFTIKSDVWSFGILLTEIVT 205

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 71.7 bits (176), Expect = 2e-14
 Identities = 44/223 (19%), Positives = 79/223 (35%), Gaps = 38/223 (17%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDY---ALKQI-EGTGLSMSA--CREIALLRELKHPNVI 79
            +G G +G VY+ +     +       A+K + E            E  ++ +  H N++
Sbjct: 78  GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137

Query: 80  NLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDG 138
             I V  S      ++L +     DL   ++  R  + ++   +    ++  +   I  G
Sbjct: 138 RCIGV--SLQSLPRFILLELMAGGDLKSFLRETRP-RPSQPSSLAMLDLL-HVARDIACG 193

Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
             YL  N  +HRD+   N L+   G      KI D G AR        +          +
Sbjct: 194 CQYLEENHFIHRDIAARNCLLTCPG-PGRVAKIGDFGMAR-------DIYRAG------Y 239

Query: 199 YR------------APELLLGARHYTKAIDIWAIGCIFAELLT 229
           YR             PE  +    +T   D W+ G +  E+ +
Sbjct: 240 YRKGGCAMLPVKWMPPEAFM-EGIFTSKTDTWSFGVLLWEIFS 281

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 70.3 bits (173), Expect = 2e-14
 Identities = 48/223 (21%), Positives = 86/223 (38%), Gaps = 52/223 (23%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQI-EGTGLSMSA---CREIALLRELKHPNVI 79
             ++G G +G V+     +       A+K I EG    MS      E  ++ +L HP ++
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKV---AIKTIREGA---MSEEDFIEEAEVMMKLSHPKLV 66

Query: 80  NLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKAN-KKPVMVPKGMVKSLLYQILD 137
            L  V L      + L+ ++ EH  L     + R  +       ++       +   + +
Sbjct: 67  QLYGVCL--EQAPICLVTEFMEHGCL---SDYLRTQRGLFAAETLL------GMCLDVCE 115

Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN-----------PLKP 186
           G+ YL    V+HRDL   N LV    +    +K++D G  R   +           P+K 
Sbjct: 116 GMAYLEEACVIHRDLAARNCLVGENQV----IKVSDFGMTRFVLDDQYTSSTGTKFPVK- 170

Query: 187 LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                      W  +PE+      Y+   D+W+ G +  E+ +
Sbjct: 171 -----------WA-SPEVFS-FSRYSSKSDVWSFGVLMWEVFS 200

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 70.3 bits (173), Expect = 3e-14
 Identities = 47/220 (21%), Positives = 89/220 (40%), Gaps = 46/220 (20%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQI-EGTGLSMSACREIALLRELKHPNVINLI 82
             ++G G +G V   + +      D A+K I EG+        E  ++  L H  ++ L 
Sbjct: 29  LKELGTGQFGVVKYGKWRG---QYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLY 85

Query: 83  SVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKAN-KKPVMVPKGMVKSLLYQILDGIH 140
            V      R ++++ +Y  +  L   + + R  +   +   ++       +   + + + 
Sbjct: 86  GVCT--KQRPIFIITEYMANGCL---LNYLREMRHRFQTQQLL------EMCKDVCEAME 134

Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN-----------PLKPLAD 189
           YL S   LHRDL   N LV  +G+    VK++D G +R   +           P++    
Sbjct: 135 YLESKQFLHRDLAARNCLVNDQGV----VKVSDFGLSRYVLDDEYTSSVGSKFPVR---- 186

Query: 190 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                   W   PE+L+    ++   DIWA G +  E+ +
Sbjct: 187 --------WS-PPEVLM-YSKFSSKSDIWAFGVLMWEIYS 216

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 71.1 bits (175), Expect = 3e-14
 Identities = 51/213 (23%), Positives = 94/213 (44%), Gaps = 28/213 (13%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQI-EGTGLSMSA--CREIALLRELKHPNVIN 80
           G ++GRG +G V+    +  +D    A+K   E     + A   +E  +L++  HPN++ 
Sbjct: 119 GEQIGRGNFGEVFSG--RLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 176

Query: 81  LISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGI 139
           LI V      + ++++ +  +  D    + F R     +   +  K +++ ++     G+
Sbjct: 177 LIGVCT--QKQPIYIVMELVQGGDF---LTFLR----TEGARLRVKTLLQ-MVGDAAAGM 226

Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPL---KPLADLDPVVVT 196
            YL S   +HRDL   N LV  + +    +KI+D G +R   + +          PV   
Sbjct: 227 EYLESKCCIHRDLAARNCLVTEKNV----LKISDFGMSREEADGVYAASGGLRQVPVK-- 280

Query: 197 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
            W  APE L     Y+   D+W+ G +  E  +
Sbjct: 281 -WT-APEALN-YGRYSSESDVWSFGILLWETFS 310

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 70.8 bits (174), Expect = 3e-14
 Identities = 43/177 (24%), Positives = 73/177 (41%), Gaps = 28/177 (15%)

Query: 24  GCKVGRGTYGHVYKARRKD---NSDTRDYALKQI-EGTGLSMSA--CREIALLREL-KHP 76
           G  +G G +G V  A          +   A+K + E    S       E+ ++ +L  H 
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109

Query: 77  NVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMV------- 128
           N++NL+          ++L+F+Y  + DL + ++  R   +  +     +  +       
Sbjct: 110 NIVNLLGA--CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167

Query: 129 ----KSLL---YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR 178
               + LL   YQ+  G+ +L     +HRDL   N+LV   G     VKI D G AR
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV-THG---KVVKICDFGLAR 220

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 70.3 bits (173), Expect = 3e-14
 Identities = 56/232 (24%), Positives = 84/232 (36%), Gaps = 54/232 (23%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDY---ALKQI-EGTGLSMSA--CREIALLRELKHPN 77
           G  +G G +G V KA          Y   A+K + E    S       E  +L+++ HP+
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87

Query: 78  VINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLL---- 132
           VI L        D  + L+ +YA++  L   ++  R            +           
Sbjct: 88  VIKLYGA--CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145

Query: 133 -----------YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFN 181
                      +QI  G+ YL    ++HRDL   NILV  EG    ++KI+D G +R   
Sbjct: 146 ALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILV-AEG---RKMKISDFGLSRDVY 201

Query: 182 N------------PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIG 221
                        P+K            W  A E L     YT   D+W+ G
Sbjct: 202 EEDSYVKRSQGRIPVK------------WM-AIESLF-DHIYTTQSDVWSFG 239

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 70.0 bits (172), Expect = 4e-14
 Identities = 46/169 (27%), Positives = 76/169 (44%), Gaps = 25/169 (14%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDY---ALKQI-EGTGLSMSA----CREIALLRELKHPN 77
           ++G G +G V+ A   + S T+D    A+K + + T   ++A     RE  LL  L+H +
Sbjct: 22  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEH 78

Query: 78  VINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGM----VKSLL 132
           ++    V    +   + ++F+Y +H DL   ++ H             +      +  +L
Sbjct: 79  IVKFYGV--CGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML 136

Query: 133 ---YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR 178
               QI  G+ YL S   +HRDL   N LV G  +    VKI D G +R
Sbjct: 137 HIASQIASGMVYLASQHFVHRDLATRNCLV-GANLL---VKIGDFGMSR 181

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 70.9 bits (174), Expect = 4e-14
 Identities = 49/217 (22%), Positives = 95/217 (43%), Gaps = 44/217 (20%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI-EGTGLSMSACREIALLRELKHPNVINLISV 84
           K+G G +G V+ A    ++     A+K +  G+    +   E  +++ L+H  ++ L +V
Sbjct: 195 KLGAGQFGEVWMATYNKHTKV---AVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251

Query: 85  FLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLH 143
                   ++++ ++     L   + F ++ + +K+P+            QI +G+ ++ 
Sbjct: 252 VT---KEPIYIITEFMAKGSL---LDFLKSDEGSKQPLPKLIDF----SAQIAEGMAFIE 301

Query: 144 SNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN-----------PLKPLADLDP 192
               +HRDL+ ANILV    +     KIAD G AR+  +           P+K       
Sbjct: 302 QRNYIHRDLRAANILVSASLV----CKIADFGLARVIEDNEYTAREGAKFPIK------- 350

Query: 193 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                W  APE +     +T   D+W+ G +  E++T
Sbjct: 351 -----WT-APEAIN-FGSFTIKSDVWSFGILLMEIVT 380

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 69.9 bits (172), Expect = 5e-14
 Identities = 52/230 (22%), Positives = 89/230 (38%), Gaps = 46/230 (20%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDY---ALKQI-EGTGLSMSA--CREIALLRELKHPNVI 79
           ++G   +G VYK      +        A+K + +     +      E  L   L+HPNV+
Sbjct: 16  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75

Query: 80  NLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVK-------SL 131
            L+ V     D+ + ++F Y  H DL   +                             L
Sbjct: 76  CLLGVVT--KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133

Query: 132 LYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLD 191
           + QI  G+ YL S+ V+H+DL   N+LV  + +    VKI+D+G  R        +   D
Sbjct: 134 VAQIAAGMEYLSSHHVVHKDLATRNVLV-YDKL---NVKISDLGLFRE-------VYAAD 182

Query: 192 PVVVTFWYR------------APELLLGARHYTKAIDIWAIGCIFAELLT 229
                 +Y+            APE ++    ++   DIW+ G +  E+ +
Sbjct: 183 ------YYKLLGNSLLPIRWMAPEAIM-YGKFSIDSDIWSYGVVLWEVFS 225

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 69.2 bits (170), Expect = 1e-13
 Identities = 58/235 (24%), Positives = 93/235 (39%), Gaps = 49/235 (20%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDY-----ALKQI-EGTGLSMSA--CREIALLREL-K 74
           G  +G G +G V  A        +       A+K + +       +    E+ +++ + K
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99

Query: 75  HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGM----VK 129
           H N+INL+       D  ++++ +YA   +L   ++  R         +          K
Sbjct: 100 HKNIINLLGA--CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157

Query: 130 SLL---YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKP 186
            L+   YQ+  G+ YL S   +HRDL   N+LV  E      +KIAD G AR  NN    
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-TENNV---MKIADFGLARDINN---- 209

Query: 187 LADLDPVVVTFWYR------------APELLLGARHYTKAIDIWAIGCIFAELLT 229
                      +Y+            APE L   R YT   D+W+ G +  E+ T
Sbjct: 210 ---------IDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFT 254

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 68.9 bits (169), Expect = 2e-13
 Identities = 44/165 (26%), Positives = 71/165 (43%), Gaps = 18/165 (10%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDY---ALKQI-EGTGLSMSA-CREIALLRELKHPNVIN 80
           ++G G +G V+ A   +    +D    A+K + E +  +     RE  LL  L+H +++ 
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107

Query: 81  LISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGM---VKSLL---Y 133
              V      R + ++F+Y  H DL   ++ H                   +  LL    
Sbjct: 108 FFGV--CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165

Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR 178
           Q+  G+ YL     +HRDL   N LV G+G+    VKI D G +R
Sbjct: 166 QVAAGMVYLAGLHFVHRDLATRNCLV-GQGLV---VKIGDFGMSR 206

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 68.4 bits (168), Expect = 2e-13
 Identities = 39/172 (22%), Positives = 66/172 (38%), Gaps = 27/172 (15%)

Query: 24  GCKVGRGTYGHVYKARRKD---NSDTRDYALKQI-EGTGLSMSACREIALLRELK----- 74
           G  +G G +G V +A              A+K +            + AL+ ELK     
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADE----KEALMSELKIMSHL 106

Query: 75  --HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMV--K 129
             H N++NL+      +   V ++ +Y  + DL + ++             +       +
Sbjct: 107 GQHENIVNLLGA--CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTR 164

Query: 130 SLL---YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR 178
            LL    Q+  G+ +L S   +HRD+   N+L+   G      KI D G AR
Sbjct: 165 DLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL-TNG---HVAKIGDFGLAR 212

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 68.5 bits (168), Expect = 2e-13
 Identities = 60/235 (25%), Positives = 94/235 (40%), Gaps = 49/235 (20%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDY-----ALKQI-EGTGLSMSA--CREIALLREL-K 74
           G  +G G +G V  A        +       A+K + +       +    E+ +++ + K
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145

Query: 75  HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGM----VK 129
           H N+INL+       D  ++++ +YA   +L   ++  R         +          K
Sbjct: 146 HKNIINLLGA--CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203

Query: 130 SLL---YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN---- 182
            L+   YQ+  G+ YL S   +HRDL   N+LV  E      +KIAD G AR  NN    
Sbjct: 204 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-TEN---NVMKIADFGLARDINNIDYY 259

Query: 183 --------PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                   P+K            W  APE L   R YT   D+W+ G +  E+ T
Sbjct: 260 KKTTNGRLPVK------------WM-APEALFD-RVYTHQSDVWSFGVLMWEIFT 300

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 67.8 bits (166), Expect = 4e-13
 Identities = 56/235 (23%), Positives = 91/235 (38%), Gaps = 49/235 (20%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDY-----ALKQI-EGTGLSMSA--CREIALLREL-K 74
           G  +G G +G V  A        +       A+K +         +    E+ +++ + K
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 75  HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGM----VK 129
           H N+INL+       D  ++++ +YA   +L   ++  R                    K
Sbjct: 134 HKNIINLLGA--CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191

Query: 130 SLL---YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKP 186
            L+   YQ+  G+ YL S   +HRDL   N+LV  E      +KIAD G AR  ++    
Sbjct: 192 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLV-TED---NVMKIADFGLARDIHH---- 243

Query: 187 LADLDPVVVTFWYR------------APELLLGARHYTKAIDIWAIGCIFAELLT 229
                      +Y+            APE L   R YT   D+W+ G +  E+ T
Sbjct: 244 ---------IDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFT 288

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 67.2 bits (163), Expect = 6e-13
 Identities = 40/283 (14%), Positives = 81/283 (28%), Gaps = 75/283 (26%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----------EGTGLSMSACREIALLREL-- 73
           K+G G +G V++            A+K I                     EI + +EL  
Sbjct: 27  KIGEGVFGEVFQTIADH----TPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSL 82

Query: 74  -------KHPNVINLISVFLSHNDR-----KVWLLFD------------YAEHDLWHIIK 109
                  +    I L SV            K W  ++            + +  L+ +++
Sbjct: 83  LSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLE 142

Query: 110 FHRAAKANKKPVMVPKGM--VKSLLYQILDGIHYLHSNW-VLHRDLKPANILVMGEGIER 166
           F       ++       +   KS+L+Q+   +    ++    HRDL   N+L+     + 
Sbjct: 143 FEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLK----KT 198

Query: 167 GRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAE 226
              K+      +       P   L   ++ +                +        +F +
Sbjct: 199 SLKKLHYTLNGKSST---IPSCGLQVSIIDYTL--------------SRLERDGIVVFCD 241

Query: 227 LLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGFPLEKDWED 269
           +   E +F               D    I+ +M       W +
Sbjct: 242 VSMDEDLF-----------TGDGDYQFDIYRLMKKENNNRWGE 273

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 67.0 bits (164), Expect = 8e-13
 Identities = 49/177 (27%), Positives = 73/177 (41%), Gaps = 28/177 (15%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDY---ALKQI-EGTGLSMSA--CREIALLRELKHPN 77
              +G G +G V++AR         +   A+K + E     M A   RE AL+ E  +PN
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111

Query: 78  VINLISVFLSHNDRKVWLLFDYAEH-DL------------WHIIKFHRAAKANKKPVMVP 124
           ++ L+ V      + + LLF+Y  + DL              +     + +A       P
Sbjct: 112 IVKLLGV--CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169

Query: 125 KGMVKSLL---YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR 178
                  L    Q+  G+ YL     +HRDL   N LV GE +    VKIAD G +R
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV-GENM---VVKIADFGLSR 222

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 63.9 bits (155), Expect = 1e-11
 Identities = 43/164 (26%), Positives = 67/164 (40%), Gaps = 20/164 (12%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKH----PNVI 79
           G K+G G++G +Y       +   + A+K             E  + R L+     PNV 
Sbjct: 12  GRKIGSGSFGEIYLGTNIQTN--EEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVR 69

Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGI 139
                F    D  V L+ D     L  +  F     + K  +M        L  Q+++ +
Sbjct: 70  W----FGVEGDYNV-LVMDLLGPSLEDLFNFCSRKLSLKTVLM--------LADQMINRV 116

Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNP 183
            ++HS   LHRD+KP N L MG G    +V I D G A+ + + 
Sbjct: 117 EFVHSKSFLHRDIKPDNFL-MGLGRRANQVYIIDFGLAKKYRDT 159

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 62.6 bits (153), Expect = 2e-11
 Identities = 57/242 (23%), Positives = 89/242 (36%), Gaps = 70/242 (28%)

Query: 17  EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA------CREIALL 70
           E      G K+G G +G VYK       +    A+K++       +        +EI ++
Sbjct: 29  ERPISVGGNKMGEGGFGVVYKGYV----NNTTVAVKKLAAMVDITTEELKQQFDQEIKVM 84

Query: 71  RELKHPNVINLISVFLSHNDRKVWLL-FDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVK 129
            + +H N++ L+      +D     L + Y                       +P G + 
Sbjct: 85  AKCQHENLVELLGFSSDGDDL---CLVYVY-----------------------MPNGSLL 118

Query: 130 SLLY-----QILD-------------GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI 171
             L        L              GI++LH N  +HRD+K ANIL + E       KI
Sbjct: 119 DRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANIL-LDEAFT---AKI 174

Query: 172 ADMGFARLFNNPLKPLADLDPV---VV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 227
           +D G AR              +   +V T  Y APE L G    T   DI++ G +  E+
Sbjct: 175 SDFGLARAS-----EKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEI 227

Query: 228 LT 229
           +T
Sbjct: 228 IT 229

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 60.1 bits (146), Expect = 2e-10
 Identities = 32/177 (18%), Positives = 64/177 (36%), Gaps = 29/177 (16%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLIS 83
           G K+G G +G +Y A   +  +     + ++E    +     E+   + +   + I    
Sbjct: 42  GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQE-NGPLFSELKFYQRVAKKDCIKKWI 100

Query: 84  VFLSHNDRKV-----------------WLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKG 126
                +   +                 +++ +    DL  I   +      K        
Sbjct: 101 ERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG--TFKKS------- 151

Query: 127 MVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNP 183
            V  L  ++LD + Y+H N  +H D+K AN+L +G      +V +AD G +  +   
Sbjct: 152 TVLQLGIRMLDVLEYIHENEYVHGDIKAANLL-LGYK-NPDQVYLADYGLSYRYCPN 206

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 59.1 bits (144), Expect = 3e-10
 Identities = 58/240 (24%), Positives = 90/240 (37%), Gaps = 68/240 (28%)

Query: 20  FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACR----EIALLRELKH 75
           FD     +G G +G VYK   +D       ALK+   T  S         EI  L   +H
Sbjct: 41  FD-HKFLIGHGVFGKVYKGVLRDG---AKVALKR--RTPESSQGIEEFETEIETLSFCRH 94

Query: 76  PNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLY-- 133
           P++++LI      N+    L++ Y                       +  G +K  LY  
Sbjct: 95  PHLVSLIGFCDERNEM--ILIYKY-----------------------MENGNLKRHLYGS 129

Query: 134 ----QILD-------------GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGF 176
                 +              G+HYLH+  ++HRD+K  NIL+     E    KI D G 
Sbjct: 130 DLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLD----ENFVPKITDFGI 185

Query: 177 ARLFNNPLKPLADLDPV--VV--TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 232
           ++          D   +  VV  T  Y  PE  +  R   K+ D+++ G +  E+L +  
Sbjct: 186 SKKG-----TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKS-DVYSFGVVLFEVLCARS 239

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 57.0 bits (138), Expect = 1e-09
 Identities = 37/160 (23%), Positives = 61/160 (38%), Gaps = 12/160 (7%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLIS 83
           G K+G G++G +Y           + A+K             E  + + ++    I  I 
Sbjct: 14  GRKIGSGSFGDIYLGTDIAAG--EEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIR 71

Query: 84  VFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLH 143
              +  D  V ++ +     L  +         N          V  L  Q++  I Y+H
Sbjct: 72  WCGAEGDYNV-MVMELLGPSLEDLF--------NFCSRKFSLKTVLLLADQMISRIEYIH 122

Query: 144 SNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNP 183
           S   +HRD+KP N L MG G +   V I D G A+ + + 
Sbjct: 123 SKNFIHRDVKPDNFL-MGLGKKGNLVYIIDFGLAKKYRDA 161

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 56.3 bits (136), Expect = 2e-09
 Identities = 30/177 (16%), Positives = 59/177 (33%), Gaps = 32/177 (18%)

Query: 24  GCKVGRGTYGHVYKARR------KDNSDTRDYALKQIEGTGLSMSACREIALL-RELKHP 76
                R   G +Y+A              + ++LK ++          E     R  K  
Sbjct: 47  KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAK--DGRLFNEQNFFQRAAKPL 103

Query: 77  NVINLISV-------------FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMV 123
            V     +             F  H D+  +L+       L   +       + K  +  
Sbjct: 104 QVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDV-----SPKHVL-- 156

Query: 124 PKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
            +  V  +  ++LD + +LH N  +H ++   NI  +    ++ +V +A  GFA  +
Sbjct: 157 SERSVLQVACRLLDALEFLHENEYVHGNVTAENIF-VDPE-DQSQVTLAGYGFAFRY 211

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 55.4 bits (134), Expect = 4e-09
 Identities = 32/165 (19%), Positives = 61/165 (36%), Gaps = 20/165 (12%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKH----PNVI 79
           G ++G G++G +++     N+  +  A+K       +     E    + L      PNV 
Sbjct: 15  GRRIGEGSFGVIFEGTNLLNN--QQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVY 72

Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGI 139
                F       V L+ D     L  ++         +K     K  V     Q+L  +
Sbjct: 73  Y----FGQEGLHNV-LVIDLLGPSLEDLLDLC-----GRK--FSVK-TVAMAAKQMLARV 119

Query: 140 HYLHSNWVLHRDLKPANILV-MGEGIERGRVKIADMGFARLFNNP 183
             +H   +++RD+KP N L+          + + D G  + + +P
Sbjct: 120 QSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 164

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 55.3 bits (133), Expect = 6e-09
 Identities = 55/283 (19%), Positives = 90/283 (31%), Gaps = 96/283 (33%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYA------LKQIEGTGLSMSACREIALLREL-KHP 76
           G  +GRG +G V +A       T          LK+        +   E+ +L  +  H 
Sbjct: 27  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86

Query: 77  NVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAA-------KANKKPVMVPKGMV 128
           NV+NL+    +     + ++ ++ +  +L   ++  R          A  +      G +
Sbjct: 87  NVVNLLGAC-TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAI 145

Query: 129 KSLLYQILD--------------------------------------------------G 138
              L + LD                                                  G
Sbjct: 146 PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKG 205

Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN------------PLKP 186
           + +L S   +HRDL   NIL+  + +    VKI D G AR                PLK 
Sbjct: 206 MEFLASRKCIHRDLAARNILLSEKNV----VKICDFGLARDIYKDPDYVRKGDARLPLK- 260

Query: 187 LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                      W  APE +   R YT   D+W+ G +  E+ +
Sbjct: 261 -----------WM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 290

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 54.8 bits (132), Expect = 8e-09
 Identities = 33/182 (18%), Positives = 59/182 (32%), Gaps = 36/182 (19%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDT---RDYALKQ--IEGTGLSMSACREIALLRELKHPNV 78
           G  +G+G +G +Y A    +          +K    +   L      E+   +    P  
Sbjct: 40  GLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFT----ELKFYQRAAKPEQ 95

Query: 79  INLISVFLSHNDRKVWLLFDYAEH-----------------DLWHIIKFHRAAKANKKPV 121
           I             V   +    H                 DL  I + +      K+  
Sbjct: 96  IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEAN-----AKR-- 148

Query: 122 MVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFN 181
              +  V  L  +ILD + Y+H +  +H D+K +N+L +       +V + D G A  + 
Sbjct: 149 -FSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLL-LNYK-NPDQVYLVDYGLAYRYC 205

Query: 182 NP 183
             
Sbjct: 206 PE 207

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 54.1 bits (131), Expect = 1e-08
 Identities = 56/244 (22%), Positives = 90/244 (36%), Gaps = 79/244 (32%)

Query: 20  FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA---CREIALLRELKHP 76
           F  +   +GRG +G VYK R  D +     A+K+++             E+ ++    H 
Sbjct: 32  FSNK-NILGRGGFGKVYKGRLADGTLV---AVKRLKEERTQGGELQFQTEVEMISMAVHR 87

Query: 77  NVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLY--- 133
           N++ L    ++  +R   L++ Y                       +  G V S L    
Sbjct: 88  NLLRLRGFCMTPTER--LLVYPY-----------------------MANGSVASCLRERP 122

Query: 134 ---QILD-------------GIHYLHSNW---VLHRDLKPANILVMGEGIERGRVKIADM 174
                LD             G+ YLH +    ++HRD+K ANIL + E  E     + D 
Sbjct: 123 ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANIL-LDEEFE---AVVGDF 178

Query: 175 GFARLFNNPLKPLADLDP--------VVVTFWYRAPE-LLLGARHYTKAIDIWAIGCIFA 225
           G A+L           D         V  T  + APE L  G    ++  D++  G +  
Sbjct: 179 GLAKLM----------DYKDTHVTTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLL 226

Query: 226 ELLT 229
           EL+T
Sbjct: 227 ELIT 230

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 52.8 bits (127), Expect = 4e-08
 Identities = 29/166 (17%), Positives = 61/166 (36%), Gaps = 22/166 (13%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKH----PNVI 79
           G K+G G +G +   +    +     A+K       +     E    ++L      P V 
Sbjct: 14  GKKIGCGNFGELRLGKNLYTN--EYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVY 71

Query: 80  NLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGI 139
                +     +   ++ +     L  +         ++      K  V  +  Q++  +
Sbjct: 72  -----YFGPCGKYNAMVLELLGPSLEDLFDLC-----DRT--FSLK-TVLMIAIQLISRM 118

Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERG--RVKIADMGFARLFNNP 183
            Y+HS  +++RD+KP N L +G    +    + I D   A+ + +P
Sbjct: 119 EYVHSKNLIYRDVKPENFL-IGRPGNKTQQVIHIIDFALAKEYIDP 163

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 47.5 bits (112), Expect = 3e-06
 Identities = 44/327 (13%), Positives = 100/327 (30%), Gaps = 97/327 (29%)

Query: 2   DYEF---KIKT-SNERTKVEDLFDYEGCKVGRG----TYGHVYKARRKDNSDTRDYALKQ 53
           +Y+F    IKT   + + +  ++  +  ++          +V   R +     R  AL +
Sbjct: 90  NYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVS--RLQPYLKLRQ-ALLE 146

Query: 54  IE-----------GTG---LSMSACREIALLRELKHPNVINLISVFLSHNDRKV------ 93
           +            G+G   +++  C    +  + K    I  +++   ++   V      
Sbjct: 147 LRPAKNVLIDGVLGSGKTWVALDVCLSYKV--QCKMDFKIFWLNLKNCNSPETVLEMLQK 204

Query: 94  -WLLFD-----YAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWV 147
                D      ++H     ++ H + +A  + ++  K     LL  +L  +    +   
Sbjct: 205 LLYQIDPNWTSRSDHSSNIKLRIH-SIQAELRRLLKSKPYENCLL--VLLNVQ---NAKA 258

Query: 148 LH------------RDLKPANILVMGEGIERGRVKIADM--GFAR-----LFNNPLK-PL 187
            +            R  +  + L          + +              L    L    
Sbjct: 259 WNAFNLSCKILLTTRFKQVTDFLS---AATTTHISLDHHSMTLTPDEVKSLLLKYLDCRP 315

Query: 188 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 247
            DL   V+T     P   L                I AE +         ++ + T + +
Sbjct: 316 QDLPREVLT---TNP-RRLS---------------IIAESI---------RDGLATWDNW 347

Query: 248 HHDQLDRIFSVMGFPLEK-DWEDIRKM 273
            H   D++ +++   L   +  + RKM
Sbjct: 348 KHVNCDKLTTIIESSLNVLEPAEYRKM 374

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	291
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.89
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.86
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.73
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.37
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.27
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.15
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.12
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.89
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.77
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.72
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.43
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.35
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.34
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.23
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.2
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.88
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.76
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.68
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.67
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.56
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.53
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.45
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.41
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.25
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.12
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.9
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.75
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.73
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.27
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.25
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.88
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	87.23
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	85.7
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	85.0

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=8.3e-56  Score=365.68  Aligned_cols=250  Identities=24%  Similarity=0.375  Sum_probs=197.1

Q ss_pred             cccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-----CChhHHHHHHHHhcCCCCCeeeEEEEEEeC
Q psy2172          14 TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-----LSMSACREIALLRELKHPNVINLISVFLSH   88 (291)
Q Consensus        14 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   88 (291)
                      .+| +.|++ .+.||+|+||.||+|.++.  +++.||+|+++...     ....+.+|+.+|++++||||+++++++  .
T Consensus        10 ~~i-g~Y~i-~~~lG~G~fg~V~~~~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~--~   83 (275)
T 3hyh_A           10 AHI-GNYQI-VKTLGEGSFGKVKLAYHTT--TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVI--K   83 (275)
T ss_dssp             -----CCEE-EEEEEC---CCEEEEECTT--TCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE--E
T ss_pred             CEe-eCeEE-EEEEecCcCeEEEEEEECC--CCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE--E
Confidence            344 46775 6799999999999999776  77899999986432     234688999999999999999999999  5


Q ss_pred             CCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCc
Q psy2172          89 NDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGR  168 (291)
Q Consensus        89 ~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~  168 (291)
                      +...+|+||||++|+|.+.+....         .+++..++.++.|++.||+|||++||+||||||+||+++    .++.
T Consensus        84 ~~~~~~ivmEy~~g~L~~~l~~~~---------~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~----~~~~  150 (275)
T 3hyh_A           84 SKDEIIMVIEYAGNELFDYIVQRD---------KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLD----EHLN  150 (275)
T ss_dssp             CSSEEEEEEECCCEEHHHHHHHSC---------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEEC----TTCC
T ss_pred             ECCEEEEEEeCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEEC----CCCC
Confidence            677999999999999998887533         299999999999999999999999999999999999998    6789


Q ss_pred             EEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc--------
Q psy2172         169 VKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED--------  240 (291)
Q Consensus       169 ~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~--------  240 (291)
                      +||+|||+|+.....    .......||+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+..        
T Consensus       151 vkl~DFGla~~~~~~----~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~  226 (275)
T 3hyh_A          151 VKIADFGLSNIMTDG----NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISN  226 (275)
T ss_dssp             EEECCSSCC-------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             EEEeecCCCeecCCC----CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc
Confidence            999999999865432    22345689999999999988665678999999999999999999999876532        


Q ss_pred             -ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhhhhhc
Q psy2172         241 -IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDFNEQ  286 (291)
Q Consensus       241 -~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (291)
                       ........++.+.+++..|..+.|..||++.++.+|||+..++-+-
T Consensus       227 ~~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~~~p~~  273 (275)
T 3hyh_A          227 GVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVDLPEY  273 (275)
T ss_dssp             TCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHTTCCGG
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCcccccCCChh
Confidence             1122334467789999999999999999999999999987665443

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.1e-55  Score=375.69  Aligned_cols=263  Identities=24%  Similarity=0.436  Sum_probs=208.4

Q ss_pred             cccceeecccccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC----hhHHHHHHHHhcCCCCCe
Q psy2172           3 YEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIALLRELKHPNV   78 (291)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~h~~i   78 (291)
                      ++.++.+.|.-++--++|++ .++||+|+||.||+|+++.  +++.||||++......    +.+.+|+.+|++++||||
T Consensus         9 sgvd~gten~~f~sme~Y~~-~~~lG~G~fg~V~~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnI   85 (350)
T 4b9d_A            9 SGVDLGTENLYFQSMEKYVR-LQKIGEGSFGKAILVKSTE--DGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI   85 (350)
T ss_dssp             ------CCCCBCSCCCCEEE-EEEC------CEEEEEETT--TCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             CCccCCCcccCCCcccceEE-eEEEecCCCeEEEEEEECC--CCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCC
Confidence            34556666666665678885 6799999999999999877  7789999999755432    358899999999999999


Q ss_pred             eeEEEEEEeCCCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcE
Q psy2172          79 INLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANI  157 (291)
Q Consensus        79 v~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Ni  157 (291)
                      |++++++  .+...+|+|||||+| +|.+++...+..       .+++..++.++.||+.||+|||++||+||||||+||
T Consensus        86 V~~~~~~--~~~~~~yiVmEy~~gg~L~~~i~~~~~~-------~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NI  156 (350)
T 4b9d_A           86 VQYRESF--EENGSLYIVMDYCEGGDLFKRINAQKGV-------LFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNI  156 (350)
T ss_dssp             CCEEEEE--EETTEEEEEEECCTTCBHHHHHHHTTTC-------CCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGE
T ss_pred             CcEEEEE--EECCEEEEEEeCCCCCcHHHHHHHcCCC-------CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHE
Confidence            9999999  557789999999985 999888754321       278999999999999999999999999999999999


Q ss_pred             EeecCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q psy2172         158 LVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  237 (291)
Q Consensus       158 l~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~  237 (291)
                      |++    .++.+||+|||+|+......   .......||+.|+|||++.+.. |+.++|||||||++|+|++|+.||.+.
T Consensus       157 Ll~----~~g~vKl~DFGla~~~~~~~---~~~~~~~GT~~YmAPE~l~~~~-y~~~~DiwSlGvilyemltG~~PF~~~  228 (350)
T 4b9d_A          157 FLT----KDGTVQLGDFGIARVLNSTV---ELARACIGTPYYLSPEICENKP-YNNKSDIWALGCVLYELCTLKHAFEAG  228 (350)
T ss_dssp             EEC----TTCCEEECSTTEESCCCHHH---HHHHHHHSCCTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             EEC----CCCCEEEcccccceeecCCc---ccccccCCCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            998    67899999999998654311   1112357999999999998854 999999999999999999999999876


Q ss_pred             ccc----------ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhhhhh
Q psy2172         238 QED----------IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDFNE  285 (291)
Q Consensus       238 ~~~----------~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (291)
                      +..          .+.........+.+++..|....|..||++.++.+|||+.+....
T Consensus       229 ~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~~~  286 (350)
T 4b9d_A          229 SMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEK  286 (350)
T ss_dssp             SHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTTGGG
T ss_pred             CHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcCCCc
Confidence            532          222334456789999999999999999999999999998876544

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.5e-54  Score=362.99  Aligned_cols=245  Identities=27%  Similarity=0.433  Sum_probs=205.5

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCC-----CCCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCce
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEG-----TGLSMSACREIALLRELKHPNVINLISVFLSHNDRK   92 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (291)
                      +.|++ ++.||+|+||.||+|.++.  +++.||||++.+     ....+.+.+|+++|++++|||||+++++|  ++...
T Consensus        32 ~dy~i-~~~lG~G~fg~V~~a~~~~--~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~--~~~~~  106 (311)
T 4aw0_A           32 EDFKF-GKILGEGSFSTVVLARELA--TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF--QDDEK  106 (311)
T ss_dssp             GGEEE-EEEEEEETTEEEEEEEETT--TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE--ECSSE
T ss_pred             cccEE-EEEEecccCeEEEEEEECC--CCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE--EeCCE
Confidence            44775 7899999999999999877  778999999963     23345689999999999999999999999  66789


Q ss_pred             EEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEE
Q psy2172          93 VWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI  171 (291)
Q Consensus        93 ~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l  171 (291)
                      +|+|||||+| +|.+.+.....         +++..++.++.||+.||+|||++||+||||||+|||++    .++.+||
T Consensus       107 ~yivmEy~~gG~L~~~i~~~~~---------l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~----~~g~vKl  173 (311)
T 4aw0_A          107 LYFGLSYAKNGELLKYIRKIGS---------FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN----EDMHIQI  173 (311)
T ss_dssp             EEEEECCCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTSCEEE
T ss_pred             EEEEEecCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEc----CCCCEEE
Confidence            9999999985 99988875432         99999999999999999999999999999999999998    6789999


Q ss_pred             eecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc---------cc
Q psy2172         172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED---------IK  242 (291)
Q Consensus       172 ~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~---------~~  242 (291)
                      +|||+|+....... .......+||+.|+|||++.+.. ++.++|+|||||++|+|++|.+||.+.+..         ..
T Consensus       174 ~DFGla~~~~~~~~-~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~  251 (311)
T 4aw0_A          174 TDFGTAKVLSPESK-QARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY  251 (311)
T ss_dssp             CCCTTCEECCTTTT-CCCBCCCCSCGGGCCHHHHHHSC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred             EEcCCceecCCCCC-cccccCcccCcccCCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Confidence            99999987654221 22335578999999999998754 899999999999999999999999876532         11


Q ss_pred             CCCCCcHHHHHHHHHhhCCCCcCChhhhhcC------CCCcchhhh
Q psy2172         243 TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM------PEHPTLLKD  282 (291)
Q Consensus       243 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~------~~~~~~~~~  282 (291)
                      ......++.+.+++..|....|..|+++.++      ..|||+..-
T Consensus       252 ~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~i  297 (311)
T 4aw0_A          252 DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV  297 (311)
T ss_dssp             CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred             CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence            2223445778999999999999999999885      567777543

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=4.3e-54  Score=365.37  Aligned_cols=242  Identities=23%  Similarity=0.417  Sum_probs=203.7

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCC--CCCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEG--TGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWL   95 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~i   95 (291)
                      +.|+. .++||+|+||.||+|.++.  +++.||||++..  ....+.+.+|+.+|+.++|||||+++++|  .+...+|+
T Consensus        74 ~~y~~-~~~iG~G~fG~V~~a~~~~--tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~--~~~~~~~i  148 (346)
T 4fih_A           74 SYLDN-FIKIGEGSTGIVCIATVRS--SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY--LVGDELWV  148 (346)
T ss_dssp             GTEEE-EEEEEECSSCEEEEEEETT--TCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEE--EETTEEEE
T ss_pred             HhcEE-eEEeecCcCeEEEEEEECC--CCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEE--EECCEEEE
Confidence            45664 6799999999999999887  778999999853  23345688999999999999999999999  45678999


Q ss_pred             EEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          96 LFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        96 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      |||||+| +|.+++...+          +++..++.++.||+.||+|||++||+||||||+|||++    .++.+||+||
T Consensus       149 vmEy~~gg~L~~~l~~~~----------l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~----~~g~vKl~DF  214 (346)
T 4fih_A          149 VMEFLEGGALTDIVTHTR----------MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT----HDGRVKLSDF  214 (346)
T ss_dssp             EECCCTTEEHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTCCEEECCC
T ss_pred             EEeCCCCCcHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEC----CCCCEEEecC
Confidence            9999986 7877765321          89999999999999999999999999999999999998    6789999999


Q ss_pred             ccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc---------cc---
Q psy2172         175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED---------IK---  242 (291)
Q Consensus       175 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~---------~~---  242 (291)
                      |+|+......   .......||+.|+|||++.+.+ |+.++|||||||++|+|++|.+||.+....         ..   
T Consensus       215 Gla~~~~~~~---~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~  290 (346)
T 4fih_A          215 GFCAQVSKEV---PRRKSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL  290 (346)
T ss_dssp             TTCEECCSSS---CCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC
T ss_pred             cCceecCCCC---CcccccccCcCcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC
Confidence            9998765432   2234568999999999998755 899999999999999999999999876431         11   


Q ss_pred             CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhh
Q psy2172         243 TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKD  282 (291)
Q Consensus       243 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (291)
                      .......+.+.+++..|....|..||++.++..|||+.+.
T Consensus       291 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~  330 (346)
T 4fih_A          291 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  330 (346)
T ss_dssp             SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence            1112335678999999999999999999999999998753

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=5.8e-54  Score=357.60  Aligned_cols=250  Identities=24%  Similarity=0.370  Sum_probs=202.3

Q ss_pred             cccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC----hhHHHHHHHHhcCCCCCeeeEEEEEEe
Q psy2172          12 ERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIALLRELKHPNVINLISVFLS   87 (291)
Q Consensus        12 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~   87 (291)
                      .....+++|.-..++||+|+||.||+|.++.  +++.||+|.+......    +.+.+|+.+|++++|||||++++++..
T Consensus        19 ~~~~~~gr~~~~~~~iG~G~fg~Vy~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~   96 (290)
T 3fpq_A           19 VGMSNDGRFLKFDIEIGRGSFKTVYKGLDTE--TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWES   96 (290)
T ss_dssp             EEECTTSSEEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             cCcCCCCceEEeeeEEecCcCcEEEEEEECC--CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEee
Confidence            3444556664336689999999999999877  7788999998654322    458899999999999999999999854


Q ss_pred             --CCCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeeccCCCcEEeecC
Q psy2172          88 --HNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNW--VLHRDLKPANILVMGE  162 (291)
Q Consensus        88 --~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~dik~~Nil~~~~  162 (291)
                        .+...+|+|||||+| +|.+++.....         +++..++.++.|++.||+|||++|  |+||||||+|||++. 
T Consensus        97 ~~~~~~~~~lvmEy~~gg~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~-  166 (290)
T 3fpq_A           97 TVKGKKCIVLVTELMTSGTLKTYLKRFKV---------MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG-  166 (290)
T ss_dssp             EETTEEEEEEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESS-
T ss_pred             ccCCCcEEEEEEeCCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEEC-
Confidence              235679999999985 88888865332         899999999999999999999998  999999999999973 


Q ss_pred             CCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc-
Q psy2172         163 GIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI-  241 (291)
Q Consensus       163 ~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~-  241 (291)
                        .++.+||+|||+|+....     .......||+.|+|||++.+ + ++.++|||||||++|+|++|+.||.+..... 
T Consensus       167 --~~g~vKl~DFGla~~~~~-----~~~~~~~GTp~YmAPE~~~~-~-y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~  237 (290)
T 3fpq_A          167 --PTGSVKIGDLGLATLKRA-----SFAKAVIGTPEFMAPEMYEE-K-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQ  237 (290)
T ss_dssp             --TTSCEEECCTTGGGGCCT-----TSBEESCSSCCCCCGGGGGT-C-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH
T ss_pred             --CCCCEEEEeCcCCEeCCC-----CccCCcccCccccCHHHcCC-C-CCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH
Confidence              357899999999975433     22234689999999999875 4 8999999999999999999999997644310 


Q ss_pred             -----------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhh
Q psy2172         242 -----------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKD  282 (291)
Q Consensus       242 -----------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (291)
                                 ........+.+.+++..|....|..||++.++..|||+.++
T Consensus       238 ~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~~  289 (290)
T 3fpq_A          238 IYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             HHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             HHHHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence                       11222334678999999999999999999999999998653

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=6.4e-53  Score=366.54  Aligned_cols=243  Identities=23%  Similarity=0.415  Sum_probs=204.9

Q ss_pred             ccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC--CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEE
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT--GLSMSACREIALLRELKHPNVINLISVFLSHNDRKVW   94 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (291)
                      .+.|++ .++||+|+||.||+|.++.  +++.||||++...  ...+.+.+|+.+|+.++|||||+++++|.  +...+|
T Consensus       150 ~~~y~~-~~~iG~G~fG~V~~a~~~~--tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~--~~~~~~  224 (423)
T 4fie_A          150 RSYLDN-FIKIGEGSTGIVCIATVRS--SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL--VGDELW  224 (423)
T ss_dssp             GGTEEE-EEEEEECSSCEEEEEEETT--TCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEE--ETTEEE
T ss_pred             hHhcEe-eeEeccCcCcEEEEEEECC--CCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEE--ECCEEE
Confidence            345664 6799999999999999887  7789999999643  33456899999999999999999999994  567899


Q ss_pred             EEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEee
Q psy2172          95 LLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIAD  173 (291)
Q Consensus        95 iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~D  173 (291)
                      +|||||+| +|.+++...+          +++..++.++.||+.||+|||++||+||||||+|||++    .++.+||+|
T Consensus       225 iVmEy~~gG~L~~~i~~~~----------l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~----~~g~vKl~D  290 (423)
T 4fie_A          225 VVMEFLEGGALTDIVTHTR----------MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT----HDGRVKLSD  290 (423)
T ss_dssp             EEEECCTTEEHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEEC----TTCCEEECC
T ss_pred             EEEeCCCCCcHHHHHhccC----------CCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc----CCCCEEEec
Confidence            99999986 7877765321          89999999999999999999999999999999999998    678999999


Q ss_pred             cccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc------------
Q psy2172         174 MGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI------------  241 (291)
Q Consensus       174 fg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~------------  241 (291)
                      ||+|.......   .......||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.+.....            
T Consensus       291 FGla~~~~~~~---~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~  366 (423)
T 4fie_A          291 FGFCAQVSKEV---PRRKSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR  366 (423)
T ss_dssp             CTTCEECCSSC---CCBCCCEECTTTCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC
T ss_pred             CccceECCCCC---ccccccccCcCcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC
Confidence            99998765432   2235678999999999998755 8999999999999999999999998754310            


Q ss_pred             cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhh
Q psy2172         242 KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKD  282 (291)
Q Consensus       242 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (291)
                      ..........+.+++..|....|..|+++.++..|||+.+.
T Consensus       367 ~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~  407 (423)
T 4fie_A          367 LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  407 (423)
T ss_dssp             CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence            11122345778999999999999999999999999998753

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1e-52  Score=355.89  Aligned_cols=229  Identities=22%  Similarity=0.303  Sum_probs=189.5

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecCCC-
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-  102 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~~~-  102 (291)
                      .++||+|+||.||+|.++.  +++.||||+++.+..   ..+|+.+++.++|||||++++++  .+...+|+||||++| 
T Consensus        63 ~~~lG~G~fG~Vy~a~~~~--~g~~vAiK~i~~~~~---~~~E~~il~~l~HpnIV~l~~~~--~~~~~~~ivmEy~~gg  135 (336)
T 4g3f_A           63 QPRVGRGSFGEVHRMKDKQ--TGFQCAVKKVRLEVF---RVEELVACAGLSSPRIVPLYGAV--REGPWVNIFMELLEGG  135 (336)
T ss_dssp             EEEEEEETTEEEEEEEETT--TCCEEEEEEEETTTC---CTHHHHTTTTCCCTTBCCEEEEE--EETTEEEEEECCCTTC
T ss_pred             CcEeccCCCeEEEEEEECC--CCCEEEEEEECHHHh---HHHHHHHHHhCCCCCCCcEEEEE--EECCEEEEEEeccCCC
Confidence            6789999999999999887  778999999976433   24799999999999999999999  557789999999985 


Q ss_pred             CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCC-cEEEeecccceecC
Q psy2172         103 DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERG-RVKIADMGFARLFN  181 (291)
Q Consensus       103 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~-~~~l~Dfg~~~~~~  181 (291)
                      +|.+++.....         +++..++.++.|++.||+|||++||+||||||+|||++    .++ ++||+|||+|+...
T Consensus       136 ~L~~~l~~~~~---------l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~----~~g~~vKl~DFGla~~~~  202 (336)
T 4g3f_A          136 SLGQLIKQMGC---------LPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS----SDGSRAALCDFGHALCLQ  202 (336)
T ss_dssp             BHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEC----TTSCCEEECCCTTCEEC-
T ss_pred             cHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEe----CCCCEEEEeeCCCCeEcc
Confidence            99988875432         99999999999999999999999999999999999998    444 69999999998765


Q ss_pred             CCCCC--CCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc------------cCCCCC
Q psy2172         182 NPLKP--LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI------------KTSNPY  247 (291)
Q Consensus       182 ~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~------------~~~~~~  247 (291)
                      .....  ........||+.|+|||++.+.+ ++.++|||||||++|+|++|++||.+.....            ....+.
T Consensus       203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  281 (336)
T 4g3f_A          203 PDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPS  281 (336)
T ss_dssp             -----------CCCCCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTT
T ss_pred             CCCcccceecCCccccCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCcc
Confidence            43211  11223457999999999998855 9999999999999999999999998765431            123345


Q ss_pred             cHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         248 HHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       248 ~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      ..+.+.+++..|....|..||++.++
T Consensus       282 ~s~~~~~li~~~L~~dP~~R~sa~el  307 (336)
T 4g3f_A          282 CAPLTAQAIQEGLRKEPVHRASAMEL  307 (336)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCHHHHHHHHHHccCCHhHCcCHHHH
Confidence            56788999999999999999998875

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=4e-53  Score=354.22  Aligned_cols=244  Identities=22%  Similarity=0.353  Sum_probs=196.6

Q ss_pred             cccccccceeCcccceEEEEEEEcc-CCCCceeEEEEeCCCC----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCce
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKD-NSDTRDYALKQIEGTG----LSMSACREIALLRELKHPNVINLISVFLSHNDRK   92 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (291)
                      +.|++ .+.||+|+||.||+|++.. ..+++.||+|+++...    ....+.+|+.+|++++|||||++++++  .+...
T Consensus        24 ~~Y~i-~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~--~~~~~  100 (304)
T 3ubd_A           24 SQFEL-LKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAF--QTEGK  100 (304)
T ss_dssp             GGEEE-EEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEE--EETTE
T ss_pred             cccEE-EEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEE--EECCE
Confidence            45775 6799999999999999754 3367889999996432    234688899999999999999999999  55779


Q ss_pred             EEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEE
Q psy2172          93 VWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI  171 (291)
Q Consensus        93 ~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l  171 (291)
                      +|+|||||+| +|.+.+.....         +++..++.++.|++.||+|||++||+||||||+|||++    .++.+||
T Consensus       101 ~~ivmEy~~gg~L~~~l~~~~~---------l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~----~~g~vKl  167 (304)
T 3ubd_A          101 LYLILDFLRGGDLFTRLSKEVM---------FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD----EEGHIKL  167 (304)
T ss_dssp             EEEEECCCTTCEEHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC----TTSCEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEc----CCCCEEe
Confidence            9999999985 88888875432         89999999999999999999999999999999999998    6789999


Q ss_pred             eecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc---------cc
Q psy2172         172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED---------IK  242 (291)
Q Consensus       172 ~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~---------~~  242 (291)
                      +|||+|+......   .......||+.|+|||++.+.+ ++.++|||||||++|+|++|+.||.+.+..         ..
T Consensus       168 ~DFGla~~~~~~~---~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~  243 (304)
T 3ubd_A          168 TDFGLSKESIDHE---KKAYSFCGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL  243 (304)
T ss_dssp             ESSEEEEC--------CCCCSCCCCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred             cccccceeccCCC---ccccccccCcccCCHHHhccCC-CCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCC
Confidence            9999998654321   2234568999999999998755 999999999999999999999999886532         11


Q ss_pred             CCCCCcHHHHHHHHHhhCCCCcCChhh-----hhcCCCCcchhh
Q psy2172         243 TSNPYHHDQLDRIFSVMGFPLEKDWED-----IRKMPEHPTLLK  281 (291)
Q Consensus       243 ~~~~~~~~~~~~i~~~~~~~~~~~~~~-----~~~~~~~~~~~~  281 (291)
                      ......+..+.+++..|....|..|++     ++++..|||+..
T Consensus       244 ~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~  287 (304)
T 3ubd_A          244 GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST  287 (304)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred             CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence            223344677899999999999999997     578889999865

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2e-51  Score=357.41  Aligned_cols=252  Identities=33%  Similarity=0.516  Sum_probs=205.5

Q ss_pred             cccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC----hhHHHHHHHHhcCCCCCeeeEEEEEEeC-
Q psy2172          14 TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIALLRELKHPNVINLISVFLSH-   88 (291)
Q Consensus        14 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~-   88 (291)
                      ..+.++|++ .+.||+|+||.||+|.++.  +++.||||+++.....    ..+.+|+++|+.++|||||++++++... 
T Consensus        50 ~~i~~~Y~~-~~~lG~G~fG~V~~a~~~~--t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  126 (398)
T 4b99_A           50 FDVGDEYEI-IETIGNGAYGVVSSARRRL--TGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTV  126 (398)
T ss_dssp             CCCCSSEEE-EEEEEECSSCEEEEEEETT--TCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSS
T ss_pred             CCCCCCeEE-EEEEecccCeEEEEEEECC--CCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccc
Confidence            446678885 6799999999999999877  7789999999765433    3577899999999999999999997432 


Q ss_pred             ---CCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCC
Q psy2172          89 ---NDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIE  165 (291)
Q Consensus        89 ---~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~  165 (291)
                         +...+|+|||||+|+|.+.+....         .+++..++.++.||+.||+|||++||+||||||+|||++    .
T Consensus       127 ~~~~~~~~~ivmE~~~g~L~~~i~~~~---------~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~----~  193 (398)
T 4b99_A          127 PYGEFKSVYVVLDLMESDLHQIIHSSQ---------PLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVN----E  193 (398)
T ss_dssp             CTTTCCCEEEEEECCSEEHHHHHTSSS---------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----T
T ss_pred             ccccCCEEEEEEeCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccC----C
Confidence               346899999999999888876432         299999999999999999999999999999999999998    6


Q ss_pred             CCcEEEeecccceecCCCC-CCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---
Q psy2172         166 RGRVKIADMGFARLFNNPL-KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---  241 (291)
Q Consensus       166 ~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---  241 (291)
                      ++.+||+|||+|+...... ..........||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+...   
T Consensus       194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~  273 (398)
T 4b99_A          194 NCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQ  273 (398)
T ss_dssp             TCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHH
T ss_pred             CCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            7899999999998664422 222334567899999999999886668999999999999999999999998765310   


Q ss_pred             -----------------------------cCCC--------CCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         242 -----------------------------KTSN--------PYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       242 -----------------------------~~~~--------~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                                                   +...        +.......+++..|....|..|+++.++..|||+.+
T Consensus       274 ~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~  350 (398)
T 4b99_A          274 LIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAK  350 (398)
T ss_dssp             HHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTT
T ss_pred             HHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCc
Confidence                                         0000        112355678899999999999999999999999864

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.8e-51  Score=359.94  Aligned_cols=279  Identities=90%  Similarity=1.487  Sum_probs=223.9

Q ss_pred             CCcccceeecccccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCCCCeee
Q psy2172           1 MDYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVIN   80 (291)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~iv~   80 (291)
                      ||+.|+++....+..+.+.|++++++||+|+||.||+|.+++..+++.||+|++........+.+|+.+++.++||||++
T Consensus         3 ~~~~~~~~~~~~~~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~   82 (405)
T 3rgf_A            3 MDYDFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVIS   82 (405)
T ss_dssp             SCHHHHHHHHHHCCCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCcccccchhhhhhhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeee
Confidence            89999999999999999999999999999999999999988666788999999998877888999999999999999999


Q ss_pred             EEEEEEeCCCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEee
Q psy2172          81 LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVM  160 (291)
Q Consensus        81 ~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~  160 (291)
                      +++++...+....|+||||++++|.+.+..............+++..++.++.|++.||+|||++||+|+||||+||++.
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~  162 (405)
T 3rgf_A           83 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVM  162 (405)
T ss_dssp             CCEEEEETTTTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred             EeeEEecCCCCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEe
Confidence            99999877788999999999999999988766544433444589999999999999999999999999999999999996


Q ss_pred             cCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc
Q psy2172         161 GEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED  240 (291)
Q Consensus       161 ~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~  240 (291)
                      .++...+.++|+|||++.................||+.|+|||++.+...++.++|||||||++|+|++|.+||.+...+
T Consensus       163 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  242 (405)
T 3rgf_A          163 GEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED  242 (405)
T ss_dssp             CSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC--
T ss_pred             cCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccc
Confidence            54336789999999999876654333334455688999999999987666899999999999999999999999998887


Q ss_pred             ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         241 IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       241 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                      .....+...+++..++..++.|....|+.+..++.+..+
T Consensus       243 ~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~  281 (405)
T 3rgf_A          243 IKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTL  281 (405)
T ss_dssp             ----CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHH
T ss_pred             ccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhh
Confidence            777778888999999999999999999998877765443

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.9e-51  Score=343.56  Aligned_cols=243  Identities=21%  Similarity=0.320  Sum_probs=194.4

Q ss_pred             ccceeCcccceEEEEEEEccC---CCCceeEEEEeCCCCC--ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEE
Q psy2172          23 EGCKVGRGTYGHVYKARRKDN---SDTRDYALKQIEGTGL--SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLF   97 (291)
Q Consensus        23 ~~~~ig~G~~g~Vy~~~~~~~---~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~   97 (291)
                      .+++||+|+||.||+|.+.+.   .++..||||.++....  .+++.+|+++|++++|||||++++++  .+....|+||
T Consensus        17 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~--~~~~~~~lV~   94 (299)
T 4asz_A           17 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVC--VEGDPLIMVF   94 (299)
T ss_dssp             EEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE--CSSSSEEEEE
T ss_pred             EeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEE--eeCCEEEEEE
Confidence            378999999999999998642   3567899999975432  34688999999999999999999999  5567899999


Q ss_pred             ecCC-CCHHHHHHHhhhhh----hCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          98 DYAE-HDLWHIIKFHRAAK----ANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        98 e~~~-~~l~~~~~~~~~~~----~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      |||+ |+|.+++...+...    .......+++..+..++.|++.||+|||+++|+||||||+|||++    .++.+||+
T Consensus        95 Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~----~~~~~Ki~  170 (299)
T 4asz_A           95 EYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG----ENLLVKIG  170 (299)
T ss_dssp             ECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----GGGCEEEC
T ss_pred             EcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEEC----CCCcEEEC
Confidence            9998 59999987654211    112233489999999999999999999999999999999999998    67899999


Q ss_pred             ecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc----------c
Q psy2172         173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED----------I  241 (291)
Q Consensus       173 Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~----------~  241 (291)
                      |||+|+....... ........||+.|+|||++.+.. ++.++|||||||++|||++ |+.||.+.+..          .
T Consensus       171 DFGla~~~~~~~~-~~~~~~~~gt~~ymAPE~~~~~~-~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~  248 (299)
T 4asz_A          171 DFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV  248 (299)
T ss_dssp             CCSCHHHHTGGGC-EEETTTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCC
T ss_pred             CcccceecCCCCc-eeecCceecChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC
Confidence            9999986543211 11223457899999999998755 9999999999999999998 99999876532          1


Q ss_pred             cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         242 KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       242 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      ........+.+.+++..|....|..||++.++
T Consensus       249 ~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i  280 (299)
T 4asz_A          249 LQRPRTCPQEVYELMLGCWQREPHMRKNIKGI  280 (299)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence            23344556788999999999999999998875

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2e-50  Score=338.67  Aligned_cols=230  Identities=20%  Similarity=0.342  Sum_probs=182.1

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC----hhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEec
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDY   99 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~   99 (291)
                      +++||+|+||.||+|.+++     .||||+++.....    +.+.+|+.+|++++|||||++++++  . ...+|+||||
T Consensus        41 ~~~iG~G~fG~Vy~~~~~~-----~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~--~-~~~~~iVmEy  112 (307)
T 3omv_A           41 STRIGSGSFGTVYKGKWHG-----DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYM--T-KDNLAIVTQW  112 (307)
T ss_dssp             EEECCCCSSSEEEEEESSS-----EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE--C-SSSCEEEEEC
T ss_pred             eeEEeeCCCcEEEEEEECC-----cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE--E-CCeEEEEEEc
Confidence            7899999999999998643     4899998743322    4588999999999999999999987  2 3457999999


Q ss_pred             CCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccce
Q psy2172         100 AEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR  178 (291)
Q Consensus       100 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~  178 (291)
                      |++ +|.+.+....        ..+++..+..++.|++.||+|||+++|+||||||+|||++    .++.+||+|||+|+
T Consensus       113 ~~gGsL~~~l~~~~--------~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~----~~~~~Ki~DFGla~  180 (307)
T 3omv_A          113 CEGSSLYKHLHVQE--------TKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLH----EGLTVKIGDFGLAT  180 (307)
T ss_dssp             CSSCBHHHHHHTSC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEE----TTEEEEECCCSSCB
T ss_pred             CCCCCHHHHHhhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEEC----CCCcEEEeeccCce
Confidence            985 8888775332        1289999999999999999999999999999999999999    67899999999998


Q ss_pred             ecCCCCCCCCCCCCceecccccccccccCC--cCCCCchhHHHHHHHHHHHHcCCCCCCCCccc---------------c
Q psy2172         179 LFNNPLKPLADLDPVVVTFWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQED---------------I  241 (291)
Q Consensus       179 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~---------------~  241 (291)
                      ....... ........||+.|+|||++.+.  ..++.++|||||||+||||++|+.||.+....               .
T Consensus       181 ~~~~~~~-~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~  259 (307)
T 3omv_A          181 VKSRWSG-SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDL  259 (307)
T ss_dssp             C-------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCS
T ss_pred             ecccCCc-ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCc
Confidence            6543211 1223456899999999998642  34899999999999999999999999875431               1


Q ss_pred             cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCC
Q psy2172         242 KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMP  274 (291)
Q Consensus       242 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  274 (291)
                      ....+...+.+.+++..|....|..||++.++.
T Consensus       260 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~  292 (307)
T 3omv_A          260 SKLYKNCPKAMKRLVADCVKKVKEERPLFPQIL  292 (307)
T ss_dssp             TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHH
T ss_pred             ccccccchHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence            112234457789999999999999999887653

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.5e-50  Score=341.33  Aligned_cols=242  Identities=21%  Similarity=0.320  Sum_probs=186.5

Q ss_pred             cceeCcccceEEEEEEEcc---CCCCceeEEEEeCCCCC--ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEe
Q psy2172          24 GCKVGRGTYGHVYKARRKD---NSDTRDYALKQIEGTGL--SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFD   98 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~---~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e   98 (291)
                      .++||+|+||.||+|.+++   ..+++.||||.++....  .+++.+|+++|++++|||||++++++  .+....|+|||
T Consensus        46 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~--~~~~~~~lV~E  123 (329)
T 4aoj_A           46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVC--TEGRPLLMVFE  123 (329)
T ss_dssp             EEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE--CSSSSEEEEEE
T ss_pred             EEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE--EECCEEEEEEE
Confidence            6799999999999999864   23567899999975432  34689999999999999999999999  56778999999


Q ss_pred             cCC-CCHHHHHHHhhhhh------hCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEE
Q psy2172          99 YAE-HDLWHIIKFHRAAK------ANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI  171 (291)
Q Consensus        99 ~~~-~~l~~~~~~~~~~~------~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l  171 (291)
                      ||+ |+|.+++.......      ......++++..+..++.|++.||+|||+++|+||||||+|||++    .++.+||
T Consensus       124 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~----~~~~~Ki  199 (329)
T 4aoj_A          124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG----QGLVVKI  199 (329)
T ss_dssp             CCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE----TTTEEEE
T ss_pred             cCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC----CCCcEEE
Confidence            998 58888886543211      111233489999999999999999999999999999999999999    7789999


Q ss_pred             eecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc----------
Q psy2172         172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED----------  240 (291)
Q Consensus       172 ~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~----------  240 (291)
                      +|||+++....... ........||+.|+|||++.+.. ++.++|||||||+||||++ |+.||.+....          
T Consensus       200 ~DFGla~~~~~~~~-~~~~~~~~gt~~ymAPE~~~~~~-~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~  277 (329)
T 4aoj_A          200 GDFGMSRDIYSTDY-YRVGGRTMLPIRWMPPESILYRK-FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR  277 (329)
T ss_dssp             CCCC-----------------CCCCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTC
T ss_pred             cccccceeccCCCc-ceecCcccccccccChhhhcCCC-CCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence            99999986543221 12223457899999999998755 9999999999999999998 89999875532          


Q ss_pred             ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         241 IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       241 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      .........+.+.+++..|....|..||++.++
T Consensus       278 ~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei  310 (329)
T 4aoj_A          278 ELERPRACPPEVYAIMRGCWQREPQQRHSIKDV  310 (329)
T ss_dssp             CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHH
T ss_pred             CCCCcccccHHHHHHHHHHcCcChhHCcCHHHH
Confidence            122334456778999999999999999988864

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=5.3e-50  Score=344.86  Aligned_cols=249  Identities=22%  Similarity=0.331  Sum_probs=200.3

Q ss_pred             ccccccccccceeCcccceEEEEEEEcc-CCCCceeEEEEeCCCCCChhHHHHHHHHhcC-CCCCeeeEEEEEEeCCCce
Q psy2172          15 KVEDLFDYEGCKVGRGTYGHVYKARRKD-NSDTRDYALKQIEGTGLSMSACREIALLREL-KHPNVINLISVFLSHNDRK   92 (291)
Q Consensus        15 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~   92 (291)
                      ++.++|++ .++||+|+||.||+|.++. ..+++.||+|.+.......++.+|+++|+.+ +||||++++++|  .+...
T Consensus        18 ~l~~~Y~i-~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~--~~~~~   94 (361)
T 4f9c_A           18 QLSNVFKI-EDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCF--RKNDH   94 (361)
T ss_dssp             GGGGTCEE-EEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEE--EETTE
T ss_pred             CccCcEEE-EEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEE--EECCE
Confidence            57788996 6799999999999998753 3467889999998776677889999999998 699999999999  55779


Q ss_pred             EEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEE
Q psy2172          93 VWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI  171 (291)
Q Consensus        93 ~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l  171 (291)
                      +|+||||++| +|.+.+.            .+++..++.++.|++.||+|||++||+||||||+|||++.   +.+.+||
T Consensus        95 ~~lvmE~~~g~~L~~~~~------------~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~---~~~~~kl  159 (361)
T 4f9c_A           95 VVIAMPYLEHESFLDILN------------SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNR---RLKKYAL  159 (361)
T ss_dssp             EEEEEECCCCCCHHHHHT------------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET---TTTEEEE
T ss_pred             EEEEEeCCCcccHHHHHc------------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeC---CCCeEEE
Confidence            9999999975 8877762            1899999999999999999999999999999999999983   2368999


Q ss_pred             eecccceecCCCCCC-------------------------CCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHH
Q psy2172         172 ADMGFARLFNNPLKP-------------------------LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAE  226 (291)
Q Consensus       172 ~Dfg~~~~~~~~~~~-------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~  226 (291)
                      +|||+|+........                         ........||+.|+|||++.+.+.++.++||||+||++|+
T Consensus       160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~e  239 (361)
T 4f9c_A          160 VDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLS  239 (361)
T ss_dssp             CCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHH
T ss_pred             CcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHH
Confidence            999999865432110                         0112345799999999999886668999999999999999


Q ss_pred             HHcCCCCCCCCccccc----------------------------------------------------------------
Q psy2172         227 LLTSEPIFHCRQEDIK----------------------------------------------------------------  242 (291)
Q Consensus       227 l~~g~~pf~~~~~~~~----------------------------------------------------------------  242 (291)
                      |++|+.||....++..                                                                
T Consensus       240 ll~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~  319 (361)
T 4f9c_A          240 LLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNL  319 (361)
T ss_dssp             HHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC--------------------
T ss_pred             HHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccc
Confidence            9999999954332100                                                                


Q ss_pred             CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         243 TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       243 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                      ......++...++++.|....|..|+++.+..+|||+..
T Consensus       320 ~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~  358 (361)
T 4f9c_A          320 EGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKD  358 (361)
T ss_dssp             --CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred             cccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence            000112345677888999999999999999999998753

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=3.7e-50  Score=338.21  Aligned_cols=241  Identities=22%  Similarity=0.340  Sum_probs=190.6

Q ss_pred             cceeCcccceEEEEEEEcc---CCCCceeEEEEeCCCC---CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEE
Q psy2172          24 GCKVGRGTYGHVYKARRKD---NSDTRDYALKQIEGTG---LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLF   97 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~---~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~   97 (291)
                      .++||+|+||.||+|.+.+   ..+++.||||.++...   ..+++.+|+.+|++++|||||++++++  .+....++||
T Consensus        31 ~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~--~~~~~~~lV~  108 (308)
T 4gt4_A           31 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVV--TKDQPLSMIF  108 (308)
T ss_dssp             EEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEE--CSSSSCEEEE
T ss_pred             eeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEE--EECCEEEEEE
Confidence            5789999999999999753   2356789999997543   235789999999999999999999999  5567889999


Q ss_pred             ecCC-CCHHHHHHHhhhhh-------hCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcE
Q psy2172          98 DYAE-HDLWHIIKFHRAAK-------ANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRV  169 (291)
Q Consensus        98 e~~~-~~l~~~~~~~~~~~-------~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~  169 (291)
                      |||+ |+|.+++.......       .......+++..+..++.|++.||+|||+++||||||||+|||++    .++.+
T Consensus       109 Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~----~~~~~  184 (308)
T 4gt4_A          109 SYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY----DKLNV  184 (308)
T ss_dssp             ECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----GGGCE
T ss_pred             EcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC----CCCCE
Confidence            9998 58988886432110       011123389999999999999999999999999999999999999    67899


Q ss_pred             EEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc--------
Q psy2172         170 KIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED--------  240 (291)
Q Consensus       170 ~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~--------  240 (291)
                      ||+|||+++....... ........||+.|+|||++.+.. ++.++|||||||+||||++ |..||.+....        
T Consensus       185 Ki~DFGlar~~~~~~~-~~~~~~~~gt~~ymAPE~l~~~~-~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~  262 (308)
T 4gt4_A          185 KISDLGLFREVYAADY-YKLLGNSLLPIRWMAPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRN  262 (308)
T ss_dssp             EECCSCCBCGGGGGGC-BCSSSSSCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHT
T ss_pred             EECCcccceeccCCCc-eeEecccccCCcccCHHHHhCCC-CCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            9999999986543221 12234567899999999998754 9999999999999999998 89999886532        


Q ss_pred             --ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         241 --IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       241 --~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                        .........+.+.+++..|....|..||++.+
T Consensus       263 ~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~e  296 (308)
T 4gt4_A          263 RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKD  296 (308)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHH
Confidence              12233445667888888888888888888775

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.4e-50  Score=339.81  Aligned_cols=244  Identities=25%  Similarity=0.397  Sum_probs=182.5

Q ss_pred             cccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCC------
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHND------   90 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------   90 (291)
                      |++ .+.||+|+||.||+|.++.  +++.||||.++....   .+.+.+|+.+|++++|||||++++++...+.      
T Consensus         7 y~~-~~~lG~G~fg~V~~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            7 FEP-IQCLGRGGFGVVFEAKNKV--DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             EEE-EEEEEECC--EEEEEEETT--TCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             CEE-eeEEecCCCeEEEEEEECC--CCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            554 6799999999999999876  778999999864332   2457899999999999999999999865432      


Q ss_pred             ----ceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCC
Q psy2172          91 ----RKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIE  165 (291)
Q Consensus        91 ----~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~  165 (291)
                          .++|+|||||.+ +|.+.+.......      ..+...++.++.|++.||+|||++||+||||||+|||++    .
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~------~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~----~  153 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIE------ERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT----M  153 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGG------GSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----T
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCC------hhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEEC----C
Confidence                358999999975 8888876433211      145677899999999999999999999999999999998    6


Q ss_pred             CCcEEEeecccceecCCCCCC---------CCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCC
Q psy2172         166 RGRVKIADMGFARLFNNPLKP---------LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  236 (291)
Q Consensus       166 ~~~~~l~Dfg~~~~~~~~~~~---------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~  236 (291)
                      ++.+||+|||+|+........         ........||+.|+|||++.+.. ++.++|||||||++|+|++   ||.+
T Consensus       154 ~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyell~---Pf~~  229 (299)
T 4g31_A          154 DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFELLY---PFST  229 (299)
T ss_dssp             TCCEEECCCCCC--------------------------CCCTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred             CCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCC-CCCHHHHHHHHHHHHHHcc---CCCC
Confidence            679999999999876543211         11223457999999999998754 9999999999999999996   7865


Q ss_pred             Cccccc--------CCCC---CcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchh
Q psy2172         237 RQEDIK--------TSNP---YHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLL  280 (291)
Q Consensus       237 ~~~~~~--------~~~~---~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  280 (291)
                      ..+...        ...+   .......+++..|..+.|..||++.++.++||+.
T Consensus       230 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~  284 (299)
T 4g31_A          230 QMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFE  284 (299)
T ss_dssp             HHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGC
T ss_pred             ccHHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhC
Confidence            432110        0111   1123356789999999999999999999998875

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.9e-48  Score=333.24  Aligned_cols=249  Identities=20%  Similarity=0.321  Sum_probs=196.6

Q ss_pred             cccccccceeCcccceEEEEEEEccCC---CCceeEEEEeCCCCCC---hhHHHHHHHHhcCCC-CCeeeEEEEEEeCCC
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNS---DTRDYALKQIEGTGLS---MSACREIALLRELKH-PNVINLISVFLSHND   90 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~---~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~   90 (291)
                      +.|++ +++||+|+||.||+|.+.+..   ..+.||||.+......   +.+.+|+.+|.+++| ||||++++++.. ..
T Consensus        64 ~~~~l-~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~-~~  141 (353)
T 4ase_A           64 DRLKL-GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK-PG  141 (353)
T ss_dssp             GGEEE-EEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC-TT
T ss_pred             HHeEE-eeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe-cC
Confidence            34553 789999999999999987532   3467999999765432   358899999999965 899999999843 34


Q ss_pred             ceEEEEEecCC-CCHHHHHHHhhhhhhC-------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecC
Q psy2172          91 RKVWLLFDYAE-HDLWHIIKFHRAAKAN-------KKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGE  162 (291)
Q Consensus        91 ~~~~iv~e~~~-~~l~~~~~~~~~~~~~-------~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~  162 (291)
                      ..+++|||||+ |+|.+++.........       .....+++..+..++.|++.||+|||+++||||||||+|||++  
T Consensus       142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~--  219 (353)
T 4ase_A          142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS--  219 (353)
T ss_dssp             SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC--
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeC--
Confidence            57899999998 5999998765432110       1122389999999999999999999999999999999999998  


Q ss_pred             CCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc-
Q psy2172         163 GIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED-  240 (291)
Q Consensus       163 ~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~-  240 (291)
                        .++.+||+|||+|+....... ........||+.|+|||++.+.. ++.++|||||||+||||++ |..||.+.... 
T Consensus       220 --~~~~vKi~DFGlar~~~~~~~-~~~~~~~~gt~~ymAPE~l~~~~-y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~  295 (353)
T 4ase_A          220 --EKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  295 (353)
T ss_dssp             --GGGCEEECCCGGGSCTTTCTT-SEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             --CCCCEEECcchhhhhcccCCC-ceeeccccccccccCHHHHhcCC-CCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence              678999999999986654321 12234567899999999998754 9999999999999999998 99999886532 


Q ss_pred             ----------ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCC
Q psy2172         241 ----------IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMP  274 (291)
Q Consensus       241 ----------~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  274 (291)
                                .........+.+.+++..|....|..||++.++.
T Consensus       296 ~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil  339 (353)
T 4ase_A          296 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV  339 (353)
T ss_dssp             HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHH
Confidence                      1223334567788899999999999999888643

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=4.5e-48  Score=350.85  Aligned_cols=246  Identities=25%  Similarity=0.385  Sum_probs=201.3

Q ss_pred             ccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC-----CCChhHHH---HHHHHhcCCCCCeeeEEEE
Q psy2172          13 RTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-----GLSMSACR---EIALLRELKHPNVINLISV   84 (291)
Q Consensus        13 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~---e~~~l~~l~h~~iv~~~~~   84 (291)
                      ...+++ |++ .++||+|+||.||+|+++.  +++.||+|++++.     .....+.+   ++.+++.++|||||+++++
T Consensus       185 ~~sldd-f~i-~k~LG~G~fG~V~la~~~~--tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~  260 (689)
T 3v5w_A          185 HLTMND-FSV-HRIIGRGGFGEVYGCRKAD--TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA  260 (689)
T ss_dssp             CCCGGG-EEE-EEEEEECSSEEEEEEEETT--TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEE
T ss_pred             CCchHH-eEE-EEEEecccCeEEEEEEECC--CCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEE
Confidence            334444 664 6799999999999999887  7889999999632     12223333   3567777899999999999


Q ss_pred             EEeCCCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCC
Q psy2172          85 FLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEG  163 (291)
Q Consensus        85 ~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~  163 (291)
                      |  ++...+|+||||+.| +|...+.....         +++..++.++.||+.||+|||++||+||||||+|||++   
T Consensus       261 f--~~~~~lylVmEy~~GGdL~~~l~~~~~---------l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld---  326 (689)
T 3v5w_A          261 F--HTPDKLSFILDLMNGGDLHYHLSQHGV---------FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD---  326 (689)
T ss_dssp             E--ECSSEEEEEECCCCSCBHHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEEC---
T ss_pred             E--EECCEEEEEEecCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEe---
Confidence            9  678899999999985 89888875432         99999999999999999999999999999999999998   


Q ss_pred             CCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc---
Q psy2172         164 IERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED---  240 (291)
Q Consensus       164 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~---  240 (291)
                       .++.+||+|||+|+.....     .....+||+.|+|||++.+...|+.++|+|||||++|+|++|.+||.+....   
T Consensus       327 -~~G~vKL~DFGlA~~~~~~-----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~  400 (689)
T 3v5w_A          327 -EHGHVRISDLGLACDFSKK-----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH  400 (689)
T ss_dssp             -TTSCEEECCCTTCEECSSC-----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH
T ss_pred             -CCCCEEecccceeeecCCC-----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence             7789999999999876542     2345689999999999975455999999999999999999999999865432   


Q ss_pred             ---------ccCCCCCcHHHHHHHHHhhCCCCcCChhh-----hhcCCCCcchhhh
Q psy2172         241 ---------IKTSNPYHHDQLDRIFSVMGFPLEKDWED-----IRKMPEHPTLLKD  282 (291)
Q Consensus       241 ---------~~~~~~~~~~~~~~i~~~~~~~~~~~~~~-----~~~~~~~~~~~~~  282 (291)
                               ........+....+++..|....|..|++     +.++..|||+..-
T Consensus       401 ~i~~~i~~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i  456 (689)
T 3v5w_A          401 EIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL  456 (689)
T ss_dssp             HHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred             HHHHhhcCCCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence                     11223344677899999999999999987     5889999998754

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.8e-47  Score=322.25  Aligned_cols=236  Identities=24%  Similarity=0.304  Sum_probs=176.3

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHH--HHHHHHhcCCCCCeeeEEEEEEeCCC--ceE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC--REIALLRELKHPNVINLISVFLSHND--RKV   93 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~--~e~~~l~~l~h~~iv~~~~~~~~~~~--~~~   93 (291)
                      +.+.+ +++||+|+||.||+|.++    ++.||||+++... ...+.  .|+..+.+++|||||++++++..++.  ..+
T Consensus         3 r~i~L-~~~iG~G~fG~Vy~~~~~----g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~   76 (303)
T 3hmm_A            3 RTIVL-QESIGKGRFGEVWRGKWR----GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGEEE-EEEEEECSSSEEEEEEET----TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             cEEEE-EEEEeeCCCeEEEEEEEC----CEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence            44553 679999999999999874    5789999997543 23333  45555667899999999999975443  468


Q ss_pred             EEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhC--------CeeeeccCCCcEEeecCCC
Q psy2172          94 WLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSN--------WVLHRDLKPANILVMGEGI  164 (291)
Q Consensus        94 ~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~--------~ivH~dik~~Nil~~~~~~  164 (291)
                      |+||||++ |+|.+.+....          +++..+..++.|++.||+|||++        +|+||||||+|||++    
T Consensus        77 ~lV~Ey~~~gsL~~~l~~~~----------l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~----  142 (303)
T 3hmm_A           77 WLVSDYHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK----  142 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEEC----
T ss_pred             EEEecCCCCCcHHHHHHhCC----------CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEEC----
Confidence            99999998 58888876432          88999999999999999999987        999999999999998    


Q ss_pred             CCCcEEEeecccceecCCCCCCC-CCCCCceecccccccccccCCc-----CCCCchhHHHHHHHHHHHHcCCCCCCCCc
Q psy2172         165 ERGRVKIADMGFARLFNNPLKPL-ADLDPVVVTFWYRAPELLLGAR-----HYTKAIDIWAIGCIFAELLTSEPIFHCRQ  238 (291)
Q Consensus       165 ~~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~-----~~~~~~Dv~slG~~l~~l~~g~~pf~~~~  238 (291)
                      .++.+||+|||+++......... .......||+.|+|||++.+..     .++.++|||||||+||||++|.+||....
T Consensus       143 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~  222 (303)
T 3hmm_A          143 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE  222 (303)
T ss_dssp             TTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCC
T ss_pred             CCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccc
Confidence            67899999999998765543221 2233467999999999997532     25678999999999999999987765432


Q ss_pred             cccc--------------------------CCC-----CCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         239 EDIK--------------------------TSN-----PYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       239 ~~~~--------------------------~~~-----~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      ....                          ...     ......+.+++..|....|..||++.++
T Consensus       223 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei  288 (303)
T 3hmm_A          223 DYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI  288 (303)
T ss_dssp             CCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHH
T ss_pred             cccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHH
Confidence            2100                          000     0112346677777888888888877753

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=6.1e-48  Score=350.61  Aligned_cols=248  Identities=20%  Similarity=0.343  Sum_probs=204.5

Q ss_pred             cccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC--ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCc
Q psy2172          14 TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL--SMSACREIALLRELKHPNVINLISVFLSHNDR   91 (291)
Q Consensus        14 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (291)
                      ..+.+.|++ .+.||+|+||.||+|.++.  +++.||+|++.....  .+.+.+|+.+|+.++||||++++++|  .+..
T Consensus       153 ~~il~~Y~i-~~~lG~G~fg~V~~~~~~~--tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~--~~~~  227 (573)
T 3uto_A          153 DHVLDHYDI-HEELGTGAFGVVHRVTERA--TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF--EDDN  227 (573)
T ss_dssp             SCGGGTEEE-EEEEEEETTEEEEEEEETT--TCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE--ECSS
T ss_pred             CcCccccEE-EEEEeeccCeEEEEEEECC--CCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEE--EECC
Confidence            345567885 6799999999999999887  778999999875432  34588999999999999999999999  6678


Q ss_pred             eEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEE
Q psy2172          92 KVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVK  170 (291)
Q Consensus        92 ~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~  170 (291)
                      .+|+|||||.| +|.+.+....        ..+++..++.++.||+.||+|||++||+||||||+||+++.+  ..+.+|
T Consensus       228 ~~~iv~E~~~gg~L~~~i~~~~--------~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~--~~~~vK  297 (573)
T 3uto_A          228 EMVMIYEFMSGGELFEKVADEH--------NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK--RSNELK  297 (573)
T ss_dssp             EEEEEEECCCCCBHHHHHTCTT--------SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS--SCCCEE
T ss_pred             EEEEEEeecCCCcHHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCC--CCCCEE
Confidence            99999999985 8887775322        128999999999999999999999999999999999999843  346899


Q ss_pred             EeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---------
Q psy2172         171 IADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---------  241 (291)
Q Consensus       171 l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---------  241 (291)
                      |+|||+++.....    .......||+.|+|||++.+.+ ++.++|||||||++|+|++|..||.+.....         
T Consensus       298 l~DFG~a~~~~~~----~~~~~~~GT~~y~APEv~~~~~-y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~  372 (573)
T 3uto_A          298 LIDFGLTAHLDPK----QSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD  372 (573)
T ss_dssp             ECCCSSCEECCTT----SEEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC
T ss_pred             EeeccceeEccCC----CceeeeEECccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCC
Confidence            9999999876543    1223457999999999998855 8999999999999999999999998765421         


Q ss_pred             -c---CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         242 -K---TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       242 -~---~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                       .   ......++...+++..|....|..|+++.++..|||+.+
T Consensus       373 ~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~  416 (573)
T 3uto_A          373 WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP  416 (573)
T ss_dssp             CCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSC
T ss_pred             CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCC
Confidence             0   011123567888999999999999999999988888753

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.9e-45  Score=314.49  Aligned_cols=249  Identities=23%  Similarity=0.360  Sum_probs=208.9

Q ss_pred             ccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCC-----CCCChhHHHHHHHHhcCCCCCeeeEEEEEEeCC
Q psy2172          15 KVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEG-----TGLSMSACREIALLRELKHPNVINLISVFLSHN   89 (291)
Q Consensus        15 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   89 (291)
                      ..-+.|.+ .+.||+|+||.||+|.+..  +++.||+|++..     ......+.+|+.+++.++||||+++++++  .+
T Consensus         6 ~~i~~Y~i-~~~lG~G~~g~V~~a~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~--~~   80 (336)
T 3h4j_B            6 RHIGPYII-RETLGEGSFGKVKLATHYK--TQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVI--TT   80 (336)
T ss_dssp             SEETTEEE-EEEEEEETTEEEEEEEETT--TCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEE--EC
T ss_pred             cccCCEEE-EEEEecCCCeEEEEEEECC--CCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEE--Ee
Confidence            44567775 7799999999999999876  778899999853     23456789999999999999999999999  55


Q ss_pred             CceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcE
Q psy2172          90 DRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRV  169 (291)
Q Consensus        90 ~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~  169 (291)
                      ....++||||++|+|.+.+.....         +++..++.++.|++.||.|||++|++|+||||+||+++    .++.+
T Consensus        81 ~~~~~lv~E~~~g~l~~~l~~~~~---------l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~----~~~~~  147 (336)
T 3h4j_B           81 PTDIVMVIEYAGGELFDYIVEKKR---------MTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLD----DNLNV  147 (336)
T ss_dssp             SSEEEEEECCCCEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEEC----TTCCE
T ss_pred             CCEEEEEEECCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEc----CCCCE
Confidence            778999999999999988875432         89999999999999999999999999999999999998    67799


Q ss_pred             EEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc-------
Q psy2172         170 KIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK-------  242 (291)
Q Consensus       170 ~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~-------  242 (291)
                      +|+|||++......    .......||+.|+|||.+.+....+.++||||||+++|+|++|..||.+......       
T Consensus       148 kl~DFG~s~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~  223 (336)
T 3h4j_B          148 KIADFGLSNIMTDG----NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC  223 (336)
T ss_dssp             EECCSSCTBTTTTS----BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSS
T ss_pred             EEEEeccceeccCC----cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC
Confidence            99999999765432    2234457899999999998866457899999999999999999999987543211       


Q ss_pred             --CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhhhhh
Q psy2172         243 --TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDFNE  285 (291)
Q Consensus       243 --~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (291)
                        .........+.+++..|..+.|..||++.++..+||+...+.+
T Consensus       224 ~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~  268 (336)
T 3h4j_B          224 VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPD  268 (336)
T ss_dssp             CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTTCCG
T ss_pred             CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccCCcc
Confidence              1222345778999999999999999999999999998765544

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=5.7e-45  Score=310.86  Aligned_cols=247  Identities=23%  Similarity=0.398  Sum_probs=205.2

Q ss_pred             cccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC----hhHHHHHHHHhcCCCCCeeeEEEEEEeCC
Q psy2172          14 TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIALLRELKHPNVINLISVFLSHN   89 (291)
Q Consensus        14 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   89 (291)
                      ....+.|++ .+.||+|+||.||+|.+..  +++.||+|++......    +.+.+|+.+++.++||||+++++++  .+
T Consensus        11 ~~~~~~y~~-~~~lG~G~~g~V~~a~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~--~~   85 (328)
T 3fe3_A           11 QPHIGNYRL-LKTIGKGNFAKVKLARHIL--TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI--ET   85 (328)
T ss_dssp             CCEETTEEE-EEEEEECSSEEEEEEEETT--TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--EC
T ss_pred             CCccCCEEE-EEEEeeCCCEEEEEEEECC--CCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE--EE
Confidence            344566775 6799999999999999876  7788999999654322    3577899999999999999999999  56


Q ss_pred             CceEEEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCc
Q psy2172          90 DRKVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGR  168 (291)
Q Consensus        90 ~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~  168 (291)
                      ....|+||||++ ++|.+.+.....         +++..++.++.|++.||+|||++||+|+||||+||+++    .++.
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~~~---------l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~----~~~~  152 (328)
T 3fe3_A           86 EKTLYLIMEYASGGEVFDYLVAHGR---------MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLD----ADMN  152 (328)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTSC
T ss_pred             CCEEEEEEECCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEc----CCCC
Confidence            778999999996 488888765432         89999999999999999999999999999999999998    6779


Q ss_pred             EEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc-------
Q psy2172         169 VKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI-------  241 (291)
Q Consensus       169 ~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~-------  241 (291)
                      ++|+|||++......    .......||+.|+|||++.+....+.++|||||||++|+|++|..||.+.....       
T Consensus       153 ~kl~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~  228 (328)
T 3fe3_A          153 IKIADFGFSNEFTVG----GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR  228 (328)
T ss_dssp             EEECSTTCCGGGSSS----CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             EEEeeccCceecCCC----CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence            999999999765432    123445789999999999886645689999999999999999999998765321       


Q ss_pred             --cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhh
Q psy2172         242 --KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKD  282 (291)
Q Consensus       242 --~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (291)
                        ..........+.+++..|....|..||++.++.++||+...
T Consensus       229 ~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~  271 (328)
T 3fe3_A          229 GKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAG  271 (328)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTT
T ss_pred             CCCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCC
Confidence              11222345778899999999999999999999999998643

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=7.2e-45  Score=313.88  Aligned_cols=249  Identities=27%  Similarity=0.439  Sum_probs=205.7

Q ss_pred             ccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC--------ChhHHHHHHHHhcCCCCCeeeEEEE
Q psy2172          13 RTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL--------SMSACREIALLRELKHPNVINLISV   84 (291)
Q Consensus        13 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~e~~~l~~l~h~~iv~~~~~   84 (291)
                      ...+.+.|.+ ++.||+|+||.||+|.++.  +++.||+|++.....        ...+.+|+.+++.++||||++++++
T Consensus         7 ~~~~~~~y~~-~~~LG~G~fg~V~~~~~~~--~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~   83 (361)
T 2yab_A            7 QQKVEDFYDI-GEELGSGQFAIVKKCREKS--TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDV   83 (361)
T ss_dssp             CSCGGGTEEE-EEEEEEETTEEEEEEEETT--TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             CCChhhceEE-eeEEeeCcCEEEEEEEECC--CCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEE
Confidence            4567788886 7799999999999999876  678899999965432        2568899999999999999999999


Q ss_pred             EEeCCCceEEEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCC
Q psy2172          85 FLSHNDRKVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEG  163 (291)
Q Consensus        85 ~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~  163 (291)
                      +  .+....|+||||+. ++|.+.+....         .+++..++.++.|++.||.|||++||+|+||||+||+++.++
T Consensus        84 ~--~~~~~~~lv~e~~~gg~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~  152 (361)
T 2yab_A           84 Y--ENRTDVVLILELVSGGELFDFLAQKE---------SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKN  152 (361)
T ss_dssp             E--ECSSEEEEEEECCCSCBHHHHHTTCS---------CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTT
T ss_pred             E--EeCCEEEEEEEcCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCC
Confidence            9  56779999999996 58888774321         289999999999999999999999999999999999998543


Q ss_pred             CCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc-
Q psy2172         164 IERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK-  242 (291)
Q Consensus       164 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~-  242 (291)
                      .....++|+|||++......    .......||+.|+|||++.+.. ++.++|+||||+++|+|++|..||.+...... 
T Consensus       153 ~~~~~vkl~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~  227 (361)
T 2yab_A          153 IPIPHIKLIDFGLAHEIEDG----VEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETL  227 (361)
T ss_dssp             SSSCCEEECCCSSCEECCTT----CCCCCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH
T ss_pred             CCccCEEEEecCCceEcCCC----CccccCCCCccEECchHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            23348999999999876543    1234457899999999998744 89999999999999999999999987543210 


Q ss_pred             --------CCC----CCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchh
Q psy2172         243 --------TSN----PYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLL  280 (291)
Q Consensus       243 --------~~~----~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  280 (291)
                              ...    ....+.+.+++..|..+.|..||++.++..|||+.
T Consensus       228 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~  277 (361)
T 2yab_A          228 ANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT  277 (361)
T ss_dssp             HHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTS
T ss_pred             HHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcC
Confidence                    000    12346688999999999999999999999999986

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.9e-44  Score=303.86  Aligned_cols=246  Identities=23%  Similarity=0.379  Sum_probs=204.0

Q ss_pred             cccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC--CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCC
Q psy2172          12 ERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT--GLSMSACREIALLRELKHPNVINLISVFLSHN   89 (291)
Q Consensus        12 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   89 (291)
                      ......++|++ .++||+|+||.||+|.+..  +++.||+|.+...  .....+.+|+.+++.++||||+++++++.  .
T Consensus        14 ~~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~   88 (297)
T 3fxz_A           14 SVGDPKKKYTR-FEKIGQGASGTVYTAMDVA--TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL--V   88 (297)
T ss_dssp             BSSCGGGTBCC-CEEEEEETTEEEEEEEBTT--TCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE--E
T ss_pred             CcCChhhceee-eeeeccCCCeEEEEEEECC--CCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEE--E
Confidence            34455677885 7799999999999999766  7788999998533  33456889999999999999999999994  4


Q ss_pred             CceEEEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCc
Q psy2172          90 DRKVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGR  168 (291)
Q Consensus        90 ~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~  168 (291)
                      ....++||||+. ++|.+.+....          +++..++.++.|++.||+|||++|++|+||||+||+++    .++.
T Consensus        89 ~~~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~----~~~~  154 (297)
T 3fxz_A           89 GDELWVVMEYLAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG----MDGS  154 (297)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTCC
T ss_pred             CCEEEEEEECCCCCCHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEC----CCCC
Confidence            668999999996 58887775431          89999999999999999999999999999999999998    6678


Q ss_pred             EEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc--------
Q psy2172         169 VKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED--------  240 (291)
Q Consensus       169 ~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~--------  240 (291)
                      ++|+|||++........   ......||+.|+|||.+.+.. ++.++||||||+++|+|++|..||.+....        
T Consensus       155 ~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~  230 (297)
T 3fxz_A          155 VKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT  230 (297)
T ss_dssp             EEECCCTTCEECCSTTC---CBCCCCSCGGGCCHHHHHCSC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred             EEEeeCCCceecCCccc---ccCCccCCcCccChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence            99999999887654322   234457899999999998755 899999999999999999999999875431        


Q ss_pred             ----ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchh
Q psy2172         241 ----IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLL  280 (291)
Q Consensus       241 ----~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  280 (291)
                          ...........+.+++..|..+.|..||++.++..++|+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~  274 (297)
T 3fxz_A          231 NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLK  274 (297)
T ss_dssp             HCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGG
T ss_pred             CCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhc
Confidence                0111223456789999999999999999999999999875

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=5.6e-44  Score=302.86  Aligned_cols=232  Identities=41%  Similarity=0.792  Sum_probs=195.4

Q ss_pred             cccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC----ChhHHHHHHHHhcCCCCCeeeEEEEEEe
Q psy2172          12 ERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL----SMSACREIALLRELKHPNVINLISVFLS   87 (291)
Q Consensus        12 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~   87 (291)
                      ..+.+.++|++ .++||+|+||.||+|.+.   +++.||+|.+.....    ...+.+|+.++++++||||+++++++  
T Consensus        15 ~~q~l~~~y~~-~~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--   88 (311)
T 3niz_A           15 YFQGLMEKYQK-LEKVGEGTYGVVYKAKDS---QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI--   88 (311)
T ss_dssp             CEECSSCEEEE-EEEEEECSSCEEEEEEET---TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEE--
T ss_pred             eecchHhhhHh-hhhccCCCCeEEEEEEEC---CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEE--
Confidence            45667888886 779999999999999974   467899999874432    24678999999999999999999999  


Q ss_pred             CCCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCC
Q psy2172          88 HNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERG  167 (291)
Q Consensus        88 ~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~  167 (291)
                      .+....++||||+++++.+.+.....        .+++..++.++.|++.||+|||++||+|+||||+||+++    .++
T Consensus        89 ~~~~~~~lv~e~~~~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~----~~~  156 (311)
T 3niz_A           89 HSERCLTLVFEFMEKDLKKVLDENKT--------GLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLIN----SDG  156 (311)
T ss_dssp             CCSSCEEEEEECCSEEHHHHHHTCTT--------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTC
T ss_pred             ccCCEEEEEEcCCCCCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEEC----CCC
Confidence            66778999999999998888764332        289999999999999999999999999999999999998    667


Q ss_pred             cEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccCCCCC
Q psy2172         168 RVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY  247 (291)
Q Consensus       168 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~~~~~  247 (291)
                      .++|+|||++........   ......||+.|+|||.+.+...++.++||||||+++|+|++|..||.+....       
T Consensus       157 ~~kl~Dfg~a~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------  226 (311)
T 3niz_A          157 ALKLADFGLARAFGIPVR---SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD-------  226 (311)
T ss_dssp             CEEECCCTTCEETTSCCC------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT-------
T ss_pred             CEEEccCcCceecCCCcc---cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH-------
Confidence            899999999987654322   2234567999999999987666899999999999999999999999987764       


Q ss_pred             cHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         248 HHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       248 ~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                        +.+..+...++.|.+..|+...++
T Consensus       227 --~~~~~i~~~~~~~~~~~~~~~~~~  250 (311)
T 3niz_A          227 --DQLPKIFSILGTPNPREWPQVQEL  250 (311)
T ss_dssp             --THHHHHHHHHCCCCTTTSGGGTTS
T ss_pred             --HHHHHHHHHHCCCChHHhhhhhcc
Confidence              788999999999999988876654

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.1e-43  Score=300.13  Aligned_cols=235  Identities=40%  Similarity=0.759  Sum_probs=187.0

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC---CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT---GLSMSACREIALLRELKHPNVINLISVFLSHNDRKVW   94 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (291)
                      +.|++ .++||+|+||.||+|.++.  +++.||+|.++..   .....+.+|+.++++++||||+++++++  .+....+
T Consensus         5 ~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--~~~~~~~   79 (317)
T 2pmi_A            5 SQFKQ-LEKLGNGTYATVYKGLNKT--TGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI--HTENKLT   79 (317)
T ss_dssp             ---------------CEEEEEECSS--SCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEE--CCTTEEE
T ss_pred             cceeE-eeEECCCCCEEEEEEEECC--CCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEE--EECCeEE
Confidence            45664 6799999999999999766  6788999998643   2346788999999999999999999999  6677999


Q ss_pred             EEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          95 LLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        95 iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      +||||++++|.+.+.......   ....+++..++.++.|++.||.|||++||+|+||||+||+++    .++.++|+||
T Consensus        80 lv~e~~~~~L~~~l~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~----~~~~~kl~Df  152 (317)
T 2pmi_A           80 LVFEFMDNDLKKYMDSRTVGN---TPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLIN----KRGQLKLGDF  152 (317)
T ss_dssp             EEEECCCCBHHHHHHHHHSSS---CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTCCEEECCC
T ss_pred             EEEEecCCCHHHHHHhccccc---cccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEc----CCCCEEECcC
Confidence            999999999998887654321   122388999999999999999999999999999999999998    6779999999


Q ss_pred             ccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccCCCCCcHHHHHH
Q psy2172         175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR  254 (291)
Q Consensus       175 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  254 (291)
                      |.+........   ......||+.|+|||++.+...++.++|||||||++|+|++|..||.+...         .+.+..
T Consensus       153 g~~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---------~~~~~~  220 (317)
T 2pmi_A          153 GLARAFGIPVN---TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND---------EEQLKL  220 (317)
T ss_dssp             SSCEETTSCCC---CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---------HHHHHH
T ss_pred             ccceecCCCcc---cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHH
Confidence            99987653321   223456799999999998755689999999999999999999999998766         378889


Q ss_pred             HHHhhCCCCcCChhhhhcCCCC
Q psy2172         255 IFSVMGFPLEKDWEDIRKMPEH  276 (291)
Q Consensus       255 i~~~~~~~~~~~~~~~~~~~~~  276 (291)
                      +...++.|.+..|+.+..++.+
T Consensus       221 i~~~~~~~~~~~~~~~~~~~~~  242 (317)
T 2pmi_A          221 IFDIMGTPNESLWPSVTKLPKY  242 (317)
T ss_dssp             HHHHHCSCCTTTCGGGGGCTTC
T ss_pred             HHHHhCCCChhHhhhhhhhhhc
Confidence            9999999999999988776654

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.5e-45  Score=318.24  Aligned_cols=252  Identities=34%  Similarity=0.557  Sum_probs=196.0

Q ss_pred             cccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC----ChhHHHHHHHHhcCC-CCCeeeEEEEEE
Q psy2172          12 ERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL----SMSACREIALLRELK-HPNVINLISVFL   86 (291)
Q Consensus        12 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~-h~~iv~~~~~~~   86 (291)
                      ....+.++|.+ .+.||+|+||.||+|.++.  +++.||+|.+.....    ...+.+|+.+++.+. ||||+++++++.
T Consensus         3 v~~~~~~~y~~-~~~lG~G~~g~V~~~~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~   79 (388)
T 3oz6_A            3 VDRHVLRKYEL-VKKLGKGAYGIVWKSIDRR--TGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLR   79 (388)
T ss_dssp             -CHHHHTTEEE-EEC-------CEEEEEETT--TCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             ccCcccCceEE-EEEeeeCCCeEEEEEEECC--CCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEe
Confidence            34556778885 6799999999999999876  778899999864322    245778999999997 999999999997


Q ss_pred             eCCCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCC
Q psy2172          87 SHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIER  166 (291)
Q Consensus        87 ~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~  166 (291)
                      .++....|+||||++++|...+....          +++..+..++.|++.||+|||++||+||||||+||+++    .+
T Consensus        80 ~~~~~~~~lv~e~~~~~L~~~~~~~~----------~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~----~~  145 (388)
T 3oz6_A           80 ADNDRDVYLVFDYMETDLHAVIRANI----------LEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLN----AE  145 (388)
T ss_dssp             CTTSSCEEEEEECCSEEHHHHHHHTC----------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TT
T ss_pred             cCCCCEEEEEecccCcCHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEc----CC
Confidence            66667899999999999888886421          88999999999999999999999999999999999998    67


Q ss_pred             CcEEEeecccceecCCCCC------------------CCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHH
Q psy2172         167 GRVKIADMGFARLFNNPLK------------------PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL  228 (291)
Q Consensus       167 ~~~~l~Dfg~~~~~~~~~~------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~  228 (291)
                      +.++|+|||+++.......                  .........||+.|+|||++.+...++.++|||||||++|+|+
T Consensus       146 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell  225 (388)
T 3oz6_A          146 CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL  225 (388)
T ss_dssp             CCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred             CCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHH
Confidence            7999999999987543111                  0111234578999999999987566899999999999999999


Q ss_pred             cCCCCCCCCcccccC--------------------------------------------------------CCCCcHHHH
Q psy2172         229 TSEPIFHCRQEDIKT--------------------------------------------------------SNPYHHDQL  252 (291)
Q Consensus       229 ~g~~pf~~~~~~~~~--------------------------------------------------------~~~~~~~~~  252 (291)
                      +|.+||.+.+.....                                                        ......+.+
T Consensus       226 ~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (388)
T 3oz6_A          226 CGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEA  305 (388)
T ss_dssp             HSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHH
T ss_pred             hCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHH
Confidence            999999876531000                                                        001224567


Q ss_pred             HHHHHhhCCCCcCChhhhhcCCCCcchh
Q psy2172         253 DRIFSVMGFPLEKDWEDIRKMPEHPTLL  280 (291)
Q Consensus       253 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~  280 (291)
                      .+++..|....|..||++.++..||++.
T Consensus       306 ~dll~~~L~~dP~~R~t~~e~l~Hp~~~  333 (388)
T 3oz6_A          306 LDLLDKLLQFNPNKRISANDALKHPFVS  333 (388)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHTTSTTTT
T ss_pred             HHHHHHhhccCcccCCCHHHHhCCHHHH
Confidence            8899999999999999999999999875

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3.4e-43  Score=295.42  Aligned_cols=230  Identities=41%  Similarity=0.756  Sum_probs=192.5

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC----ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL----SMSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      ++|++ .++||+|+||.||+|.++.  +++.||+|++.....    ...+.+|+.++++++||||+++++++  .+....
T Consensus         2 ~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~~   76 (292)
T 3o0g_A            2 QKYEK-LEKIGEGTYGTVFKAKNRE--THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL--HSDKKL   76 (292)
T ss_dssp             CSEEE-EEEEEECSSSEEEEEEETT--TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE--EETTEE
T ss_pred             CCcee-eeEecCCCCeEEEEEEECC--CCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEE--EeCCEE
Confidence            35664 6799999999999999876  678899999964432    24678999999999999999999999  456789


Q ss_pred             EEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEee
Q psy2172          94 WLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIAD  173 (291)
Q Consensus        94 ~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~D  173 (291)
                      ++||||+++++.+.+.....        .+++..++.++.|++.||+|||++||+|+||||+||+++    .++.++|+|
T Consensus        77 ~lv~e~~~~~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~----~~~~~kl~D  144 (292)
T 3o0g_A           77 TLVFEFCDQDLKKYFDSCNG--------DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN----RNGELKLAN  144 (292)
T ss_dssp             EEEEECCSEEHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEECC
T ss_pred             EEEEecCCCCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc----CCCCEEEee
Confidence            99999999998888765332        289999999999999999999999999999999999998    677999999


Q ss_pred             cccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCC-CCCCcccccCCCCCcHHHH
Q psy2172         174 MGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI-FHCRQEDIKTSNPYHHDQL  252 (291)
Q Consensus       174 fg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p-f~~~~~~~~~~~~~~~~~~  252 (291)
                      ||.+.......   .......||..|+|||++.+...++.++||||||+++|+|++|..| |.+...         .+.+
T Consensus       145 fg~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~---------~~~~  212 (292)
T 3o0g_A          145 FGLARAFGIPV---RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV---------DDQL  212 (292)
T ss_dssp             CTTCEECCSCC---SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH---------HHHH
T ss_pred             cccceecCCcc---ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH---------HHHH
Confidence            99998765332   2224457799999999998766689999999999999999987766 544443         4788


Q ss_pred             HHHHHhhCCCCcCChhhhhcCCCC
Q psy2172         253 DRIFSVMGFPLEKDWEDIRKMPEH  276 (291)
Q Consensus       253 ~~i~~~~~~~~~~~~~~~~~~~~~  276 (291)
                      ..+.+.++.|.+..|+....++.+
T Consensus       213 ~~i~~~~~~~~~~~~~~~~~~~~~  236 (292)
T 3o0g_A          213 KRIFRLLGTPTEEQWPSMTKLPDY  236 (292)
T ss_dssp             HHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred             HHHHHHhCCCChhhhhhhcccccc
Confidence            999999999999999888776543

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.5e-43  Score=302.94  Aligned_cols=242  Identities=24%  Similarity=0.371  Sum_probs=200.6

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC-----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCce
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-----GLSMSACREIALLRELKHPNVINLISVFLSHNDRK   92 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (291)
                      +.|++ .+.||+|+||.||+|.++.  +++.||+|++++.     .....+.+|+.+++.++||||+++++++  .+...
T Consensus         5 ~~y~~-~~~lG~G~fg~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~--~~~~~   79 (337)
T 1o6l_A            5 NDFDY-LKLLGKGTFGKVILVREKA--TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF--QTHDR   79 (337)
T ss_dssp             GGEEE-EEEEEECSSEEEEEEEETT--TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE--ECSSE
T ss_pred             HHeEE-EEEEecCCCeEEEEEEECC--CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE--EeCCE
Confidence            34664 6799999999999999876  7788999998642     3345688999999999999999999999  56779


Q ss_pred             EEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEE
Q psy2172          93 VWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI  171 (291)
Q Consensus        93 ~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l  171 (291)
                      .|+||||++| +|...+.....         +++..++.++.|++.||+|||++||+|+||||+||+++    .++.++|
T Consensus        80 ~~lv~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~----~~g~vkL  146 (337)
T 1o6l_A           80 LCFVMEYANGGELFFHLSRERV---------FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD----KDGHIKI  146 (337)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTSCEEE
T ss_pred             EEEEEeCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEEC----CCCCEEE
Confidence            9999999985 88777764321         89999999999999999999999999999999999998    6789999


Q ss_pred             eecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---------c
Q psy2172         172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---------K  242 (291)
Q Consensus       172 ~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---------~  242 (291)
                      +|||+++......   .......||+.|+|||++.+.. ++.++|+||||+++|+|++|..||.+.....         .
T Consensus       147 ~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~  222 (337)
T 1o6l_A          147 TDFGLCKEGISDG---ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI  222 (337)
T ss_dssp             CCCTTCBCSCCTT---CCBCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred             eeccchhhcccCC---CcccccccChhhCChhhhcCCC-CCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCC
Confidence            9999997543221   2234568999999999998754 8999999999999999999999998765321         1


Q ss_pred             CCCCCcHHHHHHHHHhhCCCCcCChh-----hhhcCCCCcchhh
Q psy2172         243 TSNPYHHDQLDRIFSVMGFPLEKDWE-----DIRKMPEHPTLLK  281 (291)
Q Consensus       243 ~~~~~~~~~~~~i~~~~~~~~~~~~~-----~~~~~~~~~~~~~  281 (291)
                      .........+.+++..|....|..|+     ++.++..||++..
T Consensus       223 ~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~  266 (337)
T 1o6l_A          223 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence            12233457788999999999999998     7888888988764

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.1e-44  Score=306.40  Aligned_cols=250  Identities=27%  Similarity=0.408  Sum_probs=204.7

Q ss_pred             ccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC--------CChhHHHHHHHHhcCCCCCeeeEEEE
Q psy2172          13 RTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG--------LSMSACREIALLRELKHPNVINLISV   84 (291)
Q Consensus        13 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~e~~~l~~l~h~~iv~~~~~   84 (291)
                      ...+.+.|.+ ++.||+|+||.||+|.++.  +++.||+|++....        ....+.+|+.+++.++||||++++++
T Consensus         6 ~~~~~~~y~~-~~~lG~G~~g~V~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~   82 (326)
T 2y0a_A            6 QENVDDYYDT-GEELGSGQFAVVKKCREKS--TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEV   82 (326)
T ss_dssp             CSCHHHHEEE-EEEEECCSSEEEEEEEETT--TCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cCCcccceEe-ceEEeeCCCeEEEEEEECC--CCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            3457778885 7799999999999999876  67889999986432        23468899999999999999999999


Q ss_pred             EEeCCCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCC
Q psy2172          85 FLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEG  163 (291)
Q Consensus        85 ~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~  163 (291)
                      +  .+....++||||+.+ +|.+.+....         .+++..++.++.|++.||.|||++|++|+||||+||+++.++
T Consensus        83 ~--~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~  151 (326)
T 2y0a_A           83 Y--ENKTDVILILELVAGGELFDFLAEKE---------SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRN  151 (326)
T ss_dssp             E--ECSSEEEEEEECCCSCBHHHHHTTSS---------CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSS
T ss_pred             E--EeCCEEEEEEEcCCCCCHHHHHHhcC---------CcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCC
Confidence            9  567789999999974 8887775321         289999999999999999999999999999999999998543


Q ss_pred             CCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc-
Q psy2172         164 IERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK-  242 (291)
Q Consensus       164 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~-  242 (291)
                      .....++|+|||++.......    ......||+.|+|||++.+.. ++.++||||||+++|+|++|..||.+...... 
T Consensus       152 ~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  226 (326)
T 2y0a_A          152 VPKPRIKIIDFGLAHKIDFGN----EFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETL  226 (326)
T ss_dssp             SSSCCEEECCCTTCEECCTTS----CCCCCCSCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH
T ss_pred             CCCCCEEEEECCCCeECCCCC----ccccccCCcCcCCceeecCCC-CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH
Confidence            334489999999998765421    223457899999999997744 89999999999999999999999977543210 


Q ss_pred             -------C-C----CCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         243 -------T-S----NPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       243 -------~-~----~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                             . .    .......+.+++..|..+.|..||++.++..|||+..
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  277 (326)
T 2y0a_A          227 ANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP  277 (326)
T ss_dssp             HHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred             HHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence                   0 0    0123466889999999999999999999999998864

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=9.2e-44  Score=307.47  Aligned_cols=252  Identities=27%  Similarity=0.398  Sum_probs=205.1

Q ss_pred             cccccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC----hhHHHHHHHHhcCCCCCeeeEEEEE
Q psy2172          10 SNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIALLRELKHPNVINLISVF   85 (291)
Q Consensus        10 ~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~   85 (291)
                      ++....+.+.|.+ .+.||+|+||.||+|.++.  +++.||+|++......    +.+.+|+.+++.++||||+++++++
T Consensus        21 ~~~~~~~~~~y~~-~~~lG~G~~g~V~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~   97 (362)
T 2bdw_A           21 MNASTKFSDNYDV-KEELGKGAFSVVRRCVHKT--TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI   97 (362)
T ss_dssp             ---CCHHHHHEEE-EEEEEEETTEEEEEEEETT--TCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ecCCCCcccCeEE-eeEEecCCCeEEEEEEECC--CCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            3445567788885 6799999999999999876  6788999999754432    4578899999999999999999999


Q ss_pred             EeCCCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCC
Q psy2172          86 LSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGI  164 (291)
Q Consensus        86 ~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~  164 (291)
                        .+....|+||||+.+ +|.+.+....         .+++..++.++.|++.||+|||++||+|+||||+||+++.+. 
T Consensus        98 --~~~~~~~lv~e~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~-  165 (362)
T 2bdw_A           98 --QEESFHYLVFDLVTGGELFEDIVARE---------FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA-  165 (362)
T ss_dssp             --ECSSEEEEEECCCCSCBHHHHHTTCS---------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSS-
T ss_pred             --EeCCEEEEEEecCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCC-
Confidence              567789999999986 8877765321         289999999999999999999999999999999999998543 


Q ss_pred             CCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---
Q psy2172         165 ERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---  241 (291)
Q Consensus       165 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---  241 (291)
                      ....++|+|||++......    .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.....   
T Consensus       166 ~~~~~kl~DfG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~  240 (362)
T 2bdw_A          166 KGAAVKLADFGLAIEVNDS----EAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYA  240 (362)
T ss_dssp             TTCCEEECCCTTCBCCTTC----CSCCCSCSCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             CCCCEEEeecCcceEecCC----cccccCCCCccccCHHHHccCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            3457999999999865532    1223467899999999998754 8999999999999999999999998754310   


Q ss_pred             -------cCCC---CCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         242 -------KTSN---PYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       242 -------~~~~---~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                             ....   ......+.+++..|..+.|..||++.++..+||+..
T Consensus       241 ~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          241 QIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             HHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred             HHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence                   0001   123567889999999999999999999999999753

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.2e-43  Score=313.90  Aligned_cols=251  Identities=24%  Similarity=0.314  Sum_probs=205.4

Q ss_pred             ccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC----ChhHHHHHHHHhcCCCCCeeeEEEEEEeC
Q psy2172          13 RTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL----SMSACREIALLRELKHPNVINLISVFLSH   88 (291)
Q Consensus        13 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   88 (291)
                      ...+.+.|++ .+.||+|+||.||+|.++.  +++.+|+|++.....    .+.+.+|+.+++.++||||+++++++  .
T Consensus         6 ~~~~~~~Y~i-~~~LG~G~fg~V~~~~~~~--~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~--~   80 (444)
T 3soa_A            6 CTRFTEEYQL-FEELGKGAFSVVRRCVKVL--AGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI--S   80 (444)
T ss_dssp             -CHHHHHEEE-EEEEEEC--CEEEEEEETT--TTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE--E
T ss_pred             cccccCCeEE-EEEeccCCCeEEEEEEECC--CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE--E
Confidence            4566778885 7799999999999999876  778999999976543    23578999999999999999999999  5


Q ss_pred             CCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCC
Q psy2172          89 NDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERG  167 (291)
Q Consensus        89 ~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~  167 (291)
                      +....|+||||+.| +|.+.+....         .+++..+..++.|++.||.|||++||+|+||||+||+++.+. ..+
T Consensus        81 ~~~~~~lv~E~~~gg~L~~~i~~~~---------~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~-~~~  150 (444)
T 3soa_A           81 EEGHHYLIFDLVTGGELFEDIVARE---------YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKL-KGA  150 (444)
T ss_dssp             CSSEEEEEECCCBCCBHHHHHHHCS---------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSS-TTC
T ss_pred             ECCEEEEEEEeCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccC-CCC
Confidence            67899999999975 8888776532         289999999999999999999999999999999999998543 357


Q ss_pred             cEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc------
Q psy2172         168 RVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI------  241 (291)
Q Consensus       168 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~------  241 (291)
                      .++|+|||++.......   .......||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.....      
T Consensus       151 ~vkL~DFG~a~~~~~~~---~~~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~  226 (444)
T 3soa_A          151 AVKLADFGLAIEVEGEQ---QAWFGFAGTPGYLSPEVLRKDP-YGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIK  226 (444)
T ss_dssp             CEEECCCSSCBCCCTTC---CBCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             cEEEccCceeEEecCCC---ceeecccCCcccCCHHHhcCCC-CCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence            89999999997655432   1223467899999999998754 8999999999999999999999997755321      


Q ss_pred             -------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhh
Q psy2172         242 -------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKD  282 (291)
Q Consensus       242 -------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (291)
                             ....+...+.+.+++..|..+.|..||++.++..|||+...
T Consensus       227 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          227 AGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             HTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             hCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence                   11112345778999999999999999999999999998643

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.3e-43  Score=302.72  Aligned_cols=243  Identities=23%  Similarity=0.383  Sum_probs=201.4

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC-----CCChhHHHHHHHHhcC-CCCCeeeEEEEEEeCCCc
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-----GLSMSACREIALLREL-KHPNVINLISVFLSHNDR   91 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~   91 (291)
                      +.|.+ .+.||+|+||.||+|.++.  +++.||+|+++..     .....+..|..++..+ +||||+++++++  .+..
T Consensus        17 ~~y~~-~~~lG~G~fg~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~--~~~~   91 (345)
T 1xjd_A           17 EDFIL-HKMLGKGSFGKVFLAEFKK--TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF--QTKE   91 (345)
T ss_dssp             TTEEE-EEEEEECSSSEEEEEEETT--TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE--ECSS
T ss_pred             HHeEE-EEEEeeCCCeEEEEEEECC--CCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE--EeCC
Confidence            45664 6799999999999999876  7789999999642     3345677899999876 899999999999  5677


Q ss_pred             eEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEE
Q psy2172          92 KVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVK  170 (291)
Q Consensus        92 ~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~  170 (291)
                      ..|+||||+.| +|.+.+.....         +++..++.++.|++.||+|||++||+|+||||+||+++    .++.++
T Consensus        92 ~~~lv~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~----~~g~vk  158 (345)
T 1xjd_A           92 NLFFVMEYLNGGDLMYHIQSCHK---------FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD----KDGHIK  158 (345)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTSCEE
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEEC----CCCCEE
Confidence            99999999975 88888765332         89999999999999999999999999999999999998    677999


Q ss_pred             EeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc---------c
Q psy2172         171 IADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED---------I  241 (291)
Q Consensus       171 l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~---------~  241 (291)
                      |+|||+++......   .......||+.|+|||++.+.. ++.++|+|||||++|+|++|..||.+....         .
T Consensus       159 L~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~  234 (345)
T 1xjd_A          159 IADFGMCKENMLGD---AKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN  234 (345)
T ss_dssp             ECCCTTCBCCCCTT---CCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred             EeEChhhhhcccCC---CcccCCCCCcccCChhhhcCCC-CCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC
Confidence            99999997543221   2234567899999999998754 899999999999999999999999876532         1


Q ss_pred             cCCCCCcHHHHHHHHHhhCCCCcCChhhhh-cCCCCcchhhh
Q psy2172         242 KTSNPYHHDQLDRIFSVMGFPLEKDWEDIR-KMPEHPTLLKD  282 (291)
Q Consensus       242 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~~~~~~~~~  282 (291)
                      ..........+.+++..|....|..||++. ++..||++...
T Consensus       235 ~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~  276 (345)
T 1xjd_A          235 PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI  276 (345)
T ss_dssp             CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence            122334457789999999999999999998 88888887643

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=5.7e-44  Score=307.70  Aligned_cols=254  Identities=22%  Similarity=0.374  Sum_probs=205.3

Q ss_pred             ccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC-------CCChhHHHHHHHHhcCCCCCeeeEEEEE
Q psy2172          13 RTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-------GLSMSACREIALLRELKHPNVINLISVF   85 (291)
Q Consensus        13 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~   85 (291)
                      ...+.+.|++ .+.||+|+||.||+|.++.  +++.||+|++...       ...+.+.+|+.+++.++||||+++++++
T Consensus        19 ~~~~~~~y~~-~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~   95 (351)
T 3c0i_A           19 DVLFEDVYEL-CEVIGKGPFSVVRRCINRE--TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETY   95 (351)
T ss_dssp             -CCHHHHEEE-EEEEEECSSEEEEEEEETT--TCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CCccccceEE-eeEEeeCCCEEEEEEEECC--CCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            3456678885 7799999999999999876  6788999998521       1345688999999999999999999999


Q ss_pred             EeCCCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCC
Q psy2172          86 LSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGI  164 (291)
Q Consensus        86 ~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~  164 (291)
                        .+....|+||||+++ +|.+.+.......     ..+++..++.++.|++.||+|||++||+|+||||+||+++.++ 
T Consensus        96 --~~~~~~~lv~e~~~g~~L~~~l~~~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~-  167 (351)
T 3c0i_A           96 --SSDGMLYMVFEFMDGADLCFEIVKRADAG-----FVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKE-  167 (351)
T ss_dssp             --EETTEEEEEEECCSSCBHHHHHHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSS-
T ss_pred             --EeCCEEEEEEeCCCCCCHHHHHHHhcccC-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCC-
Confidence              456789999999985 8877776544321     1289999999999999999999999999999999999998543 


Q ss_pred             CCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc--
Q psy2172         165 ERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK--  242 (291)
Q Consensus       165 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~--  242 (291)
                      ....++|+|||++.......   .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+......  
T Consensus       168 ~~~~vkl~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  243 (351)
T 3c0i_A          168 NSAPVKLGGFGVAIQLGESG---LVAGGRVGTPHFMAPEVVKREP-YGKPVDVWGCGVILFILLSGCLPFYGTKERLFEG  243 (351)
T ss_dssp             TTCCEEECCCTTCEECCTTS---CBCCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHH
T ss_pred             CCCcEEEecCcceeEecCCC---eeecCCcCCcCccCHHHHcCCC-CCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHH
Confidence            34569999999998765432   1223457899999999998754 89999999999999999999999987543210  


Q ss_pred             ------CCC----CCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         243 ------TSN----PYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       243 ------~~~----~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                            ...    ......+.+++..|..+.|..||++.++..|||+..
T Consensus       244 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  292 (351)
T 3c0i_A          244 IIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE  292 (351)
T ss_dssp             HHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             HHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence                  000    123467889999999999999999999999998764

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=9.9e-44  Score=307.75  Aligned_cols=254  Identities=31%  Similarity=0.512  Sum_probs=208.2

Q ss_pred             ccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC---hhHHHHHHHHhcCCCCCeeeEEEEEEeCC
Q psy2172          13 RTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS---MSACREIALLRELKHPNVINLISVFLSHN   89 (291)
Q Consensus        13 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   89 (291)
                      ...+.++|++ .+.||+|+||.||+|.+..  +++.||+|.+......   ..+.+|+.++++++||||+++++++...+
T Consensus        22 ~~~~~~~y~~-~~~lG~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   98 (364)
T 3qyz_A           22 VFDVGPRYTN-LSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT   98 (364)
T ss_dssp             BCCCTTTEEE-EEEEEECSSEEEEEEEETT--TTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS
T ss_pred             eccccccEEE-EEEeecCCCeEEEEEEECC--CCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCC
Confidence            3455678885 6799999999999999876  6788999999753322   45789999999999999999999985322


Q ss_pred             ---CceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCC
Q psy2172          90 ---DRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIER  166 (291)
Q Consensus        90 ---~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~  166 (291)
                         ....|+|||+++++|.+.+....          +++..++.++.|++.||+|||++||+|+||||+||+++    .+
T Consensus        99 ~~~~~~~~iv~e~~~~~L~~~l~~~~----------~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~----~~  164 (364)
T 3qyz_A           99 IEQMKDVYIVQDLMETDLYKLLKTQH----------LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN----TT  164 (364)
T ss_dssp             TTTCCCEEEEEECCSEEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TT
T ss_pred             ccccceEEEEEcccCcCHHHHHHhCC----------CCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEEC----CC
Confidence               24789999999999988876422          89999999999999999999999999999999999998    67


Q ss_pred             CcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccC---
Q psy2172         167 GRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT---  243 (291)
Q Consensus       167 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~---  243 (291)
                      +.++|+|||.+.................||+.|+|||++.+...++.++|||||||++|+|++|..||.+.......   
T Consensus       165 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i  244 (364)
T 3qyz_A          165 CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI  244 (364)
T ss_dssp             CCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHH
T ss_pred             CCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHH
Confidence            78999999999876544333333345688999999999876566899999999999999999999999876532100   


Q ss_pred             -------------------------------------CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhhh
Q psy2172         244 -------------------------------------SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF  283 (291)
Q Consensus       244 -------------------------------------~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (291)
                                                           ..+.....+.+++..|..+.|..||++.++..+||+.+.+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  321 (364)
T 3qyz_A          245 LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY  321 (364)
T ss_dssp             HHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred             HHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence                                                 0012245688999999999999999999999999987653

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2e-43  Score=312.32  Aligned_cols=256  Identities=32%  Similarity=0.512  Sum_probs=200.5

Q ss_pred             cccccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC----hhHHHHHHHHhcCCCCCeeeEEEEE
Q psy2172          10 SNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIALLRELKHPNVINLISVF   85 (291)
Q Consensus        10 ~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~   85 (291)
                      .-....+.++|.+ .+.||+|+||.||+|.++.  +++.||||++......    ..+.+|+.+++.++||||+++++++
T Consensus        18 ~~~~~~i~~~y~~-~~~lG~G~~g~V~~a~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~   94 (432)
T 3n9x_A           18 GIKNVHVPDNYII-KHLIGRGSYGYVYLAYDKN--TEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLI   94 (432)
T ss_dssp             CGGGCCCCTTEEE-EEEEEEETTEEEEEEEETT--TTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEEC
T ss_pred             CCCcceecCCEEE-EEEEeecCCEEEEEEEECC--CCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEE
Confidence            3456678888986 7799999999999999876  7788999999754322    4678999999999999999999998


Q ss_pred             EeCCC---ceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecC
Q psy2172          86 LSHND---RKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGE  162 (291)
Q Consensus        86 ~~~~~---~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~  162 (291)
                      ...+.   ...|+||||++++|.+.+....         .+++..++.++.||+.||+|||++||+|+||||+||+++  
T Consensus        95 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~---------~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~--  163 (432)
T 3n9x_A           95 IPDDLLKFDELYIVLEIADSDLKKLFKTPI---------FLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLN--  163 (432)
T ss_dssp             CCSCTTTCCCEEEEEECCSEEHHHHHHSSC---------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC--
T ss_pred             ecCCCCcCCeEEEEEecCCcCHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEEC--
Confidence            54322   5799999999999988886422         289999999999999999999999999999999999998  


Q ss_pred             CCCCCcEEEeecccceecCCCCCCC-------------------CCCCCceecccccccccccCCcCCCCchhHHHHHHH
Q psy2172         163 GIERGRVKIADMGFARLFNNPLKPL-------------------ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCI  223 (291)
Q Consensus       163 ~~~~~~~~l~Dfg~~~~~~~~~~~~-------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~  223 (291)
                        .++.++|+|||+++.........                   .......||+.|+|||++.....++.++|||||||+
T Consensus       164 --~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~i  241 (432)
T 3n9x_A          164 --QDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCI  241 (432)
T ss_dssp             --TTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHH
T ss_pred             --CCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHH
Confidence              67899999999998765432110                   123456789999999997555569999999999999


Q ss_pred             HHHHHcC-----------CCCCCCCcccc-------------------------------------------------cC
Q psy2172         224 FAELLTS-----------EPIFHCRQEDI-------------------------------------------------KT  243 (291)
Q Consensus       224 l~~l~~g-----------~~pf~~~~~~~-------------------------------------------------~~  243 (291)
                      +|+|++|           .++|.+.....                                                 ..
T Consensus       242 l~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~  321 (432)
T 3n9x_A          242 FAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPH  321 (432)
T ss_dssp             HHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCC
T ss_pred             HHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCC
Confidence            9999984           45554432100                                                 00


Q ss_pred             --------CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         244 --------SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       244 --------~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                              ..+...+.+.+++..|....|..||++.++.+||++..
T Consensus       322 ~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~  367 (432)
T 3n9x_A          322 RKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKD  367 (432)
T ss_dssp             CCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTT
T ss_pred             CCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhh
Confidence                    00123466778999999999999999999999988764

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=4.9e-44  Score=304.72  Aligned_cols=252  Identities=22%  Similarity=0.345  Sum_probs=203.8

Q ss_pred             ccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC---CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCc
Q psy2172          15 KVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG---LSMSACREIALLRELKHPNVINLISVFLSHNDR   91 (291)
Q Consensus        15 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (291)
                      ...+.|++ .+.||+|+||.||+|.++.  +++.||+|++....   ..+.+.+|+.+++.++||||+++++++  .+..
T Consensus         4 ~~~~~y~i-~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~--~~~~   78 (323)
T 3tki_A            4 PFVEDWDL-VQTLGEGAYGEVQLAVNRV--TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR--REGN   78 (323)
T ss_dssp             TTTTCEEE-EEEEEEETTEEEEEEEETT--TCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEE--ECSS
T ss_pred             cHhhhcee-eeEEecCCCEEEEEEEECC--CCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEE--ecCC
Confidence            34567775 7799999999999999876  67889999986432   235688999999999999999999999  5677


Q ss_pred             eEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEE
Q psy2172          92 KVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVK  170 (291)
Q Consensus        92 ~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~  170 (291)
                      ..|+||||+++ +|.+.+...         ..+++..++.++.|++.||+|||++||+|+||||+||+++    ..+.++
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~----~~~~~k  145 (323)
T 3tki_A           79 IQYLFLEYCSGGELFDRIEPD---------IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD----ERDNLK  145 (323)
T ss_dssp             EEEEEEECCTTEEGGGGSBTT---------TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTCCEE
T ss_pred             eEEEEEEcCCCCcHHHHHhhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEe----CCCCEE
Confidence            89999999976 776665422         1289999999999999999999999999999999999998    667899


Q ss_pred             EeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc--------
Q psy2172         171 IADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK--------  242 (291)
Q Consensus       171 l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~--------  242 (291)
                      |+|||++........ ........||+.|+|||++.+...++.++||||||+++|+|++|..||........        
T Consensus       146 l~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~  224 (323)
T 3tki_A          146 ISDFGLATVFRYNNR-ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK  224 (323)
T ss_dssp             ECCCTTCEECEETTE-ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTT
T ss_pred             EEEeeccceeccCCc-ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcc
Confidence            999999986543211 11223457899999999998766457899999999999999999999987654210        


Q ss_pred             ----CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhhhhh
Q psy2172         243 ----TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDFNE  285 (291)
Q Consensus       243 ----~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (291)
                          .........+.+++..|....|..||++.++..++|+.+.+..
T Consensus       225 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~  271 (323)
T 3tki_A          225 KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKK  271 (323)
T ss_dssp             CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCCC
T ss_pred             cccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccccc
Confidence                1112335678899999999999999999999999998765543

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.6e-43  Score=295.63  Aligned_cols=229  Identities=41%  Similarity=0.791  Sum_probs=189.6

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG----LSMSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      ++|++ .+.||+|+||.||+|.+.   +++.||+|.+....    ....+.+|+.+++.++||||+++++++  .+....
T Consensus         2 ~~y~~-~~~lg~G~~g~V~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~~   75 (288)
T 1ob3_A            2 EKYHG-LEKIGEGTYGVVYKAQNN---YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI--HTKKRL   75 (288)
T ss_dssp             CSEEE-EEEEEEETTEEEEEEEET---TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEE--ECSSCE
T ss_pred             ccchh-hhhcccCCCEEEEEEEcC---CCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEE--ccCCeE
Confidence            35664 679999999999999973   56789999986432    235688999999999999999999999  556789


Q ss_pred             EEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEee
Q psy2172          94 WLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIAD  173 (291)
Q Consensus        94 ~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~D  173 (291)
                      ++||||++++|.+.+.....        .+++..++.++.|++.||+|||++||+|+||||+||+++    .++.++|+|
T Consensus        76 ~lv~e~~~~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~----~~~~~kl~D  143 (288)
T 1ob3_A           76 VLVFEHLDQDLKKLLDVCEG--------GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN----REGELKIAD  143 (288)
T ss_dssp             EEEEECCSEEHHHHHHTSTT--------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTSCEEECC
T ss_pred             EEEEEecCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc----CCCCEEEeE
Confidence            99999999998888764322        288999999999999999999999999999999999998    677999999


Q ss_pred             cccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccCCCCCcHHHHH
Q psy2172         174 MGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD  253 (291)
Q Consensus       174 fg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  253 (291)
                      ||++........   ......||+.|+|||.+.+...++.++||||||+++|+|++|..||.+...         .+.+.
T Consensus       144 fg~~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---------~~~~~  211 (288)
T 1ob3_A          144 FGLARAFGIPVR---KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE---------ADQLM  211 (288)
T ss_dssp             TTHHHHHCC------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---------HHHHH
T ss_pred             CccccccCcccc---ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---------HHHHH
Confidence            999986543211   223456799999999997755689999999999999999999999988765         37788


Q ss_pred             HHHHhhCCCCcCChhhhhcCCCC
Q psy2172         254 RIFSVMGFPLEKDWEDIRKMPEH  276 (291)
Q Consensus       254 ~i~~~~~~~~~~~~~~~~~~~~~  276 (291)
                      .+.+.++.+....||...+++.+
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T 1ob3_A          212 RIFRILGTPNSKNWPNVTELPKY  234 (288)
T ss_dssp             HHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             HHHHHHCCCChhhchhhhccccc
Confidence            89999999999999887766543

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=5e-44  Score=318.38  Aligned_cols=247  Identities=30%  Similarity=0.470  Sum_probs=197.0

Q ss_pred             cccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC----CChhHHHHHHHHhcCCCCCeeeEEEEEEe
Q psy2172          12 ERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG----LSMSACREIALLRELKHPNVINLISVFLS   87 (291)
Q Consensus        12 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   87 (291)
                      ....+.++|++ .++||+|+||.||+|.+..  +++.||||++....    ....+.+|+.+++.++||||+++++++..
T Consensus        56 ~~~~~~~~y~~-~~~lG~G~~g~V~~a~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  132 (464)
T 3ttj_A           56 STFTVLKRYQN-LKPIGSGAQGIVCAAYDAV--LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP  132 (464)
T ss_dssp             CEEEEETTEEE-EEEEEECSSCEEEEEEETT--TTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred             cceeecCCeEE-EEEeecCCCeEEEEEEECC--CCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEcc
Confidence            34456778885 7799999999999999876  67889999997542    23457899999999999999999999954


Q ss_pred             C----CCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCC
Q psy2172          88 H----NDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEG  163 (291)
Q Consensus        88 ~----~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~  163 (291)
                      .    +....|+||||+++++.+.+..           .+++..++.++.|++.||+|||++||+||||||+||+++   
T Consensus       133 ~~~~~~~~~~~lv~E~~~~~l~~~~~~-----------~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~---  198 (464)
T 3ttj_A          133 QKTLEEFQDVYLVMELMDANLCQVIQM-----------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---  198 (464)
T ss_dssp             CCSTTTCCEEEEEEECCSEEHHHHHTS-----------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---
T ss_pred             CCccccCCeEEEEEeCCCCCHHHHHhh-----------cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEe---
Confidence            3    2257899999999988776631           188999999999999999999999999999999999998   


Q ss_pred             CCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc-
Q psy2172         164 IERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK-  242 (291)
Q Consensus       164 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~-  242 (291)
                       .++.++|+|||++......    .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+...... 
T Consensus       199 -~~~~~kl~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~  272 (464)
T 3ttj_A          199 -SDCTLKILDFGLARTAGTS----FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW  272 (464)
T ss_dssp             -TTSCEEECCCCCC-----C----CCC----CCCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             -CCCCEEEEEEEeeeecCCC----cccCCCcccccccCHHHHcCCC-CCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence             6779999999999865432    2234567899999999998854 89999999999999999999999987642100 


Q ss_pred             ------------------------------CCCC--------C------------cHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         243 ------------------------------TSNP--------Y------------HHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       243 ------------------------------~~~~--------~------------~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                                                    ....        .            ....+.+++..|....|..||++.+
T Consensus       273 ~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e  352 (464)
T 3ttj_A          273 NKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD  352 (464)
T ss_dssp             HHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             HHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHH
Confidence                                          0000        0            0345788999999999999999999


Q ss_pred             CCCCcchhh
Q psy2172         273 MPEHPTLLK  281 (291)
Q Consensus       273 ~~~~~~~~~  281 (291)
                      +.+|||+..
T Consensus       353 ~L~Hp~~~~  361 (464)
T 3ttj_A          353 ALQHPYINV  361 (464)
T ss_dssp             HHTSTTTGG
T ss_pred             HhcChhhhh
Confidence            999999864

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2e-43  Score=300.02  Aligned_cols=240  Identities=25%  Similarity=0.417  Sum_probs=200.6

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC-----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCce
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-----GLSMSACREIALLRELKHPNVINLISVFLSHNDRK   92 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (291)
                      +.|.+ .+.||+|+||.||+|.++.  +++.||+|+++..     .....+.+|+.+++.++||||+++++++  .+...
T Consensus         6 ~~y~~-~~~lG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~--~~~~~   80 (318)
T 1fot_A            6 QDFQI-LRTLGTGSFGRVHLIRSRH--NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF--QDAQQ   80 (318)
T ss_dssp             GGEEE-EEEEEECSSCEEEEEEETT--TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE--ECSSE
T ss_pred             HHcEE-EEEEeeCCCEEEEEEEECC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE--EeCCE
Confidence            34564 6799999999999999876  7789999998642     2345678899999999999999999999  56779


Q ss_pred             EEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEE
Q psy2172          93 VWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI  171 (291)
Q Consensus        93 ~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l  171 (291)
                      .|+||||+.| +|.+.+.....         +++..++.++.|++.||+|||++||+|+||||+||+++    .++.++|
T Consensus        81 ~~lv~e~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~----~~g~~kL  147 (318)
T 1fot_A           81 IFMIMDYIEGGELFSLLRKSQR---------FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD----KNGHIKI  147 (318)
T ss_dssp             EEEEECCCCSCBHHHHHHHTSS---------CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC----TTSCEEE
T ss_pred             EEEEEeCCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEc----CCCCEEE
Confidence            9999999975 88888765322         89999999999999999999999999999999999998    6789999


Q ss_pred             eecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc---------cc
Q psy2172         172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED---------IK  242 (291)
Q Consensus       172 ~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~---------~~  242 (291)
                      +|||++......      .....||+.|+|||++.+.. ++.++|+|||||++|+|++|..||.+....         ..
T Consensus       148 ~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  220 (318)
T 1fot_A          148 TDFGFAKYVPDV------TYTLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL  220 (318)
T ss_dssp             CCCSSCEECSSC------BCCCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC
T ss_pred             eecCcceecCCc------cccccCCccccCHhHhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence            999999865432      23457899999999998754 899999999999999999999999875432         11


Q ss_pred             CCCCCcHHHHHHHHHhhCCCCcCChh-----hhhcCCCCcchhhh
Q psy2172         243 TSNPYHHDQLDRIFSVMGFPLEKDWE-----DIRKMPEHPTLLKD  282 (291)
Q Consensus       243 ~~~~~~~~~~~~i~~~~~~~~~~~~~-----~~~~~~~~~~~~~~  282 (291)
                      ...+.....+.+++..|....|..|+     +++++..|||+...
T Consensus       221 ~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~  265 (318)
T 1fot_A          221 RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV  265 (318)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence            22334457789999999999999998     78888999998653

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-43  Score=316.45  Aligned_cols=253  Identities=33%  Similarity=0.528  Sum_probs=188.9

Q ss_pred             cccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC----hhHHHHHHHHhcCCCCCeeeEEEEEEeC-
Q psy2172          14 TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIALLRELKHPNVINLISVFLSH-   88 (291)
Q Consensus        14 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~-   88 (291)
                      ..+.++|++ .++||+|+||.||+|.++.  +++.||||.+......    ..+.+|+.+|+.++||||+++++++... 
T Consensus        49 ~~~~~~y~~-~~~lG~G~~g~V~~~~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  125 (458)
T 3rp9_A           49 WQIPDRYEI-RHLIGTGSYGHVCEAYDKL--EKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKD  125 (458)
T ss_dssp             CCSCTTEEE-CCC-------CEEEEEECC----CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred             CccCCCeEE-eeEeeecCCeEEEEEEECC--CCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCC
Confidence            456788886 6799999999999999876  6788999998654322    4578999999999999999999998543 


Q ss_pred             --CCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCC
Q psy2172          89 --NDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIER  166 (291)
Q Consensus        89 --~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~  166 (291)
                        +...+|+|||+++++|...+....         .+++..++.++.||+.||+|||++||+||||||+|||++    .+
T Consensus       126 ~~~~~~~~lv~e~~~~~L~~~~~~~~---------~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~----~~  192 (458)
T 3rp9_A          126 VEKFDELYVVLEIADSDFKKLFRTPV---------YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVN----QD  192 (458)
T ss_dssp             TTTCCCEEEEECCCSEEHHHHHHSSC---------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TT
T ss_pred             cccCceEEEEEeccccchhhhcccCC---------CCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEEC----CC
Confidence              235799999999999988876322         289999999999999999999999999999999999998    67


Q ss_pred             CcEEEeecccceecCCCCCCC------------------------CCCCCceecccccccccccCCcCCCCchhHHHHHH
Q psy2172         167 GRVKIADMGFARLFNNPLKPL------------------------ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGC  222 (291)
Q Consensus       167 ~~~~l~Dfg~~~~~~~~~~~~------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~  222 (291)
                      +.++|+|||+++.........                        .......||+.|+|||++.....++.++|||||||
T Consensus       193 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~  272 (458)
T 3rp9_A          193 CSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGC  272 (458)
T ss_dssp             CCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHH
T ss_pred             CCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHH
Confidence            799999999998765322110                        12234577999999998755456999999999999


Q ss_pred             HHHHHHc-----------CCCCCCCCcccc--------------------------------------------------
Q psy2172         223 IFAELLT-----------SEPIFHCRQEDI--------------------------------------------------  241 (291)
Q Consensus       223 ~l~~l~~-----------g~~pf~~~~~~~--------------------------------------------------  241 (291)
                      ++|+|++           |.++|.+.....                                                  
T Consensus       273 il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~  352 (458)
T 3rp9_A          273 IFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIR  352 (458)
T ss_dssp             HHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHT
T ss_pred             HHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHH
Confidence            9999998           778887654200                                                  


Q ss_pred             ----------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhh
Q psy2172         242 ----------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKD  282 (291)
Q Consensus       242 ----------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (291)
                                ....+.....+.+++..|....|..|+++.++..|||+...
T Consensus       353 ~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~  403 (458)
T 3rp9_A          353 IFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV  403 (458)
T ss_dssp             TSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             hcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence                      00011224567788899999999999999998888887643

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=9.5e-44  Score=306.09  Aligned_cols=242  Identities=24%  Similarity=0.362  Sum_probs=196.6

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC-----CCChhHHHHHHHHhcC-CCCCeeeEEEEEEeCCCc
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-----GLSMSACREIALLREL-KHPNVINLISVFLSHNDR   91 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~   91 (291)
                      +.|++ .+.||+|+||.||+|.++.  +++.||+|+++..     .....+.+|..+++.+ +||||+++++++  .+..
T Consensus        23 ~~y~~-~~~lG~G~fg~V~~~~~~~--~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~--~~~~   97 (353)
T 3txo_A           23 DNFEF-IRVLGKGSFGKVMLARVKE--TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF--QTPD   97 (353)
T ss_dssp             CCEEE-EEEEEEETTEEEEEEEETT--TCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE--ECSS
T ss_pred             hheEE-EEEEeeCCCEEEEEEEEcC--CCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE--EeCC
Confidence            45664 6799999999999999876  6788999998643     2344577899999988 799999999999  5677


Q ss_pred             eEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEE
Q psy2172          92 KVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVK  170 (291)
Q Consensus        92 ~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~  170 (291)
                      ..|+||||+.| +|...+.....         +++..++.++.|++.||+|||++||+||||||+||+++    .++.++
T Consensus        98 ~~~lv~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~----~~g~ik  164 (353)
T 3txo_A           98 RLFFVMEFVNGGDLMFHIQKSRR---------FDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLD----HEGHCK  164 (353)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTSCEE
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEEC----CCCCEE
Confidence            89999999985 88877765432         89999999999999999999999999999999999998    678999


Q ss_pred             EeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc---------c
Q psy2172         171 IADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED---------I  241 (291)
Q Consensus       171 l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~---------~  241 (291)
                      |+|||+++......   .......||+.|+|||++.+.. ++.++|+|||||++|+|++|..||.+....         .
T Consensus       165 L~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~  240 (353)
T 3txo_A          165 LADFGMCKEGICNG---VTTATFCGTPDYIAPEILQEML-YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE  240 (353)
T ss_dssp             ECCCTTCBCSCC------------CCGGGCCHHHHHHHH-CTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred             EccccceeecccCC---ccccccCCCcCeEChhhcCCCC-cCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence            99999997533221   2234567899999999998744 899999999999999999999999876542         1


Q ss_pred             cCCCCCcHHHHHHHHHhhCCCCcCChhhh------hcCCCCcchhh
Q psy2172         242 KTSNPYHHDQLDRIFSVMGFPLEKDWEDI------RKMPEHPTLLK  281 (291)
Q Consensus       242 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~------~~~~~~~~~~~  281 (291)
                      ..........+.+++..|....|..|++.      .++..||++..
T Consensus       241 ~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~  286 (353)
T 3txo_A          241 VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE  286 (353)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred             CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence            12233345778899999999999999988      67888888764

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.6e-43  Score=305.85  Aligned_cols=251  Identities=25%  Similarity=0.339  Sum_probs=194.7

Q ss_pred             ccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC-CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          15 KVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-GLSMSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        15 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      ...++|.+ .+.||+|+||.||+|.++.  +++.||+|++... .....+.+|+.+++.++||||+++++++  .+....
T Consensus        17 ~~~~~y~~-~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~--~~~~~~   91 (361)
T 3uc3_A           17 HDSDRYDF-VKDIGSGNFGVARLMRDKL--TKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVI--LTPTHL   91 (361)
T ss_dssp             CCTTTEEE-EEEESSSTTSSEEEEEETT--TCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEE--ECSSEE
T ss_pred             CCCCcEEE-EEEeccCCCEEEEEEEECC--CCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEE--eeCCEE
Confidence            34567885 6799999999999999876  6788999999754 3456788999999999999999999999  456789


Q ss_pred             EEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          94 WLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        94 ~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      ++||||+.+ +|.+.+.....         +++..++.++.|++.||+|||++||+|+||||+||+++.+  ....++|+
T Consensus        92 ~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~--~~~~~kl~  160 (361)
T 3uc3_A           92 AIIMEYASGGELYERICNAGR---------FSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGS--PAPRLKIC  160 (361)
T ss_dssp             EEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSS--SSCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC--CCceEEEe
Confidence            999999965 88887764332         8999999999999999999999999999999999999733  23459999


Q ss_pred             ecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc-----------
Q psy2172         173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI-----------  241 (291)
Q Consensus       173 Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~-----------  241 (291)
                      |||++......    .......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.....           
T Consensus       161 Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~  236 (361)
T 3uc3_A          161 DFGYSKSSVLH----SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS  236 (361)
T ss_dssp             CCCCC-------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHT
T ss_pred             ecCcccccccc----CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhc
Confidence            99998743322    222345789999999999876534455999999999999999999998754311           


Q ss_pred             ----cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhhhhh
Q psy2172         242 ----KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDFNE  285 (291)
Q Consensus       242 ----~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (291)
                          ..........+.+++..|..+.|..||++.++..|||+.+.+..
T Consensus       237 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~  284 (361)
T 3uc3_A          237 VKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPA  284 (361)
T ss_dssp             TCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCCC
T ss_pred             CCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCCch
Confidence                01111235678899999999999999999999999998765543

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.9e-43  Score=305.65  Aligned_cols=242  Identities=23%  Similarity=0.436  Sum_probs=199.7

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC-----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCce
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-----GLSMSACREIALLRELKHPNVINLISVFLSHNDRK   92 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (291)
                      +.|.+ .+.||+|+||.||+|.++.  +++.||+|++...     .....+.+|+.+++.++||||+++++++  .+...
T Consensus        15 ~~y~i-~~~LG~G~fG~V~~~~~~~--~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~--~~~~~   89 (384)
T 4fr4_A           15 DHFEI-LRAIGKGSFGKVCIVQKND--TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF--QDEED   89 (384)
T ss_dssp             GGEEE-EEEEECCTTCCEEEEEETT--TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE--ECSSE
T ss_pred             HHeEE-EEEEeeCCCeEEEEEEECC--CCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE--EeCCE
Confidence            55664 6799999999999999876  7788999998532     2345688999999999999999999999  56778


Q ss_pred             EEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEE
Q psy2172          93 VWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI  171 (291)
Q Consensus        93 ~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l  171 (291)
                      .|+||||+.| +|...+....         .+++..++.++.|++.||.|||++||+|+||||+||+++    .++.++|
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~----~~g~vkL  156 (384)
T 4fr4_A           90 MFMVVDLLLGGDLRYHLQQNV---------HFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLD----EHGHVHI  156 (384)
T ss_dssp             EEEEECCCTTEEHHHHHHTTC---------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEE
T ss_pred             EEEEEecCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEC----CCCCEEE
Confidence            9999999975 7777765322         289999999999999999999999999999999999998    6789999


Q ss_pred             eecccceecCCCCCCCCCCCCceecccccccccccCC--cCCCCchhHHHHHHHHHHHHcCCCCCCCCccc---------
Q psy2172         172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQED---------  240 (291)
Q Consensus       172 ~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~---------  240 (291)
                      +|||++......    .......||+.|+|||++.+.  ..++.++|+|||||++|+|++|..||.+....         
T Consensus       157 ~DFG~a~~~~~~----~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~  232 (384)
T 4fr4_A          157 TDFNIAAMLPRE----TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF  232 (384)
T ss_dssp             CCCTTCEECCTT----CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH
T ss_pred             eccceeeeccCC----CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH
Confidence            999999876542    223456789999999998642  34889999999999999999999999864432         


Q ss_pred             ---ccCCCCCcHHHHHHHHHhhCCCCcCChhh-hhcCCCCcchhh
Q psy2172         241 ---IKTSNPYHHDQLDRIFSVMGFPLEKDWED-IRKMPEHPTLLK  281 (291)
Q Consensus       241 ---~~~~~~~~~~~~~~i~~~~~~~~~~~~~~-~~~~~~~~~~~~  281 (291)
                         ...........+.+++..|..+.|..||+ +.++..||++..
T Consensus       233 ~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~  277 (384)
T 4fr4_A          233 ETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND  277 (384)
T ss_dssp             HHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred             hhcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence               11223344577889999999999999987 788888887754

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.5e-43  Score=310.84  Aligned_cols=248  Identities=23%  Similarity=0.328  Sum_probs=199.3

Q ss_pred             ccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCC-----CCCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCc
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEG-----TGLSMSACREIALLRELKHPNVINLISVFLSHNDR   91 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (291)
                      .+.|++ .++||+|+||.||+|.++.  +++.||+|+++.     ......+.+|..++..++||||+++++++  .+..
T Consensus        73 ~~~y~~-~~~LG~G~fG~V~~~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~--~~~~  147 (437)
T 4aw2_A           73 REDFEI-LKVIGRGAFGEVAVVKLKN--ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF--QDDN  147 (437)
T ss_dssp             GGGEEE-EEEEEECSSEEEEEEEETT--TTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE--ECSS
T ss_pred             hhheEE-EEEEEeCCCEEEEEEEEcC--CCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE--eeCC
Confidence            355664 6799999999999999876  678999999863     22334588999999999999999999999  5677


Q ss_pred             eEEEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEE
Q psy2172          92 KVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVK  170 (291)
Q Consensus        92 ~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~  170 (291)
                      .+|+||||+. |+|.+.+.....        .+++..++.++.|++.||+|||++||+||||||+||+++    .++.++
T Consensus       148 ~~~lV~Ey~~gg~L~~~l~~~~~--------~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~----~~g~vk  215 (437)
T 4aw2_A          148 NLYLVMDYYVGGDLLTLLSKFED--------RLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD----MNGHIR  215 (437)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTTT--------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEE
T ss_pred             EEEEEEecCCCCcHHHHHHHccC--------CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEc----CCCCEE
Confidence            9999999996 588888764221        289999999999999999999999999999999999998    678999


Q ss_pred             EeecccceecCCCCCCCCCCCCceeccccccccccc----CCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc------
Q psy2172         171 IADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLL----GARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED------  240 (291)
Q Consensus       171 l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~----~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~------  240 (291)
                      |+|||++........  .......||+.|+|||++.    +...++.++|+|||||++|+|++|..||.+....      
T Consensus       216 L~DFGla~~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i  293 (437)
T 4aw2_A          216 LADFGSCLKLMEDGT--VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  293 (437)
T ss_dssp             ECCCTTCEECCTTSC--EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             EcchhhhhhcccCCC--cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhh
Confidence            999999976544221  1223457899999999986    2344899999999999999999999999876532      


Q ss_pred             --------ccCCCCCcHHHHHHHHHhhCCCCcCC--hhhhhcCCCCcchhhhh
Q psy2172         241 --------IKTSNPYHHDQLDRIFSVMGFPLEKD--WEDIRKMPEHPTLLKDF  283 (291)
Q Consensus       241 --------~~~~~~~~~~~~~~i~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  283 (291)
                              .+.......+...++++.|....+..  ++++.++..|||+...-
T Consensus       294 ~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~  346 (437)
T 4aw2_A          294 MNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGID  346 (437)
T ss_dssp             HTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCC
T ss_pred             hhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCC
Confidence                    11111224567888888877666665  78888889999986543

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=9.1e-44  Score=306.17  Aligned_cols=252  Identities=27%  Similarity=0.396  Sum_probs=191.7

Q ss_pred             ccccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCC
Q psy2172          11 NERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFLSHND   90 (291)
Q Consensus        11 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   90 (291)
                      .....+.+.|++ .+.||+|+||.||+|.++.  +++.||+|++........+.+|+.++++++||||+++++++  .+.
T Consensus        46 ~~~~~~~~~y~~-~~~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~--~~~  120 (349)
T 2w4o_A           46 SNRDALSDFFEV-ESELGRGATSIVYRCKQKG--TQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIF--ETP  120 (349)
T ss_dssp             SBCSCGGGTEEE-EEEEEECSSEEEEEEEETT--TCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEE--ECS
T ss_pred             cccccccCcEEE-eeEEeeCCCEEEEEEEECC--CCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeE--ecC
Confidence            345567778886 6799999999999999876  67889999998766667788999999999999999999999  556


Q ss_pred             ceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcE
Q psy2172          91 RKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRV  169 (291)
Q Consensus        91 ~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~  169 (291)
                      ...++||||+.+ +|.+.+....         .+++..++.++.|++.||.|||++|++|+||||+||+++..+ .++.+
T Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~-~~~~~  190 (349)
T 2w4o_A          121 TEISLVLELVTGGELFDRIVEKG---------YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPA-PDAPL  190 (349)
T ss_dssp             SEEEEEECCCCSCBHHHHHTTCS---------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSS-TTCCE
T ss_pred             CeEEEEEEeCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCC-CCCCE
Confidence            789999999975 8877765321         289999999999999999999999999999999999997422 36789


Q ss_pred             EEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc--------
Q psy2172         170 KIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI--------  241 (291)
Q Consensus       170 ~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~--------  241 (291)
                      +|+|||++......    .......||+.|+|||.+.+.. ++.++|||||||++|+|++|..||.......        
T Consensus       191 kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~  265 (349)
T 2w4o_A          191 KIADFGLSKIVEHQ----VLMKTVCGTPGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILN  265 (349)
T ss_dssp             EECCCC--------------------CGGGSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHT
T ss_pred             EEccCccccccCcc----cccccccCCCCccCHHHhcCCC-CCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHh
Confidence            99999999865432    1223457899999999998754 8999999999999999999999997655321        


Q ss_pred             ------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhh
Q psy2172         242 ------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKD  282 (291)
Q Consensus       242 ------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (291)
                            ..........+.+++..|..+.|..||++.++..+||+...
T Consensus       266 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  312 (349)
T 2w4o_A          266 CEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK  312 (349)
T ss_dssp             TCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred             CCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence                  01112345678899999999999999999999988887643

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.7e-43  Score=309.64  Aligned_cols=243  Identities=22%  Similarity=0.343  Sum_probs=198.9

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCC-----CCCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCce
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEG-----TGLSMSACREIALLRELKHPNVINLISVFLSHNDRK   92 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (291)
                      +.|.+ .++||+|+||.||+|.++.  +++.||+|++++     ......+.+|+.+++.++||||+++++++  .+...
T Consensus        69 ~~y~~-~~~LG~G~fG~V~~~~~~~--~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~--~~~~~  143 (410)
T 3v8s_A           69 EDYEV-VKVIGRGAFGEVQLVRHKS--TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF--QDDRY  143 (410)
T ss_dssp             GGEEE-EEEEEECSSEEEEEEEETT--TCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEE--ECSSE
T ss_pred             cccEE-EEEEEcCCCEEEEEEEECC--CCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE--EECCE
Confidence            45664 6799999999999999876  678899999863     23445688999999999999999999999  56789


Q ss_pred             EEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEE
Q psy2172          93 VWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI  171 (291)
Q Consensus        93 ~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l  171 (291)
                      +|+||||++| +|.+++....          +++..++.++.|++.||+|||++||+||||||+||+++    .++.++|
T Consensus       144 ~~lV~E~~~gg~L~~~l~~~~----------~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~----~~g~ikL  209 (410)
T 3v8s_A          144 LYMVMEYMPGGDLVNLMSNYD----------VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD----KSGHLKL  209 (410)
T ss_dssp             EEEEECCCTTEEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEE
T ss_pred             EEEEEeCCCCCcHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeEC----CCCCEEE
Confidence            9999999965 8888775321          89999999999999999999999999999999999998    6789999


Q ss_pred             eecccceecCCCCCCCCCCCCceecccccccccccCCc---CCCCchhHHHHHHHHHHHHcCCCCCCCCcccc-------
Q psy2172         172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGAR---HYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI-------  241 (291)
Q Consensus       172 ~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~-------  241 (291)
                      +|||++........  .......||+.|+|||++.+..   .++.++|+|||||++|+|++|..||.+.+...       
T Consensus       210 ~DFG~a~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~  287 (410)
T 3v8s_A          210 ADFGTCMKMNKEGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMN  287 (410)
T ss_dssp             CCCTTCEECCTTSE--EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred             eccceeEeeccCCc--ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHh
Confidence            99999987654211  1234567999999999997643   26789999999999999999999998765320       


Q ss_pred             ------cCCCCCcHHHHHHHHHhhCCCCcCC--hhhhhcCCCCcchhh
Q psy2172         242 ------KTSNPYHHDQLDRIFSVMGFPLEKD--WEDIRKMPEHPTLLK  281 (291)
Q Consensus       242 ------~~~~~~~~~~~~~i~~~~~~~~~~~--~~~~~~~~~~~~~~~  281 (291)
                            ..........+.+++..|....+..  ++++.++..|||+..
T Consensus       288 ~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~  335 (410)
T 3v8s_A          288 HKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN  335 (410)
T ss_dssp             HHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred             ccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccC
Confidence                  1111234567888888888777777  899999999998864

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=4e-43  Score=294.01  Aligned_cols=252  Identities=25%  Similarity=0.393  Sum_probs=202.1

Q ss_pred             ccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC---CChhHHHHHHHHhcCCCCCeeeEEEEEEeCC
Q psy2172          13 RTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG---LSMSACREIALLRELKHPNVINLISVFLSHN   89 (291)
Q Consensus        13 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   89 (291)
                      -.++.++|.+ .++||+|+||.||+|.++.  ++..+|+|.+....   ....+.+|++++++++||||+++++++  .+
T Consensus        17 ~g~i~~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--~~   91 (285)
T 3is5_A           17 QGTIDDLFIF-KRKLGSGAFGDVHLVEERS--SGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF--ED   91 (285)
T ss_dssp             SSCHHHHEEE-EEEEEECSSCEEEEEEETT--TCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEE--EC
T ss_pred             CCChhhheee-cceeccCCCeEEEEEEEcc--CCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhe--ec
Confidence            3467788886 7799999999999999876  67889999986443   235788999999999999999999999  56


Q ss_pred             CceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCc
Q psy2172          90 DRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGR  168 (291)
Q Consensus        90 ~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~  168 (291)
                      ....++||||+++ +|.+.+........     .+++..++.++.|++.||++||++|++|+||||+||+++.+. ..+.
T Consensus        92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~-~~~~  165 (285)
T 3is5_A           92 YHNMYIVMETCEGGELLERIVSAQARGK-----ALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTS-PHSP  165 (285)
T ss_dssp             SSEEEEEECCCSCCBHHHHHHHHHHHTC-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSS-TTCC
T ss_pred             CCeEEEEEEeCCCCcHHHHHHhhhhccc-----CCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCC-CCCC
Confidence            7789999999985 88888876543222     289999999999999999999999999999999999996432 4578


Q ss_pred             EEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc-------
Q psy2172         169 VKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI-------  241 (291)
Q Consensus       169 ~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~-------  241 (291)
                      ++|+|||++......    .......|++.|+|||.+.+  .++.++||||||+++|+|++|..||.+.....       
T Consensus       166 ~kl~Dfg~a~~~~~~----~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~  239 (285)
T 3is5_A          166 IKIIDFGLAELFKSD----EHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY  239 (285)
T ss_dssp             EEECCCCCCCC--------------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             EEEEeeecceecCCc----ccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhcc
Confidence            999999999765432    12234567999999999864  47899999999999999999999998764321       


Q ss_pred             -----cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         242 -----KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       242 -----~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                           ........+.+.+++..|..+.|..||++.++..+||+.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          240 KEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             CCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             CCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence                 1111123567889999999999999999999999998764

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3e-43  Score=304.29  Aligned_cols=252  Identities=23%  Similarity=0.351  Sum_probs=204.0

Q ss_pred             ecccccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-CChhHHHHHHHHhcCC-----CCCeeeEE
Q psy2172           9 TSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-LSMSACREIALLRELK-----HPNVINLI   82 (291)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~-----h~~iv~~~   82 (291)
                      .......+.++|.+ .++||+|+||.||+|.+..  +++.||+|+++... ....+..|+.+++.++     ||||++++
T Consensus        26 ~~~~g~~~~~~y~~-~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~  102 (360)
T 3llt_A           26 SWKKGMLLNNAFLV-IRKMGDGTFGRVLLCQHID--NKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYH  102 (360)
T ss_dssp             CCCTTCEETTTEEE-EEEEEECSSEEEEEEEETT--TCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred             eeecceEecCEEEE-EEEEcccCCeEEEEEEECC--CCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence            34566677888986 6799999999999999876  67889999997532 2345778999999996     99999999


Q ss_pred             EEEEeCCCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecC
Q psy2172          83 SVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGE  162 (291)
Q Consensus        83 ~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~  162 (291)
                      +++.  .....++||||++++|.+.+......       .+++..++.++.|++.||+|||++||+|+||||+||+++..
T Consensus       103 ~~~~--~~~~~~lv~e~~~~~L~~~~~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~  173 (360)
T 3llt_A          103 GKFM--YYDHMCLIFEPLGPSLYEIITRNNYN-------GFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDP  173 (360)
T ss_dssp             EEEE--ETTEEEEEECCCCCBHHHHHHHTTTC-------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCT
T ss_pred             ceee--ECCeeEEEEcCCCCCHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccc
Confidence            9994  45689999999988999988754322       28899999999999999999999999999999999999731


Q ss_pred             C---------------------CCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHH
Q psy2172         163 G---------------------IERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIG  221 (291)
Q Consensus       163 ~---------------------~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG  221 (291)
                      .                     ...+.++|+|||++......      .....||+.|+|||++.+.. ++.++||||||
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~------~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG  246 (360)
T 3llt_A          174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY------HGSIINTRQYRAPEVILNLG-WDVSSDMWSFG  246 (360)
T ss_dssp             TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC------CCSCCSCGGGCCHHHHTTCC-CCTTHHHHHHH
T ss_pred             cccccccchhcccccccccccccCCCCEEEEeccCceecCCC------CcCccCcccccCcHHHcCCC-CCCccchHHHH
Confidence            1                     13678999999999864432      23457799999999998755 89999999999


Q ss_pred             HHHHHHHcCCCCCCCCccccc--------CC-----------------------------------------------CC
Q psy2172         222 CIFAELLTSEPIFHCRQEDIK--------TS-----------------------------------------------NP  246 (291)
Q Consensus       222 ~~l~~l~~g~~pf~~~~~~~~--------~~-----------------------------------------------~~  246 (291)
                      |++|+|++|..||.+......        ..                                               ..
T Consensus       247 ~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~  326 (360)
T 3llt_A          247 CVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKI  326 (360)
T ss_dssp             HHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHH
T ss_pred             HHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccccccc
Confidence            999999999999976542100        00                                               00


Q ss_pred             CcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         247 YHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       247 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                      ...+.+.+++..|..+.|..||++.++.++||+
T Consensus       327 ~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f  359 (360)
T 3llt_A          327 IKHELFCDFLYSILQIDPTLRPSPAELLKHKFL  359 (360)
T ss_dssp             CCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGG
T ss_pred             chHHHHHHHHHHHhcCChhhCCCHHHHhcCccc
Confidence            011456689999999999999999999999986

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-44  Score=305.71  Aligned_cols=249  Identities=20%  Similarity=0.319  Sum_probs=204.1

Q ss_pred             ccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC-ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          15 KVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-SMSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        15 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      .+.++|.+ ++.||+|+||.||+|.++.  +++.+|+|.+..... ...+.+|+.+++.++||||+++++++  .+....
T Consensus         2 ~~~~~y~~-~~~lG~G~~g~Vy~~~~~~--~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~--~~~~~~   76 (321)
T 1tki_A            2 ELYEKYMI-AEDLGRGEFGIVHRCVETS--SKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESF--ESMEEL   76 (321)
T ss_dssp             CCTTTEEE-EEEEEECSSEEEEEEEETT--TTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEE--EETTEE
T ss_pred             chhhceEe-eeEEecCCCeEEEEEEECC--CCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEE--ecCCEE
Confidence            46678885 7799999999999999876  778899999875432 33578999999999999999999999  456789


Q ss_pred             EEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          94 WLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        94 ~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      ++||||++| +|.+.+....        ..+++..++.++.|++.||.|||++|++|+||||+||+++.+  ..+.++|+
T Consensus        77 ~lv~e~~~g~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~--~~~~~kl~  146 (321)
T 1tki_A           77 VMIFEFISGLDIFERINTSA--------FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR--RSSTIKII  146 (321)
T ss_dssp             EEEECCCCCCBHHHHHTSSS--------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS--SCCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccC--CCCCEEEE
Confidence            999999986 8887764321        238999999999999999999999999999999999999842  25789999


Q ss_pred             ecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc---------C
Q psy2172         173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK---------T  243 (291)
Q Consensus       173 Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~---------~  243 (291)
                      |||++......    .......|++.|+|||++.+.. ++.++||||||+++|+|++|..||.+......         .
T Consensus       147 Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~  221 (321)
T 1tki_A          147 EFGQARQLKPG----DNFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYT  221 (321)
T ss_dssp             CCTTCEECCTT----CEEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC
T ss_pred             ECCCCeECCCC----CccccccCChhhcCcHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCC
Confidence            99999876542    1223457899999999998754 78999999999999999999999987653210         0


Q ss_pred             C----CCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhhh
Q psy2172         244 S----NPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF  283 (291)
Q Consensus       244 ~----~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (291)
                      .    .+.....+.+++..|..+.|..||++.++..|||+.+..
T Consensus       222 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  265 (321)
T 1tki_A          222 FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI  265 (321)
T ss_dssp             CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred             CChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence            0    012346788999999999999999999999999987543

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.8e-43  Score=297.92  Aligned_cols=244  Identities=27%  Similarity=0.430  Sum_probs=195.7

Q ss_pred             ccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC----------------------------ChhHHHHHH
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL----------------------------SMSACREIA   68 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----------------------------~~~~~~e~~   68 (291)
                      .+.|.+ .+.||+|+||.||+|.+..  +++.||+|++.....                            .+.+.+|+.
T Consensus        12 ~~~y~~-~~~lG~G~~g~Vy~a~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~   88 (298)
T 2zv2_A           12 LNQYTL-KDEIGKGSYGVVKLAYNEN--DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIA   88 (298)
T ss_dssp             ETTEEE-EEEEEC--CCEEEEEEETT--TTEEEEEEEEECC-------------------------------CHHHHHHH
T ss_pred             ecceEE-EeEEeecCCEEEEEEEECC--CCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHH
Confidence            356775 6799999999999999876  778899999864321                            245789999


Q ss_pred             HHhcCCCCCeeeEEEEEEeCCCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCe
Q psy2172          69 LLRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWV  147 (291)
Q Consensus        69 ~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~i  147 (291)
                      ++++++||||+++++++...+....++||||+++ +|.+...          ...+++..++.++.|++.||+|||++|+
T Consensus        89 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~~i  158 (298)
T 2zv2_A           89 ILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----------LKPLSEDQARFYFQDLIKGIEYLHYQKI  158 (298)
T ss_dssp             HHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----------SSCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----------cCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            9999999999999999966567799999999985 5443211          1238999999999999999999999999


Q ss_pred             eeeccCCCcEEeecCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcC--CCCchhHHHHHHHHH
Q psy2172         148 LHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARH--YTKAIDIWAIGCIFA  225 (291)
Q Consensus       148 vH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~--~~~~~Dv~slG~~l~  225 (291)
                      +|+||||+||+++    .++.++|+|||++........   ......||+.|+|||.+.+...  ++.++||||||+++|
T Consensus       159 vH~Dlkp~Nil~~----~~~~~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~  231 (298)
T 2zv2_A          159 IHRDIKPSNLLVG----EDGHIKIADFGVSNEFKGSDA---LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLY  231 (298)
T ss_dssp             ECCCCCGGGEEEC----TTSCEEECCCTTCEECSSSSC---EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHH
T ss_pred             eccCCCHHHEEEC----CCCCEEEecCCCccccccccc---cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHH
Confidence            9999999999998    667999999999987654321   1234578999999999976442  377899999999999


Q ss_pred             HHHcCCCCCCCCcccc-----------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchh
Q psy2172         226 ELLTSEPIFHCRQEDI-----------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLL  280 (291)
Q Consensus       226 ~l~~g~~pf~~~~~~~-----------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  280 (291)
                      +|++|..||.+.....           ....+...+.+.+++..|..+.|..||++.++..|||+.
T Consensus       232 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          232 CFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             HHHHSSCSSCCSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             HHHHCCCCCCCccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence            9999999998654210           111234457799999999999999999999999999875

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=4e-43  Score=299.89  Aligned_cols=238  Identities=40%  Similarity=0.752  Sum_probs=190.7

Q ss_pred             ccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC----ChhHHHHHHHHhcCCCCCeeeEEEEEEeC
Q psy2172          13 RTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL----SMSACREIALLRELKHPNVINLISVFLSH   88 (291)
Q Consensus        13 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   88 (291)
                      .....++|++ .++||+|+||.||+|.+..  +++.||+|+++....    ...+.+|+.++++++||||+++++++  .
T Consensus        29 ~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~  103 (329)
T 3gbz_A           29 SATSIDRYRR-ITKLGEGTYGEVYKAIDTV--TNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVI--H  103 (329)
T ss_dssp             ---CGGGEEE-EEEEEECSSSEEEEEEETT--TTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEE--E
T ss_pred             cccchhhEEE-EEEEEecCCeEEEEEEECC--CCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEE--e
Confidence            3445567885 6799999999999999876  778999999975432    23567899999999999999999999  4


Q ss_pred             CCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCC-CCCC
Q psy2172          89 NDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEG-IERG  167 (291)
Q Consensus        89 ~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~-~~~~  167 (291)
                      +....++||||++++|.+.+.....         +++..++.++.|++.||+|||++||+|+||||+||+++.++ ....
T Consensus       104 ~~~~~~lv~e~~~~~L~~~~~~~~~---------~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~  174 (329)
T 3gbz_A          104 HNHRLHLIFEYAENDLKKYMDKNPD---------VSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETP  174 (329)
T ss_dssp             ETTEEEEEEECCSEEHHHHHHHCTT---------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CC
T ss_pred             cCCEEEEEEecCCCCHHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccc
Confidence            5678999999999999988875432         89999999999999999999999999999999999997433 2456


Q ss_pred             cEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccCCCCC
Q psy2172         168 RVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY  247 (291)
Q Consensus       168 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~~~~~  247 (291)
                      .++|+|||++.......   .......||..|+|||++.+...++.++|||||||++|+|++|..||.+...        
T Consensus       175 ~~kl~Dfg~a~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------  243 (329)
T 3gbz_A          175 VLKIGDFGLARAFGIPI---RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE--------  243 (329)
T ss_dssp             EEEECCTTHHHHHC--------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------
T ss_pred             eEEECcCCCccccCCcc---cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH--------
Confidence            79999999998765321   1223456799999999998766689999999999999999999999988766        


Q ss_pred             cHHHHHHHHHhhCCCCcCChhhhhcCCCC
Q psy2172         248 HHDQLDRIFSVMGFPLEKDWEDIRKMPEH  276 (291)
Q Consensus       248 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  276 (291)
                       .+.+..++..++.|....|+....++.+
T Consensus       244 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (329)
T 3gbz_A          244 -IDQLFKIFEVLGLPDDTTWPGVTALPDW  271 (329)
T ss_dssp             -HHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             -HHHHHHHHHHhCCCchhhhhhhhhhhhh
Confidence             3788899999999999999888776654

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=3e-43  Score=300.08  Aligned_cols=225  Identities=40%  Similarity=0.719  Sum_probs=184.6

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHNDRKVW   94 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (291)
                      +.|.+ .++||+|+||.||+|.+..  +++.||+|++.....   ...+.+|+.+++.++||||+++++++  .+....+
T Consensus         2 ~~y~~-~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~~~   76 (324)
T 3mtl_A            2 ETYIK-LDKLGEGTYATVYKGKSKL--TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII--HTEKSLT   76 (324)
T ss_dssp             CSEEE-EEEEEECSSEEEEEEEETT--TCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEE--ECSSCEE
T ss_pred             CceEE-EEEEcCCCCEEEEEEEECC--CCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEE--eeCCEEE
Confidence            35664 6799999999999999876  678899999864322   22456799999999999999999999  5677899


Q ss_pred             EEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          95 LLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        95 iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      +||||++++|.+.+.....        .+++..++.++.|++.||.|||++||+|+||||+||+++    .++.++|+||
T Consensus        77 lv~e~~~~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~----~~~~~kl~Df  144 (324)
T 3mtl_A           77 LVFEYLDKDLKQYLDDCGN--------IINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLIN----ERGELKLADF  144 (324)
T ss_dssp             EEEECCSEEHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEEC----TTCCEEECSS
T ss_pred             EEecccccCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEEC----CCCCEEEccC
Confidence            9999999999988875432        288999999999999999999999999999999999998    6678999999


Q ss_pred             ccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccCCCCCcHHHHHH
Q psy2172         175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR  254 (291)
Q Consensus       175 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  254 (291)
                      |++.......   .......||..|+|||.+.+...++.++||||||+++|+|++|..||.+...         .+.+..
T Consensus       145 g~a~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---------~~~~~~  212 (324)
T 3mtl_A          145 GLARAKSIPT---KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV---------EEQLHF  212 (324)
T ss_dssp             SEEECC---------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---------HHHHHH
T ss_pred             cccccccCCc---cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---------HHHHHH
Confidence            9998654321   1223456799999999998756689999999999999999999999998776         378899


Q ss_pred             HHHhhCCCCcCChhhhh
Q psy2172         255 IFSVMGFPLEKDWEDIR  271 (291)
Q Consensus       255 i~~~~~~~~~~~~~~~~  271 (291)
                      +.+.++.|.+..||...
T Consensus       213 i~~~~~~~~~~~~~~~~  229 (324)
T 3mtl_A          213 IFRILGTPTEETWPGIL  229 (324)
T ss_dssp             HHHHHCCCCTTTSTTGG
T ss_pred             HHHHhCCCChHhchhhh
Confidence            99999999998888653

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1e-42  Score=291.23  Aligned_cols=249  Identities=27%  Similarity=0.390  Sum_probs=205.4

Q ss_pred             cccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC----hhHHHHHHHHhcCCCCCeeeEEEEEEeCC
Q psy2172          14 TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIALLRELKHPNVINLISVFLSHN   89 (291)
Q Consensus        14 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   89 (291)
                      +++.+.|++ .+.||+|+||.||+|.++.  +++.||+|++......    ..+.+|+.++++++||||+++++++  .+
T Consensus         2 ~~~~~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~   76 (284)
T 3kk8_A            2 TKFSDNYDV-KEELGKGAFSVVRRCVHKT--TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI--QE   76 (284)
T ss_dssp             CTTTTTEEE-EEEEEEETTEEEEEEEETT--TCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--EC
T ss_pred             chhhhhhhh-hhhhcCcCCeEEEEEEEcC--CCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE--Ec
Confidence            457788886 6799999999999999876  6788999998654322    4577899999999999999999999  56


Q ss_pred             CceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCc
Q psy2172          90 DRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGR  168 (291)
Q Consensus        90 ~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~  168 (291)
                      ....+++|||+.+ +|.+.+.....         +++..++.++.|++.||.+||++|++|+||||+||+++.++ ....
T Consensus        77 ~~~~~~v~e~~~~~~l~~~~~~~~~---------~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~~~  146 (284)
T 3kk8_A           77 ESFHYLVFDLVTGGELFEDIVAREF---------YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA-KGAA  146 (284)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSS-TTCC
T ss_pred             CCEEEEEEecCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCC-CCCc
Confidence            7789999999976 77777764322         89999999999999999999999999999999999998543 3456


Q ss_pred             EEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc-------
Q psy2172         169 VKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI-------  241 (291)
Q Consensus       169 ~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~-------  241 (291)
                      ++|+|||.+......    .......|++.|+|||.+.+.. ++.++||||||+++|+|++|..||.+.....       
T Consensus       147 ~kl~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  221 (284)
T 3kk8_A          147 VKLADFGLAIEVNDS----EAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA  221 (284)
T ss_dssp             EEECCCTTCEECCSS----CBCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             EEEeeceeeEEcccC----ccccCCCCCcCCcCchhhcCCC-CCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHh
Confidence            999999999866543    2223457899999999998754 8999999999999999999999997654321       


Q ss_pred             ------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhh
Q psy2172         242 ------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKD  282 (291)
Q Consensus       242 ------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (291)
                            ..........+.+++..|..+.|..||++.++..+||+...
T Consensus       222 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (284)
T 3kk8_A          222 GAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  268 (284)
T ss_dssp             TCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred             ccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCC
Confidence                  11112345778999999999999999999999999998643

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=8.5e-43  Score=299.93  Aligned_cols=240  Identities=22%  Similarity=0.358  Sum_probs=201.8

Q ss_pred             ccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC-----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCc
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-----GLSMSACREIALLRELKHPNVINLISVFLSHNDR   91 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (291)
                      .+.|++ .+.||+|+||.||+|.++.  +++.||+|++...     .....+.+|+.+++.++||||+++++++  .+..
T Consensus        40 ~~~y~~-~~~lG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--~~~~  114 (350)
T 1rdq_E           40 LDQFDR-IKTLGTGSFGRVMLVKHKE--SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF--KDNS  114 (350)
T ss_dssp             GGGEEE-EEEEEECSSCEEEEEEETT--TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE--ECSS
T ss_pred             HHHCEE-EEEeecCcCcEEEEEEECC--CCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE--EcCC
Confidence            356664 6799999999999999876  6789999998532     2345688899999999999999999999  5677


Q ss_pred             eEEEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEE
Q psy2172          92 KVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVK  170 (291)
Q Consensus        92 ~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~  170 (291)
                      ..|+||||++ ++|.+.+.....         +++..++.++.|++.||+|||++||+|+||||+||+++    .++.++
T Consensus       115 ~~~lv~e~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~----~~g~~k  181 (350)
T 1rdq_E          115 NLYMVMEYVAGGEMFSHLRRIGR---------FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID----QQGYIQ  181 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEE
T ss_pred             EEEEEEcCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEEC----CCCCEE
Confidence            9999999996 588888765432         89999999999999999999999999999999999998    678999


Q ss_pred             EeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc---------c
Q psy2172         171 IADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED---------I  241 (291)
Q Consensus       171 l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~---------~  241 (291)
                      |+|||++......      .....||+.|+|||++.+.. ++.++|+|||||++|+|++|..||.+....         .
T Consensus       182 L~DFg~a~~~~~~------~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~  254 (350)
T 1rdq_E          182 VTDFGFAKRVKGR------TWTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK  254 (350)
T ss_dssp             ECCCTTCEECSSC------BCCCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred             EcccccceeccCC------cccccCCccccCHHHhcCCC-CCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC
Confidence            9999999876432      23468999999999998754 899999999999999999999999876532         1


Q ss_pred             cCCCCCcHHHHHHHHHhhCCCCcCChhh-----hhcCCCCcchhh
Q psy2172         242 KTSNPYHHDQLDRIFSVMGFPLEKDWED-----IRKMPEHPTLLK  281 (291)
Q Consensus       242 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~-----~~~~~~~~~~~~  281 (291)
                      ..........+.+++..|....|..|++     +.++..||++..
T Consensus       255 ~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~  299 (350)
T 1rdq_E          255 VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence            1122344677899999999999999988     888888888764

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=6e-43  Score=298.27  Aligned_cols=240  Identities=23%  Similarity=0.410  Sum_probs=179.5

Q ss_pred             ccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCC-CCCeeeEEEEEEeCCCceEEEEEecCC
Q psy2172          23 EGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELK-HPNVINLISVFLSHNDRKVWLLFDYAE  101 (291)
Q Consensus        23 ~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~iv~e~~~  101 (291)
                      .+++||+|+||.||+|.++.  +++.||+|++... ....+.+|+.+++.+. ||||+++++++  .+....|+||||++
T Consensus        15 ~~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~-~~~~~~~e~~~l~~l~~h~niv~~~~~~--~~~~~~~lv~e~~~   89 (325)
T 3kn6_A           15 KDKPLGEGSFSICRKCVHKK--SNQAFAVKIISKR-MEANTQKEITALKLCEGHPNIVKLHEVF--HDQLHTFLVMELLN   89 (325)
T ss_dssp             TSCCSEEETTEEEEEEEETT--TCCEEEEEEEEGG-GHHHHHHHHHHHHHTTTCTTBCCEEEEE--ECSSEEEEEECCCC
T ss_pred             CCCccccCCCeEEEEEEECC--CCCEEEEEEEChh-hhhhHHHHHHHHHHhcCCCCeeEEEEEE--EcCCEEEEEEEccC
Confidence            36899999999999999876  6788999999753 3456788999999997 99999999999  56778999999997


Q ss_pred             C-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceec
Q psy2172         102 H-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF  180 (291)
Q Consensus       102 ~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~  180 (291)
                      + +|.+.+....         .+++..++.++.|++.||+|||++||+|+||||+||+++.++ ....++|+|||++...
T Consensus        90 ~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~-~~~~~kl~Dfg~a~~~  159 (325)
T 3kn6_A           90 GGELFERIKKKK---------HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDEN-DNLEIKIIDFGFARLK  159 (325)
T ss_dssp             SCBHHHHHHHCS---------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC-----CEEEECCCTTCEEC
T ss_pred             CCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCC-CcccEEEeccccceec
Confidence            5 8888876532         289999999999999999999999999999999999998432 3348999999999865


Q ss_pred             CCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc----------------CC
Q psy2172         181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK----------------TS  244 (291)
Q Consensus       181 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~----------------~~  244 (291)
                      ....   .......||+.|+|||.+.+.. ++.++||||||+++|+|++|..||.+......                ..
T Consensus       160 ~~~~---~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~  235 (325)
T 3kn6_A          160 PPDN---QPLKTPCFTLHYAAPELLNQNG-YDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF  235 (325)
T ss_dssp             CC-------------------------CC-CCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC
T ss_pred             CCCC---CcccccCCCcCccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC
Confidence            4422   1223456799999999998754 89999999999999999999999987543210                00


Q ss_pred             C----CCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         245 N----PYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       245 ~----~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                      .    ....+.+.+++..|..+.|..||++.++..+||+..
T Consensus       236 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~  276 (325)
T 3kn6_A          236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQD  276 (325)
T ss_dssp             CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCT
T ss_pred             CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhcc
Confidence            0    123567889999999999999999999999999864

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=8.5e-43  Score=295.16  Aligned_cols=232  Identities=42%  Similarity=0.773  Sum_probs=188.2

Q ss_pred             ccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC-------CCChhHHHHHHHHhcCC---CCCeeeEE
Q psy2172          13 RTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-------GLSMSACREIALLRELK---HPNVINLI   82 (291)
Q Consensus        13 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~e~~~l~~l~---h~~iv~~~   82 (291)
                      ...+.++|++ .++||+|+||.||+|.++.  +++.||+|++...       .....+.+|+.+++.++   ||||++++
T Consensus         4 g~~~~~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~   80 (308)
T 3g33_A            4 GSMATSRYEP-VAEIGVGAYGTVYKARDPH--SGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLM   80 (308)
T ss_dssp             ------CCEE-EEEECCSSSCCEEEEECTT--TCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEE
T ss_pred             CcccccceEE-EEEEecCCCeEEEEEEECC--CCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEee
Confidence            4456788885 6799999999999999766  7788999998632       22456778888888775   99999999


Q ss_pred             EEEEeCCC---ceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEe
Q psy2172          83 SVFLSHND---RKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILV  159 (291)
Q Consensus        83 ~~~~~~~~---~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~  159 (291)
                      +++.....   ...+++||+++++|.+.+.....       ..+++..++.++.|++.||+|||++|++|+||||+||++
T Consensus        81 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~-------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~  153 (308)
T 3g33_A           81 DVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPP-------PGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV  153 (308)
T ss_dssp             EEEEECCSSSEEEEEEEEECCCCBHHHHHHTCCT-------TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEE
T ss_pred             eeeeccCCCCceeEEEEehhhhcCHHHHHhhccC-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence            99865332   26899999999999988865432       128999999999999999999999999999999999999


Q ss_pred             ecCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcc
Q psy2172         160 MGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE  239 (291)
Q Consensus       160 ~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~  239 (291)
                      +    .++.++|+|||.+......    .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+...
T Consensus       154 ~----~~~~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~  224 (308)
T 3g33_A          154 T----SGGTVKLADFGLARIYSYQ----MALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSE  224 (308)
T ss_dssp             C----TTSCEEECSCSCTTTSTTC----CCSGGGGCCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTSSCSCCCSSH
T ss_pred             c----CCCCEEEeeCccccccCCC----cccCCccccccccCchHHcCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            8    6779999999999765432    2223457899999999998755 89999999999999999999999988766


Q ss_pred             cccCCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         240 DIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       240 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                               .+.+..+...++.+.+..||....
T Consensus       225 ---------~~~~~~i~~~~~~~~~~~~~~~~~  248 (308)
T 3g33_A          225 ---------ADQLGKIFDLIGLPPEDDWPRDVS  248 (308)
T ss_dssp             ---------HHHHHHHHHHHCCCCTTTSCSSCS
T ss_pred             ---------HHHHHHHHHHhCCCChhhccchhh
Confidence                     378889999999888888875443

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.6e-43  Score=304.18  Aligned_cols=249  Identities=24%  Similarity=0.454  Sum_probs=200.0

Q ss_pred             cccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCCCCeeeEEEEEEeC-------
Q psy2172          16 VEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFLSH-------   88 (291)
Q Consensus        16 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-------   88 (291)
                      ..++|.+ ++.||+|+||.||+|.+..  +++.||+|.+...  .....+|+.+++.++||||+++++++...       
T Consensus         5 ~~~~y~~-~~~lG~G~fg~V~~a~~~~--~~~~vAiK~~~~~--~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~   79 (383)
T 3eb0_A            5 SSKKYSL-GKTLGTGSFGIVCEVFDIE--SGKRFALKKVLQD--PRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP   79 (383)
T ss_dssp             -CTTEEE-EEEEECC-CEEEEEEEETT--TCCEEEEEEEECC--TTSCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred             ccceEEE-EEEEEeccCEEEEEEEECC--CCCEEEEEEEecC--cchHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence            3456775 7799999999999999876  7789999998644  23344799999999999999999998542       


Q ss_pred             -----------------------------CCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHH
Q psy2172          89 -----------------------------NDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGI  139 (291)
Q Consensus        89 -----------------------------~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l  139 (291)
                                                   +..+.++||||++++|.+.+........     .+++..++.++.|++.||
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~-----~l~~~~~~~i~~qi~~aL  154 (383)
T 3eb0_A           80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGR-----SIPMNLISIYIYQLFRAV  154 (383)
T ss_dssp             ------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTC-----CCCHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCC-----CCCHHHHHHHHHHHHHHH
Confidence                                         3346899999999998888875443221     289999999999999999


Q ss_pred             HHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHH
Q psy2172         140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWA  219 (291)
Q Consensus       140 ~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~s  219 (291)
                      +|||++||+|+||||+||+++.   .++.++|+|||++.......    ......++..|+|||.+.+...++.++||||
T Consensus       155 ~~LH~~gi~H~Dikp~Nil~~~---~~~~~kl~Dfg~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws  227 (383)
T 3eb0_A          155 GFIHSLGICHRDIKPQNLLVNS---KDNTLKLCDFGSAKKLIPSE----PSVAYICSRFYRAPELMLGATEYTPSIDLWS  227 (383)
T ss_dssp             HHHHTTTEECSCCCGGGEEEET---TTTEEEECCCTTCEECCTTS----CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHH
T ss_pred             HHHHHCcCccCccCHHHEEEcC---CCCcEEEEECCCCcccCCCC----CCcCcccCCCccCHHHhcCCCCCCcchhhhh
Confidence            9999999999999999999973   35689999999998764432    2234567889999999987666899999999


Q ss_pred             HHHHHHHHHcCCCCCCCCccccc-----------------------------C---------CCCCcHHHHHHHHHhhCC
Q psy2172         220 IGCIFAELLTSEPIFHCRQEDIK-----------------------------T---------SNPYHHDQLDRIFSVMGF  261 (291)
Q Consensus       220 lG~~l~~l~~g~~pf~~~~~~~~-----------------------------~---------~~~~~~~~~~~i~~~~~~  261 (291)
                      +||++|+|++|+.||.+......                             .         ........+.+++..|..
T Consensus       228 lG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  307 (383)
T 3eb0_A          228 IGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILR  307 (383)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCC
T ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHcc
Confidence            99999999999999987643100                             0         111234567889999999


Q ss_pred             CCcCChhhhhcCCCCcchhh
Q psy2172         262 PLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~  281 (291)
                      ..|..||++.++..||++..
T Consensus       308 ~dP~~R~t~~e~l~hp~f~~  327 (383)
T 3eb0_A          308 YEPDLRINPYEAMAHPFFDH  327 (383)
T ss_dssp             SSGGGSCCHHHHHTSGGGHH
T ss_pred             CChhhCCCHHHHhcCHHHHH
Confidence            99999999999999998764

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=303.45  Aligned_cols=245  Identities=22%  Similarity=0.371  Sum_probs=203.8

Q ss_pred             ccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC----------CChhHHHHHHHHhcCCCCCeeeEEEE
Q psy2172          15 KVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG----------LSMSACREIALLRELKHPNVINLISV   84 (291)
Q Consensus        15 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~e~~~l~~l~h~~iv~~~~~   84 (291)
                      .+.++|++ .+.||+|+||.||+|.++.  +++.||+|++....          ....+.+|+.++++++||||++++++
T Consensus        21 ~~~~~y~~-~~~lG~G~~g~Vy~a~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~   97 (335)
T 3dls_A           21 EYSQKYST-MSPLGSGAFGFVWTAVDKE--KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDI   97 (335)
T ss_dssp             HHHHHEEE-EEECSSSSSCSEEEEEETT--TTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEE
T ss_pred             ccccceEE-EeEEEecCCEEEEEEEECC--CCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            45667775 6799999999999999876  77889999997543          23357789999999999999999999


Q ss_pred             EEeCCCceEEEEEecCC-C-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecC
Q psy2172          85 FLSHNDRKVWLLFDYAE-H-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGE  162 (291)
Q Consensus        85 ~~~~~~~~~~iv~e~~~-~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~  162 (291)
                      +  .+....++||||+. | +|.+.+....         .+++..++.++.|++.||+|||++||+|+||||+||+++  
T Consensus        98 ~--~~~~~~~lv~e~~~~g~~l~~~~~~~~---------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~--  164 (335)
T 3dls_A           98 F--ENQGFFQLVMEKHGSGLDLFAFIDRHP---------RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIA--  164 (335)
T ss_dssp             E--ECSSEEEEEEECCTTSCBHHHHHHTCC---------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--
T ss_pred             E--eeCCEEEEEEEeCCCCccHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEc--
Confidence            9  56779999999986 4 7777765332         289999999999999999999999999999999999998  


Q ss_pred             CCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc
Q psy2172         163 GIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK  242 (291)
Q Consensus       163 ~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~  242 (291)
                        .++.++|+|||++.......    ......||+.|+|||++.+....+.++||||||+++|+|++|..||........
T Consensus       165 --~~~~~kL~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~  238 (335)
T 3dls_A          165 --EDFTIKLIDFGSAAYLERGK----LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVE  238 (335)
T ss_dssp             --TTSCEEECCCTTCEECCTTC----CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTT
T ss_pred             --CCCcEEEeecccceECCCCC----ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHh
Confidence              67899999999998765432    223456899999999998766458899999999999999999999986543221


Q ss_pred             ---CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         243 ---TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       243 ---~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                         .........+.+++..|..+.|..||++.++..+||+.+
T Consensus       239 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~  280 (335)
T 3dls_A          239 AAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ  280 (335)
T ss_dssp             TCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred             hccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence               122234577999999999999999999999999999764

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=6.5e-43  Score=304.49  Aligned_cols=242  Identities=23%  Similarity=0.346  Sum_probs=196.3

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-----CChhHHHHHHHHhcC-CCCCeeeEEEEEEeCCCc
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-----LSMSACREIALLREL-KHPNVINLISVFLSHNDR   91 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~   91 (291)
                      +.|++ .++||+|+||.||+|.++.  +++.||+|++++..     ....+.+|..++.++ +||||+++++++  .+..
T Consensus        52 ~~y~~-~~~LG~G~fG~V~~~~~~~--~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~--~~~~  126 (396)
T 4dc2_A           52 QDFDL-LRVIGRGSYAKVLLVRLKK--TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF--QTES  126 (396)
T ss_dssp             GGEEE-EEEEEECSSEEEEEEEETT--TTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE--ECSS
T ss_pred             hHcEE-EEEEeeCCCeEEEEEEECC--CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE--EECC
Confidence            34554 6799999999999999877  77889999997432     234578899999887 899999999999  5677


Q ss_pred             eEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEE
Q psy2172          92 KVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVK  170 (291)
Q Consensus        92 ~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~  170 (291)
                      ..|+||||+.| +|...+.....         +++..++.++.|++.||+|||++||+||||||+||+++    .++.++
T Consensus       127 ~~~lV~E~~~gg~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~----~~g~ik  193 (396)
T 4dc2_A          127 RLFFVIEYVNGGDLMFHMQRQRK---------LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD----SEGHIK  193 (396)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTSCEE
T ss_pred             EEEEEEEcCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEC----CCCCEE
Confidence            99999999986 88777764322         89999999999999999999999999999999999998    678999


Q ss_pred             EeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc----------
Q psy2172         171 IADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED----------  240 (291)
Q Consensus       171 l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~----------  240 (291)
                      |+|||+++......   .......||+.|+|||++.+.. ++.++|+|||||++|+|++|..||.+....          
T Consensus       194 L~DFGla~~~~~~~---~~~~~~~gt~~Y~aPE~l~~~~-~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~  269 (396)
T 4dc2_A          194 LTDYGMCKEGLRPG---DTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY  269 (396)
T ss_dssp             ECCCTTCBCCCCTT---CCBCCCCBCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHH
T ss_pred             EeecceeeecccCC---CccccccCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHH
Confidence            99999997533221   2234568999999999998754 899999999999999999999999753211          


Q ss_pred             --------ccCCCCCcHHHHHHHHHhhCCCCcCChhhh------hcCCCCcchhh
Q psy2172         241 --------IKTSNPYHHDQLDRIFSVMGFPLEKDWEDI------RKMPEHPTLLK  281 (291)
Q Consensus       241 --------~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~------~~~~~~~~~~~  281 (291)
                              ...........+.+++..|....|..|++.      .++..||++..
T Consensus       270 ~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~  324 (396)
T 4dc2_A          270 LFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  324 (396)
T ss_dssp             HHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred             HHHHHhccccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence                    011223345678899999999999999874      57777777654

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.6e-42  Score=297.37  Aligned_cols=232  Identities=37%  Similarity=0.668  Sum_probs=193.3

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCC----
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG----LSMSACREIALLRELKHPNVINLISVFLSHN----   89 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----   89 (291)
                      ++|++ .++||+|+||.||+|.++.  +++.||+|.+....    ....+.+|+.+++.++||||+++++++....    
T Consensus        17 ~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (351)
T 3mi9_A           17 SKYEK-LAKIGQGTFGEVFKARHRK--TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN   93 (351)
T ss_dssp             GGEEE-EEECSSCSTTSEEEEEETT--TCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred             cceeE-EEEEecCCCcEEEEEEECC--CCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence            56774 6799999999999999876  67889999985432    2346889999999999999999999985533    


Q ss_pred             --CceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCC
Q psy2172          90 --DRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERG  167 (291)
Q Consensus        90 --~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~  167 (291)
                        ....++||||+++++.+.+.....        .+++..++.++.|++.||++||++||+|+||||+||+++    .++
T Consensus        94 ~~~~~~~lv~e~~~~~l~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~----~~~  161 (351)
T 3mi9_A           94 RCKGSIYLVFDFCEHDLAGLLSNVLV--------KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT----RDG  161 (351)
T ss_dssp             ---CEEEEEEECCSEEHHHHHHCTTS--------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTS
T ss_pred             cCCceEEEEEeccCCCHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc----CCC
Confidence              457999999999988887764322        289999999999999999999999999999999999998    677


Q ss_pred             cEEEeecccceecCCCCC-CCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccCCCC
Q psy2172         168 RVKIADMGFARLFNNPLK-PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP  246 (291)
Q Consensus       168 ~~~l~Dfg~~~~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~~~~  246 (291)
                      .++|+|||++........ .........||+.|+|||++.+...++.++|||||||++|+|++|..||.+...       
T Consensus       162 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------  234 (351)
T 3mi9_A          162 VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE-------  234 (351)
T ss_dssp             CEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-------
T ss_pred             CEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh-------
Confidence            999999999987653322 122334567899999999998766689999999999999999999999998766       


Q ss_pred             CcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         247 YHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       247 ~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                        ...+..+....+.+.+..||.+...
T Consensus       235 --~~~~~~i~~~~~~~~~~~~~~~~~~  259 (351)
T 3mi9_A          235 --QHQLALISQLCGSITPEVWPNVDNY  259 (351)
T ss_dssp             --HHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred             --HHHHHHHHHHhCCCChhhccccccc
Confidence              3778888889999988888877654

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.2e-42  Score=298.88  Aligned_cols=242  Identities=25%  Similarity=0.463  Sum_probs=200.0

Q ss_pred             cccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC-----hhHHHHHHHHhcCCCCCeeeEEEEEEeCCC
Q psy2172          16 VEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS-----MSACREIALLRELKHPNVINLISVFLSHND   90 (291)
Q Consensus        16 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   90 (291)
                      ..++|.. .+.||+|+||.||+|.+..  +++.||||.+......     +.+.+|+.++++++||||+++++++.  +.
T Consensus        52 ~~~~y~~-~~~lG~G~~g~Vy~a~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~--~~  126 (348)
T 1u5q_A           52 PEKLFSD-LREIGHGSFGAVYFARDVR--NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL--RE  126 (348)
T ss_dssp             HHHHEEE-EEEEEECSSEEEEEEEETT--TTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--ET
T ss_pred             hhhheee-eeEEccCCCEEEEEEEEcc--CCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEE--EC
Confidence            3445664 6799999999999999766  7788999998654322     35789999999999999999999994  46


Q ss_pred             ceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEE
Q psy2172          91 RKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVK  170 (291)
Q Consensus        91 ~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~  170 (291)
                      ...++||||+.|++.+.+.....        .+++..++.++.|++.||.|||++||+|+||||+||+++    .++.++
T Consensus       127 ~~~~lv~e~~~g~l~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~----~~~~~k  194 (348)
T 1u5q_A          127 HTAWLVMEYCLGSASDLLEVHKK--------PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS----EPGLVK  194 (348)
T ss_dssp             TEEEEEEECCSEEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE----TTTEEE
T ss_pred             CeEEEEEecCCCCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC----CCCCEE
Confidence            68999999999998888764332        289999999999999999999999999999999999998    678999


Q ss_pred             EeecccceecCCCCCCCCCCCCceecccccccccccC--CcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc--------
Q psy2172         171 IADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLG--ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED--------  240 (291)
Q Consensus       171 l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~--------  240 (291)
                      |+|||++......       ....||+.|+|||++.+  ...++.++||||||+++|+|++|..||.+....        
T Consensus       195 L~DfG~a~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~  267 (348)
T 1u5q_A          195 LGDFGSASIMAPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ  267 (348)
T ss_dssp             ECCCTTCBSSSSB-------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred             EeeccCceecCCC-------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Confidence            9999998765431       33568999999999853  235889999999999999999999999765421        


Q ss_pred             ---ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         241 ---IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       241 ---~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                         .........+.+.+++..|....|..||++.++..++++.+
T Consensus       268 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~  311 (348)
T 1u5q_A          268 NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  311 (348)
T ss_dssp             SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence               11122344577899999999999999999999999988754

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.5e-42  Score=287.87  Aligned_cols=253  Identities=23%  Similarity=0.372  Sum_probs=207.2

Q ss_pred             ccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC--CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCC
Q psy2172          13 RTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT--GLSMSACREIALLRELKHPNVINLISVFLSHND   90 (291)
Q Consensus        13 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   90 (291)
                      ...+.++|++ .+.||+|+||.||+|.++.  ++..+|+|.+...  .....+.+|+.+++.++||||+++++++  .+.
T Consensus         4 ~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~   78 (277)
T 3f3z_A            4 KGDINQYYTL-ENTIGRGSWGEVKIAVQKG--TRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF--EDN   78 (277)
T ss_dssp             --CHHHHEEE-EEEEEEETTEEEEEEEETT--TCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEE--ECS
T ss_pred             hhhhhhhEEe-eeEEeecCCEEEEEEEeCC--CCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEE--ecC
Confidence            3457788886 6799999999999999876  6778999998643  3346788999999999999999999999  567


Q ss_pred             ceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcE
Q psy2172          91 RKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRV  169 (291)
Q Consensus        91 ~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~  169 (291)
                      ...++||||+++ +|.+.+.....         +++..++.++.|++.||++||++|++|+||||+||++..+. ..+.+
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~~~  148 (277)
T 3f3z_A           79 TDIYLVMELCTGGELFERVVHKRV---------FRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDS-PDSPL  148 (277)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSS-TTCCE
T ss_pred             CeEEEEEeccCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCC-CCCcE
Confidence            789999999975 88777765332         89999999999999999999999999999999999994322 66789


Q ss_pred             EEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc-------
Q psy2172         170 KIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK-------  242 (291)
Q Consensus       170 ~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~-------  242 (291)
                      +|+|||.+.......    ......|++.|+|||.+.+ . ++.++|+||||+++|+|++|..||.+......       
T Consensus       149 ~l~Dfg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~-~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  222 (277)
T 3f3z_A          149 KLIDFGLAARFKPGK----MMRTKVGTPYYVSPQVLEG-L-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG  222 (277)
T ss_dssp             EECCCTTCEECCTTS----CBCCCCSCTTTCCHHHHTT-C-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred             EEEecccceeccCcc----chhccCCCCCccChHHhcc-c-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC
Confidence            999999998765432    2234568999999999876 3 89999999999999999999999987553210       


Q ss_pred             --CCC----CCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhhhhhc
Q psy2172         243 --TSN----PYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDFNEQ  286 (291)
Q Consensus       243 --~~~----~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (291)
                        ...    ......+.+++..|..+.|..||++.++.+++|+.+.+...
T Consensus       223 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~  272 (277)
T 3f3z_A          223 TFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSS  272 (277)
T ss_dssp             CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHCCS
T ss_pred             CCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcccccc
Confidence              000    12346789999999999999999999999999998776543

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-43  Score=304.66  Aligned_cols=249  Identities=23%  Similarity=0.327  Sum_probs=202.8

Q ss_pred             cccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC--CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCc
Q psy2172          14 TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG--LSMSACREIALLRELKHPNVINLISVFLSHNDR   91 (291)
Q Consensus        14 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (291)
                      ..+.+.|.+ .+.||+|+||.||+|.++.  +++.||+|++....  ....+.+|+.+++.++||||+++++++  .+..
T Consensus        47 ~~~~~~y~i-~~~LG~G~~g~Vy~~~~~~--~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~--~~~~  121 (387)
T 1kob_A           47 GSVYDYYDI-LEELGSGAFGVVHRCVEKA--TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF--EDKY  121 (387)
T ss_dssp             SCGGGTEEE-EEEEEEETTEEEEEEEETT--TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE--ECSS
T ss_pred             CccccceEE-EEEEecCCCEEEEEEEECC--CCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEE--EeCC
Confidence            345567775 6799999999999999876  67889999987543  234678999999999999999999999  5677


Q ss_pred             eEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEE
Q psy2172          92 KVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVK  170 (291)
Q Consensus        92 ~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~  170 (291)
                      ..++||||+.+ +|.+.+....        ..+++..++.++.|++.||+|||++||+|+||||+||+++.+  ..+.++
T Consensus       122 ~~~lv~E~~~gg~L~~~l~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~--~~~~vk  191 (387)
T 1kob_A          122 EMVLILEFLSGGELFDRIAAED--------YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK--KASSVK  191 (387)
T ss_dssp             EEEEEEECCCCCBHHHHTTCTT--------CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST--TCCCEE
T ss_pred             EEEEEEEcCCCCcHHHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecC--CCCceE
Confidence            89999999975 8777664321        128999999999999999999999999999999999999743  346799


Q ss_pred             EeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---------
Q psy2172         171 IADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---------  241 (291)
Q Consensus       171 l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---------  241 (291)
                      |+|||++.......    ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.....         
T Consensus       192 L~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~  266 (387)
T 1kob_A          192 IIDFGLATKLNPDE----IVKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD  266 (387)
T ss_dssp             ECCCTTCEECCTTS----CEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCC
T ss_pred             EEecccceecCCCc----ceeeeccCCCccCchhccCCC-CCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence            99999998765421    122346899999999998754 8999999999999999999999998755310         


Q ss_pred             ----cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhh
Q psy2172         242 ----KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKD  282 (291)
Q Consensus       242 ----~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (291)
                          ..........+.+++..|....|..||++.++..+||+...
T Consensus       267 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  311 (387)
T 1kob_A          267 WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  311 (387)
T ss_dssp             CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence                11112345678999999999999999999999999887643

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=4.6e-43  Score=298.56  Aligned_cols=250  Identities=26%  Similarity=0.427  Sum_probs=204.5

Q ss_pred             ccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC--------ChhHHHHHHHHhcCCCCCeeeEEEE
Q psy2172          13 RTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL--------SMSACREIALLRELKHPNVINLISV   84 (291)
Q Consensus        13 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~e~~~l~~l~h~~iv~~~~~   84 (291)
                      ...+.+.|++ ++.||+|+||.||+|.++.  +++.||+|++.....        ...+.+|+.+++.++||||++++++
T Consensus         7 ~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   83 (321)
T 2a2a_A            7 QQKVEDFYDI-GEELGSGQFAIVKKCREKS--TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDV   83 (321)
T ss_dssp             CSCHHHHEEE-EEEEEECSSEEEEEEEETT--TCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             chhhhccEEE-eeEeeecCCEEEEEEEECC--CCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            3567788885 7799999999999999876  678899999864321        3468899999999999999999999


Q ss_pred             EEeCCCceEEEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCC
Q psy2172          85 FLSHNDRKVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEG  163 (291)
Q Consensus        85 ~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~  163 (291)
                      +  .+....++||||+. ++|.+.+....         .+++..++.++.|++.||++||++|++|+||||+||+++.++
T Consensus        84 ~--~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~  152 (321)
T 2a2a_A           84 Y--ENRTDVVLILELVSGGELFDFLAQKE---------SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKN  152 (321)
T ss_dssp             E--ECSSEEEEEECCCCSCBHHHHHHTCS---------CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTT
T ss_pred             E--ecCCEEEEEEEcCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCC
Confidence            9  56778999999996 48888775321         288999999999999999999999999999999999998543


Q ss_pred             CCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc-
Q psy2172         164 IERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK-  242 (291)
Q Consensus       164 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~-  242 (291)
                      .....++|+|||++.......    ......|++.|+|||.+.+.. ++.++|+||||+++|+|++|..||.+...... 
T Consensus       153 ~~~~~~kl~Dfg~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  227 (321)
T 2a2a_A          153 IPIPHIKLIDFGLAHEIEDGV----EFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETL  227 (321)
T ss_dssp             SSSCCEEECCCTTCEECCTTC----CCCCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH
T ss_pred             CCcCCEEEccCccceecCccc----cccccCCCCCccCcccccCCC-CCCccccHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence            223389999999998765432    223456899999999998744 89999999999999999999999987543210 


Q ss_pred             --------CCC----CCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         243 --------TSN----PYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       243 --------~~~----~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                              ...    ......+.+++..|..+.|..||++.++..+||+..
T Consensus       228 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~  278 (321)
T 2a2a_A          228 ANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP  278 (321)
T ss_dssp             HHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred             HHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence                    000    223467889999999999999999999999998763

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-42  Score=295.46  Aligned_cols=251  Identities=19%  Similarity=0.300  Sum_probs=196.6

Q ss_pred             ccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC---CChhHHHHHHHHhcCCCCCeeeEEEEEEeCC
Q psy2172          13 RTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG---LSMSACREIALLRELKHPNVINLISVFLSHN   89 (291)
Q Consensus        13 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   89 (291)
                      ...+.++|.+ .++||+|+||.||+|.+..  +++.||+|++....   ....+.+|+.++++++||||+++++++...+
T Consensus         4 ~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   80 (319)
T 4euu_A            4 QSTSNHLWLL-SDILGQGATANVFRGRHKK--TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT   80 (319)
T ss_dssp             EECSSEEEEE-EEEEEECSSEEEEEEEETT--TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT
T ss_pred             ccCCCCCEEE-EEEecCCCCeEEEEEEECC--CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCC
Confidence            3456678885 7799999999999999876  67889999987532   2356789999999999999999999997666


Q ss_pred             CceEEEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCc
Q psy2172          90 DRKVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGR  168 (291)
Q Consensus        90 ~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~  168 (291)
                      ....++||||++ ++|.+++.......      .+++..++.++.|++.||+|||++||+|+||||+||++.........
T Consensus        81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~  154 (319)
T 4euu_A           81 TRHKVLIMEFCPCGSLYTVLEEPSNAY------GLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSV  154 (319)
T ss_dssp             TCCEEEEEECCTTCBHHHHHHSGGGTT------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEE
T ss_pred             CceEEEEEeCCCCCCHHHHHHHhcccc------CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCce
Confidence            668999999997 58888876543221      28999999999999999999999999999999999998433326678


Q ss_pred             EEEeecccceecCCCCCCCCCCCCceecccccccccccC-------CcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc
Q psy2172         169 VKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLG-------ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI  241 (291)
Q Consensus       169 ~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-------~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~  241 (291)
                      ++|+|||++.......    ......||..|+|||++..       ...++.++|||||||++|+|++|..||.......
T Consensus       155 ~kL~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~  230 (319)
T 4euu_A          155 YKLTDFGAARELEDDE----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR  230 (319)
T ss_dssp             EEECCCTTCEECCTTC----CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGG
T ss_pred             EEEccCCCceecCCCC----ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccc
Confidence            9999999998765432    2234568999999999852       2458899999999999999999999997433210


Q ss_pred             -----------------------------------c---CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCC
Q psy2172         242 -----------------------------------K---TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEH  276 (291)
Q Consensus       242 -----------------------------------~---~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  276 (291)
                                                         +   .........+.+++..|....|..||++.++.++
T Consensus       231 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h  303 (319)
T 4euu_A          231 RNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (319)
T ss_dssp             GCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             hhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhc
Confidence                                               0   0111224567777888888888888887765433

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.9e-43  Score=296.03  Aligned_cols=245  Identities=33%  Similarity=0.616  Sum_probs=193.3

Q ss_pred             ccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC----hhHHHHHHHHhcCCCCCeeeEEEEEEeCCCce
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIALLRELKHPNVINLISVFLSHNDRK   92 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (291)
                      .++|++ .++||+|+||.||+|.+..  +++.||+|.+......    ..+.+|+.++++++||||+++++++  .+...
T Consensus         2 ~~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~   76 (311)
T 4agu_A            2 MEKYEK-IGKIGEGSYGVVFKCRNRD--TGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVF--RRKRR   76 (311)
T ss_dssp             -CCEEE-EEEEEECSSEEEEEEEETT--TCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEE--EETTE
T ss_pred             cccceE-eeEEeecCCeEEEEEEeCC--CCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhhee--ecCCe
Confidence            356774 6799999999999999876  6788999998655433    3467899999999999999999999  45678


Q ss_pred             EEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          93 VWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        93 ~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      .++||||+++++...+.....        .+++..++.++.|++.||++||++|++|+||||+||+++    .++.++|+
T Consensus        77 ~~lv~e~~~~~~l~~~~~~~~--------~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~----~~~~~kl~  144 (311)
T 4agu_A           77 LHLVFEYCDHTVLHELDRYQR--------GVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILIT----KHSVIKLC  144 (311)
T ss_dssp             EEEEEECCSEEHHHHHHHTSS--------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEEC
T ss_pred             EEEEEEeCCCchHHHHHhhhc--------CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEc----CCCCEEEe
Confidence            999999999865544433221        289999999999999999999999999999999999998    67799999


Q ss_pred             ecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccC---------
Q psy2172         173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT---------  243 (291)
Q Consensus       173 Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~---------  243 (291)
                      |||.+........   ......|+..|+|||.+.+...++.++|+||||+++|+|++|..||.+.......         
T Consensus       145 Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  221 (311)
T 4agu_A          145 DFGFARLLTGPSD---YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGD  221 (311)
T ss_dssp             CCTTCEECC---------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS
T ss_pred             eCCCchhccCccc---ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcc
Confidence            9999987654321   2234577999999999987566899999999999999999999999876432100         


Q ss_pred             -------------------------------CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         244 -------------------------------SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       244 -------------------------------~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                                                     ..+.....+.+++..|..+.|..||++.++..|||+..
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~  290 (311)
T 4agu_A          222 LIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFEN  290 (311)
T ss_dssp             CCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTT
T ss_pred             cccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHh
Confidence                                           00123455788999999999999999999999998764

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3.3e-43  Score=301.66  Aligned_cols=248  Identities=25%  Similarity=0.396  Sum_probs=201.5

Q ss_pred             cccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcC-CCCCeeeEEEEEEeCCCce
Q psy2172          14 TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLREL-KHPNVINLISVFLSHNDRK   92 (291)
Q Consensus        14 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~   92 (291)
                      ..+.+.|.+ .+.||+|+||.||+|.++.  +++.||+|++....  ....+|++++.++ +||||+++++++  .+...
T Consensus        18 ~~~~~~y~~-~~~lG~G~~g~V~~~~~~~--~~~~~avK~~~~~~--~~~~~E~~~l~~~~~hp~iv~~~~~~--~~~~~   90 (342)
T 2qr7_A           18 IQFTDGYEV-KEDIGVGSYSVCKRCIHKA--TNMEFAVKIIDKSK--RDPTEEIEILLRYGQHPNIITLKDVY--DDGKY   90 (342)
T ss_dssp             -CHHHHEEE-EEEEEECSSEEEEEEEETT--TTEEEEEEEEETTT--CCCHHHHHHHHHHTTSTTBCCEEEEE--ECSSE
T ss_pred             cCccccEEE-EEEEeeCCCEEEEEEEECC--CCCEEEEEEEEccc--CChHHHHHHHHHhcCCCCcCeEEEEE--EcCCE
Confidence            456677885 6799999999999999876  77899999997543  2345788888887 799999999999  56789


Q ss_pred             EEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEE
Q psy2172          93 VWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI  171 (291)
Q Consensus        93 ~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l  171 (291)
                      .|+||||+.| +|.+.+....         .+++..++.++.|++.||+|||++||+|+||||+||++..+......++|
T Consensus        91 ~~lv~E~~~gg~L~~~i~~~~---------~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl  161 (342)
T 2qr7_A           91 VYVVTELMKGGELLDKILRQK---------FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRI  161 (342)
T ss_dssp             EEEEECCCCSCBHHHHHHTCT---------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEE
T ss_pred             EEEEEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEE
Confidence            9999999975 8887776432         28999999999999999999999999999999999999654334457999


Q ss_pred             eecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc----------
Q psy2172         172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI----------  241 (291)
Q Consensus       172 ~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~----------  241 (291)
                      +|||++........   ......||+.|+|||++.+.. ++.++|+|||||++|+|++|..||.+...+.          
T Consensus       162 ~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~  237 (342)
T 2qr7_A          162 CDFGFAKQLRAENG---LLMTPCYTANFVAPEVLERQG-YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS  237 (342)
T ss_dssp             CCCTTCEECBCTTC---CBCCSSCCSSCCCHHHHHHHH-HHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHH
T ss_pred             EECCCcccCcCCCC---ceeccCCCccccCHHHhcCCC-CCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHcc
Confidence            99999987654321   223457799999999997644 8889999999999999999999998643210          


Q ss_pred             ---c---CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         242 ---K---TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       242 ---~---~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                         .   .......+.+.+++..|..+.|..||++.++..|||+..
T Consensus       238 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  283 (342)
T 2qr7_A          238 GKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH  283 (342)
T ss_dssp             CCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred             CCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence               0   011234577899999999999999999999999999853

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-42  Score=299.56  Aligned_cols=248  Identities=30%  Similarity=0.497  Sum_probs=196.2

Q ss_pred             ccccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC----hhHHHHHHHHhcCCCCCeeeEEEEEE
Q psy2172          11 NERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIALLRELKHPNVINLISVFL   86 (291)
Q Consensus        11 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~   86 (291)
                      .....+.++|.+ .+.||+|+||.||+|.+..  +++.||||.+......    ..+.+|+.+++.++||||+++++++.
T Consensus        18 ~~~~~~~~~y~~-~~~lG~G~~g~V~~a~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~   94 (367)
T 1cm8_A           18 KTAWEVRAVYRD-LQPVGSGAYGAVCSAVDGR--TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFT   94 (367)
T ss_dssp             SSEECCBSSEEE-EEEC------CEEEEEETT--TCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred             CceeeecceEEE-eEEeeecCCeEEEEEEECC--CCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEe
Confidence            345567788885 6799999999999999876  7788999999654332    35779999999999999999999995


Q ss_pred             eCC----CceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecC
Q psy2172          87 SHN----DRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGE  162 (291)
Q Consensus        87 ~~~----~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~  162 (291)
                      ..+    ....|+||||++++|.+++....          +++..++.++.|++.||+|||++||+|+||||+||+++  
T Consensus        95 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~----------l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~--  162 (367)
T 1cm8_A           95 PDETLDDFTDFYLVMPFMGTDLGKLMKHEK----------LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN--  162 (367)
T ss_dssp             SCSSTTTCCCCEEEEECCSEEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC--
T ss_pred             cCCccccCceEEEEEecCCCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEc--
Confidence            432    14579999999889888876421          89999999999999999999999999999999999998  


Q ss_pred             CCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc-
Q psy2172         163 GIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI-  241 (291)
Q Consensus       163 ~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~-  241 (291)
                        .++.++|+|||++......      .....+|..|+|||++.+...++.++|+||+||++|+|++|+.||.+..... 
T Consensus       163 --~~~~~kl~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~  234 (367)
T 1cm8_A          163 --EDCELKILDFGLARQADSE------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ  234 (367)
T ss_dssp             --TTCCEEECCCTTCEECCSS------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             --CCCCEEEEeeecccccccc------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence              6779999999999875432      2345779999999999875568999999999999999999999998754310 


Q ss_pred             ---------------------------------------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         242 ---------------------------------------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       242 ---------------------------------------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                                                             ....+.....+.+++..|....|..||++.++..||++..
T Consensus       235 l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~  313 (367)
T 1cm8_A          235 LKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES  313 (367)
T ss_dssp             HHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred             HHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHh
Confidence                                                   0011223456778888888899999999888888887653

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2e-42  Score=291.02  Aligned_cols=239  Identities=25%  Similarity=0.317  Sum_probs=189.2

Q ss_pred             cccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC-----ChhHHHHHHHHhcCCCCCeeeEEEEEE
Q psy2172          12 ERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-----SMSACREIALLRELKHPNVINLISVFL   86 (291)
Q Consensus        12 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~   86 (291)
                      ....+.++|++ .+.||+|+||.||+|.+..  +++.||+|.+.....     ...+.+|+.++++++||||+++++++ 
T Consensus         5 ~g~~~~~~y~i-~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-   80 (294)
T 4eqm_A            5 IGKIINERYKI-VDKLGGGGMSTVYLAEDTI--LNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-   80 (294)
T ss_dssp             CSSCEETTEEE-EEEEEEETTEEEEEEEETT--TCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-
T ss_pred             hhhHhhccEEE-EEEEccCCCEEEEEEEECC--CCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-
Confidence            34567788886 6799999999999999876  678899999853321     23578899999999999999999998 


Q ss_pred             eCCCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCC
Q psy2172          87 SHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIE  165 (291)
Q Consensus        87 ~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~  165 (291)
                       .+....|+||||+++ +|.+.+.....         +++..++.++.|++.||++||++|++|+||||+||+++    .
T Consensus        81 -~~~~~~~lv~e~~~g~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~----~  146 (294)
T 4eqm_A           81 -EEDDCYYLVMEYIEGPTLSEYIESHGP---------LSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILID----S  146 (294)
T ss_dssp             -ECSSEEEEEEECCCSCBHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----T
T ss_pred             -eeCCeEEEEEeCCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----C
Confidence             567799999999976 88888765432         89999999999999999999999999999999999998    6


Q ss_pred             CCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc----
Q psy2172         166 RGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI----  241 (291)
Q Consensus       166 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~----  241 (291)
                      ++.++|+|||++........  .......||+.|+|||.+.+.. ++.++||||||+++|+|++|..||.+.....    
T Consensus       147 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  223 (294)
T 4eqm_A          147 NKTLKIFDFGIAKALSETSL--TQTNHVLGTVQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIK  223 (294)
T ss_dssp             TSCEEECCCSSSTTC---------------CCSSCCHHHHHTCC-CCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHH
T ss_pred             CCCEEEEeCCCccccccccc--cccCccccCccccCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence            67899999999976543211  2223456899999999998754 8899999999999999999999998765321    


Q ss_pred             ----------cCCCCCcHHHHHHHHHhhCCCCcCChh-hhh
Q psy2172         242 ----------KTSNPYHHDQLDRIFSVMGFPLEKDWE-DIR  271 (291)
Q Consensus       242 ----------~~~~~~~~~~~~~i~~~~~~~~~~~~~-~~~  271 (291)
                                ....+...+.+.+++..+..+.|..|| ++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~  264 (294)
T 4eqm_A          224 HIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQ  264 (294)
T ss_dssp             HHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHH
T ss_pred             HhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHH
Confidence                      011223346788889999888888876 443

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.9e-42  Score=291.44  Aligned_cols=247  Identities=15%  Similarity=0.194  Sum_probs=201.0

Q ss_pred             ccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcC-CCCCeeeEEEEEEeCCCc
Q psy2172          13 RTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLREL-KHPNVINLISVFLSHNDR   91 (291)
Q Consensus        13 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~   91 (291)
                      ...+.+.|.+ .+.||+|+||.||+|.+..  +++.||+|++........+.+|+.+++.+ +|++++++++++  .+..
T Consensus         5 ~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~--~~~~   79 (298)
T 1csn_A            5 NNVVGVHYKV-GRRIGEGSFGVIFEGTNLL--NNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG--QEGL   79 (298)
T ss_dssp             -CEETTTEEE-EEEEEECSSCEEEEEEETT--TTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEE--EETT
T ss_pred             CcccccceEE-EEEEeecCCEEEEEEEECC--CCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeec--CCCc
Confidence            4557778885 7799999999999999766  77899999998777777899999999999 799999999998  5577


Q ss_pred             eEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCC-CCCCcEE
Q psy2172          92 KVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEG-IERGRVK  170 (291)
Q Consensus        92 ~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~-~~~~~~~  170 (291)
                      ..++||||++++|.+++.....        .+++..++.++.|++.||++||++|++|+||||+||+++.++ .....++
T Consensus        80 ~~~lv~e~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~k  151 (298)
T 1csn_A           80 HNVLVIDLLGPSLEDLLDLCGR--------KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIY  151 (298)
T ss_dssp             EEEEEEECCCCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEE
T ss_pred             eeEEEEEecCCCHHHHHHHhcc--------CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEE
Confidence            8999999998899998875432        289999999999999999999999999999999999998543 1334599


Q ss_pred             EeecccceecCCCCCCC----CCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc-----
Q psy2172         171 IADMGFARLFNNPLKPL----ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI-----  241 (291)
Q Consensus       171 l~Dfg~~~~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~-----  241 (291)
                      |+|||++..........    .......||..|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.....     
T Consensus       152 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  230 (298)
T 1csn_A          152 VVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY  230 (298)
T ss_dssp             ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH
T ss_pred             EEECccccccccccccccccccCccCCCCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHH
Confidence            99999998776532211    1234567899999999998754 8999999999999999999999998854210     


Q ss_pred             ------------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         242 ------------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       242 ------------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                                  ....+...+.+.+++..|..+.|..||++.++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l  274 (298)
T 1csn_A          231 ERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYL  274 (298)
T ss_dssp             HHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHH
T ss_pred             HHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHH
Confidence                        00111234678888999988999999887753

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2.4e-42  Score=297.20  Aligned_cols=242  Identities=23%  Similarity=0.297  Sum_probs=199.1

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC-----CCChhHHHHHHHHhcC-CCCCeeeEEEEEEeCCCc
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-----GLSMSACREIALLREL-KHPNVINLISVFLSHNDR   91 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~   91 (291)
                      +.|.+ .+.||+|+||.||+|.++.  +++.||+|+++..     .....+.+|..++..+ +||+|+++++++  .+..
T Consensus        20 ~~y~~-~~~lG~G~fg~V~~~~~~~--~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~--~~~~   94 (353)
T 2i0e_A           20 TDFNF-LMVLGKGSFGKVMLSERKG--TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF--QTMD   94 (353)
T ss_dssp             TTEEE-EEEEEEETTEEEEEEEETT--EEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE--ECSS
T ss_pred             HHcEE-EEEEeeCCCEEEEEEEECC--CCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE--EcCC
Confidence            44664 6799999999999999876  6788999998642     3345678899999988 799999999999  5677


Q ss_pred             eEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEE
Q psy2172          92 KVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVK  170 (291)
Q Consensus        92 ~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~  170 (291)
                      ..|+||||+.| +|.+.+.....         +++..++.++.|++.||+|||++||+|+||||+||+++    .++.++
T Consensus        95 ~~~lv~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~----~~g~vk  161 (353)
T 2i0e_A           95 RLYFVMEYVNGGDLMYHIQQVGR---------FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD----SEGHIK  161 (353)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTSCEE
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEc----CCCcEE
Confidence            99999999975 88888765332         89999999999999999999999999999999999998    678999


Q ss_pred             EeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---------
Q psy2172         171 IADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---------  241 (291)
Q Consensus       171 l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---------  241 (291)
                      |+|||++.......   .......||+.|+|||++.+.. ++.++|+|||||++|+|++|..||.+.....         
T Consensus       162 L~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~  237 (353)
T 2i0e_A          162 IADFGMCKENIWDG---VTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN  237 (353)
T ss_dssp             ECCCTTCBCCCCTT---CCBCCCCSCGGGCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred             EEeCCcccccccCC---cccccccCCccccChhhhcCCC-cCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC
Confidence            99999997533221   2234567899999999998754 8999999999999999999999998765321         


Q ss_pred             cCCCCCcHHHHHHHHHhhCCCCcCChh-----hhhcCCCCcchhh
Q psy2172         242 KTSNPYHHDQLDRIFSVMGFPLEKDWE-----DIRKMPEHPTLLK  281 (291)
Q Consensus       242 ~~~~~~~~~~~~~i~~~~~~~~~~~~~-----~~~~~~~~~~~~~  281 (291)
                      ..........+.+++..|....|..|+     ++.++..||++..
T Consensus       238 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~  282 (353)
T 2i0e_A          238 VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  282 (353)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred             CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence            112233457788999999999999998     4578888888754

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=6.7e-43  Score=311.11  Aligned_cols=249  Identities=25%  Similarity=0.379  Sum_probs=205.7

Q ss_pred             ccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC-----CCChhHHHHHHHHhcCCCCCeeeEEEEEEe
Q psy2172          13 RTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-----GLSMSACREIALLRELKHPNVINLISVFLS   87 (291)
Q Consensus        13 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   87 (291)
                      .....+.|.+ ++.||+|+||.||+|.+..  +++.||||++...     .....+.+|+.+++.++||||+++++++  
T Consensus        11 ~~~~~~~Y~l-~~~LG~G~fg~V~~a~~~~--~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~--   85 (476)
T 2y94_A           11 GRVKIGHYIL-GDTLGVGTFGKVKVGKHEL--TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI--   85 (476)
T ss_dssp             SCCEETTEEE-EEEEECCSSSCEEEEEETT--TCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE--
T ss_pred             CCceecCEEE-EEEEeeCCCeEEEEEEECC--CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE--
Confidence            3344566775 7899999999999999876  6788999998642     2335688999999999999999999999  


Q ss_pred             CCCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCC
Q psy2172          88 HNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIER  166 (291)
Q Consensus        88 ~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~  166 (291)
                      .+....|+||||+++ +|.+.+...         ..+++..++.++.|++.||+|||++||+|+||||+||+++    .+
T Consensus        86 ~~~~~~~lv~E~~~gg~L~~~l~~~---------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~----~~  152 (476)
T 2y94_A           86 STPSDIFMVMEYVSGGELFDYICKN---------GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLD----AH  152 (476)
T ss_dssp             ECSSEEEEEEECCSSEEHHHHTTSS---------SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEC----TT
T ss_pred             EECCEEEEEEeCCCCCcHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEe----cC
Confidence            556789999999964 887776532         1289999999999999999999999999999999999998    67


Q ss_pred             CcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc------
Q psy2172         167 GRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED------  240 (291)
Q Consensus       167 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~------  240 (291)
                      +.++|+|||++......    .......||+.|+|||++.+....+.++|||||||++|+|++|..||.+....      
T Consensus       153 ~~vkL~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i  228 (476)
T 2y94_A          153 MNAKIADFGLSNMMSDG----EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKI  228 (476)
T ss_dssp             CCEEECCCSSCEECCTT----CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHH
T ss_pred             CCeEEEeccchhhcccc----ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHH
Confidence            78999999999876542    12234578999999999988654578999999999999999999999876432      


Q ss_pred             ---ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhhh
Q psy2172         241 ---IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF  283 (291)
Q Consensus       241 ---~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (291)
                         ...........+.+++..|....|..||++.++..|||+.+.+
T Consensus       229 ~~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~  274 (476)
T 2y94_A          229 CDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDL  274 (476)
T ss_dssp             HTTCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTC
T ss_pred             hcCCcCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcC
Confidence               1112233456789999999999999999999999999987654

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-42  Score=294.52  Aligned_cols=243  Identities=25%  Similarity=0.328  Sum_probs=192.6

Q ss_pred             cccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC----hhHHHHHHHHhcC-CCCCeeeEEEEEEeCCC
Q psy2172          16 VEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIALLREL-KHPNVINLISVFLSHND   90 (291)
Q Consensus        16 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~   90 (291)
                      +.++|.+ .++||+|+||+||+|.++.  +++.||||++......    .....|+..+.++ +||||+++++++  .+.
T Consensus        55 ~~~~y~~-~~~LG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~--~~~  129 (311)
T 3p1a_A           55 FQQSFQR-LSRLGHGSYGEVFKVRSKE--DGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW--EEG  129 (311)
T ss_dssp             HHHHEEE-EEEEEEETTEEEEEEEETT--TSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--EET
T ss_pred             hhhheee-eheeccCCCeEEEEEEECC--CCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEE--EeC
Confidence            3466774 6699999999999999876  6788999998654322    2344555555554 899999999999  457


Q ss_pred             ceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEE
Q psy2172          91 RKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVK  170 (291)
Q Consensus        91 ~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~  170 (291)
                      ...++||||++++|.+.+.....        .+++..++.++.|++.||+|||++||+|+||||+||+++    .++.++
T Consensus       130 ~~~~lv~e~~~~~L~~~~~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~----~~~~~k  197 (311)
T 3p1a_A          130 GILYLQTELCGPSLQQHCEAWGA--------SLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLG----PRGRCK  197 (311)
T ss_dssp             TEEEEEEECCCCBHHHHHHHHCS--------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----GGGCEE
T ss_pred             CEEEEEEeccCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC----CCCCEE
Confidence            78999999999999888765432        289999999999999999999999999999999999998    667999


Q ss_pred             EeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc--------
Q psy2172         171 IADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK--------  242 (291)
Q Consensus       171 l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~--------  242 (291)
                      |+|||++.......    ......||+.|+|||++.+  .++.++||||||+++|+|++|..|+.+......        
T Consensus       198 l~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~  271 (311)
T 3p1a_A          198 LGDFGLLVELGTAG----AGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPP  271 (311)
T ss_dssp             ECCCTTCEECC----------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTTTCCCH
T ss_pred             EccceeeeecccCC----CCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhccCCCc
Confidence            99999988765432    2234568999999999886  389999999999999999999766654322100        


Q ss_pred             CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         243 TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       243 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                      .......+.+.+++..|..+.|..||++.++.++||+.+
T Consensus       272 ~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          272 EFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence            011123467899999999999999999999999999753

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.2e-42  Score=295.19  Aligned_cols=257  Identities=23%  Similarity=0.312  Sum_probs=199.8

Q ss_pred             ccccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC--CChhHHHHHHHHhcC-CCCCeeeEEEEEEe
Q psy2172          11 NERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG--LSMSACREIALLREL-KHPNVINLISVFLS   87 (291)
Q Consensus        11 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~   87 (291)
                      ....++.+.|++.++.||+|+||.||+|.+..  +++.||||++....  ....+.+|+.++.++ +||||+++++++  
T Consensus         5 ~~~~~~~~~y~i~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~--   80 (316)
T 2ac3_A            5 SFSGRFEDVYQLQEDVLGEGAHARVQTCINLI--TSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF--   80 (316)
T ss_dssp             SSCCCTTTSCEECCCCCCCCSSEEEEEEECSS--SCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEE--
T ss_pred             ccCcccceeEEecCceecCCceEEEEEEEEcC--CCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEE--
Confidence            44567788898877899999999999999765  67889999996543  345688999999985 799999999999  


Q ss_pred             CCCceEEEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCC
Q psy2172          88 HNDRKVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIER  166 (291)
Q Consensus        88 ~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~  166 (291)
                      .+....|+||||+. ++|.+.+.....         +++..++.++.|++.||+|||++|++|+||||+||+++.++ ..
T Consensus        81 ~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~  150 (316)
T 2ac3_A           81 EEEDRFYLVFEKMRGGSILSHIHKRRH---------FNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPN-QV  150 (316)
T ss_dssp             EETTEEEEEEECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSS-SS
T ss_pred             eeCCEEEEEEEcCCCCcHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCC-Cc
Confidence            45678999999997 588888765421         89999999999999999999999999999999999998432 23


Q ss_pred             CcEEEeecccceecCCCCC----CCCCCCCceecccccccccccCC----cCCCCchhHHHHHHHHHHHHcCCCCCCCCc
Q psy2172         167 GRVKIADMGFARLFNNPLK----PLADLDPVVVTFWYRAPELLLGA----RHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  238 (291)
Q Consensus       167 ~~~~l~Dfg~~~~~~~~~~----~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~  238 (291)
                      ..++|+|||++........    .........||..|+|||.+.+.    ..++.++||||||+++|+|++|..||.+..
T Consensus       151 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  230 (316)
T 2ac3_A          151 SPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC  230 (316)
T ss_dssp             CSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred             CceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence            4599999999876543211    01112234689999999998641    237889999999999999999999998764


Q ss_pred             cccc-----------------------CCC-----CCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         239 EDIK-----------------------TSN-----PYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       239 ~~~~-----------------------~~~-----~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                      ....                       ...     ......+.+++..|..+.|..||++.++..+||+..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~  301 (316)
T 2ac3_A          231 GSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQG  301 (316)
T ss_dssp             CSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-
T ss_pred             cccccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcC
Confidence            3210                       000     123456889999999999999999999999998764

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.7e-42  Score=296.31  Aligned_cols=242  Identities=23%  Similarity=0.355  Sum_probs=196.8

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC-----ChhHHHHHHHHhcC-CCCCeeeEEEEEEeCCCc
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-----SMSACREIALLREL-KHPNVINLISVFLSHNDR   91 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~   91 (291)
                      +.|.+ .+.||+|+||.||+|.++.  +++.||+|++.....     ...+.+|..+++++ +||||+++++++  .+..
T Consensus         9 ~~y~~-~~~lG~G~fg~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~--~~~~   83 (345)
T 3a8x_A            9 QDFDL-LRVIGRGSYAKVLLVRLKK--TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF--QTES   83 (345)
T ss_dssp             GGEEE-EEEEEECSSEEEEEEEETT--TTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE--ECSS
T ss_pred             hheEE-EEEEEecCCeEEEEEEECC--CCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE--EeCC
Confidence            45664 6799999999999999876  778999999975432     23477899999988 899999999999  5677


Q ss_pred             eEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEE
Q psy2172          92 KVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVK  170 (291)
Q Consensus        92 ~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~  170 (291)
                      ..|+||||+.+ +|...+.....         +++..++.++.|++.||+|||++||+|+||||+||+++    .++.++
T Consensus        84 ~~~lv~e~~~gg~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~----~~g~~k  150 (345)
T 3a8x_A           84 RLFFVIEYVNGGDLMFHMQRQRK---------LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD----SEGHIK  150 (345)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTSCEE
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEC----CCCCEE
Confidence            99999999975 88877764321         89999999999999999999999999999999999998    678999


Q ss_pred             EeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc----------
Q psy2172         171 IADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED----------  240 (291)
Q Consensus       171 l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~----------  240 (291)
                      |+|||+++......   .......||+.|+|||++.+.. ++.++|+|||||++|+|++|..||......          
T Consensus       151 L~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~  226 (345)
T 3a8x_A          151 LTDYGMCKEGLRPG---DTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY  226 (345)
T ss_dssp             ECCGGGCBCSCCTT---CCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHH
T ss_pred             EEeccccccccCCC---CcccccCCCccccCccccCCCC-CChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHH
Confidence            99999997533221   2234567899999999998754 899999999999999999999999752110          


Q ss_pred             --------ccCCCCCcHHHHHHHHHhhCCCCcCChhhh------hcCCCCcchhh
Q psy2172         241 --------IKTSNPYHHDQLDRIFSVMGFPLEKDWEDI------RKMPEHPTLLK  281 (291)
Q Consensus       241 --------~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~------~~~~~~~~~~~  281 (291)
                              ...........+.+++..|....|..|++.      .++..||++..
T Consensus       227 ~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~  281 (345)
T 3a8x_A          227 LFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  281 (345)
T ss_dssp             HHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred             HHHHHHcCCCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence                    011223345678899999999999999874      67888888754

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.8e-42  Score=311.19  Aligned_cols=250  Identities=26%  Similarity=0.436  Sum_probs=203.3

Q ss_pred             ccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeC
Q psy2172          13 RTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT----GLSMSACREIALLRELKHPNVINLISVFLSH   88 (291)
Q Consensus        13 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   88 (291)
                      ...+.+.|++ .++||+|+||.||+|.++.  ++..||+|++...    .....+.+|+.+++.++||||+++++++  .
T Consensus        32 ~~~~~~~y~~-~~~lG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~--~  106 (494)
T 3lij_A           32 KGHLSEMYQR-VKKLGSGAYGEVLLCRDKV--THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF--E  106 (494)
T ss_dssp             BCCHHHHEEE-EEEEECC---EEEEEEETT--TCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEE--E
T ss_pred             CCchhcCeEE-eeEEecCCCEEEEEEEECC--CCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEE--E
Confidence            3456677885 7799999999999999876  6788999998643    2346788999999999999999999999  5


Q ss_pred             CCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCC
Q psy2172          89 NDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERG  167 (291)
Q Consensus        89 ~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~  167 (291)
                      +....|+||||+.+ +|.+.+.....         +++..++.++.|++.||+|||++||+|+||||+||+++..+ ...
T Consensus       107 ~~~~~~lv~e~~~~g~L~~~~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~-~~~  176 (494)
T 3lij_A          107 DKRNYYLVMECYKGGELFDEIIHRMK---------FNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKE-KDA  176 (494)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSS-TTC
T ss_pred             eCCEEEEEEecCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCC-CCC
Confidence            67789999999975 88777764322         89999999999999999999999999999999999997533 356


Q ss_pred             cEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc------
Q psy2172         168 RVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI------  241 (291)
Q Consensus       168 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~------  241 (291)
                      .++|+|||++.......    ......||+.|+|||++.+  .++.++||||+||++|+|++|..||.+.....      
T Consensus       177 ~~kl~DfG~a~~~~~~~----~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  250 (494)
T 3lij_A          177 LIKIVDFGLSAVFENQK----KMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVE  250 (494)
T ss_dssp             CEEECCCTTCEECBTTB----CBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             cEEEEECCCCeECCCCc----cccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            79999999998765432    2234578999999999864  48999999999999999999999998765421      


Q ss_pred             ----cC---CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhhh
Q psy2172         242 ----KT---SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF  283 (291)
Q Consensus       242 ----~~---~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (291)
                          ..   ........+.+++..|..+.|..||++.++..|||+.+..
T Consensus       251 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  299 (494)
T 3lij_A          251 KGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC  299 (494)
T ss_dssp             HTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred             hCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCc
Confidence                00   0112356788999999999999999999999999987654

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.9e-42  Score=303.80  Aligned_cols=248  Identities=27%  Similarity=0.431  Sum_probs=197.0

Q ss_pred             ccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCCCCeeeEEEEEEeC----CCce
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFLSH----NDRK   92 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~~~   92 (291)
                      ...|++ .+.||+|+||.||+|.++.  +++.||||.+...  .....+|+++++.++||||+++++++...    +..+
T Consensus        53 ~~~y~~-~~~lG~G~fg~Vy~~~~~~--~~~~vaiK~~~~~--~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~  127 (420)
T 1j1b_A           53 EVSYTD-TKVIGNGSFGVVYQAKLCD--SGELVAIKKVLQD--KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY  127 (420)
T ss_dssp             EEEEEE-EEEEEECSSEEEEEEEETT--TCCEEEEEEEECC--TTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred             cceEEe-eeEEeeCCCEEEEEEEECC--CCcEEEEEEeccc--chhHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence            345664 7799999999999999876  6788999998653  23345799999999999999999998542    2345


Q ss_pred             EEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          93 VWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        93 ~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      +++||||+++++...+.......     ..+++..++.++.|++.||+|||++||+|+||||+||+++.   +...+||+
T Consensus       128 ~~lv~e~~~~~l~~~~~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~---~~~~~kl~  199 (420)
T 1j1b_A          128 LNLVLDYVPETVYRVARHYSRAK-----QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP---DTAVLKLC  199 (420)
T ss_dssp             EEEEEECCCEEHHHHHHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEET---TTTEEEEC
T ss_pred             EEeehhcccccHHHHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeC---CCCeEEec
Confidence            78999999998887776543322     12899999999999999999999999999999999999983   23578999


Q ss_pred             ecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc-----------
Q psy2172         173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI-----------  241 (291)
Q Consensus       173 Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~-----------  241 (291)
                      |||+++......    ......||..|+|||++.+...++.++|||||||++|+|++|+.||.+.....           
T Consensus       200 DFG~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~  275 (420)
T 1j1b_A          200 DFGSAKQLVRGE----PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT  275 (420)
T ss_dssp             CCTTCEECCTTC----CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred             cchhhhhcccCC----CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            999998764421    22345679999999999775568999999999999999999999998765210           


Q ss_pred             ------------------cC---------CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         242 ------------------KT---------SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       242 ------------------~~---------~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                                        +.         ..+.....+.+++..|....|..||++.++..||++..
T Consensus       276 p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~  342 (420)
T 1j1b_A          276 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE  342 (420)
T ss_dssp             CCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred             CCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcc
Confidence                              00         01122456788888999999999999998888888753

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.4e-42  Score=301.70  Aligned_cols=250  Identities=16%  Similarity=0.200  Sum_probs=200.2

Q ss_pred             cccccccccceeCcc--cceEEEEEEEccCCCCceeEEEEeCCCCCC----hhHHHHHHHHhcCCCCCeeeEEEEEEeCC
Q psy2172          16 VEDLFDYEGCKVGRG--TYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIALLRELKHPNVINLISVFLSHN   89 (291)
Q Consensus        16 ~~~~~~~~~~~ig~G--~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   89 (291)
                      -.++|++ .++||+|  +||.||+|.++.  +++.||+|++......    ..+.+|+.+++.++||||+++++++.  +
T Consensus        23 ~~~~y~~-~~~lG~G~~~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~   97 (389)
T 3gni_B           23 EGGCYEL-LTVIGKGFEDLMTVNLARYKP--TGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFI--A   97 (389)
T ss_dssp             CGGGEEE-EEEEEEETTTTEEEEEEEETT--TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--E
T ss_pred             CCCcEEE-EecccCCcCCceEEEEEEEcC--CCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEE--E
Confidence            3456775 6799999  999999999876  6789999999754322    34678999999999999999999994  5


Q ss_pred             CceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCc
Q psy2172          90 DRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGR  168 (291)
Q Consensus        90 ~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~  168 (291)
                      ....|+||||+.+ +|.+++......       .+++..++.++.|++.||+|||++||+|+||||+||+++    .++.
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~----~~~~  166 (389)
T 3gni_B           98 DNELWVVTSFMAYGSAKDLICTHFMD-------GMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS----VDGK  166 (389)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHTCTT-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTCC
T ss_pred             CCEEEEEEEccCCCCHHHHHhhhccc-------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc----CCCC
Confidence            6689999999985 888877654221       289999999999999999999999999999999999998    6779


Q ss_pred             EEEeecccceecCCCC----CCCCCCCCceecccccccccccCC-cCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccC
Q psy2172         169 VKIADMGFARLFNNPL----KPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT  243 (291)
Q Consensus       169 ~~l~Dfg~~~~~~~~~----~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~  243 (291)
                      ++|+|||.+.......    ..........||..|+|||++.+. ..++.++|||||||++|+|++|..||.+.......
T Consensus       167 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~  246 (389)
T 3gni_B          167 VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML  246 (389)
T ss_dssp             EEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH
T ss_pred             EEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence            9999999887543211    111122334778999999999763 34899999999999999999999999875432100


Q ss_pred             -------------------------------------------------------CCCCcHHHHHHHHHhhCCCCcCChh
Q psy2172         244 -------------------------------------------------------SNPYHHDQLDRIFSVMGFPLEKDWE  268 (291)
Q Consensus       244 -------------------------------------------------------~~~~~~~~~~~i~~~~~~~~~~~~~  268 (291)
                                                                             ........+.+++..|..+.|..||
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp  326 (389)
T 3gni_B          247 LEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARP  326 (389)
T ss_dssp             HHC--------------------------------------------------------CCHHHHHHHHHHTCSCTTTSC
T ss_pred             HHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCC
Confidence                                                                   1112345688899999999999999


Q ss_pred             hhhcCCCCcchhh
Q psy2172         269 DIRKMPEHPTLLK  281 (291)
Q Consensus       269 ~~~~~~~~~~~~~  281 (291)
                      ++.++..+||+.+
T Consensus       327 ta~ell~hp~f~~  339 (389)
T 3gni_B          327 SASTLLNHSFFKQ  339 (389)
T ss_dssp             CHHHHTTSGGGGG
T ss_pred             CHHHHhcCHHHHH
Confidence            9999999999864

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=8.4e-43  Score=293.42  Aligned_cols=246  Identities=23%  Similarity=0.348  Sum_probs=191.2

Q ss_pred             ccccccccccccceeCcccceEEEEEEEc--cCCCCceeEEEEeCCCCCC--hhHHHHHHHHhcCCCCCeeeEEEEEEeC
Q psy2172          13 RTKVEDLFDYEGCKVGRGTYGHVYKARRK--DNSDTRDYALKQIEGTGLS--MSACREIALLRELKHPNVINLISVFLSH   88 (291)
Q Consensus        13 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~--~~~~~~~vaiK~~~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~   88 (291)
                      .+-..+.|++ .++||+|+||.||+|.+.  +..+++.||+|++......  +.+.+|+.++++++||||+++++++...
T Consensus         5 ~~~~~~~~~~-~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   83 (295)
T 3ugc_A            5 TQFEERHLKF-LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA   83 (295)
T ss_dssp             -CCCGGGEEE-EEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred             CcCCHHHhhh-hheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            3445667775 679999999999999853  2336788999999754322  4678999999999999999999998665


Q ss_pred             CCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCC
Q psy2172          89 NDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERG  167 (291)
Q Consensus        89 ~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~  167 (291)
                      +....++||||+++ +|.+.+......        +++..++.++.|++.||+|||++|++|+||||+||+++    .++
T Consensus        84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~----~~~  151 (295)
T 3ugc_A           84 GRRNLKLIMEYLPYGSLRDYLQKHKER--------IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE----NEN  151 (295)
T ss_dssp             HHTSCEEEEECCTTCBHHHHHHHCGGG--------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE----ETT
T ss_pred             CCCceEEEEEeCCCCCHHHHHHhcccc--------cCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEc----CCC
Confidence            55678999999965 998888765432        89999999999999999999999999999999999998    667


Q ss_pred             cEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc-------
Q psy2172         168 RVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED-------  240 (291)
Q Consensus       168 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~-------  240 (291)
                      .++|+|||++.................++..|+|||.+.+.. ++.++||||||+++|+|++|..||......       
T Consensus       152 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~  230 (295)
T 3ugc_A          152 RVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN  230 (295)
T ss_dssp             EEEECCCCSCC-------------CTTCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCT
T ss_pred             eEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCC-CChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcC
Confidence            899999999987655433223334455677899999998754 899999999999999999999998754321       


Q ss_pred             -------------------ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         241 -------------------IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       241 -------------------~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                                         .........+.+.+++..|....|..||++.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e  281 (295)
T 3ugc_A          231 DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRD  281 (295)
T ss_dssp             TCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             ccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHH
Confidence                               11122334577888999999999988888775

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.6e-42  Score=296.22  Aligned_cols=244  Identities=16%  Similarity=0.190  Sum_probs=194.5

Q ss_pred             ccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcC-CCCCeeeEEEEEEeCCCceE
Q psy2172          15 KVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLREL-KHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        15 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~   93 (291)
                      .+.+.|++ .+.||+|+||.||+|.+..  +++.||||++........+.+|+.+++++ +||||+++++++  .+....
T Consensus         6 ~~~~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~--~~~~~~   80 (330)
T 2izr_A            6 MVGPNFRV-GKKIGCGNFGELRLGKNLY--TNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFG--PCGKYN   80 (330)
T ss_dssp             EETTTEEE-EEECCC-CTTSEEEEEETT--TTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEE--EETTEE
T ss_pred             EEcCCeEE-EEEeeccCCceEEEEEECC--CCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEE--ecCCcc
Confidence            45667885 7799999999999999766  77899999998776677899999999999 899999999998  446789


Q ss_pred             EEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCC-CCCcEEEe
Q psy2172          94 WLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGI-ERGRVKIA  172 (291)
Q Consensus        94 ~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~-~~~~~~l~  172 (291)
                      ++||||++++|.+++.....        .+++..++.++.|++.||+|||++||+|+||||+||+++.++. ....++|+
T Consensus        81 ~lv~e~~~~~L~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~  152 (330)
T 2izr_A           81 AMVLELLGPSLEDLFDLCDR--------TFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHII  152 (330)
T ss_dssp             EEEEECCCCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEEC
T ss_pred             EEEEEeCCCCHHHHHHHcCC--------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEE
Confidence            99999998899998876422        2899999999999999999999999999999999999984321 11239999


Q ss_pred             ecccceecCCCCCC----CCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccC-----
Q psy2172         173 DMGFARLFNNPLKP----LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT-----  243 (291)
Q Consensus       173 Dfg~~~~~~~~~~~----~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~-----  243 (291)
                      |||++.........    ........||+.|+|||++.+.. ++.++||||||+++|+|++|..||.+...+...     
T Consensus       153 DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~  231 (330)
T 2izr_A          153 DFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKE-QSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQK  231 (330)
T ss_dssp             CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHH
T ss_pred             EcccceeeecCCCCccccccccCCcCCCccccChHHHcCCC-CCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHH
Confidence            99999876543221    11234568899999999998854 899999999999999999999999885432100     


Q ss_pred             -------C-----CCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         244 -------S-----NPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       244 -------~-----~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                             .     ..... .+.+++..|....|..+|++.++
T Consensus       232 i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l  272 (330)
T 2izr_A          232 IGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYL  272 (330)
T ss_dssp             HHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHH
T ss_pred             HHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHH
Confidence                   0     00112 67778888888888888876653

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.2e-42  Score=302.65  Aligned_cols=248  Identities=22%  Similarity=0.368  Sum_probs=193.6

Q ss_pred             cccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHh-cCCCCCeeeEEEEEEe--CCCce
Q psy2172          16 VEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLR-ELKHPNVINLISVFLS--HNDRK   92 (291)
Q Consensus        16 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~--~~~~~   92 (291)
                      +.+.|++.++.||+|+||.||+|.++.  +++.||||++..   ...+.+|+.++. ..+||||+++++++..  .+...
T Consensus        59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~--~~~~vAiK~~~~---~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~  133 (400)
T 1nxk_A           59 IIDDYKVTSQVLGLGINGKVLQIFNKR--TQEKFALKMLQD---CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC  133 (400)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEEC---SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccccceeccceeeeccCeEEEEEEECC--CCCEEEEEEeCc---chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence            344555556799999999999999876  778899999863   456788888874 4589999999998843  34668


Q ss_pred             EEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEE
Q psy2172          93 VWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI  171 (291)
Q Consensus        93 ~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l  171 (291)
                      +|+||||+.| +|.+.+.....       ..+++..++.++.|++.||.|||++||+|+||||+||+++... .++.++|
T Consensus       134 ~~lv~E~~~gg~L~~~l~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~-~~~~~kl  205 (400)
T 1nxk_A          134 LLIVMECLDGGELFSRIQDRGD-------QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR-PNAILKL  205 (400)
T ss_dssp             EEEEEECCCSEEHHHHHHCC----------CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSS-TTCCEEE
T ss_pred             EEEEEEeCCCCcHHHHHHHhCC-------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCC-CCccEEE
Confidence            9999999975 88888764321       1289999999999999999999999999999999999998432 2678999


Q ss_pred             eecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc---------
Q psy2172         172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK---------  242 (291)
Q Consensus       172 ~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~---------  242 (291)
                      +|||++......    .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+......         
T Consensus       206 ~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~  280 (400)
T 1nxk_A          206 TDFGFAKETTSH----NSLTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR  280 (400)
T ss_dssp             CCCTTCEECC---------------CTTCCGGGSCCCC-SSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH
T ss_pred             EecccccccCCC----CccccCCCCCCccCHhhcCCCC-CCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH
Confidence            999999865432    1224567899999999997744 89999999999999999999999976543210         


Q ss_pred             --------CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         243 --------TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       243 --------~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                              .........+.+++..|....|..||++.++..|||+.+
T Consensus       281 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  327 (400)
T 1nxk_A          281 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  327 (400)
T ss_dssp             HTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             cCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccC
Confidence                    001234567899999999999999999999999988764

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.4e-42  Score=312.66  Aligned_cols=249  Identities=27%  Similarity=0.428  Sum_probs=203.1

Q ss_pred             ccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC---------------CChhHHHHHHHHhcCCCCC
Q psy2172          13 RTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG---------------LSMSACREIALLRELKHPN   77 (291)
Q Consensus        13 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---------------~~~~~~~e~~~l~~l~h~~   77 (291)
                      ...+.+.|.+ .++||+|+||.||+|.++.  +++.||+|++....               ..+.+.+|+.++++++|||
T Consensus        31 ~~~i~~~Y~~-~~~lG~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  107 (504)
T 3q5i_A           31 EGKIGESYFK-VRKLGSGAYGEVLLCKEKN--GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPN  107 (504)
T ss_dssp             CSCGGGTEEE-EEEEEC--CEEEEEEEETT--TCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTT
T ss_pred             CCCcccceEE-EeEecccCCeEEEEEEECC--CCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCC
Confidence            3457788886 7899999999999999876  67889999986432               2346889999999999999


Q ss_pred             eeeEEEEEEeCCCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCc
Q psy2172          78 VINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPAN  156 (291)
Q Consensus        78 iv~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~N  156 (291)
                      |+++++++  .+....|+||||+++ +|.+.+.....         +++..++.++.|++.||+|||++||+|+||||+|
T Consensus       108 iv~~~~~~--~~~~~~~lv~e~~~gg~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~N  176 (504)
T 3q5i_A          108 IIKLFDVF--EDKKYFYLVTEFYEGGELFEQIINRHK---------FDECDAANIMKQILSGICYLHKHNIVHRDIKPEN  176 (504)
T ss_dssp             BCCEEEEE--ECSSEEEEEEECCTTCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             CCeEEEEE--EcCCEEEEEEecCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHH
Confidence            99999999  567899999999975 88877765322         8999999999999999999999999999999999


Q ss_pred             EEeecCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCC
Q psy2172         157 ILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  236 (291)
Q Consensus       157 il~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~  236 (291)
                      |+++.++ ....++|+|||++......    .......||+.|+|||++.+  .++.++||||+||++|+|++|..||.+
T Consensus       177 il~~~~~-~~~~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~  249 (504)
T 3q5i_A          177 ILLENKN-SLLNIKIVDFGLSSFFSKD----YKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGG  249 (504)
T ss_dssp             EEESSTT-CCSSEEECCCTTCEECCTT----SCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             EEEecCC-CCccEEEEECCCCEEcCCC----CccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence            9998432 2347999999999876543    22344578999999999875  389999999999999999999999987


Q ss_pred             Cccccc---------CCC----CCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhh
Q psy2172         237 RQEDIK---------TSN----PYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKD  282 (291)
Q Consensus       237 ~~~~~~---------~~~----~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (291)
                      ......         ...    +.....+.+++..|..+.|..||++.++..+||+.+.
T Consensus       250 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~  308 (504)
T 3q5i_A          250 QNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY  308 (504)
T ss_dssp             SSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred             CCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence            654210         000    1234678899999999999999999999999998654

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=5.8e-42  Score=299.52  Aligned_cols=255  Identities=26%  Similarity=0.446  Sum_probs=200.3

Q ss_pred             ecccccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCCCCeeeEEEEEEeC
Q psy2172           9 TSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFLSH   88 (291)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   88 (291)
                      .........++|++ .++||+|+||.||+|.+..  +++ +|+|.+....  ....+|+.+++.++||||+++++++...
T Consensus        31 ~~~~~~~~~~~Y~~-~~~lG~G~~g~V~~a~~~~--~~~-~aikk~~~~~--~~~~~E~~il~~l~h~niv~l~~~~~~~  104 (394)
T 4e7w_A           31 DGKTGEQREIAYTN-CKVIGNGSFGVVFQAKLVE--SDE-VAIKKVLQDK--RFKNRELQIMRIVKHPNVVDLKAFFYSN  104 (394)
T ss_dssp             ESSSCCEEEEEEEE-EEEEEEETTEEEEEEEETT--TEE-EEEEEEECCT--TSCCHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred             CCCCCCcccceEEE-eEEEeeCCCeEEEEEEECC--CCe-EEEEEEecCc--chHHHHHHHHHhCCCCCcceEEEEEEec
Confidence            33445556677885 7799999999999999865  334 7777765332  2234799999999999999999998653


Q ss_pred             ----CCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCC
Q psy2172          89 ----NDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGI  164 (291)
Q Consensus        89 ----~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~  164 (291)
                          +..+.++||||+++++...+........     .+++..++.++.|++.||+|||++||+|+||||+||+++.   
T Consensus       105 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~---  176 (394)
T 4e7w_A          105 GDKKDEVFLNLVLEYVPETVYRASRHYAKLKQ-----TMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDP---  176 (394)
T ss_dssp             SSSSSCEEEEEEEECCSEEHHHHHHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET---
T ss_pred             CCCCCceEEEEEeeccCccHHHHHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcC---
Confidence                2335889999999988777665433222     2899999999999999999999999999999999999973   


Q ss_pred             CCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---
Q psy2172         165 ERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---  241 (291)
Q Consensus       165 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---  241 (291)
                      .++.++|+|||+++......    ......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.....   
T Consensus       177 ~~~~~kL~DFG~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~  252 (394)
T 4e7w_A          177 PSGVLKLIDFGSAKILIAGE----PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLV  252 (394)
T ss_dssp             TTTEEEECCCTTCEECCTTC----CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             CCCcEEEeeCCCcccccCCC----CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            35689999999998764432    22345679999999999876668999999999999999999999998765210   


Q ss_pred             --------------------------c---------CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         242 --------------------------K---------TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       242 --------------------------~---------~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                                                +         ...+.....+.+++..|....|..||++.++..||++..
T Consensus       253 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  327 (394)
T 4e7w_A          253 EIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDE  327 (394)
T ss_dssp             HHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGST
T ss_pred             HHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhh
Confidence                                      0         011123457889999999999999999999988888754

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.8e-42  Score=300.51  Aligned_cols=247  Identities=23%  Similarity=0.335  Sum_probs=196.5

Q ss_pred             cccccccc-cceeCcccceEEEEEEEccCCCCceeEEEEeCCCC--CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCce
Q psy2172          16 VEDLFDYE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG--LSMSACREIALLRELKHPNVINLISVFLSHNDRK   92 (291)
Q Consensus        16 ~~~~~~~~-~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (291)
                      +.+.|.+. .+.||+|+||.||+|.+..  +++.||+|+++...  ..+.+.+|+.++++++||||+++++++  .+...
T Consensus        85 ~~~~~~~~~~~~lG~G~~g~Vy~a~~~~--~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~--~~~~~  160 (373)
T 2x4f_A           85 VNSFYTVSKTEILGGGRFGQVHKCEETA--TGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF--ESKND  160 (373)
T ss_dssp             GGGTEEEEEEEECC-----CEEEEEETT--TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE--ECSSE
T ss_pred             cccceeeecceEEecCcCEEEEEEEEcC--CCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEE--EECCE
Confidence            34445543 5689999999999999876  67889999997643  335688999999999999999999999  55778


Q ss_pred             EEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEE
Q psy2172          93 VWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI  171 (291)
Q Consensus        93 ~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l  171 (291)
                      .++||||+++ +|.+.+.....        .+++..++.++.|++.||+|||++||+|+||||+||++..+  ..+.++|
T Consensus       161 ~~lv~E~~~~~~L~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~--~~~~~kl  230 (373)
T 2x4f_A          161 IVLVMEYVDGGELFDRIIDESY--------NLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNR--DAKQIKI  230 (373)
T ss_dssp             EEEEEECCTTCEEHHHHHHTGG--------GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEET--TTTEEEE
T ss_pred             EEEEEeCCCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecC--CCCcEEE
Confidence            9999999975 88777764332        18999999999999999999999999999999999999532  4568999


Q ss_pred             eecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc----------
Q psy2172         172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI----------  241 (291)
Q Consensus       172 ~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~----------  241 (291)
                      +|||++.......    ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.....          
T Consensus       231 ~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~  305 (373)
T 2x4f_A          231 IDFGLARRYKPRE----KLKVNFGTPEFLAPEVVNYD-FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRW  305 (373)
T ss_dssp             CCCSSCEECCTTC----BCCCCCSSCTTCCHHHHTTC-BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC
T ss_pred             EeCCCceecCCcc----ccccccCCCcEeChhhccCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC
Confidence            9999998765431    22345689999999999764 48999999999999999999999998765321          


Q ss_pred             ---cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         242 ---KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       242 ---~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                         ....+...+.+.+++..|..+.|..||++.++..+||+.+
T Consensus       306 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~  348 (373)
T 2x4f_A          306 DLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSD  348 (373)
T ss_dssp             CSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred             CCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence               0011233577899999999999999999999999998764

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=7.7e-42  Score=289.54  Aligned_cols=240  Identities=24%  Similarity=0.342  Sum_probs=192.6

Q ss_pred             ccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC--CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEE
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG--LSMSACREIALLRELKHPNVINLISVFLSHNDRKVW   94 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (291)
                      .+.|.+ +++||+|+||.||+|.++.  +++.||+|.+....  ....+.+|+.++++++||||+++++++.  +....+
T Consensus         9 ~~~~~~-~~~lG~G~~g~V~~~~~~~--~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~   83 (310)
T 3s95_A            9 PSDLIH-GEVLGKGCFGQAIKVTHRE--TGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY--KDKRLN   83 (310)
T ss_dssp             GGGEEE-EEEEECCSSEEEEEEEETT--TCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE--ETTEEE
T ss_pred             hhHeec-cceecCCCCEEEEEEEECC--CCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEe--cCCeeE
Confidence            355664 7899999999999999876  67889999886432  2346889999999999999999999994  467899


Q ss_pred             EEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEee
Q psy2172          95 LLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIAD  173 (291)
Q Consensus        95 iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~D  173 (291)
                      +||||+.+ +|.+++.....        .+++..++.++.|++.||+|||++|++|+||||+||+++    .++.++|+|
T Consensus        84 lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~----~~~~~kl~D  151 (310)
T 3s95_A           84 FITEYIKGGTLRGIIKSMDS--------QYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVR----ENKNVVVAD  151 (310)
T ss_dssp             EEEECCTTCBHHHHHHHCCT--------TSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEC----TTSCEEECC
T ss_pred             EEEEecCCCcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEEC----CCCCEEEee
Confidence            99999976 88888765322        289999999999999999999999999999999999998    677899999


Q ss_pred             cccceecCCCCCCC-----------CCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc
Q psy2172         174 MGFARLFNNPLKPL-----------ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK  242 (291)
Q Consensus       174 fg~~~~~~~~~~~~-----------~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~  242 (291)
                      ||.+..........           .......||+.|+|||.+.+.. ++.++||||||+++|+|++|..||........
T Consensus       152 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~  230 (310)
T 3s95_A          152 FGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRS-YDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM  230 (310)
T ss_dssp             CTTCEECC--------------------CCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCT
T ss_pred             cccceecccccccccccccccccccccccccCCCcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHhcCCCCCcchhhhHH
Confidence            99998765432211           0112457899999999998744 89999999999999999999999986544321


Q ss_pred             C------------CCCCcHHHHHHHHHhhCCCCcCChhhhhcCC
Q psy2172         243 T------------SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMP  274 (291)
Q Consensus       243 ~------------~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  274 (291)
                      .            ..+.....+.+++..|..+.|..||++.++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~  274 (310)
T 3s95_A          231 DFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLE  274 (310)
T ss_dssp             TSSBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             HHhhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            1            1233345688899999999999999987653

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=5.8e-42  Score=292.67  Aligned_cols=251  Identities=21%  Similarity=0.415  Sum_probs=203.1

Q ss_pred             ccccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCC-CCCeeeEEEEEEeCC
Q psy2172          11 NERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELK-HPNVINLISVFLSHN   89 (291)
Q Consensus        11 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~   89 (291)
                      .......+.|++ .++||+|+||.||+|.+..  +++.||+|+++.. ....+.+|+.++++++ ||||+++++++....
T Consensus        29 ~~~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~  104 (330)
T 3nsz_A           29 VVEWGNQDDYQL-VRKLGRGKYSEVFEAINIT--NNEKVVVKILKPV-KKKKIKREIKILENLRGGPNIITLADIVKDPV  104 (330)
T ss_dssp             CCCCEEGGGEEE-EEEEEECSSEEEEEEEETT--TCCEEEEEEECSC-CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT
T ss_pred             hhcccCCCceEE-EEEecccCCeEEEEEEECC--CCcEEEEEEeccc-chHHHHHHHHHHHHcCCCCCEEEeeeeeccCC
Confidence            344445677775 7799999999999999876  6788999999753 4567899999999997 999999999997655


Q ss_pred             CceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCC-
Q psy2172          90 DRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERG-  167 (291)
Q Consensus        90 ~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~-  167 (291)
                      ....+++|||+.+ +|.+.+.            .+++..++.++.|++.||+|||++|++|+||||+||+++    ..+ 
T Consensus       105 ~~~~~lv~e~~~~~~l~~~~~------------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~----~~~~  168 (330)
T 3nsz_A          105 SRTPALVFEHVNNTDFKQLYQ------------TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID----HEHR  168 (330)
T ss_dssp             TCCEEEEEECCCCCCHHHHGG------------GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE----TTTT
T ss_pred             CCceEEEEeccCchhHHHHHH------------hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEc----CCCC
Confidence            7789999999986 6655542            188999999999999999999999999999999999998    344 


Q ss_pred             cEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc------
Q psy2172         168 RVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI------  241 (291)
Q Consensus       168 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~------  241 (291)
                      .++|+|||++.......    ......|+..|+|||.+.+...++.++|||||||++|+|++|..||.......      
T Consensus       169 ~~kl~Dfg~a~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~  244 (330)
T 3nsz_A          169 KLRLIDWGLAEFYHPGQ----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI  244 (330)
T ss_dssp             EEEECCCTTCEECCTTC----CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHH
T ss_pred             EEEEEeCCCceEcCCCC----ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHH
Confidence            89999999998765432    22345778899999999875668999999999999999999999994322110      


Q ss_pred             -----------------------------------------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchh
Q psy2172         242 -----------------------------------------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLL  280 (291)
Q Consensus       242 -----------------------------------------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  280 (291)
                                                               ..........+.+++..|..+.|..||++.++.+|||+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~  324 (330)
T 3nsz_A          245 AKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY  324 (330)
T ss_dssp             HHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGT
T ss_pred             HHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHh
Confidence                                                     000011346788999999999999999999999999988


Q ss_pred             hhhhh
Q psy2172         281 KDFNE  285 (291)
Q Consensus       281 ~~~~~  285 (291)
                      ...++
T Consensus       325 ~~~~~  329 (330)
T 3nsz_A          325 TVVKD  329 (330)
T ss_dssp             TCC--
T ss_pred             hhccC
Confidence            76554

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-42  Score=296.98  Aligned_cols=232  Identities=42%  Similarity=0.760  Sum_probs=189.8

Q ss_pred             cccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-------CChhHHHHHHHHhcCCCCCeeeEEEEEEeC
Q psy2172          16 VEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-------LSMSACREIALLRELKHPNVINLISVFLSH   88 (291)
Q Consensus        16 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   88 (291)
                      ..++|.+ .+.||+|+||.||+|.+..  +++.||+|.+....       ....+.+|+.+++.++||||+++++++  .
T Consensus         8 ~~~~y~~-~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~   82 (346)
T 1ua2_A            8 RAKRYEK-LDFLGEGQFATVYKARDKN--TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF--G   82 (346)
T ss_dssp             -----CE-EEEEEEETTEEEEEEECSS--CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE--C
T ss_pred             HhcccEE-EeEEeecCCEEEEEEEECC--CCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEE--e
Confidence            3466774 6799999999999999766  67889999986422       234678999999999999999999999  5


Q ss_pred             CCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCc
Q psy2172          89 NDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGR  168 (291)
Q Consensus        89 ~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~  168 (291)
                      +....++||||++++|...+....        ..+++..++.++.|++.||+|||++|++|+||||+||+++    .++.
T Consensus        83 ~~~~~~lv~e~~~~~l~~~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~----~~~~  150 (346)
T 1ua2_A           83 HKSNISLVFDFMETDLEVIIKDNS--------LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD----ENGV  150 (346)
T ss_dssp             CTTCCEEEEECCSEEHHHHHTTCC--------SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTCC
T ss_pred             eCCceEEEEEcCCCCHHHHHHhcC--------cCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEc----CCCC
Confidence            677899999999998887765322        1278889999999999999999999999999999999998    6679


Q ss_pred             EEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccCCCCCc
Q psy2172         169 VKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH  248 (291)
Q Consensus       169 ~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  248 (291)
                      ++|+|||++.......   .......||+.|+|||.+.+...++.++|||||||++|+|++|.+||.+...         
T Consensus       151 ~kl~Dfg~a~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~---------  218 (346)
T 1ua2_A          151 LKLADFGLAKSFGSPN---RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---------  218 (346)
T ss_dssp             EEECCCGGGSTTTSCC---CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---------
T ss_pred             EEEEecccceeccCCc---ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH---------
Confidence            9999999998654322   1223457799999999997755689999999999999999999999988765         


Q ss_pred             HHHHHHHHHhhCCCCcCChhhhhcCCCC
Q psy2172         249 HDQLDRIFSVMGFPLEKDWEDIRKMPEH  276 (291)
Q Consensus       249 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~  276 (291)
                      .+.+..++...+.|.+..||....++++
T Consensus       219 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~  246 (346)
T 1ua2_A          219 LDQLTRIFETLGTPTEEQWPDMCSLPDY  246 (346)
T ss_dssp             HHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred             HHHHHHHHHHcCCCChhhhhhhccCccc
Confidence            4788999999999999999887665543

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.7e-42  Score=310.83  Aligned_cols=247  Identities=26%  Similarity=0.461  Sum_probs=203.5

Q ss_pred             cccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCC----CCCChhHHHHHHHHhcCCCCCeeeEEEEEEeCC
Q psy2172          14 TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEG----TGLSMSACREIALLRELKHPNVINLISVFLSHN   89 (291)
Q Consensus        14 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   89 (291)
                      ..+.++|++ .++||+|+||.||+|.++.  +++.||+|++..    ......+.+|+.++++++||||+++++++  .+
T Consensus        18 g~~~~~y~~-~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~--~~   92 (486)
T 3mwu_A           18 GTFAERYNI-VCMLGKGSFGEVLKCKDRI--TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL--ED   92 (486)
T ss_dssp             CHHHHHEEE-EEEEECCSSSEEEEEEETT--TCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEE--EC
T ss_pred             CChhcceEE-eEEEeecCCEEEEEEEECC--CCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEE--Ec
Confidence            457788886 7799999999999999876  678899999853    23446788999999999999999999999  56


Q ss_pred             CceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCc
Q psy2172          90 DRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGR  168 (291)
Q Consensus        90 ~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~  168 (291)
                      ....|+||||+.+ +|.+.+.....         +++..++.++.|++.||.|||++||+|+||||+||+++... ....
T Consensus        93 ~~~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~-~~~~  162 (486)
T 3mwu_A           93 SSSFYIVGELYTGGELFDEIIKRKR---------FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKE-KDCD  162 (486)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSS-TTCC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCC-CCCC
Confidence            7799999999975 88777765422         89999999999999999999999999999999999997433 4568


Q ss_pred             EEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc-------
Q psy2172         169 VKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI-------  241 (291)
Q Consensus       169 ~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~-------  241 (291)
                      ++|+|||++......    .......||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.....       
T Consensus       163 ~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  236 (486)
T 3mwu_A          163 IKIIDFGLSTCFQQN----TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET  236 (486)
T ss_dssp             EEECSCSCTTTBCCC--------CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             EEEEECCcCeECCCC----CccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence            999999999765443    22234578999999999976  38999999999999999999999998765321       


Q ss_pred             ---cC---CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         242 ---KT---SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       242 ---~~---~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                         ..   ......+.+.+++..|..+.|..||++.++..|||+.+
T Consensus       237 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~  282 (486)
T 3mwu_A          237 GKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK  282 (486)
T ss_dssp             TCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHH
T ss_pred             CCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhcc
Confidence               00   11123467889999999999999999999999988764

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=3.4e-42  Score=288.28  Aligned_cols=256  Identities=21%  Similarity=0.298  Sum_probs=204.0

Q ss_pred             cccccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC----CChhHHHHHHHHhcC-CCCCeeeEEEE
Q psy2172          10 SNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG----LSMSACREIALLREL-KHPNVINLISV   84 (291)
Q Consensus        10 ~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l-~h~~iv~~~~~   84 (291)
                      +.+..++.+.|++ .+.||+|+||.||+|.+..  +++.||+|.+....    ....+.+|+..+..+ +||||++++++
T Consensus         3 ~~~~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~   79 (289)
T 1x8b_A            3 MGMKSRYTTEFHE-LEKIGSGEFGSVFKCVKRL--DGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSA   79 (289)
T ss_dssp             --CCCHHHHHEEE-EEEEEEETTEEEEEEEETT--TCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEE
T ss_pred             ccccccccchhhh-hhhhcCCCceEEEEEEEcC--CCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeee
Confidence            3456677788885 6799999999999999876  67889999987532    234578899999999 89999999999


Q ss_pred             EEeCCCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCC
Q psy2172          85 FLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEG  163 (291)
Q Consensus        85 ~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~  163 (291)
                      +  .+....++||||+++ +|.+.+........     .+++..++.++.|++.||+|||++||+|+||||+||+++.++
T Consensus        80 ~--~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~  152 (289)
T 1x8b_A           80 W--AEDDHMLIQNEYCNGGSLADAISENYRIMS-----YFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTS  152 (289)
T ss_dssp             E--EETTEEEEEEECCTTCBHHHHHHHHHHHTC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---
T ss_pred             e--ecCCeEEEEEEecCCCcHHHHHHhhccccc-----CCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCC
Confidence            9  446689999999975 99988876544222     289999999999999999999999999999999999998432


Q ss_pred             ---------------CCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHH
Q psy2172         164 ---------------IERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL  228 (291)
Q Consensus       164 ---------------~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~  228 (291)
                                     .....++|+|||.+......       ....|+..|+|||.+.+...++.++||||||+++|+|+
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~  225 (289)
T 1x8b_A          153 IPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP-------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAA  225 (289)
T ss_dssp             -----------------CCCEEECCCTTCEETTCS-------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHT
T ss_pred             CCcccccccccccccCCceEEEEcccccccccCCc-------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHh
Confidence                           13457999999999876542       22358999999999987555778999999999999999


Q ss_pred             cCCCCCCCCcc-------cccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhh
Q psy2172         229 TSEPIFHCRQE-------DIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKD  282 (291)
Q Consensus       229 ~g~~pf~~~~~-------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (291)
                      +|.+|+.....       ..........+.+.+++..|..+.|..||++.++.++||+...
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          226 GAEPLPRNGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             TCCCCCSSSHHHHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             cCCCCCcchhHHHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence            99987754332       1122333456789999999999999999999999999998754

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-42  Score=302.49  Aligned_cols=246  Identities=21%  Similarity=0.282  Sum_probs=196.6

Q ss_pred             ccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC-----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCc
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-----GLSMSACREIALLRELKHPNVINLISVFLSHNDR   91 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (291)
                      .+.|++ .+.||+|+||.||+|.++.  +++.||+|++++.     .....+.+|..++..++||||+++++++  .+..
T Consensus        60 ~~~f~~-~~~lG~G~fG~V~~~~~~~--~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~--~~~~  134 (412)
T 2vd5_A           60 RDDFEI-LKVIGRGAFSEVAVVKMKQ--TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF--QDEN  134 (412)
T ss_dssp             GGGEEE-EEEEEECSSCEEEEEEETT--TCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE--ECSS
T ss_pred             hhhEEE-EEEEeeCCCeEEEEEEECC--CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE--eeCC
Confidence            355664 6799999999999999876  7789999998642     2234578899999999999999999999  6678


Q ss_pred             eEEEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEE
Q psy2172          92 KVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVK  170 (291)
Q Consensus        92 ~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~  170 (291)
                      ..|+||||+. |+|.+.+.....        .+++..++.++.|++.||+|||++||+||||||+||+++    .++.++
T Consensus       135 ~~~lVmE~~~gg~L~~~l~~~~~--------~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld----~~g~vk  202 (412)
T 2vd5_A          135 YLYLVMEYYVGGDLLTLLSKFGE--------RIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLD----RCGHIR  202 (412)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSS--------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEE
T ss_pred             EEEEEEcCCCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeec----CCCCEE
Confidence            9999999996 588888865321        289999999999999999999999999999999999998    678999


Q ss_pred             EeecccceecCCCCCCCCCCCCceecccccccccccC------CcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---
Q psy2172         171 IADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLG------ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---  241 (291)
Q Consensus       171 l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---  241 (291)
                      |+|||++........  .......||+.|+|||++..      ...++.++|+|||||++|+|++|..||.+.....   
T Consensus       203 L~DFGla~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~  280 (412)
T 2vd5_A          203 LADFGSCLKLRADGT--VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYG  280 (412)
T ss_dssp             ECCCTTCEECCTTSC--EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred             EeechhheeccCCCc--cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHH
Confidence            999999987654211  12234578999999999862      2348999999999999999999999998765321   


Q ss_pred             -----------cCCCCCcHHHHHHHHHhhCCCCcCCh---hhhhcCCCCcchhhh
Q psy2172         242 -----------KTSNPYHHDQLDRIFSVMGFPLEKDW---EDIRKMPEHPTLLKD  282 (291)
Q Consensus       242 -----------~~~~~~~~~~~~~i~~~~~~~~~~~~---~~~~~~~~~~~~~~~  282 (291)
                                 +.........+.+++..|.. .|..|   |++.++..||++...
T Consensus       281 ~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i  334 (412)
T 2vd5_A          281 KIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL  334 (412)
T ss_dssp             HHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred             HHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence                       11112345678888888877 55554   688888888887643

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=5.1e-42  Score=292.07  Aligned_cols=236  Identities=25%  Similarity=0.451  Sum_probs=195.1

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCC--CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecCC
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG--LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAE  101 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~~  101 (291)
                      .++||+|+||.||+|.++.  +++.||||++....  ....+.+|+.++++++||||+++++++.  .....++||||++
T Consensus        50 ~~~lg~G~~g~V~~a~~~~--~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~~  125 (321)
T 2c30_A           50 YVKIGEGSTGIVCLAREKH--SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL--VGEELWVLMEFLQ  125 (321)
T ss_dssp             EEEEEEETTEEEEEEEETT--TCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEE--ETTEEEEEECCCC
T ss_pred             cEEeccCCCeEEEEEEECC--CCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE--ECCEEEEEEecCC
Confidence            4699999999999999876  67889999986433  3356889999999999999999999994  4568999999997


Q ss_pred             C-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceec
Q psy2172         102 H-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF  180 (291)
Q Consensus       102 ~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~  180 (291)
                      + +|.+.+...          .+++..+..++.|++.||.|||++|++|+||||+||+++    .++.++|+|||++...
T Consensus       126 ~~~L~~~l~~~----------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~----~~~~~kl~Dfg~~~~~  191 (321)
T 2c30_A          126 GGALTDIVSQV----------RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLT----LDGRVKLSDFGFCAQI  191 (321)
T ss_dssp             SCBHHHHHTTC----------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTCCEEECCCTTCEEC
T ss_pred             CCCHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCcEEEeeeeeeeec
Confidence            6 776665321          289999999999999999999999999999999999998    6678999999999876


Q ss_pred             CCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc------------cCCCCCc
Q psy2172         181 NNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI------------KTSNPYH  248 (291)
Q Consensus       181 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~------------~~~~~~~  248 (291)
                      .....   ......||+.|+|||.+.+.. ++.++||||||+++|+|++|..||.+.....            .......
T Consensus       192 ~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (321)
T 2c30_A          192 SKDVP---KRKSLVGTPYWMAPEVISRSL-YATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKV  267 (321)
T ss_dssp             CSSSC---CBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGS
T ss_pred             ccCcc---ccccccCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccC
Confidence            54321   223457899999999998754 8999999999999999999999997654310            0111123


Q ss_pred             HHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         249 HDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       249 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                      ...+.+++..|..+.|..||++.++.++|++.+
T Consensus       268 ~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~  300 (321)
T 2c30_A          268 SPVLRDFLERMLVRDPQERATAQELLDHPFLLQ  300 (321)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGG
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcChhhcc
Confidence            467889999999999999999999999998764

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2.4e-42  Score=299.80  Aligned_cols=250  Identities=29%  Similarity=0.478  Sum_probs=194.1

Q ss_pred             ecccccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC----hhHHHHHHHHhcCCCCCeeeEEEE
Q psy2172           9 TSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIALLRELKHPNVINLISV   84 (291)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~   84 (291)
                      .+.....+.++|.+ .+.||+|+||.||+|.+..  +++.||||++......    ..+.+|+.+++.++||||++++++
T Consensus        16 ~~~~~~~~~~~y~~-~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~   92 (371)
T 2xrw_A           16 IGDSTFTVLKRYQN-LKPIGSGAQGIVCAAYDAI--LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV   92 (371)
T ss_dssp             ETTEEEEEETTEEE-EEEEEECSSEEEEEEEETT--TTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cCCcccchhhheeE-eeeeEecCCEEEEEEEECC--CCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEe
Confidence            33444566778885 6799999999999999876  6788999998754322    357789999999999999999999


Q ss_pred             EEeCC----CceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEee
Q psy2172          85 FLSHN----DRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVM  160 (291)
Q Consensus        85 ~~~~~----~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~  160 (291)
                      +...+    ....|+||||++++|.+.+..           .+++..+..++.|++.||+|||++||+|+||||+||+++
T Consensus        93 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-----------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~  161 (371)
T 2xrw_A           93 FTPQKSLEEFQDVYIVMELMDANLCQVIQM-----------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK  161 (371)
T ss_dssp             ECSCCSTTTCCEEEEEEECCSEEHHHHHHS-----------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred             eccccccccccceEEEEEcCCCCHHHHHhh-----------ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc
Confidence            95332    237899999999998877741           188999999999999999999999999999999999998


Q ss_pred             cCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc
Q psy2172         161 GEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED  240 (291)
Q Consensus       161 ~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~  240 (291)
                          .++.++|+|||++......    .......||..|+|||++.+.. ++.++|||||||++|+|++|..||.+....
T Consensus       162 ----~~~~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~  232 (371)
T 2xrw_A          162 ----SDCTLKILDFGLARTAGTS----FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHI  232 (371)
T ss_dssp             ----TTSCEEECCCCC--------------------CTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             ----CCCCEEEEEeecccccccc----cccCCceecCCccCHHHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence                6679999999999765432    1223457899999999998754 899999999999999999999999875431


Q ss_pred             c-------------------------------cCCC-------------C-------CcHHHHHHHHHhhCCCCcCChhh
Q psy2172         241 I-------------------------------KTSN-------------P-------YHHDQLDRIFSVMGFPLEKDWED  269 (291)
Q Consensus       241 ~-------------------------------~~~~-------------~-------~~~~~~~~i~~~~~~~~~~~~~~  269 (291)
                      .                               +...             +       .....+.+++..|....|..||+
T Consensus       233 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t  312 (371)
T 2xrw_A          233 DQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS  312 (371)
T ss_dssp             HHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCC
T ss_pred             HHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCC
Confidence            0                               0000             0       01356789999999999999999


Q ss_pred             hhcCCCCcchhh
Q psy2172         270 IRKMPEHPTLLK  281 (291)
Q Consensus       270 ~~~~~~~~~~~~  281 (291)
                      +.++..|||+..
T Consensus       313 ~~e~l~hp~~~~  324 (371)
T 2xrw_A          313 VDEALQHPYINV  324 (371)
T ss_dssp             HHHHHHSHHHHT
T ss_pred             HHHHhCCcchhh
Confidence            999999988754

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3.7e-42  Score=293.38  Aligned_cols=242  Identities=19%  Similarity=0.259  Sum_probs=191.1

Q ss_pred             ccccccccccceeCcccceEEEEEEEccCC-CCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCC
Q psy2172          15 KVEDLFDYEGCKVGRGTYGHVYKARRKDNS-DTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHND   90 (291)
Q Consensus        15 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~-~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   90 (291)
                      ...++|++ .+.||+|+||.||+|.++..+ .+..||||.++....   ...+.+|+.+++.++||||+++++++  .+.
T Consensus        46 ~~~~~y~i-~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~  122 (325)
T 3kul_A           46 IEASRIHI-EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVV--TRG  122 (325)
T ss_dssp             CCGGGEEE-EEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE--CGG
T ss_pred             cChhHeEE-eeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE--EeC
Confidence            34556665 679999999999999987533 345599999975432   23588999999999999999999999  567


Q ss_pred             ceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcE
Q psy2172          91 RKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRV  169 (291)
Q Consensus        91 ~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~  169 (291)
                      ...++||||+++ +|.+++.....        .+++..++.++.|++.||+|||++||+|+||||+||+++    .++.+
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~----~~~~~  190 (325)
T 3kul_A          123 RLAMIVTEYMENGSLDTFLRTHDG--------QFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVD----SNLVC  190 (325)
T ss_dssp             GCCEEEEECCTTCBHHHHHHTTTT--------CSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTCCE
T ss_pred             CccEEEeeCCCCCcHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEC----CCCCE
Confidence            789999999975 88887753321        289999999999999999999999999999999999998    67899


Q ss_pred             EEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc--------
Q psy2172         170 KIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED--------  240 (291)
Q Consensus       170 ~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~--------  240 (291)
                      +|+|||++.................+|..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+....        
T Consensus       191 kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~  269 (325)
T 3kul_A          191 KVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT-FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE  269 (325)
T ss_dssp             EECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT
T ss_pred             EECCCCcccccccCccceeeccCCCCcccccCHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc
Confidence            9999999987755433222333445677899999997644 8899999999999999998 99999775532        


Q ss_pred             --ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         241 --IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       241 --~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                        ...........+.+++..|..+.|..||++.+
T Consensus       270 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e  303 (325)
T 3kul_A          270 GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQ  303 (325)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHH
Confidence              11223344577889999999999988888775

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.8e-42  Score=304.62  Aligned_cols=252  Identities=27%  Similarity=0.409  Sum_probs=200.8

Q ss_pred             ccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC-ChhHHHHHHHHhcC------CCCCeeeEEEEE
Q psy2172          13 RTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-SMSACREIALLREL------KHPNVINLISVF   85 (291)
Q Consensus        13 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l------~h~~iv~~~~~~   85 (291)
                      ...+.++|++ .++||+|+||.||+|.+..  +++.||||+++.... ...+.+|+.+++.+      +|+||+++++++
T Consensus        92 ~~~~~~ry~~-~~~LG~G~fg~V~~a~~~~--~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~  168 (429)
T 3kvw_A           92 HDHVAYRYEV-LKVIGKGSFGQVVKAYDHK--VHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF  168 (429)
T ss_dssp             TCEETTTEEE-EEEEEESSSEEEEEEEETT--TTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE
T ss_pred             CCcccCcEEE-EEEcccCccEEEEEEEECC--CCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeec
Confidence            3456677885 6799999999999999876  678999999976432 34577788888887      577999999999


Q ss_pred             EeCCCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCC
Q psy2172          86 LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIE  165 (291)
Q Consensus        86 ~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~  165 (291)
                        ......++||||++++|.+.+......       .+++..++.++.|++.||+|||++||+|+||||+||+++.+  .
T Consensus       169 --~~~~~~~lv~e~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~--~  237 (429)
T 3kvw_A          169 --TFRNHICMTFELLSMNLYELIKKNKFQ-------GFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQ--G  237 (429)
T ss_dssp             --EETTEEEEEECCCCCBHHHHHHHTTTC-------CCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESST--T
T ss_pred             --ccCCeEEEEEeccCCCHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccC--C
Confidence              446789999999999999888764322       28999999999999999999999999999999999999832  1


Q ss_pred             CCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccC--
Q psy2172         166 RGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT--  243 (291)
Q Consensus       166 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~--  243 (291)
                      ...++|+|||++......      .....||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.......  
T Consensus       238 ~~~vkL~DFG~a~~~~~~------~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~  310 (429)
T 3kvw_A          238 RSGIKVIDFGSSCYEHQR------VYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLAC  310 (429)
T ss_dssp             SCCEEECCCTTCEETTCC------CCSSCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             CcceEEeecccceecCCc------ccccCCCCCccChHHHhCCC-CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            123999999999765432      23457799999999998855 899999999999999999999999876531000  


Q ss_pred             ------------------------------------------------------------------CCCCcHHHHHHHHH
Q psy2172         244 ------------------------------------------------------------------SNPYHHDQLDRIFS  257 (291)
Q Consensus       244 ------------------------------------------------------------------~~~~~~~~~~~i~~  257 (291)
                                                                                        ........+.+++.
T Consensus       311 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~  390 (429)
T 3kvw_A          311 MIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLK  390 (429)
T ss_dssp             HHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHH
T ss_pred             HHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHH
Confidence                                                                              00011355789999


Q ss_pred             hhCCCCcCChhhhhcCCCCcchhhhhhh
Q psy2172         258 VMGFPLEKDWEDIRKMPEHPTLLKDFNE  285 (291)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (291)
                      .|....|..||++.++..|||+.+.+..
T Consensus       391 ~~L~~dP~~Rpta~e~L~Hpw~~~~~~~  418 (429)
T 3kvw_A          391 QCLEWDPAVRMTPGQALRHPWLRRRLPK  418 (429)
T ss_dssp             HHTCSSTTTSCCHHHHHTSTTTC-----
T ss_pred             HHCCCChhhCCCHHHHhCChhhccCCCC
Confidence            9999999999999999999999876654

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=4.8e-42  Score=292.95  Aligned_cols=247  Identities=23%  Similarity=0.397  Sum_probs=192.1

Q ss_pred             ccccccccccceeCcccceEEEEEEEcc-CCCCceeEEEEeCCCC------CChhHHHHHHHHhcCCCCCeeeEEEEEEe
Q psy2172          15 KVEDLFDYEGCKVGRGTYGHVYKARRKD-NSDTRDYALKQIEGTG------LSMSACREIALLRELKHPNVINLISVFLS   87 (291)
Q Consensus        15 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~~~~vaiK~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   87 (291)
                      ...+.|++ .+.||+|+||.||+|.+.. ..+++.||+|+++...      ....+.+|+.+++.++||||+++++++  
T Consensus        14 ~~~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--   90 (327)
T 3a62_A           14 IRPECFEL-LRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF--   90 (327)
T ss_dssp             CCGGGEEE-EEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE--
T ss_pred             CCHHHeEE-EEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE--
Confidence            34466775 6799999999999999752 2367889999997542      234577899999999999999999999  


Q ss_pred             CCCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCC
Q psy2172          88 HNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIER  166 (291)
Q Consensus        88 ~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~  166 (291)
                      .+....|+||||+.+ +|.+.+.....         +++..++.++.|++.||.|||++||+|+||||+||+++    .+
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~----~~  157 (327)
T 3a62_A           91 QTGGKLYLILEYLSGGELFMQLEREGI---------FMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLN----HQ  157 (327)
T ss_dssp             ECSSCEEEEEECCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEEC----TT
T ss_pred             EcCCEEEEEEeCCCCCcHHHHHHhCCC---------CCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEEC----CC
Confidence            557789999999975 88877764321         88999999999999999999999999999999999998    66


Q ss_pred             CcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc-----
Q psy2172         167 GRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI-----  241 (291)
Q Consensus       167 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~-----  241 (291)
                      +.++|+|||++.......   .......||+.|+|||++.+.. ++.++|+||||+++|+|++|..||.+.....     
T Consensus       158 ~~~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i  233 (327)
T 3a62_A          158 GHVKLTDFGLCKESIHDG---TVTHTFCGTIEYMAPEILMRSG-HNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI  233 (327)
T ss_dssp             SCEEECCCSCC-------------CTTSSCCTTSCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             CcEEEEeCCcccccccCC---ccccccCCCcCccCHhhCcCCC-CCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            799999999987543221   1223457899999999998754 8999999999999999999999998765321     


Q ss_pred             ----cCCCCCcHHHHHHHHHhhCCCCcCChh-----hhhcCCCCcchhh
Q psy2172         242 ----KTSNPYHHDQLDRIFSVMGFPLEKDWE-----DIRKMPEHPTLLK  281 (291)
Q Consensus       242 ----~~~~~~~~~~~~~i~~~~~~~~~~~~~-----~~~~~~~~~~~~~  281 (291)
                          ....+.....+.+++..|....|..||     ++.++..||++..
T Consensus       234 ~~~~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~  282 (327)
T 3a62_A          234 LKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH  282 (327)
T ss_dssp             HHTCCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred             HhCCCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence                122334457789999999999999998     6667777887753

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.9e-42  Score=291.36  Aligned_cols=253  Identities=23%  Similarity=0.337  Sum_probs=203.0

Q ss_pred             ccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC------CCChhHHHHHHHHhcCCCCCeeeEEEEEEeC
Q psy2172          15 KVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT------GLSMSACREIALLRELKHPNVINLISVFLSH   88 (291)
Q Consensus        15 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   88 (291)
                      ++.++|.+ ++.||+|+||.||+|.+..  +++.||+|++...      .....+.+|+.++++++||||+++++++...
T Consensus         2 ~l~~~y~i-~~~lg~G~~g~V~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   78 (305)
T 2wtk_C            2 KLIGKYLM-GDLLGEGSYGKVKEVLDSE--TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE   78 (305)
T ss_dssp             ---CCBCC-CCEEEECSSCEEEEEEBTT--TCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC
T ss_pred             ccccceeE-eeEEecCCCeEEEEEEECC--CCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC
Confidence            45678886 7799999999999999766  7788999998642      2345688999999999999999999998766


Q ss_pred             CCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCc
Q psy2172          89 NDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGR  168 (291)
Q Consensus        89 ~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~  168 (291)
                      +....++||||+++++.+.+......       .+++..++.++.|++.||.+||++|++|+||||+||+++    .++.
T Consensus        79 ~~~~~~lv~e~~~~~l~~~~~~~~~~-------~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~----~~~~  147 (305)
T 2wtk_C           79 EKQKMYMVMEYCVCGMQEMLDSVPEK-------RFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLT----TGGT  147 (305)
T ss_dssp             ---CEEEEEECCSEEHHHHHHHSTTC-------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTCC
T ss_pred             CCCeEEEEehhccCCHHHHHHhCccc-------ccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEc----CCCc
Confidence            67789999999999888777654322       289999999999999999999999999999999999998    6679


Q ss_pred             EEEeecccceecCCCCCCCCCCCCceecccccccccccCCc-CCCCchhHHHHHHHHHHHHcCCCCCCCCccc-------
Q psy2172         169 VKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGAR-HYTKAIDIWAIGCIFAELLTSEPIFHCRQED-------  240 (291)
Q Consensus       169 ~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~-------  240 (291)
                      ++|+|||.+........ ........|+..|+|||.+.+.. .++.++||||||+++|+|++|..||.+....       
T Consensus       148 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~  226 (305)
T 2wtk_C          148 LKISALGVAEALHPFAA-DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIG  226 (305)
T ss_dssp             EEECCCTTCEECCTTCS-SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             EEeeccccccccCcccc-ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHh
Confidence            99999999987653211 11223456899999999987633 2477999999999999999999999875431       


Q ss_pred             --ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhh
Q psy2172         241 --IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKD  282 (291)
Q Consensus       241 --~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (291)
                        ...........+.+++..|..+.|..||++.++.+++|+.+.
T Consensus       227 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  270 (305)
T 2wtk_C          227 KGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK  270 (305)
T ss_dssp             HCCCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred             cCCCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence              112233445778999999999999999999999888887643

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=3.2e-42  Score=287.63  Aligned_cols=244  Identities=25%  Similarity=0.461  Sum_probs=200.2

Q ss_pred             ccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC-----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCc
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-----GLSMSACREIALLRELKHPNVINLISVFLSHNDR   91 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (291)
                      .+.|++ .+.||+|+||.||+|.+..  ++..||+|++...     .....+.+|+.+++.++||||+++++++  .+..
T Consensus         8 ~~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~   82 (279)
T 3fdn_A            8 LEDFEI-GRPLGKGKFGNVYLAREKQ--SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF--HDAT   82 (279)
T ss_dssp             GGGEEE-EEEEEECSSEEEEEEEETT--TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEE--ECSS
T ss_pred             cccEEE-eeEEecCCCeEEEEEEEcc--CCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheE--ecCC
Confidence            456775 7799999999999999876  6788999998532     2345688999999999999999999999  5677


Q ss_pred             eEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEE
Q psy2172          92 KVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVK  170 (291)
Q Consensus        92 ~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~  170 (291)
                      ..++||||+++ +|.+.+.....         +++..++.++.|++.||++||++|++|+||||+||+++    .++.++
T Consensus        83 ~~~lv~e~~~~~~l~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~----~~~~~~  149 (279)
T 3fdn_A           83 RVYLILEYAPLGTVYRELQKLSK---------FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG----SAGELK  149 (279)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEEC----TTSCEE
T ss_pred             EEEEEEecCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEc----CCCCEE
Confidence            89999999985 88777765432         89999999999999999999999999999999999998    677999


Q ss_pred             EeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---------
Q psy2172         171 IADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---------  241 (291)
Q Consensus       171 l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---------  241 (291)
                      |+|||++......     ......|+..|+|||.+.+. .++.++||||||+++|+|++|..||.......         
T Consensus       150 l~Dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  223 (279)
T 3fdn_A          150 IADFGWSVHAPSS-----RRTDLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE  223 (279)
T ss_dssp             ECSCCEESCC-------------CCCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC
T ss_pred             EEeccccccCCcc-----cccccCCCCCccCHhHhccC-CCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC
Confidence            9999998654332     22345678999999999874 48899999999999999999999998765321         


Q ss_pred             cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhhhh
Q psy2172         242 KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDFN  284 (291)
Q Consensus       242 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (291)
                      ........+.+.+++..|..+.|..||++.++.+|||+.....
T Consensus       224 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~  266 (279)
T 3fdn_A          224 FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS  266 (279)
T ss_dssp             CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred             CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCcc
Confidence            1223334577889999999999999999999999999876544

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3.2e-42  Score=298.02  Aligned_cols=251  Identities=26%  Similarity=0.446  Sum_probs=196.8

Q ss_pred             ccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC-------------hhHHHHHHHHhcCCCCCee
Q psy2172          13 RTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS-------------MSACREIALLRELKHPNVI   79 (291)
Q Consensus        13 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~e~~~l~~l~h~~iv   79 (291)
                      ...+.+.|.+ .+.||+|+||.||+|.+.   .++.||+|.+......             +.+.+|+.++++++||||+
T Consensus        17 ~~~~~~~y~~-~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           17 LHAMQSPYTV-QRFISSGSYGAVCAGVDS---EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHTTCSCEE-EEEEEEETTEEEEEEECT---TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHhccceEE-eEEeccCCCEEEEEEECC---CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            3456788885 779999999999999864   4678999998643221             5688999999999999999


Q ss_pred             eEEEEEEe---CCCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCc
Q psy2172          80 NLISVFLS---HNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPAN  156 (291)
Q Consensus        80 ~~~~~~~~---~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~N  156 (291)
                      ++++++..   ......|+||||++++|.+.+....        ..+++..++.++.|++.||.|||++|++|+||||+|
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N  164 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQR--------IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGN  164 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTT--------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred             ceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHH
Confidence            99999865   3345799999999999988887332        128999999999999999999999999999999999


Q ss_pred             EEeecCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCC
Q psy2172         157 ILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  236 (291)
Q Consensus       157 il~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~  236 (291)
                      |+++    .++.++|+|||.+......    .......|++.|+|||.+.+...++.++||||||+++|+|++|..||.+
T Consensus       165 Il~~----~~~~~kl~Dfg~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  236 (362)
T 3pg1_A          165 ILLA----DNNDITICDFNLAREDTAD----ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRG  236 (362)
T ss_dssp             EEEC----TTCCEEECCTTC-------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             EEEc----CCCCEEEEecCcccccccc----cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCC
Confidence            9998    6778999999999754332    2223457789999999998755689999999999999999999999987


Q ss_pred             Cccccc-----------------------------------------CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCC
Q psy2172         237 RQEDIK-----------------------------------------TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPE  275 (291)
Q Consensus       237 ~~~~~~-----------------------------------------~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  275 (291)
                      ......                                         ...+.....+.+++..|..+.|..||++.++..
T Consensus       237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          237 STFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             SSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            542100                                         001122456889999999999999999999999


Q ss_pred             Ccchhhhh
Q psy2172         276 HPTLLKDF  283 (291)
Q Consensus       276 ~~~~~~~~  283 (291)
                      |||+...+
T Consensus       317 hp~f~~~~  324 (362)
T 3pg1_A          317 HPYFESLF  324 (362)
T ss_dssp             SGGGTTTC
T ss_pred             Cchhhhcc
Confidence            99987543

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.7e-42  Score=307.69  Aligned_cols=244  Identities=23%  Similarity=0.350  Sum_probs=192.7

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC-----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCce
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-----GLSMSACREIALLRELKHPNVINLISVFLSHNDRK   92 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (291)
                      +.|++ .++||+|+||.||+|.++.  +++.||+|++...     .....+.+|+.+++.++||||+++++++  .+...
T Consensus       148 ~~y~~-~~~lG~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~--~~~~~  222 (446)
T 4ejn_A          148 NEFEY-LKLLGKGTFGKVILVKEKA--TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF--QTHDR  222 (446)
T ss_dssp             GGEEE-EEEEEEETTEEEEEEEETT--TCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEE--EETTE
T ss_pred             HHcEE-eEEEeeCcCEEEEEEEEcC--CCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEE--eeCCE
Confidence            45664 6799999999999999876  7789999998632     2335677899999999999999999999  45668


Q ss_pred             EEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCeeeeccCCCcEEeecCCCCCCcEE
Q psy2172          93 VWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHS-NWVLHRDLKPANILVMGEGIERGRVK  170 (291)
Q Consensus        93 ~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~-~~ivH~dik~~Nil~~~~~~~~~~~~  170 (291)
                      .|+||||+++ +|...+.....         +++..++.++.|++.||+|||+ +||+|+||||+||+++    .++.++
T Consensus       223 ~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~----~~~~~k  289 (446)
T 4ejn_A          223 LCFVMEYANGGELFFHLSRERV---------FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD----KDGHIK  289 (446)
T ss_dssp             EEEEECCCSSCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEEC----SSSCEE
T ss_pred             EEEEEeeCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEEC----CCCCEE
Confidence            9999999986 77777654321         8999999999999999999998 9999999999999998    677999


Q ss_pred             EeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---------
Q psy2172         171 IADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---------  241 (291)
Q Consensus       171 l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---------  241 (291)
                      |+|||++.......   .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.....         
T Consensus       290 l~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~  365 (446)
T 4ejn_A          290 ITDFGLCKEGIKDG---ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE  365 (446)
T ss_dssp             ECCCCCCCTTCC--------CCSSSCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred             EccCCCceeccCCC---cccccccCCccccCHhhcCCCC-CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC
Confidence            99999987533221   2234567899999999998754 8999999999999999999999998765321         


Q ss_pred             cCCCCCcHHHHHHHHHhhCCCCcCChh-----hhhcCCCCcchhhhh
Q psy2172         242 KTSNPYHHDQLDRIFSVMGFPLEKDWE-----DIRKMPEHPTLLKDF  283 (291)
Q Consensus       242 ~~~~~~~~~~~~~i~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~  283 (291)
                      ..........+.+++..|....|..||     ++.++..||++....
T Consensus       366 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~  412 (446)
T 4ejn_A          366 IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV  412 (446)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCC
Confidence            112233457789999999999999998     999999999987543

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=7.1e-42  Score=292.41  Aligned_cols=253  Identities=33%  Similarity=0.549  Sum_probs=199.5

Q ss_pred             ecccccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC----hhHHHHHHHHhcCCCCCeeeEEEE
Q psy2172           9 TSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIALLRELKHPNVINLISV   84 (291)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~   84 (291)
                      ..|.-+...++|++ .+.||+|+||.||+|.+..  +++.||+|.+......    ..+.+|+.++++++||||++++++
T Consensus        16 ~~~~~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   92 (331)
T 4aaa_A           16 TENLYFQSMEKYEN-LGLVGEGSYGMVMKCRNKD--TGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV   92 (331)
T ss_dssp             ---CCCBCGGGEEE-EEEGGGGTTSSEEEEEETT--TCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cchhhhhhhhhhee-eeEEeecCCEEEEEEEECC--CCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEE
Confidence            34555666677885 6799999999999999876  6788999998654433    246789999999999999999999


Q ss_pred             EEeCCCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCC
Q psy2172          85 FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGI  164 (291)
Q Consensus        85 ~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~  164 (291)
                      +  .+....++||||++++++..+.....        .+++..++.++.|++.||.+||++|++|+||||+||+++    
T Consensus        93 ~--~~~~~~~lv~e~~~~~~l~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~----  158 (331)
T 4aaa_A           93 C--KKKKRWYLVFEFVDHTILDDLELFPN--------GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVS----  158 (331)
T ss_dssp             E--EETTEEEEEEECCSEEHHHHHHHSTT--------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----
T ss_pred             e--ecCCEEEEEEecCCcchHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEc----
Confidence            9  45678999999999876665543222        289999999999999999999999999999999999998    


Q ss_pred             CCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc--
Q psy2172         165 ERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK--  242 (291)
Q Consensus       165 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~--  242 (291)
                      .++.++|+|||.+........   ......|+..|+|||.+.+...++.++||||||+++|+|++|..||.+......  
T Consensus       159 ~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  235 (331)
T 4aaa_A          159 QSGVVKLCDFGFARTLAAPGE---VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLY  235 (331)
T ss_dssp             TTSCEEECCCTTC---------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             CCCcEEEEeCCCceeecCCcc---ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence            667999999999976543221   223456789999999998765689999999999999999999999987653110  


Q ss_pred             --------------------------------C------CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         243 --------------------------------T------SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       243 --------------------------------~------~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                                                      .      ..+...+.+.+++..|..+.|..||++.++.++||+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~  312 (331)
T 4aaa_A          236 HIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM  312 (331)
T ss_dssp             HHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred             HHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence                                            0      00123467889999999999999999999999999864

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.6e-41  Score=288.02  Aligned_cols=249  Identities=24%  Similarity=0.438  Sum_probs=199.3

Q ss_pred             cccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCc
Q psy2172          12 ERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDR   91 (291)
Q Consensus        12 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (291)
                      ......+.|.+ .+.||+|+||.||+|.+..  +++.||+|.+........+.+|+.+++.++||||+++++++.  +..
T Consensus        23 ~~~~~~~~y~~-~~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~   97 (314)
T 3com_A           23 LTKQPEEVFDV-LEKLGEGSYGSVYKAIHKE--TGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYF--KNT   97 (314)
T ss_dssp             -------CEEE-EEECC----CEEEEEEETT--TCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEE--ETT
T ss_pred             hhhcchhhhhh-heeeccCCCeEEEEEEECC--CCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEE--eCC
Confidence            34455667775 6799999999999999876  678899999987777788999999999999999999999994  466


Q ss_pred             eEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEE
Q psy2172          92 KVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVK  170 (291)
Q Consensus        92 ~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~  170 (291)
                      ..++||||+++ +|.+++.....        .+++..++.++.|++.||.+||+.|++|+||+|+||+++    .++.++
T Consensus        98 ~~~lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~----~~~~~k  165 (314)
T 3com_A           98 DLWIVMEYCGAGSVSDIIRLRNK--------TLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLN----TEGHAK  165 (314)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHTC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTCCEE
T ss_pred             EEEEEeecCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEEC----CCCCEE
Confidence            89999999986 88877763221        289999999999999999999999999999999999998    667899


Q ss_pred             EeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---------
Q psy2172         171 IADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---------  241 (291)
Q Consensus       171 l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---------  241 (291)
                      |+|||.+.......   .......|+..|+|||.+.+.. ++.++|+||||+++|+|++|..||.......         
T Consensus       166 l~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  241 (314)
T 3com_A          166 LADFGVAGQLTDTM---AKRNTVIGTPFWMAPEVIQEIG-YNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP  241 (314)
T ss_dssp             ECCCTTCEECBTTB---SCBCCCCSCGGGCCHHHHSSSC-BCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred             Eeecccchhhhhhc---cccCccCCCCCccChhhcCCCC-CCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC
Confidence            99999998765421   1223456789999999998754 8899999999999999999999998654210         


Q ss_pred             ---cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         242 ---KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       242 ---~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                         ..........+.+++..|..+.|..||++.++..+|++..
T Consensus       242 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~  284 (314)
T 3com_A          242 PPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRS  284 (314)
T ss_dssp             CCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHT
T ss_pred             CcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhc
Confidence               0112223567899999999999999999999999988764

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.4e-42  Score=292.80  Aligned_cols=244  Identities=22%  Similarity=0.333  Sum_probs=187.1

Q ss_pred             cccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC-----hhHHHHHHHHhcCCCCCeeeEEEEEE
Q psy2172          12 ERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS-----MSACREIALLRELKHPNVINLISVFL   86 (291)
Q Consensus        12 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~   86 (291)
                      ....+.++|++ .+.||+|+||.||+|.+..  +++.||+|++......     ..+.+|+.++++++||||+++++++.
T Consensus         6 ~~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   82 (311)
T 3ork_A            6 TPSHLSDRYEL-GEILGFGGMSEVHLARDLR--DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGE   82 (311)
T ss_dssp             CCSEETTTEEE-EEEEEECSSEEEEEEEETT--TTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEE
T ss_pred             CcceecCcEEE-EEEEccCCCEEEEEEEECC--CCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeee
Confidence            34567888986 7799999999999999876  7789999999764322     35788999999999999999999985


Q ss_pred             eCCC--ceEEEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCC
Q psy2172          87 SHND--RKVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEG  163 (291)
Q Consensus        87 ~~~~--~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~  163 (291)
                      ..+.  ...|+||||++ ++|.+.+.....         +++..++.++.|++.||+|||++|++|+||||+||+++   
T Consensus        83 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~---  150 (311)
T 3ork_A           83 AETPAGPLPYIVMEYVDGVTLRDIVHTEGP---------MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS---  150 (311)
T ss_dssp             EEETTEEEEEEEEECCCEEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE---
T ss_pred             ccCCCCcccEEEEecCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEc---
Confidence            4332  35699999997 488888764331         89999999999999999999999999999999999998   


Q ss_pred             CCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc-
Q psy2172         164 IERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK-  242 (291)
Q Consensus       164 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~-  242 (291)
                       .++.++|+|||++.................|++.|+|||.+.+.. ++.++||||||+++|+|++|..||.+...... 
T Consensus       151 -~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  228 (311)
T 3ork_A          151 -ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA  228 (311)
T ss_dssp             -TTSCEEECCCSCC------------------CCTTCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             -CCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence             667899999999987655433333334567899999999998754 89999999999999999999999987653210 


Q ss_pred             ------------CCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         243 ------------TSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       243 ------------~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                                  .........+.+++..|..+.|..||+..+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~  270 (311)
T 3ork_A          229 YQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAA  270 (311)
T ss_dssp             HHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHH
T ss_pred             HHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHH
Confidence                        001123456888999999999988876544

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=8.9e-42  Score=285.62  Aligned_cols=246  Identities=26%  Similarity=0.476  Sum_probs=204.3

Q ss_pred             ccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCC-----CCCChhHHHHHHHHhcCCCCCeeeEEEEEEeCC
Q psy2172          15 KVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEG-----TGLSMSACREIALLRELKHPNVINLISVFLSHN   89 (291)
Q Consensus        15 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   89 (291)
                      -..+.|.+ .+.||+|+||.||+|.+..  +++.||+|++..     ......+.+|+.+++.++||||+++++++  .+
T Consensus        11 ~~~~~y~~-~~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~   85 (284)
T 2vgo_A           11 FTIDDFDI-GRPLGKGKFGNVYLAREKQ--NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF--HD   85 (284)
T ss_dssp             CCGGGEEE-EEEEEECSSEEEEEEEETT--TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE--EC
T ss_pred             hhhhhcee-eheecCCCCeEEEEEEEcC--CCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEE--Ec
Confidence            33456775 7799999999999999876  678899999853     22345688999999999999999999999  55


Q ss_pred             CceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCc
Q psy2172          90 DRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGR  168 (291)
Q Consensus        90 ~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~  168 (291)
                      ....+++|||+++ +|.+.+.....         +++..++.++.|++.||.+||++|++|+||+|+||+++    .++.
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~----~~~~  152 (284)
T 2vgo_A           86 RKRIYLMLEFAPRGELYKELQKHGR---------FDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMG----YKGE  152 (284)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEEC----TTCC
T ss_pred             CCEEEEEEEeCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEc----CCCC
Confidence            7789999999975 88888765432         89999999999999999999999999999999999998    6678


Q ss_pred             EEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc-------
Q psy2172         169 VKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI-------  241 (291)
Q Consensus       169 ~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~-------  241 (291)
                      ++|+|||.+......     ......|+..|+|||.+.+.. ++.++|+||||+++|+|++|..||.......       
T Consensus       153 ~kl~Dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  226 (284)
T 2vgo_A          153 LKIADFGWSVHAPSL-----RRRTMCGTLDYLPPEMIEGKT-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN  226 (284)
T ss_dssp             EEECCCTTCEECSSS-----CBCCCCSCGGGCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred             EEEecccccccCccc-----ccccccCCCCcCCHHHhccCC-CCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhc
Confidence            999999998765432     223456899999999998754 8899999999999999999999998754321       


Q ss_pred             --cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhhhh
Q psy2172         242 --KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDFN  284 (291)
Q Consensus       242 --~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (291)
                        ....+.....+.+++..|..+.|..||++.++.++||+...-.
T Consensus       227 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~  271 (284)
T 2vgo_A          227 VDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR  271 (284)
T ss_dssp             TCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred             cccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence              1122344577899999999999999999999999999875543

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=4.8e-42  Score=295.85  Aligned_cols=253  Identities=29%  Similarity=0.503  Sum_probs=202.9

Q ss_pred             cccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeC
Q psy2172          12 ERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSH   88 (291)
Q Consensus        12 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   88 (291)
                      ....+.+.|.+ .+.||+|+||.||+|.+..  +++.||||.+.....   ...+.+|+.+++.++||||+++++++...
T Consensus         5 ~~~~i~~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   81 (353)
T 2b9h_A            5 IVYNISSDFQL-KSLLGEGAYGVVCSATHKP--TGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPD   81 (353)
T ss_dssp             CCCCSCTTEEE-EEEEEECSSEEEEEEEETT--TTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred             cccccccceEE-eeEEcCCCCeEEEEEEECC--CCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeeccc
Confidence            34567788886 7799999999999999876  678899999964332   23567899999999999999999987432


Q ss_pred             ---CCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCC
Q psy2172          89 ---NDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIE  165 (291)
Q Consensus        89 ---~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~  165 (291)
                         +....+++|||++++|.+.+...          .+++..++.++.|++.||++||++|++|+||||+||+++    .
T Consensus        82 ~~~~~~~~~lv~e~~~~~L~~~~~~~----------~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~----~  147 (353)
T 2b9h_A           82 SFENFNEVYIIQELMQTDLHRVISTQ----------MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLIN----S  147 (353)
T ss_dssp             CSTTCCCEEEEECCCSEEHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC----T
T ss_pred             ccCccceEEEEEeccCccHHHHHhhc----------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEc----C
Confidence               23679999999999988887642          189999999999999999999999999999999999998    6


Q ss_pred             CCcEEEeecccceecCCCCCCC-------CCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCc
Q psy2172         166 RGRVKIADMGFARLFNNPLKPL-------ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  238 (291)
Q Consensus       166 ~~~~~l~Dfg~~~~~~~~~~~~-------~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~  238 (291)
                      ++.++|+|||++..........       .......||..|+|||++.+...++.++||||||+++|+|++|..||.+..
T Consensus       148 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  227 (353)
T 2b9h_A          148 NCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD  227 (353)
T ss_dssp             TCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             CCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            6789999999998765422111       112235789999999998765568999999999999999999999998764


Q ss_pred             ccc---------------------------------cC--------CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCc
Q psy2172         239 EDI---------------------------------KT--------SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHP  277 (291)
Q Consensus       239 ~~~---------------------------------~~--------~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  277 (291)
                      ...                                 ..        ..+.....+.+++..|..+.|..||++.++.++|
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  307 (353)
T 2b9h_A          228 YRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHP  307 (353)
T ss_dssp             HHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             cHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence            210                                 00        0013346678899999999999999999999999


Q ss_pred             chhh
Q psy2172         278 TLLK  281 (291)
Q Consensus       278 ~~~~  281 (291)
                      |+..
T Consensus       308 ~~~~  311 (353)
T 2b9h_A          308 YLQT  311 (353)
T ss_dssp             GGTT
T ss_pred             cccc
Confidence            8764

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=5.6e-42  Score=287.51  Aligned_cols=249  Identities=22%  Similarity=0.296  Sum_probs=188.9

Q ss_pred             ccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCCh----hHHHHHHHHhcCCCCCeeeEEEEEEeCCCce
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLISVFLSHNDRK   92 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (291)
                      .+.|++ .+.||+|+||.||+|.+..  +++.||+|++.......    .+.++...++.++||||+++++++  .+...
T Consensus         6 ~~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~--~~~~~   80 (290)
T 3fme_A            6 ADDLEP-IMELGRGAYGVVEKMRHVP--SGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGAL--FREGD   80 (290)
T ss_dssp             GGGEEE-EEEEEECSSEEEEEEEETT--TTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEE--ECSSS
T ss_pred             HHhhhh-HHhcCCCCCeEEEEEEecC--CCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeee--eccCC
Confidence            456775 6799999999999999876  77899999997543332    233445557888999999999999  45668


Q ss_pred             EEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CeeeeccCCCcEEeecCCCCCCcEEE
Q psy2172          93 VWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSN-WVLHRDLKPANILVMGEGIERGRVKI  171 (291)
Q Consensus        93 ~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~-~ivH~dik~~Nil~~~~~~~~~~~~l  171 (291)
                      .++||||++++|.+.+.......     ..+++..++.++.|++.||++||++ |++|+||||+||+++    ..+.++|
T Consensus        81 ~~lv~e~~~~~l~~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~----~~~~~kl  151 (290)
T 3fme_A           81 VWICMELMDTSLDKFYKQVIDKG-----QTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLIN----ALGQVKM  151 (290)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEEC----TTCCEEB
T ss_pred             EEEEEehhccchHHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEEC----CCCCEEE
Confidence            99999999999888877544322     1289999999999999999999998 999999999999998    6679999


Q ss_pred             eecccceecCCCCCCCCCCCCceeccccccccccc---CCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc--------
Q psy2172         172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLL---GARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED--------  240 (291)
Q Consensus       172 ~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~--------  240 (291)
                      +|||.+.......    ......|++.|+|||.+.   ....++.++||||||+++|+|++|..||......        
T Consensus       152 ~Dfg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  227 (290)
T 3fme_A          152 CDFGISGYLVDDV----AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV  227 (290)
T ss_dssp             CCC-------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHH
T ss_pred             eecCCcccccccc----cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHh
Confidence            9999997654431    223346789999999973   3345889999999999999999999999863321        


Q ss_pred             ----ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhhh
Q psy2172         241 ----IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF  283 (291)
Q Consensus       241 ----~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (291)
                          ...........+.+++..|..+.|..||++.++.++||+...-
T Consensus       228 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~  274 (290)
T 3fme_A          228 EEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE  274 (290)
T ss_dssp             HSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             ccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence                1111223456789999999999999999999999999987543

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2e-41  Score=292.74  Aligned_cols=252  Identities=29%  Similarity=0.449  Sum_probs=192.9

Q ss_pred             cccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC-CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCC-----
Q psy2172          16 VEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-GLSMSACREIALLRELKHPNVINLISVFLSHN-----   89 (291)
Q Consensus        16 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----   89 (291)
                      ..++|.+ .+.||+|+||.||+|.++.  +++.||||.+... .......+++..+..++||||+++++++...+     
T Consensus        21 ~~~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~   97 (360)
T 3e3p_A           21 EMDRFQV-ERMAGQGTFGTVQLGKEKS--TGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR   97 (360)
T ss_dssp             HHTTEEE-C----------CEEEEETT--TCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred             hccceEE-EEEEecCCCeEEEEEEECC--CCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence            3456775 6799999999999999876  6788999988543 34456778888899999999999999986422     


Q ss_pred             CceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHh--hCCeeeeccCCCcEEeecCCCCCC
Q psy2172          90 DRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLH--SNWVLHRDLKPANILVMGEGIERG  167 (291)
Q Consensus        90 ~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH--~~~ivH~dik~~Nil~~~~~~~~~  167 (291)
                      ..+.++||||+++++...+.......     ..+++..++.++.|++.||.+||  ++||+|+||||+||+++.   .++
T Consensus        98 ~~~~~lv~e~~~~~l~~~~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~---~~~  169 (360)
T 3e3p_A           98 DIYLNVVMEYVPDTLHRCCRNYYRRQ-----VAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNE---ADG  169 (360)
T ss_dssp             CEEEEEEEECCSCBHHHHHHHHHTTT-----CCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEET---TTT
T ss_pred             ceeEEEEeecccccHHHHHHHHhhcc-----cCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeC---CCC
Confidence            23489999999999887766533222     22889999999999999999999  999999999999999983   257


Q ss_pred             cEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc------
Q psy2172         168 RVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI------  241 (291)
Q Consensus       168 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~------  241 (291)
                      .++|+|||++.......    ......||+.|+|||++.+...++.++||||||+++|+|++|..||.+.....      
T Consensus       170 ~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~  245 (360)
T 3e3p_A          170 TLKLCDFGSAKKLSPSE----PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIV  245 (360)
T ss_dssp             EEEECCCTTCBCCCTTS----CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             cEEEeeCCCceecCCCC----CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHH
Confidence            99999999998665432    22345679999999999776668999999999999999999999998765320      


Q ss_pred             -----------------------------------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhh
Q psy2172         242 -----------------------------------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKD  282 (291)
Q Consensus       242 -----------------------------------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (291)
                                                         ..........+.+++..|....|..||++.++..|||+.+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  321 (360)
T 3e3p_A          246 RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL  321 (360)
T ss_dssp             HHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             HHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence                                               00111135678899999999999999999999999998754

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=4.5e-42  Score=310.24  Aligned_cols=243  Identities=25%  Similarity=0.380  Sum_probs=201.3

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC-----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCce
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-----GLSMSACREIALLRELKHPNVINLISVFLSHNDRK   92 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (291)
                      +.|.+ .+.||+|+||.||+|.++.  +++.||+|++...     .....+.+|+.+|+.++||||+++++++  .+...
T Consensus       184 ~~f~~-~~~LG~G~fG~Vy~a~~~~--tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~--~~~~~  258 (576)
T 2acx_A          184 NTFRQ-YRVLGKGGFGEVCACQVRA--TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY--ETKDA  258 (576)
T ss_dssp             GGEEE-EEEEEEETTEEEEEEEETT--TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE--ECSSE
T ss_pred             cceEE-EEEEeeCCCEEEEEEEECC--CCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE--eeCCE
Confidence            45664 6799999999999999876  7789999998532     2345678999999999999999999999  56779


Q ss_pred             EEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEE
Q psy2172          93 VWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI  171 (291)
Q Consensus        93 ~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l  171 (291)
                      .|+||||+.| +|...+.....       ..+++..++.++.|++.||+|||++||+|+||||+||+++    .++.++|
T Consensus       259 l~lVmEy~~gg~L~~~l~~~~~-------~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld----~~g~vKL  327 (576)
T 2acx_A          259 LCLVLTLMNGGDLKFHIYHMGQ-------AGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLD----DHGHIRI  327 (576)
T ss_dssp             EEEEECCCCSCBHHHHHHSSSS-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTSCEEE
T ss_pred             EEEEEEcCCCCcHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEe----CCCCeEE
Confidence            9999999974 88777654321       1289999999999999999999999999999999999998    6789999


Q ss_pred             eecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc----------
Q psy2172         172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI----------  241 (291)
Q Consensus       172 ~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~----------  241 (291)
                      +|||++.......    ......||+.|+|||++.+.. ++.++|+|||||++|+|++|..||.+.....          
T Consensus       328 ~DFGla~~~~~~~----~~~~~~GT~~Y~APEvl~~~~-~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~  402 (576)
T 2acx_A          328 SDLGLAVHVPEGQ----TIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK  402 (576)
T ss_dssp             CCCTTCEECCTTC----CEECCCSCGGGCCHHHHTTCE-ESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHH
T ss_pred             EecccceecccCc----cccccCCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhh
Confidence            9999998765421    123357899999999998755 8999999999999999999999998764321          


Q ss_pred             ---cCCCCCcHHHHHHHHHhhCCCCcCChh-----hhhcCCCCcchhh
Q psy2172         242 ---KTSNPYHHDQLDRIFSVMGFPLEKDWE-----DIRKMPEHPTLLK  281 (291)
Q Consensus       242 ---~~~~~~~~~~~~~i~~~~~~~~~~~~~-----~~~~~~~~~~~~~  281 (291)
                         ..........+.+++..|....|..|+     ++.++..|||+..
T Consensus       403 ~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~  450 (576)
T 2acx_A          403 EVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK  450 (576)
T ss_dssp             HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred             cccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence               112233457789999999999999998     7889999999875

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3.7e-42  Score=287.69  Aligned_cols=249  Identities=27%  Similarity=0.427  Sum_probs=200.7

Q ss_pred             cccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC--------CChhHHHHHHHHhcCCCCCeeeEEEEEEe
Q psy2172          16 VEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG--------LSMSACREIALLRELKHPNVINLISVFLS   87 (291)
Q Consensus        16 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   87 (291)
                      +.+.|++ .+.||+|+||.||+|.+..  +++.||+|++....        ..+.+.+|+.++++++||||+++++++  
T Consensus         3 ~~~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--   77 (283)
T 3bhy_A            3 VEDHYEM-GEELGSGQFAIVRKCRQKG--TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIF--   77 (283)
T ss_dssp             HHHHEEE-EEEEEECSSEEEEEEEETT--TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE--
T ss_pred             hhhhhhh-HHhhcccCceEEEEEEEcC--CCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhhee--
Confidence            4567775 6799999999999999876  67889999986432        235688999999999999999999999  


Q ss_pred             CCCceEEEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCC
Q psy2172          88 HNDRKVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIER  166 (291)
Q Consensus        88 ~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~  166 (291)
                      .+....++||||++ ++|.+.+....         .+++..++.++.|++.||.+||++|++|+||||+||+++.++...
T Consensus        78 ~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~  148 (283)
T 3bhy_A           78 ENKTDVVLILELVSGGELFDFLAEKE---------SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPN  148 (283)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSS
T ss_pred             cCCCeEEEEEeecCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCC
Confidence            55678999999996 58888876432         189999999999999999999999999999999999998544334


Q ss_pred             CcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc----
Q psy2172         167 GRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK----  242 (291)
Q Consensus       167 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~----  242 (291)
                      ..++|+|||.+.......    ......|++.|+|||.+.+.. ++.++|+||||+++|+|++|..||.+......    
T Consensus       149 ~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~  223 (283)
T 3bhy_A          149 PRIKLIDFGIAHKIEAGN----EFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGETKQETLTNI  223 (283)
T ss_dssp             CCEEECCCTTCEECC------------CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             CceEEEecccceeccCCC----cccccCCCcCccCcceecCCC-CCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHh
Confidence            589999999998764421    223456899999999997744 89999999999999999999999987543210    


Q ss_pred             -----C----CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhhh
Q psy2172         243 -----T----SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF  283 (291)
Q Consensus       243 -----~----~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (291)
                           .    ......+.+.+++..|..+.|..||++.++..+|++...-
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          224 SAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             HTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             HhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence                 0    0012346688999999999999999999999998876543

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=7.4e-42  Score=287.48  Aligned_cols=248  Identities=17%  Similarity=0.177  Sum_probs=192.6

Q ss_pred             cccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCc
Q psy2172          12 ERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDR   91 (291)
Q Consensus        12 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (291)
                      +...+.++|++ .+.||+|+||.||+|.+..  +++.||+|++........+.+|+.+++.++|++++..+..+. .+..
T Consensus         3 ~~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-~~~~   78 (296)
T 4hgt_A            3 MELRVGNRYRL-GRKIGSGSFGDIYLGTDIA--AGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCG-AEGD   78 (296)
T ss_dssp             --------CEE-EEEEEECSSSEEEEEEETT--TTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEE-EETT
T ss_pred             cccccCCceEE-eeeecCCCCeEEEEEEEcC--CCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeec-CCCC
Confidence            44567788985 7799999999999999876  778999999877767778999999999999887777666654 3566


Q ss_pred             eEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEE
Q psy2172          92 KVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI  171 (291)
Q Consensus        92 ~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l  171 (291)
                      ..+++|||++++|.+++.....        .+++..++.++.|++.||+|||++|++|+||||+||+++.+. ..+.++|
T Consensus        79 ~~~lv~e~~~~~L~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~-~~~~~kL  149 (296)
T 4hgt_A           79 YNVMVMELLGPSLEDLFNFCSR--------KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGK-KGNLVYI  149 (296)
T ss_dssp             EEEEEEECCCCBHHHHHHHTTS--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGG-GTTCEEE
T ss_pred             ceEEEEEccCCCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccC-CCCeEEE
Confidence            8899999998899988874332        289999999999999999999999999999999999993221 5678999


Q ss_pred             eecccceecCCCCCCC----CCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccC----
Q psy2172         172 ADMGFARLFNNPLKPL----ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT----  243 (291)
Q Consensus       172 ~Dfg~~~~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~----  243 (291)
                      +|||++..........    .......|+..|+|||.+.+.. ++.++||||||+++|+|++|..||.+.......    
T Consensus       150 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~  228 (296)
T 4hgt_A          150 IDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE  228 (296)
T ss_dssp             CCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHH
T ss_pred             ecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCC-CCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhh
Confidence            9999998765532211    2234567899999999998755 899999999999999999999999875432110    


Q ss_pred             -------------CCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         244 -------------SNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       244 -------------~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                                   ......+.+.+++..|....|..||++.++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l  271 (296)
T 4hgt_A          229 RISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYL  271 (296)
T ss_dssp             HHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHH
T ss_pred             hhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHH
Confidence                         002224678899999999999999988764

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3e-42  Score=299.20  Aligned_cols=251  Identities=31%  Similarity=0.507  Sum_probs=200.8

Q ss_pred             eeecccccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC----hhHHHHHHHHhcCCCCCeeeEE
Q psy2172           7 IKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIALLRELKHPNVINLI   82 (291)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~   82 (291)
                      .........+.++|.+ .+.||+|+||.||+|.++.  +++.||+|++......    ..+.+|+.+++.++||||++++
T Consensus        31 ~~~~~~~~~l~~~y~~-~~~lG~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~  107 (371)
T 4exu_A           31 QDVNKTAWELPKTYVS-PTHVGSGAYGSVCSAIDKR--SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL  107 (371)
T ss_dssp             EEETTEEEEEETTEEE-EEEEEECSSEEEEEEEETT--TTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred             eeeccceecccccEEE-EeEEecCCCeEEEEEEECC--CCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhh
Confidence            4444555667888885 7799999999999999876  7789999999764333    4577899999999999999999


Q ss_pred             EEEEeCCCc----eEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEE
Q psy2172          83 SVFLSHNDR----KVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANIL  158 (291)
Q Consensus        83 ~~~~~~~~~----~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil  158 (291)
                      +++...+..    ..++||||++++|.+.+..           .+++..++.++.|++.||+|||++||+|+||||+||+
T Consensus       108 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-----------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl  176 (371)
T 4exu_A          108 DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGM-----------EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLA  176 (371)
T ss_dssp             EEECSCSSSTTCCCCEEEEECCCEEHHHHTTS-----------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             hheeccCCcccceeEEEEEccccccHHHHhhc-----------CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeE
Confidence            999432221    2499999999987766521           1899999999999999999999999999999999999


Q ss_pred             eecCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCc
Q psy2172         159 VMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  238 (291)
Q Consensus       159 ~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~  238 (291)
                      ++    .++.++|+|||.+......      .....||+.|+|||.+.+...++.++||||||+++|+|++|..||.+..
T Consensus       177 l~----~~~~~kL~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  246 (371)
T 4exu_A          177 VN----EDCELKILDFGLARHADAE------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD  246 (371)
T ss_dssp             EC----TTCCEEECSTTCC--------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             EC----CCCCEEEEecCcccccccC------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            98    6778999999999765432      2345678999999999875568999999999999999999999998754


Q ss_pred             ccc----------------------------------------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcc
Q psy2172         239 EDI----------------------------------------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPT  278 (291)
Q Consensus       239 ~~~----------------------------------------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  278 (291)
                      ...                                        ....+.....+.+++..|..+.|..||++.++..+||
T Consensus       247 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  326 (371)
T 4exu_A          247 YLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF  326 (371)
T ss_dssp             HHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred             hHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcc
Confidence            210                                        0001123467889999999999999999999999999


Q ss_pred             hhh
Q psy2172         279 LLK  281 (291)
Q Consensus       279 ~~~  281 (291)
                      +..
T Consensus       327 f~~  329 (371)
T 4exu_A          327 FEP  329 (371)
T ss_dssp             GTT
T ss_pred             ccc
Confidence            764

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.8e-41  Score=285.20  Aligned_cols=248  Identities=23%  Similarity=0.326  Sum_probs=203.9

Q ss_pred             ccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-----CChhHHHHHHHHhcCCCCCeeeEEEEEEe
Q psy2172          13 RTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-----LSMSACREIALLRELKHPNVINLISVFLS   87 (291)
Q Consensus        13 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   87 (291)
                      .....++|.+ ++.||+|+||.||+|.+..  +++.+|+|++....     ..+.+.+|+.+++.++||||+++++++  
T Consensus        10 ~~~~~~~y~~-~~~lg~G~~g~Vy~~~~~~--~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--   84 (294)
T 2rku_A           10 DPRSRRRYVR-GRFLGKGGFAKCFEISDAD--TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF--   84 (294)
T ss_dssp             ETTTTEEEEE-EEEEEEETTEEEEEEEETT--TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE--
T ss_pred             CCCcccceEE-EEEEeecCCEEEEEEEECC--CCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeee--
Confidence            3455667775 7899999999999999876  67889999986432     224577899999999999999999999  


Q ss_pred             CCCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCC
Q psy2172          88 HNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIER  166 (291)
Q Consensus        88 ~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~  166 (291)
                      .+....+++|||+++ +|.+.+....         .+++..++.++.|++.||++||++|++|+||||+||+++    .+
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~----~~  151 (294)
T 2rku_A           85 EDNDFVFVVLELCRRRSLLELHKRRK---------ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN----ED  151 (294)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TT
T ss_pred             ccCCEEEEEEecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEc----CC
Confidence            557789999999985 7777665432         189999999999999999999999999999999999998    67


Q ss_pred             CcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc------
Q psy2172         167 GRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED------  240 (291)
Q Consensus       167 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~------  240 (291)
                      +.++|+|||.+........   ......|+..|+|||.+.+.. ++.++|+||||+++|+|++|..||......      
T Consensus       152 ~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~  227 (294)
T 2rku_A          152 LEVKIGDFGLATKVEYDGE---RKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI  227 (294)
T ss_dssp             CCEEECCCTTCEECCSTTC---CBCCCCSCCSSCCHHHHTTSC-BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             CCEEEEeccCceecccCcc---ccccccCCCCcCCcchhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            7899999999987653221   223456789999999998754 889999999999999999999999875431      


Q ss_pred             ---ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhh
Q psy2172         241 ---IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKD  282 (291)
Q Consensus       241 ---~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (291)
                         ...........+.+++..|..+.|..||++.++..++++...
T Consensus       228 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  272 (294)
T 2rku_A          228 KKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG  272 (294)
T ss_dssp             HTTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred             hhccCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence               111223345778999999999999999999999999887643

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.6e-42  Score=296.06  Aligned_cols=252  Identities=24%  Similarity=0.350  Sum_probs=194.7

Q ss_pred             ccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC---CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCC-
Q psy2172          15 KVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG---LSMSACREIALLRELKHPNVINLISVFLSHND-   90 (291)
Q Consensus        15 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-   90 (291)
                      +..+.|++ .+.||+|+||.||+|.++.  +++.||||+++...   ..+.+.+|+.++++++||||+++++++...+. 
T Consensus         3 ~~~~~y~~-~~~lG~G~~g~V~~a~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   79 (332)
T 3qd2_B            3 RYLTDFEP-IQCMGRGGFGVVFEAKNKV--DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPE   79 (332)
T ss_dssp             HHHHHEEE-EEEEECC-CSEEEEEEETT--TCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSC
T ss_pred             hhhhcCce-eeEecCCCCeEEEEEEEcC--CCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccc
Confidence            34566775 6799999999999999876  67889999986432   23568899999999999999999999865332 


Q ss_pred             ------------------------------------------------------ceEEEEEecCCC-CHHHHHHHhhhhh
Q psy2172          91 ------------------------------------------------------RKVWLLFDYAEH-DLWHIIKFHRAAK  115 (291)
Q Consensus        91 ------------------------------------------------------~~~~iv~e~~~~-~l~~~~~~~~~~~  115 (291)
                                                                            .+.+++|||+.+ +|.+.+.......
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~  159 (332)
T 3qd2_B           80 KWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLE  159 (332)
T ss_dssp             HHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGG
T ss_pred             hhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCcc
Confidence                                                                  248999999986 8887776533221


Q ss_pred             hCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceecCCCCCC---------
Q psy2172         116 ANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKP---------  186 (291)
Q Consensus       116 ~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~~~~~~~---------  186 (291)
                            ..+...++.++.|++.||+|||++|++|+||||+||+++    .++.++|+|||++.........         
T Consensus       160 ------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~----~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~  229 (332)
T 3qd2_B          160 ------DREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT----MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA  229 (332)
T ss_dssp             ------GSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTCCEEECCCTTCEECSCC------------
T ss_pred             ------chhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEe----CCCCEEEeecCcccccccchhhccccccccc
Confidence                  156677999999999999999999999999999999998    6679999999999877653211         


Q ss_pred             CCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc--------ccCCCCCcHHHHHHHHHh
Q psy2172         187 LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED--------IKTSNPYHHDQLDRIFSV  258 (291)
Q Consensus       187 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~--------~~~~~~~~~~~~~~i~~~  258 (291)
                      ........||+.|+|||.+.+.. ++.++||||||+++|+|++|..|+......        .+.........+.+++..
T Consensus       230 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  308 (332)
T 3qd2_B          230 YATHTGQVGTKLYMSPEQIHGNN-YSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQD  308 (332)
T ss_dssp             --CCCSCC-CGGGSCHHHHHCCC-CCTHHHHHHHHHHHHHHHSCCCCHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHH
T ss_pred             cccccccCCCcCccChHHhcCCC-CcchhhHHHHHHHHHHHHHcCCChhHHHHHHHHhhccCCCcccccCChhHHHHHHH
Confidence            11223457899999999998754 899999999999999999998877432110        000001112456788999


Q ss_pred             hCCCCcCChhhhhcCCCCcchh
Q psy2172         259 MGFPLEKDWEDIRKMPEHPTLL  280 (291)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~  280 (291)
                      |..+.|..||++.++.++|++.
T Consensus       309 ~l~~~p~~Rps~~~~l~~~~f~  330 (332)
T 3qd2_B          309 MLSPSPTERPEATDIIENAIFE  330 (332)
T ss_dssp             HHCSSGGGSCCHHHHHHSTTCC
T ss_pred             HccCCCCcCCCHHHHhhchhhh
Confidence            9999999999999998888764

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=3.1e-42  Score=287.04  Aligned_cols=252  Identities=22%  Similarity=0.340  Sum_probs=203.2

Q ss_pred             cccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC---CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCce
Q psy2172          16 VEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG---LSMSACREIALLRELKHPNVINLISVFLSHNDRK   92 (291)
Q Consensus        16 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (291)
                      ..+.|.+ .+.||+|+||.||+|.++.  +++.||+|++....   ....+.+|+.+++.++||||+++++++  .+...
T Consensus         5 ~~~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~   79 (276)
T 2yex_A            5 FVEDWDL-VQTLGEGAYGEVQLAVNRV--TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR--REGNI   79 (276)
T ss_dssp             HHHHEEE-EEEEEECSSSEEEEEEETT--TCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEE--EETTE
T ss_pred             eecceEE-EEEeecCCCcEEEEEEECC--CCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEE--EcCCE
Confidence            4466775 6799999999999999876  67889999986432   235688999999999999999999999  45678


Q ss_pred             EEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEE
Q psy2172          93 VWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI  171 (291)
Q Consensus        93 ~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l  171 (291)
                      .++||||+++ +|.+.+...         ..+++..++.++.|++.||.+||++|++|+||+|+||+++    .++.++|
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~----~~~~~kl  146 (276)
T 2yex_A           80 QYLFLEYCSGGELFDRIEPD---------IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD----ERDNLKI  146 (276)
T ss_dssp             EEEEEECCTTEEGGGGSBTT---------TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTCCEEE
T ss_pred             EEEEEEecCCCcHHHHHhhc---------cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEc----cCCCEEE
Confidence            9999999986 776655321         1289999999999999999999999999999999999998    6678999


Q ss_pred             eecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc----------
Q psy2172         172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI----------  241 (291)
Q Consensus       172 ~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~----------  241 (291)
                      +|||.+........ ........|+..|+|||.+.+....+.++|+||||+++|+|++|..||.......          
T Consensus       147 ~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  225 (276)
T 2yex_A          147 SDFGLATVFRYNNR-ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK  225 (276)
T ss_dssp             CCCTTCEECEETTE-ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTC
T ss_pred             eeCCCccccCCCcc-hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcc
Confidence            99999986543211 1122345689999999999876545788999999999999999999998765421          


Q ss_pred             --cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhhhhhc
Q psy2172         242 --KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDFNEQ  286 (291)
Q Consensus       242 --~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (291)
                        ..........+.+++..|..+.|..||++.++..++|+.+.+.+.
T Consensus       226 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  272 (276)
T 2yex_A          226 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKG  272 (276)
T ss_dssp             TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC--
T ss_pred             cccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhhcc
Confidence              011123356788999999999999999999999999988766543

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.4e-41  Score=283.60  Aligned_cols=244  Identities=24%  Similarity=0.435  Sum_probs=181.2

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC-----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCce
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-----GLSMSACREIALLRELKHPNVINLISVFLSHNDRK   92 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (291)
                      +.|.+ ++.||+|+||.||+|.+..  +++.||+|++...     ...+.+.+|+.++++++||||+++++++  .+...
T Consensus        11 ~~y~~-~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~   85 (278)
T 3cok_A           11 EDFKV-GNLLGKGSFAGVYRAESIH--TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYF--EDSNY   85 (278)
T ss_dssp             GGEEE-EEEEEECSSEEEEEEEETT--TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEE--ECSSE
T ss_pred             cccee-eeeecCCCceEEEEEEEcc--CCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEE--ccCCe
Confidence            34664 6799999999999999866  6788999998632     2335688999999999999999999999  56778


Q ss_pred             EEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEE
Q psy2172          93 VWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI  171 (291)
Q Consensus        93 ~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l  171 (291)
                      .+++|||+++ +|.+.+....        ..+++..++.++.|++.||.+||++|++|+||||+||+++    .++.++|
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~----~~~~~kl  153 (278)
T 3cok_A           86 VYLVLEMCHNGEMNRYLKNRV--------KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLT----RNMNIKI  153 (278)
T ss_dssp             EEEEEECCTTEEHHHHHHTCS--------SCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEEC----TTCCEEE
T ss_pred             EEEEEecCCCCcHHHHHhhcc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc----CCCCEEE
Confidence            9999999975 7777765321        2289999999999999999999999999999999999998    6678999


Q ss_pred             eecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc---------
Q psy2172         172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK---------  242 (291)
Q Consensus       172 ~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~---------  242 (291)
                      +|||.+........   ......|++.|+|||.+.+.. ++.++|+||||+++|+|++|..||........         
T Consensus       154 ~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  229 (278)
T 3cok_A          154 ADFGLATQLKMPHE---KHYTLCGTPNYISPEIATRSA-HGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADY  229 (278)
T ss_dssp             CCCTTCEECC--------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCC
T ss_pred             EeecceeeccCCCC---cceeccCCCCcCCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhccc
Confidence            99999987653221   123456789999999998744 88999999999999999999999986543211         


Q ss_pred             CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhh
Q psy2172         243 TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKD  282 (291)
Q Consensus       243 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (291)
                      .........+.+++..|..+.|..||++.++.++|++.+.
T Consensus       230 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  269 (278)
T 3cok_A          230 EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN  269 (278)
T ss_dssp             CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred             CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence            1222345778999999999999999999999999998654

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.3e-41  Score=286.46  Aligned_cols=237  Identities=22%  Similarity=0.322  Sum_probs=184.2

Q ss_pred             cccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC----hhHHHHHHHHhcCCCCCeeeEEEEEEeCCCc
Q psy2172          16 VEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIALLRELKHPNVINLISVFLSHNDR   91 (291)
Q Consensus        16 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (291)
                      ..+.|++ .+.||+|+||.||+|.+.    +..||+|++......    ..+.+|+.++++++||||+++++++  .+..
T Consensus        35 ~~~~y~i-~~~lG~G~~g~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--~~~~  107 (309)
T 3p86_A           35 PWCDLNI-KEKIGAGSFGTVHRAEWH----GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV--TQPP  107 (309)
T ss_dssp             CGGGEEE-EEEEEECSSEEEEEEEET----TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--CSTT
T ss_pred             ChhHcee-eeEeecCCCeEEEEEEEC----CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE--EECC
Confidence            3456664 679999999999999863    467999999765433    3578899999999999999999999  5667


Q ss_pred             eEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeeccCCCcEEeecCCCCCCc
Q psy2172          92 KVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNW--VLHRDLKPANILVMGEGIERGR  168 (291)
Q Consensus        92 ~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~dik~~Nil~~~~~~~~~~  168 (291)
                      ..++||||+.+ +|.+.+........      +++..++.++.|++.||+|||++|  ++|+||||+||+++    .++.
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~~~~~------~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~----~~~~  177 (309)
T 3p86_A          108 NLSIVTEYLSRGSLYRLLHKSGAREQ------LDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD----KKYT  177 (309)
T ss_dssp             CCEEEEECCTTCBHHHHHHSTTHHHH------SCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEEC----TTCC
T ss_pred             ceEEEEecCCCCcHHHHHhhcCCCCC------CCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEe----CCCc
Confidence            89999999975 88888765432221      889999999999999999999999  99999999999998    6779


Q ss_pred             EEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc--------
Q psy2172         169 VKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED--------  240 (291)
Q Consensus       169 ~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~--------  240 (291)
                      ++|+|||++.......   .......||+.|+|||.+.+.. ++.++||||||+++|+|++|..||.+....        
T Consensus       178 ~kL~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~  253 (309)
T 3p86_A          178 VKVCDFGLSRLKASTF---LSSKSAAGTPEWMAPEVLRDEP-SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF  253 (309)
T ss_dssp             EEECCCC--------------------CCTTSCHHHHTTCC-CCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHH
T ss_pred             EEECCCCCCccccccc---cccccCCCCccccChhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence            9999999997544321   1223457899999999998755 899999999999999999999999875432        


Q ss_pred             ---ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         241 ---IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       241 ---~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                         ...........+.+++..|....|..||++.++
T Consensus       254 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l  289 (309)
T 3p86_A          254 KCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATI  289 (309)
T ss_dssp             SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             cCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence               112233445778999999999999999887753

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.2e-42  Score=292.73  Aligned_cols=253  Identities=31%  Similarity=0.478  Sum_probs=196.9

Q ss_pred             ccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC--CChhHHHHHHHHhcCCCCCeeeEEEEEEe---
Q psy2172          13 RTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG--LSMSACREIALLRELKHPNVINLISVFLS---   87 (291)
Q Consensus        13 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---   87 (291)
                      ...+.++|.+ .+.||+|+||.||+|.+..  +++.||+|.+....  ....+.+|+.++++++||||+++++++..   
T Consensus         6 ~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   82 (320)
T 2i6l_A            6 GFDLGSRYMD-LKPLGCGGNGLVFSAVDND--CDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGS   82 (320)
T ss_dssp             CEEETTTEEE-EEECC-----CEEEEEETT--TTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSC
T ss_pred             cCccCCceeE-EEEeccCCCeEEEEEEECC--CCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccc
Confidence            4567788885 7799999999999999876  67899999986442  23467899999999999999999998732   


Q ss_pred             ---------CCCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEE
Q psy2172          88 ---------HNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANIL  158 (291)
Q Consensus        88 ---------~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil  158 (291)
                               .+....++||||++++|.+.+...          .+++..++.++.|++.||++||++|++|+||||+||+
T Consensus        83 ~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil  152 (320)
T 2i6l_A           83 QLTDDVGSLTELNSVYIVQEYMETDLANVLEQG----------PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLF  152 (320)
T ss_dssp             BCCC----CCSCSEEEEEEECCSEEHHHHHTTC----------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEE
T ss_pred             ccccccccccccCceeEEeeccCCCHHHHhhcC----------CccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEE
Confidence                     234689999999999988877421          2889999999999999999999999999999999999


Q ss_pred             eecCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCc
Q psy2172         159 VMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  238 (291)
Q Consensus       159 ~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~  238 (291)
                      ++.   .+..++|+|||.+.................++..|+|||.+.+...++.++|+||||+++|+|++|..||.+..
T Consensus       153 ~~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  229 (320)
T 2i6l_A          153 INT---EDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH  229 (320)
T ss_dssp             EET---TTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             EcC---CCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC
Confidence            973   34689999999998765432222233445678899999998765568999999999999999999999998765


Q ss_pred             cccc---------------------------------------CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         239 EDIK---------------------------------------TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       239 ~~~~---------------------------------------~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                      ....                                       ...+.....+.+++..|..+.|..||++.++.++|++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  309 (320)
T 2i6l_A          230 ELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM  309 (320)
T ss_dssp             HHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHH
T ss_pred             HHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccc
Confidence            3100                                       0011235678899999999999999999999999987


Q ss_pred             hh
Q psy2172         280 LK  281 (291)
Q Consensus       280 ~~  281 (291)
                      ..
T Consensus       310 ~~  311 (320)
T 2i6l_A          310 SI  311 (320)
T ss_dssp             HT
T ss_pred             cc
Confidence            63

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.1e-42  Score=299.43  Aligned_cols=248  Identities=31%  Similarity=0.477  Sum_probs=185.6

Q ss_pred             ccccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC----ChhHHHHHHHHhcCCCCCeeeEEEEEE
Q psy2172          11 NERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL----SMSACREIALLRELKHPNVINLISVFL   86 (291)
Q Consensus        11 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~   86 (291)
                      .....+.++|.+ .+.||+|+||.||+|.+..  +++.||||.+.....    ...+.+|+.+++.++||||+++++++.
T Consensus        22 ~~~~~~~~~y~~-~~~lG~G~~g~V~~a~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~   98 (367)
T 2fst_X           22 KTIWEVPERYQN-LSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT   98 (367)
T ss_dssp             TEEEEEETTEEE-EEECC----CCEEEEEETT--TTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred             CcccCCCCceEE-eeEEeecCCeEEEEEEECC--CCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence            445667788885 6799999999999999876  778999999975432    245778999999999999999999985


Q ss_pred             eC----CCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecC
Q psy2172          87 SH----NDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGE  162 (291)
Q Consensus        87 ~~----~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~  162 (291)
                      ..    +....|+++++++++|.+.+...          .+++..++.++.|++.||+|||++||+|+||||+||+++  
T Consensus        99 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~~----------~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~--  166 (367)
T 2fst_X           99 PARSLEEFNDVYLVTHLMGADLNNIVKCQ----------KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN--  166 (367)
T ss_dssp             SCSSGGGCCCCEEEEECCCEECC-----C----------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC--
T ss_pred             cCCccccCCeEEEEecccCCCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEEC--
Confidence            32    22568999999998888777542          189999999999999999999999999999999999998  


Q ss_pred             CCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc-
Q psy2172         163 GIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI-  241 (291)
Q Consensus       163 ~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~-  241 (291)
                        .++.++|+|||++......      .....||..|+|||++.+...++.++|||||||++|+|++|+.||.+..... 
T Consensus       167 --~~~~~kL~DFG~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~  238 (367)
T 2fst_X          167 --EDCELKILDFGLARHTADE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ  238 (367)
T ss_dssp             --TTCCEEECC---------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             --CCCCEEEeecccccccccc------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence              6779999999999764431      2345789999999999875568999999999999999999999998765310 


Q ss_pred             -------------------------------cCC--------CCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         242 -------------------------------KTS--------NPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       242 -------------------------------~~~--------~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                                                     ...        .+.....+.+++..|..+.|..||++.++..||++.+
T Consensus       239 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~  317 (367)
T 2fst_X          239 LKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ  317 (367)
T ss_dssp             HHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             HHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhh
Confidence                                           000        0112345778888999999999999999888888753

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=7.8e-42  Score=296.03  Aligned_cols=242  Identities=23%  Similarity=0.367  Sum_probs=190.4

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-----CChhHHHHHHH-HhcCCCCCeeeEEEEEEeCCCc
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-----LSMSACREIAL-LRELKHPNVINLISVFLSHNDR   91 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~   91 (291)
                      +.|.+ .+.||+|+||.||+|.++.  +++.||+|+++...     ....+.+|..+ ++.++||||+++++++  .+..
T Consensus        38 ~~y~~-~~~lG~G~fg~V~~~~~~~--~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~--~~~~  112 (373)
T 2r5t_A           38 SDFHF-LKVIGKGSFGKVLLARHKA--EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF--QTAD  112 (373)
T ss_dssp             GGEEE-EEEEECCTTCEEEEEEETT--TCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE--ECSS
T ss_pred             hheEE-EEEEeeCCCeEEEEEEEcC--CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE--EeCC
Confidence            44664 6799999999999999876  67889999996532     22345566666 5678999999999999  5677


Q ss_pred             eEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEE
Q psy2172          92 KVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVK  170 (291)
Q Consensus        92 ~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~  170 (291)
                      ..|+||||+.| +|...+.....         +++..++.++.|++.||+|||++||+|+||||+||+++    .++.++
T Consensus       113 ~~~lv~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~----~~g~ik  179 (373)
T 2r5t_A          113 KLYFVLDYINGGELFYHLQRERC---------FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD----SQGHIV  179 (373)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTSCEE
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEC----CCCCEE
Confidence            99999999975 88877765332         88999999999999999999999999999999999998    678999


Q ss_pred             EeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---------
Q psy2172         171 IADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---------  241 (291)
Q Consensus       171 l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---------  241 (291)
                      |+|||+++......   .......||+.|+|||++.+.. ++.++|+|||||++|+|++|..||.+.....         
T Consensus       180 L~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~  255 (373)
T 2r5t_A          180 LTDFGLCKENIEHN---STTSTFCGTPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP  255 (373)
T ss_dssp             ECCCCBCGGGBCCC---CCCCSBSCCCCCCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC
T ss_pred             EeeCccccccccCC---CccccccCCccccCHHHhCCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc
Confidence            99999997543221   2334567899999999998754 8999999999999999999999998765321         


Q ss_pred             cCCCCCcHHHHHHHHHhhCCCCcCChhhh----hcCCCCcchhh
Q psy2172         242 KTSNPYHHDQLDRIFSVMGFPLEKDWEDI----RKMPEHPTLLK  281 (291)
Q Consensus       242 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~----~~~~~~~~~~~  281 (291)
                      ....+.....+.+++..|....|..|++.    .++..|+++..
T Consensus       256 ~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~  299 (373)
T 2r5t_A          256 LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL  299 (373)
T ss_dssp             CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred             cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence            12234456778999999999999999876    46677777653

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2e-42  Score=310.41  Aligned_cols=249  Identities=25%  Similarity=0.399  Sum_probs=205.1

Q ss_pred             cccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC-----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeC
Q psy2172          14 TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-----GLSMSACREIALLRELKHPNVINLISVFLSH   88 (291)
Q Consensus        14 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   88 (291)
                      ..+.++|++ .++||+|+||.||+|.++.  +++.||+|++...     .....+.+|+.++++++||||+++++++  .
T Consensus        22 ~~~~~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~--~   96 (484)
T 3nyv_A           22 AIFSDRYKG-QRVLGKGSFGEVILCKDKI--TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF--E   96 (484)
T ss_dssp             CCHHHHEEE-EEEEEEETTEEEEEEEETT--TCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE--E
T ss_pred             CcccCceEE-eeEEecCCCEEEEEEEECC--CCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE--E
Confidence            456678885 7799999999999999876  7788999998543     2335688999999999999999999999  5


Q ss_pred             CCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCC
Q psy2172          89 NDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERG  167 (291)
Q Consensus        89 ~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~  167 (291)
                      +....|+||||+.+ +|.+.+....         .+++..++.++.|++.||+|||++||+|+||||+||+++... ..+
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~-~~~  166 (484)
T 3nyv_A           97 DKGYFYLVGEVYTGGELFDEIISRK---------RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKS-KDA  166 (484)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHTCS---------CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSS-TTC
T ss_pred             eCCEEEEEEecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCC-CCC
Confidence            67799999999975 8877775332         289999999999999999999999999999999999996432 567


Q ss_pred             cEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc------
Q psy2172         168 RVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI------  241 (291)
Q Consensus       168 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~------  241 (291)
                      .++|+|||++.......    ......||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.....      
T Consensus       167 ~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  240 (484)
T 3nyv_A          167 NIRIIDFGLSTHFEASK----KMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE  240 (484)
T ss_dssp             CEEECCTTHHHHBCCCC----SHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             cEEEEeeeeeEEccccc----ccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence            89999999998665431    1223468999999999976  38999999999999999999999998765321      


Q ss_pred             ----cC---CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhhh
Q psy2172         242 ----KT---SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF  283 (291)
Q Consensus       242 ----~~---~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (291)
                          ..   ......+.+.+++..|..+.|..||++.++..|||+....
T Consensus       241 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~  289 (484)
T 3nyv_A          241 KGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT  289 (484)
T ss_dssp             HCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred             cCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence                00   1112356789999999999999999999999999987544

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3.4e-41  Score=284.62  Aligned_cols=248  Identities=25%  Similarity=0.412  Sum_probs=204.9

Q ss_pred             cccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC---CChhHHHHHHHHhcCCCCCeeeEEEEEEeC
Q psy2172          12 ERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG---LSMSACREIALLRELKHPNVINLISVFLSH   88 (291)
Q Consensus        12 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   88 (291)
                      ......++|.+ .+.||+|+||.||+|.+..  +++.||+|++....   ....+.+|+.+++.++||||+++++++.  
T Consensus        16 ~~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--   90 (303)
T 3a7i_A           16 LKADPEELFTK-LEKIGKGSFGEVFKGIDNR--TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL--   90 (303)
T ss_dssp             CEECGGGTEEE-EEEEEECSSSEEEEEEETT--TCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEE--
T ss_pred             CCCChHHHHHH-hhhhcccCCeEEEEEEECC--CCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEe--
Confidence            34556677775 7799999999999999766  67889999986443   2356889999999999999999999994  


Q ss_pred             CCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCC
Q psy2172          89 NDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERG  167 (291)
Q Consensus        89 ~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~  167 (291)
                      +....++||||+++ +|.+++...          .+++..++.++.|++.||.+||++|++|+||+|+||+++    .++
T Consensus        91 ~~~~~~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~----~~~  156 (303)
T 3a7i_A           91 KDTKLWIIMEYLGGGSALDLLEPG----------PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS----EHG  156 (303)
T ss_dssp             ETTEEEEEEECCTTEEHHHHHTTS----------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTS
T ss_pred             cCCeEEEEEEeCCCCcHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEEC----CCC
Confidence            46689999999986 777766421          289999999999999999999999999999999999998    667


Q ss_pred             cEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc-------
Q psy2172         168 RVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED-------  240 (291)
Q Consensus       168 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~-------  240 (291)
                      .++|+|||.+.......   .......|+..|+|||.+.+.. ++.++|+||||+++|+|++|..||......       
T Consensus       157 ~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~  232 (303)
T 3a7i_A          157 EVKLADFGVAGQLTDTQ---IKRNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP  232 (303)
T ss_dssp             CEEECCCTTCEECBTTB---CCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred             CEEEeecccceecCccc---cccCccCCCcCccCHHHHhcCC-CCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhh
Confidence            89999999998765432   1223457899999999998754 889999999999999999999999865421       


Q ss_pred             ---ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhh
Q psy2172         241 ---IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKD  282 (291)
Q Consensus       241 ---~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (291)
                         ...........+.+++..|..+.|..||++.++..++++.+.
T Consensus       233 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          233 KNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN  277 (303)
T ss_dssp             HSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred             cCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence               122233446779999999999999999999999999988543

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.2e-41  Score=283.53  Aligned_cols=250  Identities=25%  Similarity=0.373  Sum_probs=198.6

Q ss_pred             cccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC-----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCC
Q psy2172          16 VEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-----GLSMSACREIALLRELKHPNVINLISVFLSHND   90 (291)
Q Consensus        16 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   90 (291)
                      ..+.|.+ ++.||+|+||.||+|.+..  +++.||+|++...     .....+.+|+.+++.++||||+++++++  .+.
T Consensus         9 ~~~~y~i-~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~   83 (276)
T 2h6d_A            9 KIGHYVL-GDTLGVGTFGKVKIGEHQL--TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI--STP   83 (276)
T ss_dssp             EETTEEE-EEEEEECSSEEEEEEEETT--TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE--ECS
T ss_pred             eeccEEE-EeeecCCCCeEEEEEEECC--CCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE--ecC
Confidence            3466775 7799999999999999876  6788999998532     2345688999999999999999999999  556


Q ss_pred             ceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcE
Q psy2172          91 RKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRV  169 (291)
Q Consensus        91 ~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~  169 (291)
                      ...++||||+.+ +|.+.+.....         +++..++.++.|++.||.+||++|++|+||+|+||+++    .++.+
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~----~~~~~  150 (276)
T 2h6d_A           84 TDFFMVMEYVSGGELFDYICKHGR---------VEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLD----AHMNA  150 (276)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEEC----TTSCE
T ss_pred             CeEEEEEeccCCCcHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEEC----CCCCE
Confidence            789999999975 88888865422         89999999999999999999999999999999999998    66789


Q ss_pred             EEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc---------
Q psy2172         170 KIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED---------  240 (291)
Q Consensus       170 ~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~---------  240 (291)
                      +|+|||.+.......    ......|++.|+|||.+.+....+.++|+||||+++|+|++|..||......         
T Consensus       151 ~l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  226 (276)
T 2h6d_A          151 KIADFGLSNMMSDGE----FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG  226 (276)
T ss_dssp             EECCCCGGGCCCC-----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred             EEeecccccccCCCc----ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC
Confidence            999999997654321    1234567899999999987554568999999999999999999999865421         


Q ss_pred             ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhhhhhcc
Q psy2172         241 IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDFNEQI  287 (291)
Q Consensus       241 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (291)
                      ...........+.+++..|..+.|..||++.++.++|++.+.+...+
T Consensus       227 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~~~  273 (276)
T 2h6d_A          227 VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLPSYL  273 (276)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTCCGGG
T ss_pred             cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccCchhcc
Confidence            11122334567899999999999999999999999999887765543

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.8e-41  Score=283.46  Aligned_cols=248  Identities=24%  Similarity=0.368  Sum_probs=198.2

Q ss_pred             ccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC----hhHHHHHHHHhcCCCCCeeeEEEEEEe-
Q psy2172          13 RTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIALLRELKHPNVINLISVFLS-   87 (291)
Q Consensus        13 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~-   87 (291)
                      .....+++....+.||+|+||.||+|.+..  ++..||+|.+......    +.+.+|+.+++.++||||+++++++.. 
T Consensus        20 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   97 (290)
T 1t4h_A           20 GMSNDGRFLKFDIEIGRGSFKTVYKGLDTE--TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST   97 (290)
T ss_dssp             EECTTSCEEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred             hcccCceeEEeeeeccCCCCeEEEEeEecC--CceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccc
Confidence            333444443346799999999999999876  6788999998654322    357889999999999999999999854 


Q ss_pred             -CCCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeeccCCCcEEeecCC
Q psy2172          88 -HNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNW--VLHRDLKPANILVMGEG  163 (291)
Q Consensus        88 -~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~dik~~Nil~~~~~  163 (291)
                       .+....++||||+++ +|.+.+.....         +++..++.++.|++.||.|||++|  ++|+||||+||+++.  
T Consensus        98 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~--  166 (290)
T 1t4h_A           98 VKGKKCIVLVTELMTSGTLKTYLKRFKV---------MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG--  166 (290)
T ss_dssp             SSSCEEEEEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS--
T ss_pred             cCCCceEEEEEEecCCCCHHHHHHHccC---------CCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEEC--
Confidence             245679999999975 88888765322         889999999999999999999999  999999999999963  


Q ss_pred             CCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc--
Q psy2172         164 IERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI--  241 (291)
Q Consensus       164 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~--  241 (291)
                       ..+.++|+|||++......     ......|++.|+|||.+.+  .++.++||||||+++|+|++|..||.......  
T Consensus       167 -~~~~~kl~Dfg~~~~~~~~-----~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~  238 (290)
T 1t4h_A          167 -PTGSVKIGDLGLATLKRAS-----FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI  238 (290)
T ss_dssp             -TTSCEEECCTTGGGGCCTT-----SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH
T ss_pred             -CCCCEEEeeCCCccccccc-----ccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH
Confidence             3568999999999754432     1223467899999999875  38999999999999999999999998744311  


Q ss_pred             ----------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         242 ----------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       242 ----------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                                ..........+.+++..|..+.|..||++.++..+||+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          239 YRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence                      1112223367899999999999999999999999999764

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=4.6e-42  Score=300.30  Aligned_cols=252  Identities=25%  Similarity=0.377  Sum_probs=202.1

Q ss_pred             cccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-CChhHHHHHHHHhcCC--------CCCeeeEE
Q psy2172          12 ERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-LSMSACREIALLRELK--------HPNVINLI   82 (291)
Q Consensus        12 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~--------h~~iv~~~   82 (291)
                      ....+.++|++ .++||+|+||.||+|.+..  +++.||+|++.... ....+.+|+.+++.++        |+||++++
T Consensus        31 ~g~~~~~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~  107 (397)
T 1wak_A           31 IGDLFNGRYHV-IRKLGWGHFSTVWLSWDIQ--GKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLL  107 (397)
T ss_dssp             TTCEETTTEEE-EEEEEECSSEEEEEEEETT--TTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEE
T ss_pred             hhhhcCCeEEE-EEEeeecCCeeEEEEEecC--CCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeee
Confidence            34556788886 6799999999999999876  77899999997542 2356788999999985        78899999


Q ss_pred             EEEEeC--CCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CeeeeccCCCcEEe
Q psy2172          83 SVFLSH--NDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSN-WVLHRDLKPANILV  159 (291)
Q Consensus        83 ~~~~~~--~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~-~ivH~dik~~Nil~  159 (291)
                      +++...  +....|+||||+++++.+.+......       .+++..++.++.||+.||+|||++ ||+|+||||+||++
T Consensus       108 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~-------~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll  180 (397)
T 1wak_A          108 DDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQ-------GLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILL  180 (397)
T ss_dssp             EEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTS-------CCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEE
T ss_pred             cceeecCCCCceEEEEEeccCccHHHHHHhcccC-------CCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeE
Confidence            998532  56689999999999998888754321       289999999999999999999998 99999999999999


Q ss_pred             ecCC---------------------------------------------CCCCcEEEeecccceecCCCCCCCCCCCCce
Q psy2172         160 MGEG---------------------------------------------IERGRVKIADMGFARLFNNPLKPLADLDPVV  194 (291)
Q Consensus       160 ~~~~---------------------------------------------~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~  194 (291)
                      +.++                                             .....++|+|||.+......      .....
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~------~~~~~  254 (397)
T 1wak_A          181 SVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDI  254 (397)
T ss_dssp             CCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC------SCSCC
T ss_pred             eccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc------CccCC
Confidence            8431                                             01137999999999876432      23346


Q ss_pred             ecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccC-------------------------------
Q psy2172         195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT-------------------------------  243 (291)
Q Consensus       195 g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~-------------------------------  243 (291)
                      ||..|+|||++.+.. ++.++|||||||++|+|++|..||.+.......                               
T Consensus       255 gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~  333 (397)
T 1wak_A          255 QTRQYRSLEVLIGSG-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFF  333 (397)
T ss_dssp             SCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTB
T ss_pred             CCCcccCChhhcCCC-CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccccccccc
Confidence            799999999998855 899999999999999999999999865432100                               


Q ss_pred             --------------------------CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchh
Q psy2172         244 --------------------------SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLL  280 (291)
Q Consensus       244 --------------------------~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  280 (291)
                                                ........+.+++..|..+.|..||++.++.+|||+.
T Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  396 (397)
T 1wak_A          334 TKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN  396 (397)
T ss_dssp             CTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred             CCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence                                      0111234567899999999999999999999999874

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.3e-41  Score=289.69  Aligned_cols=247  Identities=23%  Similarity=0.334  Sum_probs=203.2

Q ss_pred             ccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCC
Q psy2172          15 KVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-----LSMSACREIALLRELKHPNVINLISVFLSHN   89 (291)
Q Consensus        15 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   89 (291)
                      ...++|.+ ++.||+|+||.||+|.+..  +++.+|+|++....     ..+.+.+|+.+++.++||||+++++++  .+
T Consensus        38 ~~~~~y~~-~~~lg~G~~g~Vy~~~~~~--~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~  112 (335)
T 2owb_A           38 RSRRRYVR-GRFLGKGGFAKCFEISDAD--TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF--ED  112 (335)
T ss_dssp             TTTEEEEE-EEEEEEETTEEEEEEEETT--TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE--EC
T ss_pred             ccCCceEE-EEEEeeCCCeEEEEEEECC--CCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE--ec
Confidence            34556774 7899999999999999876  67889999986432     234578899999999999999999999  55


Q ss_pred             CceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCc
Q psy2172          90 DRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGR  168 (291)
Q Consensus        90 ~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~  168 (291)
                      ....++||||+++ +|.+.+....         .+++..++.++.|++.||.|||++|++|+||||+||+++    .++.
T Consensus       113 ~~~~~lv~e~~~~~~L~~~~~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~----~~~~  179 (335)
T 2owb_A          113 NDFVFVVLELCRRRSLLELHKRRK---------ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN----EDLE  179 (335)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC----TTCC
T ss_pred             CCeEEEEEecCCCCCHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEc----CCCC
Confidence            7789999999985 7877765432         189999999999999999999999999999999999998    6678


Q ss_pred             EEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc--------
Q psy2172         169 VKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED--------  240 (291)
Q Consensus       169 ~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~--------  240 (291)
                      ++|+|||++........   ......|+..|+|||.+.+.. ++.++||||||+++|+|++|..||......        
T Consensus       180 ~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  255 (335)
T 2owb_A          180 VKIGDFGLATKVEYDGE---RKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK  255 (335)
T ss_dssp             EEECCCTTCEECCSTTC---CBCCCCSCCSSCCHHHHHTSC-BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH
T ss_pred             EEEeeccCceecccCcc---cccccCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhc
Confidence            99999999987653221   223456899999999998754 889999999999999999999999875421        


Q ss_pred             -ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhhh
Q psy2172         241 -IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF  283 (291)
Q Consensus       241 -~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (291)
                       ...........+.+++..|..+.|..||++.++..++++....
T Consensus       256 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~  299 (335)
T 2owb_A          256 NEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY  299 (335)
T ss_dssp             TCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCC
Confidence             1112233456788999999999999999999999998876543

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.9e-41  Score=284.25  Aligned_cols=258  Identities=25%  Similarity=0.405  Sum_probs=203.7

Q ss_pred             cccccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC-----------ChhHHHHHHHHhcCC-CCC
Q psy2172          10 SNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-----------SMSACREIALLRELK-HPN   77 (291)
Q Consensus        10 ~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~e~~~l~~l~-h~~   77 (291)
                      ......+.+.|.+ .+.||+|+||.||+|.++.  +++.||+|++.....           ...+.+|+.+++++. |||
T Consensus         9 ~~~~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~   85 (298)
T 1phk_A            9 SHSTHGFYENYEP-KEILGRGVSSVVRRCIHKP--TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPN   85 (298)
T ss_dssp             ------CTTTEEE-EEEEEECSSEEEEEEEETT--TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTT
T ss_pred             ccCCcchhhccce-eeeecCCCceEEEEEEEcC--cCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            3344566778885 6799999999999999876  778899999865421           234678999999995 999


Q ss_pred             eeeEEEEEEeCCCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCc
Q psy2172          78 VINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPAN  156 (291)
Q Consensus        78 iv~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~N  156 (291)
                      |+++++++  .+....++||||+++ +|.+.+....         .+++..++.++.|++.||.+||++|++|+||+|+|
T Consensus        86 i~~~~~~~--~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~N  154 (298)
T 1phk_A           86 IIQLKDTY--ETNTFFFLVFDLMKKGELFDYLTEKV---------TLSEKETRKIMRALLEVICALHKLNIVHRDLKPEN  154 (298)
T ss_dssp             BCCEEEEE--ECSSEEEEEEECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             Eeeeeeee--ccCCeEEEEEeccCCCcHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcce
Confidence            99999999  567799999999984 8888876532         18999999999999999999999999999999999


Q ss_pred             EEeecCCCCCCcEEEeecccceecCCCCCCCCCCCCceeccccccccccc-----CCcCCCCchhHHHHHHHHHHHHcCC
Q psy2172         157 ILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLL-----GARHYTKAIDIWAIGCIFAELLTSE  231 (291)
Q Consensus       157 il~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~~Dv~slG~~l~~l~~g~  231 (291)
                      |+++    .++.++|+|||.+.......    ......|+..|+|||.+.     ....++.++|+||||+++|+|++|.
T Consensus       155 il~~----~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~  226 (298)
T 1phk_A          155 ILLD----DDMNIKLTDFGFSCQLDPGE----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS  226 (298)
T ss_dssp             EEEC----TTCCEEECCCTTCEECCTTC----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             EEEc----CCCcEEEecccchhhcCCCc----ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCC
Confidence            9998    66789999999998765432    223456789999999985     2234789999999999999999999


Q ss_pred             CCCCCCcccc----------c---CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhhhhhcccc
Q psy2172         232 PIFHCRQEDI----------K---TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDFNEQICK  289 (291)
Q Consensus       232 ~pf~~~~~~~----------~---~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (291)
                      .||.+.....          .   .........+.+++..|..+.|..||++.++..+|++.+...+.+..
T Consensus       227 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~  297 (298)
T 1phk_A          227 PPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVRH  297 (298)
T ss_dssp             CSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC------
T ss_pred             CCCcCccHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccchhhcc
Confidence            9997654321          0   01123456789999999999999999999999999998777666543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.5e-42  Score=295.78  Aligned_cols=271  Identities=20%  Similarity=0.341  Sum_probs=204.2

Q ss_pred             cccccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC-------CCChhHHHHHHHHhcCCCCCeeeEE
Q psy2172          10 SNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-------GLSMSACREIALLRELKHPNVINLI   82 (291)
Q Consensus        10 ~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~   82 (291)
                      +.....+.++|.+ .+.||+|+||.||+|.++.  +++.||+|++...       .....+.+|+.++++++||||++++
T Consensus        18 ~~~~~~~~~~y~~-~~~lG~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~   94 (345)
T 3hko_A           18 GGSLLELQKKYHL-KGAIGQGSYGVVRVAIENQ--TRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLY   94 (345)
T ss_dssp             CBCHHHHHHHEEE-EEEEEECSSCEEEEEEETT--TCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             Cchhhhhhhheee-cceeeecCCeEEEEEEECC--CCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceee
Confidence            3344567788885 6799999999999999876  7788999998532       2335688999999999999999999


Q ss_pred             EEEEeCCCceEEEEEecCCC-CHHHHHHHhhhhh-------------------------------hCCCCCCCCHHHHHH
Q psy2172          83 SVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAK-------------------------------ANKKPVMVPKGMVKS  130 (291)
Q Consensus        83 ~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~-------------------------------~~~~~~~~~~~~~~~  130 (291)
                      +++  .+....++||||+++ +|.+.+.......                               .......+++..++.
T Consensus        95 ~~~--~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (345)
T 3hko_A           95 EVY--EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISN  172 (345)
T ss_dssp             EEE--ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHH
T ss_pred             hhh--ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHH
Confidence            999  567799999999964 8877663110000                               000011246788999


Q ss_pred             HHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceecCCCC-CCCCCCCCceecccccccccccCC-
Q psy2172         131 LLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPL-KPLADLDPVVVTFWYRAPELLLGA-  208 (291)
Q Consensus       131 i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~g~~~y~aPE~~~~~-  208 (291)
                      ++.|++.||+|||++|++|+||||+||+++.+  ....++|+|||++....... ..........||+.|+|||.+.+. 
T Consensus       173 i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~--~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  250 (345)
T 3hko_A          173 IMRQIFSALHYLHNQGICHRDIKPENFLFSTN--KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTN  250 (345)
T ss_dssp             HHHHHHHHHHHHHHTTEECCCCCGGGEEESCS--SSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSS
T ss_pred             HHHHHHHHHHHHHHCCccccCCChhhEEEecC--CCceEEEeeccccccccccCccccccccccCCCccccCchhhccCC
Confidence            99999999999999999999999999999733  23489999999998764321 111223456789999999998752 


Q ss_pred             cCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc----------cCCCC---CcHHHHHHHHHhhCCCCcCChhhhhcCCC
Q psy2172         209 RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI----------KTSNP---YHHDQLDRIFSVMGFPLEKDWEDIRKMPE  275 (291)
Q Consensus       209 ~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~----------~~~~~---~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  275 (291)
                      ..++.++||||||+++|+|++|..||.+.....          ....+   .....+.+++..|..+.|..||++.++..
T Consensus       251 ~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  330 (345)
T 3hko_A          251 ESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ  330 (345)
T ss_dssp             SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred             CCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            458899999999999999999999998755321          00111   13567899999999999999999999999


Q ss_pred             Ccchhhhhhhccc
Q psy2172         276 HPTLLKDFNEQIC  288 (291)
Q Consensus       276 ~~~~~~~~~~~~~  288 (291)
                      +||+.+ +.+.+.
T Consensus       331 hp~~~~-~~~~~~  342 (345)
T 3hko_A          331 HPWISQ-FSDKIY  342 (345)
T ss_dssp             SHHHHT-TSSCSS
T ss_pred             Chhhcc-ChHhhE
Confidence            998864 334433

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.5e-41  Score=305.82  Aligned_cols=246  Identities=23%  Similarity=0.295  Sum_probs=200.3

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC-----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCce
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-----GLSMSACREIALLRELKHPNVINLISVFLSHNDRK   92 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (291)
                      +.|.+ .+.||+|+||.||+|.++.  +++.||+|++...     .....+.+|+.++++++||||+++++++  .+...
T Consensus       185 ~~f~~-~~~LG~G~fG~Vy~a~~~~--tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~--~~~~~  259 (543)
T 3c4z_A          185 DWFLD-FRVLGRGGFGEVFACQMKA--TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF--ETKTD  259 (543)
T ss_dssp             GGEEE-EEEEEECSSSEEEEEEETT--TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE--ECSSE
T ss_pred             hheEE-EEEEeeCCCeEEEEEEECC--CCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE--eeCCE
Confidence            44553 6799999999999999876  6789999998632     2345688999999999999999999999  56778


Q ss_pred             EEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEE
Q psy2172          93 VWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI  171 (291)
Q Consensus        93 ~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l  171 (291)
                      .|+||||+.| +|...+......     ...+++..++.++.|++.||.|||++||+|+||||+||+++    .++.++|
T Consensus       260 l~lVmE~~~gg~L~~~l~~~~~~-----~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~----~~g~vkL  330 (543)
T 3c4z_A          260 LCLVMTIMNGGDIRYHIYNVDED-----NPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLD----DDGNVRI  330 (543)
T ss_dssp             EEEEECCCTTCBHHHHHHTSSTT-----SCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTSCEEE
T ss_pred             EEEEEEeccCCCHHHHHHHhhcc-----cccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEe----CCCCEEE
Confidence            9999999985 887776543211     12389999999999999999999999999999999999998    6789999


Q ss_pred             eecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc-----------
Q psy2172         172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED-----------  240 (291)
Q Consensus       172 ~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~-----------  240 (291)
                      +|||++........   ......||+.|+|||++.+.. ++.++|+|||||++|+|++|..||.+....           
T Consensus       331 ~DFGla~~~~~~~~---~~~~~~GT~~Y~APE~l~~~~-~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~  406 (543)
T 3c4z_A          331 SDLGLAVELKAGQT---KTKGYAGTPGFMAPELLLGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVL  406 (543)
T ss_dssp             CCCTTCEECCTTCC---CBCCCCSCTTTSCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHH
T ss_pred             eecceeeeccCCCc---ccccccCCccccChhhhcCCC-CChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHh
Confidence            99999987654321   123457899999999998754 899999999999999999999999876421           


Q ss_pred             --ccCCCCCcHHHHHHHHHhhCCCCcCChhhh-----hcCCCCcchhh
Q psy2172         241 --IKTSNPYHHDQLDRIFSVMGFPLEKDWEDI-----RKMPEHPTLLK  281 (291)
Q Consensus       241 --~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~-----~~~~~~~~~~~  281 (291)
                        ...........+.+++..|....|..||++     .++..||++..
T Consensus       407 ~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~  454 (543)
T 3c4z_A          407 EQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD  454 (543)
T ss_dssp             HCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred             hcccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence              112233446778999999999999999964     56778888764

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=5.1e-41  Score=291.20  Aligned_cols=247  Identities=23%  Similarity=0.366  Sum_probs=194.0

Q ss_pred             ccccccccceeCcccceEEEEEEEccC-----CCCceeEEEEeCCCCCC---hhHHHHHHHHhcC-CCCCeeeEEEEEEe
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDN-----SDTRDYALKQIEGTGLS---MSACREIALLREL-KHPNVINLISVFLS   87 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~-----~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l-~h~~iv~~~~~~~~   87 (291)
                      .+.|.+ ++.||+|+||.||+|.+...     ..+..||+|+++.....   ..+.+|+.+++++ +||||+++++++  
T Consensus        80 ~~~~~~-~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~--  156 (370)
T 2psq_A           80 RDKLTL-GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC--  156 (370)
T ss_dssp             GGGEEE-EEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE--
T ss_pred             HHHCEe-eeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE--
Confidence            345664 77999999999999997532     24567999999765332   3578999999999 899999999999  


Q ss_pred             CCCceEEEEEecCCC-CHHHHHHHhhhhh-------hCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEe
Q psy2172          88 HNDRKVWLLFDYAEH-DLWHIIKFHRAAK-------ANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILV  159 (291)
Q Consensus        88 ~~~~~~~iv~e~~~~-~l~~~~~~~~~~~-------~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~  159 (291)
                      .+....|+||||+.+ +|.+++.......       .......++...++.++.|++.||+|||++||+|+||||+||++
T Consensus       157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll  236 (370)
T 2psq_A          157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV  236 (370)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred             ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE
Confidence            566789999999975 9988887643210       00111237899999999999999999999999999999999999


Q ss_pred             ecCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCc
Q psy2172         160 MGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQ  238 (291)
Q Consensus       160 ~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~  238 (291)
                      +    .++.++|+|||++........ ........+++.|+|||++.+.. ++.++|||||||++|+|++ |..||.+..
T Consensus       237 ~----~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~p~~~~~  310 (370)
T 2psq_A          237 T----ENNVMKIADFGLARDINNIDY-YKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIP  310 (370)
T ss_dssp             C----TTCCEEECCCSSCEETTCCCT-TCTTTTTTSCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             C----CCCCEEEccccCCcccCcccc-eecccCCCcccceECHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence            8    678999999999987654321 11223445678899999998754 8999999999999999998 999998755


Q ss_pred             ccc----------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         239 EDI----------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       239 ~~~----------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      ...          ..........+.+++..|..+.|..||++.+
T Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~e  354 (370)
T 2psq_A          311 VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQ  354 (370)
T ss_dssp             GGGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            321          1223344567889999999999988888775

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.2e-42  Score=293.10  Aligned_cols=244  Identities=22%  Similarity=0.324  Sum_probs=193.2

Q ss_pred             cccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC----hhHHHHHHHHhcCCC--CCeeeEEEEEEeCC
Q psy2172          16 VEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIALLRELKH--PNVINLISVFLSHN   89 (291)
Q Consensus        16 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~   89 (291)
                      ..++|++ .+.||+|+||.||+|.+.   +++.||+|++......    ..+.+|+.+++.++|  |||+++++++  .+
T Consensus         7 ~~~~y~i-~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~--~~   80 (343)
T 3dbq_A            7 KGRIYSI-LKQIGSGGSSKVFQVLNE---KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE--IT   80 (343)
T ss_dssp             SSCEEEE-EEEESCCSSEEEEEEECT---TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE--EC
T ss_pred             ecCEEEE-EEEEecCCCeEEEEEEeC---CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeE--ee
Confidence            3456775 679999999999999864   5678999998754333    457889999999976  9999999999  55


Q ss_pred             CceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcE
Q psy2172          90 DRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRV  169 (291)
Q Consensus        90 ~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~  169 (291)
                      ....++|||+.+++|.+.+....         .+++..++.++.|++.||+|||++||+|+||||+||+++     ++.+
T Consensus        81 ~~~~~lv~e~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-----~~~~  146 (343)
T 3dbq_A           81 DQYIYMVMECGNIDLNSWLKKKK---------SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-----DGML  146 (343)
T ss_dssp             SSEEEEEECCCSEEHHHHHHHSC---------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-----TTEE
T ss_pred             CCEEEEEEeCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-----CCcE
Confidence            77999999988889999887532         289999999999999999999999999999999999996     3579


Q ss_pred             EEeecccceecCCCCCCCCCCCCceecccccccccccC----------CcCCCCchhHHHHHHHHHHHHcCCCCCCCCcc
Q psy2172         170 KIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLG----------ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE  239 (291)
Q Consensus       170 ~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----------~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~  239 (291)
                      +|+|||++........ ........||+.|+|||++.+          ...++.++|||||||++|+|++|..||.....
T Consensus       147 kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~  225 (343)
T 3dbq_A          147 KLIDFGIANQMQPDTT-SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN  225 (343)
T ss_dssp             EECCCSSSCCC-------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred             EEeecccccccCcccc-cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh
Confidence            9999999986643211 112234578999999999853          13488899999999999999999999986433


Q ss_pred             c------------ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchh
Q psy2172         240 D------------IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLL  280 (291)
Q Consensus       240 ~------------~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  280 (291)
                      .            ...........+.+++..|..+.|..||++.++..+||+.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~  278 (343)
T 3dbq_A          226 QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ  278 (343)
T ss_dssp             HHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             HHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccc
Confidence            2            1112233346789999999999999999999999998875

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=5.1e-42  Score=292.80  Aligned_cols=251  Identities=27%  Similarity=0.384  Sum_probs=200.1

Q ss_pred             cccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC----CChhHHHHHHHHhcCC-CCCeeeEEEEEEeC
Q psy2172          14 TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG----LSMSACREIALLRELK-HPNVINLISVFLSH   88 (291)
Q Consensus        14 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~   88 (291)
                      ..+.++|.+.++.||+|+||.||+|.++.  +++.||+|++....    ....+.+|+.+++.++ ||||+++++++  .
T Consensus        24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~--~   99 (327)
T 3lm5_A           24 ENFNNFYILTSKELGRGKFAVVRQCISKS--TGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY--E   99 (327)
T ss_dssp             HHHHHHEEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE--E
T ss_pred             HhhhhEEeeccceeCCCCCeEEEEEEECC--CCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE--E
Confidence            34566777666899999999999999876  67899999986432    2356889999999995 69999999999  5


Q ss_pred             CCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCC
Q psy2172          89 NDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERG  167 (291)
Q Consensus        89 ~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~  167 (291)
                      +....++||||+.+ +|.+.+...       ....+++..++.++.|++.||++||++|++|+||||+||+++... ..+
T Consensus       100 ~~~~~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~-~~~  171 (327)
T 3lm5_A          100 NTSEIILILEYAAGGEIFSLCLPE-------LAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIY-PLG  171 (327)
T ss_dssp             CSSEEEEEEECCTTEEGGGGGSSC-------C-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBT-TBC
T ss_pred             eCCeEEEEEEecCCCcHHHHHHHh-------cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCC-CCC
Confidence            67789999999986 776655321       112389999999999999999999999999999999999998422 267


Q ss_pred             cEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc------
Q psy2172         168 RVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI------  241 (291)
Q Consensus       168 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~------  241 (291)
                      .++|+|||++.......    ......|++.|+|||++.+.. ++.++||||||+++|+|++|..||.+.....      
T Consensus       172 ~~kL~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  246 (327)
T 3lm5_A          172 DIKIVDFGMSRKIGHAC----ELREIMGTPEYLAPEILNYDP-ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNIS  246 (327)
T ss_dssp             CEEECCGGGCEEC-------------CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             cEEEeeCccccccCCcc----ccccccCCcCccCCeeecCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH
Confidence            89999999998765432    223457899999999998754 8999999999999999999999997765321      


Q ss_pred             -------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         242 -------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       242 -------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                             ..........+.+++..|..+.|..||++.++..+||+..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~  293 (327)
T 3lm5_A          247 QVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQ  293 (327)
T ss_dssp             HTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCC
T ss_pred             hcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcc
Confidence                   1111234567889999999999999999999999999864

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=3e-41  Score=283.83  Aligned_cols=248  Identities=17%  Similarity=0.177  Sum_probs=198.9

Q ss_pred             cccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCc
Q psy2172          12 ERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDR   91 (291)
Q Consensus        12 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (291)
                      +...+.++|++ .+.||+|+||.||+|.+..  +++.||+|++........+.+|+.+++.++|++++..+..+. ....
T Consensus         3 ~~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-~~~~   78 (296)
T 3uzp_A            3 MELRVGNRYRL-GRKIGSGSFGDIYLGTDIA--AGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCG-AEGD   78 (296)
T ss_dssp             --CEETTTEEE-EEEEEEETTEEEEEEEETT--TTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEE-EETT
T ss_pred             ccceeccEEEE-EEEEccCCCeEEEEEEEcC--CCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCcccccc-CCCC
Confidence            45567888986 7799999999999999866  778999999987777778999999999999887666665553 3466


Q ss_pred             eEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEE
Q psy2172          92 KVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI  171 (291)
Q Consensus        92 ~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l  171 (291)
                      ..++||||++++|.+++.....        .+++..++.++.|++.||+|||++|++|+||||+||+++.++ ..+.++|
T Consensus        79 ~~~lv~e~~~~~L~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~-~~~~~kl  149 (296)
T 3uzp_A           79 YNVMVMELLGPSLEDLFNFCSR--------KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGK-KGNLVYI  149 (296)
T ss_dssp             EEEEEEECCCCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGG-GTTCEEE
T ss_pred             ceEEEEEecCCCHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCC-CCCeEEE
Confidence            8899999998899998874332        289999999999999999999999999999999999995322 5578999


Q ss_pred             eecccceecCCCCCCC----CCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccC----
Q psy2172         172 ADMGFARLFNNPLKPL----ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT----  243 (291)
Q Consensus       172 ~Dfg~~~~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~----  243 (291)
                      +|||.+..........    .......|+..|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.......    
T Consensus       150 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~  228 (296)
T 3uzp_A          150 IDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE  228 (296)
T ss_dssp             CCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHH
T ss_pred             eeCCCcccccccccccccccccccccccccccCChhhhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhh
Confidence            9999998766532211    1234567899999999998755 899999999999999999999999875432100    


Q ss_pred             -------------CCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         244 -------------SNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       244 -------------~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                                   ......+.+.+++..|..+.|..||++.++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  271 (296)
T 3uzp_A          229 RISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYL  271 (296)
T ss_dssp             HHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHH
T ss_pred             hhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHH
Confidence                         012334678899999999999999987763

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=4e-41  Score=279.30  Aligned_cols=235  Identities=19%  Similarity=0.321  Sum_probs=191.9

Q ss_pred             ccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEE
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWL   95 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~i   95 (291)
                      .+.|++ .+.||+|+||.||+|.++   ++..||+|++.... ....+.+|+.++++++||||+++++++  .+....++
T Consensus         7 ~~~y~~-~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~~~l   80 (268)
T 3sxs_A            7 REEITL-LKELGSGQFGVVKLGKWK---GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC--SKEYPIYI   80 (268)
T ss_dssp             GGGEEE-EEEEEEETTEEEEEEEET---TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEE--CSSSSEEE
T ss_pred             hhheee-eeeeccCCCceEEEEEec---CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEE--ccCCceEE
Confidence            355664 679999999999999876   45679999997654 345688999999999999999999999  66778999


Q ss_pred             EEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          96 LFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        96 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      ||||+++ +|.+.+......        +++..++.++.|++.||++||++|++|+||||+||+++    .++.++|+||
T Consensus        81 v~e~~~~~~L~~~l~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~----~~~~~~l~Df  148 (268)
T 3sxs_A           81 VTEYISNGCLLNYLRSHGKG--------LEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVD----RDLCVKVSDF  148 (268)
T ss_dssp             EEECCTTCBHHHHHHHHGGG--------CCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEEC----TTCCEEECCT
T ss_pred             EEEccCCCcHHHHHHHcCCC--------CCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEEC----CCCCEEEccC
Confidence            9999975 788888654322        89999999999999999999999999999999999998    6779999999


Q ss_pred             ccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc----------cC
Q psy2172         175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI----------KT  243 (291)
Q Consensus       175 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~----------~~  243 (291)
                      |.+........  .......++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||.......          ..
T Consensus       149 g~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~  225 (268)
T 3sxs_A          149 GMTRYVLDDQY--VSSVGTKFPVKWSAPEVFHYFK-YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLY  225 (268)
T ss_dssp             TCEEECCTTCE--EECCSCCCCGGGCCHHHHHHSE-EETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred             ccceecchhhh--hcccCCCcCcccCCHHHHhccC-CchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCC
Confidence            99987654321  1223345577899999997754 8899999999999999998 999998655321          11


Q ss_pred             CCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         244 SNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       244 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      ......+.+.+++..|..+.|..||++.+
T Consensus       226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~  254 (268)
T 3sxs_A          226 RPHLASDTIYQIMYSCWHELPEKRPTFQQ  254 (268)
T ss_dssp             CCTTSCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred             CCCcChHHHHHHHHHHcCCChhhCcCHHH
Confidence            22334567889999999999999888775

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1e-41  Score=288.06  Aligned_cols=247  Identities=25%  Similarity=0.381  Sum_probs=200.2

Q ss_pred             cccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC--CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCc
Q psy2172          14 TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG--LSMSACREIALLRELKHPNVINLISVFLSHNDR   91 (291)
Q Consensus        14 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (291)
                      ..+.+.|.+ .+.||+|+||.||+|.++.  +++.||+|+++...  ....+.+|+.+++.++||||+++++++  .+..
T Consensus         5 ~~~~~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~   79 (304)
T 2jam_A            5 TNIRKTFIF-MEVLGSGAFSEVFLVKQRL--TGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY--ESTT   79 (304)
T ss_dssp             -CHHHHEEE-EEEEEECSSEEEEEEEETT--TCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEE--ECSS
T ss_pred             cchhcccee-eeeccCCCCceEEEEEECC--CCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhc--ccCC
Confidence            456778885 7799999999999999876  67889999987542  334688999999999999999999999  5677


Q ss_pred             eEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEE
Q psy2172          92 KVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVK  170 (291)
Q Consensus        92 ~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~  170 (291)
                      ..+++|||+++ +|.+.+.....         +++..++.++.|++.||.+||++|++|+||||+||++...+ ..+.++
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~-~~~~~k  149 (304)
T 2jam_A           80 HYYLVMQLVSGGELFDRILERGV---------YTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPE-ENSKIM  149 (304)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSS-TTCCEE
T ss_pred             EEEEEEEcCCCccHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCC-CCCCEE
Confidence            89999999975 88887764321         89999999999999999999999999999999999994322 567899


Q ss_pred             EeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---------
Q psy2172         171 IADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---------  241 (291)
Q Consensus       171 l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---------  241 (291)
                      |+|||.+......     ......|++.|+|||.+.+.. ++.++|+||||+++|+|++|..||.+.....         
T Consensus       150 l~Dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~  223 (304)
T 2jam_A          150 ITDFGLSKMEQNG-----IMSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGY  223 (304)
T ss_dssp             BCSCSTTCCCCCB-----TTHHHHSCCCBCCTTTBSSCS-CCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCC
T ss_pred             EccCCcceecCCC-----ccccccCCCCccChHHhccCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC
Confidence            9999998754321     223346789999999998744 8999999999999999999999997754321         


Q ss_pred             ----cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         242 ----KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       242 ----~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                          ..........+.+++..|..+.|..||++.++..+|++..
T Consensus       224 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~  267 (304)
T 2jam_A          224 YEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDG  267 (304)
T ss_dssp             CCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHS
T ss_pred             CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccC
Confidence                0111233577899999999999999999999988888753

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=8.5e-43  Score=303.26  Aligned_cols=249  Identities=14%  Similarity=0.113  Sum_probs=189.9

Q ss_pred             ccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC-----CCChhHHHHHH---HHhcCCCCCeeeEE------
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-----GLSMSACREIA---LLRELKHPNVINLI------   82 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~---~l~~l~h~~iv~~~------   82 (291)
                      .+.|.+ ++.||+|+||.||+|.++.  +++.||||++...     ...+.+.+|+.   +++.++||||++++      
T Consensus        72 ~~~y~~-~~~lG~G~~g~V~~a~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~  148 (377)
T 3byv_A           72 PRTLVR-GTVLGQEDPYAYLEATDQE--TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP  148 (377)
T ss_dssp             CEEEEE-EEEEEEETTEEEEEEEC-C--CCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCC
T ss_pred             CceEEE-cceeecCCCEEEEEEEECC--CCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhh
Confidence            456664 7799999999999999765  6789999998632     22356789995   45555799999998      


Q ss_pred             -EEEEeCCC----------c-----eEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC
Q psy2172          83 -SVFLSHND----------R-----KVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNW  146 (291)
Q Consensus        83 -~~~~~~~~----------~-----~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~  146 (291)
                       +++...+.          .     ..|++|||++|+|.+++........  ....+++..++.++.|++.||+|||++|
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~  226 (377)
T 3byv_A          149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS--THKSLVHHARLQLTLQVIRLLASLHHYG  226 (377)
T ss_dssp             SEEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTT--TTHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hhhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhcccccc--ccccccHHHHHHHHHHHHHHHHHHHhCC
Confidence             66532211          1     3889999999999999986543111  0111445888899999999999999999


Q ss_pred             eeeeccCCCcEEeecCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCC----------cCCCCchh
Q psy2172         147 VLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGA----------RHYTKAID  216 (291)
Q Consensus       147 ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----------~~~~~~~D  216 (291)
                      |+|+||||+||+++    .++.++|+|||++.....      ......| +.|+|||++.+.          ..++.++|
T Consensus       227 ivHrDikp~NIll~----~~~~~kL~DFG~a~~~~~------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~D  295 (377)
T 3byv_A          227 LVHTYLRPVDIVLD----QRGGVFLTGFEHLVRDGA------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFD  295 (377)
T ss_dssp             EECSCCCGGGEEEC----TTCCEEECCGGGCEETTC------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHH
T ss_pred             eecCCCCHHHEEEc----CCCCEEEEechhheecCC------cccCCCC-cCccChhhhcccccccccccccccCChhhh
Confidence            99999999999998    667999999999986432      1223456 889999999875          14899999


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCccccc-----CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         217 IWAIGCIFAELLTSEPIFHCRQEDIK-----TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       217 v~slG~~l~~l~~g~~pf~~~~~~~~-----~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                      ||||||++|+|++|..||.+......     .......+.+.+++..|..+.|..||++.++.++|++..
T Consensus       296 vwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~  365 (377)
T 3byv_A          296 AWALGLVIYWIWCADLPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  365 (377)
T ss_dssp             HHHHHHHHHHHHHSSCCC------CCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred             HHHHHHHHHHHHHCCCCCcccccccchhhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence            99999999999999999987553221     112344577899999999999999999999999988764

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-41  Score=283.68  Aligned_cols=241  Identities=21%  Similarity=0.304  Sum_probs=193.0

Q ss_pred             ccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      .+.|.+.++.||+|+||.||+|.++...++..||+|+++....   .+.+.+|+.++++++||||+++++++  . ....
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~-~~~~   84 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC--Q-AEAL   84 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--E-SSSE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe--c-CCCc
Confidence            3455655669999999999999987655778899999976432   34578999999999999999999998  2 3458


Q ss_pred             EEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          94 WLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        94 ~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      ++||||+++ +|.+.+....        ..+++..++.++.|++.||.+||++|++|+||||+||+++    .++.++|+
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~----~~~~~kl~  152 (287)
T 1u59_A           85 MLVMEMAGGGPLHKFLVGKR--------EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV----NRHYAKIS  152 (287)
T ss_dssp             EEEEECCTTEEHHHHHTTCT--------TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE----ETTEEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhCC--------ccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEc----CCCCEEEC
Confidence            999999986 7877765321        1289999999999999999999999999999999999998    66799999


Q ss_pred             ecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc----------c
Q psy2172         173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED----------I  241 (291)
Q Consensus       173 Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~----------~  241 (291)
                      |||.+.................++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||.+....          .
T Consensus       153 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~  231 (287)
T 1u59_A          153 DFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR  231 (287)
T ss_dssp             CCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC
T ss_pred             cccceeeeccCcceeeccccccccccccCHHHhccCC-CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCc
Confidence            9999987755433223334456688999999997644 8899999999999999998 99999875532          1


Q ss_pred             cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         242 KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       242 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      ....+.....+.+++..|..+.|..||++.++
T Consensus       232 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l  263 (287)
T 1u59_A          232 MECPPECPPELYALMSDCWIYKWEDRPDFLTV  263 (287)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred             CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            22334456788899999999999988887764

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=4.7e-41  Score=290.94  Aligned_cols=244  Identities=16%  Similarity=0.172  Sum_probs=187.2

Q ss_pred             cccccccceeCcccceEEEEEEEccCC---CCceeEEEEeCCCCC-------------ChhHHHHHHHHhcCCCCCeeeE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNS---DTRDYALKQIEGTGL-------------SMSACREIALLRELKHPNVINL   81 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~---~~~~vaiK~~~~~~~-------------~~~~~~e~~~l~~l~h~~iv~~   81 (291)
                      +.|.+ +++||+|+||.||+|.++.+.   .++.||+|++.....             ......|+..++.++||||+++
T Consensus        35 ~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           35 AAWKV-GLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CEEEE-EEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CeEEE-EEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            47775 779999999999999986532   357899999875431             1123345556677789999999


Q ss_pred             EEEEEeCC--CceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEe
Q psy2172          82 ISVFLSHN--DRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILV  159 (291)
Q Consensus        82 ~~~~~~~~--~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~  159 (291)
                      ++++....  ..+.|+||||++++|.+++.....        .+++..++.++.|++.||+|||++||+|+||||+||++
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~--------~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill  185 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAK--------RFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLL  185 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTS--------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred             EeeeeeccCCcceEEEEEeCCCCCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEE
Confidence            99986532  367899999997799988875321        28999999999999999999999999999999999999


Q ss_pred             ecCCCCCCcEEEeecccceecCCCCCC----CCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCC
Q psy2172         160 MGEGIERGRVKIADMGFARLFNNPLKP----LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH  235 (291)
Q Consensus       160 ~~~~~~~~~~~l~Dfg~~~~~~~~~~~----~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~  235 (291)
                      +.+  ..+.++|+|||+++........    ........||+.|+|||++.+.. ++.++|||||||++|+|++|..||.
T Consensus       186 ~~~--~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~Pf~  262 (364)
T 3op5_A          186 NYK--NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA-PSRRGDLEILGYCMIQWLTGHLPWE  262 (364)
T ss_dssp             ESS--CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred             ecC--CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCcc
Confidence            843  3578999999999876542111    11123456899999999998755 8999999999999999999999998


Q ss_pred             CCccccc--------------------CCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         236 CRQEDIK--------------------TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       236 ~~~~~~~--------------------~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      +...+..                    .........+.+++..|....|..+|++.++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l  320 (364)
T 3op5_A          263 DNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENL  320 (364)
T ss_dssp             GGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHH
T ss_pred             ccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHH
Confidence            6433210                    0012334667888888888899888887753

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.6e-41  Score=295.16  Aligned_cols=235  Identities=22%  Similarity=0.351  Sum_probs=189.9

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC---hhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS---MSACREIALLRELKHPNVINLISVFLSHNDRKVWL   95 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~i   95 (291)
                      .|.+ ++.||+|+||.||+|.++.  +++.||+|.++.....   ..+.+|+.++++++||||+++++++  .+....|+
T Consensus       115 ~~~~-~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~--~~~~~~~l  189 (377)
T 3cbl_A          115 DLVL-GEQIGRGNFGEVFSGRLRA--DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC--TQKQPIYI  189 (377)
T ss_dssp             GEEE-EEEEEEETTEEEEEEEETT--TCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEE--CSSSSCEE
T ss_pred             HeEE-eeEeccCCCCeEEEEEEec--CCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE--ecCCCcEE
Confidence            4443 6899999999999999876  6788999998754322   3577899999999999999999999  55678999


Q ss_pred             EEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          96 LFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        96 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      ||||++ ++|.+.+......        +++..++.++.|++.||+|||++|++|+||||+||+++    .++.++|+||
T Consensus       190 v~e~~~~g~L~~~l~~~~~~--------~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~----~~~~~kl~Df  257 (377)
T 3cbl_A          190 VMELVQGGDFLTFLRTEGAR--------LRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVT----EKNVLKISDF  257 (377)
T ss_dssp             EEECCTTCBHHHHHHHHGGG--------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTCCEEECCG
T ss_pred             EEEcCCCCCHHHHHHhcCCC--------CCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEc----CCCcEEECcC
Confidence            999997 5888888754322        88999999999999999999999999999999999998    6779999999


Q ss_pred             ccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc----------ccC
Q psy2172         175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED----------IKT  243 (291)
Q Consensus       175 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~----------~~~  243 (291)
                      |++........ ........++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+....          ...
T Consensus       258 G~s~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~  335 (377)
T 3cbl_A          258 GMSREEADGVY-AASGGLRQVPVKWTAPEALNYGR-YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLP  335 (377)
T ss_dssp             GGCEECTTSEE-ECCSSCCEEEGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCC
T ss_pred             CCceecCCCce-eecCCCCCCCcCcCCHhHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            99986543211 11112345677899999997644 8899999999999999998 99999875532          112


Q ss_pred             CCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         244 SNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       244 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      ......+.+.+++..|....|..||++.+
T Consensus       336 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~  364 (377)
T 3cbl_A          336 CPELCPDAVFRLMEQCWAYEPGQRPSFST  364 (377)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence            22334567888999999999999988775

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.4e-41  Score=293.57  Aligned_cols=244  Identities=17%  Similarity=0.122  Sum_probs=183.1

Q ss_pred             cccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC-----ChhHHHHHHHHhcC--CCCCeeeEE-------EEE
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-----SMSACREIALLREL--KHPNVINLI-------SVF   85 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l--~h~~iv~~~-------~~~   85 (291)
                      |.+ .+.||+|+||.||+|.++.  +++.||+|++.....     ...+.+|+.+++.+  +||||++++       +++
T Consensus        64 y~~-~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           64 LKL-VEPLRVGDRSVVFLVRDVE--RLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEE-EEEEEECSSEEEEEEEETT--TTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             eee-eeeccCCCCEEEEEEEECC--CCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            553 7799999999999999876  678999999986543     22456675444444  699988865       444


Q ss_pred             EeCCC---------------ceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHH------HHHHHHHHHHHHHHhh
Q psy2172          86 LSHND---------------RKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMV------KSLLYQILDGIHYLHS  144 (291)
Q Consensus        86 ~~~~~---------------~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~------~~i~~ql~~~l~~LH~  144 (291)
                      ..+..               ...|+||||++++|.+++......        ++...+      ..++.|++.||+|||+
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~--------~~~~~~~~~~vk~~i~~qi~~aL~~LH~  212 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFV--------YVFRGDEGILALHILTAQLIRLAANLQS  212 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHS--------CCCCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccc--------cchhhhhhhhhHHHHHHHHHHHHHHHHH
Confidence            32222               458999999999999999876432        444445      6778999999999999


Q ss_pred             CCeeeeccCCCcEEeecCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCC-cCCCCchhHHHHHHH
Q psy2172         145 NWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCI  223 (291)
Q Consensus       145 ~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Dv~slG~~  223 (291)
                      +||+|+||||+||+++    .++.++|+|||++.......      ....+++.|+|||++.+. ..++.++|||||||+
T Consensus       213 ~~ivHrDikp~NIll~----~~~~~kL~DFG~a~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~i  282 (371)
T 3q60_A          213 KGLVHGHFTPDNLFIM----PDGRLMLGDVSALWKVGTRG------PASSVPVTYAPREFLNASTATFTHALNAWQLGLS  282 (371)
T ss_dssp             TTEEETTCSGGGEEEC----TTSCEEECCGGGEEETTCEE------EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHH
T ss_pred             CCCccCcCCHHHEEEC----CCCCEEEEecceeeecCCCc------cCccCCcCCcChhhccCCCCCcCccccHHHHHHH
Confidence            9999999999999998    66789999999998654321      134556899999999762 348999999999999


Q ss_pred             HHHHHcCCCCCCCCccccc------------------CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhhhh
Q psy2172         224 FAELLTSEPIFHCRQEDIK------------------TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDFN  284 (291)
Q Consensus       224 l~~l~~g~~pf~~~~~~~~------------------~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (291)
                      +|+|++|+.||.+......                  ...+...+.+.+++..|..+.|..||++.++..+||+.+.-.
T Consensus       283 l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  361 (371)
T 3q60_A          283 IYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQN  361 (371)
T ss_dssp             HHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHH
T ss_pred             HHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHH
Confidence            9999999999988733210                  011244678999999999999999999999999999875433

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.2e-41  Score=295.41  Aligned_cols=242  Identities=21%  Similarity=0.325  Sum_probs=192.5

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC----hhHHHHHHHHhcCC--CCCeeeEEEEEEeCCCc
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIALLRELK--HPNVINLISVFLSHNDR   91 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~   91 (291)
                      +.|++ .+.||+|+||.||+|.+.   .++.||||++......    ..+.+|+.++++++  ||||+++++++  ....
T Consensus        56 ~~y~~-~~~LG~G~fg~Vy~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~--~~~~  129 (390)
T 2zmd_A           56 RIYSI-LKQIGSGGSSKVFQVLNE---KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE--ITDQ  129 (390)
T ss_dssp             EEEEE-EEEEECCSSEEEEEEECT---TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE--ECSS
T ss_pred             CceEE-EEEEccCCCeEEEEEEcC---CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEE--ecCC
Confidence            34664 779999999999999864   3678999998654332    45789999999996  59999999998  4566


Q ss_pred             eEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEE
Q psy2172          92 KVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI  171 (291)
Q Consensus        92 ~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l  171 (291)
                      ..|+|||+.+++|.+.+....         .+++..++.++.|++.||+|||++||+|+||||+||+++     ++.++|
T Consensus       130 ~~~lv~E~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-----~~~~kl  195 (390)
T 2zmd_A          130 YIYMVMECGNIDLNSWLKKKK---------SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-----DGMLKL  195 (390)
T ss_dssp             EEEEEEECCSEEHHHHHHHCS---------SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-----SSCEEE
T ss_pred             EEEEEEecCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-----CCeEEE
Confidence            899999987789998887543         288889999999999999999999999999999999995     368999


Q ss_pred             eecccceecCCCCCCCCCCCCceecccccccccccCC----------cCCCCchhHHHHHHHHHHHHcCCCCCCCCccc-
Q psy2172         172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGA----------RHYTKAIDIWAIGCIFAELLTSEPIFHCRQED-  240 (291)
Q Consensus       172 ~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----------~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~-  240 (291)
                      +|||++........ ........||+.|+|||++.+.          ..++.++|||||||++|+|++|..||...... 
T Consensus       196 ~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~  274 (390)
T 2zmd_A          196 IDFGIANQMQPDTT-SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI  274 (390)
T ss_dssp             CCCSSSCCC----------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH
T ss_pred             EecCccccccCCCc-cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH
Confidence            99999986643211 1122345789999999998651          24889999999999999999999999865332 


Q ss_pred             -----------ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchh
Q psy2172         241 -----------IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLL  280 (291)
Q Consensus       241 -----------~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  280 (291)
                                 ...........+.+++..|..+.|..||++.++..+||+.
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~  325 (390)
T 2zmd_A          275 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ  325 (390)
T ss_dssp             HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             HHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcc
Confidence                       0112233356789999999999999999999999998875

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.3e-42  Score=304.37  Aligned_cols=248  Identities=23%  Similarity=0.400  Sum_probs=191.4

Q ss_pred             cccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC----------CChhHHHHHHHHhcCCCCCeeeEEE
Q psy2172          14 TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG----------LSMSACREIALLRELKHPNVINLIS   83 (291)
Q Consensus        14 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~e~~~l~~l~h~~iv~~~~   83 (291)
                      ..+.+.|.+ .+.||+|+||.||+|.++.  +++.||+|++....          ....+.+|+.++++++||||+++++
T Consensus       131 ~~~~~~y~~-~~~LG~G~~g~V~~a~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  207 (419)
T 3i6u_A          131 KALRDEYIM-SKTLGSGACGEVKLAFERK--TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKN  207 (419)
T ss_dssp             HHHHTTEEE-EEEEEECSSSEEEEEEETT--TCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCE
T ss_pred             hhhhccEEE-EeEEeeCCCeEEEEEEECC--CCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            345667775 7799999999999999877  67889999986421          1235789999999999999999999


Q ss_pred             EEEeCCCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecC
Q psy2172          84 VFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGE  162 (291)
Q Consensus        84 ~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~  162 (291)
                      ++  . ....|+||||+.+ +|.+.+...         ..+++..++.++.|++.||+|||++||+|+||||+||+++.+
T Consensus       208 ~~--~-~~~~~lv~e~~~~g~L~~~l~~~---------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~  275 (419)
T 3i6u_A          208 FF--D-AEDYYIVLELMEGGELFDKVVGN---------KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ  275 (419)
T ss_dssp             EE--E-SSEEEEEEECCTTCBGGGGTSSS---------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSS
T ss_pred             EE--e-cCceEEEEEcCCCCcHHHHHhcc---------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecC
Confidence            98  3 3457999999975 766554321         238999999999999999999999999999999999999743


Q ss_pred             CCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccC--CcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc
Q psy2172         163 GIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLG--ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED  240 (291)
Q Consensus       163 ~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~  240 (291)
                      + ....++|+|||++......    .......||+.|+|||++.+  ...++.++||||||+++|+|++|..||......
T Consensus       276 ~-~~~~~kl~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~  350 (419)
T 3i6u_A          276 E-EDCLIKITDFGHSKILGET----SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ  350 (419)
T ss_dssp             S-SSCCEEECCSSTTTSCC---------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS
T ss_pred             C-CcceEEEeecccceecCCC----ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch
Confidence            3 3457999999999865432    22344678999999999853  234788999999999999999999999865432


Q ss_pred             ccC----------C----CCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         241 IKT----------S----NPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       241 ~~~----------~----~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                      ...          .    .....+.+.+++..|..+.|..||++.++..|||+..
T Consensus       351 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~  405 (419)
T 3i6u_A          351 VSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  405 (419)
T ss_dssp             CCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             HHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence            110          0    0123567889999999999999999999999999863

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=6e-41  Score=310.64  Aligned_cols=241  Identities=23%  Similarity=0.300  Sum_probs=200.8

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCC-----CCCChhHHHHHHHHhcC-CCCCeeeEEEEEEeCCCce
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEG-----TGLSMSACREIALLREL-KHPNVINLISVFLSHNDRK   92 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~   92 (291)
                      .|.+ .++||+|+||.||+|.++.  +++.||||+++.     ......+..|..++..+ +||+|+++++++  .+...
T Consensus       342 ~f~~-~~~LG~G~fG~V~~~~~~~--~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~--~~~~~  416 (674)
T 3pfq_A          342 DFNF-LMVLGKGSFGKVMLSERKG--TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF--QTMDR  416 (674)
T ss_dssp             TEEE-EEESSBTTTBCEEEEEESS--SCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC--BCSSE
T ss_pred             ceEE-EEEEccCCCEEEEEEEECC--CCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE--EeCCE
Confidence            3553 5799999999999999877  778899999863     23455688899999988 799999999999  67789


Q ss_pred             EEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEE
Q psy2172          93 VWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI  171 (291)
Q Consensus        93 ~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l  171 (291)
                      +|+||||+.| +|...+.....         +++..++.++.||+.||+|||++||+||||||+|||++    .++.++|
T Consensus       417 ~~lV~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~----~~g~ikL  483 (674)
T 3pfq_A          417 LYFVMEYVNGGDLMYHIQQVGR---------FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD----SEGHIKI  483 (674)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEEC----SSSCEEE
T ss_pred             EEEEEeCcCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEc----CCCcEEE
Confidence            9999999975 88877765432         89999999999999999999999999999999999998    6789999


Q ss_pred             eecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc---------cc
Q psy2172         172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED---------IK  242 (291)
Q Consensus       172 ~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~---------~~  242 (291)
                      +|||+++......   .......||+.|+|||++.+.. ++.++|+||||+++|+|++|..||.+.+..         ..
T Consensus       484 ~DFGla~~~~~~~---~~~~~~~GT~~Y~APE~l~~~~-~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~  559 (674)
T 3pfq_A          484 ADFGMCKENIWDG---VTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV  559 (674)
T ss_dssp             CCCTTCEECCCTT---CCBCCCCSCSSSCCHHHHTCCC-BSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCC
T ss_pred             eecceeeccccCC---cccccccCCCcccCHhhhcCCC-CCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC
Confidence            9999998643321   2234567899999999998754 899999999999999999999999886542         11


Q ss_pred             CCCCCcHHHHHHHHHhhCCCCcCChhhh-----hcCCCCcchhh
Q psy2172         243 TSNPYHHDQLDRIFSVMGFPLEKDWEDI-----RKMPEHPTLLK  281 (291)
Q Consensus       243 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~-----~~~~~~~~~~~  281 (291)
                      .........+.+++..|....|..|++.     .++..||++..
T Consensus       560 ~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~  603 (674)
T 3pfq_A          560 AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  603 (674)
T ss_dssp             CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred             CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence            2233446778999999999999999987     78888888764

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3.6e-41  Score=288.43  Aligned_cols=252  Identities=23%  Similarity=0.395  Sum_probs=202.0

Q ss_pred             cccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-CChhHHHHHHHHhcCCCC------CeeeEEEE
Q psy2172          12 ERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-LSMSACREIALLRELKHP------NVINLISV   84 (291)
Q Consensus        12 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~------~iv~~~~~   84 (291)
                      ....+.++|++ .+.||+|+||.||+|.+.. .+++.||+|+++... ....+.+|+.+++.++|+      ++++++++
T Consensus         8 ~g~~~~~~y~~-~~~lg~G~~g~V~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~   85 (339)
T 1z57_A            8 SGDVLSARYEI-VDTLGEGAFGKVVECIDHK-AGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEW   85 (339)
T ss_dssp             TTCEETTTEEE-EEEEEEETTEEEEEEEETT-TTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEE
T ss_pred             cCCCccCceEE-EEEEecCCCeEEEEEEecC-CCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecc
Confidence            34567788886 6799999999999999732 256889999997542 234678899999988654      59999999


Q ss_pred             EEeCCCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCC
Q psy2172          85 FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGI  164 (291)
Q Consensus        85 ~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~  164 (291)
                      +  .+....++||||++++|.+.+.....       ..+++..++.++.|++.||+|||++|++|+||||+||+++..+.
T Consensus        86 ~--~~~~~~~lv~e~~~~~l~~~l~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~  156 (339)
T 1z57_A           86 F--EHHGHICIVFELLGLSTYDFIKENGF-------LPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDY  156 (339)
T ss_dssp             E--EETTEEEEEEECCCCBHHHHHHHTTT-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCE
T ss_pred             c--ccCCcEEEEEcCCCCCHHHHHHhcCC-------CCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEecccc
Confidence            9  45669999999999899988875432       12889999999999999999999999999999999999974321


Q ss_pred             C---------------CCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc
Q psy2172         165 E---------------RGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT  229 (291)
Q Consensus       165 ~---------------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~  229 (291)
                      .               .+.++|+|||.+......      .....||..|+|||++.+.. ++.++||||||+++|+|++
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~  229 (339)
T 1z57_A          157 TEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH------HSTLVSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYL  229 (339)
T ss_dssp             EEEEC----CEEEEESCCCEEECCCSSCEETTSC------CCSSCSCGGGCCHHHHTTSC-CCTHHHHHHHHHHHHHHHH
T ss_pred             ccccCCccccccccccCCCceEeeCcccccCccc------cccccCCccccChHHhhCCC-CCcchhhHHHHHHHHHHHh
Confidence            0               567999999999864432      23457799999999998754 8999999999999999999


Q ss_pred             CCCCCCCCccccc-----------------------------------------------------CCCCCcHHHHHHHH
Q psy2172         230 SEPIFHCRQEDIK-----------------------------------------------------TSNPYHHDQLDRIF  256 (291)
Q Consensus       230 g~~pf~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~i~  256 (291)
                      |..||........                                                     .......+.+.+++
T Consensus       230 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  309 (339)
T 1z57_A          230 GFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLI  309 (339)
T ss_dssp             SSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHH
T ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHH
Confidence            9999987543210                                                     00111235678999


Q ss_pred             HhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         257 SVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                      ..|..+.|..||++.++..+||+..
T Consensus       310 ~~~L~~dP~~Rpt~~ell~hp~f~~  334 (339)
T 1z57_A          310 QKMLEYDPAKRITLREALKHPFFDL  334 (339)
T ss_dssp             HHHTCSSTTTSCCHHHHTTSGGGGG
T ss_pred             HHHhCcCcccccCHHHHhcCHHHHH
Confidence            9999999999999999999998863

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=3.5e-41  Score=287.61  Aligned_cols=248  Identities=24%  Similarity=0.370  Sum_probs=199.2

Q ss_pred             cccccc-cccccccceeCcccceEEEEEEEc--cCCCCceeEEEEeCCCCCC--hhHHHHHHHHhcCCCCCeeeEEEEEE
Q psy2172          12 ERTKVE-DLFDYEGCKVGRGTYGHVYKARRK--DNSDTRDYALKQIEGTGLS--MSACREIALLRELKHPNVINLISVFL   86 (291)
Q Consensus        12 ~~~~~~-~~~~~~~~~ig~G~~g~Vy~~~~~--~~~~~~~vaiK~~~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~   86 (291)
                      ..+.+. ++|++ .+.||+|+||.||+|.+.  +..+++.||+|++......  +.+.+|+.++++++||||+++++++.
T Consensus        16 ~~~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   94 (327)
T 3lxl_A           16 DPTIFEERHLKY-ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSY   94 (327)
T ss_dssp             -CCBCCGGGEEE-EEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             hhhhhchhhhhh-hhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEe
Confidence            334443 45554 779999999999999853  2336788999999765332  35889999999999999999999997


Q ss_pred             eCCCceEEEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCC
Q psy2172          87 SHNDRKVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIE  165 (291)
Q Consensus        87 ~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~  165 (291)
                      ..+....++||||++ ++|.+++......        +++..++.++.|++.||++||++|++|+||||+||+++    .
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~----~  162 (327)
T 3lxl_A           95 GPGRQSLRLVMEYLPSGCLRDFLQRHRAR--------LDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVE----S  162 (327)
T ss_dssp             CSSSCEEEEEEECCTTCBHHHHHHHHGGG--------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE----E
T ss_pred             cCCCceEEEEEeecCCCCHHHHHHhcccC--------CCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEEC----C
Confidence            777888999999996 5888888754332        89999999999999999999999999999999999998    6


Q ss_pred             CCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc----
Q psy2172         166 RGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI----  241 (291)
Q Consensus       166 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~----  241 (291)
                      ++.++|+|||.+.................++..|+|||.+.+.. ++.++||||||+++|+|++|..||.......    
T Consensus       163 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~  241 (327)
T 3lxl_A          163 EAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI-FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM  241 (327)
T ss_dssp             TTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC
T ss_pred             CCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCC-CChHHhHHHHHHHHHHHHhCCCCCccccchhhhhc
Confidence            67899999999987765433333344556788899999997754 7899999999999999999999986544320    


Q ss_pred             ---------------------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         242 ---------------------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       242 ---------------------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                                           ........+.+.+++..|..+.|..||++.++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el  294 (327)
T 3lxl_A          242 GCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL  294 (327)
T ss_dssp             C----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             ccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHH
Confidence                                 11223345678899999999999999988763

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.9e-41  Score=292.18  Aligned_cols=249  Identities=32%  Similarity=0.521  Sum_probs=199.7

Q ss_pred             ecccccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC----hhHHHHHHHHhcCCCCCeeeEEEE
Q psy2172           9 TSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIALLRELKHPNVINLISV   84 (291)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~   84 (291)
                      .......+.+.|.+ .+.||+|+||.||+|.++.  +++.||||.+......    ..+.+|+.+++.++||||++++++
T Consensus        15 ~~~~~~~l~~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   91 (353)
T 3coi_A           15 VNKTAWELPKTYVS-PTHVGSGAYGSVCSAIDKR--SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV   91 (353)
T ss_dssp             ETTEEEEEETTEEE-EEEEEECSSEEEEEEEETT--TTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred             ecCcccccCceEEE-eeeEecCCCeEEEEEEECC--CCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhhe
Confidence            33445567788885 7799999999999999876  7789999999754332    357789999999999999999999


Q ss_pred             EEeCCC----ceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEee
Q psy2172          85 FLSHND----RKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVM  160 (291)
Q Consensus        85 ~~~~~~----~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~  160 (291)
                      +...+.    ...|++|||++++|.+.+.           ..+++..++.++.|++.||++||++|++|+||||+||+++
T Consensus        92 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~-----------~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~  160 (353)
T 3coi_A           92 FTPASSLRNFYDFYLVMPFMQTDLQKIMG-----------LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN  160 (353)
T ss_dssp             ECSCSSGGGCCCCEEEEECCSEEGGGTTT-----------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC
T ss_pred             EecccccccceeEEEEeccccCCHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeEC
Confidence            953322    2469999999987765542           1289999999999999999999999999999999999998


Q ss_pred             cCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc
Q psy2172         161 GEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED  240 (291)
Q Consensus       161 ~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~  240 (291)
                          .++.++|+|||.+......      .....++..|+|||.+.+...++.++||||||+++|+|++|..||.+....
T Consensus       161 ----~~~~~kl~Dfg~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  230 (353)
T 3coi_A          161 ----EDCELKILDFGLARHADAE------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL  230 (353)
T ss_dssp             ----TTCCEEECSTTCTTC--------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH
T ss_pred             ----CCCcEEEeecccccCCCCC------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence                6779999999998754332      234567899999999987556899999999999999999999999875421


Q ss_pred             ----------------------------------------ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchh
Q psy2172         241 ----------------------------------------IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLL  280 (291)
Q Consensus       241 ----------------------------------------~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  280 (291)
                                                              .....+.....+.+++..|..+.|..||++.++..|||+.
T Consensus       231 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~  310 (353)
T 3coi_A          231 DQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE  310 (353)
T ss_dssp             HHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred             HHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchh
Confidence                                                    0111123457789999999999999999999999999875


Q ss_pred             h
Q psy2172         281 K  281 (291)
Q Consensus       281 ~  281 (291)
                      .
T Consensus       311 ~  311 (353)
T 3coi_A          311 P  311 (353)
T ss_dssp             T
T ss_pred             h
Confidence            3

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=8.4e-42  Score=295.84  Aligned_cols=254  Identities=18%  Similarity=0.267  Sum_probs=197.3

Q ss_pred             ccccccccceeCcccceEEEEEEEcc---CCCCceeEEEEeCCCCCC---hhHHHHHHHHhcCCCCCeeeEEEEEEeCCC
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKD---NSDTRDYALKQIEGTGLS---MSACREIALLRELKHPNVINLISVFLSHND   90 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~---~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   90 (291)
                      .+.|.+ .++||+|+||.||+|.+.+   ..+++.||||.++.....   ..+.+|+.++++++||||+++++++  .+.
T Consensus        70 ~~~~~~-~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~--~~~  146 (367)
T 3l9p_A           70 RKNITL-IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS--LQS  146 (367)
T ss_dssp             GGGEEE-EEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--CSS
T ss_pred             HhHeEE-eeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEE--ecC
Confidence            355664 6799999999999999653   235678999999754322   3578899999999999999999999  556


Q ss_pred             ceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcE
Q psy2172          91 RKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRV  169 (291)
Q Consensus        91 ~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~  169 (291)
                      ...++||||+.+ +|.+++.......  .....+++..++.++.|++.||+|||++||+|+||||+||+++.++ ....+
T Consensus       147 ~~~~lv~e~~~~g~L~~~l~~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-~~~~~  223 (367)
T 3l9p_A          147 LPRFILLELMAGGDLKSFLRETRPRP--SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG-PGRVA  223 (367)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHSCCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS-TTCCE
T ss_pred             CCCEEEEEeCCCCCHHHHHHhhcccc--CccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCC-CCceE
Confidence            678999999965 9988887654221  1122388999999999999999999999999999999999998543 34569


Q ss_pred             EEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc--------
Q psy2172         170 KIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED--------  240 (291)
Q Consensus       170 ~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~--------  240 (291)
                      +|+|||+++....... ........||+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....        
T Consensus       224 kL~DFG~a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~  301 (367)
T 3l9p_A          224 KIGDFGMARDIYRAGY-YRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS  301 (367)
T ss_dssp             EECCCHHHHHHHHHSS-CTTCCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred             EECCCccccccccccc-cccCCCcCCcccEECHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            9999999975432211 12233456788999999997744 8999999999999999998 99999876542        


Q ss_pred             --ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcc
Q psy2172         241 --IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPT  278 (291)
Q Consensus       241 --~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  278 (291)
                        ...........+.+++..|....|..||++.++.++.+
T Consensus       302 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~  341 (367)
T 3l9p_A          302 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE  341 (367)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence              11223344567889999999999999999887654433

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.7e-41  Score=280.54  Aligned_cols=234  Identities=20%  Similarity=0.351  Sum_probs=189.4

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLL   96 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv   96 (291)
                      +.|++ .+.||+|+||.||+|.+.   +++.||+|.+.... ..+.+.+|+.++++++||||+++++++  .+....++|
T Consensus        10 ~~y~~-~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~~~lv   83 (269)
T 4hcu_A           10 SELTF-VQEIGSGQFGLVHLGYWL---NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC--LEQAPICLV   83 (269)
T ss_dssp             GGEEE-EEEEEECSSCEEEEEEET---TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEE--CSSSSEEEE
T ss_pred             hhcee-eheecCCCccEEEEEEec---CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEE--ecCCceEEE
Confidence            45564 679999999999999976   35679999998654 345689999999999999999999999  567789999


Q ss_pred             EecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecc
Q psy2172          97 FDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMG  175 (291)
Q Consensus        97 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg  175 (291)
                      |||+++ +|.+.+.....        .+++..++.++.|++.||++||++|++|+||||+||+++    .++.++|+|||
T Consensus        84 ~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~----~~~~~kl~Dfg  151 (269)
T 4hcu_A           84 FEFMEHGCLSDYLRTQRG--------LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG----ENQVIKVSDFG  151 (269)
T ss_dssp             EECCTTCBHHHHHHTTTT--------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----GGGCEEECCTT
T ss_pred             EEeCCCCcHHHHHHhcCc--------ccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEc----CCCCEEecccc
Confidence            999975 78777754321        289999999999999999999999999999999999998    66789999999


Q ss_pred             cceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc----------ccCC
Q psy2172         176 FARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED----------IKTS  244 (291)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~----------~~~~  244 (291)
                      ++........  .......++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||.+....          ....
T Consensus       152 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~  228 (269)
T 4hcu_A          152 MTRFVLDDQY--TSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK  228 (269)
T ss_dssp             GGGGBCCHHH--HSTTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC
T ss_pred             cccccccccc--ccccCcccccccCCHHHhcCCC-CCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCC
Confidence            9976543211  1223345577899999997644 8999999999999999999 99999876532          1122


Q ss_pred             CCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         245 NPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       245 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      .....+.+.+++..|..+.|..||++.+
T Consensus       229 ~~~~~~~~~~li~~~l~~~p~~Rps~~~  256 (269)
T 4hcu_A          229 PRLASTHVYQIMNHCWRERPEDRPAFSR  256 (269)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCcCCHHHHHHHHHHccCCcccCcCHHH
Confidence            2334577888999999999988888775

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3.5e-41  Score=284.29  Aligned_cols=251  Identities=22%  Similarity=0.392  Sum_probs=197.6

Q ss_pred             ccccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC--CChhHHHHHHHHhcCCCCCeeeEEEEEEeC
Q psy2172          11 NERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG--LSMSACREIALLRELKHPNVINLISVFLSH   88 (291)
Q Consensus        11 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   88 (291)
                      .......++|++ .+.||+|+||.||+|.+..  +++.||+|++....  ....+.+|+.+++.++||||+++++++.  
T Consensus        12 ~~~~~~~~~y~i-~~~lg~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--   86 (302)
T 2j7t_A           12 RRDLDPNEVWEI-VGELGDGAFGKVYKAKNKE--TGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY--   86 (302)
T ss_dssp             BSSSCGGGTEEE-EEEEECSTTCCEEEEEETT--TCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEE--
T ss_pred             ccccCCccceee-cceeccCCCeEEEEEEEcC--CCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeee--
Confidence            344566778886 6699999999999999876  67889999986542  3357889999999999999999999994  


Q ss_pred             CCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCC
Q psy2172          89 NDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERG  167 (291)
Q Consensus        89 ~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~  167 (291)
                      +....++||||+++ +|...+.....        .+++..++.++.|++.||.+||++|++|+||||+||+++    .++
T Consensus        87 ~~~~~~lv~e~~~~~~l~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~----~~~  154 (302)
T 2j7t_A           87 HDGKLWIMIEFCPGGAVDAIMLELDR--------GLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMT----LEG  154 (302)
T ss_dssp             CC-CEEEEEECCTTEEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC----TTS
T ss_pred             eCCeEEEEEEeCCCCcHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEC----CCC
Confidence            46689999999986 66666654321        289999999999999999999999999999999999998    667


Q ss_pred             cEEEeecccceecCCCCCCCCCCCCceeccccccccccc----CCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc--
Q psy2172         168 RVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLL----GARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI--  241 (291)
Q Consensus       168 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~----~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~--  241 (291)
                      .++|+|||.+.......   .......|+..|+|||.+.    ....++.++|+||||+++|+|++|..||.......  
T Consensus       155 ~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~  231 (302)
T 2j7t_A          155 DIRLADFGVSAKNLKTL---QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL  231 (302)
T ss_dssp             CEEECCCHHHHHHHHHH---HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred             CEEEEECCCCccccccc---cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH
Confidence            89999999875432110   1113346789999999984    23458899999999999999999999998754310  


Q ss_pred             ----------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         242 ----------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       242 ----------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                                ..........+.+++..|..+.|..||++.++.++|++..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  281 (302)
T 2j7t_A          232 LKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSS  281 (302)
T ss_dssp             HHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTT
T ss_pred             HHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhh
Confidence                      1112233567899999999999999999999999998764

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=3.3e-41  Score=283.17  Aligned_cols=238  Identities=17%  Similarity=0.273  Sum_probs=189.8

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC----ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL----SMSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      +.|.+..+.||+|+||.||+|.+.....++.||+|+++....    .+.+.+|+.+++.++||||+++++++  . ....
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~-~~~~   92 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC--E-AESW   92 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE--E-SSSE
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE--C-CCCc
Confidence            456655559999999999999876655778899999975432    34688999999999999999999998  2 4468


Q ss_pred             EEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          94 WLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        94 ~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      ++||||+.+ +|.+.+.....         +++..++.++.|++.||++||++|++|+||||+||+++    .++.++|+
T Consensus        93 ~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~----~~~~~kl~  159 (291)
T 1xbb_A           93 MLVMEMAELGPLNKYLQQNRH---------VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV----TQHYAKIS  159 (291)
T ss_dssp             EEEEECCTTEEHHHHHHHCTT---------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE----ETTEEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhCcC---------CCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEe----CCCcEEEc
Confidence            899999984 88888765321         88999999999999999999999999999999999999    66799999


Q ss_pred             ecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc----------c
Q psy2172         173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED----------I  241 (291)
Q Consensus       173 Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~----------~  241 (291)
                      |||++.................++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+....          .
T Consensus       160 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~  238 (291)
T 1xbb_A          160 DFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER  238 (291)
T ss_dssp             CCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC
T ss_pred             cCCcceeeccCCCcccccccCCCCceeeChHHhccCC-CChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC
Confidence            9999987655432222223345578899999997644 7889999999999999999 99999875432          1


Q ss_pred             cCCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         242 KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       242 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      ..........+.+++..|..+.|..||++.+
T Consensus       239 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  269 (291)
T 1xbb_A          239 MGCPAGCPREMYDLMNLCWTYDVENRPGFAA  269 (291)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            1223344677899999999999999998775

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.1e-40  Score=281.39  Aligned_cols=242  Identities=20%  Similarity=0.295  Sum_probs=190.7

Q ss_pred             ccccccccceeCcccceEEEEEEEc--cCCCCceeEEEEeCCCC---CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCc
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRK--DNSDTRDYALKQIEGTG---LSMSACREIALLRELKHPNVINLISVFLSHNDR   91 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~--~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (291)
                      .+.|++ .++||+|+||.||+|.+.  +..+++.||+|++....   ....+.+|+.+++.++||||+++++++...+..
T Consensus        20 ~~~~~~-~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   98 (302)
T 4e5w_A           20 KRFLKR-IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   98 (302)
T ss_dssp             GGGEEE-EEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred             hhhhhh-hhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence            344554 779999999999999853  23377889999987442   235688999999999999999999999766567


Q ss_pred             eEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEE
Q psy2172          92 KVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVK  170 (291)
Q Consensus        92 ~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~  170 (291)
                      ..++||||+++ +|.+.+......        +++..++.++.|++.||++||++|++|+||||+||+++    .++.++
T Consensus        99 ~~~lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~----~~~~~k  166 (302)
T 4e5w_A           99 GIKLIMEFLPSGSLKEYLPKNKNK--------INLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE----SEHQVK  166 (302)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHTTT--------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE----ETTEEE
T ss_pred             eEEEEEEeCCCCcHHHHHHhcccc--------CCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEc----CCCCEE
Confidence            89999999975 888888554321        89999999999999999999999999999999999998    667999


Q ss_pred             EeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc----------
Q psy2172         171 IADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED----------  240 (291)
Q Consensus       171 l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~----------  240 (291)
                      |+|||.+.................|+..|+|||.+.+.. ++.++|+||||+++|+|++|..|+......          
T Consensus       167 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  245 (302)
T 4e5w_A          167 IGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHG  245 (302)
T ss_dssp             ECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCG
T ss_pred             ECcccccccccCCCcceeccCCCCCCccccCCeeecCCC-CCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCccc
Confidence            999999987765443333344567788899999997754 789999999999999999999886433110          


Q ss_pred             ---------------ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         241 ---------------IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       241 ---------------~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                                     .........+.+.+++..|..+.|..||++.+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  292 (302)
T 4e5w_A          246 QMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQN  292 (302)
T ss_dssp             GGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred             ccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHH
Confidence                           11122334567889999999999988888775

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.1e-41  Score=290.11  Aligned_cols=248  Identities=24%  Similarity=0.408  Sum_probs=196.6

Q ss_pred             cccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC----------CChhHHHHHHHHhcCCCCCeeeEEE
Q psy2172          14 TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG----------LSMSACREIALLRELKHPNVINLIS   83 (291)
Q Consensus        14 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~e~~~l~~l~h~~iv~~~~   83 (291)
                      ..+.+.|.+ .+.||+|+||.||+|.++.  +++.||||++....          ....+.+|+.++++++||||+++++
T Consensus         6 ~~l~~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~   82 (322)
T 2ycf_A            6 KALRDEYIM-SKTLGSGACGEVKLAFERK--TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKN   82 (322)
T ss_dssp             HHHHHHEEE-EEEEEECSSEEEEEEEETT--TTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEE
T ss_pred             hhhhhceeE-eeEEecCCCEEEEEEEEcC--CCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEee
Confidence            456677885 6799999999999999876  67889999986432          1235789999999999999999999


Q ss_pred             EEEeCCCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecC
Q psy2172          84 VFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGE  162 (291)
Q Consensus        84 ~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~  162 (291)
                      ++.  .. ..|+||||+.+ +|.+.+....         .+++..++.++.|++.||.+||++|++|+||||+||+++.+
T Consensus        83 ~~~--~~-~~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~  150 (322)
T 2ycf_A           83 FFD--AE-DYYIVLELMEGGELFDKVVGNK---------RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ  150 (322)
T ss_dssp             EEE--SS-SEEEEEECCTTEETHHHHSTTC---------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSS
T ss_pred             EEc--CC-ceEEEEecCCCCcHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecC
Confidence            983  23 38999999975 8877664321         28999999999999999999999999999999999999843


Q ss_pred             CCCCCcEEEeecccceecCCCCCCCCCCCCceeccccccccccc--CCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc
Q psy2172         163 GIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLL--GARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED  240 (291)
Q Consensus       163 ~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~  240 (291)
                      + ....++|+|||.+.......    ......|+..|+|||.+.  +...++.++||||||+++|+|++|..||......
T Consensus       151 ~-~~~~~kl~Dfg~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  225 (322)
T 2ycf_A          151 E-EDCLIKITDFGHSKILGETS----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ  225 (322)
T ss_dssp             S-SSCCEEECCCTTCEECCCCH----HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS
T ss_pred             C-CCCeEEEccCccceeccccc----ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH
Confidence            3 34469999999998654321    112346788999999974  2345889999999999999999999999865432


Q ss_pred             ccC----------C----CCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         241 IKT----------S----NPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       241 ~~~----------~----~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                      ...          .    .......+.+++..|..+.|..||++.++..+||+..
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~  280 (322)
T 2ycf_A          226 VSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  280 (322)
T ss_dssp             SCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred             HHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence            110          0    0123467889999999999999999999999999764

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2e-41  Score=292.88  Aligned_cols=249  Identities=22%  Similarity=0.347  Sum_probs=201.9

Q ss_pred             ccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCC
Q psy2172          13 RTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHN   89 (291)
Q Consensus        13 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   89 (291)
                      .....+.|++ .+.||+|+||.||+|.+..  +++.||+|++.....   ...+.+|+.+++.++||||+++++++.  +
T Consensus        28 ~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~  102 (360)
T 3eqc_A           28 GELKDDDFEK-ISELGAGNGGVVFKVSHKP--SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY--S  102 (360)
T ss_dssp             CCCCGGGEEE-EEEEEECSSCEEEEEEETT--TCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEE--E
T ss_pred             ccccccccee-eeeecCCCCeEEEEEEECC--CCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEE--E
Confidence            3445667775 6799999999999999876  678899999875432   245789999999999999999999994  4


Q ss_pred             CceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CeeeeccCCCcEEeecCCCCCC
Q psy2172          90 DRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSN-WVLHRDLKPANILVMGEGIERG  167 (291)
Q Consensus        90 ~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~-~ivH~dik~~Nil~~~~~~~~~  167 (291)
                      ....++||||+++ +|.+.+.....         +++..+..++.|++.||.|||++ ||+|+||||+||+++    .++
T Consensus       103 ~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~----~~~  169 (360)
T 3eqc_A          103 DGEISICMEHMDGGSLDQVLKKAGR---------IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN----SRG  169 (360)
T ss_dssp             TTEEEEEECCCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEEC----TTC
T ss_pred             CCEEEEEEECCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEEC----CCC
Confidence            6689999999975 88888865432         89999999999999999999996 999999999999998    667


Q ss_pred             cEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc------
Q psy2172         168 RVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI------  241 (291)
Q Consensus       168 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~------  241 (291)
                      .++|+|||++......     ......|++.|+|||++.+.. ++.++||||||+++|+|++|..||.......      
T Consensus       170 ~~kl~Dfg~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~  243 (360)
T 3eqc_A          170 EIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFG  243 (360)
T ss_dssp             CEEECCCCCCHHHHHH-----C----CCCCTTCCHHHHTTCC-CSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC
T ss_pred             CEEEEECCCCcccccc-----cccCCCCCCCeECHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc
Confidence            8999999998654321     123356789999999998754 8999999999999999999999997644210      


Q ss_pred             -----------------------------------------------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCC
Q psy2172         242 -----------------------------------------------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMP  274 (291)
Q Consensus       242 -----------------------------------------------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  274 (291)
                                                                     ..........+.+++..|..+.|..||++.++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell  323 (360)
T 3eqc_A          244 CQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM  323 (360)
T ss_dssp             ------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred             ccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHh
Confidence                                                           001112345688999999999999999999999


Q ss_pred             CCcchhhhhhh
Q psy2172         275 EHPTLLKDFNE  285 (291)
Q Consensus       275 ~~~~~~~~~~~  285 (291)
                      .|||+...-.+
T Consensus       324 ~hp~~~~~~~~  334 (360)
T 3eqc_A          324 VHAFIKRSDAE  334 (360)
T ss_dssp             TSHHHHHHHHS
T ss_pred             hChHhhcchHh
Confidence            99998765443

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-40  Score=283.81  Aligned_cols=251  Identities=22%  Similarity=0.400  Sum_probs=198.9

Q ss_pred             cccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC-CCChhHHHHHHHHhcC-CCCCeeeEEEEEEeCC--
Q psy2172          14 TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-GLSMSACREIALLREL-KHPNVINLISVFLSHN--   89 (291)
Q Consensus        14 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~--   89 (291)
                      ....++|++ .+.||+|+||.||+|.+..  +++.||+|++... .....+.+|+.+++++ +||||+++++++....  
T Consensus        20 ~~~~~~y~~-~~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   96 (326)
T 2x7f_A           20 RDPAGIFEL-VELVGNGTYGQVYKGRHVK--TGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP   96 (326)
T ss_dssp             CCCTTTEEE-EEEEEEETTEEEEEEEETT--TCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred             cCCCCcEEE-EEEeccCCCEEEEEEEECC--CCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence            345677875 7799999999999999876  6788999998643 3456788999999999 7999999999996543  


Q ss_pred             --CceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCC
Q psy2172          90 --DRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIER  166 (291)
Q Consensus        90 --~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~  166 (291)
                        ....++||||+++ +|.+++......       .+++..++.++.|++.||.+||++|++|+||||+||+++    .+
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~----~~  165 (326)
T 2x7f_A           97 GMDDQLWLVMEFCGAGSVTDLIKNTKGN-------TLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT----EN  165 (326)
T ss_dssp             CCCCEEEEEEECCTTEEHHHHHHHSGGG-------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC----TT
T ss_pred             cccceEEEEEEcCCCCcHHHHHHhcccC-------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEc----CC
Confidence              5689999999986 888888764322       289999999999999999999999999999999999998    67


Q ss_pred             CcEEEeecccceecCCCCCCCCCCCCceecccccccccccC----CcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc--
Q psy2172         167 GRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLG----ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED--  240 (291)
Q Consensus       167 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~--  240 (291)
                      +.++|+|||++.......   .......|+..|+|||.+.+    ...++.++||||||+++|+|++|..||.+....  
T Consensus       166 ~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~  242 (326)
T 2x7f_A          166 AEVKLVDFGVSAQLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA  242 (326)
T ss_dssp             CCEEECCCTTTC----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred             CCEEEeeCcCceecCcCc---cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH
Confidence            789999999987654321   12234568999999999862    234889999999999999999999999765421  


Q ss_pred             ---------ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         241 ---------IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       241 ---------~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                               ...........+.+++..|..+.|..||++.++..+|++.+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~  292 (326)
T 2x7f_A          243 LFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD  292 (326)
T ss_dssp             HHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHC
T ss_pred             HHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhh
Confidence                     11122334578999999999999999999999999988764

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.8e-41  Score=288.58  Aligned_cols=254  Identities=22%  Similarity=0.368  Sum_probs=204.1

Q ss_pred             eecccccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC--------CChhHHHHHHHHhcCC--CCC
Q psy2172           8 KTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG--------LSMSACREIALLRELK--HPN   77 (291)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~e~~~l~~l~--h~~   77 (291)
                      ........+.+.|.+ ++.||+|+||.||+|.+..  +++.||+|++....        ....+.+|+.++++++  |+|
T Consensus        33 ~~~~~~~~~~~~y~~-~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~  109 (320)
T 3a99_A           33 APGKEKEPLESQYQV-GPLLGSGGFGSVYSGIRVS--DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG  109 (320)
T ss_dssp             -------CCTTTEEE-EEECSSSSSCEEEEEEETT--TTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCS
T ss_pred             CcccccCCccCceEE-EEEEeeCCCeEEEEEEECC--CCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCC
Confidence            344556678888886 7799999999999999876  67899999986432        2245778999999996  599


Q ss_pred             eeeEEEEEEeCCCceEEEEEecCC--CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCC
Q psy2172          78 VINLISVFLSHNDRKVWLLFDYAE--HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPA  155 (291)
Q Consensus        78 iv~~~~~~~~~~~~~~~iv~e~~~--~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~  155 (291)
                      |+++++++  .+....++++|++.  ++|.+.+.....         +++..++.++.|++.||++||++||+|+||||+
T Consensus       110 i~~~~~~~--~~~~~~~lv~e~~~~~~~L~~~l~~~~~---------l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~  178 (320)
T 3a99_A          110 VIRLLDWF--ERPDSFVLILERPEPVQDLFDFITERGA---------LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDE  178 (320)
T ss_dssp             BCCEEEEE--ECSSEEEEEEECCSSEEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred             ceEEEEEE--ecCCcEEEEEEcCCCCccHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHH
Confidence            99999999  55678999999997  588888765322         899999999999999999999999999999999


Q ss_pred             cEEeecCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCC
Q psy2172         156 NILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH  235 (291)
Q Consensus       156 Nil~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~  235 (291)
                      ||+++.   ..+.++|+|||++......     ......|+..|+|||.+.+....+.++||||||+++|+|++|..||.
T Consensus       179 NIll~~---~~~~~kL~Dfg~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~  250 (320)
T 3a99_A          179 NILIDL---NRGELKLIDFGSGALLKDT-----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE  250 (320)
T ss_dssp             GEEEET---TTTEEEECCCTTCEECCSS-----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             HEEEeC---CCCCEEEeeCccccccccc-----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCC
Confidence            999973   3468999999999876542     22345689999999998765545788999999999999999999997


Q ss_pred             CCccc---ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhhh
Q psy2172         236 CRQED---IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF  283 (291)
Q Consensus       236 ~~~~~---~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (291)
                      .....   .........+.+.+++..|..+.|..||++.++..+|++...+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  301 (320)
T 3a99_A          251 HDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  301 (320)
T ss_dssp             SHHHHHHCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             ChhhhhcccccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence            64421   1122334457789999999999999999999999999876544

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=3.3e-41  Score=286.73  Aligned_cols=245  Identities=20%  Similarity=0.242  Sum_probs=195.6

Q ss_pred             cccccccccccceeCcccceEEEEEEEc--cCCCCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeC
Q psy2172          14 TKVEDLFDYEGCKVGRGTYGHVYKARRK--DNSDTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSH   88 (291)
Q Consensus        14 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~--~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   88 (291)
                      ..+.++|....++||+|+||.||++.++  +..+++.||+|++.....   ...+.+|+.++++++||||+++++++...
T Consensus        26 ~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (318)
T 3lxp_A           26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA  105 (318)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             ceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence            4466677335789999999999998763  233678899999986543   23578999999999999999999999776


Q ss_pred             CCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCC
Q psy2172          89 NDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERG  167 (291)
Q Consensus        89 ~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~  167 (291)
                      +....++||||+++ +|.+.+....          +++..++.++.|++.||++||++|++|+||||+||+++    .++
T Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~----~~~  171 (318)
T 3lxp_A          106 GAASLQLVMEYVPLGSLRDYLPRHS----------IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLD----NDR  171 (318)
T ss_dssp             TTTEEEEEECCCTTCBHHHHGGGSC----------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTC
T ss_pred             CCceEEEEEecccCCcHHHHHhhCC----------CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEc----CCC
Confidence            67899999999975 8877764321          89999999999999999999999999999999999998    677


Q ss_pred             cEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc-------
Q psy2172         168 RVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED-------  240 (291)
Q Consensus       168 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~-------  240 (291)
                      .++|+|||.+.................++..|+|||.+.+.. ++.++||||||+++|+|++|..||......       
T Consensus       172 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~  250 (318)
T 3lxp_A          172 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI  250 (318)
T ss_dssp             CEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCS
T ss_pred             CEEECCccccccccccccccccccCCCCCceeeChHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcc
Confidence            899999999987765433222334456788899999998754 789999999999999999999999764321       


Q ss_pred             ------------------ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         241 ------------------IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       241 ------------------~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                                        ...........+.+++..|..+.|..||++.++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el  301 (318)
T 3lxp_A          251 AQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENL  301 (318)
T ss_dssp             CCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             cccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHH
Confidence                              111223345778999999999999999988764

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.3e-41  Score=292.90  Aligned_cols=243  Identities=25%  Similarity=0.431  Sum_probs=197.7

Q ss_pred             cccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC----------ChhHHHHHHHHhcC-CCCCeeeEEEE
Q psy2172          16 VEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL----------SMSACREIALLREL-KHPNVINLISV   84 (291)
Q Consensus        16 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----------~~~~~~e~~~l~~l-~h~~iv~~~~~   84 (291)
                      +.+.|.+ .+.||+|+||.||+|.++.  +++.||||+++....          ...+.+|+.+++++ +||||++++++
T Consensus        92 ~~~~y~~-~~~lg~G~~g~Vy~a~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  168 (365)
T 2y7j_A           92 FYQKYDP-KDVIGRGVSSVVRRCVHRA--TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS  168 (365)
T ss_dssp             HHHHEEE-EEEEEECSSEEEEEEEETT--TCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             hhhhccc-ceEEecCCCEEEEEEEECC--CCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            4456664 5799999999999999876  678899999865431          23467899999999 79999999999


Q ss_pred             EEeCCCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCC
Q psy2172          85 FLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEG  163 (291)
Q Consensus        85 ~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~  163 (291)
                      +  ......|+||||+++ +|.+.+....         .+++..++.++.|++.||.|||+.|++|+||||+||+++   
T Consensus       169 ~--~~~~~~~lv~e~~~g~~L~~~l~~~~---------~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~---  234 (365)
T 2y7j_A          169 Y--ESSSFMFLVFDLMRKGELFDYLTEKV---------ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLD---  234 (365)
T ss_dssp             E--EBSSEEEEEECCCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---
T ss_pred             E--eeCCEEEEEEEeCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---
Confidence            8  557789999999986 8888776432         189999999999999999999999999999999999998   


Q ss_pred             CCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCC-----cCCCCchhHHHHHHHHHHHHcCCCCCCCCc
Q psy2172         164 IERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGA-----RHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  238 (291)
Q Consensus       164 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~  238 (291)
                       .++.++|+|||++.......    ......||+.|+|||++.+.     ..++.++||||||+++|+|++|..||.+..
T Consensus       235 -~~~~ikl~DfG~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~  309 (365)
T 2y7j_A          235 -DNMQIRLSDFGFSCHLEPGE----KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR  309 (365)
T ss_dssp             -TTCCEEECCCTTCEECCTTC----CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             -CCCCEEEEecCcccccCCCc----ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC
Confidence             67899999999998765432    22346789999999998632     247889999999999999999999997654


Q ss_pred             cccc-------CCC------CCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchh
Q psy2172         239 EDIK-------TSN------PYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLL  280 (291)
Q Consensus       239 ~~~~-------~~~------~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  280 (291)
                      ....       ...      ......+.+++..|..+.|..||++.++..+||+.
T Consensus       310 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~  364 (365)
T 2y7j_A          310 QILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE  364 (365)
T ss_dssp             HHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred             HHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence            3110       000      12235588999999999999999999999999874

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.3e-40  Score=286.85  Aligned_cols=253  Identities=23%  Similarity=0.388  Sum_probs=202.7

Q ss_pred             cccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-CChhHHHHHHHHhcCCCCC------eeeEEEE
Q psy2172          12 ERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-LSMSACREIALLRELKHPN------VINLISV   84 (291)
Q Consensus        12 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~------iv~~~~~   84 (291)
                      ....+.++|++ .+.||+|+||.||+|.+... .+..||+|+++... ....+.+|+.+++.++|++      ++.++++
T Consensus        13 ~g~~~~~~y~~-~~~lg~G~~g~V~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~   90 (355)
T 2eu9_A           13 IGDWLQERYEI-VGNLGEGTFGKVVECLDHAR-GKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDW   90 (355)
T ss_dssp             TTCEETTTEEE-EEEEEEETTEEEEEEEETTT-TTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEE
T ss_pred             cCceecccEEE-EEEeeccCCeEEEEEEecCC-CceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeee
Confidence            44567788886 67999999999999998652 23689999997542 2345778999999987654      8999998


Q ss_pred             EEeCCCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCC-
Q psy2172          85 FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEG-  163 (291)
Q Consensus        85 ~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~-  163 (291)
                      +  ......++||||+++++.+.+......       .+++..++.++.|++.||+|||++||+|+||||+||+++..+ 
T Consensus        91 ~--~~~~~~~lv~e~~~~~l~~~l~~~~~~-------~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~  161 (355)
T 2eu9_A           91 F--NFHGHMCIAFELLGKNTFEFLKENNFQ-------PYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEF  161 (355)
T ss_dssp             E--EETTEEEEEEECCCCBHHHHHHHTTTC-------CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCE
T ss_pred             e--eeCCeEEEEEeccCCChHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccc
Confidence            8  456689999999999998887654321       289999999999999999999999999999999999994321 


Q ss_pred             --------------CCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc
Q psy2172         164 --------------IERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT  229 (291)
Q Consensus       164 --------------~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~  229 (291)
                                    ...+.++|+|||++......      .....||..|+|||++.+.. ++.++||||||+++|+|++
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~  234 (355)
T 2eu9_A          162 ETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH------HTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYR  234 (355)
T ss_dssp             EEEECCC-CCCEEEESCCCEEECCCTTCEETTSC------CCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccCCCcEEEeecCcccccccc------ccCCcCCCcccCCeeeecCC-CCCccchHHHHHHHHHHHh
Confidence                          15678999999999864432      23457899999999998754 8999999999999999999


Q ss_pred             CCCCCCCCccccc-----------------------------------------------------CCCCCcHHHHHHHH
Q psy2172         230 SEPIFHCRQEDIK-----------------------------------------------------TSNPYHHDQLDRIF  256 (291)
Q Consensus       230 g~~pf~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~i~  256 (291)
                      |..||.+......                                                     .........+.+++
T Consensus       235 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  314 (355)
T 2eu9_A          235 GFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLM  314 (355)
T ss_dssp             SSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHH
Confidence            9999987543210                                                     00111134677999


Q ss_pred             HhhCCCCcCChhhhhcCCCCcchhhh
Q psy2172         257 SVMGFPLEKDWEDIRKMPEHPTLLKD  282 (291)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (291)
                      ..|..+.|..||++.++..+||+...
T Consensus       315 ~~~L~~dP~~Rpt~~e~l~hp~f~~~  340 (355)
T 2eu9_A          315 RRMLEFDPAQRITLAEALLHPFFAGL  340 (355)
T ss_dssp             HHHTCSSTTTSCCHHHHTTSGGGGGC
T ss_pred             HHHhcCChhhCcCHHHHhcChhhcCC
Confidence            99999999999999999999998753

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.2e-40  Score=283.99  Aligned_cols=249  Identities=34%  Similarity=0.618  Sum_probs=199.7

Q ss_pred             ccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC----CCChhHHHHHHHHhcC---CCCCeeeEEEEEEe
Q psy2172          15 KVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT----GLSMSACREIALLREL---KHPNVINLISVFLS   87 (291)
Q Consensus        15 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~   87 (291)
                      ...+.|++ .+.||+|+||.||+|.+.. .+++.||+|++...    .....+.+|+.+++.+   +||||+++++++..
T Consensus         8 ~~~~~y~~-~~~lg~G~~g~V~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~   85 (326)
T 1blx_A            8 RADQQYEC-VAEIGEGAYGKVFKARDLK-NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV   85 (326)
T ss_dssp             CGGGTEEE-EEEEEEETTEEEEEEEETT-TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred             Cchhceee-eeeecccccEEEEEEEecC-CCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence            45577885 6799999999999999852 15678999998632    2234677888887776   89999999999852


Q ss_pred             ---CCCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCC
Q psy2172          88 ---HNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGI  164 (291)
Q Consensus        88 ---~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~  164 (291)
                         ......++||||++++|.+.+......       .+++..++.++.|++.||.+||++|++|+||||+||+++    
T Consensus        86 ~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~----  154 (326)
T 1blx_A           86 SRTDRETKLTLVFEHVDQDLTTYLDKVPEP-------GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT----  154 (326)
T ss_dssp             EECSSEEEEEEEEECCSCBHHHHHHHSCTT-------CSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----
T ss_pred             cccCCCceEEEEEecCCCCHHHHHHhcccC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEc----
Confidence               255689999999999999888754322       288999999999999999999999999999999999998    


Q ss_pred             CCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---
Q psy2172         165 ERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---  241 (291)
Q Consensus       165 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---  241 (291)
                      .++.++|+|||.+......    .......|+..|+|||.+.+.. ++.++||||||+++|+|++|..||.+.....   
T Consensus       155 ~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  229 (326)
T 1blx_A          155 SSGQIKLADFGLARIYSFQ----MALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG  229 (326)
T ss_dssp             TTCCEEECSCCSCCCCCGG----GGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             CCCCEEEecCcccccccCC----CCccccccccceeCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            6679999999998765432    1223456789999999998754 8999999999999999999999998754210   


Q ss_pred             ---------------------------------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         242 ---------------------------------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       242 ---------------------------------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                                                       ....+.....+.+++..|..+.|..||++.++..+|++.+
T Consensus       230 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  302 (326)
T 1blx_A          230 KILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD  302 (326)
T ss_dssp             HHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred             HHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccc
Confidence                                             0011233566788999999999999999999998888753

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.1e-41  Score=294.43  Aligned_cols=247  Identities=19%  Similarity=0.312  Sum_probs=193.9

Q ss_pred             ccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC---CChhHHHHHHHHhcCCCCCeeeEEEEEEeCC
Q psy2172          13 RTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG---LSMSACREIALLRELKHPNVINLISVFLSHN   89 (291)
Q Consensus        13 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   89 (291)
                      .....++|.+ +++||+|+||.||+|.++.  +++.||+|++....   ....+.+|+.++++++||||+++++++...+
T Consensus         4 ~~~~~~~y~i-~~~LG~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~   80 (396)
T 4eut_A            4 QSTSNHLWLL-SDILGQGATANVFRGRHKK--TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT   80 (396)
T ss_dssp             EECSSEEEEE-EEEEEECSSEEEEEEEETT--TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT
T ss_pred             CCCCCCceEE-EEEEEcCCCeEEEEEEECC--CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC
Confidence            3456778885 7799999999999999876  67899999997532   2356789999999999999999999997666


Q ss_pred             CceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCc
Q psy2172          90 DRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGR  168 (291)
Q Consensus        90 ~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~  168 (291)
                      ....++||||+.+ +|.+++......      ..+++..++.++.|++.||+|||++||+|+||||+||++.........
T Consensus        81 ~~~~~lv~e~~~~g~L~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~  154 (396)
T 4eut_A           81 TRHKVLIMEFCPCGSLYTVLEEPSNA------YGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSV  154 (396)
T ss_dssp             TCCEEEEECCCTTEEHHHHTTSGGGT------TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEE
T ss_pred             CCeeEEEEecCCCCCHHHHHHhhhcc------cCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCcee
Confidence            6689999999975 888777643321      128999999999999999999999999999999999998433326678


Q ss_pred             EEEeecccceecCCCCCCCCCCCCceecccccccccccCC-------cCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc
Q psy2172         169 VKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGA-------RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI  241 (291)
Q Consensus       169 ~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-------~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~  241 (291)
                      ++|+|||.+.......    ......||..|+|||++.+.       ..++.++|||||||++|+|++|..||.......
T Consensus       155 ~kL~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~  230 (396)
T 4eut_A          155 YKLTDFGAARELEDDE----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR  230 (396)
T ss_dssp             EEECCGGGCEECCCGG----GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTT
T ss_pred             EEEecCCCceEccCCC----ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCccc
Confidence            9999999998765431    22345689999999998541       236789999999999999999999997533210


Q ss_pred             -----------------------------------c---CCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         242 -----------------------------------K---TSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       242 -----------------------------------~---~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                                                         +   .........+.+++..|....|..|+++.+
T Consensus       231 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e  299 (396)
T 4eut_A          231 RNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ  299 (396)
T ss_dssp             TCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHH
T ss_pred             chHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHH
Confidence                                               0   001123456778888888888888888775

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-40  Score=288.65  Aligned_cols=251  Identities=22%  Similarity=0.356  Sum_probs=197.5

Q ss_pred             cccccccccccceeCcccceEEEEEEEccC-----CCCceeEEEEeCCCCCC---hhHHHHHHHHhcC-CCCCeeeEEEE
Q psy2172          14 TKVEDLFDYEGCKVGRGTYGHVYKARRKDN-----SDTRDYALKQIEGTGLS---MSACREIALLREL-KHPNVINLISV   84 (291)
Q Consensus        14 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~-----~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l-~h~~iv~~~~~   84 (291)
                      ....++|.+ +++||+|+||.||+|.+...     ..+..||+|++......   ..+.+|+.+++++ +||||++++++
T Consensus        65 ~i~~~~y~i-~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~  143 (382)
T 3tt0_A           65 ELPRDRLVL-GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA  143 (382)
T ss_dssp             BCCGGGEEE-EEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccchhheEe-eeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence            334466764 77999999999999997542     13357999999765433   4578999999999 89999999999


Q ss_pred             EEeCCCceEEEEEecCCC-CHHHHHHHhhhhh-------hCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCc
Q psy2172          85 FLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAK-------ANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPAN  156 (291)
Q Consensus        85 ~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~-------~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~N  156 (291)
                      +  .+....++||||+++ +|.+.+.......       .......+++..++.++.|++.||++||++||+|+||||+|
T Consensus       144 ~--~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N  221 (382)
T 3tt0_A          144 C--TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN  221 (382)
T ss_dssp             E--CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             e--ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence            9  566789999999975 9988887654211       00112238999999999999999999999999999999999


Q ss_pred             EEeecCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCC
Q psy2172         157 ILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFH  235 (291)
Q Consensus       157 il~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~  235 (291)
                      |+++    .++.++|+|||++........ ........++..|+|||++.+.. ++.++||||||+++|+|++ |..||.
T Consensus       222 Ill~----~~~~~kL~DFG~a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~ellt~g~~p~~  295 (382)
T 3tt0_A          222 VLVT----EDNVMKIADFGLARDIHHIDY-YKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYP  295 (382)
T ss_dssp             EEEC----TTCCEEECSCSCCCCSSCCCT-TCCCTTCCCGGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             EEEc----CCCcEEEcccCcccccccccc-cccccCCCCCcceeCHHHhcCCC-CCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            9998    667999999999986654321 12233456688999999998744 8999999999999999999 999998


Q ss_pred             CCccc----------ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         236 CRQED----------IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       236 ~~~~~----------~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      +....          .........+.+.+++..|..+.|..||++.++
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el  343 (382)
T 3tt0_A          296 GVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL  343 (382)
T ss_dssp             TCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            75432          112233445778899999999999999887763

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.7e-41  Score=289.36  Aligned_cols=254  Identities=21%  Similarity=0.344  Sum_probs=182.3

Q ss_pred             cccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCCCCeeeEEEEEEe--CC
Q psy2172          12 ERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFLS--HN   89 (291)
Q Consensus        12 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~   89 (291)
                      ....+.+.|.+..+.||+|+||.||+|.++.  +++.||+|++...  ..........++.++||||+++++++..  .+
T Consensus        22 ~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~--~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~   97 (336)
T 3fhr_A           22 KKYAVTDDYQLSKQVLGLGVNGKVLECFHRR--TGQKCALKLLYDS--PKARQEVDHHWQASGGPHIVCILDVYENMHHG   97 (336)
T ss_dssp             BCSCGGGTEEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEESS--HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             CCccccceeEecceeeeeCCCeEEEEEEECC--CCCEEEEEEecCc--HHHHHHHHHHHHhcCCCChHHHHHHHhhccCC
Confidence            4456778888767789999999999999876  6788999998653  2222233345667799999999999843  23


Q ss_pred             CceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCc
Q psy2172          90 DRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGR  168 (291)
Q Consensus        90 ~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~  168 (291)
                      ....++||||+.+ +|.+.+.....       ..+++..++.++.|++.||.|||++|++|+||||+||+++.++ ..+.
T Consensus        98 ~~~~~lv~e~~~gg~L~~~l~~~~~-------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~-~~~~  169 (336)
T 3fhr_A           98 KRCLLIIMECMEGGELFSRIQERGD-------QAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKE-KDAV  169 (336)
T ss_dssp             EEEEEEEEECCTTEEHHHHHHTC-C-------CCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSS-TTCC
T ss_pred             CceEEEEEeccCCCCHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecC-CCce
Confidence            5578999999986 88888764321       1289999999999999999999999999999999999998533 3567


Q ss_pred             EEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc------
Q psy2172         169 VKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK------  242 (291)
Q Consensus       169 ~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~------  242 (291)
                      ++|+|||++......     ......|++.|+|||++.+.. ++.++||||||+++|+|++|..||.+......      
T Consensus       170 ~kl~Dfg~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  243 (336)
T 3fhr_A          170 LKLTDFGFAKETTQN-----ALQTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR  243 (336)
T ss_dssp             EEECCCTTCEEC---------------------------CH-HHHHHHHHHHHHHHHHHHHSSCCC--------------
T ss_pred             EEEeccccceecccc-----ccccCCCCcCccChhhhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH
Confidence            999999999865432     223456799999999997644 88999999999999999999999976543211      


Q ss_pred             -----------CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhhh
Q psy2172         243 -----------TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF  283 (291)
Q Consensus       243 -----------~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (291)
                                 .........+.+++..|..+.|..||++.++..+||+.+..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  295 (336)
T 3fhr_A          244 RIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM  295 (336)
T ss_dssp             -------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred             hhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence                       01123457789999999999999999999999999886543

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1e-40  Score=290.58  Aligned_cols=250  Identities=25%  Similarity=0.402  Sum_probs=199.3

Q ss_pred             ccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-CChhHHHHHHHHhcCC-CC-----CeeeEEEEE
Q psy2172          13 RTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-LSMSACREIALLRELK-HP-----NVINLISVF   85 (291)
Q Consensus        13 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~-h~-----~iv~~~~~~   85 (291)
                      ...+.++|++ .+.||+|+||.||+|.++.  +++.||||+++... ....+.+|+.+++.++ |+     +|+++++++
T Consensus        49 ~~~~~~~y~~-~~~lG~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~  125 (382)
T 2vx3_A           49 GEKWMDRYEI-DSLIGKGSFGQVVKAYDRV--EQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF  125 (382)
T ss_dssp             TCEETTTEEE-EEEEEEETTEEEEEEEETT--TTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred             CCEeeeeEEE-EEEEeecCCEEEEEEEEcC--CCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence            4455677885 6799999999999999876  67889999997542 2345677888888884 44     499999999


Q ss_pred             EeCCCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHh--hCCeeeeccCCCcEEeecCC
Q psy2172          86 LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLH--SNWVLHRDLKPANILVMGEG  163 (291)
Q Consensus        86 ~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH--~~~ivH~dik~~Nil~~~~~  163 (291)
                      .  .....|+||||++++|.+.+......       .+++..++.++.|++.||.+||  +.||+|+||||+||+++.+ 
T Consensus       126 ~--~~~~~~lv~e~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~-  195 (382)
T 2vx3_A          126 M--FRNHLCLVFEMLSYNLYDLLRNTNFR-------GVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNP-  195 (382)
T ss_dssp             E--ETTEEEEEEECCCCBHHHHHHHTTTS-------CCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESST-
T ss_pred             c--cCCceEEEEecCCCCHHHHHhhcCcC-------CCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecC-
Confidence            4  45789999999999999988764321       2889999999999999999999  5799999999999999632 


Q ss_pred             CCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc-
Q psy2172         164 IERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK-  242 (291)
Q Consensus       164 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~-  242 (291)
                       ..+.++|+|||++......      .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+...... 
T Consensus       196 -~~~~~kL~DFG~a~~~~~~------~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~  267 (382)
T 2vx3_A          196 -KRSAIKIVDFGSSCQLGQR------IYQYIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQM  267 (382)
T ss_dssp             -TSCCEEECCCTTCEETTCC------CCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             -CCCcEEEEeccCceecccc------cccccCCccccChHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence             4578999999999876432      23457799999999998755 89999999999999999999999987542100 


Q ss_pred             -----------------------------C---------------CCC----------------------------CcHH
Q psy2172         243 -----------------------------T---------------SNP----------------------------YHHD  250 (291)
Q Consensus       243 -----------------------------~---------------~~~----------------------------~~~~  250 (291)
                                                   .               ..+                            ...+
T Consensus       268 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (382)
T 2vx3_A          268 NKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYL  347 (382)
T ss_dssp             HHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHH
T ss_pred             HHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhH
Confidence                                         0               000                            0013


Q ss_pred             HHHHHHHhhCCCCcCChhhhhcCCCCcchhhhh
Q psy2172         251 QLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF  283 (291)
Q Consensus       251 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (291)
                      .+.+++..|....|..||++.++..|||+.+..
T Consensus       348 ~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~~  380 (382)
T 2vx3_A          348 KFKDLILRMLDYDPKTRIQPYYALQHSFFKKTA  380 (382)
T ss_dssp             HHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC--
T ss_pred             HHHHHHHHhcCCChhhCCCHHHHhcCcccccCC
Confidence            678999999999999999999999999986543

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-41  Score=290.23  Aligned_cols=247  Identities=23%  Similarity=0.345  Sum_probs=197.8

Q ss_pred             cccccccceeCcccceEEEEEEEcc-CCCCceeEEEEeCCC------CCChhHHHHHHHHhcC-CCCCeeeEEEEEEeCC
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKD-NSDTRDYALKQIEGT------GLSMSACREIALLREL-KHPNVINLISVFLSHN   89 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~~~~vaiK~~~~~------~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~   89 (291)
                      +.|.+ .+.||+|+||.||+|.+.. ..+++.||||+++..      .....+.+|+.+++.+ +||||+++++++  ..
T Consensus        54 ~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~--~~  130 (355)
T 1vzo_A           54 ENFEL-LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF--QT  130 (355)
T ss_dssp             GGEEE-EEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE--EE
T ss_pred             cceEE-EEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE--ee
Confidence            46664 6799999999999999843 236788999998642      2345677899999999 699999999999  45


Q ss_pred             CceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCc
Q psy2172          90 DRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGR  168 (291)
Q Consensus        90 ~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~  168 (291)
                      ....++||||+++ +|.+.+....         .+++..++.++.|++.||.|||++||+|+||||+||+++    .++.
T Consensus       131 ~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~----~~~~  197 (355)
T 1vzo_A          131 ETKLHLILDYINGGELFTHLSQRE---------RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD----SNGH  197 (355)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTSC
T ss_pred             CceEEEEeecCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCc
Confidence            6689999999975 8888776432         189999999999999999999999999999999999998    6779


Q ss_pred             EEEeecccceecCCCCCCCCCCCCceecccccccccccCC-cCCCCchhHHHHHHHHHHHHcCCCCCCCCccc-------
Q psy2172         169 VKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQED-------  240 (291)
Q Consensus       169 ~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~-------  240 (291)
                      ++|+|||++........  .......||+.|+|||++.+. ..++.++|||||||++|+|++|..||......       
T Consensus       198 ~kl~DfG~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~  275 (355)
T 1vzo_A          198 VVLTDFGLSKEFVADET--ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS  275 (355)
T ss_dssp             EEESCSSEEEECCGGGG--GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH
T ss_pred             EEEeeCCCCeecccCCC--CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHH
Confidence            99999999986543211  122345789999999999753 34789999999999999999999999754322       


Q ss_pred             ------ccCCCCCcHHHHHHHHHhhCCCCcCChh-----hhhcCCCCcchhhh
Q psy2172         241 ------IKTSNPYHHDQLDRIFSVMGFPLEKDWE-----DIRKMPEHPTLLKD  282 (291)
Q Consensus       241 ------~~~~~~~~~~~~~~i~~~~~~~~~~~~~-----~~~~~~~~~~~~~~  282 (291)
                            ...........+.+++..|..+.|..||     ++.++.+++++.+.
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~  328 (355)
T 1vzo_A          276 RRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  328 (355)
T ss_dssp             HHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             HHHhccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence                  1122334456788999999999999999     88899899887653

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=9.9e-41  Score=279.70  Aligned_cols=238  Identities=21%  Similarity=0.326  Sum_probs=195.3

Q ss_pred             ccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC-ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEE
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-SMSACREIALLRELKHPNVINLISVFLSHNDRKVWL   95 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~i   95 (291)
                      .+.|.+ .+.||+|+||.||+|.++.  ++..||+|.+..... .+.+.+|+.++++++||||+++++++  .+....++
T Consensus        12 ~~~~~~-~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~~~~   86 (288)
T 3kfa_A           12 RTDITM-KHKLGGGQYGEVYEGVWKK--YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC--TREPPFYI   86 (288)
T ss_dssp             GGGEEE-EEESGGGTTCSEEEEEEGG--GTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEE--CSSSSEEE
T ss_pred             ccceeE-EeecCCCCceeEEEeEecC--CCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE--ccCCCEEE
Confidence            445664 6799999999999999887  678899999975433 35688999999999999999999999  66778999


Q ss_pred             EEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          96 LFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        96 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      ||||++ ++|.+.+......       .+++..++.++.|++.||.+||++|++|+||||+||+++    .++.++|+||
T Consensus        87 v~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~----~~~~~~l~Df  155 (288)
T 3kfa_A           87 ITEFMTYGNLLDYLRECNRQ-------EVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG----ENHLVKVADF  155 (288)
T ss_dssp             EEECCTTEEHHHHHHHCCTT-------TSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEEC----GGGCEEECCC
T ss_pred             EEEcCCCCcHHHHHHhcccC-------CccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEc----CCCCEEEccC
Confidence            999998 5888888653321       289999999999999999999999999999999999998    6678999999


Q ss_pred             ccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc----------cC
Q psy2172         175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI----------KT  243 (291)
Q Consensus       175 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~----------~~  243 (291)
                      |.+........  .......++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||.+.....          ..
T Consensus       156 g~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~  232 (288)
T 3kfa_A          156 GLSRLMTGDTY--TAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME  232 (288)
T ss_dssp             CGGGTSCSSSS--EEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC
T ss_pred             ccceeccCCcc--ccccCCccccCcCChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCC
Confidence            99986553221  2233456678899999997654 8999999999999999999 999998755321          11


Q ss_pred             CCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         244 SNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       244 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      ......+.+.+++..|..+.|..||++.++
T Consensus       233 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~~  262 (288)
T 3kfa_A          233 RPEGCPEKVYELMRACWQWNPSDRPSFAEI  262 (288)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCCCHHHHHHHHHHhCCChhhCcCHHHH
Confidence            223345778899999999999999888764

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.5e-40  Score=280.47  Aligned_cols=247  Identities=22%  Similarity=0.319  Sum_probs=194.2

Q ss_pred             ccccccccceeCcccceEEEEEEEcc---CCCCceeEEEEeCCCCCC---hhHHHHHHHHhcCCCCCeeeEEEEEEeCCC
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKD---NSDTRDYALKQIEGTGLS---MSACREIALLRELKHPNVINLISVFLSHND   90 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~---~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   90 (291)
                      .+.|.+ ++.||+|+||.||+|.+..   ..+++.||+|++......   ..+.+|+.+++.++||||+++++++  .+.
T Consensus        22 ~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--~~~   98 (314)
T 2ivs_A           22 RKNLVL-GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC--SQD   98 (314)
T ss_dssp             GGGEEE-EEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE--CSS
T ss_pred             hhheee-eeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE--ecC
Confidence            455664 7899999999999998743   224578999999754332   4578899999999999999999999  566


Q ss_pred             ceEEEEEecCC-CCHHHHHHHhhhhhh---------------CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCC
Q psy2172          91 RKVWLLFDYAE-HDLWHIIKFHRAAKA---------------NKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKP  154 (291)
Q Consensus        91 ~~~~iv~e~~~-~~l~~~~~~~~~~~~---------------~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~  154 (291)
                      ...++||||++ ++|.+++........               ......+++..++.++.|++.||+|||++|++|+||||
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp  178 (314)
T 2ivs_A           99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAA  178 (314)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred             CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccch
Confidence            78999999998 589888876542100               00112388999999999999999999999999999999


Q ss_pred             CcEEeecCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCC
Q psy2172         155 ANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPI  233 (291)
Q Consensus       155 ~Nil~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p  233 (291)
                      +||+++    .++.++|+|||++......... .......++..|+|||.+.+.. ++.++||||||+++|+|++ |..|
T Consensus       179 ~NIli~----~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p  252 (314)
T 2ivs_A          179 RNILVA----EGRKMKISDFGLSRDVYEEDSY-VKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNP  252 (314)
T ss_dssp             GGEEEE----TTTEEEECCCTTCEECTTTSCE-ECSSCCCSCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             heEEEc----CCCCEEEccccccccccccccc-eeccCCCCcccccChhhhcCCC-cCchhhHHHHHHHHHHHHhCCCCC
Confidence            999998    6678999999999876543221 1223445678899999997744 8999999999999999999 9999


Q ss_pred             CCCCcccc----------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         234 FHCRQEDI----------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       234 f~~~~~~~----------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      |.+.....          ........+.+.+++..|..+.|..||++.+
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~  301 (314)
T 2ivs_A          253 YPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFAD  301 (314)
T ss_dssp             STTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHH
Confidence            98765421          1222344577889999999999998888775

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.1e-40  Score=283.91  Aligned_cols=243  Identities=22%  Similarity=0.285  Sum_probs=192.6

Q ss_pred             cccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC--ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCc
Q psy2172          14 TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL--SMSACREIALLRELKHPNVINLISVFLSHNDR   91 (291)
Q Consensus        14 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (291)
                      ....+.|++ .+.||+|+||.||+|.++   +++.||+|.+.....  ...+.+|+.+++.++||||+++++++  .+..
T Consensus        35 ~~~~~~y~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~  108 (321)
T 2qkw_B           35 EEATNNFDH-KFLIGHGVFGKVYKGVLR---DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC--DERN  108 (321)
T ss_dssp             CCCCCCCSC-CCCSCBCSSSEEEEEECT---TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEEC--CCTT
T ss_pred             HHHHhccCc-cceeecCCCeeEEEEEEC---CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEE--cCCC
Confidence            345677875 679999999999999964   567899999875433  35688999999999999999999998  5677


Q ss_pred             eEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEE
Q psy2172          92 KVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVK  170 (291)
Q Consensus        92 ~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~  170 (291)
                      ..++||||+++ +|.+.+.....     ....+++..++.++.|++.||++||++|++|+||||+||+++    .++.++
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~----~~~~~k  179 (321)
T 2qkw_B          109 EMILIYKYMENGNLKRHLYGSDL-----PTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLD----ENFVPK  179 (321)
T ss_dssp             CCEEEEECCTTCBTGGGSSSSCC-----CSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEEC----TTCCEE
T ss_pred             eEEEEEEcCCCCcHHHHHhccCC-----CccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEEC----CCCCEE
Confidence            89999999975 77666532211     122388999999999999999999999999999999999998    678999


Q ss_pred             EeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc--------
Q psy2172         171 IADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK--------  242 (291)
Q Consensus       171 l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~--------  242 (291)
                      |+|||++......... .......|+..|+|||.+.+.. ++.++||||||+++|+|++|+.||.+......        
T Consensus       180 l~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~  257 (321)
T 2qkw_B          180 ITDFGISKKGTELDQT-HLSTVVKGTLGYIDPEYFIKGR-LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV  257 (321)
T ss_dssp             ECCCTTCEECSSSSCC-CCBCCCEEETTTCCHHHHHHCB-CCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTH
T ss_pred             Eeeccccccccccccc-ccccccCCCccccCHHHhcCCC-CCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhh
Confidence            9999999865432211 1223456899999999987654 89999999999999999999999976543210        


Q ss_pred             ------------------CCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         243 ------------------TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       243 ------------------~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                                        ...+.....+.+++..|....|..||++.++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el  306 (321)
T 2qkw_B          258 ESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDV  306 (321)
T ss_dssp             HHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             hccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHH
Confidence                              0112234567888889999999999988764

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=5e-41  Score=280.25  Aligned_cols=249  Identities=27%  Similarity=0.475  Sum_probs=201.3

Q ss_pred             ccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC----hhHHHHHHHHhcCCCCCeeeEEEEEEeCCCce
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIALLRELKHPNVINLISVFLSHNDRK   92 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (291)
                      .+.|++ .+.||+|+||.||+|.++.  +++.||+|.+......    +.+.+|+.++++++||||+++++++...+...
T Consensus         5 ~~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (279)
T 2w5a_A            5 AEDYEV-LYTIGTGSYGRCQKIRRKS--DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT   81 (279)
T ss_dssp             GGGEEE-EEEEEECSSSEEEEEEETT--TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTE
T ss_pred             hhheee-ehhccCCCCcEEEEEEECC--CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCce
Confidence            356664 6799999999999999876  6788999999754332    35788999999999999999999987667779


Q ss_pred             EEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----eeeeccCCCcEEeecCCCCC
Q psy2172          93 VWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNW-----VLHRDLKPANILVMGEGIER  166 (291)
Q Consensus        93 ~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~-----ivH~dik~~Nil~~~~~~~~  166 (291)
                      .++||||+++ +|.+.+.......     ..+++..++.++.|++.||++||++|     ++|+||||+||+++    .+
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~----~~  152 (279)
T 2w5a_A           82 LYIVMEYCEGGDLASVITKGTKER-----QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD----GK  152 (279)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEEC----SS
T ss_pred             EEEEEeCCCCCCHHHHHHhhcccC-----CCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEc----CC
Confidence            9999999975 8988887654322     12899999999999999999999999     99999999999998    67


Q ss_pred             CcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc------
Q psy2172         167 GRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED------  240 (291)
Q Consensus       167 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~------  240 (291)
                      +.++|+|||.+........   ......|+..|+|||.+.+.. ++.++|+||||+++|+|++|..||......      
T Consensus       153 ~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i  228 (279)
T 2w5a_A          153 QNVKLGDFGLARILNHDTS---FAKTFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI  228 (279)
T ss_dssp             SCEEECCCCHHHHC---CH---HHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CCEEEecCchheeeccccc---cccccCCCccccChHHhccCC-CCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHH
Confidence            7899999999876543211   112246788999999998754 889999999999999999999999876532      


Q ss_pred             ----ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         241 ----IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       241 ----~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                          ...........+.+++..|..+.|..||++.++..+++...
T Consensus       229 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~  273 (279)
T 2w5a_A          229 REGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE  273 (279)
T ss_dssp             HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred             hhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence                11223344678999999999999999999999888877653

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.5e-41  Score=287.95  Aligned_cols=235  Identities=24%  Similarity=0.263  Sum_probs=185.8

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC-ChhHHHHHHHHhcCCCCCeeeEEEEEEeCC--CceEE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-SMSACREIALLRELKHPNVINLISVFLSHN--DRKVW   94 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~~~   94 (291)
                      +.|.+ .++||+|+||.||+|.+.    ++.||||++..... .....+|+.++++++||||+++++++....  ....+
T Consensus        24 ~~y~~-~~~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   98 (322)
T 3soc_A           24 MPLQL-LEVKARGRFGCVWKAQLL----NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW   98 (322)
T ss_dssp             EEEEE-EEEEECSTTCEEEEEEET----TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             hhchh-hheecccCceEEEEEEEC----CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence            45664 679999999999999864    47899999975422 234566888899999999999999996543  44689


Q ss_pred             EEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhC----------CeeeeccCCCcEEeecCC
Q psy2172          95 LLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSN----------WVLHRDLKPANILVMGEG  163 (291)
Q Consensus        95 iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~----------~ivH~dik~~Nil~~~~~  163 (291)
                      +||||+++ +|.+++....          +++..++.++.|++.||+|||+.          ||+|+||||+||+++   
T Consensus        99 lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~---  165 (322)
T 3soc_A           99 LITAFHEKGSLSDFLKANV----------VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK---  165 (322)
T ss_dssp             EEEECCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEEC---
T ss_pred             EEEecCCCCCHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEEC---
Confidence            99999975 8888886422          89999999999999999999999          999999999999998   


Q ss_pred             CCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCC----cCCCCchhHHHHHHHHHHHHcCCCCCCCCcc
Q psy2172         164 IERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGA----RHYTKAIDIWAIGCIFAELLTSEPIFHCRQE  239 (291)
Q Consensus       164 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~  239 (291)
                       ..+.++|+|||++......... .......||+.|+|||++.+.    ..++.++|||||||++|+|++|..||.+...
T Consensus       166 -~~~~~kL~DFg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~  243 (322)
T 3soc_A          166 -NNLTACIADFGLALKFEAGKSA-GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD  243 (322)
T ss_dssp             -TTCCEEECCCTTCEEECTTSCC-CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCC
T ss_pred             -CCCeEEEccCCcccccccccCc-cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcc
Confidence             6779999999999876543221 223345789999999999763    2356678999999999999999999987543


Q ss_pred             cccC-----------------------CCC---------CcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         240 DIKT-----------------------SNP---------YHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       240 ~~~~-----------------------~~~---------~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      ....                       ..+         ...+.+.+++..|..+.|..||++.+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e  308 (322)
T 3soc_A          244 EYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGC  308 (322)
T ss_dssp             CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             hhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHH
Confidence            2110                       000         11233788899999999999888775

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.9e-41  Score=293.00  Aligned_cols=240  Identities=20%  Similarity=0.286  Sum_probs=178.0

Q ss_pred             cccccccceeCcccceEEEEEEEcc-CCCCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKD-NSDTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      +.|.+ .+.||+|+||.||+|.++. ...+..||||.++....   ...+.+|+.++++++||||+++++++  .+....
T Consensus        45 ~~~~~-~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~--~~~~~~  121 (373)
T 2qol_A           45 TNISI-DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV--TKSKPV  121 (373)
T ss_dssp             GGCCC-CEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE--CSSSSC
T ss_pred             hhcee-eeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE--eeCCce
Confidence            45664 7799999999999998763 22567799999975432   24588999999999999999999999  566789


Q ss_pred             EEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          94 WLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        94 ~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      ++||||++ ++|.+++....        ..+++..++.++.|++.||+|||++||+|+||||+||+++    .++.++|+
T Consensus       122 ~lv~e~~~~~sL~~~l~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~----~~~~~kl~  189 (373)
T 2qol_A          122 MIVTEYMENGSLDSFLRKHD--------AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN----SNLVCKVS  189 (373)
T ss_dssp             EEEEECCTTCBHHHHHHTTT--------TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTCCEEEC
T ss_pred             EEEEeCCCCCcHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEc----CCCCEEEC
Confidence            99999996 58888876432        1289999999999999999999999999999999999998    67799999


Q ss_pred             ecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc----------
Q psy2172         173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI----------  241 (291)
Q Consensus       173 Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~----------  241 (291)
                      |||++.................++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.......          
T Consensus       190 Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~  268 (373)
T 2qol_A          190 DFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR  268 (373)
T ss_dssp             CC----------------------CTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEE
T ss_pred             cCccccccccCCccceeccCCCcCCCccChhhhccCC-cCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence            9999987654322222222334567899999998644 8999999999999999997 999997654321          


Q ss_pred             cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         242 KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       242 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      ..........+.+++..|....|..||++.++
T Consensus       269 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i  300 (373)
T 2qol_A          269 LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQI  300 (373)
T ss_dssp             CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCccccHHHHHHHHHHhCcChhhCcCHHHH
Confidence            11222345678899999999999999887764

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=3.6e-40  Score=292.84  Aligned_cols=230  Identities=17%  Similarity=0.300  Sum_probs=189.0

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEe
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFD   98 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e   98 (291)
                      .|.+ .+.||+|+||.||+|.+.    ++.||||+++.....+.+.+|+.+|++++||||+++++++.. .....|+|||
T Consensus       194 ~~~~-~~~lG~G~fg~V~~~~~~----~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~~iv~e  267 (450)
T 1k9a_A          194 ELKL-LQTIGKGEFGDVMLGDYR----GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE-EKGGLYIVTE  267 (450)
T ss_dssp             GEEE-EEEEEECSSEEEEEEEET----TEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEEC-TTSCEEEEEE
T ss_pred             HeEE-EeeecCcCCeeEEEEEec----CCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEc-CCCceEEEEE
Confidence            4443 679999999999999875    468999999987778889999999999999999999999854 3447899999


Q ss_pred             cCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccc
Q psy2172          99 YAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA  177 (291)
Q Consensus        99 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~  177 (291)
                      |+.+ +|.+.+......       .+++..++.++.|++.||+|||++|++|+||||+||+++    .++.++|+|||++
T Consensus       268 ~~~~g~L~~~l~~~~~~-------~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~----~~~~~kl~DfG~a  336 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRGRS-------VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS----EDNVAKVSDFGLT  336 (450)
T ss_dssp             CCTTCBHHHHHHHHCTT-------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC----TTSCEEECCCTTC
T ss_pred             ecCCCcHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEC----CCCCEEEeeCCCc
Confidence            9975 898888754321       168899999999999999999999999999999999998    6779999999999


Q ss_pred             eecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc----------cCCCC
Q psy2172         178 RLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI----------KTSNP  246 (291)
Q Consensus       178 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~----------~~~~~  246 (291)
                      ......      .....++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+.....          .....
T Consensus       337 ~~~~~~------~~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~  409 (450)
T 1k9a_A          337 KEASST------QDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD  409 (450)
T ss_dssp             EECC------------CCCTTTSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCT
T ss_pred             cccccc------ccCCCCCcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            854332      12235578899999998754 8999999999999999998 999998754321          12233


Q ss_pred             CcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         247 YHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       247 ~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      .....+.+++..|....|..||++.+
T Consensus       410 ~~~~~l~~li~~cl~~dp~~Rpt~~~  435 (450)
T 1k9a_A          410 GCPPAVYDVMKNCWHLDAATRPTFLQ  435 (450)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHH
Confidence            44577889999999999999988775

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=8.4e-41  Score=280.16  Aligned_cols=248  Identities=25%  Similarity=0.457  Sum_probs=201.8

Q ss_pred             cccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCC
Q psy2172          14 TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT----GLSMSACREIALLRELKHPNVINLISVFLSHN   89 (291)
Q Consensus        14 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   89 (291)
                      ..+.++|++ .+.||+|+||.||+|.+..  +++.||+|++...    .....+.+|+.++++++||||+++++++  .+
T Consensus        18 ~~~~~~y~i-~~~lg~G~~g~V~~~~~~~--~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~   92 (287)
T 2wei_A           18 GTFAERYNI-VCMLGKGSFGEVLKCKDRI--TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL--ED   92 (287)
T ss_dssp             HHHHHHEEE-EEEEEEETTEEEEEEEETT--TCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEE--EC
T ss_pred             HHHhhccee-eEEEcCCCCEEEEEEEEcC--CCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEE--eC
Confidence            345667885 6799999999999999876  6788999998533    2345688999999999999999999999  55


Q ss_pred             CceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCc
Q psy2172          90 DRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGR  168 (291)
Q Consensus        90 ~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~  168 (291)
                      ....+++||++.+ +|.+.+....         .+++..++.++.|++.||.+||++|++|+||+|+||+++.+. ....
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~-~~~~  162 (287)
T 2wei_A           93 SSSFYIVGELYTGGELFDEIIKRK---------RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKE-KDCD  162 (287)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS-TTCC
T ss_pred             CCeEEEEEEccCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCC-Cccc
Confidence            7789999999975 8877776432         189999999999999999999999999999999999997532 3458


Q ss_pred             EEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc-------
Q psy2172         169 VKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI-------  241 (291)
Q Consensus       169 ~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~-------  241 (291)
                      ++|+|||.+......    .......|+..|+|||.+.+ . ++.++|+||||+++|+|++|..||.+.....       
T Consensus       163 ~kL~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~-~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~  236 (287)
T 2wei_A          163 IKIIDFGLSTCFQQN----TKMKDRIGTAYYIAPEVLRG-T-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET  236 (287)
T ss_dssp             EEECSTTGGGTBCCC----SSCSCHHHHHTTCCHHHHTT-C-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             EEEeccCcceeecCC----CccccccCcccccChHHhcC-C-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence            999999998765432    12234568899999999876 3 8899999999999999999999998754321       


Q ss_pred             ---c---CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhh
Q psy2172         242 ---K---TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKD  282 (291)
Q Consensus       242 ---~---~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (291)
                         .   .........+.+++..|..+.|..||++.++.++|++.+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~  283 (287)
T 2wei_A          237 GKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY  283 (287)
T ss_dssp             CCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred             CCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence               0   0012235678999999999999999999999988887653

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2e-40  Score=287.15  Aligned_cols=241  Identities=17%  Similarity=0.191  Sum_probs=185.4

Q ss_pred             ccccccccceeCcccceEEEEEEEc---cCCCCceeEEEEeCCCCCChhHHHHHHHHhcCC---CCCeeeEEEEEEeCCC
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRK---DNSDTRDYALKQIEGTGLSMSACREIALLRELK---HPNVINLISVFLSHND   90 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~---~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~   90 (291)
                      .+.|.+ .++||+|+||.||+|.+.   ...+++.||+|+++.. ...++..|+.+++.++   |+||+++++++  ...
T Consensus        64 ~~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~--~~~  139 (365)
T 3e7e_A           64 SKLVYV-HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-NPWEFYIGTQLMERLKPSMQHMFMKFYSAH--LFQ  139 (365)
T ss_dssp             SSEEEE-EEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-CHHHHHHHHHHHHHSCGGGGGGBCCEEEEE--ECS
T ss_pred             CEEEEE-EEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-ChhHHHHHHHHHHHhhhhhhhhhhhhheee--ecC
Confidence            355664 679999999999999532   2336788999999754 4567888999999997   89999999999  456


Q ss_pred             ceEEEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecC-------
Q psy2172          91 RKVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGE-------  162 (291)
Q Consensus        91 ~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~-------  162 (291)
                      ...|+||||++ |+|.+++.......    ...+++..++.++.|++.||+|||++||+||||||+||+++.+       
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~  215 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTP----EKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE  215 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTST----TCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC---
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhccc----ccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccc
Confidence            68899999997 58988887654321    1238999999999999999999999999999999999999841       


Q ss_pred             CCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc-
Q psy2172         163 GIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI-  241 (291)
Q Consensus       163 ~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~-  241 (291)
                      ....+.++|+|||++........ ........||..|+|||++.+.. ++.++|||||||++|+|++|+.||....... 
T Consensus       216 ~~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~  293 (365)
T 3e7e_A          216 DDLSAGLALIDLGQSIDMKLFPK-GTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC  293 (365)
T ss_dssp             ---CTTEEECCCTTCEEGGGSCT-TEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE
T ss_pred             ccccCCEEEeeCchhhhhhccCC-CceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCCccccCCCCce
Confidence            11268999999999976542211 12234567899999999998855 8999999999999999999999997654421 


Q ss_pred             ----cCCCCCcHHHHHHHHHhhCCCCcCCh
Q psy2172         242 ----KTSNPYHHDQLDRIFSVMGFPLEKDW  267 (291)
Q Consensus       242 ----~~~~~~~~~~~~~i~~~~~~~~~~~~  267 (291)
                          ........+...+++..+..+.+..+
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r  323 (365)
T 3e7e_A          294 KPEGLFRRLPHLDMWNEFFHVMLNIPDCHH  323 (365)
T ss_dssp             EECSCCTTCSSHHHHHHHHHHHHCCCCTTC
T ss_pred             eechhccccCcHHHHHHHHHHHcCCCCCCc
Confidence                11122336778888887777776554

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.3e-41  Score=285.36  Aligned_cols=259  Identities=24%  Similarity=0.321  Sum_probs=184.3

Q ss_pred             ccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC---CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCc
Q psy2172          15 KVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT---GLSMSACREIALLRELKHPNVINLISVFLSHNDR   91 (291)
Q Consensus        15 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (291)
                      ...+.|.+ .+.||+|+||.||+|.+..  +++.||+|.+...   .....+.+|+.++++++||||+++++++.  ...
T Consensus        12 i~~~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~   86 (303)
T 2vwi_A           12 INRDDYEL-QEVIGSGATAVVQAAYCAP--KKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFV--VKD   86 (303)
T ss_dssp             -CCCCCEE-EEECC---CCCEEEEEC------CEEEEECCC----------------CCCCCCCTTBCCEEEEEE--SSS
T ss_pred             cchhhhhh-hheeccccceEEEEEEECC--CCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEe--ecC
Confidence            34566775 7799999999999999765  6688999998643   23456788999999999999999999994  456


Q ss_pred             eEEEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEE
Q psy2172          92 KVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVK  170 (291)
Q Consensus        92 ~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~  170 (291)
                      ..++||||++ ++|.+++........ .....+++..++.++.|++.||.+||++|++|+||+|+||+++    .++.++
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~~~~~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~----~~~~~k  161 (303)
T 2vwi_A           87 ELWLVMKLLSGGSVLDIIKHIVAKGE-HKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLG----EDGSVQ  161 (303)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHHHTTT-TTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC----TTCCEE
T ss_pred             CcEEEehhccCCchHHHHHHHhhccc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEc----CCCCEE
Confidence            7999999996 488888875433211 1223389999999999999999999999999999999999998    667899


Q ss_pred             EeecccceecCCCCC--CCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc-------
Q psy2172         171 IADMGFARLFNNPLK--PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI-------  241 (291)
Q Consensus       171 l~Dfg~~~~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~-------  241 (291)
                      |+|||.+........  .........|++.|+|||.+.+...++.++||||||+++|+|++|..||.......       
T Consensus       162 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  241 (303)
T 2vwi_A          162 IADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ  241 (303)
T ss_dssp             ECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHT
T ss_pred             EEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhc
Confidence            999999876543211  11112345689999999998754458999999999999999999999998744210       


Q ss_pred             ------------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhhh
Q psy2172         242 ------------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF  283 (291)
Q Consensus       242 ------------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (291)
                                  ..........+.+++..|..+.|..||++.++..+|++.+.-
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  295 (303)
T 2vwi_A          242 NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK  295 (303)
T ss_dssp             SSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred             cCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence                        001123346788999999999999999999999999987543

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.7e-40  Score=277.42  Aligned_cols=238  Identities=20%  Similarity=0.330  Sum_probs=180.1

Q ss_pred             cccccccccceeCcccceEEEEEEEccCC-CCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCc
Q psy2172          16 VEDLFDYEGCKVGRGTYGHVYKARRKDNS-DTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHNDR   91 (291)
Q Consensus        16 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~-~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (291)
                      ..++|.+ ++.||+|+||.||+|.+.... .+..||+|.+.....   .+.+.+|+.++++++||||+++++++  . ..
T Consensus        13 ~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~-~~   88 (281)
T 1mp8_A           13 QRERIEL-GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI--T-EN   88 (281)
T ss_dssp             CGGGEEE-EEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE--C-SS
T ss_pred             ehHHeEE-EeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE--c-cC
Confidence            4456774 779999999999999986532 346799999875432   24578899999999999999999998  2 34


Q ss_pred             eEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEE
Q psy2172          92 KVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVK  170 (291)
Q Consensus        92 ~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~  170 (291)
                      ..++||||+++ +|.+.+.....        .+++..++.++.|++.||.+||++|++|+||||+||+++    .++.++
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~----~~~~~k  156 (281)
T 1mp8_A           89 PVWIIMELCTLGELRSFLQVRKY--------SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS----SNDCVK  156 (281)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTT--------TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE----ETTEEE
T ss_pred             ccEEEEecCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEEC----CCCCEE
Confidence            67899999986 88888764321        289999999999999999999999999999999999998    667999


Q ss_pred             EeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc--------
Q psy2172         171 IADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI--------  241 (291)
Q Consensus       171 l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~--------  241 (291)
                      |+|||++........  .......+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||.+.....        
T Consensus       157 l~Dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~  233 (281)
T 1mp8_A          157 LGDFGLSRYMEDSTY--YKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG  233 (281)
T ss_dssp             ECC---------------------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred             ECccccccccCcccc--cccccCCCcccccChhhcccCC-CCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcC
Confidence            999999987654221  1223345677899999997644 8899999999999999996 999998765321        


Q ss_pred             --cCCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         242 --KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       242 --~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                        ....+.....+.+++..|..+.|..||++.+
T Consensus       234 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  266 (281)
T 1mp8_A          234 ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTE  266 (281)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence              1233344677889999999999999888775

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-40  Score=284.88  Aligned_cols=247  Identities=23%  Similarity=0.344  Sum_probs=193.4

Q ss_pred             ccccccccceeCcccceEEEEEEEccC---CCCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCC
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDN---SDTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHND   90 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~---~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   90 (291)
                      .+.|.+ .+.||+|+||.||+|.+.+.   .+++.||+|+++....   ...+.+|+.++++++||||+++++++  .+.
T Consensus        46 ~~~~~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--~~~  122 (343)
T 1luf_A           46 RNNIEY-VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC--AVG  122 (343)
T ss_dssp             GGGCEE-EEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE--CSS
T ss_pred             HHHCee-eeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE--ccC
Confidence            356664 67999999999999998742   2457899999976533   24578999999999999999999999  567


Q ss_pred             ceEEEEEecCCC-CHHHHHHHhhhhh---------------hCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCC
Q psy2172          91 RKVWLLFDYAEH-DLWHIIKFHRAAK---------------ANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKP  154 (291)
Q Consensus        91 ~~~~iv~e~~~~-~l~~~~~~~~~~~---------------~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~  154 (291)
                      ...++||||+++ +|.+++.......               .......+++..++.++.|++.||.|||++|++|+||||
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp  202 (343)
T 1luf_A          123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT  202 (343)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCc
Confidence            789999999975 9998887642111               000123489999999999999999999999999999999


Q ss_pred             CcEEeecCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCC
Q psy2172         155 ANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPI  233 (291)
Q Consensus       155 ~Nil~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p  233 (291)
                      +||+++    .++.++|+|||++........ ........++..|+|||.+.+.. ++.++|+||||+++|+|++ |..|
T Consensus       203 ~NIl~~----~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p  276 (343)
T 1luf_A          203 RNCLVG----ENMVVKIADFGLSRNIYSADY-YKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQP  276 (343)
T ss_dssp             GGEEEC----GGGCEEECCCSCHHHHTGGGC-BC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             ceEEEC----CCCeEEEeecCCCcccccCcc-ccccCCCcccceecChhhhccCC-cCcccccHHHHHHHHHHHhcCCCc
Confidence            999998    667999999999976543211 11223456788999999987644 8999999999999999998 9999


Q ss_pred             CCCCccc----------ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         234 FHCRQED----------IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       234 f~~~~~~----------~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      |.+....          ...........+.+++..|....|..||++.+
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  325 (343)
T 1luf_A          277 YYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCS  325 (343)
T ss_dssp             TTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHH
Confidence            9876432          11223344577899999999999998888775

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.5e-40  Score=287.22  Aligned_cols=249  Identities=20%  Similarity=0.337  Sum_probs=194.2

Q ss_pred             ccccccccceeCcccceEEEEEEEcc---CCCCceeEEEEeCCCCCC---hhHHHHHHHHhcC-CCCCeeeEEEEEEeCC
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKD---NSDTRDYALKQIEGTGLS---MSACREIALLREL-KHPNVINLISVFLSHN   89 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~---~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~   89 (291)
                      .++|.+ ++.||+|+||.||+|.+.+   ..+++.||||+++.....   ..+.+|+.+++++ +||||+++++++.. .
T Consensus        21 ~~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~-~   98 (359)
T 3vhe_A           21 RDRLKL-GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK-P   98 (359)
T ss_dssp             GGGEEE-EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-T
T ss_pred             ccceee-ceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec-C
Confidence            466775 7799999999999999653   335688999999765433   3588999999999 78999999999843 3


Q ss_pred             CceEEEEEecCCC-CHHHHHHHhhhhh-----------------------------------------------------
Q psy2172          90 DRKVWLLFDYAEH-DLWHIIKFHRAAK-----------------------------------------------------  115 (291)
Q Consensus        90 ~~~~~iv~e~~~~-~l~~~~~~~~~~~-----------------------------------------------------  115 (291)
                      ....++||||+.+ +|.+++.......                                                     
T Consensus        99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (359)
T 3vhe_A           99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  178 (359)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred             CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence            4458999999985 8888887543210                                                     


Q ss_pred             ----hCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceecCCCCCCCCCCC
Q psy2172         116 ----ANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLD  191 (291)
Q Consensus       116 ----~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  191 (291)
                          .......+++..++.++.|++.||+|||++||+|+||||+||+++    .++.++|+|||++........ .....
T Consensus       179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~----~~~~~kl~Dfg~a~~~~~~~~-~~~~~  253 (359)
T 3vhe_A          179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS----EKNVVKICDFGLARDIYKDPD-YVRKG  253 (359)
T ss_dssp             -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----GGGCEEECCCGGGSCTTSCTT-CEEC-
T ss_pred             cccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEc----CCCcEEEEeccceeeeccccc-chhcc
Confidence                000122288999999999999999999999999999999999998    667899999999986543222 12234


Q ss_pred             CceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc-----------ccCCCCCcHHHHHHHHHhh
Q psy2172         192 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED-----------IKTSNPYHHDQLDRIFSVM  259 (291)
Q Consensus       192 ~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~-----------~~~~~~~~~~~~~~i~~~~  259 (291)
                      ...||..|+|||++.+.. ++.++||||||+++|+|++ |..||.+....           ...........+.+++..|
T Consensus       254 ~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  332 (359)
T 3vhe_A          254 DARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC  332 (359)
T ss_dssp             -CEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHH
T ss_pred             ccCCCceeEChhhhcCCC-CCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence            567888999999997644 8999999999999999998 99999876532           1222334456788999999


Q ss_pred             CCCCcCChhhhhcC
Q psy2172         260 GFPLEKDWEDIRKM  273 (291)
Q Consensus       260 ~~~~~~~~~~~~~~  273 (291)
                      ..+.|..||++.++
T Consensus       333 l~~dP~~Rps~~el  346 (359)
T 3vhe_A          333 WHGEPSQRPTFSEL  346 (359)
T ss_dssp             TCSSGGGSCCHHHH
T ss_pred             ccCChhhCCCHHHH
Confidence            99999998887753

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.1e-40  Score=278.90  Aligned_cols=234  Identities=19%  Similarity=0.314  Sum_probs=186.7

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLL   96 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv   96 (291)
                      +.|++ .+.||+|+||.||+|.+.   ++..||+|++.... ...++.+|+.++++++||||+++++++  .+....++|
T Consensus        24 ~~y~~-~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~~~lv   97 (283)
T 3gen_A           24 KDLTF-LKELGTGQFGVVKYGKWR---GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC--TKQRPIFII   97 (283)
T ss_dssp             GGEEE-EEECC---CEEEEEEEET---TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEE--CSSSSEEEE
T ss_pred             HHHHh-HhhcCCCCCceEEEEEEc---CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEE--ecCCCeEEE
Confidence            45554 679999999999999876   45679999998654 345788999999999999999999999  667789999


Q ss_pred             EecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecc
Q psy2172          97 FDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMG  175 (291)
Q Consensus        97 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg  175 (291)
                      |||+. ++|.+.+.....        .+++..++.++.|++.||++||++|++|+||||+||+++    .++.++|+|||
T Consensus        98 ~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~----~~~~~kl~Dfg  165 (283)
T 3gen_A           98 TEYMANGCLLNYLREMRH--------RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN----DQGVVKVSDFG  165 (283)
T ss_dssp             ECCCTTCBHHHHHHCGGG--------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEEC----TTSCEEECSTT
T ss_pred             EeccCCCcHHHHHHHhcc--------CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEc----CCCCEEEcccc
Confidence            99996 588887764322        289999999999999999999999999999999999998    67799999999


Q ss_pred             cceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc----------ccCC
Q psy2172         176 FARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED----------IKTS  244 (291)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~----------~~~~  244 (291)
                      .+........  .......++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||......          ....
T Consensus       166 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~  242 (283)
T 3gen_A          166 LSRYVLDDEY--TSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR  242 (283)
T ss_dssp             GGGGBCCHHH--HSTTSTTSCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC
T ss_pred             cccccccccc--ccccCCccCcccCCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCC
Confidence            9976543211  1122345577899999998654 8999999999999999998 99999875532          1112


Q ss_pred             CCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         245 NPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       245 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      .....+.+.+++..|..+.|..||++.+
T Consensus       243 ~~~~~~~l~~li~~~l~~~p~~Rps~~~  270 (283)
T 3gen_A          243 PHLASEKVYTIMYSCWHEKADERPTFKI  270 (283)
T ss_dssp             CTTCCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred             CCcCCHHHHHHHHHHccCChhHCcCHHH
Confidence            2334577888999999999988888775

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=6.7e-41  Score=285.31  Aligned_cols=247  Identities=23%  Similarity=0.307  Sum_probs=178.5

Q ss_pred             ccccccccccceeCcccceEEEEEEEccCCC-CceeEEEEeCCCC----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCC
Q psy2172          15 KVEDLFDYEGCKVGRGTYGHVYKARRKDNSD-TRDYALKQIEGTG----LSMSACREIALLRELKHPNVINLISVFLSHN   89 (291)
Q Consensus        15 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~-~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   89 (291)
                      ...+.|++ ++.||+|+||.||+|.++..+. ...||+|+++...    ....+.+|+.++++++||||+++++++...+
T Consensus        20 i~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           20 IPEQQFTL-GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR   98 (323)
T ss_dssp             CC---CEE-EEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred             cChhHeEE-eceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence            34556775 7799999999999999765321 1379999987542    2346889999999999999999999985432


Q ss_pred             Cc----eEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCC
Q psy2172          90 DR----KVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGI  164 (291)
Q Consensus        90 ~~----~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~  164 (291)
                      ..    ..+++|||+.+ +|.+.+........   ...+++..++.++.|++.||+|||++|++|+||||+||+++    
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~----  171 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGEN---PFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA----  171 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhcccc---ccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEc----
Confidence            21    24999999986 88888876543221   22389999999999999999999999999999999999998    


Q ss_pred             CCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc--
Q psy2172         165 ERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI--  241 (291)
Q Consensus       165 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~--  241 (291)
                      .++.++|+|||.+......... .......++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+.....  
T Consensus       172 ~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~  249 (323)
T 3qup_A          172 EDMTVCVADFGLSRKIYSGDYY-RQGCASKLPVKWLALESLADNL-YTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY  249 (323)
T ss_dssp             TTSCEEECCCCC------------------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH
T ss_pred             CCCCEEEeeccccccccccccc-cccccccCcccccCchhhcCCC-CCCccchhhHHHHHHHHHhCCCCCccccChHHHH
Confidence            6679999999999865443211 1222345677899999997744 8999999999999999999 999998765421  


Q ss_pred             --------cCCCCCcHHHHHHHHHhhCCCCcCChhhhh
Q psy2172         242 --------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIR  271 (291)
Q Consensus       242 --------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  271 (291)
                              ....+...+.+.+++..|..+.|..||++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  287 (323)
T 3qup_A          250 NYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFT  287 (323)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHH
T ss_pred             HHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHH
Confidence                    223344457789999999999999999844

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3.1e-40  Score=281.69  Aligned_cols=249  Identities=18%  Similarity=0.311  Sum_probs=181.2

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC---hhHHHHHH-HHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS---MSACREIA-LLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      +.|++ .+.||+|+||.||+|.++.  +++.||+|++......   ..+..|+. +++.++||||+++++++.  +....
T Consensus        22 ~~y~~-~~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~--~~~~~   96 (327)
T 3aln_A           22 EDLKD-LGEIGRGAYGSVNKMVHKP--SGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF--REGDC   96 (327)
T ss_dssp             CSEEC--CEEEECSSEEEEEEEETT--TTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE--CSSEE
T ss_pred             HHhhe-hheeccCCCEEEEEEEEcC--CCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE--eCCce
Confidence            55664 6799999999999999876  6789999999754322   23455555 677789999999999994  56789


Q ss_pred             EEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          94 WLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSN-WVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        94 ~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~-~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      ++||||++++|.+++........    ..+++..++.++.|++.||.+||++ |++|+||||+||+++    .++.++|+
T Consensus        97 ~lv~e~~~~~l~~~~~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~----~~~~~kl~  168 (327)
T 3aln_A           97 WICMELMSTSFDKFYKYVYSVLD----DVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLD----RSGNIKLC  168 (327)
T ss_dssp             EEEECCCSEEHHHHHHHHHHTTC----CCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEE----TTTEEEEC
T ss_pred             EEEEeecCCChHHHHHHHHhhhc----ccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEc----CCCCEEEc
Confidence            99999999998888876443211    2289999999999999999999999 999999999999998    67899999


Q ss_pred             ecccceecCCCCCCCCCCCCceeccccccccccc---CCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc--------
Q psy2172         173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLL---GARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI--------  241 (291)
Q Consensus       173 Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~--------  241 (291)
                      |||++.......    ......|+..|+|||.+.   ....++.++||||||+++|+|++|..||.+.....        
T Consensus       169 Dfg~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  244 (327)
T 3aln_A          169 DFGISGQLVDSI----AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK  244 (327)
T ss_dssp             CCSSSCC----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCC
T ss_pred             cCCCceeccccc----ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhc
Confidence            999997654321    122346889999999984   22348899999999999999999999998643210        


Q ss_pred             ---cC----CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhhh
Q psy2172         242 ---KT----SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF  283 (291)
Q Consensus       242 ---~~----~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (291)
                         ..    ........+.+++..|..+.|..||++.++..+|++...-
T Consensus       245 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  293 (327)
T 3aln_A          245 GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE  293 (327)
T ss_dssp             SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence               00    1123467899999999999999999999999999987543

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=6.4e-41  Score=308.52  Aligned_cols=234  Identities=17%  Similarity=0.263  Sum_probs=186.2

Q ss_pred             cccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC----ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEE
Q psy2172          22 YEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL----SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLF   97 (291)
Q Consensus        22 ~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~   97 (291)
                      +++++||+|+||.||+|.+.....++.||||+++....    ..++.+|+.+|++++||||+++++++.   ....++||
T Consensus       372 l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~---~~~~~lv~  448 (635)
T 4fl3_A          372 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE---AESWMLVM  448 (635)
T ss_dssp             EEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE---SSSEEEEE
T ss_pred             ccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe---cCCEEEEE
Confidence            34568999999999999877666778899999975432    356889999999999999999999883   33578999


Q ss_pred             ecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeeccc
Q psy2172          98 DYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGF  176 (291)
Q Consensus        98 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~  176 (291)
                      ||+.+ +|.+++....         .+++..++.++.|++.||+|||++||+|+||||+||+++    .++.++|+|||+
T Consensus       449 E~~~~g~L~~~l~~~~---------~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~----~~~~~kL~DFGl  515 (635)
T 4fl3_A          449 EMAELGPLNKYLQQNR---------HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV----TQHYAKISDFGL  515 (635)
T ss_dssp             ECCTTEEHHHHHHHCT---------TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE----ETTEEEECCTTH
T ss_pred             EccCCCCHHHHHhhCC---------CCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEe----CCCCEEEEEcCC
Confidence            99985 8888875432         189999999999999999999999999999999999999    667999999999


Q ss_pred             ceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc----------ccCCC
Q psy2172         177 ARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED----------IKTSN  245 (291)
Q Consensus       177 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~----------~~~~~  245 (291)
                      ++................++..|+|||++.+.. ++.++||||||+++|+|++ |..||.+....          .....
T Consensus       516 a~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p  594 (635)
T 4fl3_A          516 SKALRADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP  594 (635)
T ss_dssp             HHHTTC-------------CGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC
T ss_pred             ccccccCccccccccCCCCceeeeChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            987654332222233445678899999997744 8999999999999999998 99999876542          12223


Q ss_pred             CCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         246 PYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       246 ~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      ....+.+.+++..|....|..||++.+
T Consensus       595 ~~~~~~l~~li~~cl~~dP~~RPs~~~  621 (635)
T 4fl3_A          595 AGCPREMYDLMNLCWTYDVENRPGFAA  621 (635)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             CCCCHHHHHHHHHHcCCCHhHCcCHHH
Confidence            344577889999999999999998875

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-40  Score=283.81  Aligned_cols=247  Identities=21%  Similarity=0.337  Sum_probs=192.9

Q ss_pred             cccccccceeCcccceEEEEEEEcc---CCCCceeEEEEeCCC---CCChhHHHHHHHHhcC-CCCCeeeEEEEEEeCCC
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKD---NSDTRDYALKQIEGT---GLSMSACREIALLREL-KHPNVINLISVFLSHND   90 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~---~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~   90 (291)
                      +.|.+ ++.||+|+||.||+|.+..   ..++..||+|++...   .....+.+|+.+++++ +||||+++++++  ...
T Consensus        45 ~~y~~-~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~--~~~  121 (344)
T 1rjb_A           45 ENLEF-GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC--TLS  121 (344)
T ss_dssp             GGEEE-EEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE--CSS
T ss_pred             HHcee-eeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE--eeC
Confidence            34553 6799999999999999743   335667999999743   2345788999999999 899999999999  556


Q ss_pred             ceEEEEEecCCC-CHHHHHHHhhhhh--------------hCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCC
Q psy2172          91 RKVWLLFDYAEH-DLWHIIKFHRAAK--------------ANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPA  155 (291)
Q Consensus        91 ~~~~iv~e~~~~-~l~~~~~~~~~~~--------------~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~  155 (291)
                      ...++||||+++ +|.+.+.......              .......+++..++.++.|++.||++||++||+|+||||+
T Consensus       122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~  201 (344)
T 1rjb_A          122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR  201 (344)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred             CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChh
Confidence            789999999975 9988887543210              0001123789999999999999999999999999999999


Q ss_pred             cEEeecCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCC
Q psy2172         156 NILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIF  234 (291)
Q Consensus       156 Nil~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf  234 (291)
                      ||+++    .++.++|+|||++........ ........+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||
T Consensus       202 NIll~----~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~  275 (344)
T 1rjb_A          202 NVLVT----HGKVVKICDFGLARDIMSDSN-YVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPY  275 (344)
T ss_dssp             GEEEE----TTTEEEECCCGGGSCGGGCTT-SEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             hEEEc----CCCcEEeCCCccCcccccCcc-ceeccCccCccCccCHHHhccCC-CChhHhHHHHHHHHHHHHcCCCCCc
Confidence            99998    677999999999986654321 11224456788999999987644 8999999999999999998 99999


Q ss_pred             CCCcccc-----------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         235 HCRQEDI-----------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       235 ~~~~~~~-----------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      .+.....           ........+.+.+++..|..+.|..||++.++
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  325 (344)
T 1rjb_A          276 PGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL  325 (344)
T ss_dssp             TTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             ccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence            8765321           11233346778999999999999999988764

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=4.5e-41  Score=291.83  Aligned_cols=251  Identities=25%  Similarity=0.393  Sum_probs=199.7

Q ss_pred             ccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-CChhHHHHHHHHhcCC-----------CCCeeeEEEE
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-LSMSACREIALLRELK-----------HPNVINLISV   84 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~-----------h~~iv~~~~~   84 (291)
                      .++|.+ .+.||+|+||.||+|.+..  +++.||+|++.... ....+.+|+.++++++           ||||++++++
T Consensus        18 ~~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~   94 (373)
T 1q8y_A           18 DARYIL-VRKLGWGHFSTVWLAKDMV--NNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   94 (373)
T ss_dssp             TTTEEE-EEEEEECSSEEEEEEEETT--TTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             CCeEEE-EEeeeecCCeEEEEEEecC--CCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence            456775 6799999999999999876  77899999997543 2345788999999886           7899999999


Q ss_pred             EEeC--CCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CeeeeccCCCcEEeec
Q psy2172          85 FLSH--NDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSN-WVLHRDLKPANILVMG  161 (291)
Q Consensus        85 ~~~~--~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~-~ivH~dik~~Nil~~~  161 (291)
                      +...  +....+++||+++++|.+++......       .+++..++.++.|++.||+|||++ ||+|+||||+||+++.
T Consensus        95 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~-------~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~  167 (373)
T 1q8y_A           95 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHR-------GIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEI  167 (373)
T ss_dssp             EEEEETTEEEEEEEECCCCEEHHHHHHHTTTS-------CCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEE
T ss_pred             hhccCCCCceEEEEEecCCCCHHHHHHHhhcc-------CCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEec
Confidence            8543  33489999999988999988764322       288999999999999999999998 9999999999999974


Q ss_pred             CC--CCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcc
Q psy2172         162 EG--IERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE  239 (291)
Q Consensus       162 ~~--~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~  239 (291)
                      ++  .....++|+|||++......      .....||+.|+|||++.+.. ++.++||||||+++|+|++|..||.+...
T Consensus       168 ~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~  240 (373)
T 1q8y_A          168 VDSPENLIQIKIADLGNACWYDEH------YTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEG  240 (373)
T ss_dssp             EETTTTEEEEEECCCTTCEETTBC------CCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             cCCCcCcceEEEcccccccccCCC------CCCCCCCccccCcHHHhCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCcc
Confidence            32  24458999999999876432      23346799999999998755 89999999999999999999999986542


Q ss_pred             ccc---------------------------------------------------------CCCCCcHHHHHHHHHhhCCC
Q psy2172         240 DIK---------------------------------------------------------TSNPYHHDQLDRIFSVMGFP  262 (291)
Q Consensus       240 ~~~---------------------------------------------------------~~~~~~~~~~~~i~~~~~~~  262 (291)
                      ...                                                         .........+.+++..|..+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  320 (373)
T 1q8y_A          241 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL  320 (373)
T ss_dssp             ----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCS
T ss_pred             cccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhcc
Confidence            100                                                         01112245677899999999


Q ss_pred             CcCChhhhhcCCCCcchhhhhh
Q psy2172         263 LEKDWEDIRKMPEHPTLLKDFN  284 (291)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~  284 (291)
                      .|..||++.++..+||+.+.+.
T Consensus       321 dP~~Rpt~~ell~hp~f~~~~~  342 (373)
T 1q8y_A          321 DPRKRADAGGLVNHPWLKDTLG  342 (373)
T ss_dssp             STTTCBCHHHHHTCGGGTTCTT
T ss_pred             CccccCCHHHHhhChhhhcccC
Confidence            9999999999999999876543

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=7.1e-41  Score=279.85  Aligned_cols=245  Identities=23%  Similarity=0.368  Sum_probs=197.9

Q ss_pred             ccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCCCCeeeEEEEEEe-----
Q psy2172          13 RTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFLS-----   87 (291)
Q Consensus        13 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----   87 (291)
                      ...+.+.|++ .+.||+|+||.||+|.+..  +++.||+|.+...  ...+.+|++++++++||||+++++++..     
T Consensus         6 ~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   80 (284)
T 2a19_B            6 DKRFGMDFKE-IELIGSGGFGQVFKAKHRI--DGKTYVIKRVKYN--NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDP   80 (284)
T ss_dssp             CHHHHHHEEE-EEEEECSSSCCEEEEEETT--TCCEEEEEEEECC--SGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-
T ss_pred             cchhccccce-eeeeccCCceEEEEEEEcC--CCeEEEEEEeccc--cHHHHHHHHHHHhCCCCCEEEEeeeEeccccCc
Confidence            4556677875 7799999999999999876  6788999999754  3578899999999999999999998743     


Q ss_pred             ---------CCCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcE
Q psy2172          88 ---------HNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANI  157 (291)
Q Consensus        88 ---------~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Ni  157 (291)
                               ......++||||+++ +|.+.+......       .+++..++.++.|++.||.+||++|++|+||||+||
T Consensus        81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Ni  153 (284)
T 2a19_B           81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE-------KLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNI  153 (284)
T ss_dssp             --------CCEEEEEEEEECCCCSCBHHHHHHHGGGS-------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             ccccccccccCcceEEEEEeccCCCCHHHHHhhccCC-------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHE
Confidence                     124568999999986 898888754322       289999999999999999999999999999999999


Q ss_pred             EeecCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q psy2172         158 LVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  237 (291)
Q Consensus       158 l~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~  237 (291)
                      +++    .++.++|+|||.+.......    ......|++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...
T Consensus       154 l~~----~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~~~  224 (284)
T 2a19_B          154 FLV----DTKQVKIGDFGLVTSLKNDG----KRTRSKGTLRYMSPEQISSQD-YGKEVDLYALGLILAELLHVCDTAFET  224 (284)
T ss_dssp             EEE----ETTEEEECCCTTCEESSCCS----CCCCCCSCCTTSCHHHHHCSC-CCTHHHHHHHHHHHHHHHSCCSSHHHH
T ss_pred             EEc----CCCCEEECcchhheeccccc----cccccCCcccccChhhhccCC-CcchhhhHHHHHHHHHHHhcCCcchhH
Confidence            998    66789999999998765432    223456899999999998754 899999999999999999999888542


Q ss_pred             ccc-----ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcc
Q psy2172         238 QED-----IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPT  278 (291)
Q Consensus       238 ~~~-----~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  278 (291)
                      ...     ...........+.+++..|..+.|..||++.++..+.+
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~  270 (284)
T 2a19_B          225 SKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLT  270 (284)
T ss_dssp             HHHHHHHHTTCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHhhcccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            211     01122334567889999999999999999887654443

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.5e-40  Score=297.04  Aligned_cols=232  Identities=22%  Similarity=0.326  Sum_probs=191.4

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecCC-
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAE-  101 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~~-  101 (291)
                      .++||+|+||.||+|.++.  ++..||||.++... ..+.+.+|+.+|++++||||+++++++  .+....++||||+. 
T Consensus       225 ~~~lG~G~fg~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~--~~~~~~~lv~E~~~~  300 (495)
T 1opk_A          225 KHKLGGGQYGEVYEGVWKK--YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC--TREPPFYIITEFMTY  300 (495)
T ss_dssp             EEESGGGTTSSEEEEEEGG--GTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEE--CSSSSCEEEEECCTT
T ss_pred             eeEecCCCCeEEEEEEEcC--CCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEE--ecCCcEEEEEEccCC
Confidence            6799999999999999886  67889999997543 346789999999999999999999999  55678899999998 


Q ss_pred             CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceecC
Q psy2172         102 HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFN  181 (291)
Q Consensus       102 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~~  181 (291)
                      ++|.+++......       .+++..++.++.|++.||+|||++||+|+||||+||+++    .++.++|+|||++....
T Consensus       301 g~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~----~~~~~kl~DFG~a~~~~  369 (495)
T 1opk_A          301 GNLLDYLRECNRQ-------EVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVG----ENHLVKVADFGLSRLMT  369 (495)
T ss_dssp             CBHHHHHHHSCTT-------TSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----GGGCEEECCTTCEECCT
T ss_pred             CCHHHHHHhcCcC-------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEC----CCCcEEEeecccceecc
Confidence            5898888753321       288999999999999999999999999999999999998    67799999999998764


Q ss_pred             CCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc----------cCCCCCcHH
Q psy2172         182 NPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI----------KTSNPYHHD  250 (291)
Q Consensus       182 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~----------~~~~~~~~~  250 (291)
                      ....  .......++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+.....          ........+
T Consensus       370 ~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  446 (495)
T 1opk_A          370 GDTY--TAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE  446 (495)
T ss_dssp             TCCE--ECCTTCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred             CCce--eecCCCcCCcceeCHhHHhcCC-CCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence            3211  1223345577899999997644 8999999999999999998 999998765321          112234457


Q ss_pred             HHHHHHHhhCCCCcCChhhhhcC
Q psy2172         251 QLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       251 ~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      .+.+++..|....|..||++.++
T Consensus       447 ~l~~li~~cl~~dP~~RPs~~el  469 (495)
T 1opk_A          447 KVYELMRACWQWNPSDRPSFAEI  469 (495)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHHHHcCcChhHCcCHHHH
Confidence            78899999999999999987764

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=7e-40  Score=292.20  Aligned_cols=245  Identities=19%  Similarity=0.236  Sum_probs=196.0

Q ss_pred             cccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCC-CCeeeEEEEEEeCCCce
Q psy2172          14 TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKH-PNVINLISVFLSHNDRK   92 (291)
Q Consensus        14 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~   92 (291)
                      ..+.+.|++ .++||+|+||.||+|.+..  +++.||||++........+.+|+.+++.++| ++++.+..++  .....
T Consensus         3 ~~i~~~y~i-~~~LG~G~fG~Vy~a~~~~--~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~--~~~~~   77 (483)
T 3sv0_A            3 PRVGNKFRL-GRKIGSGSFGEIYLGTNIQ--TNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFG--VEGDY   77 (483)
T ss_dssp             CEETTTEEC-CCCCEECSSCEEEEEEETT--TCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEE--EETTE
T ss_pred             CCcCCcEEE-EEEEeeCCCEEEEEEEECC--CCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEE--eeCCE
Confidence            456788886 7799999999999999876  6788999998877777789999999999987 4555555544  34668


Q ss_pred             EEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          93 VWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        93 ~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      .++||||++++|.+++.....        .+++..++.++.||+.||+|||++||+|+||||+|||++.+. ..+.++|+
T Consensus        78 ~~lvme~~g~sL~~ll~~~~~--------~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~-~~~~vkL~  148 (483)
T 3sv0_A           78 NVLVMDLLGPSLEDLFNFCSR--------KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR-RANQVYII  148 (483)
T ss_dssp             EEEEEECCCCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGG-GTTCEEEC
T ss_pred             EEEEEECCCCCHHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCC-CCCeEEEE
Confidence            899999998899999875432        289999999999999999999999999999999999995321 56799999


Q ss_pred             ecccceecCCCCCC----CCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc------
Q psy2172         173 DMGFARLFNNPLKP----LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK------  242 (291)
Q Consensus       173 Dfg~~~~~~~~~~~----~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~------  242 (291)
                      |||+++........    ........||..|+|||.+.+.. ++.++|||||||++|+|++|..||.+......      
T Consensus       149 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~  227 (483)
T 3sv0_A          149 DFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK  227 (483)
T ss_dssp             CCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHH
T ss_pred             eCCcceeccCCccccccccccccccCCCccccCHHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHH
Confidence            99999876653221    12233567899999999998755 89999999999999999999999987544210      


Q ss_pred             -----------CCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         243 -----------TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       243 -----------~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                                 .........+.+++..|....|..+|++.++
T Consensus       228 i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el  269 (483)
T 3sv0_A          228 ISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYL  269 (483)
T ss_dssp             HHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHH
T ss_pred             HhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHH
Confidence                       0001224568888888988999888887753

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.1e-40  Score=284.43  Aligned_cols=242  Identities=21%  Similarity=0.294  Sum_probs=191.5

Q ss_pred             cccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC---CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCC
Q psy2172          14 TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG---LSMSACREIALLRELKHPNVINLISVFLSHND   90 (291)
Q Consensus        14 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   90 (291)
                      ....+.|.+ .+.||+|+||.||+|.+.   +++.||+|++....   ....+.+|+.+++.++||||+++++++  .+.
T Consensus        26 ~~~~~~y~~-~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~~~   99 (326)
T 3uim_A           26 QVASDNFSN-KNILGRGGFGKVYKGRLA---DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC--MTP   99 (326)
T ss_dssp             HTTTTSSCS-TTEEECCSSSEEEEECCS---SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE--CCS
T ss_pred             HHHhhcccc-ceeEecCCCcEEEEEEec---CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE--ecC
Confidence            445677885 679999999999999753   56789999987543   233688999999999999999999999  556


Q ss_pred             ceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeeccCCCcEEeecCCCCC
Q psy2172          91 RKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSN---WVLHRDLKPANILVMGEGIER  166 (291)
Q Consensus        91 ~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~dik~~Nil~~~~~~~~  166 (291)
                      ...++||||+.+ +|.+.+......     ...+++..++.++.|++.||++||++   |++|+||||+||+++    .+
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~----~~  170 (326)
T 3uim_A          100 TERLLVYPYMANGSVASCLRERPES-----QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD----EE  170 (326)
T ss_dssp             SCCEEEEECCTTCBHHHHHHCCSTT-----CCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEEC----TT
T ss_pred             CceEEEEEeccCCCHHHHHHhcccc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEEC----CC
Confidence            678999999976 888877643322     22389999999999999999999999   999999999999998    67


Q ss_pred             CcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcc-------
Q psy2172         167 GRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE-------  239 (291)
Q Consensus       167 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~-------  239 (291)
                      +.++|+|||++........  .......||+.|+|||.+.+.. ++.++||||||+++|+|++|..||.....       
T Consensus       171 ~~~kl~Dfg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~  247 (326)
T 3uim_A          171 FEAVVGDFGLAKLMDYKDT--HVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM  247 (326)
T ss_dssp             CCEEECCCSSCEECCSSSS--CEECCCCSCGGGCCHHHHHHSE-ECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSB
T ss_pred             CCEEeccCccccccCcccc--cccccccCCcCccCHHHhccCC-CCccccchhHHHHHHHHHhCCCcccccccccccchh
Confidence            7999999999987654221  1223445899999999997755 89999999999999999999999952110       


Q ss_pred             ----------c-----c------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         240 ----------D-----I------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       240 ----------~-----~------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                                .     .      ..........+.+++..|..+.|..||++.++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el  302 (326)
T 3uim_A          248 LLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV  302 (326)
T ss_dssp             HHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHH
T ss_pred             HHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHH
Confidence                      0     0      01111223668888889999999999998864

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=5.7e-40  Score=278.21  Aligned_cols=247  Identities=21%  Similarity=0.312  Sum_probs=195.4

Q ss_pred             ccccccccceeCcccceEEEEEEEcc---CCCCceeEEEEeCCCCC---ChhHHHHHHHHhcC-CCCCeeeEEEEEEeCC
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKD---NSDTRDYALKQIEGTGL---SMSACREIALLREL-KHPNVINLISVFLSHN   89 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~---~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~   89 (291)
                      .++|.+ ++.||+|+||.||+|.+..   ..+++.||+|++.....   .+.+.+|+.+++++ +||||+++++++  .+
T Consensus        22 ~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~--~~   98 (313)
T 1t46_A           22 RNRLSF-GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC--TI   98 (313)
T ss_dssp             GGGEEE-EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--CS
T ss_pred             hhhhhH-HHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEE--ec
Confidence            356664 7799999999999998632   34667899999976543   24578999999999 899999999999  55


Q ss_pred             CceEEEEEecCCC-CHHHHHHHhhhhhh---------CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEe
Q psy2172          90 DRKVWLLFDYAEH-DLWHIIKFHRAAKA---------NKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILV  159 (291)
Q Consensus        90 ~~~~~iv~e~~~~-~l~~~~~~~~~~~~---------~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~  159 (291)
                      ....++||||+++ +|.+.+........         ......+++..++.++.|++.||++||++|++|+||||+||++
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~  178 (313)
T 1t46_A           99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL  178 (313)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence            6788999999975 99988876542100         0112238999999999999999999999999999999999999


Q ss_pred             ecCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCc
Q psy2172         160 MGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQ  238 (291)
Q Consensus       160 ~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~  238 (291)
                      +    .++.++|+|||.+........ ........++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+..
T Consensus       179 ~----~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~  252 (313)
T 1t46_A          179 T----HGRITKICDFGLARDIKNDSN-YVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (313)
T ss_dssp             E----TTTEEEECCCGGGSCTTSCTT-SEECSSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             c----CCCCEEEcccccccccccccc-ceeccCCCCcceeeChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence            8    678999999999987654322 11233456788999999987644 8999999999999999998 999998765


Q ss_pred             ccc-----------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         239 EDI-----------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       239 ~~~-----------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      ...           ..........+.+++..|..+.|..||++.+
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e  297 (313)
T 1t46_A          253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQ  297 (313)
T ss_dssp             SSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             chhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHH
Confidence            321           1122334577899999999999999888775

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=5.4e-40  Score=275.15  Aligned_cols=238  Identities=22%  Similarity=0.331  Sum_probs=188.1

Q ss_pred             cccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC---------hhHHHHHHHHhcCCCCCeeeEEEE
Q psy2172          14 TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS---------MSACREIALLRELKHPNVINLISV   84 (291)
Q Consensus        14 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~e~~~l~~l~h~~iv~~~~~   84 (291)
                      ....+.|++ .+.||+|+||.||+|.+..  +++.||+|.+......         +.+.+|+.++++++||||++++++
T Consensus        15 ~~~~~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   91 (287)
T 4f0f_A           15 TLADNEIEY-EKQIGKGGFGLVHKGRLVK--DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGL   91 (287)
T ss_dssp             BCCSTTEEE-EEECCCCSSSCEEEEEETT--TCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             hhhhcccee-hhccccCCceeEEEEEEcC--CceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhhee
Confidence            344567775 6799999999999999876  6788999998643221         568899999999999999999999


Q ss_pred             EEeCCCceEEEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeeccCCCcEEeec
Q psy2172          85 FLSHNDRKVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNW--VLHRDLKPANILVMG  161 (291)
Q Consensus        85 ~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~dik~~Nil~~~  161 (291)
                      +  .+..  ++||||+. ++|.+.+....        ..+++..++.++.|++.||++||++|  ++|+||||+||+++.
T Consensus        92 ~--~~~~--~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~  159 (287)
T 4f0f_A           92 M--HNPP--RMVMEFVPCGDLYHRLLDKA--------HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQS  159 (287)
T ss_dssp             E--TTTT--EEEEECCTTCBHHHHHHCTT--------SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESC
T ss_pred             e--cCCC--eEEEEecCCCCHHHHHhccc--------CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEec
Confidence            8  4443  69999998 58877775322        12899999999999999999999999  999999999999984


Q ss_pred             CC-CCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccC-CcCCCCchhHHHHHHHHHHHHcCCCCCCCCcc
Q psy2172         162 EG-IERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLG-ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE  239 (291)
Q Consensus       162 ~~-~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~  239 (291)
                      ++ .....++|+|||++.....      ......|++.|+|||.+.+ ...++.++||||||+++|+|++|..||.....
T Consensus       160 ~~~~~~~~~kl~Dfg~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  233 (287)
T 4f0f_A          160 LDENAPVCAKVADFGLSQQSVH------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY  233 (287)
T ss_dssp             CCTTCSCCEEECCCTTCBCCSS------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred             cCCCCceeEEeCCCCccccccc------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc
Confidence            32 1223499999999874332      1233567899999999843 23478899999999999999999999986543


Q ss_pred             cc-------------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         240 DI-------------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       240 ~~-------------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      ..             ........+.+.+++..|..+.|..||++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  279 (287)
T 4f0f_A          234 GKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSY  279 (287)
T ss_dssp             CHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             cHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHH
Confidence            21             1223344567899999999999988888774

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.7e-40  Score=280.80  Aligned_cols=239  Identities=20%  Similarity=0.293  Sum_probs=182.7

Q ss_pred             ccccccceeCcccceEEEEEEEccCC--CCceeEEEEeCCCCCC---hhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNS--DTRDYALKQIEGTGLS---MSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~--~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      .|. ..+.||+|+||.||+|.++...  .+..||+|.++.....   ..+.+|+.+++.++||||+++++++  .+....
T Consensus        45 ~~~-~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~~  121 (333)
T 1mqb_A           45 CVT-RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI--SKYKPM  121 (333)
T ss_dssp             TEE-EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE--CSSSSE
T ss_pred             Hhh-cccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE--ecCCCc
Confidence            344 3679999999999999986532  2346999999754322   3578899999999999999999999  667789


Q ss_pred             EEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          94 WLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        94 ~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      ++||||+++ +|.+.+.....        .+++..++.++.|++.||.+||++|++|+||||+||+++    .++.++|+
T Consensus       122 ~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~----~~~~~kl~  189 (333)
T 1mqb_A          122 MIITEYMENGALDKFLREKDG--------EFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN----SNLVCKVS  189 (333)
T ss_dssp             EEEEECCTTEEHHHHHHHTTT--------CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTCCEEEC
T ss_pred             EEEEeCCCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEEC----CCCcEEEC
Confidence            999999986 88887764321        289999999999999999999999999999999999998    67799999


Q ss_pred             ecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc----------c
Q psy2172         173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED----------I  241 (291)
Q Consensus       173 Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~----------~  241 (291)
                      |||.+.................++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+....          .
T Consensus       190 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~  268 (333)
T 1mqb_A          190 DFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR  268 (333)
T ss_dssp             CCCC-----------------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC
T ss_pred             CCCcchhhccccccccccCCCCccccccCchhcccCC-CCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCc
Confidence            9999987654322222223345577899999998744 8999999999999999998 99999765432          1


Q ss_pred             cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         242 KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       242 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      ..........+.+++..|..+.|..||++.++
T Consensus       269 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l  300 (333)
T 1mqb_A          269 LPTPMDCPSAIYQLMMQCWQQERARRPKFADI  300 (333)
T ss_dssp             CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             CCCcccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            11223445778899999999999999987764

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2e-40  Score=304.49  Aligned_cols=234  Identities=21%  Similarity=0.305  Sum_probs=184.3

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCC---CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecC
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG---LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYA  100 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~  100 (291)
                      ...||+|+||.||+|.++....+..||||+++...   ..+.+.+|+.+|++++||||+++++++.  + ...++||||+
T Consensus       341 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~--~-~~~~lv~E~~  417 (613)
T 2ozo_A          341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ--A-EALMLVMEMA  417 (613)
T ss_dssp             EEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEE--S-SSEEEEEECC
T ss_pred             CcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEec--c-CCeEEEEEeC
Confidence            44899999999999998765567789999997543   3457899999999999999999999984  2 4589999999


Q ss_pred             CC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeeccccee
Q psy2172         101 EH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARL  179 (291)
Q Consensus       101 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~  179 (291)
                      .+ +|.+++....        ..+++..++.++.|++.||+|||++||+|+||||+||+++    .++.++|+|||++..
T Consensus       418 ~~g~L~~~l~~~~--------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~----~~~~vkL~DFGla~~  485 (613)
T 2ozo_A          418 GGGPLHKFLVGKR--------EEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLV----NRHYAKISDFGLSKA  485 (613)
T ss_dssp             TTCBHHHHHTTCT--------TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE----ETTEEEECCCSTTTT
T ss_pred             CCCcHHHHHhhcc--------CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEc----CCCcEEEeeccCccc
Confidence            85 7777764322        1289999999999999999999999999999999999999    667999999999986


Q ss_pred             cCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc----------cCCCCCc
Q psy2172         180 FNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI----------KTSNPYH  248 (291)
Q Consensus       180 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~----------~~~~~~~  248 (291)
                      ...............++..|+|||++.+.. ++.++||||||+++|+|++ |..||.+.....          .......
T Consensus       486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~  564 (613)
T 2ozo_A          486 LGADDSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC  564 (613)
T ss_dssp             CC--------------CCTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTC
T ss_pred             ccCCCceeeeccCCCCccceeCHhhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcC
Confidence            544322222222334567899999997644 8999999999999999998 999998765421          1223345


Q ss_pred             HHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         249 HDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       249 ~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      ...+.+++..|....|..||++.++
T Consensus       565 ~~~l~~li~~cl~~dP~~RPs~~~l  589 (613)
T 2ozo_A          565 PPELYALMSDCWIYKWEDRPDFLTV  589 (613)
T ss_dssp             CHHHHHHHHHTTCSSTTTSCCHHHH
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHH
Confidence            6788899999999999999887753

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.4e-40  Score=284.50  Aligned_cols=244  Identities=15%  Similarity=0.146  Sum_probs=184.1

Q ss_pred             ccccccccceeCcccceEEEEEEEcc-CCCCceeEEEEeCCCCC-------------ChhHHHHHHHHhcCCCCCeeeEE
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKD-NSDTRDYALKQIEGTGL-------------SMSACREIALLRELKHPNVINLI   82 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~~~~vaiK~~~~~~~-------------~~~~~~e~~~l~~l~h~~iv~~~   82 (291)
                      .+.|.+ ++.||+|+||.||+|.+.. ..++..+|+|.......             ...+.+|+.+++.++||||++++
T Consensus        36 ~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~  114 (345)
T 2v62_A           36 GNQWVL-GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY  114 (345)
T ss_dssp             SCEEEE-EEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred             CceEEE-EeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence            456775 7799999999999999864 22456799999875431             22356788889999999999999


Q ss_pred             EEEEe--CCCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEee
Q psy2172          83 SVFLS--HNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVM  160 (291)
Q Consensus        83 ~~~~~--~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~  160 (291)
                      +++..  .+....|+||||++++|.+++....         .+++..++.++.|++.||+|||++||+|+||||+||+++
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~  185 (345)
T 2v62_A          115 GSGLTEFKGRSYRFMVMERLGIDLQKISGQNG---------TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLG  185 (345)
T ss_dssp             EEEEEESSSCEEEEEEEECEEEEHHHHCBGGG---------BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE
T ss_pred             cccccccCCCcEEEEEEeccCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEc
Confidence            99865  2367899999999779888776433         289999999999999999999999999999999999998


Q ss_pred             cCCCCCCcEEEeecccceecCCCCCC----CCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCC
Q psy2172         161 GEGIERGRVKIADMGFARLFNNPLKP----LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  236 (291)
Q Consensus       161 ~~~~~~~~~~l~Dfg~~~~~~~~~~~----~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~  236 (291)
                      .+  ....++|+|||+++........    ........|+..|+|||++.+.. ++.++||||||+++|+|++|..||.+
T Consensus       186 ~~--~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~pf~~  262 (345)
T 2v62_A          186 YK--NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVA-LSRRSDVEILGYCMLRWLCGKLPWEQ  262 (345)
T ss_dssp             SS--STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred             cC--CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCccc
Confidence            43  2238999999999876432111    11113457899999999998754 89999999999999999999999965


Q ss_pred             Cccccc-----------CCC---------CCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         237 RQEDIK-----------TSN---------PYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       237 ~~~~~~-----------~~~---------~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      ...+..           ...         ....+.+.+++..|..+.|..||++.++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  319 (345)
T 2v62_A          263 NLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQAL  319 (345)
T ss_dssp             GTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHH
T ss_pred             cccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHH
Confidence            322210           000         0334578889999999999999987763

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3.6e-40  Score=281.36  Aligned_cols=241  Identities=22%  Similarity=0.308  Sum_probs=185.5

Q ss_pred             ccccccccccceeCcccceEEEEEEEccCCC--CceeEEEEeCCC---CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCC
Q psy2172          15 KVEDLFDYEGCKVGRGTYGHVYKARRKDNSD--TRDYALKQIEGT---GLSMSACREIALLRELKHPNVINLISVFLSHN   89 (291)
Q Consensus        15 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~--~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   89 (291)
                      ...+.|++ .++||+|+||.||+|.+..++.  ...||+|.+...   .....+.+|+.++++++||||+++++++..  
T Consensus        12 l~~~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--   88 (327)
T 3poz_A           12 LKETEFKK-IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT--   88 (327)
T ss_dssp             CCGGGEEE-EEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES--
T ss_pred             cCHHHccc-ceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec--
Confidence            34456774 6799999999999999865322  123688887543   234578899999999999999999999953  


Q ss_pred             CceEEEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCc
Q psy2172          90 DRKVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGR  168 (291)
Q Consensus        90 ~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~  168 (291)
                      . ..+++++++. ++|.+.+.....        .+++..++.++.|++.||+|||++||+|+||||+||+++    .++.
T Consensus        89 ~-~~~~v~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~----~~~~  155 (327)
T 3poz_A           89 S-TVQLITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK----TPQH  155 (327)
T ss_dssp             S-SEEEEEECCTTCBHHHHHHHSTT--------SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE----ETTE
T ss_pred             C-CeEEEEEecCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEEC----CCCC
Confidence            3 3677888887 588887765332        289999999999999999999999999999999999998    6678


Q ss_pred             EEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc------
Q psy2172         169 VKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI------  241 (291)
Q Consensus       169 ~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~------  241 (291)
                      ++|+|||+++........ .......+|..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+.....      
T Consensus       156 ~kl~Dfg~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~  233 (327)
T 3poz_A          156 VKITDFGLAKLLGAEEKE-YHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE  233 (327)
T ss_dssp             EEECCTTHHHHHTTTCC--------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred             EEEccCcceeEccCCccc-ccccCCCccccccChHHhccCC-CCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH
Confidence            999999999876543221 1223345678899999998744 8999999999999999999 999998765421      


Q ss_pred             ----cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         242 ----KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       242 ----~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                          ....+.....+.+++..|....|..||++.++
T Consensus       234 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~el  269 (327)
T 3poz_A          234 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFREL  269 (327)
T ss_dssp             TTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHH
T ss_pred             cCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence                22334456678899999999999999988764

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3.8e-40  Score=293.10  Aligned_cols=234  Identities=20%  Similarity=0.322  Sum_probs=188.2

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLL   96 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv   96 (291)
                      +.|.+ .+.||+|+||.||+|.++   .+..||||.++... ..+.+.+|+.+|++++||||+++++++  . ....++|
T Consensus       188 ~~~~~-~~~lG~G~fg~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~--~-~~~~~lv  260 (454)
T 1qcf_A          188 ESLKL-EKKLGAGQFGEVWMATYN---KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV--T-KEPIYII  260 (454)
T ss_dssp             GGEEE-EEEEECCSSEEEEEEEET---TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEE--C-SSSCEEE
T ss_pred             HHeEE-EEEcccCCceEEEEEEEC---CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEE--e-CCccEEE
Confidence            34553 679999999999999985   35679999997643 345789999999999999999999998  3 4568999


Q ss_pred             EecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecc
Q psy2172          97 FDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMG  175 (291)
Q Consensus        97 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg  175 (291)
                      |||+. |+|.+++.......       ++...++.++.|++.||+|||++||+|+||||+||+++    .++.++|+|||
T Consensus       261 ~e~~~~g~L~~~l~~~~~~~-------~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~----~~~~~kl~DFG  329 (454)
T 1qcf_A          261 TEFMAKGSLLDFLKSDEGSK-------QPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS----ASLVCKIADFG  329 (454)
T ss_dssp             ECCCTTCBHHHHHHSHHHHT-------CCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEEC----TTCCEEECSTT
T ss_pred             EeecCCCcHHHHHHhccCCC-------CCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEC----CCCcEEEeeCC
Confidence            99997 48988887543222       78899999999999999999999999999999999998    67899999999


Q ss_pred             cceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc----------ccCC
Q psy2172         176 FARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED----------IKTS  244 (291)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~----------~~~~  244 (291)
                      ++........  .......++..|+|||++.+.. ++.++||||||+++|+|++ |..||.+....          ....
T Consensus       330 ~a~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~  406 (454)
T 1qcf_A          330 LARVIEDNEY--TAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR  406 (454)
T ss_dssp             GGGGBCCHHH--HTTCSSSSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCC
T ss_pred             CceEcCCCce--eccCCCcccccccCHHHhccCC-CCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            9986543211  1112334577899999997644 8999999999999999999 99999875432          1112


Q ss_pred             CCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         245 NPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       245 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      .....+.+.+++..|....|..||++.+
T Consensus       407 ~~~~~~~l~~li~~cl~~dp~~RPt~~~  434 (454)
T 1qcf_A          407 PENCPEELYNIMMRCWKNRPEERPTFEY  434 (454)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCHHHHHHHHHHccCChhHCcCHHH
Confidence            2344577889999999999999888775

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.2e-39  Score=274.01  Aligned_cols=242  Identities=26%  Similarity=0.385  Sum_probs=194.2

Q ss_pred             ceeCcccceEEEEEEEccCCCCceeEEEEeCCCC--CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEecCC-
Q psy2172          25 CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG--LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAE-  101 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~~~-  101 (291)
                      ..||+|+||.||+|.+..  +++.||+|.+....  ..+.+.+|+.+++.++||||+++++++  .+....++||||++ 
T Consensus        28 ~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~~~~~~~lv~e~~~~  103 (295)
T 2clq_A           28 VVLGKGTYGIVYAGRDLS--NQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF--SENGFIKIFMEQVPG  103 (295)
T ss_dssp             CEEEECSSSEEEEEEETT--TCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEE--EETTEEEEEEECCSE
T ss_pred             EEEeecCcEEEEEEEECC--CCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEE--EeCCcEEEEEEeCCC
Confidence            489999999999999876  67889999986542  345688999999999999999999999  44668999999997 


Q ss_pred             CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceecC
Q psy2172         102 HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFN  181 (291)
Q Consensus       102 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~~  181 (291)
                      ++|.+.+.....      ...+++..++.++.|++.||.+||++|++|+||+|+||+++.   ..+.++|+|||.+....
T Consensus       104 ~~L~~~l~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~---~~~~~kl~Dfg~~~~~~  174 (295)
T 2clq_A          104 GSLSALLRSKWG------PLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINT---YSGVLKISDFGTSKRLA  174 (295)
T ss_dssp             EEHHHHHHHTTC------CCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET---TTCCEEECCTTTCEESC
T ss_pred             CCHHHHHHhhcc------CCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEEC---CCCCEEEeecccccccC
Confidence            488877765321      122678899999999999999999999999999999999983   26789999999998764


Q ss_pred             CCCCCCCCCCCceecccccccccccCC-cCCCCchhHHHHHHHHHHHHcCCCCCCCCccc------------ccCCCCCc
Q psy2172         182 NPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQED------------IKTSNPYH  248 (291)
Q Consensus       182 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~------------~~~~~~~~  248 (291)
                      ....   ......|+..|+|||.+.+. ..++.++|+||||+++|+|++|..||......            ........
T Consensus       175 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (295)
T 2clq_A          175 GINP---CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESM  251 (295)
T ss_dssp             C--------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTS
T ss_pred             CCCC---cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccC
Confidence            3211   12345689999999998653 23788999999999999999999999754321            11223344


Q ss_pred             HHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhh
Q psy2172         249 HDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKD  282 (291)
Q Consensus       249 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (291)
                      ...+.+++..|..+.|..||++.++..++++...
T Consensus       252 ~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  285 (295)
T 2clq_A          252 SAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS  285 (295)
T ss_dssp             CHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence            6778999999999999999999999999887644

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.3e-40  Score=278.74  Aligned_cols=236  Identities=24%  Similarity=0.268  Sum_probs=181.1

Q ss_pred             cccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC-----ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCC
Q psy2172          16 VEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-----SMSACREIALLRELKHPNVINLISVFLSHND   90 (291)
Q Consensus        16 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   90 (291)
                      .-+.|.+ .+.||+|+||.||+|.+..  +++.||+|++.....     ...+.+|+.++++++||||+++++++.  +.
T Consensus        32 ~~~~y~~-~~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~--~~  106 (309)
T 2h34_A           32 QFGPYRL-RRLVGRGGMGDVYEAEDTV--RERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGE--ID  106 (309)
T ss_dssp             --CCEEE-EEEEEECSSSEEEEEEETT--TTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE--ET
T ss_pred             EeccEEE-EEEEcCCCCeeEEEEEEcC--CCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe--eC
Confidence            3456775 6799999999999999876  678899999875422     245789999999999999999999994  46


Q ss_pred             ceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcE
Q psy2172          91 RKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRV  169 (291)
Q Consensus        91 ~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~  169 (291)
                      ...+++|||+++ +|.+.+....         .+++..++.++.|++.||.+||++|++|+||||+||+++    .++.+
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~----~~~~~  173 (309)
T 2h34_A          107 GQLYVDMRLINGVDLAAMLRRQG---------PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVS----ADDFA  173 (309)
T ss_dssp             TEEEEEEECCCCEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTSCE
T ss_pred             CeEEEEEEecCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEc----CCCCE
Confidence            689999999986 8888876532         289999999999999999999999999999999999998    66799


Q ss_pred             EEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc---------
Q psy2172         170 KIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED---------  240 (291)
Q Consensus       170 ~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~---------  240 (291)
                      +|+|||++........  .......|+..|+|||.+.+.. ++.++|+||||+++|+|++|..||.+....         
T Consensus       174 kl~Dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  250 (309)
T 2h34_A          174 YLVDFGIASATTDEKL--TQLGNTVGTLYYMAPERFSESH-ATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQA  250 (309)
T ss_dssp             EECSCCC------------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSC
T ss_pred             EEecCccCcccccccc--ccccccCCCcCccCHHHHcCCC-CCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccC
Confidence            9999999876543211  1223456899999999998744 889999999999999999999999875532         


Q ss_pred             ---ccCCCCCcHHHHHHHHHhhCCCCcCChh-hhhc
Q psy2172         241 ---IKTSNPYHHDQLDRIFSVMGFPLEKDWE-DIRK  272 (291)
Q Consensus       241 ---~~~~~~~~~~~~~~i~~~~~~~~~~~~~-~~~~  272 (291)
                         .....+.....+.+++..|..+.|..|| ++.+
T Consensus       251 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~  286 (309)
T 2h34_A          251 IPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGD  286 (309)
T ss_dssp             CCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHH
T ss_pred             CCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHH
Confidence               1112233456788899999999998887 5554

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.1e-39  Score=276.57  Aligned_cols=252  Identities=22%  Similarity=0.294  Sum_probs=184.7

Q ss_pred             ccccccc-cccccccceeCcccceEEEEEEEccC-CCCceeEEEEeCCCCCC----hhHHHHHHHHhcCCCCCeeeEEEE
Q psy2172          11 NERTKVE-DLFDYEGCKVGRGTYGHVYKARRKDN-SDTRDYALKQIEGTGLS----MSACREIALLRELKHPNVINLISV   84 (291)
Q Consensus        11 ~~~~~~~-~~~~~~~~~ig~G~~g~Vy~~~~~~~-~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~   84 (291)
                      .....+. +.|. .++.||+|+||.||+|.+... .++..||+|.+......    ..+.+|+.++++++||||++++++
T Consensus        26 ~~~~~~~~~~y~-~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~  104 (313)
T 3brb_A           26 LEDVVIDRNLLI-LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGV  104 (313)
T ss_dssp             TTTTBCCGGGEE-EEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred             HHhcccCHHHee-eccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence            3333333 3455 478999999999999987642 34567999998754333    357889999999999999999999


Q ss_pred             EEeCCCc---eEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEee
Q psy2172          85 FLSHNDR---KVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVM  160 (291)
Q Consensus        85 ~~~~~~~---~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~  160 (291)
                      +...+..   ..+++|||+.+ +|.+.+.......   ....+++..++.++.|++.||.|||++|++|+||||+||+++
T Consensus       105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~  181 (313)
T 3brb_A          105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLET---GPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR  181 (313)
T ss_dssp             EEC-------CEEEEEECCTTCBHHHHHHHTTBTT---SCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEEC
T ss_pred             EeeccccCCcccEEEEecccCCCHHHHHHHhhhhc---CCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc
Confidence            8654332   56999999985 8888876543221   122389999999999999999999999999999999999998


Q ss_pred             cCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcc
Q psy2172         161 GEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQE  239 (291)
Q Consensus       161 ~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~  239 (291)
                          .++.++|+|||++........ ........++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+...
T Consensus       182 ----~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~  255 (313)
T 3brb_A          182 ----DDMTVCVADFGLSKKIYSGDY-YRQGRIAKMPVKWIAIESLADRV-YTSKSDVWAFGVTMWEIATRGMTPYPGVQN  255 (313)
T ss_dssp             ----TTSCEEECSCSCC-----------------CCGGGSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             ----CCCcEEEeecCcceecccccc-cCcccccCCCccccCchhhcCCC-ccchhhhHHHHHHHHHHHhcCCCCCccCCH
Confidence                667899999999976544221 11223345678899999998744 8999999999999999999 8999987654


Q ss_pred             cc----------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         240 DI----------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       240 ~~----------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      ..          ........+.+.+++..|..+.|..||++.+
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  298 (313)
T 3brb_A          256 HEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSV  298 (313)
T ss_dssp             GGHHHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred             HHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHH
Confidence            31          1222334577889999999999988888775

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=4.1e-40  Score=281.81  Aligned_cols=262  Identities=22%  Similarity=0.355  Sum_probs=199.2

Q ss_pred             cccceeecccccccccccccccceeCcccceEEEEEEEccC-----CCCceeEEEEeCCCCCC---hhHHHHHHHHhcC-
Q psy2172           3 YEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDN-----SDTRDYALKQIEGTGLS---MSACREIALLREL-   73 (291)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~-----~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l-   73 (291)
                      ++|++.....-.-..+.|.+ ++.||+|+||.||+|.+...     .++..||+|++......   ..+.+|+.+++++ 
T Consensus        20 s~~~~~~~~~~~~~~~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~   98 (334)
T 2pvf_A           20 SEYELPEDPKWEFPRDKLTL-GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG   98 (334)
T ss_dssp             ---CCCCCTTTBCCGGGEEE-EEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHC
T ss_pred             ccccCCCCccccCCHhHeEE-eeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhh
Confidence            45555555555555677775 78999999999999998531     35677999999765432   3578899999999 


Q ss_pred             CCCCeeeEEEEEEeCCCceEEEEEecCCC-CHHHHHHHhhhhhh-------CCCCCCCCHHHHHHHHHHHHHHHHHHhhC
Q psy2172          74 KHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKA-------NKKPVMVPKGMVKSLLYQILDGIHYLHSN  145 (291)
Q Consensus        74 ~h~~iv~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~-------~~~~~~~~~~~~~~i~~ql~~~l~~LH~~  145 (291)
                      +||||+++++++  .+....++||||+++ +|.+++........       ......+++..++.++.|++.||.+||++
T Consensus        99 ~hp~iv~~~~~~--~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~  176 (334)
T 2pvf_A           99 KHKNIINLLGAC--TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ  176 (334)
T ss_dssp             CCTTBCCEEEEE--CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             cCCCEeeEEEEE--ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC
Confidence            899999999999  566789999999975 88888875432100       00112388999999999999999999999


Q ss_pred             CeeeeccCCCcEEeecCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHH
Q psy2172         146 WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFA  225 (291)
Q Consensus       146 ~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~  225 (291)
                      |++|+||||+||+++    .++.++|+|||++........ ........++..|+|||.+.+.. ++.++||||||+++|
T Consensus       177 ~ivH~Dlkp~NIll~----~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~  250 (334)
T 2pvf_A          177 KCIHRDLAARNVLVT----ENNVMKIADFGLARDINNIDY-YKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMW  250 (334)
T ss_dssp             TEECSCCSGGGEEEC----TTCCEEECCCTTCEECTTTSS-EECCSCCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHH
T ss_pred             CeeCCCCccceEEEc----CCCCEEEcccccccccccccc-ccccCCCCcccceeChHHhcCCC-cChHHHHHHHHHHHH
Confidence            999999999999998    677999999999987654321 11223345678899999987644 889999999999999


Q ss_pred             HHHc-CCCCCCCCccc----------ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         226 ELLT-SEPIFHCRQED----------IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       226 ~l~~-g~~pf~~~~~~----------~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      +|++ |..||.+....          ...........+.+++..|..+.|..||++.++
T Consensus       251 ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el  309 (334)
T 2pvf_A          251 EIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQL  309 (334)
T ss_dssp             HHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHhCCCCCcCcCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence            9999 99999875432          112233445778899999999999988887764

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.1e-40  Score=276.89  Aligned_cols=239  Identities=19%  Similarity=0.291  Sum_probs=187.3

Q ss_pred             ccccccccceeCcccceEEEEEEEccC-CCCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCce
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDN-SDTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLSHNDRK   92 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~-~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (291)
                      .+.|.+ .+.||+|+||.||+|.+... ..+..||+|.+.....   .+.+.+|+.+++.++||||+++++++  .+ ..
T Consensus        11 ~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~-~~   86 (281)
T 3cc6_A           11 REDVVL-NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGII--EE-EP   86 (281)
T ss_dssp             GGGEEE-EEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEE--CS-SS
T ss_pred             ccceEE-EEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEE--cC-CC
Confidence            455664 67999999999999997643 2445699999876432   34678899999999999999999998  33 34


Q ss_pred             EEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEE
Q psy2172          93 VWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI  171 (291)
Q Consensus        93 ~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l  171 (291)
                      .+++|||+++ +|.+.+.....        .+++..++.++.|++.||.+||++|++|+||||+||+++    .++.++|
T Consensus        87 ~~~v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~----~~~~~kl  154 (281)
T 3cc6_A           87 TWIIMELYPYGELGHYLERNKN--------SLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVA----SPECVKL  154 (281)
T ss_dssp             CEEEEECCTTCBHHHHHHHHTT--------TCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE----ETTEEEE
T ss_pred             CEEEEecCCCCCHHHHHHhccc--------cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEC----CCCcEEe
Confidence            6899999985 88888765332        188999999999999999999999999999999999998    6679999


Q ss_pred             eecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc----------
Q psy2172         172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED----------  240 (291)
Q Consensus       172 ~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~----------  240 (291)
                      +|||.+........  .......++..|+|||.+.+.. ++.++||||||+++|+|++ |..||......          
T Consensus       155 ~Dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~  231 (281)
T 3cc6_A          155 GDFGLSRYIEDEDY--YKASVTRLPIKWMSPESINFRR-FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD  231 (281)
T ss_dssp             CCCCGGGCC-----------CCCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTC
T ss_pred             CccCCCcccccccc--cccccCCCCcceeCchhhccCC-CCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCC
Confidence            99999986544221  1223345678899999997644 8999999999999999998 99999754432          


Q ss_pred             ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCC
Q psy2172         241 IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMP  274 (291)
Q Consensus       241 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  274 (291)
                      .........+.+.+++..|..+.|..||++.++.
T Consensus       232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell  265 (281)
T 3cc6_A          232 RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELV  265 (281)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence            1122333457789999999999999999887643

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.7e-40  Score=281.19  Aligned_cols=247  Identities=23%  Similarity=0.340  Sum_probs=192.2

Q ss_pred             cccccccccccccceeCcccceEEEEEEEc--cCCCCceeEEEEeCCCCC--ChhHHHHHHHHhcCCCCCeeeEEEEEEe
Q psy2172          12 ERTKVEDLFDYEGCKVGRGTYGHVYKARRK--DNSDTRDYALKQIEGTGL--SMSACREIALLRELKHPNVINLISVFLS   87 (291)
Q Consensus        12 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~--~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~   87 (291)
                      +.....+.|++ .+.||+|+||.||+|.+.  +..+++.||+|.+.....  .+.+.+|+.++++++||||+++++++..
T Consensus        35 ~~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  113 (326)
T 2w1i_A           35 PTQFEERHLKF-LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYS  113 (326)
T ss_dssp             --CCCGGGEEE-EEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC
T ss_pred             ccccCHHHcee-eeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Confidence            33444556664 779999999999999853  233678899999975432  2468899999999999999999999865


Q ss_pred             CCCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCC
Q psy2172          88 HNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIER  166 (291)
Q Consensus        88 ~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~  166 (291)
                      .+....++||||+++ +|.+.+.....        .+++..++.++.|++.||++||++|++|+||||+||+++    .+
T Consensus       114 ~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~----~~  181 (326)
T 2w1i_A          114 AGRRNLKLIMEYLPYGSLRDYLQKHKE--------RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE----NE  181 (326)
T ss_dssp             ----CCEEEECCCTTCBHHHHHHHSTT--------SSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE----ET
T ss_pred             cCCCceEEEEECCCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEc----CC
Confidence            555688999999975 88888865432        288999999999999999999999999999999999998    66


Q ss_pred             CcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc------
Q psy2172         167 GRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED------  240 (291)
Q Consensus       167 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~------  240 (291)
                      +.++|+|||++.................++..|+|||.+.+.. ++.++||||||+++|+|++|..||......      
T Consensus       182 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~  260 (326)
T 2w1i_A          182 NRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG  260 (326)
T ss_dssp             TEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHC
T ss_pred             CcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCC-CCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhc
Confidence            7999999999987655432222223445677899999997754 789999999999999999999998743110      


Q ss_pred             --------------------ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         241 --------------------IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       241 --------------------~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                                          ...........+.+++..|..+.|..||++.+
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e  312 (326)
T 2w1i_A          261 NDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRD  312 (326)
T ss_dssp             TTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             cccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHH
Confidence                                01122334577888999999999999988775

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.6e-40  Score=278.78  Aligned_cols=251  Identities=27%  Similarity=0.427  Sum_probs=193.4

Q ss_pred             ccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-CChhHHHHHHHHhcCCCCCeeeEEEEEEeC-----
Q psy2172          15 KVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-LSMSACREIALLRELKHPNVINLISVFLSH-----   88 (291)
Q Consensus        15 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----   88 (291)
                      ++.+.|++ .+.||+|+||.||+|.+..  +++.||+|.+.... ....+.+|+.++++++||||+++++++...     
T Consensus         3 ~~~~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (303)
T 1zy4_A            3 RYASDFEE-IAVLGQGAFGQVVKARNAL--DSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK   79 (303)
T ss_dssp             HHHHHEEE-EEEEEECSSEEEEEEEETT--TCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred             cccccchh-hheeccCCcEEEEEEEEcC--CCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence            45567775 6799999999999999876  67889999986432 234678999999999999999999988642     


Q ss_pred             ------CCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeec
Q psy2172          89 ------NDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMG  161 (291)
Q Consensus        89 ------~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~  161 (291)
                            +....|+||||+++ +|.+.+.....        .+++..++.++.|++.||++||++|++|+||||+||+++ 
T Consensus        80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~-  150 (303)
T 1zy4_A           80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSENL--------NQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFID-  150 (303)
T ss_dssp             ------CEEEEEEEEECCCSCBHHHHHHHSCG--------GGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC-
T ss_pred             hhcccccCCceEEEEecCCCCCHHHhhhcccc--------ccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEc-
Confidence                  35689999999975 98888875332        178889999999999999999999999999999999998 


Q ss_pred             CCCCCCcEEEeecccceecCCCCC-----------CCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcC
Q psy2172         162 EGIERGRVKIADMGFARLFNNPLK-----------PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS  230 (291)
Q Consensus       162 ~~~~~~~~~l~Dfg~~~~~~~~~~-----------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g  230 (291)
                         .++.++|+|||.+........           .........|+..|+|||.+.+...++.++||||||+++|+|++ 
T Consensus       151 ---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-  226 (303)
T 1zy4_A          151 ---ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY-  226 (303)
T ss_dssp             ---TTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS-
T ss_pred             ---CCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh-
Confidence               667899999999986543211           01122345688999999999875568999999999999999998 


Q ss_pred             CCCCCCCccc--------------ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhhh
Q psy2172         231 EPIFHCRQED--------------IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF  283 (291)
Q Consensus       231 ~~pf~~~~~~--------------~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (291)
                        ||......              ...........+.+++..|..+.|..||++.++.++||+....
T Consensus       227 --p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (303)
T 1zy4_A          227 --PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH  291 (303)
T ss_dssp             --CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCC
T ss_pred             --ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCC
Confidence              44321110              1112223345688999999999999999999999999986443

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.1e-39  Score=273.57  Aligned_cols=239  Identities=21%  Similarity=0.356  Sum_probs=178.4

Q ss_pred             cccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC----hhHHHHHHHHhcCCCCCeeeEEEEEEe
Q psy2172          12 ERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIALLRELKHPNVINLISVFLS   87 (291)
Q Consensus        12 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~   87 (291)
                      ..+...+.|++ +++||+|+||.||+|.+.     ..+|+|+++.....    +.+.+|+.++++++||||++++++.  
T Consensus        18 ~~ei~~~~y~~-~~~lG~G~~g~Vy~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--   89 (289)
T 3og7_A           18 DWEIPDGQITV-GQRIGSGSFGTVYKGKWH-----GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS--   89 (289)
T ss_dssp             CCBCCTTSCEE-EEEEEECSSEEEEEEESS-----SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE--
T ss_pred             CCccCccceee-eeEecCCCCeEEEEEEEc-----CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec--
Confidence            34555667875 779999999999999854     24999998754333    4578999999999999999999965  


Q ss_pred             CCCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCC
Q psy2172          88 HNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIER  166 (291)
Q Consensus        88 ~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~  166 (291)
                       .....++||||+.+ +|.+.+.....        .+++..++.++.|++.||++||++|++|+||||+||+++    .+
T Consensus        90 -~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~----~~  156 (289)
T 3og7_A           90 -TAPQLAIVTQWCEGSSLYHHLHASET--------KFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLH----ED  156 (289)
T ss_dssp             -CSSSCEEEEECCCEEEHHHHHTTC-----------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE----TT
T ss_pred             -cCCccEEEEEecCCCcHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC----CC
Confidence             34568999999985 77776643221        289999999999999999999999999999999999999    66


Q ss_pred             CcEEEeecccceecCCCCCCCCCCCCceecccccccccccC--CcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc----
Q psy2172         167 GRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLG--ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED----  240 (291)
Q Consensus       167 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~----  240 (291)
                      +.++|+|||++........ ........|+..|+|||.+..  ...++.++||||||+++|+|++|..||.+....    
T Consensus       157 ~~~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~  235 (289)
T 3og7_A          157 NTVKIGDFGLATEKSRWSG-SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII  235 (289)
T ss_dssp             TEEEECCCC-------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHH
T ss_pred             CCEEEccceeccccccccc-cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHH
Confidence            7999999999976543211 122234578999999999862  234788999999999999999999999875432    


Q ss_pred             -----------ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         241 -----------IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       241 -----------~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                                 .........+.+.+++..|..+.|..||++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~e  278 (289)
T 3og7_A          236 EMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPR  278 (289)
T ss_dssp             HHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHH
Confidence                       11122234567888999999999988887764

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.9e-40  Score=281.72  Aligned_cols=236  Identities=19%  Similarity=0.247  Sum_probs=183.4

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCce----eEEEEeCCCC---CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCC
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRD----YALKQIEGTG---LSMSACREIALLRELKHPNVINLISVFLSHND   90 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~----vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   90 (291)
                      +.|++ .++||+|+||.||+|.+..  +++.    |++|.+....   ....+.+|+.+++.++||||+++++++  . .
T Consensus        13 ~~y~~-~~~lG~G~~g~Vy~~~~~~--~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~-~   86 (325)
T 3kex_A           13 TELRK-LKVLGSGVFGTVHKGVWIP--EGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLC--P-G   86 (325)
T ss_dssp             TTEEE-EEEEECCSSCEEEEEEECC--TTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEE--C-B
T ss_pred             hHcee-eeeeeecCCceEEEEEEcC--CCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEE--c-C
Confidence            45564 6799999999999999876  3333    7888775432   234677899999999999999999988  3 4


Q ss_pred             ceEEEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcE
Q psy2172          91 RKVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRV  169 (291)
Q Consensus        91 ~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~  169 (291)
                      ...++||||+. ++|.+.+.....        .+++..++.++.|++.||+|||++||+|+||||+||+++    ..+.+
T Consensus        87 ~~~~~v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~----~~~~~  154 (325)
T 3kex_A           87 SSLQLVTQYLPLGSLLDHVRQHRG--------ALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLK----SPSQV  154 (325)
T ss_dssp             SSEEEEEECCTTCBSHHHHHSSGG--------GSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEES----SSSCE
T ss_pred             CccEEEEEeCCCCCHHHHHHHccc--------cCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEEC----CCCeE
Confidence            56889999997 588887764322        188899999999999999999999999999999999998    67789


Q ss_pred             EEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc--------
Q psy2172         170 KIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED--------  240 (291)
Q Consensus       170 ~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~--------  240 (291)
                      +|+|||++......... .......++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+....        
T Consensus       155 kl~Dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~  232 (325)
T 3kex_A          155 QVADFGVADLLPPDDKQ-LLYSEAKTPIKWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK  232 (325)
T ss_dssp             EECSCSGGGGSCCCTTC-CC-----CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHT
T ss_pred             EECCCCcccccCccccc-ccccCCCCcccccChHHhccCC-CChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHc
Confidence            99999999876543221 1223456677899999998644 8999999999999999999 99999876532        


Q ss_pred             --ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         241 --IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       241 --~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                        ...........+.+++..|....|..||++.++
T Consensus       233 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el  267 (325)
T 3kex_A          233 GERLAQPQICTIDVYMVMVKCWMIDENIRPTFKEL  267 (325)
T ss_dssp             TCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHH
T ss_pred             CCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHH
Confidence              111222334557778888888888888887654

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=6.3e-40  Score=273.57  Aligned_cols=231  Identities=16%  Similarity=0.292  Sum_probs=183.7

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLF   97 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~   97 (291)
                      +.|++ .+.||+|+||.||+|.+.    ++.||+|+++.....+.+.+|+.++++++||||+++++++.. .....++||
T Consensus        21 ~~y~~-~~~lg~G~~g~V~~~~~~----~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~~lv~   94 (278)
T 1byg_A           21 KELKL-LQTIGKGEFGDVMLGDYR----GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE-EKGGLYIVT   94 (278)
T ss_dssp             GGEEE-EEEEEECSSCEEEEEEET----TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECC-C--CCEEEE
T ss_pred             hhceE-EeEEecCCCceEEEEEEc----CCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCCceEEEE
Confidence            55664 679999999999999864    578999999887777889999999999999999999999743 345789999


Q ss_pred             ecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeeccc
Q psy2172          98 DYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGF  176 (291)
Q Consensus        98 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~  176 (291)
                      ||+++ +|.+.+.......       +++..++.++.|++.||++||++|++|+||||+||+++    .++.++|+|||.
T Consensus        95 e~~~~~~L~~~l~~~~~~~-------~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~----~~~~~~l~Dfg~  163 (278)
T 1byg_A           95 EYMAKGSLVDYLRSRGRSV-------LGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS----EDNVAKVSDFGL  163 (278)
T ss_dssp             CCCTTEEHHHHHHHHHHHH-------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----TTSCEEECCCCC
T ss_pred             ecCCCCCHHHHHHhccccc-------CCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEe----CCCcEEEeeccc
Confidence            99986 9998887654322       78899999999999999999999999999999999998    667999999999


Q ss_pred             ceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc----------cCCC
Q psy2172         177 ARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI----------KTSN  245 (291)
Q Consensus       177 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~----------~~~~  245 (291)
                      +......      .....++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||.......          ....
T Consensus       164 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~  236 (278)
T 1byg_A          164 TKEASST------QDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP  236 (278)
T ss_dssp             ------------------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCC
T ss_pred             ccccccc------ccCCCccccccCHHHhCCCC-CCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCc
Confidence            8754432      12335678899999997644 8999999999999999998 999998754321          1223


Q ss_pred             CCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         246 PYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       246 ~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      ......+.+++..|..+.|..||++.+
T Consensus       237 ~~~~~~l~~li~~~l~~~p~~Rps~~~  263 (278)
T 1byg_A          237 DGCPPAVYEVMKNCWHLDAAMRPSFLQ  263 (278)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ccCCHHHHHHHHHHhcCChhhCCCHHH
Confidence            344677899999999999999988775

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.2e-40  Score=277.74  Aligned_cols=238  Identities=16%  Similarity=0.233  Sum_probs=185.0

Q ss_pred             ccccccccceeCcccceEEEEEEEccCCC-----CceeEEEEeCCC--CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCC
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDNSD-----TRDYALKQIEGT--GLSMSACREIALLRELKHPNVINLISVFLSHN   89 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~-----~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   89 (291)
                      .+.|.+ .+.||+|+||.||+|.++.++.     ...||+|.+...  ...+.+.+|+.++++++||||+++++++  .+
T Consensus         7 ~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~   83 (289)
T 4fvq_A            7 NEDLIF-NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVC--VC   83 (289)
T ss_dssp             GGGEEE-EEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEE--CC
T ss_pred             hhHeee-eeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEE--Ee
Confidence            456664 6799999999999999876332     256999998643  2335688999999999999999999999  55


Q ss_pred             CceEEEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCC----
Q psy2172          90 DRKVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGI----  164 (291)
Q Consensus        90 ~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~----  164 (291)
                      ....++||||++ ++|.+++......        +++..++.++.|++.||+|||++|++|+||||+||+++.+..    
T Consensus        84 ~~~~~lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~  155 (289)
T 4fvq_A           84 GDENILVQEFVKFGSLDTYLKKNKNC--------INILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTG  155 (289)
T ss_dssp             TTCCEEEEECCTTCBHHHHHHHTGGG--------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGT
T ss_pred             CCCCEEEEECCCCCCHHHHHHhCCCC--------CCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccc
Confidence            667899999998 5888888754332        889999999999999999999999999999999999985421    


Q ss_pred             CCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcC-CCCCCCCccc---
Q psy2172         165 ERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQED---  240 (291)
Q Consensus       165 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g-~~pf~~~~~~---  240 (291)
                      ....++|+|||.+......       ....|+..|+|||.+.+...++.++||||||+++|+|++| .+||......   
T Consensus       156 ~~~~~kl~Dfg~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~  228 (289)
T 4fvq_A          156 NPPFIKLSDPGISITVLPK-------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL  228 (289)
T ss_dssp             BCCEEEECCCCSCTTTSCH-------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred             ccceeeeccCcccccccCc-------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH
Confidence            1112999999998643321       2345688899999998745589999999999999999995 5666554321   


Q ss_pred             -----ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         241 -----IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       241 -----~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                           ...........+.+++..|..+.|..||++.+
T Consensus       229 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  265 (289)
T 4fvq_A          229 QFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRA  265 (289)
T ss_dssp             HHHHTTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHH
T ss_pred             HHhhccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHH
Confidence                 11122222455778888888888888888765

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.2e-40  Score=292.39  Aligned_cols=248  Identities=24%  Similarity=0.263  Sum_probs=187.1

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcC-CCCCeeeEEEEEEeCCCceEEEEE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLREL-KHPNVINLISVFLSHNDRKVWLLF   97 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~iv~   97 (291)
                      .|.+ .+.||+|+||+||.... .  +++.||||.+.... ...+.+|+.+++.+ +||||+++++++  .+....|+||
T Consensus        25 ~y~~-~~~LG~G~~G~V~~~~~-~--~~~~vAvK~~~~~~-~~~~~~E~~~l~~l~~HpnIv~l~~~~--~~~~~~~lv~   97 (432)
T 3p23_A           25 SFCP-KDVLGHGAEGTIVYRGM-F--DNRDVAVKRILPEC-FSFADREVQLLRESDEHPNVIRYFCTE--KDRQFQYIAI   97 (432)
T ss_dssp             EEEE-EEEEEECGGGCEEEEEE-S--SSSEEEEEEECTTT-EEECHHHHHHHHHSCCCTTBCCEEEEE--EETTEEEEEE
T ss_pred             EEec-CCeeecCcCEEEEEEEE-e--CCeEEEEEEECHHH-HHHHHHHHHHHHhccCCCCcCeEEEEE--ecCCEEEEEE
Confidence            3553 67999999999764332 2  56889999987542 34577899999999 799999999998  5577899999


Q ss_pred             ecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCC-CCCCcEEEeeccc
Q psy2172          98 DYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEG-IERGRVKIADMGF  176 (291)
Q Consensus        98 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~-~~~~~~~l~Dfg~  176 (291)
                      ||++++|.+.+......        .++..++.++.|++.||+|||++||+|+||||+||+++.++ .....++|+|||+
T Consensus        98 E~~~g~L~~~l~~~~~~--------~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~  169 (432)
T 3p23_A           98 ELCAATLQEYVEQKDFA--------HLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGL  169 (432)
T ss_dssp             ECCSEEHHHHHHSSSCC--------CCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred             ECCCCCHHHHHHhcCCC--------ccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence            99999999888643211        44445678999999999999999999999999999996432 1345789999999


Q ss_pred             ceecCCCCCCCCCCCCceecccccccccccC--CcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc------------
Q psy2172         177 ARLFNNPLKPLADLDPVVVTFWYRAPELLLG--ARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI------------  241 (291)
Q Consensus       177 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~------------  241 (291)
                      +.................||+.|+|||++.+  ...++.++|||||||++|+|++ |..||.......            
T Consensus       170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~  249 (432)
T 3p23_A          170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDC  249 (432)
T ss_dssp             EECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTT
T ss_pred             eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccc
Confidence            9876543332233345678999999999974  2347889999999999999999 999997643321            


Q ss_pred             cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         242 KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       242 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                      ..........+.+++..|..+.|..||++.++..||++..
T Consensus       250 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~  289 (432)
T 3p23_A          250 LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS  289 (432)
T ss_dssp             SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred             cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence            0111122445788999999999999999999999998753

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.2e-40  Score=279.19  Aligned_cols=239  Identities=25%  Similarity=0.368  Sum_probs=185.8

Q ss_pred             cccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhc--CCCCCeeeEEEEEEe--CC
Q psy2172          14 TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRE--LKHPNVINLISVFLS--HN   89 (291)
Q Consensus        14 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~--~~   89 (291)
                      ..+.+.|++ .+.||+|+||.||+|.+    +++.||+|++... ....+.+|.+++..  ++||||+++++++..  ..
T Consensus         4 ~~~~~~y~~-~~~lg~G~~g~V~~~~~----~~~~vavK~~~~~-~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~   77 (301)
T 3q4u_A            4 RTVARDITL-LECVGKGRYGEVWRGSW----QGENVAVKIFSSR-DEKSWFRETELYNTVMLRHENILGFIASDMTSRHS   77 (301)
T ss_dssp             CCCGGGCEE-EEEEEECSSEEEEEEEE----TTEEEEEEEECGG-GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETT
T ss_pred             ccccCcEEE-EEeeccCCCcEEEEEEE----CCEEEEEEEeccc-cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCC
Confidence            456778885 67999999999999986    4578999998754 34456667777776  799999999998754  34


Q ss_pred             CceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHh--------hCCeeeeccCCCcEEee
Q psy2172          90 DRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLH--------SNWVLHRDLKPANILVM  160 (291)
Q Consensus        90 ~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH--------~~~ivH~dik~~Nil~~  160 (291)
                      ....++||||+++ +|.+++...          .+++..++.++.|++.||+|||        ++|++|+||||+||+++
T Consensus        78 ~~~~~lv~e~~~~g~L~~~l~~~----------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~  147 (301)
T 3q4u_A           78 STQLWLITHYHEMGSLYDYLQLT----------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK  147 (301)
T ss_dssp             EEEEEEEECCCTTCBHHHHHTTC----------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEEC
T ss_pred             CceeEEehhhccCCCHHHHHhhc----------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEc
Confidence            5679999999985 888887421          2899999999999999999999        99999999999999998


Q ss_pred             cCCCCCCcEEEeecccceecCCCCCC-CCCCCCceecccccccccccCCc-----CCCCchhHHHHHHHHHHHHcC----
Q psy2172         161 GEGIERGRVKIADMGFARLFNNPLKP-LADLDPVVVTFWYRAPELLLGAR-----HYTKAIDIWAIGCIFAELLTS----  230 (291)
Q Consensus       161 ~~~~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~-----~~~~~~Dv~slG~~l~~l~~g----  230 (291)
                          .++.++|+|||++......... ........||+.|+|||.+.+..     .++.++||||||+++|+|++|    
T Consensus       148 ----~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~  223 (301)
T 3q4u_A          148 ----KNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSN  223 (301)
T ss_dssp             ----TTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred             ----CCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCc
Confidence                6679999999999876543221 11223457899999999997743     244689999999999999999    


Q ss_pred             ------CCCCCCCccccc----------------CCC-----CCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         231 ------EPIFHCRQEDIK----------------TSN-----PYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       231 ------~~pf~~~~~~~~----------------~~~-----~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                            ..||........                ...     ......+.+++..|....|..||++.+
T Consensus       224 ~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~  292 (301)
T 3q4u_A          224 GIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALR  292 (301)
T ss_dssp             TBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             cccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHH
Confidence                  888865432210                000     112356888999999999988888774

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.4e-40  Score=292.69  Aligned_cols=260  Identities=27%  Similarity=0.336  Sum_probs=190.8

Q ss_pred             ccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcC-CCCCeeeEEEEEEeCCCc
Q psy2172          13 RTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLREL-KHPNVINLISVFLSHNDR   91 (291)
Q Consensus        13 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~   91 (291)
                      ...+.++|. ..+.||+|+||+||.+.. .  +++.||||.+... ....+.+|+.+++++ +||||+++++++  .+..
T Consensus        10 ~~~l~~~~~-~~~~LG~G~~g~V~~~~~-~--~g~~vAvK~~~~~-~~~~~~~E~~~l~~l~~HpnIv~~~~~~--~~~~   82 (434)
T 2rio_A           10 EQSLKNLVV-SEKILGYGSSGTVVFQGS-F--QGRPVAVKRMLID-FCDIALMEIKLLTESDDHPNVIRYYCSE--TTDR   82 (434)
T ss_dssp             SCSCSSCEE-EEEEEEECSTTCEEEEEE-S--SSSEEEEEEEEGG-GHHHHHHHHHHHHHHTTSTTBCCEEEEE--ECSS
T ss_pred             hhhhhheee-ccCeEeeCCCeEEEEEEE-E--CCeEEEEEEEcHH-HHHHHHHHHHHHHhccCCCCcCeEEEEE--ecCC
Confidence            344555555 477999999999987543 2  5788999998653 245678899999876 899999999998  5677


Q ss_pred             eEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCC--------
Q psy2172          92 KVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEG--------  163 (291)
Q Consensus        92 ~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~--------  163 (291)
                      ..|+||||++++|.+++..........  ...++..++.++.|++.||+|||++||+|+||||+||+++.++        
T Consensus        83 ~~~lv~E~~~gsL~~~l~~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~  160 (434)
T 2rio_A           83 FLYIALELCNLNLQDLVESKNVSDENL--KLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQT  160 (434)
T ss_dssp             EEEEEECCCSEEHHHHHHTC--------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTT
T ss_pred             eEEEEEecCCCCHHHHHhccCCCchhh--hhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCccccccccc
Confidence            999999999999999887543321100  0013334678999999999999999999999999999997432        


Q ss_pred             -CCCCcEEEeecccceecCCCCCC-CCCCCCceecccccccccccC------CcCCCCchhHHHHHHHHHHHHc-CCCCC
Q psy2172         164 -IERGRVKIADMGFARLFNNPLKP-LADLDPVVVTFWYRAPELLLG------ARHYTKAIDIWAIGCIFAELLT-SEPIF  234 (291)
Q Consensus       164 -~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~------~~~~~~~~Dv~slG~~l~~l~~-g~~pf  234 (291)
                       .....++|+|||++......... ........||+.|+|||++.+      ...++.++|||||||++|+|++ |..||
T Consensus       161 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf  240 (434)
T 2rio_A          161 GAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF  240 (434)
T ss_dssp             CCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             CCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCC
Confidence             23468999999999876543221 112234578999999999865      2348999999999999999998 99999


Q ss_pred             CCCcccc----------cC----CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         235 HCRQEDI----------KT----SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       235 ~~~~~~~----------~~----~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                      .......          ..    ........+.+++..|..+.|..||++.++..||++..
T Consensus       241 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          241 GDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             CSTTTHHHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             CCchhhHHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            7653210          00    01122467889999999999999999999999999854

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=7.8e-40  Score=290.88  Aligned_cols=234  Identities=22%  Similarity=0.348  Sum_probs=184.1

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLL   96 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv   96 (291)
                      +.|.+ .++||+|+||.||+|.+++   ...||||.++... ..+.+.+|+.+|++++||||+++++++  .+ ...++|
T Consensus       184 ~~~~~-~~~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--~~-~~~~iv  256 (452)
T 1fmk_A          184 ESLRL-EVKLGQGCFGEVWMGTWNG---TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV--SE-EPIYIV  256 (452)
T ss_dssp             GGEEE-EEEEEECSSCEEEEEEETT---TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEE--CS-SSCEEE
T ss_pred             hHcee-eeeecCCCCeEEEEEEECC---CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEE--cC-CceEEE
Confidence            34553 6799999999999999864   3569999998643 345789999999999999999999998  33 568999


Q ss_pred             EecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecc
Q psy2172          97 FDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMG  175 (291)
Q Consensus        97 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg  175 (291)
                      |||+.+ +|.+++......       .+++..++.++.|++.||+|||++|++|+||||+||+++    .++.++|+|||
T Consensus       257 ~e~~~~gsL~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~----~~~~~kl~DfG  325 (452)
T 1fmk_A          257 TEYMSKGSLLDFLKGETGK-------YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG----ENLVCKVADFG  325 (452)
T ss_dssp             ECCCTTCBHHHHHSHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----GGGCEEECCCC
T ss_pred             ehhhcCCCHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEC----CCCCEEECCCc
Confidence            999975 898888654322       188999999999999999999999999999999999998    66799999999


Q ss_pred             cceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc----------ccCC
Q psy2172         176 FARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED----------IKTS  244 (291)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~----------~~~~  244 (291)
                      ++........  .......++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+....          ....
T Consensus       326 ~a~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~  402 (452)
T 1fmk_A          326 LARLIEDNEY--TARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC  402 (452)
T ss_dssp             TTC----------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred             cceecCCCce--ecccCCcccccccCHhHHhcCC-CCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            9986543211  1122345577899999997644 8999999999999999999 99999875432          1122


Q ss_pred             CCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         245 NPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       245 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      .+...+.+.+++..|....|..||++.+
T Consensus       403 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~  430 (452)
T 1fmk_A          403 PPECPESLHDLMCQCWRKEPEERPTFEY  430 (452)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence            3345677889999999999999988775

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=4.9e-40  Score=273.09  Aligned_cols=232  Identities=24%  Similarity=0.372  Sum_probs=177.1

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC------CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCc
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG------LSMSACREIALLRELKHPNVINLISVFLSHNDR   91 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (291)
                      +.|++ .+.||+|+||.||+|.+.    +..+|+|+++...      ..+.+.+|+.+++.++||||+++++++  .+..
T Consensus         7 ~~~~~-~~~lg~G~~g~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~   79 (271)
T 3dtc_A            7 AELTL-EEIIGIGGFGKVYRAFWI----GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVC--LKEP   79 (271)
T ss_dssp             TSEEE-EEEEEEETTEEEEEEEET----TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE--CCC-
T ss_pred             hheee-eeeeccCCCeEEEEEEEc----CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE--ecCC
Confidence            45664 679999999999999964    4679999986432      224688999999999999999999999  5677


Q ss_pred             eEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeeccCCCcEEeecCCC---
Q psy2172          92 KVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNW---VLHRDLKPANILVMGEGI---  164 (291)
Q Consensus        92 ~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~dik~~Nil~~~~~~---  164 (291)
                      ..++||||+++ +|.+.+..          ..+++..++.++.|++.||++||++|   ++|+||||+||+++.+..   
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~----------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~  149 (271)
T 3dtc_A           80 NLCLVMEFARGGPLNRVLSG----------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGD  149 (271)
T ss_dssp             -CEEEEECCTTEEHHHHHTS----------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSC
T ss_pred             ceEEEEEcCCCCCHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccccc
Confidence            89999999975 66665531          12899999999999999999999999   899999999999984321   


Q ss_pred             -CCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc---
Q psy2172         165 -ERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED---  240 (291)
Q Consensus       165 -~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~---  240 (291)
                       ..+.++|+|||.+.......     .....|++.|+|||.+.+.. ++.++|+||||+++|+|++|..||.+....   
T Consensus       150 ~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~  223 (271)
T 3dtc_A          150 LSNKILKITDFGLAREWHRTT-----KMSAAGAYAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA  223 (271)
T ss_dssp             CSSCCEEECCCCC------------------CCGGGSCHHHHHHCC-CSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH
T ss_pred             ccCcceEEccCCccccccccc-----ccCCCCccceeCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence             25789999999997654421     22456899999999997744 899999999999999999999999875532   


Q ss_pred             --------ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         241 --------IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       241 --------~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                              .........+.+.+++..|..+.|..||++.+
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e  263 (271)
T 3dtc_A          224 YGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTN  263 (271)
T ss_dssp             HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHH
Confidence                    11122344577899999999999999988775

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.3e-40  Score=272.76  Aligned_cols=234  Identities=19%  Similarity=0.348  Sum_probs=189.6

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC-ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLL   96 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv   96 (291)
                      +.|.+ .+.||+|+||.||+|.+.   +++.||+|.+..... .+.+.+|+.++++++||||+++++++  .+....+++
T Consensus         8 ~~y~~-~~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~lv   81 (267)
T 3t9t_A            8 SELTF-VQEIGSGQFGLVHLGYWL---NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC--LEQAPICLV   81 (267)
T ss_dssp             GGEEE-EEEEEEETTEEEEEEEET---TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEE--CSSSSCEEE
T ss_pred             hheee-eeEecCCCceeEEEEEec---CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEE--ccCCCeEEE
Confidence            45554 679999999999999986   456799999986543 35788999999999999999999999  556789999


Q ss_pred             EecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecc
Q psy2172          97 FDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMG  175 (291)
Q Consensus        97 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg  175 (291)
                      |||+++ +|.+.+.....        .+++..++.++.|++.||++||++|++|+||||+||+++    .++.++|+|||
T Consensus        82 ~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~----~~~~~kl~dfg  149 (267)
T 3t9t_A           82 TEFMEHGCLSDYLRTQRG--------LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG----ENQVIKVSDFG  149 (267)
T ss_dssp             ECCCTTCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC----GGGCEEECCTT
T ss_pred             EeCCCCCcHHHHHhhCcc--------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEC----CCCCEEEcccc
Confidence            999975 88888765322        288999999999999999999999999999999999998    66789999999


Q ss_pred             cceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc----------ccCC
Q psy2172         176 FARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED----------IKTS  244 (291)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~----------~~~~  244 (291)
                      .+.......  ........++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||......          ....
T Consensus       150 ~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~  226 (267)
T 3t9t_A          150 MTRFVLDDQ--YTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK  226 (267)
T ss_dssp             GGGGBCCHH--HHSTTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC
T ss_pred             ccccccccc--ccccccccccccccChhhhcCCC-ccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCC
Confidence            987654321  11122345677899999997644 8899999999999999999 89999875432          1122


Q ss_pred             CCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         245 NPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       245 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      .......+.+++..|..+.|..||++.+
T Consensus       227 ~~~~~~~l~~li~~~l~~~p~~Rps~~~  254 (267)
T 3t9t_A          227 PRLASTHVYQIMNHCWRERPEDRPAFSR  254 (267)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CccCcHHHHHHHHHHccCChhhCcCHHH
Confidence            3334577889999999999999888775

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.4e-40  Score=284.29  Aligned_cols=240  Identities=15%  Similarity=0.187  Sum_probs=189.2

Q ss_pred             ccccccccceeCcccceEEEEEEEccCC------CCceeEEEEeCCCCCChhHHHHHHHHhcCCCCCeee----------
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDNS------DTRDYALKQIEGTGLSMSACREIALLRELKHPNVIN----------   80 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~------~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~iv~----------   80 (291)
                      .+.|.+ .+.||+|+||.||+|.+..+.      .++.||+|++...   ..+.+|+.++++++||||++          
T Consensus        41 ~~~y~~-~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           41 GRQWKL-KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             SCEEEE-EEEEEEETTEEEEEEEECC-----------CEEEEEEETT---STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CCeEEE-EEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            467775 679999999999999987632      3678999998754   57889999999999998887          


Q ss_pred             -----EEEEEEeCCCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCC
Q psy2172          81 -----LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPA  155 (291)
Q Consensus        81 -----~~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~  155 (291)
                           +++++.. +....++||||++++|.+++......       .+++..++.++.|++.||+|||++|++|+||||+
T Consensus       117 ~~i~~~~~~~~~-~~~~~~lv~e~~~~~L~~~l~~~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~  188 (352)
T 2jii_A          117 LAIPTCMGFGVH-QDKYRFLVLPSLGRSLQSALDVSPKH-------VLSERSVLQVACRLLDALEFLHENEYVHGNVTAE  188 (352)
T ss_dssp             CSCCCCCEEEEE-TTTEEEEEEECCCEEHHHHHHHSGGG-------CCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGG
T ss_pred             cCccchhhcccc-CCcEEEEEecCCCcCHHHHHHhCCcC-------CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHH
Confidence                 5666643 46789999999977999998865221       2899999999999999999999999999999999


Q ss_pred             cEEeecCCCCCC--cEEEeecccceecCCCCCC----CCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc
Q psy2172         156 NILVMGEGIERG--RVKIADMGFARLFNNPLKP----LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT  229 (291)
Q Consensus       156 Nil~~~~~~~~~--~~~l~Dfg~~~~~~~~~~~----~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~  229 (291)
                      ||+++    .++  .++|+|||++.........    ........|++.|+|||.+.+.. ++.++||||||+++|+|++
T Consensus       189 NIl~~----~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~  263 (352)
T 2jii_A          189 NIFVD----PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCG-PSRRSDLQSLGYCMLKWLY  263 (352)
T ss_dssp             GEEEE----TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHH
T ss_pred             HEEEc----CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCC-CCchhhHHHHHHHHHHHHh
Confidence            99998    455  8999999999866532211    11223457899999999998754 8999999999999999999


Q ss_pred             CCCCCCCCccccc-----------CCC---------CCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         230 SEPIFHCRQEDIK-----------TSN---------PYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       230 g~~pf~~~~~~~~-----------~~~---------~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      |..||........           ...         ......+.+++..|..+.|..||++.++
T Consensus       264 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  327 (352)
T 2jii_A          264 GFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAML  327 (352)
T ss_dssp             SCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHH
T ss_pred             CCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHH
Confidence            9999987642100           000         1224778899999999999998887763

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.1e-39  Score=275.87  Aligned_cols=250  Identities=20%  Similarity=0.304  Sum_probs=197.0

Q ss_pred             ccccccccccceeCcccceEEEEEEEcc---CCCCceeEEEEeCCCCCC---hhHHHHHHHHhcCCCCCeeeEEEEEEeC
Q psy2172          15 KVEDLFDYEGCKVGRGTYGHVYKARRKD---NSDTRDYALKQIEGTGLS---MSACREIALLRELKHPNVINLISVFLSH   88 (291)
Q Consensus        15 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~---~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~   88 (291)
                      ...++|.+ .+.||+|+||.||+|.+++   ..+++.||+|.+......   ..+.+|+.+++.++||||+++++++  .
T Consensus        22 ~~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~   98 (322)
T 1p4o_A           22 VAREKITM-SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV--S   98 (322)
T ss_dssp             CCGGGEEE-EEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE--C
T ss_pred             chhhheee-eeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE--c
Confidence            34566775 7799999999999998763   124678999999754332   3478899999999999999999999  5


Q ss_pred             CCceEEEEEecCCC-CHHHHHHHhhhhhh-CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCC
Q psy2172          89 NDRKVWLLFDYAEH-DLWHIIKFHRAAKA-NKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIER  166 (291)
Q Consensus        89 ~~~~~~iv~e~~~~-~l~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~  166 (291)
                      +....++||||+++ +|.+++........ ......+++..++.++.|++.||.+||++|++|+||||+||+++    .+
T Consensus        99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~----~~  174 (322)
T 1p4o_A           99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA----ED  174 (322)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEEC----TT
T ss_pred             cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEc----CC
Confidence            66788999999975 99988876554321 11222378999999999999999999999999999999999998    66


Q ss_pred             CcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc-----
Q psy2172         167 GRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED-----  240 (291)
Q Consensus       167 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~-----  240 (291)
                      +.++|+|||++........ ........+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||.+....     
T Consensus       175 ~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  252 (322)
T 1p4o_A          175 FTVKIGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF  252 (322)
T ss_dssp             CCEEECCTTCCCGGGGGGC-EEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH
T ss_pred             CeEEECcCccccccccccc-cccccCCCCCCCccChhhhccCC-CCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHH
Confidence            7999999999876543211 11123446688899999987644 8999999999999999999 89999875432     


Q ss_pred             -----ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         241 -----IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       241 -----~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                           ...........+.+++..|..+.|..||++.++
T Consensus       253 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~  290 (322)
T 1p4o_A          253 VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEI  290 (322)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence                 122333445778899999999999999988764

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=6.4e-41  Score=288.27  Aligned_cols=250  Identities=18%  Similarity=0.350  Sum_probs=199.0

Q ss_pred             ccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC-------------------hhHHHHHHHHhcCCC
Q psy2172          15 KVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS-------------------MSACREIALLRELKH   75 (291)
Q Consensus        15 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-------------------~~~~~e~~~l~~l~h   75 (291)
                      ...+.|++ .+.||+|+||.||+|.+    +++.||+|.+......                   ..+.+|+.++++++|
T Consensus        28 ~~~~~y~~-~~~lg~G~~g~V~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h  102 (348)
T 2pml_X           28 KYINDYRI-IRTLNQGKFNKIILCEK----DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKN  102 (348)
T ss_dssp             EEETTEEE-EEEEECCSSCCEEEEEE----TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCC
T ss_pred             cccCceEE-EEEEcCCCCeEEEEEEc----CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCC
Confidence            34467775 67999999999999997    5688999998532111                   778999999999999


Q ss_pred             CCeeeEEEEEEeCCCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCeeeeccC
Q psy2172          76 PNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHS-NWVLHRDLK  153 (291)
Q Consensus        76 ~~iv~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~-~~ivH~dik  153 (291)
                      |||+++++++  .+....++||||+++ +|.+++....... ......+++..++.++.|++.||.+||+ +|++|+||+
T Consensus       103 ~~i~~~~~~~--~~~~~~~lv~e~~~~~~L~~~~~~~~~l~-~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~  179 (348)
T 2pml_X          103 EYCLTCEGII--TNYDEVYIIYEYMENDSILKFDEYFFVLD-KNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVK  179 (348)
T ss_dssp             TTBCCCSEEE--ESSSEEEEEEECCTTCBSSEESSSEESSC-SSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCC
T ss_pred             CCcceEEEEE--eeCCeEEEEEeccCCCcHHHHHHHhhhhh-hccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCC
Confidence            9999999999  456789999999986 7765522110000 0012338999999999999999999999 999999999


Q ss_pred             CCcEEeecCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCC-chhHHHHHHHHHHHHcCCC
Q psy2172         154 PANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTK-AIDIWAIGCIFAELLTSEP  232 (291)
Q Consensus       154 ~~Nil~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~~Dv~slG~~l~~l~~g~~  232 (291)
                      |+||+++    .++.++|+|||.+......     ......|+..|+|||.+.+...++. ++|+||||+++|+|++|..
T Consensus       180 p~Nil~~----~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~  250 (348)
T 2pml_X          180 PSNILMD----KNGRVKLSDFGESEYMVDK-----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV  250 (348)
T ss_dssp             GGGEEEC----TTSCEEECCCTTCEECBTT-----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSC
T ss_pred             hHhEEEc----CCCcEEEeccccccccccc-----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCC
Confidence            9999998    6679999999999876442     2234567999999999987534555 9999999999999999999


Q ss_pred             CCCCCcccc----------cCCC-------------------CCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         233 IFHCRQEDI----------KTSN-------------------PYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       233 pf~~~~~~~----------~~~~-------------------~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                      ||.+.....          ....                   ......+.+++..|..+.|..||++.++..+|++..
T Consensus       251 pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~  328 (348)
T 2pml_X          251 PFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD  328 (348)
T ss_dssp             SSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred             CCCCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccC
Confidence            998765410          0011                   344677899999999999999999999999998764

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.3e-39  Score=274.29  Aligned_cols=239  Identities=23%  Similarity=0.353  Sum_probs=185.3

Q ss_pred             ccccccceeCcccceEEEEEEEccCC-CCceeEEEEeCCCCCC---hhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNS-DTRDYALKQIEGTGLS---MSACREIALLRELKHPNVINLISVFLSHNDRKVW   94 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~-~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (291)
                      +|.+ +++||+|+||.||+|.+.... ....+|+|.+......   ..+.+|+.++++++||||+++++++.. .....+
T Consensus        26 ~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~~  103 (298)
T 3f66_A           26 IVHF-NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR-SEGSPL  103 (298)
T ss_dssp             EEEE-EEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC-SSSCCE
T ss_pred             ehhh-cceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc-CCCceE
Confidence            4554 679999999999999976432 3345899998754332   457899999999999999999998753 456789


Q ss_pred             EEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEee
Q psy2172          95 LLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIAD  173 (291)
Q Consensus        95 iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~D  173 (291)
                      ++|||+++ +|.+.+....        ..+++..++.++.|++.||++||++|++|+||||+||+++    .++.++|+|
T Consensus       104 ~v~e~~~~~~L~~~l~~~~--------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~----~~~~~kl~D  171 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNET--------HNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD----EKFTVKVAD  171 (298)
T ss_dssp             EEEECCTTCBHHHHHHCTT--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----TTCCEEECS
T ss_pred             EEEeCCCCCCHHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEC----CCCCEEECc
Confidence            99999986 8888875322        1278999999999999999999999999999999999998    677999999


Q ss_pred             cccceecCCCCC-CCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc----------
Q psy2172         174 MGFARLFNNPLK-PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI----------  241 (291)
Q Consensus       174 fg~~~~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~----------  241 (291)
                      ||.+........ .........++..|+|||.+.+.. ++.++|+||||+++|+|++ |.+||.+.....          
T Consensus       172 fg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~  250 (298)
T 3f66_A          172 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR  250 (298)
T ss_dssp             CGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC
T ss_pred             ccccccccccchhccccccCCCCCccccChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC
Confidence            999986644221 112233456678899999997744 8999999999999999999 677887655321          


Q ss_pred             cCCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         242 KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       242 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      ........+.+.+++..|..+.|..||++.+
T Consensus       251 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~e  281 (298)
T 3f66_A          251 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSE  281 (298)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCccCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            1122334577899999999999999888775

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=8.9e-40  Score=272.71  Aligned_cols=235  Identities=20%  Similarity=0.336  Sum_probs=189.0

Q ss_pred             ccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEE
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWL   95 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~i   95 (291)
                      .+.|.+ .+.||+|+||.||+|.+.   ++..||+|.+.... ....+.+|+++++.++||||+++++++.   ....++
T Consensus        12 ~~~y~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~~~~   84 (279)
T 1qpc_A           12 RETLKL-VERLGAGQFGEVWMGYYN---GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT---QEPIYI   84 (279)
T ss_dssp             GGGEEE-EEEEEEETTEEEEEEEET---TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC---SSSCEE
T ss_pred             HHhhhh-eeeecCCCCeEEEEEEEc---CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc---CCCcEE
Confidence            356664 679999999999999975   45679999987543 3457889999999999999999999983   345799


Q ss_pred             EEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          96 LFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        96 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      ||||+. ++|.+.+......       .+++..++.++.|++.||++||++|++|+||||+||+++    .++.++|+||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~----~~~~~kl~Df  153 (279)
T 1qpc_A           85 ITEYMENGSLVDFLKTPSGI-------KLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS----DTLSCKIADF  153 (279)
T ss_dssp             EEECCTTCBHHHHTTSHHHH-------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTSCEEECCC
T ss_pred             EEecCCCCCHHHHHhcCCCC-------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEc----CCCCEEECCC
Confidence            999996 5888877643321       189999999999999999999999999999999999998    6779999999


Q ss_pred             ccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc----------cC
Q psy2172         175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI----------KT  243 (291)
Q Consensus       175 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~----------~~  243 (291)
                      |.+........  .......++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+.....          ..
T Consensus       154 g~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  230 (279)
T 1qpc_A          154 GLARLIEDNEY--TAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV  230 (279)
T ss_dssp             TTCEECSSSCE--ECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred             cccccccCccc--ccccCCCCccCccChhhhccCC-CCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCC
Confidence            99987654321  1223345677899999997644 8899999999999999999 999998754321          11


Q ss_pred             CCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         244 SNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       244 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      ........+.+++..|..+.|..||++.+
T Consensus       231 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~  259 (279)
T 1qpc_A          231 RPDNCPEELYQLMRLCWKERPEDRPTFDY  259 (279)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CcccccHHHHHHHHHHhccChhhCCCHHH
Confidence            22344577889999999999999988775

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2e-39  Score=275.41  Aligned_cols=243  Identities=21%  Similarity=0.320  Sum_probs=178.2

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCCh----hHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM----SACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      +.|++ .+.||+|+||.||+|.++.  +++.||+|++.......    .+..+..+++.++||||+++++++  .+....
T Consensus        25 ~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~--~~~~~~   99 (318)
T 2dyl_A           25 NDLEN-LGEMGSGTCGQVWKMRFRK--TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTF--ITNTDV   99 (318)
T ss_dssp             GGEEE-EEEC------CEEEEEETT--TCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE--ECSSEE
T ss_pred             ccccc-cceeeecCCeeEEEEEEec--CCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEE--ecCCcE
Confidence            44553 5799999999999999876  67889999997554332    233445577888999999999999  456789


Q ss_pred             EEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          94 WLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSN-WVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        94 ~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~-~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      ++||||+++.+..+......        .+++..++.++.|++.||.+||++ |++|+||||+||+++    .++.++|+
T Consensus       100 ~lv~e~~~~~~~~l~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~----~~~~~kl~  167 (318)
T 2dyl_A          100 FIAMELMGTCAEKLKKRMQG--------PIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD----ERGQIKLC  167 (318)
T ss_dssp             EEEECCCSEEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEEC----TTSCEEEC
T ss_pred             EEEEeccCCcHHHHHHHhcc--------CCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEEC----CCCCEEEE
Confidence            99999996665555443221        289999999999999999999995 999999999999998    67799999


Q ss_pred             ecccceecCCCCCCCCCCCCceecccccccccccC----CcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc-------
Q psy2172         173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLG----ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI-------  241 (291)
Q Consensus       173 Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~-------  241 (291)
                      |||.+.......    ......|++.|+|||.+.+    ...++.++||||||+++|+|++|..||.......       
T Consensus       168 dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  243 (318)
T 2dyl_A          168 DFGISGRLVDDK----AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVL  243 (318)
T ss_dssp             CCTTC------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred             ECCCchhccCCc----cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHh
Confidence            999987654321    1234568899999999852    2348899999999999999999999998743211       


Q ss_pred             ------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         242 ------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       242 ------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                            ..........+.+++..|..+.|..||++.++.++|++..
T Consensus       244 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (318)
T 2dyl_A          244 QEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR  289 (318)
T ss_dssp             HSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred             ccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence                  0111224577899999999999999999999999998754

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.3e-39  Score=275.80  Aligned_cols=241  Identities=27%  Similarity=0.493  Sum_probs=181.6

Q ss_pred             ccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCC
Q psy2172          15 KVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-----LSMSACREIALLRELKHPNVINLISVFLSHN   89 (291)
Q Consensus        15 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   89 (291)
                      ...+.|++ .+.||+|+||.||+|.+..  +++.||+|.+....     ....+.+|+.++++++||||+++++++.  +
T Consensus        29 ~~~~~y~~-~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~  103 (310)
T 2wqm_A           29 NTLANFRI-EKKIGRGQFSEVYRAACLL--DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI--E  103 (310)
T ss_dssp             SSGGGEEE-EEEEECC--CEEEEEEETT--TCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE--E
T ss_pred             ccccceEE-EEeecCCCCceEEEEEEcC--CCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE--c
Confidence            34456775 6799999999999999876  67889999987532     1235788999999999999999999995  4


Q ss_pred             CceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCc
Q psy2172          90 DRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGR  168 (291)
Q Consensus        90 ~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~  168 (291)
                      ....++||||+++ +|.+++........     .+++..++.++.|++.||.+||++|++|+||+|+||+++    .++.
T Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~----~~~~  174 (310)
T 2wqm_A          104 DNELNIVLELADAGDLSRMIKHFKKQKR-----LIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT----ATGV  174 (310)
T ss_dssp             TTEEEEEEECCCSCBHHHHHHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTSC
T ss_pred             CCcEEEEEecCCCCCHHHHHHHhccccc-----CCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEc----CCCC
Confidence            6689999999986 88888876443221     289999999999999999999999999999999999998    6779


Q ss_pred             EEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc-------
Q psy2172         169 VKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI-------  241 (291)
Q Consensus       169 ~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~-------  241 (291)
                      ++|+|||++........   ......|+..|+|||.+.+.. ++.++||||||+++|+|++|..||.+.....       
T Consensus       175 ~kl~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  250 (310)
T 2wqm_A          175 VKLGDLGLGRFFSSKTT---AAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI  250 (310)
T ss_dssp             EEECCC---------------------CCSSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHH
T ss_pred             EEEEeccceeeecCCCc---cccccCCCeeEeChHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHh
Confidence            99999999876543211   123356789999999998754 8999999999999999999999997654221       


Q ss_pred             ------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         242 ------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       242 ------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                            ........+.+.+++..|..+.|..||++.++
T Consensus       251 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~i  288 (310)
T 2wqm_A          251 EQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYV  288 (310)
T ss_dssp             HTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             hcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHH
Confidence                  11113345778999999999999999988764

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-40  Score=281.71  Aligned_cols=250  Identities=23%  Similarity=0.351  Sum_probs=192.4

Q ss_pred             ccccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC--------ChhHHHHHHHHhcC----CCCCe
Q psy2172          11 NERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL--------SMSACREIALLREL----KHPNV   78 (291)
Q Consensus        11 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~e~~~l~~l----~h~~i   78 (291)
                      .....+.+.|++ ++.||+|+||.||+|.+..  +++.||+|++.....        ...+.+|+.++.++    +||||
T Consensus        24 ~~~~~~~~~y~~-~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i  100 (312)
T 2iwi_A           24 KDREAFEAEYRL-GPLLGKGGFGTVFAGHRLT--DRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGV  100 (312)
T ss_dssp             ---------CEE-EEEEEEETTEEEEEEECTT--TCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSB
T ss_pred             cchhhhhhceEE-eeEEEcCCCEEEEEEEEcc--CCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCe
Confidence            445667788886 7799999999999999765  678899999965432        23456789999888    89999


Q ss_pred             eeEEEEEEeCCCceEEEEEec-CC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCc
Q psy2172          79 INLISVFLSHNDRKVWLLFDY-AE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPAN  156 (291)
Q Consensus        79 v~~~~~~~~~~~~~~~iv~e~-~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~N  156 (291)
                      +++++++  .+....++++|+ +. ++|.+.+.....         +++..++.++.|++.||++||++|++|+||||+|
T Consensus       101 ~~~~~~~--~~~~~~~~v~e~~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N  169 (312)
T 2iwi_A          101 IRLLDWF--ETQEGFMLVLERPLPAQDLFDYITEKGP---------LGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDEN  169 (312)
T ss_dssp             CCEEEEC-------CEEEEECCSSEEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGG
T ss_pred             eeEEEEE--ecCCeEEEEEEecCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhh
Confidence            9999998  456678999998 44 588888875321         8999999999999999999999999999999999


Q ss_pred             EEeecCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCC
Q psy2172         157 ILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  236 (291)
Q Consensus       157 il~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~  236 (291)
                      |+++.   .++.++|+|||.+......     ......|+..|+|||.+.+....+.++||||||+++|+|++|..||..
T Consensus       170 il~~~---~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  241 (312)
T 2iwi_A          170 ILIDL---RRGCAKLIDFGSGALLHDE-----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER  241 (312)
T ss_dssp             EEEET---TTTEEEECCCSSCEECCSS-----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred             EEEeC---CCCeEEEEEcchhhhcccC-----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence            99973   3468999999999876542     223456889999999987655455689999999999999999999976


Q ss_pred             Ccccc---cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhh
Q psy2172         237 RQEDI---KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKD  282 (291)
Q Consensus       237 ~~~~~---~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (291)
                      .....   ..........+.+++..|..+.|..||++.++..++++...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~  290 (312)
T 2iwi_A          242 DQEILEAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP  290 (312)
T ss_dssp             HHHHHHTCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred             hHHHhhhccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence            43211   11223345778999999999999999999999888887653

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.8e-39  Score=273.37  Aligned_cols=231  Identities=26%  Similarity=0.368  Sum_probs=185.4

Q ss_pred             ccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC------CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEE
Q psy2172          23 EGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG------LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLL   96 (291)
Q Consensus        23 ~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv   96 (291)
                      .+++||+|+||.||+|.+    .++.||+|.+....      ..+.+.+|+.++++++||||+++++++  .+....+++
T Consensus        35 ~~~~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~~~lv  108 (307)
T 2nru_A           35 GGNKMGEGGFGVVYKGYV----NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFS--SDGDDLCLV  108 (307)
T ss_dssp             TCCEEEECSSEEEEEEES----SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEE--CSSSSCEEE
T ss_pred             cCCccccCCCeEEEEEEE----CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEE--ecCCceEEE
Confidence            368999999999999985    35679999986432      234688999999999999999999999  566789999


Q ss_pred             EecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecc
Q psy2172          97 FDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMG  175 (291)
Q Consensus        97 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg  175 (291)
                      |||++ ++|.+.+......      ..+++..++.++.|++.||.+||++|++|+||||+||+++    .++.++|+|||
T Consensus       109 ~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~----~~~~~kl~Dfg  178 (307)
T 2nru_A          109 YVYMPNGSLLDRLSCLDGT------PPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLD----EAFTAKISDFG  178 (307)
T ss_dssp             EECCTTCBHHHHHHTGGGC------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC----TTCCEEECCCT
T ss_pred             EEecCCCcHHHHHHhccCC------CCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEc----CCCcEEEeecc
Confidence            99996 5888777643221      2388999999999999999999999999999999999998    67799999999


Q ss_pred             cceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc-------------
Q psy2172         176 FARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK-------------  242 (291)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~-------------  242 (291)
                      .+......... .......|++.|+|||.+.+ . ++.++|+||||+++|+|++|..||........             
T Consensus       179 ~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  255 (307)
T 2nru_A          179 LARASEKFAQT-VMTSRIVGTTAYMAPEALRG-E-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEK  255 (307)
T ss_dssp             TCEECCSCSSC-EECSSCCSCGGGCCHHHHTT-E-ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSC
T ss_pred             ccccccccccc-ccccccCCCcCcCChHHhcC-C-CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhh
Confidence            99875542211 12234568999999999876 3 78999999999999999999999987543210             


Q ss_pred             -----------CCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         243 -----------TSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       243 -----------~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                                 .......+.+.+++..|..+.|..||++.+
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~  296 (307)
T 2nru_A          256 TIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKK  296 (307)
T ss_dssp             CHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             hhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHH
Confidence                       011222456788999999999999998875

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.4e-39  Score=278.36  Aligned_cols=247  Identities=18%  Similarity=0.298  Sum_probs=194.3

Q ss_pred             cccccccceeCcccceEEEEEEEccCC---CCceeEEEEeCCCCC---ChhHHHHHHHHhcC-CCCCeeeEEEEEEeCCC
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNS---DTRDYALKQIEGTGL---SMSACREIALLREL-KHPNVINLISVFLSHND   90 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~---~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~   90 (291)
                      +.|.+ ++.||+|+||.||+|.+...+   ....||+|.+.....   ...+.+|+.+++++ +||||+++++++  .+.
T Consensus        46 ~~~~~-~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~--~~~  122 (333)
T 2i1m_A           46 NNLQF-GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC--THG  122 (333)
T ss_dssp             TSEEE-EEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--CSS
T ss_pred             HHcee-eeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE--ecC
Confidence            34553 679999999999999986532   224799999976532   24578999999999 899999999999  566


Q ss_pred             ceEEEEEecCCC-CHHHHHHHhhhhhhCC-----CCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCC
Q psy2172          91 RKVWLLFDYAEH-DLWHIIKFHRAAKANK-----KPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGI  164 (291)
Q Consensus        91 ~~~~iv~e~~~~-~l~~~~~~~~~~~~~~-----~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~  164 (291)
                      ...++||||+++ +|.+.+..........     ....+++..++.++.|++.||++||++|++|+||||+||+++    
T Consensus       123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~----  198 (333)
T 2i1m_A          123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT----  198 (333)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE----
T ss_pred             CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC----
Confidence            789999999975 9998887654321110     112378999999999999999999999999999999999998    


Q ss_pred             CCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc--
Q psy2172         165 ERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI--  241 (291)
Q Consensus       165 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~--  241 (291)
                      .++.++|+|||++........ ........++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+.....  
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~  276 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSN-YIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF  276 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTT-SEECSSCEECGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred             CCCeEEECccccccccccccc-eeecCCCCCCccccCHHHhccCC-CChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence            677999999999986544321 11233456788999999987644 8999999999999999998 999998754321  


Q ss_pred             ---------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         242 ---------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       242 ---------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                               ..........+.+++..|..+.|..||++.++
T Consensus       277 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l  317 (333)
T 2i1m_A          277 YKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI  317 (333)
T ss_dssp             HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHH
Confidence                     11223345778899999999999999988764

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-39  Score=277.85  Aligned_cols=240  Identities=23%  Similarity=0.313  Sum_probs=182.0

Q ss_pred             cccccccccceeCcccceEEEEEEEccCCCC--ceeEEEEeCCC---CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCC
Q psy2172          16 VEDLFDYEGCKVGRGTYGHVYKARRKDNSDT--RDYALKQIEGT---GLSMSACREIALLRELKHPNVINLISVFLSHND   90 (291)
Q Consensus        16 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~--~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   90 (291)
                      ..+.|++ .++||+|+||.||+|.+...+..  ..|++|.+...   .....+.+|+.++++++||||+++++++..  .
T Consensus        13 ~~~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~   89 (327)
T 3lzb_A           13 KETEFKK-IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT--S   89 (327)
T ss_dssp             CTTTEEE-EEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES--S
T ss_pred             CHhHceE-EEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec--C
Confidence            3456774 67999999999999998763221  13577777533   234578899999999999999999999953  3


Q ss_pred             ceEEEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcE
Q psy2172          91 RKVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRV  169 (291)
Q Consensus        91 ~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~  169 (291)
                       ..+++++++. ++|.+.+.....        .+++..++.++.|++.||.|||++||+|+||||+||+++    .++.+
T Consensus        90 -~~~~v~~~~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~----~~~~~  156 (327)
T 3lzb_A           90 -TVQLITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK----TPQHV  156 (327)
T ss_dssp             -SEEEEECCCSSCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE----ETTEE
T ss_pred             -CceEEEEecCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEc----CCCCE
Confidence             3677788876 588888765432        289999999999999999999999999999999999998    66789


Q ss_pred             EEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc--------
Q psy2172         170 KIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED--------  240 (291)
Q Consensus       170 ~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~--------  240 (291)
                      +|+|||++......... .......++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+....        
T Consensus       157 kL~DfG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~  234 (327)
T 3lzb_A          157 KITDFGLAKLLGAEEKE-YHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK  234 (327)
T ss_dssp             EECCTTC-----------------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred             EEccCcceeEccCcccc-ccccCCCccccccCHHHHcCCC-CChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc
Confidence            99999999876443221 1223345677899999998744 8999999999999999999 99999876542        


Q ss_pred             --ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         241 --IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       241 --~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                        .....+.....+.+++..|..+.|..||++.++
T Consensus       235 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el  269 (327)
T 3lzb_A          235 GERLPQPPICTIDVYMIMRKCWMIDADSRPKFREL  269 (327)
T ss_dssp             TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence              122334456778899999999999999988764

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=3.7e-40  Score=281.28  Aligned_cols=258  Identities=17%  Similarity=0.261  Sum_probs=194.8

Q ss_pred             cccccccccccceeCcccceEEEEEEEcc---CCCCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEe
Q psy2172          14 TKVEDLFDYEGCKVGRGTYGHVYKARRKD---NSDTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLS   87 (291)
Q Consensus        14 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~---~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~   87 (291)
                      ....+.|.+ .+.||+|+||.||+|.+.+   ..+++.||+|.+.....   ...+.+|+.++++++||||+++++++  
T Consensus        26 ~~~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--  102 (327)
T 2yfx_A           26 EVPRKNITL-IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS--  102 (327)
T ss_dssp             BCCGGGCEE-EEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--
T ss_pred             cCChhheEE-EEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEE--
Confidence            345567775 7799999999999998542   23667899999975432   23578899999999999999999999  


Q ss_pred             CCCceEEEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCC
Q psy2172          88 HNDRKVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIER  166 (291)
Q Consensus        88 ~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~  166 (291)
                      .+....|+||||++ ++|.+++.......  .....+++..++.++.|++.||.+||++|++|+||||+||+++.++ ..
T Consensus       103 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~-~~  179 (327)
T 2yfx_A          103 LQSLPRFILMELMAGGDLKSFLRETRPRP--SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG-PG  179 (327)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTSCCS--SSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS-TT
T ss_pred             cCCCCcEEEEecCCCCcHHHHHHhhcccc--cccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCC-Cc
Confidence            55667899999996 59988887653211  1122388999999999999999999999999999999999998543 34


Q ss_pred             CcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc-----
Q psy2172         167 GRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED-----  240 (291)
Q Consensus       167 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~-----  240 (291)
                      ..++|+|||.+........ ........++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+....     
T Consensus       180 ~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~  257 (327)
T 2yfx_A          180 RVAKIGDFGMARDIYRASY-YRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF  257 (327)
T ss_dssp             CCEEECCCHHHHHHHC-------CCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred             ceEEECccccccccccccc-cccCCCcCCCcceeCHhHhcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHH
Confidence            5799999999976543221 11223456788999999987644 8999999999999999998 99999875432     


Q ss_pred             -----ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         241 -----IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       241 -----~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                           ...........+.+++..|..+.|..||++.++.++.+.
T Consensus       258 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~  301 (327)
T 2yfx_A          258 VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY  301 (327)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence                 112233445778899999999999999998876555443

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1e-39  Score=273.85  Aligned_cols=241  Identities=22%  Similarity=0.290  Sum_probs=182.2

Q ss_pred             cccccccccceeCcccceEEEEEEEccC-CCCceeEEEEeCCCC-----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCC
Q psy2172          16 VEDLFDYEGCKVGRGTYGHVYKARRKDN-SDTRDYALKQIEGTG-----LSMSACREIALLRELKHPNVINLISVFLSHN   89 (291)
Q Consensus        16 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~-~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   89 (291)
                      ..+.|++ .+.||+|+||.||+|.+... +....||+|+++...     ..+.+.+|+.++++++||||+++++++..  
T Consensus        16 ~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--   92 (291)
T 1u46_A           16 GEKDLRL-LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT--   92 (291)
T ss_dssp             CGGGEEE-EEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred             chhHeee-eeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc--
Confidence            3456775 67999999999999987542 233468999987432     22467899999999999999999999943  


Q ss_pred             CceEEEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCc
Q psy2172          90 DRKVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGR  168 (291)
Q Consensus        90 ~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~  168 (291)
                      . ..++++||+. ++|.+.+......        +++..++.++.|++.||.+||++|++|+||||+||+++    .++.
T Consensus        93 ~-~~~~v~e~~~~~~L~~~l~~~~~~--------~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~----~~~~  159 (291)
T 1u46_A           93 P-PMKMVTELAPLGSLLDRLRKHQGH--------FLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA----TRDL  159 (291)
T ss_dssp             S-SCEEEEECCTTCBHHHHHHHHGGG--------SCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE----ETTE
T ss_pred             C-CceeeEecccCCCHHHHHHhccCC--------cCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEc----CCCC
Confidence            3 3789999997 5888888754322        89999999999999999999999999999999999998    6678


Q ss_pred             EEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc-------
Q psy2172         169 VKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED-------  240 (291)
Q Consensus       169 ~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~-------  240 (291)
                      ++|+|||.+.................++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||.+....       
T Consensus       160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~  238 (291)
T 1u46_A          160 VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID  238 (291)
T ss_dssp             EEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred             EEEccccccccccccccchhhhccCCCCceeeCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHH
Confidence            99999999987655433222233456677899999997644 7899999999999999999 99999875431       


Q ss_pred             ----ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         241 ----IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       241 ----~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                          ...........+.+++..|..+.|..||++.++
T Consensus       239 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l  275 (291)
T 1u46_A          239 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL  275 (291)
T ss_dssp             TSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             ccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHH
Confidence                112223445778899999999999999888763

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.1e-39  Score=278.41  Aligned_cols=244  Identities=23%  Similarity=0.320  Sum_probs=188.1

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC---CCChhHHHHHHHHhcC-CCCCeeeEEEEEEeCCCceE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT---GLSMSACREIALLREL-KHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~   93 (291)
                      +.|.+ .+.||+|+||.||+|.++.++....+++|.+...   .....+.+|+.+++++ +||||+++++++  .+....
T Consensus        25 ~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~--~~~~~~  101 (327)
T 1fvr_A           25 NDIKF-QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC--EHRGYL  101 (327)
T ss_dssp             GGCEE-EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE--EETTEE
T ss_pred             HHccc-eeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceee--eeCCce
Confidence            45664 6799999999999999877333234599988642   2345688999999999 899999999999  456789


Q ss_pred             EEEEecCCC-CHHHHHHHhhhhhh-------CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCC
Q psy2172          94 WLLFDYAEH-DLWHIIKFHRAAKA-------NKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIE  165 (291)
Q Consensus        94 ~iv~e~~~~-~l~~~~~~~~~~~~-------~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~  165 (291)
                      ++||||+++ +|.+++........       ......+++..++.++.|++.||.+||++|++|+||||+||+++    .
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~----~  177 (327)
T 1fvr_A          102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG----E  177 (327)
T ss_dssp             EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----G
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEc----C
Confidence            999999975 89888875431110       01122389999999999999999999999999999999999998    6


Q ss_pred             CCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc----
Q psy2172         166 RGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED----  240 (291)
Q Consensus       166 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~----  240 (291)
                      ++.++|+|||++......    .......++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+....    
T Consensus       178 ~~~~kL~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~  252 (327)
T 1fvr_A          178 NYVAKIADFGLSRGQEVY----VKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE  252 (327)
T ss_dssp             GGCEEECCTTCEESSCEE----CCC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred             CCeEEEcccCcCcccccc----ccccCCCCCccccChhhhcccc-CCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHH
Confidence            679999999998743221    1223345577899999997644 8899999999999999998 99999875432    


Q ss_pred             ------ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         241 ------IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       241 ------~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                            ...........+.+++..|..+.|..||++.++
T Consensus       253 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el  291 (327)
T 1fvr_A          253 KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI  291 (327)
T ss_dssp             HGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence                  111223445778999999999999999988764

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1e-39  Score=279.20  Aligned_cols=245  Identities=21%  Similarity=0.309  Sum_probs=176.2

Q ss_pred             ccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC--CChhHHHHHHHHhcCC-CCCeeeEEEEEEe------
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG--LSMSACREIALLRELK-HPNVINLISVFLS------   87 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~------   87 (291)
                      ..+|++ .++||+|+||.||+|.+..  +++.||+|.+....  ....+.+|+.+++++. ||||+++++++..      
T Consensus        27 ~~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~  103 (337)
T 3ll6_A           27 ELRLRV-RRVLAEGGFAFVYEAQDVG--SGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD  103 (337)
T ss_dssp             TEEEEE-EEEEECCSSEEEEEEEETT--TCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred             CceEEE-EEEEccCCceEEEEEEECC--CCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence            346664 6799999999999999876  67889999885432  2345788999999996 9999999999842      


Q ss_pred             CCCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeeccCCCcEEeecCCCC
Q psy2172          88 HNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNW--VLHRDLKPANILVMGEGIE  165 (291)
Q Consensus        88 ~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~dik~~Nil~~~~~~~  165 (291)
                      .+....+++|||++|+|.+.+......      ..+++..++.++.|++.||+|||++|  ++|+||||+||+++    .
T Consensus       104 ~~~~~~~lv~e~~~g~L~~~l~~~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~----~  173 (337)
T 3ll6_A          104 TGQAEFLLLTELCKGQLVEFLKKMESR------GPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS----N  173 (337)
T ss_dssp             TSSEEEEEEEECCSEEHHHHHHHHHTT------CSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEEC----T
T ss_pred             cCCceEEEEEEecCCCHHHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEEC----C
Confidence            345579999999999999988764322      12899999999999999999999999  99999999999998    6


Q ss_pred             CCcEEEeecccceecCCCCCCC---------CCCCCceeccccccccccc--CCcCCCCchhHHHHHHHHHHHHcCCCCC
Q psy2172         166 RGRVKIADMGFARLFNNPLKPL---------ADLDPVVVTFWYRAPELLL--GARHYTKAIDIWAIGCIFAELLTSEPIF  234 (291)
Q Consensus       166 ~~~~~l~Dfg~~~~~~~~~~~~---------~~~~~~~g~~~y~aPE~~~--~~~~~~~~~Dv~slG~~l~~l~~g~~pf  234 (291)
                      ++.++|+|||++..........         .......|++.|+|||++.  ....++.++||||||+++|+|++|..||
T Consensus       174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~  253 (337)
T 3ll6_A          174 QGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF  253 (337)
T ss_dssp             TSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC
T ss_pred             CCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCC
Confidence            6799999999998765432111         1112446899999999983  2234788999999999999999999999


Q ss_pred             CCCcccc-------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCC
Q psy2172         235 HCRQEDI-------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMP  274 (291)
Q Consensus       235 ~~~~~~~-------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  274 (291)
                      .......       ..........+.+++..|..+.|..||++.++.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l  300 (337)
T 3ll6_A          254 EDGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVV  300 (337)
T ss_dssp             ------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             cchhHHHhhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHH
Confidence            7644321       111122235588899999999999999887643

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.1e-39  Score=276.55  Aligned_cols=246  Identities=22%  Similarity=0.330  Sum_probs=192.9

Q ss_pred             cccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC----hhHHHHHHHHhcCC--CCCeeeEEEEEEeCC
Q psy2172          16 VEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIALLRELK--HPNVINLISVFLSHN   89 (291)
Q Consensus        16 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~   89 (291)
                      ..+.|++ .+.||+|+||.||+|.+.   +++.||+|++......    ..+.+|+.++++++  ||||+++++++  .+
T Consensus        26 ~~~~y~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~--~~   99 (313)
T 3cek_A           26 KGRIYSI-LKQIGSGGSSKVFQVLNE---KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE--IT   99 (313)
T ss_dssp             TTEEEEE-EEEEECCSSEEEEEEECT---TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE--EC
T ss_pred             ccceEEE-EEEecCCCCEEEEEEEcC---CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe--ec
Confidence            3455774 679999999999999874   4678999998654332    45788999999997  59999999999  45


Q ss_pred             CceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcE
Q psy2172          90 DRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRV  169 (291)
Q Consensus        90 ~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~  169 (291)
                      ....+++||+.+++|.+.+....         .+++..++.++.|++.||.+||++|++|+||||+||+++    + +.+
T Consensus       100 ~~~~~lv~e~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~----~-~~~  165 (313)
T 3cek_A          100 DQYIYMVMECGNIDLNSWLKKKK---------SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----D-GML  165 (313)
T ss_dssp             SSEEEEEECCCSEEHHHHHHHCS---------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----T-TEE
T ss_pred             CCEEEEEEecCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE----C-CeE
Confidence            67899999988889998887533         288999999999999999999999999999999999996    2 689


Q ss_pred             EEeecccceecCCCCCCCCCCCCceecccccccccccCC----------cCCCCchhHHHHHHHHHHHHcCCCCCCCCcc
Q psy2172         170 KIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGA----------RHYTKAIDIWAIGCIFAELLTSEPIFHCRQE  239 (291)
Q Consensus       170 ~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----------~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~  239 (291)
                      +|+|||.+........ ........|++.|+|||.+.+.          ..++.++||||||+++|+|++|..||.....
T Consensus       166 kL~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  244 (313)
T 3cek_A          166 KLIDFGIANQMQPDTT-SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN  244 (313)
T ss_dssp             EECCCSSSCC---------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred             EEeeccccccccCccc-cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH
Confidence            9999999986543221 1122345689999999998651          2478899999999999999999999986533


Q ss_pred             cc------------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhh
Q psy2172         240 DI------------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKD  282 (291)
Q Consensus       240 ~~------------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (291)
                      ..            ..........+.+++..|..+.|..||++.++..+||+...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~  299 (313)
T 3cek_A          245 QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  299 (313)
T ss_dssp             HHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred             HHHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence            21            11223335678999999999999999999999999887643

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=276.00  Aligned_cols=230  Identities=26%  Similarity=0.379  Sum_probs=180.2

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLF   97 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~   97 (291)
                      +.|++ .+.||+|+||.||+|.+.    ++.||+|.+........+.+|+.++++++||||+++++++  .+  ..++||
T Consensus         8 ~~~~~-~~~lg~G~~g~V~~~~~~----~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--~~--~~~lv~   78 (307)
T 2eva_A            8 KEIEV-EEVVGRGAFGVVCKAKWR----AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGAC--LN--PVCLVM   78 (307)
T ss_dssp             GGEEE-EEEEECCSSSEEEEEEET----TEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBC--TT--TTEEEE
T ss_pred             hHeee-eeEeecCCCceEEEEEEC----CeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEE--cC--CcEEEE
Confidence            34554 679999999999999874    4679999998776667899999999999999999999987  32  468999


Q ss_pred             ecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeeccCCCcEEeecCCCCCC-cEEEe
Q psy2172          98 DYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHS---NWVLHRDLKPANILVMGEGIERG-RVKIA  172 (291)
Q Consensus        98 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~dik~~Nil~~~~~~~~~-~~~l~  172 (291)
                      ||+++ +|.+.+.....      ...++...++.++.|++.||+|||+   +|++|+||||+||+++    .++ .++|+
T Consensus        79 e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~----~~~~~~kl~  148 (307)
T 2eva_A           79 EYAEGGSLYNVLHGAEP------LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV----AGGTVLKIC  148 (307)
T ss_dssp             ECCTTCBHHHHHHCSSS------EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEE----TTTTEEEEC
T ss_pred             EcCCCCCHHHHHhccCC------CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEe----CCCCEEEEc
Confidence            99975 88887764321      1127888999999999999999999   8999999999999998    444 48999


Q ss_pred             ecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc------------
Q psy2172         173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED------------  240 (291)
Q Consensus       173 Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~------------  240 (291)
                      |||.+......      .....|+..|+|||.+.+.. ++.++||||||+++|+|++|+.||......            
T Consensus       149 Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~  221 (307)
T 2eva_A          149 DFGTACDIQTH------MTNNKGSAAWMAPEVFEGSN-YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT  221 (307)
T ss_dssp             CCCC------------------CCTTSSCHHHHTCCC-CCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC
T ss_pred             ccccccccccc------cccCCCCCceEChhhhCCCC-CCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC
Confidence            99998755432      12346899999999998754 899999999999999999999999864322            


Q ss_pred             ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         241 IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       241 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      ...........+.+++..|....|..||++.++
T Consensus       222 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el  254 (307)
T 2eva_A          222 RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEI  254 (307)
T ss_dssp             CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCcccccCHHHHHHHHHHhcCChhhCcCHHHH
Confidence            111223345678899999999999999987764

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-39  Score=272.63  Aligned_cols=235  Identities=26%  Similarity=0.330  Sum_probs=183.6

Q ss_pred             cceeCcccceEEEEEEEccCC-CCceeEEEEeCCCCCC---hhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEec
Q psy2172          24 GCKVGRGTYGHVYKARRKDNS-DTRDYALKQIEGTGLS---MSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDY   99 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~-~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~   99 (291)
                      +++||+|+||.||+|.+.... ....+|+|.+......   +.+.+|+.+++.++||||+++++++.. .....+++|||
T Consensus        26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~~~v~e~  104 (298)
T 3pls_A           26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLP-PEGLPHVLLPY  104 (298)
T ss_dssp             EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC-SSSCCEEEECC
T ss_pred             CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEec-CCCCcEEEEec
Confidence            689999999999999976532 3346999998754432   457799999999999999999999943 23345899999


Q ss_pred             CC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccce
Q psy2172         100 AE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR  178 (291)
Q Consensus       100 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~  178 (291)
                      +. ++|.+.+....        ..+++..++.++.|++.||++||++|++|+||||+||+++    .++.++|+|||.+.
T Consensus       105 ~~~~~L~~~~~~~~--------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~----~~~~~kl~Dfg~~~  172 (298)
T 3pls_A          105 MCHGDLLQFIRSPQ--------RNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLD----ESFTVKVADFGLAR  172 (298)
T ss_dssp             CTTCBHHHHHHCTT--------CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----TTCCEEECCTTSSC
T ss_pred             ccCCCHHHHHhccc--------cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc----CCCcEEeCcCCCcc
Confidence            86 58888775422        1278999999999999999999999999999999999998    67799999999997


Q ss_pred             ecCCCCC-CCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcC-CCCCCCCcccc----------cCCCC
Q psy2172         179 LFNNPLK-PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQEDI----------KTSNP  246 (291)
Q Consensus       179 ~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g-~~pf~~~~~~~----------~~~~~  246 (291)
                      ....... .........++..|+|||.+.+.. ++.++||||||+++|+|++| .+||.......          .....
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (298)
T 3pls_A          173 DILDREYYSVQQHRHARLPVKWTALESLQTYR-FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPE  251 (298)
T ss_dssp             TTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCT
T ss_pred             cccCCcccccccCcCCCCCccccChhhhccCC-CChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCc
Confidence            6543211 112233456788999999998754 89999999999999999995 55565544321          12233


Q ss_pred             CcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         247 YHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       247 ~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      ...+.+.+++..|..+.|..||++.+
T Consensus       252 ~~~~~l~~li~~~l~~~p~~Rps~~~  277 (298)
T 3pls_A          252 YCPDSLYQVMQQCWEADPAVRPTFRV  277 (298)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             cchHHHHHHHHHHccCChhhCcCHHH
Confidence            34577899999999999999988775

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-39  Score=282.14  Aligned_cols=236  Identities=23%  Similarity=0.342  Sum_probs=177.3

Q ss_pred             cceeCcccceEEEEEEEccCC-CCceeEEEEeCCCCCC---hhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEec
Q psy2172          24 GCKVGRGTYGHVYKARRKDNS-DTRDYALKQIEGTGLS---MSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDY   99 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~-~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~   99 (291)
                      ++.||+|+||.||+|.+.... ....||+|.++.....   ..+.+|+.++++++||||+++++++.. .....++||||
T Consensus        94 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~~lv~e~  172 (373)
T 3c1x_A           94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR-SEGSPLVVLPY  172 (373)
T ss_dssp             EEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECC-CSSCCEEEEEC
T ss_pred             CcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEc-CCCCeEEEEEC
Confidence            579999999999999986432 3356899998754332   457899999999999999999998743 34578899999


Q ss_pred             CCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccce
Q psy2172         100 AEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR  178 (291)
Q Consensus       100 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~  178 (291)
                      +++ +|.+++....        ..+++..++.++.|++.||+|||++||+|+||||+||+++    .++.++|+|||++.
T Consensus       173 ~~~g~L~~~l~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~----~~~~~kL~DFG~a~  240 (373)
T 3c1x_A          173 MKHGDLRNFIRNET--------HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD----EKFTVKVADFGLAR  240 (373)
T ss_dssp             CTTCBHHHHHHCTT--------CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTCCEEECCC----
T ss_pred             CCCCCHHHHHhhcc--------cCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEEC----CCCCEEEeeccccc
Confidence            985 8888875322        1278899999999999999999999999999999999998    67799999999998


Q ss_pred             ecCCCCCC-CCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc----------cCCCC
Q psy2172         179 LFNNPLKP-LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI----------KTSNP  246 (291)
Q Consensus       179 ~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~----------~~~~~  246 (291)
                      ........ ........++..|+|||.+.+.. ++.++||||||+++|+|++ |.+||.+.....          .....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~  319 (373)
T 3c1x_A          241 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE  319 (373)
T ss_dssp             -----------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCT
T ss_pred             cccccccccccccCCCCCcccccChHHhcCCC-CCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            65432211 11223345678899999997644 8999999999999999999 788887654321          11233


Q ss_pred             CcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         247 YHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       247 ~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      ...+.+.+++..|..+.|..||++.++
T Consensus       320 ~~~~~l~~li~~cl~~dp~~RPs~~el  346 (373)
T 3c1x_A          320 YCPDPLYEVMLKCWHPKAEMRPSFSEL  346 (373)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            445778999999999999999887763

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3.6e-39  Score=267.64  Aligned_cols=231  Identities=16%  Similarity=0.230  Sum_probs=186.1

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC----hhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      +.|.+ .+.||+|+||.||+|.+.    +..||+|++......    +.+.+|+.++++++||||+++++++...+....
T Consensus        10 ~~y~~-~~~lg~G~~g~V~~~~~~----~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   84 (271)
T 3kmu_A           10 KQLNF-LTKLNENHSGELWKGRWQ----GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP   84 (271)
T ss_dssp             GGCEE-EEEEEEETTEEEEEEEET----TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred             HHhHH-HHHhcCCCcceEEEEEEC----CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence            45664 679999999999999974    467999999755332    357899999999999999999999965545789


Q ss_pred             EEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeeccCCCcEEeecCCCCCCcEE
Q psy2172          94 WLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNW--VLHRDLKPANILVMGEGIERGRVK  170 (291)
Q Consensus        94 ~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~dik~~Nil~~~~~~~~~~~~  170 (291)
                      +++|||+++ +|.+.+.....       ..+++..++.++.|++.||+|||++|  ++|+||||+||+++    .++.++
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~----~~~~~~  153 (271)
T 3kmu_A           85 TLITHWMPYGSLYNVLHEGTN-------FVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMID----EDMTAR  153 (271)
T ss_dssp             EEEEECCTTCBHHHHHHSCSS-------CCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEEC----TTSCEE
T ss_pred             EeeecccCCCcHHHHHhhccc-------CCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEc----CCccee
Confidence            999999985 98888864321       13899999999999999999999999  99999999999998    667889


Q ss_pred             EeecccceecCCCCCCCCCCCCceecccccccccccCCcC--CCCchhHHHHHHHHHHHHcCCCCCCCCccc--------
Q psy2172         171 IADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARH--YTKAIDIWAIGCIFAELLTSEPIFHCRQED--------  240 (291)
Q Consensus       171 l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~--~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~--------  240 (291)
                      ++|||++.....        ....||+.|+|||.+.+...  ++.++||||||+++|+|++|..||.+....        
T Consensus       154 l~~~~~~~~~~~--------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~  225 (271)
T 3kmu_A          154 ISMADVKFSFQS--------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVAL  225 (271)
T ss_dssp             EEGGGSCCTTSC--------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHH
T ss_pred             EEeccceeeecc--------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHh
Confidence            998887654222        33467899999999986431  334799999999999999999999875432        


Q ss_pred             ---ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         241 ---IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       241 ---~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                         ...........+.+++..|..+.|..||++.+
T Consensus       226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  260 (271)
T 3kmu_A          226 EGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDM  260 (271)
T ss_dssp             SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence               11233344677899999999999999988775

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.6e-39  Score=274.46  Aligned_cols=249  Identities=20%  Similarity=0.332  Sum_probs=194.0

Q ss_pred             ccccccccceeCcccceEEEEEEEcc---CCCCceeEEEEeCCCCCC---hhHHHHHHHHhcC-CCCCeeeEEEEEEeCC
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKD---NSDTRDYALKQIEGTGLS---MSACREIALLREL-KHPNVINLISVFLSHN   89 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~---~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~   89 (291)
                      .+.|.+ ++.||+|+||.||+|.+.+   ..+++.||+|++......   ..+.+|+.+++++ +||||+++++++.. .
T Consensus        26 ~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-~  103 (316)
T 2xir_A           26 RDRLKL-GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK-P  103 (316)
T ss_dssp             GGGEEE-EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC-T
T ss_pred             hhheee-eeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec-C
Confidence            456664 7799999999999998753   336688999999765432   3578899999999 78999999999843 3


Q ss_pred             CceEEEEEecCCC-CHHHHHHHhhhhhhC-------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeec
Q psy2172          90 DRKVWLLFDYAEH-DLWHIIKFHRAAKAN-------KKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMG  161 (291)
Q Consensus        90 ~~~~~iv~e~~~~-~l~~~~~~~~~~~~~-------~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~  161 (291)
                      ....+++|||+++ +|.+++.........       .....+++..++.++.|++.||.+||++|++|+||||+||+++ 
T Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~-  182 (316)
T 2xir_A          104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-  182 (316)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC-
Confidence            4568999999985 888888754321100       0011278899999999999999999999999999999999998 


Q ss_pred             CCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc
Q psy2172         162 EGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED  240 (291)
Q Consensus       162 ~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~  240 (291)
                         ..+.++|+|||++........ ........++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+....
T Consensus       183 ---~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~  257 (316)
T 2xir_A          183 ---EKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKID  257 (316)
T ss_dssp             ---GGGCEEECCCGGGSCTTTCTT-SEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             ---CCCCEEECCCccccccccCcc-ceeccCCCcceeecCchhhcccc-ccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence               667899999999986544221 12234456788999999997644 8999999999999999998 99999876532


Q ss_pred             c-----------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         241 I-----------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       241 ~-----------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      .           ..........+.+++..|..+.|..||++.++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el  301 (316)
T 2xir_A          258 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL  301 (316)
T ss_dssp             HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            1           12223345678899999999999998887764

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=8.1e-40  Score=277.89  Aligned_cols=248  Identities=24%  Similarity=0.370  Sum_probs=190.5

Q ss_pred             cccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC--CChhHHHHHHHHhcCCCCCeeeEEEEEEeC--C
Q psy2172          14 TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG--LSMSACREIALLRELKHPNVINLISVFLSH--N   89 (291)
Q Consensus        14 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~   89 (291)
                      ....++|++ .+.||+|+||.||+|.+..  +++.||+|++....  ....+.+|+.+++.++||||+++++++...  .
T Consensus        25 ~i~~~~y~~-~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  101 (317)
T 2buj_A           25 IIDNKHYLF-IQKLGEGGFSYVDLVEGLH--DGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGA  101 (317)
T ss_dssp             EETTEEEEE-EEEEEC--CEEEEEEEETT--TCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred             EECCeEEEE-EEEecCCCCeEEEEEEecC--CCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence            334567775 7799999999999999866  67899999885432  334688999999999999999999998632  4


Q ss_pred             CceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCc
Q psy2172          90 DRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGR  168 (291)
Q Consensus        90 ~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~  168 (291)
                      ....++||||+.+ +|.+.+.......     ..+++..++.++.|++.||++||++|++|+||||+||+++    .++.
T Consensus       102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~----~~~~  172 (317)
T 2buj_A          102 KHEAWLLLPFFKRGTLWNEIERLKDKG-----NFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLG----DEGQ  172 (317)
T ss_dssp             EEEEEEEEECCTTCBHHHHHHHHHTTT-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTSC
T ss_pred             CceeEEEEEeCCCCcHHHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc----CCCC
Confidence            4588999999986 8888887643321     2389999999999999999999999999999999999998    6678


Q ss_pred             EEEeecccceecCCCCCCC------CCCCCceecccccccccccCCc--CCCCchhHHHHHHHHHHHHcCCCCCCCCccc
Q psy2172         169 VKIADMGFARLFNNPLKPL------ADLDPVVVTFWYRAPELLLGAR--HYTKAIDIWAIGCIFAELLTSEPIFHCRQED  240 (291)
Q Consensus       169 ~~l~Dfg~~~~~~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~--~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~  240 (291)
                      ++|+|||.+..........      .......|+..|+|||.+.+..  .++.++||||||+++|+|++|..||......
T Consensus       173 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~  252 (317)
T 2buj_A          173 PVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK  252 (317)
T ss_dssp             EEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT
T ss_pred             EEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc
Confidence            9999999887543210000      0001234588899999987533  2688999999999999999999999642110


Q ss_pred             ------------ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         241 ------------IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       241 ------------~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                                  .....+.....+.+++..|..+.|..||++.++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  297 (317)
T 2buj_A          253 GDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLL  297 (317)
T ss_dssp             TSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             cchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHH
Confidence                        011223345778999999999999999988763

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.1e-39  Score=292.52  Aligned_cols=234  Identities=22%  Similarity=0.351  Sum_probs=187.7

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLL   96 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv   96 (291)
                      +.|++ .++||+|+||.||+|.+++   ...||||+++... ..+.+.+|+.+|++++||||+++++++  .+ ...|+|
T Consensus       267 ~~~~~-~~~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~--~~-~~~~lv  339 (535)
T 2h8h_A          267 ESLRL-EVKLGQGCFGEVWMGTWNG---TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV--SE-EPIYIV  339 (535)
T ss_dssp             GGEEE-EEEEEECSSEEEEEEEETT---TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEE--CS-SSCEEE
T ss_pred             hhhhh-heecccCCCeEEEEEEECC---CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEE--ee-ccceEe
Confidence            34553 6799999999999999864   3569999998643 345789999999999999999999998  33 568999


Q ss_pred             EecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecc
Q psy2172          97 FDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMG  175 (291)
Q Consensus        97 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg  175 (291)
                      |||+.+ +|.+++......       .+++..++.++.|++.||+|||++||+|+||||+||+++    .++.++|+|||
T Consensus       340 ~e~~~~gsL~~~l~~~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~----~~~~~kl~DFG  408 (535)
T 2h8h_A          340 TEYMSKGSLLDFLKGETGK-------YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG----ENLVCKVADFG  408 (535)
T ss_dssp             ECCCTTEEHHHHHSHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----GGGCEEECCTT
T ss_pred             eehhcCCcHHHHHhhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEc----CCCcEEEcccc
Confidence            999975 898888654322       188999999999999999999999999999999999998    66799999999


Q ss_pred             cceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc----------ccCC
Q psy2172         176 FARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED----------IKTS  244 (291)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~----------~~~~  244 (291)
                      ++.......  ........++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+....          ....
T Consensus       409 ~a~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~  485 (535)
T 2h8h_A          409 LARLIEDNE--YTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC  485 (535)
T ss_dssp             STTTCCCHH--HHTTCSTTSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred             cceecCCCc--eecccCCcCcccccCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            997654311  01112334577899999987644 8999999999999999999 99999875431          1112


Q ss_pred             CCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         245 NPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       245 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      .....+.+.+++..|....|..||++.+
T Consensus       486 ~~~~~~~l~~li~~cl~~dP~~RPt~~~  513 (535)
T 2h8h_A          486 PPECPESLHDLMCQCWRKEPEERPTFEY  513 (535)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCHHHHHHHHHHcCCChhHCcCHHH
Confidence            3344577889999999999999988775

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-38  Score=270.82  Aligned_cols=238  Identities=22%  Similarity=0.312  Sum_probs=182.7

Q ss_pred             cccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcC--CCCCeeeEEEEEEeCCC-
Q psy2172          14 TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLREL--KHPNVINLISVFLSHND-   90 (291)
Q Consensus        14 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l--~h~~iv~~~~~~~~~~~-   90 (291)
                      ..+.+.|++ .++||+|+||.||+|.++    ++.||+|++... ......+|.+++..+  +||||+++++++..... 
T Consensus        33 ~~~~~~y~~-~~~lg~G~~g~V~~~~~~----~~~vavK~~~~~-~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~  106 (337)
T 3mdy_A           33 RTIAKQIQM-VKQIGKGRYGEVWMGKWR----GEKVAVKVFFTT-EEASWFRETEIYQTVLMRHENILGFIAADIKGTGS  106 (337)
T ss_dssp             TTHHHHCEE-EEEEEEETTEEEEEEEET----TEEEEEEEEEGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred             cccccceEE-EeEeecCCCeEEEEEEEC----CceEEEEEEecc-ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence            455677885 779999999999999874    578999998643 234455666776665  89999999999865433 


Q ss_pred             -ceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhC--------CeeeeccCCCcEEee
Q psy2172          91 -RKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSN--------WVLHRDLKPANILVM  160 (291)
Q Consensus        91 -~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~--------~ivH~dik~~Nil~~  160 (291)
                       ...++||||+.+ +|.+++....          +++..++.++.|++.||+|||++        |++|+||||+||+++
T Consensus       107 ~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~  176 (337)
T 3mdy_A          107 WTQLYLITDYHENGSLYDYLKSTT----------LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK  176 (337)
T ss_dssp             GCEEEEEECCCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEEC
T ss_pred             CCceEEEEeccCCCcHHHHhhccC----------CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEEC
Confidence             689999999975 9988885431          89999999999999999999998        999999999999998


Q ss_pred             cCCCCCCcEEEeecccceecCCCCCC-CCCCCCceecccccccccccCCcCCCC------chhHHHHHHHHHHHHcC---
Q psy2172         161 GEGIERGRVKIADMGFARLFNNPLKP-LADLDPVVVTFWYRAPELLLGARHYTK------AIDIWAIGCIFAELLTS---  230 (291)
Q Consensus       161 ~~~~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~------~~Dv~slG~~l~~l~~g---  230 (291)
                          .++.++|+|||++......... ........||..|+|||++.+.. .+.      ++|||||||++|+|++|   
T Consensus       177 ----~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~  251 (337)
T 3mdy_A          177 ----KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVS  251 (337)
T ss_dssp             ----TTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCB
T ss_pred             ----CCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCc
Confidence                6679999999999766543221 11223457899999999997744 333      39999999999999999   


Q ss_pred             -------CCCCCCCccccc---------------C-C-----CCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         231 -------EPIFHCRQEDIK---------------T-S-----NPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       231 -------~~pf~~~~~~~~---------------~-~-----~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                             ..||........               . .     .....+.+.+++..|..+.|..||++.+
T Consensus       252 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e  321 (337)
T 3mdy_A          252 GGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALR  321 (337)
T ss_dssp             TTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             ccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHH
Confidence                   677765332110               0 0     0123455888999999999999988776

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.7e-38  Score=271.91  Aligned_cols=235  Identities=23%  Similarity=0.272  Sum_probs=176.0

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHh--cCCCCCeeeEEEEEE---eCCCce
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLR--ELKHPNVINLISVFL---SHNDRK   92 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~--~l~h~~iv~~~~~~~---~~~~~~   92 (291)
                      +.|.+ .+.||+|+||.||+|.+    +++.||+|++... ....+..|.+++.  .++||||+++++.+.   ..+...
T Consensus        13 ~~y~~-~~~lg~G~~g~Vy~~~~----~~~~vavK~~~~~-~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           13 DNLKL-LELIGRGRYGAVYKGSL----DERPVAVKVFSFA-NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             TSEEE-EEEEEECSSEEEEEEEE----TTEEEEEEEEEGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             HHhhe-eeecccCCCeEEEEEEE----CCeEEEEEEeecc-chhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            45664 67999999999999976    4578999998643 2344555555544  479999999998653   234557


Q ss_pred             EEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhC---------CeeeeccCCCcEEeecC
Q psy2172          93 VWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSN---------WVLHRDLKPANILVMGE  162 (291)
Q Consensus        93 ~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~---------~ivH~dik~~Nil~~~~  162 (291)
                      .++||||+++ +|.+++....          .++..++.++.|++.||+|||+.         ||+|+||||+||+++  
T Consensus        87 ~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~--  154 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSLHT----------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK--  154 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEEC--
T ss_pred             EEEEEecCCCCcHHHHHhhcc----------cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEc--
Confidence            8999999964 8888885432          67888999999999999999999         999999999999998  


Q ss_pred             CCCCCcEEEeecccceecCCCCC-----CCCCCCCceecccccccccccCC------cCCCCchhHHHHHHHHHHHHcCC
Q psy2172         163 GIERGRVKIADMGFARLFNNPLK-----PLADLDPVVVTFWYRAPELLLGA------RHYTKAIDIWAIGCIFAELLTSE  231 (291)
Q Consensus       163 ~~~~~~~~l~Dfg~~~~~~~~~~-----~~~~~~~~~g~~~y~aPE~~~~~------~~~~~~~Dv~slG~~l~~l~~g~  231 (291)
                        .++.++|+|||++........     .........||..|+|||++.+.      ..++.++|||||||++|+|++|.
T Consensus       155 --~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~  232 (336)
T 3g2f_A          155 --NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC  232 (336)
T ss_dssp             --TTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred             --CCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcC
Confidence              667999999999987654221     11122345689999999999762      23567899999999999999996


Q ss_pred             CCCCCCcccccC-----------------------------------CCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         232 PIFHCRQEDIKT-----------------------------------SNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       232 ~pf~~~~~~~~~-----------------------------------~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      .||.........                                   ........+.+++..|..+.|..||++.+
T Consensus       233 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e  308 (336)
T 3g2f_A          233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQX  308 (336)
T ss_dssp             GGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             CcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHH
Confidence            555332211000                                   00112346889999999999999988776

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=7.7e-39  Score=292.19  Aligned_cols=250  Identities=26%  Similarity=0.361  Sum_probs=194.2

Q ss_pred             cccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC---ChhHHHHHHHHhcCCCCCeeeEEEEEEe----C
Q psy2172          16 VEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL---SMSACREIALLRELKHPNVINLISVFLS----H   88 (291)
Q Consensus        16 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~   88 (291)
                      ..++|++ .++||+|+||.||+|.++.  +++.||+|++.....   ...+.+|+.++++++||||+++++++..    .
T Consensus        12 ~~grY~i-~~~LG~G~fG~Vyla~~~~--tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~   88 (676)
T 3qa8_A           12 TCGPWEM-KERLGTGGFGYVLRWIHQD--TGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLA   88 (676)
T ss_dssp             -----CC-CCCCCBCSSSBCCCCCCTT--TTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCC
T ss_pred             CCCCeEE-EEEEeeCCCeEEEEEEECC--CCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccccc
Confidence            3477885 6799999999999999765  678899999875432   2357889999999999999999998732    2


Q ss_pred             CCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCC
Q psy2172          89 NDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERG  167 (291)
Q Consensus        89 ~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~  167 (291)
                      .....++||||+++ +|.+++......      ..+++..++.++.|++.||+|||++|++|+||||+||+++.++ ...
T Consensus        89 ~~~~~~LVmEy~~ggsL~~~L~~~~~~------~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g-~~~  161 (676)
T 3qa8_A           89 PNDLPLLAMEYCEGGDLRKYLNQFENC------CGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGP-QRL  161 (676)
T ss_dssp             TTSSCCCEEECCSSCBHHHHHHSSSCT------TCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCS-SSC
T ss_pred             CCCeEEEEEEeCCCCCHHHHHHhcccC------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCC-Cce
Confidence            26678999999964 888877643221      1278889999999999999999999999999999999998543 344


Q ss_pred             cEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc-------
Q psy2172         168 RVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED-------  240 (291)
Q Consensus       168 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~-------  240 (291)
                      .++|+|||.+.......    ......|+..|+|||.+.+.. ++.++||||||+++|+|++|..||......       
T Consensus       162 ~vKL~DFG~a~~~~~~~----~~~~~~gt~~Y~APE~l~~~~-~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i  236 (676)
T 3qa8_A          162 IHKIIDLGYAKELDQGE----LCTEFVGTLQYLAPELLEQKK-YTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV  236 (676)
T ss_dssp             EEEECSCCCCCBTTSCC----CCCCCCSCCTTCSSCSSCCSC-CSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTC
T ss_pred             eEEEccccccccccccc----ccccccCCcccCChHHhccCC-CCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhh
Confidence            69999999998765432    223457899999999998754 899999999999999999999999653100       


Q ss_pred             --------------------------ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchh
Q psy2172         241 --------------------------IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLL  280 (291)
Q Consensus       241 --------------------------~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  280 (291)
                                                .........+.+.+++..|..+.|..||++.++..++++.
T Consensus       237 ~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~  302 (676)
T 3qa8_A          237 REKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQ  302 (676)
T ss_dssp             C------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHH
T ss_pred             hcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHH
Confidence                                      0011223467899999999999999999999999999865

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=4.6e-38  Score=265.06  Aligned_cols=231  Identities=21%  Similarity=0.365  Sum_probs=185.0

Q ss_pred             cccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHH-hcCCCCCeeeEEEEEEe--CCC
Q psy2172          14 TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALL-RELKHPNVINLISVFLS--HND   90 (291)
Q Consensus        14 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~--~~~   90 (291)
                      ..+.+.|.+.++.||+|+||.||+|.++.  +++.||+|+++.   ...+.+|+.++ +.++||||+++++++..  .+.
T Consensus        13 ~~~~~~y~~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~---~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~   87 (299)
T 3m2w_A           13 NAIIDDYKVTSQVLGLGINGKVLQIFNKR--TQEKFALKMLQD---CPKARREVELHWRASQCPHIVRIVDVYENLYAGR   87 (299)
T ss_dssp             SCGGGTEEEEEEEEEEETTEEEEEEEETT--TCCEEEEEEEEC---SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             cccccchhhcCcccccCCCeEEEEEEEcC--CCcEEEEEEecc---cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence            34555666666889999999999999876  678999999864   45678888888 56699999999999843  346


Q ss_pred             ceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcE
Q psy2172          91 RKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRV  169 (291)
Q Consensus        91 ~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~  169 (291)
                      ...++||||+++ +|.+.+.....       ..+++..++.++.|++.||+|||++|++|+||||+||+++... ..+.+
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~~~  159 (299)
T 3m2w_A           88 KCLLIVMECLDGGELFSRIQDRGD-------QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR-PNAIL  159 (299)
T ss_dssp             EEEEEEECCCCSCBHHHHHHHCTT-------CCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSS-TTCCE
T ss_pred             ceEEEEEeecCCCcHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCC-CCCcE
Confidence            789999999975 99888876432       1289999999999999999999999999999999999998432 26789


Q ss_pred             EEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc-------
Q psy2172         170 KIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK-------  242 (291)
Q Consensus       170 ~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~-------  242 (291)
                      +|+|||++.....                          ..++.++||||||+++|+|++|..||.+......       
T Consensus       160 kl~Dfg~a~~~~~--------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  213 (299)
T 3m2w_A          160 KLTDFGFAKETTG--------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR  213 (299)
T ss_dssp             EECCCTTCEECTT--------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCS
T ss_pred             EEecccccccccc--------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHH
Confidence            9999998864321                          2367899999999999999999999976542210       


Q ss_pred             --C----CC----CCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhhh
Q psy2172         243 --T----SN----PYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF  283 (291)
Q Consensus       243 --~----~~----~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (291)
                        .    ..    ......+.+++..|..+.|..||++.++..+|++.+..
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          214 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             SCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             HhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence              0    00    22356789999999999999999999999999987654

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=4.2e-38  Score=290.83  Aligned_cols=236  Identities=20%  Similarity=0.338  Sum_probs=185.3

Q ss_pred             cccccccceeCcccceEEEEEEEccCC-CCceeEEEEeCCCCCC---hhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNS-DTRDYALKQIEGTGLS---MSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~-~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      +.|.+ ++.||+|+||.||+|.+.... .+..||+|.++.....   +.+.+|+.++++++||||+++++++  . ....
T Consensus       390 ~~y~i-~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~--~-~~~~  465 (656)
T 2j0j_A          390 ERIEL-GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI--T-ENPV  465 (656)
T ss_dssp             GGEEE-EEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--C-SSSC
T ss_pred             ccEEE-eeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE--e-cCce
Confidence            44553 679999999999999986532 3567999998754322   4688999999999999999999998  2 3458


Q ss_pred             EEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          94 WLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        94 ~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      ++||||++ ++|.+.+.....        .+++..++.++.|++.||.|||++||+|+||||+||+++    .++.++|+
T Consensus       466 ~lv~E~~~~g~L~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~----~~~~vkL~  533 (656)
T 2j0j_A          466 WIIMELCTLGELRSFLQVRKF--------SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS----SNDCVKLG  533 (656)
T ss_dssp             EEEEECCTTCBHHHHHHHTTT--------TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE----ETTEEEEC
T ss_pred             EEEEEcCCCCcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEe----CCCCEEEE
Confidence            99999998 588888764321        288999999999999999999999999999999999999    66799999


Q ss_pred             ecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc----------c
Q psy2172         173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED----------I  241 (291)
Q Consensus       173 Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~----------~  241 (291)
                      |||++........  .......++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+....          .
T Consensus       534 DFG~a~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~  610 (656)
T 2j0j_A          534 DFGLSRYMEDSTY--YKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER  610 (656)
T ss_dssp             CCCCCCSCCC------------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCC
T ss_pred             ecCCCeecCCCcc--eeccCCCCCcceeCHHHhcCCC-CCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC
Confidence            9999986644221  1223345678899999997644 8999999999999999997 99999875432          1


Q ss_pred             cCCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         242 KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       242 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      ....+.....+.+++..|..+.|..||++.+
T Consensus       611 ~~~~~~~~~~l~~li~~~l~~dP~~RPs~~e  641 (656)
T 2j0j_A          611 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTE  641 (656)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCccccHHHHHHHHHHcCCChhHCcCHHH
Confidence            1233344577889999999999988888775

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.4e-37  Score=266.71  Aligned_cols=239  Identities=23%  Similarity=0.332  Sum_probs=187.5

Q ss_pred             ccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhc--CCCCCeeeEEEEEEeCCC--
Q psy2172          15 KVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRE--LKHPNVINLISVFLSHND--   90 (291)
Q Consensus        15 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~~~--   90 (291)
                      .+.+.|.+ .+.||+|+||.||+|.+.    ++.||+|++... ....+.+|++++..  ++||||+++++++...+.  
T Consensus        39 ~~~~~y~~-~~~lg~G~~g~Vy~~~~~----~~~vavK~~~~~-~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~  112 (342)
T 1b6c_B           39 TIARTIVL-QESIGKGRFGEVWRGKWR----GEEVAVKIFSSR-EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW  112 (342)
T ss_dssp             HHHHHCEE-EEEEEEETTEEEEEEEET----TEEEEEEEECGG-GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred             cccccEEE-EeeecCCCCcEEEEEEEc----CccEEEEEeCch-hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence            45577885 779999999999999873    578999999753 34567788899888  689999999999954332  


Q ss_pred             ceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHh--------hCCeeeeccCCCcEEeec
Q psy2172          91 RKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLH--------SNWVLHRDLKPANILVMG  161 (291)
Q Consensus        91 ~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH--------~~~ivH~dik~~Nil~~~  161 (291)
                      ...++||||+++ +|.+.+....          +++..++.++.|++.||++||        ++|++|+||||+||+++ 
T Consensus       113 ~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~-  181 (342)
T 1b6c_B          113 TQLWLVSDYHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-  181 (342)
T ss_dssp             CCEEEEECCCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEEC-
T ss_pred             ceeEEEEeecCCCcHHHHHhccC----------ccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEEC-
Confidence            379999999986 8888886421          899999999999999999999        89999999999999998 


Q ss_pred             CCCCCCcEEEeecccceecCCCCCCC-CCCCCceecccccccccccCCcC-----CCCchhHHHHHHHHHHHHcC-----
Q psy2172         162 EGIERGRVKIADMGFARLFNNPLKPL-ADLDPVVVTFWYRAPELLLGARH-----YTKAIDIWAIGCIFAELLTS-----  230 (291)
Q Consensus       162 ~~~~~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~-----~~~~~Dv~slG~~l~~l~~g-----  230 (291)
                         .++.++|+|||++.......... .......|+..|+|||.+.+...     ++.++||||||+++|+|++|     
T Consensus       182 ---~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~  258 (342)
T 1b6c_B          182 ---KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG  258 (342)
T ss_dssp             ---TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred             ---CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCC
Confidence               66799999999998765432211 12244578999999999976421     23689999999999999999     


Q ss_pred             -----CCCCCCCcccc---------------cCCC------CCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         231 -----EPIFHCRQEDI---------------KTSN------PYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       231 -----~~pf~~~~~~~---------------~~~~------~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                           ..||.......               ....      ....+.+.+++..|....|..||++.++
T Consensus       259 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i  327 (342)
T 1b6c_B          259 IHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI  327 (342)
T ss_dssp             BCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             cccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHH
Confidence                 78887653210               0000      1223568889999999999999888763

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=3.2e-38  Score=277.36  Aligned_cols=243  Identities=15%  Similarity=0.080  Sum_probs=184.5

Q ss_pred             ccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-----CChhHHHHHHHHhcCCC-CC-------------------
Q psy2172          23 EGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-----LSMSACREIALLRELKH-PN-------------------   77 (291)
Q Consensus        23 ~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h-~~-------------------   77 (291)
                      .+++||+|+||.||+|.+..  +++.||||++....     ..+.+.+|+.+++.++| ++                   
T Consensus        82 ~~~~LG~G~fG~Vy~a~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  159 (413)
T 3dzo_A           82 RGTVLGQEDPYAYLEATDQE--TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD  159 (413)
T ss_dssp             EEEEEEEETTEEEEEEEETT--TCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEEC
T ss_pred             EecccccCCCEEEEEEEecC--CCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhccc
Confidence            37799999999999999876  67899999987322     24568899999999976 21                   


Q ss_pred             --eeeEEEEEEeCC---CceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeecc
Q psy2172          78 --VINLISVFLSHN---DRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDL  152 (291)
Q Consensus        78 --iv~~~~~~~~~~---~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~di  152 (291)
                        ...+..++....   ....+++|+.+.++|.+++........  ....+++..++.++.|++.||+|||++||+||||
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi  237 (413)
T 3dzo_A          160 PQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS--THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL  237 (413)
T ss_dssp             CC---------------CCSEEEEEECCSEEHHHHHHHHHHHTT--TSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred             CCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence              111111111111   345789999999999998875543221  1122778899999999999999999999999999


Q ss_pred             CCCcEEeecCCCCCCcEEEeecccceecCCCCCCCCCCCCceeccccccccccc---------CCcCCCCchhHHHHHHH
Q psy2172         153 KPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLL---------GARHYTKAIDIWAIGCI  223 (291)
Q Consensus       153 k~~Nil~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---------~~~~~~~~~Dv~slG~~  223 (291)
                      ||+||+++    .++.+||+|||+++.....      .....| +.|+|||++.         ....++.++|||||||+
T Consensus       238 Kp~NILl~----~~~~~kL~DFG~a~~~~~~------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi  306 (413)
T 3dzo_A          238 RPVDIVLD----QRGGVFLTGFEHLVRDGAS------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA  306 (413)
T ss_dssp             CGGGEEEC----TTCCEEECCGGGCEETTEE------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred             ccceEEEe----cCCeEEEEeccceeecCCc------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence            99999999    6678999999998865432      234456 8999999983         22347889999999999


Q ss_pred             HHHHHcCCCCCCCCcccc-----cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchh
Q psy2172         224 FAELLTSEPIFHCRQEDI-----KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLL  280 (291)
Q Consensus       224 l~~l~~g~~pf~~~~~~~-----~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  280 (291)
                      +|+|++|+.||.+.....     ........+.+.+++..|..+.|..||++.++..++++.
T Consensus       307 l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~  368 (413)
T 3dzo_A          307 IYWIWCADLPNTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYE  368 (413)
T ss_dssp             HHHHHHSSCCCCTTGGGSCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred             HHHHHHCCCCCCCcchhhhHHHHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHH
Confidence            999999999998765421     111223457899999999999999999999999888764

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=4.1e-38  Score=267.51  Aligned_cols=235  Identities=20%  Similarity=0.345  Sum_probs=180.4

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT----GLSMSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      +.|.+ ++.||+|+||.||+|.+.+     .+++|.+...    .....+.+|+.++++++||||+++++++  .+....
T Consensus        33 ~~~~~-~~~lg~G~~g~V~~~~~~~-----~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~~~~~~  104 (319)
T 2y4i_B           33 EQLEI-GELIGKGRFGQVYHGRWHG-----EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC--MSPPHL  104 (319)
T ss_dssp             SCEEC-CCBCCCSSSSEEEEEEESS-----SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEE--ECSSCE
T ss_pred             HHeEE-eeEeccCCceEEEEEEEcC-----eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEE--ecCCce
Confidence            45664 7799999999999998753     4899998643    2234577899999999999999999999  456679


Q ss_pred             EEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          94 WLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        94 ~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      +++|||+.+ +|.+++....        ..+++..++.++.|++.||++||++|++|+||||+||+++     ++.++|+
T Consensus       105 ~iv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-----~~~~~l~  171 (319)
T 2y4i_B          105 AIITSLCKGRTLYSVVRDAK--------IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-----NGKVVIT  171 (319)
T ss_dssp             EEECBCCCSEEHHHHTTSSC--------CCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC-------CCEEC
T ss_pred             EEEeecccCCcHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-----CCCEEEe
Confidence            999999975 8777764321        2288999999999999999999999999999999999996     3589999


Q ss_pred             ecccceecCCCC--CCCCCCCCceecccccccccccC--------CcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc-
Q psy2172         173 DMGFARLFNNPL--KPLADLDPVVVTFWYRAPELLLG--------ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI-  241 (291)
Q Consensus       173 Dfg~~~~~~~~~--~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~-  241 (291)
                      |||++.......  ..........|+..|+|||.+.+        ...++.++||||||+++|+|++|..||....... 
T Consensus       172 Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~  251 (319)
T 2y4i_B          172 DFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI  251 (319)
T ss_dssp             CCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH
T ss_pred             ecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            999987653211  11122234568999999999864        2347889999999999999999999998755321 


Q ss_pred             ----------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         242 ----------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       242 ----------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                                ..........+.+++..|..+.|..||++.++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l  293 (319)
T 2y4i_B          252 IWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKL  293 (319)
T ss_dssp             HHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHH
T ss_pred             HHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence                      11112234568889999999999999887753

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.2e-36  Score=253.15  Aligned_cols=206  Identities=12%  Similarity=0.006  Sum_probs=167.5

Q ss_pred             ccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC-----hhHHHHHHHHhcCCCCCeeeEEEEEEeCC
Q psy2172          15 KVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS-----MSACREIALLRELKHPNVINLISVFLSHN   89 (291)
Q Consensus        15 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   89 (291)
                      .+.++|++ .+.||+|+||.||+|.+..  +++.||+|++......     ..+.+|+.++.+++||||+++++++.  +
T Consensus        28 ~~~~~y~i-~~~lg~G~~g~Vy~a~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~--~  102 (286)
T 3uqc_A           28 IANGRYRL-LIFHGGVPPLQFWQALDTA--LDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVH--T  102 (286)
T ss_dssp             ETTTTEEE-EEEEEBSTTCEEEEEEETT--TTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE--E
T ss_pred             EecCcEEE-EEEEcccCCeEEEEEEecC--CCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEE--E
Confidence            56788986 5799999999999999876  6789999999765432     56889999999999999999999994  4


Q ss_pred             CceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCc
Q psy2172          90 DRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGR  168 (291)
Q Consensus        90 ~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~  168 (291)
                      ....|+||||++| +|.+++...           .....+..++.|++.||+|||++||+|+||||+||+++    .++.
T Consensus       103 ~~~~~lv~e~~~g~~L~~~l~~~-----------~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~----~~g~  167 (286)
T 3uqc_A          103 RAGGLVVAEWIRGGSLQEVADTS-----------PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVS----IDGD  167 (286)
T ss_dssp             TTEEEEEEECCCEEEHHHHHTTC-----------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE----TTSC
T ss_pred             CCcEEEEEEecCCCCHHHHHhcC-----------CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEc----CCCC
Confidence            6789999999975 888776321           35557888999999999999999999999999999999    6678


Q ss_pred             EEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccC-----
Q psy2172         169 VKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT-----  243 (291)
Q Consensus       169 ~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~-----  243 (291)
                      ++|++++                       |++        .++.++||||||+++|+|++|+.||.+.......     
T Consensus       168 ~kl~~~~-----------------------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~  216 (286)
T 3uqc_A          168 VVLAYPA-----------------------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER  216 (286)
T ss_dssp             EEECSCC-----------------------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCB
T ss_pred             EEEEecc-----------------------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHH
Confidence            8888554                       222        2788999999999999999999999876542100     


Q ss_pred             -----------CCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         244 -----------SNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       244 -----------~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                                 ..+.....+.+++..|....|..| ++.+
T Consensus       217 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~e  255 (286)
T 3uqc_A          217 DTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SAST  255 (286)
T ss_dssp             CTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHH
T ss_pred             HhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHH
Confidence                       112335678899999988888888 7665

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=7.3e-37  Score=284.56  Aligned_cols=230  Identities=23%  Similarity=0.316  Sum_probs=181.6

Q ss_pred             ccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC---hhHHHHHHHHhcCCCCCeeeEEEEEEeCC
Q psy2172          13 RTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS---MSACREIALLRELKHPNVINLISVFLSHN   89 (291)
Q Consensus        13 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   89 (291)
                      ...+.++|++ .+.||+|+||.||+|.+... +++.||||++......   ..+.+|+.++++++||||+++++++...+
T Consensus        75 g~~~~~~y~i-~~~lg~G~~g~Vy~a~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  152 (681)
T 2pzi_A           75 GDIVAGQYEV-KGCIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTD  152 (681)
T ss_dssp             TCEETTTEEE-EEEEEEETTEEEEEEEEGGG-TTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEEC
T ss_pred             CCEeCCceEE-EEEEeeCCCeEEEEEEEcCC-CCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecC
Confidence            4466788886 66999999999999998642 4578999998654322   35778999999999999999999996533


Q ss_pred             C---ceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCC
Q psy2172          90 D---RKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIE  165 (291)
Q Consensus        90 ~---~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~  165 (291)
                      .   ...|+||||++| +|.+.+..           .+++..++.++.|++.||.|||++||+|+||||+||+++    .
T Consensus       153 ~~~~~~~~lv~E~~~g~~L~~~~~~-----------~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~----~  217 (681)
T 2pzi_A          153 RHGDPVGYIVMEYVGGQSLKRSKGQ-----------KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT----E  217 (681)
T ss_dssp             TTSCEEEEEEEECCCCEECC----C-----------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----S
T ss_pred             CCCCceeEEEEEeCCCCcHHHHHhC-----------CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEe----C
Confidence            2   137999999986 66544321           289999999999999999999999999999999999997    3


Q ss_pred             CCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccCCC
Q psy2172         166 RGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN  245 (291)
Q Consensus       166 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~~~  245 (291)
                       +.++|+|||++......       ....||+.|+|||++.+.  ++.++||||||+++|+|++|..||.+.........
T Consensus       218 -~~~kl~DFG~a~~~~~~-------~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~~~  287 (681)
T 2pzi_A          218 -EQLKLIDLGAVSRINSF-------GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPED  287 (681)
T ss_dssp             -SCEEECCCTTCEETTCC-------SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCCTT
T ss_pred             -CcEEEEecccchhcccC-------CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCccccccccccc
Confidence             38999999999876442       345689999999998763  48899999999999999999999986543211111


Q ss_pred             -C--CcHHHHHHHHHhhCCCCcCChhh
Q psy2172         246 -P--YHHDQLDRIFSVMGFPLEKDWED  269 (291)
Q Consensus       246 -~--~~~~~~~~i~~~~~~~~~~~~~~  269 (291)
                       +  ...+.+.+++..|..+.|..||+
T Consensus       288 ~~~~~~~~~l~~li~~~l~~dP~~R~~  314 (681)
T 2pzi_A          288 DPVLKTYDSYGRLLRRAIDPDPRQRFT  314 (681)
T ss_dssp             CHHHHHCHHHHHHHHHHTCSSGGGSCS
T ss_pred             ccccccCHHHHHHHhhhccCChhhCCC
Confidence             0  01256788999999999988875

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=3.3e-37  Score=264.03  Aligned_cols=195  Identities=21%  Similarity=0.236  Sum_probs=155.5

Q ss_pred             ccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC----------hhHHHHHHHHhcCC---------CCC
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----------MSACREIALLRELK---------HPN   77 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----------~~~~~e~~~l~~l~---------h~~   77 (291)
                      .+.|++ .++||+|+||.||+|.+    +++.||||++......          ..+.+|+.+++.++         |||
T Consensus        19 ~~~y~~-~~~lG~G~~g~V~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~n   93 (336)
T 2vuw_A           19 TEKLQR-CEKIGEGVFGEVFQTIA----DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEG   93 (336)
T ss_dssp             HHHHHT-CEEEEEETTEEEEEEEE----TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCC
T ss_pred             cccchh-eeeecccCceEEEEEEe----CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCc
Confidence            356774 67999999999999997    3588999999754321          67889999999885         888


Q ss_pred             eeeEEEEEEeC----------------------------CCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHH
Q psy2172          78 VINLISVFLSH----------------------------NDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMV  128 (291)
Q Consensus        78 iv~~~~~~~~~----------------------------~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~  128 (291)
                      |+++.+.+...                            +....|+||||+.+ ++.+.+..          ..+++..+
T Consensus        94 iv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----------~~~~~~~~  163 (336)
T 2vuw_A           94 FIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----------KLSSLATA  163 (336)
T ss_dssp             BCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----------TCCCHHHH
T ss_pred             hhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----------cCCCHHHH
Confidence            88888876421                            26789999999965 45554421          12899999


Q ss_pred             HHHHHHHHHHHHHHh-hCCeeeeccCCCcEEeecCCC----------------CCCcEEEeecccceecCCCCCCCCCCC
Q psy2172         129 KSLLYQILDGIHYLH-SNWVLHRDLKPANILVMGEGI----------------ERGRVKIADMGFARLFNNPLKPLADLD  191 (291)
Q Consensus       129 ~~i~~ql~~~l~~LH-~~~ivH~dik~~Nil~~~~~~----------------~~~~~~l~Dfg~~~~~~~~~~~~~~~~  191 (291)
                      +.++.|++.||+||| ++||+||||||+|||++.++.                ....+||+|||+++....        .
T Consensus       164 ~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~--------~  235 (336)
T 2vuw_A          164 KSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD--------G  235 (336)
T ss_dssp             HHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET--------T
T ss_pred             HHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC--------C
Confidence            999999999999999 999999999999999985321                012899999999987653        2


Q ss_pred             CceecccccccccccCCcCCCCchhHHHHHHH-HHHHHcCCCCCCC
Q psy2172         192 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCI-FAELLTSEPIFHC  236 (291)
Q Consensus       192 ~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~-l~~l~~g~~pf~~  236 (291)
                      ...||+.|+|||++.+..  +.++||||++++ .++++.|..||..
T Consensus       236 ~~~gt~~y~aPE~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~  279 (336)
T 2vuw_A          236 IVVFCDVSMDEDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSN  279 (336)
T ss_dssp             EEECCCCTTCSGGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred             cEEEeecccChhhhcCCC--ccceehhhhhCCCCcccccccCCCcc
Confidence            347899999999998743  889999998777 7778899999964

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=3.4e-32  Score=247.23  Aligned_cols=181  Identities=16%  Similarity=0.095  Sum_probs=123.5

Q ss_pred             eeCcccceEEEEEEEccCCCCceeEEEEeCCCCC------------ChhHHHHHHHHhcC-CCCCeeeEEEEEEeCCCce
Q psy2172          26 KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL------------SMSACREIALLREL-KHPNVINLISVFLSHNDRK   92 (291)
Q Consensus        26 ~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~------------~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~   92 (291)
                      ..+.|++|.+..++...  .++.+++|++.....            .+++.+|+++|+++ .|+||+++++++  ++...
T Consensus       241 ~~~~~~~~~h~~~rr~~--fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~--ed~~~  316 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYF--FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG--ENAQS  316 (569)
T ss_dssp             C-C--------CCEEEE--ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE--ECSSE
T ss_pred             ccccCCccccccccccc--ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE--EECCE
Confidence            45667777776665544  567899999965421            13588999999999 699999999999  77889


Q ss_pred             EEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEE
Q psy2172          93 VWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI  171 (291)
Q Consensus        93 ~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l  171 (291)
                      .|+||||++| +|.+.+.....         +++.   +|+.||+.||+|+|++|||||||||+|||++    .++++||
T Consensus       317 ~yLVMEyv~G~~L~d~i~~~~~---------l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~----~dg~vKL  380 (569)
T 4azs_A          317 GWLVMEKLPGRLLSDMLAAGEE---------IDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVD----ARQHARL  380 (569)
T ss_dssp             EEEEEECCCSEEHHHHHHTTCC---------CCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEEC----TTSCEEE
T ss_pred             EEEEEecCCCCcHHHHHHhCCC---------CCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEEC----CCCCEEE
Confidence            9999999987 88888864321         5543   5889999999999999999999999999998    6789999


Q ss_pred             eecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCC
Q psy2172         172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE  231 (291)
Q Consensus       172 ~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~  231 (291)
                      +|||+++......   .......||+.|+|||++.+.  +..++|+||+|++++.+.++.
T Consensus       381 ~DFGlAr~~~~~~---~~~~t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          381 IDFGSIVTTPQDC---SWPTNLVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             CCCTTEESCC------CCSHHHHHHHHHHHHHHC-------------------CCCCTTH
T ss_pred             eecccCeeCCCCC---ccccCceechhhccHHHhCCC--CCCcccccccccchhhhcccc
Confidence            9999998654321   223456899999999999863  567899999999887765544

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=4.8e-28  Score=218.81  Aligned_cols=185  Identities=17%  Similarity=0.183  Sum_probs=133.7

Q ss_pred             cccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC----------ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCc
Q psy2172          22 YEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL----------SMSACREIALLRELKHPNVINLISVFLSHNDR   91 (291)
Q Consensus        22 ~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (291)
                      +..++||+|+||.||+|..    .+..+++|.......          .+.+.+|++++++++||||+++..+...  ..
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~----~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--~~  412 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY----LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD--LD  412 (540)
T ss_dssp             ---------CCEEEEEEEC----SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE--TT
T ss_pred             CCCCEEeeCCCEEEEEEEE----CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe--CC
Confidence            4467999999999999953    346788887643322          1236899999999999999944444432  33


Q ss_pred             eEEEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEE
Q psy2172          92 KVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVK  170 (291)
Q Consensus        92 ~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~  170 (291)
                      ..|+||||++ ++|.+.+..                 +..++.|++.||+|||++||+|+||||+||+++    .  .++
T Consensus       413 ~~~lVmE~~~ggsL~~~l~~-----------------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~----~--~~k  469 (540)
T 3en9_A          413 NKRIMMSYINGKLAKDVIED-----------------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFD----K--DLY  469 (540)
T ss_dssp             TTEEEEECCCSEEHHHHSTT-----------------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEES----S--SEE
T ss_pred             ccEEEEECCCCCCHHHHHHH-----------------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEEC----C--eEE
Confidence            4599999997 587776542                 457899999999999999999999999999997    4  899


Q ss_pred             EeecccceecCCCCCCCC----CCCCceecccccccccccCC-cCCCCchhHHHHHHHHHHHHcCCCCCC
Q psy2172         171 IADMGFARLFNNPLKPLA----DLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFH  235 (291)
Q Consensus       171 l~Dfg~~~~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~pf~  235 (291)
                      |+|||+++..........    ......||+.|+|||++.+. ..|+..+|+|+...-..+-..++.+|.
T Consensus       470 L~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          470 IIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             ECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             EEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            999999987654211000    01245789999999998751 126778899999988888887777763

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.89  E-value=4.8e-24  Score=177.52  Aligned_cols=126  Identities=20%  Similarity=0.249  Sum_probs=99.4

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC--------------------ChhHHHHHHHHhcCCCCCeeeEEE
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL--------------------SMSACREIALLRELKHPNVINLIS   83 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--------------------~~~~~~e~~~l~~l~h~~iv~~~~   83 (291)
                      ++.||+|+||.||+|.+ .  +++.||+|.++....                    ...+.+|+.++++++|   +++.+
T Consensus        95 ~~~iG~G~~g~Vy~~~~-~--~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~~  168 (282)
T 1zar_A           95 GKLMGEGKESAVFNCYS-E--KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVPK  168 (282)
T ss_dssp             EEEEEECSSEEEEEEEE-T--TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSCC
T ss_pred             cCEeccCCCceEEEEEe-C--CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcCe
Confidence            58999999999999998 4  678899999964321                    2347899999999994   45555


Q ss_pred             EEEeCCCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecC
Q psy2172          84 VFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGE  162 (291)
Q Consensus        84 ~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~  162 (291)
                      ++-   ....|+||||++| +|.+ +.             .+  ....++.|++.||.+||++||+|+||||+||+++  
T Consensus       169 ~~~---~~~~~lvmE~~~g~~L~~-l~-------------~~--~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~--  227 (282)
T 1zar_A          169 VYA---WEGNAVLMELIDAKELYR-VR-------------VE--NPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS--  227 (282)
T ss_dssp             EEE---EETTEEEEECCCCEEGGG-CC-------------CS--CHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE--
T ss_pred             EEe---ccceEEEEEecCCCcHHH-cc-------------hh--hHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE--
Confidence            441   1345999999986 7665 21             11  2457999999999999999999999999999997  


Q ss_pred             CCCCCcEEEeeccccee
Q psy2172         163 GIERGRVKIADMGFARL  179 (291)
Q Consensus       163 ~~~~~~~~l~Dfg~~~~  179 (291)
                         ++.++|+|||++..
T Consensus       228 ---~~~vkl~DFG~a~~  241 (282)
T 1zar_A          228 ---EEGIWIIDFPQSVE  241 (282)
T ss_dssp             ---TTEEEECCCTTCEE
T ss_pred             ---CCcEEEEECCCCeE
Confidence               35899999999874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.86  E-value=1.2e-21  Score=161.15  Aligned_cols=131  Identities=21%  Similarity=0.243  Sum_probs=100.2

Q ss_pred             cceeCcccceEEEEEEEccCCCCce--eEEEEeCCCCCC--------------------------hhHHHHHHHHhcCCC
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRD--YALKQIEGTGLS--------------------------MSACREIALLRELKH   75 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~--vaiK~~~~~~~~--------------------------~~~~~e~~~l~~l~h   75 (291)
                      ++.||+|+||.||+|.+..  +++.  ||||+++.....                          ..+.+|+.++.++.|
T Consensus        52 ~~~ig~G~~g~Vy~a~~~~--~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~  129 (258)
T 1zth_A           52 GGVISTGKEANVFYADGVF--DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKE  129 (258)
T ss_dssp             EEEEEECSSEEEEEEEEEE--TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCEEeecceEEEEEEEEcC--CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHh
Confidence            5799999999999999854  5677  999987543111                          257889999999987


Q ss_pred             CC--eeeEEEEEEeCCCceEEEEEecCCC------CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHh-hCC
Q psy2172          76 PN--VINLISVFLSHNDRKVWLLFDYAEH------DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLH-SNW  146 (291)
Q Consensus        76 ~~--iv~~~~~~~~~~~~~~~iv~e~~~~------~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH-~~~  146 (291)
                      ++  ++.++..      ...++||||+++      .|.+....            .++..+..++.|++.+|.+|| +.|
T Consensus       130 ~~i~~p~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~~------------~~~~~~~~i~~qi~~~l~~lH~~~g  191 (258)
T 1zth_A          130 AGVSVPQPYTY------MKNVLLMEFIGEDELPAPTLVELGRE------------LKELDVEGIFNDVVENVKRLYQEAE  191 (258)
T ss_dssp             TTCCCCCEEEE------ETTEEEEECCEETTEECCBHHHHGGG------------GGGSCHHHHHHHHHHHHHHHHHTSC
T ss_pred             CCCCCCeEEEc------CCCEEEEEecCCCCCccccHHHHhhc------------cChHHHHHHHHHHHHHHHHHHHHCC
Confidence            75  3444443      135899999953      44443211            224457889999999999999 999


Q ss_pred             eeeeccCCCcEEeecCCCCCCcEEEeecccceec
Q psy2172         147 VLHRDLKPANILVMGEGIERGRVKIADMGFARLF  180 (291)
Q Consensus       147 ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~  180 (291)
                      |+|+||||+||+++    .  .++|+|||++...
T Consensus       192 ivHrDlkp~NILl~----~--~~~liDFG~a~~~  219 (258)
T 1zth_A          192 LVHADLSEYNIMYI----D--KVYFIDMGQAVTL  219 (258)
T ss_dssp             EECSSCSTTSEEES----S--SEEECCCTTCEET
T ss_pred             EEeCCCCHHHEEEc----C--cEEEEECcccccC
Confidence            99999999999997    4  8999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.73  E-value=5.7e-18  Score=145.03  Aligned_cols=137  Identities=16%  Similarity=0.169  Sum_probs=95.0

Q ss_pred             cccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC----------------h--------hHHHHHHHHhcCCC
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----------------M--------SACREIALLRELKH   75 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----------------~--------~~~~e~~~l~~l~h   75 (291)
                      |.+ +..||+|++|.||+|.+.   +++.||||+.+.....                .        ...+|...|.++.+
T Consensus        97 Y~I-~~~IG~Gk~a~VY~a~d~---~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~  172 (397)
T 4gyi_A           97 YSV-GSRIGVGKESDIMIVADE---KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYE  172 (397)
T ss_dssp             SEE-EEEEEECSSEEEEEEECT---TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEe-cCEeeeCCceEEEEEECC---CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHh
Confidence            443 779999999999999864   5788999987532100                0        02356777777754


Q ss_pred             CCe--eeEEEEEEeCCCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeecc
Q psy2172          76 PNV--INLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDL  152 (291)
Q Consensus        76 ~~i--v~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~di  152 (291)
                      .++  +..++..  .    .++||||++| ++..+               ........++.|++.+|.+||++|||||||
T Consensus       173 ~gv~vp~p~~~~--~----~~LVME~i~G~~L~~l---------------~~~~~~~~l~~qll~~l~~lH~~gIVHrDL  231 (397)
T 4gyi_A          173 EGFPVPEPIAQS--R----HTIVMSLVDALPMRQV---------------SSVPDPASLYADLIALILRLAKHGLIHGDF  231 (397)
T ss_dssp             TTCSCCCEEEEE--T----TEEEEECCSCEEGGGC---------------CCCSCHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred             cCCCCCeeeecc--C----ceEEEEecCCccHhhh---------------cccHHHHHHHHHHHHHHHHHHHCCCcCCCC
Confidence            443  3334332  2    2799999987 43211               112234578899999999999999999999


Q ss_pred             CCCcEEeecCCCC------CCcEEEeecccceecC
Q psy2172         153 KPANILVMGEGIE------RGRVKIADMGFARLFN  181 (291)
Q Consensus       153 k~~Nil~~~~~~~------~~~~~l~Dfg~~~~~~  181 (291)
                      ||.|||++.++..      ...+.|+||+-+....
T Consensus       232 Kp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          232 NEFNILIREEKDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             STTSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             CHHHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence            9999999854210      1148999999887543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.37  E-value=4.3e-12  Score=104.13  Aligned_cols=134  Identities=19%  Similarity=0.155  Sum_probs=99.3

Q ss_pred             cccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC--CCChhHHHHHHHHhcCC-CCCeeeEEEEEEeCCCceEEEE
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT--GLSMSACREIALLRELK-HPNVINLISVFLSHNDRKVWLL   96 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~iv   96 (291)
                      |++ ...++.|+.+.||++..    .++.+++|+....  .....+.+|+.+++.+. +..+++++++.  .+....|+|
T Consensus        16 ~~~-~~~~~g~s~~~v~~~~~----~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~--~~~~~~~lv   88 (263)
T 3tm0_A           16 YRC-VKDTEGMSPAKVYKLVG----ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE--RHDGWSNLL   88 (263)
T ss_dssp             SEE-EECCSCCSSSEEEEEEC----SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE--EETTEEEEE
T ss_pred             cee-EeeccCCCCCeEEEEEC----CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEE--ecCCceEEE
Confidence            443 34667788899999973    3467999998642  33457899999999984 67788999888  345688999


Q ss_pred             EecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhh-------------------------------
Q psy2172          97 FDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHS-------------------------------  144 (291)
Q Consensus        97 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~-------------------------------  144 (291)
                      ||+++| ++.+..              .+......++.+++.++..||+                               
T Consensus        89 ~e~i~G~~l~~~~--------------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (263)
T 3tm0_A           89 MSEADGVLCSEEY--------------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD  154 (263)
T ss_dssp             EECCSSEEHHHHC--------------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCS
T ss_pred             EEecCCeehhhcc--------------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccc
Confidence            999998 544321              1112234677888899999998                               


Q ss_pred             ----------------------------CCeeeeccCCCcEEeecCCCCCCcEEEeecccce
Q psy2172         145 ----------------------------NWVLHRDLKPANILVMGEGIERGRVKIADMGFAR  178 (291)
Q Consensus       145 ----------------------------~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~  178 (291)
                                                  ..++|+|++|.||+++    +...+.|+||+.+.
T Consensus       155 ~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~----~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK----DGKVSGFIDLGRSG  212 (263)
T ss_dssp             GGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE----TTEEEEECCCTTCE
T ss_pred             cccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE----CCcEEEEEEchhcc
Confidence                                        4489999999999997    44456799999764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.27  E-value=2.1e-11  Score=99.65  Aligned_cols=128  Identities=16%  Similarity=0.103  Sum_probs=87.1

Q ss_pred             ceeC-cccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCCCC--eeeEEEEEEeCCCceEEEEEecCC
Q psy2172          25 CKVG-RGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPN--VINLISVFLSHNDRKVWLLFDYAE  101 (291)
Q Consensus        25 ~~ig-~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~~~iv~e~~~  101 (291)
                      ..++ .|..+.||++...   ++..+++|+.... ....+.+|+.+++.+.+.+  +++++.+.  .+....+++||+++
T Consensus        25 ~~~~~gg~~~~v~~~~~~---~g~~~vlK~~~~~-~~~~~~~E~~~l~~l~~~~~~vP~~~~~~--~~~~~~~~v~e~i~   98 (264)
T 1nd4_A           25 AQQTIGCSDAAVFRLSAQ---GRPVLFVKTDLSG-ALNELQDEAARLSWLATTGVPCAAVLDVV--TEAGRDWLLLGEVP   98 (264)
T ss_dssp             EECSCTTSSCEEEEEECT---TSCCEEEEEECSC-TTSCHHHHHHHHHHHHTTTCCBCCEEEEE--ECSSCEEEEEECCS
T ss_pred             EecccCCCCceEEEEecC---CCCeEEEEeCCcc-cchhhhHHHHHHHHHHhCCCCCCeEEEec--cCCCCCEEEEEecC
Confidence            4555 4556999999642   4567999997654 3456889999999985433  66788877  44557899999999


Q ss_pred             CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhC------------------------------------
Q psy2172         102 HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSN------------------------------------  145 (291)
Q Consensus       102 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~------------------------------------  145 (291)
                      |.... ..   .         .+   ...++.+++..+..||+.                                    
T Consensus        99 G~~l~-~~---~---------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (264)
T 1nd4_A           99 GQDLL-SS---H---------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH  162 (264)
T ss_dssp             SEETT-TS---C---------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred             CcccC-cC---c---------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence            83222 00   0         11   123445555555555543                                    


Q ss_pred             ----------------------CeeeeccCCCcEEeecCCCCCCcEEEeecccce
Q psy2172         146 ----------------------WVLHRDLKPANILVMGEGIERGRVKIADMGFAR  178 (291)
Q Consensus       146 ----------------------~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~  178 (291)
                                            .++|+|++|.||+++    ....+.|+||+.+.
T Consensus       163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~----~~~~~~liD~~~a~  213 (264)
T 1nd4_A          163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVE----NGRFSGFIDCGRLG  213 (264)
T ss_dssp             TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEE----TTEEEEECCCTTCE
T ss_pred             cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEE----CCcEEEEEcchhcc
Confidence                                  299999999999997    44456699999764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.15  E-value=8.9e-11  Score=100.75  Aligned_cols=140  Identities=11%  Similarity=0.201  Sum_probs=99.2

Q ss_pred             ccceeCcccceEEEEEEEccCCCCceeEEEEeC--CCC---CChhHHHHHHHHhcCC--CCCeeeEEEEEEeCCC-ceEE
Q psy2172          23 EGCKVGRGTYGHVYKARRKDNSDTRDYALKQIE--GTG---LSMSACREIALLRELK--HPNVINLISVFLSHND-RKVW   94 (291)
Q Consensus        23 ~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~--~~~---~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~-~~~~   94 (291)
                      ..+.|+.|.++.||++...    +..+++|+..  ...   ....+.+|+.+++.+.  +..+++++.+....+. ...|
T Consensus        42 ~~~~l~~G~sn~~y~v~~~----~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~  117 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP----GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF  117 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS----SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred             eEEEcCCcccceEEEEEEC----CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence            3568999999999998753    3568999876  322   2347889999999996  4568888888732211 4578


Q ss_pred             EEEecCCCC-HHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhh-----------------------------
Q psy2172          95 LLFDYAEHD-LWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHS-----------------------------  144 (291)
Q Consensus        95 iv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~-----------------------------  144 (291)
                      +|||+++|. +.+.           ....++......++.+++..|..||+                             
T Consensus       118 ~vme~v~G~~l~~~-----------~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  186 (359)
T 3dxp_A          118 YIMEFVSGRVLWDQ-----------SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQY  186 (359)
T ss_dssp             EEEECCCCBCCCCT-----------TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHH
T ss_pred             EEEEecCCeecCCC-----------ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHH
Confidence            999999983 2110           00116677788888999999999996                             


Q ss_pred             -----------------------------CCeeeeccCCCcEEeecCCCCCCcEEEeeccccee
Q psy2172         145 -----------------------------NWVLHRDLKPANILVMGEGIERGRVKIADMGFARL  179 (291)
Q Consensus       145 -----------------------------~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~  179 (291)
                                                   ..++|+|+++.||+++.++  ...+.++||+.+..
T Consensus       187 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~--~~v~~viDwe~a~~  248 (359)
T 3dxp_A          187 KLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTE--PRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSS--SCEEEECCCTTCEE
T ss_pred             HhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCC--CcEEEEECcccccc
Confidence                                         3589999999999998431  13468999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.12  E-value=2.7e-11  Score=101.58  Aligned_cols=189  Identities=16%  Similarity=0.166  Sum_probs=114.3

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcC-CCCC--eeeEEEEEEeCCC-ceEEEEEec
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLREL-KHPN--VINLISVFLSHND-RKVWLLFDY   99 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l-~h~~--iv~~~~~~~~~~~-~~~~iv~e~   99 (291)
                      .+.++.|....||++.       ..+++|+.........+.+|+.+++.+ .+..  +++++......+. ...|+||++
T Consensus        25 i~~~~~G~~n~v~~v~-------~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~   97 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-------RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK   97 (304)
T ss_dssp             CCEEEECSSEEEEEST-------TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred             eEecCCCCcceEEEEC-------CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence            4578999999999863       358999876543445788999999887 3332  4555554311111 245889999


Q ss_pred             CCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhh----------------------------------
Q psy2172         100 AEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHS----------------------------------  144 (291)
Q Consensus       100 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~----------------------------------  144 (291)
                      ++| ++......           .++......++.+++..+..||+                                  
T Consensus        98 i~G~~l~~~~~~-----------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (304)
T 3sg8_A           98 IKGVPLTPLLLN-----------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELK  166 (304)
T ss_dssp             CCCEECCHHHHH-----------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSC
T ss_pred             cCCeECCccccc-----------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCC
Confidence            998 43322110           05555666666666666666664                                  


Q ss_pred             ------------------------CCeeeeccCCCcEEeecCCCCCCcEEEeecccceecCCCCCCCCCCCC--ceecc-
Q psy2172         145 ------------------------NWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP--VVVTF-  197 (291)
Q Consensus       145 ------------------------~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~--~~g~~-  197 (291)
                                              ..++|+|++|.||+++.+  ....+.++||+.+...........-...  ..+.. 
T Consensus       167 ~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~--~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~  244 (304)
T 3sg8_A          167 GPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTE--KNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEF  244 (304)
T ss_dssp             HHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETT--TTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHH
T ss_pred             cccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCC--CCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHH
Confidence                                    237999999999999832  1456789999998764321000000000  00000 


Q ss_pred             ------cc--cc-cccccCCcCCCCchhHHHHHHHHHHHHcCCCCCC
Q psy2172         198 ------WY--RA-PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH  235 (291)
Q Consensus       198 ------~y--~a-PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~  235 (291)
                            .|  .. |+....   .....+.|+++.++|.+.+|..+|-
T Consensus       245 ~~~~l~~Y~~~~~~~~~~r---~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          245 VSKILNHYKHKDIPTVLEK---YRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHHHHHHHTCSCHHHHHHH---HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             HHHHHHHcCCCCcHHHHHH---HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence                  01  11 111110   1122689999999999999998874

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.77  E-value=8.2e-08  Score=80.37  Aligned_cols=71  Identities=14%  Similarity=0.109  Sum_probs=51.7

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCCC---CeeeEEEEEEeCCCceEEEEEecC
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHP---NVINLISVFLSHNDRKVWLLFDYA  100 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~~~~~~~~~iv~e~~  100 (291)
                      .+.++.|....||+.       +..+++|+.+.......+.+|+.+|+.+.+.   .+++++.+.. ......+++|+++
T Consensus        24 v~~l~~G~~n~v~~v-------g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~-~~~g~~~~v~e~i   95 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-------NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK-RSDGNPFVGYRKV   95 (306)
T ss_dssp             EEEEEECSSEEEEEE-------TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE-CTTSCEEEEEECC
T ss_pred             eeecCCCcceeEEEE-------CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc-cCCCceEEEEecc
Confidence            457888888899988       2458999865433345788999999999642   4667776663 2345678999999


Q ss_pred             CC
Q psy2172         101 EH  102 (291)
Q Consensus       101 ~~  102 (291)
                      +|
T Consensus        96 ~G   97 (306)
T 3tdw_A           96 QG   97 (306)
T ss_dssp             CS
T ss_pred             CC
Confidence            98

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.72  E-value=1.6e-07  Score=77.07  Aligned_cols=78  Identities=17%  Similarity=0.285  Sum_probs=54.3

Q ss_pred             ceeCcccce-EEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCC-CCCeeeEEEEEEeCCCceEEEEEecCCC
Q psy2172          25 CKVGRGTYG-HVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELK-HPNVINLISVFLSHNDRKVWLLFDYAEH  102 (291)
Q Consensus        25 ~~ig~G~~g-~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~iv~e~~~~  102 (291)
                      +.+..|..+ .||+.....  .+..+++|+-+.. ....+.+|+..|+.+. +-.+++++.+.  .+....++||++++|
T Consensus        30 ~~~~~G~S~~~v~rl~~~~--~~~~~~lk~~~~~-~~~~~~~E~~~l~~l~~~vPVP~v~~~~--~~~~~~~lvme~l~G  104 (272)
T 4gkh_A           30 ARDNVGQSGATIYRLYGKP--NAPELFLKHGKGS-VANDVTDEMVRLNWLTAFMPLPTIKHFI--RTPDDAWLLTTAIPG  104 (272)
T ss_dssp             EEEECSSSSCEEEEEECCT--TCCCEEEEEEETH-HHHHHHHHHHHHHHHTTTSCCCCEEEEE--EETTEEEEEEECCCS
T ss_pred             EEccCCCcCCeEEEEEecC--CCeEEEEEECCCC-CHhHHHHHHHHHHHhccCCCcCeEEEEE--EECCeEEEEEEeeCC
Confidence            355556555 689887543  5567999986543 3446788999998884 33477888877  445678999999998


Q ss_pred             -CHHHH
Q psy2172         103 -DLWHI  107 (291)
Q Consensus       103 -~l~~~  107 (291)
                       ++.+.
T Consensus       105 ~~~~~~  110 (272)
T 4gkh_A          105 KTAFQV  110 (272)
T ss_dssp             EEHHHH
T ss_pred             cccccc
Confidence             44433

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.35  E-value=1.8e-06  Score=73.76  Aligned_cols=78  Identities=10%  Similarity=0.101  Sum_probs=52.7

Q ss_pred             cee-CcccceEEEEEEEc--cCC--CCceeEEEEeCCCC-----CChhHHHHHHHHhcCC-C--CCeeeEEEEEEeCC-C
Q psy2172          25 CKV-GRGTYGHVYKARRK--DNS--DTRDYALKQIEGTG-----LSMSACREIALLRELK-H--PNVINLISVFLSHN-D   90 (291)
Q Consensus        25 ~~i-g~G~~g~Vy~~~~~--~~~--~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~-h--~~iv~~~~~~~~~~-~   90 (291)
                      +.| +.|....+|+....  ..+  .+..+++|+.....     ....+.+|+.+++.+. +  -.+++++.+....+ .
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            567 88889999988643  000  14579999876432     2356889999999884 2  35788888762211 0


Q ss_pred             ceEEEEEecCCC
Q psy2172          91 RKVWLLFDYAEH  102 (291)
Q Consensus        91 ~~~~iv~e~~~~  102 (291)
                      ...+++||+++|
T Consensus       106 g~~~~v~e~l~G  117 (357)
T 3ats_A          106 GTPFFLMDYVEG  117 (357)
T ss_dssp             SSCEEEEECCCC
T ss_pred             CCceEEEEecCC
Confidence            346899999987

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.23  E-value=2.2e-06  Score=74.35  Aligned_cols=74  Identities=15%  Similarity=0.060  Sum_probs=49.3

Q ss_pred             ccceeCcccceEEEEEEEccCCCCceeEEEEeCCC---------CCChhHHHHHHHHhcCCC---CCeeeEEEEEEeCCC
Q psy2172          23 EGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT---------GLSMSACREIALLRELKH---PNVINLISVFLSHND   90 (291)
Q Consensus        23 ~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~---------~~~~~~~~e~~~l~~l~h---~~iv~~~~~~~~~~~   90 (291)
                      ..+.||.|..+.||++....  +++.+++|.....         .....+..|+++++.+..   ..+++++.+.  .+ 
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~--~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~-  108 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQE--HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TE-  108 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TT-
T ss_pred             EEEECCCCceEEEEEEEECC--CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CC-
Confidence            45689999999999997543  4567999976432         123456789999988732   3456666543  32 


Q ss_pred             ceEEEEEecCCC
Q psy2172          91 RKVWLLFDYAEH  102 (291)
Q Consensus        91 ~~~~iv~e~~~~  102 (291)
                       ..++|||++++
T Consensus       109 -~~~lvmE~l~g  119 (397)
T 2olc_A          109 -MAVTVMEDLSH  119 (397)
T ss_dssp             -TTEEEECCCTT
T ss_pred             -ccEEEEEeCCC
Confidence             34799999976

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.20  E-value=1.2e-05  Score=68.00  Aligned_cols=72  Identities=18%  Similarity=0.189  Sum_probs=41.8

Q ss_pred             ceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCC--CCCeeeEEEEE----EeCCCceEEEEEe
Q psy2172          25 CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELK--HPNVINLISVF----LSHNDRKVWLLFD   98 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~----~~~~~~~~~iv~e   98 (291)
                      +.|+.|..+.||++...   + ..+++|+....  ...+..|+.+++.|.  .-.+++++...    +.......+++|+
T Consensus        38 ~~l~gG~~n~~~~v~~~---~-~~~vlk~~~~~--~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTD---S-GAVCLKRIHRP--EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EECC----CEEEEEEET---T-EEEEEEEECSC--HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeccccccCcEEEEEeC---C-CCEEEEecCCC--HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            45666788999998753   2 34999998752  344556667776663  12344544310    0012446789999


Q ss_pred             cCCC
Q psy2172          99 YAEH  102 (291)
Q Consensus        99 ~~~~  102 (291)
                      |++|
T Consensus       112 ~i~G  115 (346)
T 2q83_A          112 WIEG  115 (346)
T ss_dssp             CCCC
T ss_pred             eecC
Confidence            9987

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.88  E-value=8.1e-05  Score=61.82  Aligned_cols=67  Identities=16%  Similarity=0.108  Sum_probs=43.5

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-CChhHHHHHHHHhcCCCCCe-eeEEEEEEeCCCceEEEEEecC-
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-LSMSACREIALLRELKHPNV-INLISVFLSHNDRKVWLLFDYA-  100 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~~iv~e~~-  100 (291)
                      .+.|+.|....+|++        ..+++|+..... ......+|+.+++.+...++ ++++...  .+  .-+++++|+ 
T Consensus        23 i~~l~gG~tN~~~~~--------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~--~~~~v~e~i~   90 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA--------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PA--TGVMVTRYIA   90 (301)
T ss_dssp             CEEEESCSSEEEEEE--------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TT--TCCEEEECCT
T ss_pred             eeEcCCcccccccee--------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CC--CCEEEEeecC
Confidence            467888999999998        348999876431 12245678888887742222 5666543  32  236899999 


Q ss_pred             CC
Q psy2172         101 EH  102 (291)
Q Consensus       101 ~~  102 (291)
                      +|
T Consensus        91 ~g   92 (301)
T 3dxq_A           91 GA   92 (301)
T ss_dssp             TC
T ss_pred             CC
Confidence            66

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.76  E-value=7.4e-05  Score=62.58  Aligned_cols=75  Identities=11%  Similarity=-0.008  Sum_probs=44.5

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCCCC--eeeEEEEE----EeCCCceEEEEE
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPN--VINLISVF----LSHNDRKVWLLF   97 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~----~~~~~~~~~iv~   97 (291)
                      .+.|+.|....+|++...+    ..+++|+.........+..|+.+++.+...+  +++++...    +.......++++
T Consensus        27 ~~~i~~G~~n~~~~v~~~~----g~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~  102 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHTTK----DPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI  102 (322)
T ss_dssp             EEEECC---EEEEEEEESS----CCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred             eeccCCCcccceEEEEeCC----ccEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence            3567788889999987532    3689999876444566778888888774222  34444221    001124568999


Q ss_pred             ecCCC
Q psy2172          98 DYAEH  102 (291)
Q Consensus        98 e~~~~  102 (291)
                      ++.+|
T Consensus       103 ~~l~G  107 (322)
T 2ppq_A          103 SFLEG  107 (322)
T ss_dssp             ECCCC
T ss_pred             EeCCC
Confidence            99987

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.68  E-value=0.00049  Score=59.96  Aligned_cols=72  Identities=17%  Similarity=0.110  Sum_probs=44.9

Q ss_pred             ccceeCcccceEEEEEEEccCCCCceeEEEEeCC------CC---CChhHHHHHHHHhcC---CCCCeeeEEEEEEeCCC
Q psy2172          23 EGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEG------TG---LSMSACREIALLREL---KHPNVINLISVFLSHND   90 (291)
Q Consensus        23 ~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~------~~---~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~   90 (291)
                      ..+.||.|..+.||++..    +++.++||....      ..   .......|.+++..+   ....+++++.+.    .
T Consensus        38 ~i~~l~~G~~n~vyrv~~----~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~----~  109 (420)
T 2pyw_A           38 VIKEVGDGNLNFVFIVVG----SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD----R  109 (420)
T ss_dssp             EEEECCCSSSCEEEEEEC----SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE----T
T ss_pred             EEEEccCCCcEEEEEEEc----CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC----C
Confidence            456899999999999953    346799994321      11   112333344444333   235677887765    2


Q ss_pred             ceEEEEEecC-CC
Q psy2172          91 RKVWLLFDYA-EH  102 (291)
Q Consensus        91 ~~~~iv~e~~-~~  102 (291)
                      ...++|||++ +|
T Consensus       110 ~~~~lv~e~l~~g  122 (420)
T 2pyw_A          110 TMALIGMRYLEPP  122 (420)
T ss_dssp             TTTEEEECCCCTT
T ss_pred             CccEEEEeecCCc
Confidence            3458999999 76

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.67  E-value=0.00048  Score=57.46  Aligned_cols=72  Identities=15%  Similarity=0.116  Sum_probs=55.8

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCC---CCCeeeEEEEEEeCCCceEEEEEecC
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELK---HPNVINLISVFLSHNDRKVWLLFDYA  100 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~~~iv~e~~  100 (291)
                      .+.|+.|....+|+...    .+..+++|+.... ....+.+|+..|+.|.   ...+++++.+.  ......+++||++
T Consensus        41 ~~~l~gG~~n~~y~v~~----~~~~~vlK~~~~~-~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~--~~~g~~~lvme~l  113 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND----EVQTVFVKINERS-YRSMFRAEADQLALLAKTNSINVPLVYGIG--NSQGHSFLLLEAL  113 (312)
T ss_dssp             EEEECCSSSSEEEEEES----SSCEEEEEEEEGG-GHHHHHHHHHHHHHHHHTTSSBCCCEEEEE--ECSSEEEEEEECC
T ss_pred             eEEeCCccceeeeEEEE----CCCeEEEEeCCcc-cHHHHHHHHHHHHHHHhhCCCCcceEEEEe--ecCCceEEEEEec
Confidence            56899999999999873    3467899987643 3456788999998883   35788888877  3456789999999


Q ss_pred             CC
Q psy2172         101 EH  102 (291)
Q Consensus       101 ~~  102 (291)
                      +|
T Consensus       114 ~G  115 (312)
T 3jr1_A          114 NK  115 (312)
T ss_dssp             CC
T ss_pred             cC
Confidence            86

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.56  E-value=0.00071  Score=59.12  Aligned_cols=74  Identities=12%  Similarity=0.117  Sum_probs=50.9

Q ss_pred             ccceeCcccceEEEEEEEccC-----CCCceeEEEEeCCCCCChhHHHHHHHHhcCCCC-CeeeEEEEEEeCCCceEEEE
Q psy2172          23 EGCKVGRGTYGHVYKARRKDN-----SDTRDYALKQIEGTGLSMSACREIALLRELKHP-NVINLISVFLSHNDRKVWLL   96 (291)
Q Consensus        23 ~~~~ig~G~~g~Vy~~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~~~iv   96 (291)
                      ..+.|+.|....||++...+.     ..+..+++|+.........+.+|..+++.+... -.+++++.+  .+    .++
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~--~~----g~v  150 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF--SG----GRL  150 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE--TT----EEE
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEe--CC----CEE
Confidence            356788899999999986431     124679999885432225677899999888432 246777766  43    388


Q ss_pred             EecCCC
Q psy2172          97 FDYAEH  102 (291)
Q Consensus        97 ~e~~~~  102 (291)
                      ++|++|
T Consensus       151 ~e~l~G  156 (429)
T 1nw1_A          151 EEYIPS  156 (429)
T ss_dssp             ECCCCE
T ss_pred             EEEeCC
Confidence            999886

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.53  E-value=0.0011  Score=56.80  Aligned_cols=151  Identities=20%  Similarity=0.189  Sum_probs=83.0

Q ss_pred             ccceeCcccceEEEEEEEcc-----CCCCceeEEEEeCCC-CCChhHHHHHHHHhcCC-CCCeeeEEEEEEeCCCceEEE
Q psy2172          23 EGCKVGRGTYGHVYKARRKD-----NSDTRDYALKQIEGT-GLSMSACREIALLRELK-HPNVINLISVFLSHNDRKVWL   95 (291)
Q Consensus        23 ~~~~ig~G~~g~Vy~~~~~~-----~~~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~i   95 (291)
                      ..+.|..|-...+|++...+     ..+++.+++|+.... .......+|..+++.+. +.-.+++++.+  ++    .+
T Consensus        54 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~--~~----g~  127 (379)
T 3feg_A           54 RVYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVF--PE----GR  127 (379)
T ss_dssp             CCEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEE--TT----EE
T ss_pred             EEEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEc--CC----cc
Confidence            45688889999999998632     113467999986432 12345678999998884 33346777766  44    28


Q ss_pred             EEecCCC-CH-----------HHHHHHhhhhhhCCCC--CCC--CHHHHHHHHHHHHH-------------------HHH
Q psy2172          96 LFDYAEH-DL-----------WHIIKFHRAAKANKKP--VMV--PKGMVKSLLYQILD-------------------GIH  140 (291)
Q Consensus        96 v~e~~~~-~l-----------~~~~~~~~~~~~~~~~--~~~--~~~~~~~i~~ql~~-------------------~l~  140 (291)
                      ||||++| ++           ..........+....+  ...  -...+.++..++..                   .+.
T Consensus       128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~  207 (379)
T 3feg_A          128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG  207 (379)
T ss_dssp             EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred             EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence            9999986 21           1122222222222111  011  12344444443321                   122


Q ss_pred             HHh----h----CCeeeeccCCCcEEeecCCCCCCcEEEeeccccee
Q psy2172         141 YLH----S----NWVLHRDLKPANILVMGEGIERGRVKIADMGFARL  179 (291)
Q Consensus       141 ~LH----~----~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~  179 (291)
                      .|.    .    ..++|+|+.+.||+++.+....+.+.++||..+..
T Consensus       208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            222    2    24899999999999984321236899999998764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.45  E-value=0.0013  Score=55.21  Aligned_cols=148  Identities=14%  Similarity=0.108  Sum_probs=73.0

Q ss_pred             ceeCcccceE-EEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCC--CCeeeEEEEEEeCCCceEEEEEecCC
Q psy2172          25 CKVGRGTYGH-VYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKH--PNVINLISVFLSHNDRKVWLLFDYAE  101 (291)
Q Consensus        25 ~~ig~G~~g~-Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~~~iv~e~~~  101 (291)
                      +.|+.|+... +|+....   ++..+++|...... ...+..|+.+++.+..  -.+++++.+-  .+..  +++||+++
T Consensus        24 ~~l~gg~s~~~~~r~~~~---~~~~~vlk~~~~~~-~~~~~~e~~~l~~L~~~g~~vP~v~~~d--~~~g--~ll~e~l~   95 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSP---TGAKAVLMDWSPEE-GGDTQPFVDLAQYLRNLDISAPEIYAEE--HARG--LLLIEDLG   95 (333)
T ss_dssp             CC--------CCEEEECT---TCCEEEEEECCTTT-TCCSHHHHHHHHHHHHTTCBCCCEEEEE--TTTT--EEEECCCC
T ss_pred             eECCCCCCCceEEEEEcC---CCCeEEEEECCCCC-CccccHHHHHHHHHHhCCCCCCceeeec--CCCC--EEEEeeCC
Confidence            4566665554 6676521   24567888755431 1455667777777742  3456677653  3333  67999987


Q ss_pred             C-CHHHHHHHhhh---------------hhhCCCC--CCCCHHHHHH--------H------------HHHHHHHHHHH-
Q psy2172         102 H-DLWHIIKFHRA---------------AKANKKP--VMVPKGMVKS--------L------------LYQILDGIHYL-  142 (291)
Q Consensus       102 ~-~l~~~~~~~~~---------------~~~~~~~--~~~~~~~~~~--------i------------~~ql~~~l~~L-  142 (291)
                      + ++.+.+.....               .+.....  ..++......        +            ...+...+..+ 
T Consensus        96 ~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~  175 (333)
T 3csv_A           96 DALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQIL  175 (333)
T ss_dssp             SCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHH
T ss_pred             CcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHH
Confidence            6 55433322110               0111000  1122211100        0            00111122222 


Q ss_pred             -----hhCCeeeeccCCCcEEeecCCCCCCcEEEeecccceec
Q psy2172         143 -----HSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF  180 (291)
Q Consensus       143 -----H~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~  180 (291)
                           +...++|+|+.+.||+++.+......+.++||+.+..-
T Consensus       176 ~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          176 SAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             HHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             HhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence                 23469999999999999742111257899999988754

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.41  E-value=0.0048  Score=50.61  Aligned_cols=71  Identities=15%  Similarity=0.099  Sum_probs=50.9

Q ss_pred             ccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC--CChhHHHHHHHHhcCCC---CCeeeEEEEEEeCCCceEEEEE
Q psy2172          23 EGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG--LSMSACREIALLRELKH---PNVINLISVFLSHNDRKVWLLF   97 (291)
Q Consensus        23 ~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h---~~iv~~~~~~~~~~~~~~~iv~   97 (291)
                      ..+.+|.|..+.||+....   +++.|++|+.+...  ....+.+|+..|+.|..   -.+++++++.  .    -+++|
T Consensus        19 ~v~~~g~G~~~~vyrv~l~---DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~----~~lv~   89 (288)
T 3f7w_A           19 AVAERGHSHRWHLYRVELA---DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D----RTLAM   89 (288)
T ss_dssp             EEEEEEEETTEEEEEEEET---TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T----TEEEE
T ss_pred             EEEecCCCCCeEEEEEEEC---CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc--C----ceEEE
Confidence            4578999999999999864   56789999876432  22357889999998842   2456666653  2    27889


Q ss_pred             ecCCC
Q psy2172          98 DYAEH  102 (291)
Q Consensus        98 e~~~~  102 (291)
                      |+..+
T Consensus        90 e~l~~   94 (288)
T 3f7w_A           90 EWVDE   94 (288)
T ss_dssp             ECCCC
T ss_pred             Eeecc
Confidence            99874

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.25  E-value=0.0036  Score=52.33  Aligned_cols=74  Identities=14%  Similarity=0.129  Sum_probs=47.0

Q ss_pred             ceeCcccceEEEEEEEccCCCCceeEEEEeCCC-CCChhHHHHHHHHhcCCCC--CeeeEEEE---EEeCCCceEEEEEe
Q psy2172          25 CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-GLSMSACREIALLRELKHP--NVINLISV---FLSHNDRKVWLLFD   98 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l~h~--~iv~~~~~---~~~~~~~~~~iv~e   98 (291)
                      ..++ |....||++...   +++.+++|+.... .....+..|+.+++.+...  .+++++..   .+....+..+++++
T Consensus        32 ~~l~-g~~n~~y~v~~~---~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~  107 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDE---DRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP  107 (328)
T ss_dssp             EEEC-CSSSEEEEECCT---TCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred             Eeec-CcccceEEEEcC---CCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence            3566 888899988632   3457999998743 3345677888888887422  24444442   00011346688999


Q ss_pred             cCCC
Q psy2172          99 YAEH  102 (291)
Q Consensus        99 ~~~~  102 (291)
                      +.+|
T Consensus       108 ~i~G  111 (328)
T 1zyl_A          108 SVGG  111 (328)
T ss_dssp             CCCC
T ss_pred             ecCC
Confidence            9987

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.12  E-value=0.0012  Score=56.37  Aligned_cols=74  Identities=8%  Similarity=0.074  Sum_probs=44.7

Q ss_pred             ccceeCcccceEEEEEEEccC------CCCceeEEEEeCCCCC-ChhHHHHHHHHhcCCCCC-eeeEEEEEEeCCCceEE
Q psy2172          23 EGCKVGRGTYGHVYKARRKDN------SDTRDYALKQIEGTGL-SMSACREIALLRELKHPN-VINLISVFLSHNDRKVW   94 (291)
Q Consensus        23 ~~~~ig~G~~g~Vy~~~~~~~------~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~~~   94 (291)
                      ..+.|+.|....+|++...+.      ..+..+++|+...... ......|..+++.+...+ ++++++.+  .+    +
T Consensus        37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~----~  110 (369)
T 3c5i_A           37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--NG----G  110 (369)
T ss_dssp             EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT----E
T ss_pred             EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--CC----c
Confidence            356788888899999975421      0125688998754211 123567888888884333 55777655  32    6


Q ss_pred             EEEecCCC
Q psy2172          95 LLFDYAEH  102 (291)
Q Consensus        95 iv~e~~~~  102 (291)
                      ++++|++|
T Consensus       111 ~v~e~i~G  118 (369)
T 3c5i_A          111 RIEEWLYG  118 (369)
T ss_dssp             EEEECCCS
T ss_pred             EEEEEecC
Confidence            89999987

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.90  E-value=0.023  Score=49.91  Aligned_cols=72  Identities=14%  Similarity=0.137  Sum_probs=47.5

Q ss_pred             ccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-CChhHHHHHHHHhcCCCCCe-eeEEEEEEeCCCceEEEEEecC
Q psy2172          23 EGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-LSMSACREIALLRELKHPNV-INLISVFLSHNDRKVWLLFDYA  100 (291)
Q Consensus        23 ~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~~iv~e~~  100 (291)
                      ..+.|+.|-...+|++...+  .+..+++|+..... ...+..+|..+++.|...++ +++++.+  .+    ..|++|+
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~--~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~--~~----G~v~e~I  183 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMS--KQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF--TN----GRIEEFM  183 (458)
T ss_dssp             EEEEECC--CEEEEEEEETT--TTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE--TT----EEEEECC
T ss_pred             EEEEcCCCeEeEEEEEEECC--CCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe--CC----eEEEEee
Confidence            35688889999999998643  24678999875321 12234689999998864433 6777776  33    2599999


Q ss_pred             CC
Q psy2172         101 EH  102 (291)
Q Consensus       101 ~~  102 (291)
                      +|
T Consensus       184 ~G  185 (458)
T 2qg7_A          184 DG  185 (458)
T ss_dssp             CS
T ss_pred             CC
Confidence            86

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.75  E-value=0.016  Score=45.23  Aligned_cols=122  Identities=16%  Similarity=0.067  Sum_probs=74.7

Q ss_pred             CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHh-hCCeeeeccCCCcEEeecCCCCCCcEEEeecccceecC
Q psy2172         103 DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLH-SNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFN  181 (291)
Q Consensus       103 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH-~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~~  181 (291)
                      +|.+.+.....        +++++++|.++.|.+.+|..+- .+.-...=+.|..|++.    .++.|.+.+ ..+.   
T Consensus        34 SL~eIL~~~~~--------PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~----~dG~V~f~~-~~s~---   97 (229)
T 2yle_A           34 SLEEILRLYNQ--------PINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVW----RDGAVTLAP-AADD---   97 (229)
T ss_dssp             EHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEE----TTSCEEECC-C------
T ss_pred             cHHHHHHHcCC--------CcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEe----cCCceeccc-cccc---
Confidence            67777776543        3999999999999999987762 11111233456788887    556666553 1110   


Q ss_pred             CCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccCCCCCcHHHHHHHHHhhCC
Q psy2172         182 NPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF  261 (291)
Q Consensus       182 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~  261 (291)
                                  .....+.|||....  ..+.+.=|||||+++|..+--..|=.-.        +..++.++.++..|..
T Consensus        98 ------------~~~~~~~~pe~~~~--~~te~~~IysLG~tLY~ALDygL~e~eE--------~eLS~~LE~LL~~Mt~  155 (229)
T 2yle_A           98 ------------AGEPPPVAGKLGYS--QCMETEVIESLGIIIYKALDYGLKENEE--------RELSPPLEQLIDHMAN  155 (229)
T ss_dssp             ---------------------CCSSS--SSCHHHHHHHHHHHHHHHHTTTCCTTEE--------ECCCHHHHHHHHHHTT
T ss_pred             ------------ccccCCCChhhccc--cchHHHHHHHHHHHHHHHhhcCCCcccc--------hhhCHHHHHHHHHHHh
Confidence                        11223678887642  2567888999999999998744432211        2225889999988864


Q ss_pred             C
Q psy2172         262 P  262 (291)
Q Consensus       262 ~  262 (291)
                      -
T Consensus       156 ~  156 (229)
T 2yle_A          156 T  156 (229)
T ss_dssp             C
T ss_pred             c
Confidence            4

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.27  E-value=0.047  Score=45.89  Aligned_cols=32  Identities=25%  Similarity=0.278  Sum_probs=26.8

Q ss_pred             CCeeeeccCCCcEEeecCCCCCCcEEEeecccceec
Q psy2172         145 NWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF  180 (291)
Q Consensus       145 ~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~~~  180 (291)
                      ..++|+|+.+.||+++    .++.+.++||+.+...
T Consensus       206 ~~~~HgD~~~~N~l~~----~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVG----NEESIYIIDWDEPMLA  237 (339)
T ss_dssp             CEEECSCCCGGGEEEC----GGGCEEECCCSSCEEE
T ss_pred             ceeEeCCCCcCCEEEe----CCCeEEEEECCCCeeC
Confidence            3699999999999997    4467999999887654

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.25  E-value=0.092  Score=45.56  Aligned_cols=74  Identities=12%  Similarity=0.066  Sum_probs=49.9

Q ss_pred             ccceeCcccceEEEEEEEccCCC-----CceeEEEEeCCCC-CChhHHHHHHHHhcCC-CCCeeeEEEEEEeCCCceEEE
Q psy2172          23 EGCKVGRGTYGHVYKARRKDNSD-----TRDYALKQIEGTG-LSMSACREIALLRELK-HPNVINLISVFLSHNDRKVWL   95 (291)
Q Consensus        23 ~~~~ig~G~~g~Vy~~~~~~~~~-----~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~i   95 (291)
                      ..+.+..|-...+|++.......     ++.+++++..... ...+..+|..+++.+. +.-.+++++.+  .+    +.
T Consensus        74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~----~~  147 (424)
T 3mes_A           74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--PE----GR  147 (424)
T ss_dssp             EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT----EE
T ss_pred             EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC----CE
Confidence            45688889999999998653111     4679999865422 2234568888888884 33356677654  32    78


Q ss_pred             EEecCCC
Q psy2172          96 LFDYAEH  102 (291)
Q Consensus        96 v~e~~~~  102 (291)
                      |++|++|
T Consensus       148 I~efI~G  154 (424)
T 3mes_A          148 IEEFIDG  154 (424)
T ss_dssp             EEECCCS
T ss_pred             EEEEeCC
Confidence            9999987

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.88  E-value=0.04  Score=47.52  Aligned_cols=33  Identities=21%  Similarity=0.440  Sum_probs=26.3

Q ss_pred             eeeeccCCCcEEeecCC--CCCCcEEEeeccccee
Q psy2172         147 VLHRDLKPANILVMGEG--IERGRVKIADMGFARL  179 (291)
Q Consensus       147 ivH~dik~~Nil~~~~~--~~~~~~~l~Dfg~~~~  179 (291)
                      ++|+|+.+.||++..+.  .....+.++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            67999999999996421  1456899999998875

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=87.23  E-value=0.052  Score=47.74  Aligned_cols=57  Identities=14%  Similarity=0.100  Sum_probs=16.2

Q ss_pred             cceeCcccceEEEEEEEccCCCCceeEE------EEeCCCCC----ChhHHHHHHHHhcCCCCCeeeEEEEE
Q psy2172          24 GCKVGRGTYGHVYKARRKDNSDTRDYAL------KQIEGTGL----SMSACREIALLRELKHPNVINLISVF   85 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~~~~~vai------K~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~   85 (291)
                      .++||   ||.||++.++.  ...+||+      |..+....    ...+.+|+.+++.++|||+++.+.+.
T Consensus       147 ~~~lG---fG~v~~g~~~~--~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~  213 (463)
T 3cxl_A          147 YEHVG---YTTLNREPAYK--KHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK  213 (463)
T ss_dssp             TTTSS---BCCC-----------CCBGGGC-----------------------------------CBCCCEE
T ss_pred             cccCC---chhhhcccccc--cCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence            45676   99999999865  3346777      66543221    23577888999999999999998875

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=85.70  E-value=2.7  Score=32.56  Aligned_cols=114  Identities=13%  Similarity=0.113  Sum_probs=73.1

Q ss_pred             CCCCeeeEEEEEEeCCCceEEEEEecCCC--CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeec
Q psy2172          74 KHPNVINLISVFLSHNDRKVWLLFDYAEH--DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRD  151 (291)
Q Consensus        74 ~h~~iv~~~~~~~~~~~~~~~iv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~d  151 (291)
                      .||+++.. ..-  .+.+.+.+.++.-++  +... +.            ..+....++++.+++....+++.  -+|--
T Consensus        43 ~~~~Fl~~-~I~--e~eD~v~~~y~~~~~~~~f~~-ik------------~~~~~eKlr~l~ni~~l~~~~~~--r~tf~  104 (215)
T 4ann_A           43 HSPYFIDA-ELT--ELRDSFQIHYDINDNHTPFDN-IK------------SFTKNEKLRYLLNIKNLEEVNRT--RYTFV  104 (215)
T ss_dssp             CCTTBCCE-EEE--ECSSEEEEEECCCTTSEEGGG-GG------------GSCHHHHHHHHHHGGGGGGGGGS--SEECC
T ss_pred             cCCcccce-EEE--EcccEEEEEEEcCcccCCHHH-HH------------hcCHHHHHHHHHHHHHHHHHhcC--ceEEE
Confidence            57888866 333  344566666655442  2221 11            17888899999999987754443  36778


Q ss_pred             cCCCcEEeecCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCC
Q psy2172         152 LKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE  231 (291)
Q Consensus       152 ik~~Nil~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~  231 (291)
                      +.|+||+++    .+..+++.-.|....                    ++|..      .+...=+-.+=|++..+++++
T Consensus       105 L~P~NL~f~----~~~~p~i~~RGik~~--------------------l~P~~------~~ee~fL~qyKAliiall~~K  154 (215)
T 4ann_A          105 LAPDELFFT----RDGLPIAKTRGLQNV--------------------VDPLP------VSEAEFLTRYKALVICAFNEK  154 (215)
T ss_dssp             CSGGGEEEC----TTSCEEESCCEETTT--------------------BSCCC------CCHHHHHHHHHHHHHHHHCTT
T ss_pred             EecceEEEc----CCCCEEEEEccCccC--------------------CCCCC------CCHHHHHHHHHHHHHHHHcCC
Confidence            999999999    778899988886421                    22210      222233455667788888888


Q ss_pred             CCCC
Q psy2172         232 PIFH  235 (291)
Q Consensus       232 ~pf~  235 (291)
                      ..|.
T Consensus       155 ~~Fe  158 (215)
T 4ann_A          155 QSFD  158 (215)
T ss_dssp             CCHH
T ss_pred             CCHH
Confidence            7775

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=85.00  E-value=3.5  Score=31.98  Aligned_cols=114  Identities=11%  Similarity=0.065  Sum_probs=71.5

Q ss_pred             CCCCeeeEEEEEEeCCCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHH-HHhhCCeeeec
Q psy2172          74 KHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIH-YLHSNWVLHRD  151 (291)
Q Consensus        74 ~h~~iv~~~~~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~-~LH~~~ivH~d  151 (291)
                      .||++..-+.    .+.+.+.+.++.-.+ .-...+..            .+....++++.+|+.... +++  .-+|--
T Consensus        48 ~~~~f~~~I~----~~eD~~~i~y~~~~~~~~f~~i~~------------~~~~eKlrll~nl~~L~~~~~~--~r~tf~  109 (219)
T 4ano_A           48 VDPCIVRDID----VSEDEVKVVIKPPSSFLTFAAIRK------------TTLLSRIRAAIHLVSKVKHHSA--RRLIFI  109 (219)
T ss_dssp             SCSSSEEEEE----ECSSEEEEEEECCTTCEEHHHHHT------------SCHHHHHHHHHHHHHHHSSCCS--SSEECC
T ss_pred             cCCCCCeEEE----EeCCEEEEEEEcCcccCcHHHHHh------------cCHHHHHHHHHHHHHHHHHhhh--CceeEE
Confidence            5788733233    345566666666543 22222221            788889999999888665 443  446778


Q ss_pred             cCCCcEEeecCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCC
Q psy2172         152 LKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE  231 (291)
Q Consensus       152 ik~~Nil~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~  231 (291)
                      +.|+||+++    .+..+++.-.|...                    -++|..      .+...=+-.+=|++..++.++
T Consensus       110 l~P~NL~f~----~~~~p~i~hRGi~~--------------------~lpP~e------~~ee~fl~qyKali~all~~K  159 (219)
T 4ano_A          110 VCPENLMFN----RALEPFFLHVGVKE--------------------SLPPDE------WDDERLLREVKATVLALTEGE  159 (219)
T ss_dssp             CCGGGEEEC----TTCCEEESCCEETT--------------------TBSSCS------CCHHHHHHHHHHHHHHHTTCS
T ss_pred             EeCceEEEe----CCCcEEEEEcCCcc--------------------cCCCCC------CCHHHHHHHHHHHHHHHHcCC
Confidence            999999999    77889999888642                    123321      122222445567777777877


Q ss_pred             CCCC
Q psy2172         232 PIFH  235 (291)
Q Consensus       232 ~pf~  235 (291)
                      .-|.
T Consensus       160 ~~Fe  163 (219)
T 4ano_A          160 YRFD  163 (219)
T ss_dssp             SCHH
T ss_pred             CCHH
Confidence            7773

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	291
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-46
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-46
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-45
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-45
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	4e-45
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	9e-45
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-44
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	8e-44
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	8e-44
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-43
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-42
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-42
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	4e-42
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-42
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-41
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-41
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-41
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	5e-41
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	8e-41
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	9e-41
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	9e-40
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-39
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-39
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-38
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-38
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	5e-38
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-37
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-37
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-37
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	5e-37
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-36
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-36
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	5e-35
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	7e-35
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	7e-35
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-34
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-34
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-34
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-34
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-34
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-34
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-33
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	5e-33
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	8e-33
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-32
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-32
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	5e-32
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	9e-32
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-31
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-31
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	6e-31
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	7e-31
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-30
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-30
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-30
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-30
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	6e-30
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	8e-30
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-29
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-28
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-26
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	5e-26
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-19

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 3e-46
 Identities = 98/261 (37%), Positives = 141/261 (54%), Gaps = 35/261 (13%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI-------EGTGLSMSACREIALLRELKHPNV 78
            +G G +  VYKAR K+ +  +  A+K+I          G++ +A REI LL+EL HPN+
Sbjct: 5   FLGEGQFATVYKARDKNTN--QIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI 62

Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDG 138
           I L+  F   +   + L+FD+ E DL  II            +++    +K+ +   L G
Sbjct: 63  IGLLDAF--GHKSNISLVFDFMETDLEVII--------KDNSLVLTPSHIKAYMLMTLQG 112

Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + YLH +W+LHRDLKP N+L+     E G +K+AD G A+ F +P +        VVT W
Sbjct: 113 LEYLHQHWILHRDLKPNNLLLD----ENGVLKLADFGLAKSFGSPNRAY---THQVVTRW 165

Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSV 258
           YRAPELL GAR Y   +D+WA+GCI AELL   P      +          DQL RIF  
Sbjct: 166 YRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---------LDQLTRIFET 216

Query: 259 MGFPLEKDWEDIRKMPEHPTL 279
           +G P E+ W D+  +P++ T 
Sbjct: 217 LGTPTEEQWPDMCSLPDYVTF 237

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 6e-46
 Identities = 51/226 (22%), Positives = 93/226 (41%), Gaps = 21/226 (9%)

Query: 21  DYE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQI---EGTGLSMSACREIALLRELKHP 76
           D++    +G G YG V  A  +        A+K +          +  +EI + + L H 
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTE--EAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 63

Query: 77  NVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQIL 136
           NV+              +L  +Y                  +  + +P+   +   +Q++
Sbjct: 64  NVVKFYGHR--REGNIQYLFLEYCSGGELF--------DRIEPDIGMPEPDAQRFFHQLM 113

Query: 137 DGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVT 196
            G+ YLH   + HRD+KP N+L+     ER  +KI+D G A +F    +    L+ +  T
Sbjct: 114 AGVVYLHGIGITHRDIKPENLLLD----ERDNLKISDFGLATVFRYNNRE-RLLNKMCGT 168

Query: 197 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 242
             Y APELL     + + +D+W+ G +   +L  E  +    +  +
Sbjct: 169 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 214

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 1e-45
 Identities = 74/271 (27%), Positives = 127/271 (46%), Gaps = 30/271 (11%)

Query: 7   IKTSNERTKVEDLFDYEGCKV-GRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACR 65
           + T  +         Y   KV G G++G VY+A+  D+      A+K++          R
Sbjct: 7   VATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSG--ELVAIKKVLQD--KRFKNR 62

Query: 66  EIALLRELKHPNVINLISVFLSHNDRK----VWLLFDYAEHDLWHIIKFHRAAKANKKPV 121
           E+ ++R+L H N++ L   F S  ++K    + L+ DY    ++ + + +     ++   
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-----SRAKQ 117

Query: 122 MVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFN 181
            +P   VK  +YQ+   + Y+HS  + HRD+KP N+L+  +      +K+ D G A+   
Sbjct: 118 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT---AVLKLCDFGSAKQLV 174

Query: 182 NPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI 241
                       + + +YRAPEL+ GA  YT +ID+W+ GC+ AELL  +PIF       
Sbjct: 175 RGEPN----VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV- 229

Query: 242 KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRK 272
                   DQL  I  V+G P  +   ++  
Sbjct: 230 --------DQLVEIIKVLGTPTREQIREMNP 252

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 2e-45
 Identities = 75/306 (24%), Positives = 130/306 (42%), Gaps = 41/306 (13%)

Query: 3   YEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM- 61
           YE   +  N     ED ++  G ++G G +G VYKA+ K+ S     A K I+       
Sbjct: 1   YEHVTRDLN----PEDFWEIIG-ELGDGAFGKVYKAQNKETS--VLAAAKVIDTKSEEEL 53

Query: 62  -SACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKP 120
                EI +L    HPN++ L+  F  + +  +W+L ++        +         +  
Sbjct: 54  EDYMVEIDILASCDHPNIVKLLDAF--YYENNLWILIEFCAGGAVDAVML-------ELE 104

Query: 121 VMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLF 180
             + +  ++ +  Q LD ++YLH N ++HRDLK  NIL        G +K+AD G +   
Sbjct: 105 RPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFT----LDGDIKLADFGVSAKN 160

Query: 181 NNPLKPLADLDPVVVTFWYRAPELLLG----ARHYTKAIDIWAIGCIFAELLTSEPIFHC 236
              ++     D  + T ++ APE+++      R Y    D+W++G    E+   EP  H 
Sbjct: 161 TRTIQR---RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHE 217

Query: 237 RQED-----IKTSNPYHHDQLDRI----FSVMGFPLEKDWED---IRKMPEHPTLLKDFN 284
                    I  S P    Q  R        +   LEK+ +      ++ +HP +  D N
Sbjct: 218 LNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSN 277

Query: 285 EQICKM 290
           + I ++
Sbjct: 278 KPIREL 283

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 4e-45
 Identities = 65/231 (28%), Positives = 107/231 (46%), Gaps = 26/231 (11%)

Query: 21  DYE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIALLRELKH 75
           DYE    +G G+YG   K RRK +   +    K+++   ++         E+ LLRELKH
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDG--KILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 62

Query: 76  PNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQ 134
           PN++      +   +  ++++ +Y E  DL  +I      K  K+   + +  V  ++ Q
Sbjct: 63  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVIT-----KGTKERQYLDEEFVLRVMTQ 117

Query: 135 ILDGIHYLH-----SNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLAD 189
           +   +   H      + VLHRDLKPAN+ + G+      VK+ D G AR+ N+       
Sbjct: 118 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGK----QNVKLGDFGLARILNHDTSFAKA 173

Query: 190 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
               V T +Y +PE +     Y +  DIW++GC+  EL    P F    + 
Sbjct: 174 ---FVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQK 220

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 9e-45
 Identities = 56/276 (20%), Positives = 102/276 (36%), Gaps = 35/276 (12%)

Query: 21  DYE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQIE---GTGLSMSACREIALLRELKHP 76
           D+E   ++G G  G V+K   K +      A K I       +     RE+ +L E   P
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSG--LVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 64

Query: 77  NVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQIL 136
            ++     F  ++D ++ +  ++ +      +              +P+ ++  +   ++
Sbjct: 65  YIVGFYGAF--YSDGEISICMEHMDGGSLDQVLKKAG--------RIPEQILGKVSIAVI 114

Query: 137 DGIHYLHS-NWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVV 195
            G+ YL   + ++HRD+KP+NILV      RG +K+ D G +    + +      +  V 
Sbjct: 115 KGLTYLREKHKIMHRDVKPSNILVN----SRGEIKLCDFGVSGQLIDSM-----ANSFVG 165

Query: 196 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 255
           T  Y +PE L G  HY+   DIW++G    E+                       +L   
Sbjct: 166 TRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK--------ELELMFG 216

Query: 256 FSVMGFPLEKDWEDIRKMPEHPTLLKDFNEQICKME 291
             V G   E             +   D    +   E
Sbjct: 217 CQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFE 252

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 1e-44
 Identities = 89/265 (33%), Positives = 133/265 (50%), Gaps = 34/265 (12%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G+GT+G V+KAR +     +  ALK++    E  G  ++A REI +L+ LKH NV+NL
Sbjct: 17  KIGQGTFGEVFKARHRKTG--QKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNL 74

Query: 82  ISVFLSH------NDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQI 135
           I +  +           ++L+FD+ EHDL  ++            V      +K ++  +
Sbjct: 75  IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL--------VKFTLSEIKRVMQML 126

Query: 136 LDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP-VV 194
           L+G++Y+H N +LHRD+K AN+L+       G +K+AD G AR F+       +     V
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLIT----RDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182

Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 254
           VT WYR PELLLG R Y   ID+W  GCI AE+ T  PI     E           QL  
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ---------HQLAL 233

Query: 255 IFSVMGFPLEKDWEDIRKMPEHPTL 279
           I  + G    + W ++     +  L
Sbjct: 234 ISQLCGSITPEVWPNVDNYELYEKL 258

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 8e-44
 Identities = 85/262 (32%), Positives = 129/262 (49%), Gaps = 31/262 (11%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI---EGTGLSMSACREIALLRELKHPNVINLI 82
            +G G YG V  A   DN +    A+K+I   E         REI +L   +H N+I + 
Sbjct: 15  YIGEGAYGMVCSAY--DNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 72

Query: 83  SVFLS---HNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGI 139
            +  +      + V+L+      DL+ ++K             +    +   LYQIL G+
Sbjct: 73  DIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH----------LSNDHICYFLYQILRGL 122

Query: 140 HYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWY 199
            Y+HS  VLHRDLKP+N+L+         +KI D G AR+ +        L   V T WY
Sbjct: 123 KYIHSANVLHRDLKPSNLLLN----TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178

Query: 200 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVM 259
           RAPE++L ++ YTK+IDIW++GCI AE+L++ PIF  +          + DQL+ I  ++
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH---------YLDQLNHILGIL 229

Query: 260 GFPLEKDWEDIRKMPEHPTLLK 281
           G P ++D   I  +     LL 
Sbjct: 230 GSPSQEDLNCIINLKARNYLLS 251

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 8e-44
 Identities = 104/271 (38%), Positives = 152/271 (56%), Gaps = 32/271 (11%)

Query: 21  DYE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKH 75
           +++   K+G GTYG VYKAR K        ALK+I    E  G+  +A REI+LL+EL H
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTG--EVVALKKIRLDTETEGVPSTAIREISLLKELNH 60

Query: 76  PNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQI 135
           PN++ L+ V   H + K++L+F++   DL   +              +P  ++KS L+Q+
Sbjct: 61  PNIVKLLDVI--HTENKLYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQL 111

Query: 136 LDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVV 195
           L G+ + HS+ VLHRDLKP N+L+       G +K+AD G AR F  P++        VV
Sbjct: 112 LQGLAFCHSHRVLHRDLKPQNLLIN----TEGAIKLADFGLARAFGVPVRTY---THEVV 164

Query: 196 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 255
           T WYRAPE+LLG ++Y+ A+DIW++GCIFAE++T   +F    E          DQL RI
Sbjct: 165 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE---------IDQLFRI 215

Query: 256 FSVMGFPLEKDWEDIRKMPEHPTLLKDFNEQ 286
           F  +G P E  W  +  MP++      +  Q
Sbjct: 216 FRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 246

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  149 bits (377), Expect = 2e-43
 Identities = 48/254 (18%), Positives = 102/254 (40%), Gaps = 32/254 (12%)

Query: 21  DYE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC--REIALLRELKHPN 77
            Y+   ++G G +G V++   +      ++A K +     S      +EI  +  L+HP 
Sbjct: 27  HYDIHEELGTGAFGVVHRVTERATG--NNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 84

Query: 78  VINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQIL 136
           ++NL   F   +D ++ +++++    +L+  +          +   + +      + Q+ 
Sbjct: 85  LVNLHDAF--EDDNEMVMIYEFMSGGELFEKV--------ADEHNKMSEDEAVEYMRQVC 134

Query: 137 DGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVT 196
            G+ ++H N  +H DLKP NI+   +      +K+ D G     +    P   +     T
Sbjct: 135 KGLCHMHENNYVHLDLKPENIMFTTK--RSNELKLIDFGLTAHLD----PKQSVKVTTGT 188

Query: 197 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 256
             + APE+  G +      D+W++G +   LL+    F    +D         + L  + 
Sbjct: 189 AEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---------ETLRNVK 238

Query: 257 SVMGFPLEKDWEDI 270
           S      +  +  I
Sbjct: 239 SCDWNMDDSAFSGI 252

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  145 bits (366), Expect = 1e-42
 Identities = 96/265 (36%), Positives = 146/265 (55%), Gaps = 33/265 (12%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG VYKA+         +ALK+I    E  G+  +  REI++L+ELKH N++ L
Sbjct: 9   KIGEGTYGVVYKAQNNYG---ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL 65

Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHY 141
             V   H  +++ L+F++ + DL  ++              +     KS L Q+L+GI Y
Sbjct: 66  YDVI--HTKKRLVLVFEHLDQDLKKLLDVCEG--------GLESVTAKSFLLQLLNGIAY 115

Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            H   VLHRDLKP N+L+  EG     +KIAD G AR F  P++        +VT WYRA
Sbjct: 116 CHDRRVLHRDLKPQNLLINREG----ELKIADFGLARAFGIPVRKY---THEIVTLWYRA 168

Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
           P++L+G++ Y+  IDIW++GCIFAE++   P+F    E          DQL RIF ++G 
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA---------DQLMRIFRILGT 219

Query: 262 PLEKDWEDIRKMPEHPTLLKDFNEQ 286
           P  K+W ++ ++P++      +   
Sbjct: 220 PNSKNWPNVTELPKYDPNFTVYEPL 244

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 2e-42
 Identities = 59/227 (25%), Positives = 107/227 (47%), Gaps = 30/227 (13%)

Query: 21  DYE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQI-----EGTGLSMSACREIALLRELK 74
           D+E G  +G+G +G+VY AR K +      ALK +     E  G+     RE+ +   L+
Sbjct: 7   DFEIGRPLGKGKFGNVYLAREKQSK--FILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64

Query: 75  HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLY 133
           HPN++ L   F  H+  +V+L+ +YA    ++  ++               +    + + 
Sbjct: 65  HPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSK---------FDEQRTATYIT 113

Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           ++ + + Y HS  V+HRD+KP N+L+       G +KIAD G++    +          +
Sbjct: 114 ELANALSYCHSKRVIHRDIKPENLLLGSA----GELKIADFGWSVHAPSS-----RRTTL 164

Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
             T  Y  PE++ G R + + +D+W++G +  E L  +P F      
Sbjct: 165 CGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 210

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 4e-42
 Identities = 52/212 (24%), Positives = 97/212 (45%), Gaps = 23/212 (10%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC--REIALLRELKHPNVINLIS 83
           K+G+G  G VY A        ++ A++Q+             EI ++RE K+PN++N + 
Sbjct: 27  KIGQGASGTVYTAMDVATG--QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 84

Query: 84  VFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLH 143
            +      ++W++ +Y        +              + +G + ++  + L  + +LH
Sbjct: 85  SY--LVGDELWVVMEYLAGGSLTDVVTET---------CMDEGQIAAVCRECLQALEFLH 133

Query: 144 SNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPE 203
           SN V+HRD+K  NIL+       G VK+ D GF                +V T ++ APE
Sbjct: 134 SNQVIHRDIKSDNILLG----MDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPE 186

Query: 204 LLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
           ++   + Y   +DIW++G +  E++  EP + 
Sbjct: 187 VVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYL 217

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  144 bits (365), Expect = 4e-42
 Identities = 62/285 (21%), Positives = 119/285 (41%), Gaps = 47/285 (16%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS-----MSACREIALLRELKHPNVIN 80
           ++G G++G VY AR   NS     A+K++  +G           +E+  L++L+HPN I 
Sbjct: 22  EIGHGSFGAVYFARDVRNS--EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79

Query: 81  LISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIH 140
               +    +   WL+ +Y       +++ H+          + +  + ++ +  L G+ 
Sbjct: 80  YRGCY--LREHTAWLVMEYCLGSASDLLEVHKKP--------LQEVEIAAVTHGALQGLA 129

Query: 141 YLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYR 200
           YLHS+ ++HRD+K  NIL+     E G VK+ D G A +           +  V T ++ 
Sbjct: 130 YLHSHNMIHRDVKAGNILLS----EPGLVKLGDFGSASIMA-------PANSFVGTPYWM 178

Query: 201 APELLLGARH--YTKAIDIWAIGCIFAELLTSEPIFH-----------CRQEDIKTSNPY 247
           APE++L      Y   +D+W++G    EL   +P               + E     + +
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH 238

Query: 248 HHDQLDRIFSVMGFPLEKDWED---IRKMPEHPTLLKDFNEQICK 289
             +            L+K  +D      + +H  +L++    +  
Sbjct: 239 WSEYFRNFVDSC---LQKIPQDRPTSEVLLKHRFVLRERPPTVIM 280

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 1e-41
 Identities = 54/218 (24%), Positives = 95/218 (43%), Gaps = 28/218 (12%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC----REIALLRELKHPNVINL 81
           ++GRG++  VYK    +   T + A  +++   L+ S       E  +L+ L+HPN++  
Sbjct: 16  EIGRGSFKTVYKGLDTET--TVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 82  ISVFLS--HNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGI 139
              + S     + + L+ +                        +   +++S   QIL G+
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--------MKIKVLRSWCRQILKGL 125

Query: 140 HYLHSN--WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF 197
            +LH+    ++HRDLK  NI + G     G VKI D+G A L             V+ T 
Sbjct: 126 QFLHTRTPPIIHRDLKCDNIFITGPT---GSVKIGDLGLATLKRASF-----AKAVIGTP 177

Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
            + APE+      Y +++D++A G    E+ TSE  + 
Sbjct: 178 EFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYS 213

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 2e-41
 Identities = 67/258 (25%), Positives = 112/258 (43%), Gaps = 35/258 (13%)

Query: 21  DYE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS-----MSACREIALLRELK 74
           D++ G  +G G++  V  AR    S  R+YA+K +E   +          RE  ++  L 
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATS--REYAIKILEKRHIIKENKVPYVTRERDVMSRLD 66

Query: 75  HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLY 133
           HP  + L   F   +D K++    YA++ +L   I+   +           +   +    
Sbjct: 67  HPFFVKLYFTF--QDDEKLYFGLSYAKNGELLKYIRKIGS---------FDETCTRFYTA 115

Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           +I+  + YLH   ++HRDLKP NIL+     E   ++I D G A++ +      A  +  
Sbjct: 116 EIVSALEYLHGKGIIHRDLKPENILLN----EDMHIQITDFGTAKVLSPE-SKQARANSF 170

Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 253
           V T  Y +PELL   +   K+ D+WA+GCI  +L+   P F    E         +    
Sbjct: 171 VGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE---------YLIFQ 220

Query: 254 RIFSVMGFPLEKDWEDIR 271
           +I  +     EK +   R
Sbjct: 221 KIIKLEYDFPEKFFPKAR 238

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 3e-41
 Identities = 93/270 (34%), Positives = 136/270 (50%), Gaps = 31/270 (11%)

Query: 21  DYE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELK- 74
            YE   ++G G YG V+KAR   N   R  ALK++       G+ +S  RE+A+LR L+ 
Sbjct: 8   QYECVAEIGEGAYGKVFKARDLKNGG-RFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66

Query: 75  --HPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLL 132
             HPNV+ L  V       +   L    EH    +  +         P       +K ++
Sbjct: 67  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTE----TIKDMM 122

Query: 133 YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP 192
           +Q+L G+ +LHS+ V+HRDLKP NILV       G++K+AD G AR+++  +        
Sbjct: 123 FQLLRGLDFLHSHRVVHRDLKPQNILVT----SSGQIKLADFGLARIYSFQMAL----TS 174

Query: 193 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 252
           VVVT WYRAPE+LL    Y   +D+W++GCIFAE+   +P+F    +          DQL
Sbjct: 175 VVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---------VDQL 224

Query: 253 DRIFSVMGFPLEKDWEDIRKMPEHPTLLKD 282
            +I  V+G P E+DW     +P      K 
Sbjct: 225 GKILDVIGLPGEEDWPRDVALPRQAFHSKS 254

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  142 bits (358), Expect = 5e-41
 Identities = 69/262 (26%), Positives = 115/262 (43%), Gaps = 34/262 (12%)

Query: 15  KVEDLFD-YE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQI---EGTGLSMSACREIAL 69
           + ED+ D Y+    +G G +  V  A  K     +  A+K I      G   S   EIA+
Sbjct: 3   QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQ--KLVAIKCIAKKALEGKEGSMENEIAV 60

Query: 70  LRELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMV 128
           L ++KHPN++ L  ++   +   ++L+       +L+  I                +   
Sbjct: 61  LHKIKHPNIVALDDIY--ESGGHLYLIMQLVSGGELFDRIVEKG---------FYTERDA 109

Query: 129 KSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLA 188
             L++Q+LD + YLH   ++HRDLKP N+L      E  ++ I+D G +++ +    P +
Sbjct: 110 SRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLD-EDSKIMISDFGLSKMED----PGS 164

Query: 189 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 248
            L     T  Y APE+L   + Y+KA+D W+IG I   LL   P F+   +         
Sbjct: 165 VLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDA-------- 215

Query: 249 HDQLDRIFSVMGFPLEKDWEDI 270
               ++I           W+DI
Sbjct: 216 -KLFEQILKAEYEFDSPYWDDI 236

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  142 bits (360), Expect = 8e-41
 Identities = 52/254 (20%), Positives = 100/254 (39%), Gaps = 32/254 (12%)

Query: 21  DYE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS--MSACREIALLRELKHPN 77
            Y+   ++G G +G V++   K     R +  K I         +   EI+++ +L HP 
Sbjct: 30  YYDILEELGSGAFGVVHRCVEKATG--RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 87

Query: 78  VINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQIL 136
           +INL   F   +  ++ L+ ++    +L+  I          +   + +  V + + Q  
Sbjct: 88  LINLHDAF--EDKYEMVLILEFLSGGELFDRIA--------AEDYKMSEAEVINYMRQAC 137

Query: 137 DGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVT 196
           +G+ ++H + ++H D+KP NI+   +  +   VKI D G A   N        +     T
Sbjct: 138 EGLKHMHEHSIVHLDIKPENIMCETK--KASSVKIIDFGLATKLNPDEI----VKVTTAT 191

Query: 197 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 256
             + APE++          D+WAIG +   LL+    F               + L  + 
Sbjct: 192 AEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFA---------GEDDLETLQNVK 241

Query: 257 SVMGFPLEKDWEDI 270
                  E  +  +
Sbjct: 242 RCDWEFDEDAFSSV 255

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 9e-41
 Identities = 49/258 (18%), Positives = 109/258 (42%), Gaps = 32/258 (12%)

Query: 17  EDLFD-YE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC-REIALLREL 73
           ++L++ Y     +GRG +G V++     +   + Y  K ++  G       +EI++L   
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSK--KTYMAKFVKVKGTDQVLVKKEISILNIA 58

Query: 74  KHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLL 132
           +H N+++L   F   +  ++ ++F++    D++  I              + +  + S +
Sbjct: 59  RHRNILHLHESF--ESMEELVMIFEFISGLDIFERIN--------TSAFELNEREIVSYV 108

Query: 133 YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP 192
           +Q+ + + +LHS+ + H D++P NI+          +KI + G AR          +   
Sbjct: 109 HQVCEALQFLHSHNIGHFDIRPENIIYQTRR--SSTIKIIEFGQARQLKPG----DNFRL 162

Query: 193 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 252
           +     Y APE+       + A D+W++G +   LL+    F                 +
Sbjct: 163 LFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---------QII 212

Query: 253 DRIFSVMGFPLEKDWEDI 270
           + I +      E+ +++I
Sbjct: 213 ENIMNAEYTFDEEAFKEI 230

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 9e-40
 Identities = 97/256 (37%), Positives = 145/256 (56%), Gaps = 33/256 (12%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
           K+G GTYG V+KA+ ++       ALK++    +  G+  SA REI LL+ELKH N++ L
Sbjct: 9   KIGEGTYGTVFKAKNRETH--EIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 66

Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHY 141
             V   H+D+K+ L+F++ + DL                  +   +VKS L+Q+L G+ +
Sbjct: 67  HDVL--HSDKKLTLVFEFCDQDLKKYFDSCNG--------DLDPEIVKSFLFQLLKGLGF 116

Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
            HS  VLHRDLKP N+L+       G +K+A+ G AR F  P++        VVT WYR 
Sbjct: 117 CHSRNVLHRDLKPQNLLIN----RNGELKLANFGLARAFGIPVRC---YSAEVVTLWYRP 169

Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCRQEDIKTSNPYHHDQLDRIFSVMG 260
           P++L GA+ Y+ +ID+W+ GCIFAEL  +  P+F     D         DQL RIF ++G
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD---------DQLKRIFRLLG 220

Query: 261 FPLEKDWEDIRKMPEH 276
            P E+ W  + K+P++
Sbjct: 221 TPTEEQWPSMTKLPDY 236

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  139 bits (350), Expect = 1e-39
 Identities = 64/272 (23%), Positives = 123/272 (45%), Gaps = 33/272 (12%)

Query: 21  DYE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELK-HPNV 78
           DY+   K+GRG Y  V++A    N+      +K ++         REI +L  L+  PN+
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNN--EKVVVKILKPVKKKK-IKREIKILENLRGGPNI 92

Query: 79  INLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILD 137
           I L  +      R   L+F++  + D   + +             +    ++  +Y+IL 
Sbjct: 93  ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ------------TLTDYDIRFYMYEILK 140

Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF 197
            + Y HS  ++HRD+KP N+++  E     ++++ D G A  ++    P  + +  V + 
Sbjct: 141 ALDYCHSMGIMHRDVKPHNVMIDHEH---RKLRLIDWGLAEFYH----PGQEYNVRVASR 193

Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFS 257
           +++ PELL+  + Y  ++D+W++GC+ A ++  +  F    +        ++DQL RI  
Sbjct: 194 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD--------NYDQLVRIAK 245

Query: 258 VMGFPLEKDWEDIRKMPEHPTLLKDFNEQICK 289
           V+G     D+ D   +   P           K
Sbjct: 246 VLGTEDLYDYIDKYNIELDPRFNDILGRHSRK 277

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 1e-39
 Identities = 48/223 (21%), Positives = 92/223 (41%), Gaps = 29/223 (13%)

Query: 21  DYE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC----REIALLRELKH 75
               G ++G G++G VYK +        D A+K +  T  +         E+ +LR+ +H
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHG-----DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 63

Query: 76  PNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQ 134
            N++  +         ++ ++  + E   L+H +                   +  +  Q
Sbjct: 64  VNILLFMGY---STAPQLAIVTQWCEGSSLYHHLHIIETK--------FEMIKLIDIARQ 112

Query: 135 ILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVV 194
              G+ YLH+  ++HRDLK  NI +     E   VKI D G A + +         + + 
Sbjct: 113 TAQGMDYLHAKSIIHRDLKSNNIFLH----EDLTVKIGDFGLATVKSR-WSGSHQFEQLS 167

Query: 195 VTFWYRAPELLLG--ARHYTKAIDIWAIGCIFAELLTSEPIFH 235
            +  + APE++       Y+   D++A G +  EL+T +  + 
Sbjct: 168 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 210

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 1e-38
 Identities = 69/276 (25%), Positives = 114/276 (41%), Gaps = 41/276 (14%)

Query: 16  VEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMS--------ACREI 67
           V+D +D  G ++G G +  V K R K       YA K I+      S          RE+
Sbjct: 8   VDDYYDT-GEELGSGQFAVVKKCREKSTG--LQYAAKFIKKRRTKSSRRGVSREDIEREV 64

Query: 68  ALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGM 127
           ++L+E++HPNVI L  V+   N   V L+ +             + +   +         
Sbjct: 65  SILKEIQHPNVITLHEVY--ENKTDVILILELVAGGELFDFLAEKESLTEE--------E 114

Query: 128 VKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPL 187
               L QIL+G++YLHS  + H DLKP NI+++   + + R+KI D G A   +      
Sbjct: 115 ATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---- 170

Query: 188 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 247
            +   +  T  + APE++          D+W+IG I   LL+    F    +        
Sbjct: 171 NEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTK-------- 221

Query: 248 HHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF 283
             + L  + +V     ++ + +         L KDF
Sbjct: 222 -QETLANVSAVNYEFEDEYFSNT------SALAKDF 250

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 2e-38
 Identities = 38/214 (17%), Positives = 91/214 (42%), Gaps = 25/214 (11%)

Query: 18  DLFDYE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHP 76
           ++ + +    +G+G +G V     +        A+K I+    + +   E +++ +L+H 
Sbjct: 5   NMKELKLLQTIGKGEFGDVMLGDYRG----NKVAVKCIKNDATAQAFLAEASVMTQLRHS 60

Query: 77  NVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQI 135
           N++ L+ V +      ++++ +Y     L   ++       ++   ++    +      +
Sbjct: 61  NLVQLLGVIV-EEKGGLYIVTEYMAKGSLVDYLR-------SRGRSVLGGDCLLKFSLDV 112

Query: 136 LDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVV 195
            + + YL  N  +HRDL   N+LV     E    K++D G  +  ++        D   +
Sbjct: 113 CEAMEYLEGNNFVHRDLAARNVLV----SEDNVAKVSDFGLTKEASS------TQDTGKL 162

Query: 196 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
              + APE L   + ++   D+W+ G +  E+ +
Sbjct: 163 PVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYS 195

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  133 bits (336), Expect = 5e-38
 Identities = 66/269 (24%), Positives = 113/269 (42%), Gaps = 49/269 (18%)

Query: 21  DYE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQI-----------EGTGLSMSACREIA 68
           +YE    +GRG    V +   K     ++YA+K I           E   L  +  +E+ 
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTC--KEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61

Query: 69  LLRELK-HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKG 126
           +LR++  HPN+I L   +    +   +L+FD  +  +L+  +              + + 
Sbjct: 62  ILRKVSGHPNIIQLKDTY--ETNTFFFLVFDLMKKGELFDYLTEKVT---------LSEK 110

Query: 127 MVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKP 186
             + ++  +L+ I  LH   ++HRDLKP NIL+     +   +K+ D GF+   +    P
Sbjct: 111 ETRKIMRALLEVICALHKLNIVHRDLKPENILLD----DDMNIKLTDFGFSCQLD----P 162

Query: 187 LADLDPVVVTFWYRAPELLLGARH-----YTKAIDIWAIGCIFAELLTSEPIFHCRQEDI 241
              L  V  T  Y APE++  + +     Y K +D+W+ G I   LL   P F  R++  
Sbjct: 163 GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-- 220

Query: 242 KTSNPYHHDQLDRIFSVMGFPLEKDWEDI 270
                     L  I S        +W+D 
Sbjct: 221 -------MLMLRMIMSGNYQFGSPEWDDY 242

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  134 bits (337), Expect = 2e-37
 Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 32/225 (14%)

Query: 21  DYE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQI--------EGTGLSMSACREIALLR 71
           D+     +GRG +G VY  R+ D    + YA+K +        +G  L+++    ++L+ 
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTG--KMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 62

Query: 72  ELKHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKS 130
               P ++ +   F  H   K+  + D     DL + +  H          +  +  ++ 
Sbjct: 63  TGDCPFIVCMSYAF--HTPDKLSFILDLMNGGDLHYHLSQHG---------VFSEADMRF 111

Query: 131 LLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADL 190
              +I+ G+ ++H+ +V++RDLKPANIL+     E G V+I+D+G A  F+         
Sbjct: 112 YAAEIILGLEHMHNRFVVYRDLKPANILLD----EHGHVRISDLGLACDFSK-----KKP 162

Query: 191 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
              V T  Y APE+L     Y  + D +++GC+  +LL     F 
Sbjct: 163 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 207

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 2e-37
 Identities = 52/232 (22%), Positives = 99/232 (42%), Gaps = 22/232 (9%)

Query: 12  ERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREI-ALL 70
           ++  + D +      +G G  G V +   K       +ALK ++       A RE+    
Sbjct: 5   KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQ--EKFALKMLQD---CPKARREVELHW 59

Query: 71  RELKHPNVINLISVF--LSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGM 127
           R  + P+++ ++ V+  L    + + ++ +  +  +L+  I+       ++      +  
Sbjct: 60  RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ-------DRGDQAFTERE 112

Query: 128 VKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPL 187
              ++  I + I YLHS  + HRD+KP N+L   +      +K+ D GFA+   +     
Sbjct: 113 ASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR-PNAILKLTDFGFAKETTSHNSL- 170

Query: 188 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 239
                   T +Y APE+L     Y K+ D+W++G I   LL   P F+    
Sbjct: 171 ---TTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 218

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (334), Expect = 3e-37
 Identities = 77/259 (29%), Positives = 123/259 (47%), Gaps = 39/259 (15%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQI----EGTGLSMSACREIALLRELKHPNVINL 81
            VG G YG V  A           A+K++    +    +  A RE+ LL+ ++H NVI L
Sbjct: 25  PVGSGAYGAVCSAVDGRTG--AKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGL 82

Query: 82  ISVFLSHNDR----KVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILD 137
           + VF            +L+  +   DL  ++K  +          + +  ++ L+YQ+L 
Sbjct: 83  LDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK----------LGEDRIQFLVYQMLK 132

Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF 197
           G+ Y+H+  ++HRDLKP N+ V     E   +KI D G AR  ++ +         VVT 
Sbjct: 133 GLRYIHAAGIIHRDLKPGNLAVN----EDCELKILDFGLARQADSEMTG------YVVTR 182

Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFS 257
           WYRAPE++L    YT+ +DIW++GCI AE++T + +F             H DQL  I  
Sbjct: 183 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD---------HLDQLKEIMK 233

Query: 258 VMGFPLEKDWEDIRKMPEH 276
           V G P  +  + ++     
Sbjct: 234 VTGTPPAEFVQRLQSDEAK 252

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  131 bits (329), Expect = 5e-37
 Identities = 53/259 (20%), Positives = 92/259 (35%), Gaps = 34/259 (13%)

Query: 21  DYE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQI-----EGTGLSMSACREIALLRELK 74
            YE G  +G G    V+ AR       RD A+K +           +   RE      L 
Sbjct: 8   RYELGEILGFGGMSEVHLARDLRLH--RDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 75  HPNVINLISVFLSHNDRK--VWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSL 131
           HP ++ +     +        +++ +Y +   L  I+              +       +
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---------MTPKRAIEV 116

Query: 132 LYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLD 191
           +      +++ H N ++HRD+KPANI++         VK+ D G AR   +    +    
Sbjct: 117 IADACQALNFSHQNGIIHRDVKPANIMIS----ATNAVKVMDFGIARAIADSGNSVTQTA 172

Query: 192 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 251
            V+ T  Y +PE   G        D++++GC+  E+LT EP F                 
Sbjct: 173 AVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV---------SV 222

Query: 252 LDRIFSVMGFPLEKDWEDI 270
             +       P     E +
Sbjct: 223 AYQHVREDPIPPSARHEGL 241

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 2e-36
 Identities = 46/217 (21%), Positives = 91/217 (41%), Gaps = 21/217 (9%)

Query: 21  DYE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC-REIALLRELKHPNV 78
             +   ++G G +G V+      +      A+K ++   +S  A   E  L+++L+H  +
Sbjct: 14  TLKLVERLGAGQFGEVWMGYYNGH---TKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 70

Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDG 138
           + L +V        ++++ +Y E+                  + +    +  +  QI +G
Sbjct: 71  VRLYAVV---TQEPIYIITEYMENGSLVDFLKTP------SGIKLTINKLLDMAAQIAEG 121

Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + ++     +HRDL+ ANILV     +    KIAD G ARL  +        +       
Sbjct: 122 MAFIEERNYIHRDLRAANILVS----DTLSCKIADFGLARLIED--NEYTAREGAKFPIK 175

Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
           + APE +     +T   D+W+ G +  E++T   I +
Sbjct: 176 WTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPY 211

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 2e-36
 Identities = 57/271 (21%), Positives = 109/271 (40%), Gaps = 33/271 (12%)

Query: 21  DYE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS--------MSACREIALLR 71
            Y+ G  +G G +G VY   R  ++     A+K +E   +S             E+ LL+
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDN--LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62

Query: 72  ELK--HPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVK 129
           ++      VI L+  F   +   + L       DL+  I    A         + + + +
Sbjct: 63  KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---------LQEELAR 113

Query: 130 SLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLAD 189
           S  +Q+L+ + + H+  VLHRD+K  NIL+      RG +K+ D G   L  +       
Sbjct: 114 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLN---RGELKLIDFGSGALLKDT-----V 165

Query: 190 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 249
                 T  Y  PE +   R++ ++  +W++G +  +++  +  F   +E I+    +  
Sbjct: 166 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQ 225

Query: 250 DQLDRIFSVMGFPLEKDWED---IRKMPEHP 277
                   ++ + L     D     ++  HP
Sbjct: 226 RVSSECQHLIRWCLALRPSDRPTFEEIQNHP 256

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (316), Expect = 5e-35
 Identities = 53/245 (21%), Positives = 99/245 (40%), Gaps = 28/245 (11%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA-CREIALLRELKHPNVINLISV 84
           K+G+G +G V+         T   A+K ++   +S  A  +E  ++++L+H  ++ L +V
Sbjct: 24  KLGQGCFGEVWMGTWNG---TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 80

Query: 85  FLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHS 144
               ++  ++++ +Y               K  + P       +  +  QI  G+ Y+  
Sbjct: 81  V---SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLP------QLVDMAAQIASGMAYVER 131

Query: 145 NWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPEL 204
              +HRDL+ ANILV     E    K+AD G ARL  +                + APE 
Sbjct: 132 MNYVHRDLRAANILVG----ENLVCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEA 185

Query: 205 LLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGFPLE 264
            L    +T   D+W+ G +  EL T   + +            + + LD++      P  
Sbjct: 186 ALY-GRFTIKSDVWSFGILLTELTTKGRVPY--------PGMVNREVLDQVERGYRMPCP 236

Query: 265 KDWED 269
            +  +
Sbjct: 237 PECPE 241

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 7e-35
 Identities = 42/222 (18%), Positives = 83/222 (37%), Gaps = 21/222 (9%)

Query: 21  DYE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM-SACREIALLRELKHPNV 78
           +     ++G G +G V+     +       A+K I    +S      E  ++ +L HP +
Sbjct: 6   ELTFVQEIGSGQFGLVHLGYWLN---KDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKL 62

Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDG 138
           + L  V        + L+F++ EH                +  +     +  +   + +G
Sbjct: 63  VQLYGVC--LEQAPICLVFEFMEHGCLSDYLR-------TQRGLFAAETLLGMCLDVCEG 113

Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + YL    V+HRDL   N LV     E   +K++D G  R   +                
Sbjct: 114 MAYLEEACVIHRDLAARNCLVG----ENQVIKVSDFGMTRFVLDD--QYTSSTGTKFPVK 167

Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
           + +PE+      Y+   D+W+ G +  E+ +   I +  + +
Sbjct: 168 WASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 208

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 7e-35
 Identities = 47/216 (21%), Positives = 84/216 (38%), Gaps = 20/216 (9%)

Query: 18  DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIE---GTGLSMSACREIALLRELK 74
           D       ++G G +G V +   +      D A+K ++       +    RE  ++ +L 
Sbjct: 8   DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD 67

Query: 75  HPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLY 133
           +P ++ LI V        + L+ + A    L   +          K   +P   V  LL+
Sbjct: 68  NPYIVRLIGVC---QAEALMLVMEMAGGGPLHKFLV--------GKREEIPVSNVAELLH 116

Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           Q+  G+ YL     +HRDL   N+L++     R   KI+D G ++               
Sbjct: 117 QVSMGMKYLEEKNFVHRDLAARNVLLV----NRHYAKISDFGLSKALGADDSYYTARSAG 172

Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                + APE +   R ++   D+W+ G    E L+
Sbjct: 173 KWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALS 207

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  124 bits (313), Expect = 1e-34
 Identities = 44/270 (16%), Positives = 85/270 (31%), Gaps = 28/270 (10%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           K+G G++G +Y           + A+K             E  + + ++    I  I   
Sbjct: 14  KIGSGSFGDIYLGTDIAAG--EEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWC 71

Query: 86  LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSN 145
            +  D    ++ +     L  +  F                 V  L  Q++  I Y+HS 
Sbjct: 72  GAEGDY-NVMVMELLGPSLEDLFNFCSR--------KFSLKTVLLLADQMISRIEYIHSK 122

Query: 146 WVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNP----LKPLADLDPVVVTFWYRA 201
             +HRD+KP N L+         V I D G A+ + +       P  +   +  T  Y +
Sbjct: 123 NFIHRDVKPDNFLMGLGKKG-NLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181

Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFSVMGF 261
               LG    ++  D+ ++G +          +   +   K        +       M  
Sbjct: 182 INTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK-----MST 235

Query: 262 PLEKDWEDIRKMPEHPTLLKDFNEQICKME 291
           P+E   +        P+    +      + 
Sbjct: 236 PIEVLCKGY------PSEFATYLNFCRSLR 259

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  124 bits (312), Expect = 2e-34
 Identities = 36/220 (16%), Positives = 78/220 (35%), Gaps = 17/220 (7%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVF 85
           ++G G++G +++     N+  +  A+K       +     E    + L     I  +  +
Sbjct: 12  RIGEGSFGVIFEGTNLLNN--QQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV-YY 68

Query: 86  LSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSN 145
                    L+ D     L  ++                   V     Q+L  +  +H  
Sbjct: 69  FGQEGLHNVLVIDLLGPSLEDLLD--------LCGRKFSVKTVAMAAKQMLARVQSIHEK 120

Query: 146 WVLHRDLKPANILVMGEGIER-GRVKIADMGFARLFNNPL----KPLADLDPVVVTFWYR 200
            +++RD+KP N L+     +    + + D G  + + +P+     P  +   +  T  Y 
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180

Query: 201 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 240
           +    LG R  ++  D+ A+G +F   L     +   +  
Sbjct: 181 SINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAA 219

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 2e-34
 Identities = 52/216 (24%), Positives = 79/216 (36%), Gaps = 22/216 (10%)

Query: 21  DYE-GCKVGRGTYGHVYKAR-RKDNSDTRDYALKQIEGTGLSMSAC-----REIALLREL 73
           D     K+G G++G V +      +  T   A+K ++   LS         RE+  +  L
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68

Query: 74  KHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLY 133
            H N+I L  V L      + ++ + A                         G +     
Sbjct: 69  DHRNLIRLYGVVL---TPPMKMVTELAPLGSLLDRLRKHQGH-------FLLGTLSRYAV 118

Query: 134 QILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPV 193
           Q+ +G+ YL S   +HRDL   N+L+         VKI D G  R            +  
Sbjct: 119 QVAEGMGYLESKRFIHRDLAARNLLLATR----DLVKIGDFGLMRALPQNDDHYVMQEHR 174

Query: 194 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
            V F + APE L   R ++ A D W  G    E+ T
Sbjct: 175 KVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFT 209

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  124 bits (312), Expect = 3e-34
 Identities = 55/221 (24%), Positives = 99/221 (44%), Gaps = 29/221 (13%)

Query: 21  DYE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS-----MSACREIALLRELK 74
           D++    +G G++G V+  R + N   R YA+K ++   +           E  +L  + 
Sbjct: 5   DFQILRTLGTGSFGRVHLIRSRHNG--RYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62

Query: 75  HPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQ 134
           HP +I +   F   + ++++++ DY E      +               P  + K    +
Sbjct: 63  HPFIIRMWGTF--QDAQQIFMIMDYIEGGELFSLLRKS--------QRFPNPVAKFYAAE 112

Query: 135 ILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVV 194
           +   + YLHS  +++RDLKP NIL+     + G +KI D GFA+   +          + 
Sbjct: 113 VCLALEYLHSKDIIYRDLKPENILLD----KNGHIKITDFGFAKYVPDVTY------TLC 162

Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
            T  Y APE++   + Y K+ID W+ G +  E+L     F+
Sbjct: 163 GTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFY 202

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 4e-34
 Identities = 57/246 (23%), Positives = 107/246 (43%), Gaps = 34/246 (13%)

Query: 21  DYE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC------REIALLREL 73
           D+     +G+G++G V+ A  K  +  + +A+K ++   + M          +  L    
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTN--QFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60

Query: 74  KHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLL 132
           +HP + ++   F       ++ + +Y    DL + I+                       
Sbjct: 61  EHPFLTHMFCTF--QTKENLFFVMEYLNGGDLMYHIQSCHK---------FDLSRATFYA 109

Query: 133 YQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDP 192
            +I+ G+ +LHS  +++RDLK  NIL+     + G +KIAD G  +            + 
Sbjct: 110 AEIILGLQFLHSKGIVYRDLKLDNILLD----KDGHIKIADFGMCKENMLGDAK---TNT 162

Query: 193 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED-----IKTSNPY 247
              T  Y APE+LLG + Y  ++D W+ G +  E+L  +  FH + E+     I+  NP+
Sbjct: 163 FCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF 221

Query: 248 HHDQLD 253
           +   L+
Sbjct: 222 YPRWLE 227

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (308), Expect = 4e-34
 Identities = 37/208 (17%), Positives = 80/208 (38%), Gaps = 20/208 (9%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSA----CREIALLRELKHPNVINL 81
           ++G G +G V K   +     +  A+K ++      +       E  ++++L +P ++ +
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73

Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHY 141
           I +          L+ + AE    +                V    +  L++Q+  G+ Y
Sbjct: 74  IGIC---EAESWMLVMEMAELGPLNKYLQQN--------RHVKDKNIIELVHQVSMGMKY 122

Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
           L  +  +HRDL   N+L+    + +   KI+D G ++                    + A
Sbjct: 123 LEESNFVHRDLAARNVLL----VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178

Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLT 229
           PE +     ++   D+W+ G +  E  +
Sbjct: 179 PECINY-YKFSSKSDVWSFGVLMWEAFS 205

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (308), Expect = 2e-33
 Identities = 84/262 (32%), Positives = 122/262 (46%), Gaps = 39/262 (14%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC----REIALLRELKHPNVINL 81
            VG G YG V  A           A+K++     S+       RE+ LL+ +KH NVI L
Sbjct: 25  PVGSGAYGSVCAAFDTKTG--LRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 82

Query: 82  ISVFLS----HNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILD 137
           + VF           V+L+      DL +I+K  +          +    V+ L+YQIL 
Sbjct: 83  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILR 132

Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF 197
           G+ Y+HS  ++HRDLKP+N+ V     E   +KI D G AR  ++ +         V T 
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDDEMTG------YVATR 182

Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFS 257
           WYRAPE++L   HY + +DIW++GCI AELLT   +F             H DQL  I  
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---------HIDQLKLILR 233

Query: 258 VMGFPLEKDWEDIRKMPEHPTL 279
           ++G P  +  + I        +
Sbjct: 234 LVGTPGAELLKKISSESARNYI 255

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 5e-33
 Identities = 51/232 (21%), Positives = 91/232 (39%), Gaps = 31/232 (13%)

Query: 21  DYE-GCKVGRGTYGHVYKARRKDNSDTRD---YALKQI---EGTGLSMSACREIALLREL 73
           + E G  +G G +G V  A     S T      A+K +     +    +   E+ ++ +L
Sbjct: 38  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97

Query: 74  -KHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHR--------------AAKAN 117
             H N++NL+          ++L+F+Y  + DL + ++  R                +  
Sbjct: 98  GSHENIVNLLGAC--TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155

Query: 118 KKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA 177
           +   ++    +    YQ+  G+ +L     +HRDL   N+LV         VKI D G A
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT----HGKVVKICDFGLA 211

Query: 178 RLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
           R   +            +   + APE L     YT   D+W+ G +  E+ +
Sbjct: 212 RDIMSD-SNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFS 261

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 8e-33
 Identities = 57/271 (21%), Positives = 105/271 (38%), Gaps = 23/271 (8%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-SMSACREIALLRELKHPNVINLISV 84
            +G+G +G V++ + +      + A+K        S     EI     L+H N++  I+ 
Sbjct: 10  SIGKGRFGEVWRGKWRG----EEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 65

Query: 85  FLSHNDR--KVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHY 141
               N    ++WL+ DY EH  L+  +  +R     +  + +       L +  ++ +  
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123

Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPL-ADLDPVVVTFWYR 200
                + HRDLK  NILV     + G   IAD+G A   ++    +    +  V T  Y 
Sbjct: 124 QGKPAIAHRDLKSKNILVK----KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179

Query: 201 APELLLGARH-----YTKAIDIWAIGCIFAELLTSEPIFHCRQED---IKTSNPYHHDQL 252
           APE+L  + +       K  DI+A+G +F E+     I    ++         P      
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239

Query: 253 DRIFSVMGFPLEKDWEDIRKMPEHPTLLKDF 283
           +    V    L  +  +  +  E   ++   
Sbjct: 240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKI 270

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  118 bits (296), Expect = 3e-32
 Identities = 53/220 (24%), Positives = 88/220 (40%), Gaps = 19/220 (8%)

Query: 18  DLFDYE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC-REIALLRELKH 75
           +  D     K+G G YG VY+   K  S     A+K ++   + +    +E A+++E+KH
Sbjct: 15  ERTDITMKHKLGGGQYGEVYEGVWKKYS--LTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 72

Query: 76  PNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQI 135
           PN++ L+ V        +   F    + L ++ +             V   ++  +  QI
Sbjct: 73  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--------CNRQEVSAVVLLYMATQI 124

Query: 136 LDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVV 195
              + YL     +HRDL   N LV     E   VK+AD G +RL                
Sbjct: 125 SSAMEYLEKKNFIHRDLAARNCLVG----ENHLVKVADFGLSRLMTG--DTYTAHAGAKF 178

Query: 196 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
              + APE L     ++   D+WA G +  E+ T     +
Sbjct: 179 PIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPY 217

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (295), Expect = 4e-32
 Identities = 50/283 (17%), Positives = 102/283 (36%), Gaps = 40/283 (14%)

Query: 27  VGRGTYGHVYKARRKDNSDTRD--YALKQIEGT---GLSMSACREIALLRELKHPNVINL 81
           +G G +G VYK   K +S  ++   A+K ++        +    E  ++ +  H N+I L
Sbjct: 15  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 74

Query: 82  ISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHY 141
             V   +    +   +         + +         K        +  +L  I  G+ Y
Sbjct: 75  EGVISKYKPMMIITEYMENGALDKFLRE---------KDGEFSVLQLVGMLRGIAAGMKY 125

Query: 142 LHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRA 201
           L +   +HRDL   NILV          K++D G +R+  +  +         +   + A
Sbjct: 126 LANMNYVHRDLAARNILVN----SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181

Query: 202 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN--------PYHHDQLD 253
           PE +   +  + + D+W+ G +  E++T     +    + +           P   D   
Sbjct: 182 PEAISYRKFTSAS-DVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS 240

Query: 254 RIFSVMGFPLEKD-------------WEDIRKMPEHPTLLKDF 283
            I+ +M    +++              + + + P+    L DF
Sbjct: 241 AIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADF 283

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (298), Expect = 5e-32
 Identities = 72/259 (27%), Positives = 124/259 (47%), Gaps = 39/259 (15%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIALLRELKHPNVINL 81
            +G G  G V  A        R+ A+K++     +      A RE+ L++ + H N+I+L
Sbjct: 24  PIGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81

Query: 82  ISVFLSHN----DRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILD 137
           ++VF         + V+L+ +  + +L  +I+                  +  LLYQ+L 
Sbjct: 82  LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----------DHERMSYLLYQMLC 130

Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF 197
           GI +LHS  ++HRDLKP+NI+V  +      +KI D G AR           + P VVT 
Sbjct: 131 GIKHLHSAGIIHRDLKPSNIVVKSD----CTLKILDFGLARTAGTSFM----MTPYVVTR 182

Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFS 257
           +YRAPE++LG   Y + +DIW++GCI  E++  + +F  R            DQ +++  
Sbjct: 183 YYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDY---------IDQWNKVIE 232

Query: 258 VMGFPLEKDWEDIRKMPEH 276
            +G P  +  + ++    +
Sbjct: 233 QLGTPCPEFMKKLQPTVRN 251

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 9e-32
 Identities = 48/221 (21%), Positives = 91/221 (41%), Gaps = 26/221 (11%)

Query: 21  DYE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS-----MSACREIALLRELK 74
           D++    +G+GT+G V   R K     R YA+K +    +           E  +L+  +
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATG--RYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63

Query: 75  HPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQ 134
           HP +  L   F +H+     + +       +H+ +               +   +    +
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV----------FTEERARFYGAE 113

Query: 135 ILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVV 194
           I+  + YLHS  V++RD+K  N+++     + G +KI D G  +   +       +    
Sbjct: 114 IVSALEYLHSRDVVYRDIKLENLMLD----KDGHIKITDFGLCKEGISDGAT---MKTFC 166

Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 235
            T  Y APE+L     Y +A+D W +G +  E++     F+
Sbjct: 167 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY 206

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 1e-31
 Identities = 43/211 (20%), Positives = 81/211 (38%), Gaps = 21/211 (9%)

Query: 21  DYE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSM-SACREIALLRELKHPNV 78
           D     ++G G +G V   + +      D A+K I+   +S      E  ++  L H  +
Sbjct: 5   DLTFLKELGTGQFGVVKYGKWRGQ---YDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKL 61

Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDG 138
           + L  V      R ++++ +Y  +            +            +  +   + + 
Sbjct: 62  VQLYGVC--TKQRPIFIITEYMANGCLLNYLREMRHR-------FQTQQLLEMCKDVCEA 112

Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFW 198
           + YL S   LHRDL   N LV     ++G VK++D G +R   +                
Sbjct: 113 MEYLESKQFLHRDLAARNCLVN----DQGVVKVSDFGLSRYVLDD--EYTSSVGSKFPVR 166

Query: 199 YRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
           +  PE+L+    ++   DIWA G +  E+ +
Sbjct: 167 WSPPEVLMY-SKFSSKSDIWAFGVLMWEIYS 196

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  117 bits (294), Expect = 2e-31
 Identities = 52/243 (21%), Positives = 99/243 (40%), Gaps = 29/243 (11%)

Query: 4   EFKIKTSNERTKVEDLFDYE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS-- 60
           +F  K          L  ++    +G G++G V   + K++     YA+K ++   +   
Sbjct: 25  DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESG--NHYAMKILDKQKVVKL 82

Query: 61  ---MSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKAN 117
                   E  +L+ +  P ++ L   F  +++  + + +        H+ +  R     
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR----- 137

Query: 118 KKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA 177
                  +   +    QI+    YLHS  +++RDLKP N+L+  +    G +++ D GFA
Sbjct: 138 -----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ----GYIQVTDFGFA 188

Query: 178 RLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 237
           +              +  T    APE++L  + Y KA+D WA+G +  E+    P F   
Sbjct: 189 KRVKGRTW------TLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFAD 241

Query: 238 QED 240
           Q  
Sbjct: 242 QPI 244

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 6e-31
 Identities = 46/220 (20%), Positives = 85/220 (38%), Gaps = 22/220 (10%)

Query: 21  DYE-GCKVGRGTYGHVYKARRKDNSDT--RDYALKQI---EGTGLSMSACREIALLRELK 74
           +++    +G G +G VYK       +      A+K++        +     E  ++  + 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69

Query: 75  HPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQ 134
           +P+V  L+ + L+   + +  L  +     +            +    +    + +   Q
Sbjct: 70  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYV----------REHKDNIGSQYLLNWCVQ 119

Query: 135 ILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVV 194
           I  G++YL    ++HRDL   N+LV         VKI D G A+L     +     +   
Sbjct: 120 IAKGMNYLEDRRLVHRDLAARNVLVK----TPQHVKITDFGLAKLLGAE-EKEYHAEGGK 174

Query: 195 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 234
           V   + A E +L  R YT   D+W+ G    EL+T     
Sbjct: 175 VPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKP 213

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  115 bits (288), Expect = 7e-31
 Identities = 47/226 (20%), Positives = 83/226 (36%), Gaps = 21/226 (9%)

Query: 11  NERTKVEDLFDYE-GCKVGRGTYGHVYKARRK-DNSDTRDYALKQIEGTGLS---MSACR 65
            E  K  D+   +    +G G +G V     K         A+K ++             
Sbjct: 17  REFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLS 76

Query: 66  EIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPK 125
           E +++ +  HPNVI+L  V        V ++ ++ E+            +          
Sbjct: 77  EASIMGQFDHPNVIHLEGVV--TKSTPVMIITEFMENGSLDSFLRQNDGQFTVI------ 128

Query: 126 GMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN--P 183
             +  +L  I  G+ YL     +HRDL   NILV          K++D G +R   +   
Sbjct: 129 -QLVGMLRGIAAGMKYLADMNYVHRDLAARNILVN----SNLVCKVSDFGLSRFLEDDTS 183

Query: 184 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                      +   + APE +   R +T A D+W+ G +  E+++
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMS 228

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 1e-30
 Identities = 50/234 (21%), Positives = 93/234 (39%), Gaps = 18/234 (7%)

Query: 1   MDYEFKIKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTR-DYALKQI---EG 56
           ++ E      +       L  +    +GRG +G VY     DN   +   A+K +     
Sbjct: 9   LNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD 68

Query: 57  TGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKA 116
            G       E  ++++  HPNV++L+ + L  ++    ++  Y +H        +     
Sbjct: 69  IGEVSQFLTEGIIMKDFSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHN- 126

Query: 117 NKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGF 176
                      +     Q+  G+ +L S   +HRDL   N ++     E+  VK+AD G 
Sbjct: 127 ------PTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD----EKFTVKVADFGL 176

Query: 177 ARLFNNP-LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
           AR   +     + +     +   + A E L   +  TK+ D+W+ G +  EL+T
Sbjct: 177 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKS-DVWSFGVLLWELMT 229

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  114 bits (285), Expect = 2e-30
 Identities = 55/232 (23%), Positives = 90/232 (38%), Gaps = 31/232 (13%)

Query: 21  DYE-GCKVGRGTYGHVYKARRK---DNSDTRDYALKQI---EGTGLSMSACREIALLREL 73
           + E    +G G +G V++AR             A+K +       +     RE AL+ E 
Sbjct: 14  NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73

Query: 74  KHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFH---------------RAAKAN 117
            +PN++ L+ V      + + LLF+Y  + DL   ++                 RA  ++
Sbjct: 74  DNPNIVKLLGVC--AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131

Query: 118 KKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA 177
             P  +       +  Q+  G+ YL     +HRDL   N LV     E   VKIAD G +
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG----ENMVVKIADFGLS 187

Query: 178 RLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
           R   +            +   +  PE +     YT   D+WA G +  E+ +
Sbjct: 188 RNIYSA-DYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFS 237

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 2e-30
 Identities = 59/232 (25%), Positives = 95/232 (40%), Gaps = 24/232 (10%)

Query: 18  DLFDYE-GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS---MSACREIALLREL 73
           D  D +    +G G +G V KAR K +    D A+K+++             E+ +L +L
Sbjct: 8   DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 67

Query: 74  -KHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFH-------RAAKANKKPVMVP 124
             HPN+INL+      +   ++L  +YA H +L   ++           A AN     + 
Sbjct: 68  GHHPNIINLLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125

Query: 125 KGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPL 184
              +      +  G+ YL     +HRDL   NILV     E    KIAD G +R     +
Sbjct: 126 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG----ENYVAKIADFGLSRGQEVYV 181

Query: 185 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 236
           K         +   + A E L     YT   D+W+ G +  E+++     +C
Sbjct: 182 K----KTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYC 228

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (281), Expect = 3e-30
 Identities = 48/228 (21%), Positives = 85/228 (37%), Gaps = 24/228 (10%)

Query: 21  DYE-GCKVGRGTYGHVYKARRKDNSDT-RDYALKQIEGT---GLSMSACREIALLRELKH 75
             E G  +G G +G V++       +     A+K  +      +     +E   +R+  H
Sbjct: 8   RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67

Query: 76  PNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQI 135
           P+++ LI V     +  VW++ +             R          +    +    YQ+
Sbjct: 68  PHIVKLIGVI---TENPVWIIMELCTLGELRSFLQVRKYS-------LDLASLILYAYQL 117

Query: 136 LDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVV 195
              + YL S   +HRD+   N+LV         VK+ D G +R   +     A      +
Sbjct: 118 STALAYLESKRFVHRDIAARNVLVS----SNDCVKLGDFGLSRYMEDSTYYKA--SKGKL 171

Query: 196 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS--EPIFHCRQEDI 241
              + APE +   R +T A D+W  G    E+L    +P    +  D+
Sbjct: 172 PIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 218

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (282), Expect = 6e-30
 Identities = 54/300 (18%), Positives = 111/300 (37%), Gaps = 42/300 (14%)

Query: 1   MDYEFKIKTSNERTKVE--DLFDYE-GCKVGRGTYGHVYKARRKDNSDT-RDYALKQIEG 56
           +  + +++T+N     E   + ++E    +G G YG V+  R+    DT + YA+K ++ 
Sbjct: 3   LTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKK 62

Query: 57  TGLSMSA------CREIALLRELKHPNVINLISVFLSHNDRKVWLLFDYAEHDLWHIIKF 110
             +   A        E  +L  ++    +  +        +   +L      +L+  +  
Sbjct: 63  ATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS- 121

Query: 111 HRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVK 170
                   +     +  V+  + +I+  + +LH   +++RD+K  NIL+       G V 
Sbjct: 122 --------QRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD----SNGHVV 169

Query: 171 IADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 230
           + D G ++ F       A  D      +     +  G   + KA+D W++G +  ELLT 
Sbjct: 170 LTDFGLSKEFVADETERAY-DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 228

Query: 231 EPIFHCRQEDIKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDFNEQICKM 290
              F    E          +    I   +        +++        L KD    I ++
Sbjct: 229 ASPFTVDGE---------KNSQAEISRRILKSEPPYPQEM------SALAKDL---IQRL 270

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (281), Expect = 8e-30
 Identities = 49/221 (22%), Positives = 83/221 (37%), Gaps = 25/221 (11%)

Query: 26  KVGRGTYGHVYKARRK---DNSDTRDYALKQIEGTGLSMSAC---REIALLRELK-HPNV 78
            +G G +G V +A       +      A+K ++ +           E+ +L  L  H N+
Sbjct: 30  TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89

Query: 79  INLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVM---------VPKGMV 128
           +NL+            ++ +Y  + DL + ++  R +    K            +    +
Sbjct: 90  VNLLGAC--TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 129 KSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLA 188
            S  YQ+  G+ +L S   +HRDL   NIL+          KI D G AR   N      
Sbjct: 148 LSFSYQVAKGMAFLASKNCIHRDLAARNILLT----HGRITKICDFGLARDIKND-SNYV 202

Query: 189 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                 +   + APE +     YT   D+W+ G    EL +
Sbjct: 203 VKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFS 242

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  112 bits (279), Expect = 3e-29
 Identities = 58/261 (22%), Positives = 110/261 (42%), Gaps = 22/261 (8%)

Query: 26  KVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSAC-REIALLRELKHPNVINLISV 84
           K+G G +  V+ A+   N+     A+K + G  +   A   EI LL+ +   +     S+
Sbjct: 20  KLGWGHFSTVWLAKDMVNN--THVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 77

Query: 85  FLSHNDRKVWLLFDYAEHDLWHII------KFHRAAKANKKPVMVPKGMVKSLLYQILDG 138
             +H  + +        + +  ++      +   A     +   +P   VK +  Q+L G
Sbjct: 78  GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137

Query: 139 IHYLHSNW-VLHRDLKPANILVMGEGIER--GRVKIADMGFARLFNNPLKPLADLDPVVV 195
           + Y+H    ++H D+KP N+L+          ++KIAD+G A  ++            + 
Sbjct: 138 LDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE------HYTNSIQ 191

Query: 196 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 255
           T  YR+PE+LLG   +    DIW+  C+  EL+T + +F   + D   S     D + +I
Sbjct: 192 TREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLF---EPDEGHSYTKDDDHIAQI 247

Query: 256 FSVMGFPLEKDWEDIRKMPEH 276
             ++G        + +     
Sbjct: 248 IELLGELPSYLLRNGKYTRTF 268

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (269), Expect = 4e-28
 Identities = 49/224 (21%), Positives = 93/224 (41%), Gaps = 17/224 (7%)

Query: 26  KVGRGTYGHVYKARRKD---NSDTRDYALKQI---EGTGLSMSACREIALLRELKHPNVI 79
           ++G+G++G VY+   K    +      A+K +         +    E ++++E    +V+
Sbjct: 27  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 86

Query: 80  NLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPK-GMVKSLLYQILD 137
            L+ V      +   ++ +     DL   ++  R A AN   +  P    +  +  +I D
Sbjct: 87  RLLGVV--SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 144

Query: 138 GIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTF 197
           G+ YL++N  +HRDL   N +V     E   VKI D G  R               ++  
Sbjct: 145 GMAYLNANKFVHRDLAARNCMVA----EDFTVKIGDFGMTRDIYET-DYYRKGGKGLLPV 199

Query: 198 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED 240
            + +PE L     +T   D+W+ G +  E+ T +E  +     +
Sbjct: 200 RWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 242

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 3e-26
 Identities = 45/224 (20%), Positives = 86/224 (38%), Gaps = 21/224 (9%)

Query: 21  DYE-GCKVGRGTYGHVYKARRK---DNSDTRDYALKQI---EGTGLSMSACREIALLREL 73
             + G  +GRG +G V +A        +  R  A+K +          +   E+ +L  +
Sbjct: 14  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73

Query: 74  KHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHR-------AAKANKKPVMVPK 125
            H   +  +    +     + ++ ++ +  +L   ++  R        A  +     +  
Sbjct: 74  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133

Query: 126 GMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPLK 185
             +    +Q+  G+ +L S   +HRDL   NIL+     E+  VKI D G AR       
Sbjct: 134 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS----EKNVVKICDFGLARDIYKD-P 188

Query: 186 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                    +   + APE +   R YT   D+W+ G +  E+ +
Sbjct: 189 DYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFS 231

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (253), Expect = 5e-26
 Identities = 53/227 (23%), Positives = 93/227 (40%), Gaps = 26/227 (11%)

Query: 21  DYE-GCKVGRGTYGHVYKAR-----RKDNSDTRDYALKQIEGTGLSMSAC---REIALLR 71
               G  +G G +G V  A      +   +     A+K ++             E+ +++
Sbjct: 14  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73

Query: 72  EL-KHPNVINLISVFLSHNDRKVWLLFDYAEH-DLWHIIKFHR-------AAKANKKPVM 122
            + KH N+INL+       D  ++++ +YA   +L   ++  R          ++     
Sbjct: 74  MIGKHKNIINLLGAC--TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131

Query: 123 VPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNN 182
           +    + S  YQ+  G+ YL S   +HRDL   N+LV  + +     KIAD G AR  ++
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVM----KIADFGLARDIHH 187

Query: 183 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 229
                       +   + APE L   R YT   D+W+ G +  E+ T
Sbjct: 188 I-DYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFT 232

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 82.1 bits (202), Expect = 2e-19
 Identities = 30/204 (14%), Positives = 60/204 (29%), Gaps = 28/204 (13%)

Query: 24  GCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIAL-----LRELKHPNV 78
           G  +G G    V+    +      +  +K  +    S    +E           L   + 
Sbjct: 5   GKLMGEGKESAVFNCYSEKF---GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 61

Query: 79  INLISVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDG 138
            N            V  ++ +  + +   +   +          V       +L  IL+ 
Sbjct: 62  RNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELY------RVRVENPDEVLDMILEE 115

Query: 139 IHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFARLFNNPL-KPLADLDPVVVTF 197
           +   +   ++H DL   N+LV  EGI      I D   +        + + + D   +  
Sbjct: 116 VAKFYHRGIVHGDLSQYNVLVSEEGI-----WIIDFPQSVEVGEEGWREILERDVRNIIT 170

Query: 198 WYRAPELLLGARHYTKAIDIWAIG 221
           ++         R Y    DI +  
Sbjct: 171 YFS--------RTYRTEKDINSAI 186

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	291
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.5
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.32
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.08
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.77
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.11
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.0

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-53  Score=349.47  Aligned_cols=240  Identities=26%  Similarity=0.471  Sum_probs=203.8

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCC-----CCCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEG-----TGLSMSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      .|++ ++.||+|+||.||+|.++.  +++.||+|++..     ......+.+|+.++++++||||+++++++  .+....
T Consensus         7 dy~i-~~~iG~G~fg~Vy~~~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~--~~~~~~   81 (263)
T d2j4za1           7 DFEI-GRPLGKGKFGNVYLAREKQ--SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF--HDATRV   81 (263)
T ss_dssp             GEEE-EEEEEECSSEEEEEEEETT--TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE--ECSSEE
T ss_pred             HeEE-EEEEecCCCcEEEEEEECC--CCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEE--EECCEE
Confidence            3664 7899999999999999876  678999999852     23445688999999999999999999999  567789


Q ss_pred             EEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          94 WLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        94 ~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      |+||||+++ +|.+.+.....         +++..++.++.|++.||+|||++||+||||||+||+++    .++.+||+
T Consensus        82 ~ivmEy~~~g~L~~~l~~~~~---------l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~----~~~~~kl~  148 (263)
T d2j4za1          82 YLILEYAPLGTVYRELQKLSK---------FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG----SAGELKIA  148 (263)
T ss_dssp             EEEEECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTSCEEEC
T ss_pred             EEEEeecCCCcHHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceec----CCCCEeec
Confidence            999999985 88888765432         89999999999999999999999999999999999998    66789999


Q ss_pred             ecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---------cC
Q psy2172         173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---------KT  243 (291)
Q Consensus       173 Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---------~~  243 (291)
                      |||++......     ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+...         ..
T Consensus       149 DFG~a~~~~~~-----~~~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~  222 (263)
T d2j4za1         149 DFGWSVHAPSS-----RRTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT  222 (263)
T ss_dssp             CCCSCSCCCCC-----CCEETTEEGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC
T ss_pred             ccceeeecCCC-----cccccCCCCcccCHHHHcCCC-CCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC
Confidence            99999765432     223457999999999998854 8999999999999999999999998765321         12


Q ss_pred             CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhh
Q psy2172         244 SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKD  282 (291)
Q Consensus       244 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (291)
                      ......+.+.+++..|..+.|..||++.++.+|||+...
T Consensus       223 ~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~~  261 (263)
T d2j4za1         223 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN  261 (263)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCCc
Confidence            233446788999999999999999999999999998753

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-54  Score=354.40  Aligned_cols=248  Identities=22%  Similarity=0.348  Sum_probs=203.5

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC---CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG---LSMSACREIALLRELKHPNVINLISVFLSHNDRKVW   94 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (291)
                      +.|++ .+.||+|+||.||+|.++.  +++.||||++....   ..+.+.+|+++|++++||||+++++++  .+....|
T Consensus         5 ~dy~~-~~~lG~G~fg~V~~~~~~~--~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~--~~~~~~~   79 (271)
T d1nvra_           5 EDWDL-VQTLGEGAYGEVQLAVNRV--TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR--REGNIQY   79 (271)
T ss_dssp             TEEEE-EEEEEEETTEEEEEEEETT--TCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEE--EETTEEE
T ss_pred             cceEE-EEEEecCcCeEEEEEEECC--CCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeee--ccCceeE
Confidence            45665 6799999999999999877  67899999986432   335688999999999999999999999  4567899


Q ss_pred             EEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEee
Q psy2172          95 LLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIAD  173 (291)
Q Consensus        95 iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~D  173 (291)
                      +||||+++ +|.+.+....         .+++..++.++.|++.||+|||++||+||||||+||+++    .++.+||+|
T Consensus        80 ivmEy~~gg~L~~~l~~~~---------~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~----~~~~~KL~D  146 (271)
T d1nvra_          80 LFLEYCSGGELFDRIEPDI---------GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD----ERDNLKISD  146 (271)
T ss_dssp             EEEECCTTEEGGGGSBTTT---------BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC----TTCCEEECC
T ss_pred             EEEeccCCCcHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEEC----CCCCEEEcc
Confidence            99999985 8877664321         289999999999999999999999999999999999998    667899999


Q ss_pred             cccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc-----------
Q psy2172         174 MGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK-----------  242 (291)
Q Consensus       174 fg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~-----------  242 (291)
                      ||+|+........ .......||+.|+|||++.+...++.++|||||||++|+|++|+.||........           
T Consensus       147 FG~a~~~~~~~~~-~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~  225 (271)
T d1nvra_         147 FGLATVFRYNNRE-RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY  225 (271)
T ss_dssp             CTTCEECEETTEE-CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT
T ss_pred             chhheeeccCCcc-ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC
Confidence            9999876433211 2234568999999999998866557889999999999999999999987654311           


Q ss_pred             -CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhhhh
Q psy2172         243 -TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDFN  284 (291)
Q Consensus       243 -~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (291)
                       ...+..++.+.+++..|..+.|..||++.++..|||+.+.+.
T Consensus       226 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~l~  268 (271)
T d1nvra_         226 LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK  268 (271)
T ss_dssp             STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcCCC
Confidence             111223567888999999999999999999999999977654

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-53  Score=350.04  Aligned_cols=243  Identities=23%  Similarity=0.382  Sum_probs=202.8

Q ss_pred             ccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC--CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCce
Q psy2172          15 KVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT--GLSMSACREIALLRELKHPNVINLISVFLSHNDRK   92 (291)
Q Consensus        15 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (291)
                      ...++|++ .++||+|+||.||+|.++.  +++.||||+++..  ...+.+.+|+.++++++||||+++++++  .+...
T Consensus        17 dp~~~Y~~-~~~iG~G~fg~Vy~a~~~~--~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~--~~~~~   91 (293)
T d1yhwa1          17 DPKKKYTR-FEKIGQGASGTVYTAMDVA--TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY--LVGDE   91 (293)
T ss_dssp             CTTTTBCS-CEECCCSSSCEEEEEEBTT--TCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEE--EETTE
T ss_pred             CcccccEE-EEEEecCcCcEEEEEEECC--CCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEE--EECCE
Confidence            34567885 6799999999999999776  6789999998643  2345689999999999999999999999  45668


Q ss_pred             EEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEE
Q psy2172          93 VWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI  171 (291)
Q Consensus        93 ~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l  171 (291)
                      .|+||||++| +|.+++...          .+++..++.++.|++.||+|||++||+||||||+||+++    .++.+||
T Consensus        92 ~~ivmEy~~gg~L~~~~~~~----------~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~----~~~~vkl  157 (293)
T d1yhwa1          92 LWVVMEYLAGGSLTDVVTET----------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG----MDGSVKL  157 (293)
T ss_dssp             EEEEEECCTTCBHHHHHHHS----------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTCCEEE
T ss_pred             EEEEEEecCCCcHHHHhhcc----------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEEC----CCCcEee
Confidence            9999999986 776655432          189999999999999999999999999999999999998    6678999


Q ss_pred             eecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc----------
Q psy2172         172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI----------  241 (291)
Q Consensus       172 ~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~----------  241 (291)
                      +|||+++......   .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.....          
T Consensus       158 ~DFG~a~~~~~~~---~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~  233 (293)
T d1yhwa1         158 TDFGFCAQITPEQ---SKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT  233 (293)
T ss_dssp             CCCTTCEECCSTT---CCBCCCCSCGGGCCHHHHSSSC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS
T ss_pred             ccchhheeecccc---ccccccccCCCccChhhhcCCC-CCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC
Confidence            9999998765432   2234567999999999998854 8999999999999999999999998765321          


Q ss_pred             --cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchh
Q psy2172         242 --KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLL  280 (291)
Q Consensus       242 --~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  280 (291)
                        ........+.+.+++..|..+.|..||++.++..|||+.
T Consensus       234 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~  274 (293)
T d1yhwa1         234 PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK  274 (293)
T ss_dssp             CCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGG
T ss_pred             CCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhC
Confidence              111223457789999999999999999999999999984

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-53  Score=346.70  Aligned_cols=246  Identities=27%  Similarity=0.477  Sum_probs=193.6

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC----hhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      +.|++ .+.||+|+||.||+|+++.  +++.||+|.+......    +.+.+|++++++++||||+++++++.++....+
T Consensus         4 edy~~-~~~iG~G~fg~Vy~~~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~   80 (269)
T d2java1           4 EDYEV-LYTIGTGSYGRCQKIRRKS--DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL   80 (269)
T ss_dssp             GGEEE-EEEEEECSSEEEEEEEETT--TCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CE
T ss_pred             hhCEE-eEEEecCCCeEEEEEEECC--CCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEE
Confidence            34664 5799999999999999877  6788999999765433    347889999999999999999999976667789


Q ss_pred             EEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----eeeeccCCCcEEeecCCCCCC
Q psy2172          94 WLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNW-----VLHRDLKPANILVMGEGIERG  167 (291)
Q Consensus        94 ~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~-----ivH~dik~~Nil~~~~~~~~~  167 (291)
                      |+||||+++ +|.+++........     .+++..++.++.|++.||+|||++|     |+||||||+||+++    .++
T Consensus        81 ~ivmEy~~~g~L~~~i~~~~~~~~-----~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~----~~~  151 (269)
T d2java1          81 YIVMEYCEGGDLASVITKGTKERQ-----YLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD----GKQ  151 (269)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHHTC-----CCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEEC----TTS
T ss_pred             EEEEecCCCCcHHHHHHhccccCC-----CCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcC----CCC
Confidence            999999985 88888876543322     2899999999999999999999876     99999999999998    678


Q ss_pred             cEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc-------
Q psy2172         168 RVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED-------  240 (291)
Q Consensus       168 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~-------  240 (291)
                      .+||+|||+++......   .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..       
T Consensus       152 ~vkl~DFG~a~~~~~~~---~~~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~  227 (269)
T d2java1         152 NVKLGDFGLARILNHDT---SFAKAFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR  227 (269)
T ss_dssp             CEEECCHHHHHHC--------------CCCSCCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             cEEEeeccceeecccCC---CccccCCCCcccCCHHHHcCCC-CChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence            99999999998765422   1224567899999999998754 899999999999999999999999876532       


Q ss_pred             ---ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         241 ---IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       241 ---~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                         .........+.+.+++..|..+.|..||++.++.+|||+
T Consensus       228 ~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         228 EGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence               122334456789999999999999999999999999985

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-52  Score=348.74  Aligned_cols=246  Identities=24%  Similarity=0.411  Sum_probs=202.0

Q ss_pred             ccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC--CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEE
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG--LSMSACREIALLRELKHPNVINLISVFLSHNDRKVW   94 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (291)
                      .+.|++ .+.||+|+||.||+|.++.  +++.||+|+++...  ..+.+.+|+++|++++||||+++++++  .+....|
T Consensus        11 ~d~Y~i-~~~iG~G~fg~Vy~~~~~~--~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~--~~~~~~~   85 (288)
T d2jfla1          11 EDFWEI-IGELGDGAFGKVYKAQNKE--TSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF--YYENNLW   85 (288)
T ss_dssp             GGTEEE-EEEEEEETTEEEEEEEETT--TCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEE--EETTEEE
T ss_pred             ccCeEE-eEEEeeCCCcEEEEEEECC--CCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE--eeCCeEE
Confidence            356775 5699999999999999877  67889999986542  335788999999999999999999999  4567899


Q ss_pred             EEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEee
Q psy2172          95 LLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIAD  173 (291)
Q Consensus        95 iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~D  173 (291)
                      +||||+++ +|.+++.....        .+++..+..++.|++.||+|||++||+||||||+||+++    .++.+||+|
T Consensus        86 lvmEy~~~g~L~~~~~~~~~--------~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~----~~~~~Kl~D  153 (288)
T d2jfla1          86 ILIEFCAGGAVDAVMLELER--------PLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFT----LDGDIKLAD  153 (288)
T ss_dssp             EEEECCTTEEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEECC
T ss_pred             EEEecCCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeEC----CCCCEEEEe
Confidence            99999986 77766554322        289999999999999999999999999999999999998    667899999


Q ss_pred             cccceecCCCCCCCCCCCCceecccccccccccC----CcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc--------
Q psy2172         174 MGFARLFNNPLKPLADLDPVVVTFWYRAPELLLG----ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI--------  241 (291)
Q Consensus       174 fg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~--------  241 (291)
                      ||+|.......   .......||+.|+|||++.+    ...++.++|||||||++|+|++|+.||.+.....        
T Consensus       154 FG~a~~~~~~~---~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~  230 (288)
T d2jfla1         154 FGVSAKNTRTI---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS  230 (288)
T ss_dssp             CTTCEECHHHH---HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS
T ss_pred             chhhhccCCCc---ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC
Confidence            99997653311   11234578999999999842    2348899999999999999999999998765321        


Q ss_pred             ----cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhh
Q psy2172         242 ----KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKD  282 (291)
Q Consensus       242 ----~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (291)
                          ........+.+.+++..|..+.|..||++.++.+|||+...
T Consensus       231 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~  275 (288)
T d2jfla1         231 EPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD  275 (288)
T ss_dssp             CCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred             CCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence                11122345778999999999999999999999999998643

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-52  Score=348.77  Aligned_cols=255  Identities=26%  Similarity=0.409  Sum_probs=209.5

Q ss_pred             cccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC--------CChhHHHHHHHHhcCCCCCeeeEEE
Q psy2172          12 ERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG--------LSMSACREIALLRELKHPNVINLIS   83 (291)
Q Consensus        12 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~e~~~l~~l~h~~iv~~~~   83 (291)
                      ....++++|++ ++.||+|+||.||+|.++.  +++.||||+++...        ..+.+.+|+.+|++++||||+++++
T Consensus         4 ~~~~i~d~Y~~-~~~lG~G~fg~Vy~~~~~~--~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~   80 (293)
T d1jksa_           4 RQENVDDYYDT-GEELGSGQFAVVKKCREKS--TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE   80 (293)
T ss_dssp             BCSCGGGTEEE-EEEEEECSSEEEEEEEETT--TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cCCCcccCEEE-eEEEecCCCeEEEEEEECC--CCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence            34567888996 7899999999999999876  77899999985332        1246889999999999999999999


Q ss_pred             EEEeCCCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecC
Q psy2172          84 VFLSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGE  162 (291)
Q Consensus        84 ~~~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~  162 (291)
                      ++  .+...+|+||||+++ +|.+++.....         +++..++.++.|++.||+|||++||+||||||+||+++.+
T Consensus        81 ~~--~~~~~~~iv~E~~~gg~L~~~i~~~~~---------l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~  149 (293)
T d1jksa_          81 VY--ENKTDVILILELVAGGELFDFLAEKES---------LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDR  149 (293)
T ss_dssp             EE--ECSSEEEEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCS
T ss_pred             EE--EECCEEEEEEEcCCCccccchhccccc---------cchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecC
Confidence            99  667899999999985 88888765432         8999999999999999999999999999999999999866


Q ss_pred             CCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc
Q psy2172         163 GIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK  242 (291)
Q Consensus       163 ~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~  242 (291)
                      +.....+|++|||++......    .......||+.|+|||++.+. .++.++||||+||++|+|++|..||.+......
T Consensus       150 ~~~~~~vkl~DfG~a~~~~~~----~~~~~~~~t~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~  224 (293)
T d1jksa_         150 NVPKPRIKIIDFGLAHKIDFG----NEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQET  224 (293)
T ss_dssp             SSSSCCEEECCCTTCEECTTS----CBCSCCCCCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             CCcccceEecchhhhhhcCCC----ccccccCCCCcccCHHHHcCC-CCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH
Confidence            545567999999999876543    223456789999999999874 489999999999999999999999987653210


Q ss_pred             -----C--------CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhhhhh
Q psy2172         243 -----T--------SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDFNE  285 (291)
Q Consensus       243 -----~--------~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (291)
                           .        ..+..+..+.+++..|..+.|..||++.++..|||+.+.-.+
T Consensus       225 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~  280 (293)
T d1jksa_         225 LANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ  280 (293)
T ss_dssp             HHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC----
T ss_pred             HHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChh
Confidence                 0        112234668899999999999999999999999998754433

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-52  Score=352.19  Aligned_cols=248  Identities=26%  Similarity=0.405  Sum_probs=193.2

Q ss_pred             ccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC---CChhHHHHHHHHhcCCCCCeeeEEEEEEeCC
Q psy2172          13 RTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG---LSMSACREIALLRELKHPNVINLISVFLSHN   89 (291)
Q Consensus        13 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   89 (291)
                      ...+.++|++ .+.||+|+||.||+|.++.  +++.||||++....   ....+.+|+.+|++++||||+++++++  .+
T Consensus         4 ~edi~d~Y~~-~~~lG~G~fg~Vy~~~~~~--~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~--~~   78 (307)
T d1a06a_           4 AEDIRDIYDF-RDVLGTGAFSEVILAEDKR--TQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY--ES   78 (307)
T ss_dssp             CSCGGGTEEE-EEESBSGGGGGEEEEEETT--TCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEE--EC
T ss_pred             CCCCccceEE-EEEEeeccCeEEEEEEECC--CCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEE--EE
Confidence            4567788886 6799999999999999876  67889999986542   234577899999999999999999999  56


Q ss_pred             CceEEEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCc
Q psy2172          90 DRKVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGR  168 (291)
Q Consensus        90 ~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~  168 (291)
                      ...+|+||||++ |+|.+.+....         .+++..+..++.|++.||+|||++||+||||||+||++.... .++.
T Consensus        79 ~~~~~lvmE~~~gg~L~~~l~~~~---------~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~-~~~~  148 (307)
T d1a06a_          79 GGHLYLIMQLVSGGELFDRIVEKG---------FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLD-EDSK  148 (307)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHTCS---------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSS-TTCC
T ss_pred             CCEEEEEEeccCCCcHHHhhhccc---------CCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccC-CCce
Confidence            789999999998 58888886422         299999999999999999999999999999999999997432 4678


Q ss_pred             EEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc-------
Q psy2172         169 VKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI-------  241 (291)
Q Consensus       169 ~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~-------  241 (291)
                      +||+|||+++.....    .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.....       
T Consensus       149 vkl~DFG~a~~~~~~----~~~~~~~GT~~y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~  223 (307)
T d1a06a_         149 IMISDFGLSKMEDPG----SVLSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK  223 (307)
T ss_dssp             EEECCC----------------------CTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHT
T ss_pred             EEEeccceeEEccCC----CeeeeeeeCccccCcHHHcCCC-CCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhc
Confidence            999999999865432    2234467999999999998754 8999999999999999999999998764321       


Q ss_pred             ------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchh
Q psy2172         242 ------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLL  280 (291)
Q Consensus       242 ------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  280 (291)
                            ....+..++.+.+++..|..+.|..||++.++..|||+.
T Consensus       224 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~  268 (307)
T d1a06a_         224 AEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA  268 (307)
T ss_dssp             TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTT
T ss_pred             cCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhC
Confidence                  111233457789999999999999999999999999885

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-52  Score=344.06  Aligned_cols=241  Identities=27%  Similarity=0.425  Sum_probs=197.4

Q ss_pred             cccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCC-----CCCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCC
Q psy2172          16 VEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEG-----TGLSMSACREIALLRELKHPNVINLISVFLSHND   90 (291)
Q Consensus        16 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   90 (291)
                      -.+.|++ ++.||+|+||.||+|.++.  +++.||||++..     ....+.+.+|+++|++++||||+++++++  .+.
T Consensus         6 ~p~dy~i-~~~lG~G~fg~Vy~a~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~--~~~   80 (288)
T d1uu3a_           6 RPEDFKF-GKILGEGSFSTVVLARELA--TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF--QDD   80 (288)
T ss_dssp             CGGGEEE-EEEEEECSSCEEEEEEETT--TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEE--ECS
T ss_pred             CCCCCEE-EEEEeeCCCeEEEEEEECC--CCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEE--EEC
Confidence            3356775 7799999999999999876  678899999863     23345688999999999999999999999  567


Q ss_pred             ceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcE
Q psy2172          91 RKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRV  169 (291)
Q Consensus        91 ~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~  169 (291)
                      ..+|+||||++| +|.+++.....         +++..++.++.|++.||+|||++||+||||||+||+++    .++.+
T Consensus        81 ~~~~ivmEy~~gg~L~~~~~~~~~---------l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~----~~~~v  147 (288)
T d1uu3a_          81 EKLYFGLSYAKNGELLKYIRKIGS---------FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN----EDMHI  147 (288)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTSCE
T ss_pred             CEEEEEEEccCCCCHHHhhhccCC---------CCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccC----CCceE
Confidence            899999999985 88877665432         89999999999999999999999999999999999998    67789


Q ss_pred             EEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc--------
Q psy2172         170 KIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI--------  241 (291)
Q Consensus       170 ~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~--------  241 (291)
                      +|+|||+++....... ........||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+...        
T Consensus       148 kl~DFG~a~~~~~~~~-~~~~~~~~GT~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~  225 (288)
T d1uu3a_         148 QITDFGTAKVLSPESK-QARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL  225 (288)
T ss_dssp             EECCCTTCEECC-----------CCCCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT
T ss_pred             EecccccceecccCCc-ccccccccCCccccCceeeccCC-CCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC
Confidence            9999999987654321 12233457999999999998855 8999999999999999999999998765321        


Q ss_pred             -cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCC
Q psy2172         242 -KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEH  276 (291)
Q Consensus       242 -~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  276 (291)
                       ........+.+.+++..|..+.|..||+++++..+
T Consensus       226 ~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         226 EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             CCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence             12223446778999999999999999999986443

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-51  Score=339.46  Aligned_cols=244  Identities=25%  Similarity=0.377  Sum_probs=199.0

Q ss_pred             ccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC----ChhHHHHHHHHhcCCCCCeeeEEEEEEe--C
Q psy2172          15 KVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL----SMSACREIALLRELKHPNVINLISVFLS--H   88 (291)
Q Consensus        15 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~   88 (291)
                      ..+++|.-..++||+|+||+||+|.++.  +++.||+|.+.....    .+.+.+|+++|++++||||+++++++..  .
T Consensus         5 ~~~gry~~~~~~iG~G~fg~Vy~~~~~~--~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   82 (270)
T d1t4ha_           5 SNDGRFLKFDIEIGRGSFKTVYKGLDTE--TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK   82 (270)
T ss_dssp             CTTSCEEEEEEEEEECSSEEEEEEEETT--TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS
T ss_pred             CCCCCEEEeeeEEecCcCcEEEEEEECC--CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccc
Confidence            4456664235689999999999999876  678899999865432    2357899999999999999999999854  3


Q ss_pred             CCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeeccCCCcEEeecCCCC
Q psy2172          89 NDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNW--VLHRDLKPANILVMGEGIE  165 (291)
Q Consensus        89 ~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~dik~~Nil~~~~~~~  165 (291)
                      +...+|+||||+++ +|.+.+.....         +++..++.++.|++.||+|||+++  |+||||||+||+++.   .
T Consensus        83 ~~~~~~ivmE~~~~g~L~~~l~~~~~---------~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~---~  150 (270)
T d1t4ha_          83 GKKCIVLVTELMTSGTLKTYLKRFKV---------MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG---P  150 (270)
T ss_dssp             SCEEEEEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS---T
T ss_pred             cCCEEEEEEeCCCCCcHHHHHhcccc---------ccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeC---C
Confidence            45678999999985 88887765432         899999999999999999999998  999999999999963   3


Q ss_pred             CCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc----
Q psy2172         166 RGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI----  241 (291)
Q Consensus       166 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~----  241 (291)
                      ++.+||+|||+++.....     ......||+.|+|||++.+ + ++.++|||||||++|+|++|+.||.+.....    
T Consensus       151 ~~~~Kl~DFGla~~~~~~-----~~~~~~GT~~Y~aPE~~~~-~-~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~  223 (270)
T d1t4ha_         151 TGSVKIGDLGLATLKRAS-----FAKAVIGTPEFMAPEMYEE-K-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR  223 (270)
T ss_dssp             TSCEEECCTTGGGGCCTT-----SBEESCSSCCCCCGGGGGT-C-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH
T ss_pred             CCCEEEeecCcceeccCC-----ccCCcccCccccCHHHhCC-C-CCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHH
Confidence            568999999999754332     2234578999999999976 3 8999999999999999999999997654321    


Q ss_pred             --------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcch
Q psy2172         242 --------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTL  279 (291)
Q Consensus       242 --------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  279 (291)
                              ........+.+.+++..|..+.|..||++.++.+|||+
T Consensus       224 ~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~f  269 (270)
T d1t4ha_         224 RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF  269 (270)
T ss_dssp             HHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             HHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCccc
Confidence                    11122335678999999999999999999999999986

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.3e-52  Score=347.05  Aligned_cols=242  Identities=25%  Similarity=0.460  Sum_probs=200.8

Q ss_pred             cccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC-----hhHHHHHHHHhcCCCCCeeeEEEEEEeCCC
Q psy2172          16 VEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS-----MSACREIALLRELKHPNVINLISVFLSHND   90 (291)
Q Consensus        16 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   90 (291)
                      ..++|+. .+.||+|+||.||+|.++.  +++.||||+++.....     +.+.+|+.+|++++|||||++++++.  +.
T Consensus        13 p~~~y~~-l~~lG~G~fg~Vy~a~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~--~~   87 (309)
T d1u5ra_          13 PEKLFSD-LREIGHGSFGAVYFARDVR--NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL--RE   87 (309)
T ss_dssp             HHHHEEE-EEEEEECSSSEEEEEEETT--TTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE--ET
T ss_pred             cHHhcEe-eEEEecCCCeEEEEEEECC--CCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEE--EC
Confidence            3456774 6799999999999999876  7789999998754332     35789999999999999999999994  46


Q ss_pred             ceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEE
Q psy2172          91 RKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVK  170 (291)
Q Consensus        91 ~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~  170 (291)
                      ...|+|||||.+++...+.....        .+++..++.++.|++.||.|||++||+||||||+|||++    .++.+|
T Consensus        88 ~~~~iv~E~~~~g~l~~~~~~~~--------~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~----~~~~~K  155 (309)
T d1u5ra_          88 HTAWLVMEYCLGSASDLLEVHKK--------PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS----EPGLVK  155 (309)
T ss_dssp             TEEEEEEECCSEEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE----TTTEEE
T ss_pred             CEEEEEEEecCCCchHHHHHhCC--------CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEC----CCCCEE
Confidence            78999999999866654443221        289999999999999999999999999999999999999    678999


Q ss_pred             EeecccceecCCCCCCCCCCCCceecccccccccccCC--cCCCCchhHHHHHHHHHHHHcCCCCCCCCccc--------
Q psy2172         171 IADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQED--------  240 (291)
Q Consensus       171 l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~--------  240 (291)
                      |+|||++.....       .....||+.|+|||++.+.  ..++.++|||||||++|+|++|..||.+....        
T Consensus       156 l~DFG~a~~~~~-------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~  228 (309)
T d1u5ra_         156 LGDFGSASIMAP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ  228 (309)
T ss_dssp             ECCCTTCBSSSS-------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred             EeecccccccCC-------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence            999999976443       2345789999999998642  34889999999999999999999999876432        


Q ss_pred             ---ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         241 ---IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       241 ---~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                         ........++.+.+++..|..+.|..||++.++..|||+.+
T Consensus       229 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~  272 (309)
T d1u5ra_         229 NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (309)
T ss_dssp             SCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             CCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence               11223345678999999999999999999999999998764

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-52  Score=350.46  Aligned_cols=244  Identities=22%  Similarity=0.351  Sum_probs=201.6

Q ss_pred             cccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC---CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCce
Q psy2172          16 VEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG---LSMSACREIALLRELKHPNVINLISVFLSHNDRK   92 (291)
Q Consensus        16 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (291)
                      .++.|++ .++||+|+||.||+|.++.  +++.||+|+++...   ....+.+|+.+|++++||||++++++|  .+...
T Consensus         4 ~~d~y~~-~~~iG~G~fg~V~~~~~~~--~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~--~~~~~   78 (322)
T d1s9ja_           4 KDDDFEK-ISELGAGNGGVVFKVSHKP--SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF--YSDGE   78 (322)
T ss_dssp             CGGGEEE-EEEEECCSSCCEEEEEETT--TTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEE--ECSSE
T ss_pred             CccCCEE-EEEEecCCCeEEEEEEECC--CCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE--EECCE
Confidence            3567775 5799999999999999876  77899999986542   234688999999999999999999999  56778


Q ss_pred             EEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCeeeeccCCCcEEeecCCCCCCcEE
Q psy2172          93 VWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHS-NWVLHRDLKPANILVMGEGIERGRVK  170 (291)
Q Consensus        93 ~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~-~~ivH~dik~~Nil~~~~~~~~~~~~  170 (291)
                      +|+||||+.| +|.+++.....         +++..++.++.|++.||.|||+ +||+||||||+||+++    .++.+|
T Consensus        79 ~~iVmEy~~gg~L~~~l~~~~~---------l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~----~~~~vk  145 (322)
T d1s9ja_          79 ISICMEHMDGGSLDQVLKKAGR---------IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN----SRGEIK  145 (322)
T ss_dssp             EEEEEECCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEEC----TTCCEE
T ss_pred             EEEEEEcCCCCcHHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeEC----CCCCEE
Confidence            9999999986 88877764322         8999999999999999999997 5999999999999998    678999


Q ss_pred             EeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc--------
Q psy2172         171 IADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK--------  242 (291)
Q Consensus       171 l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~--------  242 (291)
                      |+|||+|......     ......||+.|+|||++.+.+ ++.++||||+||++|+|++|+.||.+.+....        
T Consensus       146 l~DFGla~~~~~~-----~~~~~~GT~~Y~APEvl~~~~-y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~  219 (322)
T d1s9ja_         146 LCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV  219 (322)
T ss_dssp             ECCCCCCHHHHHH-----TC---CCSSCCCCHHHHHCSC-CCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----
T ss_pred             EeeCCCccccCCC-----ccccccCCccccCchHHcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHh
Confidence            9999999865432     223468999999999999855 99999999999999999999999976543210        


Q ss_pred             ---------------------------------------------CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCc
Q psy2172         243 ---------------------------------------------TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHP  277 (291)
Q Consensus       243 ---------------------------------------------~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  277 (291)
                                                                   ......+..+.+++..|....|..||+++++..||
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hp  299 (322)
T d1s9ja_         220 EGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA  299 (322)
T ss_dssp             --------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             cCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCH
Confidence                                                         00011245678899999999999999999999999


Q ss_pred             chhhhh
Q psy2172         278 TLLKDF  283 (291)
Q Consensus       278 ~~~~~~  283 (291)
                      |+.+.-
T Consensus       300 f~~~~~  305 (322)
T d1s9ja_         300 FIKRSD  305 (322)
T ss_dssp             HHHHHH
T ss_pred             hhCcCC
Confidence            987543

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.3e-51  Score=348.93  Aligned_cols=248  Identities=20%  Similarity=0.343  Sum_probs=204.5

Q ss_pred             cccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC--ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCc
Q psy2172          14 TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL--SMSACREIALLRELKHPNVINLISVFLSHNDR   91 (291)
Q Consensus        14 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (291)
                      ..+-++|++ .+.||+|+||.||+|.++.  +++.||||++.....  .+.+.+|+.+|++++||||+++++++  .+..
T Consensus        22 ~~il~~Y~i-~~~lG~G~fg~Vy~~~~~~--~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~--~~~~   96 (350)
T d1koaa2          22 DHVLDHYDI-HEELGTGAFGVVHRVTERA--TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF--EDDN   96 (350)
T ss_dssp             SCGGGTEEE-EEEEEEETTEEEEEEEETT--TTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE--EETT
T ss_pred             CCCccCeEE-EEEEecCcCeEEEEEEECC--CCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE--EECC
Confidence            345577886 6799999999999999876  778999999975433  24578999999999999999999999  4577


Q ss_pred             eEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEE
Q psy2172          92 KVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVK  170 (291)
Q Consensus        92 ~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~  170 (291)
                      .+|+||||++| +|.+.+....        ..+++..++.++.||+.||+|||++||+||||||+||+++.+  ..+.+|
T Consensus        97 ~~~ivmE~~~gg~L~~~l~~~~--------~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~--~~~~vk  166 (350)
T d1koaa2          97 EMVMIYEFMSGGELFEKVADEH--------NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK--RSNELK  166 (350)
T ss_dssp             EEEEEECCCCSCBHHHHHTCTT--------SCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST--TSCCEE
T ss_pred             EEEEEEEcCCCCCHHHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccC--CCCeEE
Confidence            89999999985 8877774322        128999999999999999999999999999999999999743  347899


Q ss_pred             EeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---------
Q psy2172         171 IADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---------  241 (291)
Q Consensus       171 l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---------  241 (291)
                      |+|||++......    .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+...         
T Consensus       167 L~DFG~a~~~~~~----~~~~~~~gT~~Y~aPEv~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~  241 (350)
T d1koaa2         167 LIDFGLTAHLDPK----QSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD  241 (350)
T ss_dssp             ECCCTTCEECCTT----SCEEEECSCTTTCCHHHHHTCC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred             Eeecchheecccc----cccceecCcccccCHHHHcCCC-CChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence            9999999876543    1223467899999999998855 8999999999999999999999998765321         


Q ss_pred             ----cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         242 ----KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       242 ----~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                          ....+...+.+.+++..|..+.|..||++.++..|||+..
T Consensus       242 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~  285 (350)
T d1koaa2         242 WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP  285 (350)
T ss_dssp             CCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSC
T ss_pred             CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence                0011223567889999999999999999999999988754

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=6.9e-51  Score=347.22  Aligned_cols=249  Identities=23%  Similarity=0.333  Sum_probs=205.3

Q ss_pred             cccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC--ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCc
Q psy2172          14 TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL--SMSACREIALLRELKHPNVINLISVFLSHNDR   91 (291)
Q Consensus        14 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (291)
                      ..+.+.|++ .+.||+|+||.||+|.++.  +++.||||+++....  ...+.+|+.+|++++||||++++++|  .+..
T Consensus        25 ~~~~d~Y~i-~~~lG~G~fg~V~~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~--~~~~   99 (352)
T d1koba_          25 GSVYDYYDI-LEELGSGAFGVVHRCVEKA--TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF--EDKY   99 (352)
T ss_dssp             SCGGGTEEE-EEEEEEETTEEEEEEEETT--TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE--ECSS
T ss_pred             CCcccceEE-EEEEecCCCeEEEEEEECC--CCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEE--EECC
Confidence            345667885 6799999999999999876  678999999875432  23577899999999999999999999  5678


Q ss_pred             eEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEE
Q psy2172          92 KVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVK  170 (291)
Q Consensus        92 ~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~  170 (291)
                      .+|+|||||+| +|.+.+....        ..+++..++.++.||+.||+|||++||+||||||+|||++..  ..+.++
T Consensus       100 ~~~ivmE~~~gg~L~~~~~~~~--------~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~--~~~~vk  169 (352)
T d1koba_         100 EMVLILEFLSGGELFDRIAAED--------YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK--KASSVK  169 (352)
T ss_dssp             EEEEEEECCCCCBHHHHTTCTT--------CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST--TCCCEE
T ss_pred             EEEEEEEcCCCChHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccccccccccccc--CCCeEE
Confidence            99999999985 7766544221        238999999999999999999999999999999999999743  357899


Q ss_pred             EeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---------
Q psy2172         171 IADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---------  241 (291)
Q Consensus       171 l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---------  241 (291)
                      |+|||++......    .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.....         
T Consensus       170 L~DFGla~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~  244 (352)
T d1koba_         170 IIDFGLATKLNPD----EIVKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD  244 (352)
T ss_dssp             ECCCTTCEECCTT----SCEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCC
T ss_pred             EeecccceecCCC----CceeeccCcccccCHHHHcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence            9999999876543    1223457899999999998754 8999999999999999999999998765321         


Q ss_pred             ----cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhh
Q psy2172         242 ----KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKD  282 (291)
Q Consensus       242 ----~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (291)
                          ....+.....+.+++..|..+.|..||++.++.+|||+...
T Consensus       245 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         245 WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence                11122346778999999999999999999999999988644

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-50  Score=338.42  Aligned_cols=240  Identities=24%  Similarity=0.370  Sum_probs=201.6

Q ss_pred             cccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC-----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEE
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT-----GLSMSACREIALLRELKHPNVINLISVFLSHNDRKVW   94 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (291)
                      |++ .+.||+|+||.||+|+++.  +++.||+|++++.     .....+.+|+.+|++++||||+++++++  .+...+|
T Consensus         7 y~~-~~~lG~G~fg~V~~~~~~~--~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~--~~~~~~~   81 (337)
T d1o6la_           7 FDY-LKLLGKGTFGKVILVREKA--TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF--QTHDRLC   81 (337)
T ss_dssp             EEE-EEEEEECSSEEEEEEEETT--TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE--ECSSEEE
T ss_pred             cEE-EEEEecCcCeEEEEEEECC--CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee--ccccccc
Confidence            554 6799999999999999877  7789999998632     2345688999999999999999999999  6778999


Q ss_pred             EEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEee
Q psy2172          95 LLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIAD  173 (291)
Q Consensus        95 iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~D  173 (291)
                      +||||+.| +|...+.....         +++..++.++.|++.||+|||++||+||||||+||+++    .++.+||+|
T Consensus        82 iv~ey~~gg~L~~~~~~~~~---------~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~----~~g~vkl~D  148 (337)
T d1o6la_          82 FVMEYANGGELFFHLSRERV---------FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD----KDGHIKITD  148 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTSCEEECC
T ss_pred             cceeccCCCchhhhhhcccC---------CcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEec----CCCCEEEee
Confidence            99999985 77777665432         89999999999999999999999999999999999998    678999999


Q ss_pred             cccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc---------cCC
Q psy2172         174 MGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI---------KTS  244 (291)
Q Consensus       174 fg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~---------~~~  244 (291)
                      ||+|+......   .......||+.|+|||++.+.+ ++.++|+|||||++|+|++|.+||.+.+...         ...
T Consensus       149 FG~a~~~~~~~---~~~~~~~GT~~Y~aPE~~~~~~-y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~  224 (337)
T d1o6la_         149 FGLCKEGISDG---ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF  224 (337)
T ss_dssp             CTTCBCSCCTT---CCBCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred             cccccccccCC---cccccceeCHHHhhhhhccCCC-CChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCC
Confidence            99998654322   2234578999999999998855 8999999999999999999999998876431         122


Q ss_pred             CCCcHHHHHHHHHhhCCCCcCChhh-----hhcCCCCcchhh
Q psy2172         245 NPYHHDQLDRIFSVMGFPLEKDWED-----IRKMPEHPTLLK  281 (291)
Q Consensus       245 ~~~~~~~~~~i~~~~~~~~~~~~~~-----~~~~~~~~~~~~  281 (291)
                      ....+....+++..|..+.|..|++     ++++..|||+..
T Consensus       225 p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~  266 (337)
T d1o6la_         225 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             CccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCccccc
Confidence            3344667889999999999999985     677888888754

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-50  Score=334.33  Aligned_cols=237  Identities=17%  Similarity=0.266  Sum_probs=191.2

Q ss_pred             cccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC----ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEE
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL----SMSACREIALLRELKHPNVINLISVFLSHNDRKVWL   95 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~i   95 (291)
                      +.++.++||+|+||.||+|.++....++.||||+++....    .+++.+|+.+|++++|||||++++++.  + ...++
T Consensus         8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~--~-~~~~l   84 (277)
T d1xbba_           8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE--A-ESWML   84 (277)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE--S-SSEEE
T ss_pred             CeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEec--c-CCEEE
Confidence            3455678999999999999987766778899999975432    246889999999999999999999883  3 34689


Q ss_pred             EEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          96 LFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        96 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      ||||+++ +|.+++.....         +++..+..++.|++.||+|||++||+||||||+||+++    .++.++|+||
T Consensus        85 vmE~~~~g~L~~~l~~~~~---------l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~----~~~~~kl~DF  151 (277)
T d1xbba_          85 VMEMAELGPLNKYLQQNRH---------VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV----TQHYAKISDF  151 (277)
T ss_dssp             EEECCTTEEHHHHHHHCTT---------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE----ETTEEEECCC
T ss_pred             EEEcCCCCcHHHHHhhccC---------CCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccc----ccCcccccch
Confidence            9999985 78877664332         89999999999999999999999999999999999999    6789999999


Q ss_pred             ccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc----------ccC
Q psy2172         175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED----------IKT  243 (291)
Q Consensus       175 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~----------~~~  243 (291)
                      |+++................||+.|+|||.+.+.. ++.++|||||||++|||++ |+.||.+....          ...
T Consensus       152 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~  230 (277)
T d1xbba_         152 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG  230 (277)
T ss_dssp             TTCEECCTTCSEEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred             hhhhhccccccccccccccCCCceecCchhhcCCC-CCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            99987665433333334567899999999998755 8999999999999999997 89999875532          122


Q ss_pred             CCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         244 SNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       244 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      ......+.+.+++..|....|..||++.++
T Consensus       231 ~p~~~~~~~~~li~~cl~~dp~~RPs~~~i  260 (277)
T d1xbba_         231 CPAGCPREMYDLMNLCWTYDVENRPGFAAV  260 (277)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             CCcccCHHHHHHHHHHcCCCHhHCcCHHHH
Confidence            334456778999999999999999998864

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=6.4e-50  Score=336.75  Aligned_cols=237  Identities=25%  Similarity=0.429  Sum_probs=198.2

Q ss_pred             cccccceeCcccceEEEEEEEccCCCCceeEEEEeCC-----CCCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEE
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEG-----TGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVW   94 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (291)
                      |++ .+.||+|+||.||+|+++.  +++.||||+++.     ....+.+.+|+.++++++||||+++++++  .+...+|
T Consensus         6 y~i-~~~lG~G~fg~Vy~a~~~~--~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~--~~~~~~~   80 (316)
T d1fota_           6 FQI-LRTLGTGSFGRVHLIRSRH--NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF--QDAQQIF   80 (316)
T ss_dssp             EEE-EEEEEECSSCEEEEEEETT--TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE--ECSSEEE
T ss_pred             eEE-EEEEecCcCcEEEEEEECC--CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeE--eeCCeee
Confidence            554 6799999999999999876  678999999863     23345788999999999999999999999  5678999


Q ss_pred             EEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEee
Q psy2172          95 LLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIAD  173 (291)
Q Consensus        95 iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~D  173 (291)
                      +||||+.| ++...+.....         +++..++.++.|++.||+|||++||+||||||+||+++    .++.+||+|
T Consensus        81 ivmE~~~gg~l~~~~~~~~~---------~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~----~~g~vkL~D  147 (316)
T d1fota_          81 MIMDYIEGGELFSLLRKSQR---------FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD----KNGHIKITD  147 (316)
T ss_dssp             EEECCCCSCBHHHHHHHTSS---------CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC----TTSCEEECC
T ss_pred             eEeeecCCcccccccccccc---------ccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEc----CCCCEEEec
Confidence            99999986 55555543332         78899999999999999999999999999999999998    678999999


Q ss_pred             cccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc---------ccCC
Q psy2172         174 MGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED---------IKTS  244 (291)
Q Consensus       174 fg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~---------~~~~  244 (291)
                      ||+++.....      .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..         ....
T Consensus       148 FG~a~~~~~~------~~~~~Gt~~Y~APE~l~~~~-y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~  220 (316)
T d1fota_         148 FGFAKYVPDV------TYTLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF  220 (316)
T ss_dssp             CSSCEECSSC------BCCCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCC
T ss_pred             CccceEeccc------cccccCcccccCHHHHcCCC-CCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCC
Confidence            9999876542      23467899999999998754 899999999999999999999999876532         1223


Q ss_pred             CCCcHHHHHHHHHhhCCCCcCChh-----hhhcCCCCcchhh
Q psy2172         245 NPYHHDQLDRIFSVMGFPLEKDWE-----DIRKMPEHPTLLK  281 (291)
Q Consensus       245 ~~~~~~~~~~i~~~~~~~~~~~~~-----~~~~~~~~~~~~~  281 (291)
                      .+.....+.+++..|..+.|..|+     +++++..|||+.+
T Consensus       221 p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~  262 (316)
T d1fota_         221 PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE  262 (316)
T ss_dssp             CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred             CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCccccc
Confidence            344456788999999988888774     8888999999865

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-50  Score=335.19  Aligned_cols=244  Identities=23%  Similarity=0.372  Sum_probs=202.3

Q ss_pred             cccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC--------CChhHHHHHHHHhcCC--CCCeeeEEEEE
Q psy2172          16 VEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG--------LSMSACREIALLRELK--HPNVINLISVF   85 (291)
Q Consensus        16 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~e~~~l~~l~--h~~iv~~~~~~   85 (291)
                      ++++|++ ++.||+|+||.||+|.++.  +++.||||+++...        ...++.+|+.++++++  ||||+++++++
T Consensus         2 l~~~Y~i-~~~lG~G~fg~Vy~a~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~   78 (273)
T d1xwsa_           2 LESQYQV-GPLLGSGGFGSVYSGIRVS--DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF   78 (273)
T ss_dssp             CTTTEEE-EEEEEEETTEEEEEEEETT--TCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred             CCCeEEE-eEEEeeCCCeEEEEEEECC--CCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE
Confidence            5678886 7899999999999999876  67899999986432        1234678999999986  89999999999


Q ss_pred             EeCCCceEEEEEecCCC--CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCC
Q psy2172          86 LSHNDRKVWLLFDYAEH--DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEG  163 (291)
Q Consensus        86 ~~~~~~~~~iv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~  163 (291)
                        .+....|+|||++.+  ++.+.+.....         +++..++.++.|++.||+|||++||+||||||+||+++.  
T Consensus        79 --~~~~~~~lv~e~~~~~~~l~~~~~~~~~---------l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~--  145 (273)
T d1xwsa_          79 --ERPDSFVLILERPEPVQDLFDFITERGA---------LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--  145 (273)
T ss_dssp             --ECSSEEEEEEECCSSEEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET--
T ss_pred             --eeCCeEEEEEEeccCcchHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEec--
Confidence              567799999999974  66666654322         899999999999999999999999999999999999983  


Q ss_pred             CCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc---
Q psy2172         164 IERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED---  240 (291)
Q Consensus       164 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~---  240 (291)
                       +.+.++|+|||++......     ......||+.|+|||++.+.+.++.++|||||||++|+|++|+.||.+...-   
T Consensus       146 -~~~~vkl~DFG~a~~~~~~-----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~~~  219 (273)
T d1xwsa_         146 -NRGELKLIDFGSGALLKDT-----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG  219 (273)
T ss_dssp             -TTTEEEECCCTTCEECCSS-----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHC
T ss_pred             -CCCeEEECccccceecccc-----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHhhc
Confidence             3468999999999865432     2345678999999999987665678899999999999999999999875421   


Q ss_pred             ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         241 IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       241 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                      .....+..++.+.+++..|..+.|..||+++++..|||+.+
T Consensus       220 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  260 (273)
T d1xwsa_         220 QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD  260 (273)
T ss_dssp             CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred             ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence            12233445678999999999999999999999999999864

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.7e-49  Score=328.13  Aligned_cols=242  Identities=26%  Similarity=0.429  Sum_probs=203.0

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC-----------hhHHHHHHHHhcCC-CCCeeeEEEEE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS-----------MSACREIALLRELK-HPNVINLISVF   85 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----------~~~~~e~~~l~~l~-h~~iv~~~~~~   85 (291)
                      +.|++ .+.||+|+||+||+|+++.  +++.||||+++.....           ..+.+|+.++++++ ||||+++++++
T Consensus         3 ~~y~~-~~~iG~G~~g~V~~~~~~~--~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~   79 (277)
T d1phka_           3 ENYEP-KEILGRGVSSVVRRCIHKP--TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   79 (277)
T ss_dssp             TTEEE-EEEEEECSSEEEEEEEETT--TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             ccCEE-ceEEecCcCeEEEEEEECC--CCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec
Confidence            46664 7799999999999999876  7789999998654321           24778999999997 99999999999


Q ss_pred             EeCCCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCC
Q psy2172          86 LSHNDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGI  164 (291)
Q Consensus        86 ~~~~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~  164 (291)
                        .+....|+||||+++ +|.+++.....         +++..++.++.||+.||+|||++||+||||||+||+++    
T Consensus        80 --~~~~~~~ivmE~~~~g~L~~~l~~~~~---------l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~----  144 (277)
T d1phka_          80 --ETNTFFFLVFDLMKKGELFDYLTEKVT---------LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD----  144 (277)
T ss_dssp             --ECSSEEEEEEECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----
T ss_pred             --ccCcceEEEEEcCCCchHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEc----
Confidence              667899999999975 99988865332         89999999999999999999999999999999999998    


Q ss_pred             CCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccC-----CcCCCCchhHHHHHHHHHHHHcCCCCCCCCcc
Q psy2172         165 ERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLG-----ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE  239 (291)
Q Consensus       165 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~  239 (291)
                      .++.+||+|||+++......    ......||..|+|||.+.+     ...++.++||||+||++|+|++|+.||.+...
T Consensus       145 ~~~~~kl~DFG~a~~~~~~~----~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~  220 (277)
T d1phka_         145 DDMNIKLTDFGFSCQLDPGE----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ  220 (277)
T ss_dssp             TTCCEEECCCTTCEECCTTC----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             CCCCeEEccchheeEccCCC----ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH
Confidence            77899999999998765432    2244678999999999853     23478899999999999999999999998763


Q ss_pred             cc----------c---CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         240 DI----------K---TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       240 ~~----------~---~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                      ..          .   ...+..++.+.+++..|..+.|..||++.++.+|||+.+
T Consensus       221 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         221 MLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             HHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             HHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence            21          1   111244678999999999999999999999999999854

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-50  Score=330.87  Aligned_cols=239  Identities=21%  Similarity=0.297  Sum_probs=191.8

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC---hhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS---MSACREIALLRELKHPNVINLISVFLSHNDRKVWL   95 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~i   95 (291)
                      .+.+..-+||+|+||.||+|.++...++..||||.++.....   +++.+|+++|++++|||||++++++.  + +..|+
T Consensus         9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~-~~~~l   85 (285)
T d1u59a_           9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ--A-EALML   85 (285)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--S-SSEEE
T ss_pred             CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeec--c-CeEEE
Confidence            344323259999999999999877666678999999754332   45889999999999999999999883  2 35799


Q ss_pred             EEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          96 LFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        96 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      ||||+++ +|.+++...+.        .+++..+..++.|++.||+|||++||+||||||+||+++    .++.+||+||
T Consensus        86 vmE~~~~g~L~~~l~~~~~--------~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~----~~~~~Kl~DF  153 (285)
T d1u59a_          86 VMEMAGGGPLHKFLVGKRE--------EIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV----NRHYAKISDF  153 (285)
T ss_dssp             EEECCTTEEHHHHHTTCTT--------TSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE----ETTEEEECCC
T ss_pred             EEEeCCCCcHHHHhhcccc--------CCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeec----cCCceeeccc
Confidence            9999986 77776543221        289999999999999999999999999999999999999    6779999999


Q ss_pred             ccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc----------ccC
Q psy2172         175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED----------IKT  243 (291)
Q Consensus       175 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~----------~~~  243 (291)
                      |+++................||+.|+|||++.+.. ++.++|||||||++|||++ |..||.+....          ...
T Consensus       154 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~  232 (285)
T d1u59a_         154 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME  232 (285)
T ss_dssp             TTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCC
T ss_pred             hhhhcccccccccccccccccCccccChHHHhCCC-CCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            99998766444334445567899999999998754 8999999999999999997 99999876532          122


Q ss_pred             CCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         244 SNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       244 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      ..+...+.+.+++..|....|..||++.++
T Consensus       233 ~p~~~~~~l~~li~~cl~~~p~~RPs~~~i  262 (285)
T d1u59a_         233 CPPECPPELYALMSDCWIYKWEDRPDFLTV  262 (285)
T ss_dssp             CCTTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred             CCCcCCHHHHHHHHHHcCCCHhHCcCHHHH
Confidence            334456778899999999999999988764

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.7e-49  Score=337.26  Aligned_cols=239  Identities=22%  Similarity=0.368  Sum_probs=201.1

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCC-----CCCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCce
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEG-----TGLSMSACREIALLRELKHPNVINLISVFLSHNDRK   92 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (291)
                      +.|++ .+.||+|+||.||+|+++.  +++.||||++..     ....+.+.+|+.+|+.++||||+++++++  .+...
T Consensus        41 d~y~i-~~~lG~G~fg~Vy~a~~~~--~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~--~~~~~  115 (350)
T d1rdqe_          41 DQFDR-IKTLGTGSFGRVMLVKHKE--SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF--KDNSN  115 (350)
T ss_dssp             GGEEE-EEEEEECSSCEEEEEEETT--TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE--ECSSE
T ss_pred             cCeEE-EEEeecCcCcEEEEEEECC--CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccc--ccccc
Confidence            56775 6799999999999999876  678999999853     23345688999999999999999999999  56778


Q ss_pred             EEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEE
Q psy2172          93 VWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI  171 (291)
Q Consensus        93 ~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l  171 (291)
                      .++||||+.+ ++...+.....         +++..++.++.||+.||.|||++||+||||||+|||++    .++.+||
T Consensus       116 ~~~v~e~~~~g~l~~~l~~~~~---------l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~----~~g~ikL  182 (350)
T d1rdqe_         116 LYMVMEYVAGGEMFSHLRRIGR---------FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID----QQGYIQV  182 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEE
T ss_pred             cccccccccccchhhhHhhcCC---------CCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccC----CCCCEEe
Confidence            9999999985 77777654332         89999999999999999999999999999999999998    6779999


Q ss_pred             eecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc---------cc
Q psy2172         172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED---------IK  242 (291)
Q Consensus       172 ~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~---------~~  242 (291)
                      +|||+++.....      .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..         ..
T Consensus       183 ~DFG~a~~~~~~------~~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~  255 (350)
T d1rdqe_         183 TDFGFAKRVKGR------TWTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV  255 (350)
T ss_dssp             CCCTTCEECSSC------BCCCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred             eeceeeeecccc------cccccCccccCCHHHHcCCC-CCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC
Confidence            999999876542      23568999999999998854 899999999999999999999999876532         11


Q ss_pred             CCCCCcHHHHHHHHHhhCCCCcCCh-----hhhhcCCCCcchhh
Q psy2172         243 TSNPYHHDQLDRIFSVMGFPLEKDW-----EDIRKMPEHPTLLK  281 (291)
Q Consensus       243 ~~~~~~~~~~~~i~~~~~~~~~~~~-----~~~~~~~~~~~~~~  281 (291)
                      .......+.+.++++.|..+.|..|     |+++++..|||+..
T Consensus       256 ~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~  299 (350)
T d1rdqe_         256 RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccC
Confidence            2233445778999999999988776     58889999999764

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-50  Score=340.33  Aligned_cols=250  Identities=22%  Similarity=0.364  Sum_probs=202.6

Q ss_pred             ccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhc-CCCCCeeeEEEEEEe--CCCc
Q psy2172          15 KVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRE-LKHPNVINLISVFLS--HNDR   91 (291)
Q Consensus        15 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~--~~~~   91 (291)
                      .+-+.|++.++.||+|+||.||+|.++.  +++.||||+++.   ...+.+|+.++.+ ++||||++++++|..  ....
T Consensus         8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~--~~~~vAiK~i~~---~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~   82 (335)
T d2ozaa1           8 AIIDDYKVTSQVLGLGINGKVLQIFNKR--TQEKFALKMLQD---CPKARREVELHWRASQCPHIVRIVDVYENLYAGRK   82 (335)
T ss_dssp             CGGGTEEEEEEEEEECSSCEEEEEEETT--TCCEEEEEEEEC---SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             CcccCEEEeeEEeeeccCeEEEEEEECC--CCCEEEEEEECC---cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence            3445677767789999999999999877  678999999964   4678889998765 589999999999843  3456


Q ss_pred             eEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEE
Q psy2172          92 KVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVK  170 (291)
Q Consensus        92 ~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~  170 (291)
                      .+|+|||||+| +|.+.+....       ...+++..++.++.|++.||+|||++||+||||||+||+++... ..+.+|
T Consensus        83 ~~~ivmEy~~gg~L~~~i~~~~-------~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~-~~~~~K  154 (335)
T d2ozaa1          83 CLLIVMECLDGGELFSRIQDRG-------DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR-PNAILK  154 (335)
T ss_dssp             EEEEEEECCCSEEHHHHHHSCS-------CCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSS-TTCCEE
T ss_pred             EEEEEEECCCCCcHHHHHHhcC-------CCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccc-cccccc
Confidence            89999999975 8988886421       12389999999999999999999999999999999999998543 456899


Q ss_pred             EeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccC-------
Q psy2172         171 IADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT-------  243 (291)
Q Consensus       171 l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~-------  243 (291)
                      |+|||+++......    ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.......       
T Consensus       155 l~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~-y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i  229 (335)
T d2ozaa1         155 LTDFGFAKETTSHN----SLTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI  229 (335)
T ss_dssp             ECCCTTCEECCCCC----CCCCCSCCCSSCCCCCCCGGG-GSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CC
T ss_pred             ccccceeeeccCCC----ccccccCCcccCCcHHHcCCC-CCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHH
Confidence            99999998765432    234567899999999998754 899999999999999999999999876532100       


Q ss_pred             -----CC-----CCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhh
Q psy2172         244 -----SN-----PYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKD  282 (291)
Q Consensus       244 -----~~-----~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (291)
                           ..     ....+.+.+++..|....|..||++.++..|||+.+.
T Consensus       230 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  278 (335)
T d2ozaa1         230 RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  278 (335)
T ss_dssp             CSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred             hcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence                 00     1124568889999999999999999999999887643

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=4.6e-49  Score=337.57  Aligned_cols=240  Identities=25%  Similarity=0.381  Sum_probs=197.9

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-----CChhHHH---HHHHHhcCCCCCeeeEEEEEEeCCC
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-----LSMSACR---EIALLRELKHPNVINLISVFLSHND   90 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~---e~~~l~~l~h~~iv~~~~~~~~~~~   90 (291)
                      .|++ .+.||+|+||.||+|+++.  +++.||||++....     ....+.+   ++.+++.++||||+++++++  .+.
T Consensus         5 dy~i-~~~lG~G~fg~Vy~~~~~~--t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~--~~~   79 (364)
T d1omwa3           5 DFSV-HRIIGRGGFGEVYGCRKAD--TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF--HTP   79 (364)
T ss_dssp             TEEE-EEEEEECSSCEEEEEEETT--TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE--ECS
T ss_pred             hCee-eeEEecCCCeEEEEEEECC--CCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE--EEC
Confidence            4664 6799999999999999877  67899999985321     2222333   46777788899999999999  567


Q ss_pred             ceEEEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcE
Q psy2172          91 RKVWLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRV  169 (291)
Q Consensus        91 ~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~  169 (291)
                      ..+|+||||++ |+|.+.+.....         +++..++.++.||+.||+|||++||+||||||+|||++    ..+.+
T Consensus        80 ~~~~ivmE~~~gg~L~~~l~~~~~---------~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~----~~g~i  146 (364)
T d1omwa3          80 DKLSFILDLMNGGDLHYHLSQHGV---------FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD----EHGHV  146 (364)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----SSSCE
T ss_pred             CEEEEEEEecCCCcHHHHHHhccc---------ccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEc----CCCcE
Confidence            78999999998 588888765432         88999999999999999999999999999999999998    67899


Q ss_pred             EEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc--------
Q psy2172         170 KIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI--------  241 (291)
Q Consensus       170 ~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~--------  241 (291)
                      ||+|||+|+.....     ......||+.|+|||++.+...++.++|||||||++|+|++|..||.+.....        
T Consensus       147 Kl~DFGla~~~~~~-----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~  221 (364)
T d1omwa3         147 RISDLGLACDFSKK-----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT  221 (364)
T ss_dssp             EECCCTTCEECSSS-----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHS
T ss_pred             EEeeeceeeecCCC-----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence            99999999876542     23456799999999999765568999999999999999999999998755321        


Q ss_pred             ----cCCCCCcHHHHHHHHHhhCCCCcCChhh-----hhcCCCCcchhh
Q psy2172         242 ----KTSNPYHHDQLDRIFSVMGFPLEKDWED-----IRKMPEHPTLLK  281 (291)
Q Consensus       242 ----~~~~~~~~~~~~~i~~~~~~~~~~~~~~-----~~~~~~~~~~~~  281 (291)
                          ........+.+.+++..|....|..||+     ++++..|||+..
T Consensus       222 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~  270 (364)
T d1omwa3         222 LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS  270 (364)
T ss_dssp             SSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred             ccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence                1122345678999999999999999998     588889998754

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-50  Score=340.35  Aligned_cols=250  Identities=20%  Similarity=0.326  Sum_probs=205.9

Q ss_pred             ccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC-hhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          15 KVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS-MSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        15 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      .+.++|++ .+.||+|+||+||+|.++.  +++.||+|+++..... ..+.+|+++|+.++||||+++++++  .+...+
T Consensus         2 ~~~~rY~i-~~~lG~G~fg~Vy~~~~~~--~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~--~~~~~~   76 (321)
T d1tkia_           2 ELYEKYMI-AEDLGRGEFGIVHRCVETS--SKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESF--ESMEEL   76 (321)
T ss_dssp             CCTTTEEE-EEEEEECSSEEEEEEEETT--TTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEE--EETTEE
T ss_pred             CCccceEE-EEEEecCCCeEEEEEEECC--CCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEE--EECCEE
Confidence            45678886 6799999999999999877  7788999999865433 3577999999999999999999999  556789


Q ss_pred             EEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          94 WLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        94 ~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      |+|||||+| +|.+.+....        ..+++..++.++.||+.||+|||++||+||||||+||+++.+  ....++|+
T Consensus        77 ~lvmE~~~gg~L~~~i~~~~--------~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~--~~~~ikl~  146 (321)
T d1tkia_          77 VMIFEFISGLDIFERINTSA--------FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR--RSSTIKII  146 (321)
T ss_dssp             EEEECCCCCCBHHHHHTSSS--------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS--SCCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCC--CceEEEEc
Confidence            999999985 8888775322        128999999999999999999999999999999999999743  34689999


Q ss_pred             ecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc---------C
Q psy2172         173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK---------T  243 (291)
Q Consensus       173 Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~---------~  243 (291)
                      |||++......    .......+++.|+|||.+.+.. ++.++|||||||++|+|++|..||.+......         .
T Consensus       147 DFG~~~~~~~~----~~~~~~~~t~~y~ape~~~~~~-~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~  221 (321)
T d1tkia_         147 EFGQARQLKPG----DNFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYT  221 (321)
T ss_dssp             CCTTCEECCTT----CEEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC
T ss_pred             ccchhhccccC----CcccccccccccccchhccCCC-CCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Confidence            99999875442    1223457899999999998755 89999999999999999999999988664210         0


Q ss_pred             CC----CCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhhhhh
Q psy2172         244 SN----PYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLKDFN  284 (291)
Q Consensus       244 ~~----~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (291)
                      ..    +..++.+.+++..|..+.|..||++.++..|||+.+.+.
T Consensus       222 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~  266 (321)
T d1tkia_         222 FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE  266 (321)
T ss_dssp             CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGG
T ss_pred             CChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCcc
Confidence            00    123456789999999999999999999999998865543

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-49  Score=331.40  Aligned_cols=244  Identities=39%  Similarity=0.672  Sum_probs=200.9

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG----LSMSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      |.|++ .++||+|+||.||+|.++.  +++.||||+++...    ....+.+|+.+|++++||||+++++++  .+...+
T Consensus         2 d~Y~~-~~~lG~G~fg~Vy~~~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~--~~~~~~   76 (298)
T d1gz8a_           2 ENFQK-VEKIGEGTYGVVYKARNKL--TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI--HTENKL   76 (298)
T ss_dssp             TTEEE-EEEEEECSSSEEEEEEETT--TCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEE--EETTEE
T ss_pred             CCCEe-ccEEecCcCeEEEEEEECC--CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccc--ccccce
Confidence            45664 6799999999999999876  67889999996432    356788999999999999999999999  557789


Q ss_pred             EEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEee
Q psy2172          94 WLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIAD  173 (291)
Q Consensus        94 ~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~D  173 (291)
                      |+||||+++++...+......       .+++..++.++.|++.||+|||++||+||||||+||+++    .++.++|+|
T Consensus        77 ~iv~e~~~~~~~~~~~~~~~~-------~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~----~~~~~kl~D  145 (298)
T d1gz8a_          77 YLVFEFLHQDLKKFMDASALT-------GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN----TEGAIKLAD  145 (298)
T ss_dssp             EEEEECCSEEHHHHHHHTTTT-------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTSCEEECS
T ss_pred             eEEEeecCCchhhhhhhhccc-------CCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeec----ccCcceecc
Confidence            999999999887776544322       289999999999999999999999999999999999998    677999999


Q ss_pred             cccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc------------
Q psy2172         174 MGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI------------  241 (291)
Q Consensus       174 fg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~------------  241 (291)
                      ||.++......   .......||+.|+|||.+.....++.++|+||+||++|+|++|+.||.+.+...            
T Consensus       146 FG~a~~~~~~~---~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~  222 (298)
T d1gz8a_         146 FGLARAFGVPV---RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP  222 (298)
T ss_dssp             TTHHHHHCCCS---BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             CCcceeccCCc---ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            99998765432   233456789999999998877767899999999999999999999997654210            


Q ss_pred             -----------c-------C--------CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchh
Q psy2172         242 -----------K-------T--------SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLL  280 (291)
Q Consensus       242 -----------~-------~--------~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  280 (291)
                                 .       .        ..+..+..+.+++..|..+.|..||+++++..|||+.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~  287 (298)
T d1gz8a_         223 DEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ  287 (298)
T ss_dssp             CTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGT
T ss_pred             chhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhc
Confidence                       0       0        0012235678899999999999999999999999874

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=9.2e-49  Score=324.73  Aligned_cols=242  Identities=21%  Similarity=0.329  Sum_probs=187.9

Q ss_pred             cccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC-----hhHHHHHHHHhcCCCCCeeeEEEEEEeC
Q psy2172          14 TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS-----MSACREIALLRELKHPNVINLISVFLSH   88 (291)
Q Consensus        14 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~   88 (291)
                      +.|.++|++ .+.||+|+||.||+|.++.  +++.||||+++.....     ..+.+|+.+++.++||||+++++++...
T Consensus         3 ~~l~drY~i-~~~lG~G~fg~Vy~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~   79 (277)
T d1o6ya_           3 SHLSDRYEL-GEILGFGGMSEVHLARDLR--LHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE   79 (277)
T ss_dssp             SEETTTEEE-EEEEEECSSEEEEEEEETT--TTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred             cCccceeEE-eEEEeeCCCeEEEEEEECC--CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeec
Confidence            467889986 6799999999999999876  7789999999754322     3578999999999999999999998654


Q ss_pred             CC--ceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCC
Q psy2172          89 ND--RKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIE  165 (291)
Q Consensus        89 ~~--~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~  165 (291)
                      +.  ...|+||||++| +|...+.....         +++..++.++.|++.||+|||++||+||||||+||+++    .
T Consensus        80 ~~~~~~~~lvmE~~~g~~L~~~~~~~~~---------l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~----~  146 (277)
T d1o6ya_          80 TPAGPLPYIVMEYVDGVTLRDIVHTEGP---------MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS----A  146 (277)
T ss_dssp             CSSSEEEEEEEECCCEEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE----T
T ss_pred             cCCCceEEEEEECCCCCEehhhhcccCC---------CCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccC----c
Confidence            33  468999999986 77766654322         89999999999999999999999999999999999999    6


Q ss_pred             CCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc----
Q psy2172         166 RGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI----  241 (291)
Q Consensus       166 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~----  241 (291)
                      .+..+++|||.+.................||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.....    
T Consensus       147 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~  225 (277)
T d1o6ya_         147 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ  225 (277)
T ss_dssp             TSCEEECCCTTCEECC----------------TTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             cccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCC-CCcceecccchHHHHHHHhCCCCCCCcCHHHHHHH
Confidence            78899999999887655444444455678999999999998754 8999999999999999999999998765321    


Q ss_pred             ---------cCCCCCcHHHHHHHHHhhCCCCcCChh-hhhc
Q psy2172         242 ---------KTSNPYHHDQLDRIFSVMGFPLEKDWE-DIRK  272 (291)
Q Consensus       242 ---------~~~~~~~~~~~~~i~~~~~~~~~~~~~-~~~~  272 (291)
                               ....+..++.+.+++..|..+.|..|| ++++
T Consensus       226 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~  266 (277)
T d1o6ya_         226 HVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAE  266 (277)
T ss_dssp             HHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHH
T ss_pred             HHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHH
Confidence                     112233456788888888888888887 5553

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-49  Score=330.15  Aligned_cols=241  Identities=24%  Similarity=0.392  Sum_probs=200.2

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCC-----CCCChhHHHHHHHHh-cCCCCCeeeEEEEEEeCCCce
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEG-----TGLSMSACREIALLR-ELKHPNVINLISVFLSHNDRK   92 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~   92 (291)
                      .|++ ++.||+|+||+||+|.++.  +++.||||++++     ......+..|..++. .++||||+++++++  .+...
T Consensus         3 dy~i-~~~iG~G~fg~Vy~~~~~~--t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~--~~~~~   77 (320)
T d1xjda_           3 DFIL-HKMLGKGSFGKVFLAEFKK--TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF--QTKEN   77 (320)
T ss_dssp             TEEE-EEEEEECSSSEEEEEEETT--TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE--ECSSE
T ss_pred             CeEE-eeEEecCCCcEEEEEEECC--CCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE--ccCCc
Confidence            3664 6799999999999999877  788999999963     233345667777665 68999999999999  56778


Q ss_pred             EEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEE
Q psy2172          93 VWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKI  171 (291)
Q Consensus        93 ~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l  171 (291)
                      +|+||||+++ +|.+++.....         +++..++.++.|++.||+|||++||+||||||+||+++    ..+.++|
T Consensus        78 ~yivmEy~~~g~L~~~i~~~~~---------~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~----~~~~~kl  144 (320)
T d1xjda_          78 LFFVMEYLNGGDLMYHIQSCHK---------FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD----KDGHIKI  144 (320)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTSCEEE
T ss_pred             eeEEEeecCCCcHHHHhhccCC---------CCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeec----CCCceec
Confidence            9999999985 88888765432         89999999999999999999999999999999999998    6789999


Q ss_pred             eecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc---------cc
Q psy2172         172 ADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED---------IK  242 (291)
Q Consensus       172 ~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~---------~~  242 (291)
                      +|||+++......   .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..         ..
T Consensus       145 ~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~  220 (320)
T d1xjda_         145 ADFGMCKENMLGD---AKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP  220 (320)
T ss_dssp             CCCTTCBCCCCTT---CCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred             cccchhhhccccc---ccccccCCCCCcCCHHHHcCCC-CCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Confidence            9999998654322   2234467899999999998855 899999999999999999999999876542         12


Q ss_pred             CCCCCcHHHHHHHHHhhCCCCcCChhhhh-cCCCCcchhh
Q psy2172         243 TSNPYHHDQLDRIFSVMGFPLEKDWEDIR-KMPEHPTLLK  281 (291)
Q Consensus       243 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~~~~~~~~  281 (291)
                      ...+..+..+.+++..|..+.|..||++. ++..|||+.+
T Consensus       221 ~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~  260 (320)
T d1xjda_         221 FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE  260 (320)
T ss_dssp             CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred             CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhcc
Confidence            23334467799999999999999999986 7889998754

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-49  Score=329.77  Aligned_cols=222  Identities=44%  Similarity=0.802  Sum_probs=185.7

Q ss_pred             ceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-------CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEE
Q psy2172          25 CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-------LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLF   97 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~   97 (291)
                      ++||+|+||+||+|.++.  +++.||||+++...       ....+.+|+.++++++||||+++++++  .+....|+||
T Consensus         4 ~~lG~G~fg~Vy~~~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~--~~~~~~~ivm   79 (299)
T d1ua2a_           4 DFLGEGQFATVYKARDKN--TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF--GHKSNISLVF   79 (299)
T ss_dssp             EEEEEETTEEEEEEECSS--CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE--CCTTCCEEEE
T ss_pred             eEeccCcCeEEEEEEECC--CCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeee--ccCCceeehh
Confidence            589999999999999876  77899999986432       234688999999999999999999999  6677899999


Q ss_pred             ecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccc
Q psy2172          98 DYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFA  177 (291)
Q Consensus        98 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~  177 (291)
                      ||+.+++...+....        ..+++..++.++.|++.||+|||++||+||||||+||+++    ..+.+||+|||.+
T Consensus        80 E~~~~~~~~~~~~~~--------~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~----~~~~~KL~DFG~a  147 (299)
T d1ua2a_          80 DFMETDLEVIIKDNS--------LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD----ENGVLKLADFGLA  147 (299)
T ss_dssp             ECCSEEHHHHHTTCC--------SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTCCEEECCCGGG
T ss_pred             hhhcchHHhhhhhcc--------cCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEec----CCCccccccCccc
Confidence            999987665543221        2288999999999999999999999999999999999998    7789999999999


Q ss_pred             eecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccCCCCCcHHHHHHHHH
Q psy2172         178 RLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFS  257 (291)
Q Consensus       178 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~i~~  257 (291)
                      ........   ......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+...         .+++..+.+
T Consensus       148 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~---------~~~l~~i~~  215 (299)
T d1ua2a_         148 KSFGSPNR---AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---------LDQLTRIFE  215 (299)
T ss_dssp             STTTSCCC---CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---------HHHHHHHHH
T ss_pred             cccCCCcc---cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH---------HHHHHHHHH
Confidence            76554322   223457899999999997766689999999999999999999999998776         488999999


Q ss_pred             hhCCCCcCChhhhhcCC
Q psy2172         258 VMGFPLEKDWEDIRKMP  274 (291)
Q Consensus       258 ~~~~~~~~~~~~~~~~~  274 (291)
                      .++.|....|+.....+
T Consensus       216 ~~~~~~~~~~~~~~~~~  232 (299)
T d1ua2a_         216 TLGTPTEEQWPDMCSLP  232 (299)
T ss_dssp             HHCCCCTTTSSSTTSST
T ss_pred             hcCCCChhhccchhccc
Confidence            99999988887665543

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.2e-49  Score=327.72  Aligned_cols=236  Identities=22%  Similarity=0.310  Sum_probs=192.1

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC-ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLF   97 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~   97 (291)
                      .|++ .++||+|+||.||+|.++.  +++.||||.++.... .+++.+|+.+|++++|||||++++++  .+....++||
T Consensus        18 ~~~~-~~~iG~G~fg~Vy~a~~~~--~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~--~~~~~~~iv~   92 (287)
T d1opja_          18 DITM-KHKLGGGQYGEVYEGVWKK--YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC--TREPPFYIIT   92 (287)
T ss_dssp             GEEE-EEETTTTTTSSEEEEEEGG--GTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEE--CSSSSCEEEE
T ss_pred             HeEE-eeEEeeCCCeEEEEEEECC--CCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccE--eeCCeeEEEe
Confidence            4553 6799999999999999887  678899999975543 45789999999999999999999999  5667899999


Q ss_pred             ecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeeccc
Q psy2172          98 DYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGF  176 (291)
Q Consensus        98 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~  176 (291)
                      ||++ |+|...+......       .+++..+..++.|++.||+|||++||+||||||+|||++    .++.+||+|||+
T Consensus        93 E~~~~g~l~~~l~~~~~~-------~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~----~~~~~Kl~DFG~  161 (287)
T d1opja_          93 EFMTYGNLLDYLRECNRQ-------EVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG----ENHLVKVADFGL  161 (287)
T ss_dssp             ECCTTCBHHHHHHHSCTT-------TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----GGGCEEECCCCC
T ss_pred             ecccCcchHHHhhhcccc-------chHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEEC----CCCcEEEccccc
Confidence            9998 5888777643221       289999999999999999999999999999999999998    668999999999


Q ss_pred             ceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCC-CCCccc----------ccCCC
Q psy2172         177 ARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF-HCRQED----------IKTSN  245 (291)
Q Consensus       177 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf-~~~~~~----------~~~~~  245 (291)
                      ++.......  .......|+..|+|||.+.+.. ++.++|||||||++|+|++|..|| .+....          .....
T Consensus       162 a~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~-~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~  238 (287)
T d1opja_         162 SRLMTGDTY--TAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP  238 (287)
T ss_dssp             TTTCCSSSS--EEETTEEECGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCC
T ss_pred             eeecCCCCc--eeeccccccccccChHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCC
Confidence            986544221  2223456889999999998755 899999999999999999966554 443321          11223


Q ss_pred             CCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         246 PYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       246 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      ....+.+.+++..|....|..||++.++
T Consensus       239 ~~~~~~l~~li~~cl~~dP~~Rps~~ei  266 (287)
T d1opja_         239 EGCPEKVYELMRACWQWNPSDRPSFAEI  266 (287)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             ccchHHHHHHHHHHcCCCHhHCcCHHHH
Confidence            3456779999999999999999998864

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-49  Score=325.31  Aligned_cols=234  Identities=21%  Similarity=0.350  Sum_probs=183.7

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG----LSMSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      +.|.+ +++||+|+||.||+|.++     ..||||+++...    ..+.+.+|+.+|++++||||++++++.  . ....
T Consensus         8 ~~~~~-~~~lG~G~fg~Vy~~~~~-----~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~--~-~~~~   78 (276)
T d1uwha_           8 GQITV-GQRIGSGSFGTVYKGKWH-----GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS--T-APQL   78 (276)
T ss_dssp             TCCCC-CSEEEECSSCEEEEEESS-----SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEE--C-SSSC
T ss_pred             ccEEE-EEEEeeCCCcEEEEEEEC-----CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEE--e-ccEE
Confidence            45664 779999999999999853     249999986432    224688999999999999999999987  2 3467


Q ss_pred             EEEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          94 WLLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        94 ~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      ++||||++ |+|.+++.....        .+++..+..++.|+++||+|||++||+||||||+||+++    .++.+||+
T Consensus        79 ~lv~Ey~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~----~~~~~Kl~  146 (276)
T d1uwha_          79 AIVTQWCEGSSLYHHLHIIET--------KFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH----EDLTVKIG  146 (276)
T ss_dssp             EEEEECCCEEEHHHHHHTSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE----TTSSEEEC
T ss_pred             EEEEecCCCCCHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEc----CCCCEEEc
Confidence            99999998 588887754321        289999999999999999999999999999999999998    67899999


Q ss_pred             ecccceecCCCCCCCCCCCCceecccccccccccCC--cCCCCchhHHHHHHHHHHHHcCCCCCCCCccc----------
Q psy2172         173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQED----------  240 (291)
Q Consensus       173 Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~----------  240 (291)
                      |||+|+....... ........||+.|+|||++.+.  ..++.++|||||||++|||++|+.||.+....          
T Consensus       147 DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~  225 (276)
T d1uwha_         147 DFGLATVKSRWSG-SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRG  225 (276)
T ss_dssp             CCCCSCC-------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHT
T ss_pred             cccceeeccccCC-cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcC
Confidence            9999976543221 1223456789999999998643  24789999999999999999999999875432          


Q ss_pred             -----ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         241 -----IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       241 -----~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                           .........+.+.+++..|..+.|..||++.++
T Consensus       226 ~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i  263 (276)
T d1uwha_         226 YLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQI  263 (276)
T ss_dssp             SCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHH
Confidence                 111233445778999999999999999988764

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.6e-48  Score=326.09  Aligned_cols=240  Identities=19%  Similarity=0.271  Sum_probs=180.6

Q ss_pred             cccccccceeCcccceEEEEEEEccCC-CCceeEEEEeCCCCCC---hhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNS-DTRDYALKQIEGTGLS---MSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~-~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      +.|++ +++||+|+||.||+|.++.++ ....||||.+......   +.+.+|+++|++++|||||++++++  .+....
T Consensus        26 ~~~~~-~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~--~~~~~~  102 (299)
T d1jpaa_          26 SCVKI-EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVV--TKSTPV  102 (299)
T ss_dssp             GGEEE-EEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE--CSSSSC
T ss_pred             hhcEE-eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEE--eeCCEE
Confidence            44554 679999999999999987532 2345889988654333   3588999999999999999999999  556789


Q ss_pred             EEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          94 WLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        94 ~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      ++||||+++ +|.+++.....        .+++..+..++.|++.||+|||++||+||||||+|||++    .++.+||+
T Consensus       103 ~iv~Ey~~~g~L~~~~~~~~~--------~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~----~~~~~Kl~  170 (299)
T d1jpaa_         103 MIITEFMENGSLDSFLRQNDG--------QFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVN----SNLVCKVS  170 (299)
T ss_dssp             EEEEECCTTEEHHHHHHTTTT--------CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTCCEEEC
T ss_pred             EEEEEecCCCcceeeeccccC--------CCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEEC----CCCcEEEC
Confidence            999999986 67665553221        289999999999999999999999999999999999998    67899999


Q ss_pred             ecccceecCCCCCCC--CCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc---------
Q psy2172         173 DMGFARLFNNPLKPL--ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED---------  240 (291)
Q Consensus       173 Dfg~~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~---------  240 (291)
                      |||+++.........  .......||+.|+|||.+.+.. ++.++|||||||++|||++ |..||.+....         
T Consensus       171 DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~  249 (299)
T d1jpaa_         171 DFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQD  249 (299)
T ss_dssp             CC-----------------------CGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT
T ss_pred             CcccceEccCCCCcceeeecccccCCccccCHHHHhcCC-CCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            999998765432211  1222346789999999998754 8999999999999999997 89999876532         


Q ss_pred             -ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         241 -IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       241 -~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                       .........+.+.+++..|....|..||++.++
T Consensus       250 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei  283 (299)
T d1jpaa_         250 YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQI  283 (299)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHH
Confidence             122333456778999999999999999988763

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-48  Score=320.32  Aligned_cols=234  Identities=20%  Similarity=0.354  Sum_probs=180.5

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLF   97 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~   97 (291)
                      .|++ .+.||+|+||.||+|.++   +++.||||.++... ..+++.+|++++++++||||+++++++  .+....++||
T Consensus         6 ~~~~-~~~iG~G~fg~Vy~~~~~---~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~--~~~~~~~lv~   79 (263)
T d1sm2a_           6 ELTF-VQEIGSGQFGLVHLGYWL---NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC--LEQAPICLVF   79 (263)
T ss_dssp             CEEE-EEEEECCSSCCEEEEEET---TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEE--CSSSSCEEEE
T ss_pred             HcEE-EEEEeeCCCeEEEEEEEC---CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCccccccee--ccCCceEEEE
Confidence            4554 679999999999999986   34679999997644 345789999999999999999999999  4566889999


Q ss_pred             ecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeeccc
Q psy2172          98 DYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGF  176 (291)
Q Consensus        98 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~  176 (291)
                      ||+.+ +|.+++.....        .+++..+..++.|++.||+|||+++|+||||||+||+++    .++.+||+|||+
T Consensus        80 E~~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~----~~~~~Kl~DFGl  147 (263)
T d1sm2a_          80 EFMEHGCLSDYLRTQRG--------LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG----ENQVIKVSDFGM  147 (263)
T ss_dssp             ECCTTCBHHHHHHTTTT--------CCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEEC----GGGCEEECSCC-
T ss_pred             EecCCCcHHHHhhcccc--------CCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeec----CCCCeEecccch
Confidence            99985 77777654322        288999999999999999999999999999999999999    678999999999


Q ss_pred             ceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc----------ccCCC
Q psy2172         177 ARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED----------IKTSN  245 (291)
Q Consensus       177 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~----------~~~~~  245 (291)
                      ++.......  .......||..|+|||++.+.. ++.++||||||+++|||++ |.+||......          .....
T Consensus       148 a~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~-~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p  224 (263)
T d1sm2a_         148 TRFVLDDQY--TSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP  224 (263)
T ss_dssp             -------------------CTTSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCC
T ss_pred             heeccCCCc--eeecceecCcccCChHHhcCCC-CCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCc
Confidence            987654322  1223457889999999998755 9999999999999999998 57777665432          11223


Q ss_pred             CCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         246 PYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       246 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      ....+.+.+++..|..+.|..||+++++
T Consensus       225 ~~~~~~l~~li~~cl~~~p~~Rps~~~i  252 (263)
T d1sm2a_         225 RLASTHVYQIMNHCWKERPEDRPAFSRL  252 (263)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             cccCHHHHHHHHHHccCCHhHCcCHHHH
Confidence            3445778899999999999999988863

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-48  Score=319.38  Aligned_cols=235  Identities=20%  Similarity=0.349  Sum_probs=187.2

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLL   96 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv   96 (291)
                      +.|++ +++||+|+||.||+|.++   +++.||||.++... ..+.+.+|+.++++++|||||++++++.   ....++|
T Consensus        13 ~~~~~-~~~iG~G~fg~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~---~~~~~iv   85 (272)
T d1qpca_          13 ETLKL-VERLGAGQFGEVWMGYYN---GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT---QEPIYII   85 (272)
T ss_dssp             GGEEE-EEEEEEETTEEEEEEEET---TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC---SSSCEEE
T ss_pred             HHeEE-eEEEecCCCcEEEEEEEC---CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeec---cCCeEEE
Confidence            34554 679999999999999975   45679999997543 3456899999999999999999999872   2356899


Q ss_pred             EecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecc
Q psy2172          97 FDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMG  175 (291)
Q Consensus        97 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg  175 (291)
                      |||+++ +|.+.+.......       +++..+..++.|++.||+|||+++|+||||||+||+++    .++.+||+|||
T Consensus        86 ~Ey~~~g~L~~~~~~~~~~~-------l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~----~~~~~Kl~DFG  154 (272)
T d1qpca_          86 TEYMENGSLVDFLKTPSGIK-------LTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS----DTLSCKIADFG  154 (272)
T ss_dssp             EECCTTCBHHHHTTSHHHHT-------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTSCEEECCCT
T ss_pred             EEeCCCCcHHHHHhhcCCCC-------CCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeee----cccceeecccc
Confidence            999985 7766554333221       89999999999999999999999999999999999998    67899999999


Q ss_pred             cceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcC-CCCCCCCccc----------ccCC
Q psy2172         176 FARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQED----------IKTS  244 (291)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g-~~pf~~~~~~----------~~~~  244 (291)
                      +|+.......  .......|+..|+|||++.+.. ++.++|||||||++|+|++| .+||......          ....
T Consensus       155 la~~~~~~~~--~~~~~~~gt~~y~APE~~~~~~-~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~  231 (272)
T d1qpca_         155 LARLIEDNEY--TAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR  231 (272)
T ss_dssp             TCEECSSSCE--ECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred             ceEEccCCcc--ccccccCCcccccChHHHhCCC-CCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence            9987654321  2233457789999999998654 89999999999999999995 5566554321          1222


Q ss_pred             CCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         245 NPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       245 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      .....+.+.+++..|..+.|..||+++++
T Consensus       232 p~~~~~~l~~li~~cl~~~P~~Rpt~~ei  260 (272)
T d1qpca_         232 PDNCPEELYQLMRLCWKERPEDRPTFDYL  260 (272)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             cccChHHHHHHHHHHcCCCHhHCcCHHHH
Confidence            33456778999999999999999988763

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-47  Score=314.27  Aligned_cols=233  Identities=19%  Similarity=0.318  Sum_probs=191.1

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-LSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLF   97 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~   97 (291)
                      .|++ +++||+|+||.||+|+++   +++.||||.++... ..+++.+|+.++++++||||+++++++  .+....++||
T Consensus         5 ~~~~-~~~iG~G~fg~Vy~~~~~---~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~--~~~~~~~iv~   78 (258)
T d1k2pa_           5 DLTF-LKELGTGQFGVVKYGKWR---GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC--TKQRPIFIIT   78 (258)
T ss_dssp             CCCC-CCCCCEETTEEEEEEEET---TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEE--CCSSSEEEEE
T ss_pred             HCEE-eEEEecCCCeEEEEEEEC---CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEE--eeCCceEEEE
Confidence            4554 679999999999999985   56789999997644 446799999999999999999999999  5567899999


Q ss_pred             ecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeeccc
Q psy2172          98 DYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGF  176 (291)
Q Consensus        98 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~  176 (291)
                      ||+.+ ++...+.....        .+++..++.++.|+++||+|||++||+|+||||+||+++    .++.+||+|||+
T Consensus        79 Ey~~~g~l~~~~~~~~~--------~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~----~~~~~kl~DfG~  146 (258)
T d1k2pa_          79 EYMANGCLLNYLREMRH--------RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN----DQGVVKVSDFGL  146 (258)
T ss_dssp             ECCTTEEHHHHHHSGGG--------CCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEEC----TTCCEEECCCSS
T ss_pred             EccCCCcHHHhhhcccc--------CCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEc----CCCcEEECcchh
Confidence            99985 66666544332        288999999999999999999999999999999999998    678999999999


Q ss_pred             ceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc----------ccCCC
Q psy2172         177 ARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED----------IKTSN  245 (291)
Q Consensus       177 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~----------~~~~~  245 (291)
                      ++.......  .......||..|+|||.+.+.. ++.++||||||+++|+|++ |+.||.+....          .....
T Consensus       147 a~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~-~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p  223 (258)
T d1k2pa_         147 SRYVLDDEY--TSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP  223 (258)
T ss_dssp             CCBCSSSSC--CCCCCSCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCC
T ss_pred             heeccCCCc--eeecccCCCCCcCCcHHhcCCC-CCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc
Confidence            986654322  2233467899999999998755 8999999999999999998 89999876542          11223


Q ss_pred             CCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         246 PYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       246 ~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      ......+.+++..|..+.|..||++++
T Consensus       224 ~~~~~~l~~li~~cl~~dP~~RPt~~e  250 (258)
T d1k2pa_         224 HLASEKVYTIMYSCWHEKADERPTFKI  250 (258)
T ss_dssp             TTCCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred             ccccHHHHHHHHHHccCCHhHCcCHHH
Confidence            344567889999999999988888775

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-48  Score=325.67  Aligned_cols=247  Identities=21%  Similarity=0.335  Sum_probs=192.7

Q ss_pred             cccccccceeCcccceEEEEEEEccCC---CCceeEEEEeCCC---CCChhHHHHHHHHhcC-CCCCeeeEEEEEEeCCC
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNS---DTRDYALKQIEGT---GLSMSACREIALLREL-KHPNVINLISVFLSHND   90 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~---~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~   90 (291)
                      +.|++ +++||+|+||+||+|.++...   ....||+|.+...   .....+.+|+.++.++ +|||||++++++  .+.
T Consensus        37 ~~~~l-~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~--~~~  113 (325)
T d1rjba_          37 ENLEF-GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC--TLS  113 (325)
T ss_dssp             GGEEE-EEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE--CSS
T ss_pred             HHeEE-eeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE--eeC
Confidence            34554 789999999999999987532   2246899998543   3345688999999998 899999999999  567


Q ss_pred             ceEEEEEecCCC-CHHHHHHHhhhhh--------------hCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCC
Q psy2172          91 RKVWLLFDYAEH-DLWHIIKFHRAAK--------------ANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPA  155 (291)
Q Consensus        91 ~~~~iv~e~~~~-~l~~~~~~~~~~~--------------~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~  155 (291)
                      ...|+||||+++ +|.+++.......              .......+++..++.++.|++.||+|||++||+||||||+
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~  193 (325)
T d1rjba_         114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR  193 (325)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred             CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchh
Confidence            789999999984 8888886543210              0111223899999999999999999999999999999999


Q ss_pred             cEEeecCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCC
Q psy2172         156 NILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIF  234 (291)
Q Consensus       156 Nil~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf  234 (291)
                      ||+++    .++.+||+|||+|+....... ........||+.|+|||++.+.. ++.++|||||||++|+|++ |..||
T Consensus       194 Nill~----~~~~~Kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwS~Gvil~emlt~g~~Pf  267 (325)
T d1rjba_         194 NVLVT----HGKVVKICDFGLARDIMSDSN-YVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPY  267 (325)
T ss_dssp             GEEEE----TTTEEEECCCGGGSCGGGCTT-SEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             ccccc----cCCeEEEeeccccccccCCCc-eeeeccccCCCccCChHHHcCCC-CCcceeccchhHHHHHHHhCCCCCC
Confidence            99998    678999999999986654322 12224567899999999998744 8999999999999999997 89999


Q ss_pred             CCCcccc-----------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         235 HCRQEDI-----------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       235 ~~~~~~~-----------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      .+.....           ........+.+.+++..|....|..||+++++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei  317 (325)
T d1rjba_         268 PGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL  317 (325)
T ss_dssp             TTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence            8765431           12333456778999999999999999988763

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-47  Score=321.81  Aligned_cols=248  Identities=34%  Similarity=0.621  Sum_probs=197.7

Q ss_pred             cccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC----CCChhHHHHHHHHhcC---CCCCeeeEEEEEEe-
Q psy2172          16 VEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT----GLSMSACREIALLREL---KHPNVINLISVFLS-   87 (291)
Q Consensus        16 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~-   87 (291)
                      .+++|++ .++||+|+||+||+|.+..+ +++.||||+++..    .....+.+|+.+++.+   +||||+++++++.. 
T Consensus         5 ~~~~Y~i-~~~LG~G~fg~V~~a~~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~   82 (305)
T d1blxa_           5 ADQQYEC-VAEIGEGAYGKVFKARDLKN-GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   82 (305)
T ss_dssp             GGGTEEE-EEEEEEETTEEEEEEEETTT-TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred             CcCCEEE-EEEEecccCeEEEEEEEECC-CCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence            3577886 66999999999999998652 3567999998532    2344677888887776   79999999999853 


Q ss_pred             --CCCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCC
Q psy2172          88 --HNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIE  165 (291)
Q Consensus        88 --~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~  165 (291)
                        +.....+++||++++++..+.......       .+++..++.++.|++.||+|||++||+||||||+|||++    .
T Consensus        83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~----~  151 (305)
T d1blxa_          83 RTDRETKLTLVFEHVDQDLTTYLDKVPEP-------GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT----S  151 (305)
T ss_dssp             ECSSEEEEEEEEECCSCBHHHHHHHSCTT-------CSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----T
T ss_pred             ccccCceEEEEEEeccCCchhhhhhccCC-------CCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEc----C
Confidence              244689999999999877655443322       289999999999999999999999999999999999998    6


Q ss_pred             CCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc----
Q psy2172         166 RGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI----  241 (291)
Q Consensus       166 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~----  241 (291)
                      .+.++|+|||.+......    .......||+.|+|||++.+.+ ++.++||||+||++|+|++|.+||.+.+...    
T Consensus       152 ~~~~kl~dfg~~~~~~~~----~~~~~~~gT~~Y~APE~~~~~~-y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~  226 (305)
T d1blxa_         152 SGQIKLADFGLARIYSFQ----MALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK  226 (305)
T ss_dssp             TCCEEECSCCSCCCCCGG----GGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             CCCeeecchhhhhhhccc----ccCCCcccChhhcCcchhcCCC-CChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence            789999999998754332    2334568899999999998755 9999999999999999999999998754210    


Q ss_pred             --------------------------------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         242 --------------------------------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       242 --------------------------------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                                                      ........+.+.+++..|..+.|..||++.++..|||+.+
T Consensus       227 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~  298 (305)
T d1blxa_         227 ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD  298 (305)
T ss_dssp             HHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred             HHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcC
Confidence                                            0011122456778899999999999999999999998753

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-47  Score=324.23  Aligned_cols=246  Identities=28%  Similarity=0.451  Sum_probs=199.2

Q ss_pred             ccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCCCCeeeEEEEEEe----CCCceEE
Q psy2172          19 LFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFLS----HNDRKVW   94 (291)
Q Consensus        19 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~~~   94 (291)
                      .|. ..++||+|+||+||+|+++.  +++.||||++....  ....+|+.+|++++||||++++++|..    .+..++|
T Consensus        21 ~Y~-~~k~LG~G~fg~Vy~a~~~~--~~~~vAiK~i~~~~--~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~   95 (350)
T d1q5ka_          21 SYT-DTKVIGNGSFGVVYQAKLCD--SGELVAIKKVLQDK--RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN   95 (350)
T ss_dssp             EEE-EEEEEEEETTEEEEEEEETT--TCCEEEEEEEECCS--SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred             CcE-eeeEEeeCcCeEEEEEEECC--CCCEEEEEEECccc--hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence            455 36799999999999999877  77899999997543  334579999999999999999999854    2445789


Q ss_pred             EEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeec
Q psy2172          95 LLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADM  174 (291)
Q Consensus        95 iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Df  174 (291)
                      +||||+++++...+........     .+++..++.++.|++.||+|||++||+||||||+|||++.+   ...+||+||
T Consensus        96 lv~Ey~~~~~~~~l~~~~~~~~-----~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~---~~~~kl~DF  167 (350)
T d1q5ka_          96 LVLDYVPETVYRVARHYSRAKQ-----TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPD---TAVLKLCDF  167 (350)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTT---TCCEEECCC
T ss_pred             EEEeccCCccHHHHHhhhhccC-----CCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecC---CCceeEecc
Confidence            9999999987777664333221     28999999999999999999999999999999999999832   247999999


Q ss_pred             ccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc-------------
Q psy2172         175 GFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI-------------  241 (291)
Q Consensus       175 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~-------------  241 (291)
                      |++......    .......|+..|+|||.+.+...++.++||||+||++|+|++|..||.+.....             
T Consensus       168 G~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~  243 (350)
T d1q5ka_         168 GSAKQLVRG----EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT  243 (350)
T ss_dssp             TTCEECCTT----SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             cchhhccCC----cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCCh
Confidence            999876543    223345789999999998776669999999999999999999999997654210             


Q ss_pred             -------------------------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         242 -------------------------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       242 -------------------------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                                               ....+...+.+.+++..|....|..||++.++..|||+.+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~  308 (350)
T d1q5ka_         244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE  308 (350)
T ss_dssp             HHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred             HHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence                                     0011223566788999999999999999999999998754

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-47  Score=326.50  Aligned_cols=251  Identities=31%  Similarity=0.516  Sum_probs=202.3

Q ss_pred             cccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC---hhHHHHHHHHhcCCCCCeeeEEEEEEeCC-
Q psy2172          14 TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS---MSACREIALLRELKHPNVINLISVFLSHN-   89 (291)
Q Consensus        14 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-   89 (291)
                      ..|.++|++ .++||+|+||+||+|.++.  +++.||||+++.....   ..+.+|+.+|++++||||+++++++...+ 
T Consensus         4 ~~i~~rY~~-~~~LG~G~fg~Vy~~~~~~--~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~   80 (345)
T d1pmea_           4 FDVGPRYTN-LSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI   80 (345)
T ss_dssp             CCCCTTEEE-EEECC---CCCEEEEEETT--TCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred             cCcCCCeEE-EEEEeeccCeEEEEEEECC--CCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccc
Confidence            456678885 7799999999999999876  6788999999754332   35789999999999999999999985432 


Q ss_pred             --CceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCC
Q psy2172          90 --DRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERG  167 (291)
Q Consensus        90 --~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~  167 (291)
                        ....|+++++++++|.+++...+          +++..++.++.|++.||+|||++||+||||||+|||++    ..+
T Consensus        81 ~~~~~~~l~~~~~~g~L~~~l~~~~----------l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~----~~~  146 (345)
T d1pmea_          81 EQMKDVYLVTHLMGADLYKLLKTQH----------LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN----TTC  146 (345)
T ss_dssp             TTCCCEEEEEECCCEEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTC
T ss_pred             cccceEEEEEeecCCchhhhhhcCC----------CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEEC----CCC
Confidence              24578888888889998886432          89999999999999999999999999999999999998    667


Q ss_pred             cEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc-------
Q psy2172         168 RVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED-------  240 (291)
Q Consensus       168 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~-------  240 (291)
                      .+||+|||++.................||+.|+|||.+.....++.++||||+||++|+|++|+.||.+....       
T Consensus       147 ~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~  226 (345)
T d1pmea_         147 DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL  226 (345)
T ss_dssp             CEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             CEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHh
Confidence            9999999999876554333334456678999999999876666899999999999999999999999875421       


Q ss_pred             -------------------------ccC--------CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         241 -------------------------IKT--------SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       241 -------------------------~~~--------~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                                               ...        ..+..+..+.+++..|....|..||+++++.+||++.+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~  300 (345)
T d1pmea_         227 GILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ  300 (345)
T ss_dssp             HHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred             hhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence                                     000        01112345778999999999999999999999998763

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=9.3e-48  Score=320.23  Aligned_cols=242  Identities=36%  Similarity=0.619  Sum_probs=192.8

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG----LSMSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      |+|.+ .++||+|+||+||+|.++   +++.||||+++...    ....+.+|+.+|++++||||+++++++  .+....
T Consensus         2 ~~Y~~-~~~iG~G~fg~Vy~~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~--~~~~~~   75 (286)
T d1ob3a_           2 EKYHG-LEKIGEGTYGVVYKAQNN---YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI--HTKKRL   75 (286)
T ss_dssp             CSEEE-EEEEEEETTEEEEEEEET---TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEE--ECSSCE
T ss_pred             CCcee-ccEEecCCCcEEEEEEeC---CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeec--ccCCce
Confidence            46764 569999999999999975   56889999996542    345789999999999999999999999  556789


Q ss_pred             EEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEee
Q psy2172          94 WLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIAD  173 (291)
Q Consensus        94 ~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~D  173 (291)
                      +++++++.+++...+.....        .+++..++.++.|++.||+|||+.||+||||||+||+++    .++.+|++|
T Consensus        76 ~i~~e~~~~~~~~~~~~~~~--------~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~----~~~~~kl~D  143 (286)
T d1ob3a_          76 VLVFEHLDQDLKKLLDVCEG--------GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN----REGELKIAD  143 (286)
T ss_dssp             EEEEECCSEEHHHHHHTSTT--------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTSCEEECC
T ss_pred             eEEEEeehhhhHHHHHhhcC--------CcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEc----CCCCEEecc
Confidence            99999999987777654332        299999999999999999999999999999999999998    678999999


Q ss_pred             cccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc------------
Q psy2172         174 MGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI------------  241 (291)
Q Consensus       174 fg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~------------  241 (291)
                      ||.+.......   .......+++.|+|||.+.+...++.++|+|||||++|+|++|+.||.+.....            
T Consensus       144 fG~a~~~~~~~---~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~  220 (286)
T d1ob3a_         144 FGLARAFGIPV---RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTP  220 (286)
T ss_dssp             TTHHHHHCC------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             cccceecccCc---cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCC
Confidence            99998765432   122345678899999999876768999999999999999999999997654210            


Q ss_pred             --------------------------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchh
Q psy2172         242 --------------------------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLL  280 (291)
Q Consensus       242 --------------------------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  280 (291)
                                                ....+.....+.++++.|..+.|..||+++++..|||+.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~  285 (286)
T d1ob3a_         221 NSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK  285 (286)
T ss_dssp             CTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred             ChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence                                      001112234566778888888888888888888887764

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-47  Score=316.76  Aligned_cols=238  Identities=19%  Similarity=0.287  Sum_probs=178.6

Q ss_pred             cccccceeCcccceEEEEEEEccCCC--CceeEEEEeCCCCCC---hhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEE
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKDNSD--TRDYALKQIEGTGLS---MSACREIALLRELKHPNVINLISVFLSHNDRKVW   94 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~~~~--~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (291)
                      |+ +.++||+|+||.||+|.++....  ...||||.+......   .++.+|+.++++++|||||++++++  .+....+
T Consensus         9 ~~-~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~--~~~~~~~   85 (283)
T d1mqba_           9 VT-RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI--SKYKPMM   85 (283)
T ss_dssp             EE-EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE--CSSSSEE
T ss_pred             eE-eeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEE--ecCCceE
Confidence            44 46799999999999999876332  246999998754333   3578999999999999999999999  5567899


Q ss_pred             EEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEee
Q psy2172          95 LLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIAD  173 (291)
Q Consensus        95 iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~D  173 (291)
                      ++|||+.+ ++.+.+.....        .+++..+..++.|++.||+|||+++|+||||||+|||++    .++.+||+|
T Consensus        86 ~v~e~~~~~~l~~~~~~~~~--------~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~----~~~~~Kl~D  153 (283)
T d1mqba_          86 IITEYMENGALDKFLREKDG--------EFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN----SNLVCKVSD  153 (283)
T ss_dssp             EEEECCTTEEHHHHHHHTTT--------CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTCCEEECC
T ss_pred             EEEEecccCcchhhhhcccc--------cccHHHHHHHHHHHHHhhhhccccccccCccccceEEEC----CCCeEEEcc
Confidence            99999987 55554443322        289999999999999999999999999999999999998    678999999


Q ss_pred             cccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCC-CCCCCccc----------cc
Q psy2172         174 MGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP-IFHCRQED----------IK  242 (291)
Q Consensus       174 fg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~-pf~~~~~~----------~~  242 (291)
                      ||+++................||..|+|||.+.+.. ++.++|||||||++|||++|.. ||.+....          ..
T Consensus       154 FGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~  232 (283)
T d1mqba_         154 FGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL  232 (283)
T ss_dssp             CCC-----------------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC
T ss_pred             cchhhcccCCCccceEeccCCCCccccCHHHHccCC-CCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCC
Confidence            999987654332222333456789999999998754 9999999999999999998654 45433221          11


Q ss_pred             CCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         243 TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       243 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      .........+.+++..|..+.|..||++.++
T Consensus       233 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ei  263 (283)
T d1mqba_         233 PTPMDCPSAIYQLMMQCWQQERARRPKFADI  263 (283)
T ss_dssp             CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             CCchhhHHHHHHHHHHHCcCCHhHCcCHHHH
Confidence            2233345778999999999999999998864

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-47  Score=325.45  Aligned_cols=244  Identities=30%  Similarity=0.509  Sum_probs=196.6

Q ss_pred             ccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC----hhHHHHHHHHhcCCCCCeeeEEEEEEeCC-
Q psy2172          15 KVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIALLRELKHPNVINLISVFLSHN-   89 (291)
Q Consensus        15 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-   89 (291)
                      .+.++|++ .++||+|+||.||+|.++.  +++.||||+++.....    +.+.+|+.+|+.++||||++++++|...+ 
T Consensus        15 ~~~~~Y~~-i~~lG~G~fg~V~~~~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~   91 (346)
T d1cm8a_          15 EVRAVYRD-LQPVGSGAYGAVCSAVDGR--TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET   91 (346)
T ss_dssp             CCBSSEEE-EEEC------CEEEEEETT--TCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred             ecCCcEEE-EEEEecCCCeEEEEEEECC--CCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcc
Confidence            57788985 6799999999999999876  6789999999754433    35788999999999999999999995432 


Q ss_pred             ---CceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCC
Q psy2172          90 ---DRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIER  166 (291)
Q Consensus        90 ---~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~  166 (291)
                         ...+|+||||++.++.......+          +++..++.++.|++.||+|||++||+||||||+||+++    .+
T Consensus        92 ~~~~~~~~lv~e~~~~~l~~~~~~~~----------l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~----~~  157 (346)
T d1cm8a_          92 LDDFTDFYLVMPFMGTDLGKLMKHEK----------LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN----ED  157 (346)
T ss_dssp             TTTCCCCEEEEECCSEEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TT
T ss_pred             ccccceEEEEEecccccHHHHHHhcc----------ccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcc----cc
Confidence               23689999999878777665322          99999999999999999999999999999999999998    77


Q ss_pred             CcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccc-----
Q psy2172         167 GRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI-----  241 (291)
Q Consensus       167 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~-----  241 (291)
                      +.++++|||.+......      .....||+.|+|||.+.+...++.++||||+||++|+|++|+.||.+.+...     
T Consensus       158 ~~~kl~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~  231 (346)
T d1cm8a_         158 CELKILDFGLARQADSE------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI  231 (346)
T ss_dssp             CCEEECCCTTCEECCSS------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             cccccccccceeccCCc------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHH
Confidence            89999999999876542      2446789999999999876668999999999999999999999998754210     


Q ss_pred             -----------------------------------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         242 -----------------------------------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       242 -----------------------------------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                                                         ....+...+.+.+++..|....|..||++.++..|||+..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~  306 (346)
T d1cm8a_         232 MKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES  306 (346)
T ss_dssp             HHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred             HhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCc
Confidence                                               0011222456778999999999999999999999988753

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-47  Score=312.80  Aligned_cols=237  Identities=20%  Similarity=0.339  Sum_probs=180.8

Q ss_pred             cccccccceeCcccceEEEEEEEccCC-CCceeEEEEeCCCCCC---hhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNS-DTRDYALKQIEGTGLS---MSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~-~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      +.|++ ++.||+|+||.||+|.+.... ....||||.++.....   ..+.+|+.+|++++||||+++++++  . ....
T Consensus         7 ~~~~l-~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~--~-~~~~   82 (273)
T d1mp8a_           7 ERIEL-GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI--T-ENPV   82 (273)
T ss_dssp             GGEEE-EEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE--C-SSSC
T ss_pred             HHeEE-EEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE--e-cCeE
Confidence            45664 789999999999999986532 3456899998654333   3588999999999999999999998  3 3568


Q ss_pred             EEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          94 WLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        94 ~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      |+||||+.+ ++..++.....        .+++..++.++.|++.||+|||++|++||||||+||+++    ..+.+||+
T Consensus        83 ~iv~E~~~~g~l~~~~~~~~~--------~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~----~~~~~Kl~  150 (273)
T d1mp8a_          83 WIIMELCTLGELRSFLQVRKY--------SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS----SNDCVKLG  150 (273)
T ss_dssp             EEEEECCTTEEHHHHHHHTTT--------TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE----ETTEEEEC
T ss_pred             EEEEEeccCCcHHhhhhccCC--------CCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeec----CCCcEEEc
Confidence            999999985 66665543322        289999999999999999999999999999999999999    66799999


Q ss_pred             ecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc----------c
Q psy2172         173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED----------I  241 (291)
Q Consensus       173 Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~----------~  241 (291)
                      |||+++.......  .......||+.|+|||.+.+.. ++.++|||||||++|+|++ |.+||.+....          .
T Consensus       151 DfG~a~~~~~~~~--~~~~~~~gt~~y~apE~l~~~~-~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~  227 (273)
T d1mp8a_         151 DFGLSRYMEDSTY--YKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER  227 (273)
T ss_dssp             C---------------------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred             cchhheeccCCcc--eeccceecCcccchhhHhccCC-CCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC
Confidence            9999986544221  2234456789999999998754 8999999999999999987 89999876543          1


Q ss_pred             cCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         242 KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       242 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      ....+...+.+.+++..|..+.|..||++.++
T Consensus       228 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei  259 (273)
T d1mp8a_         228 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL  259 (273)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHH
Confidence            23344556789999999999999999998874

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-46  Score=315.20  Aligned_cols=247  Identities=17%  Similarity=0.183  Sum_probs=195.3

Q ss_pred             ccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCce
Q psy2172          13 RTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRK   92 (291)
Q Consensus        13 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (291)
                      ..++.++|++ ++.||+|+||.||+|.++.  +++.||||++.......++..|+++++.++|++++..+..+. .+...
T Consensus         2 ~~~vg~rY~l-~~~iG~G~fG~Vy~a~~~~--~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~-~~~~~   77 (299)
T d1ckia_           2 ELRVGNRYRL-GRKIGSGSFGDIYLGTDIA--AGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCG-AEGDY   77 (299)
T ss_dssp             CCEETTTEEE-EEEEEECSSSEEEEEEETT--TTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEE-EETTE
T ss_pred             CCeECCEEEE-eEEEeeCCCcEEEEEEECC--CCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEE-ecCCE
Confidence            4567788996 7799999999999999876  678999999887666778999999999998766554444433 34668


Q ss_pred             EEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          93 VWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        93 ~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      .++||||+++++...+.....        .+++..+..++.|++.||+|||++||+||||||+||+++..+ ....++++
T Consensus        78 ~~ivme~~~~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~-~~~~vkl~  148 (299)
T d1ckia_          78 NVMVMELLGPSLEDLFNFCSR--------KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGK-KGNLVYII  148 (299)
T ss_dssp             EEEEEECCCCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGG-GTTCEEEC
T ss_pred             EEEEEEEcCCchhhhhhhccC--------CCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccC-CCceeeee
Confidence            999999999998877664332        289999999999999999999999999999999999987543 45689999


Q ss_pred             ecccceecCCCCCC----CCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcccccC-----
Q psy2172         173 DMGFARLFNNPLKP----LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT-----  243 (291)
Q Consensus       173 Dfg~~~~~~~~~~~----~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~~-----  243 (291)
                      |||+|+........    ........||+.|+|||.+.+.+ ++.++|||||||++|+|++|..||.........     
T Consensus       149 DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~  227 (299)
T d1ckia_         149 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER  227 (299)
T ss_dssp             CCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBC-CCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHH
T ss_pred             ccCcceeccccccccceeccccCCcCCCccccCHHHHhCCC-CCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHH
Confidence            99999987653221    12334568999999999998855 899999999999999999999999875543211     


Q ss_pred             ------------CCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         244 ------------SNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       244 ------------~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                                  ..+...+.+.+++..+....|.+||++.++
T Consensus       228 ~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i  269 (299)
T d1ckia_         228 ISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYL  269 (299)
T ss_dssp             HHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHH
T ss_pred             hhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence                        112234567788888888888888877643

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-46  Score=315.90  Aligned_cols=249  Identities=34%  Similarity=0.581  Sum_probs=195.5

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC----CCChhHHHHHHHHhcCCCCCeeeEEEEEEeC-----
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT----GLSMSACREIALLRELKHPNVINLISVFLSH-----   88 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----   88 (291)
                      ++|++ .++||+|+||+||+|.++.  +++.||||++...    .....+.+|+.+|++++||||+++++++...     
T Consensus        10 ~rY~i-~~~LG~G~fg~Vy~a~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~   86 (318)
T d3blha1          10 SKYEK-LAKIGQGTFGEVFKARHRK--TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN   86 (318)
T ss_dssp             GGEEE-EEEEEECSSSEEEEEEETT--TCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred             CCEEE-EEEEecCcCeEEEEEEECC--CCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence            67775 6799999999999999876  7789999998533    3345688999999999999999999998542     


Q ss_pred             -CCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCC
Q psy2172          89 -NDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERG  167 (291)
Q Consensus        89 -~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~  167 (291)
                       .....|++||++++++........        ..+++..++.++.|++.||.|||++||+||||||+||+++    .++
T Consensus        87 ~~~~~~~iv~e~~~~~~~~~~~~~~--------~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~----~~~  154 (318)
T d3blha1          87 RCKGSIYLVFDFCEHDLAGLLSNVL--------VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT----RDG  154 (318)
T ss_dssp             ----CEEEEEECCCEEHHHHHTCTT--------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTS
T ss_pred             ccCceEEEEEeccCCCccchhhhcc--------cccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeec----CCC
Confidence             245689999999987766543222        1289999999999999999999999999999999999998    677


Q ss_pred             cEEEeecccceecCCCCC-CCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc----
Q psy2172         168 RVKIADMGFARLFNNPLK-PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK----  242 (291)
Q Consensus       168 ~~~l~Dfg~~~~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~----  242 (291)
                      .++++|||++........ .........||+.|+|||.+.+...++.++||||+||++|+|++|+.||.+......    
T Consensus       155 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i  234 (318)
T d3blha1         155 VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI  234 (318)
T ss_dssp             CEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             cEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHH
Confidence            999999999987654322 122334457899999999998766689999999999999999999999986442100    


Q ss_pred             ----------------------------CCCCC---------cHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         243 ----------------------------TSNPY---------HHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       243 ----------------------------~~~~~---------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                                                  .....         ....+.+++..|..+.|..|++++++..|||+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~  310 (318)
T d3blha1         235 SQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  310 (318)
T ss_dssp             HHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred             HHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence                                        00000         0233456889999999999999999999999864

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.9e-46  Score=318.27  Aligned_cols=250  Identities=22%  Similarity=0.411  Sum_probs=202.3

Q ss_pred             cccccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCC-CCCeeeEEEEEEeC
Q psy2172          10 SNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELK-HPNVINLISVFLSH   88 (291)
Q Consensus        10 ~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~   88 (291)
                      .+......++|++ .++||+|+||+||+|+++.  +++.||||+++.. ...++.+|+.+|+.++ ||||+++++++...
T Consensus        27 ~~~~~~~~d~y~i-~~~LG~G~fg~V~~a~~~~--~~~~vAiK~i~~~-~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~  102 (328)
T d3bqca1          27 HVVEWGNQDDYQL-VRKLGRGKYSEVFEAINIT--NNEKVVVKILKPV-KKKKIKREIKILENLRGGPNIITLADIVKDP  102 (328)
T ss_dssp             CCCCCCCGGGEEE-EEEEEECSSEEEEEEEETT--TTEEEEEEEECSS-CHHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred             cccCCCCCcCeEE-EEEEecCcCeEEEEEEECC--CCCEEEEEEECHH-HHHHHHHHHHHHHhccCCCCCcEEEEEEEec
Confidence            3444445577886 6799999999999999876  7789999999754 3567889999999995 99999999999766


Q ss_pred             CCceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCC
Q psy2172          89 NDRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERG  167 (291)
Q Consensus        89 ~~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~  167 (291)
                      .....++||||+++ +|....            ..+++..++.++.||+.||+|||++||+||||||+|||++.   ...
T Consensus       103 ~~~~~~~v~e~~~~~~L~~~~------------~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~---~~~  167 (328)
T d3bqca1         103 VSRTPALVFEHVNNTDFKQLY------------QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH---EHR  167 (328)
T ss_dssp             TTCSEEEEEECCCSCBGGGTT------------TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET---TTT
T ss_pred             CCCceeEEEeecCCCcHHHHh------------cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcC---CCC
Confidence            67789999999996 443221            12899999999999999999999999999999999999984   234


Q ss_pred             cEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc-----
Q psy2172         168 RVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK-----  242 (291)
Q Consensus       168 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~-----  242 (291)
                      .++|+|||+|.......    ......+|+.|+|||.+.+...++.++|+||+||++|+|++|..||........     
T Consensus       168 ~vkl~DFG~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i  243 (328)
T d3bqca1         168 KLRLIDWGLAEFYHPGQ----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI  243 (328)
T ss_dssp             EEEECCGGGCEECCTTC----CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHH
T ss_pred             eeeecccccceeccCCC----cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHH
Confidence            69999999998765432    234457799999999998766689999999999999999999999976432110     


Q ss_pred             ------------------------------------------CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchh
Q psy2172         243 ------------------------------------------TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLL  280 (291)
Q Consensus       243 ------------------------------------------~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  280 (291)
                                                                ...........++++.|....|..|++++++.+|||+.
T Consensus       244 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~  323 (328)
T d3bqca1         244 AKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY  323 (328)
T ss_dssp             HHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             HHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence                                                      00011235577899999999999999999999999986


Q ss_pred             hh
Q psy2172         281 KD  282 (291)
Q Consensus       281 ~~  282 (291)
                      .-
T Consensus       324 ~v  325 (328)
T d3bqca1         324 TV  325 (328)
T ss_dssp             TS
T ss_pred             CC
Confidence            54

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-46  Score=306.89  Aligned_cols=230  Identities=17%  Similarity=0.301  Sum_probs=183.6

Q ss_pred             cccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEec
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDY   99 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~   99 (291)
                      |++ +++||+|+||.||+|.++    +..||||.++++...+.+.+|++++++++||||+++++++.+ +...+|+||||
T Consensus         9 ~~~-~~~lG~G~fg~Vy~~~~~----~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~~~lv~ey   82 (262)
T d1byga_           9 LKL-LQTIGKGEFGDVMLGDYR----GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE-EKGGLYIVTEY   82 (262)
T ss_dssp             EEE-EEEEEECSSCEEEEEEET----TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECC-C--CCEEEECC
T ss_pred             eEE-eEEEecCCCeEEEEEEEC----CeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEe-cCCcEEEEEec
Confidence            443 678999999999999975    357999999988888899999999999999999999998854 33457999999


Q ss_pred             CCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccce
Q psy2172         100 AEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR  178 (291)
Q Consensus       100 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~  178 (291)
                      +++ +|.+++.......       +++..++.++.|++.||+|||+++|+|+||||+||+++    .++.++++|||+++
T Consensus        83 ~~~g~L~~~l~~~~~~~-------l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~----~~~~~kl~dfg~s~  151 (262)
T d1byga_          83 MAKGSLVDYLRSRGRSV-------LGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS----EDNVAKVSDFGLTK  151 (262)
T ss_dssp             CTTEEHHHHHHHHHHHH-------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----TTSCEEECCCCC--
T ss_pred             cCCCCHHHHHHhcCCCC-------CCHHHHHHHHHHHHhhccccccCceeccccchHhheec----CCCCEeecccccce
Confidence            975 8888886544322       89999999999999999999999999999999999998    67899999999998


Q ss_pred             ecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc----------cCCCCC
Q psy2172         179 LFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI----------KTSNPY  247 (291)
Q Consensus       179 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~----------~~~~~~  247 (291)
                      .....      .....++..|+|||.+.+.. ++.++||||||+++|||++ |.+||.......          +...+.
T Consensus       152 ~~~~~------~~~~~~~~~y~aPE~l~~~~-~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~  224 (262)
T d1byga_         152 EASST------QDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG  224 (262)
T ss_dssp             ----------------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTT
T ss_pred             ecCCC------CccccccccCCChHHHhCCC-CChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence            65432      22345688899999998754 8999999999999999998 788888765421          223334


Q ss_pred             cHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         248 HHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       248 ~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      ..+.+.+++..|....|..||++.++
T Consensus       225 ~~~~~~~li~~cl~~dP~~Rps~~~l  250 (262)
T d1byga_         225 CPPAVYEVMKNCWHLDAAMRPSFLQL  250 (262)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCHHHHHHHHHHcccCHhHCcCHHHH
Confidence            45788999999999999999998864

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-46  Score=309.66  Aligned_cols=235  Identities=22%  Similarity=0.355  Sum_probs=181.9

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC-ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL-SMSACREIALLRELKHPNVINLISVFLSHNDRKVWLL   96 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv   96 (291)
                      +.|++ ++.||+|+||.||+|.+++   ++.||||.++.... .+.+.+|+.++++++|||||++++++  .+ ...++|
T Consensus        17 ~~~~i-~~~iG~G~fg~Vy~~~~~~---~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~--~~-~~~~lv   89 (285)
T d1fmka3          17 ESLRL-EVKLGQGCFGEVWMGTWNG---TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV--SE-EPIYIV   89 (285)
T ss_dssp             GGEEE-EEEEEECSSCEEEEEEETT---TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEE--CS-SSCEEE
T ss_pred             HHEEE-eeEEeeCCCeEEEEEEECC---CCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEE--ec-CCeEEE
Confidence            34664 7799999999999999864   35699999975543 35699999999999999999999988  33 346899


Q ss_pred             EecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecc
Q psy2172          97 FDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMG  175 (291)
Q Consensus        97 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg  175 (291)
                      |||+.+ ++..++.......       +++..++.++.|++.||+|||++||+|+||||+||+++    .++.+||+|||
T Consensus        90 ~Ey~~~g~l~~~~~~~~~~~-------l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~----~~~~~kl~DfG  158 (285)
T d1fmka3          90 TEYMSKGSLLDFLKGETGKY-------LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG----ENLVCKVADFG  158 (285)
T ss_dssp             ECCCTTCBHHHHHSHHHHTT-------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----GGGCEEECCCC
T ss_pred             EEecCCCchhhhhhhccccc-------chHHHHHHHHHHHHHHHHHHhhhheecccccceEEEEC----CCCcEEEcccc
Confidence            999985 6666665443221       89999999999999999999999999999999999998    66899999999


Q ss_pred             cceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcC-CCCCCCCccc----------ccCC
Q psy2172         176 FARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQED----------IKTS  244 (291)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g-~~pf~~~~~~----------~~~~  244 (291)
                      +++.......  .......||+.|+|||++.... ++.++||||||+++|+|++| .+||.+....          ....
T Consensus       159 la~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~  235 (285)
T d1fmka3         159 LARLIEDNEY--TARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC  235 (285)
T ss_dssp             TTC----------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred             hhhhccCCCc--eeeccccccccccChHHHhCCC-CCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence            9986643221  2223457899999999998755 89999999999999999996 4555544321          1223


Q ss_pred             CCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         245 NPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       245 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      .....+.+.+++..|....|..||+++++
T Consensus       236 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i  264 (285)
T d1fmka3         236 PPECPESLHDLMCQCWRKEPEERPTFEYL  264 (285)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CcccCHHHHHHHHHHcccCHhHCcCHHHH
Confidence            44456778899999999999999988874

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-46  Score=310.04  Aligned_cols=237  Identities=22%  Similarity=0.297  Sum_probs=180.8

Q ss_pred             cccccceeCcccceEEEEEEEccC-CCCceeEEEEeCCCC-----CChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKDN-SDTRDYALKQIEGTG-----LSMSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~~-~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      |++ .+.||+|+||.||+|.+... +....||||.+....     ..+++.+|+.+|++++||||+++++++.  + ...
T Consensus        10 ~~~-~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~--~-~~~   85 (273)
T d1u46a_          10 LRL-LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL--T-PPM   85 (273)
T ss_dssp             EEE-EEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--S-SSC
T ss_pred             eEE-EEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe--e-cch
Confidence            554 66999999999999987543 234568999986432     1246889999999999999999999993  3 356


Q ss_pred             EEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEe
Q psy2172          94 WLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIA  172 (291)
Q Consensus        94 ~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~  172 (291)
                      ++||||+++ ++.+.+......        +++..++.++.|++.||+|||++||+||||||+||+++    .++.+||+
T Consensus        86 ~lv~e~~~~~~l~~~~~~~~~~--------l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~----~~~~vkl~  153 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKHQGH--------FLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA----TRDLVKIG  153 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGG--------SCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE----ETTEEEEC
T ss_pred             heeeeeecCcchhhhhhcccCC--------CCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccc----cccceeec
Confidence            899999985 777666554322        89999999999999999999999999999999999999    66799999


Q ss_pred             ecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCccc-----------
Q psy2172         173 DMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED-----------  240 (291)
Q Consensus       173 Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~-----------  240 (291)
                      |||+++................|+..|+|||.+.+.. ++.++||||||+++|||++ |..||.+.+..           
T Consensus       154 DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~  232 (273)
T d1u46a_         154 DFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE  232 (273)
T ss_dssp             CCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC
T ss_pred             cchhhhhcccCCCcceecCccccCcccCCHHHHhCCC-CCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCC
Confidence            9999998765444333344556788999999998754 8999999999999999997 89999876432           


Q ss_pred             ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         241 IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       241 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      .....+...+.+.+++..|..+.|..||++.++
T Consensus       233 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei  265 (273)
T d1u46a_         233 RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL  265 (273)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCcccccHHHHHHHHHHcCCChhHCcCHHHH
Confidence            112223445778999999999999999988864

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-46  Score=314.41  Aligned_cols=238  Identities=22%  Similarity=0.308  Sum_probs=184.7

Q ss_pred             cccccceeCcccceEEEEEEEccCCC--CceeEEEEeCCC---CCChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEE
Q psy2172          20 FDYEGCKVGRGTYGHVYKARRKDNSD--TRDYALKQIEGT---GLSMSACREIALLRELKHPNVINLISVFLSHNDRKVW   94 (291)
Q Consensus        20 ~~~~~~~ig~G~~g~Vy~~~~~~~~~--~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (291)
                      |++ .++||+|+||.||+|.+..++.  ...||+|.++..   ...+++.+|+.++++++|||||++++++.+  . ..+
T Consensus        11 y~~-~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--~-~~~   86 (317)
T d1xkka_          11 FKK-IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT--S-TVQ   86 (317)
T ss_dssp             EEE-EEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES--S-SEE
T ss_pred             CEE-eeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--C-Cee
Confidence            553 6799999999999999876322  235889988643   234578999999999999999999999843  3 345


Q ss_pred             EEEecCC-CCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEee
Q psy2172          95 LLFDYAE-HDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIAD  173 (291)
Q Consensus        95 iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~D  173 (291)
                      ++++++. ++|.+.+.....        .+++..++.++.|++.||+|||++||+||||||+||+++    .++.+||+|
T Consensus        87 ~v~e~~~~~~l~~~~~~~~~--------~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~----~~~~~kl~D  154 (317)
T d1xkka_          87 LITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK----TPQHVKITD  154 (317)
T ss_dssp             EEEECCTTCBHHHHHHHTSS--------SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE----ETTEEEECC
T ss_pred             EEEEeccCCccccccccccc--------CCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeC----CCCCeEeec
Confidence            5666665 688877664322        289999999999999999999999999999999999999    677999999


Q ss_pred             cccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcccc----------c
Q psy2172         174 MGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI----------K  242 (291)
Q Consensus       174 fg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~~~----------~  242 (291)
                      ||+++........ .......||..|+|||.+.+.. ++.++|||||||++|+|++ |.+||.+.....          .
T Consensus       155 FGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~-~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~  232 (317)
T d1xkka_         155 FGLAKLLGAEEKE-YHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL  232 (317)
T ss_dssp             CSHHHHTTTTCC---------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCC
T ss_pred             cccceeccccccc-ccccccccCccccChHHHhcCC-CChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC
Confidence            9999876543221 2223346799999999998754 8999999999999999998 899998765431          2


Q ss_pred             CCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCC
Q psy2172         243 TSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPE  275 (291)
Q Consensus       243 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  275 (291)
                      ...+.....+.+++..|....|..||++.++..
T Consensus       233 ~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~  265 (317)
T d1xkka_         233 PQPPICTIDVYMIMVKCWMIDADSRPKFRELII  265 (317)
T ss_dssp             CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHH
Confidence            233455678999999999999999999887543

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-45  Score=306.75  Aligned_cols=243  Identities=35%  Similarity=0.609  Sum_probs=196.4

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCC----ChhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGL----SMSACREIALLRELKHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (291)
                      ++|++ .++||+|+||+||+|+++.  +++.||||+++....    ...+.+|+.+|+.++||||+++++++  .+....
T Consensus         2 ~ry~~-i~~LG~G~fg~V~~~~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~--~~~~~~   76 (292)
T d1unla_           2 QKYEK-LEKIGEGTYGTVFKAKNRE--THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL--HSDKKL   76 (292)
T ss_dssp             CSEEE-EEEEEECSSSEEEEEEETT--TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE--ECSSEE
T ss_pred             CCCEe-eeEEecCcCeEEEEEEECC--CCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccc--ccccce
Confidence            46775 5699999999999999876  778899999864432    34678999999999999999999999  567789


Q ss_pred             EEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEee
Q psy2172          94 WLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIAD  173 (291)
Q Consensus        94 ~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~D  173 (291)
                      +++++++.++....+.....        .+++..++.++.|++.||+|||++||+|+||||+||+++    ..+.++|+|
T Consensus        77 ~iv~~~~~~~~l~~~~~~~~--------~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~----~~~~~kl~D  144 (292)
T d1unla_          77 TLVFEFCDQDLKKYFDSCNG--------DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN----RNGELKLAN  144 (292)
T ss_dssp             EEEEECCSEEHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTCCEEECC
T ss_pred             eEEeeecccccccccccccc--------ccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccc----cCCceeeee
Confidence            99999999866555543221        288999999999999999999999999999999999998    667899999


Q ss_pred             cccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCcc-c------------
Q psy2172         174 MGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE-D------------  240 (291)
Q Consensus       174 fg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~-~------------  240 (291)
                      ||.+........   ......++..|+|||.+.+...++.++||||+||++|+|++|+.||..... .            
T Consensus       145 FG~a~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~  221 (292)
T d1unla_         145 FGLARAFGIPVR---CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT  221 (292)
T ss_dssp             CTTCEECCSCCS---CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCC
T ss_pred             cchhhcccCCCc---cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCC
Confidence            999987654322   223345678899999988766679999999999999999999988632221 0            


Q ss_pred             --------------------------ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchh
Q psy2172         241 --------------------------IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLL  280 (291)
Q Consensus       241 --------------------------~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  280 (291)
                                                .....+.......+++..|..+.|..||+++++..|||+.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~  287 (292)
T d1unla_         222 PTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS  287 (292)
T ss_dssp             CCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGS
T ss_pred             CChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhc
Confidence                                      0011112245677899999999999999999999999985

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=7.4e-46  Score=309.33  Aligned_cols=242  Identities=15%  Similarity=0.210  Sum_probs=192.0

Q ss_pred             cccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCC-CCeeeEEEEEEeCCCceEE
Q psy2172          16 VEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKH-PNVINLISVFLSHNDRKVW   94 (291)
Q Consensus        16 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~~   94 (291)
                      +.++|++ +++||+|+||+||+|.+..  +++.||||+++.......+.+|++.++.++| +|++.+++++  ......+
T Consensus         3 ig~~Y~i-~~~iG~G~fG~Vy~a~~~~--~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~--~~~~~~~   77 (293)
T d1csna_           3 VGVHYKV-GRRIGEGSFGVIFEGTNLL--NNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG--QEGLHNV   77 (293)
T ss_dssp             ETTTEEE-EEEEEECSSCEEEEEEETT--TTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEE--EETTEEE
T ss_pred             CCCceEE-EEEEecCCCeEEEEEEECC--CCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEe--ecCCccE
Confidence            4678886 7799999999999999876  6789999998776667788999999999975 8999999998  4577899


Q ss_pred             EEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCC-CCCCcEEEee
Q psy2172          95 LLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEG-IERGRVKIAD  173 (291)
Q Consensus        95 iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~-~~~~~~~l~D  173 (291)
                      +||||++++|.+.+.....        .++...+..++.|++.||++||++||+||||||+||+++... ...+.++|+|
T Consensus        78 ~vme~~~~~l~~~~~~~~~--------~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~D  149 (293)
T d1csna_          78 LVIDLLGPSLEDLLDLCGR--------KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVD  149 (293)
T ss_dssp             EEEECCCCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred             EEEEecCCCHHHHHHhhcc--------chhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcc
Confidence            9999999999888765432        289999999999999999999999999999999999997532 1356899999


Q ss_pred             cccceecCCCCC----CCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc-------
Q psy2172         174 MGFARLFNNPLK----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK-------  242 (291)
Q Consensus       174 fg~~~~~~~~~~----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~-------  242 (291)
                      ||+|+.......    .........||+.|+|||++.+.. ++.++||||||+++|+|++|..||.+......       
T Consensus       150 FG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~-~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i  228 (293)
T d1csna_         150 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI  228 (293)
T ss_dssp             CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH
T ss_pred             cceeEEcccCccccceeecccCceEEchhhcCHHHhcCCC-CChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHH
Confidence            999988654322    122334567999999999998854 99999999999999999999999986544210       


Q ss_pred             ----------CCCCCcHHHHHHHHHhhCCCCcCChhhhh
Q psy2172         243 ----------TSNPYHHDQLDRIFSVMGFPLEKDWEDIR  271 (291)
Q Consensus       243 ----------~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  271 (291)
                                ...+...+.+.+++..+....+.++|+.+
T Consensus       229 ~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~  267 (293)
T d1csna_         229 GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYD  267 (293)
T ss_dssp             HHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHH
T ss_pred             HhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHH
Confidence                      00112234566666666656666666443

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-46  Score=317.88  Aligned_cols=253  Identities=30%  Similarity=0.472  Sum_probs=196.9

Q ss_pred             eeecccccccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC----hhHHHHHHHHhcCCCCCeeeEE
Q psy2172           7 IKTSNERTKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIALLRELKHPNVINLI   82 (291)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~   82 (291)
                      +..+...+.|.++|++ .++||+|+||+||+|.++.  +++.||||+++.....    .++.+|+.++++++||||++++
T Consensus         6 ~~~~~~~f~i~~~Y~i-~~~LG~G~fg~V~~~~d~~--t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~   82 (355)
T d2b1pa1           6 VEVGDSTFTVLKRYQN-LKPIGSGAQGIVCAAYDAV--LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL   82 (355)
T ss_dssp             EEETTEEEEEETTEEE-EEECSCC--CEEEEEEETT--TTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred             EEeCCcceeecCCeEE-EEEeecCcCeEEEEEEECC--CCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEE
Confidence            3344446667788885 6799999999999999876  7789999999765433    3478999999999999999999


Q ss_pred             EEEEeC----CCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEE
Q psy2172          83 SVFLSH----NDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANIL  158 (291)
Q Consensus        83 ~~~~~~----~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil  158 (291)
                      ++|...    +....|+||||+.+++...+..           .+++..++.++.|++.||+|||++||+|+||||+||+
T Consensus        83 ~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~~-----------~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil  151 (355)
T d2b1pa1          83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQM-----------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV  151 (355)
T ss_dssp             EEECSCCSTTTCCEEEEEEECCSEEHHHHHTS-----------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             EEEecccccccCceeEEEEeccchHHHHhhhc-----------CCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccc
Confidence            999543    4478999999999987765521           2899999999999999999999999999999999999


Q ss_pred             eecCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCc
Q psy2172         159 VMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  238 (291)
Q Consensus       159 ~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~  238 (291)
                      ++    .++.++++|||.+......    .......+|+.|+|||++.+.. ++.++||||+||++++|++|++||.+.+
T Consensus       152 ~~----~~~~~kl~df~~~~~~~~~----~~~~~~~~t~~y~aPE~l~~~~-~~~~~DiwSlG~~l~ell~g~~pF~~~~  222 (355)
T d2b1pa1         152 VK----SDCTLKILDFGLARTAGTS----FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRD  222 (355)
T ss_dssp             EC----TTCCEEECCCCC-------------------CCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cc----cccceeeechhhhhccccc----cccccccccccccChhhhcCCC-CCCCcccccccchHHHHhhCCCCCCCCC
Confidence            98    6778999999998765442    2334557899999999998854 8999999999999999999999997654


Q ss_pred             cccc-------------------------------CC--------------------CCCcHHHHHHHHHhhCCCCcCCh
Q psy2172         239 EDIK-------------------------------TS--------------------NPYHHDQLDRIFSVMGFPLEKDW  267 (291)
Q Consensus       239 ~~~~-------------------------------~~--------------------~~~~~~~~~~i~~~~~~~~~~~~  267 (291)
                      ....                               ..                    ....++.+.++++.|..+.|..|
T Consensus       223 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R  302 (355)
T d2b1pa1         223 YIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR  302 (355)
T ss_dssp             HHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTS
T ss_pred             HHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHC
Confidence            2100                               00                    00113456789999999999999


Q ss_pred             hhhhcCCCCcchhhh
Q psy2172         268 EDIRKMPEHPTLLKD  282 (291)
Q Consensus       268 ~~~~~~~~~~~~~~~  282 (291)
                      |+++++..|||+...
T Consensus       303 ~ta~elL~Hpw~~~~  317 (355)
T d2b1pa1         303 ISVDDALQHPYINVW  317 (355)
T ss_dssp             CCHHHHHTSTTTGGG
T ss_pred             cCHHHHhcCcccCCC
Confidence            999999999999753

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.4e-45  Score=306.55  Aligned_cols=246  Identities=24%  Similarity=0.347  Sum_probs=192.2

Q ss_pred             cccccccceeCcccceEEEEEEEcc---CCCCceeEEEEeCCCCCC---hhHHHHHHHHhcCCCCCeeeEEEEEEeCCCc
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKD---NSDTRDYALKQIEGTGLS---MSACREIALLRELKHPNVINLISVFLSHNDR   91 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~---~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (291)
                      +.|++ .+.||+|+||.||+|.+++   ..+++.||||+++.....   .++.+|+.++++++||||+++++++  .+..
T Consensus        13 ~~~~~-~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~--~~~~   89 (301)
T d1lufa_          13 NNIEY-VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC--AVGK   89 (301)
T ss_dssp             GGCEE-EEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE--CSSS
T ss_pred             HHcEE-eEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee--ccCC
Confidence            45664 6799999999999999864   235577999999754433   4588999999999999999999999  5677


Q ss_pred             eEEEEEecCC-CCHHHHHHHhhhh---------------hhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCC
Q psy2172          92 KVWLLFDYAE-HDLWHIIKFHRAA---------------KANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPA  155 (291)
Q Consensus        92 ~~~iv~e~~~-~~l~~~~~~~~~~---------------~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~  155 (291)
                      ..+++|||+. |+|.+++......               ........++...+..++.|++.||+|||+++++||||||+
T Consensus        90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~  169 (301)
T d1lufa_          90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR  169 (301)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEccc
Confidence            8999999997 5888887643211               01112233889999999999999999999999999999999


Q ss_pred             cEEeecCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCC-CCC
Q psy2172         156 NILVMGEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIF  234 (291)
Q Consensus       156 Nil~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~-~pf  234 (291)
                      ||+++    .++.+||+|||+++....... ........|++.|+|||.+.+.. ++.++|||||||++|||++|. +||
T Consensus       170 NILld----~~~~~Kl~DFGls~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~-~t~ksDVwS~Gvvl~ell~~~~~p~  243 (301)
T d1lufa_         170 NCLVG----ENMVVKIADFGLSRNIYSADY-YKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPY  243 (301)
T ss_dssp             GEEEC----GGGCEEECCCSCHHHHTGGGC-BC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             ceEEC----CCCcEEEccchhheeccCCcc-ccccCCCCcCcCcCCHHHHccCC-CChhhhhccchhhHHHHHccCCCCC
Confidence            99998    668899999999986544321 12234456789999999998754 999999999999999999985 788


Q ss_pred             CCCccc----------ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         235 HCRQED----------IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       235 ~~~~~~----------~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      .+....          .+.........+.+++..|..+.|..||++.+
T Consensus       244 ~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~e  291 (301)
T d1lufa_         244 YGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCS  291 (301)
T ss_dssp             TTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHH
Confidence            876543          12223344567889999999999999998876

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-45  Score=310.85  Aligned_cols=246  Identities=22%  Similarity=0.348  Sum_probs=200.4

Q ss_pred             cccccccceeCcccceEEEEEEEcc-CCCCceeEEEEeCCC------CCChhHHHHHHHHhcCCC-CCeeeEEEEEEeCC
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKD-NSDTRDYALKQIEGT------GLSMSACREIALLRELKH-PNVINLISVFLSHN   89 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~~~~vaiK~~~~~------~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~   89 (291)
                      +.|++ .+.||+|+||+||+|.+.. ..+++.||||+++..      ...+.+.+|++++++++| |||+++++++  .+
T Consensus        24 ~~y~~-~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~--~~  100 (322)
T d1vzoa_          24 ENFEL-LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF--QT  100 (322)
T ss_dssp             GGEEE-EEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE--EE
T ss_pred             hceEE-EEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee--cc
Confidence            33664 6799999999999999754 336788999998632      234568899999999976 8999999999  55


Q ss_pred             CceEEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCc
Q psy2172          90 DRKVWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGR  168 (291)
Q Consensus        90 ~~~~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~  168 (291)
                      ....+++|||+.+ +|.+.+.....         +++..++.++.|++.||+|+|++||+|+||||+||+++    .++.
T Consensus       101 ~~~~~~v~e~~~~~~L~~~i~~~~~---------~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~----~~~~  167 (322)
T d1vzoa_         101 ETKLHLILDYINGGELFTHLSQRER---------FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD----SNGH  167 (322)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTSC
T ss_pred             CCceeeeeecccccHHHHHHHhccc---------ccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeec----CCCC
Confidence            6789999999985 88887765543         78999999999999999999999999999999999998    6679


Q ss_pred             EEEeecccceecCCCCCCCCCCCCceecccccccccccCCc-CCCCchhHHHHHHHHHHHHcCCCCCCCCcccc------
Q psy2172         169 VKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGAR-HYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI------  241 (291)
Q Consensus       169 ~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~------  241 (291)
                      ++|+|||++.......  ........|++.|+|||.+.+.. .++.++|||||||+||+|++|..||.+.....      
T Consensus       168 vkL~DFG~a~~~~~~~--~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~  245 (322)
T d1vzoa_         168 VVLTDFGLSKEFVADE--TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS  245 (322)
T ss_dssp             EEESCSSEEEECCGGG--GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH
T ss_pred             EEEeeccchhhhcccc--cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9999999998654321  12234567899999999997643 47889999999999999999999998765431      


Q ss_pred             -------cCCCCCcHHHHHHHHHhhCCCCcCChhh-----hhcCCCCcchhh
Q psy2172         242 -------KTSNPYHHDQLDRIFSVMGFPLEKDWED-----IRKMPEHPTLLK  281 (291)
Q Consensus       242 -------~~~~~~~~~~~~~i~~~~~~~~~~~~~~-----~~~~~~~~~~~~  281 (291)
                             ........+.+.+++..|..+.|..|++     ++++.+|||+.+
T Consensus       246 ~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~  297 (322)
T d1vzoa_         246 RRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  297 (322)
T ss_dssp             HHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             HhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence                   1233445778999999999999999984     788899999865

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-45  Score=303.96  Aligned_cols=249  Identities=20%  Similarity=0.320  Sum_probs=184.1

Q ss_pred             cccccccceeCcccceEEEEEEEccCC---CCceeEEEEeCCCCCC---hhHHHHHHHHhcC-CCCCeeeEEEEEEeCCC
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNS---DTRDYALKQIEGTGLS---MSACREIALLREL-KHPNVINLISVFLSHND   90 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~---~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~   90 (291)
                      +.|++ +++||+|+||.||+|.+....   +++.||||.++.....   ..+.+|..++.++ +|+||+.+++++.. +.
T Consensus        13 ~~y~~-~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~-~~   90 (299)
T d1ywna1          13 DRLKL-GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK-PG   90 (299)
T ss_dssp             GGEEE-EEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-TT
T ss_pred             HHEEE-eeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc-CC
Confidence            45664 789999999999999986532   4467999998754332   3466777777776 68999999998753 44


Q ss_pred             ceEEEEEecCC-CCHHHHHHHhhhhhhC-------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecC
Q psy2172          91 RKVWLLFDYAE-HDLWHIIKFHRAAKAN-------KKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGE  162 (291)
Q Consensus        91 ~~~~iv~e~~~-~~l~~~~~~~~~~~~~-------~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~  162 (291)
                      ..+++||||++ |+|.+++.........       .....+++..++.++.|+++||+|||++||+||||||+||+++  
T Consensus        91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~--  168 (299)
T d1ywna1          91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS--  168 (299)
T ss_dssp             SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC--
T ss_pred             CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeEC--
Confidence            57899999998 5888888765432110       0122388999999999999999999999999999999999998  


Q ss_pred             CCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcC-CCCCCCCccc-
Q psy2172         163 GIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQED-  240 (291)
Q Consensus       163 ~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g-~~pf~~~~~~-  240 (291)
                        .++.+||+|||+|+....... ........||+.|+|||.+.+.. ++.++|||||||++|+|++| .+||.+.... 
T Consensus       169 --~~~~~Kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~  244 (299)
T d1ywna1         169 --EKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  244 (299)
T ss_dssp             --GGGCEEECC------CCSCTT-SCCTTSCCCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred             --CCCcEEEccCcchhhcccccc-ccccCceeeCccccchhHhhcCC-CCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence              678999999999986554322 22334567899999999998754 89999999999999999986 5788876532 


Q ss_pred             ----------ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCC
Q psy2172         241 ----------IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMP  274 (291)
Q Consensus       241 ----------~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  274 (291)
                                .........+.+.+++..|..+.|..||++.++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil  288 (299)
T d1ywna1         245 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV  288 (299)
T ss_dssp             HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             HHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence                      1222233456788999999999999999887643

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-45  Score=314.72  Aligned_cols=245  Identities=32%  Similarity=0.499  Sum_probs=196.2

Q ss_pred             cccccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC----hhHHHHHHHHhcCCCCCeeeEEEEEEe--
Q psy2172          14 TKVEDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS----MSACREIALLRELKHPNVINLISVFLS--   87 (291)
Q Consensus        14 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~--   87 (291)
                      ..+.++|++ .++||+|+||+||+|+++.  +++.||||+++.....    ..+.+|+.+|+.++|||++++++++..  
T Consensus        14 ~~~~~rY~i-~~~LG~G~fg~Vy~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~   90 (348)
T d2gfsa1          14 WEVPERYQN-LSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   90 (348)
T ss_dssp             EEEETTEEE-EEECGGGTTSSEEEEEETT--TTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             ccCCCCeEE-EEEEecCCCeEEEEEEECC--CCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecc
Confidence            456788985 6799999999999999876  7889999999755332    357899999999999999999999843  


Q ss_pred             --CCCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCC
Q psy2172          88 --HNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIE  165 (291)
Q Consensus        88 --~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~  165 (291)
                        ++....++++++++++|.+++...          .+++..++.++.|++.||+|||++||+||||||+||+++    .
T Consensus        91 ~~~~~~~~~i~~~~~gg~L~~~~~~~----------~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~----~  156 (348)
T d2gfsa1          91 SLEEFNDVYLVTHLMGADLNNIVKCQ----------KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN----E  156 (348)
T ss_dssp             STTTCCCCEEEEECCSEEHHHHHTTC----------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----T
T ss_pred             ccccCceEEEEEeecCCchhhhcccc----------cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccc----c
Confidence              223456677666667888776421          299999999999999999999999999999999999998    6


Q ss_pred             CCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccccc---
Q psy2172         166 RGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK---  242 (291)
Q Consensus       166 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~~~---  242 (291)
                      ++.++++|||.+.....      ......|+..|+|||...+...++.++|+|||||++|+|++|++||.+.+....   
T Consensus       157 ~~~~kl~dfg~a~~~~~------~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~  230 (348)
T d2gfsa1         157 DCELKILDFGLARHTDD------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL  230 (348)
T ss_dssp             TCCEEECCC----CCTG------GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             cccccccccchhcccCc------ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            78999999999875443      234467899999999988766678999999999999999999999976542100   


Q ss_pred             -----------------------------C--------CCCCcHHHHHHHHHhhCCCCcCChhhhhcCCCCcchhh
Q psy2172         243 -----------------------------T--------SNPYHHDQLDRIFSVMGFPLEKDWEDIRKMPEHPTLLK  281 (291)
Q Consensus       243 -----------------------------~--------~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (291)
                                                   .        ........+.+++..|....|..||++.++..|||+.+
T Consensus       231 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~  306 (348)
T d2gfsa1         231 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ  306 (348)
T ss_dssp             HHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             HHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCC
Confidence                                         0        00122456778999999999999999999999999864

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-45  Score=307.37  Aligned_cols=245  Identities=22%  Similarity=0.296  Sum_probs=190.9

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCC---CCChhHHHHHHHHhcC-CCCCeeeEEEEEEeCCCceE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGT---GLSMSACREIALLREL-KHPNVINLISVFLSHNDRKV   93 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~   93 (291)
                      +.|++ +++||+|+||.||+|.+++++....||||.++..   ...+.+.+|+++|.++ +||||+++++++.  +....
T Consensus        10 ~~~~~-~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~--~~~~~   86 (309)
T d1fvra_          10 NDIKF-QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE--HRGYL   86 (309)
T ss_dssp             GGCEE-EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE--ETTEE
T ss_pred             HHcEE-EEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEe--cCCee
Confidence            34554 6799999999999999987544456888887532   2345789999999999 7999999999994  46789


Q ss_pred             EEEEecCC-CCHHHHHHHhhhh-------hhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCC
Q psy2172          94 WLLFDYAE-HDLWHIIKFHRAA-------KANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIE  165 (291)
Q Consensus        94 ~iv~e~~~-~~l~~~~~~~~~~-------~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~  165 (291)
                      ++||||++ |+|.+++......       ........+++..+..++.|++.||.|||+++++||||||+|||++    .
T Consensus        87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~----~  162 (309)
T d1fvra_          87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG----E  162 (309)
T ss_dssp             EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----G
T ss_pred             EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEc----C
Confidence            99999998 5888887643211       1112233489999999999999999999999999999999999998    6


Q ss_pred             CCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCC-CCCCCCccc----
Q psy2172         166 RGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCRQED----  240 (291)
Q Consensus       166 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~-~pf~~~~~~----  240 (291)
                      ++.+||+|||+++.....    .......||..|+|||.+.+.. ++.++||||||+++|+|++|. +||.+....    
T Consensus       163 ~~~~kl~DfG~a~~~~~~----~~~~~~~gt~~y~aPE~l~~~~-~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~  237 (309)
T d1fvra_         163 NYVAKIADFGLSRGQEVY----VKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE  237 (309)
T ss_dssp             GGCEEECCTTCEESSCEE----CCC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred             CCceEEcccccccccccc----ccccceecCCcccchHHhccCC-CCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence            789999999999754432    1223446789999999998755 899999999999999999965 678765422    


Q ss_pred             ------ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcCC
Q psy2172         241 ------IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKMP  274 (291)
Q Consensus       241 ------~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  274 (291)
                            .........+.+.+++..|..+.|..||++.++.
T Consensus       238 ~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil  277 (309)
T d1fvra_         238 KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL  277 (309)
T ss_dssp             HGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             HHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence                  1222334567899999999999999999988754

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-44  Score=301.11  Aligned_cols=237  Identities=22%  Similarity=0.324  Sum_probs=185.0

Q ss_pred             cceeCcccceEEEEEEEccCC-CCceeEEEEeCCCCCC---hhHHHHHHHHhcCCCCCeeeEEEEEEeCCCceEEEEEec
Q psy2172          24 GCKVGRGTYGHVYKARRKDNS-DTRDYALKQIEGTGLS---MSACREIALLRELKHPNVINLISVFLSHNDRKVWLLFDY   99 (291)
Q Consensus        24 ~~~ig~G~~g~Vy~~~~~~~~-~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~iv~e~   99 (291)
                      +++||+|+||+||+|.+..+. ....||||.++.....   .++.+|+++|++++||||+++++++.. .....++||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~~~lv~E~  110 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR-SEGSPLVVLPY  110 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE-TTTEEEEEEEC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEe-cCCceEEEEEE
Confidence            578999999999999986532 2345899998743322   458999999999999999999998754 34578999999


Q ss_pred             CCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcEEEeecccce
Q psy2172         100 AEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRVKIADMGFAR  178 (291)
Q Consensus       100 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~~l~Dfg~~~  178 (291)
                      +++ +|.+++.....        .++...+..++.|++.||.|||+++|+||||||+|||++    .++.+||+|||+++
T Consensus       111 ~~~g~l~~~~~~~~~--------~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~----~~~~~kL~DFG~~~  178 (311)
T d1r0pa_         111 MKHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD----EKFTVKVADFGLAR  178 (311)
T ss_dssp             CTTCBHHHHHHCTTC--------CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----TTCCEEECSSGGGC
T ss_pred             eecCchhhhhccccc--------cchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeEC----CCCCEEEecccchh
Confidence            986 66665543221        267888999999999999999999999999999999998    67899999999998


Q ss_pred             ecCCCCC-CCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc-----------ccCCCC
Q psy2172         179 LFNNPLK-PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED-----------IKTSNP  246 (291)
Q Consensus       179 ~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~-----------~~~~~~  246 (291)
                      ....... .........||..|+|||.+.+.. ++.++||||||+++|||++|..||......           .+....
T Consensus       179 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~  257 (311)
T d1r0pa_         179 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE  257 (311)
T ss_dssp             CTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCT
T ss_pred             hccccccccceecccccccccccChHHHhcCC-CCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcc
Confidence            7654322 222233457899999999988744 899999999999999999977777553321           112233


Q ss_pred             CcHHHHHHHHHhhCCCCcCChhhhhcCC
Q psy2172         247 YHHDQLDRIFSVMGFPLEKDWEDIRKMP  274 (291)
Q Consensus       247 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~  274 (291)
                      ...+.+.+++..|....|..||++.++.
T Consensus       258 ~~~~~l~~li~~cl~~dP~~RPs~~ei~  285 (311)
T d1r0pa_         258 YCPDPLYEVMLKCWHPKAEMRPSFSELV  285 (311)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             cCcHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence            4457899999999999999999988643

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-44  Score=301.74  Aligned_cols=246  Identities=21%  Similarity=0.310  Sum_probs=194.4

Q ss_pred             cccccccceeCcccceEEEEEEEcc---CCCCceeEEEEeCCCCCC---hhHHHHHHHHhcC-CCCCeeeEEEEEEeCCC
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKD---NSDTRDYALKQIEGTGLS---MSACREIALLREL-KHPNVINLISVFLSHND   90 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~---~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~   90 (291)
                      +.|++ +++||+|+||.||+|.++.   ..+++.||||+++.....   ..+.+|+.+++.+ +||||+++++++  .+.
T Consensus        23 ~~~~l-~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~--~~~   99 (311)
T d1t46a_          23 NRLSF-GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC--TIG   99 (311)
T ss_dssp             GGEEE-EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--CSS
T ss_pred             HHeEE-eeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE--eeC
Confidence            45564 8899999999999999753   346678999999754432   3578899999999 699999999999  566


Q ss_pred             ceEEEEEecCCC-CHHHHHHHhhhhhh---------CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEee
Q psy2172          91 RKVWLLFDYAEH-DLWHIIKFHRAAKA---------NKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVM  160 (291)
Q Consensus        91 ~~~~iv~e~~~~-~l~~~~~~~~~~~~---------~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~  160 (291)
                      ...+++|||+++ +|.+++........         ......+++..+..++.|++.||+|||++|++||||||+||+++
T Consensus       100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~  179 (311)
T d1t46a_         100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT  179 (311)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccc
Confidence            789999999985 88887765442110         11223489999999999999999999999999999999999998


Q ss_pred             cCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcc
Q psy2172         161 GEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQE  239 (291)
Q Consensus       161 ~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~  239 (291)
                          ..+.++++|||.++....... ........||+.|+|||.+.+. .++.++|||||||++|+|++ |.+||.+...
T Consensus       180 ----~~~~~ki~DfG~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~  253 (311)
T d1t46a_         180 ----HGRITKICDFGLARDIKNDSN-YVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (311)
T ss_dssp             ----TTTEEEECCCGGGSCTTSCTT-SEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             ----ccCcccccccchheeccCCCc-ceEeeecccChHHcCHHHhcCC-CCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence                778999999999987654322 2233456889999999999864 48999999999999999998 6777766554


Q ss_pred             cc-----------cCCCCCcHHHHHHHHHhhCCCCcCChhhhhc
Q psy2172         240 DI-----------KTSNPYHHDQLDRIFSVMGFPLEKDWEDIRK  272 (291)
Q Consensus       240 ~~-----------~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  272 (291)
                      ..           ........+.+.+++..|..+.|..||++.+
T Consensus       254 ~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~  297 (311)
T d1t46a_         254 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQ  297 (311)
T ss_dssp             SHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHH
Confidence            21           1222334577889999999999988888876

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-44  Score=300.46  Aligned_cols=247  Identities=22%  Similarity=0.363  Sum_probs=188.7

Q ss_pred             cccccccceeCcccceEEEEEEEccCC-----CCceeEEEEeCCCCCC---hhHHHHHHHHhcC-CCCCeeeEEEEEEeC
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNS-----DTRDYALKQIEGTGLS---MSACREIALLREL-KHPNVINLISVFLSH   88 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~-----~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l-~h~~iv~~~~~~~~~   88 (291)
                      +.|++ ++.||+|+||.||+|++..+.     .+..||||.++.....   .++.+|+..+.++ +||||+++++++  .
T Consensus        13 ~~~~l-~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~--~   89 (299)
T d1fgka_          13 DRLVL-GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC--T   89 (299)
T ss_dssp             GGEEE-EEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--C
T ss_pred             HHeEE-eeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccc--c
Confidence            45554 789999999999999976532     2246999999765432   3577888888888 799999999999  4


Q ss_pred             CCceEEEEEecCCC-CHHHHHHHhhhh-------hhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEee
Q psy2172          89 NDRKVWLLFDYAEH-DLWHIIKFHRAA-------KANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVM  160 (291)
Q Consensus        89 ~~~~~~iv~e~~~~-~l~~~~~~~~~~-------~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~  160 (291)
                      +....++||||+.+ +|.+++......       ........+++..++.++.|++.||+|||+++|+||||||+|||++
T Consensus        90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~  169 (299)
T d1fgka_          90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT  169 (299)
T ss_dssp             SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred             cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeec
Confidence            56789999999984 888887644311       0111223489999999999999999999999999999999999998


Q ss_pred             cCCCCCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHc-CCCCCCCCcc
Q psy2172         161 GEGIERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQE  239 (291)
Q Consensus       161 ~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~pf~~~~~  239 (291)
                          .++.+||+|||.+......... .......|++.|+|||.+.+.. ++.++||||||+++|+|++ |.+||.+...
T Consensus       170 ----~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~-y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~  243 (299)
T d1fgka_         170 ----EDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  243 (299)
T ss_dssp             ----TTCCEEECSTTCCCCGGGCCTT-CCCTTSCCGGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             ----CCCCeEeccchhhccccccccc-cccccCCCChhhhhhhHhcCCC-CCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence                6789999999999877653222 2334567899999999998744 9999999999999999997 7999986553


Q ss_pred             c----------ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         240 D----------IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       240 ~----------~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      .          .........+.+.+++..|....|..||++.++
T Consensus       244 ~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~ei  287 (299)
T d1fgka_         244 EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL  287 (299)
T ss_dssp             HHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHH
Confidence            2          122333445778899999999999999888863

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-44  Score=299.27  Aligned_cols=247  Identities=20%  Similarity=0.285  Sum_probs=196.1

Q ss_pred             cccccccceeCcccceEEEEEEEccC---CCCceeEEEEeCCCCCCh---hHHHHHHHHhcCCCCCeeeEEEEEEeCCCc
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDN---SDTRDYALKQIEGTGLSM---SACREIALLRELKHPNVINLISVFLSHNDR   91 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~---~~~~~vaiK~~~~~~~~~---~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (291)
                      +.|. .+++||+|+||.||+|.++..   ..+..||||+++.....+   .+.+|+.++++++||||+++++++  ....
T Consensus        20 ~~~~-l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~--~~~~   96 (308)
T d1p4oa_          20 EKIT-MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV--SQGQ   96 (308)
T ss_dssp             GGEE-EEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE--CSSS
T ss_pred             HHeE-EeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEE--ecCC
Confidence            4555 378999999999999988642   234679999997544333   478999999999999999999999  5566


Q ss_pred             eEEEEEecCC-CCHHHHHHHhhhhh-hCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecCCCCCCcE
Q psy2172          92 KVWLLFDYAE-HDLWHIIKFHRAAK-ANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGEGIERGRV  169 (291)
Q Consensus        92 ~~~iv~e~~~-~~l~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~~~~~~~~  169 (291)
                      ..++||||+. |+|.+++....... .......++...+..++.|+++||.|||+++|+||||||+|||++    .+.++
T Consensus        97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld----~~~~~  172 (308)
T d1p4oa_          97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA----EDFTV  172 (308)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEEC----TTCCE
T ss_pred             ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeec----CCceE
Confidence            8899999997 58888877654322 222333478899999999999999999999999999999999998    77899


Q ss_pred             EEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcC-CCCCCCCccc--------
Q psy2172         170 KIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQED--------  240 (291)
Q Consensus       170 ~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g-~~pf~~~~~~--------  240 (291)
                      ||+|||+++....... ........|++.|+|||.+.+.. ++.++||||||+++|+|++| .+||.+....        
T Consensus       173 Kl~DFGla~~~~~~~~-~~~~~~~~~t~~y~aPe~l~~~~-~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~  250 (308)
T d1p4oa_         173 KIGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME  250 (308)
T ss_dssp             EECCTTCCCGGGGGGC-EEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred             EEeecccceeccCCcc-eeeccceecccccCCHHHHccCC-CCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence            9999999986654322 12223457899999999998754 88999999999999999998 5888776532        


Q ss_pred             --ccCCCCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         241 --IKTSNPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       241 --~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                        .....+.....+.+++..|....|..||++.++
T Consensus       251 ~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~i  285 (308)
T d1p4oa_         251 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEI  285 (308)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence              122334455789999999999999999998764

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-43  Score=297.01  Aligned_cols=237  Identities=24%  Similarity=0.306  Sum_probs=177.1

Q ss_pred             ccccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHH--HHHHhcCCCCCeeeEEEEEEeCCC--ce
Q psy2172          17 EDLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACRE--IALLRELKHPNVINLISVFLSHND--RK   92 (291)
Q Consensus        17 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e--~~~l~~l~h~~iv~~~~~~~~~~~--~~   92 (291)
                      ++.|.+ .+.||+|+||.||+|++    .++.||||.++... .....+|  +..+.+++||||+++++++..++.  ..
T Consensus         2 ~~~~~l-~~~iG~G~fg~Vy~~~~----~g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~   75 (303)
T d1vjya_           2 ARTIVL-QESIGKGRFGEVWRGKW----RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ   75 (303)
T ss_dssp             GGGEEE-EEEEECCSSSEEEEEEE----TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             CcEEEE-EEEEeeCCCeEEEEEEE----CCEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence            344453 67999999999999986    35789999997543 3334444  445556799999999999976443  47


Q ss_pred             EEEEEecCCC-CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhh--------CCeeeeccCCCcEEeecCC
Q psy2172          93 VWLLFDYAEH-DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHS--------NWVLHRDLKPANILVMGEG  163 (291)
Q Consensus        93 ~~iv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~--------~~ivH~dik~~Nil~~~~~  163 (291)
                      +|+||||+.+ +|.+.+....          +++..++.++.|++.||+|+|+        +||+|+||||+||+++   
T Consensus        76 ~~lv~Ey~~~g~L~~~l~~~~----------l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~---  142 (303)
T d1vjya_          76 LWLVSDYHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK---  142 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEEC---
T ss_pred             EEEEEecccCCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEc---
Confidence            8999999975 8888886422          8899999999999999999996        5999999999999998   


Q ss_pred             CCCCcEEEeecccceecCCCCCC-CCCCCCceecccccccccccCCc-----CCCCchhHHHHHHHHHHHHcCCCCCCCC
Q psy2172         164 IERGRVKIADMGFARLFNNPLKP-LADLDPVVVTFWYRAPELLLGAR-----HYTKAIDIWAIGCIFAELLTSEPIFHCR  237 (291)
Q Consensus       164 ~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~-----~~~~~~Dv~slG~~l~~l~~g~~pf~~~  237 (291)
                       .++.+||+|||++......... ........||+.|+|||++.+..     .++.++|||||||+||||++|..||...
T Consensus       143 -~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~  221 (303)
T d1vjya_         143 -KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH  221 (303)
T ss_dssp             -TTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBC
T ss_pred             -CCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcc
Confidence             6789999999999877553222 22334567899999999987532     2567899999999999999999887543


Q ss_pred             cccccC----------------------C---------CCCcHHHHHHHHHhhCCCCcCChhhhhcC
Q psy2172         238 QEDIKT----------------------S---------NPYHHDQLDRIFSVMGFPLEKDWEDIRKM  273 (291)
Q Consensus       238 ~~~~~~----------------------~---------~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  273 (291)
                      ......                      .         .......+.+++..|..+.|..||++.++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei  288 (303)
T d1vjya_         222 EDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI  288 (303)
T ss_dssp             CCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHH
T ss_pred             cccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHH
Confidence            321100                      0         00112346778888888888888887753

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.9e-39  Score=278.57  Aligned_cols=248  Identities=25%  Similarity=0.374  Sum_probs=188.3

Q ss_pred             cccccccceeCcccceEEEEEEEccCCCCceeEEEEeCCCC-CChhHHHHHHHHhcCC-----------CCCeeeEEEEE
Q psy2172          18 DLFDYEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTG-LSMSACREIALLRELK-----------HPNVINLISVF   85 (291)
Q Consensus        18 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~-----------h~~iv~~~~~~   85 (291)
                      ++|++ .++||+|+||+||+|+++.  +++.||||+++... ..+.+.+|+.+++.++           |+||+++++++
T Consensus        13 ~rY~i-~~~LG~G~fg~Vy~~~~~~--~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~   89 (362)
T d1q8ya_          13 ARYIL-VRKLGWGHFSTVWLAKDMV--NNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   89 (362)
T ss_dssp             TTEEE-EEEEEECSSEEEEEEEETT--TTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             CcEEE-EEEEeeCCCeEEEEEEECC--CCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence            46775 7899999999999999876  77899999998653 2356788999988875           57899999998


Q ss_pred             EeCCCceEEEEEecCCC--CHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCeeeeccCCCcEEeecC
Q psy2172          86 LSHNDRKVWLLFDYAEH--DLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHS-NWVLHRDLKPANILVMGE  162 (291)
Q Consensus        86 ~~~~~~~~~iv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~-~~ivH~dik~~Nil~~~~  162 (291)
                      ...+....++++.++..  +..........       ..+++..++.++.|++.||+|||+ .||+||||||+||+++.+
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~  162 (362)
T d1q8ya_          90 NHKGPNGVHVVMVFEVLGENLLALIKKYEH-------RGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV  162 (362)
T ss_dssp             EEEETTEEEEEEEECCCCEEHHHHHHHTTT-------SCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEE
T ss_pred             eeccccceeeeeeecccccccccccccccc-------cCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeecc
Confidence            66556666777666653  33333332221       228899999999999999999998 899999999999999853


Q ss_pred             CC--CCCcEEEeecccceecCCCCCCCCCCCCceecccccccccccCCcCCCCchhHHHHHHHHHHHHcCCCCCCCCccc
Q psy2172         163 GI--ERGRVKIADMGFARLFNNPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED  240 (291)
Q Consensus       163 ~~--~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~pf~~~~~~  240 (291)
                      +.  ....++++|||.+......      .....||+.|+|||++.+.. ++.++|+||+||++++|++|+.||......
T Consensus       163 ~~~~~~~~~kl~dfg~s~~~~~~------~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~pF~~~~~~  235 (362)
T d1q8ya_         163 DSPENLIQIKIADLGNACWYDEH------YTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGH  235 (362)
T ss_dssp             ETTTTEEEEEECCCTTCEETTBC------CCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             CcccccceeeEeecccccccccc------cccccccccccChhhccccC-CCccccccchHHHHHHHHHCCCCCCCCccc
Confidence            21  1235899999998765432      23457899999999998755 899999999999999999999999754321


Q ss_pred             cc---------------------------------------C------------------CCCCcHHHHHHHHHhhCCCC
Q psy2172         241 IK---------------------------------------T------------------SNPYHHDQLDRIFSVMGFPL  263 (291)
Q Consensus       241 ~~---------------------------------------~------------------~~~~~~~~~~~i~~~~~~~~  263 (291)
                      ..                                       .                  ........+.+++..|....
T Consensus       236 ~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~d  315 (362)
T d1q8ya_         236 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD  315 (362)
T ss_dssp             ---CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSS
T ss_pred             cccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCC
Confidence            00                                       0                  00112455777899999999


Q ss_pred             cCChhhhhcCCCCcchhhh
Q psy2172         264 EKDWEDIRKMPEHPTLLKD  282 (291)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~  282 (291)
                      |..||+++++..|||+...
T Consensus       316 P~~Rpta~e~L~Hp~f~~~  334 (362)
T d1q8ya_         316 PRKRADAGGLVNHPWLKDT  334 (362)
T ss_dssp             TTTCBCHHHHHTCGGGTTC
T ss_pred             hhHCcCHHHHhcCcccCCC
Confidence            9999999999999998743

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=9.5e-26  Score=175.44  Aligned_cols=130  Identities=21%  Similarity=0.183  Sum_probs=102.3

Q ss_pred             ccceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCC--------------------hhHHHHHHHHhcCCCCCeeeEE
Q psy2172          23 EGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLS--------------------MSACREIALLRELKHPNVINLI   82 (291)
Q Consensus        23 ~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~--------------------~~~~~e~~~l~~l~h~~iv~~~   82 (291)
                      .|++||+|+||+||+|.+.   +++.||||+++.....                    ....+|...+.++.|++++..+
T Consensus         4 vg~~IG~G~~g~Vy~a~~~---~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSE---KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             EEEEEEECSSEEEEEEEET---TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             hCCEeeeCcceEEEEEECC---CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            4889999999999999874   5678999987532110                    1234688899999999999988


Q ss_pred             EEEEeCCCceEEEEEecCCCCHHHHHHHhhhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCeeeeccCCCcEEeecC
Q psy2172          83 SVFLSHNDRKVWLLFDYAEHDLWHIIKFHRAAKANKKPVMVPKGMVKSLLYQILDGIHYLHSNWVLHRDLKPANILVMGE  162 (291)
Q Consensus        83 ~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~dik~~Nil~~~~  162 (291)
                      ++.  ..    +++||++++....        .       ++...+..++.|++.++++||++||+|+||||+||+++  
T Consensus        81 ~~~--~~----~lvme~~~~~~~~--------~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~--  137 (191)
T d1zara2          81 AWE--GN----AVLMELIDAKELY--------R-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS--  137 (191)
T ss_dssp             EEE--TT----EEEEECCCCEEGG--------G-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE--
T ss_pred             Eec--CC----EEEEEeecccccc--------c-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeee--
Confidence            765  22    7999999974210        0       45556778999999999999999999999999999997  


Q ss_pred             CCCCCcEEEeecccceecC
Q psy2172         163 GIERGRVKIADMGFARLFN  181 (291)
Q Consensus       163 ~~~~~~~~l~Dfg~~~~~~  181 (291)
                        + ..++|+|||.|....
T Consensus       138 --~-~~~~liDFG~a~~~~  153 (191)
T d1zara2         138 --E-EGIWIIDFPQSVEVG  153 (191)
T ss_dssp             --T-TEEEECCCTTCEETT
T ss_pred             --C-CCEEEEECCCcccCC
Confidence              3 358999999997654

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.50  E-value=4.9e-07  Score=71.71  Aligned_cols=70  Identities=20%  Similarity=0.174  Sum_probs=48.9

Q ss_pred             CcccceEEEEEEEccCCCCceeEEEEeCCC--CCChhHHHHHHHHhcCC-CCCeeeEEEEEEeCCCceEEEEEecCCCC
Q psy2172          28 GRGTYGHVYKARRKDNSDTRDYALKQIEGT--GLSMSACREIALLRELK-HPNVINLISVFLSHNDRKVWLLFDYAEHD  103 (291)
Q Consensus        28 g~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~iv~e~~~~~  103 (291)
                      +.++.+.||+...    .++.+++|+....  .....+.+|+..++.+. +--+++++.+.  ++....++||++.+|.
T Consensus        23 ~G~s~~~v~rv~~----~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~--~~~~~~~lv~~~l~G~   95 (263)
T d1j7la_          23 EGMSPAKVYKLVG----ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE--RHDGWSNLLMSEADGV   95 (263)
T ss_dssp             CCCSSSEEEEEEC----SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE--EETTEEEEEEECCSSE
T ss_pred             CCCCCCcEEEEEe----CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEE--ecCCceEEEEEecccc
Confidence            3345578998862    4456888887643  23446788999888774 33467778776  4456889999999883

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.32  E-value=2.4e-06  Score=67.26  Aligned_cols=72  Identities=15%  Similarity=0.111  Sum_probs=50.4

Q ss_pred             ceeCcccc-eEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCCC--CCeeeEEEEEEeCCCceEEEEEecCC
Q psy2172          25 CKVGRGTY-GHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELKH--PNVINLISVFLSHNDRKVWLLFDYAE  101 (291)
Q Consensus        25 ~~ig~G~~-g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~~~iv~e~~~  101 (291)
                      +.+..|.. +.||+....   ++..+++|..+.. ....+..|+..++.+..  -.+++++.+.  .+....+++|++++
T Consensus        16 ~~~~~G~s~~~v~r~~~~---~~~~~vlK~~~~~-~~~~l~~E~~~l~~L~~~gvpvP~v~~~~--~~~~~~~~v~~~i~   89 (255)
T d1nd4a_          16 AQQTIGCSDAAVFRLSAQ---GRPVLFVKTDLSG-ALNELQDEAARLSWLATTGVPCAAVLDVV--TEAGRDWLLLGEVP   89 (255)
T ss_dssp             EECSCTTSSCEEEEEECT---TSCCEEEEEECSC-TTSCHHHHHHHHHHHHTTTCCBCCEEEEE--ECSSCEEEEEECCS
T ss_pred             EEcCCcccCCeEEEEEeC---CCCEEEEEeCCcc-CHhHHHHHHHHHHHHHhcCCCCCceeeec--ccccceEEEEEeee
Confidence            35556654 688988743   4556899987654 34567888888887742  3467777776  45567899999998


Q ss_pred             C
Q psy2172         102 H  102 (291)
Q Consensus       102 ~  102 (291)
                      |
T Consensus        90 G   90 (255)
T d1nd4a_          90 G   90 (255)
T ss_dssp             S
T ss_pred             c
Confidence            6

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.08  E-value=1.8e-05  Score=66.39  Aligned_cols=75  Identities=16%  Similarity=0.092  Sum_probs=49.1

Q ss_pred             cccceeCcccceEEEEEEEccCCCCceeEEEEeCC------C---CCChhHHHHHHHHhcCC-C--CCeeeEEEEEEeCC
Q psy2172          22 YEGCKVGRGTYGHVYKARRKDNSDTRDYALKQIEG------T---GLSMSACREIALLRELK-H--PNVINLISVFLSHN   89 (291)
Q Consensus        22 ~~~~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~------~---~~~~~~~~e~~~l~~l~-h--~~iv~~~~~~~~~~   89 (291)
                      +..+.||.|....||++....  +++.+++|.-..      +   ....+...|+++|+.+. +  ..+++++.+-  ++
T Consensus        29 l~~~eig~G~~N~vfrV~~~~--~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~  104 (392)
T d2pula1          29 LTCQEIGDGNLNYVFHIYDQE--HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TE  104 (392)
T ss_dssp             CEEEECCSSSSEEEEEEEC------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TT
T ss_pred             eeEEEeCCCceEeEEEEEeCC--CCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CC
Confidence            345689999999999998654  567799997532      1   12345667888888763 2  3567777653  33


Q ss_pred             CceEEEEEecCCC
Q psy2172          90 DRKVWLLFDYAEH  102 (291)
Q Consensus        90 ~~~~~iv~e~~~~  102 (291)
                        ..+++||++++
T Consensus       105 --~~~lvmE~L~~  115 (392)
T d2pula1         105 --MAVTVMEDLSH  115 (392)
T ss_dssp             --TTEEEECCCTT
T ss_pred             --CCEEEEeccCC
Confidence              34789999875

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.77  E-value=6e-05  Score=63.14  Aligned_cols=75  Identities=12%  Similarity=0.115  Sum_probs=53.3

Q ss_pred             cccceeCcccceEEEEEEEccC-----CCCceeEEEEeCCCCCChhHHHHHHHHhcCC-CCCeeeEEEEEEeCCCceEEE
Q psy2172          22 YEGCKVGRGTYGHVYKARRKDN-----SDTRDYALKQIEGTGLSMSACREIALLRELK-HPNVINLISVFLSHNDRKVWL   95 (291)
Q Consensus        22 ~~~~~ig~G~~g~Vy~~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~i   95 (291)
                      ++.+.|+.|-.-.+|++.....     ...+.|++++...........+|..+++.+. +.-.+++++++  ++    ..
T Consensus        45 l~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~--~~----g~  118 (395)
T d1nw1a_          45 LRISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF--SG----GR  118 (395)
T ss_dssp             EEEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE--TT----EE
T ss_pred             eEEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEc--CC----ce
Confidence            4567899899999999986542     1234577777664444456778999999884 44456788877  44    68


Q ss_pred             EEecCCC
Q psy2172          96 LFDYAEH  102 (291)
Q Consensus        96 v~e~~~~  102 (291)
                      |++|.+|
T Consensus       119 I~efi~g  125 (395)
T d1nw1a_         119 LEEYIPS  125 (395)
T ss_dssp             EECCCCE
T ss_pred             EEEEecc
Confidence            8999886

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.11  E-value=0.00024  Score=57.68  Aligned_cols=68  Identities=15%  Similarity=0.165  Sum_probs=42.6

Q ss_pred             ceEEEEEEEccCCCCceeEEEEeCCCC-CChhHHHHHHHHhcCCCCCe--eeEEEE---EEeCCCceEEEEEecCCC
Q psy2172          32 YGHVYKARRKDNSDTRDYALKQIEGTG-LSMSACREIALLRELKHPNV--INLISV---FLSHNDRKVWLLFDYAEH  102 (291)
Q Consensus        32 ~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i--v~~~~~---~~~~~~~~~~iv~e~~~~  102 (291)
                      .-.||++...   ++..|++|+.+... ...++..|...+..|...++  +..+..   .........+.++++.+|
T Consensus        35 EN~vy~v~~~---dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G  108 (325)
T d1zyla1          35 ENRVYQFQDE---DRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  108 (325)
T ss_dssp             SSEEEEECCT---TCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             cceeEEEEcC---CCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence            3589999753   56779999987654 34568889998888742222  211111   000224567889999876

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.00  E-value=0.00063  Score=54.72  Aligned_cols=46  Identities=11%  Similarity=0.029  Sum_probs=29.6

Q ss_pred             ceeCcccceEEEEEEEccCCCCceeEEEEeCCCCCChhHHHHHHHHhcCC
Q psy2172          25 CKVGRGTYGHVYKARRKDNSDTRDYALKQIEGTGLSMSACREIALLRELK   74 (291)
Q Consensus        25 ~~ig~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~   74 (291)
                      +.|..|.--+.|+....+    ..+++|+........++..|+.++..|.
T Consensus        24 ~~i~~G~~N~ny~v~t~~----g~yVLri~~~~~~~~~l~~~~~~l~~L~   69 (316)
T d2ppqa1          24 KGIAEGVENSNFLLHTTK----DPLILTLYEKRVEKNDLPFFLGLMQHLA   69 (316)
T ss_dssp             EEECC---EEEEEEEESS----CCEEEEEECC---CCHHHHHHHHHHHHH
T ss_pred             ecCCCCcccCeEEEEECC----CcEEEEEcCCCCCHHHHHHHHHHHHhhh
Confidence            346677778889987532    3599999876555667777888888874